PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Kok, MGM; Halliani, A; Moerland, PD; Meijers, JCM; Creemers, EE; Pinto-Sietsma, SJ				Kok, Maayke G. M.; Halliani, Amalia; Moerland, Perry D.; Meijers, Joost C. M.; Creemers, Esther E.; Pinto-Sietsma, Sara-Joan			Normalization panels for the reliable quantification of circulating microRNAs by RT-qPCR	FASEB JOURNAL			English	Article						coronary artery disease; platelets; serum; whole blood	GENE-EXPRESSION ANALYSIS; ENDOGENOUS CONTROL; REFERENCE RNA; IDENTIFICATION; SERUM; BIOMARKERS	Circulating microRNAs (miRNAs) have been reported as biomarkers for disease diagnosis. RT-qPCR is most commonly used to detect miRNAs; however, no consensus on the most appropriate method for data normalization exists. Via a standardized selection method, we aimed to determine separate miRNA normalization panels for RT-qPCR measurements on whole blood, platelets, and serum. Candidate miRNAs were selected from studies describing circulating miRNA microarray data in the Gene Expression Omnibus or ArrayExpress. miRNA expression data of healthy controls were retrieved from each study. For each sample type, we selected those miRNAs that were least variable and sufficiently highly expressed in multiple microarray experiments, performed on at least 2 different platforms. Stability of the candidate miRNAs was assessed using NormFinder and geNorm algorithms in a RT-qPCR cohort of 10 patients with coronary artery disease and 10 healthy controls. We selected miRNA normalization panels for RT-qPCR measurements on whole blood, platelets, and serum. As a validation, we assessed the precision of all 3 panels in 3 independent RT-qPCR cohorts and compared this with normalization for miR-16 or RNU6B. The proposed normalization panels for whole blood, platelets, and serum show better precision than normalization for miR-16 or RNU6B.	[Kok, Maayke G. M.; Pinto-Sietsma, Sara-Joan] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Kok, Maayke G. M.; Meijers, Joost C. M.] Univ Amsterdam, Acad Med Ctr, Dept Expt Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Halliani, Amalia; Creemers, Esther E.] Univ Amsterdam, Acad Med Ctr, Dept Expt Cardiol, NL-1105 AZ Amsterdam, Netherlands; [Moerland, Perry D.; Pinto-Sietsma, Sara-Joan] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, NL-1105 AZ Amsterdam, Netherlands; [Meijers, Joost C. M.] Sanquin, Dept Plasma Prot, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Pinto-Sietsma, SJ (corresponding author), Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, POB 22660, NL-1100 DD Amsterdam, Netherlands.	s.j.pinto@amc.uva.nl	Moerland, Perry/AAG-1425-2020; Meijers, J.C.M./S-5981-2019; SJ, Pinto-Sietsma/AAI-3207-2021	Moerland, Perry/0000-0002-2357-3659; Meijers, J.C.M./0000-0002-4198-6780; Creemers, Esther/0000-0002-9001-3854	project INCOAG [01C-201]; Dutch Heart Foundation	project INCOAG; Dutch Heart Foundation(Netherlands Heart Foundation)	This research was performed within the framework of the Center for Translational Molecular Medicine (www.ctmm.nl), and project INCOAG (Grant 01C-201) and was supported by the Dutch Heart Foundation.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Appaiah HN, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2943; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Benz F, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.81; Brattelid T, 2011, PHYSIOL GENOMICS, V43, P604, DOI 10.1152/physiolgenomics.00131.2010; Chen X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079652; Chuaqui RF, 2002, NAT GENET, V32, P509, DOI 10.1038/ng1034; Cookson VJ, 2012, CELL ONCOL, V35, P301, DOI 10.1007/s13402-012-0089-1; Cox MB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012132; Davoren PA, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-76; Duttagupta R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031241; Filkova M, 2014, ANN RHEUM DIS, V73, P1898, DOI 10.1136/annrheumdis-2012-202815; Ge W, 2014, CLIN LAB, V60, P427, DOI 10.7754/Clin.Lab.2013.130133; Gee HE, 2011, BRIT J CANCER, V104, P1168, DOI 10.1038/sj.bjc.6606076; Gilsbach R, 2006, BIOTECHNIQUES, V40, P173, DOI 10.2144/000112052; Godfrey AC, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3428; Haider BA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089565; Hardikar AA, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000792; Hu J, 2014, INT J CANCER, V135, P1187, DOI 10.1002/ijc.28757; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Jain S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060932; Kagias K, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-222; Kang K, 2012, J ANIM SCI BIOTECHNO, V3, DOI 10.1186/2049-1891-3-4; Keller A, 2011, NAT METHODS, V8, P841, DOI [10.1038/nmeth.1682, 10.1038/NMETH.1682]; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Li PX, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000972; McCann SE, 2013, BRIT J NUTR, V109, P585, DOI 10.1017/S0007114512001936; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Mestdagh P, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn725; Mi QS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031278; Murakami Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048366; NCBI, 2015, GSE59421 NCBI; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Schrauder MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029770; Smith RD, 2003, BIOTECHNIQUES, V34, P88, DOI 10.2144/03341st05; Sondermeijer BM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025946; Thorrez L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001854; Tijsen AJ, 2012, AM J PHYSIOL-HEART C, V303, pH1085, DOI 10.1152/ajpheart.00191.2012; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Xu X, 2012, BLOOD, V120, P3575, DOI 10.1182/blood-2012-02-411264; Zernecke A, 2012, THROMB HAEMOSTASIS, V107, P626, DOI 10.1160/TH11-08-0603	42	59	60	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2015	29	9					3853	3862		10.1096/fj.15-271312	http://dx.doi.org/10.1096/fj.15-271312			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CP5IU	26023181				2022-12-26	WOS:000359915600021
J	Coghlan, BA; Goldizen, AW; Thomson, VA; Seddon, JM				Coghlan, Brett A.; Goldizen, Anne W.; Thomson, Vicki A.; Seddon, Jennifer M.			Phylogeography of Eastern Grey Kangaroos, Macropus giganteus, Suggests a Mesic Refugium in Eastern Australia	PLOS ONE			English	Article							PERCHED LAKE-SEDIMENTS; MITOCHONDRIAL-DNA; RAIN-FOREST; HISTORICAL BIOGEOGRAPHY; CLIMATIC OSCILLATIONS; POPULATION-GENETICS; STATISTICAL TESTS; CONTROL REGION; FRASER ISLAND; EVOLUTION	Phylogeographic studies around the world have identified refugia where fauna were able to persist during unsuitable climatic periods, particularly during times of glaciation. In Australia the effects of Pleistocene climate oscillations on rainforest taxa have been well studied but less is known about the effects on mesic-habitat fauna, such as the eastern grey kangaroo (Macropus giganteus). The eastern grey kangaroo is a large mammal that is common and widespread throughout eastern Australia, preferring dry mesic habitat, rather than rainforest. As pollen evidence suggests that the central-eastern part of Australia (southeast Queensland and northern New South Wales) experienced cycles of expansion in mesic habitat with contraction in rainforests, and vice versa during glacial and interglacial periods, respectively, we hypothesise that the distribution of the eastern grey kangaroo was affected by these climate oscillations and may have contracted to mesic habitat refugia. From 375 mitochondrial DNA control region sequences from across the distribution of eastern grey kangaroos we obtained 108 unique haplotypes. Phylogenetic analysis identified two clades in Queensland, one of which is newly identified and restricted to a small coastal region in southern Queensland north of Brisbane, known as the Sunshine Coast. The relatively limited geographic range of this genetically isolated clade suggests the possibility of a mesic habitat refugium forming during rainforest expansion during wetter climate cycles. Other potential, although less likely, reasons for the genetic isolation of the highly distinct clade include geographic barriers, separate northward expansions, and strong local adaptation.	[Coghlan, Brett A.; Goldizen, Anne W.; Thomson, Vicki A.] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia; [Seddon, Jennifer M.] Univ Queensland, Sch Vet Sci, Gatton, Qld, Australia	University of Queensland; University of Queensland	Coghlan, BA (corresponding author), Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia.	brett.coghlan@uqconnect.edu.au	Goldizen, Anne/G-7366-2012; Thomson, Vicki A./B-9971-2014; Seddon, Jennifer/AAM-3827-2021; Seddon, Jennifer/A-1402-2010	Goldizen, Anne/0000-0003-0101-4108; Thomson, Vicki A./0000-0001-8368-9664; Seddon, Jennifer/0000-0003-3789-6878; Seddon, Jennifer/0000-0003-3789-6878	National Geograhic Society [8055-06]; Australian Research Council [DP120102693]	National Geograhic Society; Australian Research Council(Australian Research Council)	This study was funded by a grants from the National Geograhic Society (grant 8055-06; http://www.nationalgeographic.com/explorers/grantsprograms/cre/) to AWG and from the Australian Research Council (grant DP120102693; http://arc.gov.au/) to AWG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Byrne M, 2008, MOL ECOL, V17, P4398, DOI 10.1111/j.1365-294X.2008.03899.x; Byrne M, 2008, QUATERNARY SCI REV, V27, P2576, DOI 10.1016/j.quascirev.2008.08.032; Chapple DG, 2011, J BIOGEOGR, V38, P1761, DOI 10.1111/j.1365-2699.2011.02531.x; Chapple DG, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-191; Clegg SM, 1998, MOL ECOL, V7, P679, DOI 10.1046/j.1365-294x.1998.00376.x; Commonwealth of Australia, 2011, KANGAROO POPULATION; Commonwealth of Australia (Geoscience Australia), 2006, STATES INCLUDING COA; Crisp M, 2004, PHILOS T R SOC B, V359, P1551, DOI 10.1098/rstb.2004.1528; Crisp M, 1999, FLORA AUSTR, V1, P321; Davis NE, 2008, WILDLIFE RES, V35, P684, DOI 10.1071/WR08042; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FU YX, 1993, GENETICS, V133, P693; Fu YX, 1997, GENETICS, V147, P915; Fumagalli L, 1997, MOL ECOL, V6, P1199, DOI 10.1046/j.1365-294X.1997.00298.x; Gallagher SJ, 2003, PALAEOGEOGR PALAEOCL, V193, P349, DOI 10.1016/S0031-0182(03)00231-1; Graham CH, 2010, ECOGRAPHY, V33, P1062, DOI 10.1111/j.1600-0587.2010.06430.x; Grant WS, 1998, J HERED, V89, P415, DOI 10.1093/jhered/89.5.415; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; HILL GJE, 1981, AUST WILDLIFE RES, V8, P245; Honnen AC, 2010, BIOL J LINN SOC, V99, P727, DOI 10.1111/j.1095-8312.2010.01373.x; JARMAN PJ, 1983, AUST WILDLIFE RES, V10, P33; Lee KE, 2010, CONSERV GENET, V11, P2091, DOI 10.1007/s10592-009-9987-9; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Longmore ME, 1999, QUATERN INT, V57-8, P35, DOI 10.1016/S1040-6182(98)00048-2; Longmore ME, 1997, AUST J BOT, V45, P507, DOI 10.1071/BT96109; Malekian M, 2010, MOL PHYLOGENET EVOL, V54, P122, DOI 10.1016/j.ympev.2009.07.026; McGrath R, 1998, AUST GEOGR, V29, P205, DOI 10.1080/00049189808703215; McGuigan K, 1998, MOL ECOL, V7, P175, DOI 10.1046/j.1365-294x.1998.00329.x; Moritz C, 2000, ANNU REV ECOL SYST, V31, P533, DOI 10.1146/annurev.ecolsys.31.1.533; Nauman R, 2010, QUEENSLAND AUSTRALIA; Neaves LE, 2009, MOL ECOL, V18, P3363, DOI 10.1111/j.1365-294X.2009.04293.x; Nicholls JA, 2000, J AVIAN BIOL, V31, P165, DOI 10.1034/j.1600-048X.2000.310208.x; Pavlova A, 2010, CONSERV GENET, V11, P2393, DOI 10.1007/s10592-010-0125-5; Piggott MP, 2003, AUST J ZOOL, V51, P341, DOI 10.1071/ZO03012; Polzin T, 2003, OPER RES LETT, V31, P12, DOI 10.1016/S0167-6377(02)00185-2; POOLE W E, 1982, Mammalian Species, P1, DOI 10.2307/3504005; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A., 2009, FIGTREE 1 3 1; Rix MG, 2012, MOL PHYLOGENET EVOL, V62, P375, DOI 10.1016/j.ympev.2011.10.009; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schauble CS, 2001, BIOL J LINN SOC, V74, P157, DOI 10.1006/bijl.2001.0562; Schneider C, 1999, P ROY SOC B-BIOL SCI, V266, P191, DOI 10.1098/rspb.1999.0621; Schneider CJ, 1998, MOL ECOL, V7, P487, DOI 10.1046/j.1365-294x.1998.00334.x; Sniderman JMK, 2011, J BIOGEOGR, V38, P1456, DOI 10.1111/j.1365-2699.2011.02518.x; TAJIMA F, 1989, GENETICS, V123, P585; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanner Z, 2001, STATUS AND MANAGEMEN; TAYLOR RJ, 1983, AUST WILDLIFE RES, V10, P203; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VanDerWal J, 2009, J BIOGEOGR, V36, P291, DOI 10.1111/j.1365-2699.2008.01993.x; Zenger KR, 2003, HEREDITY, V91, P153, DOI 10.1038/sj.hdy.6800293	55	4	4	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128160	10.1371/journal.pone.0128160	http://dx.doi.org/10.1371/journal.pone.0128160			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024370	gold, Green Published, Green Submitted			2022-12-26	WOS:000355319400073
J	Li, X; Du, WJ; Ma, FX; Feng, XM; Bayard, F; Han, ZC				Li, Xue; Du, Wenjing; Ma, Feng Xia; Feng, Xiaoming; Bayard, Francis; Han, Zhong Chao			High Concentrations of TNF-alpha Induce Cell Death during Interactions between Human Umbilical Cord Mesenchymal Stem Cells and Peripheral Blood Mononuclear Cells	PLOS ONE			English	Article							STROMAL CELLS; IL-6; INTERLEUKIN-6; MACROPHAGES; IL-1-BETA; PROMOTE	Human umbilical cord mesenchymal stromal cells (hUC-MSCs) are currently being used as novel therapeutic agents in numerous clinical trials. Previous works have shown that hUC-MSCs possess profound immunomodulatory capacities through IL-1 stimulation produced by peripheral blood mononuclear cells (PBMCs), their main cellular partner in most pathophysiological and therapeutic situations. The present study was designed to explore the role of TNF-alpha in these interactions. In these experiments, we demonstrated that TNF-alpha originated from PBMCs under the influence of IL-1. We also showed that TNF-alpha acted differently depending upon the concentrations reached. At low concentrations it clearly contributed to IL-6 and monocyte chemotactic protein 1 (MCP-1) production. At high concentrations, used alone or in association with the TNF-related apoptosis-inducing ligand, TNF-alpha also stimulated hUC-MSC IL-6 but, more intensely, MCP-1 production. This stimulation was associated but independent of apoptosis induction in a process involving Inhibitor of Apoptosis Proteins. Interferon gamma (IFN-gamma), tested to stimulate PBMC and tissue activation, amplified IL-6 and MCP-1 production and cell death by, apparently, a different process involving necrosis. Our findings bring new insights into the complex interactions between hUC-MSCs and PBMCs, involving cytokines, chemokines and cell death, and are of fundamental importance for tissue homeostasis.	[Li, Xue; Du, Wenjing; Ma, Feng Xia; Feng, Xiaoming; Han, Zhong Chao] Chinese Acad Med Sci, Inst Hematol, State Key Lab Expt Hematol, Tianjin, Peoples R China; [Li, Xue; Du, Wenjing; Ma, Feng Xia; Feng, Xiaoming; Han, Zhong Chao] Chinese Acad Med Sci, Hosp Blood Dis, Tianjin, Peoples R China; [Li, Xue; Du, Wenjing; Ma, Feng Xia; Feng, Xiaoming; Han, Zhong Chao] Peking Union Med Coll, Tianjin, Peoples R China; [Bayard, Francis] Fac Med Toulouse, INSERM, Inst Med Mol Rangueil, F-31073 Toulouse, France; [Han, Zhong Chao] TEDA, AmCellGene Co Ltd, Natl Engn Res Ctr Cell Prod, Tianjin, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm)	Bayard, F (corresponding author), Fac Med Toulouse, INSERM, Inst Med Mol Rangueil, U317, F-31073 Toulouse, France.	bayardchine@yahoo.fr; hanzhongchao@hotmail.com	Han, Zhong Chao/D-7157-2016	Han, Zhong Chao/0000-0002-2687-7682; Du, Wenjing/0000-0002-4096-1549	National Basic Research Program of China (973 program of China) [2011CB964802, 2013CB966904]; National Natural Science Foundation of China [81330015]	National Basic Research Program of China (973 program of China)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (973 program of China), Grant no. 2011CB964802 and Grant no. 2013CB966904; ZCH and XMF received the funding, respectively; and the National Natural Science Foundation of China, Grant no. 81330015; ZCH received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama K, 2012, CELL STEM CELL, V10, P544, DOI 10.1016/j.stem.2012.03.007; Benedict CA, 2012, J EXP MED, V209, P1903, DOI 10.1084/jem.20122235; Bianco P, 2013, NAT MED, V19, P35, DOI 10.1038/nm.3028; Chen K, 2010, CLIN IMMUNOL, V135, P448, DOI 10.1016/j.clim.2010.01.015; Cullen SP, 2013, MOL CELL, V49, P1034, DOI 10.1016/j.molcel.2013.01.025; Duluc D, 2007, BLOOD, V110, P4319, DOI 10.1182/blood-2007-02-072587; Ellingsgaard H, 2008, P NATL ACAD SCI USA, V105, P13163, DOI 10.1073/pnas.0801059105; English K, 2013, IMMUNOL CELL BIOL, V91, P19, DOI 10.1038/icb.2012.56; Flygare JA, 2012, J MED CHEM, V55, P4101, DOI 10.1021/jm300060k; Heusinkveld M, 2011, J IMMUNOL, V187, P1157, DOI 10.4049/jimmunol.1100889; Jayaraman P, 2013, J IMMUNOL, V190, P4196, DOI 10.4049/jimmunol.1202688; Keating A, 2012, CELL STEM CELL, V10, P709, DOI 10.1016/j.stem.2012.05.015; Le Blanc K, 2012, NAT REV IMMUNOL, V12, P383, DOI 10.1038/nri3209; Li F, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000634; Liu Y, 2011, NAT MED, V17, P1594, DOI 10.1038/nm.2542; Lu LL, 2006, HAEMATOLOGICA, V91, P1017; Nagamura-Inoue Tokiko, 2014, World J Stem Cells, V6, P195, DOI 10.4252/wjsc.v6.i2.195; Rafei M, 2009, J IMMUNOL, V182, P5994, DOI 10.4049/jimmunol.0803962; Roca H, 2009, J BIOL CHEM, V284, P34342, DOI 10.1074/jbc.M109.042671; Serrano AL, 2008, CELL METAB, V7, P33, DOI 10.1016/j.cmet.2007.11.011; Titmarsh DM, 2014, STEM CELL TRANSL MED, V3, P81, DOI 10.5966/sctm.2013-0118; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Wang D, 2012, CELL PHYSIOL BIOCHEM, V29, P551, DOI 10.1159/000338509; Wang D, 2010, EXP CELL RES, V316, P2414, DOI 10.1016/j.yexcr.2010.04.018	24	13	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128647	10.1371/journal.pone.0128647	http://dx.doi.org/10.1371/journal.pone.0128647			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26023782	Green Published, Green Submitted, gold			2022-12-26	WOS:000355319400100
J	Cattarino, L; Hermoso, V; Carwardine, J; Kennard, MJ; Linke, S				Cattarino, Lorenzo; Hermoso, Virgilio; Carwardine, Josie; Kennard, Mark J.; Linke, Simon			Multi-Action Planning for Threat Management: A Novel Approach for the Spatial Prioritization of Conservation Actions	PLOS ONE			English	Article							FRESH-WATER; MULTIPLE THREATS; CONNECTIVITY; RETURN; INVESTMENT; FRAMEWORK; TRAITS; TIME	Planning for the remediation of multiple threats is crucial to ensure the long term persistence of biodiversity. Limited conservation budgets require prioritizing which management actions to implement and where. Systematic conservation planning traditionally assumes that all the threats in priority sites are abated (fixed prioritization approach). However, abating only the threats affecting the species of conservation concerns may be more cost-effective. This requires prioritizing individual actions independently within the same site (independent prioritization approach), which has received limited attention so far. We developed an action prioritization algorithm that prioritizes multiple alternative actions within the same site. We used simulated annealing to find the combination of actions that remediate threats to species at the minimum cost. Our algorithm also accounts for the importance of selecting actions in sites connected through the river network (i.e., connectivity). We applied our algorithm to prioritize actions to address threats to freshwater fish species in the Mitchell River catchment, northern Australia. We compared how the efficiency of the independent and fixed prioritization approach varied as the importance of connectivity increased. Our independent prioritization approach delivered more efficient solutions than the fixed prioritization approach, particularly when the importance of achieving connectivity was high. By spatially prioritizing the specific actions necessary to remediate the threats affecting the target species, our approach can aid cost-effective habitat restoration and land-use planning. It is also particularly suited to solving resource allocation problems, where consideration of spatial design is important, such as prioritizing conservation efforts for highly mobile species, species facing climate change-driven range shifts, or minimizing the risk of threats spreading across different realms.	[Cattarino, Lorenzo; Hermoso, Virgilio; Kennard, Mark J.; Linke, Simon] Griffith Univ, Australian Rivers Inst, Nathan, Qld 4111, Australia; [Hermoso, Virgilio; Kennard, Mark J.; Linke, Simon] Griffith Univ, Natl Environm Res Program Northern Australia Hub, Nathan, Qld 4111, Australia; [Carwardine, Josie] CSIRO Ecosyst Sci, Dutton Pk, Qld, Australia	Griffith University; Griffith University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Cattarino, L (corresponding author), Griffith Univ, Australian Rivers Inst, Nathan, Qld 4111, Australia.	l.cattarino@gmail.com	Carwardine, Josie/A-5801-2011; Kennard, Mark James/C-3425-2008; Lopez, Virgilio Hermoso/H-8276-2015	Kennard, Mark James/0000-0003-4383-4999; Lopez, Virgilio Hermoso/0000-0003-3205-5033; Linke, Simon/0000-0002-1797-3947; Cattarino, Lorenzo/0000-0003-3975-550X	Australian Research Council [DP120103353, DE130100565]; Australian Government's National Environmental Research Program (NERP); Griffith University	Australian Research Council(Australian Research Council); Australian Government's National Environmental Research Program (NERP)(Australian Government); Griffith University(Griffith University)	This study was conducted with the support of funding from the Australian Research Council. The authors acknowledge the Australian Research Council (Discovery Grant No. DP120103353 to SL, MJK and JC and DECRA Grant No. DE130100565 to SL), the Australian Government's National Environmental Research Program (NERP) (SL, MJK and VH) and Griffith University (VH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABARES, 2010, CATCHM SCAL LAND US; Adams VM, 2014, CONSERV LETT, V7, P425, DOI 10.1111/conl.12080; Auerbach NA, 2014, ECOL APPL, V24, P1357, DOI 10.1890/13-0711.1; Ball I. R., 2009, SPATIAL CONSERVATION, P185, DOI DOI 10.1111/EVA.12631; Beger M, 2010, CONSERV LETT, V3, P359, DOI 10.1111/j.1755-263X.2010.00123.x; Beger M, 2010, BIOL CONSERV, V143, P565, DOI 10.1016/j.biocon.2009.11.006; Billionnet A, 2013, SYST BIOL, V62, P147, DOI 10.1093/sysbio/sys081; Bond NR, 2014, DIVERS DISTRIB, V20, P931, DOI 10.1111/ddi.12213; Carwardine J, 2012, CONSERV LETT, V5, P196, DOI 10.1111/j.1755-263X.2012.00228.x; Chades I, 2015, CONSERV BIOL, V29, P525, DOI 10.1111/cobi.12413; ESRI, 2013, ARCGIS; Evans MC, 2011, DIVERS DISTRIB, V17, P437, DOI 10.1111/j.1472-4642.2011.00747.x; Faith DP, 1996, BIODIVERS CONSERV, V5, P417, DOI 10.1007/BF00056388; Game ET, 2013, CONSERV BIOL, V27, P480, DOI 10.1111/cobi.12051; Game ET, 2008, CONSERV BIOL, V22, P1619, DOI 10.1111/j.1523-1739.2008.01037.x; Hermoso V, 2011, FRESHWATER BIOL, V56, P57, DOI 10.1111/j.1365-2427.2009.02390.x; Hermoso V, 2013, DIVERS DISTRIB, V19, P1031, DOI 10.1111/ddi.12082; Hermoso V, 2012, DIVERS DISTRIB, V18, P448, DOI 10.1111/j.1472-4642.2011.00879.x; HOF JG, 1993, FOREST SCI, V39, P816; Holzkamper A, 2007, BIOL CONSERV, V136, P117, DOI 10.1016/j.biocon.2006.11.011; Januchowski-Hartley SR, 2011, BIOL INVASIONS, V13, P1241, DOI 10.1007/s10530-011-9960-7; Joseph LN, 2009, CONSERV BIOL, V23, P328, DOI 10.1111/j.1523-1739.2008.01124.x; Kennard MJ, 2010, TROPICAL RIVERS COAS; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Levin N, 2013, BIOL CONSERV, V158, P371, DOI 10.1016/j.biocon.2012.08.032; Linke S, 2011, FRESHWATER BIOL, V56, P6, DOI 10.1111/j.1365-2427.2010.02456.x; Mace GM, 2000, NATURE, V405, P393, DOI 10.1038/35013247; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Moilanen A., 2009, SPATIAL CONSERVATION, P28; Moilanen A, 2009, SPATIAL CONSERVATION; Moilanen A, 2011, CONSERV LETT, V4, P383, DOI 10.1111/j.1755-263X.2011.00190.x; Murdoch W, 2007, BIOL CONSERV, V139, P375, DOI 10.1016/j.biocon.2007.07.011; Naidoo R, 2006, TRENDS ECOL EVOL, V21, P681, DOI 10.1016/j.tree.2006.10.003; Pouzols FM, 2013, METHODS ECOL EVOL, V4, P426, DOI 10.1111/2041-210X.12040; Pressey RL, 2004, ECOL LETT, V7, P1035, DOI 10.1111/j.1461-0248.2004.00672.x; Pringle CM, 2001, ECOL APPL, V11, P981, DOI 10.1890/1051-0761(2001)011[0981:HCATMO]2.0.CO;2; Pusey Brad, 2011, P151; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Stein JL, 2002, LANDSCAPE URBAN PLAN, V60, P1, DOI 10.1016/S0169-2046(02)00048-8; Sternberg D, 2014, ECOGRAPHY, V37, P54, DOI 10.1111/j.1600-0587.2013.00362.x; Sternberg D, 2013, FRESHWATER BIOL, V58, P1767, DOI 10.1111/fwb.12166; Treml EA, 2012, CONSERV LETT, V5, P441, DOI 10.1111/j.1755-263X.2012.00260.x; van Teeffelen Astrid J.A., 2008, Biodiversity Informatics, V5, P1; van Teeffelen AJA, 2008, J APPL ECOL, V45, P1401, DOI 10.1111/j.1365-2664.2008.01514.x; Venter O, 2013, CONSERV LETT, V6, P116, DOI 10.1111/j.1755-263X.2012.00287.x; Watts ME, 2009, ENVIRON MODELL SOFTW, V24, P1513, DOI 10.1016/j.envsoft.2009.06.005; Wilson K.A., 2009, SPATIAL CONSERVATION; Wilson K, 2010, MEANJIN, V69, P20; Wilson KA, 2007, PLOS BIOL, V5, P1850, DOI 10.1371/journal.pbio.0050223; Wilson KA, 2011, PHILOS T R SOC B, V366, P2670, DOI 10.1098/rstb.2011.0108; Wilson KA, 2011, J APPL ECOL, V48, P715, DOI 10.1111/j.1365-2664.2011.01975.x	51	28	28	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128027	10.1371/journal.pone.0128027	http://dx.doi.org/10.1371/journal.pone.0128027			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020794	Green Published, Green Submitted, gold			2022-12-26	WOS:000355187300073
J	Rowley, JJL; Tran, DTA; Frankham, GJ; Dekker, AH; Le, DTT; Truong, QN; Vinh, QD; Hoang, HD				Rowley, Jodi J. L.; Tran, Dao T. A.; Frankham, Greta J.; Dekker, Anthony H.; Le, Duong T. T.; Truong Q. Nguyen; Vinh Q. Dau; Hoang, Huy D.			Undiagnosed Cryptic Diversity in Small, Microendemic Frogs (Leptolalax) from the Central Highlands of Vietnam	PLOS ONE			English	Article							SPECIES DISTRIBUTIONS; NEOTROPICAL FROGS; NICHE MODELS; SAMPLE-SIZE; BODY-SIZE; ANURA; EVOLUTION; AMPHIBIA; PATTERNS; COMPLEX	A major obstacle in prioritizing species or habitats for conservation is the degree of unrecognized diversity hidden within complexes of morphologically similar, "cryptic" species. Given that amphibians are one of the most threatened groups of organisms on the planet, our inability to diagnose their true diversity is likely to have significant conservation consequences. This is particularly true in areas undergoing rapid deforestation, such as Southeast Asia. The Southeast Asian genus Leptolalax is a group of small-bodied, morphologically conserved frogs that inhabit the forest-floor. We examined a particularly small-bodied and morphologically conserved subset, the Leptolalax applebyi group, using a combination of molecular, morphometric, and acoustic data to identify previously unknown diversity within. In order to predict the geographic distribution of the group, estimate the effects of habitat loss and assess the degree of habitat protection, we used our locality data to perform ecological niche modelling using MaxEnt. Molecular (mtDNA and nuDNA), acoustic and subtle morphometric differences revealed a significant underestimation of diversity in the L. applebyi group; at least two-thirds of the diversity may be unrecognised. Patterns of diversification and microendemism in the group appear driven by limited dispersal, likely due to their small body size, with several lineages restricted to watershed basins. The L. applebyi group is predicted to have historically occurred over a large area of the Central Highlands of Vietnam, a considerable portion of which has already been deforested. Less than a quarter of the remaining forest predicted to be suitable for the group falls within current protected areas. The predicted distribution of the L. applebyi group extends into unsurveyed watershed basins, each potentially containing unsampled diversity, some of which may have already been lost due to deforestation. Current estimates of amphibian diversity based on morphology alone are misleading, and accurate alpha taxonomy is essential to accurately prioritize conservation efforts.	[Rowley, Jodi J. L.; Frankham, Greta J.] Australian Museum, Australian Museum Res Inst, Sydney, NSW 2000, Australia; [Tran, Dao T. A.; Le, Duong T. T.; Hoang, Huy D.] Univ Sci Ho Chi Minh City, Fac Biol, Ho Chi Minh City, Vietnam; [Dekker, Anthony H.] Federat Univ Ballarat, Mt Helen, Vic, Australia; [Truong Q. Nguyen; Vinh Q. Dau] Vietnam Acad Sci & Technol, Inst Ecol & Biol Resources, Hanoi, Vietnam	Australian Museum; Federation University Australia; Vietnam Academy of Science & Technology (VAST)	Rowley, JJL (corresponding author), Australian Museum, Australian Museum Res Inst, 6-8 Coll St, Sydney, NSW 2000, Australia.	jodi.rowley@austmus.gov.au	Rowley, Jodi J. L./F-2466-2012; Nguyen, Truong/F-3730-2012	Nguyen, Truong/0000-0002-6601-0880; Quang Vinh, Dau/0000-0002-8976-1644; Le, Duong/0000-0002-3832-7944; Rowley, Jodi/0000-0002-2011-9143	ADM Capital Foundation, Conservation International; National Geographic Conservation Trust; John D. and Catherine T. MacArthur Foundation; Alexander Koenig Society (Alexander Koenig Gesellschaft - AKG); Alexander Koenig Foundations (Alexander Koenig Stiftung - AKS); IDEA WILD, Nagao Natural Environment Foundation (NEF); Vietnamese Ministry of Education and Training (322 Project); German Academic Exchange Service (DAAD); Project of the National Program Tay Nguyen III [TN3/T07]; Alexander von Humboldt Stiftung/Foundation [VIE 114344]	ADM Capital Foundation, Conservation International; National Geographic Conservation Trust(National Geographic Society); John D. and Catherine T. MacArthur Foundation; Alexander Koenig Society (Alexander Koenig Gesellschaft - AKG); Alexander Koenig Foundations (Alexander Koenig Stiftung - AKS); IDEA WILD, Nagao Natural Environment Foundation (NEF); Vietnamese Ministry of Education and Training (322 Project); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Project of the National Program Tay Nguyen III; Alexander von Humboldt Stiftung/Foundation(Alexander von Humboldt Foundation)	Funding for aspects of this study was provided by ADM Capital Foundation, Conservation International, the National Geographic Conservation Trust, a grant from The John D. and Catherine T. MacArthur Foundation to the North Carolina Museum of Natural Sciences to JR; The Alexander Koenig Society (Alexander Koenig Gesellschaft - AKG), The Alexander Koenig Foundations (Alexander Koenig Stiftung - AKS), IDEA WILD, Nagao Natural Environment Foundation (NEF), the Vietnamese Ministry of Education and Training (322 Project), and the German Academic Exchange Service (DAAD) to DT; Project TN3/T07 of the National Program Tay Nguyen III Project TN3/T07 of the National Program Tay Nguyen III and the Alexander von Humboldt Stiftung/Foundation (VIE 114344) to TN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo A, 2010, SYST BIODIVERS, V8, P357, DOI 10.1080/14772000.2010.507264; [Anonymous], 2010, MAPPING SPECIES DIST; Ben-David A, 2008, ENG APPL ARTIF INTEL, V21, P874, DOI 10.1016/j.engappai.2007.09.009; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Boul KE, 2007, P ROY SOC B-BIOL SCI, V274, P399, DOI 10.1098/rspb.2006.3736; Brook BW, 2006, BIOTROPICA, V38, P302, DOI 10.1111/j.1744-7429.2006.00141.x; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Brown RM, 2008, ZOOTAXA, P47, DOI 10.11646/zootaxa.1888.1.3; Busby JR, 1991, NATURE CONSERVATION, P64, DOI DOI 10.1046/J.1365-294X.2001.01244.X; CARPENTER G, 1993, BIODIVERS CONSERV, V2, P667, DOI 10.1007/BF00051966; Che J, 2009, MOL PHYLOGENET EVOL, V50, P59, DOI 10.1016/j.ympev.2008.10.007; Chek AA, 2001, MOL PHYLOGENET EVOL, V18, P370, DOI 10.1006/mpev.2000.0889; CHERRY LM, 1978, SCIENCE, V200, P209, DOI 10.1126/science.635583; COCROFT RB, 1995, ANIM BEHAV, V49, P283, DOI 10.1006/anbe.1995.0043; Coloma Luis A., 2010, Zootaxa, V2574, P1; Crawford AJ, 2010, P NATL ACAD SCI USA, V107, P13777, DOI 10.1073/pnas.0914115107; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; Duellman W.E., 1970, Monograph Mus nat Hist Univ Kans, V1, P1; Edwards SV, 2000, EVOLUTION, V54, P1839; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Flot JF, 2010, MOL ECOL RESOUR, V10, P162, DOI 10.1111/j.1755-0998.2009.02732.x; Fouquet A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001109; Fouquet A, 2014, J BIOGEOGR, V41, P855, DOI 10.1111/jbi.12250; Freilich X, 2014, MOL PHYLOGENET EVOL, V71, P157, DOI 10.1016/j.ympev.2013.11.015; Frost D.R., 2021, AMPHIBIAN SPECIES WO; Gaston KJ, 1996, TRENDS ECOL EVOL, V11, P197, DOI 10.1016/0169-5347(96)10027-6; GERHARDT HC, 1994, ANNU REV ECOL SYST, V25, P293, DOI 10.1146/annurev.es.25.110194.001453; Gower DJ, 2005, RAFFLES B ZOOL, P153; Graham CH, 2004, EVOLUTION, V58, P1781, DOI 10.1554/03-274; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HASS CA, 1995, BIOTROPICA, V27, P238, DOI 10.2307/2389000; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Heyer W.R., 1984, Amphibia-Reptilia, V5, P97; Heyer W. Ronald, 1996, Amphibia-Reptilia, V17, P7, DOI 10.1163/156853896X00252; Highton R, 1989, ILLINOIS BIOL MONOGR, V57; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HILLIS DM, 1983, SYST ZOOL, V32, P132, DOI 10.2307/2413277; IUCN, 2016, NARDOSTACHYS JATAMAN, DOI DOI 10.2305/IUCN.UK.20213.RLTS.T50126627A88304158.EN; IUCN & UNEP-WCMC, 2014, WORLD DAT PROT AR WD; Jenkins CN, 2013, P NATL ACAD SCI USA, V110, pE2602, DOI 10.1073/pnas.1302251110; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Kozak KH, 2010, ECOL LETT, V13, P1378, DOI 10.1111/j.1461-0248.2010.01530.x; Lehner B., 2008, EOS T AM GEOPHYS UN, V89, P93, DOI [10.1029/2008EO100001, DOI 10.1029/2008EO100001, DOI 10.1111/j.1469-8137.2009.03092.x]; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Manel S, 2001, J APPL ECOL, V38, P921, DOI 10.1046/j.1365-2664.2001.00647.x; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; McLeod DS, 2010, MOL PHYLOGENET EVOL, V56, P991, DOI 10.1016/j.ympev.2010.04.004; Mendelson JR, 2010, ZOOTAXA, P61, DOI 10.11646/zootaxa.2396.1.5; Meyfroidt P, 2008, LAND USE POLICY, V25, P182, DOI 10.1016/j.landusepol.2007.06.001; Meyfroidt P, 2013, GLOBAL ENVIRON CHANG, V23, P1187, DOI 10.1016/j.gloenvcha.2013.04.005; Myers N, 2001, P NATL ACAD SCI USA, V98, P5389, DOI 10.1073/pnas.091092498; Urbina-Cardona JN, 2010, CONSERV BIOL, V24, P1031, DOI 10.1111/j.1523-1739.2009.01432.x; Pabijan M, 2012, J EVOLUTION BIOL, V25, P2310, DOI 10.1111/j.1420-9101.2012.02613.x; Padial JM, 2009, ZOOL SCR, V38, P431, DOI 10.1111/j.1463-6409.2008.00381.x; Palumbi S, 1991, SIMPLE FOOLS GUIDE P; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Pfenninger M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-121; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pie MR, 2013, ECOL MODEL, V250, P165, DOI 10.1016/j.ecolmodel.2012.10.019; Pilliod DS, 2002, CAN J ZOOL, V80, P1849, DOI 10.1139/Z02-175; Pimm SL, 2005, SCI AM, V293, P66, DOI 10.1038/scientificamerican0905-66; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; Rambaut A., 2007, TRACER V1 4; Raxworthy CJ, 2003, NATURE, V426, P837, DOI 10.1038/nature02205; Richards CM, 1996, MOL PHYLOGENET EVOL, V5, P522, DOI 10.1006/mpev.1996.0047; Rissler LJ, 2007, SYST BIOL, V56, P924, DOI 10.1080/10635150701703063; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rowley J, 2010, BIOL LETTERS, V6, P336, DOI 10.1098/rsbl.2009.0793; Rowley Jodi J.L., 2014, Amphibian Biology, V11, P264; Rowley JJL, 2010, ZOOTAXA, P57, DOI 10.11646/zootaxa.2567.1.3; Rowley JJL, 2011, ZOOTAXA, P15, DOI 10.11646/zootaxa.2796.1.2; Rowley JJL, 2009, ZOOTAXA, P51, DOI 10.11646/zootaxa.2198.1.5; Ryan MJ, 2003, SPR HDB AUD, V16, P225; Santos JC, 2011, P NATL ACAD SCI USA, V108, P6175, DOI 10.1073/pnas.1010952108; Shimada T, 2011, ZOOL J LINN SOC-LOND, V161, P157, DOI 10.1111/j.1096-3642.2010.00641.x; Sodhi NS, 2004, TRENDS ECOL EVOL, V19, P654, DOI 10.1016/j.tree.2004.09.006; SPIGHT TM, 1968, PHYSIOL ZOOL, V41, P195, DOI 10.1086/physzool.41.2.30155450; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stibig HJ, 2007, J BIOGEOGR, V34, P625, DOI 10.1111/j.1365-2699.2006.01637.x; Stuart BL, 2006, BIOL LETTERS, V2, P470, DOI 10.1098/rsbl.2006.0505; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Sung Y, 2014, ASIAN HERPETOL RES, V5, P80, DOI 10.3724/SP.J.1245.2014.00080; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tateishi R., 2014, J GEOGR GEOL, V6, P99, DOI [10.5539/jgg.v6n3p99, DOI 10.5539/JGG.V6N3P99]; Tedesco PA, 2014, CONSERV BIOL, V28, P1360, DOI 10.1111/cobi.12285; Vences Miguel, 2007, Amphibian Biology, V7, P2613; Vences Miguel, 2005, Front Zool, V2, P5, DOI 10.1186/1742-9994-2-5; Wilson KA, 2006, NATURE, V440, P337, DOI 10.1038/nature04366; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Wollenberg KC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-217; Wynn A, 2001, TROP ZOOL, V14, P255, DOI 10.1080/03946975.2001.10531157; Zheng YC, 2008, MOL PHYLOGENET EVOL, V46, P695, DOI 10.1016/j.ympev.2007.09.019	95	43	45	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128382	10.1371/journal.pone.0128382	http://dx.doi.org/10.1371/journal.pone.0128382			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020250	Green Published, Green Submitted, gold			2022-12-26	WOS:000355187300106
J	Spychala, J; Spychala, P; Gomez, S; Weinreb, GE				Spychala, Jozef; Spychala, Pawel; Gomez, Shawn; Weinreb, Gabriel E.			Visinets: A Web-Based Pathway Modeling and Dynamic Visualization Tool	PLOS ONE			English	Article							NETWORKS	In this report we describe a novel graphically oriented method for pathway modeling and a software package that allows for both modeling and visualization of biological networks in a user-friendly format. The Visinets mathematical approach is based on causal mapping (CMAP) that has been fully integrated with graphical interface. Such integration allows for fully graphical and interactive process of modeling, from building the network to simulation of the finished model. To test the performance of Visinets software we have applied it to: a) create executable EGFR-MAPK pathway model using an intuitive graphical way of modeling based on biological data, and b) translate existing ordinary differential equation (ODE) based insulin signaling model into CMAP formalism and compare the results. Our testing fully confirmed the potential of the CMAP method for broad application for pathway modeling and visualization and, additionally, showed significant advantage in computational efficiency. Furthermore, we showed that Visinets web-based graphical platform, along with standardized method of pathway analysis, may offer a novel and attractive alternative for dynamic simulation in real time for broader use in biomedical research. Since Visinets uses graphical elements with mathematical formulas hidden from the users, we believe that this tool may be particularly suited for those who are new to pathway modeling and without the in-depth modeling skills often required when using other software packages.	[Spychala, Jozef; Spychala, Pawel; Weinreb, Gabriel E.] Visinets Inc, Chapel Hill, NC 27515 USA; [Gomez, Shawn] Univ N Carolina, Joint Dept Biomed Engn, Chapel Hill, NC USA; [Gomez, Shawn] NC State Univ, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; North Carolina State University	Spychala, J (corresponding author), Visinets Inc, Chapel Hill, NC 27515 USA.	jsp@visinets.com; gw@visinets.com		Gomez, Shawn/0000-0002-8251-4552	Visinets, Inc.	Visinets, Inc.	Visinets, Inc., provided support in the form of salaries for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borisov N, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.19; Brannmark C, 2013, J BIOL CHEM, V288, P9867, DOI 10.1074/jbc.M112.432062; Di Cara A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-462; Ferrari E, 2011, J BIOL CHEM, V286, P4173, DOI 10.1074/jbc.M110.157420; Helikar T, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-96; Kholodenko BN, 1999, J BIOL CHEM, V274, P30169, DOI 10.1074/jbc.274.42.30169; MacLeod M, 2015, STUD HIST PHI PART C, V49, P1, DOI 10.1016/j.shpsc.2014.10.004; Nijhout HF, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00245; Saraiya P, 2005, IEEE T VIS COMPUT GR, V11, P443, DOI 10.1109/TVCG.2005.53; SMITH A, 2012, BMC BIOINFORMATICS, V13, P8, DOI DOI 10.1186/1471-2105-13-8; Tautz L, 2013, METHODS MOL BIOL, V1053, P179, DOI 10.1007/978-1-62703-562-0_13; Weinreb GE, 2006, CELL MOTIL CYTOSKEL, V63, P523, DOI 10.1002/cm.20143; Weinreb GE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005378; Zheng Y, 2013, NATURE, V499, P166, DOI 10.1038/nature12308	14	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0123773	10.1371/journal.pone.0123773	http://dx.doi.org/10.1371/journal.pone.0123773			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020230	Green Published, Green Submitted, gold			2022-12-26	WOS:000355187300004
J	Ananth, CV; Keyes, KM; Hamilton, A; Gissler, M; Wu, C; Liu, S; Luque-Fernandez, MA; Skjaerven, R; Williams, MA; Tikkanen, M; Cnattingius, S				Ananth, Cande V.; Keyes, Katherine M.; Hamilton, Ava; Gissler, Mika; Wu, Chunsen; Liu, Shiliang; Luque-Fernandez, Miguel Angel; Skjaerven, Rolv; Williams, Michelle A.; Tikkanen, Minna; Cnattingius, Sven			An International Contrast of Rates of Placental Abruption: An Age-Period-Cohort Analysis	PLOS ONE			English	Article							PERINATAL-MORTALITY; CIGARETTE-SMOKING; UNITED-STATES; RISK-FACTORS; HYPERTENSIVE DISORDERS; TEMPORAL VARIATION; MATERNAL SMOKING; CANCER RATES; FOLIC-ACID; PREGNANCY	Background Although rare, placental abruption is implicated in disproportionately high rates of perinatal morbidity and mortality. Understanding geographic and temporal variations may provide in-sights into possible amenable factors of abruption. We examined abruption frequencies by maternal age, delivery year, and maternal birth cohorts over three decades across seven countries. Methods Women that delivered in the US (n = 863,879; 1979-10), Canada (4 provinces, n = 5,407,463; 1982-11), Sweden (n = 3,266,742; 1978-10), Denmark (n = 1,773,895; 197808), Norway (n = 1,780,271, 1978-09), Finland (n = 1,411,867; 1987-10), and Spain (n = 6,151,508; 1999-12) were analyzed. Abruption diagnosis was based on ICD coding. Rates were modeled using Poisson regression within the framework of an age-period-cohort analysis, and multi-level models to examine the contribution of smoking in four countries. Results Abruption rates varied across the seven countries (3-10 per 1000), Maternal age showed a consistent J-shaped pattern with increased rates at the extremes of the age distribution. In comparison to births in 2000, births after 2000 in European countries had lower abruption rates; in the US there was an increase in rate up to 2000 and a plateau thereafter. No birth cohort effects were evident. Changes in smoking prevalence partially explained the period effect in the US (P = 0.01) and Sweden (P < 0.01). Conclusions There is a strong maternal age effect on abruption. While the abruption rate has plateaued since 2000 in the US, all other countries show declining rates. These findings suggest considerable variation in abruption frequencies across countries; differences in the distribution of risk factors, especially smoking, may help guide policy to reduce abruption rates.	[Ananth, Cande V.] Columbia Univ, Coll Phys & Surg, Dept Obstet & Gynecol, New York, NY 10027 USA; [Ananth, Cande V.; Keyes, Katherine M.; Hamilton, Ava] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Gissler, Mika] THL Natl Inst Hlth & Welf, Helsinki, Sweden; [Gissler, Mika] NHV Nord Sch Publ Hlth, Gothenburg, Sweden; [Wu, Chunsen] Aarhus Univ, Dept Publ Hlth, Epidemiol Sect, Aarhus, Denmark; [Liu, Shiliang] Publ Hlth Agcy Canada, Ctr Chron Dis Prevent, Hlth Surveillance & Epidemiol Div, Ottawa, ON, Canada; [Luque-Fernandez, Miguel Angel; Williams, Michelle A.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Skjaerven, Rolv] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Skjaerven, Rolv] Norwegian Inst Publ Hlth, Med Birth Registry Norway, Bergen, Norway; [Tikkanen, Minna] Univ Cent Hosp, Dept Obstet & Gynecol, Helsinki, Finland; [Cnattingius, Sven] Karolinska Inst, Dept Med Solna, Clin Epidemiol Unit, Stockholm, Sweden	Columbia University; Columbia University; Aarhus University; Public Health Agency of Canada; Harvard University; Harvard T.H. Chan School of Public Health; University of Bergen; Norwegian Institute of Public Health (NIPH); University of Helsinki; Helsinki University Central Hospital; Karolinska Institutet	Ananth, CV (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Obstet & Gynecol, New York, NY 10027 USA.	cande.ananth@columbia.edu	FERNANDEZ, MIGUEL ANGEL LUQUE/AAZ-5017-2020; FERNANDEZ, MIGUEL ANGEL LUQUE/L-4053-2015; FERNANDEZ, MIGUEL ANGEL LUQUE/AAK-7183-2021	FERNANDEZ, MIGUEL ANGEL LUQUE/0000-0001-6683-5164; FERNANDEZ, MIGUEL ANGEL LUQUE/0000-0001-6683-5164; FERNANDEZ, MIGUEL ANGEL LUQUE/0000-0001-6683-5164; Gissler, Mika/0000-0001-8254-7525	National Institutes of Health [K01-AA021511]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K01AA021511] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This is an unfunded project. Dr. Keyes is partially supported by a grant (K01-AA021511) from the National Institutes of Health. None of the authors received specific funding for this work.	Ananth CV, 2008, HUM GENET, V124, P137, DOI 10.1007/s00439-008-0531-7; Ananth CV, 2007, AM J EPIDEMIOL, V166, P289, DOI 10.1093/aje/kwm073; Ananth CV, 2006, OBSTET GYNECOL, V107, P785, DOI 10.1097/01.AOG.0000207560.41604.19; Ananth CV, 2010, J MATERN-FETAL NEO M, V23, P887, DOI 10.3109/14767050903334885; Ananth CV, 1996, OBSTET GYNECOL, V88, P511, DOI 10.1016/0029-7844(96)00236-0; Ananth CV, 1997, BRIT J OBSTET GYNAEC, V104, P572, DOI 10.1111/j.1471-0528.1997.tb11535.x; Ananth CV, 2005, AM J OBSTET GYNECOL, V192, P191, DOI 10.1016/j.ajog.2004.05.087; Ananth CV, 1999, OBSTET GYNECOL, V93, P622, DOI 10.1016/S0029-7844(98)00408-6; Ananth CV, 1996, OBSTET GYNECOL, V88, P309, DOI 10.1016/0029-7844(96)00088-9; Ananth CV, 1996, AM J EPIDEMIOL, V144, P881, DOI 10.1093/oxfordjournals.aje.a009022; Ananth CV, 2001, AM J EPIDEMIOL, V153, P332, DOI 10.1093/aje/153.4.332; Ananth CV, 2001, AM J EPIDEMIOL, V153, P771, DOI 10.1093/aje/153.8.771; Andersen TF, 1999, DAN MED BULL, V46, P263; Broers Teresa, 2004, Chronic Dis Can, V25, P16; Canada PHAO, 2008, CAN PER HLTH REP 200; Carstensen B, 2012, EPI PACKAGE STAT ANA; CLAYTON D, 1987, STAT MED, V6, P449, DOI 10.1002/sim.4780060405; CLAYTON D, 1987, STAT MED, V6, P469, DOI 10.1002/sim.4780060406; Cnattingius S, 2004, NICOTINE TOB RES, V6, pS125, DOI 10.1080/14622200410001669187; Cnattingius S, 1997, AM J EPIDEMIOL, V145, P319; DeFrances Carol J, 2007, Vital Health Stat 13, P1; Degenhardt L, 2007, DRUG ALCOHOL DEPEN, V90, P210, DOI 10.1016/j.drugalcdep.2007.03.007; Ekblad M, 2014, EUR J PUBLIC HEALTH, V24, P544, DOI 10.1093/eurpub/ckt128; Elsasser DA, 2010, EUR J OBSTET GYN R B, V148, P125, DOI 10.1016/j.ejogrb.2009.10.005; Gissler M, 2002, MED INFORM INTERNET, V27, P33, DOI 10.1080/14639230110119234; GISSLER M, 1995, SCAND J SOC MED, V23, P75, DOI 10.1177/140349489502300113; Health Canada, 2003, CAN PER HLTH REP 200; HIBBARD BM, 1975, S AFR MED J, V49, P1223; Jiang XH, 2012, LUNG CANCER, V78, P16, DOI 10.1016/j.lungcan.2012.06.002; Kallen B., 2003, SWEDISH MED BIRTH RE; KAREGARD M, 1986, OBSTET GYNECOL, V67, P523; Knudsen LB, 1998, DAN MED BULL, V45, P320; Kozak Lola Jean, 2004, Vital Health Stat 13, P1; Kramer MS, 1997, OBSTET GYNECOL, V89, P221, DOI 10.1016/S0029-7844(96)00478-4; NAEYE RL, 1980, OBSTET GYNECOL, V55, P701; Nilsen RM, 2008, AM J EPIDEMIOL, V167, P867, DOI 10.1093/aje/kwm373; OMALLEY PM, 1988, AM J PUBLIC HEALTH, V78, P1315, DOI 10.2105/AJPH.78.10.1315; Oyelese Y, 2006, OBSTET GYNECOL, V108, P1005, DOI 10.1097/01.AOG.0000239439.04364.9a; Pariente G, 2014, PAEDIATR PERINAT EP, V28, P32, DOI 10.1111/ppe.12089; Rasmussen S, 1996, ACTA OBSTET GYN SCAN, V75, P229, DOI 10.3109/00016349609047092; Rasmussen S, 1997, BRIT J OBSTET GYNAEC, V104, P1292, DOI 10.1111/j.1471-0528.1997.tb10977.x; Rasmussen S, 1996, ACTA OBSTET GYN SCAN, V75, P222, DOI 10.3109/00016349609047091; Rasmussen S, 2000, ACTA OBSTET GYN SCAN, V79, P496, DOI 10.1034/j.1600-0412.2000.079006496.x; Ray JG, 2005, LANCET, V366, P1797, DOI 10.1016/S0140-6736(05)67726-4; Ray JG, 1999, PLACENTA, V20, P519, DOI 10.1053/plac.1999.0417; RAYMOND EG, 1993, ACTA OBSTET GYN SCAN, V72, P633, DOI 10.3109/00016349309021156; SAFTLAS AF, 1991, OBSTET GYNECOL, V78, P1081; Sanchez SE, 2006, AM J OBSTET GYNECOL, V194, P225, DOI 10.1016/j.ajog.2005.05.013; SKJAERVEN R, 1988, AM J EPIDEMIOL, V128, P1352, DOI 10.1093/oxfordjournals.aje.a115088; Tikkanen M, 2013, ACTA OBSTET GYN SCAN, V92, P298, DOI 10.1111/aogs.12030; Tikkanen M, 2012, ACTA OBSTET GYN SCAN, V91, P1046, DOI 10.1111/j.1600-0412.2012.01457.x; WILCOX AJ, 1982, EARLY HUM DEV, V7, P165, DOI 10.1016/0378-3782(82)90135-9; WILLIAMS MA, 1991, AM J EPIDEMIOL, V134, P965, DOI 10.1093/oxfordjournals.aje.a116181; Yang Y, 2013, AGE PERIOD COHORT AN; Yasmeen S, 2006, AM J OBSTET GYNECOL, V194, P992, DOI 10.1016/j.ajog.2005.08.058	55	51	55	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0125246	10.1371/journal.pone.0125246	http://dx.doi.org/10.1371/journal.pone.0125246			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018653	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000355185600015
J	Edson, D; Field, H; McMichael, L; Jordan, D; Kung, N; Mayer, D; Smith, C				Edson, Daniel; Field, Hume; McMichael, Lee; Jordan, David; Kung, Nina; Mayer, David; Smith, Craig			Flying-Fox Roost Disturbance and Hendra Virus Spillover Risk	PLOS ONE			English	Article							STRESS; GLUCOCORTICOIDS; INFECTION; REPRODUCTION; CHIROPTERA; RESPONSES; HORSES	Bats of the genus Pteropus (flying-foxes) are the natural host of Hendra virus (HeV) which periodically causes fatal disease in horses and humans in Australia. The increased urban presence of flying-foxes often provokes negative community sentiments because of reduced social amenity and concerns of HeV exposure risk, and has resulted in calls for the dispersal of urban flying-fox roosts. However, it has been hypothesised that disturbance of urban roosts may result in a stress-mediated increase in HeV infection in flying-foxes, and an increased spillover risk. We sought to examine the impact of roost modification and dispersal on HeV infection dynamics and cortisol concentration dynamics in flying-foxes. The data were analysed in generalised linear mixed models using restricted maximum likelihood (REML). The difference in mean HeV prevalence in samples collected before (4.9%), during (4.7%) and after (3.4%) roost disturbance was small and non-significant (P = 0.440). Similarly, the difference in mean urine specific gravity-corrected urinary cortisol concentrations was small and non-significant (before = 22.71 ng/mL, during = 27.17, after = 18.39) (P = 0.550). We did find an underlying association between cortisol concentration and season, and cortisol concentration and region, suggesting that other (plausibly biological or environmental) variables play a role in cortisol concentration dynamics. The effect of roost disturbance on cortisol concentration approached statistical significance for region, suggesting that the relationship is not fixed, and plausibly reflecting the nature and timing of disturbance. We also found a small positive statistical association between HeV excretion status and urinary cortisol concentration. Finally, we found that the level of flying-fox distress associated with roost disturbance reflected the nature and timing of the activity, highlighting the need for a 'best practice' approach to dispersal or roost modification activities. The findings usefully inform public discussion and policy development in relation to Hendra virus and flying-fox management.	[Edson, Daniel; Field, Hume; McMichael, Lee; Kung, Nina; Smith, Craig] Queensland Ctr Emerging Infect Dis, Dept Agr & Fisheries, Biosecur Queensland, Brisbane, Qld, Australia; [Field, Hume] EcoHlth Alliance, New York, NY USA; [McMichael, Lee] Univ Queensland, Sch Vet Sci, Gatton, Qld, Australia; [Jordan, David] Dept Primary Ind, Wollongbar, NSW, Australia; [Mayer, David] Dept Agr & Fisheries, Brisbane, Qld, Australia	Queensland Department of Agriculture & Fisheries; EcoHealth Alliance; University of Queensland	Field, H (corresponding author), Queensland Ctr Emerging Infect Dis, Dept Agr & Fisheries, Biosecur Queensland, Brisbane, Qld, Australia.	hume.field@ecohealthalliance.org	Jordan, David/P-7281-2019; Kung, Nina Y/H-1260-2012; Mayer, David G/F-8616-2011; McMichael, Lee UQ/C-7948-2018	Mayer, David G/0000-0001-9564-9176; McMichael, Lee UQ/0000-0002-7675-4859	Queensland, New South Wales government through the National Hendra virus Research Program [NHeVRP 04]; Queensland, Australian government through the National Hendra virus Research Program [NHeVRP 04]; Queensland Centre for Emerging Infectious Diseases; New South Wales Department of Primary Industries; Queensland Department of Agriculture, Fisheries, and Forestry	Queensland, New South Wales government through the National Hendra virus Research Program; Queensland, Australian government through the National Hendra virus Research Program; Queensland Centre for Emerging Infectious Diseases; New South Wales Department of Primary Industries; Queensland Department of Agriculture, Fisheries, and Forestry	The project was primarily funded by the Queensland, New South Wales and Australian governments through the National Hendra virus Research Program (Grant# NHeVRP 04) [DE, LMc]. Additional support was provided by the Queensland Centre for Emerging Infectious Diseases [HF, NK, CS], the New South Wales Department of Primary Industries [DJ], and the Queensland Department of Agriculture, Fisheries, and Forestry [DM]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anon, 2014, WHAT IS HENDRA VIRUS; [Anonymous], 2014, FLYING FOX CAMP MAN; [Anonymous], 2014, FLYING FOX RELOCATIO; [Anonymous], 2009, YARRA BEND PARK FLYI; [Anonymous], 2014, AUTH FLYING FOX ROOS; [Anonymous], 2004, MANUAL DIAGNOSTIC TE, P1101; [Anonymous], 2013, HENDRA VIRUS CONFIRM; [Anonymous], 2001, PTER POL; [Anonymous], 2012, TOPIC HENDRA VIRUS I; Bennett C, 2008, ZOO BIOL, V27, P381, DOI 10.1002/zoo.20208; Busch DS, 2009, BIOL CONSERV, V142, P2844, DOI 10.1016/j.biocon.2009.08.013; Churchill S, 2008, AUSTR BATS, V2nd; Field H, 2012, CURR TOP MICROBIOL, V359, P11, DOI 10.1007/82_2012_214; Field H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028678; Field H, 2010, EMERG INFECT DIS, V16, P338, DOI 10.3201/eid1602.090780; GenStat, 2013, GENSTAT WIND REL 15; Hall L, 2009, WILD AUSTR GUIDE BAT; Hall L.S., 2000, FLYING FOXES FRUIT B; Halpin K, 2000, J GEN VIROL, V81, P1927, DOI 10.1099/0022-1317-81-8-1927; Hanna JN, 2006, MED J AUSTRALIA, V185, P562, DOI 10.5694/j.1326-5377.2006.tb00692.x; MacDonald A, 2013, QUEENSLAND LOCAL AUT; McCullagh P, 1989, GEN LINEAR MODELS; McMichael LA, 2014, ECOHEALTH, V11, P400, DOI 10.1007/s10393-014-0954-7; MURRAY K, 1995, SCIENCE, V268, P94, DOI 10.1126/science.7701348; OSullivan JD, 1997, LANCET, V349, P93, DOI 10.1016/S0140-6736(96)06162-4; Parry-Jones KA, 2001, AUSTRAL ECOL, V26, P47, DOI 10.1046/j.1442-9993.2001.01072.x; Playford EG, 2010, EMERG INFECT DIS, V16, P219, DOI 10.3201/eid1602.090552; Plowright RK, 2008, P ROY SOC B-BIOL SCI, V275, P861, DOI 10.1098/rspb.2007.1260; Plowright RK, 2011, P ROY SOC B-BIOL SCI, V278, P3703, DOI 10.1098/rspb.2011.0522; Reeder DM, 2005, J MAMMAL, V86, P225, DOI 10.1644/BHE-003.1; Reeder DM, 2004, J EXP ZOOL PART A, V301A, P682, DOI 10.1002/jez.a.58; Roberts BJ, 2011, BIOLOGY AND CONSERVATION OF AUSTRALASIAN BATS, P277; Roberts BJ, 2005, THESIS GRIFFITH U NA; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Selvey L., 1996, Communicable Diseases Intelligence, V20, P477; SELVEY LA, 1995, MED J AUSTRALIA, V162, P642, DOI 10.5694/j.1326-5377.1995.tb126050.x; Shilton LA, 2008, AUSTRAL ECOL, V33, P549, DOI 10.1111/j.1442-9993.2008.01910.x; Smith CS, 2014, PLOS ONE, V9, P1; Smith IL, 2001, J VIROL METHODS, V98, P33, DOI 10.1016/S0166-0934(01)00354-8; Srivastava RK, 2008, J EXP ZOOL PART A, V309A, P94, DOI 10.1002/jez.440; Tait J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109810; UNDERWOOD AJ, 1994, ECOL APPL, V4, P3, DOI 10.2307/1942110; Underwood AJ, 2003, J EXP MAR BIOL ECOL, V296, P49, DOI 10.1016/S0022-0981(03)00304-6; WIDMAIER EP, 1994, J EXP ZOOL, V269, P442, DOI 10.1002/jez.1402690507; WIDMAIER EP, 1993, J EXP ZOOL, V265, P533, DOI 10.1002/jez.1402650509	45	25	26	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0125881	10.1371/journal.pone.0125881	http://dx.doi.org/10.1371/journal.pone.0125881			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26016629	Green Submitted, gold, Green Published			2022-12-26	WOS:000355185600038
J	Dong, X; Zhu, CY; Qian, YM; Zhang, FQ; Jiao, T				Dong, Xian; Zhu, Chenyuan; Qian, Yumei; Zhang, Fuqiang; Jiao, Ting			The Influence of Obturators on the Respiration of Patients with Maxillary Defects: A Clinical Study	PLOS ONE			English	Article							FUNCTIONAL RESIDUAL CAPACITY	The study evaluated the effects of obturators on respiratory function by analyzing the changes in nasal anatomic structures and physiologic function in maxillectomy patients with and without obturators. Twenty-six patients who underwent maxillectomy were chosen and rehabilitated with obturators by a single maxillofacial prosthodontist. The geometric shape of the nasal cavity, the nasal airway resistance, and the ratio of residual volume to total lung capacity (RV/TLC) were evaluated using acoustic rhinometry, rhinomanometry, and a pulmonary function test apparatus, respectively. All patients were tested twice, with and without their obturators. The results were statistically analyzed with a paired t-test. The nasal cavities (0-7 cm to the anterior nostril) of the patients with obturators had a significantly smaller volume ([-8.92, -0.60], P = 0.027), smaller effective nasal cross-sectional area MCA2 ([-3.80, -1,81], P< 0.0001), increased airflow in the nasal cavity ([17.76, 147.39], P = 0.015), reduced nasal airway resistance ([-0.11, -0.02], P = 0.009), and reduced RV/TLC ([-5.32, -1.30], P = 0.004) compared with the patients without obturators. According to the results of this study, obturators can improve respiratory function by effectively decreasing the volume of enlarged nasal cavities as well as the nasal air resistance and volume of anatomical dead space after maxillectomy.	[Dong, Xian; Zhu, Chenyuan; Qian, Yumei; Zhang, Fuqiang; Jiao, Ting] Shanghai Jiao Tong Univ, Shanghai Key Lab Stomatol, Peoples Hosp 9, Dept Prosthodont,Sch Med, Shanghai 200030, Peoples R China; [Dong, Xian] Shanghai Inst Hlth Sci, Dept Prosthodont, Shanghai, Peoples R China; [Qian, Yumei] Branch Hosp, Shanghai Stomatol Dis Ctr, Dept Prosthodont, Shanghai, Peoples R China	Shanghai Jiao Tong University	Jiao, T (corresponding author), Shanghai Jiao Tong Univ, Shanghai Key Lab Stomatol, Peoples Hosp 9, Dept Prosthodont,Sch Med, 639 Zhi Zao Ju Rd, Shanghai 200030, Peoples R China.	jiao_ting@126.com			Innovation Key Project of Shanghai Education Committee Issues [11ZZ102]; National Natural Science Foundation of China [81100774]; Shanghai Leading Academic Discipline Project [T0202, S30206]	Innovation Key Project of Shanghai Education Committee Issues; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This research is supported by Innovation Key Project of Shanghai Education Committee Issues (Project Number: 11ZZ102), the National Natural Science Foundation of China (Project Number: 81100774) and Shanghai Leading Academic Discipline Project: (Project Number: T0202, S30206).	Beumer J, 2011, MAXILLOFACIAL REHABILITATION: PROSTHODONTIC AND SURGICAL MANAGEMENT OF CANCER-RELATED, ACQUIRED AND CONGENITAL DEFECTS OF THE HEAD AND NECK, THIRD EDITION, P155; Brewer L, 2011, J CLIN MONIT COMPUT, V25, P397, DOI 10.1007/s10877-011-9318-9; Bu G, 2002, RHINOLOGY, P131; Chhabra N, 2009, OTOLARYNG CLIN N AM, V42, P311, DOI 10.1016/j.otc.2009.02.001; Clement PAR, 2005, RHINOLOGY, V43, P169; Diederi G, 2014, CURR OPIN CRIT CARE, V20, P347, DOI [10.1097/MCC.0000000000000099, DOI 10.1097/MCC.0000000000000099]; Fan Z, 1996, PRACTICE OTORHINOLAR, p[234, 243]; FREEDMAN HM, 1979, LARYNGOSCOPE, V89, P421; Gai D, 2013, J SHANGHAI JIAOTONG, P602; Heinze H, 2010, RESP CARE, V55, P589; Huang X, 1995, OTORHINOLARYNGOLOGY; Jiang SW, 1994, MODERN OTORHINOLARYN, P253; Kornblith AB, 1996, HEAD NECK-J SCI SPEC, V18, P323, DOI 10.1002/(SICI)1097-0347(199607/08)18:4<323::AID-HED3>3.3.CO;2-1; Mu K, 1992, PRINCIPLES CLIN APPL, P52; Newth CJL, 1997, EUR RESPIR J, V10, P2174, DOI 10.1183/09031936.97.10092174; Ozlugedik S, 2008, LARYNGOSCOPE, V118, P330, DOI 10.1097/MLG.0b013e318159aa26; Papp J, 2008, ARCH OTOLARYNGOL, V134, P931, DOI 10.1001/archotol.134.9.931; Patroniti N, 2004, INTENS CARE MED, V30, P282, DOI 10.1007/s00134-003-2109-0; Qian Y, 2012, J MED BIOMECHANICS, V27, P219; Qian YM, 2013, INT J PROSTHODONT, V26, P268, DOI 10.11607/ijp2970; [钱玉梅 Qian Yumei], 2012, [医用生物力学, Journal of Medical Biomechanics], V27, P192; Shifu D, 2002, BIOSTATISTICS, P1; Wang Hong, 2002, Zhonghua Er Bi Yan Hou Ke Za Zhi, V37, P177; Zhao K, 2011, PERCEIVING NASAL PAT; Zhao Y, 2004, MAXILLOFACIAL PROSTH, P2; Zheng C, 1994, CHINESE J OTORHINOLA, V30, P343	26	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127597	10.1371/journal.pone.0127597	http://dx.doi.org/10.1371/journal.pone.0127597			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011127	Green Submitted, gold, Green Published			2022-12-26	WOS:000355183900116
J	Fatnassi, H; Pizzol, J; Senoussi, R; Biondi, A; Desneux, N; Poncet, C; Boulard, T				Fatnassi, Hicham; Pizzol, Jeannine; Senoussi, Rachid; Biondi, Antonio; Desneux, Nicolas; Poncet, Christine; Boulard, Thierry			Within-Crop Air Temperature and Humidity Outcomes on Spatio-Temporal Distribution of the Key Rose Pest Frankliniella occidentalis	PLOS ONE			English	Article							WESTERN FLOWER THRIPS; THYSANOPTERA THRIPIDAE; BENEFICIAL ARTHROPODS; PERGANDE THYSANOPTERA; NATURAL ENEMIES; GREENHOUSE; SIMULATION; PESTICIDES; MANAGEMENT; DISPERSAL	Frankliniella occidentalis (Pergande) is a key pest of various crops worldwide. In this study, we analyse the dependence of the infestation of this pest on spatially distributed micro climatic factors in a rose greenhouse. Despite the importance of this subject, the few existing studies have been realized in laboratory rather than in greenhouse conditions. However, recent progress on greenhouse microclimate characterisation has highlighted the strong indoor climate heterogeneity that may influence the within-crop pest distribution. In this study, both microclimate (air temperature and humidity) and thrips distribution were simultaneously mapped in a rose greenhouse. The measurements were sensed in a horizontal plane situated at mid-height of the rose crop inside the greenhouse. Simultaneously, thrips population dynamics were assessed after an artificial and homogeneous infestation of the rose crop. The spatio-temporal distribution of climate and thrips within the greenhouse were compared, and links between thrips infestation and climatic conditions were investigated. A statistical model was used to define the favourable climate conditions for thrips adults and larvae. Our results showed that (i) the air temperature and air humidity were very heterogeneously distributed within the crop, (ii) pest populations aggregated in the most favourable climatic areas and (iii) the highest population density of thrips adults and larvae were recorded at 27 degrees C and 22 degrees C for temperature and 63% and 86% for humidity, respectively. These findings confirm, in real rose cropping conditions, previous laboratory studies on the F. occidentalis climatic optimum and provide a solid scientific support for climatic-based control methods against this pest.	[Fatnassi, Hicham; Pizzol, Jeannine; Biondi, Antonio; Desneux, Nicolas; Poncet, Christine; Boulard, Thierry] INRA, UMR1355, ISA, F-06903 Sophia Antipolis, France; [Senoussi, Rachid] INRA, UR 0546, Biostat & Proc Spatiaux, F-84914 Montfavet, France; [Biondi, Antonio] Univ Catania, Di3A, I-95123 Catania, Italy	INRAE; UDICE-French Research Universities; Universite Cote d'Azur; INRAE; University of Catania	Fatnassi, H (corresponding author), INRA, UMR1355, ISA, 400 Route Chappes, F-06903 Sophia Antipolis, France.	hicham.fatnassi@sophia.inra.fr	BIONDI, Antonio/I-6381-2012; Desneux, Nicolas/J-6262-2013; Boulard, Thierry/B-5381-2011	BIONDI, Antonio/0000-0002-1982-7716; fatnassi, Hicham/0000-0002-4676-6461				Aguilar-Fenollosa E, 2013, J PEST SCI, V86, P469, DOI 10.1007/s10340-013-0494-x; Bartzanas T, 2002, COMPUT ELECTRON AGR, V34, P207, DOI 10.1016/S0168-1699(01)00188-0; Bergh JC, 1997, J ECON ENTOMOL, V90, P679, DOI 10.1093/jee/90.2.679; Berndt O, 2004, BIOL CONTROL, V30, P17, DOI 10.1016/j.biocontrol.2003.09.009; Bielza P, 2007, J ECON ENTOMOL, V100, P916, DOI 10.1603/0022-0493(2007)100[916:GOSRIF]2.0.CO;2; Biondi A, 2012, PEST MANAG SCI, V68, P1523, DOI 10.1002/ps.3396; Bournier A., 1987, PHYTOMA, V388, P14; BRODSGAARD HF, 1994, J APPL ENTOMOL, V117, P498, DOI 10.1111/j.1439-0418.1994.tb00767.x; Cox DR, 1974, THEORETICAL STAT; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Egger B, 2014, J PEST SCI, V87, P53, DOI 10.1007/s10340-013-0532-8; Fatnassi H, 2006, BIOSYST ENG, V93, P301, DOI 10.1016/j.biosystemseng.2005.11.014; Fatnassi H, 2003, AGR FOREST METEOROL, V118, P97, DOI 10.1016/S0168-1923(03)00071-6; Immaraju J.A., 1992, J ECON ENTOMOL, V89, P9; KAREIVA PM, 1983, OECOLOGIA, V57, P322, DOI 10.1007/BF00377175; Kirk WDJ, 2003, AGR FOREST ENTOMOL, V5, P301, DOI 10.1046/j.1461-9563.2003.00192.x; Kogan M, ANN REV ENTOMOL, V43, P243; Kumm S, 2010, J APPL ENTOMOL, V134, P491, DOI 10.1111/j.1439-0418.2009.01473.x; Lewis T, 1997, THRIPS CROP PESTS; Lu YH, 2012, NATURE, V487, P362, DOI 10.1038/nature11153; McDonald JR, 1998, EUR J ENTOMOL, V95, P301; Mehle N, 2012, J PEST SCI, V85, P179, DOI 10.1007/s10340-012-0423-4; Molina-Aiz FD, 2010, COMPUT ELECTRON AGR, V72, P69, DOI 10.1016/j.compag.2010.03.002; Morse JG, 2006, ANNU REV ENTOMOL, V51, P67, DOI 10.1146/annurev.ento.51.110104.151044; Mound L.A., 1997, THRIPS CROP PESTS; Mound LA, 2005, ANNU REV ENTOMOL, V50, P247, DOI 10.1146/annurev.ento.49.061802.123318; Mouttet R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018840; Navarro-Campos C, 2013, J PEST SCI, V86, P459, DOI 10.1007/s10340-013-0489-7; Nyasani JO, 2013, J PEST SCI, V86, P515, DOI 10.1007/s10340-013-0491-0; Pizzol J, 2006, IOBC WPRS B, V29, P31; Pizzol J, 2010, J PEST SCI, V83, P191, DOI 10.1007/s10340-010-0286-5; Rahman T, 2012, CROP PROT, V42, P281, DOI 10.1016/j.cropro.2012.07.020; Reitz SR, 2009, FLA ENTOMOL, V92, P7, DOI 10.1653/024.092.0102; Rhainds M, 2004, CAN ENTOMOL, V136, P241; Robb, 1991, UNDERSTANDING THYSAN, P343; ROBB KL, 1989, THESIS U CALIF RIVER; SHIPP JL, 1993, ENVIRON ENTOMOL, V22, P726, DOI 10.1093/ee/22.4.726; Stavrinides MC, 2010, ENVIRON ENTOMOL, V39, P1232, DOI 10.1603/EN09288; Steiner MY, 2011, AUST J ENTOMOL, V50, P179, DOI 10.1111/j.1440-6055.2010.00798.x; Steiner MY, 1998, AUST J ENTOMOL, V37, P101, DOI 10.1111/j.1440-6055.1998.tb01554.x; van Lenteren JC, 2000, CROP PROT, V19, P375, DOI 10.1016/S0261-2194(00)00038-7; VANRIJN PCJ, 1995, B ENTOMOL RES, V85, P285, DOI 10.1017/S0007485300034386; WEISENBURGER DD, 1993, HUM PATHOL, V24, P571, DOI 10.1016/0046-8177(93)90234-8; Zappala L, 2012, EUR J ENTOMOL, V109, P561, DOI 10.14411/eje.2012.070	44	15	17	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0126655	10.1371/journal.pone.0126655	http://dx.doi.org/10.1371/journal.pone.0126655			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011275	gold, Green Published, Green Submitted			2022-12-26	WOS:000355183900038
J	Gill, SV				Gill, Simone V.			Walking to the Beat of Their Own Drum: How Children and Adults Meet Timing Constraints	PLOS ONE			English	Article							DUAL-TASK CONSTRAINTS; ADAPTATION; OVERWEIGHT; INFANTS	Walking requires adapting to meet task constraints. Between 5- and 7-years old, children's walking approximates adult walking without constraints. To examine how children and adults adapt to meet timing constraints, 57 5- to 7-year olds and 20 adults walked to slow and fast audio metronome paces. Both children and adults modified their walking. However, at the slow pace, children had more trouble matching the metronome compared to adults. The youngest children's walking patterns deviated most from the slow metronome pace, and practice improved their performance. Five-year olds were the only group that did not display carryover effects to the metronome paces. Findings are discussed in relation to what contributes to the development of adaptation in children.	[Gill, Simone V.] Boston Univ, Dept Occupat Therapy, Boston, MA 02215 USA; [Gill, Simone V.] Boston Univ, Dept Med, Program Rehabil Sci PhD, Boston, MA 02215 USA	Boston University; Boston University	Gill, SV (corresponding author), Boston Univ, Dept Occupat Therapy, Boston, MA 02215 USA.	simvgill@bu.edu						Adolph KE, 2003, CHILD DEV, V74, P475, DOI 10.1111/1467-8624.7402011; Adolph KE, 2008, PSYCHOL ACTION; Berger SE, 2007, PROG BRAIN RES, V164, P237, DOI 10.1016/S0079-6123(07)64013-8; BRENIERE Y, 1989, J MOTOR BEHAV, V21, P20; BRIL B, 1989, HUM MOVEMENT SCI, V8, P99, DOI 10.1016/0167-9457(89)90012-2; Bril B, 1991, DEV TIMING CONTROL T; Choi JT, 2007, NAT NEUROSCI, V10, P1055, DOI 10.1038/nn1930; Cohen J., 1988, STAT POWER ANAL BEHA, P20, DOI DOI 10.4324/9780203771587; Cole WG, 2014, INFANT BEHAV DEV, V37, P305, DOI 10.1016/j.infbeh.2014.04.006; Forhan M, 2013, BEST PRACT RES CL EN, V27, P129, DOI 10.1016/j.beem.2013.01.003; Getchell N, 2007, MOTOR CONTROL, V11, P1; Getchell N, 2006, DEV PSYCHOBIOL, V48, P675, DOI 10.1002/dev.20186; Gill SV, 2014, RES DEV DISABIL, V35, P46, DOI 10.1016/j.ridd.2013.10.024; Gill SV, 2012, AM J PHYS MED REHAB, V91, P625, DOI 10.1097/PHM.0b013e31824fa81e; Gill SV, 2009, DEVELOPMENTAL SCI, V12, P888, DOI 10.1111/j.1467-7687.2009.00828.x; HAY JC, 1966, J EXP PSYCHOL, V71, P150, DOI 10.1037/h0022611; HAY JC, 1963, SCIENCE, V141, P167, DOI 10.1126/science.141.3576.167; Hung YC, 2013, GAIT POSTURE, V38, P450, DOI 10.1016/j.gaitpost.2013.01.009; Hung YC, 2013, AM J PHYS MED REHAB, V92, P461, DOI 10.1097/PHM.0b013e31828cd59d; INMAN VT, 1966, CAN MED ASSOC J, V94, P1047; OUNPUU S, 1991, J PEDIATR ORTHOPED, V11, P341; Sutherland D., 1988, DEV MATURE WALKING; SUTHERLAND DH, 1980, J BONE JOINT SURG AM, V62, P336, DOI 10.2106/00004623-198062030-00004; Sebastian M, 2016, J ATTEN DISORD, V20, P87, DOI 10.1177/1087054713510738; WINTER DA, 1983, J MOTOR BEHAV, V15, P302	25	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127894	10.1371/journal.pone.0127894	http://dx.doi.org/10.1371/journal.pone.0127894			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0QZ	26011538	Green Published, gold, Green Submitted			2022-12-26	WOS:000355183900160
J	Gong, L; Zhang, HX; Gan, XY; Zhang, L; Chen, YC; Nie, FJ; Shi, L; Li, M; Guo, ZQ; Zhang, GH; Song, YX				Gong, Lei; Zhang, Hongxia; Gan, Xiaoyan; Zhang, Li; Chen, Yuchao; Nie, Fengjie; Shi, Lei; Li, Miao; Guo, Zhiqian; Zhang, Guohui; Song, Yuxia			Transcriptome Profiling of the Potato (Solanum tuberosum L.) Plant under Drought Stress and Water-Stimulus Conditions	PLOS ONE			English	Article							GENE-EXPRESSION; RNA-SEQ; ABSCISIC-ACID; RESPONSIVE GENES; TOLERANCE; IDENTIFICATION; ARABIDOPSIS; RECOVERY; PATHWAYS; LIPOXYGENASE	Drought stress can seriously affect tuberization, yield and quality of potato plant. However, the precise molecular mechanisms governing potato stolon's response to drought stress and water supply are not very well understood. In this work, a potato (Solanum tuberosum L.) variant, Ningshu 4, was subjected to severe drought stress treatment (DT) and re-watering treatment (RWT) at tuber bulking stage. Strand-specific cDNA libraries of stolon materials were constructed for paired-end transcriptome sequencing analyses and differentially expressed gene (DEG) examination. In comparison to untreated-control (CT) plants, 3189 and 1797 DEGs were identified in DT and RWT plants and 4154 solely expressed DEGs were screened out from these two comparison groups. Interestingly, 263 genes showed opposite expression patterns in DT and RWT plants. Among them, genes homologous to Protein Phosphatase 2C (PP2C), Aspartic protease in guard cell 1 (ASPG1), auxin-responsive protein, Arabidopsis pseudo response regualtor 2 (APRR2), GA stimulated transcripts in Arabidopsis 6 (GASA6), Calmodulin-like protein 19 (CML19), abscisic acid 8'-hydroxylases and calcium-transporting ATPase, et al. were related with drought-stress and water stimulus response. Sixteen DEGs involved in starch synthesis, accumulation and tuber formation exhibited significantly different expression upon re-watering. In addition, 1630, 1527 and 1596 transcription factor encoding genes were detected in CT, DT and RWT. DEGs of ERF, bHLH, MYB, NAC, WRKY, C2H2, bZIP and HD-ZIP families accounted for 50% in three comparison groups, respectively. Furthermore, characteristics of 565 gene ontology (GO) and 108 Kyoto Encyclopedia of Genes and Genomes pathways (KEGG) were analyzed with the 4154 DEGs. All these results suggest that the drought-and water-stimulus response could be implemented by the regulated expression of metabolic pathway DEGs, and these genes were involved in the endogenous hormone biosynthesis and signal transduction pathways. Our data provide more direct information for future study on the interaction between key genes involved in various metabolic pathways under drought stress in potato.	[Gong, Lei; Gan, Xiaoyan; Zhang, Li; Chen, Yuchao; Nie, Fengjie; Shi, Lei; Li, Miao; Song, Yuxia] Ningxia Acad Agr & Forestry Sci, Agr Biotechnol Ctr, Ningxia Key Lab Agrobiotechnol, Yinchuan, Ningxia Hui Nat, Peoples R China; [Zhang, Hongxia] Chinese Acad Sci, Shanghai Inst Plant Physiol & Ecol, Natl Key Lab Plant Mol Genet, Shanghai, Peoples R China; [Guo, Zhiqian; Zhang, Guohui] Ningxia Acad Agr & Forestry Sci, Natl Potato Improvement Ctr, Guyuan Subctr, Guyuan, Ningxia Hui Nat, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Song, YX (corresponding author), Ningxia Acad Agr & Forestry Sci, Agr Biotechnol Ctr, Ningxia Key Lab Agrobiotechnol, Yinchuan, Ningxia Hui Nat, Peoples R China.	songyx666@163.com			China Agriculture Research System [CARS-10-ES30]; Mega Crop Breeding Project of Ningxia District-Engineering of New Potato Cultivars, Natural Science Foundation of Ningxia [NZ13098]; Scientific and Technological Innovation Priority Research Program of Ningxia Academy of Agriculture and Forestry Science [NKYG-13-05, NKYG-14-05, NKYG-15-06]	China Agriculture Research System; Mega Crop Breeding Project of Ningxia District-Engineering of New Potato Cultivars, Natural Science Foundation of Ningxia; Scientific and Technological Innovation Priority Research Program of Ningxia Academy of Agriculture and Forestry Science	This work has been jointly supported by the following grants: The China Agriculture Research System (CARS-10-ES30), The Mega Crop Breeding Project of Ningxia District-Engineering of New Potato Cultivars, Natural Science Foundation of Ningxia (NZ13098) and The Scientific and Technological Innovation Priority Research Program of Ningxia Academy of Agriculture and Forestry Science (NKYG-13-05, NKYG-14-05 and NKYG-15-06).	Alexandersson E, 2005, PLANT MOL BIOL, V59, P469, DOI 10.1007/s11103-005-0352-1; Alexandersson E, 2010, PLANT J, V61, P650, DOI 10.1111/j.1365-313X.2009.04087.x; Anithakumari AM, 2012, MOL BREEDING, V30, P1413, DOI 10.1007/s11032-012-9728-5; Bhargava S, 2013, PLANT BREEDING, V132, P21, DOI 10.1111/pbr.12004; Busch W, 2005, PLANT J, V41, P1, DOI 10.1111/j.1365-313X.2004.02272.x; Evers D, 2010, J EXP BOT, V61, P2327, DOI 10.1093/jxb/erq060; Golldack D, 2011, PLANT CELL REP, V30, P1383, DOI 10.1007/s00299-011-1068-0; Hayano-Kanashiro C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007531; Hussain SS, 2011, BIOTECHNOL PROGR, V27, P297, DOI 10.1002/btpr.514; Jain D, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-24; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kloosterman B, 2005, PLANT BIOTECHNOL J, V3, P505, DOI 10.1111/j.1467-7652.2005.00141.x; Kloosterman B, 2008, FUNCT INTEGR GENOMIC, V8, P329, DOI 10.1007/s10142-008-0083-x; Kolomiets MV, 2001, PLANT CELL, V13, P613, DOI 10.1105/tpc.13.3.613; Lata C, 2010, BIOCHEM BIOPH RES CO, V393, P720, DOI 10.1016/j.bbrc.2010.02.068; Liu GT, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-174; Liu ZN, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-594; Livaja M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-628; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu XD, 2013, PLANT PHYSIOL, V162, P440, DOI 10.1104/pp.113.214874; Marshall A, 2012, PLANT CELL, V24, P2262, DOI 10.1105/tpc.112.096677; Massa AN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026801; Mizuno H, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-121; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nam KH, 2008, J PLANT PHYSIOL, V165, P233, DOI 10.1016/j.jplph.2007.04.003; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; O'Brien M, 2002, PLANTA, V215, P485, DOI 10.1007/s00425-002-0770-0; Padmalatha KV, 2012, PLANT MOL BIOL, V78, P223, DOI 10.1007/s11103-011-9857-y; Rabbani MA, 2003, PLANT PHYSIOL, V133, P1755, DOI 10.1104/pp.103.025742; Ren XZ, 2010, PLANT J, V63, P417, DOI 10.1111/j.1365-313X.2010.04248.x; Sarkar D, 2008, PLANT CELL REP, V27, P1, DOI 10.1007/s00299-007-0457-x; Seiler C, 2014, PLANT PHYSIOL, V164, P1677, DOI 10.1104/pp.113.229062; Shin D, 2011, PLANT PHYSIOL, V155, P421, DOI 10.1104/pp.110.163634; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Talame V, 2007, J EXP BOT, V58, P229, DOI 10.1093/jxb/erl163; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vasquez-Robinet C, 2008, J EXP BOT, V59, P2109, DOI 10.1093/jxb/ern073; Villar E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-538; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang GY, 2009, J EXP BOT, V60, P3781, DOI 10.1093/jxb/erp214; Zhang N, 2014, MOL BIOL REP, V41, P505, DOI 10.1007/s11033-013-2886-7	43	70	77	4	112	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128041	10.1371/journal.pone.0128041	http://dx.doi.org/10.1371/journal.pone.0128041			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010543	Green Published, Green Submitted, gold			2022-12-26	WOS:000355183900188
J	Zhang, ZJ; Chen, JM; Su, YY; Liu, HM; Chen, Y; Luo, PG; Du, XG; Wang, D; Zhang, HY				Zhang, Zijin; Chen, Jieming; Su, Yongying; Liu, Hanmei; Chen, Yanger; Luo, Peigao; Du, Xiaogang; Wang, Dan; Zhang, Huaiyu			TaLHY, a 1R-MYB Transcription Factor, Plays an Important Role in Disease Resistance against Stripe Rust Fungus and Ear Heading in Wheat	PLOS ONE			English	Article							FUNCTIONAL-CHARACTERIZATION; CIRCADIAN-RHYTHMS; ARABIDOPSIS; MYB; GENES; PROTEIN; CLOCK; IDENTIFICATION; EXPRESSION; ENCODES	LHY (late elongated hypocotyl) is an important gene that regulates and controls biological rhythms in plants. Additionally, LHY is highly expressed in the SSH (suppression subtractive hybridization) cDNA library-induced stripe rust pathogen (CYR32) in our previous research. To identify the function of the LHY gene in disease resistance against stripe rust, we used RACE-PCR technology to clone TaLHY in the wheat variety Chuannong19. The cDNA of TaLHY is 3085 bp long with an open reading frame of 1947 bp. TaLHY is speculated to encode a 70.3 kDa protein of 648 amino acids, which has one typical plant MYB-DNA binding domain; additionally, phylogenetic tree shows that TaLHY has the highest homology with LHY of Brachypodium distachyon(BdLHY-like). Quantitative fluorescence PCR indicates that TaLHY has higher expression in the leaf, ear and stem of wheat but lower expression in the root. Infestation of CYR32 can result in up-regulated expression of TaLHY, peaking at 72 h. Using VIGS (virus-induced gene silencing) technology to disease-resistant wheat in the fourth leaf stage, plants with silenced TaLHY cannot complete their heading stage. Through the compatible interaction with the stripe rust physiological race CYR32, Chuannong 19 loses its immune capability toward the stripe rust pathogen, indicating that TaLHY may regulate and participate in the heading of wheat, as well as the defense responses against stripe rust infection.	[Zhang, Zijin; Chen, Jieming; Su, Yongying; Liu, Hanmei; Chen, Yanger; Du, Xiaogang; Zhang, Huaiyu] Sichuan Agr Univ, Biophys & Immune Engn Lab, Yaan, Sichuan, Peoples R China; [Luo, Peigao] Sichuan Agr Univ, State Key Lab Plant Breeding & Genet, Chengdu, Sichuan, Peoples R China; [Wang, Dan] Puyang Acad Agr Sci, Dept Wheat Breeding, Puyang, Henan, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University	Zhang, HY (corresponding author), Sichuan Agr Univ, Biophys & Immune Engn Lab, Yaan, Sichuan, Peoples R China.	zhyu@sicau.edu.cn		Su, Yongying/0000-0003-4459-1837	National Natural Scinece Funcdation of China [31171557]	National Natural Scinece Funcdation of China	HYZ received support from National Natural Scinece Funcdation of China (No.31171557). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alabadi D, 2001, SCIENCE, V293, P880, DOI 10.1126/science.1061320; Boddu J, 2006, PLANT MOL BIOL, V60, P185, DOI 10.1007/s11103-005-3568-1; Byrne ME, 2000, NATURE, V408, P967, DOI 10.1038/35050091; Chen YH, 2006, PLANT MOL BIOL, V60, P107, DOI 10.1007/s11103-005-2910-y; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Hein I, 2005, PLANT PHYSIOL, V138, P2155, DOI 10.1104/pp.105.062810; Holzberg S, 2002, PLANT J, V30, P315, DOI 10.1046/j.1365-313X.2002.01291.x; Honma T, 2001, NATURE, V409, P525, DOI 10.1038/35054083; Hotta CT, 2007, PLANT CELL ENVIRON, V30, P333, DOI 10.1111/j.1365-3040.2006.01627.x; Jiang CH, 2004, GENE, V326, P13, DOI 10.1016/j.gene.2003.09.049; Kim JY, 2003, EMBO J, V22, P935, DOI 10.1093/emboj/cdg075; Lee MM, 2002, PLANT CELL, V14, P611, DOI 10.1105/tpc.010434; Lipsick JS, 1996, ONCOGENE, V13, P223; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo PG, 2008, GENOME, V51, P922, DOI 10.1139/G08-079; Luo PG, 2005, PHYTOPATHOLOGY, V95, P1266, DOI 10.1094/PHYTO-95-1266; Maeda K, 2005, PLANT MOL BIOL, V59, P739, DOI 10.1007/s11103-005-0910-6; Makino S, 2002, PLANT CELL PHYSIOL, V43, P58, DOI 10.1093/pcp/pcf005; Payne CT, 2000, GENETICS, V156, P1349; Quail PH, 2002, NAT REV MOL CELL BIO, V3, P85, DOI 10.1038/nrm728; Raffaele S, 2006, FEBS LETT, V580, P3498, DOI 10.1016/j.febslet.2006.05.027; Ridley A, 2004, MYB TRANSCRIPTION FA, P6; Schaffer R, 1998, CELL, V93, P1219, DOI 10.1016/S0092-8674(00)81465-8; Scofield SR, 2005, PLANT PHYSIOL, V138, P2165, DOI 10.1104/pp.105.061861; Strayer C, 2000, SCIENCE, V289, P768, DOI 10.1126/science.289.5480.768; Suo JF, 2003, BBA-GENE STRUCT EXPR, V1630, P25, DOI 10.1016/j.bbaexp.2003.08.009; Timmermans MCP, 1999, SCIENCE, V284, P151, DOI 10.1126/science.284.5411.151; Uimari A, 1997, PLANT J, V12, P1273, DOI 10.1046/j.1365-313x.1997.12061273.x; Waites R, 1998, CELL, V93, P779, DOI 10.1016/S0092-8674(00)81439-7; Yang XY, 2007, PLANT CELL REP, V26, P219, DOI 10.1007/s00299-006-0229-z; Zhang HB, 2004, PLANT MOL BIOL, V55, P825, DOI 10.1007/s11103-005-2140-3	32	16	22	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127723	10.1371/journal.pone.0127723	http://dx.doi.org/10.1371/journal.pone.0127723			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010918	Green Submitted, Green Published, gold			2022-12-26	WOS:000355183900135
J	Prasad, JM; Migliorini, M; Galisteo, R; Strickland, DK				Prasad, Joni M.; Migliorini, Mary; Galisteo, Rebeca; Strickland, Dudley K.			Generation of a Potent Low Density Lipoprotein Receptor-related Protein 1 (LRP1) Antagonist by Engineering a Stable Form of the Receptor-associated Protein (RAP) D3 Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOXYL-TERMINAL DOMAIN; ALPHA-2-MACROGLOBULIN RECEPTOR; LIGAND-BINDING; ER RETENTION; CHAPERONE; SITES	The low density lipoprotein receptor-related protein 1 (LRP1) is a member of the low density lipoprotein receptor family and plays important roles in a number of physiological and pathological processes. Expression of LRP1 requires the receptor-associated protein (RAP), a molecular chaperone that binds LRP1 and other low density lipoprotein receptor family members in the endoplasmic reticulum and traffics with them to the Golgi where the acidic environment causes its dissociation. Exogenously added RAP is a potent LRP1 antagonist and binds to LRP1 on the cell surface, preventing ligands from binding. Following endocytosis, RAP dissociates in the acidic endosome, allowing LRP1 to recycle back to the cell surface. The acid-induced dissociation of RAP is mediated by its D3 domain, a relatively unstable three-helical bundle that denatures at pH <6.2 due to protonation of key histidine residues on helices 2 and 3. To develop an LRP1 inhibitor that does not dissociate at low pH, we introduced a disulfide bond between the second and third helices in the RAP D3 domain. By combining this disulfide bond with elimination of key histidine residues, we generated a stable RAP molecule that is resistant to both pH-and heat-induced denaturation. This molecule bound to LRP1 with high affinity at both neutral and acidic pH and proved to be a potent inhibitor of LRP1 function both in vitro and in vivo, suggesting that our stable RAP molecule may be useful in multiple pathological settings where LRP1 blockade has been shown to be effective.	Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Dept Surg, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Strickland, DK (corresponding author), Ctr Vasc & Inflammatory Dis, 800 W Baltimore St,Rm 219, Baltimore, MD 21201 USA.			Prasad, Joni/0000-0001-5224-6502	National Institutes of Health from the NHLBI [HL114379, HL120388];  [T32 HL007698]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL120388, R01HL114379, T32HL007698] Funding Source: NIH RePORTER	National Institutes of Health from the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL114379 and HL120388 from the NHLBI and by Grant T32 HL007698 (to J. M. P.). The authors declare that they have no conflicts of interest with the contents of this article.	Andersen OM, 2003, BIOCHEMISTRY-US, V42, P9355, DOI 10.1021/bi034475p; BATTEY FD, 1994, J BIOL CHEM, V269, P23268; Bu GJ, 1997, J CELL SCI, V110, P65; BU GJ, 1995, EMBO J, V14, P2269, DOI 10.1002/j.1460-2075.1995.tb07221.x; Bu GJ, 1996, J BIOL CHEM, V271, P22218, DOI 10.1074/jbc.271.36.22218; Dani VS, 2003, PROTEIN ENG, V16, P187, DOI 10.1093/proeng/gzg024; Estrada K, 2008, BIOCHEMISTRY-US, V47, P1532, DOI 10.1021/bi702076y; Fisher C, 2006, MOL CELL, V22, P277, DOI 10.1016/j.molcel.2006.02.021; HERZ J, 1991, J BIOL CHEM, V266, P21232; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Jensen JK, 2009, BIOCHEM J, V421, P273, DOI 10.1042/BJ20090175; Josephson N, 2013, HEMATOL-AM SOC HEMAT, P261, DOI 10.1182/asheducation-2013.1.261; KOUNNAS MZ, 1992, J BIOL CHEM, V267, P21162; Lee D, 2006, MOL CELL, V22, P423, DOI 10.1016/j.molcel.2006.04.011; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Medved LV, 1999, J BIOL CHEM, V274, P717, DOI 10.1074/jbc.274.2.717; Migliorini MM, 2003, J BIOL CHEM, V278, P17986, DOI 10.1074/jbc.M212592200; PERRY LJ, 1984, SCIENCE, V226, P555, DOI 10.1126/science.6387910; Polavarapu R, 2007, BLOOD, V109, P3270, DOI 10.1182/blood-2006-08-043125; Rall SC, 1998, J BIOL CHEM, V273, P24152, DOI 10.1074/jbc.273.37.24152; RIDDLES PW, 1983, METHOD ENZYMOL, V91, P49; Saenko EL, 1999, J BIOL CHEM, V274, P37685, DOI 10.1074/jbc.274.53.37685; SAUER RT, 1986, BIOCHEMISTRY-US, V25, P5992, DOI 10.1021/bi00368a024; Savonen R, 1999, J BIOL CHEM, V274, P25877, DOI 10.1074/jbc.274.36.25877; STRICKLAND DK, 1991, J BIOL CHEM, V266, P13364; STRICKLAND DK, 1990, J BIOL CHEM, V265, P17401; Wei Y, 2014, BBA-PROTEINS PROTEOM, V1844, P2331, DOI 10.1016/j.bbapap.2014.10.001; WILLIAMS SE, 1992, J BIOL CHEM, V267, P9035; Willnow TE, 1996, EMBO J, V15, P2632, DOI 10.1002/j.1460-2075.1996.tb00623.x; WILLNOW TE, 1995, P NATL ACAD SCI USA, V92, P4537, DOI 10.1073/pnas.92.10.4537; Yepes M, 2003, J CLIN INVEST, V112, P1533, DOI 10.1172/JCI200319212	31	18	19	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17262	17268		10.1074/jbc.M115.660084	http://dx.doi.org/10.1074/jbc.M115.660084			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	26013822	Green Published, hybrid			2022-12-26	WOS:000357730900022
J	Hartmann, MD; Boichenko, I; Coles, M; Lupas, AN; Alvarez, BH				Hartmann, Marcus D.; Boichenko, Iuliia; Coles, Murray; Lupas, Andrei N.; Alvarez, Birte Hernandez			Structural Dynamics of the Cereblon Ligand Binding Domain	PLOS ONE			English	Article							E3 UBIQUITIN LIGASE; LENALIDOMIDE; COMPLEX; DEGRADATION; MOLSCRIPT; MUTATION; READERS; TARGET	Cereblon, a primary target of thalidomide and its derivatives, has been characterized structurally from both bacteria and animals. Especially well studied is the thalidomide binding domain, CULT, which shows an invariable structure across different organisms and in complex with different ligands. Here, based on a series of crystal structures of a bacterial representative, we reveal the conformational flexibility and structural dynamics of this domain. In particular, we follow the unfolding of large fractions of the domain upon release of thalidomide in the crystalline state. Our results imply that a third of the domain, including the thalidomide binding pocket, only folds upon ligand binding. We further characterize the structural effect of the C-terminal truncation resulting from the mental-retardation linked R419X nonsense mutation in vitro and offer a mechanistic hypothesis for its irresponsiveness to thalidomide. At 1.2 angstrom resolution, our data provide a view of thalidomide binding at atomic resolution.	[Hartmann, Marcus D.; Boichenko, Iuliia; Coles, Murray; Lupas, Andrei N.; Alvarez, Birte Hernandez] Max Planck Inst Dev Biol, Dept Prot Evolut, Tubingen, Germany	Max Planck Society	Hartmann, MD (corresponding author), Max Planck Inst Dev Biol, Dept Prot Evolut, Tubingen, Germany.	marcus.hartmann@tuebingen.mpg.de; birte.hernandez@tuebingen.mpg.de	Hartmann, Marcus/L-8759-2019	Hartmann, Marcus/0000-0001-6937-5677; Hernandez Alvarez, Birte/0000-0003-0635-8698				Chamberlain PP, 2014, NAT STRUCT MOL BIOL, V21, P803, DOI 10.1038/nsmb.2874; Chang Xiu-Bao, 2011, Int J Biochem Mol Biol, V2, P287; Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; Fischer ES, 2014, NATURE, V512, P49, DOI 10.1038/nature13527; Gandhi AK, 2014, BRIT J HAEMATOL, V164, P811, DOI 10.1111/bjh.12708; Gayatri S, 2014, BBA-GENE REGUL MECH, V1839, P702, DOI 10.1016/j.bbagrm.2014.02.015; Hartmann MD, 2014, J STRUCT BIOL, V188, P225, DOI 10.1016/j.jsb.2014.10.010; Higgins JJ, 2004, NEUROLOGY, V63, P1927, DOI 10.1212/01.WNL.0000146196.01316.A2; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kronke J, 2014, SCIENCE, V343, P301, DOI 10.1126/science.1244851; Lee KM, 2011, BBA-MOL CELL RES, V1813, P448, DOI 10.1016/j.bbamcr.2011.01.005; Liu JY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4924; Lopez-Girona A, 2012, LEUKEMIA, V26, P2326, DOI 10.1038/leu.2012.119; Lupas AN, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004023; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Xu GQ, 2013, J BIOL CHEM, V288, P29573, DOI 10.1074/jbc.M113.472092; Yun MY, 2011, CELL RES, V21, P564, DOI 10.1038/cr.2011.42	23	15	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128342	10.1371/journal.pone.0128342	http://dx.doi.org/10.1371/journal.pone.0128342			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024445	gold, Green Published, Green Submitted			2022-12-26	WOS:000355319400086
J	Li, HY; Lindquist, JL; Yang, YF				Li, Haiyan; Lindquist, John L.; Yang, Yunfei			Effects of Sowing Date on Phenotypic Plasticity of Fitness-Related Traits in Two Annual Weeds on the Songnen Plain of China	PLOS ONE			English	Article							PIGWEED AMARANTHUS-RETROFLEXUS; LIFE-HISTORY CHARACTERS; ARABIDOPSIS-THALIANA; REDROOT PIGWEED; PHENOLOGICAL DEVELOPMENT; POPULATIONS; PHOTOPERIOD; GERMINATION; REPRODUCTION; LIGHT	Background Phenotypic plasticity of fitness-related traits is vital for plant species to adapt to variable environments. Chenopodium glaucum L. and Amaranthus retroflexus L. are two common weed species globally. Understanding the plasticity in life-history traits, especially in reproductive allocation, within and among these species is important for predicting their success and for managing them in different environments. Methodology/Principal Findings Seeds of the two plant species were sown every 10 days from 26 Jun to 15 Aug. Life-history and fitness-related traits of both phenology and morphology were measured, and dry biomass of roots, stems, leaves, and reproductive tissues was determined at physiological maturity. Length of reproductive and total life period of the two species differed among six sowing-date treatments. Later germinating plants led to relatively reduced total life period, size, and earlier reproduction than earlier germinating plants. The ratio of reproductive biomass to total plant biomass increased with later planting dates in C. glaucum but declined in A. retroflexus. Mature plant height, crown diameter, and reproductive tissue biomass, and seed production of C. glaucum and A. retroflexus increased with delayed reproductive period. Both species displayed true plasticity in reproductive allocation. However, the sowing date had a far greater effect on rate of vegetative growth than on allocation to reproduction. Conclusions/Significance The fitness of both C. glaucum and A. retroflexus populations have an apparent increase when the period between germination and seed production is much longer. However, C. glaucum appears better adapted to later sowing than A. retroflexus. Controlling seedlings prior to reproduction will alleviate the negative effect not only in the present year but also in future years.	[Li, Haiyan; Yang, Yunfei] NE Normal Univ, Inst Grassland Sci, Minist Educ, Key Lab Vegetat Ecol, Changchun, Jilin Province, Peoples R China; [Lindquist, John L.] Univ Nebraska, Dept Agron & Hort, Lincoln, NE USA	Northeast Normal University - China; University of Nebraska System; University of Nebraska Lincoln	Yang, YF (corresponding author), NE Normal Univ, Inst Grassland Sci, Minist Educ, Key Lab Vegetat Ecol, Changchun, Jilin Province, Peoples R China.	yangyf@nenu.edu.cn	Lindquist, John L/D-8656-2012		National Natural Science Foundation of China [31472134, 31170504, 30901049]; Doctoral Program of Higher Education Foundation of China [20110043110005]; Youth Foundation of Science and Technology Commission of Jilin Province, China [201101012]; Youth Foundation of Northeast Normal University of China [20090501]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Program of Higher Education Foundation of China; Youth Foundation of Science and Technology Commission of Jilin Province, China; Youth Foundation of Northeast Normal University of China	National Natural Science Foundation of China (31472134, www.nsfc.gov.cn, YFY) - decision to publish; National Natural Science Foundation of China (31170504, www.nsfc.gov.cn, YFY)-study design, data collection and analysis; National Natural Science Foundation of China (30901049, www.nsfc.gov.cn, HYL); -data collection and analysis, The Doctoral Program of Higher Education Foundation of China (20110043110005, http://www.moe.edu.cn, YFY);-preparation of the manuscript Youth Foundation of Science and Technology Commission of Jilin Province, China (201101012, www.kjt.jl.gov.cn, HYL); -preparation of the manuscript Youth Foundation of Northeast Normal University of China (20090501, www.nenu.edu.cn, HYL). -study design.	Chen MJ, 2002, FORAGE PLANTS CHINA; Donohue K, 2005, EVOLUTION, V59, P771, DOI 10.1111/j.0014-3820.2005.tb01752.x; Donohue K, 2001, EVOLUTION, V55, P692, DOI 10.1554/0014-3820(2001)055[0692:ADIPIN]2.0.CO;2; Donohue K, 2002, ECOLOGY, V83, P1006, DOI 10.1890/0012-9658(2002)083[1006:GTINSO]2.0.CO;2; Ghalambor CK, 2007, FUNCT ECOL, V21, P394, DOI 10.1111/j.1365-2435.2007.01283.x; Gianoli E, 2005, EVOL ECOL, V19, P603, DOI 10.1007/s10682-005-2220-5; HICKMAN JC, 1975, J ECOL, V63, P689, DOI 10.2307/2258745; Huang JZ, 2001, WEED SCI, V49, P500, DOI 10.1614/0043-1745(2001)049[0500:EOTAPO]2.0.CO;2; Jackson S, 1997, PLANT CELL ENVIRON, V20, P790, DOI 10.1046/j.1365-3040.1997.d01-110.x; Kantolic AG, 2005, FIELD CROP RES, V93, P212, DOI 10.1016/j.fcr.2004.10.001; KNEZEVIC SZ, 1994, WEED SCI, V42, P568, DOI 10.1017/S0043174500076967; KUDOH H, 1995, OECOLOGIA, V103, P148, DOI 10.1007/BF00329074; Li HY, 2008, J INTEGR PLANT BIOL, V50, P641, DOI 10.1111/j.1744-7909.2008.00646.x; Littell RC, 2002, SAS LINEAR MODELS; Manuel C., 2002, ECOLOGY CONCEPTS APP, V2nd, P279; Nicol JM, 2003, PLANT ECOL, V168, P191, DOI 10.1023/A:1024430919811; Pan R, 1997, PLANT PHYSIOL, P276; Pigliucci M, 1997, AM J BOT, V84, P887, DOI 10.2307/2446278; Rajcan I, 2002, CROP SCI, V42, P1930, DOI 10.2135/cropsci2002.1930; Ray J, 2006, WEED SCI, V54, P127, DOI 10.1614/WS-05-113R.1; SANS FX, 1994, CAN J BOT, V72, P10, DOI 10.1139/b94-003; SCHLICHTING CD, 1986, ANNU REV ECOL SYST, V17, P667, DOI 10.1146/annurev.es.17.110186.003315; Silvertown JW, 2003, INTRO PLANT POPULATI; STEVENS O. A., 1957, Weeds, V5, P46, DOI 10.2307/4040327; SULTAN SE, 1993, EVOLUTION, V47, P1009, DOI 10.1111/j.1558-5646.1993.tb02132.x; SULTAN SE, 1987, EVOL BIOL, V21, P127; Sultan SE, 2000, TRENDS PLANT SCI, V5, P537, DOI 10.1016/S1360-1385(00)01797-0; Sun Ju, 2007, Yingyong Shengtai Xuebao, V18, P771; Valladares F, 2007, NEW PHYTOL, V176, P749, DOI 10.1111/j.1469-8137.2007.02275.x; Weiner J, 2009, J ECOL, V97, P1220, DOI 10.1111/j.1365-2745.2009.01559.x; Wulff RD, 1999, CAN J BOT, V77, P1150, DOI 10.1139/cjb-77-8-1150; Zhou DW, 2005, CAN J BOT, V83, P28, DOI [10.1139/b04-148, 10.1139/B04-148]	33	4	4	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0127795	10.1371/journal.pone.0127795	http://dx.doi.org/10.1371/journal.pone.0127795			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26023915	Green Published, gold			2022-12-26	WOS:000355319400053
J	Val-Cid, C; Biarnes, X; Faijes, M; Planas, A				Val-Cid, Cristina; Biarnes, Xevi; Faijes, Magda; Planas, Antoni			Structural-Functional Analysis Reveals a Specific Domain Organization in Family GH20 Hexosaminidases	PLOS ONE			English	Article							BETA-N-ACETYLHEXOSAMINIDASE; SUBSTRATE-ASSISTED CATALYSIS; HUMAN-MILK OLIGOSACCHARIDES; GLYCOSIDE HYDROLASE; TAY-SACHS; BIOSIDASE; PROTEIN; INHIBITION; SEQUENCE; INSIGHT	Hexosaminidases are involved in important biological processes catalyzing the hydrolysis of N-acetyl-hexosaminyl residues in glycosaminoglycans and glycoconjugates. The GH20 enzymes present diverse domain organizations for which we propose two minimal model architectures: Model A containing at least a non-catalytic GH20b domain and the catalytic one (GH20) always accompanied with an extra alpha-helix (GH20b-GH20-alpha), and Model B with only the catalytic GH20 domain. The large Bifidobacterium bifidum lacto-N-biosidase was used as a model protein to evaluate the minimal functional unit due to its interest and structural complexity. By expressing different truncated forms of this enzyme, we show that Model A architectures cannot be reduced to Model B. In particular, there are two structural requirements general to GH20 enzymes with Model A architecture. First, the non-catalytic domain GH20b at the N-terminus of the catalytic GH20 domain is required for expression and seems to stabilize it. Second, the substrate-binding cavity at the GH20 domain always involves a remote element provided by a long loop from the catalytic domain itself or, when this loop is short, by an element from another domain of the multidomain structure or from the dimeric partner. Particularly, the lacto-N-biosidase requires GH20b and the lectin-like domain at the N- and C-termini of the catalytic GH20 domain to be fully soluble and functional. The lectin domain provides this remote element to the active site. We demonstrate restoration of activity of the inactive GH20b-GH20-alpha construct (model A architecture) by a complementation assay with the lectin-like domain. The engineering of minimal functional units of multidomain GH20 enzymes must consider these structural requirements.	[Val-Cid, Cristina; Biarnes, Xevi; Faijes, Magda; Planas, Antoni] Univ Ramon Llull, Inst Quim Sarria, Biochem Lab, Barcelona, Spain	Universitat Ramon Llull; Institut Quimic de Sarria	Faijes, M (corresponding author), Univ Ramon Llull, Inst Quim Sarria, Biochem Lab, Barcelona, Spain.	magda.faijes@iqs.edu	Biarnés, Xevi/AAA-3107-2019; Faijes, Magda/AAA-2468-2019; PLANAS, ANTONI/I-4803-2015	Biarnés, Xevi/0000-0003-4121-9474; PLANAS, ANTONI/0000-0001-7073-3320	NANO3BIO from the European Commission [FP7-KBBE-2013-7, 613931]; GLYCOZYMES from MEC, Spain [BIO2013-49022-C2-1-R]; Fundacion Instituto Danone	NANO3BIO from the European Commission; GLYCOZYMES from MEC, Spain; Fundacion Instituto Danone(Danone Nutricia)	This work was supported in part by grants NANO3BIO (FP7-KBBE-2013-7; # 613931) from the European Commission and GLYCOZYMES (BIO2013-49022-C2-1-R) from MEC, Spain. C. Val-Cid acknowledges financial support from the Fundacion Instituto Danone (2012-2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bode L, 2012, GLYCOBIOLOGY, V22, P1147, DOI 10.1093/glycob/cws074; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cuskin F, 2012, P NATL ACAD SCI USA, V109, P20889, DOI 10.1073/pnas.1212034109; Drickamer K, 2002, BIOCHEM SOC SYMP, V69, P59; Garrido D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017315; Gravel R. A., 1995, METABOLIC MOL BASIS, P2839; Hattie M, 2012, CHEMBIOCHEM, V13, P1128, DOI 10.1002/cbic.201200135; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ito T, 2013, J BIOL CHEM, V288, P11795, DOI 10.1074/jbc.M112.420109; Jiang YL, 2011, J BIOL CHEM, V286, P43004, DOI 10.1074/jbc.M111.256578; Kobata A, 2010, P JPN ACAD B-PHYS, V86, P731, DOI 10.2183/pjab.86.731; Kunz C, 2000, ANNU REV NUTR, V20, P699, DOI 10.1146/annurev.nutr.20.1.699; Langley DB, 2008, J MOL BIOL, V377, P104, DOI 10.1016/j.jmb.2007.09.028; Lemieux MJ, 2006, J MOL BIOL, V359, P913, DOI 10.1016/j.jmb.2006.04.004; Liu T, 2013, CURR PHARM DES; Liu T, 2012, CURR DRUG TARGETS, V13, P512, DOI 10.2174/138945012799499730; Liu TA, 2011, J BIOL CHEM, V286, P4049, DOI 10.1074/jbc.M110.184796; MAHURAN D, 1985, ISOZYMES-CURR T BIOL, V12, P229; Mark BL, 1998, J BIOL CHEM, V273, P19618, DOI 10.1074/jbc.273.31.19618; Mark BL, 2003, J MOL BIOL, V327, P1093, DOI 10.1016/S0022-2836(03)00216-X; Mark BL, 2001, J BIOL CHEM, V276, P42131, DOI 10.1074/jbc.M107154200; Mark BL, 2001, J BIOL CHEM, V276, P10330, DOI 10.1074/jbc.M011067200; Thi NN, 2014, BIOCHEMISTRY-US, V53, P1789, DOI 10.1021/bi401697j; Nurizzo D, 2002, STRUCTURE, V10, P547, DOI 10.1016/S0969-2126(02)00742-6; Pei JM, 2007, BIOINFORMATICS, V23, P802, DOI 10.1093/bioinformatics/btm017; Pluvinage B, 2011, STRUCTURE, V19, P1603, DOI 10.1016/j.str.2011.08.011; Prag G, 2000, J MOL BIOL, V300, P611, DOI 10.1006/jmbi.2000.3906; Ramasubbu N, 2005, J MOL BIOL, V349, P475, DOI 10.1016/j.jmb.2005.03.082; Roberts E, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-382; Rountree JSS, 2009, CHEMMEDCHEM, V4, P378, DOI 10.1002/cmdc.200800350; Sela DA, 2010, TRENDS MICROBIOL, V18, P298, DOI 10.1016/j.tim.2010.03.008; Slamova K, 2010, BIOTECHNOL ADV, V28, P682, DOI 10.1016/j.biotechadv.2010.04.004; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sumida T, 2012, ORG BIOMOL CHEM, V10, P2607, DOI 10.1039/c2ob06636j; Sumida T, 2009, J MOL BIOL, V392, P87, DOI 10.1016/j.jmb.2009.06.025; Wada J, 2008, APPL ENVIRON MICROB, V74, P3996, DOI 10.1128/AEM.00149-08; Williams SJ, 2002, J BIOL CHEM, V277, P40055, DOI 10.1074/jbc.M206481200	38	14	15	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128075	10.1371/journal.pone.0128075	http://dx.doi.org/10.1371/journal.pone.0128075			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024355	Green Published, gold, Green Submitted			2022-12-26	WOS:000355319400067
J	Ide, S; Nakamura, S; Yamamoto, Y; Kohno, Y; Fukuda, Y; Ikeda, H; Sasaki, E; Yanagihara, K; Higashiyama, Y; Hashiguchi, K; Futsuki, Y; Inoue, Y; Fukushima, K; Suyama, N; Kohno, S				Ide, Shotaro; Nakamura, Shigeki; Yamamoto, Yoshihiro; Kohno, Yoshihisa; Fukuda, Yuichi; Ikeda, Hideki; Sasaki, Eisuke; Yanagihara, Katsunori; Higashiyama, Yasuhito; Hashiguchi, Kohji; Futsuki, Yoji; Inoue, Yuichi; Fukushima, Kiyoyasu; Suyama, Naofumi; Kohno, Shigeru			Epidemiology and Clinical Features of Pulmonary Nontuberculous Mycobacteriosis in Nagasaki, Japan	PLOS ONE			English	Article							LUNG-DISEASE; AVIUM COMPLEX; PROGNOSTIC-FACTORS; BCG-VACCINATION; INFECTIONS; PREVALENCE; OUTCOMES	Background and Objectives Recent reports indicate that the incidence of nontuberculous mycobacterial- lung disease (NTM-LD) is increasing. This study aimed to investigate the epidemiology and clinical features of NTM-LD patients in Nagasaki prefecture, Japan to identify the negative prognostic factors for NTM-LD in Japan. Methods The medical records of patients newly diagnosed with NTM-LD in eleven hospitals in Nagasaki prefecture between January 2001 and February 2010 were reviewed. Data regarding the annual population of each region and the incidence of all forms of tuberculosis were collected to assess geographic variations in NTM-LD incidence, isolates, and radiological features. Results A total 975 patients were diagnosed with NTM-LD. The incidence increased over the study period and reached 11.0 and 10.1 per 100,000 population in 2008 and 2009, respectively. M. intracellulare was the most common pathogen in the southern region, and M. avium most common in other regions. The most common radiographic pattern was the nodular-bronchiectatic pattern. Age >60 years, body mass index <18.5 kg/m(2), underlying lung disease, and cavitary pattern were the negative prognostic factors at the 1-year follow-up. Conclusions The incidence of NTM-LD has been increasing in Nagasaki prefecture. The isolates and radiographic features of patients vary markedly by region.	[Ide, Shotaro; Nakamura, Shigeki; Kohno, Shigeru] Nagasaki Univ, Grad Sch Biomed Sci, Dept Resp Dis, Nagasaki 852, Japan; [Ide, Shotaro] Nagasaki Univ, Grad Sch Biomed Sci, Unit Mol Microbiol & Immunol, Nagasaki 852, Japan; [Yanagihara, Katsunori] Nagasaki Univ Hosp, Dept Lab Med, Nagasaki, Japan; [Hashiguchi, Kohji] Japanese Red Cross Nagasaki Genbaku Hosp, Nagasaki, Japan; [Futsuki, Yoji; Suyama, Naofumi] Nagasaki Municipal Hosp, Nagasaki, Japan; [Inoue, Yuichi] Isahaya Hlth Insurance Gen Hosp, Isahaya, Japan; [Fukushima, Kiyoyasu] Japanese Red Cross Nagasaki Genbaku Isahaya Hosp, Isahaya, Japan; [Fukuda, Yuichi] Sasebo City Gen Hosp, Sasebo, Japan; [Higashiyama, Yasuhito] Hokusho Cent Hosp, Sasebo, Japan; [Sasaki, Eisuke] Natl Hosp Org, Nagasaki Med Ctr, Omura, Japan; [Kohno, Yoshihisa] Izumikawa Hosp, Minami Shimabara, Japan; [Ikeda, Hideki] Nagasaki Goto Cent Hosp, Goto, Japan; [Nakamura, Shigeki] Natl Inst Infect Dis, Dept Chemotherapy & Mycoses, Shinjuku Ku, Tokyo, Japan; [Yamamoto, Yoshihiro] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Clin Infect Dis, Toyama 930, Japan	Nagasaki University; Nagasaki University; Nagasaki University; National Institute of Infectious Diseases (NIID); University of Toyama	Nakamura, S (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Resp Dis, Nagasaki 852, Japan.	moju516@nagasaki-u.ac.jp		Ide, Shotaro/0000-0001-7872-8147	Global Centers of Excellence Program; Japan Society for the Promotion of Science; Taisho Toyama Pharmaceutical Co. Ltd.	Global Centers of Excellence Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Taisho Toyama Pharmaceutical Co. Ltd.	This study was partially supported by a grant from the Global Centers of Excellence Program (S.I., S.N., and S.K.). Funding source: Japan Society for the Promotion of Science. Website: https://www.jsps.go.jp/english/index.html. Funding source: Taisho Toyama Pharmaceutical Co. Ltd. Website: http://www.taishotoyama.co.jp. These funders paid for analysis and interpretation of data, but had no involvement in the study.	Adjemian J, 2012, AM J RESP CRIT CARE, V186, P553, DOI 10.1164/rccm.201205-0913OC; Adjemian J, 2012, AM J RESP CRIT CARE, V185, P881, DOI 10.1164/rccm.201111-2016OC; Andrejak C, 2010, AM J RESP CRIT CARE, V181, P514, DOI 10.1164/rccm.200905-0778OC; Bodle EE, 2008, EMERG INFECT DIS, V14, P390, DOI 10.3201/eid1403.061143; Cassidy PM, 2009, CLIN INFECT DIS, V49, pE124, DOI 10.1086/648443; Chen CY, 2012, DIAGN MICR INFEC DIS, V72, P47, DOI 10.1016/j.diagmicrobio.2011.09.009; Chou MP, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-279; Dailloux M, 2006, EUR RESPIR J, V28, P1211, DOI 10.1183/09031936.00063806; Falkinham JO, 2009, J APPL MICROBIOL, V107, P356, DOI 10.1111/j.1365-2672.2009.04161.x; Fujikane T, 2005, INT J TUBERC LUNG D, V9, P1281; Fujita K, 2013, CLIN MICROBIOL INFEC, V19, P537, DOI 10.1111/j.1469-0691.2012.03929.x; Fujiuchi S, 2003, RESPIRATION, V70, P76, DOI 10.1159/000068416; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Hayashi M, 2012, AM J RESP CRIT CARE, V185, P575, DOI 10.1164/rccm.201107-1203OC; Hersh AL, 2003, INT J TUBERC LUNG D, V7, P22; Iseman MD, 2008, AM J RESP CRIT CARE, V178, P999, DOI 10.1164/rccm.200808-1258ED; Kajiki Akira, 2011, Kekkaku, V86, P113; Kazumi Yuko, 2006, Kekkaku, V81, P551; Kim RD, 2008, AM J RESP CRIT CARE, V178, P1066, DOI 10.1164/rccm.200805-686OC; Kobashi Yoshihiro, 2004, Journal of Infection and Chemotherapy, V10, P25, DOI 10.1007/s10156-003-0273-3; KUSUNOKI S, 1991, J CLIN MICROBIOL, V29, P1596, DOI 10.1128/JCM.29.8.1596-1603.1991; Marras TK, 2007, THORAX, V62, P661, DOI 10.1136/thx.2006.070797; Moore JE, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-612; Prevots DR, 2010, AM J RESP CRIT CARE, V182, P970, DOI 10.1164/rccm.201002-0310OC; Reed C, 2006, AM J EPIDEMIOL, V164, P32, DOI 10.1093/aje/kwj159; ROMANUS V, 1995, TUBERCLE LUNG DIS, V76, P300, DOI 10.1016/S0962-8479(05)80028-0; Simons S, 2011, EMERG INFECT DIS, V17, P343, DOI 10.3201/eid1703.100604; Singer J, 2000, INT J STD AIDS, V11, P212, DOI 10.1258/0956462001915732; Thomson RM, 2010, EMERG INFECT DIS, V16, P1576, DOI 10.3201/eid1610.091201; TRNKA L, 1994, TUBERCLE LUNG DIS, V75, P348, DOI 10.1016/0962-8479(94)90080-9; Winthrop KL, 2010, AM J RESP CRIT CARE, V182, P977, DOI 10.1164/rccm.201003-0503OC; WOLINSKY E, 1979, AM REV RESPIR DIS, V119, P107	32	35	36	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128304	10.1371/journal.pone.0128304	http://dx.doi.org/10.1371/journal.pone.0128304			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020948	Green Published, gold, Green Submitted			2022-12-26	WOS:000355187300099
J	Kouzoukas, DE; Meyer-Siegler, KL; Ma, F; Westlund, KN; Hunt, DE; Vera, PL				Kouzoukas, Dimitrios E.; Meyer-Siegler, Katherine L.; Ma, Fei; Westlund, Karin N.; Hunt, David E.; Vera, Pedro L.			Macrophage Migration Inhibitory Factor Mediates PAR-Induced Bladder Pain	PLOS ONE			English	Article							CYCLOPHOSPHAMIDE-INDUCED CYSTITIS; URINARY-TRACT-INFECTION; RAT BLADDER; UP-REGULATION; INTERSTITIAL CYSTITIS; ACTIVATED RECEPTORS; THERAPEUTIC TARGET; FACTOR MIF; INFLAMMATION; EXPRESSION	Introduction Macrophage migration inhibitory factor (MIF), a pro-inflammatory cytokine, is constitutively expressed in urothelial cells that also express protease-activated receptors (PAR). Urothelial PAR1 receptors were shown to mediate bladder inflammation. We showed that PAR1 and PAR4 activator, thrombin, also mediates urothelial MIF release. We hypothesized that stimulation of urothelial PAR1 or PAR4 receptors elicits release of urothelial MIF that acts on MIF receptors in the urothelium to mediate bladder inflammation and pain. Thus, we examined the effect of activation of specific bladder PAR receptors on MIF release, bladder pain, micturition and histological changes. Methods MIF release was measured in vitro after exposing immortalized human urothelial cells (UROtsa) to PAR1 or PAR4 activating peptides (AP). Female C57BL/6 mice received intravesical PAR1- or PAR4-AP for one hour to determine: 1) bladder MIF release in vivo within one hour; 2) abdominal hypersensitivity (allodynia) to von Frey filament stimulation 24 hours after treatment; 3) micturition parameters 24 hours after treatment; 4) histological changes in the bladder as a result of treatment; 5) changes in expression of bladder MIF and MIF receptors using real-time RT-PCR; 6) changes in urothelial MIF and MIF receptor, CXCR4, protein levels using quantitative immunofluorescence; 7) effect of MIF or CXCR4 antagonism. Results PAR1- or PAR4-AP triggered MIF release from both human urothelial cells in vitro and mouse urothelium in vivo. Twenty-four hours after intravesical PAR1- or PAR4-AP, we observed abdominal hypersensitivity in mice without changes in micturition or bladder histology. PAR4-AP was more effective and also increased expression of bladder MIF and urothelium MIF receptor, CXCR4. Bladder CXCR4 localized to the urothelium. Antagonizing MIF with ISO-1 eliminated PAR4- and reduced PAR1-induced hypersensitivity, while antagonizing CXCR4 with AMD3100 only partially prevented PAR4-induced hypersensitivity. Conclusions Bladder PAR activation elicits urothelial MIF release and urothelial MIF receptor signaling at least partly through CXCR4 to result in abdominal hypersensitivity without overt bladder inflammation. PAR-induced bladder pain may represent an interesting pre-clinical model of Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS) where pain occurs without apparent bladder injury or pathology. MIF is potentially a novel therapeutic target for bladder pain in IC/PBS patients.	[Kouzoukas, Dimitrios E.; Ma, Fei; Westlund, Karin N.; Hunt, David E.; Vera, Pedro L.] Lexington Vet Affairs Med Ctr, Res & Dev, Lexington, KY 40502 USA; [Meyer-Siegler, Katherine L.] St Petersburg Coll, Dept Nat Sci, St Petersburg, FL USA; [Ma, Fei; Westlund, Karin N.; Vera, Pedro L.] Univ Kentucky, Dept Physiol, Lexington, KY USA; [Vera, Pedro L.] Univ Kentucky, Dept Surg, Lexington, KY USA; [Kouzoukas, Dimitrios E.] Univ Kentucky, Saha Cardiovasc Res Ctr, Lexington, KY USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Lexington VA Medical Center; University of Kentucky; University of Kentucky; University of Kentucky	Kouzoukas, DE (corresponding author), Lexington Vet Affairs Med Ctr, Res & Dev, Lexington, KY 40502 USA.	dimitrios.kouzoukas@va.gov	Kouzoukas, Dimitrios/AAH-4616-2020; Kouzoukas, Dimitrios E/D-4964-2013; Kouzoukas, Dimitrios/N-6575-2019; Vera, Pedro/AAE-1514-2021; Westlund, Karin/R-6960-2019	Kouzoukas, Dimitrios E/0000-0002-1922-670X; Kouzoukas, Dimitrios/0000-0002-1922-670X; Westlund High, Karin/0000-0002-7388-4834	National Institutes of Health [DK0093496]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093496] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by funding from the National Institutes of Health (DK0093496; P.L.V.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander JK, 2012, EXP NEUROL, V236, P351, DOI 10.1016/j.expneurol.2012.04.018; Berry SH, 2011, J UROLOGY, V186, P540, DOI 10.1016/j.juro.2011.03.132; Bjorling DE, 2011, NEUROUROL URODYNAM, V30, P673, DOI 10.1002/nau.21078; BOUCHER W, 1995, BRIT J UROL, V76, P94, DOI 10.1111/j.1464-410X.1995.tb07840.x; D'Andrea MR, 2003, AM J PATHOL, V162, P907, DOI 10.1016/S0002-9440(10)63886-2; Dattilio A, 2005, J UROLOGY, V173, P635, DOI 10.1097/01.ju.0000143191.55468.1d; Flaster H, 2007, MOL ENDOCRINOL, V21, P1267, DOI 10.1210/me.2007-0065; Greven D, 2010, EXPERT OPIN THER TAR, V14, P253, DOI 10.1517/14728220903551304; Guerios SD, 2006, NEUROSCI LETT, V392, P193, DOI 10.1016/j.neulet.2005.09.026; Hoi Alberta Y., 2007, Inflammation & Allergy Drug Targets, V6, P183, DOI 10.2174/187152807781696455; Izgi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072067; Kuromitsu S, 2008, SCAND J UROL NEPHROL, V42, P455, DOI 10.1080/00365590802025881; Laird JMA, 2001, PAIN, V92, P335, DOI 10.1016/S0304-3959(01)00275-5; McDougall JJ, 2009, ARTHRITIS RHEUM-US, V60, P728, DOI 10.1002/art.24300; Meyer-Siegler KL, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/535348; Meyer-Siegler KL, 2006, J UROLOGY, V175, P1523, DOI 10.1016/S0022-5347(05)00650-6; Meyer-Siegler KL, 2005, J UROLOGY, V173, P615, DOI 10.1097/01.ju.0000143188.02802.f3; Meyer-Siegler KL, 2004, J UROLOGY, V171, P1698, DOI 10.1097/01.ju.0000115883.49365.1a; Moffatt JD, 2007, N-S ARCH PHARMACOL, V375, P1, DOI 10.1007/s00210-007-0139-9; Oz HS, 2012, WORLD J GASTROENTERO, V18, P4257, DOI 10.3748/wjg.v18.i32.4257; Rossi MR, 2001, ENVIRON HEALTH PERSP, V109, P801, DOI 10.1289/ehp.01109801; Rudick CN, 2010, J INFECT DIS, V201, P1240, DOI 10.1086/651275; Russell FA, 2011, PAIN, V152, P354, DOI 10.1016/j.pain.2010.10.038; Saban Ricardo, 2007, BMC Physiology, V7, P4, DOI 10.1186/1472-6793-7-4; Saban Ricardo, 2007, BMC Physiology, V7, P3, DOI 10.1186/1472-6793-7-3; Sugino Y, 2008, NEUROUROL URODYNAM, V27, P548, DOI 10.1002/nau.20552; Vera PL, 2008, J UROLOGY, V180, P373, DOI 10.1016/j.juro.2008.02.040; Vera PL, 2008, EXP BIOL MED, V233, P620, DOI 10.3181/0709-RM-240; Vera PL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015904; Vera PL, 2010, NEUROUROL URODYNAM, V29, P1451, DOI 10.1002/nau.20878; Vera PL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005835; Vera PL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003898; Vera PL, 2005, J UROLOGY, V174, P338, DOI 10.1097/01.ju.0000161606.15696.79; Vera PL, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-17; Wang FZ, 2011, ANESTHESIOLOGY, V114, P643, DOI 10.1097/ALN.0b013e31820a4bf3; Wang ZJ, 2013, J NEUROSCI RES, V91, P1551, DOI 10.1002/jnr.23280; Zhao PS, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00067	37	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0127628	10.1371/journal.pone.0127628	http://dx.doi.org/10.1371/journal.pone.0127628			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020638	Green Published, gold, Green Submitted			2022-12-26	WOS:000355187300048
J	Mhuantong, W; Wongwilaiwalin, S; Laothanachareon, T; Eurwilaichitr, L; Tangphatsornruang, S; Boonchayaanant, B; Limpiyakorn, T; Pattaragulwanit, K; Punmatharith, T; McEvoy, J; Khan, E; Rachakornkij, M; Champreda, V				Mhuantong, Wuttichai; Wongwilaiwalin, Sarunyou; Laothanachareon, Thanaporn; Eurwilaichitr, Lily; Tangphatsornruang, Sithichoke; Boonchayaanant, Benjaporn; Limpiyakorn, Tawan; Pattaragulwanit, Kobchai; Punmatharith, Thantip; McEvoy, John; Khan, Eakalak; Rachakornkij, Manaskorn; Champreda, Verawat			Survey of Microbial Diversity in Flood Areas during Thailand 2011 Flood Crisis Using High-Throughput Tagged Amplicon Pyrosequencing	PLOS ONE			English	Article							COMMUNITY STRUCTURE; SP-NOV; FRESH-WATER; GEN. NOV.; GEOBACTER-SULFURREDUCENS; BACTERIAL COMMUNITY; SEDIMENTS; REDUCTION; WETLAND; FUNGI	The Thailand flood crisis in 2011 was one of the largest recorded floods in modern history, causing enormous damage to the economy and ecological habitats of the country. In this study, bacterial and fungal diversity in sediments and waters collected from ten flood areas in Bangkok and its suburbs, covering residential and agricultural areas, were analyzed using high-throughput 454 pyrosequencing of 16S rRNA gene and internal transcribed spacer sequences. Analysis of microbial community showed differences in taxa distribution in water and sediment with variations in the diversity of saprophytic microbes and sulfate/nitrate reducers among sampling locations, suggesting differences in microbial activity in the habitats. Overall, Proteobacteria represented a major bacterial group in waters, while this group co-existed with Firmicutes, Bacteroidetes, and Actinobacteria in sediments. Anaeromyxobacter, Steroidobacter, and Geobacter were the dominant bacterial genera in sediments, while Sulfuricurvum, Thiovirga, and Hydrogenophaga predominated in waters. For fungi in sediments, Ascomycota, Glomeromycota, and Basidiomycota, particularly in genera Philipsia, Rozella, and Acaulospora, were most frequently detected. Chytridiomycota and Ascomycota were the major fungal phyla, and Rhizophlyctis and Mortierella were the most frequently detected fungal genera in water. Diversity of sulfate-reducing bacteria, related to odor problems, was further investigated using analysis of the dsrB gene which indicated the presence of sulfate-reducing bacteria of families Desulfobacteraceae, Desulfobulbaceae, Syntrobacteraceae, and Desulfoarculaceae in the flood sediments. The work provides an insight into the diversity and function of microbes related to biological processes in flood areas.	[Mhuantong, Wuttichai; Wongwilaiwalin, Sarunyou; Laothanachareon, Thanaporn; Eurwilaichitr, Lily; Champreda, Verawat] Natl Ctr Genet Engn & Biotechnol, Enzyme Technol Lab, Khlong Luang 12120, Pathum Thani, Thailand; [Tangphatsornruang, Sithichoke] Natl Ctr Genet Engn & Biotechnol, Genome Inst, Khlong Luang 12120, Pathum Thani, Thailand; [Boonchayaanant, Benjaporn; Limpiyakorn, Tawan; Rachakornkij, Manaskorn] Chulalongkorn Univ, Fac Engn, Dept Environm Engn, Bangkok 10330, Thailand; [Boonchayaanant, Benjaporn; Limpiyakorn, Tawan; Punmatharith, Thantip; Rachakornkij, Manaskorn] Chulalongkorn Univ, Ctr Excellence HSM, Bangkok 10330, Thailand; [Pattaragulwanit, Kobchai] Chulalongkorn Univ, Fac Sci, Dept Microbiol, Bangkok 10330, Thailand; [McEvoy, John] N Dakota State Univ, Dept Vet & Microbiol Sci, Fargo, ND 58108 USA; [Khan, Eakalak] N Dakota State Univ, Dept Civil & Environm Engn, Fargo, ND 58108 USA	National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; North Dakota State University Fargo; North Dakota State University Fargo	Champreda, V (corresponding author), Natl Ctr Genet Engn & Biotechnol, Enzyme Technol Lab, 113 Thailand Sci Pk, Khlong Luang 12120, Pathum Thani, Thailand.	verawat@biotec.or.th	Suwannasilp, Benjaporn/S-1254-2019; Tangphatsornruang, Sithichoke/G-3633-2010	Tangphatsornruang, Sithichoke/0000-0003-2673-0012; McEvoy, John/0000-0001-6843-5551; Pattaragulwanit, Kobchai/0000-0003-3744-8370; Laothanachareon, Thanaporn/0000-0002-4565-8581; Boonchayaanant Suwannasilp, Benjaporn/0000-0003-4321-5370	National Science and Technology Development Agency (NSTDA); National Science Foundation [1219755]	National Science and Technology Development Agency (NSTDA); National Science Foundation(National Science Foundation (NSF))	This material is based upon work supported by the National Science and Technology Development Agency (NSTDA) (http://www.nstda.or.th) and the National Science Foundation (http://www.nsf.gov) under Grant No. 1219755. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the NSTDA and National Science Foundation.	Abbai NS, 2013, MOL BIOTECHNOL, V54, P900, DOI 10.1007/s12033-012-9639-z; ALONGI DM, 1994, HYDROBIOLOGIA, V285, P19, DOI 10.1007/BF00005650; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2005, STANDARD METHODS EXA; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Bastida F, 2010, FEMS MICROBIOL ECOL, V73, P370, DOI 10.1111/j.1574-6941.2010.00889.x; CACCAVO F, 1994, APPL ENVIRON MICROB, V60, P3752, DOI 10.1128/AEM.60.10.3752-3759.1994; Caldwell ME, 2011, INT J SYST EVOL MICR, V61, P2659, DOI 10.1099/ijs.0.023853-0; Chaturongkasumrit Y, 2013, SCI TOTAL ENVIRON, V463, P959, DOI 10.1016/j.scitotenv.2013.06.071; Chiaramonte JB, 2013, MICROB ECOL, V66, P773, DOI 10.1007/s00248-013-0292-2; Coby AJ, 2011, APPL ENVIRON MICROB, V77, P6036, DOI 10.1128/AEM.00276-11; DEWEERD KA, 1990, ARCH MICROBIOL, V154, P23; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Fahrbach M, 2008, INT J SYST EVOL MICR, V58, P2215, DOI 10.1099/ijs.0.65342-0; Findley K, 2013, NATURE, V498, P367, DOI 10.1038/nature12171; FischerRomero C, 1996, INT J SYST BACTERIOL, V46, P183, DOI 10.1099/00207713-46-1-183; Fu B, 2011, WORLD J MICROB BIOT, V27, P915, DOI 10.1007/s11274-010-0534-0; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Green SJ, 2010, HDB HYDROCARBON LIPI, P4137, DOI DOI 10.1007/978-3-540-77587-4_323; Harmsen HJM, 1998, INT J SYST BACTERIOL, V48, P1383, DOI 10.1099/00207713-48-4-1383; Hubert CRJ, 2012, ENVIRON MICROBIOL, V14, P387, DOI 10.1111/j.1462-2920.2011.02521.x; Humblot C, 2009, APPL ENVIRON MICROB, V75, P4354, DOI 10.1128/AEM.00451-09; Kafle Gopi Krishna, 2014, Journal of Biosystems Engineering, V39, P76; Kanokratana P, 2013, MICROB ECOL, V66, P322, DOI 10.1007/s00248-013-0209-0; Kato S, 2012, GEOMICROBIOL J, V29, P896, DOI 10.1080/01490451.2011.635763; Kivlin SN, 2014, BIOGEOCHEMISTRY, V117, P23, DOI 10.1007/s10533-013-9852-2; Kjeldsen KU, 2010, INT J SYST EVOL MICR, V60, P1060, DOI 10.1099/ijs.0.014746-0; Kohout P, 2012, FEMS MICROBIOL ECOL, V80, P216, DOI 10.1111/j.1574-6941.2011.01291.x; Koljalg U, 2013, MOL ECOL, V22, P5271, DOI 10.1111/mec.12481; Krauss GJ, 2011, FEMS MICROBIOL REV, V35, P620, DOI 10.1111/j.1574-6976.2011.00266.x; Lombard M, 2000, J BIOL CHEM, V275, P115, DOI 10.1074/jbc.275.1.115; Looper JK, 2013, ENVIRON SCI-PROC IMP, V15, P2068, DOI 10.1039/c3em00200d; LOVLEY DR, 1993, ARCH MICROBIOL, V159, P336, DOI 10.1007/BF00290916; Mahadevan R, 2006, APPL ENVIRON MICROB, V72, P1558, DOI 10.1128/AEM.72.2.1558-1568.2006; Manohar CS, 2013, FEMS MICROBIOL LETT, V341, P69, DOI 10.1111/1574-6968.12087; Martin F, 2012, ENVIRON POLLUT, V162, P345, DOI 10.1016/j.envpol.2011.11.032; Medihala PG, 2012, CAN J MICROBIOL, V58, P1135, DOI [10.1139/w2012-087, 10.1139/W2012-087]; Meyer M, 2008, NAT PROTOC, V3, P267, DOI 10.1038/nprot.2007.520; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; North NN, 2004, APPL ENVIRON MICROB, V70, P4911, DOI 10.1128/aem.70.8.4911-4920.2004; Overmann J, 2000, FEMS MICROBIOL REV, V24, P591, DOI 10.1111/j.1574-6976.2000.tb00560.x; Page LH, 2015, J ENVIRON MANAGE, V152, P91, DOI 10.1016/j.jenvman.2015.01.024; Papanikolaou S, 2007, EUR J LIPID SCI TECH, V109, P1060, DOI 10.1002/ejlt.200700169; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Pascoal C, 2004, APPL ENVIRON MICROB, V70, P5266, DOI 10.1128/AEM.70.9.5266-5273.2004; Pfeffer C, 2012, NATURE, V491, P218, DOI 10.1038/nature11586; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Sanford RA, 2002, APPL ENVIRON MICROB, V68, P893, DOI 10.1128/AEM.68.2.893-900.2002; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Schwarz AO, 2012, WATER RES, V46, P3283, DOI 10.1016/j.watres.2012.03.046; Somboonna N, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S7-S29; Taylor J, 2011, ENVIRON INT, V37, P1019, DOI 10.1016/j.envint.2011.03.015; ten Veldhuis JAE, 2010, WATER RES, V44, P2910, DOI 10.1016/j.watres.2010.02.009; Thormann MN, 2007, FUNGAL DIVERS, V24, P241; Tu YT, 2014, J HYDROL, V510, P70, DOI 10.1016/j.jhydrol.2013.12.015; Wagner M, 1998, PHYLOGENY DISSIMILAT; WANG J, 2013, J BIOPHARM STAT, V23, P1677; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang Y, 2012, APPL ENVIRON MICROB, V78, P8264, DOI 10.1128/AEM.01821-12; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wongwongsee W, 2013, MAR POLLUT BULL, V74, P95, DOI 10.1016/j.marpolbul.2013.07.025; Wurzbacher C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094643; Xia FF, 2014, LETT APPL MICROBIOL, V59, P26, DOI 10.1111/lam.12240; Zeng HY, 2014, ENVIRON EARTH SCI, V71, P1339, DOI 10.1007/s12665-013-2540-7; Zhang T, 2012, APPL ENVIRON MICROB, V78, P8304, DOI 10.1128/AEM.02469-12; Zhao HP, 2011, ENVIRON SCI TECHNOL, V45, P10155, DOI 10.1021/es202569b; Zhao L, 2012, WORLD J MICROB BIOT, V28, P2077, DOI 10.1007/s11274-012-1010-9; Zhu C, 2011, AFR J AGR RES, V6, P6107, DOI 10.5897/AJAR11.1159	71	17	17	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128043	10.1371/journal.pone.0128043	http://dx.doi.org/10.1371/journal.pone.0128043			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020967	Green Published, gold, Green Submitted			2022-12-26	WOS:000355187300075
J	Persson, T; Battenberg, K; Demina, IV; Vigil-Stenman, T; Heuvel, BV; Pujic, P; Facciotti, MT; Wilbanks, EG; O'Brien, A; Fournier, P; Hernandez, MAC; Herrera, AM; Medigue, C; Normand, P; Pawlowski, K; Berry, AM				Persson, Tomas; Battenberg, Kai; Demina, Irina V.; Vigil-Stenman, Theoden; Heuvel, Brian Vanden; Pujic, Petar; Facciotti, Marc T.; Wilbanks, Elizabeth G.; O'Brien, Anna; Fournier, Pascale; Hernandez, Maria Antonia Cruz; Herrera, Alberto Mendoza; Medigue, Claudine; Normand, Philippe; Pawlowski, Katharina; Berry, Alison M.			Candidatus Frankia Datiscae Dg1, the Actinobacterial Microsymbiont of Datisca glomerata, Expresses the Canonical nod Genes nodABC in Symbiosis with Its Host Plant	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; FIXING ROOT-NODULES; RHIZOBIUM-LEGUMINOSARUM; MOLECULAR PHYLOGENY; ARBUSCULAR MYCORRHIZA; NITROGEN-FIXATION; GENUS FRANKIA; SP NOV.; EVOLUTION; STRAINS	Frankia strains are nitrogen-fixing soil actinobacteria that can form root symbioses with actinorhizal plants. Phylogenetically, symbiotic frankiae can be divided into three clusters, and this division also corresponds to host specificity groups. The strains of cluster II which form symbioses with actinorhizal Rosales and Cucurbitales, thus displaying a broad host range, show suprisingly low genetic diversity and to date can not be cultured. The genome of the first representative of this cluster, Candidatus Frankia datiscae Dg1 (Dg1), a microsymbiont of Datisca glomerata, was recently sequenced. A phylogenetic analysis of 50 different housekeeping genes of Dg1 and three published Frankia genomes showed that cluster II is basal among the symbiotic Frankia clusters. Detailed analysis showed that nodules of Datisca glomerata, independent of the origin of the inoculum, contain several closely related cluster II Frankia operational taxonomic units. Actinorhizal plants and legumes both belong to the nitrogen-fixing plant clade, and bacterial signaling in both groups involves the common symbiotic pathway also used by arbuscular mycorrhizal fungi. However, so far, no molecules resembling rhizobial Nod factors could be isolated from Frankia cultures. Alone among Frankia genomes available to date, the genome of Dg1 contains the canonical nod genes nodA, nodB and nodC known from rhizobia, and these genes are arranged in two operons which are expressed in Datisca glomerata nodules. Furthermore, Frankia Dg1 nodC was able to partially complement a Rhizobium leguminosarum A34 nodC::Tn5 mutant. Phylogenetic analysis showed that Dg1 Nod proteins are positioned at the root of both alpha- and beta-rhizobial NodABC proteins. NodA-like acyl transferases were found across the phylum Actinobacteria, but among Proteobacteria only in nodulators. Taken together, our evidence indicates an Actinobacterial origin of rhizobial Nod factors.	[Persson, Tomas; Demina, Irina V.; Vigil-Stenman, Theoden; Pawlowski, Katharina] Univ Stockholm, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden; [Battenberg, Kai; Berry, Alison M.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Heuvel, Brian Vanden] Colorado State Univ, Dept Biol, Pueblo, CO 81001 USA; [Pujic, Petar; Fournier, Pascale; Normand, Philippe] Univ Lyon 1, CNRS, Ecol Microbienne, UMR5557, F-69622 Villeurbanne, France; [Facciotti, Marc T.] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA; [Facciotti, Marc T.; Wilbanks, Elizabeth G.; O'Brien, Anna] Univ Calif Davis, UC Davis Genome Ctr, Davis, CA 95616 USA; [Hernandez, Maria Antonia Cruz; Herrera, Alberto Mendoza] Inst Politecn Nacl, Ctr Biotecnol Genom, Reynosa 88710, Tamaulipas, Mexico; [Medigue, Claudine] Genoscope, Evry, France	University of California System; University of California Davis; Colorado State University; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); VetAgro Sup; University of California System; University of California Davis; University of California System; University of California Davis; Instituto Politecnico Nacional - Mexico	Pawlowski, K (corresponding author), Univ Stockholm, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden.	katharina.pawlowski@su.se	Pujic, Petar/ACY-1850-2022; Facciotti, Marc/AAF-9227-2020; Pawlowski, Katharina/U-9955-2017; Normand, Philippe/ABD-2235-2020	Pujic, Petar/0000-0003-1957-8534; Facciotti, Marc/0000-0003-4453-3274; Pawlowski, Katharina/0000-0003-2693-885X; Normand, Philippe/0000-0002-2139-2141; O'Brien, Anna/0000-0002-8455-8620	Swedish Research Council [229-2005-679]; Swedish Research Council VR [2007-17840-52674-16]; CA Experiment Station project [PLS-2173-H]; UC Davis Plant Sciences Graduate Fellowship; NSF GRFP [DGE-1148897]; NSF [EF-0949453]; Sesam [ANR-10-BLAN-1708]; BugsInACell [ANR-13-BSV7-0013-03]; UC Mexus-Conacyt [05-24]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council VR(Swedish Research Council); CA Experiment Station project; UC Davis Plant Sciences Graduate Fellowship; NSF GRFP(National Science Foundation (NSF)NSF - Office of the Director (OD)); NSF(National Science Foundation (NSF)); Sesam; BugsInACell; UC Mexus-Conacyt(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by Swedish Research Council Formas (229-2005-679) to KP; Swedish Research Council VR (2007-17840-52674-16) to KP; CA Experiment Station project PLS-2173-H to AMB; UC Davis Plant Sciences Graduate Fellowship to KB; UC Mexus-Conacyt 05-24 to AMB and AMH; NSF GRFP DGE-1148897 to A'OB; NSF EF-0949453 to MTF; Sesam ANR-10-BLAN-1708 to PN; and BugsInACell ANR-13-BSV7-0013-03 to PN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; ABI PRISM 7700 Sequence Detection System, 2007, ABI US B, V2; Alloisio N, 2010, MOL PLANT MICROBE IN, V23, P593, DOI 10.1094/MPMI-23-5-0593; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aoki S, 2013, MOL BIOL EVOL, V30, P2494, DOI 10.1093/molbev/mst153; Barabote RD, 2009, GENOME RES, V19, P1033, DOI 10.1101/gr.084848.108; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; BENSON DR, 1993, MICROBIOL REV, V57, P293, DOI 10.1128/MMBR.57.2.293-319.1993; BERINGER JE, 1974, J GEN MICROBIOL, V84, P188; Berry AM, 2011, FUNCT PLANT BIOL, V38, P645, DOI 10.1071/FP11095; BERRY AM, 1993, P NATL ACAD SCI USA, V90, P6091, DOI 10.1073/pnas.90.13.6091; Berry AM, 2004, PLANT PHYSIOL, V135, P1849, DOI 10.1104/pp.103.031534; Bickhart DM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-468; Blom J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-154; Bond G., 1976, International Biological Programme, P443; Bontemps C, 2010, MOL ECOL, V19, P44, DOI 10.1111/j.1365-294X.2009.04458.x; BURLEIGH SH, 1995, CAN J BOT, V73, P1527, DOI 10.1139/b95-165; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caspi R, 2010, NUCLEIC ACIDS RES, V38, pD473, DOI 10.1093/nar/gkp875; Ceremonie H, 1999, CAN J BOT, V77, P1293, DOI 10.1139/cjb-77-9-1293; Chelius MK, 2000, INT J SYST EVOL MICR, V50, P751, DOI 10.1099/00207713-50-2-751; Chen WM, 2012, MICROBIOL-SGM, V158, P1758, DOI 10.1099/mic.0.058370-0; Chen WM, 2005, APPL ENVIRON MICROB, V71, P7461, DOI 10.1128/AEM.71.11.7461-7471.2005; Clark LC, 2013, SCI REP-UK, V3, DOI 10.1038/srep01109; Clawson ML, 1998, APPL ENVIRON MICROB, V64, P3539; Daubin V, 2003, MOL BIOL EVOL, V20, P471, DOI 10.1093/molbev/msg022; Delignette-Muller ML, 2013, FITDISTRPLUS HELP FI; Demina IV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072442; den Camp RO, 2011, SCIENCE, V331, P909, DOI 10.1126/science.1198181; DOWNIE JA, 1985, MOL GEN GENET, V198, P255, DOI 10.1007/BF00383003; Doyle JJ, 2011, MOL PLANT MICROBE IN, V24, P1289, DOI 10.1094/MPMI-05-11-0114; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edulamudi P, 2011, LETT APPL MICROBIOL, V53, P587, DOI 10.1111/j.1472-765X.2011.03151.x; EMBLEY TM, 1994, ANNU REV MICROBIOL, V48, P257, DOI 10.1146/annurev.mi.48.100194.001353; FAHRAEUS G, 1957, J GEN MICROBIOL, V16, P374, DOI 10.1099/00221287-16-2-374; Felsenstein J, 2005, PHILOS T R SOC B, V360, P1427, DOI 10.1098/rstb.2005.1669; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Garg B, 1999, APPL ENVIRON MICROB, V65, P2802; Genre A, 2013, NEW PHYTOL, V198, P179, DOI 10.1111/nph.12146; Gherbi H, 2008, P NATL ACAD SCI USA, V105, P4928, DOI 10.1073/pnas.0710618105; Ghodhbane-Gtari F, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00085-13; Ghodhbane-Gtari F, 2010, MICROB ECOL, V60, P487, DOI 10.1007/s00248-010-9641-6; Giraud E, 2007, SCIENCE, V316, P1307, DOI 10.1126/science.1139548; Goedhart J, 1999, BIOCHEMISTRY-US, V38, P10898, DOI 10.1021/bi990714q; Gray MW, 1999, CURR OPIN GENET DEV, V9, P678, DOI 10.1016/S0959-437X(99)00030-1; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Heuvel BDV, 2004, CAN J MICROBIOL, V50, P989, DOI [10.1139/w04-079, 10.1139/W04-079]; Hocher V, 2011, PLANT PHYSIOL, V156, P700, DOI 10.1104/pp.111.174151; Hruska K, 2012, VET MED-CZECH, V57, P623, DOI 10.17221/6558-VETMED; Husnik F, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-87; Huss-Danell K, 1997, PLANT SOIL, V197, P35, DOI 10.1023/A:1004268931699; Ivanova N, 2010, STAND GENOMIC SCI, V2, P158, DOI 10.4056/sigs.711311; Karp PD, 2010, BRIEF BIOINFORM, V11, P40, DOI 10.1093/bib/bbp043; Katoh K, 2014, METHODS MOL BIOL, V1079, P131, DOI 10.1007/978-1-62703-646-7_8; Khan SR, 2008, APPL ENVIRON MICROB, V74, P5053, DOI 10.1128/AEM.01098-08; Kistner C, 2002, TRENDS PLANT SCI, V7, P511, DOI 10.1016/S1360-1385(02)02356-7; Labeda DP, 2011, INT J SYST EVOL MICR, V61, P2525, DOI 10.1099/ijs.0.028514-0; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LAWRENCE DB, 1967, J ECOL, V55, P793, DOI 10.2307/2258426; Lee KB, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-271; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Limpens E, 2005, P NATL ACAD SCI USA, V102, P10375, DOI 10.1073/pnas.0504284102; LISTON A, 1989, Aliso, V12, P525; Madhaiyan M, 2009, INT J SYST EVOL MICR, V59, P2904, DOI 10.1099/ijs.0.009811-0; Mahillon J, 1998, MICROBIOL MOL BIOL R, V62, P725, DOI 10.1128/MMBR.62.3.725-774.1998; Maillet F, 2011, NATURE, V469, P58, DOI 10.1038/nature09622; Mansour SR, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01205-13; Markmann K, 2008, PLOS BIOL, V6, P497, DOI 10.1371/journal.pbio.0060068; Medema MH, 2011, NUCLEIC ACIDS RES, V39, pW339, DOI 10.1093/nar/gkr466; MIRZA MS, 1994, APPL ENVIRON MICROB, V60, P2371, DOI 10.1128/AEM.60.7.2371-2376.1994; MIRZA MS, 1994, PLANT SOIL, V160, P147, DOI 10.1007/BF00150356; Moran NA, 2003, CURR OPIN MICROBIOL, V6, P512, DOI 10.1016/j.mib.2003.08.001; Moran NA, 2004, CURR OPIN GENET DEV, V14, P627, DOI 10.1016/j.gde.2004.09.003; Moran NA, 2006, CURR BIOL, V16, pR866, DOI 10.1016/j.cub.2006.09.019; Munk C, 2009, STAND GENOMIC SCI, V1, P292, DOI 10.4056/sigs.47643; Normand P, 1997, PHYSIOL PLANTARUM, V99, P722, DOI 10.1034/j.1399-3054.1997.990426.x; Normand P, 1996, INT J SYST BACTERIOL, V46, P1, DOI 10.1099/00207713-46-1-1; Normand P, 2007, GENOME RES, V17, P7, DOI 10.1101/gr.5798407; Nouioui I, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00468-13; Nouioui I, 2013, J BIOSCIENCES, V38, P695, DOI 10.1007/s12038-013-9366-z; Nouioui I, 2011, ANTON LEEUW INT J G, V100, P579, DOI 10.1007/s10482-011-9613-y; Oldroyd GED, 2013, NAT REV MICROBIOL, V11, P252, DOI 10.1038/nrmicro2990; Parniske M, 2008, NAT REV MICROBIOL, V6, P763, DOI 10.1038/nrmicro1987; Pawlowski K, 2012, PROTOPLASMA, V249, P967, DOI 10.1007/s00709-012-0388-4; Persson T, 2011, J BACTERIOL, V193, P7017, DOI 10.1128/JB.06208-11; Peterson SB, 2006, APPL ENVIRON MICROB, V72, P5421, DOI 10.1128/AEM.02928-05; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pfeifer F, 2012, NAT REV MICROBIOL, V10, P705, DOI 10.1038/nrmicro2834; Prell J, 2009, P NATL ACAD SCI USA, V106, P12477, DOI 10.1073/pnas.0903653106; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; R Core Team, 2021, R LANGUAGE ENV STAT; Ran LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011486; Redecker D, 2000, SCIENCE, V289, P1920, DOI 10.1126/science.289.5486.1920; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; SCHLAMAN HRM, 1991, J BACTERIOL, V173, P4277, DOI 10.1128/JB.173.14.4277-4287.1991; Sedzielewska KA, 2011, NEW PHYTOL, V192, P794, DOI 10.1111/j.1469-8137.2011.03937.x; Sen A, 2014, INT J SYST EVOL MICR, V64, P3821, DOI 10.1099/ijs.0.063966-0; Sen A, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00103-13; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; Siguier P, 2014, FEMS MICROBIOL REV, V38, P865, DOI 10.1111/1574-6976.12067; SOLTIS DE, 1995, P NATL ACAD SCI USA, V92, P2647, DOI 10.1073/pnas.92.7.2647; Svistoonoff S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064515; Swofford D. L., 1999, PAUP 4 0 PHYLOGENETI; Swofford DL., 2003, PAUP PHYLOGENETIC AN; Takeuchi M, 2001, INT J SYST EVOL MICR, V51, P1405, DOI 10.1099/00207713-51-4-1405; Tice H, 2010, STAND GENOMIC SCI, V2, P168, DOI 10.4056/sigs.721316; Tisa LS, 2013, J BIOSCIENCES, V38, P719, DOI 10.1007/s12038-013-9364-1; Udwary DW, 2011, APPL ENVIRON MICROB, V77, P3617, DOI 10.1128/AEM.00038-11; Vallenet D, 2006, NUCLEIC ACIDS RES, V34, P53, DOI 10.1093/nar/gkj406; Vigil-Stenman V, 2014, BMC GENOMIC IN PRESS; Wall LG, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00503-13; Werner GDA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5087; Yokoyama J, 2000, MOL PHYLOGENET EVOL, V14, P11, DOI 10.1006/mpev.1999.0672; Young JPW, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r34; Zanne AE, 2014, NATURE, V506, P89, DOI 10.1038/nature12872; Zhang XC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-183	117	56	57	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0127630	10.1371/journal.pone.0127630	http://dx.doi.org/10.1371/journal.pone.0127630			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020781	Green Published, gold			2022-12-26	WOS:000355187300049
J	Farrag, M; Laufenberg, LJ; Steiner, JL; Weller, GE; Lang, CH; Ruiz-Velasco, V				Farrag, Mohamed; Laufenberg, Lacee J.; Steiner, Jennifer L.; Weller, Gregory E.; Lang, Charles H.; Ruiz-Velasco, Victor			Modulation of Voltage-Gated Ca2+ Channels by G Protein-Coupled Receptors in Celiac-Mesenteric Ganglion Neurons of Septic Rats	PLOS ONE			English	Article							NOCICEPTIN/ORPHANIN FQ; MOLECULAR-MECHANISMS; SYMPATHETIC NEURONS; SEVERE SEPSIS; CANINE MODEL; INFLAMMATION; OPIOIDS; SYSTEM; NERVE; SHOCK	Septic shock, the most severe complication associated with sepsis, is manifested by tissue hypoperfusion due, in part, to cardiovascular and autonomic dysfunction. In many cases, the splanchnic circulation becomes vasoplegic. The celiac-superior mesenteric ganglion (CSMG) sympathetic neurons provide the main autonomic input to these vessels. We used the cecal ligation puncture (CLP) model, which closely mimics the hemodynamic and metabolic disturbances observed in septic patients, to examine the properties and modulation of Ca2+ channels by G protein-coupled receptors in acutely dissociated rat CSMG neurons. Voltage-clamp studies 48 hr post-sepsis revealed that the Ca2+ current density in CMSG neurons from septic rats was significantly lower than those isolated from sham control rats. This reduction coincided with a significant increase in membrane surface area and a negligible increase in Ca2+ current amplitude. Possible explanations for these findings include either cell swelling or neurite outgrowth enhancement of CSMG neurons from septic rats. Additionally, a significant rightward shift of the concentration-response relationship for the norepinephrine (NE)-mediated Ca2+ current inhibition was observed in CSMG neurons from septic rats. Testing for the presence of opioid receptor subtypes in CSMG neurons, showed that mu opioid receptors were present in similar to 70% of CSMG, while NOP opioid receptors were found in all CSMG neurons tested. The pharmacological profile for both opioid receptor subtypes was not significantly affected by sepsis. Further, the Ca2+ current modulation by propionate, an agonist for the free fatty acid receptors GPR41 and GPR43, was not altered by sepsis. Overall, our findings suggest that CSMG function is affected by sepsis via changes in cell size and a2-adrenergic receptor-mediated Ca2+ channel modulation.	[Farrag, Mohamed; Weller, Gregory E.; Ruiz-Velasco, Victor] Penn State Coll Med, Dept Anesthesiol, Hershey, PA 17033 USA; [Laufenberg, Lacee J.] Penn State Coll Med, Dept Surg, Hershey, PA USA; [Steiner, Jennifer L.; Lang, Charles H.] Penn State Coll Med, Dept Cellular & Mol Physiol, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Ruiz-Velasco, V (corresponding author), Penn State Coll Med, Dept Anesthesiol, Hershey, PA 17033 USA.	vruizvelasco@psu.edu			National Institutes of Health [DA-025574, GM-38032, F32-AA023422]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038032, R29GM038032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [F32AA023422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025574] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Support for this study was provided by the National Institutes of Health grants DA-025574 (VRV), GM-38032 (CHL) and F32-AA023422 (JLS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annane D, 1999, AM J RESP CRIT CARE, V160, P458, DOI 10.1164/ajrccm.160.2.9810073; Bellahcene M, 2013, BRIT J NUTR, V109, P1755, DOI 10.1017/S0007114512003923; BENEDICT CR, 1992, CIRC SHOCK, V38, P165; Bindels LB, 2013, TRENDS PHARMACOL SCI, V34, P226, DOI 10.1016/j.tips.2013.02.002; Buras JA, 2005, NAT REV DRUG DISCOV, V4, P854, DOI 10.1038/nrd1854; CARRIER GO, 1992, PFLUG ARCH EUR J PHY, V421, P7, DOI 10.1007/BF00374726; CARRIER GO, 1995, BRAIN RES, V701, P1, DOI 10.1016/0006-8993(95)00756-6; Carvalho D, 2008, INTENS CARE MED, V34, P2284, DOI 10.1007/s00134-008-1313-3; Das S, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/409694; Elenkov IJ, 2000, PHARMACOL REV, V52, P595; Evans RM, 2006, TRENDS NEUROSCI, V29, P617, DOI 10.1016/j.tins.2006.08.006; FADEN AI, 1980, J PHARMACOL EXP THER, V212, P441; Fan HK, 2011, BBA-MOL CELL RES, V1813, P466, DOI 10.1016/j.bbamcr.2011.01.012; Goddard CM, 1996, AM J PHYSIOL-HEART C, V270, pH1446, DOI 10.1152/ajpheart.1996.270.4.H1446; Hausberg M, 2008, J HYPERTENS, V26, P2276, DOI 10.1097/HJH.0b013e328318efd4; HILLE B, 1994, TRENDS NEUROSCI, V17, P531, DOI 10.1016/0166-2236(94)90157-0; IKEDA SR, 1991, J PHYSIOL-LONDON, V439, P181, DOI 10.1113/jphysiol.1991.sp018663; ILLNER HP, 1981, ARCH SURG-CHICAGO, V116, P1302; Kannan Y, 1996, J IMMUNOL, V157, P313; Kimura I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2852; Landry DW, 2001, NEW ENGL J MED, V345, P588, DOI 10.1056/NEJMra002709; Laufenberg LJ, 2013, J SURG RES, V184, P973, DOI 10.1016/j.jss.2013.03.076; Lukewich MK, 2015, NEUROSCIENCE, V284, P668, DOI 10.1016/j.neuroscience.2014.10.039; Miller RJ, 1998, ANNU REV PHARMACOL, V38, P201, DOI 10.1146/annurev.pharmtox.38.1.201; Molina PE, 2006, J INTERN MED, V259, P138, DOI 10.1111/j.1365-2796.2005.01569.x; Molina PE, 2002, CLIN EXP PHARMACOL P, V29, P248, DOI 10.1046/j.1440-1681.2002.03638.x; Motagally MA, 2009, J PHYSIOL-LONDON, V587, P2623, DOI 10.1113/jphysiol.2009.172312; Motagally MA, 2009, AM J PHYSIOL-GASTR L, V296, pG1077, DOI 10.1152/ajpgi.00006.2009; Ozdem SS, 2005, VASC PHARMACOL, V43, P56, DOI 10.1016/j.vph.2005.04.001; Pugsley MK, 2002, PHARMACOL THERAPEUT, V93, P51, DOI 10.1016/S0163-7258(02)00165-1; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; RUOKONEN E, 1993, CRIT CARE MED, V21, P1296; Sayk F, 2008, AM J PHYSIOL-REG I, V295, pR891, DOI 10.1152/ajpregu.90444.2008; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Serrano-Gomez A, 2011, BRIT J ANAESTH, V106, P6, DOI 10.1093/bja/aeq337; Sina C, 2009, J IMMUNOL, V183, P7514, DOI 10.4049/jimmunol.0900063; Smeding L, 2012, SHOCK, V37, P449, DOI 10.1097/SHK.0b013e31824c3238; SOLOMON MA, 1994, AM J PHYSIOL, V266, pH757, DOI 10.1152/ajpheart.1994.266.2.H757; Solomon SB, 2003, SHOCK, V19, P215, DOI 10.1097/00024382-200303000-00004; Straub RH, 2005, J INFECT DIS, V192, P560, DOI 10.1086/432134; Swaminath G, 2008, ARCH PHARM, V341, P755, DOI 10.1002/ardp.200800096; Thomas R, 2014, J ANESTH, V28, P759, DOI 10.1007/s00540-014-1818-6; Thompson JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076682; Tschop J, 2010, J NEUROSCI, V30, P6036, DOI 10.1523/JNEUROSCI.4875-09.2010; Ulven Trond, 2012, Front Endocrinol (Lausanne), V3, P111, DOI 10.3389/fendo.2012.00111; Vallet B, 2003, CRIT CARE, V7, P130, DOI 10.1186/cc1864; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Vinolo MAR, 2011, NUTRIENTS, V3, P858, DOI 10.3390/nu3100858; Williams JP, 2008, BRIT J ANAESTH, V100, P810, DOI 10.1093/bja/aen093; Won YJ, 2013, J NEUROSCI, V33, P19314, DOI 10.1523/JNEUROSCI.3102-13.2013; Wu LL, 1999, SHOCK, V11, P39, DOI 10.1097/00024382-199901000-00006	51	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0125566	10.1371/journal.pone.0125566	http://dx.doi.org/10.1371/journal.pone.0125566			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26017846	gold, Green Published, Green Submitted			2022-12-26	WOS:000355185600027
J	Thom, MD; Daniels, JC; Kobziar, LN; Colburn, JR				Thom, Matthew D.; Daniels, Jaret C.; Kobziar, Leda N.; Colburn, Jonathan R.			Can Butterflies Evade Fire? Pupa Location and Heat Tolerance in Fire Prone Habitats of Florida	PLOS ONE			English	Article							PRESCRIBED FIRE; TALLGRASS PRAIRIE; MANAGEMENT; ABUNDANCE; CONSERVATION; HERPETOFAUNA; TEPHRITIDAE; ARTHROPODS; STRATEGIES; DIVERSITY	Butterflies such as the atala hairstreak, Eumaeus atala Poey, and the frosted elfin, Callophrys irus Godart, are restricted to frequently disturbed habitats where their larval host plants occur. Pupae of these butterflies are noted to reside at the base of host plants or in the leaf litter and soil, which may allow them to escape direct mortality by fire, a prominent disturbance in many areas they inhabit. The capacity of these species to cope with fire is a critical consideration for land management and conservation strategies in the locations where they are found. Survival of E. atala pupae in relation to temperature and duration of heat pulse was tested using controlled water bath experiments and a series of prescribed fire field experiments. Survival of E. atala pupae was correlated to peak temperature and heat exposure in both laboratory and field trials. In addition, E. atala survival following field trials was correlated to depth of burial; complete mortality was observed for pupae at the soil surface. Fifty percent of E. atala survived the heat generated by prescribed fire when experimentally placed at depths >= 1.75cm, suggesting that pupation of butterflies in the soil at depth can protect from fatal temperatures caused by fire. For a species such as E. atala that pupates above ground, a population reduction from a burn event is a significant loss, and so decreasing the impact of prescribed fire on populations is critical.	[Thom, Matthew D.] USDA ARS, N Cent Soil Conservat Res Lab, Morris, MN 56267 USA; [Daniels, Jaret C.] Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32611 USA; [Daniels, Jaret C.; Colburn, Jonathan R.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [Kobziar, Leda N.] Univ Florida, Sch Forest Resources & Conservat, Gainesville, FL 32611 USA	United States Department of Agriculture (USDA); State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Thom, MD (corresponding author), USDA ARS, N Cent Soil Conservat Res Lab, Morris, MN 56267 USA.	matt.thom@ars.usda.gov	Jaret, Daniels/AAY-2404-2020	Kobziar, Leda/0000-0002-5882-8498	UF Alumni Assistantship	UF Alumni Assistantship	This paper was part of MDT's Ph.D. dissertation conducted at the University of Florida (UF) Entomology and Nematology Department, funded in part by a UF Alumni Assistantship. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnan X, 2013, ECOGRAPHY, V36, P1182, DOI 10.1111/j.1600-0587.2013.00155.x; Battisti A, 2000, BIOCONTROL, V45, P311, DOI 10.1023/A:1009992321465; Benson TJ, 2007, J WILDLIFE MANAGE, V71, P1949, DOI 10.2193/2006-412; Borth RJ, 1997, KARNER BLUE MANAGEME, pB; Busse MD, 2010, SOIL SCI SOC AM J, V74, P947, DOI 10.2136/sssaj2009.0322; Chown S.L., 2004, INSECT PHYSL ECOLOGY, DOI DOI 10.1002/joc.5086; CHRISTIAN KA, 1992, PHYSIOL ZOOL, V65, P885, DOI 10.1086/physzool.65.5.30158548; Clayton Dale L., 2004, Journal of the Lepidopterists' Society, V58, P227; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Cook JH, 1906, CAN ENTOMOL, V38, P141; Dimou I, 2003, J APPL ENTOMOL, V127, P12, DOI 10.1046/j.1439-0418.2003.00686.x; FEDER JH, 1992, GENE DEV, V6, P1402, DOI 10.1101/gad.6.8.1402; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Ford WM, 1999, FOREST ECOL MANAG, V114, P233, DOI 10.1016/S0378-1127(98)00354-5; Freeman JE, 2011, ECOL APPL, V21, P61, DOI 10.1890/09-0948.1; FYE RE, 1978, J ECON ENTOMOL, V71, P570, DOI 10.1093/jee/71.4.570; FYE RE, 1973, J ECON ENTOMOL, V66, P657, DOI 10.1093/jee/66.3.657; Garrison E.G., 2003, NAT SCI ARC; Gongalsky KB, 2013, SOIL BIOL BIOCHEM, V57, P182, DOI 10.1016/j.soilbio.2012.07.005; Grigore MT, 1996, NAT AREA J, V16, P41; GRIME JP, 1973, NATURE, V242, P344, DOI 10.1038/242344a0; Harper MG, 2000, NAT AREA J, V20, P325; Hester T. R., 1997, FIELD METHODS ARCHAE; Heuberger KA, 2003, RESTOR ECOL, V11, P72, DOI 10.1046/j.1526-100X.2003.09982.x; Hughes Patrick R., 1993, American Entomologist, V39, P109; Keeley Jon E., 1998, P219; Kim TN, 2012, OECOLOGIA, V168, P997, DOI 10.1007/s00442-011-2130-x; Kirk K, 1996, KARNER BLUE COMMUNIT, pB; McCullough DG, 1998, ANNU REV ENTOMOL, V43, P107, DOI 10.1146/annurev.ento.43.1.107; Menges ES, 1998, ECOL APPL, V8, P935, DOI 10.1890/1051-0761(1998)008[0935:IEOFAM]2.0.CO;2; Meyer R, 2006, LUPINUS PERENNIS; Montoya P, 2008, FLA ENTOMOL, V91, P643; Myers R.L., 1990, P150; Neary D.G., 2005, WILDLAND FIRE ECOSYS; Panzer R, 2000, BIOL CONSERV, V96, P363, DOI 10.1016/S0006-3207(00)00065-3; Panzer R, 2002, CONSERV BIOL, V16, P1296, DOI 10.1046/j.1523-1739.2002.01077.x; Panzer R, 2003, NAT AREA J, V23, P14; Pausas JG, 2009, BIOSCIENCE, V59, P593, DOI 10.1525/bio.2009.59.7.10; Pavlovic NB, 2009, RESTOR ECOL, V17, P807, DOI 10.1111/j.1526-100X.2008.00417.x; PLATT WJ, 1988, AM NAT, V131, P491, DOI 10.1086/284803; Possley J, 2009, RESTOR ECOL, V17, P668, DOI 10.1111/j.1526-100X.2008.00395.x; Prodon R., 1987, P121; Ricouart F, 2013, J INSECT CONSERV, V17, P95, DOI 10.1007/s10841-012-9489-9; Rowe J.S., 1983, ROLE FIRE NO CIRCUMP, P18; Russell KR, 1999, WILDLIFE SOC B, V27, P374; Schultz CB, 1998, RESTOR ECOL, V6, P244, DOI 10.1046/j.1526-100X.1998.00637.x; SCHWEITZER D. F., 2011, RARE DECLINING POORL; Schwilk DW, 2001, OIKOS, V94, P326, DOI 10.1034/j.1600-0706.2001.940213.x; Snyder J.R., 1990, P230; Stout IJ, 1993, BIODIVERSITY SE US L; Swengel AB, 1998, BIOL CONSERV, V83, P77, DOI 10.1016/S0006-3207(96)00129-2; Swengel AB, 1996, BIOL CONSERV, V76, P73, DOI 10.1016/0006-3207(95)00085-2; Swengel AB, 2001, BIODIVERS CONSERV, V10, P1757, DOI 10.1023/A:1012051510584; Swengel AB, 2007, J INSECT CONSERV, V11, P263, DOI 10.1007/s10841-006-9042-9; Triplehorn C., 2005, BORRER DELONGS INTRO, V7; Vogel JA, 2010, J INSECT CONSERV, V14, P663, DOI 10.1007/s10841-010-9295-1; Waltz AEM, 2004, RESTOR ECOL, V12, P85, DOI 10.1111/j.1061-2971.2004.00262.x; Whelan R.J.., 1995, ECOLOGY FIRE; Wikars LO, 2001, FOREST ECOL MANAG, V141, P189, DOI 10.1016/S0378-1127(00)00328-5; Zheng XL, 2011, B INSECTOL, V64, P209	60	86	87	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0126755	10.1371/journal.pone.0126755	http://dx.doi.org/10.1371/journal.pone.0126755			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26016779	gold, Green Published, Green Submitted			2022-12-26	WOS:000355185600059
J	Akkad, DA; Olischewsky, A; Reiner, F; Hellwig, K; Esser, S; Epplen, JT; Curk, T; Gold, R; Haghikia, A				Akkad, Denis A.; Olischewsky, Alexandra; Reiner, Franziska; Hellwig, Kerstin; Esser, Sarika; Epplen, Joerg T.; Curk, Tomaz; Gold, Ralf; Haghikia, Aiden			Combinations of Susceptibility Genes Are Associated with Higher Risk for Multiple Sclerosis and Imply Disease Course Specificity	PLOS ONE			English	Article							GENETICS; LOCI	Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system that predominantly affects young adults. The genetic contributions to this multifactorial disease were underscored by a genome wide association study (GWAS) conducted by the International Multiple Sclerosis Genetic Consortium in a multinational cohort prompting the discovery of 57 non-MHC MS-associated common genetic variants. Hitherto, few of these newly reported variants have been replicated in larger independent patient cohorts. We genotyped a cohort of 1033 MS patients and 644 healthy controls with a consistent genetic background for the 57 non-MHC variants reported to be associated with MS by the first large GWAS as well as the HLA DRB1*1501 tagging SNP rs3135388. We robustly replicated three of the 57 non-MHC reported MS-associated single nucleotide polymorphisms (SNPs). In addition, our study revealed several genotype-genotype combinations with an evidently higher degree of disease association than the genotypes of the single SNPs. We further correlated well-defined clinical phenotypes, i.e. ataxia, visual impairment due to optic neuritis and paresis with single SNPs and genotype combinations, and identified several associations. The results may open new avenues for clinical implications of the MS associated genetic variants reported from large GWAS.	[Akkad, Denis A.; Esser, Sarika; Epplen, Joerg T.] Ruhr Univ Bochum, Dept Human Genet, Bochum, Germany; [Olischewsky, Alexandra; Reiner, Franziska; Hellwig, Kerstin; Gold, Ralf; Haghikia, Aiden] Ruhr Univ Bochum, St Josef Hosp, Dept Neurol, Bochum, Germany; [Curk, Tomaz] Univ Ljubljana, Fac Comp & Informat Sci, Ljubljana, Slovenia	Ruhr University Bochum; Ruhr University Bochum; University of Ljubljana	Akkad, DA (corresponding author), Ruhr Univ Bochum, Dept Human Genet, Univ Str 150, Bochum, Germany.	amer.akkad@ruhr-uni-bochum.de; aiden.haghikia@ruhr-uni-bochum.de	Curk, Tomaž/D-9836-2015	Curk, Tomaž/0000-0003-4888-7256; Epplen, Joerg T./0000-0002-6087-3327	German Research Council (DFG); Medical Faculty of The Ruhr-University Bochum (FoRUM)	German Research Council (DFG)(German Research Foundation (DFG)); Medical Faculty of The Ruhr-University Bochum (FoRUM)	Aiden Haghikia has received funding from the German Research Council (DFG) Denis A Akkad has received funding from the Medical Faculty of The Ruhr-University Bochum (FoRUM).	Akkad DA, 2015, NEUROGENETICS; Baranzini SE, 2013, AM J HUM GENET, V92, P854, DOI 10.1016/j.ajhg.2013.04.019; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; Couturier N, 2011, BRAIN, V134, P693, DOI 10.1093/brain/awr010; De Jager PL, 2009, LANCET NEUROL, V8, P1111, DOI 10.1016/S1474-4422(09)70275-3; Faresjo T, 2010, INT J ENV RES PUB HE, V7, P325, DOI 10.3390/ijerph7010325; Gauderman WJ, 2006, QUANTO 1 1 A COMPUTE; Gourraud PA, 2011, ANN NEUROL, V69, P65, DOI 10.1002/ana.22323; Gravitz L, 2012, NATURE, V484, pS2, DOI 10.1038/nature11103; Gregory AP, 2012, NATURE, V488, P508, DOI 10.1038/nature11307; Haghikia A, 2013, TRENDS MOL MED, V19, P309, DOI 10.1016/j.molmed.2013.03.004; Hauser SL, 2013, ANN NEUROL, V74, P317, DOI 10.1002/ana.24009; Hedstrom AK, 2011, BRAIN, V134, P653, DOI 10.1093/brain/awq371; Hughes T, 2012, ARTHRITIS RHEUM-US, V64, P485, DOI 10.1002/art.33354; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Oksenberg JR, 2010, NAT REV NEUROL, V6, P429, DOI 10.1038/nrneurol.2010.91; Pritchard JK, 2000, GENETICS, V155, P945; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Sawcer S, 2010, ANN NEUROL, V67, P3, DOI 10.1002/ana.21911; Wu C, 2012, NAT GENET, V44, P1090, DOI 10.1038/ng.2411	20	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127632	10.1371/journal.pone.0127632	http://dx.doi.org/10.1371/journal.pone.0127632			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011527	Green Submitted, gold, Green Published			2022-12-26	WOS:000355183900119
J	Ghate, NB; Chaudhuri, D; Das, A; Panja, S; Mandal, N				Ghate, Nikhil Baban; Chaudhuri, Dipankar; Das, Abhishek; Panja, Sourav; Mandal, Nripendranath			An Antioxidant Extract of the Insectivorous Plant Drosera burmannii Vahl. Alleviates Iron-Induced Oxidative Stress and Hepatic Injury in Mice	PLOS ONE			English	Article							THALASSEMIA MAJOR; LONG-TERM; LIVER; OVERLOAD; ACID; HEMOCHROMATOSIS; SUPEROXIDE; MECHANISMS; RESERPINE	Free iron typically leads to the formation of excess free radicals, and additional iron deposition in the liver contributes to the oxidative pathologic processes of liver disease. Many pharmacological properties of the insectivorous plant Drosera burmannii Vahl. have been reported in previous studies; however, there is no evidence of its antioxidant or hepatoprotective potential against iron overload. The antioxidant activity of 70% methanolic extract of D. burmannii (DBME) was evaluated. DBME showed excellent DPPH, hydroxyl, hypochlorous, superoxide, singlet oxygen, nitric oxide, peroxynitrite radical and hydrogen peroxide scavenging activity. A substantial iron chelation (IC50 = 40.90 +/- 0.31 mu g/ml) and supercoiled DNA protection ([P](50) = 50.41 +/- 0.55 mu g) were observed. DBME also displayed excellent in vivo hepatoprotective activity in iron-overloaded Swiss albino mice compared to the standard desirox treatment. Administration of DBME significantly normalized serum enzyme levels and restored liver antioxidant enzymes levels. DBME lowered the raised levels of liver damage parameters, also reflected from the morphological analysis of the liver sections. DBME also reduced liver iron content by 115.90% which is also seen by Perls' staining. A phytochemical analysis of DBME confirms the presence of various phytoconstituents, including phenols, flavonoids, carbohydrates, tannins, alkaloids and ascorbic acid. Alkaloids, phenols and flavonoids were abundantly found in DBME. An HPLC analysis of DBME revealed the presence of purpurin, catechin, tannic acid, reserpine, methyl gallate and rutin. Purpurin, tannic acid, methyl gallate and rutin displayed excellent iron chelation but exhibited cytotoxicity toward normal (WI-38) cells; while DBME found to be non-toxic to the normal cells. These findings suggest that the constituents present in DBME contributed to its iron chelation activity. Additional studies are needed to determine if DBME can be used as a treatment for iron overload diseases.	[Ghate, Nikhil Baban; Chaudhuri, Dipankar; Das, Abhishek; Panja, Sourav; Mandal, Nripendranath] Bose Inst, Div Mol Med, Kolkata, W Bengal, India	Department of Science & Technology (India); Bose Institute	Mandal, N (corresponding author), Bose Inst, Div Mol Med, P 1-12,Scheme VIIM, Kolkata, W Bengal, India.	mandaln@rediffmail.com	PANJA, SOURAV/AAA-7163-2022; Mandal, Nripendranath/ABC-3918-2020; Panja, Sourav/AFO-5798-2022; Chudhuri, Dipankar/AAU-6215-2021; Ghate, Nikhil/T-4153-2017	Mandal, Nripendranath/0000-0002-8733-3566; Panja, Sourav/0000-0001-8540-5266; Ghate, Nikhil/0000-0002-4447-3737; Chaudhuri, Dipankar/0000-0001-7991-0469	Department of Biotechnology (DBT), Govt. of India	Department of Biotechnology (DBT), Govt. of India(Department of Biotechnology (DBT) India)	Dr. Abhishek Das is grateful to the Department of Biotechnology (DBT), Govt. of India for the support of Research Associateship.	ALREFAIE FN, 1992, BLOOD, V80, P593; [Anonymous], 1998, WEALTH INDIA, V3; Arezzini B, 2003, INT J BIOCHEM CELL B, V35, P486, DOI 10.1016/S1357-2725(02)00298-4; Arthur MJP, 1996, J GASTROEN HEPATOL, V11, P1124, DOI 10.1111/j.1440-1746.1996.tb01840.x; ARUOMA OI, 1989, FREE RADICAL BIO MED, V6, P593, DOI 10.1016/0891-5849(89)90066-X; BARRY M, 1971, LANCET, V1, P100; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; Begum S, 2012, NAT PROD RES, V26, P2084, DOI 10.1080/14786419.2011.625502; Bibhabasu Hazra, 2012, American Journal of Pharmacology and Toxicology, V7, P109; BONAVENTURA J, 1972, ARCH BIOCHEM BIOPHYS, V150, P606, DOI 10.1016/0003-9861(72)90080-X; BONKOWSKY HL, 1981, BIOCHEM J, V196, P57, DOI 10.1042/bj1960057; Buege J A, 1978, Methods Enzymol, V52, P302; Christophe W, 2006, ETHNOPHARMACOLOGY ME, P37; Das A., 2012, ASIAN J PHARM CLIN R, V5, P74; DAWSON TM, 1992, ANN NEUROL, V32, P297, DOI 10.1002/ana.410320302; DEUGNIER YM, 1992, GASTROENTEROLOGY, V102, P2050, DOI 10.1016/0016-5085(92)90331-R; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Gardi C, 2002, BIOCHEM PHARMACOL, V64, P1139, DOI 10.1016/S0006-2952(02)01257-1; Ghate NB, 2014, CYTOTECHNOLOGY, V66, P209, DOI 10.1007/s10616-013-9553-7; Ghate NB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082293; GOLDIN A, 1957, SCIENCE, V125, P156, DOI 10.1126/science.125.3239.156-a; HABIG WH, 1974, J BIOL CHEM, V249, P7130; HALLIWELL B, 1991, AM J MED, V91, pS14, DOI 10.1016/0002-9343(91)90279-7; Harborne J.B., 1995, PHYTOCHEMICAL DICT H; Haro-Vicente JF, 2006, FOOD CHEM, V98, P639, DOI 10.1016/j.foodchem.2005.06.040; Hazra B, 2008, BMC COMPLEM ALTERN M, V8, DOI 10.1186/1472-6882-8-63; Hema B., 2009, INT J APPL RES NAT P, V2, P1; Hermes-Lima M, 1998, FREE RADICAL BIO MED, V25, P875, DOI 10.1016/S0891-5849(98)00117-8; Hynes MJ, 2002, J INORG BIOCHEM, V90, P18, DOI 10.1016/S0162-0134(02)00383-5; KAKKAR P, 1984, INDIAN J BIOCHEM BIO, V21, P130; Kochevar IE, 2000, METHOD ENZYMOL, V319, P20; Kokate C, 2017, PHARMACOGNOSY, V53rd, pA22; Kumar M., 2012, ASIAN PAC J TROP DIS, V2S, pS692, DOI [DOI 10.1016/S2222-1808(12)60245-X, 10.1016/S2222-1808(12)60245-X]; Lushchak VI, 2011, COMP BIOCHEM PHYS C, V153, P175, DOI 10.1016/j.cbpc.2010.10.004; Madhavan V, 2009, PHARM BIOL, V47, P128, DOI 10.1080/13880200802437149; MAXWELL SRJ, 1995, DRUGS, V49, P345, DOI 10.2165/00003495-199549030-00003; Nabavi S M, 2008, PHARMACOLOGYONLINE, V2, P560, DOI DOI 10.1007/BF01091994; NIEDERAU C, 1985, NEW ENGL J MED, V313, P1256, DOI 10.1056/NEJM198511143132004; OBRIEN RT, 1974, ANN NY ACAD SCI, V232, P221, DOI 10.1111/j.1749-6632.1974.tb20588.x; OLYNYK J, 1995, J HEPATOL, V22, P671, DOI 10.1016/0168-8278(95)80222-3; Perron NR, 2009, CELL BIOCHEM BIOPHYS, V53, P75, DOI 10.1007/s12013-009-9043-x; Raju A., 2012, Journal of Pharmacy Research, V5, P1418; Ramm GA, 2005, SEMIN LIVER DIS, V25, P433, DOI 10.1055/s-2005-923315; Reddy ACP, 1996, TOXICOLOGY, V107, P39, DOI 10.1016/0300-483X(95)03199-P; Richardson, 1999, Expert Opin Investig Drugs, V8, P2141, DOI 10.1517/13543784.8.12.2141; Sarkar R, 2013, INDIAN J EXP BIOL, V51, P165; Sarkar R, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/896341; Sayre Lawrence M, 2005, Ann Ist Super Sanita, V41, P143; de Jesus NZT, 2012, INT J MOL SCI, V13, P3203, DOI 10.3390/ijms13033203; VINKENBORG J, 1969, Pharmaceutisch Weekblad, V104, P45; Visioli F, 1998, BIOCHEM BIOPH RES CO, V247, P60, DOI 10.1006/bbrc.1998.8735; Wagner H., 1984, PLANT DRUG ANAL; Wang Q, 1998, Zhong Yao Cai, V21, P401; Ward FM, 1999, CLIN PHARMACOL THER, V5thed, P195; Wolf P L, 1999, Indian J Clin Biochem, V14, P59, DOI 10.1007/BF02869152; Yao LH, 2004, PLANT FOOD HUM NUTR, V59, P113, DOI 10.1007/s11130-004-0049-7	56	20	20	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128221	10.1371/journal.pone.0128221	http://dx.doi.org/10.1371/journal.pone.0128221			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010614	Green Published, gold, Green Submitted			2022-12-26	WOS:000355183900209
J	Gross, JA; Bureau, A; Croteau, J; Galfalvy, H; Oquendo, MA; Haghighi, F; Merette, C; Giegling, I; Hodgkinson, C; Goldman, D; Rujescu, D; Mann, JJ; Turecki, G				Gross, Jeffrey A.; Bureau, Alexandre; Croteau, Jordie; Galfalvy, Hanga; Oquendo, Maria A.; Haghighi, Fatemeh; Merette, Chantal; Giegling, Ina; Hodgkinson, Colin; Goldman, David; Rujescu, Dan; Mann, J. John; Turecki, Gustavo			A Genome-Wide Copy Number Variant Study of Suicidal Behavior	PLOS ONE			English	Article							BIPOLAR DISORDER; LRRK2; POPULATION; PHOSPHORYLATION; MUTATIONS; LINKAGE; RISK; CNVS	Suicide and suicide attempts are complex behaviors that result from the interaction of different factors, including genetic variants that increase the predisposition to suicidal behaviors. Copy number variations (CNVs) are deletions or duplications of a segment of DNA usually larger than one kilobase. These structural genetic changes, although quite rare, have been associated with genetic liability to mental disorders, such as autism, schizophrenia, and bipolar disorder. No genome-wide level studies have been published investigating the potential role of CNVs in suicidal behaviors. Based on single-nucleotide polymorphism array data, we followed the Penn-CNV standards to detect CNVs in 1,608 subjects, comprising 475 suicide and suicide attempt cases and 1,133 controls. Although the initial algorithms determined the presence of CNVs on chromosomes 6 and 12 in seven and eight cases, respectively, compared with none of the controls, visual inspection of the raw data did not support this finding. Furthermore we were unable to validate these findings by CNV-specific real-time polymerase chain reaction. Additionally, rare CNV burden analysis did not find an association between the frequency or length of rare CNVs and suicidal behavior in our sample population. Although our findings suggest CNVs do not play an important role in the etiology of suicidal behaviors, they are not inconsistent with the strong evidence from the literature suggesting that other genetic variants account for a portion of the total phenotypic variability in suicidal behavior.	[Gross, Jeffrey A.; Turecki, Gustavo] Douglas Mental Hlth Univ Inst, McGill Grp Suicide Studies, Montreal, PQ, Canada; [Bureau, Alexandre; Croteau, Jordie; Merette, Chantal] Univ Laval, Inst Univ Sante Mentale Quebec, Ctr Rech, Quebec City, PQ, Canada; [Galfalvy, Hanga; Haghighi, Fatemeh] Columbia Univ, Dept Psychiat, Div Biostat, New York, NY USA; [Oquendo, Maria A.; Mann, J. John] Columbia Univ, Dept Psychiat, Mol Imaging & Neuropathol Div, New York, NY USA; [Hodgkinson, Colin; Goldman, David] NIAAA, Neurogenet Lab, NIH, Rockville, MD 20852 USA; [Giegling, Ina; Rujescu, Dan] Univ Halle Wittenberg, Psychiat Clin, D-06108 Halle, Saxony Anhalt, Germany	McGill University; Laval University; Columbia University; Columbia University; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Martin Luther University Halle Wittenberg	Turecki, G (corresponding author), Douglas Mental Hlth Univ Inst, McGill Grp Suicide Studies, Montreal, PQ, Canada.	gustavo.turecki@mcgill.ca	Oquendo, Maria/AAC-6237-2019; Turecki, Gustavo/K-5100-2015; Giegling, Ina/ABA-3677-2021; Majid, Salma/AAT-2616-2020; Rujescu, Dan/GRS-3875-2022; Goldman, David/F-9772-2010; Galfalvy, Hanga/AAI-5492-2020	Majid, Salma/0000-0002-1724-5405; Goldman, David/0000-0002-1724-5405; Galfalvy, Hanga/0000-0001-7156-6106; Hodgkinson, Colin/0000-0002-5365-8119; Bureau, Alexandre/0000-0001-8220-9999; Turecki, Gustavo/0000-0003-4075-2736	NIH [R01MH082188]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH082188] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000301] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Support was provided by NIH grant R01MH082188 to GT, JJM, and DR (http://projectreporter.nih.gov/project_info_description.cfm?aid=7527841&icde=21862620&ddparam=&ddvalue=&ddsub=&cr=5&csb=default&cs=ASC).	[Anonymous], 2012, WORLD HLTH STAT; BECK AT, 1979, J CONSULT CLIN PSYCH, V47, P343, DOI 10.1037/0022-006X.47.2.343; Berkel S, 2010, NAT GENET, V42, P489, DOI 10.1038/ng.589; Brent DA, 1996, ARCH GEN PSYCHIAT, V53, P1145; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; D'haene B, 2010, METHODS, V50, P262, DOI 10.1016/j.ymeth.2009.12.007; Ernst C, 2009, PROG NEUROBIOL, V89, P315, DOI 10.1016/j.pneurobio.2009.09.001; Gehrke S, 2010, NATURE, V466, P637, DOI 10.1038/nature09191; Glessner JT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015463; Ingason A, 2011, MOL PSYCHIATR, V16, P17, DOI 10.1038/mp.2009.101; Kelly TM, 1996, ACTA PSYCHIAT SCAND, V94, P337, DOI 10.1111/j.1600-0447.1996.tb09869.x; Li HL, 2013, CNS NEUROSCI THER, V19, P207, DOI 10.1111/cns.12062; Ling H, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2013.04.011; Malhotra D, 2012, CELL, V148, P1223, DOI 10.1016/j.cell.2012.02.039; Malhotra D, 2011, NEURON, V72, P951, DOI 10.1016/j.neuron.2011.11.007; Manzoni C, 2013, BIOCHEM BIOPH RES CO, V441, P862, DOI 10.1016/j.bbrc.2013.10.159; Martin I, 2014, CELL, V157, P472, DOI 10.1016/j.cell.2014.01.064; McGirr A, 2009, AM J PSYCHIAT, V166, P1124, DOI 10.1176/appi.ajp.2009.08111744; McQuillin A, 2011, EUR J HUM GENET, V19, P588, DOI 10.1038/ejhg.2010.221; Muda K, 2014, P NATL ACAD SCI USA, V111, pE34, DOI 10.1073/pnas.1312701111; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Oquendo MA, 2014, MOL PSYCHIATR, V19, P902, DOI 10.1038/mp.2013.128; Perlis RH, 2012, AM J PSYCHIAT, V169, P1213, DOI 10.1176/appi.ajp.2012.12050592; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Samarakoon PS, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-661; Statham DJ, 1998, PSYCHOL MED, V28, P839, DOI 10.1017/S0033291798006916; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Tidemalm D, 2011, PSYCHOL MED, V41, P2527, DOI 10.1017/S0033291711000833; Turecki G, 2001, BIPOLAR DISORD, V3, P335, DOI 10.1034/j.1399-5618.2001.30608.x; Turecki G, 2012, TRENDS NEUROSCI, V35, P14, DOI 10.1016/j.tins.2011.11.008; van Heeringen K, 2014, LANCET PSYCHIAT, V1, P63, DOI 10.1016/S2215-0366(14)70220-2; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Weaver S, 2010, METHODS, V50, P271, DOI 10.1016/j.ymeth.2010.01.003; Zackrisson AL, 2010, CLIN PHARMACOL THER, V88, P354, DOI 10.1038/clpt.2009.216	38	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128369	10.1371/journal.pone.0128369	http://dx.doi.org/10.1371/journal.pone.0128369			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010658	gold, Green Published, Green Submitted			2022-12-26	WOS:000355183900230
J	Lichtenstein, JHR; Hsu, YH; Gavin, IM; Donaghey, TC; Molina, RM; Thompson, KJ; Chi, CL; Gillis, BS; Brain, JD				Lichtenstein, Jamie H. Rosenblum; Hsu, Yi-Hsiang; Gavin, Igor M.; Donaghey, Thomas C.; Molina, Ramon M.; Thompson, Khristy J.; Chi, Chih-Lin; Gillis, Bruce S.; Brain, Joseph D.			Environmental Mold and Mycotoxin Exposures Elicit Specific Cytokine and Chemokine Responses	PLOS ONE			English	Article							ACUTE PULMONARY HEMORRHAGE; BLOOD MONONUCLEAR-CELLS; STACHYBOTRYS-CHARTARUM; FUNGAL SPORES; RESPIRATORY HEALTH; ATOPIC-DERMATITIS; ALLERGIC-ASTHMA; SATRATOXIN-G; TIME-COURSE; CANCER	Background Molds can cause respiratory symptoms and asthma. We sought to use isolated peripheral blood mononuclear cells (PBMCs) to understand changes in cytokine and chemokine levels in response to mold and mycotoxin exposures and to link these levels with respiratory symptoms in humans. We did this by utilizing an ex vivo assay approach to differentiate mold-exposed patients and unexposed controls. While circulating plasma chemokine and cytokine levels from these two groups might be similar, we hypothesized that by challenging their isolated white blood cells with mold or mold extracts, we would see a differential chemokine and cytokine release. Methods and Findings Peripheral blood mononuclear cells (PBMCs) were isolated from blood from 33 patients with a history of mold exposures and from 17 controls. Cultured PBMCs were incubated with the most prominent Stachybotrys chartarum mycotoxin, satratoxin G, or with aqueous mold extract, ionomycin, or media, each with or without PMA. Additional PBMCs were exposed to spores of Aspergillus niger, Cladosporium herbarum and Penicillium chrysogenum. After 18 hours, cytokines and chemokines released into the culture medium were measured by multiplex assay. Clinical histories, physical examinations and pulmonary function tests were also conducted. After ex vivo PBMC exposures to molds or mycotoxins, the chemokine and cytokine profiles from patients with a history of mold exposure were significantly different from those of unexposed controls. In contrast, biomarker profiles from cells exposed to media alone showed no difference between the patients and controls. Conclusions These findings demonstrate that chronic mold exposures induced changes in inflammatory and immune system responses to specific mold and mycotoxin challenges. These responses can differentiate mold-exposed patients from unexposed controls. This strategy may be a powerful approach to document immune system responsiveness to molds and other inflammation-inducing environmental agents.	[Lichtenstein, Jamie H. Rosenblum; Hsu, Yi-Hsiang; Donaghey, Thomas C.; Molina, Ramon M.; Thompson, Khristy J.; Brain, Joseph D.] Harvard Univ, Dept Environm Hlth, Mol & Integrat Physiol Sci Program, TH Chan Sch Publ Hlth, Boston, MA 02163 USA; [Lichtenstein, Jamie H. Rosenblum] Emerson Coll, Inst Liberal Arts, Boston, MA 02116 USA; [Hsu, Yi-Hsiang] Hebrew Senior Life Inst Aging Res, Boston, MA USA; [Hsu, Yi-Hsiang] Harvard Univ, Sch Med, Boston, MA USA; [Hsu, Yi-Hsiang] Broad Inst & Harvard, Cambridge, MA USA; [Gavin, Igor M.] Univ Illinois, Res Resources Ctr, Chicago, IL USA; [Chi, Chih-Lin] Univ Minnesota, Sch Nursing, Inst Hlth Informat, Minneapolis, MN 55455 USA; [Gillis, Bruce S.] Univ Illinois, Coll Med, Dept Med, Chicago, IL USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Hebrew SeniorLife; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Minnesota System; University of Minnesota Twin Cities; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Lichtenstein, JHR (corresponding author), Harvard Univ, Dept Environm Hlth, Mol & Integrat Physiol Sci Program, TH Chan Sch Publ Hlth, Boston, MA 02163 USA.	jrosenbl@hsph.harvard.edu			National Institutes of Health; National Institute of Environmental Health Sciences [ES000002]; Harvard University; Bruce S. Gillis, MD, MPH, Inc.; National Institutes of Health (US) [HL007118]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000002] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Harvard University; Bruce S. Gillis, MD, MPH, Inc.; National Institutes of Health (US)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by National Institutes of Health and National Institute of Environmental Health Sciences www.nih.gov ES000002 (JHRL, YH, TCD, RMM, KJT, JDB), Harvard University www.harvard.edu Cecil K. and Philip Drinker Professorship (JDB) and Bruce S. Gillis, MD, MPH, Inc. bgillis@epicgtx.com (JDB). National Institutes of Health (US) grant #HL007118 to JHRL. BSG was actively involved in study design, patient and control recruitment, sample collection, and writing and editing the manuscript. Bruce S. Gillis, MD, MPH, Inc. provided some of the funding for the study and BSG has a financial interest in Bruce S. Gillis, MD, MPH, Inc.	Agranoff D, 2006, LANCET, V368, P1012, DOI 10.1016/S0140-6736(06)69342-2; Al-Ahmad M, 2010, ALLERGY, V65, P245, DOI 10.1111/j.1398-9995.2009.02157.x; Alkhalaf A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013421; Ambroise C, 2002, P NATL ACAD SCI USA, V99, P6562, DOI 10.1073/pnas.102102699; Bae HK, 2009, TOXICOL APPL PHARM, V237, P137, DOI 10.1016/j.taap.2009.03.006; Barbeau DN, 2010, ANNU REV PUBL HEALTH, V31, P165, DOI 10.1146/annurev.publhealth.012809.103643; Barnes PJ, 2008, J CLIN INVEST, V118, P3546, DOI 10.1172/JCI36130; Baxi SN, 2013, PEDIAT ALLERG IMM-UK, V24, P697, DOI 10.1111/pai.12127; Behm FG, 2012, BMC CLIN PATHOL, V12, DOI 10.1186/1472-6890-12-25; Betancourt DA, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-283; Bisset LR, 2005, CURR OPIN PULM MED, V11, P35, DOI 10.1097/01.mcp.0000144502.50149.e0; Blatter Joshua, 2014, Ann Am Thorac Soc, V11, P925, DOI 10.1513/AnnalsATS.201402-077OC; Boardman M, 2006, INT JOINT C NEUR NET; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P33; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P180; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chung YJ, 2003, TOXICOL MECH METHOD, V13, P247, DOI 10.1080/713857196; Clark N, 2004, DAMP INDOOR SPACES H; Crapo RO, 2000, AM J RESP CRIT CARE, V161, P309; Crook Brian, 2010, Fungal Biology Reviews, V24, P106, DOI 10.1016/j.fbr.2010.05.001; Dales RE, 1997, INT J EPIDEMIOL, V26, P120, DOI 10.1093/ije/26.1.120; de Mello LM, 2009, IMMUNOL LETT, V124, P88, DOI 10.1016/j.imlet.2009.04.011; Dearborn DG, 2002, PEDIATRICS, V110, P627, DOI 10.1542/peds.110.3.627; Dearborn DG, 1999, ENVIRON HEALTH PERSP, V107, P495, DOI 10.1289/ehp.99107s3495; Engman LH, 2007, SCAND J PUBLIC HEALT, V35, P125, DOI 10.1080/14034940600975658; Etzel RA, 1998, ARCH PEDIAT ADOL MED, V152, P757; Faraggi D, 2002, STAT MED, V21, P3093, DOI 10.1002/sim.1228; Fitzpatrick DR, 2003, CLIN IMMUNOL, V109, P37, DOI 10.1016/S1521-6616(03)00205-5; Flamant-Hulin M, 2013, PEDIAT ALLERG IMM-UK, V24, P345, DOI 10.1111/pai.12082; Flemming J, 2004, TOXICOL SCI, V78, P267, DOI 10.1093/toxsci/kfh064; Furey TS, 2000, BIOINFORMATICS, V16, P906, DOI 10.1093/bioinformatics/16.10.906; Garrett MH, 1998, CLIN EXP ALLERGY, V28, P459, DOI 10.1046/j.1365-2222.1998.00255.x; Gavin IM, 2007, ENVIRON MOL MUTAGEN, V48, P650, DOI 10.1002/em.20331; Gillis B, 2007, GENOMICS, V90, P324, DOI 10.1016/j.ygeno.2007.05.003; Grazziutti ML, 1997, J INFECT DIS, V176, P1579, DOI 10.1086/514157; Grimsley LF, 2012, ENVIRON HEALTH PERSP, V120, P1600, DOI 10.1289/ehp.1104840; Hastie T, 2004, J MACH LEARN RES, V5, P1391; Havaux X, 2005, CLIN EXP IMMUNOL, V139, P179, DOI 10.1111/j.1365-2249.2004.02679.x; Hope AP, 2007, ALLERGY ASTHMA PROC, V28, P262, DOI 10.2500/aap.2007.28.3004; Hudson B, 2005, J TOXICOL ENV HEAL A, V68, P1321, DOI 10.1080/15287390590953572; Huttunen K, 2003, ENVIRON HEALTH PERSP, V111, P85, DOI 10.1289/ehp.5478; Hyvarinen A, 2003, ARCH ENVIRON HEALTH, V58, P275; Immonen J, 2002, PEDIATR ALLERGY IMMU, V13, P125, DOI 10.1034/j.1399-3038.2002.01003.x; Inoue Y, 2005, J IMMUNOL, V175, P5439, DOI 10.4049/jimmunol.175.8.5439; Islam Z, 2008, TOXICOL SCI, V105, P142, DOI 10.1093/toxsci/kfn110; Jarvis BB, 1998, APPL ENVIRON MICROB, V64, P3620; Jin GX, 2008, J PROTEOME RES, V7, P4013, DOI 10.1021/pr8002886; Johanning E, 1996, INT ARCH OCC ENV HEA, V68, P207; Kanda N, 2002, CLIN EXP ALLERGY, V32, P1243, DOI 10.1046/j.1365-2745.2002.01459.x; Kauffman HF, 2000, J ALLERGY CLIN IMMUN, V105, P1185, DOI 10.1067/mai.2000.106210; KIM MS, 1990, APPL OPTICS, V29, P1203, DOI 10.1364/AO.29.001203; Kimura M, 1999, CLIN EXP IMMUNOL, V118, P192; Kohavi R, 1997, ARTIF INTELL, V97, P273, DOI 10.1016/S0004-3702(97)00043-X; Lappalainen MHJ, 2012, INT ARCH ALLERGY IMM, V159, P194, DOI 10.1159/000335596; LEAVITT RD, 1977, J BIOL CHEM, V252, P2961; Leino M, 2003, CLIN EXP ALLERGY, V33, P1603, DOI 10.1046/j.1365-2222.2003.01808.x; Lichtenstein JHR, 2006, AM J RESP CELL MOL, V35, P415, DOI 10.1165/rcmb.2005-0483OC; Lichtenstein JHR, 2010, TOXICOL SCI, V116, P113, DOI 10.1093/toxsci/kfq104; Liu JJ, 2005, BIOINFORMATICS, V21, P2691, DOI 10.1093/bioinformatics/bti419; Mendell MJ, 2011, ENVIRON HEALTH PERSP, V119, P748, DOI 10.1289/ehp.1002410; Moons KGM, 2006, J CLIN EPIDEMIOL, V59, P1092, DOI 10.1016/j.jclinepi.2006.01.009; Murtoniemi T, 2001, INHAL TOXICOL, V13, P233; O'Driscoll B Ronan, 2005, BMC Pulm Med, V5, P4, DOI 10.1186/1471-2466-5-4; Ozdemir Cevdet, 2009, Ther Adv Respir Dis, V3, P253, DOI 10.1177/1753465809349522; Peng SH, 2003, FEBS LETT, V555, P358, DOI 10.1016/S0014-5793(03)01275-4; Pestka JJ, 2008, TOXICOL SCI, V104, P4, DOI 10.1093/toxsci/kfm284; Purokivi MK, 2001, EUR RESPIR J, V18, P951, DOI 10.1183/09031936.01.00201201; Qin N, 2014, NATURE, V513, P59, DOI 10.1038/nature13568; Quansah R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047526; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Rao CY, 2000, MYCOPATHOLOGIA, V149, P27, DOI 10.1023/A:1007239017018; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Shahan TA, 1998, AM J RESP CELL MOL, V18, P435, DOI 10.1165/ajrcmb.18.3.2856; Shalit I, 2006, J ANTIMICROB CHEMOTH, V57, P230, DOI 10.1093/jac/dki441; Shelton BG, 2002, APPL ENVIRON MICROB, V68, P1743, DOI 10.1128/AEM.68.4.1743-1753.2002; Shore SA, 2008, J ALLERGY CLIN IMMUN, V121, P1087, DOI 10.1016/j.jaci.2008.03.004; Stark H, 2006, INHAL TOXICOL, V18, P1033, DOI 10.1080/08958370600904579; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Swirski FK, 2002, J IMMUNOL, V169, P3499, DOI 10.4049/jimmunol.169.7.3499; Tischer CG, 2013, INT J HYG ENVIR HEAL, V216, P109, DOI 10.1016/j.ijheh.2012.05.002; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; Vapnik V. N., 2000, NATURE STAT LEARNING, DOI DOI 10.1007/978-1-4757-3264-1_1; Viana ME, 2002, TOXICOL SCI, V70, P98, DOI 10.1093/toxsci/70.1.98; Weinmayr G, 2013, CLIN EXP ALLERGY, V43, P762, DOI 10.1111/cea.12107; Xiong MM, 2001, GENOME RES, V11, P1878, DOI 10.1101/gr.190001; YACHNIN S, 1972, IMMUNOLOGY, V22, P871; Yike I, 2005, TOXICOL SCI, V84, P408, DOI 10.1093/toxsci/kfi080; Yike I, 2006, ENVIRON HEALTH PERSP, V114, P1221, DOI 10.1289/ehp.9064; Zhang F, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-S1-S4; Zock JP, 2002, J ALLERGY CLIN IMMUN, V110, P285, DOI 10.1067/mai.2002.126383	93	21	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0126926	10.1371/journal.pone.0126926	http://dx.doi.org/10.1371/journal.pone.0126926			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010737	Green Published, Green Submitted, gold			2022-12-26	WOS:000355183900050
J	Vuchkova, J; Comper, WD				Vuchkova, Julijana; Comper, Wayne D.			Inhibition of the Metabolic Degradation of Filtered Albumin Is a Major Determinant of Albuminuria	PLOS ONE			English	Article							MOLECULAR-WEIGHT PROTEINS; PROXIMAL TUBULE CELLS; FRACTIONAL CLEARANCE; RENAL DEGRADATION; RAT; BARRIER; MECHANISMS; CATABOLISM; FILTRATION; FRAGMENTS	Inhibition of the degradation of filtered albumin has been proposed as a widespread, benign form of albuminuria. There have however been recent reports that radiolabeled albumin fragments in urine are not exclusively generated by the kidney and that in albuminuric states albumin fragment excretion is not inhibited. In order to resolve this controversy we have examined the fate of various radiolabeled low molecular weight protein degradation products (LMWDPs) introduced into the circulation in rats. The influence of puromycin aminonucleoside nephrosis on the processing and excretion of LMWDPs is also examined. The status and destinies of radiolabeled LMWDPs in the circulation are complex. A major finding is that LMWDPs are rapidly eliminated from the circulation (>97% in 2 h) but only small quantities (<4%) are excreted in urine. Small (<4%) but significant amounts of LMWDPs may have prolonged elimination (> 24 h) due to binding to high molecular weight components in the circulation. If LMWDPs of albumin seen in the urine are produced by extra renal degradation it would require the degradation to far exceed the known catabolic rate of albumin. Alternatively, if an estimate of the role of extra renal degradation is made from the limit of detection of LMWDPs in plasma, then extra renal degradation would only contribute <1% of the total excretion of LMWDPs of albumin. We confirm that the degradation process for albumin is specifically associated with filtered albumin and this is inhibited in albuminuric states. This inhibition is also the primary determinant of the massive change in intact albuminuria in nephrotic states.	[Vuchkova, Julijana] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Comper, Wayne D.] SalAqua Diagnost Inc, New York, NY 10019 USA	Monash University	Comper, WD (corresponding author), SalAqua Diagnost Inc, Suite 258,888c 8th Ave, New York, NY 10019 USA.	wcomper@salaqua.com			AusAm Biotechnologies (New York); SalAqua Diagnostics Inc. (New York); SalAqua Diagnostics Inc. (Melbourne Australia)	AusAm Biotechnologies (New York); SalAqua Diagnostics Inc. (New York); SalAqua Diagnostics Inc. (Melbourne Australia)	This work was supported by AusAm Biotechnologies (New York). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was also supported by SalAqua Diagnostics Inc. (New York and Melbourne Australia), who provided support in the form of a salary for author WDC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Axelsson J, 2011, AM J PHYSIOL-RENAL, V301, pF708, DOI 10.1152/ajprenal.00183.2011; BOHRER MP, 1977, J CLIN INVEST, V60, P152, DOI 10.1172/JCI108751; Burne MJ, 1998, CLIN SCI, V95, P67, DOI 10.1042/CS19980016; Burne MJ, 1999, KIDNEY INT, V55, P261, DOI 10.1046/j.1523-1755.1999.00234.x; Candiano G, 2006, J AM SOC NEPHROL, V17, P3139, DOI 10.1681/ASN.2006050486; Carson JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099771; CHRISTENSEN EI, 1976, KIDNEY INT, V10, P301, DOI 10.1038/ki.1976.113; Clavant SP, 2003, J LAB CLIN MED, V142, P372, DOI 10.1016/S0022-2143(03)00150-1; Comper WD, 2014, CONNECT TISSUE RES, V55, P2, DOI 10.3109/03008207.2013.867334; Comper WD, 2009, CURR OPIN NEPHROL HY, V18, P336, DOI 10.1097/MNH.0b013e32832cb96a; Comper WD, 2008, AM J PHYSIOL-RENAL, V295, pF1589, DOI 10.1152/ajprenal.00142.2008; Dickson LE, 2014, J AM SOC NEPHROL, V25, P443, DOI 10.1681/ASN.2013090950; Dobrinskikh E, 2014, AM J PHYSIOL-RENAL, V306, pF941, DOI 10.1152/ajprenal.00532.2013; ENG LA, 1985, J IMMUNOL METHODS, V81, P239, DOI 10.1016/0022-1759(85)90209-1; Eppel GA, 2000, AM J KIDNEY DIS, V35, P418, DOI 10.1016/S0272-6386(00)70194-6; Ferrell N, 2012, BIOTECHNOL BIOENG, V109, P797, DOI 10.1002/bit.24339; FREEMAN T, 1959, CLIN CHIM ACTA, V4, P788, DOI 10.1016/0009-8981(59)90029-4; GORNALL AG, 1949, J BIOL CHEM, V177, P751; Greive KA, 2001, AM J PATHOL, V159, P1159, DOI 10.1016/S0002-9440(10)61792-0; Gudehithlu KP, 2004, KIDNEY INT, V65, P2113, DOI 10.1111/j.1523-1755.2004.00633.x; HAAS M, 1993, KIDNEY INT, V43, P949, DOI 10.1038/ki.1993.133; Haraldsson B, 2008, PHYSIOL REV, V88, P451, DOI 10.1152/physrev.00055.2006; Hilliard LM, 2006, J LAB CLIN MED, V147, P36, DOI 10.1016/j.lab.2005.08.008; HYSING J, 1986, BIOCHIM BIOPHYS ACTA, V887, P42, DOI 10.1016/0167-4889(86)90120-5; HYSING J, 1990, ACTA PHYSIOL SCAND, V140, P419, DOI 10.1111/j.1748-1716.1990.tb09017.x; JOHNSON V, 1977, AM J PHYSIOL, V233, pF185, DOI 10.1152/ajprenal.1977.233.3.F185; KAYSEN GA, 1982, AM J PHYSIOL, V243, pF372, DOI 10.1152/ajprenal.1982.243.4.F372; Kim YH, 2001, KIDNEY INT, V60, P957, DOI 10.1046/j.1523-1755.2001.060003957.x; Koltun M, 2005, AM J PHYSIOL-HEART C, V288, pH1604, DOI 10.1152/ajpheart.00808.2004; Koltun M, 2004, MICROCIRCULATION, V11, P351, DOI 10.1080/10739680490437513; KSHIRSAGAR B, 1984, CLIN CHIM ACTA, V143, P265, DOI 10.1016/0009-8981(84)90076-7; Hellin JL, 2009, AM J KIDNEY DIS, V54, P871, DOI 10.1053/j.ajkd.2009.07.011; MAACK T, 1971, AM J PHYSIOL, V221, P1609, DOI 10.1152/ajplegacy.1971.221.6.1609; MAACK T, 1975, AM J MED, V58, P57, DOI 10.1016/0002-9343(75)90533-1; MAACK T, 1979, KIDNEY INT, V16, P251, DOI 10.1038/ki.1979.128; Maack T., 1992, KIDNEY PHYSL PATHOPH, P3005; MEGO JL, 1984, BIOCHEM J, V218, P775, DOI 10.1042/bj2180775; Nosaka K, 1997, FREE RADICAL BIO MED, V22, P597, DOI 10.1016/S0891-5849(96)00349-8; Oqvist BW, 1999, NEPHROL DIAL TRANSPL, V14, P1898, DOI 10.1093/ndt/14.8.1898; Osicka TM, 1997, CLIN SCI, V93, P65, DOI 10.1042/cs0930065; Osicka TM, 1996, NEPHROLOGY, V2, P199, DOI 10.1111/j.1440-1797.1996.tb00088.x; Osicka TM, 1997, CLIN SCI, V93, P557, DOI 10.1042/cs0930557; Osicka TM, 1999, AM J PHYSIOL-RENAL, V277, pF139, DOI 10.1152/ajprenal.1999.277.1.F139; Osicka TM, 2000, DIABETES, V49, P1579, DOI 10.2337/diabetes.49.9.1579; Rowland M, 1985, CLIN PHARMACOKINETIC; Russo LM, 2007, KIDNEY INT, V71, P504, DOI 10.1038/sj.ki.5002041; Russo LM, 2013, FEBS LETT, V587, P3738, DOI 10.1016/j.febslet.2013.09.045; Scandling J D, 1992, Adv Nephrol Necker Hosp, V21, P159; Slattery C, 2008, KIDNEY INT, V74, P1480, DOI 10.1038/ki.2008.463; Strong KJ, 2005, J LAB CLIN MED, V145, P239, DOI 10.1016/j.lab.2004.11.021; TACK BF, 1980, J BIOL CHEM, V255, P8842; Verhoelst CHJ, 2004, J ENDOCRINOL, V181, P85, DOI 10.1677/joe.0.1810085; Vuchkova J, 2014, AM J PHYSIOL-RENAL, V307, pF525, DOI 10.1152/ajprenal.00228.2014; Weyer K, 2012, J AM SOC NEPHROL, V23, P591, DOI 10.1681/ASN.2011101034; YAGAME M, 1995, INTERNAL MED, V34, P463, DOI 10.2169/internalmedicine.34.463; YEDGAR S, 1983, AM J PHYSIOL, V244, pE101, DOI 10.1152/ajpendo.1983.244.1.E101	56	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127853	10.1371/journal.pone.0127853	http://dx.doi.org/10.1371/journal.pone.0127853			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010895	Green Published, Green Submitted, gold			2022-12-26	WOS:000355183900153
J	Wu, B; Shi, Y; Gong, X; Yu, L; Chen, QJ; Wang, J; Sun, ZG				Wu, Bi; Shi, Yan; Gong, Xia; Yu, Lin; Chen, Qiuju; Wang, Jian; Sun, Zhaogui			Evaluation of Follicular Synchronization Caused by Estrogen Administration and Its Reproductive Outcome	PLOS ONE			English	Article							POLYCYSTIC-OVARY-SYNDROME; GRANULOSA-CELLS; IN-VITRO; PREGNANCY; OOCYTE; WOMEN; MICE; RAT; RECEPTORS; ESTRADIOL	To evaluate multiple follicular development synchronization after estrogen stimulation in prepubertal mice, follicular responsiveness to gonadotropin superovulation, the prospective reproductive potential and ovarian polycystic ovary syndrome (PCOS)-like symptoms at adulthood, prepubertal mice were intraperitoneally injected with estrogen to establish an animal model with solvent as control. When synchronized tertiary follicles in ovaries, in vitro oocyte maturation and fertilization rates, blastocyst formation rate, developmental potential into offspring by embryo transfer, adult fertility and PCOS-like symptoms, and involved molecular mechanisms were focused, it was found that estrogen stimulation (10 mu g/gBW) leads to follicular development synchronization at the early tertiary stage in prepubertal mice; reproduction from oocytes to offspring could be realized by means of the artificial reproductive technology though the model mice lost their natural fertility when they were reared to adulthood; and typical symptoms of PCOS, except changes in inflammatory pathways, were not remained up to adulthood. So in conclusion, estrogen can lead to synchronization in follicular development in prepubertal mice, but does not affect reproductive outcome of oocytes, and no typical symptoms of PCOS remained at adulthood despite changes related to inflammation.	[Wu, Bi] Fudan Univ, Inst Reprod & Dev, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Shi, Yan; Yu, Lin; Wang, Jian; Sun, Zhaogui] Shanghai Inst Planned Parenthood Res, Key Lab Contracept Drugs & Devices Natl Populat &, Shanghai, Peoples R China; [Gong, Xia] Shanghai Business Sch, Dept Food Sci, Shanghai, Peoples R China; [Chen, Qiuju] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Assisted Reprod, Shanghai 200030, Peoples R China	Fudan University; Shanghai Business School; Shanghai Jiao Tong University	Sun, ZG (corresponding author), Shanghai Inst Planned Parenthood Res, Key Lab Contracept Drugs & Devices Natl Populat &, Shanghai, Peoples R China.	sunzgbio@126.com			National Natural Science Foundation of China [81170569, 81370682]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors were funded by the National Natural Science Foundation of China (81170569, 81370682, both to ZGS); http://isisn.nsfc.gov.cn/egrantweb/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DH, 1998, TRENDS ENDOCRIN MET, V9, P62, DOI 10.1016/S1043-2760(98)00019-8; Azziz R, 2004, J CLIN ENDOCR METAB, V89, P2745, DOI 10.1210/jc.2003-032046; BAIRD DT, 1975, J REPROD FERTIL, V45, P611, DOI 10.1530/jrf.0.0450611; Boomsma CM, 2008, SEMIN REPROD MED, V26, P72, DOI 10.1055/s-2007-992927; CARSON RS, 1981, ENDOCRINOLOGY, V109, P1433, DOI 10.1210/endo-109-5-1433; Chang RJ, 2007, NAT CLIN PRACT ENDOC, V3, P688, DOI 10.1038/ncpendmet0637; Chapman JC, 2001, AM J REPROD IMMUNOL, V46, P288, DOI 10.1034/j.1600-0897.2001.d01-15.x; Chapman JC, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-47; FELICIO LS, 1984, BIOL REPROD, V31, P446, DOI 10.1095/biolreprod31.3.446; Findlay JD, 2001, REPROD FERT DEVELOP, V13, P543, DOI 10.1071/RD01071; FRANKS S, 1995, NEW ENGL J MED, V333, P853, DOI 10.1056/NEJM199509283331307; GOLDZIEHER JW, 1963, FERTIL STERIL, V14, P631; Gu Yan-Qiong, 2009, Shengli Xuebao, V61, P175; Kollmann M, 2014, HUM REPROD UPDATE, V20, P463, DOI 10.1093/humupd/dmu005; Kuang YP, 2014, FERTIL STERIL, V101, P105, DOI 10.1016/j.fertnstert.2013.09.007; Li H, 2013, ENDOCRINE, V43, P184, DOI 10.1007/s12020-012-9739-3; Liu KC, 2011, ENDOCRINOLOGY, V152, P4418, DOI 10.1210/en.2011-1065; MAHESH VB, 1964, RECENT PROG HORM RES, V20, P341; Miyoshi T, 2013, BIOCHEM BIOPH RES CO, V434, P401, DOI 10.1016/j.bbrc.2013.04.002; Nikolajsen CL, 2012, BIOCHEMISTRY-US, V51, P4735, DOI 10.1021/bi3004022; Pasquali R, 2011, CLIN ENDOCRINOL, V74, P424, DOI 10.1111/j.1365-2265.2010.03956.x; Razandi M, 1999, MOL ENDOCRINOL, V13, P307, DOI 10.1210/me.13.2.307; Singh KB, 2005, FERTIL STERIL, V84, P1228, DOI 10.1016/j.fertnstert.2005.06.013; Viana JHM, 2010, THERIOGENOLOGY, V73, P966, DOI 10.1016/j.theriogenology.2009.11.025; Walters KA, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097808; WILSON EA, 1979, AM J OBSTET GYNECOL, V134, P56, DOI 10.1016/0002-9378(79)90796-8; Yamauchi T, 2002, NAT GENET, V30, P221, DOI 10.1038/ng829; Yao YW, 2011, HISTOCHEM CELL BIOL, V136, P205, DOI 10.1007/s00418-011-0825-z; Zarate-Trevino Arturo, 2014, Ginecol Obstet Mex, V82, P246; Zhang MJ, 2011, ENDOCRINOLOGY, V152, P4377, DOI 10.1210/en.2011-1118	30	6	6	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127595	10.1371/journal.pone.0127595	http://dx.doi.org/10.1371/journal.pone.0127595			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010950	Green Submitted, Green Published, gold			2022-12-26	WOS:000355183900114
J	Kitchen, P; Day, RE; Taylor, LHJ; Salman, MM; Bill, RM; Conner, MT; Conner, AC				Kitchen, Philip; Day, Rebecca E.; Taylor, Luke H. J.; Salman, Mootaz M.; Bill, Roslyn M.; Conner, Matthew T.; Conner, Alex C.			Identification and Molecular Mechanisms of the Rapid Tonicity-induced Relocalization of the Aquaporin 4 Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WATER PERMEABILITY; COLLECTING DUCT; MEMBRANE TRAFFICKING; PLASMA-MEMBRANE; PHOSPHORYLATION; CALMODULIN; AQP4; TRANSLOCATION; CELLS; INVOLVEMENT	The aquaporin family of integral membrane proteins is composed of channels that mediate cellular water flow. Aquaporin 4 (AQP4) is highly expressed in the glial cells of the central nervous system and facilitates the osmotically driven pathological brain swelling associated with stroke and traumatic brain injury. Here we show that AQP4 cell surface expression can be rapidly and reversibly regulated in response to changes of tonicity in primary cortical rat astrocytes and in transfected HEK293 cells. The translocation mechanism involves PKA activation, influx of extracellular calcium, and activation of calmodulin. We identify five putative PKA phosphorylation sites and use site-directed mutagenesis to show that only phosphorylation at one of these sites, serine 276, is necessary for the translocation response. We discuss our findings in the context of the identification of new therapeutic approaches to treating brain edema.	[Kitchen, Philip; Taylor, Luke H. J.] Univ Warwick, Mol Org & Assembly Cells Doctoral Training Ctr, Coventry CV4 7AL, W Midlands, England; [Day, Rebecca E.; Salman, Mootaz M.; Conner, Matthew T.] Sheffield Hallam Univ, Biomed Res Ctr, Sheffield S1 1WB, S Yorkshire, England; [Bill, Roslyn M.] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England; [Bill, Roslyn M.] Aston Univ, Aston Res Ctr Hlth Ageing, Birmingham B4 7ET, W Midlands, England; [Conner, Alex C.] Univ Birmingham, Sch Clin & Expt Med, Birmingham B15 2TT, W Midlands, England	University of Warwick; Sheffield Hallam University; Aston University; Aston University; University of Birmingham	Bill, RM (corresponding author), Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England.	r.m.bill@aston.ac.uk; m.conner@shu.ac.uk; a.c.conner@bham.ac.uk	Kitchen, Philip/J-6936-2019; Bill, Roslyn M/D-4554-2012; Salman, Mootaz M./J-3111-2019	Kitchen, Philip/0000-0002-1558-4673; Bill, Roslyn M/0000-0003-1331-0852; Salman, Mootaz M./0000-0002-5683-1706	Engineering and Physical Sciences Research Council through the Molecular Organisation and Assembly in Cells Doctoral Training Centre, University of Warwick [EP/F500378/1]; Engineering and Physical Sciences Research Council [1091578] Funding Source: researchfish	Engineering and Physical Sciences Research Council through the Molecular Organisation and Assembly in Cells Doctoral Training Centre, University of Warwick; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the Engineering and Physical Sciences Research Council through the Molecular Organisation and Assembly in Cells Doctoral Training Centre, University of Warwick, Grant EP/F500378/1 (to P. K. and L. H. J. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Assentoft M, 2014, AM J PHYSIOL-CELL PH, V307, pC957, DOI 10.1152/ajpcell.00182.2014; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Bustamante M, 2008, J AM SOC NEPHROL, V19, P109, DOI 10.1681/ASN.2007010092; Carmosino M, 2007, BIOL CELL, V99, P25, DOI 10.1042/BC200600068; Conner AC, 2013, MOL MEMBR BIOL, V30, P101, DOI 10.3109/09687688.2012.743194; Conner MT, 2012, J BIOL CHEM, V287, P11516, DOI 10.1074/jbc.M111.329219; Conner MT, 2010, BIOCHEMISTRY-US, V49, P821, DOI 10.1021/bi902068b; De Bellis M, 2014, MOL BIOL CELL, V25, P470, DOI 10.1091/mbc.E13-06-0331; Gouraud S, 2002, J CELL SCI, V115, P3667, DOI 10.1242/jcs.00053; Gunnarson E, 2008, GLIA, V56, P587, DOI 10.1002/glia.20627; Hoffert JD, 2007, J PROTEOME RES, V6, P3501, DOI 10.1021/pr0701153; Huber VJ, 2009, BIOORGAN MED CHEM, V17, P411, DOI 10.1016/j.bmc.2007.12.040; Ishikawa Y, 2002, MOL PHARMACOL, V61, P1423, DOI 10.1124/mol.61.6.1423; JUNG JS, 1994, P NATL ACAD SCI USA, V91, P13052, DOI 10.1073/pnas.91.26.13052; Kalman K, 2008, J BIOL CHEM, V283, P21278, DOI 10.1074/jbc.M801740200; Kato J, 2013, BIOCHEM J, V454, P275, DOI 10.1042/BJ20130046; Katsura T, 1997, Am J Physiol, V272, pF817; Madrid R, 2001, EMBO J, V20, P7008, DOI 10.1093/emboj/20.24.7008; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; MARPLES D, 1995, AM J PHYSIOL-CELL PH, V269, pC655, DOI 10.1152/ajpcell.1995.269.3.C655; Moeller HB, 2009, NEUROSCIENCE, V164, P1674, DOI 10.1016/j.neuroscience.2009.09.072; Nejsum LN, 2005, AM J PHYSIOL-RENAL, V288, pF930, DOI 10.1152/ajprenal.00291.2004; Nicchia GP, 2008, GLIA, V56, P1755, DOI 10.1002/glia.20724; Papadopoulos MC, 2013, NAT REV NEUROSCI, V14, P265, DOI 10.1038/nrn3468; Rabaud NE, 2009, BIOCHEM BIOPH RES CO, V383, P54, DOI 10.1016/j.bbrc.2009.03.128; Rash JE, 2004, NEUROSCIENCE, V129, P915, DOI 10.1016/j.neuroscience.2004.06.076; Reichow SL, 2008, STRUCTURE, V16, P1389, DOI 10.1016/j.str.2008.06.011; Rossi A, 2010, J BIOL CHEM, V285, P4562, DOI 10.1074/jbc.M109.069245; Song YT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034936; Tanimura Y, 2009, J STRUCT BIOL, V166, P16, DOI 10.1016/j.jsb.2008.11.010; Varadaraj K, 2005, INVEST OPHTH VIS SCI, V46, P1393, DOI 10.1167/iovs.04-1217; Vriens J, 2004, P NATL ACAD SCI USA, V101, P396, DOI 10.1073/pnas.0303329101; Wisniewski JR, 2010, J PROTEOME RES, V9, P3280, DOI 10.1021/pr1002214; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; Zador Zsolt, 2009, Handb Exp Pharmacol, P159, DOI 10.1007/978-3-540-79885-9_7	35	61	62	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2015	290	27					16873	16881		10.1074/jbc.M115.646034	http://dx.doi.org/10.1074/jbc.M115.646034			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM3HN	26013827	hybrid, Green Published, Green Accepted			2022-12-26	WOS:000357572800032
J	Page, CM; Patel, A; Hibberd, PL				Page, Charlotte M.; Patel, Archana; Hibberd, Patricia L.			Does Smoke from Biomass Fuel Contribute to Anemia in Pregnant Women in Nagpur, India? A Cross-Sectional Study	PLOS ONE			English	Article							BIOFUEL SMOKE; RISK-FACTORS; PREVALENCE; COOKING	Background Anemia affects upwards of 50% of pregnant women in developing countries and is associated with adverse outcomes for mother and child. We hypothesized that exposure to smoke from biomass fuel - which is widely used for household energy needs in resource-limited settings - could exacerbate anemia in pregnancy, possibly as a result of systemic inflammation. Objective To evaluate whether exposure to smoke from biomass fuel (wood, straw, crop residues, or dung) as opposed to clean fuel (electricity, liquefied petroleum gas, natural gas, or biogas) is an independent risk factor for anemia in pregnancy, classified by severity. Methods A secondary analysis was performed using data collected from a rural pregnancy cohort (N = 12,782) in Nagpur, India in 2011-2013 as part of the NIH-funded Maternal and Newborn Health Registry Study. Multinomial logistic regression was used to estimate the effect of biomass fuel vs. clean fuel use on anemia in pregnancy, controlling for maternal age, body mass index, education level, exposure to household tobacco smoke, parity, trimester when hemoglobin was measured, and receipt of prenatal iron and folate supplements. Results The prevalence of any anemia (hemoglobin <11 g/dl) was 93% in biomass fuel users and 88% in clean fuel users. Moderate-to-severe anemia (hemoglobin <10 g/dl) occurred in 53% and 40% of the women, respectively. Multinomial logistic regression showed higher relative risks of mild anemia in pregnancy (hemoglobin 10-11 g/dl; RRR = 1.38, 95% CI = 1.19-1.61) and of moderate-to-severe anemia in pregnancy (RRR = 1.79, 95% CI = 1.53-2.09) in biomass fuel vs. clean fuel users, after adjusting for covariates. Conclusion In our study population, exposure to biomass smoke was associated with higher risks of mild and moderate-to-severe anemia in pregnancy, independent of covariates.	[Page, Charlotte M.; Hibberd, Patricia L.] Harvard Univ, Sch Med, Boston, MA 02138 USA; [Patel, Archana] Lata Med Res Fdn, Nagpur, Maharashtra, India; [Hibberd, Patricia L.] Massachusetts Gen Hosp Children, Div Global Hlth, Boston, MA USA	Harvard University; Harvard Medical School	Page, CM (corresponding author), Harvard Univ, Sch Med, Boston, MA 02138 USA.	charlotte_page@hms.harvard.edu		Hibberd, Patricia/0000-0002-7455-8117; Page, Charlotte/0000-0002-8038-9487	National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development [U01HD058322]; South Asia Institute at Harvard University; National Center for Research Resources; National Center for Advancing Translational Sciences (National Institutes of Health) [UL1 TR001102]; Harvard University and its affiliated academic healthcare centers; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U10HD078439, U01HD058322] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001102] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [K24AT003683] Funding Source: NIH RePORTER	National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); South Asia Institute at Harvard University; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Harvard University and its affiliated academic healthcare centers; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The Maternal and Newborn Health Registry Study is funded by the National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development (www.nichd.nih.gov) (U01HD058322 [PLH]). This secondary data analysis was funded by grants received by CP from the South Asia Institute at Harvard University (southasiainstitute.harvard.edu) and the Scholars in Medicine Office at Harvard Medical School (http://hms.harvard.edu/departments/medical-education/student-services/scholars-medicine-sim). Dr. Bernard Rosner of Harvard Catalyst vertical bar The Harvard Clinical and Translational Science Center (catalyst.harvard.edu) was consulted about statistical models. Harvard Catalyst is funded by the National Center for Research Resources and the National Center for Advancing Translational Sciences (National Institutes of Health Award UL1 TR001102) and financial contributions from Harvard University and its affiliated academic healthcare centers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Farsi YM, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-7; Al-Mehaisen L, 2011, MATERNAL ANEMIA RURA; American College of Obstetrics & Gynecology, 2008, OBSTET GYNECOL, V112, P201, DOI [DOI 10.1097/AOG.0B013E3181809C0D, 10.1097/AOG.0b013e3181809c0d]; [Anonymous], 2012, GUID DAIL IR FOL AC; Balakrishnan K., 2004, INDOOR AIR POLLUTION; Bencaiova G, 2012, EUR J INTERN MED, V23, P529, DOI 10.1016/j.ejim.2012.04.008; Bora R, 2014, J MATERN-FETAL NEO M, V27, P887, DOI 10.3109/14767058.2013.845161; Charles AM, 2010, HEALTH CARE WOMEN IN, V31, P585, DOI 10.1080/07399331003710541; Delfino RJ, 2009, ENVIRON HEALTH PERSP, V117, P1232, DOI [10.1289/journla.ehp.0800194, 10.1289/ehp.0800194]; Dutta A, 2012, TOXICOL APPL PHARM, V261, P255, DOI 10.1016/j.taap.2012.04.004; Fullerton DG, 2008, T ROY SOC TROP MED H, V102, P843, DOI 10.1016/j.trstmh.2008.05.028; Gall ET, AM J PUBLIC HLTH, V201, pe67, DOI 10.2105/AJPH.2012.300955; Ghio AJ, 2012, OCCUP ENVIRON MED, V69, P170, DOI 10.1136/oem.2011.065276; Goonewardene M, 2012, BEST PRACT RES CL OB, V26, P3, DOI 10.1016/j.bpobgyn.2011.10.010; Goudar SS, 2012, INT J GYNECOL OBSTET, V118, P190, DOI 10.1016/j.ijgo.2012.04.022; Gould William, 2000, STATA TECHNICAL B, V9, P19; Hertel S, 2010, EUR J EPIDEMIOL, V25, P581, DOI 10.1007/s10654-010-9477-x; Kalaivani K, 2009, INDIAN J MED RES, V130, P627; Kyu HH, 2010, ANN EPIDEMIOL, V20, P811, DOI 10.1016/j.annepidem.2010.07.096; Lone F W, 2004, East Mediterr Health J, V10, P801; Machisa M, 2013, T ROY SOC TROP MED H, V107, P535, DOI 10.1093/trstmh/trt055; Makhoul Z, 2012, SE ASIAN J TROP MED, V43, P735; Martin WJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001455; Mishra V, 2007, INT J EPIDEMIOL, V36, P117, DOI 10.1093/ije/dyl234; Patel AB, 2013, INT J OCCUP ENV HEAL, V19, P35, DOI 10.1179/2049396712Y.0000000013; Singh LL, 2006, DISTRICT LEVEL HOUSE, P2002; Tripathi R, 2012, J OBSTET GYNAECOL RE, V38, P203, DOI 10.1111/j.1447-0756.2011.01679.x; Tsai DH, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-24; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; WHO, 2001, IRON DEFICIENCY ANAE; World Health Organization, 2011, SER FERR CONC ASS IR	31	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0127890	10.1371/journal.pone.0127890	http://dx.doi.org/10.1371/journal.pone.0127890			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024473	Green Published, Green Submitted, gold			2022-12-26	WOS:000355319400056
J	Suwansa-ard, S; Thongbuakaew, T; Wang, T; Zhao, M; Elizur, A; Hanna, PJ; Sretarugsa, P; Cummins, SF; Sobhon, P				Suwansa-ard, Saowaros; Thongbuakaew, Tipsuda; Wang, Tianfang; Zhao, Min; Elizur, Abigail; Hanna, Peter J.; Sretarugsa, Prapee; Cummins, Scott F.; Sobhon, Prasert			In silico Neuropeptidome of Female Macrobrachium rosenbergii Based on Transcriptome and Peptide Mining of Eyestalk, Central Nervous System and Ovary	PLOS ONE			English	Article							CRUSTACEAN CARDIOACTIVE-PEPTIDE; GONADOTROPIN-RELEASING-HORMONE; EGG-LAYING HORMONE; FRESH-WATER PRAWN; CUTICLE-HARDENING HORMONE; BLACK TIGER SHRIMP; HYPERGLYCEMIC HORMONE; SHORE CRAB; DECAPOD CRUSTACEANS; FOOD-INTAKE	Macrobrachium rosenbergii is the most economically important of the cultured freshwater crustacean species, yet there is currently a deficiency in genomic and transcriptomic information for research requirements. In this study, we present an in silico analysis of neuropeptide genes within the female M. rosenbergii eyestalk, central nervous system, and ovary. We could confidently predict 37 preproneuropeptide transcripts, including those that encode bursicons, crustacean cardioactive peptide, crustacean hyperglycemic hormones, eclosion hormone, pigment-dispersing hormones, diuretic hormones, neuropeptide F, neuroparsins, SIFamide, and sulfakinin. These transcripts are most prominent within the eyestalk and central nervous system. Transcript tissue distribution as determined by reverse transcription-polymerase chain reaction revealed the presence of selected neuropeptide genes of interest mainly in the nervous tissues while others were additionally present in the non-nervous tissues. Liquid chromatography-mass spectrometry analysis of eyestalk peptides confirmed the presence of the crustacean hyperglycemic hormone precursor. This data set provides a strong foundation for further studies into the functional roles of neuropeptides in M. rosenbergii, and will be especially helpful for developing methods to improve crustacean aquaculture.	[Suwansa-ard, Saowaros; Thongbuakaew, Tipsuda; Hanna, Peter J.; Sretarugsa, Prapee; Sobhon, Prasert] Mahidol Univ, Fac Sci, Dept Anat, Bangkok 10400, Thailand; [Wang, Tianfang; Zhao, Min; Elizur, Abigail; Cummins, Scott F.] Univ Sunshine Coast, Fac Sci Hlth,Educ & Engn, Maroochydore, Qld, Australia; [Hanna, Peter J.] Deakin Univ, Fac Sci Engn & Built Environm, Pro Vice Chancellors Off, Geelong, Vic 3217, Australia	Mahidol University; University of the Sunshine Coast; Deakin University	Cummins, SF (corresponding author), Mahidol Univ, Fac Sci, Dept Anat, Bangkok 10400, Thailand.	scummins@usc.edu.au; prasert.sob@mahidol.ac.th	Wang, Tianfang/L-5192-2016; Zhao, Min/J-6588-2019; Wang, Tianfang/AAG-4290-2020; Suwansa-ard, Saowaros Mai/ABB-2227-2021; Wang, Tianfang/GRO-0844-2022; Cummins, Scott/I-6420-2016	Wang, Tianfang/0000-0002-4876-7767; Zhao, Min/0000-0001-5498-3434; Wang, Tianfang/0000-0002-4876-7767; Suwansa-ard, Saowaros Mai/0000-0002-9129-2082; Wang, Tianfang/0000-0002-4876-7767; Cummins, Scott/0000-0002-1454-2076; Elizur, Abigail/0000-0002-2960-302X; Thongbuakaew, Tipsuda/0000-0001-9643-8477	Office of the Higher Education Commission under the National Research Universities Initiatives; Distinguished Research Professor Grant (Thailand Research Fund); Distinguished Research Professor Grant (Office of the Higher Education Commission); Distinguished Research Professor Grant (Mahidol University); TRF-RGJ; ARC; University of the Sunshine Coast	Office of the Higher Education Commission under the National Research Universities Initiatives; Distinguished Research Professor Grant (Thailand Research Fund); Distinguished Research Professor Grant (Office of the Higher Education Commission); Distinguished Research Professor Grant (Mahidol University); TRF-RGJ; ARC(Australian Research Council); University of the Sunshine Coast	This work was funded by: 1. A grant from the Office of the Higher Education Commission under the National Research Universities Initiatives (http://www.op.mahidol.ac.th/orra/MU_NRU.html) and a Distinguished Research Professor Grant (co-funded by the Thailand Research Fund, the Office of the Higher Education Commission, and Mahidol University) (http://www.trf.or.th) to P. Sobhon. 2. TRF-RGJ Ph.D. Scholarship to P. Sretarugsa TT P. Sobhon SS (http://rgj.trf.or.th). 3. ARC grant to SFC (http://www.arc.gov.au). 4. University of the Sunshine Coast internal grant to SFC (http://www.usc.edu.au/university/learning-and-teaching/grants-and-awards-for-learning-and-teaching). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUDEHM U, 1993, CELL TISSUE RES, V272, P473, DOI 10.1007/BF00318553; Badisco L, 2007, GEN COMP ENDOCR, V153, P64, DOI 10.1016/j.ygcen.2007.03.008; Baker JD, 2002, J EXP BIOL, V205, P2555; Behrens HL, 2008, ANAL CHEM, V80, P6949, DOI 10.1021/ac800798h; BERNHEIM SM, 1995, J COMP PHYSIOL A, V176, P131; Chang ES, 2001, AM ZOOL, V41, P380, DOI 10.1668/0003-1569(2001)041[0380:CHHFOP]2.0.CO;2; Chen SH, 2004, MAR BIOTECHNOL, V6, P83, DOI 10.1007/s10126-003-0014-8; Chen WF, 2013, INSECT BIOCHEM MOLEC, V43, P809, DOI 10.1016/j.ibmb.2013.06.003; Christie AE, 2008, GEN COMP ENDOCR, V156, P246, DOI 10.1016/j.ygcen.2008.01.018; Christie AE, 2008, GEN COMP ENDOCR, V155, P526, DOI 10.1016/j.ygcen.2007.09.002; Christie AE, 2013, GEN COMP ENDOCR, V187, P117, DOI 10.1016/j.ygcen.2013.03.018; Christie AE, 2012, J EXP BIOL, V215, P2535, DOI 10.1242/jeb.070565; Christie AE, 2011, J EXP BIOL, V214, P1386, DOI 10.1242/jeb.053173; Christie AE, 2011, GEN COMP ENDOCR, V171, P131, DOI 10.1016/j.ygcen.2011.01.002; Christie AE, 2010, CELL MOL LIFE SCI, V67, P4135, DOI 10.1007/s00018-010-0482-8; Christie AE, 2010, GEN COMP ENDOCR, V167, P164, DOI 10.1016/j.ygcen.2010.01.005; Chung JS, 2006, J EXP BIOL, V209, P3862, DOI 10.1242/jeb.02425; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; Conzelmann M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-906; Cooke IM, 2002, BIOL BULL-US, V202, P108, DOI 10.2307/1543649; Cruz-Bermudez ND, 2007, J EXP BIOL, V210, P2873, DOI 10.1242/jeb.002949; DeKeyser SS, 2007, J PROTEOME RES, V6, P1782, DOI 10.1021/pr060603v; Dickinson PS, 2007, J EXP BIOL, V210, P2278, DOI 10.1242/jeb.004770; Dickinson PS, 2009, J EXP BIOL, V212, P1140, DOI 10.1242/jeb.028621; DIRCKSEN H, 1988, CELL TISSUE RES, V254, P347; Dircksen H, 1998, CONSERVED CRUSTACEAN; Dircksen H, 2011, J PROTEOME RES, V10, P4478, DOI 10.1021/pr200284e; Donini A, 2001, J INSECT PHYSIOL, V47, P277, DOI 10.1016/S0022-1910(00)00112-8; Ernest SC, 2008, REPRODUCTIVE BIOL CR, P299; Fanjul-Moles ML, 2006, COMP BIOCHEM PHYS C, V142, P390, DOI 10.1016/j.cbpc.2005.11.021; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Fort TJ, 2007, J NEUROPHYSIOL, V97, P3407, DOI 10.1152/jn.00939.2006; Fu Q, 2005, BIOCHEM BIOPH RES CO, V337, P765, DOI 10.1016/j.bbrc.2005.09.111; Gade G, 2004, ANNU REV ENTOMOL, V49, P93, DOI 10.1146/annurev.ento.49.061802.123354; Gallus L, 2001, EUR J HISTOCHEM, V45, P95; Gard AL, 2009, GEN COMP ENDOCR, V160, P271, DOI 10.1016/j.ygcen.2008.12.014; GIRARDIE J, 1987, INSECT BIOCHEM, V17, P977, DOI 10.1016/0020-1790(87)90106-5; GOVIND CK, 1975, J COMP PHYSIOL, V96, P185, DOI 10.1007/BF00612694; Granato FC, 2004, COMP BIOCHEM PHYS A, V138, P313, DOI 10.1016/j.cbpb.2004.04.009; Guan ZB, 2014, AQUACULTURE, V418, P67, DOI 10.1016/j.aquaculture.2013.10.010; Harshini S, 2002, PEPTIDES, V23, P1759, DOI 10.1016/S0196-9781(02)00152-3; Harzsch S, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-58; He L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0033735, 10.1371/journal.pone.0045607]; Hopkins PM, 2012, GEN COMP ENDOCR, V175, P357, DOI 10.1016/j.ygcen.2011.12.002; Horodyski FM, 1996, J INSECT PHYSIOL, V42, P917, DOI 10.1016/0022-1910(96)00035-2; Hsu YWA, 2010, J COMP NEUROL, V518, P4674, DOI 10.1002/cne.22474; Hui LM, 2012, PEPTIDES, V36, P230, DOI 10.1016/j.peptides.2012.05.007; Hull JJ, 2009, BIOCHEMISTRY-US, V48, P9047, DOI 10.1021/bi901078y; Jia CX, 2013, J PROTEOMICS, V91, P1, DOI 10.1016/j.jprot.2013.06.021; Jiang H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011175; Jiang H, 2009, COMP BIOCHEM PHYS D, V4, P227, DOI 10.1016/j.cbd.2009.05.001; Johnsen AH, 2000, EUR J BIOCHEM, V267, P1153, DOI 10.1046/j.1432-1327.2000.01113.x; Jung H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027938; KELLER R, 1992, EXPERIENTIA, V48, P439, DOI 10.1007/BF01928162; Kircher M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-382; KONO T, 1990, FEBS LETT, V263, P358, DOI 10.1016/0014-5793(90)81413-I; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee KS, 2004, J BIOL CHEM, V279, P50781, DOI 10.1074/jbc.M407842200; Li C, 2012, ANN SURG ONCOL, V7, P7, DOI DOI 10.1504/IJHPCN.2012.046371; Liu Zhipeng, 2006, Invertebrate Neuroscience, V6, P41, DOI 10.1007/s10158-006-0016-0; Luo CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030087; Luo CW, 2005, P NATL ACAD SCI USA, V102, P2820, DOI 10.1073/pnas.0409916102; Ma KY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039727; Ma MM, 2010, PEPTIDES, V31, P27, DOI 10.1016/j.peptides.2009.10.007; Ma MM, 2009, GEN COMP ENDOCR, V161, P320, DOI 10.1016/j.ygcen.2009.01.015; Maestro JL, 2001, EUR J BIOCHEM, V268, P5824, DOI 10.1046/j.0014-2956.2001.02527.x; Marco HG, 2014, PEPTIDES, V53, P97, DOI 10.1016/j.peptides.2013.10.013; Meelkop E, 2011, PROG NEUROBIOL, V93, P125, DOI 10.1016/j.pneurobio.2010.10.004; Meelkop E, 2012, MOL CELL ENDOCRINOL, V361, P232, DOI 10.1016/j.mce.2012.05.001; Meeratana P, 2007, AQUACULTURE, V270, P249, DOI 10.1016/j.aquaculture.2007.03.009; Millar RP, 2005, ANIM REPROD SCI, V88, P5, DOI 10.1016/j.anireprosci.2005.05.032; Mirabeau O, 2013, P NATL ACAD SCI USA, V110, pE2028, DOI 10.1073/pnas.1219956110; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nachman RJ, 2005, PEPTIDES, V26, P115, DOI 10.1016/j.peptides.2004.07.018; Nagaraju GPC, 2011, INTEGR BIOL-UK, V3, P218, DOI 10.1039/c0ib00086h; Nagaraju GPC, 2010, COMP BIOCHEM PHYS D, V5, P317, DOI 10.1016/j.cbd.2010.09.002; Nagaraju GPC, 2011, J ENDOCRINOL, V210, P379, DOI 10.1530/JOE-11-0154; Nagaraju GPC, 2011, J EXP BIOL, V214, P3, DOI 10.1242/jeb.047183; Nagaraju GP, 2005, INT J APPL SCI ENG, V3, P61; Nassel DR, 2011, PEPTIDES, V32, P1335, DOI 10.1016/j.peptides.2011.03.013; Nassel DR, 2013, NEUROSCIENCES MOL BE, P213, DOI DOI 10.1007/978-3-642-10769-6_11; Ngernsoungnern Apichart, 2008, Invertebrate Neuroscience, V8, P49, DOI 10.1007/s10158-008-0067-5; Ngernsoungnern P, 2008, GEN COMP ENDOCR, V155, P613, DOI 10.1016/j.ygcen.2007.08.012; Ngernsoungnern P, 2009, AQUACULTURE, V296, P143, DOI 10.1016/j.aquaculture.2009.08.011; Palasoon R, 2011, INVERTEBR NEUROSCI, V11, P29, DOI 10.1007/s10158-011-0115-4; Panchan N, 2003, PEPTIDES, V24, P1563, DOI 10.1016/j.peptides.2003.08.015; Pedrazzini T, 2003, CELL MOL LIFE SCI, V60, P350, DOI 10.1007/s000180300029; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Phlippen MK, 2000, J EXP BIOL, V203, P521; Polanska MA, 2007, CELL TISSUE RES, V330, P331, DOI 10.1007/s00441-007-0473-8; Rao KR, 2001, AM ZOOL, V41, P364, DOI 10.1668/0003-1569(2001)041[0364:CPEHCA]2.0.CO;2; Roch GJ, 2011, GEN COMP ENDOCR, V171, P1, DOI 10.1016/j.ygcen.2010.12.014; ROTHMAN BS, 1983, GEN COMP ENDOCR, V52, P134, DOI 10.1016/0016-6480(83)90166-1; Ruder T, 2013, J MOL EVOL, V76, P192, DOI 10.1007/s00239-013-9552-5; Saver MA, 1998, COMP BIOCHEM PHYS A, V120, P301, DOI 10.1016/S1095-6433(98)00033-6; Schoofs L, 2006, HANDBOOK OF BIOLOGICALLY ACTIVE PEPTIDES, P183, DOI 10.1016/B978-012369442-3/50031-3; Schooley D.A., 2012, INSECT ENDOCRINOLOGY, P366, DOI DOI 10.1016/B978-0-12-384749-2.10009-3; Shang YH, 2013, NEURON, V80, P171, DOI 10.1016/j.neuron.2013.07.029; Shmulik P, 2008, REPRODUCTIVE BIOL CR, P427; Song Qisheng, 2011, P132; Southey BR, 2006, NUCLEIC ACIDS RES, V34, pW267, DOI 10.1093/nar/gkl161; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tatemoto K, 2004, HANDB EXP PHARM, V162, P1; Tinikul Y, 2011, CELL TISSUE RES, V343, P579, DOI 10.1007/s00441-010-1112-3; Torfs P, 2002, BIOCHEM BIOPH RES CO, V299, P312, DOI 10.1016/S0006-291X(02)02624-4; Toullec JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071609; Tsai PS, 2006, GEN COMP ENDOCR, V148, P48, DOI 10.1016/j.ygcen.2005.09.016; Turner LM, 2013, J EXP BIOL, V216, P1191, DOI 10.1242/jeb.078527; Van Wielendaele P, 2013, J INSECT PHYSIOL, V59, P624, DOI 10.1016/j.jinsphys.2013.03.005; Van Wielendaele P, 2013, INSECT BIOCHEM MOLEC, V43, P102, DOI 10.1016/j.ibmb.2012.10.002; Vazquez-Acevedo N, 2009, BIOL BULL-US, V217, P313, DOI 10.1086/BBLv217n3p313; Veenstra JA, 2012, INSECT BIOCHEM MOLEC, V42, P277, DOI 10.1016/j.ibmb.2011.12.009; Vehovszky A, 2005, NEUROSCI LETT, V373, P200, DOI 10.1016/j.neulet.2004.10.020; Ventura T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097323; Verleyen P, 2009, GEN COMP ENDOCR, V162, P27, DOI 10.1016/j.ygcen.2008.10.020; Webster SG, 2013, GEN COMP ENDOCR, V182, P54, DOI 10.1016/j.ygcen.2012.11.018; Webster SG, 2012, GEN COMP ENDOCR, V175, P217, DOI 10.1016/j.ygcen.2011.11.035; Wei Z, 2000, J INSECT PHYSIOL, V46, P1259, DOI 10.1016/S0022-1910(00)00046-9; Weimann JM, 1997, J NEUROSCI, V17, P1748; Wilcockson DC, 2008, GEN COMP ENDOCR, V156, P113, DOI 10.1016/j.ygcen.2007.12.003; Yachdav G, 2014, NUCLEIC ACIDS RES, V42, pW337, DOI 10.1093/nar/gku366; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yin GL, 2006, PEPTIDES, V27, P1241, DOI 10.1016/j.peptides.2005.11.015; Zandawala M, 2012, INSECT BIOCHEM MOLEC, V42, P816, DOI 10.1016/j.ibmb.2012.06.006; Zeng V, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-581	125	77	78	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0123848	10.1371/journal.pone.0123848	http://dx.doi.org/10.1371/journal.pone.0123848			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26023789	Green Published, gold			2022-12-26	WOS:000355319400004
J	Tomita, J; Ueno, T; Mitsuyoshi, M; Kume, S; Kume, K				Tomita, Jun; Ueno, Taro; Mitsuyoshi, Madoka; Kume, Shoen; Kume, Kazuhiko			The NMDA Receptor Promotes Sleep in the Fruit Fly, Drosophila melanogaster	PLOS ONE			English	Article							PAN-NEURONAL KNOCKDOWN; TERM-MEMORY; OLFACTORY MEMORY; MUSHROOM BODIES; REDUCED SLEEP; WAKEFULNESS; DOPAMINE; IDENTIFICATION; HOMEOSTASIS; AROUSAL	Considerable evidence indicates that sleep is essential for learning and memory. Drosophila melanogaster has emerged as a novel model for studying sleep. We previously found a short sleeper mutant, fumin (fmn), and identified its mutation in the dopamine transporter gene. We reported similarities in the molecular basis of sleep and arousal regulation between mammals and Drosophila. In aversive olfactory learning tasks, fmn mutants demonstrate defective memory retention, which suggests an association between sleep and memory. In an attempt to discover additional sleep related genes in Drosophila, we carried out a microarray analysis comparing mRNA expression in heads of fmn and control flies and found that 563 genes are differentially expressed. Next, using the pan-neuronal Gal4 driver elav-Gal4 and UAS-RNA interference (RNAi) to knockdown individual genes, we performed a functional screen. We found that knockdown of the NMDA type glutamate receptor channel gene (Nmdar1) (also known as dNR1) reduced sleep. The NMDA receptor (NMDAR) plays an important role in learning and memory both in Drosophila and mammals. The application of the NMDAR antagonist, MK-801, reduced sleep in control flies, but not in fmn. These results suggest that NMDAR promotes sleep regulation in Drosophila.	[Tomita, Jun; Ueno, Taro; Mitsuyoshi, Madoka; Kume, Shoen; Kume, Kazuhiko] Kumamoto Univ, Inst Mol Embryol & Genet, Kumamoto, Japan; [Ueno, Taro] Tokyo Metropolitan Inst Med Sci, Dept Sensory & Motor Syst, Tokyo 113, Japan; [Tomita, Jun; Kume, Kazuhiko] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Neuropharmacol, Nagoya, Aichi, Japan	Kumamoto University; Tokyo Metropolitan Institute of Medical Science; Nagoya City University	Kume, K (corresponding author), Kumamoto Univ, Inst Mol Embryol & Genet, Kumamoto, Japan.	kume@phar.nagoya-cu.ac.jp	Kume, Shoen/M-4356-2016; Ueno, Taro/AAN-7260-2021	Kume, Shoen/0000-0002-4292-205X; Ueno, Taro/0000-0003-3697-4301; Kume, Kazuhiko/0000-0003-4232-1657	Japan Society for the Promotion of Science (JSPS) [22300132, 25290007, 22700433, 24700413]; Grants-in-Aid for Scientific Research [26507008, 26253059] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS) (22300132, 25290007, K.K., 22700433, 24700413, J.T.). T.U. was supported by Grant-in-Aid for JSPS Fellows.	Borbely A A, 1982, Hum Neurobiol, V1, P195; Bushey D, 2007, J NEUROSCI, V27, P5384, DOI 10.1523/JNEUROSCI.0108-07.2007; Bushey D, 2011, SCIENCE, V332, P1576, DOI 10.1126/science.1202839; Cirelli C, 2005, NATURE, V434, P1087, DOI 10.1038/nature03486; Cirelli C, 2004, NEURON, V41, P35, DOI 10.1016/S0896-6273(03)00814-6; Cirelli C, 2005, J NEUROCHEM, V94, P1411, DOI 10.1111/j.1471-4159.2005.03291.x; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Gilestro GF, 2009, SCIENCE, V324, P109, DOI 10.1126/science.1166673; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Greengard P, 1999, NEURON, V23, P435, DOI 10.1016/S0896-6273(00)80798-9; Grotewiel MS, 1998, NATURE, V391, P455, DOI 10.1038/35079; Groth RD, 2003, BIOCHEM BIOPH RES CO, V311, P1159, DOI 10.1016/j.bbrc.2003.09.002; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Huber R, 2004, SLEEP, V27, P628, DOI 10.1093/sleep/27.4.628; Joiner WJ, 2006, NATURE, V441, P757, DOI 10.1038/nature04811; Koh K, 2008, SCIENCE, V321, P372, DOI 10.1126/science.1155942; Kume K, 2005, J NEUROSCI, V25, P7377, DOI 10.1523/JNEUROSCI.2048-05.2005; Li XJ, 2009, SLEEP, V32, P1417, DOI 10.1093/sleep/32.11.1417; Liu QL, 2012, CURR BIOL, V22, P2114, DOI 10.1016/j.cub.2012.09.008; Miyashita T, 2012, NEURON, V74, P887, DOI 10.1016/j.neuron.2012.03.039; Pitman JL, 2006, NATURE, V441, P753, DOI 10.1038/nature04739; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Rohrbough J, 2000, J NEUROSCI, V20, P6868, DOI 10.1523/JNEUROSCI.20-18-06868.2000; Seugnet L, 2008, CURR BIOL, V18, P1110, DOI 10.1016/j.cub.2008.07.028; Seugnet L, 2009, J NEUROSCI, V29, P7148, DOI 10.1523/JNEUROSCI.5629-08.2009; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Takahama K, 2012, BIOCHEM BIOPH RES CO, V417, P807, DOI 10.1016/j.bbrc.2011.12.040; TOBLER I, 1983, BEHAV BRAIN RES, V8, P351, DOI 10.1016/0166-4328(83)90180-8; Tomita J, 2011, J NEUROSCI, V31, P13137, DOI 10.1523/JNEUROSCI.5860-10.2011; Ueno T, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00303; Ueno T, 2012, NAT NEUROSCI, V15, P1516, DOI 10.1038/nn.3238; Ueno T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032007; Ueno T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031513; Winder DG, 2001, NAT REV NEUROSCI, V2, P461, DOI 10.1038/35081514; Wu CL, 2007, NAT NEUROSCI, V10, P1578, DOI 10.1038/nn2005; Xia SZ, 2005, CURR BIOL, V15, P603, DOI 10.1016/j.cub.2005.02.059; Zachepilo T G, 2008, Neurosci Behav Physiol, V38, P369, DOI 10.1007/s11055-008-0052-9; Zhang S, 2008, BIOCHEM BIOPH RES CO, V370, P82, DOI 10.1016/j.bbrc.2008.03.015	39	43	44	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128101	10.1371/journal.pone.0128101	http://dx.doi.org/10.1371/journal.pone.0128101			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26023770	Green Submitted, gold, Green Published			2022-12-26	WOS:000355319400070
J	Wang, H; Liu, Z; Sun, L; Luo, Q				Wang, Hui; Liu, Zhe; Sun, Lina; Luo, Qing			Optimal Design of River Monitoring Network in Taizihe River by Matter Element Analysis	PLOS ONE			English	Article							CRITICAL SAMPLING POINTS; WATER; METHODOLOGY; SELECTION	The objective of this study is to optimize the river monitoring network in Taizihe River, Northeast China. The situation of the network and water characteristics were studied in this work. During this study, water samples were collected once a month during January 2009 - December 2010 from seventeen sites. Futhermore, the 16 monitoring indexes were analyzed in the field and laboratory. The pH value of surface water sample was found to be in the range of 6.83 to 9.31, and the average concentrations of NH4+-N, chemical oxygen demand (COD), volatile phenol and total phosphorus (TP) were found decreasing significantly. The water quality of the river has been improved from 2009 to 2010. Through the calculation of the data availability and the correlation between adjacent sections, it was found that the present monitoring network was inefficient as well as the optimization was indispensable. In order to improve the situation, the matter element analysis and gravity distance were applied in the optimization of river monitoring network, which were proved to be a useful method to optimize river quality monitoring network. The amount of monitoring sections were cut from 17 to 13 for the monitoring network was more cost-effective after being optimized. The results of this study could be used in developing effective management strategies to improve the environmental quality of Taizihe River. Also, the results show that the proposed model can be effectively used for the optimal design of monitoring networks in river systems.	[Wang, Hui; Sun, Lina; Luo, Qing] Shenyang Univ, Key Lab Reg Environm & Ecoremediat, Minist Educ, Shenyang 110044, Liaoning, Peoples R China; [Liu, Zhe] Chinese Acad Sci, Inst Appl Ecol, Key Lab Pollut Ecol & Environm Engn, Shenyang 110016, Liaoning, Peoples R China	Shenyang University; Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS	Sun, L (corresponding author), Shenyang Univ, Key Lab Reg Environm & Ecoremediat, Minist Educ, Shenyang 110044, Liaoning, Peoples R China.	sln629@163.com	Wang, Hui/AAB-7016-2021; Luo, Qing/ABD-4148-2020	Luo, Qing/0000-0002-4306-6283; Wang, Hui/0000-0002-2237-720X	Major Science and Technology Program for Water Pollution Control and Treatment [2012ZX07202-004-05]; National Basic Research Program of China (973 Program) [2014CB441106]; Shenyang Science and Technology plan project [F14-133-9-00]	Major Science and Technology Program for Water Pollution Control and Treatment; National Basic Research Program of China (973 Program)(National Basic Research Program of China); Shenyang Science and Technology plan project	This study was financially supported by Major Science and Technology Program for Water Pollution Control and Treatment (2012ZX07202-004-05), the National Basic Research Program of China (973 Program) (2014CB441106), and Shenyang Science and Technology plan project (F14-133-9-00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Association A. P. H., 2005, STANDARD METHODS EXA, P521; Ayenimo JG., 2005, KRAGUJEVAC J SCI, V27, P43; Beckers CV, 1974, DESIGN COST EFFECTIV; Chilundo M, 2008, PHYS CHEM EARTH, V33, P655, DOI 10.1016/j.pce.2008.06.055; CIENIAWSKI SE, 1995, WATER RESOUR RES, V31, P399, DOI 10.1029/94WR02039; Cong NV, 1999, THESIS CHIANG MAI U; Diagomanolin V, 2004, TOXICOL LETT, V151, P63, DOI 10.1016/j.toxlet.2004.02.018; Dixon W, 1996, WATER RES, V30, P1935, DOI 10.1016/0043-1354(96)00087-5; Dong C., 2004, THESIS SHANDONG U CH, P19; Gao M., 1997, ADV ENV SCI, V5, P77; GROOT S, 1984, WATER SCI TECHNOL, V16, P275, DOI 10.2166/wst.1984.0137; Guo SP, 2008, WATER RESOURCES HYDR, V26, P50; [郭小青 Guo Xiaoqing], 2005, [科技通报, Bulletin of Science and Technology], V21, P360; HARMANCIOGLU NB, 1992, WATER RESOUR BULL, V28, P179; Harmancioglu NB, 1992, J AM WATER RESOUR AS, V28, P179; HUDAK PF, 1995, J HYDROL, V164, P153, DOI 10.1016/0022-1694(94)02559-T; Jiang X, 2006, HEILONGJIANG ENV J, V30, P44; Junshum P., 2007, Journal of Agriculture and Social Sciences, V3, P91; Kar D, 2008, INT J ENVIRON SCI TE, V5, P119, DOI 10.1007/BF03326004; Li GX, 2010, J ANHUI AGR SCI, V38, P18337; Li S, 2011, J WATER RESOURCES WA, V22, P111; [李文生 LI Wensheng], 2007, [南水北调与水利科技, South-to-North Water Transfers and Water Science & Technology], V5, P51; Li X., 1996, THESIS NE NORMAL U C, P18; Markus M, 2003, J HYDROL, V283, P107, DOI 10.1016/S0022-1694(03)00244-0; Strobl RO, 2006, ENVIRON MONIT ASSESS, V122, P319, DOI 10.1007/s10661-006-0358-4; Strobl RO, 2006, ENVIRON MONIT ASSESS, V112, P137, DOI 10.1007/s10661-006-0774-5; Strobl RO, 2008, J ENVIRON MANAGE, V87, P639, DOI 10.1016/j.jenvman.2007.03.001; Ward RC, 1996, J AM WATER RESOUR AS, V32, P673, DOI [10.1111/j.1752-1688.1996.tb03465.x, DOI 10.1111/J.1752-1688.1996.TB03465.X]; Xiao ZX., 2008, THESIS HEFEI U TECHN, P8; [杨文艳 YANG Wenyan], 2008, [安徽农业科学, Journal of Anhui Agricultural Sciences], V36, P9197; Yang WY, 2008, J ANHUI AGR SCI, V36, P9209; Yang YJ, 2002, WATER RESOURCES PROT, V2, P15; Yang YJ, 2002, WATER RESOURCES PROT, V2, P14; Zhang Y, 2005, ENVIRON SCI TECHNOL, V28, P114; Zhu HJ, 1998, YUNNAN ENV SCI, V17, P51	35	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0127535	10.1371/journal.pone.0127535	http://dx.doi.org/10.1371/journal.pone.0127535			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26023785	gold, Green Published, Green Submitted			2022-12-26	WOS:000355319400040
J	Graziano, TS; Cuzzullin, MC; Franco, GC; Schwartz, HO; de Andrade, ED; Groppo, FC; Cogo-Muller, K				Graziano, Talita Signoreti; Cuzzullin, Maria Claudia; Franco, Gilson Cesar; Schwartz-Filho, Humberto Osvaldo; de Andrade, Eduardo Dias; Groppo, Francisco Carlos; Cogo-Mueller, Karina			Statins and Antimicrobial Effects: Simvastatin as a Potential Drug against Staphylococcus aureus Biofilm	PLOS ONE			English	Article							REDUCTASE INHIBITORS; COMBINATION; RESISTANCE; BACTERIAL; THERAPY; AGENTS	Statins are important lipid-lowering agents with other pleiotropic effects. Several studies have explored a possible protective effect of statins to reduce the morbidity and mortality of many infectious diseases. Staphylococcus aureus is one of the main pathogens implicated in nosocomial infections; its ability to form biofilms makes treatment difficult. The present study observed the MIC of atorvastatin, pravastatin and simvastatin against S. aureus, Pseudomonas aeruginosa, Escherichia coli and Enterococcus faecalis. Simvastatin was the only agent with activity against clinical isolates and reference strains of methicilin-sensitive S. aureus (MSSA) and methicillin-resistant S. aureus (MRSA). Thus, the effects of simvastatin on the growth, viability and biofilm formation of S. aureus were tested. In addition, a possible synergistic effect between simvastatin and vancomycin was evaluated. Simvastatin's MIC was 15.65 mu g/mL for S. aureus 29213 and 31.25 mu g/mL for the other strains of S. aureus. The effect of simvastatin was bactericidal at 4xMIC and bacteriostatic at the MIC concentration. No synergistic effect was found between simvastatin and vancomycin. However, the results obtained against S. aureus biofilms showed that, in addition to inhibiting adhesion and biofilm formation at concentrations from 1/16xMIC to 4xMIC, simvastatin was also able to act against mature biofilms, reducing cell viability and extra-polysaccharide production. In conclusion, simvastatin showed pronounced antimicrobial activity against S. aureus biofilms, reducing their formation and viability.	[Graziano, Talita Signoreti; Cuzzullin, Maria Claudia; de Andrade, Eduardo Dias; Groppo, Francisco Carlos; Cogo-Mueller, Karina] Univ Estadual Campinas, Piracicaba Dent Sch, Dept Physiol Sci, Pharmacol Anesthesiol & Therapeut, Piracicaba, SP, Brazil; [Franco, Gilson Cesar] Univ Estadual Ponta Grossa, Dept Gen Biol, Area Physiol & Pathophysiol, Ponta Grossa, Parana, Brazil; [Schwartz-Filho, Humberto Osvaldo; Cogo-Mueller, Karina] Univ Santo Amaro, Dept Dent, Implantol Area, Sao Paulo, SP, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Ponta Grossa; Universidade de Santo Amaro (UNISA)	Cogo-Muller, K (corresponding author), Univ Estadual Campinas, Piracicaba Dent Sch, Dept Physiol Sci, Pharmacol Anesthesiol & Therapeut, Piracicaba, SP, Brazil.	karicogo@hotmail.com	groppo, francisco carlos/HIK-2053-2022; Muller, Karina Cogo/H-2365-2012; Muller, Karina/ABA-1819-2021; Schwartz, Humberto/C-6405-2012	groppo, francisco carlos/0000-0002-8513-773X; Muller, Karina Cogo/0000-0002-9048-8702; Schwartz, Humberto/0000-0002-3873-4945	FAPESP -Sao Paulo Research Foundation [2013/06570-3, 2011/15795-3]; Brazilian National Council for Scientific and Technological Development - CNPq	FAPESP -Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian National Council for Scientific and Technological Development - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Financial support was provided by http://www.fapesp.br/en/, FAPESP -Sao Paulo Research Foundation Grant - 2013/06570-3 (KCM) and Master fellowship - 2011/15795-3 (TSG); http://www.cnpq.br/, The Brazilian National Council for Scientific and Technological Development - CNPq Graduation fellowship-PIBIC (MCC).	Abdallah M, 2014, ARCH MICROBIOL, V196, P453, DOI 10.1007/s00203-014-0983-1; Aires CP, 2008, CARIES RES, V42, P380, DOI 10.1159/000154783; Alla VM, 2013, DRUGS, V73, P1025, DOI 10.1007/s40265-013-0072-9; Almog Y, 2004, CIRCULATION, V110, P880, DOI 10.1161/01.CIR.0000138932.17956.F1; Bergman P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024394; Bjorkhem-Bergman L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010702; Bonetti PO, 2003, EUR HEART J, V24, P225, DOI 10.1016/S0195-668X(02)00419-0; Busuioc M, 2009, J BACTERIOL, V191, P7315, DOI 10.1128/JB.00425-09; Ccahuana-Vásquez Renzo Alberto, 2010, Braz. oral res., V24, P135, DOI 10.1590/S1806-83242010000200002; Chamilos G, 2006, ANTIMICROB AGENTS CH, V50, P96, DOI 10.1128/AAC.50.1.96-103.2006; Clinical and Laboratory Standards Institute (CLSI), 2006, METH DIL ANT SUSC TE; CRAIG WA, 1996, ANTIBIOTICS LAB MED; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Galgoczy L, 2009, MYCOSES, V52, P447, DOI 10.1111/j.1439-0507.2008.01634.x; Ganeshnarayan K, 2009, APPL ENVIRON MICROB, V75, P1308, DOI 10.1128/AEM.01900-08; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Hall-Stoodley L, 2005, TRENDS MICROBIOL, V13, P7, DOI 10.1016/j.tim.2004.11.004; HAWSER SP, 1994, INFECT IMMUN, V62, P915, DOI 10.1128/IAI.62.3.915-921.1994; HOFFMAN WF, 1986, J MED CHEM, V29, P849, DOI 10.1021/jm00155a040; Horn MP, 2008, J PHARMACOL EXP THER, V326, P135, DOI 10.1124/jpet.108.137927; Janda S, 2010, J CRIT CARE, V25; Jerwood S, 2008, J ANTIMICROB CHEMOTH, V61, P362, DOI 10.1093/jac/dkm496; Khan AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052929; Kozarov E, 2014, CARDIOVASC RES, V102, P362, DOI 10.1093/cvr/cvu058; Lefer DJ, 2002, CIRCULATION, V106, P2041, DOI 10.1161/01.CIR.0000033635.42612.88; Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748; Lopez-Cortes LE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082958; Mah TF, 2012, FUTURE MICROBIOL, V7, P1061, DOI [10.2217/FMB.12.76, 10.2217/fmb.12.76]; Masadeh M, 2012, ANN CLIN MICROB ANTI, V11, DOI 10.1186/1476-0711-11-13; Mason RP, 2005, AM J CARDIOL, V96, p11F, DOI 10.1016/j.amjcard.2005.06.008; McTaggart F, 2001, AM J CARDIOL, V87, p28B; Nyilasi I, 2010, FEMS MICROBIOL LETT, V307, P175, DOI 10.1111/j.1574-6968.2010.01972.x; Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301; Pillai Jr SK, 2005, ANTIBIOTICS LAB MED, P366; Raja AF, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-54; Renner LD, 2011, MRS BULL, V36, P347, DOI 10.1557/mrs.2011.65; Shitara Y, 2006, PHARMACOL THERAPEUT, V112, P71, DOI 10.1016/j.pharmthera.2006.03.003; Sievert DM, 2013, INFECT CONT HOSP EP, V34, P1, DOI 10.1086/668770; Smith SC, 2014, J AM COLL CARDIOL, V64, P601, DOI 10.1016/j.jacc.2014.06.1159; Sun LM, 2009, ANTIMICROB AGENTS CH, V53, P1586, DOI 10.1128/AAC.00940-08; Thomsen RW, 2006, CRIT CARE MED, V34, P1080, DOI 10.1097/01.CCM.0000207345.92928.E4; Van Acker H, 2014, TRENDS MICROBIOL, V22, P326, DOI 10.1016/j.tim.2014.02.001; van den Hoek HL, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7281; Wan YD, 2014, CRIT CARE, V18, DOI 10.1186/cc13828; Welsh AM, 2009, PATHOLOGY, V41, P689, DOI 10.3109/00313020903305860; Wilt TJ, 2004, ARCH INTERN MED, V164, P1427, DOI 10.1001/archinte.164.13.1427; Wu WS, 2013, J MICROBIOL IMMUNOL, V46, P89, DOI 10.1016/j.jmii.2012.03.009	49	67	71	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128098	10.1371/journal.pone.0128098	http://dx.doi.org/10.1371/journal.pone.0128098			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020797	Green Published, Green Submitted, gold			2022-12-26	WOS:000355187300079
J	Jackman, SD; Bohlmann, J; Birol, I				Jackman, Shaun D.; Bohlmann, Joerg; Birol, Inanc			UniqTag: Content-Derived Unique and Stable Identifiers for Gene Annotation	PLOS ONE			English	Article								When working on an ongoing genome sequencing and assembly project, it is rather inconvenient when gene identifiers change from one build of the assembly to the next. The gene labelling system described here, UniqTag, addresses this common challenge. UniqTag assigns a unique identifier to each gene that is a representative k-mer, a string of length k, selected from the sequence of that gene. Unlike serial numbers, these identifiers are stable between different assemblies and annotations of the same data without requiring that previous annotations be lifted over by sequence alignment. We assign UniqTag identifiers to ten builds of the Ensembl human genome spanning eight years to demonstrate this stability. The implementation of UniqTag in Ruby and an R package are available at https://github.com/sjackman/uniqtag sjackman/uniqtag. The R package is also available from CRAN: install. packages ("uniqtag"). Supplementary material and code to reproduce it is available at https://github.com/sjackman/uniqtag-paper.	[Jackman, Shaun D.; Birol, Inanc] British Columbia Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 4E6, Canada; [Jackman, Shaun D.] Univ British Columbia, Grad Program Bioinformat, Vancouver, BC V5Z 1M9, Canada; [Bohlmann, Joerg] Univ British Columbia, Michael Smith Labs, Vancouver, BC V5Z 1M9, Canada; [Birol, Inanc] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada	British Columbia Cancer Agency; University of British Columbia; University of British Columbia; University of British Columbia	Jackman, SD (corresponding author), British Columbia Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 4E6, Canada.	sjackman@bcgsc.ca; ibirol@bcgsc.ca	Birol, Inanc/G-5440-2011; Jackman, Shaun/G-9622-2013	Birol, Inanc/0000-0003-0950-7839; Jackman, Shaun/0000-0002-9275-5966	Natural Sciences and Engineering Research Council of Canada; Genome British Columbia; Genome Quebec; Genome Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Genome British Columbia; Genome Quebec; Genome Canada(Genome Canada)	This work was supported by the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/), Genome British Columbia (http://www.genomebc.ca/), Genome Quebec (http://www.genomequebec.com/) and Genome Canada (http://www.genomecanada.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Broder AZ, 1997, COMPRESSION COMPLEXI, P21; Campbell MS, 2014, PLANT PHYSIOL, V164, P513, DOI 10.1104/pp.113.230144; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Dang QH, 2012, NIST FIPS, V180, P1; Wain HM, 2002, GENOMICS, V79, P464, DOI 10.1006/geno.2002.6748	5	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128026	10.1371/journal.pone.0128026	http://dx.doi.org/10.1371/journal.pone.0128026			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020645	Green Published, Green Submitted, gold			2022-12-26	WOS:000355187300072
J	Li, XB; Zuo, R; Teng, YG; Wang, JS; Wang, B				Li, Xianbo; Zuo, Rui; Teng, Yanguo; Wang, Jinsheng; Wang, Bin			Development of Relative Risk Model for Regional Groundwater Risk Assessment: A Case Study in the Lower Liaohe River Plain, China	PLOS ONE			English	Article							MODIFIED DRASTIC MODEL; ECOLOGICAL RISK; VULNERABILITY ASSESSMENT; CONTAMINATED SITES; GIS; AQUIFER; POLLUTION; CATCHMENT; BASIN	Increasing pressure on water supply worldwide, especially in arid areas, has resulted in groundwater overexploitation and contamination, and subsequent deterioration of the groundwater quality and threats to public health. Environmental risk assessment of regional groundwater is an important tool for groundwater protection. This study presents a new approach for assessing the environmental risk assessment of regional groundwater. It was carried out with a relative risk model (RRM) coupled with a series of indices, such as a groundwater vulnerability index, which includes receptor analysis, risk source analysis, risk exposure and hazard analysis, risk characterization, and management of groundwater. The risk map is a product of the probability of environmental contamination and impact. The reliability of the RRM was verified using Monte Carlo analysis. This approach was applied to the lower Liaohe River Plain (LLRP), northeastern China, which covers 23604 km(2). A spatial analysis tool within GIS which was used to interpolate and manipulate the data to develop environmental risk maps of regional groundwater, divided the level of risk from high to low into five ranks (V, IV, III, II, I). The results indicate that areas of relative risk rank (RRR) V cover 2324 km(2), covering 9.8% of the area; RRR IV covers 3986 km(2), accounting for 16.9% of the area. It is a new and appropriate method for regional groundwater resource management and land use planning, and is a rapid and effective tool for improving strategic decision making to protect groundwater and reduce environmental risk.	[Li, Xianbo; Zuo, Rui; Teng, Yanguo; Wang, Jinsheng; Wang, Bin] Beijing Normal Univ, Coll Water Sci, Beijing 100875, Peoples R China; [Li, Xianbo; Zuo, Rui; Teng, Yanguo; Wang, Jinsheng; Wang, Bin] Minist Educ, Engn Res Ctr Groundwater Pollut Control & Remedia, Beijing 100875, Peoples R China	Beijing Normal University	Zuo, R (corresponding author), Beijing Normal Univ, Coll Water Sci, Beijing 100875, Peoples R China.	zr@bnu.edu.cn			Specific Research on Public Service of Environmental Protection in China [201009009]; National Natural Science Foundation in China [41402211]; Ministry of environmental protection, China [201009009]	Specific Research on Public Service of Environmental Protection in China; National Natural Science Foundation in China(National Natural Science Foundation of China (NSFC)); Ministry of environmental protection, China	This work was supported by the Specific Research on Public Service of Environmental Protection in China (No. 201009009) and the National Natural Science Foundation in China (No. 41402211). The Specific Research on Public Service of Environmental Protection in China (No. 201009009) is from the Ministry of environmental protection, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JJ, 2012, ENVIRON MONIT ASSESS, V184, P6637, DOI 10.1007/s10661-011-2448-1; Almasri MN, 2008, J ENVIRON MANAGE, V88, P577, DOI 10.1016/j.jenvman.2007.01.022; Almasri MN, 2007, J HYDROL, V343, P211, DOI 10.1016/j.jhydrol.2007.06.016; Babiker IS, 2005, SCI TOTAL ENVIRON, V345, P127, DOI 10.1016/j.scitotenv.2004.11.005; Chen QY, 2012, SCI TOTAL ENVIRON, V420, P79, DOI 10.1016/j.scitotenv.2011.09.044; Chinese Standardization, 1993, 1484893 GBT AQSIQ PE; De Lange HJ, 2010, SCI TOTAL ENVIRON, V408, P3871, DOI 10.1016/j.scitotenv.2009.11.009; Dixon B, 2005, APPL GEOGR, V25, P327, DOI 10.1016/j.apgeog.2005.07.002; Gao Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033503; Geological Survey of China, 2008, RES REPORT; Hamza MH, 2007, J ENVIRON MANAGE, V84, P12, DOI 10.1016/j.jenvman.2006.04.004; Howard J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011249; Huan H, 2012, SCI TOTAL ENVIRON, V440, P14, DOI 10.1016/j.scitotenv.2012.08.037; Hynds PD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093301; Kattaa B, 2010, J ENVIRON MANAGE, V91, P1103, DOI 10.1016/j.jenvman.2009.12.008; Landis WG, 1997, HUM ECOL RISK ASSESS, V3, P287, DOI 10.1080/10807039709383685; Li DQ, 2014, ENVIRON INT, V65, P16, DOI 10.1016/j.envint.2013.12.004; Li Y, 2012, ENVIRON POLLUT, V165, P77, DOI 10.1016/j.envpol.2011.12.042; Liu JL, 2011, ECOTOXICOLOGY, V20, P1131, DOI 10.1007/s10646-011-0618-0; Miller TK, 2010, BIOL CONSERV, V143, P2070, DOI 10.1016/j.biocon.2010.05.015; Moraes R, 2010, HUMAN ECOLOGICAL RIS, V8, P1779; Pizzol L, 2011, ENVIRON INT, V37, P1307, DOI 10.1016/j.envint.2011.05.010; Rahman A, 2008, APPL GEOGR, V28, P32, DOI 10.1016/j.apgeog.2007.07.008; Rau TF, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047877, 10.1371/journal.pone.0040881]; Schafer RB, 2011, SCI TOTAL ENVIRON, V409, P2055, DOI 10.1016/j.scitotenv.2011.01.053; Walker R, 2001, HUM ECOL RISK ASSESS, V7, P417, DOI 10.1080/20018091094439; Wang JJ, 2012, SCI TOTAL ENVIRON, V432, P216, DOI 10.1016/j.scitotenv.2012.06.005; Wen QC, 2011, PROCEDIA ENVIRON SCI, V8, P26, DOI 10.1016/j.proenv.2011.10.007; Xu LY, 2009, J ENVIRON MANAGE, V90, P3290, DOI 10.1016/j.jenvman.2009.05.011; Yu C, 2010, SCI TOTAL ENVIRON, V408, P6108, DOI 10.1016/j.scitotenv.2010.09.002; Yu WT, 2011, ATMOS RES, V101, P460, DOI 10.1016/j.atmosres.2011.04.011; Zabeo A, 2011, ENVIRON INT, V37, P1295, DOI 10.1016/j.envint.2011.05.005; Zhao YY, 2012, PROCEDIA ENVIRON SCI, V13, P1739, DOI 10.1016/j.proenv.2012.01.167; Zhou Ting, 2009, Shengtaixue Zazhi, V28, P762	34	10	11	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128249	10.1371/journal.pone.0128249	http://dx.doi.org/10.1371/journal.pone.0128249			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020518	Green Published, Green Submitted, gold			2022-12-26	WOS:000355187300095
J	Babic Bozovic, I; Stankovic, A; Zivkovic, M; Vranekovic, J; Kapovic, M; Brajenovic-Milic, B				Babic Bozovic, Ivana; Stankovic, Aleksandra; Zivkovic, Maja; Vranekovic, Jadranka; Kapovic, Miljenko; Brajenovic-Milic, Bojana			Altered LINE-1 Methylation in Mothers of Children with Down Syndrome	PLOS ONE			English	Article							GENOMIC DNA METHYLATION; CHROMOSOMAL INSTABILITY; METHYLENETETRAHYDROFOLATE REDUCTASE; EPIGENETIC REGULATION; FOLATE METABOLISM; COMMON MUTATION; RISK-FACTORS; HYPOMETHYLATION; ORIGIN; METHYLTRANSFERASES	Down syndrome (DS, also known as trisomy 21) most often results from chromosomal nondisjunction during oogenesis. Numerous studies sustain a causal link between global DNA hypomethylation and genetic instability. It has been suggested that DNA hypomethylation might affect the structure and dynamics of chromatin regions that are critical for chromosome stability and segregation, thus favouring chromosomal nondisjunction during meiosis. Maternal global DNA hypomethylation has not yet been analyzed as a potential risk factor for chromosome 21 nondisjunction. This study aimed to asses the risk for DS in association with maternal global DNA methylation and the impact of endogenous and exogenous factors that reportedly influence DNA methylation status. Global DNA methylation was analyzed in peripheral blood lymphocytes by quantifying LINE-1 methylation using the MethyLight method. Levels of global DNA methylation were significantly lower among mothers of children with maternally derived trisomy 21 than among control mothers (P = 0.000). The combination of MTHFR C677T genotype and diet significantly influenced global DNA methylation (R-2 = 4.5%, P = 0.046). The lowest values of global DNA methylation were observed in mothers with MTHFR 677 CT+TT genotype and low dietary folate. Although our findings revealed an association between maternal global DNA hypomethylation and trisomy 21 of maternal origin, further progress and final conclusions regarding the role of global DNA methylation and the occurrence of trisomy 21 are facing major challenges.	[Babic Bozovic, Ivana; Vranekovic, Jadranka; Kapovic, Miljenko; Brajenovic-Milic, Bojana] Univ Rijeka, Sch Med, Dept Biol & Med Genet, Rijeka, Croatia; [Stankovic, Aleksandra; Zivkovic, Maja] Univ Belgrade, Lab Radiobiol & Mol Genet, Vinca Inst Nucl Sci, Belgrade, Serbia	University of Rijeka; University of Belgrade	Brajenovic-Milic, B (corresponding author), Univ Rijeka, Sch Med, Dept Biol & Med Genet, Rijeka, Croatia.	bojanabm@medri.uniri.hr	Babic Bozovic, Ivana/T-1112-2018; Stankovic, Aleksandra D/T-1064-2018; Zivkovic, Maja/T-1038-2018; Brajenovic-Milic, Bojana/C-4275-2014; VRANEKOVIĆ, JADRANKA/I-4219-2014; Kapović, Miljenko/S-8310-2018	Babic Bozovic, Ivana/0000-0002-6071-4430; Stankovic, Aleksandra D/0000-0002-1050-5913; Zivkovic, Maja/0000-0002-0447-6626; Brajenovic-Milic, Bojana/0000-0002-9440-9346; VRANEKOVIĆ, JADRANKA/0000-0001-6365-5686; Kapović, Miljenko/0000-0002-8466-1011	University of Rijeka, Rijeka, Croatia [13.06.1.2.38]	University of Rijeka, Rijeka, Croatia	This study was supported by a grant (No. 13.06.1.2.38) from the University of Rijeka, Rijeka, Croatia.	Allen EG, 2009, HUM GENET, V125, P41, DOI 10.1007/s00439-008-0603-8; Allshire RC, 2008, NAT REV GENET, V9, P923, DOI 10.1038/nrg2466; Attig L, 2010, P NUTR SOC, V69, P221, DOI 10.1017/S002966511000008X; Bailey LB, 1999, J NUTR, V129, P779, DOI 10.1093/jn/129.4.779; Baric IC, 2009, INT J FOOD SCI NUTR, V60, P10, DOI 10.1080/09637480802249074; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Blasco MA, 2007, NAT REV GENET, V8, P299, DOI 10.1038/nrg2047; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Buard J, 2007, TRENDS GENET, V23, P301, DOI 10.1016/j.tig.2007.03.014; Castro R, 2004, J MED GENET, V41, P454, DOI 10.1136/jmg.2003.017244; Chen RZ, 1998, NATURE, V395, P89, DOI 10.1038/25779; Chowdhury S, 2011, BIRTH DEFECTS RES A, V91, P69, DOI 10.1002/bdra.20761; Coppede F, 2006, AM J MED GENET A, V140A, P1083, DOI 10.1002/ajmg.a.31217; Coppede F, 2013, OA GENETICS, V1, P1; Costello JF, 2001, J MED GENET, V38, P285, DOI 10.1136/jmg.38.5.285; De la Fuente R, 2006, NAT CELL BIOL, V8, P1448, DOI 10.1038/ncb1513; Eads CA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.8.e32; Eden A, 2003, SCIENCE, V300, P455, DOI 10.1126/science.1083557; EUROCAT, 2014, EUR NETW POP BAS REG; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Freeman SB, 2007, PUBLIC HEALTH REP, V122, P62, DOI 10.1177/003335490712200109; Friso S, 2002, P NATL ACAD SCI USA, V99, P5606, DOI 10.1073/pnas.062066299; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Gonzalo S, 2006, NAT CELL BIOL, V8, P416, DOI 10.1038/ncb1386; Guenther BD, 1999, NAT STRUCT BIOL, V6, P359, DOI 10.1038/7594; Herrera LA, 2008, CURR GENOMICS, V9, P43, DOI 10.2174/138920208783884883; James SJ, 1999, AM J CLIN NUTR, V70, P495; Ji WZ, 1997, MUTAT RES-FUND MOL M, V379, P33, DOI 10.1016/S0027-5107(97)00088-2; Karpf AR, 2005, CANCER RES, V65, P8635, DOI 10.1158/0008-5472.CAN-05-1961; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Kim M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009692; Kluijtmans LAJ, 2003, BLOOD, V101, P2483, DOI 10.1182/blood.V101.7.2483; Lehmann E. L., 2006, NONPARAMETRICS STAT; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Lengauer C, 1997, P NATL ACAD SCI USA, V94, P2545, DOI 10.1073/pnas.94.6.2545; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Lippman Z, 2004, NATURE, V431, P364, DOI 10.1038/nature02875; Morris JK, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3794; Ogino S, 2006, J MOL DIAGN, V8, P209, DOI 10.2353/jmoldx.2006.050135; Oliver TR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000033; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Pidoux AL, 2005, PHILOS T R SOC B, V360, P569, DOI 10.1098/rstb.2004.1611; Piyathilake CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054544; Pogribny IP, 2009, CELL MOL LIFE SCI, V66, P2249, DOI 10.1007/s00018-009-0015-5; Richards KL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004941; Richardson B, 2003, AGEING RES REV, V2, P245, DOI 10.1016/S1568-1637(03)00010-2; Richardson BC, 2002, J NUTR, V132, p2401S, DOI 10.1093/jn/132.8.2401S; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Rodriguez J, 2006, CANCER RES, V66, P8462, DOI 10.1158/0008-5472.CAN-06-0293; Sigurdsson MI, 2009, GENOME RES, V19, P581, DOI 10.1101/gr.086181.108; Stenvinkel P, 2007, J INTERN MED, V261, P488, DOI 10.1111/j.1365-2796.2007.01777.x; Subirana JA, 2010, NUCLEIC ACIDS RES, V38, P1172, DOI 10.1093/nar/gkp1094; Terry MB, 2011, EPIGENETICS-US, V6, P828, DOI 10.4161/epi.6.7.16500; VOGT P, 1990, HUM GENET, V84, P301; Vranekovic J, 2012, GENET TEST MOL BIOMA, V16, P70, DOI 10.1089/gtmb.2011.0066; Weisenberger DJ, 2005, NUCLEIC ACIDS RES, V33, P6823, DOI 10.1093/nar/gki987; Wilson AS, 2007, BBA-REV CANCER, V1775, P138, DOI 10.1016/j.bbcan.2006.08.007; Wilson IM, 2006, CELL CYCLE, V5, P155, DOI 10.4161/cc.5.2.2367; Woo HD, 2007, PLOS ONE, V7; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052; Yang AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh032; Zeschnigk M, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh122; Zhang FF, 2011, EPIGENETICS-US, V6, P623, DOI 10.4161/epi.6.5.15335; Zhu ZZ, 2012, INT J EPIDEMIOL, V41, P126, DOI 10.1093/ije/dyq154	65	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0127423	10.1371/journal.pone.0127423	http://dx.doi.org/10.1371/journal.pone.0127423			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26017139	Green Published, Green Submitted, gold			2022-12-26	WOS:000355185600082
J	Butts, A; Martin, JA; DiDone, L; Bradley, EK; Mutz, M; Krysan, DJ				Butts, Arielle; Martin, Jennifer A.; DiDone, Louis; Bradley, Erin K.; Mutz, Mitchell; Krysan, Damian J.			Structure-Activity Relationships for the Antifungal Activity of Selective Estrogen Receptor Antagonists Related to Tamoxifen	PLOS ONE			English	Article							CRYPTOCOCCAL MENINGITIS; CALMODULIN; BINDING; DRUGS	Cryptococcosis is one of the most important invasive fungal infections and is a significant contributor to the mortality associated with HIV/AIDS. As part of our program to repurpose molecules related to the selective estrogen receptor modulator (SERM) tamoxifen as anti-cryptococcal agents, we have explored the structure-activity relationships of a set of structurally diverse SERMs and tamoxifen derivatives. Our data provide the first insights into the structural requirements for the antifungal activity of this scaffold. Three key molecular characteristics affecting anti-cryptococcal activity emerged from our studies: 1) the presence of an alkylamino group tethered to one of the aromatic rings of the triphenylethylene core; 2) an appropriately sized aliphatic substituent at the 2 position of the ethylene moiety; and 3) electronegative substituents on the aromatic rings modestly improved activity. Using a cell-based assay of calmodulin antagonism, we found that the anti-cryptococcal activity of the scaffold correlates with calmodulin inhibition. Finally, we developed a homology model of C. neoformans calmodulin and used it to rationalize the structural basis for the activity of these molecules. Taken together, these data and models provide a basis for the further optimization of this promising anti-cryptococcal scaffold.	[Butts, Arielle] Univ Rochester, Dept Chem, Rochester, NY 14642 USA; [Martin, Jennifer A.; DiDone, Louis; Krysan, Damian J.] Univ Rochester, Dept Pediat, Rochester, NY 14642 USA; [Krysan, Damian J.] Univ Rochester, Dept Microbiol Immunol, Rochester, NY 14642 USA; [Bradley, Erin K.] LigDCipher, San Diego, CA 92121 USA; [Mutz, Mitchell] Amplyx Pharmaceut, San Diego, CA 92121 USA	University of Rochester; University of Rochester; University of Rochester	Krysan, DJ (corresponding author), Univ Rochester, Dept Pediat, 601 Elmwood Ave, Rochester, NY 14642 USA.	damian_krysan@urmc.rochester.edu		Krysan, Damian/0000-0001-6330-3365	National Institute of Allergy and Infectious Diseases [1R01AI091422]; LigDCipherd; Amplyx Pharmaceutical; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091422] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); LigDCipherd; Amplyx Pharmaceutical(Johnson & Johnson); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by grant 1R01AI091422 from the National Institute of Allergy and Infectious Diseases http://www.niaid.nih.gov. LigDCipherd and Amplyx Pharmaceutical provided support in the form of salaries for authors Erin K. Bradleyd and Mitchell Mutz but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bicanic T, 2009, CLIN INFECT DIS, V49, P702, DOI 10.1086/604716; Bisson WH, 2012, CURR TOP MED CHEM, V12, P1867; Butts A, 2014, MBIO, V5, DOI 10.1128/mBio.00765-13; Butts A, 2013, EUKARYOT CELL, V12, P278, DOI 10.1128/EC.00314-12; Butts A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002870; Chayakulkeeree M, 2006, INFECT DIS CLIN N AM, V20, P507, DOI 10.1016/j.idc.2006.07.001; COOK WJ, 1994, BIOCHEMISTRY-US, V33, P15259, DOI 10.1021/bi00255a006; Day JN, 2013, NEW ENGL J MED, V368, P2522, DOI [10.1056/NEJMc1305981, 10.1056/NEJMoa1110404]; Dolan K, 2009, ANTIMICROB AGENTS CH, V53, P3337, DOI 10.1128/AAC.01564-08; Hardcastle IR, 1996, J MED CHEM, V39, P999, DOI 10.1021/jm9505472; HERRMANN JL, 1994, J ANTIMICROB CHEMOTH, V34, P1051, DOI 10.1093/jac/34.6.1051; Kraus PR, 2003, BIOCHEM BIOPH RES CO, V311, P1151, DOI 10.1016/S0006-291X(03)01528-6; Krysan DJ, 2015, FUNGAL GENET BIOL, V78, P93, DOI 10.1016/j.fgb.2014.12.001; Lev S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051403; LIEN EA, 1991, BRIT J CANCER, V63, P641, DOI 10.1038/bjc.1991.147; LOPES MCF, 1990, CANCER RES, V50, P2753; Morello KC, 2003, CLIN PHARMACOKINET, V42, P361, DOI 10.2165/00003088-200342040-00004; National Committee for Clinical Laboratory Standards, 2002, M27A2 NAT COMM CLIN; Odom AR, 2014, MBIO, V5, DOI 10.1128/mBio.01126-14; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Perfect JR, 2010, CLIN INFECT DIS, V50, P291, DOI 10.1086/649858; Sloan DJ, 2009, CURR OPIN INFECT DIS, V22, P455, DOI 10.1097/QCO.0b013e32832fa214; Spitzer M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.31; Springer DJ, 2012, CURR FUNGAL INFECT R, V6, P245, DOI 10.1007/s12281-012-0111-0; Vertessy BG, 1998, BIOCHEMISTRY-US, V37, P15300, DOI 10.1021/bi980795a; Voelz K, 2010, EUKARYOT CELL, V9, P835, DOI 10.1128/EC.00039-10; WISEMAN H, 1989, BIOCHEM SOC T, V17, P1038, DOI 10.1042/bst0171038	27	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0125927	10.1371/journal.pone.0125927	http://dx.doi.org/10.1371/journal.pone.0125927			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26016941	Green Published, gold, Green Submitted			2022-12-26	WOS:000355185600041
J	Fan, HQ; He, W; Xu, KF; Wang, ZX; Xu, XY; Chen, H				Fan, Hong-Qi; He, Wei; Xu, Kuan-Feng; Wang, Zhi-Xiao; Xu, Xin-Yu; Chen, Heng			FTO Inhibits Insulin Secretion and Promotes NF-kappa B Activation through Positively Regulating ROS Production in Pancreatic beta cells	PLOS ONE			English	Article							TYROSINE-PHOSPHATASE-EPSILON; NEGATIVE REGULATOR; ADULT OBESITY; GENE; KINASE; EXPRESSION; CHILDHOOD; VARIANTS	FTO (Fat mass and obesity-associated) is associated with increased risk of obesity and type 2 diabetes incurrence. Pancreas islet beta cells dysfunction and insulin resistance are major causes of type 2 diabetes. However, whether FTO plays an important functional role in pancreatic beta cells as well as the related molecular mechanism is still unclear. In the present study, the tissue expression profile of FTO was firstly determined using quantitative PCR and western blot. FTO is widely expressed in various tissues and presented with relative high expression in pancreas tissue, especially in endocrine pancreas. FTO overexpression in MIN6 cells achieved by lentivirus delivery significantly inhibits insulin secretion in the presence of glucose stimulus as well as KCl. FTO silence has no effect on insulin secretion of MIN6 cells. However, FTO overexpression doesn't affect the transcription of insulin gene. Furthermore, reactive oxygen species (ROS) production and NF-kappa B activation are significantly promoted by FTO overexpression. Inhibition of intracellular ROS production by N-acetyl-L-cysteine (NAC) can alleviate NF-kappa B activation and restore the insulin secretion mediated by FTO overexpression. A whole transcript-microarray is employed to analyze the differential gene expression mediated by FTO overexpression. The genes which are modulated by FTO are involved in many important biological pathways such as G-protein coupled receptor signaling and NF-kappa B signaling. Therefore, our study indicates that FTO may contribute to pancreas islet beta cells dysfunction and the inhibition of FTO activity is a potential target for the treatment of diabetes.	[Fan, Hong-Qi; He, Wei; Xu, Kuan-Feng; Wang, Zhi-Xiao; Xu, Xin-Yu; Chen, Heng] Nanjing Med Univ, Affiliated Hosp 1, Dept Endocrinol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Fan, HQ (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Endocrinol, Nanjing, Jiangsu, Peoples R China.	hqfan_2004@163.com			National Natural Science Foundation of China [81100578]; Specialized Research Fund for the Doctoral Program of Higher Education [20113234120011]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Priority Academic Program Development of Jiangsu Higher Education Institutions	This study was supported by grants from the National Natural Science Foundation of China (81100578), the Specialized Research Fund for the Doctoral Program of Higher Education (20113234120011), and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. All the grants support the study design, data collection and decision to publish.	Aga-Mizrachi S, 2008, ENDOCRINOLOGY, V149, P605, DOI 10.1210/en.2007-0908; Bravard A, 2011, DIABETES, V60, P258, DOI 10.2337/db10-0281; Church C, 2010, NAT GENET, V42, P1086, DOI 10.1038/ng.713; Church C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000599; de Luis DA, J DIABETES COMPLICAT, V27, P346, DOI [10.1016/j.jdiacomp.2013.02.003, DOI 10.1016/J.JDIAC0MP.2013.02.003]; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Doyle SL, 2005, J BIOL CHEM, V280, P23496, DOI 10.1074/jbc.C500053200; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gao X, PLOS ONE, V5, DOI [10.1371/journal.pone.0014005, DOI 10.1371/J0URNAL.P0NE.0014005]; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Guigas B, 2014, DIABETIC MED, V31, P1001, DOI 10.1111/dme.12464; Holmkvist J, 2007, DIABETOLOGIA, V50, P2467, DOI 10.1007/s00125-007-0846-2; Jing XJ, 2005, J CLIN INVEST, V115, P146, DOI 10.1172/JCI200522518; Maurya CK, MOL CELL ENDOCRINOL, V395, P51, DOI [10.1016/j.mce.2014.08.003, DOI 10.1016/J.MCE.2014.08.003]; Merkestein M, PLOS ONE, V9, DOI [10.1371/journal.pone.0097162, DOI 10.1371/J0URNAL.P0NE.0097162]; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Nakagawa Y, 2005, ZOOL SCI, V22, P169, DOI 10.2108/zsj.22.169; Peters T, 1999, MAMM GENOME, V10, P983, DOI 10.1007/s003359901121; Russell MA, 2011, CLIN SCI, V120, P403, DOI 10.1042/CS20100416; Salem HH, 2014, DIABETES, V63, P960, DOI 10.2337/db13-1037; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Stratigopoulos G, 2008, AM J PHYSIOL-REG I, V294, pR1185, DOI 10.1152/ajpregu.00839.2007; Tan S, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-12; Trombetta M, PLOS ONE, V7, DOI [10.1371/journal.pone.0032755, DOI 10.1371/J0URNAL.P0NE.0032755]; van Weenen JED, 2011, EXP DIABETES RES, DOI 10.1155/2011/928523; Wang X, 2007, BIOCHEM BIOPH RES CO, V352, P463, DOI 10.1016/j.bbrc.2006.11.032; Wen WQ, 2012, NAT GENET, V44, P307, DOI 10.1038/ng.1087; Yajnik CS, 2009, DIABETOLOGIA, V52, P247, DOI 10.1007/s00125-008-1186-6; Zdrojowy-Welna A, 2014, ENDOKRYNOL POL, V65, P224, DOI 10.5603/EP.2014.0031; Zhang YD, 2004, CANCER RES, V64, P1902, DOI 10.1158/0008-5472.CAN-03-3361	32	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0127705	10.1371/journal.pone.0127705	http://dx.doi.org/10.1371/journal.pone.0127705			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018652	Green Published, Green Submitted, gold			2022-12-26	WOS:000355185600094
J	Han, JW; Liu, SY; Guo, W; Bao, ZY; Wang, XL; Li, L; Liu, YJ; Zhuang, DM; Li, HP; Jia, L; Gui, T; Sui, HS; Li, TY; Li, JY				Han, Jingwan; Liu, Siyang; Guo, Wei; Bao, Zuoyi; Wang, Xiaolin; Li, Lin; Liu, Yongjian; Zhuang, Daomin; Li, Hanping; Jia, Lei; Gui, Tao; Sui, Hongshuai; Li, Tianyi; Li, Jingyun			Development of an HIV-1 Subtype Panel in China: Isolation and Characterization of 30 HIV-1 Primary Strains Circulating in China	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; GUANGXI PROVINCE; GENOME SEQUENCE; WESTERN YUNNAN; RECOMBINANT; IDENTIFICATION; RESISTANCE; INFECTION; EPIDEMIC; CRF01-AE	Background The complex epidemic and significant diversity of HIV-1 strains in China pose serious challenges for surveillance and diagnostic assays, vaccine development and clinical management. There is a lack of HIV-1 isolates in current canonical HIV-1 subtype panels that can represent HIV-1 diversity in China; an HIV-1 subtype panel for China is urgently needed. Methods Blood samples were collected from HIV-1 infected patients participating in the drug-resistance surveillance program in China. The samples were isolated, cultured and stored as neat culture supernatant. The HIV-1 isolates were fully characterized. The panel was used to compare 2 viral load assays and 2 p24 assays as the examples of how this panel could be used. Results An HIV-1 subtype panel for China composed of 30 HIV-1 primary strains of four subtypes (B [including Thai-B], CRF01_AE, CRF07_BC and G) was established. The samples were isolated and cultured to a high-titer (10(6)-10(9) copies/ml)/high-volume (40ml). The HIV-1 isolates were fully characterized by the final viral load, p24 concentration, gag-pol and envC2V3 sequencing, co-receptor prediction, determination of the four amino acids at the tip of the env V3-loop, glycosylation sites in the V3 loop and the drug-resistance mutations. The comparison of two p24 assays and two viral load assays on the isolates illustrated how this panel may be used for the evaluation of diagnostic assay performance. The Pearson value between p24 assays were 0.938. The viral load results showed excellent concordance and agreement for samples of Thai-B, but lower correlations for samples of CRF01_AE. Conclusion The current panel of 30 HIV-1 isolates served as a basis for the development of a comprehensive panel of fully characterized viral isolates, which could reflect the current dynamic and complex HIV-1 epidemic in China. This panel will be available to support HIV-1 research, assay evaluation, vaccine and drug development.	[Han, Jingwan; Liu, Siyang; Guo, Wei; Bao, Zuoyi; Wang, Xiaolin; Li, Lin; Liu, Yongjian; Zhuang, Daomin; Li, Hanping; Jia, Lei; Gui, Tao; Sui, Hongshuai; Li, Tianyi; Li, Jingyun] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Dept AIDS Res, Beijing 0007, Peoples R China	Beijing Institute of Microbiology & Epidemiology	Li, JY (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Dept AIDS Res, Beijing 0007, Peoples R China.	lijy@nic.bmi.ac.cn	Liu, Yong/GWQ-6163-2022		National Science and Technology Special Projects on Major Infectious Diseases [2012ZX10001-002]	National Science and Technology Special Projects on Major Infectious Diseases	This study was supported by the National Science and Technology Special Projects on Major Infectious Diseases (Grant No. 2012ZX10001-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Buonaguro L, 2007, J VIROL, V81, P10209, DOI 10.1128/JVI.00872-07; Chen J, 1999, AIDS RES HUM RETROV, V15, P81, DOI 10.1089/088922299311754; Church D, 2011, J CLIN MICROBIOL, V49, P118, DOI 10.1128/JCM.00685-10; Feng Y, 2014, AIDS RES HUM RETROV, V30, P598, DOI [10.1089/aid.2013.0233, 10.1089/AID.2013.0233]; Feng Y, 2013, AIDS, V27, P1793, DOI 10.1097/QAD.0b013e328360db2d; Foglieni B, 2011, TRANSFUSION, V51, P719, DOI 10.1111/j.1537-2995.2010.02942.x; Gao L, 2008, J BIOL CHEM, V283, P9196, DOI 10.1074/jbc.M710148200; Guan Y, 1997, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V11, P8; Han X, 2013, GENOME ANNOUNC, V1, DOI [10.1128/genomeA.00050-12, DOI 10.1128/GEN0MEA.00050-12]; He X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047289; Henquell C, 2008, J CLIN MICROBIOL, V46, P2453, DOI 10.1128/JCM.02217-07; Hsi J, 2014, AIDS RES HUM RETROV, V30, P389, DOI [10.1089/aid.2013.0234, 10.1089/AID.2013.0234]; HWANG SS, 1991, SCIENCE, V253, P71, DOI 10.1126/science.1905842; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Kline NE, 2002, PEDIATR INFECT DIS J, V21, P885, DOI 10.1097/00006454-200209000-00023; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Li X, 2013, GENOME ANNOUNC, V1, DOI [10.1128/genomeA.00326-13, DOI 10.1128/GEN0MEA.00326-13]; Li Y W, 1997, Zhonghua Liu Xing Bing Xue Za Zhi, V18, P217; Liu W, DISTRIBUTION HIV 1 S; Liu Y, 2008, VIROLOGY, V374, P229, DOI 10.1016/j.virol.2008.01.029; Manak M, 2012, AIDS RES HUM RETROV, V28, P594, DOI [10.1089/aid.2011.0271, 10.1089/AID.2011.0271]; Ntemgwa M, 2008, AIDS RES HUM RETROV, V24, P995, DOI 10.1089/aid.2008.0064; Nubling CM, 2009, TRANSFUSION, V49, P1850, DOI 10.1111/j.1537-2995.2009.02212.x; Obaro SK, 2005, PEDIATR INFECT DIS J, V24, P183, DOI 10.1097/01.inf.0000151040.57772.40; Piyasirisilp S, 2000, J VIROL, V74, P11286, DOI 10.1128/JVI.74.23.11286-11295.2000; Qin G, 1998, Zhonghua Liu Xing Bing Xue Za Zhi, V19, P39; Sanchez AM, 2014, J IMMUNOL METHODS, V409, P117, DOI 10.1016/j.jim.2014.01.004; Sezgin E, 2010, JAIDS-J ACQ IMM DEF, V54, P343, DOI 10.1097/QAI.0b013e3181deaf4d; Snoeck J, 2006, ANTIMICROB AGENTS CH, V50, P694, DOI 10.1128/AAC.50.2.694-701.2006; Su L, 2000, J VIROL, V74, P11367, DOI 10.1128/JVI.74.23.11367-11376.2000; Taylor BS, 2008, NEW ENGL J MED, V359, P1965, DOI 10.1056/NEJMc086373; Tee KK, 2008, J VIROL, V82, P9206, DOI 10.1128/JVI.00399-08; UNAIDS, 2014, 2014 GAP REP UNAIDS; Wang FX, 2007, CHINESE MED J-PEKING, V120, P2006, DOI 10.1097/00029330-200711020-00013; Wei HM, 2014, AIDS RES HUM RETROV, V30, P384, DOI [10.1089/aid.2013.0228, 10.1089/AID.2013.0228]; Wei HM, 2014, AIDS RES HUM RETROV, V30, P380, DOI [10.1089/aid.2013.0235, 10.1089/AID.2013.0235]; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Xing Hui, 2004, Zhonghua Yufang Yixue Zazhi, V38, P300; Xu JQ, 2006, CHINESE MED J-PEKING, V119, P1941, DOI 10.1097/00029330-200612010-00002; Xu SH, 2012, J CLIN VIROL, V53, P33, DOI 10.1016/j.jcv.2011.10.001; Yu XF, 1999, J ACQ IMMUN DEF SYND, V22, P180; Zhu XG, 2000, BIOCHEMISTRY-US, V39, P11194, DOI 10.1021/bi000432m	43	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0127696	10.1371/journal.pone.0127696	http://dx.doi.org/10.1371/journal.pone.0127696			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018591	Green Published, Green Submitted, gold			2022-12-26	WOS:000355185600093
J	Lee, EJ; Merriwether, DA; Kasparov, AK; Nikolskiy, PA; Sotnikova, MV; Pavlova, EY; Pitulko, VV				Lee, Esther J.; Merriwether, D. Andrew; Kasparov, Alexei K.; Nikolskiy, Pavel A.; Sotnikova, Marina V.; Pavlova, Elena Yu; Pitulko, Vladimir V.			Ancient DNA Analysis of the Oldest Canid Species from the Siberian Arctic and Genetic Contribution to the Domestic Dog	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; WOLF; ORIGIN; HAPLOTYPE; MULTIPLE; WOLVES; LUPUS; PHYLOGEOGRAPHY; SEQUENCE; HUMANS	Modern Arctic Siberia provides a wealth of resources for archaeological, geological, and paleontological research to investigate the population dynamics of faunal communities from the Pleistocene, particularly as the faunal material coming from permafrost has proven suitable for genetic studies. In order to examine the history of the Canid species in the Siberian Arctic, we carried out genetic analysis of fourteen canid remains from various sites, including the well-documented Upper Paleolithic Yana RHS and Early Holocene Zhokhov Island sites. Estimated age of samples range from as recent as 1,700 years before present (YBP) to at least 360,000 YBP for the remains of the extinct wolf, Canis cf. variabilis. In order to examine the genetic affinities of ancient Siberian canids species to the domestic dog and modern wolves, we obtained mitochondrial DNA control region sequences and compared them to published ancient and modern canid sequences. The older canid specimens illustrate affinities with pre-domestic dog/wolf lineages while others appear in the major phylogenetic clades of domestic dogs. Our results suggest a European origin of domestic dog may not be conclusive and illustrates an emerging complexity of genetic contribution of regional wolf breeds to the modern Canis gene pool.	[Lee, Esther J.; Merriwether, D. Andrew] SUNY Binghamton, Dept Anthropol, Binghamton, NY USA; [Lee, Esther J.] Texas Tech Univ, Dept Sociol Anthropol & Social Work, Lubbock, TX 79409 USA; [Kasparov, Alexei K.; Pitulko, Vladimir V.] Russian Acad Sci, Inst Hist Mat Culture, St Petersburg 196140, Russia; [Nikolskiy, Pavel A.; Sotnikova, Marina V.] Russian Acad Sci, Inst Geol, Moscow V71, Russia; [Pavlova, Elena Yu] Arctic & Antarct Res Inst, St Petersburg, Russia	State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; Texas Tech University System; Texas Tech University; Russian Academy of Sciences; Institute for the History of Material Culture, Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Geological Institute, Russian Academy of Sciences; Russian Academy of Sciences	Lee, EJ (corresponding author), Texas Tech Univ, Dept Sociol Anthropol & Social Work, Lubbock, TX 79409 USA.	esther.lee@ttu.edu	Pavlova, Elena/AAA-3291-2019; Pitulko, Vladimir/E-2200-2015; Nikolskiy, Pavel A/C-5041-2012; Pitulko, Vladimir/N-4009-2019	Pitulko, Vladimir/0000-0001-5672-2756; Kasparov, Aleksei/0000-0001-7761-9301; Pavlova, Elena/0000-0002-3010-6290	Rock Foundation	Rock Foundation	This experimental procedures and excavations for Zhokhov, Yana RHS, and New Siberian Islands were supported by the Rock Foundation. The Ford Motor Company aided in the research of the Aachim Lighthouse site. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JR, 2003, MOL ECOL, V12, P541, DOI 10.1046/j.1365-294X.2003.01708.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barnes I, 2007, CURR BIOL, V17, P1072, DOI 10.1016/j.cub.2007.05.035; Barnett R, 2009, MOL ECOL, V18, P1668, DOI 10.1111/j.1365-294X.2009.04134.x; Campos PF, 2010, P NATL ACAD SCI USA, V107, P5675, DOI 10.1073/pnas.0907189107; Carmichael LE, 2007, MOL ECOL, V16, P3466, DOI 10.1111/j.1365-294X.2007.03381.x; Clutton-Brock J, 1995, DOMESTIC DOG ITS EVO, V14, P7; Crockford S.J., 2006, RHYTHMS LIFE THYROID; CRoCKFoRD s. J., 2000, DOGS TIME ARCHAEOLOG, V889; Crockford SJ, 2012, J ARCHAEOL SCI, V39, P2797, DOI 10.1016/j.jas.2012.04.033; DAVIS SJM, 1978, NATURE, V276, P608, DOI 10.1038/276608a0; Dikov Nikolai N., 1996, P244; Ding ZL, 2012, HEREDITY, V108, P507, DOI 10.1038/hdy.2011.114; Drake AG, 2015, SCI REP-UK, V5, DOI 10.1038/srep08299; Druzhkova AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057754; Germonpre M, 2013, J ARCHAEOL SCI, V40, P786, DOI 10.1016/j.jas.2012.06.016; Germonpre M, 2009, J ARCHAEOL SCI, V36, P473, DOI 10.1016/j.jas.2008.09.033; Giterman R.E., 1982, PALEOECOLOGY BERINGI, P43, DOI [10.1016/b978-0-12-355860-2.50011-9, DOI 10.1016/B978-0-12-355860-2.50011-9]; Gray MM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-16; Ishiguro N, 2010, ZOOL SCI, V27, P320, DOI 10.2108/zsj.27.320; Ishiguro N, 2009, ZOOL SCI, V26, P765, DOI 10.2108/zsj.26.765; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Kaplina T. N., 1978, B QUAT RES COMM, V48, P49; Klutsch CFC, 2011, ANIM GENET, V42, P100, DOI 10.1111/j.1365-2052.2010.02069.x; Kurten B., 1980, PLEISTOCENE MAMMALS; Larson G, 2012, P NATL ACAD SCI USA, V109, P8878, DOI 10.1073/pnas.1203005109; Lee EJ, 2009, J ARCHAEOL SCI, V36, P2805, DOI 10.1016/j.jas.2009.09.008; Leonard JA, 2005, MOL ECOL, V14, P9, DOI 10.1111/j.1365-294X.2004.02389.x; Leonard JA, 2002, SCIENCE, V298, P1613, DOI 10.1126/science.1076980; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Losey RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063740; Losey RJ, 2011, J ANTHROPOL ARCHAEOL, V30, P174, DOI 10.1016/j.jaa.2011.01.001; Macdonald D.W., 2004, CANIDS FOXES WOLVES; Miyao T., 1980, Journal of the Mammalogical Society of Japan, V8, P181; Musil R., 1984, BAR International Series, P23; Napierala H, 2012, INT J OSTEOARCHAEOL, V22, P127, DOI 10.1002/oa.1182; Nikolskiy PA, 2010, THESIS RUSSIAN ACAD; Nobis G, 1986, BONNER JB, V186; Ovodov ND, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022821; Pang JF, 2009, MOL BIOL EVOL, V26, P2849, DOI 10.1093/molbev/msp195; Pei W.C., 1941, PAL SIN C, V11, P1; Pionnier-Capitan M, 2011, J ARCHAEOL SCI, V38, P2123, DOI 10.1016/j.jas.2011.02.028; Pitul'ko VV, 2007, DOKL EARTH SCI, V417, P1256, DOI 10.1134/S1028334X07080284; Pitulko V.V.., 2010, GEOARCHEOLOGY RADIOC; Pitulko VV, 2004, SCIENCE, V303, P52, DOI 10.1126/science.1085219; Pitulko VV, 1996, ARCTIC ANTHROPOL, V33, P1; Pitulko VV, 2010, ADAPTATIONS PEOPLES, P38; Pitulko VV, 2001, DIKOV READINGS, P64; Pitulko VV, 2003, HUNTER GATHERERS N P, P141; Pitulko VV, 2003, P ARCT SYST SCI PROG, P189; Pitulko VV, 2006, NEOLIT PALEOMETALL S, P50; Sablin MV, 2002, CURR ANTHROPOL, V43, P795, DOI 10.1086/344372; Savolainen P, 2002, SCIENCE, V298, P1610, DOI 10.1126/science.1073906; Shapiro B, 2004, SCIENCE, V306, P1561, DOI 10.1126/science.1101074; Sher A. V., 1979, 14 PAC SCI C TOUR GU, P1; Skoglund P, 2011, MOL BIOL EVOL, V28, P1505, DOI 10.1093/molbev/msq342; Sotnikova M, 2010, QUATERN INT, V212, P86, DOI 10.1016/j.quaint.2009.06.008; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tedford Richard H., 2009, Bulletin of the American Museum of Natural History, V325, P1, DOI 10.1206/574.1; Thalmann O, 2013, SCIENCE, V342, P871, DOI 10.1126/science.1243650; Tsuda K, 1997, GENES GENET SYST, V72, P229, DOI 10.1266/ggs.72.229; Vasil'chuk YK, 2001, RADIOCARBON, V43, P541; Verginelli F, 2005, MOL BIOL EVOL, V22, P2541, DOI 10.1093/molbev/msi248; Vila C, 1997, SCIENCE, V276, P1687, DOI 10.1126/science.276.5319.1687; vonHoldt BM, 2010, NATURE, V464, P898, DOI 10.1038/nature08837; Wang GD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2814; Wayne RK, 1998, CONSERV BIOL, V12, P726, DOI 10.1046/j.1523-1739.1998.97468.x; Weckworth BV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019582; Weckworth BV, 2010, J MAMMAL, V91, P363, DOI 10.1644/09-MAMM-A-036.1; Yashina S, 2012, P NATL ACAD SCI USA, V109, P4008, DOI 10.1073/pnas.1118386109; Zanina OG, 2011, QUATERNARY SCI REV, V30, P2107, DOI 10.1016/j.quascirev.2011.01.021	71	17	17	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0125759	10.1371/journal.pone.0125759	http://dx.doi.org/10.1371/journal.pone.0125759			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018528	Green Submitted, Green Published, gold			2022-12-26	WOS:000355185600031
J	Abouna, S; Gonzalez-Rizzo, S; Grimonprez, A; Gros, O				Abouna, Sylvie; Gonzalez-Rizzo, Silvina; Grimonprez, Adrien; Gros, Olivier			First Description of Sulphur-Oxidizing Bacterial Symbiosis in a Cnidarian (Medusozoa) Living in Sulphidic Shallow-Water Environments	PLOS ONE			English	Article							CALIFORNICUM HYMAN ANTHOMEDUSA; DEEP-SEA; CLADONEMA-CALIFORNICUM; RAMAN MICROSPECTROMETRY; CHARACTER EVOLUTION; ECTOSYMBIONTS; DIVERSITY; NITROGEN; HYDROZOA; CARBON	Background Since the discovery of thioautotrophic bacterial symbiosis in the giant tubeworm Riftia pachyptila, there has been great impetus to investigate such partnerships in other invertebrates. In this study, we present the occurrence of a sulphur-oxidizing symbiosis in a metazoan belonging to the phylum Cnidaria in which this event has never been described previously. Methodology/Principal Findings Scanning Electron Microscope (SEM), Transmission Electron Microscope (TEM) observations and Energy-dispersive X-ray spectroscopy (EDXs) analysis, were employed to unveil the presence of prokaryotes population bearing elemental sulphur granules, growing on the body surface of the metazoan. Phylogenetic assessments were also undertaken to identify this invertebrate and microorganisms in thiotrophic symbiosis. Our results showed the occurrence of a thiotrophic symbiosis in a cnidarian identified as Cladonema sp. Conclusions/Significance This is the first report describing the occurrence of a sulphur-oxidizing symbiosis in a cnidarian. Furthermore, of the two adult morphologies, the polyp and medusa, this mutualistic association was found restricted to the polyp form of Cladonema sp.	[Abouna, Sylvie; Gonzalez-Rizzo, Silvina; Grimonprez, Adrien; Gros, Olivier] Univ Antilles Guyane, UFR Sci Exactes & Nat, UMR Evolut Paris Seine 7138, Inst Biol Paris Seine,Equipe Biol Mangrove,Dept B, BP 592, F-97159 Pointe A Pitre, Guadeloupe, France; [Gros, Olivier] Univ Antilles Guyane, UFR Sci Exactes & Nat, C3MAG, F-97159 Pointe A Pitre, Guadeloupe, France	UDICE-French Research Universities; Sorbonne Universite; Universite de Montpellier; Universite des Antilles; Universite de Montpellier; Universite des Antilles	Gros, O (corresponding author), Univ Antilles Guyane, UFR Sci Exactes & Nat, UMR Evolut Paris Seine 7138, Inst Biol Paris Seine,Equipe Biol Mangrove,Dept B, BP 592, F-97159 Pointe A Pitre, Guadeloupe, France.	olivier.gros@univ-ag.fr		GONZALEZ-RIZZO, Silvina/0000-0002-0097-138X				Aerne B, 1996, SCI MAR, V60, P7; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bates AE, 2011, BIOL BULL-US, V220, P118, DOI 10.1086/BBLv220n2p118; Bauermeister J, 2013, INT J SPELEOL, V42, P141, DOI 10.5038/1827-806X.42.2.6; BauerNebelsick M, 1996, EUR J PROTISTOL, V32, P18, DOI 10.1016/S0932-4739(96)80036-8; BERG CJ, 1984, AQUACULTURE, V39, P165, DOI 10.1016/0044-8486(84)90264-3; BOERO F, 1995, SCI MAR, V59, P65; Bosch TCG, 2012, BIOL BULL-US, V223, P78, DOI 10.1086/BBLv223n1p78; Bouillon J, 2000, PHYLOGENY CLASSIFICA; Burriesci MS, 2012, J EXP BIOL, V215, P3467, DOI 10.1242/jeb.070946; Carlos C, 2013, SCI REP-UK, V3, DOI 10.1038/srep01624; Cartwright P, 2010, INTEGR COMP BIOL, V50, P456, DOI 10.1093/icb/icq089; Cavanaugh CM, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 1, THIRD EDITION, P475, DOI 10.1007/0-387-30741-9_18; Chaston J, 2010, FEMS MICROBIOL REV, V34, P41, DOI 10.1111/j.1574-6976.2009.00193.x; Collins AG, 2006, SYST BIOL, V55, P97, DOI 10.1080/10635150500433615; Collins AG, 2002, J EVOLUTION BIOL, V15, P418, DOI 10.1046/j.1420-9101.2002.00403.x; Costello J, 1998, J EXP MAR BIOL ECOL, V225, P13, DOI 10.1016/S0022-0981(97)00204-9; COSTELLO J, 1991, MAR BIOL, V108, P119, DOI 10.1007/BF01313479; COSTELLO J, 1988, J EXP MAR BIOL ECOL, V123, P177, DOI 10.1016/0022-0981(88)90168-2; Daly M, 2007, ZOOTAXA, P127, DOI 10.11646/zootaxa.1668.1.11; Dattagupta S, 2009, ISME J, V3, P935, DOI 10.1038/ismej.2009.34; Davy SK, 2012, MICROBIOL MOL BIOL R, V76, P229, DOI 10.1128/MMBR.05014-11; Deming JW, 1997, MICROSC RES TECHNIQ, V37, P162, DOI 10.1002/(SICI)1097-0029(19970415)37:2<162::AID-JEMT4>3.0.CO;2-Q; Di Camillo CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039926; Dubilier N, 2008, NAT REV MICROBIOL, V6, P725, DOI 10.1038/nrmicro1992; DUCKLOW HW, 1979, LIMNOL OCEANOGR, V24, P715, DOI 10.4319/lo.1979.24.4.0715; Edgcom VP, 2011, ISME J, V5, P231, DOI 10.1038/ismej.2010.121; Fautin DG, 2009, TOXICON, V54, P1054, DOI 10.1016/j.toxicon.2009.02.024; FELBECK H, 1981, NATURE, V293, P291, DOI 10.1038/293291a0; FENCHEL TM, 1970, MAR BIOL, V7, P255, DOI 10.1007/BF00367496; Ferrier-Pages C, 1998, MAR ECOL PROG SER, V172, P265, DOI 10.3354/meps172265; FISHER CR, 1990, REV AQUAT SCI, V2, P399; Fraune S, 2007, P NATL ACAD SCI USA, V104, P13146, DOI 10.1073/pnas.0703375104; Frenkiel L, 1996, MAR BIOL, V125, P511; Galliot B, 2002, INT J DEV BIOL, V46, P39; Ganot P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002187; Giribet G, 1996, MOL BIOL EVOL, V13, P76, DOI 10.1093/oxfordjournals.molbev.a025573; Girnth AC, 2011, ENVIRON MICROBIOL, V13, P495, DOI 10.1111/j.1462-2920.2010.02353.x; Goodson MS, 2001, HYDROBIOLOGIA, V461, P79, DOI 10.1023/A:1012766609448; Gravier-Bonnet N, 2002, INVERTEBR REPROD DEV, V41, P101, DOI 10.1080/07924259.2002.9652740; Grzymski JJ, 2008, P NATL ACAD SCI USA, V105, P17516, DOI 10.1073/pnas.0802782105; Hentschel U, 1999, MAR ECOL PROG SER, V183, P149, DOI 10.3354/meps183149; Himmel D, 2009, BIOL CELL, V101, P43, DOI 10.1042/BC20080051; Jean MRN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117832; Kawaida H, 2013, MOL PHYLOGENET EVOL, V66, P906, DOI 10.1016/j.ympev.2012.11.018; Kimbell JR, 2003, INTEGR COMP BIOL, V43, P254, DOI 10.1093/icb/43.2.254; Koren O, 2006, APPL ENVIRON MICROB, V72, P5254, DOI 10.1128/AEM.00554-06; Krediet CJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2328; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Laurent MCZ, 2013, MAR ENVIRON RES, V87-88, P85, DOI 10.1016/j.marenvres.2013.03.007; Laurent MCZ, 2009, MAR ENVIRON RES, V67, P83, DOI 10.1016/j.marenvres.2008.11.006; Lucas CH, 2012, ADV MAR BIOL, V63, P133, DOI 10.1016/B978-0-12-394282-1.00003-X; Marques AC, 2002, TOXICON, V40, P213, DOI 10.1016/S0041-0101(01)00196-9; Maurin LC, 2010, MAR ENVIRON RES, V69, P382, DOI 10.1016/j.marenvres.2010.02.001; McFall-Ngai MJ, 2002, DEV BIOL, V242, P1, DOI 10.1006/dbio.2001.0522; Meyer E, 2012, BIOL BULL-US, V223, P44, DOI 10.1086/BBLv223n1p44; Miranda LS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010182; Moya A, 2008, NAT REV GENET, V9, P218, DOI 10.1038/nrg2319; Muller F, 2010, ENVIRON MICROBIOL, V12, P2371, DOI 10.1111/j.1462-2920.2010.02309.x; Novo M, 2007, PLANT PATHOL, V56, P998, DOI 10.1111/j.1365-3059.2007.01683.x; Ponsard J, 2013, ISME J, V7, P96, DOI 10.1038/ismej.2012.87; REES JT, 1982, PAC SCI, V36, P439; REES JT, 1979, J NAT HIST, V13, P295, DOI 10.1080/00222937900770231; Reshef L, 2006, ENVIRON MICROBIOL, V8, P2068, DOI 10.1111/j.1462-2920.2006.01148.x; Rinke C, 2006, APPL ENVIRON MICROB, V72, P2014, DOI 10.1128/AEM.72.3.2014-2021.2006; Rohwer F, 2002, MAR ECOL PROG SER, V243, P1, DOI 10.3354/meps243001; Ruehland C, 2010, ENVIRON MICROBIOL, V12, P2312, DOI 10.1111/j.1462-2920.2010.02256.x; Schauer R, 2011, ENVIRON MICROBIOL, V13, P2633, DOI 10.1111/j.1462-2920.2011.02530.x; Schuett C, 2012, HELGOLAND MARINE RES, V64, P205; Stachowicz JJ, 2000, OECOLOGIA, V124, P280, DOI 10.1007/s004420000372; Stewart FJ, 2005, TRENDS MICROBIOL, V13, P439, DOI 10.1016/j.tim.2005.07.007; Suescun-Bolivar LP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047182; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tarasov VG, 2005, CHEM GEOL, V224, P5, DOI 10.1016/j.chemgeo.2005.07.021; Technau U, 2011, DEVELOPMENT, V138, P1447, DOI 10.1242/dev.048959; Tokuda G, 2008, MAR ECOL-EVOL PERSP, V29, P106, DOI 10.1111/j.1439-0485.2007.00211.x; Turk T, 2009, TOXICON, V54, P1031, DOI 10.1016/j.toxicon.2009.06.031; Venn AA, 2008, J EXP BOT, V59, P1069, DOI 10.1093/jxb/erm328; Verde EA, 1998, MAR ECOL PROG SER, V168, P147, DOI 10.3354/meps168147; Vopel K, 2005, LIMNOL OCEANOGR, V50, P128, DOI 10.4319/lo.2005.50.1.0128; WILKERSON FP, 1980, MICROB ECOL, V6, P85, DOI 10.1007/BF02020377; Woyke T, 2006, NATURE, V443, P950, DOI 10.1038/nature05192; Yamamoto M, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00192; Young C, 2002, IRELANDS MARINE ATLA	84	9	10	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127625	10.1371/journal.pone.0127625	http://dx.doi.org/10.1371/journal.pone.0127625			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011278	Green Published, gold			2022-12-26	WOS:000355183900117
J	Arpino, JAJ; Baldwin, AJ; McGarrity, AR; Tippmann, EM; Jones, DD				Arpino, James A. J.; Baldwin, Amy J.; McGarrity, Adam R.; Tippmann, Eric M.; Jones, D. Dafydd			In-Frame Amber Stop Codon Replacement Mutagenesis for the Directed Evolution of Proteins Containing Non-Canonical Amino Acids: Identification of Residues Open to Bio-Orthogonal Modification	PLOS ONE			English	Article							EXPANDED GENETIC-CODE; FREE CLICK CHEMISTRY; CYTOCHROME B(562); ESCHERICHIA-COLI; BIOORTHOGONAL REACTIONS; APOCYTOCHROME B(562); MOLECULAR DIVERSITY; UNRELATED PROTEINS; ELECTRON-TRANSPORT; DOMAIN INSERTION	Expanded genetic code approaches are a powerful means to add new and useful chemistry to proteins at defined residues positions. One such use is the introduction of non-biological reactive chemical handles for site-specific biocompatible orthogonal conjugation of proteins. Due to our currently limited information on the impact of non-canonical amino acids (nAAs) on the protein structure-function relationship, rational protein engineering is a "hit and miss" approach to selecting suitable sites. Furthermore, dogma suggests surface exposed native residues should be the primary focus for introducing new conjugation chemistry. Here we describe a directed evolution approach to introduce and select for in-frame codon replacement to facilitate engineering proteins with nAAs. To demonstrate the approach, the commonly reprogrammed amber stop codon (TAG) was randomly introduced in-frame in two different proteins: the bionanotechnologically important cyt b(562) and therapeutic protein KGF. The target protein is linked at the gene level to sfGFP via a TEV protease site. In absence of a nAA, an in-frame TAG will terminate translation resulting in a non-fluorescent cell phenotype. In the presence of a nAA, TAG will encode for nAA incorporation so instilling a green fluorescence phenotype on E. coli. The presence of endogenously expressed TEV proteases separates in vivo target protein from its fusion to sfGFP if expressed as a soluble fusion product. Using this approach, we incorporated an azide reactive handle and identified residue positions amenable to conjugation with a fluorescence dye via strain-promoted azide-alkyne cycloaddition (SPAAC). Interestingly, best positions for efficient conjugation via SPAAC were residues whose native side chain were buried through analysis of their determined 3D structures and thus may not have been chosen through rational protein engineering. Molecular modeling suggests these buried native residues could become partially exposed on substitution to the azide containing nAA.	[Arpino, James A. J.; Baldwin, Amy J.; McGarrity, Adam R.; Jones, D. Dafydd] Cardiff Univ, Sch Biosci, Cardiff CF10 3AT, Wales; [Tippmann, Eric M.] Indiana Purdue Univ Ft Wayne, Dept Chem, Ft Wayne, IN 46815 USA	Cardiff University; Purdue University System; Indiana University Purdue University Fort Wayne	Jones, DD (corresponding author), Cardiff Univ, Sch Biosci, Main Bldg,Pk Pl, Cardiff CF10 3AT, Wales.	jonesdd@cf.ac.uk	Jones, Dafydd/A-4330-2010	Baldwin, Amy/0000-0002-2162-3771	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/H003746/1, BB/E007384]; Engineering and Physical Sciences Research Council (EPSRC) [EP/J015318/1]; Medical Research Council Developmental Pathway Funding Scheme (MRC DPFS) [G0900868]; Biotechnology and Biological Sciences Research Council [983743, BB/H003746/1, BB/E007384/1, BB/M000249/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/J015318/1] Funding Source: researchfish; BBSRC [BB/H003746/1, BB/M000249/1, BB/E007384/1] Funding Source: UKRI; EPSRC [EP/J015318/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council Developmental Pathway Funding Scheme (MRC DPFS)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC): BB/H003746/1 & BB/E007384, Engineering and Physical Sciences Research Council (EPSRC): EP/J015318/1, and Medical Research Council Developmental Pathway Funding Scheme (MRC DPFS): G0900868. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JC, 2004, P NATL ACAD SCI USA, V101, P7566, DOI 10.1073/pnas.0401517101; Antonczak AK, 2009, J BIOL CHEM, V284, P28795, DOI 10.1074/jbc.M109.027409; Arnesano F, 1999, BIOCHEMISTRY-US, V38, P8657, DOI 10.1021/bi982785f; Arnold FH, 2001, NATURE, V409, P253, DOI 10.1038/35051731; Arpino JAJ, 2014, STRUCTURE, V22, P889, DOI 10.1016/j.str.2014.03.014; Arpino JAJ, 2012, J AM CHEM SOC, V134, P13632, DOI 10.1021/ja301987h; Axup JY, 2012, P NATL ACAD SCI USA, V109, P16101, DOI 10.1073/pnas.1211023109; Baldwin AJ, 2009, MOL BIOSYST, V5, P764, DOI 10.1039/b904031e; Baldwin AJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn358; Baskin JM, 2007, P NATL ACAD SCI USA, V104, P16793, DOI 10.1073/pnas.0707090104; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Best MD, 2009, BIOCHEMISTRY-US, V48, P6571, DOI 10.1021/bi9007726; Bianco A, 2012, NAT CHEM BIOL, V8, P748, DOI [10.1038/nchembio.1043, 10.1038/NCHEMBIO.1043]; Blijlevens N, 2007, ANN ONCOL, V18, P817, DOI 10.1093/annonc/mdl332; Blomberg R, 2013, NATURE, V503, P418, DOI 10.1038/nature12623; Brodin JD, 2012, NAT CHEM, V4, P375, DOI [10.1038/NCHEM.1290, 10.1038/nchem.1290]; Chin JW, 2003, SCIENCE, V301, P964, DOI 10.1126/science.1084772; Chin JW, 2002, J AM CHEM SOC, V124, P9026, DOI 10.1021/ja027007w; D'Amelio N, 2002, BIOCHEMISTRY-US, V41, P5505, DOI 10.1021/bi011863n; Daggett KA, 2009, ACS CHEM BIOL, V4, P109, DOI 10.1021/cb800271f; Dalby PA, 2003, CURR OPIN STRUC BIOL, V13, P500, DOI 10.1016/S0959-440X(03)00101-5; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Della Pia EA, 2012, SMALL, V8, P2341, DOI 10.1002/smll.201102416; Della Pia EA, 2012, CHEM COMMUN, V48, P10624, DOI 10.1039/c2cc34302a; Della Pia EA, 2012, ACS NANO, V6, P355, DOI 10.1021/nn2036818; Della Pia EA, 2011, NANO LETT, V11, P176, DOI 10.1021/nl103334q; Edwards WR, 2010, BIOCHEMISTRY-US, V49, P6541, DOI 10.1021/bi100793y; Edwards WR, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn363; Feng SJ, 1997, CANCER RES, V57, P5369; FENG YQ, 1994, NAT STRUCT BIOL, V1, P30, DOI 10.1038/nsb0194-30; Forman CJ, 2012, ACS NANO, V6, P1332, DOI 10.1021/nn204140a; Giger L, 2013, NAT CHEM BIOL, V9, P494, DOI 10.1038/nchembio.1276; Greiss S, 2011, J AM CHEM SOC, V133, P14196, DOI 10.1021/ja2054034; Haapa S, 1999, NUCLEIC ACIDS RES, V27, P2777, DOI 10.1093/nar/27.13.2777; Hanwell MD, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-17; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jevsevar S, 2010, BIOTECHNOL J, V5, P113, DOI 10.1002/biot.200900218; Jewett JC, 2010, J AM CHEM SOC, V132, P3688, DOI 10.1021/ja100014q; Jones DD, 2014, METHODS MOL BIOL, V1179, P159, DOI 10.1007/978-1-4939-1053-3_11; Jones DD, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni077; Jones DD, 2005, ANGEW CHEM INT EDIT, V44, P6337, DOI 10.1002/anie.200463035; Jones DD, 2004, CHEMBIOCHEM, V5, P964, DOI 10.1002/cbic.200300569; Kim CH, 2013, CURR OPIN CHEM BIOL, V17, P412, DOI 10.1016/j.cbpa.2013.04.017; Lajoie MJ, 2013, SCIENCE, V342, P357, DOI 10.1126/science.1241459; Lang K, 2014, CHEM REV, V114, P4764, DOI 10.1021/cr400355w; Lang K, 2014, ACS CHEM BIOL, V9, P16, DOI 10.1021/cb4009292; LEDERER F, 1981, J MOL BIOL, V148, P427, DOI 10.1016/0022-2836(81)90185-6; Li FH, 2013, ANGEW CHEM INT EDIT, V52, P9700, DOI 10.1002/anie.201303477; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; Liu CC, 2008, P NATL ACAD SCI USA, V105, P17688, DOI 10.1073/pnas.0809543105; Mandell DJ, 2015, NATURE, V518, P55, DOI 10.1038/nature14121; Miyake-Stoner SJ, 2010, BIOCHEMISTRY-US, V49, P1667, DOI 10.1021/bi901947r; Neumann H, 2010, NATURE, V464, P441, DOI 10.1038/nature08817; Oohora K, 2014, CURR OPIN CHEM BIOL, V19, P154, DOI 10.1016/j.cbpa.2014.02.014; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Plotnikov AN, 2000, CELL, V101, P413, DOI 10.1016/S0092-8674(00)80851-X; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Reddington S, 2013, BIOCHEM SOC T, V41, P1177, DOI 10.1042/BST20130094; Reddington SC, 2015, CHEM SCI, V6, P1159, DOI 10.1039/c4sc02827a; Reddington SC, 2013, ANGEW CHEM INT EDIT, V52, P5974, DOI 10.1002/anie.201301490; Reddington SC, 2012, CHEM COMMUN, V48, P8419, DOI 10.1039/c2cc31887c; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; Schrodinger, 2010, PYMOL MOL GRAPHICS S; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077; Ye S, 2001, BIOCHEMISTRY-US, V40, P14429, DOI 10.1021/bi011000u; Yuen CM, 2007, NAT METHODS, V4, P995, DOI 10.1038/nmeth1207-995; Zhang WH, 2013, CURR OPIN STRUC BIOL, V23, P581, DOI 10.1016/j.sbi.2013.06.009	68	13	13	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127504	10.1371/journal.pone.0127504	http://dx.doi.org/10.1371/journal.pone.0127504			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011713	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000355183900101
J	Beko, G; Allen, JG; Weschler, CJ; Vallarino, J; Spengler, JD				Beko, Gabriel; Allen, Joseph G.; Weschler, Charles J.; Vallarino, Jose; Spengler, John D.			Impact of Cabin Ozone Concentrations on Passenger Reported Symptoms in Commercial Aircraft	PLOS ONE			English	Article							STRATOSPHERE-TROPOSPHERE EXCHANGE; US OFFICE BUILDINGS; AIR-QUALITY; INDOOR AIR; INITIATED CHEMISTRY; RELATIVE-HUMIDITY; INTERCONTINENTAL FLIGHTS; RESPIRATORY SYMPTOMS; AIRLINE CREWS; OUTDOOR OZONE	Due to elevated ozone concentrations at high altitudes, the adverse effect of ozone on air quality, human perception and health may be more pronounced in aircraft cabins. The association between ozone and passenger-reported symptoms has not been investigated under real conditions since smoking was banned on aircraft and ozone converters became more common. Indoor environmental parameters were measured at cruising altitude on 83 US domestic and international flights. Passengers completed a questionnaire about symptoms and satisfaction with the indoor air quality. Average ozone concentrations were relatively low (median: 9.5 ppb). On thirteen flights (16%) ozone levels exceeded 60 ppb, while the highest peak level reached 256 ppb for a single flight. The most commonly reported symptoms were dry mouth or lips (26%), dry eyes (22.1%) and nasal stuffiness (18.9%). 46% of passengers reported at least one symptom related to the eyes or mouth. A third of the passengers reported at least one upper respiratory symptom. Using multivariate logistic (individual symptoms) and linear (aggregated continuous symptom variables) regression, ozone was consistently associated with symptoms related to the eyes and certain upper respiratory endpoints. A concentration-response relationship was observed for nasal stuffiness and eye and upper respiratory symptom indicators. Average ozone levels, as opposed to peak concentrations, exhibited slightly weaker associations. Medium and long duration flights were significantly associated with more symptoms compared to short flights. The relationship between ultrafine particles and ozone on flights without meal service was indicative of ozone-initiated chemistry.	[Beko, Gabriel; Weschler, Charles J.] Tech Univ Denmark, Dept Civil Engn, Int Ctr Indoor Environm & Energy, DK-2800 Lyngby, Denmark; [Allen, Joseph G.; Vallarino, Jose; Spengler, John D.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Weschler, Charles J.] Rutgers State Univ, Environm & Occupat Hlth Sci Inst, Piscataway, NJ USA	Technical University of Denmark; Harvard University; Harvard T.H. Chan School of Public Health; Rutgers State University New Brunswick	Beko, G (corresponding author), Tech Univ Denmark, Dept Civil Engn, Int Ctr Indoor Environm & Energy, DK-2800 Lyngby, Denmark.	gab@byg.dtu.dk	Weschler, Charles J/A-9788-2009; Beko, Gabriel/C-8684-2009	Weschler, Charles J/0000-0002-9097-5850; Beko, Gabriel/0000-0001-6107-8336	American Society of Heating, Refrigerating and Air-Conditioning Engineers (ASHRAE) [1262-RP]; Federal Aviation Administration (FAA) [04-C-ACE, 07-C-RITE]; Danish Otto Monsteds Fond [14-70-0008]	American Society of Heating, Refrigerating and Air-Conditioning Engineers (ASHRAE); Federal Aviation Administration (FAA); Danish Otto Monsteds Fond	This project was funded by the American Society of Heating, Refrigerating and Air-Conditioning Engineers (ASHRAE; Project 1262-RP) and the Federal Aviation Administration (FAA; Cooperative Agreements 04-C-ACE and 07-C-RITE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Danish Otto Monsteds Fond partially supported the research stay of GB at Harvard School of Public Health during which the analyses were performed and the manuscript was drafted (Grant #14-70-0008).	Allen JG, 2013, J EXPO SCI ENV EPID, V23, P337, DOI 10.1038/jes.2012.62; Allen JG, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-17; Anderson SE, 2012, TOXICOL SCI, V127, P371, DOI 10.1093/toxsci/kfs102; Apte MG, 2008, INDOOR AIR, V18, P156, DOI 10.1111/j.1600-0668.2008.00521.x; Apte MG, 2000, INDOOR AIR, V10, P246, DOI 10.1034/j.1600-0668.2000.010004246.x; Beatty AL, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-81; Beko G, 2013, ENVIRON SCI TECHNOL, V47, P10240, DOI 10.1021/es402429h; Bell ML, 2005, EPIDEMIOLOGY, V16, P436, DOI 10.1097/01.ede.0000165817.40152.85; BENNETT G, 1962, AEROSPACE MED, V33, P969; Bhangar S, 2008, ENVIRON SCI TECHNOL, V42, P3938, DOI 10.1021/es702967k; Bhangar S, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/1/014006; BISCHOF W, 1973, Water Air and Soil Pollution, V2, P3, DOI 10.1007/BF00572385; Chen C, 2012, ENVIRON HEALTH PERSP, V120, P235, DOI 10.1289/ehp.1103970; Coleman BK, 2008, ATMOS ENVIRON, V42, P642, DOI 10.1016/j.atmosenv.2007.10.001; DAUBS J, 1980, AM J OPTOM PHYS OPT, V57, P95; de Ree H, 2000, AM SOC TEST MATER, V1393, P243, DOI 10.1520/STP14497S; Ebbert JO, 2007, ENVIRON HEALTH-GLOB, V6, P1, DOI 10.1186/1476-069X-6-28; Fadeyi MO, 2013, ENVIRON SCI TECHNOL, V47, P3933, DOI 10.1021/es3050828; Foucher PY, 2011, ATMOS CHEM PHYS, V11, P2455, DOI 10.5194/acp-11-2455-2011; Gent JF, 2003, JAMA-J AM MED ASSOC, V290, P1859, DOI 10.1001/jama.290.14.1859; Giaconia C, 2013, BUILD ENVIRON, V67, P69, DOI 10.1016/j.buildenv.2013.05.006; Grun G, 2012, BUILD ENVIRON, V47, P23, DOI 10.1016/j.buildenv.2011.05.004; Haghighat F, 1999, INDOOR BUILT ENVIRON, V8, P58, DOI 10.1159/000024610; HAUGLI L, 1994, AVIAT SPACE ENVIR MD, V65, P27; HOLTON JR, 1995, REV GEOPHYS, V33, P403, DOI 10.1029/95RG02097; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Hubbell BJ, 2005, ENVIRON HEALTH PERSP, V113, P73, DOI 10.1289/ehp.7186; Knudsen HN, 2003, INDOOR AIR, V13, P223, DOI 10.1034/j.1600-0668.2003.00182.x; Law KS, 2000, J GEOPHYS RES-ATMOS, V105, P1503, DOI 10.1029/1999JD900474; Lee SC, 1999, INDOOR AIR, V9, P180, DOI 10.1111/j.1600-0668.1999.t01-1-00004.x; Lee SC, 2000, AM SOC TEST MATER, V1393, P259, DOI 10.1520/STP14498S; Lindgren T, 2005, INDOOR AIR, V15, P65, DOI 10.1111/j.1600-0668.2005.00353.x; Lindgren T, 2002, INDOOR AIR, V12, P263, DOI 10.1034/j.1600-0668.2002.01121.x; Lindgren T, 2002, INT ARCH OCC ENV HEA, V75, P475, DOI 10.1007/s00420-002-0330-8; McDonnell WF, 1999, ENVIRON RES, V80, P110, DOI 10.1006/enrs.1998.3894; McNeely E, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-13; Mendell MJ, 2006, J OCCUP ENVIRON HYG, V3, P225, DOI 10.1080/15459620600628589; Morawska L, 2013, INDOOR AIR, V23, P462, DOI 10.1111/ina.12044; Nagda NL, 2003, AVIAT SPACE ENVIR MD, V74, P101; Nagda NL, 2001, INDOOR AIR, V11, P200, DOI 10.1034/j.1600-0668.2001.011003200.x; NAGDA NL, 1992, ATMOS ENVIRON A-GEN, V26, P2203, DOI 10.1016/0960-1686(92)90409-E; NASTROM GD, 1980, J AIRCRAFT, V17, P246, DOI 10.2514/3.44654; Nojgaard JK, 2005, TOXICOL LETT, V156, P241, DOI 10.1016/j.toxlet.2004.11.013; Norback D, 2006, SCAND J WORK ENV HEA, V32, P138, DOI 10.5271/sjweh.989; Persily A.K., 1997, ASHRAE T, V103, P193; Poppendieck D, 2007, ATMOS ENVIRON, V41, P3166, DOI 10.1016/j.atmosenv.2006.06.060; Pui DYH, 2008, ENVIRON HEALTH PERSP, V116, P863, DOI 10.1289/ehp.11169; Quality, 2002, STAND GUID US IND CA; Rai AC, 2013, ATMOS ENVIRON, V77, P885, DOI 10.1016/j.atmosenv.2013.05.062; Rankin WL, 2000, AM SOC TEST MATER, V1393, P269, DOI 10.1520/STP14499S; Reed D, 1980, Am J Ind Med, V1, P43, DOI 10.1002/ajim.4700010107; Samoli E, 2009, J EPIDEMIOL COMMUN H, V63, P960, DOI 10.1136/jech.2008.084012; Spengler JD, 2004, INDOOR AIR, V14, P67, DOI 10.1111/j.1600-0668.2004.00275.x; Spix C, 1998, ARCH ENVIRON HEALTH, V53, P54, DOI 10.1080/00039899809605689; Stohl A, 2003, B AM METEOROL SOC, V84, P1565, DOI 10.1175/BAMS-84-11-1565; Strom-Tejsen P, 2007, INDOOR AIR, V17, P92, DOI 10.1111/j.1600-0668.2006.00458.x; Strom-Tejsen P, 2008, J EXPO SCI ENV EPID, V18, P272, DOI 10.1038/sj.jes.7500586; Sundell J, 2011, INDOOR AIR, V21, P191, DOI 10.1111/j.1600-0668.2010.00703.x; Sunyer J, 1997, THORAX, V52, P760, DOI 10.1136/thx.52.9.760; Tamas G, 2006, INDOOR AIR, V16, P168, DOI 10.1111/j.1600-0668.2005.00413.x; TASHKIN DP, 1983, INT ARCH OCC ENV HEA, V52, P117, DOI 10.1007/BF00405416; US EPA (US ENVIRONMENT PROTECTION AGENCY), 2008, FED REG, V73; VANHEUSDEN S, 1978, AVIAT SPACE ENVIR MD, V49, P1056; Veres PR, 2013, ATMOS ENVIRON, V77, P1052, DOI 10.1016/j.atmosenv.2013.05.076; Wahlstedt K, 2010, AM J IND MED, V53, P716, DOI 10.1002/ajim.20822; Wang CY, 2014, ATMOS ENVIRON, V84, P222, DOI 10.1016/j.atmosenv.2013.11.009; Weisel C, 2013, ENVIRON SCI TECHNOL, V47, P4711, DOI 10.1021/es3046795; Weschler CJ, 2016, INDOOR AIR, V26, P6, DOI 10.1111/ina.12185; Weschler CJ, 2007, ENVIRON SCI TECHNOL, V41, P6177, DOI 10.1021/es0708520; Weschler CJ, 2006, ENVIRON HEALTH PERSP, V114, P1489, DOI 10.1289/ehp.9256; Weschler CJ, 1999, ATMOS ENVIRON, V33, P2301, DOI 10.1016/S1352-2310(99)00083-7; Weschler CJ, 2004, INDOOR AIR, V14, P184, DOI 10.1111/j.1600-0668.2004.00287.x; Weschler CJ, 2000, INDOOR AIR, V10, P269, DOI 10.1034/j.1600-0668.2000.010004269.x; WESCHLER CJ, 2003, INDOOR ENV AIRBORNE, P171; WHO, 2008, HLTH RISK OZ LONG RA; Wisthaler A, 2005, ENVIRON SCI TECHNOL, V39, P4823, DOI 10.1021/es047992j; Wisthaler A, 2010, P NATL ACAD SCI USA, V107, P6568, DOI 10.1073/pnas.0904498106; Wolkoff P, 2008, TOXICOL LETT, V181, P171, DOI 10.1016/j.toxlet.2008.07.018; Wolkoff P, 2013, TOXICOL LETT, V216, P54, DOI 10.1016/j.toxlet.2012.11.008; YOUNG WA, 1962, AEROSPACE MED, V33, P311	80	26	26	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128454	10.1371/journal.pone.0128454	http://dx.doi.org/10.1371/journal.pone.0128454			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011001	Green Published, Green Submitted, gold			2022-12-26	WOS:000355183900235
J	Chang, SH; Wang, XY				Chang, Shuhua; Wang, Xinyu			Modelling and Computation in the Valuation of Carbon Derivatives with Stochastic Convenience Yields	PLOS ONE			English	Article							FINITE-VOLUME METHOD; POWER PENALTY METHOD; FUTURES; OPTIONS; PRICES; ASSETS	The anthropogenic greenhouse gas (GHG) emission has risen dramatically during the last few decades, which mainstream researchers believe to be the main cause of climate change, especially the global warming. The mechanism of market-based carbon emission trading is regarded as a policy instrument to deal with global climate change. Although several empirical researches about the carbon allowance and its derivatives price have been made, theoretical results seem to be sparse. In this paper, we theoretically develop a mathematical model to price the CO2 emission allowance derivatives with stochastic convenience yields by the principle of absence of arbitrage opportunities. In the case of American options, we formulate the pricing problem to a linear parabolic variational inequality (VI) in two spatial dimensions and develop a power penalty method to solve it. Then, a fitted finite volume method is designed to solve the nonlinear partial differential equation (PDE) resulting from the power penalty method and governing the futures, European and American option valuation. Moreover, some numerical results are performed to illustrate the efficiency and usefulness of this method. We find that the stochastic convenience yield does effect the valuation of carbon emission derivatives. In addition, some sensitivity analyses are also made to examine the effects of some parameters on the valuation results.	[Chang, Shuhua; Wang, Xinyu] Tianjin Univ Finance & Econ, Res Ctr Math & Econ, Tianjin 300222, Peoples R China; [Chang, Shuhua] Chinese Acad Sci, Inst Policy & Management, Beijing 100190, Peoples R China	Tianjin University of Finance & Economics; Chinese Academy of Sciences; CAS Institutes of Science & Development	Chang, SH (corresponding author), Tianjin Univ Finance & Econ, Res Ctr Math & Econ, Tianjin 300222, Peoples R China.	shuhua55@126.com; xywang1990@gmail.com	Zhang, Shuhua/U-2908-2019; Wang, Xinyu/U-2910-2019	Wang, Xinyu/0000-0003-0490-1626; Zhang, Shuhua/0000-0003-1572-0804	National Basic Research Program [2012CB955804]; Major Research Plan of the National Natural Science Foundation of China [91430108]; National Natural Science Foundation of China [11171251]; Tianjin University of Finance and Economics [ZD1302]	National Basic Research Program(National Basic Research Program of China); Major Research Plan of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin University of Finance and Economics	This project was supported in part by the National Basic Research Program (2012CB955804), the Major Research Plan of the National Natural Science Foundation of China (91430108), the National Natural Science Foundation of China (11171251), and the Major Program of Tianjin University of Finance and Economics (ZD1302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benz E, 2008, THESIS; Benz E, 2009, ENERG ECON, V31, P4, DOI 10.1016/j.eneco.2008.07.003; BLACK F, 1976, J FINANC ECON, V3, P167, DOI 10.1016/0304-405X(76)90024-6; Brennan M.J., 1979, J BANKING FINANCE, V3, P133, DOI [DOI 10.1016/0378-4266(79)90011-6, 10.1016/0378-4266(79)90011-6]; Byun SJ, 2013, ENERG ECON, V40, P207, DOI 10.1016/j.eneco.2013.06.017; Chang K, 2013, SPANISH REV FINANCIA, V11, P39, DOI [10.1016/j.srfe.2013.01.001, DOI 10.1016/J.SRFE.2013.01.001]; Chevallier J, 2010, ECON MODEL, V27, P717, DOI 10.1016/j.econmod.2010.01.012; Cortazar G, 2003, ENERG ECON, V25, P215, DOI 10.1016/S0140-9883(02)00096-8; Cramton P, 2002, ENERG POLICY, V30, P333, DOI 10.1016/S0301-4215(01)00100-8; Crocker T., 1966, EC AIR POLLUT, V61, P81; Daskalakis G, 2009, J BANK FINANC, V33, P1230, DOI 10.1016/j.jbankfin.2009.01.001; Edwards TH, 2001, ENERG ECON, V23, P371, DOI 10.1016/S0140-9883(00)00077-3; HAHN RW, 1984, Q J ECON, V99, P753, DOI 10.2307/1883124; Hilliard JE, 1998, J FINANC QUANT ANAL, V33, P61, DOI 10.2307/2331378; Huang CS, 2010, IMA J NUMER ANAL, V30, P1101, DOI 10.1093/imanum/drp016; Huang CC, 2010, OPER RES LETT, V38, P72, DOI 10.1016/j.orl.2009.09.009; Huang CS, 2006, COMPUTING, V77, P297, DOI 10.1007/s00607-005-0164-4; Hull J. C., 2011, OPTIONS FUTURES OTHE; Jin Q, 2012, CHAOS SOLITON FRACT, V45, P395, DOI 10.1016/j.chaos.2012.01.004; Klaassen G, 2005, ECOL ECON, V53, P47, DOI 10.1016/j.ecolecon.2004.12.017; Leveque R. J., 2004, FINITE VOLUME METHOD; Liu C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097822; Liu JG, 2011, J COMPUT APPL MATH, V235, P5422, DOI 10.1016/j.cam.2011.05.051; Medina V, 2014, ENERG ECON, V42, P378, DOI 10.1016/j.eneco.2014.01.008; Mnif W, 2011, COMPUT RISK MANAG, P95, DOI 10.1007/978-3-642-19339-2_11; MONTGOMERY WD, 1972, J ECON THEORY, V5, P395, DOI 10.1016/0022-0531(72)90049-X; Rubin JD, 1996, J ENVIRON ECON MANAG, V31, P269, DOI 10.1006/jeem.1996.0044; SAMUELSON PA, 1965, IMR-IND MANAG REV, V6, P41; Schwartz ES, 1997, J FINANC, V52, P923, DOI 10.2307/2329512; Szolnoki A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00576; Tillmann M, 2008, THESIS I NUMERISCHE; Wagner W, 2007, CO2 EMISSIONSZERTIFI; Wang S, 2006, J OPTIMIZ THEORY APP, V129, P227, DOI 10.1007/s10957-006-9062-3; Wang S, 2004, IMA J NUMER ANAL, V24, P699, DOI 10.1093/imanum/24.4.699; Wang S, 2008, OPER RES LETT, V36, P211, DOI 10.1016/j.orl.2007.06.006; Wang Z, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.042145; Wang Z, 2013, SCI REP-UK, V3, DOI 10.1038/srep02470; Wang Z, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.011149; Wang Z, 2011, J THEOR BIOL, V277, P19, DOI 10.1016/j.jtbi.2011.02.016; [王志勇 Wang Zhiyong], 2013, [南水北调与水利科技, South-to-North Water Diversion and Water Science & Technology], V11, P1; Zhang K, 2009, NUMER MATH-THEORY ME, V2, P202	41	7	7	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0125679	10.1371/journal.pone.0125679	http://dx.doi.org/10.1371/journal.pone.0125679			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010900	gold, Green Submitted, Green Published			2022-12-26	WOS:000355183900013
J	Feng, Y; Desjardins, CA; Cooper, O; Kontor, A; Nocco, SE; Naya, FJ				Feng, Yi; Desjardins, Cody A.; Cooper, Olivia; Kontor, Akuah; Nocco, Sarah E.; Naya, Francisco J.			EGR1 Functions as a Potent Repressor of MEF2 Transcriptional Activity	PLOS ONE			English	Article							EXPRESSION; CARDIOMYOCYTES; REGULATOR; COSTAMERES; FAMILY; TARGET; SITES; CELLS	The myocyte enhancer factor 2 (MEF2) transcription factor requires interactions with co-factors for precise regulation of its target genes. Our lab previously reported that the mammalian MEF2A isoform regulates the cardiomyocyte costamere, a critical muscle-specific focal adhesion complex involved in contractility, through its transcriptional control of genes encoding proteins localized to this cytoskeletal structure. To further dissect the transcriptional mechanisms of costamere gene regulation and identify potential co-regulators of MEF2A, a bioinformatics analysis of transcription factor binding sites was performed using the proximal promoter regions of selected costamere genes. One of these predicted sites belongs to the early growth response (EGR) transcription factor family. The EGR1 isoform has been shown to be involved in a number of pathways in cardiovascular homeostasis and disease, making it an intriguing candidate MEF2 coregulator to further characterize. Here, we demonstrate that EGR1 interacts with MEF2A and is a potent and specific repressor of MEF2 transcriptional activity. Furthermore, we show that costamere gene expression in cardiomyocytes is dependent on EGR1 transcriptional activity. This study identifies a mechanism by which MEF2 activity can be modulated to ensure that costamere gene expression is maintained at levels commensurate with cardiomyocyte contractile activity.	[Feng, Yi; Desjardins, Cody A.; Cooper, Olivia; Kontor, Akuah; Nocco, Sarah E.; Naya, Francisco J.] Boston Univ, Dept Biol, Program Cell & Mol Biol, Boston, MA 02215 USA	Boston University	Naya, FJ (corresponding author), Boston Univ, Dept Biol, Program Cell & Mol Biol, 5 Cummington St, Boston, MA 02215 USA.	fnaya@bu.edu			National Institutes of Health [HL73304]; American Heart Association; Undergraduate Research Opportunities Program at Boston University; Beckman Scholars Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073304] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Undergraduate Research Opportunities Program at Boston University; Beckman Scholars Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a grant (HL73304) from the National Institutes of Health to FJN. Additional support was provided by the American Heart Association to YF, the Undergraduate Research Opportunities Program at Boston University to YF, OC, and AK, and the Beckman Scholars Program to SEN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buitrago M, 2005, NAT MED, V11, P837, DOI 10.1038/nm1272; Chabane N, 2009, J CELL BIOCHEM, V106, P453, DOI 10.1002/jcb.22027; Chapman NR, 2000, J BIOL CHEM, V275, P4719, DOI 10.1074/jbc.275.7.4719; Czubryt MP, 2004, RECENT PROG HORM RES, V59, P105, DOI 10.1210/rp.59.1.105; DANOWSKI BA, 1992, J CELL BIOL, V118, P1411, DOI 10.1083/jcb.118.6.1411; Ervasti JM, 2003, J BIOL CHEM, V278, P13591, DOI 10.1074/jbc.R200021200; Ewen EP, 2011, J BIOL CHEM, V286, P29644, DOI 10.1074/jbc.M111.268094; GASHLER A, 1995, PROG NUCLEIC ACID RE, V50, P191, DOI 10.1016/S0079-6603(08)60815-6; Giraldo A, 2012, BIOCHEM J, V444, P343, DOI 10.1042/BJ20120125; Greer PL, 2008, NEURON, V59, P846, DOI 10.1016/j.neuron.2008.09.002; Grote K, 2004, J BIOL CHEM, V279, P55675, DOI 10.1074/jbc.M406532200; Hsu SC, 2013, CARDIOVASC RES, V100, P222, DOI 10.1093/cvr/cvt190; Huang HT, 2006, J BIOL CHEM, V281, P39370, DOI 10.1074/jbc.M603244200; Kasneci A, 2009, CARDIOVASC RES, V81, P695, DOI 10.1093/cvr/cvn357; Khachigian LM, 2006, CIRC RES, V98, P186, DOI 10.1161/01.RES.0000200177.53882.c3; Lin L, 2005, MOL CELL BIOL, V25, P10285; McCalmon SA, 2010, CIRC RES, V106, P952, DOI 10.1161/CIRCRESAHA.109.209007; McKinsey TA, 2001, CURR OPIN GENET DEV, V11, P497, DOI 10.1016/S0959-437X(00)00224-0; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Miano JM, 2007, AM J PHYSIOL-CELL PH, V292, pC70, DOI 10.1152/ajpcell.00386.2006; Naya FJ, 1999, DEVELOPMENT, V126, P2045; Naya FJ, 2002, NAT MED, V8, P1303, DOI 10.1038/nm789; O'Donovan KJ, 1999, TRENDS NEUROSCI, V22, P167, DOI 10.1016/S0166-2236(98)01343-5; Pacini L, 2013, CAN J PHYSIOL PHARM, V91, P1135, DOI 10.1139/cjpp-2012-0419; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Reynolds JG, 2007, BBA-MOL CELL RES, V1773, P891, DOI 10.1016/j.bbamcr.2007.04.004; Saadane N, 2000, AM J PHYSIOL-HEART C, V278, pH796, DOI 10.1152/ajpheart.2000.278.3.H796; Shalizi AK, 2005, CURR TOP DEV BIOL, V69, P239, DOI 10.1016/S0070-2153(05)69009-6; van Oort RJ, 2006, CIRCULATION; Wang CL, 2005, CARDIOVASC RES, V65, P187, DOI 10.1016/j.cardiores.2004.09.026; Yu JX, 2004, MOL CELL, V15, P83, DOI 10.1016/j.molcel.2004.06.030	31	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127641	10.1371/journal.pone.0127641	http://dx.doi.org/10.1371/journal.pone.0127641			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011708	Green Published, gold, Green Submitted			2022-12-26	WOS:000355183900121
J	Gaisl, T; Schlatzer, C; Schwarz, EI; Possner, M; Stehli, J; Sievi, NA; Clarenbach, CF; Dey, D; Slomka, PJ; Kaufmann, PA; Kohler, M				Gaisl, Thomas; Schlatzer, Christian; Schwarz, Esther I.; Possner, Mathias; Stehli, Julia; Sievi, Noriane A.; Clarenbach, Christian F.; Dey, Damini; Slomka, Piotr J.; Kaufmann, Philipp A.; Kohler, Malcolm			Coronary Artery Calcification, Epicardial Fat Burden, and Cardiovascular Events in Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							RISK-FACTORS; PERICARDIAL FAT; BETA-BLOCKERS; MORTALITY; COPD; ATHEROSCLEROSIS; PREDICTOR; CALCIUM; HEART; QUANTIFICATION	Rationale Patients with chronic obstructive pulmonary disease (COPD) suffer from significantly more cardiovascular comorbidity and mortality than would be anticipated from conventional risk factors. The aim of this study was to determine whether COPD patients have a higher coronary artery calcium score (CACS) and epicardial fat burden, compared to control subjects, and their association with cardiovascular events. Methods From a registry of 1906 patients 81 patients with clinically diagnosed COPD were one-to-one matched to 81 non-COPD control subjects with a smoking history, according to their age, sex, and the number of classic cardiovascular risk factors (arterial hypertension, diabetes mellitus, dyslipidemia, family history of premature coronary artery disease). CACS, epicardial fat, and subsequent major adverse cardiovascular events (MACE) during follow-up were compared between groups. Results Patients with COPD (Global Initiative for Chronic Obstructive Lung Disease-classification I: 5%, II: 23%, III: 16% and IV: 56%) showed no difference in CACS (median difference 68 Agatston Units [95% confidence interval -176.5 to 192.5], p=0.899) or epicardial fat volume (mean difference -0.5 cm(3) [95% confidence interval -20.9 to 21.9], p=0.961) compared with controls. After a median follow-up of 42.6 months a higher incidence of MACE was observed in COPD patients (RR=2.80, p=0.016) compared with controls. Cox proportional hazard regression identified cardiac ischemias and CACS as independent predictors for MACE. Conclusion COPD patients experienced a higher MACE incidence compared to controls despite no baseline differences in coronary calcification and epicardial fat burden. Other mechanisms such as undersupply of medication seem to account for an excess cardiovascular comorbidity in COPD patients.	[Gaisl, Thomas; Schlatzer, Christian; Schwarz, Esther I.; Sievi, Noriane A.; Clarenbach, Christian F.; Kohler, Malcolm] Univ Zurich Hosp, Dept Pulmonol, CH-8091 Zurich, Switzerland; [Possner, Mathias; Stehli, Julia; Kaufmann, Philipp A.] Univ Zurich Hosp, Dept Nucl Med, CH-8091 Zurich, Switzerland; [Dey, Damini; Slomka, Piotr J.] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA; [Dey, Damini; Slomka, Piotr J.] Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA; [Kohler, Malcolm] Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland; [Kohler, Malcolm] Univ Zurich, Ctr Interdisciplinary Sleep Res, Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich	Kohler, M (corresponding author), Univ Zurich Hosp, Dept Pulmonol, CH-8091 Zurich, Switzerland.	Malcolm.Kohler@usz.ch	Possner, Mathias/X-9812-2019; Stehli, Julia/GRR-8802-2022; Schwarz, Esther/AAA-2325-2021; Gaisl, Thomas/I-7762-2019	Possner, Mathias/0000-0002-1683-5868; Gaisl, Thomas/0000-0002-9017-6143; Kaufmann, Philipp/0000-0002-9451-5210; Dey, Damini/0000-0003-2236-6970; Schwarz, Esther Irene/0000-0001-8840-981X	NIH; Siemens Medical Systems	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Siemens Medical Systems(Siemens AG)	PS and DD report grants from NIH, grants from Siemens Medical Systems, outside the submitted work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Austin PC, 2007, STAT MED, V26, P734, DOI 10.1002/sim.2580; Barr RG, 2012, EUR RESPIR J, V39, P846, DOI 10.1183/09031936.00165410; Chae EJ, 2013, J COMPUT ASSIST TOMO, V37, P743, DOI 10.1097/RCT.0b013e318299f9e7; Chatila Wissam M, 2008, Proc Am Thorac Soc, V5, P549, DOI 10.1513/pats.200709-148ET; Cheng VY, 2010, JACC-CARDIOVASC IMAG, V3, P352, DOI 10.1016/j.jcmg.2009.12.013; Clarenbach CF, 2013, EUR RESPIR J, V42, P1194, DOI 10.1183/09031936.00144612; Clarenbach CF, 2012, EXPERT REV RESP MED, V6, P37, DOI [10.1586/ers.11.82, 10.1586/ERS.11.82]; Curkendall SM, 2006, ANN EPIDEMIOL, V16, P63, DOI 10.1016/j.annepidem.2005.04.008; de Lucas-Ramos P, 2008, ARCH BRONCONEUMOL, V44, P233, DOI 10.1016/S1579-2129(08)60037-3; Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100; Dey D, 2008, INVEST RADIOL, V43, P145, DOI 10.1097/RLI.0b013e31815a054a; Dey D, 2010, ATHEROSCLEROSIS, V209, P136, DOI 10.1016/j.atherosclerosis.2009.08.032; Enriquez JR, 2011, CHEST, V140, P604, DOI 10.1378/chest.10-2644; Hesse B, 2005, EUR J NUCL MED MOL I, V32, P855, DOI 10.1007/s00259-005-1779-y; Iskander S, 1998, J AM COLL CARDIOL, V32, P57, DOI 10.1016/S0735-1097(98)00177-6; Mannino DM, 2006, RESP MED, V100, P115, DOI 10.1016/j.rmed.2005.03.035; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; O'Hare PE, 2014, J COMPUT ASSIST TOMO, V38, P753, DOI 10.1097/RCT.0000000000000119; Patel ARC, 2011, EXPERT REV RESP MED, V5, P647, DOI [10.1586/ERS.11.62, 10.1586/ers.11.62]; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Rasmussen T, 2013, EUR HEART J-CARD IMG, V14, P1159, DOI 10.1093/ehjci/jet057; Rosito GA, 2008, CIRCULATION, V117, P605, DOI 10.1161/CIRCULATIONAHA.107.743062; Schunemann HJ, 2000, CHEST, V118, P656, DOI 10.1378/chest.118.3.656; Selvaraj CL, 2005, AM J CARDIOL, V96, P756, DOI 10.1016/j.amjcard.2005.05.016; Smeeth L, 2004, NEW ENGL J MED, V351, P2611, DOI 10.1056/NEJMoa041747; TOCKMAN MS, 1995, AM J RESP CRIT CARE, V151, P390, DOI 10.1164/ajrccm.151.2.7842197; Topsakal R, 2009, HEART VESSELS, V24, P164, DOI 10.1007/s00380-008-1103-4; van der Woude HJ, 2005, CHEST, V127, P818, DOI 10.1378/chest.127.3.818; van Gestel AJR, 2012, DISCOV MED, V14, P359; van Gestel YRBM, 2008, AM J RESP CRIT CARE, V178, P695, DOI 10.1164/rccm.200803-384OC; Watz H, 2009, EUR RESPIR J, V33, P262, DOI 10.1183/09031936.00024608; Williams MC, 2014, THORAX, V69, P718, DOI 10.1136/thoraxjnl-2012-203151; Yasue H, 2008, J CARDIOL, V51, P2, DOI 10.1016/j.jjcc.2008.01.001; Yates T, 2014, LANCET, V383, P1059, DOI 10.1016/S0140-6736(13)62061-9; Zagaceta J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065593	37	20	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0126613	10.1371/journal.pone.0126613	http://dx.doi.org/10.1371/journal.pone.0126613			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011039	gold, Green Published, Green Accepted			2022-12-26	WOS:000355183900036
J	Karsanina, MV; Gerke, KM; Skvortsova, EB; Mallants, D				Karsanina, Marina V.; Gerke, Kirill M.; Skvortsova, Elena B.; Mallants, Dirk			Universal Spatial Correlation Functions for Describing and Reconstructing Soil Microstructure	PLOS ONE			English	Article							UNSATURATED HYDRAULIC CONDUCTIVITY; STOCHASTIC RECONSTRUCTION; SOLUTE TRANSPORT; POROUS-MEDIA; PORE-SPACE; PERMEABILITY; POROSITY; SIMULATION; SANDSTONE; MODELS	Structural features of porous materials such as soil define the majority of its physical properties, including water infiltration and redistribution, multi-phase flow (e.g. simultaneous water/air flow, or gas exchange between biologically active soil root zone and atmosphere) and solute transport. To characterize soil microstructure, conventional soil science uses such metrics as pore size and pore-size distributions and thin section-derived morphological indicators. However, these descriptors provide only limited amount of information about the complex arrangement of soil structure and have limited capability to reconstruct structural features or predict physical properties. We introduce three different spatial correlation functions as a comprehensive tool to characterize soil microstructure: 1) two-point probability functions, 2) linear functions, and 3) two-point cluster functions. This novel approach was tested on thin-sections (2.21x2.21 cm(2)) representing eight soils with different pore space configurations. The two-point probability and linear correlation functions were subsequently used as a part of simulated annealing optimization procedures to reconstruct soil structure. Comparison of original and reconstructed images was based on morphological characteristics, cluster correlation functions, total number of pores and pore-size distribution. Results showed excellent agreement for soils with isolated pores, but relatively poor correspondence for soils exhibiting dual-porosity features (i.e. superposition of pores and microcracks). Insufficient information content in the correlation function sets used for reconstruction may have contributed to the observed discrepancies. Improved reconstructions may be obtained by adding cluster and other correlation functions into reconstruction sets. Correlation functions and the associated stochastic reconstruction algorithms introduced here are universally applicable in soil science, such as for soil classification, pore-scale modelling of soil properties, soil degradation monitoring, and description of spatial dynamics of soil microbial activity.	[Karsanina, Marina V.] Russian Acad Sci, Inst Geospheres Dynam, Moscow, Russia; [Karsanina, Marina V.] AIR Technol, Moscow, Russia; [Gerke, Kirill M.; Mallants, Dirk] CSIRO Land & Water, Adelaide, SA, Australia; [Skvortsova, Elena B.] Russian Acad Sci, Dokuchaev Soil Sci Inst, Moscow, Russia	Russian Academy of Sciences; Sadovsky Institute of Geosphere Dynamics of the Russian Academy of Sciences; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Dokuchaev Soil Science Institute; Russian Academy of Sciences	Gerke, KM (corresponding author), CSIRO Land & Water, Adelaide, SA, Australia.	kirill.gerke@csiro.au	Mallants, Dirk/A-5727-2012; Gerke, Kirill M./F-5836-2013; Skvortsova, Elena/X-3301-2019	Mallants, Dirk/0000-0001-7282-1981; Gerke, Kirill M./0000-0002-8379-2132; 	Russian Scientific Foundation [14-17-00658]; Russian Foundation for Basic Reserach [12-05-01130-a, 13-04-00409-a, 12-04-32264_MOpi_a, 13-05-01176-a]; Russian Science Foundation [14-17-00658, 14-16-00065] Funding Source: Russian Science Foundation	Russian Scientific Foundation(Russian Science Foundation (RSF)); Russian Foundation for Basic Reserach; Russian Science Foundation(Russian Science Foundation (RSF))	1) Russian Scientific Foundation (http://www.rscf.ru/), grant number 14-17-00658 (developing optimized computation of diagonal correlation functions), MVK, KMG. 2) Russian Foundation for Basic Reserach (www.rfbr.ru), grants 12-05-01130-a, 13-04-00409-a, 12-04-32264_MO pi_a and 13-05-01176-a (soil tin-sections, expendables), MVK, EBS. AIR Technology provided support in the form of salaries for author Marina V. Karsanina, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bakke S, 1997, SPE J, V2, P136, DOI 10.2118/35479-PA; Baranau V, 2013, SOFT MATTER, V9, P3361, DOI 10.1039/c3sm27374a; BERRYMAN JG, 1988, J PHYS D APPL PHYS, V21, P87, DOI 10.1088/0022-3727/21/1/013; Biswal B, 1998, PHYSICA A, V255, P221, DOI 10.1016/S0378-4371(98)00111-3; Biswal B, 1999, PHYSICA A, V273, P452, DOI 10.1016/S0378-4371(99)00248-4; Biswal B, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.061303; Blair JM, 2007, SOIL SCI SOC AM J, V71, P1807, DOI 10.2136/sssaj2006.0113; Blunt MJ, 2013, ADV WATER RESOUR, V51, P197, DOI 10.1016/j.advwatres.2012.03.003; Bogner C, 2012, GEODERMA, V175, P37, DOI 10.1016/j.geoderma.2012.01.019; BRISTOW KL, 1994, SOIL SCI SOC AM J, V58, P1288, DOI 10.2136/sssaj1994.03615995005800050002x; BRYANT SL, 1993, AICHE J, V39, P387, DOI 10.1002/aic.690390303; Bullock P., 1985, HDB SOIL THIN SECTIO; Capek P, 2011, TRANSPORT POROUS MED, V88, P87, DOI 10.1007/s11242-011-9726-9; Capek P, 2014, COMP MATER SCI, V89, P142, DOI 10.1016/j.commatsci.2014.03.003; Chen DD, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.013305; Chou HY, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR011653; Chu KW, 1999, J COMPUT PHYS, V148, P646, DOI 10.1006/jcph.1998.6134; Coker DA, 1996, J GEOPHYS RES-SOL EA, V101, P17497, DOI 10.1029/96JB00811; CRAWFORD JW, 1995, EUR J SOIL SCI, V46, P369, DOI 10.1111/j.1365-2389.1995.tb01333.x; Crosbie RS, 2012, HYDROL EARTH SYST SC, V16, P3341, DOI 10.5194/hess-16-3341-2012; Cule D, 1999, J APPL PHYS, V86, P3428, DOI 10.1063/1.371225; Derossi A, 2013, FOOD BIOPHYS, V8, P311, DOI 10.1007/s11483-013-9307-2; DURNER W, 1994, WATER RESOUR RES, V30, P211, DOI 10.1029/93WR02676; Egorov VV, 1977, KLASSIFIKATSIYA DIAG; Falconer RE, 2012, SOIL SCI, V177, P111, DOI 10.1097/SS.0b013e318241133a; Gerke KM, 2012, EURASIAN SOIL SCI+, V45, P861, DOI 10.1134/S1064229312090049; Gerke KM, 2012, EURASIAN SOIL SCI+, V45, P700, DOI 10.1134/S1064229312070034; Gerke KM, 2014, EPL-EUROPHYS LETT, V106, DOI 10.1209/0295-5075/106/66002; Gerke KM, 2013, DETERMINING PHYS PRO, DOI [10.2118/167058-MS, DOI 10.2118/167058-MS]; Ghanbarian-Alavijeh B, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.066316; Gommes CJ, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.051140; Grunat DA, 2013, VADOSE ZONE J, V12, DOI 10.2136/vzj2013.03.0059; Guo EY, 2014, MATER CHARACT, V89, P33, DOI 10.1016/j.matchar.2013.12.011; Hilfer R, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.65.061510; HOSHEN J, 1976, PHYS REV B, V14, P3438, DOI 10.1103/PhysRevB.14.3438; Hunt AG, 2013, GEODERMA, V207, P268, DOI 10.1016/j.geoderma.2013.05.023; JERAULD GR, 1990, TRANSPORT POROUS MED, V5, P103, DOI 10.1007/BF00144600; Jiao Y, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.031110; Jiao Y, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.031135; Jiao Y, 2009, P NATL ACAD SCI USA, V106, P17634, DOI 10.1073/pnas.0905919106; Jiao Y, 2014, J APPL PHYS, V115, DOI 10.1063/1.4867611; Jiao Y, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.011106; Jury W. A., 2004, SOIL PHYS; Kandelous MM, 2012, AGR WATER MANAGE, V109, P81, DOI 10.1016/j.agwat.2012.02.009; Khirevich S, 2011, J CHROMATOGR A, V1218, P6489, DOI 10.1016/j.chroma.2011.07.066; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Kohne JM, 2011, VADOSE ZONE J, V10, P1082, DOI 10.2136/vzj2010.0158; Lafond JA, 2012, EUR J SOIL SCI, V63, P861, DOI 10.1111/j.1365-2389.2012.01496.x; Laudone GM, 2013, EUR J SOIL SCI, V64, P345, DOI 10.1111/ejss.12055; LEE SB, 1988, J CHEM PHYS, V89, P6427, DOI 10.1063/1.455411; Li Q, 2011, INT J HEAT MASS TRAN, V54, P2890, DOI 10.1016/j.ijheatmasstransfer.2011.03.010; Lindquist WB, 1996, J GEOPHYS RES-SOL EA, V101, P8297, DOI 10.1029/95JB03039; Mallants D, 1996, HYDROL PROCESS, V10, P55, DOI 10.1002/(SICI)1099-1085(199601)10:1&lt;55::AID-HYP299&gt;3.0.CO;2-N; Mallants D, 1996, SOIL SCI SOC AM J, V60, P747, DOI 10.2136/sssaj1996.03615995006000030010x; Manwart C, 1999, PHYS REV E, V59, P5596, DOI 10.1103/PhysRevE.59.5596; Manwart C, 2000, PHYS REV E, V62, P893, DOI 10.1103/PhysRevE.62.893; Mariethoz G, 2010, WATER RESOUR RES, V46, DOI [10.1029/2010WR009274, 10.1029/2008WR007621]; Mortazavi B, 2012, COMP MATER SCI, V59, P108, DOI 10.1016/j.commatsci.2012.03.002; Mostaghimi P, 2013, MATH GEOSCI, V45, P103, DOI 10.1007/s11004-012-9431-4; Nikooee E, 2013, TRANSPORT POROUS MED, V96, P369, DOI 10.1007/s11242-012-0093-y; Okabe H, 2007, WATER RESOUR RES, V43, DOI 10.1029/2006WR005680; Or D, 2013, VADOSE ZONE J, V12, DOI 10.2136/vzj2012.0163; Oren PE, 2002, TRANSPORT POROUS MED, V46, P311, DOI 10.1023/A:1015031122338; Piasecki R, 2011, P ROY SOC A-MATH PHY, V467, P806, DOI 10.1098/rspa.2010.0296; Raoof A, 2012, WATER RESOUR RES, V48, DOI 10.1029/2010WR010180; Raoof A, 2010, VADOSE ZONE J, V9, P624, DOI 10.2136/vzj2010.0026; Rintoul MD, 1996, PHYS REV E, V54, P2663, DOI 10.1103/PhysRevE.54.2663; ROBERTS AP, 1995, PHYS REV E, V51, P4141, DOI 10.1103/PhysRevE.51.4141; Rozenbaum O, 2012, CR GEOSCI, V344, P516, DOI 10.1016/j.crte.2012.09.004; Rozman MG, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.135501; Rozman MG, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.066701; Russ J.C., 2000, PRACTICAL STEREOLOGY, V2nd ed.; Sahimi M, 2003, HETEROGENEOUS MAT LI; Saucier A, 2002, PHYSICA A, V311, P231, DOI 10.1016/S0378-4371(02)00814-2; Schaap MG, 2000, SOIL SCI SOC AM J, V64, P843, DOI 10.2136/sssaj2000.643843x; Schluter S, 2011, J PLANT NUTR SOIL SC, V174, P395, DOI 10.1002/jpln.201000103; Sevostianova E, 2010, INT J ENG SCI, V48, P1693, DOI 10.1016/j.ijengsci.2010.06.017; Sheidaei A, 2013, COMPOS SCI TECHNOL, V80, P47, DOI 10.1016/j.compscitech.2013.03.001; Shulakova V, 2013, GEOPHYS PROSPECT, V61, P287, DOI 10.1111/j.1365-2478.2012.01082.x; Skvortsova EB, 2009, EURASIAN SOIL SCI+, V42, P1254, DOI 10.1134/S1064229309110088; Skvortsova EB, 2004, EURASIAN SOIL SCI+, V37, P980; Sumanasooriya MS, 2010, ACI MATER J, V107, P413; Tahmasebi P, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.078002; Tahmasebi P, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.066709; Takada M, 2003, MON NOT R ASTRON SOC, V340, P580, DOI 10.1046/j.1365-8711.2003.06321.x; Tang T, 2009, J MICROSC-OXFORD, V234, P262, DOI 10.1111/j.1365-2818.2009.03173.x; Thovert JF, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.056116; Thullner M, 2008, BIOTECHNOL BIOENG, V99, P1337, DOI 10.1002/bit.21708; Torkzaban S, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006541; Torquato S, 2010, REV MOD PHYS, V82, P2633, DOI 10.1103/RevModPhys.82.2633; Torquato S., 2002, APPL MECH REV, V55, pB62, DOI [10.1115/1.1483342, DOI 10.1115/1.1483342]; Uzarowicz L, 2013, GEODERMA, V197, P137, DOI 10.1016/j.geoderma.2013.01.006; Valvatne PH, 2004, WATER RESOUR RES, V40, DOI 10.1029/2003WR002627; Vogel HJ, 2010, COMPUT GEOSCI-UK, V36, P1236, DOI 10.1016/j.cageo.2010.03.007; WOOD WW, 1990, SCIENCE, V247, P1569, DOI 10.1126/science.247.4950.1569; Wu KJ, 2004, SOIL SCI SOC AM J, V68, P346, DOI 10.2136/sssaj2004.0346; Yeong CLY, 1998, PHYS REV E, V57, P495, DOI 10.1103/PhysRevE.57.495; Yeong CLY, 1998, PHYS REV E, V58, P224, DOI 10.1103/PhysRevE.58.224; Zachary CE, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.056102; Zhang QL, 2012, VADOSE ZONE J, V11, DOI 10.2136/vzj2011.0090; Zhang XX, 2005, J HYDROL, V306, P59, DOI 10.1016/j.jhydrol.2004.08.039; Zhao F, 2005, ENVIRON SCI TECHNOL, V39, P239, DOI 10.1021/es035228b	102	65	70	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0126515	10.1371/journal.pone.0126515	http://dx.doi.org/10.1371/journal.pone.0126515			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010779	Green Published, gold			2022-12-26	WOS:000355183900031
J	Nagata, T; Yasukawa, H; Kyogoku, S; Oba, T; Takahashi, J; Nohara, S; Minami, T; Mawatari, K; Sugi, Y; Shimozono, K; Pradervand, S; Hoshijima, M; Aoki, H; Fukumoto, Y; Imaizumi, T				Nagata, Takanobu; Yasukawa, Hideo; Kyogoku, Sachiko; Oba, Toyoharu; Takahashi, Jinya; Nohara, Shoichiro; Minami, Tomoko; Mawatari, Kazutoshi; Sugi, Yusuke; Shimozono, Koutatsu; Pradervand, Sylvain; Hoshijima, Masahiko; Aoki, Hiroki; Fukumoto, Yoshihiro; Imaizumi, Tsutomu			Cardiac-Specific SOCS3 Deletion Prevents In Vivo Myocardial Ischemia Reperfusion Injury through Sustained Activation of Cardioprotective Signaling Molecules	PLOS ONE			English	Article							JAK-STAT PATHWAY; CONFERS RESISTANCE; INDUCIBLE GENE; KINASE; TRANSCRIPTION-3; TRANSDUCER; HEART; AKT; OVEREXPRESSION; HYPERTROPHY	Myocardial ischemia reperfusion injury (IRI) adversely affects cardiac performance and the prognosis of patients with acute myocardial infarction. Although myocardial signal transducer and activator of transcription (STAT) 3 is potently cardioprotective during IRI, the inhibitory mechanism responsible for its activation is largely unknown. The present study aimed to investigate the role of the myocardial suppressor of cytokine signaling (SOCS)-3, an intrinsic negative feedback regulator of the Janus kinase (JAK)-STAT signaling pathway, in the development of myocardial IRI. Myocardial IRI was induced in mice by ligating the left anterior descending coronary artery for 1 h, followed by different reperfusion times. One hour after reperfusion, the rapid expression of JAK-STAT-activating cytokines was observed. We precisely evaluated the phosphorylation of cardioprotective signaling molecules and the expression of SOCS3 during IRI and then induced myocardial IRI in wild-type and cardiac-specific SOCS3 knockout mice (SOCS3-CKO). The activation of STAT3, AKT, and ERK1/2 rapidly peaked and promptly decreased during IRI. This decrease correlated with the induction of SOCS3 expression up to 24 h after IRI in wild-type mice. The infarct size 24 h after reperfusion was significantly reduced in SOCS3-CKO compared with wild-type mice. In SOCS3-CKO mice, STAT3, AKT, and ERK1/2 phosphorylation was sustained, myocardial apoptosis was prevented, and the expression of anti-apoptotic Bcl-2 family member myeloid cell leukemia-1 (Mcl-1) was augmented. Cardiac-specific SOCS3 deletion led to the sustained activation of cardioprotective signaling molecules including and prevented myocardial apoptosis and injury during IRI. Our findings suggest that SOCS3 may represent a key factor that exacerbates the development of myocardial IRI.	[Nagata, Takanobu; Yasukawa, Hideo; Kyogoku, Sachiko; Oba, Toyoharu; Takahashi, Jinya; Nohara, Shoichiro; Minami, Tomoko; Mawatari, Kazutoshi; Sugi, Yusuke; Shimozono, Koutatsu; Fukumoto, Yoshihiro] Kurume Univ, Sch Med, Dept Internal Med, Div Cardiovasc Med, Kurume, Fukuoka 830, Japan; [Yasukawa, Hideo; Aoki, Hiroki; Fukumoto, Yoshihiro] Kurume Univ, Cardiovasc Res Inst, Kurume, Fukuoka 830, Japan; [Pradervand, Sylvain] Univ Lausanne, LGTF, Lausanne, Switzerland; [Hoshijima, Masahiko] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Imaizumi, Tsutomu] Fukuoka Sanno Hosp, Fukuoka, Japan; [Imaizumi, Tsutomu] Int Univ Hlth & Welf, Fukuoka, Japan	Kurume University; Kurume University; University of Lausanne; University of California System; University of California San Diego; International University of Health & Welfare	Yasukawa, H (corresponding author), Kurume Univ, Sch Med, Dept Internal Med, Div Cardiovasc Med, Kurume, Fukuoka 830, Japan.	yahideo@med.kurume-u.ac.jp			Science Frontier Research Promotion Centers; Ministry of Education, Science, Sports, and Culture, Japan [24791957, 25861739, 18590793]; Kimura Memorial Heart Foundation; Japanese Ministry of Health, Labour and Welfare	Science Frontier Research Promotion Centers; Ministry of Education, Science, Sports, and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kimura Memorial Heart Foundation; Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan)	This study was supported in part by a grant from the Science Frontier Research Promotion Centers (mext.go.jp/english/, to TI), by Grants-in-Aid for Scientific Research from the Ministry of Education, Science, Sports, and Culture, Japan (mext.go.jp/english/, grant #24791957 to TN, #25861739 to TO, #18590793 to HY), by a Research Grant for Cardiovascular Diseases from Kimura Memorial Heart Foundation (kimura-kinen.com, to HY), and by a Japanese Ministry of Health, Labour and Welfare Research Grant (mhlw.go.jp/english/index.html, to TI).	Agah R, 1997, J CLIN INVEST, V100, P169, DOI 10.1172/JCI119509; Auernhammer CJ, 1999, P NATL ACAD SCI USA, V96, P6964, DOI 10.1073/pnas.96.12.6964; Barry SP, 2007, TRENDS MOL MED, V13, P82, DOI 10.1016/j.molmed.2006.12.002; Boengler K, 2008, CIRC RES, V102, P131, DOI 10.1161/CIRCRESAHA.107.164699; Boengler K, 2010, BASIC RES CARDIOL, V105, P771, DOI 10.1007/s00395-010-0124-1; Bolli R, 2003, TRENDS CARDIOVAS MED, V13, P72, DOI 10.1016/S1050-1738(02)00230-X; Bolli R, 2011, J MOL CELL CARDIOL, V50, P589, DOI 10.1016/j.yjmcc.2011.01.002; BRAUNWALD E, 1985, J CLIN INVEST, V76, P1713, DOI 10.1172/JCI112160; Burns RJ, 2002, J AM COLL CARDIOL, V39, P30, DOI 10.1016/S0735-1097(01)01711-9; Dabkowski ER, 2008, FREE RADICAL BIO MED, V45, P855, DOI 10.1016/j.freeradbiomed.2008.06.021; Fischer P, 2007, BASIC RES CARDIOL, V102, P279, DOI 10.1007/s00395-007-0658-z; Gibbons RJ, 2004, J AM COLL CARDIOL, V44, P1533, DOI 10.1016/j.jacc.2004.06.071; Gough DJ, 2009, SCIENCE, V324, P1713, DOI 10.1126/science.1171721; Hamanaka I, 2001, CIRC RES, V88, P727, DOI 10.1161/hh0701.088512; Hattori R, 2001, J MOL CELL CARDIOL, V33, P1929, DOI 10.1006/jmcc.2001.1456; Hausenloy DJ, 2013, J CLIN INVEST, V123, P92, DOI 10.1172/JCI62874; Heusch G, 2011, CIRC RES, V109, P1302, DOI 10.1161/CIRCRESAHA.111.255604; Hilfiker-Kleiner D, 2004, CIRC RES, V95, P187, DOI 10.1161/01.RES.0000134921.50377.61; Johnston JA, 2003, NAT IMMUNOL, V4, P507, DOI 10.1038/ni0603-507; Knight Richard A, 2012, JAKSTAT, V1, P111, DOI 10.4161/jkst.20078; Lecour S, 2005, CIRCULATION, V112, P3911, DOI 10.1161/CIRCULATIONAHA.105.581058; Liao ZH, 2002, CARDIOVASC RES, V53, P902, DOI 10.1016/S0008-6363(01)00531-4; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Matsui T, 2001, CIRCULATION, V104, P330; McCormick J, 2006, FASEB J, V20, P2115, DOI 10.1096/fj.06-6188fje; Miyazaki Y, 2011, ARTERIOSCL THROM VAS, V31, P1124, DOI 10.1161/ATVBAHA.111.224519; Mori H, 2004, NAT MED, V10, P739, DOI 10.1038/nm1071; Muraski JA, 2007, NAT MED, V13, P1467, DOI 10.1038/nm1671; Negoro S, 2001, CIRCULATION, V104, P979, DOI 10.1161/hc3401.095947; Oba T, 2012, J AM COLL CARDIOL, V59, P838, DOI 10.1016/j.jacc.2011.10.887; Oshima Y, 2005, CARDIOVASC RES, V65, P428, DOI 10.1016/j.cardiores.2004.10.021; Roubille F, 2013, CARDIOVASC DRUG THER, V27, P315, DOI 10.1007/s10557-013-6461-1; Ruan HM, 2009, J MOL CELL CARDIOL, V46, P193, DOI 10.1016/j.yjmcc.2008.10.021; Sakamoto H, 1998, BLOOD, V92, P1668, DOI 10.1182/blood.V92.5.1668.417k09_1668_1676; Scarabelli TM, 2002, CIRC RES, V90, P745, DOI 10.1161/01.RES.0000015224.07870.9A; Smith RM, 2004, CARDIOVASC RES, V63, P611, DOI 10.1016/j.cardiores.2004.06.019; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Suleman N, 2008, CARDIOVASC RES, V79, P127, DOI 10.1093/cvr/cvn067; Suzuki K, 2001, CIRCULATION, V104, pI308; Takano H, 2007, TRENDS PHARMACOL SCI, V28, P512, DOI 10.1016/j.tips.2007.09.002; Tamiya T, 2011, ARTERIOSCL THROM VAS, V31, P980, DOI 10.1161/ATVBAHA.110.207464; Wang X, 2013, GENE DEV, V27, P1351, DOI 10.1101/gad.215855.113; Xuan YT, 2001, P NATL ACAD SCI USA, V98, P9050, DOI 10.1073/pnas.161283798; Xuan YT, 2007, CIRCULATION, V116, P535, DOI 10.1161/CIRCULATIONAHA.107.689471; Yajima T, 2006, CIRCULATION, V114, P2364, DOI 10.1161/CIRCULATIONAHA.106.642454; Yang-Yen HF, 2006, J BIOMED SCI, V13, P201, DOI 10.1007/s11373-005-9064-4; Yasukawa H, 1999, EMBO J, V18, P1309, DOI 10.1093/emboj/18.5.1309; Yasukawa H, 2000, ANNU REV IMMUNOL, V18, P143, DOI 10.1146/annurev.immunol.18.1.143; Yasukawa H, 2003, J CLIN INVEST, V111, P469, DOI 10.1172/JCI200316491; Yasukawa H, 2003, NAT IMMUNOL, V4, P551, DOI 10.1038/ni938; Yasukawa H, 2001, J CLIN INVEST, V108, P1459, DOI 10.1172/JCI13939; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zhao ZQ, 2002, CARDIOVASC RES, V55, P438, DOI 10.1016/S0008-6363(02)00442-X	55	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127942	10.1371/journal.pone.0127942	http://dx.doi.org/10.1371/journal.pone.0127942			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010537	Green Published, Green Submitted, gold			2022-12-26	WOS:000355183900168
J	Siengdee, P; Trakooljul, N; Murani, E; Schwerin, M; Wimmers, K; Ponsuksili, S				Siengdee, Puntita; Trakooljul, Nares; Murani, Eduard; Schwerin, Manfred; Wimmers, Klaus; Ponsuksili, Siriluck			MicroRNAs Regulate Cellular ATP Levels by Targeting Mitochondrial Energy Metabolism Genes during C2C12 Myoblast Differentiation	PLOS ONE			English	Article							SKELETAL-MUSCLE; EXPRESSION; BIOGENESIS; MECHANISMS; PREDICTION; MIR-206	In our previous study, we identified an miRNA regulatory network involved in energy metabolism in porcine muscle. To better understand the involvement of miRNAs in cellular ATP production and energy metabolism, here we used C2C12 myoblasts, in which ATP levels increase during differentiation, to identify miRNAs modulating these processes. ATP level, miRNA and mRNA microarray expression profiles during C2C12 differentiation into myotubes were assessed. The results suggest 14 miRNAs (miR-423-3p, miR-17, miR-130b, miR-301a/b, miR-345, miR-15a, miR-16a, miR-128, miR-615, miR-1968, miR-1a/b, and miR-194) as cellular ATP regulators targeting genes involved in mitochondrial energy metabolism (Cox4i2, Cox6a2, Ndufb7, Ndufs4, Ndufs5, and Ndufv1) during C2C12 differentiation. Among these, miR-423-3p showed a high inverse correlation with increasing ATP levels. Besides having implications in promoting cell growth and cell cycle progression, its function in cellular ATP regulation is yet unknown. Therefore, miR-423-3p was selected and validated for the function together with its potential target, Cox6a2. Overexpression of miR-423-3p in C2C12 myogenic differentiation lead to decreased cellular ATP level and decreased expression of Cox6a2 compared to the negative control. These results suggest miR-423-3p as a novel regulator of ATP/energy metabolism by targeting Cox6a2.	[Siengdee, Puntita; Schwerin, Manfred; Ponsuksili, Siriluck] Res Inst Biol Farm Anim FBN, Res Unit Funct Genom, Dummerstorf, Germany; [Trakooljul, Nares; Murani, Eduard; Wimmers, Klaus] Res Inst Biol Farm Anim FBN, Res Unit Mol Biol, Dummerstorf, Germany	Forschungsinstitut fur Nutztierbiologie (FBN); Forschungsinstitut fur Nutztierbiologie (FBN)	Ponsuksili, S (corresponding author), Res Inst Biol Farm Anim FBN, Res Unit Funct Genom, Dummerstorf, Germany.	s.wimmers@fbn-dummerstorf.de	Siengdee, Puntita/AAF-4813-2019; Wimmers, Klaus/AAF-9434-2020	Siengdee, Puntita/0000-0003-0665-0912; Wimmers, Klaus/0000-0002-9523-6790; Trakooljul, Nares/0000-0002-3214-2498	German Research Foundation (Deutsche Forschungsgemeinschaft) [DFG PO753/7-1, WI 1754/10-14]; FBN (Research Institute for the Biology of Farm Animals)	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); FBN (Research Institute for the Biology of Farm Animals)	This research was supported by the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG PO753/7-1 and WI 1754/10-14) and the FBN (Research Institute for the Biology of Farm Animals). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boehm M, 2005, SCIENCE, V310, P1954, DOI 10.1126/science.1115596; Calin GA, 2006, CANCER RES, V66, P7390, DOI 10.1158/0008-5472.CAN-06-0800; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Cuellar TL, 2005, J ENDOCRINOL, V187, P327, DOI 10.1677/joe.1.06426; Demongeot J, 2013, 27 INT C ADV INF NET; Dong SW, 2012, BIOCHEM BIOPH RES CO, V418, P587, DOI 10.1016/j.bbrc.2012.01.075; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Gan ZJ, 2013, J CLIN INVEST, V123, P2564, DOI 10.1172/JCI67652; Goljanek-Whysall K, 2012, J CELL SCI, V125, P3590, DOI 10.1242/jcs.101758; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guan GF, 2014, INT J CLIN EXP PATHO, V7, P5683; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Koene S, 2011, J INHERIT METAB DIS, V34, P293, DOI 10.1007/s10545-009-9005-x; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Li MM, 2014, SCI REP-UK, V4, DOI 10.1038/srep04734; Lin J, 2011, CARCINOGENESIS, V32, P1641, DOI 10.1093/carcin/bgr199; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mimaki M, 2012, BBA-BIOENERGETICS, V1817, P851, DOI 10.1016/j.bbabio.2011.08.010; Nishi H, 2010, J BIOL CHEM, V285, P4920, DOI 10.1074/jbc.M109.082610; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Ponsuksili S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-533; Quintens R, 2013, PLOS ONE, V8; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Ryten M, 2002, J CELL BIOL, V158, P345, DOI 10.1083/jcb.200202025; Sartorelli V, 2005, CURR OPIN GENET DEV, V15, P528, DOI 10.1016/j.gde.2005.04.015; Sartorelli V, 1999, MOL CELL, V4, P725, DOI 10.1016/S1097-2765(00)80383-4; Soares RJ, 2014, J BIOL CHEM, V289, P21909, DOI 10.1074/jbc.M114.561845; Triepels RH, 2001, AM J MED GENET, V106, P37, DOI 10.1002/ajmg.1397; Tuddenham L, 2006, FEBS LETT, V580, P4214, DOI 10.1016/j.febslet.2006.06.080; Wang YP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-218; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Wu H, 2012, CELL SIGNAL, V24, P2179, DOI 10.1016/j.cellsig.2012.07.001; Yamamoto H, 2012, AM J PHYSIOL-ENDOC M, V303, pE1419, DOI 10.1152/ajpendo.00097.2012; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033	38	32	37	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127850	10.1371/journal.pone.0127850	http://dx.doi.org/10.1371/journal.pone.0127850			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010876	Green Published, Green Submitted, gold			2022-12-26	WOS:000355183900152
J	Wu, XM; Yang, HG; Zheng, BA; Cao, HF; Hu, ZM; Wu, WD				Wu, Xiao-Min; Yang, Hong-Guo; Zheng, Bo-An; Cao, Hong-Feng; Hu, Zhi-Ming; Wu, Wei-Ding			Functional Genetic Variations at the microRNA Binding-Site in the CD44 Gene Are Associated with Risk of Colorectal Cancer in Chinese Populations	PLOS ONE			English	Article							CARCINOMA; BREAST; SUSCEPTIBILITY; IDENTIFICATION; POLYMORPHISM; ACTIVATION; MIR-509-3P; APOPTOSIS; MIGRATION; VARIANTS	CD44 as one of the most putative stem cell markers plays a key role in many cellular processes, including cancer cell growth and migration. Functional single nucleotide polymorphisms (SNPs) of CD44 may modulate its gene functions and thus cancer risk. In the current study, we investigated if polymorphisms in the 3'-untranslated region (UTR) of CD44 are associated with increased susceptibility to colorectal cancer (CRC) by conducting a case-control study of 946 CRC patients and 989 cancer-free controls. Three polymorphisms (rs13347C/T, rs10836347C/T, rs11821102G/A) in the 3'-UTR of CD44 were genotyped. We found that the variant genotypes (CT and TT) of rs13347 (adjusted odds ratio (OR) = 1.79, 95% confidence interval (CI) = 1.50-2.17) increased an individual's susceptibility to CRC, compared with rs13347CC homozygous genotypes. We also found that CRC patients with the CT/TT genotype had a 1.6-fold increased risk for developing advanced (stage III + IV) CRC. Furthermore, functional assays showed that the C to T base change at rs13347C/T disrupts the binding site for the microRNA hsa-mir-509-3p, thereby increasing CD44 transcriptional activity and expression level. These findings suggest that the rs13347C/T in microRNA binding site may be potential biomarkers for genetic susceptibility to CRC.	[Wu, Xiao-Min] Zhejiang Prov Peoples Hosp, Dept Anesthesiol, Hangzhou, Zhejiang, Peoples R China; [Hu, Zhi-Ming; Wu, Wei-Ding] Zhejiang Prov Peoples Hosp, Dept Hepatobiliary & Pancreat Surg, Hangzhou, Zhejiang, Peoples R China; [Yang, Hong-Guo] Zhejiang Prov Peoples Hosp, Haining Branch, Dept Gen Surg, Jiaxing, Zhejiang, Peoples R China; [Zheng, Bo-An; Cao, Hong-Feng] Zhejiang Prov Peoples Hosp, Dept Colorectal Surg, Hangzhou, Zhejiang, Peoples R China	Zhejiang Provincial People's Hospital; Zhejiang Provincial People's Hospital; Zhejiang Provincial People's Hospital; Zhejiang Provincial People's Hospital	Wu, WD (corresponding author), Zhejiang Prov Peoples Hosp, Dept Hepatobiliary & Pancreat Surg, Hangzhou, Zhejiang, Peoples R China.	weidingwu@126.com			Zhejiang Provincial Natural Science Foundation [2013C33106]	Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province)	This study was supported by the Zhejiang Provincial Natural Science Foundation (No. 2013C33106). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand M T, 2014, Indian J Cancer, V51, P247, DOI 10.4103/0019-509X.146752; Bourguignon Lilly Y. W., 1998, Frontiers in Bioscience, V3, pD637; Chou YE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093692; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Du HN, 2014, SCI REP-UK, V4, DOI 10.1038/srep06700; Du L, 2008, CLIN CANCER RES, V14, P6751, DOI 10.1158/1078-0432.CCR-08-1034; Gerger A, 2011, CLIN CANCER RES, V17, P6934, DOI 10.1158/1078-0432.CCR-11-1180; Goodison S, 1999, J CLIN PATHOL-MOL PA, V52, P189; Huxley RR, 2009, INT J CANCER, V125, P171, DOI 10.1002/ijc.24343; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jiang L, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3225; Kozovska Z, 2014, BIOMED PHARMACOTHER, V68, P911, DOI 10.1016/j.biopha.2014.10.019; Lassmann Silke, 2008, Gastroenterology, V134, P1262, DOI 10.1053/j.gastro.2008.02.050; Li N, 2014, CARCINOGENESIS, V35, P2687, DOI 10.1093/carcin/bgu201; Li W, 2014, GASTROENTEROLOGY, V146, P1714, DOI 10.1053/j.gastro.2014.03.002; Marhaba R, 2004, J MOL HISTOL, V35, P211; McKallip RJ, 2005, INFECT IMMUN, V73, P50, DOI 10.1128/IAI.73.1.50-61.2005; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Rafi A, 1997, BLOOD, V89, P2901, DOI 10.1182/blood.V89.8.2901; SCREATON GR, 1992, P NATL ACAD SCI USA, V89, P12160, DOI 10.1073/pnas.89.24.12160; SETH A, 1991, P NATL ACAD SCI USA, V88, P7877, DOI 10.1073/pnas.88.17.7877; Shang Z, 2014, ONCOTARGET; Sharma KL, 2014, TUMOR BIOL, V35, P2583, DOI 10.1007/s13277-013-1340-8; Song M, 2014, INTERNATIONAL JOURNA; Tsong WH, 2007, BRIT J CANCER, V96, P821, DOI 10.1038/sj.bjc.6603623; Tu L, 2014, MOLECULAR GENETICS A; Tulsyan S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071073; Udabage L, 2005, EXP CELL RES, V310, P205, DOI 10.1016/j.yexcr.2005.07.026; Wang Y, 2014, CANCER LETT, V352, P169, DOI 10.1016/j.canlet.2014.05.007; Wilson BJ, 2011, CURR COLORECT CANC R, V7, P128, DOI 10.1007/s11888-011-0093-2; Winder T, 2011, INT J CANCER, V129, P1096, DOI 10.1002/ijc.25787; Xiao M, 2013, MUTAGENESIS, V28, P577, DOI 10.1093/mutage/get035; Yang L, 2003, INT J CANCER, V106, P771, DOI 10.1002/ijc.11300; Zhai QN, 2012, BIOCHEM BIOPH RES CO, V419, P621, DOI 10.1016/j.bbrc.2012.02.060; Zheng J, 2012, CARCINOGENESIS, V33, P2409, DOI 10.1093/carcin/bgs307	35	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127557	10.1371/journal.pone.0127557	http://dx.doi.org/10.1371/journal.pone.0127557			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010608	Green Submitted, gold, Green Published			2022-12-26	WOS:000355183900109
J	Yue, CH; Huang, CY; Tsai, JH; Hsu, CW; Hsieh, YH; Lin, H; Liu, JY				Yue, Chia-Herng; Huang, Chih-Yang; Tsai, Jen-Hsiang; Hsu, Chih-Wei; Hsieh, Yi-Hsien; Lin, Ho; Liu, Jer-Yuh			MZF-1/Elk-1 Complex Binds to Protein Kinase C alpha Promoter and Is Involved in Hepatocellular Carcinoma	PLOS ONE			English	Article							ZINC-FINGER GENE; PKC-ALPHA; ELK-1; MZF-1; EXPRESSION; TRANSCRIPTION; ACTIVATION; APOPTOSIS; PATHWAY; DOMAIN	In this study, the molecular mechanism of protein kinase C alpha (PKC alpha) gene regulation in hepatocellular carcinoma (HCC) involving Ets-like protein-1 (Elk-1) and myeloid zinc finger-1 (MZF-1) was investigated. The luciferase reporter assay results revealed that the presence of both MZF-1 and Elk-1 significantly contributed to the upregulation of PKC alpha gene transcription activity, and the transcriptional activity decreased when the transfection included a DNA-binding-deficient (Delta DBD) gene vector of either MZF-1 or Elk-1 DNA-binding deficiency (MZF-1 Delta DBD or Elk-1 Delta DBD), thereby indicating that the enhanced expression of PKC alpha was caused by the binding of MZF-1 and/or Elk-1 with the PKC alpha promoter. We investigated MZF-1 and Elk-1 to determine whether they bind to each other. The results of immunoprecipitation (IP), Co-IP, chromatin IP (ChIP), and Re-ChIP analyses indicated that Elk-1 can directly bind to the N-terminal region of MZF-1 and MZF-1 can directly bind to the C-terminal region of Elk-1 to form a complex before attaching to the PKC alpha promoter. Furthermore, when MZF-1 Delta DBD or Elk-1 Delta DBD was added to the cells, PKC alpha expression decreased, and cell proliferation, migration, invasion, and tumorigenicity also decreased. These findings suggest that PKC alpha expression in HCC could be stimulated by the formation of MZF-1/Elk-1 complex, which directly binds to the PKC alpha promoter.	[Yue, Chia-Herng; Lin, Ho] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Yue, Chia-Herng; Hsu, Chih-Wei] Tungs Taichung MetroHarbor Hosp, Dept Surg, Taichung, Taiwan; [Huang, Chih-Yang] China Med Univ, Grad Inst Chinese Med Sci, Sch Chinese Med, Taichung, Taiwan; [Huang, Chih-Yang] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Huang, Chih-Yang] Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung, Taiwan; [Tsai, Jen-Hsiang] Fooyin Univ, Coll Med & Hlth, Basic Med Sci Educ Ctr, Kaohsiung, Taiwan; [Hsu, Chih-Wei] Natl Chiayi Univ, Dept Appl Chem, Chiayi, Taiwan; [Hsieh, Yi-Hsien] Chung Shan Med Univ Hosp, Clin Lab, Taichung 40201, Taiwan; [Hsieh, Yi-Hsien] Chung Shan Med Univ, Coll Med, Inst Biochem & Biotechnol, Taichung, Taiwan; [Liu, Jer-Yuh] China Med Univ Hosp, Ctr Mol Med, Taichung, Taiwan; [Liu, Jer-Yuh] China Med Univ, Grad Inst Canc Biol, Taichung, Taiwan	National Chung Hsing University; Tungs' Taichung MetroHarbor Hospital; China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan; Fooyin University; National Chiayi University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Hsieh, YH (corresponding author), Chung Shan Med Univ Hosp, Clin Lab, Taichung 40201, Taiwan.	hyhsien@csmu.edu.tw; hlin@dragon.nchu.edu.tw; jyl@mail.cmu.edu.tw	Yuang, Chih-Yang/O-5111-2015	Lin, Ho/0000-0001-7849-9137	Ministry of Science and Technology, Republic of China [NSC 99-2632-B-039-001-MY3, NSC 102-2320-B-039-049, NSC102-2911-I-002-303]; Taiwan Department of Health Clinical Trial and Research Center of Excellence, Taiwan, Republic of China [DOH102-TD-B-111-004]	Ministry of Science and Technology, Republic of China; Taiwan Department of Health Clinical Trial and Research Center of Excellence, Taiwan, Republic of China	This work was supported by grants from the Ministry of Science and Technology, Republic of China (NSC 99-2632-B-039-001-MY3, NSC 102-2320-B-039-049 and NSC102-2911-I-002-303) and by the Taiwan Department of Health Clinical Trial and Research Center of Excellence (DOH102-TD-B-111-004), Taiwan, Republic of China.	Bader GD, 2002, NAT BIOTECHNOL, V20, P991, DOI 10.1038/nbt1002-991; BAVISOTTO L, 1991, J EXP MED, V174, P1097, DOI 10.1084/jem.174.5.1097; Besnard A, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00035; Clark JH, 2002, BIOCHEMISTRY-US, V41, P11847, DOI 10.1021/bi025600k; De Petro G, 1998, CANCER RES, V58, P2234; Fromm JR, 1997, ARCH BIOCHEM BIOPHYS, V343, P92, DOI 10.1006/abbi.1997.0147; Ghosh S, 1996, J BIOL CHEM, V271, P9911, DOI 10.1074/jbc.271.17.9911; Gin P, 2008, J BIOL CHEM, V283, P29554, DOI 10.1074/jbc.M802579200; HROMAS R, 1991, J BIOL CHEM, V266, P14183; HROMAS R, 1995, CANCER RES, V55, P3610; Hsieh YH, 2006, BIOCHEM BIOPH RES CO, V339, P217, DOI 10.1016/j.bbrc.2005.11.015; Hsieh YH, 2007, CANCER RES, V67, P4320, DOI 10.1158/0008-5472.CAN-06-2486; Hsieh YH, 2007, CHINESE J PHYSIOL, V50, P9; Hsu YH, 2014, CANCER RES, V74, P4822, DOI 10.1158/0008-5472.CAN-14-0584; Kannan-Thulasiraman P, 2002, J BIOL CHEM, V277, P41230, DOI 10.1074/jbc.M200379200; Khurana A, 2002, FEBS LETT, V527, P119, DOI 10.1016/S0014-5793(02)03192-7; Mackay HJ, 2007, NAT REV CANCER, V7, P554, DOI 10.1038/nrc2168; Martiny-Baron G, 2007, PHARMACOL RES, V55, P477, DOI 10.1016/j.phrs.2007.04.001; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Robertson KA, 1998, LEUKEMIA, V12, P690, DOI 10.1038/sj.leu.2401005; Shao NS, 1998, ONCOGENE, V17, P527, DOI 10.1038/sj.onc.1201931; Tam WL, 2013, CANCER CELL, V24, P347, DOI 10.1016/j.ccr.2013.08.005; Vanhoutte P, 2001, J BIOL CHEM, V276, P5189, DOI 10.1074/jbc.M006678200; Wiren KM, 2004, J MOL ENDOCRINOL, V32, P209, DOI 10.1677/jme.0.0320209; Wu TT, 2007, CLIN CHIM ACTA, V382, P54, DOI 10.1016/j.cca.2007.03.018; Ying TH, 2008, CELL BIOL INT, V32, P210, DOI 10.1016/j.cellbi.2007.08.027	27	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127420	10.1371/journal.pone.0127420	http://dx.doi.org/10.1371/journal.pone.0127420			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010542	Green Published, Green Submitted, gold			2022-12-26	WOS:000355183900088
J	Shir-Shapira, H; Sharabany, J; Filderman, M; Ideses, D; Ovadia-Shochat, A; Mannervik, M; Juven-Gershon, T				Shir-Shapira, Hila; Sharabany, Julia; Filderman, Matan; Ideses, Diana; Ovadia-Shochat, Avital; Mannervik, Mattias; Juven-Gershon, Tamar			Structure-Function Analysis of the Drosophila melanogaster Caudal Transcription Factor Provides Insights into Core Promoter-preferential Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREB-BINDING PROTEIN; GAP GENE GIANT; HOX GENE; OVERLAPPING FUNCTIONS; POSTERIOR AXIS; TATA-BOX; EXPRESSION; RNA; CDX2; GRADIENT	Regulation of RNA polymerase II transcription is critical for the proper development, differentiation, and growth of an organism. The RNA polymerase II core promoter is the ultimate target of a multitude of transcription factors that control transcription initiation. Core promoters encompass the RNA start site and consist of functional elements such as the TATA box, initiator, and downstream core promoter element (DPE), which confer specific properties to the core promoter. We have previously discovered that Drosophila Caudal, which is a master regulator of genes involved in development and differentiation, is a DPE-specific transcriptional activator. Here, we show that the mouse Caudal-related homeobox (Cdx) proteins (mCdx1, mCdx2, and mCdx4) are also preferential core promoter transcriptional activators. To elucidate the mechanism that enables Caudal to preferentially activate DPE transcription, we performed structure-function analysis. Using a systematic series of deletion mutants (all containing the intact DNA-binding homeodomain) we discovered that the C-terminal region of Caudal contributes to the preferential activation of the fushi tarazu (ftz) Caudal target gene. Furthermore, the region containing both the homeodomain and the C terminus of Caudal was sufficient to confer core promoter-preferential activation to the heterologous GAL4 DNA-binding domain. Importantly, we discovered that Drosophila CREB-binding protein (dCBP) is a co-activator for Caudal-regulated activation of ftz. Strikingly, dCBP conferred the ability to preferentially activate the DPE-dependent ftz reporter to mini-Caudal proteins that were unable to preferentially activate ftz transcription themselves. Taken together, it is the unique combination of dCBP and Caudal that enables the co-activation of ftz in a core promoter-preferential manner.	[Shir-Shapira, Hila; Sharabany, Julia; Filderman, Matan; Ideses, Diana; Ovadia-Shochat, Avital; Juven-Gershon, Tamar] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel; [Mannervik, Mattias] Stockholm Univ, Dev Biol, Wenner Gren Inst, Arrhenius Labs E3, SE-10691 Stockholm, Sweden	Bar Ilan University; Stockholm University	Juven-Gershon, T (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel.	tamar.gershon@biu.ac.il	Juven-Gershon, Tamar/AAC-7799-2022	Juven-Gershon, Tamar/0000-0003-2607-5476; Mannervik, Mattias/0000-0003-4999-9655	Israel Science Foundation [798/10]; European Union Seventh Framework Programme (Marie Curie International Reintegration Grant) [256491]; United States-Israel Binational Science Foundation [2009428]	Israel Science Foundation(Israel Science Foundation); European Union Seventh Framework Programme (Marie Curie International Reintegration Grant); United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation)	This work was supported by Israel Science Foundation Grant 798/10 (to T. J.-G) and the European Union Seventh Framework Programme (Marie Curie International Reintegration Grant 256491 to T. J.-G.). The analysis of the transcriptional activity of Bicoid was supported by United States-Israel Binational Science Foundation Grant 2009428 (to T. J.-G. and James T. Kadonaga). The authors declare that they have no conflicts of interest with the contents of this article.	Burke TW, 1997, GENE DEV, V11, P3020, DOI 10.1101/gad.11.22.3020; Burke TW, 1996, GENE DEV, V10, P711, DOI 10.1101/gad.10.6.711; Burley SK, 1996, ANNU REV BIOCHEM, V65, P769, DOI 10.1146/annurev.bi.65.070196.004005; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Chalkley GE, 1999, EMBO J, V18, P4835, DOI 10.1093/emboj/18.17.4835; Charite J, 1998, DEVELOPMENT, V125, P4349; Chawengsaksophak K, 2004, P NATL ACAD SCI USA, V101, P7641, DOI 10.1073/pnas.0401654101; Chawengsaksophak K, 1997, NATURE, V386, P84, DOI 10.1038/386084a0; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Copf T, 2004, P NATL ACAD SCI USA, V101, P17711, DOI 10.1073/pnas.0407327102; Davidson AJ, 2003, NATURE, V425, P300, DOI 10.1038/nature01973; Davidson AJ, 2006, DEV BIOL, V292, P506, DOI 10.1016/j.ydbio.2006.01.003; De Guzman RN, 2005, BIOCHEMISTRY-US, V44, P490, DOI 10.1021/bi048161t; DEAROLF CR, 1989, NATURE, V341, P340, DOI 10.1038/341340a0; Dikstein R, 2011, TRANSCR-AUSTIN, V2, P201, DOI 10.4161/trns.2.5.17271; Edgar LG, 2001, DEV BIOL, V229, P71, DOI 10.1006/dbio.2000.9977; ELDON ED, 1991, DEVELOPMENT, V111, P367; EMAMI KH, 1995, MOL CELL BIOL, V15, P5906; Epstein M, 1997, DEVELOPMENT, V124, P3805; Faas L, 2009, DEV DYNAM, V238, P835, DOI 10.1002/dvdy.21901; FitzGerald PC, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r53; Flores MVC, 2008, GASTROENTEROLOGY, V135, P1665, DOI 10.1053/j.gastro.2008.07.024; Fu DC, 2005, NUCLEIC ACIDS RES, V33, P3985, DOI 10.1093/nar/gki691; Fu DC, 2004, J BIOL CHEM, V279, P48725, DOI 10.1074/jbc.M407066200; Fuda NJ, 2009, NATURE, V461, P186, DOI 10.1038/nature08449; Gershenzon NI, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-161; GOLDBERG ML, 1979, THESIS STANFORD U; Grainger S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054757; Grainger S, 2010, DEV BIOL, V339, P155, DOI 10.1016/j.ydbio.2009.12.025; Heintzman ND, 2007, CELL MOL LIFE SCI, V64, P386, DOI 10.1007/s00018-006-6295-0; HOEY T, 1986, P NATL ACAD SCI USA, V83, P4809, DOI 10.1073/pnas.83.13.4809; Holmqvist PH, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002769; Hunter CP, 1996, CELL, V87, P217, DOI 10.1016/S0092-8674(00)81340-9; Hussain MA, 1999, J BIOL CHEM, V274, P28950, DOI 10.1074/jbc.274.41.28950; Juven-Gershon T, 2008, GENE DEV, V22, P2823, DOI 10.1101/gad.1698108; Juven-Gershon T, 2008, CURR OPIN CELL BIOL, V20, P253, DOI 10.1016/j.ceb.2008.03.003; Juven-Gershon T, 2010, DEV BIOL, V339, P225, DOI 10.1016/j.ydbio.2009.08.009; Kadonaga JT, 2012, WIRES DEV BIOL, V1, P40, DOI 10.1002/wdev.21; Kedmi A, 2014, GENE DEV, V28, P2163, DOI 10.1101/gad.245670.114; KRAUT R, 1991, DEVELOPMENT, V111, P601; Kutach AK, 2000, MOL CELL BIOL, V20, P4754, DOI 10.1128/MCB.20.13.4754-4764.2000; Lafontaine CA, 2012, BIOCHEMISTRY-US, V51, P9698, DOI 10.1021/bi301241q; Lagha M, 2012, TRENDS GENET, V28, P409, DOI 10.1016/j.tig.2012.03.006; Lenhard B, 2012, NAT REV GENET, V13, P233, DOI 10.1038/nrg3163; LEVINE M, 1985, COLD SPRING HARB SYM, V50, P209, DOI 10.1101/SQB.1985.050.01.027; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Levine M, 2005, P NATL ACAD SCI USA, V102, P4936, DOI 10.1073/pnas.0408031102; Levine M, 2014, CELL, V157, P13, DOI 10.1016/j.cell.2014.02.009; Lim CY, 2004, GENE DEV, V18, P1606, DOI 10.1101/gad.1193404; Lohnes D, 2003, BIOESSAYS, V25, P971, DOI 10.1002/bies.10340; Ludlam WH, 2002, MOL CELL BIOL, V22, P3832, DOI 10.1128/MCB.22.11.3832-3841.2002; MacArthur S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r80; MACDONALD PM, 1986, NATURE, V324, P537, DOI 10.1038/324537a0; Marom K, 1997, MECH DEVELOP, V64, P41, DOI 10.1016/S0925-4773(97)00043-9; MEYER BI, 1993, DEVELOPMENT, V117, P191; MLODZIK M, 1990, DEVELOPMENT, V109, P271; MLODZIK M, 1987, CELL, V48, P465, DOI 10.1016/0092-8674(87)90197-8; MLODZIK M, 1985, EMBO J, V4, P2961, DOI 10.1002/j.1460-2075.1985.tb04030.x; Moreno E, 1999, NATURE, V400, P873, DOI 10.1038/23709; Ohler U., 2002, GENOME BIOL, V3, pRESEARCH0087, DOI [10.1186/gb-2002-3-12-research0087, DOI 10.1186/GB-2002-3-12-RESEARCH0087]; Ohler U, 2010, DEVELOPMENT, V137, P15, DOI 10.1242/dev.035493; Parry TJ, 2010, GENE DEV, V24, P2013, DOI 10.1101/gad.1951110; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Pilon N, 2007, DEVELOPMENT, V134, P2315, DOI 10.1242/dev.001206; Ponjavic J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r78; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; Rawat VPS, 2012, BLOOD, V120, P519, DOI 10.1182/blood-2012-02-385898; Reeve JN, 2003, MOL MICROBIOL, V48, P587, DOI 10.1046/j.1365-2958.2003.03439.x; RIVERAPOMAR R, 1995, NATURE, V376, P253, DOI 10.1038/376253a0; Savory JGA, 2011, MECH DEVELOP, V128, P41, DOI 10.1016/j.mod.2010.09.004; Savory JGA, 2009, DEVELOPMENT, V136, P4099, DOI 10.1242/dev.041582; Savory JGA, 2009, DEV BIOL, V330, P114, DOI 10.1016/j.ydbio.2009.03.016; Sikorski TW, 2009, CURR OPIN CELL BIOL, V21, P344, DOI 10.1016/j.ceb.2009.03.006; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Smale ST, 2001, GENE DEV, V15, P2503, DOI 10.1101/gad.937701; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; SUBRAMANIAN V, 1995, CELL, V83, P641, DOI 10.1016/0092-8674(95)90104-3; Tee WW, 2014, DEVELOPMENT, V141, P2376, DOI 10.1242/dev.096982; Theisen JWM, 2010, MOL CELL BIOL, V30, P3471, DOI 10.1128/MCB.00053-10; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; van den Akker E, 2002, DEVELOPMENT, V129, P2181; van Nes J, 2006, DEVELOPMENT, V133, P419, DOI 10.1242/dev.02216; Vo N, 2001, J BIOL CHEM, V276, P13505, DOI 10.1074/jbc.R000025200; Wang Y, 2008, P NATL ACAD SCI USA, V105, P7756, DOI 10.1073/pnas.0708951105; Wolff C, 1998, DEVELOPMENT, V125, P3645; Zehavi Y, 2014, J BIOL CHEM, V289, P11993, DOI 10.1074/jbc.M114.550251	88	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17293	17305		10.1074/jbc.M114.632109	http://dx.doi.org/10.1074/jbc.M114.632109			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	26018075	Green Published, hybrid			2022-12-26	WOS:000357730900025
J	Kim, ES; Jeon, HB; Lim, H; Shin, JH; Park, SJ; Jo, YK; Oh, W; Yang, YS; Cho, DH; Kim, JY				Kim, Eun Sung; Jeon, Hong Bae; Lim, Hoon; Shin, Ji Hyun; Park, So Jung; Jo, Yoon Kyung; Oh, Wonil; Yang, Yoon Sun; Cho, Dong-Hyung; Kim, Ju-Yeon			Conditioned Media from Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Inhibits Melanogenesis by Promoting Proteasomal Degradation of MITF	PLOS ONE			English	Article							BONE-MARROW; MELANOMA; ACTIVATION; SUMOYLATION; MELANOCYTES; EXPANSION; PATHWAY	Human umbilical cord blood-derived mesenchymal stem cells (hUCB-MSCs) secrete various beneficial molecules, which have anti-apoptotic activity and cell proliferation. However, the effect of hUCB-MSCs in melanogenesis is largely unclear. In this study, we show that conditioned media (CM) derived from hUCB-MSCs inhibit melanogenesis by regulating microphthalmia-associated transcription factor (MITF) expression via the ERK signalling pathway. Treatment of hUCB-MSC-CM strongly inhibited the alpha-melanocyte stimulating hormone-induced hyperpigmentation in melanoma cells as well as melanocytes. Treatment of hUCB-MSC-CM induced ERK1/2 activation in melanocytes. In addition, inhibition of ERK1/2 suppressed the anti-pigmentation activity of the hUCB-MSC-CM in melanocytes and in vitro artificial skin models. We also found that the expression of MITF was appreciably diminished while expression of phosphorylated MITF, which leads to its proteasomal degradation, was increased in cells treated with hUCB-MSC-CM. These results suggested that hUCB-MSC-CM significantly suppresses melanin synthesis via MITF degradation by the ERK pathway activation.	[Kim, Eun Sung; Shin, Ji Hyun; Park, So Jung; Jo, Yoon Kyung; Cho, Dong-Hyung] Kyung Hee Univ, Grad Sch East West Med Sci, Yongin, Gyeonggi Do, South Korea; [Jeon, Hong Bae; Lim, Hoon; Oh, Wonil; Yang, Yoon Sun; Kim, Ju-Yeon] MEDIPOST Co Ltd, Biomed Res Inst, Songnam, Gyeonggi Do, South Korea	Kyung Hee University; MEDIPOST	Cho, DH (corresponding author), Kyung Hee Univ, Grad Sch East West Med Sci, Yongin, Gyeonggi Do, South Korea.	dhcho@khu.ac.kr; msc@medi-post.co.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2013R1A1A1058361]; MOTIE; KEIT [10048038]; MEDIPOST Co., Ltd.	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning(National Research Foundation of KoreaMinistry of Science, ICT & Future Planning, Republic of Korea); MOTIE(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea); KEIT; MEDIPOST Co., Ltd.	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2013R1A1A1058361) (www.nrf.re.kr), and was supported by industrial technology development program funded by the MOTIE and KEIT (10048038) (www.motie.go.kr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MEDIPOST Co., Ltd. provided support in the form of salaries for authors (BH Jeon, H Lim, W Oh, YS Yang, JY Kim), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the Author Contributions section.	BEAVO JA, 1970, MOL PHARMACOL, V6, P597; Bellei B, 2011, PIGM CELL MELANOMA R, V24, P309, DOI 10.1111/j.1755-148X.2010.00800.x; Bertolotto C, 1998, MOL CELL BIOL, V18, P694, DOI 10.1128/MCB.18.2.694; Bieback K, 2004, STEM CELLS, V22, P625, DOI 10.1634/stemcells.22-4-625; Brenner M, 2008, PHOTOCHEM PHOTOBIOL, V84, P539, DOI 10.1111/j.1751-1097.2007.00226.x; Chakraborty AK, 1998, PIGM CELL RES, V11, P206, DOI 10.1111/j.1600-0749.1998.tb00731.x; Choi H, 2013, J INVEST DERMATOL, V133, P528, DOI 10.1038/jid.2012.331; Englaro W, 1998, J BIOL CHEM, V273, P9966, DOI 10.1074/jbc.273.16.9966; Flynn A, 2007, CYTOTHERAPY, V9, P717, DOI 10.1080/14653240701584578; Hwang I, 2013, J DERMATOL SCI, V72, P274, DOI 10.1016/j.jdermsci.2013.08.006; Jenhani F, 2011, TRANSPL P, V43, P639, DOI 10.1016/j.transproceed.2011.01.021; Jeong SY, 2013, STEM CELLS, V31, P2136, DOI 10.1002/stem.1471; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Jin HJ, 2013, INT J MOL SCI, V14, P17986, DOI 10.3390/ijms140917986; Kim DS, 2003, J CELL SCI, V116, P1699, DOI 10.1242/jcs.00366; Kim HS, 2013, GASTROENTEROLOGY, V145, P1392, DOI 10.1053/j.gastro.2013.08.033; Kim JY, 2012, CELL DEATH DIFFER, V19, P680, DOI 10.1038/cdd.2011.140; Kim JY, 2010, FEBS LETT, V584, P3601, DOI 10.1016/j.febslet.2010.07.028; Kim WS, 2008, BIOL PHARM BULL, V31, P606, DOI 10.1248/bpb.31.606; Kim WS, 2007, J DERMATOL SCI, V48, P15, DOI 10.1016/j.jdermsci.2007.05.018; Koo HM, 2002, P NATL ACAD SCI USA, V99, P3052, DOI 10.1073/pnas.052707699; KORNER A, 1982, SCIENCE, V217, P1163, DOI 10.1126/science.6810464; Lin JY, 2007, NATURE, V445, P843, DOI 10.1038/nature05660; Liu JJ, 2010, PIGM CELL MELANOMA R, V23, P741, DOI 10.1111/j.1755-148X.2010.00775.x; Mareschi K, 2006, J CELL BIOCHEM, V97, P744, DOI 10.1002/jcb.20681; Miller AJ, 2005, J BIOL CHEM, V280, P146, DOI 10.1074/jbc.M411757200; Murakami H, 2005, PIGM CELL RES, V18, P265, DOI 10.1111/j.1600-0749.2005.00234.x; Oka M, 2000, J INVEST DERMATOL, V115, P699, DOI 10.1046/j.1523-1747.2000.00095.x; Okazaki M, 2005, BRIT J DERMATOL, V153, P23, DOI 10.1111/j.1365-2133.2005.06966.x; Secco M, 2008, STEM CELLS, V26, P146, DOI 10.1634/stemcells.2007-0381; Takeda K, 2000, HUM MOL GENET, V9, P125, DOI 10.1093/hmg/9.1.125; TAMAGAWA T, 1985, FEBS LETT, V183, P433, DOI 10.1016/0014-5793(85)80825-5; Vachtenheim J, 2010, EXP DERMATOL, V19, P617, DOI 10.1111/j.1600-0625.2009.01053.x; Wang M, 2009, IMMUNOLOGY, V126, P220, DOI 10.1111/j.1365-2567.2008.02891.x; Wu M, 2000, GENE DEV, V14, P301; Xu WD, 2000, EXP CELL RES, V255, P135, DOI 10.1006/excr.2000.4803; Yamaguchi Y, 2007, J BIOL CHEM, V282, P27557, DOI 10.1074/jbc.R700026200; Yoshida Y, 2007, AM J PHYSIOL-GASTR L, V293, pG1089, DOI 10.1152/ajpgi.00187.2007; Zaba LC, 2009, J INVEST DERMATOL, V129, P79, DOI 10.1038/jid.2008.194	39	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128078	10.1371/journal.pone.0128078	http://dx.doi.org/10.1371/journal.pone.0128078			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024475	gold, Green Published, Green Submitted			2022-12-26	WOS:000355319400068
J	Kumar, S; Bhatia, S				Kumar, Santosh; Bhatia, Sabhyata			Isolation of Catharanthus roseus (L.) G. Don Nuclei and Measurement of Rate of Tryptophan decarboxylase Gene Transcription Using Nuclear Run-On Transcription Assay	PLOS ONE			English	Article							FERREDOXIN-1 MESSENGER-RNA; MOLECULAR-CLONING; EXPRESSION; ALKALOIDS; PATHWAY; YEAST	Background An accurate assessment of transcription 'rate' is often desired to describe the promoter activity. In plants, isolation of transcriptionally active nuclei and their subsequent use in nuclear run-on assays has been challenging and therefore limit an accurate measurement of gene transcription 'rate'. Catharanthus roseus has emerged as a model medicinal plant as it exhibits an unsurpassed spectrum of chemodiversity, producing over 130 alkaloids through the terpenoid indole alkaloid (TIA) pathway and therefore serves as a 'molecular hub' to understand gene expression profiles. Results The protocols presented here streamline, adapt and optimize the existing methods of nuclear run-on assay for use in C. roseus. Here, we fully describe all the steps to isolate transcriptionally active nuclei from C. roseus leaves and utilize them to perform nuclear run-on transcription assay. Nuclei isolated by this method transcribed at a level consistent with their response to external stimuli, as transcription rate of TDC gene was found to be higher in response to external stimuli i.e. when seedlings were subjected to UV-B light or to methyl jasmonate (MeJA). However, the relative transcript abundance measured parallel through qRT-PCR was found to be inconsistent with the synthesis rate indicating that some post transcriptional events might have a role in transcript stability in response to stimuli. Conclusions Our study provides an optimized, efficient and inexpensive method of isolation of intact nuclei and nuclear 'run-on' transcription assay to carry out in-situ measurement of gene transcription rate in Catharanthus roseus. This would be valuable in investigating the transcriptional and post transcriptional response of other TIA pathway genes in C. roseus. Isolated nuclei may also provide a resource that could be used for performing the chip assay as well as serve as the source of nuclear proteins for in-vitro EMSA studies. Moreover, nascent nuclear run-on transcript could be further subjected to RNA-Seq for global nuclear run-on assay (GNRO-Seq) for genome wide in-situ measurement of transcription rate of plant genes.	[Kumar, Santosh; Bhatia, Sabhyata] Natl Inst Plant Genome Res, New Delhi 110067, India	Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR)	Bhatia, S (corresponding author), Natl Inst Plant Genome Res, Aruna Asaf Ali Marg,POB 10531, New Delhi 110067, India.	sabhyatabhatia@nipgr.ac.in		Bhatia, Sabhyata/0000-0003-0811-219X	National Institute of Plant Genome Research (NIPGR); Council for Scientific and Industrial Research (CSIR)	National Institute of Plant Genome Research (NIPGR)(Department of Biotechnology (DBT) India); Council for Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India)	This research was supported by the National Institute of Plant Genome Research (NIPGR) for the funding support and the Council for Scientific and Industrial Research (CSIR) for fellowship grant to SK.	AERTS RJ, 1994, PLANT J, V5, P635, DOI 10.1111/j.1365-313X.1994.00635.x; ALWINE JC, 1977, P NATL ACAD SCI USA, V74, P5350, DOI 10.1073/pnas.74.12.5350; Anderson MB, 1999, PLANT CELL, V11, P1579, DOI 10.1105/tpc.11.8.1579; BAERSON SR, 1990, MOL CELL BIOL, V10, P842, DOI 10.1128/MCB.10.2.842; Chan MT, 1998, PLANT J, V15, P685, DOI 10.1046/j.1365-313x.1998.00244.x; COX KH, 1988, PLANT MOL BIOL PRACT, P1; DEAMER DW, 1967, J CELL BIOL, V33, P395, DOI 10.1083/jcb.33.2.395; DELIDOW BC, 1989, GENE ANAL TECH, V6, P120, DOI 10.1016/0735-0651(89)90002-2; DELUCA V, 1989, P NATL ACAD SCI USA, V86, P2582; DELUCA V, 1986, J PLANT PHYSIOL, V125, P147, DOI 10.1016/S0176-1617(86)80252-8; FEINBAUM RL, 1988, MOL CELL BIOL, V8, P1985, DOI 10.1128/MCB.8.5.1985; FENNOY SL, 1995, PLANT J, V7, P287, DOI 10.1046/j.1365-313X.1995.7020287.x; Folta KM, 2006, NAT PROTOC, V1, P3094, DOI 10.1038/nprot.2006.471; Folta KM, 2000, PLANT CELL REP, V19, P504, DOI 10.1007/s002990050764; Folta KM, 2003, PLANT MOL BIOL, V51, P609, DOI 10.1023/A:1022393406204; FORNACE AJ, 1989, MOL CELL BIOL, V9, P4196, DOI 10.1128/MCB.9.10.4196; Gaal T, 1997, SCIENCE, V278, P2092, DOI 10.1126/science.278.5346.2092; GALLAGHER TF, 1982, EMBO J, V1, P1493, DOI 10.1002/j.1460-2075.1982.tb01345.x; GRUMMT I, 1976, CELL, V7, P447, DOI 10.1016/0092-8674(76)90175-6; HAJELA RK, 1990, PLANT PHYSIOL, V93, P1246, DOI 10.1104/pp.93.3.1246; Hansen ER, 2001, PLANT PHYSIOL, V125, P770, DOI 10.1104/pp.125.2.770; HIGUCHI R, 1993, BIO-TECHNOL, V11, P1026, DOI 10.1038/nbt0993-1026; Hoffer P, 2011, P NATL ACAD SCI USA, V108, P409, DOI 10.1073/pnas.1009805108; HONDA SI, 1966, J EXP BOT, V17, P460, DOI 10.1093/jxb/17.3.460; Jaggi M, 2011, APPL MICROBIOL BIOT, V90, P1005, DOI 10.1007/s00253-011-3131-8; Kanazawa A, 2000, PLANT MOL BIOL REP, V18, P377, DOI 10.1007/BF02825066; Kinkema M, 2000, PLANT CELL, V12, P2339, DOI 10.1105/tpc.12.12.2339; Laflamme P, 2001, PLANT PHYSIOL, V125, P189, DOI 10.1104/pp.125.1.189; LESCURE B, 1981, NUCLEIC ACIDS RES, V9, P31, DOI 10.1093/nar/9.1.31; LUTHE DS, 1980, PLANT PHYSIOL, V65, P305, DOI 10.1104/pp.65.2.305; MARRS KA, 1989, P NATL ACAD SCI USA, V86, P4492, DOI 10.1073/pnas.86.12.4492; MAUNDRELL K, 1990, J BIOL CHEM, V265, P10857; MCCLURE BA, 1989, PLANT CELL, V1, P229, DOI 10.1105/tpc.1.2.229; Meng L, 2003, PLANT MOL BIOL REP, V21, P65, DOI 10.1007/BF02773398; Menke FLH, 1999, PLANT PHYSIOL, V119, P1289, DOI 10.1104/pp.119.4.1289; MITTLER R, 1994, PLANT J, V5, P397, DOI 10.1111/j.1365-313X.1994.00397.x; Murata J, 2008, PLANT CELL, V20, P524, DOI 10.1105/tpc.107.056630; Ouwerkerk PBF, 1999, PLANT MOL BIOL, V41, P491, DOI 10.1023/A:1006321100550; Park MY, 2005, P NATL ACAD SCI USA, V102, P3691, DOI 10.1073/pnas.0405570102; Petracek ME, 1998, P NATL ACAD SCI USA, V95, P9009, DOI 10.1073/pnas.95.15.9009; Pollier J, 2014, PLANT PHYSIOL BIOCH, V83, P20, DOI 10.1016/j.plaphy.2014.07.004; Roepke J, 2010, P NATL ACAD SCI USA, V107, P15287, DOI 10.1073/pnas.0911451107; Sambrook J., 1989, MOLECULAR CLONING A; STRAND R, 1994, MOL CELL BIOCHEM, V139, P149, DOI 10.1007/BF01081738; Van Breukelen F, 2000, J EXP BIOL, V203, P1123; van der Heijden R, 2004, CURR MED CHEM, V11, P607; Van Moerkercke A, 2013, PLANT CELL PHYSIOL, V54, P673, DOI 10.1093/pcp/pct039; VANBLOKLAND R, 1994, PLANT J, V6, P861, DOI 10.1046/j.1365-313X.1994.6060861.x; WEBER J, 1977, CELL, V10, P611, DOI 10.1016/0092-8674(77)90093-9	49	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0127892	10.1371/journal.pone.0127892	http://dx.doi.org/10.1371/journal.pone.0127892			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024519	Green Submitted, Green Published, gold			2022-12-26	WOS:000355319400057
J	Niessen, SJM; Forcada, Y; Mantis, P; Lamb, CR; Harrington, N; Fowkes, R; Korbonits, M; Smith, K; Church, DB				Niessen, Stijn J. M.; Forcada, Yaiza; Mantis, Panagiotis; Lamb, Christopher R.; Harrington, Norelene; Fowkes, Rob; Korbonits, Marta; Smith, Ken; Church, David B.			Studying Cat (Felis catus) Diabetes: Beware of the Acromegalic Imposter	PLOS ONE			English	Article							GROWTH-HORMONE; DOMESTIC CATS; RISK-FACTORS; MELLITUS; PREVALENCE; DIAGNOSIS; INSULIN; DISEASE; COMPLEX; PLASMA	Naturally occurring diabetes mellitus (DM) is common in domestic cats (Felis catus). It has been proposed as a model for human Type 2 DM given many shared features. Small case studies demonstrate feline DM also occurs as a result of insulin resistance due to a somatotrophinoma. The current study estimates the prevalence of hypersomatotropism or acromegaly in the largest cohort of diabetic cats to date, evaluates clinical presentation and ease of recognition. Diabetic cats were screened for hypersomatotropism using serum total insulin-like growth factor-1 (IGF-1; radioimmunoassay), followed by further evaluation of a subset of cases with suggestive IGF-1 (>1000 ng/ml) through pituitary imaging and/or histopathology. Clinicians indicated pre-test suspicion for hypersomatotropism. In total 1221 diabetic cats were screened; 319 (26.1%) demonstrated a serum IGF-1>1000 ng/ml (95% confidence interval: 23.6-28.6%). Of these cats a subset of 63 (20%) underwent pituitary imaging and 56/63 (89%) had a pituitary tumour on computed tomography; an additional three on magnetic resonance imaging and one on necropsy. These data suggest a positive predictive value of serum IGF-1 for hypersomatotropism of 95% (95% confidence interval: 90-100%), thus suggesting the overall hypersomatotropism prevalence among UK diabetic cats to be 24.8% (95% confidence interval: 21.2-28.6%). Only 24% of clinicians indicated a strong pre-test suspicion; most hypersomatotropism cats did not display typical phenotypical acromegaly signs. The current data suggest hypersomatotropism screening should be considered when studying diabetic cats and opportunities exist for comparative acromegaly research, especially in light of the many detected communalities with the human disease.	[Niessen, Stijn J. M.; Forcada, Yaiza; Mantis, Panagiotis; Lamb, Christopher R.; Church, David B.] Univ London, Royal Vet Coll, Dept Clin Sci & Serv, London, England; [Niessen, Stijn J. M.] Univ Newcastle, Inst Cellular Med, Diabet Res Grp, Newcastle, Tyne & Wear, England; [Harrington, Norelene; Smith, Ken] Univ London, Royal Vet Coll, Dept Pathol & Pathogen Biol, London, England; [Fowkes, Rob] Univ London, Royal Vet Coll, Dept Comparat Biol, London, England; [Korbonits, Marta] Queen Mary Univ London, WHRI, Barts & Royal London Sch Med & Dent, Dept Endocrinol, London, England	University of London; University of London Royal Veterinary College; Newcastle University - UK; University of London; University of London Royal Veterinary College; University of London; University of London Royal Veterinary College; University of London; Queen Mary University London	Niessen, SJM (corresponding author), Univ London, Royal Vet Coll, Dept Clin Sci & Serv, London, England.	sniessen@rvc.ac.uk	Fowkes, Robert/HHT-0664-2022; Harrington, Norelene/AAQ-4669-2020; Fowkes, Robert/AAI-4756-2020	Fowkes, Robert/0000-0002-2222-2056; Mantis, Panagiotis/0000-0003-0799-5330; Korbonits, Marta/0000-0002-4101-9432				Aflorei ED, 2014, J NEURO-ONCOL, V117, P379, DOI 10.1007/s11060-013-1354-5; Alexopoulou O, 2014, PITUITARY, V17, P81, DOI 10.1007/s11102-013-0471-7; Alt N, 2007, RES VET SCI, V83, P331, DOI 10.1016/j.rvsc.2007.01.014; Biering H, 2000, ACTA MED AUST, V27, P27, DOI 10.1046/j.1563-2571.2000.00106.x; Brearley MJ, 2006, VET COMP ONCOL, V4, P209, DOI 10.1111/j.1476-5829.2006.00108.x; CAPEN CC, 1989, TOXICOL PATHOL, V17, P234, DOI 10.1177/019262338901700202; Daly AF, 2006, J CLIN ENDOCR METAB, V91, P4769, DOI 10.1210/jc.2006-1668; De Decker S, 2015, J VET INTERN MED, V29, P405, DOI 10.1111/jvim.12522; Dirtu AC, 2013, ENVIRON INT, V57-58, P60, DOI 10.1016/j.envint.2013.04.004; Forcada Y, 2014, J VET INTERN MED, V28, P458, DOI 10.1111/jvim.12275; Gostelow R, 2014, J VET INTERN MED, V28, P1030; Hoenig M, 2000, AM J PATHOL, V157, P2143, DOI 10.1016/S0002-9440(10)64852-3; Hoenig M, 2002, MOL CELL ENDOCRINOL, V197, P221, DOI 10.1016/S0303-7207(02)00264-2; Hoppener JWM, 2006, INT J BIOCHEM CELL B, V38, P726, DOI 10.1016/j.biocel.2005.12.009; JOHNSON KH, 1986, AM J PATHOL, V125, P416; KOKKA N, 1971, ENDOCRINOLOGY, V88, P359, DOI 10.1210/endo-88-2-359; Lamb CR, 2014, J FELINE MED SURG, V16, P99, DOI 10.1177/1098612X13497212; Lederer R, 2009, VET J, V179, P254, DOI 10.1016/j.tvjl.2007.09.019; Lewitt MS, 2000, J ENDOCRINOL, V166, P21, DOI 10.1677/joe.0.1660021; McCann TM, 2007, J FELINE MED SURG, V9, P289, DOI 10.1016/j.jfms.2007.02.001; Melmed S, 2006, NEW ENGL J MED, V355, P2558, DOI 10.1056/NEJMra062453; NABARRO JDN, 1987, CLIN ENDOCRINOL, V26, P481, DOI 10.1111/j.1365-2265.1987.tb00805.x; Niessen SJM, 2007, J VET INTERN MED, V21, P899, DOI 10.1892/0891-6640(2007)21[899:FAAUE]2.0.CO;2; Niessen SJM, 2007, VET REC, V160, P902, DOI 10.1136/vr.160.26.902; Niessen S, 2010, J FELINE MED SURG, V12, P15, DOI 10.1016/j.jfms.2009.12.003; Niessen SJM, 2013, VET CLIN N AM-SMALL, V43, P319, DOI 10.1016/j.cvsm.2012.12.004; O'Brien TD, 2002, MOL CELL ENDOCRINOL, V197, P213, DOI 10.1016/S0303-7207(02)00265-4; Prahl A, 2007, J FELINE MED SURG, V9, P351, DOI 10.1016/j.jfms.2007.02.004; Resmini E, 2009, ACTA DIABETOL, V46, P85, DOI 10.1007/s00592-009-0112-9; Reusch CE, 2006, VET REC, V158, P195, DOI 10.1136/vr.158.6.195; Rosario PW, 2011, PITUITARY, V14, P217, DOI 10.1007/s11102-010-0281-0; Scacchi Massimo, 2006, Pituitary, V9, P297, DOI 10.1007/s11102-006-0409-4; SHISHKO PI, 1994, DIABETES RES CLIN PR, V25, P1, DOI 10.1016/0168-8227(94)90155-4; THORNER MO, 1982, J CLIN INVEST, V70, P965, DOI 10.1172/JCI110708; Tyson R, 2005, VET RADIOL ULTRASOUN, V46, P33, DOI 10.1111/j.1740-8261.2005.00006.x	35	37	37	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0127794	10.1371/journal.pone.0127794	http://dx.doi.org/10.1371/journal.pone.0127794			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26023776	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000355319400052
J	Taus, F; Santucci, MB; Greco, E; Morandi, M; Palucci, I; Mariotti, S; Poerio, N; Nisini, R; Delogu, G; Fraziano, M				Taus, Francesco; Santucci, Marilina B.; Greco, Emanuela; Morandi, Matteo; Palucci, Ivana; Mariotti, Sabrina; Poerio, Noemi; Nisini, Roberto; Delogu, Giovanni; Fraziano, Maurizio			Monosodium Urate Crystals Promote Innate Anti-Mycobacterial Immunity and Improve BCG Efficacy as a Vaccine against Tuberculosis	PLOS ONE			English	Article							URIC-ACID; MYCOBACTERIUM-TUBERCULOSIS; INFLAMMATION; REINFECTION; MACROPHAGES; PROTECTION; RESPONSES; FUSION	A safer and more effective anti-Tuberculosis vaccine is still an urgent need. We probed the effects of monosodium urate crystals (MSU) on innate immunity to improve the Bacille Calmette-Guerin (BCG) vaccination. Results showed that in vitro MSU cause an enduring macrophage stimulation of the anti-mycobacterial response, measured as intracellular killing, ROS production and phagolysosome maturation. The contribution of MSU to anti-mycobacterial activity was also shown in vivo. Mice vaccinated in the presence of MSU showed a lower number of BCG in lymph nodes draining the vaccine inoculation site, in comparison to mice vaccinated without MSU. Lastly, we showed that MSU improved the efficacy of BCG vaccination in mice infected with Mycobacterium tuberculosis (MTB), measured in terms of lung and spleen MTB burden. These results demonstrate that the use of MSU as adjuvant may represent a novel strategy to enhance the efficacy of BCG vaccination.	[Taus, Francesco; Santucci, Marilina B.; Greco, Emanuela; Poerio, Noemi; Fraziano, Maurizio] Univ Roma Tor Vergata, Dept Biol, Rome, Italy; [Morandi, Matteo; Palucci, Ivana; Delogu, Giovanni] Univ Cattolica Sacro Cuore, Inst Microbiol, I-00168 Rome, Italy; [Mariotti, Sabrina; Nisini, Roberto] Ist Super Sanita, Dept Infect Parasit & Immunomediated, I-00161 Rome, Italy	University of Rome Tor Vergata; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Istituto Superiore di Sanita (ISS)	Fraziano, M (corresponding author), Univ Roma Tor Vergata, Dept Biol, Rome, Italy.	fraziano@bio.uniroma2.it	Poerio, Noemi/AAB-4835-2022; MARIOTTI, SABRINA/M-4361-2015; Nisini, Roberto/M-4363-2015; Fraziano, Maurizio/F-1425-2013; palucci, ivana/J-8542-2018	Poerio, Noemi/0000-0002-7025-6496; MARIOTTI, SABRINA/0000-0002-7009-7616; Nisini, Roberto/0000-0003-1077-423X; Fraziano, Maurizio/0000-0002-5643-0769; Delogu, Giovanni/0000-0003-0182-8267; Taus, Francesco/0000-0003-4728-6686; palucci, ivana/0000-0003-2106-1761	EU [N. 643558]; Italian Ministry of University [2008L57JXW 005, 2009N98ST4_003]	EU(European Commission); Italian Ministry of University(Ministry of Education, Universities and Research (MIUR))	EU framework programme for research and innovation Horizon 2020 "Eliciting Mucosal Immunity to tuberculosis" (EMI-TB), Grant N. 643558. Italian Ministry of University (grant number 2008L57JXW 005). EG was supported by the Italian Ministry of University (grant number 2009N98ST4_003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMSON S, 1982, ARTHRITIS RHEUM, V25, P174, DOI 10.1002/art.1780250210; Andersen P, 2014, TRENDS IMMUNOL, V35, P387, DOI 10.1016/j.it.2014.04.006; Arai Y, 2014, BIOCHEM BIOPH RES CO, V443, P556, DOI 10.1016/j.bbrc.2013.12.007; Babior BM, 2004, CURR OPIN IMMUNOL, V16, P42, DOI 10.1016/j.coi.2003.12.001; Bieber JD, 2004, ARTHRITIS RHEUM-US, V50, P2400, DOI 10.1002/art.20438; Chen CJ, 2006, J CLIN INVEST, V116, P2262, DOI 10.1172/JCI28075; Conforti-Andreoni C, 2011, J IMMUNOL, V187, P5842, DOI 10.4049/jimmunol.1101408; Desaulniers P, 2001, J LEUKOCYTE BIOL, V70, P659; Greco E, 2012, P NATL ACAD SCI USA, V109, pE1360, DOI 10.1073/pnas.1200484109; Greco E, 2010, IMMUNOLOGY, V129, P125, DOI 10.1111/j.1365-2567.2009.03145.x; Hesseling AC, 2008, INT J TUBERC LUNG D, V12, P1376; Hu DE, 2004, CANCER RES, V64, P5059, DOI 10.1158/0008-5472.CAN-04-1586; Kleinnijenhuis J, 2012, P NATL ACAD SCI USA, V109, P17537, DOI 10.1073/pnas.1202870109; Kool M, 2008, J EXP MED, V205, P869, DOI 10.1084/jem.20071087; Ma XJ, 2007, WORLD J GASTROENTERO, V13, P1060, DOI 10.3748/wjg.v13.i7.1060; Mak TK, 2008, LANCET, V372, P786, DOI 10.1016/S0140-6736(08)61318-5; Malik ZA, 2000, J EXP MED, V191, P287, DOI 10.1084/jem.191.2.287; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2010, IMMUNOL REV, V233, P218, DOI 10.1111/j.0105-2896.2009.00860.x; Mayer-Barber KD, 2014, NATURE, V511, P99, DOI 10.1038/nature13489; Nunes P, 2010, J LEUKOCYTE BIOL, V88, P57, DOI 10.1189/jlb.0110028; Pethe K, 2004, P NATL ACAD SCI USA, V101, P13642, DOI 10.1073/pnas.0401657101; Pitt JM, 2013, MICROB PATHOGENESIS, V58, P2, DOI 10.1016/j.micpath.2012.12.002; Quintin J, 2014, CURR OPIN IMMUNOL, V29, P1, DOI 10.1016/j.coi.2014.02.006; Quintin J, 2012, CELL HOST MICROBE, V12, P223, DOI 10.1016/j.chom.2012.06.006; Rock KL, 2005, SPRINGER SEMIN IMMUN, V26, P231, DOI 10.1007/s00281-004-0173-3; Rybicka JM, 2010, P NATL ACAD SCI USA, V107, P10496, DOI 10.1073/pnas.0914867107; Saiga H., 2014, J INFECT DIS; Sakamaki I, 2011, NUCLEOS NUCLEOT NUCL, V30, P1077, DOI 10.1080/15257770.2011.597368; Sali M, 2010, INFECT IMMUN, V78, P5202, DOI 10.1128/IAI.00267-10; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Shi Y, 2010, IMMUNOL REV, V233, P203, DOI 10.1111/j.0105-2896.2009.00851.x; STURGILLKOSZYCKI S, 1994, SCIENCE, V263, P678, DOI 10.1126/science.8303277; Swaminathan S, 2010, CLIN INFECT DIS, V50, pS184, DOI 10.1086/651490; von Reyn CF, 2012, INT J TUBERC LUNG D, V16, P718, DOI 10.5588/ijtld.11.0444; Young DB, 2008, J CLIN INVEST, V118, P1255, DOI 10.1172/JCI34614; Zhang Y, 2010, J IMMUNOL, V184, P5104, DOI 10.4049/jimmunol.0902851	37	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0127279	10.1371/journal.pone.0127279	http://dx.doi.org/10.1371/journal.pone.0127279			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26023779	gold, Green Published, Green Submitted			2022-12-26	WOS:000355319400034
J	Wolff, M; Unuchek, D; Zhang, B; Gordeliy, V; Willbold, D; Nagel-Steger, L				Wolff, Martin; Unuchek, Dmitry; Zhang, Bo; Gordeliy, Valentin; Willbold, Dieter; Nagel-Steger, Luitgard			Amyloid beta Oligomeric Species Present in the Lag Phase of Amyloid Formation	PLOS ONE			English	Article							SEDIMENTATION-VELOCITY EXPERIMENTS; PROTEIN-PROTEIN INTERACTIONS; ANALYTICAL ULTRACENTRIFUGATION; ALZHEIMERS-DISEASE; SOLUBLE OLIGOMERS; MOLECULAR-WEIGHT; PEPTIDE; HETEROGENEITY; DISTRIBUTIONS; A-BETA-40	Alzheimer's disease (AD)-associated amyloid beta peptide (A beta) is one of the main actors in AD pathogenesis. A beta is characterized by its high tendency to self-associate, leading to the generation of oligomers and amyloid fibrils. The elucidation of pathways and intermediates is crucial for the understanding of protein assembly mechanisms in general and in conjunction with neurodegenerative diseases, e.g., for the identification of new therapeutic targets. Our study focused on A beta 42 and its oligomeric assemblies in the lag phase of amyloid formation, as studied by sedimentation velocity (SV) centrifugation. The assembly state of A beta during the lag phase, the time required by an A beta solution to reach the exponential growth phase of aggregation, was characterized by a dominant monomer fraction below 1 S and a population of oligomeric species between 4 and 16 S. From the oligomer population, two major species close to a 12-mer and an 18-mer with a globular shape were identified. The recurrence of these two species at different initial concentrations and experimental conditions as the smallest assemblies present in solution supports the existence of distinct, energetically favored assemblies in solution. The sizes of the two species suggest an A beta 42 aggregation pathway that is based on a basic hexameric building block. The study demonstrates the potential of SV analysis for the evaluation of protein aggregation pathways.	[Wolff, Martin; Willbold, Dieter; Nagel-Steger, Luitgard] Univ Dusseldorf, Inst Phys Biol, Dusseldorf, Germany; [Wolff, Martin; Zhang, Bo; Gordeliy, Valentin; Willbold, Dieter; Nagel-Steger, Luitgard] Res Ctr Julich, Inst Complex Syst, Struct Biochem ICS 6, Julich, Germany; [Unuchek, Dmitry; Gordeliy, Valentin] Moscow Inst Phys & Technol, Dep Mol & Chem Phys, Dolgoprudnyi, Russia; [Zhang, Bo] Res Ctr Julich, Inst Complex Syst, Neutron Scattering ICS 1, Julich, Germany; [Gordeliy, Valentin] Univ Grenoble Alpes, Inst Biol Struct JP Ebel, Grenoble, France; [Gordeliy, Valentin] CNRS, Inst Biol Struct JP Ebel, Grenoble, France; [Gordeliy, Valentin] CEA Grenoble, Direct Sci Vivant, Inst Biol Struct JP Ebel, F-38054 Grenoble, France	Heinrich Heine University Dusseldorf; Helmholtz Association; Research Center Julich; Moscow Institute of Physics & Technology; Helmholtz Association; Research Center Julich; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Nagel-Steger, L (corresponding author), Univ Dusseldorf, Inst Phys Biol, Dusseldorf, Germany.		Gordeliy, Valentin I/J-3636-2013; Willbold, Dieter/A-6280-2013; Nagel-Steger, Luitgard/H-6415-2013	Gordeliy, Valentin I/0000-0001-5782-5896; Willbold, Dieter/0000-0002-0065-7366; Nagel-Steger, Luitgard/0000-0001-5232-2149; Unuchek, Dmitrii/0000-0003-2590-2644	NSF Teragrid Allocation grant [TGMCB070038]; Helmholtz Association	NSF Teragrid Allocation grant; Helmholtz Association(Helmholtz Association)	Computing time and computational support for UltraScan III software was provided by the Texas Advanced Computing Centre from UT Austin, and is supported by an NSF Teragrid Allocation grant, TGMCB070038. Helmholtz Association funded this work through the Helmholtz-Portfolio Topics "Technology and Medicine" and "Drug Research". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Bernstein SL, 2009, NAT CHEM, V1, P326, DOI [10.1038/NCHEM.247, 10.1038/nchem.247]; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Brookes E, 2010, EUR BIOPHYS J BIOPHY, V39, P423, DOI 10.1007/s00249-009-0418-0; Brookes E, 2010, EUR BIOPHYS J BIOPHY, V39, P405, DOI 10.1007/s00249-009-0413-5; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Cohn E. J., 1943, PROTEINS AMINO ACIDS; Correia JJ, 2010, METHOD CELL BIOL, V95, P275, DOI 10.1016/S0091-679X(10)95015-2; Dam J, 2005, BIOPHYS J, V89, P619, DOI 10.1529/biophysj.105.059568; Demeler B, 2014, ULTRASCAN SOFTWARE C; Demeler B, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P210; Demeler B, 2009, METHOD ENZYMOL, V454, P87, DOI 10.1016/S0076-6879(08)03804-4; Durchschlag H., 1986, THERMODYNAMIC DATA B; Fawzi NL, 2011, NATURE, V480, P268, DOI 10.1038/nature10577; Fezoui Y, 2000, AMYLOID, V7, P166, DOI 10.3109/13506120009146831; Fezoui Y, 2002, J BIOL CHEM, V277, P36948, DOI 10.1074/jbc.M204168200; Findeis MA, 2007, PHARMACOL THERAPEUT, V116, P266, DOI 10.1016/j.pharmthera.2007.06.006; Finder VH, 2007, NEURODEGENER DIS, V4, P13, DOI 10.1159/000100355; Gabrielson JP, 2011, METHODS, V54, P83, DOI 10.1016/j.ymeth.2010.12.030; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Gu L, 2013, J BIOL CHEM, V288, P18673, DOI 10.1074/jbc.M113.457739; Harding SE, 2010, BIOCHEM SOC T, V38, P901, DOI 10.1042/BST0380901; Hayden EY, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt226; Hepler RW, 2006, BIOCHEMISTRY-US, V45, P15157, DOI 10.1021/bi061850f; Hosszu LLP, 2009, J BIOL CHEM, V284, P21981, DOI 10.1074/jbc.M809173200; Howlett GJ, 2006, CURR OPIN CHEM BIOL, V10, P430, DOI 10.1016/j.cbpa.2006.08.017; Jang H, 2013, J PHYS CHEM B; Kar SR, 2000, ANAL BIOCHEM, V285, P135, DOI 10.1006/abio.2000.4748; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Klyubin I, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-25; Kumar A, 2012, J BIOL CHEM, V287, P21253, DOI 10.1074/jbc.M112.355156; Kumar A, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0018759, 10.1371/journal.pone.0026520, 10.1371/journal.pone.0020701]; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lamm O., 1929, ARK MAT ASTR FYS, V21B, P1; Larson ME, 2012, J NEUROCHEM, V120, P125, DOI 10.1111/j.1471-4159.2011.07478.x; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Laue TM, 2014, SEDNTERP; Legleiter J, 2011, METHODS MOL BIOL, V670, P57, DOI 10.1007/978-1-60761-744-0_5; Lendel C, 2014, ANGEW CHEM INT EDIT, V53, P12756, DOI 10.1002/anie.201406357; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Liu J, 2006, AAPS J, V8, pE580, DOI 10.1208/aapsj080367; Masters CL, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006262; Mok YF, 2006, METHOD ENZYMOL, V413, P199, DOI 10.1016/S0076-6879(06)13011-6; Mok YF, 2011, METHODS, V54, P67, DOI 10.1016/j.ymeth.2010.10.004; Nagel-Steger L, 2010, EUR BIOPHYS J BIOPHY, V39, P415, DOI 10.1007/s00249-009-0416-2; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Rai N, 2005, STRUCTURE, V13, P723, DOI 10.1016/j.str.2005.02.012; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Roychaudhuri R, 2013, J MOL BIOL, V425, P292, DOI 10.1016/j.jmb.2012.11.006; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schuck P, 2014, SEDFIT; Tomaselli S, 2006, CHEMBIOCHEM, V7, P257, DOI 10.1002/cbic.200500223; Trevitt CR, 2014, J BIOL CHEM, V289, P25497, DOI 10.1074/jbc.M114.566588; VANHOLDE KE, 1978, BIOPOLYMERS, V17, P1387, DOI 10.1002/bip.1978.360170602; Walsh DM, 2002, BIOCHEM SOC T, V30, P552, DOI 10.1042/BST0300552; Wang HW, 2002, BRAIN RES, V924, P133, DOI 10.1016/S0006-8993(01)03058-X; Yankner BA, 2009, J BIOL CHEM, V284, P4754, DOI 10.1074/jbc.R800018200	58	20	20	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0127865	10.1371/journal.pone.0127865	http://dx.doi.org/10.1371/journal.pone.0127865			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024352	Green Published, gold			2022-12-26	WOS:000355319400055
J	Eze, JI; Correia-Gomes, C; Borobia-Belsue, J; Tucker, AW; Sparrow, D; Strachan, DW; Gunn, GJ				Eze, J. I.; Correia-Gomes, C.; Borobia-Belsue, J.; Tucker, A. W.; Sparrow, D.; Strachan, D. W.; Gunn, G. J.			Comparison of Respiratory Disease Prevalence among Voluntary Monitoring Systems for Pig Health and Welfare in the UK	PLOS ONE			English	Article							ENZOOTIC PNEUMONIA; SLAUGHTER; HERDS; INFECTIONS; PLEURITIS; LESIONS	Surveillance of animal diseases provides information essential for the protection of animal health and ultimately public health. The voluntary pig health schemes, implemented in the United Kingdom, are integrated systems which capture information on different macroscopic disease conditions detected in slaughtered pigs. Many of these conditions have been associated with a reduction in performance traits and consequent increases in production costs. The schemes are the Wholesome Pigs Scotland in Scotland, the BPEX Pig Health Scheme in England and Wales and the Pig Regen Ltd. health and welfare checks done in Northern Ireland. This report set out to compare the prevalence of four respiratory conditions (enzootic pneumonia-like lesions, pleurisy, pleuropneumonia lesions and abscesses in the lung) assessed by these three Pig Health Schemes. The seasonal variations and year trends associated with the conditions in each scheme are presented. The paper also highlights the differences in prevalence for each condition across these schemes and areas where further research is needed. A general increase in the prevalence of enzootic pneumonia like lesions was observed in Scotland, England and Wales since 2009, while a general decrease was observed in Northern Ireland over the years of the scheme. Pleurisy prevalence has increased since 2010 in all three schemes, whilst pleuropneumonia has been decreasing. Prevalence of abscesses in the lung has decreased in England, Wales and Northern Ireland but has increased in Scotland. This analysis highlights the value of surveillance schemes based on abattoir pathology monitoring of four respiratory lesions. The outputs at scheme level have significant value as indicators of endemic and emerging disease, and for producers and herd veterinarians in planning and evaluating herd health control programs when comparing individual farm results with national averages.	[Eze, J. I.; Correia-Gomes, C.; Gunn, G. J.] Scottish Rural Coll, Edinburgh, Midlothian, Scotland; [Borobia-Belsue, J.; Sparrow, D.] MossVet, Craigavon, County Armagh, North Ireland; [Tucker, A. W.] Univ Cambridge, Dept Vet Med, Cambridge, England; [Strachan, D. W.] Boehringer Ingelheim Vetmed, Bracknell, Berks, England	University of Cambridge; Boehringer Ingelheim	Eze, JI (corresponding author), Scottish Rural Coll, Kings Bldg,West Mains Rd, Edinburgh, Midlothian, Scotland.	jude.eze@sruc.ac.uk		Eze, Jude/0000-0001-5308-7080; Gomes, Carla/0000-0002-2909-4608	Scottish Government (RERAD funded programme. Food, Land and People (Programme 2)	Scottish Government (RERAD funded programme. Food, Land and People (Programme 2)	This work was underpinned by Theme 6 work funded by the Scottish Government (RERAD funded programme. Food, Land and People (Programme 2)). MossVet and Boehringer Ingelheim Vetmedica provided support in the form of salaries for authors Borobia-Belsue J, Sparrow D and Strachan, W.D. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BPEX, 2014, EXPL BPHS LES TIM TR; Brockmeier S. L, 2002, POLYMICROBIAL DIS; Cleveland-Nielsen A, 2002, PREV VET MED, V55, P121, DOI 10.1016/S0167-5877(02)00089-2; FALK K, 1991, ACTA VET SCAND, V32, P67; Hansen MS, 2010, J COMP PATHOL, V143, P120, DOI 10.1016/j.jcpa.2010.01.012; Harley S, 2012, IRISH VET J, V65, DOI 10.1186/2046-0481-65-11; Hoinville LJ, 2013, PREV VET MED, V112, P1, DOI 10.1016/j.prevetmed.2013.06.006; Jager HC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029655; Jubb K.V.F., 1993, PATHOLOGY DOMESTIC A; Maes DG, 2001, VET REC, V148, P41, DOI 10.1136/vr.148.2.41; Martinez J, 2009, VET J, V179, P240, DOI 10.1016/j.tvjl.2007.10.006; Meyns T, 2011, VET J, V187, P388, DOI 10.1016/j.tvjl.2009.12.027; Nathues H, 2013, ACTA VET SCANDINAVIC, V55; Opriessnig T., 2011, Animal Health Research Reviews, V12, P133, DOI 10.1017/S1466252311000120; Pijoan C., 2006, DIS SWINE, P719; Pol JMA, 1997, VET MICROBIOL, V55, P259, DOI 10.1016/S0378-1135(96)01323-5; Sanchez-Vazquez MJ, 2011, VET REC, V169, P413, DOI 10.1136/vr.d4814; Sanchez-Vazquez M. J., 2010, Pig Journal, V63, P25; Sanchez-Vazquez MJ, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-151; Siugzdaite J, 2005, MED WETER, V61, P42; Stolwijk AM, 1999, J EPIDEMIOL COMMUN H, V53, P235, DOI 10.1136/jech.53.4.235; Wahba G., 1990, SPLINE MODELS OBSERV; Williamson SM, 2012, VET REC, V171, P271, DOI 10.1136/vr.100673; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Woodbine KA, 2007, VET REC, V160, P751, DOI 10.1136/vr.160.22.751	25	16	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128137	10.1371/journal.pone.0128137	http://dx.doi.org/10.1371/journal.pone.0128137			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020635	Green Published, gold, Green Submitted			2022-12-26	WOS:000355187300084
J	Liu, SM; Lacape, JM; Constable, GA; Llewellyn, DJ				Liu, Shiming; Lacape, Jean-Marc; Constable, Greg A.; Llewellyn, Danny J.			Inheritance and QTL Mapping of Leaf Nutrient Concentration in a Cotton Inter-Specific Derived RIL Population	PLOS ONE			English	Article							SEED MINERAL CONCENTRATIONS; QUANTITATIVE TRAIT LOCI; SALT TOLERANCE; POTASSIUM NUTRITION; GENOME SEQUENCE; USE-EFFICIENCY; PHOSPHORUS; CULTIVARS; GROWTH; MECHANISM	Developing and deploying cotton cultivars with high nutrient uptake, use efficiency and tolerance to nutrient related soil stresses is desirable to assist sustainable soil management. Genetic variation, heritability, selection response and quantitative trait loci (QTLs) were investigated for five macronutrients (P, K, Ca, Mg, S) and five micronutrients (Fe, Mn, B, Zn, and Cu) in a recombinant inbred line (RIL) population from an inter-specific cross between Gossypium hirsutum cv. Guazuncho 2, and G. barbadense accession VH8-4602. Na and K/Na ratio were also studied as the imbalance between Na and other nutrients is detrimental to cotton growth and development. The concentrations of nutrients were measured for different plant parts of the two parents and for leaf samples of the whole population collected at early to peak flowering in field experiments over two years in a sodic Vertosol soil. Parental contrast was large for most nutrient concentrations in leaves when compared with other plant parts. Segregation for leaf nutrient concentration was observed within the population with transgression for P, K, K/Na ratio and all micronutrients. Genotypic difference was the major factor behind within-population variation for most nutrients, while narrow sense heritability was moderate (0.27 for Mn and Cu, and 0.43 for B). At least one significant QTL was identified for each nutrient except K and more than half of those QTLs were clustered on chromosomes 14, 18 and 22. Selection response was predicted to be low for P and all micronutrients except B, high for K, Na and B, and very high for K/Na ratio. Correlations were more common between macronutrients, Na and K/Na ratio where the nature and strength of the relations varied (r=-0.69 to 0.76). We conclude that there is sufficient genetic diversity between these two tetraploid cotton species that could be exploited to improve cotton nutrient status by introgressing species-unique favourable alleles.	[Liu, Shiming; Constable, Greg A.] CSIRO, Agr Flagship, Narrabri, NSW 2390, Australia; [Lacape, Jean-Marc] CIRAD, UMR AGAP, F-34398 Montpellier, France; [Llewellyn, Danny J.] CSIRO, Agr Flagship, Canberra, ACT 2601, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); CIRAD; Universite de Montpellier; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Liu, SM (corresponding author), CSIRO, Agr Flagship, Narrabri, NSW 2390, Australia.	shiming.liu@csiro.au	Llewellyn, Danny J/D-5230-2009; Liu, Shiming/F-2557-2011; Lacape, Jean-Marc/B-4326-2008; Lacape, JM/Y-1806-2019	Llewellyn, Danny J/0000-0001-9535-8707; Lacape, Jean-Marc/0000-0003-0891-8329; 	French National Research Agency, ANR [ANR-06-GPLA-018]; Cotton Breeding Australia Joint Venture	French National Research Agency, ANR(French National Research Agency (ANR)); Cotton Breeding Australia Joint Venture(Cotton R&D Corp)	The French National Research Agency, ANR, through its program specialized in plant genomics, Genoplante, has sponsored the QTL aspects of this research (project nr ANR-06-GPLA-018). Field studies in Australia were funded through the Cotton Breeding Australia Joint Venture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2002, TASKS VEG SCI, V37, P199; Ashraf M, 2002, CRIT REV PLANT SCI, V21, P1, DOI 10.1016/S0735-2689(02)80036-3; Baligar VC, 2001, COMMUN SOIL SCI PLAN, V32, P921, DOI 10.1081/CSS-100104098; Basten C. J., 2003, QTL CARTOGRAPHER VER; BENNETT O. L., 1965, AGRON J, V57, P296; Bernardo R., 2010, BREEDING QUANTITATIV; Bienert S., 2005, PROJEKTFINANZIERUNG; BLAND WL, 1989, SOIL SCI SOC AM J, V53, P1850, DOI 10.2136/sssaj1989.03615995005300060039x; BLEVINS DG, 1994, PHYSIOLOGY AND DETERMINATION OF CROP YIELD, P259; Boyce Chartered Accountants, 2012, AUSTR COTT COMP AN 2, P50; BRAUD M, 1974, Coton et Fibres Tropicales, V29, P215; BROUDER SM, 1990, FIELD CROP RES, V23, P187, DOI 10.1016/0378-4290(90)90054-F; Brown JF, 1990, P 5 AUSTR COTT C, P67; Butler DG, 2009, QUEENSLAND DEP PRIMA; CAKMAK I, 1986, PHYSIOL PLANTARUM, V68, P483, DOI 10.1111/j.1399-3054.1986.tb03386.x; CASSMAN KG, 1989, AGRON J, V81, P870, DOI 10.2134/agronj1989.00021962008100060006x; CHHIPA BR, 1995, AUST J AGR RES, V46, P533, DOI 10.1071/AR9950533; CONSTABLE GA, 1988, AUST J EXP AGR, V28, P351, DOI 10.1071/EA9880351; CRAMER GR, 1987, PLANT PHYSIOL, V83, P510, DOI 10.1104/pp.83.3.510; Ding GD, 2010, ANN BOT-LONDON, V105, P1221, DOI 10.1093/aob/mcq050; EVANS LT, 1993, CROP EVOLUTION ADAPT, P317; Fageria N.K., 2009, USE NUTR CROP PLANTS; Falconer D. S., 1996, INTRO QUANTITATIVE G; Foolad MR, 1999, PLANT BREEDING, V118, P167, DOI 10.1046/j.1439-0523.1999.118002167.x; Foolad MR, 1997, PLANT BREEDING, V116, P53, DOI 10.1111/j.1439-0523.1997.tb00974.x; FOY CD, 1981, AGRON J, V73, P107, DOI 10.2134/agronj1981.00021962007300010024x; FOY CD, 1969, AGRON J, V61, P690, DOI 10.2134/agronj1969.00021962006100050012x; Garcia A, 1997, PLANT CELL ENVIRON, V20, P1167, DOI 10.1046/j.1365-3040.1997.d01-146.x; Genc Y, 2010, THEOR APPL GENET, V121, P877, DOI 10.1007/s00122-010-1357-y; Gholamhossein H., 2011, World Cotton Research Conference-5, Mumbai, India, 7-11 November 2011, P85; Gilmour A. R., 1997, Journal of Agricultural, Biological, and Environmental Statistics, V2, P269, DOI 10.2307/1400446; Girma K, 2007, J COTTON SCI, V11, P12; Gorham J, 2010, PHYSIOLOGY OF COTTON, P129, DOI 10.1007/978-90-481-3195-2_13; Hearn A. B., 1981, Field Crop Abstracts, V34, P11; Hodges SC, 2010, PHYSIOLOGY OF COTTON, P142, DOI 10.1007/978-90-481-3195-2_14; Holland JB, 2002, PL BRED RE, V22, P9; Iqbal R. J., 2001, International Journal of Agriculture and Biology, V3, P186; James RA, 2006, PLANT PHYSIOL, V142, P1537, DOI 10.1104/pp.106.086538; JOHAM HE, 1955, PLANT PHYSIOL, V30, P4, DOI 10.1104/pp.30.1.4; Kerby T. A., 1985, Potassium in Agriculture, P843; Lacape JM, 2013, FIELD CROP RES, V144, P256, DOI 10.1016/j.fcr.2013.01.001; Lacape JM, 2009, THEOR APPL GENET, V119, P281, DOI 10.1007/s00122-009-1037-y; Li FG, 2014, NAT GENET, V46, P567, DOI 10.1038/ng.2987; Liu SM, 2015, EUPHYTICA, V201, P253, DOI 10.1007/s10681-014-1205-2; Liu SM, 2011, EUPHYTICA, V178, P309, DOI 10.1007/s10681-010-0289-6; Lopez M, 2008, J PLANT NUTR, V31, P1947, DOI 10.1080/01904160802402963; Mullins GL, 2010, PHYSIOLOGY OF COTTON, P97, DOI 10.1007/978-90-481-3195-2_9; OHKI K, 1975, AGRON J, V67, P30, DOI 10.2134/agronj1975.00021962006700010008x; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; Peleg Z, 2009, THEOR APPL GENET, V119, P353, DOI 10.1007/s00122-009-1044-z; Rana RS, 1980, P INT S SALT AFF SOI, P487; RATHERT G, 1982, J PLANT NUTR, V5, P183, DOI 10.1080/01904168209362948; REUTER DJ, 1986, PLANT ANAL INTERPRET, P38; Rochester I., 2012, FLOWERING FRUITING C, V8, P35; Rochester IJ, 2015, FIELD CROP RES, V173, P14, DOI 10.1016/j.fcr.2015.01.001; Rochester IJ, 2010, CROP PASTURE SCI, V61, P825, DOI 10.1071/CP10043; Rochester IJ, 2003, P WORLD COTT RES C 3, V3, P681; ROTHWELL A., 1967, Coir. Grow. Rev., V44, P23; Sankaran RP, 2009, THEOR APPL GENET, V119, P241, DOI 10.1007/s00122-009-1033-2; Schwab GJ, 2000, COMMUN SOIL SCI PLAN, V31, P149, DOI 10.1080/00103620009370426; Soil Survey Staff, 1996, KEYS SOIL TAX; THENABADU MW, 1966, NATURE, V209, P165, DOI 10.1038/209165a0; Tiwari RS, 2013, EUPHYTICA, V194, P1, DOI 10.1007/s10681-013-0927-x; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Waddle BA, 1984, COTTON AGRONOMY MONO, V24, P233; Wang ZN, 2013, G3-GENES GENOM GENET, V3, P1759, DOI 10.1534/g3.113.006890; Ward WT, 1999, 2199 CSIRO; Waters BM, 2008, NEW PHYTOL, V179, P1033, DOI 10.1111/j.1469-8137.2008.02544.x; Welch RM, 2004, J EXP BOT, V55, P353, DOI 10.1093/jxb/erh064; WHITENBERG D. C, 1964, BOT GAZ, V125, P56, DOI 10.1086/336245; Wright PR, 1999, PLANT SOIL, V211, P231, DOI 10.1023/A:1004652728420; ZARCINAS BA, 1987, COMMUN SOIL SCI PLAN, V18, P131, DOI 10.1080/00103628709367806; Zia-ul-hassan, 2011, J PLANT NUTR, V34, P1957, DOI 10.1080/01904167.2011.610483	74	4	4	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128100	10.1371/journal.pone.0128100	http://dx.doi.org/10.1371/journal.pone.0128100			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020945	Green Published, gold			2022-12-26	WOS:000355187300080
J	Long, JA; Burrow, CJ; Ginter, M; Maisey, JG; Trinajstic, KM; Coates, MI; Young, GC; Senden, TJ				Long, John A.; Burrow, Carole J.; Ginter, Michal; Maisey, John G.; Trinajstic, Kate M.; Coates, Michael I.; Young, Gavin C.; Senden, Tim J.			First Shark from the Late Devonian (Frasnian) Gogo Formation, Western Australia Sheds New Light on the Development of Tessellated Calcified Cartilage	PLOS ONE			English	Article							PRIMITIVE CHONDRICHTHYAN BRAINCASE; PLACODERM FISH; TRIBODUS-LIMAE; ARTHRODIRE; ORIGIN; ELASMOBRANCHII; PRESERVATION; JAWS; SKELETON; REVEALS	Background Living gnathostomes (jawed vertebrates) comprise two divisions, Chondrichthyes (cartilaginous fishes, including euchondrichthyans with prismatic calcified cartilage, and extinct stem chondrichthyans) and Osteichthyes (bony fishes including tetrapods). Most of the early chondrichthyan ('shark') record is based upon isolated teeth, spines, and scales, with the oldest articulated sharks that exhibit major diagnostic characters of the group-prismatic calcified cartilage and pelvic claspers in males-being from the latest Devonian, c. 360 Mya. This paucity of information about early chondrichthyan anatomy is mainly due to their lack of endoskeletal bone and consequent low preservation potential. Methodology/Principal Findings Here we present new data from the first well-preserved chondrichthyan fossil from the early Late Devonian (ca. 380-384 Mya) Gogo Formation Legerstatte of Western Australia. The specimen is the first Devonian shark body fossil to be acid-prepared, revealing the endoskeletal elements as three-dimensional undistorted units: Meckel's cartilages, nasal, ceratohyal, basibranchial and possible epibranchial cartilages, plus left and right scapulocoracoids, as well as teeth and scales. This unique specimen is assigned to Gogoselachus lynnbeazleyae n. gen. n. sp. Conclusions/Significance The Meckel's cartilages show a jaw articulation surface dominated by an expansive cotylus, and a small mandibular knob, an unusual condition for chondrichthyans. The scapulocoracoid of the new specimen shows evidence of two pectoral fin basal articulation facets, differing from the standard condition for early gnathostomes which have either one or three articulations. The tooth structure is intermediate between the 'primitive' ctenacanthiform and symmoriiform condition, and more derived forms with a euselachian-type base. Of special interest is the highly distinctive type of calcified cartilage forming the endoskeleton, comprising multiple layers of nonprismatic subpolygonal tesserae separated by a cellular matrix, interpreted as a transitional step toward the tessellated prismatic calcified cartilage that is recognized as the main diagnostic character of the chondrichthyans.	[Long, John A.] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia; [Long, John A.; Young, Gavin C.] Australian Natl Univ, Dept Earth & Marine Sci, Canberra, ACT, Australia; [Long, John A.] Museum Victoria, Geosci, Melbourne, Vic, Australia; [Burrow, Carole J.] Queensland Museum, Ancient Environm, Hendra, Qld, Australia; [Ginter, Michal] Univ Warsaw, Palaeontol Sect, Warsaw, Poland; [Maisey, John G.] Amer Museum Nat Hist, New York, NY 10024 USA; [Trinajstic, Kate M.] Curtin Univ, Environm & Agr, Perth, WA 6845, Australia; [Trinajstic, Kate M.] Western Australian Museum, Earth & Planetary Sci, Perth, WA 6000, Australia; [Coates, Michael I.] Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; [Senden, Tim J.] Australian Natl Univ, Dept Appl Math, Canberra, ACT, Australia	Flinders University South Australia; Australian National University; Museum Victoria; Queensland Museum; University of Warsaw; American Museum of Natural History (AMNH); Curtin University; Western Australian Museum; University of Chicago; Australian National University	Long, JA (corresponding author), Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia.	john.long@flinders.edu.au	Burrow, Carole J./AAG-4327-2021; Coates, Michael/AAO-3810-2020; Senden, Tim J/A-7319-2008	Coates, Michael/0000-0003-2843-1075; Senden, Tim J/0000-0001-6808-7219; Trinajstic, Kate/0000-0002-6519-6396; Ginter, Michal/0000-0002-7210-7312; Long, John/0000-0001-8012-0114	Australian Research Council [DP 0772138, DP1092870]	Australian Research Council(Australian Research Council)	This work was supported by grants from the Australian Research Council DP 0772138 awarded to GCY and JAL for travel and scanning of specimens at the ANU; and DP1092870 awarded to KMT for travel to collaborate. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basden AM, 2000, NATURE, V403, P185, DOI 10.1038/35003183; Brazeau MD, 2009, NATURE, V457, P305, DOI 10.1038/nature07436; Burrow CJ, 2008, ACTA GEOL POL, V58, P155; Burrow Carole J., 2004, Fossils and Strata, V50, P8; Burrow CJ, 2009, ANTARCT SCI, V21, P71, DOI 10.1017/S0954102008001521; Burrow CJ, 2005, LETHAIA, V38, P205, DOI 10.1080/00241160510013286; Burrow CJ, 2012, HIST BIOL, V21, P71; Cappetta H., 1987, HDB PALEOICHTHYOLO B, V3B; Coates MI, 1998, NATURE, V396, P729, DOI 10.1038/25467; Coates MI, 2001, J VERTEBR PALEONTOL, V21, P438, DOI 10.1671/0272-4634(2001)021[0438:ANSCFT]2.0.CO;2; Coates MI, 1998, T ROY SOC EDIN-EARTH, V89, P63, DOI 10.1017/S026359330000701X; Coates MI, 2007, PALAEONTOLOGY, V50, P1421, DOI 10.1111/j.1475-4983.2007.00719.x; Davis SP, 2012, NATURE, V486, P247, DOI 10.1038/nature11080; Dean MN, 2009, J ANAT, V215, P227, DOI 10.1111/j.1469-7580.2009.01116.x; DENNIS K, 1979, ZOOL J LINN SOC-LOND, V67, P1, DOI 10.1111/j.1096-3642.1979.tb01102.x; DENNIS K, 1981, ZOOL J LINN SOC-LOND, V73, P213, DOI 10.1111/j.1096-3642.1981.tb01594.x; DICK J R F, 1978, Transactions of the Royal Society of Edinburgh, V70, P63; Dupret V, 2014, NATURE, V507, P500, DOI 10.1038/nature12980; Eames BF, 2007, J ANAT, V210, P542, DOI 10.1111/j.1469-7580.2007.00723.x; Furbringer P, 1903, MORPHOLOGISCHES JB, V31, P360; Gardiner B. G., 1984, B BRIT MUS NAT HIST, V37, P1; Gardiner B.G., 1977, PROBLEMS EARLY VERTE, P227; Gegenbaur C., 1872, UNTERSUCHUNGEN VERGL; Ginter M., 2010, HDB PALEOICHTHYOLOGY; Ginter M., 2005, ICHTHYOL ISSUES SPEC, V8, P11; Ginter Michal, 2010, P145; Ginter Michal, 2002, Acta Geologica Polonica, V52, P169; Gross W., 1973, Palaeontographica Abt A, V142, P51; Gross W., 1971, Palaeontographica A, V136, P1; Gross W, 1937, SENCKENBERGIANIA, V20, P123; Hairapetian V, 2006, ACTA PALAEONTOL POL, V51, P499; Hairapetian V, 2009, ACTA GEOL POL, V59, P173; HOTTON NICHOLAS, 1952, JOUR PALEONTOL, V26, P489; Jaekel O., 1921, Palaeontologische Zeitschrift Berlin, V3, P213; Janvier P., 1996, EARLY VERTEBRATES; Janvier Philippe, 2010, P431; KEMP NE, 1979, J MORPHOL, V160, P75, DOI 10.1002/jmor.1051600106; Lane JA, 2012, J PALEONTOL, V86, P886, DOI 10.1666/11-139.1; Lane JA, 2009, J VERTEBR PALEONTOL, V29, P25, DOI 10.1080/02724634.2009.10010359; Long J., 2006, SWIMMING STONE AMAZI; Long J.A., 1997, Records of the Western Australian Museum Supplement, V53, P1; LONG JA, 1995, PALAEONTOLOGY, V38, P39; Long JA, 2008, NATURE, V453, P650, DOI 10.1038/nature06966; Long JA, 2015, NATURE, V517, P196, DOI 10.1038/nature13825; Long JA, 2010, ANNU REV EARTH PL SC, V38, P255, DOI 10.1146/annurev-earth-040809-152416; Long JA, 2009, NATURE, V457, P1124, DOI 10.1038/nature07732; Maisey J.G., 1989, Journal of Vertebrate Paleontology, V9, P174; Maisey JG, 2005, B AM MUS NAT HIST, P1; Maisey JG, 2001, J VERTEBR PALEONTOL, V21, P702, DOI 10.1671/0272-4634(2001)021[0702:APCBFT]2.0.CO;2; Maisey JG, 2001, J VERTEBR PALEONTOL, V21, P807, DOI 10.1671/0272-4634(2001)021[0807:CSRNCF]2.0.CO;2; Maisey JG, 2001, SYST ASSOC SPEC VOL, V61, P263; Maisey JG, 1989, AM MUSEUM NOVITATES, V2931; Maisey J, 2009, ACTA ZOOL-STOCKHOLM, V90, P109, DOI 10.1111/j.1463-6395.2008.00330.x; Maisey John G., 2013, Revue de Paleobiologie, V32, P355; Martinez-Perez C, 2010, J VERTEBR PALEONTOL, V30, P1622, DOI 10.1080/02724634.2010.501451; Melendez I, 2013, GEOLOGY, V41, P123, DOI 10.1130/G33492.1; Miles R.S., 1973, Zoological J Linn Soc, V53, P63; MILES RS, 1977, ZOOL J LINN SOC-LOND, V61, P1, DOI 10.1111/j.1096-3642.1977.tb01031.x; Miller RF, 2003, NATURE, V425, P501, DOI 10.1038/nature02001; Newberry J.S., 1875, REPORT GEOLOGICAL SU, V2, P1; Orvig T., 1951, Arkiv for Zoologi (2), V2, P321; Pradel A, 2014, NATURE, V509, P608, DOI 10.1038/nature13195; REIF W-E, 1978, Palaeontologische Zeitschrift, V52, P110; Rucklin M, 2012, NATURE, V491, P748, DOI 10.1038/nature11555; Schaeffer B., 1975, Colloques Internationaux du Centre National de la Recherche Scientifique, P101; Soares MC, 2013, J MORPHOL, V274, P1111, DOI 10.1002/jmor.20166; Trinajstic K, 2007, BIOL LETTERS, V3, P197, DOI 10.1098/rsbl.2006.0604; Trinajstic K, 2013, SCIENCE, V341, P160, DOI 10.1126/science.1237275; Trinajstic K, 2009, PALAEONTOLOGY, V52, P641, DOI 10.1111/j.1475-4983.2009.00870.x; Turner S., 1993, P174; TURNER S, 1982, Journal of Vertebrate Paleontology, V2, P117; Turner Susan, 2000, Courier Forschungsinstitut Senckenberg, V223, P487; Wells J. W., 1944, PALAEONTOGRAPH AMER, V3, P99; Williams ME, 2001, J VERTEBR PALEONTOL, V21, P214, DOI 10.1671/0272-4634(2001)021[0214:TRICSW]2.0.CO;2; Williams ME, 1998, J VERTEBR PALEONTOL, V18, P251, DOI 10.1080/02724634.1998.10011054; Woodward A.S., 1892, GEOL MAG, P1, DOI [10.1017/S0016756800188533, DOI 10.1017/S0016756800188533]; YOUNG GC, 1982, PALAEONTOLOGY, V25, P817; YOUNG GC, 1984, PALAEONTOLOGY, V27, P635; Zangerl R., 1981, HDB PALEOICHTHYOLOGY; Zhu M, 1999, NATURE, V397, P607, DOI 10.1038/17594; Zhu M, 2001, NATURE, V410, P81, DOI 10.1038/35065078; Zhu M, 2013, NATURE, V502, P188, DOI 10.1038/nature12617; Zhu M, 2009, NATURE, V458, P469, DOI 10.1038/nature07855	83	23	23	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0126066	10.1371/journal.pone.0126066	http://dx.doi.org/10.1371/journal.pone.0126066			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020788	Green Published, gold, Green Submitted			2022-12-26	WOS:000355187300019
J	Moghimi, E; Solomon, JA; Gianforcaro, A; Hamadeh, MJ				Moghimi, Elnaz; Solomon, Jesse A.; Gianforcaro, Alexandro; Hamadeh, Mazen J.			Dietary Vitamin D-3 Restriction Exacerbates Disease Pathophysiology in the Spinal Cord of the G93A Mouse Model of Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							MOTOR-NEURON DEGENERATION; MANGANESE SUPEROXIDE-DISMUTASE; NITRIC-OXIDE SYNTHASE; OXIDATIVE STRESS; CU/ZN-SUPEROXIDE; D DEFICIENCY; AUTOIMMUNE ENCEPHALOMYELITIS; CYTOKINE PRODUCTION; GONADAL-STEROIDS; SEX-DIFFERENCES	Background Dietary vitamin D-3 (D-3) restriction reduces paw grip endurance and motor performance in G93A mice, and increases inflammation and apoptosis in the quadriceps of females. ALS, a neuromuscular disease, causes progressive degeneration of motor neurons in the brain and spinal cord. Objective We analyzed the spinal cords of G93A mice following dietary D-3 restriction at 2.5% the adequate intake (AI) for oxidative damage (4-HNE, 3-NY), antioxidant enzymes (SOD2, catalase, GPx1), inflammation (TNF-alpha, IL-6, IL-10), apoptosis (bax/bcl-2 ratio, cleaved/procaspase 3 ratio), neurotrophic factor (GDNF) and neuron count (ChAT, SMI-36/SMI-32 ratio). Methods Beginning at age 25 d, 42 G93A mice were provided food ad libitum with either adequate (AI; 1 IU D-3/g feed; 12 M, 11 F) or deficient (DEF; 0.025 IU D-3/g feed; 10 M, 9 F) D3. At age 113 d, the spinal cords were analyzed for protein content. Differences were considered significant at P <= 0.10, since this was a pilot study. Results DEF mice had 16% higher 4-HNE (P = 0.056), 12% higher GPx1 (P = 0.057) and 23% higher Bax/Bcl2 ratio (P = 0.076) vs. AI. DEF females had 29% higher GPx1 (P = 0.001) and 22% higher IL-6 (P = 0.077) vs. AI females. DEF males had 23% higher 4-HNE (P = 0.066) and 18% lower SOD2 (P = 0.034) vs. AI males. DEF males had 27% lower SOD2 (P = 0.004), 17% lower GPx1 (P = 0.070), 29% lower IL-6 (P = 0.023) and 22% lower ChAT (P = 0.082) vs. DEF females. Conclusion D-3 deficiency exacerbates disease pathophysiology in the spinal cord of G93A mice, the exact mechanisms are sex-specific. This is in accord with our previous results in the quadriceps, as well as functional and disease outcomes.	[Moghimi, Elnaz; Solomon, Jesse A.; Gianforcaro, Alexandro; Hamadeh, Mazen J.] York Univ, Fac Hlth, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada; [Moghimi, Elnaz; Solomon, Jesse A.; Gianforcaro, Alexandro; Hamadeh, Mazen J.] York Univ, Muscle Hlth Res Ctr, Toronto, ON M3J 2R7, Canada	York University - Canada; York University - Canada	Hamadeh, MJ (corresponding author), York Univ, Fac Hlth, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada.	hamadeh@yorku.ca			Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Natural Sciences and Engineering Research Council of Canada (http://www.nserccrsng.gc.ca/Index_eng.asp) received by MJH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1977, J Nutr, V107, P1340; [Anonymous], 2005, EST SAF START DOS CL; Barp J, 2012, CAN J PHYSIOL PHARM, V90, P1229, DOI [10.1139/y2012-078, 10.1139/Y2012-078]; BECKMAN JS, 1993, NATURE, V364, P584, DOI 10.1038/364584a0; Berthod F, IN VIVO IN VITRO MOD; Bishop A, 2009, J NEUROCHEM, V109, P74, DOI 10.1111/j.1471-4159.2009.05884.x; Bobjer J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061466; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Camu W, 2014, NEUROBIOL AGING, V35, P1198, DOI 10.1016/j.neurobiolaging.2013.11.005; Cernetich A, 2006, INFECT IMMUN, V74, P3190, DOI 10.1128/IAI.00008-06; Cervetto C, 2013, TOXICOLOGY, V311, P69, DOI 10.1016/j.tox.2013.04.004; Chakrabarti S, 2012, AM J PHYSIOL-CELL PH, V302, pC666, DOI 10.1152/ajpcell.00181.2011; Codoner-Franch P, 2012, J PEDIATR-US, V161, P848, DOI 10.1016/j.jpeds.2012.04.046; Coletta RD, 2002, ORAL MICROBIOL IMMUN, V17, P186, DOI 10.1034/j.1399-302X.2002.170309.x; Czlonkowska A, 2005, CURR PHARM DESIGN, V11, P1017, DOI 10.2174/1381612053381693; Dadon-Nachum M, 2011, J MOL NEUROSCI, V43, P470, DOI 10.1007/s12031-010-9467-1; de Aguilar JLG, 2000, NEUROBIOL DIS, V7, P406, DOI 10.1006/nbdi.2000.0295; Foran E, 2009, ANTIOXID REDOX SIGN, V11, P1587, DOI 10.1089/ars.2009.2444; Frakes AE, 2014, NEURON, V81, P1009, DOI 10.1016/j.neuron.2014.01.013; GALLAGHER JC, 1980, J CLIN ENDOCR METAB, V51, P1359, DOI 10.1210/jcem-51-6-1359; Gan XF, 2014, INT J CLIN EXP MED, V7, P2530; Garcia-Segura LM, 2003, PROG NEUROBIOL, V71, P31, DOI 10.1016/j.pneurobio.2003.09.005; Garcion E, 1998, GLIA, V22, P282, DOI 10.1002/(SICI)1098-1136(199803)22:3<282::AID-GLIA7>3.0.CO;2-7; Gianforcaro A, 2014, CNS NEUROSCI THER, V20, P101, DOI 10.1111/cns.12204; Gianforcaro A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0030243; Gianforcaro A, 2012, CNS NEUROSCI THER, V18, P547, DOI 10.1111/j.1755-5949.2012.00316.x; Groeneveld GJ, 2004, BRAIN RES, V1021, P128, DOI 10.1016/j.brainres.2004.06.024; Gros-Louis F, 2006, BBA-MOL BASIS DIS, V1762, P956, DOI 10.1016/j.bbadis.2006.01.004; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Halhali A, 2010, J STEROID BIOCHEM, V121, P448, DOI 10.1016/j.jsbmb.2010.03.008; Hamden K, 2009, J NUTR SCI VITAMINOL, V55, P215, DOI 10.3177/jnsv.55.215; Ibi M, 2001, NEUROPHARMACOLOGY, V40, P761, DOI 10.1016/S0028-3908(01)00009-0; Isse K, 2010, HEPATOLOGY, V51, P869, DOI 10.1002/hep.23386; Jardim BV, 2013, ONCOL REP, V30, P1119, DOI 10.3892/or.2013.2540; Jennum P, 2013, J NEUROL, V260, P785, DOI 10.1007/s00415-012-6706-0; Jin X, 2007, HEPATOLOGY, V46, P802, DOI 10.1002/hep.21728; Karam C, 2013, J CLIN NEUROSCI; Keeney JTR, 2013, FREE RADICAL BIO MED, V65, P324, DOI 10.1016/j.freeradbiomed.2013.07.019; Luong KVQ, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-16; Kiaei M, 2007, EXP NEUROL, V205, P74, DOI 10.1016/j.expneurol.2007.01.036; Kinuta K, 2000, ENDOCRINOLOGY, V141, P1317, DOI 10.1210/en.141.4.1317; Knippenberg S, 2011, ACTA NEUROL SCAND, V124, P171, DOI 10.1111/j.1600-0404.2010.01447.x; Laird E, 2014, J CLIN ENDOCR METAB, V99, P1807, DOI 10.1210/jc.2013-3507; Lechtzin N, 2006, RESP CARE, V51, P871; LI ZG, 1993, CLIN EXP RHEUMATOL, V11, P157; Lim S, 2013, AM J CLIN NUTR, V97, P524, DOI 10.3945/ajcn.112.048496; Littlejohns TJ, 2014, NEUROLOGY, V83, P920, DOI 10.1212/WNL.0000000000000755; Liu MY, 2007, J CEREBR BLOOD F MET, V27, P135, DOI 10.1038/sj.jcbfm.9600331; de Almeida JPL, 2012, NEUROL SCI, V33, P9, DOI 10.1007/s10072-011-0921-9; MacMillan-Crow LA, 2001, FREE RADICAL RES, V34, P325, DOI 10.1080/10715760100300281; Maggio M, 2006, J CLIN ENDOCR METAB, V91, P345, DOI 10.1210/jc.2005-1097; Mark LP, 2001, AM J NEURORADIOL, V22, P1813; Milionis A, 2012, FASEB J, V26; Miller RR, 2007, J GERONTOL A-BIOL, V62, P1402, DOI 10.1093/gerona/62.12.1402; Mitchell JD, 2000, AMYOTROPH LATERAL SC, V1, P235, DOI 10.1080/14660820050515061; Moghimi E, 2015, PLOS ONE UNPUB; Nakamizo T, 2000, NEUROREPORT, V11, P3493, DOI 10.1097/00001756-200011090-00019; Nashold FE, 2009, J IMMUNOL, V183, P3672, DOI 10.4049/jimmunol.0901351; Nguyen D, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.117; Nishitoh H, 2008, GENE DEV, V22, P1451, DOI 10.1101/gad.1640108; Numakawa T, 2011, J TOXICOL-US, V2011, DOI 10.1155/2011/405194; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Parakh S, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/408681; Parkhomenko E, 2012, FASEB J, V26; Parkhomenko EA, 2011, DIETARY VITAMIN D3 5, P329; Parkhomenko EA, 2011, VITAMIN D DEFICIENCY, V328; Patel BP, 2009, CLIN NUTR, V28, P604, DOI 10.1016/j.clnu.2009.06.002; Pedersen WA, 1998, ANN NEUROL, V44, P819, DOI 10.1002/ana.410440518; Peterson CA, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-10; Pierrot-Deseilligny C, 2009, J NEUROL, V256, P1468, DOI 10.1007/s00415-009-5139-x; Rao AK, 2011, J STEROID BIOCHEM, V127, P382, DOI 10.1016/j.jsbmb.2011.06.008; Ravid A, 2002, J ENDOCRINOL, V173, DOI 10.1677/joe.0.1730525; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Renton AE, 2014, NAT NEUROSCI, V17, P17, DOI 10.1038/nn.3584; Robberecht W, 2013, NAT REV NEUROSCI, V14, P248, DOI 10.1038/nrn3430; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Saedisomeolia A, 2013, Indian J Med Sci, V67, P29; Saldanha CJ, 2009, FRONT NEUROENDOCRIN, V30, P106, DOI 10.1016/j.yfrne.2009.04.016; Samuel S, 2008, NUTR REV, V66, pS116, DOI 10.1111/j.1753-4887.2008.00094.x; Sapan CV, 1999, BIOTECHNOL APPL BIOC, V29, P99; Schubert D, 2001, J NEUROSCI, V21, P7455, DOI 10.1523/JNEUROSCI.21-19-07455.2001; Shahsavar S, 2013, FASEB J, V27; Sharma HS, 2005, ANN NY ACAD SCI, V1053, P422, DOI 10.1196/annals.1344.037; Siddiqui MA, 2011, HUM EXP TOXICOL, V30, P860, DOI 10.1177/0960327110382130; Solomon JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029354; Solomon JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020582; Spach KM, 2005, J IMMUNOL, V175, P4119, DOI 10.4049/jimmunol.175.6.4119; Steensberg A, 2003, AM J PHYSIOL-ENDOC M, V285, pE433, DOI 10.1152/ajpendo.00074.2003; Summerday Nicole Marie, 2012, J Pharm Pract, V25, P75, DOI 10.1177/0897190011421839; Suzuki M, 2007, AMYOTROPH LATERAL SC, V8, P20, DOI 10.1080/17482960600982447; Swartz KR, 2001, BRAIN RES, V896, P86, DOI 10.1016/S0006-8993(01)02013-3; Taheri-Shalmani S, 2013, FASEB J, V27; Tangpong J, 2007, J NEUROCHEM, V100, P191, DOI 10.1111/j.1471-4159.2006.04179.x; Trieu VN, 1999, BIOCHEM BIOPH RES CO, V258, P685, DOI 10.1006/bbrc.1999.0577; Tripanichkul W, 2007, BRAIN RES, V1164, P24, DOI 10.1016/j.brainres.2007.05.076; Tripodoro Vilma Adriana, 2008, Curr Opin Support Palliat Care, V2, P173, DOI 10.1097/SPC.0b013e32830c9049; Trumbull KA, 2009, ANTIOXID REDOX SIGN, V11, P1627, DOI 10.1089/ARS.2009.2574; UCHINO M, 1994, J NEUROL SCI, V127, P61, DOI 10.1016/0022-510X(94)90136-8; Veglianese P, 2006, MOL CELL NEUROSCI, V31, P218, DOI 10.1016/j.mcn.2005.09.009; Wang J, 2001, J NEUROCHEM, V77, P804, DOI 10.1046/j.1471-4159.2001.00271.x; Whitacre CC, 2001, NAT IMMUNOL, V2, P777, DOI 10.1038/ni0901-777; Wijesekera LC, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-3; Willis KS, 2012, OPEN ACCESS J SPORTS, V3, P35, DOI 10.2147/OAJSM.S31022; WOODROOFE MN, 1995, NEUROLOGY, V45, pS6, DOI 10.1212/WNL.45.6_Suppl_6.S6; Wrzosek M, 2013, PHARMACOL REP, V65, P271, DOI 10.1016/S1734-1140(13)71003-X; Wu SP, 2011, DISCOV MED, V11, P325; YANAGIHARA R, 1984, ANN NEUROL, V15, P42, DOI 10.1002/ana.410150108; Zaldivar V, 2011, NEUROENDOCRINOLOGY, V93, P106, DOI 10.1159/000323760; Zhang Y, 2012, J IMMUNOL, V188, P2127, DOI 10.4049/jimmunol.1102412; Zhao L, 2004, J BIOL CHEM, V279, P44093, DOI 10.1074/jbc.M313131200	110	9	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0126355	10.1371/journal.pone.0126355	http://dx.doi.org/10.1371/journal.pone.0126355			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020962	gold, Green Published			2022-12-26	WOS:000355187300021
J	Li, YF; Yao, YT; Qian, X; Shi, L; Zhou, JX; Ma, QL; Yao, YF				Li, Yingfu; Yao, Yueting; Qian, Xu; Shi, Li; Zhou, Jingxian; Ma, Qianli; Yao, Yufeng			The Association of Adiponectin Gene Promoter Variations with Non-Small Cell Lung Cancer in a Han Chinese Population	PLOS ONE			English	Article							BREAST-CANCER; ENDOMETRIAL CANCER; COLORECTAL-CANCER; CIRCULATING ADIPONECTIN; INSULIN-RESISTANCE; RISK; ADIPOQ; POLYMORPHISMS; VARIANTS; SHESIS	Recently, in vitro studies have demonstrated that adiponectin has antiangiogenic and tumor growth-limiting properties. Additionally, serum adiponectin levels have been associated with the risk of several cancers; specifically, serum adiponectin was significantly lower in lung cancer patients with advanced-stage disease. In this study, we examined the association of adiponectin gene promoter variations associated with adiponectin gene expression and plasma levels in non-small cell lung cancer (NSCLC) in a Han Chinese population. A total of 319 patients with NSCLC and 489 healthy individuals were recruited to evaluate the association of four adiponectin gene promoter single-nucleotide polymorphisms (SNPs) (SNP-12140G>A, SNP-11426A>G, SNP-11391G>A and SNP-11377C>G) with NSCLS risk. Additionally, we constructed haplotypes of these four SNPs and evaluated the association of these haplotypes with NSCLS risk. Our results showed that among these four SNPs, only SNP-12140G>A was associated with NSCLC risk(P < 0.05). The haplotype analysis showed that no haplotype was associated with NSCLC after performing a Bonferroni correction (P>0.05). Additionally, an association analysis of the four SNPs stratified into pathologic stages I+II and III+IV showed that these SNPs did not exhibit significant differences between pathologic stages I+II and III+IV. Moreover, we did not observe any differences in allele and genotype frequency for these SNPs between adenocarcinoma and squamous cell carcinoma. Our results indicated that the G allele of SNP-12140may be a risk factor for NSCLC (OR = 1.516; 95% CI: 1.098-2.094) in this Han Chinese population.	[Li, Yingfu] Kunming Med Univ, Affiliated Hosp 1, Dept Geriatr, Kunming 650032, Peoples R China; [Yao, Yueting; Shi, Li; Zhou, Jingxian; Yao, Yufeng] Chinese Acad Med Sci, Inst Med Biol, Kunming 650118, Peoples R China; [Yao, Yueting; Shi, Li; Zhou, Jingxian; Yao, Yufeng] Peking Union Med Coll, Yunnan Key Lab Vaccine Res & Dev Severe Infect Di, Kunming 650118, Peoples R China; [Qian, Xu] Yanan Hosp Kunming, Dept Cardiothorac Surg, Kunming 650051, Peoples R China; [Ma, Qianli] Kunming Med Univ, Affiliated Hosp 3, Dept Thorac Surg, Kunming 650118, Peoples R China	Kunming Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; Yunnan Key Laboratory of Vaccine Research & Development on Severe Infectious Diseases; Peking Union Medical College; Kunming Medical University	Ma, QL (corresponding author), Kunming Med Univ, Affiliated Hosp 3, Dept Thorac Surg, Kunming 650118, Peoples R China.	maqianli78@126.com; leoyyf@gmail.com			Association Foundation Program of the Yunnan Provincial Science and Technology Department and Kunming Medical University [2012FB064]; Foundation Program of the Yunnan Province [2014NS139]	Association Foundation Program of the Yunnan Provincial Science and Technology Department and Kunming Medical University; Foundation Program of the Yunnan Province	This work was supported by grants from the Association Foundation Program of the Yunnan Provincial Science and Technology Department and Kunming Medical University (No. 2012FB064) and Foundation Program of the Yunnan Province (No. 2014NS139).	Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Carvajal-Carmona LG, 2009, HUM MOL GENET, V18, P1889, DOI 10.1093/hmg/ddp109; Cui EH, 2011, BIOCHEM CELL BIOL, V89, P308, DOI [10.1139/o11-005, 10.1139/O11-005]; Cust AE, 2007, J CLIN ENDOCR METAB, V92, P255, DOI 10.1210/jc.2006-1371; Dal Maso L, 2004, J CLIN ENDOCR METAB, V89, P1160, DOI 10.1210/jc.2003-031716; Dieudonne MN, 2006, BIOCHEM BIOPH RES CO, V345, P271, DOI 10.1016/j.bbrc.2006.04.076; Dupont WD, 1998, CONTROL CLIN TRIALS, V19, P589, DOI 10.1016/S0197-2456(98)00037-3; Groome PA, 2007, J THORAC ONCOL, V2, P694, DOI 10.1097/JTO.0b013e31812d05d5; Heid IM, 2006, DIABETES, V55, P375, DOI 10.2337/diabetes.55.02.06.db05-0747; Johnson JL, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/940405; Kaklamani VG, 2008, JAMA-J AM MED ASSOC, V300, P1523, DOI 10.1001/jama.300.13.1523; Korner A, 2007, J CLIN ENDOCR METAB, V92, P1041, DOI 10.1210/jc.2006-1858; Laumen H, 2009, DIABETES, V58, P984, DOI 10.2337/db07-1646; Li SS, 2009, JAMA-J AM MED ASSOC, V302, P179, DOI 10.1001/jama.2009.976; Li Y, 2014, J KUNMING MED U, V35, P52; Li YP, 2012, DIABETES-METAB RES, V28, P551, DOI 10.1002/dmrr.2309; Li ZQ, 2009, CELL RES, V19, P519, DOI 10.1038/cr.2009.33; Mantzoros C, 2004, J CLIN ENDOCR METAB, V89, P1102, DOI 10.1210/jc.2003-031804; Miyoshi Y, 2003, CLIN CANCER RES, V9, P5699; Nigro E, 2013, INT J BIOCHEM CELL B, V45, P1145, DOI 10.1016/j.biocel.2013.03.003; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pei Y, 2015, TUMOR BIOL, V36, P585, DOI 10.1007/s13277-014-2654-x; Petridou E, 2003, J CLIN ENDOCR METAB, V88, P993, DOI 10.1210/jc.2002-021209; Petridou ET, 2007, ONCOLOGY-BASEL, V73, P261, DOI 10.1159/000127424; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; Soliman PT, 2006, CANCER-AM CANCER SOC, V106, P2376, DOI 10.1002/cncr.21866; Spyridopoulos TN, 2007, INT J CANCER, V120, P1573, DOI 10.1002/ijc.22526; Tworoger SS, 2007, J CLIN ENDOCR METAB, V92, P1510, DOI 10.1210/jc.2006-1975; Wei EK, 2005, JNCI-J NATL CANCER I, V97, P1688, DOI 10.1093/jnci/dji376; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Xu YQ, 2013, MOL BIOL REP, V40, P1135, DOI 10.1007/s11033-012-2154-2; Yang WS, 2002, OBES RES, V10, P1104, DOI 10.1038/oby.2002.150; Yang Y, 2013, CYTOKINE, V61, P565, DOI 10.1016/j.cyto.2012.10.030	34	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0127751	10.1371/journal.pone.0127751	http://dx.doi.org/10.1371/journal.pone.0127751			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018909	gold, Green Published, Green Submitted			2022-12-26	WOS:000355185600096
J	Osterblom, H; Jouffray, JB; Folke, C; Crona, B; Troell, M; Merrie, A; Rockstrom, J				Osterblom, Henrik; Jouffray, Jean-Baptiste; Folke, Carl; Crona, Beatrice; Troell, Max; Merrie, Andrew; Rockstrom, Johan			Transnational Corporations as 'Keystone Actors' in Marine Ecosystems	PLOS ONE			English	Article							FORAGE FISH; AQUACULTURE; ANTHROPOCENE; EMERGENCE; IMPACTS; RESILIENCE; SYSTEMS; COMMONS; FOOD	Keystone species have a disproportionate influence on the structure and function of ecosystems. Here we analyze whether a keystone-like pattern can be observed in the relationship between transnational corporations and marine ecosystems globally. We show how thirteen corporations control 11-16% of the global marine catch (9-13 million tons) and 19-40% of the largest and most valuable stocks, including species that play important roles in their respective ecosystem. They dominate all segments of seafood production, operate through an extensive global network of subsidiaries and are profoundly involved in fisheries and aquaculture decision-making. Based on our findings, we define these companies as keystone actors of the Anthropocene. The phenomenon of keystone actors represents an increasingly important feature of the human-dominated world. Sustainable leadership by keystone actors could result in cascading effects throughout the entire seafood industry and enable a critical transition towards improved management of marine living resources and ecosystems.	[Osterblom, Henrik; Jouffray, Jean-Baptiste; Folke, Carl; Crona, Beatrice; Merrie, Andrew; Rockstrom, Johan] Stockholm Univ, Stockholm Resilience Ctr, S-10691 Stockholm, Sweden; [Jouffray, Jean-Baptiste; Folke, Carl; Crona, Beatrice; Troell, Max] Royal Swedish Acad Sci, Global Econ Dynam & Biosphere Acad Programme, S-10405 Stockholm, Sweden; [Folke, Carl; Troell, Max] Royal Swedish Acad Sci, Beijer Inst Ecol Econ, S-10405 Stockholm, Sweden	Stockholm University; Royal Swedish Academy of Sciences; Global Economic Dynamics & Biosphere - The Erling-Persson Family Academy Program; Royal Swedish Academy of Sciences; Beijer Institute of Ecological Economics	Osterblom, H (corresponding author), Stockholm Univ, Stockholm Resilience Ctr, S-10691 Stockholm, Sweden.	henrik.osterblom@su.se	Jouffray, Jean-Baptiste/AAN-1329-2020; Crona, Beatrice/HHZ-3183-2022; Troell, Max/I-1724-2019; Folke, Carl/Z-1545-2019	Jouffray, Jean-Baptiste/0000-0002-4105-6372; Crona, Beatrice/0000-0003-1617-4067; Troell, Max/0000-0002-7509-8140; Osterblom, Henrik/0000-0002-1913-5197; Folke, Carl/0000-0002-4050-3281; Rockstrom, Johan/0000-0001-8988-2983	Swedish Government; Nippon Foundation; Family Erling Persson Foundation; Kjell and Marta Beijer Foundation; Ivar Bendixsons fond	Swedish Government; Nippon Foundation(Nippon Foundation); Family Erling Persson Foundation; Kjell and Marta Beijer Foundation; Ivar Bendixsons fond	Baltic Ecosystem Adaptive Management (BEAM) is a strategic research initiative funded by the Swedish Government: http://www.regeringen.se/ (HO), the Nippon Foundation: http://www.nippon-foundation.or.jp/en/(HO, CF, AM), the Family Erling Persson Foundation: http://familjenerlingperssonsstiftelse.se/en/ (CF, BC, JBJ), the Kjell and Marta Beijer Foundation: http://www.beijerstiftelsen.se/(CF, MT, BC), Mistra (CF, JR, HO), Ivar Bendixsons fond (HO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adger WN, 2009, FRONT ECOL ENVIRON, V7, P150, DOI 10.1890/070148; Ainley DG, 2010, POLAR REC, V46, P233, DOI 10.1017/S003224740999009X; Ainley DG, 2009, FISH FISH, V10, P13, DOI 10.1111/j.1467-2979.2008.00293.x; Alder J, 2008, ANNU REV ENV RESOUR, V33, P153, DOI 10.1146/annurev.environ.33.020807.143204; [Anonymous], 2014, BLOOMBERG BUSINESSWE; [Anonymous], 2012, LONG TERM SUSTAINABI; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Berger M, 2013, SUSTAINABLE SEAFOOD; Berry M.A., 1998, ACAD MANAGE PERSPECT, V12, P38, DOI [10.5465/ame.1998.650515, DOI 10.5465/AME.1998.650515]; Biermann F, 2012, SCIENCE, V335, P1306, DOI 10.1126/science.1217255; Chakravarty S, 2009, P NATL ACAD SCI USA, V106, P11884, DOI 10.1073/pnas.0905232106; Cox SP, 2002, CAN J FISH AQUAT SCI, V59, P1736, DOI 10.1139/F02-138; Crona BI, 2016, FISH FISH, V17, P1175, DOI 10.1111/faf.12109; Cury PM, 2011, SCIENCE, V334, P1703, DOI 10.1126/science.1212928; Dicken P., 2011, GLOBAL SHIFT MAPPING, V6th; Essington TE, 2015, P NATL ACAD SCI USA, V112, P6648, DOI 10.1073/pnas.1422020112; FAO, 2014, FAO YB FISH STAT AQ; FAO, 2011, STAT WORLD FISH AQ O; FAO, 2013, FAO YB FISH STAT AQ; FAO, 2014, FISH AQ AT GLOB CAPT; FishSource, 2014, FISHSOURCE STAT ENV; FOLKE C, 1989, AMBIO, V18, P234; Folke C, 2011, AMBIO, V40, P719, DOI 10.1007/s13280-011-0184-y; GAA, 2014, GLOB AQ ALL FEED WOR; Galaz V, 2011, PUBLIC ADMIN, V89, P361, DOI 10.1111/j.1467-9299.2010.01883.x; Gilman EL, 2011, MAR POLICY, V35, P590, DOI 10.1016/j.marpol.2011.01.021; Hamilton A, 2011, MARKET IND DYNAMICS; Heede R, 2014, CLIMATIC CHANGE, V122, P229, DOI 10.1007/s10584-013-0986-y; Howard Philip H., 2009, Sustainability, V1, P1266, DOI 10.3390/su1041266; Hughes TP, 2005, TRENDS ECOL EVOL, V20, P380, DOI 10.1016/j.tree.2005.03.022; ICIJ, 2012, LOOT SEAS; IntraFish, 2013, INTRAFISH 150 REP; Jacquet J, 2013, SUSTAINABILITY-BASEL, V5, P1036, DOI 10.3390/su5031036; Kerstens D, 2013, INVESTING SEAFOOD 20; Merrick Richard L., 1997, Journal of Northwest Atlantic Fishery Science, V22, P343; Meyfroidt P, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/7/074012; Naylor RL, 2000, NATURE, V405, P1017, DOI 10.1038/35016500; Naylor RL, 2009, P NATL ACAD SCI USA, V106, P15103, DOI 10.1073/pnas.0905235106; OECD, 2010, GLOB FISH AQ OPP CHA; Osterblom H, 2008, OIKOS, V117, P967, DOI 10.1111/j.2008.0030-1299.16501.x; Osterblom H, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0278; Osterblom H, 2013, ECOL SOC, V18, DOI 10.5751/ES-05373-180204; Osterblom H, 2012, CONSERV BIOL, V26, P638, DOI 10.1111/j.1523-1739.2012.01850.x; Osterblom H, 2011, GLOBAL ENVIRON CHANG, V21, P972, DOI 10.1016/j.gloenvcha.2011.04.013; OSTROM E, 1993, J ECON PERSPECT, V7, P93, DOI 10.1257/jep.7.4.93; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; PAULY D., 1987, PERUVIAN ANCHOVETA I; Pauly D, 2014, FISH FISH, V15, P474, DOI 10.1111/faf.12032; Power ME, 1996, BIOSCIENCE, V46, P609, DOI 10.2307/1312990; Rabobank, 2011, SPOTL SEAF INV GUID; Rocha J, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0273; Roman M., 2013, BYCATCH NONTUNA CATC; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scheffer M, 2012, SCIENCE, V338, P344, DOI 10.1126/science.1225244; Sibert J, 2006, SCIENCE, V314, P1773, DOI 10.1126/science.1135347; Smith ADM, 2011, SCIENCE, V333, P1147, DOI 10.1126/science.1209395; Steffen W, 2007, AMBIO, V36, P614, DOI 10.1579/0044-7447(2007)36[614:TAAHNO]2.0.CO;2; Steffen W, 2011, PHILOS T R SOC A, V369, P842, DOI 10.1098/rsta.2010.0327; Sumaila UR, 2000, ECOL ECON, V32, P457, DOI 10.1016/S0921-8009(99)00120-2; Sutton M, 2008, SEAFOOD ECOLABELLING; Tacon AGJ, 2009, REV FISH SCI, V17, P305, DOI 10.1080/10641260802677074; Tallberg J, 2013, ISA ANN CONV SAN FRA; Torrissen O, 2011, REV FISH SCI, V19, P257, DOI 10.1080/10641262.2011.597890; Troell M, 2014, P NATL ACAD SCI USA, V111, P13257, DOI 10.1073/pnas.1404067111; Undercurrentnews, 2013, UNDERCURRENTNEWS; Valls A, 2015, ECOL MONOGR, V85, P29, DOI 10.1890/14-0306.1; van der Lingen D, 2006, LAR MAR ECOSYST, V14, P147; Vitali S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025995; Young OR, 2006, GLOBAL ENVIRON CHANG, V16, P304, DOI 10.1016/j.gloenvcha.2006.03.004	69	133	134	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0127533	10.1371/journal.pone.0127533	http://dx.doi.org/10.1371/journal.pone.0127533			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0RO	26017777	Green Published, Green Submitted, gold			2022-12-26	WOS:000355185600087
J	Petrone, P; Niola, M; Di Lorenzo, P; Paternoster, M; Graziano, V; Quaremba, G; Buccelli, C				Petrone, Pierpaolo; Niola, Massimo; Di Lorenzo, Pierpaolo; Paternoster, Mariano; Graziano, Vincenzo; Quaremba, Giuseppe; Buccelli, Claudio			Early Medical Skull Surgery for Treatment of Post-Traumatic Osteomyelitis 5,000 Years Ago	PLOS ONE			English	Article							MIDDLE BRONZE-AGE; CRANIAL SURGERY; CALLUS FORMATION; BONE; TREPANATION; FRACTURES; RECOMMENDATIONS; TREPHINATION; DIAGNOSIS; INJURY	Here we describe the findings of a unique example of the early techniques adopted in neurosurgery around 5000 years ago, consisting in a double well healed skull trephination associated with a post-cranial traumatic event occurring intra vitam to a young male from the Early Chalcolithic cemetery of Pontecagnano (South Italy, ca. 4,900 - 4,500 cal BP). Morphological, X-ray and 3D-CT scan skull-cap evaluation revealed that the main orifice was produced by scraping, obtained by clockwise rotary motion of a right-handed surgeon facing the patient, while the partial trephination was carried out by using a stone point as a drilling tool. In both cases, bone regrowth is indicative of the individual's prolonged postoperative survival and his near-complete recovery. The right femur shows a poorly healed mid-shaft fracture presumably induced by a high energy injury, and a resulting chronic osteomyelitis, affecting both femurs by hematogenous spread of the infection. Our observations on the visual and radiological features of skull and femur lesions, along with evidence on the timing of experimental bone regrowth vs. healing of lower limb fractures associated to long-term bone infections now suggest that this young man underwent a double skull trephination in order to alleviate his extremely painful condition induced by chronic osteomyelitis, which is thought to have been the cause of death.	[Petrone, Pierpaolo] Univ Naples Federico II, Dept Adv Biomed Sci, Lab Human Osteobiol & Forens Anthropol, I-80131 Naples, Italy; [Niola, Massimo; Di Lorenzo, Pierpaolo; Paternoster, Mariano; Graziano, Vincenzo; Buccelli, Claudio] Univ Naples Federico II, Azienda Osped Univ, Dept Adv Biomed Sci, I-80131 Naples, Italy; [Quaremba, Giuseppe] Univ Naples Federico II, Dept Ind Engn, Div Mech & Energet, I-80135 Naples, Italy	University of Naples Federico II; University of Naples Federico II; University of Naples Federico II	Petrone, P (corresponding author), Univ Naples Federico II, Dept Adv Biomed Sci, Lab Human Osteobiol & Forens Anthropol, I-80131 Naples, Italy.	pipetron@unina.it	Paternoster, Mariano/Y-4332-2018	Paternoster, Mariano/0000-0002-3063-9839; Quaremba, Giuseppe/0000-0002-4956-0303; DI LORENZO, Pierpaolo/0000-0002-8688-6257; Petrone, Pier Paolo/0000-0002-8897-8171; GRAZIANO, Vincenzo/0000-0002-9248-7439; BUCCELLI, Claudio/0000-0002-1070-7048; NIOLA, Massimo/0000-0002-5350-8460				Achneck HE, 2010, ANN SURG, V251, P217, DOI 10.1097/SLA.0b013e3181c3bcca; Alt KW, 1997, NATURE, V387, P360, DOI 10.1038/387360a0; Andrushko VA, 2008, AM J PHYS ANTHROPOL, V137, P4, DOI 10.1002/ajpa.20836; [Anonymous], 1980, J HUM EVOL, V9, P517; Appelboom T, 1999, LANCET, V354, P2153, DOI 10.1016/S0140-6736(99)07113-5; Arensburg B., 1988, B MEM SOC ANTHRO PAR, V5, P139; Asensi V, 2003, AM J MED GENET A, V119A, P132, DOI 10.1002/ajmg.a.20137; Aufderheide A. C., 1998, HUMAN PALEOPATHOLOGY; Bailo Modesti G, 1998, AION ARCHSTANT QUAD; Bereczki Z, 2015, INT J OSTEOARCHAEOL, V25, P322, DOI 10.1002/oa.2304; Bereczki ZS., 2005, ACTA MED LITU, V12, P65; Beredjiklian PK, 1999, U PENNSYLVANIA ORTHO, V12, P52; Breasted J.H., 1930, E SMITH SURG PAPYRUS; Broca P., 1876, B MEM SOC ANTHRO PAR, V11, P236; Broca P., 1867, B SOC ANTHROPOL PAR, V32, P866; Brothwell Donald R., 1967, DIS ANTIQUITY, P673; Buikstra Jane E., 1994, RES SERIES, V44; CAMPILLO D, 1984, ACTA NEUROCHIR, V70, P275, DOI 10.1007/BF01406656; Capasso L, 2002, LANCET, V359, P2206, DOI 10.1016/S0140-6736(02)09084-0; Capasso L, 1998, LANCET, V352, P1984; Chege N, 1996, INT J OSTEOARCHAEOL, V6, P249, DOI 10.1002/(SICI)1099-1212(199606)6:3<249::AID-OA269>3.3.CO;2-A; Cierny G, 1999, CLIN ORTHOP RELAT R, P97, DOI 10.1097/00003086-199903000-00012; Cierny III G, 2010, AM ACAD ORTHOP SURG, V7, P71; CIERNY III G, 1985, CONT ORTHOP, V10, P17, DOI DOI 10.1097/01.BLO.0000088564.81746.62; Crubezy E, 2001, CR ACAD SCI II A, V332, P417, DOI 10.1016/S1251-8050(01)01546-4; Crubezy E., 1996, ANTHROPOLOGIE BRNO, V34, P329; Cucina A, 2005, S ASIAN ARCHAEOLOGY, V1, P79; DASTUGUE J, 1973, ANTHROPOLOGIE, V77, P63; Dastugue J, 1962, NECROPOLE EPIPALEOLI, P133; Dimopoulos VG, 2008, J HIST NEUROSCI, V17, P131, DOI 10.1080/09647040701296770; Dobanovacki D., 2012, ARCH ONCOL, V20, P28; DUDAY H, 1990, Bulletins et Memoires de la Societe d'Anthropologie de Paris, V2, P29, DOI 10.3406/bmsap.1990.1740; El Ouarzazi A, 2005, Proceedings of the 13th World Congress of Neurological Surgery, Vols 1 and 2, P517; ERIKSEN EF, 1986, ENDOCR REV, V7, P379, DOI 10.1210/edrv-7-4-379; Ferembach D, 1962, NECROPOLE EPIPALEOLI, P3, DOI [10.1126/scitranslmed.aaa4642, DOI 10.1126/SCITRANSLMED.AAA4642]; FEREMBACH D., 1970, SUMER, V26, P21; Formicola V, 2012, J ANTHROPOL SCI, V90, P1; Fornaciari G, 1993, ORIGINI CHIRURGIA IT, P67; Galloway A, 1999, BROKEN BONES ANTHR A, P160; Germana Franco, 1992, TRAPANAZIONI CRANIOT; GOIKHMAN V. A., 1966, VOPROSY ANTROPOLOGII, V23, P111; Heidecker Karl-Maria, 2006, Wurzbg Medizinhist Mitt, V25, P113; HERSHKOVITZ I, 1991, AM J FOREN MED PATH, V12, P194, DOI 10.1097/00000433-199109000-00004; Hershkovitz I, 1987, JISRPREHISTSOC, V20, P128; Jackes M, 1997, ANTIQUITY, V71, P639, DOI 10.1017/S0003598X00085379; Jordanov J, 1990, HOMO, V41, P266; Kaufman MH, 1997, J ARCHAEOL SCI, V24, P193, DOI 10.1006/jasc.1995.0104; Lew DP, 1997, NEW ENGL J MED, V336, P999, DOI 10.1056/NEJM199704033361406; Lillie MC, 1998, NATURE, V391, P854, DOI 10.1038/36023; Lisowski F. P, 1967, DIS ANTIQUITY, P651; Littleton J, 2006, ARAB ARCHAEOL EPIGR, V17, P139, DOI 10.1111/j.1600-0471.2006.00267.x; Lopez B, 2011, ANTHROPOL SCI, V119, P247, DOI 10.1537/ase.100913; LOVEJOY CO, 1985, AM J PHYS ANTHROPOL, V68, P47, DOI 10.1002/ajpa.1330680105; Lyman R.L., 2001, VERTEBRATE TAPHONOMY; Mastrolorenzo G, 2006, P NATL ACAD SCI USA, V103, P4366, DOI 10.1073/pnas.0508697103; Mastrolorenzo G, 2001, NATURE, V410, P769, DOI 10.1038/35071167; Mastrolorenzo G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011127; MEINDL RS, 1985, AM J PHYS ANTHROPOL, V68, P57, DOI 10.1002/ajpa.1330680106; Mesching R, 1981, TREPANATIONS AFRIQUE, P17; Miles A., 1963, J DENT RES, V42, P255, DOI [10.1177/00220345630420012701, DOI 10.1177/00220345630420012701]; MOGLE P, 1995, INT J OSTEOARCHAEOL, V5, P77, DOI 10.1002/oa.1390050108; Mogliazza S, 2009, J ANTHROPOL SCI, V87, P187; Muller MENS., 1990, COMPREHENSIVE CLASSI, V1st ed; Nerlich A, 2003, TREPANATION: HISTORY, DISCOVERY, THEORY, P43; Ortner D. J., 2003, IDENTIFICATION PATHO, DOI DOI 10.1016/B978-012528628-2/50057-0; Ozan F, 2010, ACTA ORTHOP TRAUMATO, V44, P313, DOI 10.3944/AOTT.2010.2277; Passariello I, 2010, GEOCHRONOMETRIA, V35, P25, DOI 10.2478/v10003-010-0008-2; PERKINS R, 1987, J BONE JOINT SURG BR, V69, P521, DOI 10.1302/0301-620X.69B4.3611150; Petrone P, 2000, S ASIAN ARCHAEOLOGY, V1, P285; Petrone PP, 1998, AION ARCHSTANT QUAD, P201; Pineda Carlos, 2009, Semin Plast Surg, V23, P80, DOI 10.1055/s-0029-1214160; Podborsky V, 1993, PRAV KE JINY MORAVY; PODOLSKY S, 1962, Med Ann Dist Columbia, V31, P268; RIFKINSONMANN S, 1988, NEUROSURGERY, V23, P411, DOI 10.1227/00006123-198810000-00001; ROCHE J, 1959, CR HEBD ACAD SCI, V249, P729; ROESGEN M, 1989, ARCH ORTHOP TRAUM SU, V108, P1, DOI 10.1007/BF00934149; Rosing FW, 2007, HOMO, V58, P75, DOI 10.1016/j.jchb.2005.07.002; Salminen S., 2005, FEMORAL SHAFT FRACTU; Santos AL, 2015, INT J OSTEOARCHAEOL, V25, P110, DOI 10.1002/oa.2276; Schenker ML, 2012, J BONE JOINT SURG AM, V94A, P1057, DOI 10.2106/JBJS.K.00582; Skvarilova B, 2007, Acta Chir Plast, V49, P103; SPENCER RF, 1987, J BONE JOINT SURG BR, V69, P525, DOI 10.1302/0301-620X.69B4.3611151; Steinbock R., 1976, PALEOPATHOLOGICAL DI; Tabata Y, 1999, J NEUROSURG, V91, P851, DOI 10.3171/jns.1999.91.5.0851; Verano JW, 2003, TREPANATION: HISTORY, DISCOVERY, THEORY, P223; Wakely J, 1993, HISTOLOGY ANCIENT HU, P205; Weber J, 2006, INT J OSTEOARCHAEOL, V16, P536, DOI 10.1002/oa.844; White TD, 2005, HUMAN BONE MANUAL, P31; Yang TY, 2012, J BONE JOINT SURG BR, V94B, P227, DOI 10.1302/0301-620X.94B2.28193; Zias J., 1992, INT J OSTEOARCHAEOL, V2, P183, DOI [10.1002/oa.1390020210, DOI 10.1002/OA.1390020210]; Zias J, 1982, BASOR, V246, P55	91	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0124790	10.1371/journal.pone.0124790	http://dx.doi.org/10.1371/journal.pone.0124790			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018014	gold, Green Submitted, Green Published			2022-12-26	WOS:000355185600008
J	Cao, SY; Hepowit, N; Maupin-Furlow, JA				Cao, Shiyun; Hepowit, Nathaniel; Maupin-Furlow, Julie A.			Ubiquitin-Like Protein SAMP1 and JAMM/MPN plus Metalloprotease HvJAMM1 Constitute a System for Reversible Regulation of Metabolic Enzyme Activity in Archaea	PLOS ONE			English	Article							MOLYBDOPTERIN SYNTHASE; MOLYBDENUM COFACTOR; BIOSYNTHESIS; PATHWAY	Ubiquitin/ubiquitin-like (Ub/Ubl) proteins are involved in diverse cellular processes by their covalent linkage to protein substrates. Here, we provide evidence for a post-translational modification system that regulates enzyme activity which is composed of an archaeal Ubl protein (SAMP1) and a JAMM/MPN+ metalloprotease (HvJAMM1). Molybdopterin (MPT) synthase activity was found to be inhibited by covalent linkage of SAMP1 to the large subunit (MoaE) of MPT synthase. HvJAMM1 was shown to cleave the covalently linked inactive form of SAMP1-MoaE to the free functional individual SAMP1 and MoaE subunits of MPT synthase, suggesting reactivation of MPT synthase by this metalloprotease. Overall, this study provides new insight into the broad idea that Ub/Ubl modification is a post-translational process that can directly and reversibly regulate the activity of metabolic enzymes. In particular, we show that Ub/Ubl linkages on the active site residues of an enzyme (MPT synthase) can inhibit its catalytic activity and that the enzyme can be reactivated through cleavage by a JAMM/MPN+ metalloprotease.	[Cao, Shiyun; Hepowit, Nathaniel; Maupin-Furlow, Julie A.] Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA; [Maupin-Furlow, Julie A.] Univ Florida, Genet Inst, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Maupin-Furlow, JA (corresponding author), Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA.	jmaupin@ufl.edu	Maupin-Furlow, Julie/AAW-4035-2020; Hepowit, Nathaniel/GVU-1096-2022; Hepowit, Nathaniel L/J-2282-2016	Maupin-Furlow, Julie/0000-0001-6105-0923; Hepowit, Nathaniel L/0000-0002-7614-2756	U.S. Department of Energy, Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences and Biosciences, Physical Biosciences Program [DE-FG02-05ER15650]; National Institutes of Health [R01 GM57498]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057498] Funding Source: NIH RePORTER	U.S. Department of Energy, Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences and Biosciences, Physical Biosciences Program(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge funding awarded to JAM through the U.S. Department of Energy, Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences and Biosciences, Physical Biosciences Program (Grant DE-FG02-05ER15650) for work on ubiquitin-fold protein function in biosynthetic pathways and the National Institutes of Health (Grant R01 GM57498) for work on JAMM/MPN+ metalloproteases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bitan-Banin G, 2003, J BACTERIOL, V185, P772, DOI 10.1128/JB.185.3.772-778.2003; Chavarria NE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099104; Hepowit NL, 2012, MOL MICROBIOL, V86, P971, DOI 10.1111/mmi.12038; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Humbard MA, 2010, NATURE, V463, P54, DOI 10.1038/nature08659; Iobbi-Nivol C, 2013, BBA-BIOENERGETICS, V1827, P1086, DOI 10.1016/j.bbabio.2012.11.007; Lake MW, 2001, NATURE, V414, P325, DOI 10.1038/35104586; Leimkuhler S, 2011, COORDIN CHEM REV, V255, P1129, DOI 10.1016/j.ccr.2010.12.003; Maupin-Furlow JA, 2013, TRENDS MICROBIOL, V21, P31, DOI 10.1016/j.tim.2012.09.006; Miranda HV, 2014, MOL CELL PROTEOMICS, V13, P220, DOI 10.1074/mcp.M113.029652; Miranda HV, 2011, P NATL ACAD SCI USA, V108, P4417, DOI 10.1073/pnas.1018151108; Pearce MJ, 2008, SCIENCE, V322, P1104, DOI 10.1126/science.1163885; Rudolph MJ, 2001, NAT STRUCT BIOL, V8, P42; Sapir A, 2014, P NATL ACAD SCI USA, V111, pE3880, DOI 10.1073/pnas.1414748111; Sato Y, 2008, NATURE, V455, P358, DOI 10.1038/nature07254; Schwarz G, 2009, NATURE, V460, P839, DOI 10.1038/nature08302; van der Veen AG, 2012, ANNU REV BIOCHEM, V81, P323, DOI 10.1146/annurev-biochem-093010-153308; Williams MJ, 2011, J BACTERIOL, V193, P98, DOI 10.1128/JB.00774-10; Wuebbens MM, 2003, J BIOL CHEM, V278, P14523, DOI 10.1074/jbc.M300453200	19	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128399	10.1371/journal.pone.0128399	http://dx.doi.org/10.1371/journal.pone.0128399			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010867	Green Submitted, Green Published, gold			2022-12-26	WOS:000355183900232
J	Chang, YC; Yao, G; Hu, SC; Wang, JD				Chang, Yu-Chen; Yao, Grace; Hu, Susan C.; Wang, Jung-Der			Depression Affects the Scores of All Facets of the WHOQOL-BREF and May Mediate the Effects of Physical Disability among Community-Dwelling Older Adults	PLOS ONE			English	Article							QUALITY-OF-LIFE; MINI-MENTAL-STATE; BARTHEL INDEX; STROKE REHABILITATION; ALZHEIMERS-DISEASE; PEOPLE; PREVALENCE; TAIWAN; ADAPTATION; VALIDATION	Background Geriatric depression is associated with the overall quality of life (QOL). However, how depressive symptoms affect the different domains and facets of QOL in older adults, and whether depressive symptoms mediate the relationship between physical disability and QOL in older adults are unclear. Methods A total of 490 ambulatory community-dwelling older adults aged 65 years or above were interviewed using the brief version of the World Health Organisation Quality of Life instrument (WHOQOL-BREF), the Modified Barthel Index (MBI), the 15-item Geriatric Depression Scale (GDS-15), and the Mini-Mental State Examination (MMSE). Sequential models for multiple linear regressions were analysed to determine if the MBI, GDS-15 and MMSE scores predict the WHOQOL-BREF scores. The potential mediation effects of depression (as determined by the GDS-15) on the relationship between MBI and WHOQOL-BREF were also analysed. Results The GDS-15 score was predictive of the scores of the four domains and all 26 facets of the WHOQOL-BREF. The significant predictive effects of the MBI score on 15 of the 26 facets of the WHOQOL-BREF were reduced to three after the adjustment for the GDS-15 score. Depression (as assessed by the GDS-15) is a mediator of the relationship between MBI and the physical, psychological and environmental domains of the WHOQOL-BREF. Conclusions Depression (assessed by the GDS-15) may affect the scores of every domain and all facets of the WHOQOL-BREF in the elderly. Furthermore, it may mediate the relationship between the MBI and on QOL scores. We recommend taking depressive symptoms into consideration when measuring community-dwelling older adults' QOL and providing active ageing programs.	[Chang, Yu-Chen] Chia Yi Christian Hosp, Dept Community Hlth, Chiayi, Taiwan; [Chang, Yu-Chen] Chia Yi Christian Hosp, Div Geriatr, Chiayi, Taiwan; [Yao, Grace] Natl Taiwan Univ, Dept Psychol, Taipei 10764, Taiwan; [Hu, Susan C.; Wang, Jung-Der] Natl Cheng Kung Univ, Coll Med, Dept Publ Hlth, Tainan 70101, Taiwan; [Wang, Jung-Der] Natl Cheng Kung Univ, Dept Internal Med, Tainan 70101, Taiwan; [Wang, Jung-Der] Natl Cheng Kung Univ, Dept Occupt & Environm Med, Tainan 70101, Taiwan	National Taiwan University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University	Wang, JD (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Publ Hlth, Tainan 70101, Taiwan.	jdwang121@gmail.com	Hu, Susan C./AFU-5419-2022	Hu, Susan C./0000-0003-2437-5918	National Science Council [NSC 101-3114-Y-006-001]; Chia-Yi Christian Hospital [R102-6]	National Science Council(Ministry of Science and Technology, Taiwan); Chia-Yi Christian Hospital	JDW received the fund from National Science Council (NSC 101-3114-Y-006-001), and YCC received the fund from Chia-Yi Christian Hospital (R102-6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arslantas D, 2009, ARCH GERONTOL GERIAT, V48, P127, DOI 10.1016/j.archger.2007.11.005; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Beekman ATF, 1999, BRIT J PSYCHIAT, V174, P307, DOI 10.1192/bjp.174.4.307; Berlim MT, 2007, PSYCHIAT RES, V153, P253, DOI 10.1016/j.psychres.2006.07.006; Black SA, 1999, J CLIN EPIDEMIOL, V52, P1095, DOI 10.1016/S0895-4356(99)00100-6; Bowling A, 2007, AGE AGEING, V36, P310, DOI 10.1093/ageing/afm023; Chan ACM, 1996, J AGING HEALTH, V8, P238, DOI 10.1177/089826439600800205; Chan SWC, 2009, INT PSYCHOGERIATR, V21, P1171, DOI 10.1017/S1041610209990950; Chong MY, 2001, BRIT J PSYCHIAT, V178, P29, DOI 10.1192/bjp.178.1.29; Chou KL, 2005, INT J GERIATR PSYCH, V20, P41, DOI 10.1002/gps.1246; Fang CT, 2002, QUAL LIFE RES, V11, P753, DOI 10.1023/A:1020870402019; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Garin N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111498; GRANGER CV, 1979, ARCH PHYS MED REHAB, V60, P14; GRANGER CV, 1979, ARCH PHYS MED REHAB, V60, P145; Harper A, 1998, PSYCHOL MED, V28, P551, DOI 10.1017/S0033291798006667; Hwang HF, 2003, AGE AGEING, V32, P593, DOI 10.1093/ageing/afg102; IsHak WW, 2011, HARVARD REV PSYCHIAT, V19, P229, DOI 10.3109/10673229.2011.614099; Jang Y, 2004, ARCH PHYS MED REHAB, V85, P1890, DOI 10.1016/j.apmr.2004.02.032; Kucukdeveci AA, 2000, SCAND J REHABIL MED, V32, P87; Lu IC, 2011, QUAL LIFE RES, V20, P1469, DOI 10.1007/s11136-011-9889-4; MAHONEY F I, 1965, Md State Med J, V14, P61; Marc LG, 2008, AM J GERIAT PSYCHIAT, V16, P914, DOI 10.1097/JGP.0b013e318186bd67; Netuveli G, 2006, J EPIDEMIOL COMMUN H, V60, P357, DOI 10.1136/jech.2005.040071; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Rodda J, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5219; Ruo B, 2003, JAMA-J AM MED ASSOC, V290, P215, DOI 10.1001/jama.290.2.215; SHAH S, 1989, J CLIN EPIDEMIOL, V42, P703, DOI 10.1016/0895-4356(89)90065-6; Sheikh JI, 1986, GERIATRIC DEPRESSION; Spering CC, 2012, J GERONTOL A-BIOL, V67, P890, DOI 10.1093/gerona/gls006; Strine TW, 2009, J NERV MENT DIS, V197, P61, DOI 10.1097/NMD.0b013e3181924ad8; TOMBAUGH TN, 1992, J AM GERIATR SOC, V40, P922, DOI 10.1111/j.1532-5415.1992.tb01992.x; Ward A, 2002, INT PSYCHOGERIATR, V14, P249, DOI 10.1017/S1041610202008451; Webb E, 2011, J EPIDEMIOL COMMUN H, V65, P542, DOI 10.1136/jech.2009.101758; World Health Organization (WHO), 2014, IMPROVING HLTH WORKP; Yao G, 2007, J FORMOS MED ASSOC, V106, P592, DOI 10.1016/S0929-6646(07)60012-6	36	34	34	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128356	10.1371/journal.pone.0128356	http://dx.doi.org/10.1371/journal.pone.0128356			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0QZ	26010571	Green Submitted, Green Published, gold			2022-12-26	WOS:000355183900229
J	Kunnimalaiyaan, S; Sokolowski, KM; Balamurugan, M; Gamblin, TC; Kunnimalaiyaan, M				Kunnimalaiyaan, Selvi; Sokolowski, Kevin M.; Balamurugan, Mariappan; Gamblin, T. Clark; Kunnimalaiyaan, Muthusamy			Xanthohumol Inhibits Notch Signaling and Induces Apoptosis in Hepatocellular Carcinoma	PLOS ONE			English	Article							GAMMA-SECRETASE INHIBITORS; HUMULUS-LUPULUS L.; COLON-CANCER CELLS; PRENYLATED CHALCONE; EXPRESSION; PATHWAY; HOPS; SAFETY; PROLIFERATION; ACTIVATION	Despite improvement in therapeutic strategies, median survival in advanced hepatocellular carcinoma (HCC) remains less than one year. Therefore, molecularly targeted compounds with less toxic profiles are needed. Xanthohumol (XN), a prenylated chalcone has been shown to have anti-proliferative effects in various cancers types in vitro. XN treatment in healthy mice and humans yielded favorable pharmacokinetics and bioavailability. Therefore, we determined to study the effects of XN and understand the mechanism of its action in HCC. The effects of XN on a panel of HCC cell lines were assessed for cell viability, colony forming ability, and cellular proliferation. Cell lysates were analyzed for pro-apoptotic (c-PARP and cleaved caspase-3) and anti-apoptotic markers (survivin, cyclin D1, and Mcl-1). XN concentrations of 5 mu M and above significantly reduced the cell viability, colony forming ability and also confluency of all four HCC cell lines studied. Furthermore, growth suppression due to apoptosis was evidenced by increased expression of pro-apoptotic and reduced expression of anti-apoptotic proteins. Importantly, XN treatment inhibited the Notch signaling pathway as evidenced by the decrease in the expression of Notch1 and HES-1 proteins. Ectopic expression of Notch1 in HCC cells reverses the anti-proliferative effect of XN as evidenced by reduced growth suppression compared to control. Taken together these results suggested that XN mediated growth suppression is appeared to be mediated by the inhibition of the Notch signaling pathway. Therefore, our findings warrants further studies on XN as a potential agent for the treatment for HCC.	[Kunnimalaiyaan, Muthusamy] Med Coll Wisconsin, Div Surg Oncol, Dept Surg, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Ctr Canc, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin	Kunnimalaiyaan, M (corresponding author), Med Coll Wisconsin, Div Surg Oncol, Dept Surg, Milwaukee, WI 53226 USA.	mkunnima@mcw.edu		Kunnimalaiyaan, Muthusamy/0000-0003-3712-7497	Research Affairs Committee Award-MCW; American Cancer Society [86-004-26]; MCW Cancer Center grant; Medical College of Wisconsin Dean's Program Development; Froedtert Hospital Foundation	Research Affairs Committee Award-MCW; American Cancer Society(American Cancer Society); MCW Cancer Center grant; Medical College of Wisconsin Dean's Program Development; Froedtert Hospital Foundation	This study was supported in part by the grants from Research Affairs Committee Award-MCW, Institutional Research Grant # 86-004-26 from the American Cancer Society and MCW Cancer Center grant, The Medical College of Wisconsin Dean's Program Development, and Froedtert Hospital Foundation (M.K and T.C.G)	Ahn S, 2013, HEPATOB PANCREAT DIS, V12, P286, DOI 10.1016/S1499-3872(13)60046-6; Carter YM, 2014, CANCER BIOL THER, V15, P510, DOI 10.4161/cbt.28015; Chen YQ, 2011, CANCER BIOL THER, V11, P14, DOI 10.4161/cbt.11.1.13730; Cook MR, 2010, AM J SURG, V199, P315, DOI 10.1016/j.amjsurg.2009.08.034; Deeb D, 2010, ANTICANCER RES, V30, P3333; Delmulle L, 2008, PHYTOTHER RES, V22, P197, DOI 10.1002/ptr.2286; Dorn C, 2010, INT J ONCOL, V36, P435, DOI 10.3892/ijo_00000517; Drenzek JG, 2011, GYNECOL ONCOL, V122, P396, DOI 10.1016/j.ygyno.2011.04.027; Espinoza I, 2013, PHARMACOL THERAPEUT, V139, P95, DOI 10.1016/j.pharmthera.2013.02.003; Gao J, 2008, DIGEST LIVER DIS, V40, P114, DOI 10.1016/j.dld.2007.08.001; Gerhauser C, 2002, MOL CANCER THER, V1, P959; Hanske L, 2005, MOL NUTR FOOD RES, V49, P868, DOI 10.1002/mnfr.200500048; Hussong R, 2005, MOL NUTR FOOD RES, V49, P861, DOI 10.1002/mnfr.200500089; Kang Y, 2013, BBA-GEN SUBJECTS, V1830, P2638, DOI 10.1016/j.bbagen.2012.12.005; Kim SY, 2013, CHEM-BIOL INTERACT, V203, P565, DOI 10.1016/j.cbi.2013.03.012; Legette L, 2014, MOL NUTR FOOD RES, V58, P248, DOI 10.1002/mnfr.201300333; Lin YZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079299; Lust S, 2005, MOL NUTR FOOD RES, V49, P844, DOI 10.1002/mnfr.200500045; Meng RD, 2009, CANCER RES, V69, P573, DOI 10.1158/0008-5472.CAN-08-2088; Moellering RE, 2009, NATURE, V462, P182, DOI 10.1038/nature08543; Monteiro R, 2008, J CELL BIOCHEM, V104, P1699, DOI 10.1002/jcb.21738; Naganuma S, 2012, AM J CANCER RES, V2, P459; Pan L, 2005, MOL NUTR FOOD RES, V49, P837, DOI 10.1002/mnfr.200500065; Shih IM, 2007, CANCER RES, V67, P1879, DOI 10.1158/0008-5472.CAN-06-3958; Sun Q, 2014, INT J ONCOL, V45, P1638, DOI 10.3892/ijo.2014.2537; Sun Q, 2014, ONCOL REP, V31, P933, DOI 10.3892/or.2013.2917; Vanhoecke B, 2005, INT J CANCER, V117, P889, DOI 10.1002/ijc.21249; Vanhoecke BW, 2005, IN VIVO, V19, P103; Vene R, 2012, MOL MED, V18, P1292, DOI 10.2119/molmed.2012.00174; Wang XQ, 2012, INT J CANCER, V131, pE163, DOI 10.1002/ijc.27336; Worns MA, 2014, INTERNIST, V55, P23, DOI 10.1007/s00108-013-3318-4; Worns MA, 2013, DIGEST LIVER DIS, V45, P408, DOI 10.1016/j.dld.2012.10.010; Worns MA, 2010, EXPERT OPIN INV DRUG, V19, P615, DOI 10.1517/13543781003767418; Worns MA, 2009, J CLIN GASTROENTEROL, V43, P489, DOI 10.1097/MCG.0b013e31818ddfc6; Wu Y, 2010, NATURE, V464, P1052, DOI 10.1038/nature08878; Yabuuchi S, 2013, CANCER LETT, V335, P41, DOI 10.1016/j.canlet.2013.01.054; Yang JD, 2010, NAT REV GASTRO HEPAT, V7, P448, DOI 10.1038/nrgastro.2010.100; Yang MB, 2013, INT IMMUNOPHARMACOL, V16, P466, DOI 10.1016/j.intimp.2013.04.029; Zajc I, 2012, PHYTOTHER RES, V26, P1709, DOI 10.1002/ptr.4636; Zhou L, 2013, DIGEST DIS SCI, V58, P1016, DOI 10.1007/s10620-012-2434-7; Zhou L, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0057382, 10.1371/journal.pone.0073724]	41	44	48	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127464	10.1371/journal.pone.0127464	http://dx.doi.org/10.1371/journal.pone.0127464			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011160	Green Submitted, Green Published, gold			2022-12-26	WOS:000355183900096
J	Lei, XG; Li, H; Huang, BH; Rizak, J; Li, L; Xu, LQ; Liu, L; Wu, J; Lu, LB; Wang, ZB; Hu, YZ; Le, WD; Deng, XL; Li, JL; Yao, YG; Xu, L; Hu, XT; Zhang, BR				Lei, Xiaoguang; Li, Hao; Huang, Baihui; Rizak, Joshua; Li, Ling; Xu, Liqi; Liu, Li; Wu, Jing; Lu, Longbao; Wang, Zhengbo; Hu, Yingzhou; Le, Weidong; Deng, Xingli; Li, Jiali; Yao, Yonggang; Xu, Lin; Hu, Xintian; Zhang, Baorong			1-Methyl-4-Phenylpyridinium Stereotactic Infusion Completely and Specifically Ablated the Nigrostriatal Dopaminergic Pathway in Rhesus Macaque	PLOS ONE			English	Article							MPTP-TREATED MONKEYS; PARKINSONS-DISEASE; ANIMAL-MODELS; ESSENTIAL TREMOR; BRAIN; MECHANISMS; NEURONS; 6-HYDROXYDOPAMINE; PATHOPHYSIOLOGY; COMMUNICATION	Introduction Complete and specific ablation of a single dopaminergic (DA) pathway is a critical step to distinguish the roles of DA pathways in vivo. However, this kind of technique has not been reported in non-human primates. This study aimed to establish a lesioning method with a complete and specific ablation. Method A carefully designed infusion route based on a MRI stereotactic technique was developed to deliver the highly selective dopaminergic toxin 1-methyl-4-phenylpyridinium (MPP+) unilaterally into multiple sites of compact part of substantia nigra (SNc) and striatum in monkeys. The nigrostriatal DA pathway was selected because lesioning of this pathway may induce symptoms that are suitable for evaluation. The pathological, behavioral, neuropharmacological, and clinical laboratorial data were collected to evaluate the lesioning effects. Result Pathological examination revealed a complete ablation of tyrosine hydroxylase positive (TH+) neurons in the SNc, while preserving intact TH+ neurons in the ventral tegmental area (VTA) nearby. TH+ projections in the striatum were also unilaterally lost. The monkeys displayed stable (>28 weeks) rotations and symptoms which were expected with loss of DA neurons in the SNc, with rest tremor being an exception. No item implied the presence of a severe side effect caused by the operation or the intracerebral MPP+ infusion. The results suggested that rest tremor may not directly rely on the nigrostriatal pathway. Conclusion Taken together, in addition to providing a specific nigrostriatal DA lesioned model, this method, combined with brain stimulation or other techniques, can be applied as a powerful tool for the complete lesion of any desired DA pathway in order to study its specific functions in the brain.	[Lei, Xiaoguang; Zhang, Baorong] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Neurol, Hangzhou 310027, Zhejiang, Peoples R China; [Li, Hao; Huang, Baihui; Rizak, Joshua; Wu, Jing; Wang, Zhengbo; Hu, Yingzhou; Li, Jiali; Yao, Yonggang; Xu, Lin; Hu, Xintian] Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan, Peoples R China; [Li, Hao; Huang, Baihui] Univ Chinese Acad Sci, Beijing, Peoples R China; [Li, Ling; Xu, Liqi; Liu, Li] Kunming Gen Hosp PLA, Dept Med Imaging, Kunming, Yunnan, Peoples R China; [Lu, Longbao] Chinese Acad Sci, Kunming Primate Res Ctr, Kunming Inst Zool, Kunming, Yunnan, Peoples R China; [Le, Weidong] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai, Peoples R China; [Deng, Xingli] Kunming Med Univ, Affiliated Hosp 1, Dept Neurosurg, Kunming, Yunnan, Peoples R China; [Yao, Yonggang; Xu, Lin; Hu, Xintian] Chinese Acad Sci, Ctr Excellence Brain Sci, Shanghai, Peoples R China	Zhejiang University; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Kunming General Hospital; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Kunming Medical University; Chinese Academy of Sciences	Zhang, BR (corresponding author), Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Neurol, Hangzhou 310027, Zhejiang, Peoples R China.	xthu@mail.kiz.ac.cn; brzhang@zju.edu.cn	Xu, Lin/T-5531-2017; Li, Hao/GPS-9834-2022; Yao, Yong-Gang/AAH-2303-2021; li, Jiali/HGF-2395-2022	Xu, Lin/0000-0002-2710-3507; Yao, Yong-Gang/0000-0002-2955-0693; li, Jiali/0000-0001-6202-7741; wang, zhengbo/0000-0002-4717-5137; Lei, Xiaoguang/0000-0002-1106-6465; Li, Jiali/0000-0002-0039-3671	CAS [XDB02020000]; National Program on Key Basic Research Project (973 Programs) [2015CB755605, 2012CB825503, 2012CBA01304]; Chinese Academy of Sciences [KZCC-EW-103-2]; National Natural Science Foundation of China [91332120, 31271167, 81271495, 81471312, 81271248]; Yunnan Provincial Project to Attract One-hundred Exceptional Talents from Overseas; CAS; Zhejiang Province Department of Science and Technology [2011C14026]	CAS(Chinese Academy of Sciences); National Program on Key Basic Research Project (973 Programs)(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Provincial Project to Attract One-hundred Exceptional Talents from Overseas; CAS(Chinese Academy of Sciences); Zhejiang Province Department of Science and Technology	This work was supported by grants from the Strategic Priority Research Program of CAS (XDB02020000), National Program on Key Basic Research Project (973 Programs 2015CB755605, 2012CB825503, 2012CBA01304), Key Program of the Chinese Academy of Sciences (KZCC-EW-103-2), Training Program of the Major Research Plan of the National Natural Science Foundation of China (91332120), National Natural Science Foundation of China (31271167, 81271495, 81471312, 81271248), The Yunnan Provincial Project to Attract One-hundred Exceptional Talents from Overseas, Selected Frontier Scientific Significant Breakthrough Project of CAS, International Cooperation Projection (2011C14026) of Zhejiang Province Department of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson G, 2007, EXP NEUROL, V207, P4, DOI 10.1016/j.expneurol.2007.05.010; [Anonymous], 2011, GUIDE CARE USE LAB A; Beal MF, 2001, NAT REV NEUROSCI, V2, P325, DOI 10.1038/35072550; Bergman H, 2002, MOVEMENT DISORD, V17, pS28, DOI 10.1002/mds.10140; Bezard E, 2011, MOVEMENT DISORD, V26, P993, DOI 10.1002/mds.23696; Bjorklund A, 2007, TRENDS NEUROSCI, V30, P194, DOI 10.1016/j.tins.2007.03.006; Blandini F, 2012, FEBS J, V279, P1156, DOI 10.1111/j.1742-4658.2012.08491.x; Blesa J, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/845618; Boulet S, 2008, J NEUROSCI, V28, P9575, DOI 10.1523/JNEUROSCI.3465-08.2008; Bucher SF, 1997, ANN NEUROL, V41, P32, DOI 10.1002/ana.410410108; CARLSSON A, 1957, NATURE, V180, P1200, DOI 10.1038/1801200a0; Collier TJ, 2003, EXP NEUROL, V183, P258, DOI 10.1016/S0014-4886(03)00246-2; DAMATO RJ, 1986, SCIENCE, V231, P987, DOI 10.1126/science.3080808; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Duty S, 2011, BRIT J PHARMACOL, V164, P1357, DOI 10.1111/j.1476-5381.2011.01426.x; Fox SH, 2012, MOVEMENT DISORD, V27, P1373, DOI 10.1002/mds.25133; Gerlach M, 1996, J NEURAL TRANSM, V103, P987, DOI 10.1007/BF01291788; Goridis C, 2002, NAT REV NEUROSCI, V3, P531, DOI 10.1038/nrn871; Helmich RC, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0378-8; Imbert C, 2000, J NEUROSCI METH, V96, P71, DOI 10.1016/S0165-0270(99)00184-3; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; KOPIN IJ, 1988, ANNU REV NEUROSCI, V11, P81, DOI 10.1146/annurev.neuro.11.1.81; KRAEMER GW, 1981, PSYCHOPHARMACOLOGY, V73, P1, DOI 10.1007/BF00431091; Lieu CA, 2012, BRAIN RES BULL, V87, P1, DOI 10.1016/j.brainresbull.2011.09.013; Lotharius J, 2002, NAT REV NEUROSCI, V3, P932, DOI 10.1038/nrn983; Mikula S, 2007, NEUROIMAGE, V35, P9, DOI 10.1016/j.neuroimage.2006.11.053; Mounayar S, 2007, BRAIN, V130, P2898, DOI 10.1093/brain/awm208; Muthuraman M, 2012, NEUROIMAGE, V60, P1331, DOI 10.1016/j.neuroimage.2012.01.088; Neumane S, 2012, NEUROBIOL DIS, V48, P27, DOI 10.1016/j.nbd.2012.06.002; OpackaJuffry J, 1996, J NEURAL TRANSM, V103, P1429, DOI 10.1007/BF01271256; Pain S, 2013, EXP TOXICOL PATHOL, V65, P689, DOI 10.1016/j.etp.2012.09.001; Paxinos G., 1999, RHESUS MONKEY BRAIN, DOI DOI 10.1016/J.CEJA.2021.100223; Porras G, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009308; Potts LF, 2013, EXP NEUROL; SABEL BA, 1982, PHYSIOL BEHAV, V28, P1017, DOI 10.1016/0031-9384(82)90169-X; Saper CB, 1999, BRAIN, V122, P1401, DOI 10.1093/brain/122.8.1401; Schnitzler A, 2005, NAT REV NEUROSCI, V6, P285, DOI 10.1038/nrn1650; SMITH RD, 1993, NEUROSCIENCE, V52, P7, DOI 10.1016/0306-4522(93)90176-G; Storch A, 2004, J NEURAL TRANSM, V111, P1267, DOI 10.1007/s00702-004-0203-2; Tande D, 2006, BRAIN, V129, P1194, DOI 10.1093/brain/awl041; Tieu K, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a009316; Timmermann L, 2003, BRAIN, V126, P199, DOI 10.1093/brain/awg022; Vila M, 2003, NAT REV NEUROSCI, V4, P365, DOI 10.1038/nrn1100; Watanabe Y, 2005, MED SCI MONITOR, V11, pRA17; Wu J, 2010, J NEUROSCI METH, V193, P203, DOI 10.1016/j.jneumeth.2010.07.039; Yan T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088404; Yazdani U, 2006, EXP NEUROL, V200, P172, DOI 10.1016/j.expneurol.2006.02.002	47	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127953	10.1371/journal.pone.0127953	http://dx.doi.org/10.1371/journal.pone.0127953			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010745	Green Published, gold			2022-12-26	WOS:000355183900170
J	Lerner, MD; Potthoff, LM; Hunter, SJ				Lerner, Matthew D.; Potthoff, Lauren M.; Hunter, Scott J.			Optimizing Cross-Sectional Prediction of Social Functioning in Youth Referred for Neuropsychological Testing	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; POSITIVE ILLUSORY BIAS; TRAUMATIC BRAIN-INJURY; PRAGMATIC DEFICITS; EXECUTIVE FUNCTION; CHILDREN; AUTISM; SKILLS; BEHAVIOR; ADOLESCENTS	The current study aimed to establish a fine-grained, efficient characterization of the concurrent neuropsychological contributions to social functioning in neuropsychologically-referred youth. A secondary aim was to demonstrate a useful statistic approach for such investigations (Partial Least Squares Regression; PLSR), which is underutilized in this field. Forty-five participants (70 - 164 months; M-age = 110.89; 34 male) were recruited from a large neuropsychological assessment clinic. Participants completed subtests from the NEPSY-II focusing on neuropsychological constructs that have been linked to social functioning (affect decoding, social memory, motor skills, visuomotor skills, response inhibition, attention and set-shifting, and verbal comprehension). Mothers completed the BASC-2, from which Atypicality and Social Skills scales were analyzed. PLSR revealed that difficulty with social memory, sensorimotor integration, and the ability to attend to and accurately discriminate auditory stimuli combine to best predict atypical or "odd" behavior. In terms of social skills, two factors emerged. The first factor indicated that, counterintuitively, greater emotional perception, visuospatial perception, ability to attend to and accurately discriminate auditory stimuli, and understand instructions was related to poorer social skills. The second factor indicated that a pattern of better facial memory, and sensorimotor ability (execution & integration) characterized a distinct profile of greater social ability. PLSR results were compared to traditional OLS and Backwards Stepwise regression approaches to demonstrate utility. Results also suggested that these findings were consistent across age, gender, and diagnostic group, indicating common neuropsychological substrates of social functioning in this sample of referred youth. Overall, this study provides the first characterization of optimized combinations of neuropsychological variables in predicting social functioning in assessment clinic-referred youth, and introduces to this literature a valuable statistical approach for obtaining such characterizations.	[Lerner, Matthew D.] SUNY Stony Brook, Dept Psychol, Stony Brook, NY 11794 USA; [Potthoff, Lauren M.] Northwestern Univ, Feinberg Sch Med, Dept Psychiat & Behav Sci, Chicago, IL 60611 USA; [Hunter, Scott J.] Univ Chicago, Dept Psychiat & Behav Neurosci, Chicago, IL 60637 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Northwestern University; Feinberg School of Medicine; University of Chicago	Lerner, MD (corresponding author), SUNY Stony Brook, Dept Psychol, Stony Brook, NY 11794 USA.	matthew.lerner@stonybrook.edu	Hunter, Scott J./AAB-8814-2020; Hunter, Scott/AAC-1179-2020; Hunter, Scott/S-7866-2016	Hunter, Scott/0000-0001-7434-2327; Hunter, Scott/0000-0001-7434-2327; Lerner, Matthew/0000-0002-7373-6663				American Psychiatric Association, 2013, DIAG STAT MAN MENT D; [Anonymous], 2008, MEMORY AUTISM THEORY; BARONCOHEN S, 1988, J AUTISM DEV DISORD, V18, P379, DOI 10.1007/BF02212194; Bart O, 2007, INFANT CHILD DEV, V16, P597, DOI 10.1002/icd.514; Beauchamp MH, 2010, PSYCHOL BULL, V136, P39, DOI 10.1037/a0017768; Bender HA, 2007, PEDIATR NEUROL, V36, P312, DOI 10.1016/j.pediatrneurol.2007.01.011; Carrascal LM, 2009, OIKOS, V118, P681, DOI 10.1111/j.1600-0706.2008.16881.x; Cartledge G., 1986, TEACHING SOCIAL SKIL; Chin WW, 2003, INFORM SYST RES, V14, P189, DOI 10.1287/isre.14.2.189.16018; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; CONTE R, 1995, ALBERTA J EDUC RES, V41, P84; Cummins A, 2005, DEV MED CHILD NEUROL, V47, P437, DOI 10.1017/S001216220500085X; de Boo GM, 2007, CLIN PSYCHOL REV, V27, P78, DOI 10.1016/j.cpr.2006.03.006; De Los Reyes A, 2005, PSYCHOL BULL, V131, P483, DOI 10.1037/0033-2909.131.4.483; Demopoulos C, 2013, J AUTISM DEV DISORD, V43, P1157, DOI 10.1007/s10803-012-1657-y; DuPaul GJ, 2001, J AM ACAD CHILD PSY, V40, P508, DOI 10.1097/00004583-200105000-00009; Elliott C, 2007, DIFFERENTIAL ABILITY; ELLIOTT SN, 1988, PROF PSYCHOL-RES PR, V19, P68, DOI 10.1037/0735-7028.19.1.68; ERWIN PG, 1994, J PSYCHOL, V128, P299, DOI 10.1080/00223980.1994.9712732; Fujiki M, 2008, INT J LANG COMM DIS, V43, P330, DOI 10.1080/13682820701507377; Gilotty L, 2002, CHILD NEUROPSYCHOL, V8, P241, DOI 10.1076/chin.8.4.241.13504; Ginsburg GS, 1998, J ABNORM CHILD PSYCH, V26, P175, DOI 10.1023/A:1022668101048; GRESHAM FM, 1987, J SPEC EDUC, V21, P167, DOI 10.1177/002246698702100115; Gresham FM, 1997, ED TREATMENT CHILDRE; Gresham FM, 1988, SOCIAL SKILLS; GUEVREMONT DC, 1994, J EMOT BEHAV DISORD, V2, P164, DOI 10.1177/106342669400200304; Haenlein M., 2004, UNDERSTANDING STAT, V3, P283, DOI [10.1207/s15328031us0304_4, DOI 10.1207/S15328031US0304_4]; Harrison JR, 2011, J ATTEN DISORD, V15, P147, DOI 10.1177/1087054709356170; Hass MR, 2012, REM SPEC EDUC, V33, P173, DOI 10.1177/0741932510383160; Holloway J, 2014, SOCIAL SKILLS DEFICI, P1133, DOI [10.1007/978-1-4614-4788-7_62, DOI 10.1007/978-1-4614-4788-7_62]; Howes C., 1988, PEER INTERACTION YOU; HUGHES JN, 1988, J SCHOOL PSYCHOL, V26, P167, DOI 10.1016/0022-4405(88)90018-0; HUMPHREYS AP, 1987, CHILD DEV, V58, P201, DOI 10.2307/1130302; Hunter SJ, 2012, EXECUTIVE FUNCTION AND DYSFUNCTION: IDENTIFICATION, ASSESSMENT AND TREATMENT, P1, DOI 10.1017/CBO9780511977954; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; Kavale KA, 1996, J LEARN DISABIL, V29, P226, DOI 10.1177/002221949602900301; Kenworthy L, 2009, CHILD NEUROPSYCHOL, V15, P425, DOI 10.1080/09297040802646983; Korkman M, 2007, NEPSY 2 EDITION NEPS; Krishnan A, 2011, NEUROIMAGE, V56, P455, DOI 10.1016/j.neuroimage.2010.07.034; LADD GW, 1983, PSYCHOL REV, V90, P127, DOI 10.1037/0033-295X.90.2.127; LADD GW, 1979, CHILD DEV, V50, P402, DOI 10.1111/j.1467-8624.1979.tb04121.x; LaFontana KM, 1999, J GENET PSYCHOL, V160, P225, DOI 10.1080/00221329909595394; Lerner Matthew D, 2012, Dialogues Clin Neurosci, V14, P307; Lerner MD, 2012, J AUTISM DEV DISORD, V42, P2680, DOI 10.1007/s10803-012-1525-9; Lerner MD, 2012, ENCY PRIMARY PREVENT, V3; Lerner MD., 2013, KNOWLEDGE PERFORMANC; Linkenauger SA, 2012, AUTISM RES, V5, P352, DOI 10.1002/aur.1248; Liong B, 2008, J COMMUNITY PSYCHOL, V36, P499, DOI 10.1002/jcop.20246; Lipton M., 2009, J DEV PROCESSES, V4, P99; Losh M, 2003, J AUTISM DEV DISORD, V33, P239, DOI 10.1023/A:1024446215446; Maag J, 2005, EXCEPTIONALITY, V13, P155, DOI [10.1207/s15327035ex1303_2, DOI 10.1207/S15327035EX1303_2]; Maag J. W., 2016, CENGAGE LEARNING; Maccoby E, 1998, 2 GENDERS GROWING AP; Mahan S, 2011, RES AUTISM SPECT DIS, V5, P119, DOI 10.1016/j.rasd.2010.02.007; Manning S, 2001, J ATTEN DISORD, V5, P41, DOI DOI 10.1177/108705470100500104; Marcoulides GA, 2009, MANAGEMENT INFORM SY, V33, P10; Matson JL, 2009, SOCIAL BEHAVIOR AND SKILLS IN CHILDREN, P1, DOI 10.1007/978-1-4419-0234-4; McClean B, 2012, J INTELLECT DEV DIS, V37, P221, DOI 10.3109/13668250.2012.704981; McIntosh HJ, 1988, THESIS U S FLORIDA; McKnight ME, 2012, FOCUS AUTISM DEV DIS, V27, P247, DOI 10.1177/1088357612454917; McMahon CM, 2013, ADOLESC HEALTH MED T, V4, P23, DOI 10.2147/AHMT.S25402; Merrell K.W., 2014, SOCIAL SKILLS CHILDR; Mikami AY, 2013, J CONSULT CLIN PSYCH, V81, P100, DOI 10.1037/a0029654; Mikami AY, 2010, CHILD DEV PERSPECT, V4, P123, DOI 10.1111/j.1750-8606.2010.00130.x; Mikami AY, 2010, CLIN CHILD FAM PSYCH, V13, P181, DOI 10.1007/s10567-010-0067-y; Mikami AY, 2010, J CLIN CHILD ADOLESC, V39, P373, DOI 10.1080/15374411003691735; MUNDY P, 1986, J CHILD PSYCHOL PSYC, V27, P657, DOI 10.1111/j.1469-7610.1986.tb00190.x; Owens JS, 2007, CLIN CHILD FAM PSYCH, V10, P335, DOI 10.1007/s10567-007-0027-3; Patterson ML, 1999, EVOLUTION PARALLEL P; Reinvall O, 2012, J ATTENTIONAL DISORD, V5, P41; Reinvall O, 2013, J AUTISM DEV DISORD, V43, P1367, DOI 10.1007/s10803-012-1692-8; Reynolds C.R., 2004, BEHAV ASSESSMENT CHI; Romanczyk R. G., 2005, J EARLY INTENSIVE BE, V2, P177; RUBIN KH, 1983, MERRILL PALMER QUART, V29, P337; Saalasti S, 2008, J AUTISM DEV DISORD, V38, P1574, DOI 10.1007/s10803-008-0540-3; Schmitt AJ, 2004, ARCH CLIN NEUROPSYCH, V19, P1077, DOI 10.1016/j.acn.2004.02.002; Spence Susan H, 2003, Child Adolesc Ment Health, V8, P84, DOI 10.1111/1475-3588.00051; Staikova E, 2013, J CHILD PSYCHOL PSYC, V54, P1275, DOI 10.1111/jcpp.12082; Tseng WL, 2013, J CHILD PSYCHOL PSYC, V54, P996, DOI 10.1111/jcpp.12072; Volker MA, 2010, J AUTISM DEV DISORD, V40, P188, DOI 10.1007/s10803-009-0849-6; Vrij A, 2002, LAW HUMAN BEHAV, V26, P261, DOI 10.1023/A:1015313120905; WALKER HM, 1994, TOP LANG DISORD, V14, P70, DOI 10.1097/00011363-199405000-00007; Walker HM, 1986, CHILDRENS SOCIAL BEH; Wechsler D, 2003, WISC 4 ADM SCORING M; Wechsler D, 2008, WAIS 4 WECHSLER ADUL, DOI [10.1080/14622200801979019, DOI 10.1080/14622200801979019]; Wilson A, 2013, INFANT CHILD DEV, V22, P151, DOI 10.1002/icd.1773; Yeates KO, 2014, CLIN PSYCHOL SCI, V2, P97, DOI 10.1177/2167702613499734; Zhu J., 1999, WECHSLER ABBREVIATED	88	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128303	10.1371/journal.pone.0128303	http://dx.doi.org/10.1371/journal.pone.0128303			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0QZ	26011533	gold, Green Submitted, Green Published			2022-12-26	WOS:000355183900219
J	Xie, JJ; Lei, B; Niu, ML; Huang, Y; Kong, QS; Bie, ZL				Xie, Junjun; Lei, Bo; Niu, Mengliang; Huang, Yuan; Kong, Qiusheng; Bie, Zhilong			High Throughput Sequencing of Small RNAs in the Two Cucurbita Germplasm with Different Sodium Accumulation Patterns Identifies Novel MicroRNAs Involved in Salt Stress Response	PLOS ONE			English	Article							EXPRESSION; SALINITY; CUCUMBER; MECHANISMS; TOLERANCE; ROOTSTOCK; PROTEINS; PUMPKIN; ROLES; MELON	MicroRNAs (miRNAs), a class of small non-coding RNAs, recognize their mRNA targets based on perfect sequence complementarity. MiRNAs lead to broader changes in gene expression after plants are exposed to stress. High-throughput sequencing is an effective method to identify and profile small RNA populations in non-model plants under salt stresses, significantly improving our knowledge regarding miRNA functions in salt tolerance. Cucurbits are sensitive to soil salinity, and the Cucurbita genus is used as the rootstock of other cucurbits to enhance salt tolerance. Several cucurbit crops have been used for miRNA sequencing but salt stress-related miRNAs in cucurbit species have not been reported. In this study, we subjected two Cucurbita germplasm, namely, N12 (Cucurbita. maxima Duch.) and N15 (Cucurbita. moschata Duch.), with different sodium accumulation patterns, to Illumina sequencing to determine small RNA populations in root tissues after 4 h of salt treatment and control. A total of 21,548,326 and 19,394,108 reads were generated from the control and salt-treated N12 root tissues, respectively. By contrast, 19,108,240 and 20,546,052 reads were obtained from the control and salt-treated N15 root tissues, respectively. Fifty-eight conserved miRNA families and 33 novel miRNAs were identified in the two Cucurbita germplasm. Seven miRNAs (six conserved miRNAs and one novel miRNAs) were up-regulated in salt-treated N12 and N15 samples. Most target genes of differentially expressed novel miRNAs were transcription factors and salt stress-responsive proteins, including dehydration-induced protein, cation/H+ antiporter 18, and CBL-interacting serine/threonine-protein kinase. The differential expression of miRNAs between the two Cucurbita germplasm under salt stress conditions and their target genes demonstrated that novel miRNAs play an important role in the response of the two Cucurbita germplasm to salt stress. The present study initially explored small RNAs in the response of pumpkin to salt stress, and provided valuable information on novel miRNAs and their target genes in Cucurbita.	[Xie, Junjun; Lei, Bo; Niu, Mengliang; Huang, Yuan; Kong, Qiusheng; Bie, Zhilong] Huazhong Agr Univ, Key Lab Hort Plant Biol, Minist Educ, Coll Hort & Forestry, Wuhan 430070, Peoples R China	Huazhong Agricultural University	Bie, ZL (corresponding author), Huazhong Agr Univ, Key Lab Hort Plant Biol, Minist Educ, Coll Hort & Forestry, Wuhan 430070, Peoples R China.	biezhilong@hotmail.com	Kong, Qiusheng/F-7710-2012	Kong, Qiusheng/0000-0003-0939-4424	National Natural Science Foundation of China [31172000, 31372110]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The research was supported by National Natural Science Foundation of China (31172000, 31372110). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Arnon, 1950, WATER CULTURE METHOD, V347, DOI DOI 10.1073/PNAS.1211132109; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Axtell MJ, 2007, PLANT CELL, V19, P1750, DOI 10.1105/tpc.107.051706; Bottino MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059423; Chen Z, 2007, J EXP BOT, V58, P4245, DOI 10.1093/jxb/erm284; Ding D, 2009, ANN BOT-LONDON, V103, P29, DOI 10.1093/aob/mcn205; Edelstein M, 2011, J EXP BOT, V62, P177, DOI 10.1093/jxb/erq255; Fan ML, 2014, PLANTA, V239, P397, DOI 10.1007/s00425-013-1976-z; Gonzalez-Ibeas D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-393; Hu JH, 2014, BIOCHIMIE, V102, P137, DOI 10.1016/j.biochi.2014.03.002; Huang Y, 2013, SCI HORTIC-AMSTERDAM, V149, P80, DOI 10.1016/j.scienta.2012.02.009; Huang Y, 2013, SCI HORTIC-AMSTERDAM, V149, P47, DOI 10.1016/j.scienta.2012.04.018; Huang Y, 2009, SCI HORTIC-AMSTERDAM, V122, P26, DOI 10.1016/j.scienta.2009.04.004; Ismail A, 2014, J EXP BOT, V65, P2963, DOI 10.1093/jxb/eru159; Jagadeeswaran G, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-329; Jia XY, 2009, PLANT MOL BIOL, V71, P51, DOI 10.1007/s11103-009-9508-8; Khraiwesh B, 2012, BBA-GENE REGUL MECH, V1819, P137, DOI 10.1016/j.bbagrm.2011.05.001; Kong QS, 2014, SCI HORTIC-AMSTERDAM, V175, P150, DOI 10.1016/j.scienta.2014.06.009; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Kumar R, 2014, APPL BIOCHEM BIOTECH, V174, P93, DOI 10.1007/s12010-014-0914-2; Lehti-Shiu MD, 2009, PLANT PHYSIOL, V150, P12, DOI 10.1104/pp.108.134353; Lei B, 2014, PHYSIOL PLANTARUM, V152, P738, DOI 10.1111/ppl.12223; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039650; Liu HH, 2008, RNA, V14, P836, DOI 10.1261/rna.895308; Liu N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057359; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mao WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033040; Martinez G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019523; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Nam MH, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-25; Nie XZ, 2002, GENOME, V45, P905, DOI [10.1139/g02-062, 10.1139/G02-062]; Paul S, 2011, PLANT CELL TISS ORG, V105, P233, DOI 10.1007/s11240-010-9857-7; Puranik S, 2012, TRENDS PLANT SCI, V17, P369, DOI 10.1016/j.tplants.2012.02.004; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Shi R, 2005, BIOTECHNIQUES, V39, P519, DOI 10.2144/000112010; Singh KB, 2002, CURR OPIN PLANT BIOL, V5, P430, DOI 10.1016/S1369-5266(02)00289-3; Sunkar R, 2012, TRENDS PLANT SCI, V17, P196, DOI 10.1016/j.tplants.2012.01.010; Sunkar R, 2010, SEMIN CELL DEV BIOL, V21, P805, DOI 10.1016/j.semcdb.2010.04.001; Xie FL, 2014, PLANT BIOTECHNOL J, V12, P354, DOI 10.1111/pbi.12142; Yin ZJ, 2012, MOL BIOL REP, V39, P4961, DOI 10.1007/s11033-011-1292-2; Zhang BH, 2015, J EXP BOT, V66, P1749, DOI 10.1093/jxb/erv013; Zhao BT, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-29; Zhao Q, 2013, J PROTEOMICS, V82, P230, DOI 10.1016/j.jprot.2013.01.024; Zhu J, 2008, SOIL SCI PLANT NUTR, V54, P895, DOI 10.1111/j.1747-0765.2008.00306.x; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	47	20	21	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127412	10.1371/journal.pone.0127412	http://dx.doi.org/10.1371/journal.pone.0127412			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010449	Green Published, Green Submitted, gold			2022-12-26	WOS:000355183900087
J	Sekine, Y; Togi, S; Muromoto, R; Kon, S; Kitai, Y; Yoshimura, A; Oritani, K; Matsuda, T				Sekine, Yuichi; Togi, Sumihito; Muromoto, Ryuta; Kon, Shigeyuki; Kitai, Yuichi; Yoshimura, Akihiko; Oritani, Kenji; Matsuda, Tadashi			STAP-2 Protein Expression in B16F10 Melanoma Cells Positively Regulates Protein Levels of Tyrosinase, Which Determines Organs to Infiltrate in the Body	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSDUCING ADAPTER PROTEIN-2; OCULOCUTANEOUS ALBINISM; MELANOGENIC PROTEINS; IMPROVED SURVIVAL; MURINE MELANOMA; PIVOTAL ROLE; IN-VITRO; CHEMOKINE; GENE; ACTIVATION	Melanoma is the most serious type of skin cancer, with a highly metastatic phenotype. In this report, we show that signal transducing adaptor protein 2 (STAP-2) is involved in cell migration, proliferation, and melanogenesis as well as chemokine receptor expression and tumorigenesis in B16F10 melanoma cells. This was evident in mice injected with STAP-2 shRNA (shSTAP-2)-expressing B16F10 cells, which infiltrated organs in a completely different pattern from the original cells, showing massive colonization in the liver, kidney, and neck but not in the lung. The most important finding was that STAP-2 expression determined tyrosinase protein content. STAP-2 colocalized with tyrosinase in lysosomes and protected tyrosinase from protein degradation. It is noteworthy that B16F10 cells with knocked down tyrosinase showed similar cell characteristics as shSTAP-2 cells. These results indicated that tyrosinase contributed to some cellular events beyond melanogenesis. Taken together, one possibility is that STAP-2 positively regulates the protein levels of tyrosinase, which determines tumor invasion via controlling chemokine receptor expression.	[Sekine, Yuichi; Togi, Sumihito; Muromoto, Ryuta; Kon, Shigeyuki; Kitai, Yuichi; Matsuda, Tadashi] Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Immunol, Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Yoshimura, Akihiko] Keio Univ, Dept Microbiol & Immunol, Sch Med, Shinjuku Ku, Tokyo 1608582, Japan; [Oritani, Kenji] Osaka Univ, Grad Sch Med, Dept Hematol & Oncol, Suita, Osaka 5650871, Japan	Hokkaido University; Keio University; Osaka University	Matsuda, T (corresponding author), Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Immunol, Kita Ku, Kita 12 Nishi 6, Sapporo, Hokkaido 0600812, Japan.	tmatsuda@pharm.hokudai.ac.jp	Yoshimura, Akihiko/K-5515-2013; Matsuda, Tadashi/A-3835-2012; Muromoto, Ryuta/E-4203-2012; Togi, Sumihito/ABH-6734-2020; Sekine, Yuichi/S-8813-2019	Matsuda, Tadashi/0000-0002-3089-3757; Muromoto, Ryuta/0000-0002-7474-493X; Sekine, Yuichi/0000-0002-2861-603X; Togi, Sumihito/0000-0002-3189-8111	Astellas Foundation for Research on Metabolic Disorders; Ministry of Education, Culture, Sports, Science, and Technology of Japan	Astellas Foundation for Research on Metabolic Disorders; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by the Astellas Foundation for Research on Metabolic Disorders and a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Aksan I, 1998, MOL CELL BIOL, V18, P6930, DOI 10.1128/MCB.18.12.6930; Ando H, 1999, J LIPID RES, V40, P1312; Avihingsanon Y, 2006, KIDNEY INT, V69, P747, DOI 10.1038/sj.ki.5000132; Belperio JA, 2000, J LEUKOCYTE BIOL, V68, P1; Benedito E, 1997, BBA-GEN SUBJECTS, V1336, P59, DOI 10.1016/S0304-4165(97)00011-1; Bertolotto C, 1998, ONCOGENE, V16, P1665, DOI 10.1038/sj.onc.1201685; Bertolotto C, 1998, MOL CELL BIOL, V18, P694, DOI 10.1128/MCB.18.2.694; Bertolotto C, 1998, J CELL BIOL, V142, P827, DOI 10.1083/jcb.142.3.827; Boissy RE, 1996, AM J HUM GENET, V58, P1145; Busca R, 2000, EMBO J, V19, P2900, DOI 10.1093/emboj/19.12.2900; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Erhardt A, 2011, J IMMUNOL, V186, P5284, DOI 10.4049/jimmunol.1003750; FIDLER IJ, 1975, CANCER RES, V35, P218; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; HALABAN R, 1988, P NATL ACAD SCI USA, V85, P7241, DOI 10.1073/pnas.85.19.7241; HEARING VJ, 1992, PIGM CELL RES, V5, P264, DOI 10.1111/j.1600-0749.1992.tb00547.x; Hearing VJ, 1999, J INVEST DERM SYMP P, V4, P24, DOI 10.1038/sj.jidsp.5640176; Ikeda O, 2007, BIOCHEM BIOPH RES CO, V358, P931, DOI 10.1016/j.bbrc.2007.05.030; Kang JS, 2003, CANCER IMMUNOL IMMUN, V52, P693, DOI 10.1007/s00262-003-0407-6; Kawada K, 2004, CANCER RES, V64, P4010, DOI 10.1158/0008-5472.CAN-03-1757; King RA, 2003, HUM GENET, V113, P502, DOI 10.1007/s00439-003-0998-1; Kuhnelt-Leddihn L, 2012, ARCH DERMATOL RES, V304, P185, DOI 10.1007/s00403-012-1222-8; Minoguchi M, 2003, J BIOL CHEM, V278, P11182, DOI 10.1074/jbc.M211230200; MISHIMA Y, 1994, PIGM CELL RES, V7, P376, DOI 10.1111/j.1600-0749.1994.tb00065.x; Moser B, 2001, NAT IMMUNOL, V2, P123, DOI 10.1038/84219; Murakami T, 2002, CANCER RES, V62, P7328; Oetting WS, 2000, PIGM CELL RES, V13, P320, DOI 10.1034/j.1600-0749.2000.130503.x; Oetting WS, 1999, HUM MUTAT, V13, P99, DOI 10.1002/(SICI)1098-1004(1999)13:2<99::AID-HUMU2>3.3.CO;2-3; Panzer U, 2007, J AM SOC NEPHROL, V18, P2071, DOI 10.1681/ASN.2006111237; Panzer U, 2006, J AM SOC NEPHROL, V17, P454, DOI 10.1681/ASN.2005040364; Park H. Y., 2012, FITZPATRICKS DERMATO, P765; Riley PA, 2003, PIGM CELL RES, V16, P548, DOI 10.1034/j.1600-0749.2003.00069.x; Romagnani P, 1999, J AM SOC NEPHROL, V10, P2518; Sahin H, 2012, HEPATOLOGY, V55, P1610, DOI 10.1002/hep.25545; Santodomingo-Garzon T, 2009, HEPATOLOGY, V49, P1267, DOI 10.1002/hep.22761; Segerer S, 2004, AM J PATHOL, V164, P635, DOI 10.1016/S0002-9440(10)63152-5; Sekine Y, 2006, J IMMUNOL, V176, P380, DOI 10.4049/jimmunol.176.1.380; Sekine Y, 2005, J BIOL CHEM, V280, P8188, DOI 10.1074/jbc.M411692200; Sekine Y, 2007, J IMMUNOL, V179, P2397, DOI 10.4049/jimmunol.179.4.2397; Sekine Y, 2014, J IMMUNOL, V192, P3488, DOI 10.4049/jimmunol.1300886; Sekine Y, 2012, J IMMUNOL, V188, P6194, DOI 10.4049/jimmunol.1103467; Sekine Y, 2009, J IMMUNOL, V183, P7966, DOI 10.4049/jimmunol.0902096; Shimada Y, 2009, J PERIODONTOL, V80, P317, DOI [10.1902/jop.2009.080409, 10.1902/jop.2009.080409 ]; Tachibana M, 1996, NAT GENET, V14, P50, DOI 10.1038/ng0996-50; TOMITA Y, 1994, ARCH DERMATOL, V130, P355, DOI 10.1001/archderm.130.3.355; Uong A, 2010, J CELL PHYSIOL, V222, P38, DOI 10.1002/jcp.21935; Wiley HE, 2001, J NATL CANCER I, V93, P1638, DOI 10.1093/jnci/93.21.1638; WINDER A, 1994, CELL MOL BIOL RES, V40, P613; WONG G, 1975, NATURE, V255, P644, DOI 10.1038/255644a0; Wu M, 2000, GENE DEV, V14, P301; WULF E, 1979, P NATL ACAD SCI USA, V76, P4498, DOI 10.1073/pnas.76.9.4498; Yamaguchi Y, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a017046; Yamamoto T, 2003, BIOCHEM BIOPH RES CO, V306, P767, DOI 10.1016/S0006-291X(03)01042-8; YOKOYAMA K, 1994, BBA-GENE STRUCT EXPR, V1217, P317, DOI 10.1016/0167-4781(94)90292-5; Zeremski M, 2007, J VIRAL HEPATITIS, V14, P675, DOI 10.1111/j.1365-2893.2006.00838.x	56	7	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17462	17473		10.1074/jbc.M115.658575	http://dx.doi.org/10.1074/jbc.M115.658575			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	26023234	Green Published, hybrid			2022-12-26	WOS:000357730900038
J	Cheng, Y; Qu, JF; Chen, Y; Zhao, MW; Li, XX				Cheng, Yong; Qu, Jinfeng; Chen, Yi; Zhao, Mingwei; Li, Xiaoxin			Anterior Segment Neovascularization in Diabetic Retinopathy: A Masquerade	PLOS ONE			English	Article							OCULAR ISCHEMIC SYNDROME; CAROTID-ENDARTERECTOMY; BLOOD-FLOW; ARTERY; CIRCULATION; STENOSIS; DISEASE; ORBIT; EYE	Purpose Anterior segment neovascularization (ASNV) could be a masquerade for ocular ischemic syndrome (OIS) in diabetic patients which misleads diagnosis and treatment. The purpose of our study is to find the relationship between blood flow velocity in carotid siphon and the development of ASNV in diabetic. Methods We reviewed 34 eyes of 17 diabetic patients who had Transcranial Color Doppler (TCD) examination with unilateral ASNV. The circulatory parameters of both eyes of each patient were compared and analyzed. In addition, 9 patients with more than 50% stenosis of extracranial internal carotid artery (ICA) and low velocity flow through TCD had been treated by carotid revascularization surgery. Results The maximal velocity in systole (Vmax) of carotid siphon (SCA) was lower in the eyes with ASNV than in the eyes without ASNV (P<0.05). ASNV of all the 9 patients regressed totally and BCVA improved significantly (P<0.05). Stenosis of ICA and arm-retina time (ART) decreased significantly (P<0.01) and SCA and ophthalmic artery (OA) increased significantly (P<0.01). Conclusions Our study showed ASNV could be a masquerade for OIS in patients with diabetic retinopathy. The decreased blood flow velocity in carotid siphon is related to the development of ASNV. Circulatory parameters screening of SCA by TCD is important to help us to evaluate the blood flow in SCA, the possibility of development of ASNV, and the prognosis of the patient. Interference such as carotid endarterectomy (CEA) or carotid artery stenting (CAS) can be performed if necessary to improve the blood flow in SCA and make ASNV regression.	[Cheng, Yong; Qu, Jinfeng; Chen, Yi; Zhao, Mingwei; Li, Xiaoxin] Peking Univ, Peoples Hosp, Dept Ophthalmol, Beijing 100871, Peoples R China; [Cheng, Yong; Qu, Jinfeng; Chen, Yi; Zhao, Mingwei; Li, Xiaoxin] Minist Educ, Key Lab Vis Loss & Restorat, Beijing, Peoples R China; [Cheng, Yong; Qu, Jinfeng; Chen, Yi; Zhao, Mingwei; Li, Xiaoxin] Beijing Key Lab Diag & Therapy Retinal & Choroid, Beijing, Peoples R China	Peking University	Li, XX (corresponding author), Peking Univ, Peoples Hosp, Dept Ophthalmol, Beijing 100871, Peoples R China.	drlixiaoxin@163.com						Baumgartner RW, 2006, FRONT NEUROL NEUROSC, V21, P105, DOI 10.1159/000092393; Biller J, 1998, CIRCULATION, V97, P501; CARTER JE, 1985, STROKE, V16, P721, DOI 10.1161/01.STR.16.4.721; Chaturvedi S, 2005, NEUROLOGY, V65, P794, DOI 10.1212/01.wnl.0000176036.07558.82; Chen Celia S, 2007, Compr Ophthalmol Update, V8, P17; Dimitrova G, 2010, SURV OPHTHALMOL, V55, P193, DOI 10.1016/j.survophthal.2009.06.010; GOEBEL W, 1995, INVEST OPHTH VIS SCI, V36, P864; Hayreh SS, 2007, PROG RETIN EYE RES, V26, P470, DOI 10.1016/j.preteyeres.2007.06.001; Hazin R, 2009, CURR OPIN OPHTHALMOL, V20, P430, DOI 10.1097/ICU.0b013e3283313d38; HU HH, 1995, ACTA NEUROL SCAND, V92, P242; Ishikawa K, 2002, AM J OPHTHALMOL, V134, P295, DOI 10.1016/S0002-9394(02)01531-3; Kawaguchi S, 2001, NEUROSURGERY, V48, P328, DOI 10.1097/00006123-200102000-00016; Kawaguchi S, 2006, CEREBROVASC DIS, V22, P402, DOI 10.1159/000094859; Klein R, 2012, ARCH OPHTHALMOL-CHIC, V130, P749, DOI 10.1001/archophthalmol.2011.2560; Kodama A, 2010, CLIN OPHTHALMOL, V4, P1177, DOI 10.2147/OPTH.S13899; Lieb WE, 1998, RADIOL CLIN N AM, V36, P1059, DOI 10.1016/S0033-8389(05)70231-1; Mendrinos E, 2010, SURV OPHTHALMOL, V55, P2, DOI 10.1016/j.survophthal.2009.02.024; Miyajima Yoshiyasu, 2011, Rinsho Byori, V59, P1043; Mizener JB, 1997, OPHTHALMOLOGY, V104, P859, DOI 10.1016/S0161-6420(97)30221-8; Nagahara M, 2002, AM J OPHTHALMOL, V133, P270, DOI 10.1016/S0002-9394(01)01312-5; Nagaoka T, 2010, INVEST OPHTH VIS SCI, V51, P6729, DOI 10.1167/iovs.10-5364; Picard Francois, 2013, Rev Prat, V63, P759; Senn B C, 1996, Ger J Ophthalmol, V5, P386; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; Terelak-Borys B, 2012, MED SCI MONITOR, V18, pRA138, DOI 10.12659/MSM.883260; Vandamme H, 2005, Rev Med Liege, V60, P737; Williamson TH, 1996, SURV OPHTHALMOL, V40, P255, DOI 10.1016/S0039-6257(96)82001-7	27	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0123627	10.1371/journal.pone.0123627	http://dx.doi.org/10.1371/journal.pone.0123627			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26029908	Green Published, gold, Green Submitted			2022-12-26	WOS:000356630900008
J	Fan, T; Li, XM; Yang, W; Xia, KF; Jie, OY; Zhang, MY				Fan, Tian; Li, Xiumei; Yang, Wu; Xia, Kuaifei; Jie Ouyang; Zhang, Mingyong			Rice osa-miR171c Mediates Phase Change from Vegetative to Reproductive Development and Shoot Apical Meristem Maintenance by Repressing Four OsHAM Transcription Factors	PLOS ONE			English	Article							GRAS GENE FAMILY; FUNCTIONAL DIVERSIFICATION; OVER-EXPRESSION; PLANT MICRORNAS; FLORAL MERISTEM; JUVENILE-ADULT; PHYTOCHROME-C; SMALL RNAS; ARABIDOPSIS; ORTHOLOG	Phase change from vegetative to reproductive development is one of the critical developmental steps in plants, and it is regulated by both environmental and endogenous factors. The maintenance of shoot apical meristem (SAM) identity, miRNAs and flowering integrators are involved in this phase change process. Here, we report that the miRNA osa-miR171c targets four GRAS (GAI-RGA-SCR) plant-specific transcription factors (OsHAM1, OsHAM2, OsHAM3, and OsHAM4) to control the floral transition and maintenance of SAM indeterminacy in rice (Oryza sativa). We characterized a rice T-DNA insertion delayed heading (dh) mutant, where the expression of OsMIR171c gene is up-regulated. This mutant showed pleiotropic phenotypic defects, including especially prolonged vegetative phase, delayed heading date, and bigger shoot apex. Parallel expression analysis showed that osa-miR171c controlled the expression change of four OsHAMs in the shoot apex during floral transition, and responded to light. In the dh mutant, the expression of the juvenile-adult phase change negative regulator osa-miR156 was up-regulated, expression of the flowering integrators Hd3a and RFT1 was inhibited, and expression of FON4 negative regulators involved in the maintenance of SAM indeterminacy was also inhibited. From these data, we propose that the inhibition of osa-miR171c-mediated OsHAM transcription factors regulates the phase transition from vegetative to reproductive development by maintaining SAM indeterminacy and inhibiting flowering integrators.	[Fan, Tian; Yang, Wu; Xia, Kuaifei; Zhang, Mingyong] Chinese Acad Sci, Key Lab South China Agr Plant Mol Anal & Genet Im, Guangzhou, Guangdong, Peoples R China; [Fan, Tian; Yang, Wu; Xia, Kuaifei; Zhang, Mingyong] Chinese Acad Sci, Guangdong Prov Key Lab Appl Bot, Guangzhou, Guangdong, Peoples R China; [Fan, Tian; Li, Xiumei; Yang, Wu] Univ Chinese Acad Sci, Beijing, Peoples R China; [Li, Xiumei] Chinese Acad Sci, Suth China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China; [Jie Ouyang] Chongqing Acad Agr Sci, Rice Inst, Chongqing, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; South China Botanical Garden, CAS	Zhang, MY (corresponding author), Chinese Acad Sci, Key Lab South China Agr Plant Mol Anal & Genet Im, Guangzhou, Guangdong, Peoples R China.	zhangmy@scbg.ac.cn	Zhang, Mingyong/GQZ-6217-2022; li, xiu/GXV-1745-2022		National Science Foundation of China [31272240/31371604]; Natural Science Foundation of Guangdong [S2013020012830]; South China Botanical Garden-Shanghai Institute of Plant Physiology & Ecology Joint Fund	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong(National Natural Science Foundation of Guangdong Province); South China Botanical Garden-Shanghai Institute of Plant Physiology & Ecology Joint Fund	This work was supported by the National Science Foundation of China (31272240/31371604), the Natural Science Foundation of Guangdong (S2013020012830), and South China Botanical Garden-Shanghai Institute of Plant Physiology & Ecology Joint Fund.	Asai K, 2002, DEVELOPMENT, V129, P265; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Axtell MJ, 2008, TRENDS PLANT SCI, V13, P343, DOI 10.1016/j.tplants.2008.03.009; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bolle C, 2004, PLANTA, V218, P683, DOI 10.1007/s00425-004-1203-z; Bommert P, 2005, DEVELOPMENT, V132, P1235, DOI 10.1242/dev.01671; Boss PK, 2004, PLANT CELL, V16, pS18, DOI 10.1105/tpc.015958; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chu HW, 2006, PLANT PHYSIOL, V142, P1039, DOI 10.1104/pp.106.086736; Chuck G, 2007, NAT GENET, V39, P544, DOI 10.1038/ng2001; Cuperus JT, 2011, PLANT CELL, V23, P431, DOI 10.1105/tpc.110.082784; Curaba J, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-6; Day RB, 2004, PLANT MOL BIOL, V54, P261, DOI 10.1023/B:PLAN.0000028792.72343.ee; Doi K, 2004, GENE DEV, V18, P926, DOI 10.1101/gad.1189604; Engstrom EM, 2012, PLANT SIGNAL BEHAV, V7, P227, DOI 10.4161/psb.18958; Engstrom EM, 2011, PLANT PHYSIOL, V155, P735, DOI 10.1104/pp.110.168757; Fattash I, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-13; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Ikeda A, 2001, PLANT CELL, V13, P999, DOI 10.1105/tpc.13.5.999; Ikeda K, 2007, PLANT J, V51, P1030, DOI 10.1111/j.1365-313X.2007.03200.x; Ikeda-Kawakatsu K, 2012, PLANT J, V69, P168, DOI 10.1111/j.1365-313X.2011.04781.x; Izawa T, 2011, PLANT CELL, V23, P1741, DOI 10.1105/tpc.111.083238; Jaeger KE, 2007, CURR BIOL, V17, P1050, DOI 10.1016/j.cub.2007.05.008; Jiao YQ, 2010, NAT GENET, V42, P541, DOI 10.1038/ng.591; Komiya R, 2008, DEVELOPMENT, V135, P767, DOI 10.1242/dev.008631; Komiya R, 2009, DEVELOPMENT, V136, P3443, DOI 10.1242/dev.040170; Kulcheski FR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-307; Lauter N, 2005, P NATL ACAD SCI USA, V102, P9412, DOI 10.1073/pnas.0503927102; Li WF, 2014, TREE GENET GENOMES, V10, P223, DOI 10.1007/s11295-013-0668-y; Li WX, 2008, PLANT CELL, V20, P2238, DOI 10.1105/tpc.108.059444; Li XY, 2003, NATURE, V422, P618, DOI 10.1038/nature01518; Liu XY, 2014, PLANT MOL BIOL REP, V32, P1129, DOI 10.1007/s11105-014-0721-5; Liu YG, 2007, BIOTECHNIQUES, V43, P649, DOI 10.2144/000112601; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Lu SF, 2005, PLANT CELL, V17, P2186, DOI 10.1105/tpc.105.033456; Lu XY, 2008, BIOCHEM BIOPH RES CO, V368, P458, DOI 10.1016/j.bbrc.2008.02.007; Matsubara K, 2011, PLANT J, V66, P603, DOI 10.1111/j.1365-313X.2011.04517.x; Mu CS, 2005, PLANT PROD SCI, V8, P51, DOI 10.1626/pps.8.51; Nelson T, 1997, PLANT CELL, V9, P1121, DOI 10.1105/tpc.9.7.1121; Nishida H, 2013, PLANT PHYSIOL, V163, P804, DOI 10.1104/pp.113.222570; Ohmori Y, 2013, PLANT CELL, V25, P229, DOI 10.1105/tpc.112.103432; Okano Y, 2008, PLANT J, V53, P65, DOI 10.1111/j.1365-313X.2007.03313.x; Parizotto EA, 2004, GENE DEV, V18, P2237, DOI 10.1101/gad.307804; Poethig RS, 2009, CURR OPIN GENET DEV, V19, P374, DOI 10.1016/j.gde.2009.06.001; Poethig RS, 2003, SCIENCE, V301, P334, DOI 10.1126/science.1085328; Pysh LD, 1999, PLANT J, V18, P111, DOI 10.1046/j.1365-313X.1999.00431.x; Rubio-Somoza I, 2011, TRENDS PLANT SCI, V16, P258, DOI 10.1016/j.tplants.2011.03.001; Sablowski R, 2011, CURR OPIN PLANT BIOL, V14, P4, DOI 10.1016/j.pbi.2010.08.001; Sakamoto T, 2008, CURR OPIN PLANT BIOL, V11, P209, DOI 10.1016/j.pbi.2008.01.009; Scarpella E, 2003, DEVELOPMENT, V130, P645, DOI 10.1242/dev.00243; Schoof H, 2000, CELL, V100, P635, DOI 10.1016/S0092-8674(00)80700-X; Schulze S, 2010, PLANT J, V64, P668, DOI 10.1111/j.1365-313X.2010.04359.x; Smith MR, 2009, P NATL ACAD SCI USA, V106, P5424, DOI 10.1073/pnas.0812729106; Song CNA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010861; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Suzaki T, 2004, DEVELOPMENT, V131, P5649, DOI 10.1242/dev.01441; Suzaki T, 2008, PLANT CELL, V20, P2049, DOI 10.1105/tpc.107.057257; Suzaki T, 2006, PLANT CELL PHYSIOL, V47, P1591, DOI 10.1093/pcp/pcl025; Tabuchi H, 2011, PLANT CELL, V23, P3276, DOI 10.1105/tpc.111.088765; Takano M, 2005, PLANT CELL, V17, P3311, DOI 10.1105/tpc.105.035899; Tamaki S, 2007, SCIENCE, V316, P1033, DOI 10.1126/science.1141753; Tanaka N, 2011, PLANT CELL, V23, P2143, DOI 10.1105/tpc.111.083436; Tian CG, 2004, PLANT MOL BIOL, V54, P519, DOI 10.1023/B:PLAN.0000038256.89809.57; Tsuda K, 2011, PLANT CELL, V23, P4368, DOI 10.1105/tpc.111.090050; Varkonyi-Gasic E, 2011, METHODS MOL BIOL, V744, P145, DOI 10.1007/978-1-61779-123-9_10; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Wang L, 2010, MOL PLANT, V3, P794, DOI 10.1093/mp/ssq042; Wu G, 2006, DEVELOPMENT, V133, P3539, DOI 10.1242/dev.02521; Wu G, 2013, J GENET GENOMICS, V40, P217, DOI 10.1016/j.jgg.2013.04.002; Wu G, 2009, CELL, V138, P750, DOI 10.1016/j.cell.2009.06.031; Xia KF, 2012, PLOS ONE, V7, P364, DOI 10.1371/journal.pone.0030039; Xie KB, 2006, PLANT PHYSIOL, V142, P280, DOI 10.1104/pp.106.084475; Xie KB, 2012, PLANT PHYSIOL, V158, P1382, DOI 10.1104/pp.111.190488; Xue XY, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004266; Yokota K, 2010, PLANT CELL PHYSIOL, V51, P1436, DOI 10.1093/pcp/pcq124; Yoo SY, 2005, PLANTA, V221, P523, DOI 10.1007/s00425-004-1466-4; Yoshida A, 2012, PLANT J, V70, P327, DOI 10.1111/j.1365-313X.2011.04872.x; Yoshida S., 1976, LAB MANUAL PHYSL STU, P61; Zhu QH, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-149	79	51	55	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0125833	10.1371/journal.pone.0125833	http://dx.doi.org/10.1371/journal.pone.0125833			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26023934	gold, Green Published, Green Submitted			2022-12-26	WOS:000355319400011
J	Ma, C; Zhang, Y; Li, YQ; Chen, C; Cai, W; Zeng, YL				Ma, Chi; Zhang, Ying; Li, Yu-qing; Chen, Cheng; Cai, Wei; Zeng, Yue-lin			The Role of PPAR gamma in Advanced Glycation End Products-Induced Inflammatory Response in Human Chondrocytes	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; HUMAN OSTEOARTHRITIC CHONDROCYTES; EXPRESSION; PIOGLITAZONE; AGONIST; ALPHA; CELLS; MODEL; RAGE; BETA	Objective Advances made in the past ten years highlight the notion that peroxisome proliferator-activated receptors gamma (PPAR gamma) has protective properties in the pathophysiology of osteoarthritis (OA). The aim of this study was to define the roles of PPAR gamma in AGEs-induced inflammatory response in human chondrocytes. Methods Primary human chondrocytes were stimulated with AGEs in the presence or absence of neutralizing antibody against RAGE (anti-RAGE), MAPK specific inhibitors and PPAR gamma agonist pioglitazone. The expression of IL-1, MMP-13, TNF-alpha, PPAR gamma, nuclear NF-kappa B p65 and cytosol I kappa B alpha was determined by western blotting and real-time PCR. Results AGEs could enhance the expression of IL-1, TNF-alpha, and MMP-13, but the level of PPAR gamma was decreased in a time-and dose-dependent manner, which was inhibited by anti-RAGE, SB203580 (P38 MAPK specific inhibitor) and SP600125 (a selective inhibitor of JNK). PPAR gamma agonist pioglitazone could inhibit the effects of AGEs-induced inflammatory response and PPAR gamma down-regulation. In human chondrocytes, AGEs could induce cytosol I kappa B alpha degradation and increase the level of nuclear NF-kappa B p65, which was inhibited by PPAR gamma agonist pioglitazone. Conclusions In primary human chondrocytes, AGEs could down-regulate PPAR gamma expression and increase the inflammatory mediators, which could be reversed by PPAR gamma agonist pioglitazone. Activation of RAGE by AGEs triggers a cascade of downstream signaling, including MAPK JNK/p38, PPAR gamma and NF-kappa B. Taken together, PPAR gamma could be a potential target for pharmacologic intervention in the treatment of OA.	[Ma, Chi; Zhang, Ying; Li, Yu-qing; Chen, Cheng; Cai, Wei; Zeng, Yue-lin] Hunan Normal Univ, Affiliated Hosp 2, Peoples Liberat Army, Cent Hosp 163,Dept Orthoped, Changsha 410003, Hunan, Peoples R China	Hunan Normal University	Chen, C (corresponding author), Hunan Normal Univ, Affiliated Hosp 2, Peoples Liberat Army, Cent Hosp 163,Dept Orthoped, Changsha 410003, Hunan, Peoples R China.	jc163yy@163.com			National Natural Science Foundation of China [81201432]; Army Medical Research Subject of the "12th Five-Year-Plan" [CWS11J275]; Scientific Research Fund of Hunan Provincial Education Department [10B066]; Hunan Provincial Innovation Foundation for Postgraduate [CX2013B236]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Army Medical Research Subject of the "12th Five-Year-Plan"; Scientific Research Fund of Hunan Provincial Education Department(Hunan Provincial Education Department); Hunan Provincial Innovation Foundation for Postgraduate	The study was supported by National Natural Science Foundation of China (NO. 81201432), Army Medical Research Subject of the "12th Five-Year-Plan" (NO. CWS11J275), Scientific Research Fund of Hunan Provincial Education Department (NO. 10B066), and Hunan Provincial Innovation Foundation for Postgraduate (NO. CX2013B236).	Anderson AS, 2010, BEST PRACT RES CL RH, V24, P15, DOI 10.1016/j.berh.2009.08.006; Boileau C, 2007, ARTHRITIS RHEUM-US, V56, P2288, DOI 10.1002/art.22726; Burgermeister E, 2007, MOL CELL BIOL, V27, P803, DOI 10.1128/MCB.00601-06; Chen JR, 1999, RHEUMATOLOGY, V38, P1275, DOI 10.1093/rheumatology/38.12.1275; Chen YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066611; Cho MC, 2008, PPAR RES, V2008, DOI 10.1155/2008/679137; Cortizo AM, 2003, MOL CELL BIOCHEM, V250, P1, DOI 10.1023/A:1024934008982; Dukic-Stefanovic S, 2003, J NEUROCHEM, V87, P44, DOI 10.1046/j.1471-4159.2003.01988.x; Haseeb A, 2013, CLIN IMMUNOL, V146, P185, DOI 10.1016/j.clim.2012.12.011; Ishibashi Y, 2013, MICROVASC RES, V85, P54, DOI 10.1016/j.mvr.2012.10.007; Ji JD, 2001, J AUTOIMMUN, V17, P215, DOI 10.1006/jaut.2001.0542; Jiang LY, 2012, CNS NEUROSCI THER, V18, P659, DOI 10.1111/j.1755-5949.2012.00341.x; Kobayashi T, 2005, ARTHRITIS RHEUM-US, V52, P479, DOI 10.1002/art.20792; Li F, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0306-0; Liang C, 2009, BRIT J PHARMACOL, V158, P1865, DOI 10.1111/j.1476-5381.2009.00450.x; Lin JG, 2012, BRIT J PHARMACOL, V166, P2212, DOI 10.1111/j.1476-5381.2012.01910.x; Lin TH, 2011, J CELL PHYSIOL, V226, P3242, DOI 10.1002/jcp.22685; Loeser RF, 2005, ARTHRITIS RHEUM, V52, P2376, DOI 10.1002/art.21199; Loeser RF, 2013, CURR OPIN RHEUMATOL, V25, P108, DOI 10.1097/BOR.0b013e32835a9428; Mahali SK, 2012, BIOCHEM PHARMACOL, V84, P1681, DOI 10.1016/j.bcp.2012.09.033; Monemdjou R, 2012, ARTHRITIS RHEUM-US, V64, P1551, DOI 10.1002/art.33490; Nah SS, 2008, RHEUMATOLOGY, V47, P425, DOI 10.1093/rheumatology/kem376; Nah SS, 2007, FEBS LETT, V581, P1928, DOI 10.1016/j.febslet.2007.03.090; Nebbaki SS, 2013, J RHEUMATOL, V40, P877, DOI 10.3899/jrheum.120738; Puddu A, 2012, REGUL PEPTIDES, V177, P79, DOI 10.1016/j.regpep.2012.05.089; Rasheed Z, 2011, RHEUMATOLOGY, V50, P838, DOI 10.1093/rheumatology/keq380; Rasheed Z, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2700; Reiser KM, 1998, P SOC EXP BIOL MED, V218, P23; SCHMIDT AM, 1995, NAT MED, V1, P1002, DOI 10.1038/nm1095-1002; Szanto A, 2008, IMMUNOBIOLOGY, V213, P789, DOI 10.1016/j.imbio.2008.07.015; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Vasheghani F, 2013, AM J PATHOL, V182, P1099, DOI 10.1016/j.ajpath.2012.12.012; Yamagishi S, 2009, PHARMACOL RES, V60, P174, DOI 10.1016/j.phrs.2009.01.006; Yang QS, 2010, EUR J PHARMACOL, V649, P108, DOI 10.1016/j.ejphar.2010.09.025; Yuan XC, 2011, J GENET GENOMICS, V38, P193, DOI 10.1016/j.jgg.2011.04.001; Zhang YH, 2010, INT J MOL MED, V25, P729, DOI 10.3892/ijmm_00000398	36	37	39	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0125776	10.1371/journal.pone.0125776	http://dx.doi.org/10.1371/journal.pone.0125776			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024533	gold, Green Submitted, Green Published			2022-12-26	WOS:000355319400009
J	Zhu, YX; Abdullah, LH; Doyle, SP; Nguyen, K; Ribeiro, CMP; Vasquez, PA; Forest, MG; Lethem, MI; Dickey, BF; Davis, CW				Zhu, Yunxiang; Abdullah, Lubna H.; Doyle, Sean P.; Nguyen, Kristine; Ribeiro, Carla M. P.; Vasquez, Paula A.; Forest, M. Gregory; Lethem, Michael I.; Dickey, Burton F.; Davis, C. William			Baseline Goblet Cell Mucin Secretion in the Airways Exceeds Stimulated Secretion over Extended Time Periods, and Is Sensitive to Shear Stress and Intracellular Mucin Stores	PLOS ONE			English	Article							BRONCHIAL EPITHELIAL-CELLS; VON-WILLEBRAND-FACTOR; CYSTIC-FIBROSIS; GENE-EXPRESSION; ATP RELEASE; NUCLEOTIDE REGULATION; MUCUS GLYCOPROTEINS; GRANULE EXOCYTOSIS; OLIGOMERIC MUCINS; LUNG	Airway mucin secretion studies have focused on goblet cell responses to exogenous agonists almost to the exclusion of baseline mucin secretion ( BLMS). In human bronchial epithelial cell cultures (HBECCs), maximal agonist-stimulated secretion exceeds baseline by similar to 3-fold as measured over hour-long periods, but mucin stores are discharged completely and require 24 h for full restoration. Hence, over 24 h, total baseline exceeds agonist-induced secretion by several-fold. Studies with HBECCs and mouse tracheas showed that BLMS is highly sensitive to mechanical stresses. Harvesting three consecutive 1 h baseline luminal incubations with HBECCs yielded equal rates of BLMS; however, lengthening the middle period to 72 h decreased the respective rate significantly, suggesting a stimulation of BLMS by the gentle washes of HBECC luminal surfaces. BLMS declined exponentially after washing HBECCs (t(1/2) = 2.75 h), to rates approaching zero. HBECCs exposed to low perfusion rates exhibited spike-like increases in BLMS when flow was jumped 5-fold: BLMS increased >4 fold, then decreased within 5 min to a stable plateau at 1.5-2-fold over control. Higher flow jumps induced proportionally higher BLMS increases. Inducing mucous hyperplasia in HBECCs increased mucin production, BLMS and agonist-induced secretion. Mouse tracheal BLMS was similar to 6-fold higher during perfusion, than when flow was stopped. Munc13-2 null mouse tracheas, with their defect of accumulated cellular mucins, exhibited similar BLMS as WT, contrary to predictions of lower values. Graded mucous metaplasia induced in WT and Munc13-2 null tracheas with IL-13, caused proportional increases in BLMS, suggesting that naive Munc13-2 mouse BLMS is elevated by increased mucin stores. We conclude that BLMS is, [i] a major component of mucin secretion in the lung, [ii] sustained by the mechanical activity of a dynamic lung, [iii] proportional to levels of mucin stores, and [iv] regulated differentially from agonist-induced mucin secretion.	[Zhu, Yunxiang; Abdullah, Lubna H.; Doyle, Sean P.; Nguyen, Kristine; Ribeiro, Carla M. P.; Davis, C. William] Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC 27599 USA; [Davis, C. William] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA; [Vasquez, Paula A.; Forest, M. Gregory] Univ N Carolina, Dept Math, Chapel Hill, NC 27599 USA; [Lethem, Michael I.] Univ Brighton, Pharm & Biomol Sci, Brighton BN2 4GJ, Moulsecoomb, England; [Dickey, Burton F.] Univ Texas MD Anderson Canc Ctr, Dept Pulm Med, Houston, TX 77030 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Brighton; University of Texas System; UTMD Anderson Cancer Center	Davis, CW (corresponding author), Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC 27599 USA.	cwdavis@med.unc.edu	Ribeiro, Carla Maria P/A-6955-2009		National Institutes of Health [R01 HL097000]; Cystic Fibrosis Foundation [MCC DAVIS07XX0]; Cystic Fibrosis Foundation RDP grant [R026-CR11]; National Institutes of Health Molecular Therapy Core Center grant [P30 DK065988]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL129795, R01HL097000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK065988] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1412844] Funding Source: National Science Foundation; Division Of Mathematical Sciences [1462992] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Cystic Fibrosis Foundation RDP grant; National Institutes of Health Molecular Therapy Core Center grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Division Of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	The studies described in this paper were supported by grants from the National Institutes of Health (R01 HL097000) and the Cystic Fibrosis Foundation (MCC DAVIS07XX0). Additionally, the authors' acknowledge the use of UNC Cystic Fibrosis/Pulmonary Research and Treatment Center Tissue Culture and Imaging/Histology Cores, which both received support from a Cystic Fibrosis Foundation RDP grant (R026-CR11) and a National Institutes of Health Molecular Therapy Core Center grant (P30 DK065988). NIH Grants website: http://grants.nih.gov/grants/guide/index.html?CFID=163646478&CFTOKEN=34654896&jsessionid=f630cf6c020e432511b04b3d7a1126d160f1 Cystic Fibrosis Foundation Grants website: http://www.cff.org/research/ForResearchers/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah LH, 1996, BIOCHEM J, V316, P943, DOI 10.1042/bj3160943; Abdullah LH, 2007, AM J PHYSIOL-LUNG C, V293, pL591, DOI 10.1152/ajplung.00150.2007; Abdullah LH, 2012, METHODS MOL BIOL, V842, P259, DOI 10.1007/978-1-61779-513-8_16; Adler Kenneth B, 2013, Front Endocrinol (Lausanne), V4, P129, DOI 10.3389/fendo.2013.00129; Belvisi MG, 2002, CURR OPIN PHARMACOL, V2, P211, DOI 10.1016/S1471-4892(02)00145-5; Button B, 2008, RESP PHYSIOL NEUROBI, V163, P189, DOI 10.1016/j.resp.2008.04.020; Button B, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003755; CARLSTEDT I, 1983, BIOCHEM J, V211, P13, DOI 10.1042/bj2110013; Chen Y, 2001, AM J RESP CELL MOL, V25, P409, DOI 10.1165/ajrcmb.25.4.4413; Choi JY, 2003, ACTA OTO-LARYNGOL, V123, P1080, DOI 10.1080/00016480310002528; Clancy SM, 2004, AM J RESP CELL MOL, V31, P663, DOI 10.1165/rcmb.2003-0331OC; Conway JD, 2003, AM J PHYSIOL-LUNG C, V284, pL945, DOI 10.1152/ajplung.00410.2002; Cressman VL, 1999, J BIOL CHEM, V274, P26461, DOI 10.1074/jbc.274.37.26461; Cressman VL, 1998, AM J RESP CELL MOL, V19, P853, DOI 10.1165/ajrcmb.19.6.3194; Dang LT, 2011, J BIOL CHEM, V286, P25763, DOI 10.1074/jbc.M111.249151; Davis CW, 2008, ANNU REV PHYSIOL, V70, P487, DOI 10.1146/annurev.physiol.70.113006.100638; DAVIS CW, 1992, AM J PHYSIOL, V262, pC1313, DOI 10.1152/ajpcell.1992.262.5.C1313; Davis CW, 2008, RESP PHYSL NEUROBIOL; Ehre C, 2007, AM J PHYSIOL-CELL PH, V293, pC1445, DOI 10.1152/ajpcell.00051.2007; Evans CM, 2004, AM J RESP CELL MOL, V31, P382, DOI 10.1165/rcmb.2004-0060OC; Fahy JV, 2010, NEW ENGL J MED, V363, P2233, DOI 10.1056/NEJMra0910061; FREDBERG JJ, 1978, J ACOUST SOC AM, V63, P954, DOI 10.1121/1.381775; Fulcher M Leslie, 2005, Methods Mol Med, V107, P183; Giblin JP, 2008, BLOOD, V112, P957, DOI 10.1182/blood-2007-12-130740; Gray TE, 1996, AM J RESP CELL MOL, V14, P104, DOI 10.1165/ajrcmb.14.1.8534481; Grygorczyk R, 2013, J PHYSIOL-LONDON, V591, P1195, DOI 10.1113/jphysiol.2012.244145; HARKEMA JR, 1987, J HISTOCHEM CYTOCHEM, V35, P279, DOI 10.1177/35.3.2434556; Herschlag G, 2013, J THEOR BIOL, V325, P42, DOI 10.1016/j.jtbi.2013.01.023; Holmen JM, 2004, AM J PHYSIOL-LUNG C, V287, pL824, DOI 10.1152/ajplung.00108.2004; Huang AY, 2001, J BIOL CHEM, V276, P22296, DOI 10.1074/jbc.M100211200; Jones LC, 2011, J PHYSL, V2011; Kemp PA, 2004, AM J RESP CELL MOL, V31, P446, DOI 10.1165/rcmb.2003-0211OC; Kesimer M, 2013, MUCOSAL IMMUNOL, V6, P379, DOI 10.1038/mi.2012.81; Kirkham S, 2002, BIOCHEM J, V361, P537, DOI 10.1042/0264-6021:3610537; Kogel T, 2010, RESULTS PROBL CELL D, V50, P1, DOI 10.1007/400_2009_31; Kreda SM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009589; Lazarowski ER, 2011, ADV PHARMACOL, V61, P221, DOI 10.1016/B978-0-12-385526-8.00008-4; LETHEM MI, 1993, AM J RESP CELL MOL, V9, P315, DOI 10.1165/ajrcmb/9.3.315; Livraghi A, 2009, J IMMUNOL, V182, P4357, DOI 10.4049/jimmunol.0802557; Malsam J, 2008, CELL MOL LIFE SCI, V65, P2814, DOI 10.1007/s00018-008-8352-3; McGookin R, 1985, METHOD MOL BIOL, V2, P116, DOI [10.1385/0-89603-064-4:113, DOI 10.1385/0-89603-064-4:113]; Okada SF, 2013, AM J RESP CELL MOL, V49, P814, DOI 10.1165/rcmb.2012-0493OC; PARR CE, 1994, P NATL ACAD SCI USA, V91, P3275, DOI 10.1073/pnas.91.8.3275; Ramsingh R, 2011, AM J PHYSIOL-LUNG C, V300, pL587, DOI 10.1152/ajplung.00345.2010; Ribeiro CMP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005806; Ribeiro CMP, 2005, J BIOL CHEM, V280, P17798, DOI 10.1074/jbc.M410618200; Rock JR, 2010, DIS MODEL MECH, V3, P545, DOI 10.1242/dmm.006031; Rose MC, 2006, PHYSIOL REV, V86, P245, DOI 10.1152/physrev.00010.2005; Rossi AH, 2004, J PHYSIOL-LONDON, V559, P555, DOI 10.1113/jphysiol.2004.070433; Rousseau K, 2003, HYBRIDOMA HYBRIDOM, V22, P293, DOI 10.1089/153685903322538818; Roy MG, 2014, NATURE, V505, P412, DOI 10.1038/nature12807; Roy MG, 2011, AM J RESP CELL MOL, V44, P755, DOI 10.1165/rcmb.2010-0020OC; Saegusa C, 2006, GENES CELLS, V11, P623, DOI 10.1111/j.1365-2443.2006.00964.x; SHEEHAN JK, 1991, BIOCHEM J, V274, P293, DOI 10.1042/bj2740293; Shimura S, 1994, AIRWAY SECRETION PHY, P325; Sudhof TC, 2013, NEURON, V80, P675, DOI 10.1016/j.neuron.2013.10.022; Sudhof TC, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011353; Tarran R, 2006, ANNU REV PHYSIOL, V68, P543, DOI 10.1146/annurev.physiol.68.072304.112754; Tarran R, 2005, J BIOL CHEM, V280, P35751, DOI 10.1074/jbc.M505832200; Thai P, 2008, ANNU REV PHYSIOL, V70, P405, DOI 10.1146/annurev.physiol.70.113006.100441; Thornton DJ, 2008, ANNU REV PHYSIOL, V70, P459, DOI 10.1146/annurev.physiol.70.113006.100702; Tschumperlin DJ, 2006, ANNU REV PHYSIOL, V68, P563, DOI 10.1146/annurev.physiol.68.072304.113102; Turner MD, 2000, J BIOL CHEM, V275, P14025, DOI 10.1074/jbc.275.19.14025; Tuvim MJ, 2009, J BIOL CHEM, V284, P9781, DOI 10.1074/jbc.M807849200; Varoqueaux F, 2002, P NATL ACAD SCI USA, V99, P9037, DOI 10.1073/pnas.122623799; Young HWJ, 2006, AM J RESP CELL MOL, V35, P549, DOI 10.1165/rcmb.2006-0060OC; Zhu Y, 2008, J PHYSIOL-LONDON, V586, P1977, DOI 10.1113/jphysiol.2007.149310	67	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0127267	10.1371/journal.pone.0127267	http://dx.doi.org/10.1371/journal.pone.0127267			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024524	Green Submitted, Green Published, gold			2022-12-26	WOS:000355319400033
J	Gong, XC; Li, Y; Chen, HL; Qu, HB				Gong, Xingchu; Li, Yao; Chen, Huali; Qu, Haibin			Design Space Development for the Extraction Process of Danhong Injection Using a Monte Carlo Simulation Method	PLOS ONE			English	Article							ICH Q8 DEFINITION; OPTIMIZATION STRATEGY; ETHANOL PRECIPITATION; QUALITY; IMPLEMENTATION; CHROMATOGRAPHY; PURIFICATION; SEPARATION; SUGAR; WATER	A design space approach was applied to optimize the extraction process of Danhong injection. Dry matter yield and the yields of five active ingredients were selected as process critical quality attributes (CQAs). Extraction number, extraction time, and the mass ratio of water and material (W/M ratio) were selected as critical process parameters (CPPs). Quadratic models between CPPs and CQAs were developed with determination coefficients higher than 0.94. Active ingredient yields and dry matter yield increased as the extraction number increased. Monte-Carlo simulation with models established using a stepwise regression method was applied to calculate the probability-based design space. Step length showed little effect on the calculation results. Higher simulation number led to results with lower dispersion. Data generated in a Monte Carlo simulation following a normal distribution led to a design space with a smaller size. An optimized calculation condition was obtained with 10000 simulation times, 0.01 calculation step length, a significance level value of 0.35 for adding or removing terms in a stepwise regression, and a normal distribution for data generation. The design space with a probability higher than 0.95 to attain the CQA criteria was calculated and verified successfully. Normal operating ranges of 8.2-10 g/g of W/M ratio, 1.25-1.63 h of extraction time, and two extractions were recommended. The optimized calculation conditions can conveniently be used in design space development for other pharmaceutical processes.	[Gong, Xingchu; Li, Yao; Chen, Huali; Qu, Haibin] Zhejiang Univ, Coll Pharmaceut Sci, Pharmaceut Informat Inst, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University	Qu, HB (corresponding author), Zhejiang Univ, Coll Pharmaceut Sci, Pharmaceut Informat Inst, Hangzhou 310058, Zhejiang, Peoples R China.	quhb@zju.edu.cn			National Natural Science Foundation of China [81273992]; Zhejiang Provincial Natural Science Foundation [LQ12H29004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province)	This work was supported by the National Natural Science Foundation of China (No. 81273992) and Zhejiang Provincial Natural Science Foundation (LQ12H29004). Haibin Qu received the first fund. The website is http://www.nsfc.gov.cn/. Xingchu Gong received the second fund. The website is http://www.zjnsf.gov.cn/. Funds were used to buy materials, chemicals, and pay labor costs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouchard A, 2007, J CHEM ENG DATA, V52, P1838, DOI 10.1021/je700190m; [初阳 CHU Yang], 2006, [中草药, Chinese Traditional and Herbal Drugs], V37, P1161; Debrus B, 2011, J CHROMATOGR A, V1218, P5205, DOI 10.1016/j.chroma.2011.05.102; Debrus B, 2011, ANAL CHIM ACTA, V691, P33, DOI 10.1016/j.aca.2011.02.035; [杜中良 Du Zhongliang], 2010, [中国药房, China Pharmacy], V21, P2911; Fan L, 2011, J CHIN PHARM SCI, V20, P47, DOI DOI 10.5246/JCPS.2011.01.007; Getaz D, 2013, J CHROMATOGR A, V1284, P80, DOI 10.1016/j.chroma.2013.01.117; Gong XW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092961; Gong XC, 2014, SEP PURIF TECHNOL, V132, P126, DOI 10.1016/j.seppur.2014.05.014; Gong XC, 2011, IND ENG CHEM RES, V50, P7542, DOI 10.1021/ie2004972; Gong XC, 2011, CHINESE J CHEM ENG, V19, P217, DOI 10.1016/S1004-9541(11)60157-2; [顾娟 GU Juan], 2005, [广东微量元素科学, Guangdong Weiliang Yuansu Kexue], V12, P61; Guo YX, 2007, J PHARMACEUT BIOMED, V43, P435, DOI 10.1016/j.jpba.2006.07.046; He Y, 2012, J ETHNOPHARMACOL, V144, P387, DOI 10.1016/j.jep.2012.09.025; ICH, 2009, PHARM DEV Q8 R2; Ingvarsson PT, 2013, PHARM RES-DORDR, V30, P2772, DOI 10.1007/s11095-013-1096-2; Korakianiti E, 2011, PHARM RES-DORDR, V28, P1465, DOI 10.1007/s11095-010-0315-3; Li HL, 2008, J MASS SPECTROM, V43, P1545, DOI 10.1002/jms.1441; Li Yao, 2013, Zhongguo Zhong Yao Za Zhi, V38, P1653; Liu HT, 2013, BIOMED CHROMATOGR, V27, P655, DOI 10.1002/bmc.2842; Liu Shuang-Yue, 2013, Zhongguo Zhong Yao Za Zhi, V38, P1657; Mbinze JK, 2012, J CHROMATOGR A, V1263, P113, DOI 10.1016/j.chroma.2012.09.038; Nistor I, 2011, J PHARMACEUT BIOMED, V56, P30, DOI 10.1016/j.jpba.2011.04.027; Nistor I, 2013, J PHARMACEUT BIOMED, V74, P273, DOI 10.1016/j.jpba.2012.10.015; Pan JY, 2013, J PHARMACEUT BIOMED, V85, P28, DOI 10.1016/j.jpba.2013.06.020; Peterson JJ, 2008, J BIOPHARM STAT, V18, P959, DOI 10.1080/10543400802278197; Peterson JJ, 2010, STAT BIOPHARM RES, V2, P249, DOI 10.1198/sbr.2009.08065; Ren XP, 2013, CNS NEUROSCI THER, V19, P1, DOI 10.1111/cns.12029; Rozet E, 2013, TRAC-TREND ANAL CHEM, V42, P157, DOI 10.1016/j.trac.2012.09.007; Tsavas P, 2004, IND ENG CHEM RES, V43, P8391, DOI 10.1021/ie049353n; Xu XM, 2012, INT J PHARMACEUT, V434, P349, DOI 10.1016/j.ijpharm.2012.06.002; Xu ZH, 2012, PREP BIOCHEM BIOTECH, V42, P183, DOI 10.1080/10826068.2012.654572; Yan Bin-Jun, 2013, Zhongguo Zhong Yao Za Zhi, V38, P1676; Yu LX, 2008, PHARM RES, V25, P781, DOI 10.1007/s11095-007-9511-1; Zhang L, 2013, AAPS PHARMSCITECH, V14, P277, DOI 10.1208/s12249-012-9919-8	35	12	18	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128236	10.1371/journal.pone.0128236	http://dx.doi.org/10.1371/journal.pone.0128236			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020778	Green Published, gold, Green Submitted			2022-12-26	WOS:000355187300091
J	van der Walt, A; Kolbe, S; Mitchell, P; Wang, YJ; Butzkueven, H; Egan, G; Yiannikas, C; Graham, S; Kilpatrick, T; Klistorner, A				van der Walt, Anneke; Kolbe, Scott; Mitchell, Peter; Wang, Yejun; Butzkueven, Helmut; Egan, Gary; Yiannikas, Con; Graham, Stuart; Kilpatrick, Trevor; Klistorner, Alexander			Parallel Changes in Structural and Functional Measures of Optic Nerve Myelination after Optic Neuritis	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS LESIONS; VISUAL-EVOKED POTENTIALS; AXONAL LOSS; REMYELINATION; MRI; ASSOCIATION; ATROPHY; CELLS	Introduction Visual evoked potential (VEP) latency prolongation and optic nerve lesion length after acute optic neuritis (ON) corresponds to the degree of demyelination, while subsequent recovery of latency may represent optic nerve remyelination. We aimed to investigate the relationship between multifocal VEP (mfVEP) latency and optic nerve lesion length after acute ON. Methods Thirty acute ON patients were studied at 1,3,6 and 12 months using mfVEP and at 1 and 12 months with optic nerve MRI. LogMAR and low contrast visual acuity were documented. By one month, the mfVEP amplitude had recovered sufficiently for latency to be measured in 23 (76.7%) patients with seven patients having no recordable mfVEP in more than 66% of segments in at least one test. Only data from these 23 patients was analysed further. Results Both latency and lesion length showed significant recovery during the follow-up period. Lesion length and mfVEP latency were highly correlated at 1 (r = 0.94, p = <0.0001) and 12 months (r = 0.75, p < 0.001). Both measures demonstrated a similar trend of recovery. Speed of latency recovery was faster in the early follow-up period while lesion length shortening remained relatively constant. At 1 month, latency delay was worse by 1.76ms for additional 1mm of lesion length while at 12 months, 1mm of lesion length accounted for 1.94ms of latency delay. Conclusion A strong association between two putative measures of demyelination in early and chronic ON was found. Parallel recovery of both measures could reflect optic nerve remyelination.	[Graham, Stuart; Klistorner, Alexander] Univ Sydney, Save Sight Inst, Dept Ophthalmol, Sydney, NSW, Australia; [van der Walt, Anneke; Kolbe, Scott; Wang, Yejun; Kilpatrick, Trevor] Univ Melbourne, Ctr Neurosci, Melbourne, Vic, Australia; [van der Walt, Anneke; Butzkueven, Helmut; Kilpatrick, Trevor] Royal Melbourne Hosp, Dept Neurol, Melbourne, Vic, Australia; [van der Walt, Anneke; Butzkueven, Helmut] Univ Melbourne, Dept Med, Melbourne, Vic, Australia; [Butzkueven, Helmut] Box Hill Hosp, Dept Neurol, Melbourne, Vic, Australia; [Egan, Gary] Monash Univ, Melbourne, Vic 3004, Australia; [Mitchell, Peter] Royal Melbourne Hosp, Dept Radiol, Melbourne, Vic, Australia; [Yiannikas, Con] Concord Hosp, Dept Neurol, Sydney, NSW, Australia; [Graham, Stuart] Macquarie Univ, Australian Sch Adv Med, Sydney, NSW 2109, Australia	University of Sydney; University of Melbourne; Royal Melbourne Hospital; University of Melbourne; Box Hill Hospital; Monash University; Royal Melbourne Hospital; Concord Repatriation General Hospital; Macquarie University	van der Walt, A (corresponding author), Univ Melbourne, Ctr Neurosci, Melbourne, Vic, Australia.	anneke.vanderwalt@mh.org.au	Egan, Gary F./A-1381-2013	Egan, Gary/0000-0002-3186-4026; Kolbe, Scott/0000-0003-4685-1380; Butzkueven, Helmut/0000-0003-3940-8727; Kilpatrick, Trevor/0000-0003-3999-085X; Graham, Stuart/0000-0001-7519-969X; Klistorner, Alexander/0000-0003-0361-6399	National Health and Medical Research Council; Multiple Sclerosis Research Australia; Sydney Foundation for Medical Research	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Multiple Sclerosis Research Australia; Sydney Foundation for Medical Research	This work was supported by the National Health and Medical Research Council (AK, GFE, AV, HB, SCK), Multiple Sclerosis Research Australia grant (AK) and Sydney Foundation for Medical Research (AK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakshi Rohit, 2005, NeuroRx, V2, P277, DOI 10.1007/BF03206672; Balcer LJ, 2000, MULT SCLER J, V6, P163, DOI 10.1191/135245800701566025; BARNES D, 1991, BRAIN, V114, P1271, DOI 10.1093/brain/114.3.1271; BECH RW, 1991, ARCH OPHTHALMOL-CHIC, V109, P1673, DOI 10.1001/archopht.1991.01080120057025; Bland JM, 2003, ULTRASOUND OBST GYN, V22, P85, DOI 10.1002/uog.122; Bruck W, 2003, J NEUROL SCI, V206, P181, DOI 10.1016/s0022-510x(02)00191-0; Brusa A, 2001, BRAIN, V124, P468, DOI 10.1093/brain/124.3.468; Chandran S, 2008, PHILOS T R SOC B, V363, P171, DOI 10.1098/rstb.2006.2019; Costello F, 2008, MULT SCLER J, V14, P893, DOI 10.1177/1352458508091367; Davies MB, 1998, NEURORADIOLOGY, V40, P765, DOI 10.1007/s002340050681; Dubois-Dalcq M, 2008, BRAIN, V131, P1686, DOI 10.1093/brain/awn076; Fahle M., 2006, PRINCIPLES PRACTICE, P207; Filippi M, 2012, LANCET NEUROL, V11, P349, DOI 10.1016/S1474-4422(12)70003-0; Franklin R, 2008, NAT REV NEUROSCI; GUTTMANN CRG, 1995, AM J NEURORADIOL, V16, P1481; Hickman SJ, 2004, BRAIN, V127, P692, DOI 10.1093/brain/awh076; Jennings AR, 2002, J NEUROCYTOL, V31, P27, DOI 10.1023/A:1022567414294; Klistorner AI, 2001, INVEST OPHTH VIS SCI, V42, P2145; Klistorner A, 2008, ANN NEUROL, V64, P325, DOI 10.1002/ana.21474; Klistorner A, 2008, DOC OPHTHALMOL, V116, P19, DOI 10.1007/s10633-007-9072-y; Klistorner A, 2010, MULT SCLER J, V16, P786, DOI 10.1177/1352458510371408; Kolbe S, 2009, NEUROIMAGE, V45, P679, DOI 10.1016/j.neuroimage.2008.12.047; Lassmann H, 2005, MULTIPLE SCLEROSIS N, P153; Martin M, 2006, MYELIN DEFICIENCIES; McDonald WI, 1977, VISUAL EVOKED POTENT, P427; Merkler D, 2005, NMR BIOMED, V18, P395, DOI 10.1002/nbm.972; Mi S, 2005, NAT NEUROSCI, V8, P745, DOI 10.1038/nn1460; Miller RH, 2002, PROG NEUROBIOL, V67, P451, DOI 10.1016/S0301-0082(02)00058-8; Naismith RT, 2012, ARCH NEUROL-CHICAGO, V69, P65, DOI 10.1001/archneurol.2011.243; O'riordan J, 1998, PROGNOSTIC VALUE BRA; Patani R, 2007, NEUROPATH APPL NEURO, V33, P277, DOI 10.1111/j.1365-2990.2007.00805.x; Patrikios P, 2006, BRAIN, V129, P3165, DOI 10.1093/brain/awl217; Perier O, 1965, ELECT MICROSCOPIC FE, P937; PRINEAS JW, 1978, NEUROLOGY, V28, P68, DOI 10.1212/WNL.28.9_Part_2.68; PRINEAS JW, 1979, ANN NEUROL, V5, P22, DOI 10.1002/ana.410050105; PRINEAS JW, 1993, ANN NEUROL, V33, P137, DOI 10.1002/ana.410330203; PRINEAS JW, 1989, LAB INVEST, V61, P489; Rodriguez M, 2003, BRAIN, V126, P751, DOI 10.1093/brain/awg070; Rosset A, 2004, J DIGIT IMAGING, V17, P205, DOI 10.1007/s10278-004-1014-6; Smith KJ, 2005, MULTIPLE SCLEROSIS N, P85, DOI [10.1016/B978-012738761-1/50007-9, DOI 10.1016/B978-012738761-1/50007-9]; Suhs KW, 2012, ANN NEUROL, V72, P199, DOI 10.1002/ana.23573; Trapp BD, 1999, CURR OPIN NEUROL, V12, P295, DOI 10.1097/00019052-199906000-00008; Trip SA, 2006, NEUROIMAGE, V31, P286, DOI 10.1016/j.neuroimage.2005.11.051; van Waesberghe JHTM, 1999, ANN NEUROL, V46, P747; Wang C, 2013, LESION LENGTH ALONG; Waxman SG., 2005, MULTIPLE SCLEROSIS N, P165; You YY, 2011, INVEST OPHTH VIS SCI, V52, P6911, DOI 10.1167/iovs.11-7434; YOUL BD, 1991, BRAIN, V114, P2437, DOI 10.1093/brain/114.6.2437; Zhao C, 2005, J NEUROL SCI, V233, P87, DOI 10.1016/j.jns.2005.03.008	49	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0121084	10.1371/journal.pone.0121084	http://dx.doi.org/10.1371/journal.pone.0121084			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020925	Green Published, gold			2022-12-26	WOS:000355187300002
J	Brown, JR; Livesay, DR				Brown, Jenna R.; Livesay, Dennis R.			Flexibility Correlation between Active Site Regions Is Conserved across Four AmpC beta-Lactamase Enzymes	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; ALLOSTERIC MODULATION; CITROBACTER-FREUNDII; ESCHERICHIA-COLI; OMEGA-LOOP; SPECTRUM; STABILITY; MECHANISM; EVOLUTION; RESISTANCE	beta-lactamases are bacterial enzymes that confer resistance to beta-lactam antibiotics, such as penicillins and cephalosporins. There are four classes of beta-lactamase enzymes, each with characteristic sequence and structure properties. Enzymes from class A are the most common and have been well characterized across the family; however, less is known about how physicochemical properties vary across the C and D families. In this report, we compare the dynamical properties of four AmpC (class C) beta-lactamases using our distance constraint model (DCM). The DCM reliably predicts thermodynamic and mechanical properties in an integrated way. As a consequence, quantitative stability/flexibility relationships (QSFR) can be determined and compared across the whole family. The DCM calculates a large number of QSFR metrics. Perhaps the most useful is the flexibility index (FI), which quantifies flexibility along the enzyme backbone. As typically observed in other systems, FI is well conserved across the four AmpC enzymes. Cooperativity correlation (CC), which quantifies intramolecular couplings within structure, is rarely conserved across protein families; however, it is in AmpC. In particular, the bulk of each structure is composed of a large rigid cluster, punctuated by three flexibly correlated regions located at the active site. These regions include several catalytic residues and the O-loop. This evolutionary conservation combined with active their site location strongly suggests that these coupled dynamical modes are important for proper functioning of the enzyme.	[Brown, Jenna R.] Univ N Carolina, Dept Biol Sci, Charlotte, NC 28262 USA; [Livesay, Dennis R.] Univ N Carolina, Dept Bioinformat & Genom, Charlotte, NC 28262 USA	University of North Carolina; University of North Carolina Charlotte; University of North Carolina; University of North Carolina Charlotte	Livesay, DR (corresponding author), Univ N Carolina, Dept Bioinformat & Genom, Charlotte, NC 28262 USA.	drlivesa@uncc.edu			National Institutes of Health [GM101570]; Charlotte Research Scholars summer research fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM101570] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charlotte Research Scholars summer research fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported in part by a National Institutes of Health grant GM101570 to DRL and a Charlotte Research Scholars summer research fellowship to JRB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham EP, 1940, NATURE, V146, P837, DOI 10.1038/146837a0; Azzaroni O, 2008, PHYS CHEM CHEM PHYS, V10, P7031, DOI 10.1039/b806445h; Banerjee S, 1998, BIOCHEMISTRY-US, V37, P3286, DOI 10.1021/bi972127f; Beadle BM, 1999, PROTEIN SCI, V8, P1816, DOI 10.1110/ps.8.9.1816; Blizzard TA, 2010, BIOORG MED CHEM LETT, V20, P918, DOI 10.1016/j.bmcl.2009.12.069; Bos F, 2009, BIOPHYS J, V97, P2550, DOI 10.1016/j.bpj.2009.08.031; Brown MC, 2014, METHODS MOL BIOL, V1084, P227, DOI 10.1007/978-1-62703-658-0_12; Bu, 2010, HLTH INF BIOINF HIBI; BUSH K, 1995, ANTIMICROB AGENTS CH, V39, P1211, DOI 10.1128/AAC.39.6.1211; Bush K, 2010, ANTIMICROB AGENTS CH, V54, P969, DOI 10.1128/AAC.01009-09; Chen Y, 2006, J AM CHEM SOC, V128, P2970, DOI 10.1021/ja056806m; Chen Y, 2009, PROTEIN SCI, V18, P662, DOI 10.1002/pro.60; Crichlow GV, 2001, BIOCHEMISTRY-US, V40, P6233, DOI 10.1021/bi010131s; Dahiyat BI, 1997, PROTEIN SCI, V6, P1333, DOI 10.1002/pro.5560060622; Diaz N, 2006, BIOCHEMISTRY-US, V45, P439, DOI 10.1021/bi051600j; Donadio S, 2010, J ANTIBIOT, V63, P423, DOI 10.1038/ja.2010.62; Drawz SM, 2010, CLIN MICROBIOL REV, V23, P160, DOI 10.1128/CMR.00037-09; Emery CL, 1997, J CLIN MICROBIOL, V35, P2061, DOI 10.1128/JCM.35.8.2061-2067.1997; Goldberg SD, 2003, PROTEIN SCI, V12, P1633, DOI 10.1110/ps.0302903; HUDSON JW, 1993, J MOL BIOL, V234, P700, DOI 10.1006/jmbi.1993.1621; Jacobs D., 2012, BIOPHYSICS INTECH, P91; Jacobs DJ, 2005, BIOPHYS J, V88, P903, DOI 10.1529/biophysj.104.048496; Jacobs DJ, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.061109; JACOBS DJ, 1995, PHYS REV LETT, V75, P4051, DOI 10.1103/PhysRevLett.75.4051; Jacobs DJ, 2001, PROTEINS, V44, P150, DOI 10.1002/prot.1081; Jacobs DJ, 2006, RECENT RES DEV BIOPH, V5, P71; Jacobs DJ, 2012, METHODS MOL BIOL, V796, P279, DOI 10.1007/978-1-61779-334-9_15; Jacobs DJ, 2010, CURR OPIN PHARMACOL, V10, P760, DOI 10.1016/j.coph.2010.09.014; Jacoby GA, 2005, NEW ENGL J MED, V352, P380, DOI 10.1056/NEJMra041359; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; Jensen AA, 2004, EUR J PHARM SCI, V21, P407, DOI 10.1016/j.ejps.2003.11.007; Kato-Toma Y, 2003, BIOCHEM J, V371, P175, DOI 10.1042/BJ20021447; Kim JY, 2006, MOL MICROBIOL, V60, P907, DOI 10.1111/j.1365-2958.2006.05146.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li TJ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0082499, 10.1371/journal.pone.0092870]; Li T, 2014, PROTEIN PEPTIDE LETT, V21, P752; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Liu CT, 2014, J AM CHEM SOC, V136, P10349, DOI 10.1021/ja5038947; Livesay DR, 2006, J CHEM THEORY COMPUT, V2, P927, DOI 10.1021/ct600066z; Livesay DR, 2008, CHEM CENT J, V2, DOI 10.1186/1752-153X-2-17; Livesay DR, 2006, PROTEINS, V62, P130, DOI 10.1002/prot.20745; Livesay DR, 2004, FEBS LETT, V576, P468, DOI 10.1016/j.febslet.2004.09.057; MADGWICK PJ, 1987, BIOCHEM J, V248, P657, DOI 10.1042/bj2480657; Majiduddin FK, 2002, INT J MED MICROBIOL, V292, P127, DOI 10.1078/1438-4221-00198; May LT, 2004, CURR PHARM DESIGN, V10, P2003, DOI 10.2174/1381612043384303; MONNAIE D, 1994, BIOCHEM J, V302, P1; Mottonen JM, 2010, BIOPHYS J, V99, P2245, DOI 10.1016/j.bpj.2010.07.043; Mottonen JM, 2009, PROTEINS, V75, P610, DOI 10.1002/prot.22273; Nukaga M, 2004, J BIOL CHEM, V279, P9344, DOI 10.1074/jbc.M312356200; Nukaga M, 1998, BIOCHEMISTRY-US, V37, P10461, DOI 10.1021/bi980184i; OEFNER C, 1990, NATURE, V343, P284, DOI 10.1038/343284a0; Orencia MC, 2001, NAT STRUCT BIOL, V8, P238, DOI 10.1038/84981; Paterson DL, 2003, ANTIMICROB AGENTS CH, V47, P3554, DOI 10.1128/AAC.47.11.3554-3560.2003; Poirel L, 2005, ANTIMICROB AGENTS CH, V49, P3593, DOI 10.1128/AAC.49.8.3593-3597.2005; Rasheed JK, 1997, ANTIMICROB AGENTS CH, V41, P647, DOI 10.1128/AAC.41.3.647; Royer WE, 2005, J BIOL CHEM, V280, P27477, DOI 10.1074/jbc.R500006200; Royer WE, 2001, TRENDS BIOCHEM SCI, V26, P297, DOI 10.1016/S0968-0004(01)01811-4; Savard PY, 2006, BIOCHEMISTRY-US, V45, P11414, DOI 10.1021/bi060414q; Teotico DG, 2009, P NATL ACAD SCI USA, V106, P7455, DOI 10.1073/pnas.0813029106; Thomas VL, 2010, J MOL BIOL, V396, P47, DOI 10.1016/j.jmb.2009.11.005; Verma D, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003155; Verma D, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002409; Vorov OK, 2011, BIOPHYS J, V100, P1129, DOI 10.1016/j.bpj.2011.01.027; Vorov OK, 2009, BIOPHYS J, V97, P3000, DOI 10.1016/j.bpj.2009.09.013; Wernli D, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001022	65	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0125832	10.1371/journal.pone.0125832	http://dx.doi.org/10.1371/journal.pone.0125832			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018804	gold, Green Published, Green Submitted			2022-12-26	WOS:000355185600036
J	Dey, P; Velazquez-Villegas, LA; Faria, M; Turner, A; Jonsson, P; Webb, P; Williams, C; Gustafsson, JA; Strom, AM				Dey, Prasenjit; Velazquez-Villegas, Laura A.; Faria, Michelle; Turner, Anthony; Jonsson, Philp; Webb, Paul; Williams, Cecilia; Gustafsson, Jan-Ake; Stroem, Anders M.			Estrogen Receptor beta 2 Induces Hypoxia Signature of Gene Expression by Stabilizing HIF-1 alpha in Prostate Cancer	PLOS ONE			English	Article							TUMOR-SUPPRESSOR PROTEIN; HIPPEL-LINDAU PROTEIN; ANDROGEN RECEPTOR; ER-BETA; ALPHA; GROWTH; HIF; TRANSCRIPTION; METASTASIS; MECHANISM	The estrogen receptor (ER) beta variant ER beta 2 is expressed in aggressive castration-resistant prostate cancer and has been shown to correlate with decreased overall survival. Genome-wide expression analysis after ER beta 2 expression in prostate cancer cells revealed that hypoxia was an overrepresented theme. Here we show that ER beta 2 interacts with and stabilizes HIF-1 alpha protein in normoxia, thereby inducing a hypoxic gene expression signature. HIF-1 alpha is known to stimulate metastasis by increasing expression of Twist1 and increasing vascularization by directly activating VEGF expression. We found that ER beta 2 interacts with HIF-1 alpha and piggybacks to the HIF-1 alpha response element present on the proximal Twist1 and VEGF promoters. These findings suggest that at least part of the oncogenic effects of ER beta 2 is mediated by HIF-1 alpha and that targeting of this ER beta 2 -HIF-1 alpha interaction may be a strategy to treat prostate cancer.	[Dey, Prasenjit; Velazquez-Villegas, Laura A.; Faria, Michelle; Turner, Anthony; Jonsson, Philp; Williams, Cecilia; Gustafsson, Jan-Ake; Stroem, Anders M.] Univ Houston, Dept Biol & Biochem, Ctr Nucl Receptors & Cell Signaling, Sci & Engn Res Ctr, Houston, TX 77204 USA; [Webb, Paul] Weill Cornell Med Coll, Houston Methodist Res Inst, Genom Med Program, Houston, TX 77030 USA; [Gustafsson, Jan-Ake] Karolinska Inst, Dept BioSci & Nutr, S-14157 Huddinge, Sweden; [Williams, Cecilia] KTH Royal Inst Technol, Dept Prote & Nanotechnol, Sci Life Lab, S-17121 Stockholm, Sweden	University of Houston System; University of Houston; Cornell University; The Methodist Hospital System; The Methodist Hospital - Houston; Karolinska Institutet; Royal Institute of Technology	Strom, AM (corresponding author), Univ Houston, Dept Biol & Biochem, Ctr Nucl Receptors & Cell Signaling, Sci & Engn Res Ctr, 3605 Cullen Blvd,Bldg 545, Houston, TX 77204 USA.	amstrom@uh.edu	Williams, Cecilia/A-6677-2009	Williams, Cecilia/0000-0002-0602-2062; Velazquez-Villegas, Laura/0000-0002-5310-5637; Jonsson, Philip/0000-0002-1537-0624	Cancer Prevention & Research Institute of Texas (CPRIT) [HIRP100680, RP110444]; Texas Emerging Technology Fund [300-9-1958]; Robert A. Welch Foundation [E-0004]; Swedish Cancer Fund; Marie Curie Actions FP7-PEOPLE-COFUND via the VINNOVA programme Mobility for Growth [GROWTH 291795]	Cancer Prevention & Research Institute of Texas (CPRIT); Texas Emerging Technology Fund; Robert A. Welch Foundation(The Welch Foundation); Swedish Cancer Fund; Marie Curie Actions FP7-PEOPLE-COFUND via the VINNOVA programme Mobility for Growth	This work was supported by The Cancer Prevention & Research Institute of Texas (CPRIT) grants HIRP100680 and RP110444, the Texas Emerging Technology Fund under Agreement no. 300-9-1958, the Robert A. Welch Foundation (Grant E-0004), the Swedish Cancer Fund and Marie Curie Actions FP7-PEOPLE-2011-COFUND (GROWTH 291795) via the VINNOVA programme Mobility for Growth (to C.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae MK, 2002, J BIOL CHEM, V277, P9, DOI 10.1074/jbc.C100442200; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Chantzi MI, 2013, J CANCER RES CLIN, V139, P1489, DOI 10.1007/s00432-013-1467-4; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; Dey P, 2014, ONCOGENE, V33, P4213, DOI 10.1038/onc.2013.384; Dey P, 2012, MOL ENDOCRINOL, V26, P1991, DOI 10.1210/me.2012.1227; Fixemer T, 2003, PROSTATE, V54, P79, DOI 10.1002/pros.10171; Gimm T, 2010, FASEB J, V24, P4443, DOI 10.1096/fj.10-159806; Guo ZY, 2009, CANCER RES, V69, P2305, DOI 10.1158/0008-5472.CAN-08-3795; Horvath LG, 2001, CANCER RES, V61, P5331; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Kwon TG, 2011, J CELL BIOCHEM, V112, P3582, DOI 10.1002/jcb.23289; Latil A, 2001, CANCER RES, V61, P1919; Leav I, 2001, AM J PATHOL, V159, P79, DOI 10.1016/S0002-9440(10)61676-8; Leung YK, 2010, ENDOCR-RELAT CANCER, V17, P675, DOI 10.1677/ERC-09-0294; Li XF, 2007, CANCER RES, V67, P7646, DOI 10.1158/0008-5472.CAN-06-4353; Longo PA, 2013, METHOD ENZYMOL, V529, P227, DOI 10.1016/B978-0-12-418687-3.00018-5; Mak P, 2013, P NATL ACAD SCI USA, V110, P4708, DOI 10.1073/pnas.1221654110; Mak P, 2010, CANCER CELL, V17, P319, DOI 10.1016/j.ccr.2010.02.030; Marin-Hernandez A, 2009, MINI-REV MED CHEM, V9, P1084, DOI 10.2174/138955709788922610; Min JH, 2002, SCIENCE, V296, P1886, DOI 10.1126/science.1073440; Mohler JL, 2011, CANCER RES, V71, P1486, DOI 10.1158/0008-5472.CAN-10-1343; Montgomery RB, 2008, CANCER RES, V68, P4447, DOI 10.1158/0008-5472.CAN-08-0249; Ogawa S, 1998, NUCLEIC ACIDS RES, V26, P3505, DOI 10.1093/nar/26.15.3505; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Paatero I, 2012, J BIOL CHEM, V287, P9659, DOI 10.1074/jbc.M111.299537; Perlmutter Mark A, 2007, Rev Urol, V9 Suppl 1, pS3; Qi JF, 2010, CANCER CELL, V18, P23, DOI 10.1016/j.ccr.2010.05.024; Ragnum HB, 2013, INT J RADIAT ONCOL, V87, P753, DOI 10.1016/j.ijrobp.2013.07.023; Richter K, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-75; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; Weihua Zhang, 2001, Proceedings of the National Academy of Sciences of the United States of America, V98, P6330, DOI 10.1073/pnas.111150898; Yan Q, 2007, MOL CELL BIOL, V27, P2092, DOI 10.1128/MCB.01514-06; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691	36	31	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128239	10.1371/journal.pone.0128239	http://dx.doi.org/10.1371/journal.pone.0128239			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010887	Green Submitted, Green Published, gold			2022-12-26	WOS:000355183900212
J	Stobart, B; Diaz, D; Alvarez, F; Alonso, C; Mallol, S; Goni, R				Stobart, Ben; Diaz, David; Alvarez, Federico; Alonso, Cristina; Mallol, Sandra; Goni, Raquel			Performance of Baited Underwater Video: Does It Underestimate Abundance at High Population Densities?	PLOS ONE			English	Article							PALINURUS-ELEPHAS FABRICIUS; FISH ASSEMBLAGES; REEF FISH; RELATIVE DENSITY; IDENTIFICATION; BIODIVERSITY; VARIABILITY; ATTRACTION; CARCHARIAS; FISHERIES	Video survey techniques are now commonly used to estimate animal abundance under the assumption that estimates relate to true abundance, a key property needed to make video a valid survey tool. Using the spiny lobster Palinurus elephas as our model organism, we evaluate the effectiveness of baited underwater video (BUV) for estimating abundance in areas with widely different population density. We test three BUV abundance metrics and compare the results with an independently obtained abundance index from trammel-net surveys (Trammel). Video metrics used to estimate relative abundance include a value for total number of individuals per recording (TotN), the traditional maximum number of fish observed in a single video frame (MaxN), and the recently suggested alternative, the average of the mean MaxN from 5-minute periods throughout the duration of the recording (MeanN). This is the first video study of a wild population to include an estimate for TotN. Comparison of TotN with the other two BUV relative abundance metrics demonstrates that both of the latter lack resolution at high population densities. In spite of this, the three BUV metrics tested, as well as the independent estimate Trammel, distinguished high density areas from low density areas. Thus they could all be used to identify areas of differing population density, but MaxN and MeanN would not be appropriate metrics for studies aimed at documenting increases in abundance, such as those conducted to assess marine protected area effectiveness, as they are prone to sampling saturation. We also demonstrate that time of first arrival (T1) is highly correlated with all of the abundance indices; suggesting T1 may be a potentially useful index of abundance. However, these relationships require further investigation as our data suggests T1 may not adequately represent lobster abundance in areas of high density.	[Stobart, Ben; Diaz, David; Alvarez, Federico; Mallol, Sandra; Goni, Raquel] Ctr Oceanog Baleares, Inst Espanol Oceanog, Palma de Mallorca 07015, Spain; [Stobart, Ben] Port Lincoln Marine Sci Ctr, South Australian Res & Dev Inst, Port Lincoln, SA 5606, Australia; [Diaz, David] CSIC, Inst Ciencies Mar, E-08003 Barcelona, Spain; [Alonso, Cristina] Univ Alicante, IMEM Ramon Margalef, E-03080 Alicante, Spain	Spanish Institute of Oceanography; South Australian Research & Development Institute (SARDI); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); Universitat d'Alacant	Stobart, B (corresponding author), Ctr Oceanog Baleares, Inst Espanol Oceanog, Muelle Poniente S-N, Palma de Mallorca 07015, Spain.	ben.stobart@sa.gov.au	Ning, Yin/B-4034-2017; Ning〕, 宁印〔Yin/AAN-7682-2020; Ning, Yin/N-7040-2019; DIAZ, DAVID/AAS-8722-2021	Ning, Yin/0000-0003-1808-3513; Ning, Yin/0000-0003-1808-3513; DIAZ, DAVID/0000-0003-0611-2516; MALLOL, SANDRA/0000-0002-0394-9794	Spanish National Plan for Scientific and Technological Research and Innovation; RECMARE project [CTM2012-36982 MAR]; SGP (Spanish Ministry of Agriculture, Environment and Fisheries); South Australian Research Institute	Spanish National Plan for Scientific and Technological Research and Innovation; RECMARE project; SGP (Spanish Ministry of Agriculture, Environment and Fisheries); South Australian Research Institute	This work was supported by a grant from the Spanish National Plan for Scientific and Technological Research and Innovation, the RECMARE project (CTM2012-36982 MAR) and by the SGP (Spanish Ministry of Agriculture, Environment and Fisheries) for the ERICOL project. The South Australian Research Institute provided in-kind funding support.	Babcock RC, 2010, P NATL ACAD SCI USA, V107, P18256, DOI 10.1073/pnas.0908012107; Bacheler NM, 2013, FISH RES, V143, P81, DOI 10.1016/j.fishres.2013.01.013; Bernard ATF, 2012, MAR ECOL PROG SER, V471, P235, DOI 10.3354/meps10039; Birt MJ, 2012, J EXP MAR BIOL ECOL, V416, P92, DOI 10.1016/j.jembe.2012.02.011; Brooks Edward J., 2011, Endangered Species Research, V13, P231, DOI 10.3354/esr00331; Cappo M, 2004, J EXP MAR BIOL ECOL, V302, P123, DOI 10.1016/j.jembe.2003.10.006; Cappo M., 2007, CUTTINGEDGE TECHNOLO, V1, P101; Cappo M., 2002, AQUATIC PROTECTED AR, P455; Connolly RM, 2002, MAR FRESHWATER RES, V53, P777, DOI 10.1071/MF01168; Diaz D, 2011, MAR ECOL PROG SER, V433, P149, DOI 10.3354/meps09182; Domeier ML, 2007, MAR BIOL, V150, P977, DOI 10.1007/s00227-006-0380-7; ELLIS DM, 1995, FISH B-NOAA, V93, P67; Farnsworth KD, 2007, MAR ECOL PROG SER, V350, P223, DOI 10.3354/meps07190; Frisch AJ, 2007, J EXP MAR BIOL ECOL, V351, P294, DOI 10.1016/j.jembe.2007.07.008; GOBERT B, 1992, FISH RES, V13, P353, DOI 10.1016/0165-7836(92)90057-Z; Goni R, 2005, CAH BIOL MAR, V46, P127; Goni R, 2003, FISH RES, V65, P295, DOI 10.1016/j.fishres.2003.09.021; Goni R, 2010, MAR ECOL PROG SER, V400, P233, DOI 10.3354/meps08419; Harvey ES, 2007, MAR ECOL PROG SER, V350, P245, DOI 10.3354/meps07192; Harvey ES, 2012, FISH RES, V125, P108, DOI 10.1016/j.fishres.2012.01.026; Heagney EC, 2007, MAR ECOL PROG SER, V350, P255, DOI 10.3354/meps07193; Jury SH, 2001, MAR FRESHWATER RES, V52, P1125, DOI 10.1071/MF01096; MacDiarmid AB, 2005, NEW ZEAL J MAR FRESH, V39, P551, DOI 10.1080/00288330.2005.9517333; Mallet D, 2014, FISH RES, V154, P44, DOI 10.1016/j.fishres.2014.01.019; McConney P, 2007, FISH RES, V87, P77, DOI 10.1016/j.fishres.2007.06.011; Merritt D, 2011, FISH B-NOAA, V109, P56; Meyer-Rochow V.B., 1984, ZOOLOGICA, V45, P1; SAINTE-MARIE B, 1987, MAR BIOL, V94, P431, DOI 10.1007/BF00428250; Schobernd ZH, 2014, CAN J FISH AQUAT SCI, V71, P464, DOI 10.1139/cjfas-2013-0086; Stobart B, 2007, J EXP MAR BIOL ECOL, V345, P158, DOI 10.1016/j.jembe.2007.02.009; Stoner AW, 2008, J EXP MAR BIOL ECOL, V354, P202, DOI 10.1016/j.jembe.2007.11.008; Taylor MD, 2013, FISH RES, V140, P96, DOI 10.1016/j.fishres.2012.12.013; Tessier E, 2005, J EXP MAR BIOL ECOL, V315, P17, DOI 10.1016/j.jembe.2004.08.027; Van Tienhoven AM, 2007, J APPL ECOL, V44, P273, DOI 10.1111/j.1365-2664.2006.01273.x; Willis TJ, 2000, MAR FRESHWATER RES, V51, P755, DOI 10.1071/MF00010; Willis TJ, 2000, MAR ECOL PROG SER, V198, P249, DOI 10.3354/meps198249; Willis TJ, 2003, J APPL ECOL, V40, P214, DOI 10.1046/j.1365-2664.2003.00775.x; Wilson SK, 2006, J FISH BIOL, V69, P928, DOI 10.1111/j.1095-8649.2006.01128.x; Wraith JA, 2007, ASSESSING REEF ASSEM; Wraith J, 2013, MAR ECOL PROG SER, V477, P189, DOI 10.3354/meps10137	40	26	27	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127559	10.1371/journal.pone.0127559	http://dx.doi.org/10.1371/journal.pone.0127559			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010738	Green Published, gold, Green Submitted			2022-12-26	WOS:000355183900110
J	Uyama, T; Kawai, K; Kono, N; Watanabe, M; Tsuboi, K; Inoue, T; Araki, N; Arai, H; Ueda, N				Uyama, Toru; Kawai, Katsuhisa; Kono, Nozomu; Watanabe, Masahiro; Tsuboi, Kazuhito; Inoue, Tomohito; Araki, Nobukazu; Arai, Hiroyuki; Ueda, Natsuo			Interaction of Phospholipase A/Acyltransferase-3 with Pex19p A POSSIBLE INVOLVEMENT IN THE DOWN-REGULATION OF PEROXISOMES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-PROTEINS; RAS PROTEINS; N-ACYLPHOSPHATIDYLETHANOLAMINE; LIPID-METABOLISM; IMPORT RECEPTOR; CDNA CLONING; BIOGENESIS; GENE; BIOCHEMISTRY; DEGRADATION	Phospholipase A/acyltransferase (PLA/AT)-3 (also known as H-rev107 or AdPLA) was originally isolated as a tumor suppressor and was later shown to have phospholipase A(1)/A(2) activity. We have also found that the overexpression of PLA/AT-3 in mammalian cells results in specific disappearance of peroxisomes. However, its molecular mechanism remained unclear. In the present study, we first established a HEK293 cell line, which stably expresses a fluorescent peroxisome marker protein (DsRed2-Peroxi) and expresses PLA/AT-3 in a tetracycline-dependent manner. The treatment with tetracycline, as expected, caused disappearance of peroxisomes within 24 h, as revealed by diffuse signals of DsRed2-Peroxi and a remarkable decrease in a peroxisomal membrane protein, PMP70. A time-dependent decrease in ether-type lipid levels was also seen. Because the activation of LC3, a marker of autophagy, was not observed, the involvement of autophagy was unlikely. Among various peroxins responsible for peroxisome biogenesis, Pex19p functions as a chaperone protein for the transportation of peroxisomal membrane proteins. Immunoprecipitation analysis showed that PLA/AT-3 binds to Pex19p through its N-terminal proline-rich and C-terminal hydrophobic domains. The protein level and enzyme activity of PLA/AT-3 were increased by its coexpression with Pex19p. Moreover, PLA/AT-3 inhibited the binding of Pex19 to peroxisomal membrane proteins, such as Pex3p and Pex11 beta p. A catalytically inactive point mutant of PLA/AT-3 could bind to Pex19p but did not inhibit the chaperone activity of Pex19p. Altogether, these results suggest a novel regulatory mechanism for peroxisome biogenesis through the interaction between Pex19p and PLA/AT-3.	[Uyama, Toru; Watanabe, Masahiro; Tsuboi, Kazuhito; Inoue, Tomohito; Ueda, Natsuo] Kagawa Univ, Sch Med, Dept Biochem, Miki, Kagawa 7610793, Japan; [Kawai, Katsuhisa; Araki, Nobukazu] Kagawa Univ, Sch Med, Dept Histol & Cell Biol, Miki, Kagawa 7610793, Japan; [Kono, Nozomu; Arai, Hiroyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo 1130033, Japan; [Watanabe, Masahiro] Kagawa Univ Hosp, Miki, Kagawa 7610793, Japan; [Inoue, Tomohito] Shikoku Med Ctr Children & Adults, Dept Orthoped Surg, Zentsuji, Kagawa 7650001, Japan	Kagawa University; Kagawa University; University of Tokyo; Kagawa University	Ueda, N (corresponding author), 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan.	nueda@med.kagawa-u.ac.jp	KONO, nozomu/AAM-3178-2020	Araki, Nobukazu/0000-0001-6160-210X	Japan Society for the Promotion of Science [24590355, 25460370]; Fund for Kagawa University Young Scientists; Naito Foundation; Japan Foundation for Applied Enzymology; Grants-in-Aid for Scientific Research [15K08278, 25460370] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Fund for Kagawa University Young Scientists; Naito Foundation(Naito Memorial Foundation); Japan Foundation for Applied Enzymology; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research (C) 24590355 (to T. U.) and 25460370 (to N. U.) from the Japan Society for the Promotion of Science; the Fund for Kagawa University Young Scientists 2014 (to T. U.); the Naito Foundation (to T. U.); and the Japan Foundation for Applied Enzymology (to N. U.). The authors declare that they have no conflicts of interest with the contents of this article.	Bartz R, 2007, J LIPID RES, V48, P837, DOI 10.1194/jlr.M600413-JLR200; Benjamin DI, 2013, P NATL ACAD SCI USA, V110, P14912, DOI 10.1073/pnas.1310894110; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Duncan RE, 2008, J BIOL CHEM, V283, P25428, DOI 10.1074/jbc.M804146200; Fujiki Y, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00307; Fujiki Y, 2012, BBA-MOL BASIS DIS, V1822, P1337, DOI 10.1016/j.bbadis.2012.06.004; HAJNAL A, 1994, ONCOGENE, V9, P479; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Hara-Kuge S, 2008, EXP CELL RES, V314, P3531, DOI 10.1016/j.yexcr.2008.09.015; Hummasti S, 2008, J LIPID RES, V49, P2535, DOI 10.1194/jlr.M800269-JLR200; Islinger M, 2010, BBA-MOL CELL RES, V1803, P881, DOI 10.1016/j.bbamcr.2010.03.013; Iwata J, 2006, J BIOL CHEM, V281, P4035, DOI 10.1074/jbc.M512283200; Jaworski K, 2009, NAT MED, V15, P159, DOI 10.1038/nm.1904; Jin XH, 2007, J BIOL CHEM, V282, P3614, DOI 10.1074/jbc.M606369200; Jin XH, 2009, BBA-MOL CELL BIOL L, V1791, P32, DOI 10.1016/j.bbalip.2008.09.006; Jones JM, 2004, J CELL BIOL, V164, P57, DOI 10.1083/jcb.200304111; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kurochkin IV, 2007, EMBO J, V26, P835, DOI 10.1038/sj.emboj.7601525; Lodhi IJ, 2014, CELL METAB, V19, P380, DOI 10.1016/j.cmet.2014.01.002; Ma CL, 2011, J CELL BIOL, V193, P7, DOI 10.1083/jcb.201010022; Manjithaya R, 2010, FEBS LETT, V584, P1367, DOI 10.1016/j.febslet.2010.01.019; Martens K, 2012, MOL GENET METAB, V107, P735, DOI 10.1016/j.ymgme.2012.10.015; Matsuzaki T, 2008, J CELL BIOL, V183, P1275, DOI 10.1083/jcb.200806062; Matsuzono Y, 2006, J BIOL CHEM, V281, P36, DOI 10.1074/jbc.M509819200; Matsuzono Y, 1999, P NATL ACAD SCI USA, V96, P2116, DOI 10.1073/pnas.96.5.2116; Matsuzono Y, 2006, J CELL SCI, V119, P3539, DOI 10.1242/jcs.03100; Misaki R, 2010, J CELL BIOL, V191, P23, DOI 10.1083/jcb.200911143; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Morales M, 2014, EMBO MOL MED, V6, P865, DOI 10.15252/emmm.201303675; Nordgren M, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00145; Purdue PE, 2001, ANNU REV CELL DEV BI, V17, P701, DOI 10.1146/annurev.cellbio.17.1.701; Sacksteder KA, 2000, J CELL BIOL, V148, P931, DOI 10.1083/jcb.148.5.931; Shinohara N, 2011, J LIPID RES, V52, P1927, DOI 10.1194/jlr.M015081; Smith JJ, 2013, NAT REV MOL CELL BIO, V14, P803, DOI 10.1038/nrm3700; Steinberg SJ, 2006, BBA-MOL CELL RES, V1763, P1733, DOI 10.1016/j.bbamcr.2006.09.010; Tabak HF, 2013, ANNU REV BIOCHEM, V82, P723, DOI 10.1146/annurev-biochem-081111-125123; Theodoulou FL, 2013, BIOCHEM J, V451, P345, DOI 10.1042/BJ20130078; Ueda N, 2013, FEBS J, V280, P1874, DOI 10.1111/febs.12152; Uyama T, 2013, BBA-MOL CELL BIOL L, V1831, P1690, DOI 10.1016/j.bbalip.2013.08.017; Uyama T, 2012, J BIOL CHEM, V287, P31905, DOI 10.1074/jbc.M112.368712; Uyama T, 2012, J BIOL CHEM, V287, P2706, DOI 10.1074/jbc.M111.267575; Uyama T, 2009, BBA-MOL CELL BIOL L, V1791, P1114, DOI 10.1016/j.bbalip.2009.07.001; Uyama T, 2009, J LIPID RES, V50, P685, DOI 10.1194/jlr.M800453-JLR200; Vaccari CM, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-63; Van Veldhoven PP, 2010, J LIPID RES, V51, P2863, DOI 10.1194/jlr.R005959; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; Wang CH, 2014, J BIOMED SCI, V21, DOI 10.1186/1423-0127-21-36; Weller S, 2003, ANNU REV GENOM HUM G, V4, P165, DOI 10.1146/annurev.genom.4.070802.110424; Xiong SB, 2014, P NATL ACAD SCI USA, V111, P11145, DOI 10.1073/pnas.1404139111; Yao F, 1998, HUM GENE THER, V9, P1939, DOI 10.1089/hum.1998.9.13-1939; Yonekawa S, 2011, P NATL ACAD SCI USA, V108, P12746, DOI 10.1073/pnas.1103283108	53	21	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17520	17534		10.1074/jbc.M114.635433	http://dx.doi.org/10.1074/jbc.M114.635433			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	26018079	hybrid, Green Published			2022-12-26	WOS:000357730900043
J	Bozic, D; Papaefthimiou, D; Bruckner, K; de Vos, RCH; Tsoleridis, CA; Katsarou, D; Papanikolaou, A; Pateraki, I; Chatzopoulou, FM; Dimitriadou, E; Kostas, S; Manzano, D; Scheler, U; Ferrer, A; Tissier, A; Makris, AM; Kampranis, SC; Kanellis, AK				Bozic, Dragana; Papaefthimiou, Dimitra; Brueckner, Kathleen; de Vos, Ric C. H.; Tsoleridis, Constantinos A.; Katsarou, Dimitra; Papanikolaou, Antigoni; Pateraki, Irini; Chatzopoulou, Fani M.; Dimitriadou, Eleni; Kostas, Stefanos; Manzano, David; Scheler, Ulschan; Ferrer, Albert; Tissier, Alain; Makris, Antonios M.; Kampranis, Sotirios C.; Kanellis, Angelos K.			Towards Elucidating Carnosic Acid Biosynthesis in Lamiaceae: Functional Characterization of the Three First Steps of the Pathway in Salvia fruticosa and Rosmarinus officinalis	PLOS ONE			English	Article							IN-VITRO ANTIOXIDANT; SUBCELLULAR-LOCALIZATION; DIPHOSPHATE SYNTHASE; PHENOLIC DITERPENES; ROSEMARY; GENE; L.; EXPRESSION; METABOLISM; CRETICUS	Carnosic acid (CA) is a phenolic diterpene with anti-tumour, anti-diabetic, antibacterial and neuroprotective properties that is produced by a number of species from several genera of the Lamiaceae family, including Salvia fruticosa (Cretan sage) and Rosmarinus officinalis (Rosemary). To elucidate CA biosynthesis, glandular trichome transcriptome data of S. fruticosa were mined for terpene synthase genes. Two putative diterpene synthase genes, namely SfCPSand SfKSL, showing similarities to copalyl diphosphate synthase and kaurene synthase-like genes, respectively, were isolated and functionally characterized. Recombinant expression in Escherichia coli followed by in vitro enzyme activity assays confirmed that SfCPS is a copalyl diphosphate synthase. Coupling of SfCPS with SfKSL, both in vitro and in yeast, resulted in the synthesis miltiradiene, as confirmed by 1D and 2D NMR analyses (H-1, C-13, DEPT, COSY H-H, HMQC and HMBC). Coupled transient in vivo assays of SfCPS and SfKSL in Nicotiana benthamiana further confirmed production of miltiradiene in planta. To elucidate the subsequent biosynthetic step, RNA-Seq data of S. fruticosa and R. officinalis were searched for cytochrome P450 (CYP) encoding genes potentially involved in the synthesis of the first phenolic compound in the CA pathway, ferruginol. Three candidate genes were selected, SfFS, RoFS1 and RoFS2. Using yeast and N. benthamiana expression systems, all three where confirmed to be coding for ferruginol synthases, thus revealing the enzymatic activities responsible for the first three steps leading to CA in two Lamiaceae genera.	[Bozic, Dragana; Papaefthimiou, Dimitra; Katsarou, Dimitra; Papanikolaou, Antigoni; Chatzopoulou, Fani M.; Dimitriadou, Eleni; Kanellis, Angelos K.] Aristotle Univ Thessaloniki, Dept Pharmaceut Sci, Lab Pharmacognosy, Grp Biotechnol Pharmaceut Plants, Thessaloniki 54124, Greece; [Brueckner, Kathleen; Scheler, Ulschan; Tissier, Alain] Leibniz Inst Plant Biochem, Dept Cell & Metab Biol, Halle, Germany; [de Vos, Ric C. H.] Wageningen Univ & Res Ctr, Plant Res Int, Wageningen, Netherlands; [Tsoleridis, Constantinos A.] Aristotle Univ Thessaloniki, Dept Chem, Organ Chem Lab, Thessaloniki 54124, Greece; [Pateraki, Irini; Ferrer, Albert] CSIC IRTA UAB UB, Ctr Res Agr Genom, Dept Mol Genet, Barcelona 08193, Spain; [Ferrer, Albert] Univ Barcelona, Fac Pharm, Dept Biochem & Mol Biol, Barcelona 08028, Spain; [Kostas, Stefanos] Aristotle Univ Thessaloniki, Sch Agr, Lab Floriculture, Thessaloniki 54124, Greece; [Makris, Antonios M.] Ctr Res & Technol Hellas, Inst Appl Biosci, Thermi, Greece; [Kampranis, Sotirios C.] Univ Crete, Sch Med, Dept Biochem, Iraklion 71003, Greece; [de Vos, Ric C. H.] Netherlands Metab Ctr, Leiden, Netherlands	Aristotle University of Thessaloniki; Leibniz Institut fur Pflanzenbiochemie; Wageningen University & Research; Aristotle University of Thessaloniki; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); IRTA; University of Barcelona; Aristotle University of Thessaloniki; Centre for Research & Technology Hellas; University of Crete	Kanellis, AK (corresponding author), Aristotle Univ Thessaloniki, Dept Pharmaceut Sci, Lab Pharmacognosy, Grp Biotechnol Pharmaceut Plants, Thessaloniki 54124, Greece.	kanellis@pharm.auth.gr	Chatzopoulou, Fani/AAK-1799-2021; Tissier, Alain F/B-2108-2017; Kampranis, Sotirios C/G-8374-2016; Ferrer, Albert/AAI-4595-2021; De Vos, Ric/F-5012-2017; Kanellis, Angelos/B-7998-2010; Pateraki, Irini/A-5957-2015	Tissier, Alain F/0000-0002-9406-4245; Kampranis, Sotirios C/0000-0001-6208-1684; Ferrer, Albert/0000-0002-0741-2388; Matekalo, Dragana/0000-0001-6565-4580; Chatzopoulou, Fani/0000-0003-4695-5753; Kanellis, Angelos/0000-0002-7653-440X; Pateraki, Irini/0000-0002-7526-2334; Bathe, Ulschan/0000-0002-0454-502X	EU [KBBE-227448]; Netherlands Metabolomics Centre, Netherlands Genomics Initiative/Netherlands Organization; Cost Action [FA1006]; European Commission	EU(European Commission); Netherlands Metabolomics Centre, Netherlands Genomics Initiative/Netherlands Organization; Cost Action(European Cooperation in Science and Technology (COST)); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by EU Grant agreement KBBE-227448 for the TERPMED project (http://www.terpmed.eu). RCHdV acknowledges the Netherlands Metabolomics Centre, which is part of the Netherlands Genomics Initiative/Netherlands Organization for additional financial support. Support from Cost Action FA1006 is greatly appreciated. Funding for having this publication made available Open Access has been provided by the European Commission through its FP7 post-grant Gold Open Access Pilot. The funders had no role in the study design, data collection and analysis, decisions to publish, or preparation of the manuscript.	[Anonymous], 1989, PLANT MOL BIOL MANUA; Bak Soren, 2011, Arabidopsis Book, V9, pe0144, DOI 10.1199/tab.0144; Bauer J, 2012, J PHARMACOL EXP THER, V342, P169, DOI 10.1124/jpet.112.193847; Bruckner K, 2014, PHYTOCHEMISTRY, V101, P52, DOI 10.1016/j.phytochem.2014.01.021; Caniard A, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-119; Chatzopoulou FM, 2010, PLANT CELL REP, V29, P523, DOI 10.1007/s00299-010-0841-9; Chen F, 2011, PLANT J, V66, P212, DOI 10.1111/j.1365-313X.2011.04520.x; Cvetkovikj I, 2013, J CHROMATOGR A, V1282, P38, DOI 10.1016/j.chroma.2012.12.068; Dilas S, 2012, INT J FOOD SCI TECH, V47, P2052, DOI 10.1111/j.1365-2621.2012.03069.x; El-Banna H., 2013, J PHYS PHARM ADV, V3, P41, DOI [10.5455/jppa.20130228054608, DOI 10.5455/JPPA.20130228054608]; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Falara V, 2008, PLANT MOL BIOL, V68, P633, DOI 10.1007/s11103-008-9399-0; Falara V, 2010, PLANT PHYSIOL, V154, P301, DOI 10.1104/pp.110.159566; Fischedick JT, 2013, BIOORGAN MED CHEM, V21, P2618, DOI 10.1016/j.bmc.2013.02.019; Gao W, 2009, ORG LETT, V11, P5170, DOI 10.1021/ol902051v; Gaya M, 2013, BBA-GEN SUBJECTS, V1830, P3796, DOI 10.1016/j.bbagen.2013.03.021; GLEAVE AP, 1992, PLANT MOL BIOL, V20, P1203, DOI 10.1007/BF00028910; Guo J, 2013, P NATL ACAD SCI USA, V110, P12108, DOI 10.1073/pnas.1218061110; Hidalgo PJ, 1998, J AGR FOOD CHEM, V46, P2624, DOI 10.1021/jf970974j; Hillwig ML, 2011, PLANT J, V68, P1051, DOI 10.1111/j.1365-313X.2011.04756.x; Hofer R, 2014, PLANT PHYSIOL, V166, P1149, DOI 10.1104/pp.114.244814; Ignea C, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-162; Ignea C, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-4; INATANI R, 1982, AGR BIOL CHEM TOKYO, V46, P1661, DOI 10.1080/00021369.1982.10865273; Iwamoto M, 2003, PLANTA MED, V69, P69, DOI 10.1055/s-2003-37037; Jordan MJ, 2012, J AGR FOOD CHEM, V60, P9603, DOI 10.1021/jf302881t; Karousou R., 1997, Willdenowia, V27, P113, DOI 10.3372/wi.27.2710; Kianbakht S, 2013, COMPLEMENT THER MED, V21, P441, DOI 10.1016/j.ctim.2013.07.004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Jimenez A, 2013, EUR J NUTR, V52, P85, DOI 10.1007/s00394-011-0289-x; Masuda T, 2001, J AGR FOOD CHEM, V49, P5560, DOI 10.1021/jf010693i; Matsingou TC, 2003, J AGR FOOD CHEM, V51, P6696, DOI 10.1021/jf034516o; MUHAMMAD I, 1992, PHYTOTHER RES, V6, P261, DOI 10.1002/ptr.2650060508; Nelson D, 2011, PLANT J, V66, P194, DOI 10.1111/j.1365-313X.2011.04529.x; Ono M, 1999, J NAT PROD, V62, P1532, DOI 10.1021/np990204x; Park M, 2013, EXP DERMATOL, V22, P336, DOI 10.1111/exd.12138; Pateraki I, 2008, PHYTOCHEMISTRY, V69, P1641, DOI 10.1016/j.phytochem.2008.02.005; Peters RJ, 2010, NAT PROD REP, V27, P1521, DOI 10.1039/c0np00019a; Petiwala SM, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00029; Pizzale L, 2002, J SCI FOOD AGR, V82, P1645, DOI 10.1002/jsfa.1240; Poeckel D, 2008, BIOCHEM PHARMACOL, V76, P91, DOI 10.1016/j.bcp.2008.04.013; Richheimer SL, 1996, J AM OIL CHEM SOC, V73, P507, DOI 10.1007/BF02523927; Ro DK, 2002, PLANT PHYSIOL, V130, P1837, DOI 10.1104/pp.008011; Rodriguez JA, 2006, LIFE SCI, V78, P2503, DOI 10.1016/j.lfs.2005.10.018; Sakamoto T, 2004, PLANT PHYSIOL, V134, P1642, DOI 10.1104/pp.103.033696; Sallaud C, 2012, PLANT J, V72, P1, DOI 10.1111/j.1365-313X.2012.05068.x; Shimura K, 2007, J BIOL CHEM, V282, P34013, DOI 10.1074/jbc.M703344200; Simon P, 2003, BIOINFORMATICS, V19, P1439, DOI 10.1093/bioinformatics/btg157; Skoula M, 1999, BIOCHEM SYST ECOL, V27, P559, DOI 10.1016/S0305-1978(98)00122-7; Skoula M, 2000, BIOCHEM SYST ECOL, V28, P551, DOI 10.1016/S0305-1978(99)00095-2; Sugai Y, 2011, J BIOL CHEM, V286, P42840, DOI 10.1074/jbc.M111.302703; SUN TP, 1994, PLANT CELL, V6, P1509, DOI 10.1105/tpc.6.10.1509; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TARSHIS LC, 1994, BIOCHEMISTRY-US, V33, P10871, DOI 10.1021/bi00202a004; Tounekti T, 2012, ENVIRON EXP BOT, V78, P146, DOI 10.1016/j.envexpbot.2011.12.037; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Wang Q, 2012, J BIOL CHEM, V287, P6159, DOI 10.1074/jbc.M111.305599; Zhou L, 1999, INDUCIBLE GENE EXPRESSION IN PLANTS, P127; Zi JC, 2013, ORG BIOMOL CHEM, V11, P7650, DOI 10.1039/c3ob41885e	59	42	47	4	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0124106	10.1371/journal.pone.0124106	http://dx.doi.org/10.1371/journal.pone.0124106			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020634	Green Published, gold, Green Submitted			2022-12-26	WOS:000355187300006
J	Jahrling, N; Becker, K; Wegenast-Braun, BM; Grathwohl, SA; Jucker, M; Dodt, HU				Jaehrling, Nina; Becker, Klaus; Wegenast-Braun, Bettina M.; Grathwohl, Stefan A.; Jucker, Mathias; Dodt, Hans-Ulrich			Cerebral beta-Amyloidosis in Mice Investigated by Ultramicroscopy	PLOS ONE			English	Article							TRANSGENIC MICE; A-BETA; DISEASE; MODELS	Alzheimer's disease (AD) is the most common neurodegenerative disorder. AD neuropathology is characterized by intracellular neurofibrillary tangles and extracellular beta-amyloid deposits in the brain. To elucidate the complexity of AD pathogenesis a variety of transgenic mouse models have been generated. An ideal imaging system for monitoring beta-amyloid plaque deposition in the brain of these animals should allow 3D-reconstructions of beta-amyloid plaques via a single scan of an uncropped brain. Ultramicroscopy makes this possible by replacing mechanical slicing in standard histology by optical sectioning. It allows a time efficient analysis of the amyloid plaque distribution in the entire mouse brain with 3D cellular resolution. We herein labeled beta-amyloid deposits in a transgenic mouse model of cerebral beta-amyloidosis (APPPS1 transgenic mice) with two intraperitoneal injections of the amyloid-binding fluorescent dye methoxy-X04. Upon postmortem analysis the total number of beta-amyloid plaques, the beta-amyloid load (volume percent) and the amyloid plaque size distributions were measured in the frontal cortex of two age groups (2.5 versus 7-8.5 month old mice). Applying ultramicroscopy we found in a proof-of-principle study that the number of beta-amyloid plaques increases with age. In our experiments we further observed an increase of large plaques in the older age group of mice. We demonstrate that ultramicroscopy is a fast, and accurate analysis technique for studying beta-amyloid lesions in transgenic mice allowing the 3D staging of beta-amyloid plaque development. This in turn is the basis to study neural network degeneration upon cerebral beta-amyloidosis and to assess A beta-targeting therapeutics.	[Jaehrling, Nina; Becker, Klaus; Dodt, Hans-Ulrich] Vienna Univ Technol, FKE, Dept Bioelect, A-1040 Vienna, Austria; [Jaehrling, Nina; Becker, Klaus; Dodt, Hans-Ulrich] MUW, Ctr Brain Res, Sect Bioelect, Vienna, Austria; [Wegenast-Braun, Bettina M.; Grathwohl, Stefan A.; Jucker, Mathias] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Cellular Neurol, Tubingen, Germany; [Wegenast-Braun, Bettina M.; Grathwohl, Stefan A.; Jucker, Mathias] German Ctr Neurodegenerat Dis DZNE, Tubingen, Germany	Technische Universitat Wien; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Jahrling, N (corresponding author), Vienna Univ Technol, FKE, Dept Bioelect, A-1040 Vienna, Austria.	nina.jaehrling@tuwien.ac.at		Becker, Klaus/0000-0002-2406-0476	Hertie Foundation; Austrian "Fonds zur Forderung der wissenschaftlichen Forschung" (FWF) [P23102-N22]	Hertie Foundation; Austrian "Fonds zur Forderung der wissenschaftlichen Forschung" (FWF)(Austrian Science Fund (FWF))	This study was supported by the Hertie Foundation and by the Austrian "Fonds zur Forderung der wissenschaftlichen Forschung" (FWF; grant no. P23102-N22). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker K, 2008, J BIOPHOTONICS, V1, P36, DOI 10.1002/jbio.200710011; Becker K, 2012, PLOS ONE; Bittner T, 2012, ACTA NEUROPATHOL, V124, P797, DOI 10.1007/s00401-012-1047-8; Chung K, 2013, NAT METHODS, V10, P508, DOI [10.1038/nmeth.2481, 10.1038/NMETH.2481]; Dodt HU, 2007, NAT METHODS, V4, P331, DOI 10.1038/NMETH1036; Duyckaerts C, 2008, ACTA NEUROPATHOL, V115, P5, DOI 10.1007/s00401-007-0312-8; Erturk A, 2012, NAT MED, V18, P166, DOI 10.1038/nm.2600; Hefendehl JK, 2011, J NEUROSCI, V31, P624, DOI 10.1523/JNEUROSCI.5147-10.2011; Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002369; Jucker M, 2010, NAT MED, V16, P1210, DOI 10.1038/nm.2224; Klunk WE, 2002, J NEUROPATH EXP NEUR, V61, P797, DOI 10.1093/jnen/61.9.797; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Klymkowsky M, 1991, METHODS CELL BIOL, V36; Maier FC, 2014, NAT MED, V20, P1485, DOI 10.1038/nm.3734; Manook A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031310; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Theer P, 2003, OPT LETT, V28, P1022, DOI 10.1364/OL.28.001022; Vettenburg T, 2014, NAT METHODS, V11, P541, DOI [10.1038/NMETH.2922, 10.1038/nmeth.2922]; Wegenast-Braun BM, 2009, AM J PATHOL, V175, P271, DOI 10.2353/ajpath.2009.090044	19	19	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0125418	10.1371/journal.pone.0125418	http://dx.doi.org/10.1371/journal.pone.0125418			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26017149	Green Published, gold, Green Submitted			2022-12-26	WOS:000355185600022
J	Nyaga, JM; Neff, JC; Cramer, MD				Nyaga, Justine M.; Neff, Jason C.; Cramer, Michael D.			The Contribution of Occult Precipitation to Nutrient Deposition on the West Coast of South Africa	PLOS ONE			English	Article							ORGANIC NITROGEN; MARINE AEROSOLS; SPECTROPHOTOMETRIC DETERMINATION; FOLIAR APPLICATION; SOUTHWESTERN CAPE; FYNBOS ECOSYSTEM; RICINUS-COMMUNIS; RAIN-FOREST; FOG; NITRATE	The Strandveld mediterranean-ecosystem of the west coast of South Africa supports floristically diverse vegetation growing on mostly nutrient-poor aeolian sands and extending from the Atlantic Ocean tens of kilometers inland. The cold Benguela current upwelling interacts with warm onshore southerly winds in summer causing coastal fogs in this region. We hypothesized that fog and other forms of occult precipitation contribute moisture and nutrients to the vegetation. We measured occult precipitation over one year along a transect running inland in the direction of the prevailing wind and compared the nutrient concentrations with those in rainwater. Occult deposition rates of P, N, K, Mg, Ca, Na, Al and Fe all decreased with distance from the ocean. Furthermore, ratios of cations to Na were similar to those of seawater, suggesting a marine origin for these. In contrast, N and P ratios in occult precipitation were higher than in seawater. We speculate that this is due to marine foam contributing to occult precipitation. Nutrient loss in leaf litter from dominant shrub species was measured to indicate nutrient demand. We estimated that occult precipitation could meet the demand of the dominant shrubby species for annual N, P, K and Ca. Of these species, those with small leaves intercepted more moisture and nutrients than those with larger leaves and could take up foliar deposits of glycine, NO3-, NH4+ and Li (as tracer for K) through leaf surfaces. We conclude that occult deposition together with rainfall deposition are potentially important nutrient and moisture sources for the Strandveld vegetation that contribute to this vegetation being floristically distinct from neighbouring nutrient-poor Fynbos vegetation.	[Nyaga, Justine M.; Cramer, Michael D.] Univ Cape Town, Dept Biol Sci, ZA-7925 Cape Town, South Africa; [Nyaga, Justine M.] Embu Univ Coll, Dept Biol Sci, Embu, Kenya; [Neff, Jason C.] Univ Colorado, Geol Sci & Environm Studies, Boulder, CO 80309 USA	University of Cape Town; University of Colorado System; University of Colorado Boulder	Cramer, MD (corresponding author), Univ Cape Town, Dept Biol Sci, ZA-7925 Cape Town, South Africa.	Michael.cramer@uct.ac.za	Cramer, Michael D/A-3213-2013	Cramer, Michael D/0000-0003-0989-3266; NEFF, JASON/0000-0002-8290-1472	Andrew Mellon Foundation; Oppenheimner Memorial Trust of South Africa	Andrew Mellon Foundation; Oppenheimner Memorial Trust of South Africa	This research was supported by the Andrew Mellon Foundation (www.mellon.org). The Oppenheimner Memorial Trust of South Africa provided additional doctoral bursary to JMN and sabbatical support to MDC.	Abanda PA, 2011, GEODERMA, V164, P128, DOI 10.1016/j.geoderma.2011.05.015; Aerts R, 1996, J ECOL, V84, P597, DOI 10.2307/2261481; AZEVEDO J, 1974, ECOLOGY, V55, P1135, DOI 10.2307/1940364; BAILEY GW, 1991, PROG OCEANOGR, V28, P9, DOI 10.1016/0079-6611(91)90019-I; Bergh NG, 2014, FYNBOS: ECOLOGY, EVOLUTION, AND CONSERVATION OF A MEGADIVERSE REGION, P1; BIRCH GF, 1977, T ROY SOC S AFR, V42, P223, DOI 10.1080/00359197709519915; Boyce RL, 1996, CAN J FOREST RES, V26, P1539, DOI 10.1139/x26-173; BROWN G, 1984, J ECOL, V72, P547, DOI 10.2307/2260065; BRUIJNZEEL LA, 1995, ECOL STU AN, V110, P38; Brunner U, 1998, TOXICOL ENVIRON CHEM, V67, P171, DOI DOI 10.1080/02772249809358612; Cape JN, 2010, ENVIRON POLLUT, V158, P2926, DOI 10.1016/j.envpol.2010.06.002; Castle SC, 2009, ECOSYSTEMS, V12, P101, DOI 10.1007/s10021-008-9210-8; Cavelier J, 1996, J TROP ECOL, V12, P357, DOI 10.1017/S026646740000955X; Chapin F. S. III, 1989, Plant physiological ecology: field methods and instrumentation., P185; Compton J., 2004, ROCKS MOUNTAINS CAPE; Cornell SE, 2003, ATMOS ENVIRON, V37, P2173, DOI 10.1016/S1352-2310(03)00133-X; Cowling RM, 1999, PLANT ECOL, V142, P3, DOI 10.1023/A:1009831308074; Cramer MD, 2009, PALAEOGEOGR PALAEOCL, V274, P125, DOI 10.1016/j.palaeo.2008.12.021; Cramer MD, 2014, FYNBOS: ECOLOGY, EVOLUTION, AND CONSERVATION OF A MEGADIVERSE REGION, P248; Dawson TE, 1998, OECOLOGIA, V117, P476, DOI 10.1007/s004420050683; Derry LA, 2007, ELEMENTS, V3, P333, DOI 10.2113/gselements.3.5.333; Doane TA, 2003, ANAL LETT, V36, P2713, DOI 10.1081/AL-120024647; Doyle A, 2004, SOIL SCI SOC AM J, V68, P669, DOI 10.2136/sssaj2004.0669; Facchini MC, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034210; FITZGERALD JW, 1991, ATMOS ENVIRON A-GEN, V25, P533, DOI 10.1016/0960-1686(91)90050-H; Franceschini G, 2006, J COASTAL RES, V22, P1158, DOI 10.2112/05-0576.1; FRANZEN LG, 1990, AMBIO, V19, P180; Garten CT, 1998, FOREST ECOL MANAG, V103, P211, DOI 10.1016/S0378-1127(97)00185-0; Gower ST, 1999, REMOTE SENS ENVIRON, V70, P29, DOI 10.1016/S0034-4257(99)00056-5; Heydoorn AE, 1980, 380 CSIR 1; Hutley LB, 1997, AUST J BOT, V45, P311, DOI 10.1071/BT96014; Jenny H., 1941, FACTORS SOIL FORMATI, DOI 10.1097/00010694-194111000-00009; Jobbagy EG, 2001, BIOGEOCHEMISTRY, V53, P51, DOI 10.1023/A:1010760720215; Kawamura K, 1999, J GEOPHYS RES-ATMOS, V104, P3501, DOI 10.1029/1998JD100041; KEENE WC, 1986, J GEOPHYS RES-ATMOS, V91, P6647, DOI 10.1029/JD091iD06p06647; Kraaij T, 2014, FYNBOS ECOLOGY EVOLU, P248; Likens G. E., 2014, USDA FOREST SERVICE, P463; Maathuis FJM, 1999, ANN BOT-LONDON, V84, P123, DOI 10.1006/anbo.1999.0912; MADGWICK H. A. I., 1959, FORESTRY, V32, P14, DOI 10.1093/forestry/32.1.14; Majdi H, 2005, PLANT SOIL, V276, P1, DOI 10.1007/s11104-005-3104-8; Martorell C, 2007, OECOLOGIA, V151, P561, DOI 10.1007/s00442-006-0614-x; Mills A. J., 2012, South African Journal of Plant and Soil, V29, P191, DOI 10.1080/02571862.2012.730636; MINAGAWA M, 1984, ANAL CHEM, V56, P1859, DOI 10.1021/ac00275a023; MOTOMIZU S, 1983, ANALYST, V108, P361, DOI 10.1039/an9830800361; Mucina L., 2006, VEGETATION S AFRICA; Neff JC, 2003, FRONT ECOL ENVIRON, V1, P205, DOI 10.1890/1540-9295(2003)001[0205:BITCDO]2.0.CO;2; Nyaga JM, 2013, ATMOS ENVIRON, V81, P625, DOI 10.1016/j.atmosenv.2013.09.021; O'Dowd CD, 2007, PHILOS T R SOC A, V365, P1753, DOI 10.1098/rsta.2007.2043; Olivier J, 2002, WATER SA, V28, P349; Peuke AD, 1998, NEW PHYTOL, V140, P625, DOI 10.1046/j.1469-8137.1998.00304.x; Peuke AD, 1998, NEW PHYTOL, V138, P675, DOI 10.1046/j.1469-8137.1998.00158.x; Piketh SJ, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2002JD002056; Radloff FGT, 2010, OECOLOGIA, V164, P567, DOI 10.1007/s00442-010-1731-0; Richardson SJ, 2005, ECOLOGY, V86, P20, DOI 10.1890/04-0524; Richardson SJ, 2004, OECOLOGIA, V139, P267, DOI 10.1007/s00442-004-1501-y; Rollenbeck R, 2011, HYDROL PROCESS, V25, P344, DOI 10.1002/hyp.7799; Schilling K, 2011, WATER RES, V45, P4355, DOI 10.1016/j.watres.2011.06.004; SCHLESINGER WH, 1980, AM MIDL NAT, V103, P114, DOI 10.2307/2425045; Smith M, 2004, APPL GEOCHEM, V19, P645, DOI 10.1016/j.apgeochem.2003.10.003; Soderberg K, 2007, ECOSYSTEMS, V10, P550, DOI 10.1007/s10021-007-9032-0; Sparks JP, 2009, OECOLOGIA, V159, P1, DOI 10.1007/s00442-008-1188-6; Specht RL, 1988, MEDITERRANEAN TYPE E, P149; STAAF H, 1982, CAN J BOT, V60, P1561, DOI 10.1139/b82-199; STOCK WD, 1986, S AFR J BOT, V52, P273, DOI 10.1016/S0254-6299(16)31519-8; Tinley KL, 1985, 109 SANSP; Trudgill ST, 1988, SOIL VEGETATION SYST; TYREE MT, 1990, PLANT PHYSIOL, V92, P103, DOI 10.1104/pp.92.1.103; Unsworth MH, 1987, POLLUTANT TRANSPORT, P125; Uscola M, 2014, ENVIRON EXP BOT, V104, P34, DOI 10.1016/j.envexpbot.2014.03.004; VELIMIROV B, 1980, MAR BIOL, V58, P311, DOI 10.1007/BF00390779; VELIMIROV B, 1982, Marine Ecology, V3, P97, DOI 10.1111/j.1439-0485.1982.tb00376.x; Vogelmann H. W., 1973, BioScience, V23, P96, DOI 10.2307/1296569; WEATHERBURN MW, 1967, ANAL CHEM, V39, P971, DOI 10.1021/ac60252a045; Weathers KC, 1997, ENVIRON SCI TECHNOL, V31, P210, DOI 10.1021/es9603416; Weathers KC, 2000, ECOSYSTEMS, V3, P590, DOI 10.1007/s100210000051; WITKOWSKI ETF, 1987, J ECOL, V75, P1159, DOI 10.2307/2260320; Wrzesinsky T, 2004, ECOL STU AN, V172, P191; YATES DJ, 1995, AUST J BOT, V43, P157, DOI 10.1071/BT9950157; Yates MJ, 2010, FUNCT ECOL, V24, P485, DOI 10.1111/j.1365-2435.2009.01678.x	79	8	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0126225	10.1371/journal.pone.0126225	http://dx.doi.org/10.1371/journal.pone.0126225			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26017747	Green Published, gold			2022-12-26	WOS:000355185600047
J	Slavik, O; Horky, P; Maciak, M				Slavik, Ondrej; Horky, Pavel; Maciak, Matus			Ostracism of an Albino Individual by a Group of Pigmented Catfish	PLOS ONE			English	Article							JUVENILE ATLANTIC SALMON; ODDITY; SIGNAL; COLOR; SHOAL	Physiological and behavioural constraints hinder albino individuals. Albino animals are rare in the wild; this trait is associated with easy detection by predators, non-native or damaged environments, and exclusively aphotic environments in total darkness. The social aspect of albinism is reported only for human beings, and the effect is distinguishable in time and space when social benefits, are used to a limited the extent. Thus far, the social consequences of albinism for animals remain unknown. We used socially established groups of the pigmented catfish, (Silurus glanis), to observe space and temporal distance detachment of albino specimens in laboratory conditions. The albino fish were separated at larger distances from the group than pigmented individuals with the same social status determined by familiarity, and this asymmetry also varied in time. Albinism-related ostracism results in a solitary existence, usually followed by enhanced predation risk. The motivation for an individual's exclusion from a group appears to be the avoidance of the predation risk that increases not only for an odd individual but also for conspecifics within a group. Our findings indicate a role for albinism in behavioural processes related to sociality in a group of conspecifics.	[Slavik, Ondrej; Horky, Pavel] Czech Univ Life Sci Prague, Fac Agrobiol Food & Nat Resources, Dept Zool & Fisheries, Prague, Czech Republic; [Maciak, Matus] Univ Alberta, Dept Math & Stat Sci, Edmonton, AB, Canada	Czech University of Life Sciences Prague; University of Alberta	Slavik, O (corresponding author), Czech Univ Life Sci Prague, Fac Agrobiol Food & Nat Resources, Dept Zool & Fisheries, Kamycka 129, Prague, Czech Republic.	oslavik@af.czu.cz	Slavík, Ondrej/A-4732-2013; Maciak, Matus/D-7836-2016; Horký, Pavel/A-3857-2013; Slavík, Ondřej/P-4253-2019	Maciak, Matus/0000-0002-9414-2151; Horký, Pavel/0000-0002-1738-7753; Slavík, Ondřej/0000-0003-3443-4125	Czech Science Foundation [13-058725]	Czech Science Foundation(Grant Agency of the Czech Republic)	The work was supported by the Czech Science Foundation (no. 13-058725), www.gacr.cz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanara A, 2001, J ANIM ECOL, V70, P980, DOI 10.1046/j.0021-8790.2001.00550.x; Bolker JA, 2000, J FISH BIOL, V56, P1029, DOI 10.1111/j.1095-8649.2000.tb02121.x; Bouletreau S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025732; Burnham K. P., 1998, MODEL SELECTION INFE; Carden SM, 1998, BRIT J OPHTHALMOL, V82, P189, DOI 10.1136/bjo.82.2.189; CHIVERS DP, 1995, CAN J ZOOL, V73, P955, DOI 10.1139/z95-111; DEFRIES JC, 1969, NATURE, V221, P65, DOI 10.1038/221065a0; Ellegren H, 1997, NATURE, V389, P593, DOI 10.1038/39303; Estrada-Hernandez N, 2007, REHABIL PSYCHOL, V52, P263, DOI 10.1037/0090-5550.52.3.263; Gomez-Laplaza LM, 2009, BEHAV PROCESS, V82, P39, DOI 10.1016/j.beproc.2009.04.002; Griffiths SW, 2004, P ROY SOC B-BIOL SCI, V271, P695, DOI 10.1098/rspb.2003.2648; GRUTER M, 1986, ETHOL SOCIOBIOL, V7, P149, DOI 10.1016/0162-3095(86)90043-9; Hoglund E, 2000, J EXP BIOL, V203, P1711; Hong ES, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-212; Hupfeld D, 2006, BEHAV BRAIN RES, V170, P29, DOI 10.1016/j.bbr.2006.01.022; Javangwe G, 2012, EARLY CHILD DEV CARE, V182, P1593, DOI 10.1080/03004430.2011.630074; Krause J, 2002, LIVING GROUPS; LANDEAU L, 1986, ANIM BEHAV, V34, P1372, DOI 10.1016/S0003-3472(86)80208-1; Leclercq E, 2010, FISH FISH, V11, P159, DOI 10.1111/j.1467-2979.2009.00346.x; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; McRobert SP, 1998, ANIM BEHAV, V56, P611, DOI 10.1006/anbe.1998.0846; METCALFE NB, 1995, P ROY SOC B-BIOL SCI, V259, P207, DOI 10.1098/rspb.1995.0030; Nakatani I, 1999, J CRUSTACEAN BIOL, V19, P380, DOI 10.2307/1549245; O'Connor KI, 1999, ANIM BEHAV, V58, P1269, DOI 10.1006/anbe.1999.1260; Protas ME, 2006, NAT GENET, V38, P107, DOI 10.1038/ng1700; Prusky GT, 2002, BEHAV BRAIN RES, V136, P339, DOI 10.1016/S0166-4328(02)00126-2; Rodgers GM, 2013, J EXP BIOL, V216, P2760, DOI 10.1242/jeb.080879; Rodgers GM, 2010, ANIM BEHAV, V79, P1025, DOI 10.1016/j.anbehav.2010.01.017; Slavik O, 2011, AQUACULTURE, V313, P73, DOI 10.1016/j.aquaculture.2011.01.002; Slavik O, 2012, APPL ANIM BEHAV SCI, V142, P116, DOI 10.1016/j.applanim.2012.09.005; SMITH AP, 1977, NATURE, V266, P527, DOI 10.1038/266527a0; Spence R, 2007, ETHOLOGY, V113, P62, DOI 10.1111/j.1439-0310.2006.01295.x; Suter HC, 2002, J FISH BIOL, V61, P606, DOI 10.1006/jfbi.2002.2084; Tao J., 2002, MIXED SAS SYSTEM COU; THEODORAKIS CW, 1989, ANIM BEHAV, V38, P496, DOI 10.1016/S0003-3472(89)80042-9; Williams KD., 1997, PL S SOC CL, P133	36	16	17	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0128279	10.1371/journal.pone.0128279	http://dx.doi.org/10.1371/journal.pone.0128279			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018869	Green Submitted, Green Published, gold			2022-12-26	WOS:000355185600115
J	Chang, CJ; Jian, DY; Lin, MW; Zhao, JZ; Ho, LT; Juan, CC				Chang, Chi-Jen; Jian, Deng-Yuan; Lin, Ming-Wei; Zhao, Jun-Zhi; Ho, Low-Tone; Juan, Chi-Chang			Evidence in Obese Children: Contribution of Hyperlipidemia, Obesity-Inflammation, and Insulin Sensitivity	PLOS ONE			English	Article							FACTOR-ANALYSIS REVEALS; METABOLIC SYNDROME; RISK-FACTORS; SYSTEMIC INFLAMMATION; RESISTANCE SYNDROME; ADOLESCENTS; ADIPONECTIN; ASSOCIATION; LEPTIN; MARKERS	Background Evidence shows a high incidence of insulin resistance, inflammation and dyslipidemia in adult obesity. The aim of this study was to assess the relevance of inflammatory markers, circulating lipids, and insulin sensitivity in overweight/obese children. Methods We enrolled 45 male children (aged 6 to 13 years, lean control = 16, obese = 19, overweight = 10) in this study. The plasma total cholesterol, HDL cholesterol, triglyceride, glucose and insulin levels, the circulating levels of inflammatory factors, such as TNF-alpha, IL-6, and MCP-1, and the high-sensitive CRP level were determined using quantitative colorimetric sandwich ELISA kits. Results Compared with the lean control subjects, the obese subjects had obvious insulin resistance, abnormal lipid profiles, and low-grade inflammation. The overweight subjects only exhibited significant insulin resistance and low-grade inflammation. Both TNF-alpha and leptin levels were higher in the overweight/obese subjects. A concurrent correlation analysis showed that body mass index (BMI) percentile and fasting insulin were positively correlated with insulin resistance, lipid profiles, and inflammatory markers but negatively correlated with adiponectin. A factor analysis identified three domains that explained 74.08% of the total variance among the obese children (factor 1: lipid, 46.05%; factor 2: obesity-inflammation, 15.38%; factor 3: insulin sensitivity domains, 12.65%). Conclusions Our findings suggest that lipid, obesity-inflammation, and insulin sensitivity domains predominantly exist among obese children. These factors might be applied to predict the outcomes of cardiovascular diseases in the future.	[Chang, Chi-Jen; Zhao, Jun-Zhi] Shin Kong Wu Ho Hosp, Dept Surg, Div Pediat Surg, Taipei, Taiwan; [Chang, Chi-Jen] Fu Jen Catholic Univ, Sch Med, New Taipei City, Taiwan; [Jian, Deng-Yuan; Ho, Low-Tone; Juan, Chi-Chang] Natl Yang Ming Univ, Sch Med, Inst Physiol, Taipei 112, Taiwan; [Jian, Deng-Yuan] Wen Lin Hemodialysis Unit, Div Nephrol, Taipei, Taiwan; [Lin, Ming-Wei] Natl Yang Ming Univ, Sch Med, Inst Publ Hlth, Taipei 112, Taiwan; [Lin, Ming-Wei; Ho, Low-Tone; Juan, Chi-Chang] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Juan, Chi-Chang] Taipei City Hosp, Dept Educ & Res, Taipei, Taiwan	Shin Kong Wu Ho Su Memorial Hospital; Fu Jen Catholic University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei City Hospital	Juan, CC (corresponding author), Natl Yang Ming Univ, Sch Med, Inst Physiol, Taipei 112, Taiwan.	ccjuan@ym.edu.tw			Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan [SKH8302-99-DR-19]; Ministry of Education, Aim for the Top University Plan	Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan; Ministry of Education, Aim for the Top University Plan(Ministry of Education, Taiwan)	This study was supported by research grants from the Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan (SKH8302-99-DR-19) and from the Ministry of Education, Aim for the Top University Plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah AR, 2009, METAB SYNDR RELAT D, V7, P17, DOI 10.1089/met.2008.0045; Agueda M, 2012, NUTR METAB CARDIOVAS, V22, P208, DOI 10.1016/j.numecd.2010.06.010; Anderson PJ, 2001, INT J OBESITY, V25, P1782, DOI 10.1038/sj.ijo.0801837; Angin Y, 2014, TURKISH J PEDIATR, V56, P259; Arrigo T, 2013, EUR J ENDOCRINOL, V168, P631, DOI 10.1530/EJE-13-0037; Aycan Z, 2005, J PEDIATR ENDOCR MET, V18, P275; Becton LJ, 2012, INDIAN J PEDIATR, V79, P1056, DOI 10.1007/s12098-012-0777-x; Breslin WL, 2012, PEDIATRICS, V129, pE1180, DOI 10.1542/peds.2011-2477; Brito N, 2010, J PEDIATR ENDOCR MET, V23, P97; Charlton R, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-764; Cohen JI, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-26; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Da Costa LA, 2012, DIABET METAB SYND OB, V5, P347, DOI 10.2147/DMSO.S35115; DeBoer MD, 2013, NUTRITION, V29, P379, DOI 10.1016/j.nut.2012.07.003; Ding D, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/709756; Edwards KL, 1998, AM J EPIDEMIOL, V147, P441, DOI 10.1093/oxfordjournals.aje.a009469; Finucane OM, 2012, P NUTR SOC, V22, P1; Flynn JT, 2011, J CLIN HYPERTENS, V13, P323, DOI 10.1111/j.1751-7176.2011.00452.x; Friedemann C, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4759; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Frost PH, 1996, CIRCULATION, V94, P2381, DOI 10.1161/01.CIR.94.10.2381; Garanty-Bogacka B, 2005, NEUROENDOCRINOL LETT, V26, P242; Garanty-Bogacka B, 2011, ENDOKRYNOL POL, V62, P499; Gong CD, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-129; Guo XF, 2012, INTERNAL MED, V51, P23, DOI 10.2169/internalmedicine.51.6347; Hanley AJG, 2004, DIABETES, V53, P1773, DOI 10.2337/diabetes.53.7.1773; Hobkirk JP, 2012, METAB SYNDR RELAT D, V10, P20, DOI 10.1089/met.2011.0050; Illan-Gomez F, 2012, OBES SURG, V22, P950, DOI 10.1007/s11695-012-0643-y; Jurimae J, 2011, J PEDIATR ENDOCR MET, V24, P419, DOI 10.1515/JPEM.2011.054; l'Allemand-Jander D, 2010, INT J OBESITY, V34, pS32, DOI 10.1038/ijo.2010.237; LaBresh KA, 2014, PEDIATRICS, V134, pE732, DOI 10.1542/peds.2014-0876; Lawlor DA, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6224; Lin MW, 2006, AM J HYPERTENS, V19, P1118, DOI 10.1016/j.amjhyper.2006.04.003; Lopez KN, 2012, CONGENIT HEART DIS, V7, P189, DOI 10.1111/j.1747-0803.2011.00618.x; Lutgens E, 2011, THROMB HAEMOSTASIS, V106, P755, DOI 10.1160/TH11-10-0683; Maestu J, 2010, MED SPORT SCI, V55, P56, DOI 10.1159/000321972; Masuo K, 2010, CURR DIABETES REV, V6, P58, DOI 10.2174/157339910790909396; Meigs JB, 2000, AM J EPIDEMIOL, V152, P908, DOI 10.1093/aje/152.10.908; Mertens Ilse, 2005, Semin Vasc Med, V5, P48, DOI 10.1055/s-2005-871741; Miranda PJ, 2005, AM HEART J, V149, P33, DOI 10.1016/j.ahj.2004.07.013; Mokha JS, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-73; Montero D, 2012, OBES REV, V13, P441, DOI 10.1111/j.1467-789X.2011.00956.x; Nasreddine L, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-798; Orsi CM, 2011, CURR OPIN ENDOCRINOL, V18, P14, DOI 10.1097/MED.0b013e3283423de1; Palmer BF, 2015, MOL CELL ENDOCRINOL, V402, P113, DOI 10.1016/j.mce.2014.11.029; Panagopoulou P, 2008, J PEDIATR GASTR NUTR, V47, P356, DOI 10.1097/MPG.0b013e31817fcb67; Pyrzak B, 2010, EUR J MED RES, V15, P147; Raj Manu, 2012, Indian J Endocrinol Metab, V16, P13, DOI 10.4103/2230-8210.91176; Rana JS, 2007, DIABETES OBES METAB, V9, P218, DOI 10.1111/j.1463-1326.2006.00594.x; Rubin DA, 2010, MED SPORT SCI, V55, P43, DOI 10.1159/000321971; Saffari F, 2012, THER CLIN RISK MANAG, V8, P55, DOI 10.2147/TCRM.S26673; Stelzer I, 2012, TRANSL RES, V159, P118, DOI 10.1016/j.trsl.2011.10.001; Taube A, 2012, AM J PHYSIOL-HEART C, V302, pH2148, DOI 10.1152/ajpheart.00907.2011; Utsal L, 2012, HORM RES PAEDIAT, V78, P31, DOI 10.1159/000339831; Valle M, 2005, DIABETES METAB, V31, P55, DOI 10.1016/S1262-3636(07)70167-2; van Vliet M, 2011, EUR J PEDIATR, V170, P589, DOI 10.1007/s00431-010-1323-3; Vykoukal D, 2012, VASCULAR, V20, P156, DOI 10.1258/vasc.2011.201201; Wang X, 2013, DIABETES CARE, V36, P166, DOI 10.2337/dc12-0702; Wasilewska A, 2012, ACTA PAEDIATR, V101, P497, DOI 10.1111/j.1651-2227.2011.02582.x	60	48	51	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0125935	10.1371/journal.pone.0125935	http://dx.doi.org/10.1371/journal.pone.0125935			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011530	Green Published, gold, Green Submitted			2022-12-26	WOS:000355183900019
J	Figuera-Losada, M; Stathis, M; Dorskind, JM; Thomas, AG; Bandaru, VVR; Yoo, SW; Westwood, NJ; Rogers, GW; McArthur, JC; Haughey, NJ; Slusher, BS; Rojas, C				Figuera-Losada, Mariana; Stathis, Marigo; Dorskind, Joelle M.; Thomas, Ajit G.; Bandaru, Veera Venkata Ratnam; Yoo, Seung-Wan; Westwood, Nicholas J.; Rogers, Graeme W.; McArthur, Justin C.; Haughey, Norman J.; Slusher, Barbara S.; Rojas, Camilo			Cambinol, a Novel Inhibitor of Neutral Sphingomyelinase 2 Shows Neuroprotective Properties	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; HUMAN-IMMUNODEFICIENCY-VIRUS; ALZHEIMERS-DISEASE; SPHINGOLIPID METABOLISM; BIOLOGICAL EVALUATION; SELECTIVE INHIBITORS; SIRTUIN INHIBITORS; NMDA RECEPTORS; CERAMIDE; EXOSOMES	Ceramide is a bioactive lipid that plays an important role in stress responses leading to apoptosis, cell growth arrest and differentiation. Ceramide production is due in part to sphingomyelin hydrolysis by sphingomyelinases. In brain, neutral sphingomyelinase 2 (nSMase2) is expressed in neurons and increases in its activity and expression have been associated with pro-inflammatory conditions observed in Alzheimer's disease, multiple sclerosis and human immunodeficiency virus (HIV-1) patients. Increased nSMase2 activity translates into higher ceramide levels and neuronal cell death, which can be prevented by chemical or genetic inhibition of nSMase2 activity or expression. However, to date, there are no soluble, specific and potent small molecule inhibitor tool compounds for in vivo studies or as a starting point for medicinal chemistry optimization. Moreover, the majority of the known inhibitors were identified using bacterial, bovine or rat nSMase2. In an attempt to identify new inhibitor scaffolds, two activity assays were optimized as screening platform using the recombinant human enzyme. First, active hits were identified using a fluorescence-based high throughput compatible assay. Then, hits were confirmed using a C-14 sphingomyelin-based direct activity assay. Pharmacologically active compounds and approved drugs were screened using this strategy which led to the identification of cambinol as a novel uncompetitive nSMase2 inhibitor (K-i = 7 mu M). The inhibitory activity of cambinol for nSMase2 was approximately 10-fold more potent than for its previously known target, silence information regulator 1 and 2 (SIRT1/2). Cambinol decreased tumor necrosis factor-alpha or interleukin-1 beta-induced increases of ceramide and cell death in primary neurons. A preliminary study of cambinol structure and activity allowed the identification of the main structural features required for nSMase2 inhibition. Cambinol and its analogs may be useful as nSMase2 inhibitor tool compounds to prevent ceramide-dependent neurodegeneration.	[Figuera-Losada, Mariana; Stathis, Marigo; Thomas, Ajit G.; Slusher, Barbara S.; Rojas, Camilo] Johns Hopkins Univ, Sch Med, Brain Sci Inst Drug Discovery Program, Baltimore, MD 21205 USA; [Figuera-Losada, Mariana; Dorskind, Joelle M.; Bandaru, Veera Venkata Ratnam; Yoo, Seung-Wan; McArthur, Justin C.; Haughey, Norman J.; Slusher, Barbara S.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Westwood, Nicholas J.; Rogers, Graeme W.] Univ St Andrews, Sch Chem, St Andrews KY16 9ST, Fife, Scotland; [Westwood, Nicholas J.; Rogers, Graeme W.] Univ St Andrews, Biomed Sci Res Ctr, St Andrews KY16 9ST, Fife, Scotland; [Westwood, Nicholas J.; Rogers, Graeme W.] EaStCHEM, St Andrews KY16 9ST, Fife, Scotland; [Slusher, Barbara S.] Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA; [Slusher, Barbara S.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Rojas, Camilo] Johns Hopkins Univ, Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD 21205 USA; [Haughey, Norman J.] Johns Hopkins Univ, Sch Med, Richard T Johnson Div Neuroimmunol & Neurol Infec, Baltimore, MD 21205 USA; [Figuera-Losada, Mariana; Stathis, Marigo; Dorskind, Joelle M.; Thomas, Ajit G.; Bandaru, Veera Venkata Ratnam; Yoo, Seung-Wan; McArthur, Justin C.; Haughey, Norman J.; Slusher, Barbara S.; Rojas, Camilo] Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; University of St Andrews; University of St Andrews; University of St Andrews; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Haughey, NJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.	nhaughe1@jhmi.edu; bslusher@jhmi.edu; crojas2@jhmi.edu		Westwood, Nicholas/0000-0003-0630-0138	National Institute of Mental Health [P30 MH075673-06, R01 MH096636, R01 MH077542]; Johns Hopkins Brain Science Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH075673, R01MH110246, P01MH105280, R01MH096636, R03MH103985, R01MH077542] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Johns Hopkins Brain Science Institute(Johns Hopkins University); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institute of Mental Health grants: P30 MH075673-06 to BSS, CR, NJH and JCM; R01 MH096636 and R01 MH077542 to NJH (http://projectreporter.nih.gov/reporter.cfm); and The Johns Hopkins Brain Science Institute to BSS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amtmann E, 2003, DRUG EXP CLIN RES, V29, P5; Arenz C, 2001, BIOORGAN MED CHEM, V9, P2901, DOI 10.1016/S0968-0896(01)00165-1; Bandaru VVR, 2007, NEUROLOGY, V68, P1481, DOI 10.1212/01.wnl.0000260610.79853.47; Barbone AG, 2000, METHOD ENZYMOL, V311, P168; Barth BM, 2012, J NEUROSCI RES, V90, P229, DOI 10.1002/jnr.22748; Bartke N, 2009, J LIPID RES, V50, pS91, DOI 10.1194/jlr.R800080-JLR200; Canals D, 2011, BRIT J PHARMACOL, V163, P694, DOI 10.1111/j.1476-5381.2011.01279.x; Chang CW, 2013, NEUROSCI LETT, V548, P190, DOI 10.1016/j.neulet.2013.06.009; Clarke CJ, 2006, BBA-BIOMEMBRANES, V1758, P1893, DOI 10.1016/j.bbamem.2006.06.025; Clarke CJ, 2006, BIOCHEMISTRY-US, V45, P11247, DOI 10.1021/bi061307z; Clarke CJ, 2011, BIOCHEM J, V435, P381, DOI 10.1042/BJ20101752; Clarke CJ, 2011, ADV ENZYME REGUL, V51, P51, DOI 10.1016/j.advenzreg.2010.09.016; Cutler RG, 2004, P NATL ACAD SCI USA, V101, P2070, DOI 10.1073/pnas.0305799101; Cutler RG, 2002, ANN NEUROL, V52, P448, DOI 10.1002/ana.10312; Delgado A, 2006, BBA-BIOMEMBRANES, V1758, P1957, DOI 10.1016/j.bbamem.2006.08.017; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Fleming A, 2014, PATHOG DIS; Goni FM, 2002, FEBS LETT, V531, P38, DOI 10.1016/S0014-5793(02)03482-8; Grozinger CM, 2001, J BIOL CHEM, V276, P38837, DOI 10.1074/jbc.M106779200; Hakogi T, 2003, ORG LETT, V5, P2801, DOI 10.1021/ol034771u; Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359; Haughey NJ, 2004, ANN NEUROL, V55, P257, DOI 10.1002/ana.10828; Haughey NJ, 2008, FRONT BIOSCI, V13, P5120, DOI 10.2741/3068; Heltweg B, 2006, CANCER RES, V66, P4368, DOI 10.1158/0008-5472.CAN-05-3617; Karakashian AA, 2004, FASEB J, V18, P968, DOI 10.1096/fj.03-0875fje; Kosicek M, 2013, INT J MOL SCI, V14, P1310, DOI 10.3390/ijms14011310; Lee DH, 2011, ARCH PHARM RES, V34, P229, DOI 10.1007/s12272-011-0208-y; Lee JT, 2004, J CELL BIOL, V164, P123, DOI 10.1083/jcb.200307017; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Luberto C, 2002, J BIOL CHEM, V277, P41128, DOI 10.1074/jbc.M206747200; Lugrin J, 2013, BBA-MOL CELL RES, V1833, P1498, DOI 10.1016/j.bbamcr.2013.03.004; Mai A, 2005, J MED CHEM, V48, P7789, DOI 10.1021/jm050100l; Martinez TN, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-45; Medda F, 2011, MEDCHEMCOMM, V2, P611, DOI 10.1039/c1md00023c; Medda F, 2009, J MED CHEM, V52, P2673, DOI 10.1021/jm8014298; Mielke MM, 2012, NEUROLOGY, V79, P633, DOI 10.1212/WNL.0b013e318264e380; Mielke MM, 2011, J ALZHEIMERS DIS, V27, P259, DOI 10.3233/JAD-2011-110405; Mielke MM, 2010, J NEUROVIROL, V16, P445, DOI 10.3109/13550284.2010.525599; Mielke MM, 2010, ALZHEIMERS DEMENT, V6, P378, DOI 10.1016/j.jalz.2010.03.014; Napper AD, 2005, J MED CHEM, V48, P8045, DOI 10.1021/jm050522v; Ogorevc E, 2013, RADIOL ONCOL, V47, P197, DOI 10.2478/raon-2013-0037; Onderwater RCA, 1999, CHEM RES TOXICOL, V12, P396, DOI 10.1021/tx980198p; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; SHAIKH NA, 1994, ANAL BIOCHEM, V216, P313, DOI 10.1006/abio.1994.1047; Soeda S, 2004, NEUROCHEM INT, V45, P619, DOI 10.1016/j.neuint.2004.04.001; SPENCE MW, 1978, J NEUROCHEM, V30, P917, DOI 10.1111/j.1471-4159.1978.tb10804.x; Taguchi M, 2003, BIOORG MED CHEM LETT, V13, P3681, DOI 10.1016/j.bmcl.2003.08.020; Taguchi M, 2003, BIOORG MED CHEM LETT, V13, P1963, DOI 10.1016/S0960-894X(03)00360-3; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Uchida R, 2001, J ANTIBIOT, V54, P882, DOI 10.7164/antibiotics.54.882; Uchida R, 1999, J ANTIBIOT, V52, P572, DOI 10.7164/antibiotics.52.572; Urbanelli L, 2013, GENES-BASEL, V4, P152, DOI 10.3390/genes4020152; van Echten-Deckert G, 2012, PROG LIPID RES, V51, P378, DOI 10.1016/j.plipres.2012.07.001; Wang GH, 2012, J BIOL CHEM, V287, P21384, DOI 10.1074/jbc.M112.340513; Wheeler D, 2009, J NEUROCHEM, V109, P1237, DOI 10.1111/j.1471-4159.2009.06038.x; Xu HX, 2011, J NEUROSCI, V31, P17074, DOI 10.1523/JNEUROSCI.4072-11.2011; Zeng C, 2005, J NEUROCHEM, V94, P703, DOI 10.1111/j.1471-4159.2005.03217.x	58	55	57	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0124481	10.1371/journal.pone.0124481	http://dx.doi.org/10.1371/journal.pone.0124481			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010541	Green Submitted, Green Published, gold			2022-12-26	WOS:000355183900008
J	Navarathna, DHMLP; Stein, EV; Lessey-Morillon, EC; Nayak, D; Martin-Manso, G; Roberts, DD				Navarathna, Dhammika H. M. L. P.; Stein, Erica V.; Lessey-Morillon, Elizabeth C.; Nayak, Debasis; Martin-Manso, Gema; Roberts, David D.			CD47 Promotes Protective Innate and Adaptive Immunity in a Mouse Model of Disseminated Candidiasis	PLOS ONE			English	Article							T-CELL-ACTIVATION; SIRP-ALPHA; NEUTROPHIL TRANSMIGRATION; DENDRITIC CELLS; ALBICANS; THROMBOSPONDIN-1; RESPONSES; INTEGRIN; PATHOGENESIS; EXPRESSION	CD47 is a widely expressed receptor that regulates immunity by engaging its counter-receptor SIRP alpha on phagocytes and its secreted ligand thrombospondin-1. Mice lacking CD47 can exhibit enhanced or impaired host responses to bacterial pathogens, but its role in fungal immunity has not been examined. cd47(-/-) mice on a C57BL/6 background showed significantly increased morbidity and mortality following Candida albicans infection when compared with wild-type mice. Despite normal fungal colonization at earlier times, cd47(-/-) mice at four days post-infection had increased colonization of brain and kidneys accompanied by stronger inflammatory reactions. Neutrophil and macrophage numbers were significantly elevated in kidneys and neutrophils in the brains of infected cd47(-/-) mice. However, no defect in phagocytic activity towards C. albicans was observed in cd47(-/-) bone-marrow-derived macrophages, and neutrophil and macrophage killing of C. albicans was not impaired. CD47-deficiency did not alter the early humoral immune response to C. albicans. Th1, Th2, and Th17 population of CD4(+) T cells were expanded in the spleen, and gene expression profiles of spleen and kidney showed stronger pro-inflammatory signaling in infected cd47(-/-) mice. The chemoattractant chemokines MIP-2 alpha and MIP-2 beta were highly expressed in infected spleens of cd47(-/-) mice. G-CSF, GM-CSF, and the inflammasome component NLRP3 were more highly expressed in infected cd47(-/-) kidneys than in infected wild-type controls. Circulating pro-(TNF-alpha, IL-6) and anti-inflammatory cytokines (IL-10) were significantly elevated, but IL-17 was decreased. These data indicate that CD47 plays protective roles against disseminated candidiasis and alters pro-inflammatory and immunosuppressive pathways known to regulate innate and T cell immunity.	[Navarathna, Dhammika H. M. L. P.; Stein, Erica V.; Lessey-Morillon, Elizabeth C.; Martin-Manso, Gema; Roberts, David D.] NCI, Pathol Lab, Ctr Canc Res, Bethesda, MD 20892 USA; [Nayak, Debasis] NINDS, NIH, Bethesda, MD 20892 USA; [Stein, Erica V.] George Washington Univ, Microbiol & Immunol Program, Inst Biomed Sci, Dept Microbiol, Washington, DC 20037 USA; [Stein, Erica V.] George Washington Univ, Microbiol & Immunol Program, Inst Biomed Sci, Dept Immunol, Washington, DC 20037 USA; [Nayak, Debasis] George Washington Univ, Microbiol & Immunol Program, Inst Biomed Sci, Dept Trop Med, Washington, DC 20037 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); George Washington University; George Washington University; George Washington University	Roberts, DD (corresponding author), NCI, Pathol Lab, Ctr Canc Res, Bethesda, MD 20892 USA.	droberts@helix.nih.gov	Roberts, David D./A-9699-2008; Navarathna, Dhammika/GXM-8674-2022	Roberts, David D./0000-0002-2481-2981; Stein, Erica/0000-0001-8778-8846; Nayak, Debasis/0000-0002-4762-4553	NIH, National Cancer Institute, Center for Cancer Research; National Institute of Neurological Disorders and Stroke; NATIONAL CANCER INSTITUTE [ZIASC009173] Funding Source: NIH RePORTER	NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research (DDR) and the National Institute of Neurological Disorders and Stroke (DN).	Ashman RB, 2008, FRONT BIOSCI-LANDMRK, V13, P3334; Azcutia V, 2012, J IMMUNOL, V189, P2553, DOI 10.4049/jimmunol.1103606; Baba N, 2013, J EXP MED, V210, P1251, DOI 10.1084/jem.20122037; Bellocchio S, 2005, MED MYCOL, V43, pS181, DOI 10.1080/14789940500051417; Bian Z, 2013, J IMMUNOL, V190, P411, DOI 10.4049/jimmunol.1201963; Brieland J, 2001, INFECT IMMUN, V69, P5046, DOI 10.1128/IAI.69.8.5046-5055.2001; Cameron CM, 2005, VIROLOGY, V337, P55, DOI 10.1016/j.virol.2005.03.037; CASADEVALL A, 1995, INFECT IMMUN, V63, P4211, DOI 10.1128/IAI.63.11.4211-4218.1995; Chao MP, 2012, CURR OPIN IMMUNOL, V24, P225, DOI 10.1016/j.coi.2012.01.010; D'Angelo JA, 2010, J IMMUNOL, V185, P3217, DOI 10.4049/jimmunol.1001199; Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018; Doyen V, 2003, J EXP MED, V198, P1277, DOI 10.1084/jem.20030705; Dunne Aisling, 2003, Sci STKE, V2003, pre3, DOI 10.1126/stke.2003.171.re3; Evans Scott E, 2010, Proc Am Thorac Soc, V7, P197, DOI 10.1513/pats.200907-075AL; Fortin G, 2009, J EXP MED, V206, P1995, DOI 10.1084/jem.20082805; Fortina P, 2008, NAT BIOTECHNOL, V26, P293, DOI 10.1038/nbt0308-293; Garay J, 2010, J IMMUNOL, V185, P3227, DOI 10.4049/jimmunol.0903066; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Grimbert P, 2006, J IMMUNOL, V177, P3534, DOI 10.4049/jimmunol.177.6.3534; Huang WT, 2004, J INFECT DIS, V190, P624, DOI 10.1086/422329; Igyarto BZ, 2011, IMMUNITY, V35, P260, DOI 10.1016/j.immuni.2011.06.005; Isenberg JS, 2009, J BIOL CHEM, V284, P1116, DOI 10.1074/jbc.M804860200; Jaiswal S, 2010, TRENDS IMMUNOL, V31, P212, DOI 10.1016/j.it.2010.04.001; Johansson U, 2004, SCAND J IMMUNOL, V59, P40, DOI 10.1111/j.0300-9475.2004.01355.x; Johansson U, 2004, SCAND J IMMUNOL, V59, P50, DOI 10.1111/j.0300-9475.2004.01354.x; Kaur S, 2014, J IMMUNOL, V193, P3914, DOI 10.4049/jimmunol.1303116; Kaur S, 2011, J BIOL CHEM, V286, P14991, DOI 10.1074/jbc.M110.179663; Kim J, 2011, J MICROBIOL, V49, P171, DOI 10.1007/s12275-011-1064-7; Kim MJ, 2008, TUMOR BIOL, V29, P28, DOI 10.1159/000132568; Kullberg Bart Jan, 2002, P327; Kurihara H, 2010, AM J PHYSIOL-RENAL, V299, pF517, DOI 10.1152/ajprenal.00571.2009; Lamy L, 2007, J IMMUNOL, V178, P5930, DOI 10.4049/jimmunol.178.9.5930; Li ZQ, 2002, J CELL BIOL, V157, P509, DOI 10.1083/jcb.200109098; Li ZQ, 2001, J IMMUNOL, V166, P2427, DOI 10.4049/jimmunol.166.4.2427; Lindberg FP, 1996, SCIENCE, V274, P795, DOI 10.1126/science.274.5288.795; Lionakis MS, 2013, J CLIN INVEST, V123, P5035, DOI 10.1172/JCI71307; Lionakis MS, 2011, J INNATE IMMUN, V3, P180, DOI 10.1159/000321157; Liu Y, 2001, J BIOL CHEM, V276, P40156, DOI 10.1074/jbc.M104138200; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002; Martin-Manso G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048775; Matozaki T, 2009, TRENDS CELL BIOL, V19, P72, DOI 10.1016/j.tcb.2008.12.001; McAllister F, 2005, J IMMUNOL, V175, P404, DOI 10.4049/jimmunol.175.1.404; Miller TW, 2013, MATRIX BIOL, V32, P316, DOI 10.1016/j.matbio.2013.02.009; Mittal R, 2010, J IMMUNOL, V185, P2998, DOI 10.4049/jimmunol.1001296; Navarathna DHMLP, 2007, INFECT IMMUN, V75, P4006, DOI 10.1128/IAI.00397-07; Navarathna DHMLP, 2007, INFECT IMMUN, V75, P1609, DOI 10.1128/IAI.01182-06; Navarathna DHMLP, 2013, NMR BIOMED, V26, P1125, DOI 10.1002/nbm.2926; Navarathna DHMLP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048475; Navarathna DHMLP, 2010, FREE RADICAL BIO MED, V49, P1561, DOI 10.1016/j.freeradbiomed.2010.08.020; Navarathna DHMLP, 2005, J ANTIMICROB CHEMOTH, V56, P1156, DOI 10.1093/jac/dki383; NICKERSON WJ, 1953, J INFECT DIS, V93, P43, DOI 10.1093/infdis/93.1.43; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Overland G, 2005, SCAND J IMMUNOL, V62, P148, DOI 10.1111/j.1365-3083.2005.01653.x; RAAB SS, 1994, MODERN PATHOL, V7, P599; Raymond M, 2009, J ALLERGY CLIN IMMUN, V124, P1333, DOI 10.1016/j.jaci.2009.07.021; Reinhold MI, 1997, J EXP MED, V185, P1, DOI 10.1084/jem.185.1.1; Reinhold MI, 1999, INT IMMUNOL, V11, P707, DOI 10.1093/intimm/11.5.707; Roberts DD, 2012, MATRIX BIOL, V31, P162, DOI 10.1016/j.matbio.2012.01.005; Romani L, 1999, CURR OPIN MICROBIOL, V2, P363, DOI 10.1016/S1369-5274(99)80064-2; Saito Y, 2010, BLOOD, V116, P3517, DOI 10.1182/blood-2010-03-277244; Scott CL, 2014, EUR J IMMUNOL, V44, P3658, DOI 10.1002/eji.201444859; Shenderov K, 2013, J IMMUNOL, V190, P5722, DOI 10.4049/jimmunol.1203343; Soto Pantoja DR, 2013, UCSD MOL PAGES, V2, P1; Soto-Pantoja DR, 2013, EXPERT OPIN THER TAR, V17, P89, DOI 10.1517/14728222.2013.733699; Su X, 2008, J IMMUNOL, V180, P6947, DOI 10.4049/jimmunol.180.10.6947; Sudbery PE, 2011, NAT REV MICROBIOL, V9, P737, DOI 10.1038/nrmicro2636; Traynor TR, 2001, MED MYCOL, V39, P41, DOI 10.1080/714030978; Van VQ, 2006, EMBO J, V25, P5560, DOI 10.1038/sj.emboj.7601415; Verdrengh M, 1999, MICROBES INFECT, V1, P745, DOI 10.1016/S1286-4579(99)80076-8; YOUNG M, 1994, J CLIN INVEST, V93, P2578, DOI 10.1172/JCI117269; Zhao XW, 2011, P NATL ACAD SCI USA, V108, P18342, DOI 10.1073/pnas.1106550108	73	20	21	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128220	10.1371/journal.pone.0128220	http://dx.doi.org/10.1371/journal.pone.0128220			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010544	Green Published, Green Submitted, gold			2022-12-26	WOS:000355183900208
J	Sharma, A; Solmaz, SR; Blobel, G; Melcak, I				Sharma, Alok; Solmaz, Sozanne R.; Blobel, Guenter; Melcak, Ivo			Ordered Regions of Channel Nucleoporins Nup62, Nup54, and Nup58 Form Dynamic Complexes in Solution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-PORE COMPLEX; SEDIMENTATION EQUILIBRIUM; P62 COMPLEX; ANALYTICAL ULTRACENTRIFUGATION; TRANSPORT; GLYCOPROTEINS; ARCHITECTURE; PREDICTION; BINDING; DOMAIN	Three out of similar to 30 nucleoporins, Nup62, Nup54, and Nup58, line the nuclear pore channel. These "channel" nucleoporins each contain an ordered region of similar to 150-200 residues, which is predicted to be segmented into 3-4 alpha-helical regions of similar to 40-80 residues. Notably, these segmentations are evolutionarily conserved between uni- and multicellular eukaryotes. Strikingly, the boundaries of these segments match our previously reported mapping and crystal data, which collectively identified two "cognate" segments of Nup54, each interacting with cognate segments, one in Nup58 and the other one in Nup62. Because Nup54 and Nup58 cognate segments form crystallographic hetero- or homo-oligomers, we proposed that these oligomers associate into inter-convertible "mid-plane" rings: a single large ring (40-50 nm diameter, consisting of eight heterododecamers) or three small rings (10-20 nm diameter, each comprising eight homo-tetramers). Each "ring cycle" would recapitulate" dilation" and "constriction" of the nuclear pore complex's central transport channel. As for the Nup54.Nup62 interactome, it forms a 1: 2 triple helix ("finger"), multiples of which project alternately up and down from mid-plane ring(s). Collectively, our previous crystal data suggested a copy number of 128, 64, and 32 for Nup62, Nup54, and Nup58, respectively, that is, a 4: 2: 1 stoichiometry. Here, we carried out solution analysis utilizing the entire ordered regions of Nup62, Nup54, and Nup58, and demonstrate that they form a dynamic "triple complex" that is heterogeneously formed from our previously characterized Nup54.Nup58 and Nup54.Nup62 interactomes. These data are consistent both with our crystal structure-deduced copy numbers and stoichiometries and also with our ring cycle model for structure and dynamics of the nuclear pore channel.	[Sharma, Alok; Solmaz, Sozanne R.; Blobel, Guenter; Melcak, Ivo] Rockefeller Univ, Cell Biol Lab, Howard Hughes Med Inst, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University	Blobel, G (corresponding author), Rockefeller Univ, Cell Biol Lab, Howard Hughes Med Inst, 1230 York Ave, New York, NY 10065 USA.	blobel@rockefeller.edu; melcaki@rockefeller.edu	Sharma, Alok/AAE-4725-2022	Sharma, Alok/0000-0002-7668-3501; Sharma, Alok/0000-0001-5199-2319; Solmaz, Sozanne R/0000-0002-1703-3701	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Asakawa H, 2014, NUCLEUS-PHILA, V5, P149, DOI 10.4161/nucl.28487; Bailer SM, 2001, MOL CELL BIOL, V21, P7944, DOI 10.1128/MCB.21.23.7944-7955.2001; BUSS F, 1995, J CELL BIOL, V128, P251, DOI 10.1083/jcb.128.3.251; Cole JL, 2008, METHOD CELL BIOL, V84, P143, DOI 10.1016/S0091-679X(07)84006-4; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; FINLAY DR, 1991, J CELL BIOL, V114, P169, DOI 10.1083/jcb.114.1.169; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, DOI DOI 10.1385/1592598900; GRANDI P, 1995, EMBO J, V14, P76, DOI 10.1002/j.1460-2075.1995.tb06977.x; GUAN TL, 1995, MOL BIOL CELL, V6, P1591, DOI 10.1091/mbc.6.11.1591; Hoelz A, 2011, ANNU REV BIOCHEM, V80, P613, DOI 10.1146/annurev-biochem-060109-151030; Hu TH, 1996, J CELL BIOL, V134, P589, DOI 10.1083/jcb.134.3.589; KITA K, 1993, J BIOCHEM-TOKYO, V113, P377, DOI 10.1093/oxfordjournals.jbchem.a124054; Koh J, 2015, CELL, V161, P1361, DOI 10.1016/j.cell.2015.05.013; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Louis-Jeune C, 2012, PROTEINS, V80, P374, DOI 10.1002/prot.23188; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Melcak I, 2007, SCIENCE, V315, P1729, DOI 10.1126/science.1135730; Pollard TD, 2010, MOL BIOL CELL, V21, P4061, DOI 10.1091/mbc.E10-08-0683; ROARK DE, 1976, BIOPHYS CHEM, V5, P185, DOI 10.1016/0301-4622(76)80034-8; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Solmaz SR, 2013, P NATL ACAD SCI USA, V110, P5858, DOI 10.1073/pnas.1302655110; Solmaz SR, 2011, CELL, V147, P590, DOI 10.1016/j.cell.2011.09.034; Ulrich A, 2014, MOL BIOL CELL, V25, P1484, DOI 10.1091/mbc.E13-12-0745; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014	24	12	12	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18370	18378		10.1074/jbc.M115.663500	http://dx.doi.org/10.1074/jbc.M115.663500			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26025361	Green Published, hybrid			2022-12-26	WOS:000358512100010
J	Kundumani-Sridharan, V; Subramani, J; Das, KC				Kundumani-Sridharan, Venkatesh; Subramani, Jaganathan; Das, Kumuda C.			Thioredoxin Activates MKK4-NF kappa B Pathway in a Redox-dependent Manner to Control Manganese Superoxide Dismutase Gene Expression in Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; ALPHA-INDUCED APOPTOSIS; MEK KINASE 1; PROTEIN-KINASE; SIGNALING PATHWAY; MNSOD GENE; TNF-ALPHA; INDUCTION; STRESS; MECHANISM	The mitogen-activated protein kinase kinase 4 (MKK4) is activated via phosphorylation of Ser-257 and Thr-261 by upstream MAP3Ks and activates JNK and p38 MAPKs in response to cellular stress. We show that thioredoxin (Trx), a cellular redox protein, activates MKK4 via Cys-246 and Cys-266 residues as mutation of these residues renders MKK4 insensitive to phosphorylation by MAP3Ks, TNF alpha, or Trx. MKK4 is activated in vitro by reduced Trx but not oxidized Trx in the absence of an upstream kinase, suggesting that autophosphorylation of this protein occurs due to reduction of Cys-246 and Cys-266 by Trx. Additionally, mutation of Cys-246 and Cys-266 resulted in loss of kinase activity suggesting that the redox state of Cys-246 and Cys-266 is a critical determinant of MKK4 activation. Trx induces manganese superoxide dismutase (MnSOD) gene transcription by activating MKK4 via redox control of Cys246 and Cys-266, as mutation of these residues abrogates MKK4 activation and MnSOD expression. We further show that MKK4 activates NF kappa B for its binding to the MnSOD promoter, which leads to AP-1 dissociation followed by MnSOD transcription. Taken together, our studies show that the redox status of Cys246 and Cys-266 in MKK4 controls its activities independent of MAP3K, demonstrating integration of the endothelial redox environment to MAPK signaling.	Texas Tech Univ, Hlth Sci Ctr, Dept Anesthesiol, Lubbock, TX 79430 USA; Texas Tech Univ, Hlth Sci Ctr, Ctr Excellence Cardiovasc Res, Lubbock, TX 79430 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center	Das, KC (corresponding author), 3601 4th St MS 6598, Lubbock, TX 79430 USA.	kumuda.das@ttuhsc.edu	Kundumani-Sridharan, Venkatesh/ABD-9613-2021; Regan, Clinton/E-6250-2012; Kundumani-Sridharan, Venkatesh/I-4799-2016; Kundumani-Sridharan, Venkatesh/AAB-4535-2020; Subramani, Jaganathan/I-5155-2016	Kundumani-Sridharan, Venkatesh/0000-0002-6134-4371; Kundumani-Sridharan, Venkatesh/0000-0002-6134-4371; Subramani, Jaganathan/0000-0002-5707-8621	National Institutes of Health [HL 1R01HL107885, 1R01HL109397]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109397, R01HL107885] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL 1R01HL107885 and 1R01HL109397 (to K. C. D.). The authors declare that they have no conflicts of interest with the contents of this article.	Abid MR, 2004, J BIOL CHEM, V279, P44030, DOI 10.1074/jbc.M408285200; Abid MR, 2001, FASEB J, V15, P2548, DOI 10.1096/fj.01-0338fje; Bianchi A, 2002, FREE RADICAL BIO MED, V32, P1132, DOI 10.1016/S0891-5849(02)00834-1; Brandt B, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.1; Bunse L, 2015, J CLIN INVEST, V125, P593, DOI 10.1172/JCI77780; Clerch LB, 1996, PEDIATR RES, V39, P253, DOI 10.1203/00006450-199602000-00011; Cross JV, 2004, BIOCHEM J, V381, P675, DOI 10.1042/BJ20040591; Cuenda A, 2000, INT J BIOCHEM CELL B, V32, P581, DOI 10.1016/S1357-2725(00)00003-0; Darville MI, 2000, ENDOCRINOLOGY, V141, P153, DOI 10.1210/en.141.1.153; Das KC, 1997, AM J RESP CELL MOL, V17, P713, DOI 10.1165/ajrcmb.17.6.2809; Das KC, 1998, J BIOL CHEM, V273, P34639, DOI 10.1074/jbc.273.51.34639; Das KC, 2001, J BIOL CHEM, V276, P4662, DOI 10.1074/jbc.M006206200; DAS KC, 1995, MOL CELL BIOCHEM, V148, P45, DOI 10.1007/BF00929502; DAS KC, 1995, AM J PHYSIOL-LUNG C, V269, pL588, DOI 10.1152/ajplung.1995.269.5.L588; Das KC, 2015, AM J PHYSIOL-LUNG C, V308, pL429, DOI 10.1152/ajplung.00285.2014; Das KC, 2010, MOL CELL BIOCHEM, V337, P53, DOI 10.1007/s11010-009-0285-0; Davidson SM, 2010, CARDIOVASC RES, V88, P58, DOI 10.1093/cvr/cvq195; Davies C, 2012, BIOCHEM SOC T, V40, P85, DOI 10.1042/BST20110641; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Deacon K, 1997, J BIOL CHEM, V272, P14489, DOI 10.1074/jbc.272.22.14489; Delhalle S, 2002, ONCOGENE, V21, P3917, DOI 10.1038/sj.onc.1205489; Haeusgen W, 2011, EUR J CELL BIOL, V90, P536, DOI 10.1016/j.ejcb.2010.11.008; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; HOLMGREN A, 1995, METHOD ENZYMOL, V252, P199; Johnson NL, 1996, J BIOL CHEM, V271, P3229, DOI 10.1074/jbc.271.6.3229; Kaur S, 2005, J BIOL CHEM, V280, P38599, DOI 10.1074/jbc.M505671200; Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051; Kinscherf R, 1997, FASEB J, V11, P1317, DOI 10.1096/fasebj.11.14.9409551; Lee DY, 2013, J BIOL CHEM, V288, P28668, DOI 10.1074/jbc.M113.470971; Lee FS, 1998, P NATL ACAD SCI USA, V95, P9319, DOI 10.1073/pnas.95.16.9319; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Luo JL, 2005, J CLIN INVEST, V115, P2625, DOI 10.1172/JCI26322; Muniyappa H, 2009, J BIOL CHEM, V284, P17069, DOI 10.1074/jbc.M109.008557; Pacchiana R, 2014, HISTOCHEM CELL BIOL, V142, P593, DOI 10.1007/s00418-014-1244-8; Papa S, 2004, NAT CELL BIOL, V6, P146, DOI 10.1038/ncb1093; Papa S, 2004, J CELL SCI, V117, P5197, DOI 10.1242/jcs.01483; Ravi D, 2004, CANCER CHEMOTH PHARM, V54, P449, DOI 10.1007/s00280-004-0833-y; Sanna MG, 2002, MOL CELL BIOL, V22, P1754, DOI 10.1128/MCB.22.6.1754-1766.2002; Stehlik C, 1998, J EXP MED, V188, P211, DOI 10.1084/jem.188.1.211; SUZUKI K, 1993, AM J PHYSIOL, V265, pH1173, DOI 10.1152/ajpheart.1993.265.4.H1173; Tao L, 2006, BRIT J PHARMACOL, V149, P311, DOI 10.1038/sj.bjp.0706853; Tao L, 2004, P NATL ACAD SCI USA, V101, P11471, DOI 10.1073/pnas.0402941101; VISNER GA, 1992, BIOCHEM BIOPH RES CO, V188, P453; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; Wang B, 2015, BRAIN RES, V1615, P89, DOI 10.1016/j.brainres.2015.04.033; Wang TH, 1998, J BIOL CHEM, V273, P4928, DOI 10.1074/jbc.273.9.4928; Wang X, 2007, BBA-MOL CELL RES, V1773, P1349, DOI 10.1016/j.bbamcr.2006.10.016; Weibrecht I, 2010, EXPERT REV PROTEOMIC, V7, P401, DOI 10.1586/EPR.10.10; Wen Hairuo, 2012, World J Hypertens, V2, P34; Widmann C, 1997, ONCOGENE, V15, P2439, DOI 10.1038/sj.onc.1201421; Widmann C, 1998, MOL CELL BIOL, V18, P2416, DOI 10.1128/MCB.18.4.2416; WONG GHW, 1988, SCIENCE, V242, P941, DOI 10.1126/science.3263703; WONG GHW, 1989, CELL, V58, P923, DOI 10.1016/0092-8674(89)90944-6; Xia DR, 2007, J BIOL CHEM, V282, P3507, DOI 10.1074/jbc.M610141200; Xu Y, 1999, DNA CELL BIOL, V18, P709, DOI 10.1089/104454999314999	55	14	15	4	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17505	17519		10.1074/jbc.M115.660365	http://dx.doi.org/10.1074/jbc.M115.660365			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	26028649	Green Published, hybrid			2022-12-26	WOS:000357730900042
J	Park, S; Kanayama, K; Kaur, K; Tseng, HCH; Banankhah, S; Quje, DT; Sayre, JW; Jewett, A; Nishimura, I				Park, Sil; Kanayama, Keiichi; Kaur, Kawaljit; Tseng, Han-Ching Helen; Banankhah, Sina; Quje, Davood Talebi; Sayre, James W.; Jewett, Anahid; Nishimura, Ichiro			Osteonecrosis of the Jaw Developed in Mice DISEASE VARIANTS REGULATED BY gamma delta T CELLS IN ORAL MUCOSAL BARRIER IMMUNITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BISPHOSPHONATE-RELATED OSTEONECROSIS; SURGEONS POSITION PAPER; BREAST-CANCER PATIENTS; ZOLEDRONIC ACID; AMERICAN ASSOCIATION; INDUCE OSTEONECROSIS; MULTIPLE-MYELOMA; ANTIGEN RECEPTOR; RISK-FACTORS; BONE-MARROW	Osteonecrosis of the jaw (ONJ), an uncommon co-morbidity in patients treated with bisphosphonates (BP), occurs in the segment of jawbone interfacing oral mucosa. This study aimed to investigate a role of oral mucosal barrier gamma delta T cells in the pathogenesis of ONJ. Female C57Bl/6J (B6) mice received a bolus zoledronate intravenous injection (ZOL, 540 mu g/kg), and their maxillary left first molars were extracted 1 week later. ZOL-treated mice (WT ZOL) delayed oral wound healing with patent open wounds 4 weeks after tooth extraction with characteristic oral epithelial hyperplasia. gamma delta T cells appeared within the tooth extraction site and hyperplastic epithelium in WT ZOL mice. In ZOL-treated gamma delta T cell null (Tcrd(-/-) ZOL) mice, the tooth extraction open wound progressively closed; however, histological ONJ-like lesions were identified in 75 and 60% of WT ZOL and Tcrd(-/-) ZOL mice, respectively. Although the bone exposure phenotype of ONJ was predominantly observed in WT ZOL mice, Tcrd(-/-) ZOL mice developed the pustule/fistula disease phenotype. We further addressed the role of gamma delta T cells from human peripheral blood (h-gamma delta T cells). When co-cultured with ZOL-pretreated human osteoclasts in vitro, h-gamma delta T cells exhibited rapid expansion and robust IFN-gamma secretion. When h-gamma delta T cells were injected into ZOL-treated immunodeficient (Rag2(-/-) ZOL) mice, the oral epithelial hyperplasia developed. However, Rag2(-/-) ZOL mice did not develop osteonecrosis. The results indicate that gamma delta T cells are unlikely to influence the core osteonecrosis mechanism; however, they may serve as a critical modifier contributing to the different oral mucosal disease variations of ONJ.	[Park, Sil; Kanayama, Keiichi; Banankhah, Sina; Quje, Davood Talebi; Nishimura, Ichiro] Univ Calif Los Angeles, Sch Dent, Weintraub Ctr Reconstruct Biotechnol, Div Adv Prosthodont, Los Angeles, CA 90095 USA; [Park, Sil; Kaur, Kawaljit; Tseng, Han-Ching Helen; Jewett, Anahid; Nishimura, Ichiro] Univ Calif Los Angeles, Sch Dent, Div Oral Biol & Med, Los Angeles, CA 90095 USA; [Kanayama, Keiichi] Asahi Univ, Dept Periodontol, Sch Dent, Gifu 5010296, Japan; [Sayre, James W.] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Biostat, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Asahi University; University of California System; University of California Los Angeles	Nishimura, I (corresponding author), Univ Calif Los Angeles, Sch Dent, Weintraub Ctr Reconstruct Biotechnol, Box 951668,CHS B3-087, Los Angeles, CA 90095 USA.	inishimura@dentistry.ucla.edu			National Institutes of Health from NIDCR [R01 DE022552]; National Institutes of Health from the National Center for Research Resources Research Facilities Improvement Program Grant [C06 RR014529]; Investigator Initiated Study Program Grant from Merck [38519]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR014529] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022552] Funding Source: NIH RePORTER	National Institutes of Health from NIDCR; National Institutes of Health from the National Center for Research Resources Research Facilities Improvement Program Grant; Investigator Initiated Study Program Grant from Merck; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DE022552 from NIDCR and was conducted in part in a facility supported by National Institutes of Health Grant C06 RR014529 from the National Center for Research Resources Research Facilities Improvement Program Grant. This work was also supported by Investigator Initiated Study Program Grant 38519 from Merck. The authors declare that they have no conflicts of interest with the contents of this article.	Akilov OE, 2007, ARCH DERMATOL RES, V299, P315, DOI 10.1007/s00403-007-0765-6; Barasch A, 2011, J DENT RES, V90, P439, DOI 10.1177/0022034510397196; Bedogni A, 2008, ORAL SURG ORAL MED O, V105, P358, DOI 10.1016/j.tripleo.2007.08.040; Bi YM, 2010, AM J PATHOL, V177, P280, DOI 10.2353/ajpath.2010.090592; Cetiner S, 2009, J BONE MINER METAB, V27, P435, DOI 10.1007/s00774-009-0047-9; Coleman R, 2011, BREAST CANCER RES TR, V127, P429, DOI 10.1007/s10549-011-1429-y; Coleman RE, 2011, NEW ENGL J MED, V365, P1396, DOI 10.1056/NEJMoa1105195; Eberl M, 2009, TRENDS IMMUNOL, V30, P562, DOI 10.1016/j.it.2009.09.001; Hansen T, 2006, J ORAL PATHOL MED, V35, P155, DOI 10.1111/j.1600-0714.2006.00391.x; Hao ZY, 2001, J EXP MED, V194, P1151, DOI 10.1084/jem.194.8.1151; Havran WL, 2010, J IMMUNOL, V184, P5423, DOI 10.4049/jimmunol.0902733; Havran WL, 2000, IMMUNOL RES, V21, P63, DOI 10.1385/IR:21:2-3:63; Hemingway F, 2011, CALCIFIED TISSUE INT, V89, P389, DOI 10.1007/s00223-011-9530-0; Hokugo A, 2010, J BONE MINER RES, V25, P1337, DOI 10.1002/jbmr.23; Hunter RP, 2008, J ZOO WILDLIFE MED, V39, P517, DOI 10.1638/2008-0041.1; Ibusuki A, 2014, J INVEST DERMATOL, V134, P396, DOI 10.1038/jid.2013.353; Inoue SI, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00258; ITOHARA S, 1993, CELL, V72, P337, DOI 10.1016/0092-8674(93)90112-4; Jewett A, 1997, J IMMUNOL, V158, P5492; Kalyan S, 2013, J BONE MINER RES, V28, P728, DOI 10.1002/jbmr.1769; Kang B, 2013, J BONE MINER RES, V28, P1631, DOI 10.1002/jbmr.1894; Karunakaran MM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00648; Karunakaran MM, 2014, IMMUNOGENETICS, V66, P243, DOI 10.1007/s00251-014-0763-8; Khamaisi M, 2007, J CLIN ENDOCR METAB, V92, P1172, DOI 10.1210/jc.2006-2036; Khosla S, 2007, J BONE MINER RES, V22, P1479, DOI 10.1359/JBMR.0707ONJ; Kikuiri T, 2010, J BONE MINER RES, V25, P1668, DOI 10.1002/jbmr.37; Kobayashi Y, 2010, J BONE MINER METAB, V28, P165, DOI 10.1007/s00774-009-0128-9; Kunzmann V, 2000, BLOOD, V96, P384; Kuroshima S, 2013, BONE, V56, P101, DOI 10.1016/j.bone.2013.05.013; Kyrgidis A, 2008, J CLIN ONCOL, V26, P4634, DOI 10.1200/JCO.2008.16.2768; Mavrokokki T, 2007, J ORAL MAXIL SURG, V65, P415, DOI 10.1016/j.joms.2006.10.061; Miyazaki H, 2012, BJU INT, V110, pE520, DOI 10.1111/j.1464-410X.2012.11205.x; Morag Y, 2009, RADIOGRAPHICS, V29, P1971, DOI 10.1148/rg.297095050; Ngamphaiboon N, 2011, CLIN BREAST CANCER, V11, P252, DOI 10.1016/j.clbc.2011.02.001; Presland Richard B, 2002, J Dent Educ, V66, P564; Prinz I, 2006, NAT IMMUNOL, V7, P995, DOI 10.1038/ni1371; Reid IR, 2012, NAT REV RHEUMATOL, V8, P90, DOI 10.1038/nrrheum.2011.181; Roelofs AJ, 2010, J BONE MINER RES, V25, P606, DOI 10.1359/jbmr.091009; Rossini M, 2012, CALCIFIED TISSUE INT, V91, P395, DOI 10.1007/s00223-012-9647-9; Ruggiero SL, 2014, J ORAL MAXIL SURG, V72, P1938, DOI 10.1016/j.joms.2014.04.031; Ruggiero SL, 2009, J ORAL MAXIL SURG, V67, P2, DOI 10.1016/j.joms.2009.01.009; Ruggiero SL, 2004, J ORAL MAXIL SURG, V62, P527, DOI 10.1016/j.joms.2004.02.004; Saad F, 2012, ANN ONCOL, V23, P1341, DOI 10.1093/annonc/mdr435; Schiodt M, 2014, OR SURG OR MED OR PA, V117, P204, DOI 10.1016/j.oooo.2013.10.010; Smidt-Hansen T, 2013, J ORAL MAXIL SURG, V71, P1532, DOI 10.1016/j.joms.2013.03.019; Ting K, 1999, AM J PATHOL, V155, P1993, DOI 10.1016/S0002-9440(10)65518-6; Wilhelm M, 2003, BLOOD, V102, P200, DOI 10.1182/blood-2002-12-3665; Woo SB, 2006, ANN INTERN MED, V144, P753, DOI 10.7326/0003-4819-144-10-200605160-00009; Yardeni T, 2011, LAB ANIMAL, V40, P155, DOI 10.1038/laban0511-155; Zhang QZ, 2013, CLIN CANCER RES, V19, P3176, DOI 10.1158/1078-0432.CCR-13-0042; Zhao YH, 2012, CALCIFIED TISSUE INT, V91, P400, DOI 10.1007/s00223-012-9649-7	51	31	33	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17349	17366		10.1074/jbc.M115.652305	http://dx.doi.org/10.1074/jbc.M115.652305			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	26013832	Green Published, hybrid			2022-12-26	WOS:000357730900030
J	Dickie, DA; Job, DE; Gonzalez, DR; Shenkin, SD; Wardlaw, JM				Dickie, David Alexander; Job, Dominic E.; Gonzalez, David Rodriguez; Shenkin, Susan D.; Wardlaw, Joanna M.			Use of Brain MRI Atlases to Determine Boundaries of Age-Related Pathology: The Importance of Statistical Method	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; ALZHEIMERS-DISEASE; OLDER-ADULTS; RANDOM-FIELDS; GRAY-MATTER; ATROPHY; IMAGES; REGISTRATION; AD	Introduction Neurodegenerative disease diagnoses may be supported by the comparison of an individual patient's brain magnetic resonance image (MRI) with a voxel-based atlas of normal brain MRI. Most current brain MRI atlases are of young to middle-aged adults and parametric, e. g., mean +/- standard deviation (SD); these atlases require data to be Gaussian. Brain MRI data, e. g., grey matter (GM) proportion images, from normal older subjects are apparently not Gaussian. We created a nonparametric and a parametric atlas of the normal limits of GM proportions in older subjects and compared their classifications of GM proportions in Alzheimer's disease (AD) patients. Methods Using publicly available brain MRI from 138 normal subjects and 138 subjects diagnosed with AD (all 55-90 years), we created: a mean +/- SD atlas to estimate parametrically the percentile ranks and limits of normal ageing GM; and, separately, a nonparametric, rank order-based GM atlas from the same normal ageing subjects. GM images from AD patients were then classified with respect to each atlas to determine the effect statistical distributions had on classifications of proportions of GM in AD patients. Results The parametric atlas often defined the lower normal limit of the proportion of GM to be negative (which does not make sense physiologically as the lowest possible proportion is zero). Because of this, for approximately half of the AD subjects, 25-45% of voxels were classified as normal when compared to the parametric atlas; but were classified as abnormal when compared to the nonparametric atlas. These voxels were mainly concentrated in the frontal and occipital lobes. Discussion To our knowledge, we have presented the first nonparametric brain MRI atlas. In conditions where there is increasing variability in brain structure, such as in old age, nonparametric brain MRI atlases may represent the limits of normal brain structure more accurately than parametric approaches. Therefore, we conclude that the statistical method used for construction of brain MRI atlases should be selected taking into account the population and aim under study. Parametric methods are generally robust for defining central tendencies, e.g., means, of brain structure. Nonparametric methods are advisable when studying the limits of brain structure in ageing and neurodegenerative disease.	[Dickie, David Alexander; Job, Dominic E.; Gonzalez, David Rodriguez; Wardlaw, Joanna M.] Univ Edinburgh, Sch Med, Ctr Clin Brain Sci, Neuroimaging Sci, Edinburgh, Midlothian, Scotland; [Dickie, David Alexander; Job, Dominic E.; Gonzalez, David Rodriguez; Shenkin, Susan D.; Wardlaw, Joanna M.] Univ Edinburgh, Royal Infirm Edinburgh, Geriatr Med Unit, Edinburgh, Midlothian, Scotland; [Shenkin, Susan D.] Scottish Imaging Network, Glasgow, Lanark, Scotland	University of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh	Dickie, DA (corresponding author), Univ Edinburgh, Sch Med, Ctr Clin Brain Sci, Neuroimaging Sci, Edinburgh, Midlothian, Scotland.	ddickie1@staffmail.ed.ac.uk	Wardlaw, Joanna M/Y-3456-2019; Shenkin, Susan/GWZ-3174-2022; Rodriguez Gonzalez, David/AAA-1966-2019; Hernandez, María/GYU-3543-2022	Wardlaw, Joanna M/0000-0002-9812-6642; Rodriguez Gonzalez, David/0000-0002-9160-5106; Shenkin, Susan/0000-0001-7375-4776; Job, Dominic/0000-0002-7829-7217; Dickie, David Alexander/0000-0002-9443-8403	Scottish Funding Council; Scottish Executive Chief Scientist Office; Scottish Executive Chief Scientist Office through the SINAPSE collaboration; SINAPSE industrial collaboration (SPIRIT) PhD scholarship; Medical Research Council (MRC) scholarship; Tony Watson Scholarship; Wellcome Trust [007393/Z/05/Z]; BBSRC; EPSRC; ESRC; MRC; National Institutes of Health (NIH) [U01 AG024904]; NIH [P30 AG010129, K01 AG030514]; Open Access Series of Imaging Studies (OASIS) [P50 AG05681, P01 AG03991, R01 AG021910, P20 MH071616, U24 RR021382]; NATIONAL CENTER FOR RESEARCH RESOURCES [U24RR021382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH071616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG010129, P50AG005681, R01AG021910, K01AG030514, U01AG024904, P01AG003991] Funding Source: NIH RePORTER; Medical Research Council [G0700704, MR/K026992/1] Funding Source: researchfish; MRC [G0700704] Funding Source: UKRI	Scottish Funding Council; Scottish Executive Chief Scientist Office; Scottish Executive Chief Scientist Office through the SINAPSE collaboration; SINAPSE industrial collaboration (SPIRIT) PhD scholarship; Medical Research Council (MRC) scholarship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Tony Watson Scholarship; Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Open Access Series of Imaging Studies (OASIS); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors would like to acknowledge and thank the following centres and funders. This work was carried out in The University of Edinburgh Brain Research Imaging Centre (BRIC; http://www.bric.ed.ac.uk/). BRIC is part of the Scottish Imaging Network, A Platform for Scientific Excellence (SINAPSE) collaboration (http://www.sinapse.ac.uk/), funded by the Scottish Funding Council, Scottish Executive Chief Scientist Office, and the six collaborator Universities. Professor Joanna M. Wardlaw was funded by the Scottish Funding Council and Scottish Executive Chief Scientist Office through the SINAPSE collaboration. David Alexander Dickie was funded by a SINAPSE industrial collaboration (SPIRIT) PhD scholarship, a Medical Research Council (MRC) scholarship, and the Tony Watson Scholarship bequest to The University of Edinburgh. Dr Dominic E. Job was funded by Wellcome Trust Grant 007393/Z/05/Z. Dr Susan D. Shenkin and Professor Joanna M. Wardlaw are members of The University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology, part of the cross council Lifelong Health and Wellbeing Initiative (G0700704/84698). Funding from the BBSRC, EPSRC, ESRC, and MRC is gratefully acknowledged. The Alzheimer's Disease Neuroimaging Initiative (ADNI - PI Michael W. Weiner, MD) data were acquired through the National Institutes of Health (NIH) Grant U01 AG024904, National Institute on Aging, National Institute of Biomedical Imaging and Bioengineering, Abbott, Alzheimer's Association, Alzheimer's Drug Discovery Foundation, Amorfix Life Sciences Ltd., AstraZeneca, Bayer HealthCare, BioClinica, Inc., Biogen Idec Inc., Bristol-Myers Squibb Company, Eisai Inc., Elan Pharmaceuticals Inc., Eli Lilly and Company, F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc., GE Healthcare, Innogenetics, N.V., IXICO Ltd., Janssen Alzheimer Immunotherapy Research & Development, LLC., Johnson & Johnson Pharmaceutical Research & Development LLC., Medpace, Inc., Merck & Co., Inc., Meso Scale Diagnostics, LLC., Novartis Pharmaceuticals Corporation, Pfizer Inc., Servier, Synarc Inc., Takeda Pharmaceutical Company, Canadian Institutes of Health Research, Foundation for the National Institutes of Health (www.fnih.org), Northern California Institute for Research and Education, Alzheimer's Disease Cooperative Study at the University of California, San Diego, Laboratory for Neuro Imaging at the University of California, Los Angeles, and NIH grants P30 AG010129 and K01 AG030514. The Open Access Series of Imaging Studies (OASIS) data were acquired through grants: P50 AG05681, P01 AG03991, R01 AG021910, P20 MH071616, U24 RR021382.	Allen JS, 2005, NEUROBIOL AGING, V26, P1245, DOI 10.1016/j.neurobiolaging.2005.05.023; Aribisala BS, 2012, EUR RADIOL, DOI [10.1007/s00330-00012-02677-x, DOI 10.1007/S00330-00012-02677-X]; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Aubert-Broche B, 2011, NEUROIMAGE, V58, P409, DOI 10.1016/j.neuroimage.2011.03.025; Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; Braak H, 1997, Int Psychogeriatr, V9 Suppl 1, P257, DOI 10.1017/S1041610297004973; BRODY JA, 1985, NATURE, V315, P463, DOI 10.1038/315463a0; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Cole TJ, 1998, STAT MED, V17, P407, DOI 10.1002/(SICI)1097-0258(19980228)17:4&lt;407::AID-SIM742&gt;3.0.CO;2-L; DeCarlo LT, 1997, PSYCHOL METHODS, V2, P292, DOI 10.1037/1082-989X.2.3.292; Dennis J, 2013, ANN NEUROL, V74, P328, DOI 10.1002/ana.24001; Dickie DA, 2014, PRETERM INFANT BRAIN; Dickie DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084093; Dickie DA, 2012, EUR RADIOL, V22, P1385, DOI 10.1007/s00330-012-2392-7; ELVEBACK LR, 1970, J AMER MED ASSOC, V211, P69, DOI 10.1001/jama.211.1.69; Evans AC, 2012, NEUROIMAGE, V62, P911, DOI 10.1016/j.neuroimage.2012.01.024; Farrell C, 2009, EUR RADIOL, V19, P177, DOI 10.1007/s00330-008-1119-2; Ferguson KJ, 2010, J NEUROIMAGING, V20, P157, DOI 10.1111/j.1552-6569.2009.00368.x; Fotenos AF, 2005, NEUROLOGY, V64, P1032, DOI 10.1212/01.WNL.0000154530.72969.11; Fox NC, 2004, LANCET, V363, P392, DOI 10.1016/S0140-6736(04)15441-X; Freedman D., 2010, STAT MODELS CAUSAL I; Ge YL, 2002, AM J NEURORADIOL, V23, P1327; Geroldi C, 1999, NEUROLOGY, V53, P1825, DOI 10.1212/WNL.53.8.1825; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Hill DLG, 2002, LECT NOTES COMPUT SC, V2488, P532; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Jack CR, 1997, NEUROLOGY, V49, P786, DOI 10.1212/WNL.49.3.786; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kim N, 2014, FRONTIERS PUBLIC HLT, V2; Kim N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059382; Luo WL, 2003, NEUROIMAGE, V19, P1014, DOI 10.1016/S1053-8119(03)00149-6; Magnin B, 2009, NEURORADIOLOGY, V51, P73, DOI 10.1007/s00234-008-0463-x; Marcus DS, 2007, J COGNITIVE NEUROSCI, V19, P1498, DOI 10.1162/jocn.2007.19.9.1498; Mayer AR, 2014, HUM BRAIN MAPP, V35, P5457, DOI 10.1002/hbm.22563; Pernet CR, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-67; Raz N, 2010, NEUROIMAGE, V51, P501, DOI 10.1016/j.neuroimage.2010.03.020; Resnick SM, 2003, J NEUROSCI, V23, P3295; Rorden C, 2007, NEUROIMAGE, V35, P1531, DOI 10.1016/j.neuroimage.2006.12.043; Salmond CH, 2002, NEUROIMAGE, V17, P1027, DOI 10.1006/nimg.2002.1153; Shattuck DW, 2002, MED IMAGE ANAL, V6, P129, DOI 10.1016/S1361-8415(02)00054-3; Shenton ME, 2001, SCHIZOPHR RES, V49, P1, DOI 10.1016/S0920-9964(01)00163-3; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Thompson PM, 2003, J NEUROSCI, V23, P994; Viviani R, 2007, HUM BRAIN MAPP, V28, P1075, DOI 10.1002/hbm.20332; Viviani R, 2007, NEUROIMAGE, V35, P121, DOI 10.1016/j.neuroimage.2006.11.037; Wardlaw JM, 2011, INT J STROKE, V6, P547, DOI 10.1111/j.1747-4949.2011.00683.x; Watts R, 2014, RADIOLOGY; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424; Zhao L, 2013, HUM BRAIN MAPP, V34, P2113, DOI 10.1002/hbm.22050; Ziegler G, 2014, NEUROIMAGE IN PRESS	51	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0127939	10.1371/journal.pone.0127939	http://dx.doi.org/10.1371/journal.pone.0127939			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26023913	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000355319400059
J	Lim, C; Paris, DH; Blacksell, SD; Laongnualpanich, A; Kantipong, P; Chierakul, W; Wuthiekanun, V; Day, NPJ; Cooper, B; Limmathurotsakul, D				Lim, Cherry; Paris, Daniel H.; Blacksell, Stuart D.; Laongnualpanich, Achara; Kantipong, Pacharee; Chierakul, Wirongrong; Wuthiekanun, Vanaporn; Day, Nicholas P. J.; Cooper, Ben S.; Limmathurotsakul, Direk			How to Determine the Accuracy of an Alternative Diagnostic Test when It Is Actually Better than the Reference Tests: A Re-Evaluation of Diagnostic Tests for Scrub Typhus Using Bayesian LCMs	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; PROTEIN ANTIGEN R56; ORIENTIA-TSUTSUGAMUSHI; PCR ASSAY; MURINE TYPHUS; GOLD STANDARD; INFECTION; LAOS; RICKETTSIOSES; COMBINATION	Background The indirect immunofluorescence assay (IFA) is considered a reference test for scrub typhus. Recently, the Scrub Typhus Infection Criteria (STIC; a combination of culture, PCR assays and IFA IgM) were proposed as a reference standard for evaluating alternative diagnostic tests. Here, we use Bayesian latent class models (LCMs) to estimate the true accuracy of each diagnostic test, and of STIC, for diagnosing scrub typhus. Methods/Principal Findings Data from 161 patients with undifferentiated fever were re-evaluated using Bayesian LCMs. Every patient was evaluated for the presence of an eschar, and tested with blood culture for Orientia tsutsugamushi, three different PCR assays, IFA IgM, and the Panbio IgM immunochromatographic test (ICT). True sensitivity and specificity of culture (24.4% and 100%), 56kDa PCR assay (56.8% and 98.4%), 47kDa PCR assay (63.2% and 96.1%), groEL PCR assay (71.4% and 93.0%), IFA IgM (70.0% and 83.8%), PanBio IgM ICT (72.8% and 96.8%), presence of eschar (42.7% and 98.9%) and STIC (90.5% and 82.5%) estimated by Bayesian LCM were considerably different from those obtained when using STIC as a reference standard. The IgM ICT had comparable sensitivity and significantly higher specificity compared to IFA (p=0.34 and p<0.001, respectively). Conclusions The low specificity of STIC was caused by the low specificity of IFA IgM. Neither STIC nor IFA IgM can be used as reference standards against which to evaluate alternative diagnostic tests. Further evaluation of new diagnostic tests should be done with a carefully selected set of diagnostic tests and appropriate statistical models.	[Lim, Cherry; Paris, Daniel H.; Blacksell, Stuart D.; Chierakul, Wirongrong; Wuthiekanun, Vanaporn; Day, Nicholas P. J.; Cooper, Ben S.; Limmathurotsakul, Direk] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Paris, Daniel H.; Blacksell, Stuart D.; Day, Nicholas P. J.; Cooper, Ben S.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med & Global Hlth, Oxford, England; [Laongnualpanich, Achara; Kantipong, Pacharee] Chiang Rai Prachanukroh Hosp, Chiang Rai, Thailand; [Limmathurotsakul, Direk] Mahidol Univ, Fac Trop Med, Dept Trop Hyg, Bangkok, Thailand	Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford; Mahidol University	Limmathurotsakul, D (corresponding author), Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand.	direk@tropmedres.ac	Chierakul, Wirongrong/AAC-3226-2020; Paris, Daniel/AFV-4762-2022; Paris, Daniel/GLN-7566-2022; Blacksell, Stuart/D-5530-2018	Chierakul, Wirongrong/0000-0003-2103-9425; Blacksell, Stuart/0000-0001-6576-726X; PARIS, Daniel/0000-0003-4743-5987; Limmathurotsakul, Direk/0000-0001-7240-5320; Cooper, Ben/0000-0002-9445-7217; Lim, Cherry/0000-0003-2555-6980	Wellcome Trust [100484/Z/12Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust [100484/Z/12Z]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blacksell SD, 2007, CLIN INFECT DIS, V44, P391, DOI 10.1086/510585; Blacksell SD, 2012, CLIN VACCINE IMMUNOL, V19, P391, DOI 10.1128/CVI.05478-11; Blacksell SD, 2010, AM J TROP MED HYG, V83, P365, DOI 10.4269/ajtmh.2010.09-0534; Ching WM, 2001, CLIN DIAGN LAB IMMUN, V8, P409, DOI 10.1128/CDLI.8.2.409-414.2001; Ching WM, 1998, CLIN DIAGN LAB IMMUN, V5, P519, DOI 10.1128/CDLI.5.4.519-526.1998; Choi YJ, 2005, EMERG INFECT DIS, V11, P237, DOI 10.3201/eid1102.040603; Coleman RE, 2002, AM J TROP MED HYG, V67, P497, DOI 10.4269/ajtmh.2002.67.497; Dendukuri N, 2001, BIOMETRICS, V57, P158, DOI 10.1111/j.0006-341X.2001.00158.x; Horinouchi H, 1996, AM J TROP MED HYG, V54, P647, DOI 10.4269/ajtmh.1996.54.647; Jiang J, 2004, AM J TROP MED HYG, V70, P351, DOI 10.4269/ajtmh.2004.70.351; JOSEPH L, 1995, AM J EPIDEMIOL, V141, P263, DOI 10.1093/oxfordjournals.aje.a117428; Kim DM, 2007, AM J TROP MED HYG, V76, P806; Kim DM, 2011, J CLIN MICROBIOL, V49, P607, DOI 10.1128/JCM.01216-09; Koh GCKW, 2010, AM J TROP MED HYG, V82, P368, DOI 10.4269/ajtmh.2010.09-0233; Lim C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079489; Limmathurotsakul D, 2012, CLIN INFECT DIS, V55, P322, DOI 10.1093/cid/cis403; Limmathurotsakul D, 2011, CLIN INFECT DIS, V52, P1024, DOI 10.1093/cid/cir080; Limmathurotsakul D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012485; Liu YX, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-82; Luksameetanasan Rungnapa, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P91; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Paris DH, 2009, CLIN MICROBIOL INFEC, V15, P488, DOI 10.1111/j.1469-0691.2008.02671.x; Paris DH, 2008, T ROY SOC TROP MED H, V102, P186, DOI 10.1016/j.trstmh.2007.11.001; Paris DH, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001307; Parola P, 2003, EMERG INFECT DIS, V9, P592, DOI 10.3201/eid0905.020511; Phetsouvanh R, 2013, AM J TROP MED HYG, V88, P932, DOI 10.4269/ajtmh.12-0325; Phommasone K, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002163; Phongmany S, 2006, EMERG INFECT DIS, V12, P256; Prakash JAJ, 2011, INDIAN J MED MICROBI, V29, P47, DOI 10.4103/0255-0857.76524; Reisner BS, 1999, AM J CLIN PATHOL, V111, P503; Shiao CC, 2011, CAN MED ASSOC J, V183, pE1152, DOI 10.1503/cmaj.101929; Sonthayanon P, 2013, AM J TROP MED HYG, V89, P797, DOI 10.4269/ajtmh.13-0402; Tay S. T., 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P171; Thap Lon Chan, 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P780; Trikalinos TA, 2012, OPTIONS SUMMARIZING; Wang CC, 2007, AM J TROP MED HYG, V76, P1148, DOI 10.4269/ajtmh.2007.76.1148; Yasunaga H, 2011, INTERNAL MED, V50, P37, DOI 10.2169/internalmedicine.50.4220; Zhuo X, 2008, STAT METHODS DIAGNOS, P359	38	43	43	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0114930	10.1371/journal.pone.0114930	http://dx.doi.org/10.1371/journal.pone.0114930			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024375	Green Submitted, gold, Green Published			2022-12-26	WOS:000355319400001
J	Kumagai, H; Ikeda, Y; Motozawa, Y; Fujishiro, M; Okamura, T; Fujio, K; Okazaki, H; Nomura, S; Takeda, N; Harada, M; Toko, H; Takimoto, E; Akazawa, H; Morita, H; Suzuki, J; Yamazaki, T; Yamamoto, K; Komuro, I; Yanagisawa, M				Kumagai, Hidetoshi; Ikeda, Yuichi; Motozawa, Yoshihiro; Fujishiro, Mitsuhiro; Okamura, Tomohisa; Fujio, Keishi; Okazaki, Hiroaki; Nomura, Seitaro; Takeda, Norifumi; Harada, Mutsuo; Toko, Haruhiro; Takimoto, Eiki; Akazawa, Hiroshi; Morita, Hiroyuki; Suzuki, Jun-ichi; Yamazaki, Tsutomu; Yamamoto, Kazuhiko; Komuro, Issei; Yanagisawa, Masashi			Quantitative Measurement of GPCR Endocytosis via Pulse-Chase Covalent Labeling	PLOS ONE			English	Article							MU-OPIOID RECEPTOR; PROTEIN-ANALYSIS; IN-VIVO; INTERNALIZATION; TRAFFICKING; TECHNOLOGY; MOUSE	G protein-coupled receptors (GPCRs) play a critical role in many physiological systems and represent one of the largest families of signal-transducing receptors. The number of GPCRs at the cell surface regulates cellular responsiveness to their cognate ligands, and the number of GPCRs, in turn, is dynamically controlled by receptor endocytosis. Recent studies have demonstrated that GPCR endocytosis, in addition to affecting receptor desensitization and resensitization, contributes to acute G protein-mediated signaling. Thus, endocytic GPCR behavior has a significant impact on various aspects of physiology. In this study, we developed a novel GPCR internalization assay to facilitate characterization of endocytic GPCR behavior. We genetically engineered chimeric GPCRs by fusing HaloTag (a catalytically inactive derivative of a bacterial hydrolase) to the N-terminal end of the receptor (HT-GPCR). HaloTag has the ability to form a stable covalent bond with synthetic HaloTag ligands that contain fluorophores or a high-affinity handle (such as biotin) and the HaloTag reactive linker. We selectively labeled HT-GPCRs at the cell surface with a HaloTag PEG ligand, and this pulse-chase covalent labeling allowed us to directly monitor the relative number of internalized GPCRs after agonist stimulation. Because the endocytic activities of GPCR ligands are not necessarily correlated with their agonistic activities, applying this novel methodology to orphan GPCRs, or even to already characterized GPCRs, will increase the likelihood of identifying currently unknown ligands that have been missed by conventional pharmacological assays.	[Kumagai, Hidetoshi; Ikeda, Yuichi; Motozawa, Yoshihiro; Nomura, Seitaro; Takeda, Norifumi; Harada, Mutsuo; Toko, Haruhiro; Takimoto, Eiki; Akazawa, Hiroshi; Morita, Hiroyuki; Komuro, Issei] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo, Japan; [Kumagai, Hidetoshi; Ikeda, Yuichi; Yanagisawa, Masashi] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dept Mol Genet, Dallas, TX 75390 USA; [Kumagai, Hidetoshi; Suzuki, Jun-ichi] Univ Tokyo, Dept Adv Clin Sci & Therapeut, Tokyo, Japan; [Fujishiro, Mitsuhiro] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan; [Okamura, Tomohisa; Fujio, Keishi] Univ Tokyo, Grad Sch Med, Dept Allergy & Rheumatol, Tokyo, Japan; [Okamura, Tomohisa] Univ Tokyo, Max Plank Ctr Integrat Inflammol, Tokyo, Japan; [Okazaki, Hiroaki] Univ Tokyo, Grad Sch Med, Dept Diabet & Metab Dis, Tokyo, Japan; [Yamazaki, Tsutomu] Univ Tokyo, Clin Res Support Ctr, Tokyo, Japan; [Yanagisawa, Masashi] Univ Tsukuba, Int WPI IIIS, Tsukuba, Ibaraki, Japan	University of Tokyo; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; University of Tsukuba	Kumagai, H (corresponding author), Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo, Japan.	hdtshkmg@gmail.com	Takimoto, Eiki/AAC-5100-2021; 藤城, 光弘/AAN-3131-2020	Akazawa, Hiroshi/0000-0002-3574-9607; TAKEDA, NORIFUMI/0000-0003-4818-3347	Howard Hughes Medical Institute; Perot Family Foundation; Exploratory Research for Advanced Technology of Japan Science and Technology Corporation (ERATO);  [14463492]	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Perot Family Foundation; Exploratory Research for Advanced Technology of Japan Science and Technology Corporation (ERATO); 	This research was supported by the Howard Hughes Medical Institute, the Perot Family Foundation, Exploratory Research for Advanced Technology of Japan Science and Technology Corporation (ERATO) (to MY), and Grant-in-Aid for Scientific Research C (# 14463492) (to HK).	Audet M, 2012, CELL, V151, P14, DOI 10.1016/j.cell.2012.09.003; Enquist J, 2011, J PHARMACOL EXP THER, V338, P633, DOI 10.1124/jpet.111.179754; Keith DE, 1998, MOL PHARMACOL, V53, P377, DOI 10.1124/mol.53.3.377; Keith DE, 1996, J BIOL CHEM, V271, P19021, DOI 10.1074/jbc.271.32.19021; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kotowski SJ, 2011, NEURON, V71, P278, DOI 10.1016/j.neuron.2011.05.036; Los GV, 2008, ACS CHEM BIOL, V3, P373, DOI 10.1021/cb800025k; Los GV, 2007, METH MOL B, V356, P195; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Salahpour A, 2011, METHODS MOL BIOL, V756, P311, DOI 10.1007/978-1-61779-160-4_18; Scherrer G, 2006, P NATL ACAD SCI USA, V103, P9691, DOI 10.1073/pnas.0603359103; Shenoy SK, 2003, BIOCHEM J, V375, P503, DOI 10.1042/BJ20031076; Sternini C, 1996, P NATL ACAD SCI USA, V93, P9241, DOI 10.1073/pnas.93.17.9241; Tsvetanova NG, 2014, NAT CHEM BIOL, V10, P1061, DOI 10.1038/nchembio.1665; Vassilatis DK, 2003, P NATL ACAD SCI USA, V100, P4903, DOI 10.1073/pnas.0230374100; von Zastrow M, 2012, NEURON, V76, P22, DOI 10.1016/j.neuron.2012.09.022	16	7	7	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0129394	10.1371/journal.pone.0129394	http://dx.doi.org/10.1371/journal.pone.0129394			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020647	Green Published, Green Submitted, gold			2022-12-26	WOS:000355187300126
J	Tao, H; Yan, J; Zhao, JW; Tian, YQ; Jin, ZY; Xu, XM				Tao, Han; Yan, Juan; Zhao, Jianwei; Tian, Yaoqi; Jin, Zhengyu; Xu, Xueming			Effect of Multiple Freezing/Thawing Cycles on the Structural and Functional Properties of Waxy Rice Starch	PLOS ONE			English	Article							IN-VITRO DIGESTIBILITY; PHYSICOCHEMICAL PROPERTIES; RHEOLOGICAL PROPERTIES; CEREAL STARCHES; AMYLOSE CONTENT; DAMAGED STARCH; CHAIN-LENGTH; MAIZE STARCH; WHEAT-STARCH; GELATINIZATION	The structural and functional properties of non-gelatinized waxy rice starch were investigated after 1, 3, 7, and 10 freezing/thawing cycles. Freezing caused an increasing damaged starch from 1.36% in native waxy rice starch to 5.77% in 10 freezing/thawing-treated starch (FTS), as evidenced by the cracking surface on starch granules. More dry matter concentration was leached, which was characterized by high amylopectin concentration (4.34 mg/mL). The leaching was accompanied by a decrease in relative crystallinity from 35.19% in native starch to 31.34% in 10 FTS. Freezing treatment also led to significant deviations in the functional characteristics, for instance decreased gelatinization temperature range, enthalpy, and pasting viscosities. The resistant starch content of 10FTS significantly decreased from 58.9% to 19%, whereas the slowly digested starch content greatly increased from 23.8% in native starch to 50.3%. The increase in susceptibility to enzyme hydrolysis may be attributed to porous granular surface, amylopectin leaching, and the decrease in the relative crystallinity caused by freezing water.	[Tao, Han; Yan, Juan; Zhao, Jianwei; Jin, Zhengyu; Xu, Xueming] Jiangnan Univ, Sch Food Sci & Technol, Wuxi, Peoples R China; [Tian, Yaoqi; Jin, Zhengyu] Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi, Peoples R China; [Xu, Xueming] Jiangnan Univ, Synerget Innovat Ctr Food Safety & Nutr, Wuxi, Jiangsu, Peoples R China	Jiangnan University; Jiangnan University; Jiangnan University	Xu, XM (corresponding author), Jiangnan Univ, Sch Food Sci & Technol, Wuxi, Peoples R China.	xmxu@jiangnan.edu.cn	Tian, Yaoqi/E-7493-2010	Tian, Yaoqi/0000-0001-5693-8872	National "Twelfth Five-Year" Plan for Science & Technology Support of China [2012BAD37B06, 2012BAD37B07]; graduate student innovation project of Jiangsu province [KYLX_1165]	National "Twelfth Five-Year" Plan for Science & Technology Support of China; graduate student innovation project of Jiangsu province	This work was supported by the National "Twelfth Five-Year" Plan for Science & Technology Support of China (Nos. 2012BAD37B06 & 2012BAD37B07), and the graduate student innovation project of Jiangsu province (KYLX_1165).	American Association of Cereal Chemists, 2000, APPR METH AM ASS CER, V10th ed.; Anon M. C., 2004, Handbook of frozen foods, P571; AOAC, 1995, OFFICIAL METHODS ANA, V16th; Barrera GN, 2013, J FOOD ENG, V116, P233, DOI 10.1016/j.jfoodeng.2012.11.020; Cheetham NWH, 1998, CARBOHYD POLYM, V36, P277, DOI 10.1016/S0144-8617(98)00007-1; Chung HJ, 2006, J CEREAL SCI, V43, P353, DOI 10.1016/j.jcs.2005.12.001; Chung HJ, 2011, FOOD HYDROCOLLOID, V25, P968, DOI 10.1016/j.foodhyd.2010.09.011; COLONNA P, 1992, EUR J CLIN NUTR, V46, pS17; de la Hera E, 2013, CARBOHYD POLYM, V98, P421, DOI 10.1016/j.carbpol.2013.06.002; Giannou V, 2003, TRENDS FOOD SCI TECH, V14, P99, DOI 10.1016/S0924-2244(02)00278-9; GIDLEY MJ, 1987, CARBOHYD RES, V161, P291, DOI 10.1016/S0008-6215(00)90086-7; Goesaert H, 2005, TRENDS FOOD SCI TECH, V16, P12, DOI 10.1016/j.tifs.2004.02.011; Jacobson MR, 1998, CEREAL CHEM, V75, P22, DOI 10.1094/CCHEM.1998.75.1.22; Jane J, 1999, CEREAL CHEM, V76, P629, DOI 10.1094/CCHEM.1999.76.5.629; KOMIYA T, 1986, STARCH-STARKE, V38, P9, DOI 10.1002/star.19860380104; Leray G, 2010, J FOOD ENG, V100, P70, DOI 10.1016/j.jfoodeng.2010.03.029; Li EP, 2014, STARCH-STARKE, V66, P15, DOI 10.1002/star.201200224; Lorenzo G, 2009, J CEREAL SCI, V50, P255, DOI 10.1016/j.jcs.2009.06.003; Marston P, 1978, BAKERS DIG; Mezaize S, 2010, FOOD RES INT, V43, P2186, DOI 10.1016/j.foodres.2010.07.030; Meziani S, 2011, J FOOD ENG, V107, P358, DOI 10.1016/j.jfoodeng.2011.07.003; MORRISON WR, 1994, J CEREAL SCI, V20, P69, DOI 10.1006/jcrs.1994.1046; Pomeranz Y., 1971, WHEAT CHEM TECHNOL, V3, P385; Srichuwong S, 2007, FOOD SCI BIOTECHNOL, V16, P663; Szymonska J, 2000, INT J BIOL MACROMOL, V27, P307, DOI 10.1016/S0141-8130(00)00137-9; Szymonska J, 2005, FOOD HYDROCOLLOID, V19, P753, DOI 10.1016/j.foodhyd.2004.08.004; TESTER RF, 1990, CEREAL CHEM, V67, P551; Tester RF, 2004, J CEREAL SCI, V39, P151, DOI 10.1016/j.jcs.2003.12.001; TESTER RF, 1990, CEREAL CHEM, V67, P558; Wang SJ, 2014, J AGR FOOD CHEM, V62, P3636, DOI 10.1021/jf500249w; Warren FJ, 2011, CARBOHYD POLYM, V86, P1038, DOI 10.1016/j.carbpol.2011.05.062; Wei BX, 2013, INT J BIOL MACROMOL, V62, P652, DOI 10.1016/j.ijbiomac.2013.10.008; You SY, 2014, CARBOHYD POLYM, V112, P729, DOI 10.1016/j.carbpol.2014.06.065; Yu SF, 2010, LWT-FOOD SCI TECHNOL, V43, P1138, DOI 10.1016/j.lwt.2010.03.004	34	22	22	3	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0127138	10.1371/journal.pone.0127138	http://dx.doi.org/10.1371/journal.pone.0127138			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018506	gold, Green Published, Green Submitted			2022-12-26	WOS:000355185600071
J	Moncla, BJ; Chappell, CA; Mahal, LK; Debo, BM; Meyn, LA; Hillier, SL				Moncla, Bernard J.; Chappell, Catherine A.; Mahal, Lara K.; Debo, Brian M.; Meyn, Leslie A.; Hillier, Sharon L.			Impact of Bacterial Vaginosis, as Assessed by Nugent Criteria and Hormonal Status on Glycosidases and Lectin Binding in Cervicovaginal Lavage Samples	PLOS ONE			English	Article							RAPID PRESUMPTIVE IDENTIFICATION; SIALIDASE NEURAMINIDASE ACTIVITY; GARDNERELLA-VAGINALIS; MUCINS; EXPRESSION; IGA; OLIGOSACCHARIDES; DESIALYLATION; PATHOGENESIS; BARRIER	The objective of this study was to evaluate the impact of hormonal status and bacterial vaginosis (BV) on the glycosidases present and glycosylation changes as assessed by lectin binding to cervicovaginal lavage constituents. Frozen cervicovaginal lavage samples from a completed study examining the impact of reproductive hormones on the physicochemical properties of vaginal fluid were utilized for the present study. In the parent study, 165 women were characterized as having BV, intermediate or normal microflora using the Nugent criteria. The presence of glycosidases in the samples was determined using quantitative 4-methyl-umbelliferone based assays, and glycosylation was assessed using enzyme linked lectin assays (ELLA). Women with BV had elevated sialidase, alpha-galactosidase, beta-galactosidase and alpha-glucosidase activities compared to intermediate or normal women (P< 0.001, 0.003, 0.006 and 0.042 respectively). The amount of sialic acid (Sambucus nigra, P = 0.003) and high mannose (griffithsin, P< 0.001) were reduced, as evaluated by lectin binding, in women with BV. When the data were stratified according to hormonal status, alpha-glucosidase and griffithsin binding were decreased among postmenopausal women (P< 0.02) when compared to premenopausal groups. These data suggest that both hormonal status and BV impact the glycosidases and lectin binding sites present in vaginal fluid. The sialidases present at increased levels in women with BV likely reduce the number of sialic acid binding sites. Other enzymes likely reduce griffithsin binding. The alterations in the glycosidase content, high mannose and sialic acid binding sites in the cervicovaginal fluid associated with bacterial vaginosis may impact susceptibility to viruses, such as HIV, that utilize glycans as a portal of entry.	[Moncla, Bernard J.; Chappell, Catherine A.; Hillier, Sharon L.] Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15260 USA; [Moncla, Bernard J.; Meyn, Leslie A.; Hillier, Sharon L.] Magee Womens Res Inst, Pittsburgh, PA USA; [Mahal, Lara K.] NYU, Dept Chem, Inst Biomed Chem, New York, NY 10003 USA; [Debo, Brian M.] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; New York University; University of Pennsylvania	Moncla, BJ (corresponding author), Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15260 USA.	bjm4@pitt.edu	Mahal, Lara/GRY-7287-2022	Mahal, Lara/0000-0003-4791-8524	National Institutes of Health [U19AI082639]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI082639] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant U19AI082639.	Andersch-Bjorkman Y, 2007, MOL CELL PROTEOMICS, V6, P708, DOI 10.1074/mcp.M600439-MCP200; ANT J, 1991, Journal of Dental Research, V70, P584; AUDIE JP, 1995, HUM REPROD, V10, P98, DOI 10.1093/humrep/10.1.98; Bai XM, 2001, GLYCOBIOLOGY, V11, P621, DOI 10.1093/glycob/11.8.621; BRAHAM PH, 1992, J CLIN MICROBIOL, V30, P649, DOI 10.1128/JCM.30.3.649-654.1992; BRISELDEN AM, 1992, J CLIN MICROBIOL, V30, P663, DOI 10.1128/JCM.30.3.663-666.1992; Carson DD, 1998, HUM REPROD UPDATE, V4, P459, DOI 10.1093/humupd/4.5.459; Cauci S, 1998, AM J OBSTET GYNECOL, V178, P511, DOI 10.1016/S0002-9378(98)70430-2; Cauci S, 1998, J INFECT DIS, V178, P1698, DOI 10.1086/314505; Cauci S, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.08.061; Cauci S, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.05.035; Chappell CA, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.03.041; Cone RA, 2009, ADV DRUG DELIVER REV, V61, P75, DOI 10.1016/j.addr.2008.09.008; Corfield AP, 2015, BBA-GEN SUBJECTS, V1850, P236, DOI 10.1016/j.bbagen.2014.05.003; CORFIELD AP, 1992, INFECT IMMUN, V60, P3971, DOI 10.1128/IAI.60.10.3971-3978.1992; ENGEL LD, 1988, J PERIODONTOL, V59, P841, DOI 10.1902/jop.1988.59.12.841; GEYER H, 1988, J BIOL CHEM, V263, P11760; Gipson IK, 1999, BIOL REPROD, V60, P58, DOI 10.1095/biolreprod60.1.58; Gipson IK, 2001, FRONT BIOSCI-LANDMRK, V6, pD1245, DOI 10.2741/Gipson; HOADLEY ME, 1990, BIOCHEM J, V266, P757, DOI 10.1042/bj2660757; HOMER KA, 1994, J MED MICROBIOL, V41, P184, DOI 10.1099/00222615-41-3-184; Homer KA, 2001, J CLIN MICROBIOL, V39, P995, DOI 10.1128/JCM.39.3.995-1001.2001; Howe L, 1999, INT J STD AIDS, V10, P442, DOI 10.1258/0956462991914438; Hunter RHF, 2011, J ASSIST REPROD GEN, V28, P191, DOI 10.1007/s10815-010-9531-3; Keller MJ, 2012, JAIDS-J ACQ IMM DEF, V61, P194, DOI 10.1097/QAI.0b013e31826867ae; King SJ, 2006, MOL MICROBIOL, V59, P961, DOI 10.1111/j.1365-2958.2005.04984.x; Kutteh WH, 1996, CLIN EXP IMMUNOL, V104, P538, DOI 10.1046/j.1365-2249.1996.36742.x; Lewis WG, 2012, J BIOL CHEM, V287, P2079, DOI 10.1074/jbc.M111.278135; Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MCGREGOR JA, 1994, AM J OBSTET GYNECOL, V170, P1048, DOI 10.1016/S0002-9378(94)70098-2; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; Moncla BJ, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-78; MONCLA BJ, 1991, J CLIN MICROBIOL, V29, P1955, DOI 10.1128/JCM.29.9.1955-1958.1991; MONCLA BJ, 1989, J CLIN MICROBIOL, V27, P182, DOI 10.1128/JCM.27.1.182-184.1989; MONCLA BJ, 1990, J CLIN MICROBIOL, V28, P422, DOI 10.1128/JCM.28.3.422-425.1990; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Pluta K, 2012, PHYSIOL GENOMICS, V44, P1165, DOI 10.1152/physiolgenomics.00088.2012; Rose MC, 2006, PHYSIOL REV, V86, P245, DOI 10.1152/physrev.00010.2005; Schauer R, 2009, CURR OPIN STRUC BIOL, V19, P507, DOI 10.1016/j.sbi.2009.06.003; Srinivasan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037818; Srinivasan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010197; Srinivasan Sujatha, 2008, Interdiscip Perspect Infect Dis, V2008, P750479, DOI 10.1155/2008/750479; Stamatos NM, 1997, VIROLOGY, V228, P123, DOI 10.1006/viro.1996.8373; Stamatos NM, 2004, J LEUKOCYTE BIOL, V75, P307, DOI 10.1189/jlb.0503241; Traving C, 1998, CELL MOL LIFE SCI, V54, P1330, DOI 10.1007/s000180050258; Varki A., 2009, ESSENTIALS GLYCOBIOL; Vogel I, 2003, INT J GYNECOL OBSTET, V83, P307, DOI 10.1016/S0020-7292(03)00268-6; Wang L, 2015, PLOS ONE IN PRESS; Wiggins R, 2001, SEX TRANSM INFECT, V77, P402, DOI 10.1136/sti.77.6.402; YUREWICZ EC, 1987, J BIOL CHEM, V262, P4733	51	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127091	10.1371/journal.pone.0127091	http://dx.doi.org/10.1371/journal.pone.0127091			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011704	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000355183900061
J	Zhang, XL; Guariglia, SR; McGlothan, JL; Stansfield, KH; Stanton, PK; Guilarte, TR				Zhang, Xiao-lei; Guariglia, Sara R.; McGlothan, Jennifer L.; Stansfield, Kirstie H.; Stanton, Patric K.; Guilarte, Tomas R.			Presynaptic Mechanisms of Lead Neurotoxicity: Effects on Vesicular Release, Vesicle Clustering and Mitochondria Number	PLOS ONE			English	Article							LONG-TERM POTENTIATION; SCHAFFER COLLATERAL-CA1 SYNAPSES; PROBABILITY FLUCTUATION ANALYSIS; GABAERGIC TRANSMISSION; SYNAPTIC-TRANSMISSION; EXPOSURE; DEPRESSION; GLUTAMATE; DEFICITS; PB2+	Childhood lead (Pb2+) intoxication is a global public health problem and accounts for 0.6% of the global burden of disease associated with intellectual disabilities. Despite the recognition that childhood Pb2+ intoxication contributes significantly to intellectual disabilities, there is a fundamental lack of knowledge on presynaptic mechanisms by which Pb2+ disrupts synaptic function. In this study, using a well-characterized rodent model of developmental Pb2+ neurotoxicity, we show that Pb2+ exposure markedly inhibits presynaptic vesicular release in hippocampal Schaffer collateral-CA1 synapses in young adult rats. This effect was associated with ultrastructural changes which revealed a reduction in vesicle number in the readily releasable/docked vesicle pool, disperse vesicle clusters in the resting pool, and a reduced number of presynaptic terminals with multiple mitochondria with no change in presynaptic calcium influx. These studies provide fundamental knowledge on mechanisms by which Pb2+ produces profound inhibition of presynaptic vesicular release that contribute to deficits in synaptic plasticity and intellectual development.	[Zhang, Xiao-lei; Stanton, Patric K.] New York Med Coll, Dept Cell Biol & Anat, Valhalla, NY 10595 USA; [Guariglia, Sara R.; McGlothan, Jennifer L.; Stansfield, Kirstie H.; Guilarte, Tomas R.] Columbia Univ, Mailman Sch Publ Hlth, Dept Environm Hlth Sci, New York, NY 10027 USA	New York Medical College; Columbia University	Guilarte, TR (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Environm Hlth Sci, New York, NY 10027 USA.	trguilarte@columbia.edu		Dziedzic, Jennifer/0000-0001-5577-0262	National Institute of Environmental Health Sciences [ES006189, ES020465]; NIEHS Center for Environmental Health in Northern Manhattan [ES009089]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES006189, P30ES009089, R01ES020465] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS Center for Environmental Health in Northern Manhattan; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by grants ES006189 and ES020465 from the National Institute of Environmental Health Sciences to TRG. The authors also acknowledge support from the metals core facilities of the NIEHS Center for Environmental Health in Northern Manhattan grant number ES009089. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen P, 1967, Prog Brain Res, V27, P400; BELLINGER DC, 1992, PEDIATRICS, V90, P855; Braga MFM, 1999, BRAIN RES, V826, P10, DOI 10.1016/S0006-8993(99)01193-2; Braga MFM, 1999, BRAIN RES, V826, P22, DOI 10.1016/S0006-8993(99)01194-4; Brustein E, 2003, PFLUG ARCH EUR J PHY, V446, P766, DOI 10.1007/s00424-003-1138-4; Burgdorf J, 2013, NEUROPSYCHOPHARMACOL, V38, P729, DOI 10.1038/npp.2012.246; Bykhovskaia M, 2011, SEMIN CELL DEV BIOL, V22, P387, DOI 10.1016/j.semcdb.2011.07.003; Canfield RL, 2003, NEW ENGL J MED, V348, P1517, DOI 10.1056/NEJMoa022848; Cecil KM, 2008, PLOS MED, V5, P741, DOI 10.1371/journal.pmed.0050112; Clements JD, 2000, TRENDS NEUROSCI, V23, P105, DOI 10.1016/S0166-2236(99)01520-9; Denker Annette, 2010, Front Synaptic Neurosci, V2, P135, DOI 10.3389/fnsyn.2010.00135; Foster KA, 2004, NEURON, V43, P119, DOI 10.1016/j.neuron.2004.06.022; Guilarte TR, 2003, ANN NEUROL, V53, P50, DOI 10.1002/ana.10399; Jusko TA, 2008, ENVIRON HEALTH PERSP, V116, P243, DOI 10.1289/ehp.10424; Kuhlmann AC, 1997, NEUROSCI LETT, V233, P101, DOI 10.1016/S0304-3940(97)00633-2; Lanphear BP, 2005, ENVIRON HEALTH PERSP, V113, P894, DOI 10.1289/ehp.7688; Lasley SM, 2002, TOXICOL SCI, V66, P139, DOI 10.1093/toxsci/66.1.139; LI L, 1995, P NATL ACAD SCI USA, V92, P9235, DOI 10.1073/pnas.92.20.9235; Ly CV, 2006, NEUROSCIENTIST, V12, P291, DOI 10.1177/1073858406287661; McGlothan JL, 2008, NEUROTOXICOLOGY, V29, P1127, DOI 10.1016/j.neuro.2008.06.010; Neal AP, 2010, MOL NEUROBIOL, V42, P151, DOI 10.1007/s12035-010-8146-0; Neal AP, 2010, TOXICOL SCI, V116, P249, DOI 10.1093/toxsci/kfq111; Needleman H, 2004, ANNU REV MED, V55, P209, DOI 10.1146/annurev.med.55.091902.103653; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Nihei MK, 2000, NEUROSCIENCE, V99, P233, DOI 10.1016/S0306-4522(00)00192-5; Nikonenko AG, 2004, MICROSC RES TECHNIQ, V65, P287, DOI 10.1002/jemt.20134; Oleskevich S, 2000, J PHYSIOL-LONDON, V524, P513, DOI 10.1111/j.1469-7793.2000.00513.x; Pechstein A, 2011, FRONT SYNAPTIC NEURO, V2, P1; Peng SQ, 2002, MOL PHARMACOL, V62, P1418, DOI 10.1124/mol.62.6.1418; REGEHR WG, 1991, J NEUROSCI METH, V37, P111, DOI 10.1016/0165-0270(91)90121-F; Reid CA, 1999, J PHYSIOL-LONDON, V518, P121, DOI 10.1111/j.1469-7793.1999.0121r.x; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Saghatelyan AK, 2004, MOL CELL NEUROSCI, V26, P191, DOI 10.1016/j.mcn.2004.01.008; Schwartz BS, 2000, NEUROLOGY, V55, P1144, DOI 10.1212/WNL.55.8.1144; Shupliakov O, 2011, SEMIN CELL DEV BIOL, V22, P393, DOI 10.1016/j.semcdb.2011.07.006; Silver RA, 2003, J NEUROSCI METH, V130, P127, DOI 10.1016/j.jneumeth.2003.09.030; Silver RA, 1998, J PHYSIOL-LONDON, V510, P881, DOI 10.1111/j.1469-7793.1998.881bj.x; Stansfield K.H., 2015, TRANSL PSY; Stansfield KH, 2012, TOXICOL SCI, V127, P277, DOI 10.1093/toxsci/kfs090; Stanton PK, 2005, EUR J NEUROSCI, V22, P2451, DOI 10.1111/j.1460-9568.2005.04437.x; Stanton PK, 2003, J NEUROSCI, V23, P5936; Stewart WF, 2006, NEUROLOGY, V66, P1476, DOI 10.1212/01.wnl.0000216138.69777.15; Tong S, 2000, B WORLD HEALTH ORGAN, V78, P1068; Toscano CD, 2005, BRAIN RES REV, V49, P529, DOI 10.1016/j.brainresrev.2005.02.004; van Spronsen M, 2010, CURR NEUROL NEUROSCI, V10, P207, DOI 10.1007/s11910-010-0104-8; Verina T, 2007, NEUROSCIENCE, V145, P1037, DOI 10.1016/j.neuroscience.2006.12.040; Verstegen AMJ, 2014, J NEUROSCI, V34, P7266, DOI 10.1523/JNEUROSCI.3973-13.2014; Vos M, 2010, FRONT SYNAPTIC NEURO, V2, P1, DOI [10.3389/neuro.19.001.2010, DOI 10.3389/NEURO.19.001.2010]; Xiao C, 2006, BRAIN RES, V1088, P93, DOI 10.1016/j.brainres.2006.03.005; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039; Zhang XL, 2006, J NEUROSCI, V26, P10270, DOI 10.1523/JNEUROSCI.3091-06.2006; Zhang XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020500; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	53	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127461	10.1371/journal.pone.0127461	http://dx.doi.org/10.1371/journal.pone.0127461			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011056	Green Submitted, Green Published, gold			2022-12-26	WOS:000355183900095
J	Cahoon, RE; Lutke, WK; Cameron, JC; Chen, SX; Lee, SG; Rivard, RS; Rea, PA; Jez, JM				Cahoon, Rebecca E.; Lutke, W. Kevin; Cameron, Jeffrey C.; Chen, Sixue; Lee, Soon Goo; Rivard, Rebecca S.; Rea, Philip A.; Jez, Joseph M.			Adaptive Engineering of Phytochelatin-based Heavy Metal Tolerance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTAMATE-CYSTEINE LIGASE; N-TERMINAL DOMAIN; ARABIDOPSIS-THALIANA; GAMMA-GLUTAMYLCYSTEINE; INDIAN MUSTARD; CADMIUM TOLERANCE; GLUTATHIONE SYNTHETASE; FUNCTIONAL-PROPERTIES; NUCLEOTIDE-BINDING; KINETIC MECHANISM	Metabolic engineering approaches are increasingly employed for environmental applications. Because phytochelatins (PC) protect plants from heavy metal toxicity, strategies directed at manipulating the biosynthesis of these peptides hold promise for the remediation of soils and groundwaters contaminated with heavy metals. Directed evolution of Arabidopsis thaliana phytochelatin synthase (AtPCS1) yields mutants that confer levels of cadmium tolerance and accumulation greater than expression of the wild-type enzyme in Saccharomyces cerevisiae, Arabidopsis, or Brassica juncea. Surprisingly, the AtPCS1 mutants that enhance cadmium tolerance and accumulation are catalytically less efficient than wild-type enzyme. Metabolite analyses indicate that transformation with AtPCS1, but not with the mutant variants, decreases the levels of the PC precursors, glutathione and gamma-glutamylcysteine, upon exposure to cadmium. Selection of AtPCS1 variants with diminished catalytic activity alleviates depletion of these metabolites, which maintains redox homeostasis while supporting PC synthesis during cadmium exposure. These results emphasize the importance of metabolic context for pathway engineering and broaden the range of tools available for environmental remediation.	[Cahoon, Rebecca E.; Cameron, Jeffrey C.; Lee, Soon Goo; Jez, Joseph M.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Cahoon, Rebecca E.; Lutke, W. Kevin; Chen, Sixue; Rivard, Rebecca S.; Jez, Joseph M.] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA; [Chen, Sixue] Univ Florida, Genet Inst, Dept Biol, Gainesville, FL 32610 USA; [Rea, Philip A.; Jez, Joseph M.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	Washington University (WUSTL); Donald Danforth Plant Science Center; State University System of Florida; University of Florida; University of Pennsylvania	Jez, JM (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	jjez@biology2.wustl.edu	Lutke, Kevin/M-2846-2013; CHEN, SI/GZL-4800-2022		Enivironmental Protection Agency [EPA-X-83220101]; United States Department of Agriculture [NRI-2005-02518]; National Science Foundation [MCB-0904215]; Washington University iCARES	Enivironmental Protection Agency; United States Department of Agriculture(United States Department of Agriculture (USDA)); National Science Foundation(National Science Foundation (NSF)); Washington University iCARES	This work was supported by Enivironmental Protection Agency Grant EPA-X-83220101, United States Department of Agriculture Grant NRI-2005-02518, National Science Foundation Grant MCB-0904215, and Washington University iCARES (to J. M. J.). The authors declare that they have no conflicts of interest with the contents of this article.	Bick JA, 2001, BIOCHEMISTRY-US, V40, P9040, DOI 10.1021/bi010518v; Bizily SP, 2000, NAT BIOTECHNOL, V18, P213, DOI 10.1038/72678; Brunetti P, 2015, J EXP BOT, V66, P3815, DOI 10.1093/jxb/erv185; Cameron JC, 2010, PLANT PHYSIOL, V154, P1672, DOI 10.1104/pp.110.162990; Chia JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082675; Clemens S, 1999, EMBO J, V18, P3325, DOI 10.1093/emboj/18.12.3325; Clemens S, 2013, TRENDS PLANT SCI, V18, P92, DOI 10.1016/j.tplants.2012.08.003; Cobbett C, 2002, ANNU REV PLANT BIOL, V53, P159, DOI 10.1146/annurev.arplant.53.100301.135154; Dhankher OP, 2002, NAT BIOTECHNOL, V20, P1140, DOI 10.1038/nbt747; Gasic K, 2007, PLANT MOL BIOL, V64, P361, DOI 10.1007/s11103-007-9158-7; Gasic K, 2007, PLANTA, V225, P1277, DOI 10.1007/s00425-006-0421-y; GLEAVE AP, 1992, PLANT MOL BIOL, V20, P1203, DOI 10.1007/BF00028910; GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6; Gromes R, 2008, PLANT J, V54, P1063, DOI 10.1111/j.1365-313X.2008.03477.x; Ha SB, 1999, PLANT CELL, V11, P1153, DOI 10.1105/tpc.11.6.1153; Hicks LM, 2007, PLANT CELL, V19, P2653, DOI 10.1105/tpc.107.052597; Hothorn M, 2006, J BIOL CHEM, V281, P27557, DOI 10.1074/jbc.M602770200; HOWDEN R, 1995, PLANT PHYSIOL, V107, P1067, DOI 10.1104/pp.107.4.1067; HOWDEN R, 1995, PLANT PHYSIOL, V107, P1059, DOI 10.1104/pp.107.4.1059; Huang J, 2012, PLANT PHYSIOL, V158, P1779, DOI 10.1104/pp.111.192872; Jez JM, 2004, J BIOL CHEM, V279, P42726, DOI 10.1074/jbc.M407961200; Jez JM, 2004, J BIOL CHEM, V279, P33463, DOI 10.1074/jbc.M405127200; Jez JM, 2011, INT J PHYTOREMEDIAT, V13, P77, DOI 10.1080/15226514.2011.568537; Johnson MD, 2003, NAT MED, V9, P1081, DOI 10.1038/nm902; Lassner M, 2001, CURR OPIN PLANT BIOL, V4, P152, DOI 10.1016/S1369-5266(00)00152-7; Lee S, 2003, PLANT PHYSIOL, V131, P656, DOI 10.1104/pp.014118; Li YJ, 2004, PLANT CELL PHYSIOL, V45, P1787, DOI 10.1093/pcp/pch202; Li ZS, 1996, J BIOL CHEM, V271, P6509, DOI 10.1074/jbc.271.11.6509; Li ZS, 1997, P NATL ACAD SCI USA, V94, P42, DOI 10.1073/pnas.94.1.42; LOEFFLER S, 1989, FEBS LETT, V258, P42, DOI 10.1016/0014-5793(89)81611-4; Lu YP, 1997, P NATL ACAD SCI USA, V94, P8243, DOI 10.1073/pnas.94.15.8243; MEISTER A, 1995, METHOD ENZYMOL, V252, P26; Mendoza-Cozatl DG, 2010, J BIOL CHEM, V285, P40416, DOI 10.1074/jbc.M110.155408; Park J, 2012, PLANT J, V69, P278, DOI 10.1111/j.1365-313X.2011.04789.x; Pilon-Smits E, 2002, CRIT REV PLANT SCI, V21, P439, DOI 10.1080/0735-260291044313; Pomponi M, 2006, PLANTA, V223, P180, DOI 10.1007/s00425-005-0073-3; Ravilious GE, 2013, J BIOL CHEM, V288, P6107, DOI 10.1074/jbc.M112.439414; Ravilious GE, 2012, NAT PROD REP, V29, P1138, DOI 10.1039/c2np20009k; Ravilious GE, 2012, J BIOL CHEM, V287, P30385, DOI 10.1074/jbc.M112.387001; Ravilious GE, 2012, P NATL ACAD SCI USA, V109, P309, DOI 10.1073/pnas.1115772108; Rea PA, 2004, PLANT PHYSIOL, V136, P2463, DOI 10.1104/pp.104.048579; Rea PA, 2012, PHYSIOL PLANTARUM, V145, P154, DOI 10.1111/j.1399-3054.2012.01571.x; Romanyuk ND, 2006, PLANT PHYSIOL, V141, P858, DOI 10.1104/pp.106.082131; Rugh CL, 1996, P NATL ACAD SCI USA, V93, P3182, DOI 10.1073/pnas.93.8.3182; Ruotolo R, 2004, J BIOL CHEM, V279, P14686, DOI 10.1074/jbc.M314325200; Salt DE, 1998, ANNU REV PLANT PHYS, V49, P643, DOI 10.1146/annurev.arplant.49.1.643; Song WY, 2010, P NATL ACAD SCI USA, V107, P21187, DOI 10.1073/pnas.1013964107; Song WY, 2003, NAT BIOTECHNOL, V21, P914, DOI 10.1038/nbt850; Vatamaniuk OK, 2005, J BIOL CHEM, V280, P23684, DOI 10.1074/jbc.M503362200; Vatamaniuk OK, 2001, J BIOL CHEM, V276, P20817, DOI 10.1074/jbc.C100152200; Vatamaniuk OK, 2000, J BIOL CHEM, V275, P31451, DOI 10.1074/jbc.M002997200; Vatamaniuk OK, 1999, P NATL ACAD SCI USA, V96, P7110, DOI 10.1073/pnas.96.12.7110; Vatamaniuk OK, 2004, J BIOL CHEM, V279, P22449, DOI 10.1074/jbc.M313142200; Vivares D, 2005, P NATL ACAD SCI USA, V102, P18848, DOI 10.1073/pnas.0505833102; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Yi H, 2010, MOL PLANT, V3, P269, DOI 10.1093/mp/ssp112; Zhang M, 2012, J AM CHEM SOC, V134, P16979, DOI 10.1021/ja3078522; Zhu YL, 1999, PLANT PHYSIOL, V121, P1169, DOI 10.1104/pp.121.4.1169; Zhu YL, 1999, PLANT PHYSIOL, V119, P73, DOI 10.1104/pp.119.1.73	59	18	18	0	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17321	17330		10.1074/jbc.M115.652123	http://dx.doi.org/10.1074/jbc.M115.652123			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	26018077	hybrid, Green Published			2022-12-26	WOS:000357730900027
J	Steinke, KV; Gorinski, N; Wojciechowski, D; Todorov, V; Guseva, D; Ponimaskin, E; Fahlke, C; Fischer, M				Steinke, Kim Vanessa; Gorinski, Nataliya; Wojciechowski, Daniel; Todorov, Vladimir; Guseva, Daria; Ponimaskin, Evgeni; Fahlke, Christoph; Fischer, Martin			Human CLC-K Channels Require Palmitoylation of Their Accessory Subunit Barttin to Be Functional	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNDROME TYPE-IV; CHLORIDE CHANNELS; SENSORINEURAL DEAFNESS; BETA-SUBUNIT; SURFACE EXPRESSION; SODIUM-CHANNELS; BSND GENE; KIDNEY; TRAFFICKING; RECEPTOR	CLC-K/barttin chloride channels are essential for NaCl re-absorption in Henle's loop and for potassium secretion by the stria vascularis in the inner ear. Here, we studied the posttranslational modification of such channels by palmitoylation of their accessory subunit barttin. We found that barttin is palmitoylated in vivo and in vitro and identified two conserved cysteine residues at positions 54 and 56 as palmitoylation sites. Point mutations at these two residues reduce the macroscopic current amplitudes in cells expressing CLC-K/barttin channels proportionally to the relative reduction in palmitoylated barttin. CLCK/barttin expression, plasma membrane insertion, and single channel properties remain unaffected, indicating that these mutations decrease the number of active channels. R8W and G47R, two naturally occurring barttin mutations identified in patients with Bartter syndrome type IV, reduce barttin palmitoylation and CLC-K/barttin channel activity. Palmitoylation of the accessory subunit barttin might thus play a role in chloride channel dysfunction in certain variants of Bartter syndrome. We did not observe pronounced alteration of barttin palmitoylation upon increased salt and water intake or water deprivation, indicating that this posttranslational modification does not contribute to long term adaptation to variable water intake. Our results identify barttin palmitoylation as a novel posttranslational modification of CLC-K/barttin chloride channels.	[Steinke, Kim Vanessa; Gorinski, Nataliya; Wojciechowski, Daniel; Guseva, Daria; Ponimaskin, Evgeni; Fischer, Martin] Hannover Med Sch, Inst Neurophysiol, D-30625 Hannover, Germany; [Wojciechowski, Daniel; Fahlke, Christoph] FZ Julich, Inst Complex Syst, Zellulare Biophys ICS 4, D-52428 Julich, Germany; [Todorov, Vladimir] Univ Hosp Dresden, Div Nephrol, Lab Expt Nephrol, D-01307 Dresden, Germany	Hannover Medical School; Technische Universitat Dresden; Carl Gustav Carus University Hospital	Fahlke, C (corresponding author), FZ Julich, Inst Complex Syst, Zellulare Biophys ICS 4, Leo Brandt Str, D-52428 Julich, Germany.	c.fahlke@fz-juelich.de; fischer.martin@mh-hannover.de	Guseva, Daria/AAW-2546-2021; Fahlke, Christoph/G-3635-2013; Guseva, Daria/S-8582-2018	Fahlke, Christoph/0000-0001-8602-9952; Todorov, Vladimir/0000-0002-7011-8130; Ponimaskin, evgeni/0000-0002-4570-5130; Guseva, PD, PhD, Daria/0000-0002-8844-572X	Deutsche Forschungsgemeinschaft [FA301/10, PO732]; Cluster of Excellence REBIRTH	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cluster of Excellence REBIRTH	This work was supported by Deutsche Forschungsgemeinschaft Grants FA301/10 (to Ch. F.) and PO732 (to E. P.) and by Cluster of Excellence REBIRTH. (A preliminary account was presented at the 91st Annual Meeting of the Deutsche Physiologische Gesellschaft (DPG), March 22-25, 2012, Dresden, Germany (Steinke, K. V., Gorinski, N., Wojciechowski, D., Ponimaskin, E., Fischer, M., and Fahlke, Ch. (2012) Acta Physiol. 204, Suppl. 689 (Abstr. P262)). The authors declare that they have no conflicts of interest with the contents of this article.	Alekov AK, 2009, J GEN PHYSIOL, V133, P485, DOI 10.1085/jgp.200810155; Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Baekkeskov S, 2009, MOL MEMBR BIOL, V26, P42, DOI 10.1080/09687680802680108; Birkenhager R, 2001, NAT GENET, V29, P310, DOI 10.1038/ng752; Bosmans F, 2011, P NATL ACAD SCI USA, V108, P20213, DOI 10.1073/pnas.1108497108; Brum S, 2007, NEPHROL DIAL TRANSPL, V22, P288, DOI 10.1093/ndt/gfl493; Chamberlain LH, 2013, BIOCHEM SOC T, V41, P62, DOI 10.1042/BST20120243; Charollais J, 2009, MOL MEMBR BIOL, V26, P55, DOI 10.1080/09687680802620369; Chien AJ, 1996, J BIOL CHEM, V271, P26465, DOI 10.1074/jbc.271.43.26465; Davda D, 2013, ACS CHEM BIOL, V8, P1912, DOI 10.1021/cb400380s; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Estevez R, 2001, NATURE, V414, P558, DOI 10.1038/35107099; Fahlke C, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00155; Fischer M, 2010, J AM SOC NEPHROL, V21, P1281, DOI 10.1681/ASN.2009121274; Garcia-Nieto V, 2006, PEDIATR NEPHROL, V21, P643, DOI 10.1007/s00467-006-0062-1; Hanwell D, 2002, J BIOL CHEM, V277, P9772, DOI 10.1074/jbc.M110904200; Hautmann M, 2007, J AM SOC NEPHROL, V18, P1150, DOI 10.1681/ASN.2006060633; Hayama A, 2003, HISTOCHEM CELL BIOL, V119, P485, DOI 10.1007/s00418-003-0535-2; Hayashi T, 2005, NEURON, V47, P709, DOI 10.1016/j.neuron.2005.06.035; Hayashi T, 2009, NEURON, V64, P213, DOI 10.1016/j.neuron.2009.08.017; Hebeisen S, 2005, BIOPHYS J, V89, P1710, DOI 10.1529/biophysj.104.056093; Ho GPH, 2011, NEURON, V71, P131, DOI 10.1016/j.neuron.2011.05.033; Imbrici P, 2014, BBA-BIOMEMBRANES, V1838, P2484, DOI 10.1016/j.bbamem.2014.05.017; Janssen AGH, 2009, J AM SOC NEPHROL, V20, P145, DOI 10.1681/ASN.2008010102; Jeck N, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.1.e5; Jeffries O, 2010, J BIOL CHEM, V285, P33307, DOI 10.1074/jbc.M110.153940; Jentsch TJ, 2008, CRIT REV BIOCHEM MOL, V43, P3, DOI [10.1080/10409230701829110, 10.1080/10409230701829110 ]; Kandasamy SK, 2006, BIOPHYS J, V90, P2326, DOI 10.1529/biophysj.105.073395; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; KIEFERLE S, 1994, P NATL ACAD SCI USA, V91, P6943, DOI 10.1073/pnas.91.15.6943; LANDAU D, 1995, AM J MED GENET, V59, P454, DOI 10.1002/ajmg.1320590411; Matsumura Y, 1999, NAT GENET, V21, P95, DOI 10.1038/5036; Miyamura N, 2003, J CLIN ENDOCR METAB, V88, P781, DOI 10.1210/jc.2002-021398; Nothmann D, 2011, J BIOL CHEM, V286, P3935, DOI 10.1074/jbc.M110.187492; Park CW, 2011, CLIN NEPHROL, V75, pS69, DOI 10.2379/CN106509; Ponimaskin EG, 2002, J BIOL CHEM, V277, P2534, DOI 10.1074/jbc.M106529200; Qin N, 1998, P NATL ACAD SCI USA, V95, P4690, DOI 10.1073/pnas.95.8.4690; Renner U, 2007, MOL PHARMACOL, V72, P502, DOI 10.1124/mol.107.037085; Riazuddin S, 2009, AM J HUM GENET, V85, P273, DOI 10.1016/j.ajhg.2009.07.003; Rocks O, 2010, CELL, V141, P458, DOI 10.1016/j.cell.2010.04.007; Schlingmann KP, 2004, NEW ENGL J MED, V350, P1314, DOI 10.1056/NEJMoa032843; Scholl U, 2006, P NATL ACAD SCI USA, V103, P11411, DOI 10.1073/pnas.0601631103; Sesti F, 1998, J GEN PHYSIOL, V112, P651, DOI 10.1085/jgp.112.6.651; Shipston MJ, 2011, J BIOL CHEM, V286, P8709, DOI 10.1074/jbc.R110.210005; SIGWORTH FJ, 1977, NATURE, V270, P265, DOI 10.1038/270265a0; Simon DB, 1997, NAT GENET, V17, P171, DOI 10.1038/ng1097-171; Tajima M, 2007, BIOCHEM BIOPH RES CO, V362, P858, DOI 10.1016/j.bbrc.2007.08.097; TAUBER R, 1986, EMBO J, V5, P2109, DOI 10.1002/j.1460-2075.1986.tb04473.x; Tian LJ, 2008, P NATL ACAD SCI USA, V105, P21006, DOI 10.1073/pnas.0806700106; Uchida S, 2005, ANNU REV PHYSIOL, V67, P759, DOI 10.1146/annurev.physiol.67.032003.153547; Vandewalle A, 1997, AM J PHYSIOL-RENAL, V272, pF678, DOI 10.1152/ajprenal.1997.272.5.F678; Waldegger S, 2002, PFLUG ARCH EUR J PHY, V444, P411, DOI 10.1007/s00424-002-0819-8; Wan J, 2007, NAT PROTOC, V2, P1573, DOI 10.1038/nprot.2007.225; Wolfe JT, 2003, NATURE, V424, P209, DOI 10.1038/nature01772	54	15	16	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17390	17400		10.1074/jbc.M114.631705	http://dx.doi.org/10.1074/jbc.M114.631705			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	26013830	Green Published, hybrid			2022-12-26	WOS:000357730900033
J	Nomme, J; Antanasijevic, A; Caffrey, M; Van Itallie, CM; Anderson, JM; Fanning, AS; Lavie, A				Nomme, Julian; Antanasijevic, Aleksandar; Caffrey, Michael; Van Itallie, Christina M.; Anderson, James M.; Fanning, Alan S.; Lavie, Arnon			Structural Basis of a Key Factor Regulating the Affinity between the Zonula Occludens First PDZ Domain and Claudins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TIGHT-JUNCTION; EXTRACELLULAR DOMAINS; EPITHELIAL-CELLS; PROTEIN ZO-1; RECOGNITION; SPECIFICITY; PHOSPHORYLATION; DETERMINANTS; DIMERIZATION; BARRIER	The molecular seal between epithelial cells, called the tight junction (TJ), is built by several membrane proteins, with claudins playing the most prominent role. The scaffold proteins of the zonula occludens family are required for the correct localization of claudins and hence formation of the TJ. The intracellular C terminus of claudins binds to the N-terminal PDZ domain of zonula occludens proteins (PDZ1). Of the 23 identified human claudin proteins, nine possess a tyrosine at the -6 position. Here we show that the claudin affinity for PDZ1 is dependent on the presence or absence of this tyrosine and that the affinity is reduced if the tyrosine is modified by phosphorylation. The PDZ1 beta 2-beta 3 loop undergoes a significant conformational change to accommodate this tyrosine. Cell culture experiments support a regulatory role for this tyrosine. Plasticity has been recognized as a critical property of TJs that allow cell remodeling and migration. Our work provides a molecular framework for how TJ plasticity may be regulated.	[Nomme, Julian; Antanasijevic, Aleksandar; Caffrey, Michael; Lavie, Arnon] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA; [Van Itallie, Christina M.; Anderson, James M.] NHLBI, Lab Tight Junct Struct & Funct, NIH, Bethesda, MD 20892 USA; [Fanning, Alan S.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of North Carolina; University of North Carolina Chapel Hill	Lavie, A (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA.	lavie@uic.edu	Regan, Clinton/E-6250-2012	Lavie, Arnon/0000-0001-5591-8722; Anderson, James/0000-0003-2765-7996	National Institutes of Health [DK61397, AI101676]; Division of Intramural Research, National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006207] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI101676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061397, R56DK061397] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Intramural Research, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK61397 (to A. S. F. and A. L.) and AI101676 (to M. C.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Division of Intramural Research, National Institutes of Health.	Amasheh S, 2002, J CELL SCI, V115, P4969, DOI 10.1242/jcs.00165; Anderson JM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002584; Antanasijevic A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076363; Appleton BA, 2006, J BIOL CHEM, V281, P22312, DOI 10.1074/jbc.M602901200; Birrane G, 2003, J BIOL CHEM, V278, P1399, DOI 10.1074/jbc.C200571200; Chen J, 2008, EMBO J, V27, P2113, DOI 10.1038/emboj.2008.138; Colegio OR, 2003, AM J PHYSIOL-CELL PH, V284, pC1346, DOI 10.1152/ajpcell.00547.2002; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fanning AS, 2007, J BIOL CHEM, V282, P37710, DOI 10.1074/jbc.M707255200; Findley MK, 2009, IUBMB LIFE, V61, P431, DOI 10.1002/iub.175; Guo A, 2008, P NATL ACAD SCI USA, V105, P692, DOI 10.1073/pnas.0707270105; Ikari A, 2010, BBA-BIOMEMBRANES, V1798, P415, DOI 10.1016/j.bbamem.2009.11.005; Im YJ, 2010, J MOL BIOL, V397, P457, DOI 10.1016/j.jmb.2010.01.048; Itoh M, 1999, J CELL BIOL, V147, P1351, DOI 10.1083/jcb.147.6.1351; Jeansonne B, 2003, CELL MOL BIOL, V49, P13; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karthikeyan S, 2002, J BIOL CHEM, V277, P18973, DOI 10.1074/jbc.M201507200; Luck K, 2012, FEBS LETT, V586, P2648, DOI 10.1016/j.febslet.2012.03.056; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Niethammer M, 1998, NEURON, V20, P693, DOI 10.1016/S0896-6273(00)81009-0; Nomme J, 2011, J BIOL CHEM, V286, P43352, DOI 10.1074/jbc.M111.304089; Poliak S, 2002, J CELL BIOL, V159, P361, DOI 10.1083/jcb.200207050; Rodgers LS, 2013, J CELL SCI, V126, P1565, DOI 10.1242/jcs.113399; Twiss F, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.27425; Umeda K, 2006, CELL, V126, P741, DOI 10.1016/j.cell.2006.06.043; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Van Itallie CM, 2012, J CELL SCI, V125, P4902, DOI 10.1242/jcs.111237; Van Itallie CM, 2011, J BIOL CHEM, V286, P3442, DOI 10.1074/jbc.M110.195578; Van Itallie CM, 2009, MOL BIOL CELL, V20, P3930, DOI 10.1091/mbc.E09-04-0320; Van Itallie CM, 2009, ANN NY ACAD SCI, V1165, P82, DOI 10.1111/j.1749-6632.2009.04052.x; Wang CK, 2010, PROTEIN CELL, V1, P737, DOI 10.1007/s13238-010-0099-6; Ye F, 2013, BIOCHEM J, V455, P1, DOI 10.1042/BJ20130783; Zhang JX, 2008, J MOL BIOL, V384, P255, DOI 10.1016/j.jmb.2008.09.034; Zhang YN, 2006, J BIOL CHEM, V281, P22299, DOI 10.1074/jbc.M602902200	35	33	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2015	290	27					16595	16606		10.1074/jbc.M115.646695	http://dx.doi.org/10.1074/jbc.M115.646695			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM3HN	26023235	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000357572800012
J	Badaeva, ED; Keilwagen, J; Knupffer, H; Wassermann, L; Dedkova, OS; Mitrofanova, OP; Kovaleva, ON; Liapunova, OA; Pukhalskiy, VA; Ozkan, H; Graner, A; Willcox, G; Kilian, B				Badaeva, Ekaterina D.; Keilwagen, Jens; Knuepffer, Helmut; Wassermann, Louise; Dedkova, Olga S.; Mitrofanova, Olga P.; Kovaleva, Olga N.; Liapunova, Olga A.; Pukhalskiy, Vitaly A.; Ozkan, Hakan; Graner, Andreas; Willcox, George; Kilian, Benjamin			Chromosomal Passports Provide New Insights into Diffusion of Emmer Wheat	PLOS ONE			English	Article							TRITICUM-TURGIDUM L.; AGRICULTURAL ORIGINS; GENETIC DIVERSITY; DOMESTICATION; WILD; EVOLUTION; DICOCCUM; POLYMORPHISM; POPULATIONS; DIVERGENCE	Emmer wheat, Triticum dicoccon SCHRANK (syn. T. dicoccum (SCHRANK) SCHUBL.), is one of the earliest domesticated crops, harboring a wide range of genetic diversity and agronomically valuable traits. The crop, however, is currently largely neglected. We provide a wealth of karyotypic information from a comprehensive collection of emmer wheat and related taxa. In addition to C-banding polymorphisms, we identified 43 variants of chromosomal rearrangements in T. dicoccon; among them 26 (60.4%) were novel. The T7A:5B translocation was most abundant in Western Europe and the Mediterranean. The plant genetic resources investigated here might become important in the future for wheat improvement. Based on cluster analysis four major karyotypic groups were discriminated within the T. dicoccon genepool, each harboring characteristic C-banding patterns and translocation spectra: the BALKAN, ASIAN, EUROPEAN and ETHIOPIAN groups. We postulate four major diffusion routes of the crop and discuss their migration out of the Fertile Crescent considering latest archaeobotanical findings.	[Badaeva, Ekaterina D.; Dedkova, Olga S.; Pukhalskiy, Vitaly A.] Russian Acad Sci, NI Vavilov Inst Gen Genet, Moscow 119991, Russia; [Badaeva, Ekaterina D.] Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow 119991, Russia; [Keilwagen, Jens; Wassermann, Louise] Julius Kuhn Inst, Fed Res Ctr Cultivated Plants, D-06484 Quedlinburg, Germany; [Knuepffer, Helmut; Graner, Andreas; Kilian, Benjamin] Leibniz Inst Plant Genet & Crop Plant Res IPK Gat, D-06466 Stadt Seeland Ot Gatersl, Germany; [Mitrofanova, Olga P.; Kovaleva, Olga N.; Liapunova, Olga A.] Russian Acad Agr Sci, NI Vavilov Inst Plant Ind VIR, St Petersburg 190000, Russia; [Ozkan, Hakan] Cukurova Univ, Fac Agr, Dept Field Crops, TR-01330 Adana, Turkey; [Willcox, George] Univ Lyon 2, Archeorient CNRS UMR 5133, F-07460 Berrias, St Paul Le Jeun, France	Russian Academy of Sciences; Vavilov Institute of General Genetics; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Julius Kuhn-Institut; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; Vavilov All-Russian Institute of Plant Genetic Resources; Cukurova University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS)	Badaeva, ED (corresponding author), Russian Acad Sci, NI Vavilov Inst Gen Genet, Gubkina St 3, Moscow 119991, Russia.	katerinabadaeva@gmail.com	Badaeva, Ekaterina D./N-4368-2017; ÖZKAN, Hakan/C-8510-2011	Badaeva, Ekaterina D./0000-0001-7101-9639; ÖZKAN, Hakan/0000-0003-3530-2626; Kilian, Benjamin/0000-0002-9145-6980; Keilwagen, Jens/0000-0002-6792-7076; Mitrofanova, Olga/0000-0002-9171-2964; Graner, Andreas/0000-0003-3246-6393; Knupffer, Helmut/0000-0002-0525-9244	German Federal Ministry of Food and Agriculture (BLE) [01/12-13-KAD]; Russian Foundation for Basic Research [14-04-00142a, 14-04-00247a]	German Federal Ministry of Food and Agriculture (BLE); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This study was supported by grants from German Federal Ministry of Food and Agriculture (BLE), Grant No 01/12-13-KAD and Russian Foundation for Basic Research, Grants Nos. 14-04-00142a, 14-04-00247a. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaby RG, 2010, VEG HIST ARCHAEOBOT, V19, P151, DOI 10.1007/s00334-009-0232-8; [Anonymous], 1970, EXCAVATIONS HACILAR; Badaeva ED, 2007, GENOME, V50, P907, DOI 10.1139/G07-072; Badaeva ED, 2005, BIOL MEMBRANY, V22, P232; BADAEVA ED, 1994, PLANT SYST EVOL, V192, P117, DOI 10.1007/BF00985912; BADAEVA ED, 1990, CEREAL RES COMMUN, V18, P273; Badaeva ED, 2013, CHROMOSOMAL CHANGES, P110; Balfourier F, 2007, THEOR APPL GENET, V114, P1265, DOI 10.1007/s00122-007-0517-1; Ballouche A, 2003, REV ARCHEOMETRIE, V27, P49, DOI DOI 10.3406/ARSCI.2003.1041; Bar-Yosef O, 2004, CURR ANTHROPOL, V45, pS1, DOI 10.1086/423970; Bar-Yosef O, 1998, EVOL ANTHROPOL, V6, P159, DOI 10.1002/(SICI)1520-6505(1998)6:5<159::AID-EVAN4>3.0.CO;2-7; Blumler MA., 1998, ORIGINS AGR CROP DOM, P252; Boric D, 2013, P NATL ACAD SCI USA, V110, P3298, DOI 10.1073/pnas.1211474110; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Charles M., 2010, ORIGINS AGR W CENTRA, p[150, 256]; Civan P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081955; Costantini L., 1984, S ASIAN ARCHAEOLOGY, P29; DAMANIA AB, 1992, HEREDITAS, V116, P163, DOI 10.1111/j.1601-5223.1992.tb00222.x; Dedkova OS, 2007, RUSS J GENET+, V43, P1271, DOI 10.1134/S1022795407110105; Dedkova OS, 2009, RUSS J GENET+, V45, P1082, DOI 10.1134/S1022795409090099; Dedkova OS, 2004, RUSS J GENET+, V40, P1111, DOI 10.1023/B:RUGE.0000044755.18085.7e; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Dorofeev VF, 1979, CULTIVATED FLORA USS, V1; Feldman M., 2001, WORLD WHEAT BOOK HIS, P3; Feldman M, 2007, ISR J PLANT SCI, V55, P207, DOI 10.1560/IJPS.55.3-4.207; Figliuolo G, 2004, GENET RESOUR CROP EV, V51, P519, DOI 10.1023/B:GRES.0000024153.75636.6f; Friebe Bernd, 1996, P39; Fuller DQ, 2006, J WORLD PREHIST, V20, P1, DOI 10.1007/s10963-006-9006-8; Gupta PK, 2013, PLANT BREEDING, V132, P431, DOI 10.1111/pbr.12110; Haak W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000536; Hammer K, 2014, GENET RESOUR CROP EV, P1; Hamon C., 2008, PALEORIENT, V34, P85, DOI DOI 10.3406/PALE0.2008.5258; Heslot H, 1959, WHEAT INFORM SERV, V9-10, P15; Hovsepyan R, 2008, VEG HIST ARCHAEOBOT, V17, pS63, DOI 10.1007/s00334-008-0158-6; Jakob SS, 2014, GENOME BIOL EVOL, V6, P685, DOI 10.1093/gbe/evu047; Jakubziner MM, 1956, MAT HIST AGR USSR, P17; Jones Huw, 2008, Plant Genetic Resources Characterization and Utilization, V6, P98, DOI 10.1017/S1479262108993138; Khoshbakht K, 2009, J AGR RURAL DEV TROP, P189; Kihara H, 1965, MORPHOLOGICAL PHYSL, P1; Kilian B, 2009, PLANT GENET GENOMICS, V7, P81, DOI 10.1007/978-0-387-77489-3_3; Knupffer H, 2009, PLANT GENET GENOMICS, V7, P31, DOI 10.1007/978-0-387-77489-3_2; Knupffer H, 2014, BIODIVERSITY DATA J; Kuckuck, 1956, DISTRIBUTION VARIATI; Lehmensiek A, 2005, AUST J AGR RES, V56, P1347, DOI 10.1071/AR05126; Lisitsyna GN, 1977, PALEO BOT FINDS CAUC; Luo MC, 2007, THEOR APPL GENET, V114, P947, DOI 10.1007/s00122-006-0474-0; Maechler M., 2015, CLUSTER CLUSTER ANAL; Mani BR, 2006, KASHMIR NEOLITHIC EA, P230; Masson VM, 1982, ENEOLYTH OF THE USSR; Matsuoka Y, 2011, PLANT CELL PHYSIOL, V52, P750, DOI 10.1093/pcp/pcr018; Mondini L, 2014, GENET RESOUR CROP EV, V61, P69, DOI 10.1007/s10722-013-0016-y; MORGANTE M, 1993, PLANT J, V3, P175, DOI 10.1111/j.1365-313X.1993.tb00020.x; Mori N, 1997, GENES GENET SYST, V72, P153, DOI 10.1266/ggs.72.153; Mori N., 2003, P 10 INT WHEAT GEN S, P25; Nabholz B, 2014, MOL ECOL, V23, P2210, DOI 10.1111/mec.12738; Nesbitt M, 1996, HULLED WHEATS, V4, P41; Oliveira HR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037063; Ozkan H, 2005, THEOR APPL GENET, V110, P1052, DOI 10.1007/s00122-005-1925-8; Ozkan H, 2011, GENET RESOUR CROP EV, V58, P11, DOI 10.1007/s10722-010-9581-5; Peng JH, 2011, AUST J CROP SCI, V5, P1127; Pistrick E, 2004, GENET RESOUR CROP EV, V51, P1, DOI 10.1023/B:GRES.0000026038.92932.8b; Pomortsev AA, 2008, RUSS J GENET+, V44, P709, DOI 10.1134/S1022795408060112; Riehl S, 2013, SCIENCE, V341, P65, DOI 10.1126/science.1236743; Roussel V, 2005, THEOR APPL GENET, V111, P162, DOI 10.1007/s00122-005-2014-8; Salamini F, 2002, NAT REV GENET, V3, P429, DOI 10.1038/nrg817; Schiemann E, 1939, NATURWISSENSCHAFTEN, V27, P394, DOI 10.1007/BF01489506; Schlegel R., 1996, WHEAT INF SERV, V83, P35; Stoletova EA, 1924, B APPL BOT PLANT BRE, V14, P1; SYBENGA J, 1970, GENETICA, V41, P101, DOI 10.1007/BF00958897; Szabo A. T., 1996, Hulled wheats. Proceedings of the First International Workshop on Hulled Wheats, held at Castelvecchio Pascoli, Tuscany, Italy, 21-22 July 1995., P2; Takenaka S, 2012, THEOR APPL GENET, V125, P999, DOI 10.1007/s00122-012-1890-y; Takenaka S, 2010, BREEDING SCI, V60, P212, DOI 10.1270/jsbbs.60.212; Tanno K, 2012, VEG HIST ARCHAEOBOT, V21, P107, DOI 10.1007/s00334-011-0316-0; Teklu Y, 2007, GENET RESOUR CROP EV, V54, P543, DOI 10.1007/s10722-006-0011-7; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; Van Slageren M.W., 1994, ICARDA WAGENINGEN AG; Vavilov NI, 1926, NEWS IN AGRONOMY, P76; Watanabe N, 1999, EUPHYTICA, V106, P39, DOI 10.1023/A:1003589117853; Zaharieva MZ, 2010, GENET RESOUR CROP EV, V57, P937, DOI 10.1007/s10722-010-9572-6; Zeder MA, 2008, P NATL ACAD SCI USA, V105, P11597, DOI 10.1073/pnas.0801317105; Zohary D, 2012, DOMESTICATION OF PLANTS IN THE OLD WORLD: THE ORIGIN AND SPREAD OF DOMESTICATED PLANTS IN SOUTH-WEST ASIA, EUROPE, AND THE MEDITERRANEAN BASIN, 4TH EDITION, P1, DOI 10.1093/acprof:osobl/9780199549061.001.0001	81	17	17	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128556	10.1371/journal.pone.0128556	http://dx.doi.org/10.1371/journal.pone.0128556			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024381	Green Submitted, gold, Green Published			2022-12-26	WOS:000355319400097
J	Ejeskar, K; Vickes, O; Kuchipudi, A; Wettergren, Y; Uv, A; Sopasakis, VR				Ejeskar, Katarina; Vickes, Oscar; Kuchipudi, Arunakar; Wettergren, Yvonne; Uv, Anne; Sopasakis, Victoria Rotter			The Unique Non-Catalytic C-Terminus of P37delta-PI3K Adds Proliferative Properties In Vitro and In Vivo	PLOS ONE			English	Article							DROSOPHILA PHOSPHOINOSITIDE 3-KINASE; LIFE-SPAN; PHOSPHATIDYLINOSITOL 3-KINASE; NEUROBLASTOMA TUMORS; P110 DELTA; FAT-BODY; GROWTH; EXPRESSION; SUBUNIT; PTEN	The PI3K/Akt pathway is central for numerous cellular functions and is frequently deregulated in human cancers. The catalytic subunits of PI3K, p110, are thought to have a potential oncogenic function, and the regulatory subunit p85 exerts tumor suppressor properties. The fruit fly, Drosophila melanogaster, is a highly suitable system to investigate PI3K signaling, expressing one catalytic, Dp110, and one regulatory subunit, Dp60, and both show strong homology with the human PI3K proteins p110 and p85. We recently showed that p37 delta, an alternatively spliced product of human PI3K p110 delta, displayed strong proliferation-promoting properties despite lacking the catalytic domain completely. Here we functionally evaluate the different domains of human p37 delta in Drosophila. The N-terminal region of Dp110 alone promotes cell proliferation, and we show that the unique C-terminal region of human p37 delta further enhances these proliferative properties, both when expressed in Drosophila, and in human HEK-293 cells. Surprisingly, although the N-terminal region of Dp110 and the C-terminal region of p37 delta both display proliferative effects, over-expression of full length Dp110 or the N-terminal part of Dp110 decreases survival in Drosophila, whereas the unique C-terminal region of p37 delta prevents this effect. Furthermore, we found that the N-terminal region of the catalytic subunit of PI3K p110, including only the Dp60 (p85)-binding domain and a minor part of the Ras binding domain, rescues phenotypes with severely impaired development caused by Dp60 over-expression in Drosophila, possibly by regulating the levels of Dp60, and also by increasing the levels of phosphorylated Akt. Our results indicate a novel kinase-independent function of the PI3K catalytic subunit.	[Ejeskar, Katarina; Vickes, Oscar; Kuchipudi, Arunakar] Univ Skovde, Syst Biol Res Ctr, Sch Biosci, Skovde, Sweden; [Ejeskar, Katarina; Uv, Anne] Gothenburg Univ, Dept Med & Clin Genet, Gothenburg, Sweden; [Wettergren, Yvonne] Gothenburg Univ, Dept Gen Surg, Gothenburg, Sweden; [Sopasakis, Victoria Rotter] Gothenburg Univ, Inst Med, Dept Mol & Clin Med, Wallenberg Lab, Gothenburg, Sweden	University of Skovde; University of Gothenburg; University of Gothenburg; University of Gothenburg	Ejeskar, K (corresponding author), Univ Skovde, Syst Biol Res Ctr, Sch Biosci, Skovde, Sweden.	katarina.ejeskar@his.se		Ejeskar, Katarina/0000-0001-8962-0860	Swedish Children's Cancer Fund; Assar Gabrielsson Foundation; Swedish research council; KK-Stiftelsen	Swedish Children's Cancer Fund; Assar Gabrielsson Foundation; Swedish research council(Swedish Research CouncilEuropean Commission); KK-Stiftelsen	This work was supported by grants from the Swedish Children's Cancer Fund (KE), the Assar Gabrielsson Foundation (KE), The Swedish research council (VRS) and KK-Stiftelsen (KE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber Domingo F, 2006, Sci STKE, V2006, ppe49, DOI 10.1126/stke.3622006pe49; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Chagpar RB, 2010, P NATL ACAD SCI USA, V107, P5471, DOI 10.1073/pnas.0908899107; Chantry D, 1997, J BIOL CHEM, V272, P19236, DOI 10.1074/jbc.272.31.19236; Cizkova M, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-545; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Eickholt BJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000869; Fransson S, 2012, ONCOGENE, V31, P3277, DOI 10.1038/onc.2011.492; Fransson S, 2007, GENE CHROMOSOME CANC, V46, P45, DOI 10.1002/gcc.20387; Fransson S, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0724-3; Fransson S, 2013, INT J ONCOL, V42, P609, DOI 10.3892/ijo.2012.1732; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Leevers SJ, 1996, EMBO J, V15, P6584, DOI 10.1002/j.1460-2075.1996.tb01049.x; Leslie NR, 2004, BIOCHEM J, V382, P1, DOI 10.1042/BJ20040825; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Moskalev AA, 2010, REJUV RES, V13, P246, DOI 10.1089/rej.2009.0903; Oldham S, 2003, TRENDS CELL BIOL, V13, P79, DOI 10.1016/S0962-8924(02)00042-9; Oldham S, 2002, DEVELOPMENT, V129, P4103; Philp AJ, 2001, CANCER RES, V61, P7426; Rabinovsky R, 2009, MOL CELL BIOL, V29, P5377, DOI 10.1128/MCB.01649-08; Rusten TE, 2004, DEV CELL, V7, P179, DOI 10.1016/j.devcel.2004.07.005; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Taniguchi CM, 2010, CANCER RES, V70, P5305, DOI 10.1158/0008-5472.CAN-09-3399; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Tzenaki N, 2012, FASEB J, V26, P2498, DOI 10.1096/fj.11-198192; Vanhaesebroeck B, 2005, TRENDS BIOCHEM SCI, V30, P194, DOI 10.1016/j.tibs.2005.02.008; Vanhaesebroeck B, 1997, P NATL ACAD SCI USA, V94, P4330, DOI 10.1073/pnas.94.9.4330; Weinkove D, 1999, CURR BIOL, V9, P1019, DOI 10.1016/S0960-9822(99)80450-3; Weinkove D, 1997, J BIOL CHEM, V272, P14606, DOI 10.1074/jbc.272.23.14606	30	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0127497	10.1371/journal.pone.0127497	http://dx.doi.org/10.1371/journal.pone.0127497			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024481	Green Published, Green Submitted, gold			2022-12-26	WOS:000355319400038
J	Chen, J; Kim, H; Yoo, G				Chen, Jingjing; Kim, Hyunjin; Yoo, Gayoung			Effects of Biochar Addition on CO2 and N2O Emissions following Fertilizer Application to a Cultivated Grassland Soil	PLOS ONE			English	Article							GREENHOUSE-GAS EMISSIONS; NITROUS-OXIDE EMISSION; MICROBIAL BIOMASS-C; HETEROTROPHIC NITRIFICATION; RICE PADDY; LOAM SOIL; DENITRIFICATION; IMPACT; CROP; RESPIRATION	Carbon (C) sequestration potential of biochar should be considered together with emission of greenhouse gases when applied to soils. In this study, we investigated CO2 and N2O emissions following the application of rice husk biochars to cultivated grassland soils and related gas emissions tos oil C and nitrogen (N) dynamics. Treatments included biochar addition (CHAR, NO CHAR) and amendment (COMPOST, UREA, NO FERT). The biochar application rate was 0.3% by weight. The temporal pattern of CO2 emissions differed according to biochar addition and amendments. CO2 emissions from the COMPOST soils were significantly higher than those from the UREA and NO FERT soils and less CO2 emission was observed when biochar and compost were applied together during the summer. Overall N2O emission was significantly influenced by the interaction between biochar and amendments. In UREA soil, biochar addition increased N2O emission by 49% compared to the control, while in the COMPOST and NO FERT soils, biochar did not have an effect on N2O emission. Two possible mechanisms were proposed to explain the higher N2O emissions upon biochar addition to UREA soil than other soils. Labile C in the biochar may have stimulated microbial N mineralization in the C-limited soil used in our study, resulting in an increase in N2O emission. Biochar may also have provided the soil with the ability to retain mineral N, leading to increased N2O emission. The overall results imply that biochar addition can increase C sequestration when applied together with compost, and might stimulate N2O emission when applied to soil amended with urea.	[Chen, Jingjing; Kim, Hyunjin; Yoo, Gayoung] Kyung Hee Univ, Coll Engn, Ctr Environm Studies, Dept Appl Environm Sci, Gyeonggido, South Korea	Kyung Hee University	Yoo, G (corresponding author), Kyung Hee Univ, Coll Engn, Ctr Environm Studies, Dept Appl Environm Sci, 1 Seochon Dong, Gyeonggido, South Korea.	gayoo@khu.ac.kr	Yoo, Gayoung/AAK-7174-2020		"Cooperative Research Program for Agriculture Science & Technology Development," Rural Development Administration [PJ009253022015]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Republic of Korea [NRF-2013R1A1A2060747]	"Cooperative Research Program for Agriculture Science & Technology Development," Rural Development Administration; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Republic of Korea	This work was carried out with the support of the "Cooperative Research Program for Agriculture Science & Technology Development (Project No. PJ009253022015)," Rural Development Administration, and Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2013R1A1A2060747), Republic of Korea.	Adam G, 2001, SOIL BIOL BIOCHEM, V33, P943, DOI 10.1016/S0038-0717(00)00244-3; Ahmad M, 2012, BIORESOURCE TECHNOL, V118, P536, DOI 10.1016/j.biortech.2012.05.042; Ameloot N, 2013, SOIL BIOL BIOCHEM, V57, P401, DOI 10.1016/j.soilbio.2012.10.025; [Anonymous], 1996, METHODS SOIL ANAL 3; Alburquerque JA, 2013, AGRON SUSTAIN DEV, V33, P475, DOI 10.1007/s13593-012-0128-3; Awad YM, 2012, EUR J SOIL BIOL, V48, P1, DOI 10.1016/j.ejsobi.2011.09.005; Bateman EJ, 2005, BIOL FERT SOILS, V41, P379, DOI 10.1007/s00374-005-0858-3; Beck T, 1997, SOIL BIOL BIOCHEM, V29, P1023, DOI 10.1016/S0038-0717(97)00030-8; Bouwman AF, 1996, NUTR CYCL AGROECOSYS, V46, P53, DOI 10.1007/BF00210224; Bruun EW, 2012, SOIL BIOL BIOCHEM, V46, P73, DOI 10.1016/j.soilbio.2011.11.019; Burton DL, 2008, CAN J SOIL SCI, V88, P219, DOI 10.4141/CJSS06020; Case SDC, 2012, SOIL BIOL BIOCHEM, V51, P125, DOI 10.1016/j.soilbio.2012.03.017; CASTIGNETTI D, 1984, APPL ENVIRON MICROB, V47, P620, DOI 10.1128/AEM.47.4.620-623.1984; Chan K. Y., 2010, BIOCHAR ENV MANAGEME, P67, DOI Gateshead; Chintala R, 2015, ENVIRON SCI POLLUT R, V22, P5152, DOI 10.1007/s11356-014-3762-2; Chintala R, 2014, J HAZARD MATER, V279, P244, DOI 10.1016/j.jhazmat.2014.06.074; Chintala R, 2014, CLEAN-SOIL AIR WATER, V42, P626, DOI 10.1002/clen.201300089; Chintala R, 2013, MICROPOR MESOPOR MAT, V179, P250, DOI 10.1016/j.micromeso.2013.05.023; Clough TJ, 2010, SOIL SCI SOC AM J, V74, P852, DOI 10.2136/sssaj2009.0185; Clough TJ, 2010, J ENVIRON QUAL, V39, P1218, DOI 10.2134/jeq2010.0204; Cross A, 2011, SOIL BIOL BIOCHEM, V43, P2127, DOI 10.1016/j.soilbio.2011.06.016; DeLuca TH, 2006, ECOLOGY, V87, P2511, DOI 10.1890/0012-9658(2006)87[2511:FFANTI]2.0.CO;2; ELLINGTON A, 1986, FERT RES, V8, P283, DOI 10.1007/BF01048631; Gao XP, 2013, CAN J SOIL SCI, V93, P1, DOI 10.4141/CJSS2012-057; Gava GJD, 2005, PESQUI AGROPECU BRAS, V40, P689, DOI 10.1590/S0100-204X2005000700010; Hayatsu M, 2008, SOIL SCI PLANT NUTR, V54, P33, DOI 10.1111/j.1747-0765.2007.00195.x; HAYNES RJ, 1993, J SOIL SCI, V44, P665, DOI 10.1111/j.1365-2389.1993.tb02331.x; Institute SAS, 2008, SAS US GUID; Jones DL, 2012, SOIL BIOL BIOCHEM, V45, P113, DOI 10.1016/j.soilbio.2011.10.012; Kammann C, 2012, J ENVIRON QUAL, V41, P1052, DOI 10.2134/jeq2011.0132; Karhu K, 2011, AGR ECOSYST ENVIRON, V140, P309, DOI 10.1016/j.agee.2010.12.005; Keith H, 1997, PLANT SOIL, V190, P127, DOI 10.1023/A:1004279300622; Laird D, 2010, GEODERMA, V158, P436, DOI 10.1016/j.geoderma.2010.05.012; Lehmann J., 2006, Mitigation and Adaptation Strategies for Global Change, V11, P403, DOI 10.1007/s11027-005-9006-5; LEHMANN J, 2003, AMAZONIAN DARK EARTH; Liang B, 2006, SOIL SCI SOC AM J, V70, P1719, DOI 10.2136/sssaj2005.0383; Cayuela ML, 2013, SCI REP-UK, V3, DOI 10.1038/srep01732; Maag M, 1996, APPL SOIL ECOL, V4, P5, DOI 10.1016/0929-1393(96)00106-0; Major J, 2010, PLANT SOIL, V333, P117, DOI 10.1007/s11104-010-0327-0; Ogawa M, 1994, FARMING JAPAN, V28, P10; Pramer D., 1965, EXPT SOIL MICROBIOLO; Rochette P, 1998, CAN J SOIL SCI, V78, P283, DOI 10.4141/S97-066; Rogovska N, 2011, SOIL SCI SOC AM J, V75, P871, DOI 10.2136/sssaj2010.0270; Rondon MA, 2006, 18 WORLD C SOIL SCI; Sanchez-Monedero MA, 2008, BIOL FERT SOILS, V44, P885, DOI 10.1007/s00374-007-0263-1; Schindlbacher A, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004590; SIMS GK, 1995, COMMUN SOIL SCI PLAN, V26, P303, DOI 10.1080/00103629509369298; Spokas A, 2009, ANN ENV SCI, V3; Steiner C, 2008, PEDOBIOLOGIA, V51, P359, DOI 10.1016/j.pedobi.2007.08.002; Troy SM, 2013, SOIL BIOL BIOCHEM, V60, P173, DOI 10.1016/j.soilbio.2013.01.019; van Zwieten L, 2010, AUST J SOIL RES, V48, P569, DOI 10.1071/SR10003; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Wang JY, 2012, PLANT SOIL, V360, P287, DOI 10.1007/s11104-012-1250-3; Wang JY, 2011, BIOL FERT SOILS, V47, P887, DOI 10.1007/s00374-011-0595-8; Wrage N, 2001, SOIL BIOL BIOCHEM, V33, P1723, DOI 10.1016/S0038-0717(01)00096-7; Wu L, 2002, J ENVIRON QUAL, V31, P1323, DOI 10.2134/jeq2002.1323; Yanai Y, 2007, SOIL SCI PLANT NUTR, V53, P181, DOI 10.1111/j.1747-0765.2007.00123.x; Yoo G, 2014, SOIL SCI SOC AM J, V78, P852, DOI 10.2136/sssaj2013.05.0160; Yoo G, 2012, J ENVIRON QUAL, V41, P1193, DOI 10.2134/jeq2011.0157; Zhang AF, 2012, FIELD CROP RES, V127, P153, DOI 10.1016/j.fcr.2011.11.020; Zhang AF, 2012, PLANT SOIL, V351, P263, DOI 10.1007/s11104-011-0957-x; Zhang JB, 2011, BIORESOURCE TECHNOL, V102, P9866, DOI 10.1016/j.biortech.2011.07.118; Zimmerman AR, 2011, SOIL BIOL BIOCHEM, V43, P1169, DOI 10.1016/j.soilbio.2011.02.005	63	20	23	13	131	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0126841	10.1371/journal.pone.0126841	http://dx.doi.org/10.1371/journal.pone.0126841			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020941	Green Published, Green Submitted, gold			2022-12-26	WOS:000355187300026
J	Mao, FY; Wang, YQ; Meng, J				Mao, Fangyuan; Wang, Yuanqing; Meng, Jin			A Systematic Study on Tooth Enamel Microstructures of Lambdopsalis bulla (Multituberculate, Mammalia) - Implications for Multituberculate Biology and Phylogeny	PLOS ONE			English	Article							NUMERICAL DENSITY; EVOLUTION; TEETH; PIGMENTATION; THICKNESS; FIBRILS; TUBULES; ORIGIN; PRISMS; SIZE	Tooth enamel microstructure is a reliable and widely used indicator of dietary interpretations and data for phylogenetic reconstruction, if all levels of variability are investigated. It is usually difficult to have a thorough examination at all levels of enamel structures for any mammals, especially for the early mammals, which are commonly represented by sparse specimens. Because of the random preservation of specimens, enamel microstructures from different teeth in various species are often compared. There are few examples that convincingly show intraspecific variation of tooth enamel microstructure in full dentition of a species, including multituberculates. Here we present a systematic survey of tooth enamel microstructures of Lambdopsalis bulla, a taeniolabidoid multituberculate from the Late Paleocene Nomogen Formation, Inner Mongolia. We examined enamel structures at all hierarchical levels. The samples are treated differently in section orientations and acid preparation and examined using different imaging methods. The results show that, except for preparation artifacts, the crystallites, enamel types, Schmelzmuster and dentition types of Lambdopsalis are relatively consistent in all permanent teeth, but the prism type, including the prism shape, size and density, may vary in different portions of a single tooth or among different teeth of an individual animal. The most common Schmelzmuster of the permanent teeth in Lambdopsalis is a combination of radial enamel in the inner and middle layers, aprismatic enamel in the outer layer, and irregular decussations in tooth crown area with great curvature. The prism seam is another comparably stable characteristic that may be a useful feature for multituberculate taxonomy. The systematic documentation of enamel structures in Lambdopsalis may be generalized for the enamel microstructure study, and thus for taxonomy and phylogenetic reconstruction, of multituberculates and even informative for the enamel study of other early mammals.	[Mao, Fangyuan; Wang, Yuanqing; Meng, Jin] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origin, Beijing, Peoples R China; [Meng, Jin] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; American Museum of Natural History (AMNH)	Mao, FY (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origin, Beijing, Peoples R China.	maofangyuan@ivpp.ac.cn			Major Basic Research Projects of MST of China [2012CB821900]; National Natural Science Foundation of China [41404022]; Chinese Academy of Sciences [KZCX2-EW-106]; Special Fund for Fossil Excavation and Preparation of Chinese Academy of Sciences; China Geological Survey [1212011120142]	Major Basic Research Projects of MST of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Special Fund for Fossil Excavation and Preparation of Chinese Academy of Sciences; China Geological Survey(China Geological Survey)	The work was supported by the Major Basic Research Projects of MST of China (Nos. 2012CB821900), the National Natural Science Foundation of China (No. 41404022), the Chinese Academy of Sciences (No. KZCX2-EW-106), the Special Fund for Fossil Excavation and Preparation of Chinese Academy of Sciences, and the China Geological Survey (Nos. 1212011120142). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archibald J. D., 1982, STUDY MAMMALIA GEOLO; Avery J., 2006, ESSENTIALS ORAL HIST; Beynon AD, 1998, J HUM EVOL, V35, P163, DOI 10.1006/jhev.1998.0230; Bonaparte J.F., 1986, 4 C ARG PAL BIOESTR, V4, P63; BOYDE A, 1982, ANAT EMBRYOL, V165, P193, DOI 10.1007/BF00305477; Boyde A., 1984, P341; BOYDE A, 1967, Z ZELLFORSCH MIK ANA, V82, P558, DOI 10.1007/BF00337122; Boyde A, 1964, THESIS LONDON HOSP M; Butler PM, 2005, ACTA PALAEONTOL POL, V50, P185; CARLSON S J, 1985, Contributions from the Museum of Paleontology University of Michigan, V27, P1; Carlson S.J., 1990, SKELETAL BIOMINERALI, P235; Chiego JDJ, 2014, ESSENTIALS ORAL HIST; Clemens W.A., 1979, P99; Clemens WA, 1997, TOOTH ENAMEL MICROSTRUCTURE, P85; Clemens WA, 1991, J VERTEBR PALEONTOL, V11, p43A; COOPER JS, 1973, J ZOOL, V169, P85; CROMPTON AW, 1968, BIOL REV, V43, P427, DOI 10.1111/j.1469-185X.1968.tb00966.x; DOTSCH C, 1978, Z SAUGETIERKD, V43, P65; Dumont M, 2014, J STRUCT BIOL, V186, P38, DOI 10.1016/j.jsb.2014.02.006; FOSSE G, 1968, ACTA ODONTOL SCAND, V26, P315, DOI 10.3109/00016356809026139; Fosse G, 2003, ACTA PALAEONTOL POL, V48, P657; FOSSE G, 1978, ZOOL SCR, V7, P57, DOI 10.1111/j.1463-6409.1978.tb00588.x; FOSSE G, 1985, PALAEONTOLOGY, V28, P435; FOSSE G, 1969, ACTA ODONTOL SCAND, V27, P237, DOI 10.3109/00016356909008953; FOSSE G, 1971, Z ZELLFORSCH MIK ANA, V115, P341, DOI 10.1007/BF00324937; FREEMAN E F, 1976, Proceedings of the Geologists' Association, V87, P231; FREEMAN E F, 1979, Palaeontology (Oxford), V22, P135; Gantt D.G., 1983, P249; Gilkeson CF, 1997, TOOTH ENAMEL MICROSTRUCTURE, P113; Gordon LM, 2015, SCIENCE, V347, P746, DOI 10.1126/science.1258950; Hahn G, 2003, ACTA PALAEONTOL POL, V48, P349; Hahn G., 1999, PALAEONTOGRAPHICA A, V253, P77; Hahn Gerhard, 2006, Geologica et Palaeontologica, V40, P173; HOPSON JA, 1973, AM NAT, V107, P446, DOI 10.1086/282846; Kemp T.S, 1982, MAMMAL LIKE REPTILES; Kielan-Jaworowska Z, 2001, PALAEONTOLOGY, V44, P389, DOI 10.1111/1475-4983.00185; Kielan-Jaworowska Z., 2005, MAMMALS AGE DINOSAUR; Kielan-Jaworowska Z, 2007, ACTA PALAEONTOL POL, V52, P257; KIELANJAWOROWSKA Z, 1979, NATURE, V277, P402, DOI 10.1038/277402a0; Koenigswald W.v., 1993, P303; Korvenkontio V. A., 1934, Annales Zoologici Societatis Zoologico-Botanicae Fennicae Vanamo, V2, P1; KOZAWA Y, 1988, HISTOCHEMISTRY, V90, P61, DOI 10.1007/BF00495708; Krause David W., 1997, P3; Krause DW, 2013, CAN J EARTH SCI, V50, P324, DOI 10.1139/e2012-074; Krause DW, 1992, J VERTEBR PALEONTOL, V12, P351, DOI 10.1080/02724634.1992.10011465; KRAUSE DW, 1987, J MAMMAL, V68, P755, DOI 10.2307/1381552; KRAUSE DW, 1986, SCAN ELECTRON MICROS, V1986, P1591; Krause DW, 1997, NATURE, V390, P504, DOI 10.1038/37343; KRAUSE DW, 1993, P NATL ACAD SCI USA, V90, P9379, DOI 10.1073/pnas.90.20.9379; Krause DW, 1996, J VERTEBR PALEONTOL, V16, p46A; KRISHTALKA L, 1982, J PALEONTOL, V56, P791; Lester K S, 1987, Adv Dent Res, V1, P181; LESTER KS, 1989, SCANNING MICROSCOPY, V3, P639; LESTER KS, 1988, SCANNING MICROSCOPY, V2, P371; LESTER KS, 1989, SCANNING MICROSCOPY, V3, P645; LESTER KS, 1987, SCANNING MICROSCOPY, V1, P421; LESTER KS, 1987, SCANNING MICROSCOPY, V1, P401; LESTER KS, 1970, J ULTRA MOL STRUCT R, V30, P64, DOI 10.1016/S0022-5320(70)90064-X; Maas MC, 1999, EVOL ANTHROPOL, V8, P133; Mao FY, 2016, ACTA PALAEONTOL POL, V61, P429, DOI 10.4202/app.00117.2014; MARTIN L, 1985, NATURE, V314, P260, DOI 10.1038/314260a0; Martin T, 1992, SCHMELZMIKROSTRUKTUR; McKenna MC, 1997, CLASSIFICATION MAMMA; Meng Jin, 1994, Journal of Mammalian Evolution, V2, P185, DOI 10.1007/BF01473528; Miao D-S, 1986, ROCKY MOUNTAIN GEOLO, V24, P65; Miao D-S., 1988, CONTRIB GEOL U WYOMI, V4, P1; Parmar V, 2013, NATURWISSENSCHAFTEN, V100, P515, DOI 10.1007/s00114-013-1047-0; Pascual R, 1999, J VERTEBR PALEONTOL, V19, P373, DOI 10.1080/02724634.1999.10011148; POND CM, 1977, EVOLUTION, V31, P177, DOI [10.2307/2407556, 10.1111/j.1558-5646.1977.tb00995.x]; POOLE DFG, 1961, ARCH ORAL BIOL, V5, P14, DOI 10.1016/0003-9969(61)90110-8; Prothero D.R., 1992, EOCENE OLIGOCENE CLI, P46, DOI DOI 10.1515/9781400862924.46; QUADE J, 1992, CHEM GEOL, V94, P183, DOI 10.1016/0168-9622(92)90011-X; Rich TH, 2009, ACTA PALAEONTOL POL, V54, P1, DOI 10.4202/app.2009.0101; RISNES S, 1974, ACTA ANAT, V87, P275; ROBINSON P, 1964, SCIENCE, V145, P809, DOI 10.1126/science.145.3634.809; SAHNI A, 1979, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V166, P37; Sander PM, 1997, TOOTH ENAMEL MICROSTRUCTURE, P41; SELVIG KA, 1975, SCAND J DENT RES, V83, P88; Sigogneau-Russell D, 1991, NEUES JB GEOLOGIE PA, V2, P119; Simmons Greenwald N., 1988, Journal of Vertebrate Paleontology, V8, P265; SIMMONS NB, 1993, MAMMAL PHYLOGENY, P146; Stefen C, 1995, THESIS U BONN BONN; STEIN G, 1959, ARCH ORAL BIOL, V1, P97, DOI 10.1016/0003-9969(59)90002-0; Stern DN, 1995, ASP DENT BIOL PAL AN, P3; v. Koenigswald Wighart, 1997, P267; Vogel ER, 2008, J HUM EVOL, V55, P60, DOI 10.1016/j.jhevol.2007.12.005; von Koenigswald W., 1988, Memoires du Museum National d'Histoire Naturelle Serie C Sciences de la Terre, V53, P147; von Koenigswald W., 1980, Abhandlungen der Senckenbergischen Naturforschenden Gesellschaft, P1; von Koenigswald Wighart, 1995, Neues Jahrbuch fuer Geologie und Palaeontologie Monatshefte, V10, P605; VONKOENIGSWALD W, 1992, SCANNING MICROSCOPY, V6, P195; vonKoenigswald W, 1997, TOOTH ENAMEL MICROSTRUCTURE, P193; VONKOENIGSWALD W, 1994, ZOOL J LINN SOC-LOND, V110, P141, DOI 10.1006/zjls.1994.1008; vonKoenigswald W, 1997, TOOTH ENAMEL MICROSTRUCTURE, P203; Weil A, 2008, EVOLUTION OF TERTIARY MAMMALS OF NORTH AMERICA, VOL 2, P19; Wible John R., 2000, Bulletin of the American Museum of Natural History, V247, P1, DOI 10.1206/0003-0090(2000)247<0001:CAOKDM>2.0.CO;2; Wood C. B., 1999, Journal of Mammalian Evolution, V6, P177, DOI 10.1023/A:1020624222324; Wood CB, 1997, TOOTH ENAMEL MICROSTRUCTURE, P63; Wood CB, 1992, COMP STUDIES ENAMEL; Wood CS, 2005, PHOTON SPECTRA, V39, P12; Zhao L-X, 2000, ACTA ANTHR SINICA S, V19, P77	100	13	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128243	10.1371/journal.pone.0128243	http://dx.doi.org/10.1371/journal.pone.0128243			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020958	Green Published, gold, Green Submitted			2022-12-26	WOS:000355187300093
J	Navarro, C; Moore, J; Ott, A; Baumert, E; Mohan, A; Gill, KS; Sandhu, D				Navarro, Christopher; Moore, Jerott; Ott, Alina; Baumert, Eric; Mohan, Amita; Gill, Kulvinder S.; Sandhu, Devinder			Evolutionary, Comparative and Functional Analyses of the Brassinosteroid Receptor Gene, BRI1, in Wheat and Its Relation to Other Plant Genomes	PLOS ONE			English	Article							LEUCINE-RICH-REPEAT; STEROID-HORMONE; KINASE; GROWTH; PHOSPHORYLATION; EXPRESSION; IDENTIFICATION; ELONGATION; PERCEPTION; REGULATORS	Brassinosteroids (BRs) are plant hormones, fundamental for the growth and development of plants. A trans-membrane protein receptor kinase, Brassinosteroid-Insensitive 1 (BRI1), is known to interact with BRs and be directly involved in plant development. This study investigates the structural organization of BRI1 orthologs in several taxa, with a specific interest in Triticum aestivum. True orthologs of Arabidopsis thaliana BRI1 (AtBRI1) from seven-plant species showed sequence identity ranging from 54% to 95% at the protein level. All gene sequences lacked introns, leading to speculation that post-transcriptional processing in TaBRI1 is similar to AtBRI1. Based on in silico analysis, a single copy of BRI1 was present in each of the three wheat genomes on the long arm of chromosome 3. Domain structure of BRI1 orthologs among different taxa showed multiple leucine rich repeats (LRRs), an island domain (ID), a juxtamembrane/transmembrane domain (JTMD), a catalytic kinase domain (KD), C and N-Terminal domains. The KD showed the highest level of conservation while the LRRs and JTMD were most variable. Phosphorylation of residues in the juxtamembrane domain, known to be involved in the activation of the KD, is conserved in TaBRI1. While TaBRI1 has well-defined differences in the ID and LRR domains, many residues involved in ligand binding are conserved. The activation loop present in the KD showed 100% conservation in all taxa. Despite residue differences, hydrophobicity was conserved in the BR binding pocket across taxa, suggesting that function may not differ as drastically as residue identity may suggest. Predicted 3D structure of AtBRI1 and TaBRI1 showed a conserved super helical assembly, a feature essential in protein-protein interactions. An unrooted phylogram showed TaBRI1 in the monocot clade to be distinct from that of dicots. New insight in the structure and functions of BRI1 may help in targeting BR pathway for crop improvement.	[Navarro, Christopher; Moore, Jerott; Ott, Alina; Baumert, Eric; Sandhu, Devinder] Univ Wisconsin, Dept Biol, Stevens Point, WI 54481 USA; [Mohan, Amita; Gill, Kulvinder S.] Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA	University of Wisconsin System; University of Wisconsin Stevens Point; Washington State University	Sandhu, D (corresponding author), Univ Wisconsin, Dept Biol, Stevens Point, WI 54481 USA.	dsandhu@uwsp.edu		Sandhu, Devinder/0000-0003-4193-3408; Ott, Alina/0000-0003-4830-8509	National Science Foundation - Basic Research to Enable Agricultural Development (NSF-BREAD) [ISO-0965533]; UWSP Student Research Fund	National Science Foundation - Basic Research to Enable Agricultural Development (NSF-BREAD)(National Science Foundation (NSF)NSF - Office of the Director (OD)); UWSP Student Research Fund	This research project was supported by the National Science Foundation - Basic Research to Enable Agricultural Development (NSF-BREAD) project (ISO-0965533) and the UWSP Student Research Funds.	Altmann T, 1999, PLANTA, V208, P1, DOI 10.1007/s004250050528; Bajguz A, 2003, PHYTOCHEMISTRY, V62, P1027, DOI 10.1016/S0031-9422(02)00656-8; Bajwa VS, 2013, PLANT PHYSIOL, V163, P30, DOI 10.1104/pp.113.221465; Bojar D, 2014, PLANT J, V78, P31, DOI 10.1111/tpj.12445; Chaw SM, 2004, J MOL EVOL, V58, P424, DOI 10.1007/s00239-003-2564-9; Chono M, 2003, PLANT PHYSIOL, V133, P1209, DOI 10.1104/pp.103.026195; Clouse SD, 1998, ANNU REV PLANT PHYS, V49, P427, DOI 10.1146/annurev.arplant.49.1.427; Deng W, 2007, BIOINFORMATICS, V23, P2334, DOI 10.1093/bioinformatics/btm331; Dockter C, 2014, PLANT PHYSIOL, V166, P1912, DOI 10.1104/pp.114.250738; Enkhbayar P, 2004, PROTEINS, V54, P394, DOI 10.1002/prot.10605; Fridman Y, 2013, PLANT SCI, V209, P24, DOI 10.1016/j.plantsci.2013.04.002; Gendron JM, 2007, CURR OPIN PLANT BIOL, V10, P436, DOI 10.1016/j.pbi.2007.08.015; He JX, 2005, SCIENCE, V307, P1634, DOI 10.1126/science.1107580; Hothorn M, 2011, NATURE, V474, P467, DOI 10.1038/nature10153; Isom DG, 2010, P NATL ACAD SCI USA, V107, P16096, DOI 10.1073/pnas.1004213107; Jaillais Y, 2011, P NATL ACAD SCI USA, V108, P8503, DOI 10.1073/pnas.1103556108; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kellogg EA, 2001, PLANT PHYSIOL, V125, P1198, DOI 10.1104/pp.125.3.1198; Kim TW, 2009, NAT CELL BIOL, V11, P1254, DOI 10.1038/ncb1970; Kinoshita T, 2005, NATURE, V433, P167, DOI 10.1038/nature03227; KOBE B, 1994, TRENDS BIOCHEM SCI, V19, P415, DOI 10.1016/0968-0004(94)90090-6; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Leister D, 2004, TRENDS GENET, V20, P116, DOI 10.1016/j.tig.2004.01.007; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Li JM, 1997, CELL, V90, P929, DOI 10.1016/S0092-8674(00)80357-8; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Matsushima N, 2005, CELL MOL LIFE SCI, V62, P2771, DOI 10.1007/s00018-005-5187-z; Matsushima N, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-124; Matsushima N, 2012, BIOMOLECULES, V2, P288, DOI 10.3390/biom2020288; Matsushima N, 2009, BBA-GEN SUBJECTS, V1790, P1217, DOI 10.1016/j.bbagen.2009.06.014; Montoya T, 2002, PLANT CELL, V14, P3163, DOI 10.1105/tpc.006379; Morinaka Y, 2006, PLANT PHYSIOL, V141, P924, DOI 10.1104/pp.106.077081; Morris ER, 2003, CURR OPIN PLANT BIOL, V6, P339, DOI 10.1016/S1369-5266(03)00055-4; Nam KH, 2002, CELL, V110, P203, DOI 10.1016/S0092-8674(02)00814-0; Noguchi T, 1999, PLANT PHYSIOL, V121, P743, DOI 10.1104/pp.121.3.743; Nomura T, 2003, PLANT J, V36, P291, DOI 10.1046/j.1365-313X.2003.01863.x; Oh MH, 2012, P NATL ACAD SCI USA, V109, P327, DOI 10.1073/pnas.1108321109; Oh MH, 2009, P NATL ACAD SCI USA, V106, P658, DOI 10.1073/pnas.0810249106; Peng P, 2008, MOL PLANT, V1, P338, DOI 10.1093/mp/ssn001; Russinova E, 2004, PLANT CELL, V16, P3216, DOI 10.1105/tpc.104.025387; Santiago J, 2013, SCIENCE, V341, P889, DOI 10.1126/science.1242468; Schreiber AW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-285; She J, 2011, NATURE, V474, P472, DOI 10.1038/nature10178; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; Shpak ED, 2005, SCIENCE, V309, P290, DOI 10.1126/science.1109710; Sreeramulu S, 2013, PLANT J, V74, P905, DOI 10.1111/tpj.12175; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tong HN, 2014, PLANT CELL, V26, P4376, DOI 10.1105/tpc.114.132092; Vij S, 2008, MOL PLANT, V1, P732, DOI 10.1093/mp/ssn047; Wang HC, 2009, P NATL ACAD SCI USA, V106, P3853, DOI 10.1073/pnas.0813376106; Wang XF, 2005, PLANT CELL, V17, P1685, DOI 10.1105/tpc.105.031393; Wang XL, 2006, SCIENCE, V313, P1118, DOI 10.1126/science.1127593; Wang ZY, 2012, ANNU REV GENET, V46, P701, DOI 10.1146/annurev-genet-102209-163450; Yamamuro C, 2000, PLANT CELL, V12, P1591, DOI 10.1105/tpc.12.9.1591; Yin YH, 2005, CELL, V120, P249, DOI 10.1016/j.cell.2004.11.044; Yin YH, 2002, CELL, V109, P181, DOI 10.1016/S0092-8674(02)00721-3; Zhang D, 2014, PLANT CELL, V26, P2472, DOI 10.1105/tpc.113.121848; Zullo MA, 2002, BRAZ J PLANT PHYS, V14	58	11	11	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0127544	10.1371/journal.pone.0127544	http://dx.doi.org/10.1371/journal.pone.0127544			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020768	Green Submitted, gold, Green Published			2022-12-26	WOS:000355187300043
J	Stavrakas, V; Melas, IN; Sakellaropoulos, T; Alexopoulos, LG				Stavrakas, Vassilis; Melas, Ioannis N.; Sakellaropoulos, Theodore; Alexopoulos, Leonidas G.			Network Reconstruction Based on Proteomic Data and Prior Knowledge of Protein Connectivity Using Graph Theory	PLOS ONE			English	Article							SIGNALING NETWORKS; MODELS; PATHWAYS	Modeling of signal transduction pathways is instrumental for understanding cells' function. People have been tackling modeling of signaling pathways in order to accurately represent the signaling events inside cells' biochemical microenvironment in a way meaningful for scientists in a biological field. In this article, we propose a method to interrogate such pathways in order to produce cell-specific signaling models. We integrate available prior knowledge of protein connectivity, in a form of a Prior Knowledge Network (PKN) with phosphoproteomic data to construct predictive models of the protein connectivity of the interrogated cell type. Several computational methodologies focusing on pathways' logic modeling using optimization formulations or machine learning algorithms have been published on this front over the past few years. Here, we introduce a light and fast approach that uses a breadth-first traversal of the graph to identify the shortest pathways and score proteins in the PKN, fitting the dependencies extracted from the experimental design. The pathways are then combined through a heuristic formulation to produce a final topology handling inconsistencies between the PKN and the experimental scenarios. Our results show that the algorithm we developed is efficient and accurate for the construction of medium and large scale signaling networks. We demonstrate the applicability of the proposed approach by interrogating a manually curated interaction graph model of EGF/TNFA stimulation against made up experimental data. To avoid the possibility of erroneous predictions, we performed a cross-validation analysis. Finally, we validate that the introduced approach generates predictive topologies, comparable to the ILP formulation. Overall, an efficient approach based on graph theory is presented herein to interrogate protein-protein interaction networks and to provide meaningful biological insights.	[Stavrakas, Vassilis; Sakellaropoulos, Theodore; Alexopoulos, Leonidas G.] Natl Tech Univ Athens, Dept Mech Engn, Zografos 15780, Greece; [Melas, Ioannis N.] European Bioinformat Inst EMBL EBI, Cambridge CB10 1SD, England	National Technical University of Athens; European Molecular Biology Laboratory (EMBL)	Alexopoulos, LG (corresponding author), Natl Tech Univ Athens, Dept Mech Engn, Heroon Polytech 9, Zografos 15780, Greece.	leo@mail.ntua.gr	Alexopoulos, Leonidas/AAN-1148-2021; Sakellaropoulos, Theodore/AAJ-7256-2021	Sakellaropoulos, Theodore/0000-0001-9946-9498; Alexopoulos, Leonidas G/0000-0003-0425-166X; Stavrakas, Vassilis/0000-0003-1073-4561	European Union (European Social Fund -ESF); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF)-Research Funding Program: Thalis	European Union (European Social Fund -ESF)(European Social Fund (ESF)); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF)-Research Funding Program: Thalis	This work was supported by European Union (European Social Fund -ESF) and Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF)-Research Funding Program: Thalis. Investing in knowledge society through the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge BB, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000340; Alexopoulos LG, 2010, MOL CELL PROTEOMICS, V9, P1849, DOI 10.1074/mcp.M110.000406; Bosl WJ, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-13; Butcher EC, 2005, NAT REV DRUG DISCOV, V4, P461, DOI 10.1038/nrd1754; Chindelevitch L, 2012, BIOINFORMATICS, V28, P1114, DOI 10.1093/bioinformatics/bts090; Chu Y, 2007, IET SYST BIOL, V1, P342, DOI 10.1049/iet-syb:20060053; Cusick ME, 2005, HUM MOL GENET, V14, pR171, DOI 10.1093/hmg/ddi335; Downward J, 2001, NATURE, V411, P759, DOI 10.1038/35081138; Eungdamrong NJ, 2004, TRENDS CELL BIOL, V14, P661, DOI 10.1016/j.tcb.2004.10.007; Feiglin A, 2012, BIOINFORMATICS, V28, P2811, DOI 10.1093/bioinformatics/bts517; Floyd RW, 1962, COMMUN ACM, V5, P345; Gebser M, 2011, THEOR PRACT LOG PROG, V11, P323, DOI 10.1017/S1471068410000554; Gonzalez A, 2010, BIOSYSTEMS, V102, P16, DOI 10.1016/j.biosystems.2010.07.013; Gutierrez-Rios RM, 2003, GENOME RES, V13, P2435, DOI 10.1101/gr.1387003; Guziolowski C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-244; Kholodenko BN, 2002, P NATL ACAD SCI USA, V99, P12841, DOI 10.1073/pnas.192442699; Kim HD, 2009, SCIENCE, V325, P429, DOI 10.1126/science.1171347; Klamt S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-56; Klamt S, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-2; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Lipshtat A, 2009, ANN NY ACAD SCI, V1158, P44, DOI 10.1111/j.1749-6632.2008.03748.x; Ma'ayan A, 2009, J BIOL CHEM, V284, P5451, DOI 10.1074/jbc.R800056200; MacNamara A, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/4/045003; Melas IN, 2014, OSTEOARTHR CARTILAGE, V22, P509, DOI 10.1016/j.joca.2014.01.001; Melas IN, 2013, BIOPHARM DRUG DISPOS, V34, P477, DOI 10.1002/bdd.1859; Melas IN, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003204; Melas IN, 2012, MOL BIOSYST, V8, P1571, DOI 10.1039/c2mb05482e; Melas IN, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-107; Mitsos A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050085; Mitsos A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000591; Morris MK, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001099; Morris MK, 2010, BIOCHEMISTRY-US, V49, P3216, DOI 10.1021/bi902202q; Pandey A, 2000, NATURE, V405, P837, DOI 10.1038/35015709; Poussin C, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.9; Qiu P, 2011, IEEE T BIO-MED ENG, V58, P3518, DOI 10.1109/TBME.2011.2163188; Quach M, 2007, BIOINFORMATICS, V23, P3209, DOI 10.1093/bioinformatics/btm510; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Saez-Rodriguez J, 2011, CANCER RES, V71, P5400, DOI 10.1158/0008-5472.CAN-10-4453; Saez-Rodriguez J, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001844; Saez-Rodriguez J, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.87; Samaga R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000438; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; Sedgewick R., 1990, GRAPH ALGORITHMS ALG, V1, P485; Siegel A, 2006, BIOSYSTEMS, V84, P153, DOI 10.1016/j.biosystems.2005.10.006; Vasilyev Dmitry M, 2014, BMC Res Notes, V7, P516, DOI 10.1186/1756-0500-7-516; Wang RS, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/5/055001; Zheng Y, 2006, IEE P SYST BIOL, V153, P201, DOI 10.1049/ip-syb:20050088	47	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128411	10.1371/journal.pone.0128411	http://dx.doi.org/10.1371/journal.pone.0128411			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020784	Green Published, gold, Green Submitted			2022-12-26	WOS:000355187300109
J	Zhang, W; Niu, YQ; Zou, H; Luo, LQ; Liu, QC; Wu, WJ				Zhang, Wen; Niu, Yanqing; Zou, Hua; Luo, Longqiang; Liu, Qianchao; Wu, Weijian			Accurate Prediction of Immunogenic T-Cell Epitopes from Epitope Sequences Using the Genetic Algorithm-Based Ensemble Learning	PLOS ONE			English	Article							MHC CLASS-I; PROTEIN SUBCELLULAR LOCATIONS; TAP TRANSPORT EFFICIENCY; BINDING PEPTIDES; PROTEASOMAL CLEAVAGE; AFFINITY; DATABASE; SERVER; SVMHC	Background T-cell epitopes play the important role in T-cell immune response, and they are critical components in the epitope-based vaccine design. Immunogenicity is the ability to trigger an immune response. The accurate prediction of immunogenic T-cell epitopes is significant for designing useful vaccines and understanding the immune system. Methods In this paper, we attempt to differentiate immunogenic epitopes from non-immunogenic epitopes based on their primary structures. First of all, we explore a variety of sequence-derived features, and analyze their relationship with epitope immunogenicity. To effectively utilize various features, a genetic algorithm (GA)-based ensemble method is proposed to determine the optimal feature subset and develop the high-accuracy ensemble model. In the GA optimization, a chromosome is to represent a feature subset in the search space. For each feature subset, the selected features are utilized to construct the base predictors, and an ensemble model is developed by taking the average of outputs from base predictors. The objective of GA is to search for the optimal feature subset, which leads to the ensemble model with the best cross validation AUC (area under ROC curve) on the training set. Results Two datasets named 'IMMA2' and 'PAAQD' are adopted as the benchmark datasets. Compared with the state-of-the-art methods POPI, POPISK, PAAQD and our previous method, the GA-based ensemble method produces much better performances, achieving the AUC score of 0.846 on IMMA2 dataset and the AUC score of 0.829 on PAAQD dataset. The statistical analysis demonstrates the performance improvements of GA-based ensemble method are statistically significant. Conclusions The proposed method is a promising tool for predicting the immunogenic epitopes. The source codes and datasets are available in S1 File.	[Zhang, Wen; Zou, Hua; Liu, Qianchao; Wu, Weijian] Wuhan Univ, Sch Comp, Wuhan 430072, Peoples R China; [Zhang, Wen] Wuhan Univ, Res Inst Shenzhen, Shenzhen 518057, Peoples R China; [Niu, Yanqing] South Cent Univ Nationalities, Sch Math & Stat, Wuhan 430074, Peoples R China; [Luo, Longqiang] Wuhan Univ, Sch Math & Stat, Wuhan 430072, Peoples R China	Wuhan University; Wuhan University; South Central Minzu University; Wuhan University	Zhang, W (corresponding author), Wuhan Univ, Sch Comp, Wuhan 430072, Peoples R China.	zhangwen@whu.edu.cn	Zhang, Wen/W-7471-2019	Zhang, Wen/0000-0001-5221-2628	National Science Foundation of China [61103126]; Shenzhen development Foundation [JCYJ20130401160028781]; China Scholarship Council [201406275015]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen development Foundation; China Scholarship Council(China Scholarship Council)	The financial disclosure is updated as follows. WZ's work is supported by the National Science Foundation of China (61103126), Shenzhen development Foundation (JCYJ20130401160028781) and China Scholarship Council (201406275015).	Abeel T, 2009, BIOINFORMATICS, V25, pI313, DOI 10.1093/bioinformatics/btp191; Adamczak R, 2005, PROTEINS, V59, P467, DOI 10.1002/prot.20441; Antes I, 2006, BIOINFORMATICS, V22, pE16, DOI 10.1093/bioinformatics/btl216; Bhasin M, 2004, PROTEIN SCI, V13, P596, DOI 10.1110/ps.03373104; Bhasin M, 2005, NUCLEIC ACIDS RES, V33, pW202, DOI 10.1093/nar/gki587; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chen J, 2007, AMINO ACIDS, V33, P423, DOI 10.1007/s00726-006-0485-9; Chou KC, 2000, BIOCHEM BIOPH RES CO, V278, P477, DOI 10.1006/bbrc.2000.3815; Chou KC, 2005, BIOINFORMATICS, V21, P10, DOI 10.1093/bioinformatics/bth466; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; Donnes P, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-25; Donnes P, 2005, PROTEIN SCI, V14, P2132, DOI 10.1110/ps.051352405; Donnes P, 2006, NUCLEIC ACIDS RES, V34, pW194, DOI 10.1093/nar/gkl284; DUBCHAK I, 1995, P NATL ACAD SCI USA, V92, P8700, DOI 10.1073/pnas.92.19.8700; Hakenberg Jorg, 2003, Appl Bioinformatics, V2, P155; HORNE DS, 1988, BIOPOLYMERS, V27, P451, DOI 10.1002/bip.360270308; Jacob L, 2008, BIOINFORMATICS, V24, P358, DOI 10.1093/bioinformatics/btm611; Kawashima S, 2008, NUCLEIC ACIDS RES, V36, pD202, DOI 10.1093/nar/gkm998; Kesmir C, 2002, PROTEIN ENG, V15, P287, DOI 10.1093/protein/15.4.287; Larsen MV, 2005, EUR J IMMUNOL, V35, P2295, DOI 10.1002/eji.200425811; Liao L, 2003, J COMPUT BIOL, V10, P857, DOI 10.1089/106652703322756113; Liu W, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-182; Liu Wen, 2007, V409, P283, DOI 10.1007/978-1-60327-118-9_20; Nielsen M, 2004, BIOINFORMATICS, V20, P1388, DOI 10.1093/bioinformatics/bth100; Nielsen M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000796; Nussbaum AK, 2001, IMMUNOGENETICS, V53, P87, DOI 10.1007/s002510100300; Park KJ, 2003, BIOINFORMATICS, V19, P1656, DOI 10.1093/bioinformatics/btg222; PARKER KC, 1994, J IMMUNOL, V152, P163; Peters B, 2003, J IMMUNOL, V171, P1741, DOI 10.4049/jimmunol.171.4.1741; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Reche PA, 2004, IMMUNOGENETICS, V56, P405, DOI 10.1007/s00251-004-0709-7; Reche Pedro A., 2007, V409, P185, DOI 10.1007/978-1-60327-118-9_13; Rudolph MG, 2002, ANNU REV BIOPH BIOM, V31, P121, DOI 10.1146/annurev.biophys.31.082901.134423; Saethang T, 2013, J IMMUNOL METHODS, V387, P293, DOI 10.1016/j.jim.2012.09.016; SILVER ML, 1992, NATURE, V360, P367, DOI 10.1038/360367a0; Stewart-Jones GBE, 2003, NAT IMMUNOL, V4, P657, DOI 10.1038/ni942; Tenzer S, 2005, CELL MOL LIFE SCI, V62, P1025, DOI 10.1007/s00018-005-4528-2; Tung CW, 2007, BIOINFORMATICS, V23, P942, DOI 10.1093/bioinformatics/btm061; Tung CW, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-446; Vita R, 2010, NUCLEIC ACIDS RES, V38, pD854, DOI 10.1093/nar/gkp1004; Wan J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-463; Wen Zhang, 2013, 2013 IEEE International Conference on Bioinformatics and Biomedicine (BIBM), P4, DOI 10.1109/BIBM.2013.6732451; Zhang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043575; Zhang W, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-341	44	26	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128194	10.1371/journal.pone.0128194	http://dx.doi.org/10.1371/journal.pone.0128194			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020952	Green Published, gold, Green Submitted			2022-12-26	WOS:000355187300087
J	Corcoran, JA; Jordan, MD; Thrimawithana, AH; Crowhurst, RN; Newcomb, RD				Corcoran, Jacob A.; Jordan, Melissa D.; Thrimawithana, Amali H.; Crowhurst, Ross N.; Newcomb, Richard D.			The Peripheral Olfactory Repertoire of the Lightbrown Apple Moth, Epiphyas postvittana	PLOS ONE			English	Article							DROSOPHILA ODORANT RECEPTORS; IONOTROPIC GLUTAMATE RECEPTORS; CANDIDATE PHEROMONE RECEPTORS; SEX-PHEROMONE; BINDING-PROTEINS; FUNCTIONAL-CHARACTERIZATION; LEPIDOPTERA; ANTENNAE; TORTRICIDAE; RESPONSES	The lightbrown apple moth, Epiphyas postvittana is an increasingly global pest of horticultural crops. Like other moths, E. postvittana relies on olfactory cues to locate mates and oviposition sites. To detect these cues, moths have evolved families of genes encoding elements of the peripheral olfactory reception system, including odor carriers, receptors and degrading enzymes. Here we undertake a transcriptomic approach to identify members of these families expressed in the adult antennae of E. postvittana, describing open reading frames encoding 34 odorant binding proteins, 13 chemosensory proteins, 70 odorant receptors, 19 ionotropic receptors, nine gustatory receptors, two sensory neuron membrane proteins, 27 carboxylesterases, 20 glutathione-S-transferases, 49 cytochrome p450s and 18 takeout proteins. For the odorant receptors, quantitative RT-PCR corroborated RNAseq count data on steady state transcript levels. Of the eight odorant receptors that group phylogenetically with pheromone receptors from other moths, two displayed significant male-biased expression patterns, one displayed significant female-biased expression pattern and five were expressed equally in the antennae of both sexes. In addition, we found two male-biased odorant receptors that did not group with previously described pheromone receptors. This suite of olfaction-related genes provides a substantial resource for the functional characterization of this signal transduction system and the development of odor-mediated control strategies for horticultural pests.	[Corcoran, Jacob A.; Newcomb, Richard D.] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Corcoran, Jacob A.; Jordan, Melissa D.; Thrimawithana, Amali H.; Crowhurst, Ross N.; Newcomb, Richard D.] New Zealand Inst Plant & Food Res Ltd, Auckland, New Zealand	University of Auckland; New Zealand Institute for Plant & Food Research Ltd	Newcomb, RD (corresponding author), Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand.	Richard.Newcomb@plantandfood.co.nz	Thrimawithana, Amali H/O-4702-2017; Crowhurst, Ross N/N-8892-2017; Newcomb, Richard/C-2067-2009	Thrimawithana, Amali H/0000-0001-6325-2334; Crowhurst, Ross N/0000-0003-0608-2134; Newcomb, Richard/0000-0002-7307-9755; Corcoran, Jacob/0000-0002-2698-850X	New Zealand Ministry of Business, Innovation and Employment [C06X0701]; Agricultural and Marketing Research and Development Trust of New Zealand [1161]	New Zealand Ministry of Business, Innovation and Employment(New Zealand Ministry of Business, Innovation and Employment (MBIE)); Agricultural and Marketing Research and Development Trust of New Zealand	This work was supported by the New Zealand Ministry of Business, Innovation and Employment (C06X0701) to RDN (http://www.mbie.govt.nz/) and The Agricultural and Marketing Research and Development Trust of New Zealand (1161) to MDJ (http://www.agmardt.org.nz/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AR, 2009, INSECT BIOCHEM MOLEC, V39, P189, DOI 10.1016/j.ibmb.2008.11.002; Andrews S., 2010, FASTQC QUALITY CONTR; Aronesty E, UTILS COMMAND LINE T; Begum D, 2011, THESIS U AUCKLAND AU; BELLAS TE, 1983, J CHEM ECOL, V9, P503, DOI 10.1007/BF00990222; Bengtsson JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031620; Benton R, 2006, CHEM SENSES, V31, pA5; Benton R, 2007, NATURE, V450, P289, DOI 10.1038/nature06328; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Biomatters, GEN V6 0 6; Carraher C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038391; Corcoran JA, 2014, INSECT BIOCHEM MOLEC, V54, P22, DOI 10.1016/j.ibmb.2014.08.005; Damberger FF, 2013, P NATL ACAD SCI USA, V110, P18680, DOI 10.1073/pnas.1317706110; Dasmahapatra KK, 2012, NATURE, V487, P94, DOI 10.1038/nature11041; El-Sayed AM, 2011, J CHEM ECOL, V37, P640, DOI 10.1007/s10886-011-9964-x; Fan J, 2011, GENET MOL RES, V10, P3056, DOI 10.4238/2011.December.8.2; Forstner Maike, 2009, Int J Biol Sci, V5, P745; Grosse-Wilde E, 2007, EUR J NEUROSCI, V25, P2364, DOI 10.1111/j.1460-9568.2007.05512.x; Grosse-Wilde E, 2006, CHEM SENSES, V31, P547, DOI 10.1093/chemse/bjj059; Hamiaux C, 2009, J BIOL CHEM, V284, P3496, DOI 10.1074/jbc.M807467200; Hamiaux C, 2013, J STRUCT BIOL, V182, P259, DOI 10.1016/j.jsb.2013.03.013; Hekmat-Scafe DS, 2002, GENOME RES, V12, P1357, DOI 10.1101/gr.239402; Ishida Y, 2005, P NATL ACAD SCI USA, V102, P14075, DOI 10.1073/pnas.0505340102; Ishida Y, 2008, P NATL ACAD SCI USA, V105, P9076, DOI 10.1073/pnas.0802610105; Jordan MD, 2008, INSECT MOL BIOL, V17, P361, DOI 10.1111/j.1365-2583.2008.00812.x; Jordan MD, 2009, CHEM SENSES, V34, P383, DOI 10.1093/chemse/bjp010; KANAUJIA S, 1985, J INSECT PHYSIOL, V31, P71, DOI 10.1016/0022-1910(85)90044-7; Krieger J, 2004, P NATL ACAD SCI USA, V101, P11845, DOI 10.1073/pnas.0403052101; Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635; Masante-Roca I, 2005, J EXP BIOL, V208, P1147, DOI 10.1242/jeb.01508; Miura N, 2010, INSECT BIOCHEM MOLEC, V40, P64, DOI 10.1016/j.ibmb.2009.12.011; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Newcomb RD, 2002, INSECT BIOCHEM MOLEC, V32, P1543, DOI 10.1016/S0965-1748(02)00075-9; Pelosi P, 1996, J NEUROBIOL, V30, P3; PELOSI P, 1995, COMP BIOCHEM PHYS B, V111, P503, DOI 10.1016/0305-0491(95)00019-5; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Rambaut A, FIGTREE V1 4 0; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Rogers ME, 2001, CELL TISSUE RES, V303, P433, DOI 10.1007/s004410000305; Rogers ME, 2001, J NEUROBIOL, V49, P47, DOI 10.1002/neu.1065; RUMBO ER, 1983, PHYSIOL ENTOMOL, V8, P195, DOI 10.1111/j.1365-3032.1983.tb00349.x; RYBCZYNSKI R, 1990, J BIOL CHEM, V265, P19712; Rytz R, 2013, INSECT BIOCHEM MOLEC, V43, P888, DOI 10.1016/j.ibmb.2013.02.007; Sakurai T, 2004, P NATL ACAD SCI USA, V101, P16653, DOI 10.1073/pnas.0407596101; Sato K, 2008, CHEM SENSES, V33, pS74; SINGH P, 1974, New Zealand Journal of Zoology, V1, P241; Smart R, 2008, INSECT BIOCHEM MOLEC, V38, P770, DOI 10.1016/j.ibmb.2008.05.002; Suckling DM, 2010, ANNU REV ENTOMOL, V55, P285, DOI 10.1146/annurev-ento-112408-085311; Suckling DM, 1996, NEW ZEAL J CROP HORT, V24, P323, DOI 10.1080/01140671.1996.9513969; Syed Z, 2010, P NATL ACAD SCI USA, V107, P9436, DOI 10.1073/pnas.1003881107; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tooman LK, 2011, J ECON ENTOMOL, V104, P920, DOI 10.1603/EC10342; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Varela N, 2009, CELL TISSUE RES, V337, P513, DOI 10.1007/s00441-009-0839-1; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; Vogt RG, 2005, MOL BASIS PHEROMONE; Vogt Richard G., 2003, P391, DOI 10.1016/B978-012107151-6/50016-5; Wang G, 2011, INSECT MOL BIOL, V20, P125, DOI 10.1111/j.1365-2583.2010.01045.x; Wanner KW, 2007, INSECT MOL BIOL, V16, P107, DOI 10.1111/j.1365-2583.2007.00708.x; Wanner KW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008685; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Xia QY, 2008, INSECT BIOCHEM MOLEC, V38, P1036, DOI [10.1016/j.ibmb.2009.01.004, 10.1016/j.ibmb.2008.11.004]; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031; Yasukochi Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018843; You MS, 2013, NAT GENET, V45, P220, DOI 10.1038/ng.2524; Zhan S, 2011, CELL, V147, P1171, DOI 10.1016/j.cell.2011.09.052	69	36	39	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0128596	10.1371/journal.pone.0128596	http://dx.doi.org/10.1371/journal.pone.0128596			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26017144	Green Submitted, Green Published, gold			2022-12-26	WOS:000355185600122
J	Pearse, WD; Chase, MW; Crawley, MJ; Dolphin, K; Fay, MF; Joseph, JA; Powney, G; Preston, CD; Rapacciuolo, G; Roy, DB; Purvis, A				Pearse, William D.; Chase, Mark W.; Crawley, Michael J.; Dolphin, Konrad; Fay, Michael F.; Joseph, Jeffrey A.; Powney, Gary; Preston, Chris D.; Rapacciuolo, Giovanni; Roy, David B.; Purvis, Andy			Beyond the EDGE with EDAM: Prioritising British Plant Species According to Evolutionary Distinctiveness, and Accuracy and Magnitude of Decline	PLOS ONE			English	Article							PHYLOGENETIC DIVERSITY; DISTRIBUTION MODELS; CONSERVATION; TAXA; ESTABLISHMENT; BIODIVERSITY	Conservation biologists have only finite resources, and so must prioritise some species over others. The EDGE-listing approach ranks species according to their combined evolutionary distinctiveness and degree of threat, but ignores the uncertainty surrounding both threat and evolutionary distinctiveness. We develop a new family of measures for species, which we name EDAM, that incorporates evolutionary distinctiveness, the magnitude of decline, and the accuracy with which decline can be predicted. Further, we show how the method can be extended to explore phyogenetic uncertainty. Using the vascular plants of Britain as a case study, we find that the various EDAM measures emphasise different species and parts of Britain, and that phylogenetic uncertainty can strongly affect the prioritisation scores of some species.	[Pearse, William D.; Crawley, Michael J.; Dolphin, Konrad; Powney, Gary; Rapacciuolo, Giovanni; Purvis, Andy] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Ascot, Berks, England; [Pearse, William D.; Powney, Gary; Preston, Chris D.; Rapacciuolo, Giovanni; Roy, David B.; Purvis, Andy] Ctr Ecol & Hydrol, Wallingford, Oxon, England; [Pearse, William D.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Chase, Mark W.; Fay, Michael F.; Joseph, Jeffrey A.] Jodrell Lab, Royal Bot Gardens Kew, Richmond TW7 3DS, Surrey, England; [Purvis, Andy] Nat Hist Museum, Dept Life Sci, London SW7 5BD, England	Imperial College London; UK Centre for Ecology & Hydrology (UKCEH); University of Minnesota System; University of Minnesota Twin Cities; Royal Botanic Gardens, Kew; Natural History Museum London	Pearse, WD (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Ascot, Berks, England.	will.pearse@gmail.com	Chase, Mark W/A-6642-2011; Fay, Michael F/G-4741-2010; Purvis, Andy/A-7529-2008; Roy, David/A-6619-2009; Fay, Michael/AAU-5861-2021	Fay, Michael F/0000-0003-3491-9093; Purvis, Andy/0000-0002-8609-6204; Roy, David/0000-0002-5147-0331; Chase, Mark/0000-0002-9927-4938; Pearse, William D/0000-0002-6241-3164; Rapacciuolo, Giovanni/0000-0003-1494-9017; Powney, Gary/0000-0003-3313-7786	Natural Environment Research Council (NERC); NERC [ceh020002] Funding Source: UKRI; Natural Environment Research Council [ceh020002] Funding Source: researchfish	Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	WDP was funded by a Natural Environment Research Council (NERC) Collaborative Award in Science and Engineering (CASE) PhD studentship.	Aberer AJ, 2013, SYST BIOL, V62, P162, DOI 10.1093/sysbio/sys078; Araujo MB, 2012, ECOLOGY, V93, P1527, DOI 10.1890/11-1930.1; Bennett JR, 2014, BIOL CONSERV, V174, P47, DOI 10.1016/j.biocon.2014.03.013; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bivand R., 2013, CLASSINT CHOOSE UNIV; Bossard M., 2000, 40 EEA; Braithwaite ME, 2006, CHANG BRIT FLORA 198; Britton T, 2007, SYSTEMATIC BIOL, V56, P741, DOI 10.1080/10635150701613783; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Cheffings C. M., 2005, SPECIES STATUS, V7, P1; Collen B, 2011, PHILOS T R SOC B, V366, P2611, DOI 10.1098/rstb.2011.0109; Dobrowski SZ, 2011, ECOL MONOGR, V81, P241, DOI 10.1890/10-1325.1; Fay MF, 1998, TAXON, V47, P43, DOI 10.2307/1224017; Fay Michael F., 1997, Kew Bulletin, V52, P111, DOI 10.2307/4117844; Hartmann K, 2013, BIODIVERS CONSERV, V22, P449, DOI 10.1007/s10531-012-0422-z; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; Hill M.O., 2004, PLANTATT ATTRIBUTES; Isaac NJB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000296; Isaac NJB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043912; Jetz W, 2014, CURR BIOL, V24, P919, DOI 10.1016/j.cub.2014.03.011; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kharouba HM, 2009, ECOLOGY, V90, P2213, DOI 10.1890/08-1304.1; Kissling WD, 2012, J BIOGEOGR, V39, P2163, DOI 10.1111/j.1365-2699.2011.02663.x; Kores Paul J., 1997, Lindleyana, V12, P1; Kuhn TS, 2011, METHODS ECOL EVOL, V2, P427, DOI 10.1111/j.2041-210X.2011.00103.x; Lledo MD, 1998, SYST BOT, V23, P21, DOI 10.2307/2419571; Mace GM, 2008, CONSERV BIOL, V22, P1424, DOI 10.1111/j.1523-1739.2008.01044.x; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING SY; Mooers AO, 2005, CONSERV BIOL SER, V8, P120; MYERS N, 1993, AMBIO, V22, P74; Orme D., 2013, CAPER COMP ANAL PHYL; Pearse WD, 2013, METHODS ECOL EVOL, V4, P692, DOI 10.1111/2041-210X.12055; Perring F.H., 1962, ATLAS BRIT FLORA; Phillips SJ, 2010, ECOLOGY, V91, P2476, DOI 10.1890/09-0760.1; Pilgrim ES, 2004, BIOL CONSERV, V120, P161, DOI 10.1016/j.biocon.2004.02.008; Possingham HP, 2002, TRENDS ECOL EVOL, V17, P503, DOI 10.1016/S0169-5347(02)02614-9; Powney GD, 2014, BIODIVERS CONSERV, V23, P171, DOI 10.1007/s10531-013-0590-5; Preston C, 2002, NEW ATLAS BRIT IRISH; Rapacciuolo G, 2014, METHODS ECOL EVOL, V5, P407, DOI 10.1111/2041-210X.12181; Rapacciuolo G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040212; Redding DW, 2006, CONSERV BIOL, V20, P1670, DOI 10.1111/j.1523-1739.2006.00555.x; Ridgeway G., 2007, GBM GEN BOOSTED REGR; Rosindell J, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001406; Safi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063582; Sanderson MJ, 2011, SCIENCE, V333, P448, DOI 10.1126/science.1206357; Southall H, 2009, VISION BRITAIN TIME; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Strauss SY, 2006, P NATL ACAD SCI USA, V103, P5841, DOI 10.1073/pnas.0508073103; Telfer MG, 2002, BIOL CONSERV, V107, P99, DOI 10.1016/S0006-3207(02)00050-2; Tingley R, 2011, AM NAT, V177, P382, DOI 10.1086/658342; UK Biodiversity Reporting and Information Group, 2007, TECHNICAL REPORT; Van Wilgen NJ, 2012, CONSERV BIOL, V26, P267, DOI 10.1111/j.1523-1739.2011.01804.x; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Weitzman ML, 1998, ECONOMETRICA, V66, P1279, DOI 10.2307/2999617; Wiens JJ, 2010, ECOL LETT, V13, P1310, DOI 10.1111/j.1461-0248.2010.01515.x; Winter M, 2013, TRENDS ECOL EVOL, V28, P199, DOI 10.1016/j.tree.2012.10.015	57	10	10	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0126524	10.1371/journal.pone.0126524	http://dx.doi.org/10.1371/journal.pone.0126524			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018568	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000355185600053
J	Smith, RWA; Monroe, C; Bolnick, DA				Smith, Rick W. A.; Monroe, Cara; Bolnick, Deborah A.			Detection of Cytosine Methylation in Ancient DNA from Five Native American Populations Using Bisulfite Sequencing	PLOS ONE			English	Article							PRESERVATION; EXTRACTION; EVOLUTION; PATTERNS; BONES	While cytosine methylation has been widely studied in extant populations, relatively few studies have analyzed methylation in ancient DNA. Most existing studies of epigenetic marks in ancient DNA have inferred patterns of methylation in highly degraded samples using post-mortem damage to cytosines as a proxy for cytosine methylation levels. However, this approach limits the inference of methylation compared with direct bisulfite sequencing, the current gold standard for analyzing cytosine methylation at single nucleotide resolution. In this study, we used direct bisulfite sequencing to assess cytosine methylation in ancient DNA from the skeletal remains of 30 Native Americans ranging in age from approximately 230 to 4500 years before present. Unmethylated cytosines were converted to uracils by treatment with sodium bisulfite, bisulfite products of a CpG-rich retrotransposon were pyrosequenced, and C-to-T ratios were quantified for a single CpG position. We found that cytosine methylation is readily recoverable from most samples, given adequate preservation of endogenous nuclear DNA. In addition, our results indicate that the precision of cytosine methylation estimates is inversely correlated with aDNA preservation, such that samples of low DNA concentration show higher variability in measures of percent methylation than samples of high DNA concentration. In particular, samples in this study with a DNA concentration above 0.015 ng/mu L generated the most consistent measures of cytosine methylation. This study presents evidence of cytosine methylation in a large collection of ancient human remains, and indicates that it is possible to analyze epigenetic patterns in ancient populations using direct bisulfite sequencing approaches.	[Smith, Rick W. A.; Bolnick, Deborah A.] Univ Texas Austin, Dept Anthropol, Austin, TX 78712 USA; [Monroe, Cara] Washington State Univ, Dept Anthropol, Pullman, WA 99164 USA; [Monroe, Cara] Univ Calif Santa Barbara, Dept Anthropol, Santa Barbara, CA 93106 USA; [Bolnick, Deborah A.] Univ Texas Austin, Populat Res Ctr, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; Washington State University; University of California System; University of California Santa Barbara; University of Texas System; University of Texas Austin	Smith, RWA (corresponding author), Univ Texas Austin, Dept Anthropol, Austin, TX 78712 USA.	rickwasmith@utexas.edu			University of Texas at Austin; Sigma Xi [G2012162144]	University of Texas at Austin; Sigma Xi	Research funds were provided to DAB by the University of Texas at Austin. Sigma Xi Grant-in-Aid of Research (Grant ID: G2012162144) was granted to RWAS (https://www.sigmaxi.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler CJ, 2011, J ARCHAEOL SCI, V38, P956, DOI 10.1016/j.jas.2010.11.010; Allentoft ME, 2012, P ROY SOC B-BIOL SCI, V279, P4724, DOI 10.1098/rspb.2012.1745; Attwood JT, 2002, CELL MOL LIFE SCI, V59, P241, DOI 10.1007/s00018-002-8420-z; Bestor TH, 1998, CIBA F SYMP, V214, P187; Boissinot S, 2000, MOL BIOL EVOL, V17, P915, DOI 10.1093/oxfordjournals.molbev.a026372; Bolnick DA, 2007, AM ANTIQUITY, V72, P627, DOI 10.2307/25470437; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Briggs AW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1163; Burger J, 1999, ELECTROPHORESIS, V20, P1722; Campos PF, 2012, ANN ANAT, V194, P7, DOI 10.1016/j.aanat.2011.07.003; GAMASOSA MA, 1983, BIOCHIM BIOPHYS ACTA, V740, P212, DOI 10.1016/0167-4781(83)90079-9; Gilbert MTP, 2005, TRENDS ECOL EVOL, V20, P541, DOI 10.1016/j.tree.2005.07.005; Gokhman D, 2014, SCIENCE, V344, P523, DOI 10.1126/science.1250368; Grand A, 2014, J MOL MODEL, V20, DOI 10.1007/s00894-014-2290-9; Grunau C, 2001, NUCLEIC ACIDS RES, V29, P1; Hummel S, 2002, INT J LEGAL MED, V116, P327, DOI 10.1007/s00414-002-0315-x; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Kaestle FA, 2002, YEARB PHYS ANTHROPOL, V45, P92, DOI 10.1002/ajpa.10179; Kazazian H, 1998, NAT GENET; Kemp BM, 2006, J ARCHAEOL SCI, V33, P1680, DOI 10.1016/j.jas.2006.02.015; King CE, 2009, BIOTECHNIQUES, V47, P941, DOI 10.2144/000113244; Llamas B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030226; Mata-Miguez J, 2012, AM J PHYS ANTHROPOL, V149, P504, DOI 10.1002/ajpa.22152; Myers JS, 2002, AM J HUM GENET, V71, P312, DOI 10.1086/341718; Nestor CE, 2012, GENOME RES, V22, P467, DOI 10.1101/gr.126417.111; Orlando L, 2014, SCIENCE, V345, P511, DOI 10.1126/science.1256515; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Pedersen JS, 2014, GENOME RES, V24, P454, DOI 10.1101/gr.163592.113; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; R Core Team, 2013, LANG ENV STAT COMP, DOI [DOI 10.3758/S13428-013-0330-5, 10.3758/s13428-013-0330-5]; Rakotoarisoa G, 2006, MOL ECOL NOTES, V6, P1122, DOI 10.1111/j.1471-8286.2006.01458.x; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Rohland N, 2007, NAT PROTOC, V2, P1756, DOI 10.1038/nprot.2007.247; Rusmintratip V, 2000, P NATL ACAD SCI USA, V97, P14183, DOI 10.1073/pnas.97.26.14183; Ruzov A, 2011, CELL RES, V21, P1332, DOI 10.1038/cr.2011.113; Sawyer S, 2012, PLOS ONE, V7, P1; Schwarz C, 2009, NUCLEIC ACIDS RES, V37, P3215, DOI 10.1093/nar/gkp159; Shapiro B, 2012, METHODS MOL BIOL, V840, P1, DOI 10.1007/978-1-61779-516-9; Sheen FM, 2000, GENOME RES, V10, P1496, DOI 10.1101/gr.149400; Smith O, 2014, SCI REP-UK, V4, DOI 10.1038/srep05559; SVED J, 1990, P NATL ACAD SCI USA, V87, P4692, DOI 10.1073/pnas.87.12.4692; Villanea FA, 2013, AM J PHYS ANTHROPOL, V151, P649, DOI 10.1002/ajpa.22292; Willerslev E, 2005, P ROY SOC B-BIOL SCI, V272, P3, DOI 10.1098/rspb.2004.2813; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5; Zhang FF, 2011, J NUTR, V141, P1165, DOI 10.3945/jn.110.134536	45	29	29	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0125344	10.1371/journal.pone.0125344	http://dx.doi.org/10.1371/journal.pone.0125344			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26016479	Green Submitted, Green Published, gold			2022-12-26	WOS:000355185600017
J	Teves, ME; Sundaresan, G; Cohen, DJ; Hyzy, SL; Kajan, I; Maczis, M; Zhang, ZB; Costanzo, RM; Zweit, J; Schwartz, Z; Boyan, BD; Strauss, JF				Teves, Maria Eugenia; Sundaresan, Gobalakrishnan; Cohen, David J.; Hyzy, Sharon L.; Kajan, Illya; Maczis, Melissa; Zhang, Zhibing; Costanzo, Richard M.; Zweit, Jamal; Schwartz, Zvi; Boyan, Barbara D.; Strauss, Jerome F., III			Spag17 Deficiency Results in Skeletal Malformations and Bone Abnormalities	PLOS ONE			English	Article							PRIMARY CILIUM; GROWTH; LOCI; PF6; PATTERN; COMPLEX; HEIGHT; CELLS	Height is the result of many growth and development processes. Most of the genes associated with height are known to play a role in skeletal development. Single-nucleotide polymorphisms in the SPAG17 gene have been associated with human height. However, it is not clear how this gene influences linear growth. Here we show that a targeted mutation in Spag17 leads to skeletal malformations. Hind limb length in mutants was significantly shorter than in wild-type mice. Studies revealed differences in maturation of femur and tibia suggesting alterations in limb patterning. Morphometric studies showed increased bone formation evidenced by increased trabecular bone area and the ratio of bone area to total area, leading to reductions in the ratio of marrow area/total area in the femur. Micro-CTs and von Kossa staining demonstrated increased mineral in the femur. Moreover, osteocalcin and osterix were more highly expressed in mutant mice than in wild-type mice femurs. These data suggest that femur bone shortening may be due to premature ossification. On the other hand, tibias appear to be shorter due to a delay in cartilage and bone development. Morphometric studies showed reduction in growth plate and bone formation. These defects did not affect bone mineralization, although the volume of primary bone and levels of osteocalcin and osterix were higher. Other skeletal malformations were observed including fused sternebrae, reduced mineralization in the skull, medial and metacarpal phalanges. Primary cilia from chondrocytes, osteoblasts, and embryonic fibroblasts (MEFs) isolated from knockout mice were shorter and fewer cells had primary cilia in comparison to cells from wild-type mice. In addition, Spag17 knockdown in wild-type MEFs by Spag17 siRNA duplex reproduced the shorter primary cilia phenotype. Our findings disclosed unexpected functions for Spag17 in the regulation of skeletal growth and mineralization, perhaps because of its role in primary cilia of chondrocytes and osteoblasts.	[Teves, Maria Eugenia; Zhang, Zhibing; Strauss, Jerome F., III] Virginia Commonwealth Univ, Dept Obstet & Gynecol, Richmond, VA 23284 USA; [Sundaresan, Gobalakrishnan; Zweit, Jamal] Virginia Commonwealth Univ, Dept Radiol, Richmond, VA USA; [Cohen, David J.; Hyzy, Sharon L.; Kajan, Illya; Maczis, Melissa; Schwartz, Zvi; Boyan, Barbara D.] Virginia Commonwealth Univ, Dept Biomed Engn, Richmond, VA USA; [Zhang, Zhibing; Boyan, Barbara D.; Strauss, Jerome F., III] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Richmond, VA USA; [Costanzo, Richard M.] Virginia Commonwealth Univ, Dept Physiol & Biophys, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Strauss, JF (corresponding author), Virginia Commonwealth Univ, Dept Obstet & Gynecol, Med Coll Virginia Campus, Richmond, VA 23284 USA.	jfstrauss@vcu.edu	Teves, Maria/AAJ-9523-2020	Teves, Maria/0000-0001-7035-2202; Costanzo, Richard/0000-0002-6839-3520; Gobalakrishnan, Sundaresan/0000-0002-9620-5611	National Institutes of Health [R01 HD-37416, R01 HD-076257]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD076257] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD037416] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by National Institutes of Health [grant number R01 HD-37416 to J.F.S., R01 HD-076257 to Z.Z.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; BOYAN BD, 1988, ENDOCRINOLOGY, V122, P2851, DOI 10.1210/endo-122-6-2851; BOYAN BD, 1989, ANAT REC, V224, P211, DOI 10.1002/ar.1092240210; BRUDER SP, 1989, CONNECT TISSUE RES, V20, P65, DOI 10.3109/03008208909023875; CHEN JM, 1952, J ANAT, V86, P373; Day TF, 2008, J BONE JOINT SURG AM, V90A, P19, DOI 10.2106/JBJS.G.01174; Delaine-Smith RM, 2014, FASEB J, V28, P430, DOI 10.1096/fj.13-231894; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Goduti DJ, 2012, CYTOSKELETON, V69, P179, DOI 10.1002/cm.21010; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Hajihosseini MK, 2004, DEVELOPMENT, V131, P325, DOI 10.1242/dev.00940; Hoey DA, 2012, J BIOMECH, V45, P17, DOI 10.1016/j.jbiomech.2011.08.008; Kim JJ, 2010, J HUM GENET, V55, P27, DOI 10.1038/jhg.2009.116; Kimura A, 2010, DEVELOPMENT, V137, P1159, DOI 10.1242/dev.045005; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Liakhovitskaia A, 2010, DEV BIOL, V340, P539, DOI 10.1016/j.ydbio.2010.02.005; Lohmann CH, 2000, J BONE MINER RES, V15, P1169, DOI 10.1359/jbmr.2000.15.6.1169; Michigami T, 2013, CELL MOL LIFE SCI, V70, P4213, DOI 10.1007/s00018-013-1346-9; N'Diaye A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002298; Niswander L, 2003, NAT REV GENET, V4, P133, DOI 10.1038/nrg1001; Ovchinnikov Dmitry, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.prot5170; Rupp G, 2001, MOL BIOL CELL, V12, P739, DOI 10.1091/mbc.12.3.739; Schmidts M, 2014, J PEDIATR GENET, V3, P49, DOI 10.3233/PGE-14089; Silina K, 2011, J IMMUNOTHER, V34, P28, DOI 10.1097/CJI.0b013e3181fb64fa; Takeuchi F, 2009, J HUM GENET, V54, P749, DOI 10.1038/jhg.2009.99; Temiyasathit S, 2010, ANN NY ACAD SCI, V1192, P422, DOI 10.1111/j.1749-6632.2009.05243.x; Teves ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107271; Teves ME, 2013, AM J RESP CELL MOL, V48, P765, DOI 10.1165/rcmb.2012-0362OC; van der Valk RJP, 2015, HUM MOL GENET, V24, P1155, DOI 10.1093/hmg/ddu510; Wang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112708; Wargo MJ, 2005, J CELL SCI, V118, P4655, DOI 10.1242/jcs.02585; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Weedon MN, 2008, TRENDS GENET, V24, P595, DOI 10.1016/j.tig.2008.09.006; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Yuan X, 2015, ANN NY ACAD SCI, V1335, P78, DOI 10.1111/nyas.12463; Zhang ZB, 2005, MOL CELL PROTEOMICS, V4, P914, DOI 10.1074/mcp.M400177-MCP200; Zhao JH, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-96	37	23	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0125936	10.1371/journal.pone.0125936	http://dx.doi.org/10.1371/journal.pone.0125936			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26017218	Green Submitted, Green Published, gold			2022-12-26	WOS:000355185600043
J	Bolotov, IN; Bespalaya, YV; Vikhrev, IV; Aksenova, OV; Aspholm, PE; Gofarov, MY; Klishko, OK; Kolosova, YS; Kondakov, AV; Lyubas, AA; Paltser, IS; Konopleva, ES; Tumpeesuwan, S; Bolotov, NI; Voroshilova, IS				Bolotov, Ivan N.; Bespalaya, Yulia V.; Vikhrev, Ilya V.; Aksenova, Olga V.; Aspholm, Paul E.; Gofarov, Mikhail Y.; Klishko, Olga K.; Kolosova, Yulia S.; Kondakov, Alexander V.; Lyubas, Artyom A.; Paltser, Inga S.; Konopleva, Ekaterina S.; Tumpeesuwan, Sakboworn; Bolotov, Nikita I.; Voroshilova, Irina S.			Taxonomy and Distribution of Freshwater Pearl Mussels (Unionoida: Margaritiferidae) of the Russian Far East	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; BIVALVIA MARGARITIFERIDAE; CONSERVATION GENETICS; DAHURICA MIDDENDORFF; MITOCHONDRIAL GENOME; COMPARATORY METHOD; GLOBAL DIVERSITY; SPECIES BIVALVIA; LAEVIS BIVALVIA; MOLLUSCA	The freshwater pearl mussel family Margaritiferidae includes 13 extant species, which are all listed by IUCN as endangered or vulnerable taxa. In this study, an extensive spatial sampling of Margaritifera spp. across the Russian Far East (Amur Basin, Kamchatka Peninsula, Kurile Archipelago and Sakhalin Island) was conducted for a revision of their taxonomy and distribution ranges. Based on their DNA sequences, shell and soft tissue morphology, three valid species were identified: Margaritifera dahurica (Middendorff, 1850), M. laevis (Haas, 1910) and M. middendorffi (Rosen, 1926). M. dahurica ranges across the Amur basin and some of the nearest river systems. M. laevis is distributed in Japan, Sakhalin Island and the Kurile Archipelago. M. middendorffi was previously considered an endemic species of the Kamchatka. However, it is widespread in the rivers of Kamchatka, Sakhalin Island, the Kurile Islands ( across the Bussol Strait, which is the most significant biogeographical boundary within the archipelago), and, likely, in Japan. The Japanese species M. togakushiensis Kondo & Kobayashi, 2005 seems to be conspecific with M. middendorffi because of similar morphological patterns, small shell size (<100 mm long) and overlapped ranges, but it is in need of a separate revision. Phylogenetic analysis reveals that two NW Pacific margaritiferid species, M. laevis and M. middendorffi, formed a monophyletic 18S rDNA clade together with the North American species M. marrianae and M. falcata. The patterns that were found in these Margaritifera spp. are similar to those of freshwater fishes, indicating multiple colonizations of Eastern Asia by different mitochondrial lineages, including an ancient Beringian exchange between freshwater faunas across the Pacific.	[Bolotov, Ivan N.; Bespalaya, Yulia V.; Vikhrev, Ilya V.; Aksenova, Olga V.; Gofarov, Mikhail Y.; Kolosova, Yulia S.; Kondakov, Alexander V.; Lyubas, Artyom A.; Paltser, Inga S.; Konopleva, Ekaterina S.; Bolotov, Nikita I.] Russian Acad Sci, Inst Ecol Problems North, Ural Branch, Arkhangelsk, Russia; [Aspholm, Paul E.] Svanhovd, Norwegian Inst Agr & Environm Res Bioforsk, Svanvik, Norway; [Klishko, Olga K.] Russian Acad Sci, Inst Nat Resources Ecol & Cryol, Siberian Branch, Chita, Russia; [Tumpeesuwan, Sakboworn] Maha Sarakham Univ, Fac Sci, Dept Biol, Maha Sarakham, Thailand; [Voroshilova, Irina S.] Russian Acad Sci, ID Papanin Inst Biol Inland Waters, Borok, Yaroslavl Oblas, Russia	N. Laverov Federal Center for Integrated Arctic Research; Institute of Ecological Problems of the North, Ural Branch of the RAS; Russian Academy of Sciences; Bioforsk; Russian Academy of Sciences; Mahasarakham University; Papanin Institute for Biology of Inland Waters; Russian Academy of Sciences	Vikhrev, IV (corresponding author), Russian Acad Sci, Inst Ecol Problems North, Ural Branch, Arkhangelsk, Russia.	vikhrevilja@gmail.com	Yulia, Bespalaya V/C-6844-2015; Vikhrev, Ilya V/F-2902-2017; Kondakov, Alexander V/C-9202-2018; Bolotov, Ivan N/P-2892-2015; Aksenova, Olga V./C-7734-2014; Gofarov, Mikhail Y/U-9024-2017; Kolosova, Yulia/J-4040-2018; Voroshilova, Irina S/R-4122-2016; Konopleva, Ekaterina S./D-1484-2018; Lyubas, Artem/AAF-3215-2021	Yulia, Bespalaya V/0000-0002-9066-4833; Vikhrev, Ilya V/0000-0002-8612-7736; Kondakov, Alexander V/0000-0002-6305-6496; Aksenova, Olga V./0000-0002-0817-7105; Gofarov, Mikhail Y/0000-0002-8532-0307; Voroshilova, Irina S/0000-0002-2257-1475; Bolotov, Ivan/0000-0002-3878-4192	Federal Agency for Scientific Organisations [0410-2014-0028]; Ural Branch of Russian Academy of Sciences [15-12-5-3, 15-2-5-7]; Russian Foundation for Basic Research [14-04-98801, 15-04-05638]; Ministry of Science and Education of Russia [P362];  [MD-6465.2014.5];  [MK-4735.2015.4]	Federal Agency for Scientific Organisations; Ural Branch of Russian Academy of Sciences(Russian Academy of Sciences); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Ministry of Science and Education of Russia; ; 	This study was supported by the Federal Agency for Scientific Organisations (no. 0410-2014-0028), the Ural Branch of Russian Academy of Sciences (nos. 15-12-5-3 and 15-2-5-7), grants from the President of Russia (no. MD-6465.2014.5 and MK-4735.2015.4) and the Russian Foundation for Basic Research (nos. 14-04-98801 and 15-04-05638) and the Ministry of Science and Education of Russia (no. P362). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama Y, 2007, ZOOL SCI, V24, P890, DOI 10.2108/zsj.24.890; Akiyama Yoshihiro B., 2013, Venus (Tokyo), V71, P191; Akiyama YB, 2009, FUND APPL LIMNOL, V175, P295, DOI 10.1127/1863-9135/2009/0175-0295; [Anonymous], 2014, TRACER V1 6; Araujo R, 2005, J MOLLUS STUD, V71, P25, DOI 10.1093/mollus/eyi002; Araujo R, 2009, J MOLLUS STUD, V75, P95, DOI 10.1093/mollus/eyn043; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Baba Karoly, 2000, Bollettino Malacologico, V36, P133; Banarescu P, 1992, ZOOGEOGRAPHY FRESH W, V2; BOGAN AE, 1993, AM ZOOL, V33, P599; Bogan AE, 2008, J N AM BENTHOL SOC, V27, P349, DOI 10.1899/07-069.1; Bogatov VV, 2013, BIOL BULL+, V40, P488, DOI 10.1134/S1062359013050026; Bogatov VV, 2012, BIOL BULL+, V39, P672, DOI 10.1134/S1062359012080031; Bogatov V.V., 2001, Byulleten' Dal'nevostochnogo Malakologicheskogo Obshchestva, V5, P71; Bogatov Victor V., 2003, Ruthenica, V13, P41; Bogatov VV, 1988, P ZOOLOGICAL I USSR, V171, P155; Bogutskaya NG, 2008, ICHTHYOL EXPLOR FRES, V19, P301; Bohlen J, 2006, MOL PHYLOGENET EVOL, V40, P856, DOI 10.1016/j.ympev.2006.04.020; Bolotov IN, 2013, BIOL BULL+, V40, P221, DOI 10.1134/S1062359013020027; BRANDT R A M, 1974, Archiv fuer Molluskenkunde, V105, P1; Buldovsky AT, 1935, P FAR E BRANCH USSR, V12, P39; BUYANOVSKY AI, 1993, ZOOL ZH, V72, P29; Curole JP, 2004, CONSERV GENET, V5, P271, DOI 10.1023/B:COGE.0000030005.14751.76; Dashi-Dorgi A, 1953, THESIS IRKUTSK STATE; Eyerdam W. J., 1938, Nautilus Philadelphia, V52, P56; Fang Z-J, 2009, U KANSAS PALEONTOLOG, V17, P1; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Geist J, 2010, HYDROBIOLOGIA, V644, P69, DOI 10.1007/s10750-010-0190-2; Graf DL, 2007, P ACAD NAT SCI PHILA, V156, P71, DOI 10.1635/0097-3157(2007)156[71:PFMMBU]2.0.CO;2; Graf DL, 2007, J MOLLUS STUD, V73, P291, DOI 10.1093/mollus/eym029; Graf DL, 2006, ZOOL J LINN SOC-LOND, V148, P343, DOI 10.1111/j.1096-3642.2006.00259.x; Graf DL, 2013, AM MALACOL BULL, V31, P135, DOI 10.4003/006.031.0106; Graf DL, 2013, FRESHWATER MUSSELS U; Grande T, 2004, COPEIA, P743; Haag Wendell R., 2009, P107; Haas F., 1910, Annals & Magazine of Natural History Series 8, V6; Haas F., 1969, TIERREICH, V88, P1; HAAS FRITZ, 1940, ZOOL SER [PUBL 464] FIELD MUS NAT HIST, V24, P115; Habe T, 1991, HITACHIOBI, V56, P3; HALL T., 2013, BIOEDIT VERSION 7 2; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Honda Y, 1986, PALAEONTOLOGICAL SOC, P3, DOI [10.1186/1471-2148-11-118.Terrestrial, DOI 10.1186/1471-2148-11-118.TERRESTRIAL]; Huff SW, 2004, J MOLLUS STUD, V70, P379, DOI 10.1093/mollus/70.4.379; Imoto JM, 2013, GENE, V514, P112, DOI 10.1016/j.gene.2012.10.019; Inoue K, 2014, HEREDITY, V112, P282, DOI 10.1038/hdy.2013.104; Iwata H, 2002, J HERED, V93, P384, DOI 10.1093/jhered/93.5.384; JOHNSON R I, 1983, Occasional Papers on Mollusks Museum of Comparative Zoology Harvard University, V4, P299; Khalloufi N, 2011, J MOLLUS STUD, V77, P103, DOI 10.1093/mollus/eyq046; Klishko OK, 2014, BIOL BULL+, V41, P434, DOI 10.1134/S1062359014050057; Klishko O.K., 2012, Byulleten' Dal'nevostochnogo Malakologicheskogo Obshchestva, V15-1, P31; Klishko O. K., 2008, Vestnik Zoologii, V42, P291; Klishko Olga K., 2013, Ellipsaria, V15, P31; Klishko Olga K., 2009, Korean Journal of Malacology, V25, P237; Kobayashi Osamu, 2005, Venus (Tokyo), V64, P63; Kobayashi Osamu, 2009, Venus (Tokyo), V67, P189; Kobayashi Osamu, 2008, Venus (Tokyo), V67, P61; Kobayashi Osamu, 2007, Venus (Tokyo), V65, P355; Kobelt W, 1879, ABHANDLUNGEN SENCKEN, V11, P285; Kondo T, 2008, SPECIAL PUBLICATION, V3, P1; Kondo Takaki, 2005, Venus (Tokyo), V64, P135; Kurenkov II, 1966, QUESTIONS KAMCHATKA, V4, P110; Kurihara Yoshihiro, 2005, Venus (Tokyo), V64, P55; Liu X., 1981, B CHENGDU I GEOL MIN, V2, P121; Machordom A, 2003, BIOL J LINN SOC, V78, P235, DOI 10.1046/j.1095-8312.2003.00158.x; Melnychenko R. K., 2004, Vestnik Zoologii, V38, P19; Middendorff A. T., 1850, B ACAD IMPERIALE PM, V9, P108; Middendorff A. T., 1851, REISE AUSSERSTEN NOR, VII, P163, DOI DOI 10.1160/600TAXA.3795.4.10; Miyadi D., 1938, Internationale Revue der Hydrobiologie Leipzig, V37, P125; Moskvicheva I.M., 1973, Zoologicheskii Zh, V52, P1458; Noda H, 1970, T P PALAEONTOLOGICAL, V77, P235; Pietsch TW, 2003, J BIOGEOGR, V30, P1297, DOI 10.1046/j.1365-2699.2003.00956.x; Preston SJ, 2010, AQUAT CONSERV, V20, P568, DOI 10.1002/aqc.1121; Prozorova LA, 2004, FLORA FAUNA SAKHALIN, V1, P138; Rambaut A., 2012, FIGTREE VERSION 1 4; Reis J, 2009, J NAT HIST, V43, P1929, DOI 10.1080/00222930902993724; Reshetnikov YuS, 2010, FISHES NATURE RESERV, V1; Rosen OV, 1926, ANN MUSEE ZOOLOGIQUE, V27, P261; Sayenko E.M., 2007, Byulleten' Dal'nevostochnogo Malakologicheskogo Obshchestva, V11, P100; Scholz H, 2007, NEUES JAHRB GEOL P-A, V244, P43, DOI 10.1127/0077-7749/2007/0244-0043; Schrenck Lv, 1867, REISEN FORSCHUNGEN A, V2, P605; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Simpson CT, 1895, P US NATL MUS, V28, P295; SMITH DG, 1983, ZOOL SCR, V12, P67, DOI 10.1111/j.1463-6409.1983.tb00550.x; Smith DG, 2001, ECOL STU AN, V145, P33; Smith DG, 2001, J CONCHOL, V37, P119; Suzuki K, 1944, J GEOLOGICAL SOC JAP, V51, P100, DOI DOI 10.5575/GEOSOC.51.100; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TAYLOR DW, 1988, PALAEOGEOGR PALAEOCL, V62, P511, DOI 10.1016/0031-0182(88)90071-5; Tsalolikhin S. J., 2004, OPREDELITEL PRESNOVO, V6, P9; Uchiyama R, 2010, ANIMAL DISTRIBUTION, P43; Villesen P, 2007, MOL ECOL NOTES, V7, P965, DOI 10.1111/j.1471-8286.2007.01821.x; Yokoyama M., 1932, J Fac Sci Univ Tokyo Geol etc (2), V3, P221; Yokoyama M, 1959, SPECIAL PAPERS PALAE, V5; Zaki SAH, 2008, BIOL J LINN SOC, V95, P337, DOI 10.1111/j.1095-8312.2008.01050.x; ZATRAVKIN MN, 1984, ZOOL ZH, V63, P1785; Zatravkin MN, 1987, LARGE BIVALVE MOLLUS, P152; Zeng Q, 2011, MITOCHONDR DNA, V22, P162, DOI 10.3109/19401736.2011.636435; Zhadin V. I., 1938, FAUNA SSSR M, V4, P1, DOI DOI 10.1371/JOURNAL.PONE.0111546; Zhadin VI, 1952, ZOOLOGICAL I USSR AC, V46, P1; Zieritz A, 2009, BIOL J LINN SOC, V98, P814, DOI 10.1111/j.1095-8312.2009.01329.x; Zuiganov V., 1994, FRESHWATER PEARL MUS, P104, DOI [10.1086/419023, DOI 10.1086/419023]	101	25	33	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0122408	10.1371/journal.pone.0122408	http://dx.doi.org/10.1371/journal.pone.0122408			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011762	Green Submitted, gold, Green Published			2022-12-26	WOS:000355183900001
J	Cheng, Y; Lu, F; Lee, SK; Kong, DH; Ha, KS; Wang, B; Sattabongkot, J; Tsuboi, T; Han, ET				Cheng, Yang; Lu, Feng; Lee, Seong-Kyun; Kong, Deok-Hoon; Ha, Kwon-Soo; Wang, Bo; Sattabongkot, Jetsumon; Tsuboi, Takafumi; Han, Eun-Taek			Characterization of Plasmodium vivax Early Transcribed Membrane Protein 11.2 and Exported Protein 1	PLOS ONE			English	Article							HOST-CELL CYTOPLASM; ERYTHROCYTE-MEMBRANE; PARASITE INVASION; MALARIA; FALCIPARUM; FAMILY; INFECTION; IDENTIFICATION; ETRAMPS; COMPLEX	In Plasmodium, the membrane of intracellular parasites is initially formed during invasion as an invagination of the red blood cell surface, which forms a barrier between the parasite and infected red blood cells in asexual blood stage parasites. The membrane proteins of intracellular parasites of Plasmodium species have been identified such as early-transcribed membrane proteins (ETRAMPs) and exported proteins (EXPs). However, there is little or no information regarding the intracellular parasite membrane in Plasmodium vivax. In the present study, recombinant PvETRAMP11.2 (PVX_003565) and PvEXP1 (PVX_091700) were expressed and evaluated antigenicity tests using sera from P. vivax-infected patients. A large proportion of infected individuals presented with IgG antibody responses against PvETRAMP11.2 (76.8%) and PvEXP1 (69.6%). Both of the recombinant proteins elicited high antibody titers capable of recognizing parasites of vivax malaria patients. PvETRAMP11.2 partially co-localized with PvEXP1 on the intracellular membranes of immature schizont. Moreover, they were also detected at the apical organelles of newly formed merozoites of mature schizont. We first proposed that these proteins might be synthesized in the preceding schizont stage, localized on the parasite membranes and apical organelles of infected erythrocytes, and induced high IgG antibody responses in patients.	[Cheng, Yang; Lu, Feng; Lee, Seong-Kyun; Wang, Bo; Han, Eun-Taek] Kangwon Natl Univ, Sch Med, Dept Med Environm Biol & Trop Med, Chunchon, Gangwon Do, South Korea; [Cheng, Yang] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA; [Lu, Feng] Jiangsu Inst Parasit Dis, Minist Hlth, Key Lab Parasit Dis Control & Prevent, Wuxi, Jiangsu, Peoples R China; [Lu, Feng] Jiangsu Inst Parasit Dis, Jiangsu Prov Key Lab Parasite Mol Biol, Wuxi, Jiangsu, Peoples R China; [Kong, Deok-Hoon; Ha, Kwon-Soo] Kangwon Natl Univ, Sch Med, Dept Mol & Cellular Biochem, Chunchon, Gangwon Do, South Korea; [Wang, Bo] Anhui Med Univ, Affiliated Hosp 1, Dept Clin Lab, Hefei, Anhui, Peoples R China; [Sattabongkot, Jetsumon] Mahidol Univ, Fac Trop Med, Mahidol Vivax Res Unit, Bangkok 10700, Thailand; [Tsuboi, Takafumi] Ehime Univ, Proteosci Ctr, Div Malaria Res, Matsuyama, Ehime, Japan	Kangwon National University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Kangwon National University; Anhui Medical University; Mahidol University; Ehime University	Tsuboi, T (corresponding author), Ehime Univ, Proteosci Ctr, Div Malaria Res, Matsuyama, Ehime, Japan.	tsuboi.takafumi.mb@ehime-u.ac.jp; ethan@kangwon.ac.kr	Lu, Feng/AAW-7341-2021; Prachumsri, Jetsumon/AAZ-7732-2021; Cheng, Yang/AAN-2357-2020; Tsuboi, Takafumi/AAK-6145-2021; Ha, Kwon-Soo/AAU-4417-2020	Sattabongkot, Jetsumon/0000-0002-3938-4588; Tsuboi, Takafumi/0000-0002-7415-1325; Ha, Kwon-Soo/0000-0002-4219-1787	National Research Foundation (NRF) of Korea Grant - Korean government (MEST) [2011-0016401]; Korea Health technology R&D Project, Ministry of Health & Welfare, Republic of Korea [A121180]; MEXT KAKENHI [23117008]; JSPS KAKENHI in Japan [23406007]	National Research Foundation (NRF) of Korea Grant - Korean government (MEST); Korea Health technology R&D Project, Ministry of Health & Welfare, Republic of Korea; MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS KAKENHI in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by National Research Foundation (NRF) of Korea Grant funded by the Korean government (MEST) (2011-0016401) and a grant from the Korea Health technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A121180). This work was also supported in part by MEXT KAKENHI (23117008) and JSPS KAKENHI (23406007) in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JH, 1990, CELL, V63, P141, DOI 10.1016/0092-8674(90)90295-P; AIKAWA M, 1983, CIBA F SYMP, V94, P45; [Anonymous], 2008, METHODS MALARIA RES; Ansorge I, 1997, MOL BIOCHEM PARASIT, V84, P259, DOI 10.1016/S0166-6851(96)02806-X; Arevalo-Pinzon G, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-60; Arumugam TU, 2011, INFECT IMMUN, V79, P4523, DOI 10.1128/IAI.05412-11; Birago C, 2003, MOL BIOCHEM PARASIT, V126, P209, DOI 10.1016/S0166-6851(02)00275-X; Blackman MJ, 2004, CELL MICROBIOL, V6, P893, DOI 10.1111/j.1462-5822.2004.00437.x; Blackman MJ, 2001, MOL BIOCHEM PARASIT, V117, P11, DOI 10.1016/S0166-6851(01)00328-0; Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327; Chen JH, 2010, J PROTEOME RES, V9, P6479, DOI 10.1021/pr100705g; Cheng Y, 2014, PARASITOL RES, V113, P2559, DOI 10.1007/s00436-014-3907-8; Cheng Y, 2013, INFECT IMMUN, V81, P1585, DOI 10.1128/IAI.01117-12; Curra C, 2012, TRAFFIC, V13, P388, DOI 10.1111/j.1600-0854.2011.01313.x; de Koning-Ward TF, 2009, NATURE, V459, P945, DOI 10.1038/nature08104; Fan YT, 2013, J PROTEOMICS, V78, P148, DOI 10.1016/j.jprot.2012.11.020; Haldar K, 2007, ANNU REV PATHOL-MECH, V2, P217, DOI 10.1146/annurev.pathol.2.010506.091913; Hiller NL, 2003, J BIOL CHEM, V278, P48413, DOI 10.1074/jbc.M307266200; JOHNSON D, 1994, PARASITOLOGY, V109, P1, DOI 10.1017/S0031182000077696; Li J, 2012, PARASITOL INT, V61, P443, DOI 10.1016/j.parint.2012.02.008; Lu F, 2014, J PROTEOMICS, V102, P66, DOI 10.1016/j.jprot.2014.02.029; LUSTIGMAN S, 1988, MOL BIOCHEM PARASIT, V30, P217, DOI 10.1016/0166-6851(88)90090-4; MacKellar DC, 2011, CELL MICROBIOL, V13, P1755, DOI 10.1111/j.1462-5822.2011.01656.x; Nguitragool W, 2011, CELL, V145, P665, DOI 10.1016/j.cell.2011.05.002; Pinder JC, 2000, PARASITOL TODAY, V16, P240, DOI 10.1016/S0169-4758(00)01664-1; Sibley LD, 2004, SCIENCE, V304, P248, DOI 10.1126/science.1094717; SIMMONS D, 1987, EMBO J, V6, P485, DOI 10.1002/j.1460-2075.1987.tb04779.x; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Spielmann T, 2006, MOL MICROBIOL, V59, P779, DOI 10.1111/j.1365-2958.2005.04983.x; Spielmann T, 2003, MOL BIOL CELL, V14, P1529, DOI 10.1091/mbc.E02-04-0240; Spielmann T, 2000, MOL BIOCHEM PARASIT, V111, P453, DOI 10.1016/S0166-6851(00)00333-9; Spielmann T, 2012, INT J MED MICROBIOL, V302, P179, DOI 10.1016/j.ijmm.2012.07.011; STENZEL DJ, 1989, EUR J CELL BIOL, V49, P311; Tsuboi T, 2010, METHODS MOL BIOL, V607, P73, DOI 10.1007/978-1-60327-331-2_8; Vincensini L, 2008, MOL BIOCHEM PARASIT, V160, P81, DOI 10.1016/j.molbiopara.2008.04.002	35	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127500	10.1371/journal.pone.0127500	http://dx.doi.org/10.1371/journal.pone.0127500			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011536	Green Submitted, Green Published, gold			2022-12-26	WOS:000355183900099
J	Ispas, G; Koul, A; Verbeeck, J; Sheehan, J; Sanders-Beer, B; Roymans, D; Andries, K; Rouan, MC; De Jonghe, S; Bonfanti, JF; Vanstockem, M; Simmen, K; Verloes, R				Ispas, Gabriela; Koul, Anil; Verbeeck, Johan; Sheehan, Jennifer; Sanders-Beer, Brigitte; Roymans, Dirk; Andries, Koen; Rouan, Marie-Claude; De Jonghe, Sandra; Bonfanti, Jean-Francois; Vanstockem, Marc; Simmen, Kenneth; Verloes, Rene			Antiviral Activity of TMC353121, a Respiratory Syncytial Virus (RSV) Fusion Inhibitor, in a Non-Human Primate Model	PLOS ONE			English	Article							HIGH-RISK INFANTS; CLINICAL CANDIDATE; YOUNG-CHILDREN; INFECTION; BRONCHIOLITIS; PALIVIZUMAB; SELECTION; EFFICACY; ANTIBODY; MONKEYS	Background The study assessed the antiviral activity of TMC353121, a respiratory syncytial virus (RSV) fusion inhibitor, in a preclinical non-human primate challenge model with a viral shedding pattern similar to that seen in humans, following continuous infusion (CI). Methods African green monkeys were administered TMC353121 through CI, in 2 studies. Study 1 evaluated the prophylactic and therapeutic efficacy of TMC353121 at a target plasma level of 50 ng/mL (n= 15; Group 1: prophylactic arm [Px50], 0.033 mg/mL TMC353121, flow rate 2.5 mL/kg/h from 24 hours pre-infection to 10 days; Group 2: therapeutic arm [Tx50], 0.033mg/mL TMC353121 from 24 hours postinfection to 8 days; Group 3: control [Vh1] vehicle, 24 hours post-infection to 8 days). Study 2 evaluated the prophylactic efficacy of TMC353121 at target plasma levels of 5 and 500 ng/mL (n= 12; Group 1: prophylactic 5 arm [Px5], 0.0033 mg/mL TMC353121, flow rate 2.5 mL/kg/h from 72 hours pre-infection to 14 days; Group 2: prophylactic 500 arm [Px500], 0.33 mg/mL TMC353121; Group 3: control [Vh2] vehicle, 14 days). Bronchoalveolar lavage fluid and plasma were collected every 2 days from day 1 postinfection for pharmacokinetics and safety analysis. Findings TMC353121 showed a dose-dependent antiviral activity, varying from 1log(10) reduction of peak viral load to complete inhibition of the RSV replication. Complete inhibition of RSV shedding was observed for a relatively low plasma exposure (0.39 mu g/mL) and was associated with a dose-dependent reduction in INF gamma, IL6 and MIP1 alpha. TMC353121 administered as CI for 16 days was generally well-tolerated. Conclusion TMC353121 exerted dose-dependent antiviral effect ranging from full inhibition to absence of antiviral activity, in a preclinical model highly permissive for RSV replication. No new safety findings emerged from the study.	[Ispas, Gabriela; Koul, Anil; Roymans, Dirk; Andries, Koen; Vanstockem, Marc; Verloes, Rene] Janssen Infect Dis, Beerse, Belgium; [Verbeeck, Johan] Janssen Res & Dev, London, England; [Sheehan, Jennifer] Huntingdon Life Sci, Somerset, NJ 08873 USA; [Sanders-Beer, Brigitte] BIOQUAL Inc, Rockville, MD 20850 USA; [Rouan, Marie-Claude; De Jonghe, Sandra] Janssen Res & Dev, Beerse, Belgium; [Bonfanti, Jean-Francois] Janssen Res & Dev, Jan Cil France, Paris, France; [Simmen, Kenneth] J&J Pharmaceut Res & Dev, Jan Cil UK, High Wycombe, Bucks, England	BIOQUAL Inc.; Johnson & Johnson; Janssen Pharmaceuticals; Johnson & Johnson	Ispas, G (corresponding author), Janssen Infect Dis, Beerse, Belgium.	gispas@its.jnj.com	Roymans, Dirk/AFQ-3892-2022		Janssen Pharmaceutical Companies of JJ	Janssen Pharmaceutical Companies of JJ	Janssen Pharmaceutical Companies of J&J funded the study and was involved in the study design, data collection and analysis, decision to publish, and preparation of the manuscript. Huntigton Life Sciences and Bioqual were involved in study design, data collection and analysis and preparation of the manuscript.	Andries K, 2003, ANTIVIR RES, V60, P209, DOI 10.1016/j.antiviral.2003.07.004; Baker KA, 1999, POSTGRAD MED, V106, P97, DOI 10.3810/pgm.1999.12.803; Blyth DI, 1996, AM J RESP CELL MOL, V14, P425, DOI 10.1165/ajrcmb.14.5.8624247; Bonfanti JF, 2008, J MED CHEM, V51, P875, DOI 10.1021/jm701284j; Bonfanti JF, 2007, J MED CHEM, V50, P4572, DOI 10.1021/jm070143x; Cianci C, 2004, ANTIMICROB AGENTS CH, V48, P2448, DOI 10.1128/AAC.48.7.2448-2454.2004; DeVincenzo J, 2010, P NATL ACAD SCI USA, V107, P8800, DOI 10.1073/pnas.0912186107; DeVincenzo JP, 2010, AM J RESP CRIT CARE, V182, P1305, DOI 10.1164/rccm.201002-0221OC; Durbin AP, 2003, CLIN INFECT DIS, V37, P1668, DOI 10.1086/379775; El Kholy AA, 2013, PEDIATR INT, V55, P283, DOI 10.1111/ped.12051; Falsey AR, 2014, J INFECT DIS, V209, P1873, DOI 10.1093/infdis/jit839; Garofalo RP, 2005, J MED VIROL, V75, P282, DOI 10.1002/jmv.20268; Geskey JM, 2007, BIOL-TARGETS THER, V1, P33; Gong EY, 2013, METHODS IN MOLECULAR; Haeberle HA, 2001, J VIROL, V75, P878, DOI 10.1128/JVI.75.2.878-890.2001; Hashem M, 2003, J CLIN VIROL, V27, P14, DOI 10.1016/S1386-6532(03)00047-7; Hayden FG, 1998, J CLIN INVEST, V101, P643, DOI 10.1172/JCI1355; Jefferson T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004876.pub3; Jin H, 2003, VACCINE, V21, P3647, DOI 10.1016/S0264-410X(03)00426-2; Johnson S, 1997, J INFECT DIS, V176, P1215, DOI 10.1086/514115; Lee FEH, 2004, ANTIVIR RES, V63, P191, DOI 10.1016/j.antiviral.2004.04.005; Littel-van den Hurk SV, 2007, REV MED VIROL, V17, P5, DOI 10.1002/rmv.518; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Olszewska W, 2011, EUR RESPIR J, V38, P401, DOI 10.1183/09031936.00005610; Player MR, 1998, P NATL ACAD SCI USA, V95, P8874, DOI 10.1073/pnas.95.15.8874; Rouan MC, 2010, ANTIMICROB AGENTS CH, V54, P4534, DOI 10.1128/AAC.00643-10; Roymans D, 2010, P NATL ACAD SCI USA, V107, P308, DOI 10.1073/pnas.0910108106; Tripp Ralph A, 2005, Proc Am Thorac Soc, V2, P147, DOI 10.1513/pats.200502-014AW; Wang D, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15050; Weiss WJ, 2003, J MED PRIMATOL, V32, P82, DOI 10.1034/j.1600-0684.2003.00014.x; Welliver RC, 2003, J PEDIATR-US, V143, pS112, DOI 10.1067/S0022-3476(03)00508-0; Weltzin R, 1996, J INFECT DIS, V174, P256, DOI 10.1093/infdis/174.2.256	32	20	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0126959	10.1371/journal.pone.0126959	http://dx.doi.org/10.1371/journal.pone.0126959			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010881	Green Published, Green Submitted, gold			2022-12-26	WOS:000355183900052
J	Lee, C; Clark, SE				Lee, Chunghee; Clark, Steven E.			A WUSCHEL-Independent Stem Cell Specification Pathway Is Repressed by PHB, PHV and CNA in Arabidopsis	PLOS ONE			English	Article							SHOOT APICAL MERISTEM; ZIPPER GENE FAMILY; ORGAN DEVELOPMENT; FATE; CLAVATA1; THALIANA; ARGONAUTE1; EXPRESSION; CLV3; REGULATOR	The homeostatic maintenance of stem cells that carry out continuous organogenesis at the shoot meristem is crucial for plant development. Key known factors act to signal between the stem cells and an underlying group of cells thought to act as the stem cell niche. In Arabidopsis thaliana the homeodomain transcription factor WUSCHEL (WUS) is essential for stem cell initiation and maintenance at shoot and flower meristems. Recent data suggest that the WUS protein may move from the niche cells directly into the stem cells to maintain stem cell identity. Here we provide evidence for a second, previously unknown, pathway for stem cell specification at shoot and flower meristems that bypasses the requirement for WUS. We demonstrate that this novel stem cell specification pathway is normally repressed by the activity of the HD-zip III transcription factors PHABULOSA (PHB), PHAVOLUTA (PHV) and CORONA (CNA). When de-repressed, this second stem cell pathway leads to an accumulation of stem cells and an enlargement of the stem cell niche. When de-repressed in a wus mutant background, this second stem cell pathway leads to functional meristems with largely normal cell layering and meristem morphology, activation of WUS cis regulatory elements, and extensive, but not indeterminate, organogenesis. Thus, WUS is largely dispensable for stem cell specification and meristem function, suggesting a set of key stem cell specification factors, competitively regulated by WUS and PHB/PHV/CNA, remain unidentified.	[Lee, Chunghee; Clark, Steven E.] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Clark, SE (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA.	clarks@umich.edu			National Institutes of Health [R01GM62962]; US Department of Agriculture [2006-35304-17403]; University of Michigan MCubed program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062962] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Agriculture(United States Department of Agriculture (USDA)); University of Michigan MCubed program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by the National Institutes of Health (R01GM62962), the US Department of Agriculture (2006-35304-17403), and the University of Michigan MCubed program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton MK, 2010, DEV BIOL, V341, P95, DOI 10.1016/j.ydbio.2009.11.029; BARTON MK, 1993, DEVELOPMENT, V119, P823; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Baurle I, 2005, PLANT CELL, V17, P2271, DOI 10.1105/tpc.105.032623; Bowman JL, 2002, TRENDS GENET, V18, P134, DOI 10.1016/S0168-9525(01)02601-4; Brand U, 2002, PLANT PHYSIOL, V129, P565, DOI 10.1104/pp.001867; Brand U, 2000, SCIENCE, V289, P617, DOI 10.1126/science.289.5479.617; Busch W, 2010, DEV CELL, V18, P849, DOI 10.1016/j.devcel.2010.03.012; CLARK SE, 1993, DEVELOPMENT, V119, P397; CLARK SE, 1995, DEVELOPMENT, V121, P2057; Clark SE, 1997, PLANT CELL, V9, P1067, DOI 10.1105/tpc.9.7.1067; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Daum G, 2014, P NATL ACAD SCI USA, V111, P14619, DOI 10.1073/pnas.1406446111; Dievart A, 2003, PLANT CELL, V15, P1198, DOI 10.1105/tpc.010504; Dodsworth S, 2009, DEV BIOL, V336, P1, DOI 10.1016/j.ydbio.2009.09.031; DREWS GN, 1991, CELL, V65, P991, DOI 10.1016/0092-8674(91)90551-9; Emery JF, 2003, CURR BIOL, V13, P1768, DOI 10.1016/j.cub.2003.09.035; Fletcher LC, 1999, SCIENCE, V283, P1911, DOI 10.1126/science.283.5409.1911; FURNER IJ, 1992, DEVELOPMENT, V115, P755; Gagne JM, 2010, PLANT CELL, V22, P729, DOI 10.1105/tpc.109.068734; Gallois JL, 2002, DEVELOPMENT, V129, P3207; Green KA, 2005, PLANT CELL, V17, P691, DOI 10.1105/tpc.104.026179; Gross-Hardt R, 2002, GENE DEV, V16, P1129, DOI 10.1101/gad.225202; Guo YF, 2010, PLANT J, V63, P889, DOI 10.1111/j.1365-313X.2010.04295.x; Ha CM, 2010, CURR TOP DEV BIOL, V91, P103, DOI 10.1016/S0070-2153(10)91004-1; Haecker A, 2004, DEVELOPMENT, V131, P657, DOI 10.1242/dev.00963; IRISH VF, 1992, DEVELOPMENT, V115, P745; Jeong S, 1999, PLANT CELL, V11, P1925, DOI 10.1105/tpc.11.10.1925; Ji LJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001358; Jung J, 2007, PLANTA, V225, P575, DOI 10.1007/s00425-006-0373-2; Kayes JM, 1998, DEVELOPMENT, V125, P3843; Kerstetter RA, 1997, PLANT CELL, V9, P1001, DOI 10.1105/tpc.9.7.1001; Laux T, 1996, DEVELOPMENT, V122, P87; Lee CH, 2013, WIRES DEV BIOL, V2, P671, DOI 10.1002/wdev.110; Leibfried A, 2005, NATURE, V438, P1172, DOI 10.1038/nature04270; Lenhard M, 2002, DEVELOPMENT, V129, P3195; Liu QL, 2009, PLANT J, V58, P27, DOI 10.1111/j.1365-313X.2008.03757.x; Lynn K, 1999, DEVELOPMENT, V126, P469; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; McConnell JR, 2001, NATURE, V411, P709, DOI 10.1038/35079635; Morel JB, 2002, PLANT CELL, V14, P629, DOI 10.1105/tpc.010358; Moussian B, 1998, EMBO J, V17, P1799, DOI 10.1093/emboj/17.6.1799; Muller R, 2008, PLANT CELL, V20, P934, DOI 10.1105/tpc.107.057547; Ni J, 2006, PLANT PHYSIOL, V140, P726, DOI 10.1104/pp.105.072678; Ogawa M, 2008, SCIENCE, V319, P294, DOI 10.1126/science.1150083; Otsuga D, 2001, PLANT J, V25, P223, DOI 10.1046/j.1365-313x.2001.00959.x; Pogany JA, 1998, J PLANT RES, V111, P307, DOI 10.1007/BF02512189; Prigge MJ, 2005, PLANT CELL, V17, P61, DOI 10.1105/tpc.104.026161; Qi Y, 2005, MOL CELL, V19, P421, DOI 10.1016/j.molcel.2005.06.014; Rojo E, 2002, PLANT CELL, V14, P969, DOI 10.1105/tpc.002196; Sarkar AK, 2007, NATURE, V446, P811, DOI 10.1038/nature05703; Schoof H, 2000, CELL, V100, P635, DOI 10.1016/S0092-8674(00)80700-X; Schuster C, 2014, DEV CELL, V28, P438, DOI 10.1016/j.devcel.2014.01.013; Song SK, 2006, DEVELOPMENT, V133, P4691, DOI 10.1242/dev.02652; Steeves T.A., 1989, PATTERNS PLANT DEV, DOI 10.1017/CBO9780511626227; Stewart R. N., 1940, AM J BOT, V27, P875; STEWART RN, 1975, AM J BOT, V62, P935, DOI 10.2307/2441638; Vaucheret H, 2004, GENE DEV, V18, P1187, DOI 10.1101/gad.1201404; Williams L, 2005, DEVELOPMENT, V132, P3657, DOI 10.1242/dev.01942; Yadav RK, 2011, GENE DEV, V25, P2025, DOI 10.1101/gad.17258511; Yadav RK, 2010, DEVELOPMENT, V137, P3581, DOI 10.1242/dev.054973; Yadav RK, 2009, P NATL ACAD SCI USA, V106, P4941, DOI 10.1073/pnas.0900843106; Yu LP, 2003, CURR BIOL, V13, P179, DOI 10.1016/S0960-9822(03)00042-3; Zhang XR, 2006, GENE DEV, V20, P3255, DOI 10.1101/gad.1495506; Zhu HL, 2011, CELL, V145, P242, DOI 10.1016/j.cell.2011.03.024	65	28	31	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0126006	10.1371/journal.pone.0126006	http://dx.doi.org/10.1371/journal.pone.0126006			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011610	Green Published, gold, Green Submitted			2022-12-26	WOS:000355183900020
J	Moreira, CA; Bando, SY; Bertonha, FB; Iamashita, P; Silva, FN; Costa, LD; Silva, AV; Castro, LHM; Wen, HT				Moreira-Filho, Carlos Alberto; Bando, Silvia Yumi; Bertonha, Fernanda Bernardi; Iamashita, Priscila; Silva, Filipi Nascimento; Costa, Luciano da Fontoura; Silva, Alexandre Valotta; Martins Castro, Luiz Henrique; Wen, Hung-Tzu			Community Structure Analysis of Transcriptional Networks Reveals Distinct Molecular Pathways for Early- and Late-Onset Temporal Lobe Epilepsy with Childhood Febrile Seizures	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN; LONG-TERM POTENTIATION; FACTOR-KAPPA-B; OXIDATIVE STRESS; GENE-EXPRESSION; NERVOUS-SYSTEM; HIPPOCAMPAL SCLEROSIS; STATUS EPILEPTICUS; DNA FRAGMENTATION; COMPLEX NETWORKS	Age at epilepsy onset has a broad impact on brain plasticity and epilepsy pathomechanisms. Prolonged febrile seizures in early childhood (FS) constitute an initial precipitating insult (IPI) commonly associated with mesial temporal lobe epilepsy (MTLE). FS-MTLE patients may have early disease onset, i.e. just after the IPI, in early childhood, or late-onset, ranging from mid-adolescence to early adult life. The mechanisms governing early (E) or late (L) disease onset are largely unknown. In order to unveil the molecular pathways underlying E and L subtypes of FS-MTLE we investigated global gene expression in hippocampal CA3 explants of FS-MTLE patients submitted to hippocampectomy. Gene coexpression networks (GCNs) were obtained for the E and L patient groups. A network-based approach for GCN analysis was employed allowing: i) the visualization and analysis of differentially expressed (DE) and complete (CO) - all valid GO annotated transcripts - GCNs for the E and L groups; ii) the study of interactions between all the system's constituents based on community detection and coarse-grained community structure methods. We found that the E-DE communities with strongest connection weights harbor highly connected genes mainly related to neural excitability and febrile seizures, whereas in L-DE communities these genes are not only involved in network excitability but also playing roles in other epilepsy-related processes. Inversely, in E-CO the strongly connected communities are related to compensatory pathways (seizure inhibition, neuronal survival and responses to stress conditions) while in L-CO these communities harbor several genes related to pro-epileptic effects, seizure-related mechanisms and vulnerability to epilepsy. These results fit the concept, based on fMRI and behavioral studies, that early onset epilepsies, although impacting more severely the hippocampus, are associated to compensatory mechanisms, while in late MTLE development the brain is less able to generate adaptive mechanisms, what has implications for epilepsy management and drug discovery.	[Moreira-Filho, Carlos Alberto; Bando, Silvia Yumi; Bertonha, Fernanda Bernardi; Iamashita, Priscila] FMUSP, Dept Pediat, Sao Paulo, SP, Brazil; [Silva, Filipi Nascimento; Costa, Luciano da Fontoura] Univ Sao Paulo, Inst Fis Sao Carlos, Sao Carlos, SP, Brazil; [Silva, Alexandre Valotta] FMUSP, Grad Program Expt Pathophysiol, Sao Paulo, SP, Brazil; [Martins Castro, Luiz Henrique] FMUSP, Dept Neurol, Sao Paulo, SP, Brazil; [Martins Castro, Luiz Henrique] FMUSP, Hosp Clin, Clin Neurol Div, Sao Paulo, SP, Brazil; [Wen, Hung-Tzu] FMUSP, Hosp Clin, Epilepsy Surg Grp, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Moreira, CA (corresponding author), FMUSP, Dept Pediat, Sao Paulo, SP, Brazil.	carlos.moreira@hc.fm.usp.br	Silva, Filipi Nascimento/C-7620-2012; Silva, Alexandre V/A-2634-2011; da F. Costa, Luciano/H-5475-2011; Bertonha, Fernanda Bernardi/H-3333-2015; moreira-filho, carlos alberto/J-2551-2014; Castro, Luiz H M/H-9427-2012	Silva, Filipi Nascimento/0000-0002-9151-6517; Silva, Alexandre V/0000-0001-7107-0864; da F. Costa, Luciano/0000-0001-5203-4366; Bertonha, Fernanda Bernardi/0000-0002-3675-1362; moreira-filho, carlos alberto/0000-0003-3433-4714; Castro, Luiz H M/0000-0003-1878-8548; Bando, Silvia Yumi/0000-0003-3794-2440	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2009/53443-1, 2005/56446-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [305635/2009-3]; FAPESP [2005/00587-5, 2011/50761-2]; CNPq [307333/2013-2]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); FAPESP-MCT/CNPq/PRONEX [2011/50761-2]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP-MCT/CNPq/PRONEX	This work was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) research grants 2009/53443-1 and 2005/56446-0 and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) grant 305635/2009-3 to CAM-F. LdFC was funded by FAPESP grants 2005/00587-5 and 2011/50761-2 and CNPq grants 307333/2013-2. FNS and PI were funded by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). FNS, CAM-F and LdFC are funded by FAPESP-MCT/CNPq/PRONEX grant 2011/50761-2.	Ahmad S, 2010, SEMIN PEDIATR NEUROL, V17, P150, DOI 10.1016/j.spen.2010.06.004; Alam H, 2011, MOL BIOL CELL, V22, P4068, DOI 10.1091/mbc.E10-08-0703; Alegro MD, 2012, MAGN RESON MED, V68, P1647, DOI 10.1002/mrm.24174; [Anonymous], 1960, HIPPOCAMPUS, V18, P460, DOI [10.1002/hipo.20409, DOI 10.1002/HIP0.20409]; Arion D, 2006, NEUROBIOL DIS, V22, P374, DOI 10.1016/j.nbd.2005.12.012; Aruga J, 2004, MOL CELL NEUROSCI, V26, P205, DOI 10.1016/j.mcn.2004.01.004; Bai DM, 2014, NUCLEIC ACIDS RES, V42, P1799, DOI 10.1093/nar/gkt971; Balosso S, 2013, EXP NEUROL, V247, P267, DOI 10.1016/j.expneurol.2013.05.010; Bando SY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026268; Bando SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079913; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Barreau C, 2006, BIOCHIMIE, V88, P515, DOI 10.1016/j.biochi.2005.10.011; Bartolini F, 2010, BBA-MOL CELL RES, V1803, P164, DOI 10.1016/j.bbamcr.2009.07.006; Baulac M, 2015, REV NEUROL, V26; Bernhardt BC, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00624; Bernhardt BC, 2011, CEREB CORTEX, V21, P2147, DOI 10.1093/cercor/bhq291; Bhanot K, 2011, J PROTEOME RES, V10, P5118, DOI 10.1021/pr200564g; Bhargava S, 2014, MOL CELL BIOCHEM, V387, P55, DOI 10.1007/s11010-013-1869-2; Bianchi MG, 2014, CELL MOL LIFE SCI, V71, P2001, DOI 10.1007/s00018-013-1484-0; Bierhals T, 2013, EUR J MED GENET, V56, P325, DOI 10.1016/j.ejmg.2013.03.009; Bilevicius E, 2010, NEUROLOGY, V75, P1695, DOI 10.1212/WNL.0b013e3181fc29dd; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Blumcke I, 2013, EPILEPSIA, V54, P1315, DOI 10.1111/epi.12220; Bosio Y, 2012, EUR J CELL BIOL, V91, P662, DOI 10.1016/j.ejcb.2012.03.002; Brockmann D, 2009, REV NONLINEAR DYNAMI, P55, DOI DOI 10.1002/9783527628001.CH1; Broomfield A, 2013, JIMD REP, V11, P93, DOI 10.1007/8904_2013_227; Buchser WJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038101; Burk K, 2013, INT J NEUROSCI, V123, P278, DOI 10.3109/00207454.2012.755180; Cai JJ, 2010, GENOME BIOL EVOL, V2, P815, DOI 10.1093/gbe/evq064; Cao GD, 2001, J NEUROSCI, V21, P4678, DOI 10.1523/JNEUROSCI.21-13-04678.2001; Carpentier C, 2014, BBA-MOL BASIS DIS, V1842, P654, DOI 10.1016/j.bbadis.2014.01.004; da Fonseca ACC, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00362; Casanova JR, 2013, EUR J NEUROSCI, V38, P3115, DOI 10.1111/ejn.12315; Charong N, 2011, J CANCER RES CLIN, V137, P89, DOI 10.1007/s00432-010-0863-2; Charytoniuk DA, 2000, NEUROSCIENCE, V100, P33, DOI 10.1016/S0306-4522(00)00246-3; Chaussabel D, 2014, NAT REV IMMUNOL, V14, P271, DOI 10.1038/nri3642; Chen ZL, 2003, MOL BIOL CELL, V14, P2665, DOI 10.1091/mbc.E02-12-0832; Cheung ZH, 2004, NEUROSCI LETT, V361, P47, DOI 10.1016/j.neulet.2003.12.117; Chiang S, 2014, CLIN NEUROPHYSIOL, V125, P1295, DOI 10.1016/j.clinph.2014.04.004; Choudhary S, 2011, J BIOL CHEM, V286, P37187, DOI 10.1074/jbc.M111.224923; Choy M, 2014, J NEUROSCI, V34, P8672, DOI 10.1523/JNEUROSCI.4806-13.2014; Chungath M, 2008, NAT CLIN PRACT NEURO, V4, P610, DOI 10.1038/ncpneuro0922; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Cloix JF, 2009, CURR MED CHEM, V16, P841, DOI 10.2174/092986709787549316; Cornejo BJ, 2007, ANN NEUROL, V61, P411, DOI 10.1002/ana.21071; Costa LD, 2008, PHYSICA A, V387, P6201, DOI 10.1016/j.physa.2008.06.034; Costa LD, 2011, ADV PHYS, V60, P329, DOI 10.1080/00018732.2011.572452; Costa LD, 2006, J STAT PHYS, V125, P845, DOI 10.1007/s10955-006-9130-y; Coxon CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049543; Crepaldi L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003699; Davies KG, 1996, EPILEPSY RES, V24, P119, DOI 10.1016/0920-1211(96)00008-3; Devos SL, 2013, J NEUROSCI, V33, P12887, DOI 10.1523/JNEUROSCI.2107-13.2013; Doucet G, 2013, HUM BRAIN MAPP, V34, P2202, DOI 10.1002/hbm.22059; Doucet GE, 2015, BRAIN TOPOGR, V28, P113, DOI 10.1007/s10548-014-0366-6; Du YS, 2013, BRAIN RES, V1509, P79, DOI 10.1016/j.brainres.2013.03.005; Dube C, 2006, BRAIN, V129, P911, DOI 10.1093/brain/awl018; Dube CM, 2009, BRAIN DEV-JPN, V31, P366, DOI 10.1016/j.braindev.2008.11.010; El-Hattab AW, 2011, CLIN GENET, V79, P531, DOI 10.1111/j.1399-0004.2010.01496.x; Erck C, 2005, P NATL ACAD SCI USA, V102, P7853, DOI 10.1073/pnas.0409626102; Feliciano P, 2013, J NEUROSCI, V33, P18319, DOI 10.1523/JNEUROSCI.5293-12.2013; Francis JS, 2011, GLIA, V59, P1435, DOI 10.1002/glia.21187; Furukawa A, 2011, NEUROBIOL DIS, V43, P706, DOI 10.1016/j.nbd.2011.05.024; Gasteier JE, 2005, EXP CELL RES, V306, P192, DOI 10.1016/j.yexcr.2005.02.006; Ghanta KS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017135; Glynn P, 2013, BBA-MOL CELL BIOL L, V1831, P633, DOI 10.1016/j.bbalip.2012.07.023; Gomez-Ospina N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060526; GRIFFIN WST, 1995, J NEUROCHEM, V65, P228; Gunzel D, 2009, J CELL SCI, V122, P1507, DOI 10.1242/jcs.040113; Hakimi MA, 2003, J BIOL CHEM, V278, P7234, DOI 10.1074/jbc.M208992200; Halder SK, 2012, CELL MOL NEUROBIOL, V32, P59, DOI 10.1007/s10571-011-9734-x; Hasegawa H, 2007, J NEUROSCI, V27, P14404, DOI 10.1523/JNEUROSCI.4908-07.2007; Helmstaedter C, 2004, EPILEPSY BEHAV, V5, P696, DOI 10.1016/j.yebeh.2004.06.008; Heuser K, 2011, SEIZURE-EUR J EPILEP, V20, P163, DOI 10.1016/j.seizure.2010.11.015; Hinnebusch AG, 2014, ANN REV BIO IN PRESS; Hoang SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081972; Holm PC, 2007, MOL CELL NEUROSCI, V34, P99, DOI 10.1016/j.mcn.2006.10.008; Huang CT, 2008, NEUROPSYCHOBIOLOGY, V58, P171, DOI 10.1159/000191123; Huang JH, 2011, FEBS J, V278, P1651, DOI 10.1111/j.1742-4658.2011.08085.x; Huang YY, 2012, SYNAPSE, V66, P151, DOI 10.1002/syn.20995; Huh YH, 2013, CELL MOL LIFE SCI, V70, P4841, DOI 10.1007/s00018-013-1447-5; Jacquemet G, 2013, J CELL SCI, V126, P4121, DOI 10.1242/jcs.121988; Janszky J, 2004, NEUROLOGY, V63, P1296, DOI 10.1212/01.WNL.0000140701.40447.88; Jung JJ, 2012, BIOSCIENCE REP, V32, P383, DOI 10.1042/BSR20120006; Kanari Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059026; Kienesberger PC, 2009, J LIPID RES, V50, pS63, DOI 10.1194/jlr.R800082-JLR200; Kim H, 2009, PHARMACOGENOMICS, V10, P171, DOI 10.2217/14622416.10.2.171; Kim JE, 2008, EXP NEUROL, V211, P128, DOI 10.1016/j.expneurol.2008.01.029; Kim JE, 2010, J COMP NEUROL, V518, P4612, DOI 10.1002/cne.22482; Kim KC, 2014, MOL NEUROBIOL, V49, P512, DOI 10.1007/s12035-013-8535-2; Kim MH, 2009, J NEUROSCI, V29, P1586, DOI 10.1523/JNEUROSCI.4306-08.2009; Kobayashi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035820; Kobow K, 2012, EPILEPSIA, V53, P11, DOI 10.1111/epi.12031; Kondo T, 2014, DEV CELL, V28, P94, DOI 10.1016/j.devcel.2013.11.021; Krug A, 2014, EUR ARCH PSY CLIN N, V264, P103, DOI 10.1007/s00406-013-0428-x; Kuraoka I, 2007, DNA REPAIR, V6, P841, DOI 10.1016/j.dnarep.2007.01.014; Lauritzen F, 2013, BRAIN STRUC IN PRESS; Lauritzen F, 2012, NEUROBIOL DIS, V45, P165, DOI 10.1016/j.nbd.2011.08.001; Lauritzen F, 2011, NEUROBIOL DIS, V41, P577, DOI 10.1016/j.nbd.2010.11.005; Leandro-Garcia LJ, 2010, CYTOSKELETON, V67, P214, DOI 10.1002/cm.20436; Lee CH, 2012, MOL CELL NEUROSCI, V51, P61, DOI 10.1016/j.mcn.2012.07.010; Lee MC, 2001, HUM PATHOL, V32, P643, DOI 10.1053/hupa.2001.24997; Lee TS, 2006, ACTA NEUROPATHOL, V111, P351, DOI 10.1007/s00401-005-0017-9; Lewerenz J, 2012, CELL DEATH DIFFER, V19, P847, DOI 10.1038/cdd.2011.165; Lewerenz J, 2014, ANTIOXID REDOX SIGN, V20, P2907, DOI 10.1089/ars.2013.5455; Lewerenz J, 2009, J BIOL CHEM, V284, P1106, DOI 10.1074/jbc.M807325200; Linnartz B, 2013, GLIA, V61, P37, DOI 10.1002/glia.22359; Linnartz-Gerlach B, 2014, NEUROSCIENCE, V275, P113, DOI 10.1016/j.neuroscience.2014.05.061; Liu G, 2002, ONCOGENE, V21, P7195, DOI 10.1038/sj.onc.1205862; Liu Y, 2008, J BIOL CHEM, V283, P6561, DOI 10.1074/jbc.M708096200; Lu CF, 2010, NEUROSCI LETT, V484, P139, DOI 10.1016/j.neulet.2010.08.036; Ludwig A, 2011, J NEUROSCI, V31, P644, DOI 10.1523/JNEUROSCI.2006-10.2011; Lum H, 2002, AM J PHYSIOL-CELL PH, V282, pC59, DOI 10.1152/ajpcell.00256.2001; Ma YY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-109; Marat AL, 2011, J BIOL CHEM, V286, P13791, DOI 10.1074/jbc.R110.217067; Margineanu DG, 2012, EPILEPSY RES, V98, P104, DOI 10.1016/j.eplepsyres.2011.10.006; Matsuki H, 2013, GENES CELLS, V18, P135, DOI 10.1111/gtc.12023; McClelland S, 2011, NEUROSCI LETT, V497, P155, DOI 10.1016/j.neulet.2011.02.032; Medrihan L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2515; Menssen R, 2012, J BIOL CHEM, V287, P25602, DOI 10.1074/jbc.M112.363762; Millard CJ, 2014, CANCER METAST REV, V33, P857, DOI 10.1007/s10555-014-9513-5; Miller-Delaney SFC, 2012, J NEUROSCI, V32, P1577, DOI 10.1523/JNEUROSCI.5180-11.2012; Miyagi M, 2011, NEUROSCIENCE, V176, P93, DOI 10.1016/j.neuroscience.2010.12.027; Moorthamer M, 1999, BIOCHEM BIOPH RES CO, V255, P631, DOI 10.1006/bbrc.1999.0145; Moreira-Filho CA, 2014, TRANSCRIPTOMICS HLTH, P79; Mulley JC, 2013, EPILEPSIA, V54, pe122, DOI 10.1111/epi.12323; N'Gouemo P, 2011, EXPERT OPIN THER TAR, V15, P1283, DOI 10.1517/14728222.2011.620607; Nam J, 2011, SEMIN CELL DEV BIOL, V22, P492, DOI 10.1016/j.semcdb.2011.06.005; Narayanan T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067237; Naylor DE, 2013, NEUROBIOL DIS, V54, P225, DOI 10.1016/j.nbd.2012.12.015; Newman M.E.J., 2010, NETWORKS INTRO; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Ogawa M, 2013, BIOCHEM BIOPH RES CO, V440, P88, DOI 10.1016/j.bbrc.2013.09.022; Otalora LFP, 2008, BRAIN RES, V1200, P116, DOI 10.1016/j.brainres.2008.01.017; Pandithage R, 2008, J CELL BIOL, V180, P915, DOI 10.1083/jcb.200707126; Parrish RR, 2013, NEUROSCIENCE, V248, P602, DOI 10.1016/j.neuroscience.2013.06.029; Patterson KP, 2014, NEUROTHERAPEUTICS, V11, P242, DOI 10.1007/s13311-014-0263-4; Pechenino AS, 2009, NEUROBIOL LEARN MEM, V91, P313, DOI 10.1016/j.nlm.2008.09.017; Perosa SR, 2002, BRAIN RES BULL, V58, P509, DOI 10.1016/S0361-9230(02)00822-5; Poppe R, 1997, J NEUROCHEM, V69, P84, DOI 10.1046/j.1471-4159.1997.69010084.x; Puskarjov M, 2014, EMBO REP, V15, P723, DOI 10.1002/embr.201438749; Putkonen N, 2011, EUR J NEUROSCI, V34, P1212, DOI 10.1111/j.1460-9568.2011.07858.x; Radzicki D, 2013, J NEUROSCI, V33, P9920, DOI 10.1523/JNEUROSCI.5482-12.2013; Ramirez DMO, 2012, NEURON, V73, P121, DOI 10.1016/j.neuron.2011.10.034; Ravenall SJ, 2002, EUR J NEUROSCI, V15, P281, DOI 10.1046/j.0953-816x.2001.01862.x; Richardson RJ, 2013, CHEM-BIOL INTERACT, V203, P238, DOI 10.1016/j.cbi.2012.10.024; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Rothermundt M, 2003, MICROSC RES TECHNIQ, V60, P614, DOI 10.1002/jemt.10303; Rowley S, 2013, FREE RADICAL BIO MED, V62, P121, DOI 10.1016/j.freeradbiomed.2013.02.002; Russo I, 2013, NEUROMOL MED, V15, P324, DOI 10.1007/s12017-013-8221-6; Saha S, 2013, J BIOL CHEM, V288, P7815, DOI 10.1074/jbc.M112.417196; Sahni N, 2013, CURR OPIN GENET DEV, V23, P649, DOI 10.1016/j.gde.2013.11.002; Saitoh F, 2004, J BIOL CHEM, V279, P29461, DOI 10.1074/jbc.M401471200; Salat K, 2011, FUTURE MED CHEM, V3, P211, DOI 10.4155/FMC.10.298; Sanchez J, 2014, SEIZURE-EUR J EPILEP, V23, P448, DOI 10.1016/j.seizure.2014.03.003; Santos SD, 2012, J BIOL CHEM, V287, P6868, DOI 10.1074/jbc.M111.322909; Sasaki K, 2009, PEDIATR NEUROL, V41, P114, DOI 10.1016/j.pediatrneurol.2009.03.003; Sasaki N, 2005, BIOCHEM BIOPH RES CO, V333, P131, DOI 10.1016/j.bbrc.2005.05.082; Sato T, 2010, J COMP NEUROL, V518, P4513, DOI 10.1002/cne.22469; Sequeira KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053204; Sha L, 2014, MOL CELLULA IN PRESS; Shen AG, 2002, NEUROSCI LETT, V327, P45, DOI 10.1016/S0304-3940(02)00381-6; Shi Y, 2012, INT J INF TECH DECIS, V11, P1, DOI 10.1142/S0219622012010018; Simms BA, 2014, NEURON, V82, P24, DOI 10.1016/j.neuron.2014.03.016; Singh NA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000649; Smirnova E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065605; Soerensen J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001813; Souchet B, 2014, NEUROBIOL DIS, V69, P65, DOI 10.1016/j.nbd.2014.04.016; Steiger JL, 2004, J NEUROSCI, V24, P6115, DOI 10.1523/JNEUROSCI.1200-04.2004; Steinhoff BJ, 1999, EPILEPSY RES, V36, P75, DOI 10.1016/S0920-1211(99)00026-1; Teocchi MA, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-53; Tian LJ, 2012, J BIOL CHEM, V287, P14718, DOI 10.1074/jbc.M111.335547; Tiedje KE, 2010, NEUROCHEM INT, V57, P177, DOI 10.1016/j.neuint.2010.06.001; Troller U, 2004, CELL SIGNAL, V16, P245, DOI 10.1016/S0898-6568(03)00135-9; Turturici G, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/618127; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; Van Kuilenburg ABP, 1999, HUM GENET, V104, P1, DOI 10.1007/PL00008711; Vezzani A, 2014, EPILEPSY CURR, V14, P3, DOI 10.5698/1535-7511-14.s2.3; Vielhaber S, 2008, EPILEPSIA, V49, P40, DOI 10.1111/j.1528-1167.2007.01280.x; Viggiano A, 2012, BRAIN RES, V1471, P66, DOI 10.1016/j.brainres.2012.06.048; Villarroel-Campos D, 2014, J NEUROCHEM, V129, P240, DOI 10.1111/jnc.12676; Wagnon JL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003067; Wang Y, 2006, MOL MEMBR BIOL, V23, P377, DOI 10.1080/09687860600776734; Wang YJ, 2012, J CELL BIOCHEM, V113, P2696, DOI 10.1002/jcb.24145; Wei ZY, 2011, MOL CELL, V43, P586, DOI 10.1016/j.molcel.2011.07.021; Wende H, 1999, MAMM GENOME, V10, P154, DOI 10.1007/s003359900961; Weser S, 2004, J BIOL CHEM, V279, P27022, DOI 10.1074/jbc.M312790200; West S, 2008, NUCLEIC ACIDS RES, V36, P905, DOI 10.1093/nar/gkm1112; White HS, 2014, NEUROTHERAPEUTICS, V11, P373, DOI 10.1007/s13311-013-0250-1; Willemsen MH, 2011, J MED GENET, V48, P810, DOI 10.1136/jmedgenet-2011-100294; Witte H, 2008, J CELL BIOL, V180, P619, DOI 10.1083/jcb.200707042; Woods JO, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-203; Wu CC, 2011, MOL CELL BIOL, V31, P2715, DOI 10.1128/MCB.05151-11; Xiao F, 2008, BRAIN RES, V1233, P168, DOI 10.1016/j.brainres.2008.07.101; Yang F, 2008, HIPPOCAMPUS, V18, P460, DOI 10.1002/hipo.20409; Yang JW, 2006, AMINO ACIDS, V30, P477, DOI 10.1007/s00726-005-0281-y; Yang RQ, 2011, MOL CELL BIOL, V31, P542, DOI 10.1128/MCB.01162-10; Yoo DY, 2015, NEUROL RES, V37, P69, DOI 10.1179/1743132814Y.0000000416; You JJ, 2010, J BIOL CHEM, V285, P11652, DOI 10.1074/jbc.M109.051094; Zha QQ, 2008, J NEUROCHEM, V105, P68, DOI 10.1111/j.1471-4159.2007.05110.x; Zhang BL, 2007, BIOCHEM BIOPH RES CO, V356, P536, DOI 10.1016/j.bbrc.2007.02.160; Zhang C, 1999, J NEUROCHEM, V73, P1650, DOI 10.1046/j.1471-4159.1999.0731650.x; Zhang DM, 1998, J NEUROSCI, V18, P3314; Zhang SJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000604; Zhou Yun, 2013, Front Endocrinol (Lausanne), V4, P165, DOI 10.3389/fendo.2013.00165; Zhu XW, 2007, GENE DEV, V21, P1010, DOI 10.1101/gad.1528707	208	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128174	10.1371/journal.pone.0128174	http://dx.doi.org/10.1371/journal.pone.0128174			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011637	Green Published, Green Submitted, gold			2022-12-26	WOS:000355183900201
J	Srinivasan, PP; Parajuli, A; Price, C; Wang, LY; Duncan, RL; Kirn-Safran, CB				Srinivasan, Padma P.; Parajuli, Ashutosh; Price, Christopher; Wang, Liyun; Duncan, Randall L.; Kirn-Safran, Catherine B.			Inhibition of T-Type Voltage Sensitive Calcium Channel Reduces Load-Induced OA in Mice and Suppresses the Catabolic Effect of Bone Mechanical Stress on Chondrocytes	PLOS ONE			English	Article							SUBCHONDRAL BONE; FLUID-FLOW; CARTILAGE DEGENERATION; MC3T3-E1 OSTEOBLASTS; ARTICULAR-CARTILAGE; CA2+ CHANNELS; SHEAR-STRESS; ION-CHANNEL; IN-VIVO; OSTEOARTHRITIS	Voltage-sensitive calcium channels (VSCC) regulate cellular calcium influx, one of the earliest responses to mechanical stimulation in osteoblasts. Here, we postulate that T-type VSCCs play an essential role in bone mechanical response to load and participate in events leading to the pathology of load-induced OA. Repetitive mechanical insult was used to induce OA in Ca(v)3.2 T-VSCC null and wild-type control mouse knees. Osteoblasts (MC3T3-E1) and chondrocytes were treated with a selective T-VSCC inhibitor and subjected to fluid shear stress to determine how blocking of T-VSCCs alters the expression profile of each cell type upon mechanical stimulation. Conditioned-media (CM) obtained from static and sheared MC3T3-E1 was used to assess the effect of osteoblast-derived factors on the chondrocyte phenotype. T-VSCC null knees exhibited significantly lower focal articular cartilage damage than age-matched controls. In vitro inhibition of T-VSCC significantly reduced the expression of both early and late mechanoresponsive genes in osteoblasts but had no effect on gene expression in chondrocytes. Furthermore, treatment of chondrocytes with CM obtained from sheared osteoblasts induced expression of markers of hypertrophy in chondrocytes and this was nearly abolished when osteoblasts were pre-treated with the T-VSCC-specific inhibitor. These results indicate that T-VSCC plays a role in signaling events associated with induction of OA and is essential to the release of osteoblast-derived factors that promote an early OA phenotype in chondrocytes. Further, these findings suggest that local inhibition of T-VSCC may serve as a therapy for blocking load-induced bone formation that results in cartilage degeneration.	[Srinivasan, Padma P.; Duncan, Randall L.; Kirn-Safran, Catherine B.] Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA; [Parajuli, Ashutosh; Price, Christopher; Duncan, Randall L.; Kirn-Safran, Catherine B.] Univ Delaware, Biomed Engn Program, Newark, DE 19716 USA; [Wang, Liyun; Duncan, Randall L.] Univ Delaware, Dept Mech Engn, Newark, DE 19716 USA	University of Delaware; University of Delaware; University of Delaware	Kirn-Safran, CB (corresponding author), Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA.	ckirn@udel.edu	Price, Christopher/I-4851-2018; Duncan, Randall/AAK-3888-2020; Kirn-Safran, Catherine/AAB-9089-2022	Duncan, Randall/0000-0001-5733-6603	National Institutes of Health (USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103333] Funding Source: NIH RePORTER	National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (USA): CBKS RLD LW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed E, 2009, MOL MEMBR BIOL, V26, P146, DOI 10.1080/09687680802612721; Alford AI, 2003, BONE, V33, P64, DOI 10.1016/S8756-3282(03)00167-4; Bergink AP, 2005, BONE, V37, P446, DOI 10.1016/j.bone.2005.05.001; Bessa PC, 2008, J TISSUE ENG REGEN M, V2, P81, DOI 10.1002/term.74; CATTERALL WA, 1995, ANNU REV BIOCHEM, V64, P493, DOI 10.1146/annurev.biochem.64.1.493; Chen CC, 2003, SCIENCE, V302, P1416, DOI 10.1126/science.1089268; Choi S, 2007, GENES BRAIN BEHAV, V6, P425, DOI 10.1111/j.1601-183X.2006.00268.x; Clark AL, 2010, ARTHRITIS RHEUM-US, V62, P2973, DOI 10.1002/art.27624; D'Angelo M, 2000, J CELL BIOCHEM, V77, P678, DOI 10.1002/(SICI)1097-4644(20000615)77:4<678::AID-JCB15>3.3.CO;2-G; DUNCAN R, 1989, FEBS LETT, V251, P17, DOI 10.1016/0014-5793(89)81420-6; DUNCAN RL, 1995, CALCIFIED TISSUE INT, V57, P344, DOI 10.1007/BF00302070; Duncan RL, 1998, SEMIN NEPHROL, V18, P178; Genetos DC, 2005, J BONE MINER RES, V20, P41, DOI 10.1359/jbmr.041009; Glasson SS, 2007, OSTEOARTHR CARTILAGE, V15, P1061, DOI 10.1016/j.joca.2007.03.006; Goldring MB, 2010, ANN NY ACAD SCI, V1192, P230, DOI 10.1111/j.1749-6632.2009.05240.x; Hayami T, 2004, ARTHRITIS RHEUM-US, V50, P1193, DOI 10.1002/art.20124; Herman BC, 2010, BONE, V47, P766, DOI 10.1016/j.bone.2010.07.006; Huang HD, 2004, AM J PHYSIOL-CELL PH, V287, pC1, DOI 10.1152/ajpcell.00559.2003; Huang LP, 2004, J PHARMACOL EXP THER, V309, P193, DOI 10.1124/jpet.103.060814; HUNG CT, 1995, CLIN ORTHOP RELAT R, P256; Hunter David J, 2003, Curr Rheumatol Rep, V5, P15, DOI 10.1007/s11926-003-0078-5; Kapur S, 2010, J BIOL CHEM, V285, P37607, DOI 10.1074/jbc.M110.169714; Kennedy OD, 2012, BONE, V50, P1115, DOI 10.1016/j.bone.2012.01.025; Ko FC, 2013, ARTHRITIS RHEUM-US, V65, P1569, DOI 10.1002/art.37906; Krakow D, 2009, AM J HUM GENET, V84, P307, DOI 10.1016/j.ajhg.2009.01.021; Kronbergs A, 2011, THESIS U DELAWARE; Li JL, 2002, J BONE MINER RES, V17, P1795, DOI 10.1359/jbmr.2002.17.10.1795; Lu XL, 2012, J BONE MINER RES, V27, P563, DOI 10.1002/jbmr.1474; Martel-Pelletier J, 2010, EKLEM HAST CERRAHISI, V21, P2; McDonald J.H., 2009, HDB BIOL STAT; Mohtai M, 1996, J ORTHOP RES, V14, P67, DOI 10.1002/jor.1100140112; Muramatsu S, 2007, J BIOL CHEM, V282, P32158, DOI 10.1074/jbc.M706158200; Ohba S, 2010, OSTEOARTHR CARTILAGE, V18, P1620, DOI 10.1016/j.joca.2010.09.006; Pan J, 2012, BONE, V51, P212, DOI 10.1016/j.bone.2011.11.030; Pavalko FM, 1998, AM J PHYSIOL-CELL PH, V275, pC1591; Phan MN, 2009, ARTHRITIS RHEUM-US, V60, P3028, DOI 10.1002/art.24799; Pitsillides AA, 2011, NAT REV RHEUMATOL, V7, P654, DOI 10.1038/nrrheum.2011.129; Poulet B, 2011, ARTHRITIS RHEUM-US, V63, P137, DOI 10.1002/art.27765; Prasadam I, 2010, ARTHRITIS RHEUM-US, V62, P1349, DOI 10.1002/art.27397; Price C, 2011, J BONE MINER RES, V26, P277, DOI 10.1002/jbmr.211; RADIN EL, 1986, CLIN ORTHOP RELAT R, P34; Robling AG, 2002, BONE, V31, P562, DOI 10.1016/S8756-3282(02)00871-2; Rubin J, 2006, GENE, V367, P1, DOI 10.1016/j.gene.2005.10.028; Ryder KD, 2001, J BONE MINER RES, V16, P240, DOI 10.1359/jbmr.2001.16.2.240; Shao Y, 2005, DEV DYNAM, V234, P54, DOI 10.1002/dvdy.20517; Smalt R, 1997, AM J PHYSIOL-ENDOC M, V273, pE751, DOI 10.1152/ajpendo.1997.273.4.E751; Srinivasan PP, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/2/024109; Suzuki T, 2013, BONE, V54, P172, DOI 10.1016/j.bone.2013.01.001; Tat SK, 2010, BEST PRACT RES CL RH, V24, P51, DOI 10.1016/j.berh.2009.08.004; Todorovic SM, 2011, BRIT J PHARMACOL, V163, P484, DOI 10.1111/j.1476-5381.2011.01256.x; Todorovic SM, 2001, MOL PHARMACOL, V60, P603; Truong LH, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2101; Westacott C., 2002, Journal of Musculoskeletal & Neuronal Interactions, V2, P507; Zhou XZ, 2010, J BIOMECH, V43, P1598, DOI 10.1016/j.jbiomech.2009.12.028	54	17	18	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127290	10.1371/journal.pone.0127290	http://dx.doi.org/10.1371/journal.pone.0127290			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011709	Green Published, gold			2022-12-26	WOS:000355183900079
J	Szeto, CC; Kwan, BCH; Chow, KM; Kwok, JSS; Lai, KB; Cheng, PMS; Pang, WF; Ng, JKC; Chan, MHM; Lit, LCW; Leung, CB; Li, PKT				Szeto, Cheuk-Chun; Kwan, Bonnie Ching-Ha; Chow, Kai-Ming; Kwok, Jeffrey Sung-Shing; Lai, Ka-Bik; Cheng, Phyllis Mei-Shan; Pang, Wing-Fai; Ng, Jack Kit-Chung; Chan, Michael Ho-Ming; Lit, Lydia Choi-Wan; Leung, Chi-Bon; Li, Philip Kam-Tao			Circulating Bacterial-Derived DNA Fragment Level Is a Strong Predictor of Cardiovascular Disease in Peritoneal Dialysis Patients	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; SYSTEMIC INFLAMMATION; RENAL-FAILURE; ALL-CAUSE; ENDOTOXEMIA; ATHEROSCLEROSIS; MORTALITY; HEMODIALYSIS; ASSOCIATION; EPIDEMIOLOGY	Background Circulating bacterial DNA fragment is related to systemic inflammatory state in peritoneal dialysis (PD) patients. We hypothesize that plasma bacterial DNA level predicts cardiovascular events in new PD patients. Methods We measured plasma bacterial DNA level in 191 new PD patients, who were then followed for at least a year for the development of cardiovascular event, hospitalization, and patient survival. Results The average age was 59.3 +/- 11.8 years; plasma bacterial DNA level 34.9 +/- 1.5 cycles; average follow up 23.2 +/- 9.7 months. At 24 months, the event-free survival was 86.1%, 69.8%, 55.4% and 30.8% for plasma bacterial DNA level quartiles I, II, III and IV, respectively (p < 0.0001). After adjusting for confounders, plasma bacterial DNA level, baseline residual renal function and malnutrition-inflammation score were independent predictors of composite cardiovascular end-point; each doubling in plasma bacterial DNA level confers a 26.9% (95% confidence interval, 13.0 - 42.5%) excess in risk. Plasma bacterial DNA also correlated with the number of hospital admission (r = -0.379, p < 0.0001) and duration of hospitalization for cardiovascular reasons (r = -0.386, p < 0.0001). Plasma bacterial DNA level did not correlate with baseline arterial pulse wave velocity (PWV), but with the change in carotid-radial PWV in one year (r = -0.238, p = 0.005). Conclusions Circulating bacterial DNA fragment level is a strong predictor of cardiovascular event, need of hospitalization, as well as the progressive change in arterial stiffness in new PD patients.	[Szeto, Cheuk-Chun; Kwan, Bonnie Ching-Ha; Chow, Kai-Ming; Lai, Ka-Bik; Cheng, Phyllis Mei-Shan; Pang, Wing-Fai; Ng, Jack Kit-Chung; Leung, Chi-Bon; Li, Philip Kam-Tao] Chinese Univ Hong Kong, Prince Wales Hosp, Carol & Richard Yu Peritoneal Dialysis Res Ctr, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China; [Kwok, Jeffrey Sung-Shing; Chan, Michael Ho-Ming; Lit, Lydia Choi-Wan] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Chem Pathol, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital	Szeto, CC (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Carol & Richard Yu Peritoneal Dialysis Res Ctr, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China.	ccszeto@cuhk.edu.hk	Kwan, Bonnie/N-3463-2015; Ming, Chow Kai/Y-5568-2019; Ng, Jack KC/L-6473-2019; Szeto, Cheuk Chun/N-4954-2015; Li, Philip K. T./D-4051-2017	Kwan, Bonnie/0000-0001-6742-8480; Ming, Chow Kai/0000-0001-5310-5197; Ng, Jack KC/0000-0002-9549-9611; Szeto, Cheuk Chun/0000-0002-8898-8505; Chan, Michael/0000-0003-1949-1666	Baxter Extramural Grant program; Richard Yu Chinese University of Hong Kong (CUHK) PD Research Fund; CUHK research account [6901031]	Baxter Extramural Grant program; Richard Yu Chinese University of Hong Kong (CUHK) PD Research Fund; CUHK research account(Chinese University of Hong Kong)	This study was supported in part by the Baxter Extramural Grant program, the Richard Yu Chinese University of Hong Kong (CUHK) PD Research Fund, and CUHK research account 6901031. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders HJ, 2013, KIDNEY INT, V83, P1010, DOI 10.1038/ki.2012.440; Bergstrom J, 1998, PERITON DIALYSIS INT, V18, P467; Bossola M, 2009, CLIN J AM SOC NEPHRO, V4, P379, DOI 10.2215/CJN.03490708; Churchill DN, 1998, J AM SOC NEPHROL, V9, P1285; de Almeida Duarte Joan Bosco, 2004, Urol Res, V32, P266; Dumea R, 2014, INT UROL NEPHROL, V46, P461, DOI 10.1007/s11255-013-0542-8; ENIA G, 1993, NEPHROL DIAL TRANSPL, V8, P1094; Foley RN, 2005, J AM SOC NEPHROL, V16, P489, DOI 10.1681/ASN.2004030203; Harrison LEA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040209; John SG, 2011, CLIN J AM SOC NEPHRO, V6, P2389, DOI 10.2215/CJN.11211210; Kalantar-Zadeh K, 2001, AM J KIDNEY DIS, V38, P1251, DOI 10.1053/ajkd.2001.29222; KREDIET R T, 1986, Blood Purification, V4, P194, DOI 10.1159/000169445; Kwan BCH, 2013, NEPHRON CLIN PRACT, V123, P246, DOI 10.1159/000354714; Kwan BCH, 2013, NEPHROL DIAL TRANSPL, V28, P2139, DOI 10.1093/ndt/gft100; Levin A, 2003, SEMIN DIALYSIS, V16, P101, DOI 10.1046/j.1525-139X.2003.16025.x; McIntyre CW, 2011, CLIN J AM SOC NEPHRO, V6, P133, DOI 10.2215/CJN.04610510; NOE DA, 1991, J PHARM SCI, V80, P501, DOI 10.1002/jps.2600800520; Owen WF, 1998, KIDNEY INT, V54, P627, DOI 10.1046/j.1523-1755.1998.00032.x; Parikh NI, 2006, ARCH INTERN MED, V166, P1884, DOI 10.1001/archinte.166.17.1884; Peritoneal Dialysis Adequacy Work Group, 2001, AM J KIDNEY DIS, V37, pS65; Ramezani A, 2014, J AM SOC NEPHROL, V25, P657, DOI 10.1681/ASN.2013080905; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Selgas R, 1996, Perit Dial Int, V16 Suppl 1, pS215; Stenvinkel P, 1999, KIDNEY INT, V55, P1899, DOI 10.1046/j.1523-1755.1999.00422.x; Stenvinkel P, 2002, NEPHROL DIAL TRANSPL, V17, P33, DOI 10.1093/ndt/17.suppl_8.33; Stoll LL, 2004, ARTERIOSCL THROM VAS, V24, P2227, DOI 10.1161/01.ATV.0000147534.69062.dc; Szeto CC, 2000, KIDNEY INT, V58, P400, DOI 10.1046/j.1523-1755.2000.00179.x; Szeto CC, 2003, J AM SOC NEPHROL, V14, P2119, DOI 10.1097/01.ASN.0000080316.37254.7A; Szeto CC, 2003, NEPHROL DIAL TRANSPL, V18, P977, DOI 10.1093/ndt/gfg027; Szeto CC, 2008, CLIN J AM SOC NEPHRO, V3, P431, DOI 10.2215/CJN.03600807; Szeto CC, 2007, J AM SOC NEPHROL, V18, P1966, DOI 10.1681/ASN.2006101184; Szeto CC, 2007, NEPHROL DIAL TRANSPL, V22, P552, DOI 10.1093/ndt/gfl559; Szeto CC, 2012, AM J NEPHROL, V35, P127, DOI 10.1159/000335580; Szeto CC, 2010, PERITON DIALYSIS INT, V30, P178, DOI 10.3747/pdi.2008.00242; Tripepi G, 2005, J AM SOC NEPHROL, V16, pS83, DOI 10.1681/ASN.2004110972; Wang Angela Y-M, 2005, Curr Opin Investig Drugs, V6, P879; Weiner DE, 2006, AM J KIDNEY DIS, V48, P392, DOI 10.1053/j.ajkd.2006.05.021; Wiedermann CJ, 1999, J AM COLL CARDIOL, V34, P1975, DOI 10.1016/S0735-1097(99)00448-9; Yeun JY, 1997, AM J KIDNEY DIS, V30, P923, DOI 10.1016/S0272-6386(97)90105-0	40	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0125162	10.1371/journal.pone.0125162	http://dx.doi.org/10.1371/journal.pone.0125162			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010741	gold, Green Submitted, Green Published			2022-12-26	WOS:000355183900010
J	Sawada, T; Arai, D; Jing, XF; Furushima, K; Chen, QF; Kawakami, K; Yokote, H; Miyajima, M; Sakaguchi, K				Sawada, Takahiro; Arai, Daiki; Jing, Xuefeng; Furushima, Kenryo; Chen, Qingfa; Kawakami, Kazuki; Yokote, Hideyuki; Miyajima, Masayasu; Sakaguchi, Kazushige			Trans-Activation between EphA and FGFR Regulates Self-Renewal and Differentiation of Mouse Embryonic Neural Stem/Progenitor Cells via Differential Activation of FRS2 alpha	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; NUCLEOTIDE EXCHANGE FACTOR; STEM-CELLS; MAPK CASCADE; PC12 CELLS; IN-VIVO; RECEPTORS; PROLIFERATION; INHIBITION; MECHANISMS	Ephs and FGFRs belong to a superfamily of receptor tyrosine kinases, playing important roles in stem cell biology. We previously reported that EphA4 and FGFR form a heterodimer following stimulation with ligands, trans-activating each other and signaling through a docking protein, FRS2 alpha, that binds to both receptors. Here, we investigated whether the interaction between EphA4 and FGFRs can be generalized to other Ephs and FGFRs, and, in addition, examined the downstream signal mediating their function in embryonic neural stem/progenitor cells. We revealed that various Ephs and FGFRs interact with each other through similar molecular domains. When neural stem/progenitor cells were stimulated with FGF2 and ephrin-A1, the signal transduced from the EphA4/FGFR/FRS2 alpha complex enhanced self-renewal, while stimulation with ephrin-A1 alone induced neuronal differentiation. The downstream signal required for neuronal differentiation appears to be MAP kinase mainly linked to the Ras family of G proteins. MAP kinase activation was delayed and sustained, distinct from the transient activation induced by FGF2. Interestingly, this effect on neuronal differentiation required the presence of FGFRs. Specific FGFR inhibitor almost completely abolished the function of ephrin-A1 stimulation. These findings suggest that the ternary complex of EphA, FGFR and FRS2 alpha formed by ligand stimulation regulates self-renewal and differentiation of mouse embryonic neural stem/progenitor cells by ligand-specific fine tuning of the downstream signal via FRS2 alpha.	[Sawada, Takahiro; Arai, Daiki; Jing, Xuefeng; Furushima, Kenryo; Chen, Qingfa; Kawakami, Kazuki; Yokote, Hideyuki; Sakaguchi, Kazushige] Inst Adv Med, Dept Mol Cell Biol & Mol Med, Wakayama, Wakayama, Japan; [Miyajima, Masayasu] Wakayama Med Univ, Lab Anim Ctr, Wakayama, Japan	Wakayama Medical University	Sawada, T (corresponding author), Inst Adv Med, Dept Mol Cell Biol & Mol Med, Wakayama, Wakayama, Japan.	t-sawada@hokuto7.or.jp; ksaka@wakayama-med.ac.jp	Chen, Qingfa/AAG-1036-2020		Wakayama Medical Award for Young Reseachers; Japanese Government [19300132, 19700346]; Wakayama Medical University; Wakayama Foundation for the Promotion of Medicine	Wakayama Medical Award for Young Reseachers; Japanese Government; Wakayama Medical University; Wakayama Foundation for the Promotion of Medicine	This work was supported in part by the 2011 Wakayama Medical Award for Young Reseachers (to T.S.); the Japanese Government Grant-in-Aid for Scientific Research #19300132 (to K.S.); a Research Grant on Priority Areas from Wakayama Medical University (to K.S.); a Medical Research Grant from the Wakayama Foundation for the Promotion of Medicine (to K.S.); and the Japanese Government Grant-in-Aid for Scientific Research #19700346 (to T.S.).	Ahmed S, 2009, J CELL BIOCHEM, V106, P1, DOI 10.1002/jcb.21972; Aoki M, 2004, J BIOL CHEM, V279, P32643, DOI 10.1074/jbc.M313247200; Delaune E, 2005, DEVELOPMENT, V132, P299, DOI 10.1242/dev.01582; Ferron SR, 2007, NAT PROTOC, V2, P849, DOI 10.1038/nprot.2007.104; Gotoh N, 2008, CANCER SCI, V99, P1319, DOI 10.1111/j.1349-7006.2008.00840.x; Hadari YR, 2001, P NATL ACAD SCI USA, V98, P8578, DOI 10.1073/pnas.161259898; Hu JG, 2012, J MOL NEUROSCI, V46, P644, DOI 10.1007/s12031-011-9652-x; Jing XF, 2012, CELL REP, V2, P652, DOI 10.1016/j.celrep.2012.08.021; Jing XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032019; Kao SC, 2001, J BIOL CHEM, V276, P18169, DOI 10.1074/jbc.M008870200; Khodosevich K, 2011, J CELL SCI, V124, P1268, DOI 10.1242/jcs.076059; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Konstantinova I, 2007, CELL, V129, P359, DOI 10.1016/j.cell.2007.02.044; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Miao H, 2009, CANCER CELL, V16, P9, DOI 10.1016/j.ccr.2009.04.009; Nomura T, 2010, CELL STEM CELL, V7, P730, DOI 10.1016/j.stem.2010.11.009; Ojeda L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023414; Sawada T, 2010, GENES CELLS, V15, P297, DOI 10.1111/j.1365-2443.2010.01391.x; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Shinya M, 2001, DEVELOPMENT, V128, P4153; Sun P, 2006, GENES CELLS, V11, P1097, DOI 10.1111/j.1365-2443.2006.01002.x; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Wu CB, 2001, J NEUROSCI, V21, P5406, DOI 10.1523/JNEUROSCI.21-15-05406.2001; Xu QL, 1999, NATURE, V399, P267, DOI 10.1038/20452; Yamamoto S, 2005, P NATL ACAD SCI USA, V102, P15983, DOI 10.1073/pnas.0507961102; Yokote H, 2005, P NATL ACAD SCI USA, V102, P18866, DOI 10.1073/pnas.0509741102; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451; Zhang Y, 2007, J BIOL CHEM, V282, P31103, DOI 10.1074/jbc.M704430200; Zhao C, 2006, CELL METAB, V4, P111, DOI 10.1016/j.cmet.2006.05.012	29	11	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128826	10.1371/journal.pone.0128826	http://dx.doi.org/10.1371/journal.pone.0128826			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024354	Green Published, gold, Green Submitted			2022-12-26	WOS:000355319400103
J	Yi, HS; Eun, HS; Lee, YS; Jung, JY; Park, SH; Park, KG; Choi, HS; Suh, JM; Jeong, WI				Yi, Hyon-Seung; Eun, Hyuk Soo; Lee, Young-Sun; Jung, Ju Yeon; Park, Seol-Hee; Park, Keun-Gyu; Choi, Hueng-Sik; Suh, Jae Myoung; Jeong, Won-Il			Treatment with 4-Methylpyrazole Modulated Stellate Cells and Natural Killer Cells and Ameliorated Liver Fibrosis in Mice	PLOS ONE			English	Article							INDUCED HEPATIC-FIBROSIS; RETINOIC ACID; VITAMIN-A; ETHYLENE-GLYCOL; TGF-BETA; RATS; ACTIVATION; ALCOHOL; CYTOTOXICITY; COLLAGEN	Background & Aims Accumulating evidence suggests that retinol and its metabolites are closely associated with liver fibrogenesis. Recently, we demonstrated that genetic ablation of alcohol dehydrogenase 3 (ADH3), a retinol metabolizing gene that is expressed in hepatic stellate cells (HSCs) and natural killer (NK) cells, attenuated liver fibrosis in mice. In the current study, we investigated whether pharmacological ablation of ADH3 has therapeutic effects on experimentally induced liver fibrosis in mice. Methods Liver fibrosis was induced by intraperitoneal injections of carbon tetrachloride (CCl4) or bile duct ligation (BDL) for two weeks. To inhibit ADH3-mediated retinol metabolism, 10 mu g 4-methylpyrazole (4-MP)/g of body weight was administered to mice treated with CCl4 or subjected to BDL. The mice were sacrificed at week 2 to evaluate the regression of liver fibrosis. Liver sections were stained for collagen and alpha-smooth muscle actin (alpha-SMA). In addition, HSCs and NK cells were isolated from control and treated mice livers for molecular and immunological studies. Results Treatment with 4-MP attenuated CCl4- and BDL-induced liver fibrosis in mice, without any adverse effects. HSCs from 4-MP treated mice depicted decreased levels of retinoic acids and increased retinol content than HSCs from control mice. In addition, the expression of alpha-SMA, transforming growth factor-beta 1 (TGF-beta 1), and type I collagen alpha 1 was significantly reduced in the HSCs of 4-MP treated mice compared to the HSCs from control mice. Furthermore, inhibition of retinol metabolism by 4-MP increased interferon-gamma production in NK cells, resulting in increased apoptosis of activated HSCs. Conclusions Based on our data, we conclude that inhibition of retinol metabolism by 4-MP ameliorates liver fibrosis in mice through activation of NK cells and suppression of HSCs. Therefore, retinol and its metabolizing enzyme, ADH3, might be potential targets for therapeutic intervention of liver fibrosis.	[Yi, Hyon-Seung; Eun, Hyuk Soo; Lee, Young-Sun; Jung, Ju Yeon; Suh, Jae Myoung; Jeong, Won-Il] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Lab Liver Res, Taejon 305701, South Korea; [Lee, Young-Sun] Korea Univ, Coll Med, Dept Internal Med, Seoul 136705, South Korea; [Park, Seol-Hee] Seoul Natl Univ, Coll Vet Med, Dept Internal Med, Seoul, South Korea; [Park, Keun-Gyu] Kyungpook Natl Univ, Sch Med, Dept Internal Med, Daegu, South Korea; [Choi, Hueng-Sik] Chonnam Natl Univ, Natl Creat Res Initiat Ctr Nucl Receptor Signals, Gwangju, South Korea; [Choi, Hueng-Sik] Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Gwangju, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea University; Korea University Medicine (KU Medicine); Seoul National University (SNU); Kyungpook National University; Chonnam National University; Chonnam National University	Jeong, WI (corresponding author), Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Lab Liver Res, Taejon 305701, South Korea.	wijeong@kaist.ac.kr	Suh, Jae Myoung/B-3268-2015; Yi, Hyon-Seung/ABA-2729-2022; JEONG, WON IL/B-6615-2011	Suh, Jae Myoung/0000-0001-8097-4662; EUN, HYUK SOO/0000-0003-0485-0072; Yi, Hyon-Seung/0000-0002-3767-1954; Lee, Young-Sun/0000-0001-6396-0859	National Research Foundation of Korea (NRF) - Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [A111345, A111498]; Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea [PJ009957]	National Research Foundation of Korea (NRF) - Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea	This work was supported by the National Research Foundation of Korea (NRF) grant funded by grants of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea, (A111345 and A111498) and a grant from the Next-Generation BioGreen 21 Program, (No. PJ009957), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; BAUD FJ, 1988, NEW ENGL J MED, V319, P97, DOI 10.1056/NEJM198807143190206; Brent J, 1999, NEW ENGL J MED, V340, P832, DOI 10.1056/NEJM199903183401102; Brent J, 2001, NEW ENGL J MED, V344, P424, DOI 10.1056/NEJM200102083440605; CARMAN JA, 1991, J IMMUNOL, V147, P1247; Eipel C, 2013, INT J CLIN EXP PATHO, V6, P80; Faisel H, 2000, PUBLIC HEALTH NUTR, V3, P321, DOI 10.1017/S1368980000000367; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Gao B, 2008, HEPATOLOGY, V47, P729, DOI 10.1002/hep.22034; George J, 2007, GENE THER, V14, P790, DOI 10.1038/sj.gt.3302929; George J, 2004, INT J BIOCHEM CELL B, V36, P307, DOI 10.1016/S1357-2725(03)00253-X; George J, 2001, TOXICOLOGY, V156, P129, DOI 10.1016/S0300-483X(00)00352-8; Hisamori S, 2008, LIVER INT, V28, P1217, DOI 10.1111/j.1478-3231.2008.01745.x; Ichikawa S, 2011, J IMMUNOL, V186, P5549, DOI 10.4049/jimmunol.1003917; Jacobsen D, 1997, J TOXICOL-CLIN TOXIC, V35, P127, DOI 10.3109/15563659709001182; Jeong WI, 2008, GASTROENTEROLOGY, V134, P248, DOI 10.1053/j.gastro.2007.09.034; Jeong WI, 2006, HEPATOLOGY, V44, P1441, DOI 10.1002/hep.21419; Jeong WI, 2011, HEPATOLOGY, V53, P1342, DOI 10.1002/hep.24190; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kluwe J, 2011, GUT, V60, P1260, DOI 10.1136/gut.2010.209551; Koda H, 1996, BIOCHEM BIOPH RES CO, V221, P565, DOI 10.1006/bbrc.1996.0636; Komarova TV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090239; Lee YS, 2012, J GASTROEN HEPATOL, V27, P75, DOI 10.1111/j.1440-1746.2011.07007.x; Lopez-Valencia V, 2007, BIOCHEM PHARMACOL, V73, P586, DOI 10.1016/j.bcp.2006.10.021; Mormone E, 2011, CHEM-BIOL INTERACT, V193, P225, DOI 10.1016/j.cbi.2011.07.001; Murakami K, 2011, PEDIATR SURG INT, V27, P863, DOI 10.1007/s00383-011-2853-0; Natarajan SK, 2005, ARCH BIOCHEM BIOPHYS, V443, P93, DOI 10.1016/j.abb.2005.09.008; Okuno M, 1997, HEPATOLOGY, V26, P913, DOI 10.1002/hep.510260417; PALAKODETY RB, 1988, J BIOL CHEM, V263, P878; Radaeva S, 2006, GASTROENTEROLOGY, V130, P435, DOI 10.1053/j.gastro.2005.10.055; Radaeva S, 2007, AM J PHYSIOL-GASTR L, V293, pG809, DOI 10.1152/ajpgi.00212.2007; Sarkola T, 2001, ALCOHOL CLIN EXP RES, V25, P513, DOI 10.1111/j.1530-0277.2001.tb02244.x; Semba RD, 1998, NUTR REV, V56, pS38, DOI 10.1111/j.1753-4887.1998.tb01643.x; SENOO H, 1985, LAB INVEST, V52, P182; Sommerfeld K, 2012, PHARMACOL REP, V64, P1547, DOI 10.1016/S1734-1140(12)70952-0; Suh YG, 2012, HEPATOLOGY, V56, P1902, DOI 10.1002/hep.25817; Urtasun R, 2012, HEPATOLOGY, V55, P594, DOI 10.1002/hep.24701; Wang L, 2002, ARCH BIOCHEM BIOPHYS, V401, P262, DOI 10.1016/S0003-9861(02)00058-9; Yi HS, 2014, HEPATOLOGY, V60, P1044, DOI 10.1002/hep.27137; Yi HS, 2013, J GASTROEN HEPATOL, V28, P99, DOI 10.1111/jgh.12017; ZHAO ZR, 1995, J NUTR, V125, P2064, DOI 10.1093/jn/125.8.2064; ZHAO ZR, 1994, NAT IMMUN, V13, P29	43	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0127946	10.1371/journal.pone.0127946	http://dx.doi.org/10.1371/journal.pone.0127946			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024318	Green Published, Green Submitted, gold			2022-12-26	WOS:000355319400061
J	Prasad, R; Dyrkheeva, N; Williams, J; Wilson, SH				Prasad, Rajendra; Dyrkheeva, Nadezhda; Williams, Jason; Wilson, Samuel H.			Mammalian Base Excision Repair: Functional Partnership between PARP-1 and APE1 in AP-Site Repair	PLOS ONE			English	Article							DNA-POLYMERASE-BETA; STRAND BREAK REPAIR; APURINIC APYRIMIDINIC SITES; CELL NUCLEAR ANTIGEN; POLY(ADP-RIBOSE) POLYMERASE-1; APURINIC/APYRIMIDINIC ENDONUCLEASE-1; MOUSE FIBROBLASTS; PROTEIN XRCC1; LIGASE-III; IN-VITRO	The apurinic/apyrimidinic-(AP-) site in genomic DNA arises through spontaneous base loss and base removal by DNA glycosylases and is considered an abundant DNA lesion in mammalian cells. The base excision repair (BER) pathway repairs the AP-site lesion by excising and replacing the site with a normal nucleotide via template directed gap-filling DNA synthesis. The BER pathway is mediated by a specialized group of proteins, some of which can be found in multiprotein complexes in cultured mouse fibroblasts. Using a DNA polymerase (pol) beta immunoaffinity-capture technique to isolate such a complex, we identified five tightly associated and abundant BER factors in the complex: PARP-1, XRCC1, DNA ligase III, PNKP, and Tdp1. AP endonuclease 1 (APE1), however, was not present. Nevertheless, the complex was capable of BER activity, since repair was initiated by PARP-1's AP lyase strand incision activity. Addition of purified APE1 increased the BER activity of the pol beta complex. Surprisingly, the pol beta complex stimulated the strand incision activity of APE1. Our results suggested that PARP-1 was responsible for this effect, whereas other proteins in the complex had no effect on APE1 strand incision activity. Studies of purified PARP-1 and APE1 revealed that PARP-1 was able to stimulate APE1 strand incision activity. These results illustrate roles of PARP-1 in BER including a functional partnership with APE1.	[Prasad, Rajendra; Dyrkheeva, Nadezhda; Wilson, Samuel H.] NIEHS, Genome Integr & Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA; [Williams, Jason] NIEHS, Epigenet & Stem Cell Biol Lab, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Wilson, SH (corresponding author), NIEHS, Genome Integr & Struct Biol Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	wilson5@niehs.nih.gov	Wilson, Samuel H/E-6644-2019	Wilson, Samuel H/0000-0002-1702-5293; Dyrkheeva, Nadezhda/0000-0002-8360-1041	Intramural Research Program of the National Institutes of Health (NIH), National Institute of Environmental Health Sciences [Z01ES050158, Z01ES050159]; Eli Lilly and Co.; United States Department of State, United States-Russia; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES050158, Z01ES050159, ZIAES050158, ZIAES050159, ZICES102488] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health (NIH), National Institute of Environmental Health Sciences; Eli Lilly and Co.(Eli Lilly); United States Department of State, United States-Russia; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by the Intramural Research Program of the National Institutes of Health (NIH), National Institute of Environmental Health Sciences, project numbers Z01ES050158 and Z01ES050159. ND is supported in part by Eli Lilly and Co. and the United States Department of State, as part of the United States-Russia Collaboration in the Biomedical Sciences NIH Visiting Fellows Program.	BAILLY V, 1987, BIOCHEM J, V242, P565, DOI 10.1042/bj2420565; BAILLY V, 1989, BIOCHEM J, V262, P581, DOI 10.1042/bj2620581; Barnes DE, 1993, CURR OPIN CELL BIOL, V5, P424, DOI 10.1016/0955-0674(93)90007-D; Beard WA, 1995, METHOD ENZYMOL, V262, P98; Bennett RAO, 1997, P NATL ACAD SCI USA, V94, P7166, DOI 10.1073/pnas.94.14.7166; Biade S, 1998, J BIOL CHEM, V273, P898, DOI 10.1074/jbc.273.2.898; Caldecott KW, 2003, BIOCHEM SOC T, V31, P247, DOI 10.1042/bst0310247; Caldecott KW, 2001, BIOESSAYS, V23, P447, DOI 10.1002/bies.1063; CALDECOTT KW, 1994, MOL CELL BIOL, V14, P68, DOI 10.1128/MCB.14.1.68; Caldecott KW, 1995, NUCLEIC ACIDS RES, V23, P4836, DOI 10.1093/nar/23.23.4836; Cannavo E, 2007, J BIOL CHEM, V282, P2976, DOI 10.1074/jbc.M609989200; Cistulli C, 2004, DNA REPAIR, V3, P581, DOI 10.1016/j.dnarep.2003.09.012; Della-Maria J, 2012, J BIOL CHEM, V287, P39233, DOI 10.1074/jbc.M112.369975; DOETSCH PW, 1986, BIOCHEMISTRY-US, V25, P2212, DOI 10.1021/bi00356a054; DOETSCH PW, 1990, MUTAT RES, V236, P173, DOI 10.1016/0921-8777(90)90004-O; Fortini P, 1998, BIOCHEMISTRY-US, V37, P3575, DOI 10.1021/bi972999h; Frosina G, 1996, J BIOL CHEM, V271, P9573, DOI 10.1074/jbc.271.16.9573; Fung H, 2005, MOL CELL, V17, P463, DOI 10.1016/j.molcel.2004.12.029; Gembka A, 2007, NUCLEIC ACIDS RES, V35, P2596, DOI 10.1093/nar/gkl1139; Hanssen-Bauer A, 2011, ENVIRON MOL MUTAGEN, V52, P623, DOI 10.1002/em.20663; Horton JK, 2003, DNA REPAIR, V2, P27, DOI 10.1016/S1568-7864(02)00184-2; Horton JK, 2000, J BIOL CHEM, V275, P2211, DOI 10.1074/jbc.275.3.2211; Horton JK, 2014, MOL CANCER RES, V12, P1128, DOI 10.1158/1541-7786.MCR-13-0502; Hou EW, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm639; Jobert L, 2014, CELL MOL LIFE SCI, V71, P2451, DOI 10.1007/s00018-014-1562-y; Kedar PS, 2002, J BIOL CHEM, V277, P31115, DOI 10.1074/jbc.M201497200; Khodyreva SN, 2010, P NATL ACAD SCI USA, V107, P22090, DOI 10.1073/pnas.1009182107; Klungland A, 1999, P NATL ACAD SCI USA, V96, P13300, DOI 10.1073/pnas.96.23.13300; Klungland A, 1997, EMBO J, V16, P3341, DOI 10.1093/emboj/16.11.3341; KUMAR A, 1990, J BIOL CHEM, V265, P2124; KUMAR A, 1990, BIOCHEMISTRY-US, V29, P7156, DOI 10.1021/bi00483a002; Lan L, 2004, P NATL ACAD SCI USA, V101, P13738, DOI 10.1073/pnas.0406048101; Lavrik OI, 2001, J BIOL CHEM, V276, P25541, DOI 10.1074/jbc.M102125200; Lindahl T, 2000, MUTAT RES-REV MUTAT, V462, P129, DOI 10.1016/S1383-5742(00)00024-7; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; LINDAHL T, 1982, ANNU REV BIOCHEM, V51, P61, DOI 10.1146/annurev.bi.51.070182.000425; LINDAHL T, 1972, BIOCHEMISTRY-US, V11, P3610, DOI 10.1021/bi00769a018; Liu YA, 2007, J BIOL CHEM, V282, P13532, DOI 10.1074/jbc.M611295200; LOEB LA, 1985, CELL, V40, P483, DOI 10.1016/0092-8674(85)90191-6; Lu ML, 2010, NUCLEIC ACIDS RES, V38, P510, DOI 10.1093/nar/gkp1023; Maher RL, 2007, J BIOL CHEM, V282, P30577, DOI 10.1074/jbc.M704341200; Masson M, 1998, MOL CELL BIOL, V18, P3563, DOI 10.1128/MCB.18.6.3563; MATSUMOTO Y, 1995, SCIENCE, V269, P699, DOI 10.1126/science.7624801; Mendez F, 2000, RADIAT RES, V153, P186, DOI 10.1667/0033-7587(2000)153[0186:HSPAWB]2.0.CO;2; Mol CD, 2000, NATURE, V403, P451, DOI 10.1038/35000249; MOSBAUGH DW, 1994, PROG NUCLEIC ACID RE, V48, P315, DOI 10.1016/S0079-6603(08)60859-4; Nakamura J, 1999, CANCER RES, V59, P2522; Oda N, 1996, J BIOL CHEM, V271, P13816, DOI 10.1074/jbc.271.23.13816; Parlanti E, 2004, DNA REPAIR, V3, P703, DOI 10.1016/j.dnarep.2003.12.009; Parlanti E, 2007, NUCLEIC ACIDS RES, V35, P1569, DOI 10.1093/nar/gkl1159; Piersen CE, 1996, J BIOL CHEM, V271, P17811, DOI 10.1074/jbc.271.30.17811; Plo I, 2003, DNA REPAIR, V2, P1087, DOI 10.1016/S1568-7864(03)00116-2; Poletto M, 2014, MOL BIOL CELL, V25, P1641, DOI 10.1091/mbc.E13-12-0717; Prasad R, 1996, J BIOL CHEM, V271, P16000, DOI 10.1074/jbc.271.27.16000; Prasad R, 2007, MOL CELL, V27, P829, DOI 10.1016/j.molcel.2007.06.029; Prasad R, 2014, NUCLEIC ACIDS RES, V42, P6337, DOI 10.1093/nar/gku288; Prasad R, 2012, NUCLEIC ACIDS RES, V40, P11571, DOI 10.1093/nar/gks898; Prasad R, 2010, J BIOL CHEM, V285, P40479, DOI 10.1074/jbc.M110.155267; PRIGENT C, 1994, MOL CELL BIOL, V14, P310, DOI 10.1128/MCB.14.1.310; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rusyn I, 2005, DNA REPAIR, V4, P1099, DOI 10.1016/j.dnarep.2005.05.009; Sassa A, 2014, J BIOL CHEM, V289, P13996, DOI 10.1074/jbc.M114.557769; Sassa A, 2013, JOVE-J VIS EXP, DOI 10.3791/50695; Schermerhorn KM, 2013, BIOCHEMISTRY-US, V52, P7669, DOI 10.1021/bi401218r; SEEBERG E, 1995, TRENDS BIOCHEM SCI, V20, P391, DOI 10.1016/S0968-0004(00)89086-6; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; Slupphaug G, 2003, MUTAT RES-FUND MOL M, V531, P231, DOI 10.1016/j.mrfmmm.2003.06.002; SLUPPHAUG G, 1995, BIOCHEMISTRY-US, V34, P128, DOI 10.1021/bi00001a016; Sobol RW, 1996, NATURE, V379, P183, DOI 10.1038/379183a0; Srivastava DK, 1998, J BIOL CHEM, V273, P21203, DOI 10.1074/jbc.273.33.21203; Strauss PR, 1997, J BIOL CHEM, V272, P1302, DOI 10.1074/jbc.272.2.1302; Tell G, 2009, CURR PHARM DESIGN, V15, P2908, DOI 10.2174/138161209789058174; Tsutakawa SE, 2013, J BIOL CHEM, V288, P8445, DOI 10.1074/jbc.M112.422774; Vidal AE, 2001, NUCLEIC ACIDS RES, V29, P1285, DOI 10.1093/nar/29.6.1285; Watters D, 1997, ONCOGENE, V14, P1911, DOI 10.1038/sj.onc.1201037; Whitehouse CJ, 2001, CELL, V104, P107, DOI 10.1016/S0092-8674(01)00195-7; Wiederhold L, 2004, MOL CELL, V15, P209, DOI 10.1016/j.molcel.2004.06.003; Wilson SH, 1998, MUTAT RES-DNA REPAIR, V407, P203, DOI 10.1016/S0921-8777(98)00002-0	79	34	37	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0124269	10.1371/journal.pone.0124269	http://dx.doi.org/10.1371/journal.pone.0124269			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020771	Green Published, gold, Green Submitted			2022-12-26	WOS:000355187300007
J	Su, S; Cassey, P; Vall-Llosera, M; Blackburn, TM				Su, Shan; Cassey, Phillip; Vall-Llosera, Miquel; Blackburn, Tim M.			Going Cheap: Determinants of Bird Price in the Taiwanese Pet Market	PLOS ONE			English	Article							PHYLOGENETIC SIGNAL; EXTINCTION RISK; GLOBAL TRADE; BODY-SIZE; PATTERNS; PATHWAYS; TRENDS; NONRANDOMNESS; ESTABLISHMENT; INVASIONS	Background International wildlife trade is the largest emerging source of vertebrate invasive alien species. In order to prevent invasions, it is essential to understand the mechanics of trade and, in particular, which traded species are most likely to be released or escape into the wild. A species' economic value is a key factor, because we expect cheaper species to be less assiduously secured against escaping, and more likely to be deliberately released. Here, we investigate determinants of the price of species in the Taiwanese bird trade. Taiwan is an international hub for bird trade, and several native species are threatened by alien bird species. Methodology We investigated the relationship between the traded species sale price in Taiwan and the species availability for trade (the number of birds for sale, geographic range size and their origin, conservation and CITES status) and traits (body size, coloration, song attractiveness). We used phylogenetic generalized least squares models, with multi-model inference, to assess the variables that are best related to the price of birds in the Taiwanese pet trade. Principal Findings / Conclusions We found that species available for sale in larger numbers, native to Taiwan, not globally endangered, and small-bodied are all relatively cheaper, as too are species lacking yellow coloration and without attractive songs. Our models of price revealed high levels of phylogenetic correlation, and hence that closely related species tended to be sold for similar prices. We suggest that, on the basis of price, native species are more likely to be deliberately or accidentally released than alien species. Nevertheless, our survey of bird shops recorded 160 species alien to Taiwan (7,631 individuals), several of which are for sale cheaply and in large numbers. Alien bird species in trade therefore present an ongoing, non-trivial invasion risk on the island.	[Su, Shan] Zool Soc London, Inst Zool, London NW1 4RY, England; [Su, Shan; Blackburn, Tim M.] UCL, Res Dept Genet Evolut & Environm, London, England; [Su, Shan; Cassey, Phillip; Vall-Llosera, Miquel; Blackburn, Tim M.] Univ Adelaide, Sch Biol Sci, Adelaide, SA, Australia; [Blackburn, Tim M.] Univ Stellenbosch, Dept Bot & Zool, Ctr Invas Biol, ZA-7600 Stellenbosch, South Africa	Zoological Society of London; University of London; University College London; University of Adelaide; Stellenbosch University	Su, S (corresponding author), Zool Soc London, Inst Zool, Regents Pk, London NW1 4RY, England.	su.shan@ioz.ac.uk	Blackburn, Tim M/A-7685-2011; Vall-llosera, Miquel/AAM-8895-2020; Blackburn, Tim/AAC-3144-2019	Vall-llosera, Miquel/0000-0003-2644-2643; Blackburn, Tim/0000-0003-0152-2663; Cassey, Phillip/0000-0002-2626-0172	Institute of Zoology, Zoological Society of London; Invasive Animals CRC	Institute of Zoology, Zoological Society of London; Invasive Animals CRC(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	PC is an ARC Future Fellow (FT0991420). This study received financial support from Institute of Zoology, Zoological Society of London (zsl.org), and from the Invasive Animals CRC (to MV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agoramoorthy G., 2009, J INT WILDL LAW POLI, V12, P190, DOI DOI 10.1080/13880290903202690; Agoramoorthy G, 2007, HUM ECOL, V35, P251, DOI 10.1007/s10745-006-9068-3; [Anonymous], 2014, R LANG ENV STAT COMP; Bennett P. M., 2002, OX ECOL EV; Bennett PM, 1997, P ROY SOC B-BIOL SCI, V264, P401, DOI 10.1098/rspb.1997.0057; Blackburn TM, 2007, DIVERS DISTRIB, V13, P519, DOI 10.1111/j.1472-4642.2007.00358.x; Blackburn TM, 2006, J ANIM ECOL, V75, P1426, DOI 10.1111/j.1365-2656.2006.01167.x; Blackburn TM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001850; Blackburn TM, 2014, ETHOLOGY, V120, P305, DOI 10.1111/eth.12211; Blackburn TM, 2011, TRENDS ECOL EVOL, V26, P333, DOI 10.1016/j.tree.2011.03.023; BLACKBURN TM, 1995, J BIOGEOGR, V22, P7, DOI 10.2307/2846069; Blackburn TM, 2004, SCIENCE, V305, P1955, DOI 10.1126/science.1101617; Blackburn TM, 2009, OXFORD AVIAN BIOL, P1; BLACKBURN TM, 1994, OIKOS, V69, P336, DOI 10.2307/3546157; Blackburn TM, 2001, J BIOGEOGR, V28, P927, DOI 10.1046/j.1365-2699.2001.00597.x; Bohning-Gaese K, 1999, EVOL ECOL RES, V1, P347; Brooks-Moizer F, 2009, ECOL SOC, V14; Bush ER, 2014, CONSERV BIOL, V28, P663, DOI 10.1111/cobi.12240; C-T Yao, 2007, 9603804 END SPEC RES; Carrete M, 2008, FRONT ECOL ENVIRON, V6, P207, DOI 10.1890/070075; Cassey P, 2004, GLOBAL CHANGE BIOL, V10, P417, DOI 10.1111/j.1529-8817.2003.00748.x; Chen G-M., 2007, CHINA MEDIA RES, V3, P102; Clavero M, 2005, TRENDS ECOL EVOL, V20, P110, DOI 10.1016/j.tree.2005.01.003; Colunga-Garcia M., 2013, NeoBiota, P103; Courchamp F, 2006, PLOS BIOL, V4, P2405, DOI 10.1371/journal.pbio.0040415; Davis M. A., 2009, INVASION BIOL; Ding T-S, 2012, 2012 CWBF CHECKLIST; Dunning Jr JB, 1992, CRC HDB AVIAN BODY M; Edmunds K, 2011, ECOHEALTH, V8, P63, DOI 10.1007/s10393-011-0691-0; Environment and Animal Society of Taiwan, 2009, INV PRAYER AN REL TA; Environment and Animal Society of Taiwan, 2004, REP PRAYER AN TAIW S; Environment and Animal Society of Taiwan (EAST) & Kaohsiung Teacher's Association, 2004, PRACT PRAYER AN REL; Forster P, 2014, ECOHEALTH, V11, P15, DOI 10.1007/s10393-013-0887-6; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Frenot Y, 2005, BIOL REV, V80, P45, DOI 10.1017/S1464793104006542; Fritz SA, 2010, CONSERV BIOL, V24, P1042, DOI 10.1111/j.1523-1739.2010.01455.x; Frynta D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012568; Garcia-Diaz P, 2015, GLOBAL CHANGE BIOL, V21, P1078, DOI 10.1111/gcb.12790; Garrett Valery, 2008, CHINESE DRESS QING D; Gaston K.J., 1994, RARITY, P1; Gaston K.J., 2000, PATTERN PROCESS MACR, DOI [10.1002/9780470999592, DOI 10.1002/9780470999592]; GASTON KJ, 1991, OIKOS, V61, P434, DOI 10.2307/3545251; GASTON KJ, 1994, ECOGRAPHY, V17, P198, DOI 10.1111/j.1600-0587.1994.tb00094.x; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; International Traffic Network, 1992, PERC CONS MAN WILD B; IUCN, 2013, IUCN RED LIST THREAT; Jepson P, 2005, ORYX, V39, P442, DOI 10.1017/S0030605305001110; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Kellert StephenR., 1984, ADV ANIMAL WELFARE S, P177; Knegtering E, 2011, ENVIRON CONSERV, V38, P28, DOI 10.1017/S0376892910000755; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Lee TW, 2005, ENDEM SPECIES RES, V7, P1; Li SH, 2010, J AVIAN BIOL, V41, P64, DOI 10.1111/j.1600-048X.2009.04719.x; Liskova S, 2013, ANTHROZOOS, V26, P27, DOI 10.2752/175303713X13534238631399; Lockwood J, 2001, BIOTIC HOMOGENIZATIO; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; Low BW, 2014, EMU, V114, P277, DOI 10.1071/MU13094; Meyerson LA, 2007, FRONT ECOL ENVIRON, V5, P199, DOI 10.1890/1540-9295(2007)5[199:IASIAE]2.0.CO;2; Nash SV, 1993, SOLD SONG TRADE SE A; Nuwer R, 2014, AUDUBON          JAN; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Olson VA, 2009, ECOL LETT, V12, P249, DOI 10.1111/j.1461-0248.2009.01281.x; Orme CDL, 2006, PLOS BIOL, V4, P1276, DOI 10.1371/journal.pbio.0040208; Revell LJ, 2010, METHODS ECOL EVOL, V1, P319, DOI 10.1111/j.2041-210X.2010.00044.x; Robinson JM, 2001, ENVIRON CONSERV, V28, P76, DOI 10.1017/S0376892901000078; Severinghaus LL, 1999, BIOL CONSERV, V89, P301, DOI 10.1016/S0006-3207(98)00155-4; Severinghaus LL, 2007, J NATL PARK, V17, P27; Shepherd C.R., 2012, EXPORT REEXPORT CITE; Regueira RFS, 2012, BIOL CONSERV, V149, P16, DOI 10.1016/j.biocon.2012.02.009; Simberloff D, 2009, ANNU REV ECOL EVOL S, V40, P81, DOI 10.1146/annurev.ecolsys.110308.120304; Soma I, 1997, HDB JAPAN US ENV BEH, P101; Su S, 2014, BIOL INVASIONS, V16, P2563, DOI 10.1007/s10530-014-0686-1; Tella JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107546; Webb TJ, 2007, J ANIM ECOL, V76, P123, DOI 10.1111/j.1365-2656.2006.01192.x; Westphal MI, 2008, BIOL INVASIONS, V10, P391, DOI 10.1007/s10530-007-9138-5; Wilson JRU, 2009, TRENDS ECOL EVOL, V24, P136, DOI 10.1016/j.tree.2008.10.007; Wilson LH, 1998, J AM VET MED ASSOC, V212, P1222; Worthley R., 1990, INT MARKET REV, V8, P21, DOI [10.1108/02651339110137279, DOI 10.1108/02651339110137279]; Young AM, 2012, ANIM CONSERV, V15, P28, DOI 10.1111/j.1469-1795.2011.00477.x; Zhang S., 2008, FRONT BIOL CHINA, V3, P308, DOI DOI 10.1007/S11515-008-0042-X	80	38	38	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0127482	10.1371/journal.pone.0127482	http://dx.doi.org/10.1371/journal.pone.0127482			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0RO	26017386	Green Published, gold, Green Submitted			2022-12-26	WOS:000355185600084
J	Yen, CY; Chiang, WF; Liu, SY; Lin, CC; Liao, KA; Lin, CY; Hsieh, WF; Cheng, YC; Hsu, KC; Lin, PY; Chen, TC; Lee, IL; Lin, MH; Liu, YC				Yen, Ching-Yu; Chiang, Wei-Fan; Liu, Shyun-Yeu; Lin, Chung-Chih; Liao, Kuo-An; Lin, Che-Yi; Hsieh, Wan-Fang; Cheng, Yon-Chi; Hsu, Kai-Cheng; Lin, Pin-Yen; Chen, Tai-Chi; Lee, I-Ling; Lin, Mei-Huei; Liu, Young-Chau			Impacts of Autophagy-Inducing Ingredient of Areca Nut on Tumor Cells	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; BECLIN 1-INDEPENDENT AUTOPHAGY; 30-100 KDA FRACTION; SIGNALING PATHWAY; CROSS-TALK; AMPK; CANCER; INDUCTION; ARECOLINE; APOPTOSIS	Areca nut (AN) is a popular carcinogen used by about 0.6-1.2 billion people worldwide. Although AN contains apoptosis-inducing ingredients, we previously demonstrated that both AN extract (ANE) and its 30-100 kDa fraction (ANE 30-100K) predominantly induce autophagic cell death in both normal and malignant cells. In this study, we further explored the action mechanism of ANE 30-100K-induced autophagy (AIA) in Jurkat T lymphocytes and carcinoma cell lines including OECM-1 (mouth), CE81T/VGH (esophagus), SCC25 (tongue), and SCC-15 (tongue). The results showed that chemical-and small hairpin RNA (shRNA)-mediated inhibition of AMP-activated protein kinase (AMPK) resulted in the attenuation of AIA in Jurkat T but not in OECM-1 cells. Knockdown of Atg5 and Beclin 1 expressions ameliorated AIA in OECM-1/CE81T/VGH/Jurkat T and OECM-1/SCC25/SCC-15, respectively. Furthermore, ANE 30-100K could activate caspase-3 after inhibition of Beclin 1 expression in OECM-1/SCC25/SCC15 cells. Meanwhile, AMPK was demonstrated to be the upstream activator of the extracellular-regulated kinase (ERK) in Jurkat T cells, and inhibition of MEK attenuated AIA in Jurkat T/OECM-1/CE81T/VGH cells. Finally, we also found that multiple myeloma RPMI8226, lymphoma U937, and SCC15 cells survived from long-term non-cytotoxic ANE 30-100K treatment exhibited stronger resistance against serum deprivation through upregulated autophagy. Collectively, our studies indicate that Beclin-1 and Atg5 but not AMPK are commonly required for AIA, and MEK/ERK pathway is involved in AIA. Meanwhile, it is also suggested that long-term AN usage might increase the resistance of survived tumor cells against serum-limited conditions.	[Yen, Ching-Yu; Liu, Shyun-Yeu] Taipei Med Univ, Dept Dent, Taipei, Taiwan; [Yen, Ching-Yu; Liu, Shyun-Yeu] Natl Def Med Ctr, Dept Dent, Taipei, Taiwan; [Yen, Ching-Yu; Liu, Shyun-Yeu] Chi Mei Med Ctr, Oral & Maxillofacial Surg Sect, Tainan, Taiwan; [Chiang, Wei-Fan; Liao, Kuo-An; Lin, Che-Yi; Lee, I-Ling] Chi Mei Hosp, Oral & Maxillofacial Surg Sect, Liouying, Taiwan; [Chiang, Wei-Fan] Natl Yang Ming Univ, Sch Dent, Taipei 112, Taiwan; [Lin, Chung-Chih] Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan; [Lin, Che-Yi] Natl Yang Ming Univ, Inst Genome Sci, Taipei 112, Taiwan; [Hsieh, Wan-Fang; Cheng, Yon-Chi; Hsu, Kai-Cheng; Lin, Pin-Yen; Lin, Mei-Huei] Chia Nan Univ Pharm, Dept Biotechnol, Tainan, Taiwan; [Hsieh, Wan-Fang; Cheng, Yon-Chi; Hsu, Kai-Cheng; Lin, Pin-Yen; Chen, Tai-Chi; Lin, Mei-Huei; Liu, Young-Chau] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Liu, Young-Chau] Shu Te Univ, Coll Liberal Educ, Div Nat Sci, Kaohsiung, Taiwan	Taipei Medical University; National Defense Medical Center; Chi Mei Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Chia Nan University of Pharmacy & Science; Chi Mei Hospital; Shu-Te University	Lin, MH (corresponding author), Chia Nan Univ Pharm, Dept Biotechnol, Tainan, Taiwan.	mhlin3224@mail.cnu.edu.tw; god15539@stu.edu.tw	Yen, Ching Yu/A-2771-2013; Chiang, Wei-Fan/L-6537-2019	Chiang, Wei-Fan/0000-0002-9240-1404	Ministry of Science and Technology [NSC98-2314-B384-002-MY3, NSC98-2314-B041-002, NSC99-2314-B-041-002, NSC101-2320-B-366-001, NSC102-2314-B-041-001-MY3]; Chi Mei Medical Center [CMFHR9903, CMFHR9936, CMFHR9948, CMFHR10051, CMFHR10055, CMFHR10159, CMFHR10203, CMFHR10209, CMFHR10307, CMFHR10301]; Chi Mei Hospital [CLFHR10107, CLFHR10223]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Chi Mei Medical Center; Chi Mei Hospital	This study is supported by grants from Ministry of Science and Technology (previously named: National Science Council) (NSC98-2314-B384-002-MY3, NSC98-2314-B041-002, NSC99-2314-B-041-002, NSC101-2320-B-366-001, and NSC102-2314-B-041-001-MY3), Chi Mei Medical Center (CMFHR9903, CMFHR9936, CMFHR9948, CMFHR10051, CMFHR10055, CMFHR10159, CMFHR10203, CMFHR10209, CMFHR10307, and CMFHR10301), and Chi Mei Hospital (CLFHR10107 and CLFHR10223). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alers S, 2012, MOL CELL BIOL, V32, P2, DOI 10.1128/MCB.06159-11; Chen YB, 2012, J SURG ONCOL, V105, P542, DOI 10.1002/jso.22151; Chu CT, 2007, AUTOPHAGY, V3, P663, DOI 10.4161/auto.4625; Damm E, 2012, MOL ENDOCRINOL, V26, P643, DOI 10.1210/me.2011-1218; Gao P, 2010, J BIOL CHEM, V285, P25570, DOI 10.1074/jbc.M110.118125; Gewirtz DA, 2014, CANCER RES, V74, P647, DOI 10.1158/0008-5472.CAN-13-2966; Gillis JM, 2011, TRAFFIC, V12, P1897, DOI 10.1111/j.1600-0854.2011.01270.x; Green DR, 2014, CELL, V157, P65, DOI 10.1016/j.cell.2014.02.049; Honda S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5004; Hwang SL, 2013, BRIT J PHARMACOL, V169, P69, DOI 10.1111/bph.12124; Juenemann Katrin, 2012, Int J Cell Biol, V2012, P189794, DOI 10.1155/2012/189794; Kayampilly PP, 2012, ENDOCRINOLOGY, V153, P2831, DOI 10.1210/en.2011-1967; Kim MJ, 2010, J BIOL CHEM, V285, P14617, DOI 10.1074/jbc.M109.085456; Klionsky DJ, 2014, AUTOPHAGY, V10, P715, DOI 10.4161/auto.28813; Lee JHW, 2009, J HYDRO-ENVIRON RES, V3, P1, DOI 10.1016/j.jher.2009.05.002; Lee PH, 2006, TOXICOLOGY, V220, P81, DOI 10.1016/j.tox.2005.07.026; Lin HX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060516; Lin MH, 2008, AUTOPHAGY, V4, P967, DOI 10.4161/auto.6821; Lin MH, 2010, ORAL ONCOL, V46, P822, DOI 10.1016/j.oraloncology.2010.08.002; Liu CY, 2013, BIOMED REP, V1, P855, DOI 10.3892/br.2013.171; Liu SY, 2008, J BIOMED SCI, V15, P823, DOI 10.1007/s11373-008-9273-8; Liu XN, 2014, MOL CANCER THER, V13, P596, DOI 10.1158/1535-7163.MCT-13-0579; Maiuri MC, 2010, EMBO J, V29, P515, DOI 10.1038/emboj.2009.377; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Mehrpour M, 2010, CELL RES, V20, P748, DOI 10.1038/cr.2010.82; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nishida Y, 2009, NATURE, V461, P654, DOI 10.1038/nature08455; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; RHEINWALD JG, 1981, CANCER RES, V41, P1657; Scarlatti F, 2008, CELL DEATH DIFFER, V15, P1318, DOI 10.1038/cdd.2008.51; Seo G, 2011, FREE RADICAL RES, V45, P389, DOI 10.3109/10715762.2010.535530; Shen CH, 2013, MOL CELL, V52, P161, DOI 10.1016/j.molcel.2013.08.044; Sid B, 2014, BIOCHEM PHARMACOL, V91, P168, DOI 10.1016/j.bcp.2014.07.010; Smith DM, 2010, CELL DEATH DIFFER, V17, P1867, DOI 10.1038/cdd.2010.53; Steele S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003562; Tian SH, 2010, AUTOPHAGY, V6, P1032, DOI 10.4161/auto.6.8.13336; Wang CC, 2009, TOXICOL IN VITRO, V23, P1234, DOI 10.1016/j.tiv.2009.07.033; Wang JR, 2009, J BIOL CHEM, V284, P21412, DOI 10.1074/jbc.M109.026013; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262; Williams T, 2009, AUTOPHAGY, V5, P1155, DOI 10.4161/auto.5.8.10090; Wu XY, 2013, TUMOR BIOL, V34, P713, DOI 10.1007/s13277-012-0599-5; Yen CY, 2014, J ORAL PATHOL MED, V43, P91, DOI 10.1111/jop.12102; Yen CY, 2011, ORAL ONCOL, V47, P345, DOI 10.1016/j.oraloncology.2011.02.014; Yeung ED, 2012, PROSTATE, V72, P165, DOI 10.1002/pros.21417; Zhou WH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080338; Zhu BL, 2012, J VIROL, V86, P12003, DOI 10.1128/JVI.01434-12	47	9	10	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0128011	10.1371/journal.pone.0128011	http://dx.doi.org/10.1371/journal.pone.0128011			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26017803	gold, Green Published, Green Submitted			2022-12-26	WOS:000355185600107
J	Austin, KG; Kasibhatla, PS; Urban, DL; Stolle, F; Vincent, J				Austin, Kemen G.; Kasibhatla, Prasad S.; Urban, Dean L.; Stolle, Fred; Vincent, Jeffrey			Reconciling Oil Palm Expansion and Climate Change Mitigation in Kalimantan, Indonesia	PLOS ONE			English	Article							AGRICULTURAL LAND; TROPICAL REGIONS; DEFORESTATION; EMISSIONS; PERFORMANCE; REGRESSION; FORESTS; DEMAND; MODELS; MAP	Our society faces the pressing challenge of increasing agricultural production while minimizing negative consequences on ecosystems and the global climate. Indonesia, which has pledged to reduce greenhouse gas (GHG) emissions from deforestation while doubling production of several major agricultural commodities, exemplifies this challenge. Here we focus on palm oil, the world's most abundant vegetable oil and a commodity that has contributed significantly to Indonesia's economy. Most oil palm expansion in the country has occurred at the expense of forests, resulting in significant GHG emissions. We examine the extent to which land management policies can resolve the apparently conflicting goals of oil palm expansion and GHG mitigation in Kalimantan, a major oil palm growing region of Indonesia. Using a logistic regression model to predict the locations of new oil palm between 2010 and 2020 we evaluate the impacts of six alternative policy scenarios on future emissions. We estimate net emissions of 128.4-211.4 MtCO(2) yr(-1) under business as usual expansion of oil palm plantations. The impact of diverting new plantations to low carbon stock land depends on the design of the policy. We estimate that emissions can be reduced by 9-10% by extending the current moratorium on new concessions in primary forests and peat lands, 35% by limiting expansion on all peat and forestlands, 46% by limiting expansion to areas with moderate carbon stocks, and 55-60% by limiting expansion to areas with low carbon stocks. Our results suggest that these policies would reduce oil palm profits only moderately but would vary greatly in terms of cost-effectiveness of emissions reductions. We conclude that a carefully designed and implemented oil palm expansion plan can contribute significantly towards Indonesia's national emissions mitigation goal, while allowing oil palm area to double.	[Austin, Kemen G.; Kasibhatla, Prasad S.; Urban, Dean L.; Vincent, Jeffrey] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Stolle, Fred] World Resources Inst, Washington, DC 20006 USA	Duke University	Austin, KG (corresponding author), Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA.	kemen.austin@duke.edu	Austin, Kemen G/AFL-1822-2022	Austin, Kemen G/0000-0002-7690-8774; Kasibhatla, Prasad/0000-0003-3562-3737	National Science Foundation [DGE-1106401]	National Science Foundation(National Science Foundation (NSF))	KGA is supported by the National Science Foundation's Graduate Research Fellowship Program (DGE-1106401 http://www.nsfgrfp.org/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abood SA, 2015, CONSERV LETT, V8, P58, DOI 10.1111/conl.12103; Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1; [Anonymous], 2014, 2006 IPCC GUIDELIN S; [Anonymous], 2005, EC HUM WELL BEING SY; [Anonymous], 2013, OIL PALM LAND USE CH; Atmadja S, 2012, MITIG ADAPT STRAT GL, V17, P311, DOI 10.1007/s11027-011-9328-4; Austin Kemen., 2014, INDONESIAS FOREST MO; Baccini A, 2012, NAT CLIM CHANGE, V2, P182, DOI [10.1038/NCLIMATE1354, 10.1038/nclimate1354]; BPS, 2011, IND OIL PALM STAT; Butler R., 2015, PALM OIL MAJOR MAKES; Carlson KM, 2013, NAT CLIM CHANGE, V3, P283, DOI [10.1038/nclimate1702, 10.1038/NCLIMATE1702]; Chatterjee S., 2012, REGRESSION ANAL EXAM; CLOGG CC, 1995, AM J SOCIOL, V100, P1261, DOI 10.1086/230638; Dewi S., 2009, WORLD AGROFOR CENT I; DNPI and Government of Central Kalimantan, 2010, CREAT LOW C IN PRESS; DNPI and Government of East Kalimantan, 2011, E KAL ENV S IN PRESS; Etter A, 2006, AGR ECOSYST ENVIRON, V114, P369, DOI 10.1016/j.agee.2005.11.013; FARZIN YH, 1984, J POLIT ECON, V92, P841, DOI 10.1086/261261; Ferreira S, 2010, ENVIRON RESOUR ECON, V47, P241, DOI 10.1007/s10640-010-9374-5; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Gaveau DLA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069887; Gibbs HK, 2010, P NATL ACAD SCI USA, V107, P16732, DOI 10.1073/pnas.0910275107; Gingold B, 2012, IDENTIFY DEGRADED LA, P1; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Harris N.L., 2013, PROJECTIONS OIL PALM; Harris NL, 2012, SCIENCE, V336, P1573, DOI 10.1126/science.1217962; Hartley CWS, 1967, OIL PALM, V3rd; Hertel TW, 2011, AM J AGR ECON, V93, P259, DOI 10.1093/ajae/aaq189; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hilbe J., 2011, NEGATIVE BINOMIAL RE; Huber P. J., 1967, P 5 BERK S MATH STAT, V1, P221; Intergovernmental Panel on Climate Change (IPCC), 2014, CLIM CHANG 2014; Intergovernmental Panel on Climate Change (IPCC), 2006, 2006 IPCC GUIDELINES, V4; Koh LP, 2010, SPATIALLY EXPLICIT S, V107; Lee JSH, 2014, CONSERV LETT, V7, P25, DOI 10.1111/conl.12039; Mantel S, 2007, BIOPHYSICAL LAND SUI; Margono BA, 2014, NAT CLIM CHANGE, V4, P730, DOI [10.1038/nclimate2277, 10.1038/NCLIMATE2277]; Maulia E, 2010, INDONESIA PLEDGES FE; McCarthy J, 2010, LAW POLICY, V32; McConnell WJ, 2004, AGR ECOSYST ENVIRON, V101, P171, DOI 10.1016/j.agee.2003.09.012; Ministry of Forestry, 2010, PERK AGR PLANT; Ministry of Forestry, 2013, IND MAP SUSP NEW LIC; Ministry of Forestry, 2010, LEG CLASS MAPS PROV; Minnemeyer S, 2009, INTERACTIVE ATLAS IN; Murdiyarso Daniel., 2011, INDONESIAS FOREST MO; Obidinski K, 2012, ECOLOGY SOC, V17; Page S. E., 2011, REV PEAT SURFACE GRE; Paoli G. D., 2013, OIL PALM INDONESIA G; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; Peters J.A.H.W, 2012, TRENDS GLOBAL CO2 EM; R Core Team, 2012, R LANG ENV STAT COMP; Ramdani F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070323; RePPProT, 1990, REG PHYS PLANN PROGR; Rist L, 2010, BIODIVERS CONSERV, V19, P1009, DOI 10.1007/s10531-010-9815-z; Saatchi SS, 2011, P NATL ACAD SCI USA, V108, P9899, DOI 10.1073/pnas.1019576108; Schrier-Uijl A.P., 2013, ENV SOCIAL IMPACTS O; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Sloan S, 2012, CONSERV LETT, V5, P222, DOI 10.1111/j.1755-263X.2012.00233.x; Stolle F, 2003, ENVIRON CONSERV, V30, P375, DOI 10.1017/S0376892903000390; Sukuwan S, 2012, CARBON ASSESSMENT TO; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; UKP4, 2012, REDD NAT STRAT; UNEP/GRID-Arendal, 2011, AR QUAL PROT IND LAW; USDA, 2014, OILS WORLD MARK TRAD; USDA, 2009, COMM INT REP IND PAL; USGS, 2004, SHUTTL RAD TOP MISS; Wetlands International, 2004, MAPS PEAT LAND DISTR; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; Wooldridge JM, 2013, INTRO ECONOMETRICS M, V5th	69	39	39	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127963	10.1371/journal.pone.0127963	http://dx.doi.org/10.1371/journal.pone.0127963			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011182	Green Published, Green Submitted, gold			2022-12-26	WOS:000355183900173
J	Buck, AKW; Ding, ZH; Elder, CP; Towse, TF; Damon, BM				Buck, Amanda K. W.; Ding, Zhaohua; Elder, Christopher P.; Towse, Theodore F.; Damon, Bruce M.			Anisotropic Smoothing Improves DT-MRI-Based Muscle Fiber Tractography	PLOS ONE			English	Article							AXONAL PROJECTIONS; SKELETAL-MUSCLE; DIFFUSION; NOISE; TRACKING; BRAIN; ARCHITECTURE; IMAGES	Purpose To assess the effect of anisotropic smoothing on fiber tracking measures, including pennation angle, fiber tract length, and fiber tract number in the medial gastrocnemius (MG) muscle in healthy subjects using diffusion-weighted magnetic resonance imaging (DW-MRI). Materials and Methods 3T DW-MRI data were used for muscle fiber tractography in the MG of healthy subjects. Anisotropic smoothing was applied at three levels (5%, 10%, 15%), and pennation angle, tract length, fiber tract number, fractional anisotropy, and principal eigenvector orientation were quantified for each smoothing level. Results Fiber tract length increased with pre-fiber tracking smoothing, and local heterogeneities in fiber direction were reduced. However, pennation angle was not affected by smoothing. Conclusion Modest anisotropic smoothing (10%) improved fiber-tracking results, while preserving structural features.	[Buck, Amanda K. W.; Ding, Zhaohua; Elder, Christopher P.; Towse, Theodore F.; Damon, Bruce M.] Vanderbilt Univ, Inst Imaging Sci, Nashville, TN 37235 USA; [Buck, Amanda K. W.; Ding, Zhaohua; Elder, Christopher P.; Towse, Theodore F.; Damon, Bruce M.] Vanderbilt Univ, Dept Radiol & Radiol Sci, Nashville, TN 37235 USA; [Buck, Amanda K. W.; Ding, Zhaohua; Damon, Bruce M.] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA; [Ding, Zhaohua] Vanderbilt Univ, Dept Elect Engn & Comp Sci, Nashville, TN 37235 USA; [Towse, Theodore F.] Vanderbilt Univ, Dept Phys Med & Rehabil, Nashville, TN 37235 USA; [Damon, Bruce M.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Damon, BM (corresponding author), Vanderbilt Univ, Inst Imaging Sci, 221 Kirkland Hall, Nashville, TN 37235 USA.	bruce.m.damon@vanderbilt.edu	Buck, Amanda Kathleen Wake/GYK-0734-2022; Ding, Zhaohua/AHC-7551-2022	Ding, Zhaohua/0000-0002-1805-2955; Buck, Amanda/0000-0003-1042-6374	National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01 AR050101]; National Institutes of Health; National Center for Research Resources [2 ULI TR000445-06]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB001628] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	AKWB, ZD, CPE, TFT, and BMD received support from the National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases; www.niams.nih.gov; R01 AR050101. TFT received support from the National Institutes of Health; National Center for Research Resources; www.nih.gov; 2 ULI TR000445-06	Alexander R.M., 1975, J HUMAN MOVEMENT STU, V1, P115; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Basser PJ, 2000, MAGNET RESON MED, V44, P41, DOI 10.1002/1522-2594(200007)44:1<41::AID-MRM8>3.0.CO;2-O; Damon BM, 2002, MAGN RESON MED, V48, P97, DOI 10.1002/mrm.10198; Damon BM, 2008, MAGN RESON MED, V60, P934, DOI 10.1002/mrm.21707; Damon BM, 2012, MAGN RESON IMAGING, V30, P589, DOI 10.1016/j.mri.2012.02.003; Ding ZH, 2005, MAGN RESON MED, V53, P485, DOI 10.1002/mrm.20339; Englund EK, 2011, AM J PHYSIOL-REG I, V300, pR1079, DOI 10.1152/ajpregu.00474.2010; Fillard P, 2007, IEEE T MED IMAGING, V26, P1472, DOI 10.1109/TMI.2007.899173; Froeling M, 2013, NMR BIOMED, V26, P1339, DOI 10.1002/nbm.2959; Haldar JP, 2013, MAGN RESON MED, V69, P277, DOI 10.1002/mrm.24229; Heemskerk AM, 2005, MAGNET RESON MED, V53, P1333, DOI 10.1002/mrm.20476; Koay CG, 2006, J MAGN RESON, V182, P115, DOI 10.1016/j.jmr.2006.06.020; Lansdown DA, 2007, J APPL PHYSIOL, V103, P673, DOI 10.1152/japplphysiol.00290.2007; Lohmann G, 2010, MAGN RESON MED, V64, P15, DOI 10.1002/mrm.22488; Manjon JV, 2010, J MAGN RESON IMAGING, V31, P192, DOI 10.1002/jmri.22003; Moraschi M, 2010, J MAGN RESON IMAGING, V31, P690, DOI 10.1002/jmri.22040; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; Nagy Z, 2008, MAGN RESON MED, V60, P1256, DOI 10.1002/mrm.21746; Netsch T, 2004, IEEE T MED IMAGING, V23, P789, DOI 10.1109/TMI.2004.827479; Oouchi H, 2007, AM J NEURORADIOL, V28, P1102, DOI 10.3174/ajnr.A0488; Sinha U, 2011, J APPL PHYSIOL, V110, P807, DOI 10.1152/japplphysiol.00923.2010; Van Hecke W, 2010, HUM BRAIN MAPP, V31, P98, DOI 10.1002/hbm.20848; Xu Q, 2010, MAGN RESON IMAGING, V28, P200, DOI 10.1016/j.mri.2009.10.001; Xue R, 1999, MAGNET RESON MED, V42, P1123, DOI 10.1002/(SICI)1522-2594(199912)42:6<1123::AID-MRM17>3.0.CO;2-H; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	28	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0126953	10.1371/journal.pone.0126953	http://dx.doi.org/10.1371/journal.pone.0126953			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010830	gold, Green Published, Green Submitted			2022-12-26	WOS:000355183900051
J	Cunniff, B; Newick, K; Nelson, KJ; Wozniak, AN; Beuschel, S; Leavitt, B; Bhave, A; Butnor, K; Koenig, A; Chouchani, ET; James, AM; Haynes, AC; Lowther, WT; Murphy, MP; Shukla, A; Heintz, NH				Cunniff, Brian; Newick, Kheng; Nelson, Kimberly J.; Wozniak, Alexandra N.; Beuschel, Stacie; Leavitt, Bruce; Bhave, Anant; Butnor, Kelly; Koenig, Andreas; Chouchani, Edward T.; James, Andrew M.; Haynes, Alexina C.; Lowther, W. Todd; Murphy, Michael P.; Shukla, Arti; Heintz, Nicholas H.			Disabling Mitochondrial Peroxide Metabolism via Combinatorial Targeting of Peroxiredoxin 3 as an Effective Therapeutic Approach for Malignant Mesothelioma	PLOS ONE			English	Article							OXIDATIVE STRESS; CANCER-CELLS; ANTIOXIDANT DEFENSE; MELANOMA-CELLS; COMPLEX-I; THIOSTREPTON; FOXM1; EXPRESSION; REDUCTASE; TUMOR	Dysregulation of signaling pathways and energy metabolism in cancer cells enhances production of mitochondrial hydrogen peroxide that supports tumorigenesis through multiple mechanisms. To counteract the adverse effects of mitochondrial peroxide many solid tumor types up-regulate the mitochondrial thioredoxin reductase 2-thioredoxin 2 (TRX2)-peroxiredoxin 3 (PRX3) antioxidant network. Using malignant mesothelioma cells as a model, we show that thiostrepton (TS) irreversibly disables PRX3 via covalent crosslinking of peroxidatic and resolving cysteine residues in homodimers, and that targeting the oxidoreductase TRX2 with the triphenylmethane gentian violet (GV) potentiates adduction by increasing levels of disulfide-bonded PRX3 dimers. Due to the fact that activity of the PRX3 catalytic cycle dictates the rate of adduction by TS, immortalized and primary human mesothelial cells are significantly less sensitive to both compounds. Moreover, stable knockdown of PRX3 reduces mesothelioma cell proliferation and sensitivity to TS. Expression of catalase in shPRX3 mesothelioma cells restores defects in cell proliferation but not sensitivity to TS. In a SCID mouse xenograft model of human mesothelioma, administration of TS and GV together reduced tumor burden more effectively than either agent alone. Because increased production of mitochondrial hydrogen peroxide is a common phenotype of malignant cells, and TS and GV are well tolerated in mammals, we propose that targeting PRX3 is a feasible redox-dependent strategy for managing mesothelioma and other intractable human malignancies.	[Cunniff, Brian; Wozniak, Alexandra N.; Beuschel, Stacie; Butnor, Kelly; Shukla, Arti; Heintz, Nicholas H.] Univ Vermont, Coll Med, Dept Pathol, Burlington, VT 05405 USA; [Newick, Kheng] Univ Penn, Sch Med, Div Pulm, Thorac Oncol Res Lab, Philadelphia, PA 19147 USA; [Nelson, Kimberly J.; Haynes, Alexina C.; Lowther, W. Todd] Wake Forest Sch Med, Dept Biochem, Med Ctr Blvd, Winston Salem, NC 27157 USA; [Leavitt, Bruce] Univ Vermont, Coll Med, Dept Surg, Burlington, VT 05405 USA; [Bhave, Anant] Univ Vermont, Coll Med, Dept Radiol, Burlington, VT 05405 USA; [Koenig, Andreas] Univ Vermont, Dept Immunol Med, Burlington, VT 05405 USA; [Chouchani, Edward T.; James, Andrew M.; Murphy, Michael P.] MRC, Mitochondrial Biol Unit, Cambridge CB2 0XY, England; [Chouchani, Edward T.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England	University of Vermont; University of Pennsylvania; Wake Forest University; University of Vermont; University of Vermont; University of Vermont; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Cunniff, B (corresponding author), Univ Vermont, Coll Med, Dept Pathol, 149 Beaumont Ave, Burlington, VT 05405 USA.	Nicholas.Heintz@uvm.edu	James, Andrew M/A-2639-2015; Chouchani, Edward T./HCH-3775-2022; Murphy, Michael/C-2120-2009	James, Andrew M/0000-0002-0515-9649; Nelson, Kimberly/0000-0003-2464-7696; Murphy, Michael/0000-0003-1115-9618	National Institute of General Medical Sciences of the National Institutes of Health [P20GM103449]; Mini-Fellowship from the Society for Free Radical Biology and Medicine; UVM Department of Pathology; NIEHS [T32 ES 007122]; National Institutes of Health [GM072866, GM050389]; Comprehensive Cancer Center of Wake Forest University [NCI CCSG P30CA012197]; Vermont Cancer Center; Gates Cambridge Trust; Canadian Institutes of Health Research; NATIONAL CANCER INSTITUTE [P30CA012197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES021110, T32ES007122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103449, R01GM050389, R01GM072866] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Mini-Fellowship from the Society for Free Radical Biology and Medicine; UVM Department of Pathology; NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Comprehensive Cancer Center of Wake Forest University; Vermont Cancer Center; Gates Cambridge Trust; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	UVM Proteomics facility supported by the National Institute of General Medical Sciences of the National Institutes of Health under grant number P20GM103449 provided technical assistance. Nicole Bishop and Doug Taatjes of the UVM Microscopy Imaging Center provided technical expertise for IHC of tumor sections. The Advanced Genomic Technologies Center of the Vermont Cancer Center performed the quantitative RT-PCR. BC was supported for work at the MRC, Cambridge in MM's lab by a Mini-Fellowship from the Society for Free Radical Biology and Medicine, and a graduate fellowship from the UVM Department of Pathology. KN was supported by a training grant in Environmental Pathology from the NIEHS (T32 ES 007122). Studies by WTL and KJN were supported in part by grants from the National Institutes of Health (GM072866, GM050389) and the Comprehensive Cancer Center of Wake Forest University (NCI CCSG P30CA012197). ESI-TOF-MS analysis was performed by Cristina Furdui, Julie Reisz Haines and Nelmi Devarie Baez at Wake Forest School of Medicine. Studies by NHH were supported by a 40 pilot project award from the Vermont Cancer Center. ETC was supported by the Gates Cambridge Trust (doctoral scholarship) and the Canadian Institutes of Health Research (postdoctoral fellowship). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON WS, 1976, ACCOUNTS CHEM RES, V9, P293, DOI 10.1021/ar50104a003; Basu A, 2011, PROSTATE, V71, P755, DOI 10.1002/pros.21292; Bausch SL, 2005, J BIOL CHEM, V280, P29956, DOI 10.1074/jbc.M504182200; Bhat UG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006593; Bowling BD, 2008, CANCER CHEMOTH PHARM, V63, P37, DOI 10.1007/s00280-008-0705-y; Burch PM, 2004, MOL CELL BIOL, V24, P4696, DOI 10.1128/MCB.24.11.4696-4709.2004; Burhans WC, 2009, FREE RADICAL BIO MED, V47, P1282, DOI 10.1016/j.freeradbiomed.2009.05.026; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Cao Z, 2007, J MOL BIOL, V372, P1022, DOI 10.1016/j.jmb.2007.07.018; Chan DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052578; Chang JW, 2001, BIOCHEM BIOPH RES CO, V289, P507, DOI 10.1006/bbrc.2001.5989; Chang TS, 2004, J BIOL CHEM, V279, P41975, DOI 10.1074/jbc.M407707200; Chappell J. B., 1972, SUBCELLULAR COMPONEN; Cheng CW, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.204; Chiu ML, 1996, BIOCHEMISTRY-US, V35, P2332, DOI 10.1021/bi952073e; Chua PJ, 2010, INT J ONCOL, V36, P359, DOI 10.3892/ijo_00000507; Cox AG, 2010, BIOCHEM J, V425, P313, DOI 10.1042/BJ20091541; Cox AG, 2009, BIOCHEMISTRY-US, V48, P6495, DOI 10.1021/bi900558g; Cox AG, 2009, BIOCHEM J, V421, P51, DOI 10.1042/BJ20090242; Cunniff B, 2014, REDOX BIOL, V3, P79, DOI 10.1016/j.redox.2014.11.003; Cunniff B, 2014, REDOX BIOL, V2, P475, DOI 10.1016/j.redox.2014.01.021; Cunniff B, 2013, ANAL BIOCHEM, V443, P34, DOI 10.1016/j.ab.2013.08.013; Cunniff B, 2013, J CELL PHYSIOL, V228, P835, DOI 10.1002/jcp.24232; Diers AR, 2010, BIOCHEM J, V426, P31, DOI 10.1042/BJ20091293; Dranka BP, 2011, FREE RADICAL BIO MED, V51, P1621, DOI 10.1016/j.freeradbiomed.2011.08.005; Dranka BP, 2010, FREE RADICAL BIO MED, V48, P905, DOI 10.1016/j.freeradbiomed.2010.01.015; Faivre S, 2006, SEMIN ONCOL, V33, P407, DOI 10.1053/j.seminoncol.2006.04.005; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; Fried L, 2008, PIGM CELL MELANOMA R, V21, P117, DOI 10.1111/j.1755-148X.2008.00451.x; Friedman M, 1977, Adv Exp Med Biol, V86B, P213; FRIEDRICH T, 1994, EUR J BIOCHEM, V219, P691, DOI 10.1111/j.1432-1033.1994.tb19985.x; Gartel AL, 2010, EXPERT OPIN INV DRUG, V19, P235, DOI 10.1517/13543780903563364; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Gupta SC, 2012, ANTIOXID REDOX SIGN, V16, P1295, DOI 10.1089/ars.2011.4414; Haynes AC, 2013, J BIOL CHEM, V288, P29714, DOI 10.1074/jbc.M113.473470; Hegde NS, 2011, NAT CHEM, V3, P725, DOI [10.1038/NCHEM.1114, 10.1038/nchem.1114]; Hill BG, 2012, BIOL CHEM, V393, P1485, DOI 10.1515/hsz-2012-0198; Ho JCM, 2001, CANCER RES, V61, P8578; Hurd TR, 2007, J BIOL CHEM, V282, P22040, DOI 10.1074/jbc.M703591200; Jonsson TJ, 2009, J BIOL CHEM, V284, P33305, DOI 10.1074/jbc.M109.036400; Jones DP, 2010, J INTERN MED, V268, P432, DOI 10.1111/j.1365-2796.2010.02268.x; Karihtala P, 2003, CLIN CANCER RES, V9, P3418; Kinnula VL, 2002, J PATHOL, V196, P316, DOI 10.1002/path.1042; Kwok JMM, 2008, MOL CANCER THER, V7, P2022, DOI 10.1158/1535-7163.MCT-08-0188; Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936; Newick K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039404; Park HJ, 2009, EMBO J, V28, P2908, DOI 10.1038/emboj.2009.239; Perkins A, 2013, BIOCHEMISTRY-US, V52, P8708, DOI 10.1021/bi4011573; Poole LB, 2000, BIOCHEMISTRY-US, V39, P6602, DOI 10.1021/bi000405w; Qiao SX, 2012, BIOCHEM PHARMACOL, V83, P1229, DOI 10.1016/j.bcp.2012.01.027; Rhee SG, 2011, ANTIOXID REDOX SIGN, V15, P781, DOI 10.1089/ars.2010.3393; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Song IS, 2011, INT J MOL SCI, V12, P7163, DOI 10.3390/ijms12107163; Ummanni R, 2012, J PROTEOME RES, V11, P2452, DOI 10.1021/pr201172n; Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365; Wang M, 2012, CELL CYCLE, V11, P3370, DOI 10.4161/cc.21290; Wang M, 2011, MOL CANCER THER, V10, P2287, DOI 10.1158/1535-7163.MCT-11-0536; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Watabe S, 1997, EUR J BIOCHEM, V249, P52, DOI 10.1111/j.1432-1033.1997.t01-1-00052.x; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; WEINHOUSE S, 1956, SCIENCE, V124, P267, DOI 10.1126/science.124.3215.267; WENNER CE, 1956, J BIOL CHEM, V222, P399; Wondrak GT, 2009, ANTIOXID REDOX SIGN, V11, P3013, DOI [10.1089/ars.2009.2541, 10.1089/ARS.2009.2541]; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Xiang XR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014640; Younis IR, 2008, J PHARMACOL EXP THER, V327, P770, DOI 10.1124/jpet.108.142208; Yun J, 2014, CELL METAB, V19, P757, DOI 10.1016/j.cmet.2014.01.011; Zhang L, 2005, FEBS LETT, V579, P6423, DOI 10.1016/j.febslet.2005.09.103; Zhang X, 2011, FREE RADICAL BIO MED, V50, P811, DOI 10.1016/j.freeradbiomed.2010.12.036; Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391	70	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127310	10.1371/journal.pone.0127310	http://dx.doi.org/10.1371/journal.pone.0127310			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011724	Green Published, gold, Green Submitted			2022-12-26	WOS:000355183900080
J	Gururani, MA; Venkatesh, J; Ganesan, M; Strasser, RJ; Han, Y; Kim, JI; Lee, HY; Song, PS				Gururani, Mayank Anand; Venkatesh, Jelli; Ganesan, Markkandan; Strasser, Reto Joerg; Han, Yunjeong; Kim, Jeong-Il; Lee, Hyo-Yeon; Song, Pill-Soon			In Vivo Assessment of Cold Tolerance through Chlorophyll-a Fluorescence in Transgenic Zoysiagrass Expressing Mutant Phytochrome A	PLOS ONE			English	Article							ABIOTIC STRESS TOLERANCE; ELECTRON-TRANSPORT; CHILLING TOLERANCE; HYDROGEN-PEROXIDE; FREEZING TOLERANCE; OXIDATIVE STRESS; SALINITY STRESS; SALICYLIC-ACID; LIGHT-QUALITY; POTATO PLANTS	Chlorophyll-a fluorescence analysis provides relevant information about the physiology of plants growing under abiotic stress. In this study, we evaluated the influence of cold stress on the photosynthetic machinery of transgenic turfgrass, Zoysia japonica, expressing oat phytochrome A (PhyA) or a hyperactive mutant phytochrome A (S599A) with post-translational phosphorylation blocked. Biochemical analysis of zoysiagrass subjected to cold stress revealed reduced levels of hydrogen peroxide, increased proline accumulation, and enhanced specific activities of antioxidant enzymes compared to those of control plants. Detailed analyses of the chlorophyll-a fluorescence data through the so-called OJIP test exhibited a marked difference in the physiological status among transgenic and control plants. Overall, these findings suggest an enhanced level of cold tolerance in S599A zoysiagrass cultivars as reflected in the biochemical and physiological analyses. Further, we propose that chlorophyll-a fluorescence analysis using OJIP test is an efficient tool in determining the physiological status of plants under cold stress conditions.	[Gururani, Mayank Anand; Ganesan, Markkandan; Lee, Hyo-Yeon; Song, Pill-Soon] Jeju Natl Univ, Fac Biotechnol, Subtrop Hort Res Inst, Jeju 690756, South Korea; [Venkatesh, Jelli] Konkuk Univ, Dept Mol Biotechnol, Seoul 143701, South Korea; [Ganesan, Markkandan] Presidency Univ, Dept Biol Sci, Kolkata 700073, W Bengal, India; [Strasser, Reto Joerg] Univ Geneva, Bioenerget Lab, CH-1254 Geneva, Switzerland; [Han, Yunjeong; Kim, Jeong-Il] Chonnam Natl Univ, Dept Biotechnol, Gwangju 500757, South Korea; [Han, Yunjeong; Kim, Jeong-Il] Chonnam Natl Univ, Kumho Life Sci Lab, Gwangju 500757, South Korea; [Gururani, Mayank Anand] Yeungnam Univ, Sch Biotechnol, Gyongsan 712749, Gyeongbook, South Korea	Jeju National University; Konkuk University; Presidency University, Kolkata; University of Geneva; Chonnam National University; Chonnam National University; Yeungnam University	Song, PS (corresponding author), Jeju Natl Univ, Fac Biotechnol, Subtrop Hort Res Inst, Jeju 690756, South Korea.	pssong@gmail.com	Venkatesh, Jelli/E-7887-2018; Venkatesh, Jelli/O-8942-2019; Gururani, Mayank/E-9978-2012	Venkatesh, Jelli/0000-0002-8896-0385; Venkatesh, Jelli/0000-0002-8896-0385; Gururani, Mayank/0000-0003-4254-6450; Markkandan, Ganesan/0000-0002-3402-9747	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education (NRF) [2012R1A1A2000706, 2009-0094059, PJ00949101]; Science and Technology, Next-Generation Biogreen 21 Program, Rural Development Administration, Korea [PJ009499012014]; Technology Development Program for Agriculture and Forestry, Ministry for Agriculture, Forestry and Fisheries, Republic of Korea [309017-5]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education (NRF); Science and Technology, Next-Generation Biogreen 21 Program, Rural Development Administration, Korea; Technology Development Program for Agriculture and Forestry, Ministry for Agriculture, Forestry and Fisheries, Republic of Korea	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF Grant No. 2012R1A1A2000706 to PSS, 2009-0094059, PJ00949101), Science and Technology, Next-Generation Biogreen 21 Program, Rural Development Administration, Korea (Grant No. PJ009499012014), and by the Technology Development Program for Agriculture and Forestry, Ministry for Agriculture, Forestry and Fisheries, Republic of Korea (to J.-I Kim, grant no. 309017-5).	Agati G, 1996, J PLANT PHYSIOL, V148, P384, DOI 10.1016/S0176-1617(96)80270-7; Ashraf M, 2007, ENVIRON EXP BOT, V59, P206, DOI 10.1016/j.envexpbot.2005.12.006; Bae TW, 2008, J ENVIRON QUAL, V37, P207, DOI 10.2134/jeq2007.0128; Baker NR, 2008, ANNU REV PLANT BIOL, V59, P89, DOI 10.1146/annurev.arplant.59.032607.092759; Baker NR, 2004, J EXP BOT, V55, P1607, DOI 10.1093/jxb/erh196; Ballottari M, 2007, J BIOL CHEM, V282, P8947, DOI 10.1074/jbc.M606417200; Camejo D, 2010, J HORTIC SCI BIOTECH, V85, P137, DOI 10.1080/14620316.2010.11512644; Cheeseman JM, 2006, J EXP BOT, V57, P2435, DOI 10.1093/jxb/erl004; Chen LS, 2009, PHOTOSYNTHETICA, V47, P112, DOI 10.1007/s11099-009-0017-4; Chen LS, 2009, ENVIRON EXP BOT, V66, P110, DOI 10.1016/j.envexpbot.2008.12.017; Chinnusamy V, 2007, TRENDS PLANT SCI, V12, P444, DOI 10.1016/j.tplants.2007.07.002; De Ronde JA, 2004, J PLANT PHYSIOL, V161, P1211, DOI 10.1016/j.jplph.2004.01.014; Dechaine JM, 2009, PLANT CELL ENVIRON, V32, P1297, DOI 10.1111/j.1365-3040.2009.01998.x; Donohue K, 2008, NEW PHYTOL, V177, P367, DOI 10.1111/j.1469-8137.2007.02281.x; Elavarthi S, 2010, METHODS MOL BIOL, V639, P273, DOI 10.1007/978-1-60761-702-0_16; Foyer CH, 2011, PLANT PHYSIOL, V155, P93, DOI 10.1104/pp.110.166181; Franklin KA, 2007, NAT GENET, V39, P1410, DOI 10.1038/ng.2007.3; Ganesan M, 2012, PLANTA, V236, P1135, DOI 10.1007/s00425-012-1662-6; Goltsev V, 2012, BBA-BIOENERGETICS, V1817, P1490, DOI 10.1016/j.bbabio.2012.04.018; Govindjee, 2004, ADV PHOTOSYNTH RESP, V19, P1; GOVINDJEE, 1995, AUST J PLANT PHYSIOL, V22, P131, DOI 10.1071/PP9950131; Govindjee, 2010, ENCY LIFE SCI ELS; Gururani MA, 2016, J PLANT GROWTH REGUL, V35, P11, DOI 10.1007/s00344-015-9502-0; Gururani MA, 2015, BIOTECHNOL ADV, V33, P53, DOI 10.1016/j.biotechadv.2014.12.005; Gururani MA, 2013, J PLANT GROWTH REGUL, V32, P245, DOI 10.1007/s00344-012-9292-6; Gururani MA, 2013, PLANT SCI, V198, P7, DOI 10.1016/j.plantsci.2012.09.014; Gururani MA, 2012, PLANT PHYSIOL BIOCH, V58, P182, DOI 10.1016/j.plaphy.2012.07.003; Heschel MS, 2007, NEW PHYTOL, V174, P735, DOI 10.1111/j.1469-8137.2007.02044.x; HUANG J, 2009, J PLANT PHYSL, V389, P556, DOI DOI 10.1016/J.BBRC.2009.09.032; Kautsky H., 1931, NATURWISSENSCHAFTEN, V19, P964, DOI [DOI 10.1007/BF01516164, 10.1007/BF01516164]; Kim J, 2004, PLANT CELL, V16, P2629, DOI 10.1105/tpc.104.023879; KRAUSE GH, 1991, ANNU REV PLANT PHYS, V42, P313, DOI 10.1146/annurev.pp.42.060191.001525; Kruger GHJ, 2014, S AFR J BOT, V95, P85, DOI 10.1016/j.sajb.2014.07.010; Mahajan S, 2005, ARCH BIOCHEM BIOPHYS, V444, P139, DOI 10.1016/j.abb.2005.10.018; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Mora-Herrera ME, 2005, PHYSIOL PLANTARUM, V125, P430, DOI 10.1111/j.1399-3054.2005.00572.x; OKane D, 1996, PLANTA, V198, P371, DOI 10.1007/BF00620053; PAILLOTIN G, 1976, J THEOR BIOL, V58, P237, DOI 10.1016/0022-5193(76)90150-8; Papageorgiou GC, 2014, ADV PHOTOSYNTH RESP, V40, P1, DOI 10.1007/978-94-017-9032-1_1; Qian YL, 2000, CROP SCI, V40, P488, DOI 10.2135/cropsci2000.402488x; Ranjan S, 2014, PLANT PHYSIOL BIOCH, V79, P48, DOI 10.1016/j.plaphy.2014.03.007; Redondo-Gomez S., 2013, MOL STRESS PHYSL PLA, P1; Rochaix JD, 2011, BBA-BIOENERGETICS, V1807, P375, DOI 10.1016/j.bbabio.2010.11.010; Schansker G, 2014, PHOTOSYNTH RES, V120, P43, DOI 10.1007/s11120-013-9806-5; Stirbet A, 2014, BIOCHEMISTRY-MOSCOW+, V79, P291, DOI 10.1134/S0006297914040014; Stirbet A, 2012, PHOTOSYNTH RES, V113, P15, DOI 10.1007/s11120-012-9754-5; Stirbet A, 2011, J PHOTOCH PHOTOBIO B, V104, P236, DOI 10.1016/j.jphotobiol.2010.12.010; Strasser R.J., 1981, PHOTOSYNTHESIS STRUC, P727; Strasser R.J., 2000, PROBING PHOTOSYNTHES, P445; Strasser R.J., 2001, CHIMIE NOUVELLE SRC, V75, P3321; Strasser RJ, 2010, BBA-BIOENERGETICS, V1797, P1313, DOI 10.1016/j.bbabio.2010.03.008; Strasser RJ, 2004, ADV PHOTO RESPIRAT, V19, P321; STRASSER RJ, 1995, PHOTOCHEM PHOTOBIOL, V61, P32, DOI 10.1111/j.1751-1097.1995.tb09240.x; STRASSER RJ, 1992, NATO ADV SCI I A-LIF, V226, P423; Strauss AJ, 2006, ENVIRON EXP BOT, V56, P147, DOI 10.1016/j.envexpbot.2005.01.011; Takahashi S, 2008, TRENDS PLANT SCI, V13, P178, DOI 10.1016/j.tplants.2008.01.005; Takahashi S, 2011, TRENDS PLANT SCI, V16, P53, DOI 10.1016/j.tplants.2010.10.001; Toth SZ, 2011, PLANT PHYSIOL, V156, P382, DOI 10.1104/pp.110.171918; Upadhyaya CP, 2011, BIOTECHNOL LETT, V33, P2297, DOI 10.1007/s10529-011-0684-7; Venkatesh J, 2012, HORTIC ENVIRON BIOTE, V53, P320, DOI 10.1007/s13580-012-0035-1; Wang Y, 2009, BIOL PLANTARUM, V53, P179, DOI 10.1007/s10535-009-0030-2; Warnke S., 2003, TURFGRASS BIOL GENET, P175; Yan BF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080770; Yusuf MA, 2010, BBA-BIOENERGETICS, V1797, P1428, DOI 10.1016/j.bbabio.2010.02.002; Zhou J, 2012, PLANT PHYSIOL BIOCH, V60, P141, DOI 10.1016/j.plaphy.2012.07.010; Zivcak M, 2014, J PHOTOCH PHOTOBIO B, V137, P107, DOI 10.1016/j.jphotobiol.2014.01.007; Zivcak M, 2014, PHOTOSYNTH RES, V119, P339, DOI 10.1007/s11120-014-9969-8; Zurek G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091475; Zushi K, 2012, SCI HORTIC-AMSTERDAM, V148, P39, DOI 10.1016/j.scienta.2012.09.022	69	51	53	4	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127200	10.1371/journal.pone.0127200	http://dx.doi.org/10.1371/journal.pone.0127200			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010864	gold, Green Submitted, Green Published			2022-12-26	WOS:000355183900071
J	Salloum-Asfar, S; Boelen, A; Reitsma, PH; van Vlijmen, BJM				Salloum-Asfar, Salam; Boelen, Anita; Reitsma, Pieter H.; van Vlijmen, Bart J. M.			The Immediate and Late Effects of Thyroid Hormone (Triiodothyronine) on Murine Coagulation Gene Transcription	PLOS ONE			English	Article							IN-VIVO; MICE; EXPRESSION; BETA; ANTAGONISTS; MODULATION; DISORDERS; PROTEINS; BINDING; LIVER	Thyroid dysfunction is associated with changes in coagulation. The aim of our study was to gain more insight into the role of thyroid hormone in coagulation control. C57Black/6J mice received a low-iodine diet and drinking water supplemented with perchlorate to suppress endogenous triiodothyronine (T-3) and thyroxine (T-4) production. Under these conditions, the impact of exogenous T-3 on plasma coagulation, and hepatic and vessel-wall-associated coagulation gene transcription was studied in a short-(4 hours) and long-term (14 days) setting. Comparing euthyroid conditions (normal mice), with hypothyroidism (conditions of a shortage of thyroid hormone) and those with replacement by incremental doses of T3, dosages of 0 and 0.5 mu g T-3/mouse/day were selected to study the impact of T-3 on coagulation gene transcription. Under these conditions, a single injection of T-3 injection increased strongly hepatic transcript levels of the well-characterized T-3-responsive genes deiodinase type 1 (Dio1) and Spot14 within 4 hours. This coincided with significantly reduced mRNA levels of Fgg, Serpinc1, Proc, Proz, and Serpin10, and the reduction of the latter three persisted upon daily treatment with T-3 for 14 days. Prolonged T-3 treatment induced a significant down-regulation in factor (F) 2, F9 and F10 transcript levels, while F11 and F12 levels increased. Activity levels in plasma largely paralleled these mRNA changes. Thbd transcript levels in the lung (vessel-wall-associated coagulation) were significantly up-regulated after a single T3 injection, and persisted upon prolonged T-3 exposure. Two-week T-3 administration also resulted in increased Vwf and Tfpi mRNA levels, whereas Tf levels decreased. These data showed that T-3 has specific effects on coagulation, with Fgg, Serpinc1, Proc, Proz, Serpin10 and Thbd responding rapidly, making these likely direct thyroid hormone receptor targets. F2, F9, F10, F11, F12, Vwf, Tf and Tfpi are late responding genes and probably indirectly modulated by T-3.	[Salloum-Asfar, Salam; Reitsma, Pieter H.; van Vlijmen, Bart J. M.] Leiden Univ, Med Ctr, Dept Thrombosis & Hemostasis, Einthoven Lab Expt Vasc Med, Leiden, Netherlands; [Salloum-Asfar, Salam] Univ Murcia, IMIB Arrixaca, Ctr Reg Hemodonac, Dept Hematol & Med Oncol, Murcia, Spain; [Boelen, Anita] Univ Amsterdam, Acad Med Ctr, Dept Endocrinol & Metab, NL-1105 AZ Amsterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Hospital Clinico Universitario Virgen de la Arrixaca; University of Murcia; University of Amsterdam; Academic Medical Center Amsterdam	van Vlijmen, BJM (corresponding author), Leiden Univ, Med Ctr, Dept Thrombosis & Hemostasis, Einthoven Lab Expt Vasc Med, Leiden, Netherlands.	b.j.m.van_vlijmen@lumc.nl	Salloum-Asfar, Salam/AAQ-4772-2021	Salloum-Asfar, Salam/0000-0002-8357-2180	Netherlands Heart Foundation [2006B0045]	Netherlands Heart Foundation(Netherlands Heart Foundation)	This study was supported by grant 2006B0045 from the Netherlands Heart Foundation (https://www.hartstichting.nl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burggraaf J, 2001, THYROID, V11, P153, DOI 10.1089/105072501300042820; Cleuren ACA, 2010, J THROMB HAEMOST, V8, P1838, DOI 10.1111/j.1538-7836.2010.03930.x; Debeij J, 2014, J THROMB HAEMOST, V12, P839, DOI 10.1111/jth.12573; Dong HY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012136; Erem C, 2011, SEMIN THROMB HEMOST, V37, P17, DOI 10.1055/s-0030-1270067; Feng X, 2000, MOL ENDOCRINOL, V14, P947, DOI 10.1210/me.14.7.947; Flores-Morales A, 2002, MOL ENDOCRINOL, V16, P1257, DOI 10.1210/me.16.6.1257; Forrest D, 1996, EMBO J, V15, P3006, DOI 10.1002/j.1460-2075.1996.tb00664.x; Franchini M, 2009, SEMIN THROMB HEMOST, V35, P288, DOI 10.1055/s-0029-1222607; Gothe S, 1999, GENE DEV, V13, P1329, DOI 10.1101/gad.13.10.1329; Inoue Y, 2006, J MOL MED, V84, P334, DOI 10.1007/s00109-005-0013-5; Lin KH, 2003, J ENDOCRINOL, V179, P367, DOI 10.1677/joe.0.1790367; NIESSEN RWLM, 1995, THROMB HAEMOSTASIS, V74, P686; Schapira M, 2003, P NATL ACAD SCI USA, V100, P7354, DOI 10.1073/pnas.1131854100; Selva DM, 2009, J MOL ENDOCRINOL, V43, P19, DOI 10.1677/JME-09-0025; Shih CH, 2004, ENDOCRINOLOGY, V145, P2804, DOI 10.1210/en.2003-1372; Takeuchi Y, 2002, ENDOCRINOLOGY, V143, P1346, DOI 10.1210/en.143.4.1346; van Beeren HC, 2003, ENDOCRINOLOGY, V144, P552, DOI 10.1210/en.2002-220604; van Beeren HC, 2012, THYROID, V22, P1275, DOI 10.1089/thy.2012.0135; van Zaane B, 2010, BLOOD, V115, P4344, DOI 10.1182/blood-2009-11-253724; WIERSINGA WM, 1982, METHOD ENZYMOL, V84, P272; Wikstrom L, 1998, EMBO J, V17, P455, DOI 10.1093/emboj/17.2.455; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097; Yen PM, 2003, EMBO REP, V4, P581, DOI 10.1038/sj.embor.embor862	24	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127469	10.1371/journal.pone.0127469	http://dx.doi.org/10.1371/journal.pone.0127469			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011296	Green Published, gold, Green Submitted			2022-12-26	WOS:000355183900097
J	Schuck, PF; Milanez, AP; Felisberto, F; Galant, LS; Machado, JL; Furlanetto, CB; Petronilho, F; Dal-Pizzol, F; Streck, EL; Ferreira, GC				Schuck, Patricia Fernanda; Milanez, Ana Paula; Felisberto, Francine; Galant, Leticia Selinger; Machado, Jessica Luca; Furlanetto, Camila Brulezi; Petronilho, Fabricia; Dal-Pizzol, Felipe; Streck, Emilio Luiz; Ferreira, Gustavo Costa			Brain and Muscle Redox Imbalance Elicited by Acute Ethylmalonic Acid Administration	PLOS ONE			English	Article							ELECTRON-TRANSPORT CHAIN; CREATINE-KINASE ACTIVITY; LIPID-PEROXIDATION; OXIDATIVE DAMAGE; MITOCHONDRIA; INHIBITION; STRESS	Ethylmalonic acid (EMA) accumulates in tissues and biological fluids of patients affected by short-chain acyl-CoA dehydrogenase deficiency (SCADD) and ethylmalonic encephalopathy, illnesses characterized by neurological and muscular symptoms. Considering that the mechanisms responsible for the brain and skeletal muscle damage in these diseases are poorly known, in the present work we investigated the effects of acute EMA administration on redox status parameters in cerebral cortex and skeletal muscle from 30-day-old rats. Animals received three subcutaneous injections of EMA (6 mu mol/g; 90 min interval between injections) and were killed 1 h after the last administration. Control animals received saline in the same volumes. EMA administration significantly increased thiobarbituric acid-reactive substances levels in cerebral cortex and skeletal muscle, indicating increased lipid peroxidation. In addition, carbonyl content was increased in EMA-treated animal skeletal muscle when compared to the saline group. EMA administration also significantly increased 2', 7'-dihydrodichlorofluorescein oxidation and superoxide production (reactive species markers), and decreased glutathione peroxidase activity in cerebral cortex, while glutathione levels were decreased only in skeletal muscle. On the other hand, respiratory chain complex I-III activity was altered by acute EMA administration neither in cerebral cortex nor in skeletal muscle. The present results show that acute EMA administration elicits oxidative stress in rat brain and skeletal muscle, suggesting that oxidative damage may be involved in the pathophysiology of the brain and muscle symptoms found in patients affected by SCADD and ethylmalonic encephalopathy.	[Schuck, Patricia Fernanda; Milanez, Ana Paula; Machado, Jessica Luca; Furlanetto, Camila Brulezi] Univ Extremo Sul Catarinense, Unidade Acad Ciencias Saude, Programa Posgrad Ciencias Saude, Lab Erros Inatos Metabolismo, Criciuma, SC, Brazil; [Felisberto, Francine; Galant, Leticia Selinger; Dal-Pizzol, Felipe] Univ Extremo Sul Catarinense, Unidade Acad Ciencias Saude, Programa Posgrad Ciencias Saude, Lab Fisiopatol Expt, Criciuma, SC, Brazil; [Petronilho, Fabricia] Univ Sul Santa Catarina, Programa Posgrad Ciencias Saude, Lab Imunopatol Clin & Expt, Tubarao, SC, Brazil; Univ Extremo Catarinense, Unidade Acad Ciencias Saude, Programa Posgrad Ciencias Saude, Lab Erros Inatos Metabolismo, Criciuma, SC, Brazil; [Streck, Emilio Luiz] Univ Extremo Sul Catarinense, Unidade Acad Ciencias Saude, Programa Posgrad Ciencias Saude, Lab Bioenerget, Criciuma, SC, Brazil; [Ferreira, Gustavo Costa] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas, Lab Neuroquim, Rio De Janeiro, Brazil	Universidade do Extremo Sul Catarinense; Universidade do Extremo Sul Catarinense; Universidade do Sul de Santa Catarina; Universidade do Extremo Sul Catarinense; Universidade Federal do Rio de Janeiro	Schuck, PF (corresponding author), Univ Extremo Sul Catarinense, Unidade Acad Ciencias Saude, Programa Posgrad Ciencias Saude, Lab Erros Inatos Metabolismo, Criciuma, SC, Brazil.	patricia.schuck@pq.cnpq.br	Petronilho, Fabricia/D-8822-2013; Galant, Letícia Selinger/AAJ-9163-2020; Schuck, Patricia Fernanda/O-1344-2013	Schuck, Patricia Fernanda/0000-0003-3148-4952; SELINGER GALANT, LETICIA/0000-0001-7965-5648	Universidade do Extremo Sul Catarinense; Nucleo de Excelencia em Neurociencias Aplicada de Santa Catarina; Conselho Nacional de Pesquisa e Desenvolvimento Tecnologico; Fundacao de Amparo a Pesquisa e Inovacao do Estado de Santa Catarina	Universidade do Extremo Sul Catarinense; Nucleo de Excelencia em Neurociencias Aplicada de Santa Catarina; Conselho Nacional de Pesquisa e Desenvolvimento Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa e Inovacao do Estado de Santa Catarina(Fundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC))	Universidade do Extremo Sul Catarinense: PFS GCF ELS FDP LSG FF CBF JLM Nucleo de Excelencia em Neurociencias Aplicada de Santa Catarina: PFS ELS FDP; Conselho Nacional de Pesquisa e Desenvolvimento Tecnologico: PFS GCF ELS FDP; Fundacao de Amparo a Pesquisa e Inovacao do Estado de Santa Catarina: PFS ELS FDP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam-Vizi V, 2005, ANTIOXID REDOX SIGN, V7, P1140, DOI 10.1089/ars.2005.7.1140; Aebi H, 1984, Methods Enzymol, V105, P121; Aksenov MY, 2001, NEUROSCI LETT, V302, P141, DOI 10.1016/S0304-3940(01)01636-6; BANNISTER JV, 1987, METHOD BIOCHEM ANAL, V32, P279; Barschak AG, 2006, METAB BRAIN DIS, V21, P11, DOI 10.1007/s11011-006-9000-y; BENZI G, 1995, FREE RADICAL BIO MED, V19, P77, DOI 10.1016/0891-5849(94)00244-E; Browne R W, 1998, Methods Mol Biol, V108, P347; Campos D, 2012, METAB BRAIN DIS, V27, P121, DOI 10.1007/s11011-012-9302-1; CARLBERG I, 1985, METHOD ENZYMOL, V113, P484; Ferreira GD, 2006, METAB BRAIN DIS, V21, P29, DOI 10.1007/s11011-006-9004-7; Di Meo I, 2012, EMBO MOL MED, V4, P1008, DOI 10.1002/emmm.201201433; ESTERBAUER H, 1990, METHOD ENZYMOL, V186, P407; Evelson P, 2001, ARCH BIOCHEM BIOPHYS, V388, P261, DOI 10.1006/abbi.2001.2292; Jafari P, 2011, MOL GENET METAB, V104, P425, DOI 10.1016/j.ymgme.2011.08.027; LEBEL CP, 1992, CHEM RES TOXICOL, V5, P227, DOI 10.1021/tx00026a012; Leipnitz G, 2003, NEUROCHEM RES, V28, P771, DOI 10.1023/A:1022874103630; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Nowaczyk MJM, 1998, METABOLISM, V47, P836, DOI 10.1016/S0026-0495(98)90122-6; Pedersen CB, 2010, J INHERIT METAB DIS, V33, P211, DOI 10.1007/s10545-010-9086-6; Poderoso JJ, 1996, ARCH BIOCHEM BIOPHYS, V328, P85, DOI 10.1006/abbi.1996.0146; Reed TT, 2011, FREE RADICAL BIO MED, V51, P1302, DOI 10.1016/j.freeradbiomed.2011.06.027; REZNICK AZ, 1994, METHOD ENZYMOL, V233, P357; Roe CR, 2001, METABOLIC MOL BASES; Schapira AHV, 1998, ARCH NEUROL-CHICAGO, V55, P1293, DOI 10.1001/archneur.55.10.1293; Schuck PF, 2013, SYNAPSE, V67, P111, DOI 10.1002/syn.21618; Schuck PF, 2010, NEUROCHEM RES, V35, P298, DOI 10.1007/s11064-009-0055-0; Schuck PF, 2009, BEHAV BRAIN RES, V197, P364, DOI 10.1016/j.bbr.2008.09.031; Schuck PF, 2002, NEUROCHEM RES, V27, P1633, DOI 10.1023/A:1021682910373; Strassburger M, 2005, FREE RADICAL BIO MED, V38, P1458, DOI 10.1016/j.freeradbiomed.2005.02.009; Tiranti V, 2011, AM J HUM GENET, V74, P239; Tiranti V, 2009, NAT MED, V15, P200, DOI 10.1038/nm.1907; Vargas CR, 2011, MOL GENET METAB, V104, pS97, DOI 10.1016/j.ymgme.2011.07.010; Vazquez MC, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/205713; Wendel A, 1981, Methods Enzymol, V77, P325; Zolkipli Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017534	35	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0126606	10.1371/journal.pone.0126606	http://dx.doi.org/10.1371/journal.pone.0126606			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010931	gold, Green Published, Green Submitted			2022-12-26	WOS:000355183900035
J	Wang, B; Xie, XB; Yin, JQ; Zou, CY; Wang, J; Huang, G; Wang, YQ; Shen, JN				Wang, Bo; Xie, Xianbiao; Yin, Junqiang; Zou, Changye; Wang, Jin; Huang, Gang; Wang, Yongqian; Shen, Jingnan			Reconstruction with Modular Hemipelvic Endoprosthesis after Pelvic Tumor Resection: A Report of 50 Consecutive Cases	PLOS ONE			English	Article							INTERNAL HEMIPELVECTOMY	Purpose To evaluate the effectiveness of reconstruction with a modular hemipelvic endoprosthesis after pelvic tumor resection. Methods We retrospectively studied 50 consecutive patients diagnosed with pelvic tumor from 2003 to 2013. All patients received limb-salvage surgery and reconstruction with modular hemipelvic endoprosthesis. Results Patients were followed for an average of 54 months. At the most recent follow-up, 32 patients were alive with an estimated three-year and five-year survival rate of 66.3% and 57.5% according to the Kaplan-Meier survival analysis. Eighteen patients died from the tumor, with a mean survival of 28 months, and 9 patients experienced local recurrence at an average of 19.6 months after surgery. Patients with marginal or intracapsular surgical margins had a significantly higher recurrence rate than those with wide margins (p=0.02). Metastasis occurred in 12 cases at an average of 16 months after surgery. The perioperative complication rate was 48.0%, and the most common complications were wound healing disturbance (28.0%) and deep infection (14.0%). The endoprosthetic complication rate was 16.0%, and breakage of the pubic connection plate was the most common complication. The mean Musculoskeletal Tumor Society score was 61.4%. Conclusion Reconstruction with a modular hemipelvic endoprosthesis after pelvic tumor resection can improve function, with an acceptable complication rate.	[Wang, Bo; Xie, Xianbiao; Yin, Junqiang; Zou, Changye; Wang, Jin; Huang, Gang; Wang, Yongqian; Shen, Jingnan] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Musculoskeletal Oncol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Shen, JN (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Musculoskeletal Oncol, Guangzhou 510275, Guangdong, Peoples R China.	shenjingnan@126.com						Ayvaz M, 2014, SCI WORLD J, DOI 10.1155/2014/605019; Bruns J, 1997, ARCH ORTHOP TRAUM SU, V116, P27, DOI 10.1007/BF00434096; ENNEKING W, 1990, Chirurgia degli Organi di Movimento, V75, P217; ENNEKING WF, 1978, J BONE JOINT SURG AM, V60, P731, DOI 10.2106/00004623-197860060-00002; ENNEKING WF, 1986, CLIN ORTHOP RELAT R, P9; ENNEKING WF, 1993, CLIN ORTHOP RELAT R, P241; Falkinstein Y, 2008, J BONE JOINT SURG BR, V90B, P371, DOI 10.1302/0301-620X.90B3.20144; Guo W, 2007, CLIN ORTHOP RELAT R, P180, DOI 10.1097/BLO.0b013e31806165d5; Ham SJ, 1997, EUR J SURG ONCOL, V23, P540, DOI 10.1016/S0748-7983(97)93173-5; HARRINGTON KD, 1992, J BONE JOINT SURG AM, V74A, P331, DOI 10.2106/00004623-199274030-00003; Jaiswal PK, 2008, J BONE JOINT SURG BR, V90B, P1222, DOI 10.1302/0301-620X.90B9.20758; Ji T, 2013, EJSO-EUR J SURG ONC, V39, P53, DOI 10.1016/j.ejso.2012.10.002; Langlais F, 2001, CLIN ORTHOP RELAT R, P178; Mankin Henry J, 2005, Surg Oncol Clin N Am, V14, P381, DOI 10.1016/j.soc.2004.11.010; Muller PE, 2002, INT ORTHOP, V26, P76, DOI 10.1007/s00264-001-0322-4; Ozaki T, 2002, CLIN ORTHOP RELAT R, P197; Refaat Y, 2002, CLIN ORTHOP RELAT R, P298; Tunn PU, 2007, Z ORTHOP UNFALLCHIR, V145, P753, DOI 10.1055/s-2007-965757; Witte D, 2009, EJSO-EUR J SURG ONC, V35, P1318, DOI 10.1016/j.ejso.2009.04.011	19	30	36	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127263	10.1371/journal.pone.0127263	http://dx.doi.org/10.1371/journal.pone.0127263			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011448	Green Submitted, Green Published, gold			2022-12-26	WOS:000355183900076
J	Park, SJ; Shim, JW; Park, HS; Eum, DY; Park, MT; Yi, JM; Choi, SH; Kim, SD; Son, TG; Lu, W; Kim, ND; Yang, K; Heo, K				Park, S-J; Shim, J. W.; Park, H. S.; Eum, D-Y; Park, M-T; Yi, J. Mi; Choi, S. H.; Kim, S. D.; Son, T. G.; Lu, W.; Kim, N. D.; Yang, K.; Heo, K.			MacroH2A1 downregulation enhances the stem-like properties of bladder cancer cells by transactivation of Lin28B	ONCOGENE			English	Article							INITIATING CELLS; HISTONE VARIANTS; SIDE POPULATION; LIN-28; EXPRESSION; RADIORESISTANCE; PROLIFERATION; PROGRESSION; REPRESSION; CARCINOMA	The histone variant, macroH2A1, has an important role in embryonic stem cell differentiation and tumor progression in various types of tumors. However, the regulatory roles of macroH2A1 on bladder cancer progression have not been fully elucidated. Here, we show that macroH2A1 knockdown promotes stem-like properties of bladder cancer cells. The knockdown of macroH2A1 in bladder cancer cells increased tumorigenicity, radioresistance, degeneration of reactive oxygen species, increased sphere formation capability and an increase in the proportion of side populations. We found that macroH2A1 is required for the suppression of Lin28B identified as a novel downstream target of macroH2A1 in bladder cancer. Loss of macroH2A1 expression significantly correlated with the elevated levels of Lin28B expression and subsequently inhibited the mature let-7 microRNA expression. Furthermore, the stable overexpression of Lin28B enhances the several phenotypes, including tumorigenicity and sphere-forming ability, which are induced by macroH2A1 depletion. Importantly, Lin28B expression was regulated by macroH2A1-mediated reciprocal binding of p300 and EZH2/SUV39H1. Our results suggest that Lin28B/let-7 pathway is tightly regulated by macroH2A1 and its cofactors, and have a pivotal role in the bladder tumor progression and the regulation of stem-like characteristics of bladder cancer cells.	[Park, S-J; Shim, J. W.; Park, H. S.; Eum, D-Y; Park, M-T; Yi, J. Mi; Choi, S. H.; Kim, S. D.; Son, T. G.; Yang, K.; Heo, K.] Dongnam Inst Radiol & Med Sci DIRAMS, Res Ctr, Jwadong Gil 40, Busan 619953, South Korea; [Park, S-J; Kim, N. D.] Pusan Natl Univ, Dept Pharm, Busan, South Korea; [Lu, W.] Univ So Calif, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Dept Biochem & Mol Biol, Los Angeles, CA USA; [Yang, K.] Dongnam Inst Radiol & Med Sci, Dept Radiat Oncol, Busan, South Korea; [Yang, K.] Korea Inst Radiol & Med Sci, Dept Radiat Oncol, Seoul, South Korea	Korea Institute of Radiological & Medical Sciences; Pusan National University; University of Southern California; Korea Institute of Radiological & Medical Sciences; Korea Institute of Radiological & Medical Sciences	Yang, K; Heo, K (corresponding author), Dongnam Inst Radiol & Med Sci DIRAMS, Res Ctr, Jwadong Gil 40, Busan 619953, South Korea.	kmyang@dirams.re.kr; khjhk33@gmail.com		Heo, Kyu/0000-0001-8833-4731	National Research Foundation of Korea (DIRAMS) grant - Korea government (MSIP) [50590-2015]; (Basic Science Research Program) through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [NRF-2014 M2A2A 7043665]	National Research Foundation of Korea (DIRAMS) grant - Korea government (MSIP); (Basic Science Research Program) through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning	We thank Peter Jones for the UROtsa and LD611 cell lines. This work was supported by the National Research Foundation of Korea (DIRAMS) grant funded by the Korea government (MSIP) (50590-2015) and the (Basic Science Research Program) through the National Research Foundation of Korea (NRF) (NRF-2014 M2A2A 7043665) funded by the Ministry of Science, ICT & Future Planning.	Angelov D, 2003, MOL CELL, V11, P1033, DOI 10.1016/S1097-2765(03)00100-X; Banaszynski LA, 2010, DEV CELL, V19, P662, DOI 10.1016/j.devcel.2010.10.014; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Barrero MJ, 2013, CELL REP, V3, P1005, DOI 10.1016/j.celrep.2013.02.029; Baumann M, 2008, NAT REV CANCER, V8, P545, DOI 10.1038/nrc2419; Bussing I, 2008, TRENDS MOL MED, V14, P400, DOI 10.1016/j.molmed.2008.07.001; Cai WY, 2013, J CELL SCI, V126, P2877, DOI 10.1242/jcs.123810; Chan KS, 2010, CURR OPIN UROL, V20, P393, DOI 10.1097/MOU.0b013e32833cc9df; Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106; Cheng SW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080053; Copley MR, 2013, NAT CELL BIOL, V15, P916, DOI 10.1038/ncb2783; Costanzi C, 1998, NATURE, V393, P599, DOI 10.1038/31275; Dai B, 2007, STEM CELLS, V25, P2567, DOI 10.1634/stemcells.2007-0131; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Doyen CM, 2006, MOL CELL BIOL, V26, P1156, DOI 10.1128/MCB.26.3.1156-1164.2006; Easwaran H, 2014, MOL CELL, V54, P716, DOI 10.1016/j.molcel.2014.05.015; Gamble MJ, 2010, CELL CYCLE, V9, P2568, DOI 10.4161/cc.9.13.12144; Gaspar-Maia A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2582; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Guo YQ, 2006, GENE, V384, P51, DOI 10.1016/j.gene.2006.07.011; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Hua S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.25; Kapoor A, 2010, NATURE, V468, P1105, DOI 10.1038/nature09590; Kim JM, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.40; King CE, 2011, CANCER RES, V71, P4260, DOI 10.1158/0008-5472.CAN-10-4637; Lee DF, 2012, CELL STEM CELL, V11, P179, DOI 10.1016/j.stem.2012.05.020; Li XF, 2012, J BIOL CHEM, V287, P23171, DOI 10.1074/jbc.M112.379412; Lu LG, 2012, CARCINOGENESIS, V33, P2119, DOI 10.1093/carcin/bgs243; Moss EG, 2003, DEV BIOL, V258, P432, DOI 10.1016/S0012-1606(03)00126-X; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Nguyen LV, 2012, NAT REV CANCER, V12, P133, DOI 10.1038/nrc3184; Novikov L, 2011, MOL CELL BIOL, V31, P4244, DOI 10.1128/MCB.05244-11; Park SJ, 2013, BIOCHEM BIOPH RES CO, V434, P722, DOI 10.1016/j.bbrc.2013.03.091; Pasque V, 2012, J CELL SCI, V125, P6094, DOI 10.1242/jcs.113019; Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495; Shyh-Chang N, 2013, CELL STEM CELL, V12, P395, DOI 10.1016/j.stem.2013.03.005; Sporn JC, 2009, ONCOGENE, V28, P3423, DOI 10.1038/onc.2009.26; Sporn JC, 2012, AM J PATHOL, V180, P2516, DOI 10.1016/j.ajpath.2012.02.027; Svotelis A, 2010, CELL CYCLE, V9, P364, DOI 10.4161/cc.9.2.10465; Tanasijevic B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021512; Vardabasso C, 2014, CELL MOL LIFE SCI, V71, P379, DOI 10.1007/s00018-013-1343-z; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wang WJ, 2013, CANCER RES, V73, P1219, DOI 10.1158/0008-5472.CAN-12-1408; Wang YC, 2010, CARCINOGENESIS, V31, P1516, DOI 10.1093/carcin/bgq107; Wu CL, 2007, CANCER RES, V67, P8216, DOI 10.1158/0008-5472.CAN-07-0999; Xia ZB, 2013, MOL CANCER RES, V11, P1101, DOI 10.1158/1541-7786.MCR-13-0044; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	48	28	29	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 10	2016	35	10					1292	1301		10.1038/onc.2015.187	http://dx.doi.org/10.1038/onc.2015.187			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DG0NY	26028027	Green Published, hybrid			2022-12-26	WOS:000371763100009
J	Zanetti, A; Affatato, R; Centritto, F; Fratelli, M; Kurosaki, M; Barzago, MM; Bolis, M; Terao, M; Garattini, E; Paroni, G				Zanetti, Adriana; Affatato, Roberta; Centritto, Floriana; Fratelli, Maddalena; Kurosaki, Mami; Barzago, Maria Monica; Bolis, Marco; Terao, Mineko; Garattini, Enrico; Paroni, Gabriela			All-trans-retinoic Acid Modulates the Plasticity and Inhibits the Motility of Breast Cancer Cells ROLE OF NOTCH1 AND TRANSFORMING GROWTH FACTOR (TGF beta)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GENE-EXPRESSION; UP-REGULATION; E-CADHERIN; IN-VIVO; ACTIVATION; METASTASIS; REPRESSION; MIGRATION; INVASION	All-trans-retinoic acid (ATRA) is a natural compound proposed for the treatment/chemoprevention of breast cancer. Increasing evidence indicates that aberrant regulation of epithelial-to-mesenchymal transition (EMT) is a determinant of the cancer cell invasive and metastatic behavior. The effects of ATRA on EMT are largely unknown. In HER2-positive SKBR3 and UACC812 cells, showing co-amplification of the ERBB2 and RARA genes, ATRA activates a RAR alpha-dependent epithelial differentiation program. In SKBR3 cells, this causes the formation/reorganization of adherens and tight junctions. Epithelial differentiation and augmented cell-cell contacts underlie the antimigratory action exerted by the retinoid in cells exposed to the EMT-inducing factors EGF and heregulin-beta 1. Down-regulation of NOTCH1, an emerging EMT modulator, is involved in the inhibition of motility by ATRA. Indeed, the retinoid blocks NOTCH1 up-regulation by EGF and/or heregulin-beta 1. Pharmacological inhibition of gamma-secretase and NOTCH1 processing also abrogates SKBR3 cell migration. Stimulation of TGF beta contributes to the anti-migratory effect of ATRA. The retinoid switches TGF beta from an EMT-inducing and pro-migratory determinant to an anti-migratory mediator. Inhibition of the NOTCH1 pathway not only plays a role in the anti-migratory action of ATRA; it is relevant also for the anti-proliferative activity of the retinoid in HCC1599 breast cancer cells, which are addicted to NOTCH1 for growth/viability. This effect is enhanced by the combination of ATRA and the gamma-secretase inhibitor N-(N-(3,5-difluorophenacetyl)-L-alanyl)-S-phenylglycine t-butyl ester, supporting the concept that the two compounds act at the transcriptional and post-translational levels along the NOTCH1 pathway.	[Zanetti, Adriana; Affatato, Roberta; Centritto, Floriana; Fratelli, Maddalena; Kurosaki, Mami; Barzago, Maria Monica; Bolis, Marco; Terao, Mineko; Garattini, Enrico; Paroni, Gabriela] Ist Ric Farmacol Mario Negri, Mol Biol Lab, I-20156 Milan, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Paroni, G (corresponding author), Ist Ric Farmacol Mario Negri, Mol Biol Lab, Via La Masa 19, I-20156 Milan, Italy.	gabriela.paroni@marionegri.it	terao, mineko/AAU-8089-2020; Fratelli, Maddalena/AAA-6446-2020; adriana, zanetti/ABA-1189-2020; Garattini, Enrico/AAI-1998-2019; Terao, Mineko/AAA-6415-2020; Paroni, Gabriela/J-4848-2018; Bolis, Marco/AAC-2379-2019; Barzago, Maria Monica/AAA-6402-2020; KUROSAKI, Mami/ABG-2224-2020; Affatato, Roberta/AHD-9757-2022	Fratelli, Maddalena/0000-0002-1769-3427; adriana, zanetti/0000-0002-5825-9707; Terao, Mineko/0000-0002-9976-9869; Paroni, Gabriela/0000-0003-0132-0869; Bolis, Marco/0000-0003-4377-5079; Barzago, Maria Monica/0000-0002-6952-0069; KUROSAKI, Mami/0000-0001-8231-713X; Affatato, Roberta/0000-0002-2235-039X; Garattini, Enrico/0000-0001-8983-886X	Associazione Italiana per la Ricerca sul il Cancro (MFAG) [12100]; Fondazione "Italo Monzino"	Associazione Italiana per la Ricerca sul il Cancro (MFAG)(Fondazione AIRC per la ricerca sul cancro); Fondazione "Italo Monzino"	This work was supported by a grant from the Associazione Italiana per la Ricerca sul il Cancro (MFAG 2011 Grant 12100) (to G. P.). This work was also supported by the Fondazione "Italo Monzino."	Nieto MA, 2013, SCIENCE, V342, P708, DOI 10.1126/science.1234850; Barroga EF, 2000, RES VET SCI, V68, P79, DOI 10.1053/rvsc.1999.0360; Blick T, 2008, CLIN EXP METASTAS, V25, P629, DOI 10.1007/s10585-008-9170-6; Bolos V, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3447; Brabletz T, 2012, NAT REV CANCER, V12, P425, DOI 10.1038/nrc3265; Centritto F., 2015, EMBO MOL MED, DOI 10.15252/emmm.201404670; Cheng LS, 2009, CANCER LETT, V280, P50, DOI 10.1016/j.canlet.2009.02.007; Cho KW, 2012, DEV BIOL, V365, P259, DOI 10.1016/j.ydbio.2012.02.020; Corada M, 2001, BLOOD, V97, P1679, DOI 10.1182/blood.V97.6.1679; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Doi A, 2015, MOL ONCOL, V9, P355, DOI 10.1016/j.molonc.2014.09.005; Friedl P, 2012, NAT CELL BIOL, V14, P777, DOI 10.1038/ncb2548; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Garattini E, 2014, CANCER TREAT REV, V40, P739, DOI 10.1016/j.ctrv.2014.01.001; GIANNI M, 1993, BIOCHEM BIOPH RES CO, V196, P252, DOI 10.1006/bbrc.1993.2242; Guruharsha KG, 2012, NAT REV GENET, V13, P654, DOI 10.1038/nrg3272; Hardy KM, 2010, J MAMMARY GLAND BIOL, V15, P191, DOI 10.1007/s10911-010-9172-2; Heldin CH, 2012, FEBS LETT, V586, P1959, DOI 10.1016/j.febslet.2012.02.037; Hollestelle A, 2013, BREAST CANCER RES TR, V138, P47, DOI 10.1007/s10549-013-2415-3; Hugo HJ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-235; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Lacroix M, 2004, BREAST CANCER RES TR, V83, P249, DOI 10.1023/B:BREA.0000014042.54925.cc; Leong KG, 2007, J EXP MED, V204, P2935, DOI 10.1084/jem.20071082; Liu H, 2003, BREAST CANCER RES TR, V79, P63, DOI 10.1023/A:1023366117157; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo HW, 2007, CANCER RES, V67, P9066, DOI 10.1158/0008-5472.CAN-07-0575; Lo-Coco F, 2008, SEMIN ONCOL, V35, P401, DOI 10.1053/j.seminoncol.2008.04.010; Micalizzi DS, 2010, J MAMMARY GLAND BIOL, V15, P117, DOI 10.1007/s10911-010-9178-9; Micchelli CA, 2002, FASEB J, V16, P79, DOI 10.1096/fj.02-0394fje; Nam DH, 2008, CLIN CANCER RES, V14, P4059, DOI 10.1158/1078-0432.CCR-07-4039; Niederreither K, 2008, NAT REV GENET, V9, P541, DOI 10.1038/nrg2340; Ocana OH, 2012, CANCER CELL, V22, P709, DOI 10.1016/j.ccr.2012.10.012; Paroni G, 2012, ONCOGENE, V31, P3431, DOI 10.1038/onc.2011.506; Paroni G, 2001, J BIOL CHEM, V276, P21907, DOI 10.1074/jbc.M011565200; Parr C, 2004, INT J MOL MED, V14, P779; Robinson DR, 2011, NAT MED, V17, P1646, DOI 10.1038/nm.2580; Rochette-Egly Cecile, 2009, Nucl Recept Signal, V7, pe005, DOI 10.1621/nrs.07005; Rustighi A, 2009, NAT CELL BIOL, V11, P133, DOI 10.1038/ncb1822; Sahlgren C, 2008, P NATL ACAD SCI USA, V105, P6392, DOI 10.1073/pnas.0802047105; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Sekimoto G, 2007, CANCER RES, V67, P5090, DOI 10.1158/0008-5472.CAN-06-4629; Shah S, 2002, J BIOL CHEM, V277, P25313, DOI 10.1074/jbc.M203158200; Shao S, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0295-3; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Trimboli AJ, 2008, CANCER RES, V68, P937, DOI 10.1158/0008-5472.CAN-07-2148; Vogelmann R, 2005, J CELL SCI, V118, P4901, DOI 10.1242/jcs.02594; Voigt W, 2005, METH MOLEC MED, V110, P39; Voura EB, 1998, MICROSC RES TECHNIQ, V43, P265, DOI 10.1002/(SICI)1097-0029(19981101)43:3<265::AID-JEMT9>3.0.CO;2-Z; Wang SE, 2008, MOL CELL BIOL, V28, P5605, DOI 10.1128/MCB.00787-08; Wang YA, 2005, DEV DYNAM, V234, P892, DOI 10.1002/dvdy.20570; Wolbach SB, 1925, J EXP MED, V42, P753, DOI 10.1084/jem.42.6.753; Wolbach SB, 1933, J EXP MED, V57, P511, DOI 10.1084/jem.57.3.511; Wu Q, 2002, ACTA PHARMACOL SIN, V23, P835; Yugawa T, 2007, MOL CELL BIOL, V27, P3732, DOI 10.1128/MCB.02119-06; Zavadil J, 2004, EMBO J, V23, P1155, DOI 10.1038/sj.emboj.7600069; Zhang CC, 2012, CLIN CANCER RES, V18, P5008, DOI 10.1158/1078-0432.CCR-12-1379	59	38	41	1	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					17690	17709		10.1074/jbc.M115.638510	http://dx.doi.org/10.1074/jbc.M115.638510			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26018078	hybrid, Green Published			2022-12-26	WOS:000358511700005
J	Taroni, P; Quarto, G; Pifferi, A; Abbate, F; Balestreri, N; Menna, S; Cassano, E; Cubeddu, R				Taroni, Paola; Quarto, Giovanna; Pifferi, Antonio; Abbate, Francesca; Balestreri, Nicola; Menna, Simona; Cassano, Enrico; Cubeddu, Rinaldo			Breast Tissue Composition and Its Dependence on Demographic Risk Factors for Breast Cancer: Non-Invasive Assessment by Time Domain Diffuse Optical Spectroscopy	PLOS ONE			English	Article							BACKGROUND PARENCHYMAL ENHANCEMENT; MAMMOGRAPHIC DENSITY; NEOADJUVANT CHEMOTHERAPY; FIBROGLANDULAR-TISSUE; SCATTERING PARAMETERS; RESOLVED REFLECTANCE; YOUNG-WOMEN; MRI; QUANTIFICATION; PROLIFERATION	Background Breast tissue composition is recognized as a strong and independent risk factor for breast cancer. It is a heritable feature, but is also significantly affected by several other elements (e.g., age, menopause). Nowadays it is quantified by mammographic density, thus requiring the use of ionizing radiation. Optical techniques are absolutely non-invasive and have already proved effective in the investigation of biological tissues, as they are sensitive to tissue composition and structure. Methods Time domain diffuse optical spectroscopy was performed at 7 wavelengths (635-1060 nm) on 200 subjects to derive their breast tissue composition (in terms of water, lipid and collagen content), blood parameters (total hemoglobin content and oxygen saturation level), and information on the microscopic structure (scattering amplitude and power). The dependence of all optically-derived parameters on age, menopausal status, body mass index, and use of oral contraceptives, and the correlation with mammographic density were investigated. Results Younger age, premenopausal status, lower body mass index values, and use of oral contraceptives all correspond to significantly higher water, collagen and total hemoglobin content, and lower lipid content (always p < 0.05 and often p < 10(-4)), while oxygen saturation level and scattering parameters show significant dependence only on some conditions. Even when age-adjusted groups of subjects are compared, several optically derived parameters (and in particular always collagen and total hemoglobin content) remain significantly different. Conclusions Time domain diffuse optical spectroscopy can probe non-invasively breast tissue composition and physiologic blood parameters, and provide information on tissue structure. The measurement is suitable for in vivo studies and monitoring of changes in breast tissue (e.g., with age, lifestyle, chemotherapy, etc.) and to gain insight into related processes, like the origin of cancer risk associated with breast density.	[Taroni, Paola; Quarto, Giovanna; Pifferi, Antonio; Cubeddu, Rinaldo] Politecn Milan, Dipartimento Fis, I-20133 Milan, Italy; [Pifferi, Antonio; Cubeddu, Rinaldo] CNR, Ist Foton & Nanotecnol, I-20133 Milan, Italy; [Abbate, Francesca; Menna, Simona; Cassano, Enrico] European Inst Oncol, Breast Imaging Unit, Milan, Italy; [Balestreri, Nicola] European Inst Oncol, Dept Radiol, Milan, Italy	Polytechnic University of Milan; Consiglio Nazionale delle Ricerche (CNR); IRCCS European Institute of Oncology (IEO); IRCCS European Institute of Oncology (IEO)	Taroni, P (corresponding author), Politecn Milan, Dipartimento Fis, I-20133 Milan, Italy.	paola.taroni@polimi.it	Menna, Simona/AAQ-7127-2020; Pifferi, Antonio/C-4688-2012; Taroni, Paola/C-4709-2012	Pifferi, Antonio/0000-0002-2261-2089; Taroni, Paola/0000-0001-7486-0001				Anderson GL, 2007, IWG E CR H COMBINED; [Anonymous], BI RADS MAMM 2013; Barcus CE, 2013, J BIOL CHEM, V288, P12722, DOI 10.1074/jbc.M112.447631; Bassi A, 2007, OPT EXPRESS, V15, P14482, DOI 10.1364/OE.15.014482; Boyd N, 2002, CANCER EPIDEM BIOMAR, V11, P1048; Boyd NF, 2002, NEW ENGL J MED, V347, P886, DOI 10.1056/NEJMoa013390; Boyd N, 2009, LANCET ONCOL, V10, P569, DOI 10.1016/S1470-2045(09)70078-6; Boyd NF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100937; Boyd NF, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2942; Boyd NF, 2010, JNCI-J NATL CANCER I, V102, P1224, DOI 10.1093/jnci/djq239; Checka CM, 2012, AM J ROENTGENOL, V198, pW292, DOI 10.2214/AJR.10.6049; Choe R, 2012, IEEE J SEL TOP QUANT, V18, P1367, DOI 10.1109/JSTQE.2011.2177963; CUBEDDU R, 1994, IEEE J QUANTUM ELECT, V30, P2421, DOI 10.1109/3.328616; D'Andrea C, 2006, OPT EXPRESS, V14, P1888, DOI 10.1364/OE.14.001888; Dorgan JF, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3228; Durduran T, 2010, REP PROG PHYS, V73, DOI 10.1088/0034-4885/73/7/076701; Evans A, 2013, BRIT J CANCER, V109, P2798, DOI 10.1038/bjc.2013.660; Farina A, 2009, APPL SPECTROSC, V63, P48, DOI 10.1366/000370209787169795; Ghosh K, 2012, BREAST CANCER RES TR, V131, P267, DOI 10.1007/s10549-011-1727-4; Gibson A, 2009, PHILOS T R SOC A, V367, P3055, DOI 10.1098/rsta.2009.0080; Gibson AP, 2005, PHYS MED BIOL, V50, pR1, DOI 10.1088/0031-9155/50/4/R01; HASKELL RC, 1994, J OPT SOC AM A, V11, P2727, DOI 10.1364/JOSAA.11.002727; Hattangadi J, 2008, AM J ROENTGENOL, V190, P1630, DOI 10.2214/AJR.07.2533; Isaksson E, 2001, BREAST CANCER RES TR, V65, P163, DOI 10.1023/A:1006482418082; Kim J, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3221; King V, 2012, EUR RADIOL, V22, P2641, DOI 10.1007/s00330-012-2553-8; Lee NA, 1997, AM J ROENTGENOL, V168, P501, DOI 10.2214/ajr.168.2.9016235; Li T, 2005, CANCER EPIDEM BIOMAR, V14, P343, DOI 10.1158/1055-9965.EPI-04-0490; Luparello C, 2013, J CARCINOG MUTAGEN, V13, DOI [10.4172/2157-2518.S13-007, DOI 10.4172/2157-2518.S13-007]; McCormack VA, 2006, CANCER EPIDEM BIOMAR, V15, P1159, DOI 10.1158/1055-9965.EPI-06-0034; Mourant JR, 1997, APPL OPTICS, V36, P949, DOI 10.1364/AO.36.000949; Nilsson AMK, 1998, APPL OPTICS, V37, P1256, DOI 10.1364/AO.37.001256; Pasarica M, 2009, DIABETES, V58, P718, DOI 10.2337/db08-1098; PATTERSON MS, 1989, APPL OPTICS, V28, P2331, DOI 10.1364/AO.28.002331; Pifferi A, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2735567; Pike MC, 2013, ANN ONCOL, V24, P37, DOI 10.1093/annonc/mdt310; Pogue BW, 2004, J BIOMED OPT, V9, P541, DOI 10.1117/1.1691028; Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38; Shah N, 2003, DIS MARKERS, V19, P95, DOI 10.1155/2004/460797; Shah N, 2004, J BIOMED OPT, V9, P534, DOI 10.1117/1.1695560; Stomper PC, 1996, AM J ROENTGENOL, V167, P1261, DOI 10.2214/ajr.167.5.8911192; Stone J, 2006, CANCER EPIDEM BIOMAR, V15, P612, DOI 10.1158/1055-9965.EPI-05-0127; Taroni P, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.6.060507; Taroni P, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3506043; Taroni P, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3251051; Taroni P, 2009, OPT EXPRESS, V17, P15932, DOI 10.1364/OE.17.015932; Tromberg B, 2012, CANCER RES, V71, DOI [10.1158/0008-5472.SABCS11-OT2-05-02, DOI 10.1158/0008-5472.SABCS11-0T2-05-02]; Ueda S, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-514; Vachon CM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1829; Wang X, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2098607	50	31	33	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128941	10.1371/journal.pone.0128941	http://dx.doi.org/10.1371/journal.pone.0128941			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26029912	gold, Green Published			2022-12-26	WOS:000356630900200
J	Wu, RH; Tang, XQ; Sheng, XZ; Zhan, WB				Wu, Ronghua; Tang, Xiaoqian; Sheng, Xiuzhen; Zhan, Wenbin			Relationship between Expression of Cellular Receptor-27.8kDa and Lymphocystis Disease Virus (LCDV) Infection	PLOS ONE			English	Article							FLOUNDER PARALICHTHYS-OLIVACEUS; CANINE-DISTEMPER VIRUS; MONOCLONAL-ANTIBODIES; GILL; PROTEIN; IDENTIFICATION; INTEGRIN; CELLS; ENTRY; LINE	The 27.8kDa membrane protein from flounder (Paralichthys olivaceus) gill (FG) cells was previously identified as a putative cellular receptor involved in lymphocystis disease virus (LCDV) infection. In this paper, the expression of receptor-27.8kDa (27.8R) and LCDV loads in FG cells and hirame natural embryo (HINAE) cells were investigated upon LCDV infection and anti-27.8R monoclonal antibody (MAb) treatment. The results showed the 27.8R was expressed and co-localized with LCDV in both FG and HINAE cell surface. After LCDV infection, the expression of 27.8R exhibited a dose-dependent up-regulation with the increasing of LCDV titers, and demonstrated a tendency to increase firstly and then decrease during a time course up to 9 days; LCDV copies showed a similar variation trend to the 27.8R expression, however, it reached the highest level later than did the 27.8R expression. Additionally, the 27.8R expression and LCDV copies in FG cells were higher than those in HINAE cells. In the presence of increasing concentration of the anti-27.8R MAbs, the up-regulation of 27.8R expression and the copy numbers of LCDV significantly declined post LCDV infection, and the cytopathic effect induced by LCDV in the two cell lines was accordingly reduced, indicating anti-27.8R MAbs pre-incubation could inhibit the up-regulation of 27.8R expression and LCDV infection. These results suggested that LCDV infection could induce up-regulation of 27.8R expression, which in turn increased susceptibility and availability of FG and HINAE cells for LCDV entry, providing important new insights into the LCDV replication cycle and the interaction between this virus and the host cells.	[Wu, Ronghua; Tang, Xiaoqian; Sheng, Xiuzhen; Zhan, Wenbin] Ocean Univ China, Lab Pathol & Immunol Aquat Anim, Qingdao 266003, Peoples R China	Ocean University of China	Sheng, XZ (corresponding author), Ocean Univ China, Lab Pathol & Immunol Aquat Anim, 5 Yushan Rd, Qingdao 266003, Peoples R China.	xzsheng@ouc.edu.cn			National Science Fund of China [31472295, 31172429, 31072232]	National Science Fund of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by National Science Fund of China (grant 31472295, 31172429 and 31072232). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN F, 1986, INTERVIROLOGY, V25, P141, DOI 10.1159/000149667; Charlermroj R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062344; Cheng SF, 2006, J VIROL METHODS, V135, P173, DOI 10.1016/j.jviromet.2006.03.016; Harikrishnan R, 2010, FISH SHELLFISH IMMUN, V29, P868, DOI 10.1016/j.fsi.2010.07.031; HEPPELL J, 1992, ARCH VIROL, V125, P215, DOI 10.1007/BF01309639; Hu GB, 2004, J FISH DIS, V27, P657, DOI 10.1111/j.1365-2761.2004.00588.x; Iwakiri S, 2014, FISH SHELLFISH IMMUN, V38, P406, DOI 10.1016/j.fsi.2014.03.028; Iwamoto R, 2002, J AQUAT ANIM HEALTH, V14, P114, DOI 10.1577/1548-8667(2002)014&lt;0114:IACOTJ&gt;2.0.CO;2; Jang HB, 2011, J FISH DIS, V34, P555, DOI 10.1111/j.1365-2761.2011.01268.x; Kasai Hisae, 2001, Bulletin of Fisheries Sciences Hokkaido University, V52, P67; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Noutsias M, 2001, CIRCULATION, V104, P275; Noyce RS, 2013, VIROLOGY, V436, P210, DOI 10.1016/j.virol.2012.11.011; Papi A, 1999, J BIOL CHEM, V274, P9707, DOI 10.1074/jbc.274.14.9707; Pontejo SM, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-188; Reed L.J., 1938, SIMPLE METHOD ESTIMA, V27, P493, DOI [10.1093/oxfordjournals.aje.a118408, DOI 10.1093/OXFORDJOURNALS.AJE.A118408]; Sheng XZ, 2012, DIS AQUAT ORGAN, V100, P19, DOI 10.3354/dao02485; Sun C, 2013, DEV COMP IMMUNOL, V40, P28, DOI 10.1016/j.dci.2012.12.009; Tang QH, 2010, VET IMMUNOL IMMUNOP, V133, P237, DOI 10.1016/j.vetimm.2009.07.005; Tang XQ, 2012, AQUACULTURE, V358, P132, DOI 10.1016/j.aquaculture.2012.06.031; Tayyari F, 2011, NAT MED, V17, P1132, DOI 10.1038/nm.2444; Tian D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031965; Tian JY, 2011, FISH SHELLFISH IMMUN, V30, P109, DOI 10.1016/j.fsi.2010.09.016; Tong SL, 1997, AQUACULTURE, V156, P327, DOI 10.1016/S0044-8486(97)00070-7; Wang M, 2011, DIS AQUAT ORGAN, V94, P9, DOI 10.3354/dao02311; Wenzlow N, 2007, VET PATHOL, V44, P943, DOI 10.1354/vp.44-6-943; Zhan WB, 1999, J AQUAT ANIM HEALTH, V11, P17, DOI 10.1577/1548-8667(1999)011&lt;0017:POMAMA&gt;2.0.CO;2; Zhan WB, 2010, CHIN J OCEANOL LIMN, V28, P1213, DOI 10.1007/s00343-010-9934-0; Zhang JL, 2007, BIOCHEM BIOPH RES CO, V356, P763, DOI 10.1016/j.bbrc.2007.03.051; Zhong RJ, 2013, FISH SHELLFISH IMMUN, V35, P539, DOI 10.1016/j.fsi.2013.05.004; Zhu ZW, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056662, 10.1371/journal.pone.0080028]	32	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0127940	10.1371/journal.pone.0127940	http://dx.doi.org/10.1371/journal.pone.0127940			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024218	Green Submitted, gold, Green Published			2022-12-26	WOS:000355319400060
J	Ito, H; Uchida, T; Makita, K				Ito, Hiroyuki; Uchida, Tokujiro; Makita, Koshi			Ketamine Causes Mitochondrial Dysfunction in Human Induced Pluripotent Stem Cell-Derived Neurons	PLOS ONE			English	Article							APOPTOTIC NEURODEGENERATION; CORTICAL-NEURONS; DEVELOPING BRAIN; DRUG DISCOVERY; EARLY EXPOSURE; PATHWAY; FUSION; INHIBITION; FISSION; CULTURE	Purpose Ketamine toxicity has been demonstrated in nonhuman mammalian neurons. To study the toxic effect of ketamine on human neurons, an experimental model of cultured neurons from human induced pluripotent stem cells (iPSCs) was examined, and the mechanism of its toxicity was investigated. Methods Human iPSC-derived dopaminergic neurons were treated with 0, 20, 100 or 500 mu M ketamine for 6 and 24 h. Ketamine toxicity was evaluated by quantification of caspase 3/7 activity, reactive oxygen species (ROS) production, mitochondrial membrane potential, ATP concentration, neurotransmitter reuptake activity and NADH/NAD(+) ratio. Mitochondrial morphological change was analyzed by transmission electron microscopy and confocal microscopy. Results Twenty-four-hour exposure of iPSC-derived neurons to 500 mu M ketamine resulted in a 40% increase in caspase 3/7 activity (P < 0.01), 14% increase in ROS production (P < 0.01), and 81% reduction in mitochondrial membrane potential (P < 0.01), compared with untreated cells. Lower concentration of ketamine (100 mu M) decreased the ATP level (22%, P < 0.01) and increased the NADH/NAD(+) ratio (46%, P < 0.05) without caspase activation. Transmission electron microscopy showed enhanced mitochondrial fission and autophagocytosis at the 100 mu M ketamine concentration, which suggests that mitochondrial dysfunction preceded ROS generation and caspase activation. Conclusions We established an in vitro model for assessing the neurotoxicity of ketamine in iPSC-derived neurons. The present data indicate that the initial mitochondrial dysfunction and autophagy may be related to its inhibitory effect on the mitochondrial electron transport system, which underlies ketamine-induced neural toxicity. Higher ketamine concentration can induce ROS generation and apoptosis in human neurons.	[Ito, Hiroyuki; Uchida, Tokujiro; Makita, Koshi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Anesthesiol, Bunkyo Ku, Tokyo, Japan	Tokyo Medical & Dental University (TMDU)	Ito, H (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Anesthesiol, Bunkyo Ku, Tokyo, Japan.	hiro-ito.mane@tmd.ac.jp			Japan Society for the Promotion of Science, Japan [25670666]; Grants-in-Aid for Scientific Research [25670759, 15H05004] Funding Source: KAKEN	Japan Society for the Promotion of Science, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study is funded by Grant-in-Aid 25670666 (KM) from the Japan Society for the Promotion of Science, Japan (https://www.jsps.go.jp/english/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDRIDGE WN, 1960, BIOCHEM J, V76, P47, DOI 10.1042/bj0760047; Archer SL, 2013, NEW ENGL J MED, V369, P2236, DOI 10.1056/NEJMra1215233; Bai XW, 2013, ANESTH ANALG, V116, P869, DOI 10.1213/ANE.0b013e3182860fc9; Bosnjak ZJ, 2012, CURR DRUG SAF, V7, P106, DOI 10.2174/157488612802715663; Braun S, 2010, BRIT J ANAESTH, V105, P347, DOI 10.1093/bja/aeq169; CHANCE B, 1963, J BIOL CHEM, V238, P418; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Colleoni M, 1996, PHARMACOL TOXICOL, V78, P69, DOI 10.1111/j.1600-0773.1996.tb00182.x; Deng WB, 2010, EMBO REP, V11, P161, DOI 10.1038/embor.2010.15; DOMINO EF, 1982, ANESTH ANALG, V61, P87; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Flick RP, 2011, PEDIATRICS, V128, pE1053, DOI 10.1542/peds.2011-0351; Fredriksson A, 2004, BEHAV BRAIN RES, V153, P367, DOI 10.1016/j.bbr.2003.12.026; GRANT IS, 1983, BRIT J ANAESTH, V55, P1107, DOI 10.1093/bja/55.11.1107; Hanley PJ, 1998, J PHYSIOL-LONDON, V506, P231, DOI 10.1111/j.1469-7793.1998.231bx.x; Hroudova J, 2012, TOXICOL LETT, V213, P345, DOI 10.1016/j.toxlet.2012.07.017; Huang LN, 2012, BRAIN RES, V1476, P164, DOI 10.1016/j.brainres.2012.07.059; Ichinose S, 2010, LAB INVEST, V90, P210, DOI 10.1038/labinvest.2009.125; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; KISSIN I, 1983, ANESTHESIOLOGY, V59, P447, DOI 10.1097/00000542-198311000-00016; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kumar KK, 2012, NEUROTOXICOLOGY, V33, P518, DOI 10.1016/j.neuro.2012.02.005; Lee ST, 2009, BRIT J ANAESTH, V102, P80, DOI 10.1093/bja/aen322; Leist M, 2008, ALTEX-ALTERN TIEREXP, V25, P163; Liu WW, 2013, J BIOCHEM MOL TOXIC, V27, P17, DOI 10.1002/jbt.21470; Martinou I, 1999, J CELL BIOL, V144, P883, DOI 10.1083/jcb.144.5.883; McLean RF, 1996, CAN J ANAESTH, V43, P580, DOI 10.1007/BF03011770; Mouli PK, 2009, BIOPHYS J, V96, P3509, DOI 10.1016/j.bpj.2008.12.3959; Paule MG, 2011, NEUROTOXICOL TERATOL, V33, P220, DOI 10.1016/j.ntt.2011.01.001; Rintoul GL, 2010, BBA-MOL BASIS DIS, V1802, P143, DOI 10.1016/j.bbadis.2009.09.005; Slikker W, 2007, TOXICOL SCI, V98, P145, DOI 10.1093/toxsci/kfm084; STONG LJ, 1975, ANESTHESIOLOGY, V42, P123, DOI 10.1097/00000542-197502000-00003; Takadera T, 2006, TOXICOL APPL PHARM, V210, P100, DOI 10.1016/j.taap.2005.10.005; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Twig G, 2011, ANTIOXID REDOX SIGN, V14, P1939, DOI 10.1089/ars.2010.3779; Venancio C, 2015, ANESTH ANALG, V120, P320, DOI 10.1213/ANE.0000000000000539; Venancio C, 2013, LIFE SCI, V93, P464, DOI 10.1016/j.lfs.2013.08.001; Vojnits K, 2010, TOXICOLOGY, V270, P10, DOI 10.1016/j.tox.2009.12.003; Wang C, 2006, TOXICOL SCI, V91, P192, DOI 10.1093/toxsci/kfj144; Wang C, 2005, NEUROSCIENCE, V132, P967, DOI 10.1016/j.neuroscience.2005.01.053; Wang C, 2010, THESCIENTIFICWORLDJO, V10, P1473, DOI 10.1100/tsw.2010.118; Wei HF, 2011, ANESTH ANALG, V113, P972, DOI 10.1213/ANE.0b013e3182323261; Wilder RT, 2009, ANESTHESIOLOGY, V110, P796, DOI 10.1097/01.anes.0000344728.34332.5d; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Young C, 2005, BRIT J PHARMACOL, V146, P189, DOI 10.1038/sj.bjp.0706301; Zou XJ, 2009, INT J DEV NEUROSCI, V27, P727, DOI 10.1016/j.ijdevneu.2009.06.010	47	38	40	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128445	10.1371/journal.pone.0128445	http://dx.doi.org/10.1371/journal.pone.0128445			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020236	Green Published, Green Submitted, gold			2022-12-26	WOS:000355187300112
J	Kotomura, N; Harada, N; Ishihara, S				Kotomura, Naoe; Harada, Nobuhiro; Ishihara, Satoru			The Proportion of Chromatin Graded between Closed and Open States Determines the Level of Transcripts Derived from Distinct Promoters in the CYP19 Gene	PLOS ONE			English	Article							MAMMALIAN-CELLS; HUMAN GENOME; AROMATASE; EXPRESSION; BINDING; TISSUES; RECOGNITION; METHYLATION; TARGET	The human CYP19 gene encodes aromatase, which converts androgens to estrogens. CYP19 mRNA variants are transcribed mainly from three promoters. Quantitative RT-PCR was used to measure the relative amounts of each of the three transcripts and determine the on/off state of the promoters. While some of the promoters were silent, CYP19 mRNA production differed among the other promoters, whose estimated transcription levels were 0.001% to 0.1% of that of the TUBB control gene. To investigate the structural aspects of chromatin that were responsible for this wide range of activity of the CYP19 promoters, we used a fractionation protocol, designated SEVENS, which sequentially separates densely packed nucleosomes from dispersed nucleosomes. The fractional distribution of each inactive promoter showed a similar pattern to that of the repressed reference loci; the inactive regions were distributed toward lower fractions, in which closed chromatin comprising packed nucleosomes was enriched. In contrast, active CYP19 promoters were raised toward upper fractions, including dispersed nucleosomes in open chromatin. Importantly, these active promoters were moderately enriched in the upper fractions as compared to active reference loci, such as the TUBB promoter; the proportion of open chromatin appeared to be positively correlated to the promoter strength. These results, together with ectopic transcription accompanied by an increase in the proportion of open chromatin in cells treated with an H3K27me inhibitor, indicate that CYP19 mRNA could be transcribed from a promoter in which chromatin is shifted toward an open state in the equilibrium between closed and open chromatin.	[Kotomura, Naoe; Harada, Nobuhiro; Ishihara, Satoru] Fujita Hlth Univ, Sch Med, Dept Biochem, Toyoake, Aichi 47011, Japan	Fujita Health University	Ishihara, S (corresponding author), Fujita Hlth Univ, Sch Med, Dept Biochem, Toyoake, Aichi 47011, Japan.	satorui@fujita-hu.ac.jp			Japan Society for the Promotion of Science KAKENHI [22570006, 22591019, 22510219, 26430188]; Fujita Gakuen; Grants-in-Aid for Scientific Research [25461398] Funding Source: KAKEN	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Fujita Gakuen; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science KAKENHI grants (#22570006 to NK, #22591019 to NH, #22510219 and #26430188 to SI, URL: http://kaken.nii.ac.jp/) and Fujita Gakuen (to NH and SI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal VR, 1996, J CLIN ENDOCR METAB, V81, P3843, DOI 10.1210/jc.81.11.3843; Bai L, 2010, TRENDS GENET, V26, P476, DOI 10.1016/j.tig.2010.08.003; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; Cheng C, 2012, GENOME RES, V22, P1658, DOI 10.1101/gr.136838.111; Davuluri RV, 2008, TRENDS GENET, V24, P167, DOI 10.1016/j.tig.2008.01.008; Fiskus W, 2009, BLOOD, V114, P2733, DOI 10.1182/blood-2009-03-213496; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; HAN M, 1988, CELL, V55, P1137, DOI 10.1016/0092-8674(88)90258-9; Harada N, 1997, J STEROID BIOCHEM, V61, P175; Harada N, 2003, J STEROID BIOCHEM, V86, P327, DOI 10.1016/S0960-0760(03)00375-3; Hihara S, 2012, CELL REP, V2, P1645, DOI 10.1016/j.celrep.2012.11.008; Ishihara S, 2011, J IMMUNOL, V187, P3292, DOI 10.4049/jimmunol.1003173; Ishihara S, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq203; Karlic R, 2010, P NATL ACAD SCI USA, V107, P2926, DOI 10.1073/pnas.0909344107; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Lee D, 2002, J BIOL CHEM, V277, P22330, DOI 10.1074/jbc.M111987200; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; MEANS GD, 1991, MOL ENDOCRINOL, V5, P2005, DOI 10.1210/mend-5-12-2005; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; Mujtaba S, 2007, ONCOGENE, V26, P5521, DOI 10.1038/sj.onc.1210618; Ng HH, 2000, TRENDS BIOCHEM SCI, V25, P121; Nishi Y, 2001, ENDOCRINOLOGY, V142, P437, DOI 10.1210/en.142.1.437; Nowak DE, 2005, BIOTECHNIQUES, V39, P715, DOI 10.2144/000112014; PABO CO, 1992, ANNU REV BIOCHEM, V61, P1053, DOI 10.1146/annurev.bi.61.070192.005201; Santen RJ, 2009, ENDOCR REV, V30, P343, DOI 10.1210/er.2008-0016; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Schwabish MA, 2004, MOL CELL BIOL, V24, P10111, DOI 10.1128/MCB.24.23.10111-10117.2004; Stehr R, 2008, BIOPHYS J, V95, P3677, DOI 10.1529/biophysj.107.120543; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Torchia J, 1998, CURR OPIN CELL BIOL, V10, P373, DOI 10.1016/S0955-0674(98)80014-8; Vo N, 2001, J BIOL CHEM, V276, P13505, DOI 10.1074/jbc.R000025200; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Workman JL, 2006, GENE DEV, V20, P2009, DOI 10.1101/gad.1435706; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545	38	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128282	10.1371/journal.pone.0128282	http://dx.doi.org/10.1371/journal.pone.0128282			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020632	Green Submitted, Green Published, gold			2022-12-26	WOS:000355187300096
J	Cautain, B; de Pedro, N; Schulz, C; Pascual, J; Sousa, TD; Martin, J; Perez-Victoria, I; Asensio, F; Gonzalez, I; Bills, GF; Reyes, F; Genilloud, O; Vicente, F				Cautain, Bastien; de Pedro, Nuria; Schulz, Christian; Pascual, Javier; Sousa, Thiciana da S.; Martin, Jesus; Perez-Victoria, Ignacio; Asensio, Francisco; Gonzalez, Ignacio; Bills, Gerald F.; Reyes, Fernando; Genilloud, Olga; Vicente, Francisca			Identification of the Lipodepsipeptide MDN-0066, a Novel Inhibitor of VHL/HIF Pathway Produced by a New Pseudomonas Species	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; VON-HIPPEL-LINDAU; DNA-DAMAGE; NATURAL-PRODUCTS; PROLIFERATION; HIF; CHECKPOINTS; METABOLISM; REPAIR; DRUGS	Throughout recent history, metabolites of microbial origin have had an extraordinary impact on the welfare of humanity. In fact, natural products have largely been - and still are-considered an exceedingly valuable platform for the discovery of new drugs against diverse pathologies. Such value is partly due to their higher complexity and chemical diversity as compared to those of synthetic and combinatorial compounds. Mutations in the Von Hippel-Lindau (vhl) gene are responsible for VHL disease, congenital polycythemia, and are found in many sporadic tumor types. The primary cause of morbidity and mortality for these patients arises from progression of Renal Cell Carcinoma (RCC) or end-stage renal disease. Inactivation of the Von Hippel-Lindau (vhl) tumor suppressor gene arises in the majority of Renal Cell Carcinoma (RCC) as well as in other types of cancer and is associated with a high degree of vascularization and poor prognosis. Loss of pVHL function thus represents a pathognomonic molecular defect for therapeutic exploitation. In this study, renal carcinoma cell lines with naturally occurring vhl mutations (RCC4 VA) and their genetically matched wild-type vhl (RCC4 VHL) counterparts were seeded onto 96-well plates and treated with a collection of 1,040 organic extracts obtained from 130 bacterial strains belonging to at least 25 genera of the phyla Actinobacteria, Firmicutes, Proteobacteria and Bacteroidetes. This strategy allowed us to identify several extracts obtained from bacterial strain F-278,770(T), the type strain of the recently proposed new species Pseudomonas granadensis, showing biological activities not associated with previously known bioactive metabolites. The fractionation and structural elucidation of one of these extracts led to the discovery of a new lipodepsipeptide (MDN-0066) with specific toxicity in pVHL deficient cells that is not detectable in cells with pVHL expression rescue. This specific toxicity is associated with apoptosis induction in VHL deficient cell line as demonstrated with PARP activation and Annexin V staining. Our study demonstrated the feasibility of selectively targeting the loss of the vhl tumor suppressor gene for potential clinical benefit. Our results may have great impact on the development of new targeted therapies from natural products for the treatment of cancer and other genetic diseases.	[Cautain, Bastien; de Pedro, Nuria; Schulz, Christian; Pascual, Javier; Sousa, Thiciana da S.; Martin, Jesus; Perez-Victoria, Ignacio; Asensio, Francisco; Gonzalez, Ignacio; Bills, Gerald F.; Reyes, Fernando; Genilloud, Olga; Vicente, Francisca] Fdn MEDINA, Granada 18016, Spain		Cautain, B (corresponding author), Fdn MEDINA, Parque Tecnol Ciencias Salud,Avda Conocimiento 3, Granada 18016, Spain.	bastien.cautain@medinaandalucia.es	vicente, francisca/N-5126-2014; González, Ignacio/I-1089-2015; Reyes, Fernando/G-4027-2013; pascual, javier/M-5964-2019; Pérez-Victoria, Ignacio/I-1559-2015; Genilloud, Olga/I-2779-2015; Cautain, Bastien/W-1948-2018; Martín-Serrano, Jesús/M-1937-2014	vicente, francisca/0000-0003-3198-9205; González, Ignacio/0000-0002-8490-2401; Reyes, Fernando/0000-0003-1607-5106; pascual, javier/0000-0002-1900-7099; Pérez-Victoria, Ignacio/0000-0002-4556-688X; Genilloud, Olga/0000-0002-4202-1219; Martín-Serrano, Jesús/0000-0001-7487-2790; Cautain, Bastien/0000-0002-1324-3576; Bills, Gerald/0000-0003-2352-8417	Non-Oriented Basic Research Program of the Spanish Ministry of Science [SAF2010-15010]; Fundacion MEDINA; Merck Sharp & Dohme de Espana S.A./Universidad de Granada/Junta de Andalucia; MICINN [PCT-010000-2010-3, PCT-010000-2010-4, INP-2011-0016-PCT-010000-ACT7]	Non-Oriented Basic Research Program of the Spanish Ministry of Science; Fundacion MEDINA; Merck Sharp & Dohme de Espana S.A./Universidad de Granada/Junta de Andalucia; MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission)	This research was supported by the Non-Oriented Basic Research Program of the Spanish Ministry of Science (Project SAF2010-15010) and by Fundacion MEDINA, a public-private partnership of Merck Sharp & Dohme de Espana S.A./Universidad de Granada/Junta de Andalucia. In addition, the equipment used in this work was supported by MICINN (Grants PCT-010000-2010-3, PCT-010000-2010-4 and INP-2011-0016-PCT-010000-ACT7). The authors thank the administration of the Tejeda, Almijara and Alhama Natural Parks and the Sierra Nevada National Park for their permission to collect soil.	Banumathy G, 2010, CANCER BIOL THER, V10, P658, DOI 10.4161/cbt.10.7.13247; Berdy J, 2005, J ANTIBIOT, V58, P1, DOI 10.1038/ja.2005.1; Beutler JA, 2009, CURR PROTOC PHARM, V9; Cautain B, 2013, ADV BIOSCIENCE BIOTE, V4, P398; Coleman ML, 2009, CURR PHARM DESIGN, V15, P3904, DOI 10.2174/138161209789649448; Demain AL, 2009, J ANTIBIOT, V62, P5, DOI 10.1038/ja.2008.16; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Genilloud O, 2012, RSC SERIES; GNARRA JR, 1995, SEMIN ONCOL, V22, P3; Goda N, 2003, MOL CELL BIOL, V23, P359, DOI 10.1128/MCB.23.1.359-369.2003; Gordan JD, 2007, CANCER CELL, V12, P108, DOI 10.1016/j.ccr.2007.07.006; Gossage L, 2010, NAT REV CLIN ONCOL, V7, P277, DOI 10.1038/nrclinonc.2010.42; HARTWELL L, 1992, CELL, V71, P543, DOI 10.1016/0092-8674(92)90586-2; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hill R, 2014, ONCOTARGET, V5, P11, DOI 10.18632/oncotarget.1457; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; MARFEY P, 1984, CARLSBERG RES COMMUN, V49, P591, DOI 10.1007/BF02908688; Matsui S, 2002, MAMM GENOME, V13, P680, DOI 10.1007/s00335-002-2197-0; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Newlands ES, 1996, BRIT J CANCER, V74, P648, DOI 10.1038/bjc.1996.415; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Newman DJ, 2009, CURR OPIN INVEST DR, V10, P1280; Nordstrom-O'Brien M, 2010, HUM MUTAT, V31, P521, DOI 10.1002/humu.21219; Pascual J, 2015, INT J SYST EVOL MICR, V65, P625, DOI 10.1099/ijs.0.069260-0; Pause A, 1998, P NATL ACAD SCI USA, V95, P993, DOI 10.1073/pnas.95.3.993; Raaijmakers JM, 2006, MOL PLANT MICROBE IN, V19, P699, DOI 10.1094/MPMI-19-0699; Raaijmakers JM, 2010, FEMS MICROBIOL REV, V34, P1037, DOI 10.1111/j.1574-6976.2010.00221.x; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Singh SB, 2013, J NAT PROD, V76, P334, DOI 10.1021/np300704s; Turcotte S, 2008, CANCER CELL, V14, P90, DOI 10.1016/j.ccr.2008.06.004; Webb JD, 2009, CELL MOL LIFE SCI, V66, P3539, DOI 10.1007/s00018-009-0147-7; Weinert T, 1998, CELL, V94, P555, DOI 10.1016/S0092-8674(00)81597-4; Zhang Y, 2007, RADIAT RES, V168, P115, DOI 10.1667/RR0811.1; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	34	28	28	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0125221	10.1371/journal.pone.0125221	http://dx.doi.org/10.1371/journal.pone.0125221			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018559	gold, Green Published, Green Submitted			2022-12-26	WOS:000355185600012
J	Matsuo, Y; Watanabe, M; Taniike, M; Mohri, I; Kobashi, S; Tachibana, M; Kobayashi, Y; Kitamura, Y				Matsuo, Yuka; Watanabe, Masayuki; Taniike, Masako; Mohri, Ikuko; Kobashi, Syoji; Tachibana, Masaya; Kobayashi, Yasushi; Kitamura, Yuri			Gap Effect Abnormalities during a Visually Guided Pro-Saccade Task in Children with Attention Deficit Hyperactivity Disorder	PLOS ONE			English	Article							MONKEY SUPERIOR COLLICULUS; DEFICIT/HYPERACTIVITY DISORDER; EYE-MOVEMENTS; BASAL GANGLIA; VOLITIONAL ACTIONS; VOLUNTARY CONTROL; DOPAMINE THEORY; REACTION-TIME; NEUROBIOLOGY; ADHD	Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder that starts in early childhood and has a comprehensive impact on psychosocial activity and education as well as general health across the lifespan. Despite its prevalence, the current diagnostic criteria for ADHD are debated. Saccadic eye movements are easy to quantify and may be a quantitative biomarker for a wide variety of neurological and psychiatric disorders, including ADHD. The goal of this study was to examine whether children with ADHD exhibit abnormalities during a visually guided pro-saccadic eye-movement and to clarify the neurophysiological mechanisms associated with their behavioral impairments. Thirty-seven children with ADHD (aged 5-11 years) and 88 typically developing (TD) children (aged 5-11 years) were asked to perform a simple saccadic eye-movement task in which step and gap conditions were randomly interleaved. We evaluated the gap effect, which is the difference in the reaction time between the two conditions. Children with ADHD had a significantly longer reaction time than TD children (p < 0.01) and the gap effect was markedly attenuated (p < 0.01). These results suggest that the measurement of saccadic eye movements may provide a novel method for evaluating the behavioral symptoms and clinical features of ADHD, and that the gap effect is a potential biomarker for the diagnosis of ADHD in early childhood.	[Matsuo, Yuka; Kitamura, Yuri] Osaka Univ, Grad Sch Med, Dept Social & Environm Med, Suita, Osaka, Japan; [Watanabe, Masayuki] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Taniike, Masako; Mohri, Ikuko] Osaka Univ, United Grad Sch Child Dev, Mol Res Ctr Childrens Mental Dev, Suita, Osaka, Japan; [Kobashi, Syoji] Univ Hyogo, Grad Sch Engn, Dept Elect Engn & Comp Sci, Himeji, Hyogo 6712201, Japan; [Tachibana, Masaya] Mayo Clin Florida, Dept Neurosci, Jacksonville, FL USA; [Kobayashi, Yasushi] Osaka Univ, Grad Sch Frontier Biosci, Visual Neurosci Lab, Suita, Osaka, Japan; [Kobayashi, Yasushi] Natl Inst Informat & Communicat Technol, Ctr Informat & Neural Networks, Suita, Osaka, Japan; [Kobayashi, Yasushi] Osaka Univ, Suita, Osaka, Japan	Osaka University; Queens University - Canada; Osaka University; University of Hyogo; Mayo Clinic; Osaka University; National Institute of Information & Communications Technology (NICT) - Japan; Osaka University	Kitamura, Y (corresponding author), Osaka Univ, Grad Sch Med, Dept Social & Environm Med, Suita, Osaka, Japan.	ytkitamura@envi.med.osaka-u.ac.jp	Tachibana, Masaya/AAW-3526-2020; Kobashi, Syoji/O-7773-2016	Tachibana, Masaya/0000-0002-6761-7158; Kobashi, Syoji/0000-0003-3659-4114; Kobayashi, Yasushi/0000-0002-2690-6527	Japan Society for the Promotion of Science (JSPS) KAKENHI [21610011]; Precursory Research for Embryonic Science and Technology (PRESTO) of Japan Science and Technology (JST); Kato Memorial Trust for NAMBYO Research; Grants-in-Aid for Scientific Research [15H02669] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Precursory Research for Embryonic Science and Technology (PRESTO) of Japan Science and Technology (JST)(Japan Science & Technology Agency (JST)); Kato Memorial Trust for NAMBYO Research(Kato Memorial Trust for Nambyo Research); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant 21610011 and Precursory Research for Embryonic Science and Technology (PRESTO) of Japan Science and Technology (JST) and The Kato Memorial Trust for NAMBYO Research 2010 to Yuri Kitamura, Yasushi Kobayashi, and Yuri Kitamura, respectively. The funders had no role in study design, data collection and analylsis, decision to publish, or preparation of the manuscript.	Achenbach T. M., 2000, MANUAL ASEBA SCH AGE; American Psychiatric, 2000, DIAGN STAT MAN MENT; Arnsten AF, 2009, J PEDIAT, V154; Banaschewski T, 2008, BIOL PSYCHOL, V77, P53, DOI 10.1016/j.biopsycho.2007.09.003; Biederman J, 2002, J Atten Disord, V6 Suppl 1, pS7; Biederman J, 2001, J CLIN CHILD PSYCHOL, V30, P492, DOI 10.1207/S15374424JCCP3004_06; Bucci MP, 2012, EXP BRAIN RES, V222, P21, DOI 10.1007/s00221-012-3192-7; Cairney S, 2001, EXP BRAIN RES, V141, P507, DOI 10.1007/s002210100890; Carpenter RHS, 2000, CURR BIOL, V10, pR291, DOI 10.1016/S0960-9822(00)00430-9; Castellanos FX, 1996, ARCH GEN PSYCHIAT, V53, P607; Connor DF, 2002, J DEV BEHAV PEDIATR, V23, pS1, DOI 10.1097/00004703-200202001-00002; Curatolo P, 2009, EUR J PAEDIATR NEURO, V13, P299, DOI 10.1016/j.ejpn.2008.06.003; Dorris MC, 2002, J COGNITIVE NEUROSCI, V14, P1256, DOI 10.1162/089892902760807249; Dorris MC, 1997, J NEUROSCI, V17, P8566; DuPaul GJ, 2003, PSYCHOL ASSESSMENT, V15, P115, DOI 10.1037/1040-3590.15.1.115; Faraone Stephen V, 2003, World Psychiatry, V2, P104; Faraone SV, 1998, BIOL PSYCHIAT, V44, P951, DOI 10.1016/S0006-3223(98)00240-6; Feifel D, 2004, BIOL PSYCHIAT, V56, P333, DOI 10.1016/j.biopsych.2004.06.019; Fukushima J, 2000, BRAIN DEV-JPN, V22, P173, DOI 10.1016/S0387-7604(00)00101-7; Gooding DC, 2008, BRAIN COGNITION, V68, P371, DOI 10.1016/j.bandc.2008.08.024; Goto Y, 2010, BRAIN DEV-JPN, V32, P347, DOI 10.1016/j.braindev.2009.04.017; Hikosaka O, 2000, PHYSIOL REV, V80, P953, DOI 10.1152/physrev.2000.80.3.953; Hikosaka O, 1998, ADV BIOPHYS, V35, P81, DOI 10.1016/S0065-227X(98)80004-X; Himelstein J, 2000, FRONT BIOSCI, V5, pD461, DOI 10.2741/Himelste; Karatekin C, 2010, SCHIZOPHRENIA BULL, V36, P1167, DOI 10.1093/schbul/sbp035; Klein C, 2003, PSYCHOPHYSIOLOGY, V40, P17, DOI 10.1111/1469-8986.00003; Klein C, 2002, EXP BRAIN RES, V145, P121, DOI 10.1007/s00221-002-1105-x; Levy F, 2001, AUST NZ J PSYCHIAT, V35, P504, DOI 10.1046/j.1440-1614.2001.00923.x; LEVY F, 1991, AUST NZ J PSYCHIAT, V25, P277, DOI 10.3109/00048679109077746; Mahone EM, 2009, J AM ACAD CHILD PSY, V48, P749, DOI 10.1097/CHI.0b013e3181a565f1; MATTES JA, 1980, COMPR PSYCHIAT, V21, P358, DOI 10.1016/0010-440X(80)90017-6; McLoughlin G, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-66; MIYASHITA Y, 1980, BRAIN RES, V198, P210, DOI 10.1016/0006-8993(80)90357-1; Mostofsky SH, 2001, J AM ACAD CHILD PSY, V40, P1464, DOI 10.1097/00004583-200112000-00018; MUNOZ DP, 1992, J NEUROPHYSIOL, V67, P1000, DOI 10.1152/jn.1992.67.4.1000; MUNOZ DP, 1995, J NEUROPHYSIOL, V73, P2334, DOI 10.1152/jn.1995.73.6.2334; MUNOZ DP, 1995, J NEUROPHYSIOL, V73, P2313, DOI 10.1152/jn.1995.73.6.2313; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; Munoz DP, 2002, PROG BRAIN RES, V140, P3; Munoz DP, 2003, J NEUROPHYSIOL, V90, P503, DOI 10.1152/jn.00192.2003; Munoz DP, 1998, EXP BRAIN RES, V121, P391, DOI 10.1007/s002210050473; Narbona-Garcia J, 1999, Rev Neurol, V28 Suppl 2, pS160; O'Driscoll GA, 2005, BIOL PSYCHIAT, V57, P1452, DOI 10.1016/j.biopsych.2005.02.029; Ohnishi M, 2010, RES DEV DISABIL, V31, P1305, DOI 10.1016/j.ridd.2010.07.011; Pare M, 2001, EXP BRAIN RES, V137, P354, DOI 10.1007/s002210000647; Pare M, 1996, J NEUROPHYSIOL, V76, P3666, DOI 10.1152/jn.1996.76.6.3666; Peltsch A, 2008, EXP BRAIN RES, V186, P457, DOI 10.1007/s00221-007-1248-x; Renner TJ, 2008, NERVENARZT, V79, P771, DOI 10.1007/s00115-008-2513-3; Rommelse NNJ, 2008, BRAIN COGNITION, V68, P391, DOI 10.1016/j.bandc.2008.08.025; Russell VA, 2007, J NEUROSCI METH, V161, P185, DOI 10.1016/j.jneumeth.2006.12.005; Tani I, 2010, RES DEV DISABIL, V31, P1426, DOI 10.1016/j.ridd.2010.06.016; Tannock R, 1998, J CHILD PSYCHOL PSYC, V39, P65, DOI 10.1017/S0021963097001777; Temel Y, 2009, EXP NEUROL, V216, P481, DOI 10.1016/j.expneurol.2009.01.007; Tinsley CJ, 2002, PROG BRAIN RES, V140, P61; Trappenberg TP, 2001, J COGNITIVE NEUROSCI, V13, P256, DOI 10.1162/089892901564306; Valera EM, 2007, BIOL PSYCHIAT, V61, P1361, DOI 10.1016/j.biopsych.2006.06.011; Watanabe M, 2014, EUR J NEUROSCI, V39, P2098, DOI 10.1111/ejn.12566; Watanabe M, 2010, J NEUROSCI, V30, P10144, DOI 10.1523/JNEUROSCI.1738-10.2010; Watanabe M, 2009, EUR J NEUROSCI, V30, P2165, DOI 10.1111/j.1460-9568.2009.06998.x; Wickens JR, 2007, J NEUROSCI METH, V166, P293, DOI 10.1016/j.jneumeth.2007.09.011; World Health Organization, 1990, INT CLASS DIS, V10th; Zwicker JG, 2009, J CHILD NEUROL, V24, P1273, DOI 10.1177/0883073809333537	63	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0125573	10.1371/journal.pone.0125573	http://dx.doi.org/10.1371/journal.pone.0125573			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018057	Green Published, Green Submitted, gold			2022-12-26	WOS:000355185600028
J	Quillfeldt, P; Cherel, Y; Masello, JF; Delord, K; McGill, RAR; Furness, RW; Moodley, Y; Weimerskirch, H				Quillfeldt, Petra; Cherel, Yves; Masello, Juan F.; Delord, Karine; McGill, Rona A. R.; Furness, Robert W.; Moodley, Yoshan; Weimerskirch, Henri			Half a World Apart? Overlap in Nonbreeding Distributions of Atlantic and Indian Ocean Thin-Billed Prions	PLOS ONE			English	Article							TRANS-EQUATORIAL MIGRATION; THEMISTO-GAUDICHAUDII; PACHYPTILA-BELCHERI; ROUND DISTRIBUTION; WINTERING AREAS; STABLE-ISOTOPES; FEEDING ECOLOGY; FORAGING AREAS; SMALL PETREL; FOOD-WEB	Distant populations of animals may share their non-breeding grounds or migrate to distinct areas, and this may have important consequences for population differentiation and dynamics. Small burrow-nesting seabirds provide a suitable case study, as they are often restricted to safe breeding sites on islands, resulting in a patchy breeding distribution. For example, Thin-billed prions Pachyptila belcheri have two major breeding colonies more than 8,000 km apart, on the Falkland Islands in the south-western Atlantic and in the Kerguelen Archipelago in the Indian Ocean. We used geolocators and stable isotopes to compare at-sea movements and trophic levels of these two populations during their nonbreeding season, and applied ecological niche models to compare environmental conditions in the habitat. Over three winters, birds breeding in the Atlantic showed a high consistency in their migration routes. Most individuals migrated more than 3000 km eastwards, while very few remained over the Patagonian Shelf. In contrast, all Indian Ocean birds migrated westwards, resulting in an overlapping nonbreeding area in the eastern Atlantic sector of the Southern Ocean. Geolocators and isotopic signature of feathers indicated that prions from the Falklands moulted at slightly higher latitudes than those from Kerguelen Islands. All birds fed on low trophic level prey, most probably crustaceans. The phenology differed notably between the two populations. Falkland birds returned to the Patagonian Shelf after 2-3 months, while Kerguelen birds remained in the nonbreeding area for seven months, before returning to nesting grounds highly synchronously and at high speed. Habitat models identified sea surface temperature and chlorophyll a concentration as important environmental parameters. In summary, we show that even though the two very distant populations migrate to roughly the same area to moult, they have distinct wintering strategies: They had significantly different realized niches and timing which may contribute to spatial niche partitioning.	[Quillfeldt, Petra; Masello, Juan F.] Univ Giessen, Dept Anim Ecol & Systemat, D-35392 Giessen, Germany; [Quillfeldt, Petra; Cherel, Yves; Delord, Karine; Weimerskirch, Henri] Univ La Rochelle, CNRS, Ctr Etud Biol Chize, UMR 7372, F-79360 Villiers En Bois, France; [McGill, Rona A. R.] Scottish Univ, Environm Res Ctr, Life Sci Mass Spectrometry Facil, Glasgow G75 0QF, Lanark, Scotland; [Furness, Robert W.] Univ Glasgow, Coll Med Vet & Life Sci, Glasgow G12 8QQ, Lanark, Scotland; [Moodley, Yoshan] Univ Vet Med Vienna, Konrad Lorenz Inst Ethol, A-1160 Vienna, Austria	Justus Liebig University Giessen; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); La Rochelle Universite; Scottish Universities Research & Reactor Center; University of Glasgow; University of Veterinary Medicine Vienna	Quillfeldt, P (corresponding author), Univ Giessen, Dept Anim Ecol & Systemat, D-35392 Giessen, Germany.	Petra.Quillfeldt@bio.uni-giessen.de	Quillfeldt, Petra/A-9549-2009; McGill, Rona/F-1793-2010; Weimerskirch, Henri/K-7306-2019; Weimerskirch, Henri/F-5562-2013; Masello, Juan/C-7133-2009	Quillfeldt, Petra/0000-0002-4450-8688; McGill, Rona/0000-0003-0400-7288; Weimerskirch, Henri/0000-0002-0457-586X; Masello, Juan/0000-0002-6826-4016; Moodley, Yoshan/0000-0003-4216-2924	German Science Foundation DFG [Qu 148/5]; IPEV [109]; NERC Grant [NE/I02237X/1]; Natural Environment Research Council [NE/I02237X/1, lsmsf010002] Funding Source: researchfish; NERC [lsmsf010002, NE/I02237X/1] Funding Source: UKRI	German Science Foundation DFG(German Research Foundation (DFG)); IPEV; NERC Grant(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Grants were provided by the German Science Foundation DFG (Qu 148/5). Fieldwork at Kerguelen was supported by IPEV (Programme 109 to HW). RWF was supported by NERC Grant NE/I02237X/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acha EM, 2004, J MARINE SYST, V44, P83, DOI 10.1016/j.jmarsys.2003.09.005; [Anonymous], 2014, R LANG ENV STAT COMP; Bearhop S, 2002, PHYSIOL BIOCHEM ZOOL, V75, P451, DOI 10.1086/342800; Becker BH, 2007, CONDOR, V109, P451, DOI 10.1650/0010-5422(2007)109[451:DSINAC]2.0.CO;2; Beyer HL, 2004, HAWTHS ANAL TOOLS AR; Bocher P, 2001, MAR ECOL PROG SER, V223, P261, DOI 10.3354/meps223261; Bridge Eli S., 2006, Marine Ornithology, V34, P7; Brooke ML., 2004, ALBATROSSES PETRELS; Chapman BB, 2011, OIKOS, V120, P1764, DOI 10.1111/j.1600-0706.2011.20131.x; Cherel Y, 2002, MAR ECOL PROG SER, V228, P263, DOI 10.3354/meps228263; Cherel Y, 2014, MAR ECOL PROG SER, V505, P267, DOI 10.3354/meps10795; Cherel Y, 2010, LIMNOL OCEANOGR, V55, P324, DOI 10.4319/lo.2010.55.1.0324; De Solla SR, 1999, J ANIM ECOL, V68, P221, DOI 10.1046/j.1365-2656.1999.00279.x; Dong SF, 2006, J PHYS OCEANOGR, V36, P2075, DOI 10.1175/JPO2973.1; Egevang C, 2010, P NATL ACAD SCI USA, V107, P2078, DOI 10.1073/pnas.0909493107; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Friesen VL, 2007, MOL ECOL, V16, P1765, DOI 10.1111/j.1365-294X.2006.03197.x; Gonzalez-Solis J, 2007, FRONT ECOL ENVIRON, V5, P297, DOI 10.1890/1540-9295(2007)5[297:TMAMIT]2.0.CO;2; Gonzalez-Solis J, 2009, MAR ECOL PROG SER, V391, P221, DOI 10.3354/meps08128; Guilford T, 2009, P ROY SOC B-BIOL SCI, V276, P1215, DOI 10.1098/rspb.2008.1577; Hedd A, 2012, MAR ECOL PROG SER, V449, P277, DOI 10.3354/meps09538; HOBSON KA, 1992, CONDOR, V94, P181, DOI 10.2307/1368807; Jaeger A, 2010, RAPID COMMUN MASS SP, V24, P3456, DOI 10.1002/rcm.4792; Kane J. E., 1966, Discovery Reports, V34, P163; Marchant S., 1990, HDB AUSTR NZ ANTARCT, V1; Martin TG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000751; Masello JF, 2010, ECOSPHERE, V1, DOI 10.1890/ES10-00103.1; Mateos M, 2011, MAR BIOL, V158, P329, DOI 10.1007/s00227-010-1561-y; Michalik A, 2010, RAPID COMMUN MASS SP, V24, P875, DOI 10.1002/rcm.4462; Navarro J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062897; Newton I., 2010, BIRD MIGRATION; Nussey DH, 2005, SCIENCE, V310, P304, DOI 10.1126/science.1117004; Padovani LN, 2012, J SEA RES, V67, P85, DOI 10.1016/j.seares.2011.10.007; Pakhomov EA, 2000, DEEP-SEA RES PT I, V47, P1663, DOI 10.1016/S0967-0637(99)00122-3; Pakhomov EA, 1996, POLAR BIOL, V16, P271, DOI 10.1007/s003000050054; Phillips RA, 2004, MAR ECOL PROG SER, V266, P265, DOI 10.3354/meps266265; Putz K, 2006, POLAR BIOL, V29, P735, DOI 10.1007/s00300-006-0110-0; Quillfeldt P, 2003, POLAR BIOL, V26, P746, DOI 10.1007/s00300-003-0544-6; Quillfeldt P, 2014, J AVIAN BIOL, V45, P315, DOI 10.1111/jav.00307; Quillfeldt P, 2013, J BIOGEOGR, V40, P430, DOI 10.1111/jbi.12008; Quillfeldt P, 2012, MAR BIOL, V159, P1809, DOI 10.1007/s00227-012-1971-0; Quillfeldt P, 2010, MAR BIOL, V157, P2043, DOI 10.1007/s00227-010-1472-y; Quillfeldt P, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-15; Quillfeldt P, 2010, BEHAV ECOL SOCIOBIOL, V64, P1157, DOI 10.1007/s00265-010-0931-2; Quillfeldt P, 2008, MAR ECOL PROG SER, V373, P137, DOI 10.3354/meps07751; Rayner MJ, 2012, EMU, V112, P107, DOI 10.1071/MU11066; RIDOUX V, 1989, POLAR BIOL, V9, P137, DOI 10.1007/BF00297168; Schreiber Elizabeth, 2002, BIOL MARINE BIRDS, DOI 10.1201/9781420036305; Shaffer SA, 2006, P NATL ACAD SCI USA, V103, P12799, DOI 10.1073/pnas.0603715103; Sprintall J, 2008, PROG OCEANOGR, V77, P316, DOI 10.1016/j.pocean.2006.06.004; Thiebot JB, 2012, ECOLOGY, V93, P122, DOI 10.1890/11-0385.1; THOMPSON KR, 1992, IBIS, V134, P11, DOI 10.1111/j.1474-919X.1992.tb07223.x; Tyberghein L, 2012, GLOBAL ECOL BIOGEOGR, V21, P272, DOI 10.1111/j.1466-8238.2011.00656.x; Webster MS, 2002, TRENDS ECOL EVOL, V17, P76, DOI 10.1016/S0169-5347(01)02380-1; Weiss F, 2009, POLAR BIOL, V32, P1753, DOI 10.1007/s00300-009-0674-6	55	19	19	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0125007	10.1371/journal.pone.0125007	http://dx.doi.org/10.1371/journal.pone.0125007			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018194	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000355185600009
J	Verde, Z; Reinoso, L; Chicharro, LM; Resano, P; Sanchez-Hernandez, I; Gonzalez-Moro, JMR; Bandres, F; Gomez-Gallego, F; Santiago, C				Verde, Zoraida; Reinoso, Luis; Chicharro, Luis Miguel; Resano, Pilar; Sanchez-Hernandez, Ignacio; Gonzalez-Moro, Jose Miguel Rodriguez; Bandres, Fernando; Gomez-Gallego, Felix; Santiago, Catalina			Are SNP-Smoking Association Studies Needed in Controls? DNA Repair Gene Polymorphisms and Smoking Intensity	PLOS ONE			English	Article							LUNG-CANCER RISK; ENVIRONMENT INTERACTIONS; APE1 ASP148GLU; XPD; VARIANTS; XRCC1; POPULATION; ADDUCTS; PATHWAY; ERCC2	Variations in tobacco-related cancers, incidence and prevalence reflect differences in tobacco consumption in addition to genetic factors. Besides, genes related to lung cancer risk could be related to smoking behavior. Polymorphisms altering DNA repair capacity may lead to synergistic effects with tobacco carcinogen-induced lung cancer risk. Common problems in genetic association studies, such as presence of gene-by-environment (G x E) correlation in the population, may reduce the validity of these designs. The main purpose of this study was to evaluate the independence assumption for selected SNPs and smoking behaviour in a cohort of 320 healthy Spanish smokers. We found an association between the wild type alleles of XRCC3 Thr241Met or KLC3 Lys751Gln and greater smoking intensity (OR = 12.98, 95% CI = 2.86-58.82 and OR=16.90, 95% CI=2.09-142.8; respectively). Although preliminary, the results of our study provide evidence that genetic variations in DNA-repair genes may influence both smoking habits and the development of lung cancer. Population-specific G x E studies should be carried out when genetic and environmental factors interact to cause the disease.	[Verde, Zoraida; Reinoso, Luis; Chicharro, Luis Miguel] Univ Europea, Dept Morphol Sci & Biomed, Madrid, Spain; [Reinoso, Luis] Dept Occupat Hlth, Grp Banco Popular, Madrid, Spain; [Resano, Pilar] Hosp Guadalajara, Dept Neumol, Guadalajara, Spain; [Sanchez-Hernandez, Ignacio] Hosp Carlos III, Dept Neumol, Madrid, Spain; [Gonzalez-Moro, Jose Miguel Rodriguez] Hosp Gregorio Maranon, Dept Neumol, Madrid, Spain; [Bandres, Fernando] Univ Complutense, Dept Toxicol & Hlth Sanit, E-28040 Madrid, Spain; [Gomez-Gallego, Felix; Santiago, Catalina] Univ Europea, Sch Doctoral Studies & Res, Madrid, Spain	Hospital Carlos III; General University Gregorio Maranon Hospital; Complutense University of Madrid	Verde, Z (corresponding author), Univ Europea, Dept Morphol Sci & Biomed, Madrid, Spain.	zoraida.verde@uem.es	Gomez-Gallego, Felix/H-6925-2013; Santiago, Catalina/P-8177-2019; Gomez-Gallego, Felix/AAD-9617-2020; VERDE, ZORAIDA/A-9914-2012	Gomez-Gallego, Felix/0000-0002-1968-1761; Santiago, Catalina/0000-0003-3852-8217; VERDE, ZORAIDA/0000-0002-9260-7672; Rodriguez Gonzalez-Moro, Jose Miguel/0000-0002-8446-3373; BANDRES MOYA, FERNANDO/0000-0002-4675-8226	Universidad Europea, Madrid [2012/UEM17]; Catedra Florencio Tejerina-UEM [2010/UEM19]	Universidad Europea, Madrid; Catedra Florencio Tejerina-UEM	This study was supported by a grant from Universidad Europea, Madrid (project number 2012/UEM17) and Catedra Florencio Tejerina-UEM (project number 2010/UEM19). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert PS, 2001, AM J EPIDEMIOL, V154, P687, DOI 10.1093/aje/154.8.687; Attia J, 2009, JAMA-J AM MED ASSOC, V301, P304, DOI 10.1001/jama.2008.993; Buch SC, 2012, MOL CARCINOGEN, V51, pE11, DOI 10.1002/mc.20858; Cai LY, 2014, TUMOR BIOL, V35, P5237, DOI 10.1007/s13277-014-1681-y; CAPORASO N, 1991, PHARMACOGENETICS, V1, P4, DOI 10.1097/00008571-199110000-00003; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Dong ZM, 2008, J CLIN GASTROENTEROL, V42, P910, DOI 10.1097/MCG.0b013e3180f6262c; Duell EJ, 2000, CARCINOGENESIS, V21, P965, DOI 10.1093/carcin/21.5.965; Lopez-Cima MF, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-433; Frosina G, 2004, FREE RADICAL RES, V38, P1037, DOI 10.1080/10715760400011445; Hafeman DM, 2011, EPIDEMIOLOGY, V22, P753, DOI 10.1097/EDE.0b013e3181c311b2; Hecht SS, 1999, JNCI-J NATL CANCER I, V91, P1194, DOI 10.1093/jnci/91.14.1194; Hodgson ME, 2010, CANCER EPIDEM BIOMAR, V19, P3055, DOI 10.1158/1055-9965.EPI-10-0877; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Hoffmann H, 2005, MUTAGENESIS, V20, P455, DOI 10.1093/mutage/gei064; Hung RJ, 2005, AM J EPIDEMIOL, V162, P925, DOI 10.1093/aje/kwi318; Ito H, 2004, CARCINOGENESIS, V25, P1395, DOI 10.1093/carcin/bgh153; Kazma R, 2012, HUM HERED, V74, P205, DOI 10.1159/000346825; Kazma R, 2012, CARCINOGENESIS, V33, P1059, DOI 10.1093/carcin/bgs116; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kogevinas M, 2005, CANC LAB ESPANA; Lazary Judit, 2011, Neuropsychopharmacol Hung, V13, P7; Leitch DN, 2005, RESP MED, V99, P32, DOI 10.1016/j.rmed.2004.03.027; Lessov-Schlaggar CN, 2008, BIOCHEM PHARMACOL, V75, P178, DOI 10.1016/j.bcp.2007.08.018; Letkova L, 2013, MOL BIOL REP, V40, P5261, DOI 10.1007/s11033-013-2626-z; Li WY, 2014, ONCOL LETT, V8, P1725, DOI 10.3892/ol.2014.2351; Li WS, 2014, GENE, V538, P361, DOI 10.1016/j.gene.2013.12.028; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lopez-Cima MF, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-162; Lu XB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060006; Lunn RM, 2000, CARCINOGENESIS, V21, P551, DOI 10.1093/carcin/21.4.551; Matullo G, 2006, CARCINOGENESIS, V27, P997, DOI 10.1093/carcin/bgi280; Matullo G, 2001, INT J CANCER, V92, P562, DOI 10.1002/ijc.1228; Matullo G, 2001, CARCINOGENESIS, V22, P1437, DOI 10.1093/carcin/22.9.1437; Mohrenweiser Harvey W, 2004, Toxicol Pathol, V32 Suppl 1, P136, DOI 10.1080/01926230490424671; Peluso M, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/386798; Popanda O, 2004, CARCINOGENESIS, V25, P2433, DOI 10.1093/carcin/bgh264; Taylor EM, 1997, P NATL ACAD SCI USA, V94, P8658, DOI 10.1073/pnas.94.16.8658; Uppal Vibha, 2014, J Clin Diagn Res, V8, pCC17, DOI 10.7860/JCDR/2014/10061.5132; US Department of Health Human Services, 2014, HLTH CONSMOK 50 YE, P17, DOI DOI 10.1037/E510072014-001; Verde Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026668; Verde Z, 2009, THROMB HAEMOSTASIS, V101, P591, DOI 10.1160/TH08-09-0578; Vineis P, 2009, JNCI-J NATL CANCER I, V101, P24, DOI 10.1093/jnci/djn437; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Wang R, 2014, SCIENCE, V346, P1127, DOI 10.1126/science.1258973; Wang RT, 2014, TUMOR BIOL, V35, P1739, DOI 10.1007/s13277-013-1435-2; Wilding CS, 2005, MUTAT RES-FUND MOL M, V570, P137, DOI 10.1016/j.mrfmmm.2004.11.002; Wilson DM, 2003, J MOL BIOL, V330, P1027, DOI 10.1016/S0022-2836(03)00712-5; Wood RD, 2005, MUTAT RES-FUND MOL M, V577, P275, DOI 10.1016/j.mrfmmm.2005.03.007; World Health Organization, 2008, WHO REP GLOB TOB EP; Xing DY, 2002, LUNG CANCER-J IASLC, V38, P123, DOI 10.1016/S0169-5002(02)00184-8; Zienolddiny S, 2006, CARCINOGENESIS, V27, P560, DOI 10.1093/carcin/bgi232	52	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0129374	10.1371/journal.pone.0129374	http://dx.doi.org/10.1371/journal.pone.0129374			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26017978	Green Published, Green Submitted, gold			2022-12-26	WOS:000355185600128
J	Ye, J; Nielsen, S; Joseph, S; Thomas, T				Ye, Jun; Nielsen, Shaun; Joseph, Stephen; Thomas, Torsten			High-Resolution and Specific Detection of Bacteria on Complex Surfaces Using Nanoparticle Probes and Electron Microscopy	PLOS ONE			English	Article							SITU HYBRIDIZATION FISH; PHYLOGENETIC IDENTIFICATION; COMBINING FLUORESCENCE; MICROBIAL-CELLS; SOIL; MICROORGANISMS; NANOGOLD	The study of the interaction of bacteria with surfaces requires the detection of specific bacterial groups with high spatial resolution. Here, we describe a method to rapidly and efficiently add nanogold particles to oligonucleotide probes, which target bacterial ribosomal RNA. These nanogold-labeled probes are then used in an in situ hybridization procedure that ensures both cellular integrity and high specificity. Electron microscopy subsequently enables the visualization of specific cells with high local precision on complex surface structures. This method will contribute to an increased understanding of how bacteria interact with surface structures on a sub-micron scale.	[Ye, Jun; Nielsen, Shaun; Thomas, Torsten] Univ New S Wales, Ctr Marine Bioinnovat, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Joseph, Stephen] Univ New S Wales, Sch Mat Sci & Engn, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney	Thomas, T (corresponding author), Univ New S Wales, Ctr Marine Bioinnovat, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia.	t.thomas@unsw.edu.au	YE, JUN/B-1801-2018	YE, JUN/0000-0002-6476-6406; Thomas, Torsten/0000-0001-9557-3001	Australian Research Council	Australian Research Council(Australian Research Council)	The study was supported by the Australian Research Council. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alivisatos AP, 1996, NATURE, V382, P609, DOI 10.1038/382609a0; AMANN RI, 1990, J BACTERIOL, V172, P762, DOI 10.1128/jb.172.2.762-770.1990; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Amann R, 2008, NAT REV MICROBIOL, V6, P339, DOI 10.1038/nrmicro1888; Binder BJ, 1998, APPL ENVIRON MICROB, V64, P3346; Brehm-Stecher BF, 2004, MICROBIOL MOL BIOL R, V68, P538, DOI 10.1128/MMBR.68.3.538-559.2004; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; de la Torre BG, 2002, HELV CHIM ACTA, V85, P2594, DOI 10.1002/1522-2675(200209)85:9<2594::AID-HLCA2594>3.0.CO;2-R; DELONG EF, 1989, SCIENCE, V243, P1360, DOI 10.1126/science.2466341; Dubertret B, 2001, NAT BIOTECHNOL, V19, P365, DOI 10.1038/86762; Ehrhardt CJ, 2009, J MICROSC-OXFORD, V236, P5, DOI 10.1111/j.1365-2818.2009.03207.x; Eickhorst T, 2008, SOIL BIOL BIOCHEM, V40, P1883, DOI 10.1016/j.soilbio.2008.03.024; Eickhorst T, 2008, SOIL BIOL BIOCHEM, V40, P1284, DOI 10.1016/j.soilbio.2007.06.019; Emmanuelle G, 2005, JOURNAL OF MICROBIOL, V63, P20, DOI [10.1016/j.mimet.2005.02.018, DOI 10.1016/J.MIMET.2005.02.018]; Hazrin-Chong NH, 2012, J MICROBIOL METH, V90, P96, DOI 10.1016/j.mimet.2012.04.014; Hermann R, 1996, HISTOCHEM CELL BIOL, V106, P31; Huang B, 2010, CELL, V143, P1047, DOI 10.1016/j.cell.2010.12.002; Kenzaka T, 2005, APPL ENVIRON MICROB, V71, P5523, DOI 10.1128/AEM.71.9.5523-5531.2005; Kubota K, 2014, SYST APPL MICROBIOL, V37, P261, DOI 10.1016/j.syapm.2014.02.003; Kubota K, 2013, MICROBES ENVIRON, V28, P3, DOI 10.1264/jsme2.ME12107; Lehmann J, 2011, SOIL BIOL BIOCHEM, V43, P1812, DOI 10.1016/j.soilbio.2011.04.022; Loweth CJ, 1999, ANGEW CHEM INT EDIT, V38, P1808, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1808::AID-ANIE1808>3.0.CO;2-C; Luef B, 2013, ISME J, V7, P338, DOI 10.1038/ismej.2012.103; MANZ W, 1992, SYST APPL MICROBIOL, V15, P593, DOI 10.1016/S0723-2020(11)80121-9; Melton ED, 2014, NAT REV MICROBIOL, V12, P797, DOI 10.1038/nrmicro3347; Schmidt H, 2014, FEMS MICROBIOL ECOL, V87, P390, DOI 10.1111/1574-6941.12232; Schmidt H, 2012, SYST APPL MICROBIOL, V35, P518, DOI 10.1016/j.syapm.2012.04.006; Vos M, 2013, FEMS MICROBIOL REV, V37, P936, DOI 10.1111/1574-6976.12023; Weipoltshammer K, 2000, HISTOCHEM CELL BIOL, V114, P489; Williams DB, 1996, THE TRANSMISSION ELE; Zanchet D, 2001, NANO LETT, V1, P32, DOI 10.1021/nl005508e	32	3	3	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0126404	10.1371/journal.pone.0126404	http://dx.doi.org/10.1371/journal.pone.0126404			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018431	Green Published, gold, Green Submitted			2022-12-26	WOS:000355185600051
J	Anton, BP; Mongodin, EF; Agrawal, S; Fomenkov, A; Byrd, DR; Roberts, RJ; Raleigh, EA				Anton, Brian P.; Mongodin, Emmanuel F.; Agrawal, Sonia; Fomenkov, Alexey; Byrd, Devon R.; Roberts, Richard J.; Raleigh, Elisabeth A.			Complete Genome Sequence of ER2796, a DNA Methyltransferase-Deficient Strain of Escherichia coli K-12	PLOS ONE			English	Article							RESTRICTION-MODIFICATION SYSTEM; METHYLASE DAM MUTANTS; HELICOBACTER-PYLORI; CYTOSINE METHYLATION; STATIONARY-PHASE; GENE CONVERSION; SINGLE-MOLECULE; MUTATIONS; RECOMBINATION; EXPRESSION	We report the complete sequence of ER2796, a laboratory strain of Escherichia coli K-12 that is completely defective in DNA methylation. Because of its lack of any native methylation, it is extremely useful as a host into which heterologous DNA methyltransferase genes can be cloned and the recognition sequences of their products deduced by Pacific Biosciences Single-Molecule Real Time (SMRT) sequencing. The genome was itself sequenced from a long-insert library using the SMRT platform, resulting in a single closed contig devoid of methylated bases. Comparison with K-12 MG1655, the first E. coli K-12 strain to be sequenced, shows an essentially co-linear relationship with no major rearrangements despite many generations of laboratory manipulation. The comparison revealed a total of 41 insertions and deletions, and 228 single base pair substitutions. In addition, the long-read approach facilitated the surprising discovery of four gene conversion events, three involving rRNA operons and one between two cryptic prophages. Such events thus contribute both to genomic homogenization and to bacteriophage diversification. As one of relatively few laboratory strains of E. coli to be sequenced, the genome also reveals the sequence changes underlying a number of classical mutant alleles including those affecting the various native DNA methylation systems.	[Anton, Brian P.; Fomenkov, Alexey; Byrd, Devon R.; Roberts, Richard J.; Raleigh, Elisabeth A.] New England Biolabs Inc, Ipswich, MA 01938 USA; [Mongodin, Emmanuel F.; Agrawal, Sonia] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA	New England Biolabs; University System of Maryland; University of Maryland Baltimore	Raleigh, EA (corresponding author), New England Biolabs Inc, Ipswich, MA 01938 USA.	raleigh@neb.com	Mongodin, Emmanuel/AAF-1850-2020; Agrawal, Sonia/AAC-6273-2020	Mongodin, Emmanuel/0000-0003-3833-7437; Agrawal, Sonia/0000-0003-4484-7433; Roberts, Richard/0000-0002-4348-0169; Raleigh, Elisabeth A./0000-0003-0745-9925				Archer CT, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-9; Bachmann B. J., 1987, ESCHERICHIA COLI SAL, V2, P807; Barker CS, 2004, J BACTERIOL, V186, P7529, DOI 10.1128/JB.186.22.7529-7537.2004; Beckwith J, 1978, THE OPERON, P11; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Broadbent SE, 2007, J BACTERIOL, V189, P4325, DOI 10.1128/JB.01854-06; BROOKS JE, 1989, NUCLEIC ACIDS RES, V17, P979, DOI 10.1093/nar/17.3.979; Casjens S, 2003, MOL MICROBIOL, V49, P277, DOI 10.1046/j.1365-2958.2003.03580.x; Clark TA, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1146; DAR ME, 1993, MOL MICROBIOL, V9, P823, DOI 10.1111/j.1365-2958.1993.tb01741.x; DRYDEN DTF, 1993, J BIOL CHEM, V268, P13228; Durfee T, 2008, J BACTERIOL, V190, P2597, DOI 10.1128/JB.01695-07; Dutra BE, 2007, P NATL ACAD SCI USA, V104, P216, DOI 10.1073/pnas.0608293104; Edwards RA, 1998, GENE, V207, P149, DOI 10.1016/S0378-1119(97)00619-7; Fang G, 2012, NAT BIOTECHNOL, V30, P1232, DOI 10.1038/nbt.2432; Ferenci T, 2009, J BACTERIOL, V191, P4025, DOI 10.1128/JB.00118-09; FRAM RJ, 1985, MOL PHARMACOL, V28, P51; Fridman O, 2014, NATURE, V513, P418, DOI 10.1038/nature13469; GARRICKS.L, 1970, GENETICS, V66, P231; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HARAYAMA S, 1983, J BACTERIOL, V153, P408, DOI 10.1128/JB.153.1.408-415.1983; Hayashi K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100049; INOKUCHI H, 1979, J MOL BIOL, V132, P663, DOI 10.1016/0022-2836(79)90381-4; Jensen KF, 1993, J BACTERIOL, V175, P3401; Jeong H, 2009, J MOL BIOL, V394, P644, DOI 10.1016/j.jmb.2009.09.052; Kahramanoglou C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1878; KARRAN P, 1982, NATURE, V296, P868, DOI 10.1038/296868a0; Keseler IM, 2013, NUCLEIC ACIDS RES, V41, pD605, DOI 10.1093/nar/gks1027; KLECKNER N, 1979, J MOL BIOL, V127, P89, DOI 10.1016/0022-2836(79)90461-3; Kong HM, 2000, NUCLEIC ACIDS RES, V28, P3216, DOI 10.1093/nar/28.17.3216; Krebes J, 2014, NUCLEIC ACIDS RES, V42, P2415, DOI 10.1093/nar/gkt1201; Kusano K, 1997, J BACTERIOL, V179, P5380, DOI 10.1128/jb.179.17.5380-5390.1997; Laehnemann D, 2014, GENOME BIOL EVOL, V6, P1287, DOI 10.1093/gbe/evu106; LEDERBERG J, 1946, NATURE, V158, P558, DOI 10.1038/158558a0; Lee H, 2012, P NATL ACAD SCI USA, V109, pE2774, DOI 10.1073/pnas.1210309109; Lieb M, 1996, MOL MICROBIOL, V20, P467, DOI 10.1046/j.1365-2958.1996.5291066.x; Lobner-Olesen A, 2005, CURR OPIN MICROBIOL, V8, P154, DOI 10.1016/j.mib.2005.02.009; Loenen WAM, 2014, NUCLEIC ACIDS RES, V42, P56, DOI 10.1093/nar/gkt747; LOW B, 1968, P NATL ACAD SCI USA, V60, P160, DOI 10.1073/pnas.60.1.160; MACNEIL DJ, 1988, J BACTERIOL, V170, P5607, DOI 10.1128/jb.170.12.5607-5612.1988; MARINUS MG, 1974, J MOL BIOL, V85, P309, DOI 10.1016/0022-2836(74)90366-0; MARINUS MG, 1976, MOL GEN GENET, V149, P273, DOI 10.1007/BF00268528; Marinus MG, 2000, J BACTERIOL, V182, P463, DOI 10.1128/JB.182.2.463-468.2000; MARINUS MG, 1973, J BACTERIOL, V114, P1143, DOI 10.1128/JB.114.3.1143-1150.1973; Militello KT, 2012, FEMS MICROBIOL LETT, V328, P78, DOI 10.1111/j.1574-6968.2011.02482.x; Murray IA, 2012, NUCLEIC ACIDS RES, V40, P11450, DOI 10.1093/nar/gks891; Neidhardt, 1996, ESCHERICHIA COLIAND, V2, P2460; Nichols BP, 1998, J BACTERIOL, V180, P6408; Oshima T, 2002, MOL MICROBIOL, V45, P673, DOI 10.1046/j.1365-2958.2002.03037.x; PALMER BR, 1994, GENE, V143, P1, DOI 10.1016/0378-1119(94)90597-5; PARKER B, 1988, GENE, V73, P531, DOI 10.1016/0378-1119(88)90517-3; Parker BW, 2013, J BIOL CHEM, V288, P32574, DOI 10.1074/jbc.M113.503516; PETERSON KR, 1985, MOL GEN GENET, V201, P14, DOI 10.1007/BF00397979; PETERSON KR, 1993, J BACTERIOL, V175, P7505, DOI 10.1128/JB.175.22.7505-7508.1993; Raghavan R, 2011, J BACTERIOL, V193, P2871, DOI 10.1128/JB.00398-11; RALEIGH EA, 1992, MOL MICROBIOL, V6, P1079, DOI 10.1111/j.1365-2958.1992.tb01546.x; RALEIGH EA, 1984, J MOL BIOL, V173, P437, DOI 10.1016/0022-2836(84)90390-5; RALEIGH EA, 1989, GENETICS, V122, P279; Riley M, 2006, NUCLEIC ACIDS RES, V34, P1, DOI 10.1093/nar/gkj405; Santoyo G, 2005, J BACTERIOL, V187, P4116, DOI 10.1128/JB.187.12.4116-4126.2005; Sibley MH, 2004, NUCLEIC ACIDS RES, V32, P522, DOI 10.1093/nar/gkh194; Singaravelan B, 2010, J BACTERIOL, V192, P6039, DOI 10.1128/JB.00474-10; SINGER M, 1989, MICROBIOL REV, V53, P1; Stewart FJ, 2007, J MOL EVOL, V65, P44, DOI 10.1007/s00239-006-0235-3; Surette MG, 1999, P NATL ACAD SCI USA, V96, P1639, DOI 10.1073/pnas.96.4.1639; Suzuki S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019534; Talarico S, 2012, MOL MICROBIOL, V84, P1050, DOI 10.1111/j.1365-2958.2012.08073.x; Turner PC, 2012, J IND MICROBIOL BIOT, V39, P629, DOI 10.1007/s10295-011-1052-2; Visick JE, 1997, J BACTERIOL, V179, P4158, DOI 10.1128/jb.179.13.4158-4163.1997; Zhou J, 2013, NUCLEIC ACIDS RES, V41, pD613, DOI DOI 10.1093/NAR/GKS1235; ZIPSER D, 1967, J MOL BIOL, V25, P567, DOI 10.1016/0022-2836(67)90209-4; ZIPSER D, 1970, J MOL BIOL, V49, P251, DOI 10.1016/0022-2836(70)90392-X	72	26	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127446	10.1371/journal.pone.0127446	http://dx.doi.org/10.1371/journal.pone.0127446			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010885	Green Submitted, gold, Green Published			2022-12-26	WOS:000355183900092
J	Berge, LI; Riise, T; Tell, GS; Iversen, MM; Ostbye, T; Lund, A; Knudsen, AK				Berge, Line I.; Riise, Trond; Tell, Grethe S.; Iversen, Marjolein M.; Ostbye, Truls; Lund, Anders; Knudsen, Ann Kristin			Depression in Persons with Diabetes by Age and Antidiabetic Treatment: A Cross-Sectional Analysis with Data from the Hordaland Health Study	PLOS ONE			English	Article							POPULATION-BASED COHORT; MENTAL-DISORDERS; GLYCEMIC CONTROL; RISK-FACTOR; METAANALYSIS; PREVALENCE; METFORMIN; SYMPTOMS; DISEASES; ATHEROSCLEROSIS	Background Persons with diabetes have increased risk of depression, however, studies addressing whether the risk varies by age and type of antidiabetic treatment have yielded conflicting results. The aim of this study was to investigate if the association between diabetes and depression varied by type of antidiabetic treatment in a large community based sample of middle-aged (40-47 years) and older adults (70-72 years). Methods Data from 21845 participants in the Hordaland Health Study (HUSK) were analyzed in a cross-sectional design. Diabetes was assessed by self-report and classified as un-medicated, treated by oral antidiabetic agents or by insulin. Depression was defined as a score >= 8 on the depression subscale of the Hospital Anxiety and Depression Scale and/or self-reported use of antidepressant agents. Associations between diabetes and depression were estimated using logistic regression. Results Persons in their forties with diabetes had a doubled prevalence of depression (OR: 1.96 (95% C. I.: 1.35, 2.83)) compared to persons without diabetes, while a lower and non-significant association was found among persons in their seventies. Persons in their forties with orally treated diabetes had about three times higher prevalence of depression (OR: 2.92 (95% C. I.: 1.48, 5.77)) after adjustment for gender, BMI, physical activity, alcohol consumption and education, compared to non-diabetic persons in the same age-group. No association between depression and insulin or un-medicated diabetes was found. Conclusions Clinicians should be aware that persons in their forties with orally treated diabetes are at a marked increased risk of depression.	[Berge, Line I.; Riise, Trond; Tell, Grethe S.; Ostbye, Truls; Knudsen, Ann Kristin] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Berge, Line I.; Lund, Anders] Univ Bergen, Sect Psychiat, Dept Clin Med 1, Bergen, Norway; [Berge, Line I.; Lund, Anders] Univ Bergen, Haukeland Univ Hosp, Mood Net Res Grp, Bergen, Norway; [Iversen, Marjolein M.] Bergen Univ Coll, Ctr Evidence Based Practice, Bergen, Norway; [Iversen, Marjolein M.] Stavanger Univ Hosp, Endocrinol Sect, Dept Med, Stavanger, Norway; [Ostbye, Truls] Duke Univ, Global Hlth Inst, Durham, NC 27706 USA; [Knudsen, Ann Kristin] Norwegian Inst Publ Hlth, Dept Hlth Registries, Bergen, Norway	University of Bergen; University of Bergen; University of Bergen; Haukeland University Hospital; Western Norway University of Applied Sciences; Stavanger University Hospital; Duke University; Norwegian Institute of Public Health (NIPH)	Berge, LI (corresponding author), Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway.	line.iden.berge@gmail.com	Knudsen, Ann Kristin/AAB-2465-2019; Riise, Trond/H-1390-2018; Tell, Grethe/G-5639-2015	Riise, Trond/0000-0001-9644-5140; Tell, Grethe/0000-0003-1386-1638; Knudsen, Ann Kristin/0000-0002-1218-798X; Iversen, Marjolein Memelink/0000-0001-9954-171X	University of Bergen	University of Bergen	The authors received no specific funding for this particular work. This work is a part of a PHD funded by the University of Bergen.	Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x; [Anonymous], 2013, DIABETES ATLAS; Anstey KJ, 2009, PSYCHOSOM MED, V71, P937, DOI 10.1097/PSY.0b013e3181beab60; Barnard K, 2013, DIABETES CARE, V36, P3337, DOI 10.2337/dc13-0560; Berge LI, 2012, DIABETIC MED, V29, P509, DOI 10.1111/j.1464-5491.2011.03530.x; Berkowitz SA, 2013, DIABETOLOGIA, V56, P2593, DOI 10.1007/s00125-013-3036-4; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Bromet E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-90; Chen PC, 2013, DIABETES CARE, V36, P376, DOI 10.2337/dc12-0473; Collins MM, 2009, DIABETIC MED, V26, P153, DOI 10.1111/j.1464-5491.2008.02648.x; Engum A, 2007, J PSYCHOSOM RES, V62, P31, DOI 10.1016/j.jpsychores.2006.07.009; Gendelman N, 2009, DIABETES CARE, V32, P575, DOI 10.2337/dc08-1835; Golden SH, 2007, PSYCHOSOM MED, V69, P529, DOI 10.1097/PSY.0b013e3180f61c5c; Gonzalez JS, 2007, DIABETES CARE, V30, P2222, DOI 10.2337/dc07-0158; Gonzalez JS, 2008, DIABETES CARE, V31, P2398, DOI 10.2337/dc08-1341; Heckbert SR, 2010, J GEN INTERN MED, V25, P524, DOI 10.1007/s11606-010-1272-6; Hessler DM, 2011, PATIENT EDUC COUNS, V85, P154, DOI 10.1016/j.pec.2010.10.030; Hsu CC, 2011, J ALZHEIMERS DIS, V24, P485, DOI 10.3233/JAD-2011-101524; Institute for Health Metrics and Evaluation, 2013, THE GLOBAL BURDEN OF; Klungel OH, 1999, NETH J MED, V55, P177, DOI 10.1016/S0300-2977(99)00045-5; Knol MJ, 2007, PSYCHOSOM MED, V69, P300, DOI 10.1097/PSY.0b013e31805f48b9; Knudsen AK, 2010, AM J EPIDEMIOL, V172, P1306, DOI 10.1093/aje/kwq257; Langhammer A, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-143; Li CY, 2008, DIABETES CARE, V31, P105, DOI 10.2337/dc07-1154; Lin EHB, 2010, DIABETES CARE, V33, P264, DOI 10.2337/dc09-1068; Lin EHB, 2008, J PSYCHOSOM RES, V65, P571, DOI 10.1016/j.jpsychores.2008.06.007; Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934; Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985; Miller GE, 2011, PSYCHOL BULL, V137, P959, DOI 10.1037/a0024768; Pan A, 2010, ARCH INTERN MED, V170, P1884, DOI 10.1001/archinternmed.2010.356; Park M, 2013, GEN HOSP PSYCHIAT, V35, P217, DOI 10.1016/j.genhosppsych.2013.01.006; Roy T, 2012, DIABETIC MED, V29, P164, DOI 10.1111/j.1464-5491.2011.03401.x; Roy T, 2012, J AFFECT DISORDERS, V142, pS8, DOI 10.1016/S0165-0327(12)70004-6; Rubin RR, 2005, DIABETES CARE, V28, P830; Schneider ALC, 2012, AM J EPIDEMIOL, V176, P738, DOI 10.1093/aje/kws156; Schram MT, 2009, CURR DIABETES REV, V5, P112, DOI 10.2174/157339909788166828; Schumann G, 2014, EUR NEUROPSYCHOPHARM, V24, P5, DOI 10.1016/j.euroneuro.2013.09.010; Stringhini S, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001479; Wahlqvist ML, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-150; Wahlqvist ML, 2012, PARKINSONISM RELAT D, V18, P753, DOI 10.1016/j.parkreldis.2012.03.010; Waitzfelder B, 2010, PRIM CARE DIABETES, V4, P215, DOI 10.1016/j.pcd.2010.07.002; Yoon JM, 2013, KOREAN J FAM MED, V34, P228, DOI 10.4082/kjfm.2013.34.4.228	42	22	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127161	10.1371/journal.pone.0127161	http://dx.doi.org/10.1371/journal.pone.0127161			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0QZ	26010615	Green Submitted, Green Published, gold			2022-12-26	WOS:000355183900069
J	Xiong, FZ; Obholzer, ND; Noche, RR; Megason, SG				Xiong, Fengzhu; Obholzer, Nikolaus D.; Noche, Ramil R.; Megason, Sean G.			Multibow: Digital Spectral Barcodes for Cell Tracing	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; FLUORESCENT PROTEINS; STEM-CELLS; ZEBRAFISH; EXPRESSION; BRAINBOW; LINEAGE; PROMOTER; SYSTEM; IDENTIFICATION	We introduce a multicolor labeling strategy (Multibow) for cell tracing experiments in developmental and regenerative processes. Building on Brainbow-based approaches that produce colors by differential expression levels of different fluorescent proteins, Multibow adds a layer of label diversity by introducing a binary code in which reporters are initially OFF and then probabilistically ON or OFF following Cre recombination. We have developed a library of constructs that contains seven different colors and three different subcellular localizations. Combining constructs from this library in the presence of Cre generates cells labeled with multiple independently expressed colors based on if each construct is ON or OFF following recombination. These labels form a unique "barcode" that allows the tracking of the cell and its clonal progenies in addition to expression level differences of each color. We tested Multibow in zebrafish which validates its design concept and suggests its utility for cell tracing applications in development and regeneration.	[Xiong, Fengzhu; Obholzer, Nikolaus D.; Noche, Ramil R.; Megason, Sean G.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Megason, SG (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	megason@hms.harvard.edu	XIONG, FENGZHU/A-9590-2015	XIONG, FENGZHU/0000-0002-6153-0254; Noche, Ramil R./0000-0002-4894-5682	NIH [R01 DC010791]; Biological Sciences in Dental Medicine at Harvard University; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010791] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biological Sciences in Dental Medicine at Harvard University; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by R01 DC010791 from NIH. F.X. is also supported by the graduate program of Biological Sciences in Dental Medicine at Harvard University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai HW, 2007, BIOCHEMISTRY-US, V46, P5904, DOI 10.1021/bi700199g; Blake WJ, 2006, MOL CELL, V24, P853, DOI 10.1016/j.molcel.2006.11.003; Boulina M, 2013, DEVELOPMENT, V140, P1605, DOI 10.1242/dev.088930; Cai D, 2013, NAT METHODS, V10, P540, DOI [10.1038/NMETH.2450, 10.1038/nmeth.2450]; Card JP, 2011, P NATL ACAD SCI USA, V108, P3377, DOI 10.1073/pnas.1015033108; Casco-Robles MM, 2010, DEV DYNAM, V239, P3275, DOI 10.1002/dvdy.22463; Garcia-Marques J, 2013, CEREB CORTEX, V23, P1463, DOI 10.1093/cercor/bhs134; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gupta V, 2012, NATURE, V484, P479, DOI 10.1038/nature11045; Hadjieconomou D, 2011, NAT METHODS, V8, P260, DOI 10.1038/NMETH.1567; Hampel S, 2011, NAT METHODS, V8, P253, DOI 10.1038/NMETH.1566; Kawakami K, 2000, P NATL ACAD SCI USA, V97, P11403, DOI 10.1073/pnas.97.21.11403; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Loulier K, 2014, NEURON, V81, P505, DOI 10.1016/j.neuron.2013.12.016; Megason Sean G., 2009, V546, P317, DOI 10.1007/978-1-60327-977-2_19; Mosaliganti KR, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002780; Mosimann C, 2011, DEVELOPMENT, V138, P169, DOI 10.1242/dev.059345; Pan YA, 2013, DEVELOPMENT, V140, P2835, DOI 10.1242/dev.094631; Pan YA, 2011, COLD SPRING HARB PRO, V2011; Park HC, 2000, DEV BIOL, V227, P279, DOI 10.1006/dbio.2000.9898; Shaner NC, 2007, J CELL SCI, V120, P4247, DOI 10.1242/jcs.005801; Shcherbo D, 2009, BIOCHEM J, V418, P567, DOI 10.1042/BJ20081949; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Swoger J, 2011, J BIOPHOTONICS, V4, P122, DOI 10.1002/jbio.201000087; Tu S, 2011, DEV CELL, V20, P725, DOI 10.1016/j.devcel.2011.04.013; Urasaki A, 2008, GENE, V425, P64, DOI 10.1016/j.gene.2008.08.008; Wachsman G, 2011, PLANT CELL, V23, P2581, DOI 10.1105/tpc.111.086199; Weber K, 2012, NAT PROTOC, V7, P839, DOI 10.1038/nprot.2012.026; Worley MI, 2013, DEVELOPMENT, V140, P3275, DOI 10.1242/dev.096057; Xiong FZ, 2014, CELL, V159, P415, DOI 10.1016/j.cell.2014.09.007; Xiong FZ, 2013, CELL, V153, P550, DOI 10.1016/j.cell.2013.03.023	31	11	11	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127822	10.1371/journal.pone.0127822	http://dx.doi.org/10.1371/journal.pone.0127822			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010570	Green Published, gold, Green Submitted			2022-12-26	WOS:000355183900149
J	Niu, J; Xue, A; Chi, Y; Xue, J; Wang, W; Zhao, Z; Fan, M; Yang, CH; Shao, ZM; Pfeffer, LM; Wu, J; Wu, ZH				Niu, J.; Xue, A.; Chi, Y.; Xue, J.; Wang, W.; Zhao, Z.; Fan, M.; Yang, C. H.; Shao, Z-M; Pfeffer, L. M.; Wu, J.; Wu, Z-H			Induction of miRNA-181a by genotoxic treatments promotes chemotherapeutic resistance and metastasis in breast cancer	ONCOGENE			English	Article							NF-KAPPA-B; SQUAMOUS-CELL CARCINOMA; DNA-DAMAGE RESPONSE; TARGETING MICRORNAS; UP-REGULATION; EXPRESSION; PATHWAY; PHOSPHORYLATION; CHEMORESISTANCE; ACTIVATION	Acquired therapeutic resistance is the major drawback to effective systemic therapies for cancers. Aggressive triple-negative breast cancers (TNBC) develop resistance to chemotherapies rapidly, whereas the underlying mechanisms are not completely understood. Here we show that genotoxic treatments significantly increased the expression of miR-181a in TNBC cells, which enhanced TNBC cell survival and metastasis upon Doxorubicin treatment. Consistently, high miR-181a level associated with poor disease free survival and overall survival after treatments in breast cancer patients. The upregulation of miR-181a was orchestrated by transcription factor STAT3 whose activation depended on NF-kappa B-mediated IL-6 induction in TNBC cells upon genotoxic treatment. Intriguingly, activated STAT3 not only directly bound to MIR181A1 promoter to drive transcription but also facilitated the recruitment of MSK1 to the same region where MSK1 promoted a local active chromatin state by phosphorylating histone H3. We further identified BAX as a direct functional target of miR-181a, whose suppression decreased apoptosis and increased invasion of TNBC cells upon Dox treatment. These results were further confirmed by evidence that suppression of miR-181a significantly enhanced therapeutic response and reduced lung metastasis in a TNBC orthotopic model. Collectively, our data suggested that miR-181a induction had a critical role in promoting therapeutic resistance and aggressive behavior of TNBC cells upon genotoxic treatment. Antagonizing miR-181a may serve as a promising strategy to sensitize TNBC cells to chemotherapy and mitigate metastasis.	[Niu, J.; Wang, W.; Fan, M.; Yang, C. H.; Pfeffer, L. M.; Wu, Z-H] Univ Tennessee, Ctr Hlth Sci, Dept Pathol & Lab Med, Memphis, TN 38163 USA; [Niu, J.; Chi, Y.; Wang, W.; Fan, M.; Yang, C. H.; Pfeffer, L. M.; Wu, Z-H] Univ Tennessee, Ctr Hlth Sci, Canc Res Ctr, Memphis, TN 38163 USA; [Xue, A.; Zhao, Z.] Fudan Univ, Shanghai Med Coll, Dept Forens Med, Shanghai 200032, Peoples R China; [Chi, Y.; Xue, J.; Shao, Z-M; Wu, J.] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China; [Chi, Y.; Xue, J.; Shao, Z-M; Wu, J.] Fudan Univ, Shanghai Canc Ctr, Dept Breast Surg, 270 Dong An Rd, Shanghai 200032, Peoples R China	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Fudan University; Fudan University; Fudan University	Wu, J (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Breast Surg, 270 Dong An Rd, Shanghai 200032, Peoples R China.; Wu, ZH (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Pathol, 19S Manassas St, Memphis, TN 38163 USA.	wujiong1122@vip.sina.com; zwu6@uthsc.edu		Pfeffer, Lawrence/0000-0003-2809-1234; fan, meiyun/0000-0002-0185-5065	National Cancer Institute [R01 CA149251]; American Cancer Society [RSG-13-186-01-CSM]; National Natural Science Foundation of China (NSFC) [81272924]; NATIONAL CANCER INSTITUTE [R01CA140346, R01CA149251] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Bert Vogelstein (Johns Hopkins University) for wild-type and DICER - / - HCT116 cells. The BAX expression construct was a generous gift from Dr Douglas Green (St Jude Children's Research Hospital). We also thank Dr R. Laribee (UTHSC) for stimulating discussion and critical reading of the manuscript. This work was supported in part by grants from National Cancer Institute (R01 CA149251 to ZW), American Cancer Society (RSG-13-186-01-CSM to ZW), and National Natural Science Foundation of China (NSFC) (81272924 to JW).	Baek SH, 2011, MOL CELL, V42, P274, DOI 10.1016/j.molcel.2011.03.022; Baldwin AS, 2012, IMMUNOL REV, V246, P327, DOI 10.1111/j.1600-065X.2012.01095.x; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boldin MP, 2012, IMMUNOL REV, V246, P205, DOI 10.1111/j.1600-065X.2011.01089.x; Bonnay F, 2014, EMBO J, V33, P2349, DOI 10.15252/embj.201488456; Carey L, 2010, NAT REV CLIN ONCOL, V7, P683, DOI 10.1038/nrclinonc.2010.154; Chaudhry MA, 2010, DNA CELL BIOL, V29, P553, DOI 10.1089/dna.2009.0978; Chen YR, 2014, EXP CELL RES, V320, P12, DOI 10.1016/j.yexcr.2013.10.014; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Enerly E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016915; Fan MY, 2013, J BIOL CHEM, V288, P27480, DOI 10.1074/jbc.M113.491803; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Galluzzi L, 2010, CANCER RES, V70, P1793, DOI 10.1158/0008-5472.CAN-09-3112; Garofalo M, 2013, DRUG RESIST UPDATE, V16, P47, DOI 10.1016/j.drup.2013.05.001; Garzon R, 2010, NAT REV DRUG DISCOV, V9, P775, DOI 10.1038/nrd3179; Gehani SS, 2010, MOL CELL, V39, P886, DOI 10.1016/j.molcel.2010.08.020; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hedrich CM, 2014, P NATL ACAD SCI USA, V111, P13457, DOI 10.1073/pnas.1408023111; Hickey CJ, 2013, BLOOD, V121, P159, DOI 10.1182/blood-2012-05-428573; Ji DB, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-86; Jiao XY, 2013, BREAST CANCER RES TR, V139, P717, DOI 10.1007/s10549-013-2607-x; Kasinski AL, 2011, NAT REV CANCER, V11, P849, DOI 10.1038/nrc3166; Kato M, 2009, ONCOGENE, V28, P2419, DOI 10.1038/onc.2009.106; Lau PNI, 2011, P NATL ACAD SCI USA, V108, P2801, DOI 10.1073/pnas.1012798108; Ling H, 2013, NAT REV DRUG DISCOV, V12, P847, DOI 10.1038/nrd4140; Liu M, 2013, BIOCHEM BIOPH RES CO, V441, P364, DOI 10.1016/j.bbrc.2013.10.051; Llambi F, 2011, MOL CELL, V44, P517, DOI 10.1016/j.molcel.2011.10.001; McCool KW, 2012, IMMUNOL REV, V246, P311, DOI 10.1111/j.1600-065X.2012.01101.x; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Niu JX, 2013, EMBO J, V32, P3206, DOI 10.1038/emboj.2013.247; Niu JX, 2012, J BIOL CHEM, V287, P21783, DOI 10.1074/jbc.M112.355495; Ouyang M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096228; Ouyang YB, 2012, MITOCHONDRION, V12, P213, DOI 10.1016/j.mito.2011.09.001; Ozsolak F, 2008, GENE DEV, V22, P3172, DOI 10.1101/gad.1706508; Parikh A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms3977; Riaz M, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3415; Sansone P, 2012, J CLIN ONCOL, V30, P1005, DOI 10.1200/JCO.2010.31.8907; Sawicka A, 2014, GENOME RES, V24, P1808, DOI 10.1101/gr.176255.114; Tan GY, 2012, J BIOL CHEM, V287, P33036, DOI 10.1074/jbc.M112.383273; Tartey S, 2014, EMBO J, V33, P2332, DOI 10.15252/embj.201488447; Taylor MA, 2013, J CLIN INVEST, V123, P150, DOI 10.1172/JCI64946; Wakahara R, 2012, GENES CELLS, V17, P132, DOI 10.1111/j.1365-2443.2011.01575.x; Wang Y, 2011, ONCOGENE, V30, P1470, DOI 10.1038/onc.2010.531; Wu ZH, 2007, J MOL MED, V85, P1187, DOI 10.1007/s00109-007-0227-9; Yang CH, 2010, CANCER RES, V70, P8108, DOI 10.1158/0008-5472.CAN-10-2579; Yang JB, 2010, P NATL ACAD SCI USA, V107, P21499, DOI 10.1073/pnas.1016147107; Zhang XN, 2011, MOL CELL, V41, P371, DOI 10.1016/j.molcel.2011.01.020; Zhou WY, 2014, CANCER CELL, V25, P501, DOI 10.1016/j.ccr.2014.03.007	49	98	101	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 10	2016	35	10					1302	1313		10.1038/onc.2015.189	http://dx.doi.org/10.1038/onc.2015.189			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DG0NY	26028030	Green Accepted			2022-12-26	WOS:000371763100010
J	Malini, E; Zampieri, S; Deganuto, M; Romanello, M; Sechi, A; Bembi, B; Dardis, A				Malini, Erika; Zampieri, Stefania; Deganuto, Marta; Romanello, Milena; Sechi, Annalisa; Bembi, Bruno; Dardis, Andrea			Role of LIMP-2 in the intracellular trafficking of beta-glucosidase in different human cellular models	FASEB JOURNAL			English	Article						lysosomal disease; Gaucher disease; AMRF syndrome	PROGRESSIVE MYOCLONUS EPILEPSY; LIVER LYSOSOMAL MEMBRANES; RENAL FAILURE SYNDROME; GAUCHER-DISEASE; GLUCOCEREBROSIDASE; RECEPTOR; CELLS; MUTATION; SCARB2; SIALOGLYCOPROTEIN	Acid beta-glucosidase (GCase), the enzyme deficient in Gaucher disease (GD), is transported to lysosomes by the lysosomal integral membrane protein (LIMP)-2. In humans, LIMP-2 deficiency leads to action myoclonus-renal failure (AMRF) syndrome. GD and AMRF syndrome share some clinical features. However, they are different from clinical and biochemical points of view, suggesting that the role of LIMP-2 in the targeting of GCase would be different in different tissues. Besides, the role of LIMP-2 in the uptake and trafficking of the human recombinant (hr) GCase used in the treatment of GD is unknown. Thus, we compared GCase activity and intracellular localization in immortalized lymphocytes, fibroblasts, and a neuronal model derived from multi-potent adult stem cells, from apatient with AMRF syndrome, patients with GD, and control subjects. In fibroblasts and neuronlike cells, GCase targeting to the lysosomes is completely dependent on LIMP-2, whereas in blood cells, GCase is partially targeted to lysosomes by a LIMP-2-independent mechanism. Although hrGCase cellular uptake is independent of LIMP-2, its trafficking to the lysosomes is mediated by this receptor. These data provide new insights into the mechanisms involved in the intracellular trafficking of GCase and in the pathogeneses of GD and AMRF syndrome.	[Malini, Erika; Zampieri, Stefania; Deganuto, Marta; Romanello, Milena; Sechi, Annalisa; Bembi, Bruno; Dardis, Andrea] Univ Hosp Santa Maria della Misericordia, Reg Coordinator Ctr Rare Dis, I-33100 Udine, Italy	Hospital Santa Maria della Misericordia	Dardis, A (corresponding author), Univ Hosp Santa Maria della Misericordia, Reg Coordinator Ctr Rare Dis, Ple Santa Maria della Misericordia 15, I-33100 Udine, Italy.	dardis.andrea@aoud.sanita.fvg.it	Zampieri, Stefania/AAC-2314-2022; Sechi, Annalisa/AAC-1497-2019; Dardis, Andrea/AAB-9900-2022	Sechi, Annalisa/0000-0003-1708-7563; zampieri, stefania/0000-0003-3921-8405	Ministero della Salute [PRF 37/08]; Fondazione Telethon Funding Source: Custom	Ministero della Salute(Ministry of Health, Italy); Fondazione Telethon(Fondazione Telethon)	The authors thank Silvia Cattarossi for technical assistance and Federica Benvenuti for technical advice. This work was supported by Grant PRF 37/08 (clinical history and long-term cost-effectiveness of enzyme replacement therapy for Gaucher disease in Italy) from the Ministero della Salute. Some samples were obtained from the Cell Line and DNA Biobank from Patients Affected by Genetic Diseases (Giananni Gaslini Institute, Genoa, Italy), a Telethon Network of Genetic Biobanks (Project No. GTB12001A). The authors declare no conflicts of interest.	Badhwar A, 2004, BRAIN, V127, P2173, DOI 10.1093/brain/awh263; Balreira A, 2008, HUM MOL GENET, V17, P2238, DOI 10.1093/hmg/ddn124; Beltrami AR, 2007, BLOOD, V110, P3438, DOI 10.1182/blood-2006-11-055566; Bergamin N, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-34; Beutler E., 2001, METABOLIC MOL BASES, VIII, P3635; Blanz J, 2010, HUM MOL GENET, V19, P563, DOI 10.1093/hmg/ddp523; Cesselli D, 2009, CIRC RES, V104, P1225, DOI 10.1161/CIRCRESAHA.109.195859; Chaves J, 2011, SEIZURE-EUR J EPILEP, V20, P738, DOI 10.1016/j.seizure.2011.06.018; Cox TM, 2010, BIOL-TARGETS THER, V4, P299, DOI 10.2147/BTT.S7582; Dardis A, 2009, MOL GENET METAB, V97, P309, DOI 10.1016/j.ymgme.2009.04.011; Dibbens LM, 2009, ANN NEUROL, V66, P532, DOI 10.1002/ana.21765; Dibbens LM, 2011, ARCH NEUROL-CHICAGO, V68, P812, DOI 10.1001/archneurol.2011.120; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Friedman BA, 1999, BLOOD, V93, P2807; FUJITA H, 1991, BIOCHEM BIOPH RES CO, V178, P444, DOI 10.1016/0006-291X(91)90127-S; Gaspar P, 2014, J LIPID RES, V55, P138, DOI 10.1194/jlr.M043802; Guerrero-Lopez R, 2012, MOVEMENT DISORD, V27, P1826, DOI 10.1002/mds.25114; Higashiyama Y, 2013, MOVEMENT DISORD, V28, P552, DOI 10.1002/mds.25296; Krieger M, 2001, J CLIN INVEST, V108, P793, DOI 10.1172/JCI200114011; Liou B, 2014, J BIOL CHEM, V289, P30063, DOI 10.1074/jbc.M114.593616; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; Miocic Snjezana, 2005, Hum Mutat, V25, P100, DOI 10.1002/humu.9301; Mistry PK, 1996, LANCET, V348, P1555, DOI 10.1016/S0140-6736(96)04451-0; Neculai D, 2013, NATURE, V504, P172, DOI 10.1038/nature12684; OKAZAKI I, 1992, J BIOCHEM, V111, P763, DOI 10.1093/oxfordjournals.jbchem.a123833; Park JK, 2003, PEDIATR RES, V53, P387, DOI 10.1203/01.PDR.0000049515.79882.94; Reczek D, 2007, CELL, V131, P770, DOI 10.1016/j.cell.2007.10.018; Rubboli G, 2011, EPILEPSIA, V52, P2356, DOI 10.1111/j.1528-1167.2011.03307.x; Schroter CJ, 1999, J IMMUNOL METHODS, V227, P161, DOI 10.1016/S0022-1759(99)00079-4; SUAREZQUIAN CA, 1987, TISSUE CELL, V19, P495, DOI 10.1016/0040-8166(87)90043-7; TRIMBLE RB, 1991, J BIOL CHEM, V266, P1646; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; VANWEELY S, 1990, EUR J BIOCHEM, V191, P669; Zhao YG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5321	34	10	10	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2015	29	9					3839	3852		10.1096/fj.15-271148	http://dx.doi.org/10.1096/fj.15-271148			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CP5IU	26018676				2022-12-26	WOS:000359915600020
J	Lev, N; Barhum, Y; Ben-Zur, T; Aharony, I; Trifonov, L; Regev, N; Melamed, E; Gruzman, A; Offen, D				Lev, Nirit; Barhum, Yael; Ben-Zur, Tali; Aharony, Israel; Trifonov, Lena; Regev, Noa; Melamed, Eldad; Gruzman, Arie; Offen, Daniel			A DJ-1 Based Peptide Attenuates Dopaminergic Degeneration in Mice Models of Parkinson's Disease via Enhancing Nrf2	PLOS ONE			English	Article							MITOCHONDRIAL-FUNCTION; OXIDATIVE STRESS; PROTECTS; NEUROPROTECTION; ACTIVATION; MUTATIONS; REGULATOR; TOXICITY; NEURONS; BINDING	Drugs currently used for treating Parkinson's disease patients provide symptomatic relief without altering the neurodegenerative process. Our aim was to examine the possibility of using DJ-1 (PARK7), as a novel therapeutic target for Parkinson's disease. We designed a short peptide, named ND-13. This peptide consists of a 13 amino acids segment of the DJ-1-protein attached to 7 amino acids derived from TAT, a cell penetrating protein. We examined the effects of ND-13 using in vitro and in vivo experimental models of Parkinson's disease. We demonstrated that ND-13 protects cultured cells against oxidative and neurotoxic insults, reduced reactive oxygen species accumulation, activated the protective erythroid-2 related factor 2 system and increased cell survival. ND-13 robustly attenuated dopaminergic system dysfunction and in improved the behavioral outcome in the 6-hydroxydopamine mouse model of Parkinson's disease, both in wild type and in DJ-1 knockout mice. Moreover, ND-13 restored dopamine content in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model. These findings validate DJ-1 as a promising therapeutic target in Parkinson's disease and identify a novel peptide with clinical potential, which may be significant for a broader range of neurological diseases, possibly with an important impact for the neurosciences.	[Lev, Nirit; Barhum, Yael; Ben-Zur, Tali; Aharony, Israel; Regev, Noa; Melamed, Eldad; Offen, Daniel] Tel Aviv Univ, Sackler Sch Med, Felsenstein Med Res Ctr, Petah Tiqwa, Israel; [Lev, Nirit; Melamed, Eldad] Rabin Med Ctr, Dept Neurol, Petah Tiqwa, Israel; [Trifonov, Lena; Gruzman, Arie] Bar Ilan Univ, Fac Exact Sci, Dept Chem, Div Med Chem, Ramat Gan, Israel	Tel Aviv University; Sackler Faculty of Medicine; Rabin Medical Center; Bar Ilan University	Offen, D (corresponding author), Tel Aviv Univ, Sackler Sch Med, Felsenstein Med Res Ctr, Petah Tiqwa, Israel.	danioffen@gmail.com	Lev, Nirit/AAA-1253-2020	Trifonov, Lena/0000-0002-8559-6944; Regev, Noa/0000-0002-5865-4774	Legacy Heritage Clinical Research Initiative of the Israel Science Foundation [1690/09]; UGH Pharma, Inc.	Legacy Heritage Clinical Research Initiative of the Israel Science Foundation; UGH Pharma, Inc.	This research was supported by The Legacy Heritage Clinical Research Initiative of the Israel Science Foundation (grant No. 1690/09) and funding from UGH Pharma, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Sleiman PM, 2003, ANN NEUROL, V54, P283, DOI 10.1002/ana.10675; Aleyasin H, 2010, P NATL ACAD SCI USA, V107, P3186, DOI 10.1073/pnas.0914876107; Bandopadhyay R, 2004, BRAIN, V127, P420, DOI 10.1093/brain/awh054; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Brewer GJ, 2007, NAT PROTOC, V2, P1490, DOI 10.1038/nprot.2007.207; Choi J, 2006, J BIOL CHEM, V281, P10816, DOI 10.1074/jbc.M509079200; Clements CM, 2006, P NATL ACAD SCI USA, V103, P15091, DOI 10.1073/pnas.0607260103; Doeppner TR, 2010, NEUROBIOL DIS, V40, P265, DOI 10.1016/j.nbd.2010.05.033; Finkelstein DI, 2000, NEUROSCIENCE, V97, P99, DOI 10.1016/S0306-4522(00)00009-9; Foged C, 2008, EXPERT OPIN DRUG DEL, V5, P105, DOI 10.1517/17425247.5.1.105; Gan L, 2010, EUR J NEUROSCI, V31, P967, DOI 10.1111/j.1460-9568.2010.07138.x; Gou XC, 2011, J DRUG TARGET, V19, P86, DOI 10.3109/10611861003733961; Hague S, 2003, ANN NEUROL, V54, P271, DOI 10.1002/ana.10663; Hao LY, 2010, P NATL ACAD SCI USA, V107, P9747, DOI 10.1073/pnas.0911175107; Hong Z, 2010, BRAIN, V133, P713, DOI 10.1093/brain/awq008; Im JY, 2012, HUM MOL GENET, V21, P3013, DOI 10.1093/hmg/dds131; Irrcher I, 2010, HUM MOL GENET, V19, P3734, DOI 10.1093/hmg/ddq288; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Jakel RJ, 2007, BRAIN RES, V1144, P192, DOI 10.1016/j.brainres.2007.01.131; Jenner P, 1996, NEUROLOGY, V47, pS161, DOI 10.1212/WNL.47.6_Suppl_3.161S; Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Lev N, 2008, NEUROTOXICOLOGY, V29, P397, DOI 10.1016/j.neuro.2008.01.007; Lev N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117190; Lev N, 2013, J GERONTOL A-BIOL, V68, P215, DOI 10.1093/gerona/gls147; Lev N, 2009, J NEURAL TRANSM, V116, P151, DOI 10.1007/s00702-008-0134-4; Malhotra D, 2008, AM J RESP CRIT CARE, V178, P592, DOI 10.1164/rccm.200803-380OC; Martin I, 2011, ANNU REV GENOM HUM G, V12, P301, DOI 10.1146/annurev-genom-082410-101440; Mccoy MK, 2011, AUTOPHAGY, V7, P531, DOI 10.4161/auto.7.5.14684; Meulener M, 2005, CURR BIOL, V15, P1572, DOI 10.1016/j.cub.2005.07.064; Shi M, 2011, ANN NEUROL, V69, P570, DOI 10.1002/ana.22311; Siebert A, 2009, J NEUROSCI RES, V87, P1659, DOI 10.1002/jnr.21975; Stanic D, 2003, EUR J NEUROSCI, V18, P1175, DOI 10.1046/j.1460-9568.2003.02800.x; Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074; Tao F, 2008, MOL THER, V16, P1776, DOI 10.1038/mt.2008.192; Tarantino P, 2009, PARKINSONISM RELAT D, V15, P324, DOI 10.1016/j.parkreldis.2008.07.001; Thomas KJ, 2011, HUM MOL GENET, V20, P40, DOI 10.1093/hmg/ddq430; Vasseur S, 2009, P NATL ACAD SCI USA, V106, P1111, DOI 10.1073/pnas.0812745106; Waak J, 2009, J BIOL CHEM, V284, P14245, DOI 10.1074/jbc.M806902200; Waragai M, 2007, NEUROSCI LETT, V425, P18, DOI 10.1016/j.neulet.2007.08.010; Waragai M, 2006, BIOCHEM BIOPH RES CO, V345, P967, DOI 10.1016/j.bbrc.2006.05.011; Zhong N, 2006, J BIOL CHEM, V281, P20940, DOI 10.1074/jbc.M601935200; Zhong ZY, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-30	43	29	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0127549	10.1371/journal.pone.0127549	http://dx.doi.org/10.1371/journal.pone.0127549			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024237	Green Published, gold, Green Submitted			2022-12-26	WOS:000355319400042
J	Musicki, B; Zhang, YX; Chen, HL; Brown, TR; Zirkin, BR; Burnett, AL				Musicki, Biljana; Zhang, Yuxi; Chen, Haolin; Brown, Terry R.; Zirkin, Barry R.; Burnett, Arthur L.			Mechanism of Testosterone Deficiency in the Transgenic Sickle Cell Mouse	PLOS ONE			English	Article							TESTICULAR INFARCTION; TRANSLOCATOR PROTEIN; LIPID-PEROXIDATION; GONADAL-FUNCTION; DISEASE; MICE; ANEMIA; MEN; SECONDARY; HORMONE	Testosterone deficiency is associated with sickle cell disease (SCD), but its underlying mechanism is not known. We investigated the possible occurrence and mechanism of testosterone deficiency in a mouse model of human SCD. Transgenic sickle male mice (Sickle) exhibited decreased serum and intratesticular testosterone and increased luteinizing hormone (LH) levels compared with wild type (WT) mice, indicating primary hypogonadism in Sickle mice. LH-, dbcAMP-, and pregnenolone- (but not 22-hydroxycholesterol)-stimulated testosterone production by Leydig cells isolated from the Sickle mouse testis was decreased compared to that of WT mice, implying defective Leydig cell steroidogenesis. There also was reduced protein expression of steroidogenic acute regulatory protein (STAR), but not cholesterol side-chain cleavage enzyme (P450scc), in the Sickle mouse testis. These data suggest that the capacity of P450scc to support testosterone production may be limited by the supply of cholesterol to the mitochondria in Sickle mice. The sickle mouse testis exhibited upregulated NADPH oxidase subunit gp91phox and increased oxidative stress, measured as 4-hydroxy-2-nonenal, and unchanged protein expression of an antioxidant glutathione peroxidase-1. Mice heterozygous for the human sickle globin (Hemi) exhibited intermediate hypogonadal changes between those of WT and Sickle mice. These results demonstrate that testosterone deficiency occurs in Sickle mice, mimicking the human condition. The defects in the Leydig cell steroidogenic pathway in Sickle mice, mainly due to reduced availability of cholesterol for testosterone production, may be related to NADPH oxidase-derived oxidative stress. Our findings suggest that targeting testicular oxidative stress or steroidogenesis mechanisms in SCD offers a potential treatment for improving phenotypic changes associated with testosterone deficiency in this disease.	[Musicki, Biljana; Zhang, Yuxi; Burnett, Arthur L.] Johns Hopkins Sch Med, James Buchanan Brady Urol Inst, Baltimore, MD 21205 USA; [Musicki, Biljana; Zhang, Yuxi; Burnett, Arthur L.] Johns Hopkins Sch Med, Dept Urol, Baltimore, MD USA; [Chen, Haolin; Brown, Terry R.; Zirkin, Barry R.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Musicki, B (corresponding author), Johns Hopkins Sch Med, James Buchanan Brady Urol Inst, Baltimore, MD 21205 USA.	bmusicki@jhmi.edu			NIH/NIDDK [RO1DK093917]; NIH/NIA [R37AG021092]; Eunice Kennedy Shriver NICHD/NIH (SCCPIR) [U54-HD28934]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD028934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093917] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG021092] Funding Source: NIH RePORTER	NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Eunice Kennedy Shriver NICHD/NIH (SCCPIR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH/NIDDK grant RO1DK093917 (to ALB) and NIH/NIA grant R37AG021092 (to BRZ). The University of Virginia, Center for Research in Reproduction, Ligand Assay and Analysis Core is supported by the Eunice Kennedy Shriver NICHD/NIH (SCCPIR) grant U54-HD28934. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBASI AA, 1976, ANN INTERN MED, V85, P601, DOI 10.7326/0003-4819-85-5-601; Abudu Emmanuel K, 2011, BMC Res Notes, V4, P298, DOI 10.1186/1756-0500-4-298; Akinsheye I, 2010, J CELL PHYSIOL, V224, P620, DOI 10.1002/jcp.22195; Bomhard EM, 2013, ARCH TOXICOL, V87, P1201, DOI 10.1007/s00204-013-1024-6; Brachet C, 2007, J PEDIAT HEMATOL ONC, V29, P445, DOI 10.1097/MPH.0b013e31806451ac; Catala A, 2009, CHEM PHYS LIPIDS, V157, P1, DOI 10.1016/j.chemphyslip.2008.09.004; CHANDRASHEKAR V, 1991, BIOL REPROD, V44, P135, DOI 10.1095/biolreprod44.1.135; Chung JY, 2013, ENDOCRINOLOGY, V154, P2156, DOI 10.1210/en.2012-2226; Cohen G, 2013, FREE RADICAL BIO MED, V65, P978, DOI 10.1016/j.freeradbiomed.2013.08.163; COLLIN O, 1993, J REPROD FERTIL, V97, P115; DADA OA, 1980, CLIN CHIM ACTA, V105, P269, DOI 10.1016/0009-8981(80)90469-6; ELHAZMI MAF, 1992, J TROP PEDIATRICS, V38, P307, DOI 10.1093/tropej/38.6.307; FALLEST PC, 1995, BIOL REPROD, V53, P103, DOI 10.1095/biolreprod53.1.103; Gofrit ON, 1998, J UROLOGY, V160, P835, DOI 10.1016/S0022-5347(01)62803-9; Hebbel Robert P., 2009, Cardiovascular & Hematological Disorders - Drug Targets, V9, P271; Holmes NM, 1998, J UROLOGY, V160, P130, DOI 10.1016/S0022-5347(01)63058-1; Hsu LL, 2007, BLOOD, V109, P3088, DOI 10.1182/blood-2006-08-039438; Huber G, 2002, J CLIN ENDOCR METAB, V87, P3221, DOI 10.1210/jc.87.7.3221; Hurt KJ, 2002, P NATL ACAD SCI USA, V99, P4061, DOI 10.1073/pnas.052712499; Jaremko L, 2014, SCIENCE, V343, P1363, DOI 10.1126/science.1248725; Kassim AA, 2013, ANNU REV MED, V64, P451, DOI 10.1146/annurev-med-120611-143127; Kato Gregory J, 2009, Am J Hematol, V84, P618, DOI 10.1002/ajh.21475; Kaul DK, 2008, AM J PHYSIOL-HEART C, V295, pH39, DOI 10.1152/ajpheart.00162.2008; Le B, 2014, ANDROLOGY-US, V2, P484, DOI 10.1111/j.2047-2927.2014.00225.x; Li M, 2003, UROLOGY, V62, P551; Loscalzo Joseph, 2010, Expert Rev Endocrinol Metab, V5, P15; Luo LD, 2006, J ANDROL, V27, P240, DOI 10.2164/jandrol.05075; Manci EA, 2006, BLOOD, V107, P1651, DOI 10.1182/blood-2005-07-2839; Midzak A, 2014, TRAFFIC, V15, P895, DOI 10.1111/tra.12177; MODEBE O, 1995, FERTIL STERIL, V63, P907, DOI 10.1016/S0015-0282(16)57500-1; Montezano AC, 2011, CLIN SCI, V120, P131, DOI 10.1042/CS20100384; Morrison BF, 2013, ANDROLOGY-US, V1, P576, DOI 10.1111/j.2047-2927.2013.00084.x; Musicki B, 2014, J SEX MED, V11, P424, DOI 10.1111/jsm.12391; Naik RP, 2014, JAMA-J AM MED ASSOC, V312, P2115, DOI 10.1001/jama.2014.15063; Odievre Marie-Helene, 2011, Indian J Med Res, V134, P532; OSEGBE DN, 1987, POSTGRAD MED J, V63, P95, DOI 10.1136/pgmj.63.736.95; Papadopoulos V, 2007, MOL CELL ENDOCRINOL, V265, P59, DOI 10.1016/j.mce.2006.12.004; PARSHAD O, 1994, W INDIAN MED J, V43, P12; Paszty C, 1997, SCIENCE, V278, P876, DOI 10.1126/science.278.5339.876; Reyes JG, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/929285; Ridha A, 2014, LANCET, V384, P2172, DOI 10.1016/S0140-6736(14)61944-9; Rone MB, 2009, BBA-MOL CELL BIOL L, V1791, P646, DOI 10.1016/j.bbalip.2009.03.001; Salva A, 2001, J ANDROL, V22, P665; SINGHAL A, 1995, W INDIAN MED J, V44, P20; Sun KQ, 2013, CURR OPIN HEMATOL, V20, P215, DOI 10.1097/MOH.0b013e32835f55f9; Tajar A, 2010, J CLIN ENDOCR METAB, V95, P1810, DOI 10.1210/jc.2009-1796; Williams R, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00015; Wood KC, 2007, CLIN EXP PHARMACOL P, V34, P926, DOI 10.1111/j.1440-1681.2007.04639.x; Wu FCW, 2008, J CLIN ENDOCR METAB, V93, P2737, DOI 10.1210/jc.2007-1972; Zhang GL, 2013, REPROD TOXICOL, V36, P60, DOI 10.1016/j.reprotox.2012.12.002	50	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128694	10.1371/journal.pone.0128694	http://dx.doi.org/10.1371/journal.pone.0128694			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26023917	Green Published, gold, Green Submitted			2022-12-26	WOS:000355319400101
J	Petty, SK; Zuckerberg, B; Pauli, JN				Petty, Sonia K.; Zuckerberg, Benjamin; Pauli, Jonathan N.			Winter Conditions and Land Cover Structure the Subnivium, A Seasonal Refuge beneath the Snow	PLOS ONE			English	Article							CLIMATE; FOREST; RANGE; DISTRIBUTIONS; ACCUMULATION; TEMPERATURE; MELT	In seasonally snow-covered environments, many organisms endure winter by using the subnivium, a below-snow thermally stable seasonal refugium. Because the insulation of snow is dependent on snow depth and density, the stability of temperatures within the subnivium varies across land cover types. Additionally, across much of the Northern Hemisphere snow extent, depth and duration are generally decreasing while snow density is increasing due to climate change. These changes are likely to destabilize the thermal profile of the subnivium, although they have not yet been quantified. To explore the effects of land cover and climate change on the subnivium, we measured snow pack characteristics (depth and density), and ambient and subnivium temperatures from three different land cover types (prairie, deciduous forest, and coniferous forest) and within a micro-greenhouse (2.5 x 2.5 x 2 m) that maintained a temperature of 5 degrees C warmer than outdoor ambient temperatures, and automatically opened during snow events throughout the winter of 2013/14. We found that the mean daily subnivium temperature was significantly colder in the deciduous cover type than the prairie cover type, and that prairie had higher maximum subnivium temperatures than both of the other cover types. Our climate change simulation revealed that, although ambient temperatures within the micro-greenhouse were 5 degrees C warmer than outside the greenhouse, the daily minimum subnivium temperature was significantly lower inside the greenhouse. Our findings suggest that climate change could have considerable effects on the refuge quality of the subnivium, and that some cover types appear to be more susceptible to these effects than others.	[Petty, Sonia K.; Zuckerberg, Benjamin; Pauli, Jonathan N.] Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Pauli, JN (corresponding author), Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI 53706 USA.	jnpauli@wisc.edu			National Science Foundation [EF-1340632]; Wisconsin Department of Natural Resources; Division Of Environmental Biology [1340632] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Wisconsin Department of Natural Resources; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding was provided by the National Science Foundation (EF-1340632) and the Wisconsin Department of Natural Resources to JNP and BZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breshears DD, 2010, AUSTRAL ECOL, V35, P31, DOI 10.1111/j.1442-9993.2009.02009.x; Brown PJ, 2011, AGR FOREST METEOROL, V151, P947, DOI 10.1016/j.agrformet.2011.02.014; Brown RD, 2011, CRYOSPHERE, V5, P219, DOI 10.5194/tc-5-219-2011; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; Dery SJ, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031474; Ford KR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065008; Ge Y, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012798; Hartmann DL, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P159; Hickling R, 2006, GLOBAL CHANGE BIOL, V12, P450, DOI 10.1111/j.1365-2486.2006.01116.x; Hitch AT, 2007, CONSERV BIOL, V21, P534, DOI 10.1111/j.1523-1739.2006.00609.x; Jost G, 2007, J HYDROL, V347, P101, DOI 10.1016/j.jhydrol.2007.09.006; Kuznetsova A, 2014, LMERTEST TESTS RANDO; Lemke P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P337; Lundquist JD, 2013, WATER RESOUR RES, V49, P6356, DOI 10.1002/wrcr.20504; Lundquist JD, 2008, WATER RESOUR RES, V44, DOI 10.1029/2008WR006979; Lutz JA, 2012, NORTHWEST SCI, V86, P108, DOI 10.3955/046.086.0203; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pauli JN, 2013, FRONT ECOL ENVIRON, V11, P260, DOI 10.1890/120222; Pinzer BR, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039618; R Core Team, 2014, R LANG ENV STAT COMP, DOI [10.1016/j.jneumeth.2014.06.019, DOI 10.1016/J.JNEUMETH.2014.06.019]; Rowlands DJ, 2012, NAT GEOSCI, V5, P256, DOI [10.1038/NGEO1430, 10.1038/ngeo1430]; Scull P, 2007, PHYS GEOGR, V28, P360, DOI 10.2747/0272-3646.28.4.360; Sinha T, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012188; Storck P, 2002, WATER RESOUR RES, V38, DOI 10.1029/2002WR001281; Suggitt AJ, 2011, OIKOS, V120, P1, DOI 10.1111/j.1600-0706.2010.18270.x; Thomas CD, 2006, TRENDS ECOL EVOL, V21, P415, DOI 10.1016/j.tree.2006.05.012; Varhola A, 2010, J HYDROL, V392, P219, DOI 10.1016/j.jhydrol.2010.08.009; Williams CM, 2015, BIOL REV, V90, P214, DOI 10.1111/brv.12105; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279	30	27	27	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0127613	10.1371/journal.pone.0127613	http://dx.doi.org/10.1371/journal.pone.0127613			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024489	Green Published, gold, Green Submitted			2022-12-26	WOS:000355319400044
J	Wirth, K; Peter, RS; Saely, CH; Concin, H; Nagel, G				Wirth, Katharina; Peter, Raphael S.; Saely, Christoph H.; Concin, Hans; Nagel, Gabriele			Long-Term Weight Change: Association with Impaired Glucose Metabolism in Young Austrian Adults	PLOS ONE			English	Article							BODY-MASS INDEX; CARDIOVASCULAR-DISEASE; FASTING GLUCOSE; OBESITY; PREVALENCE; OVERWEIGHT; COHORT; RISK; MEN; MORTALITY	Little is known about the associations between long-term weight change and the natural history of impaired fasting glucose (IFG) in young adults. We investigated the association between long-term body mass index (BMI) change and the risk of IFG using data of 24,930 20- to 40-year-old participants from the Vorarlberg Health Monitoring and Promotion Program (VHM&PP) cohort. Poisson models were applied to estimate the 10-year risk for new development of IFG (>= 5.6 mmol/L), and persistence of IFG. Over 10 years, most men (68.2%) and women (70.0%) stayed within their initial BMI category. The risk for incident IFG was highest for men and women with persisting obesity (37.4% and 24.1%) and lowest with persisting normal weight (15.7% and 9.3%). Men transitioning from normal to overweight increased their risk of incident IFG by factor 1.45 (95%- CI: 1.31, 1.62), women by 1.70 (95%- CI: 1.50, 1.93), whereas transitioning from overweight to normal weight decreased the risk in men by 0.69 (95%- CI: 0.53, 0.90) and 0.94 (95%- CI: 0.66, 1.33) in women. Relative risks for men and women transitioning from obesity to overweight were 0.58 and 0.44, respectively. In conclusion, 10 year weight increase was associated with an increased IFG risk, weight decrease with a decreased risk of IFG in young adults.	[Wirth, Katharina; Peter, Raphael S.; Nagel, Gabriele] Univ Ulm, Inst Epidemiol & Med Biometry, D-89069 Ulm, Germany; [Saely, Christoph H.] Vorarlberg Inst Vasc Investigat & Treatment, Feldkirch, Austria; [Saely, Christoph H.] Acad Teaching Hosp Feldkirch, Dept Med & Cardiol, Feldkirch, Austria; [Saely, Christoph H.] Private Univ Principal Liechtenstein, Triesen, Liechtenstein; [Concin, Hans; Nagel, Gabriele] Agcy Prevent & Social Med, Bregenz, Austria	Ulm University	Nagel, G (corresponding author), Univ Ulm, Inst Epidemiol & Med Biometry, D-89069 Ulm, Germany.	gabriele.nagel@uni-ulm.de	Peter, Raphael/J-3101-2019; Nagel, Gabriele/C-3635-2012; vhmpp, aks/F-9756-2012	Peter, Raphael/0000-0003-4310-9500; Nagel, Gabriele/0000-0001-6185-8535; 	federal state of Vorarlberg	federal state of Vorarlberg	The VHM& PP was supported by the federal state of Vorarlberg.	Adams KF, 2014, AM J EPIDEMIOL, V179, P135, DOI 10.1093/aje/kwt254; [Anonymous], 2014, AM J HUM BIOL; Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; Chen CM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1123; Coutinho M, 1999, DIABETES CARE, V22, P233, DOI 10.2337/diacare.22.2.233; Cowie CC, 2010, DIABETES CARE, V33, P562, DOI 10.2337/dc09-1524; Gabir MM, 2000, DIABETES CARE, V23, P1108, DOI 10.2337/diacare.23.8.1108; Gallus S., 2014, EUR J NUTR, P1, DOI [DOI 10.1007/S00394-014-0776-Y, 10.1007/s00394-014-0776-y]; Grossschadl F, 2013, EUR J PUBLIC HEALTH, V23, P306, DOI 10.1093/eurpub/cks033; Hastie T., 1986, STAT SCI, V1, P297; Jacobs-van der Bruggen MAM, 2010, AM J EPIDEMIOL, V172, P263, DOI 10.1093/aje/kwq134; Kim SM, 2006, DIABETES CARE, V29, P226, DOI 10.2337/diacare.29.02.06.dc05-0481; Klenk J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084817; Kodama S, 2013, EPIDEMIOLOGY, V24, P778, DOI 10.1097/EDE.0b013e31829f6c31; Koebnick C, 2012, ANN EPIDEMIOL, V22, P609, DOI 10.1016/j.annepidem.2012.05.006; Lahti-Koski M, 2001, INT J OBESITY, V25, P727, DOI 10.1038/sj.ijo.0801588; Lee DC, 2011, CIRCULATION, V124, P2483, DOI 10.1161/CIRCULATIONAHA.111.038422; Mensink GBM, 2013, BUNDESGESUNDHEITSBLA, V56, P786, DOI 10.1007/s00103-012-1656-3; Nagel G, 2008, CLIN CHEM, V54, P317, DOI 10.1373/clinchem.2007.094821; Rapp K, 2005, BRIT J CANCER, V93, P1062, DOI 10.1038/sj.bjc.6602819; Schmidt M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002698; Shaw JA, 1999, DIABETES CARE, V22, P399, DOI 10.2337/diacare.22.3.399; Song SH, 2013, ADV EXP MED BIOL, V771, P51; Stabouli S, 2012, HELL J CARDIOL, V53, P41; The NS, 2013, DIABETES CARE, V36, P865, DOI 10.2337/dc12-0536; The NS, 2010, JAMA-J AM MED ASSOC, V304, P2042, DOI 10.1001/jama.2010.1635; Tirosh A, 2011, NEW ENGL J MED, V364, P1315, DOI 10.1056/NEJMoa1006992; Ulmer H, 2003, EUR HEART J, V24, P1004, DOI 10.1016/S0195-668X(03)00170-2; Vazquez G, 2007, EPIDEMIOL REV, V29, P115, DOI 10.1093/epirev/mxm008; Wannamethee SG, 2005, J EPIDEMIOL COMMUN H, V59, P134, DOI 10.1136/jech.2003.015651	30	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0127186	10.1371/journal.pone.0127186	http://dx.doi.org/10.1371/journal.pone.0127186			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024372	gold, Green Submitted, Green Published			2022-12-26	WOS:000355319400031
J	Amend, SR; Wilson, WC; Chu, L; Lu, L; Liu, PY; Serie, D; Su, XM; Xu, YL; Wang, DY; Gramolini, A; Wen, XY; O'Neal, J; Hurchla, M; Vachon, CM; Colditz, G; Vij, R; Weilbaecher, KN; Tomasson, MH				Amend, Sarah R.; Wilson, William C.; Chu, Liang; Lu, Lan; Liu, Pengyuan; Serie, Daniel; Su, Xinming; Xu, Yalin; Wang, Dingyan; Gramolini, Anthony; Wen, Xiao-Yan; O'Neal, Julie; Hurchla, Michelle; Vachon, Celine M.; Colditz, Graham; Vij, Ravi; Weilbaecher, Katherine N.; Tomasson, Michael H.			Whole Genome Sequence of Multiple Myeloma-Prone C57BL/KaLwRij Mouse Strain Suggests the Origin of Disease Involves Multiple Cell Types	PLOS ONE			English	Article							UNDETERMINED SIGNIFICANCE MGUS; MONOCLONAL GAMMOPATHY; GENE-EXPRESSION; MODEL; HACS1; RISK	Monoclonal gammopathy of undetermined significance (MGUS) is the requisite precursor to multiple myeloma (MM), a malignancy of antibody-producing plasma B-cells. The genetic basis of MGUS and its progression to MM remains poorly understood. C57BL/KaLwRij (KaLwRij) is a spontaneously-derived inbred mouse strain with a high frequency of benign idiopathic paraproteinemia (BIP), a phenotype with similarities to MGUS including progression to MM. Using mouse haplotype analysis, human MM SNP array data, and whole exome and whole genome sequencing of KaLwRij mice, we identified novel KaLwRij gene variants, including deletion of Samsn1 and deleterious point mutations in Tnfrsf22 and Tnfrsf23. These variants significantly affected multiple cell types implicated in MM pathogenesis including B-cells, macrophages, and bone marrow stromal cells. These data demonstrate that multiple cell types contribute to MM development prior to the acquisition of somatic driver mutations in KaLwRij mice, and suggest that MM may an inherently non-cell autonomous malignancy.	[Amend, Sarah R.; Wilson, William C.; Chu, Liang; Lu, Lan; Su, Xinming; Xu, Yalin; O'Neal, Julie; Hurchla, Michelle; Vij, Ravi; Weilbaecher, Katherine N.; Tomasson, Michael H.] Washington Univ, Sch Med, Div Oncol, St Louis, MO 63130 USA; [Liu, Pengyuan] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Colditz, Graham] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA; [Wang, Dingyan; Gramolini, Anthony; Wen, Xiao-Yan] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Serie, Daniel; Vachon, Celine M.] Mayo Clin, Coll Med, Dept Hlth Sci Res, Div Epidemiol, Rochester, MN USA	Washington University (WUSTL); Medical College of Wisconsin; Washington University (WUSTL); University of Toronto; Mayo Clinic	Tomasson, MH (corresponding author), Washington Univ, Sch Med, Div Oncol, St Louis, MO 63130 USA.	tomasson@dom.wustl.edu	Wilson, William/Y-8857-2019; Su, Xinming/G-1643-2012; Colditz, Graham/A-3963-2009	Wilson, William/0000-0002-7877-9224; Colditz, Graham/0000-0002-7307-0291; Wen, Xiao-Yan/0000-0001-6728-0025; Wilson, William/0000-0002-1526-5939; Tomasson, Michael/0000-0003-4518-7123; Amend, Sarah R./0000-0002-5606-1262	National Institute on Aging [R21AG040777]; National Cancer Institute [1F31CA174096-01A1, R01 CA097250, 2P01 CA100730]; St. Louis Men's Group against Cancer; Washington University Musculoskeletal Research Center (National Institutes of Health) [P30 AR057235]; Barnes Jewish Foundation; NATIONAL CANCER INSTITUTE [P01CA100730, R01CA097250, F31CA174096, T32CA113275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG040777] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); St. Louis Men's Group against Cancer; Washington University Musculoskeletal Research Center (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Barnes Jewish Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institute on Aging R21AG040777 (to MHT), the National Cancer Institute 1F31CA174096-01A1 (to SRA), the National Cancer Institute R01 CA097250, 2P01 CA100730 (to KNW, MH, YX, SRA, and XS), the St. Louis Men's Group against Cancer and Barnes Jewish Foundation (to KNW, MH, YX, SRA, and XS), and the Washington University Musculoskeletal Research Center (National Institutes of Health P30 AR057235) (to MH). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chng WJ, 2007, CANCER RES, V67, P2982, DOI 10.1158/0008-5472.CAN-06-4046; Claudio J, 2001, ONCOGENE, V20, P5373, DOI 10.1038/sj.onc.1204698; Colucci S, 2004, BLOOD, V104, P3722, DOI 10.1182/blood-2004-02-0474; Davies FE, 2003, BLOOD, V102, P4504, DOI 10.1182/blood-2003-01-0016; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Epstein J, 1543, SCID HU MYELOMA MODE; Fowler JA, 2011, BLOOD, V118, P5872, DOI 10.1182/blood-2011-01-330407; Garrett IR, 1997, BONE, V20, P515, DOI 10.1016/S8756-3282(97)00056-2; Kumar SK, 2014, LEUKEMIA, V28, P1122, DOI 10.1038/leu.2013.313; Kyle RA, 2010, LEUKEMIA, V24, P1121, DOI 10.1038/leu.2010.60; Kyle RA, 2006, NEW ENGL J MED, V354, P1362, DOI 10.1056/NEJMoa054494; Landgren O, 2006, BLOOD, V107, P904, DOI 10.1182/blood-2005-08-3449; Lohr JG, 1878, WIDESPREAD GENETIC H; RADL J, 1978, CLIN EXP IMMUNOL, V33, P395; Sarah Amend LC, 2013, 55 AM SOC HEM ANN M; Schneider P, IDENTIFICATION NEW M; von Holleben M, 2011, J BIOL CHEM, V286, P13489, DOI 10.1074/jbc.M110.155184; Wang DY, 2010, FASEB J, V24, P947, DOI 10.1096/fj.09-140806; Weinhold N, 2014, BLOOD, V123, P2513, DOI 10.1182/blood-2013-10-532283; Zhu YX, 2004, J EXP MED, V200, P737, DOI 10.1084/jem.20031816	21	21	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0127828	10.1371/journal.pone.0127828	http://dx.doi.org/10.1371/journal.pone.0127828			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020268	gold, Green Published, Green Submitted			2022-12-26	WOS:000355187300058
J	Babur, BK; Kabiri, M; Klein, TJ; Lott, WB; Doran, MR				Babur, Betul Kul; Kabiri, Mahboubeh; Klein, Travis Jacob; Lott, William B.; Doran, Michael Robert			The Rapid Manufacture of Uniform Composite Multicellular-Biomaterial Micropellets, Their Assembly into Macroscopic Organized Tissues, and Potential Applications in Cartilage Tissue Engineering	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; ARTICULAR-CARTILAGE; MATRIX; KNEE	We and others have published on the rapid manufacture of micropellet tissues, typically formed from 100-500 cells each. The micropellet geometry enhances cellular biological properties, and in many cases the micropellets can subsequently be utilized as building blocks to assemble complex macrotissues. Generally, micropellets are formed from cells alone, however when replicating matrix-rich tissues such as cartilage it would be ideal if matrix or biomaterials supplements could be incorporated directly into the micropellet during the manufacturing process. Herein we describe a method to efficiently incorporate donor cartilage matrix into tissue engineered cartilage micropellets. We lyophilized bovine cartilage matrix, and then shattered it into microscopic pieces having average dimensions < 10 mu m diameter; we termed this microscopic donor matrix "cartilage dust (CD)". Using a microwell platform, we show that similar to 0.83 mu g CD can be rapidly and efficiently incorporated into single multicellular aggregates formed from 180 bone marrow mesenchymal stem/stromal cells (MSC) each. The microwell platform enabled the rapid manufacture of thousands of replica composite micropellets, with each micropellet having a material/CD core and a cellular surface. This micropellet organization enabled the rapid bulking up of the micropellet core matrix content, and left an adhesive cellular outer surface. This morphological organization enabled the ready assembly of the composite micropellets into macroscopic tissues. Generically, this is a versatile method that enables the rapid and uniform integration of biomaterials into multicellular micropellets that can then be used as tissue building blocks. In this study, the addition of CD resulted in an approximate 8-fold volume increase in the micropellets, with the donor matrix functioning to contribute to an increase in total cartilage matrix content. Composite micropellets were readily assembled into macroscopic cartilage tissues; the incorporation of CD enhanced tissue size and matrix content, but did not enhance chondrogenic gene expression.	[Babur, Betul Kul; Kabiri, Mahboubeh; Lott, William B.; Doran, Michael Robert] Queensland Univ Technol, Translat Res Inst, Inst Hlth & Biomed Innovat, Stem Cell Therapies Lab, Brisbane, Qld 4001, Australia; [Kabiri, Mahboubeh] Univ Tehran, Coll Sci, Dept Biotechnol, Tehran, Iran; [Klein, Travis Jacob] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Cartilage Regenerat Lab, Brisbane, Qld 4001, Australia; [Doran, Michael Robert] Univ Queensland, Mater Med Res, Brisbane, Qld, Australia	Queensland University of Technology (QUT); University of Tehran; Queensland University of Technology (QUT); Mater Research; University of Queensland	Doran, MR (corresponding author), Queensland Univ Technol, Translat Res Inst, Inst Hlth & Biomed Innovat, Stem Cell Therapies Lab, Brisbane, Qld 4001, Australia.	michael.doran@qut.edu.au	Doran, Michael R/F-6059-2014; Lott, William B/J-1062-2012; Kabiri, Mahboubeh/ABE-1182-2021; Klein, Travis/J-1117-2012	Lott, William B/0000-0001-7118-7560; Klein, Travis/0000-0002-6669-7766; Doran, Michael/0000-0001-5876-4757	Australian National Health and Medical Research Council (NHMRC) [631629]	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This study was funded by the Australian National Health and Medical Research Council (NHMRC), grant number 631629 (https://www.nhmrc.gov.au/), MRD received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babur BK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058865; Barbour KE, 2013, MMWR-MORBID MORTAL W, V62, P869; Behrens P, 1999, MMW Fortschr Med, V141, P49; Bhumiratana S, 2014, P NATL ACAD SCI USA, V111, P6940, DOI 10.1073/pnas.1324050111; Brand CA, 2013, ARTHRITIS CARE RES H; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; Buckwalter JA, 2004, CLIN ORTHOP RELAT R, P7, DOI 10.1097/01.blo.0000131638.81519.de; Chen A, 2012, ARTHRITIS, DOI 10.1155/2012/698709; Chen CC, 2012, J ORTHOP RES, V30, P393, DOI 10.1002/jor.21541; Chen WC, 2011, J BIOSCI BIOENG, V111, P226, DOI 10.1016/j.jbiosc.2010.10.002; Ebert JR, 2008, OSTEOARTHR CARTILAGE, V16, P1131, DOI 10.1016/j.joca.2008.03.010; Ghanavi P, 2012, CELL TISSUE RES, V347, P643, DOI 10.1007/s00441-012-1323-x; Gong YY, 2011, BIOMATERIALS, V32, P2265, DOI 10.1016/j.biomaterials.2010.11.078; Johnstone B, 2013, EUR CELLS MATER, V25, P248, DOI 10.22203/eCM.v025a18; Markway BD, 2010, CELL TRANSPLANT, V19, P29, DOI 10.3727/096368909X478560; Minas T, 1999, CLIN SPORT MED, V18, P13, DOI 10.1016/S0278-5919(05)70128-9; Murphy CM, 2012, J MECH BEHAV BIOMED, V11, P53, DOI 10.1016/j.jmbbm.2011.11.009; Peretti GM, 1998, J ORTHOP RES, V16, P89, DOI 10.1002/jor.1100160115; Peretti GM, 2000, TISSUE ENG, V6, P567, DOI 10.1089/107632700750022206; Peretti GM, 2003, J BIOMED MATER RES A, V64A, P517, DOI 10.1002/jbm.a.10367; POTTENGER LA, 1982, J BIOL CHEM, V257, P1479; Robertson WB, 2004, STANDARD PRACTICE EX; Schuurman W, 2013, J TISSUE ENG REGENER; Shin YS, 2014, INT J PEDIATR OTORHI, V78, P32, DOI 10.1016/j.ijporl.2013.10.014; Woolf AD, 2003, B WORLD HEALTH ORGAN, V81, P646; Yang Q, 2008, BIOMATERIALS, V29, P2378, DOI 10.1016/j.biomaterials.2008.01.037; Zheng XF, 2011, J MATER SCI-MATER M, V22, P693, DOI 10.1007/s10856-011-4248-0	27	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0122250	10.1371/journal.pone.0122250	http://dx.doi.org/10.1371/journal.pone.0122250			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020956	Green Published, Green Submitted, gold			2022-12-26	WOS:000355187300003
J	Romero, IC; Schwing, PT; Brooks, GR; Larson, RA; Hastings, DW; Ellis, G; Goddard, EA; Hollander, DJ				Romero, Isabel C.; Schwing, Patrick T.; Brooks, Gregg R.; Larson, Rebekka A.; Hastings, David W.; Ellis, Greg; Goddard, Ethan A.; Hollander, David J.			Hydrocarbons in Deep-Sea Sediments following the 2010 Deepwater Horizon Blowout in the Northeast Gulf of Mexico	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; TERRIGENOUS ORGANIC-MATTER; SURFACE SEDIMENTS; MISSISSIPPI RIVER; OIL-SPILL; POLYAROMATIC HYDROCARBONS; PETROLEUM BIOMARKERS; SOURCE APPORTIONMENT; ATCHAFALAYA RIVER; COASTAL SEDIMENTS	The Deepwater Horizon (DWH) spill released 4.9 million barrels of oil into the Gulf of Mexico (GoM) over 87 days. Sediment and water sampling efforts were concentrated SW of the DWH and in coastal areas. Here we present geochemistry data from sediment cores collected in the aftermath of the DWH event from 1000 - 1500 m water depth in the DeSoto Canyon, NE of the DWH wellhead. Cores were analyzed at high-resolution (at 2 mm and 5 mm intervals) in order to evaluate the concentration, composition and input of hydrocarbons to the seafloor. Specifically, we analyzed total organic carbon (TOC), aliphatic, polycyclic aromatic hydrocarbon (PAHs), and biomarker (hopanes, steranes, diasteranes) compounds to elucidate possible sources and transport pathways for deposition of hydrocarbons. Results showed higher hydrocarbon concentrations during 2010-2011 compared to years prior to 2010. Hydrocarbon inputs in 2010-2011 were composed of a mixture of sources including terrestrial, planktonic, and weathered oil. Our results suggest that after the DWH event, both soluble and highly insoluble hydrocarbons were deposited at enhanced rates in the deep-sea. We proposed two distinct transport pathways of hydrocarbon deposition: 1) sinking of oil-particle aggregates (hydrocarbon-contaminated marine snow and/or suspended particulate material), and 2) advective transport and direct contact of the deep plume with the continental slope surface sediments between 1000-1200 m. Our findings underline the complexity of the depositional event observed in the aftermath of the DWH event in terms of multiple sources, variable concentrations, and spatial (depth-related) variability in the DeSoto Canyon, NE of the DWH wellhead.	[Romero, Isabel C.; Schwing, Patrick T.; Larson, Rebekka A.; Ellis, Greg; Goddard, Ethan A.; Hollander, David J.] Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA; [Brooks, Gregg R.; Larson, Rebekka A.; Hastings, David W.] Eckerd Coll, St Petersburg, FL 33711 USA	State University System of Florida; University of South Florida	Romero, IC (corresponding author), Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA.	isabelromero@mail.usf.edu	Schwing, Patrick/AAK-8593-2020	Schwing, Patrick/0000-0001-8466-4952; Goddard, Ethan/0000-0001-6749-7937; Romero, Isabel C./0000-0002-8590-5989	British Petroleum/Florida Institute of Oceanography (BP/FIO)-Gulf Oil Spill Prevention, Response, and Recovery Grants Program; BP/The Gulf of Mexico Research Initiative (GOMRI); Deep Sea to Coast Connectivity in the Eastern Gulf of Mexico (Deep-C) consortia	British Petroleum/Florida Institute of Oceanography (BP/FIO)-Gulf Oil Spill Prevention, Response, and Recovery Grants Program; BP/The Gulf of Mexico Research Initiative (GOMRI); Deep Sea to Coast Connectivity in the Eastern Gulf of Mexico (Deep-C) consortia	The authors acknowledge the British Petroleum/Florida Institute of Oceanography (BP/FIO)-Gulf Oil Spill Prevention, Response, and Recovery Grants Program for funding several of the initial research cruises and laboratory analysis during 2010 and 2011. This research was made possible by funding from BP/The Gulf of Mexico Research Initiative (GOMRI), specifically the Center for Integrated Modeling and Analysis of the Gulf Ecosystem (C-IMAGE) and the Deep Sea to Coast Connectivity in the Eastern Gulf of Mexico (Deep-C) consortia.	Aeppli C, 2014, ENVIRON SCI TECHNOL, V48, P6726, DOI 10.1021/es500825q; Ahad JME, 2011, MAR CHEM, V126, P239, DOI 10.1016/j.marchem.2011.06.002; [Anonymous], 2007, 8015C EM, P1; APPLEBY PG, 1983, HYDROBIOLOGIA, V103, P29, DOI 10.1007/BF00028424; Barakat AO, 2002, SPILL SCI TECHNOL B, V7, P229, DOI 10.1016/S1353-2561(02)00039-7; Barakat AO, 2011, MAR POLLUT BULL, V62, P1969, DOI 10.1016/j.marpolbul.2011.06.024; Baumard P, 1998, MAR POLLUT BULL, V36, P951, DOI 10.1016/S0025-326X(98)00088-5; Binford, 1990, J PALEOLIMNOL, V3, P253, DOI DOI 10.1007/BF00219461; Brodie CR, 2011, QUATERNARY SCI REV, V30, P3076, DOI 10.1016/j.quascirev.2011.07.003; Camilli R, 2010, SCIENCE, V330, P201, DOI 10.1126/science.1195223; Chang YL, 2011, OCEAN DYNAM, V61, P829, DOI 10.1007/s10236-011-0397-4; Chanton JP, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/4/045303; Commendatore MG, 2012, MAR ENVIRON RES, V74, P20, DOI 10.1016/j.marenvres.2011.11.010; Corbett DR, 2006, CONT SHELF RES, V26, P2125, DOI 10.1016/j.csr.2006.07.012; Dickhut RM, 2000, ENVIRON SCI TECHNOL, V34, P4635, DOI 10.1021/es000971e; Diercks AR, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045046; El Nemr A, 2013, ENVIRON MONIT ASSESS, V185, P4571, DOI 10.1007/s10661-012-2889-1; Goni MA, 1997, NATURE, V389, P275, DOI 10.1038/38477; Goni MA, 1998, GEOCHIM COSMOCHIM AC, V62, P3055, DOI 10.1016/S0016-7037(98)00217-8; Gordon ES, 2004, MAR CHEM, V92, P331, DOI 10.1016/j.marchem.2004.06.035; Gordon ES, 2003, GEOCHIM COSMOCHIM AC, V67, P2359, DOI 10.1016/S0016-7037(02)01412-6; Graham WM, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/4/045301; Harrison RM, 1996, ENVIRON SCI TECHNOL, V30, P825, DOI 10.1021/es950252d; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; Hu LM, 2009, MAR CHEM, V113, P197, DOI 10.1016/j.marchem.2009.02.001; Iqbal J, 2007, MAR POLLUT BULL, V54, P792, DOI 10.1016/j.marpolbul.2007.02.004; Joye SB, 2011, NAT GEOSCI, V4, P160, DOI [10.1038/ngeo1067, 10.1038/NGEO1067]; KENNICUTT MC, 1988, AQUAT TOXICOL, V11, P191, DOI 10.1016/0166-445X(88)90013-6; Kessler JD, 2011, SCIENCE, V331, P312, DOI 10.1126/science.1199697; Khelifa A, 2005, DEV EARTH ENV SCI, V3, P131; Kostka JE, 2011, APPL ENVIRON MICROB, V77, P7962, DOI 10.1128/AEM.05402-11; Kujau A, 2010, PALAEOGEOGR PALAEOCL, V298, P311, DOI 10.1016/j.palaeo.2010.10.005; Lang YH, 2014, B ENVIRON CONTAM TOX, V92, P30, DOI 10.1007/s00128-013-1164-7; Li GC, 2006, ENVIRON POLLUT, V144, P985, DOI 10.1016/j.envpol.2006.01.047; Lin Q, 2012, IMPACTS RECOVERY DEE; Liu ZF, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/035302; LONG ER, 1995, ENVIRON MANAGE, V19, P81, DOI 10.1007/BF02472006; MacDonald IR, 2002, GEOFLUIDS, V2, P95, DOI 10.1046/j.1468-8123.2002.00023.x; MCGRODDY SE, 1995, ENVIRON SCI TECHNOL, V29, P1542, DOI 10.1021/es00006a016; McNutt MK, 2012, P NATL ACAD SCI USA, V109, P20222, DOI 10.1073/pnas.1214389109; Mitra S, 2003, MAR CHEM, V82, P273, DOI 10.1016/S0304-4203(03)00074-4; Mitra S, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL049505; Montagna PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070540; Mulabagal V, 2013, MAR POLLUT BULL, V70, P147, DOI 10.1016/j.marpolbul.2013.02.026; Murawski SA, 2014, T AM FISH SOC, V143, P1084, DOI 10.1080/00028487.2014.911205; Ocean Studies Board and Marine Board, 2003, OIL SEA; OSAT-1, 2010, SUMM REP SUBS SUBS O; Paris CB, 2012, ENVIRON SCI TECHNOL, V46, P13293, DOI 10.1021/es303197h; Passow U, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/035301; Payne JR, 2003, SPILL SCI TECHNOL B, V8, P201, DOI 10.1016/S1353-2561(03)00048-3; Peterson CH, 1996, CAN J FISH AQUAT SCI, V53, P2637, DOI 10.1139/cjfas-53-11-2637; Presley BJ, 1998, HIST CONTAMINATION M; Qiao M, 2006, ENVIRON INT, V32, P28, DOI 10.1016/j.envint.2005.04.005; Reddy CM, 2012, P NATL ACAD SCI USA, V109, P20229, DOI 10.1073/pnas.1101242108; Rosenheim BE, 2016, DEEP-SEA RES PT II, V129, P249, DOI 10.1016/j.dsr2.2014.03.020; Rowe G., 2009, NO GULF MEXICO CONTI; Ruttenberg KC, 1997, MAR GEOL, V139, P123, DOI 10.1016/S0025-3227(96)00107-7; Ryerson TB, 2012, P NATL ACAD SCI USA, V109, P20246, DOI 10.1073/pnas.1110564109; Santschi PH, 2001, MAR ENVIRON RES, V52, P51, DOI 10.1016/S0141-1136(00)00260-9; Scarlett A, 2007, J SOIL SEDIMENT, V7, P200, DOI 10.1065/jss2007.06.232; Schaum J, 2010, ENVIRON SCI TECHNOL, V44, P9383, DOI 10.1021/es103559w; Schneider AR, 2001, ENVIRON SCI TECHNOL, V35, P3809, DOI 10.1021/es002044d; Schwing P, 2015, PLOS ONE; Song Z, 2008, GEOFLUIDS, V8, P293, DOI 10.1111/j.1468-8123.2008.00225.x; Tansel B, 2011, MAR POLLUT BULL, V62, P2659, DOI 10.1016/j.marpolbul.2011.09.026; Turpin R., 1999, INT OIL SPILL C P, V1999, P1287, DOI [10.7901/2169-3358-1999-1-1287, DOI 10.7901/2169-3358-1999-1-1287]; USEPA (United States Environmental Protection Agency), 2007, TECHNICAL RESOURCE D, P1; Valentine DL, 2014, P NATL ACAD SCI USA, V111, P15906, DOI 10.1073/pnas.1414873111; Valentine DL, 2012, P NATL ACAD SCI USA, V109, P20286, DOI 10.1073/pnas.1108820109; Valentine DL, 2010, SCIENCE, V330, P208, DOI 10.1126/science.1196830; Valentine MM, 2013, MAR POLLUT BULL, V77, P196, DOI 10.1016/j.marpolbul.2013.10.004; Valsangkar AB, 2007, CURRENT SCI, V92, P5; VERSCHUREN D, 1993, LIMNOL OCEANOGR, V38, P1796, DOI 10.4319/lo.1993.38.8.1796; Wang CY, 2013, MAR POLLUT BULL, V71, P64, DOI 10.1016/j.marpolbul.2013.03.034; Wang CP, 2011, MAR POLLUT BULL, V62, P2714, DOI 10.1016/j.marpolbul.2011.09.016; Wang ZD, 2003, MAR POLLUT BULL, V47, P423, DOI 10.1016/S0025-326X(03)00215-7; Waterson EJ, 2008, ORG GEOCHEM, V39, P422, DOI 10.1016/j.orggeochem.2008.01.011; Weisberg RH, 2011, GEOPHYS MONOGR SER, V195, P205, DOI 10.1029/2011GM001131; White HK, 2012, P NATL ACAD SCI USA, V109, P20303, DOI 10.1073/pnas.1118029109; Yu CC, 1992, PETROGENIC BIOGENIC, P53; Yunker MB, 2003, ORG GEOCHEM, V34, P1429, DOI 10.1016/S0146-6380(03)00136-0; Zhang ZL, 2004, ENVIRON POLLUT, V130, P249, DOI 10.1016/j.envpol.2003.12.002; Ziervogel K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034816	83	80	80	0	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128371	10.1371/journal.pone.0128371	http://dx.doi.org/10.1371/journal.pone.0128371			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020923	gold, Green Published, Green Submitted			2022-12-26	WOS:000355187300104
J	Yang, J; Yang, XD; Lin, YH; Ng, TB; Lin, J; Ye, XY				Yang, Jie; Yang, Xiaodan; Lin, Yonghui; Ng, Tzi Bun; Lin, Juan; Ye, Xiuyun			Laccase-Catalyzed Decolorization of Malachite Green: Performance Optimization and Degradation Mechanism	PLOS ONE			English	Article							RESPONSE-SURFACE METHODOLOGY; TRIPHENYLMETHANE DYES; BIODEGRADATION; DETOXIFICATION; PURIFICATION; REDUCTION; GENE	Malachite green (MG) was decolorized by laccase (LacA) of white-rot fungus Cerrena sp. with strong decolorizing ability. Decolorization conditions were optimized with response surface methodology. A highly significant quadratic model was developed to investigate MG decolorization with LacA, and the maximum MG decolorization ratio of 91.6% was predicted under the conditions of 2.8 U mL(-1) LacA, 109.9 mg L-1 MG and decolorization for 172.4 min. Kinetic studies revealed the Km and kcat values of LacA toward MG were 781.9 mM and 9.5 s(-1), respectively. UV-visible spectra confirmed degradation of MG, and the degradation mechanism was explored with liquid chromatography-mass spectrometry (LC-MS) analysis. Based on the LC-MS spectra of degradation products, LacA catalyzed MG degradation via two simultaneous pathways. In addition, the phytotoxicity of MG, in terms of inhibition on seed germination and seedling root elongation of Nicotiana tabacum and Lactuca sativa, was reduced after laccase treatment. These results suggest that laccase of Cerrena was effective in decolorizing MG and promising in bioremediation of wastewater in food and aquaculture industries.	[Yang, Jie; Yang, Xiaodan; Lin, Juan; Ye, Xiuyun] Fuzhou Univ, Coll Biol Sci & Technol, Fuzhou 350002, Fujian, Peoples R China; [Yang, Jie; Yang, Xiaodan; Lin, Juan; Ye, Xiuyun] Fujian Key Lab Marine Enzyme Engn, Fuzhou, Fujian, Peoples R China; [Lin, Yonghui] Fujian Entry Exit Inspect & Quarantine Bur, Ctr Tech, Fuzhou, Fujian, Peoples R China; [Ng, Tzi Bun] Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China	Fuzhou University; Chinese University of Hong Kong	Lin, J (corresponding author), Fuzhou Univ, Coll Biol Sci & Technol, Fuzhou 350002, Fujian, Peoples R China.	ljuan@fzu.edu.cn; xiuyunye@fzu.edu.cn			Natural Science Foundation of China [41306120]; Oceanic Public Welfare Industry Special Research Project of China [2013418015]; Fujian Provincial Development and Reform Commission Bio-industry Special Project [[2011]1598]; Fuzhou Science and Technology Bureau [2012-G-125]; Foundation of Key Laboratory of Yangtze River Water Environment, Ministry of Education (Tongji University), China [YRWEF201506]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Oceanic Public Welfare Industry Special Research Project of China; Fujian Provincial Development and Reform Commission Bio-industry Special Project; Fuzhou Science and Technology Bureau; Foundation of Key Laboratory of Yangtze River Water Environment, Ministry of Education (Tongji University), China	The work was funded by grants from Natural Science Foundation of China (41306120), Oceanic Public Welfare Industry Special Research Project of China (2013418015), Fujian Provincial Development and Reform Commission Bio-industry Special Project ([2011]1598), Fuzhou Science and Technology Bureau (2012-G-125) and the Foundation of Key Laboratory of Yangtze River Water Environment, Ministry of Education (Tongji University), China, (No. YRWEF201506). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azmi W, 1998, ENZYME MICROB TECH, V22, P185, DOI 10.1016/S0141-0229(97)00159-2; Balan K, 2012, J TAIWAN INST CHEM E, V43, P776, DOI 10.1016/j.jtice.2012.04.005; Ben Younes S, 2011, EUR FOOD RES TECHNOL, V233, P751, DOI 10.1007/s00217-011-1569-7; Berberidou C, 2007, APPL CATAL B-ENVIRON, V74, P63, DOI 10.1016/j.apcatb.2007.01.013; Bergwerff AA, 2003, J CHROMATOGR B, V788, P351, DOI 10.1016/S1570-0232(03)00042-4; Cha CJ, 2001, APPL ENVIRON MICROB, V67, P4358, DOI 10.1128/AEM.67.9.4358-4360.2001; Chen CC, 2007, J HAZARD MATER, V141, P520, DOI 10.1016/j.jhazmat.2006.07.011; Chhabra M, 2009, J BIOTECHNOL, V143, P69, DOI 10.1016/j.jbiotec.2009.06.011; Couto SR, 2006, BIOTECHNOL ADV, V24, P500, DOI 10.1016/j.biotechadv.2006.04.003; Daassi D, 2012, J ENVIRON MANAGE, V108, P84, DOI 10.1016/j.jenvman.2012.04.039; Du LN, 2011, ECOTOXICOLOGY, V20, P438, DOI 10.1007/s10646-011-0595-3; Eggert C, 1998, APPL ENVIRON MICROB, V64, P1766; Fischer AR, 2011, CHEMOSPHERE, V82, P210, DOI 10.1016/j.chemosphere.2010.10.019; Forgacs E, 2004, ENVIRON INT, V30, P953, DOI 10.1016/j.envint.2004.02.001; Jang MS, 2005, APPL ENVIRON MICROB, V71, P7955, DOI 10.1128/AEM.71.12.7955-7960.2005; Jasinska A, 2012, INT BIODETER BIODEGR, V73, P33, DOI 10.1016/j.ibiod.2012.06.025; Kalyani DC, 2008, BIORESOURCE TECHNOL, V99, P4635, DOI 10.1016/j.biortech.2007.06.058; Kang HW, 2014, BIOTECHNOL BIOPROC E, V19, P519, DOI 10.1007/s12257-013-0663-z; Kumar VV, 2012, J MOL CATAL B-ENZYM, V74, P63, DOI 10.1016/j.molcatb.2011.08.015; Maalej-Kammoun M, 2009, INT BIODETER BIODEGR, V63, P600, DOI 10.1016/j.ibiod.2009.04.003; Morozova OV, 2007, APPL BIOCHEM MICRO+, V43, P523, DOI 10.1134/S0003683807050055; Murugesan K, 2009, APPL MICROBIOL BIOT, V82, P341, DOI 10.1007/s00253-008-1819-1; Papinutti VL, 2004, FEMS MICROBIOL LETT, V231, P205, DOI 10.1016/S0378-1097(03)00957-1; Parshetti G, 2006, ACTA CHIM SLOV, V53, P492; Piontek K, 2002, J BIOL CHEM, V277, P37663, DOI 10.1074/jbc.M204571200; Pogni R, 2015, CELL MOL LIFE SCI, V72, P885, DOI 10.1007/s00018-014-1825-7; Rahman IA, 2005, BIORESOURCE TECHNOL, V96, P1578, DOI 10.1016/j.biortech.2004.12.015; Roriz MS, 2009, J HAZARD MATER, V169, P691, DOI 10.1016/j.jhazmat.2009.03.150; Saravanakumar T, 2013, APPL BIOCHEM BIOTECH, V171, P1178, DOI 10.1007/s12010-013-0220-4; Sathishkumar P, 2013, CLEAN-SOIL AIR WATER, V41, P665, DOI 10.1002/clen.201100521; Solomon EI, 2001, ANGEW CHEM INT EDIT, V40, P4570, DOI 10.1002/1521-3773(20011217)40:24<4570::AID-ANIE4570>3.0.CO;2-4; Srivastava S, 2004, AQUAT TOXICOL, V66, P319, DOI 10.1016/j.aquatox.2003.09.008; Tamayo-Ramos JA, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-165; Wang JY, 2012, INT CONF INFORM SCI, P7, DOI 10.1109/ISISE.2012.11; Wong DWS, 2009, APPL BIOCHEM BIOTECH, V157, P174, DOI 10.1007/s12010-008-8279-z; Yang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110834; Zhang C, 2013, J AGR FOOD CHEM, V61, P5468, DOI 10.1021/jf4010498	37	35	41	3	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0127714	10.1371/journal.pone.0127714	http://dx.doi.org/10.1371/journal.pone.0127714			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020270	Green Published, gold, Green Submitted			2022-12-26	WOS:000355187300052
J	Arizzi, A; Brummer, M; Martin-Sanchez, I; Cultrone, G; Viles, H				Arizzi, Anna; Bruemmer, Monika; Martin-Sanchez, Ines; Cultrone, Giuseppe; Viles, Heather			The Influence of the Type of Lime on the Hygric Behaviour and Bio-Receptivity of Hemp Lime Composites Used for Rendering Applications in Sustainable New Construction and Repair Works	PLOS ONE			English	Article							FIBERS; CONCRETE	The benefits of using sustainable building materials are linked not only to the adoption of manufacturing processes that entail reduced pollution, CO2 emissions and energy consumption, but also to the onset of improved performance in the building. In particular, hemplime composite shows low shrinkage and high thermal and acoustic insulating properties. However, this material also shows a great ability to absorb water, an aspect that can turn out to be negative for the long-term durability of the building. For this reason, the hygric properties of hemp-based composites need to be studied to ensure the correct use of this material in construction and repair works. The water absorption, drying and transpirability of hemp composites made with aerial (in the form of dry powder and putty) and hydraulic limes were investigated here and related to the microbial growth induced by the water movements within the material. Results show that hemp-natural hydraulic lime mixes exhibit the highest transpirability and drying rate, the lowest water absorption by immersion and capillary uptake and the least intense microbial attack and chromatic change. A microscopical study of the hemp shives also related their great ability to absorb water to the near-irreversible swelling of their structure under dry-wet conditions.	[Arizzi, Anna; Viles, Heather] Univ Oxford, Sch Geog & Environm, Oxford OX1 3QY, England; [Bruemmer, Monika] CANNABRIC, E-18500 Granada, Spain; [Martin-Sanchez, Ines] Univ Granada, Dept Microbiol, Granada 18002, Spain; [Cultrone, Giuseppe] Univ Granada, Dept Mineral & Petrol, Granada 18002, Spain	University of Oxford; University of Granada; University of Granada	Arizzi, A (corresponding author), Univ Oxford, Sch Geog & Environm, Dyson Perrins Bldg,South Parks Rd, Oxford OX1 3QY, England.	anna.arizzi@ouce.ox.ac.uk	Cultrone, Giuseppe/ABF-7168-2021; Arizzi, Anna/A-8608-2019	Arizzi, Anna/0000-0002-8996-0205; Viles, Heather/0000-0002-2444-1295	European Union [326983]; Spanish project of the Ministerio de Ciencia y Competitividad [MAT-2012-34473]	European Union(European Commission); Spanish project of the Ministerio de Ciencia y Competitividad	The research leading to these results has received funding from the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 326983 (NaturALiMe), and the Spanish project MAT-2012-34473 of the Ministerio de Ciencia y Competitividad. Author MB, owner of the CANNABRIC company, had some role in the design and preparation of mortar samples and in the preparation of this manuscript, but did not have any additional role in data collection and analysis. The specific role of this author is articulated in the author contributions section.	Amziane S, 2013, BIOAGGREGATE BASED B, p[83, 122]; Anna A, 2014, ENVIRON EARTH SCI, V71, P1699, DOI 10.1007/s12665-013-2574-x; [Anonymous], 2000, 1971 EN; [Anonymous], 2011, 15886 UNEEN; [Anonymous], 2008, 13755 UNIEN CNRICR; [Anonymous], 1988, 2988 NORMAL CNRICR; [Anonymous], 2010, 4591 BSEN; [Anonymous], 2000, 1925 UNIEN CNRICR; Arandigoyen M, 2006, APPL SURF SCI, V252, P8077, DOI 10.1016/j.apsusc.2005.10.019; Arnaud L, 2012, CONSTR BUILD MATER, V28, P50, DOI 10.1016/j.conbuildmat.2011.07.052; Benavente D, 2009, ENVIRON GEOL, V56, P1495, DOI 10.1007/s00254-008-1246-8; Bevan R, 2008, HEMP LIME CONSTRUCTI, P9; Bledzki AK, 1999, PROG POLYM SCI, V24, P221, DOI 10.1016/S0079-6700(98)00018-5; Colinart T, 2012, CONSTR BUILD MATER, V30, P372, DOI 10.1016/j.conbuildmat.2011.12.030; Collet F, 2008, CONSTR BUILD MATER, V22, P1271, DOI 10.1016/j.conbuildmat.2007.01.018; Cutler N, 2010, GEOMICROBIOL J, V27, P630, DOI 10.1080/01490451003702933; Faruk O, 2012, PROG POLYM SCI, V37, P1552, DOI 10.1016/j.progpolymsci.2012.04.003; Faure P, 2012, CEMENT CONCRETE RES, V42, P1468, DOI 10.1016/j.cemconres.2012.07.007; Groot C, 2010, TC203RHM RILEM ITAM; Groot C.J.W.P., 2010, HERON, V55, P141; Hall C, 2007, P R SOC A, V463, P1871, DOI 10.1098/rspa.2007.1855; Lawrence M, 2013, PROC INST CIV ENG-CO, V166, P257, DOI 10.1680/coma.12.00031; Le Troedec M, 2009, J EUR CERAM SOC, V29, P1861, DOI 10.1016/j.jeurceramsoc.2008.11.016; Mwaikambo LY, 2002, J APPL POLYM SCI, V84, P2222, DOI 10.1002/app.10460; Newman G, 2008, EUROPEAN DECORTICATI; Nozahic V, 2012, CEMENT CONCRETE COMP, V34, P231, DOI 10.1016/j.cemconcomp.2011.09.002; Pejic BM, 2008, BIORESOURCE TECHNOL, V99, P7152, DOI 10.1016/j.biortech.2007.12.073; SCHERER GW, 1990, J AM CERAM SOC, V73, P3, DOI 10.1111/j.1151-2916.1990.tb05082.x; Sgriccia N, 2008, COMPOS PART A-APPL S, V39, P1632, DOI 10.1016/j.compositesa.2008.07.007; Valadez-Gonzalez A, 1999, COMPOS PART B-ENG, V30, P309, DOI 10.1016/S1359-8368(98)00054-7; Veniale F, 2002, CEMENT CONCRETE COMP, V25, P1123; Walker P, 2005, RAMMED EARTH DESIGN, P14; Wood C, 2010, THESIS U OXFORD	33	12	12	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0125520	10.1371/journal.pone.0125520	http://dx.doi.org/10.1371/journal.pone.0125520			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26017563	Green Published, gold			2022-12-26	WOS:000355185600025
J	Gordon, T; Hendry, M; Lafontaine, CA; Cartar, H; Zhang, JJ; Borschel, GH				Gordon, Tessa; Hendry, Michael; Lafontaine, Christine A.; Cartar, Holliday; Zhang, Jennifer J.; Borschel, Gregory H.			Nerve Cross-Bridging to Enhance Nerve Regeneration in a Rat Model of Delayed Nerve Repair	PLOS ONE			English	Article							TO-SIDE NEURORRHAPHY; NEUROTROPHIC FACTOR EXPRESSION; POOR FUNCTIONAL RECOVERY; SCHWANN-CELLS; AXONAL REGENERATION; MOTOR UNITS; WALLERIAN DEGENERATION; IMPAIRED REGENERATION; CONTRIBUTING FACTORS; PARTIAL DENERVATION	There are currently no available options to promote nerve regeneration through chronically denervated distal nerve stumps. Here we used a rat model of delayed nerve repair asking of prior insertion of side-to-side cross-bridges between a donor tibial (TIB) nerve and a recipient denervated common peroneal (CP) nerve stump ameliorates poor nerve regeneration. First, numbers of retrogradely-labelled TIB neurons that grew axons into the nerve stump within three months, increased with the size of the perineurial windows opened in the TIB and CP nerves. Equal numbers of donor TIB axons regenerated into CP stumps either side of the cross-bridges, not being affected by target neurotrophic effects, or by removing the perineurium to insert 5-9 cross-bridges. Second, CP nerve stumps were coapted three months after inserting 0-9 cross-bridges and the number of 1) CP neurons that regenerated their axons within three months or 2) CP motor nerves that reinnervated the extensor digitorum longus (EDL) muscle within five months was determined by counting and motor unit number estimation (MUNE), respectively. We found that three but not more cross-bridges promoted the regeneration of axons and reinnervation of EDL muscle by all the CP motoneurons as compared to only 33% regenerating their axons when no cross-bridges were inserted. The same 3-fold increase in sensory nerve regeneration was found. In conclusion, side-to-side cross-bridges ameliorate poor regeneration after delayed nerve repair possibly by sustaining the growth-permissive state of denervated nerve stumps. Such autografts may be used in human repair surgery to improve outcomes after unavoidable delays.	[Gordon, Tessa; Hendry, Michael; Lafontaine, Christine A.; Cartar, Holliday; Zhang, Jennifer J.; Borschel, Gregory H.] Univ Toronto, Hosp Sick Children, Dept Surg, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Gordon, T (corresponding author), Univ Toronto, Hosp Sick Children, Dept Surg, Toronto, ON M5G 1X8, Canada.	tessat.gordon@gmail.com			Canadian Institutes of Health Research [253172]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research #253172.	ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; Akeda K, 2006, PLAST RECONSTR SURG, V117, P1194, DOI 10.1097/01.prs.0000201460.54187.d7; Al-Qattan MM, 1998, BRIT J PLAST SURG, V51, P238, DOI 10.1054/bjps.1997.0188; Arthur-Farraj PJ, 2012, NEURON, V75, P633, DOI 10.1016/j.neuron.2012.06.021; Bain JR, 2001, NEUROSCIENCE, V103, P503, DOI 10.1016/S0306-4522(00)00577-7; BEUCHE W, 1984, J NEUROCYTOL, V13, P767, DOI 10.1007/BF01148493; Boyd JG, 2001, J NEUROBIOL, V49, P314, DOI 10.1002/neu.10013; Boyd JG, 2002, EUR J NEUROSCI, V15, P613, DOI 10.1046/j.1460-9568.2002.01891.x; Boyd JG, 2003, MOL NEUROBIOL, V27, P277, DOI 10.1385/MN:27:3:277; BRAUNEWELL KH, 1995, EUR J NEUROSCI, V7, P792, DOI 10.1111/j.1460-9568.1995.tb00682.x; Bruck W, 1997, BRAIN PATHOL, V7, P741, DOI 10.1111/j.1750-3639.1997.tb01060.x; Brushart TM, 2013, EXP NEUROL, V247, P272, DOI 10.1016/j.expneurol.2013.05.007; Brushart TM, 2002, J NEUROSCI, V22, P6631; CHEN S, 1993, J COMP NEUROL, V335, P576, DOI 10.1002/cne.903350409; Fricker FR, 2011, FUTUR NEUROL, V6, P809, DOI 10.2217/FNL.11.45; Fricker FR, 2011, J NEUROSCI, V31, P3225, DOI 10.1523/JNEUROSCI.2568-10.2011; FU SY, 1995, J NEUROSCI, V15, P3876; FU SY, 1995, J NEUROSCI, V15, P3886; Fu SY, 1997, MOL NEUROBIOL, V14, P67, DOI 10.1007/BF02740621; Furey MJ, 2007, NEUROSURGERY, V60, P723, DOI 10.1227/01.NEU.0000255412.63184.CC; Gaudet AD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-110; Goheen-Robillard B, 2002, LARYNGOSCOPE, V112, P899, DOI 10.1097/00005537-200205000-00022; GORDON T, 1993, BRAIN RES BULL, V30, P477, DOI 10.1016/0361-9230(93)90281-F; GORDON T, 1982, J PHYSIOL-LONDON, V323, P307, DOI 10.1113/jphysiol.1982.sp014074; Gordon T, 2014, EXP NEUROL, V254, P99, DOI 10.1016/j.expneurol.2014.01.012; Gordon T, 2011, J NEUROSCI, V31, P5325, DOI 10.1523/JNEUROSCI.6156-10.2011; Gordon T, 2010, J COMMUN DISORD, V43, P265, DOI 10.1016/j.jcomdis.2010.04.003; Groves ML, 2005, EXP NEUROL, V195, P278, DOI 10.1016/j.expneurol.2005.04.007; Hall SM, 1999, ANN NY ACAD SCI, V883, P215, DOI 10.1111/j.1749-6632.1999.tb08584.x; Haninec P, 2007, J NEUROSURG, V106, P391, DOI 10.3171/jns.2007.106.3.391; Hart AM, 2002, EXP BRAIN RES, V142, P308, DOI 10.1007/s00221-001-0929-0; Hayashi A, 2008, EXP NEUROL, V211, P539, DOI 10.1016/j.expneurol.2008.02.031; Hegedus J, 2008, J PHYSIOL-LONDON, V586, P3337, DOI 10.1113/jphysiol.2007.149286; Hendry JM, 2015, NEUROSURG IN PRESS; Hirata K, 1999, J NEUROCYTOL, V28, P685, DOI 10.1023/A:1007012916530; Hirata K, 2002, MICROSC RES TECHNIQ, V57, P541, DOI 10.1002/jemt.10108; HOFFER JA, 1979, BRAIN RES, V178, P347, DOI 10.1016/0006-8993(79)90698-X; Hoke A, 2006, J NEUROSCI, V26, P9646, DOI 10.1523/JNEUROSCI.1620-06.2006; Hoke A, 2002, EXP NEUROL, V173, P77, DOI 10.1006/exnr.2001.7826; Houle JD, 2006, J NEUROSCI, V26, P7405, DOI 10.1523/JNEUROSCI.1166-06.2006; Hudson A R, 1977, Clin Neurosurg, V24, P391; Huebner EA, 2009, RESULTS PROBL CELL D, V48, P339, DOI 10.1007/400_2009_19; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; Jessen KR, 2008, GLIA, V56, P1479, DOI 10.1002/glia.20779; Kemp SWP, 2013, J PERIPHER NERV SYST, V18, P220, DOI 10.1111/jns5.12035; Knott EP, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/651625; Ladak A, 2011, NEUROSURGERY, V68, P1654, DOI 10.1227/NEU.0b013e31821246a8; Liu K, 1999, J ORTHOP RES, V17, P293, DOI 10.1002/jor.1100170220; Lundborg G., 2004, NERVE INJURY REPAIR; MACKINNON SE, 1991, MUSCLE NERVE, V14, P1116, DOI 10.1002/mus.880141113; Magill CK, 2010, ARCH FACIAL PLAST S, V12, P315, DOI 10.1001/archfacial.2010.71; Major LA, 2007, J NEUROPHYSIOL, V97, P1846, DOI 10.1152/jn.00904.2006; MILNER TE, 1981, J NEUROL NEUROSUR PS, V44, P485, DOI 10.1136/jnnp.44.6.485; Mirsky R, 2008, J PERIPHER NERV SYST, V13, P122, DOI 10.1111/j.1529-8027.2008.00168.x; Moore AM, 2012, J NEUROSCI METH, V204, P19, DOI 10.1016/j.jneumeth.2011.10.011; More HL, 2011, J NEUROSCI METH, V201, P149, DOI 10.1016/j.jneumeth.2011.07.026; MORRISSEY TK, 1995, P NATL ACAD SCI USA, V92, P1431, DOI 10.1073/pnas.92.5.1431; Mueller M, 2001, AM J PATHOL, V159, P2187, DOI 10.1016/S0002-9440(10)63070-2; Oyamatsu H, 2012, J PLAST SURG HAND SU, V46, P299, DOI 10.3109/2000656X.2012.696264; RAFUSE VF, 1992, J NEUROPHYSIOL, V68, P1261, DOI 10.1152/jn.1992.68.4.1261; Ray WZ, 2010, EXP NEUROL, V223, P77, DOI 10.1016/j.expneurol.2009.03.031; Rotshenker S, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-109; SCHMALBRUCH H, 1986, ANAT REC, V215, P71, DOI 10.1002/ar.1092150111; Stoll G, 1999, BRAIN PATHOL, V9, P313; STOLL G, 1989, J NEUROCYTOL, V18, P671, DOI 10.1007/BF01187086; Sulaiman OAR, 2000, GLIA, V32, P234, DOI 10.1002/1098-1136(200012)32:3<234::AID-GLIA40>3.0.CO;2-3; Tam S.L., 2011, ENCL NEUROSCI, P1; Tam SL, 2003, J NEUROCYTOL, V32, P961, DOI 10.1023/B:NEUR.0000020635.41233.0f; Tarasidis G, 1997, ANN OTO RHINOL LARYN, V106, P506, DOI 10.1177/000348949710600612; Udina E, 2010, EXP NEUROL, V223, P143, DOI 10.1016/j.expneurol.2009.08.026; Veltri K, 2005, J RECONSTR MICROSURG, V21, P57, DOI 10.1055/s-2005-862783; Viterbo F, 1998, Sao Paulo Med J, V116, P1808; VITERBO F, 1994, BRIT J PLAST SURG, V47, P75, DOI 10.1016/0007-1226(94)90162-7; Viterbo F, 1992, Rev Paul Med, V110, P267; Viterbo Fausto, 2009, Plast Reconstr Surg, V124, pe351, DOI 10.1097/PRS.0b013e3181bf8471; Walker JC, 2004, J NEUROTRAUM, V21, P217, DOI 10.1089/089771504322778677; Wang XX, 2012, EXP NEUROL, V237, P55, DOI 10.1016/j.expneurol.2012.06.009; Witzel C, 2005, J COMP NEUROL, V485, P183, DOI 10.1002/cne.20436; Yan JG, 2002, J HAND SURG-AM, V27A, P484, DOI 10.1053/jhsu.2002.32953; You SJ, 1997, GLIA, V20, P87, DOI 10.1002/(SICI)1098-1136(199706)20:2<87::AID-GLIA1>3.0.CO;2-1; Yuksel F, 1999, PLAST RECONSTR SURG, V104, P2092; Zhang ZJ, 1999, MICROSURG, V19, P281; Zuo J, 2002, EXP NEUROL, V176, P221, DOI 10.1006/exnr.2002.7922; Zuo J, 1998, J NEUROBIOL, V34, P41, DOI 10.1002/(SICI)1097-4695(199801)34:1<41::AID-NEU4>3.3.CO;2-4	84	16	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0127397	10.1371/journal.pone.0127397	http://dx.doi.org/10.1371/journal.pone.0127397			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26016986	Green Published, Green Submitted, gold			2022-12-26	WOS:000355185600081
J	Henschell, MA; Webster, CR; Flaspohler, DJ; Fortin, CR				Henschell, Max A.; Webster, Christopher R.; Flaspohler, David J.; Fortin, Chad R.			Influence of Plant Community Composition on Biomass Production in Planted Grasslands	PLOS ONE			English	Article							FLORISTIC QUALITY ASSESSMENT; SPECIES COMPOSITION; CONSUMERS GUIDE; DIVERSITY; BIODIVERSITY; SWITCHGRASS; BIOENERGY; INVASION; EVENNESS; IMPACTS	United States energy policy mandates increased use of renewable fuels. Restoring grasslands could contribute to a portion of this requirement through biomass harvest for bioenergy use. We investigated which plant community characteristics are associated with differences in biomass yield from a range of realistic native prairie plantings (n = 11; i.e., conservation planting, restoration, and wildlife cover). Our primary goal was to understand whether patterns in plant community composition and the Floristic Quality Index (FQI) were related to productivity as evidenced by dormant season biomass yield. FQI is an objective measure of how closely a plant community represents that of a pre-European settlement community. Our research was conducted in planted fields of native tallgrass prairie species, and provided a gradient in floristic quality index, species richness, species diversity, and species evenness in south-central Wisconsin during 2008 and 2009. We used a network of 15 randomly located 1 m(2) plots within each field to characterize the plant community and estimate biomass yield by clipping the plots at the end of each growing season. While plant community composition and diversity varied significantly by planting type, biomass yield did not vary significantly among planting types (ANOVA; P > 0.05). Biomass yield was positively correlated with plant community evenness, richness, C4 grass cover, and floristic quality index, but negatively correlated with plant species diversity in our multi-season multiple linear mixed effects models. Concordantly, plots with biomass yield in the lowest quartile (biomass yield <3500 kh/ha) had 8% lower plant community evenness and 9% lower FQI scores than those in the upper quartile (biomass yield > 5800 kh/ha). Our results suggest that promoting the establishment of fields with high species evenness and floristic quality may increase biomass yield, while simultaneously supporting biodiversity.	[Henschell, Max A.; Webster, Christopher R.; Flaspohler, David J.; Fortin, Chad R.] Michigan Technol Univ, Sch Forest Resources & Environm Sci, Houghton, MI 49931 USA	Michigan Technological University	Henschell, MA (corresponding author), Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI 53706 USA.	henschell@wisc.edu			National Science Foundation Materials Use: Science, Engineering, and Society [0524872]; Wisconsin Focus on Energy [08-13]	National Science Foundation Materials Use: Science, Engineering, and Society; Wisconsin Focus on Energy	This work was funded by the National Science Foundation (www.nsf.gov) Materials Use: Science, Engineering, and Society grant #0524872 and from the Wisconsin Focus on Energy (https://focusonenergy.com) grant # 08-13. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PR, 2006, AGRON J, V98, P1518, DOI 10.2134/agronj2005.0351; Adler PR, 2009, ECOL APPL, V19, P2202, DOI 10.1890/07-2094.1; Anderson D, 2004, MODEL SELECTION MULT, V2nd; Baer SG, 2002, ECOL APPL, V12, P1688, DOI 10.1890/1051-0761(2002)012[1688:CIESAF]2.0.CO;2; Bernthal TW, 2003, DEV FLORISTIC QUALIT, P22; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; CAMARGO JA, 1992, B ENVIRON CONTAM TOX, V48, P428; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Chalcraft DR, 2009, BIODIVERS CONSERV, V18, P91, DOI 10.1007/s10531-008-9457-6; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Cohen MJ, 2004, ECOL APPL, V14, P784, DOI 10.1890/02-5378; Di Virgilio N, 2007, FIELD CROP RES, V101, P232, DOI 10.1016/j.fcr.2006.11.009; Fargione JE, 2005, ECOL LETT, V8, P604, DOI 10.1111/j.1461-0248.2005.00753.x; Fargione JE, 2009, BIOSCIENCE, V59, P767, DOI 10.1525/bio.2009.59.9.8; Garlock RJ, 2012, BIOMASS BIOENERG, V37, P49, DOI 10.1016/j.biombioe.2011.12.036; Gorley C.K., 2006, GETTING STARTED PRIM; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Herman KD, 1997, NAT AREA J, V17, P265; Hill J, 2006, P NATL ACAD SCI USA, V103, P11206, DOI 10.1073/pnas.0604600103; Johnson MVV, 2010, BIOENERG RES, V3, P353, DOI 10.1007/s12155-010-9094-2; Jungers JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061209; Keshwani DR, 2009, BIORESOURCE TECHNOL, V100, P1515, DOI 10.1016/j.biortech.2008.09.035; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Lee D, 2013, GCB BIOENERGY, V5, P6, DOI 10.1111/j.1757-1707.2012.01177.x; Liebman M, 2013, RENEW AGR FOOD SYST, V28, P115, DOI 10.1017/S1742170512000300; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; MCKANE RB, 1990, ECOLOGY, V71, P1126, DOI 10.2307/1937380; Mitchell R, 2008, BIOFUEL BIOPROD BIOR, V2, P530, DOI 10.1002/bbb.106; Monti A, 2009, BIOMASS BIOENERG, V33, P841, DOI 10.1016/j.biombioe.2009.01.006; Mushet DM, 2002, WETLANDS, V22, P126, DOI 10.1672/0277-5212(2002)022[0126:FQAOON]2.0.CO;2; Naeem S, 2000, OIKOS, V91, P97, DOI 10.1034/j.1600-0706.2000.910108.x; Paine LK, 1996, BIOMASS BIOENERG, V10, P231, DOI 10.1016/0961-9534(95)00072-0; Peet RK, 1998, FLEXIBLE MULTIPURPOS, P63; R Core Development Team, 2013, R LANG ENV STAT COMP; Robertson BA, 2013, BIOENERG RES, V6, P311, DOI 10.1007/s12155-012-9258-3; Robertson BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016941; Roscher C, 2009, ACTA OECOL, V35, P206, DOI 10.1016/j.actao.2008.10.003; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Smith B, 1996, OIKOS, V76, P70, DOI 10.2307/3545749; Smith MD, 2003, ECOL LETT, V6, P509, DOI 10.1046/j.1461-0248.2003.00454.x; Stevens MHH, 2001, OIKOS, V92, P291, DOI 10.1034/j.1600-0706.2001.920211.x; Swink F, 1979, PLANTS CHICAGO REGIO; Taft JB, 2006, BIOL CONSERV, V131, P42, DOI 10.1016/j.biocon.2006.02.006; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; Tilman D, 2006, SCIENCE, V314, P1598, DOI 10.1126/science.1133306; Tuomisto H, 2012, OIKOS, V121, P1203, DOI 10.1111/j.1600-0706.2011.19897.x; U. S. Energy Information Administration. Monthly Energy Review February 2015, 2015, DOEEIA0035 OFF EN ST, P224; van Ruijven J, 2005, P NATL ACAD SCI USA, V102, P695, DOI 10.1073/pnas.0407524102; Webster CR, 2010, BIOFUELS-UK, V1, P451, DOI 10.4155/BFS.10.18; Werling BP, 2014, P NATL ACAD SCI USA, V111, P1652, DOI 10.1073/pnas.1309492111; White R.P., 2000, GRASSLAND ECOSYSTEMS; Wilsey BJ, 2011, PERSPECT PLANT ECOL, V13, P265, DOI 10.1016/j.ppees.2011.07.002; Yurkonis KA, 2005, J ECOL, V93, P1053, DOI 10.1111/j.1365-2745.2005.01029.x; Zar J.H., 1999, ZAR KUHR 5 2019, V4th	55	5	5	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0125758	10.1371/journal.pone.0125758	http://dx.doi.org/10.1371/journal.pone.0125758			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018412	gold, Green Submitted, Green Published			2022-12-26	WOS:000355185600030
J	Teichert, T; Hellwig, A; Pessler, A; Hellwig, M; Vossoughi, M; Sugiri, D; Vierkotter, A; Schulte, T; Freund, J; Roden, M; Hoffmann, B; Schikowski, T; Luckhaus, C; Kramer, U; Henle, T; Herder, C				Teichert, Tom; Hellwig, Anne; Pessler, Annette; Hellwig, Michael; Vossoughi, Mohammad; Sugiri, Dorothea; Vierkoetter, Andrea; Schulte, Thomas; Freund, Juliane; Roden, Michael; Hoffmann, Barbara; Schikowski, Tamara; Luckhaus, Christian; Kraemer, Ursula; Henle, Thomas; Herder, Christian			Association between Advanced Glycation End Products and Impaired Fasting Glucose: Results from the SALIA Study	PLOS ONE			English	Article							METHYLGLYOXAL-DERIVED HYDROIMIDAZOLONE; EPSILON-CARBOXYMETHYL-LYSINE; INCREASED SERUM-LEVELS; OXIDATIVE STRESS; ENDPRODUCTS AGES; MONOCLONAL-ANTIBODY; INSULIN-RESISTANCE; RENAL FIBROSIS; PROTEIN; PLASMA	Advanced glycation end products (AGEs) may contribute to the development of type 2 diabetes and related complications, whereas their role in the early deterioration of glycaemia is unknown. While previous studies used antibody-based methods to quantify AGEs, data from tandem mass spectrometry coupled liquid chromatography (LC-MS/MS)-based measurements are limited to patients with known diabetes. Here, we used the LC-MS/MSmethod to test the hypothesis that plasma AGE levels are higher in individuals with impaired fasting glucose (IFG) than in those with normal fasting glucose (NFG). Secondary aims were to assess correlations of plasma AGEs with quantitative markers of glucose metabolism and biomarkers of subclinical inflammation. This study included on 60 women with NFG or IFG (n = 30 each, mean age 74 years) from the German SALIA cohort. Plasma levels of free metabolites (3-deoxyfructose, 3-deoxypentosone, 3-deoxypentulose), two hydroimidazolones, oxidised adducts (carboxymethyllysine, carboxyethyllysine, methionine sulfoxide) and Ne-fructosyllysine were measured using LC-MS/MS. Plasma concentrations of all tested AGEs did not differ between the NFG and IFG groups (all p>0.05). Associations between plasma levels of AGEs and fasting glucose, insulin and HOMA-IR as a measure of insulin resistance were weak (r between -0.2 and 0.2, all p>0.05). The association between 3-deoxyglucosone-derived hydroimidazolone with several proinflammatory biomarkers disappeared upon adjustment for multiple testing. In conclusion, plasma AGEs assessed by LC-MS/MS were neither increased in IFG nor associated with parameters of glucosemetabolism and subclinical inflammation in our study. Thus, these data argue against strong effects of AGEs in the early stages of deterioration of glucosemetabolism.	[Teichert, Tom; Roden, Michael; Herder, Christian] Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Clin Diabetol, Dusseldorf, Germany; [Teichert, Tom; Roden, Michael; Herder, Christian] DZD eV, Partner Dusseldorf, German Ctr Diabet Res, Dusseldorf, Germany; [Hellwig, Anne; Pessler, Annette; Hellwig, Michael; Freund, Juliane; Henle, Thomas] Tech Univ Dresden, Inst Food Chem, D-01062 Dresden, Germany; [Vossoughi, Mohammad; Sugiri, Dorothea; Vierkoetter, Andrea; Hoffmann, Barbara; Schikowski, Tamara; Kraemer, Ursula] Univ Dusseldorf, IUF Leibniz Res Inst Environm Med, Dusseldorf, Germany; [Schulte, Thomas; Luckhaus, Christian] Univ Dusseldorf, Dept Psychiat & Psychotherapy, Dusseldorf, Germany; [Roden, Michael] Univ Dusseldorf, Fac Med, Dept Endocrinol & Diabetol, Dusseldorf, Germany; [Hoffmann, Barbara] Univ Dusseldorf, Fac Med, Dusseldorf, Germany; [Schikowski, Tamara] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Schikowski, Tamara] Univ Basel, Basel, Switzerland	Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Technische Universitat Dresden; Heinrich Heine University Dusseldorf; Leibniz Institut fur Umweltmedizinische Forschung (IUF); Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; University of Basel; Swiss Tropical & Public Health Institute; University of Basel	Herder, C (corresponding author), Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Clin Diabetol, Dusseldorf, Germany.	christian.herder@ddz.uni-duesseldorf.de	Roden, Michael/AAD-3843-2019	Hellwig, Michael/0000-0001-8528-6893	Deutsche Forschungsgemeinschaft (DFG) [HE-4510/2-1, KR 1938/3-1, LU 691/4-1]; Ministry of the Environment of the State of North Rhine-Westphalia (Dusseldorf, Germany); Federal Ministry of the Environment (Berlin, Germany); DGUV (German statutory accident assurance) VT [266.1]; Ministry of Science and Research of the State of North Rhine-Westphalia (MIWF NRW); German Federal Ministry of Health (BMG); German Federal Ministry of Education and Research (BMBF)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Ministry of the Environment of the State of North Rhine-Westphalia (Dusseldorf, Germany); Federal Ministry of the Environment (Berlin, Germany); DGUV (German statutory accident assurance) VT; Ministry of Science and Research of the State of North Rhine-Westphalia (MIWF NRW); German Federal Ministry of Health (BMG); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This study was supported by research grants from the Deutsche Forschungsgemeinschaft (DFG; HE-4510/2-1, KR 1938/3-1, LU 691/4-1). SALIA received funds from the Ministry of the Environment of the State of North Rhine-Westphalia (Dusseldorf, Germany) and the Federal Ministry of the Environment (Berlin, Germany). The follow-up investigation was funded by the DGUV (German statutory accident assurance) VT 266.1. This work was supported by the Ministry of Science and Research of the State of North Rhine-Westphalia (MIWF NRW), the German Federal Ministry of Health (BMG) and in part by a grant from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD e. V.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson JL, 2005, ATHEROSCLEROSIS, V178, P115, DOI 10.1016/j.atherosclerosis.2004.08.007; Accacha S, 2013, HORM RES PAEDIAT, V80, P318, DOI 10.1159/000354831; Ahmed N, 2002, BIOCHEM J, V364, P1; Ahmed N, 2005, DIABETES CARE, V28, P2465, DOI 10.2337/diacare.28.10.2465; Ahmed N, 2005, DIABETES RES CLIN PR, V67, P3, DOI 10.1016/j.diabres.2004.09.004; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Beisswenger PJ, 2014, AMINO ACIDS, V46, P311, DOI 10.1007/s00726-013-1533-x; Beisswenger PJ, 2012, AMINO ACIDS, V42, P1171, DOI 10.1007/s00726-010-0784-z; Cai WJ, 2008, AM J PATHOL, V173, P327, DOI 10.2353/ajpath.2008.080152; Cerami C, 1997, P NATL ACAD SCI USA, V94, P13915, DOI 10.1073/pnas.94.25.13915; Davis KE, 2014, NUTR RES, V34, P478, DOI 10.1016/j.nutres.2014.04.012; Degen J, 2014, J AGR FOOD CHEM, V62, P2449, DOI 10.1021/jf405546q; Evans JL, 2002, ENDOCR REV, V23, P599, DOI 10.1210/er.2001-0039; Forbes JM, 2003, FASEB J, V17, P1762, DOI 10.1096/fj.02-1102fje; Forbes JM, 2014, AMINO ACIDS, V46, P321, DOI 10.1007/s00726-013-1542-9; Fosmark DS, 2006, METABOLISM, V55, P232, DOI 10.1016/j.metabol.2005.08.017; GRANDHEE SK, 1991, J BIOL CHEM, V266, P11649; Hanssen NMJ, 2013, J CLIN ENDOCR METAB, V98, pE1369, DOI 10.1210/jc.2013-1068; HAYWARD LD, 1977, CARBOHYD RES, V53, P13; Heier M, 2015, DIABETES VASC DIS RE, V12, P139, DOI 10.1177/1479164114560910; Hellwig M, 2011, CHEMBIOCHEM, V12, P1270, DOI 10.1002/cbic.201000759; Henle T, 2005, AMINO ACIDS, V29, P313, DOI 10.1007/s00726-005-0200-2; Henle T, 2003, KIDNEY INT, V63, pS145, DOI 10.1046/j.1523-1755.63.s84.16.x; Herder C, 2013, DIABETES OBES METAB, V15, P39, DOI 10.1111/dom.12155; Herder C, 2014, DIABETOLOGIA, V57, P16, DOI 10.1007/s00125-013-3061-3; Hofmann SM, 2002, DIABETES, V51, P2082, DOI 10.2337/diabetes.51.7.2082; Jakus V, 2014, PHYSIOL RES, V63, P297, DOI 10.33549/physiolres.932672; Kellow NJ, 2013, EUR J CLIN NUTR, V67, P239, DOI 10.1038/ejcn.2012.220; Kilhovd BK, 2003, METABOLISM, V52, P163, DOI 10.1053/meta.2003.50035; KNECHT KJ, 1992, ARCH BIOCHEM BIOPHYS, V294, P130, DOI 10.1016/0003-9861(92)90146-N; Kramer U, 2010, ENVIRON HEALTH PERSP, V118, P1273, DOI 10.1289/ehp.0901689; Kusunoki H, 2003, DIABETES CARE, V26, P1889, DOI 10.2337/diacare.26.6.1889; Lacinov? K., 2010, ADV MOL MECH PHARM D, P17; Liu RM, 2010, FREE RADICAL BIO MED, V48, P1, DOI 10.1016/j.freeradbiomed.2009.09.026; Mera K, 2010, J PHARM SCI-US, V99, P1614, DOI 10.1002/jps.21927; MIYATA S, 1992, J CLIN INVEST, V89, P1102, DOI 10.1172/JCI115690; Nagai R, 2003, BIOCHEM SOC T, V31, P1438; Nicholl ID, 1998, MOL MED, V4, P594, DOI 10.1007/BF03401759; Poulsen MW, 2013, FOOD CHEM TOXICOL, V60, P10, DOI 10.1016/j.fct.2013.06.052; Rabbani N, 2011, SEMIN CELL DEV BIOL, V22, P309, DOI 10.1016/j.semcdb.2011.02.015; SCHRAY KJ, 1978, ACCOUNTS CHEM RES, V11, P136, DOI 10.1021/ar50124a002; Semba RD, 2011, J NUTR, V141, P1726, DOI 10.3945/jn.111.143172; Sjogren P, 2007, ATHEROSCLEROSIS, V195, pE168, DOI 10.1016/j.atherosclerosis.2007.06.003; Stirban A, 2014, MOL METAB, V3, P94, DOI 10.1016/j.molmet.2013.11.006; Tabak AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9; Tahara N, 2012, CARDIOVASC THER, V30, P42, DOI 10.1111/j.1755-5922.2010.00177.x; Tan KCB, 2011, DIABETES-METAB RES, V27, P488, DOI 10.1002/dmrr.1188; Tan KCB, 2004, DIABETES CARE, V27, P223, DOI 10.2337/diacare.27.1.223; Teichert T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083042; Thornalley P., 2011, DRUG METABOL DRUG IN, V23, P125; Thornalley PJ, 2014, BBA-GEN SUBJECTS, V1840, P818, DOI 10.1016/j.bbagen.2013.03.025; Thornalley PJ, 2003, BIOCHEM J, V375, P581, DOI 10.1042/BJ20030763; Turk Z, 2009, CLIN LAB, V55, P431; Uribarri J, 2007, J GERONTOL A-BIOL, V62, P427, DOI 10.1093/gerona/62.4.427; Uribarri J, 2011, DIABETES CARE, V34, P1610, DOI 10.2337/dc11-0091; Usui T, 2007, BIOSCI BIOTECH BIOCH, V71, P2465, DOI 10.1271/bbb.70229; Vlassara H, 2002, J INTERN MED, V251, P87, DOI 10.1046/j.1365-2796.2002.00932.x; Vlassara H, 2002, P NATL ACAD SCI USA, V99, P15596, DOI 10.1073/pnas.242407999; Vlassara H, 2010, US ENDOCRINOL, V6, P14; Wang TN, 2012, J AM CHEM SOC, V134, P8958, DOI 10.1021/ja301994d; WELLSKNECHT KJ, 1994, DIABETES, V43, P1152, DOI 10.2337/diabetes.43.9.1152; Zhou GH, 2004, AM J PATHOL, V165, P2033, DOI 10.1016/S0002-9440(10)63254-3	62	16	16	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0128293	10.1371/journal.pone.0128293	http://dx.doi.org/10.1371/journal.pone.0128293			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018950	gold, Green Published, Green Accepted			2022-12-26	WOS:000355185600116
J	Guajardo, V; Solis, S; Sagredo, B; Gainza, F; Munoz, C; Gasic, K; Hinrichsen, P				Guajardo, Vernoica; Solis, Simon; Sagredo, Boris; Gainza, Felipe; Munoz, Carlos; Gasic, Ksenija; Hinrichsen, Patricio			Construction of High Density Sweet Cherry (Prunus avium L.) Linkage Maps Using Microsatellite Markers and SNPs Detected by Genotyping-by-Sequencing (GBS)	PLOS ONE			English	Article							GENETIC DIVERSITY; GENOME; PEACH; SOFTWARE	Linkage maps are valuable tools in genetic and genomic studies. For sweet cherry, linkage maps have been constructed using mainly microsatellite markers (SSRs) and, recently, using single nucleotide polymorphism markers (SNPs) from a cherry 6K SNP array. Genotyping-by-sequencing (GBS), a new methodology based on high-throughput sequencing, holds great promise for identification of high number of SNPs and construction of high density linkage maps. In this study, GBS was used to identify SNPs from an intra-specific sweet cherry cross. A total of 8,476 high quality SNPs were selected for mapping. The physical position for each SNP was determined using the peach genome, Peach v1.0, as reference, and a homogeneous distribution of markers along the eight peach scaffolds was obtained. On average, 65.6% of the SNPs were present in genic regions and 49.8% were located in exonic regions. In addition to the SNPs, a group of SSRs was also used for construction of linkage maps. Parental and consensus high density maps were constructed by genotyping 166 siblings from a 'Rainier' x 'Rivedel' (Ra x Ri) cross. Using Ra x Ri population, 462, 489 and 985 markers were mapped into eight linkage groups in 'Rainier', 'Rivedel' and the Ra x Ri map, respectively, with 80% of mapped SNPs located in genic regions. Obtained maps spanned 549.5, 582.6 and 731.3 cM for 'Rainier', 'Rivedel' and consensus maps, respectively, with an average distance of 1.2 cM between adjacent markers for both 'Rainier' and 'Rivedel' maps and of 0.7 cM for Ra x Ri map. High synteny and co-linearity was observed between obtained maps and with Peach v1.0. These new high density linkage maps provide valuable information on the sweet cherry genome, and serve as the basis for identification of QTLs and genes relevant for the breeding of the species.	[Guajardo, Vernoica; Solis, Simon; Gainza, Felipe] CEAF, Los Choapinos, Rengo, Chile; [Sagredo, Boris] INIA Rayentue, Inst Invest Agr, Rengo, Chile; [Munoz, Carlos] Univ Chile, Fac Ciencias Agron, Santiago, Chile; [Gasic, Ksenija] Clemson Univ, Dept Agr & Environm Sci, Clemson, SC USA; [Hinrichsen, Patricio] INIA La Platina, Inst Invest Agr, Santiago, Chile	Universidad de Chile; Clemson University	Hinrichsen, P (corresponding author), INIA La Platina, Inst Invest Agr, Santiago, Chile.	phinrichsen@inia.cl	Guajardo, Verónica/J-8190-2017; Munoz, Carlos E/A-8260-2011; Gasic, Ksenija/AAN-6234-2021; Gasic, Ksenija/H-8254-2017	Guajardo, Verónica/0000-0002-8756-628X; Gasic, Ksenija/0000-0003-4391-5262; Gasic, Ksenija/0000-0003-4391-5262; gainza, felipe/0000-0003-2513-2504	CONICYT [24121618]; FONDECYT [1121117]; FONDEF-Chile [G09I1008]; University of Chile Doctoral Program;  [CONICYT/REGIONAL/GORE/O'HIGGINS/CEAF/R08I1001]	CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); FONDEF-Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDEF); University of Chile Doctoral Program; 	This work was funded by CONICYT/REGIONAL/GORE/O'HIGGINS/CEAF/R08I1001, CONICYT fellowship 24121618, FONDECYT 1121117, FONDEF-Chile (G09I1008), and the University of Chile Doctoral Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranzana MJ, 2002, PLANT BREEDING, V121, P87, DOI 10.1046/j.1439-0523.2002.00656.x; Barba P, 2014, THEOR APPL GENET, V127, P73, DOI 10.1007/s00122-013-2202-x; Boskovic R, 1998, EUPHYTICA, V103, P273, DOI 10.1023/A:1018664600714; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Browning BL, 2011, AM J HUM GENET, V88, P173, DOI 10.1016/j.ajhg.2011.01.010; Cabrera A, 2012, TREE GENET GENOMES, V8, P237, DOI 10.1007/s11295-011-0436-9; Cabrera A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-562; Cantini C, 2001, J AM SOC HORTIC SCI, V126, P205, DOI 10.21273/JASHS.126.2.205; Carrasco B, 2013, BIOL RES, V46, P219, DOI 10.4067/S0716-97602013000300001; Clarke JB, 2009, TREE GENET GENOMES, V5, P41, DOI 10.1007/s11295-008-0166-9; Clarke JB, 2003, MOL ECOL NOTES, V3, P578, DOI 10.1046/j.1471-8286.2003.00517.x; Di Genova A, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-7; Dirlewanger E, 2004, P NATL ACAD SCI USA, V101, P9891, DOI 10.1073/pnas.0307937101; Dirlewanger E, 2002, THEOR APPL GENET, V105, P127, DOI 10.1007/s00122-002-0867-7; Eduardo I, 2013, TREE GENET GENOMES, V9, P189, DOI 10.1007/s11295-012-0546-z; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Fresnedo-Ramirez J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-750; Gardner Kyle M, 2014, G3 (Bethesda), V4, P1681, DOI 10.1534/g3.114.011023; Glaubitz JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090346; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; Guajardo V, 2013, ACTA HORTIC IN PRESS; Klagges C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054743; Koepke T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-18; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li XH, 2014, G3-GENES GENOM GENET, V4, P1971, DOI 10.1534/g3.114.012245; Ma XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033821; Olmstead JW, 2008, TREE GENET GENOMES, V4, P897, DOI 10.1007/s11295-008-0161-1; Peace C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048305; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Rauh B, 2013, 21 PLANT AN GEN C JA; Rojas G, 2008, ELECTRON J BIOTECHN, V11, DOI 10.2225/vol11-issue5-fulltext-1; Russell J, 2014, MOL BREEDING, V33, P835, DOI 10.1007/s11032-013-9996-8; Sanchez G, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-137; Sonah H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054603; Sonneveld T, 2003, THEOR APPL GENET, V107, P1059, DOI 10.1007/s00122-003-1274-4; Spindel J, 2013, THEOR APPL GENET, V126, P2699, DOI 10.1007/s00122-013-2166-x; STAM P, 1993, PLANT J, V3, P739, DOI 10.1111/j.1365-313X.1993.00739.x; Stockinger EJ, 1996, J HERED, V87, P214, DOI 10.1093/oxfordjournals.jhered.a022987; Struss D, 2002, HORTSCIENCE, V37, P191, DOI 10.21273/HORTSCI.37.1.191; Struss D, 2003, J AM SOC HORTIC SCI, V128, P904, DOI 10.21273/JASHS.128.6.0904; Tavassolian I, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-551; Van Ooijen J., 2006, SOFTWARE CALCULATION; Verde I, 2013, NAT GENET, V45, P487, DOI 10.1038/ng.2586; Verde I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035668; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Ward JA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-2	46	62	66	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127750	10.1371/journal.pone.0127750	http://dx.doi.org/10.1371/journal.pone.0127750			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011256	Green Published, gold, Green Submitted			2022-12-26	WOS:000355183900138
J	Ondoa, P; Gautam, R; Rusine, J; Lutter, R; Jurriaans, S; Kootstra, N; Karita, E; van de Wijgert, J				Ondoa, Pascale; Gautam, Raju; Rusine, John; Lutter, Rene; Jurriaans, Suzanne; Kootstra, Neeltje; Karita, Etienne; van de Wijgert, Janneke			Twelve-Month Antiretroviral Therapy Suppresses Plasma and Genital Viral Loads but Fails to Alter Genital Levels of Cytokines, in a Cohort of HIV-Infected Rwandan Women	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; BACTERIAL VAGINOSIS; TRACT; RNA; TRANSMISSION; INFLAMMATION; TRICHOMONAS; MODULATION; ACTIVATION; EXPRESSION	Background Genital viral load (GVL) is the main determinant of sexual transmission of human immune-deficiency virus (HIV). The effect of antiretroviral therapy (ART) on local cervico-vaginal immunological factors associated with GVL is poorly described. We aimed to identify the risk factors of detectable GVL, and the impact of ART on HIV genital shedding and its correlates in a cohort of HIV-infected women, attending HIV care in Kigali, Rwanda. Materials and Methods All participants were evaluated for GVL, plasma viral load (PVL), CD4 count, various sexually-transmitted infections (STIs) at baseline and at month 12. Genital concentration of 19 cytokines and mRNA expression of APOBEC3G and BST2, two host HIV restriction factors, were evaluated at baseline in all participants. Cytokine levels were re-assessed at month 12 only in participants eligible for ART at baseline. Risk factors of GVL >= 40copies/mL at baseline and month 12 were assessed using logistic regression. Effect of 12-month ART on various local and systemic immunological parameters was examined using a paired t-test and McNemar as appropriate. Results 96 of the 247 women enrolled in the study were eligible for ART. After 12 months of ART, PVL and GVL decreased to undetectable level in respectively 74 and 88% of treated participants. ART did not affect cytokine levels. HIV genital shedding occurred only when PVL was detectable. At baseline, GVL was independently associated with IL-1 beta after controlling for PVL, age and N. gonorrhea infection ( 95% CI 1.32-2.15) and at month 12 with MIP-1 beta ( 95% CI 0.96-21.32) after controlling for baseline GVL, PVL and month 12 IL-8. Conclusion Suppressive ART does not necessarily reduce genital level of immune activation. Minimizing all conditions favoring genital inflammation, including active detection and treatment of STIs, might reduce the risk of HIV transmission as supplement to the provision of potent ART.	[Ondoa, Pascale] Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, AIGHD, NL-1105 AZ Amsterdam, Netherlands; [Gautam, Raju; van de Wijgert, Janneke] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England; [Rusine, John] INTERACT Program, Kigali, Rwanda; [Rusine, John] Natl Reference Lab, Kigali, Rwanda; [Lutter, Rene] Univ Amsterdam, Acad Med Ctr, Dept Resp Med, NL-1105 AZ Amsterdam, Netherlands; [Lutter, Rene; Kootstra, Neeltje] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, NL-1105 AZ Amsterdam, Netherlands; [Jurriaans, Suzanne] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [Karita, Etienne] Project San Francisco, Kigali, Rwanda	University of Amsterdam; Academic Medical Center Amsterdam; University of Liverpool; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Ondoa, P (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, AIGHD, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	p.ondoa@aighd.org		van de Wijgert, Janneke H.H.M./0000-0003-2728-4560; Kootstra, Neeltje A./0000-0001-9429-7754	Netherlands-African partnership for Capacity development and Clinical interventions against Poverty-related diseases (NACCAP) [W 0705 201 00]; European Developing Countries Clinical Trials Partnership (EDCTP) [CT-ct-05-33070-001]	Netherlands-African partnership for Capacity development and Clinical interventions against Poverty-related diseases (NACCAP); European Developing Countries Clinical Trials Partnership (EDCTP)	This study was funded by The Netherlands-African partnership for Capacity development and Clinical interventions against Poverty-related diseases (NACCAP, grant number W 0705 201 00) and the European Developing Countries Clinical Trials Partnership (EDCTP). NACCAP: http://www.nwo.nl/en/research-and-results/programmes/NACCAP. EDCTP: http://www.edctp.org/ (grant number CT-ct-05-33070-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton G, 2008, INFECTION, V36, P147, DOI 10.1007/s15010-007-7152-2; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Blish CA, 2012, JAIDS-J ACQ IMM DEF, V61, P436, DOI 10.1097/QAI.0b013e31826c2edd; Chakraborty H, 2001, AIDS, V15, P621, DOI 10.1097/00002030-200103300-00012; Cohn MA, 2001, J INFECT DIS, V184, P410, DOI 10.1086/322780; Cu-Uvin S, 2006, JAIDS-J ACQ IMM DEF, V42, P584, DOI 10.1097/01.qai.0000229997.52246.95; Cu-Uvin S, 2010, AIDS, V24, P2486, DOI 10.1097/QAD.0b013e32833e5043; Ferreira VH, 2014, AM J REPROD IMMUNOL, V71, P543, DOI 10.1111/aji.12221; FOLKS TM, 1986, J EXP MED, V164, P280, DOI 10.1084/jem.164.1.280; French MA, 2009, J INFECT DIS, V200, P1212, DOI 10.1086/605890; Ghanem KG, 2005, J INFECT DIS, V191, P358, DOI 10.1086/427190; Goila-Gaur R, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-51; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Jarvis GA, 2012, CURR HIV RES, V10, P211, DOI 10.2174/157016212800618138; Jimenez VC, 2012, SCI REP-UK, V2, DOI 10.1038/srep00763; Johnson LF, 2008, SEX TRANSM DIS, V35, P946, DOI 10.1097/OLQ.0b013e3181812d15; Kedzierska K, 2003, REV MED VIROL, V13, P39, DOI 10.1002/rmv.369; Kovacs A, 2001, LANCET, V358, P1593, DOI 10.1016/S0140-6736(01)06653-3; Lamkanfi M, 2011, J IMMUNOL, V187, P597, DOI 10.4049/jimmunol.1100229; Lederman MM, 2011, J INFECT DIS, V204, P1217, DOI 10.1093/infdis/jir507; Low N, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000416; Ma B, 2012, ANNU REV MICROBIOL, V66, P371, DOI 10.1146/annurev-micro-092611-150157; Mirmonsef P, 2012, CURR HIV RES, V10, P202, DOI 10.2174/157016212800618165; Mitchell C, 2011, AIDS RES HUM RETROV, V27, P35, DOI 10.1089/aid.2010.0129; Mkhize NN, 2010, J VIROL, V84, P10765, DOI 10.1128/JVI.00518-10; Natividad-Villanueva GU, 2003, INT J STD AIDS, V14, P826, DOI 10.1258/095646203322556165; Neely MN, 2007, JAIDS-J ACQ IMM DEF, V44, P38, DOI 10.1097/01.qai.0000248352.18007.1f; Pillai SK, 2012, P NATL ACAD SCI USA, V109, P3035, DOI 10.1073/pnas.1111573109; Politch JA, 2012, AIDS, V26, P1535, DOI 10.1097/QAD.0b013e328353b11b; Rebbapragada A, 2008, JAIDS-J ACQ IMM DEF, V49, P520, DOI 10.1097/QAI.0b013e318189a7ca; Rusine J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064345; Rusine J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063303; *RWAND MIN HLTH, 2011, NAT HIV CAR TREATM G; Sachdeva RK, 2010, J INTERF CYTOK RES, V30, P299, DOI 10.1089/jir.2009.0056; Salter JD, 2014, TRENDS BIOCHEM SCI, V39, P373, DOI 10.1016/j.tibs.2014.07.001; Sawada M, 2006, INT J GYNECOL OBSTET, V92, P117, DOI 10.1016/j.ijgo.2005.10.004; Simhan HN, 2007, AM J OBSTET GYNECOL, V196, P59, DOI 10.1016/j.ajog.2006.08.035; Spear GT, 2008, J REPROD IMMUNOL, V78, P76, DOI 10.1016/j.jri.2007.11.001; Spear GT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019560; Tokarev A, 2009, AIDS RES HUM RETROV, V25, P1197, DOI 10.1089/aid.2009.0253; Vettore MV, 2006, J INFECTION, V52, P290, DOI 10.1016/j.jinf.2005.06.002; WHO, 2010, ANT THER HIV INF AD	42	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127201	10.1371/journal.pone.0127201	http://dx.doi.org/10.1371/journal.pone.0127201			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010956	Green Published, Green Submitted, gold			2022-12-26	WOS:000355183900072
J	Verma, M; Beaulieu-Abdelahad, D; Ait-Ghezala, G; Li, RN; Crawford, F; Mullan, M; Paris, D				Verma, Megha; Beaulieu-Abdelahad, David; Ait-Ghezala, Ghania; Li, Rena; Crawford, Fiona; Mullan, Michael; Paris, Daniel			Chronic Anatabine Treatment Reduces Alzheimer's Disease (AD)-Like Pathology and Improves Socio-Behavioral Deficits in a Transgenic Mouse Model of AD	PLOS ONE			English	Article							AMYLOID-PRECURSOR-PROTEIN; BETA OLIGOMERS; SYNAPTIC PLASTICITY; PLAQUE-FORMATION; SOCIAL MEMORY; IN-VIVO; MICE; GENE; CYCLOOXYGENASE-2; EXPRESSION	Anatabine is a minor tobacco alkaloid, which is also found in plants of the Solanaceae family and displays a chemical structure similarity with nicotine. We have shown previously that anatabine displays some anti-inflammatory properties and reduces microgliosis and tau phosphorylation in a pure mouse model of tauopathy. We therefore investigated the effects of a chronic oral treatment with anatabine in a transgenic mouse model (Tg PS1/APPswe) of Alzheimer's disease (AD) which displays pathological A beta deposits, neuroinflammation and behavioral deficits. In the elevated plus maze, Tg PS1/APPswe mice exhibited hyperactivity and disinhibition compared to wild-type mice. Six and a half months of chronic oral anatabine treatment, suppressed hyperactivity and disinhibition in Tg PS1/APPswe mice compared to Tg PS1/APPswe receiving regular drinking water. Tg PS1/APPswe mice also elicited profound social interaction and social memory deficits, which were both alleviated by the anatabine treatment. We found that anatabine reduces the activation of STAT3 and NF kappa B in the vicinity of A beta deposits in Tg PS1/APPswe mice resulting in a reduction of the expression of some of their target genes including Bace1, iNOS and Cox-2. In addition, a significant reduction in microgliosis and pathological deposition of A beta was observed in the brain of Tg PS1/APPswe mice treated with anatabine. This is the first study to investigate the impact of chronic anatabine treatment on AD-like pathology and behavior in a transgenic mouse model of AD. Overall, our data show that anatabine reduces beta-amyloidosis, neuroinflammation and alleviates some behavioral deficits in Tg PS1/APPswe, supporting further exploration of anatabine as a possible disease modifying agent for the treatment of AD.	[Verma, Megha; Beaulieu-Abdelahad, David; Ait-Ghezala, Ghania; Li, Rena; Crawford, Fiona; Mullan, Michael; Paris, Daniel] Roskamp Inst, Sarasota, FL 34243 USA; [Verma, Megha] Open Univ, Milton Keynes MK7 6AA, Bucks, England; [Mullan, Michael] Rock Creek Pharmaceut, Sarasota, FL 34243 USA	Open University - UK	Verma, M (corresponding author), Roskamp Inst, Sarasota, FL 34243 USA.	mverma@roskampinstitute.net	Verma, Megha/I-3172-2019	Verma, Megha/0000-0001-7767-612X; Ait-Ghezala, Ghania/0000-0002-9836-8617; Paris, Daniel/0000-0002-9622-0846	Rock Creek Pharmaceuticals	Rock Creek Pharmaceuticals	Rock Creek Pharmaceuticals provided support in the form of salary for author MM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Alkadhi KA, 2012, INT J NEUROPSYCHOPH, V15, P223, DOI 10.1017/S1461145711000162; APPLEBY SB, 1994, BIOCHEM J, V302, P723, DOI 10.1042/bj3020723; Babcock AA, 2015, BRAIN BEHAV IMMUN; Bachmanov AA, 2002, BEHAV GENET, V32, P435, DOI 10.1023/A:1020884312053; Baron R, 2014, AGING CELL, V13, P584, DOI 10.1111/acel.12210; BECKER JT, 1994, ARCH NEUROL-CHICAGO, V51, P585, DOI 10.1001/archneur.1994.00540180063015; Bediou B, 2009, J GERIATR PSYCH NEUR, V22, P130, DOI 10.1177/0891988709332939; Bitner RS, 2010, J PHARMACOL EXP THER, V334, P875, DOI 10.1124/jpet.110.167213; Brown GC, 2007, BIOCHEM SOC T, V35, P1119, DOI 10.1042/BST0351119; Buggia-Prevot V, 2008, J BIOL CHEM, V283, P10037, DOI 10.1074/jbc.M706579200; Caturegli P, 2012, ENDOCRINOLOGY, V153, P4580, DOI 10.1210/en.2012-1452; Chami L, 2012, J BIOL CHEM, V287, P24573, DOI 10.1074/jbc.M111.333054; Cheng D, 2013, BEHAV BRAIN RES, V245, P120, DOI 10.1016/j.bbr.2013.02.008; Cheng IH, 2007, J BIOL CHEM, V282, P23818, DOI 10.1074/jbc.M701078200; Chung JA, 2000, NEUROL CLIN, V18, P829, DOI 10.1016/S0733-8619(05)70228-0; Court JA, 2005, NEUROPATH APPL NEURO, V31, P522, DOI 10.1111/j.1365-2990.2005.00674.x; Crawley JN, 2007, BRAIN PATHOL, V17, P448, DOI 10.1111/j.1750-3639.2007.00096.x; Cui YQ, 2012, CNS NEUROSCI THER, V18, P827, DOI 10.1111/j.1755-5949.2012.00372.x; Echeverria V, 2011, J ALZHEIMERS DIS, V24, P817, DOI 10.3233/JAD-2011-102136; Ellegood J, 2013, NEUROIMAGE, V70, P288, DOI 10.1016/j.neuroimage.2012.12.029; FILE SE, 1985, BRIT J PHARMACOL, V86, P729, DOI 10.1111/j.1476-5381.1985.tb08952.x; Font-Nieves M, 2012, J BIOL CHEM, V287, P6454, DOI 10.1074/jbc.M111.327874; Frisoni GB, 1999, DEMENT GERIATR COGN, V10, P130, DOI 10.1159/000017113; Hanzel CE, 2014, NEUROBIOL AGING, V35, P2249, DOI 10.1016/j.neurobiolaging.2014.03.026; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Harris JA, 2010, NEURON, V68, P428, DOI 10.1016/j.neuron.2010.10.020; Hellstrom-Lindahl E, 2004, NEUROBIOL DIS, V15, P351, DOI 10.1016/j.nbd.2003.11.024; Heneka MT, 2010, J NEURAL TRANSM, V117, P919, DOI 10.1007/s00702-010-0438-z; Hitti FL, 2014, NATURE, V508, P88, DOI 10.1038/nature13028; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Inestrosa NC, 2013, NEUROMOL MED, V15, P549, DOI 10.1007/s12017-013-8242-1; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Kitamura Y, 1999, BIOCHEM BIOPH RES CO, V254, P582, DOI 10.1006/bbrc.1998.9981; Kotilinek LA, 2008, BRAIN, V131, P651, DOI 10.1093/brain/awn008; Kroker KS, 2013, BRAIN RES BULL, V96, P28, DOI 10.1016/j.brainresbull.2013.04.006; Kummer MP, 2011, NEURON, V71, P833, DOI 10.1016/j.neuron.2011.07.001; Lanier RK, 2015, DRUG ALCOHOL DEPEN, V146, pe167, DOI DOI 10.1016/J.DRUGALCDEP.2014.09.371; Levin ED, 2014, J PSYCHOPHARMACOL, V28, P915, DOI 10.1177/0269881114543721; Liu Q, 2007, FASEB J, V21, P61, DOI 10.1096/fj.06-5841com; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo HW, 2010, MOL CANCER RES, V8, P232, DOI 10.1158/1541-7786.MCR-09-0391; Lo HW, 2005, CANCER CELL, V7, P575, DOI 10.1016/j.ccr.2005.05.007; Maciuk A, 2008, J PHARMACEUT BIOMED, V48, P238, DOI 10.1016/j.jpba.2007.11.024; Medeiros R, 2014, AM J PATHOL, V184, P520, DOI 10.1016/j.ajpath.2013.10.010; Meilandt WJ, 2009, J NEUROSCI, V29, P1977, DOI 10.1523/JNEUROSCI.2984-08.2009; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Mrak Robert E, 2012, Int J Alzheimers Dis, V2012, P165021, DOI 10.1155/2012/165021; Newhouse P, 2012, NEUROLOGY, V78, P91, DOI 10.1212/WNL.0b013e31823efcbb; Nie HZ, 2011, NEUROCHEM RES, V36, P904, DOI 10.1007/s11064-011-0420-7; Ognibene E, 2005, BEHAV BRAIN RES, V156, P225, DOI 10.1016/j.bbr.2004.05.028; Ojo JO, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00213; Paris D, 2014, BRAIN DISORDERS THER; Paris D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055392; Paris D, 2013, EUR J PHARMACOL, V698, P145, DOI 10.1016/j.ejphar.2012.11.017; Paris D, 2011, EUR J PHARMACOL, V670, P384, DOI 10.1016/j.ejphar.2011.09.019; Sambamurti K, 2004, FASEB J, V18, P1034, DOI 10.1096/fj.03-1378fje; Srivareerat M, 2011, NEUROBIOL AGING, V32, P834, DOI 10.1016/j.neurobiolaging.2009.04.015; Takata K, 2012, J PHARMACOL SCI, V118, P331, DOI 10.1254/jphs.11R10FM; Taylor BS, 1998, J BIOL CHEM, V273, P15148, DOI 10.1074/jbc.273.24.15148; Viggiano D, 2008, BEHAV BRAIN RES, V194, P1, DOI 10.1016/j.bbr.2008.06.033; Wan J, 2010, J NEUROSCI, V30, P6873, DOI 10.1523/JNEUROSCI.0519-10.2010; Wen Y, 2008, NEURON, V57, P680, DOI 10.1016/j.neuron.2008.02.024; Yang LY, 2013, J NEUROSCI, V33, P5275, DOI 10.1523/JNEUROSCI.3200-12.2013; Yasojima K, 1999, BRAIN RES, V830, P226, DOI 10.1016/S0006-8993(99)01389-X	64	22	22	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128224	10.1371/journal.pone.0128224	http://dx.doi.org/10.1371/journal.pone.0128224			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010758	Green Submitted, Green Published, gold			2022-12-26	WOS:000355183900210
J	Kuriyama, S; Yoshida, M; Yano, S; Aiba, N; Kohno, T; Minamiya, Y; Goto, A; Tanaka, M				Kuriyama, S.; Yoshida, M.; Yano, S.; Aiba, N.; Kohno, T.; Minamiya, Y.; Goto, A.; Tanaka, M.			LPP inhibits collective cell migration during lung cancer dissemination	ONCOGENE			English	Article							LIPOMA-PREFERRED PARTNER; N-CADHERIN EXPRESSION; MATRIX METALLOPROTEINASES; FOCAL ADHESION; VALPROIC ACID; METASTASIS; INVASION; REQUIRES; DOMAIN; ADENOCARCINOMA	Lipoma preferred partner (LPP) is a LIM domain protein, which has multiple functions as an actin-binding protein and a transcriptional coactivator, and it has been suggested that LPP has some roles in cell migration or invasion, however, its role in cancer cells remains to be elucidated. Here, we showed that LPP degraded N-cadherin in lung cancer, PC14PE6 cells via regulating the expression of matrix metalloproteinase 15 (MMP-15), and loss-of-LPP increases collective cell migration (CCM) and dissemination consequently. Knockdown of LPP and its functional partner, Etv5, markedly restores the full-length N-cadherin and increases cell-cell adhesion. We investigated the common target of LPP and Etv5, and found that MMP-15 is transcribed as their direct transcriptional target. Furthermore, MMP-15 could directly digest the N-cadherin extracellular domain. LPP knockdown in PC14PE6 cells increases N-cadherin-dependent CCM in the three-dimensional collagen gel invasion assays, and promoted the dissemination of cancer cells when they were orthotopically implanted in nude mice. Immunohistochemistry of lung adenocarcinoma specimens revealed the heterogeneity of LPP intensity and complementary expression of LPP and N-cadherin in the primary tumors. These findings suggest that loss-of-LPP, Etv5 or MMP-15 can be a prognostic marker of increasing malignancy.	[Kuriyama, S.; Aiba, N.; Tanaka, M.] Akita Univ, Grad Sch, Dept Mol Med & Biochem, Akita 0108543, Japan; [Kuriyama, S.; Yoshida, M.; Aiba, N.; Goto, A.; Tanaka, M.] Akita Univ, Fac Med, Akita 0108543, Japan; [Yoshida, M.; Goto, A.] Akita Univ, Grad Sch, Dept Cellular & Organ Pathol, Akita 0108543, Japan; [Yano, S.] Kanazawa Univ, Canc Res Inst, Canc Therapeut Dev Program, Div Med Oncol, Kanazawa, Ishikawa 920, Japan; [Kohno, T.] Natl Canc Res Ctr Inst, Div Genome Biol, Grp Dev Mol Diagnost & Individualized Therapy, Chiba, Japan; [Minamiya, Y.] Akita Univ, Dept Thoras Surg, Akita 0108543, Japan	Akita University; Akita University; Akita University; Kanazawa University; Akita University	Tanaka, M (corresponding author), Akita Univ, Dept Mol Med & Biochem, Hondo 1-1-1, Akita 0108543, Japan.	mastanak@med.akita-u.ac.jp	Kuriyama, Sei/AAV-2368-2020; Goto, Akiteru/P-5775-2014	Kuriyama, Sei/0000-0002-5502-7177; Goto, Akiteru/0000-0001-8776-9004	NICHD; JST KAKENHI [24700962, 25290042, 26640068]; MEXT KAKENHI [25111702]	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); JST KAKENHI; MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Dr Yuichiro Hamanaka for kindly providing the melanoma cell lines. The MNCD2 antibody developed by Takeichi and Matsunami was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of NICHD and maintained by Department of Biology, The University of Iowa, Iowa City, IA, USA. This work is supported by JST KAKENHI (grant number 24700962, SK; grant number 25290042, 26640068, MT) and MEXT KAKENHI (grant number 25111702, SK).	Asano K, 2004, J NEURO-ONCOL, V70, P3, DOI 10.1023/B:NEON.0000040811.14908.f2; Breindel JL, 2013, CANCER RES, V73, P5053, DOI 10.1158/0008-5472.CAN-12-3775; Camand E, 2012, J CELL SCI, V125, P844, DOI 10.1242/jcs.087668; Carey MF, 2009, COLD SPRING HARB PRO, V114; Colas E, 2012, ONCOGENE, V31, P4778, DOI 10.1038/onc.2011.632; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Covington MD, 2006, AM J PHYSIOL-RENAL, V290, pF43, DOI 10.1152/ajprenal.00179.2005; Cui Zheng Yun, 2006, Cancer Res Treat, V38, P234, DOI 10.4143/crt.2006.38.4.234; d'Ortho MP, 1997, EUR J BIOCHEM, V250, P751, DOI 10.1111/j.1432-1033.1997.00751.x; de Launoit Y, 2006, BBA-REV CANCER, V1766, P79, DOI 10.1016/j.bbcan.2006.02.002; Doki Y, 1999, BRIT J CANCER, V79, P1121, DOI 10.1038/sj.bjc.6690178; Firlej V, 2008, J CELL SCI, V121, P3393, DOI 10.1242/jcs.027201; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gorenne I, 2003, AM J PHYSIOL-CELL PH, V285, pC674, DOI 10.1152/ajpcell.00608.2002; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Grunewald TGP, 2009, TRANSL ONCOL, V2, P107, DOI 10.1593/tlo.09112; Guo BQ, 2006, MOL CELL BIOL, V26, P4529, DOI 10.1128/MCB.01667-05; Haeger A, 2014, BBA-GEN SUBJECTS, V1840, P2386, DOI 10.1016/j.bbagen.2014.03.020; Hazan RB, 2000, J CELL BIOL, V148, P779, DOI 10.1083/jcb.148.4.779; Hegerfeldt Y, 2002, CANCER RES, V62, P2125; Ikebe D, 2007, GENES CELLS, V12, P197, DOI 10.1111/j.1365-2443.2007.01043.x; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kobayashi K, 2004, ONCOGENE, V23, P3089, DOI 10.1038/sj.onc.1207433; Kohutek ZA, 2009, J NEUROSCI, V29, P4605, DOI 10.1523/JNEUROSCI.5126-08.2009; Kuphal S, 2006, ONCOGENE, V25, P248, DOI 10.1038/sj.onc.1209054; Kuriyama S, 2014, J CELL BIOL, V206, P113, DOI 10.1083/jcb.201402093; Lettice LA, 2012, DEV CELL, V22, P459, DOI 10.1016/j.devcel.2011.12.010; Li B, 2003, J CELL SCI, V116, P1359, DOI 10.1242/jcs.00309; Li G, 2001, CANCER RES, V61, P3819; Maret D, 2010, NEOPLASIA, V12, P1066, DOI 10.1593/neo.10954; MIYATANI S, 1989, SCIENCE, V245, P631, DOI 10.1126/science.2762814; Nieman MT, 1999, J CELL BIOL, V147, P631, DOI 10.1083/jcb.147.3.631; Petit MMR, 2008, CIRC RES, V103, P61, DOI 10.1161/CIRCRESAHA.108.177436; Petit MMR, 2003, J BIOL CHEM, V278, P2157, DOI 10.1074/jbc.M206106200; Petit MMR, 2000, MOL BIOL CELL, V11, P117, DOI 10.1091/mbc.11.1.117; Petit MMR, 1996, GENOMICS, V36, P118, DOI 10.1006/geno.1996.0432; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Satoyoshi R, 2015, ONCOGENE, V34, P650, DOI 10.1038/onc.2013.584; Shih WT, 2012, J CELL SCI, V125, P3661, DOI 10.1242/jcs.103861; Tanaka H, 2010, NAT MED, V16, P1414, DOI 10.1038/nm.2236; Tanaka M, 1997, FEBS LETT, V402, P219, DOI 10.1016/S0014-5793(96)01537-2; Tanaka M, 2012, J CELL SCI, V125, P4343, DOI 10.1242/jcs.104083; Theveneau E, 2010, DEV CELL, V19, P39, DOI 10.1016/j.devcel.2010.06.012; Wang Y, 2003, BBA-MOL CELL RES, V1593, P115, DOI 10.1016/S0167-4889(02)00349-X; Wells A, 2008, CLIN EXP METASTAS, V25, P621, DOI 10.1007/s10585-008-9167-1; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; Xu J, 2004, J BIOL CHEM, V279, P10459, DOI 10.1074/jbc.M311891200; Yamaura T, 2000, NEOPLASIA, V2, P315, DOI 10.1038/sj.neo.7900098; Yano S, 1997, ONCOL RES, V9, P573; Zwolinska AK, 2012, ONCOGENE, V31, P3311, DOI 10.1038/onc.2011.507	52	29	29	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 25	2016	35	8					952	964		10.1038/onc.2015.155	http://dx.doi.org/10.1038/onc.2015.155			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DE7NF	26028032				2022-12-26	WOS:000370823300002
J	O'Brien, R; DeGiacomo, F; Holcomb, J; Bonner, A; Ring, KL; Zhang, NZ; Zafar, K; Weiss, A; Lager, B; Schilling, B; Gibson, BW; Chen, S; Kwak, S; Ellerby, LM				O'Brien, Robert; DeGiacomo, Francesco; Holcomb, Jennifer; Bonner, Akilah; Ring, Karen L.; Zhang, Ningzhe; Zafar, Khan; Weiss, Andreas; Lager, Brenda; Schilling, Birgit; Gibson, Bradford W.; Chen, Sylvia; Kwak, Seung; Ellerby, Lisa M.			Integration-independent Transgenic Huntington Disease Fragment Mouse Models Reveal Distinct Phenotypes and Life Span in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINAL MUTANT HUNTINGTIN; WILD-TYPE HUNTINGTIN; CASPASE CLEAVAGE; INTRANUCLEAR INCLUSIONS; REDUCES TOXICITY; RAN TRANSLATION; CAG REPEAT; PROTEIN; PHOSPHORYLATION; AGGREGATION	The cascade of events that lead to cognitive decline, motor deficits, and psychiatric symptoms in patients with Huntington disease (HD) is triggered by a polyglutamine expansion in the N-terminal region of the huntingtin (HTT) protein. A significant mechanism in HD is the generation of mutant HTT fragments, which are generally more toxic than the full-length HTT. The protein fragments observed in human HD tissue and mouse models of HD are formed by proteolysis or aberrant splicing of HTT. To systematically investigate the relative contribution of the various HTT protein proteolysis events observed in vivo, we generated transgenic mouse models of HD representing five distinct proteolysis fragments ending at amino acids 171, 463, 536, 552, and 586 with a polyglutamine length of 148. All lines contain a single integration at the ROSA26 locus, with expression of the fragments driven by the chicken beta-actin promoter at nearly identical levels. The transgenic mice N171-Q148 and N552-Q148 display significantly accelerated phenotypes and a shortened life span when compared with N463-Q148, N536-Q148, and N586-Q148 transgenic mice. We hypothesized that the accelerated phenotype was due to altered HTT protein interactions/complexes that accumulate with age. We found evidence for altered HTT complexes in caspase-2 fragment transgenic mice (N552-Q148) and a stronger interaction with the endogenous HTT protein. These findings correlate with an altered HTT molecular complex and distinct proteins in the HTT interactome set identified by mass spectrometry. In particular, we identified HSP90AA1 (HSP86) as a potential modulator of the distinct neurotoxicity of the caspase-2 fragment mice (N552-Q148) when compared with the caspase-6 transgenic mice (N586-Q148).	[O'Brien, Robert; DeGiacomo, Francesco; Holcomb, Jennifer; Bonner, Akilah; Ring, Karen L.; Zhang, Ningzhe; Zafar, Khan; Schilling, Birgit; Gibson, Bradford W.; Chen, Sylvia; Ellerby, Lisa M.] Buck Inst Res Aging, Novato, CA 94945 USA; [Weiss, Andreas] Evotec AG, D-22419 Hamburg, Germany; [Lager, Brenda; Kwak, Seung] CHDI Management CHDI Fdn Inc, Princeton, NJ 08540 USA	Buck Institute for Research on Aging; Evotec	Ellerby, LM (corresponding author), Buck Inst Res Aging, 8001 Redwood Blvd, Novato, CA 94945 USA.	lellerby@buckinstitute.org	Regan, Clinton/E-6250-2012		National Institutes of Health [T32 AG000266, F32 NS080551]; CHDI; NCRR [1S10 OD016281]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS080551] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000266] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016281] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CHDI; NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant T32 AG000266 (to L.M.E., R.O., and K.L.R.), Training Grant F32 NS080551 (to R.O.), and NCRR Shared Instrumentation Program Grant 1S10 OD016281 for TripleTOF 5600 (to B.W.G.). This work was also supported by CHDI (to L.M.E.). The authors declare that they have no conflicts of interest with the contents of this article.	Anne SL, 2007, J NEUROSCI, V27, P7318, DOI 10.1523/JNEUROSCI.1831-07.2007; Atwal RS, 2011, NAT CHEM BIOL, V7, P453, DOI [10.1038/NCHEMBIO.582, 10.1038/nchembio.582]; Baldo B, 2012, J BIOL CHEM, V287, P1406, DOI 10.1074/jbc.M111.294801; Bates GP, 1997, HUM MOL GENET, V6, P1633, DOI 10.1093/hmg/6.10.1633; Bhat KP, 2014, P NATL ACAD SCI USA, V111, P5706, DOI 10.1073/pnas.1402215111; Brown TB, 2008, HUM MOL GENET, V17, P3095, DOI 10.1093/hmg/ddn206; Cardoso F, 2014, NEURODEGENER DIS MAN, V4, P67, DOI [10.2217/nmt.13.78, 10.2217/NMT.13.78]; Carroll JB, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-59; Cleary JD, 2013, HUM MOL GENET, V22, pR45, DOI 10.1093/hmg/ddt371; Cong X, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009829; Culver BP, 2012, J BIOL CHEM, V287, P21599, DOI 10.1074/jbc.M112.359307; Daturpalli S, 2013, J MOL BIOL, V425, P4614, DOI 10.1016/j.jmb.2013.08.006; Di Pardo A, 2012, P NATL ACAD SCI USA, V109, P3528, DOI 10.1073/pnas.1114502109; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Gafni J, 2004, J BIOL CHEM, V279, P20211, DOI 10.1074/jbc.M401267200; Gafni J, 2002, J NEUROSCI, V22, P4842, DOI 10.1523/JNEUROSCI.22-12-04842.2002; Gafni J, 2012, J NEUROSCI, V32, P7454, DOI 10.1523/JNEUROSCI.6379-11.2012; Gipson TA, 2013, RNA BIOL, V10, P1647, DOI 10.4161/rna.26706; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Graham RK, 2010, J NEUROSCI, V30, P15019, DOI 10.1523/JNEUROSCI.2071-10.2010; Gu XF, 2009, NEURON, V64, P828, DOI 10.1016/j.neuron.2009.11.020; Harrison D.E., 2008, BASELINE LIFE SPAN D; Havel LS, 2011, HUM MOL GENET, V20, P1424, DOI 10.1093/hmg/ddr023; HEDREEN JC, 1991, NEUROSCI LETT, V133, P257, DOI 10.1016/0304-3940(91)90583-F; Heikkinen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050717; Hermel E, 2004, CELL DEATH DIFFER, V11, P424, DOI 10.1038/sj.cdd.4401358; Hickey MA, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-12; Hockly E, 2003, BRAIN RES BULL, V61, P469, DOI 10.1016/S0361-9230(03)00185-0; Humbert S, 2002, DEV CELL, V2, P831, DOI 10.1016/S1534-5807(02)00188-0; Iuchi S, 2003, P NATL ACAD SCI USA, V100, P2409, DOI 10.1073/pnas.0437660100; Jeong H, 2009, CELL, V137, P60, DOI 10.1016/j.cell.2009.03.018; Jia HQ, 2012, NEUROBIOL DIS, V46, P351, DOI 10.1016/j.nbd.2012.01.016; Kaltenbach LS, 2007, PLOS GENET, V3, P689, DOI 10.1371/journal.pgen.0030082; KIYAMA H, 1990, BRAIN RES, V525, P209, DOI 10.1016/0006-8993(90)90866-A; Labbadia J, 2011, J CLIN INVEST, V121, P3306, DOI 10.1172/JCI57413; Landles C, 2010, J BIOL CHEM, V285, P8808, DOI 10.1074/jbc.M109.075028; Lunkes A, 2002, MOL CELL, V10, P259, DOI 10.1016/S1097-2765(02)00602-0; Luo SQ, 2005, J CELL BIOL, V169, P647, DOI 10.1083/jcb.200412071; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Maiuri T, 2013, HUM MOL GENET, V22, P1383, DOI 10.1093/hmg/dds554; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Marcellin D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044457; Menalled LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049838; Mende-Mueller LM, 2001, J NEUROSCI, V21, P1830, DOI 10.1523/JNEUROSCI.21-06-01830.2001; Mielcarek M, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001717; Miller JP, 2010, NEURON, V67, P199, DOI 10.1016/j.neuron.2010.06.021; Pouladi MA, 2012, HUM MOL GENET, V21, P2219, DOI 10.1093/hmg/dds037; Pouladi MA, 2010, HUM MOL GENET, V19, P1528, DOI 10.1093/hmg/ddq026; Pratt WB, 2014, EXP BIOL MED, V239, P1405, DOI 10.1177/1535370214539444; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Ratovitski T, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.185348; Ratovitski T, 2009, J BIOL CHEM, V284, P10855, DOI 10.1074/jbc.M804813200; Reddy K, 2013, NEURON, V78, P405, DOI 10.1016/j.neuron.2013.04.034; Rigamonti D, 2001, J BIOL CHEM, V276, P14545, DOI 10.1074/jbc.C100044200; Rigamonti D, 2000, J NEUROSCI, V20, P3705, DOI 10.1523/JNEUROSCI.20-10-03705.2000; Sathasivam K, 2013, P NATL ACAD SCI USA, V110, P2366, DOI 10.1073/pnas.1221891110; Schilling B, 2006, J BIOL CHEM, V281, P23686, DOI 10.1074/jbc.M513507200; Schilling B, 2012, MOL CELL PROTEOMICS, V11, P202, DOI 10.1074/mcp.M112.017707; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Shirasaki DI, 2012, NEURON, V75, P41, DOI 10.1016/j.neuron.2012.05.024; Stanek LM, 2013, J HUNTINGTONS DIS, V2, P217, DOI 10.3233/JHD-130057; Tebbenkamp ATN, 2011, HUM MOL GENET, V20, P2770, DOI 10.1093/hmg/ddr176; Thompson LM, 2009, J CELL BIOL, V187, P1083, DOI 10.1083/jcb.200909067; Toneff T, 2002, J NEUROCHEM, V82, P84, DOI 10.1046/j.1471-4159.2002.00940.x; Tourette C, 2014, J BIOL CHEM, V289, P6709, DOI 10.1074/jbc.M113.523696; Waldron-Roby E, 2012, J NEUROSCI, V32, P183, DOI 10.1523/JNEUROSCI.1305-11.2012; Wang CE, 2008, HUM MOL GENET, V17, P2738, DOI 10.1093/hmg/ddn175; Warby SC, 2008, HUM MOL GENET, V17, P2390, DOI 10.1093/hmg/ddn139; Weiss A, 2009, ANAL BIOCHEM, V395, P8, DOI 10.1016/j.ab.2009.08.001; Wellington CL, 2002, J NEUROSCI, V22, P7862; Wellington CL, 2000, J BIOL CHEM, V275, P19831, DOI 10.1074/jbc.M001475200; Wellington CL, 1998, J BIOL CHEM, V273, P9158, DOI 10.1074/jbc.273.15.9158; Wheeler VC, 1999, HUM MOL GENET, V8, P115, DOI 10.1093/hmg/8.1.115; Wilkins MR, 1999, METH MOL B, V112, P531; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Xia JR, 2003, HUM MOL GENET, V12, P1393, DOI 10.1093/hmg/ddg156; Yang XL, 2011, NEUROSURGERY, V68, P932, DOI 10.1227/NEU.0b013e3182098c30; Young D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075108; Zhang Y, 2006, EMBO J, V25, P5896, DOI 10.1038/sj.emboj.7601445; Zhang YU, 2003, J NEUROCHEM, V87, P101, DOI 10.1046/j.1471-4159.2003.01980.x; Zheng ZQ, 2013, J BIOL CHEM, V288, P6063, DOI 10.1074/jbc.M112.413575	82	14	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					19287	19306		10.1074/jbc.M114.623561	http://dx.doi.org/10.1074/jbc.M114.623561			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26025364	hybrid, Green Published			2022-12-26	WOS:000358781100041
J	Szabo, A; Ludwig, M; Hegyi, E; Szepeova, R; Witt, H; Sahin-Toth, M				Szabo, Andras; Ludwig, Maren; Hegyi, Eszter; Szepeova, Renata; Witt, Heiko; Sahin-Toth, Miklos			Mesotrypsin Signature Mutation in a Chymotrypsin C (CTRC) Variant Associated with Chronic Pancreatitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CATIONIC TRYPSINOGEN; SUBSTRATE RECOGNITION; INHIBITOR RESISTANCE; PROTEASE INHIBITORS; ESCHERICHIA-COLI; SPECIFICITY; DEGRADATION; AFFINITY; SECRETION; CALDECRIN	Human chymotrypsin C (CTRC) protects against pancreatitis by degrading trypsinogen and thereby curtailing harmful intra-pancreatic trypsinogen activation. Loss-of-function mutations in CTRC increase the risk for chronic pancreatitis. Here we describe functional analysis of eight previously uncharacterized natural CTRC variants tested for potential defects in secretion, proteolytic stability, and catalytic activity. We found that all variants were secreted from transfected cells normally, and none suffered proteolytic degradation by trypsin. Five variants had normal enzymatic activity, whereas variant p.R29Q was catalytically inactive due to loss of activation by trypsin and variant p.S239C exhibited impaired activity possibly caused by disulfide mispairing. Surprisingly, variant p.G214R had increased activity on a small chromogenic peptide substrate but was markedly defective in cleaving bovine beta-casein or the natural CTRC substrates human cationic trypsinogen and procarboxypeptidase A1. Mutation p.G214R is analogous to the evolutionary mutation in human mesotrypsin, which rendered this trypsin isoform resistant to proteinaceous inhibitors and conferred its ability to cleave these inhibitors. Similarly to the mesotrypsin phenotype, CTRC variant p.G214R was inhibited poorly by eglin C, ecotin, or a CTRC-specific variant of SGPI-2, and it readily cleaved the reactive-site peptide bonds in eglin C and ecotin. We conclude that CTRC variants p.R29Q, p.G214R, and p.S239C are risk factors for chronic pancreatitis. Furthermore, the mesotrypsin-like CTRC variant highlights how the same natural mutation in homologous pancreatic serine proteases can evolve a new physiological role or lead to pathology, determined by the biological context of protease function.	[Szabo, Andras; Ludwig, Maren; Sahin-Toth, Miklos] Boston Univ, Henry M Goldman Sch Dent Med, Dept Mol & Cell Biol, Boston, MA 02118 USA; [Ludwig, Maren; Witt, Heiko] Tech Univ Munich, Pediat Nutr Med, D-85350 Munich, Germany; [Ludwig, Maren; Witt, Heiko] Tech Univ Munich, Else Kroner Fresenius Zentrum EKFZ Ernahrungsmed, D-85350 Munich, Germany; [Hegyi, Eszter] Comenius Univ, Fac Med Bratislava, Univ Childrens Hosp Bratislava, Dept Pediat 2, Bratislava 83340, Slovakia; [Szepeova, Renata] Comenius Univ, Jessenius Fac Med Martin, Martin Univ Hosp, Clin Children & Adolescents, Martin 03601, Slovakia	Boston University; Technical University of Munich; Technical University of Munich; Comenius University Bratislava; Comenius University Bratislava	Sahin-Toth, M (corresponding author), 72 East Concord St,Evans 433, Boston, MA 02118 USA.	miklos@bu.edu	Regan, Clinton/E-6250-2012	Sahin-Toth, Miklos/0000-0003-4513-9922; Ewers, Maren/0000-0002-9029-2240; Szabo, Andras/0000-0001-8687-470X	National Institutes of Health [R01DK082412, R01DK058088, R01DK095753]; Comenius University, Bratislava [573/2013]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058088, R01DK095753, R01DK082412] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Comenius University, Bratislava; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R01DK082412, R01DK058088, and R01DK095753 (to M. S.-T.) and by Grant 573/2013 from the Comenius University, Bratislava (to E. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Batra J, 2013, J BIOL CHEM, V288, P9848, DOI 10.1074/jbc.M113.457382; Beer S, 2013, GUT, V62, P1616, DOI 10.1136/gutjnl-2012-303090; CHUNG CH, 1983, J BIOL CHEM, V258, P1032; Eggers CT, 2001, J MOL BIOL, V308, P975, DOI 10.1006/jmbi.2001.4754; FOLK JE, 1965, J BIOL CHEM, V240, P193; FOLK JE, 1965, J BIOL CHEM, V240, P181; Geisz A, 2013, FEBS J, V280, P2888, DOI 10.1111/febs.12292; IIOAKAMA K, 1985, BIOCHIM BIOPHYS ACTA, V831, P249, DOI 10.1016/0167-4838(85)90042-1; Katona G, 2002, J MOL BIOL, V315, P1209, DOI 10.1006/jmbi.2001.5305; KNECHT R, 1983, ANAL BIOCHEM, V130, P65, DOI 10.1016/0003-2697(83)90650-4; Komiyama T, 2000, BIOCHEMISTRY-US, V39, P15156, DOI 10.1021/bi001907c; Lengyel Z, 1998, PROTEIN EXPRES PURIF, V12, P291, DOI 10.1006/prep.1997.0837; Masamune A, 2013, GUT, V62, P653, DOI 10.1136/gutjnl-2012-303860; Masson E, 2008, HUM GENET, V123, P83, DOI 10.1007/s00439-007-0459-3; MCGRATH ME, 1991, J BIOL CHEM, V266, P6620; Mock WL, 1996, ANAL BIOCHEM, V239, P218, DOI 10.1006/abio.1996.0318; Nemoda Z, 2006, J BIOL CHEM, V281, P11879, DOI 10.1074/jbc.M600124200; Nyaruhucha CNM, 1997, J BIOL CHEM, V272, P10573; Paliwal S, 2013, GUT, V62, P1602, DOI 10.1136/gutjnl-2012-302448; Pendlebury D, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.609560; RINDERKNECHT H, 1979, GUT, V20, P886, DOI 10.1136/gut.20.10.886; RINDERKNECHT H, 1984, GASTROENTEROLOGY, V86, P681; RINDERKNECHT H, 1985, DIGEST DIS SCI, V30, P65, DOI 10.1007/BF01318373; Rosendahl J, 2008, NAT GENET, V40, P78, DOI 10.1038/ng.2007.44; Rosendahl J, 2013, GUT, V62, P582, DOI 10.1136/gutjnl-2011-300645; Salameh MA, 2008, J BIOL CHEM, V283, P4115, DOI 10.1074/jbc.M708268200; Salameh MA, 2012, PROTEIN SCI, V21, P1103, DOI 10.1002/pro.2097; Salameh MA, 2011, BIOCHEM J, V440, P95, DOI 10.1042/BJ20110788; Salameh MA, 2010, J BIOL CHEM, V285, P36884, DOI 10.1074/jbc.M110.171348; Salameh MA, 2010, J BIOL CHEM, V285, P1939, DOI 10.1074/jbc.M109.057216; Szabo A, 2014, J BIOL CHEM, V289, P4753, DOI 10.1074/jbc.M113.538884; Szabo A, 2012, FEBS J, V279, P4283, DOI 10.1111/febs.12018; Szabo A, 2011, J BIOL CHEM, V286, P22535, DOI 10.1074/jbc.M111.235754; Szmola R, 2003, J BIOL CHEM, V278, P48580, DOI 10.1074/jbc.M310301200; Szmola R, 2007, P NATL ACAD SCI USA, V104, P11227, DOI 10.1073/pnas.0703714104; Szmola R, 2011, J BIOL CHEM, V286, P1819, DOI 10.1074/jbc.M110.187369; Szmola R, 2010, GUT, V59, P365, DOI 10.1136/gut.2009.198903; Tomomura A, 1996, FEBS LETT, V386, P26, DOI 10.1016/0014-5793(96)00377-8	38	13	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17282	17292		10.1074/jbc.M114.618439	http://dx.doi.org/10.1074/jbc.M114.618439			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	26013824	Green Accepted, hybrid, Green Published			2022-12-26	WOS:000357730900024
J	Prendiville, TW; Guo, HD; Lin, ZQ; Zhou, PZ; Stevens, SM; He, AB; VanDusen, N; Chen, JH; Zhong, L; Wang, DZ; Gao, GP; Pu, WT				Prendiville, Terence W.; Guo, Haidong; Lin, Zhiqiang; Zhou, Pingzhu; Stevens, Sean M.; He, Aibin; VanDusen, Nathan; Chen, Jinghai; Zhong, Li; Wang, Da-Zhi; Gao, Guangping; Pu, William T.			Novel Roles of GATA4/6 in the Postnatal Heart Identified through Temporally Controlled, Cardiomyocyte-Specific Gene Inactivation by Adeno-Associated Virus Delivery of Cre Recombinase	PLOS ONE			English	Article							MYOCARDIAL EXPRESSION; CARDIAC-HYPERTROPHY; TAMOXIFEN; MICE; INDUCTION; DELETION; FAILURE; GATA-4	GATA4 and GATA6 are central cardiac transcriptional regulators. The postnatal, stage-specific function of the cardiac transcription factors GATA4 and GATA6 have not been evaluated. In part, this is because current Cre-loxP approaches to cardiac gene inactivation require time consuming and costly breeding of Cre-expressing and "floxed" mouse lines, often with limited control of the extent or timing of gene inactivation. We investigated the stage-specific functions of GATA4 and GATA6 in the postnatal heart by using adeno-associated virus serotype 9 to control the timing and extent of gene inactivation by Cre. Systemic delivery of recombinant, adeno-associated virus 9 (AAV9) expressing Cre from the cardiac specific Tnnt2 promoter was well tolerated and selectively and efficiently recombined floxed target genes in cardiomyocytes. AAV9: Tnnt2-Cre efficiently inactivated Gata4 and Gata6. Neonatal Gata4/6 inactivation caused severe, rapidly lethal systolic heart failure. In contrast, Gata4/6 inactivation in adult heart caused only mild systolic dysfunction but severe diastolic dysfunction. Reducing the dose of AAV9: Tnnt2-Cre generated mosaics in which scattered cardiomyocytes lacked Gata4/6. This mosaic knockout revealed that Gata4/6 are required cell autonomously for physiological cardiomyocyte growth. Our results define novel roles of GATA4 and GATA6 in the neonatal and adult heart. Furthermore, our data demonstrate that evaluation of gene function hinges on controlling the timing and extent of gene inactivation. AAV9: Tnnt2-Cre is a powerful tool for controlling these parameters.	[Prendiville, Terence W.; Guo, Haidong; Lin, Zhiqiang; Zhou, Pingzhu; Stevens, Sean M.; He, Aibin; VanDusen, Nathan; Chen, Jinghai; Wang, Da-Zhi; Pu, William T.] Boston Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA; [Guo, Haidong] Shanghai Univ Tradit Chinese Med, Sch Basic Med, Dept Anat, Shanghai, Peoples R China; [He, Aibin] Peking Univ, Peking Tsinghua Ctr Life Sci, Inst Mol Med, Beijing, Peoples R China; [Zhong, Li; Gao, Guangping; Pu, William T.] Univ Massachusetts, Sch Med, Gene Therapy Ctr, Worcester, MA USA; [Wang, Da-Zhi] Harvard Stem Cell Inst, Cambridge, MA USA	Harvard University; Boston Children's Hospital; Shanghai University of Traditional Chinese Medicine; Peking University; University of Massachusetts System; University of Massachusetts Worcester; Harvard University	Pu, WT (corresponding author), Boston Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA.	wpu@pulab.org	VanDusen, Nathan/ABF-9945-2021; Pu, William/AAJ-8301-2020; He, Aibin/AAI-1639-2019; Zhong, Li/GZM-4358-2022	VanDusen, Nathan/0000-0002-2636-7228; Pu, William/0000-0002-4551-8079; He, Aibin/0000-0002-3489-2305; Zhong, Li/0000-0003-1611-5171; Lin, zhiqiang/0000-0002-2034-2492	Irish Cardiac Society Brian McGovern Travelling Fellowship; NIH [R01 HL095712, U01 HL098166]; AHA Established Investigator Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL098166, R01HL095712, T32HL007572] Funding Source: NIH RePORTER	Irish Cardiac Society Brian McGovern Travelling Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA Established Investigator Award(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	TWP was funded by the Irish Cardiac Society Brian McGovern Travelling Fellowship. WTP was supported by NIH (R01 HL095712, U01 HL098166), an AHA Established Investigator Award, and by a charitable donation from Dr. and Mrs. Edwin A. Boger. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastassiadis K, 2010, METHOD ENZYMOL, V477, P109, DOI 10.1016/S0076-6879(10)77007-5; Bersell K, 2013, DIS MODEL MECH, V6, P1459, DOI 10.1242/dmm.010447; Buerger A, 2006, J CARD FAIL, V12, P392, DOI 10.1016/j.cardfail.2006.03.002; Charron F, 1999, MOL CELL BIOL, V19, P4355; Hall ME, 2011, AM J PHYSIOL-HEART C, V301, pH253, DOI 10.1152/ajpheart.00786.2010; He AB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5907; IZUMO S, 1988, P NATL ACAD SCI USA, V85, P339, DOI 10.1073/pnas.85.2.339; IZUMO S, 1987, J CLIN INVEST, V79, P970, DOI 10.1172/JCI112908; Koitabashi N, 2009, CIRC RES, V105, P12, DOI 10.1161/CIRCRESAHA.109.198416; Lee DS, 2009, CIRCULATION, V119, P3070, DOI 10.1161/CIRCULATIONAHA.108.815944; Lee Y, 1998, MOL CELL BIOL, V18, P3120, DOI 10.1128/MCB.18.6.3120; Lexow J, 2013, DIS MODEL MECH, V6, P1470, DOI 10.1242/dmm.010470; Lin ZQ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3006681; MOLKENTIN JD, 1994, MOL CELL BIOL, V14, P4947, DOI 10.1128/MCB.14.7.4947; Molkentin JD, 2009, J MOL CELL CARDIOL, V46, P130, DOI 10.1016/j.yjmcc.2008.09.002; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; O'Connell Timothy D, 2007, Methods Mol Biol, V357, P271; Oka T, 2006, CIRC RES, V98, P837, DOI 10.1161/01.RES.0000215985.18538.c4; Patrick DM, 2010, J CLIN INVEST, V120, P3912, DOI 10.1172/JCI43604; Shimshek DR, 2002, GENESIS, V32, P19, DOI 10.1002/gene.10023; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; van Berlo JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084591; van Berlo JH, 2010, CIRC RES, V107, P1032, DOI 10.1161/CIRCRESAHA.110.220764; Watt AJ, 2004, P NATL ACAD SCI USA, V101, P12573, DOI 10.1073/pnas.0400752101; Werfel S, 2014, CARDIOVASC RES, V104, P15, DOI 10.1093/cvr/cvu174; Xin M, 2006, P NATL ACAD SCI USA, V103, P11189, DOI 10.1073/pnas.0604604103; Zacchigna S, 2014, CIRC RES, V114, P1827, DOI 10.1161/CIRCRESAHA.114.302331; Zeisberg EM, 2005, J CLIN INVEST, V115, P1522, DOI 10.1172/JCI23769; Zhao RO, 2005, MOL CELL BIOL, V25, P2622, DOI 10.1128/MCB.25.7.2622-2631.2005; Zheng RN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083723; Zincarelli C, 2008, MOL THER, V16, P1073, DOI 10.1038/mt.2008.76	31	27	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128105	10.1371/journal.pone.0128105	http://dx.doi.org/10.1371/journal.pone.0128105			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26023924	Green Published, Green Submitted, gold			2022-12-26	WOS:000355319400071
J	Goswami, N; Evans, J; Schneider, S; von der Wiesche, M; Mulder, E; Rossler, A; Hinghofer-Szalkay, H; Blaber, AP				Goswami, Nandu; Evans, Joyce; Schneider, Stefan; von der Wiesche, Melanie; Mulder, Edwin; Roessler, Andreas; Hinghofer-Szalkay, Helmut; Blaber, Andrew P.			Effects of Individualized Centrifugation Training on Orthostatic Tolerance in Men and Women	PLOS ONE			English	Article							BODY NEGATIVE-PRESSURE; HEAD-DOWN TILT; BLOOD-VOLUME; SINGLE BOUT; MAXIMAL EXERCISE; AMBULATORY MEN; PLASMA-VOLUME; FLOW; RESPONSIVENESS; SPACEFLIGHT	Aims Exposure to artificial gravity (AG) at different G loads and durations on human centrifuges has been shown to improve orthostatic tolerance in men. However, the effects on women and of an individual-specific AG training protocol on tolerance are not known. Methods We examined the effects of 90 minutes of AG vs. 90 minutes of supine rest on the orthostatic tolerance limit (OTL), using head up tilt and lower body negative pressure until presyncope of 7 men and 5 women. Subjects were placed in the centrifuge nacelle while instrumented and after one-hour they underwent either: 1) AG exposure (90 minutes) in supine position [protocol 1, artificial gravity exposure], or 2) lay supine on the centrifuge for 90 minutes in supine position without AG exposure [protocol 2, control]. The AG training protocol was individualized, by first determining each subject's maximum tolerable G load, and then exposing them to 45 minutes of ramp training at sub-presyncopal levels. Results Both sexes had improved OTL (14 minutes vs 11 minutes, p < 0.0019) following AG exposure. When cardiovascular (CV) variables at presyncope in the control test were compared with the CV variables at the same tilt-test time (isotime) during post-centrifuge, higher blood pressure, stroke volume and cardiac output and similar heart rates and peripheral resistance were found post-centrifuge. Conclusions These data suggest a better-maintained central circulating blood volume post-centrifugation across gender and provide an integrated insight into mechanisms of blood pressure regulation and the possible implementation of in-flight AG countermeasure profiles during spaceflights.	[Goswami, Nandu; Roessler, Andreas; Hinghofer-Szalkay, Helmut] Med Univ Graz, Inst Physiol, Graz, Austria; [Evans, Joyce] Univ Kentucky, Lexington, KY 40506 USA; [Schneider, Stefan] German Sports Univ, Cologne, Germany; [Schneider, Stefan] Univ Sunshine Coast, Fac Sci Hlth Educ & Engn, Marrochydore, Qld, Australia; [von der Wiesche, Melanie; Mulder, Edwin] German Aerosp Ctr DLR, Inst Aerosp Med, Cologne, Germany; [Blaber, Andrew P.] Simon Fraser Univ, Burnaby, BC V5A 1S6, Canada	Medical University of Graz; University of Kentucky; German Sport University Cologne; University of the Sunshine Coast; Helmholtz Association; German Aerospace Centre (DLR); Simon Fraser University	Goswami, N (corresponding author), Med Univ Graz, Inst Physiol, Graz, Austria.	nandu.goswami@medunigraz.at	Roessler, Andreas/A-5751-2008; Schneider, Stefan/AAH-7418-2020	Roessler, Andreas/0000-0001-9543-8870; Schneider, Stefan/0000-0002-4563-9890	European Space Agency's CORA-GBF program	European Space Agency's CORA-GBF program	The European Space Agency's CORA-GBF program supported this study. Land Steiermark, Austria, also supported Dr. Nandu Goswami. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blaber AP, 2013, EUR J APPL PHYSIOL, V113, P1909, DOI 10.1007/s00421-012-2539-x; Blaber AP, 2013, AVIAT SPACE ENVIR MD, V84, P59, DOI 10.3357/ASEM.3424.2013; Blaber AP, 2011, STROKE, V42, P1844, DOI 10.1161/STROKEAHA.110.610576; Convertino VA, 1996, AM J PHYSIOL-REG I, V270, pR3, DOI 10.1152/ajpregu.1996.270.1.R3; Convertino VA, 2003, J APPL PHYSIOL, V95, P192, DOI 10.1152/japplphysiol.00123.2003; DELP MD, 1995, MED SCI SPORT EXER, V27, P1152; Engelke KA, 1996, AM J PHYSIOL-REG I, V271, pR837, DOI 10.1152/ajpregu.1996.271.4.R837; ENGELKE KA, 1995, AM J PHYSIOL-REG I, V269, pR614, DOI 10.1152/ajpregu.1995.269.3.R614; Evans JM, 2004, AVIAT SPACE ENVIR MD, V75, P850; Fong KJ, 2007, J GRAVIT PHYSL, V14, pP15; FritschYelle JM, 1996, J APPL PHYSIOL, V81, P2134, DOI 10.1152/jappl.1996.81.5.2134; Goswami N, 2009, PHYSIOL RES, V58, P311, DOI 10.33549/physiolres.931431; Goswami N, 2009, ACTA PHYSIOL HUNG, V96, P157, DOI 10.1556/APhysiol.96.2009.2.2; Goswami N, 2013, EUR J APPL PHYSIOL, V113, P1645, DOI 10.1007/s00421-012-2507-5; Grasser EK, 2009, PHYSIOL RES, V58, P817, DOI 10.33549/physiolres.931591; Hinghofer-Szalkay H, 2011, EUR J CLIN INVEST, V41, P1180, DOI 10.1111/j.1365-2362.2011.02523.x; Hinghofer-Szalkay HG, 2008, AM J PHYSIOL-GASTR L, V295, pG332, DOI 10.1152/ajpgi.00042.2008; Iwase Satoshi, 2002, Environmental Medicine (Nagoya), V46, P29; Leonetti P, 2004, CLIN AUTON RES, V14, P176, DOI 10.1007/s10286-004-0191-1; LIEBERMAN EH, 1994, ANN INTERN MED, V121, P936, DOI 10.7326/0003-4819-121-12-199412150-00005; Meendering JR, 2005, AM J PHYSIOL-HEART C, V289, pH631, DOI 10.1152/ajpheart.00029.2005; Stenger MB, 2007, ACTA ASTRONAUT, V60, P267, DOI 10.1016/j.actaastro.2006.08.008; Stenger MB, 2012, EUR J APPL PHYSIOL, V112, P605, DOI 10.1007/s00421-011-2005-1; Taneja I, 2007, AM J PHYSIOL-HEART C, V292, pH1420, DOI 10.1152/ajpheart.01096.2006; Waters WW, 2002, J APPL PHYSIOL, V92, P586, DOI 10.1152/japplphysiol.00544.2001	25	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0125780	10.1371/journal.pone.0125780	http://dx.doi.org/10.1371/journal.pone.0125780			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020542	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000355187300017
J	Kim, A; Im, M; Hwang, YH; Yang, HJ; Ma, JY				Kim, Aeyung; Im, Minju; Hwang, Youn-Hwan; Yang, Hye Jin; Ma, Jin Yeul			Jaeumganghwa-Tang Induces Apoptosis via the Mitochondrial Pathway and Lactobacillus Fermentation Enhances Its Anti-Cancer Activity in HT1080 Human Fibrosarcoma Cells	PLOS ONE			English	Article							TRADITIONAL CHINESE MEDICINE; SIGNALING PATHWAY; HERBAL MEDICINES; CANCER; THERAPY	Jaeumganghwa-tang (JGT, Zi-yin-jiang-huo-tang in Chinese and Jiin-koka-to in Japanese) is an oriental herbal formula that has long been used as a traditional medicine to treat respiratory and kidney diseases. Recent studies revealed that JGT exhibited potent inhibitory effects on allergies, inflammation, pain, convulsions, and prostate hyperplasia. Several constituent herbs in JGT induce apoptotic cancer cell death. However, the anti-cancer activity of JGT has not been examined. In this study, we investigated the anti-cancer effects of JGT using highly tumorigenic HT1080 human fibrosarcoma cells and elucidated the underlying mechanisms. In addition, we examined whether the Lactobacillus fermentation of JGT enhanced its anti-cancer activity using an in vivo xenograft model because fermentation of herbal extracts is thought to strengthen their therapeutic effects. Data revealed that JGT suppressed the growth of cancer cells efficiently by stimulating G1 cell cycle arrest and then inducing apoptotic cell death by causing mitochondrial damage and activating caspases. The phosphorylation of p38 and ERK also played a role in JGT-induced cell death. In vitro experiments demonstrated that JGT fermented with Lactobacillus acidophilus, designated fJGT162, elicited similar patterns of cell death as did non-fermented JGT. Meanwhile, the daily oral administration of 120 mg/kg fJGT162 to HT1080-bearing BALB/c nude mice suppressed tumor growth dramatically (up to 90%) compared with saline treatment, whereas the administration of non-fermented JGT suppressed tumor growth by similar to 70%. Collectively, these results suggest that JGT and fJGT162 are safe and useful complementary and alternative anti-cancer herbal therapies, and that Lactobacillus fermentation improves the in vivo anti-cancer efficacy of JGT significantly.	[Kim, Aeyung; Im, Minju; Hwang, Youn-Hwan; Yang, Hye Jin; Ma, Jin Yeul] KIOM, KM Based Herbal Drug Dev Ctr, Taejon, South Korea	Korea Institute of Oriental Medicine (KIOM)	Ma, JY (corresponding author), KIOM, KM Based Herbal Drug Dev Ctr, Taejon, South Korea.	jyma@kiom.re.kr	Hwang, Youn-Hwan/AAU-9373-2021		Ministry of Science, ICT and Future Planning (MSIP), Republic of Korea [K15280]	Ministry of Science, ICT and Future Planning (MSIP), Republic of Korea	This work has been supported by the Grant K15280 awarded to Korea Institute of Oriental Medicine (KIOM) from Ministry of Science, ICT and Future Planning (MSIP), Republic of Korea.	Bae EA, 2004, ARCH PHARM RES, V27, P61, DOI 10.1007/BF02980048; Efferth T, 2007, TRENDS MOL MED, V13, P353, DOI 10.1016/j.molmed.2007.07.001; Eum HA, 2011, AFR J TRADIT COMPLEM, V8, P312; Hambright HG, 2015, MOL CARCINOGEN, V54, P1227, DOI 10.1002/mc.22192; Hsiao WLW, 2010, PLANTA MED, V76, P1118, DOI 10.1055/s-0030-1250186; Jang DS, 2003, J NAT PROD, V66, P1166, DOI 10.1021/np0302100; Jang YS, 2009, CHINESE SCI BULL, V54, P227, DOI 10.1007/s11434-008-0567-z; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Joo SS, 2009, PHYTOTHER RES, V23, P913, DOI 10.1002/ptr.2758; Kang MH, 2009, CLIN CANCER RES, V15, P1126, DOI 10.1158/1078-0432.CCR-08-0144; Kang SH, 2009, ENVIRON TOXICOL PHAR, V28, P430, DOI 10.1016/j.etap.2009.07.007; Kim A, 2014, PHARMACOGN MAG, V10, P463, DOI 10.4103/0973-1296.139774; Kim A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098703; Kim A, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-233; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Kim YK, 2004, KOREAN J ORIEN INTER, V25, P174; Konkimalla VB, 2008, J ETHNOPHARMACOL, V116, P207, DOI 10.1016/j.jep.2007.12.009; Kwon KB, 2006, BIOL PHARM BULL, V29, P1082, DOI 10.1248/bpb.29.1082; Lee HJ, 2006, CARCINOGENESIS, V27, P2455, DOI 10.1093/carcin/bgl104; Lee JE, 2011, AM J CHINESE MED, V39, P1235, DOI 10.1142/S0192415X11009524; Lee JH, 2013, KOREAN J ORIEN INTER, V34, P155; Lee JJ, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-78; Lee Kwang Jin, 2013, Journal of Applied Biological Chemistry, V56, P131, DOI 10.3839/jabc.2013.021; Li M, 2014, ONCOL REP, V32, P2845, DOI 10.3892/or.2014.3543; Li-Weber M, 2013, CANCER LETT, V332, P304, DOI 10.1016/j.canlet.2010.07.015; Lu W, 2015, MOL MED REP, V11, P3920, DOI 10.3892/mmr.2014.3139; Ly JD, 2003, APOPTOSIS, V8, P115, DOI 10.1023/A:1022945107762; Ng CC, 2011, J BIOSCI BIOENG, V111, P289, DOI 10.1016/j.jbiosc.2010.11.011; Oh YC, 2014, PHARMACOGN MAG, V10, P645, DOI 10.4103/0973-1296.139815; Oh YC, 2012, AM J CHINESE MED, V40, P813, DOI 10.1142/S0192415X12500619; Oh YC, 2012, AM J CHINESE MED, V40, P611, DOI 10.1142/S0192415X12500462; Oh YC, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-17; Qi FH, 2010, BIOSCI TRENDS, V4, P297; Santarpia L, 2012, EXPERT OPIN THER TAR, V16, P103, DOI 10.1517/14728222.2011.645805; Seo I, 2011, IMMUNOPHARM IMMUNOT, V33, P682, DOI 10.3109/08923973.2011.560159; Shim KS, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-106; Shim KS, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/325791; Shin IS, 2012, J KOREAN SOC APPL BI, V55, P205, DOI 10.1007/s13765-012-1174-x; Sohn Y, 2012, FOOD CHEM TOXICOL, V50, P2987, DOI 10.1016/j.fct.2012.06.001; Thirugnanam S, 2008, ONCOL REP, V20, P1387, DOI 10.3892/or_00000157; Xu W, 2006, EUR J CANCER CARE, V15, P397, DOI 10.1111/j.1365-2354.2006.00685.x; Zheng Hong-mei, 2010, [The Journal of Korean Oriental Internal Medicine, 대한한방내과학회지], V31, P395	42	10	11	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0127898	10.1371/journal.pone.0127898	http://dx.doi.org/10.1371/journal.pone.0127898			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020238	gold, Green Submitted, Green Published			2022-12-26	WOS:000355187300064
J	Li, XP; Li, YP; Zhang, Z; Li, XG				Li, Xiaopeng; Li, Yupeng; Zhang, Zhong; Li, Xingang			Influences of Environmental Factors on Leaf Morphology of Chinese Jujubes	PLOS ONE			English	Article							REGULATED DEFICIT IRRIGATION; PLANT FUNCTIONAL TRAITS; DIFFERENT GROWTH-STAGES; WATER-USE EFFICIENCY; VENATION ARCHITECTURE; SOUTHERN BEECH; EVOLUTION; DROUGHT; CLIMATE; LEAVES	Rainfall and temperature are the primary limiting factors for optimum quality and yield of cultivated jujube (Ziziphus jujuba Mill.). Adaptation to arid and cool environments has been and remains an important goal of many jujube improvement programs. This study summarized the survey results of 116 Chinese jujube varieties grown at 33 sites in China. The objective was to identify the environmental factors that influence leaf morphology, and the implications for breeding and introduction of new jujube varieties. Jujube leaf morphological traits were evaluated for their potential relationships with mean annual temperature (MAT) and mean annual precipitation (MAP). The results showed that many leaf morphological traits had a strong linear relationship with local precipitation and temperature. Longer veins per unit area (VLA) and reduced leaf area and leaf perimeter were typical of arid areas. VLA was inversely related to MAT and MAP at the centers of origin of jujube. There was a positive relationship between leaf shape (perimeter(2)/area) and both MAT and MAP. These results indicated that leaf vein traits of Chinese jujubes might have resulted from their adaptation to environmental factors in the course of long-term evolution. Principal component analysis allocated the 116 jujube varieties to three different groups, differentiated on the basis of morphological and physiological leaf characteristics. Jujube varieties from the Hebei, Shandong, Henan, southern Shanxi and central Shaanxi provinces were closely related, as were varieties from northwest Shanxi and northeast Shaanxi provinces, and varieties from the Gansu and Ningxia provinces. These close relationships were partially attributed to the frequent exchanges of varieties within each group. Leaf venation characteristics might be used as reference indices for jujube variety introduction between different locations.	[Li, Xiaopeng; Zhang, Zhong; Li, Xingang] Northwest A&F Univ, Coll Forestry, Yangling, Shaanxi, Peoples R China; [Li, Xiaopeng; Zhang, Zhong; Li, Xingang] Northwest A&F Univ, State Forestry Adm, Res Ctr Jujube Engn & Technol, Yangling, Shaanxi, Peoples R China; [Li, Yupeng] Northwest A&F Univ, Coll Water Resources & Architectural Engineeing, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China; Northwest A&F University - China	Li, XG (corresponding author), Northwest A&F Univ, Coll Forestry, Yangling, Shaanxi, Peoples R China.	xingangle@nwsuaf.edu.cn			State Forestry Administration of P. R. China [201304110]; Ministry of Science and Technology of P. R. China [2013BAD14B03]	State Forestry Administration of P. R. China; Ministry of Science and Technology of P. R. China(Ministry of Science and Technology, China)	The Public Welfare Project from the State Forestry Administration of P. R. China (Grant no. 201304110); The Ministry of Science and Technology of P. R. China (Grant no. 2013BAD14B03).	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Breckle S.W, 2002, WALTERS VEGETATION E; Brodribb TJ, 2007, PLANT PHYSIOL, V144, P1890, DOI 10.1104/pp.107.101352; Brodribb TJ, 2010, FUNCT PLANT BIOL, V37, P488, DOI 10.1071/FP10010; Brodribb TJ, 2010, ECOL LETT, V13, P175, DOI 10.1111/j.1461-0248.2009.01410.x; Choat B, 2007, NEW PHYTOL, V175, P686, DOI 10.1111/j.1469-8137.2007.02137.x; Cruz ZN, 2012, PLANT SCI, V197, P77, DOI 10.1016/j.plantsci.2012.09.006; Cui NB, 2008, AGR WATER MANAGE, V95, P489, DOI 10.1016/j.agwat.2007.11.007; Cui NB, 2009, AGR WATER MANAGE, V96, P1615, DOI 10.1016/j.agwat.2009.06.009; Cui NB, 2009, AGR WATER MANAGE, V96, P1237, DOI 10.1016/j.agwat.2009.03.015; Diaz S, 1998, J VEG SCI, V9, P113, DOI 10.2307/3237229; Donovan LA, 2011, TRENDS ECOL EVOL, V26, P88, DOI 10.1016/j.tree.2010.11.011; Dunbar-Co S, 2009, INT J PLANT SCI, V170, P61, DOI 10.1086/593111; Feild TS, 2005, PLANT CELL ENVIRON, V28, P1179, DOI 10.1111/j.1365-3040.2005.01354.x; Flann C, 2002, AUST SYST BOT, V15, P205, DOI 10.1071/SB01018; Gao QH, 2011, SCI HORTIC-AMSTERDAM, V130, P67, DOI 10.1016/j.scienta.2011.06.005; Garnier J, 2002, SCOPE COLL MAR RES, P51; Gupta AK, 2004, CURR SCI INDIA, V87, P54; Hao GY, 2010, FUNCT ECOL, V24, P731, DOI 10.1111/j.1365-2435.2010.01724.x; Hovenden MJ, 2004, NEW PHYTOL, V161, P585, DOI 10.1046/j.1469-8137.2003.00931.x; Hovenden MJ, 2001, AUST J BOT, V49, P427, DOI 10.1071/BT01001; Huff PM, 2003, PALAIOS, V18, P266, DOI 10.1669/0883-1351(2003)018<0266:DFFPEF>2.0.CO;2; JONES CS, 1995, AM J BOT, V82, P346, DOI 10.2307/2445580; Li F., 2005, CHIN B BOT, VS1, P118; Li L, 2010, AGR SCI CHINA, V9, P1278, DOI 10.1016/S1671-2927(09)60217-0; Li Li, 2009, Acta Horticulturae Sinica, V36, P475; Liu MengJun, 2006, Horticultural Reviews, V32, P229; Liu MengJun, 1999, Acta Horticulturae Sinica, V26, P302; Ma FS, 2007, AGR WATER MANAGE, V90, P190, DOI 10.1016/j.agwat.2006.12.009; McLellan T, 1998, SYST BIOL, V47, P264, DOI 10.1080/106351598260914; Mengjun Liu MW., 2008, GERMPLASM RESOURCES; Niinemets U, 2006, PROG BOT, V67, P385, DOI 10.1007/3-540-27998-9_17; Niinemets U, 2001, ECOLOGY, V82, P453, DOI 10.1890/0012-9658(2001)082[0453:GSCCOL]2.0.CO;2; Peng JianYing, 2000, Acta Horticulturae Sinica, V27, P171; Peppe DJ, 2011, NEW PHYTOL, V190, P724, DOI 10.1111/j.1469-8137.2010.03615.x; Perez-Harguindeguy N, 2013, AUST J BOT, V61, P167, DOI 10.1071/BT12225; Qu Z, 1993, FRUIT TREE RECORD CH; Quero JL, 2006, NEW PHYTOL, V170, P819, DOI 10.1111/j.1469-8137.2006.01713.x; Roth-Nebelsick A, 2001, ANN BOT-LONDON, V87, P553, DOI 10.1006/anbo.2001.1391; Royer DL, 2008, NEW PHYTOL, V179, P808, DOI 10.1111/j.1469-8137.2008.02496.x; Royer DL, 2006, INT J PLANT SCI, V167, P11, DOI 10.1086/497995; Royer DL, 2005, AM J BOT, V92, P1141, DOI 10.3732/ajb.92.7.1141; Sack L, 2003, PLANT CELL ENVIRON, V26, P1343, DOI 10.1046/j.0016-8025.2003.01058.x; Sack L, 2003, AM J BOT, V90, P32, DOI 10.3732/ajb.90.1.32; Sack L, 2013, REV LIFE LEAF S VOGE, V63, P981; Sack L, 2008, P NATL ACAD SCI USA, V105, P1567, DOI 10.1073/pnas.0709333105; Sack L, 2006, ANNU REV PLANT BIOL, V57, P361, DOI 10.1146/annurev.arplant.56.032604.144141; Sack L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1835; Sack L, 2013, J EXP BOT, V64, P4053, DOI 10.1093/jxb/ert316; Sack L, 2013, NEW PHYTOL, V198, P983, DOI 10.1111/nph.12253; Scoffoni C, 2011, PLANT PHYSIOL, V156, P832, DOI 10.1104/pp.111.173856; Su PX, 2005, SCI HORTIC-AMSTERDAM, V104, P339, DOI 10.1016/j.scienta.2004.08.012; Traiser C, 2005, NEW PHYTOL, V166, P465, DOI 10.1111/j.1469-8137.2005.01316.x; Uhl D, 1999, PALAEOGEOGR PALAEOCL, V149, P15, DOI 10.1016/S0031-0182(98)00189-8; Volaire F, 2008, EUR J AGRON, V29, P116, DOI 10.1016/j.eja.2008.04.008; Walter A, 2005, ANN BOT-LONDON, V95, P891, DOI 10.1093/aob/mci103; Wolfe A, 1998, PLANT MOL SYSTEMATIC, DOI [10.1007/978-1-4615-5419-6, DOI 10.1007/978-1-4615-5419-6]; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Wright IJ, 2001, FUNCT ECOL, V15, P423, DOI 10.1046/j.0269-8463.2001.00542.x; Zhang SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040080; Zhu YH, 2012, TREES-STRUCT FUNCT, V26, P597, DOI 10.1007/s00468-011-0624-0	63	16	18	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0127825	10.1371/journal.pone.0127825	http://dx.doi.org/10.1371/journal.pone.0127825			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020971	Green Submitted, Green Published, gold			2022-12-26	WOS:000355187300057
J	Chen, XH; Motani, R; Cheng, L; Jiang, DY; Rieppel, O				Chen, Xiao-hong; Motani, Ryosuke; Cheng, Long; Jiang, Da-yong; Rieppel, Olivier			A New Specimen of Carroll's Mystery Hupehsuchian from the Lower Triassic of China	PLOS ONE			English	Article								A new specimen of an enigmatic hupehsuchian genus is reported. The genus was first recognized by Robert L. Carroll and Zhi-ming Dong in 1991, who refrained from naming it because of the poor quality of the only specimen known at the time. After more than two decades, we finally report a second specimen of this genus, which remained unprepared until recently. The new specimen preserves most of the skeleton except the skull, allowing us to erect a new genus and species, Eretmorhipis carrolldongi. The new species shares many characters with Parahupehsuchus longus, including the strange axial skeleton that forms a bony body tube. However, the body tube is short in the new species, being limited to the pectoral region. The vertebral count and limb morphology considerably differ between the new species and P. longus. The forelimb of E. carrolldongi is markedly larger than its hind limb as in Hupehsuchus nanchangensis but unlike in P. longus. The new species is unique among hupehsuchians in a list of features. It has manual and pedal digits that spread radially, forming manus and pes that are almost as wide as long. The third-layer elements of the dermal armor are unusually large, spanning four vertebral segments, yet there are substantial gaps among them. With the addition of the unique paddle, it is now clear that Hupehsuchia had diverse forelimb morphologies spanning from paddles to flippers, unlike ichthyopterygians that were taxonomically more diverse yet only had flippers.	[Chen, Xiao-hong; Cheng, Long] Wuhan Ctr China Geol Survey, Wuhan, Hubei, Peoples R China; [Motani, Ryosuke] Univ Calif Davis, Dept Earth & Planetary Sci, Davis, CA 95616 USA; [Jiang, Da-yong] Peking Univ, Dept Geol, Lab Orogen Belt & Crustal Evolut, MOE, Beijing 100871, Peoples R China; [Jiang, Da-yong] Peking Univ, Geol Museum, Beijing 100871, Peoples R China; [Rieppel, Olivier] Ctr Integrat Res, Field Museum, Chicago, IL USA	China Geological Survey; University of California System; University of California Davis; Peking University; Peking University; Field Museum of Natural History (Chicago)	Motani, R (corresponding author), Univ Calif Davis, Dept Earth & Planetary Sci, Davis, CA 95616 USA.	rmotani@ucdavis.edu	Motani, Ryosuke/K-2607-2015	Motani, Ryosuke/0000-0001-5022-1053	Ministry of Land and Resources, China [201311062]; China Geological Survey [1212011120148]; National Natural Science Foundation of China [40920124002, 41372016]; Ministry of Education, China; Research Fund for the Doctoral Program of Higher Education Project [20120001110072]	Ministry of Land and Resources, China; China Geological Survey(China Geological Survey); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education, China(Ministry of Education, China); Research Fund for the Doctoral Program of Higher Education Project	Funding provided by Ministry of Land and Resources, China (http://www.mlr.gov.cn/mlrenglish/), Special project for scientific research Project 201311062 to Xiao-hong Chen, China Geological Survey (http://en.cgs.gov.cn/), Project 1212011120148 to Long Cheng, National Natural Science Foundation of China (http://www.nsfc.gov.cn/publish/portal1/), Projects 40920124002 and 41372016 to Da-yong Jiang and Ministry of Education, China (http://en.ustc.edu.cn/dictionary/201105/t20110509_111375.html), Research Fund for the Doctoral Program of Higher Education Project 20120001110072 to Da-yong Jiang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CARROLL RL, 1991, PHILOS T ROY SOC B, V331, P131, DOI 10.1098/rstb.1991.0004; Chen XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115244; Chen XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102361; Chen XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094396; Delfino M, 2010, ORG DIVERS EVOL, V10, P69, DOI 10.1007/s13127-010-0019-x; GOLOBOFF P, 2000, TNT TREE ANAL USING; Laurenti J. N, 1768, SPECIMEN MEDICUM EXH; Li Jin-Ling, 2002, Vertebrata Palasiatica, V40, P241; Maxwell EE, 2012, J EXP ZOOL PART B, V318B, P545, DOI 10.1002/jez.b.22459; Motani R, 1999, J VERTEBR PALEONTOL, V19, P28, DOI 10.1080/02724634.1999.10011120; Osborn HF, 1903, MEMOIRS AM MUSEUM NA, V1, P449; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Wang K., 1959, Acta Palaeontologica Sinica, V7, P367; Wu XC, 2003, NATURE, V426, P516, DOI 10.1038/426516a; Young C, 1972, AQUATIC REPTILES TRI, P1	15	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0126024	10.1371/journal.pone.0126024	http://dx.doi.org/10.1371/journal.pone.0126024			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26017585	gold, Green Published, Green Submitted			2022-12-26	WOS:000355185600046
J	Duan, AG; Zhang, JG; Zhang, XQ; He, CY				Duan, Aiguo; Zhang, Jianguo; Zhang, Xiongqing; He, Caiyun			Relationship between Modelling Accuracy and Inflection Point Attributes of Several Equations while Modelling Stand Diameter Distributions	PLOS ONE			English	Article							GROWTH; HEIGHTS	In this study, seven popular equations, including 3-parameter Weibull, 2-parameter Weibull, Gompertz, Logistic, Mitscherlich, Korf and R distribution, were used to model stand diameter distributions for exploring the relationship between the equations' inflection point attributes and model accuracy. A database comprised of 146 diameter frequency distributions of Chinese fir (Cunninghamia lanceolata (Lamb.) Hook.) plantations was used to demonstrate model fitting and comparison. Results showed that the inflection points of the stand diameter cumulative percentage distribution ranged from 0.4 to 0.6, showing a 1/2 close rule. The equation's inflection point attribute was strongly related to its model accuracy. Equation with an inflection point showed much higher accuracy than that without an inflection point. The larger the effective inflection point interval of the fitting curve of the equation was, and the closer the inflection point was to 0.5 for the equations with fixed inflection points, the higher the equation's accuracy was. It could be found that the equation's inflection point had close relationship with skewness of diameter distribution and stand age, stand density, which provided a scientific basis for model selection of a stand diameter distribution for Chinese fir plantations and other tree species.	[Duan, Aiguo; Zhang, Jianguo; Zhang, Xiongqing; He, Caiyun] Chinese Acad Forestry, Res Inst Forestry, State Key Lab Tree Genet & Breeding, Key Lab Tree Breeding & Cultivat State Forestry A, Beijing, Peoples R China	Chinese Academy of Forestry; Research Institute of Forestry, CAF; State Key Laboratory of Tree Genetics & Breeding, CAF	Zhang, JG (corresponding author), Chinese Acad Forestry, Res Inst Forestry, State Key Lab Tree Genet & Breeding, Key Lab Tree Breeding & Cultivat State Forestry A, Beijing, Peoples R China.	zhangjg@caf.ac.cn	Zhang, Xiongqing/AAW-6171-2020	Zhang, Xiongqing/0000-0001-5592-6730	Scientific and Technological Task in China [2015BAD09B01, 2012BAD01B01]; National Natural Science Foundation of China [31370629]; Collaborative Innovation Center of Sustaintable Forestry in Southern China, Nanjing Forestry University	Scientific and Technological Task in China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Collaborative Innovation Center of Sustaintable Forestry in Southern China, Nanjing Forestry University	This study was supported by the Scientific and Technological Task in China (No. 2015BAD09B01, 2012BAD01B01), the National Natural Science Foundation of China (31370629) and Collaborative Innovation Center of Sustaintable Forestry in Southern China, Nanjing Forestry University.	Aaron RW, 2009, FOREST ECOL MANAG, V258, P323; BAILEY RL, 1973, FOREST SCI, V19, P97; Birch CPD, 1999, ANN BOT-LONDON, V83, P713, DOI 10.1006/anbo.1999.0877; Brooks J. R., 1992, Southern Journal of Applied Forestry, V16, P130; Burgess D, 2005, FOREST ECOL MANAG, V209, P117, DOI 10.1016/j.foreco.2005.01.006; Burkhart HE, 1974, ROYAL COLL FOR RES N, V30, P128; Calegario N, 2005, FOREST ECOL MANAG, V204, P11, DOI 10.1016/j.foreco.2004.07.051; Duan AG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062605; Gadow K.V., 1998, MODELLING FOREST DEV; Garcia O, 1997, WORKING PAPER; Gompertz B., 1825, PHILOS T ROYAL SOC L, V115, P515, DOI [DOI 10.1098/RSTL.1825.0026, 10.1098/rstl.1825.0026]; HAFLEY WL, 1977, CAN J FOREST RES, V7, P481, DOI 10.1139/x77-062; HUANG SM, 1992, CAN J FOREST RES, V22, P1297, DOI 10.1139/x92-172; Ishikawa Y, 1998, J PLANN, V31, P15; Kerman SC, 2013, STAT PROBABIL LETT, V83, P2129, DOI 10.1016/j.spl.2013.05.028; Kilkki P., 1989, Silva Fennica, V23, P311; Kilkki P., 1986, Silva Fennica, V20, P149; Kiviste AK, 1988, MATH FUNCTIONS FORES; Lei YC, 2001, SE10 USDA FOR SERV S; Li FS, 2002, FOREST SCI, V48, P47; LITTLE SN, 1983, CAN J FOREST RES, V13, P85, DOI 10.1139/x83-012; Mitscherlich EA, 1919, LANDW JB, V53, P167; Monness E. N., 1982, Meddelelser fra Norsk Institutt for Skogforskning, V36; Monness E, 2011, CAN J FOREST RES, V41, P707, DOI [10.1139/x10-246, 10.1139/X10-246]; Newton PF, 2005, FOREST ECOL MANAG, V209, P181, DOI 10.1016/j.foreco.2005.01.020; Rennolls K, 2005, CAN J FOREST RES, V35, P575, DOI [10.1139/x05-006, 10.1139/X05-006]; RICHARDS FJ, 1959, J EXP BOT, V10, P290, DOI 10.1093/jxb/10.2.290; SAS Institute Inc, 1999, SAS STAT US GUID VER; Sun HG, 2011, FOREST ECOL MANAG, V261, P1010, DOI 10.1016/j.foreco.2010.12.019; Verhulst P. F., 1838, CORRES MATH PHYS, V10, P113, DOI DOI 10.1007/BF02309004; Wang ML, 2008, FOREST ECOL MANAG, V255, P2659, DOI 10.1016/j.foreco.2008.01.030; WEST PW, 1987, ANN BOT-LONDON, V60, P571, DOI 10.1093/oxfordjournals.aob.a087480; ZEIDE B, 1989, CAN J FOREST RES, V19, P1283, DOI 10.1139/x89-195; ZEIDE B, 1993, FOREST SCI, V39, P594, DOI 10.1093/forestscience/39.3.594	34	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0126831	10.1371/journal.pone.0126831	http://dx.doi.org/10.1371/journal.pone.0126831			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26016995	Green Published, Green Submitted, gold			2022-12-26	WOS:000355185600061
J	Gallardo, B; Zieritz, A; Aldridge, DC				Gallardo, Belinda; Zieritz, Alexandra; Aldridge, David C.			The Importance of the Human Footprint in Shaping the Global Distribution of Terrestrial, Freshwater and Marine Invaders	PLOS ONE			English	Article							SPECIES DISTRIBUTIONS; CLIMATE-CHANGE; PLANT INVASIONS; GREAT-BRITAIN; MODELS; PREDICTION; HABITAT; RISK; PERFORMANCE; ABILITY	Human activities such as transport, trade and tourism are likely to influence the spatial distribution of non-native species and yet, Species Distribution Models (SDMs) that aim to predict the future broad scale distribution of invaders often rely on environmental (e.g. climatic) information only. This study investigates if and to what extent do human activities that directly or indirectly influence nature (hereafter the human footprint) affect the global distribution of invasive species in terrestrial, freshwater and marine ecosystems. We selected 72 species including terrestrial plants, terrestrial animals, freshwater and marine invasive species of concern in a focus area located in NW Europe (encompassing Great Britain, France, The Netherlands and Belgium). Species Distribution Models were calibrated with the global occurrence of species and a set of high-resolution (9x9 km) environmental (e.g. topography, climate, geology) layers and human footprint proxies (e.g. the human influence index, population density, road proximity). Our analyses suggest that the global occurrence of a wide range of invaders is primarily limited by climate. Temperature tolerance was the most important factor and explained on average 42% of species distribution. Nevertheless, factors related to the human footprint explained a substantial amount (23% on average) of species distributions. When global models were projected into the focus area, spatial predictions integrating the human footprint featured the highest cumulative risk scores close to transport networks (proxy for invasion pathways) and in habitats with a high human influence index (proxy for propagule pressure). We conclude that human related information-currently available in the form of easily accessible maps and databases-should be routinely implemented into predictive frameworks to inform upon policies to prevent and manage invasions. Otherwise we might be seriously underestimating the species and areas under highest risk of future invasions.	[Gallardo, Belinda; Zieritz, Alexandra; Aldridge, David C.] Univ Cambridge, Dept Zool, Aquat Ecol Grp, Cambridge, England; [Gallardo, Belinda] CSIC, IPE, Dept Biodivers & Restorat, Appl & Restorat Ecol Grp, Zaragoza, Spain	University of Cambridge; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Pirenaico de Ecologia (IPE)	Gallardo, B (corresponding author), Univ Cambridge, Dept Zool, Aquat Ecol Grp, Cambridge, England.	galla82@hotmail.com	Gallardo, Belinda/H-9038-2013	Gallardo, Belinda/0000-0002-1552-8233; Zieritz, Alexandra/0000-0002-0305-8270	European Regional Development Fund through RINSE (Reducing the Impacts of Non-native Species in Europe); RINSE; Spanish Ministerio de Economia y Competitividad, through the Severo Ochoa Program for Centres of Excellence in R+D+I [SEV-2012-0262]	European Regional Development Fund through RINSE (Reducing the Impacts of Non-native Species in Europe); RINSE; Spanish Ministerio de Economia y Competitividad, through the Severo Ochoa Program for Centres of Excellence in R+D+I	Research leading to this study has been funded by the European Regional Development Fund through RINSE (Reducing the Impacts of Non-native Species in Europe, http://www.rinse-europe.eu/). BG received financial support from RINSE and the Spanish Ministerio de Economia y Competitividad, through the Severo Ochoa Program for Centres of Excellence in R+D+I (SEV-2012-0262). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022985; [Anonymous], 2014, R LANG ENV STAT COMP; Araujo MB, 2013, ECOL LETT, V16, P1206, DOI 10.1111/ele.12155; Bellard C, 2013, GLOBAL CHANGE BIOL, V19, P3740, DOI 10.1111/gcb.12344; Chytry M, 2009, DIVERS DISTRIB, V15, P98, DOI 10.1111/j.1472-4642.2008.00515.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Ferreira JG, 2011, ESTUAR COAST SHELF S, V93, P117, DOI 10.1016/j.ecss.2011.03.014; Flory SL, 2009, BIOL CONSERV, V142, P2531, DOI 10.1016/j.biocon.2009.05.024; Gallardo B, 2014, ETHOL ECOL EVOL, V26, P130, DOI 10.1080/03949370.2014.896417; Gallardo B, 2013, J BIOGEOGR, V40, P2274, DOI 10.1111/jbi.12170; Gallardo B, 2013, J APPL ECOL, V50, P757, DOI 10.1111/1365-2664.12079; Gallardo B, 2013, ECOL APPL, V23, P352, DOI 10.1890/12-1018.1; Gallardo B, 2012, BIOL INVASIONS, V14, P1265, DOI 10.1007/s10530-011-0154-0; Gonzalez-Moreno P, 2015, GLOBAL ECOL BIOGEOGR, V24, P360, DOI 10.1111/geb.12271; Gonzalez-Moreno P, 2014, DIVERS DISTRIB, V20, P720, DOI 10.1111/ddi.12206; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Guisan A, 2013, ECOL LETT, V16, P1424, DOI 10.1111/ele.12189; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hijmans RJ, 2006, GLOBAL CHANGE BIOL, V12, P2272, DOI 10.1111/j.1365-2486.2006.01256.x; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Jeschke JM, 2008, ANN NY ACAD SCI, V1134, P1, DOI 10.1196/annals.1439.002; Jimenez-Valverde A, 2014, BIODIVERS CONSERV, V23, P369, DOI 10.1007/s10531-013-0606-1; Keller RP, 2009, CONSERV BIOL, V23, P1526, DOI 10.1111/j.1523-1739.2009.01249.x; Kiritani K, 2003, INVASIVE SPECIES VEC, P518; Leprieur F, 2008, PLOS BIOL, V6, P404, DOI 10.1371/journal.pbio.0060028; Levinsky I, 2007, BIODIVERS CONSERV, V16, P3803, DOI 10.1007/s10531-007-9181-7; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Barbosa AM, 2013, DIVERS DISTRIB, V19, P1188, DOI 10.1111/ddi.12106; McNeely, 2001, GREAT RESHUFFLING HU; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Mortensen DA, 2009, INVAS PLANT SCI MANA, V2, P191, DOI 10.1614/IPSM-08-125.1; Murtaugh PA, 2009, ECOL LETT, V12, P1061, DOI 10.1111/j.1461-0248.2009.01361.x; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; Pearson RG, 2004, ECOGRAPHY, V27, P285, DOI 10.1111/j.0906-7590.2004.03740.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pysek P, 2010, P NATL ACAD SCI USA, V107, P12157, DOI 10.1073/pnas.1002314107; Real R, 2008, DIVERS DISTRIB, V14, P364, DOI 10.1111/j.1472-4642.2007.00419.x; Rodriguez-Castaneda G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044402; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Seebens H, 2013, ECOL LETT, V16, P782, DOI 10.1111/ele.12111; Taylor BW, 2004, P NATL ACAD SCI USA, V101, P17725, DOI 10.1073/pnas.0405176101; Theoharides KA, 2007, NEW PHYTOL, V176, P256, DOI 10.1111/j.1469-8137.2007.02207.x; Trombulak SC, 2000, CONSERV BIOL, V14, P18, DOI 10.1046/j.1523-1739.2000.99084.x; Tyberghein L, 2012, GLOBAL ECOL BIOGEOGR, V21, P272, DOI 10.1111/j.1466-8238.2011.00656.x; Vila M, 2001, BIOL CONSERV, V100, P397, DOI 10.1016/S0006-3207(01)00047-7; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Zerebecki RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014806; Zieritz Alexandra, 2014, NeoBiota, V23, P65; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	55	103	106	5	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0125801	10.1371/journal.pone.0125801	http://dx.doi.org/10.1371/journal.pone.0125801			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018575	Green Published, Green Submitted, gold			2022-12-26	WOS:000355185600033
J	Suzuki, H; Watari, A; Hashimoto, E; Yonemitsu, M; Kiyono, H; Yagi, K; Kondoh, M; Kunisawa, J				Suzuki, Hidehiko; Watari, Akihiro; Hashimoto, Eri; Yonemitsu, Miki; Kiyono, Hiroshi; Yagi, Kiyohito; Kondoh, Masuo; Kunisawa, Jun			C-Terminal Clostridium perfringens Enterotoxin-Mediated Antigen Delivery for Nasal Pneumococcal Vaccine	PLOS ONE			English	Article							PROTEIN-A PSPA; PATCH M CELLS; STREPTOCOCCUS-PNEUMONIAE; INTRANASAL IMMUNIZATION; PROTECTIVE IMMUNITY; CLAUDIN MODULATOR; HETEROLOGOUS PSPA; ANTIBODIES; MICE; FRAGMENT	Efficient vaccine delivery to mucosal tissues including mucosa-associated lymphoid tissues is essential for the development of mucosal vaccine. We previously reported that claudin-4 was highly expressed on the epithelium of nasopharynx-associated lymphoid tissue (NALT) and thus claudin-4-targeting using C-terminal fragment of Clostridium perfringens enterotoxin (C-CPE) effectively delivered fused antigen to NALT and consequently induced antigen-specific immune responses. In this study, we applied the C-CPE-based vaccine delivery system to develop a nasal pneumococcal vaccine. We fused C-CPE with pneumococcal surface protein A (PspA), an important antigen for the induction of protective immunity against Streptococcus pneumoniae infection, (PspA-C-CPE). PspA-C-CPE binds to claudin-4 and thus efficiently attaches to NALT epithelium, including antigen-sampling M cells. Nasal immunization with PspA-C-CPE induced PspA-specific IgG in the serum and bronchoalveolar lavage fluid (BALF) as well as IgA in the nasal wash and BALF. These immune responses were sufficient to protect against pneumococcal infection. These results suggest that C-CPE is an efficient vaccine delivery system for the development of nasal vaccines against pneumococcal infection.	[Suzuki, Hidehiko; Hashimoto, Eri; Yonemitsu, Miki; Kunisawa, Jun] Natl Inst Biomed Innovat Hlth & Nutr, Lab Vaccine Mat, Osaka 5670085, Japan; [Suzuki, Hidehiko; Watari, Akihiro; Yagi, Kiyohito; Kondoh, Masuo] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Bio Funct Mol Chem, Suita, Osaka 5650871, Japan; [Hashimoto, Eri; Kiyono, Hiroshi; Kunisawa, Jun] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Mucosal Immunol, Tokyo 1088639, Japan; [Kiyono, Hiroshi; Kunisawa, Jun] Univ Tokyo, Int Res & Dev Ctr Mucosal Vaccines, Inst Med Sci, Tokyo 1088639, Japan; [Kiyono, Hiroshi; Kunisawa, Jun] Japan Sci & Technol Agcy, CREST, Tokyo, Japan; [Kunisawa, Jun] Kobe Univ, Grad Sch Med, Dept Microbiol & Infect Dis, Kobe, Hyogo 6500017, Japan; [Kunisawa, Jun] Osaka Univ, Grad Sch Pharmaceut Sci, Grad Sch Med, Osaka 5650871, Japan; [Kunisawa, Jun] Osaka Univ, Grad Sch Dent, Osaka 5650871, Japan	Osaka University; University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); Kobe University; Osaka University; Osaka University	Kondoh, M (corresponding author), Osaka Univ, Grad Sch Pharmaceut Sci, Lab Bio Funct Mol Chem, Suita, Osaka 5650871, Japan.	masuo@phs.osaka-u.ac.jp; kunisawa@nibiohn.go.jp	Kiyono, Hiroshi/AAC-6735-2022		Ministry of Health and Welfare of Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries, and Food Industry; Program for Promotion of Basic and Applied Research for Innovations in Bio-oriented Industry; Japan Science and Technology Agency, Core Research for Evolutional Science and Technology (CREST); Kowa Life Science Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research	Ministry of Health and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries, and Food Industry; Program for Promotion of Basic and Applied Research for Innovations in Bio-oriented Industry; Japan Science and Technology Agency, Core Research for Evolutional Science and Technology (CREST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Kowa Life Science Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research	This work was supported by grants from the Ministry of Health and Welfare of Japan (J.K., H.K., and M.K.); from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (J.K., H.K., and M.K.); Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries, and Food Industry (J.K.); the Program for Promotion of Basic and Applied Research for Innovations in Bio-oriented Industry (J.K.); from Japan Science and Technology Agency, Core Research for Evolutional Science and Technology (CREST; to H.K.); Kowa Life Science Foundation (J.K.); and Mochida Memorial Foundation for Medical and Pharmaceutical Research (J.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Brandtzaeg P, 2007, VACCINE, V25, P5467, DOI 10.1016/j.vaccine.2006.12.001; Briles DE, 2000, INFECT IMMUN, V68, P796, DOI 10.1128/IAI.68.2.796-800.2000; Briles DE, 2000, J INFECT DIS, V182, P1694, DOI 10.1086/317602; Calix JJ, 2010, J INFECT DIS, V202, P29, DOI 10.1086/653123; Nguyen CT, 2011, VACCINE, V29, P5731, DOI 10.1016/j.vaccine.2011.05.095; Clark MA, 1998, INFECT IMMUN, V66, P1237, DOI 10.1128/IAI.66.3.1237-1243.1998; CRAIN MJ, 1990, INFECT IMMUN, V58, P3293, DOI 10.1128/IAI.58.10.3293-3299.1990; Dlugonska Henryka, 2012, Annals of Parasitology, V58, P1; Fujkuyama Y, 2012, EXPERT REV VACCINES, V11, P367, DOI [10.1586/erv.11.196, 10.1586/ERV.11.196]; Fukuyama Y, 2010, J IMMUNOL, V185, P1755, DOI 10.4049/jimmunol.1000831; Furuse M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002907; Goulart C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059605; Goulart C, 2011, VACCINE, V29, P1634, DOI 10.1016/j.vaccine.2010.12.074; Grevers G, 2010, INT J PEDIATR OTORHI, V74, P572, DOI 10.1016/j.ijporl.2010.03.049; HANNA PC, 1991, J BIOL CHEM, V266, P11037; Harboe ZB, 2014, CLIN INFECT DIS; Hase K, 2009, NATURE, V462, P226, DOI 10.1038/nature08529; Helander A, 2003, J VIROL, V77, P7964, DOI 10.1128/JVI.77.14.7964-7977.2003; Ivanov AI, 2004, MOL BIOL CELL, V15, P176, DOI 10.1091/mbc.E03-05-0319; Jensen VB, 1998, INFECT IMMUN, V66, P3758, DOI 10.1128/IAI.66.8.3758-3766.1998; Kakutani H, 2010, BIOMATERIALS, V31, P5463, DOI 10.1016/j.biomaterials.2010.03.047; KokaiKun JF, 1997, INFECT IMMUN, V65, P1014, DOI 10.1128/IAI.65.3.1014-1022.1997; Kondoh M, 2005, MOL PHARMACOL, V67, P749, DOI 10.1124/mol.104.008375; Kong IG, 2013, INFECT IMMUN, V81, P1625, DOI 10.1128/IAI.00240-13; Kunisawa J, 2008, TRENDS IMMUNOL, V29, P505, DOI 10.1016/j.it.2008.07.008; Kunisawa J, 2012, ADV DRUG DELIVER REV, V64, P523, DOI 10.1016/j.addr.2011.07.003; Kurono Y, 1999, J INFECT DIS, V180, P122, DOI 10.1086/314827; Mabbott NA, 2013, MUCOSAL IMMUNOL, V6, P666, DOI 10.1038/mi.2013.30; Miyaji EN, 2013, CELL MOL LIFE SCI, V70, P3303, DOI 10.1007/s00018-012-1234-8; Moreno AT, 2010, CLIN VACCINE IMMUNOL, V17, P439, DOI 10.1128/CVI.00430-09; Nabors GS, 2000, VACCINE, V18, P1743, DOI 10.1016/S0264-410X(99)00530-7; Nochi T, 2007, J EXP MED, V204, P2789, DOI 10.1084/jem.20070607; Ogunniyi AD, 2007, INFECT IMMUN, V75, P1843, DOI 10.1128/IAI.01384-06; Park IH, 2007, J CLIN MICROBIOL, V45, P1225, DOI 10.1128/JCM.02199-06; Rajapaksa TE, 2010, J CONTROL RELEASE, V142, P196, DOI 10.1016/j.jconrel.2009.10.033; Shaper M, 2004, INFECT IMMUN, V72, P5031, DOI 10.1128/IAI.72.9.5031-5040.2004; Shima H, 2014, INT IMMUNOL, V26, P619, DOI 10.1093/intimm/dxu061; Smedley JG, 2007, INFECT IMMUN, V75, P2381, DOI 10.1128/IAI.01737-06; Sonoda N, 1999, J CELL BIOL, V147, P195, DOI 10.1083/jcb.147.1.195; Suzuki H, 2011, PHARMAZIE, V66, P543, DOI 10.1691/ph.2011.0365; Suzuki H, 2010, PHARMAZIE, V65, P766, DOI 10.1691/ph.2010.0097; Takahashi A, 2005, J CONTROL RELEASE, V108, P56, DOI 10.1016/j.jconrel.2005.07.008; Tu AHT, 1999, INFECT IMMUN, V67, P4720, DOI 10.1128/IAI.67.9.4720-4724.1999; Van Itallie CM, 2008, J BIOL CHEM, V283, P268, DOI 10.1074/jbc.M708066200; Wang XH, 2003, J IMMUNOL, V171, P4717, DOI 10.4049/jimmunol.171.9.4717; Zhang Z, 2009, J CLIN INVEST, V119, P1899, DOI 10.1172/JCI36731; Zhao AS, 2014, INT J PEDIATR OTORHI, V78, P499, DOI 10.1016/j.ijporl.2013.12.028	48	31	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0126352	10.1371/journal.pone.0126352	http://dx.doi.org/10.1371/journal.pone.0126352			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018248	Green Published, Green Submitted, gold			2022-12-26	WOS:000355185600050
J	Tang, WJ; Dong, WW; Xie, P; Cheng, PF; Bai, SJ; Ren, YF; Wang, G; Chen, XY; Cui, C; Zhuang, YX; Huang, W				Tang, Weiju; Dong, Weiwei; Xie, Peng; Cheng, Pengfei; Bai, Shunjie; Ren, Yifei; Wang, Gong; Chen, Xiuying; Cui, Chun; Zhuang, Yuxiang; Huang, Wen			The Effect of Pre-Condition Cerebella Fastigial Nucleus Electrical Stimulation within and beyond the Time Window of Thrombolytic on Ischemic Stroke in the Rats	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; CEREBRAL-ARTERY OCCLUSION; HIPPOCAMPAL-NEURONS; BRAIN-INJURY; NEUROPROTECTION; EXPRESSION; MECHANISM; ALTEPLASE	Objective To investigate the effect of neurogenic neuroprotection conferred by cerebellar fastigial nucleus stimulation (FNS) and the role of PPAR gamma-mediated inflammation in a rat model of cerebral ischemia reperfusion. Methods After a continuous 1 hour fastigial nucleus electric stimulation, the male Sprague Dawley (SD) rats were given middle cerebral artery occlusion (MCAO) for 1, 3, 6, 9, 12 and 15 hours undergoing reperfusion with intravenous recombinant tissue plasminogen activator (rt-PA), while the control group received without FNS. After 72h of reperfusion, the neurological deficits, infarct volume and brain edema were evaluated. The brain tissue in ischemic penumbra was determined the myeloperoxidase (MPO) activity by a spectrophotometer and expression of PPAR. was measured by Rt-PCR and Western blotting. Results Our findings showed that FNS group had significantly reduced infarct volume and brain edema, and improved neurological deficits compared with the control group, especially in 6h and 9h reperfusion subgroups(p<0.05). The expression levels of PPAR. increased gradually and the peak may be before and after 9h reperfusion, the 3h, 6h, 9h, 12h and 15h reperfusion subgroups were higher than each control group(p<0.05). The MPO activity of 6h, 12h and 15h reperfusion subgroups were higher than each control group(p<0.05). Conclusions The neuroprotective effects of FNS have been shown to prolong the therapeutic window in cerebral ischemia/reperfusion, which might be related to the PPAR gamma mediated-inflammation in penumbral region.	[Tang, Weiju; Wang, Gong; Chen, Xiuying; Huang, Wen] Third Mil Med Univ, Xinqiao Hosp, Dept Neurol, Chongqing, Peoples R China; [Dong, Weiwei; Xie, Peng; Cheng, Pengfei; Bai, Shunjie; Ren, Yifei] Third Mil Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing, Peoples R China; [Cui, Chun; Zhuang, Yuxiang] Third Mil Med Univ, Xinqiao Hosp, Dept Radiol, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University	Huang, W (corresponding author), Third Mil Med Univ, Xinqiao Hosp, Dept Neurol, Chongqing, Peoples R China.	bosshuangwen@126.com			National Natural Science Foundation of China [81171113]; Natural Science Foundation of Chongqing, China [CSTC 2011BA5012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Chongqing, China(Natural Science Foundation of Chongqing)	This work was supported by research grants from the National Natural Science Foundation of China (Grant # 81171113), the Natural Science Foundation of Chongqing, China (Grant # CSTC 2011BA5012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barreto GE, 2012, EXP NEUROL, V238, P284, DOI 10.1016/j.expneurol.2012.08.015; Busch E, 1997, BRAIN RES, V778, P16, DOI 10.1016/S0006-8993(97)01008-1; Chen JG, 2007, J PHARMACOL SCI, V103, P317, DOI 10.1254/jphs.FP0061235; Durukan A, 2007, PHARMACOL BIOCHEM BE, V87, P179, DOI 10.1016/j.pbb.2007.04.015; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Feigin VL, 2003, LANCET NEUROL, V2, P43, DOI 10.1016/S1474-4422(03)00266-7; Golanov EV, 2003, CELL MOL NEUROBIOL, V23, P651, DOI 10.1023/A:1025088516742; Golanov EV, 1998, NEUROREPORT, V9, P819, DOI 10.1097/00001756-199803300-00010; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Inestrosa NC, 2005, EXP CELL RES, V304, P91, DOI 10.1016/j.yexcr.2004.09.032; Kinouchi T, 2012, STROKE, V43, P478, DOI 10.1161/STROKEAHA.111.618926; Lakhan SE, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-97; Lee CH, 2014, ANAT CELL BIOL, V47, P111, DOI 10.5115/acb.2014.47.2.111; Liu JL, 2014, NEURAL REGEN RES, V9, P727, DOI 10.4103/1673-5374.131577; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Luo YM, 2006, J NEUROCHEM, V97, P435, DOI 10.1111/j.1471-4159.2006.03758.x; Majid Arshad, 2014, ISRN Neurol, V2014, P515716, DOI 10.1155/2014/515716; MATSUO Y, 1994, STROKE, V25, P1469, DOI 10.1161/01.STR.25.7.1469; Mohammadi A, 2014, IRAN J BASIC MED SCI, V17, P263; Nour M, 2012, INTERV NEUROL, V1, P185, DOI 10.1159/000353125; Okami N, 2013, J CEREBR BLOOD F MET, V33, P106, DOI 10.1038/jcbfm.2012.138; Owens B, 2014, NATURE, V510, pS1, DOI 10.1038/510S1a; Reis DJ, 1990, STROKE, V21, P172; Rupadevi M, 2011, J PHARMACOL PHARMACO, V2, P36, DOI 10.4103/0976-500X.77113; Sun H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041716; Sundararajan S, 2005, NEUROSCIENCE, V130, P685, DOI 10.1016/j.neuroscience.2004.10.021; Wahlgren N, 2007, LANCET, V369, P275, DOI 10.1016/S0140-6736(07)60149-4; Wang QA, 2011, STROKE, V42, P389, DOI 10.1161/STROKEAHA.110.597336; Zhao XR, 2009, J NEUROSCI, V29, P6186, DOI 10.1523/JNEUROSCI.5857-08.2009; Zhou P, 2005, J NEUROCHEM, V95, P221, DOI 10.1111/j.1471-4159.2005.03358.x; 夏一鲁, 1999, [中风与神经疾病杂志, Journal of Apoplexy and Nervous Diseases], V16, P3	32	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0128447	10.1371/journal.pone.0128447	http://dx.doi.org/10.1371/journal.pone.0128447			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26016630	Green Submitted, Green Published, gold			2022-12-26	WOS:000355185600118
J	Imai, N; Yasuda, T; Kamijo-Ikemori, A; Shibagaki, Y; Kimura, K				Imai, Naohiko; Yasuda, Takashi; Kamijo-Ikemori, Atsuko; Shibagaki, Yugo; Kimura, Kenjiro			Distinct Roles of Urinary Liver-Type Fatty Acid-Binding Protein in Non-Diabetic Patients with Anemia	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; L-FABP; ERYTHROPOIETIN; BIOMARKER; EXCRETION; REFLECTS	Background Various stresses including ischemia are known to up-regulate renal L-FABP gene expression and increase the urinary excretion of L-FABP. In diabetic patients with anemia, the urinary excretion of L-FABP is significantly increased. We studied the clinical significance of urinary L-FABP and its relationship with anemia in non-diabetic patients. Subjects and Methods A total of 156 patients were studied in this retrospective cross-sectional analysis. The associations between anemia and urinary L-FABP levels, and the predictors of urinary L-FABP levels in non-diabetic patients were evaluated. Results Urinary L-FABP levels were significantly higher in patients with anemia compared to those in patients without anemia. Similarly, the urinary L-FABP levels were significantly higher in patients with albuminuria compared to those in patients without albuminuria. Urinary L-FABP levels correlated with urinary albumin-to-creatinine ratios, estimated glomerular filtration rates, body mass index, and hemoglobin levels. Multivariate linear regression analysis determined that hemoglobin levels (beta = -0.249, P = 0.001) and urinary albumin-to-creatinine ratios (beta = 0.349, P < 0.001) were significant predictors of urinary L-FABP levels. Conclusions Urinary L-FABP is strongly associated with anemia in non-diabetic patients.	[Imai, Naohiko; Yasuda, Takashi; Kamijo-Ikemori, Atsuko; Shibagaki, Yugo] St Marianna Univ, Sch Med, Dept Internal Med, Div Nephrol & Hypertens, Kawasaki, Kanagawa, Japan; [Kimura, Kenjiro] Tokyo Takanawa Hosp, Dept Internal Med, Tokyo, Japan	Saint Marianna University	Imai, N (corresponding author), St Marianna Univ, Sch Med, Dept Internal Med, Div Nephrol & Hypertens, Kawasaki, Kanagawa, Japan.	naohiko.imai@gmail.com		Imai, Naohiko/0000-0001-9984-2889				Babazono T, 2006, DIABETOLOGIA, V49, P1387, DOI 10.1007/s00125-006-0247-y; Dikow R, 2002, NEPHROL DIAL TRANSPL, V17, P67, DOI 10.1093/ndt/17.suppl_1.67; Erturk S, 1996, NEPHROL DIAL TRANSPL, V11, P396, DOI 10.1093/oxfordjournals.ndt.a027287; Hayashi K, 2001, KIDNEY INT, V60, P1910, DOI 10.1046/j.1523-1755.2001.00028.x; Huang H, 2002, J BIOL CHEM, V277, P29139, DOI 10.1074/jbc.M202923200; Izuhara Y, 2005, J AM SOC NEPHROL, V16, P3631, DOI 10.1681/ASN.2005050522; Kamijo A, 2004, AM J PATHOL, V165, P1243, DOI 10.1016/S0002-9440(10)63384-6; Kamijo A, 2004, J LAB CLIN MED, V143, P23, DOI 10.1016/j.lab.2003.08.001; Kamijo A, 2006, MOL CELL BIOCHEM, V284, P175, DOI 10.1007/s11010-005-9047-9; Kamijo-Ikemori A, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0513-1; Lawrence JW, 2000, J LIPID RES; MAATMAN RGHJ, 1991, BIOCHEM J, V273, P759, DOI 10.1042/bj2730759; Matsui K, 2011, AM J PATHOL, V178, P1021, DOI 10.1016/j.ajpath.2010.12.002; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Mayer GL, 2006, FATS OF LIFE, V20, P4; McCullough Peter A, 2005, Rev Cardiovasc Med, V6, P1; Nakamura T, 2007, DIABETOLOGIA, V50, P490, DOI 10.1007/s00125-006-0545-4; Nakamura T, 2005, DIABETES CARE, V28, P2728, DOI 10.2337/diacare.28.11.2728; Nakamura T, 2006, AM J NEPHROL, V26, P276, DOI 10.1159/000093934; Nangaku M, 2005, J AM SOC NEPHROL, V16, P1195, DOI 10.1681/ASN.2004121098; Nielsen SE, 2009, DIABETES CARE, V32, P1684, DOI 10.2337/dc09-0429; Portilla D, 2008, KIDNEY INT, V73, P465, DOI 10.1038/sj.ki.5002721; Thomas MC, 2003, DIABETES CARE, V26, P1164, DOI 10.2337/diacare.26.4.1164; von Eynatten M, 2010, EUR J CLIN INVEST, V40, P95, DOI 10.1111/j.1365-2362.2009.02220.x; Vrtovsnik F, 1999, KIDNEY INT, V56, pS92, DOI 10.1046/j.1523-1755.1999.07123.x; World Health Organization, 2011, SER FERR CONC ASS IR; Yamamoto T, 2007, J AM SOC NEPHROL, V18, P2894, DOI 10.1681/ASN.2007010097; Yokoyama T, 2009, AM J PATHOL, V174, P2096, DOI 10.2353/ajpath.2009.080780	28	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0126990	10.1371/journal.pone.0126990	http://dx.doi.org/10.1371/journal.pone.0126990			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010898	Green Submitted, Green Published, gold			2022-12-26	WOS:000355183900053
J	Ito, A; Nagai, M; Tajino, J; Yamaguchi, S; Iijima, H; Zhang, XK; Aoyama, T; Kuroki, H				Ito, Akira; Nagai, Momoko; Tajino, Junichi; Yamaguchi, Shoki; Iijima, Hirotaka; Zhang, Xiangkai; Aoyama, Tomoki; Kuroki, Hiroshi			Culture Temperature Affects Human Chondrocyte Messenger RNA Expression in Monolayer and Pellet Culture Systems	PLOS ONE			English	Article							HUMAN ARTICULAR CHONDROCYTES; OXYGEN-TENSION; OSTEOARTHRITIC CHONDROCYTES; HYDROSTATIC-PRESSURE; CARTILAGE FORMATION; GENE-EXPRESSION; RETINOIC ACID; 3D CULTURES; STEM-CELLS; REDIFFERENTIATION	Cell-based therapy has been explored for articular cartilage regeneration. Autologous chondrocyte implantation is a promising cell-based technique for repairing articular cartilage defects. However, there are several issues such as chondrocyte de-differentiation. While numerous studies have been designed to overcome some of these issues, only a few have focused on the thermal environment that can affect chondrocyte metabolism and phenotype. In this study, the effects of different culture temperatures on human chondrocyte metabolism-and phenotype-related gene expression were investigated in 2D and 3D environments. Human chondrocytes were cultured in a monolayer or in a pellet culture system at three different culture temperatures (32 degrees C, 37 degrees C, and 41 degrees C) for 3 days. The results showed that the total RNA level, normalized to the threshold cycle value of internal reference genes, was higher at lower temperatures in both culture systems. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and citrate synthase (CS), which are involved in glycolysis and the citric acid cycle, respectively, were expressed at similar levels at 32 degrees C and 37 degrees C in pellet cultures, but the levels were significantly lower at 41 degrees C. Expression of the chondrogenic markers, collagen type IIA1 (COL2A1) and aggrecan (ACAN), was higher at 37 degrees C than at 32 degrees C and 41 degrees C in both culture systems. However, this phenomenon did not coincide with SRY (sex-determining region Y)-box 9 (SOX9), which is a fundamental transcription factor for chondrogenesis, indicating that a SOX9-independent pathway might be involved in this phenomenon. In conclusion, the expression of chondrocyte metabolism-related genes at 32 degrees C was maintained or enhanced compared to that at 37 degrees C. However, chondrogenesis-related genes were further induced at 37 degrees C in both culture systems. Therefore, manipulating the culture temperature may be an advantageous approach for regulating human chondrocyte metabolic activity and chondrogenesis.	[Ito, Akira; Nagai, Momoko; Tajino, Junichi; Yamaguchi, Shoki; Iijima, Hirotaka; Zhang, Xiangkai; Kuroki, Hiroshi] Kyoto Univ, Grad Sch Med, Dept Motor Funct Anal Human Hlth Sci, Kyoto, Japan; [Ito, Akira; Yamaguchi, Shoki] Japan Soc Promot Sci, Tokyo, Japan; [Aoyama, Tomoki] Kyoto Univ, Grad Sch Med, Dept Dev & Rehabil Motor Funct Human Hlth Sci, Kyoto, Japan	Kyoto University; Japan Society for the Promotion of Science; Kyoto University	Kuroki, H (corresponding author), Kyoto Univ, Grad Sch Med, Dept Motor Funct Anal Human Hlth Sci, Kyoto, Japan.	kuroki.hiroshi.6s@kyoto-u.ac.jp	Ito, Akira/AAA-4872-2021; Iijima, Hirotaka/AAV-9480-2020	Ito, Akira/0000-0002-9645-9777; 	JSPS KAKENHI [25242055, 25560258];  [253611]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); 	This study was supported in part by a Grant-in-Aid for Japan Society for the Promotion of Science (JSPS, http://www.jsps.go.jp/index.html) Research Fellows (no. 253611) to AI, a JSPS KAKENHI Grant-in-Aid for Scientific Research (A) (no. 25242055) and a JSPS KAKENHI Grant-in-Aid for Challenging Exploratory Research (no. 25560258) to HK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Babur BK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058865; Baik JY, 2006, BIOTECHNOL BIOENG, V93, P361, DOI 10.1002/bit.20717; Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174; BENYA PD, 1988, J CELL BIOL, V106, P161, DOI 10.1083/jcb.106.1.161; Bernstein P, 2009, BIOTECHNOL PROGR, V25, P1146, DOI 10.1002/btpr.186; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Blain EJ, 2009, INT J EXP PATHOL, V90, P1, DOI 10.1111/j.1365-2613.2008.00625.x; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; Buckley CT, 2010, OSTEOARTHR CARTILAGE, V18, P1345, DOI 10.1016/j.joca.2010.07.004; Caron MMJ, 2012, OSTEOARTHR CARTILAGE, V20, P1170, DOI 10.1016/j.joca.2012.06.016; Chen J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091561; Chuppa S, 1997, BIOTECHNOL BIOENG, V55, P328, DOI 10.1002/(SICI)1097-0290(19970720)55:2<328::AID-BIT10>3.0.CO;2-D; Dehne T, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2800; DEWEY WC, 1977, RADIOLOGY, V123, P463, DOI 10.1148/123.2.463; Domm C, 2002, OSTEOARTHR CARTILAGE, V10, P13, DOI 10.1053/joca.2001.0477; Elder SH, 2006, J ORTHOP RES, V24, P740, DOI 10.1002/jor.20086; Foldager CB, 2011, ACTA ORTHOP, V82, P234, DOI 10.3109/17453674.2011.566135; Fortier LA, 2011, CLIN ORTHOP RELAT R, V469, P2706, DOI 10.1007/s11999-011-1857-3; Freyria AM, 2012, INJURY, V43, P259, DOI 10.1016/j.injury.2011.05.035; Gallagher S, 2001, Curr Protoc Protein Sci, VAppendix 4, p4K, DOI 10.1002/0471140864.psa04ks13; Gigante A, 2008, EUR J HISTOCHEM, V52, P169; Hendrick V, 2001, CYTOTECHNOLOGY, V36, P71, DOI 10.1023/A:1014088919546; Hojo Tatsuya, 2003, J Orthop Sci, V8, P396, DOI 10.1007/s10776-002-0643-2; Idowu BD, 2000, HISTOCHEM J, V32, P165, DOI 10.1023/A:1004095207330; Ito Akira, 2014, J Jpn Phys Ther Assoc, V17, P14, DOI 10.1298/jjpta.Vol17_003; Ito A, 2014, INT J HYPERTHER, V30, P210, DOI 10.3109/02656736.2014.906048; Ito A, 2014, INT J HYPERTHER, V30, P96, DOI 10.3109/02656736.2014.880857; Ito A, 2012, ULTRASOUND MED BIOL, V38, P1726, DOI 10.1016/j.ultrasmedbio.2012.06.005; Jeon JE, 2012, OSTEOARTHR CARTILAGE, V20, P906, DOI 10.1016/j.joca.2012.04.019; KIM HKW, 1991, J BONE JOINT SURG AM, V73A, P1301, DOI 10.2106/00004623-199173090-00004; Kocaoglu B, 2011, ARTHROSCOPY, V27, P526, DOI 10.1016/j.arthro.2010.10.019; Lafont JE, 2008, J BIOL CHEM, V283, P4778, DOI 10.1074/jbc.M707729200; Lee CH, 2010, LANCET, V376, P440, DOI 10.1016/S0140-6736(10)60668-X; Lee CR, 2003, J BIOMED MATER RES A, V64A, P560, DOI 10.1002/jbm.a.10443; Li S, 2014, BIOTECHNOL BIOENG, V111, P1876, DOI 10.1002/bit.25241; Makris EA, 2013, OSTEOARTHR CARTILAGE, V21, P634, DOI 10.1016/j.joca.2013.01.007; MALLEINGERIN F, 1991, EUR J CELL BIOL, V56, P364; MANKIN HJ, 1982, J BONE JOINT SURG AM, V64, P460, DOI 10.2106/00004623-198264030-00022; Moore A, 1997, CYTOTECHNOLOGY, V23, P47, DOI 10.1023/A:1007919921991; Mouw JK, 2005, OSTEOARTHR CARTILAGE, V13, P828, DOI 10.1016/j.joca.2005.04.020; MOW VC, 1992, BIOMATERIALS, V13, P67, DOI 10.1016/0142-9612(92)90001-5; Murphy CL, 2004, J CELL PHYSIOL, V199, P451, DOI 10.1002/jcp.10481; Ono Y, 2013, BIOCHEM BIOPH RES CO, V435, P733, DOI 10.1016/j.bbrc.2013.05.052; OOSTERVELD FGJ, 1994, SEMIN ARTHRITIS RHEU, V24, P82, DOI 10.1016/S0049-0172(05)80002-2; PARKKINEN JJ, 1995, J ORTHOPAED RES, V13, P495, DOI 10.1002/jor.1100130404; Peterson L, 2000, CLIN ORTHOP RELAT R, P212, DOI 10.1097/00003086-200005000-00020; Roberts S, 2009, KNEE, V16, P398, DOI 10.1016/j.knee.2009.02.004; Roelofs AJ, 2013, OSTEOARTHR CARTILAGE, V21, P892, DOI 10.1016/j.joca.2013.04.008; Sanchez-Inchausti G, 2005, ARTHROSCOPY, V21, P552, DOI 10.1016/j.arthro.2005.01.011; Schnabel M, 2002, OSTEOARTHR CARTILAGE, V10, P62, DOI 10.1053/joca.2001.0482; Schrobback K, 2012, CELL TISSUE RES, V347, P649, DOI 10.1007/s00441-011-1193-7; Sekiya I, 2000, J BIOL CHEM, V275, P10738, DOI 10.1074/jbc.275.15.10738; Sirover MA, 1999, BBA-PROTEIN STRUCT M, V1432, P159, DOI 10.1016/S0167-4838(99)00119-3; Siu PM, 2003, J APPL PHYSIOL, V94, P555, DOI 10.1152/japplphysiol.00821.2002; Tan GK, 2011, BIOMATERIALS, V32, P5600, DOI 10.1016/j.biomaterials.2011.04.033; VONDERMARK K, 1977, NATURE, V267, P531, DOI 10.1038/267531a0; Wang LM, 2010, BIOMATERIALS, V31, P1612, DOI 10.1016/j.biomaterials.2009.11.024; WHEATLEY DN, 1989, INT J HYPERTHER, V5, P145, DOI 10.3109/02656738909140444; Ylarinne JH, 2014, CELL TISSUE RES, V358, P541, DOI 10.1007/s00441-014-1970-1; Yoon SK, 2003, BIOTECHNOL BIOENG, V82, P289, DOI 10.1002/bit.10566; Zheng MH, 2007, TISSUE ENG, V13, P737, DOI 10.1089/ten.2006.0246	62	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128082	10.1371/journal.pone.0128082	http://dx.doi.org/10.1371/journal.pone.0128082			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010859	Green Published, gold, Green Submitted			2022-12-26	WOS:000355183900191
J	Leng, YQ; Zhong, SB				Leng, Yueqiang; Zhong, Shaobin			The Role of Mitogen-Activated Protein (MAP) Kinase Signaling Components in the Fungal Development, Stress Response and Virulence of the Fungal Cereal Pathogen Bipolaris sorokiniana	PLOS ONE			English	Article							COCHLIOBOLUS-SATIVUS; MYCOSPHAERELLA-GRAMINICOLA; MAGNAPORTHE-GRISEA; OXIDATIVE STRESS; CRYPHONECTRIA-PARASITICA; CHLAMYDOSPORE FORMATION; APPRESSORIUM FORMATION; FUSARIUM-GRAMINEARUM; CANDIDA-ALBICANS; PLANT INFECTION	Mitogen-activated protein kinases (MAPKs) have been demonstrated to be involved in fungal development, sexual reproduction, pathogenicity and/or virulence in many filamentous plant pathogenic fungi, but genes for MAPKs in the fungal cereal pathogen Bipolaris sorokiniana have not been characterized. In this study, orthologues of three MAPK genes (CsSLT2, CsHOG1 and CsFUS3) and one MAPK kinase kinase (MAPKKK) gene (CsSTE11) were identified in the whole genome sequence of the B. sorokiniana isolate ND90Pr, and knockout mutants were generated for each of them. The Delta Csfus3 and Delta Csste11 mutants were defective in conidiation and formation of appressoria-like structures, showed hypersensitivity to oxidative stress and lost pathogenicity on non-wounded leaves of barley cv. Bowman. When inoculated on wounded leaves of Bowman, the Delta Csfus3 and Delta Csste11 mutants were reduced in virulence compared to the wild type. No morphological changes were observed in the Delta Cshog1 mutants in comparison with the wild type; however, they were slightly reduced in growth under oxidative stress and were hypersensitive to hyperosmotic stress. The Delta Cshog1 mutants formed normal appressoria-like structures but were reduced in virulence when inoculated on Bowman leaves. The Delta Csslt2 mutants produced more vegetative hyphae, had lighter pigmentation, were more sensitive to cell wall degrading enzymes, and were reduced in virulence on Bowman leaves, although they formed normal appressoria like the wild type. Root infection assays indicated that the Delta Cshog1 and Delta Csslt2 mutants were able to infect barley roots while the Delta Csfus3 and Delta Csste11 failed to cause any symptoms. However, no significant difference in virulence was observed for Delta Cshog1 mutants while Delta Csslt2 mutants showed significantly reduced virulence on barley roots in comparison with the wild type. Our results indicated that all of these MAPK and MAPKKK genes are involved in the regulation of fungal development under normal and stress conditions and required for full virulence on barley plants.	[Leng, Yueqiang; Zhong, Shaobin] N Dakota State Univ, Dept Plant Pathol, Fargo, ND 58105 USA	North Dakota State University Fargo	Zhong, SB (corresponding author), N Dakota State Univ, Dept Plant Pathol, Fargo, ND 58105 USA.	shaobin.zhong@ndsu.edu			Triticeae-CAP project from the USDA National Institute of Food and Agriculture [2011-68002-30029]; North Dakota State University	Triticeae-CAP project from the USDA National Institute of Food and Agriculture; North Dakota State University	This study was partially supported by the Triticeae-CAP project (2011-68002-30029) from the USDA National Institute of Food and Agriculture. Additional funding was provided by North Dakota State University. The authors received no specific funding from other sources for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Monge R, 2003, EUKARYOT CELL, V2, P351, DOI 10.1128/EC.2.2.351-361.2003; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Bahn YS, 2005, MOL BIOL CELL, V16, P2285, DOI 10.1091/mbc.E04-11-0987; Catlett N.L., 2003, FUNGAL GENET NEWSL, V50, P9, DOI DOI 10.4148/1941-4765.1150; Choi ES, 2005, MICROBIOL-SGM, V151, P1349, DOI 10.1099/mic.0.27796-0; Condon BJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003233; Cousin A, 2006, MOL PLANT PATHOL, V7, P269, DOI [10.1111/j.1364-3703.2006.00337.x, 10.1111/J.1364-3703.2006.00337.X]; Dixon KP, 1999, PLANT CELL, V11, P2045, DOI 10.1105/tpc.11.10.2045; Eisman B, 2006, EUKARYOT CELL, V5, P347, DOI 10.1128/EC.5.2.347-358.2006; Eliahu N, 2007, EUKARYOT CELL, V6, P421, DOI 10.1128/EC.00264-06; Fetch TG, 1999, PLANT DIS, V83, P213, DOI 10.1094/PDIS.1999.83.3.213; Friesen TL, 2006, NAT GENET, V38, P953, DOI 10.1038/ng1839; Hamel LP, 2012, PLANT CELL, V24, P1327, DOI 10.1105/tpc.112.096156; Heinisch JJ, 2005, BBA-PROTEINS PROTEOM, V1754, P171, DOI 10.1016/j.bbapap.2005.07.032; Hou ZM, 2002, MOL PLANT MICROBE IN, V15, P1119, DOI 10.1094/MPMI.2002.15.11.1119; Igbaria A, 2008, MOL PLANT MICROBE IN, V21, P769, DOI 10.1094/MPMI-21-6-0769; Izumitsu K, 2009, CURR GENET, V55, P439, DOI 10.1007/s00294-009-0257-7; Jenczmionka NJ, 2003, CURR GENET, V43, P87, DOI 10.1007/s00294-003-0379-2; KOCH E, 1990, PLANT CELL, V2, P437, DOI 10.1105/tpc.2.5.437; Leng YQ, 2012, MOL PLANT PATHOL, V13, P375, DOI 10.1111/j.1364-3703.2011.00756.x; Lev S, 1999, P NATL ACAD SCI USA, V96, P13542, DOI 10.1073/pnas.96.23.13542; LILJEROTH E, 1993, PHYTOPATHOLOGY, V83, P1484, DOI 10.1094/Phyto-83-1484; Mathre D. E., 1997, COMPENDIUM BARLEY DI; Mehrabi R, 2006, MOL PLANT MICROBE IN, V19, P389, DOI 10.1094/MPMI-19-0389; Mehrabi R, 2006, MOL PLANT MICROBE IN, V19, P1262, DOI 10.1094/MPMI-19-1262; Mey G, 2002, MOL MICROBIOL, V46, P305, DOI 10.1046/j.1365-2958.2002.03133.x; Moriwaki A, 2006, FEMS MICROBIOL LETT, V257, P253, DOI 10.1111/j.1574-6968.2006.00178.x; Moriwaki A, 2007, MICROBIOL RES, V162, P108, DOI 10.1016/j.micres.2006.01.014; Park SM, 2004, MOL MICROBIOL, V51, P1267, DOI 10.1111/j.1365-2958.2004.03919.x; Ruiz-Roldan MC, 2001, MOL PLANT MICROBE IN, V14, P116, DOI 10.1094/MPMI.2001.14.2.116; Segmuller N, 2007, EUKARYOT CELL, V6, P211, DOI 10.1128/EC.00153-06; Solomon PS, 2005, CURR GENET, V48, P60, DOI 10.1007/s00294-005-0588-y; Takano Y, 2000, MOL PLANT MICROBE IN, V13, P374, DOI 10.1094/MPMI.2000.13.4.374; TINLINE R. D., 1960, CANADIAN JOUR BOT, V38, P275, DOI 10.1139/b60-028; TURGEON BG, 1987, MOL CELL BIOL, V7, P3297, DOI 10.1128/MCB.7.9.3297; ValjavecGratian M, 1997, PLANT DIS, V81, P1275, DOI 10.1094/PDIS.1997.81.11.1275; Wiese M.V., 1977, COMPENDIUM WHEAT DIS; WINDELS CE, 1988, PHYTOPATHOLOGY, V78, P107, DOI 10.1094/Phyto-78-107; Xu JR, 1998, P NATL ACAD SCI USA, V95, P12713, DOI 10.1073/pnas.95.21.12713; Xu JR, 1996, GENE DEV, V10, P2696, DOI 10.1101/gad.10.21.2696; Yoshimi A, 2005, EUKARYOT CELL, V4, P1820, DOI 10.1128/EC.4.11.1820-1828.2005; Zhao XH, 2005, PLANT CELL, V17, P1317, DOI 10.1105/tpc.104.029116; Zhao XH, 2007, EUKARYOT CELL, V6, P1701, DOI 10.1128/EC.00216-07; Zhong SB, 2002, MOL PLANT MICROBE IN, V15, P481, DOI 10.1094/MPMI.2002.15.5.481	44	23	28	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128291	10.1371/journal.pone.0128291	http://dx.doi.org/10.1371/journal.pone.0128291			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011429	Green Published, Green Submitted, gold			2022-12-26	WOS:000355183900218
J	Lin, WY; Lee, CC; Hsu, CW; Huang, KY; Lyu, SR				Lin, Wen-Yan; Lee, Ching-Chih; Hsu, Chia-Wen; Huang, Kuang-Yung; Lyu, Shaw-Ruey			Patients with Knee Osteoarthritis Undergoing Total Knee Arthroplasty Have a Lower Risk of Subsequent Severe Cardiovascular Events: Propensity Score and Instrumental Variable Analysis	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; QUALITY-OF-LIFE; PHYSICAL-ACTIVITY; MYOCARDIAL-INFARCTION; NATIONAL-HEALTH; OUTCOMES; PREVALENCE; PREVENTION; NUTRITION; MORTALITY	Objective This population-based study investigated the subsequent cardiovascular risk of patients with knee osteoarthritis underwent total knee arthroplasty in Taiwan. Materials and methods This was a population-based follow-up study of 22931 patients diagnosed with knee osteoarthritis between 2008 and 2011. Each patient was followed for 3 years or until death. Treatment was dichotomized into conservative treatment and TKA. The association between TKA and cardiovascular disease (CVD) events was analyzed using propensity score analysis and instrumental variable analysis and two-stage least-squares regression model. Results Patients with knee osteoarthritis who underwent TKA had a lower 3-year cumulative risk of stroke and acute myocardial infarction (AMI). After adjusting for measured risk and confounding factors, propensity score showed a 0.56 fold (adjusted OR = 0.56; 95% CI, 0.51-0.61; p<0.001) risk for CVD in those with TKA. Use of instrumental variable analysis for adjusting measured and unmeasured factors and two-stage least squares regression model revealed that the average treatment effect of TKA was statistically associated with a decreased 7% risk of CVD events (95% CI, 0.2%-13.6%). Conclusion Our study revealed that patients with knee osteoarthritis who underwent TKA had a lower risk of suffering from a future severe cardiovascular event. This benefit may be attributed to an improvement in physical activity, reduction of psychosocial stress, and/or a decreased use of NSAIDs as a result of having undergone TKA.	[Lin, Wen-Yan] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Orthoped, Chiayi, Taiwan; [Lee, Ching-Chih] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Otolaryngol, Chiayi, Taiwan; [Lee, Ching-Chih; Lyu, Shaw-Ruey] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Educ, Chiayi, Taiwan; [Lee, Ching-Chih; Huang, Kuang-Yung; Lyu, Shaw-Ruey] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Lee, Ching-Chih] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Ctr Clin Epidemiol & Biostat, Chiayi, Taiwan; [Hsu, Chia-Wen] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Med Res, Chiayi, Taiwan; [Huang, Kuang-Yung] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Internal Med, Div Allergy Immunol & Rheumatol, Chiayi, Taiwan; [Huang, Kuang-Yung] Natl Chung Cheung Univ, Dept Life Sci, Chiayi, Taiwan; [Huang, Kuang-Yung] Natl Chung Cheung Univ, Inst Mol Biol, Chiayi, Taiwan; [Lyu, Shaw-Ruey] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Joint Ctr, Chiayi, Taiwan	Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital	Lyu, SR (corresponding author), Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Educ, Chiayi, Taiwan.	srlyu@seed.net.tw	Lyu, Shaw-Ruey/AAC-5480-2022; Lyu, Shaw-Ruey/AAD-9397-2022	Lyu, Shaw-Ruey/0000-0003-3797-4848; 				Andersen RE, 1999, J AM GERIATR SOC, V47, P1435, DOI 10.1111/j.1532-5415.1999.tb01563.x; [Anonymous], 2007, PREV CARD DIS GUID A; Brown GA, 2013, J AM ACAD ORTHOP SUR, V21, P577, DOI [10.5435/00124635-201309020-00009, 10.5435/JAAOS-21-09-577]; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Clays E, 2013, EUR J EPIDEMIOL, V28, P241, DOI 10.1007/s10654-013-9764-4; Cram P, 2012, JAMA-J AM MED ASSOC, V308, P1227, DOI 10.1001/2012.jama.11153; Davies NM, 2013, EPIDEMIOLOGY, V24, P352, DOI 10.1097/EDE.0b013e318289e024; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dowsey MM, 2013, INT J RHEUMATOL, V2013, DOI 10.1155/2013/506518; Ethgen O, 2004, J BONE JOINT SURG AM, V86A, P963, DOI 10.2106/00004623-200405000-00012; Graham DJ, 2005, LANCET, V365, P475, DOI 10.1016/S0140-6736(05)17864-7; Haapanen N, 1997, INT J EPIDEMIOL, V26, P739, DOI 10.1093/ije/26.4.739; Hawker G, 1998, J BONE JOINT SURG AM, V80A, P163, DOI 10.2106/00004623-199802000-00003; Hawker GA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091286; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Iwashyna Theodore J, 2013, Ann Am Thorac Soc, V10, P255, DOI 10.1513/AnnalsATS.201303-054FR; Kane RL, 2005, J BONE JOINT SURG AM, V87A, P1719, DOI 10.2106/JBJS.D.02714; Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681; Lindstrom J, 2003, DIABETES CARE, V26, P3230, DOI 10.2337/diacare.26.12.3230; Marks R., 2013, AM J MED STUD SCI ED, V1, P11, DOI [10.12691/ajms-1-3-1], DOI 10.12691/AJMS-1-3-1]; Muraki S, 2009, OSTEOARTHR CARTILAGE, V17, P1137, DOI 10.1016/j.joca.2009.04.005; Nelson ME, 2007, MED SCI SPORT EXER, V39, P1435, DOI [10.1249/mss.0b013e3180616aa2, 10.1161/CIRCULATIONAHA.107.185650]; Nuesch E, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1165; Ravi B, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6187; Ries MD, 1996, J BONE JOINT SURG AM, V78A, P1696, DOI 10.2106/00004623-199611000-00009; Thompson PD, 2003, CIRCULATION, V107, P3109, DOI 10.1161/01.CIR.0000075572.40158.77; Tseng CH, 2004, DIABETES CARE, V27, P1605, DOI 10.2337/diacare.27.7.1605; Tu Karen, 2007, Open Med, V1, pe18; Yeh RW, 2014, CIRC-CARDIOVASC QUAL, V7, P118, DOI 10.1161/CIRCOUTCOMES.113.000476	29	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127454	10.1371/journal.pone.0127454	http://dx.doi.org/10.1371/journal.pone.0127454			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010912	Green Published, gold, Green Submitted			2022-12-26	WOS:000355183900093
J	Mafurah, JJ; Ma, HF; Zhang, MX; Xu, J; He, F; Ye, TY; Shen, DY; Chen, YY; Rajput, NA; Dou, DL				Mafurah, Joseph Juma; Ma, Huifei; Zhang, Meixiang; Xu, Jing; He, Feng; Ye, Tingyue; Shen, Danyu; Chen, Yanyu; Rajput, Nasir Ahmed; Dou, Daolong			A Virulence Essential CRN Effector of Phytophthora capsici Suppresses Host Defense and Induces Cell Death in Plant Nucleus	PLOS ONE			English	Article							RXLR EFFECTOR; SOJAE; RESISTANCE; PROTEINS; NICOTIANA; AVIRULENCE; SEQUENCE; TOMATO; SIGNAL	Phytophthora capsici is a soil-borne plant pathogen with a wide range of hosts. The pathogen secretes a large array of effectors during infection of host plants, including Crinkler (CRN) effectors. However, it remains largely unknown on the roles of these effectors in virulence especially in P. capsici. In this study, we identified a cell death-inducing CRN effector PcCRN4 using agroinfiltration approach. Transient expression of PcCRN4 gene induced cell death in N. benthamiana, N. tabacum and Solanum lycopersicum. Overexpression of the gene in N. benthamiana enhanced susceptibility to P. capsici. Subcellular localization results showed that PcCRN4 localized to the plant nucleus, and the localization was required for both of its cell death-inducing activity and virulent function. Silencing PcCRN4 gene in P. capsici significantly reduced pathogen virulence. The expression of the pathogenesis-related gene PR1b in N. benthamiana was significantly induced when plants were inoculated with PcCRN4-silenced P. capsici transformant compared to the wilt-type. Callose deposits were also abundant at sites inoculated with PcCRN4-silenced transformant, indicating that silencing of PcCRN4 in P. capsici reduced the ability of the pathogen to suppress plant defenses. Transcriptions of cell death-related genes were affected when PcCRN4-silenced line were inoculated on Arabidopsis thaliana, suggesting that PcCRN4 may induce cell death by manipulating cell death-related genes. Overall, our results demonstrate that PcCRN4 is a virulence essential effector and it needs target to the plant nucleus to suppress plant immune responses.	[Mafurah, Joseph Juma; Ma, Huifei; Zhang, Meixiang; Xu, Jing; He, Feng; Ye, Tingyue; Shen, Danyu; Chen, Yanyu; Rajput, Nasir Ahmed; Dou, Daolong] Nanjing Agr Univ, Dept Plant Pathol, Nanjing 210095, Jiangsu, Peoples R China	Nanjing Agricultural University	Dou, DL (corresponding author), Nanjing Agr Univ, Dept Plant Pathol, Nanjing 210095, Jiangsu, Peoples R China.	ddou@njau.edu.cn	Shen, Danyu/AAF-1644-2019; Dou, Daolong/AAW-1678-2021	Dou, Daolong/0000-0001-5226-6642	National Natural Science Foundation of China [31371894]; Natural Science Foundation of Jiangsu Province [BK2012027]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by the National Natural Science Foundation of China, (31371894), http://www.nsfc.gov.cn/; and Natural Science Foundation of Jiangsu Province, (BK2012027), www.jstd.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bierne H, 2012, CELL MICROBIOL, V14, P622, DOI 10.1111/j.1462-5822.2012.01758.x; Bos JIB, 2006, PLANT J, V48, P165, DOI 10.1111/j.1365-313X.2006.02866.x; Chen XR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074588; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Coll NS, 2011, CELL DEATH DIFFER, V18, P1247, DOI 10.1038/cdd.2011.37; Dong SM, 2008, PLANT CELL REP, V27, P1559, DOI 10.1007/s00299-008-0554-5; Dong SM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002353; Dong SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005556; Dou DL, 2008, PLANT CELL, V20, P1930, DOI 10.1105/tpc.107.056093; Dou DL, 2008, PLANT CELL, V20, P1118, DOI 10.1105/tpc.107.057067; Dou DL, 2012, CELL HOST MICROBE, V12, P484, DOI 10.1016/j.chom.2012.09.003; Fu ZQ, 2013, ANNU REV PLANT BIOL, V64, P839, DOI 10.1146/annurev-arplant-042811-105606; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Hellens R, 2000, TRENDS PLANT SCI, V5, P446, DOI 10.1016/S1360-1385(00)01740-4; Hogenhout SA, 2009, MOL PLANT MICROBE IN, V22, P115, DOI 10.1094/MPMI-22-2-0115; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jupe J, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r63; Kaminaka H, 2006, EMBO J, V25, P4400, DOI 10.1038/sj.emboj.7601312; Kamoun S, 2003, EUKARYOT CELL, V2, P191, DOI 10.1128/EC.2.2.191-199.2003; Kamoun S, 2015, MOL PLANT PATHOL, V16, P413, DOI 10.1111/mpp.12190; Kazan K, 2014, PLANT CELL, V26, P2285, DOI 10.1105/tpc.114.125419; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Lamour KH, 2012, MOL PLANT MICROBE IN, V25, P1350, DOI 10.1094/MPMI-02-12-0028-R; Lamour KH, 2012, MOL PLANT PATHOL, V13, P329, DOI 10.1111/j.1364-3703.2011.00754.x; Liu TL, 2011, PLANT PHYSIOL, V155, P490, DOI 10.1104/pp.110.166470; Morgan W, 2007, CURR OPIN MICROBIOL, V10, P332, DOI 10.1016/j.mib.2007.04.005; Nasir KHB, 2005, PLANT J, V43, P491, DOI 10.1111/j.1365-313X.2005.02472.x; Nguyen HP, 2010, MOL PLANT MICROBE IN, V23, P991, DOI 10.1094/MPMI-23-8-0991; Rajput NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098114; Rusterucci C, 2001, PLANT CELL, V13, P2211, DOI 10.1105/tpc.13.10.2211; Schornack S, 2010, P NATL ACAD SCI USA, V107, P17421, DOI 10.1073/pnas.1008491107; Shen DY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070036; Shen QH, 2007, SCIENCE, V315, P1098, DOI 10.1126/science.1136372; Sohn KH, 2007, PLANT CELL, V19, P4077, DOI 10.1105/tpc.107.054262; Stam R, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00387; Stam R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059517; Takemoto D, 2005, PLANT PHYSIOL, V138, P1491, DOI 10.1104/pp.104.058388; Torto TA, 2003, GENOME RES, V13, P1675, DOI 10.1101/gr.910003; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; van Damme M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002875; Wang QQ, 2011, PLANT CELL, V23, P2064, DOI 10.1105/tpc.111.086082; Wang YL, 2009, MICROB PATHOGENESIS, V47, P78, DOI 10.1016/j.micpath.2009.04.013; Watanabe N, 2006, PLANT J, V45, P884, DOI 10.1111/j.1365-313X.2006.02654.x; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203; Yu XL, 2012, NEW PHYTOL, V196, P247, DOI 10.1111/j.1469-8137.2012.04241.x	45	27	31	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127965	10.1371/journal.pone.0127965	http://dx.doi.org/10.1371/journal.pone.0127965			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011314	Green Published, Green Submitted, gold			2022-12-26	WOS:000355183900174
J	Vega, Y; Delgado, E; Fernandez-Garcia, A; Cuevas, MT; Thomson, MM; Montero, V; Sanchez, M; Sanchez, AM; Perez-Alvarez, L				Vega, Yolanda; Delgado, Elena; Fernandez-Garcia, Aurora; Teresa Cuevas, Maria; Thomson, Michael M.; Montero, Vanessa; Sanchez, Monica; Maria Sanchez, Ana; Perez-Alvarez, Lucia		Spanish Grp Study New HIV-1 Diag G	Epidemiological Surveillance of HIV-1 Transmitted Drug Resistance in Spain in 2004-2012: Relevance of Transmission Clusters in the Propagation of Resistance Mutations	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE INHIBITORS; NEWLY-DIAGNOSED PATIENTS; NON-B SUBTYPES; INFECTED INDIVIDUALS; PREVALENCE; PREVENTION; VIRUS	Our objectives were to carry out an epidemiological surveillance study on transmitted drug resistance (TDR) among individuals newly diagnosed of HIV-1 infection during a nine year period in Spain and to assess the role of transmission clusters (TC) in the propagation of resistant strains. An overall of 1614 newly diagnosed individuals were included in the study from January 2004 through December 2012. Individuals come from two different Spanish regions: Galicia and the Basque Country. Resistance mutations to reverse transcriptase inhibitors (RTI) and protease inhibitors (PI) were analyzed according to mutations included in the surveillance drug-resistance mutations list updated in 2009. TC were defined as those comprising viruses from five or more individuals whose sequences clustered in maximum likelihood phylogenetic trees with a bootstrap value >= 90%. The overall prevalence of TDR to any drug was 9.9%: 4.9% to nucleoside RTIs (NRTIs), 3.6% to non-nucleoside RTIs (NNRTIs), and 2.7% to PIs. A significant decrease of TDR to NRTIs over time was observed [from 10% in 2004 to 2% in 2012 (p=0.01)]. Sixty eight (42.2%) of 161 sequences with TDR were included in 25 TC composed of 5 or more individuals. Of them, 9 clusters harbored TDR associated with high level resistance to antiretroviral drugs. T215D revertant mutation was transmitted in a large cluster comprising 25 individuals. The impact of epidemiological networks on TDR frequency may explain its persistence in newly diagnosed individuals. The knowledge of the populations involved in TC would facilitate the design of prevention programs and public health interventions.	[Vega, Yolanda; Delgado, Elena; Fernandez-Garcia, Aurora; Teresa Cuevas, Maria; Thomson, Michael M.; Montero, Vanessa; Sanchez, Monica; Maria Sanchez, Ana; Perez-Alvarez, Lucia] Inst Salud Carlos III, Ctr Nacl Microbiol, Unidad Biol & Variabilidad VIH, Madrid, Spain	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM)	Cuevas, MT (corresponding author), Inst Salud Carlos III, Ctr Nacl Microbiol, Unidad Biol & Variabilidad VIH, Madrid, Spain.	tcuevas@isciii.es	Thomson, Michael M/P-8949-2017; gonzalez-nico, maria teresa cuevas/E-2001-2014; Delgado, Elena/E-2785-2019	Thomson, Michael M/0000-0002-0622-7527; gonzalez-nico, maria teresa cuevas/0000-0002-4195-1975; Coira Nieto, Amparo/0000-0003-1412-4242; Delgado, Elena/0000-0002-0754-8533; OCAMPO HERMIDA, ANTONIO/0000-0002-3176-9758; Lopez-Soria, Leyre/0000-0003-2335-8665; Matilde, Trigo Dapota/0000-0001-7006-2854	Conselleria de Sanidade, Government of Galicia, Spain [MVI - 1291/08]; Osakidetza-Servicio Vasco de Salud, Basque Country, Spain [MVI-1255-08]; Ministerio de Sanidad, Servicios Sociales e Igualdad, Direccion General de Salud Publica, Cohesion e Innovacion [PI EC11-272]	Conselleria de Sanidade, Government of Galicia, Spain; Osakidetza-Servicio Vasco de Salud, Basque Country, Spain; Ministerio de Sanidad, Servicios Sociales e Igualdad, Direccion General de Salud Publica, Cohesion e Innovacion	This work was supported by Conselleria de Sanidade, Government of Galicia, Spain (MVI - 1291/08), Osakidetza-Servicio Vasco de Salud, Basque Country, Spain (MVI-1255-08) and Ministerio de Sanidad, Servicios Sociales e Igualdad, Direccion General de Salud Publica, Cohesion e Innovacion (PI EC11-272). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett DE, 2008, ANTIVIR THER, V13, P1; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Brenner B, 2013, AIDS, V27, P1045, DOI 10.1097/QAD.0b013e32835cffd9; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Chilton DN, 2010, ANTIVIR THER, V15, P985, DOI 10.3851/IMP1658; de Mendoza C, 2005, CLIN INFECT DIS, V41, P1350, DOI 10.1086/496982; Dolling D, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5253; Drescher SM, 2014, CLIN INFECT DIS, V58, P285, DOI 10.1093/cid/cit694; Frentz D, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-407; Frentz D, 2012, AIDS REV, V14, P17; Garcia F, 2011, ANTIVIR RES, V91, P150, DOI 10.1016/j.antiviral.2011.05.010; Garcia-Lerma JG, 2001, P NATL ACAD SCI USA, V98, P13907, DOI 10.1073/pnas.241300698; Geretti AM, 2007, CURR OPIN INFECT DIS, V20, P22, DOI 10.1097/QCO.0b013e328013caff; Grgic I, 2013, AIDS RES HUM RETROV, V29, P329, DOI [10.1089/aid.2012.0191, 10.1089/AID.2012.0191]; Hunt GM, 2012, CLIN INFECT DIS, V54, pS334, DOI 10.1093/cid/cir1017; Johnson Victoria A, 2008, Top HIV Med, V16, P138; Jordan MR, 2008, ANTIVIR THER, V13, P15; Karlsson A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033484; Kaye M, 2008, JAIDS-J ACQ IMM DEF, V49, P9, DOI 10.1097/QAI.0b013e318180c8af; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Monge S, 2012, CLIN MICROBIOL INFEC, V18, pE485, DOI 10.1111/1469-0691.12011; Perez-Alvarez L, 2003, ANTIVIR THER, V8, P355; Pineda-Pena AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101738; Romero A, 2011, ENFERM INFEC MICR CL, V29, P482, DOI 10.1016/j.eimc.2011.03.001; Schmidt D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104474; Sigaloff KCE, 2012, AIDS RES HUM RETROV, V28, P833, DOI [10.1089/aid.2011.0348, 10.1089/AID.2011.0348]; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sungkanuparph S, 2012, JAIDS-J ACQ IMM DEF, V59, pE3, DOI 10.1097/QAI.0b013e31823ac978; Cuevas MT, 2009, JAIDS-J ACQ IMM DEF, V51, P99, DOI 10.1097/QAI.0b013e318199063e; Thomson MM, 2009, JAIDS-J ACQ IMM DEF, V51, P332, DOI 10.1097/QAI.0b013e31819c1757; Turner D, 2012, HIV MED, V13, P202, DOI 10.1111/j.1468-1293.2011.00960.x; Vercauteren J, 2009, J INFECT DIS, V200, P1503, DOI 10.1086/644505; Wensing AMJ, 2008, AIDS, V22, P625, DOI 10.1097/QAD.0b013e3282f5e062; Yebra G, 2010, ANTIVIR RES, V85, P409, DOI 10.1016/j.antiviral.2009.11.010; Yebra G, 2014, ARCH VIROL, V159, P1079, DOI 10.1007/s00705-013-1933-y; Yerly S, 2009, AIDS, V23, P1415, DOI 10.1097/QAD.0b013e32832d40ad	37	30	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0125699	10.1371/journal.pone.0125699	http://dx.doi.org/10.1371/journal.pone.0125699			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010948	Green Published, Green Submitted, gold			2022-12-26	WOS:000355183900014
J	Vega-Rodriguez, J; Pastrana-Mena, R; Crespo-Llado, KN; Ortiz, JG; Ferrer-Rodriguez, I; Serrano, AE				Vega-Rodriguez, Joel; Pastrana-Mena, Rebecca; Crespo-Llado, Keila N.; Ortiz, Jose G.; Ferrer-Rodriguez, Ivan; Serrano, Adelfa E.			Implications of Glutathione Levels in the Plasmodium berghei Response to Chloroquine and Artemisinin	PLOS ONE			English	Article							GAMMA-GLUTAMYLCYSTEINE SYNTHETASE; FERRIPROTOPORPHYRIN-IX; MALARIA PARASITES; FALCIPARUM MALARIA; RODENT MALARIA; INTRACELLULAR GLUTATHIONE; ANTIMALARIAL ACTION; DRUG-RESISTANCE; INHIBITION; MECHANISM	Malaria is one of the most devastating parasitic diseases worldwide. Plasmodium drug resistance remains a major challenge to malaria control and has led to the re-emergence of the disease. Chloroquine (CQ) and artemisinin (ART) are thought to exert their anti-malarial activity inducing cytotoxicity in the parasite by blocking heme degradation (for CQ) and increasing oxidative stress. Besides the contribution of the CQ resistance transporter (PfCRT) and the multidrug resistant gene (pfmdr), CQ resistance has also been associated with increased parasite glutathione (GSH) levels. ART resistance was recently shown to be associated with mutations in the K13-propeller protein. To analyze the role of GSH levels in CQ and ART resistance, we generated transgenic Plasmodium bergheiparasites either deficient in or overexpressing the gamma-glutamylcysteine synthetase gene (pbggcs) encoding the rate-limiting enzyme in GSH biosynthesis. These lines produce either lower (pbggcs-ko) or higher (pbggcs-oe) levels of GSH than wild type parasites. In addition, GSH levels were determined in P. berghei parasites resistant to CQ and mefloquine (MQ). Increased GSH levels were detected in both, CQ and MQ resistant parasites, when compared to the parental sensitive clone. Sensitivity to CQ and ART remained unaltered in both pgggcs-ko and pbggcs-oe parasites when tested in a 4 days drug suppressive assay. However, recrudescence assays after the parasites have been exposed to a sub-lethal dose of ART showed that parasites with low levels of GSH are more sensitive to ART treatment. These results suggest that GSH levels influence Plasmodium berghei response to ART treatment.	[Vega-Rodriguez, Joel; Pastrana-Mena, Rebecca; Crespo-Llado, Keila N.; Ferrer-Rodriguez, Ivan; Serrano, Adelfa E.] Univ Puerto Rico, Dept Microbiol & Med Zool, San Juan, PR 00936 USA; [Ortiz, Jose G.] Univ Puerto Rico, Sch Med, Dept Pharmacol, San Juan, PR 00936 USA	University of Puerto Rico; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus	Serrano, AE (corresponding author), Univ Puerto Rico, Dept Microbiol & Med Zool, San Juan, PR 00936 USA.	adelfa.serrano@upr.edu			National Institute of Health (AES): National Institute of General Medicine [S06GM008224]; National Institute on Minority Health and Health Disparities [G12-MD 007600]; National Center on Minority Health and Health Disparities [T37 MD001477]; National Institute of Allergy and Infectious Diseases [F31A1056662]; Fogarty International Center; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [T37MD001477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM061838, S06GM008224] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007600] Funding Source: NIH RePORTER	National Institute of Health (AES): National Institute of General Medicine; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Center on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This study was partially supported by the following awards of the National Institute of Health (AES): National Institute of General Medicine S06GM008224, National Institute on Minority Health and Health Disparities G12-MD 007600, The Fogarty International Center and National Center on Minority Health and Health Disparities T37 MD001477, and the National Institute of Allergy and Infectious Diseases F31A1056662 (Ruth L. Kirschstein National Research Service Award Individual Predoctoral Fellowship award to JVR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaratunga C, 2012, LANCET INFECT DIS, V12, P851, DOI 10.1016/S1473-3099(12)70181-0; [Anonymous], 2014, STAT REP ART RES; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; BAGGALEY VC, 1972, T ROY SOC TROP MED H, V66, P4, DOI 10.1016/0035-9203(72)90005-3; Baird L, 2011, ARCH TOXICOL, V85, P241, DOI 10.1007/s00204-011-0674-5; Birago C, 2001, J PHARMACEUT BIOMED, V25, P759, DOI 10.1016/S0731-7085(01)00379-X; CHOU AC, 1980, BIOCHEMISTRY-US, V19, P1543, DOI 10.1021/bi00549a600; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Dorn A, 1998, BIOCHEM PHARMACOL, V55, P727, DOI 10.1016/S0006-2952(97)00510-8; DUBOIS VL, 1995, EXP PARASITOL, V81, P117, DOI 10.1006/expr.1995.1099; Egan TJ, 1997, J INORG BIOCHEM, V68, P137, DOI 10.1016/S0162-0134(97)00086-X; Famin O, 1999, BIOCHEM PHARMACOL, V58, P59, DOI 10.1016/S0006-2952(99)00059-3; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; Ghorbal M, 2014, NAT BIOTECHNOL, V32, P819, DOI 10.1038/nbt.2925; Ginsburg H, 1998, BIOCHEM PHARMACOL, V56, P1305, DOI 10.1016/S0006-2952(98)00184-1; Gonzalez-Pons M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-1; Haynes RK, 2010, CHEMMEDCHEM, V5, P1282, DOI 10.1002/cmdc.201000225; Huynh TT, 2003, J BIOL CHEM, V278, P39794, DOI 10.1074/jbc.M306306200; Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53; KILLICKKENDRICK R, 1974, PARASITOLOGY, V69, P225, DOI 10.1017/S0031182000048071; Klonis N, 2011, P NATL ACAD SCI USA, V108, P11405, DOI 10.1073/pnas.1104063108; Leed A, 2002, BIOCHEMISTRY-US, V41, P10245, DOI 10.1021/bi020195i; Lehane AM, 2012, INT J PARASITOL-DRUG, V2, P47, DOI 10.1016/j.ijpddr.2011.11.001; Lim P, 2003, ANTIMICROB AGENTS CH, V47, P87, DOI 10.1128/AAC.47.1.87-94.2003; MANSOOR MA, 1992, ANAL BIOCHEM, V200, P218, DOI 10.1016/0003-2697(92)90456-H; Martin RE, 2009, SCIENCE, V325, P1680, DOI 10.1126/science.1175667; Meierjohann S, 2002, BIOCHEM J, V368, P761, DOI 10.1042/BJ20020962; MESHNICK SR, 1991, MOL BIOCHEM PARASIT, V49, P181, DOI 10.1016/0166-6851(91)90062-B; MOREAU S, 1982, BIOCHIMIE, V64, P1015, DOI 10.1016/S0300-9084(82)80382-9; Mukanganyama S, 2001, FREE RADICAL RES, V35, P427, DOI 10.1080/10715760100300941; Noedl H, 2010, CLIN INFECT DIS, V51, pE82, DOI 10.1086/657120; Paitayatat S, 1997, J MED CHEM, V40, P633, DOI 10.1021/jm960767v; Pandey AV, 2001, BIOCHEM J, V355, P333, DOI 10.1042/0264-6021:3550333; Pastrana-Mena R, 2010, J BIOL CHEM, V285, P27045, DOI 10.1074/jbc.M110.122275; Patzewitz EM, 2013, ANTIOXID REDOX SIGN, V19, P683, DOI 10.1089/ars.2012.4625; Perez-Rosado J, 2002, EXP PARASITOL, V101, P175, DOI 10.1016/S0014-4894(02)00138-8; PETERS W, 1975, ANN TROP MED PARASIT, V69, P155, DOI 10.1080/00034983.1975.11686997; PETERS W, 1965, EXP PARASITOL, V17, P80, DOI 10.1016/0014-4894(65)90012-3; PETERS W, 1977, ANN TROP MED PARASIT, V71, P419, DOI 10.1080/00034983.1977.11687207; Peters W, 1987, CHEMOTHERAPY DRUG RE; Platel DFN, 1999, MOL BIOCHEM PARASIT, V98, P215, DOI 10.1016/S0166-6851(98)00170-4; Price RN, 2014, LANCET INFECT DIS, V14, P982, DOI 10.1016/S1473-3099(14)70855-2; Rodriguez JF, 1998, PEDIATR INFECT DIS J, V17, P236, DOI 10.1097/00006454-199803000-00012; Safeukui I, 2004, BIOCHEM PHARMACOL, V68, P1903, DOI 10.1016/j.bcp.2004.05.049; SEELIG GF, 1985, METHOD ENZYMOL, V113, P379; Sidhu ABS, 2002, SCIENCE, V298, P210, DOI 10.1126/science.1074045; Srivastava P, 1999, TROP MED INT HEALTH, V4, P251, DOI 10.1046/j.1365-3156.1999.00387.x; Straimer J, 2015, SCIENCE, V347, P428, DOI 10.1126/science.1260867; Sullivan DJ, 2002, INT J PARASITOL, V32, P1645, DOI 10.1016/S0020-7519(02)00193-5; Summers RL, 2014, P NATL ACAD SCI USA, V111, pE1759, DOI 10.1073/pnas.1322965111; TEW KD, 1994, CANCER RES, V54, P4313; Vega-Rodriguez J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000302; Wang DY, 2000, CHEM COMMUN, P2193, DOI 10.1039/b006906j; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Wichmann O, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-17	56	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128212	10.1371/journal.pone.0128212	http://dx.doi.org/10.1371/journal.pone.0128212			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010448	Green Submitted, Green Published, gold			2022-12-26	WOS:000355183900207
J	Mora, I; Cabrefiga, J; Montesinos, E				Mora, Isabel; Cabrefiga, Jordi; Montesinos, Emilio			Cyclic Lipopeptide Biosynthetic Genes and Products, and Inhibitory Activity of Plant-Associated Bacillus against Phytopathogenic Bacteria	PLOS ONE			English	Article							INDUCED SYSTEMIC RESISTANCE; COMPLETE GENOME SEQUENCE; BIOLOGICAL-CONTROL; ANTIFUNGAL ACTIVITY; BIOFILM FORMATION; BACILLOMYCIN-D; SUBTILIS; IDENTIFICATION; BIOCONTROL; STRAINS	The antibacterial activity against bacterial plant pathogens and its relationships with the presence of the cyclic lipopeptide (cLP) biosynthetic genes ituC (iturin), bmyB (bacillomycin), fenD (fengycin) and srfAA (surfactin), and their corresponding antimicrobial peptide products have been studied in a collection of 64 strains of Bacillus spp. isolated from plant environments. The most frequent antimicrobial peptide (AMP) genes were bmyB, srfAAand fenD (34-50% of isolates). Most isolates (98.4%) produced surfactin isoforms, 90.6% iturins and 79.7% fengycins. The antibacterial activity was very frequent and generally intense among the collection of strains because 75% of the isolates were active against at least 6 of the 8 bacterial plant pathogens tested. Hierarchical and correspondence analysis confirmed the presence of two clearly differentiated groups. One group consisted of Bacillus strains that showed a strong antibacterial activity, presented several cLPs genes and produced several isoforms of cLPs simultaneously, mainly composed of B. subtilis and B. amyloliquefaciens, although the last one was exclusive to this group. Another group was characterized by strains with very low or none antibacterial activity, that showed one or none of the cLP genes and produced a few or none of the corresponding cLPs, and was the most heterogenous group including B. subtilis, B. licheniformis, B. megaterium, B. pumilus, B. cereusand B. thuringiensis, although the last two were exclusive to this group. This work demonstrated that the antagonistic capacity of plant-associated Bacillusagainst plant pathogenic bacteria is related to the presence of cLP genes and to the production of the corresponding cLPs, and it is mainly associated to the species B. subtilisand B. amyloliquefaciens. Our findings would help to increase the yield and efficiency of screening methods to obtain candidate strains to biocontrol agents with a mechanism of action relaying on the production of antimicrobial cLPs.	[Mora, Isabel; Cabrefiga, Jordi; Montesinos, Emilio] Univ Girona, Plant Pathol Lab, Inst Food & Agr Technol XaRTA CIDSAV, Girona 17071, Spain	Universitat de Girona	Montesinos, E (corresponding author), Univ Girona, Plant Pathol Lab, Inst Food & Agr Technol XaRTA CIDSAV, Campus Montilivi, Girona 17071, Spain.	emilio.montesinos@udg.edu	Mora, Isabel/H-7734-2015; Cabrefiga, Jordi/H-3340-2015; Cabrefiga, Jordi/AAV-7844-2021; Montesinos, Emili/H-5246-2015	Mora, Isabel/0000-0001-7447-7520; Cabrefiga, Jordi/0000-0002-8913-2573; Cabrefiga, Jordi/0000-0002-8913-2573; Montesinos, Emili/0000-0003-4455-8332	Programa Nacional de Agricultura y Alimentacion (CICYT) of the MINECO of Spain [AGL-2009-13255-C02-01]; DROPSA project of the European Union [613678]; TECNIO net from Catalonia;  [SGR 2009-0812];  [2014 SGR 697]	Programa Nacional de Agricultura y Alimentacion (CICYT) of the MINECO of Spain(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); DROPSA project of the European Union; TECNIO net from Catalonia; ; 	Funding was provided by Programa Nacional de Agricultura y Alimentacion (CICYT) (Ref. AGL-2009-13255-C02-01) of the MINECO of Spain, and FP7 KBBE.2013.1.2-04. Ref. 613678. DROPSA project of the European Union. The research group is accredited and supported in part by SGR 2009-0812, 2014 SGR 697 and TECNIO net from Catalonia.	Abderrahmani A, 2011, APPL MICROBIOL BIOT, V92, P571, DOI 10.1007/s00253-011-3453-6; Arguelles-Arias A, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-63; Athukorala SNP, 2009, CAN J MICROBIOL, V55, P1021, DOI [10.1139/W09-067, 10.1139/w09-067]; Bais HP, 2004, PLANT PHYSIOL, V134, P307, DOI 10.1104/pp.103.028712; Banat IM, 2000, APPL MICROBIOL BIOT, V53, P495, DOI 10.1007/s002530051648; Beric T, 2012, FOOD TECHNOL BIOTECH, V50, P25; Branda SS, 2001, P NATL ACAD SCI USA, V98, P11621, DOI 10.1073/pnas.191384198; Cazorla FM, 2007, J APPL MICROBIOL, V103, P1950, DOI 10.1111/j.1365-2672.2007.03433.x; Chandna P, 2013, APPL MICROBIOL BIOT, V97, P6991, DOI 10.1007/s00253-012-4434-0; Chen XH, 2009, J BIOTECHNOL, V140, P38, DOI 10.1016/j.jbiotec.2008.10.015; Chen XH, 2007, NAT BIOTECHNOL, V25, P1007, DOI 10.1038/nbt1325; Chen Y, 2013, ENVIRON MICROBIOL, V15, P848, DOI 10.1111/j.1462-2920.2012.02860.x; Chitarra GS, 2003, J APPL MICROBIOL, V94, P159, DOI 10.1046/j.1365-2672.2003.01819.x; Cho MJ, 2004, J MICROBIOL BIOTECHN, V14, P599; Chung S, 2008, APPL MICROBIOL BIOT, V80, P115, DOI 10.1007/s00253-008-1520-4; Chung S, 2007, APPL MICROBIOL BIOT, V76, P217, DOI 10.1007/s00253-007-0992-y; De Meyer SE, 2015, SOIL BIOL BIOCHEM, V83, P1, DOI 10.1016/j.soilbio.2015.01.002; Eppinger M, 2011, J BACTERIOL, V193, P4199, DOI 10.1128/JB.00449-11; Fahim S, 2012, BIORESOURCE TECHNOL, V126, P1, DOI 10.1016/j.biortech.2012.09.019; Fravel DR, 2005, ANNU REV PHYTOPATHOL, V43, P337, DOI 10.1146/annurev.phyto.43.032904.092924; Fritze D, 2004, PHYTOPATHOLOGY, V94, P1245, DOI 10.1094/PHYTO.2004.94.11.1245; Giacomodonato MN, 2001, WORLD J MICROB BIOT, V17, P51, DOI 10.1023/A:1016610610294; Henry G, 2011, CELL MICROBIOL, V13, P1824, DOI 10.1111/j.1462-5822.2011.01664.x; Hofemeister J, 2004, MOL GENET GENOMICS, V272, P363, DOI 10.1007/s00438-004-1056-y; Hu QP, 2008, WORLD J MICROB BIOT, V24, P2451, DOI 10.1007/s11274-008-9767-6; Jacobsen BJ, 2004, PHYTOPATHOLOGY, V94, P1272, DOI 10.1094/PHYTO.2004.94.11.1272; Joshi R, 2006, PHYTOPATHOLOGY, V96, P145, DOI 10.1094/PHYTO-96-0145; Ki JS, 2009, J MICROBIOL METH, V77, P48, DOI 10.1016/j.mimet.2009.01.003; Kim PI, 2010, J MICROBIOL BIOTECHN, V20, P138, DOI 10.4014/jmb.0905.05007; Kloepper JW, 2004, PHYTOPATHOLOGY, V94, P1259, DOI 10.1094/PHYTO.2004.94.11.1259; Ko KS, 2003, J CLIN MICROBIOL, V41, P2908, DOI 10.1128/JCM.41.7.2908-2914.2003; Koumoutsi A, 2004, J BACTERIOL, V186, P1084, DOI 10.1128/JB.186.4.1084-1096.2004; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Landa BB, 1997, PHYTOPARASITICA, V25, P305, DOI 10.1007/BF02981094; Landa BB, 2004, PLANT PATHOL, V53, P341, DOI 10.1111/j.0032-0862.2004.01008.x; Lasch P, 2009, APPL ENVIRON MICROB, V75, P7229, DOI 10.1128/AEM.00857-09; Lee KJ, 2008, WORLD J MICROB BIOT, V24, P1139, DOI 10.1007/s11274-007-9585-2; Liu JJ, 2014, FUNGAL BIOL-UK, V118, P855, DOI 10.1016/j.funbio.2014.07.004; LOEFFLER W, 1986, J PHYTOPATHOL, V115, P204, DOI 10.1111/j.1439-0434.1986.tb00878.x; Malfanova N, 2012, ARCH MICROBIOL, V194, P893, DOI 10.1007/s00203-012-0823-0; McSpadden GBB, 2004, PHYTOPATHOLOGY, V94, P1252, DOI DOI 10.1094/PHYT0.2004.94.11.1252; Miranda CAC, 2008, ANTON LEEUW INT J G, V93, P297, DOI 10.1007/s10482-007-9204-0; Montesinos E, 2009, ENCY MICROBIOLOGY, P110, DOI DOI 10.1016/J.BIOTECHADV.2013.01.004; Montesinos E, 2007, FEMS MICROBIOL LETT, V270, P1, DOI 10.1111/j.1574-6968.2007.00683.x; Mootz HD, 2001, J BIOL CHEM, V276, P37289, DOI 10.1074/jbc.M103556200; Mora I, 2011, INT MICROBIOL, V14, P213, DOI 10.2436/20.1501.01.151; Moyne AL, 2001, J APPL MICROBIOL, V90, P622, DOI 10.1046/j.1365-2672.2001.01290.x; NAKANO MM, 1991, J BACTERIOL, V173, P5487, DOI 10.1128/jb.173.17.5487-5493.1991; Ongena M, 2008, TRENDS MICROBIOL, V16, P115, DOI 10.1016/j.tim.2007.12.009; Ongena M, 2007, ENVIRON MICROBIOL, V9, P1084, DOI 10.1111/j.1462-2920.2006.01202.x; Pathak KV, 2014, 3 BIOTECH, V4, P41, DOI 10.1007/s13205-013-0119-3; Perez-Garcia A, 2011, CURR OPIN BIOTECH, V22, P187, DOI 10.1016/j.copbio.2010.12.003; Phister TG, 2004, APPL ENVIRON MICROB, V70, P631, DOI 10.1128/AEM.70.1.631-634.2004; Price NPJ, 2007, FEMS MICROBIOL LETT, V271, P83, DOI 10.1111/j.1574-6968.2007.00702.x; Pueyo M, 2009, MICROB ECOL, V57, P367, DOI 10.1007/s00248-008-9464-x; Raaijmakers JM, 2010, FEMS MICROBIOL REV, V34, P1037, DOI 10.1111/j.1574-6976.2010.00221.x; Ramarathnam R, 2007, CAN J MICROBIOL, V53, P901, DOI 10.1139/W07-049; Romero D, 2004, APPL MICROBIOL BIOT, V64, P263, DOI 10.1007/s00253-003-1439-8; Romero D, 2007, MOL PLANT MICROBE IN, V20, P430, DOI 10.1094/MPMI-20-4-0430; Ruckert C, 2011, J BIOTECHNOL, V155, P78, DOI 10.1016/j.jbiotec.2011.01.006; Schallmey M, 2004, CAN J MICROBIOL, V50, P1, DOI 10.1139/W03-076; Stein T, 2005, MOL MICROBIOL, V56, P845, DOI 10.1111/j.1365-2958.2005.04587.x; Stein T, 2008, RAPID COMMUN MASS SP, V22, P1146, DOI 10.1002/rcm.3481; Suihko ML, 2003, J APPL MICROBIOL, V94, P25, DOI 10.1046/j.1365-2672.2003.01803.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Yu XM, 2011, EUR J SOIL BIOL, V47, P138, DOI 10.1016/j.ejsobi.2010.11.001; Zeriouh H, 2011, MOL PLANT MICROBE IN, V24, P1540, DOI 10.1094/MPMI-06-11-0162	68	64	71	3	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0127738	10.1371/journal.pone.0127738	http://dx.doi.org/10.1371/journal.pone.0127738			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024374	gold, Green Submitted, Green Published			2022-12-26	WOS:000355319400049
J	Kondratiuk, I; Plucinska, G; Miszczuk, D; Wozniak, G; Szydlowska, K; Kaczmarek, L; Filipkowski, RK; Lukasiuk, K				Kondratiuk, Ilona; Plucinska, Gabriela; Miszczuk, Diana; Wozniak, Grazyna; Szydlowska, Kinga; Kaczmarek, Leszek; Filipkowski, Robert K.; Lukasiuk, Katarzyna			Epileptogenesis following Kainic Acid-Induced Status Epilepticus in Cyclin D2 Knock-Out Mice with Diminished Adult Neurogenesis	PLOS ONE			English	Article							SEIZURE-INDUCED NEUROGENESIS; ECTOPIC GRANULE CELLS; HIPPOCAMPAL NEUROGENESIS; BRAIN NEUROGENESIS; DENTATE GYRUS; PROLIFERATION; ATTENUATION; INTEGRATION; NEURONS; MODELS	The goal of this study was to determine whether a substantial decrease in adult neurogenesis influences epileptogenesis evoked by the intra-amygdala injection of kainic acid (KA). Cyclin D2 knockout (cD2 KO) mice, which lack adult neurogenesis almost entirely, were used as a model. First, we examined whether status epilepticus (SE) evoked by an intra-amygdala injection of KA induces cell proliferation in cD2 KO mice. On the day after SE, we injected BrdU into mice for 5 days and evaluated the number of DCX- and DCX/BrdU-immunopositive cells 3 days later. In cD2 KO control animals, only a small number of DCX+ cells was observed. The number of DCX+ and DCX/BrdU+ cells/mm of subgranular layer in cD2 KO mice increased significantly following SE (p<0.05). However, the number of newly born cells was very low and was significantly lower than in KA-treated wild type (wt) mice. To evaluate the impact of diminished neurogenesis on epileptogenesis and early epilepsy, we performed video-EEG monitoring of wt and cD2 KO mice for 16 days following SE. The number of animals with seizures did not differ between wt (11 out of 15) and cD2 KO (9 out of 12) mice. The median latency to the first spontaneous seizure was 4 days (range 2 - 10 days) in wt mice and 8 days (range 2 - 16 days) in cD2 KO mice and did not differ significantly between groups. Similarly, no differences were observed in median seizure frequency (wt: 1.23, range 0.1 - 3.4; cD2 KO: 0.57, range 0.1 - 2.0 seizures/day) or median seizure duration (wt: 51 s, range 23 -103; cD2 KO: 51 s, range 23 - 103). Our results indicate that SE-induced epileptogenesis is not disrupted in mice with markedly reduced adult neurogenesis. However, we cannot exclude the contribution of reduced neurogenesis to the chronic epileptic state.	[Kondratiuk, Ilona; Wozniak, Grazyna; Kaczmarek, Leszek; Filipkowski, Robert K.] Polish Acad Sci, Nencki Inst Expt Biol, Neurobiol Lab, Warsaw, Poland; [Plucinska, Gabriela; Miszczuk, Diana; Szydlowska, Kinga; Lukasiuk, Katarzyna] Polish Acad Sci, Nencki Inst Expt Biol, Lab Epileptogenesis, Warsaw, Poland; [Filipkowski, Robert K.] Univ Finance & Management Warsaw, Lab Biol Psychol, Warsaw, Poland; [Filipkowski, Robert K.] Polish Acad Sci, Mossakowski Med Res Ctr, Behav & Metab Res Lab, Warsaw, Poland	Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences	Lukasiuk, K (corresponding author), Polish Acad Sci, Nencki Inst Expt Biol, Lab Epileptogenesis, Warsaw, Poland.	k.lukasiuk@nencki.gov.pl	Kaczmarek, Leszek/AHA-0076-2022; Szydlowska, Kinga/D-1301-2016; Lukasiuk, Katarzyna/F-4636-2010; Kaczmarek, Leszek/B-6171-2008; Kondratiuk, Ilona/M-7078-2018	Kaczmarek, Leszek/0000-0002-7207-3490; Szydlowska, Kinga/0000-0001-9019-7676; Kaczmarek, Leszek/0000-0002-7207-3490; Lukasiuk, Katarzyna/0000-0002-1582-0920; Kondratiuk, Ilona/0000-0002-7740-8923; Miszczuk, Diana/0000-0001-9798-6088	Polish Ministry of Science and Higher Education [190/6, PR UE/2006/7]; Polish Science Foundation [MPD/2009/4]; University of Finance and Management in Warsaw; European Union structural funds Innovative Economy Operational Program [POIG.01.01.02-00-109/09]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Polish Science Foundation(Foundation for Polish Science); University of Finance and Management in Warsaw; European Union structural funds Innovative Economy Operational Program	The study was supported by Polish Ministry of Science and Higher Education grant 190/6, PR UE/2006/7 (KL), Polish Science Foundation grant MPD/2009/4 (DM, IK), statutory funds of the University of Finance and Management in Warsaw (RKF), and by the European Union structural funds Innovative Economy Operational Program - Project No. POIG.01.01.02-00-109/09 (LK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Ansorg A, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-46; Ben Abdallah NMB, 2013, BEHAV BRAIN RES, V252, P275, DOI 10.1016/j.bbr.2013.05.034; Bielefeld P, 2014, EUR J NEUROSCI, V39, P1, DOI 10.1111/ejn.12387; Borges K, 2003, EXP NEUROL, V182, P21, DOI 10.1016/S0014-4886(03)00086-4; Drexel M, 2011, NEUROSCIENCE, V189, P316, DOI 10.1016/j.neuroscience.2011.05.021; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Filipkowski RK, 2005, ACTA BIOCHIM POL, V52, P359; Frankland PW, 2013, BEHAV NEUROSCI, V127, P126, DOI 10.1037/a0031512; Garthe A, 2014, GENES BRAIN BEHAV, V13, P357, DOI 10.1111/gbb.12130; Glickstein SB, 2007, DEVELOPMENT, V134, P4083, DOI 10.1242/dev.008524; Gray WP, 1998, BRAIN RES, V790, P52, DOI 10.1016/S0006-8993(98)00030-4; Huusko N, 2015, BRAIN STRUCT FUNCT, V220, P153, DOI 10.1007/s00429-013-0644-1; Jaholkowski P, 2011, GENES BRAIN BEHAV, V10, P551, DOI 10.1111/j.1601-183X.2011.00692.x; Jaholkowski P, 2009, LEARN MEMORY, V16, P439, DOI 10.1101/lm.1459709; Jedynak P, 2014, J PSYCHIATR RES, V56, P106, DOI 10.1016/j.jpsychires.2014.05.009; Jedynak P, 2012, BEHAV BRAIN RES, V227, P159, DOI 10.1016/j.bbr.2011.11.007; Jung KH, 2006, NEUROBIOL DIS, V23, P237, DOI 10.1016/j.nbd.2006.02.016; Jung KH, 2004, EUR J NEUROSCI, V19, P3219, DOI 10.1111/j.0953-816X.2004.03412.x; Kokaia M, 2011, EUR J NEUROSCI, V33, P1133, DOI 10.1111/j.1460-9568.2011.07612.x; Kowalczyk A, 2004, J CELL BIOL, V167, P209, DOI 10.1083/jcb.200404181; Kron MM, 2010, J NEUROSCI, V30, P2051, DOI 10.1523/JNEUROSCI.5655-09.2010; Ledergerber D, 2006, EXP NEUROL, V199, P130, DOI 10.1016/j.expneurol.2006.02.010; Murphy BL, 2011, J NEUROSCI, V31, P105, DOI 10.1523/JNEUROSCI.2728-10.2011; Parent J. M., 2012, NEUROGENESIS EPILEPS; Parent JM, 2008, EPILEPSIA, V49, P19, DOI 10.1111/j.1528-1167.2008.01634.x; Parent JM, 2006, ANN NEUROL, V59, P81, DOI 10.1002/ana.20699; Parent JM, 1997, J NEUROSCI, V17, P3727; Pekcec A, 2010, HIPPOCAMPUS; Raedt R, 2007, EPILEPSIA, V48, P1952, DOI 10.1111/j.1528-1167.2007.01146.x; Scharfman H, 2007, DEV NEUROSCI-BASEL, V29, P14, DOI 10.1159/000096208; Scharfman HE, 2007, EPILEPSIA, V48, P33, DOI 10.1111/j.1528-1167.2007.01065.x; Sicinski P, 1996, NATURE, V384, P470, DOI 10.1038/384470a0; Silva AJ, 1997, NEURON, V19, P755, DOI 10.1016/S0896-6273(00)80958-7; Tanaka K, 2010, EPILEPSY RES, V88, P151, DOI 10.1016/j.eplepsyres.2009.10.012; Wood JC, 2011, EXP NEUROL, V229, P484, DOI 10.1016/j.expneurol.2011.03.019	36	17	17	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128285	10.1371/journal.pone.0128285	http://dx.doi.org/10.1371/journal.pone.0128285			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020770	Green Published, Green Submitted, gold			2022-12-26	WOS:000355187300097
J	Moriyama, T; Ito, A; Omote, S; Miura, Y; Tsumoto, H				Moriyama, Takanori; Ito, Aimi; Omote, Sumire; Miura, Yuri; Tsumoto, Hiroki			Heat Resistant Characteristics of Major Royal Jelly Protein 1 (MRJP1) Oligomer	PLOS ONE			English	Article							RAT HEPATOCYTES; 57-KDA PROTEIN; IN-VITRO; HONEY; PROTEOMICS; PROLIFERATION; PURIFICATION; STIMULATION; RECOMBINANT; COMPONENT	Soluble royal jelly protein is a candidate factor responsible for mammiferous cell proliferation. Major royal jelly protein 1 (MRJP1), which consists of oligomeric and monomeric forms, is an abundant proliferative protein in royal jelly. We previously reported that MRJP1 oligomer has biochemical heat resistance. Therefore, in the present study, we investigated the effects of several heat treatments (56, 65 and 96 degrees C) on the proliferative activity of MRJP1 oligomer. Heat resistance studies showed that the oligomer molecular forms were slightly maintained until 56 degrees C, but the molecular forms were converted to macromolecular heat-aggregated MRJP1 oligomer at 65 degrees C and 96 degrees C. But, the growth activity of MRJP1 oligomer treated with 96 degrees C was slightly attenuated when compared to unheated MRJP1 oligomer. On the other hand, the cell proliferation activity was preserved until 96 degrees C by the cell culture analysis of Jurkat cells. In contrast, those of IEC-6 cells were not preserved even at 56 degrees C. The present observations suggest that the bioactive heat-resistance properties were different by the origin of the cells. The cell proliferation analysis showed that MRJP1 oligomer, but not MRJP2 and MRJP3, significantly increased cell numbers, suggesting that MRJP1 oligomer is the predominant proliferation factor for mammiferous cells.	[Moriyama, Takanori] Hokkaido Univ, Fac Hlth Sci, Kita Ku, Sapporo, Hokkaido, Japan; [Ito, Aimi] Toranomon Gen Hosp, Div Clin Labs, Kawasaki, Kanagawa, Japan; [Omote, Sumire] Hokkaido Univ, Grad Sch Hlth Sci, Kita Ku, Sapporo, Hokkaido, Japan; [Miura, Yuri; Tsumoto, Hiroki] Tokyo Metropolitan Inst Gerontol, Res Team Mech Aging, Itabashi Ku, Tokyo, Japan	Hokkaido University; Toranomon Hospital; Hokkaido University; Tokyo Metropolitan Institute of Gerontology	Moriyama, T (corresponding author), Hokkaido Univ, Fac Hlth Sci, Kita Ku, Sapporo, Hokkaido, Japan.	moriyama@hs.hokudai.ac.jp			Sapporo Regional Innovation Strategy Promotion Program Grant from the Knowledge Cluster Initiative of the Ministry of Education, Sports, Science and Technology (MEXT); Japan Royal Jelly Co., Ltd.; Hokkaido University, Sapporo, Japan	Sapporo Regional Innovation Strategy Promotion Program Grant from the Knowledge Cluster Initiative of the Ministry of Education, Sports, Science and Technology (MEXT); Japan Royal Jelly Co., Ltd.; Hokkaido University, Sapporo, Japan	This study was supported by a Sapporo Regional Innovation Strategy Promotion Program Grant from the Knowledge Cluster Initiative of the Ministry of Education, Sports, Science and Technology (MEXT) and by Japan Royal Jelly Co., Ltd. Other research funds were provided from the internal funds of Hokkaido University, Sapporo, Japan. Japan Royal Jelly Co., Ltd., did not have any role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Albert T, 2004, J INSECT PHYSIOL, V50, P51, DOI 10.1016/j.jinsphys.2003.09.008; Bilikova K, 2002, FEBS LETT, V528, P125, DOI 10.1016/S0014-5793(02)03272-6; Bilikova K, 2010, J AGR FOOD CHEM, V58, P8776, DOI 10.1021/jf101583s; Bilikova K, 2009, PROTEOMICS, V9, P2131, DOI 10.1002/pmic.200800705; CHEN CS, 1995, FOOD CHEM, V54, P195, DOI 10.1016/0308-8146(95)00031-D; Fontana R, 2004, PEPTIDES, V25, P919, DOI 10.1016/j.peptides.2004.03.016; FUJIWARA S, 1990, J BIOL CHEM, V265, P11333; Furusawa T, 2008, J PROTEOME RES, V7, P3194, DOI 10.1021/pr800061j; Golias J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037156; HOWE SR, 1985, J APICULT RES, V24, P52, DOI 10.1080/00218839.1985.11100649; Iwamura Makoto, 2014, Fukuoka University Review of Technological Sciences, P1; JONES DB, 1982, J IMMUNOL METHODS, V53, P201, DOI 10.1016/0022-1759(82)90142-9; Judova J, 1998, BIOLOGIA, V53, P777; Kamakura M, 2002, J BIOCHEM, V132, P911, DOI 10.1093/oxfordjournals.jbchem.a003304; Kamakura M, 2001, BIOSCI BIOTECH BIOCH, V65, P277, DOI 10.1271/bbb.65.277; Kamakura M, 2001, BIOCHEM BIOPH RES CO, V282, P865, DOI 10.1006/bbrc.2001.4656; Kamakura M, 2011, NATURE, V473, P478, DOI 10.1038/nature10093; KNECHT D, 1990, APIDOLOGIE, V21, P457, DOI 10.1051/apido:19900507; Kohno K, 2004, BIOSCI BIOTECH BIOCH, V68, P138, DOI 10.1271/bbb.68.138; LENSKY Y, 1983, COMP BIOCHEM PHYS B, V75, P607, DOI 10.1016/0305-0491(83)90104-9; Li JK, 2008, J PROTEOME RES, V7, P3339, DOI 10.1021/pr8002276; Li JK, 2007, J AGR FOOD CHEM, V55, P8411, DOI 10.1021/jf0717440; Majtan J, 2006, INT IMMUNOPHARMACOL, V6, P269, DOI 10.1016/j.intimp.2005.08.014; MAKINO M, 1986, J CLIN LAB IMMUNOL, V21, P151; Mishima S, 2005, J ETHNOPHARMACOL, V101, P215, DOI 10.1016/j.jep.2005.04.012; Narita Y, 2006, BIOSCI BIOTECH BIOCH, V70, P2508, DOI 10.1271/bbb.60240; Nozaki R, 2012, FOOD CHEM, V134, P2332, DOI 10.1016/j.foodchem.2012.03.106; Okamoto I, 2003, LIFE SCI, V73, P2029, DOI 10.1016/S0024-3205(03)00562-9; OSTREIKO KK, 1987, IMMUNOL LETT, V15, P311, DOI 10.1016/0165-2478(87)90134-9; Schmitzova J, 1998, CELL MOL LIFE SCI, V54, P1020, DOI 10.1007/s000180050229; Schonleben S, 2007, ANAL BIOANAL CHEM, V389, P1087, DOI 10.1007/s00216-007-1498-2; Shen LR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047194; Shen LR, 2010, J AGR FOOD CHEM, V58, P9190, DOI 10.1021/jf1007133; Simuth J, 2004, J AGR FOOD CHEM, V52, P2154, DOI 10.1021/jf034777y; Simuth J, 2001, APIDOLOGIE, V32, P69, DOI 10.1051/apido:2001112; Tamura S, 2009, PROTEOMICS, V9, P5534, DOI 10.1002/pmic.200900541; Tamura S, 2009, FOOD CHEM, V114, P1491, DOI 10.1016/j.foodchem.2008.11.058; Watanabe K, 1996, BIOTECHNOL TECH, V10, P959, DOI 10.1007/BF00180402; Watanabe K, 1998, CYTOTECHNOLOGY, V26, P23, DOI 10.1023/A:1007928408128; Yohannes G, 2010, ANAL CHIM ACTA, V675, P191, DOI 10.1016/j.aca.2010.07.016	40	19	21	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0119169	10.1371/journal.pone.0119169	http://dx.doi.org/10.1371/journal.pone.0119169			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020775	Green Published, gold, Green Submitted			2022-12-26	WOS:000355187300001
J	Oprenyeszk, F; Sanchez, C; Dubuc, JE; Maquet, V; Henrist, C; Compere, P; Henrotin, Y				Oprenyeszk, Frederic; Sanchez, Christelle; Dubuc, Jean-Emile; Maquet, Veronique; Henrist, Catherine; Compere, Philippe; Henrotin, Yves			Chitosan Enriched Three-Dimensional Matrix Reduces Inflammatory and Catabolic Mediators Production by Human Chondrocytes	PLOS ONE			English	Article							HUMAN ARTICULAR CHONDROCYTES; MESENCHYMAL STEM-CELLS; KNEE OSTEOARTHRITIS; OARSI RECOMMENDATIONS; ARTHROSCOPIC DEBRIDEMENT; CARTILAGE DEFECTS; TISSUE INHIBITOR; IN-VIVO; ALGINATE; MANAGEMENT	This in vitro study investigated the metabolism of human osteoarthritic (OA) chondrocytes encapsulated in a spherical matrix enriched of chitosan. Human OA chondrocytes were encapsulated and cultured for 28 days either in chitosan-alginate beads or in alginate beads. The beads were formed by slowly passing dropwise either the chitosan 0.6%-alginate 1.2% or the alginate 1.2% solution through a syringe into a 102 mM CaCl2 solution. Beads were analyzed histologically after 28 days. Interleukin (IL)-6 and -8, prostaglandin (PG) E-2, matrix metalloproteinases (MMPs), hyaluronan and aggrecan were quantified directly in the culture supernatant by specific ELISA and nitric oxide (NO) by using a colorimetric method based on the Griess reaction. Hematoxylin and eosin staining showed that chitosan was homogeneously distributed through the matrix and was in direct contact with chondrocytes. The production of IL-6, IL-8 and MMP-3 by chondrocytes significantly decreased in chitosan-alginate beads compared to alginate beads. PGE(2) and NO decreased also significantly but only during the first three days of culture. Hyaluronan and aggrecan production tended to increase in chitosan-alginate beads after 28 days of culture. Chitosan-alginate beads reduced the production of inflammatory and catabolic mediators by OA chondrocytes and tended to stimulate the synthesis of cartilage matrix components. These particular effects indicate that chitosan-alginate beads are an interesting scaffold for chondrocytes encapsulation before transplantation to repair cartilage defects.	[Oprenyeszk, Frederic; Sanchez, Christelle; Henrotin, Yves] Univ Liege, Arthropole Liege, Bone & Cartilage Res Unit, Liege, Belgium; [Dubuc, Jean-Emile] Clin Univ St Luc, Dept Orthopaed, B-1200 Brussels, Belgium; [Maquet, Veronique] KitoZyme SA, Herstal, Belgium; [Henrist, Catherine] Univ Liege, Grp Res Energy & Environm Mat, Liege, Belgium; [Henrist, Catherine] Univ Liege, Ctr Appl Technol Microscopy, Liege, Belgium; [Compere, Philippe] Univ Liege, Dept Environm Sci & Management, Lab Funct & Evolut Morphol, Liege, Belgium	University of Liege; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; University of Liege; University of Liege; University of Liege	Henrotin, Y (corresponding author), Univ Liege, Arthropole Liege, Bone & Cartilage Res Unit, Liege, Belgium.	yhenrotin@ulg.ac.be		sanchez, christelle/0000-0002-1005-8172; Henrotin, Yves/0000-0003-1073-449X	KitoZyme S.A.; "Region Wallonne": FIRST Post-Doc program for the CARTIMAT project [716609]; CWaLity-Appel, ARTHROVISC [1217650]; University of Liege	KitoZyme S.A.; "Region Wallonne": FIRST Post-Doc program for the CARTIMAT project; CWaLity-Appel, ARTHROVISC; University of Liege(University of Liege)	This work was supported in part by KitoZyme S.A. and was granted by "Region Wallonne": FIRST Post-Doc program for the CARTIMAT project (funding grant No. 716609) and CWaLity-Appel 2012:ARTHROVISC (funding grant No. 1217650). University of Liege received the funding. The funder provided support in the form of salaries for authors FO, CS, CH, PC, and YH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	American College of Rheumatology Subcommittee on Osteoarthritis Guidelines, 2000, ARTHRITIS AND RHEUMA, V43, P1905, DOI DOI 10.1002/1529-0131(200009)43:9<1905::AID-ANR1>3.0.CO;2-P; Babister JC, 2008, BIOMATERIALS, V29, P58, DOI 10.1016/j.biomaterials.2007.09.006; Berenbaum F, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2462; Bertone AL, 2001, VET SURG, V30, P528, DOI 10.1053/jvet.2001.28430; Day B, 2005, ORTHOP CLIN N AM, V36, P413, DOI 10.1016/j.ocl.2005.06.003; de Vries-van Melle ML, 2014, EUR CELLS MATER, V27, P112, DOI 10.22203/eCM.v027a09; Dewan AK, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/272481; Forsey RW, 2012, BIOTECHNOL APPL BIOC, V59, P142, DOI 10.1002/bab.1009; Galois L, 2005, PATHOL BIOL, V53, P590, DOI 10.1016/j.patbio.2004.12.019; Garcia FJB, 1999, OSTEOARTHR CARTILAGE, V7, P308, DOI 10.1053/joca.1998.0174; Guo CA, 2007, J BIOSCI BIOENG, V103, P547, DOI 10.1263/jbb.103.547; Hao T, 2010, OSTEOARTHR CARTILAGE, V18, P257, DOI 10.1016/j.joca.2009.08.007; Hauselmann HJ, 1996, AM J PHYSIOL-CELL PH, V271, pC742, DOI 10.1152/ajpcell.1996.271.3.C742; HEMBRY RM, 1995, ANN RHEUM DIS, V54, P25, DOI 10.1136/ard.54.1.25; Henrotin Y. KF, INVENTORCELL CULTIVA; Henrotin YE, 2003, OSTEOARTHR CARTILAGE, V11, P747, DOI 10.1016/S1063-4584(03)00150-X; Henrotin Yves, 2009, F1000 Med Rep, V1, DOI 10.3410/M1-88; Jordan KM, 2003, ANN RHEUM DIS, V62, P1145, DOI 10.1136/ard.2003.011742; Kerker JT, 2008, SPORTS MED ARTHROSC, V16, P208, DOI 10.1097/JSA.0b013e31818cdbaa; Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009; KNAUPER V, 1993, BIOCHEM J, V295, P581; Lahiji A, 2000, J BIOMED MATER RES, V51, P586; Legendre F, 2003, J BIOL CHEM, V278, P2903, DOI 10.1074/jbc.M110773200; Li ZS, 2008, J BIOMED MATER RES A, V86A, P552, DOI 10.1002/jbm.a.31596; Li ZS, 2005, J BIOMED MATER RES A, V75A, P485, DOI 10.1002/jbm.a.30449; Liu SQ, 2005, RHEUMATOL INT, V26, P52, DOI 10.1007/s00296-004-0569-3; Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P1697, DOI 10.1002/art.34453; Lu JX, 1999, BIOMATERIALS, V20, P1937; Marcacci M, 2007, AM J SPORT MED, V35, P2014, DOI 10.1177/0363546507305455; Marsich E, 2008, J BIOMED MATER RES A, V84A, P364, DOI 10.1002/jbm.a.31307; Martel-Pelletier Johanne, 1999, Frontiers in Bioscience, V4, pd694, DOI 10.2741/Martel; MARTELPELLETIER J, 1994, LAB INVEST, V70, P807; MATRISIAN LM, 1990, TRENDS GENET, V6, P121, DOI 10.1016/0168-9525(90)90126-Q; MOSKOWITZ RW, 1973, ARTHRITIS RHEUM-US, V16, P397, DOI 10.1002/art.1780160317; MURPHY G, 1987, BIOCHEM J, V248, P265, DOI 10.1042/bj2480265; Nam KS, 2007, J MICROBIOL BIOTECHN, V17, P2042; Nettles DL, 2004, ANN BIOMED ENG, V32, P391, DOI 10.1023/B:ABME.0000017552.65260.94; Pangestuti R, 2011, INT J BIOL MACROMOL, V49, P599, DOI 10.1016/j.ijbiomac.2011.06.014; Pelletier JP, 2001, ARTHRITIS RHEUM-US, V44, P1237, DOI 10.1002/1529-0131(200106)44:6<1237::AID-ART214>3.0.CO;2-F; Pleumeekers MM, 2014, EUR CELLS MATER, V27, P264, DOI 10.22203/eCM.v027a19; Qin Yimin, 2004, Med Device Technol, V15, P34; Rannou F, 2010, BEST PRACT RES CL RH, V24, P93, DOI 10.1016/j.berh.2009.08.013; Sakharov AV, 2008, B EXP BIOL MED+, V146, P124, DOI 10.1007/s10517-008-0220-5; SAKURAI H, 1995, J CLIN INVEST, V96, P2357, DOI 10.1172/JCI118292; Sanchez C, 2004, OSTEOARTHR CARTILAGE, V12, P801, DOI 10.1016/j.joca.2004.06.011; Sanchez C, 2003, BIOCHEM PHARMACOL, V65, P377, DOI 10.1016/S0006-2952(02)01485-5; Sanchez C, 2002, J RHEUMATOL, V29, P772; Sechriest VF, 2000, J BIOMED MATER RES, V49, P534, DOI 10.1002/(SICI)1097-4636(20000315)49:4<534::AID-JBM12>3.0.CO;2-#; Siparsky P, 2007, CLIN ORTHOP RELAT R, P107, DOI 10.1097/BLO.0b013e31802fc18c; Stanish WD, 2013, J BONE JOINT SURG AM, V95A, P1640, DOI 10.2106/JBJS.L.01345; Stark Y, 2006, EXP TOXICOL PATHOL, V57, P305, DOI 10.1016/j.etp.2005.10.005; Stevens MM, 2004, BIOMATERIALS, V25, P887, DOI 10.1016/j.biomaterials.2003.07.002; Stuart MJ, 2006, ARTHROSCOPY, V22, P238, DOI 10.1016/j.arthro.2006.01.008; TASKIRAN D, 1994, BIOCHEM BIOPH RES CO, V200, P142, DOI 10.1006/bbrc.1994.1426; Tigli RS, 2009, J MATER SCI-MATER M, V20, P699, DOI 10.1007/s10856-008-3624-x; Xu FY, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/539789; Zhang W, 2008, OSTEOARTHR CARTILAGE, V16, P137, DOI 10.1016/j.joca.2007.12.013; Zhang W, 2007, OSTEOARTHR CARTILAGE, V15, P981, DOI 10.1016/j.joca.2007.06.014; Zhang W, 2010, OSTEOARTHR CARTILAGE, V18, P476, DOI 10.1016/j.joca.2010.01.013	59	20	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128362	10.1371/journal.pone.0128362	http://dx.doi.org/10.1371/journal.pone.0128362			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020773	Green Published, gold, Green Submitted			2022-12-26	WOS:000355187300103
J	Quan, H; Kim, JM; Lee, HJ; Lee, SH; Choi, JI; Bae, HB				Quan, Hui; Kim, Joung-Min; Lee, Hyun-Jung; Lee, Seong-Heon; Choi, Jeong-Il; Bae, Hong-Beom			AICAR Enhances the Phagocytic Ability of Macrophages towards Apoptotic Cells through P38 Mitogen Activated Protein Kinase Activation Independent of AMP-Activated Protein Kinase	PLOS ONE			English	Article							ACUTE LUNG INJURY; SIGNALING PATHWAY; 5-AMINOIMIDAZOLE-4-CARBOXAMIDE RIBOSIDE; INHIBITS EFFEROCYTOSIS; BACTERIAL PHAGOCYTOSIS; SAURURUS-CHINENSIS; MUSCLE-CELLS; MAP KINASE; TGF-BETA; EXPRESSION	Recent studies have suggested that 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR) increases macrophage phagocytosis through adenosine monophosphate-activated protein kinase (AMPK). However, little information is available on the effects of AICAR on the clearance of apoptotic cells by macrophages, known as efferocytosis, which is essential in maintaining tissue homeostasis and resolving inflammation. AICAR increased p38 MAPK activation and the phagocytosis of apoptotic cells by macrophages, which were inhibited by the p38 MAPK inhibitor, SB203580, the TGF-beta-activated kinase 1 (TAK1) inhibitor, (5Z)-7-oxozeaenol, and siRNA-mediated knock-down of p38 alpha. AICAR increased phosphorylation of Akt, but the inhibition of PI3K/Akt activity using LY294002 did not affect the AICAR-induced changes in efferocytosis in macrophages. CGS15943, a nonselective adenosine receptor antagonist, did not affect AICAR-induced changes in efferocytosis, but dipyridamole, an adenosine transporter inhibitor, diminished the AICAR-mediated increases in efferocytosis. AICAR-induced p38 MAPK phosphorylation was not inhibited by the AMPK inhibitor, compound C, or siRNA-mediated knock-down of AMPK alpha 1. Inhibition of AMPK using compound C or 5'-iodotubercidin did not completely block AICAR-mediated increases in efferocytosis. Furthermore, AICAR also increased the removal of apoptotic neutrophils or thymocytes in mouse lungs. These results reveal a novel mechanism by which AICAR increases macrophage-mediated phagocytosis of apoptotic cells and suggest that AICAR may be used to treat efferocytosis-related inflammatory conditions.	[Quan, Hui; Kim, Joung-Min; Lee, Hyun-Jung; Lee, Seong-Heon; Choi, Jeong-Il; Bae, Hong-Beom] Chonnam Natl Univ, Sch Med, Dept Anesthesiol & Pain Med, Gwangju, South Korea; [Quan, Hui; Bae, Hong-Beom] Chonnam Natl Univ, Res Inst Med Sci, Gwangju, South Korea	Chonnam National University; Chonnam National University	Bae, HB (corresponding author), Chonnam Natl Univ, Sch Med, Dept Anesthesiol & Pain Med, Gwangju, South Korea.	nextphil2@jnu.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-2012R1A1A1003707]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R43AI051202] Funding Source: NIH RePORTER	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (NRF-2012R1A1A1003707). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae HB, 2013, J IMMUNOL, V190, P2273, DOI 10.4049/jimmunol.1200625; Bae HB, 2011, FASEB J, V25, P4358, DOI 10.1096/fj.11-190587; Bumpus NN, 2011, J PHARMACOL EXP THER, V339, P886, DOI 10.1124/jpet.111.184242; Chang MY, 2010, BIOCHEM PHARMACOL, V80, P1210, DOI 10.1016/j.bcp.2010.06.049; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Cui J, 2009, CELL IMMUNOL, V256, P6, DOI 10.1016/j.cellimm.2008.12.003; Donnelly LE, 2012, CHEST, V141, P1055, DOI 10.1378/chest.11-2348; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Frasch SC, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.181800; Friggeri A, 2012, MOL MED, V18, P825, DOI 10.2119/molmed.2012.00005; Gadalla AE, 2004, J NEUROCHEM, V88, P1272, DOI 10.1046/j.1471-4159.2003.02253.x; Giri S, 2004, J NEUROSCI, V24, P479, DOI 10.1523/JNEUROSCI.4288-03.2004; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Han HJ, 2013, INT IMMUNOPHARMACOL, V17, P471, DOI 10.1016/j.intimp.2013.07.011; Henson PM, 2006, TRENDS IMMUNOL, V27, P244, DOI 10.1016/j.it.2006.03.005; Hoogendijk AJ, 2013, J BIOL CHEM, V288, P7047, DOI 10.1074/jbc.M112.413138; Ishii N, 2009, J BIOL CHEM, V284, P34561, DOI 10.1074/jbc.M109.028043; Jeong KM, 2014, EUR J PHARMACOL, V728, P176, DOI 10.1016/j.ejphar.2014.01.039; Jhun BS, 2004, BIOCHEM BIOPH RES CO, V318, P372, DOI 10.1016/j.bbrc.2004.04.035; Jiang SN, 2013, J BIOL CHEM, V288, P26013, DOI 10.1074/jbc.M113.489468; Katayama T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040813; Kim MS, 2008, DIABETES, V57, P64, DOI 10.2337/db07-0832; Kuo CL, 2008, J CELL BIOCHEM, V103, P931, DOI 10.1002/jcb.21466; Lee YM, 2008, J BIOL CHEM, V283, P33969, DOI 10.1074/jbc.M804469200; Leverrier Y, 2003, J BIOL CHEM, V278, P38437, DOI 10.1074/jbc.M306649200; Li J, 2005, CIRC RES, V97, P872, DOI 10.1161/01.RES.0000187458.77026.10; Li SZ, 2009, CIRC RES, V105, P1072, DOI 10.1161/CIRCRESAHA.109.199570; Ninkovic J, 2012, AM J PATHOL, V180, P1068, DOI 10.1016/j.ajpath.2011.11.034; Osada Y, 2009, J BIOCHEM, V145, P387, DOI 10.1093/jb/mvn176; Pichon S, 2004, J CELL SCI, V117, P2569, DOI 10.1242/jcs.01110; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; Tosello-Trampont AC, 2003, J BIOL CHEM, V278, P49911, DOI 10.1074/jbc.M306079200; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Vandivier RW, 2006, CHEST, V129, P1673, DOI 10.1378/chest.129.6.1673; Wilkinson MG, 2000, FASEB J, V14, P2147, DOI 10.1096/fj.00-0102rev; Xi X, 2001, J BIOL CHEM, V276, P41029, DOI 10.1074/jbc.M102824200; Xie M, 2006, P NATL ACAD SCI USA, V103, P17378, DOI 10.1073/pnas.0604708103; Xing JJ, 2013, AM J PATHOL, V182, P1021, DOI 10.1016/j.ajpath.2012.11.022; Yang YP, 2010, AM J RESP CRIT CARE, V182, P1516, DOI 10.1164/rccm.201003-0452OC; Zhang WY, 2010, ARTERIOSCL THROM VAS, V30, P1000, DOI 10.1161/ATVBAHA.110.203141; Zhao X, 2008, AM J PHYSIOL-LUNG C, V295, pL497, DOI 10.1152/ajplung.90210.2008	42	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0127885	10.1371/journal.pone.0127885	http://dx.doi.org/10.1371/journal.pone.0127885			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020972	Green Published, gold, Green Submitted			2022-12-26	WOS:000355187300063
J	Rosauer, DF; Catullo, RA; VanDerWal, J; Moussalli, A; Moritz, C				Rosauer, Dan F.; Catullo, Renee A.; VanDerWal, Jeremy; Moussalli, Adnan; Moritz, Craig			Lineage Range Estimation Method Reveals Fine-Scale Endemism Linked to Pleistocene Stability in Australian Rainforest Herpetofauna	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; BRAZILIAN ATLANTIC FOREST; QUATERNARY CLIMATE-CHANGE; NARROW CONTACT ZONE; HISTORICAL BIOGEOGRAPHY; WET TROPICS; COMPARATIVE PHYLOGEOGRAPHY; PHYLOGENETIC ENDEMISM; PHYLLURUS LACERTILIA; NORTHEAST AUSTRALIA	Areas of suitable habitat for species and communities have arisen, shifted, and disappeared with Pleistocene climate cycles, and through this shifting landscape, current biodiversity has found paths to the present. Evolutionary refugia, areas of relative habitat stability in this shifting landscape, support persistence of lineages through time, and are thus crucial to the accumulation and maintenance of biodiversity. Areas of endemism are indicative of refugial areas where diversity has persisted, and endemism of intraspecific lineages in particular is strongly associated with late-Pleistocene habitat stability. However, it remains a challenge to consistently estimate the geographic ranges of intraspecific lineages and thus infer phylogeographic endemism, because spatial sampling for genetic analyses is typically sparse relative to species records. We present a novel technique to model the geographic distribution of intraspecific lineages, which is informed by the ecological niche of a species and known locations of its constituent lineages. Our approach allows for the effects of isolation by unsuitable habitat, and captures uncertainty in the extent of lineage ranges. Applying this method to the arc of rainforest areas spanning 3500 km in eastern Australia, we estimated lineage endemism for 53 species of rainforest dependent herpetofauna with available phylogeographic data. We related endemism to the stability of rainforest habitat over the past 120,000 years and identified distinct concentrations of lineage endemism that can be considered putative refugia. These areas of lineage endemism are strongly related to historical stability of rainforest habitat, after controlling for the effects of current environment. In fact, a dynamic stability model that allows movement to track suitable habitat over time was the most important factor in explaining current patterns of endemism. The techniques presented here provide an objective, practical method for estimating geographic ranges below the species level, and including them in spatial analyses of biodiversity.	[Rosauer, Dan F.; Catullo, Renee A.; Moritz, Craig] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia; [Rosauer, Dan F.; Catullo, Renee A.; Moritz, Craig] Australian Natl Univ, Ctr Biodivers Anal, Canberra, ACT, Australia; [Catullo, Renee A.; Moritz, Craig] CSIRO Land & Water Flagship, Canberra, ACT, Australia; [VanDerWal, Jeremy] James Cook Univ, Coll Marine & Environm Sci, Ctr Trop Biodivers & Climate Change, Townsville, Qld 4811, Australia; [VanDerWal, Jeremy] James Cook Univ, ERes Ctr, Div Res & Innovat, Townsville, Qld 4811, Australia; [Moussalli, Adnan] Museum Victoria, Dept Sci, Melbourne, Vic, Australia	Australian National University; Australian National University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); James Cook University; James Cook University; Museum Victoria	Rosauer, DF (corresponding author), Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia.	dan.rosauer@anu.edu.au	Rosauer, Dan F/C-3735-2008	Rosauer, Dan F/0000-0002-2371-1767; Catullo, Renee/0000-0002-1790-7085	Australian Research Council Laureate Fellowship [FL110100104]; Science and Industry Endowment Fund	Australian Research Council Laureate Fellowship(Australian Research Council); Science and Industry Endowment Fund	DR and CM were funded by an Australian Research Council Laureate Fellowship FL110100104 to CM, www.arc.gov.au/. RC was partially funded by a grant from the Science and Industry Endowment Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe-Ouchi A, 2013, NATURE, V500, P190, DOI 10.1038/nature12374; Amante C., 2009, ETOPO1 1 ARC MINUTE; [Anonymous], 2012, ARCG2S 10 1; Australian Government Department of Sustainability E Water Population and Communities, 2012, AUSTR EST PRE 1750 M; Bell RC, 2012, P ROY SOC B-BIOL SCI, V279, P991, DOI 10.1098/rspb.2011.1229; Bell RC, 2010, MOL ECOL, V19, P2531, DOI 10.1111/j.1365-294X.2010.04676.x; Beven KJ., 1979, HYDROL SCI J, V24, P43, DOI [10.1080/ 02626667909491834, 10.1080/02626667909491834, DOI 10.1080/02626667909491834]; Bivand R, 2014, SPDEP R PACKAGE SPAT; BURBRIDGE NANCY T., 1960, AUSTRALIAN JOUR BOT, V8, P75, DOI 10.1071/BT9600075; Bush A, 2014, DIVERS DISTRIB, V20, P1016, DOI 10.1111/ddi.12196; Calabrese JM, 2014, GLOBAL ECOL BIOGEOGR, V23, P99, DOI 10.1111/geb.12102; Carnaval AC, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1461; Carnaval AC, 2009, SCIENCE, V323, P785, DOI 10.1126/science.1166955; Chapple DG, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-191; Costion CM, 2015, DIVERS DISTRIB, V21, P279, DOI 10.1111/ddi.12266; Couper PJ, 2008, REC AUST MUS, V60, P87, DOI 10.3853/j.0067-1975.60.2008.1492; Couper Patrick J., 2008, Memoirs of the Queensland Museum, V52, P139; Crisp MD, 2001, J BIOGEOGR, V28, P183, DOI 10.1046/j.1365-2699.2001.00524.x; Crisp MD, 1995, SYST BIOL, V44, P457, DOI 10.2307/2413654; Davies TJ, 2009, AM NAT, V174, P297, DOI 10.1086/603614; de Lima NE, 2014, J BIOGEOGR, V41, P673, DOI 10.1111/jbi.12269; DiNezio PN, 2013, NAT GEOSCI, V6, P485, DOI [10.1038/ngeo1823, 10.1038/NGEO1823]; Dobrowski SZ, 2011, GLOBAL CHANGE BIOL, V17, P1022, DOI 10.1111/j.1365-2486.2010.02263.x; Dolman G, 2006, EVOLUTION, V60, P573, DOI 10.1554/05-487.1; Dynesius M, 2000, P NATL ACAD SCI USA, V97, P9115, DOI 10.1073/pnas.97.16.9115; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Forester BR, 2013, DIVERS DISTRIB, V19, P1480, DOI 10.1111/ddi.12098; Fuchs J, 2013, BIOL J LINN SOC, V108, P658, DOI 10.1111/j.1095-8312.2012.02022.x; Graham CH, 2010, ECOGRAPHY, V33, P1062, DOI 10.1111/j.1600-0587.2010.06430.x; Greenwood D. R., 2005, Tropical rainforests: past, present and future, P336; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hijmans R. J., 2013, R PACKAGE DISMO SPEC; Hilbert DW, 2007, PALAEOGEOGR PALAEOCL, V251, P104, DOI 10.1016/j.palaeo.2007.02.020; Hoskin CJ, 2003, AUST J ZOOL, V51, P153, DOI 10.1071/ZO02072; Hoskin CJ, 2013, ZOOTAXA, V3722, P385; Hoskin CJ, 2013, ZOOTAXA, V3717, P543, DOI 10.11646/zootaxa.3717.4.6; Hoskin CJ, 2011, AM NAT, V178, P561, DOI 10.1086/662164; Houlder D. J., 2000, ANUCLIM USERS GUIDE; Hugall A, 2003, SM S COMP E, P270; Kelly AE, 2008, P NATL ACAD SCI USA, V105, P11823, DOI 10.1073/pnas.0802891105; KERSHAW AP, 1988, J BIOGEOGR, V15, P589, DOI 10.2307/2845438; Knowles R, 2004, REC AUST MUS, V56, P57, DOI 10.3853/j.0067-1975.56.2004.1391; Kooyman RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080685; Laffan SW, 2010, ECOGRAPHY, V33, P643, DOI 10.1111/j.1600-0587.2010.06237.x; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Macqueen P, 2010, MOL PHYLOGENET EVOL, V57, P1134, DOI 10.1016/j.ympev.2010.08.010; Martins FD, 2011, BIOL J LINN SOC, V104, P499, DOI 10.1111/j.1095-8312.2011.01745.x; Moritz C, 2005, CONSERV BIOL SER, V8, P243; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Moritz C, 2009, P ROY SOC B-BIOL SCI, V276, P1235, DOI 10.1098/rspb.2008.1622; Moritz C, 2012, PHILOS T R SOC B, V367, P1680, DOI 10.1098/rstb.2012.0018; Moussalli A, 2005, MOL PHYLOGENET EVOL, V34, P190, DOI 10.1016/j.ympev.2004.08.022; Moussalli A, 2009, MOL ECOL, V18, P483, DOI 10.1111/j.1365-294X.2008.04035.x; Nix HA, 1991, RAINFOREST ANIMALS A, P11; Oza AU, 2012, MOL PHYLOGENET EVOL, V62, P407, DOI 10.1016/j.ympev.2011.10.010; Phillips BL, 2004, EVOLUTION, V58, P1536; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; Powney GD, 2010, GLOBAL ECOL BIOGEOGR, V19, P386, DOI 10.1111/j.1466-8238.2009.00521.x; Reside A. E., 2013, CLIMATE CHANGE REFUG; Reside AE, 2014, AUSTRAL ECOL, V39, P887, DOI 10.1111/aec.12146; Rissler LJ, 2006, AM NAT, V167, P655, DOI 10.1086/503332; Rix MG, 2012, MOL PHYLOGENET EVOL, V62, P375, DOI 10.1016/j.ympev.2011.10.009; Rosauer D, 2009, MOL ECOL, V18, P4061, DOI 10.1111/j.1365-294X.2009.04311.x; Rosauer DF, 2015, GLOBAL ECOL BIOGEOGR, V24, P168, DOI 10.1111/geb.12237; Sandel B, 2011, SCIENCE, V334, P660, DOI 10.1126/science.1210173; Schneider CJ, 1998, MOL ECOL, V7, P487, DOI 10.1046/j.1365-294x.1998.00334.x; Shea G, 2011, ZOOTAXA, P1; Shoo LP, 2010, INT J BIOMETEOROL, V54, P475, DOI 10.1007/s00484-009-0286-4; Shull HC, 2005, MOL PHYLOGENET EVOL, V37, P249, DOI 10.1016/j.ympev.2005.04.034; Siddall M, 2003, NATURE, V423, P853, DOI 10.1038/nature01690; Singarayer JS, 2010, QUATERNARY SCI REV, V29, P43, DOI 10.1016/j.quascirev.2009.10.011; Singhal S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2246; Singhal S, 2012, EVOLUTION, V66, P1474, DOI 10.1111/j.1558-5646.2011.01539.x; Slatyer C, 2007, J BIOGEOGR, V34, P583, DOI 10.1111/j.1365-2699.2006.01647.x; Slavich E, 2014, DIVERS DISTRIB, V20, P952, DOI 10.1111/ddi.12216; Stuart-Fox DM, 2001, AUST J ZOOL, V49, P119, DOI 10.1071/ZO00092; Tarroso P, 2015, MOL ECOL RESOUR, V15, P349, DOI 10.1111/1755-0998.12312; Thomassen HA, 2010, EVOL APPL, V3, P1, DOI 10.1111/j.1752-4571.2009.00093.x; Vandergast AG, 2008, BIOL CONSERV, V141, P1648, DOI 10.1016/j.biocon.2008.04.009; VanDerWal J., 2011, CLIMATES METHODS WOR; VanDerWal J, 2009, J BIOGEOGR, V36, P291, DOI 10.1111/j.1365-2699.2008.01993.x; Warren DL, 2014, TRENDS ECOL EVOL, V29, P572, DOI 10.1016/j.tree.2014.08.003; Weber LC, 2014, J BIOGEOGR, V41, P222, DOI 10.1111/jbi.12219	85	36	37	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0126274	10.1371/journal.pone.0126274	http://dx.doi.org/10.1371/journal.pone.0126274			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020936	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000355187300020
J	Skeie, JM; Roybal, CN; Mahajan, VB				Skeie, Jessica M.; Roybal, C. Nathaniel; Mahajan, Vinit B.			Proteomic Insight into the Molecular Function of the Vitreous	PLOS ONE			English	Article							PROLIFERATIVE DIABETIC-RETINOPATHY; VITRECTOMY; EXPRESSION; UVEITIS; KINASE; INFLAMMATION; MEMBRANE; PROTEINS; MUTATION; PEPTIDE	The human vitreous contains primarily water, but also contains proteins which have yet to be fully characterized. To gain insight into the four vitreous substructures and their potential functions, we isolated and analyzed the vitreous protein profiles of three non-diseased human eyes. The four analyzed substructures were the anterior hyaloid, the vitreous cortex, the vitreous core, and the vitreous base. Proteins were separated by multidimensional liquid chromatography and identified by tandem mass spectrometry. Bioinformatics tools then extracted the expression profiles, signaling pathways, and interactomes unique to each tissue. From each substructure, a mean of 2,062 unique proteins were identified, with many being differentially expressed in a specific substructure: 278 proteins were unique to the anterior hyaloid, 322 to the vitreous cortex, 128 to the vitreous base, and 136 to the vitreous core. When the identified proteins were organized according to relevant functional pathways and networks, key patterns appeared. The blood coagulation pathway and extracellular matrix turnover networks were highly represented. Oxidative stress regulation and energy metabolism proteins were distributed throughout the vitreous. Immune functions were represented by high levels of immunoglobulin, the complement pathway, damage-associated molecular patterns (DAMPs), and evolutionarily conserved antimicrobial proteins. The majority of vitreous proteins detected were intracellular proteins, some of which originate from the retina, including rhodopsin (RHO), phosphodiesterase 6 (PDE6), and glial fibrillary acidic protein (GFAP). This comprehensive analysis uncovers a picture of the vitreous as a biologically active tissue, where proteins localize to distinct substructures to protect the intraocular tissues from infection, oxidative stress, and energy disequilibrium. It also reveals the retina as a potential source of inflammatory mediators. The vitreous proteome catalogues the dynamic interactions between the vitreous and surrounding tissues. It therefore could be an indirect and effective method for surveying vitreoretinal disease for specific biomarkers.	[Skeie, Jessica M.; Mahajan, Vinit B.] Univ Iowa, Dept Ophthalmol & Visual Sci, Omics Lab, Iowa City, IA 52242 USA; [Roybal, C. Nathaniel; Mahajan, Vinit B.] Univ Iowa, Dept Ophthalmol & Visual Sci, Iowa City, IA USA	University of Iowa; University of Iowa	Mahajan, VB (corresponding author), Univ Iowa, Dept Ophthalmol & Visual Sci, Omics Lab, Iowa City, IA 52242 USA.	vinit-mahajan@uiowa.edu		Mahajan, Vinit/0000-0003-1886-1741	National Institutes of Health [K08EY020530]; Doris Duke Charitable Foundation [2013103]; NATIONAL EYE INSTITUTE [R01EY024665, K08EY020530] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding sources are National Institutes of Health (K08EY020530), The Doris Duke Charitable Foundation (2013103) and Research to Prevent Blindness. The funders had no role in study design, data collection, decision to publish or preparation of the manuscript.	Aliyar HA, 2004, POLYM PREP, V45, P469; Angi M, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/148039; Beavis Ronald C., 2006, V328, P217; Becker M, 2005, AM J OPHTHALMOL, V140, P1096, DOI 10.1016/j.ajo.2005.07.017; Benoit YD, 2014, CLIN CANCER RES, V20, P5372, DOI 10.1158/1078-0432.CCR-13-2491; Bishop PN, 2000, PROG RETIN EYE RES, V19, P323, DOI 10.1016/S1350-9462(99)00016-6; Bjornson RD, 2008, J PROTEOME RES, V7, P293, DOI 10.1021/pr0701198; Boohaker Rebecca J, 2014, Biomed J, V37, P3, DOI 10.4103/2319-4170.125655; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Colombo E, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00063; Craig R, 2006, J PROTEOME RES, V5, P1843, DOI 10.1021/pr0602085; Ekins S, 2007, METH MOL B, V356, P319; Eklund L, 2013, EXP CELL RES, V319, P1271, DOI 10.1016/j.yexcr.2013.03.011; Funaki H, 2001, INVEST OPHTH VIS SCI, V42, P1193; Gao BB, 2008, J PROTEOME RES, V7, P2516, DOI 10.1021/pr800112g; Gao BB, 2007, NAT MED, V13, P181, DOI 10.1038/nm1534; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Grus FH, 2007, PROTEOM CLIN APPL, V1, P876, DOI 10.1002/prca.200700105; Halfter W, 2008, EYE, V22, P1207, DOI 10.1038/eye.2008.19; Hauck SM, 2012, J PROTEOMICS, V75, P4545, DOI 10.1016/j.jprot.2012.04.052; Holekamp NM, 2010, AM J OPHTHALMOL, V149, P32, DOI 10.1016/j.ajo.2009.07.036; Hong SK, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/526341; Huang J, 2015, AGEING RES REV, V24, P3, DOI 10.1016/j.arr.2014.10.004; Kang GY, 2014, J PROTEOME RES, V13, P581, DOI 10.1021/pr400751k; Kim T, 2007, PROTEOMICS, V7, P4203, DOI 10.1002/pmic.200700745; Koss MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096895; Li Y, 2010, RAPID COMMUN MASS SP, V24, P807, DOI 10.1002/rcm.4448; MacLean B, 2006, BIOINFORMATICS, V22, P2830, DOI 10.1093/bioinformatics/btl379; Mahajan VB, 2000, P NATL ACAD SCI USA, V97, P12062, DOI 10.1073/pnas.97.22.12062; Mahajan VB, 2014, PROTEOM CLIN APPL, V8, P204, DOI 10.1002/prca.201300062; Mahajan VB, 2010, AM J MED GENET A, V152A, P2875, DOI 10.1002/ajmg.a.33621; McCubrey JA, 2014, ONCOTARGET, V5, P2881, DOI 10.18632/oncotarget.2037; Moller B, 2001, MOL HUM REPROD, V7, P65, DOI 10.1093/molehr/7.1.65; Montenarh M, 2010, CELL TISSUE RES, V342, P139, DOI 10.1007/s00441-010-1068-3; Murakami Y, 2014, CELL DEATH DIFFER, V21, P270, DOI 10.1038/cdd.2013.109; Murthy KR, 2014, CLIN PROTEOM, V11, DOI 10.1186/1559-0275-11-29; Nace G, 2012, J INNATE IMMUN, V4, P6, DOI 10.1159/000334245; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; Oliveros J.C., 2007, VENNY INTERACTIVE TO; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Simo-Servat O, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/872978; Sivak JM, 2002, PROG RETIN EYE RES, V21, P1, DOI 10.1016/S1350-9462(01)00015-5; Skeie JM, 2014, JAMA OPHTHALMOL, V132, P1271, DOI 10.1001/jamaophthalmol.2014.2065; Skeie JM, 2014, PROTEOM CLIN APPL, V8, P209, DOI 10.1002/prca.201300043; Skeie JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082140; Skeie JM, 2011, MOL VIS, V17, P576; Skeie JM, 2011, JOVE-J VIS EXP, DOI 10.3791/2455; Smith SK, 1995, HUM REPROD UPDATE, V1, P162, DOI 10.1093/humupd/1.2.162; Soheilian M, 2013, OCUL IMMUNOL INFLAMM, V21, P93, DOI 10.3109/09273948.2012.734536; Verbraeken H, 1996, GRAEF ARCH CLIN EXP, V234, P288, DOI 10.1007/BF00220702; Kamei RRW, 2012, ARQ BRAS OFTALMOL, V75, P107, DOI 10.1590/S0004-27492012000200007; Walia S, 2010, SEMIN OPHTHALMOL, V25, P289, DOI 10.3109/08820538.2010.518912; Wang H, 2013, EXP EYE RES, V108, P110, DOI 10.1016/j.exer.2012.11.023; Wilkins HM, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00311; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Yin J, 2014, AMYLOID, V21, P140, DOI 10.3109/13506129.2014.892871; Yokoi T, 2009, GRAEF ARCH CLIN EXP, V247, P715, DOI 10.1007/s00417-008-1016-z	57	56	56	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0127567	10.1371/journal.pone.0127567	http://dx.doi.org/10.1371/journal.pone.0127567			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020955	Green Published, gold, Green Submitted			2022-12-26	WOS:000355187300045
J	Stamler, RA; Holguin, O; Dungan, B; Schaub, T; Sanogo, S; Goldberg, N; Randall, JJ				Stamler, Rio A.; Holguin, Omar; Dungan, Barry; Schaub, Tanner; Sanogo, Soumaila; Goldberg, Natalie; Randall, Jennifer J.			BABA and Phytophthora nicotianae Induce Resistance to Phytophthora capsici in Chile Pepper (Capsicum annuum)	PLOS ONE			English	Article							ACID-INDUCED RESISTANCE; CELL-WALL INVERTASE; ARABIDOPSIS; GLYCEROL-3-PHOSPHATE; ACCUMULATION; INHIBITION; INFECTION; PATHOGENS; BLIGHT; LEAVES	Induced resistance in plants is a systemic response to certain microorganisms or chemicals that enhances basal defense responses during subsequent plant infection by pathogens. Inoculation of chile pepper with zoospores of non-host Phytophthora nicotianae or the chemical elicitor beta-aminobutyric acid (BABA) significantly inhibited foliar blight caused by Phytophthora capsici. Tissue extract analyses by GC/MS identified conserved change in certain metabolite concentrations following P. nicotianae or BABA treatment. Induced chile pepper plants had reduced concentrations of sucrose and TCA cycle intermediates and increased concentrations of specific hexose-phosphates, hexose-disaccharides and amino acids. Galactose, which increased significantly in induced chile pepper plants, was shown to inhibit growth of P. capsici in a plate assay.	[Stamler, Rio A.; Sanogo, Soumaila; Randall, Jennifer J.] New Mexico State Univ, Dept Entomol Plant Pathol & Weed Sci, Las Cruces, NM 88003 USA; [Holguin, Omar] New Mexico State Univ, Dept Plant & Environm Sci, Las Cruces, NM 88003 USA; [Goldberg, Natalie] New Mexico State Univ, Dept Extens Plant Sci, Las Cruces, NM 88003 USA; [Dungan, Barry; Schaub, Tanner] New Mexico State Univ, Chem Anal & Instrumentat Lab, Las Cruces, NM 88003 USA	New Mexico State University; New Mexico State University; New Mexico State University; New Mexico State University	Randall, JJ (corresponding author), New Mexico State Univ, Dept Entomol Plant Pathol & Weed Sci, Las Cruces, NM 88003 USA.	jrandall@nmsu.edu		Schaub, Tanner/0000-0002-5747-4237	New Mexico Chile Association	New Mexico Chile Association	This work was partially funded through the New Mexico Chile Association. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Andres JL, 2003, J PLANT PATHOL, V85, P91; Andres JL, 2014, SPAN J AGRIC RES, V4, P248; Broeckling CD, 2005, J EXP BOT, V56, P323, DOI 10.1093/jxb/eri058; Chanda B, 2008, PLANT PHYSIOL, V147, P2017, DOI 10.1104/pp.108.121335; Chanda B, 2011, NAT GENET, V43, P421, DOI 10.1038/ng.798; de Jongh WA, 2008, BIOTECHNOL BIOENG, V101, P317, DOI 10.1002/bit.21890; Diaz J, 2005, PLANT PATHOL, V54, P773, DOI 10.1111/j.1365-3059.2005.01285.x; Essmann J, 2008, PLANT PHYSIOL, V147, P1288, DOI 10.1104/pp.108.121418; Evers D, 2006, BIOL PLANTARUM, V50, P265, DOI 10.1007/s10535-006-0017-1; Fotopoulos V, 2003, PLANT PHYSIOL, V132, P821, DOI 10.1104/pp.103.021428; French JM, 2011, PLANT DIS, V95, P1028, DOI 10.1094/PDIS-01-11-0048; Garg AK, 2002, P NATL ACAD SCI USA, V99, P15898, DOI 10.1073/pnas.252637799; Jakab G, 2001, EUR J PLANT PATHOL, V107, P29, DOI 10.1023/A:1008730721037; Lamour KH, 2012, MOL PLANT MICROBE IN, V25, P1350, DOI 10.1094/MPMI-02-12-0028-R; Lee SC, 2005, PLANTA, V221, P790, DOI 10.1007/s00425-005-1488-6; Lunn JE, 2006, BIOCHEM J, V397, P139, DOI 10.1042/BJ20060083; MARCAN H, 1979, PHYSIOL PLANT PATHOL, V14, P1, DOI 10.1016/0048-4059(79)90018-3; Martins MCM, 2013, PLANT PHYSIOL, V163, P1142, DOI 10.1104/pp.113.226787; Monroy-Barbosa A, 2010, HORTSCIENCE, V45, P1563, DOI 10.21273/HORTSCI.45.10.1563; Pastor V, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00295; Qutob D, 2002, PLANT J, V32, P361, DOI 10.1046/j.1365-313X.2002.01439.x; Sanogo S, 2012, CAN J PLANT PATHOL, V34, P479, DOI 10.1080/07060661.2012.732117; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; Ton J, 2004, PLANT J, V38, P119, DOI 10.1111/j.1365-313X.2004.02028.x; Voll LM, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00039; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Xie JH, 1999, AGR WATER MANAGE, V42, P127, DOI 10.1016/S0378-3774(99)00038-4; Zhang YH, 2009, PLANT PHYSIOL, V149, P1860, DOI 10.1104/pp.108.133934	28	7	7	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128327	10.1371/journal.pone.0128327	http://dx.doi.org/10.1371/journal.pone.0128327			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020237	Green Published, gold, Green Submitted			2022-12-26	WOS:000355187300100
J	Parag, T; Chakraborty, A; Plaza, S; Scheffer, L				Parag, Toufiq; Chakraborty, Anirban; Plaza, Stephen; Scheffer, Louis			A Context-Aware Delayed Agglomeration Framework for Electron Microscopy Segmentation	PLOS ONE			English	Article								Electron Microscopy (EM) image (or volume) segmentation has become significantly important in recent years as an instrument for connectomics. This paper proposes a novel agglomerative framework for EM segmentation. In particular, given an over-segmented image or volume, we propose a novel framework for accurately clustering regions of the same neuron. Unlike existing agglomerative methods, the proposed context-aware algorithm divides superpixels (over-segmented regions) of different biological entities into different subsets and agglomerates them separately. In addition, this paper describes a "delayed" scheme for agglomerative clustering that postpones some of the merge decisions, pertaining to newly formed bodies, in order to generate a more confident boundary prediction. We report significant improvements attained by the proposed approach in segmentation accuracy over existing standard methods on 2D and 3D datasets.	[Parag, Toufiq; Plaza, Stephen; Scheffer, Louis] HHMI, Ashburn, VA USA; [Chakraborty, Anirban] Natl Univ Singapore, Dept Diagnost Radiol, Singapore 117548, Singapore	Howard Hughes Medical Institute; National University of Singapore	Parag, T (corresponding author), HHMI, Ashburn, VA USA.	paragt@janelia.hhmi.org						Andres B, 2008, LECT NOTES COMPUT SC, V5096, P142, DOI 10.1007/978-3-540-69321-5_15; Andres Bjoern, 2012, ECCV; [Anonymous], 2014, ARXIV14091801; Arbelaez P, 2011, IEEE T PATTERN ANAL, V33, P898, DOI 10.1109/TPAMI.2010.161; Beucher S., 1993, MATH MORPHOLOGY IMAG, P433, DOI DOI 10.1201/9781482277234-12; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chklovskii DB, 2010, CURR OPIN NEUROBIOL, V20, P667, DOI 10.1016/j.conb.2010.08.002; Ciresan D, 2012, NIPS, V2012, P2852; Funke J., 2012, CVPR; Helmstaedter M, 2013, NATURE, V500, P168, DOI 10.1038/nature12346; Helmstaedter M, 2013, NAT METHODS, V10, P501, DOI [10.1038/nmeth.2476, 10.1038/NMETH.2476]; Jain V., 2011, ADV NEURAL INFORM PR, P648; Jain V., 2010, CVPR; Jurrus E, 2010, MED IMAGE ANAL, V14, P770, DOI 10.1016/j.media.2010.06.002; Krahenbuhl P., 2011, ADV NEURAL INFORM PR, P109; Ladicky L, 2009, IEEE I CONF COMP VIS, P739, DOI 10.1109/ICCV.2009.5459248; Liu T., 2012, ICPR; Liu T, 2014, J NEUROSCI METH, V226, P88, DOI 10.1016/j.jneumeth.2014.01.022; Lucchi A, 2012, IEEE T MED IMAGING, V31, P474, DOI 10.1109/TMI.2011.2171705; Meila M, 2003, LECT NOTES ARTIF INT, V2777, P173, DOI 10.1007/978-3-540-45167-9_14; Nunez-Iglesias J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071715; Parag T., 2014, MICCAI; Sommer C., 2011, ISBI; Takemura S, 2013, NATURE, V500, P175, DOI 10.1038/nature12450; Uzunbas M., 2014, MICCAI; Vazquez-Reina A., 2011, ICCV	26	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0125825	10.1371/journal.pone.0125825	http://dx.doi.org/10.1371/journal.pone.0125825			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018659	gold, Green Published, Green Submitted			2022-12-26	WOS:000355185600035
J	Rabna, P; Ramos, J; Ponce, G; Sanca, L; Mane, M; Armada, A; Machado, D; Vieira, F; Gomes, VF; Martins, E; Colombatti, R; Riccardi, F; Perdigao, J; Sotero, J; Portugal, I; Couto, I; Atouguia, J; Rodrigues, A; Viveiros, M				Rabna, Paulo; Ramos, Jorge; Ponce, Gema; Sanca, Lilica; Mane, Morto; Armada, Ana; Machado, Diana; Vieira, Fina; Gomes, Victor F.; Martins, Elisabete; Colombatti, Raffaella; Riccardi, Fabio; Perdigao, Joao; Sotero, Joana; Portugal, Isabel; Couto, Isabel; Atouguia, Jorge; Rodrigues, Amabelia; Viveiros, Miguel			Direct Detection by the Xpert MTB/RIF Assay and Characterization of Multi and Poly Drug-Resistant Tuberculosis in Guinea-Bissau, West Africa	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; RAPID IDENTIFICATION; MIRU-VNTRPLUS; COMPLEX; DATABASE; IMPACT	Background This study aimed to evaluate the usefulness of the Xpert MTB/RIF assay for the rapid direct detection of M. tuberculosis complex (MTBC) strains and rifampicin resistance associated mutations in a resource-limited setting such as Guinea-Bissau and its implications in the management of tuberculosis (TB) and drug resistant tuberculosis, complementing the scarce information on resistance and genotypic diversity of MTBC strains in this West African country. Methods and Results This cross-sectional prospective study included 100 consecutive TB patients with positive acid-fast smears at two months of anti-tuberculosis treatment or in a re-treatment situation, between May and December 2012. Resistance to rifampicin was detected using the Gen-eXpert system and the Xpert MTB/RIF assay. MTBC isolates obtained with the BACTEC MGIT 960 system were tested for susceptibility to first- and second-line anti-tuberculosis drugs. Overall, the prevalence of multidrug-resistant tuberculosis (MDR-TB) was found to be 9 cases. Of these, 67% (6 patients) of confirmed MDR-TB cases had no past history of TB treatment and 33% (3 patients) were previously treated cases. Extensively drug-resistant TB was not found. Molecular typing of the MDR-TB strains revealed recent transmission patterns of imported MDR strains. Conclusions The Xpert MTB/RIF assay was reliable for the detection of rifampicin resistant MTBC strains directly from sputum samples of patients undergoing first-line treatment for two months, being more trustworthy than the simple presence of acid-fast bacilli in the smear. Its implementation is technically simple, does not require specialized laboratory infrastructures and is suitable for resource-limited settings when a regular source of electricity and maintenance is available as well as financial and operation sustainability is guaranteed by the health authorities. A high prevalence of MDR-TB among patients at risk of MDR-TB after two months of first-line treatment was found, in support of the WHO recommendations for its use in the management of this risk group.	[Rabna, Paulo; Sanca, Lilica; Mane, Morto; Rodrigues, Amabelia] Inst Nacl Saude Publ Projecto Saude Bandim INASA, Bissau, Guinea Bissau; [Ramos, Jorge; Armada, Ana; Machado, Diana; Couto, Isabel; Viveiros, Miguel] Univ Nova Lisboa, Inst Higiene & Med Trop, Unidade Microbiol Med, Grp Micobacterias,GHTM,IHMT,UNL, P-1200 Lisbon, Portugal; [Ponce, Gema; Atouguia, Jorge] Univ Nova Lisboa, Unidade Clin Trop, Inst Higiene & Med Trop Lisboa, IHMT,UNL, P-1200 Lisbon, Portugal; [Armada, Ana; Atouguia, Jorge; Viveiros, Miguel] Univ Nova Lisboa, Ctr Malaria & Outras Doencas Tropicais CMDT, Inst Higiene & Med Trop Lisboa, IHMT,UNL, P-1200 Lisbon, Portugal; [Vieira, Fina; Martins, Elisabete] Hosp Raoul Follereau, Bissau, Guinea Bissau; [Gomes, Victor F.] Minist Saude, Programa Nacl Luta Tuberculose, Bissau, Guinea Bissau; [Colombatti, Raffaella; Riccardi, Fabio] Aid Hlth & Dev Onlus Ahead Onlus, Rome, Italy; [Perdigao, Joao; Sotero, Joana; Portugal, Isabel] Univ Lisbon, Fac Farm, URIA, Ctr Patogenese Mol, P-1699 Lisbon, Portugal	Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Universidade de Lisboa	Viveiros, M (corresponding author), Univ Nova Lisboa, Inst Higiene & Med Trop, Unidade Microbiol Med, Grp Micobacterias,GHTM,IHMT,UNL, P-1200 Lisbon, Portugal.	mviveiros@ihmt.unl.pt	Machado, Diana/L-7027-2013; Armada, Ana/I-2113-2012; Viveiros, Miguel/A-7326-2008; Couto, Isabel/I-2640-2012; Portugal, Isabel/B-1491-2008; Perdigão, João/L-6893-2013; iMed.ULisboa, M2B/B-5277-2014; Colombatti, Raffaella/D-2910-2017; Atouguia, Jorge M/J-2877-2012	Machado, Diana/0000-0003-2375-2726; Armada, Ana/0000-0001-5066-9982; Viveiros, Miguel/0000-0001-9676-6251; Couto, Isabel/0000-0003-3536-2733; Portugal, Isabel/0000-0002-7843-0006; Perdigão, João/0000-0002-0339-1305; iMed.ULisboa, M2B/0000-0002-1245-3715; Colombatti, Raffaella/0000-0001-9797-0457; Atouguia, Jorge/0000-0001-9854-0854; RICCARDI, Fabio/0000-0003-4523-3556; Sanca, Lilica Hulile/0000-0002-1787-2396; Ramos, Jorge/0000-0001-6419-5351	Fundacao para a Ciencia e a Tecnologia (FCT, Portugal) through Global Program for Science of UNESCO [SFRH/BPD/5148/2011]; Gulbenkian Foundation; FCT, Portugal [SFRH/BD/65060/2009, PTDC/SAU-EPI/122400/2010, SFRH/BPD/95406/2013]	Fundacao para a Ciencia e a Tecnologia (FCT, Portugal) through Global Program for Science of UNESCO; Gulbenkian Foundation; FCT, Portugal(Portuguese Foundation for Science and Technology)	The Pos-Doc study project of Paulo Rabna was funded by Fundacao para a Ciencia e a Tecnologia (FCT, Portugal) through a grant of the Global Program for Science of UNESCO (SFRH/BPD/5148/2011). Gulbenkian Foundation is acknowledged for a clinical research grant to Gema Ponce. Diana Machado was supported by grant SFRH/BD/65060/2009 from FCT, Portugal. Joao Perdigao was supported by post-doctoral fellowships from Project PTDC/SAU-EPI/122400/2010 and SFRH/BPD/95406/2013 from FCT, Portugal. The funding Institutions had no role in study design, data collection, analysis, interpretation, preparation of the manuscript, or decision to publish.	Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P2692, DOI 10.1128/JCM.00540-08; [Anonymous], 2012, GLOBAL TUBERCULOSIS, P1; Atun RA, 2005, INT J STD AIDS, V16, P560, DOI 10.1258/0956462054679124; Blakemore R, 2010, J CLIN MICROBIOL, V48, P2495, DOI 10.1128/JCM.00128-10; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Drobniewski FA, 2008, EUR RESPIR J, V26, P298; Groenheit R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018601; International Air Transport Association, 2006, INF SUBST SHIPP GUID; Kallenius G, 1999, J CLIN MICROBIOL, V37, P3872; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kent PT, 1985, MYCOBACTERIOLOGY GUI; Machado D, 2013, J ANTIMICROB CHEMOTH, V68, P1728, DOI 10.1093/jac/dkt090; McNerney R, 2015, CURR OPIN PULM MED, V21, P304, DOI 10.1097/MCP.0000000000000161; Ministerio da Saude da Republica da Guine-Bissau, 2009, PROGR NAC LUT TUB RE; Ministerio da Saude da Republica da Guine-Bissau, 2013, MAN GEST PROGR NAC L; Olaru ID, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106075; Imperiale BR, 2014, J ANTIBIOT, V67, P749, DOI 10.1038/ja.2014.61; SHRIVER MD, 1995, MOL BIOL EVOL, V12, P914; Siddiqi S, 2006, MGIT960 PROCEDURE MA; Steingart KR, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009593.pub2, 10.1002/14651858.CD009593.pub3]; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Vieira F, 2014, MEDITERR J HEMATOL I, V6, DOI 10.4084/MJHID.2014.049; Viveiros M, 2005, J CLIN MICROBIOL, V43, P4880, DOI 10.1128/JCM.43.9.4880-4884.2005; Viveiros M, 2010, EXPERT REV ANTI-INFE, V8, P465, DOI [10.1586/eri.10.20, 10.1586/ERI.10.20]; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351; WHO, 2011, AUT REAL TIM NUCL AC; World Health Organization, 2011, WHOHTMTB20116; World Health Organization, 2014, XPERT MTB RIF IMPL M; World Health Organization, 2014, WHOHTMTB201408; World Health Organization, 2008, WHOHTHTB2008; World Health Organization, 2013, WHOHTMTB201311; World Health Organization & Stop TB Partnership, 2010, WHOHTMSTB20102; World Health Organization (WHO), 2009, WHOHTMTB2009420	33	15	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0127536	10.1371/journal.pone.0127536	http://dx.doi.org/10.1371/journal.pone.0127536			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26017968	Green Published, gold			2022-12-26	WOS:000355185600088
J	Uitdehaag, JCM; de Roos, JADM; van Doornmalen, AM; Prinsen, MBW; Spijkers-Hagelstein, JAP; de Vetter, JRF; de Man, J; Buijsman, RC; Zaman, GJR				Uitdehaag, Joost C. M.; de Roos, Jeroen A. D. M.; van Doornmalen, Antoon M.; Prinsen, Martine B. W.; Spijkers-Hagelstein, Jill A. P.; de Vetter, Judith R. F.; de Man, Jos; Buijsman, Rogier C.; Zaman, Guido J. R.			Selective Targeting of CTNBB1-, KRAS-or MYC-Driven Cell Growth by Combinations of Existing Drugs	PLOS ONE			English	Article							SYNTHETIC LETHAL INTERACTION; KINASE INHIBITOR; BETA-CATENIN; COLON-CANCER; TYROSINE KINASE; MEK INHIBITION; BRAF; EGFR; RESISTANCE; MELANOMA	The aim of combination drug treatment in cancer therapy is to improve response rate and to decrease the probability of the development of drug resistance. Preferably, drug combinations are synergistic rather than additive, and, ideally, drug combinations work synergistically only in cancer cells and not in non-malignant cells. We have developed a workflow to identify such targeted synergies, and applied this approach to selectively inhibit the proliferation of cell lines with mutations in genes that are difficult to modulate with small molecules. The approach is based on curve shift analysis, which we demonstrate is a more robust method of determining synergy than combination matrix screening with Bliss-scoring. We show that the MEK inhibitor trametinib is more synergistic in combination with the BRAF inhibitor dabrafenib than with vemurafenib, another BRAF inhibitor. In addition, we show that the combination of MEK and BRAF inhibitors is synergistic in BRAF-mutant melanoma cells, and additive or antagonistic in, respectively, BRAF-wild type melanoma cells and nonmalignant fibroblasts. This combination exemplifies that synergistic action of drugs can depend on cancer genotype. Next, we used curve shift analysis to identify new drug combinations that specifically inhibit cancer cell proliferation driven by difficult-to-drug cancer genes. Combination studies were performed with compounds that as single agents showed preference for inhibition of cancer cells with mutations in either the CTNNB1 gene (coding for beta-catenin), KRAS, or cancer cells expressing increased copy numbers of MYC. We demonstrate that the Wnt-pathway inhibitor ICG-001 and trametinib acted synergistically in Wnt-pathway-mutant cell lines. The ERBB2 inhibitor TAK-165 was synergistic with trametinib in KRAS-mutant cell lines. The EGFR/ERBB2 inhibitor neratinib acted synergistically with the spindle poison docetaxel and with the Aurora kinase inhibitor GSK-1070916 in cell lines with MYC amplification. Our approach can therefore efficiently discover novel drug combinations that selectively target cancer genes.	[Uitdehaag, Joost C. M.; de Roos, Jeroen A. D. M.; van Doornmalen, Antoon M.; Prinsen, Martine B. W.; Spijkers-Hagelstein, Jill A. P.; de Vetter, Judith R. F.; de Man, Jos; Buijsman, Rogier C.; Zaman, Guido J. R.] Netherlands Translat Res Ctr BV, Oss, Netherlands		Zaman, GJR (corresponding author), Netherlands Translat Res Ctr BV, Oss, Netherlands.	guido.zaman@ntrc.nl			Innovation Office of the Ministry of Economic Affairs of the Netherlands [INT 111039]; Netherlands Translational Research Center B. V.	Innovation Office of the Ministry of Economic Affairs of the Netherlands; Netherlands Translational Research Center B. V.	This research was supported by a grant from the Innovation Office of the Ministry of Economic Affairs of the Netherlands (INT 111039). Netherlands Translational Research Center B. V. provided support in the form of salaries for authors JCNU, JADMR, AMVD, MBWP, JAPSH, JDM, RCB and GJRZ, but did not have any additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adams ND, 2010, J MED CHEM, V53, P3973, DOI 10.1021/jm901870q; Addepalli MK, 2010, GENE THER, V17, P352, DOI 10.1038/gt.2009.155; Al-Lazikani B, 2012, NAT BIOTECHNOL, V30, P679, DOI 10.1038/nbt.2284; Astsaturov I, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001083; Babij C, 2011, CANCER RES, V71, P5818, DOI 10.1158/0008-5472.CAN-11-0778; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; Borisy AA, 2003, P NATL ACAD SCI USA, V100, P7977, DOI 10.1073/pnas.1337088100; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chan DA, 2011, NAT REV DRUG DISCOV, V10, P351, DOI 10.1038/nrd3374; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Chow LWC, 2013, BRIT J CANCER, V108, P1985, DOI 10.1038/bjc.2013.178; Cokol M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.71; Corcoran RB, 2012, CANCER DISCOV, V2, P227, DOI 10.1158/2159-8290.CD-11-0341; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; den Hollander J, 2010, BLOOD, V116, P1498, DOI 10.1182/blood-2009-11-251074; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Emami KH, 2004, P NATL ACAD SCI USA, V101, P12682, DOI 10.1073/pnas.0404875101; Evan G, 2012, SCIENCE, V335, P293, DOI 10.1126/science.1217819; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Gosens R, 2010, FASEB J, V24, P757, DOI 10.1096/fj.09-136325; Griner LAM, 2014, P NATL ACAD SCI USA, V111, P2349, DOI 10.1073/pnas.1311846111; Haagensen EJ, 2012, BRIT J CANCER, V106, P1386, DOI 10.1038/bjc.2012.70; Hauschild A, 2012, LANCET, V380, P358, DOI 10.1016/S0140-6736(12)60868-X; Hoellein A, 2011, ONCOTARGET, V2, P599; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Hung LY, 2008, NUCLEIC ACIDS RES, V36, P4337, DOI 10.1093/nar/gkn417; Hynes NE, 2001, J MAMMARY GLAND BIOL, V6, P141, DOI 10.1023/A:1009528918064; Kim SY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008979; King AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067583; Li FF, 2014, INT J CANCER, V134, P1257, DOI 10.1002/ijc.28261; Liu DX, 2008, THYROID, V18, P853, DOI 10.1089/thy.2007.0357; Loewe S, 1926, N-S ARCH EX PATH PH, V114, P313; McLornan DP, 2014, NEW ENGL J MED, V371, P1725, DOI 10.1056/NEJMra1407390; Mitsui F, 2007, MODERN PATHOL, V20, P622, DOI 10.1038/modpathol.3800777; Nagasawa J, 2006, INT J UROL, V13, P587, DOI 10.1111/j.1442-2042.2006.01342.x; Naik S, 2009, CLIN CANCER RES, V15, P7529, DOI 10.1158/1078-0432.CCR-09-0336; Nair R, 2014, ONCOGENE, V33, P3992, DOI 10.1038/onc.2013.368; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; R Core Team, 2018, R LANG ENV STAT COMP; Rabindran SK, 2004, CANCER RES, V64, P3958, DOI 10.1158/0008-5472.CAN-03-2868; Scholl C, 2009, CELL, V137, P821, DOI 10.1016/j.cell.2009.03.017; Shimizu T, 2012, CLIN CANCER RES, V18, P2316, DOI 10.1158/1078-0432.CCR-11-2381; Singh A, 2009, CELL CYCLE, V8, P2676, DOI 10.4161/cc.8.17.9336; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Sos ML, 2009, P NATL ACAD SCI USA, V106, P18351, DOI 10.1073/pnas.0907325106; Straetemans R, 2005, BIOMETRICAL J, V47, P299, DOI 10.1002/bimj.200410124; Sun C, 2014, CELL REP, V7, P86, DOI 10.1016/j.celrep.2014.02.045; Toyoshima M, 2012, P NATL ACAD SCI USA, V109, P9545, DOI 10.1073/pnas.1121119109; Uitdehaag JCM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092146; Uitdehaag JCM, 2012, BRIT J PHARMACOL, V166, P858, DOI 10.1111/j.1476-5381.2012.01859.x; Uitdehaag JCM, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-94; Vasan N, 2014, CLIN CANCER RES, V20, P3921, DOI 10.1158/1078-0432.CCR-13-1762; Violette S, 2002, INT J CANCER, V98, P498, DOI 10.1002/ijc.10146; Yang D, 2010, P NATL ACAD SCI USA, V107, P13836, DOI 10.1073/pnas.1008366107; Yap TA, 2013, J CLIN ONCOL, V31, P1592, DOI 10.1200/JCO.2011.37.6418; Zhao L, 2004, CLIN CANCER RES, V10, P7994, DOI 10.1158/1078-0432.CCR-04-1087	61	14	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0125021	10.1371/journal.pone.0125021	http://dx.doi.org/10.1371/journal.pone.0125021			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018524	Green Published, gold, Green Submitted			2022-12-26	WOS:000355185600011
J	Pan, HH; Zhao, XY; Zhang, XW; Abouelsoud, M; Sun, JL; April, C; Amleh, A; Fan, JB; Hu, YF; Li, R				Pan, Haihui; Zhao, Xiayan; Zhang, Xiaowen; Abouelsoud, Mohamed; Sun, Jianlong; April, Craig; Amleh, Asma; Fan, Jian-Bing; Hu, Yanfen; Li, Rong			Translational Initiation at a Non-AUG Start Codon for Human and Mouse Negative Elongation Factor-B	PLOS ONE			English	Article							RNA-POLYMERASE-II; TRANSCRIPTION ELONGATION; P-TEFB; EUKARYOTIC RIBOSOMES; ACTIVE PROMOTERS; MAMMALIAN-CELLS; POL-II; NELF; DROSOPHILA; COMPLEX	Negative elongation factor (NELF), a four-subunit protein complex in metazoan, plays an important role in regulating promoter-proximal pausing of RNA polymerase II (RNAPII). Genetic studies demonstrate that the B subunit of mouse NELF (NELF-B) is critical for embryonic development and homeostasis in adult tissue. We report here that both human and mouse NELF-B proteins are translated from a non-AUG codon upstream of the annotated AUG. This non-AUG codon sequence is conserved in mammalian NELF-B but not NELF-B orthologs of lower metazoan. The full-length and a truncated NELF-B that starts at the first AUG codon both interact with the other three NELF subunits. Furthermore, these two forms of NELF-B have a similar impact on the transcriptomics and proliferation of mouse embryonic fibroblasts. These results strongly suggest that additional amino acid sequence upstream of the annotated AUG is dispensable for the essential NELF function in supporting cell growth in vitro. The majority of mouse adult tissues surveyed express the full-length NELF-B protein, and some contain a truncated NELF-B protein with the same apparent size as the AUG-initiated version. This result raises the distinct possibility that translational initiation of mouse NELF-B is regulated in a tissue-dependent manner.	[Pan, Haihui; Zhao, Xiayan; Zhang, Xiaowen; Sun, Jianlong; Hu, Yanfen; Li, Rong] Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, San Antonio, TX 78229 USA; [Abouelsoud, Mohamed; Amleh, Asma] Amer Univ Cairo, Sch Sci & Engn, Dept Biol, New Cairo 11835, Egypt; [April, Craig; Fan, Jian-Bing] Illumina Inc, San Diego, CA 92121 USA	University of Texas System; University of Texas Health San Antonio; Egyptian Knowledge Bank (EKB); American University Cairo; Illumina	Li, R (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, San Antonio, TX 78229 USA.	lir3@uthscsa.edu			National Institutes of Health [NIH CA170306, CA161349, CA191837]; Cancer Therapy and Research Center at University of Texas Health Science Center at San Antonio [P30CA054174]; DoD Breast Cancer Research Predoctoral Fellowship; Al Alfi Foundation Biotechnology Fellowship Program at the American University at Cairo; NATIONAL CANCER INSTITUTE [P30CA054174, R21CA191837, R01CA161349] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Therapy and Research Center at University of Texas Health Science Center at San Antonio; DoD Breast Cancer Research Predoctoral Fellowship; Al Alfi Foundation Biotechnology Fellowship Program at the American University at Cairo; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported by grants to Y.H. from the National Institutes of Health (NIH CA170306), to R.L. from NIH (CA161349 and CA191837) and Cancer Therapy and Research Center at University of Texas Health Science Center at San Antonio (P30CA054174), to H.P. from the DoD Breast Cancer Research Predoctoral Fellowship, and to M.A. from the Al Alfi Foundation Biotechnology Fellowship Program at the American University at Cairo. The genomic data are available at NIH Gene Expression Omnibus site (GSE62248). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Aiyar SE, 2004, GENE DEV, V18, P2134, DOI 10.1101/gad.1214104; Amleh A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005034; Baugh LR, 2009, SCIENCE, V324, P92, DOI 10.1126/science.1169628; Chen SJ, 2008, J BIOL CHEM, V283, P3173, DOI 10.1074/jbc.M706968200; Cheng B, 2007, J BIOL CHEM, V282, P21901, DOI 10.1074/jbc.M702936200; Gilchrist DA, 2008, GENE DEV, V22, P1921, DOI 10.1101/gad.1643208; Glover-Cutter K, 2008, NAT STRUCT MOL BIOL, V15, P71, DOI 10.1038/nsmb1352; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ivanov IP, 2011, NUCLEIC ACIDS RES, V39, P4220, DOI 10.1093/nar/gkr007; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Kozak M, 2002, GENE, V299, P1, DOI 10.1016/S0378-1119(02)01056-9; KOZAK M, 1990, P NATL ACAD SCI USA, V87, P8301, DOI 10.1073/pnas.87.21.8301; KOZAK M, 1989, MOL CELL BIOL, V9, P5073, DOI 10.1128/MCB.9.11.5073; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Krempler A, 2002, J BIOL CHEM, V277, P43216, DOI 10.1074/jbc.M207662200; Lee CY, 2008, MOL CELL BIOL, V28, P3290, DOI 10.1128/MCB.02224-07; Lee S, 2012, P NATL ACAD SCI USA, V109, pE2424, DOI 10.1073/pnas.1207846109; Lee TI, 2013, CELL, V152, P1237, DOI 10.1016/j.cell.2013.02.014; Levine M, 2011, CELL, V145, P502, DOI 10.1016/j.cell.2011.04.021; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Narita T, 2003, MOL CELL BIOL, V23, P1863, DOI 10.1128/MCB.23.6.1863-1873.2003; Narita T, 2007, MOL CELL, V26, P349, DOI 10.1016/j.molcel.2007.04.011; Pan HH, 2014, CELL REP, V7, P79, DOI 10.1016/j.celrep.2014.02.028; PEABODY DS, 1989, J BIOL CHEM, V264, P5031; Ping YH, 2001, J BIOL CHEM, V276, P12951, DOI 10.1074/jbc.M006130200; PORTIS JL, 1994, J VIROL, V68, P3879, DOI 10.1128/JVI.68.6.3879-3887.1994; Renner DB, 2001, J BIOL CHEM, V276, P42601, DOI 10.1074/jbc.M104967200; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Saunders A, 2013, GENE DEV, V27, P1146, DOI 10.1101/gad.215459.113; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Sun JL, 2008, J CELL BIOCHEM, V103, P1798, DOI 10.1002/jcb.21568; Sun J, 2007, J STEROID BIOCHEM, V107, P131, DOI 10.1016/j.jsbmb.2007.05.031; Sun JL, 2011, J BIOL CHEM, V286, P36248, DOI 10.1074/jbc.M111.269167; Wada T, 2000, MOL CELL, V5, P1067, DOI 10.1016/S1097-2765(00)80272-5; Wada T, 1998, GENE DEV, V12, P343, DOI 10.1101/gad.12.3.343; Wang XL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011498; Williams LH, 2015, MOL CELL IN PRESS; Wu CH, 2005, NUCLEIC ACIDS RES, V33, P1269, DOI 10.1093/nar/gki274; Xu Jianming, 2005, Curr Protoc Mol Biol, VChapter 28, DOI 10.1002/0471142727.mb2801s70; Yamaguchi Y, 2002, MOL CELL BIOL, V22, P2918, DOI 10.1128/MCB.22.9.2918-2927.2002; Yamaguchi Y, 1999, CELL, V97, P41, DOI 10.1016/S0092-8674(00)80713-8; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26	46	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127422	10.1371/journal.pone.0127422	http://dx.doi.org/10.1371/journal.pone.0127422			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010750	Green Submitted, gold, Green Published			2022-12-26	WOS:000355183900090
J	Qin, B; Zhou, JL				Qin, Bo; Zhou, Junlan			Src Family Kinases (SFK) Mediate Angiotensin II-Induced Myosin Light Chain Phosphorylation and Hypertension	PLOS ONE			English	Article							RECEPTOR	Angiotensin (Ang) II is the major bioactive peptide of the renin-angiotensin system (RAS); it contributes to the pathogenesis of hypertension by inducing vascular contraction and adverse remodeling, thus elevated peripheral resistance. Ang II also activates Src family kinases (SFK) in the vascular system, which has been implicated in cell proliferation and migration. However, the role of SFK in Ang II-induced hypertension is largely unknown. In this study, we found that administration of a SFK inhibitor SU6656 markedly lowered the level of systemic BP in Ang II-treated mice, which was associated with an attenuated phosphorylation of the smooth-muscle myosin-light-chain (MLC) in the mesenteric resistant arteries. In the cultured human coronary artery smooth muscle cells (SMCs), pretreatment with SU6656 blocked Ang II-induced MLC phosphorylation and contraction. These results for the first time demonstrate that SFK directly regulate vascular contractile machinery to influence BP. Thus our study provides an additional mechanistic link between Ang II and vasoconstriction via SFK-enhanced MLC phosphorylation in SMCs, and suggests that targeted inhibition of Src may provide a new therapeutic opportunity in the treatment of hypertension.	[Qin, Bo] Northwestern Univ, Weinberg Coll Arts & Sci, Chicago, IL 60611 USA; [Zhou, Junlan] Northwestern Univ, Feinberg Sch Med, Feinberg Cardiovasc Res Inst, Chicago, IL 60611 USA	Northwestern University; Northwestern University; Feinberg School of Medicine	Zhou, JL (corresponding author), Northwestern Univ, Feinberg Sch Med, Feinberg Cardiovasc Res Inst, Chicago, IL 60611 USA.	junlan-zhou@northwestern.edu			American Heart Association [13SDG17120011]	American Heart Association(American Heart Association)	This work was supported by the American Heart Association (Grant# 13SDG17120011 to J.Z.).	Abe K, 2008, HYPERTENS RES, V31, P987, DOI 10.1291/hypres.31.987; Aurelie NDC, 2011, CURR HYPERTENS REP, V13, P122, DOI 10.1007/s11906-011-0187-x; Cheng M, 2015, J MOL CELL CARDIOL, V81, P49, DOI 10.1016/j.yjmcc.2015.01.024; Corey SJ, 2013, BLOOD, V122, P4009, DOI 10.1182/blood-2013-10-533158; Eliceiri BP, 1999, MOL CELL, V4, P915, DOI 10.1016/S1097-2765(00)80221-X; Garrido AM, 2009, MOL CELL ENDOCRINOL, V302, P148, DOI 10.1016/j.mce.2008.11.003; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Higuchi S, 2007, CLIN SCI, V112, P417, DOI 10.1042/CS20060342; Ikebe R, 1999, J BIOL CHEM, V274, P30122, DOI 10.1074/jbc.274.42.30122; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Mugabe BE, 2010, J PHARMACOL EXP THER, V332, P116, DOI 10.1124/jpet.109.157552; Oda Y, 1999, CAN J PHYSIOL PHARM, V77, P606, DOI 10.1139/cjpp-77-8-606; Schiffrin EL, 2000, CIRCULATION, V101, P1653; Sever PS, 2011, EUR HEART J, V32, P2499, DOI 10.1093/eurheartj/ehr177; Tang DD, 2008, J CARDIOVASC PHARM T, V13, P130, DOI 10.1177/1074248407313737; Tatton L, 2003, J BIOL CHEM, V278, P4847, DOI 10.1074/jbc.M209321200; Touyz RM, 2001, J HYPERTENS, V19, P441, DOI 10.1097/00004872-200103000-00012; Walsh MP, 2011, IUBMB LIFE, V63, P987, DOI 10.1002/iub.527; Zhou JL, 2009, CIRCULATION, V120, P1213, DOI 10.1161/CIRCULATIONAHA.109.859207	19	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127891	10.1371/journal.pone.0127891	http://dx.doi.org/10.1371/journal.pone.0127891			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011449	Green Submitted, gold, Green Published			2022-12-26	WOS:000355183900159
J	van der Meer, E; van Oers, K				van der Meer, Esther; van Oers, Kees			Gender and Personality Differences in Response to Social Stressors in Great Tits (Parus major)	PLOS ONE			English	Article							STARLINGS STURNUS-VULGARIS; HORMONAL RESPONSES; IMMUNE FUNCTION; ANNUAL CYCLE; REALIZED HERITABILITY; DOMINANCE HIERARCHIES; EXPLORATORY-BEHAVIOR; COPING STRATEGIES; HANDLING STRESS; MICE	In response to stressors, animals can increase the activity of the hypothalamic-pituitary-adrenocortical axis, resulting in elevated glucocorticoid concentrations. An increase in glucocorticoids results in an increase in heterophils and a decrease in lymphocytes, which ratio (H/L-ratio) is an indicator of stress in birds. The physiological response to a stressor can depend on individual characteristics, like dominance rank, sex and personality. Although the isolated effects of these characteristics on the response to a stressor have been well studied, little is known about the response in relation to a combination of these characteristics. In this study we investigate the relationship between social stress, dominance rank, sex and exploratory behaviour as a validated operational measure of personality in great tits (Parus major). Great tits show consistent individual differences in behaviour and physiology in response to stressors, and exploratory behaviour can be classified as fast or slow exploring. We group-housed four birds, two fast and two slow explorers, of the same sex that were previously singly housed, in an aviary and compared the H/L-ratio, lymphocyte and heterophil count before and after group housing. After experiencing the social context all birds increased their H/L-ratio and heterophil count. Females showed a stronger increase in H/Lratio and heterophil count than males, which seemed to be related to a higher number of agonistic interactions compared to males. Dominance rank and exploration type did not affect the H/L-ratio or heterophil count. Contrary to our expectations, all birds increased their lymphocyte count. However, this increase was slower for fast than for slow explorers. Our study suggests that personality and sex related differences, but not dominance rank, are associated with changes in an individual's physiological response due to a social context.	[van der Meer, Esther; van Oers, Kees] Netherlands Inst Ecol NIOO KNAW, Dept Anim Ecol, Wageningen, Netherlands; [van der Meer, Esther] Cheetah Conservat Project Zimbabwe, Victoria Falls, Zimbabwe	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	van der Meer, E (corresponding author), Netherlands Inst Ecol NIOO KNAW, Dept Anim Ecol, Wageningen, Netherlands.	esther@cheetahzimbabwe.org	van Oers, Kees/B-2562-2009; KNAW, NIOO-KNAW/A-4320-2012	van Oers, Kees/0000-0001-6984-906X; KNAW, NIOO-KNAW/0000-0002-3835-159X				APPLEBY MC, 1983, ANIM BEHAV, V31, P600, DOI 10.1016/S0003-3472(83)80084-0; Azpiroz A, 2008, BRAIN BEHAV IMMUN, V22, P690, DOI 10.1016/j.bbi.2007.10.007; Baugh AT, 2013, GEN COMP ENDOCR, V189, P96, DOI 10.1016/j.ygcen.2013.04.030; Baugh AT, 2012, GEN COMP ENDOCR, V175, P488, DOI 10.1016/j.ygcen.2011.12.012; BENUS RF, 1991, EXPERIENTIA, V47, P1008, DOI 10.1007/BF01923336; BERCOVITCH FB, 1995, PHYSIOL BEHAV, V58, P215, DOI 10.1016/0031-9384(95)00055-N; Bergman TJ, 2005, ANIM BEHAV, V70, P703, DOI 10.1016/j.anbehav.2004.12.017; Bolivar VJ, 2009, NEUROBIOL LEARN MEM, V92, P206, DOI 10.1016/j.nlm.2009.02.002; BURLEY N, 1981, SCIENCE, V211, P721, DOI 10.1126/science.211.4483.721; BURLEY N, 1982, ANIM BEHAV, V30, P444, DOI 10.1016/S0003-3472(82)80055-9; Carere C, 2004, PHYSIOL BEHAV, V82, P905, DOI 10.1016/j.physbeh.2004.07.009; Carere C, 2003, HORM BEHAV, V43, P540, DOI 10.1016/S0018-506X(03)00065-5; Carere C, 2005, ANIM BEHAV, V70, P795, DOI 10.1016/j.anbehav.2005.01.003; Cartledge CA, 2005, COMP BIOCHEM PHYS A, V141, P100, DOI 10.1016/j.cbpb.2005.04.008; Cirule D, 2012, J ORNITHOL, V153, P161, DOI 10.1007/s10336-011-0719-9; Colleter M, 2011, ANIM BEHAV, V81, P1231, DOI 10.1016/j.anbehav.2011.03.011; Creel S, 2001, TRENDS ECOL EVOL, V16, P491, DOI 10.1016/S0169-5347(01)02227-3; Davis AK, 2008, FUNCT ECOL, V22, P760, DOI 10.1111/j.1365-2435.2008.01467.x; Davis AK, 2005, J FIELD ORNITHOL, V76, P334, DOI 10.1648/0273-8570-76.4.334; DAWSON A, 1983, GEN COMP ENDOCR, V51, P303, DOI 10.1016/0016-6480(83)90085-0; de Boer SF, 2003, BEHAV GENET, V33, P485, DOI 10.1023/A:1025766415159; DELAET J, 1984, ORNIS SCAND, V15, P73, DOI 10.2307/3675940; DEUSTER PA, 1989, METABOLISM, V38, P141, DOI 10.1016/0026-0495(89)90253-9; Dhabhar FS, 2012, PSYCHONEUROENDOCRINO, V37, P1345, DOI 10.1016/j.psyneuen.2012.05.008; Dhabhar FS, 1997, BRAIN BEHAV IMMUN, V11, P286, DOI 10.1006/brbi.1997.0508; Dingemanse NJ, 2004, BEHAV ECOL, V15, P1023, DOI 10.1093/beheco/arh115; Drent P.J, 1983, THESIS U GRONINGEN; Drent PJ, 2003, P ROY SOC B-BIOL SCI, V270, P45, DOI 10.1098/rspb.2002.2168; Dugatkin LA, 1997, BEHAV ECOL, V8, P583, DOI 10.1093/beheco/8.6.583; Eeva T, 2005, J AVIAN BIOL, V36, P405, DOI 10.1111/j.0908-8857.2005.03449.x; Everly Jr GS, 2012, CLIN GUIDE TREATMENT, P17; Filby AL, 2010, PHYSIOL BEHAV, V101, P576, DOI 10.1016/j.physbeh.2010.09.004; Fucikova E, 2009, ETHOLOGY, V115, P366, DOI 10.1111/j.1439-0310.2009.01618.x; Fukushiro DF, 2011, PHARMACOL BIOCHEM BE, V100, P180, DOI 10.1016/j.pbb.2011.08.015; Gallo L, 2013, AVIAN DIS, V57, P737, DOI 10.1637/10521-022713-Reg.1; Gesquiere LR, 2011, SCIENCE, V333, P357, DOI 10.1126/science.1207120; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; GROSS WB, 1983, AVIAN DIS, V27, P972, DOI 10.2307/1590198; Hegemann A, 2012, OECOLOGIA, V170, P605, DOI 10.1007/s00442-012-2339-3; HESSING MJC, 1994, PHYSIOL BEHAV, V55, P39, DOI 10.1016/0031-9384(94)90007-8; Ros AFH, 2006, J EXP ZOOL PART A, V305A, P986, DOI 10.1002/jez.a.349; Huntingford FA, 1987, CHAPMAN HALL ANIMAL; Ingolfsdottir HB, 2008, APPL ANIM BEHAV SCI, V114, P485, DOI 10.1016/j.applanim.2008.04.014; Jakubas D, 2011, ANN ZOOL FENN, V48, P243, DOI 10.5735/086.048.0405; Jawale CV, 2014, VACCINE, V32, P1093, DOI 10.1016/j.vaccine.2013.12.053; Jones BC, 1998, PSYCHONEUROENDOCRINO, V23, P505; Krams I, 1998, J AVIAN BIOL, V29, P55, DOI 10.2307/3677341; Krams I, 2013, ETHOLOGY, V119, P397, DOI 10.1111/eth.12075; Krams I, 2011, J ORNITHOL, V152, P889, DOI 10.1007/s10336-011-0672-7; Lange H, 2004, BEHAV ECOL, V15, P549, DOI 10.1093/beheco/arh044; Leussis MP, 2006, NEUROSCI BIOBEHAV R, V30, P1045, DOI 10.1016/j.neubiorev.2006.03.006; Maxwell MH, 1998, WORLD POULTRY SCI J, V54, P155, DOI 10.1079/WPS19980012; Moller AP, 2005, BEHAV ECOL SOCIOBIOL, V58, P534, DOI 10.1007/s00265-005-0962-2; Morales J, 2014, BEHAV ECOL SOCIOBIOL, V68, P1195, DOI 10.1007/s00265-014-1730-y; Muller MN, 2004, BEHAV ECOL SOCIOBIOL, V55, P332, DOI 10.1007/s00265-003-0713-1; Noujaim JC, 2008, POULTRY SCI, V87, P927, DOI 10.3382/ps.2007-00476; OSBORNE B, 1980, J COMP PHYSIOL PSYCH, V94, P536, DOI 10.1037/h0077688; Pap PL, 2010, ARDEA, V98, P105, DOI 10.5253/078.098.0113; Puerta M, 1996, COMP HAEMATOL INT, V6, P102, DOI 10.1007/BF00426050; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Rivier C, 1999, PHARMACOL BIOCHEM BE, V64, P739; Romero LM, 2000, GEN COMP ENDOCR, V119, P52, DOI 10.1006/gcen.2000.7491; Romero LM, 2005, COMP BIOCHEM PHYS A, V140, P73, DOI 10.1016/j.cbpb.2004.11.004; Salomons AR, 2010, BEHAV BRAIN RES, V215, P95, DOI 10.1016/j.bbr.2010.06.035; SCHWABL H, 1988, BEHAVIOUR, V107, P107, DOI 10.1163/156853988X00223; Setchell JM, 2010, HORM BEHAV, V58, P720, DOI 10.1016/j.yhbeh.2010.07.004; SIEGEL HS, 1995, BRIT POULTRY SCI, V36, P3, DOI 10.1080/00071669508417748; Sloman KA, 2000, FISH PHYSIOL BIOCHEM, V22, P11, DOI 10.1023/A:1007837400713; Stefanski V, 2000, PSYCHONEUROENDOCRINO, V25, P389, DOI 10.1016/S0306-4530(99)00066-9; Tamashiro KLK, 2005, FRONT NEUROENDOCRIN, V26, P27, DOI 10.1016/j.yfrne.2005.03.001; TERRY WS, 1979, ANIM LEARN BEHAV, V7, P525, DOI 10.3758/BF03209714; Trainor BC, 2010, HORM BEHAV, V58, P506, DOI 10.1016/j.yhbeh.2010.04.008; van Oers K, 2004, P ROY SOC B-BIOL SCI, V271, P65, DOI 10.1098/rspb.2003.2518; van Oers K, 2011, ANIM BEHAV, V81, P1055, DOI 10.1016/j.anbehav.2011.02.014; Veenema AH, 2003, HORM BEHAV, V43, P197, DOI 10.1016/S0018-506X(02)00013-2; Verbeek MEM, 1996, BEHAVIOUR, V133, P945, DOI 10.1163/156853996X00314; VERBEEK MEM, 1994, ANIM BEHAV, V48, P1113, DOI 10.1006/anbe.1994.1344; Verbeek MEM, 1999, BEHAVIOUR, V136, P23, DOI 10.1163/156853999500659; VOIGT K, 1990, PSYCHONEUROENDOCRINO, V15, P173, DOI 10.1016/0306-4530(90)90028-8; Weiser MJ, 2009, NEUROSCIENCE, V159, P883, DOI 10.1016/j.neuroscience.2008.12.058; Zhuang XX, 2001, P NATL ACAD SCI USA, V98, P1982, DOI 10.1073/pnas.98.4.1982	81	9	9	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127984	10.1371/journal.pone.0127984	http://dx.doi.org/10.1371/journal.pone.0127984			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011633	Green Published, gold			2022-12-26	WOS:000355183900177
J	Veiga, N; Pereira, C; Resende, C; Amaral, O; Ferreira, M; Nelas, P; Chaves, C; Duarte, J; Cirnes, L; Machado, JC; Ferreira, P; Correia, IJ				Veiga, Nelio; Pereira, Carlos; Resende, Carlos; Amaral, Odete; Ferreira, Manuela; Nelas, Paula; Chaves, Claudia; Duarte, Joao; Cirnes, Luis; Machado, Jose Carlos; Ferreira, Paula; Correia, Ilidio J.			Oral and Gastric Helicobacter Pylori: Effects and Associations	PLOS ONE			English	Article							DENTAL PLAQUE; CAVITY; INFECTION; HEALTH; CHILDREN; SALIVA; VACA; SEROPREVALENCE; PREVALENCE; HYGIENE	Introduction This study consisted in the comparison of the prevalence of Helicobacter pylori (H. pylori) present in the stomach and in saliva of a sample of Portuguese adolescents and the assessment of the association between H. pylori infection with socio-demographic variables and prevalence of dental caries. Materials and Methods A cross-sectional study was designed including a sample of 447 adolescents aged 12 to 19 years old, attending a public school in Satao, Portugal. A questionnaire about socio-demographic variables and oral health behaviors was applied. Gastric H. pylori infection was determined using the urease breath test (UBT). Saliva collection was obtained and DNA was extracted by Polymerase Chain Reaction (PCR) in order to detect the presence of oral H. pylori. Results The prevalence of gastric H. pylori detected by UBT was 35.9%. Within the adolescents with a gastric UBT positive, only 1.9% were positive for oral H. pylori. The presence of gastric H. pylori was found to be associated with age (> 15years, Odds ratio(OR)= 1.64,95% CI= 1.08-2.52), residence area (urban, OR= 1.48,95% CI= 1.03-2.29) and parents' professional situation (unemployed, OR= 1.22,95% CI= 1.02-1.23). Among those with detected dental caries during the intra-oral observation, 37.4% were positive for gastric H. pylori and 40.2% negative for the same bacterial strain (p=0.3). Conclusions The oral cavity cannot be considered a reservoir for infection of H. pylori. Gastric H. pylori infection was found to be associated with socio-demographic variables such as age, residence area and socioeconomic status.	[Veiga, Nelio; Correia, Ilidio J.] Beira Interior Univ, Fac Hlth Sci, Hlth Sci Res Ctr, Covilha, Portugal; [Veiga, Nelio; Pereira, Carlos; Amaral, Odete; Ferreira, Manuela; Nelas, Paula; Chaves, Claudia; Duarte, Joao] Polytech Inst Viseu, Res Ctr Educ Technol & Hlth Studies, Viseu, Portugal; [Veiga, Nelio; Ferreira, Paula] Univ Coimbra, Dept Chem Engn, Chem Proc Engn & Forest Prod Res Ctr, Coimbra, Portugal; [Veiga, Nelio] Portuguese Catholic Porto, Dept Hlth Sci, Viseu, Portugal; [Resende, Carlos; Cirnes, Luis; Machado, Jose Carlos] Univ Porto, Inst Mol Pathol & Immunol, P-4100 Oporto, Portugal	Universidade da Beira Interior; Instituto Politecnico de Viseu; Universidade de Coimbra; Universidade Catolica Portuguesa; Universidade do Porto	Veiga, N (corresponding author), Beira Interior Univ, Fac Hlth Sci, Hlth Sci Res Ctr, Covilha, Portugal.	nelioveiga@gmail.com	Amaral, Odete P/C-1451-2016; Correia, Ilidio/S-8295-2016; Ferreira, Paula/ABD-5826-2020; Machado, Jose Carlos/C-5907-2009; Ferreira, Paula/I-6288-2013; Ferreira, Paula/GQP-0550-2022; Correia, I. J./AAE-2400-2020; Chaves, Claudia/E-9556-2018; Veiga, Nelio/F-5279-2017; Ferreira, Manuela/N-1236-2013	Amaral, Odete P/0000-0002-3382-6074; Correia, Ilidio/0000-0003-1613-9675; Machado, Jose Carlos/0000-0003-4741-8415; Ferreira, Paula/0000-0003-3393-4427; Ferreira, Paula/0000-0003-3393-4427; Correia, I. J./0000-0003-1613-9675; Chaves, Claudia/0000-0002-8103-7221; Veiga, Nelio/0000-0001-6288-0435; Resende, Carlos/0000-0001-7143-7099; Nelas, Paula/0000-0003-0043-3597; Ferreira, Manuela/0000-0002-8452-2222	Fundacao para a Ciencia e Tecnologia; CIDETS (Portugal)	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); CIDETS (Portugal)	This study was funded by the Fundacao para a Ciencia e Tecnologia and CI&DETS (Portugal).	Adler I, 2014, WORLD J GASTROENTERO, V20, P9922, DOI 10.3748/wjg.v20.i29.9922; Al Sayed A, 2014, ISRN GASTROENTEROL, V2014, P1; Almeida M, 2012, ACTA PEDIAT PORT, V43, pS37; Assumpcao MB, 2010, WORLD J GASTROENTERO, V16, P3033, DOI 10.3748/wjg.v16.i24.3033; Atherton JC, 1997, GASTROENTEROLOGY, V112, P92, DOI 10.1016/S0016-5085(97)70223-3; Berroteran A, 2002, J MED MICROBIOL, V51, P764, DOI 10.1099/0022-1317-51-9-764; Bharath T Sreenivasa, 2014, J Oral Maxillofac Pathol, V18, P19, DOI 10.4103/0973-029X.131885; Boyanova L, 2013, DIAGN MICR INFEC DIS, V77, P287, DOI 10.1016/j.diagmicrobio.2013.06.030; Buergers R, 2008, EUR J ORAL SCI, V116, P297, DOI 10.1111/j.1600-0722.2008.00543.x; Camargo MC, 2004, HELICOBACTER, V9, P106, DOI 10.1111/j.1083-4389.2004.00206.x; Chaudhry S, 2011, JCPSP-J COLL PHYSICI, V21, P589, DOI 10.2011/JCPSP.589592; Chen YYM, 1996, INFECT IMMUN, V64, P585, DOI 10.1128/IAI.64.2.585-592.1996; Dunn BE, 1997, CLIN MICROBIOL REV, V10, P720, DOI 10.1128/CMR.10.4.720; Dus I, 2013, POSTEP HIG MED DOSW, V67, P261; El-Fakhfakh Effat Abd El-Monem, 2014, J Egypt Soc Parasitol, V44, P275; Fernando N, 2001, HELICOBACTER, V6, P169, DOI 10.1046/j.1523-5378.2001.00025.x; Goh KL, 2011, HELICOBACTER, V16, P1, DOI 10.1111/j.1523-5378.2011.00874.x; Kabir S, 2004, HELICOBACTER, V9, P115, DOI 10.1111/j.1083-4389.2004.00207.x; Kignel S, 2005, ORAL DIS, V11, P17, DOI 10.1111/j.1601-0825.2004.01043.x; Kilmartin Catherine M, 2002, J Can Dent Assoc, V68, P489; Kodaira MS, 2002, REV SAUDE PUBL, V36, P356, DOI 10.1590/S0034-89102002000300017; Liu P, 2013, ASIA-PAC J PUBLIC HE, V25, p49S, DOI 10.1177/1010539513495555; Loster BW, 2006, J PHYSIOL PHARMACOL, V57, P91; Mana F, 2013, ACTA GASTRO-ENT BELG, V76, P381; Medina ML, 2010, MED ORAL PATOL ORAL, V15, pE38, DOI 10.4317/medoral.15.e38; Momtaz H, 2012, WORLD J GASTROENTERO, V18, P2105, DOI 10.3748/wjg.v18.i17.2105; Monno R, 2008, INFECTION, V36, P345, DOI 10.1007/s15010-008-6338-6; Namiot DB, 2010, ADV MED SCI-POLAND, V55, P167, DOI 10.2478/v10039-010-0032-5; Nisha KJ, 2016, J INVESTIG CLIN DENT, V7, P37, DOI 10.1111/jicd.12122; Panahi O, 2011, JPCS, V2, P13; Miranda ACP, 2010, SAO PAULO MED J, V128, P187, DOI 10.1590/S1516-31802010000400002; Roman-Roman A, 2013, ENFERM INFEC MICR CL, V31, P130, DOI 10.1016/j.eimc.2012.09.002; Salazar CR, 2012, CARCINOGENESIS, V33, P399, DOI 10.1093/carcin/bgr284; Satheehkumar P, 2013, ORAL ONCOL, V49, P20; Sepulveda E, 2012, REV CHIL INFECTOL, V29, P278, DOI 10.4067/S0716-10182012000300005; Rossi-Aguiar VPS, 2009, ORAL MICROBIOL IMMUN, V24, P255, DOI 10.1111/j.1399-302X.2008.00491.x; Sousa M B, 2001, Arq Gastroenterol, V38, P132; Vahedi M, 2011, J Dent (Tehran), V8, P165; WHO World Health Organization, 2003, OR HLTH SURV BAS MET; Wichelhaus A, 2011, J OROFAC ORTHOP, V72, P187, DOI 10.1007/s00056-011-0024-5; Zou QH, 2011, J ORAL PATHOL MED, V40, P317, DOI 10.1111/j.1600-0714.2011.01006.x	41	8	10	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0126923	10.1371/journal.pone.0126923	http://dx.doi.org/10.1371/journal.pone.0126923			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010595	Green Published, Green Submitted, gold			2022-12-26	WOS:000355183900049
J	Pourie, G; Martin, N; Bossenmeyer-Pourie, C; Akchiche, N; Gueant-Rodriguez, RM; Geoffroy, A; Jeannesson, E; Chehadeh, SE; Mimoun, K; Brachet, P; Koziel, V; Alberto, JM; Helle, D; Debard, R; Leininger, B; Daval, JL; Gueant, JL				Pourie, Gregory; Martin, Nicolas; Bossenmeyer-Pourie, Carine; Akchiche, Nassila; Gueant-Rodriguez, Rosa Maria; Geoffroy, Andrea; Jeannesson, Elise; Chehadeh, Sarah El Hajj; Mimoun, Khalid; Brachet, Patrick; Koziel, Violette; Alberto, Jean-Marc; Helle, Deborah; Debard, Renee; Leininger, Brigitte; Daval, Jean-Luc; Gueant, Jean-Louis			Folate- and vitamin B-12-deficient diet during gestation and lactation alters cerebellar synapsin expression via impaired influence of estrogen nuclear receptor alpha	FASEB JOURNAL			English	Article						epigenomics; methyl donor; neuroplasticity	METHYL DONOR DEFICIENCY; COGNITIVE IMPAIRMENT; ARGININE METHYLATION; BRAIN-DEVELOPMENT; TRANSCRIPTION; GENE; DIFFERENTIATION; PGC-1-ALPHA; ACTIVATION; PLASTICITY	Deficiency in the methyl donors vitamin B-12 and folate during pregnancy and postnatal life impairs proper brain development. We studied the consequences of this combined deficiency on cerebellum plasticity in offspring from rat mothers subjected to deficient diet during gestation and lactation and in rat neuroprogenitor cells expressing cerebellum markers. The major proteomic change in cerebellum of 21-d-old deprived females was a 2.2-fold lower expression of synapsins, which was confirmed in neuroprogenitors cultivated in the deficient condition. A pathway analysis suggested that these proteomic changes were related to estrogen receptor a (ER-alpha)/Src tyrosine kinase. The influence of impaired ER-alpha pathway was confirmed by abnormal negative geotaxis test at d 19-20 and decreased phsophorylation of synapsins in deprived females treated by ER-alpha antagonist 1,3-bis(4-hydroxyphenyl)-4-methyl-5-[4-(2-piperidinylethoxy) phenol]-1H-pyrazole dihydrochloride (MPP). This effect was consistent with 2-fold decreased expression and methylation of ER-a and subsequent decreased ER-alpha/PPAR-gamma coactivator 1 alpha (PGC-1 alpha) interaction in deficiency condition. The impaired ER-a pathway led to decreased expression of synapsins through 2-fold decreased EGR-1/Zif-268 transcription factor and to 1.7-fold reduced Src-dependent phosphorylation of synapsins. The treatment of neuroprogenitors with either MPP or PP1 (4-(4'-phenoxyanilino)-6,7-dimethoxyquinazoline, 6,7-dimethoxy-N-(4-phenoxyphenyl)-4-quinazolinamine, SKI-1, Src-11) Src inhibitor produced similar effects. In conclusion, the deficiency during pregnancy and lactation impairs the expression of synapsins through a deregulation of ER-alpha pathway.	[Pourie, Gregory; Martin, Nicolas; Bossenmeyer-Pourie, Carine; Akchiche, Nassila; Gueant-Rodriguez, Rosa Maria; Geoffroy, Andrea; Jeannesson, Elise; Chehadeh, Sarah El Hajj; Mimoun, Khalid; Koziel, Violette; Alberto, Jean-Marc; Helle, Deborah; Debard, Renee; Leininger, Brigitte; Daval, Jean-Luc; Gueant, Jean-Louis] Nancy Univ, Fac Med, INSERM, Nutr Genet & Environm Exposure U954, F-54500 Vandoeuvre Les Nancy, France; [Pourie, Gregory; Martin, Nicolas; Bossenmeyer-Pourie, Carine; Akchiche, Nassila; Gueant-Rodriguez, Rosa Maria; Geoffroy, Andrea; Jeannesson, Elise; Chehadeh, Sarah El Hajj; Mimoun, Khalid; Koziel, Violette; Alberto, Jean-Marc; Helle, Deborah; Debard, Renee; Leininger, Brigitte; Daval, Jean-Luc; Gueant, Jean-Louis] Nancy Univ, Univ Hosp Ctr, F-54500 Vandoeuvre Les Nancy, France; [Brachet, Patrick] Univ Auvergne, INRA, Ctr Theix, Human Nutr Unit,Unite Mixte Rech 1019, St Genes Champanelle, France; [Gueant, Jean-Louis] Oasi Maria Santissima Inst Res Mental Retardat &, Ist Ricovero & Cura Carattere Sci, Troina, Italy	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; CHU de Nancy; Universite de Lorraine; INRAE; Universite Clermont Auvergne (UCA)	Gueant, JL (corresponding author), Nancy Univ, Fac Med, INSERM, Nutr Genet & Environm Exposure U954, F-54500 Vandoeuvre Les Nancy, France.	gregory.pourie@iutnb.uhp-nancy.fr; jean-louis.gueant@univ-lorraine.fr	Bossenmeyer-Pourié, Carine/F-7695-2019; Daval, Jean-Luc/G-6502-2014	Bossenmeyer-Pourié, Carine/0000-0003-3831-4809; 	French National Agency for Research (ANR Nutrivigene project); Region of Lorraine (France)	French National Agency for Research (ANR Nutrivigene project)(French National Research Agency (ANR)); Region of Lorraine (France)(Region Grand-Est)	Institutional grants were received from the French National Agency for Research (ANR Nutrivigene project) and the Region of Lorraine (France).	Akchiche N, 2012, FASEB J, V26, P3980, DOI 10.1096/fj.12-205757; Al-Sarraj A, 2005, J CELL BIOCHEM, V94, P153, DOI 10.1002/jcb.20305; Battaglia-Hsu SF, 2009, P NATL ACAD SCI USA, V106, P21930, DOI 10.1073/pnas.0811794106; BENFENATI F, 1992, NEURON, V8, P377, DOI 10.1016/0896-6273(92)90303-U; Black MM, 2008, FOOD NUTR BULL, V29, pS126, DOI 10.1177/15648265080292S117; Blaise SA, 2007, AM J PATHOL, V170, P667, DOI 10.2353/ajpath.2007.060339; Borrelli E, 2008, NEURON, V60, P961, DOI 10.1016/j.neuron.2008.10.012; Burdge GC, 2010, ANNU REV NUTR, V30, P315, DOI 10.1146/annurev.nutr.012809.104751; Cesca F, 2010, PROG NEUROBIOL, V91, P313, DOI 10.1016/j.pneurobio.2010.04.006; Chanson A, 2005, J NUTR, V135, P2524, DOI 10.1093/jn/135.11.2524; Chintala S, 2009, BRAIN RES, V1266, P18, DOI 10.1016/j.brainres.2009.02.035; Daval JL, 2009, P NATL ACAD SCI USA, V106, pE1, DOI 10.1073/pnas.0809217106; Douaud G, 2013, P NATL ACAD SCI USA, V110, P9523, DOI 10.1073/pnas.1301816110; Ekici M, 2008, J BIOL CHEM, V283, P9257, DOI 10.1074/jbc.M709388200; Forges T, 2007, HUM REPROD UPDATE, V13, P225, DOI 10.1093/humupd/dml063; Garcia MM, 2011, J PATHOL, V225, P324, DOI 10.1002/path.2881; Ghemrawi R, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.69; Gueant J. L., 2013, TRENDS ENDOCRINOL ME, V24, P279; Gueant JL, 2014, PFLUG ARCH EUR J PHY, V466, P833, DOI 10.1007/s00424-013-1339-4; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; Hatanaka Y, 2009, BIOCHEM BIOPH RES CO, V381, P728, DOI 10.1016/j.bbrc.2009.02.130; Hedges VL, 2012, FRONT NEUROENDOCRIN, V33, P403, DOI 10.1016/j.yfrne.2012.08.005; Kerek R, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.278; Kushner SA, 2005, J NEUROSCI, V25, P9721, DOI 10.1523/JNEUROSCI.2836-05.2005; Le Romancer M, 2008, MOL CELL, V31, P212, DOI 10.1016/j.molcel.2008.05.025; McCaddon A, 2013, BIOCHIMIE, V95, P1066, DOI 10.1016/j.biochi.2012.11.017; Messa M, 2010, J CELL SCI, V123, P2256, DOI 10.1242/jcs.068445; Murphy BC, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-115; Noguchi KK, 2008, CELL DEATH DIFFER, V15, P1582, DOI 10.1038/cdd.2008.97; Ohtani-Kaneko R, 2010, NEUROSCI RES, V66, P180, DOI 10.1016/j.neures.2009.10.012; Paonessa F, 2013, J BIOL CHEM, V288, P3227, DOI 10.1074/jbc.M112.399782; PETERSOHN D, 1995, J BIOL CHEM, V270, P24361, DOI 10.1074/jbc.270.41.24361; Pooya S, 2012, J HEPATOL, V57, P344, DOI 10.1016/j.jhep.2012.03.028; Revest JM, 2010, MOL PSYCHIATR, V15, P1140, DOI 10.1038/mp.2010.40; Reynolds E, 2006, LANCET NEUROL, V5, P949, DOI 10.1016/S1474-4422(06)70598-1; Scalabrino G, 2009, PROG NEUROBIOL, V88, P203, DOI 10.1016/j.pneurobio.2009.04.004; Suarez I, 2004, DEV NEUROSCI-BASEL, V26, P45, DOI 10.1159/000080711; Tang BQ, 2010, NUTRITION, V26, P1170, DOI 10.1016/j.nut.2009.10.006; Teyssier C, 2005, GENE DEV, V19, P1466, DOI 10.1101/gad.1295005; Teyssier C, 2010, TRENDS ENDOCRIN MET, V21, P181, DOI 10.1016/j.tem.2009.11.002; THIEL G, 1994, J BIOL CHEM, V269, P15294; Tiemeier H, 2010, NEUROIMAGE, V49, P63, DOI 10.1016/j.neuroimage.2009.08.016; Troen AM, 2008, P NATL ACAD SCI USA, V105, P12474, DOI 10.1073/pnas.0805350105; Wessler S, 2006, J STEROID BIOCHEM, V98, P25, DOI 10.1016/j.jsbmb.2005.08.003; Zeisel SH, 2012, ANN NUTR METAB, V60, P19, DOI 10.1159/000337310	45	22	22	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2015	29	9					3713	3725		10.1096/fj.14-264267	http://dx.doi.org/10.1096/fj.14-264267			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CP5IU	26018677				2022-12-26	WOS:000359915600010
J	Rosler, KS; Mercier, E; Andrews, IC; Wieden, HJ				Rosler, Kirsten S.; Mercier, Evan; Andrews, Ian C.; Wieden, Hans-Joachim			Histidine 114 Is Critical for ATP Hydrolysis by the Universally Conserved ATPase YchF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS-RESPONSE; ASSEMBLY GTPASE RBGA; OBG-LIKE ATPASE; MOLECULAR-DYNAMICS; CATALYTIC MACHINERY; CRYSTAL-STRUCTURE; SWISS-MODEL; RIBOSOME; OLA1; MECHANISM	GTPases perform a wide range of functions, ranging from protein synthesis to cell signaling. Of all known GTPases, only eight are conserved across all three domains of life. YchF is one of these eight universally conserved GTPases; however, its cellular function and enzymatic properties are poorly understood. YchF differs from the classical GTPases in that it has a higher affinity for ATP than for GTP and is a functional ATPase. As a hydrophobic amino acid-substituted ATPase, YchF does not possess the canonical catalytic Gln required for nucleotide hydrolysis. To elucidate the catalytic mechanism of ATP hydrolysis by YchF, we have taken a two-pronged approach combining classical biochemical and in silico techniques. The use of molecular dynamics simulations allowed us to complement our biochemical findings with information about the structural dynamics of YchF. We have thereby identified the highly conserved His-114 as critical for the ATPase activity of YchF from Escherichia coli. His-114 is located in a flexible loop of the G-domain, which undergoes nucleotide-dependent conformational changes. The use of a catalytic His is also observed in the hydrophobic amino acid-substituted GTPase RbgA and is an identifier of the translational GTPase family.	[Rosler, Kirsten S.; Mercier, Evan; Andrews, Ian C.; Wieden, Hans-Joachim] Univ Lethbridge, Dept Chem & Biochem, Alberta RNA Res & Training Inst, Lethbridge, AB T1K 3M4, Canada	University of Lethbridge	Wieden, HJ (corresponding author), Univ Lethbridge, Dept Chem & Biochem, Univ Dr, Lethbridge, AB T1K 3M4, Canada.	hj.wieden@uleth.ca		Wieden, Hans-Joachim/0000-0001-5181-6059	Canadian Institutes of Health Research (CIHR) [MOP 114938, 103033, 89353, 84917]; Canada Foundation for Innovation (CFI) [202588]; Alberta Innovates Technology Futures	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Alberta Innovates Technology Futures	This work was supported by Canadian Institutes of Health Research (CIHR) Operating Grants MOP 114938, 103033, 89353, and 84917 and Canada Foundation for Innovation (CFI) Grant 202588 (to H.-J. W.), Alberta Innovates Technology Futures New Investigator Award, iCORE Strategic Chair Program (to H.-J. W.) and postgraduate scholarships (to E. M. and K. S. R.), and resource allocations from Compute Canada and WestGrid. The authors declare that they have no conflicts of interest with the contents of this article.	Achila D, 2012, J BIOL CHEM, V287, P8417, DOI 10.1074/jbc.M111.331322; Anand B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009944; Anand B, 2009, BIOCHEM BIOPH RES CO, V386, P602, DOI 10.1016/j.bbrc.2009.06.078; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Ash MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023355; Becker M, 2012, RNA BIOL, V9, P1288, DOI 10.4161/rna.22131; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; Caldon CE, 2003, CURR OPIN MICROBIOL, V6, P135, DOI 10.1016/S1369-5274(03)00037-7; Chen YC, 2011, INT J MED MICROBIOL, V301, P469, DOI 10.1016/j.ijmm.2011.02.002; Cheung MY, 2010, J BIOL CHEM, V285, P37359, DOI 10.1074/jbc.M110.172080; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; Danese I, 2004, INFECT IMMUN, V72, P5783, DOI 10.1128/IAI.72.10.5783-5790.2004; Daviter T, 2003, J MOL BIOL, V332, P689, DOI 10.1016/S0022-2836(03)00947-1; Fernebro J, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-65; Foucher AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046795; Glykos NM, 2006, J COMPUT CHEM, V27, P1765, DOI 10.1002/jcc.20482; Gradia DF, 2009, INT J PARASITOL, V39, P49, DOI 10.1016/j.ijpara.2008.05.019; Guerrero C, 2006, MOL CELL PROTEOMICS, V5, P366, DOI 10.1074/mcp.M500303-MCP200; Gulati M, 2013, NUCLEIC ACIDS RES, V41, P3217, DOI 10.1093/nar/gks1475; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Koller-Eichhorn R, 2007, J BIOL CHEM, V282, P19928, DOI 10.1074/jbc.M700541200; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Marlovits TC, 2002, P NATL ACAD SCI USA, V99, P16243, DOI 10.1073/pnas.242338299; Matsuzawa A, 2014, MOL CELL, V53, P101, DOI 10.1016/j.molcel.2013.10.028; Mishra R, 2005, PROTEINS, V59, P332, DOI 10.1002/prot.20413; NOEL JP, 1993, NATURE, V366, P654, DOI 10.1038/366654a0; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Scrima A, 2006, EMBO J, V25, P2940, DOI 10.1038/sj.emboj.7601171; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Sprang SR, 1997, CURR OPIN STRUC BIOL, V7, P849, DOI 10.1016/S0959-440X(97)80157-1; Teplyakov A, 2003, J BACTERIOL, V185, P4031, DOI 10.1128/JB.185.14.4031-4037.2003; Tomar SK, 2011, BIOCHEM BIOPH RES CO, V408, P459, DOI 10.1016/j.bbrc.2011.04.052; Verstraeten N, 2011, MICROBIOL MOL BIOL R, V75, P507, DOI 10.1128/MMBR.00009-11; Voet D., 2005, BIOCHEMISTRY-US; Wenk M, 2012, J BIOL CHEM, V287, P43585, DOI 10.1074/jbc.M112.413070; Zhang JW, 2009, J ZHEJIANG UNIV-SC B, V10, P796, DOI 10.1631/jzus.B0910009; Zhang J, 2009, P NATL ACAD SCI USA, V106, P15356, DOI 10.1073/pnas.0907213106	41	7	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18650	18661		10.1074/jbc.M114.598227	http://dx.doi.org/10.1074/jbc.M114.598227			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26018081	hybrid, Green Published			2022-12-26	WOS:000358512100034
J	Deng, RZ; Hua, X; Li, J; Chi, W; Zhang, ZD; Lu, F; Zhang, LL; Pflugfelder, SC; Li, DQ				Deng, Ruzhi; Hua, Xia; Li, Jin; Chi, Wei; Zhang, Zongduan; Lu, Fan; Zhang, Lili; Pflugfelder, Stephen C.; Li, De-Quan			Oxidative Stress Markers Induced by Hyperosmolarity in Primary Human Corneal Epithelial Cells	PLOS ONE			English	Article							REACTIVE OXYGEN; OCULAR SURFACE; SUPEROXIDE-DISMUTASE; LIPID-PEROXIDATION; REDOX REGULATION; DNA; EXPRESSION; ACTIVATION; INDUCTION; ACONITASE	Oxidative stress has been known to be involved in pathogenesis of dry eye disease. However, few studies have comprehensively investigated the relationship between hyperosmolarity and oxidative damage in human ocular surface. This study was to explore whether and how hyperosmolarity induces oxidative stress markers in primary human corneal epithelial cells (HCECs). Primary HCECs were established from donor limbal explants. The hyperosmolarity model was made in HCECs cultured in isosmolar (312 mOsM) or hyperosmotic (350, 400, 450 mOsM) media. Production of reactive oxygen species (ROS), oxidative damage markers, oxygenases and anti-oxidative enzymes were analyzed by DCFDA kit, RT-qPCR, immunofluorescent and immunohistochemical staining and Western blotting. Compared to isosmolar medium, ROS production significantly increased at time-and osmolarity-dependent manner in HCECs exposed to media with increasing osmolarities (350450 mOsM). Hyperosmolarity significantly induced oxidative damage markers in cell membrane with increased toxic products of lipid peroxidation, 4-hydroxynonenal (4-HNE) and malondialdehyde (MDA), and in nuclear and mitochondria DNA with increased aconitase-2 and 8-OHdG. Hyperosmotic stress also increased the mRNA expression and protein production of heme oxygenase-1 (HMOX1) and cyclooxygenase-2 (COX2), but reduced the levels of antioxidant enzymes, superoxide dismutase-1 (SOD1), and glutathione peroxidase-1 (GPX1). In conclusion, our comprehensive findings demonstrate that hyperosmolarity induces oxidative stress in HCECs by stimulating ROS production and disrupting the balance of oxygenases and antioxidant enzymes, which in turn cause cell damage with increased oxidative markers in membrane lipid peroxidation and mitochondrial DNA damage.	[Deng, Ruzhi; Hua, Xia; Li, Jin; Zhang, Zongduan; Lu, Fan] Wenzhou Med Univ, Sch Optometry & Ophthalmol, Wenzhou, Peoples R China; [Deng, Ruzhi; Li, Jin; Chi, Wei; Zhang, Zongduan; Zhang, Lili; Pflugfelder, Stephen C.; Li, De-Quan] Baylor Coll Med, Ocular Surface Ctr, Cullen Eye Inst, Dept Ophthalmol, Houston, TX 77030 USA; [Hua, Xia] Tianjin Med Univ, Tianjin Eye Hosp, Tianjin Key Lab Ophthalmol & Visual Sci, Clin Coll Ophthalmol, Tianjin, Peoples R China	Wenzhou Medical University; Baylor College of Medicine; Tianjin Medical University	Lu, F (corresponding author), Wenzhou Med Univ, Sch Optometry & Ophthalmol, Wenzhou, Peoples R China.	lufan@mail.eye.ac.cn; dequanl@bcm.edu			NIH [R01EY023598, EY011915, EY002520]; Allergan Inc.; Eye Bank Association of America; Lions Foundation for Sight, Research to Prevent Blindness; Oshman Foundation; William Stamps Farish Fund; NATIONAL EYE INSTITUTE [R01EY023598, R01EY011915, P30EY002520] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Allergan Inc.(AbbVieAllergan); Eye Bank Association of America; Lions Foundation for Sight, Research to Prevent Blindness; Oshman Foundation; William Stamps Farish Fund; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by NIH NEI Grants R01EY023598 (DQL), EY011915 (SCP) and Core Grant for Vision Research EY002520, Allergan Inc., Eye Bank Association of America (DQL), Lions Foundation for Sight, Research to Prevent Blindness, Oshman Foundation, and William Stamps Farish Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade AS, 2014, EXP EYE RES, V120, P1, DOI 10.1016/j.exer.2013.12.014; Armstrong JS, 2004, BIOESSAYS, V26, P894, DOI 10.1002/bies.20071; Bao F, 2004, J NEUROCHEM, V90, P1194, DOI 10.1111/j.1471-4159.2004.02580.x; Baudouin C, 2013, OCUL SURF, V11, P246, DOI 10.1016/j.jtos.2013.07.003; Behndig A, 1998, INVEST OPHTH VIS SCI, V39, P471; Berg F, 2006, PLOS GENET, V2, P1178, DOI 10.1371/journal.pgen.0020129; Boyle JJ, 2012, CURR OPIN LIPIDOL, V23, P453, DOI 10.1097/MOL.0b013e328356b145; BRAMBILLA G, 1986, MUTAT RES, V171, P169, DOI 10.1016/0165-1218(86)90051-0; Cano M, 2010, VISION RES, V50, P652, DOI 10.1016/j.visres.2009.08.018; Cejkova J, 2009, HISTOL HISTOPATHOL, V24, P1357, DOI 10.14670/HH-24.1357; Chang YC, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00191; Chen XJ, 2005, SCIENCE, V307, P714, DOI 10.1126/science.1106391; Chen YH, 2014, J CLIN NEUROL, V10, P84, DOI 10.3988/jcn.2014.10.2.84; Chen Z, 2004, STEM CELLS, V22, P355, DOI 10.1634/stemcells.22-3-355; Del Rio D, 2005, NUTR METAB CARDIOVAS, V15, P316, DOI 10.1016/j.numecd.2005.05.003; Delanty N, 1998, ACTA NEUROL SCAND, V98, P145, DOI 10.1111/j.1600-0404.1998.tb07285.x; Devasagayam T P A, 2004, J Assoc Physicians India, V52, P794; Dong QY, 2008, EUR J OPHTHALMOL, V18, P94, DOI 10.1177/112067210801800116; ECKL PM, 1993, MUTAT RES, V290, P183, DOI 10.1016/0027-5107(93)90158-C; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Figueira TR, 2013, ANTIOXID REDOX SIGN, V18, P2029, DOI 10.1089/ars.2012.4729; Gronert K, 2010, EXP EYE RES, V91, P478, DOI 10.1016/j.exer.2010.07.004; Higuchi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045612; Julio G, 2012, OPHTHAL PHYSL OPT, V32, P317, DOI 10.1111/j.1475-1313.2012.00915.x; Kim HS, 2004, EXP EYE RES, V79, P41, DOI 10.1016/j.exer.2004.02.015; Kim SJ, 2014, J BIOL CHEM, V289, P6165, DOI 10.1074/jbc.M113.515130; Kleiveland CR, 2008, EXP CELL RES, V314, P1831, DOI 10.1016/j.yexcr.2008.02.004; Lee SH, 2005, J BIOL CHEM, V280, P28337, DOI 10.1074/jbc.M504178200; Lemp MA, 2011, AM J OPHTHALMOL, V151, P792, DOI 10.1016/j.ajo.2010.10.032; Li DQ, 2004, INVEST OPHTH VIS SCI, V45, P4302, DOI 10.1167/iovs.04-0299; LI DQ, 1995, J CELL PHYSIOL, V163, P61, DOI 10.1002/jcp.1041630108; Li DQ, 2006, EXP EYE RES, V82, P588, DOI 10.1016/j.exer.2005.08.019; Luo LH, 2004, INVEST OPHTH VIS SCI, V45, P4293, DOI 10.1167/iovs.03-1145; Luo Lihui, 2005, Eye Contact Lens, V31, P186, DOI 10.1097/01.ICL.0000162759.79740.46; Ma P, 2009, INVEST OPHTH VIS SCI, V50, P2702, DOI 10.1167/iovs.08-3074; Madrigal Jose L. M., 2006, CNS & Neurological Disorders-Drug Targets, V5, P561; Marczynski B, 2000, MUTAT RES-GEN TOX EN, V468, P195, DOI 10.1016/S1383-5718(00)00053-X; Maynard S, 2013, AGING-US, V5, P850, DOI 10.18632/aging.100618; Nakamura S, 2007, INVEST OPHTH VIS SCI, V48, P1552, DOI 10.1167/iovs.06-1027; Pan Z, 2011, INVEST OPHTH VIS SCI, V52, P485, DOI 10.1167/iovs.10-5801; Patel PR, 2007, FREE RADICAL BIO MED, V42, P552, DOI 10.1016/j.freeradbiomed.2006.11.025; Pescosolido N, 2008, DRUGS R&D, V9, P3, DOI 10.2165/0126839-200809001-00002; Png E, 2011, J CELL PHYSIOL, V226, P693, DOI 10.1002/jcp.22389; Polidori MC, 2001, FREE RADICAL BIO MED, V30, P456, DOI 10.1016/S0891-5849(00)00345-2; Raukas M, 2012, FREE RADICAL RES, V46, P1490, DOI 10.3109/10715762.2012.728286; Shah AA, 2013, EUR J DERMATOL, V23, P5, DOI 10.1684/ejd.2012.1884; Sosa V, 2013, AGEING RES REV, V12, P376, DOI 10.1016/j.arr.2012.10.004; Tyrrell R, 1999, FREE RADICAL RES, V31, P335, DOI 10.1080/10715769900300901; Uchida K, 2003, PROG LIPID RES, V42, P318, DOI 10.1016/S0163-7827(03)00014-6; Uchino Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045805; Uchino Yuichi, 2012, Cornea, V31 Suppl 1, pS63, DOI 10.1097/ICO.0b013e31826a5de1; Valavanidis A, 2009, J ENVIRON SCI HEAL C, V27, P120, DOI 10.1080/10590500902885684; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; Van Houten B, 2006, DNA REPAIR, V5, P145, DOI 10.1016/j.dnarep.2005.03.002; Wakamatsu TH, 2013, INVEST OPHTH VIS SCI, V54, P201, DOI 10.1167/iovs.12-10325; Wakamatsu TH, 2010, MOL VIS, V16, P2465; Wakamatsu TH, 2008, ARQ BRAS OFTALMOL, V71, P72, DOI 10.1590/S0004-27492008000700015; Waldeck AR, 1996, CHEM RES TOXICOL, V9, P954, DOI 10.1021/tx960057s; Ward PA, 2010, ANN NY ACAD SCI, V1203, P53, DOI 10.1111/j.1749-6632.2010.05552.x; Woo JM, 2012, MOL VIS, V18, P901; Yang TX, 2005, J BIOL CHEM, V280, P34966, DOI 10.1074/jbc.M502430200; Yoon KC, 2007, INVEST OPHTH VIS SCI, V48, P2561, DOI 10.1167/iovs.07-0002; Zhang Y, 2011, MOL VIS, V17, P2325; Zhang Z, 2004, P NATL ACAD SCI USA, V101, P9491, DOI 10.1073/pnas.0402961101; Zheng QX, 2014, EXP EYE RES, V125, P1, DOI 10.1016/j.exer.2014.05.001	66	84	85	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0126561	10.1371/journal.pone.0126561	http://dx.doi.org/10.1371/journal.pone.0126561			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024535	Green Published, Green Submitted, gold			2022-12-26	WOS:000355319400015
J	Fresard, L; Leroux, S; Roux, PF; Klopp, C; Fabre, S; Esquerre, D; Dehais, P; Djari, A; Gourichon, D; Lagarrigue, S; Pitel, F				Fresard, Laure; Leroux, Sophie; Roux, Pierre-Francois; Klopp, Christophe; Fabre, Stephane; Esquerre, Diane; Dehais, Patrice; Djari, Anis; Gourichon, David; Lagarrigue, Sandrine; Pitel, Frederique			Genome-Wide Characterization of RNA Editing in Chicken Embryos Reveals Common Features among Vertebrates	PLOS ONE			English	Article							B MESSENGER-RNA; ACCURATE IDENTIFICATION; TRANSCRIPTOME; ADENOSINE; SEQ; MECHANISMS; EVOLUTION; FRAGMENT; TARGETS; OCCURS	RNA editing results in a post-transcriptional nucleotide change in the RNA sequence that creates an alternative nucleotide not present in the DNA sequence. This leads to a diversification of transcription products with potential functional consequences. Two nucleotide substitutions are mainly described in animals, from adenosine to inosine(A-to-I) and from cytidine to uridine(C-to-U). This phenomenon is described in more details in mammals, notably since the availability of next generation sequencing technologies allowing whole genome screening of RNA-DNA differences. The number of studies recording RNA editing in other vertebrates like chicken is still limited. We chose to use high throughput sequencing technologies to search for RNA editing in chicken, and to extend the knowledge of its conservation among vertebrates. We performed sequencing of RNA and DNA from 8 embryos. Being aware of common pitfalls inherent to sequence analyses that lead to false positive discovery, we stringently filtered our datasets and found fewer than 40 reliable candidates. Conservation of particular sites of RNA editing was attested by the presence of 3 edited sites previously detected in mammals. We then characterized editing levels for selected candidates in several tissues and at different time points, from 4.5 days of embryonic development to adults, and observed a clear tissue-specificity and a gradual increase of editing level with time. By characterizing the RNA editing landscape in chicken, our results highlight the extent of evolutionary conservation of this phenomenon within vertebrates, attest to its tissue and stage specificity and provide support of the absence of non A-to-I events from the chicken transcriptome.	[Fresard, Laure; Leroux, Sophie; Fabre, Stephane; Esquerre, Diane; Dehais, Patrice; Djari, Anis; Pitel, Frederique] INRA, Genet Physiol & Syst Elevage, F-31326 Castanet Tolosan, France; [Fresard, Laure; Leroux, Sophie; Fabre, Stephane; Esquerre, Diane; Dehais, Patrice; Djari, Anis; Pitel, Frederique] Univ Toulouse, INP, ENSAT, Genet Physiol & Syst Elevage, Castanet Tolosan, France; [Fresard, Laure; Leroux, Sophie; Fabre, Stephane; Esquerre, Diane; Dehais, Patrice; Djari, Anis; Pitel, Frederique] Univ Toulouse, INP, ENVT, Genet Physiol & Syst Elevage, Toulouse, France; [Roux, Pierre-Francois; Lagarrigue, Sandrine] Agrocampus Ouest Physiol Environm & Genet Anim, Rennes, France; [Roux, Pierre-Francois; Lagarrigue, Sandrine] INRA, Physiol Environm & Genet Anim & Syst Elevage, F-35042 Rennes, France; [Klopp, Christophe; Dehais, Patrice; Djari, Anis] INRA, Sigenae Biometrie & Intelligence Artificielle, F-31326 Castanet Tolosan, France; [Esquerre, Diane] INRA, GeT PlaGe Genotoul, F-31326 Castanet Tolosan, France; [Gourichon, David] INRA, Pole Expt Avicole Tours, F-37380 Nouzilly, France	INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite de Toulouse; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse; Institut Agro; Agrocampus Ouest; INRAE; INRAE; INRAE; INRAE	Lagarrigue, S (corresponding author), Agrocampus Ouest Physiol Environm & Genet Anim, Rennes, France.	sandrine.lagarrigue@agrocampus-ouest.fr; frederique.pitel@toulouse.inra.fr	Pitel, Frédérique/C-2847-2009; FABRE, Stéphane/AAQ-8400-2020; Klopp, Christophe/J-3164-2019; Fabre, Stéphane/ABC-1483-2020; Roux, Pierre-François/J-8875-2019	Pitel, Frédérique/0000-0002-1477-7633; FABRE, Stéphane/0000-0001-7350-9500; Klopp, Christophe/0000-0001-7126-5477; Roux, Pierre-François/0000-0002-0695-4206; Lagarrigue, Sandrine/0000-0002-4887-7245; Fresard, Laure/0000-0001-8154-6328	Region Midi-Pyrenees and Animal Genetics Division (INRA); Region Bretagne and Animal Genetics Division (INRA); French Agence Nationale de la Recherche "EpiBird" grant [ANR-009-GENM-004]; INRA Animal Genetics Division ELASETIC program	Region Midi-Pyrenees and Animal Genetics Division (INRA)(Region Occitanie); Region Bretagne and Animal Genetics Division (INRA); French Agence Nationale de la Recherche "EpiBird" grant(French National Research Agency (ANR)); INRA Animal Genetics Division ELASETIC program	LF is supported by Region Midi-Pyrenees and Animal Genetics Division (INRA). PFR is co-supported by Region Bretagne and Animal Genetics Division (INRA). This work is supported by the French Agence Nationale de la Recherche "EpiBird" grant (ANR-009-GENM-004) and the INRA Animal Genetics Division ELASETIC program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athanasiadis A, 2004, PLOS BIOL, V2, P2144, DOI 10.1371/journal.pbio.0020391; Bahn JH, 2012, GENOME RES, V22, P142, DOI 10.1101/gr.124107.111; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Bazak L, 2014, GENOME RES, V24, P365, DOI 10.1101/gr.164749.113; BENNE R, 1986, CELL, V46, P819, DOI 10.1016/0092-8674(86)90063-2; Blanc V, 2003, J BIOL CHEM, V278, P1395, DOI 10.1074/jbc.R200024200; BORDAS A, 1992, BRIT POULTRY SCI, V33, P741, DOI 10.1080/00071669208417515; BUMSTEAD N, 1988, BRIT POULTRY SCI, V29, P521, DOI 10.1080/00071668808417078; Chen JY, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004274; Danecek P, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-4-r26; Daniel C, 2011, J BIOL CHEM, V286, P2031, DOI 10.1074/jbc.M110.130096; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Enstero M, 2009, NUCLEIC ACIDS RES, V37, P6916, DOI 10.1093/nar/gkp731; Fresard L, 2014, NUCLEIC ACIDS RES, V42, P3768, DOI 10.1093/nar/gkt1390; Garncarz W, 2013, RNA BIOL, V10, P192, DOI 10.4161/rna.23208; Gott JM, 2000, ANNU REV GENET, V34, P499, DOI 10.1146/annurev.genet.34.1.499; Gray MW, 2012, BIOCHEMISTRY-US, V51, P5235, DOI 10.1021/bi300419r; Gray MW, 2010, SCIENCE, V330, P920, DOI 10.1126/science.1198594; Groenen MAM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-274; Hansen KD, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq224; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Holmes AP, 2013, BIOGERONTOLOGY, V14, P395, DOI 10.1007/s10522-013-9433-8; Irimia M, 2012, RNA BIOL, V9, P12, DOI 10.4161/rna.9.1.18387; Kleinman CL, 2012, SCIENCE, V335, DOI [10.1126/science.1209658, 10.1126/science.1210624]; Knoop V, 2011, CELL MOL LIFE SCI, V68, P567, DOI 10.1007/s00018-010-0538-9; Kubota-Sakashita M, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-5; Lagarrigue S, 2013, GENETICS, V193, P1107, DOI 10.1534/genetics.112.149054; LAU PP, 1991, J BIOL CHEM, V266, P20550; Lee JH, 2013, RNA, V19, P725, DOI 10.1261/rna.037903.112; Levanon EY, 2005, NUCLEIC ACIDS RES, V33, P1162, DOI 10.1093/nar/gki239; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li MY, 2011, SCIENCE, V333, P53, DOI 10.1126/science.1207018; Maas S, 2011, BIOCHEM BIOPH RES CO, V412, P407, DOI 10.1016/j.bbrc.2011.07.075; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Olson Sue A, 2002, Brief Bioinform, V3, P87, DOI 10.1093/bib/3.1.87; Park E, 2012, GENOME RES, V22, P1626, DOI 10.1101/gr.134957.111; Peng ZY, 2012, NAT BIOTECHNOL, V30, P253, DOI 10.1038/nbt.2122; Picardi E, 2010, NUCLEIC ACIDS RES, V38, P4755, DOI 10.1093/nar/gkq202; Pickrell JK, 2012, SCIENCE, V335, DOI 10.1126/science.1210484; Pinto Y, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r5; Piskol R, 2013, NAT BIOTECHNOL, V31, P19, DOI 10.1038/nbt.2472; Ramaswami G, 2012, NAT METHODS, V9, P579, DOI [10.1038/NMETH.1982, 10.1038/nmeth.1982]; Ring H, 2010, VISUAL NEUROSCI, V27, P149, DOI 10.1017/S0952523810000180; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Savva YA, 2014, GENOME BIOL, V15, DOI 10.1186/gb4157; Schrider DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025842; Seeburg PH, 2003, CURR OPIN NEUROBIOL, V13, P279, DOI 10.1016/S0959-4388(03)00062-X; Severi F, 2011, MOL BIOL EVOL, V28, P1125, DOI 10.1093/molbev/msq338; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Shtrichman R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041576; Song WZ, 2004, J BIOL CHEM, V279, P32554, DOI 10.1074/jbc.M402392200; Speijer D, 2011, BIOESSAYS, V33, P344, DOI 10.1002/bies.201100010; TENG BB, 1992, J BIOL CHEM, V267, P21265; Tian N, 2011, NUCLEIC ACIDS RES, V39, P5669, DOI 10.1093/nar/gkr144; Veno MT, 2012, RNA BIOL, V9, P1054, DOI 10.4161/rna.21082; Wahlstedt H, 2009, GENOME RES, V19, P978, DOI 10.1101/gr.089409.108; Wang QD, 2000, J NEUROCHEM, V74, P1290; Wang Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S10-S5; Yang JH, 1997, P NATL ACAD SCI USA, V94, P4354, DOI 10.1073/pnas.94.9.4354	61	13	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0126776	10.1371/journal.pone.0126776	http://dx.doi.org/10.1371/journal.pone.0126776			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024316	Green Submitted, Green Published, gold			2022-12-26	WOS:000355319400019
J	Tedjo, DI; Jonkers, DMAE; Savelkoul, PH; Masclee, AA; van Best, N; Pierik, MJ; Penders, J				Tedjo, Danyta I.; Jonkers, Daisy M. A. E.; Savelkoul, Paul H.; Masclee, Ad A.; van Best, Niels; Pierik, Marieke J.; Penders, John			The Effect of Sampling and Storage on the Fecal Microbiota Composition in Healthy and Diseased Subjects	PLOS ONE			English	Article							EFFICACY	Large-scale cohort studies are currently being designed to investigate the human microbiome in health and disease. Adequate sampling strategies are required to limit bias due to shifts in microbial communities during sampling and storage. Therefore, we examined the impact of different sampling and storage conditions on the stability of fecal microbial communities in healthy and diseased subjects. Fecal samples from 10 healthy controls, 10 irritable bowel syndrome and 8 inflammatory bowel disease patients were collected on site, aliquoted immediately after defecation and stored at -80 degrees C, -20 degrees C for 1 week, at +4 degrees C or room temperature for 24 hours. Fecal transport swabs (FecalSwab, Copan) were collected and stored for 48-72 hours at room temperature. We used pyrosequencing of the 16S gene to investigate the stability of microbial communities. Alpha diversity did not differ between all storage methods and -80 degrees C, except for the fecal swabs. UPGMA clustering and principal coordinate analysis showed significant clustering by test subject (p<0.001) but not by storage method. Bray-Curtis dissimilarity and (un) weighted UniFrac showed a significant higher distance between fecal swabs and -80 degrees C versus the other methods and -80 degrees C samples (p<0.009). The relative abundance of Ruminococcus and Enterobacteriaceae did not differ between the storage methods versus -80 degrees C, but was higher in fecal swabs (p<0.05). Storage up to 24 hours (at +4 degrees C or room temperature) or freezing at -20 degrees C did not significantly alter the fecal microbial community structure compared to direct freezing of samples from healthy subjects and patients with gastrointestinal disorders.	[Tedjo, Danyta I.; Jonkers, Daisy M. A. E.; Masclee, Ad A.; Pierik, Marieke J.] Maastricht Univ, Med Ctr, Sch Nutr & Translat Res Metab NUTRIM, Div Gastroenterol Hepatol, NL-6200 MD Maastricht, Netherlands; [Tedjo, Danyta I.; Savelkoul, Paul H.; van Best, Niels; Penders, John] Maastricht Univ, Med Ctr, Sch Nutr & Translat Res Metab NUTRIM, Dept Med Microbiol, NL-6200 MD Maastricht, Netherlands; [Penders, John] Maastricht Univ, Sch Publ Hlth & Primary Care Caphri, Dept Epidemiol, NL-6200 MD Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University	Penders, J (corresponding author), Maastricht Univ, Med Ctr, Sch Nutr & Translat Res Metab NUTRIM, Dept Med Microbiol, NL-6200 MD Maastricht, Netherlands.	j.penders@maastrichtuniversity.nl	van Best, Niels/AAA-9232-2020; Penders, John/A-1280-2011	van Best, Niels/0000-0003-3577-7285; Penders, John/0000-0001-9146-5919	DSM; Grunenthal; Abott; Danone	DSM; Grunenthal(HAL Allergy Group); Abott; Danone(Danone Nutricia)	A. Masclee receives grants from DSM, Grunenthal, Abott and Danone. M. Pierik acted as a consultant for Takeda in the past and was a former lecturer for Abbvie, Falk, MSD and Ferning.	Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cardona S, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-158; Carroll IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046953; D'Haens G, 2007, GASTROENTEROLOGY, V132, P763, DOI 10.1053/j.gastro.2006.12.038; Dethlefsen L, 2006, TRENDS ECOL EVOL, V21, P517, DOI 10.1016/j.tree.2006.06.013; Dridi B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007063; Favalli C., 2013, ADV MICROBIOL, V2013, P504, DOI [10.4236/aim.2013.36067, DOI 10.4236/AIM.2013.36067]; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Lauber CL, 2010, FEMS MICROBIOL LETT, V307, P80, DOI 10.1111/j.1574-6968.2010.01965.x; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Mehal WZ, 2013, NAT REV GASTRO HEPAT, V10, P637, DOI 10.1038/nrgastro.2013.146; Musser JMB, 2011, J VET DIAGN INVEST, V23, P95, DOI 10.1177/104063871102300115; ODONNELL LJD, 1990, BMJ-BRIT MED J, V300, P439, DOI 10.1136/bmj.300.6722.439; Roesch Luiz F W, 2009, Open Microbiol J, V3, P40, DOI 10.2174/1874285800903010040; SANDBORN WJ, 1994, MAYO CLIN PROC, V69, P409, DOI 10.1016/S0025-6196(12)61634-6; Santiago A, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-112; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; WASFY M, 1995, J CLIN MICROBIOL, V33, P2176, DOI 10.1128/JCM.33.8.2176-2178.1995; Wu GD, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-206	20	113	117	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0126685	10.1371/journal.pone.0126685	http://dx.doi.org/10.1371/journal.pone.0126685			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024217	Green Published, gold, Green Submitted			2022-12-26	WOS:000355319400018
J	Yin, HC; Shakeel, M; Kuang, J; Li, JH				Yin, Haichen; Shakeel, Muhammad; Kuang, Jing; Li, Jianhong			An Opposite Pattern to the Conventional Thermal Hypothesis: Temperature-Dependent Variation in Coloration of Adults of Saccharosydne procerus (Homoptera: Delphacidae)	PLOS ONE			English	Article							IMMUNE FUNCTION; TRADE-OFFS; CUTICULAR MELANISM; PEPPERED MOTHS; RESISTANCE; MELANIZATION; PROPHYLAXIS; EXPRESSION; THERMOREGULATION; LEPIDOPTERA	Melanism is a common polymorphism in many insect species that also influences immune function. According to the thermal melanin hypothesis, ectothermic individuals from cooler environments have darker cuticles and higher polyphenol oxidase (PO) levels, which represent a better immunocompetence. In this study, the links among environmental temperature, melanism, and PO activity of Saccharosydne procerus (Matsumura) were examined. Most S. procerus have a black spot on their forewings at high temperatures in the field and in the laboratory. In PO activity assay, a positive association between PO level and temperature was found. Our results showed that a diversification of melanism occurred under different temperatures and that melanism in S. procerus presented an opposite pattern to the one proposed by the thermal hypothesis.	[Yin, Haichen; Shakeel, Muhammad; Li, Jianhong] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Peoples R China; [Kuang, Jing] Wuhan Vegetable Res Inst, Wuhan, Peoples R China	Huazhong Agricultural University	Li, JH (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Peoples R China.	jianhl@mail.hzau.edu.cn	Shakeel, Muhammad/B-5096-2019	Shakeel, Muhammad/0000-0002-8515-0053	National Key Technology RD Program [2012BAD27B00]; Hubei Research and Development Program [2011BBB043]; Fundamental Research Funds for the Central Universities [2014PY036]	National Key Technology RD Program(National Key Technology R&D Program); Hubei Research and Development Program; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by (1) National Key Technology R&D Program (grant no. 2012BAD27B00); (2) Hubei Research and Development Program (grant no. 2011BBB043); (3) Fundamental Research Funds for the Central Universities (grant no. 2014PY036). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsaei SM, 2013, EUR J ENTOMOL, V110, P241, DOI 10.14411/eje.2013.035; Armitage SAO, 2005, HEREDITY, V94, P650, DOI 10.1038/sj.hdy.6800675; Bailey NW, 2011, PHYSIOL ENTOMOL, V36, P155, DOI 10.1111/j.1365-3032.2011.00782.x; Barnes AI, 2000, P ROY SOC B-BIOL SCI, V267, P177, DOI 10.1098/rspb.2000.0984; BENJAMIN ND, 1973, J FOOD SCI, V38, P799, DOI 10.1111/j.1365-2621.1973.tb02079.x; Catalan TP, 2012, J INSECT PHYSIOL, V58, P1450, DOI 10.1016/j.jinsphys.2012.08.011; Christensen BM, 2005, TRENDS PARASITOL, V21, P192, DOI 10.1016/j.pt.2005.02.007; Clusella Trullas S, 2007, J THERM BIOL, V32, P235, DOI 10.1016/j.jtherbio.2007.01.013; Clusella-Trullas S, 2008, FUNCT ECOL, V22, P232, DOI 10.1111/j.1365-2435.2007.01377.x; Clusella-Trullas S, 2009, ECOLOGY, V90, P2297, DOI 10.1890/08-1502.1; Contreras-Garduno J, 2007, J INSECT PHYSIOL, V53, P612, DOI 10.1016/j.jinsphys.2007.03.003; Cotter SC, 2008, J EVOLUTION BIOL, V21, P1744, DOI 10.1111/j.1420-9101.2008.01587.x; Cotter SC, 2004, J EVOLUTION BIOL, V17, P421, DOI 10.1046/j.1420-9101.2003.00655.x; CREED ER, 1980, BIOL J LINN SOC, V13, P251, DOI 10.1111/j.1095-8312.1980.tb00086.x; DeJong PW, 1996, J EXP BIOL, V199, P2655; Dubovskiy IM, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0584; Eleftherianos I, 2011, J INNATE IMMUN, V3, P28, DOI 10.1159/000321931; Fedorka KM, 2013, EVOL ECOL, V27, P521, DOI 10.1007/s10682-012-9620-0; Futahashi R, 2011, INSECT BIOCHEM MOLEC, V41, P191, DOI 10.1016/j.ibmb.2010.12.003; Grant BS, 1996, J HERED, V87, P351, DOI 10.1093/oxfordjournals.jhered.a023013; HARRIS AC, 1988, J ROY SOC NEW ZEAL, V18, P333, DOI 10.1080/03036758.1988.10426474; Harvell D, 2009, ECOLOGY, V90, P912, DOI 10.1890/08-0616.1; Ito K, 2013, EXP APPL ACAROL, V60, P471, DOI 10.1007/s10493-013-9660-3; Karlsson M, 2010, EVOL ECOL, V24, P975, DOI 10.1007/s10682-010-9399-9; Kuang J, 2012, PRELIMINARY STUDY GR; Kutch IC, 2014, J EXP BIOL, V217, P3664, DOI 10.1242/jeb.106294; Lee KP, 2006, ECOL ENTOMOL, V31, P196, DOI 10.1111/j.0307-6946.2006.00780.x; Liu ZW, 2005, P NATL ACAD SCI USA, V102, P8420, DOI 10.1073/pnas.0502901102; Masuoka Y, 2013, ARTHROPOD STRUCT DEV, V42, P469, DOI 10.1016/j.asd.2013.08.003; Mills S, 2012, CORAL REEFS, V31, P603, DOI 10.1007/s00338-012-0883-2; Rajpurohit Subhash, 2008, Entomological Research, V38, P49, DOI 10.1111/j.1748-5967.2008.00129.x; Reeson AF, 1998, P ROY SOC B-BIOL SCI, V265, P1787, DOI 10.1098/rspb.1998.0503; Roulin A, 2016, BIOL REV, V91, P328, DOI 10.1111/brv.12171; Roulin A, 2014, GLOBAL CHANGE BIOL, V20, P3344, DOI 10.1111/gcb.12594; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; True JR, 2003, TRENDS ECOL EVOL, V18, P640, DOI 10.1016/j.tree.2003.09.006; van't Hof AE, 2011, SCIENCE, V332, P958, DOI 10.1126/science.1203043; Verhoog MD, 1996, PROCEEDINGS OF THE SECTION EXPERIMENTAL AND APPLIED ENTOMOLOGY OF THE NETHERLANDS ENTOMOLOGICAL SOCIETY (N.E.V.), VOL 7, 1996, P127; Wang S, 2013, J INSECT BEHAV, V26, P679; Wilson K, 1998, ECOL ENTOMOL, V23, P100, DOI 10.1046/j.1365-2311.1998.00107.x; Wilson K, 2001, ECOL LETT, V4, P637, DOI 10.1046/j.1461-0248.2001.00279.x; Wittkopp PJ, 2003, TRENDS GENET, V19, P495, DOI 10.1016/S0168-9525(03)00194-X; Yu XQ, 2003, INSECT BIOCHEM MOLEC, V33, P197, DOI 10.1016/S0965-1748(02)00191-1; Zufelato MS, 2004, INSECT BIOCHEM MOLEC, V34, P1257, DOI 10.1016/j.ibmb.2004.08.005	44	3	3	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128859	10.1371/journal.pone.0128859	http://dx.doi.org/10.1371/journal.pone.0128859			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024474	gold, Green Published, Green Submitted			2022-12-26	WOS:000355319400104
J	Ismail, MZB; Hodges, MD; Boylan, M; Achall, R; Shirras, A; Broughton, SJ				Ismail, Mohd Zamri Bin Haji; Hodges, Matt D.; Boylan, Michael; Achall, Rajesh; Shirras, Alan; Broughton, Susan J.			The Drosophila Insulin Receptor Independently Modulates Lifespan and Locomotor Senescence	PLOS ONE			English	Article							AGE-RELATED IMPAIRMENT; OXIDATIVE STRESS; CENTRAL COMPLEX; FUNCTIONAL SENESCENCE; NEGATIVE GEOTAXIS; GROWTH; GLUTAMATE; EXPRESSION; LONGEVITY; CELLS	The Insulin/IGF-like signalling (IIS) pathway plays an evolutionarily conserved role in ageing. In model organisms reduced IIS extends lifespan and ameliorates some forms of functional senescence. However, little is known about IIS in nervous system ageing and behavioural senescence. To investigate this role in Drosophila melanogaster, we measured the effect of reduced IIS on senescence of two locomotor behaviours, negative geotaxis and exploratory walking. Two long-lived fly models with systemic IIS reductions (daGAL4/UAS-InRDN (ubiquitous expression of a dominant negative insulin receptor) and d2GAL/UAS-rpr (ablation of insulin-like peptide producing cells)) showed an amelioration of negative geotaxis senescence similar to that previously reported for the long-lived IIS mutant chico. In contrast, exploratory walking in daGAL4/UAS-InRDN and d2GAL/UAS-rpr flies declined with age similarly to controls. To determine the contribution of IIS in the nervous system to these altered senescence patterns and lifespan, the InRDN was targeted to neurons (elavGAL4/UAS-InRDN), which resulted in extension of lifespan in females, normal negative geotaxis senescence in males and females, and detrimental effects on age-specific exploratory walking behaviour in males and females. These data indicate that the Drosophila insulin receptor independently modulates lifespan and age-specific function of different types of locomotor behaviour. The data suggest that ameliorated negative geotaxis senescence of long-lived flies with systemic IIS reductions is due to ageing related effects of reduced IIS outside the nervous system. The lifespan extension and coincident detrimental or neutral effects on locomotor function with a neuron specific reduction (elavGAL4/UAS-InRDN) indicates that reduced IIS is not beneficial to the neural circuitry underlying the behaviours despite increasing lifespan.	[Ismail, Mohd Zamri Bin Haji; Hodges, Matt D.; Boylan, Michael; Achall, Rajesh; Shirras, Alan; Broughton, Susan J.] Univ Lancaster, Fac Hlth & Med, Div Biomed & Life Sci, Lancaster LA1 4YQ, England	Lancaster University	Broughton, SJ (corresponding author), Univ Lancaster, Fac Hlth & Med, Div Biomed & Life Sci, Lancaster LA1 4YQ, England.	s.j.broughton@lancaster.ac.uk	Hodges, Matthew/GZB-0433-2022	Hodges, Matthew David John/0000-0002-6815-751X; Shirras, Alan/0000-0002-1377-5134; Broughton, Sue/0000-0001-8168-5387	Lancaster University; Government of Brunei Darussalam's Studentship	Lancaster University; Government of Brunei Darussalam's Studentship	Funding was provided by Lancaster University to SJB and AS, and by Government of Brunei Darussalam's Studentship to MZBHI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcedo J, 2004, NEURON, V41, P45, DOI 10.1016/S0896-6273(03)00816-X; Alic N, 2014, CELL REP, V6, P608, DOI 10.1016/j.celrep.2014.01.015; Bai H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003941; Barnes C, 2011, SCIENTIST, V25, P30; Bass TM, 2007, J GERONTOL A-BIOL, V62, P1071, DOI 10.1093/gerona/62.10.1071; Bhandari P, 2007, AGING CELL, V6, P631, DOI 10.1111/j.1474-9726.2007.00320.x; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; Broughton S, 2009, BIOCHEM J, V418, P1, DOI 10.1042/BJ20082102; Broughton SJ, 2010, AGING CELL, V9, P336, DOI 10.1111/j.1474-9726.2010.00558.x; Burger JMS, 2008, EVOLUTION, V62, P1294, DOI 10.1111/j.1558-5646.2008.00376.x; Burger JMS, 2006, EXP GERONTOL, V41, P1108, DOI 10.1016/j.exger.2006.08.008; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Cook-Wiens E, 2002, EXP GERONTOL, V37, P1347, DOI 10.1016/S0531-5565(02)00096-7; Costello DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031124; Demontis F, 2010, CELL, V143, P813, DOI 10.1016/j.cell.2010.10.007; Donahue AN, 2006, MECH AGEING DEV, V127, P57, DOI 10.1016/j.mad.2005.09.003; Droge W, 2007, AGING CELL, V6, P361, DOI 10.1111/j.1474-9726.2007.00294.x; Fedele G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5391; Garcia-Galloway E, 2003, MOL CELL NEUROSCI, V24, P1027, DOI 10.1016/j.mcn.2003.08.005; Gronke S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000857; Grotewiel MS, 2005, AGEING RES REV, V4, P372, DOI 10.1016/j.arr.2005.04.001; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Ikeya T, 2009, P ROY SOC B-BIOL SCI, V276, P3799, DOI 10.1098/rspb.2009.0778; Jones MA, 2011, EXP GERONTOL, V46, P320, DOI 10.1016/j.exger.2010.08.012; Jones MA, 2009, EXP GERONTOL, V44, P532, DOI 10.1016/j.exger.2009.05.007; Kahsai L, 2012, NEUROSCIENCE, V208, P11, DOI 10.1016/j.neuroscience.2012.02.007; Kahsai L, 2011, J COMP NEUROL, V519, P290, DOI 10.1002/cne.22520; Keller A, 2002, J NEUROBIOL, V50, P221, DOI 10.1002/neu.10029; Kerr F, 2011, NEUROBIOL AGING, V32, P1977, DOI 10.1016/j.neurobiolaging.2009.10.015; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kinney BA, 2001, HORM BEHAV, V39, P277, DOI 10.1006/hbeh.2001.1654; Martin I, 2006, EXP GERONTOL, V41, P877, DOI 10.1016/j.exger.2006.06.052; Martin JR, 2004, BEHAV PROCESS, V67, P207, DOI 10.1016/j.beproc.2004.04.003; Martin-Pena A, 2007, J NEUROCHEM, V102, P15; Rakshit K, 2013, AGING CELL, V12, P752, DOI 10.1111/acel.12100; Rhodenizer D, 2008, EXP GERONTOL, V43, P739, DOI 10.1016/j.exger.2008.04.011; Rival T, 2004, CURR BIOL, V14, P599, DOI 10.1016/j.cub.2004.03.039; Robie AA, 2010, J EXP BIOL, V213, P2494, DOI 10.1242/jeb.041749; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Selman C, 2008, SCIENCE, V320, DOI 10.1126/science.1152366; Selman C, 2008, FASEB J, V22, P807, DOI 10.1096/fj.07-9261com; Serway CN, 2009, J NEUROGENET, V23, P173, DOI 10.1080/01677060802572895; Simon AF, 2006, MECH AGEING DEV, V127, P647, DOI 10.1016/j.mad.2006.02.006; Skorokhod A, 1999, BIOL BULL-US, V197, P198, DOI 10.2307/1542615; Strauss R, 2002, CURR OPIN NEUROBIOL, V12, P633, DOI 10.1016/S0959-4388(02)00385-9; Sun LY, 2005, NEUROBIOL AGING, V26, P929, DOI 10.1016/j.neurobiolaging.2004.07.010; Taguchi A, 2007, SCIENCE, V317, P369, DOI 10.1126/science.1142179; Tomioka M, 2006, NEURON, V51, P613, DOI 10.1016/j.neuron.2006.07.024; Vellai T, 2006, GENETICS, V174, P309, DOI 10.1534/genetics.106.061499; Werren JH, 2000, P ROY SOC B-BIOL SCI, V267, P1277, DOI 10.1098/rspb.2000.1139; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147; Yang JL, 2011, MECH AGEING DEV, V132, P405, DOI 10.1016/j.mad.2011.06.005	54	21	22	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0125312	10.1371/journal.pone.0125312	http://dx.doi.org/10.1371/journal.pone.0125312			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020640	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000355187300012
J	Li, SF; Wang, ML; Shen, S; Hu, ZH; Wang, HL; Deng, F				Li, Shufen; Wang, Manli; Shen, Shu; Hu, Zhihong; Wang, Hualin; Deng, Fei			The FP25K Acts as a Negative Factor for the Infectivity of AcMNPV Budded Virus	PLOS ONE			English	Article							NUCLEAR POLYHEDROSIS-VIRUS; AUTOGRAPHA-CALIFORNICA NUCLEOPOLYHEDROVIRUS; OCCLUSION-DERIVED VIRUS; SINGLE NUCLEOCAPSID NUCLEOPOLYHEDROVIRUS; BACULOVIRUS EXPRESSION VECTORS; GP64 ENVELOPE GLYCOPROTEIN; PROTEIN-COMPOSITION; TRICHOPLUSIA-NI; SERIAL PASSAGE; FUSION PROTEIN	Baculoviruses generally produce two progeny phenotypes-the budded virus (BV) and the occlusion-derived virus (ODV)-and the intricate mechanisms that regulate the temporal synthesis of the two phenotypes are critical for the virus replication cycle, which are far from being clearly understood. FP25K was reported to be responsible for the regulation of BV/ODV, and the mutations within result in a decrease of normal ODVs formation and an increase of BVs production. In this study, we demonstrated that the increase of BV titer in an fp25k knockout recombinant (fp25k-negative) was a result of higher infectivity of BVs rather than an increased production of BVs. The constitution of the major structural proteins and genome of parental and fp25k-negative BVs were analyzed. The results showed that the integrity of the majority of DNA packaged into the fp25k-negative BVs was intact; i.e., the genomic DNA of fp25k-negative BV had better transformation and transfection efficiency than that of the parental virus, indicating more intact genomes in the virions. Although the analysis of proteins associated with BVs revealed that more envelope protein GP64 were incorporated into the fp25k-negative BVs, subsequent experiments suggested that overexpression of GP64 did not improve the titer of BVs. Thus, we conclude that the main reason for higher infectivity of BVs is due to better genome integrity, which benefits from the deletion of fp25k resulting in increased stability of the genome and produce a higher proportion of infectious BVs. FP25K acts as a negative factor for the infectivity of BV.	[Li, Shufen; Wang, Manli; Shen, Shu; Hu, Zhihong; Wang, Hualin; Deng, Fei] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS	Wang, HL (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China.	h.wang@wh.iov.cn; df@wh.iov.cn	Hu, Zhihong/AAS-2215-2020	Hu, Zhihong/0000-0002-1560-0928; shen, shu/0000-0002-0013-5365	National Science Foundation of China [31125003, 31130058, 31321001]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by grants from the National Science Foundation of China (Grant Nos. 31125003, 31130058, and 31321001). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEAMES B, 1989, VIROLOGY, V168, P344, DOI 10.1016/0042-6822(89)90275-4; BEAMES B, 1988, VIROLOGY, V162, P206, DOI 10.1016/0042-6822(88)90410-2; BLISSARD GW, 1989, VIROLOGY, V170, P537, DOI 10.1016/0042-6822(89)90445-5; BLISSARD GW, 1992, J VIROL, V66, P6829, DOI 10.1128/JVI.66.11.6829-6835.1992; Braunagel SC, 2004, P NATL ACAD SCI USA, V101, P8372, DOI 10.1073/pnas.0402727101; Braunagel SC, 2003, P NATL ACAD SCI USA, V100, P9797, DOI 10.1073/pnas.1733972100; Braunagel SC, 1999, J VIROL, V73, P8559, DOI 10.1128/JVI.73.10.8559-8570.1999; Deng F, 2007, J VIROL, V81, P9377, DOI 10.1128/JVI.00632-07; Fang M, 2007, J VIROL, V81, P9859, DOI 10.1128/JVI.00588-07; Giri L, 2012, J GEN VIROL, V93, P389, DOI 10.1099/vir.0.036566-0; GRANADOS RR, 1981, VIROLOGY, V108, P297, DOI 10.1016/0042-6822(81)90438-4; Harrison RL, 1996, VIROLOGY, V226, P34, DOI 10.1006/viro.1996.0625; HARRISON RL, 1995, J GEN VIROL, V76, P1451, DOI 10.1099/0022-1317-76-6-1451; HINK WF, 1973, J INVERTEBR PATHOL, V22, P168, DOI 10.1016/0022-2011(73)90129-8; Hitchman RB, 2010, BIOTECHNOL APPL BIOC, V56, P85, DOI 10.1042/BA20090130; Hou DH, 2013, J VIROL, V87, P829, DOI 10.1128/JVI.02329-12; Hou S, 2002, BIOTECHNIQUES, V32, P783, DOI 10.2144/02324st04; Kaba SA, 2004, J VIROL METHODS, V122, P113, DOI 10.1016/j.jviromet.2004.07.006; KEDDIE BA, 1989, SCIENCE, V243, P1728, DOI 10.1126/science.2648574; KOOL M, 1991, VIROLOGY, V183, P739, DOI 10.1016/0042-6822(91)91003-Y; Li Shu-fen, 2012, Virologica Sinica, V27, P71, DOI 10.1007/s12250-012-3236-y; Liu XY, 2008, INTERVIROLOGY, V51, P369, DOI 10.1159/000193462; Monsma SA, 1996, J VIROL, V70, P4607, DOI 10.1128/JVI.70.7.4607-4616.1996; Oomens AGP, 1999, VIROLOGY, V254, P297, DOI 10.1006/viro.1998.9523; OReilly D.R., 1992, BACULOVIRUS EXPRESSI; Perera O, 2007, J VIROL, V81, P4585, DOI 10.1128/JVI.02391-06; Pijlman GP, 2003, J GEN VIROL, V84, P2669, DOI 10.1099/vir.0.19438-0; POTTER KN, 1976, J VIROL, V18, P1040; ROHRMANN GF, 1992, J GEN VIROL, V73, P749, DOI 10.1099/0022-1317-73-4-749; Rosas-Acosta G, 2001, J VIROL, V75, P10829, DOI 10.1128/JVI.75.22.10829-10842.2001; Sambrook J, 2006, CONDENSED PROTOCOLS, V800; Shen S, 2012, J GEN VIROL, V93, P2705, DOI 10.1099/vir.0.046458-0; SUMMERS MD, 1971, J ULTRA MOL STRUCT R, V35, P606, DOI 10.1016/S0022-5320(71)80014-X; VAUGHN JL, 1977, IN VITRO CELL DEV B, V13, P213; VOLKMAN LE, 1977, J INVERTEBR PATHOL, V30, P102, DOI 10.1016/0022-2011(77)90045-3; Wang ML, 2008, J VIROL, V82, P9800, DOI 10.1128/JVI.00759-08; Wang ML, 2010, J VIROL, V84, P8821, DOI 10.1128/JVI.00072-10; Wang RR, 2010, J VIROL, V84, P7233, DOI 10.1128/JVI.00040-10; Wu D, 2005, J GEN VIROL, V86, P2439, DOI 10.1099/vir.0.81110-0; Wu WB, 2008, J VIROL, V82, P12356, DOI 10.1128/JVI.00948-08	40	3	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128471	10.1371/journal.pone.0128471	http://dx.doi.org/10.1371/journal.pone.0128471			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020780	Green Published, gold, Green Submitted			2022-12-26	WOS:000355187300115
J	Shankar, M; Mohapatra, SS; Biswas, S; Biswas, I				Shankar, Manoharan; Mohapatra, Saswat S.; Biswas, Saswati; Biswas, Indranil			Gene Regulation by the LiaSR Two-Component System in Streptococcus mutans	PLOS ONE			English	Article							ENVELOPE STRESS-RESPONSE; BACILLUS-SUBTILIS; STAPHYLOCOCCUS-AUREUS; KINETIC CHARACTERIZATION; LIAFSR SYSTEM; PROTEINS; PHOSPHORYLATION; EXPRESSION; VIRULENCE; OPERON	The LiaSR two-component signal transduction system regulates cellular responses to several environmental stresses, including those that induce cell envelope damages. Downstream regulons of the LiaSR system have been implicated in tolerance to acid, antibiotics and detergents. In the dental pathogen Streptococcus mutans, the LiaSR system is necessary for tolerance against acid, antibiotics, and cell wall damaging stresses during growth in the oral cavity. To understand the molecular mechanisms by which LiaSR regulates gene expression, we created a mutant LiaR in which the conserved aspartic acid residue (the phosphorylation site), was changed to alanine residue (D58A). As expected, the LiaR-D58A variant was unable to acquire the phosphate group and bind to target promoters. We also noted that the predicted LiaR-binding motif upstream of the lia operon does not appear to be well conserved. Consistent with this observation, we found that LiaR was unable to bind to the promoter region of lia; however, we showed that LiaR was able to bind to the promoters of SMU. 753, SMU. 2084 and SMU. 1727. Based on sequence analysis and DNA binding studies we proposed a new 25-bp conserved motif essential for LiaR binding. Introducing alterations at fully conserved positions in the 25-bp motif affected LiaR binding, and the binding was dependent on the combination of positions that were altered. By scanning the S. mutans genome for the occurrence of the newly defined LiaR binding motif, we identified the promoter of hrcA (encoding a key regulator of the heat shock response) that contains a LiaR binding motif, and we showed that hrcA is negatively regulated by the LiaSR system. Taken together our results suggest a putative role of the LiaSR system in heat shock responses of S. mutans.	[Shankar, Manoharan; Mohapatra, Saswat S.; Biswas, Saswati; Biswas, Indranil] Univ Kansas, Med Ctr, Dept Microbiol Mol Genet & Immunol, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center	Biswas, I (corresponding author), Univ Kansas, Med Ctr, Dept Microbiol Mol Genet & Immunol, Kansas City, KS 66103 USA.	ibiswas@kumc.edu	Mohapatra, Saswat Sourav/B-6487-2011; Manoharan, Shankar/M-9826-2016; Manoharan, Shankar/AAG-4459-2020	Mohapatra, Saswat Sourav/0000-0003-2776-1363; Manoharan, Shankar/0000-0001-8030-2073; Manoharan, Shankar/0000-0001-8030-2073	NIH (NIDCR) [DE22660]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022660] Funding Source: NIH RePORTER	NIH (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by NIH (NIDCR), DE22660 (www.nih.gov).	Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Banerjee A, 2008, APPL ENVIRON MICROB, V74, P2037, DOI 10.1128/AEM.02346-07; Barbieri CM, 2008, ANAL BIOCHEM, V376, P73, DOI 10.1016/j.ab.2008.02.004; Beier D, 2006, CURR OPIN MICROBIOL, V9, P143, DOI 10.1016/j.mib.2006.01.005; Belcheva A, 2008, J BIOL CHEM, V283, P12354, DOI 10.1074/jbc.M710010200; Biswas S, 2006, J BACTERIOL, V188, P988, DOI 10.1128/JB.188.3.988-998.2006; Boll JM, 2011, P NATL ACAD SCI USA, V108, P20160, DOI 10.1073/pnas.1113013108; Butcher BG, 2007, J BACTERIOL, V189, P8616, DOI 10.1128/JB.01181-07; Chong P, 2008, INFECT IMMUN, V76, P3093, DOI 10.1128/IAI.01627-07; Concepcion J, 2009, COMB CHEM HIGH T SCR, V12, P791, DOI 10.2174/138620709789104915; Dmitriev A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020127; Eldholm V, 2010, J BACTERIOL, V192, P1761, DOI 10.1128/JB.01489-09; Fritsch F, 2011, MICROBIOL-SGM, V157, P373, DOI 10.1099/mic.0.044776-0; Galbusera E, 2011, ANTIMICROB AGENTS CH, V55, P1008, DOI 10.1128/AAC.00720-10; Gao R, 2009, ANNU REV MICROBIOL, V63, P133, DOI 10.1146/annurev.micro.091208.073214; Gotoh Y, 2010, CURR OPIN MICROBIOL, V13, P232, DOI 10.1016/j.mib.2010.01.008; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Jordan S, 2007, MICROBIOL-SGM, V153, P2530, DOI 10.1099/mic.0.2007/006817-0; Jordan S, 2006, J BACTERIOL, V188, P5153, DOI 10.1128/JB.00310-06; Kajfasz JK, 2010, J BACTERIOL, V192, P2546, DOI 10.1128/JB.00028-10; Kinoshita E, 2012, PROTEOMICS, V12, P192, DOI 10.1002/pmic.201100524; Klinzing DC, 2013, MICROBIOL-SGM, V159, P1521, DOI 10.1099/mic.0.064444-0; Kuroda M, 2003, MOL MICROBIOL, V49, P807, DOI 10.1046/j.1365-2958.2003.03599.x; Laub MT, 2007, ANNU REV GENET, V41, P121, DOI 10.1146/annurev.genet.41.042007.170548; Lemos JAC, 2001, J BACTERIOL, V183, P6074, DOI 10.1128/JB.183.20.6074-6084.2001; LUKAT GS, 1992, P NATL ACAD SCI USA, V89, P718, DOI 10.1073/pnas.89.2.718; Mascher T, 2004, ANTIMICROB AGENTS CH, V48, P2888, DOI 10.1128/AAC.48.8.2888-2896.2004; Mascher T, 2003, MOL MICROBIOL, V50, P1591, DOI 10.1046/j.1365-2958.2003.03786.x; McCallum N, 2011, ANTIMICROB AGENTS CH, V55, P1391, DOI 10.1128/AAC.01213-10; Munita JM, 2014, CLIN INFECT DIS, V59, P1277, DOI 10.1093/cid/ciu642; Perry JA, 2008, LETT APPL MICROBIOL, V47, P439, DOI 10.1111/j.1472-765X.2008.02455.x; Qureshi NK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085873; Roces C, 2009, INT J FOOD MICROBIOL, V133, P279, DOI 10.1016/j.ijfoodmicro.2009.06.002; Schachern PA, 2014, INT J PEDIATR OTORHI, V78, P1517, DOI 10.1016/j.ijporl.2014.06.024; Scharf BE, 2010, CURR OPIN MICROBIOL, V13, P246, DOI 10.1016/j.mib.2010.01.006; Schrecke K, 2013, MOL MICROBIOL, V87, P769, DOI 10.1111/mmi.12130; Schulz A, 1996, J BACTERIOL, V178, P1088, DOI 10.1128/jb.178.4.1088-1093.1996; Silversmith RE, 1997, BIOCHEMISTRY-US, V36, P14965, DOI 10.1021/bi9715573; Suntharalingam P, 2009, J BACTERIOL, V191, P2973, DOI 10.1128/JB.01563-08; Worthington RJ, 2013, FUTURE MED CHEM, V5, P1265, DOI 10.4155/fmc.13.58; Wu ZC, 2013, J BACTERIOL, V195, P4545, DOI 10.1128/JB.00792-13; Yin SH, 2006, ANTIMICROB AGENTS CH, V50, P336, DOI 10.1128/AAC.50.1.336-343.2006; Zhang JQ, 2009, MICROBIOL-SGM, V155, P61, DOI 10.1099/mic.0.023077-0	43	21	25	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128083	10.1371/journal.pone.0128083	http://dx.doi.org/10.1371/journal.pone.0128083			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020679	Green Published, gold, Green Submitted			2022-12-26	WOS:000355187300078
J	Eiri, DM; Suwannapong, G; Endler, M; Nieh, JC				Eiri, Daren M.; Suwannapong, Guntima; Endler, Matthew; Nieh, James C.			Nosema ceranae Can Infect Honey Bee Larvae and Reduces Subsequent Adult Longevity	PLOS ONE			English	Article							APIS-MELLIFERA; MICROSPORIDIA; VIRULENCE; COLONIES; PARASITE; DISEASE; BOMBI; SUSCEPTIBILITY; HYMENOPTERA; PATHOGEN	Nosema ceranae causes a widespread disease that reduces honey bee health but is only thought to infect adult honey bees, not larvae, a critical life stage. We reared honey bee (Apis mellifera) larvae in vitro and provide the first demonstration that N. ceranae can infect larvae and decrease subsequent adult longevity. We exposed three-day-old larvae to a single dose of 40,000 (40K), 10,000 (10K), zero (control), or 40K autoclaved (control) N. ceranae spores in larval food. Spores developed intracellularly in midgut cells at the pre-pupal stage (8 days after egg hatching) of 41% of bees exposed as larvae. We counted the number of N. ceranae spores in dissected bee midguts of pre-pupae and, in a separate group, upon adult death. Pre-pupae exposed to the 10K or 40K spore treatments as larvae had significantly elevated spore counts as compared to controls. Adults exposed as larvae had significantly elevated spore counts as compared to controls. Larval spore exposure decreased longevity: a 40K treatment decreased the age by which 75% of adult bees died by 28%. Unexpectedly, the low dose (10K) led to significantly greater infection (1.3 fold more spores and 1.5 fold more infected bees) than the high dose (40K) upon adult death. Differential immune activation may be involved if the higher dose triggered a stronger larval immune response that resulted in fewer adult spores but imposed a cost, reducing lifespan. The impact of N. ceranae on honey bee larval development and the larvae of naturally infected colonies therefore deserve further study.	[Eiri, Daren M.; Endler, Matthew; Nieh, James C.] Univ Calif San Diego, Div Biol Sci, Sect Ecol Behav & Evolut, La Jolla, CA 92093 USA; [Suwannapong, Guntima] Burapha Univ, Fac Sci, Dept Biol, Chon Buri 20131, Thailand	University of California System; University of California San Diego; Burapha University	Eiri, DM (corresponding author), Univ Calif San Diego, Div Biol Sci, Sect Ecol Behav & Evolut, 9500 Gilman Dr,MC 0116, La Jolla, CA 92093 USA.	dareneiri@gmail.com	Nieh, James C/H-8705-2014; Suwannapong, Guntima/AAV-8447-2021	Nieh, James C/0000-0001-6237-0726; Suwannapong, Guntima/0000-0002-3180-4103	University of California San Diego Academic Senate; National Honey Board; North American Pollinator Protection Campaign	University of California San Diego Academic Senate; National Honey Board; North American Pollinator Protection Campaign	This research was made possible by funding from the University of California San Diego Academic Senate (https://senate.ucsd.edu/), National Honey Board (http://www.honey.com/honey-industry/honey-and-bee-research/honey-bee-research/c/2012-research-projects), and the North American Pollinator Protection Campaign (http://www.pollinator.org/honeybee_health.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 2009, CURR BIOL, V19, P915, DOI 10.1016/j.cub.2009.03.071; Aufauvre J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00326; BAILEY L, 1955, PARASITOLOGY, V45, P86, DOI 10.1017/S0031182000027451; Blaser M, 2005, J INVERTEBR PATHOL, V89, P251, DOI 10.1016/j.jip.2005.04.004; Botias C, 2012, RES VET SCI, V93, P150, DOI 10.1016/j.rvsc.2011.08.002; Calderone, 2000, BEE CULT, V128, P1, DOI DOI 10.3896/IBRA.1.49.1.01; Cameron SA, 2001, SYST BIOL, V50, P194, DOI 10.1080/10635150151125851; CANTWELL G E, 1970, American Bee Journal, V110, P222; Chaimanee V, 2013, VET PARASITOL, V193, P260, DOI 10.1016/j.vetpar.2012.12.004; Chaimanee V, 2012, J INSECT PHYSIOL, V58, P1090, DOI 10.1016/j.jinsphys.2012.04.016; Cornman RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043562; Crailsheim K, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.05; da Cruz-Landim C, 2003, ZOOL SCI, V20, P1099, DOI 10.2108/zsj.20.1099; Dadant, 1975, HIV HON; Dainat B, 2012, ENV MICROBIOL REP, V4, P123, DOI 10.1111/j.1758-2229.2011.00312.x; Di Pasquale G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072016; Dussaubat C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037017; FISHER FM, 1962, J PARASITOL, V48, P926, DOI 10.2307/3275124; Fontbonne R, 2013, INFECT GENET EVOL, V17, P188, DOI 10.1016/j.meegid.2013.04.016; Forsgren E, 2010, VET PARASITOL, V170, P212, DOI 10.1016/j.vetpar.2010.02.010; Fries I, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.14; Fujiwara T., 1979, Journal of Sericultural Science of Japan, V48, P376; Fukuda H., 1968, Researches on Population Ecology Kyoto University, V10, P31, DOI 10.1007/BF02514731; Genersch E, 2010, APIDOLOGIE, V41, P332, DOI 10.1051/apido/2010014; Gisder S, 2013, J INVERTEBR PATHOL, V113, P1, DOI 10.1016/j.jip.2013.01.004; Gisder S, 2010, APPL ENVIRON MICROB, V76, P3032, DOI 10.1128/AEM.03097-09; Goblirsch M, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058165, 10.1371/journal.pone.0069831]; Hakim RS, 2010, ANNU REV ENTOMOL, V55, P593, DOI 10.1146/annurev-ento-112408-085450; HASSANEIN MH, 1951, ANN APPL BIOL, V38, P844, DOI 10.1111/j.1744-7348.1951.tb07854.x; Higes M, 2008, ENVIRON MICROBIOL, V10, P2659, DOI 10.1111/j.1462-2920.2008.01687.x; Higes M, 2008, J INVERTEBR PATHOL, V97, P76, DOI 10.1016/j.jip.2007.06.002; Higes M, 2007, J INVERTEBR PATHOL, V94, P211, DOI 10.1016/j.jip.2006.11.001; Higes M, 2013, ENV MICROBIOL REP, V5, P17, DOI 10.1111/1758-2229.12024; Higes M, 2010, ENV MICROBIOL REP, V2, P243, DOI 10.1111/j.1758-2229.2009.00099.x; Huang Q, 2014, APIDOLOGIE, V45, P248, DOI 10.1007/s13592-013-0243-4; Huang Q, 2012, J INVERTEBR PATHOL, V109, P297, DOI 10.1016/j.jip.2012.01.004; Huang WF, 2007, APIDOLOGIE, V38, P30, DOI 10.1051/apido:2006054; Huang WF, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003185; Huang WF, 2013, J INVERTEBR PATHOL, V113, P35, DOI 10.1016/j.jip.2013.01.001; Huang Z, 2009, STANDARDIZED PROCEDU; HUANG ZY, 1991, J INSECT BEHAV, V4, P305, DOI 10.1007/BF01048280; Kaftanoglu O, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.9601; KELLEN WR, 1968, J INVERTEBR PATHOL, V11, P104, DOI 10.1016/0022-2011(68)90059-1; Kralj J, 2010, APIDOLOGIE, V41, P21, DOI 10.1051/apido/2009046; Losey JE, 2006, BIOSCIENCE, V56, P311, DOI 10.1641/0006-3568(2006)56[311:TEVOES]2.0.CO;2; Maiolino P., 2014, VET MED ANIM SCI, V2, P4, DOI [10.7243/2054-3425-2-4, DOI 10.7243/2054-3425-2-4]; Martin-Hernandez R, 2011, PARASITOL RES, V109, P605, DOI 10.1007/s00436-011-2292-9; Mayack C, 2009, J INVERTEBR PATHOL, V100, P185, DOI 10.1016/j.jip.2008.12.001; Meana A, 2010, J APICULT RES, V49, P212, DOI 10.3896/IBRA.1.49.2.12; Neumann P, 2013, J APICULT RES, V52, P1, DOI [10.3896/IBRA.1.52.1.04, DOI 10.3896/IBRA.1.52.1.04]; Otti O, 2008, ECOL ENTOMOL, V33, P577, DOI 10.1111/j.1365-2311.2008.00998.x; Paxton RJ, 2007, APIDOLOGIE, V38, P558, DOI 10.1051/apido:2007037; Pettis JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070182; Pettis JS, 2012, NATURWISSENSCHAFTEN, V99, P153, DOI 10.1007/s00114-011-0881-1; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Rennich K, 2012, NATL HONEY BEE PESTS; Rueppell O, 2010, J EVOLUTION BIOL, V23, P1538, DOI 10.1111/j.1420-9101.2010.02022.x; Rutrecht ST, 2008, APIDOLOGIE, V39, P504, DOI 10.1051/apido:2008031; Schmid-Hempel P, 1998, APIDOLOGIE, V29, P525, DOI 10.1051/apido:19980605; Smart MD, 2012, J INVERTEBR PATHOL, V109, P148, DOI 10.1016/j.jip.2011.09.009; Smith ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043319; SOLTER LF, 1990, J INVERTEBR PATHOL, V55, P337, DOI 10.1016/0022-2011(90)90076-I; Spivak M, 2001, APIDOLOGIE, V32, P555, DOI 10.1051/apido:2001103; Spleen AM, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.2.07; Suwannapong G, 2011, J INVERTEBR PATHOL, V106, P236, DOI 10.1016/j.jip.2010.10.003; Suwannapong G, 2010, J ASIA-PAC ENTOMOL, V13, P361, DOI 10.1016/j.aspen.2010.07.003; Swanson JAI, 2009, J CHEM ECOL, V35, P1108, DOI 10.1007/s10886-009-9683-8; Traver BE, 2012, J INVERTEBR PATHOL, V110, P408, DOI 10.1016/j.jip.2012.04.001; Traver BE, 2011, J INVERTEBR PATHOL, V107, P234, DOI 10.1016/j.jip.2011.05.016; UNDEEN AH, 1973, J INVERTEBR PATHOL, V22, P258, DOI 10.1016/0022-2011(73)90143-2; van der Steen JJM, 2008, APIDOLOGIE, V39, P273, DOI 10.1051/apido:2008006; vanEngelsdorp D, 2010, J ECON ENTOMOL, V103, P1517, DOI 10.1603/EC09429; Vidau C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021550; Webster TC, 2004, APIDOLOGIE, V35, P49, DOI 10.1051/apido:2003063; Winfree R, 2011, ECOL ECON, V71, P80, DOI 10.1016/j.ecolecon.2011.08.001; Winston M., 1987, The biology of the honey bee.; Zhu WY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0077547	77	58	63	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0126330	10.1371/journal.pone.0126330	http://dx.doi.org/10.1371/journal.pone.0126330			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018139	Green Published, gold			2022-12-26	WOS:000355185600049
J	Gong, M; Yang, JT; Liu, YQ; Tang, LH; Wang, Y; Wang, LJ; Zhang, FJ; Yan, M				Gong, Ming; Yang, Jin-Ting; Liu, Yun-Qing; Tang, Li-Hui; Wang, Yin; Wang, Lie-Ju; Zhang, Feng-Jiang; Yan, Min			Irradiation Can Selectively Kill Tumor Cells while Preserving Erythrocyte Viability in a Co-Culture System	PLOS ONE			English	Article							INTRAOPERATIVE BLOOD SALVAGE; LEUKOCYTE DEPLETION FILTERS; CANCER-SURGERY; HEPATOCELLULAR-CARCINOMA; RADICAL PROSTATECTOMY; EFFICIENT ELIMINATION; AUTOTRANSFUSION; TRANSFUSION; MODELS; MOUSE	An understanding of how to safely apply intraoperative blood salvage (IBS) in cancer surgery has not yet been obtained. Here, we investigated the optimal dose of Cs-137 gamma-ray irradiation for killing human hepatocarcinoma (HepG2), gastrocarcinoma (SGC7901), and colonic carcinoma (SW620) tumor cells while preserving co-cultured erythrocytes obtained from 14 healthy adult volunteers. HepG2, SGC7901, or SW620 cells were mixed into the aliquots of erythrocytes. After the mixed cells were treated with Cs-137 gamma-ray irradiation (30, 50, and 100 Gy), tumor cells and erythrocytes were separated by density gradient centrifugation in Percoll with a density of 1.063 g/ml. The viability, clonogenicity, DNA synthesis, tumorigenicity, and apoptosis of the tumor cells were determined by MTT assay, plate colony formation, 5-ethynyl-2'-deoxyuridine (EdU) incorporation, subcutaneous xenograft implantation into immunocompromised mice, and annexin V/7-AAD staining, respectively. The ATP concentration, 2,3-DPG level, free Hb concentration, osmotic fragility, membrane phosphatidylserine externalization, blood gas variables, reactive oxygen species levels, and superoxide dismutase levels in erythrocytes were analyzed. We found that Cs-137 gamma-ray irradiation at 50 Gy effectively inhibited the viability, proliferation, and tumorigenicity of HepG2, SGC7901, and SW620 cells without markedly damaging the oxygen-carrying ability or membrane integrity or increasing the oxidative stress of erythrocytes in vitro. These results demonstrated that 50 Gy irradiation in a standard Cs-137 blood irradiator might be a safe and effective method of inactivating HepG2, SGC7901, and SW620 cells mixed with erythrocytes, which might help to safely allow IBS in cancer surgery.	[Gong, Ming; Yang, Jin-Ting; Tang, Li-Hui; Zhang, Feng-Jiang; Yan, Min] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Anesthesiol, Hangzhou 310009, Zhejiang, Peoples R China; [Liu, Yun-Qing; Wang, Yin; Wang, Lie-Ju] Xuzhou Med Coll, Jiangsu Prov Key Lab Anesthesiol, Xuzhou 221004, Peoples R China	Zhejiang University; Xuzhou Medical University	Yan, M (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Anesthesiol, Hangzhou 310009, Zhejiang, Peoples R China.	zryanmin@zju.edu.cn			Chinese Ministry of Health-Zhejiang Health Department, China [WKJ2008-2-021, WKJ2013-2-019]	Chinese Ministry of Health-Zhejiang Health Department, China	This work was supported by grants for Scientific Research from Chinese Ministry of Health-Zhejiang Health Department, China (WKJ2008-2-021 and WKJ2013-2-019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adias TC, 2006, S AFR J SURG, V44, P114; Bosman GJCGM, 2011, TRANSFUSION, V51, P1072, DOI 10.1111/j.1537-2995.2010.02929.x; Bower MR, 2011, ANN SURG ONCOL, V18, P166, DOI 10.1245/s10434-010-1228-4; BUTTON LN, 1981, TRANSFUSION, V21, P419, DOI 10.1046/j.1537-2995.1981.21481275998.x; Catling S, 2008, ANAESTHESIA, V63, P1332, DOI 10.1111/j.1365-2044.2008.05637.x; Choi ES, 2013, ANAESTHESIA, V68, P1259, DOI 10.1111/anae.12420; d'Almeida MS, 2000, TRANSFUSION MED, V10, P291, DOI 10.1046/j.1365-3148.2000.00267.x; Eriksson D, 2010, TUMOR BIOL, V31, P363, DOI 10.1007/s13277-010-0042-8; Futamura N, 2005, AM SURGEON, V71, P585; George A, 2013, BLOOD, V121, P2099, DOI 10.1182/blood-2012-07-441188; Gobbel GT, 2001, J NEUROCHEM, V76, P520, DOI 10.1046/j.1471-4159.2001.00070.x; Gorin MA, 2012, WORLD J UROL, V30, P379, DOI 10.1007/s00345-011-0746-4; Gu YJ, 2009, EUR J CARDIO-THORAC, V36, P877, DOI 10.1016/j.ejcts.2009.04.058; Gwak MS, 2005, LIVER TRANSPLANT, V11, P331, DOI 10.1002/lt.20346; Hansen E, 1999, TRANSFUSION, V39, P608, DOI 10.1046/j.1537-2995.1999.39060608.x; HANSEN E, 1995, ARCH SURG-CHICAGO, V130, P387; Hansen E, 2002, TRANSFUS APHER SCI, V27, P153, DOI 10.1016/S1473-0502(02)00037-X; Hasegawa A, 2012, BLOOD, V119, P2615, DOI 10.1182/blood-2011-09-382473; Hod EA, 2010, VOX SANG, V99, P99, DOI 10.1111/j.1423-0410.2010.01327.x; Holzapfel BM, 2013, CANCER METAST REV, V32, P129, DOI 10.1007/s10555-013-9437-5; Ishihara C, 2003, J VET MED SCI, V65, P831, DOI 10.1292/jvms.65.831; ISHIHARA C, 1994, J VET MED SCI, V56, P1149, DOI 10.1292/jvms.56.1149; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Kessack LK, 2010, ANAESTHESIA, V65, P745, DOI 10.1111/j.1365-2044.2010.06301.x; Kumar N, 2014, LANCET ONCOL, V15, pE33, DOI 10.1016/S1470-2045(13)70245-6; Liang TB, 2008, TRANSPLANTATION, V85, P863, DOI 10.1097/TP.0b013e3181671f2e; Martin RCG, 2005, ANN SURG ONCOL, V12, P1017, DOI 10.1245/ASO.2005.12.018; Pietraforte D, 2007, FREE RADICAL BIO MED, V42, P202, DOI 10.1016/j.freeradbiomed.2006.10.035; Poli M, 2008, VOX SANG, V95, P308, DOI 10.1111/j.1423-0410.2008.01109.x; Puchala M, 2004, J RADIAT RES, V45, P275, DOI 10.1269/jrr.45.275; Raval JS, 2012, TRANSFUSION, V52, P2590, DOI 10.1111/j.1537-2995.2012.03682.x; Shi L, 2014, TRANSFUSION, V54, P471, DOI 10.1111/trf.12273; Sojka BN, 2008, VOX SANG, V94, P56, DOI 10.1111/j.1423-0410.2007.00990.x; Sreelakshmi TR, 2010, ANAESTHESIA, V65, P742, DOI 10.1111/j.1365-2044.2009.06190.x; SUDA BA, 1993, TRANSFUSION, V33, P389, DOI 10.1046/j.1537-2995.1993.33593255598.x; Tamulevicius P, 2007, RADIAT RES, V167, P1, DOI 10.1667/RR0751.1; Ubee S, 2011, ANN ROY COLL SURG, V93, P157, DOI 10.1308/003588411X561044; Wang XH, 2012, ARTIF ORGANS, V36, P931, DOI 10.1111/j.1525-1594.2012.01494.x; Waters JH, 2012, TRANSFUSION, V52, P2167, DOI 10.1111/j.1537-2995.2011.03555.x; Winslow RM, 2007, RESP PHYSIOL NEUROBI, V158, P121, DOI 10.1016/j.resp.2007.03.011; Yang SH, 2011, BIOL REPROD, V84, P1182, DOI 10.1095/biolreprod.110.087569; Yonar SM, 2014, ECOTOX ENVIRON SAFE, V102, P202, DOI 10.1016/j.ecoenv.2014.01.007; Zbikowska HM, 2012, INT J RADIAT BIOL, V88, P654, DOI 10.3109/09553002.2012.705223; Zhu ZC, 2013, J NEURO-ONCOL, V112, P17, DOI 10.1007/s11060-012-1032-z; Zimring JC, 2014, TRANSFUSION, V54, P137, DOI 10.1111/trf.12264	45	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0127181	10.1371/journal.pone.0127181	http://dx.doi.org/10.1371/journal.pone.0127181			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018651	gold, Green Submitted, Green Published			2022-12-26	WOS:000355185600073
J	Lee, JR; Maggini, R; Taylor, MFJ; Fuller, RA				Lee, Jasmine R.; Maggini, Ramona; Taylor, Martin F. J.; Fuller, Richard A.			Mapping the Drivers of Climate Change Vulnerability for Australia's Threatened Species	PLOS ONE			English	Article							MOUNTAIN PYGMY-POSSUM; BURRAMYS-PARVUS; DISPERSAL; HABITAT; FRAGMENTATION; CONSEQUENCES; MARSUPIALIA; FRAMEWORK; IMPACTS; DEBATE	Effective conservation management for climate adaptation rests on understanding the factors driving species' vulnerability in a spatially explicit manner so as to direct on-ground action. However, there have been only few attempts to map the spatial distribution of the factors driving vulnerability to climate change. Here we conduct a species-level assessment of climate change vulnerability for a sample of Australia's threatened species and map the distribution of species affected by each factor driving climate change vulnerability across the continent. Almost half of the threatened species assessed were considered vulnerable to the impacts of climate change: amphibians being the most vulnerable group, followed by plants, reptiles, mammals and birds. Species with more restricted distributions were more likely to show high climate change vulnerability than widespread species. The main factors driving climate change vulnerability were low genetic variation, dependence on a particular disturbance regime and reliance on a particular moisture regime or habitat. The geographic distribution of the species impacted by each driver varies markedly across the continent, for example species impacted by low genetic variation are prevalent across the human-dominated south-east of the country, while reliance on particular moisture regimes is prevalent across northern Australia. Our results show that actions to address climate adaptation will need to be spatially appropriate, and that in some regions a complex suite of factors driving climate change vulnerability will need to be addressed. Taxonomic and geographic variation in the factors driving climate change vulnerability highlights an urgent need for a spatial prioritisation of climate adaptation actions for threatened species.	[Lee, Jasmine R.; Maggini, Ramona; Fuller, Richard A.] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia; [Maggini, Ramona] Univ Queensland, Australian Res Council, CEED, Brisbane, Qld, Australia; [Taylor, Martin F. J.] WWF Australia, Brisbane, Qld, Australia	University of Queensland; University of Queensland; World Wildlife Fund	Lee, JR (corresponding author), Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia.	jasmine.lee1@uqconnect.edu.au	Fuller, Richard/B-7971-2008	Fuller, Richard/0000-0001-9468-9678	WWF-Australia; National Climate Change Adaptation Research Facility; Australian Government's National Environmental Research Program; Australian Research Council Centre of Excellence for Environmental Decisions	WWF-Australia; National Climate Change Adaptation Research Facility; Australian Government's National Environmental Research Program(Australian Government); Australian Research Council Centre of Excellence for Environmental Decisions(Australian Research Council)	This research was funded by a scholarship to J. R. L. from WWF-Australia, a grant from the National Climate Change Adaptation Research Facility, and additional funding from the Australian Government's National Environmental Research Program and the Australian Research Council Centre of Excellence for Environmental Decisions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MB, 2006, SCIENCE, V313, P1396, DOI 10.1126/science.1131758; Arribas P, 2012, GLOBAL CHANGE BIOL, V18, P2135, DOI 10.1111/j.1365-2486.2012.02691.x; Bagne KE, 2011, RMRSGTR257 USDA; Bartholome E, 2005, INT J REMOTE SENS, V26, P1959, DOI 10.1080/01431160412331291297; Bozinovic F, 2011, ANNU REV ECOL EVOL S, V42, P155, DOI 10.1146/annurev-ecolsys-102710-145055; BRERETON R, 1995, BIOL CONSERV, V72, P339, DOI 10.1016/0006-3207(94)00016-J; Broome LS, 2001, AUSTRAL ECOL, V26, P275, DOI 10.1046/j.1442-9993.2001.01114.x; Cardoso MJ, 2011, THESIS U NEW S WALES; Carvalho SB, 2010, GLOBAL CHANGE BIOL, V16, P3257, DOI 10.1111/j.1365-2486.2010.02212.x; Cary GJ, 2000, ADV GLOB CHANGE RES, V3, P233; Crossman ND, 2012, DIVERS DISTRIB, V18, P60, DOI 10.1111/j.1472-4642.2011.00851.x; Department of Sustainability Environment Water Population and Communities, 2012, INT BIOG REG AUSTR I; Department of Sustainability Environment Water Population and Communities, 2008, SPEC NAT ENV SIGN DA; Department of Sustainability Environment Water Population and Communities, 2011, SPEC PROF THREATS DA; Duarte H, 2012, GLOBAL CHANGE BIOL, V18, P412, DOI 10.1111/j.1365-2486.2011.02518.x; Erasmus BFN, 2002, GLOBAL CHANGE BIOL, V8, P679, DOI 10.1046/j.1365-2486.2002.00502.x; Evans MC, 2011, BIOSCIENCE, V61, P281, DOI 10.1525/bio.2011.61.4.8; FODEN W, 2008, 2008 REV IUCN RED LI; Foden WB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065427; Galbraith H, 2009, FRAMEWORK C IN PRESS; Gardali T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029507; Hagger V, 2013, AUSTRAL ECOL, V38, P465, DOI 10.1111/j.1442-9993.2012.02437.x; He TH, 2009, NEW PHYTOL, V181, P725, DOI 10.1111/j.1469-8137.2008.02686.x; Hennessy K., 2005, CLIMATE CHANGE IMPAC; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; Hughes L, 2003, AUSTRAL ECOL, V28, P423, DOI 10.1046/j.1442-9993.2003.01300.x; Hunter ML, 2007, CONSERV BIOL, V21, P1356, DOI 10.1111/j.1523-1739.2007.00780.x; Johnson JE, 2007, CLIMATE CHANGE GREAT; Kittel TGF, 2011, REG ENVIRON CHANGE, V11, pS249, DOI 10.1007/s10113-010-0180-y; Lowe AJ, 2005, HEREDITY, V95, P255, DOI 10.1038/sj.hdy.6800725; Mackey Brendan G., 2008, Biodiversity (Ottawa), V9, P11; Martin TG, 2012, CONSERV LETT, V5, P274, DOI 10.1111/j.1755-263X.2012.00239.x; Matthes M., 2000, ALLOCASUARINA PORTUE; McLachlan JS, 2007, CONSERV BIOL, V21, P297, DOI 10.1111/j.1523-1739.2007.00676.x; Midgley GF, 2002, GLOBAL ECOL BIOGEOGR, V11, P445, DOI 10.1046/j.1466-822X.2002.00307.x; Mitrovski P, 2007, MOL ECOL, V16, P75, DOI 10.1111/j.1365-294X.2006.03125.x; Mooney P.A., 2005, RECOVERY PLAN S AUST; Murray KA, 2011, P ROY SOC B-BIOL SCI, V278, P1515, DOI 10.1098/rspb.2010.1872; Nakicenovic N, 2000, SPECIAL REPORT EMISS, DOI [10.1073/pnas.1119787109, DOI 10.1073/PNAS.1119787109]; National Geophysical Data Center, 2011, DIG EL MOD DEM; Osborne MJ, 2000, MOL ECOL, V9, P609, DOI 10.1046/j.1365-294x.2000.00908.x; Paull David C., 2009, Pacific Conservation Biology, V15, P254; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Perry LG, 2012, GLOBAL CHANGE BIOL, V18, P821, DOI 10.1111/j.1365-2486.2011.02588.x; Pimm SL, 2008, CURR BIOL, V18, pR117, DOI 10.1016/j.cub.2007.11.055; PRIMACK RB, 1992, CONSERV BIOL, V6, P513, DOI 10.1046/j.1523-1739.1992.06040513.x; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; R Core Team, 2018, R LANG ENV STAT COMP; Reside AE, 2012, ECOL EVOL, V2, P705, DOI 10.1002/ece3.197; Sattler P., 2002, AUSTR TERRESTRIAL BI; Schneider SH, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P779; Shoo LP, 2011, J APPL ECOL, V48, P487, DOI 10.1111/j.1365-2664.2010.01942.x; Soderquist TR, 2000, AUST J ZOOL, V48, P551, DOI 10.1071/ZO00029; Steffen, 2009, AUSTR BIODIVERSITY C; Summers DM, 2012, GLOBAL CHANGE BIOL, V18, P2335, DOI 10.1111/j.1365-2486.2012.02700.x; Thomas CD, 2011, TRENDS ECOL EVOL, V26, P216, DOI 10.1016/j.tree.2011.02.006; Tokushima H, 2008, AUST J ZOOL, V56, P363, DOI 10.1071/ZO08042; Williams RJ., 2009, INTERACTIONS CLIMATE; Williams SE, 2008, PLOS BIOL, V6, P2621, DOI 10.1371/journal.pbio.0060325; Woinarski JCZ, 2004, FALCUNCULUS FRONTATU; Young A, 1996, TRENDS ECOL EVOL, V11, P413, DOI 10.1016/0169-5347(96)10045-8; Young B., 2011, GUIDELINES USING NAT; Young BE, 2013, CONSERVING WILDLIFE, P129	63	9	9	0	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0124766	10.1371/journal.pone.0124766	http://dx.doi.org/10.1371/journal.pone.0124766			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26017785	gold, Green Published			2022-12-26	WOS:000355185600007
J	Vecino, E; Heller, JP; Veiga-Crespo, P; Martin, KR; Fawcett, JW				Vecino, Elena; Heller, Janosch P.; Veiga-Crespo, Patricia; Martin, Keith R.; Fawcett, James W.			Influence of Extracellular Matrix Components on the Expression of Integrins and Regeneration of Adult Retinal Ganglion Cells	PLOS ONE			English	Article							IN-VITRO; RAT RETINA; LAMININ; SURVIVAL; GLAUCOMA; AXONS; RECEPTORS; NEUROTROPHINS; FIBERS; INVIVO	Purpose Retinal ganglion cells (RGCs) are exposed to injury in a variety of optic nerve diseases including glaucoma. However, not all cells respond in the same way to damage and the capacity of individual RGCs to survive or regenerate is variable. In order to elucidate factors that may be important for RGC survival and regeneration we have focussed on the extracellular matrix (ECM) and RGC integrin expression. Our specific questions were: (1) Do adult RGCs express particular sets of integrins in vitro and in vivo? (2) Can the nature of the ECM influence the expression of different integrins? (3) Can the nature of the ECM affect the survival of the cells and the length or branching complexity of their neurites? Methods Primary RGC cultures from adult rat retina were placed on glass coverslips treated with different substrates: Poly-L-Lysine (PL), or PL plus laminin (L), collagen I (CI), collagen IV (CIV) or fibronectin (F). After 10 days in culture, we performed double immunostaining with an antibody against beta III-Tubulin to identify the RGCs, and antibodies against the integrin subunits: alpha V, alpha 1, alpha 3, alpha 5, beta 1 or beta 3. The number of adhering and surviving cells, the number and length of the neurites and the expression of the integrin subunits on the different substrates were analysed. Results PL and L were associated with the greatest survival of RGCs while CI provided the least favourable conditions. The type of substrate affected the number and length of neurites. L stimulated the longest growth. We found at least three different types of RGCs in terms of their capacity to regenerate and extend neurites. The different combinations of integrins expressed by the cells growing on different substrata suggest that RGCs expressed predominantly alpha 1 beta 1 or alpha 3 beta 1 on L, alpha 1 beta 1 on CI and CIV, and alpha 5 beta 3 on F. The activity of the integrins was demonstrated by the phosphorylation of focal adhesion kinase (FAK). Conclusions Adult rat RGCs can survive and grow in the presence of different ECM tested. Further studies should be done to elucidate the different molecular characteristics of the RGCs subtypes in order to understand the possible different sensitivity of different RGCs to damage in diseases like glaucoma in which not all RGCs die at the same time.	[Vecino, Elena; Veiga-Crespo, Patricia] Univ Basque Country, UPV EHU, Dept Cell Biol & Histol, Leioa, Vizcaya, Spain; [Vecino, Elena; Heller, Janosch P.; Martin, Keith R.; Fawcett, James W.] Univ Cambridge, Dept Clin Neurosci, John van Geest Ctr Brain Repair, Cambridge, England; [Martin, Keith R.] Univ Cambridge, Welcome Trust MRC Cambridge Stem Cell Inst, Cambridge, England	University of Basque Country; University of Cambridge; University of Cambridge	Vecino, E (corresponding author), Univ Basque Country, Dept Cell Biol & Histol, Leioa, Vizcaya, Spain.	elena.vecino@ehu.es	Vecino, Elena/AAO-3462-2021; Heller, Janosch/GVT-5921-2022; Heller, Janosch/J-7509-2019; Veiga-Crespo, Patricia/A-1402-2012	Vecino, Elena/0000-0002-1672-5132; Heller, Janosch/0000-0002-8825-3787; Veiga-Crespo, Patricia/0000-0001-8595-3553; Fawcett, James/0000-0002-7990-4568	Grupos Consolidados Gobierno Vasco [IT437-10]; Basque Country Goberment/Clare Hall Fellowship; Fight for Sight; Jukes Glaucoma Research Foundation; Medical Reseach Council (GB); Medical Research Council [G1000864] Funding Source: researchfish; Fight for Sight [1867/68] Funding Source: researchfish; International Spinal Research Trust [NRB110] Funding Source: researchfish; MRC [G1000864] Funding Source: UKRI	Grupos Consolidados Gobierno Vasco; Basque Country Goberment/Clare Hall Fellowship; Fight for Sight; Jukes Glaucoma Research Foundation; Medical Reseach Council (GB); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Fight for Sight; International Spinal Research Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Financial support was provided by Grupos Consolidados Gobierno Vasco (IT437-10), Basque Country Goberment/Clare Hall Fellowship to EV, Fight for Sight and the Jukes Glaucoma Research Foundation to KRM, and Medical Reseach Council (GB) to JWF.	ADAMS JC, 1993, DEVELOPMENT, V117, P1183; Bates CA, 1997, DEV BIOL, V181, P91, DOI 10.1006/dbio.1996.8438; Bauch H, 1998, J NEUROSCI, V18, P1774; Brocco MA, 1999, DEV BRAIN RES, V118, P23, DOI 10.1016/S0165-3806(99)00120-0; BURKE JM, 1980, EXP EYE RES, V31, P213, DOI 10.1016/0014-4835(80)90079-2; Chen DF, 1997, NATURE, V385, P434, DOI 10.1038/385434a0; Chierzi S, 1999, J NEUROSCI, V19, P8367; Chintala SK, 2002, J BIOL CHEM, V277, P47461, DOI 10.1074/jbc.M204824200; COHEN J, 1986, NATURE, V322, P465, DOI 10.1038/322465a0; Cui Q, 2003, MOL CELL NEUROSCI, V22, P49, DOI 10.1016/S1044-7431(02)00037-4; ELICES MJ, 1989, P NATL ACAD SCI USA, V86, P9906, DOI 10.1073/pnas.86.24.9906; Franze K, 2013, DEVELOPMENT, V140, P3069, DOI 10.1242/dev.079145; Fukada Y, 1977, BRAIN RES, V119, P327; Garcia M, 2003, INVEST OPHTH VIS SCI, V44, P4532, DOI 10.1167/iovs.03-0419; Garcia M, 2002, INVEST OPHTH VIS SCI, V43, P3735; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; GLOVINSKY Y, 1992, ARCH OPHTHALMOL-CHIC, V110, P486, DOI 10.1001/archopht.1992.01080160064031; Goldberg JL, 2002, NEURON, V33, P689, DOI 10.1016/S0896-6273(02)00602-5; Grimpe B, 2002, J NEUROSCI, V22, P3144, DOI 10.1523/JNEUROSCI.22-08-03144.2002; Guo L, 2005, INVEST OPHTH VIS SCI, V46, P175, DOI 10.1167/iovs.04-0832; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; Humphries MJ, 2000, BIOCHEM SOC T, V28, P311, DOI 10.1042/0300-5127:0280311; HUNTER DD, 1992, NEURON, V8, P399, DOI 10.1016/0896-6273(92)90269-J; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; LETOURNEAU PC, 1975, DEV BIOL, V44, P92, DOI 10.1016/0012-1606(75)90379-6; Lodovichi C, 2001, EUR J NEUROSCI, V13, P833, DOI 10.1046/j.1460-9568.2001.01440.x; Luo XM, 2001, INVEST OPHTH VIS SCI, V42, P1096; MEREDITH JE, 1993, MOL BIOL CELL, V4, P953, DOI 10.1091/mbc.4.9.953; MEY J, 1993, BRAIN RES, V602, P304, DOI 10.1016/0006-8993(93)90695-J; MORGAN JE, 1994, BRIT J OPHTHALMOL, V78, P875, DOI 10.1136/bjo.78.11.875; Morgan JE, 1994, BR J OPHTHALMOL, V78, P879; QUIGLEY HA, 1987, INVEST OPHTH VIS SCI, V28, P913; Ruiz-Ederra J, 2004, MOL VIS, V10, P83; Tan CL, 2011, J NEUROSCI, V31, P6289, DOI 10.1523/JNEUROSCI.0008-11.2011; Vecino E, 2002, VISION RES, V42, P151, DOI 10.1016/S0042-6989(01)00251-6; Vecino E, 1998, GEN PHARMACOL-VASC S, V30, P305, DOI 10.1016/S0306-3623(97)00361-3; Vecino E, 1999, NEUROREPORT, V10, P1103, DOI 10.1097/00001756-199904060-00036; Vecino E., 2015, PROGR RETIN IN PRESS	38	39	39	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0125250	10.1371/journal.pone.0125250	http://dx.doi.org/10.1371/journal.pone.0125250			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018803	Green Published, gold, Green Submitted			2022-12-26	WOS:000355185600016
J	Baboota, RK; Sarma, SM; Boparai, RK; Kondepudi, KK; Mantri, S; Bishnoi, M				Baboota, Ritesh K.; Sarma, Siddhartha M.; Boparai, Ravneet K.; Kondepudi, Kanthi Kiran; Mantri, Shrikant; Bishnoi, Mahendra			Microarray Based Gene Expression Analysis of Murine Brown and Subcutaneous Adipose Tissue: Significance with Human	PLOS ONE			English	Article							DIET-INDUCED OBESITY; ENERGY-EXPENDITURE; COLD-EXPOSURE; FAT-CELL; WHITE; ADIPOCYTES; MICE; TRANSCRIPTION; AGONISTS; DISTINCT	Background Two types of adipose tissues, white (WAT) and brown (BAT) are found in mammals. Increasingly novel strategies are being proposed for the treatment of obesity and its associated complications by altering amount and/or activity of BAT using mouse models. Methodology/Principle Findings The present study was designed to: (a) investigate the differential expression of genes in LACA mice subcutaneous WAT (sWAT) and BAT using mouse DNA microarray, (b) to compare mouse differential gene expression with previously published human data; to understand any inter-species differences between the two and (c) tomake a comparative assessment with C57BL/6 mouse strain. In mouse microarray studies, over 7003, 1176 and 401 probe sets showedmore than two-fold, five-fold and ten-fold change respectively in differential expression between murine BAT andWAT. Microarray data was validated using quantitative RT-PCR of key genes showing high expression in BAT (Fabp3, Ucp1, Slc27a1) and sWAT (Ms4a1, H2-Ob, Bank1) or showing relatively low expression in BAT (Pgk1, Cox6b1) and sWAT (Slc20a1, Cd74). Multi-omic pathway analysis was employed to understand possible links between the organisms. When murine two fold data was compared with published human BAT and sWAT data, 90 genes showed parallel differential expression in bothmouse and human. Out of these 90 genes, 46 showed same pattern of differential expression whereas the pattern was opposite for the remaining 44 genes. Based on our microarray results and its comparison with human data, we were able to identify genes (targets) (a) which can be studied inmouse model systems to extrapolate results to human (b) where caution should be exercised before extrapolation of murine data to human. Conclusion Our study provides evidence for inter species (mouse vs human) differences in differential gene expression between sWAT and BAT. Critical understanding of this data may help in development of novel ways to engineer one form of adipose tissue to another using murine model with focus on human.	[Baboota, Ritesh K.; Sarma, Siddhartha M.; Kondepudi, Kanthi Kiran; Mantri, Shrikant; Bishnoi, Mahendra] Natl Agri Food Biotechnol Inst NABI, Sas Nagar, Punjab, India; [Boparai, Ravneet K.] Panjab Univ, Dept Biochem, Chandigarh 160014, India	Department of Biotechnology (DBT) India; National Agri Food Biotechnology Institute (NABI); Panjab University	Mantri, S (corresponding author), Natl Agri Food Biotechnol Inst NABI, Sas Nagar, Punjab, India.	shrikant@nabi.res.in; mbishnoi@gmail.com	Bishnoi, Mahendra/CAG-3229-2022; Baboota, Ritesh Kumar/AAQ-2606-2020; Kondepudi, Kanthi Kiran/P-8336-2014	Kondepudi, Kanthi Kiran/0000-0001-8036-7555; Mantri, Shrikant/0000-0002-7493-459X; Bishnoi, Mahendra/0000-0002-7785-1204; boparai, ravneet/0000-0002-0520-768X	Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	The authors would like to thank the Department of Biotechnology, Government of India for research grants given to National Agri-Food Biotechnology Institute (NABI).	Almind K, 2007, P NATL ACAD SCI USA, V104, P2366, DOI 10.1073/pnas.0610416104; Arch JRS, 2002, EUR J PHARMACOL, V440, P99, DOI 10.1016/S0014-2999(02)01421-8; Buettner R, 2007, OBESITY, V15, P798, DOI 10.1038/oby.2007.608; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Carey AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091997; Cinti S, 2000, Eat Weight Disord, V5, P132; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; FAWCETT DW, 1952, J MORPHOL, V90, P363, DOI 10.1002/jmor.1050900208; Frontini A, 2010, CELL METAB, V11, P253, DOI 10.1016/j.cmet.2010.03.004; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Hansen JB, 2006, BIOCHEM J, V398, P153, DOI 10.1042/BJ20060402; Hany TF, 2002, EUR J NUCL MED MOL I, V29, P1393, DOI 10.1007/s00259-002-0902-6; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Jespersen NZ, 2013, CELL METAB, V17, P798, DOI 10.1016/j.cmet.2013.04.011; Kanzleiter T, 2009, BBA-MOL BASIS DIS, V1792, P777, DOI 10.1016/j.bbadis.2009.05.002; Klingenberg M, 1999, J BIOENERG BIOMEMBR, V31, P419, DOI 10.1023/A:1005440221914; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Mitschke MM, 2013, FASEB J, V27, P1621, DOI 10.1096/fj.12-221580; Moraes RC, 2003, ENDOCRINOLOGY, V144, P4773, DOI 10.1210/en.2003-0456; Murholm M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008458; Narvaez CJ, 2009, ENDOCRINOLOGY, V150, P651, DOI 10.1210/en.2008-1118; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Nookaew I, 2013, J CLIN ENDOCR METAB, V98, pE370, DOI 10.1210/jc.2012-2764; Ohno H, 2012, CELL METAB, V15, P395, DOI 10.1016/j.cmet.2012.01.019; Ouellet V, 2012, J CLIN INVEST, V122, P545, DOI 10.1172/JCI60433; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Scheele C, 2014, ADIPOCYTE, V3, P54, DOI 10.4161/adip.26520; Scheffler Immo E., 1999, MITOCHONDRIA, P266; Schulz TJ, 2013, NATURE, V495, P379, DOI 10.1038/nature11943; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2009, GENE DEV, V23, P788, DOI 10.1101/gad.1779209; Sharp LZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049452; Shen W, 2013, J LIPID RES, V54, P909, DOI 10.1194/jlr.M030924; Shin S, 2009, EUR J PHARMACOL, V620, P138, DOI 10.1016/j.ejphar.2009.08.022; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Svensson P., 2011, INT J MOL MED, V27; Vila-Brau A, 2011, J BIOL CHEM, V286, P20423, DOI 10.1074/jbc.M111.235044; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Voshol PJ, 2009, BBA-MOL CELL BIOL L, V1791, P479, DOI 10.1016/j.bbalip.2008.12.015; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Yadav H, 2012, FRONT ENDOCRINOL, V3; Zingaretti MC, 2009, FASEB J, V23, P3113, DOI 10.1096/fj.09-133546	44	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127701	10.1371/journal.pone.0127701	http://dx.doi.org/10.1371/journal.pone.0127701			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010905	Green Published, Green Submitted, gold			2022-12-26	WOS:000355183900134
J	Billioux, A; Nakigozi, G; Newell, K; Chang, LW; Quinn, TC; Gray, RH; Ndyanabo, A; Galiwango, R; Kiggundu, V; Serwadda, D; Reynolds, SJ				Billioux, Alexander; Nakigozi, Gertrude; Newell, Kevin; Chang, Larry W.; Quinn, Thomas C.; Gray, Ron H.; Ndyanabo, Anthony; Galiwango, Ronald; Kiggundu, Valerian; Serwadda, David; Reynolds, Steven J.			Durable Suppression of HIV-1 after Virologic Monitoring-Based Antiretroviral Adherence Counseling in Rakai, Uganda	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; VIRAL LOAD; THERAPY; OUTCOMES; ADULTS; PREDICTORS; PREVENTION; MORTALITY; COUNTRIES; FAILURE	Objectives HIV viral load is recommended for monitoring antiretroviral treatment and identifying treatment failure. We assessed the durability of viral suppression after viral load-triggered adherence counseling among patients with HIV viremia 6 months after ART initiation. Design Observational cohort enrolled in an antiretroviral treatment program in rural Uganda. Methods Participants who underwent routine viral load determination every 24 weeks and had at least 48 weeks of follow-up were included in this analysis. Patients with viral loads > 400 copies/ml at 24 weeks of treatment were given additional adherence counseling, and all patients were followed to assess the duration of viral suppression and development of virologic failure. Results 1,841 participants initiating antiretroviral therapy were enrolled in the Rakai Health Sciences Program between June 2005 and June 2011 and were followed with viral load monitoring every 24 weeks. 148 (8%) of patients did not achieve viral suppression at 24 weeks and were given additional adherence counseling. 85 (60%) of these patients had undetectable viral loads at 48 weeks, with a median duration of viral suppression of 240 weeks (IQR 193-288 weeks). Failure to achieve an undetectable viral load at 48 weeks was associated with age < 30 years and 24 week viral load > 2,000 copies/ml in multivariate logistic regression analysis. Conclusions The majority of patients with persistent viremia who were provided adherence counseling achieved robust viral suppression for a median 4.6 years. Access to virologic monitoring and adherence counseling is a priority in resource-limited settings.	[Billioux, Alexander; Chang, Larry W.; Quinn, Thomas C.; Reynolds, Steven J.] Johns Hopkins Sch Med, Baltimore, MD 21205 USA; [Billioux, Alexander; Nakigozi, Gertrude; Chang, Larry W.; Quinn, Thomas C.; Ndyanabo, Anthony; Galiwango, Ronald; Kiggundu, Valerian; Serwadda, David; Reynolds, Steven J.] Rakai Hlth Sci Program, Rakai, Uganda; [Newell, Kevin] Leidos Biomed Res Inc, Clin Monitoring Res Program, Clin Res Directorate, Frederick Natl Lab Canc Res, Frederick, MD USA; [Quinn, Thomas C.; Reynolds, Steven J.] NIAID, NIH, Bethesda, MD 20892 USA; [Chang, Larry W.; Gray, Ron H.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Serwadda, David] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Kampala, Uganda	Johns Hopkins University; Johns Hopkins Medicine; Rakai Health Sciences Program; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Makerere University	Reynolds, SJ (corresponding author), Johns Hopkins Sch Med, Baltimore, MD 21205 USA.	sjr@jhmi.edu		Reynolds, Steven/0000-0002-5403-2759	National Cancer Institute [HHSN261200800001E]; National Institute of Mental Health [K23MH086338]; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; Leidos Biomedical Research, Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI094189, ZIAAI000361, ZIAAI001040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH086338] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Leidos Biomedical Research, Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This project has been funded in whole or in part with federal funds from the National Cancer Institute under Contract No. HHSN261200800001E, the National Institute of Mental Health under contract K23MH086338, and by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. Leidos Biomedical Research, Inc., provided support in the form of a salary for author KN, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Aghokeng AF, 2014, CLIN INFECT DIS, V58, P99, DOI 10.1093/cid/cit627; Almeida JM, 2011, AIDS RES HUM RETROV, V27, P705, DOI [10.1089/aid.2010.0200, 10.1089/AID.2010.0200]; Alvarez-Uria G, 2012, TROP MED INT HEALTH, V17, P1152, DOI 10.1111/j.1365-3156.2012.02982.x; Bonner K, 2013, JAIDS-J ACQ IMM DEF, V64, P74, DOI 10.1097/QAI.0b013e31829f05ac; Chang LW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010923; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; De Beaudrap P, 2008, EUR J EPIDEMIOL, V23, P227, DOI 10.1007/s10654-007-9221-3; Enriquez M, 2011, HIV AIDS-RES PALLIAT, V3, P45, DOI 10.2147/HIV.S8993; Fregonese F, 2012, JAIDS-J ACQ IMM DEF, V60, P91, DOI 10.1097/QAI.0b013e31824bd33f; Grabar S, 2005, JAIDS-J ACQ IMM DEF, V39, P284, DOI 10.1097/01.qai.0000160925.33935.72; Howard AA, 2002, AIDS, V16, P2175, DOI 10.1097/00002030-200211080-00010; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Jourdain G, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001494; Keiser O, 2011, AIDS, V25, P1761, DOI 10.1097/QAD.0b013e328349822f; Keiser O, 2009, AIDS, V23, P1867, DOI 10.1097/QAD.0b013e32832e05b2; Mannheimer S, 2002, CLIN INFECT DIS, V34, P1115, DOI 10.1086/339074; McNabb J, 2001, CLIN INFECT DIS, V33, P700, DOI 10.1086/322590; Medley A, 2009, AIDS EDUC PREV, V21, P181, DOI 10.1521/aeap.2009.21.3.181; Mermin J, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6792; Metzner KJ, 2007, AIDS, V21, P703, DOI 10.1097/QAD.0b013e3280121ac6; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Pirkle CM, 2009, HIV MED, V10, P152, DOI 10.1111/j.1468-1293.2008.00664.x; Reynolds SJ, 2009, AIDS, V23, P697, DOI 10.1097/QAD.0b013e3283262a78; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; Townsend David, 2009, J Int Assoc Physicians AIDS Care (Chic), V8, P314, DOI 10.1177/1545109709343966; von Wyl V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077691; Wilson D, 2009, T ROY SOC TROP MED H, V103, P601, DOI 10.1016/j.trstmh.2008.11.007	29	20	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127235	10.1371/journal.pone.0127235	http://dx.doi.org/10.1371/journal.pone.0127235			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011158	Green Published, gold, Green Submitted			2022-12-26	WOS:000355183900074
J	Charolidi, N; Schilling, T; Eder, C				Charolidi, Nicoletta; Schilling, Tom; Eder, Claudia			Microglial Kv1.3 Channels and P2Y12 Receptors Differentially Regulate Cytokine and Chemokine Release from Brain Slices of Young Adult and Aged Mice	PLOS ONE			English	Article							NEURONAL NMDA RECEPTORS; POTASSIUM CHANNELS; INFLAMMATORY RESPONSES; ACTIVATED MICROGLIA; EXPRESSION; ASTROCYTES; CULTURE; MODEL	Brain tissue damage following stroke or traumatic brain injury is accompanied by neuroinflammatory processes, while microglia play a central role in causing and regulating neuroinflammation via production of proinflammatory substances, including cytokines and chemokines. Here, we used brain slices, an established in situ brain injury model, from young adult and aged mice to investigate cytokine and chemokine production with particular focus on the role of microglia. Twenty four hours after slice preparation, higher concentrations of proinflammatory cytokines, i.e. TNF-alpha and IL-6, and chemokines, i.e. CCL2 and CXCL1, were released from brain slices of aged mice than from slices of young adult mice. However, maximal microglial stimulation with LPS for 24 h did not reveal age-dependent differences in the amounts of released cytokines and chemokines. Mechanisms underlying microglial cytokine and chemokine production appear to be similar in young adult and aged mice. Inhibition of microglial Kv1.3 channels with margatoxin reduced release of IL-6, but not release of CCL2 and CXCL1. In contrast, blockade of microglial P2Y12 receptors with PSB0739 inhibited release of CCL2 and CXCL1, whereas release of IL-6 remained unaffected. Cytokine and chemokine production was not reduced by inhibitors of Kir2.1 K+ channels or adenosine receptors. In summary, our data suggest that brain tissue damage-induced production of cytokines and chemokines is age-dependent, and differentially regulated by microglial Kv1.3 channels and P2Y12 receptors.	[Charolidi, Nicoletta; Schilling, Tom; Eder, Claudia] Univ London, Inst Infect & Immun, London SW17 0RE, England	University of London	Eder, C (corresponding author), Univ London, Inst Infect & Immun, Cranmer Terrace, London SW17 0RE, England.	ceder@sgul.ac.uk		Schilling, Tom/0000-0002-0274-5482; Charolidi, Nicoletta/0000-0002-5721-5155	EU-FP7 grant "TargetBraIn" [279017]	EU-FP7 grant "TargetBraIn"	Funding provided by EU-FP7 grant "TargetBraIn" (#279017).	Bartok A, 2014, TOXICON, V87, P6, DOI 10.1016/j.toxicon.2014.05.002; Benakis C, 2015, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00461; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Chen Y, 2014, CURR MED CHEM, V21, P2146, DOI 10.2174/0929867321666131228203906; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Dissing-Olesen L, 2014, J NEUROSCI, V34, P10511, DOI 10.1523/JNEUROSCI.0405-14.2014; Duque A, 2013, DEV NEUROBIOL, V73, P841, DOI 10.1002/dneu.22105; Eder C, 2005, J NEUROSCI RES, V81, P314, DOI 10.1002/jnr.20476; Eyo UB, 2014, J NEUROSCI, V34, P10528, DOI 10.1523/JNEUROSCI.0416-14.2014; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; Huuskonen J, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-25; Jaerve A, 2012, CELL TISSUE RES, V349, P229, DOI 10.1007/s00441-012-1427-3; Kawabori M, 2015, CURR MED CHEM, V22, P1258, DOI 10.2174/0929867322666150209154036; Kigerl KA, 2014, EXP NEUROL, V258, P5, DOI 10.1016/j.expneurol.2014.01.001; Kim B, 2011, J IMMUNOL, V186, P3701, DOI 10.4049/jimmunol.1000212; Koizumi S, 2007, NATURE, V446, P1091, DOI 10.1038/nature05704; Kumar A, 2013, NEUROBIOL AGING, V34, P1397, DOI 10.1016/j.neurobiolaging.2012.11.013; Lambertsen KL, 2012, J CEREBR BLOOD F MET, V32, P1677, DOI 10.1038/jcbfm.2012.88; Lyons SA, 2000, J CEREBR BLOOD F MET, V20, P1537, DOI 10.1097/00004647-200011000-00003; Melani A, 2005, NEUROCHEM INT, V47, P442, DOI 10.1016/j.neuint.2005.05.014; Menteyne A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006770; Mosher KI, 2014, BIOCHEM PHARMACOL, V88, P594, DOI 10.1016/j.bcp.2014.01.008; Njie EG, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.05.008; Norden DM, 2015, NEUROPHARMACOLOGY, V96, P29, DOI 10.1016/j.neuropharm.2014.10.028; NORENBERG W, 1994, J PHYSIOL-LONDON, V475, P15; Orr AG, 2009, NAT NEUROSCI, V12, P872, DOI 10.1038/nn.2341; Orre M, 2014, NEUROBIOL AGING, V35, P1, DOI 10.1016/j.neurobiolaging.2013.07.008; Peng Y, 2014, NEURO-ONCOLOGY, V16, P528, DOI 10.1093/neuonc/not221; Quick ED, 2014, J VIROL, V88, P13005, DOI 10.1128/JVI.01994-14; Rangaraju S, 2015, J ALZHEIMERS DIS, V44, P797, DOI 10.3233/JAD-141704; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Schilling T, 2007, BRAIN RES, V1186, P21, DOI 10.1016/j.brainres.2007.10.027; Schilling T, 2015, GLIA, V63, P664, DOI 10.1002/glia.22776; Sierra A, 2007, GLIA, V55, P412, DOI 10.1002/glia.20468; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.0.CO;2-J; Stock C, 2006, J IMMUNOL, V177, P8560, DOI 10.4049/jimmunol.177.12.8560; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Streit WJ, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0142-6; Streit WJ, 2014, CURR OPIN IMMUNOL, V29, P93, DOI 10.1016/j.coi.2014.05.005; Taylor RA, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/746068; Van Wagoner NJ, 1999, J NEUROSCI, V19, P5236; Wang HR, 2011, ACS CHEM BIOL, V6, P845, DOI 10.1021/cb200146a; Wong WT, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00022	43	32	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128463	10.1371/journal.pone.0128463	http://dx.doi.org/10.1371/journal.pone.0128463			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011191	Green Submitted, gold, Green Published			2022-12-26	WOS:000355183900237
J	Martins, HA; Simas, RC; Brolio, MP; Ferreira, CR; Perecin, F; Nogueira, GD; Miglino, MA; Martins, DS; Eberlin, MN; Ambrosio, CE				Martins-Junior, Helio A.; Simas, Rosineide C.; Brolio, Marina P.; Ferreira, Christina R.; Perecin, Felipe; Nogueira, Guilherme de P.; Miglino, Maria A.; Martins, Daniele S.; Eberlin, Marcos N.; Ambrosio, Carlos E.			Profiles of Steroid Hormones in Canine X-Linked Muscular Dystrophy via Stable Isotope Dilution LC-MS/MS	PLOS ONE			English	Article							MASS-SPECTROMETRY; GRMD DOGS; MUSCLE; MODEL; ENHANCEMENT; CARRIERS; LOCUS; GENE	Golden retriever muscular dystrophy (GRMD) provides the best animal model for characterizing the disease progress of the human disorder, Duchenne muscular dystrophy (DMD). The purpose of this study was to determine steroid hormone concentration profiles in healthy golden retriever dogs (control group - CtGR) versus GRMD-gene carrier (CaGR) and affected female dogs (AfCR). Therefore, a sensitive and specific analytical method was developed and validated to determine the estradiol, progesterone, cortisol, and testosterone levels in the canine serum by isotope dilution liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS). To more accurately understand the dynamic nature of the serum steroid profile, the fluctuating levels of these four steroid hormones over the estrous cycle were compared across the three experimental groups using a multivariate statistical analysis. The concentration profiles of estradiol, cortisol, progesterone, and testosterone revealed a characteristic pattern for each studied group at each specific estrous phase. Additionally, several important changes in the serum concentrations of cortisol and estradiol in the CaGR and AfCR groups seem to be correlated with the status and progression of the muscular dystrophy. A comprehensive and quantitative monitoring of steroid profiles throughout the estrous cycle of normal and GRMD dogs were achieved. Significant differences in these profiles were observed between GRMD and healthy animals, most notably for estradiol. These findings contribute to a better understanding of both dog reproduction and the muscular dystrophy pathology. Our data open new venues for hormonal behavior studies in dystrophinopathies and that may affect the quality of life of DMD patients.	[Martins-Junior, Helio A.; Simas, Rosineide C.; Ferreira, Christina R.; Eberlin, Marcos N.] Univ Campinas UNICAMP, Inst Chem, ThoMSon Mass Spectrometry Lab, Campinas, SP, Brazil; [Martins-Junior, Helio A.] AB SCIEX Brazil, Sao Paulo, SP, Brazil; [Simas, Rosineide C.; Nogueira, Guilherme de P.] Sao Paulo State Univ UNESP, Fac Vet Med, DAPSA, Aracatuba, SP, Brazil; [Brolio, Marina P.; Perecin, Felipe; Martins, Daniele S.; Ambrosio, Carlos E.] Univ Sao Paulo, FZEA, Pirassununga, SP, Brazil; [Miglino, Maria A.] Univ Sao Paulo, Fac Vet Med & Anim Sci FMVZ, Sao Paulo, SP, Brazil; [Ferreira, Christina R.] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA	Universidade Estadual de Campinas; Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade de Sao Paulo; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Ambrosio, CE (corresponding author), Univ Sao Paulo, FZEA, Pirassununga, SP, Brazil.	ceambrosio@usp.br	Ambrosio, Carlos Eduardo/F-3402-2010; Martins-Júnior, Helio A/B-7769-2015; Miglino, Maria Angelica/B-9519-2012; Ferreira, Christina Ramires/F-4744-2012; dos Santos Martins, Daniele/ABH-1262-2020; de Paula Nogueira, Guilherme/I-3595-2012; Perecin, Felipe/C-7268-2012; dos Santos Martins, Daniele/C-9004-2013; Simas, Rosineide Costa/J-2729-2015	Ambrosio, Carlos Eduardo/0000-0002-8224-5022; Miglino, Maria Angelica/0000-0003-4979-115X; Ferreira, Christina Ramires/0000-0003-3988-6454; dos Santos Martins, Daniele/0000-0002-6277-4664; de Paula Nogueira, Guilherme/0000-0002-5277-7220; Perecin, Felipe/0000-0003-2009-5863; dos Santos Martins, Daniele/0000-0002-6277-4664; Simas, Rosineide Costa/0000-0002-2018-0403; Eberlin, Marcos Nogueira/0000-0003-4868-0618	FAPESP [2007/51222-2, 2010/15167-0, 2010/51677-2]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The authors would like to thank FAPESP projects 2007/51222-2, 2010/15167-0, and 2010/51677-2.	Ambrosio CE, 2009, GENET MOL RES, V8, P389, DOI 10.4238/vol8-2gmr581; Araujo KPC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061367; Beerda B, 1999, PHYSIOL BEHAV, V66, P243, DOI 10.1016/S0031-9384(98)00290-X; Brinkmeyer-Langford C, 2013, CURR GENOMICS, V14, P330, DOI 10.2174/13892029113149990004; Brolio MP, 2014, ANIM REPROD SCI, V150, P56, DOI 10.1016/j.anireprosci.2014.08.005; Collins CA, 2003, INT J EXP PATHOL, V84, P165, DOI 10.1046/j.1365-2613.2003.00354.x; COOPER BJ, 1988, NATURE, V334, P154, DOI 10.1038/334154a0; David ON, 2007, VERTEBRATE ENDOCRINO; Etter ML, 2006, J CHROMATOGR B, V840, P69, DOI 10.1016/j.jchromb.2006.04.038; Fanelli F, 2011, STEROIDS, V76, P244, DOI 10.1016/j.steroids.2010.11.005; Feldman EN, 2003, CANINE FELINE ENDOCR; Fortin T, 2009, ANAL CHEM, V81, P9343, DOI 10.1021/ac901447h; Gaiad TP, 2011, RES VET SCI, V91, P188, DOI 10.1016/j.rvsc.2011.01.007; Giton F, 2010, CLIN CHIM ACTA, V411, P1208, DOI 10.1016/j.cca.2010.04.022; Grebe Stefan Kg, 2011, Clin Biochem Rev, V32, P5; Gust M, 2010, J CHROMATOGR B, V878, P1487, DOI 10.1016/j.jchromb.2010.03.046; GUYTON AC, 2006, TXB MED PHYSL, P944; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Hydbring-Sandberg E, 2004, J ENDOCRINOL, V180, P439, DOI 10.1677/joe.0.1800439; Inaba T, 2002, NEUROSCI LETT, V333, P107, DOI 10.1016/S0304-3940(02)01001-7; Isabelle GT, 2007, RES VET SCI, V82, P195, DOI 10.1016/j.rvsc.2006.07.010; Janssen PML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088360; Jones AC, 2006, HORM BEHAV, V50, P393, DOI 10.1016/j.yhbeh.2006.04.007; Kerkis I, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-35; Koal T, 2012, J STEROID BIOCHEM, V129, P129, DOI 10.1016/j.jsbmb.2011.12.001; Kushnir MM, 2011, CLIN BIOCHEM, V44, P77, DOI 10.1016/j.clinbiochem.2010.07.008; Liang HR, 2003, RAPID COMMUN MASS SP, V17, P2815, DOI 10.1002/rcm.1268; Morini AC, 2011, PESQUI VET BRASIL, V31, P94, DOI 10.1590/S0100-736X2011000100015; Nghiem PP, 2013, AM J PATHOL, V183, P1411, DOI 10.1016/j.ajpath.2013.07.013; Nguyen F, 2002, J COMP PATHOL, V126, P100, DOI 10.1053/jcpa.2001.0526; Nozoe KT, 2014, SEX MED-UK, V2, P133, DOI 10.1002/sm2.29; Peres MA, 2014, ANDROLOGIA, V46, P277, DOI 10.1111/and.12079; Pfaff DW, 2004, PRINCIPLES HORMONAL, P61; Samsa M, 2004, LAUR048575; Selk Ghaffari M., 2009, COMP CLIN PATHOL, V18, P341, DOI 10.1007/s00580-009-0815-x; SHARP NJH, 1989, SEMIN VET MED SURG, V4, P133; Stanczyk FZ, 2010, J STEROID BIOCHEM, V121, P491, DOI 10.1016/j.jsbmb.2010.05.001; Stapleton DI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091514; VALENTINE BA, 1988, J NEUROL SCI, V88, P69, DOI 10.1016/0022-510X(88)90206-7	39	9	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0126585	10.1371/journal.pone.0126585	http://dx.doi.org/10.1371/journal.pone.0126585			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010907	gold, Green Published, Green Submitted			2022-12-26	WOS:000355183900034
J	Yu, XK; He, L; Cao, P; Yu, Q				Yu, Xiaokui; He, Li; Cao, Peng; Yu, Qiang			Eriocalyxin B Inhibits STAT3 Signaling by Covalently Targeting STAT3 and Blocking Phosphorylation and Activation of STAT3	PLOS ONE			English	Article							CELL-CYCLE ARREST; ANTITUMOR-ACTIVITY; TYROSINE KINASES; LEUKEMIA-CELLS; DNA-BINDING; TRANSCRIPTION; APOPTOSIS; PROTEIN; TRANSDUCERS; PATHWAY	Activated STAT3 plays an important role in oncogenesis by stimulating cell proliferation and resisting apoptosis. STAT3 therefore is an attractive target for cancer therapy. We have screened a traditional Chinese herb medicine compound library and found Eriocalyxin B (EB), a diterpenoid from Isodon eriocalyx, as a specific inhibitor of STAT3. EB selectively inhibited constitutive as well as IL-6-induced phosphorylation of STAT3 and induced apoptosis of STAT3-dependent tumor cells. EB did not affect the upstream protein tyrosine kinases or the phosphatase (PTPase) of STAT3, but rather interacted directly with STAT3. The effects of EB could be abolished by DTT or GSH, suggesting a thiol-mediated covalent linkage between EB and STAT3. Site mutagenesis of cysteine in and near the SH2 domain of STAT3 identified Cys712 to be the critical amino acid for the EB-induced inactivation of STAT3. Furthermore, LC/MS/MS analyses demonstrated that an a, beta-unsaturated carbonyl of EB covalently interacted with the Cys712 of STAT3. Computational modeling analyses also supported a direct interaction between EB and the Cys712 of STAT3. These data strongly suggest that EB directly targets STAT3 through a covalent linkage to inhibit the phosphorylation and activation of STAT3 and induces apoptosis of STAT3-dependent tumor cells.	[Yu, Xiaokui; He, Li; Yu, Qiang] Chinese Acad Sci, Shanghai Inst Mat Med, Dept Pharmacol, Shanghai 200031, Peoples R China; [Cao, Peng] Jiangsu Prov Acad Tradit Chinese Med, Lab Cellular & Mol Biol, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Nanjing University of Chinese Medicine	Yu, Q (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Dept Pharmacol, Shanghai 200031, Peoples R China.	qyu@sibs.ac.cn		, Peng/0000-0002-2044-3074	China Ministry of Science & Technology "Key New Drug Creation and Manufacturing Program" [2013ZX09102015]; China Ministry of Science and Technology [2013ZX10002010-009]; China National Natural Science Foundation [81373447, 91129701, 91213304, 81274150]; National Science and Technology 973 grants [2012CB910704, 2013CB910900]	China Ministry of Science & Technology "Key New Drug Creation and Manufacturing Program"; China Ministry of Science and Technology(Ministry of Science and Technology, China); China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Science and Technology 973 grants	This work was supported by the China Ministry of Science & Technology "Key New Drug Creation and Manufacturing Program" Grant 2013ZX09102015; the China Ministry of Science and Technology Research Grant 2013ZX10002010-009; the China National Natural Science Foundation Grants 81373447, 91129701, 91213304, and 81274150; the National Science and Technology 973 grants 2012CB910704 and 2013CB910900. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamkova L, 2007, FOLIA BIOL-PRAGUE, V53, P1; Avalle Lidia, 2012, JAKSTAT, V1, P65, DOI 10.4161/jkst.20045; Becker S, 1998, NATURE, V394, P145, DOI 10.1038/28101; Blaskovich MA, 2003, CANCER RES, V63, P1270; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Bromberg J, 2002, J CLIN INVEST, V109, P1139, DOI 10.1172/JCI200215617; Buettner R, 2011, ACS CHEM BIOL, V6, P432, DOI 10.1021/cb100253e; Cao D, 2007, AM J PHYSIOL-LUNG C, V292, pL422, DOI 10.1152/ajplung.00204.2006; Chaturvedi MM, 2000, METHOD ENZYMOL, V319, P585; Chen Z, 2012, ACTA PHARMACOL SIN, V33, P101, DOI 10.1038/aps.2011.164; Chen Z, 2008, MED RES REV, V28, P185, DOI 10.1002/med.20101; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Garcia R, 2001, ONCOGENE, V20, P2499, DOI 10.1038/sj.onc.1204349; Gough DJ, 2009, SCIENCE, V324, P1713, DOI 10.1126/science.1171721; Gritsko T, 2006, CLIN CANCER RES, V12, P11, DOI 10.1158/1078-0432.CCR-04-1752; Heidelberger S, 2013, BIOORG MED CHEM LETT, V23, P4719, DOI 10.1016/j.bmcl.2013.05.066; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; HORVATH CM, 1995, GENE DEV, V9, P984, DOI 10.1101/gad.9.8.984; Ihle JN, 1996, CELL, V84, P331, DOI 10.1016/S0092-8674(00)81277-5; Inghirami G, 2005, CELL CYCLE, V4, P1131, DOI 10.4161/cc.4.9.1985; Kanda N, 2004, ONCOGENE, V23, P4921, DOI 10.1038/sj.onc.1207606; Kim DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010290; Klampfer L, 2006, CURR CANCER DRUG TAR, V6, P107, DOI 10.2174/156800906776056491; Kortylewski M, 2005, CANCER METAST REV, V24, P315, DOI 10.1007/s10555-005-1580-1; Leclerc GM, 2000, BIOTECHNIQUES, V29, P590, DOI 10.2144/00293rr02; Leeman RJ, 2006, EXPERT OPIN BIOL TH, V6, P231, DOI 10.1517/14712598.6.3.231; Li L, 2012, TOXICOL APPL PHARM, V262, P80, DOI 10.1016/j.taap.2012.04.021; Liu DB, 2012, ACTA PHARMACOL SIN, V33, P682, DOI 10.1038/aps.2012.18; Lu Y, 2013, P NATL ACAD SCI USA, V110, P2258, DOI 10.1073/pnas.1222426110; Paukku K, 2004, CYTOKINE GROWTH F R, V15, P435, DOI 10.1016/j.cytogfr.2004.09.001; Pellegrini S, 1997, EUR J BIOCHEM, V248, P615, DOI 10.1111/j.1432-1033.1997.00615.x; Qi Qian-Rong, 2014, World J Biol Chem, V5, P231, DOI 10.4331/wjbc.v5.i2.231; Qing YL, 2004, J BIOL CHEM, V279, P41679, DOI 10.1074/jbc.M406413200; Rodig SJ, 1998, CELL, V93, P373, DOI 10.1016/S0092-8674(00)81166-6; Sareila O, 2006, MEDIAT INFLAMM, V2006, DOI 10.1155/MI/2006/16161; Schuringa JJ, 2000, BLOOD, V95, P3765, DOI 10.1182/blood.V95.12.3765; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Shin DS, 2009, CANCER RES, V69, P193, DOI 10.1158/0008-5472.CAN-08-2575; SHUAI K, 1994, CELL, V76, P821, DOI 10.1016/0092-8674(94)90357-3; Siddiquee K, 2007, P NATL ACAD SCI USA, V104, P7391, DOI 10.1073/pnas.0609757104; Song LX, 2003, ONCOGENE, V22, P4150, DOI 10.1038/sj.onc.1206479; SUN HD, 1995, PHYTOCHEMISTRY, V38, P1451, DOI 10.1016/0031-9422(94)00815-B; Tammineni P, 2013, J BIOL CHEM, V288, P4723, DOI 10.1074/jbc.M112.378984; Thoennissen NH, 2009, CANCER RES, V69, P5876, DOI 10.1158/0008-5472.CAN-09-0536; Urn HJ, 2012, BIOCHEM BIOPH RES CO, V427, P24, DOI 10.1016/j.bbrc.2012.08.133; Wang L, 2007, CELL DEATH DIFFER, V14, P306, DOI 10.1038/sj.cdd.4401996; Wang Y, 2009, CANCER RES, V69, P7302, DOI 10.1158/0008-5472.CAN-09-0462; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Xu XA, 1996, SCIENCE, V273, P794, DOI 10.1126/science.273.5276.794; Xu XL, 1998, CANCER RES, V58, P2832; Ye YC, 2012, ACTA PHARMACOL SIN, V33, P1055, DOI 10.1038/aps.2012.53; Zhang YW, 2010, EXP HEMATOL, V38, P191, DOI 10.1016/j.exphem.2009.12.005; Zhao Y, 2007, EUR J MED CHEM, V42, P494, DOI 10.1016/j.ejmech.2006.11.004	53	28	32	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128406	10.1371/journal.pone.0128406	http://dx.doi.org/10.1371/journal.pone.0128406			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010889	Green Published, Green Submitted, gold			2022-12-26	WOS:000355183900233
J	Sasaki, Y; Margolin, Z; Borgo, B; Havranek, JJ; Milbrandt, J				Sasaki, Yo; Margolin, Zachary; Borgo, Benjamin; Havranek, James J.; Milbrandt, Jeffrey			Characterization of Leber Congenital Amaurosis-associated NMNAT1 Mutants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DELAYS AXONAL DEGENERATION; MUTATIONS; STRESS; MITOCHONDRIAL; SPECIFICITY; ACTIVATION; SUBSTRATE	Leber congenital amaurosis 9 (LCA9) is an autosomal recessive retinal degeneration condition caused by mutations in the NAD(+) biosynthetic enzyme NMNAT1. This condition leads to early blindness but no other consistent deficits have been reported in patients with NMNAT1 mutations despite its central role in metabolism and ubiquitous expression. To study how these mutations affect NMNAT1 function and ultimately lead to the retinal degeneration phenotype, we performed detailed analysis of LCA-associated NMNAT1 mutants, including the expression, nuclear localization, enzymatic activity, secondary structure, oligomerization, and promotion of axonal and cellular integrity in response to injury. In many assays, most mutants produced results similar to wild type NMNAT1. Indeed, NAD(+) synthetic activity is unlikely to be a primary mechanism underlying retinal degeneration as most LCA-associated NMNAT1 mutants had normal enzymatic activity. In contrast, the secondary structure of many NMNAT1 mutants was relatively less stable as they lost enzymatic activity after heat shock, whereas wild type NMNAT1 retains significant activity after this stress. These results suggest that LCA-associated NMNAT1 mutants are more vulnerable to stressful conditions that lead to protein unfolding, a potential contributor to the retinal degeneration observed in this syndrome.	[Sasaki, Yo; Margolin, Zachary; Borgo, Benjamin; Havranek, James J.; Milbrandt, Jeffrey] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	Washington University (WUSTL)	Sasaki, Y (corresponding author), Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA.	ysasaki@genetics.wustl.edu	Regan, Clinton/E-6250-2012	Milbrandt, Jeffrey/0000-0002-5477-7689	National Institutes of Health [R01AG013730, R01NS065053, RO1NS078007, R01NS087632, R01GM101602]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101602] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065053, R01NS078007, R01NS087632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013730] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health Grants R01AG013730 (to J. M.), R01NS065053 (to J. M. and A. D.), RO1NS078007 (to J. M. and A. D.), R01NS087632 (to J. M.), and R01GM101602 (to J. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Athanasiou D, 2013, FEBS LETT, V587, P2008, DOI 10.1016/j.febslet.2013.05.020; Beatty S, 2000, SURV OPHTHALMOL, V45, P115, DOI 10.1016/S0039-6257(00)00140-5; Borgo B, 2012, P NATL ACAD SCI USA, V109, P1494, DOI 10.1073/pnas.1115172109; Chiang PW, 2012, NAT GENET, V44, P972, DOI 10.1038/ng.2370; Conforti L, 2011, FEBS J, V278, P2666, DOI 10.1111/j.1742-4658.2011.08193.x; den Hollander AI, 2008, PROG RETIN EYE RES, V27, P391, DOI 10.1016/j.preteyeres.2008.05.003; Falk MJ, 2012, NAT GENET, V44, P1040, DOI 10.1038/ng.2361; Greenfield NJ, 2004, METHOD ENZYMOL, V383, P282; Keen TJ, 2003, EUR J HUM GENET, V11, P420, DOI 10.1038/sj.ejhg.5200981; Koenekoop RK, 2012, NAT GENET, V44, P1035, DOI 10.1038/ng.2356; Kuhlman B, 2000, P NATL ACAD SCI USA, V97, P10383, DOI 10.1073/pnas.97.19.10383; NGUYEN VT, 1989, J BIOL CHEM, V264, P10487; Perrault I, 2012, NAT GENET, V44, P975, DOI 10.1038/ng.2357; Press C, 2008, J NEUROSCI, V28, P4861, DOI 10.1523/JNEUROSCI.0525-08.2008; Rallis A, 2013, J CELL SCI, V126, P838, DOI 10.1242/jcs.117259; Rozanowska M, 2005, PHOTOCHEM PHOTOBIOL, V81, P1305, DOI 10.1562/2004-11-13-IR-371; Sasaki Y, 2006, J NEUROSCI, V26, P8484, DOI 10.1523/JNEUROSCI.2320-06.2006; Sasaki Y, 2009, J NEUROSCI, V29, P6526, DOI 10.1523/JNEUROSCI.1429-09.2009; Sasaki Y, 2009, J NEUROSCI, V29, P5525, DOI 10.1523/JNEUROSCI.5469-08.2009; Siemiatkowska AM, 2014, JAMA OPHTHALMOL, V132, P1002, DOI 10.1001/jamaophthalmol.2014.983; Sorci L, 2007, BIOCHEMISTRY-US, V46, P4912, DOI 10.1021/bi6023379; Sparrow JR, 2005, EXP EYE RES, V80, P595, DOI 10.1016/j.exer.2005.01.007; Summers DW, 2014, J NEUROSCI, V34, P9338, DOI 10.1523/JNEUROSCI.0877-14.2014; Zhai RG, 2006, PLOS BIOL, V4, P2336, DOI 10.1371/journal.pbio.0040416; Zhou TJ, 2002, J BIOL CHEM, V277, P13148, DOI 10.1074/jbc.M111469200	26	26	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17228	17238		10.1074/jbc.M115.637850	http://dx.doi.org/10.1074/jbc.M115.637850			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	26018082	Green Published, hybrid			2022-12-26	WOS:000357730900019
J	Sun, GN; Hu, ZR; Min, ZY; Yan, XH; Guan, ZP; Su, HX; Fu, Y; Ma, XP; Chen, YG; Zhang, MQ; Tao, QH; Wu, W				Sun, Guanni; Hu, Zhirui; Min, Zheying; Yan, Xiaohua; Guan, Zhenpo; Su, Hanxia; Fu, Yu; Ma, Xiaopeng; Chen, Ye-Guang; Zhang, Michael Q.; Tao, Qinghua; Wu, Wei			Small C-terminal Domain Phosphatase 3 Dephosphorylates the Linker Sites of Receptor-regulated Smads (R-Smads) to Ensure Transforming Growth Factor beta (TGF beta)-mediated Germ Layer Induction in Xenopus Embryos	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE MORPHOGENETIC PROTEIN; TGF-BETA; SIGNALING PATHWAYS; MESENDODERM FORMATION; MATERNAL VEGT; IN-VIVO; BMP; MESODERM; PHOSPHORYLATION; IDENTIFICATION	Germ layer induction is one of the earliest events shortly after fertilization that initiates body formation of vertebrate embryos. In Xenopus, the maternally deposited transcriptional factor VegT promotes the expression of zygotic Nodal/Activin ligands that further form a morphogen gradient along the vegetal-animal axis and trigger the induction of the three germ layers. Here we found that SCP3 (small C-terminal domain phosphatase 3) is maternally expressed and vegetally enriched in Xenopus embryos and is essential for the timely induction of germ layers. SCP3 is required for the full activation of Nodal/Activin and bone morphogenetic protein signals and functions via dephosphorylation in the linker regions of receptor-regulated Smads. Consistently, the linker regions of receptor-regulated Smads are heavily phosphorylated in fertilized eggs, and this phosphorylation is gradually removed when embryos approach the midblastula transition. Knockdown of maternal SCP3 attenuates these dephosphorylation events and the activation of Nodal/Activin and bone morphogenetic protein signals after midblastula transition. This study thus suggested that the maternal SCP3 serves as a vegetally enriched, intrinsic factor to ensure a prepared status of Smads for their activation by the upcoming ligands during germ layer induction of Xenopus embryos.	[Sun, Guanni; Guan, Zhenpo; Su, Hanxia; Fu, Yu; Wu, Wei] Tsinghua Univ, Sch Life Sci, MOE Key Lab Prot Sci, Beijing 100084, Peoples R China; [Hu, Zhirui; Ma, Xiaopeng; Zhang, Michael Q.] Tsinghua Univ, TNLIST, Ctr Synthet & Syst Biol, Bioinformat Div, Beijing 100084, Peoples R China; [Min, Zheying; Tao, Qinghua] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Yan, Xiaohua; Chen, Ye-Guang] Tsinghua Univ, Sch Life Sci, Tsinghua Peking Ctr Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Zhang, Michael Q.] Univ Texas Dallas, Ctr Syst Biol, Dept Biol Sci, Richardson, TX 75080 USA	Tsinghua University; Tsinghua University; Tsinghua University; Tsinghua University; University of Texas System; University of Texas Dallas	Zhang, MQ (corresponding author), Tsinghua Univ, TNLIST, Ctr Synthet & Syst Biol, Bioinformat Div, Beijing 100084, Peoples R China.	michael.zhang@utdallas.edu; qhtaolab@mail.tsinghua.edu.cn; wwu@mail.tsinghua.edu.cn	Chen, Ye-Guang/L-6998-2019; Yan, Xiaohua/J-4922-2015	Yan, Xiaohua/0000-0002-7528-5771	MOST [2011CB943803, 2011CB943800]; National Natural Science Foundation of China (NSFC) [31221064]; NSFC [91019016]; National Basic Research Foundation of China (NBRPC) [2012CB316503]	MOST; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NSFC(National Natural Science Foundation of China (NSFC)); National Basic Research Foundation of China (NBRPC)(National Basic Research Program of China)	This work was supported by MOST Grant 2011CB943803 and National Natural Science Foundation of China (NSFC) Grant 31221064 (to W. W.), MOST Grant 2011CB943800 (to Q. T.), and NSFC Grant 91019016 and National Basic Research Foundation of China (NBRPC) Grant 2012CB316503 (to M. Q. Z.). The authors declare that they have no conflicts of interest with the contents of this article.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Archambault J, 1998, J BIOL CHEM, V273, P27593, DOI 10.1074/jbc.273.42.27593; Bandyopadhyay A, 2013, BIOCHEM PHARMACOL, V85, P857, DOI 10.1016/j.bcp.2013.01.004; Bruce DL, 2012, FEBS LETT, V586, P1897, DOI 10.1016/j.febslet.2012.02.001; Claussen M, 2004, DEVELOPMENT, V131, P4263, DOI 10.1242/dev.01283; Clements D, 1999, DEVELOPMENT, V126, P4903; Dale L, 1999, BIOESSAYS, V21, P751, DOI 10.1002/(SICI)1521-1878(199909)21:9<751::AID-BIES6>3.0.CO;2-I; Engel ME, 1999, J BIOL CHEM, V274, P37413, DOI 10.1074/jbc.274.52.37413; Faure S, 2000, DEVELOPMENT, V127, P2917; Fritz BR, 2001, DEV BIOL, V236, P230, DOI 10.1006/dbio.2001.0324; Fuentealba LC, 2007, CELL, V131, P980, DOI 10.1016/j.cell.2007.09.027; Gao S, 2009, MOL CELL, V36, P457, DOI 10.1016/j.molcel.2009.09.043; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Hata A, 2000, CELL, V100, P229, DOI 10.1016/S0092-8674(00)81561-5; HEASMAN J, 1991, METHOD CELL BIOL, V36, P213; Heasman J, 2006, SEMIN CELL DEV BIOL, V17, P93, DOI 10.1016/j.semcdb.2005.11.005; Hill CS, 2001, CURR OPIN GENET DEV, V11, P533, DOI 10.1016/S0959-437X(00)00229-X; HUANG HC, 1995, EMBO J, V14, P5965, DOI 10.1002/j.1460-2075.1995.tb00285.x; JONES EA, 1987, DEVELOPMENT, V101, P557; Kamaraju SK, 2005, J BIOL CHEM, V280, P1024, DOI 10.1074/jbc.M403960200; Kamato D, 2013, CELL SIGNAL, V25, P2017, DOI 10.1016/j.cellsig.2013.06.001; Kaneko K, 2008, J EXP ZOOL PART B, V310B, P492, DOI 10.1002/jez.b.21222; Kataoka K, 2005, DEV GROWTH DIFFER, V47, P511; Knockaert M, 2006, P NATL ACAD SCI USA, V103, P11940, DOI 10.1073/pnas.0605133103; Kofron M, 1999, DEVELOPMENT, V126, P5759; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Kretzschmar M, 1997, NATURE, V389, P618, DOI 10.1038/39348; Kurata T, 2001, DIFFERENTIATION, V67, P33, DOI 10.1046/j.1432-0436.2001.067001033.x; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Liu T, 2010, BIOCHEM J, V430, P191, DOI 10.1042/BJ20100427; Loose M, 2004, DEV BIOL, V271, P467, DOI 10.1016/j.ydbio.2004.04.014; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Matsuura I, 2004, NATURE, V430, P226, DOI 10.1038/nature02650; Mori S, 2004, ONCOGENE, V23, P7416, DOI 10.1038/sj.onc.1207981; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; Olson David J, 2012, Methods Mol Biol, V917, P167, DOI 10.1007/978-1-61779-992-1_10; Pera EM, 2003, GENE DEV, V17, P3023, DOI 10.1101/gad.1153603; Rana AA, 2006, PLOS GENET, V2, P1751, DOI 10.1371/journal.pgen.0020193; Saka Y, 2007, DEVELOPMENT, V134, P4209, DOI 10.1242/dev.010645; Sapkota G, 2007, MOL CELL, V25, P441, DOI 10.1016/j.molcel.2007.01.006; Sapkota G, 2006, J BIOL CHEM, V281, P40412, DOI 10.1074/jbc.M610172200; Schohl A, 2002, DEVELOPMENT, V129, P37; Sudou N, 2012, DEVELOPMENT, V139, P1651, DOI 10.1242/dev.068395; Taverner NV, 2005, MECH DEVELOP, V122, P333, DOI 10.1016/j.mod.2004.10.010; Wang Y, 2010, J BIOL CHEM, V285, P10890, DOI 10.1074/jbc.M109.058347; Wardle FC, 2006, SEMIN CELL DEV BIOL, V17, P99, DOI 10.1016/j.semcdb.2005.11.008; Wrighton KH, 2006, J BIOL CHEM, V281, P38365, DOI 10.1074/jbc.M607246200; Wylie C, 1996, DEVELOPMENT, V122, P2987; Yan XH, 2009, J BIOL CHEM, V284, P30097, DOI 10.1074/jbc.M109.049304; Yeo M, 2003, J BIOL CHEM, V278, P26078, DOI 10.1074/jbc.M301791200; Zhang J, 1998, CELL, V94, P515, DOI 10.1016/S0092-8674(00)81592-5; Zhao YL, 2014, J BIOL CHEM, V289, P26441, DOI 10.1074/jbc.M114.568964	53	3	4	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17239	17249		10.1074/jbc.M115.655605	http://dx.doi.org/10.1074/jbc.M115.655605			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	26013826	hybrid, Green Published			2022-12-26	WOS:000357730900020
J	Collado, S; Coll, E; Nicolau, C; Pons, M; Cruzado, JM; Pascual, J; Cases, A				Collado, Slvia; Coll, Elisabeth; Nicolau, Carlos; Pons, Mercedes; Cruzado, Josep M.; Pascual, Julio; Cases, Aleix			Carotid Atherosclerotic Disease Predicts Cardiovascular Events in Hemodialysis Patients: A Prospective Study	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; CHRONIC KIDNEY-DISEASE; CHRONIC-RENAL-FAILURE; ALL-CAUSE MORTALITY; RISK-FACTORS; DIALYSIS PATIENTS; PROGNOSTIC VALUE; WALL THICKNESS; FOLLOW-UP; PLAQUE	Background To evaluate the predictive value of carotid atherosclerotic disease (CAD) and intima-media thickness (IMT) on incident cardiovascular disease and mortality in hemodialysis patients. Methods Multicenter, observational, prospective study including 110 patients, followed-up to 6 years. Carotid doppler ultrasonographic findings were classified in 4 degrees of severity: 1) IMT < 0.9 mm, 2) IMT > 0.9 mm, 3) carotid plaque with stenosis < 50% and 4) plaque with stenosis > 50%. The associations between IMT and CAD and cardiovascular events, total and cardiovascular mortality were assessed. Results 83% of the patients had atherosclerotic plaques (CAD degrees 3-4). During follow-up, 29.1% of patients experienced cardiovascular events, and 28.2% died, 38.7% of cardiovascular origin. The presence of plaques was associated with cardiovascular events (p = 0.03) while calcified plaques were associated with both cardiovascular events (p = 0.01), cardiovascular mortality (p = 0.03) and non-significantly with overall mortality (p = 0.08) in the survival analysis. Carotid IMT was not associated with outcomes. Cardiovascular events correlated with CAD severity (HR 2.27, 95% CI 1.13-4.54), age (HR 1.04, 1.01-1.06), previous cardiovascular disease (HR 1.75, 1.05-4.42), dyslipidemia (HR 2.25, 1.11-4.53), lipoprotein (a) (HR 1.01, 1.00-1.02), troponin I (HR 3.89, 1.07-14.18), fibrinogen levels (HR 1.38, 0.98-1.94) and antiplatelet therapy (HR 2.14, 1.04-4.4). In an age-adjusted multivariate model, cardiovascular events were independently associated with previous coronary artery disease (HR 3.29, 1.52-7.15) and lipoprotein (a) (HR 1.01, 1.00-1.02). Conclusions The presence of carotid plaques and, especially, calcified plaques, are predictors of new cardiovascular events and cardiovascular mortality in hemodialysis patients, while IMT was not. The prognostic value of calcified plaques should be confirmed in future studies.	[Collado, Slvia; Pascual, Julio] Hosp del Mar, Dept Nephrol, Barcelona, Spain; [Coll, Elisabeth] Fdn Puigvert, Dept Nephrol, Barcelona, Spain; [Nicolau, Carlos] Hosp Clin Barcelona, Dept Radiol, Barcelona, Spain; [Pons, Mercedes] CETIRSA Barcelona, Fresenius Med Care,Barcelona, Barcelona, Spain; [Cruzado, Josep M.] Inst Hemodialisi Barcelona, Barcelona, Spain; [Cases, Aleix] Hosp Clin Barcelona, Dept Nephrol, Barcelona, Spain; [Cases, Aleix] Univ Barcelona, Barcelona, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Fundacio Puigvert; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona	Collado, S (corresponding author), Hosp del Mar, Dept Nephrol, Barcelona, Spain.	scolladonieto@yahoo.es	Cases, Aleix/N-4736-2018	Cases, Aleix/0000-0002-6962-8184; COLLADO NIETO, SILVIA/0000-0002-1812-1367	Spanish Ministry of Health [03/0791]; Fondo de Investigacion Sanitaria Instituto Carlos III, Ministerio de Sanidad y Consumo [03/0791]	Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); Fondo de Investigacion Sanitaria Instituto Carlos III, Ministerio de Sanidad y Consumo	This study was supported in part by the FISS project 03/0791 (a public grant from the Spanish Ministry of Health) ["Fondo de Investigacion Sanitaria Instituto Carlos III, Ministerio de Sanidad y Consumo. FIS project 03/0791, http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-financiacion/ convocatorias-ayudas-accion-estrategica-salud.shtml].	Aggarwal HK, 2010, RENAL FAILURE, V32, P647, DOI 10.3109/0886022X.2010.486097; Benedetto FA, 2001, J AM SOC NEPHROL, V12, P2458, DOI 10.1681/ASN.V12112458; Benedetto FA, 2008, J AM SOC NEPHROL, V19, P757, DOI 10.1681/ASN.2007070813; Blacher J, 1999, CIRCULATION, V99, P2434, DOI 10.1161/01.CIR.99.18.2434; Cao JJ, 2007, CIRCULATION, V116, P32, DOI 10.1161/CIRCULATIONAHA.106.645606; Chambless LE, 2000, AM J EPIDEMIOL, V151, P478; Chambless LE, 1997, AM J EPIDEMIOL, V146, P483, DOI 10.1093/oxfordjournals.aje.a009302; Cheung AK, 2000, KIDNEY INT, V58, P353, DOI 10.1046/j.1523-1755.2000.00173.x; Drozdz Maciej, 2011, Przegl Lek, V68, P1162; Falaknazil K, 2012, SAUDI J KIDNEY DIS T, V23, P31; Junyent M, 2010, NEFROLOGIA, V30, P119, DOI 10.3265/Nefrologia.pre2010.Jan.10216; Kato A, 2003, KIDNEY INT, V64, P1472, DOI 10.1046/j.1523-1755.2003.00205.x; Kato K, 2013, CIRC-CARDIOVASC IMAG, V6, P448, DOI 10.1161/CIRCIMAGING.112.000165; Leskinen Y, 2003, ATHEROSCLEROSIS, V171, P295, DOI 10.1016/j.atherosclerosis.2003.08.010; Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f; Nakano T, 2013, KIDNEY INT, V84, P373, DOI 10.1038/ki.2013.111; Nakashima A, 2003, INTERNAL MED, V42, P1095, DOI 10.2169/internalmedicine.42.1095; Nambi V, 2010, J AM COLL CARDIOL, V55, P1600, DOI 10.1016/j.jacc.2009.11.075; NICHOLS P, 1990, Q J MED, V77, P1175, DOI 10.1093/qjmed/77.2.1175; Ortiz A, 2012, NAT REV NEPHROL, V8, P141, DOI 10.1038/nrneph.2011.170; Ossareh S, 2011, IRAN J KIDNEY DIS, V5, P169; Park SH, 2012, J RENAL NUTR, V22, P120, DOI 10.1053/j.jrn.2011.10.021; Peters SAE, 2011, AM J CARDIOVASC DRUG, V11, P253, DOI 10.2165/11591960-000000000-00000; Rakhit DJ, 2006, HEART, V92, P1402, DOI 10.1136/hrt.2005.074393; Sanchez-Alvarez JE, 2010, NEFROLOGIA, V30, P427, DOI 10.3265/Nefrologia.pre2010.Mar.10277; Savage T, 1998, NEPHROL DIAL TRANSPL, V13, P2004, DOI 10.1093/ndt/13.8.2004; Schwaiger JP, 2006, AM J KIDNEY DIS, V47, P888, DOI 10.1053/j.ajkd.2006.01.011; Schwarz U, 2000, NEPHROL DIAL TRANSPL, V15, P218, DOI 10.1093/ndt/15.2.218; Shah DS, 2008, NEPHROLOGY, V13, P667, DOI 10.1111/j.1440-1797.2008.00982.x; Sharma K, 2009, AM J CARDIOL, V103, P1316, DOI 10.1016/j.amjcard.2009.01.020; Stenvinkel P, 1999, KIDNEY INT, V55, P1899, DOI 10.1046/j.1523-1755.1999.00422.x; Stenvinkel P, 2012, NAT REV NEPHROL, V8, P72, DOI 10.1038/nrneph.2011.212; Touboul PJ, 2012, CEREBROVASC DIS, V34, P290, DOI 10.1159/000343145; van den Oord SCH, 2013, ATHEROSCLEROSIS, V228, P1, DOI 10.1016/j.atherosclerosis.2013.01.025; Wang JG, 2006, STROKE, V37, P1933, DOI 10.1161/01.STR.0000227223.90239.13; Zoccali C, 2000, NEPHROL DIAL TRANSPL, V15, P454, DOI 10.1093/ndt/15.4.454	36	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0127344	10.1371/journal.pone.0127344	http://dx.doi.org/10.1371/journal.pone.0127344			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26029907	Green Published, Green Submitted, gold			2022-12-26	WOS:000356630900048
J	Yan, DD; Tu, YF; Jiang, F; Wang, J; Zhang, R; Sun, X; Wang, T; Wang, SY; Bao, YQ; Hu, C; Jia, WP				Yan, Dandan; Tu, Yinfang; Jiang, Feng; Wang, Jie; Zhang, Rong; Sun, Xue; Wang, Tao; Wang, Shiyun; Bao, Yuqian; Hu, Cheng; Jia, Weiping			Uric Acid Is Independently Associated with Diabetic Kidney Disease: A Cross-Sectional Study in a Chinese Population	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; RENAL-DISEASE; NITRIC-OXIDE; NEPHROPATHY; RISK; ALLOPURINOL; PROGRESSION; GLUCOSE	Background Association between hyperuricaemia and chronic kidney disease has been studied widely, but the influence of uric acid on the kidneys remains controversial. We aimed to summarize the association between uric acid and diabetic kidney disease (DKD), and to evaluate the role of uric acid in DKD. Methods We enrolled 3,212 type 2 diabetic patients in a cross-sectional study. The patients' basic characteristics (sex, age, BMI, duration of disease, and blood pressure) and chemical parameters (triglycerides, total cholesterol, low-density lipoprotein cholesterol (LDL-c), high-density lipoprotein cholesterol (HDL-c), microalbuminuria, creatinine, and uric acid) were recorded, and the association between uric acid and DKD was evaluated. Results In the 3,212 diabetic patients, the prevalence of diabetic kidney disease was higher in hyperuricaemic patients than in patients with normouricaemia (68.3% vs 41.5%). The prevalence of DKD increased with increasing uric acid (p<0.0001). Logistic analysis identified uric acid as an independent predictor of DKD (p<0.0001; adjusted OR (95%CI) = 1.005 (1.004-1.007), p<0.0001). Uric acid was positively correlated with albuminuria and creatinine levels (p<0.0001) but negatively correlated with eGFR (p<0.0001) after adjusting for confounding factors. Conclusions Hyperuricaemia is a risk factor for DKD. Serum uric acid levels within the high-normal range are independently associated with DKD.	[Yan, Dandan; Tu, Yinfang; Jiang, Feng; Wang, Jie; Zhang, Rong; Sun, Xue; Wang, Tao; Wang, Shiyun; Bao, Yuqian; Hu, Cheng; Jia, Weiping] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Key Lab Diabet Mellitus, Shanghai Diabet Inst,Shanghai Clin Ctr Diabet, Shanghai 200030, Peoples R China; [Hu, Cheng] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, South Branch, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Hu, C (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Key Lab Diabet Mellitus, Shanghai Diabet Inst,Shanghai Clin Ctr Diabet, Shanghai 200030, Peoples R China.	alfredhc@sjtu.edu.cn; wpjia@sjtu.edu.cn	Hu, Cheng/C-3346-2008	Hu, Cheng/0000-0003-4314-2386	National Science Foundation of China [81200582, 81322010, 81300691]; Key Discipline of Public Health of Shanghai [12GWZX0104]; Excellent Young Medical Expert of Shanghai [XYQ2011041]; Shanghai Talent Development Grant [2012041]; National Program for Support of Top-notch Young Professionals	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Discipline of Public Health of Shanghai; Excellent Young Medical Expert of Shanghai; Shanghai Talent Development Grant; National Program for Support of Top-notch Young Professionals	This work was funded by grants from the National Science Foundation of China (81200582, 81322010 and 81300691), Key Discipline of Public Health of Shanghai (12GWZX0104), Excellent Young Medical Expert of Shanghai (XYQ2011041), Shanghai Talent Development Grant (2012041) and the National Program for Support of Top-notch Young Professionals. The authors appreciate all of the participants of this research study. The authors gratefully acknowledge the skillful technical support of all nursing and medical staff at the Shanghai Clinical Center for Diabetes.	Altemtam N, 2012, NEPHROL DIAL TRANSPL, V27, P1847, DOI 10.1093/ndt/gfr561; Arora MK, 2014, CURR DRUG TARGETS, V15, P531, DOI 10.2174/1389450115666140321120635; Bardin T, 2014, CURR OPIN RHEUMATOL, V26, P186, DOI 10.1097/BOR.0000000000000028; BECK LH, 1986, KIDNEY INT, V30, P280, DOI 10.1038/ki.1986.179; Cai XL, 2011, CHINESE MED J-PEKING, V124, P3629, DOI 10.3760/cma.j.issn.0366-6999.2011.22.006; Caulfield MJ, 2008, PLOS MED, V5, P1509, DOI 10.1371/journal.pmed.0050197; Chino Y, 2014, BIOPHARM DRUG DISPOS, V35, P391, DOI 10.1002/bdd.1909; Choi HK, 2008, RHEUMATOLOGY, V47, P713, DOI 10.1093/rheumatology/ken066; Feig DI, 2006, J AM SOC NEPHROL, V17, pS69, DOI 10.1681/ASN.2005121331; Filiopoulos V, 2012, RENAL FAILURE, V34, P510, DOI 10.3109/0886022X.2011.653753; Gersch C, 2008, NUCLEOS NUCLEOT NUCL, V27, P967, DOI 10.1080/15257770802257952; Hsu CY, 2009, ARCH INTERN MED, V169, P342, DOI 10.1001/archinternmed.2008.605; Ito H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027817; Jalal DI, 2011, SEMIN NEPHROL, V31, P459, DOI 10.1016/j.semnephrol.2011.08.011; Johnson RJ, 2013, NEPHROL DIAL TRANSPL, V28, P2221, DOI 10.1093/ndt/gft029; Johnson RJ, 2003, HYPERTENSION, V41, P1183, DOI 10.1161/01.HYP.0000069700.62727.C5; Kanbay M, 2011, CLIN J AM SOC NEPHRO, V6, P1887, DOI 10.2215/CJN.11451210; Kang DH, 2002, J AM SOC NEPHROL, V13, P2888, DOI 10.1097/01.ASN.0000034910.58454.FD; Kao MP, 2011, J AM SOC NEPHROL, V22, P1382, DOI 10.1681/ASN.2010111185; Kohagura K, 2013, HYPERTENS RES, V36, P43, DOI 10.1038/hr.2012.135; Kuzkaya N, 2005, BIOCHEM PHARMACOL, V70, P343, DOI 10.1016/j.bcp.2005.05.009; Lim AKH, 2014, INT J NEPHROL RENOV, V7, P361, DOI 10.2147/IJNRD.S40172; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; MacIsaac RJ, 2014, AM J KIDNEY DIS, V63, pS39, DOI 10.1053/j.ajkd.2013.10.048; Mather A, 2011, KIDNEY INT, V79, pS1, DOI 10.1038/ki.2010.509; Miyaoka T, 2014, HEART VESSELS, V29, P504, DOI 10.1007/s00380-013-0396-0; Nakagawa T, 2011, NAT REV NEPHROL, V7, P36, DOI 10.1038/nrneph.2010.152; Nieto FJ, 2000, ATHEROSCLEROSIS, V148, P131, DOI 10.1016/S0021-9150(99)00214-2; Sakurai H, 2013, CURR OPIN NEPHROL HY, V22, P545, DOI 10.1097/MNH.0b013e328363ffc8; Sautin YY, 2008, NUCLEOS NUCLEOT NUCL, V27, P608, DOI 10.1080/15257770802138558; Sheikhbahaei S, 2014, METAB SYNDR RELAT D, V12, P102, DOI 10.1089/met.2013.0119; SHICHIRI M, 1990, AM J NEPHROL, V10, P115, DOI 10.1159/000168065; Singh DK, 2011, NAT REV ENDOCRINOL, V7, P176, DOI 10.1038/nrendo.2010.212; Wang TG, 2011, ENDOCRINE, V40, P109, DOI 10.1007/s12020-011-9449-2; Zoppini G, 2012, DIABETES CARE, V35, P99, DOI 10.2337/dc11-1346	35	32	40	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0129797	10.1371/journal.pone.0129797	http://dx.doi.org/10.1371/journal.pone.0129797			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26029914	gold, Green Published, Green Submitted			2022-12-26	WOS:000356630900232
J	Finlay, K; Stoecker, C; Cunningham, S				Finlay, Keith; Stoecker, Charles; Cunningham, Scott			Willingness-To-Accept Pharmaceutical Retail Inconvenience: Evidence from a Contingent Choice Experiment	PLOS ONE			English	Article							METHAMPHETAMINE USE; PRESCRIPTION; PSEUDOEPHEDRINE; PHENYLEPHRINE; BENEFITS; DRUGS	Objectives Restrictions on retail purchases of pseudoephedrine are one regulatory approach to reduce the social costs of methamphetamine production and use, but may impose costs on legitimate users of nasal decongestants. This is the first study to evaluate the costs of restricting access to medications on consumer welfare. Our objective was to measure the inconvenience cost consumers place on restrictions for cold medication purchases including identification requirements, purchase limits, over-the-counter availability, prescription requirements, and the active ingredient. Methods We conducted a contingent choice experiment with Amazon Mechanical Turk workers that presented participants with randomized, hypothetical product prices and combinations of restrictions that reflect the range of public policies. We used a conditional logit model to calculate willingness-to-accept each restriction. Results Respondents' willingness-to-accept prescription requirements was $14.17 ($9.76-$18.58) and behind-the-counter restrictions was $9.68 ($7.03-$12.33) per box of pseudoephedrine product. Participants were willing to pay $4.09 ($1.66-$6.52) per box to purchase pseudoephedrine- based products over phenylephrine-based products. Conclusions Restricting access to medicines as a means of reducing the social costs of non-medical use can imply large inconvenience costs for legitimate consumers. These results are relevant to discussions of retail access restrictions on other medications.	[Finlay, Keith] Tulane Univ, Dept Econ, New Orleans, LA 70118 USA; [Stoecker, Charles] Tulane Univ, Dept Global Hlth Management & Policy, Sch Publ Hlth & Trop Med, New Orleans, LA 70118 USA; [Cunningham, Scott] Baylor Univ, Dept Econ, Waco, TX 76798 USA	Tulane University; Tulane University; Baylor University	Stoecker, C (corresponding author), Tulane Univ, Dept Global Hlth Management & Policy, Sch Publ Hlth & Trop Med, New Orleans, LA 70118 USA.	cfstoecker@tulane.edu			National Science Foundation award [SMA-1004569]; Robert Wood Johnson Foundation [70509]	National Science Foundation award(National Science Foundation (NSF)); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF))	This work was supported by the National Science Foundation award SMA-1004569 (www.nsf. gov, KF SC) and the Robert Wood Johnson Foundation (Public Health Law Research award 70509, http://publichealthlawresearch.org/, KF SC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barr AM, 2006, J PSYCHIATR NEUROSCI, V31, P301; Berinsky AJ, 2012, POLIT ANAL, V20, P351, DOI 10.1093/pan/mpr057; Brass EP, 2001, NEW ENGL J MED, V345, P810, DOI 10.1056/NEJMra011080; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Cohen JP, 2005, BRIT MED J, V330, P39, DOI 10.1136/bmj.330.7481.39; de Bekker-Grob EW, 2012, HEALTH ECON, V21, P145, DOI 10.1002/hec.1697; DeShazo JR, 2002, J ENVIRON ECON MANAG, V44, P123, DOI 10.1006/jeem.2001.1199; Eccles R, 2007, BRIT J CLIN PHARMACO, V63, P10, DOI 10.1111/j.1365-2125.2006.02833.x; Hanley N, 1998, J AGR ECON, V49, P1, DOI 10.1111/j.1477-9552.1998.tb01248.x; Hatton RC, 2007, ANN PHARMACOTHER, V41, P381, DOI 10.1345/aph.1H679; Hensher D., 2005, APPL CHOICE ANAL PRI, DOI 10.1017/CBO9780511610356; Hershey MR, 2009, PS-POLIT SCI POLIT, V42, P87, DOI 10.1017/S1049096509090234; Horton JJ, 2011, EXP ECON, V14, P399, DOI 10.1007/s10683-011-9273-9; Iritani BJ, 2007, ADDICTION, V102, P1102, DOI 10.1111/j.1360-0443.2007.01847.x; Kaye S, 2007, ADDICTION, V102, P1204, DOI 10.1111/j.1360-0443.2007.01874.x; Krieger A. M., 1991, MARKET LETT, V2, P337, DOI DOI 10.1007/BF00664220; Krupnikov Yanna., 2014, J EXP POLIT SCI, V1, P59, DOI DOI 10.1017/XPS.2014.7; Louviere J. J., 2000, STATED CHOICE METHOD, DOI DOI 10.1017/CBO9780511753831; Louviere JJ, 2008, J CONSUM RES, V35, P360, DOI 10.1086/586913; Luchini S, 2014, ECON LETT, V124, P9, DOI 10.1016/j.econlet.2014.04.005; McKetin R, 2014, ADDICTION, V109, P798, DOI 10.1111/add.12474; OEHLERT GW, 1992, AM STAT, V46, P27, DOI 10.2307/2684406; Paolacci G, 2010, JUDGM DECIS MAK, V5, P411; Prasad M, 2002, VALUE HEALTH, V5, P193, DOI [10.1016/S1098-3015(10)60991-6, DOI 10.1016/S1098-3015(10)60991-6]; Reynolds T, 2002, ANN INTERN MED, V136, P177, DOI 10.7326/0003-4819-136-2-200201150-00026; RYAN M, 1990, HEALTH POLICY, V16, P233, DOI 10.1016/0168-8510(90)90424-C; Shoptaw S, 2007, ADDICTION, V102, P130, DOI 10.1111/j.1360-0443.2006.01775.x; Simons DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051876; Talbert J, 2012, JAMA-J AM MED ASSOC, V308, P1524, DOI 10.1001/jama.2012.12992; [US DEA] United States Drug Enforcement Administration, 2010, FED REGISTER, V75, P79407; [US DEA] United States Drug Enforcement Administration, 2007, 2005 EPH PSEUD LEG M; Wiley JB., 1978, ADV CONSUM RES, V5, P171	32	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0126790	10.1371/journal.pone.0126790	http://dx.doi.org/10.1371/journal.pone.0126790			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ2MQ	26024444	Green Published, Green Submitted, gold			2022-12-26	WOS:000355319400020
J	Sato, S; Ohara, S; Tsutsui, KI; Iijima, T				Sato, Sho; Ohara, Shinya; Tsutsui, Ken-Ichiro; Iijima, Toshio			Effects of G-gene Deletion and Replacement on Rabies Virus Vector Gene Expression	PLOS ONE			English	Article							VESICULAR STOMATITIS-VIRUS; CENTRAL-NERVOUS-SYSTEM; MATRIX PROTEIN; TRANSNEURONAL TRACER; IN-VIVO; GLYCOPROTEIN; TRANSCRIPTION; RECOMBINANT; REPLICATION; APOPTOSIS	The glycoprotein-gene (G gene) -deleted rabies virus (RV) vector is a powerful tool to examine the function and structure of neural circuits. We previously reported that the deletion of the G gene enhances the transgene expression level of the RV vector. However, the mechanism of this enhancement remains to be clarified. We presume that there are two possible factors for this enhancement. The first factor is the glycoprotein of RV, which shows cytotoxicity; thus, may cause a dysfunction in the translation process of infected cells. The second possible factor is the enhanced expression of the L gene, which encodes viral RNA polymerase. In the RV, it is known that the gene expression level is altered depending on the position of the gene. Since G-gene deletion displaces the L gene in the genome, the expression of the L gene and viral transcription may be enhanced. In this study, we compared the transgene expression level and viral transcription of three recombinant RV vectors. The effect of glycoprotein was examined by comparing the viral gene expression of G-gene-intact RV and G-gene-replaced RV. Despite the fact that the L-gene transcription level of these two RV vectors was similar, the G-gene-replaced RV vector showed higher viral transcription and transgene expression level than the G-gene-intact RV vector. To examine the effect of the position of the L gene, we compared the viral gene expression of the G-gene-deleted RV and G-gene-replaced RV. The G-gene-deleted RV vector showed higher L-gene transcription, viral transcription, and transgene expression level than the G-gene-replaced RV vector. These results indicate that G-gene deletion enhances the transgene expression level through at least two factors, the absence of glycoprotein and enhancement of L-gene expression. These findings enable investigators to design a useful viral vector that shows a controlled desirable transgene expression level in applications.	[Sato, Sho; Ohara, Shinya; Tsutsui, Ken-Ichiro; Iijima, Toshio] Tohoku Univ, Grad Sch Life Sci, Div Syst Neurosci, Sendai, Miyagi 980, Japan	Tohoku University	Iijima, T (corresponding author), Tohoku Univ, Grad Sch Life Sci, Div Syst Neurosci, Sendai, Miyagi 980, Japan.	t-iijima@m.tohoku.ac.jp	Tsutsui, Ken-Ichiro/B-4378-2008; Ohara, Shinya/AAW-9705-2021	Tsutsui, Ken-Ichiro/0000-0001-5781-2948; Ohara, Shinya/0000-0003-0681-5086	Institute for International Advanced Research and Education of Tohoku University; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [24333004];  [25119001]	Institute for International Advanced Research and Education of Tohoku University; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 	This study was supported by Research fund for IIARE doctoral course students from the Institute for International Advanced Research and Education of Tohoku University, and by Grant-in-Aid for Scientific Research (KAKENHI) #24333004 from Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. The study was partly supported by Grants-in-Aid for Scientific Research on Innovative Areas (#25119001). The funders had no role in this study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM G, 1976, P NATL ACAD SCI USA, V73, P1504, DOI 10.1073/pnas.73.5.1504; BALL LA, 1976, P NATL ACAD SCI USA, V73, P442, DOI 10.1073/pnas.73.2.442; Callaway EM, 2008, CURR OPIN NEUROBIOL, V18, P617, DOI 10.1016/j.conb.2009.03.007; Conzelmann KK, 1998, ANNU REV GENET, V32, P123, DOI 10.1146/annurev.genet.32.1.123; Dietzschold B, 2008, FUTURE VIROL, V3, P481, DOI 10.2217/17460794.3.5.481; Etessami R, 2000, J GEN VIROL, V81, P2147, DOI 10.1099/0022-1317-81-9-2147; Faber M, 2002, J VIROL, V76, P3374, DOI 10.1128/JVI.76.7.3374-3381.2002; Faber M, 2007, J VIROL, V81, P7041, DOI 10.1128/JVI.00357-07; Finke S, 2005, VIRUS RES, V111, P120, DOI 10.1016/j.virusres.2005.04.004; Finke S, 2003, J VIROL, V77, P12074, DOI 10.1128/JVI.77.22.12074-12082.2003; Finke S, 2003, J GEN VIROL, V84, P1613, DOI 10.1099/vir.0.19128-0; Ginger M, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00002; Inoue K, 2003, J VIROL METHODS, V107, P229, DOI 10.1016/S0166-0934(02)00249-5; Inoue K, 2004, SOC NEUR ABSTR, V124, P12; IVERSON LE, 1981, CELL, V23, P477, DOI 10.1016/0092-8674(81)90143-4; Kelly RM, 2000, J NEUROSCI METH, V103, P63, DOI 10.1016/S0165-0270(00)00296-X; Liu HS, 1999, BIOCHEM BIOPH RES CO, V260, P712, DOI 10.1006/bbrc.1999.0954; Marshel JH, 2010, NEURON, V67, P562, DOI 10.1016/j.neuron.2010.08.001; Mebatsion T, 1996, CELL, V84, P941, DOI 10.1016/S0092-8674(00)81072-7; Miyamichi K, 2011, NATURE, V472, P191, DOI 10.1038/nature09714; Morimoto K, 1999, J VIROL, V73, P510, DOI 10.1128/JVI.73.1.510-518.1999; Morimoto K, 2000, J NEUROVIROL, V6, P373, DOI 10.3109/13550280009018301; Morimoto K, 2011, MICROBIOL IMMUNOL, V55, P558, DOI 10.1111/j.1348-0421.2011.00354.x; Nakahara K, 1999, MICROBIOL IMMUNOL, V43, P259, DOI 10.1111/j.1348-0421.1999.tb02402.x; Ohara S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080245; Ohara S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078928; Ohara S, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.001.2009; Osakada F, 2011, NEURON, V71, P617, DOI 10.1016/j.neuron.2011.07.005; Prehaud C, 2003, J VIROL, V77, P10537, DOI 10.1128/JVI.77.19.10537-10547.2003; Pulmanausahakul R, 2008, J VIROL, V82, P2330, DOI 10.1128/JVI.02327-07; RYAN MD, 1991, J GEN VIROL, V72, P2727, DOI 10.1099/0022-1317-72-11-2727; Subach OM, 2008, CHEM BIOL, V15, P1116, DOI 10.1016/j.chembiol.2008.08.006; UGOLINI G, 1995, J COMP NEUROL, V356, P457, DOI 10.1002/cne.903560312; Ugolini G, 2010, J NEUROSCI METH, V194, P2, DOI 10.1016/j.jneumeth.2009.12.001; Wall NR, 2013, NEURON, V79, P347, DOI 10.1016/j.neuron.2013.05.014; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Wickersham IR, 2007, NAT METHODS, V4, P47, DOI 10.1038/NMETH999; Wickersham IR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3332; Wickersham IR, 2010, NAT PROTOC, V5, P595, DOI 10.1038/nprot.2009.248; WIKTOR TJ, 1984, DEV BIOLOGICALS, V57, P199	41	0	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128020	10.1371/journal.pone.0128020	http://dx.doi.org/10.1371/journal.pone.0128020			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26023771	Green Submitted, gold, Green Published			2022-12-26	WOS:000355319400064
J	Liu, TX; Wu, HY; Cao, DN; Li, QY; Zhang, YQ; Li, N; Hu, XX				Liu, Tongxin; Wu, Hanyu; Cao, Dainan; Li, Qingyuan; Zhang, Yaqiong; Li, Ning; Hu, Xiaoxiang			Oviduct-Specific Expression of Human Neutrophil Defensin 4 in Lentivirally Generated Transgenic Chickens	PLOS ONE			English	Article							PRIMORDIAL GERM-CELLS; ANTIMICROBIAL PEPTIDES; NONDIVIDING CELLS; OVALBUMIN GENE; MILK; PROTEIN; VECTOR; TRANSMISSION; PURIFICATION; KNOCKOUT	The expression of oviduct-specific recombinant proteins in transgenic chickens is a promising technology for the production of therapeutic biologics in eggs. In this study, we constructed a lentiviral vector encoding an expression cassette for human neutrophil defensin 4 (HNP4), a compound that displays high activity against Escherichia coli, and produced transgenic chickens that expressed the recombinant HNP4 protein in egg whites. After the antimicrobial activity of the recombinant HNP4 protein was tested at the cellular level, a 2.8-kb ovalbumin promoter was used to drive HNP4 expression specifically in oviduct tissues. From 669 injected eggs, 218 chickens were successfully hatched. Ten G(0) roosters, with semens identified as positive for the transgene, were mated with wild-type hens to generate G(1) chickens. From 1,274 total offspring, fifteen G1 transgenic chickens were positive for the transgene, which was confirmed by PCR and Southern blotting. The results of the Southern blotting and genome walking indicated that a single copy of the HNP4 gene was integrated into chromosomes 1, 2, 3, 4, 6 and 24 of the chickens. As expected, HNP4 expression was restricted to the oviduct tissues, and the levels of both transcriptional and translational HNP4 expression varied greatly in transgenic chickens with different transgene insertion sites. The amount of HNP4 protein expressed in the eggs of G(1) and G(2) heterozygous transgenic chickens ranged from 1.65 mu g/ml to 10.18 mu g/ml. These results indicated that the production of transgenic chickens that expressed HNP4 protein in egg whites was successful.	[Liu, Tongxin; Wu, Hanyu; Cao, Dainan; Li, Qingyuan; Zhang, Yaqiong; Li, Ning; Hu, Xiaoxiang] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China	China Agricultural University	Hu, XX (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	huxx@cau.edu.cn		Cao, Dainan/0000-0001-6119-9357	948 Program of the Ministry of Agriculture of China [2012-G1]; National High Technology Research and Development Program of China [2011AA100301]; Key Technology Research and Development Program of Guangdong Emerging Strategic Industries [2012A020800005]	948 Program of the Ministry of Agriculture of China; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Key Technology Research and Development Program of Guangdong Emerging Strategic Industries	This work was supported by a grant from 948 Program of the Ministry of Agriculture of China (2012-G1), the National High Technology Research and Development Program of China (2011AA100301) and Key Technology Research and Development Program of Guangdong Emerging Strategic Industries (2012A020800005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avidan MS, 2005, ANESTHESIOLOGY, V102, P276, DOI 10.1097/00000542-200502000-00007; Bals R, 2000, Respir Res, V1, P141, DOI 10.1186/rr25; Borwornpinyo S, 2005, POULTRY SCI, V84, P1477, DOI 10.1093/ps/84.9.1477; BOSSELMAN RA, 1989, SCIENCE, V243, P533, DOI 10.1126/science.2536194; Brophy B, 2003, NAT BIOTECHNOL, V21, P157, DOI 10.1038/nbt783; Byun SJ, 2011, BIOSCI BIOTECH BIOCH, V75, P646, DOI 10.1271/bbb.100721; Chapman SC, 2005, DEVELOPMENT, V132, P935, DOI 10.1242/dev.01652; de Lucca AJ, 1999, ANTIMICROB AGENTS CH, V43, P1, DOI 10.1093/jac/43.1.1; DENMAN J, 1991, BIO-TECHNOL, V9, P839, DOI 10.1038/nbt0991-839; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; HAECKER SAE, 1995, MOL ENDOCRINOL, V9, P1113, DOI 10.1210/me.9.9.1113; Hancock REW, 1997, J MED MICROBIOL, V46, P1; Harvey AJ, 2002, NAT BIOTECHNOL, V20, P396, DOI 10.1038/nbt0402-396; Hoskin DW, 2008, BBA-BIOMEMBRANES, V1778, P357, DOI 10.1016/j.bbamem.2007.11.008; Ko JH, 2000, TRANSGENIC RES, V9, P215, DOI 10.1023/A:1008972010351; Kwon SC, 2010, BIOL REPROD, V82, P1057, DOI 10.1095/biolreprod.109.081687; Lehrer RI, 1999, CURR OPIN IMMUNOL, V11, P23, DOI 10.1016/S0952-7915(99)80005-3; Lillico SG, 2007, P NATL ACAD SCI USA, V104, P1771, DOI 10.1073/pnas.0610401104; Lillico SG, 2005, DRUG DISCOV TODAY, V10, P191, DOI 10.1016/S1359-6446(04)03317-3; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lonberg N., 2008, V181, P69; McGrew MJ, 2004, EMBO REP, V5, P728, DOI 10.1038/sj.embor.7400171; Naldini L, 1998, CURR OPIN BIOTECH, V9, P457, DOI 10.1016/S0958-1669(98)80029-3; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Paleyanda RK, 1997, NAT BIOTECHNOL, V15, P971, DOI 10.1038/nbt1097-971; Park HM, 2000, BIOCHEMISTRY-US, V39, P8537, DOI 10.1021/bi0005862; Park TS, 2014, P NATL ACAD SCI USA, V111, P12716, DOI 10.1073/pnas.1410555111; PERRY MM, 1988, NATURE, V331, P70, DOI 10.1038/331070a0; Reddy KVR, 2004, INT J ANTIMICROB AG, V24, P536, DOI 10.1016/j.ijantimicag.2004.09.005; RYAN TM, 1990, SCIENCE, V247, P566, DOI 10.1126/science.2154033; SALTER DW, 1986, POULTRY SCI, V65, P1445, DOI 10.3382/ps.0651445; Schambach A, 2006, GENE THER, V13, P641, DOI 10.1038/sj.gt.3302698; Schnieke AE, 1997, SCIENCE, V278, P2130, DOI 10.1126/science.278.5346.2130; Schusser B, 2013, P NATL ACAD SCI USA, V110, P20170, DOI 10.1073/pnas.1317106110; Vakili N, 2011, MOL CELL ENDOCRINOL, V345, P48, DOI 10.1016/j.mce.2011.07.010; van de Lavoir MC, 2006, NATURE, V441, P766, DOI 10.1038/nature04831; WILDE CG, 1989, J BIOL CHEM, V264, P11200; WRIGHT G, 1991, BIO-TECHNOL, V9, P830, DOI 10.1038/nbt0991-830; Wu ZB, 2005, FEBS LETT, V579, P162, DOI 10.1016/j.febslet.2004.11.062	39	15	17	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0127922	10.1371/journal.pone.0127922	http://dx.doi.org/10.1371/journal.pone.0127922			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020529	Green Published, gold, Green Submitted			2022-12-26	WOS:000355187300065
J	Mils, V; Bosch, S; Roy, J; Bel-Vialar, S; Belenguer, P; Pituello, F; Miquel, MC				Mils, Valerie; Bosch, Stephanie; Roy, Julie; Bel-Vialar, Sophie; Belenguer, Pascale; Pituello, Fabienne; Miquel, Marie-Christine			Mitochondrial Reshaping Accompanies Neural Differentiation in the Developing Spinal Cord	PLOS ONE			English	Article							DOMINANT OPTIC ATROPHY; STEM-CELL DIFFERENTIATION; DYNAMIN-RELATED PROTEIN; EMBRYONIC-DEVELOPMENT; ENERGY-METABOLISM; SYNAPSE FORMATION; OPA1; FUSION; PLASTICITY; MORPHOLOGY	Mitochondria, long known as the cell powerhouses, also regulate redox signaling and arbitrate cell survival. The organelles are now appreciated to exert additional critical roles in cell state transition from a pluripotent to a differentiated state through balancing glycolytic and respiratory metabolism. These metabolic adaptations were recently shown to be concomitant with mitochondrial morphology changes and are thus possibly regulated by contingencies of mitochondrial dynamics. In this context, we examined, for the first time, mitochondrial network plasticity during the transition from proliferating neural progenitors to post-mitotic differentiating neurons. We found that mitochondria underwent morphological reshaping in the developing neural tube of chick and mouse embryos. In the proliferating population, mitochondria in the mitotic cells lying at the apical side were very small and round, while they appeared thick and short in interphase cells. In differentiating neurons, mitochondria were reorganized into a thin, dense network. This reshaping of the mitochondrial network was not specific of a subtype of progenitors or neurons, suggesting that this is a general event accompanying neurogenesis in the spinal cord. Our data shed new light on the various changes occurring in the mitochondrial network during neurogenesis and suggest that mitochondrial dynamics could play a role in the neurogenic process.	[Mils, Valerie; Bosch, Stephanie; Roy, Julie; Bel-Vialar, Sophie; Belenguer, Pascale; Pituello, Fabienne; Miquel, Marie-Christine] Univ Toulouse 3, Univ Toulouse, CNRS, Ctr Biol Dev,UMR5547, Toulouse, France; [Miquel, Marie-Christine] Univ Paris 06, Sorbonne Univ, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; UDICE-French Research Universities; Sorbonne Universite	Miquel, MC (corresponding author), Univ Toulouse 3, Univ Toulouse, CNRS, Ctr Biol Dev,UMR5547, Toulouse, France.	marie-christine.miquel@univ-tlse3.fr		Miquel, Marie-Christine/0000-0002-9332-2572; Belenguer, Pascale/0000-0003-0229-5554	French CNRS; French Universite Toulouse 3; French AMMI [5841174]	French CNRS(Centre National de la Recherche Scientifique (CNRS)); French Universite Toulouse 3; French AMMI	This work was funded by French CNRS, perennial grants (http://www.cnrs.fr/), French Universite Toulouse 3, perennial grants (http://www.univ-tlse3.fr/), and French AMMI, grant 5841174 (http://www.association-ammi.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavi MV, 2007, BRAIN, V130, P1029, DOI 10.1093/brain/awm005; Armstrong L, 2010, STEM CELLS, V28, P661, DOI 10.1002/stem.307; Basak NP, 2014, J BIOL CHEM, V289, P7320, DOI 10.1074/jbc.M113.519405; Bertholet AM, 2013, BRAIN, V136, P1518, DOI 10.1093/brain/awt060; Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529; Chen CT, 2012, BBA-GEN SUBJECTS, V1820, P571, DOI 10.1016/j.bbagen.2011.09.013; Chen CT, 2010, BBA-GEN SUBJECTS, V1800, P257, DOI 10.1016/j.bbagen.2009.09.001; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; Choi SY, 2013, FASEB J, V27, P51, DOI 10.1096/fj.12-211920; Cohen M, 2013, CURR OPIN GENET DEV, V23, P423, DOI 10.1016/j.gde.2013.04.003; Davies VJ, 2007, HUM MOL GENET, V16, P1307, DOI 10.1093/hmg/ddm079; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; Erecinska M, 2004, PROG NEUROBIOL, V73, P397, DOI 10.1016/j.pneurobio.2004.06.003; Facucho-Oliveira JM, 2009, STEM CELL REV REP, V5, P140, DOI 10.1007/s12015-009-9058-0; Folmes CDL, 2012, ANN NY ACAD SCI, V1254, P82, DOI 10.1111/j.1749-6632.2012.06487.x; Galloway CA, 2012, FREE RADICAL BIO MED, V53, P2218, DOI 10.1016/j.freeradbiomed.2012.09.035; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Horn SR, 2011, MOL BIOL CELL, V22, P1207, DOI 10.1091/mbc.E10-07-0567; Ishihara N, 2006, EMBO J, V25, P2966, DOI 10.1038/sj.emboj.7601184; Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907; Kageyama Y, 2012, J CELL BIOL, V197, P535, DOI 10.1083/jcb.201110034; Kasahara A, 2014, TRENDS CELL BIOL; Kasahara A, 2013, SCIENCE, V342, P734, DOI 10.1126/science.1241359; Kosodo Y, 2012, CELL MOL LIFE SCI, V69, P2727, DOI 10.1007/s00018-012-0952-2; Landor SKJ, 2011, P NATL ACAD SCI USA, V108, P18814, DOI 10.1073/pnas.1104943108; Le Dreau G, 2013, CELL MOL LIFE SCI, V70, P4293, DOI 10.1007/s00018-013-1354-9; Lee S, 2012, HUM MOL GENET, V21, P4827, DOI 10.1093/hmg/dds352; Li H, 2008, P NATL ACAD SCI USA, V105, P2169, DOI 10.1073/pnas.0711647105; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Lobjois V, 2004, DEV BIOL, V273, P195, DOI 10.1016/j.ydbio.2004.05.031; Lonergan T, 2007, MITOCHONDRION, V7, P289, DOI 10.1016/j.mito.2007.05.002; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Olichon A, 2002, FEBS LETT, V523, P171, DOI 10.1016/S0014-5793(02)02985-X; Prigione A, 2010, STEM CELLS, V28, P721, DOI 10.1002/stem.404; Shimojo H, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00078; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Tondera D, 2009, EMBO J, V28, P1589, DOI 10.1038/emboj.2009.89; Van Blerkom J, 2011, MITOCHONDRION, V11, P797, DOI 10.1016/j.mito.2010.09.012; Wagatsuma A, 2013, THESCIENTIFICWORLDJO, V2013, DOI DOI 10.1155/2013/593267; Wakabayashi J, 2009, J CELL BIOL, V186, P805, DOI 10.1083/jcb.200903065; Wang XL, 2009, J NEUROSCI, V29, P9090, DOI 10.1523/JNEUROSCI.1357-09.2009; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	43	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128130	10.1371/journal.pone.0128130	http://dx.doi.org/10.1371/journal.pone.0128130			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020522	Green Published, gold, Green Submitted			2022-12-26	WOS:000355187300083
J	Zhao, XY; Wang, SM; Wu, JJ; Li, XY; Wang, X; Gao, ZQ; Wu, WT; Wang, HJ; Wang, JC; Qian, J; Ma, K; Li, H; Han, BH; Bai, CX; Li, Q; Liu, WB; Lu, DR				Zhao, Xueying; Wang, Shiming; Wu, Junjie; Li, Xiaoying; Wang, Xun; Gao, Zhiqiang; Wu, Wenting; Wang, Haijian; Wang, Jiucun; Qian, Ji; Ma, Ke; Li, Hui; Han, Baohui; Bai, Chunxue; Li, Qiang; Liu, Wenbin; Lu, Daru			Association of TERT Polymorphisms with Clinical Outcome of Non-Small Cell Lung Cancer Patients	PLOS ONE			English	Article							TELOMERASE REVERSE-TRANSCRIPTASE; PLATINUM-BASED CHEMOTHERAPY; PROGRESSION-FREE SURVIVAL; SURROGATE END-POINT; GENETIC-VARIANTS; SEVERE TOXICITY; NEVER-SMOKERS; EXPRESSION; HTERT; LOCUS	TERT is of great importance in cancer initiation and progression. Many studies have demonstrated the TERT polymorphisms as risk factors for many cancer types, including lung cancer. However, the impacts of TERT variants on cancer progression and treatment efficacy have remained controversial. This study aimed to investigate the association of TERT polymorphisms with clinical outcome of advanced non-small cell lung cancer (NSCLC) patients receiving first-line platinum-based chemotherapy, including response rate, clinical benefit, progression-free survival (PFS), overall survival (OS), and grade 3 or 4 toxicity. Seven polymorphisms of TERT were assessed, and a total of 1004 inoperable advanced NSCLC patients treated with platinum-based chemotherapy were enrolled. It is exhibited that the variant heterozygote of rs4975605 showed significant association with a low rate of clinical benefit, and displayed a much stronger effect in never-smoking female subset, leading to the clinical benefit rate decreased from 82.9% (C/C genotype) to 56.4% (C/A genotype; adjusted OR, 3.58; P=1.40x10(-4)). It is also observed that the polymorphism rs2736109 showed significant correlation with PFS (log-rank P=0.023). In age > 58 subgroup, patients carrying the heterozygous genotype had a longer median PFS than those carrying the wildtype genotypes (P=0.002). The results from the current study, for the first time to our knowledge, provide suggestive evidence of an effect of TERT polymorphisms on disease progression variability among Chinese patients with platinum-treated advanced NSCLC.	[Zhao, Xueying; Wang, Shiming; Wu, Junjie; Li, Xiaoying; Wu, Wenting; Wang, Haijian; Wang, Jiucun; Qian, Ji; Lu, Daru] Fudan Univ, Sch Life Sci, Inst Genet, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Zhao, Xueying; Wang, Shiming; Wu, Junjie; Li, Xiaoying; Wu, Wenting; Wang, Haijian; Wang, Jiucun; Qian, Ji; Lu, Daru] Fudan Univ, Sch Life Sci, Inst Genet, MOE Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China; [Wu, Junjie; Li, Qiang] Second Mil Med Univ, Changhai Hosp Shanghai, Dept Pneumol, Shanghai, Peoples R China; [Wang, Xun; Bai, Chunxue] Fudan Univ, Zhongshan Hosp, Dept Pulm Med, Shanghai 200433, Peoples R China; [Gao, Zhiqiang; Han, Baohui] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Resp Dis, Shanghai 200030, Peoples R China	Fudan University; Fudan University; Naval Medical University; Fudan University; Shanghai Jiao Tong University	Liu, WB (corresponding author), Shanghai Res Inst Criminal Sci & Technol, Shanghai Key Lab Crime Scene Evidence, Shanghai, Peoples R China.	wbliu1981@163.com; drlu@fudan.edu.cn	wu, wenting/Q-4979-2016	wu, wenting/0000-0003-0982-771X; Bai, Chunxue/0000-0001-5798-3130				Beck S, 2011, MOL CELLS, V31, P9, DOI 10.1007/s10059-011-0008-8; Bertorelle R, 2013, BRIT J CANCER, V108, P278, DOI 10.1038/bjc.2012.602; Cecchin E, 2009, J CLIN ONCOL, V27, P2457, DOI 10.1200/JCO.2008.19.0314; Chen D, 2008, CARCINOGENESIS, V29, P342, DOI 10.1093/carcin/bgm285; Choi JK, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040010; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Colangelo D, 2005, CURR MED CHEM, V12, P3091, DOI 10.2174/092986705774933416; Ding DQ, 2013, FEBS J, V280, P3205, DOI 10.1111/febs.12258; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Garon EB, 2012, LUNG CANCER, V77, P475, DOI 10.1016/j.lungcan.2012.06.007; Ghosh A, 2012, NAT CELL BIOL, V14, P1270, DOI 10.1038/ncb2621; Han BH, 2011, LUNG CANCER, V72, P238, DOI 10.1016/j.lungcan.2010.09.001; Han KL, 2014, NEURO-ONCOLOGY, V16, P696, DOI 10.1093/neuonc/not236; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hsiung CA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001051; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Lan Q, 2012, NAT GENET, V44, P1330, DOI 10.1038/ng.2456; Lantuejoul S, 2004, BRIT J CANCER, V90, P1222, DOI 10.1038/sj.bjc.6601643; Li YH, 2014, CANCER RES, V74, P1639, DOI 10.1158/0008-5472.CAN-13-3568; McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254; Mocellin S, 2012, JNCI-J NATL CANCER I, V104, P840, DOI 10.1093/jnci/djs222; Peng Y, 2014, INT J CANCER, V135, P2687, DOI 10.1002/ijc.28892; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Rudin CM, 2009, CLIN CANCER RES, V15, P5646, DOI 10.1158/1078-0432.CCR-09-0377; Ruzzo A, 2006, J CLIN ONCOL, V24, P1883, DOI 10.1200/JCO.2005.04.8322; Sidhu R, 2013, CLIN CANCER RES, V19, P969, DOI 10.1158/1078-0432.CCR-12-2502; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Sun YH, 2010, J CLIN ONCOL, V28, P4616, DOI 10.1200/JCO.2010.29.6038; Tchirkov A, 2003, BRIT J CANCER, V88, P516, DOI 10.1038/sj.bjc.6600754; Wang L, 2002, CLIN CANCER RES, V8, P2883; Wang YF, 2010, CARCINOGENESIS, V31, P234, DOI 10.1093/carcin/bgp287; Wang YF, 2008, NAT GENET, V40, P1407, DOI 10.1038/ng.273; Wright WE, 1996, DEV GENET, V18, P173; Wu WT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033200; Wu WT, 2009, CLIN CANCER RES, V15, P3889, DOI 10.1158/1078-0432.CCR-08-2715	36	10	11	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0129232	10.1371/journal.pone.0129232	http://dx.doi.org/10.1371/journal.pone.0129232			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020272	gold, Green Published, Green Submitted			2022-12-26	WOS:000355187300124
J	Heininga, VE; Oldehinkel, AJ; Veenstra, R; Nederhof, E				Heininga, Vera E.; Oldehinkel, Albertine J.; Veenstra, Rene; Nederhof, Esther			I Just Ran a Thousand Analyses: Benefits of Multiple Testing in Understanding Equivocal Evidence on Gene-Environment Interactions	PLOS ONE			English	Article							SEROTONIN TRANSPORTER GENE; STRESSFUL LIFE EVENTS; 5-HTTLPR GENOTYPE; SENSITIVE PERIODS; DEPRESSION; POLYMORPHISM; ADVERSITY; REPLICATION; MODERATION; BRAIN	Background In psychiatric genetics research, the volume of ambivalent findings on gene-environment interactions (G x E) is growing at an accelerating pace. In response to the surging suspicions of systematic distortion, we challenge the notion of chance capitalization as a possible contributor. Beyond qualifying multiple testing as a mere methodological issue that, if uncorrected, leads to chance capitalization, we advance towards illustrating the potential benefits of multiple tests in understanding equivocal evidence in genetics literature. Method We focused on the interaction between the serotonin-transporter-linked promotor region (5-HTTLPR) and childhood adversities with regard to depression. After testing 2160 interactions with all relevant measures available within the Dutch population study of adolescents TRAILS, we calculated percentages of significant (p < .05) effects for several subsets of regressions. Using chance capitalization (i.e. overall significance rate of 5% alpha and randomly distributed findings) as a competing hypothesis, we expected more significant effects in the subsets of regressions involving: 1) interview-based instead of questionnaire-based measures; 2) abuse instead of milder childhood adversities; and 3) early instead of later adversities. Furthermore, we expected equal significance percentages across 4) male and female subsamples, and 5) various genotypic models of 5-HTTLPR. Results We found differences in the percentages of significant interactions among the subsets of analyses, including those regarding sex-specific subsamples and genetic modeling, but often in unexpected directions. Overall, the percentage of significant interactions was 7.9% which is only slightly above the 5% that might be expected based on chance. Conclusion Taken together, multiple testing provides a novel approach to better understand equivocal evidence on G x E, showing that methodological differences across studies are a likely reason for heterogeneity in findings - but chance capitalization is at least equally plausible.	[Heininga, Vera E.; Oldehinkel, Albertine J.; Nederhof, Esther] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands; [Veenstra, Rene] Univ Groningen, Dept Sociol, Groningen, Netherlands	University of Groningen; University of Groningen	Heininga, VE (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands.	v.e.heininga@umcg.nl	Veenstra, René/G-6696-2011; Heininga, Vera/AAA-3738-2020	Veenstra, René/0000-0001-6686-6307; Heininga, Vera/0000-0003-0889-8524	VICI grant from the Netherlands Organization for Scientific Research [NWO Vici 016.001/002]; Netherlands Organization for Scientific Research NWO (Medical Research Council) [GB-MW 940-38-011]; Netherlands Organization for Scientific Research NWO (ZonMW Brainpower grant) [100-001-004]; Netherlands Organization for Scientific Research NWO (ZonMw Risk Behaviour and Dependence grants) [60-60600-97-118]; Netherlands Organization for Scientific Research NWO (ZonMw Culture and Health grant) [261-98-710]; Netherlands Organization for Scientific Research NWO (Social Sciences Council medium-sized investment grants) [GB-MaGW 480-01-006, GB-MaGW 480-07-001]; Netherlands Organization for Scientific Research NWO (Social Sciences Council project) [GB-MaGW 452-04-314, GB-MaGW 452-06-004]; Netherlands Organization for Scientific Research NWO (NWO large-sized investment grant) [175.010.2003.005]; Netherlands Organization for Scientific Research NWO (NWO Longitudinal Survey and Panel Funding) [481-08-013]; Dutch Ministry of Justice (WODC); European Science Foundation (EuroSTRESS project) [FP-006]; Biobanking and Biomolecular Resources Research Infrastructure BBMRI-NL [CP 32]; Accare Center for Child and Adolescent Psychiatry	VICI grant from the Netherlands Organization for Scientific Research; Netherlands Organization for Scientific Research NWO (Medical Research Council)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Scientific Research NWO (ZonMW Brainpower grant); Netherlands Organization for Scientific Research NWO (ZonMw Risk Behaviour and Dependence grants); Netherlands Organization for Scientific Research NWO (ZonMw Culture and Health grant); Netherlands Organization for Scientific Research NWO (Social Sciences Council medium-sized investment grants); Netherlands Organization for Scientific Research NWO (Social Sciences Council project); Netherlands Organization for Scientific Research NWO (NWO large-sized investment grant); Netherlands Organization for Scientific Research NWO (NWO Longitudinal Survey and Panel Funding)(Netherlands Organization for Scientific Research (NWO)); Dutch Ministry of Justice (WODC); European Science Foundation (EuroSTRESS project); Biobanking and Biomolecular Resources Research Infrastructure BBMRI-NL; Accare Center for Child and Adolescent Psychiatry	This research was made possible by a VICI grant from the Netherlands Organization for Scientific Research (NWO Vici 016.001/002) to Dr. Oldehinkel. The data used were collected as part of the TRacking Adolescents' Individual Lives Survey (TRAILS). Participating centers of TRAILS include various departments of the University Medical Center and University of Groningen, the Erasmus University Medical Center Rotterdam, the University of Utrecht, the Radboud Medical Center Nijmegen, and the Parnassia Bavo group, all in the Netherlands. TRAILS has been financially supported by various grants from the Netherlands Organization for Scientific Research NWO (Medical Research Council program grant GB-MW 940-38-011; ZonMW Brainpower grant 100-001-004; ZonMw Risk Behaviour and Dependence grants 60-60600-97-118; ZonMw Culture and Health grant 261-98-710; Social Sciences Council medium-sized investment grants GB-MaGW 480-01-006 and GB-MaGW 480-07-001; Social Sciences Council project grants GB-MaGW 452-04-314 and GB-MaGW 452-06-004; NWO large-sized investment grant 175.010.2003.005; NWO Longitudinal Survey and Panel Funding 481-08-013), the Dutch Ministry of Justice (WODC), the European Science Foundation (EuroSTRESS project FP-006), Biobanking and Biomolecular Resources Research Infrastructure BBMRI-NL (CP 32), the participating universities, and Accare Center for Child and Adolescent Psychiatry.	Achenbach TM, 2003, J CLIN CHILD ADOLESC, V32, P328, DOI 10.1207/S15374424JCCP3203_02; Achenbach TM, 2001, MANUAL ASEBA SCH AGE, DOI [10.1007/s00127-013-0685-z, DOI 10.1007/S00127-013-0685-Z]; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Andersen SL, 2008, TRENDS NEUROSCI, V31, P183, DOI 10.1016/j.tins.2008.01.004; Bernstein DP, 1998, CHILDHOOD TRAUMA QUE; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452; Colhoun HM, 2003, LANCET, V361, P865, DOI 10.1016/S0140-6736(03)12715-8; de Winter AF, 2005, EUR J EPIDEMIOL, V20, P173, DOI 10.1007/s10654-004-4948-6; Duncan LE, 2011, AM J PSYCHIAT, V168, P1041, DOI 10.1176/appi.ajp.2011.11020191; Eaves LJ, 2006, TWIN RES HUM GENET, V9, P1, DOI 10.1375/183242706776403073; Fergusson DM, 2011, BRIT J PSYCHIAT, V198, P129, DOI 10.1192/bjp.bp.110.085993; Flint J, 2013, CURR OPIN NEUROBIOL, V23, P57, DOI 10.1016/j.conb.2012.07.005; Haro JM, 2006, INT J METH PSYCH RES, V15, P167, DOI 10.1002/mpr.196; Heim C, 2012, EXP NEUROL, V233, P102, DOI 10.1016/j.expneurol.2011.10.032; Homberg JR, 2012, PROG NEUROBIOL, V99, P117, DOI 10.1016/j.pneurobio.2012.08.003; Hu XZ, 2006, AM J HUM GENET, V78, P815, DOI 10.1086/503850; IBM Corp, 2013, IBM SPSS STAT WINDOW; Ioannidis JPA, 2014, TRENDS COGN SCI, V18, P235, DOI 10.1016/j.tics.2014.02.010; Ioannidis JPA, 2007, PLOS MED, V4, P1132, DOI 10.1371/journal.pmed.0040215; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Karg K, 2011, ARCH GEN PSYCHIAT, V68, P444, DOI 10.1001/archgenpsychiatry.2010.189; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; Kessler RC, 2009, INT J METH PSYCH RES, V18, P69, DOI 10.1002/mpr.279; Laucht M, 2009, INT J NEUROPSYCHOPH, V12, P737, DOI 10.1017/S1461145708009875; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Markus CR, 2013, PSYCHIAT GENET, V23, P108, DOI 10.1097/YPG.0b013e32835fe3e1; Martel MM, 2013, PSYCHOL BULL, V139, P1221, DOI 10.1037/a0032247; Martin J, 2007, MOL PSYCHIATR, V12, P421, DOI 10.1038/sj.mp.4001952; McEwen BS, 2000, BIOL PSYCHIAT, V48, P721, DOI 10.1016/S0006-3223(00)00964-1; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Monroe SM, 2008, ANNU REV CLIN PSYCHO, V4, P33, DOI 10.1146/annurev.clinpsy.4.022007.141207; Munafo MR, 2008, BIOL PSYCHIAT, V63, P852, DOI 10.1016/j.biopsych.2007.08.016; Munafo MR, 2009, INT J NEUROPSYCHOPH, V12, P727, DOI 10.1017/S1461145709000479; Munafo MR, 2009, BIOL PSYCHIAT, V65, P211, DOI 10.1016/j.biopsych.2008.06.009; Nederhof E, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-93; Nederhof E, 2010, BIOL PSYCHIAT, V68, P209, DOI 10.1016/j.biopsych.2010.04.006; Ormel J, 2012, J AM ACAD CHILD PSY, V51, P1020, DOI 10.1016/j.jaac.2012.08.004; Risch N, 2009, JAMA-J AM MED ASSOC, V301, P2462, DOI 10.1001/jama.2009.878; Roisman GI, 2012, DEV PSYCHOPATHOL, V24, P389, DOI 10.1017/S0954579412000065; Sheikh HI, 2008, PERS INDIV DIFFER, V45, P425, DOI 10.1016/j.paid.2008.05.020; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Sullivan PF, 2007, BIOL PSYCHIAT, V61, P1121, DOI 10.1016/j.biopsych.2006.11.010; Uher R, 2008, MOL PSYCHIATR, V13, P131, DOI 10.1038/sj.mp.4002067; Uher R, 2010, MOL PSYCHIATR, V15, P18, DOI 10.1038/mp.2009.123; Williams RB, 2003, NEUROPSYCHOPHARMACOL, V28, P533, DOI 10.1038/sj.npp.1300054; Young NS, 2008, PLOS MED, V5, P1418, DOI 10.1371/journal.pmed.0050201; Zalsman G, 2010, EUR PSYCHIAT, V25, P284, DOI 10.1016/j.eurpsy.2010.01.007	48	12	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0125383	10.1371/journal.pone.0125383	http://dx.doi.org/10.1371/journal.pone.0125383			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26016887	Green Published, gold, Green Submitted			2022-12-26	WOS:000355185600020
J	Liao, HB; Cheng, XJ; Zhu, DK; Wang, MS; Jia, RY; Chen, S; Chen, XY; Biville, F; Liu, MF; Cheng, AC				Liao, HeBin; Cheng, XingJun; Zhu, DeKang; Wang, MingShu; Jia, RenYong; Chen, Shun; Chen, XiaoYue; Biville, Francis; Liu, MaFeng; Cheng, AnChun			TonB Energy Transduction Systems of Riemerella anatipestifer Are Required for Iron and Hemin Utilization	PLOS ONE			English	Article							OUTER-MEMBRANE; VIBRIO-CHOLERAE; UPTAKE GENES; PSEUDOMONAS-AERUGINOSA; VIRULENCE; ACQUISITION; TRANSPORT; PROTEIN; IDENTIFICATION; EXBB	Riemerella anatipestifer (R. anatipestifer) is one of the most important pathogens in ducks. The bacteria causes acute or chronic septicemia characterized by fibrinous pericarditis and meningitis. The R. anatipestifer genome encodes multiple iron/hemin-uptake systems that facilitate adaptation to iron-limited host environments. These systems include several TonB-dependent transporters and three TonB proteins responsible for energy transduction. These three tonB genes are present in all the R. anatipestifer genomes sequenced so far. Two of these genes are contained within the exbB-exbD-tonB1 and exbB-exbD-exbD-tonB2 operons. The third, tonB3, forms a monocistronic transcription unit. The inability to recover derivatives deleted for this gene suggests its product is essential for R. anatipestifer growth. Here, we show that deletion of tonB1 had no effect on hemin uptake of R. anatipestifer, though disruption of tonB2 strongly decreases hemin uptake, and disruption of both tonB1 and tonB2 abolishes the transport of exogenously added hemin. The ability of R. anatipestifer to grow on iron-depleted medium is decreased by tonB2 but not tonB1 disruption. When expressed in an E. coli model strain, the TonB1 complex, TonB2 complex, and TonB3 protein from R. anatipestifer cannot energize heterologous hemin transporters. Further, only the TonB1 complex can energize a R. anatipestifer hemin transporter when co-expressed in an E. coli model strain.	[Liao, HeBin; Cheng, XingJun; Zhu, DeKang; Wang, MingShu; Jia, RenYong; Chen, Shun; Chen, XiaoYue; Liu, MaFeng; Cheng, AnChun] Sichuan Agr Univ, Coll Vet Med, Avian Dis Res Ctr, Yaan, Sichuan, Peoples R China; [Liao, HeBin; Cheng, XingJun; Zhu, DeKang; Wang, MingShu; Jia, RenYong; Chen, Shun; Chen, XiaoYue; Liu, MaFeng; Cheng, AnChun] Sichuan Agr Univ, Inst Prevent Vet Med, Chengdu, Sichuan, Peoples R China; [Liao, HeBin; Cheng, XingJun; Zhu, DeKang; Wang, MingShu; Jia, RenYong; Chen, Shun; Chen, XiaoYue; Liu, MaFeng; Cheng, AnChun] Sichuan Agr Univ, Key Lab Anim Dis & Human Hlth Sichuan Prov, Chengdu, Sichuan, Peoples R China; [Biville, Francis] Inst Pasteur, Unite Infect Bacteriennes Invas, Paris, France	Sichuan Agricultural University; Sichuan Agricultural University; Key Laboratory of Animal Disease & Human Health of Sichuan Province; Sichuan Agricultural University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Liu, MF (corresponding author), Sichuan Agr Univ, Coll Vet Med, Avian Dis Res Ctr, Yaan, Sichuan, Peoples R China.	liumafengra@163.com; chenganchun@vip.163.com	Zhu, Dekang/A-2292-2014	Zhu, Dekang/0000-0002-7314-1088	National Natural Science Foundation of China [31302131]; Research Fund for the Doctoral Program of Higher Education of China [20135103120006]; China Postdoctoral Science Foundation [2014M552378]; National science and technology support program [2015BAD12B05]; National Special Fund for Agro-scientific Research in the Public Interest [201003012]; China Agricultural Research System [CARS-43-8]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National science and technology support program; National Special Fund for Agro-scientific Research in the Public Interest; China Agricultural Research System	Funding for this work comes from the following sources: National Natural Science Foundation of China (Grant No. 31302131, http://www.nsfc.gov.cn/), Research Fund for the Doctoral Program of Higher Education of China (Grant No. 20135103120006, http://www.cutech.edu.cn/cn/index.htm), China Postdoctoral Science Foundation (Grant No. 2014M552378, http://jj.chinapostdoctor.org.cn/V1/Program1/Default.aspx), National science and technology support program (No. 2015BAD12B05, http://www.most.gov.cn/kjjh/gjkjjh/), National Special Fund for Agro-scientific Research in the Public Interest (No. 201003012, http://www.moa.gov.cn/), and China Agricultural Research System (CARS-43-8, http://www.moa.gov.cn/).	Abbas A, 2007, FEMS MICROBIOL LETT, V274, P269, DOI 10.1111/j.1574-6968.2007.00845.x; Alvarez B, 2008, MICROBIOL-SGM, V154, P1144, DOI 10.1099/mic.0.2007/010900-0; Benevides-Matos N, 2008, J BACTERIOL, V190, P21, DOI 10.1128/JB.01389-07; Benson DR, 2013, METAL IONS LIFE SCI, V12, P279, DOI 10.1007/978-94-007-5561-1_9; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; Cescau S, 2007, BIOMETALS, V20, P603, DOI 10.1007/s10534-006-9050-y; Chasteen ND, 1999, J STRUCT BIOL, V126, P182, DOI 10.1006/jsbi.1999.4118; Chu BCH, 2007, BIOMETALS, V20, P467, DOI 10.1007/s10534-006-9049-4; Contreras H, 2014, CURR OPIN CHEM BIOL, V19, P34, DOI 10.1016/j.cbpa.2013.12.014; Crasta KC, 2002, J BACTERIOL, V184, P1932, DOI 10.1128/JB.184.7.1932-1939.2002; Fournier C, 2011, MOL MICROBIOL, V80, P133, DOI 10.1111/j.1365-2958.2011.07562.x; Ghigo JM, 1997, J BACTERIOL, V179, P3572, DOI 10.1128/jb.179.11.3572-3579.1997; GrayOwen SD, 1996, TRENDS MICROBIOL, V4, P185, DOI 10.1016/0966-842X(96)10025-1; Hess C, 2013, AVIAN PATHOL, V42, P151, DOI 10.1080/03079457.2013.775401; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Holden KM, 2012, COMP IMMUNOL MICROB, V35, P129, DOI 10.1016/j.cimid.2011.12.004; Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836; Hu QH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039805; Hu QH, 2011, VET MICROBIOL, V150, P278, DOI 10.1016/j.vetmic.2011.01.022; Huynh C, 2008, CELL MICROBIOL, V10, P293, DOI 10.1111/j.1462-5822.2007.01095.x; Koebnik R, 2005, TRENDS MICROBIOL, V13, P343, DOI 10.1016/j.tim.2005.06.005; Krewulak KD, 2008, BBA-BIOMEMBRANES, V1778, P1781, DOI 10.1016/j.bbamem.2007.07.026; Lu FY, 2013, VET MICROBIOL, V167, P713, DOI 10.1016/j.vetmic.2013.08.020; Luan BQ, 2010, PROTEINS, V78, P1153, DOI 10.1002/prot.22635; Maniatis T., 1989, LAB MANUAL, Vsecond; Mey AR, 2003, J BACTERIOL, V185, P1195, DOI 10.1128/JB.185.4.1195-1207.2003; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Nairz M, 2010, CELL MICROBIOL, V12, P1691, DOI 10.1111/j.1462-5822.2010.01529.x; Najimi M, 2008, ARCH MICROBIOL, V190, P439, DOI 10.1007/s00203-008-0391-5; Neugebauer H, 2005, J BACTERIOL, V187, P8300, DOI 10.1128/JB.187.24.8300-8311.2005; Nijssen E, 2009, CLIN MICROBIOL INFEC, V15, P118, DOI 10.1111/j.1469-0691.2008.02193.x; Occhino DA, 1998, MOL MICROBIOL, V29, P1493, DOI 10.1046/j.1365-2958.1998.01034.x; PATHANASOPHON P, 1995, AVIAN PATHOL, V24, P195, DOI 10.1080/03079459508419059; Pathanasophon P, 2002, AVIAN PATHOL, V31, P267, DOI 10.1080/03079450220136576; Pauer H, 2013, J MED MICROBIOL, V62, P1524, DOI 10.1099/jmm.0.054692-0; Pawelek PD, 2006, SCIENCE, V312, P1399, DOI 10.1126/science.1128057; Peacock RS, 2005, J MOL BIOL, V345, P1185, DOI 10.1016/j.jmb.2004.11.026; Reeves SA, 2000, INFECT IMMUN, V68, P6329, DOI 10.1128/IAI.68.11.6329-6336.2000; Rio SJ, 2005, ARCH MICROBIOL, V183, P347, DOI 10.1007/s00203-005-0779-4; Runyen-Janecky LJ, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00055; Schauer K, 2007, MOL MICROBIOL, V63, P1054, DOI 10.1111/j.1365-2958.2006.05578.x; Seliger SS, 2001, MOL MICROBIOL, V39, P801, DOI 10.1046/j.1365-2958.2001.02273.x; Shultis DD, 2006, SCIENCE, V312, P1396, DOI 10.1126/science.1127694; Stork M, 2004, INFECT IMMUN, V72, P7326, DOI 10.1128/IAI.72.12.7326-7329.2004; Tong Y, 2009, ARCH BIOCHEM BIOPHYS, V481, P1, DOI 10.1016/j.abb.2008.10.013; Tu J, 2014, VET MICROBIOL, V168, P395, DOI 10.1016/j.vetmic.2013.11.027; Wandersman C, 2000, CURR OPIN MICROBIOL, V3, P215, DOI 10.1016/S1369-5274(00)00078-3; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811; Wang QY, 2008, ARCH MICROBIOL, V190, P595, DOI 10.1007/s00203-008-0407-1; Wang XJ, 2014, BMC GENOMICS, V15, DOI [10.1186/1471-2164-15-630, 10.1186/1471-2164-15-479]; Weng SC, 1999, FEMS MICROBIOL LETT, V179, P11, DOI 10.1111/j.1574-6968.1999.tb08701.x; Wiggerich HG, 2000, MICROBIOL-UK, V146, P1053, DOI 10.1099/00221287-146-5-1053; Xiong AS, 2006, NAT PROTOC, V1, P791, DOI 10.1038/nprot.2006.103; Zeng XM, 2013, FEMS MICROBIOL LETT, V347, P83, DOI 10.1111/1574-6968.12221; Zhao QX, 2000, FEMS MICROBIOL LETT, V184, P127, DOI 10.1111/j.1574-6968.2000.tb09002.x; Zimbler DL, 2013, INFECT IMMUN, V81, P3382, DOI 10.1128/IAI.00540-13	56	19	26	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0127506	10.1371/journal.pone.0127506	http://dx.doi.org/10.1371/journal.pone.0127506			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26017672	Green Published, Green Submitted, gold			2022-12-26	WOS:000355185600086
J	Du, W; Pang, CH; Wang, DL; Zhang, QJ; Xue, YK; Jiao, HL; Zhan, L; Ma, Q; Wei, XT				Du, Wei; Pang, Changhe; Wang, Dongliang; Zhang, Qingjun; Xue, Yake; Jiao, Hongliang; Zhan, Lei; Ma, Qian; Wei, Xinting			Decreased FOXD3 Expression Is Associated with Poor Prognosis in Patients with High-Grade Gliomas	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FOXD3; TUMOR-SUPPRESSOR; MURINE MODEL; PROGRESSION; REQUIREMENT; DISEASE	Background The transcription factor forkhead box D3 (FOXD3) plays important roles in the development of neural crest and has been shown to suppress the development of various cancers. However, the expression and its potential biological roles of FOXD3 in high-grade gliomas (HGGs) remain unknown. Methods The mRNA and protein expression levels of FOXD3 were examined using real-time quantitative PCR and western blotting in 23 HGG and 13 normal brain samples, respectively. Immunohistochemistry was used to validate the expression FOXD3 protein in 184 HGG cases. The association between FOXD3 expression and the prognosis of HGG patients were analyzed using Kaplan-Meier survival curves and Cox proportional hazards regression models. In addition, we further examined the effects of FOXD3 on the proliferation and serum starvation-induced apoptosis of glioma cells. Results In comparison to normal brain tissues, FOXD3 expression was significantly decreased in HGG tissues at both mRNA and protein levels. Immunohistochemistry further validated the expression of FOXD3 in HGG tissues. Moreover, low FOXD3 expression was significantly associated with poor prognosis in HGG patients. Depletion of FOXD3 expression promoted glioma cell proliferation and inhibited serum starvation-induced apoptosis, whereas overexpression of FOXD3 inhibited glioma cell proliferation and promoted serum starvation-induced apoptosis. Conclusions Our results indicated that FOXD3 might serve as an independent prognostic biomarker and a potential therapeutic target for HGGs, which warrant further investigation.	[Du, Wei; Pang, Changhe; Xue, Yake; Jiao, Hongliang; Wei, Xinting] Zhengzhou Univ, Affiliated Hosp 1, Dept Neurosurg, Zhengzhou 450052, Peoples R China; [Wang, Dongliang; Zhang, Qingjun] Peking Univ, Peoples Hosp, Dept Neurosurg, Beijing 100044, Peoples R China; [Zhan, Lei] Harbin Med Univ, Affiliated Hosp 2, Dept Gastroenterol, Harbin 150086, Peoples R China; [Ma, Qian] Zhengzhou Univ, Affiliated Hosp 1, Prenatal Diag Ctr, Dept Gynecol & Obstet, Zhengzhou 450052, Peoples R China	Zhengzhou University; Peking University; Harbin Medical University; Zhengzhou University	Wei, XT (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Neurosurg, Zhengzhou 450052, Peoples R China.	weixinting777@163.com			First Affiliated Hospital of Zhengzhou University	First Affiliated Hospital of Zhengzhou University	The present study was supported by the First Affiliated Hospital of Zhengzhou University Research and Development Funds.	Abel EV, 2010, CANCER RES, V70, P2891, DOI 10.1158/0008-5472.CAN-09-3139; Blaes J, 2014, J NEURO-ONCOL, V117, P25, DOI 10.1007/s11060-013-1357-2; Chen SS, 2009, CELL CYCLE, V8, P3663, DOI 10.4161/cc.8.22.9957; Cheng ASL, 2013, GASTROENTEROLOGY, V144, P122, DOI 10.1053/j.gastro.2012.10.002; Chu TL, 2014, BIOCHEM BIOPH RES CO, V446, P580, DOI 10.1016/j.bbrc.2014.03.019; Dottori M, 2001, DEVELOPMENT, V128, P4127; Hanna LA, 2002, GENE DEV, V16, P2650, DOI 10.1101/gad.1020502; Katiyar P, 2011, MOL CANCER RES, V9, P545, DOI 10.1158/1541-7786.MCR-10-0454; Katoh M, 2013, CANCER LETT, V328, P198, DOI 10.1016/j.canlet.2012.09.017; Kleihues P, 2002, J NEUROPATH EXP NEUR, V61, P215, DOI 10.1093/jnen/61.3.215; Kos R, 2001, DEVELOPMENT, V128, P1467; Li D, 2013, ONCOTARGET, V4, P2021, DOI 10.18632/oncotarget.1579; Liu Y, 2008, STEM CELLS, V26, P2475, DOI 10.1634/stemcells.2008-0269; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Schmid CA, 2013, GASTROENTEROLOGY, V144, P22, DOI 10.1053/j.gastro.2012.11.014; Sun BQ, 2009, J NEURO-ONCOL, V94, P213, DOI 10.1007/s11060-009-9859-7; Teng L, 2008, DEVELOPMENT, V135, P1615, DOI 10.1242/dev.012179; Van Meir EG, 2010, CA-CANCER J CLIN, V60, P166, DOI 10.3322/caac.20069; van Roon EH, 2013, CLIN EPIGENETICS, V5, DOI 10.1186/1868-7083-5-2; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wijchers PJEC, 2006, BIOCHEM J, V397, P233, DOI 10.1042/BJ20060387; Xu T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048415; Zhao H, 2014, INT J CLIN EXP PATHO, V7, P670	24	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127976	10.1371/journal.pone.0127976	http://dx.doi.org/10.1371/journal.pone.0127976			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011451	Green Published, Green Submitted, gold			2022-12-26	WOS:000355183900175
J	Hosoki, K; Ying, S; Corrigan, C; Qi, HB; Kurosky, A; Jennings, K; Sun, Q; Boldogh, I; Sur, S				Hosoki, Koa; Ying, Sun; Corrigan, Christopher; Qi, Huibin; Kurosky, Alexander; Jennings, Kristofer; Sun, Qian; Boldogh, Istvan; Sur, Sanjiv			Analysis of a Panel of 48 Cytokines in BAL Fluids Specifically Identifies IL-8 Levels as the Only Cytokine that Distinguishes Controlled Asthma from Uncontrolled Asthma, and Correlates Inversely with FEV1	PLOS ONE			English	Article							BRONCHOALVEOLAR LAVAGE FLUID; BRONCHIAL EPITHELIAL-CELLS; ATOPIC ASTHMA; ALLERGEN CHALLENGE; AIRWAY HYPERRESPONSIVENESS; MESSENGER-RNA; T-CELLS; EOSINOPHILIC BRONCHITIS; PERIPHERAL-BLOOD; CLUSTER-ANALYSIS	We sought to identify cells and cytokines in bronchoalveolar lavage (BAL) fluids that distinguish asthma from healthy control subjects and those that distinguish controlled asthma from uncontrolled asthma. Following informed consent, 36 human subjects were recruited for this study. These included 11 healthy control subjects, 15 subjects with controlled asthma with FEV1 >= 80% predicted and 10 subjects with uncontrolled asthma with FEV1<80% predicted. BAL fluid was obtained from all subjects. The numbers of different cell types and the levels of 48 cytokines were measured in these fluids. Compared to healthy control subjects, patients with asthma had significantly more percentages of eosinophils and neutrophils, IL-1RA, IL-1 alpha, IL-1 beta, IL-2R alpha, IL-5, IL-6, IL-7, IL-8, G-CSF, GRO alpha (CXCL1), MIP-1 beta (CCL4), MIG (CXCL9), RANTES (CCL5) and TRAIL in their BAL fluids. The only inflammatory markers that distinguished controlled asthma from uncontrolled asthma were neutrophil percentage and IL-8 levels, and both were inversely correlated with FEV1. We examined whether grouping asthma subjects on the basis of BAL eosinophil % or neutrophil % could identify specific cytokine profiles. The only differences between neutrophil-normal asthma (neutrophil <= 2.4%) and neutrophil-high asthma (neutrophils%>2.4%) were a higher BAL fluid IL-8 levels, and a lower FEV1 in the latter group. By contrast, compared to eosinophil-normal asthma (eosinophils <= 0.3%), eosinophil-high asthma (eosinophils>0.3%) had higher levels of IL-5, IL-13, IL-16, and PDGF-bb, but same neutrophil percentage, IL-8, and FEV1. Our results identify neutrophils and IL-8 are the only inflammatory components in BAL fluids that distinguish controlled asthma from uncontrolled asthma, and both correlate inversely with FEV1.	[Hosoki, Koa; Qi, Huibin; Sun, Qian; Sur, Sanjiv] Univ Texas Med Branch, Dept Internal Med, Div Allergy & Immunol, Galveston, TX 77555 USA; [Ying, Sun; Corrigan, Christopher] Kings Coll London, Div Asthma Allergy & Lung Biol, London SE1 9RT, England; [Ying, Sun; Corrigan, Christopher] Kings Coll London, MRC, London SE1 9RT, England; [Ying, Sun; Corrigan, Christopher] Kings Coll London, Asthma UK Ctr Allerg Mech, London SE1 9RT, England; [Kurosky, Alexander] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Jennings, Kristofer] Univ Texas Med Branch, Off Biostat Prevent Med & Community Hlth, Galveston, TX 77555 USA; [Boldogh, Istvan] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of London; King's College London; University of London; King's College London; University of London; King's College London; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Sur, S (corresponding author), Univ Texas Med Branch, Dept Internal Med, Div Allergy & Immunol, Galveston, TX 77555 USA.	sasur@UTMB.EDU		Jennings, Kristofer/0000-0002-5442-9326; Hosoki, Koa/0000-0003-4228-2176; Corrigan, Chris/0000-0002-0706-6534	NAID [P01 AI062885-06A1]; NHLBI Proteomic Center [N01HV00245]; NIEHS [RO1 ES18948]; Medical Research Council [G1000758B, G1000758] Funding Source: researchfish; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028184] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI062885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES018948] Funding Source: NIH RePORTER	NAID; NHLBI Proteomic Center; NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NAID P01 AI062885-06A1, NHLBI Proteomic Center, N01HV00245. NIEHS RO1 ES18948, Leon Bromberg Professorship, UTMB.	Abraham B, 2003, EUR RESPIR J, V22, P470, DOI 10.1183/09031936.03.00261903; Anagnostou K, 2012, PRIM CARE RESP J, V21, P71, DOI 10.4104/pcrj.2011.00097; Anderson GP, 2008, LANCET, V372, P1107, DOI 10.1016/S0140-6736(08)61452-X; Arron JR, 2014, EUR RESPIR J, V43, P627, DOI 10.1183/09031936.00117013; Bossley CJ, 2012, J ALLERGY CLIN IMMUN, V129, P974, DOI 10.1016/j.jaci.2012.01.059; Braman SS, 2006, CHEST, V130, p4S, DOI 10.1378/chest.130.1_suppl.4S; Brasier AR, 2008, J ALLERGY CLIN IMMUN, V121, P30, DOI 10.1016/j.jaci.2007.10.015; Brightling CE, 2003, THORAX, V58, P528, DOI 10.1136/thorax.58.6.528; Chu HW, 2000, J ALLERGY CLIN IMMUN, V106, P1115; Chung KF, 2014, EUR RESPIR J, V43, P343, DOI 10.1183/09031936.00202013; COX G, 1995, J IMMUNOL, V154, P4719; COX G, 1991, AM J RESP CELL MOL, V4, P525, DOI 10.1165/ajrcmb/4.6.525; Emadi S, 2005, BLOOD, V105, P464, DOI 10.1182/blood-2003-12-4415; Fernando RI, 2011, CANCER RES, V71, P5296, DOI 10.1158/0008-5472.CAN-11-0156; Fitzpatrick AM, 2010, J ALLERGY CLIN IMMUN, V125, P851, DOI 10.1016/j.jaci.2010.01.048; Flood-Page PT, 2003, AM J RESP CRIT CARE, V167, P199, DOI 10.1164/rccm.200208-789OC; Gagliardo R, 2003, AM J RESP CRIT CARE, V168, P1190, DOI 10.1164/rccm.200205-479OC; Godard P, 2002, EUR RESPIR J, V19, P61, DOI 10.1183/09031936.02.00232001; Gras D, 2012, J ALLERGY CLIN IMMUN, V129, P1259, DOI 10.1016/j.jaci.2012.01.073; Green RH, 2002, THORAX, V57, P875, DOI 10.1136/thorax.57.10.875; Grosse-Steffen T, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/720768; GUNDEL RH, 1991, J CLIN INVEST, V87, P1470, DOI 10.1172/JCI115155; Haldar P, 2008, AM J RESP CRIT CARE, V178, P218, DOI 10.1164/rccm.200711-1754OC; Hampton MB, 1998, BLOOD, V92, P3007, DOI 10.1182/blood.V92.9.3007.421k47_3007_3017; HUANG SK, 1995, J IMMUNOL, V155, P2688; Humbert M, 1996, AM J RESP CRIT CARE, V154, P1497, DOI 10.1164/ajrccm.154.5.8912771; Irvin C, 2014, J ALLERGY CLIN IMMUN, V134, P1175, DOI 10.1016/j.jaci.2014.05.038; Jatakanon A, 1999, AM J RESP CRIT CARE, V160, P1532, DOI 10.1164/ajrccm.160.5.9806170; Justice JP, 2003, AM J PHYSIOL-LUNG C, V284, pL169, DOI 10.1152/ajplung.00260.2002; Kotsimbos TC, 1996, P ASSOC AM PHYSICIAN, V108, P368; Kroegel C, 1996, EUR RESPIR J, V9, P899, DOI 10.1183/09031936.96.09050899; Kuo PL, 2011, TOXICOL SCI, V121, P177, DOI 10.1093/toxsci/kfr030; Lamblin C, 1998, AM J RESP CRIT CARE, V157, P394, DOI 10.1164/ajrccm.157.2.97-02099; Lamkhioued B, 1997, J IMMUNOL, V159, P4593; Leckie MJ, 2000, LANCET, V356, P2144, DOI 10.1016/S0140-6736(00)03496-6; Lee JJ, 2004, SCIENCE, V305, P1773, DOI 10.1126/science.1099472; LEUNG DYM, 1995, J EXP MED, V181, P33, DOI 10.1084/jem.181.1.33; Lilly CM, 2001, AM J RESP CRIT CARE, V163, P1669, DOI 10.1164/ajrccm.163.7.9812044; Moller GM, 1996, AM J RESP CELL MOL, V14, P439; Moore WC, 2007, J ALLERGY CLIN IMMUN, V119, P405, DOI 10.1016/j.jaci.2006.11.639; Moore WC, 2014, J ALLERGY CLIN IMMUN, V133, P1557, DOI 10.1016/j.jaci.2013.10.011; Moore WC, 2010, AM J RESP CRIT CARE, V181, P315, DOI 10.1164/rccm.200906-0896OC; Nair P, 2012, CLIN EXP ALLERGY, V42, P1097, DOI 10.1111/j.1365-2222.2012.04014.x; Ordonez CL, 2000, AM J RESP CRIT CARE, V161, P1185, DOI 10.1164/ajrccm.161.4.9812061; Park SJ, 2006, J IMMUNOL, V176, P2538, DOI 10.4049/jimmunol.176.4.2538; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; Sakamoto N, 2005, AM J PHYSIOL-LUNG C, V288, pL508, DOI 10.1152/ajplung.00076.2004; Sevin CM, 2013, AM J RESP CELL MOL, V49, P396, DOI 10.1165/rcmb.2012-0442OC; SUR S, 1995, J ALLERGY CLIN IMMUN, V96, P661, DOI 10.1016/S0091-6749(95)70265-2; Sur S, 1996, J ALLERGY CLIN IMMUN, V97, P1272, DOI 10.1016/S0091-6749(96)70195-1; SUR S, 1993, AM REV RESPIR DIS, V148, P713, DOI 10.1164/ajrccm/148.3.713; Suzuki T, 1996, AM J RESP CRIT CARE, V153, P1405, DOI 10.1164/ajrccm.153.4.8616573; Tillie-Leblond I, 2000, AM J RESP CRIT CARE, V162, P586, DOI 10.1164/ajrccm.162.2.9907014; Vega A, 2011, J INVEST ALLERG CLIN, V21, P38; Verbout NG, 2009, AM J PHYSIOL-LUNG C, V297, pL228, DOI 10.1152/ajplung.90540.2008; VIRCHOW JC, 1995, AM J RESP CRIT CARE, V151, P960; WALKER C, 1994, AM J RESP CRIT CARE, V150, P1038, DOI 10.1164/ajrccm.150.4.7921434; WALKER C, 1992, AM REV RESPIR DIS, V146, P109, DOI 10.1164/ajrccm/146.1.109; WARDLAW AJ, 1988, AM REV RESPIR DIS, V137, P62, DOI 10.1164/ajrccm/137.1.62; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; Wenzel SE, 1999, AM J RESP CRIT CARE, V160, P1001, DOI 10.1164/ajrccm.160.3.9812110; Woodman L, 2006, CHEST, V130, P371, DOI 10.1378/chest.130.2.371; Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P388, DOI 10.1164/rccm.200903-0392OC; XIU Q, 1995, CLIN EXP ALLERGY, V25, P51, DOI 10.1111/j.1365-2222.1995.tb01002.x; Ying S, 1997, J IMMUNOL, V158, P3539; Ying S, 1997, EUR J IMMUNOL, V27, P3507, DOI 10.1002/eji.1830271252; Ying S, 2008, J IMMUNOL, V181, P2790, DOI 10.4049/jimmunol.181.4.2790	67	61	65	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0126035	10.1371/journal.pone.0126035	http://dx.doi.org/10.1371/journal.pone.0126035			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011707	Green Submitted, Green Published, gold			2022-12-26	WOS:000355183900021
J	Rose, SJ; Babrak, LM; Bermudez, LE				Rose, Sasha J.; Babrak, Lmar M.; Bermudez, Luiz E.			Mycobacterium avium Possesses Extracellular DNA that Contributes to Biofilm Formation, Structural Integrity, and Tolerance to Antibiotics	PLOS ONE			English	Article							COMPLEX MAC; RELEASE; ROLES; FORM; IDENTIFICATION; ABILITY; GROWTH	Mycobacterium avium subsp. hominissuis is an opportunistic pathogen that is associated with biofilm-related infections of the respiratory tract and is difficult to treat. In recent years, extracellular DNA (eDNA) has been found to be a major component of bacterial biofilms, including many pathogens involved in biofilm-associated infections. To date, eDNA has not been described as a component of mycobacterial biofilms. In this study, we identified and characterized eDNA in a high biofilm-producing strain of Mycobacterium avium subsp. hominissuis (MAH). In addition, we surveyed for presence of eDNA in various MAH strains and other nontuberculous mycobacteria. Biofilms of MAH A5 (high biofilm-producing strain) and MAH 104 (reference strain) were established at 22 degrees C and 37 degrees C on abiotic surfaces. Acellular biofilm matrix and supernatant from MAH A5 7 day-old biofilms both possess abundant eDNA, however very little eDNA was found in MAH 104 biofilms. A survey of MAH clinical isolates and other clinically relevant nontuberculous mycobacterial species revealed many species and strains that also produce eDNA. RAPD analysis demonstrated that eDNA resembles genomic DNA. Treatment with DNase I reduced the biomass of MAH A5 biofilms when added upon biofilm formation or to an already established biofilm both on abiotic surfaces and on top of human pharyngeal epithelial cells. Furthermore, co-treatment of an established biofilm with DNase 1 and either moxifloxacin or clarithromycin significantly increased the susceptibility of the bacteria within the biofilm to these clinically used antimicrobials. Collectively, our results describe an additional matrix component of mycobacterial biofilms and a potential new target to help treat biofilm-associated nontuberculous mycobacterial infections.	[Rose, Sasha J.; Babrak, Lmar M.; Bermudez, Luiz E.] Oregon State Univ, Coll Vet Med, Dept Biomed Sci, Corvallis, OR 97331 USA; [Rose, Sasha J.; Babrak, Lmar M.; Bermudez, Luiz E.] Oregon State Univ, Coll Sci, Dept Microbiol, Corvallis, OR 97331 USA	Oregon State University; Oregon State University	Bermudez, LE (corresponding author), Oregon State Univ, Coll Vet Med, Dept Biomed Sci, Corvallis, OR 97331 USA.	Luiz.Bermudez@oregonstate.edu			NIH	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The work was supported by a NIH grant. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allesen-Holm M, 2006, MOL MICROBIOL, V59, P1114, DOI 10.1111/j.1365-2958.2005.05008.x; Asally M, 2012, P NATL ACAD SCI USA, V109, P18891, DOI 10.1073/pnas.1212429109; Barnes AMT, 2012, MBIO, V3, DOI 10.1128/mBio.00193-12; Bockelmann U, 2006, FEMS MICROBIOL LETT, V262, P31, DOI 10.1111/j.1574-6968.2006.00361.x; Carter G, 2003, J MED MICROBIOL, V52, P747, DOI 10.1099/jmm.0.05224-0; Chen JM, 2006, J BACTERIOL, V188, P633, DOI 10.1128/JB.188.2.633-641.2006; Conover MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016861; Das T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058299; Das T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046718; Das T, 2011, SOFT MATTER, V7, P2927, DOI 10.1039/c0sm01142h; Falkinham JO, 2008, J WATER HEALTH, V6, P209, DOI [10.2166/wh.2008.232, 10.2166/wh.2008.032]; Feazel LM, 2009, P NATL ACAD SCI USA, V106, P16393, DOI 10.1073/pnas.0908446106; Freeman R, 2006, APPL ENVIRON MICROB, V72, P7554, DOI 10.1128/AEM.01633-06; Gloag ES, 2013, P NATL ACAD SCI USA, V110, P11541, DOI 10.1073/pnas.1218898110; Godeke J, 2011, APPL ENVIRON MICROB, V77, P5342, DOI 10.1128/AEM.00643-11; Grande R, 2011, J APPL MICROBIOL, V110, P490, DOI 10.1111/j.1365-2672.2010.04911.x; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Hannan S, 2010, FEMS IMMUNOL MED MIC, V59, P345, DOI 10.1111/j.1574-695X.2010.00661.x; Harmsen M, 2010, APPL ENVIRON MICROB, V76, P2271, DOI 10.1128/AEM.02361-09; Hymes SR, 2013, J INFECT DIS, V207, P1491, DOI 10.1093/infdis/jit047; Jurcisek JA, 2007, J BACTERIOL, V189, P3868, DOI 10.1128/JB.01935-06; Kaplan JB, 2012, J ANTIBIOT, V65, P73, DOI 10.1038/ja.2011.113; Lappann M, 2010, MOL MICROBIOL, V75, P1355, DOI 10.1111/j.1365-2958.2010.07054.x; Liao SM, 2014, J BACTERIOL, V196, P2355, DOI 10.1128/JB.01493-14; Liu RY, 2012, SCI TOTAL ENVIRON, V435, P124, DOI 10.1016/j.scitotenv.2012.07.022; Manzanillo PS, 2012, CELL HOST MICROBE, V11, P469, DOI 10.1016/j.chom.2012.03.007; Marsollier L, 2007, PLOS PATHOG, V3, P582, DOI 10.1371/journal.ppat.0030062; McNabe M, 2011, CLIN MICROBIOL INFEC, V17, P697, DOI 10.1111/j.1469-0691.2010.03307.x; Moscoso M, 2006, J BACTERIOL, V188, P7785, DOI 10.1128/JB.00673-06; Nessar R, 2011, MICROBIOL-SGM, V157, P1187, DOI 10.1099/mic.0.046557-0; Nishiuchi Y, 2007, CLIN INFECT DIS, V45, P347, DOI 10.1086/519383; Nishiuchi Y, 2009, JPN J INFECT DIS, V62, P182; Ojha A, 2005, CELL, V123, P861, DOI 10.1016/j.cell.2005.09.012; Ojha AK, 2008, MOL MICROBIOL, V69, P164, DOI 10.1111/j.1365-2958.2008.06274.x; Pillai SR, 2001, VET MICROBIOL, V79, P275, DOI 10.1016/S0378-1135(00)00358-8; Prados-Rosales R, 2011, J CLIN INVEST, V121, P1471, DOI 10.1172/JCI44261; Qin ZQ, 2007, MICROBIOL-SGM, V153, P2083, DOI 10.1099/mic.0.2007/006031-0; Ramasoota P, 2001, VET MICROBIOL, V78, P251, DOI 10.1016/S0378-1135(00)00302-3; Recht J, 2001, J BACTERIOL, V183, P5718, DOI 10.1128/JB.183.19.5718-5724.2001; Ren HP, 2007, MOL MICROBIOL, V63, P1345, DOI 10.1111/j.1365-2958.2007.05603.x; Rice KC, 2007, P NATL ACAD SCI USA, V104, P8113, DOI 10.1073/pnas.0610226104; Rose SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108703; Rose SJ, 2014, INFECT IMMUN, V82, P405, DOI 10.1128/IAI.00820-13; Sahu Praveen K, 2012, ScientificWorldJournal, V2012, P973436, DOI 10.1100/2012/973436; Seper A, 2011, MOL MICROBIOL, V82, P1015, DOI 10.1111/j.1365-2958.2011.07867.x; Tetz GV, 2009, ANTIMICROB AGENTS CH, V53, P1204, DOI 10.1128/AAC.00471-08; Thomas VC, 2008, J BACTERIOL, V190, P5690, DOI 10.1128/JB.00314-08; Vilain S, 2009, APPL ENVIRON MICROB, V75, P2861, DOI 10.1128/AEM.01317-08; Whiley H, 2012, J APPL MICROBIOL, V113, P223, DOI 10.1111/j.1365-2672.2012.05298.x; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Wu CW, 2009, MICROB PATHOGENESIS, V46, P222, DOI 10.1016/j.micpath.2009.01.010; Yamazaki Y, 2006, APPL ENVIRON MICROB, V72, P819, DOI 10.1128/AEM.72.1.819-825.2006; Yamazaki Y, 2006, CELL MICROBIOL, V8, P806, DOI 10.1111/j.1462-5822.2005.00667.x; Zambrano MM, 2005, CELL, V123, P762, DOI 10.1016/j.cell.2005.11.011	54	44	45	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128772	10.1371/journal.pone.0128772	http://dx.doi.org/10.1371/journal.pone.0128772			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010725	gold, Green Published, Green Submitted			2022-12-26	WOS:000355183900250
J	Hakkarainen, J; Jokela, H; Pakarinen, P; Heikela, H; Katkanaho, L; Vandenput, L; Ohlsson, C; Zhang, FP; Poutanen, M				Hakkarainen, Janne; Jokela, Heli; Pakarinen, Pirjo; Heikela, Hanna; Katkanaho, Laura; Vandenput, Liesbeth; Ohlsson, Claes; Zhang, Fu-Ping; Poutanen, Matti			Hydroxysteroid (17 beta)-dehydrogenase 1-deficient female mice present with normal puberty onset but are severely subfertile due to a defect in luteinization and progesterone production	FASEB JOURNAL			English	Article						ovary; estrogen; fertility; HSD17B enzymes	RAT 17-BETA-HYDROXYSTEROID-DEHYDROGENASE TYPE-1; FOLLICLE-STIMULATING-HORMONE; ESTROGEN-RECEPTORS ALPHA; GRANULOSA-CELLS; MESSENGER-RNA; SEX REVERSAL; ER-ALPHA; DEHYDROGENASE; EXPRESSION; ESTRADIOL	Hydroxysteroid (17 beta)-dehydrogenase type 1 (HSD17B1) catalyzes the conversion of low active 17-ketosteroids, androstenedione (A-dione) and estrone (E1) to highly active 17-hydroxysteroids, testosterone (T) and E2, respectively. In this study, the importance of HSD17B1 in ovarian estrogen production was determined using Hsd17b1 knockout (HSD17B1KO) mice. In these mice, the ovarian HSD17B enzyme activity was markedly reduced, indicating a central role of HSD17B1 in ovarian physiology. The lack of Hsd17b activity resulted in increased ovarian E1: E2 and A-dione: T ratios, but we also observed reduced progesterone concentration in HSD17B1KO ovaries. Accordingly with the altered steroid production, altered expression of Star, Cyp11a1, Lhcgr, Hsd17b7, and especially Cyp17a1 was observed. The ovaries of HSD17B1KO mice presented with all stages of folliculogenesis, while the corpus luteums tructure was less defined and number reduced. Surprisingly, bundles of large granular cells of unknown origin appeared in the stroma of the KO ovaries. The HSD17B1KO mice presented with severe subfertility and failed to initiate pseudopregnancy. However, the HSD17B1KO females presented with normal estrous cycle defined by vaginal smears and normal puberty appearance. This study indicates that HSD17B1 is a key enzyme in ovarian steroidogenesis and has a novel function in initiation and stabilization of pregnancy.	[Hakkarainen, Janne; Jokela, Heli; Pakarinen, Pirjo; Heikela, Hanna; Katkanaho, Laura; Zhang, Fu-Ping; Poutanen, Matti] Univ Turku, Inst Biomed, Dept Physiol, FI-20520 Turku, Finland; [Hakkarainen, Janne; Jokela, Heli; Pakarinen, Pirjo; Heikela, Hanna; Katkanaho, Laura; Zhang, Fu-Ping; Poutanen, Matti] Univ Turku, Turku Ctr Dis Modeling, FI-20520 Turku, Finland; [Vandenput, Liesbeth; Ohlsson, Claes] Gothenburg Univ, Sahlgrenska Acad, Inst Med, Gothenburg, Sweden	University of Turku; University of Turku; University of Gothenburg	Poutanen, M (corresponding author), Univ Turku, Inst Biomed, Dept Physiol, Kiinamyllynkatu 10, FI-20520 Turku, Finland.	matti.poutanen@utu.fi	Vandenput, Liesbeth/AAI-4100-2021; Vandenput, Liesbeth/AAP-3655-2020; Ohlsson, Claes/AGP-3544-2022; Poutanen, Matti/I-1700-2018	Vandenput, Liesbeth/0000-0002-1712-6131; Vandenput, Liesbeth/0000-0002-1712-6131; Ohlsson, Claes/0000-0002-9633-2805; Poutanen, Matti/0000-0002-8953-1734; Jokela, Heli/0000-0003-1839-7870	Academy of Finland; Sigrid Juselius Foundation; Swedish Research Council; Swedish Foundation for Strategic Research; Salhgrenska University Hospital; Lundberg Foundation; Torsten and Ragnar Soderberg Foundation; Novo Nordisk Foundation; Novo Nordisk Fonden [NNF14OC0010513, NNF14OC0009883, NNF13OC0005785, NNF13OC0004839] Funding Source: researchfish	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Salhgrenska University Hospital; Lundberg Foundation(European Commission); Torsten and Ragnar Soderberg Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Novo Nordisk Fonden(Novo Nordisk Foundation)	The authors thank N. Messner, H. Niittymaki, K. Hovirinta, T. Kirjonen, J. Palmu, M. Niiranen, E. Nyman, and T. Poikkipuoli for technical assistance. This work was supported in part by the Academy of Finland, the Sigrid Juselius Foundation, the Swedish Research Council, the Swedish Foundation for Strategic Research, a research grant from Salhgrenska University Hospital, the Lundberg Foundation, the Torsten and Ragnar Soderberg Foundation, and the Novo Nordisk Foundation.	Akinola LA, 1997, ENDOCRINOLOGY, V138, P2886, DOI 10.1210/en.138.7.2886; Byers SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035538; Clement P. B., 2007, HISTOLOGY PATHOLOGIS, P1064; Cornel KMC, 2012, J CLIN ENDOCR METAB, V97, pE591, DOI 10.1210/jc.2011-2994; Couse JF, 1999, SCIENCE, V286, P2328, DOI 10.1126/science.286.5448.2328; Couse JF, 2003, MOL ENDOCRINOL, V17, P1039, DOI 10.1210/me.2002-0398; Duan WR, 1997, ENDOCRINOLOGY, V138, P3216, DOI 10.1210/en.138.8.3216; Dupont S, 2000, DEVELOPMENT, V127, P4277; FOURNETDULGUEROV N, 1987, J CLIN ENDOCR METAB, V65, P757, DOI 10.1210/jcem-65-4-757; GHERSEVICH S, 1994, ENDOCRINOLOGY, V135, P1963, DOI 10.1210/en.135.5.1963; GHERSEVICH S, 1994, ENDOCRINOLOGY, V135, P1477, DOI 10.1210/en.135.4.1477; GHERSEVICH SA, 1994, J ENDOCRINOL, V140, P409, DOI 10.1677/joe.0.1400409; GHERSEVICH SA, 1994, J ENDOCRINOL, V143, P139, DOI 10.1677/joe.0.1430139; Gibori G., 1993, OVARY, P261; Gunnarsson C, 2008, BREAST CANCER RES TR, V108, P35, DOI 10.1007/s10549-007-9579-7; HAAVISTO AM, 1993, ENDOCRINOLOGY, V132, P1687, DOI 10.1210/en.132.4.1687; Huhtinen K, 2012, J CLIN ENDOCR METAB, V97, P4228, DOI 10.1210/jc.2012-1154; Husen B, 2006, ENDOCRINOLOGY, V147, P5333, DOI 10.1210/en.2006-0778; Jokela H, 2010, ENDOCRINOLOGY, V151, P1884, DOI 10.1210/en.2009-0928; Lukacik P, 2006, MOL CELL ENDOCRINOL, V248, P61, DOI 10.1016/j.mce.2005.12.007; Luu-The V, 2006, MOL ENDOCRINOL, V20, P437, DOI 10.1210/me.2005-0058; MAENTAUSTA O, 1992, CANCER, V70, P1551, DOI 10.1002/1097-0142(19920915)70:6<1551::AID-CNCR2820700618>3.0.CO;2-#; McLean M P, 1990, Chin J Physiol, V33, P353; MCLEAN MP, 1990, ENDOCRINOLOGY, V126, P1796, DOI 10.1210/endo-126-4-1796; Moeller G, 2006, MOL CELL ENDOCRINOL, V248, P47, DOI 10.1016/j.mce.2005.11.031; Moon YA, 2003, J BIOL CHEM, V278, P7335, DOI 10.1074/jbc.M211684200; Myers M, 2004, REPRODUCTION, V127, P569, DOI 10.1530/rep.1.00095; Nilsson M., 2015, ENDOCRINOLOGY; Nokelainen P, 1996, EUR J BIOCHEM, V236, P482, DOI 10.1111/j.1432-1033.1996.00482.x; Nokelainen P, 2000, ENDOCRINOLOGY, V141, P772, DOI 10.1210/en.141.2.772; PARMER TG, 1992, ENDOCRINOLOGY, V131, P2213, DOI 10.1210/en.131.5.2213; Pelletier G, 2004, J MOL ENDOCRINOL, V33, P459, DOI 10.1677/jme.1.01567; Peltoketo H, 1999, J MOL ENDOCRINOL, V23, P1, DOI 10.1677/jme.0.0230001; POUTANEN M, 1993, ENDOCRINOLOGY, V133, P2639, DOI 10.1210/en.133.6.2639; POUTANEN M, 1992, INT J CANCER, V50, P386, DOI 10.1002/ijc.2910500310; Robker RL, 1998, MOL ENDOCRINOL, V12, P924, DOI 10.1210/me.12.7.924; Saloniemi T, 2007, MOL ENDOCRINOL, V21, P2627, DOI 10.1210/me.2007-0144; Saloniemi T, 2010, AM J PATHOL, V176, P1443, DOI 10.2353/ajpath.2010.090325; SEGALOFF DL, 1990, MOL ENDOCRINOL, V4, P1856, DOI 10.1210/mend-4-12-1856; Shehu A, 2011, MOL ENDOCRINOL, V25, P754, DOI 10.1210/me.2010-0261; Taniguchi F, 2007, FASEB J, V21, P586, DOI 10.1096/fj.06-6681com; Torn S, 2003, BIOCHEM BIOPH RES CO, V305, P37, DOI 10.1016/S0006-291X(03)00694-6; TSENG L, 1974, ENDOCRINOLOGY, V94, P419, DOI 10.1210/endo-94-2-419; van Casteren JIJ, 2000, BIOL REPROD, V62, P886, DOI 10.1095/biolreprod62.4.886; WU L, 1993, J BIOL CHEM, V268, P12964; Wu XQ, 2007, MOL CELL ENDOCRINOL, V265, P71, DOI 10.1016/j.mce.2006.12.006; Zhu SJ, 2002, J ENDOCRINOL, V172, P31, DOI 10.1677/joe.0.1720031	47	29	29	2	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2015	29	9					3806	3816		10.1096/fj.14-269035	http://dx.doi.org/10.1096/fj.14-269035			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CP5IU	26018678				2022-12-26	WOS:000359915600017
J	Chirita-Emandi, A; Socolov, D; Haivas, C; Calapis, A; Gheorghiu, C; Puiu, M				Chirita-Emandi, Adela; Socolov, Demetra; Haivas, Carmen; Calapis, Anca; Gheorghiu, Cristina; Puiu, Maria			Vitamin D Status: A Different Story in the Very Young versus the Very Old Romanian Patients	PLOS ONE			English	Article							BONE-MINERAL DENSITY; D DEFICIENCY; PARATHYROID-HORMONE; 25-HYDROXYVITAMIN D; D SUPPLEMENTATION; CALCIUM; ADOLESCENTS; CHILDREN	Background In Romania (latitude 48 degrees 15'N to 43 degrees 40'N), vitamin D supplementation is common practice mostly in infants 0-1 year old. No published information is available regarding epidemiological data on vitamin D status in the Romanian population for a wide age range and geographical territory. In this context, we aimed to evaluate the seasonal and age variation of vitamin D status in a large Romanian population. Methods 6631 individuals from across Romania had performed 7544 vitamin D assessments (20122014) in a chain of private laboratories. Vitamin D (25-hydroxyvitamin D2 and 25-hydroxyvitamin D3) was measured using High Performance Liquid Chromatography. Vitamin D levels were classified as severe deficiency<10ng/mL, deficiency 10-20ng/mL, insufficiency 2129ng/mL, sufficiency >= 30ng/mL and potentially harmful>100ng/ml. Results Male to female ratio was 1: 2.9. Age ranged from 0 to 85 years. Mean vitamin D levels increased from April (26.3ng/ml) to September (35.6ng/ml) and decreased from October (33.5ng/ml) to March (24.4ng/ml). Overall 40% had sufficient vitamin D, while the rest were insufficient 33%, deficient 22%, severely deficient 4% and 1% potentially harmful (of them 81% under 1 year old). Males compared to females showed higher percentages of sufficiency (47% vs. 38%). Children 0-2 years presented the highest percentage of vitamin D sufficiency (77%). Lowest percentages (21%) of sufficiency were in people 80-84 years. Conclusion In Romania, suboptimal vitamin D levels are common (59%), especially in older age, wintertime and in women. Vitamin D supplementation would be most warranted from January to April in the Romanian population. 25-hydroxyvitamin D levels>100ng/ml were relatively prevalent in children 0-1 year old (17.3%). This was attributed to supplementation errors and the fact that high-risk individuals were more likely to visit for medical check-up. Nonetheless, it stresses the need to increase awareness of the importance of preventing Vitamin D supplementation administration errors in the young.	[Chirita-Emandi, Adela; Gheorghiu, Cristina; Puiu, Maria] Univ Med & Farm Timisoara, Dept Genet, Timisoara, Romania; [Socolov, Demetra] Univ Med & Pharm Gr T Popa, Ginecol Dept, Iasi, Romania; [Haivas, Carmen] Univ Med & Farm Timisoara, Dept Anat, Timisoara, Romania; [Calapis, Anca] Bioclin Lab SA, Timisoara, Romania; [Puiu, Maria] Clin Emergency Hosp Children Louis Turcanu, Dept Genet, Timisoara, Romania	Romanian Academy of Sciences; Institute of Chemistry, Timisoara; Victor Babes University of Medicine & Pharmacy, Timisoara; Grigore T Popa University of Medicine & Pharmacy; Victor Babes University of Medicine & Pharmacy, Timisoara; Romanian Academy of Sciences; Institute of Chemistry, Timisoara	Chirita-Emandi, A (corresponding author), Univ Med & Farm Timisoara, Dept Genet, Timisoara, Romania.	adela.chirita@umft.ro	Puiu, Maria/F-3138-2016; Chirita-Emandi, Adela/G-5574-2016; Socolov, Demetra/AAT-2782-2021	Chirita-Emandi, Adela/0000-0001-7554-4625; Puiu, Maria/0000-0002-4078-2831	Human Resources Development Operational Programme [POSDRU/159/1.5/136893]; Center of Genomic Medicine from the University of Medicine and Pharmacy "Victor Babes" Timisoara [POSCCE-A2O2.2.1-2013-1]; Bioclinica Laboratoarele	Human Resources Development Operational Programme; Center of Genomic Medicine from the University of Medicine and Pharmacy "Victor Babes" Timisoara; Bioclinica Laboratoarele	Chirita-Emandi Adela is a Postdoctoral fellow under the frame of European Social Fund, Human Resources Development Operational Programme 2007-2013, project no. POSDRU/159/1.5/136893. Maria Puiu was funded under Operational program: Development of existing infrastructure and creation of new infrastructure (laboratories, research centers). POSCCE-A2O2.2.1-2013-1, in the Center of Genomic Medicine from the University of Medicine and Pharmacy "Victor Babes" Timisoara. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All other authors received no specific funding for this work. Coauthor Anca CalapiS is employed by Bioclinica Laboratoarele, SA. Bioclinica Laboratoarele provided support in the form of salary for author AC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Absoud M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022179; [Anonymous], 2014, REV MED CHIR SOC MED; Autier P, 2007, ARCH INTERN MED, V167, P1730, DOI 10.1001/archinte.167.16.1730; Avenell A, 2007, AGE AGEING, V36, P574, DOI 10.1093/ageing/afm091; Azab SFA, 2013, ITAL J PEDIATR, V39, DOI 10.1186/1824-7288-39-73; Bener A, 2014, J FAM COMMUNITY MED, V21, P154, DOI 10.4103/2230-8229.142967; Braegger C, 2013, J PEDIATR GASTR NUTR, V56, P692, DOI 10.1097/MPG.0b013e31828f3c05; Bruyere O, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-32; Daly RM, 2012, CLIN ENDOCRINOL, V77, P26, DOI 10.1111/j.1365-2265.2011.04320.x; de Wildt SN, 2014, ARCH DIS CHILD, V99, P1137, DOI 10.1136/archdischild-2013-305212; Dobnig H, 2008, ARCH INTERN MED, V168, P1340, DOI 10.1001/archinte.168.12.1340; Dumitrescu G, 2013, MED-SURG J, V117, P23; El-Hajj Fuleihan G, 2006, J CLIN ENDOCR METAB, V91, P405, DOI 10.1210/jc.2005-1436; Fodor D, 2014, ACTA PHYSIOL HUNG, V101, P216, DOI 10.1556/APhysiol.101.2014.2.10; GARLAND CF, 1989, LANCET, V2, P1176, DOI 10.1016/s0140-6736(89)91789-3; Gill RS, 2012, CAN J SURG, V55, P239, DOI 10.1503/cjs.035710; Gill TK, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1001; Ginde AA, 2009, ARCH INTERN MED, V169, P626, DOI 10.1001/archinternmed.2008.604; Gonzalez-Gross M, 2012, BRIT J NUTR, V107, P755, DOI 10.1017/S0007114511003527; Gradinaru D, 2012, AGING CLIN EXP RES, V24, P595, DOI 10.3275/8591; Grundmann M, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-146; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Hunt K, 2011, J HEALTH SERV RES PO, V16, P108, DOI 10.1258/jhsrp.2010.009131; Huss L, 2014, CANCER CAUSE CONTROL, V25, P1131, DOI 10.1007/s10552-014-0413-3; Jacques PF, 1997, AM J CLIN NUTR, V66, P929, DOI 10.1093/ajcn/66.4.929; Lips P, 2001, ENDOCR REV, V22, P477, DOI 10.1210/er.22.4.477; Looker AC, 2011, NCHS DATA BRIEF, V59, P1; MACLAUGHLIN J, 1985, J CLIN INVEST, V76, P1536, DOI 10.1172/JCI112134; Martineau AR, 2007, AM J RESP CRIT CARE, V176, P208, DOI 10.1164/rccm.200701-007OC; McCullough ML, 2010, AM J EPIDEMIOL, V172, P21, DOI 10.1093/aje/kwq113; Mocanu V, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-137; Pludowski P, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/589587; Poole KES, 2006, STROKE, V37, P243, DOI 10.1161/01.STR.0000195184.24297.c1; Porojnicu AC, 2012, PUBLIC HEALTH NUTR, V15, P2157, DOI 10.1017/S1368980012000158; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Smith GR, 2005, J RHEUMATOL, V32, P684; Steingrimsdottir L, 2005, JAMA-J AM MED ASSOC, V294, P2336, DOI 10.1001/jama.294.18.2336; Vierucci F, 2013, EUR J PEDIATR, V172, P1607, DOI 10.1007/s00431-013-2119-z; Villamor E, 2011, AM J CLIN NUTR, V94, P1020, DOI 10.3945/ajcn.111.018168	39	17	17	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128010	10.1371/journal.pone.0128010	http://dx.doi.org/10.1371/journal.pone.0128010			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024516	gold, Green Published, Green Submitted			2022-12-26	WOS:000355319400063
J	Murakami, M; Kouyama, T				Murakami, Midori; Kouyama, Tsutomu			Crystallographic Study of the LUMI Intermediate of Squid Rhodopsin	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; CRYSTAL-STRUCTURE; LOW-TEMPERATURES; NMR SYSTEM; PHOTOREACTION; CONFORMATION; MOVEMENT; OPSIN; LIGHT	Upon absorption of light, the retinal chromophore in rhodopsin isomerizes from the 11-cis to the trans configuration, initiating a photoreaction cycle. The primary photoreaction state, bathorhodopsin (BATHO), relaxes thermally through lumirhodopsin (LUMI) into a photoactive state, metarhodopsin (META), which stimulates the conjugated G-protein. Previous crystallographic studies of squid and bovine rhodopsins have shown that the structural change in the primary photoreaction of squid rhodopsin is considerably different from that observed in bovine rhodopsin. It would be expected that there is a fundamental difference in the subsequent thermal relaxation process between vertebrate and invertebrate rhodopsins. In this work, we performed crystallographic analyses of the LUMI state of squid rhodopsin using the P62 crystal. When the crystal was illuminated at 100 K with blue light, a half fraction of the protein was converted into BATHO. This reaction state relaxed into LUMI when the illuminated crystal was warmed in the dark to 170 K. It was found that, whereas trans retinal is largely twisted in BATHO, it takes on a more planar configuration in LUMI. This relaxation of retinal is accompanied by reorientation of the Schiff base NH bond, the hydrogen-bonding partner of which is switched to Asn185 in LUMI. Unlike bovine rhodopsin, the BATHO-to-LUMI transition in squid rhodopsin was accompanied by no significant change in the position/orientation of the beta-ionone ring of retinal.	[Murakami, Midori; Kouyama, Tsutomu] Nagoya Univ, Dept Phys, Grad Sch Sci, Nagoya, Aichi 464, Japan; [Kouyama, Tsutomu] RIKEN, Harima Inst, Sayo, Hyogo, Japan	Nagoya University; RIKEN	Kouyama, T (corresponding author), Nagoya Univ, Dept Phys, Grad Sch Sci, Nagoya, Aichi 464, Japan.	kouyama@bio.hys.nagoya-u.ac.jp	murakami, midori/AAL-1023-2021		Ministry of Education, Science, and Culture of Japan	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Funding was provided by a grant-in-aid from the Ministry of Education, Science, and Culture of Japan.	[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; [Anonymous], PYMOL MOL GRAPH SYST; Borhan B, 2000, SCIENCE, V288, P2209, DOI 10.1126/science.288.5474.2209; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; HUBBARD R, 1958, J GEN PHYSIOL, V41, P501, DOI 10.1085/jgp.41.3.501; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; MAEDA A, 1978, FEBS LETT, V92, P77, DOI 10.1016/0014-5793(78)80725-X; Matsui Y, 2002, J MOL BIOL, V324, P469, DOI 10.1016/S0022-2836(02)01110-5; McRee D.E., 1999, PRACTICAL PROTEIN CR, V2nd ed., P91; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Murakami M, 2007, ACTA CRYSTALLOGR F, V63, P475, DOI 10.1107/S1744309107017423; Murakami M, 2011, J MOL BIOL, V413, P615, DOI 10.1016/j.jmb.2011.08.044; Nakamichi H, 2006, P NATL ACAD SCI USA, V103, P12729, DOI 10.1073/pnas.0601765103; Nakamichi H, 2006, ANGEW CHEM INT EDIT, V45, P4270, DOI 10.1002/anie.200600595; Nishimura S, 1997, BIOCHEMISTRY-US, V36, P864, DOI 10.1021/bi961795i; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Sakai K, 2002, J APPL CRYSTALLOGR, V35, P270, DOI 10.1107/S0021889801021331; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; SHICHIDA Y, 1978, BIOCHIM BIOPHYS ACTA, V504, P413, DOI 10.1016/0005-2728(78)90064-6; Yamamoto M, 2009, J MOL BIOL, V393, P559, DOI 10.1016/j.jmb.2009.08.047; YARFITZ S, 1994, J BIOL CHEM, V269, P14329; YOSHIZAWA T, 1963, NATURE, V197, P1279, DOI 10.1038/1971279a0; YOSHIZAWA T, 1964, NATURE, V201, P340, DOI 10.1038/201340a0	28	5	5	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0126970	10.1371/journal.pone.0126970	http://dx.doi.org/10.1371/journal.pone.0126970			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024518	gold, Green Submitted, Green Published			2022-12-26	WOS:000355319400027
J	Rotsch, D; Brossard, T; Bihmidine, S; Ying, WJ; Gaddam, V; Harmata, M; Robertson, JD; Swyers, M; Jurisson, SS; Braun, DM				Rotsch, David; Brossard, Tom; Bihmidine, Saadia; Ying, Weijiang; Gaddam, Vikram; Harmata, Michael; Robertson, J. David; Swyers, Michael; Jurisson, Silvia S.; Braun, David M.			Radiosynthesis of 6 '-Deoxy-6 '[F-18] Fluorosucrose via Automated Synthesis and Its Utility to Study In Vivo Sucrose Transport in Maize (Zea mays) Leaves	PLOS ONE			English	Article							PROMOTE CARBOHYDRATE EXPORT; SUBSTRATE-SPECIFICITY; PHLOEM; PLANT; GENE; CARBON; TRANSLOCATION; ACCUMULATION; METABOLISM; INHIBITION	Sugars produced from photosynthesis in leaves are transported through the phloem tissues within veins and delivered to non-photosynthetic organs, such as roots, stems, flowers, and seeds, to support their growth and/or storage of carbohydrates. However, because the phloem is located internally within the veins, it is difficult to access and to study the dynamics of sugar transport. Radioactive tracers have been extensively used to study vascular transport in plants and have provided great insights into transport dynamics. To better study sucrose partitioning in vivo, a novel radioactive analog of sucrose was synthesized through a completely chemical synthesis route by substituting fluorine-18 (half-life 110 min) at the 6' position to generate 6'-deoxy-6'[18F] fluorosucrose ((FS)-F-18). This radiotracer was then used to compare sucrose transport between wild-type maize plants and mutant plants lacking the Sucrose transporter1 (Sut1) gene, which has been shown to function in sucrose phloem loading. Our results demonstrate that (FS)-F-18 is transported in vivo, with the wild-type plants showing a greater rate of transport down the leaf blade than the sut1 mutant plants. A similar transport pattern was also observed for universally labeled [U-C-14] sucrose ([U-C-14] suc). Our findings support the proposed sucrose phloem loading function of the Sut1 gene in maize, and additionally demonstrate that the (FS)-F-18 analog is a valuable, new tool that offers imaging advantages over [U-C-14] suc for studying phloem transport in plants.	[Rotsch, David; Brossard, Tom; Ying, Weijiang; Gaddam, Vikram; Harmata, Michael; Robertson, J. David; Jurisson, Silvia S.] Univ Missouri, Dept Chem, Columbia, MO 65211 USA; [Bihmidine, Saadia; Swyers, Michael; Braun, David M.] Univ Missouri, Div Biol Sci, Interdisciplinary Plant Grp, Columbia, MO 65211 USA; [Bihmidine, Saadia; Swyers, Michael; Braun, David M.] Univ Missouri, Missouri Maize Ctr, Columbia, MO 65211 USA; [Robertson, J. David] Univ Missouri, Univ Missouri Res Reactor, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Braun, DM (corresponding author), Univ Missouri, Div Biol Sci, Interdisciplinary Plant Grp, Columbia, MO 65211 USA.	braundm@missouri.edu		Robertson, John/0000-0002-6675-8469	U.S. Department of Energy [DE-SC0002040, DE-SC0006810]; U.S. National Science Foundation [IOS-1025976, IIA-1430428]; Direct For Biological Sciences [1025976] Funding Source: National Science Foundation	U.S. Department of Energy(United States Department of Energy (DOE)); U.S. National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by grants from the U.S. Department of Energy (DE-SC0002040 to SJ, and DE-SC0006810 to DMB) and the U.S. National Science Foundation (IOS-1025976 to DMB, and IIA-1430428 to SJ and DMB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth EA, 2011, PLANT PHYSIOL, V155, P64, DOI 10.1104/pp.110.167684; Alauddin MM, 2012, AM J NUCL MED MOLEC, V2, P55; Alauddin MM, 2002, J LABELLED COMPD RAD, V45, P583, DOI 10.1002/jlcr.549; Alauddin MM, 2002, SYNTHETIC COMMUN, V32, P1757, DOI 10.1081/SCC-120004272; Anderson H, 2010, NUCL MED BIOL, V37, P439, DOI 10.1016/j.nucmedbio.2010.01.003; Aoki N, 1999, PLANT CELL PHYSIOL, V40, P1072, DOI 10.1093/oxfordjournals.pcp.a029489; Aoki N, 2003, PLANT CELL PHYSIOL, V44, P223, DOI 10.1093/pcp/pcg030; Ayre BG, 2011, MOL PLANT, V4, P377, DOI 10.1093/mp/ssr014; Babst BA, 2013, PLANT CELL PHYSIOL, V54, P1016, DOI 10.1093/pcp/pct045; Baker RF, 2007, PLANT PHYSIOL, V144, P867, DOI 10.1104/pp.107.098814; Baker RF, 2012, MOL PLANT, V5, P766, DOI 10.1093/mp/sss054; Berjak P, 2013, FRONT PLANT SCI, V4, DOI [10.3389/fpls.2013.00177, 10.3389/fpls.2013.00478]; BINDER TP, 1986, CARBOHYD RES, V147, P149, DOI 10.1016/0008-6215(86)85014-5; Braun DM, 2014, J EXP BOT, V65, P1713, DOI 10.1093/jxb/ert416; Braun DM, 2012, SCIENCE, V335, P173, DOI 10.1126/science.1216828; Braun DM, 2009, PLANT PHYSIOL, V149, P71, DOI 10.1104/pp.108.129049; Burkle L, 1998, PLANT PHYSIOL, V118, P59, DOI 10.1104/pp.118.1.59; CALVIN M, 1948, SCIENCE, V107, P476, DOI 10.1126/science.107.2784.476; CARD PJ, 1984, J AM CHEM SOC, V106, P5348, DOI 10.1021/ja00330a051; CARD PJ, 1986, J AM CHEM SOC, V108, P158, DOI 10.1021/ja00261a025; Carpaneto A, 2005, J BIOL CHEM, V280, P21437, DOI 10.1074/jbc.M501785200; Chandran D, 2003, J BIOL CHEM, V278, P44320, DOI 10.1074/jbc.M308490200; Chen LQ, 2012, SCIENCE, V335, P207, DOI 10.1126/science.1213351; Chin FT, 2008, MOL IMAGING BIOL, V10, P82, DOI 10.1007/s11307-007-0122-3; EKLUND SH, 1988, CARBOHYD RES, V177, P253, DOI 10.1016/0008-6215(88)85061-4; Fatangare A, 2014, NUCL MED BIOL, V41, P737, DOI 10.1016/j.nucmedbio.2014.05.143; Ferrieri AP, 2013, PLANT PHYSIOL, V161, P692, DOI 10.1104/pp.112.208868; Ferrieri AP, 2012, NUCL MED BIOL, V39, P1152, DOI 10.1016/j.nucmedbio.2012.06.005; Ferrieri RA, 2005, PLANT CELL ENVIRON, V28, P591, DOI 10.1111/j.1365-3040.2004.01303.x; FRITZ E, 1983, PLANTA, V159, P193, DOI 10.1007/BF00397525; Gaddam V, 2013, CARBOHYD RES, V369, P38, DOI 10.1016/j.carres.2012.12.001; Gao XF, 2014, CARBOHYD RES, V400, P14, DOI 10.1016/j.carres.2014.08.015; Gifford AN, 2012, J LABELLED COMPD RAD, V55, P441, DOI 10.1002/jlcr.2969; GOLDBERG RN, 1989, J BIOL CHEM, V264, P9901; Gomez S, 2012, ENTOMOL EXP APPL, V144, P101, DOI 10.1111/j.1570-7458.2012.01268.x; Goodman MM, 1997, J NUCL MED, V38, P119; Goodman MM, 2000, NUCL MED BIOL, V27, P1, DOI 10.1016/S0969-8051(99)00080-3; Gottwald JR, 2000, P NATL ACAD SCI USA, V97, P13979, DOI 10.1073/pnas.250473797; Hanik N, 2010, J CHEM ECOL, V36, P1058, DOI 10.1007/s10886-010-9835-x; Hare PD, 1998, PLANT CELL ENVIRON, V21, P535, DOI 10.1046/j.1365-3040.1998.00309.x; Hattori E, 2008, PLANTA, V227, P1181, DOI 10.1007/s00425-008-0701-9; Hirose T, 2010, J EXP BOT, V61, P3639, DOI 10.1093/jxb/erq175; HITZ WD, 1988, ACS SYM SER, V374, P138; HITZ WD, 1986, J BIOL CHEM, V261, P1986; HITZ WD, 1985, PLANT PHYSIOL, V77, P291, DOI 10.1104/pp.77.2.291; HOFSTRA G, 1969, CAN J BOTANY, V47, P1435, DOI 10.1139/b69-205; Horst RJ, 2008, J PLANT PHYSIOL, V165, P19, DOI 10.1016/j.jplph.2007.05.008; Kim D, 2014, APPL RADIAT ISOTOPES, V94, P338, DOI 10.1016/j.apradiso.2014.09.008; Kiser MR, 2008, HFSP J, V2, P189, DOI 10.2976/1.2921207; Kronzucker HJ, 1998, PLANT PHYSIOL, V116, P581, DOI 10.1104/pp.116.2.581; Kuhn C, 2010, CURR OPIN PLANT BIOL, V13, P287, DOI 10.1016/j.pbi.2010.02.001; Kuhn C, 1996, PLANT CELL ENVIRON, V19, P1115, DOI 10.1111/j.1365-3040.1996.tb00426.x; Lalonde S, 2004, ANNU REV PLANT BIOL, V55, P341, DOI 10.1146/annurev.arplant.55.031903.141758; Lappchen T, 2012, APPL RADIAT ISOTOPES, V70, P205, DOI 10.1016/j.apradiso.2011.09.005; Lee S, 2013, NORTHEAST ASIAN PERSPECTIVES ON INTERNATIONAL LAW: CONTEMPORARY ISSUES AND CHALLENGES, P1; Lemoine R, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00272; Li ZB, 2010, ADV DRUG DELIVER REV, V62, P1031, DOI 10.1016/j.addr.2010.09.007; Ma Y, 2008, PLANTA, V227, P527, DOI 10.1007/s00425-007-0636-6; Mangner TJ, 2003, NUCL MED BIOL, V30, P215, DOI 10.1016/S0969-8051(02)00445-6; MARGOLIS HA, 1991, CAN J BOT, V69, P1225, DOI 10.1139/b91-157; Mason MG, 2014, P NATL ACAD SCI USA, V111, P6092, DOI 10.1073/pnas.1322045111; Matsuhashi S, 2006, APPL RADIAT ISOTOPES, V64, P435, DOI 10.1016/j.apradiso.2005.08.020; Nakanishi TM, 2001, J RADIOANAL NUCL CH, V249, P503; PADGETT HC, 1989, APPL RADIAT ISOTOPES, V40, P433, DOI 10.1016/0883-2889(89)90213-X; Paolillo V, 2009, J LABELLED COMPD RAD, V52, P553, DOI 10.1002/jlcr.1674; Peng D, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00615; Rae AL, 2005, PLANTA, V220, P817, DOI 10.1007/s00425-004-1399-y; Reinders A, 2006, PLANT CELL ENVIRON, V29, P1871, DOI 10.1111/j.1365-3040.2006.01563.x; Reinders A, 2012, J BIOL CHEM, V287, P30296, DOI 10.1074/jbc.M112.372888; Reinders A, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00022; RIESMEIER JW, 1994, EMBO J, V13, P1; ROBINSONBEERS K, 1990, BOT ACTA, V103, P424, DOI 10.1111/j.1438-8677.1990.tb00184.x; Sauer N, 2007, FEBS LETT, V581, P2309, DOI 10.1016/j.febslet.2007.03.048; SIMIAND C, 1995, J CARBOHYD CHEM, V14, P977, DOI 10.1080/07328309508005389; Slewinski TL, 2012, PLANT PHYSIOL, V160, P1540, DOI 10.1104/pp.112.202473; Slewinski TL, 2010, PLANT SIGNAL BEHAV, V5, P687, DOI 10.4161/psb.5.6.11575; Slewinski TL, 2010, GENETICS, V185, P221, DOI 10.1534/genetics.109.113357; Slewinski TL, 2010, PLANT SCI, V178, P341, DOI 10.1016/j.plantsci.2010.01.010; Slewinski TL, 2009, J EXP BOT, V60, P881, DOI 10.1093/jxb/ern335; Sowinski P, 1999, ACTA PHYSIOL PLANT, V21, P75, DOI 10.1007/s11738-999-0030-z; Srivastava AC, 2008, PLANT PHYSIOL, V148, P200, DOI 10.1104/pp.108.124776; Srivastava AC, 2009, ANN BOT-LONDON, V104, P1121, DOI 10.1093/aob/mcp215; Tanoi K, 2005, J RADIOANAL NUCL CH, V263, P547; Thorpe MR, 2007, PLANTA, V226, P541, DOI 10.1007/s00425-007-0503-5; Torres A. P., 1994, Journal of Food Process Engineering, V17, P191, DOI 10.1111/j.1745-4530.1994.tb00335.x; TURGEON R, 1988, PLANT PHYSIOL, V87, P179, DOI 10.1104/pp.87.1.179; Turkman N, 2010, J LABELLED COMPD RAD, V53, P782, DOI 10.1002/jlcr.1797; VANBEL AJE, 1993, ANNU REV PLANT PHYS, V44, P253, DOI 10.1146/annurev.pp.44.060193.001345; Wahid A, 2007, ENVIRON EXP BOT, V61, P199, DOI 10.1016/j.envexpbot.2007.05.011; Wang Q, 2014, PHYS MED BIOL, V59, P5613, DOI 10.1088/0031-9155/59/19/5613; WARDLAW IF, 1990, NEW PHYTOL, V116, P341, DOI 10.1111/j.1469-8137.1990.tb00524.x; Ying WJ, 2013, ORG LETT, V15, P2723, DOI 10.1021/ol401044h; ZIKOPOULOS JN, 1982, CARBOHYD RES, V104, P245, DOI 10.1016/S0008-6215(00)82586-0	93	11	11	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128989	10.1371/journal.pone.0128989	http://dx.doi.org/10.1371/journal.pone.0128989			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024520	Green Published, gold, Green Submitted			2022-12-26	WOS:000355319400105
J	El-Tarabany, MS; El-Bayomi, K; Abdelhamid, T				El-Tarabany, Mahmoud Salah; El-Bayomi, Khairy; Abdelhamid, Tamer			Semen Characteristics of Purebred and Crossbred Male Rabbits	PLOS ONE			English	Article							ARTIFICIAL-INSEMINATION; DAMASCUS GOATS; SPERM OUTPUT; SAUDI ARADI; GROWTH-RATE; TRAITS; HETEROSIS; VARIABILITY; FERTILITY; QUALITY	The aim of this investigation was to evaluate the semen quality traits of purebred male rabbits and their crosses under subtropical Egyptian conditions. A full 3 x 3 diallel crossing was performed for producing the first generation progeny of New Zealand White (N), Flander (F) and Rex (R) breeds. The highest ejaculate volume (p<0.05) and percentage of live sperms (p<0.01) with the lowest percentage of sperm cell morphological abnormalities (p<0.05) had been recorded in the NF bucks. Moreover, they possessed positive estimates of direct heterosis for ejaculate volume, mass motility (Mm), individual motility (Im) and sperm cell concentration (SCC). On the contrary, pH had negative estimates of direct heterosis in all crosses and their reciprocal. Semen pH was negatively correlated with SCC (r = -0.18), Mm (r = -0.13) and Im (r = -0.23). In conclusion, the superiority of crossbreeding was particularly obvious in the New Zealand White x Flander males, which cumulated heterosis and favorable maternal effects of the Flander dams.	[El-Tarabany, Mahmoud Salah; El-Bayomi, Khairy; Abdelhamid, Tamer] Zagazig Univ, Anim Wealth Dev Dept, Sharkia, Egypt	Egyptian Knowledge Bank (EKB); Zagazig University	El-Tarabany, MS (corresponding author), Zagazig Univ, Anim Wealth Dev Dept, Sharkia, Egypt.	mahmoudtarabany2887@yahoo.com		El-Tarabany, Mahmoud/0000-0002-9354-2209				Ain-Baziz H, 2012, P 10 WORLD RABB C 3, VA, P347; ALSOBAYIL K, 2002, P 3 SCI C RABB PROD, P151; Alvarino J., 2000, P 7 WORLD RABB C VAL, V8, P13; ARROITA Z, 2000, P 7 WORLD RABB C 4 7, P81; BAMBA K, 1988, THERIOGENOLOGY, V29, P1245, DOI 10.1016/0093-691X(88)90004-0; BENCHEIKH N, 1995, ANN ZOOTECH, V44, P263, DOI 10.1051/animres:19950306; Brun JM, 2002, ANIM REPROD SCI, V70, P139, DOI 10.1016/S0378-4320(01)00197-X; Brun JM, 2002, ANIM RES, V51, P433, DOI 10.1051/animres:2002030; Coffey D.S., 1988, P1081; Dickerson GE., 1969, ANIM BREED ABSTR, V37, P191; DUCROCQ V, 1995, LIVEST PROD SCI, V41, P1, DOI 10.1016/0301-6226(94)00029-7; El-Bayomi KM, 1992, ZAG VET J, V20, P420; ELEZZ ZRA, 1985, BEILTRGE TROPISCHEN, V23, P249; Garcia-Tomas M, 2006, ANIM REPROD SCI, V93, P88, DOI 10.1016/j.anireprosci.2005.06.011; Garcia-Tomas M, 2006, LIVEST SCI, V100, P111, DOI 10.1016/j.livprodsci.2005.08.004; Goericke-Pesch S, 2015, ANIM REPROD SCI, V152, P83, DOI 10.1016/j.anireprosci.2014.11.002; Hagen D. R., 2002, World Rabbit Science, V10, P135; Khalil MH, 2007, ANIMAL, V1, P923, DOI 10.1017/S1751731107000341; Khalil MH, 2010, SMALL RUMINANT RES, V94, P10, DOI 10.1016/j.smallrumres.2010.05.020; Klein M, 1963, PHYSIOLOGIE, P697; Lavara R, 2011, J ANIM BREED GENET, V128, P44, DOI 10.1111/j.1439-0388.2010.00889.x; MINELLI G, 1999, WORLD RABBIT SCI, V7, P31; Mohammed KM, 2013, SMALL RUMINANT RES, V112, P7, DOI 10.1016/j.smallrumres.2012.10.001; More O'Ferral GJ, 1968, P 6 INT C REPR AN AR, V2, P1279; MORRELL JM, 1995, BRIT VET J, V151, P477, DOI 10.1016/S0007-1935(05)80022-3; Oseni SO, 2014, WORLD RABBIT SCI, V22, P147, DOI 10.4995/wrs.2014.1348; Petitjean M, 1965, MEMOIREE ETUDES INGE, P85; Piles M, 2013, WORLD RABBIT SCI, V21, P61, DOI 10.4995/wrs.2013.1240; Pirchner F., 1983, POPULATION GENETICS, V2nd, P414; RAMAMURTHY N, 1989, INDIAN VET J, V66, P584; Rodriguez-De Lara R, 2015, ANIM REPROD SCI, V152, P90, DOI 10.1016/j.anireprosci.2014.11.005; Ruiz-Sanchez AL, 2006, THERIOGENOLOGY, V66, P736, DOI 10.1016/j.theriogenology.2005.12.012; SAS Institute Inc, 2003, SAS STAT US GUID; Schlolaut W., 1992, 5 C WORLD RABB SCI A, VA, P594; Sharaf MM, 1992, ZAG VET J, V20, P471; Shrestha JNB, 2007, SMALL RUMINANT RES, V67, P93, DOI 10.1016/j.smallrumres.2005.10.018; Smital J, 2004, ANIM REPROD SCI, V80, P121, DOI 10.1016/S0378-4320(03)00142-8; SMITH JT, 1955, FERTIL STERIL, V6, P271; Tusell L, 2012, J ANIM SCI, V90, P1385, DOI 10.2527/jas.2011-4165; VENGE O., 1951, Acta Agriculturae Scandinavica, V1, P291; Wierzbicki Heliodor, 2010, Medycyna Weterynaryjna, V66, P765; WILLIAMS J, 1990, FUND APPL TOXICOL, V15, P651, DOI 10.1016/0272-0590(90)90182-J; Wysokinska A, 2013, ARCH TIERZUCHT, V56, P65, DOI 10.7482/0003-9438-56-007	43	6	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128435	10.1371/journal.pone.0128435	http://dx.doi.org/10.1371/journal.pone.0128435			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020961	gold, Green Published, Green Submitted			2022-12-26	WOS:000355187300111
J	Grosse-Wilde, A; d'Herouel, AF; McIntosh, E; Ertaylan, G; Skupin, A; Kuestner, RE; del Sol, A; Walters, KA; Huang, S				Grosse-Wilde, Anne; d'Herouel, Aymeric Fouquier; McIntosh, Ellie; Ertaylan, Gokhan; Skupin, Alexander; Kuestner, Rolf E.; del Sol, Antonio; Walters, Kathie-Anne; Huang, Sui			Stemness of the hybrid Epithelial/Mesenchymal State in Breast Cancer and Its Association with Poor Survival	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GENE-EXPRESSION SIGNATURE; IN-VITRO PROPAGATION; TUMOR-CELLS; METASTATIC COLONIZATION; PROGNOSTIC-SIGNIFICANCE; SUBTYPES; DIFFERENTIATION; IDENTIFICATION; PROGENITORS	Breast cancer stem cells (CSCs) are thought to drive recurrence and metastasis. Their identity has been linked to the epithelial to mesenchymal transition (EMT) but remains highly controversial since-depending on the cell-line studied-either epithelial (E) or mesenchymal (M) markers, alone or together have been associated with stemness. Using distinct transcript expression signatures characterizing the three different E, M and hybrid E/M cell-types, our data support a novel model that links a mixed EM signature with stemness in 1) individual cells, 2) luminal and basal cell lines, 3) in vivo xenograft mouse models, and 4) in all breast cancer subtypes. In particular, we found that co-expression of E and M signatures was associated with poorest outcome in luminal and basal breast cancer patients as well as with enrichment for stem-like cells in both E and M breast cell-lines. This link between a mixed EM expression signature and stemness was explained by two findings: first, mixed cultures of E and M cells showed increased cooperation in mammosphere formation (indicative of stemness) compared to the more differentiated E and M cell-types. Second, singlecell qPCR analysis revealed that E and M genes could be co-expressed in the same cell. These hybrid E/M cells were generated by both E or M cells and had a combination of several stem-like traits since they displayed increased plasticity, self-renewal, mammosphere formation, and produced ALDH1+ progenies, while more differentiated M cells showed less plasticity and E cells showed less self-renewal. Thus, the hybrid E/M state reflecting stemness and its promotion by E-M cooperation offers a dual biological rationale for the robust association of the mixed EM signature with poor prognosis, independent of cellular origin. Together, our model explains previous paradoxical findings that breast CSCs appear to be M in luminal cell-lines but E in basal breast cancer cell-lines. Our results suggest that targeting E/M heterogeneity by eliminating hybrid E/M cells and cooperation between E and M cell-types could improve breast cancer patient survival independent of breast cancer-subtype.	[Grosse-Wilde, Anne; d'Herouel, Aymeric Fouquier; McIntosh, Ellie; Skupin, Alexander; Kuestner, Rolf E.; Walters, Kathie-Anne; Huang, Sui] Inst Syst Biol, Seattle, WA 98109 USA; [d'Herouel, Aymeric Fouquier; Ertaylan, Gokhan; Skupin, Alexander; del Sol, Antonio] Luxembourg Ctr Syst Biomed, L-4362 Esch Sur Alzette, Luxembourg	Institute for Systems Biology (ISB); University of Luxembourg	Grosse-Wilde, A (corresponding author), Inst Syst Biol, Seattle, WA 98109 USA.	anne@grwil.de; shuang@systemsbiology.org		Ertaylan, Gokhan/0000-0001-5602-6435; SKUPIN, Alexander/0000-0002-8955-8304	Institute for Systems Biology; University of Luxembourg; NIH Center for Systems Biology [2P50GM075647]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109964] Funding Source: NIH RePORTER	Institute for Systems Biology; University of Luxembourg; NIH Center for Systems Biology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the strategic partnership between the Institute for Systems Biology and the University of Luxembourg, and the NIH Center for Systems Biology/2P50GM075647.	Aceto N, 2014, CELL, V158, P1110, DOI 10.1016/j.cell.2014.07.013; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Azzam DJ, 2013, EMBO MOL MED, V5, P1502, DOI 10.1002/emmm.201302558; Baccelli I, 2013, NAT BIOTECHNOL, V31, P539, DOI 10.1038/nbt.2576; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bhat-Nakshatri P, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-411; Celia-Terrassa T, 2012, J CLIN INVEST, V122, P1849, DOI 10.1172/JCI59218; Chaffer CL, 2011, P NATL ACAD SCI USA, V108, P7950, DOI 10.1073/pnas.1102454108; Chen L, 2012, BIOMATERIALS, V33, P1437, DOI 10.1016/j.biomaterials.2011.10.056; Cleary AS, 2014, NATURE, V508, P113, DOI 10.1038/nature13187; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Granit RZ, 2014, WIRES SYST BIOL MED, V6, P93, DOI 10.1002/wsbm.1252; Grimshaw MJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2106; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; Huang S, 2007, DEV BIOL, V305, P695, DOI 10.1016/j.ydbio.2007.02.036; Jolly MK, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0962; Jones Robin L, 2012, Surg Pathol Clin, V5, P701, DOI 10.1016/j.path.2012.06.008; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Keller PJ, 2012, P NATL ACAD SCI USA, V109, P2772, DOI 10.1073/pnas.1017626108; Kim HJ, 2011, BREAST, V20, P78, DOI 10.1016/j.breast.2010.08.001; Kim J, 2012, P NATL ACAD SCI USA, V109, P6124, DOI 10.1073/pnas.1203203109; Korpal M, 2011, NAT MED, V17, P1101, DOI 10.1038/nm.2401; Li CI, 2009, CANCER RES, V69, P6865, DOI 10.1158/0008-5472.CAN-09-1355; Li QY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-474; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Liu SL, 2014, STEM CELL REP, V2, P78, DOI 10.1016/j.stemcr.2013.11.009; Loboda A, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-9; Lu MY, 2014, CANCER RES, V74, P4574, DOI 10.1158/0008-5472.CAN-13-3367; Lu M, 2013, P NATL ACAD SCI USA, V110, P18144, DOI 10.1073/pnas.1318192110; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marcus JS, 2006, ANAL CHEM, V78, P3084, DOI 10.1021/ac0519460; Medema JP, 2013, NAT CELL BIOL, V15, P338, DOI 10.1038/ncb2717; Mihaly Zsuzsanna, 2013, Microarrays (Basel), V2, P228, DOI 10.3390/microarrays2030228; Molyneux G, 2010, CELL STEM CELL, V7, P403, DOI 10.1016/j.stem.2010.07.010; Montserrat N, 2013, CELL STEM CELL, V13, P341, DOI 10.1016/j.stem.2013.06.019; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Mylona E, 2008, HUM PATHOL, V39, P1096, DOI 10.1016/j.humpath.2007.12.003; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Ocana OH, 2012, CANCER CELL, V22, P709, DOI 10.1016/j.ccr.2012.10.012; Ombrato Luigi, 2014, Critical Reviews in Oncogenesis, V19, P349; Patsialou A, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3344; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ringner M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017911; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Strauss R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016186; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tam WL, 2013, NAT MED, V19, P1438, DOI 10.1038/nm.3336; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tian XJ, 2013, BIOPHYS J, V105, P1079, DOI 10.1016/j.bpj.2013.07.011; Tsai JH, 2012, CANCER CELL, V22, P725, DOI 10.1016/j.ccr.2012.09.022; Tsuji T, 2008, CANCER RES, V68, P10377, DOI 10.1158/0008-5472.CAN-08-1444; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Venet D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002240; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522; Zhang CJ, 2011, J CANCER RES CLIN, V137, P1679, DOI 10.1007/s00432-011-1038-5; Zhang JY, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005304; Zhou JX, 2011, TRENDS GENET, V27, P55, DOI 10.1016/j.tig.2010.11.002	68	218	222	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0126522	10.1371/journal.pone.0126522	http://dx.doi.org/10.1371/journal.pone.0126522			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020648	Green Submitted, gold, Green Published			2022-12-26	WOS:000355187300024
J	Wang, C; Lai, DYF; Tong, C; Wang, WQ; Huang, JF; Zeng, CS				Wang, Chun; Lai, Derrick Y. F.; Tong, Chuan; Wang, Weiqi; Huang, Jiafang; Zeng, Chongsheng			Variations in Temperature Sensitivity (Q(10)) of CH4 Emission from a Subtropical Estuarine Marsh in Southeast China	PLOS ONE			English	Article							CARBON-DIOXIDE FLUX; MIN RIVER ESTUARY; SOIL RESPIRATION; METHANE EMISSIONS; ORGANIC-CARBON; ECOSYSTEM RESPIRATION; VEGETATION ZONES; NITROGEN; WETLANDS; CO2	Understanding the functional relationship between greenhouse gas fluxes and environmental variables is crucial for predicting the impacts of wetlands on future climate change in response to various perturbations. We examined the relationships between methane (CH4) emission and temperature in two marsh stands dominated by the Phragmites australis and Cyperus malaccensis, respectively, in a subtropical estuarine wetland in southeast China based on three years of measurement data (2007-2009). We found that the Q(10) coefficient of CH4 emission to soil temperature (Qs(10)) from the two marsh stands varied slightly over the three years (P > 0.05), with a mean value of 3.38 +/- 0.46 and 3.89 +/- 0.41 for the P. australis and C. malaccensis stands, respectively. On the other hand, the three-year mean Q(a10) values (Q(10) coefficients of CH4 emission to air temperature) were 3.39 +/- 0.59 and 4.68 +/- 1.10 for the P. australis and C. malaccensis stands, respectively, with a significantly higher Q(a10) value for the C. malaccensis stand in 2008 (P < 0.05). The seasonal variations of Q(10) (Q(s10) and Q(a10)) differed among years, with generally higher values in the cold months than those in the warm months in 2007 and 2009. We found that the Q(s10) values of both stands were negatively correlated with soil conductivity, but did not obtain any conclusive results about the difference in Q(10) of CH4 emission between the two tidal stages (before flooding and after ebbing). There were no significant differences in both Q(s10) and Q(a10) values of CH4 emission between the P. australis stand and the C. malaccensis stands (P > 0.05). Our results show that the Q(10) values of CH4 emission in this estuarine marsh are highly variable across space and time. Given that the overall CH4 flux is governed by a suite of environmental factors, the Q(10) values derived from field measurements should only be considered as a semi-empirical parameter for simulating CH4 emissions.	[Wang, Chun; Tong, Chuan; Wang, Weiqi; Huang, Jiafang; Zeng, Chongsheng] Fujian Normal Univ, Key Lab Humid Subtrop Ecogeog Proc, Minist Educ, Fuzhou, Peoples R China; [Wang, Chun] Fujian Normal Univ, Sch Geog Sci, Fuzhou, Peoples R China; [Lai, Derrick Y. F.] Chinese Univ Hong Kong, Dept Geog & Resource Management, Shatin, Hong Kong, Peoples R China; [Lai, Derrick Y. F.] Chinese Univ Hong Kong, Ctr Environm Policy & Resource Management, Shatin, Hong Kong, Peoples R China; [Tong, Chuan; Wang, Weiqi; Huang, Jiafang; Zeng, Chongsheng] Fujian Normal Univ, Inst Geog, Fuzhou, Peoples R China	Fujian Normal University; Fujian Normal University; Chinese University of Hong Kong; Chinese University of Hong Kong; Fujian Normal University	Tong, C (corresponding author), Fujian Normal Univ, Key Lab Humid Subtrop Ecogeog Proc, Minist Educ, Fuzhou, Peoples R China.	tongch@fjnu.edu.cn	Lai, Derrick Y.F./B-1387-2009; Wang, weiqi/AAN-8209-2020	Lai, Derrick Y.F./0000-0002-1225-9904; wang, weiqi/0000-0001-8503-0978	National Science Foundation of China [40671174, 41071148]; Program for Innovative Research Team in Fujian Normal University [IRTL1205]; Research Grants Council of the Hong Kong Special Administrative Region, China [CUHK458913]; Chinese University of Hong Kong [SS12434]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Innovative Research Team in Fujian Normal University; Research Grants Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council); Chinese University of Hong Kong(Chinese University of Hong Kong)	This work was financially supported by the National Science Foundation of China (Grant No: 40671174 and 41071148), the Program for Innovative Research Team in Fujian Normal University IRTL1205), Research Grants Council of the Hong Kong Special Administrative Region, China (CUHK458913), and The Chinese University of Hong Kong (SS12434). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews JA, 2000, SOIL BIOL BIOCHEM, V32, P699, DOI 10.1016/S0038-0717(99)00206-0; Arkebauer TJ, 2001, AM J BOT, V88, P653, DOI 10.2307/2657065; Bai JH, 2005, GEODERMA, V124, P181, DOI 10.1016/j.geoderma.2004.04.012; Bergman I, 1998, SOIL BIOL BIOCHEM, V30, P729, DOI 10.1016/S0038-0717(97)00181-8; Biswas H, 2007, J MARINE SYST, V68, P55, DOI 10.1016/j.jmarsys.2006.11.001; Chambers LG, 2013, BIOGEOCHEMISTRY, V115, P363, DOI 10.1007/s10533-013-9841-5; Chang TC, 2003, ATMOS ENVIRON, V37, P4551, DOI 10.1016/S1352-2310(03)00588-0; Chen BY, 2010, SOIL BIOL BIOCHEM, V42, P1735, DOI 10.1016/j.soilbio.2010.06.010; Chen H, 2005, J INTEGR PLANT BIOL, V47, P1288, DOI 10.1111/j.1744-7909.2005.00211.x; Conant RT, 2011, GLOBAL CHANGE BIOL, V17, P3392, DOI 10.1111/j.1365-2486.2011.02496.x; Crill PM, 1988, GLOBAL BIOGEOCHEM CY, V2, P371, DOI 10.1029/GB002i004p00371; Cusack DF, 2010, GLOBAL CHANGE BIOL, V16, P2555, DOI 10.1111/j.1365-2486.2009.02131.x; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; DISE NB, 1993, J GEOPHYS RES-ATMOS, V98, P10583, DOI 10.1029/93JD00160; Drewitt GB, 2002, AGR FOREST METEOROL, V110, P299, DOI 10.1016/S0168-1923(01)00294-5; Duan Xiao-nan, 2007, Huanjing Kexue, V28, P455; DUNFIELD P, 1993, SOIL BIOL BIOCHEM, V25, P321, DOI 10.1016/0038-0717(93)90130-4; Gunther A, 2014, ENVIRON MONIT ASSESS, V186, P2151, DOI 10.1007/s10661-013-3524-5; HARRISS RC, 1982, NATURE, V297, P673, DOI 10.1038/297673a0; Hirota M, 2004, SOIL BIOL BIOCHEM, V36, P737, DOI 10.1016/j.soilbio.2003.12.009; Inglett KS, 2012, BIOGEOCHEMISTRY, V108, P77, DOI 10.1007/s10533-011-9573-3; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; Janssens IA, 2003, GLOBAL CHANGE BIOL, V9, P911, DOI 10.1046/j.1365-2486.2003.00636.x; Koch O, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2007GB002983; Lai DYF, 2014, ATMOS ENVIRON, V89, P249, DOI 10.1016/j.atmosenv.2014.02.034; Luo YQ, 2001, NATURE, V413, P622, DOI 10.1038/35098065; Ma AN, 2012, J COASTAL RES, V28, P1319, DOI 10.2112/JCOASTRES-D-11-00001.1; Macdonald JA, 1998, ATMOS ENVIRON, V32, P3219, DOI 10.1016/S1352-2310(97)00464-0; Magenheimer JF, 1996, ESTUARIES, V19, P139, DOI 10.2307/1352658; Mahecha MD, 2010, SCIENCE, V329, P838, DOI 10.1126/science.1189587; Miller RL, 2011, WETLANDS, V31, P1055, DOI 10.1007/s13157-011-0215-2; Min K, 2014, SOIL BIOL BIOCHEM, V76, P193, DOI 10.1016/j.soilbio.2014.05.021; Moore TR, 2011, ECOSYSTEMS, V14, P646, DOI 10.1007/s10021-011-9435-9; MOORE TR, 1990, BIOGEOCHEMISTRY, V11, P45; Neubauer SC, 2013, ESTUAR COAST, V36, P491, DOI 10.1007/s12237-011-9455-x; Olefeldt D, 2013, GLOBAL CHANGE BIOL, V19, P589, DOI 10.1111/gcb.12071; RAICH JW, 1992, TELLUS B, V44, P81, DOI 10.1034/j.1600-0889.1992.t01-1-00001.x; Rask H, 2002, SOIL BIOL BIOCHEM, V34, P435, DOI 10.1016/S0038-0717(01)00197-3; ROULET NT, 1992, J GEOPHYS RES-ATMOS, V97, P3739, DOI 10.1029/91JD03109; SANSONE FJ, 1981, SCIENCE, V211, P707, DOI 10.1126/science.211.4483.707; Schipper LA, 2014, GLOBAL CHANGE BIOL, V20, P3578, DOI 10.1111/gcb.12596; SCHUTZ H, 1990, BIOGEOCHEMISTRY, V11, P77; Segers R, 1998, BIOGEOCHEMISTRY, V41, P23, DOI 10.1023/A:1005929032764; Shangguan XJ, 1994, J GRADUATE SCH ACAD, V11, P214; Smith P, 2007, AR4 CLIMATE CHANGE 2007: MITIGATION OF CLIMATE CHANGE, P497; Song Chang-chun, 2006, Huanjing Kexue, V27, P2369; Song CC, 2009, GLOBAL CHANGE BIOL, V15, P692, DOI 10.1111/j.1365-2486.2008.01821.x; Sun ZG, 2013, PLANT SOIL, V369, P317, DOI 10.1007/s11104-012-1564-1; Tong C, 2014, WETLANDS, V34, P225, DOI 10.1007/s13157-013-0478-x; Tong C, 2012, BIOGEOCHEMISTRY, V111, P677, DOI 10.1007/s10533-012-9712-5; Tong C, 2010, J ENVIRON SCI HEAL A, V45, P506, DOI 10.1080/10934520903542261; Treat CC, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2006JG000210; UPDEGRAFF K, 1995, ECOL APPL, V5, P151, DOI 10.2307/1942060; VALENTINE DW, 1994, J GEOPHYS RES-ATMOS, V99, P1563, DOI 10.1029/93JD00391; Van der Nat FJ, 2000, BIOGEOCHEMISTRY, V49, P103, DOI 10.1023/A:1006333225100; van Winden JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039614; Verville JH, 1998, BIOGEOCHEMISTRY, V41, P215, DOI 10.1023/A:1005984701775; Wallenstein MD, 2009, GLOBAL CHANGE BIOL, V15, P1631, DOI 10.1111/j.1365-2486.2008.01819.x; Wang CK, 2006, GLOBAL CHANGE BIOL, V12, P2103, DOI 10.1111/j.1365-2486.2006.01234.x; WESTERMANN P, 1989, APPL ENVIRON MICROB, V55, P1262, DOI 10.1128/AEM.55.5.1262-1266.1989; Zheng ZM, 2009, SOIL BIOL BIOCHEM, V41, P1531, DOI 10.1016/j.soilbio.2009.04.013	61	18	19	2	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0125227	10.1371/journal.pone.0125227	http://dx.doi.org/10.1371/journal.pone.0125227			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020528	Green Published, gold, Green Submitted			2022-12-26	WOS:000355187300011
J	Arriaza, MC; Dominguez-Rodrigo, M; Martinez-Maza, C; Mabulla, A; Baquedano, E				Carmen Arriaza, Mari; Dominguez-Rodrigo, Manuel; Martinez-Maza, Cayetana; Mabulla, Audax; Baquedano, Enrique			Differential Predation by Age and Sex Classes in Blue Wildebeest in Serengeti: Study of a Modern Carnivore Den in Olduvai Gorge (Tanzania)	PLOS ONE			English	Article							POPULATION-DYNAMICS; PREY; CONSEQUENCES; PATTERNS; BEHAVIOR; SEASON; LION	Age and sex selection of prey is an aspect of predator ecology which has been extensively studied in both temperate and African ecosystems. This dimension, along with fecundity, survival rates of prey and mortality factors other than predation are important in laying down the population dynamics of prey and have important implications in the management of species. A carnivore den located in the short-grassland ecological unit of the Serengeti was studied. Sex-and age-class (using five age categories) of the wildebeest remains recovered were analyzed through horn morphology, biometrics of the bones and tooth wear patterns. We compared our results with previous studies from lion and hyaena kills through multivariate analyses. Seasonality of the accumulation was analyzed through tooth histology. PCA and CVA results show that age class selection by predators depends on season, habitat-type, and growth rate of the wildebeest population. Female-biased predation was found to contradict classical hypotheses based on territorial male behaviour. The lion and spotted hyaena showed strong selection on age classes, contrary to previous studies. Migratory wildebeest sex ratio is regulated through differential predation by seasons and female deaths in the wet season are a trade-off for population stability. These data are crucial for an effective management of the species and the new method created may be useful for different carnivore species and their prey.	[Carmen Arriaza, Mari] Univ Alcala De Henares, Dept Geol Geog & Med Ambiente, Madrid 28871, Spain; [Carmen Arriaza, Mari; Dominguez-Rodrigo, Manuel; Baquedano, Enrique] Inst Evoluc Africa IDEA, Madrid, Spain; [Dominguez-Rodrigo, Manuel] Univ Complutense, Dept Prehist, E-28040 Madrid, Spain; [Martinez-Maza, Cayetana] CSIC, Museo Nacl Ciencias Nat, Dept Paleobiol, E-28006 Madrid, Spain; [Mabulla, Audax] Univ Dar Es Salaam, Dept Archaeol, Dar Es Salaam, Tanzania; [Baquedano, Enrique] Museo Arqueol Reg Comunidad Madrid, Madrid, Spain	Universidad de Alcala; Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); University of Dar es Salaam	Arriaza, MC (corresponding author), Univ Alcala De Henares, Dept Geol Geog & Med Ambiente, Edificio Ciencia,Campus ExternoCtra A-2 Km 33 600, Madrid 28871, Spain.	mcarmen.arriaza@uah.es	Mabulla, Audax ZP/ABE-2455-2020; Baquedano, Enrique/ABE-9997-2020; del Carmen Arriaza Dorado, María/AAB-3468-2021	del Carmen Arriaza Dorado, María/0000-0003-1393-4323	Spanish Ministry of Science and Innovation through the European project I + D [HAR2013-45246-C3-1P]; Spanish Ministry of Culture through the Heritage Institute; Program of Funding for Archaeological Projects Abroad; JAE-DOC postdoctoral contract (CSIC); European Social Fund; Comunidad de Madrid through the I + D project [S2010/BMD-2330]	Spanish Ministry of Science and Innovation through the European project I + D(Ministry of Science and Innovation, Spain (MICINN)); Spanish Ministry of Culture through the Heritage Institute(Spanish Government); Program of Funding for Archaeological Projects Abroad; JAE-DOC postdoctoral contract (CSIC); European Social Fund(European Social Fund (ESF)); Comunidad de Madrid through the I + D project(Comunidad de Madrid)	The authors greatly appreciate the major funding provided by the Spanish Ministry of Science and Innovation through the European project I + D HAR2013-45246-C3-1P and the Spanish Ministry of Culture through the Heritage Institute and the Program of Funding for Archaeological Projects Abroad. CMM was supported by a JAE-DOC postdoctoral contract (CSIC) co-funded by the European Social Fund. The authors also thank the Comunidad de Madrid for funding provided through the I + D project S2010/BMD-2330 (I+D activities programme for research groups of the Consejeria de Educacion). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arceredillo D, 2011, J ARCHAEOL SCI, V38, P2450, DOI 10.1016/j.jas.2011.05.013; ATTWELL CAM, 1980, S AFR J ZOOL, V15, P121; Boukal DS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002687; Bunn HT, 2010, QUATERNARY RES, V74, P395, DOI 10.1016/j.yqres.2010.07.012; CASWELL H, 1986, AM NAT, V128, P707, DOI 10.1086/284598; Creel S., 2002, AFRICAN WILD DOG BEH; Davidson Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055182; Dennis B., 1989, Natural Resource Modeling, V3, P481; DOEBELI M, 1994, P ROY SOC B-BIOL SCI, V257, P17, DOI 10.1098/rspb.1994.0088; Dominguez-Rodrigo M, 2007, DECONSTRUCTING OLDUV; Dominguez-Rodrigo M, 2012, ARCHAEOL ANTHROP SCI, V4, P47, DOI 10.1007/s12520-011-0082-z; ELLIOTT JP, 1978, CAN J ZOOL, V56, P1726, DOI 10.1139/z78-237; ESTES R D, 1976, East African Wildlife Journal, V14, P135; ESTES RD, 1966, NATURE, V212, P999, DOI 10.1038/212999a0; ESTES RD, 1991, BEHAV GUIDE AFRICAN; Fryxell John M., 1995, P257; GINSBERG JR, 1994, CONSERV BIOL, V8, P157, DOI 10.1046/j.1523-1739.1994.08010157.x; Hay R.L., 1976, GEOLOGY OLDUVAI GORG; Hopcraft JGC., 2010, ECOLOGICAL IMPLICATI; Jarman P. J., 1979, SERENGETI DYNAMICS E, P185; Kingdom J, 1982, E AFRICAN MAMMALS AT; Klevezal G., 1996, RECORDING STRUCTURES; KLEVEZAL GA, 1987, ACTA THERIOL, V32, P115, DOI 10.4098/AT.arch.87-10; Kruuk H., 1972, SPOTTED HYENA STUDY; Lehmann MB, 2008, S AFR J WILDL RES, V38, P66, DOI 10.3957/0379-4369-38.1.66; Lindstrom J, 1998, P ROY SOC B-BIOL SCI, V265, P483, DOI 10.1098/rspb.1998.0320; McCarthy MA, 1997, ECOL MODEL, V103, P99, DOI 10.1016/S0304-3800(97)00104-X; Mduma SAR, 1999, J ANIM ECOL, V68, P1101, DOI 10.1046/j.1365-2656.1999.00352.x; Mduma SAR, 1996, THESIS U BRIT COLUMB; MILLS MGL, 1992, J ANIM ECOL, V61, P693, DOI 10.2307/5624; Mills MGL, 1990, KALAHARY HYAENAS; Mysterud A, 2002, J ANIM ECOL, V71, P907, DOI 10.1046/j.1365-2656.2002.00655.x; Ndibalema VG, 2009, AFR J ECOL, V47, P574, DOI 10.1111/j.1365-2028.2008.00994.x; Ndibalema VG, 2007, THESIS U SCI TECHNOL; Owen-Smith N, 2008, OIKOS, V117, P602, DOI 10.1111/j.0030-1299.2008.16309.x; Pienaar U. de V., 1969, Koedoe, VNo. 12, P108; Radloff FGT, 2004, J ANIM ECOL, V73, P410, DOI 10.1111/j.0021-8790.2004.00817.x; Rankin DJ, 2007, OIKOS, V116, P335, DOI [10.1111/j.2006.0030-1299.15451.x, 10.1111/j.0030-1299.2007.15451.x]; Schaller G. B., 1972, SERENGETI LION STUDY; Sinclair A.R.E., 1977, AFRICAN BUFFALO STUD; SINCLAIR ARE, 1977, NATURE, V267, P832, DOI 10.1038/267832a0; Sinclair ARE, 2003, NATURE, V425, P288, DOI 10.1038/nature01934; SINCLAIR ARE, 1995, ECOLOGY, V76, P882, DOI 10.2307/1939353; Stephens PA, 1999, OIKOS, V87, P185, DOI 10.2307/3547011; Stiner M.C., 1994, HONOR THIEVES ZOOARC; STINER MC, 1990, J ANTHROPOL ARCHAEOL, V9, P305, DOI 10.1016/0278-4165(90)90010-B; Talbot LM., 1963, E AFRICA, P3; von den Driesch A, 1972, OSTEOARCHAOLOGISCHE, V3; Watson R.M., 1967, THESIS CAMBRIDGE U; Wilson B, 1982, OXFORD BAR BRIT SERI, V109; Yravedra J, 2009, J QUATERNARY SCI, V24, P85, DOI 10.1002/jqs.1164	51	7	7	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0125944	10.1371/journal.pone.0125944	http://dx.doi.org/10.1371/journal.pone.0125944			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26017363	Green Published, gold, Green Submitted			2022-12-26	WOS:000355185600044
J	Lu, GW; Zhang, JL; Zhang, CT; Li, XL; Shi, DW; Yang, ZP; Wang, CM				Lu, Guangwu; Zhang, Jilei; Zhang, Chuntao; Li, Xiaolu; Shi, Dawei; Yang, Zhaopeng; Wang, Chengming			One-Step Reverse-Transcription FRET-PCR for Differential Detection of Five Ebolavirus Species	PLOS ONE			English	Article							HEMORRHAGIC-FEVER; VIRUS; FILOVIRUSES; STRAIN; ZAIRE; ASSAY; PANEL	Ebola is an emerging infectious disease caused by a deadly virus belonging to the family Filoviridae, genus Ebolavirus. Based on their geographical distribution, Ebolavirus has been classified into total five species so far, mainly Zaire, Sudan, Tai Forest, Bundibugyo and Reston. It is important to be able to differentiate the Ebolavirus species as they significantly differ in pathogenicity and more than one species can be present in an area. We have developed a one-step step-down RT-PCR detecting all five Ebolavirus species with high sensitivity (1 copy of Ebolavirus DNA, 10 copies of RNA and 320 copies of RNA spiked in 1 ml whole blood). The primers and FRET-probes we designed enabled us to differentiate five Ebolavirus species by distinct T-m (Zaire: flat peaks between 53.0 degrees C and 56.9 degrees C; Sudan: 51.6 degrees C; Reston: flat peaks between 47.5 degrees C and 54.9 degrees C; Tai Forest: 52.8 degrees C; Bundibugyo: dual peaks at 48.9 degrees C and 53.5 degrees C), and by different amplicon sizes (Zaire 255bp, Sudan 211bp, Reston 192bp, Tai Forest 166bp, Bundibugyo 146bp). This one-size-fit-all assay enables the rapid detection and discrimination of the five Ebolavirus species in a single reaction.	[Lu, Guangwu; Zhang, Jilei; Wang, Chengming] Yangzhou Univ, Coll Vet Med, Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou 225009, Jiangsu, Peoples R China; [Zhang, Chuntao; Shi, Dawei; Yang, Zhaopeng] China Food & Drug Adm, Natl Inst Food & Drug Control NIFDC, Beijing 100050, Peoples R China; [Li, Xiaolu] Donghua Univ, Coll Chem Chem Engn & Biotechnol, Shanghai 201620, Peoples R China	Yangzhou University; National Institute of Food & Drug Control - China; Donghua University	Wang, CM (corresponding author), Yangzhou Univ, Coll Vet Med, Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou 225009, Jiangsu, Peoples R China.	wangcm@yzu.edu.cn	Zhang, Jilei/L-8672-2019	Zhang, Jilei/0000-0002-9589-1162	National Natural Science Foundation of China [31472225]; Priority Academic Program Development of Jiangsu Higher Education Institutions, Yangzhou, Jiangsu, P. R. China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions, Yangzhou, Jiangsu, P. R. China	This project was supported by grant from the National Natural Science Foundation of China (NO: 31472225; http://www.nsfc.gov.cn/publish/portal1/) and the Priority Academic Program Development of Jiangsu Higher Education Institutions, Yangzhou, Jiangsu, P. R. China (http://jsycw.ec.js.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrette RW, 2009, SCIENCE, V325, P204, DOI 10.1126/science.1172705; Bhaumik S, 2012, NATL MED J INDIA, V25, P317; Burd EM, 2015, J CLIN MICROBIOL, V53, P4, DOI 10.1128/JCM.03115-14; Carroll SA, 2013, J VIROL, V87, P2608, DOI 10.1128/JVI.03118-12; Chen XJS, 2000, MOL CELL, V5, P557, DOI 10.1016/S1097-2765(00)80449-9; Drosten C, 2001, J CLIN MICROBIOL, V39, P4302, DOI 10.1128/JCM.39.12.4302-4308.2001; Fajfr M, 2014, EPIDEMIOL MIKROBI IM, V63, P238; Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8; Gibb TR, 2001, J CLIN MICROBIOL, V39, P4125, DOI 10.1128/JCM.39.11.4125-4130.2001; Goeijenbier M, 2014, NETH J MED, V72, P442; Hartman AL, 2010, CLIN LAB MED, V30, P161, DOI 10.1016/j.cll.2009.12.001; HEYMANN DL, 1980, J INFECT DIS, V142, P372, DOI 10.1093/infdis/142.3.372; Huang Yi, 2012, Virologica Sinica, V27, P273, DOI 10.1007/s12250-012-3252-y; JOHNSON KM, 1977, LANCET, V1, P569; Joshi SM, 2000, J VIROL, V74, P10260, DOI 10.1128/JVI.74.21.10260-10268.2000; Kelly PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053450; Kuhn JH, 2014, ARCH VIROL, V159, P1229, DOI 10.1007/s00705-013-1877-2; LEGUENNO B, 1995, LANCET, V345, P1271, DOI 10.1016/S0140-6736(95)90925-7; Li YH, 2014, EPIDEMIOL INFECT, V142, P1138, DOI 10.1017/S0950268813002215; Liu Yang, 2012, Chinese Journal of Virology, V28, P567; Ogawa H, 2011, J VIROL METHODS, V171, P310, DOI 10.1016/j.jviromet.2010.11.010; Panning M, 2007, J INFECT DIS, V196, pS199, DOI 10.1086/520600; Pigott DM, 2014, ELIFE, V3, DOI [10.7554/eLife.02851, 10.7554/eLife.04395]; Ross AGP, 2014, INT J INFECT DIS, V28, P217, DOI 10.1016/j.ijid.2014.09.001; Towner JS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000212; Towner JS, 2004, J VIROL, V78, P4330, DOI 10.1128/JVI.78.8.4330-4341.2004; Trombley AR, 2010, AM J TROP MED HYG, V82, P954, DOI 10.4269/ajtmh.2010.09-0636; Wang CM, 2010, VET PARASITOL, V168, P11, DOI 10.1016/j.vetpar.2009.10.015; World Health Organization, 2015, EBOLA CURRENT SITUAT; Xiang JH, 2002, J MED VIROL, V68, P537, DOI 10.1002/jmv.10237; Yang Yu, 2012, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V26, P313	31	8	8	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0126281	10.1371/journal.pone.0126281	http://dx.doi.org/10.1371/journal.pone.0126281			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26017916	Green Published, gold, Green Submitted			2022-12-26	WOS:000355185600048
J	Walsh, JC; Angstmann, CN; Duggin, IG; Curmi, PMG				Walsh, James C.; Angstmann, Christopher N.; Duggin, Iain G.; Curmi, Paul M. G.			Molecular Interactions of the Min Protein System Reproduce Spatiotemporal Patterning in Growing and Dividing Escherichia coli Cells	PLOS ONE			English	Article							TOPOLOGICAL SPECIFICITY FACTOR; DIVISION SITE; MEMBRANE INTERACTION; PREVENT FORMATION; PROPER PLACEMENT; POLE OSCILLATION; SURFACE-WAVES; RAPID POLE; ATP; LOCALIZATION	Oscillations of the Min protein system are involved in the correct midcell placement of the divisome during Escherichia coli cell division. Based on molecular interactions of the Min system, we formulated a mathematical model that reproduces Min patterning during cell growth and division. Specifically, the increase in the residence time of MinD attached to the membrane as its own concentration increases, is accounted for by dimerisation of membrane-bound MinD and its interaction with MinE. Simulation of this system generates unparalleled correlation between the waveshape of experimental and theoretical MinD distributions, suggesting that the dominant interactions of the physical system have been successfully incorporated into the model. For cells where MinD is fully-labelled with GFP, the model reproduces the stationary localization of MinD-GFP for short cells, followed by oscillations from pole to pole in larger cells, and the transition to the symmetric distribution during cell filamentation. Cells containing a secondary, GFP-labelled MinD display a contrasting pattern. The model is able to account for these differences, including temporary midcell localization just prior to division, by increasing the rate constant controlling MinD ATPase and heterotetramer dissociation. For both experimental conditions, the model can explain how cell division results in an equal distribution of MinD and MinE in the two daughter cells, and accounts for the temperature dependence of the period of Min oscillations. Thus, we show that while other interactions may be present, they are not needed to reproduce the main characteristics of the Min system in vivo.	[Walsh, James C.; Curmi, Paul M. G.] Univ New S Wales, Sch Phys, Sydney, NSW 2052, Australia; [Walsh, James C.; Duggin, Iain G.] Univ Technol Sydney, ithree Inst, Sydney, NSW 2007, Australia; [Angstmann, Christopher N.] Univ New S Wales, Sch Math & Stat, Sydney, NSW 2052, Australia	University of New South Wales Sydney; University of Technology Sydney; University of New South Wales Sydney	Curmi, PMG (corresponding author), Univ New S Wales, Sch Phys, Sydney, NSW 2052, Australia.	p.curmi@unsw.edu.au	Duggin, Iain/B-3904-2011; Angstmann, Christopher N/G-1990-2015; Curmi, Paul/G-7185-2011	Duggin, Iain/0000-0003-4868-7350; Angstmann, Christopher N/0000-0002-6688-9346; Curmi, Paul/0000-0001-5762-7638; Walsh, James/0000-0003-0447-2323	Australian Postgraduate Award	Australian Postgraduate Award(Australian Government)	JCW was the recipient of an Australian Postgraduate Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragon JL, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.026201; Arjunan Satya Nanda Vel, 2010, Syst Synth Biol, V4, P35, DOI 10.1007/s11693-009-9047-2; Berg H. C., 1983, RANDOM WALKS BIOL; BI E, 1993, J BACTERIOL, V175, P1118, DOI 10.1128/JB.175.4.1118-1125.1993; Bonny M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003347; CAHN JW, 1958, J CHEM PHYS, V28, P258, DOI 10.1063/1.1744102; DEBOER PAJ, 1989, CELL, V56, P641, DOI 10.1016/0092-8674(89)90586-2; Di Ventura B, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.44; Di Ventura B, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.111; Fange D, 2006, PLOS COMPUT BIOL, V2, P637, DOI 10.1371/journal.pcbi.0020080; Fischer-Friedrich E, 2007, PHYS BIOL, V4, P38, DOI 10.1088/1478-3975/4/1/005; Fischer-Friedrich E, 2010, P NATL ACAD SCI USA, V107, P6134, DOI 10.1073/pnas.0911708107; Fu XL, 2001, P NATL ACAD SCI USA, V98, P980, DOI 10.1073/pnas.031549298; Ghasriani Houman, 2011, Commun Integr Biol, V4, P101, DOI 10.4161/cib.4.1.14162; Ghosal D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6341; GOULIAN M, 1993, EUROPHYS LETT, V22, P145, DOI 10.1209/0295-5075/22/2/012; Halatek J, 2012, CELL REP, V1, P741, DOI 10.1016/j.celrep.2012.04.005; Hale CA, 2001, EMBO J, V20, P1563, DOI 10.1093/emboj/20.7.1563; Hsieh CW, 2010, MOL MICROBIOL, V75, P499, DOI 10.1111/j.1365-2958.2009.07006.x; Hu ZL, 2002, P NATL ACAD SCI USA, V99, P6761, DOI 10.1073/pnas.102059099; Hu ZL, 1999, MOL MICROBIOL, V34, P82, DOI 10.1046/j.1365-2958.1999.01575.x; Hu ZL, 2001, MOL CELL, V7, P1337, DOI 10.1016/S1097-2765(01)00273-8; Huang KC, 2004, PHYS BIOL, V1, P229, DOI 10.1088/1478-3967/1/4/005; Huang KC, 2003, P NATL ACAD SCI USA, V100, P12724, DOI 10.1073/pnas.2135445100; Ivanov V, 2010, P NATL ACAD SCI USA, V107, P8071, DOI 10.1073/pnas.0911036107; Juarez JR, 2010, J BACTERIOL, V192, P4134, DOI 10.1128/JB.00364-10; Kang GB, 2010, MOL MICROBIOL, V76, P1222, DOI 10.1111/j.1365-2958.2010.07160.x; Kelly C., 2011, EFFECT ANTIMICROBIAL; Kerr RA, 2006, P NATL ACAD SCI USA, V103, P347, DOI 10.1073/pnas.0505825102; King GF, 2000, NAT STRUCT BIOL, V7, P1013, DOI 10.1038/80917; Knight JD, 2010, BIOPHYS J, V99, P2879, DOI 10.1016/j.bpj.2010.08.046; Kruse K, 2007, MOL MICROBIOL, V63, P1279, DOI 10.1111/j.1365-2958.2007.05607.x; Lackner LL, 2003, J BACTERIOL, V185, P735, DOI 10.1128/JB.185.3.735-749.2003; Landgraf D, 2012, NAT METHODS, V9, P480, DOI [10.1038/NMETH.1955, 10.1038/nmeth.1955]; Loose M, 2008, SCIENCE, V320, P789, DOI 10.1126/science.1154413; Loose M, 2011, NAT STRUCT MOL BIOL, V18, P577, DOI 10.1038/nsmb.2037; Loose M, 2011, ANNU REV BIOPHYS, V40, P315, DOI 10.1146/annurev-biophys-042910-155332; Meacci G, 2006, PHYS BIOL, V3, P255, DOI 10.1088/1478-3975/3/4/003; Meacci G, 2005, PHYS BIOL, V2, P89, DOI 10.1088/1478-3975/2/2/002; Mileykovskaya E, 2003, J BIOL CHEM, V278, P22193, DOI 10.1074/jbc.M302603200; Oliferenko S, 2009, GENE DEV, V23, P660, DOI 10.1101/gad.1772009; Park KT, 2012, MOL MICROBIOL, V85, P271, DOI 10.1111/j.1365-2958.2012.08110.x; Park KT, 2011, CELL, V146, P396, DOI 10.1016/j.cell.2011.06.042; PICHOFF S, 1995, MOL MICROBIOL, V18, P321, DOI 10.1111/j.1365-2958.1995.mmi_18020321.x; Raskin DM, 1999, P NATL ACAD SCI USA, V96, P4971, DOI 10.1073/pnas.96.9.4971; Rh Stokes RAR., 2002, ELECTROLYTE SOLUTION, P76; Sengupta S, 2007, PHYS BIOL, V4, P145, DOI 10.1088/1478-3975/4/3/001; Shih YL, 2003, P NATL ACAD SCI USA, V100, P7865, DOI 10.1073/pnas.1232225100; Shih YL, 2002, EMBO J, V21, P3347, DOI 10.1093/emboj/cdf323; Sliusarenko O, 2011, MOL MICROBIOL, V80, P612, DOI 10.1111/j.1365-2958.2011.07579.x; Suefuji K, 2002, P NATL ACAD SCI USA, V99, P16776, DOI 10.1073/pnas.262671699; Sun Q, 1998, J BACTERIOL, V180, P2050, DOI 10.1128/JB.180.8.2050-2056.1998; Taghbalout A, 2006, J BACTERIOL, V188, P2993, DOI 10.1128/JB.188.8.2993-3001.2006; Tostevin F, 2006, PHYS BIOL, V3, P1, DOI 10.1088/1478-3975/3/1/001; Touhami A, 2006, J BACTERIOL, V188, P7661, DOI 10.1128/JB.00911-06; Wu W, 2011, MOL MICROBIOL, V79, P1515, DOI 10.1111/j.1365-2958.2010.07536.x; Yu XC, 1999, MOL MICROBIOL, V32, P315, DOI 10.1046/j.1365-2958.1999.01351.x	57	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0128148	10.1371/journal.pone.0128148	http://dx.doi.org/10.1371/journal.pone.0128148			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018614	Green Submitted, Green Published, gold			2022-12-26	WOS:000355185600113
J	Sim, JH; Chung, D; Lim, JS; Lee, MY; Chung, CH; Shin, JY; Huh, JH				Sim, Jeong Han; Chung, Dawn; Lim, Jung Soo; Lee, Mi Young; Chung, Choon Hee; Shin, Jang Yel; Huh, Ji Hye			Maternal Age at First Delivery Is Associated with the Risk of Metabolic Syndrome in Postmenopausal Women: From 2008-2010 Korean National Health and Nutrition Examination Survey	PLOS ONE			English	Article							REPRODUCTIVE FACTORS; INSULIN-RESISTANCE; GLUCOSE-TOLERANCE; DIABETES-MELLITUS; MENARCHE; PARITY; AMERICAN; HORMONES; DISEASE	Background Recent cross-sectional studies demonstrated that earlier maternal age at first childbirth is correlated with a higher risk of diabetes in postmenopausal women. In this study, we evaluated whether the age at first delivery is associated with the risk of metabolic syndrome (MetS) in postmenopausal women. Methods A total of 4,261 postmenopausal women aged 45 years or older were analyzed using data generated from Korea National Health and Nutrition Examination Surveys (2008-2010). Subjects were divided into three groups according to the maternal age at first delivery as follows: <= 20 years (n=878), 21-25 years (n=2314), and >= 26 years (n=1069). Results Approximately 37% of subjects had MetS. The prevalence of MetS showed a gradual increase as maternal age at first delivery decreased (>= 26 years = 30.9% vs. 21-25 years = 39.9% vs. <= 20 years = 50.8%, respectively, p < 0.001). Central obesity indices such as trunk fat mass and waist circumference were significantly higher in the group aged <= 20 years than other groups. After adjustments for confounding factors, the odds ratios (ORs) for predicting the presence of MetS increased gradually as first delivery age decreased (>= 26 years vs. 21-25 years vs. <= 20 years: OR [95% CI] = 1 vs. 1.324 [1.118-1.567] vs. 1.641 [1.322-2.036], respectively). Among components of MetS, younger maternal age at first delivery (<= 20 years) was significantly associated with increased waist circumference (OR [95% CI] = 1.735 [1.41-2.13]), elevated blood pressure (1.261 [1.02-1.57]), high triglyceride (1.333 [1.072-1.659]), and low HDL-cholesterol (1.335[1.084-1.643]). Conclusions Our findings suggest that younger maternal age at first delivery is independently associated with a higher risk of central obesity and MetS in postmenopausal women.	[Sim, Jeong Han; Lim, Jung Soo; Lee, Mi Young; Chung, Choon Hee; Shin, Jang Yel; Huh, Ji Hye] Yonsei Univ, Wonju Coll Med, Dept Internal Med, Wonju, Gwangwondo, South Korea; [Chung, Dawn] Yonsei Univ, Wonju Coll Med, Dept Obstet & Gynecol, Wonju, Gwangwondo, South Korea	Yonsei University; Yonsei University	Huh, JH (corresponding author), Yonsei Univ, Wonju Coll Med, Dept Internal Med, Wonju, Gwangwondo, South Korea.	png1212@yonsei.ac.kr		Chung, Choon/0000-0003-1144-7206; Chung, Dawn/0000-0002-4495-1559				Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; BERAL V, 1985, J EPIDEMIOL COMMUN H, V39, P343, DOI 10.1136/jech.39.4.343; BJORNTORP P, 1991, DIABETES CARE, V14, P1132, DOI 10.2337/diacare.14.12.1132; Cernaro V, 2014, MED RES REV, V34, P77, DOI 10.1002/med.21277; Cohen A, 2006, J WOMENS HEALTH, V15, P763, DOI 10.1089/jwh.2006.15.763; DESPRES JP, 1995, INT J OBESITY, V19, pS76; Dreyfus JG, 2012, DIABETOLOGIA, V55, P2371, DOI 10.1007/s00125-012-2616-z; Galassi A, 2006, AM J MED, V119, P812, DOI 10.1016/j.amjmed.2006.02.031; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Herrera E, 2002, ENDOCRINE, V19, P43, DOI 10.1385/ENDO:19:1:43; Kaaja RJ, 2005, JAMA-J AM MED ASSOC, V294, P2751, DOI 10.1001/jama.294.21.2751; Kim JH, 2014, DIABETES CARE, V37, P671, DOI 10.2337/dc13-1784; Kirchengast S, 1998, COLLEGIUM ANTROPOL, V22, P393; KRITZSILVERSTEIN D, 1989, NEW ENGL J MED, V321, P1214, DOI 10.1056/NEJM198911023211802; Lakshman R, 2008, DIABETOLOGIA, V51, P781, DOI 10.1007/s00125-008-0948-5; Lakshman R, 2009, J CLIN ENDOCR METAB, V94, P4953, DOI 10.1210/jc.2009-1789; Lao XQ, 2006, CLIN ENDOCRINOL, V65, P460, DOI 10.1111/j.1365-2265.2006.02615.x; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; PALMER JR, 1992, AM J EPIDEMIOL, V136, P408, DOI 10.1093/oxfordjournals.aje.a116513; Parikh NI, 2010, AM HEART J, V159, DOI 10.1016/j.ahj.2009.11.017; Ryan EA, 2003, LANCET, V362, P1777, DOI 10.1016/S0140-6736(03)14942-2; RYAN EA, 1988, J CLIN ENDOCR METAB, V67, P341, DOI 10.1210/jcem-67-2-341; Salamone LM, 2000, J APPL PHYSIOL, V89, P345, DOI 10.1152/jappl.2000.89.1.345; Saquib N, 2005, CLIMACTERIC, V8, P76, DOI 10.1080/13697130500062688; Stockl D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026076; SYMONDS EM, 1995, ARCH DIS CHILD-FETAL, V72, pF139, DOI 10.1136/fn.72.2.F139; Wen W, 2003, INT J OBESITY, V27, P933, DOI 10.1038/sj.ijo.0802318	27	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127860	10.1371/journal.pone.0127860	http://dx.doi.org/10.1371/journal.pone.0127860			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010910	Green Published, gold, Green Submitted			2022-12-26	WOS:000355183900154
J	Teramoto, M; Moonie, S; Cross, CL; Chino, M; Alpert, PT				Teramoto, Masaru; Moonie, Sheniz; Cross, Chad L.; Chino, Michelle; Alpert, Patricia T.			Association of Leisure-Time Physical Activity to Cardiovascular Disease Prevalence in Relation to Smoking among Adult Nevadans	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; CIGARETTE-SMOKING; MYOCARDIAL-INFARCTION; ATHEROSCLEROSIS RISK; MORTALITY; CESSATION; EXERCISE; MEN; FITNESS; STROKE	It is well known that cigarette smoking and physical activity have significant impacts on cardiovascular disease (CVD) mortality and morbidity. Meanwhile, it is of interest to understand whether physical activity protects against CVD for smokers in a similar manner as it does for non-smokers. The present study examined how leisure-time physical activity (LTPA) is associated with the prevalence of CVD in relation to smoking status among adult Nevadans, using data from the 2010 Nevada Behavioral Risk Factor Surveillance System. Of the 3,913 survey respondents, 8.5% self-reported that they had ever been diagnosed with CVD. People with a history of CVD were significantly less likely to engage in LTPA than those with no history of CVD (p < 0.05). After adjusting for common sociodemographic variables, it was revealed that people with CVD were twice more likely to not engage in LTPA than their counterparts independent of smoking status. Without taking LTPA into account, the odds of having CVD for current and former smokers was 1.87-2.25 times higher than the odds for non-smokers. Interestingly, however, if LTPA was accounted for, there was no significant difference in the odds of having CVD between current and non-smokers. These results indicate that LTPA is inversely associated with the prevalence of CVD independent of smoking status, and that regular physical activity may protect against CVD for smokers as well as for non-smokers. Physical activity, along with smoking cessation, should be promoted to better prevent and control CVD among smokers.	[Teramoto, Masaru] Univ Utah, Div Phys Med & Rehabil, Salt Lake City, UT 84112 USA; [Moonie, Sheniz; Chino, Michelle] Univ Nevada, Sch Community Hlth Sci, Las Vegas, NV 89154 USA; [Cross, Chad L.] Nevada State Coll, Dept Phys & Life Sci, Henderson, NV USA; [Alpert, Patricia T.] Univ Nevada, Sch Nursing, Las Vegas, NV 89154 USA	Utah System of Higher Education; University of Utah; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Nevada System of Higher Education (NSHE); Nevada State College; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas	Teramoto, M (corresponding author), Univ Utah, Div Phys Med & Rehabil, Salt Lake City, UT 84112 USA.	teramot4@gmail.com	Moonie, Sheniz/R-6215-2016	Moonie, Sheniz/0000-0002-3192-9205; Cross, Chad/0000-0002-8756-5607				Adhikari B., 2008, Morbidity and Mortality Weekly Report, V57, P1226; Barbeau EM, 2004, AM J PUBLIC HEALTH, V94, P269, DOI 10.2105/AJPH.94.2.269; Blair SN, 1996, JAMA-J AM MED ASSOC, V276, P205, DOI 10.1001/jama.276.3.205; Bullen Christopher, 2008, Expert Rev Cardiovasc Ther, V6, P883, DOI 10.1586/14779072.6.6.883; Burns DM, 2003, PROG CARDIOVASC DIS, V46, P11, DOI 10.1016/S0033-0620(03)00079-3; Centers for Disease Control and Prevention, 2013, BEH RISK FACT SURV S; Centers for Disease Control and Prevention (CDC), 2011, BEH RISK FACT SURV S; Colberg SR, 2010, DIABETES CARE, V33, P2692, DOI [10.2337/dc10-1548, 10.2337/dc10-9990]; Department of Health and Human Services Nevada State Health Division Bureau of Health Statistics Planning Epidemiology and Response Office of Public Health Informatics and Epidemiology, 2012, NEV BEH RISK FACT SU; Donnelly JE, 2009, MED SCI SPORT EXER, V41, P459, DOI 10.1249/MSS.0b013e3181949333; Ezzati M, 2005, CIRCULATION, V112, P489, DOI 10.1161/CIRCULATIONAHA.104.521708; Garrett Bridgette E., 2011, Morbidity and Mortality Weekly Report, V60, P109; Gregg EW, 2003, JAMA-J AM MED ASSOC, V289, P2379, DOI 10.1001/jama.289.18.2379; Howard G, 1998, JAMA-J AM MED ASSOC, V279, P119, DOI 10.1001/jama.279.2.119; Hu FB, 2004, NEW ENGL J MED, V351, P2694, DOI 10.1056/NEJMoa042135; Imamura H, 2002, METABOLISM, V51, P1313, DOI 10.1053/meta.2002.34040; Jacobs DR, 1999, ARCH INTERN MED, V159, P733, DOI 10.1001/archinte.159.7.733; Kenfield SA, 2008, JAMA-J AM MED ASSOC, V299, P2037, DOI 10.1001/jama.299.17.2037; King Brian, 2011, Morbidity and Mortality Weekly Report, V60, P1207; Kronenberg F, 2000, ATHEROSCLEROSIS, V153, P433, DOI 10.1016/S0021-9150(00)00426-3; Lightwood JM, 1997, CIRCULATION, V96, P1089, DOI 10.1161/01.CIR.96.4.1089; Maarcher Ann, 2011, Morbidity and Mortality Weekly Report, V60, P1513; Mendis S., 2011, GLOB ATL CARD DIS PR; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; PAFFENBARGER RS, 1993, NEW ENGL J MED, V328, P538, DOI 10.1056/NEJM199302253280804; Papathanasiou G, 2007, EUR J CARDIOV PREV R, V14, P646, DOI 10.1097/HJR.0b013e3280ecfe2c; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; SHINTON R, 1989, BMJ-BRIT MED J, V298, P789, DOI 10.1136/bmj.298.6676.789; Slentz CA, 2007, J APPL PHYSIOL, V103, P432, DOI 10.1152/japplphysiol.01314.2006; Stevens J, 2002, AM J EPIDEMIOL, V156, P832, DOI 10.1093/aje/kwf114; Syamlal Girija, 2011, Morbidity and Mortality Weekly Report, V60, P1305; Teramoto M, 2009, RES Q EXERCISE SPORT, V80, P138, DOI 10.1080/02701367.2009.10599547; Thun MJ, 1997, CHANGES CIGARETTE RE, V8, P383; U.S. Department of Health and Human Services, 1996, PHYS ACT HLTH REP SU; U.S. Department of Health and Human Services, 2012, HLTH PEOPL 2020; US Department of Health and Human Services, 2010, TOB SMOK CAUS DIS BI; VanderWeele TJ, 2009, EPIDEMIOLOGY, V20, P863, DOI 10.1097/EDE.0b013e3181ba333c; WANNAMETHEE SG, 1995, JAMA-J AM MED ASSOC, V274, P155; Wannamethee SG, 1998, LANCET, V351, P1603, DOI 10.1016/S0140-6736(97)12355-8; Wilson K, 2000, ARCH INTERN MED, V160, P939, DOI 10.1001/archinte.160.7.939; World Health Organization, 2007, PREV CARD DIS GUID A	42	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128424	10.1371/journal.pone.0128424	http://dx.doi.org/10.1371/journal.pone.0128424			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010914	Green Submitted, Green Published, gold			2022-12-26	WOS:000355183900234
J	Balchand, SK; Mann, BJ; Titus, J; Ross, JL; Wadsworth, P				Balchand, Sai K.; Mann, Barbara J.; Titus, Janel; Ross, Jennifer L.; Wadsworth, Patricia			TPX2 Inhibits Eg5 by Interactions with Both Motor and Microtubule	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AURORA-A ACTIVATION; MITOTIC SPINDLE; KINESIN MOTOR; DIRECTIONAL MOTILITY; MAMMALIAN-CELLS; CROSS-LINKS; PROTEIN; DYNEIN; PROMOTES; LOCALIZATION	The microtubule-associated protein, TPX2, regulates the activity of the mitotic kinesin, Eg5, but the mechanism of regulation is not established. Using total internal reflection fluorescence microscopy, we observed that Eg5, in extracts of mammalian cells expressing Eg5-EGFP, moved processively toward the microtubule plus-end at an average velocity of 14 nm/s. TPX2 bound to microtubules with an apparent dissociation constant of similar to 200 nM, and microtubule binding was not dependent on the C-terminal tails of tubulin. Using single molecule assays, we found that full-length TPX2 dramatically reduced Eg5 velocity, whereas truncated TPX2, which lacks the domain that is required for the interaction with Eg5, was a less effective inhibitor at the same concentration. To determine the region(s) of Eg5 that is required for interaction with TPX2, we performed microtubule gliding assays. Dimeric, but not monomeric, Eg5 was differentially inhibited by full-length and truncated TPX2, demonstrating that dimerization or residues in the neck region are important for the interaction of TPX2 with Eg5. These results show that both microtubule binding and interaction with Eg5 contribute to motor inhibition by TPX2 and demonstrate the utility of mammalian cell extracts for biophysical assays.	[Balchand, Sai K.; Mann, Barbara J.; Titus, Janel; Ross, Jennifer L.; Wadsworth, Patricia] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA; [Ross, Jennifer L.] Univ Massachusetts, Dept Phys, Amherst, MA 01003 USA; [Wadsworth, Patricia] Univ Massachusetts, Program Mol & Cellular Biol, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Wadsworth, P (corresponding author), Univ Massachusetts, Dept Biol, 221 Morrill South,611 N Pleasant St, Amherst, MA 01003 USA.		Ross, Jennifer L/D-7208-2012	Ross, Jennifer L/0000-0002-4838-3798	National Science Foundation Major Research Instrumentation [DBI-0923318]; National Science Foundation [DMR-1207783]	National Science Foundation Major Research Instrumentation(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF))	The multicolor TIRF microscopy was performed on a user-supported instrument funded by National Science Foundation Major Research Instrumentation Grant DBI-0923318 (to J. L. R. and P. W.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by National Science Foundation Grant DMR-1207783.	Barlan K, 2013, CURR BIOL, V23, P317, DOI 10.1016/j.cub.2013.01.008; Bayliss R, 2003, MOL CELL, V12, P851, DOI 10.1016/S1097-2765(03)00392-7; Brouhard GJ, 2008, CELL, V132, P79, DOI 10.1016/j.cell.2007.11.043; Cai DW, 2007, BIOPHYS J, V92, P4137, DOI 10.1529/biophysj.106.100206; Cai DW, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000216; Cheeseman Iain M, 2005, Sci STKE, V2005, ppl1, DOI 10.1126/stke.2662005pl1; Day RN, 2009, CHEM SOC REV, V38, P2887, DOI 10.1039/b901966a; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; Drechsler H, 2014, ELIFE, V3, DOI 10.7554/eLife.01724; Eckerdt F, 2008, CURR BIOL, V18, P519, DOI 10.1016/j.cub.2008.02.077; Eyers PA, 2004, J BIOL CHEM, V279, P9008, DOI 10.1074/jbc.M312424200; Gable A, 2012, MOL BIOL CELL, V23, P1254, DOI 10.1091/mbc.E11-09-0820; Garrett S, 2002, CURR BIOL, V12, P2055, DOI 10.1016/S0960-9822(02)01277-0; Gerson-Gurwitz A, 2011, EMBO J, V30, P4942, DOI 10.1038/emboj.2011.403; Groen AC, 2008, J CELL SCI, V121, P2293, DOI 10.1242/jcs.024018; Gruss OJ, 2002, NAT CELL BIOL, V4, P871, DOI 10.1038/ncb870; Helenius J, 2006, NATURE, V441, P115, DOI 10.1038/nature04736; Hinrichs MH, 2012, J BIOL CHEM, V287, P38559, DOI 10.1074/jbc.M112.369785; HYMAN A, 1991, METHOD ENZYMOL, V196, P478; Illenberger S, 1996, J BIOL CHEM, V271, P10834, DOI 10.1074/jbc.271.18.10834; Kapitein LC, 2005, NATURE, V435, P114, DOI 10.1038/nature03503; Kapitein LC, 2008, J CELL BIOL, V182, P421, DOI 10.1083/jcb.200801145; Korneev MJ, 2007, EUR BIOPHYS J BIOPHY, V36, P675, DOI 10.1007/s00249-007-0134-6; Kufer TA, 2002, J CELL BIOL, V158, P617, DOI 10.1083/jcb.200204155; Kwok BH, 2006, NAT CHEM BIOL, V2, P480, DOI 10.1038/nchembio812; Larson AG, 2010, BIOPHYS J, V98, P2619, DOI 10.1016/j.bpj.2010.03.014; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ma N, 2011, J CELL BIOL, V195, P87, DOI 10.1083/jcb.201106149; Ma N, 2010, MOL BIOL CELL, V21, P979, DOI 10.1091/mbc.E09-07-0601; Markus SM, 2012, CURR BIOL, V22, P2221, DOI 10.1016/j.cub.2012.10.017; PASCHAL BM, 1989, NATURE, V342, P569, DOI 10.1038/342569a0; Petry S, 2013, CELL, V152, P768, DOI 10.1016/j.cell.2012.12.044; Roostalu J, 2011, SCIENCE, V332, P94, DOI 10.1126/science.1199945; Skoufias DA, 2006, J BIOL CHEM, V281, P17559, DOI 10.1074/jbc.M511735200; Sung HH, 2008, DEV CELL, V15, P866, DOI 10.1016/j.devcel.2008.10.006; Thorn KS, 2000, J CELL BIOL, V151, P1093, DOI 10.1083/jcb.151.5.1093; Tulu US, 2006, CURR BIOL, V16, P536, DOI 10.1016/j.cub.2006.01.060; Valentine MT, 2006, NAT CELL BIOL, V8, P470, DOI 10.1038/ncb1394; van den Wildenberg SMJL, 2008, CURR BIOL, V18, P1860, DOI 10.1016/j.cub.2008.10.026; Walczak CE, 2008, INT REV CYTOL, V265, P111, DOI 10.1016/S0074-7696(07)65003-7; Wang Z., 2000, BIOPHYS J, V78, P1955; Welburn JPI, 2012, MOL BIOL CELL, V23, P4786, DOI 10.1091/mbc.E12-03-0214; Wittmann T, 1998, J CELL BIOL, V143, P673, DOI 10.1083/jcb.143.3.673; Wittmann T, 2000, J CELL BIOL, V149, P1405, DOI 10.1083/jcb.149.7.1405	44	22	24	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17367	17379		10.1074/jbc.M114.612903	http://dx.doi.org/10.1074/jbc.M114.612903			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	26018074	Green Published, hybrid			2022-12-26	WOS:000357730900031
J	Batrakou, DG; Heras, JID; Czapiewski, R; Mouras, R; Schirmer, EC				Batrakou, Dzmitry G.; Heras, Jose I. de Las; Czapiewski, Rafal; Mouras, Rabah; Schirmer, Eric C.			TMEM120A and B: Nuclear Envelope Transmembrane Proteins Important for Adipocyte Differentiation	PLOS ONE			English	Article							LMNA MUTATIONS; LAMIN A/C; MEMBRANE PROTEIN; PPAR-GAMMA; CELL; TRANSCRIPTION; ACTIVATION; LIPODYSTROPHY; ADIPOGENESIS; ADIPONECTIN	Recent work indicates that the nuclear envelope is a major signaling node for the cell that can influence tissue differentiation processes. Here we present two nuclear envelope transmembrane proteins TMEM120A and TMEM120B that are paralogs encoded by the Tmem120A and Tmem120B genes. The TMEM120 proteins are expressed preferentially in fat and both are induced during 3T3-L1 adipocyte differentiation. Knockdown of one or the other protein altered expression of several genes required for adipocyte differentiation, Gata3, Fasn, Glut4, while knockdown of both together additionally affected Pparg and Adipoq. The double knockdown also increased the strength of effects, reducing for example Glut4 levels by 95% compared to control 3T3-L1 cells upon pharmacologically induced differentiation. Accordingly, TMEM120A and B knockdown individually and together impacted on adipocyte differentiation/metabolism as measured by lipid accumulation through binding of Oil Red O and coherent anti-Stokes Raman scattering microscopy (CARS). The nuclear envelope is linked to several lipodystrophies through mutations in lamin A; however, lamin A is widely expressed. Thus it is possible that the TMEM120A and B fat-specific nuclear envelope transmembrane proteins may play a contributory role in the tissue-specific pathology of this disorder or in the wider problem of obesity.	[Batrakou, Dzmitry G.; Heras, Jose I. de Las; Czapiewski, Rafal; Schirmer, Eric C.] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland; [Mouras, Rabah] Univ Edinburgh, Inst Mat & Proc, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Schirmer, EC (corresponding author), Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland.	e.schirmer@ed.ac.uk	Mouras, Rabah/AAV-8487-2020	Mouras, Rabah/0000-0001-5100-4739; Schirmer, Eric/0000-0003-2635-1338; Czapiewski, Rafal/0000-0003-0211-8435	Wellcome Trust [076616, 095209]; Wellcome Trust Centre for Cell Biology [092076]; Darwin Trust studentship	Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust Centre for Cell Biology(Wellcome Trust); Darwin Trust studentship	This work was supported by Wellcome Trust Senior Research Fellowship (076616 and 095209) to ECS, core funding to the Wellcome Trust Centre for Cell Biology (092076), and a Darwin Trust studentship to DGB. The funders had no role in the study design, data collection and analysis, decision to publish, or the preparation of the manuscript.	Ali AT, 2013, EUR J CELL BIOL, V92, P229, DOI 10.1016/j.ejcb.2013.06.001; Bai LA, 2011, HEPATOLOGY, V53, P1164, DOI 10.1002/hep.24155; Boguslavsky RL, 2006, HUM MOL GENET, V15, P653, DOI 10.1093/hmg/ddi480; Bourgeois B, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003411; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; Byerly MS, 2010, PHYSIOL GENOMICS, V42, P157, DOI 10.1152/physiolgenomics.00029.2010; Cao H, 2000, HUM MOL GENET, V9, P109, DOI 10.1093/hmg/9.1.109; Chen LS, 2003, LANCET, V362, P440, DOI 10.1016/S0140-6736(03)14069-X; Clouthier DE, 1997, J CLIN INVEST, V100, P2697, DOI 10.1172/JCI119815; Csoka AB, 2004, J MED GENET, V41, P304, DOI 10.1136/jmg.2003.015651; Dahm AEA, 2012, THROMB RES, V130, P45, DOI 10.1016/j.thromres.2011.12.009; de las Heras JI, 2013, NUCLEUS-PHILA, V4, P460, DOI 10.4161/nucl.26872; Diez JJ, 2003, EUR J ENDOCRINOL, V148, P293, DOI 10.1530/eje.0.1480293; Dittmer TA, 2014, MOL BIOL CELL, V25, P1493, DOI 10.1091/mbc.E14-02-0733; Fall T, 2014, MOL CELL ENDOCRINOL, V382, P740, DOI 10.1016/j.mce.2012.08.018; Follenzi A, 2000, NAT GENET, V25, P217, DOI 10.1038/76095; Foster LJ, 2006, CELL, V125, P187, DOI 10.1016/j.cell.2006.03.022; GREEN H, 1974, CELL, V1, P113, DOI 10.1016/0092-8674(74)90126-3; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Haakonsson AK, 2013, MOL ENDOCRINOL, V27, P1536, DOI 10.1210/me.2013-1080; Kim JB, 1998, P NATL ACAD SCI USA, V95, P4333, DOI 10.1073/pnas.95.8.4333; Kim JB, 1996, GENE DEV, V10, P1096, DOI 10.1101/gad.10.9.1096; Korfali N, 2012, NUCLEUS-PHILA, V3, P552, DOI 10.4161/nucl.22257; Korfali N, 2010, MOL CELL PROTEOMICS, V9, P2571, DOI 10.1074/mcp.M110.002915; Liu W, 2014, MOL GENET GENOMICS, V289, P847, DOI 10.1007/s00438-014-0859-8; Lloyd DJ, 2002, HUM MOL GENET, V11, P769, DOI 10.1093/hmg/11.7.769; Malik P, 2010, CELL MOL LIFE SCI, V67, P1353, DOI 10.1007/s00018-010-0257-2; Maraldi NM, 2011, J CELL BIOCHEM, V112, P979, DOI 10.1002/jcb.22992; Mouras R, 2011, PROC SPIE, V8086, DOI 10.1117/12.889780; Muchir A, 2007, HUM MOL GENET, V16, P1884, DOI 10.1093/hmg/ddm137; Muchir A, 2007, J CLIN INVEST, V117, P1282, DOI 10.1172/JCI29042; Novelli G, 2002, AM J HUM GENET, V71, P426, DOI 10.1086/341908; Ntambi JM, 2000, J NUTR, V130, p3122S, DOI 10.1093/jn/130.12.3122S; Osada SI, 2003, DEVELOPMENT, V130, P1783, DOI 10.1242/dev.00401; Pan D, 2005, J BIOL CHEM, V280, P15992, DOI 10.1074/jbc.M411234200; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pinto MT, 2014, AIDS RES HUM RETROV, V30, P610, DOI [10.1089/aid.2013.0109, 10.1089/AID.2013.0109]; Prior MJ, 2011, J PROTEOME RES, V10, P4970, DOI 10.1021/pr200446r; R Core Team, 2018, R LANG ENV STAT COMP; Raju GP, 2003, J BIOL CHEM, V278, P428, DOI 10.1074/jbc.M210505200; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; RUSSELL TR, 1976, P NATL ACAD SCI USA, V73, P4516, DOI 10.1073/pnas.73.12.4516; Samejima K, 2008, P NATL ACAD SCI USA, V105, P2457, DOI 10.1073/pnas.0712083105; Schirmer EC, 2003, SCIENCE, V301, P1380, DOI 10.1126/science.1088176; Shackleton S, 2000, NAT GENET, V24, P153, DOI 10.1038/72807; Taher L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028358; Tilgner K, 2009, J CELL SCI, V122, P401, DOI 10.1242/jcs.026179; Tong Q, 2000, SCIENCE, V290, P134, DOI 10.1126/science.290.5489.134; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Wilkie GS, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003129; Willyard C, 2014, NATURE, V508, pS58, DOI 10.1038/508S58a; World Health Organization, 2016, OB OV; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Zuleger N, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-2-r14; Zumbusch A, 1999, PHYS REV LETT, V82, P4142, DOI 10.1103/PhysRevLett.82.4142	55	33	37	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0127712	10.1371/journal.pone.0127712	http://dx.doi.org/10.1371/journal.pone.0127712			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024229	Green Submitted, Green Published, gold			2022-12-26	WOS:000355319400048
J	Wigg, JP; Zhang, H; Yang, D				Wigg, Jonathan P.; Zhang, Hong; Yang, Dong			A Quantitative and Standardized Method for the Evaluation of Choroidal Neovascularization Using MICRON III Fluorescein Angiograms in Rats	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MACULAR DEGENERATION; IN-VIVO; MONOCLONAL-ANTIBODY; MURINE MODEL; LASER; MICE; AGE; INHIBITOR; RETINOPATHY	Introduction In-vivo imaging of choroidal neovascularization (CNV) has been increasingly recognized as a valuable tool in the investigation of age-related macular degeneration (AMD) in both clinical and basic research applications. Arguably the most widely utilised model replicating AMD is laser generated CNV by rupture of Bruch's membrane in rodents. Heretofore CNV evaluation via in-vivo imaging techniques has been hamstrung by a lack of appropriate rodent fundus camera and a non-standardised analysis method. The aim of this study was to establish a simple, quantifiable method of fluorescein fundus angiogram (FFA) image analysis for CNV lesions. Methods Laser was applied to 32 Brown Norway Rats; FFA images were taken using a rodent specific fundus camera (Micron III, Phoenix Laboratories) over 3 weeks and compared to conventional ex-vivo CNV assessment. FFA images acquired with fluorescein administered by intraperitoneal injection and intravenous injection were compared and shown to greatly influence lesion properties. Utilising commonly used software packages, FFA images were assessed for CNV and chorioretinal burns lesion area by manually outlining the maximum border of each lesion and normalising against the optic nerve head. Net fluorescence above background and derived value of area corrected lesion intensity were calculated. Results CNV lesions of rats treated with anti-VEGF antibody were significantly smaller in normalised lesion area (p<0.001) and fluorescent intensity (p<0.001) than the PBS treated control two weeks post laser. The calculated area corrected lesion intensity was significantly smaller (p<0.001) in anti-VEGF treated animals at 2 and 3 weeks post laser. The results obtained using FFA correlated with, and were confirmed by conventional lesion area measurements from isolectin stained choroidal flatmounts, where lesions of anti-VEGF treated rats were significantly smaller at 2 weeks (p = 0.049) and 3 weeks (p<0.001) post laser. Conclusion The presented method of in-vivo FFA quantification of CNV, including acquisition variable corrections, using the Micron III system and common use software establishes a reliable method for detecting and quantifying CNV enabling longitudinal studies and represents an important alternative to conventional CNV quantification methods.	[Wigg, Jonathan P.; Zhang, Hong; Yang, Dong] Univ Melbourne, Ctr Eye Res Australia, Royal Victorian Eye & Ear Hosp, East Melbourne, Vic, Australia; [Zhang, Hong] Harbin Med Univ, Hosp Eye, Harbin, Heilongjiang Pr, Peoples R China	Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne; Harbin Medical University	Zhang, H (corresponding author), Univ Melbourne, Ctr Eye Res Australia, Royal Victorian Eye & Ear Hosp, East Melbourne, Vic, Australia.	hong.zhang@unimelb.edu.au	Zhang, Hong/AAX-9632-2020		National Health and Medical Research Council (NHMRC) [APP1047603]; National Natural Science Foundation of China (NNSFC) [81201184]; Heilongjiang Provincial Nature Science Grants [LC2012C24]; Foundation for the New Century Talents by the Educational Committee of Heilongjiang Province [1251-NCET-011]; Doctoral Program of Higher Education Research Fund [20132307110027];  [2014CJHB006]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); National Natural Science Foundation of China (NNSFC)(National Natural Science Foundation of China (NSFC)); Heilongjiang Provincial Nature Science Grants; Foundation for the New Century Talents by the Educational Committee of Heilongjiang Province; Doctoral Program of Higher Education Research Fund; 	This work was supported by the following sources of funding: 1. National Health and Medical Research Council (NHMRC, http://www.nhmrc.gov.au/) Grant No APP1047603, HZ; 2. National Natural Science Foundation of China (NNSFC http://www.nsfc.gov.cn/) Grant No. 81201184, HZ; 3. Heilongjiang Provincial Nature Science Grants (http://www.nsf.hljkj.cn) Grant No. LC2012C24; 4. Foundation for the New Century Talents by the Educational Committee of Heilongjiang Province (http://www.hlje.net) Grant No. 1251-NCET-011).; 5. Support Program for Changjiang Scholars candidate (http://www.hlje.net) Grant No. 2014CJHB006, HZ; and 6. Doctoral Program of Higher Education Research Fund (http://www.nsf.hljkj.cn) Grant No. 20132307110027, HZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello LP, 1997, DIABETES, V46, P1473, DOI 10.2337/diabetes.46.9.1473; CALDERONE L, 1986, EXP EYE RES, V42, P331, DOI 10.1016/0014-4835(86)90026-6; Campa C, 2008, INVEST OPHTH VIS SCI, V49, P1178, DOI 10.1167/iovs.07-1194; Campos M, 2006, INVEST OPHTH VIS SCI, V47, P5163, DOI 10.1167/iovs.06-0156; Criswell MH, 2008, ARCH OPHTHALMOL-CHIC, V126, P946, DOI 10.1001/archopht.126.7.946; Cui J, 2014, PHOTOMED LASER SURG, V32, P30, DOI 10.1089/pho.2013.3588; DOBI ET, 1989, ARCH OPHTHALMOL-CHIC, V107, P264, DOI 10.1001/archopht.1989.01070010270035; Edelman JL, 2000, EXP EYE RES, V71, P523, DOI 10.1006/exer.2000.0907; Espinosa-Heidmann DG, 2002, INVEST OPHTH VIS SCI, V43, P1567; FRANK RN, 1989, CURR EYE RES, V8, P239, DOI 10.3109/02713688908997565; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P532; Funakoshi T, 2006, EXP EYE RES, V83, P1102, DOI 10.1016/j.exer.2006.05.016; Geng Y, 2009, INVEST OPHTH VIS SCI, V50, P5872, DOI 10.1167/iovs.09-3675; Grossniklaus HE, 2010, PROG RETIN EYE RES, V29, P500, DOI 10.1016/j.preteyeres.2010.05.003; Guaiquil VH, 2013, INVEST OPHTH VIS SCI, V54, P5294, DOI 10.1167/iovs.12-11492; Han ZC, 2013, INVEST OPHTH VIS SCI, V54, P574, DOI 10.1167/iovs.12-10959; Hardin W, 2010, VISION SYSTEM DESIGN, V15; Hu Y, 2013, INVEST OPHTH VIS SCI, V54, P141, DOI 10.1167/iovs.12-10281; Huang HL, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001620; Kim Hyungjin Myra, 2007, J Diabetes Sci Technol, V1, P531; Lambert V, 2013, NAT PROTOC, V8, P2197, DOI 10.1038/nprot.2013.135; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Lin YS, 1999, J PHARMACOL EXP THER, V288, P371; Lu F, 2009, GRAEF ARCH CLIN EXP, V247, P171, DOI 10.1007/s00417-008-0936-y; Nishiwaki H, 2002, PHOTOCHEM PHOTOBIOL, V75, P149, DOI 10.1562/0031-8655(2002)075<0149:LTPOOR>2.0.CO;2; Qu Y, 2009, OPHTHALMIC RES, V42, P36, DOI 10.1159/000219683; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Ryan S J, 1979, Trans Am Ophthalmol Soc, V77, P707; Schalenbourg A, 2013, EYE, V27, P224, DOI 10.1038/eye.2012.267; Seo MS, 1999, AM J PATHOL, V154, P1743, DOI 10.1016/S0002-9440(10)65430-2; Serlin Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061599; Tanemura M, 2003, INVEST OPHTH VIS SCI, V44, pU109; Tobe T, 1998, AM J PATHOL, V153, P1641, DOI 10.1016/S0002-9440(10)65753-7; Toma HS, 2010, MICROVASC RES, V80, P295, DOI 10.1016/j.mvr.2010.05.011; Wang JL, 2012, INVEST OPHTH VIS SCI, V53, P7348, DOI 10.1167/iovs.12-9955; Wang WQ, 2011, INVEST OPHTH VIS SCI, V52, P7213, DOI 10.1167/iovs.10-7097; Xie B, 2009, J CELL PHYSIOL, V218, P192, DOI 10.1002/jcp.21588; Zarbin MA, 1998, EUR J OPHTHALMOL, V8, P199, DOI 10.1177/112067219800800401; Zhao Shi-hong, 2003, Zhonghua Yan Ke Za Zhi, V39, P298; Zhou XL, 2012, BIOMED OPT EXPRESS, V3, P1811, DOI 10.1364/BOE.3.001811; Zhu J, 2009, EXP EYE RES, V88, P910, DOI 10.1016/j.exer.2008.11.034	41	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128418	10.1371/journal.pone.0128418	http://dx.doi.org/10.1371/journal.pone.0128418			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024231	Green Published, gold			2022-12-26	WOS:000355319400090
J	Chintala, S; Cheng, M; Zhang, X				Chintala, Shravan; Cheng, Mei; Zhang, Xiao			Decreased Expression of DREAM Promotes the Degeneration of Retinal Neurons	PLOS ONE			English	Article							GANGLION-CELL DEATH; NMDA-RECEPTOR; RAT RETINA; IN-VIVO; PROTEIN; ACTIVATION; DAMAGE; MATRIX-METALLOPROTEINASE-9; PHOSPHORYLATION; EXCITOTOXICITY	The intrinsic mechanisms that promote the degeneration of retinal ganglion cells (RGCs) following the activation of N-Methyl-D-aspartic acid-type glutamate receptors (NMDARs) are unclear. In this study, we have investigated the role of downstream regulatory element antagonist modulator (DREAM) in NMDA-mediated degeneration of the retina. NMDA, phosphate-buffered saline (PBS), and MK801 were injected into the vitreous humor of C57BL/6 mice. At 12, 24, and 48 hours after injection, expression of DREAM in the retina was determined by immunohistochemistry, western blot analysis, and electrophoretic mobility-shift assay (EMSA). Apoptotic death of cells in the retina was determined by terminal deoxynucleotidyl transferace dUTP nick end labeling (TUNEL) assays. Degeneration of RGCs in cross sections and in whole mount retinas was determined by using antibodies against Tuj1 and Brn3a respectively. Degeneration of amacrine cells and bipolar cells was determined by using antibodies against calretinin and protein kinase C (PKC)-alpha respectively. DREAM was expressed constitutively in RGCs, amacrine cells, bipolar cells, as well as in the inner plexiform layer (IPL). NMDA promoted a progressive decrease in DREAM levels in all three cell types over time, and at 48 h after NMDA-treatment very low DREAM levels were evident in the IPL only. DREAM expression in retinal nuclear proteins was decreased progressively after NMDA-treatment, and correlated with its decreased binding to the c-fos-DRE oligonucleotides. A decrease in DREAM expression correlated significantly with apoptotic death of RGCs, amacrine cells and bipolar cells. Treatment of eyes with NMDA antagonist MK801, restored DREAM expression to almost normal levels in the retina, and significantly decreased NMDA-mediated apoptotic death of RGCs, amacrine cells, and bipolar cells. Results presented in this study show for the first time that down-regulation of DREAM promotes the degeneration of RGCs, amacrine cells, and bipolar cells.	[Chintala, Shravan] Oakland Univ, Lab Ophthalm Neurobiol, Rochester, MI 48063 USA; Oakland Univ, Eye Res Inst, Rochester, MI 48063 USA	Oakland University; Oakland University	Chintala, S (corresponding author), Oakland Univ, Lab Ophthalm Neurobiol, Rochester, MI 48063 USA.	Chintala@oakland.edu			National Eye Institute project [EY017853-01A2]; NATIONAL EYE INSTITUTE [R01EY017853] Funding Source: NIH RePORTER	National Eye Institute project; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by National Eye Institute project grant EY017853-01A2 (to SKC).	Asami Y, 2014, CURR EYE RES, V30, P1; Bai N, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-34; Chavira-Suarez E, 2008, NEUROSCI LETT, V432, P121, DOI 10.1016/j.neulet.2007.12.021; Chavira-Suarez E, 2011, BIOCHEM BIOPH RES CO, V404, P678, DOI 10.1016/j.bbrc.2010.12.041; Chidlow G, 2003, BRAIN RES, V963, P298, DOI 10.1016/S0006-8993(02)04052-0; Chintala SK, 2015, INVEST OPHTH VIS SCI, V56, P505, DOI 10.1167/iovs.14-15539; Furuya T, 2012, CURR EYE RES, V37, P170, DOI 10.3109/02713683.2011.645105; Ganesh BS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018305; Hama Y, 2006, NEUROSCI RES, V56, P279, DOI 10.1016/j.neures.2006.07.008; Kaur C, 2012, J NEUROPATH EXP NEUR, V71, P330, DOI 10.1097/NEN.0b013e31824deb21; Kumada M, 2005, INVEST OPHTH VIS SCI, V46, P1504, DOI 10.1167/iovs.04-0595; Kwong JMK, 2011, INVEST OPHTH VIS SCI, V52, P9694, DOI 10.1167/iovs.11-7869; Kwong JMK, 2000, EXP EYE RES, V71, P437, DOI 10.1006/exer.2000.0894; Li Y, 1999, INVEST OPHTH VIS SCI, V40, P1004; Mali RS, 2011, EXP EYE RES, V92, P528, DOI 10.1016/j.exer.2011.03.017; Mali RS, 2005, FASEB J, V19, P1280, DOI 10.1096/fj.04-3403com; Manabe S, 2005, INVEST OPHTH VIS SCI, V46, P4747, DOI 10.1167/iovs.05-0128; Manabe S, 2003, INVEST OPHTH VIS SCI, V44, P385, DOI 10.1167/iovs.02-0187; Mellstrom B, 2008, PHYSIOL REV, V88, P421, DOI 10.1152/physrev.00041.2005; Munemasa Y, 2006, J NEUROSCI RES, V83, P907, DOI 10.1002/jnr.20786; Naruoka T, 2013, EUR J PHARMACOL, V718, P138, DOI 10.1016/j.ejphar.2013.08.041; Nguyen D, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.117; Oku H, 2004, CURR EYE RES, V29, P403, DOI 10.1080/02713680490517917; Omodaka K, 2014, BRAIN RES, V1586, P203, DOI 10.1016/j.brainres.2014.08.053; Onder HI, 2013, J OCUL PHARMACOL TH, V29, P427, DOI 10.1089/jop.2012.0075; Saggu SK, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-97; Takeda H, 2007, BRAIN RES, V1184, P306, DOI 10.1016/j.brainres.2007.09.055; Wang KW, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00039; Wang N, 2001, NAT MED, V7, P304, DOI 10.1038/85446; Zaidi NF, 2004, J NEUROCHEM, V89, P593, DOI 10.1046/j.1471-4159.2004.02362.x; Zhang X, 2004, INVEST OPHTH VIS SCI, V45, P2374, DOI 10.1167/iovs.03-1239; Zhang Y, 2010, J NEUROSCI, V30, P7575, DOI 10.1523/JNEUROSCI.1312-10.2010	32	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0127776	10.1371/journal.pone.0127776	http://dx.doi.org/10.1371/journal.pone.0127776			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020793	Green Published, gold, Green Submitted			2022-12-26	WOS:000355187300055
J	Millow, CJ; Mackintosh, SA; Lewison, RL; Dodder, NG; Hoh, E				Millow, Christopher J.; Mackintosh, Susan A.; Lewison, Rebecca L.; Dodder, Nathan G.; Hoh, Eunha			Identifying Bioaccumulative Halogenated Organic Compounds Using a Nontargeted Analytical Approach: Seabirds as Sentinels	PLOS ONE			English	Article							FLIGHT MASS-SPECTROMETRY; EGGS; PERSISTENT; MERCURY; POLLUTANTS; TRICLOSAN; TRIS(4-CHLOROPHENYL)METHANOL; ORGANOCHLORINES; IDENTIFICATION; CONTAMINANTS	Persistent organic pollutants (POPs) are typically monitored via targeted mass spectrometry, which potentially identifies only a fraction of the contaminants actually present in environmental samples. With new anthropogenic compounds continuously introduced to the environment, novel and proactive approaches that provide a comprehensive alternative to targeted methods are needed in order to more completely characterize the diversity of known and unknown compounds likely to cause adverse effects. Nontargeted mass spectrometry attempts to extensively screen for compounds, providing a feasible approach for identifying contaminants that warrant future monitoring. We employed a nontargeted analytical method using comprehensive two-dimensional gas chromatography coupled to time-of-flight mass spectrometry (GCxGC/TOF-MS) to characterize halogenated organic compounds (HOCs) in California Black skimmer (Rynchops niger) eggs. Our study identified 111 HOCs; 84 of these compounds were regularly detected via targeted approaches, while 27 were classified as typically unmonitored or unknown. Typically unmonitored compounds of note in bird eggs included tris(4-chlorophenyl) methane (TCPM), tris(4-chlorophenyl) methanol (TCPMOH), triclosan, permethrin, heptachloro-1'-methyl-1,2'-bipyrrole (MBP), as well as four halogenated unknown compounds that could not be identified through database searching or the literature. The presence of these compounds in Black skimmer eggs suggests they are persistent, bioaccumulative, potentially biomagnifying, and maternally transferring. Our results highlight the utility and importance of employing nontargeted analytical tools to assess true contaminant burdens in organisms, as well as to demonstrate the value in using environmental sentinels to proactively identify novel contaminants.	[Millow, Christopher J.; Lewison, Rebecca L.] San Diego State Univ, Dept Biol, Ecol Program Area, San Diego, CA 92182 USA; [Mackintosh, Susan A.; Hoh, Eunha] San Diego State Univ, Grad Sch Publ Hlth, San Diego, CA 92182 USA; [Mackintosh, Susan A.] San Diego State Univ, Res Fdn, San Diego, CA 92182 USA; [Dodder, Nathan G.] Southern Calif Coastal Water Res Project Author, Costa Mesa, CA USA	California State University System; San Diego State University; California State University System; San Diego State University; California State University System; San Diego State University; Southern California Coastal Water Research Project	Millow, CJ (corresponding author), San Diego State Univ, Dept Biol, Ecol Program Area, San Diego, CA 92182 USA.	cmillow@gmail.com	Dodder, Nathan/C-7971-2015	Dodder, Nathan/0000-0001-5913-1767; Lewison, Rebecca/0000-0003-3065-2926; Hoh, Eunha/0000-0002-4075-040X	Environmental Protection Agency Science to Achieve Results Graduate Fellowship [FP-91748601-0]; San Diego State University Grant Program; California State University Program for Education and Research in Biotechnology; National Institute of Environmental Health Sciences - Oceans and Human Health Program [P01-ES021921]; California State University Council on Ocean Affairs, Science, and Technology Graduate Research Award; Waterbird Society, Nisbet Award; Association of Field Ornithologists, Bergstrom Award; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES021921] Funding Source: NIH RePORTER	Environmental Protection Agency Science to Achieve Results Graduate Fellowship; San Diego State University Grant Program; California State University Program for Education and Research in Biotechnology; National Institute of Environmental Health Sciences - Oceans and Human Health Program; California State University Council on Ocean Affairs, Science, and Technology Graduate Research Award; Waterbird Society, Nisbet Award; Association of Field Ornithologists, Bergstrom Award; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was funded in part by the following entities and organizations: Environmental Protection Agency Science to Achieve Results Graduate Fellowship: FP-91748601-0, (http://www.epa.gov/ncer/fellowships/CJM), San Diego State University Grant Program, (http://newscenter.sdsu.edu/researchaffairs/ugp.aspx RLL, EH), California State University Program for Education and Research in Biotechnology, (http://www.calstate.edu/csuperb/grants/ EH); National Institute of Environmental Health Sciences - Oceans and Human Health Program: P01-ES021921, (http://www.niehs.nih.gov/research/supported/dert/programs/oceans/EH), California State University Council on Ocean Affairs, Science, and Technology Graduate Research Award (http://www.calstate.edu/coast/funding/internal_funding.shtml#studentAward CJM), the Waterbird Society, Nisbet Award (http://www.waterbirds.org/grants/nisbet-research-award CJM), and the Association of Field Ornithologists, Bergstrom Award(http:/www.afonet.org/grants/Bergstrom/Bergstrom.html CJM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman JT, 2007, SCI TOTAL ENVIRON, V384, P452, DOI 10.1016/j.scitotenv.2007.04.027; Alonso MB, 2012, ENVIRON INT, V47, P99, DOI 10.1016/j.envint.2012.06.010; Braune BM, 2001, ENVIRON POLLUT, V114, P39, DOI 10.1016/S0269-7491(00)00210-4; Brown FR, 2006, CHEMOSPHERE, V64, P276, DOI 10.1016/j.chemosphere.2005.12.012; Burger J, 2002, ENVIRON RES, V90, P33, DOI 10.1006/enrs.2002.4381; Burger J., 1990, BLACK SKIMMER SOCIAL; BUSER HR, 1995, ENVIRON SCI TECHNOL, V29, P2133, DOI 10.1021/es00008a036; Celo V, 2006, SCI TOTAL ENVIRON, V368, P126, DOI 10.1016/j.scitotenv.2005.09.043; Corsolini S, 2007, ENVIRON SCI POLLUT R, V14, P421, DOI 10.1065/espr2006.01.017; Crosse JD, 2012, ENVIRON POLLUT, V161, P93, DOI 10.1016/j.envpol.2011.10.003; Elliott JE, 2013, SCIENCE, V340, P556, DOI 10.1126/science.1235197; Falandysz J, 1999, ENVIRON SCI TECHNOL, V33, P517, DOI 10.1021/es980548u; Fernie KJ, 2009, ENVIRON SCI TECHNOL, V43, P2124, DOI 10.1021/es8027346; Finkelstein ME, 2007, ENVIRON TOXICOL CHEM, V26, P1896, DOI 10.1897/06-505R.1; Foster CR, 2009, ESTUAR COAST, V32, P1079, DOI 10.1007/s12237-009-9224-2; Gilbertson M., 1987, International Council for Bird Preservation Technical Publication, P231; Halden AN, 2010, AQUAT TOXICOL, V100, P30, DOI 10.1016/j.aquatox.2010.07.010; Harris HH, 2003, SCIENCE, V301, P1203, DOI 10.1126/science.1085941; Hoh E, 2012, ENVIRON SCI TECHNOL, V46, P8001, DOI 10.1021/es301139q; Hoh E, 2009, ENVIRON SCI TECHNOL, V43, P3240, DOI 10.1021/es803486x; Holmstrand H, 2010, APPL GEOCHEM, V25, P1301, DOI 10.1016/j.apgeochem.2010.06.001; Howard PH, 2010, ENVIRON SCI TECHNOL, V44, P2277, DOI 10.1021/es903383a; JARMAN WM, 1992, ENVIRON SCI TECHNOL, V26, P1770, DOI 10.1021/es00033a009; Johansson AK, 2009, ENVIRON TOXICOL CHEM, V28, P9, DOI 10.1897/08-142.1; Kannan K, 2004, ENVIRON POLLUT, V131, P425, DOI 10.1016/j.envpol.2004.03.004; Karlsson H, 1999, ENVIRON SCI TECHNOL, V33, P1353, DOI 10.1021/es9809962; Komoroske LM, 2011, CHEMOSPHERE, V84, P544, DOI 10.1016/j.chemosphere.2011.04.023; Koschier F, 2011, FOOD CHEM TOXICOL, V49, P2074, DOI 10.1016/j.fct.2011.05.019; Lavoie RA, 2010, ENVIRON POLLUT, V158, P2189, DOI 10.1016/j.envpol.2010.02.016; Lebeuf M, 2014, SCI TOTAL ENVIRON, V485, P377, DOI 10.1016/j.scitotenv.2014.03.097; Long ER, 2000, ECOL APPL, V10, P338, DOI 10.1890/1051-0761(2000)010[0338:DSQIUS]2.0.CO;2; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Mathews S, 2014, ENVIRON SCI POLLUT R, V21, P6025, DOI 10.1007/s11356-013-2474-3; Molina KC, 2008, CALIFORNIA BIRD SPEC, P199; Muir DCG, 2006, ENVIRON SCI TECHNOL, V40, P7157, DOI 10.1021/es061677a; Nash SMB, 2008, SCI TOTAL ENVIRON, V407, P304, DOI 10.1016/j.scitotenv.2008.08.034; Owen TM, 2013, WATERBIRDS, V36, P342, DOI 10.1675/063.036.0311; Pangallo K, 2008, CHEMOSPHERE, V71, P1557, DOI 10.1016/j.chemosphere.2007.11.051; Perron MM, 2012, ENVIRON TOXICOL CHEM, V31, P1861, DOI 10.1002/etc.1884; Prosser RS, 2014, ENVIRON TOXICOL CHEM, V33, P975, DOI 10.1002/etc.2505; Reddy CM, 2004, ENVIRON SCI TECHNOL, V38, P1992, DOI 10.1021/es030568i; Rochman CM, 2013, ENVIRON SCI TECHNOL, V47, P1646, DOI 10.1021/es303700s; Shaul NJ, 2015, ENVIRON SCI TECHNOL, V49, P1328, DOI 10.1021/es505156q; Skarphedinsdottir H, 2010, ARCH ENVIRON CON TOX, V58, P800, DOI 10.1007/s00244-009-9376-x; Tittlemier SA, 1999, ENVIRON SCI TECHNOL, V33, P26, DOI 10.1021/es980646f; Van den Steen E, 2009, ENVIRON POLLUT, V157, P430, DOI 10.1016/j.envpol.2008.09.031; Vetter W, 2002, ANAL CHEM, V74, P4287, DOI 10.1021/ac025696o; Vetter W, 2008, ANAL BIOANAL CHEM, V392, P489, DOI 10.1007/s00216-008-2277-4; Vetter W, 2006, REV ENVIRON CONTAM T, V188, P1, DOI 10.1007/978-0-387-32964-2_1; WALKER W, 1989, CHEMOSPHERE, V18, P1799, DOI 10.1016/0045-6535(89)90463-3; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Zeeman C, 2008, CHARACTERIZING EXPOS; Zeeman CQT, 2004, ECOLOGICAL RISK BASE; ZOOK DR, 1992, AMBIO, V21, P557	54	31	31	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0127205	10.1371/journal.pone.0127205	http://dx.doi.org/10.1371/journal.pone.0127205			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020245	Green Published, Green Submitted, gold			2022-12-26	WOS:000355187300034
J	Brenndorfer, J; Altmann, A; Widner-Andra, R; Putz, B; Czamara, D; Tilch, E; Kam-Thong, T; Weber, P; Rex-Haffner, M; Bettecken, T; Bultmann, A; Muller-Myhsok, B; Binder, EE; Landgraf, R; Czibere, L				Brenndoerfer, Julia; Altmann, Andre; Widner-Andrae, Regina; Puetz, Benno; Czamara, Darina; Tilch, Erik; Kam-Thong, Tony; Weber, Peter; Rex-Haffner, Monika; Bettecken, Thomas; Bultmann, Andrea; Mueller-Myhsok, Bertram; Binder, Elisabeth E.; Landgraf, Rainer; Czibere, Ludwig			Connecting Anxiety and Genomic Copy Number Variation: A Genome-Wide Analysis in CD-1 Mice	PLOS ONE			English	Article							REAL-TIME PCR; GENE-EXPRESSION; GLYOXALASE-I; STRUCTURAL VARIATION; CANDIDATE GENES; ANIMAL-MODEL; DE-NOVO; MOUSE; KINASE; DISORDER	Genomic copy number variants (CNVs) have been implicated in multiple psychiatric disorders, but not much is known about their influence on anxiety disorders specifically. Using next-generation sequencing (NGS) and two additional array-based genotyping approaches, we detected CNVs in a mouse model consisting of two inbred mouse lines showing high (HAB) and low (LAB) anxiety-related behavior, respectively. An influence of CNVs on gene expression in the central (CeA) and basolateral (BLA) amygdala, paraventricular nucleus (PVN), and cingulate cortex (Cg) was shown by a two-proportion Z-test (p = 1.6 x 10(-31)), with a positive correlation in the CeA (p = 0.0062), PVN (p = 0.0046) and Cg (p = 0.0114), indicating a contribution of CNVs to the genetic predisposition to trait anxiety in the specific context of HAB/LAB mice. In order to confirm anxiety-relevant CNVs and corresponding genes in a second mouse model, we further examined CD-1 outbred mice. We revealed the distribution of CNVs by genotyping 64 CD 1 individuals using a high-density genotyping array (Jackson Laboratory). 78 genes within those CNVs were identified to show nominally significant association (48 genes), or a statistical trend in their association (30 genes) with the time animals spent on the open arms of the elevated plus-maze (EPM). Fifteen of them were considered promising candidate genes of anxiety-related behavior as we could show a significant overlap (permutation test, p = 0.0051) with genes within HAB/LAB CNVs. Thus, here we provide what is to our knowledge the first extensive catalogue of CNVs in CD-1 mice and potential corresponding candidate genes linked to anxiety-related behavior in mice.	[Brenndoerfer, Julia; Widner-Andrae, Regina; Bettecken, Thomas; Bultmann, Andrea; Landgraf, Rainer; Czibere, Ludwig] Max Planck Inst Psychiat, Dept Behav Neuroendocrinol, Munich, Germany; [Altmann, Andre; Puetz, Benno; Czamara, Darina; Kam-Thong, Tony; Mueller-Myhsok, Bertram] Max Planck Inst Psychiat, Dept Stat Genet, D-80804 Munich, Germany; [Weber, Peter; Rex-Haffner, Monika; Binder, Elisabeth E.] Max Planck Inst Psychiat, Dept Mol Genet Affect Disorders, D-80804 Munich, Germany; [Tilch, Erik] Helmholtz Zentrum Munchen, Inst Human Genet, Munich, Germany; [Tilch, Erik] Tech Univ Munich, Inst Human Genet, D-80290 Munich, Germany	Max Planck Society; Max Planck Society; Max Planck Society; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Brenndorfer, J (corresponding author), Max Planck Inst Psychiat, Dept Behav Neuroendocrinol, Munich, Germany.	jbrenndoerfer@mpipsykl.mpg.de	Altmann, Andre/ABF-1675-2020	Altmann, Andre/0000-0002-9265-2393; Czibere, Ludwig/0000-0002-7508-5841	Max Planck Institute of Psychiatry	Max Planck Institute of Psychiatry(Max Planck Society)	This study was funded by the Max Planck Institute of Psychiatry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkan C, 2011, NAT REV GENET, V12, P363, DOI 10.1038/nrg2958; Almal SH, 2012, J HUM GENET, V57, P6, DOI 10.1038/jhg.2011.108; Altmann A, 2012, HUM GENET, V131, P1541, DOI 10.1007/s00439-012-1213-z; Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Barclay AN, 2006, NAT REV IMMUNOL, V6, P457, DOI 10.1038/nri1859; Belonogova NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065395; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernardo V, 2013, ANAL BIOCHEM, V432, P131, DOI 10.1016/j.ab.2012.09.029; Bochukova EG, 2010, NATURE, V463, P666, DOI 10.1038/nature08689; Brasch-Andersen C, 2004, HUM MUTAT, V24, P208, DOI 10.1002/humu.20074; Cahan P, 2009, NAT GENET, V41, P430, DOI 10.1038/ng.350; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Cobb MH, 1999, PROG BIOPHYS MOL BIO, V71, P479, DOI 10.1016/S0079-6107(98)00056-X; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; Cutler G, 2007, GENOME RES, V17, P1743, DOI 10.1101/gr.6754607; Czibere L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023604; Di Benedetto B, 2009, NEUROPSYCHOPHARMACOL, V34, P356, DOI 10.1038/npp.2008.57; Diekstra FP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035333; Distler Margaret G., 2012, Frontiers in Genetics, V3, P250, DOI 10.3389/fgene.2012.00250; Distler MG, 2012, J CLIN INVEST, V122, P2306, DOI 10.1172/JCI61319; Farber CR, 2013, G3-GENES GENOM GENET, V3, P119, DOI 10.1534/g3.112.004788; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Fujimoto M, 2008, NEUROSCI LETT, V438, P196, DOI 10.1016/j.neulet.2008.04.024; Graubert TA, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030003; Grayton HM, 2012, PROG NEUROBIOL, V99, P81, DOI 10.1016/j.pneurobio.2012.07.005; Hambsch B, 2010, J NEUROCHEM, V113, P1240, DOI 10.1111/j.1471-4159.2010.06693.x; Haraksingh RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027859; Hayashi A, 2004, J BIOL CHEM, V279, P29450, DOI 10.1074/jbc.M400950200; Henrichsen CN, 2009, NAT GENET, V41, P424, DOI 10.1038/ng.345; Henrichsen CN, 2009, HUM MOL GENET, V18, pR1, DOI 10.1093/hmg/ddp011; HOLM S, 1979, SCAND J STAT, V6, P65; Hovatta I, 2005, NATURE, V438, P662, DOI 10.1038/nature04250; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Jeon JP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-426; Jurek B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037060; Kam-Thong T, 2012, HUM HERED, V73, P220, DOI 10.1159/000341885; Kam-Thong T, 2011, EUR J HUM GENET, V19, P465, DOI 10.1038/ejhg.2010.196; Kawamura Y, 2011, J HUM GENET, V56, P852, DOI 10.1038/jhg.2011.117; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kharitonenkov A, 1997, NATURE, V386, P181, DOI 10.1038/386181a0; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Kollmannsberger LK, 2013, G3-GENES GENOM GENET, V3, P1311, DOI 10.1534/g3.113.006445; Kromer SA, 2005, J NEUROSCI, V25, P4375, DOI 10.1523/JNEUROSCI.0115-05.2005; Lachman HM, 2007, AM J MED GENET B, V144B, P259, DOI 10.1002/ajmg.b.30498; Landgraf R, 2002, BEHAV GENET, V32, P301, DOI 10.1023/A:1020258104318; Landgraf R, 2007, NEUROSCI BIOBEHAV R, V31, P89, DOI 10.1016/j.neubiorev.2006.07.003; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Levy D, 2011, NEURON, V70, P886, DOI 10.1016/j.neuron.2011.05.015; Levy RJ, 2012, METHODS MOL BIOL, V838, P97, DOI 10.1007/978-1-61779-507-7_4; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liebsch G, 1998, BEHAV BRAIN RES, V94, P301, DOI 10.1016/S0166-4328(97)00198-8; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUPSKI JR, 1992, NAT GENET, V1, P29, DOI 10.1038/ng0492-29; Malhotra D, 2012, CELL, V148, P1223, DOI 10.1016/j.cell.2012.02.039; Malhotra D, 2011, NEURON, V72, P951, DOI 10.1016/j.neuron.2011.11.007; Orton RJ, 2005, BIOCHEM J, V392, P249, DOI 10.1042/BJ20050908; Paxinos G., 2001, MOUSE BRAIN STEREOTA; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Pinto D, 2011, NAT BIOTECHNOL, V29, P512, DOI 10.1038/nbt.1852; Plomin R, 2009, NAT REV GENET, V10, P872, DOI 10.1038/nrg2670; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Roberts PC, 2008, BIOTECHNOL ANN REV, V14, P29, DOI 10.1016/S1387-2656(08)00002-1; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Rucker JJH, 2013, MOL PSYCHIATR, V18, P183, DOI 10.1038/mp.2011.144; Sartori SB, 2011, FUTUR NEUROL, V6, P531, DOI 10.2217/FNL.11.34; Shlien A, 2009, GENOME MED, V1, DOI 10.1186/gm62; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; St Clair D, 2009, SCHIZOPHRENIA BULL, V35, P9, DOI 10.1093/schbul/sbn147; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Thornalley PJ, 2006, TRENDS MOL MED, V12, P195, DOI 10.1016/j.molmed.2006.03.004; Touma C, 2008, PSYCHONEUROENDOCRINO, V33, P839, DOI 10.1016/j.psyneuen.2008.03.013; Touma C, 2011, BIOL PSYCHIAT, V70, P928, DOI 10.1016/j.biopsych.2011.07.023; van de Wiel MA, 2011, BRIEF BIOINFORM, V12, P10, DOI 10.1093/bib/bbq004; Vrijenhoek T, 2008, AM J HUM GENET, V83, P504, DOI 10.1016/j.ajhg.2008.09.011; Warden M, 2011, METHODS MOL BIOL, V719, P235, DOI 10.1007/978-1-61779-027-0_11; Wefers B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035035; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Widner-Andra R, 2011, THESIS; Williams R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004649; Wu CT, 1999, CURR OPIN GENET DEV, V9, P237, DOI 10.1016/S0959-437X(99)80035-5; Xi RB, 2010, BRIEF FUNCT GENOMICS, V9, P405, DOI 10.1093/bfgp/elq025; Yang H, 2011, MOUSEDIVGENO VIGNETT; Yang H, 2010, MOUSEDIVGENO TOOLS A; Yang H, 2009, NAT METHODS, V6, P663, DOI [10.1038/NMETH.1359, 10.1038/nmeth.1359]; Zhang DD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014511	91	3	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128465	10.1371/journal.pone.0128465	http://dx.doi.org/10.1371/journal.pone.0128465			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011321	Green Published, gold, Green Submitted			2022-12-26	WOS:000355183900238
J	Chikan, NA; Bukhari, S; Shabir, N; Amin, A; Shafi, S; Qadri, RA; Patel, TNC				Chikan, Naveed Anjum; Bukhari, Shoiab; Shabir, Nadeem; Amin, Asif; Shafi, Sheikh; Qadri, Raies Ahmad; Patel, Trupti Navin Chandra			Atomic Insight into the Altered O-6-Methylguanine-DNA Methyltransferase Protein Architecture in Gastric Cancer	PLOS ONE			English	Article							N-NITROSO COMPOUNDS; HUMAN O(6)-ALKYLGUANINE-DNA ALKYLTRANSFERASE; AMINO-ACID SUBSTITUTIONS; LUNG-CANCER; DNA-REPAIR; MOLECULAR-DYNAMICS; RISK; POLYMORPHISMS; MUTATIONS; KASHMIR	O-6-methylguanine-DNA methyltransferase (MGMT) is one of the major DNA repair protein that counteracts the alkalyting agent-induced DNA damage by replacing O-6-methylguanine (mutagenic lesion) back to guanine, eventually suppressing the mismatch errors and double strand crosslinks. Exonic alterations in the form of nucleotide polymorphism may result in altered protein structure that in turn can lead to the loss of function. In the present study, we focused on the population feared for high exposure to alkylating agents owing to their typical and specialized dietary habits. To this end, gastric cancer patients pooled out from the population were selected for the mutational screening of a specific error prone region of MGMT gene. We found that nearly 40% of the studied neoplastic samples harbored missense mutation at codon(151) resulting into Serine to Isoleucine variation. This variation resulted in bringing about the structural disorder, subsequently ensuing into a major stoichiometric variance in recognition domain, substrate binding and selectivity loop of the active site of the MGMT protein, as observed under virtual microscope of molecular dynamics simulation (MDS). The atomic insight into MGMT protein by computational approach showed a significant change in the intra molecular hydrogen bond pattern, thus leading to the observed structural anomalies. To further examine the mutational implications on regulatory plugs of MGMT that holds the protein in a DNA-Binding position, a MDS based analysis was carried out on, all known physically interacting amino acids essentially clustered into groups based on their position and function. The results generated by physical-functional clustering of protein indicated that the identified mutation in the vicinity of the active site of MGMT protein causes the local and global destabilization of a protein by either eliminating the stabilizing salt bridges in cluster C3, C4, and C5 or by locally destabilizing the "protein stabilizing hing" mapped on C3-C4 cluster, preceding the active site.	[Chikan, Naveed Anjum; Patel, Trupti Navin Chandra] VIT Univ, Sch Biosci & Technol, Div Med Biotechnol, Vellore 632014, Tamil Nadu, India; [Chikan, Naveed Anjum; Bukhari, Shoiab; Amin, Asif; Qadri, Raies Ahmad] Univ Kashmir, Dept Biotechnol, Srinagar 190006, Kashmir, India; [Shabir, Nadeem] Anand Agr Univ, Coll Vet Sci, Dept Anim Biotechnol, Anand 388001, Gujarat, India; [Shafi, Sheikh] Sherikashmir Inst Med Sci, Dept Clin Biochem, Srinagar 190011, Kashmir, India	Vellore Institute of Technology; University of Kashmir; Anand Agricultural University; Sher-i-Kashmir Institute of Medical Sciences	Patel, TNC (corresponding author), VIT Univ, Sch Biosci & Technol, Div Med Biotechnol, Vellore 632014, Tamil Nadu, India.	tnpatel@vit.ac.in	Shabir, Nadeem/AAY-9151-2020; Patel, Trupti N/F-6301-2017; Patel, Trupti/AAR-3277-2021; CHIKAN, NAVEED/N-5912-2014	Shabir, Nadeem/0000-0001-6358-5251; Patel, Trupti N/0000-0002-7941-602X; Patel, Trupti/0000-0002-7941-602X; CHIKAN, NAVEED/0000-0002-5977-0531; Bukhari, Shoiab/0000-0002-1172-7139; Qadri, Raies A./0000-0001-6018-4786	VIT University research associate grant	VIT University research associate grant	The research was funded by VIT University research associate grant and the funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accelrys Software Inc, 2012, DISC STUD MOD ENV RE; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Amadei A, 1996, J BIOMOL STRUCT DYN, V13, P615, DOI 10.1080/07391102.1996.10508874; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bromberg Y, 2007, NUCLEIC ACIDS RES, V35, P3823, DOI 10.1093/nar/gkm238; Bukhari S, 2015, MOL BIOSYST, V11, P159, DOI 10.1039/c4mb00506f; Calabrese R, 2009, HUM MUTAT, V30, P1237, DOI 10.1002/humu.21047; Capriotti E, 2006, BIOINFORMATICS, V22, P2729, DOI 10.1093/bioinformatics/btl423; CHEATHAM TE, 1995, J AM CHEM SOC, V117, P4193, DOI 10.1021/ja00119a045; Chikan NA, 2012, ASIAN PAC J CANCER P, V13, P1077, DOI 10.7314/APJCP.2012.13.3.1077; Cohet C, 2004, CANCER EPIDEM BIOMAR, V13, P320, DOI 10.1158/1055-9965.EPI-03-0120; Daniels DS, 2000, MUTAT RES-DNA REPAIR, V460, P151, DOI 10.1016/S0921-8777(00)00024-0; Daniels DS, 2000, EMBO J, V19, P1719, DOI 10.1093/emboj/19.7.1719; Daniels DS, 2004, NAT STRUCT MOL BIOL, V11, P714, DOI 10.1038/nsmb791; DHAR GM, 1993, J EPIDEMIOL COMMUN H, V47, P290, DOI 10.1136/jech.47.4.290; Doss CGP, 2014, ADV PROTEIN CHEM STR, V94, P177, DOI 10.1016/B978-0-12-800168-4.00006-8; Duguid EM, 2005, J MOL BIOL, V350, P657, DOI 10.1016/j.jmb.2005.05.028; Edara S, 1999, CARCINOGENESIS, V20, P103, DOI 10.1093/carcin/20.1.103; Egyhazi S, 2002, Hum Mutat, V20, P408, DOI 10.1002/humu.9078; El-Rifai W, 2002, SEMIN RADIAT ONCOL, V12, P128, DOI 10.1053/srao.2002.30815; Engelbergs J, 2000, MUTAT RES-FUND MOL M, V450, P139, DOI 10.1016/S0027-5107(00)00021-X; Ferlay J, 2014, INT J CANC; Fiocca R, 2001, HEPATO-GASTROENTEROL, V48, P1523; Ford BN, 2000, CARCINOGENESIS, V21, P1977, DOI 10.1093/carcin/21.11.1977; George Doss C Priya, 2014, Theranostics, V4, P366, DOI 10.7150/thno.7473; George P. D. C., 2014, SCI REPORTS, V4; Gonnelli G, 2012, J BIOTECHNOL, V161, P287, DOI 10.1016/j.jbiotec.2012.06.020; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; ITO T, 1994, MUTAT RES, V314, P273, DOI 10.1016/0921-8777(94)90071-X; Kaur TB, 2000, CANCER EPIDEM BIOMAR, V9, P339; KHUROO MS, 1992, GUT, V33, P11, DOI 10.1136/gut.33.1.11; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; KUMAR R, 1990, CANCER LETT, V54, P61, DOI 10.1016/0304-3835(90)90092-C; Li B, 2009, BIOINFORMATICS, V25, P2744, DOI 10.1093/bioinformatics/btp528; Li CP, 2005, CANCER LETT, V227, P49, DOI 10.1016/j.canlet.2005.03.043; MONTESANO R, 1985, BIOCHIMIE, V67, P919, DOI 10.1016/S0300-9084(85)80288-1; NAKATSURU Y, 1991, MUTAT RES, V254, P225, DOI 10.1016/0921-8777(91)90060-3; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; PEGG AE, 1992, FASEB J, V6, P2302, DOI 10.1096/fasebj.6.6.1544541; PEGG AE, 1990, CANCER RES, V50, P6119; Petsko G., 2004, PROTEIN STRUCTURE FU; Priyadharshini C. J., 2014, FRONTIERS BIOSCIENCE, V20, P335; Sakumi K, 1997, CANCER RES, V57, P2415; Sekiguchi M, 1996, J CANCER RES CLIN, V122, P199, DOI 10.1007/BF01209646; SIDDIQI M, 1988, CANCER LETT, V39, P37, DOI 10.1016/0304-3835(88)90038-9; SIDDIQI M, 1988, CANCER LETT, V39, P259, DOI 10.1016/0304-3835(88)90068-7; Turner, 2005, XMGRACE VERSION 51 1; Wang L, 2006, CANCER EPIDEM BIOMAR, V15, P2364, DOI 10.1158/1055-9965.EPI-06-0437; Warren JJ, 2006, P NATL ACAD SCI USA, V103, P19701, DOI 10.1073/pnas.0609580103; Wibley JEA, 2000, NUCLEIC ACIDS RES, V28, P393, DOI 10.1093/nar/28.2.393; Yang MH, 2004, LUNG CANCER, V44, P281, DOI 10.1016/j.lungcan.2003.12.003; Zheng Leizhen, 2004, Gastric Cancer, V7, P61	53	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127741	10.1371/journal.pone.0127741	http://dx.doi.org/10.1371/journal.pone.0127741			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011121	Green Submitted, gold, Green Published			2022-12-26	WOS:000355183900137
J	Dubey, A; Goswami, M; Yadav, K; Chaudhary, D				Dubey, Akhilesh; Goswami, Mukunda; Yadav, Kamalendra; Chaudhary, Dharmendra			Oxidative Stress and Nano-Toxicity Induced by TiO2 and ZnO on WAG Cell Line	PLOS ONE			English	Article							TITANIUM-DIOXIDE NANOPARTICLES; IN-VITRO; MANUFACTURED NANOPARTICLES; SILVER NANOPARTICLES; PARTICLE-SIZE; CATLA-CATLA; GILL TISSUE; FISH; CYTOTOXICITY; ECOTOXICOLOGY	Metallic nanoparticles are widely used in cosmetics, food products and textile industry. These particles are known to cause respiratory toxicity and epithelial inflammation. They are eventually released to aquatic environment necessitating toxicity studies in cells from respiratory organs of aquatic organisms. Hence, we have developed and characterized a new cell line, WAG, from gill tissue of Wallago attu for toxicity assessment of TiO2 and ZnO nanoparticles. The efficacy of the cell line as an in vitro system for nanoparticles toxicity studies was established using electron microscopy, cytotoxicity assays, genotoxicity assays and oxidative stress biomarkers. Results obtained with MTT assay, neutral red uptake assay and lactate dehydrogenase assay showed acute toxicity to WAG cells with IC50 values of 25.29+/-0.12, 34.99+/-0.09 and 35.06+/-0.09 mg/l for TiO2 and 5.716+/-0.1, 3.160+/-0.1 and 5.57+/-0.12 mg/l for ZnO treatment respectively. The physicochemical properties and size distribution of nanoparticles were characterized using electron microscopy with integrated energy dispersive X-ray spectroscopy and Zetasizer. Dose dependent increase in DNA damage, lipid peroxidation and protein carbonylation along with a significant decrease in activity of Superoxide Dismutase, Catalase, total Glutathione levels and total antioxidant capacity with increasing concentration of exposed nanoparticles indicated that the cells were under oxidative stress. The study established WAG cell line as an in vitro system to study toxicity mechanisms of nanoparticles on aquatic organisms.	[Dubey, Akhilesh; Goswami, Mukunda; Chaudhary, Dharmendra] Natl Bur Fish Genet Resources, Lucknow, Uttar Pradesh, India; [Yadav, Kamalendra] Natl Agri Food Biotechnol Inst, Mohali, Punjab, India	Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Fish Genetic Resources; Department of Biotechnology (DBT) India; National Agri Food Biotechnology Institute (NABI)	Goswami, M (corresponding author), Natl Bur Fish Genet Resources, Lucknow, Uttar Pradesh, India.	mukugoswami@gmail.com			Department of Biotechnology, India [BT/PR13538/AAQ/03/506/2010]	Department of Biotechnology, India(Department of Biotechnology (DBT) India)	Department of Biotechnology, India is deeply acknowledged for the financial support. Grant number: BT/PR13538/AAQ/03/506/2010; dated 09.11.2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SM, 1996, INTERCONNECTIONS HUM, P91; Aitken RJ, 2006, OCCUP MED-OXFORD, V56, P300, DOI 10.1093/occmed/kql051; ALVAREZ MC, 1991, J FISH BIOL, V39, P817, DOI 10.1111/j.1095-8649.1991.tb04411.x; AshaRani PV, 2009, ACS NANO, V3, P279, DOI 10.1021/nn800596w; BeruBe K, 2007, CLIN EXP PHARMACOL P, V34, P1044, DOI 10.1111/j.1440-1681.2007.04733.x; Bols NC, 2005, BIOCH MOLEC, V6, P43; Bols NC, 2001, DEV COMP IMMUNOL, V25, P853, DOI 10.1016/S0145-305X(01)00040-4; Braydich-Stolle LK, 2009, J NANOPART RES, V11, P1361, DOI 10.1007/s11051-008-9523-8; Cadet J, 1999, MUTAT RES-FUND MOL M, V424, P9, DOI 10.1016/S0027-5107(99)00004-4; Castano A, 2003, ATLA-ALTERN LAB ANIM, V31, P317, DOI 10.1177/026119290303100314; Chen JS, 2004, J ENVIRON MANAGE, V70, P43, DOI 10.1016/j.jenvman.2003.09.019; Daughton CG, 1999, ENVIRON HEALTH PERSP, V107, P907, DOI 10.2307/3434573; Dayeh VR, 2002, WATER RES, V36, P3727, DOI 10.1016/S0043-1354(02)00078-7; Dechsakulthorn F., 2007, AATEX, V14, P397, DOI DOI 10.1021/NL0517480; Dubey A, 2014, MOL BIOL REP, V41, P915, DOI 10.1007/s11033-013-2936-1; Evans DH, 1987, ENV HLTH PERSPECT, V71, P54, DOI DOI 10.2307/3430412; Federici G, 2007, AQUAT TOXICOL, V84, P415, DOI 10.1016/j.aquatox.2007.07.009; FERIN J, 1985, AM IND HYG ASSOC J, V46, P69, DOI 10.1202/0002-8894(1985)046<0069:BEATAO>2.3.CO;2; Freshney R.I, 2010, CULTURE ANIMAL CELLS, Vsixth, P732; Goswami M, 2014, DRUG CHEM TOXICOL, V37, P48, DOI 10.3109/01480545.2013.806531; Handy RD, 2007, HEALTH RISK SOC, V9, P125, DOI 10.1080/13698570701306807; Handy RD, 2008, ECOTOXICOLOGY, V17, P287, DOI 10.1007/s10646-008-0199-8; Hussain S, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-10; Hussain SM, 2005, TOXICOL IN VITRO, V19, P975, DOI 10.1016/j.tiv.2005.06.034; Kreuter J, 2008, TUMORI J, V94, P271; Kumar C, 2006, NANOMATERIALS TOXICI, V5; Lee LEJ, 2009, IN VITRO CELL DEV-AN, V45, P127, DOI 10.1007/s11626-008-9173-2; Majeed SA, 2013, CELL BIOL TOXICOL, V29, P59, DOI 10.1007/s10565-012-9237-7; Monserrat JM, 2007, COMP BIOCHEM PHYS C, V146, P221, DOI 10.1016/j.cbpc.2006.08.012; Nativo P, 2008, ACS NANO, V2, P1639, DOI 10.1021/nn800330a; Nemmar A, 2002, CIRCULATION, V105, P411, DOI 10.1161/hc0402.104118; Notter DA, 2014, ENVIRON TOXICOL CHEM, V33, P2733, DOI 10.1002/etc.2732; Nurkiewicz TR, 2006, ENVIRON HEALTH PERSP, V114, P412, DOI 10.1289/ehp.8413; Ogino C, 2007, J BIOSCI BIOENG, V104, P339, DOI 10.1263/jbb.104.339; Palumbi S, 1991, SIMPLE FOOLS GUIDE P; Pan D, 2015, NANOMEDICINE: A SOFT MATTER PERSPECTIVE, P131; Pujalte I, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-10; Raisuddin S, 2004, ENVIRON MOL MUTAGEN, V44, P83, DOI 10.1002/em.20027; Saquib Q, 2012, TOXICOL IN VITRO, V26, P351, DOI 10.1016/j.tiv.2011.12.011; Schirmer K, 2006, TOXICOLOGY, V224, P163, DOI 10.1016/j.tox.2006.04.042; Setyan A, 2009, PHYS CHEM CHEM PHYS, V11, P6205, DOI 10.1039/b902509j; Skubal LR, 2002, J PHOTOCH PHOTOBIO A, V148, P393, DOI 10.1016/S1010-6030(02)00069-2; Song L, 2014, NANOTOXICOLOGY, V8, P383, DOI 10.3109/17435390.2013.790997; Su JF, 2008, J NANOSCI NANOTECHNO, V8, P1174, DOI 10.1166/jnn.2008.317; Swanson JA, 2008, NAT REV MOL CELL BIO, V9, P639, DOI 10.1038/nrm2447; Taju G, 2014, COMP BIOCHEM PHYS C, V161, P41, DOI 10.1016/j.cbpc.2014.01.007; Taju G, 2013, CHEMOSPHERE, V90, P2172, DOI 10.1016/j.chemosphere.2012.11.027; Tan WB, 2007, BIOMATERIALS, V28, P1565, DOI 10.1016/j.biomaterials.2006.11.018; Ternes TA, 2004, ENVIRON SCI TECHNOL, V38, p392A, DOI 10.1021/es040639t; WANG R, 1995, FISH SHELLFISH IMMUN, V5, P329, DOI 10.1006/fsim.1995.0032; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Warheit DB, 2006, TOXICOL SCI, V91, P227, DOI 10.1093/toxsci/kfj140; Warheit DB, 2005, TOXICOL SCI, V88, P514, DOI 10.1093/toxsci/kfi331; Xia T, 2008, ACS NANO, V2, P2121, DOI 10.1021/nn800511k; Xia T, 2006, NANO LETT, V6, P1794, DOI 10.1021/nl061025k; Xiong DW, 2011, SCI TOTAL ENVIRON, V409, P1444, DOI 10.1016/j.scitotenv.2011.01.015; Yang H, 2009, J APPL TOXICOL, V29, P69, DOI 10.1002/jat.1385; Yoon KY, 2007, SCI TOTAL ENVIRON, V373, P572, DOI 10.1016/j.scitotenv.2006.11.007; Zelikoff JT, 1998, TOXICOLOGY, V129, P63, DOI 10.1016/S0300-483X(98)00064-X; Zhao Y., 2006, NANOTOXICOLOGY INTER	60	68	71	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127493	10.1371/journal.pone.0127493	http://dx.doi.org/10.1371/journal.pone.0127493			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011447	gold, Green Submitted, Green Published			2022-12-26	WOS:000355183900098
J	Garciadiego-Cazares, D; Aguirre-Sanchez, HI; Abarca-Buis, RF; Kouri, JB; Velasquillo, C; Ibarra, C				Garciadiego-Cazares, David; Aguirre-Sanchez, Hilda I.; Abarca-Buis, Rene F.; Kouri, Juan B.; Velasquillo, Cristina; Ibarra, Clemente			Regulation of alpha 5 and alpha V Integrin Expression by GDF-5 and BMP-7 in Chondrocyte Differentiation and Osteoarthritis	PLOS ONE			English	Article							DEVELOPING APPENDICULAR SKELETON; INDIAN HEDGEHOG; ARTICULAR-CARTILAGE; HYPERTROPHIC DIFFERENTIATION; JOINT FORMATION; SYNOVIAL JOINT; PROLIFERATION; MATRIX; ALPHA(V)BETA(3); COLLAGEN	The Integrin beta 1 family is the major receptors of the Extracellular matrix (ECM), and the synthesis and degradation balance of ECM is seriously disrupted during Osteoarthritis (OA). In this scenario, integrins modify their pattern expression and regulate chondrocyte differentiation in the articular cartilage. Members of the Transforming growth factor beta (Tgf-beta) Superfamily, such as Growth differentiation factor 5 (Gdf-5) and Bone morphogenetic protein 7 (Bmp-7), play a key role in joint formation and could regulate the integrin expression during chondrocyte differentiation and osteoarthritis progression in an experimental OA rat model. Decrease of alpha 5 integrin expression in articular cartilage was related with chondrocyte dedifferentiation during OA progression, while increase of alpha 1, alpha 2, and alpha 3 integrin expression was related with fibrous areas in articular cartilage during OA. Hypertrophic chondrocytes expressed alpha V integrin and was increased in the articular cartilage of rats with OA. Integrin expression during chondrocyte differentiation was also analyzed in a micromass culture system of mouse embryo mesenchymal cells, micromass cultures was treated with Gdf-5 or Bmp-7 for 4 and 6 days, respectively. Gdf-5 induced the expression of the alpha 5 sub-unit, while Bmp-7 induced the expression of the alpha V sub-unit. This suggests a switch in signaling for prehypertrophic chondrocyte differentiation towards hypertrophy, where Gdf-5 could maintain the articular chondrocyte phenotype and Bmp-7 would induce hypertrophy. Decrease of Ihh expression during late stages of OA in rat model suggest that the ossification in OA rat knees and endochondral ossification could be activated by Bmp-7 and alpha V integrin in absence of Ihh. Thus, chondrocyte phenotype in articular cartilage is similar to prehypetrophic chondrocyte in growth plate, and is preserved due to the presence of Indian hedgehog (Ihh), Gdf-5 and alpha 5 integrin to maintain articular cartilage and prevent hy-pertrophy.	[Garciadiego-Cazares, David; Aguirre-Sanchez, Hilda I.; Velasquillo, Cristina; Ibarra, Clemente] INR, Secretaria Salud SSA, Unidad Ingn Tejidos Terapia Celular & Med Regener, Mexico City, DF, Mexico; [Abarca-Buis, Rene F.] INR, Secretaria Salud SSA, Lab Tejido Conjunt, Mexico City, DF, Mexico; [Kouri, Juan B.] Inst Politecn Nacl CINVESTAV IPN, Ctr Invest & Estudios Avanzados, Dept Infectom & Patogenesis Mol, Mexico City, DF, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Garciadiego-Cazares, D (corresponding author), INR, Secretaria Salud SSA, Unidad Ingn Tejidos Terapia Celular & Med Regener, Mexico City, DF, Mexico.	dgarciadiego@ciencias.unam.mx	Garciadiego-Cazares, David/AAA-9452-2022	Garciadiego-Cazares, David/0000-0002-7668-4133; kouri, juan/0000-0002-0155-9418; Abarca-Buis, Rene Fernando/0000-0003-3372-813X	Consejo Nacional de Ciencia y Tecnologia (CONACyT), Mexico [CB-84683-2007]; CONACyT	Consejo Nacional de Ciencia y Tecnologia (CONACyT), Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This project was supported by grant CB-84683-2007 from the Consejo Nacional de Ciencia y Tecnologia (CONACyT), Mexico, awarded to DG-C. HIA-S (14689), and RFA-B received a scholarship from CONACyT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abudd-Lozoya KA, 2000, PATHOL RES PRACT, V196, P729; Aszodi A, 2003, GENE DEV, V17, P2465, DOI 10.1101/gad.277003; BROOKS PC, 1995, J CLIN INVEST, V96, P1815, DOI 10.1172/JCI118227; BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; Buckwalter JA, 1999, ARTICULAR CARTILAGE, V1st; Camper L, 2001, CELL TISSUE RES, V306, P107, DOI 10.1007/s004410100385; Camper L, 1997, J CELL BIOL, V138, P1159, DOI 10.1083/jcb.138.5.1159; Eerola I, 1998, ARTHRITIS RHEUM-US, V41, P1287, DOI 10.1002/1529-0131(199807)41:7<1287::AID-ART20>3.0.CO;2-D; EnomotoIwamoto M, 1997, J BONE MINER RES, V12, P1124, DOI 10.1359/jbmr.1997.12.7.1124; Garciadiego-Cazares D, 2004, DEVELOPMENT, V131, P4735, DOI 10.1242/dev.01345; Goldring Mary B, 2012, HSS J, V8, P7, DOI 10.1007/s11420-011-9250-z; Hartmann C, 2001, CELL, V104, P341, DOI 10.1016/S0092-8674(01)00222-7; Hirsch MS, 1997, DEV DYNAM, V210, P249, DOI 10.1002/(SICI)1097-0177(199711)210:3<249::AID-AJA6>3.0.CO;2-G; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Klatt AR, 2009, FEBS LETT, V583, P3611, DOI 10.1016/j.febslet.2009.10.035; Lai TH, 2009, J CELL PHYSIOL, V218, P334, DOI 10.1002/jcp.21601; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; Loeser RF, 2000, BIORHEOLOGY, V37, P109; Macias D, 1997, DEVELOPMENT, V124, P1109; Mak KK, 2008, DEVELOPMENT, V135, P1947, DOI 10.1242/dev.018044; Minina E, 2002, DEV CELL, V3, P439, DOI 10.1016/S1534-5807(02)00261-7; Minina E, 2001, DEVELOPMENT, V128, P4523; Pacifici Maurizio, 2005, Birth Defects Research, V75, P237, DOI 10.1002/bdrc.20050; Pulai JI, 2002, ARTHRITIS RHEUM, V46, P1528, DOI 10.1002/art.10334; Rao HW, 2006, J BONE MINER RES, V21, P1657, DOI 10.1359/JBMR.060718; SALTER DM, 1995, J HISTOCHEM CYTOCHEM, V43, P447, DOI 10.1177/43.4.7897185; Segat D, 2002, J BIOL CHEM, V277, P31612, DOI 10.1074/jbc.M203471200; Shakibaei M, 1999, CELL TISSUE RES, V296, P565, DOI 10.1007/s004410051318; Sharma AR, 2013, INT J MOL SCI, V14, P19805, DOI 10.3390/ijms141019805; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Storgard CM, 1999, J CLIN INVEST, V103, P47, DOI 10.1172/JCI3756; STORM EE, 1994, NATURE, V368, P639, DOI 10.1038/368639a0; Storm EE, 1996, DEVELOPMENT, V122, P3969; Tanaka K, 2007, MATRIX BIOL, V26, P409, DOI 10.1016/j.matbio.2007.04.005; Tarui T, 2001, J BIOL CHEM, V276, P39562, DOI 10.1074/jbc.M101815200; van der Weyden L, 2006, AM J PATHOL, V169, P515, DOI 10.2353/ajpath.2006.050981; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Wang ZP, 2010, J BIOL CHEM, V285, P20806, DOI 10.1074/jbc.M110.118521; WRIGHT E, 1995, NAT GENET, V9, P15, DOI 10.1038/ng0195-15; Wu QQ, 2001, J BIOL CHEM, V276, P35290, DOI 10.1074/jbc.M101055200; Wuelling M, 2010, PEDIATR NEPHROL, V25, P625, DOI 10.1007/s00467-009-1368-6; Xu L, 2007, ARTHRITIS RHEUM, V56, P2663, DOI 10.1002/art.22761; Zemmyo M, 2003, ARTHRITIS RHEUM-US, V48, P2873, DOI 10.1002/art.11246	43	30	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127166	10.1371/journal.pone.0127166	http://dx.doi.org/10.1371/journal.pone.0127166			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010756	Green Published, Green Submitted, gold			2022-12-26	WOS:000355183900070
J	Gothwal, VK; Bharani, S; Kekunnaya, R; Chhablani, P; Sachdeva, V; Pehere, NK; Narasaiah, A; Gunturu, R				Gothwal, Vijaya K.; Bharani, Seelam; Kekunnaya, Ramesh; Chhablani, PreetiPatil; Sachdeva, Virender; Pehere, Niranjan K.; Narasaiah, Asa; Gunturu, Rekha			Measuring Health-Related Quality of Life in Strabismus: A Modification of the Adult Strabismus-20 (AS-20) Questionnaire Using Rasch Analysis	PLOS ONE			English	Article							CATARACT-SURGERY OUTCOMES; DAILY VISION SCALE; PSYCHOSOCIAL-ASPECTS; DEPRESSION SCALE; CHINESE VERSION; YOUNG-ADULTS; SELF-ESTEEM; IMPACT; INSTRUMENTS; AMBLYOPIA	Purpose To evaluate the psychometric properties of the Adult Strabismus-20 (AS-20)-a health-related quality of life (HRQoL) questionnaire in adults with strabismus, and if flawed, to revise the AS-20 and its subscales creating valid measurement scales. Methods 584 adults (meanage, 27.5 years) with strabismus were recruited from an outpatient clinic at a South Indian tertiary eye care centre and were administered the AS-20 questionnaire. The AS-20 was translated and back translated into two Indian languages. The AS-20 and its two 10-item subscales - 'psychosocial' and 'function'were assessed separately for fit to the Rasch model, including an assessment of the rating scale, unidimensionality (by principal components analysis), measurement precision by person separation reliability, PSR, targeting, and differential item functioning (DIF; notable > 1.0 logits). Results Response categories were not used as intended, thereby, required re-organization and reducing their number from 5 to 3. The AS-20 had adequate measurement precision (PSR = 0.87) but lacked unidimensionality; however, deletion of the six multi-dimensionality causing items and an additional three misfitting items resulted in 11-item unidimensional questionnaire (AS-11). Two items failed to satisfy the model expectations in the 'psychosocial' subscale and were deleted - resulting in an 8-item unidimensional scale with adequate PSR (0.81) and targeting (0.23 logits). One item misfit in the 'function' subscale and was deleted-resulting in a 9 item Rasch-revised unidimensional subscale with acceptable PSR (0.80) and targeting (0.97 logits). None of the items displayed notable DIF by age, gender and level of education. Conclusions The AS-11 and its two Rasch-revised subscales - 8-item psychosocial and 9-item function subscale may be more appropriate than the original AS-20 and its two 10-item subscales for use as unidimensional measures of HRQoL in adults with strabismus in India. Further work is required to establish the validity of the revised rating scale.	[Gothwal, Vijaya K.; Bharani, Seelam] LV Prasad Eye Inst, Meera & LB Deshpande Ctr Sight Enhancement, Hyderabad, Andhra Pradesh, India; [Kekunnaya, Ramesh; Chhablani, PreetiPatil] LV Prasad Eye Inst, Jasti V Ramanamma Childrens Eye Care Ctr, Hyderabad, Andhra Pradesh, India; [Sachdeva, Virender; Gunturu, Rekha] LV Prasad Eye Inst, Nimmagadda Prasad Childrens Eye Care Ctr, Vishakapatnam, India; [Pehere, Niranjan K.; Narasaiah, Asa] David Brown Childrens Eye Care Ctr, Vijayawada, India	L. V. Prasad Eye Institute; L. V. Prasad Eye Institute; L. V. Prasad Eye Institute	Gothwal, VK (corresponding author), LV Prasad Eye Inst, Meera & LB Deshpande Ctr Sight Enhancement, KallamAnji Reddy Campus, Hyderabad, Andhra Pradesh, India.	vijayagothwal@gmail.com	Gothwal, Vijaya/AAY-4526-2020		Hyderabad Eye Research Foundation, Hyderabad, India	Hyderabad Eye Research Foundation, Hyderabad, India	This study was supported by the Hyderabad Eye Research Foundation, Hyderabad, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Alam D, 2014, INDIAN J OPHTHALMOL, V62, P799, DOI 10.4103/0301-4738.138620; ANDRICH D, 1978, PSYCHOMETRIKA, V43, P561, DOI 10.1007/BF02293814; Beauchamp CL, 2006, J AAPOS, V10, P394, DOI 10.1016/j.jaapos.2006.06.004; Bez Y, 2009, J AAPOS, V13, P249, DOI 10.1016/j.jaapos.2009.02.010; Bond TG, 2013, APPL RASCH MODEL FUN, DOI [10.1186/1471-2377-13-78, DOI 10.1186/1471-2377-13-78]; Burke JH, 1997, AM J CARDIOL, V79, P178, DOI 10.1016/S0002-9149(96)00707-2; Burke JP, 1997, J PEDIAT OPHTH STRAB, V34, P159; Carlton J, 2011, BRIT J OPHTHALMOL, V95, P325, DOI 10.1136/bjo.2009.178889; CHAO RK, 1995, ETHOS, V23, P328, DOI 10.1525/eth.1995.23.3.02a00030; CHEN C, 1995, PSYCHOL SCI, V6, P170, DOI 10.1111/j.1467-9280.1995.tb00327.x; Coats DK, 2005, ARCH OPHTHALMOL-CHIC, V123, P497, DOI 10.1001/archopht.123.4.497; Duncan PW, 2003, ARCH PHYS MED REHAB, V84, P950, DOI 10.1016/S0003-9993(03)00035-2; Gothwal VK, 2009, BRIT J OPHTHALMOL, V93, P1652, DOI 10.1136/bjo.2009.159806; Gothwal VK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101295; Gothwal VK, 2012, INVEST OPHTH VIS SCI, V53, P6081, DOI 10.1167/iovs.12-9885; Gothwal VK, 2010, INVEST OPHTH VIS SCI, V51, P694, DOI 10.1167/iovs.09-3448; Gothwal VK, 2009, CLIN EXP OPHTHALMOL, V37, P785, DOI 10.1111/j.1442-9071.2009.02133.x; Gothwal VK, 2009, OPTOMETRY VISION SCI, V86, P1160, DOI 10.1097/OPX.0b013e3181bab10c; Gothwal VK, 2009, J CATARACT REFR SURG, V35, P1509, DOI 10.1016/j.jcrs.2009.03.056; Gothwal VK, 2009, OPTOMETRY VISION SCI, V86, P836, DOI 10.1097/OPX.0b013e3181ae1ec7; Gunton KB, 2014, CURR OPIN OPHTHALMOL, V25, P406, DOI 10.1097/ICU.0000000000000087; GUYATT GH, 1993, ANN INTERN MED, V118, P622, DOI 10.7326/0003-4819-118-8-199304150-00009; Hatt SR, 2007, AM J OPHTHALMOL, V144, P643, DOI 10.1016/j.ajo.2007.06.032; Hatt SR, 2012, OPHTHALMOLOGY, V119, P1930, DOI 10.1016/j.ophtha.2012.02.035; Hatt SR, 2012, AM J OPHTHALMOL, V153, P614, DOI 10.1016/j.ajo.2011.10.001; Hatt SR, 2010, OPHTHALMOLOGY, V117, P2322, DOI 10.1016/j.ophtha.2010.03.042; Hatt SR, 2009, AM J OPHTHALMOL, V148, P558, DOI 10.1016/j.ajo.2009.05.009; Hatt SR, 2009, OPHTHALMOLOGY, V116, P139, DOI 10.1016/j.ophtha.2008.08.043; Jackson S, 2006, BRIT J OPHTHALMOL, V90, P883, DOI 10.1136/bjo.2005.089516; Kim H, 1999, J PERS SOC PSYCHOL, V77, P785, DOI 10.1037/0022-3514.77.4.785; Lambert S, 2011, PSYCHO-ONCOLOGY, V20, P919, DOI 10.1002/pon.1803; Leske DA, 2012, INVEST OPHTH VIS SCI, V53, P2630, DOI 10.1167/iovs.11-8308; Linacre J. M., 2009, USERS GUIDE WINSTEPS; Linacre JM, 2008, WINSTEPS RASCH MEASU; LONG VO, 1991, J PSYCHOL, V125, P263, DOI 10.1080/00223980.1991.10543290; Mallinson T, 2004, MED CARE, V42, P17, DOI 10.1097/01.mlr.0000103522.78233.c3; Mallinson T, 2007, OPTOMETRY VISION SCI, V84, P675, DOI 10.1097/OPX.0b013e3181339f44; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; Massof RW, 2002, OPTOMETRY VISION SCI, V79, P516, DOI 10.1097/00006324-200208000-00015; McKenzie JA, 2009, ARCH OPHTHALMOL-CHIC, V127, P743, DOI 10.1001/archophthalmol.2009.68; Menon V, 2002, J PEDIAT OPHTH STRAB, V39, P203, DOI 10.3928/0191-3913-20020701-07; Middleton KL, 2000, PSYCHOL MARKET, V17, P149, DOI 10.1002/(SICI)1520-6793(200002)17:2<149::AID-MAR6>3.0.CO;2-L; Mohney BG, 2008, PEDIATRICS, V122, P1033, DOI 10.1542/peds.2007-3484; Nelson BA, 2008, J AAPOS, V12, P72, DOI 10.1016/j.jaapos.2007.08.006; Pallant JF, 2006, BMC PSYCHIATRY, V6, DOI 10.1186/1471-244X-6-28; PATRICK DL, 1989, MED CARE, V27, pS217, DOI 10.1097/00005650-198903001-00018; Pesudovs K, 2003, INVEST OPHTH VIS SCI, V44, P2892, DOI 10.1167/iovs.02-1075; Pesudovs K, 2007, OPTOMETRY VISION SCI, V84, P663, DOI 10.1097/OPX.0b013e318141fe75; Pickard AS, 2006, VALUE HEALTH, V9, P59, DOI 10.1111/j.1524-4733.2006.00082.x; Rasch G., 1960, PROBABILISTIC MODELS; SATTERFIELD D, 1993, ARCH OPHTHALMOL-CHIC, V111, P1100, DOI 10.1001/archopht.1993.01090080096024; SCHUMACHER M, 1991, STAT MED, V10, P1915, DOI 10.1002/sim.4780101207; Smith Everett V Jr, 2002, J Appl Meas, V3, P205; Streiner D. L., 2003, HLTH MEASUREMENT SCA; Tennant A, 2004, VALUE HEALTH, V7, pS22, DOI 10.1111/j.1524-4733.2004.7s106.x; Twenge JM, 2002, PSYCHOL BULL, V128, P371, DOI 10.1037//0033-2909.128.3.371; van de Graaf E S, 2004, Strabismus, V12, P181; Velozo C A, 2000, J Outcome Meas, V4, P667; Vianya-Estopa M, 2010, INVEST OPHTH VIS SCI, V51, P2496, DOI 10.1167/iovs.09-4381; Wang ZW, 2014, APPL GEOPHYS, V11, P139, DOI 10.1007/s11770-014-0440-6; Wang ZH, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-180; WRIGHT B, 1975, 19 MESA U CHIC DEP E; Wright B. D., 1976, 21 MESA U CHIC DEP E; Wright BD., 1994, RASCH MEASUREMENT T, V8, P370, DOI DOI 10.1177/01461672012710004; Yu HY, 2013, OPHTHAL EPIDEMIOL, V20, P239, DOI 10.3109/09286586.2013.809771	65	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127064	10.1371/journal.pone.0127064	http://dx.doi.org/10.1371/journal.pone.0127064			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0QZ	26011430	Green Published, Green Submitted, gold			2022-12-26	WOS:000355183900058
J	Hong, JW; Ku, CR; Noh, JH; Ko, KS; Rhee, BD; Kim, DJ				Hong, Jae Won; Ku, Cheol Ryong; Noh, Jung Hyun; Ko, Kyung Soo; Rhee, Byoung Doo; Kim, Dong-Jun			Association between Self-Reported Smoking and Hemoglobin A1c in a Korean Population without Diabetes: The 2011-2012 Korean National Health and Nutrition Examination Survey	PLOS ONE			English	Article							MODERATE ALCOHOL INTAKE; CIGARETTE-SMOKING; INSULIN SENSITIVITY; GLYCOSYLATED HEMOGLOBIN; GLYCATED HEMOGLOBIN; CONSUMPTION; GLUCOSE; NICOTINE; HBA(1C); A(1C)	Background Several Western studies have revealed that among non-diabetics, glycosylated hemoglobin A1c (HbA1c) levels are higher in smokers than non-smokers. While studies conducted in Western populations consistently support this association, a recent meta-analysis reported that studies carried out in non-Western populations, including studies of Chinese, Egyptian, and Japanese-Americans, did not detect any significant differences in HbA1c levels between smokers and non-smokers. Objectives We assessed the association between smoking habits and HbA1c levels in the general Korean adult population using data from the Korean National Health and Nutrition Examination Survey (KNHANES) performed in 2011-2012. Methods A total of 10,241 participants (weighted n=33,946,561 including 16,769,320 men and 17,177,241 women) without diabetes were divided into four categories according to their smoking habits: never smokers (unweighted n/weighted n=6,349/19,105,564), ex-smokers (unweighted n/weighted n=1,912/6,207,144), current light smokers (< 15 cigarettes per day, unweighted n/weighted n=1,205/5,130,073), and current heavy smokers (>= 15 cigarettes per day, unweighted n/weighted n=775/3,503,781). Results In age- and gender-adjusted comparisons, the HbA1c levels of each group were 5.52 +/- 0.01% in non-smokers, 5.49 +/- 0.01% in ex-smokers, 5.53 +/- 0.01% in light smokers, and 5.61 +/- 0.02% in heavy smokers. HbA1c levels were significantly higher in light smokers than in ex-smokers (p = 0.033), and in heavy smokers compared with light smokers (p < 0.001). The significant differences remained after adjusting for age, gender, fasting plasma glucose, heavy alcohol drinking, hematocrit, college graduation, and waist circumference. Linear regression analyses for HbA1c using the above-mentioned variables as covariates revealed that a significant association between current smoking and HbA1c (coefficient 0.021, 95% CI 0.003-0.039, p = 0.019). Conclusions Current smoking was independently associated with higher HbA1c levels in a cigarette exposure-dependent manner in a representative population of Korean non-diabetic adults. In this study, we have observed an association between smoking status and HbA1c levels in non-diabetics drawn from a non-Western population, consistent with previous findings in Western populations.	[Hong, Jae Won; Noh, Jung Hyun; Kim, Dong-Jun] Inje Univ, Coll Med, Ilsan Paik Hosp, Dept Internal Med, Koyang, Gyeonggi Do, South Korea; [Ku, Cheol Ryong] Yonsei Univ, Coll Med, Endocrinol, Seoul 120749, South Korea; [Ko, Kyung Soo; Rhee, Byoung Doo] Inje Univ, Coll Med, Dept Internal Med, Sanggye Paik Hosp,Cardiovasc & Metab Dis Ctr, Koyang, Gyeonggi Do, South Korea	Inje University; Yonsei University; Yonsei University Health System; Inje University	Kim, DJ (corresponding author), Inje Univ, Coll Med, Ilsan Paik Hosp, Dept Internal Med, Koyang, Gyeonggi Do, South Korea.	djkim@paik.ac.kr	Noh, Junghyun/ABD-9067-2021; Noh, Junghyun/AAU-8113-2020	Noh, Junghyun/0000-0002-7964-0515; Ku, Cheol Ryong/0000-0001-8693-9630				ALBANES D, 1987, AM J PUBLIC HEALTH, V77, P439, DOI 10.2105/AJPH.77.4.439; Axelsson T, 2001, J INTERN MED, V249, P539, DOI 10.1046/j.1365-2796.2001.00840.x; Bajaj M, 2012, DIABETES, V61, P3078, DOI 10.2337/db12-1100; Bamia C, 2004, INT J OBESITY, V28, P1091, DOI 10.1038/sj.ijo.0802697; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Boeing H, 2000, AM J CLIN NUTR, V71, P1115; Carlsson S, 2005, DIABETOLOGIA, V48, P1051, DOI 10.1007/s00125-005-1768-5; Cerami C, 1997, P NATL ACAD SCI USA, V94, P13915, DOI 10.1073/pnas.94.25.13915; Chiolero A, 2007, OBESITY, V15, P1311, DOI 10.1038/oby.2007.153; Cho NH, 2009, CLIN ENDOCRINOL, V71, P679, DOI 10.1111/j.1365-2265.2009.03586.x; Clair C, 2011, DIABETES CARE, V34, P2250, DOI 10.2337/dc11-0710; DAVIE SJ, 1992, DIABETES, V41, P167, DOI 10.2337/diabetes.41.2.167; Davies MJ, 2002, JAMA-J AM MED ASSOC, V287, P2559, DOI 10.1001/jama.287.19.2559; Eldeirawi K, 2003, AM J EPIDEMIOL, V157, P624, DOI 10.1093/aje/kwg023; Eliasson B, 1996, CIRCULATION, V94, P878, DOI 10.1161/01.CIR.94.5.878; Eliasson B, 2003, PROG CARDIOVASC DIS, V45, P405, DOI 10.1053/pcad.2003.00103; FACCHINI F, 1994, DIABETES CARE, V17, P115, DOI 10.2337/diacare.17.2.115; Foy CG, 2005, DIABETES CARE, V28, P2501, DOI 10.2337/diacare.28.10.2501; Harding AH, 2002, EUR J CLIN NUTR, V56, P882, DOI 10.1038/sj.ejcn.1601408; HASHIMOTO Y, 1995, DIABETES CARE, V18, P1337, DOI 10.2337/diacare.18.10.1337; Herman WH, 2007, DIABETES CARE, V30, P2453, DOI 10.2337/dc06-2003; Higgins Trefor, 2009, J Diabetes Sci Technol, V3, P644; Jansen H, 2013, J INTERN MED, V273, P283, DOI 10.1111/joim.12010; Ko SH, 2011, DIABETES METAB J, V35, P431, DOI 10.4093/dmj.2011.35.5.431; Koppes LLJ, 2005, DIABETES CARE, V28, P719, DOI 10.2337/diacare.28.3.719; Korea Centers for Disease Control and Prevention, 2013, KOR NAT HLTH NUTR EX; Kroenke CH, 2003, DIABETES CARE, V26, P1971, DOI 10.2337/diacare.26.7.1971; Krone CA, 2004, MED HYPOTHESES, V62, P275, DOI 10.1016/S0306-9877(03)00313-X; Lee H, 2013, DIABETES RES CLIN PR, V99, P231, DOI 10.1016/j.diabres.2012.09.030; Manson JE, 2000, AM J MED, V109, P538, DOI 10.1016/S0002-9343(00)00568-4; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Nielsen TL, 2006, INT J OBESITY, V30, P805, DOI 10.1038/sj.ijo.0803197; NILSSON PM, 1995, METABOLISM, V44, P557, DOI 10.1016/0026-0495(95)90110-8; Pani LN, 2008, DIABETES CARE, V31, P1991, DOI 10.2337/dc08-0577; Sargeant LA, 2001, INT J EPIDEMIOL, V30, P547, DOI 10.1093/ije/30.3.547; Soulimane S, 2014, DIABETOLOGIA, V57, P30, DOI 10.1007/s00125-013-3058-y; URBERG M, 1989, J FAM PRACTICE, V28, P529; Vlassopoulos A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1013; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; Wolffenbuttel BHR, 2013, DIABETES CARE, V36, P2931, DOI 10.2337/dc12-2711; Xie XT, 2009, ACTA PHARMACOL SIN, V30, P784, DOI 10.1038/aps.2009.49; Yang YC, 1997, DIABETES CARE, V20, P988, DOI 10.2337/diacare.20.6.988; Ziemer DC, 2010, ANN INTERN MED, V152, P770, DOI 10.7326/0003-4819-152-12-201006150-00004	43	13	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0126746	10.1371/journal.pone.0126746	http://dx.doi.org/10.1371/journal.pone.0126746			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011526	Green Published, gold, Green Submitted			2022-12-26	WOS:000355183900040
J	Osathanunkul, M; Madesis, P; de Boer, H				Osathanunkul, Maslin; Madesis, Panagiotis; de Boer, Hugo			Bar-HRM for Authentication of Plant-Based Medicines: Evaluation of Three Medicinal Products Derived from Acanthaceae Species	PLOS ONE			English	Article							RESOLUTION MELTING ANALYSIS; DNA BARCODES; FORENSIC USES; SUBSTITUTION; GENUS	Medicinal plants are used as a popular alternative to synthetic drugs, both in developed and developing countries. The economic importance of the herbal and natural supplement industry is increasing every year. As the herbal industry grows, consumer safety is one issue that cannot be overlooked. Herbal products in Thai local markets are commonly sold without packaging or labels. Plant powders are stored in large bags or boxes, and therefore buying local herbal products poses a high risk of acquiring counterfeited, substituted and/or adulterated products. Due to these issues, a reliable method to authenticate products is needed. Here DNA barcoding was used in combination with High Resolution Melting analysis (Bar-HRM) to authenticate three medicinal Acanthaceae species (Acanthus ebracteatus, Andrographis paniculata and Rhinacanthus nasutus) commonly used in Thailand. The rbcL barcode was selected for use in primers design for HRM analysis to produce standard melting profiles of the selected species. Melting data from the HRM assay using the designed rbcL primers showed that the three chosen species could be distinguished from each other. HRM curves of all fifteen test samples indicated that three of tested products did not contain the indicated species. Two closely related species (A. paniculata and R. nasutus), which have a high level of morphological similarity, were interchanged with one another in three tested products. Incorrect information on packaging and labels of the tested herbal products was the cause of the results shown here. Morphological similarity among the species of interest also hindered the collection process. The Bar-HRM method developed here proved useful in aiding in the identification and authentication of herbal species in processed samples. In the future, species authentication through Bar-HRM could be used to promote consumer trust, as well as raising the quality of herbal products.	[Osathanunkul, Maslin] Chiang Mai Univ, Fac Sci, Dept Biol, Chiang Mai 50000, Thailand; [Madesis, Panagiotis] Ctr Res & Technol Hellas CERTH, Inst Appl Biosci, Thessaloniki, Greece; [de Boer, Hugo] Uppsala Univ, Evolutionary Biol Ctr, Dept Organismal Biol, Uppsala, Sweden; [de Boer, Hugo] Naturalis Biodivers Ctr, Leiden, Netherlands; [de Boer, Hugo] Univ Oslo, Nat Hist Museum, Oslo, Norway	Chiang Mai University; Centre for Research & Technology Hellas; Naturalis Biodiversity Center; University of Oslo	Osathanunkul, M (corresponding author), Chiang Mai Univ, Fac Sci, Dept Biol, Chiang Mai 50000, Thailand.	omaslin@gmail.com	de Boer, Hugo Joris/AAS-7585-2020; Madesis, Panagiotis/AAL-5980-2020	de Boer, Hugo Joris/0000-0003-1985-7859; Madesis, Panagiotis/0000-0003-1447-3514	Thailand Research Fund [TRG5780027]	Thailand Research Fund(Thailand Research Fund (TRF))	This work was financially supported by the new researcher grant from the Thailand Research Fund (grant number TRG5780027). URL: http://academic.trf.or.th/index.php/fund. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Baker DA, 2012, J AOAC INT, V95, P1023, DOI 10.5740/jaoacint.11-261; Bastian M., 2009, INT AAAI C WEBL SOC, V8, P361, DOI DOI 10.13140/2.1.1341.1520; Bosmali I, 2012, FOOD RES INT, V46, P141, DOI 10.1016/j.foodres.2011.12.013; Burns JM, 2008, P NATL ACAD SCI USA, V105, P6350, DOI 10.1073/pnas.0712181105; Calixto JB, 2000, BRAZ J MED BIOL RES, V33, P179, DOI 10.1590/S0100-879X2000000200004; Chase MW, 2009, SCIENCE, V325, P682, DOI 10.1126/science.1176906; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Cho Y, 2004, P NATL ACAD SCI USA, V101, P17741, DOI 10.1073/pnas.0408302101; Coghlan ML, 2012, PLOS GENET, V8, P436, DOI 10.1371/journal.pgen.1002657; Crawford AJ, 2012, MOL ECOL RESOUR; de Boer HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084291; DeSmet PAGM, 1997, DRUGS, V54, P801, DOI 10.2165/00003495-199754060-00003; Fazekas AJ, 2009, MOL ECOL RESOUR, V9, P130, DOI 10.1111/j.1755-0998.2009.02652.x; Ganopoulos I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060945; Ganopoulos I, 2013, J SCI FOOD AGR, V93, P2281, DOI 10.1002/jsfa.6040; Ganopoulos I, 2012, PLANT MOL BIOL REP, V30, P1322, DOI 10.1007/s11105-012-0453-3; Ganopoulos I, 2012, FOOD CHEM, V133, P505, DOI 10.1016/j.foodchem.2012.01.015; GIA, 2013, HERB SUPPL REM GLOB; Gurib-Fakim A., 2006, MOL ASPECTS MED, V27, P1, DOI [10.1016/j.mam.2005.07.008, DOI 10.1016/J.MAM.2005.07.008]; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hollingsworth PM, 2011, P NATL ACAD SCI USA, V108, P19451, DOI 10.1073/pnas.1116812108; Ize-Ludlow D, 2004, PEDIATRICS, V114, pE653, DOI 10.1542/peds.2004-0058; Kool A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039459; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Madesis P, 2014, FOOD RES INT, V60, P163, DOI 10.1016/j.foodres.2013.10.042; Madesis P, 2013, FOOD RES INT, V50, P351, DOI 10.1016/j.foodres.2012.10.038; Madesis P, 2012, FOOD CONTROL, V25, P576, DOI 10.1016/j.foodcont.2011.11.034; Newmaster SG, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-222; Ouarghidi A, 2012, ECON BOT, V66, P370, DOI 10.1007/s12231-012-9215-2; Rates SMK, 2001, TOXICON, V39, P603, DOI 10.1016/S0041-0101(00)00154-9; Silva-Brandao KL, 2009, NEOTROP ENTOMOL, V38, P441, DOI 10.1590/S1519-566X2009000400001; Skalli S, 2002, B SOC PATHOL EXOT, V95, P284; Stoeckle MY, 2011, SCI REP-UK, V1, DOI 10.1038/srep00042; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Veldman S, 2014, NOVEL PLANT BIORESOURCES: APPLICATIONS IN FOOD, MEDICINE AND COSMETICS, P81; Wallace LJ, 2012, FOOD RES INT, V49, P446, DOI 10.1016/j.foodres.2012.07.048; Wittwer CT, 2003, CLIN CHEM, V49, P853, DOI 10.1373/49.6.853; World Health Organization, 2003, TRADITIONAL MED	44	47	51	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128476	10.1371/journal.pone.0128476	http://dx.doi.org/10.1371/journal.pone.0128476			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011474	Green Submitted, Green Published, gold			2022-12-26	WOS:000355183900239
J	Sampath, S; Klimas, M; Feng, D; Baumgartner, R; Manigbas, E; Liang, AL; Evelhoch, JL; Chin, CL				Sampath, Smita; Klimas, Michael; Feng, Dai; Baumgartner, Richard; Manigbas, Elaine; Liang, Ai-Leng; Evelhoch, Jeffrey L.; Chin, Chih-Liang			Characterization of Regional Left Ventricular Function in Nonhuman Primates Using Magnetic Resonance Imaging Biomarkers: A Test-Retest Repeatability and Inter-Subject Variability Study	PLOS ONE			English	Article							MATRIX-METALLOPROTEINASE INHIBITION; CONGESTIVE-HEART-FAILURE; TYPE-2 DIABETES-MELLITUS; MYOCARDIAL-INFARCTION; NONINVASIVE ASSESSMENT; DIASTOLIC DYSFUNCTION; SYSTOLIC FUNCTION; CARDIAC-FUNCTION; GENE-TRANSFER; STEM-CELLS	Pre-clinical animal models are important to study the fundamental biological and functional mechanisms involved in the longitudinal evolution of heart failure (HF). Particularly, large animal models, like nonhuman primates (NHPs), that possess greater physiological, biochemical, and phylogenetic similarity to humans are gaining interest. To assess the translatability of these models into human diseases, imaging biomarkers play a significant role in non-invasive phenotyping, prediction of downstream remodeling, and evaluation of novel experimental therapeutics. This paper sheds insight into NHP cardiac function through the quantification of magnetic resonance (MR) imaging biomarkers that comprehensively characterize the spatiotemporal dynamics of left ventricular (LV) systolic pumping and LV diastolic relaxation. MR tagging and phase contrast (PC) imaging were used to quantify NHP cardiac strain and flow. Temporal inter-relationships between rotational mechanics, myocardial strain and LV chamber flow are presented, and functional biomarkers are evaluated through test-retest repeatability and inter subject variability analyses. The temporal trends observed in strain and flow was similar to published data in humans. Our results indicate a dominant dimension based pumping during early systole, followed by a torsion dominant pumping action during late systole. Early diastole is characterized by close to 65% of untwist, the remainder of which likely contributes to efficient filling during atrial kick. Our data reveal that moderate to good intra-subject repeatability was observed for peak strain, strain-rates, E/circumferential strain-rate (CSR) ratio, E/longitudinal strain-rate (LSR) ratio, and deceleration time. The inter-subject variability was high for strain dyssynchrony, diastolic strain-rates, peak torsion and peak untwist rate. We have successfully characterized cardiac function in NHPs using MR imaging. Peak strain, average systolic strain-rate, diastolic E/CSR and E/LSR ratios, and deceleration time were identified as robust biomarkers that could potentially be applied to future pre-clinical drug studies.	[Sampath, Smita; Liang, Ai-Leng; Chin, Chih-Liang] Merck Sharp & Dohme Ltd, Merck Res Labs, Imaging, Singapore, Singapore; [Klimas, Michael; Evelhoch, Jeffrey L.] Merck & Co Inc, Merck Res Labs, Imaging, West Point, PA USA; [Feng, Dai; Baumgartner, Richard] Merck & Co Inc, Merck Res Labs, Biostat & Res Decis Sci, Biometr Res, Rahway, NJ 07065 USA; [Manigbas, Elaine] Maccine Pte Ltd, MRI Dept, Singapore, Singapore	Merck & Company; Merck & Company	Sampath, S (corresponding author), Merck Sharp & Dohme Ltd, Merck Res Labs, Imaging, Singapore, Singapore.	smita.sampath@merck.com	Evelhoch, Jeffrey/R-2619-2019		Merck Co.	Merck Co.(Merck & Company)	This research was funded by Merck & Co. The authors would like to declare that the following individuals are current or former employees of the funder: Smita Sampath, Michael Klimas, Dai Feng, Richard Baumgartner, Ai-Leng Liang, Jeffrey L. Evelhoch, Chih-Liang Chin. Their roles include study design, data collection and analysis, decision to publish and preparation of the manuscript.	Akkan D, 2008, EUR J HEART FAIL, V10, P689, DOI 10.1016/j.ejheart.2008.05.007; AXEL L, 1989, RADIOLOGY, V172, P349, DOI 10.1148/radiology.172.2.2748813; Brok HPM, 2001, IMMUNOL REV, V183, P173, DOI 10.1034/j.1600-065x.2001.1830114.x; Brotman D, 2013, MAGN RESON MED, V69, P1421, DOI 10.1002/mrm.24373; Capitanio JP, 2008, LANCET, V371, P1126, DOI 10.1016/S0140-6736(08)60489-4; Castillo E, 2005, J CARDIOVASC MAGN R, V7, P783, DOI 10.1080/10976640500295417; Cefalu WT, 2006, ILAR J, V47, P186, DOI 10.1093/ilar.47.3.186; Chetboul V, 2008, J VET INTERN MED, V22, P342, DOI 10.1111/j.1939-1676.2007.0037.x; Chu GX, 2002, J CARD FAIL, V8, pS432, DOI 10.1054/jcaf.2002.129284; De Marchi SF, 2000, HEART, V83, P678, DOI 10.1136/heart.83.6.678; Ding SY, 2007, METABOLISM, V56, P838, DOI 10.1016/j.metabol.2007.01.015; Edvardsen T, 2006, AM HEART J, V151, P109, DOI 10.1016/j.ahj.2005.02.018; Epstein FH, 2004, MAGN RESON MED, V52, P774, DOI 10.1002/mrm.20232; Eriksson J, 2011, AM J PHYSIOL-HEART C, V300, pH2135, DOI 10.1152/ajpheart.00993.2010; FEINBERG DA, 1985, MAGNET RESON MED, V2, P555, DOI 10.1002/mrm.1910020606; FIRMIN DN, 1987, J COMPUT ASSIST TOMO, V11, P751, DOI 10.1097/00004728-198709000-00001; FLETCHER PJ, 1981, CIRC RES, V49, P618, DOI 10.1161/01.RES.49.3.618; Ginis I, 2004, DEV BIOL, V269, P360, DOI 10.1016/j.ydbio.2003.12.034; Gorman JH, 1998, J THORAC CARDIOV SUR, V115, P615, DOI 10.1016/S0022-5223(98)70326-5; Gotte MJW, 2006, J AM COLL CARDIOL, V48, P2002, DOI 10.1016/j.jacc.2006.07.048; HAENDCHEN RV, 1983, CIRCULATION, V67, P1234, DOI 10.1161/01.CIR.67.6.1234; Haghighi K, 2003, J CLIN INVEST, V111, P869, DOI 10.1172/JCI200317892; Hayashi N, 1997, ARZNEIMITTELFORSCH, V47, P625; Heiberg Einar, 2010, BMC Med Imaging, V10, P1, DOI 10.1186/1471-2342-10-1; Janiczek RL, 2011, MAGN RESON MED, V66, P1382, DOI 10.1002/mrm.22937; Jugdutt BI, 2004, J CARD FAIL, V10, P74, DOI 10.1016/S1071-9164(03)00584-0; Jung B, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-87; Kawase Y, 2008, J AM COLL CARDIOL, V51, P1112, DOI 10.1016/j.jacc.2007.12.014; King Gerard J, 2003, Cardiovasc Ultrasound, V1, P9, DOI 10.1186/1476-7120-1-9; Korosoglou G, 2012, J MAGN RESON IMAGING, V35, P804, DOI 10.1002/jmri.22879; Kraitchman DL, 1998, MAGN RESON MED, V40, P311, DOI 10.1002/mrm.1910400217; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Mewton N, 2008, INVEST RADIOL, V43, P219, DOI 10.1097/RLI.0b013e318161613e; Miyamoto MI, 2000, P NATL ACAD SCI USA, V97, P793, DOI 10.1073/pnas.97.2.793; Moerman KM, 2011, MED PHYS, V38, P1248, DOI 10.1118/1.3533942; Moore C C, 2000, Top Magn Reson Imaging, V11, P359, DOI 10.1097/00002142-200012000-00005; Morita H, 2006, AM J PHYSIOL-HEART C, V290, pH2522, DOI 10.1152/ajpheart.00932.2005; Mukherjee R, 2003, CIRCULATION, V107, P618, DOI 10.1161/01.CIR.0000046449.36178.00; Narayanan A, 2009, CIRC-CARDIOVASC IMAG, V2, P382, DOI 10.1161/CIRCIMAGING.108.811620; Okura H, 2009, CIRC J, V73, P86, DOI 10.1253/circj.CJ-08-0457; Onishi T, 2010, CIRC-CARDIOVASC IMAG, V3, P134, DOI 10.1161/CIRCIMAGING.109.888354; Osman NF, 1999, MAGN RESON MED, V42, P1048, DOI 10.1002/(SICI)1522-2594(199912)42:6<1048::AID-MRM9>3.0.CO;2-M; Osman NF, 2004, IEEE T BIO-MED ENG, V51, P1428, DOI 10.1109/TBME.2004.827932; Osman NF, 2000, PHYS MED BIOL, V45, P1665, DOI 10.1088/0031-9155/45/6/318; Osman NF, 2000, IEEE T MED IMAGING, V19, P186, DOI 10.1109/42.845177; Parthasarathy V., 2006, CHARACTERIZATION HAR; PFEFFER JM, 1985, CIRC RES, V57, P84, DOI 10.1161/01.RES.57.1.84; PFEFFER MA, 1979, CIRC RES, V44, P503, DOI 10.1161/01.RES.44.4.503; Pleger ST, 2007, CIRCULATION, V115, P2506, DOI 10.1161/CIRCULATIONAHA.106.671701; Poirier P, 2001, DIABETES CARE, V24, P5, DOI 10.2337/diacare.24.1.5; PRZYKLENK K, 1986, CARDIOVASC RES, V20, P403, DOI 10.1093/cvr/20.6.403; REIMER KA, 1979, LAB INVEST, V40, P633; Russel IK, 2008, J CARDIOVASC MAGN R, V10, DOI 10.1186/1532-429X-10-26; Shen YT, 2000, CURR OPIN INVEST DR, V11, P1025; Sironi AM, 2008, HYPERTENSION, V51, P282, DOI 10.1161/HYPERTENSIONAHA.107.098640; SMITS JFM, 1992, J CARDIOVASC PHARM, V20, P772, DOI 10.1097/00005344-199211000-00013; Stuber M, 1999, MAGN RESON MATER PHY, V9, P85; Vinge LE, 2008, CIRC RES, V102, P1458, DOI 10.1161/CIRCRESAHA.108.173195; Wagner JD, 2001, TOXICOL PATHOL, V29, P142, DOI 10.1080/019262301301418955; WEBER KT, 1987, CIRCULATION, V75, P40; WEINBERG EO, 1994, CIRCULATION, V90, P1410, DOI 10.1161/01.CIR.90.3.1410; WHITE FC, 1986, LAB ANIM SCI, V36, P351; Yarbrough WM, 2003, CIRCULATION, V108, P1753, DOI 10.1161/01.CIR.0000091087.78630.79; Zeng LP, 2007, CIRCULATION, V115, P1866, DOI 10.1161/CIRCULATIONAHA.106.659730; ZERHOUNI EA, 1988, RADIOLOGY, V169, P59, DOI 10.1148/radiology.169.1.3420283; Zhang H, 2007, J THORAC CARDIOV SUR, V134, P1234, DOI 10.1016/j.jtcvs.2007.07.019; Zhong J, 2010, MAGN RESON MED, V64, P1315, DOI 10.1002/mrm.22530	67	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127947	10.1371/journal.pone.0127947	http://dx.doi.org/10.1371/journal.pone.0127947			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010607	Green Published, gold, Green Submitted			2022-12-26	WOS:000355183900169
J	Tynyakov, J; Bentov, S; Abehsera, S; Khalaila, I; Manor, R; Abilevich, LK; Weil, S; Aflalo, ED; Sagi, A				Tynyakov, Jenny; Bentov, Shmuel; Abehsera, Shai; Khalaila, Isam; Manor, Rivka; Abilevich, Lihie Katzir; Weil, Simy; Aflalo, Eliahu D.; Sagi, Amir			A Novel Chitin Binding Crayfish Molar Tooth Protein with Elasticity Properties	PLOS ONE			English	Article							TRANSCRIPT EXPRESSION PATTERNS; CHERAX-QUADRICARINATUS; CUTICULAR PROTEINS; MATRIX PROTEINS; OVO GENE; EXTRACELLULAR-MATRIX; PROCAMBARUS-CLARKII; ANDROGENIC GLAND; BIOLOGICAL ROLES; CROSS-LINKING	The molar tooth of the crayfish Cherax quadricarinatus is part of the mandible, and is covered by a layer of apatite (calcium phosphate). This tooth sheds and is regenerated during each molting cycle together with the rest of the exoskeleton. We discovered that molar calcification occurs at the pre-molt stage, unlike calcification of the rest of the new exoskeleton. We further identified a novel molar protein from C. quadricarinatus and cloned its transcript from the molar-forming epithelium. We termed this protein Cq-M13. The temporal level of transcription of Cq-M13 in an NGS library of molar-forming epithelium at different molt stages coincides with the assembly and mineralization pattern of the molar tooth. The predicted protein was found to be related to the pro-resilin family of cuticular proteins. Functionally, in vivo silencing of the transcript caused molt cycle delay and a recombinant version of the protein was found to bind chitin and exhibited elastic properties.	[Tynyakov, Jenny; Bentov, Shmuel; Abehsera, Shai; Manor, Rivka; Abilevich, Lihie Katzir; Weil, Simy; Aflalo, Eliahu D.; Sagi, Amir] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Tynyakov, Jenny; Bentov, Shmuel; Sagi, Amir] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel; [Khalaila, Isam] Ben Gurion Univ Negev, Dept Biotechnol Engn, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University; Ben Gurion University	Sagi, A (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.	sagia@bgu.ac.il	khalaila, Isam/F-1498-2012	khalaila, Isam/0000-0003-3250-5778; Sagi, Amir/0000-0002-4229-1059; Aflalo, Eli/0000-0003-1385-2387	Israel Science Foundation (ISF) [613/13]; National Institute for Biotechnology in the Negev (NIBN)	Israel Science Foundation (ISF)(Israel Science Foundation); National Institute for Biotechnology in the Negev (NIBN)	This study was supported in part by grants from the Israel Science Foundation (ISF, Grant 613/13) and the National Institute for Biotechnology in the Negev (NIBN).	Addadi L, 2014, PHYS SCRIPTA, V89, DOI 10.1088/0031-8949/89/9/098003; Alexander R. McNeill, 2003, P1, DOI 10.1017/CBO9780511546327.003; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andersen SO, 2000, INSECT BIOCHEM MOLEC, V30, P569, DOI 10.1016/S0965-1748(00)00029-1; ANDERSEN SVEND OLAV, 1964, ADVANCES INSECT PHYSIOL, V2, P1, DOI 10.1016/S0065-2806(08)60071-5; Andersen Svend Olav, 2003, P259, DOI 10.1017/CBO9780511546327.015; Andersen SO, 2011, INSECT BIOCHEM MOLEC, V41, P620, DOI 10.1016/j.ibmb.2011.03.015; Andersen SO, 2010, INSECT BIOCHEM MOLEC, V40, P541, DOI 10.1016/j.ibmb.2010.05.002; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Beniash E, 2011, WIRES NANOMED NANOBI, V3, P47, DOI 10.1002/wnan.105; Bentov S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1839; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cornman RS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008345; Dai X, 1998, GENE DEV, V12, P3452, DOI 10.1101/gad.12.21.3452; DENNY M, 1976, J EXP BIOL, V65, P483; Deshpande AS, 2010, J BIOL CHEM, V285, P19277, DOI 10.1074/jbc.M109.079939; Elvin CM, 2005, NATURE, V437, P999, DOI 10.1038/nature04085; Fang PA, 2011, P NATL ACAD SCI USA, V108, P14097, DOI 10.1073/pnas.1106228108; Fujisawa R, 2012, FRONT BIOSCI-LANDMRK, V17, P1891, DOI 10.2741/4026; Futahashi R, 2008, DEV GENES EVOL, V218, P491, DOI 10.1007/s00427-008-0243-y; GARFINKEL MD, 1994, MOL CELL BIOL, V14, P6809, DOI 10.1128/MCB.14.10.6809; George A, 2008, CHEM REV, V108, P4670, DOI 10.1021/cr0782729; Gilman JJ, 1973, SCI HARDNESS TESTING, P51; Glazer L, 2013, J EXP BIOL, V216, P1898, DOI 10.1242/jeb.080945; Glazer L, 2012, INVERTEBR REPROD DEV, V56, P57, DOI 10.1080/07924259.2011.588010; Glazer L, 2010, J BIOL CHEM, V285, P12831, DOI 10.1074/jbc.M109.071068; Gosline J, 2002, PHILOS T R SOC B, V357, P121, DOI 10.1098/rstb.2001.1022; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Harris MA, 2008, NUCLEIC ACIDS RES, V36, pD440, DOI 10.1093/nar/gkm883; He G, 2005, J BIOL CHEM, V280, P33109, DOI 10.1074/jbc.M500159200; Iconomidou VA, 2005, INSECT BIOCHEM MOLEC, V35, P553, DOI 10.1016/j.ibmb.2005.01.017; Inoue H, 2001, BIOSCI BIOTECH BIOCH, V65, P1840, DOI 10.1271/bbb.65.1840; Karouzou MV, 2007, INSECT BIOCHEM MOLEC, V37, P754, DOI 10.1016/j.ibmb.2007.03.007; LISOWSKY T, 1992, MOL GEN GENET, V232, P58, DOI 10.1007/BF00299137; Lu YB, 2007, DEV BIOL, V303, P191, DOI 10.1016/j.ydbio.2006.11.001; Luquet G, 2012, ZOOKEYS, P103, DOI 10.3897/zookeys.176.2318; Magkrioti CK, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-138; Manor R, 2007, GEN COMP ENDOCR, V150, P326, DOI 10.1016/j.ygcen.2006.09.006; Metodiev MD, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004110; MEVELNINIO M, 1991, EMBO J, V10, P2259, DOI 10.1002/j.1460-2075.1991.tb07762.x; MEVELNINIO M, 1995, MECH DEVELOP, V49, P83, DOI 10.1016/0925-4773(94)00305-7; Nagasawa Hiromichi, 2011, P315, DOI 10.1007/978-3-642-21230-7_11; NEVILLE AC, 1963, J INSECT PHYSIOL, V9, P265, DOI 10.1016/0022-1910(63)90103-3; OBRIEN JJ, 1991, BIOL BULL, V181, P427, DOI 10.2307/1542363; Oliver WC, 2004, J MATER RES, V19, P3, DOI 10.1557/jmr.2004.19.1.3; OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564; Pamuru RR, 2012, GEN COMP ENDOCR, V178, P227, DOI 10.1016/j.ygcen.2012.05.007; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; POLLOCK M, 1994, AM J PHYSIOL, V266, pR1016, DOI 10.1152/ajpregu.1994.266.3.R1016; Qin GK, 2009, BIOMACROMOLECULES, V10, P3227, DOI 10.1021/bm900735g; REBERS JE, 1988, J MOL BIOL, V203, P411, DOI 10.1016/0022-2836(88)90009-5; Rosen O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015281; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Shechter A, 2005, BIOL REPROD, V73, P72, DOI 10.1095/biolreprod.104.038554; Shechter A, 2008, P NATL ACAD SCI USA, V105, P7129, DOI 10.1073/pnas.0800193105; Shechter A, 2008, BIOL BULL-US, V214, P122, DOI 10.2307/25066669; Shechter A, 2007, J EXP BIOL, V210, P3525, DOI 10.1242/jeb.006791; SHIMIZU S, 1989, J CLIN INVEST, V84, P1990, DOI 10.1172/JCI114389; Sievers F, FAST SCALABLE GENERA, DOI [10.1038/msb.2011.75, DOI 10.1038/MSB.2011.75]; Suderman RJ, 2006, INSECT BIOCHEM MOLEC, V36, P353, DOI 10.1016/j.ibmb.2006.01.012; Suzuki M, 2013, BIOSCI BIOTECH BIOCH, V77, P361, DOI 10.1271/bbb.120787; Tabor D, 1986, INDENTATION HARDNESS; Tatham AS, 2000, TRENDS BIOCHEM SCI, V25, P567, DOI 10.1016/S0968-0004(00)01670-4; Tellam RL, 1999, INSECT BIOCHEM MOLEC, V29, P87, DOI 10.1016/S0965-1748(98)00123-4; Ventura T, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097261; Ventura T, 2009, ENDOCRINOLOGY, V150, P1278, DOI 10.1210/en.2008-0906; WEISFOGH T, 1961, J MOL BIOL, V3, P648, DOI 10.1016/S0022-2836(61)80028-4; Wu H, 2011, GENE DEV, V25, P679, DOI 10.1101/gad.2036011; YOUNG MF, 1992, CLIN ORTHOP RELAT R, P275; Yudkovski Y, 2007, INSECT MOL BIOL, V16, P661, DOI 10.1111/j.1365-2583.2007.00762.x; Yudkovski Y, 2010, COMP BIOCHEM PHYS D, V5, P171, DOI 10.1016/j.cbd.2010.03.010	72	6	7	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127871	10.1371/journal.pone.0127871	http://dx.doi.org/10.1371/journal.pone.0127871			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010981	Green Published, gold			2022-12-26	WOS:000355183900155
J	Vogiatzoglou, A; Mulligan, AA; Lentjes, MAH; Luben, RN; Spencer, JPE; Schroeter, H; Khaw, KT; Kuhnle, GGC				Vogiatzoglou, Anna; Mulligan, Angela A.; Lentjes, Marleen A. H.; Luben, Robert N.; Spencer, Jeremy P. E.; Schroeter, Hagen; Khaw, Kay-Tee; Kuhnle, Gunter G. C.			Flavonoid Intake in European Adults (18 to 64 Years)	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE MORTALITY; DIETARY FLAVONOIDS; ANTHOCYANIN INTAKE; TOPOISOMERASE-II; BLOOD-PRESSURE; RISK; CANCER; FLAVAN-3-OLS; PROANTHOCYANIDINS; DETERMINANTS	Background Flavonoids are a group of phenolic secondary plant metabolites that are ubiquitous in plant-based diets. Data from anthropological, observational and intervention studies have shown that many flavonoids are bioactive. For this reason, there is an increasing interest in investigating the potential health effects of these compounds. The translation of these findings into the context of the health of the general public requires detailed information on habitual dietary intake. However, only limited data are currently available for European populations. Objective The objective of this study is to determine the habitual intake and main sources of anthocyanidins, flavanols, flavanones, flavones, flavonols, proanthocyanidins, theaflavins and thearubigins in the European Union. Design We use food consumption data from the European Food Safety Authority (EFSA) and the FLAVIOLA Food Composition Database to estimate intake of flavonoids. Results Mean (+/- SEM) intake of total flavonoids in Europe was 428 +/- 49 mg/d, of which 136 +/- 14 mg/d were monomeric compounds. Gallated flavan-3-ols (53 +/- 12 mg/d) were the main contributor. The lowest flavonoid intake was observed in Mediterranean countries (monomeric compounds: 95 +/- 11 mg/d). The distribution of intake was skewed in many countries, especially in Germany (monomeric flavonoids; mean intake: 181 mg/d; median intake: 3 mg/d). Conclusions The habitual intake of flavonoids in Europe is below the amounts found to have a significant health effect.	[Vogiatzoglou, Anna; Spencer, Jeremy P. E.; Kuhnle, Gunter G. C.] Univ Reading, Dept Food & Nutr Sci, Reading, Berks, England; [Mulligan, Angela A.; Lentjes, Marleen A. H.; Luben, Robert N.; Kuhnle, Gunter G. C.] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Schroeter, Hagen] Mars Inc, Mclean, VA 22101 USA; [Khaw, Kay-Tee] Univ Cambridge, Sch Clin Med, Clin Gerontol Unit, Cambridge, England	University of Reading; University of Cambridge; Mars; University of Cambridge	Kuhnle, GGC (corresponding author), Univ Reading, Dept Food & Nutr Sci, Reading, Berks, England.	g.g.kuhnle@reading.ac.uk	Spencer, Jeremy P. E./F-4757-2010; Khaw, Kay-Tee/AAZ-3209-2021; Kuhnle, Gunter/AAG-5264-2019; Luben, Robert N/H-5519-2015	Spencer, Jeremy P. E./0000-0003-2931-7274; Kuhnle, Gunter/0000-0002-8081-8931; Luben, Robert N/0000-0002-5088-6343; Lentjes, Marleen/0000-0003-4713-907X; Schroeter, Hagen/0000-0001-6569-382X	European Union [226588]; Mars, Inc., a member of the FLAVIOLA research consortium; MRC [G0801534] Funding Source: UKRI; Cancer Research UK [14136] Funding Source: researchfish; Medical Research Council [G0401527, G1000143, UD99999933, G0801534] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10114] Funding Source: researchfish	European Union(European Commission); Mars, Inc., a member of the FLAVIOLA research consortium; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This project was supported by the European Union (grant 226588, "Flaviola"). Mars, Inc., a member of the FLAVIOLA research consortium, provided support in the form of salaries for author HS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author is articulated in the 'author contributions' section.	[Anonymous], 2011, FOOD CLASSIFICATION; [Anonymous], 2011, EFSA COMPREHENSIVE E; Armentano L, 1936, DEUT MED WOCHENSCHR, V62, P1325, DOI 10.1055/s-0028-1141260; Bai W, 2014, INT J FOOD SCI NUTR, V65, P9, DOI 10.3109/09637486.2013.832170; Bandele OJ, 2008, CHEM RES TOXICOL, V21, P1253, DOI 10.1021/tx8000785; Beking K, 2011, INT J FOOD SCI NUTR, V62, P17, DOI 10.3109/09637486.2010.511165; Berends KAW, 1829, HDB PRAKTISCHEN ARZN; Cassidy A, 2013, CIRCULATION, V127, P188, DOI 10.1161/CIRCULATIONAHA.112.122408; Cassidy A, 2012, STROKE, V43, P946, DOI 10.1161/STROKEAHA.111.637835; Cassidy A, 2011, AM J CLIN NUTR, V93, P338, DOI 10.3945/ajcn.110.006783; Chang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054318; Commenges D, 2000, EUR J EPIDEMIOL, V16, P357, DOI 10.1023/A:1007614613771; Crozier A, 1997, J AGR FOOD CHEM, V45, P590, DOI 10.1021/jf960339y; Davies, 2012, FLAVONOID PHARMACOKI, P281; Ellinger S, 2012, AM J CLIN NUTR, V95, P1365, DOI 10.3945/ajcn.111.029330; HERTOG MGL, 1993, NUTR CANCER, V20, P21, DOI 10.1080/01635589309514267; HERTOG MGL, 1993, LANCET, V342, P1007, DOI 10.1016/0140-6736(93)92876-U; Holland B., 1991, COMPOSITION FOODS; Hollenberg NK, 1997, HYPERTENSION, V29, P171, DOI 10.1161/01.HYP.29.1.171; Hollman PCH, 1996, FOOD CHEM, V57, P43, DOI 10.1016/0308-8146(96)00065-9; Hooper L, 2012, AM J CLIN NUTR, V95, P740, DOI 10.3945/ajcn.111.023457; Jaeger A, 1988, Prog Clin Biol Res, V280, P379; Jennings A, 2012, AM J CLIN NUTR, V96, P781, DOI 10.3945/ajcn.112.042036; Johannot L, 2006, PUBLIC HEALTH NUTR, V9, P1045, DOI 10.1017/PHN2006971; Justesen U, 1997, CANCER LETT, V114, P165, DOI 10.1016/S0304-3835(97)04651-X; Keli SO, 1996, ARCH INTERN MED, V156, P637, DOI 10.1001/archinte.156.6.637; Lentjes MAH, 2013, BRIT J NUTR IN PRESS; Lupton JR, 2014, EUR J NUTR, V53, P1, DOI 10.1007/s00394-014-0666-3; Martinez SE., 2012, FLAVONOID PHARMACOKI; Max Rubner-Institut, 2008, ERG NAT VERZ 2; Mazzanti G, 2009, EUR J CLIN PHARMACOL, V65, P331, DOI 10.1007/s00228-008-0610-7; McCullough ML, 2012, AM J CLIN NUTR, V95, P454, DOI 10.3945/ajcn.111.016634; Mink PJ, 2007, AM J CLIN NUTR, V85, P895, DOI 10.1093/ajcn/85.3.895; Neveu V, 2010, DATABASE-OXFORD, DOI 10.1093/database/bap024; Pendleton M, 2014, ANN NY ACAD SCI, V1310, P98, DOI 10.1111/nyas.12358; Quadri F, 1987, Schweiz Rundsch Med Prax, V76, P1338; Ried K, 2017, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008893.pub2, 10.1002/14651858.CD008893.pub3]; Schroeder I, 1655, PHARMACOPOEIA MED CH; Strack D., 1997, PLANT BIOCH, P387, DOI DOI 10.1016/B978-012214674-9/50011-4; Strick R, 2000, P NATL ACAD SCI USA, V97, P4790, DOI 10.1073/pnas.070061297; Tang NP, 2009, JPN J CLIN ONCOL, V39, P352, DOI 10.1093/jjco/hyp028; Team RC, 2014, R LANG ENV STAT COMP, DOI [10.1016/j.jneumeth.2014.06.019, DOI 10.1016/J.JNEUMETH.2014.06.019]; Tresserra-Rimbau A, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-77; USDA, 2011, USDA DAT FLAV CONT S, DOI [10.1080/21551197.2012.702530, DOI 10.1080/21551197.2012.702530]; USDA, 2007, USDA DAT PROANTH CON; Vogiatzoglou A, 2015, FREE RADICAL BIO MED, V84, P1, DOI 10.1016/j.freeradbiomed.2015.03.005; Vogiatzoglou A, 2014, BRIT J NUTR, V111, P1463, DOI 10.1017/S0007114513003930; WALTI M, 1986, SCHWEIZ MED WSCHR, V116, P98; Wang L, 2009, AM J CLIN NUTR, V89, P905, DOI 10.3945/ajcn.2008.26913; Wang X, 2014, BRIT J NUTR, V111, P1, DOI 10.1017/S000711451300278X; Ward HA, 2010, ARCH BIOCHEM BIOPHYS, V501, P170, DOI 10.1016/j.abb.2010.05.018; Wasson AP, 2006, PLANT CELL, V18, P1617, DOI 10.1105/tpc.105.038232; Wedick NM, 2012, AM J CLIN NUTR, V95, P925, DOI 10.3945/ajcn.111.028894; Welch AA, 2001, PUBLIC HEALTH NUTR, V4, P1253, DOI 10.1079/PHN2001196; Williams RJ, 2004, FREE RADICAL BIO MED, V36, P838, DOI 10.1016/j.freeradbiomed.2004.01.001; Woo Hae Dong, 2013, PLoS One, V8, pe75604, DOI 10.1371/journal.pone.0075604; Woo HD, 2013, WORLD J GASTROENTERO, V19, P1011, DOI 10.3748/wjg.v19.i7.1011; Zamora-Ros R, 2013, EUR J CLIN NUTR, V67, P779, DOI 10.1038/ejcn.2013.89; Zamora-Ros R, 2014, J NUTR, V144, P335, DOI 10.3945/jn.113.184945; Zamora-Ros R, 2011, BRIT J NUTR, V106, P1915, DOI 10.1017/S000711451100239X; Zamora-Ros R, 2011, BRIT J NUTR, V106, P1090, DOI [10.1017/S0007114511001437, 10.1017/S0007114511006386]; ZILVA SS, 1949, BIOCHEM J, V45, P79, DOI 10.1042/bj0450079	62	111	113	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128132	10.1371/journal.pone.0128132	http://dx.doi.org/10.1371/journal.pone.0128132			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010916	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000355183900194
J	Geng, YP; Kedrov, A; Caumanns, JJ; Crevenna, AH; Lamb, DC; Beckmann, R; Driessen, AJM				Geng, Yanping; Kedrov, Alexej; Caumanns, Joseph J.; Crevenna, Alvaro H.; Lamb, Don C.; Beckmann, Roland; Driessen, Arnold J. M.			Role of the Cytosolic Loop C2 and the C Terminus of YidC in Ribosome Binding and Insertion Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-PROTEIN INSERTION; FLUORESCENCE CORRELATION SPECTROSCOPY; PHOSPHOLIPID-BILAYER NANODISCS; ESCHERICHIA-COLI YIDC; F1F0 ATP SYNTHASE; SUBUNIT-C; SECYEG TRANSLOCON; COMPLEX; OXA1; RECONSTITUTION	Members of the YidC/Oxa1/Alb3 protein family mediate membrane protein insertion, and this process is initiated by the assembly of YidC.ribosome nascent chain complexes at the inner leaflet of the lipid bilayer. The positively charged C terminus of Escherichia coli YidC plays a significant role in ribosome binding but is not the sole determinant because deletion does not completely abrogate ribosome binding. The positively charged cytosolic loops C1 and C2 of YidC may provide additional docking sites. We performed systematic sequential deletions within these cytosolic domains and studied their effect on the YidC insertase activity and interaction with translation-stalled (programmed) ribosome. Deletions within loop C1 strongly affected the activity of YidC in vivo but did not influence ribosome binding or substrate insertion, whereas loop C2 appeared to be involved in ribosome binding. Combining the latter deletion with the removal of the C terminus of YidC abolished YidC-mediated insertion. We propose that these two regions play an crucial role in the formation and stabilization of an active YidC.ribosome nascent chain complex, allowing for co-translational membrane insertion, whereas loop C1 may be involved in the downstream chaperone activity of YidC or in other protein-protein interactions.	[Geng, Yanping; Caumanns, Joseph J.; Driessen, Arnold J. M.] Univ Groningen, Biomol Sci & Biotechnol Inst, Mol Microbiol, NL-9747 AG Groningen, Netherlands; [Geng, Yanping; Caumanns, Joseph J.; Driessen, Arnold J. M.] Univ Groningen, Zernike Inst Adv Mat, NL-9747 AG Groningen, Netherlands; [Kedrov, Alexej; Beckmann, Roland] Univ Munich, Gene Ctr Munich, D-81377 Munich, Germany; [Crevenna, Alvaro H.; Lamb, Don C.] Univ Munich, NanoSyst Initiat Munich, Ctr Nanosci, Dept Chem,Phys Chem, D-81377 Munich, Germany; [Crevenna, Alvaro H.; Lamb, Don C.] Univ Munich, Ctr Integrated Prot Sci Munich, D-81377 Munich, Germany	University of Groningen; University of Groningen; University of Munich; University of Munich; University of Munich	Driessen, AJM (corresponding author), Univ Groningen, Biomol Sci & Biotechnol Inst, Mol Microbiol, Nijenborgh 7, NL-9747 AG Groningen, Netherlands.	a.j.m.driessen@rug.nl	Crevenna, Alvaro/Q-4476-2019; Lamb, Don C/G-9501-2014; Crevenna, Alvaro/E-9125-2016; Institute, Zernike/W-7033-2019; Driessen, Arnold J.M./D-1876-2012	Crevenna, Alvaro/0000-0002-5580-3711; Lamb, Don C/0000-0002-0232-1903; Crevenna, Alvaro/0000-0002-5580-3711; Kedrov, Alexej/0000-0001-9117-752X; Driessen, Arnold J.M./0000-0001-9258-9104	Netherlands Foundation for Scientific Research; Chinese Scholarship Council; European Research Council Advanced Grant; Deutsche Forschungsgemeinschaft [SFB 646 B11]; Excellent Clusters Nanosystems Initative Munich; Center for Integrated Protein Science Munich; Ludwig-Maximilians-Universitat Munchen via the LMUInnovativ BioImaging Network; Center for NanoScience	Netherlands Foundation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Chinese Scholarship Council(China Scholarship Council); European Research Council Advanced Grant(European Research Council (ERC)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellent Clusters Nanosystems Initative Munich; Center for Integrated Protein Science Munich; Ludwig-Maximilians-Universitat Munchen via the LMUInnovativ BioImaging Network; Center for NanoScience	This work was supported by Chemical Sciences and Earth and Life Sciences that are both subsidized by the Netherlands Foundation for Scientific Research and by the Chinese Scholarship Council. This work was also supported by a European Research Council Advanced Grant (to R. B.), Deutsche Forschungsgemeinschaft Grant SFB 646 B11 (to D. C. L.), and funds from the Excellent Clusters Nanosystems Initative Munich, the Center for Integrated Protein Science Munich, the Ludwig-Maximilians-Universitat Munchen via the LMUInnovativ BioImaging Network, and the Center for NanoScience (to D. C. L.).	Aschtgen MS, 2012, MICROBIOLOGYOPEN, V1, P71, DOI 10.1002/mbo3.9; BANEYX F, 1990, J BACTERIOL, V172, P491, DOI 10.1128/JB.172.1.491-494.1990; Bischoff L, 2014, CELL REP, V9, P469, DOI 10.1016/j.celrep.2014.09.011; Chen MY, 2002, J BIOL CHEM, V277, P7670, DOI 10.1074/jbc.M110644200; Chen YY, 2014, J BIOL CHEM, V289, P35656, DOI 10.1074/jbc.M114.595082; Crevenna AH, 2013, J BIOL CHEM, V288, P12102, DOI 10.1074/jbc.M113.456327; Dalbey RE, 2014, BBA-MOL CELL RES, V1843, P1489, DOI 10.1016/j.bbamcr.2013.12.022; de Keyzer J, 2002, FEBS LETT, V510, P17, DOI 10.1016/S0014-5793(01)03213-6; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; Du Plessis DJF, 2011, BBA-BIOMEMBRANES, V1808, P851, DOI 10.1016/j.bbamem.2010.08.016; du Plessis DJF, 2006, J BIOL CHEM, V281, P12248, DOI 10.1074/jbc.M600048200; Funes S, 2011, BIOL CHEM, V392, P13, DOI 10.1515/BC.2011.013; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hatzixanthis K, 2003, MOL MICROBIOL, V49, P1377, DOI 10.1046/j.1365-2958.2003.03642.x; Jia LX, 2003, EMBO J, V22, P6438, DOI 10.1093/emboj/cdg624; Jiang FL, 2003, J BIOL CHEM, V278, P48965, DOI 10.1074/jbc.M307362200; Kedrov A, 2013, J MOL BIOL, V425, P4112, DOI 10.1016/j.jmb.2013.07.042; Kedrov A, 2011, EMBO J, V30, P4387, DOI 10.1038/emboj.2011.314; Kohler R, 2009, MOL CELL, V34, P344, DOI 10.1016/j.molcel.2009.04.019; Kol S, 2008, J BIOL CHEM, V283, P9871, DOI 10.1074/jbc.M709408200; Krichevsky O, 2002, REP PROG PHYS, V65, P251, DOI 10.1088/0034-4885/65/2/203; Kumazaki K, 2014, SCI REP-UK, V4, DOI 10.1038/srep07299; Kumazaki K, 2014, NATURE, V509, P516, DOI 10.1038/nature13167; Muller CB, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/46001; Neugebauer SA, 2012, J MOL BIOL, V417, P375, DOI 10.1016/j.jmb.2012.01.046; Pop OI, 2009, FEBS J, V276, P4891, DOI 10.1111/j.1742-4658.2009.07188.x; Price CE, 2011, FEBS LETT, V585, P249, DOI 10.1016/j.febslet.2010.11.057; Price CE, 2010, PROTEOMICS, V10, P3235, DOI 10.1002/pmic.201000284; Price CE, 2010, J BIOL CHEM, V285, P3575, DOI 10.1074/jbc.M109.051128; Ritchie TK, 2009, METHOD ENZYMOL, V464, P211, DOI 10.1016/S0076-6879(09)64011-8; Saaf A, 1998, J BIOL CHEM, V273, P30415, DOI 10.1074/jbc.273.46.30415; Sachelaru I, 2013, J BIOL CHEM, V288, P16295, DOI 10.1074/jbc.M112.446583; Samuelson JC, 2000, NATURE, V406, P637, DOI 10.1038/35020586; Samuelson JC, 2001, J BIOL CHEM, V276, P34847, DOI 10.1074/jbc.M105793200; Seitl I, 2014, MOL MICROBIOL, V91, P408, DOI 10.1111/mmi.12465; Szyrach G, 2003, EMBO J, V22, P6448, DOI 10.1093/emboj/cdg623; van Bloois E, 2006, J BIOL CHEM, V281, P10002, DOI 10.1074/jbc.M511357200; van der Laan M, 2004, J CELL BIOL, V165, P213, DOI 10.1083/jcb.200402100; van der Laan M, 2001, EMBO REP, V2, P519, DOI 10.1093/embo-reports/kve106; Wagner S, 2008, J BIOL CHEM, V283, P17881, DOI 10.1074/jbc.M801481200; Wang P, 2011, BBA-BIOMEMBRANES, V1808, P866, DOI 10.1016/j.bbamem.2010.08.014; Wickles S, 2014, ELIFE, V3, DOI 10.7554/eLife.03035; Wu ZC, 2013, J BACTERIOL, V195, P4545, DOI 10.1128/JB.00792-13; Wu ZC, 2012, J BIOL CHEM, V287, P7885, DOI 10.1074/jbc.M111.297911; Yi L, 2004, J BIOL CHEM, V279, P39260, DOI 10.1074/jbc.M405490200; Zhu L, 2013, J BIOL CHEM, V288, P28180, DOI 10.1074/jbc.M113.491613; Zhu L, 2013, J BIOL CHEM, V288, P7704, DOI 10.1074/jbc.M112.429431	47	19	19	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17250	17261		10.1074/jbc.M115.650309	http://dx.doi.org/10.1074/jbc.M115.650309			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	26023232	Green Published, hybrid			2022-12-26	WOS:000357730900021
J	Vermathen, M; Paul, LEH; Diserens, G; Vermathen, P; Furrer, J				Vermathen, Martina; Paul, Lydia E. H.; Diserens, Gaelle; Vermathen, Peter; Furrer, Julien			H-1 HR-MAS NMR Based Metabolic Profiling of Cells in Response to Treatment with a Hexacationic Ruthenium Metallaprism as Potential Anticancer Drug	PLOS ONE			English	Article							VISIBLE LIPIDS; PLATINUM DRUGS; MOBILE LIPIDS; TUMOR-CELLS; HEPG2 CELLS; NAMI-A; H-1-NMR; DEATH; SPECTROSCOPY; INHIBITION	H-1 high resolution magic angle spinning (HR-MAS) NMR spectroscopy was applied in combination with multivariate statistical analyses to study the metabolic response of whole cells to the treatment with a hexacationic ruthenium metallaprism [1](6+) as potential anticancer drug. Human ovarian cancer cells (A2780), the corresponding cisplatin resistant cells (A2780cisR), and human embryonic kidney cells (HEK-293) were each incubated for 24 h and 72 h with [1](6+) and compared to untreated cells. Different responses were obtained depending on the cell type and incubation time. Most pronounced changes were found for lipids, choline containing compounds, glutamate and glutathione, nucleotide sugars, lactate, and some amino acids. Possible contributions of these metabolites to physiologic processes are discussed. The time-dependent metabolic response patterns suggest that A2780 cells on one hand and HEK-293 cells and A2780cisR cells on the other hand may follow different cell death pathways and exist in different temporal stages thereof.	[Vermathen, Martina; Paul, Lydia E. H.; Furrer, Julien] Univ Bern, Dept Chem & Biochem, Bern, Switzerland; [Diserens, Gaelle; Vermathen, Peter] Univ Bern, Dept Clin Res, Bern, Switzerland; [Diserens, Gaelle; Vermathen, Peter] Univ Bern, AMSM, Dept Radiol, Bern, Switzerland	University of Bern; University of Bern; University of Bern	Vermathen, M (corresponding author), Univ Bern, Dept Chem & Biochem, Bern, Switzerland.	martina.vermathen@dcb.unibe.ch	Vermathen, Martina/ABA-1385-2020; Vermathen, P./J-5789-2012; Furrer, Julien/A-9482-2015	Vermathen, P./0000-0001-8649-1098; Furrer, Julien/0000-0003-2096-0618; Vermathen, Martina/0000-0002-0796-1643	Department of Chemistry & Biochemistry at the University of Bern; Swiss National Science Foundation SNF [206021-128736, 200021_149438, 320030-138150]	Department of Chemistry & Biochemistry at the University of Bern; Swiss National Science Foundation SNF(Swiss National Science Foundation (SNSF))	Financial supports from the Department of Chemistry & Biochemistry at the University of Bern (http://www.dcb.unibe.ch/content/index_ger.html) (JF) and from the Swiss National Science Foundation SNF (http://www.snf.ch/en/Pages/default.aspx) grants # 206021-128736 (MV, PV), # 200021_149438 (MV, JF), and # 320030-138150 (PV) are greatly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerstaff E, 2003, J CELL BIOCHEM, V90, P525, DOI 10.1002/jcb.10659; Allardyce CS, 2001, CHEM COMMUN, P1396, DOI 10.1039/b104021a; Ang WH, 2011, J ORGANOMET CHEM, V696, P989, DOI 10.1016/j.jorganchem.2010.11.009; Antonarakis ES, 2010, CANCER CHEMOTH PHARM, V66, P1, DOI 10.1007/s00280-010-1293-1; Baban DF, 1998, ADV DRUG DELIVER REV, V34, P109, DOI 10.1016/S0169-409X(98)00003-9; Barry NPE, 2009, EUR J INORG CHEM, P4695, DOI 10.1002/ejic.200900649; Bayet-Robert M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057971; Bayet-Robert M, 2010, MAGN RESON MED, V63, P1172, DOI 10.1002/mrm.22303; Bergamo A, 2012, J INORG BIOCHEM, V106, P90, DOI 10.1016/j.jinorgbio.2011.09.030; Blankenberg FG, 1996, BLOOD, V87, P1951; Blunden BM, 2014, MACROMOLECULES, V47, P1646, DOI 10.1021/ma402078d; Brisdelli F, 2003, BIOCHEM PHARMACOL, V65, P1271, DOI 10.1016/S0006-2952(03)00080-7; Cloarec O, 2005, ANAL CHEM, V77, P517, DOI 10.1021/ac048803i; Cuperlovic-Culf M, 2010, DRUG DISCOV TODAY, V15, P610, DOI 10.1016/j.drudis.2010.06.012; del Val IJ, 2013, ANAL BIOCHEM, V443, P172, DOI 10.1016/j.ab.2013.09.005; Delikatny EJ, 2002, CANCER RES, V62, P1394; Di Vito M, 2001, BBA-MOL CELL BIOL L, V1530, P47, DOI 10.1016/S1388-1981(00)00165-7; Dieterle F, 2006, ANAL CHEM, V78, P4281, DOI 10.1021/ac051632c; Duarte IF, 2013, MOL PHARMACEUT, V10, P4242, DOI 10.1021/mp400335k; Duarte IF, 2010, J PROTEOME RES, V9, P5877, DOI 10.1021/pr100635n; Duarte IF, 2009, ANAL CHEM, V81, P5023, DOI 10.1021/ac900545q; European Collection of Cell Cultures (ECACC), 2014, PROD INF; Gao D, 2014, TALANTA, V118, P382, DOI 10.1016/j.talanta.2013.09.018; GODWIN AK, 1992, P NATL ACAD SCI USA, V89, P3070, DOI 10.1073/pnas.89.7.3070; Grande S, 2011, NMR BIOMED, V24, P68, DOI 10.1002/nbm.1557; Griffin JL, 2004, NAT REV CANCER, V4, P551, DOI 10.1038/nrc1390; Griffin JL, 2003, BBA-GEN SUBJECTS, V1619, P151, DOI 10.1016/S0304-4165(02)00475-0; Griffin JL, 2002, NMR BIOMED, V15, P375, DOI 10.1002/nbm.792; Hagrman D, 2004, J PHARMACOL EXP THER, V308, P658, DOI 10.1124/jpet.103.059410; Hakumaki JM, 1999, NAT MED, V5, P1323, DOI 10.1038/15279; Hakumaki JM, 2000, TRENDS BIOCHEM SCI, V25, P357, DOI 10.1016/S0968-0004(00)01614-5; Hayeshi R, 2004, PHYTOTHER RES, V18, P877, DOI 10.1002/ptr.1481; Lamego I, 2014, J PROTEOME RES, V13, P6033, DOI 10.1021/pr500907d; Lindon JC, 2009, PROG NUCL MAG RES SP, V55, P79, DOI 10.1016/j.pnmrs.2008.11.004; Lutz NW, 2005, METABOLOMICS, V1, P251, DOI 10.1007/s11306-005-0005-z; Massimi M, 2012, BBA-GEN SUBJECTS, V1820, P1, DOI 10.1016/j.bbagen.2011.10.005; Miccheli AT, 2006, BBA-GEN SUBJECTS, V1760, P1723, DOI 10.1016/j.bbagen.2006.09.009; Mirbahai L, 2011, INT J BIOCHEM CELL B, V43, P990, DOI 10.1016/j.biocel.2010.07.002; Muhammad N, 2014, CURR OPIN CHEM BIOL, V19, P144, DOI 10.1016/j.cbpa.2014.02.003; Murray BS, 2014, CHEM SCI, V5, P2536, DOI 10.1039/c4sc00116h; Pan XY, 2011, J PROTEOME RES, V10, P3493, DOI 10.1021/pr200114v; Paul LEH, 2015, J BIOL INORG CHEM, V20, P49, DOI 10.1007/s00775-014-1208-4; Paul LEH, 2013, J ORGANOMET CHEM, V734, P45, DOI 10.1016/j.jorganchem.2012.12.011; Paul LEH, 2012, J BIOL INORG CHEM, V17, P1053, DOI 10.1007/s00775-012-0918-8; Paul LEH, 2012, INORG CHEM, V51, P1057, DOI 10.1021/ic2021935; PLOEMEN JHTM, 1991, BIOCHEM PHARMACOL, V41, P1665, DOI 10.1016/0006-2952(91)90167-4; Rainaldi G, 2008, RADIAT RES, V169, P170, DOI 10.1667/RR0958.1; Rehberg M, 2014, APPL MICROBIOL BIOT, V98, P385, DOI 10.1007/s00253-013-5329-4; ROSENBERG B, 1965, NATURE, V205, P698, DOI 10.1038/205698a0; Rosi A, 2004, NMR BIOMED, V17, P76, DOI 10.1002/nbm.867; Sava G, 1996, INT J CANCER, V68, P60, DOI 10.1002/(SICI)1097-0215(19960927)68:1<60::AID-IJC12>3.3.CO;2-7; Sava G, 2003, CLIN CANCER RES, V9, P1898; Sawers L, 2014, BRIT J CANCER, V111, P1150, DOI 10.1038/bjc.2014.386; Schreier C, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/878374; Schulze A, 2012, NATURE, V491, P364, DOI 10.1038/nature11706; Sitter B, 2009, PROG NUCL MAG RES SP, V54, P239, DOI 10.1016/j.pnmrs.2008.10.001; Suss-Fink G, 2010, DALTON T, V39, P1673, DOI 10.1039/b916860p; Therrien B, 2008, ANGEW CHEM INT EDIT, V47, P3773, DOI 10.1002/anie.200800186; Therrien B, 2007, J CLUST SCI, V18, P741, DOI 10.1007/s10876-007-0140-y; Tiziani S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004251; Valverde D, 2006, NMR BIOMED, V19, P223, DOI 10.1002/nbm.1024; Viant MR, 2009, ENVIRON SCI TECHNOL, V43, P219, DOI 10.1021/es802198z; Wheate NJ, 2010, DALTON T, V39, P8113, DOI 10.1039/c0dt00292e; Wolters DA, 2012, METALLOMICS, V4, P1185, DOI 10.1039/c2mt20070h; Wu B, 2011, CHEM-EUR J, V17, P3562, DOI 10.1002/chem.201100298; Yang T, 2010, BIOCHEM J, V429, P533, DOI 10.1042/BJ20100238; Zhang AH, 2013, MAGN RESON CHEM, V51, P549, DOI 10.1002/mrc.3985; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506	68	26	26	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128478	10.1371/journal.pone.0128478	http://dx.doi.org/10.1371/journal.pone.0128478			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024484	Green Published, gold			2022-12-26	WOS:000355319400092
J	Gu, Y; Yang, J; Chen, HJ; Li, J; Xu, M; Hua, J; Yao, J; Wang, YJ; Liu, Y; Liu, M				Gu, Yun; Yang, Jian; Chen, Haijiao; Li, Jing; Xu, Man; Hua, Juan; Yao, Jian; Wang, Yongjun; Liu, Yan; Liu, Mei			Different Astrocytic Activation between Adult Gekko japonicus and Rats during Wound Healing In Vitro	PLOS ONE			English	Article							REGENERATION; INJURY; GENE; TOOL	Glial scar formation is a major obstacle to regeneration after spinal cord injury. Moreover, it has been shown that the astrocytic response to injury differs between species. Gekko japonicas is a type of reptile and it shows differential glial activation compared to that of rats. The purpose of the present study was to compare the proliferation and migration of astrocytes in the spinal cords of geckos and rats after injury in vitro. Spinal cord homogenate stimulation and scratch wound models were used to induce astrocytic activation in adult and embryonic rats, as well as in adult geckos. Our results indicated that astrocytes from the adult rat were likely activated by mechanical stimulation, even though they showed lower proliferation abilities than the astrocytes from the gecko under normal conditions. Furthermore, a transcriptome analysis revealed that the differentially expressed genes in astrocytes from adult rats and those from geckos were enriched in pathways involved in proliferation and the response to stimuli. This implies that intrinsic discrepancies in gene expression patterns might contribute to the differential activation of astrocytes between species.	[Gu, Yun; Yang, Jian; Chen, Haijiao; Li, Jing; Xu, Man; Hua, Juan; Wang, Yongjun; Liu, Yan; Liu, Mei] Nantong Univ, Coinnovat Ctr Neuroregenerat, Jiangsu Key Lab Neuroregenerat, Nantong 226001, Jiangsu, Peoples R China; [Yao, Jian] Nantong Univ, Coll Med, Dept Histol & Embryol, Nantong 226001, Jiangsu, Peoples R China	Nantong University; Nantong University	Liu, Y (corresponding author), Nantong Univ, Coinnovat Ctr Neuroregenerat, Jiangsu Key Lab Neuroregenerat, Nantong 226001, Jiangsu, Peoples R China.	liuyan@ntu.edu.cn; liumei@ntu.edu.cn	Liu, Mei/K-9005-2019; J, Y/GYE-2288-2022	Liu, Mei/0000-0003-1168-6119; J, Y/0000-0001-6318-8854	NSFC [31171007, 31071874]; NSF of Education department of Jiangsu province [11KJA180004]; Starting Foundation for Returned Overseas Chinese Scholars; PAPD of Jiangsu Higher Education Institutions	NSFC(National Natural Science Foundation of China (NSFC)); NSF of Education department of Jiangsu province; Starting Foundation for Returned Overseas Chinese Scholars(Scientific Research Foundation for the Returned Overseas Chinese Scholars); PAPD of Jiangsu Higher Education Institutions	This study was supported by the grants to ML from NSFC (31171007), NSF of Education department of Jiangsu province (11KJA180004), and the Starting Foundation for Returned Overseas Chinese Scholars, the funding from PAPD of Jiangsu Higher Education Institutions; and a grant from NSFC (31071874) to YL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht PJ, 2002, EXP NEUROL, V173, P46, DOI 10.1006/exnr.2001.7834; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bradbury EJ, 2011, BRAIN RES BULL, V84, P306, DOI 10.1016/j.brainresbull.2010.06.015; Buss A, 2007, BRAIN, V130, P940, DOI 10.1093/brain/awl374; Chou RC, 2003, BRAIN RES PROTOC, V11, P162, DOI 10.1016/S1385-299X(03)00043-6; Cregg JM, 2014, EXP NEUROL, V253, P197, DOI 10.1016/j.expneurol.2013.12.024; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Fawcett James W, 2012, Handb Clin Neurol, V109, P503, DOI 10.1016/B978-0-444-52137-8.00031-0; Ferretti P, 2008, CELL MOL LIFE SCI, V65, P45, DOI 10.1007/s00018-007-7430-2; Ferretti P, 2003, DEV DYNAM, V226, P245, DOI 10.1002/dvdy.10226; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Gao DH, 2010, CELL MOL BIOL LETT, V15, P582, DOI 10.2478/s11658-010-0029-x; Goldshmit Y, 2012, J NEUROSCI, V32, P7477, DOI 10.1523/JNEUROSCI.0758-12.2012; Huang Y, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0966-8; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Karimi-Abdolrezaee S, 2012, MOL NEUROBIOL, V46, P251, DOI 10.1007/s12035-012-8287-4; Li J, 2013, INT J MOL SCI, V14, P8787, DOI 10.3390/ijms14058787; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liu M, 2010, CELL BIOL INT, V34, P153, DOI 10.1042/CBI20090015; M'Dahoma S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102027; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Pan Qing, 2011, Invest Ophthalmol Vis Sci, V52, P1723, DOI 10.1167/iovs.10-5866; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; ZHOU Y, 2012, GUANGZHOU DAXUE XUEB, V11, P44; Zukor KA, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-1	27	9	9	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0127663	10.1371/journal.pone.0127663	http://dx.doi.org/10.1371/journal.pone.0127663			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020931	Green Submitted, Green Published, gold			2022-12-26	WOS:000355187300050
J	Hwang, J; Lee, S; Lee, JH; Kang, WH; Kang, JH; Kang, MY; Oh, CS; Kang, BC				Hwang, Jeena; Lee, Seonhee; Lee, Joung-Ho; Kang, Won-Hee; Kang, Jin-Ho; Kang, Min-Young; Oh, Chang-Sik; Kang, Byoung-Cheorl			Plant Translation Elongation Factor 1B beta Facilitates Potato Virus X (PVX) Infection and Interacts with PVX Triple Gene Block Protein 1	PLOS ONE			English	Article							DEPENDENT RNA-POLYMERASE; MOSAIC-VIRUS; FACTOR 1A; RECESSIVE RESISTANCE; ACTIN CYTOSKELETON; ECTOPIC EXPRESSION; FACTOR 1B-GAMMA; CELL-DEATH; STEM-LOOP; REPLICATION	The eukaryotic translation elongation factor 1 (eEF1) has two components: the G-protein eEF1A and the nucleotide exchange factor eEF1B. In plants, eEF1B is itself composed of a structural protein (eEF1B.) and two nucleotide exchange subunits (eEF1B alpha and eEF1B beta). To test the effects of elongation factors on virus infection, we isolated eEF1A and eEF1B genes from pepper (Capsicum annuum) and suppressed their homologs in Nicotiana benthamiana using virus-induced gene silencing (VIGS). The accumulation of a green fluorescent protein (GFP)-tagged Potato virus X (PVX) was significantly reduced in the eEF1B beta-or eEF1B gamma-silenced plants as well as in eEF1A-silenced plants. Yeast two-hybrid and co-immunoprecipitation analyses revealed that eEF1B alpha and eEF1B beta interacted with eEF1A and that eEF1A and eEF1B beta interacted with triple gene block protein 1 (TGBp1) of PVX. These results suggest that both eEF1A and eEF1B beta play essential roles in the multi-plication of PVX by physically interacting with TGBp1. Furthermore, using eEF1B beta deletion constructs, we found that both N-(1-64 amino acids) and C-terminal (150-195 amino acids) domains of eEF1B beta are important for the interaction with PVX TGBp1 and that the C-terminal domain of eEF1B beta is involved in the interaction with eEF1A. These results suggest that eEF1B beta could be a potential target for engineering virus-resistant plants.	[Hwang, Jeena; Lee, Seonhee; Lee, Joung-Ho; Kang, Won-Hee; Kang, Jin-Ho; Kang, Min-Young; Kang, Byoung-Cheorl] Seoul Natl Univ, Plant Genom & Breeding Inst, Dept Plant Sci, Seoul 151921, South Korea; [Hwang, Jeena; Lee, Seonhee; Lee, Joung-Ho; Kang, Won-Hee; Kang, Jin-Ho; Kang, Min-Young; Kang, Byoung-Cheorl] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul 151921, South Korea; [Hwang, Jeena] Korea Inst Sci & Technol Informat, Seoul 130741, South Korea; [Kang, Jin-Ho; Kang, Byoung-Cheorl] Seoul Natl Univ, Crop Biotechnol Inst GreenBio Sci & Technol, Pyeongchang 232916, South Korea; [Oh, Chang-Sik] Kyung Hee Univ, Dept Hort Biotechnol, Yongin 446701, South Korea	Seoul National University (SNU); Seoul National University (SNU); Korea Institute of Science & Technology Information (KISTI); Seoul National University (SNU); Kyung Hee University	Kang, BC (corresponding author), Seoul Natl Univ, Plant Genom & Breeding Inst, Dept Plant Sci, Seoul 151921, South Korea.	bk54@snu.ac.kr	Kang, Byoung-Cheorl/Q-6174-2019; Oh, Chang-Sik/AAK-7131-2020	Oh, Chang-Sik/0000-0002-2123-862X	Golden Seed Project, Ministry of Agriculture, Food and Rural Affairs (MAFRA); Ministry of Oceans and Fisheries (MOF); Rural Development Administration (RDA); Korea Forest Service (KFS); Vegetable Breeding Research Center through the R&D Convergence Center Support Program, Ministry of Agriculture, Food and Rural Affairs (MAFRA) Republic of Korea [710001-07]	Golden Seed Project, Ministry of Agriculture, Food and Rural Affairs (MAFRA); Ministry of Oceans and Fisheries (MOF); Rural Development Administration (RDA)(Rural Development Administration (RDA), Republic of Korea); Korea Forest Service (KFS); Vegetable Breeding Research Center through the R&D Convergence Center Support Program, Ministry of Agriculture, Food and Rural Affairs (MAFRA) Republic of Korea	This research was supported by the Golden Seed Project, Ministry of Agriculture, Food and Rural Affairs (MAFRA), Ministry of Oceans and Fisheries (MOF), Rural Development Administration (RDA) and Korea Forest Service (KFS) and a grant (Project No. 710001-07) from the Vegetable Breeding Research Center through the R&D Convergence Center Support Program, Ministry of Agriculture, Food and Rural Affairs (MAFRA) Republic of Korea. The authors thank S.P. Dinesh-Kumar (University of California, Davis) for the TRV-LIC vector, K.H. Kim (Seoul National University) for PVX-GFP and D. Choi (Seoul National University) for access to the C. annuum sequence database.	Ahlquist P, 2003, J VIROL, V77, P8181, DOI 10.1128/JVI.77.15.8181-8186.2003; Angell SM, 1996, VIROLOGY, V216, P197, DOI 10.1006/viro.1996.0046; BASTIN M, 1976, J VIROL, V20, P117, DOI 10.1128/JVI.20.1.117-122.1976; BECK DL, 1991, VIROLOGY, V183, P695, DOI 10.1016/0042-6822(91)90998-Q; Blackwell JL, 1997, J VIROL, V71, P6433, DOI 10.1128/JVI.71.9.6433-6444.1997; CHAPMAN S, 1992, VIROLOGY, V191, P223, DOI 10.1016/0042-6822(92)90183-P; Cho SY, 2012, VIROLOGY, V427, P166, DOI 10.1016/j.virol.2012.02.005; Corbi N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014481; Cotton S, 2009, J VIROL, V83, P10460, DOI 10.1128/JVI.00819-09; Das T, 1998, P NATL ACAD SCI USA, V95, P1449, DOI 10.1073/pnas.95.4.1449; Davis WG, 2007, J VIROL, V81, P10172, DOI 10.1128/JVI.00531-07; De Nova-Ocampo M, 2002, VIROLOGY, V295, P337, DOI 10.1006/viro.2002.1407; Dinesh-Kumar SP, 2003, METH MOL B, V236, P287; Dong Y, 2007, PLANT PHYSIOL, V145, P1161, DOI 10.1104/pp.107.107391; Dufresne PJ, 2008, VIROLOGY, V374, P217, DOI 10.1016/j.virol.2007.12.014; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Ejiri S, 2002, BIOSCI BIOTECH BIOCH, V66, P1, DOI 10.1271/bbb.66.1; Esposito AM, 2010, J BIOL CHEM, V285, P37995, DOI 10.1074/jbc.M110.160887; Esposito AM, 2007, FREE RADICAL BIO MED, V43, pS150; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Gross SR, 2005, NAT STRUCT MOL BIOL, V12, P772, DOI 10.1038/nsmb979; Gross SR, 2007, MOL CELL BIOL, V27, P1974, DOI 10.1128/MCB.00832-06; HUISMAN MJ, 1988, J GEN VIROL, V69, P1789, DOI 10.1099/0022-1317-69-8-1789; Hwang J, 2013, VIROLOGY, V439, P105, DOI 10.1016/j.virol.2013.02.004; JOSHI RL, 1986, EMBO J, V5, P1143, DOI 10.1002/j.1460-2075.1986.tb04339.x; Kang BC, 2005, ANNU REV PHYTOPATHOL, V43, P581, DOI 10.1146/annurev.phyto.43.011205.141140; Kang BC, 2007, PLANT BIOTECHNOL J, V5, P526, DOI 10.1111/j.1467-7652.2007.00262.x; Kang WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043136; Kidmose RT, 2010, P NATL ACAD SCI USA, V107, P10884, DOI 10.1073/pnas.1003015107; Kim J, 2014, MOL PLANT PATHOL, V15, P615, DOI 10.1111/mpp.12120; Le Sourd F, 2006, BBA-GENE STRUCT EXPR, V1759, P13, DOI 10.1016/j.bbaexp.2006.02.003; Li DS, 2013, MICROBIOL MOL BIOL R, V77, P253, DOI 10.1128/MMBR.00059-12; Li ZH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001175; Li ZH, 2009, VIROLOGY, V385, P245, DOI 10.1016/j.virol.2008.11.041; Liu JZ, 2005, PLANT PHYSIOL, V138, P1853, DOI 10.1104/pp.105.065722; Mateyak MK, 2010, J BIOL CHEM, V285, P21209, DOI 10.1074/jbc.R110.113795; Matsuda D, 2004, VIROLOGY, V321, P36, DOI 10.1016/j.virol.2003.10.023; Mazier M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029595; Nagy PD, 2012, NAT REV MICROBIOL, V10, P137, DOI 10.1038/nrmicro2692; Oh CS, 2013, FEBS LETT, V587, P1460, DOI 10.1016/j.febslet.2013.03.033; Park MR, 2009, VIROLOGY, V386, P257, DOI 10.1016/j.virol.2008.12.044; Pittman YR, 2009, J BIOL CHEM, V284, P4739, DOI 10.1074/jbc.M807945200; Pomerening JR, 2003, MOL GENET GENOMICS, V269, P776, DOI 10.1007/s00438-003-0888-1; Rodnina MV, 2009, CURR OPIN CELL BIOL, V21, P435, DOI 10.1016/j.ceb.2009.01.023; Sasikumar AN, 2012, WIRES RNA, V3, P543, DOI 10.1002/wrna.1118; Sasvari Z, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002438; Schaad MC, 1997, EMBO J, V16, P4049, DOI 10.1093/emboj/16.13.4049; Seo E, 2012, MOL CELLS, V33, P415, DOI 10.1007/s10059-012-0017-2; Takeshita D, 2010, P NATL ACAD SCI USA, V107, P15733, DOI 10.1073/pnas.1006559107; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thivierge K, 2008, VIROLOGY, V377, P216, DOI 10.1016/j.virol.2008.04.015; Tilsner J, 2013, J CELL BIOL, V201, P981, DOI 10.1083/jcb.201304003; Tilsner J, 2012, PLANT PHYSIOL, V158, P1359, DOI 10.1104/pp.111.189605; Truniger V, 2009, ADV VIRUS RES, V75, P119, DOI 10.1016/S0065-3527(09)07504-6; Verchot-Lubicz J, 2005, MOL PLANT MICROBE IN, V18, P283, DOI 10.1094/MPMI-18-0283; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Yamaji Y, 2006, VIROLOGY, V347, P100, DOI 10.1016/j.virol.2005.11.031; Yeom SI, 2012, PLANT J, V69, P755, DOI 10.1111/j.1365-313X.2011.04828.x; Zeenko VV, 2002, J VIROL, V76, P5678, DOI 10.1128/JVI.76.11.5678-5691.2002	59	7	9	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128014	10.1371/journal.pone.0128014	http://dx.doi.org/10.1371/journal.pone.0128014			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020533	Green Published, gold, Green Submitted			2022-12-26	WOS:000355187300071
J	Li, CL; Wang, ZJ; Wang, CX; Ma, Q; Zhao, YX				Li, Changlong; Wang, Zhijian; Wang, Chunxiao; Ma, Qian; Zhao, Yingxin			Perivascular Adipose Tissue-Derived Adiponectin Inhibits Collar-Induced Carotid Atherosclerosis by Promoting Macrophage Autophagy	PLOS ONE			English	Article							APOLIPOPROTEIN-E-DEFICIENT; OXIDATIVE STRESS; CANCER CELLS; PATHWAY; MICE; ATHEROGENESIS; ACTIVATION; MECHANISMS; DISEASE; PLAQUES	Objectives Adiponectin (APN) secreted from perivascular adipose tissue (PVAT) is one of the important anti-inflammatory adipokines to inhibit the development of atherosclerosis, but the underlying mechanism has not been clarified. In this study, we aimed to elucidate how APN regulates plaque formation in atherosclerosis. Methods and Results To assess the role of APN secreted by PVAT in atherosclerosis progression, we performed PVAT transplantation experiments on carotid artery atherosclerosis model: ApoE knockout (ApoE(-/-)) mice with a perivascular collar placement around the left carotid artery in combination with a high-fat diet feeding. Our results show that the ApoE(-/-) mice with PVAT derived from APN knockout (APN(-/-)) mice exhibited accelerated plaque volume formation compared to ApoE(-/-) mice transplanted with wild-type littermate tissue. Conversely, autophagy in macrophages was significantly attenuated in ApoE(-/-) mice transplanted with APN(-/-) mouse-derived PVAT compared to controls. Furthermore, in vitro studies indicate that APN treatment increased autophagy in primary macrophages, as evidenced by increased LC3-I processing and Beclin1 expression, which was accompanied by down-regulation of p62. Moreover, our results demonstrate that APN promotes macrophage autophagy via suppressing the Akt/FOXO3a signaling pathway. Conclusions Our results indicate that PVAT-secreted APN suppresses plaque formation by inducing macrophage autophagy.	[Li, Changlong; Wang, Zhijian; Ma, Qian; Zhao, Yingxin] Beijing Inst Heart Lung & Blood Vessel Dis, Beijing, Peoples R China; [Wang, Chunxiao; Zhao, Yingxin] Capital Med Univ, Anzhen Hosp, Dept Cardiol, Beijing, Peoples R China	Capital Medical University	Zhao, YX (corresponding author), Beijing Inst Heart Lung & Blood Vessel Dis, Beijing, Peoples R China.	zyingxinmi@126.com	wang, jie/GRS-0942-2022; WANG, JINGYI/GSJ-1241-2022		National Natural Science Foundation of China [81170265]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The present study was supported by grants from a National Natural Science Foundation of China (Grant No. 81170265). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barb D, 2007, ENDOCR-RELAT CANCER, V14, P995, DOI 10.1677/ERC-06-0091; Chen S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.380; De Meyer I, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0269-1; Errafiy R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083318; Essick EE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068697; Essick EE, 2011, AM J PHYSIOL-HEART C, V301, pH984, DOI 10.1152/ajpheart.00428.2011; Farini D, 2007, DEV BIOL, V306, P572, DOI 10.1016/j.ydbio.2007.03.031; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Guo R, 2013, BBA-MOL BASIS DIS, V1832, P1136, DOI 10.1016/j.bbadis.2013.03.013; Huypens PR, 2007, MED HYPOTHESES, V68, P1134, DOI 10.1016/j.mehy.2006.09.046; Iacobellis G, 2008, CURR DIABETES REP, V8, P20, DOI 10.1007/s11892-008-0005-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Kawahito H, 2013, AM J PHYSIOL-HEART C, V305, pH667, DOI 10.1152/ajpheart.00053.2013; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Levine B, 2009, CELL DEATH DIFFER, V16, P1, DOI 10.1038/cdd.2008.139; Li BH, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.146; Li L, 2010, CIRC J, V74, P552, DOI 10.1253/circj.CJ-09-0304; Liao XH, 2012, CELL METAB, V15, P545, DOI 10.1016/j.cmet.2012.01.022; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Maiuri M. C., 2013, MEDIAT INFLAMM, V2013, DOI DOI 10.1155/2013/584715; Miao CY, 2012, BRIT J PHARMACOL, V165, P643, DOI 10.1111/j.1476-5381.2011.01404.x; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Muller C, 2011, AUTOPHAGY, V7, P541, DOI 10.4161/auto.7.5.15003; Nawrocki AR, 2010, ARTERIOSCL THROM VAS, V30, P1159, DOI 10.1161/ATVBAHA.109.195826; Ni HM, 2013, AM J PATHOL, V183, P1815, DOI 10.1016/j.ajpath.2013.08.011; Ohman MK, 2011, ATHEROSCLEROSIS, V219, P33, DOI 10.1016/j.atherosclerosis.2011.07.012; Okamoto Y, 2002, CIRCULATION, V106, P2767, DOI 10.1161/01.CIR.0000042707.50032.19; Okamoto Y, 2006, CLIN SCI, V110, P267, DOI 10.1042/CS20050182; Okamoto Y, 2008, CIRC RES, V102, P218, DOI 10.1161/CIRCRESAHA.107.164988; Ouwens DM, 2010, J CELL MOL MED, V14, P2223, DOI 10.1111/j.1582-4934.2010.01141.x; Peng N, 2014, SCI REP-UK, V4, DOI 10.1038/srep05519; Razani B, 2012, CELL METAB, V15, P534, DOI 10.1016/j.cmet.2012.02.011; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Scherz-Shouval R, 2011, TRENDS BIOCHEM SCI, V36, P30, DOI 10.1016/j.tibs.2010.07.007; Shi GD, 2011, BIOCHEM BIOPH RES CO, V404, P941, DOI 10.1016/j.bbrc.2010.12.085; Shibata R, 2005, NAT MED, V11, P1096, DOI 10.1038/nm1295; Sobiesiak M, 2009, J IMMUNOL, V183, P4395, DOI 10.4049/jimmunol.0803017; Strozyk E, 2013, INT J MOL SCI, V14, P15260, DOI 10.3390/ijms140815260; Tian Z, 2013, J MOL CELL CARDIOL, V57, P1, DOI 10.1016/j.yjmcc.2013.01.004; Tsubakio-Yamamoto K, 2008, BIOCHEM BIOPH RES CO, V375, P390, DOI 10.1016/j.bbrc.2008.08.009; Verheye S, 2007, J AM COLL CARDIOL, V49, P706, DOI 10.1016/j.jacc.2006.09.047; von der Thusen JH, 2001, CIRCULATION, V103, P1164, DOI 10.1161/01.CIR.103.8.1164; Wang XM, 2014, MED SCI MONITOR, V20, P1792, DOI 10.12659/MSM.892299; Yang K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095935	44	47	49	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0124031	10.1371/journal.pone.0124031	http://dx.doi.org/10.1371/journal.pone.0124031			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020520	Green Submitted, Green Published, gold			2022-12-26	WOS:000355187300005
J	McNeilly, TN; Mitchell, MC; Corbishley, A; Nath, M; Simmonds, H; McAteer, SP; Mahajan, A; Low, JC; Smith, DGE; Huntley, JF; Gally, DL				McNeilly, Tom N.; Mitchell, Mairi C.; Corbishley, Alexander; Nath, Mintu; Simmonds, Hannah; McAteer, Sean P.; Mahajan, Arvind; Low, J. Christopher; Smith, David G. E.; Huntley, John F.; Gally, David L.			Optimizing the Protection of Cattle against Escherichia coli O157:H7 Colonization through Immunization with Different Combinations of H7 Flagellin, Tir, Intimin-531 or EspA	PLOS ONE			English	Article							III SECRETED PROTEINS; FEEDLOT CATTLE; SIDEROPHORE RECEPTOR; DOMESTIC RUMINANTS; TERMINAL RECTUM; O157-H7; VACCINATION; INFECTION; REDUCE; FECES	Enterohemorrhagic Escherichia coli (EHEC) are important human pathogens, causing hemorrhagic colitis and hemolytic uraemic syndrome in humans. E. coli O157:H7 is the most common serotype associated with EHEC infections worldwide, although other non-O157 serotypes cause life-threatening infections. Cattle are a main reservoir of EHEC and intervention strategies aimed at limiting EHEC excretion from cattle are predicted to lower the risk of human infection. We have previously shown that immunization of calves with recombinant versions of the type III secretion system (T3SS)-associated proteins EspA, intimin and Tir from EHEC O157: H7 significantly reduced shedding of EHEC O157 from experimentally-colonized calves, and that protection could be augmented by the addition of H7 flagellin to the vaccine formulation. The main aim of the present study was to optimize our current EHEC O157 subunit vaccine formulations by identifying the key combinations of these antigens required for protection. A secondary aim was to determine if vaccine-induced antibody responses exhibited cross-reactive potential with antigens from other EHEC serotypes. Immunization with EspA, intimin and Tir resulted in a reduction in mean EHEC O157 shedding following challenge, but not the mean proportion of calves colonized. Removal of Tir resulted in more prolonged shedding compared with all other groups, whereas replacement of Tir with H7 flagellin resulted in the highest levels of protection, both in terms of reducing both mean EHEC O157 shedding and the proportion of colonized calves. Immunization of calves with recombinant EHEC O157 EspA, intimin and Tir resulted in the generation of antibodies capable of cross-reacting with antigens from non-O157 EHEC serotypes, suggesting that immunization with these antigens may provide a degree of cross-protection against other EHEC serotypes. Further studies are now required to test the efficacy of these vaccines in the field, and to formally test the cross-protective potential of the vaccines against other non-O157 EHEC.	[McNeilly, Tom N.; Mitchell, Mairi C.; Corbishley, Alexander; Huntley, John F.] Moredun Res Inst, Edinburgh EH17 7JH, Midlothian, Scotland; [Corbishley, Alexander; Simmonds, Hannah; McAteer, Sean P.; Mahajan, Arvind; Low, J. Christopher; Gally, David L.] Univ Edinburgh, Roslin Inst, Div Immun & Infect, Edinburgh, Midlothian, Scotland; [Nath, Mintu] Biomath & Stat Scotland, Edinburgh, Midlothian, Scotland; [Smith, David G. E.] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland	Moredun Research Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; James Hutton Institute; University of Glasgow	McNeilly, TN (corresponding author), Moredun Res Inst, 408 Gilmerton Rd, Edinburgh EH17 7JH, Midlothian, Scotland.	Tom.McNeilly@moredun.ac.uk	Corbishley, Alexander/AAP-9466-2021; McNeilly, Tom/AAC-8264-2019; Smith, David/N-9743-2018	Corbishley, Alexander/0000-0002-7902-0914; McNeilly, Tom/0000-0001-6469-0512; Smith, David/0000-0002-2484-2603; Gally, David/0000-0002-2566-0844	Department for Environment, Food and Rural Affairs-NOVARTIS LINK [LK0666]; Scottish Government; BBSRC; Bioniche Life Sciences Ltd.; BBSRC [BB/I013954/1, BB/I011625/1, BBS/E/D/20231761] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/20231761, BB/I013954/1, BB/I011625/1] Funding Source: researchfish	Department for Environment, Food and Rural Affairs-NOVARTIS LINK; Scottish Government; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Bioniche Life Sciences Ltd.; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Department for Environment, Food and Rural Affairs-NOVARTIS LINK project number LK0666 (http://randd.defra.gov.uk) to TNM, MCM, AM, JCL, DGES, JFH, DLG; Scottish Government (http://www.scotland.gov.uk/) to TNM, MN, DGES; BBSRC (http://www.bbsrc.ac.uk) to DLG, SM; Bioniche Life Sciences Ltd. (http://www.bioniche.com) PhD studentship to AC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen KJ, 2011, CAN J VET RES, V75, P98; Asper DJ, 2007, VACCINE, V25, P8262, DOI 10.1016/j.vaccine.2007.09.054; Asper DJ, 2011, CLIN VACCINE IMMUNOL, V18, P1052, DOI 10.1128/CVI.00068-11; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blanco M, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-23; Brady MJ, 2007, CELL MICROBIOL, V9, P2242, DOI 10.1111/j.1462-5822.2007.00954.x; BUTLER JE, 1983, VET IMMUNOL IMMUNOP, V4, P43, DOI 10.1016/0165-2427(83)90056-9; Cernicchiaro N, 2014, J FOOD PROTECT, V77, P732, DOI 10.4315/0362-028X.JFP-13-358; Chase-Topping M, 2008, NAT REV MICROBIOL, V6, P904, DOI 10.1038/nrmicro2029; Cook SR, 2005, CAN J ANIM SCI, V85, P291, DOI 10.4141/A04-076; Corbishley A, 2014, INFECT IMMUN, V82, P5117, DOI 10.1128/IAI.02462-14; Dean-Nystrom EA, 2002, INFECT IMMUN, V70, P2414, DOI 10.1128/IAI.70.5.2414-2418.2002; DeVinney R, 1999, INFECT IMMUN, V67, P2389, DOI 10.1128/IAI.67.5.2389-2398.1999; Dziva F, 2004, MICROBIOL-SGM, V150, P3631, DOI 10.1099/mic.0.27448-0; Dziva F, 2007, VET MICROBIOL, V123, P254, DOI 10.1016/j.vetmic.2007.02.016; Ferens WA, 2011, FOODBORNE PATHOG DIS, V8, P465, DOI 10.1089/fpd.2010.0673; Harriff MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097515; Hoffman MA, 2006, CLIN VACCINE IMMUNOL, V13, P1322, DOI 10.1128/CVI.00205-06; Hurd HS, 2012, FOODBORNE PATHOG DIS, V9, P952, DOI 10.1089/fpd.2012.1150; Johnson R. P., 2008, Animal Health Research Reviews, V9, P201, DOI 10.1017/S1466252308001576; Karch H, 2005, INT J MED MICROBIOL, V295, P405, DOI 10.1016/j.ijmm.2005.06.009; Karmali MA, 2010, VET MICROBIOL, V140, P360, DOI 10.1016/j.vetmic.2009.04.011; Kelly G, 1999, NAT STRUCT BIOL, V6, P313; Lai YS, 2013, CELL MICROBIOL, V15, P1796, DOI 10.1111/cmi.12179; Mahajan A, 2009, CELL MICROBIOL, V11, P121, DOI 10.1111/j.1462-5822.2008.01244.x; Matthews L, 2006, P NATL ACAD SCI USA, V103, P547, DOI 10.1073/pnas.0503776103; Matthews L, 2013, P NATL ACAD SCI USA, V110, P16265, DOI 10.1073/pnas.1304978110; McNeilly TN, 2008, INFECT IMMUN, V76, P2594, DOI 10.1128/IAI.01452-07; McNeilly TN, 2010, VACCINE, V28, P1422, DOI 10.1016/j.vaccine.2009.10.076; Menge C, 1999, INFECT IMMUN, V67, P2209, DOI 10.1128/IAI.67.5.2209-2217.1999; Menge C, 2003, EXP BIOL MED, V228, P377, DOI 10.1177/153537020322800408; Moxley RA, 2009, FOODBORNE PATHOG DIS, V6, P879, DOI 10.1089/fpd.2009.0297; Naylor SW, 2005, MICROBIOL-SGM, V151, P2773, DOI 10.1099/mic.0.28060-0; Naylor SW, 2003, INFECT IMMUN, V71, P1505, DOI 10.1128/IAI.71.3.1505-1512.2003; Neves BC, 2003, INFECT IMMUN, V71, P2262, DOI 10.1128/IAI.71.4.2262-2265.2003; Paddock ZD, 2014, FOODBORNE PATHOG DIS, V11, P186, DOI 10.1089/fpd.2013.1659; Pennington H, 2010, LANCET, V376, P1428, DOI 10.1016/S0140-6736(10)60963-4; Potter AA, 2004, VACCINE, V22, P362, DOI 10.1016/j.vaccine.2003.08.007; R Development Core Team, 2014, R LANG ENV STAT COMP; Sargeant JM, 2007, ZOONOSES PUBLIC HLTH, V54, P260, DOI 10.1111/j.1863-2378.2007.01059.x; Sheng HQ, 2005, J CLIN MICROBIOL, V43, P3213, DOI 10.1128/JCM.43.7.3213-3220.2005; Sinclair JF, 2006, INFECT IMMUN, V74, P1255, DOI 10.1128/IAI.74.2.1255-1265.2006; Snedeker KG, 2012, ZOONOSES PUBLIC HLTH, V59, P126, DOI 10.1111/j.1863-2378.2011.01426.x; Stanford K, 2014, FOODBORNE PATHOG DIS, V11, P379, DOI 10.1089/fpd.2013.1693; Thomson DU, 2009, FOODBORNE PATHOG DIS, V6, P871, DOI 10.1089/fpd.2009.0290; Thornton AB, 2009, J FOOD PROTECT, V72, P866, DOI 10.4315/0362-028X-72.4.866; Tobe T, 2006, P NATL ACAD SCI USA, V103, P14941, DOI 10.1073/pnas.0604891103; Vilte DA, 2011, VACCINE, V29, P3962, DOI 10.1016/j.vaccine.2011.03.079; Waddell N, 2012, COMMUNICATION; Wang D, 2008, MOL MICROBIOL, V69, P1499, DOI 10.1111/j.1365-2958.2008.06377.x; Yekta MA, 2011, VET IMMUNOL IMMUNOP, V140, P42, DOI 10.1016/j.vetimm.2010.11.010; Zhang XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091632; Zhao T, 1998, J CLIN MICROBIOL, V36, P641, DOI 10.1128/JCM.36.3.641-647.1998	53	22	22	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128391	10.1371/journal.pone.0128391	http://dx.doi.org/10.1371/journal.pone.0128391			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020530	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000355187300107
J	Ding, N; Dear, K; Guo, SY; Xiang, F; Lucas, R				Ding, Ning; Dear, Keith; Guo, Shuyu; Xiang, Fan; Lucas, Robyn			Tightrope Walking: Using Predictors of 25 (OH)D Concentration Based on Multivariable Linear Regression to Infer Associations with Health Risks	PLOS ONE			English	Article							VITAMIN-D STATUS; PLASMA 25-HYDROXYVITAMIN D; CANCER; MORTALITY; PROSTATE	The debate on the causal association between vitamin D status, measured as serum concentration of 25-hydroxyvitamin D (25[OH] D), and various health outcomes warrants investigation in large-scale health surveys. Measuring the 25(OH) D concentration for each participant is not always feasible, because of the logistics of blood collection and the costs of vitamin D testing. To address this problem, past research has used predicted 25(OH) D concentration, based on multivariable linear regression, as a proxy for unmeasured vitamin D status. We restate this approach in a mathematical framework, to deduce its possible pitfalls. Monte Carlo simulation and real data from the National Health and Nutrition Examination Survey 2005-06 are used to confirm the deductions. The results indicate that variables that are used in the prediction model (for 25[OH] D concentration) but not in the model for the health outcome (called instrumental variables), play an essential role in the identification of an effect. Such variables should be unrelated to the health outcome other than through vitamin D; otherwise the estimate of interest will be biased. The approach of predicted 25 (OH) D concentration derived from multivariable linear regression may be valid. However, careful verification that the instrumental variables are unrelated to the health outcome is required.	[Ding, Ning] Univ Canberra, Fac Hlth, Canberra, ACT 2601, Australia; [Ding, Ning; Guo, Shuyu; Xiang, Fan; Lucas, Robyn] Australian Natl Univ, Res Sch Populat Hlth, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT 2600, Australia; [Dear, Keith] Duke Kunshan Univ, Duke Global Hlth Inst, Kunshan 215316, Jiangsu, Peoples R China; [Lucas, Robyn] Univ Western Australia, Telethon Kids Inst, Perth, WA 6009, Australia	University of Canberra; Australian National University; Duke Kunshan University; Telethon Kids Institute; University of Western Australia	Ding, N (corresponding author), Univ Canberra, Fac Hlth, Canberra, ACT 2601, Australia.	ning.ding@canberra.edu.au		Lucas, Robyn/0000-0003-2736-3541; Dear, Keith/0000-0002-0788-7404	NHMRC Career Development Fellowship [1024898]	NHMRC Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	The authors received no specific funding for this work. Dr. Robyn Lucas would like to acknowledge that she is supported by a NHMRC Career Development Fellowship (1024898), https://www.nhmrc.gov.au/grants-funding/apply-funding/career-development-fellows hips.	Ananthakrishnan AN, 2012, GASTROENTEROLOGY, V142, P482, DOI 10.1053/j.gastro.2011.11.040; Bertrand KA, 2012, BRIT J NUTR, V108, P1889, DOI 10.1017/S0007114511007409; Bhaskaran K, 2014, INT J EPIDEMIOL, P1, DOI [10.1093/ije/dyuu080, DOI 10.1093/IJE/DYUU080]; Bilinski KL, 2012, MED J AUSTRALIA, V197, P90, DOI 10.5694/mja12.10561; Centers for Disease Control and Prevention, 2014, NAT CTR HLTH STAT NA; GARLAND CF, 1980, INT J EPIDEMIOL, V9, P227, DOI 10.1093/ije/9.3.227; GARLAND FC, 1990, PREV MED, V19, P614, DOI 10.1016/0091-7435(90)90058-R; Gilbert R, 2012, CANCER CAUSE CONTROL, V23, P575, DOI 10.1007/s10552-012-9919-8; Giovannucci E, 2006, JNCI-J NATL CANCER I, V98, P451, DOI 10.1093/jnci/djj101; Grant WB, 2009, ANN EPIDEMIOL, V19, P446, DOI 10.1016/j.annepidem.2008.12.014; Greene W, 2012, ECONOMETRIC ANAL; Harris HR, 2013, AM J EPIDEMIOL, V177, P420, DOI 10.1093/aje/kws247; Heckman JJ, 2008, INT STAT REV, V76, P1, DOI 10.1111/j.1751-5823.2007.00024.x; Hofmann JN, 2010, CANCER EPIDEM BIOMAR, V19, P927, DOI 10.1158/1055-9965.EPI-09-1121; Hoggatt KJ, 2003, INT J EPIDEMIOL, V32, P553, DOI 10.1093/ije/dyg222; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; IMBENS GW, 1994, ECONOMETRICA, V62, P467, DOI 10.2307/2951620; Jimenez M, 2014, PUBLIC HEALTH NUTR, V17, P844, DOI 10.1017/S1368980013000177; Joh HK, 2013, JNCI-J NATL CANCER I, V105, P726, DOI 10.1093/jnci/djt082; Jorde R, 2010, AM J EPIDEMIOL, V171, P903, DOI 10.1093/aje/kwq005; Kotsopoulos J, 2010, CANCER EPIDEM BIOMAR, V19, P938, DOI 10.1158/1055-9965.EPI-09-1318; Liu EJ, 2010, AM J CLIN NUTR, V91, P1627, DOI 10.3945/ajcn.2009.28441; Liu JJ, 2013, ANN ONCOL, V24, P687, DOI 10.1093/annonc/mds509; McCullagh P, 1989, GEN LINEAR MODELS; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Ng K, 2009, BRIT J CANCER, V101, P916, DOI 10.1038/sj.bjc.6605262; Sattar N, 2012, LANCET, V379, P95, DOI 10.1016/S0140-6736(11)61816-3; SchmidtGayk H, 1997, SCAND J CLIN LAB INV, V57, P35; Vimaleswaran KS, 2014, LANCET DIABETES ENDO, V2, P719, DOI 10.1016/S2213-8587(14)70113-5	29	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0125551	10.1371/journal.pone.0125551	http://dx.doi.org/10.1371/journal.pone.0125551			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26017695	Green Published, gold			2022-12-26	WOS:000355185600026
J	Ho-Pham, LT; Lai, TQ; Nguyen, MTT; Nguyen, TV				Ho-Pham, Lan T.; Lai, Thai Q.; Nguyen, Mai T. T.; Nguyen, Tuan V.			Relationship between Body Mass Index and Percent Body Fat in Vietnamese: Implications for the Diagnosis of Obesity	PLOS ONE			English	Article							RISK-FACTORS; WAIST CIRCUMFERENCE; FOOD-CONSUMPTION; OVERWEIGHT; BMI; PREVALENCE; CHINESE; ADULTS; MORTALITY; POINTS	Background The burden of obesity in Vietnam has not been well defined because there is a lack of reference data for percent body fat (PBF) in Asians. This study sought to define the relationship between PBF and body mass index (BMI) in the Vietnamese population. Methods The study was designed as a comparative cross-sectional investigation that involved 1217 individuals of Vietnamese background (862 women) aged 20 years and older (average age 47 yr) who were randomly selected from the general population in Ho Chi Minh City. Lean mass (LM) and fat mass (FM) were measured by DXA (Hologic QDR 4500). PBF was derived as FM over body weight. Results Based on BMI >= 30, the prevalence of obesity was 1.1% and 1.3% for men and women, respectively. The prevalence of overweight and obesity combined (BMI >= 25) was similar to 24% and similar to 19% in men and women, respectively. Based on the quadratic relationship between BMI and PBF, the approximate PBF corresponding to the BMI threshold of 30 (obese) was 30.5 in men and 41 in women. Using the criteria of PBF > 30 in men and PBF > 40 in women, approximately 15% of men and women were considered obese. Conclusion These data suggest that body mass index underestimates the prevalence of obesity. We suggest that a PBF > 30 in men or PBF > 40 in women is used as criteria for the diagnosis of obesity in Vietnamese adults. Using these criteria, 15% of Vietnamese adults in Ho Chi Minh City was considered obese.	[Ho-Pham, Lan T.; Nguyen, Tuan V.] Ton Duc Thang Univ, Fac Sci Appl, Bone & Muscle Res Div, Ho Chi Minh City, Vietnam; [Ho-Pham, Lan T.] Pham Ngoc Thach Univ Med, Dept Internal Med, Ho Chi Minh City, Vietnam; [Ho-Pham, Lan T.; Lai, Thai Q.] Peoples Hosp 115, Dept Rheumatol, Ho Chi Minh City, Vietnam; [Nguyen, Mai T. T.] Pham Ngoc Thach Univ Med, Dept Med Eth Behav Sci, Ho Chi Minh City, Vietnam; [Nguyen, Tuan V.] Garvan Inst Med Res, Osteoporosis & Bone Biol, Sydney, NSW, Australia; [Nguyen, Tuan V.] UNSW Australia, Sch Publ Hlth & Community Med, Sydney, NSW, Australia; [Nguyen, Tuan V.] Univ Technol Sydney, Ctr Hlth Technol, Sydney, NSW 2007, Australia	Ton Duc Thang University; Garvan Institute of Medical Research; University of New South Wales Sydney; University of Technology Sydney	Ho-Pham, LT (corresponding author), Ton Duc Thang Univ, Fac Sci Appl, Bone & Muscle Res Div, Ho Chi Minh City, Vietnam.	hophamthuclan@tdt.edu.vn			Department of Science and Technology, Ho Chi Minh City; University Commission for Development (CUD) program, Belgium	Department of Science and Technology, Ho Chi Minh City(Department of Science & Technology (India)); University Commission for Development (CUD) program, Belgium	The study was partially supported by a grant from the Department of Science and Technology, Ho Chi Minh City and a grant from the University Commission for Development (CUD) program, Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah A, 2010, DIABETES RES CLIN PR, V89, P309, DOI 10.1016/j.diabres.2010.04.012; [Anonymous], 2000, WHO TECH REP SER, P894; Anuurad E, 2003, J OCCUP HEALTH, V45, P335, DOI 10.1539/joh.45.335; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bray GA, 2004, J CLIN ENDOCR METAB, V89, P2583, DOI 10.1210/jc.2004-0535; Chang CJ, 2003, INT J OBESITY, V27, P253, DOI 10.1038/sj.ijo.802197; Cole TJ, 2008, AM J CLIN NUTR, V87, P1959, DOI 10.1093/ajcn/87.6.1959; Deurenberg P, 1998, INT J OBESITY, V22, P1164, DOI 10.1038/sj/ijo/0800741; Deurenberg P, 2001, BRIT J NUTR, V85, P135, DOI 10.1079/BJN2000273; Deurenberg-Yap M, 2002, Obes Rev, V3, P209, DOI 10.1046/j.1467-789X.2002.00069.x; Deurenberg-Yap M, 2000, INT J OBESITY, V24, P1011, DOI 10.1038/sj.ijo.0801353; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Gomez-Ambrosi J, 2012, INT J OBESITY, V36, P286, DOI 10.1038/ijo.2011.100; Gu DF, 2006, JAMA-J AM MED ASSOC, V295, P776, DOI 10.1001/jama.295.7.776; Ha DTP, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-62; He M, 2001, INT J OBESITY, V25, P748, DOI 10.1038/sj.ijo.0801612; Ho-Pham LT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094563; Ho-Pham LT, 2011, MAYO CLIN PROC, V86, P584, DOI 10.4065/mcp.2011.0097; Ho-Pham LT, 2010, OBESITY, V18, P1242, DOI 10.1038/oby.2010.19; Ho-Pham LT, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-59; Jitnarin N, 2011, EAT WEIGHT DISORD-ST, V16, pE242, DOI 10.1007/BF03327467; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Kelly TL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007038; Kim CH, 2011, AM J CLIN NUTR, V94, P34, DOI 10.3945/ajcn.110.001867; Ko GTC, 2001, BRIT J NUTR, V85, P239, DOI 10.1079/BJN2000251; Kodama S, 2012, AM J EPIDEMIOL, V176, P959, DOI 10.1093/aje/kws172; Lee K, 2007, ASIA PAC J CLIN NUTR, V16, P649; Lin WY, 2011, CAN MED ASSOC J, V183, pE329, DOI 10.1503/cmaj.101303; Martin AD, 2011, J STAT SOFTW, V42, P1; Mohamud WNW, 2011, ASIA PAC J CLIN NUTR, V20, P35; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Odegaard AO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014000; Pasco JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029580; R Development Core Team, 2008, LANG ENV STAT COMP; Reynolds K, 2007, OBESITY, V15, P10, DOI 10.1038/oby.2007.527; Romero-Corral A, 2008, INT J OBESITY, V32, P959, DOI 10.1038/ijo.2008.11; Thang NM, 2004, EUR J CLIN NUTR, V58, P145, DOI 10.1038/sj.ejcn.1601761; Tuan NT, 2008, EUR J CLIN NUTR, V62, P78, DOI 10.1038/sj.ejcn.1602675; WANG J, 1994, AM J CLIN NUTR, V60, P23, DOI 10.1093/ajcn/60.1.23; Weisell RC, 2002, ASIA PAC J CLIN NUTR, V11, pS681, DOI 10.1046/j.1440-6047.11.s8.5.x; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; World Bank, 2018, WORLD DEV IND; World Health Organization, 1995, PHYS STAT US INT ANT; Yajnik CS, 2004, LANCET, V363, P163, DOI 10.1016/S0140-6736(03)15269-5; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P83	45	40	41	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0127198	10.1371/journal.pone.0127198	http://dx.doi.org/10.1371/journal.pone.0127198			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018910	Green Published, gold, Green Submitted			2022-12-26	WOS:000355185600075
J	Mika, A; Van Treuren, W; Gonzalez, A; Herrera, JJ; Knight, R; Fleshner, M				Mika, Agnieszka; Van Treuren, Will; Gonzalez, Antonio; Herrera, Jonathan J.; Knight, Rob; Fleshner, Monika			Exercise Is More Effective at Altering Gut Microbial Composition and Producing Stable Changes in Lean Mass in Juvenile versus Adult Male F344 Rats	PLOS ONE			English	Article							INTESTINAL MICROBIOTA; UNCONTROLLABLE STRESS; WEIGHT; EXPRESSION; DIVERSITY; BUTYRATE; BACTERIA; AGE; CONSEQUENCES; MICROFLORA	The mammalian intestine harbors a complex microbial ecosystem that influences many aspects of host physiology. Exposure to specific microbes early in development affects hostmetabolism, immune function, and behavior across the lifespan. Just as the physiology of the developing organism undergoes a period of plasticity, the developing microbial ecosystem is characterized by instability and may also be more sensitive to change. Early life thus presents a window of opportunity for manipulations that produce adaptive changes in microbial composition. Recent insights have revealed that increasing physical activity can increase the abundance of beneficial microbial species. We therefore investigated whether six weeks of wheel running initiated in the juvenile period (postnatal day 24) would produce more robust and stable changes in microbial communities versus exercise initiated in adulthood (postnatal day 70) in male F344 rats. 16S rRNA gene sequencing was used to characterize the microbial composition of juvenile versus adult runners and their sedentary counterparts across multiple time points during exercise and following exercise cessation. Alpha diversity measures revealed that the microbial communities of young runners were less even and diverse, a community structure that reflects volatility and malleability. Juvenile onset exercise altered several phyla and, notably, increased Bacteroidetes and decreased Firmicutes, a configuration associated with leanness. At the genus level of taxonomy, exercise altered more genera in juveniles than in the adults and produced patterns associated with adaptive metabolic consequences. Given the potential of these changes to contribute to a lean phenotype, we examined body composition in juvenile versus adult runners. Interestingly, exercise produced persistent increases in lean body mass in juvenile but not adult runners. Taken together, these results indicate that the impact of exercise on gut microbiota composition as well as body composition may depend on the developmental stage during which exercise is initiated.	[Mika, Agnieszka; Herrera, Jonathan J.; Fleshner, Monika] Univ Colorado, Dept Integrat Physiol, Boulder, CO 80301 USA; [Mika, Agnieszka; Herrera, Jonathan J.; Fleshner, Monika] Univ Colorado, Ctr Neurosci, Boulder, CO 80301 USA; [Van Treuren, Will] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Gonzalez, Antonio; Knight, Rob] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Knight, Rob] Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Stanford University; University of California System; University of California San Diego; University of California System; University of California San Diego	Fleshner, M (corresponding author), Univ Colorado, Dept Integrat Physiol, Boulder, CO 80301 USA.	fleshner@colorado.edu	Knight, Rob/D-1299-2010; Gonzalez, Antonio/A-6421-2018	Fleshner, Monika/0000-0002-0470-0827; Knight, Rob/0000-0002-0975-9019	National Institutes of Health [R01-MH068283]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH068283] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding provided by National Institutes of Health R01-MH068283. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADOLPH EF, 1947, AM J PHYSIOL, V151, P110, DOI 10.1152/ajplegacy.1947.151.1.110; Ajslev TA, 2011, INT J OBESITY, V35, P522, DOI 10.1038/ijo.2011.27; Aronsson L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013087; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bercik P, 2011, NEUROGASTROENT MOTIL, V23, P1132, DOI 10.1111/j.1365-2982.2011.01796.x; BERG RD, 1979, INFECT IMMUN, V23, P403, DOI 10.1128/IAI.23.2.403-411.1979; Bisgaard H, 2011, J ALLERGY CLIN IMMUN, V128, P646, DOI 10.1016/j.jaci.2011.04.060; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Caporaso JG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r50; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Clarke SF, 2014, GUT; CONLY JM, 1994, AM J GASTROENTEROL, V89, P915; Cox LM, 2014, CELL, V158, P705, DOI 10.1016/j.cell.2014.05.052; Desbonnet L, 2008, J PSYCHIATR RES, V43, P164, DOI 10.1016/j.jpsychires.2008.03.009; Duncan SH, 2008, INT J OBESITY, V32, P1720, DOI 10.1038/ijo.2008.155; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Evans CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092193; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Gao ZG, 2009, DIABETES, V58, P1509, DOI 10.2337/db08-1637; Greenwood BN, 2008, NEUROMOL MED, V10, P81, DOI 10.1007/s12017-008-8029-y; Greenwood BN, 2012, BEHAV BRAIN RES, V233, P314, DOI 10.1016/j.bbr.2012.05.017; Greenwood BN, 2011, BEHAV BRAIN RES, V217, P354, DOI 10.1016/j.bbr.2010.11.005; Greenwood BN, 2005, BRAIN RES, V1033, P164, DOI 10.1016/j.brainres.2004.11.037; Greenwood BN, 2003, J NEUROSCI, V23, P2889; Haange SB, 2012, J PROTEOME RES, V11, P5406, DOI 10.1021/pr3006364; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Hill MJ, 1997, EUR J CANCER PREV, V6, pS43, DOI 10.1097/00008469-199703001-00009; Hooper LV, 2003, NAT IMMUNOL, V4, P269, DOI 10.1038/ni888; Hrncir T, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-65; Queipo-Ortuno MI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065465; Kalliomaki M, 2008, AM J CLIN NUTR, V87, P534, DOI 10.1093/ajcn/87.3.534; Kang SS, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-36; Knights D, 2011, FEMS MICROBIOL REV, V35, P343, DOI 10.1111/j.1574-6976.2010.00251.x; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Korecka A, 2013, AM J PHYSIOL-GASTR L, V304, pG1025, DOI 10.1152/ajpgi.00293.2012; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Mai V, 2007, MOL CARCINOGEN, V46, P42, DOI 10.1002/mc.20233; Mann PB, 2010, CARCINOGENESIS, V31, P1279, DOI 10.1093/carcin/bgq063; Maslanik T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050636; Matsumoto M, 2008, BIOSCI BIOTECH BIOCH, V72, P572, DOI 10.1271/bbb.70474; McAllan L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088904; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; Meijer JH, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0210; Messaoudi M, 2011, BRIT J NUTR, V105, P755, DOI 10.1017/S0007114510004319; Million M, 2013, INT J OBESITY, V37, P1460, DOI 10.1038/ijo.2013.20; Murphy R, 2014, INT J OBESITY, V38, P1115, DOI 10.1038/ijo.2013.218; Navas-Molina JA, 2013, METHOD ENZYMOL, V531, P371, DOI 10.1016/B978-0-12-407863-5.00019-8; O'Toole PW, 2010, INT DAIRY J, V20, P281, DOI 10.1016/j.idairyj.2009.11.010; Ohara Y, 2000, ACT NEUR S, V76, P117; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Petriz BA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-511; Rao A. Ravishankar, 2009, P1; RESTREPO C, 1987, PSYCHONEUROENDOCRINO, V12, P393, DOI 10.1016/0306-4530(87)90068-0; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Salonen A., 2014, ISME J; Santacruz A, 2009, OBESITY, V17, P1906, DOI 10.1038/oby.2009.112; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Shindo D, 2014, J APPL PHYSIOL, V116, P674, DOI 10.1152/japplphysiol.00405.2013; Smith Dl Jr, 2009, Int J Body Compos Res, V7, P21; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Speaker KJ, 2014, BRAIN BEHAV IMMUN, V39, P87, DOI 10.1016/j.bbi.2013.10.028; STEVENSON JA, 1966, J APPL PHYSIOL, V21, P118, DOI 10.1152/jappl.1966.21.1.118; Sudo N, 2004, J PHYSIOL-LONDON, V558, P263, DOI 10.1113/jphysiol.2004.063388; Sudo N, 1997, J IMMUNOL, V159, P1739; TAKEMOTO TI, 1975, TOHOKU J EXP MED, V117, P153, DOI 10.1620/tjem.117.153; Tlaskalova-Hogenova H, 2004, IMMUNOL LETT, V93, P97, DOI 10.1016/j.imlet.2004.02.005; Trasande L, 2013, INT J OBESITY, V37, P16, DOI 10.1038/ijo.2012.132; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vazquez-Baeza Y, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-16; Wall R, 2009, CLIN MED INSIGHTS-PE, V3, P45; Wilson M., 2005, MICROBIAL INHABITANT; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	80	110	116	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0125889	10.1371/journal.pone.0125889	http://dx.doi.org/10.1371/journal.pone.0125889			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26016739	gold, Green Published			2022-12-26	WOS:000355185600039
J	Shim, DW; Heo, KH; Kim, YK; Sim, EJ; Kang, TB; Choi, JW; Sim, DW; Cheong, SH; Lee, SH; Bang, JK; Won, HS; Lee, KH				Shim, Do-Wan; Heo, Kang-Hyuck; Kim, Young-Kyu; Sim, Eun-Jeong; Kang, Tae-Bong; Choi, Jae-Wan; Sim, Dae-Won; Cheong, Sun-Hee; Lee, Seung-Hong; Bang, Jeong-Kyu; Won, Hyung-Sik; Lee, Kwang-Ho			Anti-Inflammatory Action of an Antimicrobial Model Peptide That Suppresses the TRIF-Dependent Signaling Pathway via Inhibition of Toll-Like Receptor 4 Endocytosis in Lipopolysaccharide-Stimulated Macrophages	PLOS ONE			English	Article							HOST-DEFENSE PEPTIDES; FROG-SKIN; INNATE; EXPRESSION; INDUCTION; LPS; TOLL-LIKE-RECEPTOR-4; ACTIVATION; BINDING	Antimicrobial peptides (AMPs), also called host defense peptides, particularly those with amphipathic helical structures, are emerging as target molecules for therapeutic development due to their immunomodulatory properties. Although the antimicrobial activity of AMPs is known to be exerted primarily by permeation of the bacterial membrane, the mechanism underlying its anti-inflammatory activity remains to be elucidated. We report potent anti-inflammatory activity of WALK11.3, an antimicrobial model peptide with an amphipathic helical conformation, in lipopolysaccharide (LPS)-stimulated RAW264.7 cells. This peptide inhibited the expression of inflammatory mediators, including nitric oxide, COX-2, IL-1 beta, IL-6, INF-beta, and TNF-alpha. Although WALK11.3 did not exert a major effect on all downstream signaling in the MyD88-dependent pathway, toll-like receptor 4 (TLR4)-mediated pro-inflammatory signals were markedly attenuated in the TRIF-dependent pathway due to inhibition of the phosphorylation of STAT1 by attenuation of IRF3 phosphorylation. WALK11.3 specifically inhibited the endocytosis of TLR4, which is essential for triggering TRIF-mediated signaling in macrophage cells. Hence, we suggest that specific interference with TLR4 endocytosis could be one of the major modes of the anti-inflammatory action of AMPs. Our designed WALK11 peptides, which possess both antimicrobial and anti-inflammatory activities, may be promising molecules for the development of therapies for infectious inflammation.	[Shim, Do-Wan; Heo, Kang-Hyuck; Kim, Young-Kyu; Sim, Eun-Jeong; Kang, Tae-Bong; Choi, Jae-Wan; Sim, Dae-Won; Cheong, Sun-Hee; Won, Hyung-Sik; Lee, Kwang-Ho] Konkuk Univ, Coll Biomed & Hlth Sci, Dept Biotechnol, Chungju, Chungbuk, South Korea; [Lee, Seung-Hong] Konkuk Univ, Coll Biomed & Hlth Sci, Div Food Biosci, Chungju, Chungbuk, South Korea; [Bang, Jeong-Kyu] Korea Basic Sci Inst, Div Magnet Resonance, Ochang, Chungbuk, South Korea	Konkuk University; Konkuk University; Korea Basic Science Institute (KBSI)	Won, HS (corresponding author), Konkuk Univ, Coll Biomed & Hlth Sci, Dept Biotechnol, Chungju, Chungbuk, South Korea.	wonhs@kku.ac.kr; kwangho@kku.ac.kr	kang, Tae-bong/AAD-7950-2022	kang, Tae-bong/0000-0003-1441-9470	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2012-A419-0040]; Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea [A092006]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology; Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012-A419-0040) and in part by the Korea Healthcare Technology R&D Project (no. A092006), Ministry for Health, Welfare & Family Affairs, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Conlon JM, 2014, PEPTIDES, V57, P67, DOI 10.1016/j.peptides.2014.04.019; Fjell CD, 2012, NAT REV DRUG DISCOV, V11, P37, DOI 10.1038/nrd3591; Ge L, 2014, SCI WORLD J, V2014; Hilchie AL, 2013, NAT CHEM BIOL, V9, P761, DOI [10.1038/NCHEMBIO.1393, 10.1038/nchembio.1393]; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; Jacob B, 2014, AMINO ACIDS, V46, P187, DOI 10.1007/s00726-013-1616-8; Jacobs AT, 2001, J BIOL CHEM, V276, P47950, DOI 10.1074/jbc.M106639200; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kim SJ, 2013, MOLECULES, V18, P859, DOI 10.3390/molecules18010859; Lee E, 2013, BBA-BIOMEMBRANES, V1828, P271, DOI 10.1016/j.bbamem.2012.10.028; Lee SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074194; Lee SH, 2011, REGUL PEPTIDES, V166, P36, DOI 10.1016/j.regpep.2010.08.010; Meng P, 2012, BIOCHIMIE, V94, P2508, DOI 10.1016/j.biochi.2012.06.029; Moore KJ, 2000, J IMMUNOL, V165, P4272, DOI 10.4049/jimmunol.165.8.4272; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Moynagh PN, 2005, TRENDS IMMUNOL, V26, P469, DOI 10.1016/j.it.2005.06.009; Nagaoka I, 2001, J IMMUNOL, V167, P3329, DOI 10.4049/jimmunol.167.6.3329; Nakatsuji T, 2012, J INVEST DERMATOL, V132, P887, DOI 10.1038/jid.2011.387; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Nguyen LT, 2011, TRENDS BIOTECHNOL, V29, P464, DOI 10.1016/j.tibtech.2011.05.001; Rosenfeld Y, 2006, J BIOL CHEM, V281, P1636, DOI 10.1074/jbc.M504327200; Shim DW, 2013, J ETHNOPHARMACOL, V150, P1007, DOI 10.1016/j.jep.2013.09.056; Tabas I, 2013, SCIENCE, V339, P166, DOI 10.1126/science.1230720; Toshchakov V, 2002, NAT IMMUNOL, V3, P392, DOI 10.1038/ni774; Wang JX, 2009, ACTA PHARMACOL SIN, V30, P1428, DOI 10.1038/aps.2009.138; Wei L, 2013, J MED CHEM, V56, P3546, DOI 10.1021/jm4004158; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051	34	28	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0126871	10.1371/journal.pone.0126871	http://dx.doi.org/10.1371/journal.pone.0126871			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26017270	gold, Green Published, Green Submitted			2022-12-26	WOS:000355185600063
J	Bermudez, M; Imaz-Rosshandler, I; Rangel-Escareno, C; Zeichner-David, M; Arzate, H; Mercado-Celis, GE				Bermudez, Mercedes; Imaz-Rosshandler, Ivan; Rangel-Escareno, Claudia; Zeichner-David, Margarita; Arzate, Higinio; Mercado-Celis, Gabriela E.			CEMP1 Induces Transformation in Human Gingival Fibroblasts	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; PERIODONTAL-LIGAMENT CELLS; PROSTATE-CANCER; BREAST-CANCER; E-CADHERIN; CEMENTUM; EXPRESSION; CARCINOMA; PROTEIN; OVEREXPRESSION	Cementum Protein 1 (CEMP1) is a key regulator of cementogenesis. CEMP1 promotes cell attachment, differentiation, deposition rate, composition, and morphology of hydroxyapatite crystals formed by human cementoblastic cells. Its expression is restricted to cementoblasts and progenitor cell subpopulations present in the periodontal ligament. CEMP1 transfection into non-osteogenic cells such as adult human gingival fibroblasts results in differentiation of these cells into a "mineralizing" cell phenotype. Other studies have shown evidence that CEMP1 could have a therapeutic potential for the treatment of bone defects and regeneration of other mineralized tissues. To better understand CEMP1's biological effects in vitro we investigated the consequences of its expression in human gingival fibroblasts (HGF) growing in non-mineralizing media by comparing gene expression profiles. We identified several mRNAs whose expression is modified by CEMP1 induction in HGF cells. Enrichment analysis showed that several of these newly expressed genes are involved in oncogenesis. Our results suggest that CEMP1 causes the transformation of HGF and NIH3T3 cells. CEMP1 is overexpressed in cancer cell lines. We also determined that the region spanning the CEMP1 locus is commonly amplified in a variety of cancers, and finally we found significant overexpression of CEMP1 in leukemia, cervix, breast, prostate and lung cancer. Our findings suggest that CEMP1 exerts modulation of a number of cellular genes, cellular development, cellular growth, cell death, and cell cycle, and molecules associated with cancer.	[Bermudez, Mercedes; Arzate, Higinio] Univ Nacl Autonoma Mexico, Fac Odontol, Lab Biol Periodontal, Mexico City 04510, DF, Mexico; [Imaz-Rosshandler, Ivan; Rangel-Escareno, Claudia; Mercado-Celis, Gabriela E.] SSA, Inst Nacl Med Genom, Mexico City, DF, Mexico; [Zeichner-David, Margarita] Univ So Calif, Ostrow Sch Dent, Los Angeles, CA USA	Universidad Nacional Autonoma de Mexico; Instituto Nacional de Medicina Genomica; University of Southern California	Mercado-Celis, GE (corresponding author), Univ Nacl Autonoma Mexico, Fac Odontol, Lab Genom, Mexico City 04510, DF, Mexico.	gemercadoc@unam.mx	Mercado-Celis, Gabriela E./AAR-7836-2020; Rangel-Escareno, Claudia/F-4587-2012; Arzate, Higinio/K-1934-2019	Mercado-Celis, Gabriela E./0000-0003-3113-0687; Rangel-Escareno, Claudia/0000-0003-1303-0834; Imaz Rosshandler, Ivan/0000-0001-5975-0138	Consejo Nacional de Ciencia y Tecnologia [224081, 142158]; Direccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico [IT200414]; Internal Research Program Instituto Nacional de Medicina Genomica	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Direccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico); Internal Research Program Instituto Nacional de Medicina Genomica	This work was supported by Consejo Nacional de Ciencia y Tecnologia (224081) (HA); Consejo Nacional de Ciencia y Tecnologia (142158) (GEM) (www.conacyt.mx); Direccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico (IT200414) (HA); and Internal Research Program Instituto Nacional de Medicina Genomica (GEM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Perez MA, 2006, BONE, V38, P409, DOI 10.1016/j.bone.2005.09.009; Arzate H, 2002, J DENT RES, V81, P541, DOI 10.1177/154405910208100808; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bartold PM, 2000, PERIODONTOL 2000, V24, P253, DOI 10.1034/j.1600-0757.2000.2240113.x; Benjamini Y, CONTROLLING FALSE DI; Brannon RB, 2002, ORAL SURG ORAL MED O, V93, P311, DOI 10.1067/moe.2002.121993; Carmona-Rodriguez B, 2007, BIOCHEM BIOPH RES CO, V358, P763, DOI 10.1016/j.bbrc.2007.04.204; Chen W, 2012, STEM CELLS DEV, V21, P3372, DOI 10.1089/scd.2012.0121; Chin L, 2011, GENE DEV, V25, P534, DOI 10.1101/gad.2017311; Choucair KA, 2012, TRANSL ONCOL, V5, P453, DOI 10.1593/tlo.12286; Fan M, 2013, TUMORI J, V99, P689, DOI 10.1700/1390.15457; Feng S, 2014, HISTOL HISTOPATHOL; Paula-Silva FWG, 2010, CALCIFIED TISSUE INT, V87, P144, DOI 10.1007/s00223-010-9368-x; Geissmann Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054072; Giunti L, 2014, AM J CANCER RES, V4, P293; Gonzalez-Alva P, 2013, J ORAL RES, P2; Gonzalez-Perez A, 2013, NAT METHODS, V10, P723, DOI 10.1038/nmeth.2562; Grzesik WJ, 2002, CRIT REV ORAL BIOL M, V13, P474, DOI 10.1177/154411130201300605; Hoz L, 2012, CELL BIOL INT, V36, P129, DOI 10.1042/CBI20110168; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Komaki M, 2012, J CELL PHYSIOL, V227, P649, DOI 10.1002/jcp.22770; Kostova N, 2010, MOL CELL BIOCHEM, V337, P251, DOI 10.1007/s11010-009-0305-0; Lacle MM, 2013, MODERN PATHOL, V26, P1461, DOI 10.1038/modpathol.2013.94; Lee BK, 2013, J KOR ASSOC ORAL MAX, V39, P255, DOI 10.5125/jkaoms.2013.39.6.255; Lerch JK, 2014, MOL CELL NEUROSCI, V59, P97, DOI 10.1016/j.mcn.2014.02.002; Lu Y, 2005, BIOINFORMATICS, V21, P3105, DOI 10.1093/bioinformatics/bti496; Man TK, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-45; Maurer M, 2009, CANCER RES, V69, P6299, DOI 10.1158/0008-5472.CAN-09-0820; MCCARTHY SA, 1995, GENE DEV, V9, P1953, DOI 10.1101/gad.9.16.1953; MORELLO D, 1990, ONCOGENE, V5, P1511; Nakamura K, 2006, GASTROENTEROLOGY, V131, P1530, DOI 10.1053/j.gastro.2006.08.030; NARAYANAN AS, 1976, J BIOL CHEM, V251, P5464; Naylor TL, 2005, BREAST CANCER RES, V7, pR1186, DOI 10.1186/bcr1356; Neves F S, 2009, Minerva Stomatol, V58, P55; Nunez J, 2012, J PERIODONTAL RES, V47, P33, DOI 10.1111/j.1600-0765.2011.01402.x; Ongusaha PP, 2004, CANCER RES, V64, P5283, DOI 10.1158/0008-5472.CAN-04-0925; Raphael BJ, 2014, GENOME MED, V6, DOI 10.1186/gm524; Rodini CO, 2012, INT J ONCOL, V40, P1180, DOI 10.3892/ijo.2011.1321; Saha B, 2008, PROSTATE, V68, P78, DOI 10.1002/pros.20670; Saha B, 2007, ANTICANCER RES, V27, P3903; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Serrano J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078807; Sharma A, 2008, CANCER INVEST, V26, P843, DOI 10.1080/07357900801954210; Shen H, 2008, CANCER GENET CYTOGEN, V181, P100, DOI 10.1016/j.cancergencyto.2007.11.012; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Tai YC, 2005, STAT ANAL MICROARRAY; De Hoyos AV, 2012, J DENT RES, V91, P203, DOI 10.1177/0022034511428155; Villarreal-Ramirez E, 2009, BIOCHEM BIOPH RES CO, V384, P49, DOI 10.1016/j.bbrc.2009.04.072; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang W, 2013, ONCOL LETT, V5, P884, DOI 10.3892/ol.2012.1091; Webster MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081757; Zhang CY, 2009, CLIN CANCER RES, V15, P4017, DOI 10.1158/1078-0432.CCR-08-2824	55	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127286	10.1371/journal.pone.0127286	http://dx.doi.org/10.1371/journal.pone.0127286			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011628	Green Submitted, Green Published, gold			2022-12-26	WOS:000355183900078
J	Iessi, E; Zischler, L; Etringer, A; Bergeret, M; Morle, A; Jacquemin, G; Morizot, A; Shirley, S; Lalaoui, N; Elifio-Esposito, SL; Fais, S; Garrido, C; Solary, E; Micheau, O				Iessi, Elisabetta; Zischler, Luciana; Etringer, Aurelie; Bergeret, Marion; Morle, Aymeric; Jacquemin, Guillaume; Morizot, Alexandre; Shirley, Sarah; Lalaoui, Najoua; Elifio-Esposito, Selene L.; Fais, Stefano; Garrido, Carmen; Solary, Eric; Micheau, Olivier			Death Receptor-Induced Apoptosis Signalling Regulation by Ezrin Is Cell Type Dependent and Occurs in a DISC-Independent Manner in Colon Cancer Cells	PLOS ONE			English	Article							MEDIATED APOPTOSIS; PHOSPHORYLATION; IDENTIFICATION; TRAIL; SENSITIVITY; MECHANISM; REVEALS; FADD	Ezrin belongs to the ERM (ezrin-radixin-moesin) protein family and has been demonstrated to regulate early steps of Fas receptor signalling in lymphoid cells, but its contribution to TRAIL-induced cell death regulation in adherent cancer cells remains unknown. In this study we report that regulation of FasL and TRAIL-induced cell death by ezrin is cell type dependant. Ezrin is a positive regulator of apoptosis in T-lymphoma cell line Jurkat, but a negative regulator in colon cancer cells. Using ezrin phosphorylation or actin-binding mutants, we provide evidence that negative regulation of death receptor-induced apoptosis by ezrin occurs in a cytoskeleton-and DISC-independent manner, in colon cancer cells. Remarkably, inhibition of apoptosis induced by these ligands was found to be tightly associated with regulation of ezrin phosphorylation on serine 66, the tumor suppressor gene WWOX and activation of PKA. Deficiency in WWOX expression in the liver cancer SK-HEP1 or the pancreatic Mia PaCa-2 cell lines as well as WWOX silencing or modulation of PKA activation by pharmacological regulators, in the colon cancer cell line SW480, abrogated regulation of TRAIL signalling by ezrin. Altogether our results show that death receptor pro-apoptotic signalling regulation by ezrin can occur downstream of the DISC in colon cancer cells.	[Iessi, Elisabetta; Zischler, Luciana; Etringer, Aurelie; Bergeret, Marion; Morle, Aymeric; Jacquemin, Guillaume; Morizot, Alexandre; Shirley, Sarah; Lalaoui, Najoua; Garrido, Carmen; Micheau, Olivier] INSERM, U866, F-21079 Dijon, France; [Iessi, Elisabetta; Etringer, Aurelie; Bergeret, Marion; Morle, Aymeric; Jacquemin, Guillaume; Morizot, Alexandre; Shirley, Sarah; Lalaoui, Najoua; Garrido, Carmen; Micheau, Olivier] Univ Bourgogne, UFR Sci Sante, F-21079 Dijon, France; [Zischler, Luciana; Elifio-Esposito, Selene L.] Pontificia Univ Catolica Parana, Escola Med, Posgrad Ciencias Saude, BR-80215901 Curitiba, Parana, Brazil; [Fais, Stefano] Ist Super Sanita, Dept Therapeut Res & Med Evaluat, Antitumor Drugs Sect, I-00161 Rome, Italy; [Solary, Eric] INSERM, U1009, F-94805 Villejuif, France; [Solary, Eric] Univ Paris 11, Inst Gustave Roussy, F-94805 Villejuif, France; [Garrido, Carmen; Micheau, Olivier] Ctr Georges Francois Leclerc, F-21000 Dijon, France	Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Universite de Bourgogne; Pontificia Universidade Catolica do Parana; Istituto Superiore di Sanita (ISS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UNICANCER; Centre Georges-Francois Leclerc	Micheau, O (corresponding author), INSERM, U866, F-21079 Dijon, France.	olivier.micheau@inserm.fr	Esposito, Selene/AAR-3671-2021; Garrido, carmen/G-1633-2018; Lalaoui, Najoua/C-1410-2014; Garrido, Carolina/GWM-5557-2022; micheau, olivier/C-3574-2011; Fais, Stefano/J-8638-2016; Iessi, Elisabetta/O-2460-2017	Garrido, carmen/0000-0003-1368-1493; Lalaoui, Najoua/0000-0002-0165-3324; micheau, olivier/0000-0001-8499-7984; Fais, Stefano/0000-0001-9060-2766; Iessi, Elisabetta/0000-0001-7221-9173; Elifio-Esposito, Selene/0000-0002-8676-134X; Solary, Eric/0000-0002-8629-1341; Zischler, PhD, Dr. Luciana/0000-0001-8169-7601	European Community (ApopTrain Marie Curie RTN); program "Investissements d'Avenir" [ANR-11-LABX-0021-01-LipSTIC Labex]; University of Bourgogne; Conseil Regional de Bourgogne; INCa (Institut National du Cancer) [POLYNOM-174]; Canceropole Grand-Est; Ligue Nationale contre le Cancer; ARC (Association pour la Recherche sur le Cancer); Ministry of Research and Education; Marie Curie RTN; INCa; CAPES [BEX4938/14-3]	European Community (ApopTrain Marie Curie RTN)(European Commission); program "Investissements d'Avenir"(French National Research Agency (ANR)); University of Bourgogne; Conseil Regional de Bourgogne(Region Bourgogne-Franche-Comte); INCa (Institut National du Cancer)(Institut National du Cancer (INCA) France); Canceropole Grand-Est(Region Grand-Est); Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); ARC (Association pour la Recherche sur le Cancer)(Fondation ARC pour la Recherche sur le Cancer); Ministry of Research and Education; Marie Curie RTN(European Commission); INCa(Institut National du Cancer (INCA) France); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by grants from the European Community (ApopTrain Marie Curie RTN), the program "Investissements d'Avenir" with reference ANR-11-LABX-0021-01-LipSTIC Labex, the University of Bourgogne, the Conseil Regional de Bourgogne, the INCa (Institut National du Cancer, POLYNOM-174), the Canceropole Grand-Est, the Ligue Nationale contre le Cancer, ARC (Association pour la Recherche sur le Cancer), and Ministry of Research and Education. EI, SS, LZ and AM were supported by fellowships from the Marie Curie RTN, INCa, CAPES (No BEX4938/14-3) and the Ligue Nationale Contre le Cancer, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aqeilan RI, 2007, P NATL ACAD SCI USA, V104, P3949, DOI 10.1073/pnas.0609783104; Bodmer JL, 2000, NAT CELL BIOL, V2, P241, DOI 10.1038/35008667; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Chakrabandhu K, 2007, EMBO J, V26, P209, DOI 10.1038/sj.emboj.7601456; Chaudhary PM, 1997, IMMUNITY, V7, P821, DOI 10.1016/S1074-7613(00)80400-8; Crepaldi T, 1997, J CELL BIOL, V138, P423, DOI 10.1083/jcb.138.2.423; Fievet BT, 2004, J CELL BIOL, V164, P653, DOI 10.1083/jcb.200307032; Fluur C, 2007, J IMMUNOL, V178, P5340, DOI 10.4049/jimmunol.178.8.5340; Gautreau A, 1999, P NATL ACAD SCI USA, V96, P7300, DOI 10.1073/pnas.96.13.7300; Hebert M, 2008, J IMMUNOL, V181, P5963, DOI 10.4049/jimmunol.181.9.5963; Hughes MA, 2009, MOL CELL, V35, P265, DOI 10.1016/j.molcel.2009.06.012; Jin CJ, 2006, BIOCHEM BIOPH RES CO, V341, P784, DOI 10.1016/j.bbrc.2006.01.023; KRIEG J, 1992, J BIOL CHEM, V267, P19258; Kuo WC, 2010, ONCOGENE, V29, P1374, DOI 10.1038/onc.2009.417; Lozupone F, 2004, J BIOL CHEM, V279, P9199, DOI 10.1074/jbc.M305561200; Luciani F, 2004, CELL DEATH DIFFER, V11, P574, DOI 10.1038/sj.cdd.4401374; MacFarlane M, 1997, J BIOL CHEM, V272, P25417, DOI 10.1074/jbc.272.41.25417; Merino D, 2007, EXPERT OPIN THER TAR, V11, P1299, DOI 10.1517/14728222.11.10.1299; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; Pan GH, 1997, SCIENCE, V276, P111, DOI 10.1126/science.276.5309.111; Parlato S, 2000, EMBO J, V19, P5123, DOI 10.1093/emboj/19.19.5123; Piazzolla D, 2005, J CELL BIOL, V171, P1013, DOI 10.1083/jcb.200504137; Ramaswamy M, 2007, J IMMUNOL, V179, P6384, DOI 10.4049/jimmunol.179.10.6384; Saleh HS, 2009, J MOL BIOL, V385, P1015, DOI 10.1016/j.jmb.2008.11.051; Scaffidi C, 1999, J BIOL CHEM, V274, P22532, DOI 10.1074/jbc.274.32.22532; Schneider P, 2000, METHOD ENZYMOL, V322, P325; Schneider P, 1997, FEBS LETT, V416, P329, DOI 10.1016/S0014-5793(97)01231-3; Srivastava J, 2005, MOL BIOL CELL, V16, P1481, DOI 10.1091/mbc.e04-08-0721; Walczak H, 1997, EMBO J, V16, P5386, DOI 10.1093/emboj/16.17.5386; Zhang P, 2012, MOL MED REP, V6, P121, DOI 10.3892/mmr.2012.860; Zhou RH, 2003, J BIOL CHEM, V278, P35651, DOI 10.1074/jbc.M303416200	31	9	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0126526	10.1371/journal.pone.0126526	http://dx.doi.org/10.1371/journal.pone.0126526			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010871	Green Published, gold, Green Submitted			2022-12-26	WOS:000355183900032
J	Shen, YP; Zheng, YM; Jiang, JT; Liu, YM; Luo, XM; Shen, Z; Chen, X; Wang, Y; Dai, YH; Zhao, J; Liang, H; Chen, AM; Yuan, W				Shen, Yueping; Zheng, Yanmin; Jiang, Jingting; Liu, Yinmei; Luo, Xiaoming; Shen, Zongji; Chen, Xin; Wang, Yan; Dai, Yiheng; Zhao, Jing; Liang, Hong; Chen, Aimin; Yuan, Wei			Higher Urinary Bisphenol A Concentration Is Associated with Unexplained Recurrent Miscarriage Risk: Evidence from a Case-Control Study in Eastern China	PLOS ONE			English	Article							POLYCARBONATE DRINKING BOTTLES; IN-VITRO FERTILIZATION; SPONTANEOUS-ABORTION; LIQUID-CHROMATOGRAPHY; TEMPORAL VARIABILITY; MATERNAL SERUM; UNITED-STATES; NORMAL WOMEN; EXPOSURE; INFERTILITY	Background Evidence about the association between Bisphenol A (BPA) and the risk of recurrent miscarriage (RM) in human being is still limited. Objective We evaluated the association of urinary BPA concentrations with RM in human being. Methods A hospital-based 1: 2 matched case-control study on RM was carried out in Suzhou and Kunshan in Jiangsu Province in China between August 2008 and November 2011. Total urinary BPA concentrations in 264 eligible urine samples (102 RM patients and 162 controls) were measured using liquid chromatography-tandem mass spectrometry (LC-MS/MS). The Wilcoxon test and conditional logistic regression were used to estimate the differences between the groups and odds ratios (OR) with 95% confidence intervals (CI), respectively. Results The median +/- IQR (interquartile range) (P-75-P-25) values of non-creatinine-adjusted total urinary BPA levels in the RM patients and the controls were 1.66 +/- 3.69ng/ml and 0.58 +/- 1.07ng/ml, respectively (0.98 +/- 2.67 mu g/g Cr (creatinine) and 0.40 +/- 0.77 mu g/g Cr. The adjusted BPA level was significantly higher in the RM patients than in the controls (Wilcoxon test, Z = 4.476, P<0.001). Higher level of urinary BPA was significantly associated with an increased risk of RM (P-trend <0.001). Compared to the groups with urinary BPA levels less than 0.16 mu g/g Cr, the women with levels of 0.40-0.93 mu g/g Cr and 0.93 mu g/g Cr or above had a significantly higher risk of RM (OR = 3.91, 95% CI: 1.23-12.45 and OR = 9.34, 95% CI: 3.06-28.44) that persisted after adjusting for confounding factors. The time from recently RM date to recruitment does not significantly influence the urinary BPA level (P = 0.090). Conclusion Exposure to BPA may be associated with RM risk.	[Shen, Yueping] Soochow Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Jiangsu Key Lab Prevent & Translat Med Geriatr Di, Suzhou 215123, Peoples R China; [Zheng, Yanmin] Suzhou Ctr Dis Prevent & Control, Suzhou 215004, Peoples R China; [Jiang, Jingting] Suzhou Univ, Affiliated Hosp 3, Changzhou 213003, Peoples R China; [Liu, Yinmei] Shanghai Tenth Peoples Hosp, Dept Nosocomial Infect & Dis Control, Shanghai 200072, Peoples R China; [Luo, Xiaoming] Maternal & Child Hlth Bur Kunshan, Kunshan 215301, Peoples R China; [Shen, Zongji] Soochow Univ, Affiliated Hosp 1, Dept Obstet & Gynaecol, Suzhou 215006, Peoples R China; [Chen, Xin] Soochow Univ, Affiliated Hosp 2, Dept Obstet & Gynaecol, Suzhou 215004, Peoples R China; [Wang, Yan; Dai, Yiheng; Zhao, Jing] Soochow Univ, Coll Med, Sch Radiat Med & Protect, Suzhou 215123, Peoples R China; [Liang, Hong; Yuan, Wei] Shanghai Inst Planned Parenthood Res, Dept Reprod Epidemiol & Social Sci, Shanghai 200032, Peoples R China; [Chen, Aimin] Univ Cincinnati, Coll Med, Dept Environm Hlth, Div Epidemiol & Biostat, Cincinnati, OH 45221 USA; [Yuan, Wei] NPFPC Lab Contracept & Devices, Shanghai 200032, Peoples R China; [Yuan, Wei] Fudan Univ, Inst Reprod & Dev, Shanghai 200032, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China; Soochow University - China; University System of Ohio; University of Cincinnati; Fudan University	Yuan, W (corresponding author), Shanghai Inst Planned Parenthood Res, Dept Reprod Epidemiol & Social Sci, Shanghai 200032, Peoples R China.	yuanwei11@yahoo.com		liang, hong/0000-0002-3430-9167; Chen, Aimin/0000-0001-9713-6438	National Natural Science Foundation of China [30872176]; Soochow University Medical Development Foundation [EE126705]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006096, R01ES020349, RC4ES019755] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Soochow University Medical Development Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This project was supported by the National Natural Science Foundation of China (Grant No. 30872176) and the Soochow University Medical Development Foundation (EE126705). YP Shen received the funding and he had a role in study design, data collection and analysis.	Balakrishnan B, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.025; Bellver J, 2003, FERTIL STERIL, V79, P1136, DOI 10.1016/S0015-0282(03)00176-6; Bloom MS, 2011, ENVIRON TOXICOL PHAR, V32, P319, DOI 10.1016/j.etap.2011.06.003; Braun JM, 2012, ENVIRON HEALTH PERSP, V120, P739, DOI 10.1289/ehp.1104139; Braun JM, 2009, ENVIRON HEALTH PERSP, V117, P1945, DOI 10.1289/ehp.0900979; Brock JW, 2001, J EXPO ANAL ENV EPID, V11, P323, DOI 10.1038/sj.jea.7500174; Calafat AM, 2009, ENVIRON HEALTH PERSP, V117, P639, DOI 10.1289/ehp.0800265; Cantonwine D, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-62; Chao HH, 2012, HISTOCHEM CELL BIOL, V137, P249, DOI 10.1007/s00418-011-0894-z; Chen XJ, 2013, CHEMOSPHERE, V93, P217, DOI 10.1016/j.chemosphere.2013.04.067; CLIFFORD K, 1994, HUM REPROD, V9, P1328, DOI 10.1093/oxfordjournals.humrep.a138703; Daya S, 1994, OBSTET GYNECOLOGY, V6, P153; Duan Z-H, 2008, CHINA ENV SCI, V3, P018; Ehrlich S, 2012, ENVIRON HEALTH PERSP, V120, P978, DOI 10.1289/ehp.1104307; Garcia-Prieto A, 2008, ANAL CHIM ACTA, V630, P19, DOI 10.1016/j.aca.2008.09.060; Greaves M, 2000, BRIT J HAEMATOL, V109, P704, DOI 10.1046/j.1365-2141.2000.02069.x; He YH, 2009, ENVIRON RES, V109, P629, DOI 10.1016/j.envres.2009.04.003; Herath CB, 2004, ENDOCRINE, V25, P163, DOI 10.1385/ENDO:25:2:163; Hiroi H, 2004, ENDOCR J, V51, P595, DOI 10.1507/endocrj.51.595; Homer HA, 2000, FERTIL STERIL, V73, P1, DOI 10.1016/S0015-0282(99)00480-X; Honma S, 2002, REPROD TOXICOL, V16, P117, DOI 10.1016/S0890-6238(02)00006-0; Hornung RW, 1990, APPL OCCUP ENVIRON H, V5, P46, DOI [10.1080/1047322X.1990.10389587, DOI 10.1080/1047322X.1990.10389587]; Kang JH, 2003, J FOOD PROTECT, V66, P1444, DOI 10.4315/0362-028X-66.8.1444; Kubwabo C, 2009, FOOD ADDIT CONTAM A, V26, P928, DOI 10.1080/02652030802706725; LaKind JS, 2012, J EXPO SCI ENV EPID, V22, P219, DOI 10.1038/jes.2012.1; Lang IA, 2008, JAMA-J AM MED ASSOC, V300, P1303, DOI 10.1001/jama.300.11.1303; Lathi RB, 2014, FERTIL STERIL, V102, P123, DOI 10.1016/j.fertnstert.2014.03.024; Le HH, 2008, TOXICOL LETT, V176, P149, DOI 10.1016/j.toxlet.2007.11.001; Lemos MFL, 2010, CHEMOSPHERE, V78, P907, DOI 10.1016/j.chemosphere.2009.10.063; Li D, 2010, HUM REPROD, V25, P519, DOI 10.1093/humrep/dep381; Li TC, 2002, HUM REPROD UPDATE, V8, P463, DOI 10.1093/humupd/8.5.463; Mahalingaiah S, 2008, ENVIRON HEALTH PERSP, V116, P173, DOI 10.1289/ehp.10605; Matsumoto A, 2003, ENVIRON HEALTH PERSP, V111, P101, DOI 10.1289/ehp.5512; Meeker JD, 2010, REPROD TOXICOL, V30, P532, DOI 10.1016/j.reprotox.2010.07.005; Nishikawa M, 2010, ENVIRON HEALTH PERSP, V118, P1196, DOI 10.1289/ehp.0901575; Ouchi K, 2002, J CHROMATOGR B, V780, P365, DOI 10.1016/S1570-0232(02)00547-0; Politch JA, 2006, ENVIRON HEALTH PERSP, V114, pA16, DOI 10.1289/ehp.114-a16a; REGAN L, 1990, LANCET, V336, P1141, DOI 10.1016/0140-6736(90)92765-A; Richter CA, 2007, REPROD TOXICOL, V24, P199, DOI 10.1016/j.reprotox.2007.06.004; Sakurai K, 2000, Nihon Rinsho, V58, P2508; STIRRAT GM, 1990, LANCET, V336, P673, DOI 10.1016/0140-6736(90)92159-F; Sugiura-Ogasawara M, 2003, AM J REPROD IMMUNOL, V50, P485, DOI 10.1046/j.8755-8920.2003.00106.x; Sugiura-Ogasawara M, 2005, HUM REPROD, V20, P2325, DOI 10.1093/humrep/deh888; Takeuchi T, 2004, ENDOCR J, V51, P165, DOI 10.1507/endocrj.51.165; Teitelbaum SL, 2008, ENVIRON RES, V106, P257, DOI 10.1016/j.envres.2007.09.010; TULPPALA M, 1993, HUM REPROD, V8, P764, DOI 10.1093/oxfordjournals.humrep.a138137; Vandenberg LN, 2007, REPROD TOXICOL, V24, P139, DOI 10.1016/j.reprotox.2007.07.010; Vokel W, 2002, CHEM RES TOXICOL, V15, P1281, DOI 10.1021/tx025548t; Wang JX, 2002, OBES RES, V10, P551, DOI 10.1038/oby.2002.74; Watts MM, 2001, AQUAT TOXICOL, V55, P113, DOI 10.1016/S0166-445X(01)00148-5; Weiss A, 2005, HUM REPROD, V20, P2628, DOI 10.1093/humrep/dei081; Wetherill YB, 2007, REPROD TOXICOL, V24, P178, DOI 10.1016/j.reprotox.2007.05.010; Wolff MS, 2008, ENVIRON HEALTH PERSP, V116, P1092, DOI 10.1289/ehp.11007; Yamada H, 2002, REPROD TOXICOL, V16, P735, DOI 10.1016/S0890-6238(02)00051-5; Yang MH, 2003, ARCH ENVIRON CON TOX, V44, P546, DOI 10.1007/s00244-002-2124-0; Ye XB, 2008, ENVIRON RES, V108, P260, DOI 10.1016/j.envres.2008.07.014; Zhang HQ, 2012, MOL BIOL REP, V39, P5651, DOI 10.1007/s11033-011-1372-3	57	37	41	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127886	10.1371/journal.pone.0127886	http://dx.doi.org/10.1371/journal.pone.0127886			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011304	Green Published, gold, Green Submitted			2022-12-26	WOS:000355183900158
J	Smolina, K; Hanley, GE; Mintzes, B; Oberlander, TF; Morgan, S				Smolina, Kate; Hanley, Gillian E.; Mintzes, Barbara; Oberlander, Tim F.; Morgan, Steve			Trends and Determinants of Prescription Drug Use during Pregnancy and Postpartum in British Columbia, 2002-2011: A Population-Based Cohort Study	PLOS ONE			English	Article							MEDICATION USE; PRIMARY-CARE; WOMEN; LACTATION; ANTIDEPRESSANTS; TERATOGENICITY; NETHERLANDS; PREVALENCE; DEPRESSION; EXPOSURE	Purpose To describe trends, patterns, and determinants of prescription drug use during pregnancy and postpartum. Methods This is a retrospective, population-based study of all women who gave birth between January 2002 and 31 December 2011 in British Columbia, Canada. Study population consisted of 225,973 women who had 322,219 pregnancies. We examined administrative datasets containing person-specific information on filled prescriptions, hospitalizations, and medical services. Main outcome measures were filled prescriptions during pregnancy and postpartum. We used logistic regressions to examine associations between prescription drug use and maternal characteristics. Results Approximately two thirds of women filled a prescription during pregnancy, increasing from 60% in 2002 to 66% in 2011. The proportion of pregnant women using medicines in all three trimesters of pregnancy increased from 20% in 2002 to 27% in 2011. Use of four or more different types of prescription drug during at least one trimester increased from 8.4% in 2002 to 11.7% in 2011. Higher BMI, smoking during pregnancy, age under 25, carrying multiples, and being diagnosed with a chronic condition all significantly increased the odds of prescription drug use during pregnancy. Conclusions The observed increase in the number of prescriptions and number of different drugs being dispensed suggests a trend in prescribing practices with potentially important implications for mothers, their neonates, and caregivers. Monitoring of prescribing practices and further research into the safety of most commonly prescribed medications is crucial in better understanding risks and benefits to the fetus and the mother.	[Smolina, Kate; Morgan, Steve] Univ British Columbia, Ctr Hlth Serv & Policy Res, Vancouver, BC V5Z 1M9, Canada; [Hanley, Gillian E.] Univ British Columbia, Dept Obstet & Gynaecol, Vancouver, BC V5Z 1M9, Canada; [Mintzes, Barbara] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Oberlander, Tim F.] Univ British Columbia, Child & Family Res Inst, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia; University of British Columbia; Child & Family Research Institute; University of British Columbia	Smolina, K (corresponding author), Univ British Columbia, Ctr Hlth Serv & Policy Res, Vancouver, BC V5Z 1M9, Canada.	kate.smolina@ubc.ca	Mintzes, Barbara/AFK-6613-2022	Mintzes, Barbara/0000-0002-8671-915X; Morgan, Steven/0000-0002-7529-0028; Oberlander, Tim/0000-0003-4781-6579; Hanley, Gillian/0000-0001-9594-0545	Canadian Institutes of Health Research [CIHR DC0190GP]; Canadian Institutes of Health Research Banting Postdoctoral Fellowship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research Banting Postdoctoral Fellowship(Canadian Institutes of Health Research (CIHR))	This study was supported by a grant from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) (CIHR DC0190GP). Dr. Smolina is funded, in part, by a Canadian Institutes of Health Research Banting Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam MP, 2011, AM J MED GENET C, V157C, P175, DOI 10.1002/ajmg.c.30313; Administration; UFaD, 2007, PUBL HLTH ADV US COD; Alexander GC, 2011, PHARMACOEPIDEM DR S, V20, P177, DOI 10.1002/pds.2082; Andrade SE, 2004, AM J OBSTET GYNECOL, V191, P398, DOI 10.1016/j.ajog.2004.04.025; [Anonymous], 2012, VIT STAT DEATHS; Arsenault Marc-Yvon, 2002, J Obstet Gynaecol Can, V24, P817; Bakker MK, 2006, BJOG-INT J OBSTET GY, V113, P559, DOI 10.1111/j.1471-0528.2006.00927.x; Berard A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093870; Bjorn Anne-Mette Bay, 2011, Clin Epidemiol, V3, P149, DOI 10.2147/CLEP.S17747; British Columbia Ministry of Health, 2013, DISCH ABSTR DAT HOSP; Chan M, 2012, OBSTET GYNAECOL, V14, P87, DOI 10.1111/j.1744-4667.2012.00096.x; Chin JW, 2013, AM J PERINATOL; Cleary BJ, 2010, PHARMACOEPIDEM DR S, V19, P408, DOI 10.1002/pds.1906; Colvin L, 2009, PHARMACOEPIDEM DR S, V18, P211, DOI 10.1002/pds.1705; Daw JR, 2011, PHARMACOEPIDEM DR S, V20, P895, DOI 10.1002/pds.2184; Daw JR, 2011, CLIN THER; Egen-Lappe V, 2004, EUR J CLIN PHARMACOL, V60, P659, DOI 10.1007/s00228-004-0817-1; Engeland A, 2008, BRIT J CLIN PHARMACO, V65, P653, DOI 10.1111/j.1365-2125.2008.03102.x; Food U, 1999, FED REGISTER, V64, P43190; Gagne JJ, 2008, EUR J CLIN PHARMACOL, V64, P1125, DOI 10.1007/s00228-008-0546-y; Hanley GE, 2010, MED CARE, V48, P402, DOI 10.1097/MLR.0b013e3181ca3d5d; Hanley GE, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-79; Health Canada, 2005, IMP SAF INF PAX PAR; Irvine L, 2010, DRUG SAFETY, V33, P593, DOI 10.2165/11532330-000000000-00000; Joseph KS, 2009, J OBSTET GYNAECOL CA, V31, P422, DOI 10.1016/S1701-2163(16)34173-1; Kessler RC, 2006, AM J PSYCHIAT, V163, P716, DOI 10.1176/appi.ajp.163.4.716; Koren G, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.07.030; Lacroix I, 2009, EUR J CLIN PHARMACOL, V65, P839, DOI 10.1007/s00228-009-0647-2; Lagoy CT, 2005, J WOMENS HEALTH, V14, P104, DOI 10.1089/jwh.2005.14.104; Lo WY, 2002, OBSTET GYNECOL, V100, P465, DOI 10.1016/S0029-7844(02)02122-1; Lupattelli A, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004365; Malm H, 2003, EUR J CLIN PHARMACOL, V59, P127, DOI 10.1007/s00228-003-0584-4; Mitchell AA, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.02.029; Nakhai-Pour HR, 2010, CAN MED ASSOC J, V182, P1031, DOI 10.1503/cmaj.091208; Oberlander TF, 2006, ARCH GEN PSYCHIAT, V63, P898, DOI 10.1001/archpsyc.63.8.898; Olesen C, 1999, EUR J CLIN PHARMACOL, V55, P139, DOI 10.1007/s002280050608; Olesen C, 2006, EUR J CLIN PHARMACOL, V62, P547, DOI 10.1007/s00228-006-0119-x; Parisi MA, 2011, AM J MED GENET C, V157C, P247, DOI 10.1002/ajmg.c.30309; Persaud N, 2014, J OBSTET GYNAECOL CA, V36, P343, DOI 10.1016/S1701-2163(15)30611-3; Riley EH, 2005, J WOMENS HEALTH, V14, P401, DOI 10.1089/jwh.2005.14.401; Schirm E, 2004, EUR J OBSTET GYN R B, V114, P182, DOI 10.1016/j.ejogrb.2003.10.024; Stephansson Olof, 2011, Clin Epidemiol, V3, P43, DOI 10.2147/CLEP.S16305; Swanson LM, 2011, J WOMENS HEALTH, V20, P553, DOI 10.1089/jwh.2010.2371; Tamblyn R, 2014, ANN INTERN MED, V160, P441, DOI 10.7326/M13-1705; World Health Organization, 2011, AN THER CLASS STRUCT; Yang TB, 2008, PHARMACOEPIDEM DR S, V17, P270, DOI 10.1002/pds.1538	46	44	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128312	10.1371/journal.pone.0128312	http://dx.doi.org/10.1371/journal.pone.0128312			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011706	Green Submitted, gold, Green Published			2022-12-26	WOS:000355183900221
J	Cisowski, J; Sayin, VI; Liu, M; Karlsson, C; Bergo, MO				Cisowski, J.; Sayin, V. I.; Liu, M.; Karlsson, C.; Bergo, M. O.			Oncogene-induced senescence underlies the mutual exclusive nature of oncogenic KRAS and BRAF	ONCOGENE			English	Article							HUMAN-MELANOMA; RAS ONCOGENES; LUNG-CANCER; K-RAS; MUTATIONS; PATHWAY; BRAF(V600E); PROGRESSION; NRAS(Q61R); ACTIVATION	KRAS and BRAF are among the most commonly mutated oncogenes in human cancer that contribute to tumorigenesis in both distinct and overlapping tissues. However, KRAS and BRAF mutations are mutually exclusive; they never occur in the same tumor cell. The reason for the mutual exclusivity is unknown, but there are several possibilities. The two mutations could be functionally redundant and not create a selective advantage to tumor cells. Alternatively, they could be deleterious for the tumor cell and induce apoptosis or senescence. To distinguish between these possibilities, we activated the expression of BRAF(V600E) and KRAS(G12D) from their endogenous promoters in mouse lungs. Although the tumor-forming ability of BRAF(V600E) was higher than KRAS(G12D), KRAS(G12D) tumors were larger and more advanced. Coactivation of BRAF(V600E) and KRAS(G12D) markedly reduced lung tumor numbers and overall tumor burden compared with activation of BRAF(V600E) alone. Moreover, several tumors expressed only one oncogene, suggesting negative selection against expression of both. Similarly, expression of both oncogenes in mouse embryonic fibroblasts essentially stopped proliferation. The expression of both oncogenes hyperactivated the MEK-ERK-cyclin D pathway but reduced proliferation by increasing the production of p15, p16 and p19 proteins encoded by the Ink4/Arf locus and thereby increased senescence-associated beta-galactosidase-positive cells. The data suggest that coexpression of BRAF(V600E) and KRAS(G12D) in early tumorigenesis leads to negative selection due to oncogene-induced senescence.	[Cisowski, J.; Sayin, V. I.; Karlsson, C.; Bergo, M. O.] Univ Gothenburg, Inst Med, Sahlgrenska Canc Ctr, Dept Mol & Clin Med, Med Gatan 1G,POB 425, S-41390 Gothenburg, Sweden; [Sayin, V. I.] Univ Gothenburg, Inst Med, Wallenberg Lab, Dept Mol & Clin Med, S-41390 Gothenburg, Sweden; [Liu, M.] Univ Gothenburg, Inst Biomed, Dept Clin Chem & Transfus Med, S-41390 Gothenburg, Sweden	University of Gothenburg; University of Gothenburg; University of Gothenburg	Bergo, MO (corresponding author), Univ Gothenburg, Inst Med, Sahlgrenska Canc Ctr, Dept Mol & Clin Med, Med Gatan 1G,POB 425, S-41390 Gothenburg, Sweden.	martin.bergo@gu.se		Liu, Viktor/0000-0003-2865-034X	Swedish Cancer Society; Swedish Research Council; Goran Gustafsson Foundation; Swedish Children's Cancer Fund; BioCARE-a strategic research program at the University of Gothenburg; Ingabritt and Arne Lundberg's Research Foundation; Assar Gabrielsson Foundation	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Goran Gustafsson Foundation; Swedish Children's Cancer Fund; BioCARE-a strategic research program at the University of Gothenburg; Ingabritt and Arne Lundberg's Research Foundation; Assar Gabrielsson Foundation	We thank R Ister for technical assistance. This study was supported by grants from the Swedish Cancer Society, the Swedish Research Council, the Goran Gustafsson Foundation, the Swedish Children's Cancer Fund, BioCARE-a strategic research program at the University of Gothenburg, and Ingabritt and Arne Lundberg's Research Foundation (to MOB); and the Assar Gabrielsson Foundation (to VIS).	Alsina J, 2003, CLIN CANCER RES, V9, P6419; Andreadi C, 2012, GENE DEV, V26, P1945, DOI 10.1101/gad.193458.112; Borras E, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-406; Dankort D, 2007, GENE DEV, V21, P379, DOI 10.1101/gad.1516407; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987; Goydos JS, 2005, J AM COLL SURGEONS, V200, P362, DOI 10.1016/j.jamcollsurg.2004.10.032; Itahana Koji, 2007, Methods Mol Biol, V371, P21; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Karreth FA, 2009, MOL CELL, V36, P477, DOI 10.1016/j.molcel.2009.10.017; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Kinno T, 2014, ANN ONCOL, V25, P138, DOI 10.1093/annonc/mdt495; Maitra A, 2006, BEST PRACT RES CL GA, V20, P211, DOI 10.1016/j.bpg.2005.10.002; Matallanas D, 2011, MOL CELL, V44, P893, DOI 10.1016/j.molcel.2011.10.016; Monticone M, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-92; Pao W, 2011, LANCET ONCOL, V12, P175, DOI 10.1016/S1470-2045(10)70087-5; Petti C, 2006, CANCER RES, V66, P6503, DOI 10.1158/0008-5472.CAN-05-4671; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Rajagopalan H, 2002, NATURE, V418, P934, DOI 10.1038/418934a; Sayin VI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055720; Sensi M, 2006, ONCOGENE, V25, P3357, DOI 10.1038/sj.onc.1209379; Seth R, 2009, GUT, V58, P1234, DOI 10.1136/gut.2008.159137; Trejo CL, 2012, CANCER RES, V72, P3048, DOI 10.1158/0008-5472.CAN-11-3649; Vandal G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084745; Yeang CH, 2008, FASEB J, V22, P2605, DOI 10.1096/fj.08-108985	26	51	51	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 10	2016	35	10					1328	1333		10.1038/onc.2015.186	http://dx.doi.org/10.1038/onc.2015.186			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DG0NY	26028035				2022-12-26	WOS:000371763100013
J	Al-Dossary, AA; Bathala, P; Caplan, JL; Martin-DeLeon, PA				Al-Dossary, Amal A.; Bathala, Pradeepthi; Caplan, Jeffrey L.; Martin-DeLeon, Patricia A.			Oviductosome-Sperm Membrane Interaction in Cargo Delivery DETECTION OF FUSION AND UNDERLYING MOLECULAR PLAYERS USING THREE-DIMENSIONAL SUPER-RESOLUTION STRUCTURED ILLUMINATION MICROSCOPY (SR-SIM)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE SPERM; ALPHA-V-BETA-3 INTEGRIN; MAMMALIAN SPERM; LIPID RAFTS; HYPERACTIVATED MOTILITY; MALE-FERTILITY; SPAM1; CA2+; EXPRESSION; FUSION	Oviductosomes ((OVS), exosomes/microvesicles), which deliver the Ca2(+) efflux pump, plasma membrane Ca2(+) ATPase 4 (PMCA4), to sperm are likely to play an important role in sperm fertilizing ability (Al-Dossary, A. A., Strehler, E. E., and Martin-DeLeon, P. A. (2013) PloS one 8, e80181). It is unknown how exosomes/microvesicles deliver transmembrane proteins such as PMCA4 to sperm. Here we define a novel experimental approach for the assessment of the interaction of OVS with sperm at a nanoscale level, using a lipophilic dye (FM4-64FX) and three-dimensional SR/SIM, which has an 8-fold increase in volumetric resolution, compared with conventional confocal microscopy. Coincubation assays detected fusion of prelabeled OVS with sperm, primarily over the head and midpiece. Immunofluorescence revealed oviductosomal delivery of PMCA4a to WT and Pmca4 KO sperm, and also endogenous PMCA4a on the inner acrosomal membrane. Fusion was confirmed by transmission immunoelectron microscopy, showing immunogold particles in OVS, and fusion stalks on sperm membrane. Immunofluorescence colocalized OVS with the alpha v integrin subunit which, along with CD9, resides primarily on the sperm head and midpiece. In capacitated and acrosome reacted sperm, fusion was significantly (p < 0.001) inhibited by blocking integrin/ligand interactions via antibodies, exogenous ligands (vitronectin and fibronectin), and their RGD recognition motif. Our results provide evidence that receptor/ligand interactions, involving alpha v beta 3 and alpha 5 beta 1integrins on sperm and OVS, facilitate fusion of OVS in the delivery of transmembrane proteins to sperm. The mechanism uncovered is likely to be also involved in cargo delivery of prostasomes, epididymosomes, and uterosomes.	[Al-Dossary, Amal A.; Bathala, Pradeepthi; Caplan, Jeffrey L.; Martin-DeLeon, Patricia A.] Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA; [Caplan, Jeffrey L.] Delaware Biotechnol Inst, Newark, DE 19711 USA	University of Delaware	Martin-DeLeon, PA (corresponding author), Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA.	pdeleon@udel.edu	Regan, Clinton/E-6250-2012	Al-Dossary, Amal/0000-0002-4634-6483; Caplan, Jeffrey/0000-0002-3991-0912	National Institutes of Health [RO3HD073523, 5P20RR015588]; INBRE Core Access Award; Saudi Arabian Cultural Mission to USA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R03HD073523] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103446] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); INBRE Core Access Award; Saudi Arabian Cultural Mission to USA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant RO3HD073523, National Institutes of Health Grant 5P20RR015588 (to P. A. D.), INBRE Core Access Award (to P. A. D.), and the Saudi Arabian Cultural Mission to USA (to A. A. A.). The authors declare that they have no conflicts of interest with the contents of this article.	Al-Dossary AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080181; Aravindan RG, 2012, J CELL PHYSIOL, V227, P3138, DOI 10.1002/jcp.24000; Asano A, 2009, J CELL PHYSIOL, V218, P537, DOI 10.1002/jcp.21623; Boissonnas CC, 2010, DEV DYNAM, V239, P773, DOI 10.1002/dvdy.22206; Brandenburger T, 2011, J BIOL CHEM, V286, P7938, DOI 10.1074/jbc.M110.142836; Bronson RA, 1996, MOL HUM REPROD, V2, P153, DOI 10.1093/molehr/2.3.153; Caballero Julieta, 2010, Vet Med Int, V2011, P757194, DOI 10.4061/2011/757194; Chen H, 2006, BIOL REPROD, V74, P923, DOI 10.1095/biolreprod.105.048587; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Costello S, 2009, REPRODUCTION, V138, P425, DOI 10.1530/REP-09-0134; Coy P, 2012, REPRODUCTION, V144, P649, DOI 10.1530/REP-12-0279; Cross NL, 2004, BIOL REPROD, V71, P1367, DOI 10.1095/biolreprod.104.030502; DANEN EHJ, 1994, HISTOPATHOLOGY, V24, P249, DOI 10.1111/j.1365-2559.1994.tb00517.x; Deng XN, 1999, MOL REPROD DEV, V52, P196, DOI 10.1002/(SICI)1098-2795(199902)52:2&lt;196::AID-MRD11&gt;3.0.CO;2-A; Filoteo AG, 1997, J BIOL CHEM, V272, P23741, DOI 10.1074/jbc.272.38.23741; Fusi FM, 1996, MOL HUM REPROD, V2, P169, DOI 10.1093/molehr/2.3.169; FUSI FM, 1992, J ANDROL, V13, P488; Gadella BM, 2014, THERIOGENOLOGY, V81, P74, DOI 10.1016/j.theriogenology.2013.09.005; Geho DH, 2003, BIOCONJUGATE CHEM, V14, P703, DOI 10.1021/bc034037v; Gille J, 1996, ANN NY ACAD SCI, V797, P93, DOI 10.1111/j.1749-6632.1996.tb52952.x; Griffiths GS, 2008, MOL REPROD DEV, V75, P1627, DOI 10.1002/mrd.20907; Griffiths GS, 2009, BIOL REPROD, V81, P562, DOI 10.1095/biolreprod.108.075739; Hemler ME, 1998, CURR OPIN CELL BIOL, V10, P578, DOI 10.1016/S0955-0674(98)80032-X; Hemler ME, 2003, ANNU REV CELL DEV BI, V19, P397, DOI 10.1146/annurev.cellbio.19.111301.153609; Ho HC, 2003, BIOL REPROD, V68, P1590, DOI 10.1095/biolreprod.102.011320; Ho HC, 2002, DEV BIOL, V250, P208, DOI 10.1006/dbio.2002.0797; Hong XM, 2008, ENDOCRINOLOGY, V149, P6207, DOI 10.1210/en.2008-0294; Ito C, 2010, CELL TISSUE RES, V340, P583, DOI 10.1007/s00441-010-0967-7; KOZLOV MM, 1989, EUR BIOPHYS J BIOPHY, V17, P121; LEIKIN SL, 1987, J THEOR BIOL, V129, P411, DOI 10.1016/S0022-5193(87)80021-8; Maecker HT, 1997, FASEB J, V11, P428, DOI 10.1096/fasebj.11.6.9194523; Modelski MJ, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.113.115857; Okunande GW, 2004, J BIOL CHEM, V279, P33742, DOI 10.1074/jbc.M404628200; Patel R, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.108712; Peddibhotla SSD, 2013, MOL BIOL CELL, V24, P933, DOI 10.1091/mbc.E12-06-0481; Pencer J, 2008, EUR BIOPHYS J BIOPHY, V37, P665, DOI 10.1007/s00249-008-0304-1; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Reese KL, 2010, MOL REPROD DEV, V77, P759, DOI 10.1002/mrd.21217; Schuh K, 2004, J BIOL CHEM, V279, P28220, DOI 10.1074/jbc.M312599200; Schwarz A, 2013, CELL TISSUE RES, V353, P549, DOI 10.1007/s00441-013-1633-7; SEFTOR REB, 1992, P NATL ACAD SCI USA, V89, P1557, DOI 10.1073/pnas.89.5.1557; Sepulveda MR, 2006, J BIOL CHEM, V281, P447, DOI 10.1074/jbc.M506950200; Sleight SB, 2005, BIOL REPROD, V73, P721, DOI 10.1095/biolreprod.105.041533; Strehler EE, 2007, BIOCHEM SOC T, V35, P919, DOI 10.1042/BST0350919; Strehler EE, 2001, PHYSIOL REV, V81, P21, DOI 10.1152/physrev.2001.81.1.21; Suarez SS, 2003, CELL MOL BIOL, V49, P351; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Thys M., 2012, BIRDS EYE VIEW VET M, DOI [10.5772/37408., DOI 10.5772/37408]; Travis AJ, 2001, DEV BIOL, V240, P599, DOI 10.1006/dbio.2001.0475; Wennemuth G, 2003, J GEN PHYSIOL, V122, P115, DOI 10.1085/jgp.200308839; Yeung C.-H., 2002, EPIDIDYMIS MOL CLIN, P417, DOI DOI 10.1007/978-1-4615-0679-9_24	52	61	64	2	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					17710	17723		10.1074/jbc.M114.633156	http://dx.doi.org/10.1074/jbc.M114.633156			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26023236	Green Published, hybrid			2022-12-26	WOS:000358511700006
J	Kostylev, MA; Kaufman, AC; Nygaard, HB; Patel, P; Haas, LT; Gunther, EC; Vortmeyer, A; Strittmatter, SM				Kostylev, Mikhail A.; Kaufman, Adam C.; Nygaard, Haakon B.; Patel, Pujan; Haas, Laura T.; Gunther, Erik C.; Vortmeyer, Alexander; Strittmatter, Stephen M.			Prion-Protein-interacting Amyloid-beta Oligomers of High Molecular Weight Are Tightly Correlated with Memory Impairment in Multiple Alzheimer Mouse Models	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-SECRETASE INHIBITION; GLUTAMATE-RECEPTOR 5; LONG-TERM-MEMORY; A-BETA; IN-VIVO; NEUROPATHOLOGIC ASSESSMENT; NATIONAL INSTITUTE; TRANSGENIC MICE; ASSOCIATION GUIDELINES; COGNITIVE DYSFUNCTION	Alzheimer disease (AD) is characterized by amyloid-beta accumulation, with soluble oligomers (A beta o) being the most synaptotoxic. However, the multivalent and unstable nature of A beta o limits molecular characterization and hinders research reproducibility. Here, we characterized multiple A beta o forms throughout the life span of various AD mice and in post-mortem human brain. A beta o exists in several populations, where prion protein (PrPC)-interacting A beta o is a high molecular weight A beta assembly present in multiple mice and humans with AD. Levels of PrPC-interacting A beta o match closely with mouse memory and are equal or superior to other A beta measures in predicting behavioral impairment. However, A beta o metrics vary considerably between mouse strains. Deleting PrPC expression in mice with relatively low PrPC-interacting A beta o (Tg2576) results in partial rescue of cognitive performance as opposed to complete recovery in animals with a high percentage of PrPC-interacting A beta o (APP/PSEN1). These findings highlight the relative contributions and interplay of A beta o forms in AD.	[Kostylev, Mikhail A.; Kaufman, Adam C.; Nygaard, Haakon B.; Patel, Pujan; Haas, Laura T.; Gunther, Erik C.; Strittmatter, Stephen M.] Yale Univ, Sch Med, Program Cellular Neurosci Neurodegenerat & Repair, New Haven, CT 06536 USA; [Vortmeyer, Alexander] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06536 USA; [Nygaard, Haakon B.; Gunther, Erik C.; Strittmatter, Stephen M.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Strittmatter, SM (corresponding author), Yale Univ, Sch Med, CNNR Program, BCMM 436,295 Congress Ave, New Haven, CT 06536 USA.	stephen.strittmatter@yale.edu	Regan, Clinton/E-6250-2012; Strittmatter, Stephen/F-5739-2011	Kostylev, Mikhail/0000-0003-0435-8141; Strittmatter, Stephen/0000-0001-8188-3092	National Institutes of Health; BrightFocus Foundation; Alzheimer's Association; Falk Medical Research Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034924, P50AG047270] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BrightFocus Foundation(BrightFocus Foundation); Alzheimer's Association(Alzheimer's Association); Falk Medical Research Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by a National Institutes of Health grant. This work was also supported by the BrightFocus Foundation, Alzheimer's Association, and Falk Medical Research Trust (to S. M. S.). S. M. S. is a co-founder of Axerion Therapeutics seeking to develop PrP-based therapeutics for Alzheimer disease.	Abramowski D, 2008, J PHARMACOL EXP THER, V327, P411, DOI 10.1124/jpet.108.140327; Arendt T, 2009, ACTA NEUROPATHOL, V118, P167, DOI 10.1007/s00401-009-0536-x; Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107; Ball M, 1997, NEUROBIOL AGING, V18, pS1, DOI 10.1016/s0197-4580(97)00057-2; Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Barry AE, 2011, J NEUROSCI, V31, P7259, DOI 10.1523/JNEUROSCI.6500-10.2011; Bate C, 2011, J BIOL CHEM, V286, P37955, DOI 10.1074/jbc.M111.248724; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Best JD, 2007, J PHARMACOL EXP THER, V320, P552, DOI 10.1124/jpet.106.114330; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Bouter Y, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00075; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Bruggink KA, 2013, ANAL BIOCHEM, V433, P112, DOI 10.1016/j.ab.2012.09.014; Calella AM, 2010, EMBO MOL MED, V2, P306, DOI 10.1002/emmm.201000082; Chang WP, 2011, FASEB J, V25, P775, DOI 10.1096/fj.10-167213; Chen RQ, 2012, CELL REP, V2, P1329, DOI 10.1016/j.celrep.2012.09.030; Chen SG, 2010, J BIOL CHEM, V285, P26377, DOI 10.1074/jbc.M110.145516; Chung E, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-130; Cirrito JR, 2003, J NEUROSCI, V23, P8844; Cisse M, 2011, J NEUROSCI, V31, P10427, DOI 10.1523/JNEUROSCI.1459-11.2011; Comery TA, 2005, J NEUROSCI, V25, P8898, DOI 10.1523/JNEUROSCI.2693-05.2005; CZECH C, 2013, DRUG DISCOV TODAY, V10, pE73; Dash PK, 2005, BIOCHEM BIOPH RES CO, V338, P777, DOI 10.1016/j.bbrc.2005.10.006; Dohler F, 2014, BRAIN, V137, P873, DOI 10.1093/brain/awt375; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Esparza TJ, 2013, ANN NEUROL, V73, P104, DOI 10.1002/ana.23748; Fluharty BR, 2013, J BIOL CHEM, V288, P7857, DOI 10.1074/jbc.M112.423954; Freir DB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1341; Ganzinger KA, 2014, CHEMBIOCHEM, V15, P2515, DOI 10.1002/cbic.201402377; Garcia-Alloza M, 2006, NEUROBIOL DIS, V24, P516, DOI 10.1016/j.nbd.2006.08.017; Garcia-Alloza M, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-19; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Haas LT, 2014, J BIOL CHEM, V289, P28460, DOI 10.1074/jbc.M114.584342; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hall AM, 2012, BRAIN RES BULL, V88, P3, DOI 10.1016/j.brainresbull.2011.11.017; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hu NW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4374; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Hyde LA, 2005, BEHAV BRAIN RES, V160, P344, DOI 10.1016/j.bbr.2004.12.017; Hyman BT, 2012, ALZHEIMERS DEMENT, V8, P1, DOI 10.1016/j.jalz.2011.10.007; Hyman BT, 1997, J NEUROPATH EXP NEUR, V56, P1095, DOI 10.1097/00005072-199710000-00002; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Kayed R, 2013, J ALZHEIMERS DIS, V33, pS67, DOI 10.3233/JAD-2012-129001; Kessels HW, 2010, NATURE, V466, pE3, DOI 10.1038/nature09217; Klaver AC, 2011, J NEUROSCI METH, V195, P249, DOI 10.1016/j.jneumeth.2010.12.001; Klyubin I, 2014, J NEUROSCI, V34, P6140, DOI 10.1523/JNEUROSCI.3526-13.2014; Koffie RM, 2009, P NATL ACAD SCI USA, V106, P4012, DOI 10.1073/pnas.0811698106; Kudo W, 2012, HUM MOL GENET, V21, P1138, DOI 10.1093/hmg/ddr542; Lalonde R, 2005, NEUROSCI LETT, V390, P87, DOI 10.1016/j.neulet.2005.08.028; Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x; Larson M, 2012, J NEUROSCI, V32, P16857, DOI 10.1523/JNEUROSCI.1858-12.2012; Larson ME, 2012, J NEUROCHEM, V120, P125, DOI 10.1111/j.1471-4159.2011.07478.x; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Loong TW, 2003, BMJ-BRIT MED J, V327, P716, DOI 10.1136/bmj.327.7417.716; Mayeux R, 2003, ANNU REV NEUROSCI, V26, P81, DOI 10.1146/annurev.neuro.26.043002.094919; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Nicoll AJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3416; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Ostapchenko VG, 2013, J NEUROSCI, V33, P16552, DOI 10.1523/JNEUROSCI.3214-13.2013; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Reiman EM, 2009, P NATL ACAD SCI USA, V106, P6820, DOI 10.1073/pnas.0900345106; Resenberger UK, 2011, EMBO J, V30, P2057, DOI 10.1038/emboj.2011.86; Rushworth JV, 2013, J BIOL CHEM, V288, P8935, DOI 10.1074/jbc.M112.400358; Savage MJ, 2014, J NEUROSCI, V34, P2884, DOI 10.1523/JNEUROSCI.1675-13.2014; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2011, METHODS MOL BIOL, V670, P33, DOI 10.1007/978-1-60761-744-0_3; Takeda S, 2013, FASEB J, V27, P3239, DOI 10.1096/fj.13-229666; Tomic JL, 2009, NEUROBIOL DIS, V35, P352, DOI 10.1016/j.nbd.2009.05.024; Um JW, 2013, NEURON, V79, P887, DOI 10.1016/j.neuron.2013.06.036; Um JW, 2012, NAT NEUROSCI, V15, P1227, DOI 10.1038/nn.3178; Vonsattel JPG, 2008, ACTA NEUROPATHOL, V115, P509, DOI 10.1007/s00401-007-0311-9; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh KP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095995; Yang T, 2013, ALZHEIMERS DEMENT, V9, P99, DOI 10.1016/j.jalz.2012.11.005; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145; Zou WQ, 2011, J BIOL CHEM, V286, P15095, DOI 10.1074/jbc.M110.199356	87	83	84	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17415	17438		10.1074/jbc.M115.643577	http://dx.doi.org/10.1074/jbc.M115.643577			24	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	26018073	Green Published, hybrid			2022-12-26	WOS:000357730900035
J	Wei, L; Gao, JX; Zhang, SM; Wu, SJ; Xie, ZP; Ling, GY; Kuang, YQ; Yang, YL; Yu, HN; Wang, YP				Wei, Lin; Gao, Jiuxiang; Zhang, Shumin; Wu, Sijin; Xie, Zeping; Ling, Guiying; Kuang, Yi-Qun; Yang, Yongliang; Yu, Haining; Wang, Yipeng			Identification and Characterization of the First Cathelicidin from Sea Snakes with Potent Antimicrobial and Anti-inflammatory Activity and Special Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNATE IMMUNITY; PEPTIDES; ANTIBIOTICS; INFECTIONS; FAMILY; VENOM; LIPOPOLYSACCHARIDE; HYDROPHIINAE; STABILITY; MOLECULES	Cathelicidins are a family of gene-encoded peptide effectors of innate immunity found exclusively in vertebrates. They play pivotal roles in host immune defense against microbial invasions. Dozens of cathelicidins have been identified from several vertebrate species. However, no cathelicidin from marine reptiles has been characterized previously. Here we report the identification and characterization of a novel cathelicidin (Hc-CATH) from the sea snake Hydrophis cyanocinctus. Hc-CATH is composed of 30 amino acids, and the sequence is KFFKRLLKSVRRAVKKFRKKPRLIGLSTLL. Circular dichroism spectroscopy and structure modeling analysis indicated that Hc-CATH mainly assumes an amphipathic alpha-helical conformation in bacterial membrane-mimetic solutions. It possesses potent broad-spectrum and rapid antimicrobial activity. Meanwhile, it is highly stable and shows low cytotoxicity toward mammalian cells. The microbial killing activity of Hc-CATH is executed through the disruption of cell membrane and lysis of bacterial cells. In addition, Hc-CATH exhibited potent anti-inflammatory activity by inhibiting the LPS-induced production of nitric oxide (NO) and pro-inflammatory cytokines such as TNF-alpha, IL-1 beta, and IL-6. Hc-CATH directly binds with LPS to neutralize its toxicity, and it also binds to Toll-like receptor 4 (TLR4/MD2 complex), which therefore inhibits the binding of LPS to TLR4/MD2 complex and the subsequent activation of LPS-induced inflammatory response pathways. Taken together, our study demonstrates that Hc-CATH, the first cathelicidin from sea snake discovered to have both antimicrobial and anti-inflammatory activity, is a potent candidate for the development of peptide antibiotics.	[Wang, Yipeng] Soochow Univ, Coll Pharmaceut Sci, Dept Pharmaceut Sci, Suzhou 215123, Jiangsu, Peoples R China; [Gao, Jiuxiang; Wu, Sijin; Yang, Yongliang; Yu, Haining] Dalian Univ Technol, Dept Biosci & Biotechnol, Dalian 116023, Liaoning, Peoples R China; [Zhang, Shumin; Xie, Zeping] Binzhou Med Univ, Pharmaceut Coll, Yantai 264003, Shandong, Peoples R China; [Wei, Lin] Soochow Univ, Inst Biol, Jiangsu Key Lab Infect & Immun, Suzhou 215123, Jiangsu, Peoples R China; [Wei, Lin] Soochow Univ, Inst Med Sci, Jiangsu Key Lab Infect & Immun, Suzhou 215123, Jiangsu, Peoples R China; [Ling, Guiying] Guiyang Med Coll, Affiliated Hosp, Canc Immunol & Immunotherapy Ctr, Guiyang 550004, Guizhou, Peoples R China; [Kuang, Yi-Qun] Henan Univ, Huaihe Clin Inst, Ctr Translat Med, Kaifeng 475000, Henan, Peoples R China	Soochow University - China; Dalian University of Technology; Binzhou Medical University; Soochow University - China; Soochow University - China; Guizhou Medical University; Henan University	Yu, HN (corresponding author), Dalian Univ Technol, Dept Biosci & Biotechnol, Dalian 116023, Liaoning, Peoples R China.	yuhaining@dlut.edu.cn; yipengwang@suda.edu.cn	Wu, Sijin/AAB-2006-2020; Wang, Yipeng/AAA-1499-2020; Wu, Sijin/AAL-3482-2020; Wei, Lin/AAE-3043-2022; Kuang, Yi-Qun/AAW-4884-2021	Wang, Yipeng/0000-0003-1385-4470; Wei, Lin/0000-0003-3359-2471; Kuang, Yi-Qun/0000-0002-1452-4388	Chinese National Natural Science Foundation [41206153, 81402830]; Suzhou Science and Technology Development Project [SYN201407]; Jiangsu Province Natural Science Foundation [BK20140362, 14KJD350003]; Growth Project for Liaoning Distinguished Young Scientists of Colleges and Universities [LJQ2013010]; Dalian Distinguished Young Scientists Funding [2013J21DW013]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Suzhou Science and Technology Development Project; Jiangsu Province Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Growth Project for Liaoning Distinguished Young Scientists of Colleges and Universities; Dalian Distinguished Young Scientists Funding	This work was supported by Grants 41206153 and 81402830 from the Chinese National Natural Science Foundation, SYN201407 from the Suzhou Science and Technology Development Project, BK20140362 and 14KJD350003 from the Jiangsu Province Natural Science Foundation, LJQ2013010 from the Growth Project for Liaoning Distinguished Young Scientists of Colleges and Universities, and 2013J21DW013 from the Dalian Distinguished Young Scientists Funding. The authors declare that they have no conflicts of interest with the contents of this article.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bals R, 2003, CELL MOL LIFE SCI, V60, P711, DOI 10.1007/s00018-003-2186-9; Berendsen BJA, 2011, FOOD ADDIT CONTAM A, V28, P1657, DOI 10.1080/19440049.2011.604045; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Chow JYC, 2013, WORLD J GASTROENTERO, V19, P2731, DOI 10.3748/wjg.v19.i18.2731; Falcao CB, 2014, AMINO ACIDS, V46, P2561, DOI 10.1007/s00726-014-1801-4; Finlay BB, 2004, NAT REV MICROBIOL, V2, P497, DOI 10.1038/nrmicro908; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Goldman MJ, 1997, CELL, V88, P553, DOI 10.1016/S0092-8674(00)81895-4; Hancock REW, 2012, NAT REV MICROBIOL, V10, P243, DOI 10.1038/nrmicro2745; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Li SA, 2012, ANTIMICROB AGENTS CH, V56, P3309, DOI 10.1128/AAC.06304-11; Ling GY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093216; Lu ZK, 2010, FEBS J, V277, P2329, DOI 10.1111/j.1742-4658.2010.07648.x; Mookherjee N, 2007, CELL MOL LIFE SCI, V64, P922, DOI 10.1007/s00018-007-6475-6; Mookherjee N, 2007, EXPERT OPIN THER TAR, V11, P993, DOI 10.1517/14728222.11.8.993; Nair DG, 2007, BIOCHEM J, V402, P93, DOI 10.1042/BJ20060318; Nakatsuji T, 2012, J INVEST DERMATOL, V132, P887, DOI 10.1038/jid.2011.387; Oguiura N, 2005, TOXICON, V46, P363, DOI 10.1016/j.toxicon.2005.06.009; Okerman L, 2007, ANAL CHIM ACTA, V586, P284, DOI 10.1016/j.aca.2006.10.034; Pasupuleti M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005285; Radek K, 2007, SEMIN IMMUNOPATHOL, V29, P27, DOI 10.1007/s00281-007-0064-5; Ramanathan B, 2002, MICROBES INFECT, V4, P361, DOI 10.1016/S1286-4579(02)01549-6; Sanders KL, 2008, J EVOLUTION BIOL, V21, P682, DOI 10.1111/j.1420-9101.2008.01525.x; Sanders KL, 2010, J EVOLUTION BIOL, V23, P2685, DOI 10.1111/j.1420-9101.2010.02131.x; Scott MG, 2007, NAT BIOTECHNOL, V25, P465, DOI 10.1038/nbt1288; Spellberg B, 2004, CLIN INFECT DIS, V38, P1279, DOI 10.1086/420937; Steinstraesser L, 2011, IMMUNOBIOLOGY, V216, P322, DOI 10.1016/j.imbio.2010.07.003; Theuretzbacher U, 2006, CURR OPIN INVEST DR, V7, P158; Tosi MF, 2005, J ALLERGY CLIN IMMUN, V116, P241, DOI 10.1016/j.jaci.2005.05.036; Travis SM, 2000, INFECT IMMUN, V68, P2748, DOI 10.1128/IAI.68.5.2748-2755.2000; van Hoek ML, 2014, PHARMACEUTICALS, V7, P723, DOI 10.3390/ph7060723; Viriyakosol S, 2001, J BIOL CHEM, V276, P38044; Wang YP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022120; Wang YP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003217; Wei L, 2013, J MED CHEM, V56, P3546, DOI 10.1021/jm4004158; Xiao YJ, 2009, J INNATE IMMUN, V1, P268, DOI 10.1159/000174822; Xiao YJ, 2006, J BIOL CHEM, V281, P2858, DOI 10.1074/jbc.M507180200; Zaiou M, 2002, J MOL MED, V80, P549, DOI 10.1007/s00109-002-0350-6; Zaiou M, 2007, J MOL MED, V85, P317, DOI 10.1007/s00109-006-0143-4; Zanetti M, 2004, J LEUKOCYTE BIOL, V75, P39, DOI 10.1189/jlb.0403147; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83; Zhao H, 2008, PEPTIDES, V29, P1685, DOI 10.1016/j.peptides.2008.06.008	45	73	78	7	58	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2015	290	27					16633	16652		10.1074/jbc.M115.642645	http://dx.doi.org/10.1074/jbc.M115.642645			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM3HN	26013823	Green Published, hybrid			2022-12-26	WOS:000357572800015
J	Gurke, J; Hirche, F; Thieme, R; Haucke, E; Schindler, M; Stangl, GI; Fischer, B; Santos, AN				Guerke, Jacqueline; Hirche, Frank; Thieme, Rene; Haucke, Elisa; Schindler, Maria; Stangl, Gabriele I.; Fischer, Bernd; Santos, Anne Navarrete			Maternal Diabetes Leads to Adaptation in Embryonic Amino Acid Metabolism during Early Pregnancy	PLOS ONE			English	Article							INSULIN; CHAIN; BLASTOCYST; LEUCINE; RABBIT; EXPRESSION; GLUCOSE; GROWTH; TROPHECTODERM; TRANSPORTER	During pregnancy an adequate amino acid supply is essential for embryo development and fetal growth. We have studied amino acid composition and branched chain amino acid (BCAA) metabolism at day 6 p.c. in diabetic rabbits and blastocysts. In the plasma of diabetic rabbits the concentrations of 12 amino acids were altered in comparison to the controls. Notably, the concentrations of the BCAA leucine, isoleucine and valine were approximately three-fold higher in diabetic rabbits than in the control. In the cavity fluid of blastocysts from diabetic rabbits BCAA concentrations were twice as high as those from controls, indicating a close link between maternal diabetes and embryonic BCAA metabolism. The expression of BCAA oxidizing enzymes and BCAA transporter was analysed in maternal tissues and in blastocysts. The RNA amounts of three oxidizing enzymes, i.e. branched chain aminotransferase 2 (Bcat2), branched chain ketoacid dehydrogenase (Bckdha) and dehydrolipoyl dehydrogenase (Dld), were markedly increased in maternal adipose tissue and decreased in liver and skeletal muscle of diabetic rabbits than in those of controls. Blastocysts of diabetic rabbits revealed a higher Bcat2 mRNA and protein abundance in comparison to control blastocysts. The expression of BCAA transporter LAT1 and LAT2 were unaltered in endometrium of diabetic and healthy rabbits, whereas LAT2 transcripts were increased in blastocysts of diabetic rabbits. In correlation to high embryonic BCAA levels the phosphorylation amount of the nutrient sensor mammalian target of rapamycin (mTOR) was enhanced in blastocysts caused by maternal diabetes. These results demonstrate a direct impact of maternal diabetes on BCAA concentrations and degradation in mammalian blastocysts with influence on embryonic mTOR signalling.	[Guerke, Jacqueline; Thieme, Rene; Haucke, Elisa; Schindler, Maria; Fischer, Bernd; Santos, Anne Navarrete] Univ Halle Wittenberg, Fac Med, Dept Anat & Cell Biol, D-06108 Halle, Germany; [Hirche, Frank; Stangl, Gabriele I.] Univ Halle Wittenberg, Dept Agr & Nutr Sci, D-06108 Halle, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg	Gurke, J (corresponding author), Univ Halle Wittenberg, Fac Med, Dept Anat & Cell Biol, D-06108 Halle, Germany.	jacqueline.guerke@medizin.uni-halle.de	Gürke, Jacqueline/L-6610-2019		EU FP7 EpiHealth [278418]; EpiConcept [FA1201]; RGB-Net [TD1101]; Wilhelm Roux Programme of the MLU Faculty of Medicine	EU FP7 EpiHealth; EpiConcept; RGB-Net; Wilhelm Roux Programme of the MLU Faculty of Medicine	This work was supported by EU FP7 EpiHealth (N<SUP>o</SUP> 278418), EpiConcept FA1201, RGB-Net TD1101, and the Wilhelm Roux Programme of the MLU Faculty of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BATTAGLIA FC, 1988, ANNU REV NUTR, V8, P43, DOI 10.1146/annurev.nu.08.070188.000355; BAVISTER BD, 1983, BIOL REPROD, V28, P235, DOI 10.1095/biolreprod28.1.235; Bavister BD, 1991, SER S PREIM IN PRESS; BERGER M, 1978, METABOLISM, V27, P793, DOI 10.1016/0026-0495(78)90214-7; Brosnan JT, 2006, J NUTR, V136, p207S, DOI 10.1093/jn/136.1.207S; Chung M, 1998, AM J PHYSIOL-ENDOC M, V274, pE13, DOI 10.1152/ajpendo.1998.274.1.E13; CipcicSchmidt S, 1996, EUR J PEDIATR, V155, pS173, DOI 10.1007/PL00014241; Devreker F, 2001, HUM REPROD, V16, P749, DOI 10.1093/humrep/16.4.749; Eckert JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052791; FELIG P, 1970, DIABETES, V19, P727, DOI 10.2337/diab.19.10.727; FELIG P, 1969, NEW ENGL J MED, V281, P811, DOI 10.1056/NEJM196910092811503; Fischer B, 2012, REPRODUCTION, V144, P1, DOI 10.1530/REP-12-0091; Fleming TP, 2012, ANIM REPROD SCI, V130, P193, DOI 10.1016/j.anireprosci.2012.01.015; FORLANI G, 1984, METABOLISM, V33, P147, DOI 10.1016/0026-0495(84)90127-6; GARDNER DK, 1990, J REPROD FERTIL, V88, P361, DOI 10.1530/jrf.0.0880361; GARDNER DK, 1994, BIOL REPROD, V50, P390, DOI 10.1095/biolreprod50.2.390; GARDNER DK, 1993, BIOL REPROD, V48, P377, DOI 10.1095/biolreprod48.2.377; Gaull GE, 1975, BIOL BRAIN DYSFUNCTI, P47; GELFAND RA, 1986, AM J PHYSIOL, V250, pE407, DOI 10.1152/ajpendo.1986.250.4.E407; Gopichandran N, 2003, REPRODUCTION, V126, P299, DOI 10.1530/rep.0.1260299; Gwatkin R, 1966, ANN N Y ACAD SCI, V139, P79; HANNA AK, 1980, METABOLISM, V29, P321, DOI 10.1016/0026-0495(80)90005-0; Harris SE, 2005, THERIOGENOLOGY, V64, P992, DOI 10.1016/j.theriogenology.2005.01.004; Herman MA, 2010, J BIOL CHEM, V285, P11348, DOI 10.1074/jbc.M109.075184; Houghton FD, 2002, HUM REPROD, V17, P999, DOI 10.1093/humrep/17.4.999; ICHIHARA A, 1966, J BIOCHEM-TOKYO, V59, P160, DOI 10.1093/oxfordjournals.jbchem.a128277; Jozwik M, 2001, AM J OBSTET GYNECOL, V185, P487, DOI 10.1067/mob.2001.116096; KALKHOFF RK, 1988, METABOLISM, V37, P234, DOI 10.1016/0026-0495(88)90101-1; Kanai Y, 1998, J BIOL CHEM, V273, P23629, DOI 10.1074/jbc.273.37.23629; Kim J, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.105080; Layman DK, 2003, J NUTR, V133, p261S, DOI 10.1093/jn/133.1.261S; Leese HJ, 2008, REPROD FERT DEVELOP, V20, P1, DOI 10.1071/RD07153; Leese HJ, 2002, BIOESSAYS, V24, P845, DOI 10.1002/bies.10137; LOUARD RJ, 1990, CLIN SCI, V79, P457, DOI 10.1042/cs0790457; Luetscher JA, 1942, J CLIN INVEST, V21, P275, DOI 10.1172/JCI101300; Martin PM, 2003, BIOL REPROD, V69, P1101, DOI 10.1095/biolreprod.103.018010; Martin PM, 2001, DEV BIOL, V240, P182, DOI 10.1006/dbio.2001.0461; Maurer R. R., 1978, Methods in mammalian reproduction., P259; Mordier S, 2000, J BIOL CHEM, V275, P29900, DOI 10.1074/jbc.M003633200; Pietilainen KH, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050051; POZEFSKY T, 1969, J CLIN INVEST, V48, P2273, DOI 10.1172/JCI106193; Ramin N, 2010, ENDOCRINOLOGY, V151, P4158, DOI 10.1210/en.2010-0187; Teodoro GFR, 2012, J NUTR, V142, P924, DOI 10.3945/jn.111.146266; Santos AN, 2000, BIOL REPROD, V62, P1, DOI 10.1095/biolreprod62.1.1; Santos AN, 2008, ENDOCRINOLOGY, V149, P515, DOI 10.1210/en.2007-0821; SAUDUBRAY JM, 1984, J INHERIT METAB DIS, V7, P2, DOI 10.1007/BF03047365; SCHUSTER R, 1988, J CHROMATOGR-BIOMED, V431, P271, DOI 10.1016/S0378-4347(00)83096-0; Segawa H, 1999, J BIOL CHEM, V274, P19745, DOI 10.1074/jbc.274.28.19745; STYRUD J, 1995, PEDIATR RES, V37, P343, DOI 10.1203/00006450-199503000-00015; TAKAHASHI Y, 1992, THERIOGENOLOGY, V37, P963, DOI 10.1016/0093-691X(92)90096-A; TEERLINK T, 1994, CLIN CHEM, V40, P245; Thieme R, 2012, MOL CELL ENDOCRINOL, V348, P112, DOI 10.1016/j.mce.2011.07.044; Tonack S, 2004, ANAT EMBRYOL, V208, P225, DOI 10.1007/s00429-004-0388-z; Torrazza RM, 2010, J NUTR, V140, P2145, DOI 10.3945/jn.110.128421; VANNINI P, 1982, DIABETOLOGIA, V22, P217, DOI 10.1007/BF00283757; VANWINKLE LJ, 1983, J REPROD FERTIL, V68, P437, DOI 10.1530/jrf.0.0680437; WAHREN J, 1976, J CLIN INVEST, V57, P987, DOI 10.1172/JCI108375; WAHREN J, 1972, J CLIN INVEST, V51, P1870, DOI 10.1172/JCI106989; Wijekoon EP, 2004, CAN J PHYSIOL PHARM, V82, P506, DOI [10.1139/y04-067, 10.1139/Y04-067]; Zheng C, 2009, ASIAN AUSTRAL J ANIM, V22, P1495, DOI 10.5713/ajas.2009.90127	60	15	15	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0127465	10.1371/journal.pone.0127465	http://dx.doi.org/10.1371/journal.pone.0127465			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020623	Green Submitted, Green Published, gold			2022-12-26	WOS:000355187300042
J	Shafagati, N; Lundberg, L; Baer, A; Patanarut, A; Fite, K; Lepene, B; Kehn-Hall, K				Shafagati, Nazly; Lundberg, Lindsay; Baer, Alan; Patanarut, Alexis; Fite, Katherine; Lepene, Benjamin; Kehn-Hall, Kylene			The Use of Nanotrap Particles in the Enhanced Detection of Rift Valley Fever Virus Nucleoprotein	PLOS ONE			English	Article							HYDROGEL PARTICLES; DIAGNOSTICS; DISCOVERY; PROTEINS	Background Rift Valley fever virus (RVFV) is a highly pathogenic arthropod-borne virus that has a detrimental effect on both livestock and human populations. While there are several diagnostic methodologies available for RVFV detection, many are not sensitive enough to diagnose early infections. Furthermore, detection may be hindered by high abundant proteins such as albumin. Previous findings have shown that Nanotrap particles can be used to significantly enhance detection of various small analytes of low abundance. We have expanded upon this repertoire to show that this simple and efficient sample preparation technology can drastically improve the detection of the RVFV nucleoprotein (NP), the most abundant and widely used viral protein for RVFV diagnostics. Results After screening multiple Nanotrap particle architectures, we found that one particle, NT45, was optimal for RVFV NP capture, as demonstrated by western blotting. NT45 significantly enhanced detection of the NP at levels undetectable without the technology. Importantly, we demonstrated that Nanotrap particles are capable of concentrating NP in a number of matrices, including infected cell lysates, viral supernatants, and animal sera. Specifically, NT45 enhanced detection of NP at various viral titers, multiplicity of infections, and time points. Our most dramatic results were observed in spiked serum samples, where high abundance serum proteins hindered detection of NP without Nanotrap particles. Nanotrap particles allowed for sample cleanup and subsequent detection of RVFV NP. Finally, we demonstrated that incubation of our samples with Nanotrap particles protects the NP from degradation over extended periods of time (up to 120 hours) and at elevated temperatures (at 37 degrees C). Conclusion This study demonstrates that Nanotrap particles are capable of drastically lowering the limit of detection for RVFV NP by capturing, concentrating, and preserving RVFV NP in clinically relevant matrices. These studies can be extended to a wide range of pathogens and their analytes of diagnostic interest.	[Shafagati, Nazly; Lundberg, Lindsay; Baer, Alan; Fite, Katherine; Kehn-Hall, Kylene] George Mason Univ, Sch Syst Biol, Natl Ctr Biodefense & Infect Dis, Manassas, VA 20110 USA; [Patanarut, Alexis; Lepene, Benjamin] Ceres Nanosci, Manassas, VA USA	George Mason University	Kehn-Hall, K (corresponding author), George Mason Univ, Sch Syst Biol, Natl Ctr Biodefense & Infect Dis, Manassas, VA 20110 USA.	kkehnhal@gmu.edu	Kehn-Hall, Kylene/I-5752-2013		Institute for Infectious Animal Diseases (IIAD), Texas AM/DHS; IIAD, HS-STEM Career Development Program; U.S. Department of Homeland Security [20011-ST-104-000002]	Institute for Infectious Animal Diseases (IIAD), Texas AM/DHS; IIAD, HS-STEM Career Development Program; U.S. Department of Homeland Security(United States Department of Homeland Security (DHS))	This work was supported by a grant from The Institute for Infectious Animal Diseases (IIAD), Texas A&M/DHS to BL and KKH. NS was supported through a graduate student fellowship provided through the IIAD, HS-STEM Career Development Program. This material is based upon work supported by the U.S. Department of Homeland Security under Grant Award Number 20011-ST-104-000002. The views and conclusions contained in this document are those of the authors and should not be interpreted as necessarily representing the official policies, either expressed or implied, of the U.S. Department of Homeland Security. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; [Anonymous], TRANSM RIFT VALL FEV; Baer A, 2014, JOVE-J VIS EXP, DOI 10.3791/52065; CAPLEN H, 1985, J GEN VIROL, V66, P2271, DOI 10.1099/0022-1317-66-10-2271; *CDCP, 2006, MMWR-MORBID MORTAL W, V56, P73; Douglas TA, 2011, BIOMATERIALS, V32, P1157, DOI 10.1016/j.biomaterials.2010.10.004; Faburay B, 2013, VECTOR-BORNE ZOONOT, V13, P619, DOI 10.1089/vbz.2012.1285; Ferron F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002030; Gerdes GH, 2004, REV SCI TECH OIE, V23, P613, DOI 10.20506/rst.23.2.1500; Isaacson M, 2001, CLIN INFECT DIS, V33, P1707, DOI 10.1086/322620; Jaworski E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096778; Liu L, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-82; Longo C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004763; Luchini A, 2010, CURR MOL MED, V10, P133, DOI 10.2174/156652410790963268; Luchini A, 2008, NANO LETT, V8, P350, DOI 10.1021/nl072174l; Madani TA, 2003, CLIN INFECT DIS, V37, P1084, DOI 10.1086/378747; Narayanan A, 2014, VIROLOGY, V449, P270, DOI 10.1016/j.virol.2013.11.023; Patanarut A, 2010, COLLOID SURFACE A, V362, P8, DOI 10.1016/j.colsurfa.2010.03.023; Paul D, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/783131; Pepin M, 2010, VET RES, V41, DOI 10.1051/vetres/2010033; Shafagati N, 2014, PATHOG DIS, V71, P162, DOI 10.1111/2049-632X.12136; Shafagati N, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002296; Stellwagen E, 2001, DYE AFFINITY CHROMAT; SUBRAMANIAN S, 1984, CRC CR REV BIOCH MOL, V16, P169, DOI 10.3109/10409238409102302; Tamburro D, 2011, J AM CHEM SOC, V133, P19178, DOI 10.1021/ja207515j; Thomas PC, 2011, SOFT MATTER, V7, P8192, DOI 10.1039/c1sm05369h; Tuck MK, 2009, J PROTEOME RES, V8, P113, DOI 10.1021/pr800545q	27	11	11	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128215	10.1371/journal.pone.0128215	http://dx.doi.org/10.1371/journal.pone.0128215			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020252	Green Published, gold, Green Submitted			2022-12-26	WOS:000355187300088
J	Spezzaferri, S; Kucera, M; Pearson, PN; Wade, BS; Rappo, S; Poole, CR; Morard, R; Stalder, C				Spezzaferri, Silvia; Kucera, Michal; Pearson, Paul Nicholas; Wade, Bridget Susan; Rappo, Sacha; Poole, Christopher Robert; Morard, Raphael; Stalder, Claudio			Fossil and Genetic Evidence for the Polyphyletic Nature of the Planktonic Foraminifera "Globigerinoides", and Description of the New Genus Trilobatus	PLOS ONE			English	Article							SACCULIFER BRADY; MOLECULAR EVOLUTION; PERFORMANCE	Planktonic foraminifera are one of the most abundant and diverse protists in the oceans. Their utility as paleo proxies requires rigorous taxonomy and comparison with living and genetically related counterparts. We merge genetic and fossil evidence of "Globigerinoides", characterized by supplementary apertures on spiral side, in a new approach to trace their "total evidence phylogeny" since their first appearance in the latest Paleogene. Combined fossil and molecular genetic data indicate that this genus, as traditionally understood, is polyphyletic. Both datasets indicate the existence of two distinct lineages that evolved independently. One group includes "Globigerinoides" trilobus and its descendants, the extant "Globigerinoides" sacculifer, Orbulina universa and Sphaeroidinella dehiscens. The second group includes the Globigerinoides ruber clade with the extant G. conglobatus and G. elongatus and ancestors. In molecular phylogenies, the trilobus group is not the sister taxon of the ruber group. The ruber group clusters consistently together with the modern Globoturborotalita rubescens as a sister taxon. The re-analysis of the fossil record indicates that the first "Globigerinoides" in the late Oligocene are ancestral to the trilobus group, whereas the ruber group first appeared at the base of the Miocene with representatives distinct from the trilobus group. Therefore, polyphyly of the genus "Globigerinoides" as currently defined can only be avoided either by broadening the genus concept to include G. rubescens and a large number of fossil species without supplementary apertures, or if the trilobus group is assigned to a separate genus. Since the former is not feasible due to the lack of a clear diagnosis for such a broad genus, we erect a new genus Trilobatus for the trilobus group (type species Globigerina triloba Reuss) and amend Globoturborotalita and Globigerinoides to clarify morphology and wall textures of these genera. In the new concept, Trilobatus n. gen. is paraphyletic and gave rise to the Praeorbulina / Orbulina and Sphaeroidinellopsis / Sphaeroidinella lineages.	[Spezzaferri, Silvia; Rappo, Sacha; Stalder, Claudio] Univ Fribourg, Dept Geosci, CH-1700 Fribourg, Switzerland; [Kucera, Michal; Morard, Raphael] Univ Bremen, Ctr Marine Environm Sci MARUM, D-28359 Bremen, Germany; [Pearson, Paul Nicholas] Cardiff Univ, Sch Earth & Ocean Sci, Cardiff CF10 3AX, S Glam, Wales; [Wade, Bridget Susan; Poole, Christopher Robert] UCL, Dept Earth Sci, London, England	University of Fribourg; University of Bremen; Cardiff University; University of London; University College London	Spezzaferri, S (corresponding author), Univ Fribourg, Dept Geosci, CH-1700 Fribourg, Switzerland.	silvia.spezzaferri@unifr.ch	Kucera, Michal/AAE-8115-2020; Pearson, Paul N/B-2276-2009; Kucera, Michal/ABH-6065-2020; Wade, Bridget S/F-4987-2014; Kucera, Michal/B-9277-2009	Kucera, Michal/0000-0002-7817-9018; Pearson, Paul N/0000-0003-4628-9818; Wade, Bridget S/0000-0002-7245-8614; Kucera, Michal/0000-0002-7817-9018; Poole, Christopher R./0000-0003-1401-3307	Swiss National Science Foundation [200020_153125]; Natural Environment Research Council [NE/G014817/2] Funding Source: researchfish; NERC [NE/G014817/2] Funding Source: UKRI	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The authors were funded by Swiss National Science Foundation grant 200020_153125. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre A, 2013, PALEOBIOLOGY, V39, P21, DOI 10.1666/0094-8373-39.1.21; Aurahs R, 2009, BIOINFORM BIOL INSIG, V3, P155; Aze T, 2011, BIOL REV, V86, P900, DOI 10.1111/j.1469-185X.2011.00178.x; BE AWH, 1977, ECOLOGICAL ZOOGEOGRA, P1; Berggren W. A., 1995, GEOCHRONOLOGY TIME S, P129, DOI DOI 10.2110/PEC.95.04.0129; BIJMA J, 1994, DEEP-SEA RES PT I, V41, P485, DOI 10.1016/0967-0637(94)90092-2; Blow W. H., 1969, P199; Blow W.H., 1962, FUNDAMENTALS MIDTERT, P61; BLOW WH, 1979, CAINOZOIC FORAMINIFE; Bolli H. M., 1957, Bulletin United States National Museum, VNo. 215, P97; Bolli H.M., 1985, P155; BOLLL HANS M., 1966, ECOLOGAE GEOL HELV, V59, P449; Boltovskoy E., 1976, RECENT FORAMINIFERA; Brady HB, 1887, GEOL MAG, V4, P534; BRUMMER GJA, 1987, MAR MICROPALEONTOL, V12, P357, DOI 10.1016/0377-8398(87)90028-4; Calbet A, 2008, ICES J MAR SCI, V65, P325, DOI 10.1093/icesjms/fsn013; CANDE SC, 1995, J GEOPHYS RES-SOL EA, V100, P6093, DOI 10.1029/94JB03098; Coxall HK, 2007, PALEOBIOLOGY, V33, P495, DOI 10.1666/06034.1; CUSHMAN JOSEPH A., 1927, CONTR CUSHMAN LAB FORAMINIFERAL RES, V2, P77; d'Orbigny A, 1846, FORAMINIFERES FOSSIL; Darling KF, 2000, NATURE, V405, P43, DOI 10.1038/35011002; Darling KF, 1997, MAR MICROPALEONTOL, V30, P251, DOI 10.1016/S0377-8398(96)00057-6; Darling KF, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2001PA000723; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; deVargas C, 1997, J MOL EVOL, V45, P285, DOI 10.1007/PL00006232; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hemleben C., 1991, Geologisches Jahrbuch Reihe A, V128, P117; HEMLEBEN C, 1987, MAR MICROPALEONTOL, V12, P305, DOI 10.1016/0377-8398(87)90025-9; Hemleben C., 1989, MODERN PLANKTONIC FO, DOI [DOI 10.1016/S0016-6995(89)80108-1, DOI 10.1007/978-1-4612-3544-6_2]; Hemleben Christoph, 2006, Cushman Foundation for Foraminiferal Research Special Publication, V41, P47; Jenkins D.G., 1985, P263; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; KELLER G, 1981, MAR MICROPALEONTOL, V6, P269; Kennett J.P., 1983, NEOGENE PLANKTONIC F; Kucera M, 2013, SO2263 MARUM U BREM; Kucera M, 2007, DEV MARINE GEOL, V1, P213, DOI 10.1016/S1572-5480(07)01011-1; Kurasawa A, GENETIC VARIAB UNPUB; Kuroyanagi A, 2008, MAR MICROPALEONTOL, V68, P236, DOI 10.1016/j.marmicro.2008.04.004; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Loeblich Jr A.R., 1994, CUSHMAN FDN FORAMINI, V31; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; Morard R, 2009, MAR MICROPALEONTOL, V71, P148, DOI 10.1016/j.marmicro.2009.03.001; Neil H, 2005, WATER ATMOSPHERE, V13, P18; Olsson Richard K., 2006, Cushman Foundation for Foraminiferal Research Special Publication, V41, P111; Papp A, 1985, FOSSILIEN FORAMINIFE; Parize O, 2008, CR GEOSCI, V340, P390, DOI 10.1016/j.crte.2008.03.004; Pawlowski J, 2010, J EUKARYOT MICROBIOL, V57, P197, DOI 10.1111/j.1550-7408.2009.00468.x; Pearson P.N., 2006, CUSHMAN FDN SPECIAL, V41; Pearson PN, 2014, PALEOBIOLOGY, V40, P130, DOI 10.1666/13004; Roegl Fred, 2012, Annalen des Naturhistorischen Museums in Wien A Mineralogie Petrologie Geologie Palaeontologie Archaeozoologie Anthropologie Praehistorie, V114A, P179; Seears HA, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-54; Sen Gupta B.K., 1999, MODERN FORAMINIFERA, DOI [10.1007/0-306-48104-9, DOI 10.1007/0-306-48104-9]; SHAFIK S, 1978, BMR (Bureau of Mineral Resources) Journal of Australian Geology and Geophysics, V3, P135; SPEZZAFERRI S, 1991, PALAEOGEOGR PALAEOCL, V83, P217, DOI 10.1016/0031-0182(91)90080-B; SPEZZAFERRI S, 1995, PALAEOGEOGR PALAEOCL, V114, P43, DOI 10.1016/0031-0182(95)00076-X; Spezzaferri Silvia, 1994, Palaeontographia Italica, V81, P1; Spezzaferri Silvia, 1996, Giornale di Geologia (Bologna), V58, P119; STEINECK PL, 1978, J PALEONTOL, V52, P618; Steininger FF, 1997, EPISODES, V20, P23; Turco E, 2011, STRATIGRAPHY, V8, P163; Ujiie Y, 2009, J FORAMIN RES, V39, P145, DOI 10.2113/gsjfr.39.3.145; Wade BS, 2011, EARTH-SCI REV, V104, P111, DOI 10.1016/j.earscirev.2010.09.003; Weiner AKM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092148	63	87	93	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128108	10.1371/journal.pone.0128108	http://dx.doi.org/10.1371/journal.pone.0128108			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020968	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000355187300081
J	Altukhov, AV; Andrews, RD; Calkins, DG; Gelatt, TS; Gurarie, ED; Loughlin, TR; Mamaev, EG; Nikulin, VS; Permyakov, PA; Ryazanov, SD; Vertyankin, VV; Burkanov, VN				Altukhov, Alexey V.; Andrews, Russel D.; Calkins, Donald G.; Gelatt, Thomas S.; Gurarie, Eliezer D.; Loughlin, Thomas R.; Mamaev, Evgeny G.; Nikulin, Victor S.; Permyakov, Peter A.; Ryazanov, Sergey D.; Vertyankin, Vladimir V.; Burkanov, Vladimir N.			Age Specific Survival Rates of Steller Sea Lions at Rookeries with Divergent Population Trends in the Russian Far East	PLOS ONE			English	Article							NUTRITIONAL STRESS HYPOTHESIS; EUMETOPIAS-JUBATUS; ATTENDANCE PATTERNS; BIGHORN SHEEP; ALEUTIAN ISLANDS; ALASKA; DECLINE; VERTEBRATES; MORTALITY; RECOVERY	After a dramatic population decline, Steller sea lions have begun to recover throughout most of their range. However, Steller sea lions in the Western Aleutians and Commander Islands are continuing to decline. Comparing survival rates between regions with different population trends may provide insights into the factors driving the dynamics, but published data on vital rates have been extremely scarce, especially in regions where the populations are still declining. Fortunately, an unprecedented dataset of marked Steller sea lions at rookeries in the Russian Far East is available, allowing us to determine age and sex specific survival in sea lions up to 22 years old. We focused on survival rates in three areas in the Russian range with differing population trends: the Commander Islands (Medny Island rookery), Eastern Kamchatka (Kozlov Cape rookery) and the Kuril Islands (four rookeries). Survival rates differed between these three regions, though not necessarily as predicted by population trends. Pup survival was higher where the populations were declining (Medny Island) or not recovering (Kozlov Cape) than in all Kuril Island rookeries. The lowest adult (> 3 years old) female survival was found on Medny Island and this may be responsible for the continued population decline there. However, the highest adult survival was found at Kozlov Cape, not in the Kuril Islands where the population is increasing, so we suggest that differences in birth rates might be an important driver of these divergent population trends. High pup survival on the Commander Islands and Kamchatka Coast may be a consequence of less frequent (e. g. biennial) reproduction there, which may permit females that skip birth years to invest more in their offspring, leading to higher pup survival, but this hypothesis awaits measurement of birth rates in these areas.	[Altukhov, Alexey V.; Andrews, Russel D.] Univ Alaska Fairbanks, Fairbanks, AK 99775 USA; [Altukhov, Alexey V.; Ryazanov, Sergey D.; Burkanov, Vladimir N.] RAS, FEB, Pacific Geog Inst, Kamchatka Branch, Petropavlovsk Kamchatski, Kamchatsky Kray, Russia; [Andrews, Russel D.] Alaska SeaLife Ctr, Seward, AK USA; [Calkins, Donald G.; Burkanov, Vladimir N.] North Pacific Wildlife Consulting LLC, Anchorage, AK USA; [Gelatt, Thomas S.; Burkanov, Vladimir N.] NOAA, NMFS, AFSC, Natl Marine Mammal Lab, Seattle, WA USA; [Gurarie, Eliezer D.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Gurarie, Eliezer D.] Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA; [Loughlin, Thomas R.] TRL Wildlife Consulting, NMML, Seattle, WA USA; [Mamaev, Evgeny G.] State Nat Reserve Komandorsky, Nikolskoe, Kamchatsky Kray, Russia; [Nikulin, Victor S.] Kamchatka Res Inst Fisheries & Oceanog, Petropavlovsk Kamchatski, Kamchatsky Kray, Russia; [Permyakov, Peter A.; Ryazanov, Sergey D.] RAS, FEB, VI Il Iichev Pacific Oceanol Inst, Vladivostok, Primorsky Kray, Russia; [Vertyankin, Vladimir V.] Kronotsky Reserve, Yelizovo, Kamchatsky Kray, Russia	University of Alaska System; University of Alaska Fairbanks; Pacific Geographical Institute of the Far Eastern Branch of the Russian Academy of Sciences; Russian Academy of Sciences; National Oceanic Atmospheric Admin (NOAA) - USA; University System of Maryland; University of Maryland College Park; University of Washington; University of Washington Seattle; Research lnstitute of Fisheries & Oceanography; Ilichev Pacific Oceanological Institute; Russian Academy of Sciences	Altukhov, AV (corresponding author), Univ Alaska Fairbanks, Fairbanks, AK 99775 USA.	aaltukhov@gmail.com	Permyakov, Petr/AAO-2623-2020; Gurarie, Eliezer/AGI-0958-2022; Ryazanov, Sergey/GWV-6301-2022; Burkanov, Vladimir/C-3116-2012	Gurarie, Eliezer/0000-0002-8666-9674; Ryazanov, Sergey/0000-0001-6586-5759; Andrews, Russel/0000-0002-4545-137X; Burkanov, Vladimir/0000-0002-0129-7884; Altukhov, Alexey/0000-0001-8532-0596	NOAA Fisheries; North Pacific Wildlife Consulting; Alaska Sea Life Center; Kamchatrybvod Agency; Russian Academy of Sciences; Pollock Conservation Cooperative Research Center; North Pacific Wildlife Consulting LLC; TRL Wildlife Consulting	NOAA Fisheries(National Oceanic Atmospheric Admin (NOAA) - USA); North Pacific Wildlife Consulting; Alaska Sea Life Center; Kamchatrybvod Agency; Russian Academy of Sciences(Russian Academy of Sciences); Pollock Conservation Cooperative Research Center; North Pacific Wildlife Consulting LLC; TRL Wildlife Consulting	Funding for this research was provided by grants from NOAA Fisheries, North Pacific Wildlife Consulting, Alaska Sea Life Center, Kamchatrybvod Agency, and Russian Academy of Sciences, with additional support from the Pollock Conservation Cooperative Research Center. Although one of the coauthors is employed by NOAA Fisheries, the work and results presented are collaborative and partial funding by NOAA Fisheries of the work presented here did not influence study design, data collection and analysis, decision to publish, or preparation of this manuscript. None of the other funding agencies influenced any aspects of this manuscript. North Pacific Wildlife Consulting LLC and TRL Wildlife Consulting provided support in the form of salaries for authors (DGC, TRL), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Altukhov AV, 2008, ZOOL ZH, V87, P876; Altukhov AV, 2012, RUSS J MAR BIOL+, V38, P442, DOI 10.1134/S106307401206003X; Altukhov AV, 2012, THESIS MOSCOW STATE; [Anonymous], 2000, MAR FISH REV; [Anonymous], 2014, R LANG ENV STAT COMP; Atkinson S, 2008, MAMMAL REV, V38, P1, DOI 10.1111/j.1365-2907.2008.00128.x; Baker AR, 2005, J MAMMAL, V86, P1075, DOI 10.1644/04-MAMM-A-113R1.1; Becker RA, 2013, MAPS DRAW GEOGRAPHIC; BRAHAM HW, 1980, J WILDLIFE MANAGE, V44, P25, DOI 10.2307/3808347; Burkanov V N., 2005, MAR FISH REV, V67, P1; Burkanov V, 2011, J MAMMAL, V92, P352, DOI 10.1644/10-MAMM-A-194.1; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burnham KP, 2001, WILDLIFE RES, V28, P111, DOI 10.1071/WR99107; CLINTON WL, 1993, ECOLOGY, V74, P1884, DOI 10.2307/1939945; Clutton-Brock TH, 2007, P ROY SOC B-BIOL SCI, V274, P3097, DOI 10.1098/rspb.2007.1138; Clutton-Brock TH., 1982, RED DEER BEHAV ECOLO; Cooch E. G., 2014, PROGRAM MARK GENTLE; Eberhardt LL, 2002, ECOLOGY, V83, P2841, DOI 10.2307/3072020; Fay G, 2013, ECOL APPL, V23, P1455, DOI 10.1890/12-1645.1; Festa-Bianchet M, 1998, BEHAV ECOL, V9, P144, DOI 10.1093/beheco/9.2.144; FestaBianchet M, 1997, CAN J ZOOL, V75, P1372, DOI 10.1139/z97-763; Fiscus CH, 1961, J MAMMAL, V42, P218, DOI [10.2307/1376831, DOI 10.2307/1376831]; Fowler C.W., 1981, P437; Fritz L, 2013, NMFSAFSC251 NOAA US; Fritz LW, 2014, ENDANGER SPECIES RES, V26, P13, DOI 10.3354/esr00634; Fritz LW, 2005, MAR MAMMAL SCI, V21, P476, DOI 10.1111/j.1748-7692.2005.tb01245.x; Gaillard JM, 2003, ECOLOGY, V84, P3294, DOI 10.1890/02-0409; Gisiner R, 1985, THESIS U CALIFORNIA; Hastie T, 2009, ELEMENTS STAT LEARNI, P43; Hastings KK, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00215.1; Heath RB, 1997, J WILDLIFE DIS, V33, P206, DOI 10.7589/0090-3558-33.2.206; Hogg JT, 1997, BEHAV ECOL SOCIOBIOL, V41, P33, DOI 10.1007/s002650050361; Holmes EE, 2007, ECOL APPL, V17, P2214, DOI 10.1890/07-0508.1; Holmes EE, 2003, CONSERV BIOL, V17, P1794, DOI 10.1111/j.1523-1739.2003.00191.x; Horning M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030173; Jorgenson JT, 1997, ECOLOGY, V78, P1019, DOI 10.1890/0012-9658(1997)078[1019:EOASDA]2.0.CO;2; Laake J, 2014, PROGRAM MARK GENTLE, P1; Laake JL., 2013, RMARK R INTERFACE AN; Laskina NB, 2012, MARINE MAMMALS HOLAR, P376; Loughlin Thomas R., 1997, Society for Marine Mammalogy Special Publication, V3, P159; LOUGHLIN TR, 1992, MAR MAMMAL SCI, V8, P220, DOI 10.1111/j.1748-7692.1992.tb00406.x; Mamaev E, 1999, THESIS MOSCOW STATE; Mamaev E.G., 2004, P359; Maniscalco JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096328; Maniscalco JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010076; Marakov SV, 1966, PRIRODA, V8, P67; Merrick R, 1996, NMFSAFSC68 NOAA US D; Merrick RL, 1997, CAN J ZOOL, V75, P776, DOI 10.1139/z97-099; National Marine Fisheries Service, 2008, REC PLAN STELL SEA L; Nikulin VS, 2010, RES AQUATIC BIOL RES, V19, P90; PASCUAL MA, 1994, ECOL APPL, V4, P393, DOI 10.2307/1941942; Pendleton GW, 2006, CAN J ZOOL, V84, P1163, DOI 10.1139/Z06-103; Permyakov P, 2012, MARINE MAMMALS HOLAR, V2, P181; PITCHER KW, 1981, J MAMMAL, V62, P599, DOI 10.2307/1380406; Pitcher KW, 1998, CAN J ZOOL, V76, P2075, DOI 10.1139/cjz-76-11-2075; Ryazanov SD, 2013, RES AQUATIC BIOL RES, V28, P36; Trites Andrew W., 2006, Aquatic Mammals, V32, P85, DOI 10.1578/AM.32.1.2006.85; Trites AW, 2003, MAMMAL REV, V33, P3, DOI 10.1046/j.1365-2907.2003.00009.x; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Winship AJ, 2006, MAR MAMMAL SCI, V22, P124, DOI 10.1111/j.1748-7692.2006.00009.x; YORK AE, 1994, MAR MAMMAL SCI, V10, P38, DOI 10.1111/j.1748-7692.1994.tb00388.x	61	15	15	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0127292	10.1371/journal.pone.0127292	http://dx.doi.org/10.1371/journal.pone.0127292			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26016772	Green Published, Green Submitted, gold			2022-12-26	WOS:000355185600079
J	Fontes, JD; Ramsey, J; Polk, JM; Koop, A; Denisova, JV; Belousov, AB				Fontes, Joseph D.; Ramsey, Jon; Polk, Jeremy M.; Koop, Andre; Denisova, Janna V.; Belousov, Andrei B.			Death of Neurons following Injury Requires Conductive Neuronal Gap Junction Channels but Not a Specific Connexin	PLOS ONE			English	Article							CELL-DEATH; BRAIN; HEMICHANNELS; VULNERABILITY; EXPRESSION; GLUTAMATE; ISCHEMIA; PERMEABILITY; MECHANISMS; ASTROCYTES	Pharmacological blockade or genetic knockout of neuronal connexin 36 (Cx36)-containing gap junctions reduces neuronal death caused by ischemia, traumatic brain injury and NMDA receptor (NMDAR)-mediated excitotoxicity. However, whether Cx36 gap junctions contribute to neuronal death via channel-dependent or channel-independent mechanism remains an open question. To address this, we manipulated connexin protein expression via lentiviral transduction of mouse neuronal cortical cultures and analyzed neuronal death twenty-four hours following administration of NMDA (a model of NMDAR excitotoxicity) or oxygen-glucose deprivation (a model of ischemic injury). In cultures prepared from wildtype mice, over-expression and knockdown of Cx36-containing gap junctions augmented and prevented, respectively, neuronal death from NMDAR-mediated excitotoxicity and ischemia. In cultures obtained form from Cx36 knockout mice, re-expression of functional gap junction channels, containing either neuronal Cx36 or non-neuronal Cx43 or Cx31, resulted in increased neuronal death following insult. In contrast, the expression of communication-deficient gap junctions (containing mutated connexins) did not have this effect. Finally, the absence of ethidium bromide uptake in non-transduced wild-type neurons two hours following NMDAR excitotoxicity or ischemia suggested the absence of active endogenous hemichannels in those neurons. Taken together, these results suggest a role for neuronal gap junctions in cell death via a connexin type-independent mechanism that likely relies on channel activities of gap junctional complexes among neurons. A possible contribution of gap junction channel-permeable death signals in neuronal death is discussed.	[Fontes, Joseph D.; Ramsey, Jon] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66103 USA; [Polk, Jeremy M.; Koop, Andre; Denisova, Janna V.; Belousov, Andrei B.] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Belousov, AB (corresponding author), Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66103 USA.	abelousov@kumc.edu		Fontes, Joseph/0000-0003-4796-343X	National Institutes of Health (NIH) [R21 NS076925]; University of Kansas Medical Center; NIH [P20 GM104936, P30 AG035982, UL1 TR000001]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD002528] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS076925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG035982] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Kansas Medical Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by National Institutes of Health (NIH) (R21 NS076925) and the University of Kansas Medical Center funds to A. B. B. The study also was supported in part by NIH P20 GM104936, P30 AG035982 and UL1 TR000001. Core support was provided by NIH HD002528. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumugam H, 2005, NAT NEUROSCI, V8, P1720, DOI 10.1038/nn1588; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Bargiotas P, 2012, BRAIN RES, V1479, P80, DOI 10.1016/j.brainres.2012.08.046; Bargiotas P, 2011, P NATL ACAD SCI USA, V108, P20772, DOI 10.1073/pnas.1018262108; Bargiotas P, 2009, CURR MOL MED, V9, P186, DOI 10.2174/156652409787581646; Bedner P, 2012, BBA-BIOMEMBRANES, V1818, P1971, DOI 10.1016/j.bbamem.2011.10.016; Belousov AB, 2014, J NEURAL TRANSM, V121, P837, DOI 10.1007/s00702-013-1109-7; Belousov AB, 2013, TRENDS NEUROSCI, V36, P227, DOI 10.1016/j.tins.2012.11.001; Belousov AB, 2012, NEUROSCI LETT, V524, P16, DOI 10.1016/j.neulet.2012.06.065; Bennett MVL, 2004, NEURON, V41, P495, DOI 10.1016/S0896-6273(04)00043-1; Chang QA, 2000, J NEUROSCI, V20, P674, DOI 10.1523/JNEUROSCI.20-02-00674.2000; Contreras JE, 2002, P NATL ACAD SCI USA, V99, P495, DOI 10.1073/pnas.012589799; Cusato K, 2006, CELL DEATH DIFFER, V13, P1707, DOI 10.1038/sj.cdd.4401876; de Pina-Benabou MH, 2005, STROKE, V36, P2232, DOI 10.1161/01.STR.0000182239.75969.d8; Deans MR, 2001, NEURON, V31, P477, DOI 10.1016/S0896-6273(01)00373-7; Decrock E, 2009, CELL DEATH DIFFER, V16, P524, DOI 10.1038/cdd.2008.196; Decrock E, 2013, BBA-MOL CELL RES, V1833, P1772, DOI 10.1016/j.bbamcr.2012.12.016; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Ek-Vitorin JF, 2013, BBA-BIOMEMBRANES, V1828, P51, DOI 10.1016/j.bbamem.2012.02.003; ELFGANG C, 1995, J CELL BIOL, V129, P805, DOI 10.1083/jcb.129.3.805; Frantseva MV, 2002, J NEUROSCI, V22, P644, DOI 10.1523/JNEUROSCI.22-03-00644.2002; Froger N, 2010, MOL CELL NEUROSCI, V45, P37, DOI 10.1016/j.mcn.2010.05.007; Gajda Z, 2003, EPILEPSIA, V44, P1596, DOI 10.1111/j.0013-9580.2003.25803.x; Garrett FG, 2008, NEURON GLIA BIOL, V4, P295, DOI 10.1017/S1740925X09990093; Goldberg GS, 1999, NAT CELL BIOL, V1, P457, DOI 10.1038/15693; Goldberg GS, 2002, J BIOL CHEM, V277, P36725, DOI 10.1074/jbc.M109797200; Hazell AS, 2007, NEUROCHEM INT, V50, P941, DOI 10.1016/j.neuint.2007.04.026; Hormuzdi SG, 2001, NEURON, V31, P487, DOI 10.1016/S0896-6273(01)00387-7; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Kar R, 2012, ARCH BIOCHEM BIOPHYS, V524, P2, DOI 10.1016/j.abb.2012.03.008; Lynn BD, 2012, J MEMBRANE BIOL, V245, P303, DOI 10.1007/s00232-012-9451-5; Oguro K, 2001, J NEUROSCI, V21, P7534, DOI 10.1523/JNEUROSCI.21-19-07534.2001; Ohsumi A, 2006, ACTA NEUROCHIR SUPPL, V96, P148; Orellana JA, 2011, J NEUROSCI, V31, P4962, DOI 10.1523/JNEUROSCI.6417-10.2011; Park WM, 2011, J NEUROSCI, V31, P5909, DOI 10.1523/JNEUROSCI.6787-10.2011; Paschon V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045449; PEREZVELAZQUEZ JL, 1994, J NEUROSCI, V14, P4308; Ramsey JE, 2013, MOL IMMUNOL, V56, P768, DOI 10.1016/j.molimm.2013.07.001; Rash JE, 2000, P NATL ACAD SCI USA, V97, P7573, DOI 10.1073/pnas.97.13.7573; Retamal MA, 2006, P NATL ACAD SCI USA, V103, P4475, DOI 10.1073/pnas.0511118103; Roscoe W, 2005, J BIOL CHEM, V280, P11458, DOI 10.1074/jbc.M409564200; Sohl G, 2005, NAT REV NEUROSCI, V6, P191, DOI 10.1038/nrn1627; Srinivas M, 1999, J NEUROSCI, V19, P9848; Stauch K, 2012, J BIOL CHEM, V287, P27771, DOI 10.1074/jbc.M112.382572; Striedinger K, 2005, EUR J NEUROSCI, V22, P605, DOI 10.1111/j.1460-9568.2005.04228.x; Thompson RJ, 2008, SCIENCE, V322, P1555, DOI 10.1126/science.1165209; Udawatte C, 2005, APOPTOSIS, V10, P1019, DOI 10.1007/s10495-005-0776-8; Vaccari JCDR, 2007, J NEUROPHYSIOL, V98, P2878, DOI 10.1152/jn.00362.2007; Wang XJ, 2008, NEUROCHEM RES, V33, P826, DOI 10.1007/s11064-007-9514-7; Wang YF, 2012, J NEUROSCI, V32, P713, DOI 10.1523/JNEUROSCI.3872-11.2012; Wang YF, 2010, J NEUROPHYSIOL, V104, P3551, DOI 10.1152/jn.00656.2010	51	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0125395	10.1371/journal.pone.0125395	http://dx.doi.org/10.1371/journal.pone.0125395			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26017008	Green Submitted, Green Published, gold			2022-12-26	WOS:000355185600021
J	Sala, N; Arsuaga, JL; Pantoja-Perez, A; Pablos, A; Martinez, I; Quam, RM; Gomez-Olivencia, A; de Castro, JMB; Carbonell, E				Sala, Nohemi; Arsuaga, Juan Luis; Pantoja-Perez, Ana; Pablos, Adrian; Martinez, Ignacio; Quam, Rolf M.; Gomez-Olivencia, Asier; Bermudez de Castro, Jose Marea; Carbonell, Eudald			Lethal Interpersonal Violence in the Middle Pleistocene	PLOS ONE			English	Article							BLUNT HEAD TRAUMA; LOS HUESOS ATAPUERCA; BREAKAGE PATTERNS; POSTMORTEM INTERVAL; FRACTURE PATTERNS; BONE-FRACTURES; FORCE TRAUMA; SIMA; CANNIBALISM; DISCRIMINATION	Evidence of interpersonal violence has been documented previously in Pleistocene members of the genus Homo, but only very rarely has this been posited as the possible manner of death. Here we report the earliest evidence of lethal interpersonal violence in the hominin fossil record. Cranium 17 recovered from the Sima de los Huesos Middle Pleistocene site shows two clear perimortem depression fractures on the frontal bone, interpreted as being produced by two episodes of localized blunt force trauma. The type of injuries, their location, the strong similarity of the fractures in shape and size, and the different orientations and implied trajectories of the two fractures suggest they were produced with the same object in face-to-face interpersonal conflict. Given that either of the two traumatic events was likely lethal, the presence of multiple blows implies an intention to kill. This finding shows that the lethal interpersonal violence is an ancient human behavior and has important implications for the accumulation of bodies at the site, supporting an anthropic origin.	[Sala, Nohemi; Arsuaga, Juan Luis; Pantoja-Perez, Ana; Pablos, Adrian; Martinez, Ignacio; Quam, Rolf M.; Gomez-Olivencia, Asier] UCM, Ctr Mixto, ISCIII, Evoluc Comportamiento Humanos, Madrid, Spain; [Arsuaga, Juan Luis] Univ Complutense Madrid, Fac Ciencias Geol, Dept Palaeontol, Madrid, Spain; [Pablos, Adrian; Martinez, Ignacio] Univ Alcala, Dept Ciencias Vida, Area Antropol Fis, Madrid, Spain; [Quam, Rolf M.] SUNY Binghamton, Dept Anthropol, Binghamton, NY 13902 USA; [Quam, Rolf M.] Amer Museum Nat Hist, Div Anthropol, New York, NY 10024 USA; [Gomez-Olivencia, Asier] Euskal Herriko Unibertsitatea, Fac Ciencias & Tecnol, Dept Estratig & Paleontol, Bilbao, Spain; [Gomez-Olivencia, Asier] Ikerbasque, Basque Fdn Sci, Bilbao, Spain; [Gomez-Olivencia, Asier] Museum Natl Hist Nat, Musee Homme, Dept Prehist, Equipe Paleontol Humaine, F-75231 Paris, France; [Bermudez de Castro, Jose Marea] Ctr Nacl Invest Evoluc Humana, Burgos, Spain; [Carbonell, Eudald] Univ Rovira & Virgili, Dept Hist & Hist Art, Area Prehist, E-43007 Tarragona, Spain; [Carbonell, Eudald] Inst Catala Paleoecol Humana & Evoluc Social, Tarragona, Spain; [Carbonell, Eudald] Inst Vertebrate Paleontol & Paleoanthropol Beijin, Beijing, Peoples R China	Complutense University of Madrid; Instituto de Salud Carlos III; Complutense University of Madrid; Universidad de Alcala; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; American Museum of Natural History (AMNH); University of Basque Country; Basque Foundation for Science; Museum National d'Histoire Naturelle (MNHN); Centro Nacional de Investigacion de La Evolucion Humana (CENIEH); Universitat Rovira i Virgili; Universitat Rovira i Virgili; Catalan Institute of Human Paleo-Ecology & Social Evolution (IPHES); Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Sala, N (corresponding author), UCM, Ctr Mixto, ISCIII, Evoluc Comportamiento Humanos, Madrid, Spain.	nsala@isciii.es	Pérez, Ana Pantoja/AAG-7145-2019; Pablos, Adrián/H-4751-2015; Gómez-Olivencia, Asier/D-6531-2015; Pablos, Adrián/N-7531-2019; Sala, Nohemi/N-9961-2014; Sala, Nohemi/AAA-8881-2020	Pérez, Ana Pantoja/0000-0001-9302-1756; Pablos, Adrián/0000-0003-1630-4941; Gómez-Olivencia, Asier/0000-0001-7831-3902; Pablos, Adrián/0000-0003-1630-4941; Sala, Nohemi/0000-0002-0896-1493; Arsuaga, Juan Luis/0000-0001-5361-2295; Bermudez de Castro, Jose Maria/0000-0003-1314-3273; martinez, ignacio/0000-0002-1835-9199	Ministerio de Economia y Competitividad of the government of Spain [CGL2012-38434-C03-01, CGL2012-38434-C03-02, CGL2012-38434-C03-03]; Junta de Castilla y Leon [BU005A09]; Junta de Castilla y Leon; Fundacion Atapuerca; Binghamton University (SUNY)	Ministerio de Economia y Competitividad of the government of Spain(Spanish Government); Junta de Castilla y Leon(Junta de Castilla y Leon); Junta de Castilla y Leon(Junta de Castilla y Leon); Fundacion Atapuerca; Binghamton University (SUNY)	This research was supported by the Ministerio de Economia y Competitividad of the government of Spain (Project Nos. CGL2012-38434-C03-01, 02 & 03). CT scanning was carried out in collaboration with the Laboratorio de la Evolucion Humana at the Universidad de Burgos (Spain) with funding provided by the Junta de Castilla y Leon Project No. BU005A09. Fieldwork at the Atapuerca sites was funded by the Junta de Castilla y Leon and the Fundacion Atapuerca. N.S and A.P.P. have received postdoctoral and predoctoral respectively grants from the Fundacion Atapuerca. R.M.Q. has received financial support from Binghamton University (SUNY).	Aguirre E, 2000, TENDENCIAS ACTUALES, P31; Andrews P, 1997, J HUM EVOL, V33, P191, DOI 10.1006/jhev.1997.0137; Aranburu A, 2017, QUATERN INT, V433, P5, DOI 10.1016/j.quaint.2015.02.044; Arsuaga JL, 2014, SCIENCE, V344, P1358, DOI 10.1126/science.1253958; Arsuaga JL, 1997, J HUM EVOL, V33, P109, DOI 10.1006/jhev.1997.0132; ARSUAGA JL, 1990, HUM EVOL, V5, P505; BERGER TD, 1995, J ARCHAEOL SCI, V22, P841, DOI 10.1016/0305-4403(95)90013-6; BERRYMAN HE, 1996, INT J OSTEOARCHAEOL, V6, P2; Brink O, 1998, INJURY, V29, P705, DOI 10.1016/S0020-1383(98)00176-4; Brink O, 2009, J TRAUMA, V67, P147, DOI 10.1097/TA.0b013e318182f77f; Caceres I, 2007, AM J PHYS ANTHROPOL, V133, P899, DOI 10.1002/ajpa.20610; Carbonell E, 2010, CURR ANTHROPOL, V51, P539, DOI 10.1086/653807; de Bakker BS, 2013, J FORENSIC RADIOL IM, V1, P176, DOI 10.1016/j.jofri.2013.07.005; de Castro JMB, 2004, J ANTHROPOL RES, V60, P5; DECASTRO JMB, 1988, J HUM EVOL, V17, P403, DOI 10.1016/0047-2484(88)90029-2; Diez JC, 1990, I JORNADAS BURGALESA, P517; Fernandez-Jalvo Y, 1996, SCIENCE, V271, P277, DOI 10.1126/science.271.5247.277; Fleming-Farrell D, 2013, FORENSIC SCI INT, V229, DOI 10.1016/j.forsciint.2013.03.032; Frayer DW, 2012, LATERALITY, V17, P51, DOI 10.1080/1357650X.2010.529451; Galloway A, 1999, BROKEN BONES ANTHR A, P35; GURDJIAN ES, 1950, J NEUROSURG, V7, P106, DOI 10.3171/jns.1950.7.2.0106; Guyomarc'h P, 2010, J FORENSIC SCI, V55, P423, DOI 10.1111/j.1556-4029.2009.01310.x; HUSSAIN K, 1994, J TRAUMA, V36, P34, DOI 10.1097/00005373-199401000-00006; Jimenez-Brobeil SA, 2009, AM J PHYS ANTHROPOL, P140; Johnson E., 1985, ADV ARCHAEOLOGICAL M, P157, DOI [DOI 10.1016/B978-0-12-003108-5.50010-5, 10.1016/B978-0-12-003108-5.50010-5]; Jordana F, 2013, ROM J LEG MED, V21, P287, DOI 10.4323/rjlm.2013.287; Jordana F, 2013, J FORENSIC SCI, V58, pS156, DOI 10.1111/1556-4029.12012; Kremer C, 2008, J FORENSIC SCI, V53, P716, DOI 10.1111/j.1556-4029.2008.00725.x; Kremer C, 2009, J FORENSIC SCI, V54, P923, DOI 10.1111/j.1556-4029.2009.01072.x; Lovell NC, 1997, YEARB PHYS ANTHROPOL, V40, P139; Lozano M, 2009, EVOL HUM BEHAV, V30, P369, DOI 10.1016/j.evolhumbehav.2009.03.001; Martin DL, 2015, AM J PHYS ANTHROPOL, V156, P116, DOI 10.1002/ajpa.22662; Otterbein KF, 2011, CURR ANTHROPOL, V52, P439, DOI 10.1086/659742; Outram AK, 2005, J ARCHAEOL SCI, V32, P1699, DOI 10.1016/j.jas.2005.05.008; Perez PJ, 1997, J HUM EVOL, V33, P409, DOI 10.1006/jhev.1997.0139; Raul JS, 2008, SKELETAL TRAUMA: IDENTIFICATION OF INJURIES RESULTING FROM HUMAN RIGHTS ABUSE AND ARMED CONFLICT, P21; Sala N, 2015, J ARCHAEOL SCI, V55, P113, DOI 10.1016/j.jas.2015.01.002; Sala N, 2014, QUATERNARY SCI REV, V97, P71, DOI 10.1016/j.quascirev.2014.05.004; Saladie P, 2012, J HUM EVOL, V63, P682, DOI 10.1016/j.jhevol.2012.07.004; Smith MO, 2003, AM J PHYS ANTHROPOL, V121, P303, DOI 10.1002/ajpa.10232; Spencer SD, 2012, INT J PALEOPATHOL, V2, P112, DOI 10.1016/j.ijpp.2012.09.007; Symes S.A., 2002, ADV FORENSIC TAPHONO, P403, DOI [10.1201/9781420058352-26, DOI 10.1201/9781420058352-26]; Thomas LM, 1984, MAXILLOFACIAL TRAUMA, P74; TRINKAUS E, 1982, AM J PHYS ANTHROPOL, V57, P61, DOI 10.1002/ajpa.1330570108; Trinkaus E, 2012, INT J OSTEOARCHAEOL, V22, P655, DOI 10.1002/oa.1227; Trinkaus E, 1983, THE SHANIDAR NEANDER; Trinkaus E, 2012, J ARCHAEOL SCI, V39, P3691, DOI 10.1016/j.jas.2012.05.039; Turner C.G., 1999, MAN CORN CANNIBALISM; VILLA P, 1991, J HUM EVOL, V21, P27, DOI 10.1016/0047-2484(91)90034-S; VILLA P, 1986, SCIENCE, V233, P431, DOI 10.1126/science.233.4762.431; Villa P., 1992, EVOLUTIONARY ANTHR, V1, P93, DOI DOI 10.1002/EVAN.1360010307; WALKER PL, 1989, AM J PHYS ANTHROPOL, V80, P313, DOI 10.1002/ajpa.1330800305; Waters CJ, 2008, SKELETAL TRAUMA: IDENTIFICATION OF INJURIES RESULTING FROM HUMAN RIGHTS ABUSE AND ARMED CONFLICT, P321; Wedel V, 2014, BROKEN BONES ANTHROP; Wheatley BP, 2008, J FORENSIC SCI, V53, P69, DOI 10.1111/j.1556-4029.2008.00593.x; White T.D., 1992, PREHISTORIC CANNIBAL; Wieberg DAM, 2008, J FORENSIC SCI, V53, P1028, DOI 10.1111/j.1556-4029.2008.00801.x; Wu XJ, 2011, P NATL ACAD SCI USA, V108, P19558, DOI 10.1073/pnas.1117113108; Zollikofer CPE, 2002, P NATL ACAD SCI USA, V99, P6444, DOI 10.1073/pnas.082111899	59	59	61	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0126589	10.1371/journal.pone.0126589	http://dx.doi.org/10.1371/journal.pone.0126589			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0RO	26018668	Green Submitted, Green Published, gold			2022-12-26	WOS:000355185600055
J	Domnich, A; Panatto, D; Signori, A; Lai, PL; Gasparini, R; Amicizia, D				Domnich, Alexander; Panatto, Donatella; Signori, Alessio; Lai, Piero Luigi; Gasparini, Roberto; Amicizia, Daniela			Age-Related Differences in the Accuracy of Web Query-Based Predictions of Influenza-Like Illness	PLOS ONE			English	Article							PANDEMIC INFLUENZA; DISEASE SURVEILLANCE; INFORMATION-SEEKING; HEALTH INFORMATION; INTERNET; SEARCH; CHILDREN; INFODEMIOLOGY; COMMUNICATION; EPIDEMIC	Background Web queries are now widely used for modeling, nowcasting and forecasting influenza-like illness (ILI). However, given that ILI attack rates vary significantly across ages, in terms of both magnitude and timing, little is known about whether the association between ILI morbidity and ILI-related queries is comparable across different age-groups. The present study aimed to investigate features of the association between ILI morbidity and ILI-related query volume from the perspective of age. Methods Since Google Flu Trends is unavailable in Italy, Google Trends was used to identify entry terms that correlated highly with official ILI surveillance data. All-age and age-class-specific modeling was performed by means of linear models with generalized least-square estimation. Hold-out validation was used to quantify prediction accuracy. For purposes of comparison, predictions generated by exponential smoothing were computed. Results Five search terms showed high correlation coefficients of >.6. In comparison with exponential smoothing, the all-age query-based model correctly predicted the peak time and yielded a higher correlation coefficient with observed ILI morbidity (. 978 vs..929). However, query-based prediction of ILI morbidity was associated with a greater error. Age-class-specific query-based models varied significantly in terms of prediction accuracy. In the 0-4 and 25-44-year age-groups, these did well and outperformed exponential smoothing predictions; in the 15-24 and >= 65-year age-classes, however, the query-based models were inaccurate and highly overestimated peak height. In all but one age-class, peak timing predicted by the query-based models coincided with observed timing. Conclusions The accuracy of web query-based models in predicting ILI morbidity rates could differ among ages. Greater age-specific detail may be useful in flu query-based studies in order to account for age-specific features of the epidemiology of ILI.	[Domnich, Alexander; Panatto, Donatella; Signori, Alessio; Lai, Piero Luigi; Gasparini, Roberto; Amicizia, Daniela] Univ Genoa, Dept Hlth Sci, Genoa, Italy; [Panatto, Donatella; Lai, Piero Luigi; Gasparini, Roberto; Amicizia, Daniela] Inter Univ Ctr Res Influenza & Other Transmissibl, Genoa, Italy	University of Genoa	Domnich, A (corresponding author), Univ Genoa, Dept Hlth Sci, Genoa, Italy.	alexander.domnich@gmail.com	Bragazzi, Nicola Luigi/G-1672-2011; Signori, Alessio/L-3081-2016	Bragazzi, Nicola Luigi/0000-0001-8409-868X; Signori, Alessio/0000-0001-6289-9144	Inter-University Centre of Research on Influenza and other Transmissible Infections (CIRI-IT), Genoa, Italy	Inter-University Centre of Research on Influenza and other Transmissible Infections (CIRI-IT), Genoa, Italy	The study was supported by the Inter-University Centre of Research on Influenza and other Transmissible Infections (CIRI-IT), Genoa, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althouse BM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001258; Amicizia D, 2013, HUM VACC IMMUNOTHER, V9, P2634, DOI 10.4161/hv.26010; [Anonymous], SEARCH ENGINE USE 20; [Anonymous], 2014, R LANG ENV STAT COMP; Ansaldi F, 2008, J Prev Med Hyg, V49, P131; Bernardo TM, 2013, J MED INTERNET RES, V15, P239, DOI 10.2196/jmir.2740; Bernhardt JM, 2004, J MED INTERNET RES, V6, DOI 10.2196/jmir.6.1.e7; Broniatowski DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083672; Brownstein JS, 2005, AM J EPIDEMIOL, V162, P686, DOI 10.1093/aje/kwi257; Butler D, 2013, NATURE, V494, P155, DOI 10.1038/494155a; Cho S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081422; Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023; Cohen R. A., 2011, USE INTERNET HLTH IN; Cook AR, 2010, EMERG INFECT DIS, V16, P1647, DOI 10.3201/eid1610.100840; Lange MMA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-881; Debin M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073675; Domnich A, 2014, INT J PUBLIC HEALTH, V59, P841, DOI 10.1007/s00038-014-0581-7; Dugas AF, 2012, CLIN INFECT DIS, V54, P463, DOI 10.1093/cid/cir883; Elliot A, 2009, EURO SURVEILL, V14; Eysenbach Gunther, 2006, AMIA Annu Symp Proc, P244; Eysenbach G, 2011, AM J PREV MED, V40, pS154, DOI 10.1016/j.amepre.2011.02.006; Eysenbach G, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1157; Fauci AS, 2006, J INFECT DIS, V194, pS73, DOI 10.1086/507550; Fowlkes A, 2013, INFLUENZA OTHER RESP, V7, P694, DOI 10.1111/irv.12014; FOX J, 2002, TIME SERIES REGRESSI; Gasparini R, 2013, HUM VACC IMMUNOTHER, V9, P561, DOI 10.4161/hv.23235; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Glass LM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-61; Glatman-Freedman A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050228; Hulth A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004378; Jayasundara K, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0670-5; Kang M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055205; Khoo K, 2008, J PAEDIATR CHILD H, V44, P419, DOI 10.1111/j.1440-1754.2008.01322.x; Lai P L, 2011, J Prev Med Hyg, V52, P142; Lazer D, GOOGLE FLU TRENDS ST; Lazer D, 2014, SCIENCE, V343, P1203, DOI 10.1126/science.1248506; McIver DJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003581; Milinovich GJ, 2014, LANCET INFECT DIS, V14, P160, DOI 10.1016/S1473-3099(13)70244-5; Nagar R, 2014, J MED INTERNET RES, V16, P260, DOI 10.2196/jmir.3416; Olson DR, 2007, PLOS MED, V4, P1349, DOI 10.1371/journal.pmed.0040247; Olson DR, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003256; Ortiz JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018687; Paolotti D, 2010, P 3 INT ICST C EL HE; Polgreen PM, 2008, CLIN INFECT DIS, V47, P1443, DOI 10.1086/593098; Santillana M, 2014, AM J PREV MED, V47, P341, DOI 10.1016/j.amepre.2014.05.020; Santos JC, 2014, THEOR BIOL MED MODEL, V11, DOI 10.1186/1742-4682-11-S1-S6; Schanzer D, 2011, AM J EPIDEMIOL, V174, P109, DOI 10.1093/aje/kwr037; Seifter A, 2010, GEOSPATIAL HEALTH, V4, P135, DOI 10.4081/gh.2010.195; Signorelli C, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h116; Sim NZ, 2007, J PEDIATR SURG, V42, P305, DOI 10.1016/j.jpedsurg.2006.10.003; Skranes LP, 2014, J PUBLIC HEALTH-HEID, V22, P423, DOI 10.1007/s10389-014-0631-x; Viboud C, 2004, INT CONGR SER, V1263, P291, DOI 10.1016/j.ics.2004.01.013; Wainstein BK, 2006, J PAEDIATR CHILD H, V42, P528, DOI 10.1111/j.1440-1754.2006.00916.x; Yuan QY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064323; Zhou XC, 2010, J ZHEJIANG U-SCI C, V11, P241, DOI 10.1631/jzus.C0910371	55	18	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127754	10.1371/journal.pone.0127754	http://dx.doi.org/10.1371/journal.pone.0127754			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011418	Green Submitted, gold, Green Published			2022-12-26	WOS:000355183900139
J	Ranthe, MF; Petersen, JA; Bundgaard, H; Wohlfahrt, J; Melbye, M; Boyd, HA				Ranthe, Mattis Flyvholm; Petersen, Jonathan Aavang; Bundgaard, Henning; Wohlfahrt, Jan; Melbye, Mads; Boyd, Heather A.			A Detailed Family History of Myocardial Infarction and Risk of Myocardial Infarction - A Nationwide Cohort Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; DEATH; ASSOCIATION; POPULATION	Background Family history of myocardial infarction (MI) is an independent risk factor for MI. Several genetic variants are associated with increased risk of MI and family history of MI in a first-degree relative doubles MI risk. However, although family history of MI is not a simple dichotomous risk factor, the impact of specific, detailed family histories has not received much attention, despite its high clinical relevance. We examined risk of MI by MIs in first-and second-degree relatives and by number and age of affected relatives. Methods and Findings Using Danish national registers, we established a nationwide cohort of persons born between 1930 and 1992 with identifiable first-or second- degree relatives. Incident MIs in both cohort members and relatives aged >= 20 years were identified. We calculated incidence rate ratios (IRRs) for MI by family history of MI, by Poisson regression. In 4.4 million persons followed for 104 million person-years, we identified 128,384 incident MIs. IRRs with 95% confidence intervals [CIs] for MI by history of MI in 1, 2 or >= 3 first-degree relatives were 1.46 (1.42-1.49), 2.38 ( 2.22-2.56) and 3.58 (2.66-4.81), respectively. Corresponding estimates for second- degree relatives were 1.17 (1.05-1.30), 1.87 (1.46-2.38) and 2.18 (1.09-4.36). A history of MI in combinations of first-and second- degree relatives increased risks 1.8- to 7-fold in middle-aged persons (36 to 55 years). Estimates were robust to adjustment for diabetes, hypertension, dyslipidemia and use of cardiovascular medications. Conclusion A detailed family history, particularly number of affected first-and second- degree relatives, contributes meaningfully to risk assessment, especially in middle-aged persons. Future studies should test for potential improvement of risk algorithm prediction using detailed family histories.	[Ranthe, Mattis Flyvholm; Petersen, Jonathan Aavang; Wohlfahrt, Jan; Melbye, Mads; Boyd, Heather A.] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; [Bundgaard, Henning] Copenhagen Univ Hosp, Ctr Heart, Unit Inherited Cardiac Dis, Copenhagen, Denmark	Statens Serum Institut; University of Copenhagen	Ranthe, MF (corresponding author), Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark.	mfrante@gmail.com	Bundgaard, Henning/AAA-4381-2020; Aavang Petersen, jonathan/ABG-7320-2021	Bundgaard, Henning/0000-0002-0563-7049; melbye, mads/0000-0001-8264-6785; Boyd, Heather/0000-0001-6849-9985; Aavang Petersen, Jonathan/0000-0003-0635-4144; Ranthe, Mattis Flyvholm/0000-0002-6363-6386	Danish Heart Foundation [10-04-R78-A2799-22615]; Dagmar Marshall's Foundation; Novo Nordisk Fonden [NNF14OC0012809] Funding Source: researchfish	Danish Heart Foundation; Dagmar Marshall's Foundation; Novo Nordisk Fonden(Novo Nordisk Foundation)	The Danish Heart Foundation: Grant 10-04-R78-A2799-22615 (http://www.hjerteforeningen.dk/om_os/in_english/) Dagmar Marshall's Foundation: In 2011 this Foundation granted 40,000 DKR (similar to 6,820 USD) for regular salary for Dr. Ranthe while he was employed at the Department of Epidemiology Research, Statens Serum Institut. Dagmar Marshall's Foundation is a small private fund managed by a local Danish law firm, Dagmar Marshall's Foundation do not provide grant numbers and has no webpage. None of the funding sources had any role in the design and conduct of the study; in the collection, management, analysis, and interpretation of the data; or in the preparation, review, or approval of the manuscript.	Bachmann JM, 2012, CIRCULATION, V125, P3092, DOI 10.1161/CIRCULATIONAHA.111.065490; BARRETTCONNOR E, 1984, CIRCULATION, V69, P1065, DOI 10.1161/01.CIR.69.6.1065; Carstensen B, 2011, SCAND J PUBLIC HEALT, V39, P58, DOI 10.1177/1403494811404278; Chow CK, 2007, BMJ-BRIT MED J, V335, P481, DOI 10.1136/bmj.39253.577859.BE; Chow CK, 2011, J AM COLL CARDIOL, V57, P619, DOI 10.1016/j.jacc.2010.07.054; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Dent THS, 2010, ATHEROSCLEROSIS, V213, P345, DOI 10.1016/j.atherosclerosis.2010.06.019; Di Angelantonio E, 2012, CIRC-CARDIOVASC GENE, V5, P387, DOI 10.1161/CIRCGENETICS.112.964148; Ebrahim S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001561.pub3; Framingham Heart Study, 2010, RISK SCOR PROF; Germano G, 2012, EUR HEART J, V33, P137; Jorgensen T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3617; Jouven X, 1999, CIRCULATION, V99, P1978, DOI 10.1161/01.CIR.99.15.1978; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Lloyd-Jones DM, 2004, JAMA-J AM MED ASSOC, V291, P2204, DOI 10.1001/jama.291.18.2204; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Madsen M, 2003, J CLIN EPIDEMIOL, V56, P124, DOI 10.1016/S0895-4356(02)00591-7; Miller M, 2011, CIRCULATION, V123, P2292, DOI 10.1161/CIR.0b013e3182160726; Nielsen M, 2013, EUR HEART J, V34, P1198, DOI 10.1093/eurheartj/ehs475; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Prabhakaran D, 2012, MT SINAI J MED, V79, P721, DOI 10.1002/msj.21348; Qureshi N, 2012, ANN INTERN MED, V156, P253, DOI 10.7326/0003-4819-156-4-201202210-00002; Ranthe MF, 2012, J AM COLL CARDIOL, V60, P814, DOI 10.1016/j.jacc.2012.06.018; Roberts R, 2014, CIRC RES, V114, P1890, DOI 10.1161/CIRCRESAHA.114.302692; Roberts R, 2012, J AM COLL CARDIOL, V60, P1715, DOI 10.1016/j.jacc.2011.12.062; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Sivapalaratnam S, 2010, HEART, V96, P1985, DOI 10.1136/hrt.2010.210740; Valdez R, 2010, ANNU REV PUBL HEALTH, V31, P69, DOI 10.1146/annurev.publhealth.012809.103621; Yeboah J, 2012, JAMA-J AM MED ASSOC, V308, P788, DOI 10.1001/jama.2012.9624	29	16	16	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0125896	10.1371/journal.pone.0125896	http://dx.doi.org/10.1371/journal.pone.0125896			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011129	Green Published, Green Submitted, gold			2022-12-26	WOS:000355183900016
J	Wendel, SO; Menon, S; Alshetaiwi, H; Shrestha, TB; Chlebanowski, L; Hsu, WW; Bossmann, SH; Narayanan, S; Troyer, DL				Wendel, Sebastian O.; Menon, Sailesh; Alshetaiwi, Hamad; Shrestha, Tej B.; Chlebanowski, Lauren; Hsu, Wei-Wen; Bossmann, Stefan H.; Narayanan, Sanjeev; Troyer, Deryl L.			Cell Based Drug Delivery: Micrococcus luteus Loaded Neutrophils as Chlorhexidine Delivery Vehicles in a Mouse Model of Liver Abscesses in Cattle	PLOS ONE			English	Article							FUSOBACTERIUM-NECROPHORUM LEUKOTOXIN; FEEDLOT CATTLE; RESISTANCE; ANTISEPTICS; BACTERIA	The recent WHO report on antibiotic resistances shows a dramatic increase of microbial resistance against antibiotics. With only a few new antibiotics in the pipeline, a different drug delivery approach is urgently needed. We have obtained evidence demonstrating the effectiveness of a cell based drug delivery system that utilizes the innate immune system as targeting carrier for antibacterial drugs. In this study we show the efficient loading of neutrophil granulocytes with chlorhexidine and the complete killing of E. coli as well as Fusobacterium necrophorum in in-vitro studies. Fusobacterium necrophorum causes hepatic abscesses in cattle fed high grain diets. We also show in a mouse model that this delivery system targets infections of F. necrophorum in the liver and reduces the bacterial burden by an order of magnitude from approximately 2.10(6) to 1.10(5).	[Wendel, Sebastian O.] Kansas State Univ, Dept Chem Engn, Manhattan, KS 66506 USA; [Menon, Sailesh; Narayanan, Sanjeev] Kansas State Univ, Dept Diagnost Med & Pathobiol, Manhattan, KS 66506 USA; [Alshetaiwi, Hamad; Shrestha, Tej B.; Troyer, Deryl L.] Kansas State Univ, Dept Anat & Physiol, Manhattan, KS 66506 USA; [Hsu, Wei-Wen] Kansas State Univ, Dept Stat, Manhattan, KS 66506 USA; [Bossmann, Stefan H.] Kansas State Univ, Dept Chem, Manhattan, KS 66506 USA; [Alshetaiwi, Hamad] Univ Hail, Hail, Saudi Arabia; [Chlebanowski, Lauren] Augustana Coll, Dept Chem, Rock Isl, IL 61201 USA	Kansas State University; Kansas State University; Kansas State University; Kansas State University; Kansas State University; University Ha'il	Narayanan, S (corresponding author), Kansas State Univ, Dept Diagnost Med & Pathobiol, Manhattan, KS 66506 USA.	sanjeev@vet.k-state.edu	Bossmann, Stefan/AAG-9881-2020	Wendel, Sebastian/0000-0002-5515-0968	National Science Foundation Division of Material Research [1242765]; National Science Foundation Major Research Instrumentation [NSF-13-517]; Direct For Mathematical & Physical Scien [1242765] Funding Source: National Science Foundation	National Science Foundation Division of Material Research(National Science Foundation (NSF)); National Science Foundation Major Research Instrumentation(National Science Foundation (NSF)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	The work was supported by National Science Foundation Division of Material Research-1242765 (SHB, DLT) and National Science Foundation Major Research Instrumentation NSF-13-517 (SHB, DLT, SN).	Alhariri M, 2013, EXPERT OPIN DRUG DEL, V10, P1515, DOI 10.1517/17425247.2013.822860; Baldridge CW, 1933, AM J PHYSIOL, V103, P235, DOI 10.1152/ajplegacy.1932.103.1.235; Bolhuis A, 2014, BIOORG CHEM, V55, P51, DOI 10.1016/j.bioorg.2014.03.009; BRINK DR, 1990, J ANIM SCI, V68, P1201; Brooks SE, 2002, INFECT CONT HOSP EP, V23, P692, DOI 10.1086/501996; Checkley SL, 2005, CAN VET J, V46, P1002; COOKSON BD, 1991, ANTIMICROB AGENTS CH, V35, P1997, DOI 10.1128/AAC.35.10.1997; CRITCHLOW DE, 1991, COMMUN STAT THEORY, V20, P127, DOI 10.1080/03610929108830487; Dhandapani N V, 2013, INT J RES PHARM SCI, V4, P187; Dwass M., 1960, CONTRIBUTIONS PROBAB, P198; Genuit T, 2001, Surg Infect (Larchmt), V2, P5, DOI 10.1089/109629601750185316; Hurst JK, 2012, FREE RADICAL BIO MED, V53, P508, DOI 10.1016/j.freeradbiomed.2012.05.008; Jones CG, 1997, PERIODONTOL 2000, V15, P55, DOI 10.1111/j.1600-0757.1997.tb00105.x; Leikin J.B., 2008, POISONING TOXICOLOGY, DOI [10.3109/9781420044805, DOI 10.3109/9781420044805]; Li J, 2006, LANCET INFECT DIS, V6, P589, DOI 10.1016/S1473-3099(06)70580-1; MARTIN AR, 1959, J CLIN PATHOL, V12, P48, DOI 10.1136/jcp.12.1.48; Maruyama K, 2011, ADV DRUG DELIVER REV, V63, P161, DOI 10.1016/j.addr.2010.09.003; McDonnell G, 1999, CLIN MICROBIOL REV, V12, P147, DOI 10.1128/CMR.12.1.147; Nagaraja TG, 2007, VET CLIN N AM-FOOD A, V23, P351, DOI 10.1016/j.cvfa.2007.05.002; Nagaraja TG, 1998, J ANIM SCI, V76, P287; Nagaraja TG, 1999, J ANIM SCI, V77, P973; Narayanan S, 2002, INFECT IMMUN, V70, P4609, DOI 10.1128/IAI.70.8.4609-4620.2002; Narayanan SK, 2003, VET MICROBIOL, V93, P335, DOI 10.1016/S0378-1135(03)00045-2; Nuzzi Paul A, 2007, Methods Mol Biol, V370, P23; Perera AS, 2013, LANGMUIR, V29, P308, DOI 10.1021/la3037296; Pillay J, 2010, BLOOD, V116, P625, DOI 10.1182/blood-2010-01-259028; Puig-Silla M, 2008, MED ORAL PATOL ORAL, V13, pE257; REISS M, 1978, J CLIN INVEST, V61, P480, DOI 10.1172/JCI108959; ROWE R, 1977, APPL ENVIRON MICROB, V33, P675, DOI 10.1128/AEM.33.3.675-680.1977; Morones-Ramirez JR, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006276; Steel R.G.D., 1960, TECHNOMETRICS, VVol. 2, P197, DOI [DOI 10.1080/00401706.1960.10489894, 10.1080/00401706.1960.10489894]; Tadepalli S, 2008, J MED MICROBIOL, V57, P225, DOI 10.1099/jmm.0.47598-0; TAN ZL, 1994, APPL ENVIRON MICROB, V60, P1387, DOI 10.1128/AEM.60.4.1387-1389.1994; TAN ZL, 1994, J ANIM SCI, V72, P502, DOI 10.2527/1994.722502x; Timar CI, 2013, PFLUG ARCH EUR J PHY, V465, P1521, DOI 10.1007/s00424-013-1285-1; VanDonkersgoed J, 1997, CAN VET J, V38, P217; World Health Organization, 2014, ANT RES GLOB REP SUR; Young M, 2010, J BACTERIOL, V192, P841, DOI 10.1128/JB.01254-09	38	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128144	10.1371/journal.pone.0128144	http://dx.doi.org/10.1371/journal.pone.0128144			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011247	Green Published, Green Submitted, gold			2022-12-26	WOS:000355183900197
J	Gormley, AM; Forsyth, DM; Wright, EF; Lyall, J; Elliott, M; Martini, M; Kappers, B; Perry, M; McKay, M				Gormley, Andrew M.; Forsyth, David M.; Wright, Elaine F.; Lyall, John; Elliott, Mike; Martini, Mark; Kappers, Benno; Perry, Mike; McKay, Meredith			Cost-Effective Large-Scale Occupancy-Abundance Monitoring of Invasive Brushtail Possums (Trichosurus Vulpecula) on New Zealand's Public Conservation Land	PLOS ONE			English	Article							PRESENCE-ABSENCE DATA; CHAIN MONTE-CARLO; GLOBAL BIODIVERSITY; OBSERVING SYSTEM; DISTRIBUTIONS; ISLANDS; ECOLOGY; SPACE	There is interest in large-scale and unbiased monitoring of biodiversity status and trend, but there are few published examples of such monitoring being implemented. The New Zealand Department of Conservation is implementing a monitoring program that involves sampling selected biota at the vertices of an 8-km grid superimposed over the 8.6 million hectares of public conservation land that it manages. The introduced brushtail possum (Trichosurus Vulpecula) is a major threat to some biota and is one taxon that they wish to monitor and report on. A pilot study revealed that the traditional method of monitoring possums using leg-hold traps set for two nights, termed the Trap Catch Index, was a constraint on the cost and logistical feasibility of the monitoring program. A phased implementation of the monitoring program was therefore conducted to collect data for evaluating the trade-off between possum occupancy- abundance estimates and the costs of sampling for one night rather than two nights. Reducing trapping effort from two nights to one night along four trap-lines reduced the estimated costs of monitoring by 5.8% due to savings in labour, food and allowances; it had a negligible effect on estimated national possum occupancy but resulted in slightly higher and less precise estimates of relative possum abundance. Monitoring possums for one night rather than two nights would provide an annual saving of NZ$72,400, with 271 fewer field days required for sampling. Possums occupied 60% (95% credible interval; 53-68) of sampling locations on New Zealand's public conservation land, with a mean relative abundance (Trap Catch Index) of 2.7% (2.0-3.5). Possum occupancy and abundance were higher in forest than in non-forest habitats. Our case study illustrates the need to evaluate relationships between sampling design, cost, and occupancy-abundance estimates when designing and implementing large-scale occupancy-abundance monitoring programs.	[Gormley, Andrew M.] Landcare Res, Lincoln, NE USA; [Forsyth, David M.; Wright, Elaine F.; McKay, Meredith] Sci & Capabil Grp, Dept Conservat, Christchurch, New Zealand; [Lyall, John; Elliott, Mike; Martini, Mark] Dept Conservat, Hokitika, New Zealand; [Kappers, Benno] Sci & Capabil Grp, Dept Conservat, Wellington, New Zealand; [Perry, Mike] Landcare Res, Palmerston North, New Zealand	Landcare Research - New Zealand	Forsyth, DM (corresponding author), Arthur Rylah Inst Environm Res, Dept Environm Land Water & Planning, Heidelberg, Vic, Australia.	dave.forsyth@delwp.vic.gov.au		Forsyth, David/0000-0001-5356-9573; Gormley, Andrew/0000-0001-9833-7012	Department of Conservation	Department of Conservation	The work presented, including the salaries of the two authors employed by Landcare Research, was funded by the Department of Conservation (www.doc.govt.nz). The Department of Conservation and Landcare Research had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript, other than in the form of the authors being employees within those organisations. The specific roles of authors are articulated in the 'author contributions' section.	Allen RB, 2006, ECOL STU AN, V186, P435; Allen R. B., 2009, LC0809153 DEP CONS L; [Anonymous], 2005, HDB NZ MAMMALS; [Anonymous], 2010, AUSTR BIOD CONS STRA; Bellingham PJ, 2013, LC1621 DEP CONS LAND; Blackburn TM, 2004, SCIENCE, V305, P1955, DOI 10.1126/science.1101617; Brashares JS, 2005, BIODIVERS CONSERV, V14, P2709, DOI 10.1007/s10531-005-8404-z; BURBIDGE AA, 1991, NATURE CONSERVATION, P3; Caughley G., 1977, ANAL VERTEBRATE POPU; Clout Mick N., 2000, P1; Cochran WG., 1963, SAMPLING TECHNIQUES; Croll DA, 2005, SCIENCE, V307, P1959, DOI 10.1126/science.1108485; Department of Conservation, 2012, DOCDM828397; Department of Conservation, 2012, ANN REP YEAR END 30; Efford Murray, 2000, P47; Efford MG, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-00308.1; Elton C. S., 1958, ECOLOGY INVASIONS AN; Forsyth DM, 2005, J WILDLIFE MANAGE, V69, P976, DOI 10.2193/0022-541X(2005)069[0976:NASBIA]2.0.CO;2; Gardner TA, 2008, ECOL LETT, V11, P139, DOI 10.1111/j.1461-0248.2007.01133.x; Gibbs JP, 2000, METH C CONS, P213; Glen AS, 2012, NEW ZEAL J ECOL, V36, P29; Gormley AM, 2012, J APPL ECOL, V49, P1296, DOI 10.1111/j.1365-2664.2012.02219.x; Gormley AM, 2011, J APPL ECOL, V48, P25, DOI 10.1111/j.1365-2664.2010.01911.x; Hone J, 2007, WILDLIFE DAMAGE CONTROL, P1; Jones JPG, 2011, CONSERV BIOL, V25, P450, DOI 10.1111/j.1523-1739.2010.01605.x; King CM., 2005, HDB NZ MAMMALS; Landcare Research, 2012, LAN COV DAT VERS 3; Lee W, 2005, LC0405122 DEP CONS L; Levrel H, 2010, ECOL ECON, V69, P1580, DOI 10.1016/j.ecolecon.2010.03.001; Likens GE, 2011, AUSTRAL ECOL, V36, P1, DOI 10.1111/j.1442-9993.2010.02179.x; Lindenmayer DB, 2009, TRENDS ECOL EVOL, V24, P482, DOI 10.1016/j.tree.2009.03.005; Link WA, 2002, J WILDLIFE MANAGE, V66, P277, DOI 10.2307/3803160; Lunn D, 2009, STAT MED, V28, P3049, DOI 10.1002/sim.3680; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Mackenzie DI, 2005, J APPL ECOL, V42, P1105, DOI 10.1111/j.1365-2664.2005.01098.x; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; MacLeod CJ, 2012, NEW ZEAL J ECOL, V36, P300; MacLeod CJ, 2012, LC1102 DEP CONS LAND; Martin LJ, 2012, FRONT ECOL ENVIRON, V10, P195, DOI 10.1890/110154; McDonald-Madden E, 2009, SCIENCE, V323, P43, DOI 10.1126/science.1164342; Morgan David, 2000, P143; National Pest Control Agencies, 2011, A1 POSS POP MON US T; NELSON L, 1973, J MAMMAL, V54, P295, DOI 10.2307/1378903; Nugent G, 2011, VET MICROBIOL, V151, P34, DOI 10.1016/j.vetmic.2011.02.023; Parker I.M., 1999, Biological Invasions, V1, P3, DOI 10.1023/A:1010034312781; Payton IA, 2014, NZ CARBON MONITORING; Pekelharing CJ, 1998, NEW ZEAL J ECOL, V22, P197; Pereira HM, 2013, SCIENCE, V339, P277, DOI 10.1126/science.1229931; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Pereira HM, 2010, FRONT ECOL ENVIRON, V8, P458, DOI 10.1890/10.WB.23; Pereira HM, 2012, ANNU REV ENV RESOUR, V37, P25, DOI 10.1146/annurev-environ-042911-093511; Pereira HM, 2006, TRENDS ECOL EVOL, V21, P123, DOI 10.1016/j.tree.2005.10.015; Pimentel D, 2001, AGR ECOSYST ENVIRON, V84, P1, DOI 10.1016/S0167-8809(00)00178-X; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; R Development Core Team, 2013, R LANG ENV STAT COMP, DOI [10.3758/s13428-013-0330-5, DOI 10.3758/S13428-013-0330-5]; Ramsey D, 2005, WILDLIFE RES, V32, P229, DOI 10.1071/WR03119; Robinson AC, 1991, NATURE CONSERVATION, P142; Royle JA, 2007, ECOLOGY, V88, P1813, DOI 10.1890/06-0669.1; Royle JA, 2005, OIKOS, V110, P353, DOI 10.1111/j.0030-1299.2005.13534.x; Royle JA, 2003, ECOLOGY, V84, P777, DOI 10.1890/0012-9658(2003)084[0777:EAFRPA]2.0.CO;2; Sadleir Richard, 2000, P126; Sargeant GA, 2005, J WILDLIFE MANAGE, V69, P483, DOI 10.2193/0022-541X(2005)069[0483:MCMCEO]2.0.CO;2; Scholes RJ, 2008, SCIENCE, V321, P1044, DOI 10.1126/science.1162055; Scholes RJ, 2012, CURR OPIN ENV SUST, V4, P139, DOI 10.1016/j.cosust.2011.12.005; Veltman CJ, 2001, J WILDLIFE MANAGE, V65, P476, DOI 10.2307/3803100; Warburton Bruce, 2000, P132; Webster RA, 1999, OPTIMISING TRAP CATC; Wenger SJ, 2008, ECOLOGY, V89, P2953, DOI 10.1890/07-1127.1; Williams B. K., 2002, ANAL MANAGEMENT ANIM; Yoccoz NG, 2001, TRENDS ECOL EVOL, V16, P446, DOI 10.1016/S0169-5347(01)02205-4	71	4	4	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0127693	10.1371/journal.pone.0127693	http://dx.doi.org/10.1371/journal.pone.0127693			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26029890	Green Published, gold, Green Submitted			2022-12-26	WOS:000356630900072
J	Brito, H; Martins, AC; Lavrado, J; Mendes, E; Francisco, AP; Santos, SA; Ohnmacht, SA; Kim, NS; Rodrigues, CMP; Moreira, R; Neidle, S; Borralho, PM; Paulo, A				Brito, Hugo; Martins, Ana Claudia; Lavrado, Joao; Mendes, Eduarda; Francisco, Ana Paula; Santos, Sofia A.; Ohnmacht, Stephan A.; Kim, Nam-Soon; Rodrigues, Cecilia M. P.; Moreira, Rui; Neidle, Stephen; Borralho, Pedro M.; Paulo, Alexandra			Targeting KRAS Oncogene in Colon Cancer Cells with 7-Carboxylate Indolo[3,2-b]quinoline Tri-Alkylamine Derivatives	PLOS ONE			English	Article							TELOMERIC G-QUADRUPLEX; RNA G-QUADRUPLEXES; BINDING; DNA; APOPTOSIS; PROMOTER; INHIBITION; ACTIVATION; TYROSINASE; SEQUENCES	Background A guanine-rich strand within the promoter of the KRAS gene can fold into an intra-molecular G-quadruplex structure (G4), which has an important role in the regulation of KRAS transcription. We have previously identified indolo[3,2-b]quinolines with a 7-carboxylate group and three alkylamine side chains (IQ3A) as effective G4 stabilizers and promising selective anticancer leads. Herein we investigated the anticancer mechanism of action of these compounds, which we hypothesized due to stabilization of the G4 sequence in the KRAS promoter and subsequent down-regulation of gene expression. Methodology/Principal Findings IQ3A compounds showed greater stabilization of G4 compared to duplex DNA structures and reduced KRAS promoter activity in a dual luciferase reporter assay. Moreover, IQ3A compounds showed high anti-proliferative activity in HCT116 and SW620 colon cancer cells (IC50 < 2.69 mu M), without eliciting cell death in non-malignant HEK293T human embryonic kidney, and human colon fibroblasts CCD18co. IQ3A compounds significantly reduced KRAS mRNA and protein steady-state levels at IC50 concentrations, and increased p53 protein steady-state levels and cell death by apoptosis in HCT116 cells (mut KRAS, wt p53). Furthermore, KRAS silencing in HCT116 p53 wild-type (p53(+/+)) and null (p53(-/-)) isogenic cell lines induced a higher level of cell death, and a higher IQ3A-induced cell death in HCT116 p53(+/+) compared to HCT116 p53(-/-). Conclusions Herein we provide evidence that G4 ligands such as IQ3A compounds can target G4 motifs present in KRAS promoter, down-regulate the expression of the mutant KRAS gene through inhibition of transcription and translation, and induce cell death by apoptosis in colon cancer cell lines. Thus, targeting KRAS at the genomic level with G4 ligands may be a new anticancer therapy strategy for colon cancer.	[Brito, Hugo; Rodrigues, Cecilia M. P.; Borralho, Pedro M.] Univ Lisbon, Fac Pharm, Res Inst Med iMed ULisboa, Cell Funct & Therapeut Targeting Grp, P-1649003 Lisbon, Portugal; [Martins, Ana Claudia; Lavrado, Joao; Santos, Sofia A.; Moreira, Rui; Paulo, Alexandra] Univ Lisbon, Fac Pharm, Res Inst Med iMed ULisboa, Med Chem Grp, P-1649003 Lisbon, Portugal; [Mendes, Eduarda; Francisco, Ana Paula] Univ Lisbon, Fac Pharm, P-1649003 Lisbon, Portugal; [Santos, Sofia A.] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Ohnmacht, Stephan A.; Neidle, Stephen] UCL, UCL Sch Pharm, London WC1N 1AX, England; [Kim, Nam-Soon] Korea Res Inst Biosci & Biotechnol, Med Genom Res Ctr, Taejon 305333, South Korea	Universidade de Lisboa; Universidade de Lisboa; Universidade de Lisboa; Harvard University; Massachusetts General Hospital; University of London; University College London; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Borralho, PM (corresponding author), Univ Lisbon, Fac Pharm, Res Inst Med iMed ULisboa, Cell Funct & Therapeut Targeting Grp, Av Prof Gama Pinto, P-1649003 Lisbon, Portugal.	mapaulo@ff.ulisboa.pt; borralho@ff.ulisboa.pt	Moreira, Rui/G-7485-2011; iMed.ULisboa, CellFun/A-4244-2014; Mendes, Eduarda/E-1398-2015; AP, Francisco/M-4178-2013; Paulo, Alexandra/M-6683-2013; Rodrigues, Cecilia MP/M-3572-2013; Borralho, Pedro/AAJ-2829-2021; Lavrado, João MF/D-6757-2011; Paulo, Alexandra/AAE-3405-2020; Borralho, Pedro/C-2727-2011	Moreira, Rui/0000-0003-0727-9852; Mendes, Eduarda/0000-0002-7926-8821; AP, Francisco/0000-0001-6602-2075; Paulo, Alexandra/0000-0003-1433-5402; Rodrigues, Cecilia MP/0000-0002-4829-754X; Lavrado, João MF/0000-0001-7746-5808; Paulo, Alexandra/0000-0003-1433-5402; Brito, Hugo/0000-0002-4520-7203; Borralho, Pedro/0000-0003-4488-7240	Fundacao para a Ciencia e Tecnologia (FCT) Portugal [EXPL/QEQ-MED/0502/2012, HMSP-ICT/0018/2011, PEst-OE/SAU/UI4013/2014]; FCT [SFRH/BPD/72903/2010]; SAS [SFRH/BD/80162/2011]; Pancreatic Cancer Research Fund; Medical Research Council	Fundacao para a Ciencia e Tecnologia (FCT) Portugal(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); SAS; Pancreatic Cancer Research Fund; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Authors from iMed-ULisboa acknowledge Fundacao para a Ciencia e Tecnologia (FCT), Portugal, for financial support through project grants EXPL/QEQ-MED/0502/2012, HMSP-ICT/0018/2011, and PEst-OE/SAU/UI4013/2014. HB, CMPR and PMB also thank Sociedade Portuguesa de Gastroenterologia and the Korea Human Gene Bank (KHGB), Medical Genomics Research Center, KRIBB, Republic of Korea. JL acknowledges FCT for the Post-Doctoral grant SFRH/BPD/72903/2010 and SAS for PhD grant SFRH/BD/80162/2011. The Neidle laboratory acknowledges support from the Pancreatic Cancer Research Fund and the Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasubramanian S, 2011, NAT REV DRUG DISCOV, V10, P261, DOI 10.1038/nrd3428; Borralho PM, 2007, BBA-MOL BASIS DIS, V1772, P40, DOI 10.1016/j.bbadis.2006.09.005; Borralho PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023787; Borralho PM, 2009, FEBS J, V276, P6689, DOI 10.1111/j.1742-4658.2009.07383.x; Bugaut A, 2012, NUCLEIC ACIDS RES, V40, P4727, DOI 10.1093/nar/gks068; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Caprio V, 2000, BIOORG MED CHEM LETT, V10, P2063, DOI 10.1016/S0960-894X(00)00378-4; Capucha V, 2012, BIOORG MED CHEM LETT, V22, P6903, DOI 10.1016/j.bmcl.2012.09.029; Cogoi S, 2008, NUCLEIC ACIDS RES, V36, P3765, DOI 10.1093/nar/gkn120; Cogoi S, 2006, NUCLEIC ACIDS RES, V34, P2536, DOI 10.1093/nar/gkl286; Cogoi S, 2013, NUCLEIC ACIDS RES, V41, P4049, DOI 10.1093/nar/gkt127; Collie GW, 2012, J AM CHEM SOC, V134, P2723, DOI 10.1021/ja2102423; Collie GW, 2011, CHEM SOC REV, V40, P5867, DOI 10.1039/c1cs15067g; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; Dunn EF, 2011, ONCOGENE, V30, P561, DOI 10.1038/onc.2010.430; Faudale M, 2012, CHEM COMMUN, V48, P874, DOI 10.1039/c1cc15850c; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Krens LL, 2010, DRUG DISCOV TODAY, V15, P502, DOI 10.1016/j.drudis.2010.05.012; Lavrado J, 2010, CURR MED CHEM, V17, P2348, DOI 10.2174/092986710791698521; Lavrado J, 2013, CHEMMEDCHEM, V8, P1648, DOI 10.1002/cmdc.201300288; Lavrado J, 2010, BIOORG MED CHEM LETT, V20, P7042, DOI 10.1016/j.bmcl.2010.09.110; Lebedeva IV, 2007, ONCOGENE, V26, P733, DOI 10.1038/sj.onc.1209813; Luqmani YA, 2005, MED PRIN PRACT, V14, P35, DOI 10.1159/000086183; Mansoor TA, 2013, J ETHNOPHARMACOL, V149, P463, DOI 10.1016/j.jep.2013.06.051; Monteiro AS, 2013, EUR J MED CHEM, V70, P1, DOI 10.1016/j.ejmech.2013.09.040; Moore MJB, 2006, J MED CHEM, V49, P582, DOI 10.1021/jm050555a; Neidle S, 2010, FEBS J, V277, P1118, DOI 10.1111/j.1742-4658.2009.07463.x; Ohnmacht SA, 2014, BIOORG MED CHEM LETT, V24, P2602, DOI 10.1016/j.bmcl.2014.04.029; Ohnmacht SA, 2012, BIOORG MED CHEM LETT, V22, P5930, DOI 10.1016/j.bmcl.2012.07.065; Ou TM, 2007, J MED CHEM, V50, P1465, DOI 10.1021/jm0610088; Paramasivam M, 2011, CHEM COMMUN, V47, P4965, DOI 10.1039/c1cc10269a; Perry MJ, 2009, EUR J MED CHEM, V44, P3228, DOI 10.1016/j.ejmech.2009.03.025; Silva TFS, 2012, DALTON T, V41, P12888, DOI 10.1039/c2dt11577h; Tsujii M, 2012, DIGESTION, V85, P99, DOI 10.1159/000334678; Wang JS, 2014, NUCLEIC ACIDS RES, V42, P3792, DOI 10.1093/nar/gkt1354; Zilfou JT, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001883	36	38	39	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0126891	10.1371/journal.pone.0126891	http://dx.doi.org/10.1371/journal.pone.0126891			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024321	Green Published, Green Submitted, gold			2022-12-26	WOS:000355319400025
J	Sohn, DH; Sohn, HJ; Lee, HJ; Lee, SD; Kim, S; Hyun, SJ; Cho, HI; Cho, SG; Lee, SK; Kim, TG				Sohn, Dae-Hee; Sohn, Hyun-Jung; Lee, Hyun-Joo; Lee, Seon-Duk; Kim, Sueon; Hyun, Seung-Joo; Cho, Hyun-Il; Cho, Seok-Goo; Lee, Suk-Kyeong; Kim, Tai-Gyu			Measurement of CD8(+) and CD4(+) T Cell Frequencies Specific for EBV LMP1 and LMP2a Using mRNA-Transfected DCs	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; MHC CLASS-II; IMMUNE-RESPONSE; ANTIGEN; LYMPHOCYTES; IMMUNODOMINANCE; CD40; RECOGNITION; ASSOCIATION; MONOCYTES	An EBV-specific cellular immune response is associated with the control of EBV-associated malignancies and lymphoproliferative diseases, some of which have been successfully treated by adoptive T cell therapy. Therefore, many methods have been used to measure EBV-specific cellular immune responses. Previous studies have mainly used autologous EBV-transformed B-lymphoblastoid cell lines (B-LCLs), recombinant viral vectors transfected or peptide pulsed dendritic cells (DCs) as stimulators of CD8(+) and CD4(+) T lymphocytes. In the present study, we used an interferon-gamma (IFN-gamma) enzyme-linked immunospot (ELISPOT) assay by using isolated CD8(+) and CD4(+) T cells stimulated with mRNA-transfected DCs. The frequency of latent membrane protein 1 (LMP1)-specific IFN-gamma producing CD4(+) T cells was significantly higher than that of LMP2a. The frequency of IFN-gamma producing CD4(+) T cells was significantly correlated with that of CD8(+) T cells in LMP1-specific immune responses (r = 0.7187, Pc < 0.0001). To determine whether there were changes in LMP1- or LMP2a-specific immune responses, subsequent peripheral blood mononuclear cells (PBMCs) samples were analyzed. Significant changes were observed in 5 of the 10 donors examined, and CD4(+) T cell responses showed more significant changes than CD8(+) T cell responses. CD8(+) and CD4(+) T cells from EBV-seropositive donors secreted only the Th1 cytokines IFN-gamma, TNF-alpha, and IL-2, while Th2 (IL-4) and Th17 (IL-17a) cytokines were not detected. CD4(+) T cells secreted significantly higher cytokine levels than did CD8(+) T cells. Analysis of EBV-specific T cell responses using autologous DCs transfected with mRNA might provide a comprehensive tool for monitoring EBV infection and new insights into the pathogenesis of EBV-associated diseases.	[Sohn, Dae-Hee; Hyun, Seung-Joo; Kim, Tai-Gyu] Catholic Univ Korea, Coll Med, Dept Microbiol, Seoul, South Korea; [Sohn, Hyun-Jung; Lee, Hyun-Joo; Lee, Seon-Duk; Kim, Sueon; Cho, Hyun-Il; Kim, Tai-Gyu] Catholic Univ Korea, Coll Med, Hematopoiet Stem Cell Bank, Seoul, South Korea; [Cho, Hyun-Il; Kim, Tai-Gyu] Catholic Univ Korea, Coll Med, Canc Res Inst, Seoul, South Korea; [Cho, Seok-Goo] Catholic Univ Korea, Coll Med, Dept Internal Med, Dept Hematol, Seoul, South Korea; [Lee, Suk-Kyeong] Catholic Univ Korea, Coll Med, Dept Med Lifesci, Res Inst Immunobiol, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Catholic University of Korea	Kim, TG (corresponding author), Catholic Univ Korea, Coll Med, Dept Microbiol, Seoul, South Korea.	kimtg@catholic.ac.kr	Lee, Suk Kyeong/ABD-6402-2020	Cho, Seok-Goo/0000-0002-5429-4839; KIM, SUEON/0000-0003-2591-5357; Lee, Suk Kyeong/0000-0002-3751-7682	Ministry of Health & Welfare, Republic of Korea [HI12C0718]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2013R1A1A2065937]; Korean Health Technology RD Project	Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education(National Research Foundation of Korea); Korean Health Technology RD Project	This study was supported by a grant from the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI12C0718) and Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2013R1A1A2065937). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikary D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000583; Ariza ME, 2009, J IMMUNOL, V182, P851, DOI 10.4049/jimmunol.182.2.851; Bickham K, 2001, J CLIN INVEST, V107, P121, DOI 10.1172/JCI10209; Calarota SA, 2013, IMMUNOLOGY, V139, P533, DOI 10.1111/imm.12106; Callan MFC, 1998, J EXP MED, V187, P1395, DOI 10.1084/jem.187.9.1395; Cella M, 1996, J EXP MED, V184, P747, DOI 10.1084/jem.184.2.747; Chen MR, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00005; Cohen JI, 2000, NEW ENGL J MED, V343, P481, DOI 10.1056/NEJM200008173430707; Depil S, 2007, J IMMUNOTHER, V30, P215, DOI 10.1097/01.cji.0000211338.99137.4f; Fiola S, 2010, J IMMUNOL, V185, P3620, DOI 10.4049/jimmunol.0903736; Gahn B, 2001, INT J CANCER, V93, P706, DOI 10.1002/ijc.1396; Gaudreault E, 2007, J VIROL, V81, P8016, DOI 10.1128/JVI.00403-07; Gordillo GM, 1999, TRANSPL IMMUNOL, V7, P83, DOI 10.1016/S0966-3274(99)80024-0; Gottschalk S, 2003, BLOOD, V101, P1905, DOI 10.1182/blood-2002-05-1514; Gurer C, 2008, BLOOD, V112, P1231, DOI 10.1182/blood-2008-03-148072; Hislop AD, 2002, J EXP MED, V195, P893, DOI 10.1084/jem.20011692; Hislop AD, 2007, ANNU REV IMMUNOL, V25, P587, DOI 10.1146/annurev.immunol.25.022106.141553; Iwakiri D, 2009, J EXP MED, V206, P2091, DOI 10.1084/jem.20081761; James JA, 2006, CURR OPIN RHEUMATOL, V18, P462, DOI 10.1097/01.bor.0000240355.37927.94; Kalady MF, 2002, J SURG RES, V105, P17, DOI 10.1006/jsre.2002.6435; Kalams SA, 1999, J VIROL, V73, P6715, DOI 10.1128/JVI.73.8.6715-6720.1999; Kieff E, EPSTEIN BARR VIRUS A; Kobayashi H, 2008, CANCER RES, V68, P901, DOI 10.1158/0008-5472.CAN-07-3212; Koch F, 1996, J EXP MED, V184, P741, DOI 10.1084/jem.184.2.741; Kuball J, 2002, GENE THER, V9, P833, DOI 10.1038/sj.gt.3301709; Kuzushima K, 1999, BLOOD, V94, P3094, DOI 10.1182/blood.V94.9.3094.421k14_3094_3100; Leen A, 2001, J VIROL, V75, P8649, DOI 10.1128/JVI.75.18.8649-8659.2001; Leung C, 2013, EUR J IMMUNOL, V43, P2246, DOI 10.1002/eji.201343815; Lin XR, 2008, CANCER IMMUNOL IMMUN, V57, P963, DOI 10.1007/s00262-007-0427-8; Lunemann JD, 2008, J IMMUNOL, V181, P991, DOI 10.4049/jimmunol.181.2.991; McAulay KA, 2009, J IMMUNOL, V182, P3892, DOI 10.4049/jimmunol.0803572; Meij P, 2002, INT J CANCER, V99, P93, DOI 10.1002/ijc.10309; MEIXLSPERGER S, 2013, BLOOD, V121, P5034, DOI DOI 10.1182/BL00D-2012-12-473413; Morales O, 2012, J IMMUNOTHER, V35, P254, DOI 10.1097/CJI.0b013e31824d72c5; Munz C, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00308; Munz C, 2000, J EXP MED, V191, P1649, DOI 10.1084/jem.191.10.1649; Ning RJ, 2011, IMMUNOLOGY, V134, P161, DOI 10.1111/j.1365-2567.2011.03476.x; Pagano JS, 2004, SEMIN CANCER BIOL, V14, P453, DOI 10.1016/j.semcancer.2004.06.009; Raab-Traub N, 2002, SEMIN CANCER BIOL, V12, P431, DOI 10.1016/S1044579X0200086X; Reizis B, 2011, ANNU REV IMMUNOL, V29, P163, DOI 10.1146/annurev-immunol-031210-101345; Rickinson AB, 1997, ANNU REV IMMUNOL, V15, P405, DOI 10.1146/annurev.immunol.15.1.405; Salvetti M, 2009, CURR OPIN NEUROL, V22, P201, DOI 10.1097/WCO.0b013e32832b4c8d; Severa M, 2013, EUR J IMMUNOL, V43, P147, DOI 10.1002/eji.201242552; Steigerwald-Mullen P, 2000, J VIROL, V74, P6748, DOI 10.1128/JVI.74.15.6748-6759.2000; Strobel I, 2000, GENE THER, V7, P2028, DOI 10.1038/sj.gt.3301326; Strowig T, 2009, J EXP MED, V206, P1423, DOI 10.1084/jem.20081720; Sun Q, 2002, BLOOD, V99, P3302, DOI 10.1182/blood.V99.9.3302; Toussirot E, 2008, BEST PRACT RES CL RH, V22, P883, DOI 10.1016/j.berh.2008.09.007; Van Tendeloo VFI, 2001, BLOOD, V98, P49, DOI 10.1182/blood.V98.1.49; Vogl BA, 2012, J MED VIROL, V84, P119, DOI 10.1002/jmv.22258; Williams H, 2005, BRIT J HAEMATOL, V129, P266, DOI 10.1111/j.1365-2141.2005.05452.x; Woodberry T, 2005, J INFECT DIS, V192, P1513, DOI 10.1086/491741; Yang J, 2000, BLOOD, V95, P241, DOI 10.1182/blood.V95.1.241.001a19_241_248; Younesi V, 2014, CYTOTECHNOLOGY, V66, P95, DOI 10.1007/s10616-013-9542-x; Zhai YF, 1996, J IMMUNOL, V156, P700	55	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0127899	10.1371/journal.pone.0127899	http://dx.doi.org/10.1371/journal.pone.0127899			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26023769	Green Published, Green Submitted, gold			2022-12-26	WOS:000355319400058
J	Balazik, MT; Musick, JA				Balazik, Matthew T.; Musick, John A.			Dual Annual Spawning Races in Atlantic Sturgeon	PLOS ONE			English	Article							ACIPENSER-OXYRINCHUS; SUWANNEE RIVER; SOUTH-CAROLINA; GULF STURGEON; NORTH-AMERICA; LIFE-HISTORY; JAMES RIVER; MANAGEMENT; VIRGINIA; ESTUARY	Atlantic sturgeon (Acipenser oxyrinchus oxyrinchus, Acipenseridae) populations in the United States were listed as either endangered or threatened under the Endangered Species Act in 2012. Because of the endangered/threatened status, a better understanding of Atlantic sturgeon life-history behavior and habitat use is important for effective management. It has been widely documented that Atlantic sturgeon reproduction occurs from late winter to early summer, varying clinally with latitude. However, recent data show Atlantic sturgeon also spawn later in the year. The group that spawns later in the year seems to be completely separate from the spring spawning run. Recognition of the later spawning season has drastically modified estimates of the population status of Atlantic sturgeon in Virginia. With the combination of new telemetry data and historical documentation we describe a dual spawning strategy that likely occurs in various degrees along most, if not all, of the Atlantic sturgeon's range. Using new data combined with historical sources, a new spawning strategy emerges which managers and researchers should note when determining the status of Atlantic sturgeon populations and implementing conservation measures.	[Balazik, Matthew T.] Virginia Commonwealth Univ, Ctr Environm Studies, Richmond, VA 23284 USA; [Musick, John A.] Virginia Inst Marine Sci, Coll William & Mary, Gloucester Point, VA 23062 USA	Virginia Commonwealth University; William & Mary; Virginia Institute of Marine Science	Balazik, MT (corresponding author), Virginia Commonwealth Univ, Ctr Environm Studies, 1000 West Cary St, Richmond, VA 23284 USA.	balazikmt@vcu.edu			Professional Association of Diving Instructors Foundation [7381]; NOAA Section 6 grant [NA13NMF4720037]; National Marine Fisheries Service	Professional Association of Diving Instructors Foundation; NOAA Section 6 grant; National Marine Fisheries Service	This work was supported by grant #7381, Professional Association of Diving Instructors Foundation (http://www.padifoundation.org/) to MTB, and NOAA Section 6 grant #NA13NMF4720037, National Marine Fisheries Service (http://www.nmfs.noaa.gov/sfa/state_federal/State-Federal-WEB/afca.htm) to GCG.	[Anonymous], 1878, F LESLIES ILLUSTRATE, V1878, P370, DOI [10.1074/jbc.M110.192013, DOI 10.1074/JBC.M110.192013]; ASSRT (Atlantic Sturgeon Status Review Team), 2007, STAT REV ATL STURG A; Balazik MT, 2015, N AM J FISH MANAGE, V35, P398, DOI 10.1080/02755947.2015.1011358; Balazik MT, 2013, T AM FISH SOC, V142, P1640, DOI 10.1080/00028487.2013.824924; Balazik MT, 2012, T AM FISH SOC, V141, P1465, DOI 10.1080/00028487.2012.703157; Balazik MT, 2012, T AM FISH SOC, V141, P1074, DOI 10.1080/00028487.2012.676590; Barbour P. L., 1986, COMPLETE WORKS CAPTA; Berg, 1962, FRESHWATER FISHES US; BERG LS, 1959, J FISH RES BOARD CAN, V16, P515, DOI 10.1139/f59-041; BIRSTEIN VJ, 1993, CONSERV BIOL, V7, P773, DOI 10.1046/j.1523-1739.1993.740773.x; Borodin N., 1925, T AM FISH SOC, V55, P184, DOI [10.1577/1548-8659(1925)55[184:BOOTAS]2.0.CO;2, DOI 10.1577/1548-8659(1925)55[184:BOOTAS]2.0.CO;2, DOI 10.1577/1548-8659(1925)55[]; Breece MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081321; Cobb J.N., 1900, REPORT COMMISSIONER, V25, P369; Coleman C. W., 1892, COSMOPOLITAN, P366; Collins MR, 2000, T AM FISH SOC, V129, P982, DOI 10.1577/1548-8659(2000)129&lt;0982:HUABCO&gt;2.3.CO;2; Dadswell MJ, 2006, FISHERIES, V31, P218, DOI 10.1577/1548-8446(2006)31[218:AROTSO]2.0.CO;2; DOVEL WL, 1983, NEW YORK FISH GAME J, V30, P140; Evermann B. W., 1903, STAT FISHERIES MI 28, P430; Fernandez-Pasquier V., 2000, Boletin Instituto Espanol de Oceanografia, V16, P109; Forsythe PS, 2012, CAN J FISH AQUAT SCI, V69, P60, DOI 10.1139/F2011-132; Goode GB, 1887, HIST METHODS FISHERI; Goode GB, 1887, GEOGRAPHICAL REV FIS; Hatin D, 2002, J APPL ICHTHYOL, V18, P586, DOI 10.1046/j.1439-0426.2002.00395.x; Hildebrand S. F., 1927, US BUREAU FISHERIES, V43; HOLCIK J, 1989, FRESHWATER FISHES EU, V1; Jerome Jr WC, 1965, MASSACHUSETTS DIVISI, V1; King TL, 2001, CONSERV GENET, V2, P103, DOI 10.1023/A:1011895429669; Leland III JG, 1968, SURVEY STURGEON FISH; Lossing Benson J., 1866, HUDSON WILDERNESS SE; McCord JW, 2007, AM FISH S S, V56, P397; Meehan W. E., 1909, T AM FISH SOC, V39, P85; Meehan W. E., 1893, FISH FISHING FISHERI; Murawski SA, 1997, NATL MARINE FISHERIE, V10, P1; NOAA (National Oceanic and Atmospheric Administration), 2012, US FED REG, V77, P5880; Randall MT, 2012, J APPL ICHTHYOL, V28, P489, DOI 10.1111/j.1439-0426.2012.01960.x; Rogers HM., 1936, THESIS U TORONTO; RYDER JA, 1888, B US FISH COMM, V8, P231; Scott W. B., 1973, FRESHWATER FISHES CA; Secor DH, 2002, AM FISH S S, V28, P89; Seeley HG., 1886, FRESH WATER FISHES E; Smith JA, 2015, T AM FISH SOC, V144, P48, DOI 10.1080/00028487.2014.965344; Smith T.I.J., 1984, North American Journal of Fisheries Management, V4, P164, DOI 10.1577/1548-8659(1984)4<164:TASFIS>2.0.CO;2; SMITH TIJ, 1985, ENVIRON BIOL FISH, V14, P61, DOI 10.1007/BF00001577; Smith TIJ, 1997, ENVIRON BIOL FISH, V48, P335, DOI 10.1023/A:1007307507468; Sulak KJ, 1998, T AM FISH SOC, V127, P758, DOI 10.1577/1548-8659(1998)127<0758:ELHSOG>2.0.CO;2; Townsend CH, 1901, STAT FISHERIES MI 26, P311; USA Federal Register, 2012, US FED REG, V77, P5914; VanEenennaam JP, 1996, ESTUARIES, V19, P769, DOI 10.2307/1352296; Wharton J., 1957, BOUNTY CHESAPEAKE; Wipplehauser GS., 2013, REGIONAL CONSERVATIO; Yang G. R., 1986, ICHTHYOGRAPHY HUBEI; Zen Q.Z., 1990, FISHERIES RESOURCES; Zhuang P, 1997, ENVIRON BIOL FISH, V48, P257, DOI 10.1023/A:1007399729080	53	21	21	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128234	10.1371/journal.pone.0128234	http://dx.doi.org/10.1371/journal.pone.0128234			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020631	Green Published, Green Submitted, gold			2022-12-26	WOS:000355187300090
J	Watzlawik, JO; Kahoud, RJ; O'Toole, RJ; White, KAM; Ogden, AR; Painter, MM; Wootla, B; Papke, LM; Denic, A; Weimer, JM; Carey, WA; Rodriguez, M				Watzlawik, Jens O.; Kahoud, Robert J.; O'Toole, Ryan J.; White, Katherine A. M.; Ogden, Alyssa R.; Painter, Meghan M.; Wootla, Bharath; Papke, Louisa M.; Denic, Aleksandar; Weimer, Jill M.; Carey, William A.; Rodriguez, Moses			Abbreviated Exposure to Hypoxia Is Sufficient to Induce CNS Dysmyelination, Modulate Spinal Motor Neuron Composition, and Impair Motor Development in Neonatal Mice	PLOS ONE			English	Article							WHITE-MATTER INJURY; OLIGODENDROCYTE LINEAGE PROGRESSION; CEREBRAL-BLOOD-FLOW; PERIVENTRICULAR LEUKOMALACIA; ANIMAL-MODELS; BRAIN; MATURATION; MOUSE; UNDERNUTRITION; REGENERATION	Neonatal white matter injury (nWMI) is an increasingly common cause of cerebral palsy that results predominantly from hypoxic injury to progenitor cells including those of the oligodendrocyte lineage. Existing mouse models of nWMI utilize prolonged periods of hypoxia during the neonatal period, require complex cross-fostering and exhibit poor growth and high mortality rates. Abnormal CNS myelin composition serves as the major explanation for persistent neuro-motor deficits. Here we developed a simplified model of nWMI with low mortality rates and improved growth without cross-fostering. Neonatal mice are exposed to low oxygen from postnatal day (P) 3 to P7, which roughly corresponds to the period of human brain development between gestational weeks 32 and 36. CNS hypomyelination is detectable for 2-3 weeks post injury and strongly correlates with levels of body and brain weight loss. Immediately following hypoxia treatment, cell death was evident in multiple brain regions, most notably in superficial and deep cortical layers as well as the subventricular zone progenitor compartment. PDGF alpha R, Nkx2.2, and Olig2 positive oligodendrocyte progenitor cell were significantly reduced until postnatal day 27. In addition to CNS dysmyelination we identified a novel pathological marker for adult hypoxic animals that strongly correlates with life-long neuro-motor deficits. Mice reared under hypoxia reveal an abnormal spinal neuron composition with increased small and medium diameter axons and decreased large diameter axons in thoracic lateral and anterior funiculi. Differences were particularly pronounced in white matter motor tracts left and right of the anterior median fissure. Our findings suggest that 4 days of exposure to hypoxia are sufficient to induce experimental nWMI in CD1 mice, thus providing a model to test new therapeutics. Pathological hallmarks of this model include early cell death, decreased OPCs and hypomyelination in early postnatal life, followed by dysmyelination, abnormal spinal neuron composition, and neuro-motor deficits in adulthood.	[Watzlawik, Jens O.; Kahoud, Robert J.; Painter, Meghan M.; Wootla, Bharath; Papke, Louisa M.; Denic, Aleksandar; Rodriguez, Moses] Mayo Clin, Coll Med, Dept Neurol, Rochester, MN 55905 USA; [Kahoud, Robert J.; Carey, William A.] Mayo Clin, Coll Med, Dept Pediat & Adolescent Med, Rochester, MN USA; [O'Toole, Ryan J.; White, Katherine A. M.; Ogden, Alyssa R.; Weimer, Jill M.] Childrens Hlth Res Ctr, Sanford Res, Sioux Falls, SD USA	Mayo Clinic; Mayo Clinic; Sanford Health	Rodriguez, M (corresponding author), Mayo Clin, Coll Med, Dept Neurol, Rochester, MN 55905 USA.	rodriguez.moses@mayo.edu	; WOOTLA, Bharath/E-5882-2015	Rodriguez, Moses/0000-0001-6328-6497; Watzlawik, Jens/0000-0003-0610-0267; Denic, Aleksandar/0000-0001-9157-5405; WOOTLA, Bharath/0000-0001-7522-1121	National Institutes of Health [R01 GM092993, R01 NS048357, 5R01NS082283-02, R21 NS073684]; National Institutes of Health COBRE grants at Sanford Research [P20 GM103620, P20 GM103548]; National Multiple Sclerosis Society [CA 1060A]; T. Denny Sanford Pediatric Collaborative Research Fund; High-Impact Pilot and Feasibility Award (HIPFA); Novel Methodology Award (NMDA) from the Mayo Clinic Center for Translational Science Activities (CTSA); Mayo Clinic CTSA grant from the National Center for Advancing Translational Sciences (NCATS) [UL1 TR000135]; Applebaum Foundation; Hilton Foundation; Peterson Foundation; Moon and Marilyn Park Directorship Fund; McNeilus family	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health COBRE grants at Sanford Research; National Multiple Sclerosis Society(National Multiple Sclerosis Society); T. Denny Sanford Pediatric Collaborative Research Fund; High-Impact Pilot and Feasibility Award (HIPFA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novel Methodology Award (NMDA) from the Mayo Clinic Center for Translational Science Activities (CTSA); Mayo Clinic CTSA grant from the National Center for Advancing Translational Sciences (NCATS); Applebaum Foundation; Hilton Foundation; Peterson Foundation; Moon and Marilyn Park Directorship Fund; McNeilus family	This work was supported by grants from the National Institutes of Health (R01 GM092993 (MR), R01 NS048357 (MR), 5R01NS082283-02 (JMW) and R21 NS073684 (MR)), the National Institutes of Health COBRE grants at Sanford Research (P20 GM103620 and P20 GM103548) (JMW), the National Multiple Sclerosis Society (CA 1060A) (MR), the T. Denny Sanford Pediatric Collaborative Research Fund (JMW, WAC), a High-Impact Pilot and Feasibility Award (HIPFA) (MR) and Novel Methodology Award (NMDA) (MR) from the Mayo Clinic Center for Translational Science Activities (CTSA) and Mayo Clinic CTSA grant (UL1 TR000135 from the National Center for Advancing Translational Sciences (NCATS)) (MR). The authors also acknowledge with thanks support from the Applebaum (MR), Hilton (MR), and Peterson (MR) Foundations, the Moon and Marilyn Park Directorship Fund (JOW) and the McNeilus family (MR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Back SA, 2006, ANN NEUROL, V60, P696, DOI 10.1002/ana.21008; Billiards SS, 2008, BRAIN PATHOL, V18, P153, DOI 10.1111/j.1750-3639.2007.00107.x; Buitrago MM, 2004, NEUROBIOL LEARN MEM, V81, P211, DOI 10.1016/j.nlm.2004.01.001; Buser JR, 2012, ANN NEUROL, V71, P93, DOI 10.1002/ana.22627; Chahboune H, 2009, CEREB CORTEX, V19, P2891, DOI 10.1093/cercor/bhp068; Chen Yiju, 2012, PLoS One, V7, pe34762, DOI 10.1371/journal.pone.0034762; Craig A, 2003, EXP NEUROL, V181, P231, DOI 10.1016/S0014-4886(03)00032-3; Dean JM, 2011, DEV NEUROSCI-BASEL, V33, P251, DOI 10.1159/000327242; Denic A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026001; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; Douglas RM, 2007, AM J PHYSIOL-REG I, V292, pR1254, DOI 10.1152/ajpregu.00404.2006; Fagel DM, 2006, EXP NEUROL, V199, P77, DOI 10.1016/j.expneurol.2005.04.006; Fagel DM, 2009, J NEUROSCI, V29, P1202, DOI 10.1523/JNEUROSCI.4516-08.2009; Ferriero DM, 2004, NEW ENGL J MED, V351, P1985, DOI 10.1056/NEJMra041996; Ganat Y, 2002, NEUROSCIENCE, V112, P977, DOI 10.1016/S0306-4522(02)00060-X; Hack M, 2005, JAMA-J AM MED ASSOC, V294, P318, DOI 10.1001/jama.294.3.318; Hagberg H, 2002, DEV NEUROSCI-BASEL, V24, P364, DOI 10.1159/000069040; Howe CL, 2007, NEUROBIOL DIS, V25, P354, DOI 10.1016/j.nbd.2006.10.001; Jablonska B, 2012, J NEUROSCI, V32, P14775, DOI 10.1523/JNEUROSCI.2060-12.2012; JONES BJ, 1968, J PHARM PHARMACOL, V20, P302, DOI 10.1111/j.2042-7158.1968.tb09743.x; JONES BJ, 1968, N-S ARCH PHARMAKOL, V259, P211, DOI 10.1007/BF00537801; Kahoud RJ, 2014, DEV DYNAM, V243, P440, DOI 10.1002/dvdy.24090; Kanaan A, 2006, AM J PHYSIOL-REG I, V290, pR1105, DOI 10.1152/ajpregu.00535.2005; Kovner Israel, 2010, Int J Body Compos Res, V8, P17; LAI M, 1980, J COMP NEUROL, V193, P973, DOI 10.1002/cne.901930410; LAI M, 1980, J COMP NEUROL, V193, P965, DOI 10.1002/cne.901930409; Lalonde R, 2003, PHYSIOL BEHAV, V80, P333, DOI 10.1016/j.physbeh.2003.08.006; Lan WCJ, 2011, PEDIATR RES, V70, P15, DOI 10.1203/PDR.0b013e31821b98a3; Li Q, 2009, AM J PATHOL, V175, P2133, DOI 10.2353/ajpath.2009.090354; Lodygensky GA, 2010, J ANAT, V217, P418, DOI 10.1111/j.1469-7580.2010.01280.x; Martini F., 2010, ANATOMY PHYSL; Maurissen JPJ, 2003, NEUROTOXICOL TERATOL, V25, P543, DOI 10.1016/S0892-0362(03)00073-4; Ment LR, 1998, DEV BRAIN RES, V111, P197, DOI 10.1016/S0165-3806(98)00139-4; Meyer O A, 1979, Neurobehav Toxicol, V1, P233; Radom-Aizik S, 2013, PEDIATR RES, V74, P111, DOI 10.1038/pr.2013.80; Rezaie P, 2002, NEUROPATHOLOGY, V22, P106, DOI 10.1046/j.1440-1789.2002.00438.x; Riddle A, 2006, J NEUROSCI, V26, P3045, DOI 10.1523/JNEUROSCI.5200-05.2006; ROBAIN O, 1978, BRAIN RES, V149, P379, DOI 10.1016/0006-8993(78)90482-1; ROMIJN HJ, 1991, EARLY HUM DEV, V26, P61, DOI 10.1016/0378-3782(91)90044-4; Scafidi J, 2014, NATURE, V506, P230, DOI 10.1038/nature12880; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Shinzawa K, 2008, J NEUROSCI, V28, P2212, DOI 10.1523/JNEUROSCI.4354-07.2008; Silbereis JC, 2010, DIS MODEL MECH, V3, P678, DOI 10.1242/dmm.002915; Turner CP, 2003, P NATL ACAD SCI USA, V100, P11718, DOI 10.1073/pnas.1931975100; Verney C, 2012, J NEUROPATH EXP NEUR, V71, P251, DOI 10.1097/NEN.0b013e3182496429; Vetrone SA, 2009, J CLIN INVEST, V119, P1583, DOI 10.1172/JCI37662; Volpe J.J., 2008, NEUROLOGY NEWBORN; Volpe JJ, 2001, PEDIATR RES, V50, P553, DOI 10.1203/00006450-200111000-00003; Voron S, 2011, VESTIBULAR SYSTEM; Watson C, 2012, ANAT REC, V295, P1692, DOI 10.1002/ar.22549; Watzlawik JO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055149; Weimer JM, 2009, DEVELOPMENT, V136, P2965, DOI 10.1242/dev.036616; Weiss J, 2004, EXP NEUROL, V189, P141, DOI 10.1016/j.expneurol.2004.05.018; Welin AK, 2005, PEDIATR RES, V58, P100, DOI 10.1203/01.PDR.0000163388.04017.26; WIGGINS RC, 1978, J NEUROCHEM, V30, P1231, DOI 10.1111/j.1471-4159.1978.tb10450.x; Woodward LJ, 2006, NEW ENGL J MED, V355, P685, DOI 10.1056/NEJMoa053792; Zhou D, 2008, PHYSIOL GENOMICS, V32, P370, DOI 10.1152/physiolgenomics.00147.2007	58	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128007	10.1371/journal.pone.0128007	http://dx.doi.org/10.1371/journal.pone.0128007			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020269	Green Published, gold, Green Submitted			2022-12-26	WOS:000355187300070
J	Yang, YF; Li, WQ; Zhang, HX; Yang, G; Wang, XJ; Ding, ML; Jiang, TZ; Lv, LX				Yang, Yongfeng; Li, Wenqiang; Zhang, Hongxing; Yang, Ge; Wang, Xiujuan; Ding, Minli; Jiang, Tianzi; Lv, Luxian			Association Study of N-Methyl-D-Aspartate Receptor Subunit 2B (GRIN2B) Polymorphisms and Schizophrenia Symptoms in the Han Chinese Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GENE GRIN2B; BIPOLAR DISORDER; GLUTAMATE; IDENTIFICATION; SUSCEPTIBILITY; PERFORMANCE; MECHANISMS; MUTATIONS; VARIANTS	Schizophrenia (SZ) is a common and complex psychiatric disorder that has a significant genetic component. The glutamatergic system is the major excitatory neurotransmitter system in the central nervous system, and is mediated by N-methyl-D-aspartate (NMDA) receptors. Disturbances in this system have been hypothesized to play a major role in SZ pathogenesis. Several studies have revealed that the NMDA receptor subunit 2B (GRIN2B) potentially associates with SZ and its psychiatric symptoms. In this study, we performed a case-control study to identify polymorphisms of the GRIN2B gene thatmay confer susceptibility to SZ in the Han Chinese population. Thirty-four single nucleotide polymorphisms (SNPs) were genotyped in 528 paranoid SZ patients and 528 control subjects. A significant association was observed in allele and genotype between SZ and controls at rs2098469 (chi(2) = 8.425 and 4.994; p = 0.025 and 0.014, respectively). Significant associations were found in the allele at rs12319804 (chi(2) = 4.436; p = 0.035), as well as in the genotype at rs12820037 and rs7298664 between SZ and controls (chi(2) = 11.162 and 38.204; p = 0.003 and 4.27x10(-8), respectively). After applying the Bonferroni correction, rs7298664 still had significant genotype associations with SZ (p = 1.71x10(-7)). In addition, rs2098469 genotype and allele frequencies, and 12820037 allele frequencies were nominally associated with SZ. Three haplotypes, CGA (rs10845849-rs12319804-rs10845851), CC (rs12582848-rs7952915), and AAGAC (rs2041986-rs11055665rs7314376- rs7297101-rs2098469), had significant differences between SZ and controls (chi(2) = 4.324, 4.582, and 4.492; p = 0.037, 0.032, and 0.034, respectively). In addition, three SNPs, rs2098469, rs12820037, and rs7298664, were significantly associated with cognition factors PANSS subscores in SZ (F = 16.799, 7.112, and 13.357; p = 0.000, 0.017, and 0.000, respectively). In conclusion, our study provides novel evidence for an association between GRIN2B polymorphisms and SZ susceptibility and symptoms in the Han Chinese population.	[Yang, Yongfeng; Jiang, Tianzi] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Key Lab NeuroInformat, Minist Educ, Chengdu 610054, Peoples R China; [Yang, Yongfeng; Li, Wenqiang; Zhang, Hongxing; Yang, Ge; Wang, Xiujuan; Ding, Minli; Lv, Luxian] Xinxiang Med Univ, Affiliated Hosp 2, Henan Mental Hosp, Dept Psychiat, Xinxiang, Peoples R China; [Yang, Yongfeng; Li, Wenqiang; Zhang, Hongxing; Wang, Xiujuan; Ding, Minli; Lv, Luxian] Xinxiang Med Univ, Henan Key Lab Biol Psychiat, Xinxiang, Peoples R China	University of Electronic Science & Technology of China; Xinxiang Medical University; Xinxiang Medical University	Jiang, TZ (corresponding author), Univ Elect Sci & Technol China, Sch Life Sci & Technol, Key Lab NeuroInformat, Minist Educ, Chengdu 610054, Peoples R China.	jiangtz@nlpr.ia.ac.cn; lvx928@126.com	Jiang, Tianzi/I-4256-2012	Jiang, Tianzi/0000-0001-9531-291X	National Natural Science Foundation of China [U1404811, 81371472, 81201040, 81101000]; Program for New Century Excellent Talentsin University [NCET-10-0137]; Natural Science Foundation of Henan [112300413226, 122300413212]; Plan for Scientific Innovation Talent of Henan Province [124200510019]; Scientific Research Fund of Xinxiang Medical University [ZD2011-20, ZD200991, 2013QN102]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talentsin University(Program for New Century Excellent Talents in University (NCET)); Natural Science Foundation of Henan; Plan for Scientific Innovation Talent of Henan Province; Scientific Research Fund of Xinxiang Medical University	Funding for this study was provided by the National Natural Science Foundation of China (to Y-F Y, U1404811; to L-X L, 81371472; to W-Q L, 81201040; 81101000), the Program for New Century Excellent Talentsin University (to H-X Z, NCET-10-0137), the Natural Science Foundation of Henan (to L-X L, 112300413226; to W-Q L, 122300413212), the Plan for Scientific Innovation Talent of Henan Province (to L-X L, 124200510019), and the Scientific Research Fund of Xinxiang Medical University (to W-Q L, ZD2011-20; to L-X L, ZD200991; to Y-F Y, 2013QN102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; ANDREASEN NC, 1992, ARCH GEN PSYCHIAT, V49, P615; Austin Jehannine, 2005, J Genet Couns, V14, P329, DOI 10.1007/s10897-005-1622-4; Bakker PR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050970; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Breier A, 1999, BRIT J PSYCHIAT, V174, P16, DOI 10.1192/S0007125000293604; Cai J, 2013, PSYCHOPHARMACOLOGY, V230, P49, DOI 10.1007/s00213-013-3137-2; Cherlyn SYT, 2010, NEUROSCI BIOBEHAV R, V34, P958, DOI 10.1016/j.neubiorev.2010.01.002; de Quervain DJF, 2006, P NATL ACAD SCI USA, V103, P4270, DOI 10.1073/pnas.0510212103; Di Maria E, 2004, AM J MED GENET B, V128B, P27, DOI 10.1002/ajmg.b.30028; Endele S, 2010, NAT GENET, V42, P1021, DOI 10.1038/ng.677; Gaspar PA, 2009, J NEUROCHEM, V111, P891, DOI 10.1111/j.1471-4159.2009.06325.x; Goff DC, 2001, AM J PSYCHIAT, V158, P1367, DOI 10.1176/appi.ajp.158.9.1367; Gottesman I.I., 1991, SCHIZOPHRENIA GENESI; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Hong CJ, 2001, PSYCHIAT GENET, V11, P219, DOI 10.1097/00041444-200112000-00007; Iwayama Y, 2006, NEUROSCI LETT, V394, P101, DOI 10.1016/j.neulet.2005.10.025; Jablensky A, 2011, GENES BRAIN BEHAV, V10, P410, DOI 10.1111/j.1601-183X.2011.00679.x; JAVITT D C, 1987, Hillside Journal of Clinical Psychiatry, V9, P12; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kim JH, 2012, PSYCHIAT RES, V197, P285, DOI 10.1016/j.psychres.2011.10.006; Lewis DA, 2006, NAT MED, V12, P1016, DOI 10.1038/nm1478; Li DW, 2007, GENET MED, V9, P4, DOI 10.1097/01.gim.0000250507.96760.4b; Li WQ, 2013, PROG NEURO-PSYCHOPH, V44, P290, DOI 10.1016/j.pnpbp.2013.04.003; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Martucci L, 2006, SCHIZOPHR RES, V84, P214, DOI 10.1016/j.schres.2006.02.001; Mesholam-Gately RI, 2009, NEUROPSYCHOLOGY, V23, P315, DOI 10.1037/a0014708; Miyatake R, 2002, MOL PSYCHIATR, V7, P1101, DOI 10.1038/sj.mp.4001152; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; Mueser KT, 2004, LANCET, V363, P2063, DOI 10.1016/S0140-6736(04)16458-1; Myers RA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001318; NAKANISHI S, 1994, ANNU REV BIOPH BIOM, V23, P319, DOI 10.1146/annurev.bb.23.060194.001535; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; Ocklenburg S, 2011, BEHAV BRAIN RES, V225, P284, DOI 10.1016/j.bbr.2011.07.042; Ohtsuki T, 2001, MOL PSYCHIATR, V6, P211, DOI 10.1038/sj.mp.4000808; Owen MJ, 2005, TRENDS GENET, V21, P518, DOI 10.1016/j.tig.2005.06.011; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Qin SY, 2005, EUR J HUM GENET, V13, P807, DOI 10.1038/sj.ejhg.5201418; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Schultz SK, 1999, LANCET, V353, P1425, DOI 10.1016/S0140-6736(98)07549-7; Shi YY, 2011, NAT GENET, V43, P1224, DOI 10.1038/ng.980; Sodhi Monsheel, 2008, Expert Rev Neurother, V8, P1389, DOI 10.1586/14737175.8.9.1389; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Tsai GC, 2002, ANNU REV PHARMACOL, V42, P165, DOI 10.1146/annurev.pharmtox.42.082701.160735; White T, 2006, BIOL PSYCHIAT, V60, P463, DOI 10.1016/j.biopsych.2006.01.002; Williams HJ, 2012, SCHIZOPHR RES, V141, P274, DOI 10.1016/j.schres.2012.08.024; Williams HJ, 2009, J HUM GENET, V54, P9, DOI 10.1038/jhg.2008.7; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236; Yue WH, 2011, NAT GENET, V43, P1228, DOI 10.1038/ng.979	51	15	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0125925	10.1371/journal.pone.0125925	http://dx.doi.org/10.1371/journal.pone.0125925			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020650	gold, Green Submitted, Green Published			2022-12-26	WOS:000355187300018
J	Capala, ME; Maat, H; Bonardi, F; van den Boom, V; Kuipers, J; Vellenga, E; Giepmans, BNG; Schuringa, JJ				Capala, Marta E.; Maat, Henny; Bonardi, Francesco; van den Boom, Vincent; Kuipers, Jeroen; Vellenga, Edo; Giepmans, Ben N. G.; Schuringa, Jan Jacob			Mitochondrial Dysfunction in Human Leukemic Stem/Progenitor Cells upon Loss of RAC2	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELL; ACUTE MYELOID-LEUKEMIA; LONG-TERM MAINTENANCE; GTPASES; ACTIVATION; MIGRATION; NICHES; MICROENVIRONMENT; CHEMOTHERAPY; ENGRAFTMENT	Leukemic stem cells (LSCs) reside within bone marrow niches that maintain their relatively quiescent state and convey resistance to conventional treatment. Many of the microenvironmental signals converge on RAC GTPases. Although it has become clear that RAC proteins fulfill important roles in the hematopoietic compartment, little has been revealed about the downstream effectors and molecular mechanisms. We observed that in BCR-ABL-transduced human hematopoietic stem/progenitor cells (HSPCs) depletion of RAC2 but not RAC1 induced a marked and immediate decrease in proliferation, progenitor frequency, cobblestone formation and replating capacity, indicative for reduced self-renewal. Cell cycle analyses showed reduced cell cycle activity in RAC2-depleted BCR-ABL leukemic cobblestones coinciding with an increased apoptosis. Moreover, a decrease in mitochondrial membrane potential was observed upon RAC2 downregulation, paralleled by severe mitochondrial ultrastructural malformations as determined by automated electron microscopy. Proteome analysis revealed that RAC2 specifically interacted with a set of mitochondrial proteins including mitochondrial transport proteins SAM50 and Metaxin 1, and interactions were confirmed in independent co-immunoprecipitation studies. Downregulation of SAM50 also impaired the proliferation and replating capacity of BCR-ABL-expressing cells, again associated with a decreased mitochondrial membrane potential. Taken together, these data suggest an important role for RAC2 in maintaining mitochondrial integrity.	[Capala, Marta E.; Maat, Henny; Bonardi, Francesco; van den Boom, Vincent; Vellenga, Edo; Giepmans, Ben N. G.; Schuringa, Jan Jacob] Canc Res Ctr Groningen, Dept Expt Hematol, Groningen, Netherlands; [Kuipers, Jeroen] Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, Groningen, Netherlands	University of Groningen	Schuringa, JJ (corresponding author), Canc Res Ctr Groningen, Dept Expt Hematol, Groningen, Netherlands.	j.j.schuringa@umcg.nl	Giepmans, Ben N.G./R-4564-2016	Giepmans, Ben N.G./0000-0001-5105-5915	Netherlands Organization for Scientific Research [NWO-VIDI 91796312]; ZonMW [91111.006]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); ZonMW(Netherlands Organization for Health Research and Development)	This work was supported by a grant from The Netherlands Organization for Scientific Research (NWO-VIDI 91796312) to JJS and ZonMW 91111.006 to BG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Adams GB, 2007, NAT BIOTECHNOL, V25, P238, DOI 10.1038/nbt1281; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Cancelas JA, 2011, TRANSFUSION, V51, p153S, DOI 10.1111/j.1537-2995.2011.03378.x; Cancelas JA, 2005, NAT MED, V11, P886, DOI 10.1038/nm1274; Capala ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111568; Carta A, 2005, BRIT J OPHTHALMOL, V89, P825, DOI 10.1136/bjo.2004.060590; Colmone A, 2008, SCIENCE, V322, P1861, DOI 10.1126/science.1164390; del Pozo MA, 2004, SCIENCE, V303, P839, DOI 10.1126/science.1092571; del Pozo MA, 1999, EUR J IMMUNOL, V29, P3609; Filippi MD, 2004, NAT IMMUNOL, V5, P744, DOI 10.1038/ni1081; Flis K, 2012, LEUKEMIA LYMPHOMA, V53, P2474, DOI 10.3109/10428194.2012.696313; Fuhler GM, 2008, BLOOD, V111, P359, DOI 10.1182/blood-2006-11-060632; Gallipoli P, 2011, HEMATOL ONCOL CLIN N, V25, P951, DOI 10.1016/j.hoc.2011.09.001; Gu Y, 2003, SCIENCE, V302, P445, DOI 10.1126/science.1088485; Hamilton A, 2012, BLOOD, V119, P1501, DOI 10.1182/blood-2010-12-326843; Ishikawa F, 2007, NAT BIOTECHNOL, V25, P1315, DOI 10.1038/nbt1350; Jansen M, 2005, STEM CELLS, V23, P335, DOI 10.1634/stemcells.2004-0216; John GB, 2005, MOL BIOL CELL, V16, P1543, DOI 10.1091/mbc.e04-08-0697; Kiel MJ, 2008, NAT REV IMMUNOL, V8, P290, DOI 10.1038/nri2279; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kozjak V, 2003, J BIOL CHEM, V278, P48520, DOI 10.1074/jbc.C300442200; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Mizukawa B, 2011, BLOOD, V118, P5235, DOI 10.1182/blood-2011-04-351817; Nervi B, 2009, BLOOD, V113, P6206, DOI 10.1182/blood-2008-06-162123; Nieborowska-Skorska M, 2012, BLOOD, V119, P4253, DOI 10.1182/blood-2011-10-385658; Orkin SH, 2008, CELL, V132, P712, DOI 10.1016/j.cell.2008.02.013; Ott C, 2012, MOL CELL BIOL, V32, P1173, DOI 10.1128/MCB.06388-11; Radich JP, 2013, J NATL COMPR CANC NE, V11, P663, DOI 10.6004/jnccn.2013.0196; Ravelli RBG, 2013, SCI REP-UK, V3, DOI 10.1038/srep01804; Rizo A, 2008, BLOOD, V111, P2621, DOI 10.1182/blood-2007-08-106666; Rozenveld-Geugien M, 2007, EXP HEMATOL, V35, P782, DOI 10.1016/j.exphem.2007.02.006; Schepers H, 2007, BLOOD, V110, P2880, DOI 10.1182/blood-2006-08-039073; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Schuringa JJ, 2004, J EXP MED, V200, P623, DOI 10.1084/jem.20041024; Sengupta A, 2010, BLOOD, V116, P81, DOI 10.1182/blood-2009-10-247437; Sinclair A, 2013, BRIT J PHARMACOL, V169, P1693, DOI 10.1111/bph.12183; Skorski T, 1998, P NATL ACAD SCI USA, V95, P11858, DOI 10.1073/pnas.95.20.11858; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Taylor ML, 2000, HEMATOL ONCOL CLIN N, V14, P517, DOI 10.1016/S0889-8588(05)70294-X; Thomas EK, 2008, LEUKEMIA, V22, P898, DOI 10.1038/leu.2008.71; Thomas EK, 2007, CANCER CELL, V12, P467, DOI 10.1016/j.ccr.2007.10.015; Timokhina I, 1998, EMBO J, V17, P6250, DOI 10.1093/emboj/17.21.6250; van den Boom V, 2013, BLOOD, V121, P2452, DOI 10.1182/blood-2012-08-451666; Yang FC, 2001, P NATL ACAD SCI USA, V98, P5614, DOI 10.1073/pnas.101546898; Zamora M, 2004, J BIOL CHEM, V279, P38415, DOI 10.1074/jbc.M404928200; Zeng ZH, 2009, BLOOD, V113, P6215, DOI 10.1182/blood-2008-05-158311; Zon LI, 2008, NATURE, V453, P306, DOI 10.1038/nature07038	49	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0128585	10.1371/journal.pone.0128585	http://dx.doi.org/10.1371/journal.pone.0128585			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26016997	Green Published, Green Submitted, gold			2022-12-26	WOS:000355185600121
J	Johnson, MW; Johnson, PS; Herrmann, ES; Sweeney, MM				Johnson, Matthew W.; Johnson, Patrick S.; Herrmann, Evan S.; Sweeney, Mary M.			Delay and Probability Discounting of Sexual and Monetary Outcomes in Individuals with Cocaine Use Disorders and Matched Controls	PLOS ONE			English	Article							IMPROVING HIV/AIDS KNOWLEDGE; TEST-RETEST RELIABILITY; SUBSTANCE USE DISORDERS; INJECTION-DRUG USERS; HIV RISK BEHAVIORS; CIGARETTE SMOKERS; HYPOTHETICAL REWARDS; POTENTIALLY REAL; CRACK COCAINE; PATHOLOGICAL GAMBLERS	Individuals with cocaine use disorders are disproportionately affected by HIV/AIDS, partly due to higher rates of unprotected sex. Recent research suggests delay discounting of condom use is a factor in sexual HIV risk. Delay discounting is a behavioral economic concept describing how delaying an event reduces that event's value or impact on behavior. Probability discounting is a related concept describing how the uncertainty of an event decreases its impact on behavior. Individuals with cocaine use disorders (n = 23) and matched non-co-caine-using controls (n = 24) were compared in decision-making tasks involving hypothetical outcomes: delay discounting of condom-protected sex (Sexual Delay Discounting Task), delay discounting of money, the effect of sexually transmitted infection (STI) risk on likelihood of condom use (Sexual Probability Discounting Task), and probability discounting of money. The Cocaine group discounted delayed condom-protected sex (i.e., were more likely to have unprotected sex vs. wait for a condom) significantly more than controls in two of four Sexual Delay Discounting Task partner conditions. The Cocaine group also discounted delayed money (i.e., preferred smaller immediate amounts over larger delayed amounts) significantly more than controls. In the Sexual Probability Discounting Task, both groups showed sensitivity to STI risk, however the groups did not differ. The Cocaine group did not consistently discount probabilistic money more or less than controls. Steeper discounting of delayed, but not probabilistic, sexual outcomes may contribute to greater rates of sexual HIV risk among individuals with cocaine use disorders. Probability discounting of sexual outcomes may contribute to risk of unprotected sex in both groups. Correlations showed sexual and monetary results were unrelated, for both delay and probability discounting. The results highlight the importance of studying specific behavioral processes (e.g., delay and probability discounting) with respect to specific outcomes (e.g., monetary and sexual) to understand decision making in problematic behavior.	[Johnson, Matthew W.; Johnson, Patrick S.; Herrmann, Evan S.; Sweeney, Mary M.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Behav Pharmacol Res Unit, Baltimore, MD 21205 USA	Johns Hopkins University	Johnson, MW (corresponding author), Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Behav Pharmacol Res Unit, Baltimore, MD 21205 USA.	mwj@jhu.edu	Johnson, Matthew/AAA-3299-2020	Sweeney, Mary Margaret/0000-0001-6931-4321	National Institute on Drug Abuse [R01DA032363, T32DA007209]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA032363, T32DA007209, T32DA007294] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by National Institute on Drug Abuse (http://www.drugabuse.gov) grant R01DA032363 (MWJ). PSJ, ESH, and MMS were supported by an institutional training grant from the National Institute on Drug Abuse (T32DA007209). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMMONS RB, 1962, PSYCHOL REP, V11, P111, DOI 10.1177/003329416201100106; Andrade LF, 2012, PSYCHOPHARMACOLOGY, V219, P491, DOI 10.1007/s00213-011-2508-9; Axon RN, 2009, J AM SOC HYPERTENS, V3, P35, DOI 10.1016/j.jash.2008.08.005; Baker F, 2003, J ABNORM PSYCHOL, V112, P382, DOI 10.1037/0021-843X.112.3.382; Baumeister R.F., 2001, REV GEN PSYCHOL, V5, P323, DOI [10.1037//1089-2680.5.4.323, DOI 10.1037//1089-2680.5.4.323, https://doi.org/10.1037/1089-2680.5.4.323, DOI 10.1037/1089-2680.5.4.323]; Bickel WK, 2014, ANNU REV CLIN PSYCHO, V10, P641, DOI 10.1146/annurev-clinpsy-032813-153724; Bickel WK, 2009, J NEUROSCI, V29, P8839, DOI 10.1523/JNEUROSCI.5319-08.2009; Booth RE, 2000, DRUG ALCOHOL DEPEN, V58, P219, DOI 10.1016/S0376-8716(99)00094-0; BOOTH RE, 1993, AM J PUBLIC HEALTH, V83, P1144, DOI 10.2105/AJPH.83.8.1144; Bornovalova MA, 2005, EXP CLIN PSYCHOPHARM, V13, P311, DOI 10.1037/1064-1297.13.4.311; Bradford WD, 2010, MED DECIS MAKING, V30, P99, DOI 10.1177/0272989X09342276; Centers for Disease Control and Prevention, 2010, HIV AIDS US FACT SHE; CHAISSON RE, 1989, JAMA-J AM MED ASSOC, V261, P561, DOI 10.1001/jama.261.4.561; Chan SK, 2014, MMWR-MORBID MORTAL W, V63, P209; Coffey SF, 2003, EXP CLIN PSYCHOPHARM, V11, P18, DOI 10.1037/1064-1297.11.1.18; Dariotis JK, 2015, EXP CLIN PSYCHOPHARM, V23, P49, DOI 10.1037/a0038399; DARKE S, 1991, AIDS, V5, P181, DOI 10.1097/00002030-199102000-00008; Daugherty JR, 2010, PERS INDIV DIFFER, V48, P202, DOI 10.1016/j.paid.2009.10.007; Dixon MR, 2003, J APPL BEHAV ANAL, V36, P449, DOI 10.1901/jaba.2003.36-449; Du WJ, 2002, PSYCHOL REC, V52, P479, DOI 10.1007/BF03395199; Fields SA, 2013, APPETITE, V70, P60, DOI 10.1016/j.appet.2013.06.089; Green L, 1999, J EXP PSYCHOL LEARN, V25, P418, DOI 10.1037/0278-7393.25.2.418; GREEN L, 1994, PSYCHOL SCI, V5, P33, DOI 10.1111/j.1467-9280.1994.tb00610.x; Green RM, 2014, BEHAV PROCESS, V108, P50, DOI 10.1016/j.beproc.2014.09.008; Heil SH, 2006, ADDICT BEHAV, V31, P1290, DOI 10.1016/j.addbeh.2005.09.005; Heil SH, 2005, EXP CLIN PSYCHOPHARM, V13, P238, DOI 10.1037/1064-1297.13.3.238; Herrmann ES, 2014, DRUG ALCOHOL DEPEN, V144, P53, DOI 10.1016/j.drugalcdep.2014.07.026; Herrmann ES, 2013, DRUG ALCOHOL DEPEN, V127, P220, DOI 10.1016/j.drugalcdep.2012.07.006; Hinvest NS, 2010, Q J EXP PSYCHOL, V63, P1072, DOI 10.1080/17470210903276350; Holt DD, 2014, PSYCHON B REV, V21, P794, DOI 10.3758/s13423-013-0557-2; Holt DD, 2003, BEHAV PROCESS, V64, P355, DOI 10.1016/S0376-6357(03)00141-4; HUDGINS R, 1995, DRUG ALCOHOL DEPEN, V37, P7, DOI 10.1016/0376-8716(94)01060-X; HUDZIAK JJ, 1993, COMPR PSYCHIAT, V34, P375, DOI 10.1016/0010-440X(93)90061-8; Jarmolowicz DP, 2012, BEHAV PROCESS, V91, P308, DOI 10.1016/j.beproc.2012.09.001; Jikko Yuriko, 2007, Shinrigaku Kenkyu, V78, P269; Johnson MW, 2008, EXP CLIN PSYCHOPHARM, V16, P264, DOI 10.1037/1064-1297.16.3.264; Johnson MW, 2007, EXP CLIN PSYCHOPHARM, V15, P187, DOI 10.1037/1064-1297.15.2.187; Johnson MW, 2013, EXP CLIN PSYCHOPHARM, V21, P277, DOI 10.1037/a0033071; Johnson MW, 2012, EXP CLIN PSYCHOPHARM, V20, P191, DOI 10.1037/a0027088; Johnson MW, 2012, DRUG ALCOHOL DEPEN, V123, P15, DOI 10.1016/j.drugalcdep.2011.09.032; Johnson MW, 2010, EXP CLIN PSYCHOPHARM, V18, P99, DOI 10.1037/a0018333; Johnson MW, 2002, J EXP ANAL BEHAV, V77, P129, DOI 10.1901/jeab.2002.77-129; Johnson PS, 2015, J EXP ANAL BEHAV, V103, P87, DOI 10.1002/jeab.110; KAHNEMAN D, 1984, AM PSYCHOL, V39, P341, DOI 10.1037/0003-066X.39.4.341; Kaplan BA, 2014, PSYCHOL REC, V64, P261, DOI 10.1007/s40732-014-0041-z; Kirby KN, 2004, ADDICTION, V99, P461, DOI 10.1111/j.1360-0443.2003.00669.x; Kral AH, 1998, AM J PUBLIC HEALTH, V88, P108, DOI 10.2105/AJPH.88.1.108; Lagorio CH, 2005, BEHAV PROCESS, V69, P173, DOI 10.1016/j.beproc.2005.02.003; Lawyer SR, 2013, BEHAV PROCESS, V96, P71, DOI 10.1016/j.beproc.2013.03.001; Lawyer SR, 2011, EXP CLIN PSYCHOPHARM, V19, P263, DOI 10.1037/a0024141; Lawyer SR, 2010, BEHAV PROCESS, V84, P687, DOI 10.1016/j.beproc.2010.04.002; Lejuez CW, 2005, DRUG ALCOHOL DEPEN, V77, P169, DOI 10.1016/j.drugalcdep.2004.08.013; MacKillop J, 2011, PSYCHOPHARMACOLOGY, V216, P305, DOI 10.1007/s00213-011-2229-0; Madden GJ, 2004, EXP CLIN PSYCHOPHARM, V12, P251, DOI 10.1037/1064-1297.12.4.251; Madden GJ, 2003, EXP CLIN PSYCHOPHARM, V11, P139, DOI 10.1037/1064-1297.11.2.139; MALOW RM, 1994, AIDS EDUC PREV, V6, P113; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; Matusiewicz AK, 2013, BEHAV PROCESS, V100, P116, DOI 10.1016/j.beproc.2013.07.019; McCoy CB, 2004, ANN EPIDEMIOL, V14, P535, DOI 10.1016/j.annepidem.2003.10.001; Mitchell SH, 1999, PSYCHOPHARMACOLOGY, V146, P455, DOI 10.1007/PL00005491; Morissette C, 2007, INT J DRUG POLICY, V18, P204, DOI 10.1016/j.drugpo.2006.08.004; Motulsky H, 2003, PRACTICAL GUIDE CURV; MYERSON J, 1995, J EXP ANAL BEHAV, V64, P263, DOI 10.1901/jeab.1995.64-263; Myerson J, 2003, J ECON PSYCHOL, V24, P619, DOI 10.1016/S0167-4870(03)00005-9; Myerson J, 2001, J EXP ANAL BEHAV, V76, P235, DOI 10.1901/jeab.2001.76-235; Ohmura Y, 2005, PSYCHOPHARMACOLOGY, V182, P508, DOI 10.1007/s00213-005-0110-8; Petry NM, 2001, J ABNORM PSYCHOL, V110, P482, DOI 10.1037/0021-843X.110.3.482; Petry NM, 2001, SUBST USE MISUSE, V36, P1731, DOI 10.1081/JA-100107576; Prendergast ML, 2001, J CONSULT CLIN PSYCH, V69, P389, DOI 10.1037//0022-006X.69.3.389; RACHLIN H, 1991, J EXP ANAL BEHAV, V55, P233, DOI 10.1901/jeab.1991.55-233; Rachlin H., 1989, JUDGMENT DECISION CH; Rasmussen EB, 2010, BEHAV PROCESS, V83, P23, DOI 10.1016/j.beproc.2009.09.001; Reynolds B, 2004, BEHAV PROCESS, V65, P35, DOI 10.1016/S0376-6357(03)00109-8; Reynolds B, 2003, BEHAV PROCESS, V64, P333, DOI 10.1016/S0376-6357(03)00168-2; Richards JB, 1999, J EXP ANAL BEHAV, V71, P121, DOI 10.1901/jeab.1999.71-121; Semaan S, 2002, J ACQ IMMUN DEF SYND, V30, pS73, DOI 10.1097/01.QAI.0000017613.32101.90; Shead NW, 2009, J EXP ANAL BEHAV, V92, P1, DOI 10.1901/jeab.2009.92-1; Strathdee SA, 2003, J URBAN HEALTH, V80, P7; Substance Abuse Mental Health Services Administration, 2014, NSDUH SER H, V(SMA) 14-4863; Takahashi T, 2009, NEUROENDOCRINOL LETT, V30, P749; Weller RE, 2008, APPETITE, V51, P563, DOI 10.1016/j.appet.2008.04.010; Wilkinson G, 1993, WRAT 3 WIDE RANGE AC; Winhusen TM, 2014, EVALUATION SUBSTANCE; Yi R, 2005, LEARN BEHAV, V33, P324, DOI 10.3758/BF03192861; Yi R, 2007, BEHAV PHARMACOL, V18, P633, DOI 10.1097/FBP.0b013e3282effbd3; Yi R, 2012, BEHAV PHARMACOL, V23, P358, DOI 10.1097/FBP.0b013e3283564e11; Yi R, 2012, NICOTINE TOB RES, V14, P547, DOI 10.1093/ntr/ntr252; Yoon JH, 2007, EXP CLIN PSYCHOPHARM, V15, P176, DOI 10.1037/1064-1297.15.2.186	88	58	59	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0128641	10.1371/journal.pone.0128641	http://dx.doi.org/10.1371/journal.pone.0128641			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26017273	Green Published, gold, Green Submitted			2022-12-26	WOS:000355185600123
J	Guo, ZX; Xing, ZQ; Cheng, XY; Fang, ZQ; Jiang, C; Su, J; Zhou, ZL; Xu, ZH; Holmberg, A; Nilsson, S; Liu, ZX				Guo, Zhaoxin; Xing, Zhaoquan; Cheng, Xiangyu; Fang, Zhiqing; Jiang, Chao; Su, Jing; Zhou, Zunlin; Xu, Zhonghua; Holmberg, Anders; Nilsson, Sten; Liu, Zhaoxu			Somatostatin Derivate (smsDX) Attenuates the TAM-Stimulated Proliferation, Migration and Invasion of Prostate Cancer via NF-kappa B Regulation	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; TRANSCRIPTION FACTOR; INFLAMMATION; INFILTRATION; EXPRESSION; CARCINOMA; ANGIOGENESIS; ASSOCIATION; PROGRESSION; METASTASIS	Tumor development and progression are influenced by macrophages of the surrounding microenvironment. To investigate the influences of an inflammatory tumor microenvironment on the growth and metastasis of prostate cancer, the present study used a co-culture model of prostate cancer (PCa) cells with tumor-associated macrophage (TAM)-conditioned medium (MCM). MCM promoted PCa cell (LNCaP, DU145 and PC-3) growth, and a xenograft model in nude mice consistently demonstrated that MCM could promote tumor growth. MCM also stimulated migration and invasion in vitro. Somatostatin derivate (smsDX) significantly attenuated the TAM-stimulated proliferation, migration and invasion of prostate cancer. Immunohistochemistry revealed that NF-kappa B was over-expressed in PCa and BPH with chronic inflammatory tissue specimens and was positively correlated with macrophage infiltration. Further investigation into the underlying mechanism revealed that NF-kappa B played an important role in macrophage infiltration. SmsDX inhibited the paracrine loop between TAM and PCa cells and may represent a potential therapeutic agent for PCa.	[Guo, Zhaoxin; Xing, Zhaoquan; Cheng, Xiangyu; Fang, Zhiqing; Jiang, Chao; Zhou, Zunlin; Xu, Zhonghua; Liu, Zhaoxu] Shandong Univ, Qilu Hosp, Dept Urol, Jinan 250100, Shandong, Peoples R China; [Guo, Zhaoxin; Fang, Zhiqing] Shandong Univ, Qilu Hosp, Dept Cardiol, Key Lab Cardiovasc Remodeling & Funct Res,Chinese, Jinan 250100, Shandong, Peoples R China; [Guo, Zhaoxin; Fang, Zhiqing] Shandong Univ, Qilu Hosp, Dept Cardiol, Chinese Minist Publ Hlth, Jinan 250100, Shandong, Peoples R China; [Su, Jing; Liu, Zhaoxu] Shandong Univ, Sch Nursing, Jinan 250100, Shandong, Peoples R China; [Holmberg, Anders; Nilsson, Sten; Liu, Zhaoxu] Karolinska Inst, Dept Pathol & Oncol, Stockholm, Sweden	Shandong University; Shandong University; Shandong University; Shandong University; Karolinska Institutet	Liu, ZX (corresponding author), Shandong Univ, Qilu Hosp, Dept Urol, Jinan 250100, Shandong, Peoples R China.	zhaoxvl@sdu.edu.cn			National Natural Science Foundation of China [30772294]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 30772294). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armani C, 2007, J LEUKOCYTE BIOL, V81, P845, DOI 10.1189/jlb.0606417; Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008; Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Behe M, 2001, MED ONCOL, V18, P59; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Biswas SK, 2006, BLOOD, V107, P2112, DOI 10.1182/blood-2005-01-0428; CHAO TC, 1995, REGUL PEPTIDES, V58, P1, DOI 10.1016/0167-0115(95)00051-C; Chen JJW, 2003, CLIN CANCER RES, V9, P729; Chen LY, 2012, BRAIN RES, V1475, P80, DOI 10.1016/j.brainres.2012.07.052; Comito G, 2014, ONCOGENE, V33, P2423, DOI 10.1038/onc.2013.191; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; Eguchi K, 2013, DIABETES OBES METAB, V15, P152, DOI 10.1111/dom.12168; Fang ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062823; Gollapudi K, 2013, AM J CANCER RES, V3, P523; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; Huang S, 2000, CLIN CANCER RES, V6, P2573; Isaacs JT, 1999, UROL CLIN N AM, V26, P263, DOI 10.1016/S0094-0143(05)70066-5; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kang BN, 2001, REGUL PEPTIDES, V101, P43, DOI 10.1016/S0167-0115(01)00264-6; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Karin M, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000141; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Loberg RD, 2007, NEOPLASIA, V9, P556, DOI 10.1593/neo.07307; Ludwig L, 2001, CANCER RES, V61, P4526; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mauro C, 2011, NAT CELL BIOL, V13, P1272, DOI 10.1038/ncb2324; Mayo MW, 2002, J BIOL CHEM, V277, P11116, DOI 10.1074/jbc.M108670200; Mikhaevich EI, 2013, B EXP BIOL MED+, V154, P669, DOI 10.1007/s10517-013-2026-3; Naugler WE, 2008, CURR OPIN GENET DEV, V18, P19, DOI 10.1016/j.gde.2008.01.020; Nonomura N, 2010, CANCER SCI, V101, P1570, DOI 10.1111/j.1349-7006.2010.01563.x; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Pinter E, 2006, PHARMACOL THERAPEUT, V112, P440, DOI 10.1016/j.pharmthera.2006.04.010; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; Ren J, 2011, BRIT J CANCER, V105, P1905, DOI 10.1038/bjc.2011.492; Rocha VZ, 2009, NAT REV CARDIOL, V6, P399, DOI 10.1038/nrcardio.2009.55; Shimura S, 2000, CANCER RES, V60, P5857; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Solinas G, 2009, J LEUKOCYTE BIOL, V86, P1065, DOI 10.1189/jlb.0609385; Tai DI, 2000, CANCER, V89, P2274, DOI 10.1002/1097-0142(20001201)89:11<2274::AID-CNCR16>3.0.CO;2-2; ten Bokum AMC, 2000, EUR CYTOKINE NETW, V11, P161; Tian H, 2009, INFLAMMATION, V32, P191, DOI 10.1007/s10753-009-9120-8; Wang DD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113754; Wang WX, 1999, CLIN CANCER RES, V5, P119; Wang Y, 2014, CIRC RES, V114, P421, DOI 10.1161/CIRCRESAHA.114.302153; Wong CP, 2009, CANCER LETT, V276, P38, DOI 10.1016/j.canlet.2008.10.025; Wu Y, 2010, BRIT J CANCER, V102, P639, DOI 10.1038/sj.bjc.6605530; Yan L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055790; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0; Zhu P, 2006, CELL, V124, P615, DOI 10.1016/j.cell.2005.12.032	54	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0124292	10.1371/journal.pone.0124292	http://dx.doi.org/10.1371/journal.pone.0124292			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010447	Green Submitted, Green Published, gold			2022-12-26	WOS:000355183900007
J	Petersen, MB; Giessing, A; Nielsen, J				Petersen, Michael Bang; Giessing, Ann; Nielsen, Jesper			Physiological Responses and Partisan Bias: Beyond Self-Reported Measures of Party Identification	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; POLITICAL BELIEFS; PUBLIC-OPINION; COGNITION; POLARIZATION; ATTITUDES; IDENTITY; POLICY; CUES	People are biased partisans: they tend to agree with policies from political parties they identify with, independent of policy content. Here, we investigate how physiological reactions to political parties shape bias. Using changes in galvanic skin conductance responses to the visual presentation of party logos, we obtained an implicit and physiological measure of the affective arousal associated with political parties. Subsequently, we exposed subjects to classical party cue experiments where the party sponsors of specific policies were experimentally varied. We found that partisan bias only obtains among those exhibiting a strong physiological reaction to the party source; being a self-reported party identifier is not sufficient on its own. This suggests that partisan bias is rooted in implicit, affective reactions.	[Petersen, Michael Bang; Giessing, Ann; Nielsen, Jesper] Aarhus Univ, Dept Polit Sci, Aarhus, Denmark	Aarhus University	Petersen, MB (corresponding author), Aarhus Univ, Dept Polit Sci, Aarhus, Denmark.	michael@ps.au.dk		Petersen, Michael Bang/0000-0002-6782-5635				Achen CH, 1982, QUANTITATIVE APPL SO; Bullock JG, 2011, AM POLIT SCI REV, V105, P496, DOI 10.1017/S0003055411000165; Burdein I, 2006, POLIT PSYCHOL, V27, P359, DOI 10.1111/j.1467-9221.2006.00504.x; Burden BC, 2005, POLIT PSYCHOL, V26, P869, DOI 10.1111/j.1467-9221.2005.00448.x; Campbell Angus., 1960, AM VOTER; Cohen GL, 2003, J PERS SOC PSYCHOL, V85, P808, DOI 10.1037/0022-3514.85.5.808; Downs A., 1957, EC THEORY DEMOCRACY; Druckman JN, 2013, AM POLIT SCI REV, V107, P57, DOI 10.1017/S0003055412000500; Fazio RH, 2003, ANNU REV PSYCHOL, V54, P297, DOI 10.1146/annurev.psych.54.101601.145225; Figner B., 2011, HDB PROCESS TRACING, P163, DOI DOI 10.4324/9780203875292-18/USING-SKIN-CONDUCTANCE-JUDGMENT-DECISION-MAKING-RESEARCH-MICHAEL-SCHULTE-MECKLENBECK-ANTON-KUEHBERGER-JOSEPH-JOHNSON-JOSEPH-JOHNSON; FIORINA MORRIS P., 1981, RETROSPECTIVE VOTING, P89; Franzese RJ., 2009, MODELING INTERPRETIN; Green D. P., 2002, PARTISAN HEARTS MIND; Greene S, 2002, POLIT BEHAV, V24, P171, DOI 10.1023/A:1021859907145; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greitemeyer T, 2009, EUR J SOC PSYCHOL, V39, P22, DOI 10.1002/ejsp.497; Huddy L, 2015, AM POLIT SCI REV, V109, P1, DOI 10.1017/S0003055414000604; Iyengar S, 2012, PUBLIC OPIN QUART, V76, P405, DOI 10.1093/poq/nfs038; Jennings, 1974, POLITICAL CHARACTER; Kam CD, 2005, POLIT BEHAV, V27, P163, DOI 10.1007/s11109-005-1764-y; Lau RR, 2006, CAMB STUD PUB OPIN, P1, DOI 10.2277/ 052161306X; Matz DC, 2005, J PERS SOC PSYCHOL, V88, P22, DOI 10.1037/0022-3514.88.1.22; McDermott R., 2007, THE AFFECT EFFECT, P375; MONDAK JJ, 1993, AM J POLIT SCI, V37, P186, DOI 10.2307/2111529; Neely F, 2007, POLIT PSYCHOL, V28, P667, DOI 10.1111/j.1467-9221.2007.00599.x; Niemi, 1981, GENERATIONS POLITICS; Oxley DR, 2008, SCIENCE, V321, P1667, DOI 10.1126/science.1157627; Petersen MB, 2013, POLIT BEHAV, V35, P831, DOI 10.1007/s11109-012-9213-1; Pietraszewski D, 2015, COGNITION, V140, P24, DOI 10.1016/j.cognition.2015.03.007; RAHN WM, 1993, AM J POLIT SCI, V37, P472, DOI 10.2307/2111381; Rosema M, 2006, ELECT STUD, V25, P467, DOI 10.1016/j.electstud.2005.06.017; Smith KB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025552; Sniderman P. M., 2014, PARADOXES LIBERAL DE; WALLIN BG, 1981, PSYCHOPHYSIOLOGY, V18, P470, DOI 10.1111/j.1469-8986.1981.tb02483.x	34	8	8	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0126922	10.1371/journal.pone.0126922	http://dx.doi.org/10.1371/journal.pone.0126922			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0QZ	26010527	Green Published, Green Submitted, gold			2022-12-26	WOS:000355183900048
J	Pithukpakorn, M; Roothumnong, E; Angkasekwinai, N; Suktitipat, B; Assawamakin, A; Luangwedchakarn, V; Umrod, P; Thongnoppakhun, W; Foongladda, S; Suputtamongkol, Y				Pithukpakorn, Manop; Roothumnong, Ekkapong; Angkasekwinai, Nasikarn; Suktitipat, Bhoom; Assawamakin, Anunchai; Luangwedchakarn, Voravich; Umrod, Pinklow; Thongnoppakhun, Wanna; Foongladda, Suporn; Suputtamongkol, Yupin			HLA-DRB1 and HLA-DQB1 Are Associated with Adult-Onset Immunodeficiency with Acquired Anti-Interferon-Gamma Autoantibodies	PLOS ONE			English	Article							THAI POPULATION; HLA; DISEASE; HAPLOTYPES; INFECTION; ALLELES; TAIWAN	Recently a newly identified clinical syndrome of disseminated non-tuberculous mycobacterial diseases (with or without other opportunistic infections in adult patients who were previously healthy, has been recognized in association with an acquired autoantibody to interferon-gamma. This syndrome is emerging as an important cause of morbidity and mortality, especially among people of Asian descent. Trigger for the production of this autoantibody remains unknown, but genetic factors are strongly suspected to be involved. We compared HLA genotyping between 32 patients with this clinical syndrome, and 38 controls. We found that this clinical syndrome was associated with very limited allele polymorphism, with HLA-DRB1 and DQB1 alleles, especially HLA-DRB1*15:01, DRB1*16:02, DQB1*05:01 and DQB1*05:02. Odds ratio of DRB1*15:01, DRB1*16:02, DQB1*05:01 and DQB1*05:02 were 7.03 (95% CI, 2.18-22.69, P<0.0001, 9.06 (95% CI, 2.79-29.46, P<0.0001), 6.68 (95% CI, 2.29-19.52, P = 0.0004), and 6.64 (95% CI, 2.30-19.20, P = 0.0004), respectively. Further investigation is warranted to provide better understanding on pathogenesis of this association.	[Pithukpakorn, Manop; Roothumnong, Ekkapong] Mahidol Univ, Fac Med, Siriraj Hosp, Dept Med,Div Med Genet, Bangkok 10700, Thailand; [Roothumnong, Ekkapong; Assawamakin, Anunchai; Thongnoppakhun, Wanna] Mahidol Univ, Fac Med, Siriraj Hosp, Dept Res & Dev,Div Mol Genet, Bangkok 10700, Thailand; [Angkasekwinai, Nasikarn; Suputtamongkol, Yupin] Mahidol Univ, Fac Med, Siriraj Hosp, Dept Med,Div Infect Dis & Trop Med, Bangkok 10700, Thailand; [Suktitipat, Bhoom] Mahidol Univ, Fac Med, Siriraj Hosp, Dept Biochem, Bangkok 10700, Thailand; [Assawamakin, Anunchai] Mahidol Univ, Fac Pharm, Dept Pharmacol, Bangkok 10700, Thailand; [Luangwedchakarn, Voravich; Umrod, Pinklow] Mahidol Univ, Fac Med, Siriraj Hosp, Dept Immunol, Bangkok 10700, Thailand; [Foongladda, Suporn] Mahidol Univ, Fac Med, Siriraj Hosp, Dept Microbiol, Bangkok 10700, Thailand	Mahidol University; Mahidol University; Mahidol University; Mahidol University; Mahidol University; Mahidol University; Mahidol University	Suputtamongkol, Y (corresponding author), Mahidol Univ, Fac Med, Siriraj Hosp, Dept Med,Div Infect Dis & Trop Med, Bangkok 10700, Thailand.	yupin.sup@mahidol.ac.th	Angkasekwinai, Nasikarn/AAS-3199-2020; Suktitipat, Bhoom/H-4239-2019; Pithukpakorn, Manop/K-9825-2013	Suktitipat, Bhoom/0000-0001-8034-7757; Pithukpakorn, Manop/0000-0003-3611-5718	Siriraj Research Development Grant [R015634003]; National Science and Technology Development Agency Grant [P-13-00374]; Siriraj Core Research Facility (SiCRF) Grant; Siriraj Chalermphrakiat Grant	Siriraj Research Development Grant; National Science and Technology Development Agency Grant; Siriraj Core Research Facility (SiCRF) Grant; Siriraj Chalermphrakiat Grant	This work was supported by Siriraj Research Development Grant (Grant No. R015634003) and National Science and Technology Development Agency Grant (Grant No. P-13-00374) to YS; Siriraj Core Research Facility (SiCRF) Grant to MP; and Siriraj Chalermphrakiat Grant to MP, NA, BS, WT, SF and YS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackwell JM, 2009, CLIN MICROBIOL REV, V22, P370, DOI 10.1128/CMR.00048-08; Brode SK, 2014, INT J TUBERC LUNG D, V18, P1370, DOI 10.5588/ijtld.14.0120; Browne SK, 2012, NEW ENGL J MED, V367, P725, DOI 10.1056/NEJMoa1111160; Chen P, 2011, NEW ENGL J MED, V364, P1126, DOI 10.1056/NEJMoa1009717; Chetchotisakd P, 2007, CLIN INFECT DIS, V45, P421, DOI 10.1086/520030; Chi CY, 2013, BLOOD, V121, P1357, DOI 10.1182/blood-2012-08-452482; Ding L, 2012, J CLIN IMMUNOL, V32, P238, DOI 10.1007/s10875-011-9621-8; Gonzalez-Galarza FF, 2011, NUCLEIC ACIDS RES, V39, pD913, DOI 10.1093/nar/gkq1128; Lionetti E, 2014, NEW ENGL J MED, V371, P1295, DOI 10.1056/NEJMoa1400697; Pratesi F, 2013, AUTOIMMUN REV, V12, P1182, DOI 10.1016/j.autrev.2013.08.002; Romphruk AV, 2010, TISSUE ANTIGENS, V75, P701, DOI 10.1111/j.1399-0039.2010.01448.x; Romphruk AV, 1999, EUR J IMMUNOGENET, V26, P129, DOI 10.1046/j.1365-2370.1999.00133.x; Stankov K, 2013, PEDIATRICS, V132, P1112, DOI 10.1542/peds.2013-1652; Tassaneeyakul W, 2009, PHARMACOGENET GENOM, V19, P704, DOI 10.1097/FPC.0b013e328330a3b8; Thomas GP, 2010, IMMUNOL REV, V233, P162, DOI 10.1111/j.0105-2896.2009.00852.x; Tsai S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00321; Wallach D, 2006, J AM ACAD DERMATOL, V55, P1066, DOI 10.1016/j.jaad.2006.07.016	17	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128481	10.1371/journal.pone.0128481	http://dx.doi.org/10.1371/journal.pone.0128481			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011559	Green Submitted, gold, Green Published			2022-12-26	WOS:000355183900240
J	Pitisuttithum, P; Rerks-Ngarm, S; Stablein, D; Dawson, P; Nitayaphan, S; Kaewkungwal, J; Michael, NL; Kim, JH; Robb, ML; O'Connell, RJ; Yoon, IK; Fernandez, S; Excler, JL				Pitisuttithum, Punnee; Rerks-Ngarm, Supachai; Stablein, Donald; Dawson, Peter; Nitayaphan, Sorachai; Kaewkungwal, Jaranit; Michael, Nelson L.; Kim, Jerome H.; Robb, Merlin L.; O'Connell, Robert J.; Yoon, In-Kyu; Fernandez, Stefan; Excler, Jean-Louis			Accuracy of Clinical Diagnosis of Dengue Episodes in the RV144 HIV Vaccine Efficacy Trial in Thailand	PLOS ONE			English	Article							DISEASE BURDEN; TRANSMISSION; INFECTION; AIDSVAX; ADULTS; ALVAC	RV144 was a community-based HIV vaccine efficacy trial conducted in HIV-uninfected adults in Thailand, where dengue virus continues to cause a large number of infections every year. We attempted to document the accuracy of clinically diagnosed dengue episodes reported as serious adverse events (SAEs) and adverse events (AEs) and examine whether dengue serology would support the clinical diagnosis. Subjects without a clinical dengue diagnosis but with an infection or idiopathic fever were selected as a control population. Dengue serology was performed by hemagglutination inhibition on plasma samples. A total of 124 clinical dengue episodes were reported (103 SAEs and 21 AEs). Overall 82.6% of the clinically diagnosed dengue episodes were supported by a positive dengue serology: 71.4% of the AEs and 85.0% of the SAEs. Of the 100 subjects with both clinical dengue and positive serology, all presented with fever, 83% with leucopenia, 54% with thrombocytopenia, and 27% with hemorrhagic symptoms. All episodes resolved spontaneously without sequellae. Only two of 15 subjects with a negative serology presented with fever. The sensitivity and specificity of clinical dengue diagnosis were 90.9% and 74.4%, respectively, when compared to the control population, and with a positive predictive value of 82.6% and negative predictive value of 84.7% when compared to dengue serology. Clinical diagnosis of dengue is an accurate method of dengue diagnosis in adults in Thailand. Large-scale clinical trials offer the opportunity to systematically study infectious diseases such as dengue and other infections that may occur during the trial.	[Pitisuttithum, Punnee] Mahidol Univ, Vaccine Trial Ctr, Fac Trop Med, Bangkok 10700, Thailand; [Rerks-Ngarm, Supachai] Minist Publ Hlth, Dept Dis Control, Nonthaburi, Thailand; [Stablein, Donald; Dawson, Peter] EMMES Corp, Rockville, MD USA; [Nitayaphan, Sorachai] AFRIMS, Royal Thai Army Component, Bangkok, Thailand; [Kaewkungwal, Jaranit] Mahidol Univ, Fac Trop Med, Ctr Excellence Biomed & Publ Hlth Informat, Bangkok 10700, Thailand; [Michael, Nelson L.; Kim, Jerome H.; Robb, Merlin L.; O'Connell, Robert J.; Excler, Jean-Louis] US Mil HIV Res Program MHRP, Bethesda, MD 20817 USA; [Robb, Merlin L.; Excler, Jean-Louis] Henry M Jackson Fdn Advancement Mil Med, Bethesda, MD USA; [O'Connell, Robert J.] US Component AFRIMS, Dept Retrovirol, Bangkok, Thailand; [Yoon, In-Kyu; Fernandez, Stefan] AFRIMS, Dept Virol, Bangkok, Thailand	Mahidol University; Ministry of Public Health - Thailand; Emmes Corporation; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); Mahidol University; Walter Reed Army Institute of Research (WRAIR); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS)	Excler, JL (corresponding author), US Mil HIV Res Program MHRP, Bethesda, MD 20817 USA.	jexcler@hivresearch.org		Kaewkungwal, Jaranit/0000-0001-7916-8460	U.S. Army Medical Research and Materiel Command (USAMRMC) [Y1-AI-2642-12]; National Institutes of Allergy and Infectious Diseases [Y1-AI-2642-12]; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. [W81XWH-07-2-0067]; U.S. Department of Defense (DOD) [W81XWH-07-2-0067]; EMMES; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI002642] Funding Source: NIH RePORTER	U.S. Army Medical Research and Materiel Command (USAMRMC)(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.; U.S. Department of Defense (DOD)(United States Department of Defense); EMMES; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The preparation of this manuscript was supported in part by an Interagency Agreement Y1-AI-2642-12 between U.S. Army Medical Research and Materiel Command (USAMRMC) and the National Institutes of Allergy and Infectious Diseases. In addition this work was supported by a cooperative agreement (W81XWH-07-2-0067) between the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., and the U.S. Department of Defense (DOD). Co-authors Donald Stablein (DS) and Peter Dawson (PD) are employed by The EMMES Corporation. EMMES provided support in the form of salary for authors DS and PD as well as other EMMES employees involved in the RV144 study design, analysis, and preparation of this manuscript. The specific roles of the authors DS and PD are articulated in the "author contributions" section. The EMMES Corporation otherwise did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aung KLL, 2013, SE ASIAN J TROP MED, V44, P602; Campbell KM, 2013, AM J TROP MED HYG, V89, P1066, DOI 10.4269/ajtmh.13-0321; Capeding MR, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002331; CLARKE DH, 1958, AM J TROP MED HYG, V7, P561, DOI 10.4269/ajtmh.1958.7.561; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Horstick O, 2014, AM J TROP MED HYG, V91, P621, DOI 10.4269/ajtmh.13-0676; Limkittikul K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003241; Low JGH, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001191; MAKINO Y, 1994, MICROBIOL IMMUNOL, V38, P951, DOI 10.1111/j.1348-0421.1994.tb02152.x; Mansfield KL, 2011, J GEN VIROL, V92, P2821, DOI 10.1099/vir.0.031641-0; Ministry of Public Health T, 2008, ANN EP SURV REP; Namvongsa Vannyda, 2013, Southeast Asian J Trop Med Public Health, V44, P772; Pitisuttithum P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027837; Pongpan S, 2014, RISK MANAG HEALTHC P, V7, P45, DOI 10.2147/RMHP.S57257; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Robb ML, 2012, LANCET INFECT DIS, V12, P531, DOI 10.1016/S1473-3099(12)70088-9; Rodriguez-Barraquer I, 2014, AM J EPIDEMIOL, V179, P353, DOI 10.1093/aje/kwt256; Shepard DS, 2013, PLOS NEGLECT TROP D, V7, DOI [10.1371/journal.pntd.0002055, 10.1371/journal.pntd.0002056]; Wichmann O, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000996; World Health Organization (WHO) and Special Programme for Research and Training in Tropical Diseases (TDR), 2009, GEN S DENG GUID DIAG; Yoon IK, 2012, J INFECT DIS, V206, P389, DOI 10.1093/infdis/jis357	21	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127998	10.1371/journal.pone.0127998	http://dx.doi.org/10.1371/journal.pone.0127998			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011728	Green Published, Green Submitted, gold			2022-12-26	WOS:000355183900179
J	Sepanlou, SG; Malekzadeh, R; Poustchi, H; Sharafkhah, M; Ghodsi, S; Malekzadeh, F; Etemadi, A; Pourshams, A; Pharoah, PD; Abnet, CC; Brennan, P; Boffetta, P; Dawsey, SM; Kamangar, F				Sepanlou, Sadaf G.; Malekzadeh, Reza; Poustchi, Hossein; Sharafkhah, Maryam; Ghodsi, Saeed; Malekzadeh, Fatemeh; Etemadi, Arash; Pourshams, Akram; Pharoah, Paul D.; Abnet, Christian C.; Brennan, Paul; Boffetta, Paolo; Dawsey, Sanford M.; Kamangar, Farin			The Clinical Performance of an Office-Based Risk Scoring System for Fatal Cardiovascular Diseases in North-East of Iran	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; GLOBAL BURDEN; GOLESTAN COHORT; PREDICTION; POPULATION; PROFILE; VALIDATION; HEALTH; PREVENTION; MORTALITY	Background Cardiovascular diseases (CVD) are becoming major causes of death in developing countries. Risk scoring systems for CVD are needed to prioritize allocation of limited resources. Most of these risk score algorithms have been based on a long array of risk factors including blood markers of lipids. However, risk scoring systems that solely use office-based data, not including laboratory markers, may be advantageous. In the current analysis, we validated the office-based Framingham risk scoring system in Iran. Methods The study used data from the Golestan Cohort in North-East of Iran. The following risk factors were used in the development of the risk scoring method: sex, age, body mass index, systolic blood pressure, hypertension treatment, current smoking, and diabetes. Cardiovascular risk functions for prediction of 10-year risk of fatal CVDs were developed. Results A total of 46,674 participants free of CVD at baseline were included. Predictive value of estimated risks was examined. The resulting Area Under the ROC Curve (AUC) was 0.774 (95% CI: 0.762-0.787) in all participants, 0.772 (95% CI: 0.753-0.791) in women, and 0.763 (95% CI: 0.747-0.779) in men. AUC was higher in urban areas (0.790, 95% CI: 0.766-0.815). The predicted and observed risks of fatal CVD were similar in women. However, in men, predicted probabilities were higher than observed. Conclusion The AUC in the current study is comparable to results of previous studies while lipid profile was replaced by body mass index to develop an office-based scoring system. This scoring algorithm is capable of discriminating individuals at high risk versus low risk of fatal CVD.	[Sepanlou, Sadaf G.; Malekzadeh, Reza; Poustchi, Hossein; Sharafkhah, Maryam; Ghodsi, Saeed; Malekzadeh, Fatemeh; Etemadi, Arash; Pourshams, Akram; Kamangar, Farin] Univ Tehran Med Sci, Shariati Hosp, Digest Dis Res Inst, Tehran, Iran; [Etemadi, Arash; Abnet, Christian C.; Dawsey, Sanford M.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Pharoah, Paul D.] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Brennan, Paul] Int Agcy Res Canc, F-69372 Lyon, France; [Boffetta, Paolo] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA; [Boffetta, Paolo] Icahn Sch Med Mt Sinai, Inst Translat Epidemiol, New York, NY 10029 USA; [Kamangar, Farin] Morgan State Univ, Sch Community Hlth & Policy, Dept Publ Hlth Anal, Baltimore, MD 21239 USA	Tehran University of Medical Sciences; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Cambridge; World Health Organization; International Agency for Research on Cancer (IARC); Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Morgan State University	Malekzadeh, R (corresponding author), Univ Tehran Med Sci, Shariati Hosp, Digest Dis Res Inst, Tehran, Iran.	malek@ams.ac.ir	Malekzadeh, Reza/U-1382-2017; Etemadi, Arash/Y-7082-2018; Etemadi, Arash/C-1386-2016; Abnet, Christian C/C-4111-2015; Boffetta, Paolo/AAI-7767-2021; Sepanlou, Sadaf G/H-9343-2016; Pharoah, Paul/V-6658-2019	Malekzadeh, Reza/0000-0002-9820-6335; Etemadi, Arash/0000-0002-3458-1072; Etemadi, Arash/0000-0002-3458-1072; Abnet, Christian C/0000-0002-3008-7843; Boffetta, Paolo/0000-0002-3811-2791; Sepanlou, Sadaf G/0000-0002-3669-5129; Pharoah, Paul/0000-0001-8494-732X; Pourshams, Akram/0000-0002-7950-3983	Division of Cancer Epidemiology and Genetics of the National Cancer Institute, NIH; Digestive Disease Research Institute of Tehran University of Medical Sciences [82-603]; Cancer Research UK (CRUK); International Agency for Research on Cancer	Division of Cancer Epidemiology and Genetics of the National Cancer Institute, NIH; Digestive Disease Research Institute of Tehran University of Medical Sciences; Cancer Research UK (CRUK)(Cancer Research UK); International Agency for Research on Cancer	This study was supported in part by the intramural research program of the Division of Cancer Epidemiology and Genetics of the National Cancer Institute, NIH, by the Digestive Disease Research Institute of Tehran University of Medical Sciences (grant No 82-603), by Cancer Research UK (CRUK), and by the International Agency for Research on Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON KM, 1991, CIRCULATION, V83, P356, DOI 10.1161/01.CIR.83.1.356; Assmann G, 2002, CIRCULATION, V105, P310, DOI 10.1161/hc0302.102575; Bozorgmanesh M, 2011, INT J CLIN PRACT, V65, P264, DOI 10.1111/j.1742-1241.2010.02529.x; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; De Backer G, 2003, EUR HEART J, V24, P1601, DOI 10.1016/S0195-668X(03)00347-6; Etemadi A, 2014, EUR J EPIDEMIOL, V29, P95, DOI 10.1007/s10654-014-9883-6; Ferrario M, 2005, INT J EPIDEMIOL, V34, P413, DOI 10.1093/ije/dyh405; Forouzanfar MH, 2014, ARCH IRAN MED, V17, P304, DOI 0141705/AIM.004; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]; Gu DF, 2006, JAMA-J AM MED ASSOC, V295, P776, DOI 10.1001/jama.295.7.776; Hippisley-Cox J, 2008, HEART, V94, P34, DOI 10.1136/hrt.2007.134890; Hippisley-Cox J, 2007, BMJ-BRIT MED J, V335, P136, DOI 10.1136/bmj.39261.471806.55; Islami F, 2013, HEART, V99, P272, DOI 10.1136/heartjnl-2012-302861; Jackson R, 2005, LANCET, V365, P434, DOI 10.1016/S0140-6736(05)17833-7; Jackson R, 2000, BMJ-BRIT MED J, V320, P709, DOI 10.1136/bmj.320.7236.709; Johannesson M, 2001, EUR HEART J, V22, P919, DOI 10.1053/euhj.2000.2484; Khademi H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011183; Khalili D, 2012, AM J EPIDEMIOL, V176, P177, DOI 10.1093/aje/kws204; Liu J, 2004, JAMA-J AM MED ASSOC, V291, P2591, DOI 10.1001/jama.291.21.2591; Malekzadeh F, 2010, INT J CLIN PRACT, V64, P1220, DOI 10.1111/j.1742-1241.2010.02412.x; Marrugat J, 2003, J EPIDEMIOL COMMUN H, V57, P634, DOI 10.1136/jech.57.8.634; Menotti A, 2005, NUTR METAB CARDIOVAS, V15, P426, DOI 10.1016/j.numecd.2005.07.007; Murray CJL, 2013, NEW ENGL J MED, V369, P448, DOI 10.1056/NEJMra1201534; Naghavi M, 2014, ARCH IRAN MED, V17, P321, DOI 0141705/AIM.005; Pourshams A, 2010, INT J EPIDEMIOL, V39, P52, DOI 10.1093/ije/dyp161; Rastegarpanah M, 2008, ARCH IRAN MED, V11, P306, DOI 08113/AIM.0012; Ridker PM, 2007, JAMA-J AM MED ASSOC, V297, P611, DOI 10.1001/jama.297.6.611; Sepanlou SG, 2012, ARCH IRAN MED, V15, P531, DOI 012159/AIM.004; Shahraz S, 2014, ARCH IRAN MED, V17, P336, DOI 0141705/AIM.006; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Woodward M, 2007, HEART, V93, P172, DOI 10.1136/hrt.2006.108167; Zhang XF, 2005, J CLIN EPIDEMIOL, V58, P951, DOI 10.1016/j.jclinepi.2005.01.013	34	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0126779	10.1371/journal.pone.0126779	http://dx.doi.org/10.1371/journal.pone.0126779			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011607	Green Published, gold, Green Submitted			2022-12-26	WOS:000355183900041
J	Chen, CC; Kim, KH; Lau, LF				Chen, C-C; Kim, K-H; Lau, L. F.			The matricellular protein CCN1 suppresses hepato-carcinogenesis by inhibiting compensatory proliferation	ONCOGENE			English	Article							HEPATOCELLULAR-CARCINOMA; TUMOR-SUPPRESSOR; LIVER FIBROSIS; MOUSE MODELS; IN-VIVO; CYR61; CANCER; P53; HEPATOCARCINOGENESIS; APOPTOSIS	Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related deaths worldwide, and is on the rise in the United States. Previous studies showed that the matricellular protein CCN1 (CYR61) is induced during hepatic injuries and functions to restrict and resolve liver fibrosis. Here, we show that CCN1 suppresses hepatocarcinogenesis by inhibiting carcinogen-induced compensatory hepatocyte proliferation, thus limiting the expansion of damaged and potentially oncogenic hepatocytes. Consistent with tumor suppression, CCN1 expression is downregulated in human HCC. Ccn1(Delta Hep) mice with hepatocyte-specific deletion of Ccn1 suffer increased HCC tumor multiplicity induced by the hepatocarcinogen diethylnitrosamine (DEN). Knockin mice (Ccn1(dm/dm)) that express an integrin alpha(6)beta(1)-binding defective CCN1 phenocopied Ccn1(Delta Hep) mice, indicating that CCN1 acts through its alpha(6)beta(1) binding sites in this context. CCN1 effectively inhibits epidermal growth factor receptor (EGFR)-dependent hepatocyte proliferation through integrin alpha(6)-mediated accumulation of reactive oxygen species (ROS), thereby triggering p53 activation and cell cycle block. Consequently, Ccn1(dm/dm) mice exhibit diminished p53 activation and elevated compensatory hepatocyte proliferation, resulting in increased HCC. Furthermore, we show that a single dose of the EGFR inhibitor erlotinib delivered prior to DEN-induced injury was sufficient to block compensatory proliferation and annihilate development of HCC nodules observed 8 months later, suggesting potential chemoprevention by targeting CCN1-inhibitable EGFR-dependent hepatocyte proliferation. Together, these results show that CCN1 is an injury response protein that functions not only to restrict fibrosis in the liver, but also to suppress hepatocarcinogenesis by inhibiting EGFR-dependent hepatocyte compensatory proliferation.	[Chen, C-C; Kim, K-H; Lau, L. F.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Lau, LF (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, Coll Med, 900 S Ashland Ave, Chicago, IL 60607 USA.	LFLau@uic.edu		Kim, Ki-Hyun/0000-0001-8265-6609; Lau, Lester/0000-0002-4364-2914	NIH [R01GM78492]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR061791] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078492] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Seungwon Shin and Guoqiang Yan for technical assistance. This work was supported by a grant from the NIH (R01GM78492) to LFL.	Babic AM, 1998, P NATL ACAD SCI USA, V95, P6355, DOI 10.1073/pnas.95.11.6355; Baffy G, 2012, J HEPATOL, V56, P1384, DOI 10.1016/j.jhep.2011.10.027; Bakiri L, 2013, MOL ONCOL, V7, P206, DOI 10.1016/j.molonc.2013.01.005; Chen CC, 2007, EMBO J, V26, P1257, DOI 10.1038/sj.emboj.7601596; Chen NY, 2004, J BIOL CHEM, V279, P44166, DOI 10.1074/jbc.M406813200; Chen X, 2002, MOL BIOL CELL, V13, P1929, DOI 10.1091/mbc.02-02-0023; Chien WW, 2004, J BIOL CHEM, V279, P53087, DOI 10.1074/jbc.M410254200; Choi JS, 2015, MUCOSAL IMMUNOL, V8, P1285, DOI 10.1038/mi.2015.19; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Dumaz N, 1999, EMBO J, V18, P7002, DOI 10.1093/emboj/18.24.7002; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Feng P, 2008, INT J BIOCHEM CELL B, V40, P98, DOI 10.1016/j.biocel.2007.06.020; Fuchs BC, 2014, HEPATOLOGY, V59, P1577, DOI 10.1002/hep.26898; Gery S, 2005, CLIN CANCER RES, V11, P7243, DOI 10.1158/1078-0432.CCR-05-0231; Giono LE, 2006, J CELL PHYSIOL, V209, P13, DOI 10.1002/jcp.20689; Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256; Haque I, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-8; Hiotis SP, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-64; Jun JI, 2011, NAT REV DRUG DISCOV, V10, P945, DOI 10.1038/nrd3599; Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070; Juric V, 2009, MOL CELL BIOL, V29, P3266, DOI 10.1128/MCB.00064-09; Kang JS, 2007, CANCER RES, V67, P11141, DOI 10.1158/0008-5472.CAN-07-1369; Kardeh S, 2014, EUR J PHARMACOL, V735, P150, DOI 10.1016/j.ejphar.2014.04.023; Kim KH, 2015, J CLIN INVEST, V125, P1886, DOI 10.1172/JCI79327; Kim KH, 2013, MOL CELL BIOL, V33, P2078, DOI 10.1128/MCB.00049-13; Kuraishy A, 2011, IMMUNITY, V35, P467, DOI 10.1016/j.immuni.2011.09.006; Lai D, 2011, CANCER RES, V71, P2728, DOI 10.1158/0008-5472.CAN-10-2711; Lee JS, 2004, NAT GENET, V36, P1306, DOI 10.1038/ng1481; Li WC, 2010, METHODS MOL BIOL, V633, P185, DOI 10.1007/978-1-59745-019-5_13; Li ZY, 2012, COMPUT ENG APPL, V2012, P1, DOI DOI 10.1371/J0URNAL.P0NE.0040132; Liebermann DA, 2007, CELL CYCLE, V6, P166, DOI 10.4161/cc.6.2.3789; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Mas VR, 2009, MOL MED, V15, P85, DOI 10.2119/molmed.2008.00110; Mellert H, 2013, CELL REP, V3, P1335, DOI 10.1016/j.celrep.2013.05.011; Mo FE, 2006, CIRC RES, V99, P961, DOI 10.1161/01.RES.0000248426.35019.89; Mo FE, 2002, MOL CELL BIOL, V22, P8709, DOI 10.1128/MCB.22.24.8709-8720.2002; O'Connor S., 2010, Morbidity and Mortality Weekly Report, V59, P517; Roessler S, 2010, CANCER RES, V70, P10202, DOI 10.1158/0008-5472.CAN-10-2607; Sakurai T, 2013, CANCER RES, V73, P215, DOI 10.1158/0008-5472.CAN-12-1602; Schiffer E, 2005, HEPATOLOGY, V41, P307, DOI 10.1002/hep.20538; She QB, 2000, J BIOL CHEM, V275, P20444, DOI 10.1074/jbc.M001020200; Smith NF, 2008, BRIT J CANCER, V98, P1630, DOI 10.1038/sj.bjc.6604353; Stepniak E, 2006, GENE DEV, V20, P2306, DOI 10.1101/gad.390506; Sun BC, 2013, FRONT MED-PRC, V7, P242, DOI 10.1007/s11684-013-0256-4; Teoh N, 2010, GASTROENTEROLOGY, V138, P1155, DOI 10.1053/j.gastro.2009.11.008; Thomas MB, 2007, CANCER-AM CANCER SOC, V110, P1059, DOI 10.1002/cncr.22886; Todorovic V, 2005, J CELL BIOL, V171, P559, DOI 10.1083/jcb.200504015; Tong XJ, 2001, J BIOL CHEM, V276, P47709, DOI 10.1074/jbc.M107878200; Tsai MS, 2002, ONCOGENE, V21, P8178, DOI 10.1038/sj.onc.1205682; Verna L, 1996, PHARMACOL THERAPEUT, V71, P57, DOI 10.1016/0163-7258(96)00062-9; Wurmbach E, 2007, HEPATOLOGY, V45, P938, DOI 10.1002/hep.21622; Xie D, 2004, CANCER RES, V64, P1987, DOI 10.1158/0008-5472.CAN-03-0666; Yan HX, 2013, ONCOGENE, V32, P4565, DOI 10.1038/onc.2012.451; Yang JD, 2010, NAT REV GASTRO HEPAT, V7, P448, DOI 10.1038/nrgastro.2010.100	55	34	36	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 10	2016	35	10					1314	1323		10.1038/onc.2015.190	http://dx.doi.org/10.1038/onc.2015.190			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DG0NY	26028023	Green Accepted			2022-12-26	WOS:000371763100011
J	Kharat, SS; Tripathi, V; Damodaran, AP; Priyadarshini, R; Chandra, S; Tikoo, S; Nandhakumar, R; Srivastava, V; Priya, S; Hussain, M; Kaur, S; Fishman, JB; Sengupta, S				Kharat, S. S.; Tripathi, V.; Damodaran, A. P.; Priyadarshini, R.; Chandra, S.; Tikoo, S.; Nandhakumar, R.; Srivastava, V.; Priya, S.; Hussain, M.; Kaur, S.; Fishman, J. B.; Sengupta, S.			Mitotic phosphorylation of Bloom helicase at Thr182 is required for its proteasomal degradation and maintenance of chromosomal stability	ONCOGENE			English	Article							BLM HELICASE; CELL-CYCLE; HOMOLOGOUS RECOMBINATION; REPLICATION STRESS; UBIQUITIN LIGASE; RECQ HELICASES; DNA-DAMAGE; MULTISITE PHOSPHORYLATION; SYNDROME PROTEIN; F-BOX	Mutations in Bloom helicase (BLM) lead to Bloom Syndrome (BS). BS is characterized by multiple clinical manifestations including predisposition to a wide spectrum of cancers. Studies have revealed the mechanism of BLM recruitment after stalled replication and its role during the repair of DNA damage. We now provide evidence that BLM undergoes K48-linked ubiquitylation and subsequent degradation during mitosis due to the E3 ligase, Fbw7 alpha. Fbw7 alpha carries out its function after GSK3 beta- and CDK2/cyclin A2-dependent phosphorylation events on Thr171 and Ser175 of BLM which lies within a well-defined phosphodegron, a sequence which is conserved in all primates. Phosphorylation on BLM Thr171 and Ser175 depends on prior phosphorylation at Thr182 by Chk1/Chk2. Thr182 phosphorylation not only controls BLM ubiquitylation and degradation during mitosis but is also a determinant for its localization on the ultrafine bridges. Consequently lack of Thr182 phosphorylation leads to multiple manifestations of chromosomal instability including increased levels of DNA damage, lagging chromatin, micronuclei formation, breaks and quadriradials. Hence Thr182 phosphorylation on BLM has two functions-it regulates BLM turnover during mitosis and also helps to maintain the chromosomal stability.	[Kharat, S. S.; Tripathi, V.; Damodaran, A. P.; Priyadarshini, R.; Chandra, S.; Tikoo, S.; Nandhakumar, R.; Srivastava, V.; Priya, S.; Hussain, M.; Kaur, S.; Sengupta, S.] Natl Inst Immunol, Aruna Asaf Ali Marg, New Delhi 110067, India; [Fishman, J. B.] 21st Century Biochem, 260 Cedar Hill St, Marlborough, MA USA	Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Sengupta, S (corresponding author), Natl Inst Immunol, Aruna Asaf Ali Marg, New Delhi 110067, India.	sagar@nii.ac.in	Tripathi, Vivek/O-9164-2018; Tikoo, Shweta/AAX-1902-2021; Sengupta, Sagar/AGR-1063-2022; Kharat, Suhas/V-2129-2019; Hussain, Mansoor/GQI-2915-2022	Tripathi, Vivek/0000-0002-4453-0105; Tikoo, Shweta/0000-0001-5850-8075; Sengupta, Sagar/0000-0002-6365-1770; Kharat, Suhas/0000-0003-2283-7429; Hussain, Mansoor/0000-0003-4260-2256	National Institute of Immunology core funds, Department of Biotechnology (DBT), India [BT/PR3148/AGR/36/706/2011]; Science and Engineering Research Board, India [SR/SO/BB-0124/2013]; Indo-French Centre for the Promotion of Advanced Research (IFCPAR) [IFC/4603-A/2011/1250]; Council of Scientific and Industrial Research (CSIR), India [37(1541)/12/EMR-II]	National Institute of Immunology core funds, Department of Biotechnology (DBT), India; Science and Engineering Research Board, India; Indo-French Centre for the Promotion of Advanced Research (IFCPAR)(Indo-French Centre for the Promotion of Advanced Research (IFCPAR/CEFIPRA)); Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India)	We acknowledge Bruce Clurman, Markus Welcker, Jonathan Grim, Ian Hickson, Stephen Elledge, Thanos Halazonetis, Jerry Shay, Nathan Ellis, Bert Vogelstein for plasmids and cells, Simon Gemble for help with SCEs and UFB staining, Priyanka Modi for transfection experiments, Jyoti Kumari for lentivirus-mediated stable line generation and Richa Mudgal for bioinformatic analysis. SS acknowledges National Institute of Immunology core funds, Department of Biotechnology (DBT), India (BT/PR3148/AGR/36/706/2011); Science and Engineering Research Board, India (SR/SO/BB-0124/2013); Indo-French Centre for the Promotion of Advanced Research (IFCPAR) (IFC/4603-A/2011/1250) and Council of Scientific and Industrial Research (CSIR), India [37(1541)/12/EMR-II] for financial assistance.	Ababou M, 2000, ONCOGENE, V19, P5955, DOI 10.1038/sj.onc.1204003; Aguilera A, 2013, ANNU REV GENET, V47, P1, DOI 10.1146/annurev-genet-111212-133232; Bachrati CZ, 2003, BIOCHEM J, V374, P577, DOI 10.1042/BJ20030491; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Bayart E, 2006, CELL CYCLE, V5, P1681, DOI 10.4161/cc.5.15.3122; Beamish H, 2002, J BIOL CHEM, V277, P30515, DOI 10.1074/jbc.M203801200; Bendris N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022879; Bohm S, 2014, DNA REPAIR, V22, P123, DOI 10.1016/j.dnarep.2014.07.007; Bugreev DV, 2007, GENE DEV, V21, P3085, DOI 10.1101/gad.1609007; Busino L, 2004, ONCOGENE, V23, P2050, DOI 10.1038/sj.onc.1207394; Chan KL, 2009, NAT CELL BIOL, V11, P753, DOI 10.1038/ncb1882; Chan KL, 2007, EMBO J, V26, P3397, DOI 10.1038/sj.emboj.7601777; Chandra S, 2013, J CELL SCI, V126, P3782, DOI 10.1242/jcs.124719; Chu WK, 2009, NAT REV CANCER, V9, P644, DOI 10.1038/nrc2682; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Dai XP, 2014, ONCOTARGET, V5, P3307, DOI 10.18632/oncotarget.1939; Davies SL, 2007, NAT STRUCT MOL BIOL, V14, P677, DOI 10.1038/nsmb1267; Davies SL, 2004, MOL CELL BIOL, V24, P1279, DOI 10.1128/MCB.24.3.1279-1291.2004; De Boer L, 2008, ONCOGENE, V27, P4261, DOI 10.1038/onc.2008.74; Dutertre S, 2000, ONCOGENE, V19, P2731, DOI 10.1038/sj.onc.1203595; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; Franchitto A, 2002, J CELL BIOL, V157, P19, DOI 10.1083/jcb.200110009; GERMAN J, 1993, MEDICINE, V72, P393, DOI 10.1097/00005792-199311000-00003; Hao B, 2007, MOL CELL, V26, P131, DOI 10.1016/j.molcel.2007.02.022; Janssen A, 2011, SCIENCE, V333, P1895, DOI 10.1126/science.1210214; Kaur S, 2010, MOL CANCER RES, V8, P1234, DOI 10.1158/1541-7786.MCR-10-0233; Ke YW, 2011, EMBO J, V30, P3309, DOI 10.1038/emboj.2011.226; Kimura T, 2003, CANCER SCI, V94, P431, DOI 10.1111/j.1349-7006.2003.tb01460.x; Leng M, 2006, P NATL ACAD SCI USA, V103, P11485, DOI 10.1073/pnas.0601828103; Melixetian M, 2009, NAT CELL BIOL, V11, P1247, DOI 10.1038/ncb1969; Naim V, 2009, NAT CELL BIOL, V11, P761, DOI 10.1038/ncb1883; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Nimonkar AV, 2008, P NATL ACAD SCI USA, V105, P16906, DOI 10.1073/pnas.0809380105; Nimonkar AV, 2011, GENE DEV, V25, P350, DOI 10.1101/gad.2003811; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Perez-Benavente B, 2013, ONCOGENE, V32, P2189, DOI 10.1038/onc.2012.235; Petsalaki E, 2014, J CELL SCI, V127, P3902, DOI 10.1242/jcs.155176; Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313; Reavie L, 2013, CANCER CELL, V23, P362, DOI 10.1016/j.ccr.2013.01.025; ROSIN MP, 1985, HUM GENET, V71, P187, DOI 10.1007/BF00284570; Rouzeau S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033905; Sanz MM, 2000, CYTOGENET CELL GENET, V91, P217, DOI 10.1159/000056848; Schmitt E, 2006, J CELL SCI, V119, P4269, DOI 10.1242/jcs.03200; Spruck CH, 2002, CANCER RES, V62, P4535; Srivastava V, 2009, J CELL SCI, V122, P3093, DOI 10.1242/jcs.051813; Suhasini AN, 2011, EMBO J, V30, P692, DOI 10.1038/emboj.2010.362; Swaney DL, 2013, NAT METHODS, V10, P676, DOI [10.1038/NMETH.2519, 10.1038/nmeth.2519]; Takeishi S, 2013, CANCER CELL, V23, P347, DOI 10.1016/j.ccr.2013.01.026; Tan MJ, 2011, DEV CELL, V21, P1062, DOI 10.1016/j.devcel.2011.09.014; Tikoo S, 2013, EMBO J, V32, P1778, DOI 10.1038/emboj.2013.117; Tikoo Shweta, 2010, Genome Integr, V1, P14, DOI 10.1186/2041-9414-1-14; Tripathi V, 2008, CARCINOGENESIS, V29, P52, DOI 10.1093/carcin/bgm238; Tripathi V, 2007, J CELL BIOL, V178, P9, DOI 10.1083/jcb.200610051; Wang JD, 2013, MOL CELL, V52, P667, DOI 10.1016/j.molcel.2013.10.012; Wang ZW, 2014, NAT REV CANCER, V14, P233, DOI 10.1038/nrc3700; Welcker M, 2003, MOL CELL, V12, P381, DOI 10.1016/S1097-2765(03)00287-9; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290	57	11	12	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 25	2016	35	8					1025	1038		10.1038/onc.2015.157	http://dx.doi.org/10.1038/onc.2015.157			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DE7NF	26028025				2022-12-26	WOS:000370823300008
J	Heinick, A; Husser, X; Himmler, K; Kirchhefer, U; Nunes, F; Schulte, JS; Seidl, MD; Rolfes, C; Dedman, JR; Kaetzel, MA; Gerke, V; Schmitz, W; Muller, FU				Heinick, Alexander; Husser, Xenia; Himmler, Kirsten; Kirchhefer, Uwe; Nunes, Frank; Schulte, Jan S.; Seidl, Matthias D.; Rolfes, Christina; Dedman, John R.; Kaetzel, Marcia A.; Gerke, Volker; Schmitz, Wilhelm; Mueller, Frank U.			Annexin A4 is a novel direct regulator of adenylyl cyclase type 5	FASEB JOURNAL			English	Article						cAMP; beta-AR stimulation; CRE-mediated transcription; CREB	ACTIVATED CHLORIDE CONDUCTANCE; LEFT-VENTRICULAR FUNCTION; SELF-ASSOCIATION; LIVING CELLS; HEART; IV; DISRUPTION; MEMBRANE; CREB; CALCIUM	Annexin A4 (AnxA4), a Ca2+- and phospholipid-binding protein, is up-regulated in the human failing heart. In this study, we examined the impact of AnxA4 on beta-adrenoceptor (beta-AR)/cAMP-dependent signal transduction. Expression of murine AnxA4 in human embryonic kidney (HEK)293 cells dose-dependently inhibited cAMP levels after direct stimulation of adenylyl cyclases (ACs) with forskolin (FSK), as determined with an exchange protein activated by cAMP-Forster resonance energy transfer (EPAC-FRET) sensor and an ELISA (control vs. +AnxA4: 1956 +/- 162 vs. 1304 +/- 185 fmol/mu g protein; n = 8). Disruption of the anxA4 gene led to a consistent increase in intracellular cAMP levels in isolated adult mouse cardiomyocytes, with heart-directed expression of the EPAC-FRET sensor, stimulated with FSK, and as determined by ELISA, also in mouse cardiomyocytes stimulated with the beta-AR agonist isoproterenol (ISO) (anxA4a(+/+) vs. anxA4a(-/-): 5.1 +/- 0.3 vs. 6.7 +/- 0.6 fmol/mu g protein) or FSK (anxA4a(+/+) vs. anxA4a(-/-): 1891 +/- 238 vs. 2796 +/- 343 fmol/mu g protein; n = 9-10). Coimmunoprecipitation experiments in HEK293 cells revealed a direct interaction of murine AnxA4 with human membrane-bound AC type 5 (AC5). As a functional consequence of AnxA4-mediated AC inhibition, AnxA4 inhibited the FSK-induced transcriptional activation mediated by the cAMP response element (CRE) in reporter gene studies (10-fold vs. control; n = 4 transfections) and reduced the FSK-induced phosphorylation of the CRE-binding protein (CREB) measured on Western blots (control vs. +AnxA4: 150 +/- 17% vs. 105 +/- 10%; n = 6) and by the use of the indicator of CREB activation caused by phosphorylation (ICAP)-FRET sensor, indicating CREB phosphorylation. Inactivation of AnxA4 in anxA4a(-/-) mice was associated with an increased cardiac response to beta-AR stimulation. Together, these results suggest that AnxA4 is a novel direct negative regulator of AC5, adding a new facet to the functions of annexins.	[Heinick, Alexander; Husser, Xenia; Himmler, Kirsten; Kirchhefer, Uwe; Nunes, Frank; Schulte, Jan S.; Seidl, Matthias D.; Rolfes, Christina; Schmitz, Wilhelm; Mueller, Frank U.] Univ Munster, Inst Pharmacol & Toxicol, D-48149 Munster, Germany; [Gerke, Volker] Univ Munster, Ctr Mol Biol Inflammat, Inst Med Biochem, D-48149 Munster, Germany; [Gerke, Volker] Univ Munster, Interdisciplinary Clin Res Ctr, D-48149 Munster, Germany; [Dedman, John R.; Kaetzel, Marcia A.] Univ Cincinnati, Genome Res Inst, Dept Genome Sci, Cincinnati, OH USA	University of Munster; University of Munster; University of Munster; University System of Ohio; University of Cincinnati	Heinick, A (corresponding author), Univ Munster, Inst Pharmacol & Toxicol, Domagkstr 12, D-48149 Munster, Germany.	a.heinick@uni-muenster.de		Heinick, Alexander/0000-0002-3770-105X; Schulte, Jan Sebastian/0000-0003-0336-2632	Deutsche Forschungsgemeinschaft (DFG) [Mu 1376/11-1, Ge 514/9-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The authors thank Melanie Voss, Stefanie Triebel, Andrea Walter, Danuta Mitko, and Heidrun Sickler for excellent technical assistance. This study was supported by Deutsche Forschungsgemeinschaft (DFG) Grants Mu 1376/11-1 ( to F.U.M.) and Ge 514/9-1 ( to V.G.).	Alig J, 2009, P NATL ACAD SCI USA, V106, P12189, DOI 10.1073/pnas.0810332106; Arnold P, 2014, CRIT CARE MED, V42, pE32, DOI 10.1097/CCM.0b013e3182a63e01; Atwood Brady K, 2011, BMC Genomics, V12, P14, DOI 10.1186/1471-2164-12-14; Bauman AL, 2006, MOL CELL, V23, P925, DOI 10.1016/j.molcel.2006.07.025; Boknik P, 2009, BRIT J PHARMACOL, V158, P1557, DOI 10.1111/j.1476-5381.2009.00441.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Camors E, 2005, CARDIOVASC RES, V65, P793, DOI 10.1016/j.cardiores.2004.11.010; CHAN HC, 1994, J BIOL CHEM, V269, P32464; Crosby KC, 2013, BIOPHYS J, V104, P1875, DOI 10.1016/j.bpj.2013.02.057; Defer N, 2000, AM J PHYSIOL-RENAL, V279, pF400, DOI 10.1152/ajprenal.2000.279.3.F400; Delghandi MP, 2005, CELL SIGNAL, V17, P1343, DOI 10.1016/j.cellsig.2005.02.003; Draeger A, 2011, BIOCHEM PHARMACOL, V81, P703, DOI 10.1016/j.bcp.2010.12.027; Dreier R, 1998, HISTOCHEM CELL BIOL, V110, P137, DOI 10.1007/s004180050275; Escriba PV, 2007, BBA-BIOMEMBRANES, V1768, P836, DOI 10.1016/j.bbamem.2006.09.001; ESPINASSE I, 1995, J MOL CELL CARDIOL, V27, P1789, DOI 10.1016/0022-2828(95)90002-0; Friedrich MW, 2010, J BIOL CHEM, V285, P23283, DOI 10.1074/jbc.M110.124545; Geng WD, 2005, AM J PHYSIOL-CELL PH, V288, pC1305, DOI 10.1152/ajpcell.00584.2004; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; GILMANSHIN R, 1994, BIOCHEMISTRY-US, V33, P8225, DOI 10.1021/bi00193a008; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Guellich A, 2014, PFLUG ARCH EUR J PHY, V466, P1163, DOI 10.1007/s00424-014-1515-1; GULICK J, 1991, J BIOL CHEM, V266, P9180; GunteskiHamblin AM, 1996, AM J PHYSIOL-HEART C, V270, pH1091, DOI 10.1152/ajpheart.1996.270.3.H1091; Hanoune J, 2001, ANNU REV PHARMACOL, V41, P145, DOI 10.1146/annurev.pharmtox.41.1.145; Hurley JH, 1999, J BIOL CHEM, V274, P7599, DOI 10.1074/jbc.274.12.7599; Jeon YJ, 2010, CELL MOL LIFE SCI, V67, P2271, DOI 10.1007/s00018-010-0331-9; KAETZEL MA, 1994, J BIOL CHEM, V269, P5297; Lai L, 2013, CIRCULATION, V127, P1692, DOI 10.1161/CIRCULATIONAHA.112.001212; Lee KW, 2002, J NEUROSCI, V22, P7931; Lewin G, 2009, CIRCULATION, V119, P79, DOI 10.1161/CIRCULATIONAHA.108.786533; Li BL, 2003, J BIOL CHEM, V278, P43276, DOI 10.1074/jbc.M306361200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Matteo RG, 2000, CARDIOVASC RES, V45, P961, DOI 10.1016/S0008-6363(99)00409-5; Moss SE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-219; Muller FU, 2002, FASEB J, V16, P103, DOI 10.1096/fj.02-0486fje; Nikolaev VO, 2006, CIRC RES, V99, P1084, DOI 10.1161/01.RES.0000250046.69918.d5; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Piljic A, 2006, MOL BIOL CELL, V17, P3318, DOI 10.1091/mbc.E06-01-0041; Polouliakh N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004189; Schrickel JW, 2007, CARDIOVASC RES, V76, P257, DOI 10.1016/j.cardiores.2007.07.001; Schulte JS, 2012, AM J PHYSIOL-HEART C, V302, pH1998, DOI 10.1152/ajpheart.00057.2011; Tang T, 2006, BASIC RES CARDIOL, V101, P117, DOI 10.1007/s00395-005-0559-y; Tang T, 2008, CIRCULATION, V117, P61, DOI 10.1161/CIRCULATIONAHA.107.730069; van der Krogt GNM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001916; Vatner SF, 2013, AM J PHYSIOL-HEART C, V305, pH1, DOI 10.1152/ajpheart.00080.2013; Vatner SF, 2009, CIRC J, V73, P195, DOI 10.1253/circj.CJ-08-0957; Yan L, 2007, CELL, V130, P247, DOI 10.1016/j.cell.2007.05.038; ZAKS WJ, 1991, BIOCHEMISTRY-US, V30, P9607, DOI 10.1021/bi00104a007	49	24	25	1	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2015	29	9					3773	3787		10.1096/fj.14-269837	http://dx.doi.org/10.1096/fj.14-269837			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CP5IU	26023182				2022-12-26	WOS:000359915600015
J	Subramanian, D; Bunjobpol, W; Sabapathy, K				Subramanian, Deepa; Bunjobpol, Wilawan; Sabapathy, Kanaga			Interplay between TAp73 Protein and Selected Activator Protein-1 (AP-1) Family Members Promotes AP-1 Target Gene Activation and Cellular Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-JUN; TRANSCRIPTIONAL ACTIVATION; TUMOR-SUPPRESSOR; DNA-DAMAGE; MATRIX METALLOPROTEINASE-1; P53-RELATED PROTEIN; MOUSE DEVELOPMENT; P73; P53; EXPRESSION	Unlike p53, which is mutated at a high rate in human cancers, its homologue p73 is not mutated but is often overexpressed, suggesting a possible context-dependent role in growth promotion. Previously, we have shown that co-expression of TAp73 with the proto-oncogene c-Jun can augment cellular growth and potentiate transactivation of activator protein (AP)-1 target genes such as cyclin D1. Here, we provide further mechanistic insights into the cooperative activity between these two transcription factors. Our data show that TAp73-mediated AP-1 target gene transactivation relies on c-Jun dimerization and requires the canonical AP-1 sites on target gene promoters. Interestingly, only selected members of the Fos family of proteins such as c-Fos and Fra1 were found to cooperate with TAp73 in a c-Jun-dependent manner to transactivate AP-1 target promoters. Inducible expression of TAp73 led to the recruitment of these Fos family members to the AP-1 target promoters on which TAp73 was found to be bound near the AP-1 site. Consistent with the binding of TAp73 and AP-1 members on the target promoters in a c-Jun-dependent manner, TAp73 was observed to physically interact with c-Jun specifically at the chromatin via its carboxyl-terminal region. Furthermore, co-expression of c-Fos or Fra1 was able to cooperate with TAp73 in potentiating cellular growth, similarly to c-Jun. These data together suggest that TAp73 plays a vital role in activation of AP-1 target genes via direct binding to c-Jun at the target promoters, leading to enhanced loading of other AP-1 family members, thereby leading to cellular growth.	[Subramanian, Deepa; Bunjobpol, Wilawan; Sabapathy, Kanaga] Natl Canc Ctr, Humphrey Oei Inst Canc Res, Div Cellular & Mol Res, Singapore 169610, Singapore; [Sabapathy, Kanaga] Duke NUS Grad Med Sch, Canc & Stem Cell Biol Program, Singapore 169857, Singapore; [Sabapathy, Kanaga] Natl Univ Singapore, Dept Biochem, Singapore 117597, Singapore	National Cancer Centre Singapore (NCCS); National University of Singapore; National University of Singapore	Sabapathy, K (corresponding author), Natl Canc Ctr, Humphrey Oei Inst Canc Res, Div Cellular & Mol Res, Mol Carcinogenesis Lab, 11 Hosp Dr, Singapore 169610, Singapore.	cmrksb@nccs.com.sg			National Medical Research Council	National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the National Medical Research Council (to K. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Bakiri L, 2002, MOL CELL BIOL, V22, P4952, DOI 10.1128/MCB.22.13.4952-4964.2002; Brown PH, 1996, CELL GROWTH DIFFER, V7, P1013; Bunjobpo W, 2014, CELL DEATH DIFFER, V21, P1240, DOI 10.1038/cdd.2014.41; Chen XB, 2001, ONCOGENE, V20, P769, DOI 10.1038/sj.onc.1204149; Conforti F, 2012, AGING-US, V4, P202, DOI 10.18632/aging.100441; Dotsch V, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004887; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Du WJ, 2013, NAT CELL BIOL, V15, P991, DOI 10.1038/ncb2789; Dulloo I, 2005, J BIOL CHEM, V280, P28203, DOI 10.1074/jbc.M501702200; ESTUS S, 1994, J CELL BIOL, V127, P1717, DOI 10.1083/jcb.127.6.1717; Gong JG, 1999, NATURE, V399, P806; GRIGORIADIS AE, 1993, J CELL BIOL, V122, P685, DOI 10.1083/jcb.122.3.685; Hasenfuss SC, 2014, CELL METAB, V19, P84, DOI 10.1016/j.cmet.2013.11.018; HERBER B, 1994, ONCOGENE, V9, P1295; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Ishimoto O, 2002, CANCER RES, V62, P636; Ji ZL, 2012, MOL CELL BIOL, V32, P385, DOI 10.1128/MCB.05504-11; Jochum W, 2001, ONCOGENE, V20, P2401, DOI 10.1038/sj.onc.1204389; Jost CA, 1997, NATURE, V389, P191, DOI 10.1038/38298; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Koeppel M, 2011, NUCLEIC ACIDS RES, V39, P6069, DOI 10.1093/nar/gkr028; Lee CW, 1999, ONCOGENE, V18, P4171, DOI 10.1038/sj.onc.1202793; Lefkimmiatis K, 2009, CANCER RES, V69, P8563, DOI 10.1158/0008-5472.CAN-09-0259; Levrero M, 2000, J CELL SCI, V113, P1661; Lin KW, 2004, NEOPLASIA, V6, P546, DOI 10.1593/neo.04205; Melino G, 2002, NAT REV CANCER, V2, P605, DOI 10.1038/nrc861; Moll UM, 2004, MOL CANCER RES, V2, P371; Novak U, 2001, ANN ONCOL, V12, P981, DOI 10.1023/A:1011153206003; Passegue E, 2000, EMBO J, V19, P2969, DOI 10.1093/emboj/19.12.2969; Passegue E, 2002, NAT GENET, V30, P158, DOI 10.1038/ng790; SAEZ E, 1995, CELL, V82, P721, DOI 10.1016/0092-8674(95)90469-7; Schreiber M, 1999, GENE DEV, V13, P607, DOI 10.1101/gad.13.5.607; Shaulian E, 2000, CELL, V103, P897, DOI 10.1016/S0092-8674(00)00193-8; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shikama N, 1997, TRENDS CELL BIOL, V7, P230, DOI 10.1016/S0962-8924(97)01048-9; Shiozawa T, 2004, ONCOGENE, V23, P8603, DOI 10.1038/sj.onc.1207849; Sprowles A, 2003, ONCOGENE, V22, P498, DOI 10.1038/sj.onc.1206165; Stiewe T, 2002, CELL DEATH DIFFER, V9, P237, DOI 10.1038/sj.cdd.4400995; Sun YB, 2002, J BIOL CHEM, V277, P1544, DOI 10.1074/jbc.M100567200; Talotta F, 2010, ONCOGENE, V29, P4732, DOI 10.1038/onc.2010.211; Toh WH, 2008, NUCLEIC ACIDS RES, V36, P4498, DOI 10.1093/nar/gkn414; Toh WH, 2005, J BIOL CHEM, V280, P17329, DOI 10.1074/jbc.M500044200; Toh WH, 2004, J BIOL CHEM, V279, P44713, DOI 10.1074/jbc.M407672200; Tomasini R, 2008, GENE DEV, V22, P2677, DOI 10.1101/gad.1695308; Verde P, 2007, CELL CYCLE, V6, P2633, DOI 10.4161/cc.6.21.4850; Vikhanskaya F, 2007, NAT CELL BIOL, V9, P698, DOI 10.1038/ncb1598; White LA, 1995, MATRIX BIOL, V14, P715, DOI 10.1016/S0945-053X(05)80014-9; Wilhelm MT, 2010, GENE DEV, V24, P549, DOI 10.1101/gad.1873910; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607; Zaika A, 2001, J BIOL CHEM, V276, P11310, DOI 10.1074/jbc.M005737200; Zaika AI, 2002, J EXP MED, V196, P765, DOI 10.1084/jem.20020179; Zeng XY, 2000, MOL CELL BIOL, V20, P1299, DOI 10.1128/MCB.20.4.1299-1310.2000; Zhu JH, 1998, CANCER RES, V58, P5061; Zwahlen D, 2000, INT J CANCER, V88, P66	55	21	22	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18636	18649		10.1074/jbc.M115.636548	http://dx.doi.org/10.1074/jbc.M115.636548			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26018080	Green Published, hybrid			2022-12-26	WOS:000358512100033
J	Merhi, A; De Mees, C; Abdo, R; Alberola, JV; Marini, AM				Merhi, Ahmad; De Mees, Christelle; Abdo, Rami; Alberola, Jennifer Victoria; Marini, Anna Maria			Wnt/beta-Catenin Signaling Regulates the Expression of the Ammonium Permease Gene RHBG in Human Cancer Cells	PLOS ONE			English	Article							BETA-CATENIN; CYCLIN D1; TRANSPORTER PROTEINS; GLUTAMINE-SYNTHETASE; B GLYCOPROTEIN; COLON-CANCER; MOUSE; RHCG; ACTIVATION; IDENTIFICATION	Ammonium is a metabolic waste product mainly detoxified by the liver. Hepatic dysfunction can lead to cytotoxic accumulation of circulating ammonium and to subsequent encephalopathy. Transmembrane ammonium transport is a widely spread process ensured by the highly conserved proteins of the Mep-Amt-Rh superfamily, including the mammalian Rhesus (Rh) factors. The regulatory mechanisms involved in the control of RH genes expression remain poorly studied. Here we addressed the expression regulation of one of these factors, RHBG. We identify HepG2 hepatocellular carcinoma cells and SW480 colon adenocarcinoma cells as expressing RHBG and show that its expression relies on beta-catenin signaling. siRNA-mediated beta-catenin knockdown resulted in significant reduction of RHBG mRNA in both cell lines. Pharmaceutical inhibition of the TCF4/beta-catenin interaction or knockdown of the transcription factor TCF4 also downregulated RHBG expression. We identify a minimal RHBG regulatory sequence displaying a promoter activity and show that beta-catenin and TCF4 bind to this fragment in vivo. We finally characterize the role of potential TCF4 binding sites in RHBG regulation. Taken together, our results indicate RHBG expression as a direct target of beta-catenin regulation, a pathway frequently deregulated in many cancers and associated with tumorigenesis.	[Merhi, Ahmad; De Mees, Christelle; Abdo, Rami; Alberola, Jennifer Victoria; Marini, Anna Maria] Univ Libre Bruxelles, IBMM, Biol Membrane Transport Lab, Gosselies, Belgium	Universite Libre de Bruxelles	Marini, AM (corresponding author), Univ Libre Bruxelles, IBMM, Biol Membrane Transport Lab, Gosselies, Belgium.	amarini@ulb.ac.be		Merhi, Ahmad/0000-0001-7046-2508	Belgian Fonds de la Recherche Scientifique F.R.S.-FNRS [F.R.S.M. 3.4633.09, M.I.S. F.4.521.10.F]; Federation Wallonie-Bruxelles (Action de Recherche Concertee); International Brachet Stiftung; Jean Brachet foundation; Alice et David Van Buuren foundation; Televie grant; da Vinci program	Belgian Fonds de la Recherche Scientifique F.R.S.-FNRS(Fonds de la Recherche Scientifique - FNRS); Federation Wallonie-Bruxelles (Action de Recherche Concertee); International Brachet Stiftung; Jean Brachet foundation; Alice et David Van Buuren foundation; Televie grant; da Vinci program	This work was supported by grants from the Belgian Fonds de la Recherche Scientifique F.R.S.-FNRS (F.R.S.M. 3.4633.09, M.I.S. F.4.521.10.F), the Federation Wallonie-Bruxelles (Action de Recherche Concertee), the International Brachet Stiftung, the Jean Brachet and the Alice et David Van Buuren foundations. A.M. is a scientific research worker supported by a Televie grant, C.D. was a scientific research worker of the F.R.S.-FNRS, JVA was supported by a da Vinci program, and A.M.M. is a senior research associate of the F.R.S.-FNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit S, 2002, GENE DEV, V16, P1066, DOI 10.1101/gad.230302; Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Auron A, 2012, PEDIATR NEPHROL, V27, P207, DOI 10.1007/s00467-011-1838-5; Benhamouche S, 2006, DEV CELL, V10, P759, DOI 10.1016/j.devcel.2006.03.015; Bishop JM, 2010, AM J PHYSIOL-RENAL, V299, pF1065, DOI 10.1152/ajprenal.00277.2010; Biver S, 2008, NATURE, V456, P339, DOI 10.1038/nature07518; Bottomly D, 2010, NUCLEIC ACIDS RES, V38, P5735, DOI 10.1093/nar/gkq363; Cadoret A, 2002, ONCOGENE, V21, P8293, DOI 10.1038/sj.onc.1206118; Cha MY, 2004, HEPATOLOGY, V39, P1683, DOI 10.1002/hep.20245; Chambrey R, 2005, AM J PHYSIOL-RENAL, V289, pF1281, DOI 10.1152/ajprenal.00172.2005; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; de La Coste A, 1998, P NATL ACAD SCI USA, V95, P8847; Desbois-Mouthon C, 2002, HEPATOLOGY, V36, P1528, DOI 10.1053/jhep.2002.37192; Eng CH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000911; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Harder LM, 2014, COMP PHOSPHOPROTEOMI, P1, DOI [10.4161/auto.26863, DOI 10.4161/AUT0.26863]; Iyer VV, 2010, BIOTECHNOL BIOENG, V107, P347, DOI 10.1002/bit.22799; Javelle A, 2005, BIOCHEM J, V390, P215, DOI 10.1042/BJ20042094; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Kim SE, 2013, SCIENCE, V340, P867, DOI 10.1126/science.1232389; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Lee HW, 2013, REPRODUCTION, V146, P283, DOI 10.1530/REP-13-0154; Lepourcelet M, 2004, CANCER CELL, V5, P91, DOI 10.1016/S1535-6108(03)00334-9; Leung JY, 2002, J BIOL CHEM, V277, P21657, DOI 10.1074/jbc.M200139200; Lin SY, 2000, P NATL ACAD SCI USA, V97, P4262, DOI 10.1073/pnas.060025397; Liu XX, 2005, CURR BIOL, V15, P1989, DOI 10.1016/j.cub.2005.10.050; Liu Z, 2000, J BIOL CHEM, V275, P25641, DOI 10.1074/jbc.M003353200; Liu Z, 2001, J BIOL CHEM, V276, P1424, DOI 10.1074/jbc.M007528200; Ma L, 2014, GASTROINTESTINAL CAN, V4, P49, DOI DOI 10.2147/GICTT.S44256; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; MARINI AM, 1994, EMBO J, V13, P3456, DOI 10.1002/j.1460-2075.1994.tb06651.x; Marini AM, 1997, TRENDS BIOCHEM SCI, V22, P460, DOI 10.1016/S0968-0004(97)01132-8; Marini AM, 2000, NAT GENET, V26, P341, DOI 10.1038/81656; Marini AM, 1997, MOL CELL BIOL, V17, P4282, DOI 10.1128/MCB.17.8.4282; Mavri-Damelin Demetra, 2007, Int J Biochem Cell Biol, V39, P555, DOI 10.1016/j.biocel.2006.10.007; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; MUNEMITSU S, 1995, P NATL ACAD SCI USA, V92, P3046, DOI 10.1073/pnas.92.7.3046; Najafov A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037013; Nakhoul NL, 2013, MOL ASPECTS MED, V34, P629, DOI 10.1016/j.mam.2012.05.013; NINNEMANN O, 1994, EMBO J, V13, P3464, DOI 10.1002/j.1460-2075.1994.tb06652.x; Quentin F, 2003, J AM SOC NEPHROL, V14, P545, DOI 10.1097/01.ASN.0000050413.43662.55; Rowan AJ, 2000, P NATL ACAD SCI USA, V97, P3352, DOI 10.1073/pnas.97.7.3352; Rubinfeld B, 1997, SCIENCE, V275, P1790, DOI 10.1126/science.275.5307.1790; RUBINFELD B, 1995, J BIOL CHEM, V270, P5549, DOI 10.1074/jbc.270.10.5549; Rubinfeld B, 1997, CANCER RES, V57, P4624; Saegusa M, 2006, INT J CANCER, V119, P2294, DOI 10.1002/ijc.22112; Sekine S, 2006, HEPATOLOGY, V43, P817, DOI 10.1002/hep.21131; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Solanas G, 2008, J CELL SCI, V121, P2224, DOI 10.1242/jcs.021667; Stahl S, 2005, HEPATOLOGY, V42, P353, DOI 10.1002/hep.20768; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Tardito S, 2011, CURR CANCER DRUG TAR, V11, P929, DOI 10.2174/156800911797264725; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; van Straaten HWM, 2006, BIOCHEM CELL BIOL, V84, P215, DOI 10.1139/O05-170; Verlander JW, 2003, AM J PHYSIOL-RENAL, V284, pF323, DOI 10.1152/ajprenal.00050.2002; von Wiren N, 2004, TOP CURR GENET, V9, P95; Weiner ID, 2013, COMPR PHYSIOL, V3, P201, DOI 10.1002/cphy.c120010; Weiner ID, 2003, ACTA PHYSIOL SCAND, V179, P331, DOI 10.1046/j.0001-6772.2003.01210.x; Weiner ID, 2003, GASTROENTEROLOGY, V124, P1432, DOI 10.1016/S0016-5085(03)00277-4; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Wu G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004926; Xu LF, 2000, GENE DEV, V14, P585; Yamashita T, 2007, CANCER RES, V67, P10831, DOI 10.1158/0008-5472.CAN-07-0908; Zeng G, 2007, NEOPLASIA, V9, P951, DOI 10.1593/neo.07469; Zidi-Yahiaoui N, 2005, BIOCHEM J, V391, P33, DOI 10.1042/BJ20050657	68	15	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128683	10.1371/journal.pone.0128683	http://dx.doi.org/10.1371/journal.pone.0128683			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26029888	gold, Green Submitted, Green Published			2022-12-26	WOS:000356630900184
J	Gupta, MK; Asosingh, K; Aronica, M; Comhair, S; Cao, GY; Erzurum, S; Panettieri, RA; Prasad, SVN				Gupta, Manveen K.; Asosingh, Kewal; Aronica, Mark; Comhair, Suzy; Cao, Gaoyuan; Erzurum, Serpil; Panettieri, Reynold A., Jr.; Prasad, Sathyamangla V. Naga			Defective Resensitization in Human Airway Smooth Muscle Cells Evokes beta-Adrenergic Receptor Dysfunction in Severe Asthma	PLOS ONE			English	Article							PHOSPHOINOSITIDE 3-KINASE GAMMA; IN-VIVO; DESENSITIZATION; AGONISTS; KINASE; BETA(2)-ADRENOCEPTOR; METAANALYSIS; INHIBITION; MECHANISMS	beta(2)-adrenergic receptor (beta(2)AR) agonists (beta(2)-agonist) are the most commonly used therapy for acute relief in asthma, but chronic use of these bronchodilators paradoxically exacerbates airway hyper-responsiveness. Activation of beta ARs by beta-agonist leads to desensitization (inactivation) by phosphorylation through G-protein coupled receptor kinases (GRKs) which mediate beta-arrestin binding and beta AR internalization. Resensitization occurs by dephosphorylation of the endosomal beta ARs which recycle back to the plasma membrane as agonist-ready receptors. To determine whether the loss in beta-agonist response in asthma is due to altered beta AR desensitization and/or resensitization, we used primary human airway smooth muscle cells (HASMCs) isolated from the lungs of non-asthmatic and fatal-asthmatic subjects. Asthmatic HASMCs have diminished adenylyl cyclase activity and cAMP response to beta-agonist as compared to non-asthmatic HASMCs. Confocal microscopy showed significant accumulation of phosphorylated beta(2)ARs in asthmatic HASMCs. Systematic analysis of desensitization components including GRKs and beta-arrestin showed no appreciable differences between asthmatic and non-asthmatic HASMCs. However, asthmatic HASMC showed significant increase in PI3K gamma activity and was associated with reduction in PP2A activity. Since reduction in PP2A activity could alter receptor resensitization, endosomal fractions were isolated to assess the agonist ready beta(2)ARs as a measure of resensitization. Despite significant accumulation of beta(2)ARs in the endosomes of asthmatic HASMCs, endosomal beta(2)ARs cannot robustly activate adenylyl cyclase. Furthermore, endosomes from asthmatic HASMCs are associated with significant increase in PI3K gamma and reduced PP2A activity that inhibits beta(2)AR resensitization. Our study shows that resensitization, a process considered to be a homeostasis maintaining passive process is inhibited in asthmatic HASMCs contributing to beta(2)AR dysfunction which may underlie asthma pathophysiology and loss in asthma control.	[Gupta, Manveen K.; Prasad, Sathyamangla V. Naga] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44106 USA; [Asosingh, Kewal; Aronica, Mark; Comhair, Suzy; Erzurum, Serpil] Cleveland Clin, Lerner Res Inst, Dept Pathol, Cleveland, OH 44106 USA; [Cao, Gaoyuan; Panettieri, Reynold A., Jr.] Univ Penn, Airways Biol Initiat Pulm Allergy & Crit Care Div, Philadelphia, PA 19104 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of Pennsylvania	Prasad, SVN (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44106 USA.	prasads2@ccf.org	panettieri, reynold/AAG-9485-2019		Molecular Cardiology start-up funds [HL089473, HL115008, HL081064, HL103453, P01-HL114471, P30-ES013508]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL103453, R24HL123767, U01HL110942, R01HL115008, P01HL081064, P01HL114471, R01HL089473] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER	Molecular Cardiology start-up funds; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by Molecular Cardiology start-up funds & HL089473 (SVNP); HL115008 (SVNP & SE); HL081064, HL103453 (SE); P01-HL114471 & P30-ES013508 (RAP), http://www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes PJ, 2010, MED PRIN PRACT, V19, P330, DOI 10.1159/000316368; Bond RA, 2011, BRIT J PHARMACOL, V163, P1, DOI 10.1111/j.1476-5381.2011.01239.x; Choi DJ, 1997, J BIOL CHEM, V272, P17223, DOI 10.1074/jbc.272.27.17223; Deshpande DA, 2008, FASEB J, V22, P2134, DOI 10.1096/fj.07-102459; Deshpande DA, 2006, CELL SIGNAL, V18, P2105, DOI 10.1016/j.cellsig.2006.04.008; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Hata Jonathan A, 2003, Mol Interv, V3, P264, DOI 10.1124/mi.3.5.264; Hegde A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116458; Heitzler D, 2009, CR BIOL, V332, P947, DOI 10.1016/j.crvi.2009.09.002; Huang ZM, 2011, FRONT BIOSCI-LANDMRK, V16, P3047, DOI 10.2741/3898; Iaccarino G, 2005, EUR HEART J, V26, P1752, DOI 10.1093/eurheartj/ehi429; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Johnson M, 2006, J ALLERGY CLIN IMMUN, V117, P18, DOI 10.1016/j.jaci.2005.11.012; Kong KC, 2008, BIOCHEMISTRY-US, V47, P9279, DOI 10.1021/bi801056w; Krueger KM, 1997, J BIOL CHEM, V272, P5; Li M, 1998, METH MOL B, V93, P59; Lin R, 2008, PULM PHARMACOL THER, V21, P115, DOI 10.1016/j.pupt.2007.06.003; Lin R, 2012, BRIT J PHARMACOL, V165, P2365, DOI 10.1111/j.1476-5381.2011.01725.x; Lopez-Ilasaca M, 1998, J BIOL CHEM, V273, P2505, DOI 10.1074/jbc.273.5.2505; Loza Matthew J, 2010, Front Biosci (Schol Ed), V2, P969; Luttrell LM, 2002, J CELL SCI, V115, P455; Mak JCW, 2002, BRIT J PHARMACOL, V135, P987, DOI 10.1038/sj.bjp.0704545; Morgan SJ, 2014, J BIOL CHEM; Moulton BC, 2011, BRIT J PHARMACOL, V163, P44, DOI 10.1111/j.1476-5381.2010.01190.x; Nienaber JJ, 2003, J CLIN INVEST, V112, P1067, DOI 10.1172/JCI200318213; Penn Raymond B, 2008, Proc Am Thorac Soc, V5, P47, DOI 10.1513/pats.200705-054VS; Penn Raymond B, 2014, Handb Exp Pharmacol, V219, P387, DOI 10.1007/978-3-642-41199-1_20; Penn RB, 2009, P NATL ACAD SCI USA, V106, P2095, DOI 10.1073/pnas.0812935106; Penn RB, 1998, AM J RESP CELL MOL, V19, P338, DOI 10.1165/ajrcmb.19.2.3025; Penn RB, 2001, J BIOL CHEM, V276, P32648, DOI 10.1074/jbc.M104143200; Perrino C, 2005, CIRCULATION, V111, P2579, DOI 10.1161/CIRCULATIONAHA.104.508796; Prasad SVN, 2000, J BIOL CHEM, V275, P4693, DOI 10.1074/jbc.275.7.4693; Prasad SVN, 2005, NAT CELL BIOL, V7, P785, DOI 10.1038/ncb1278; Prasad SVN, 2001, J BIOL CHEM, V276, P18953, DOI 10.1074/jbc.M102376200; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; Salpeter SR, 2006, ANN INTERN MED, V144, P904, DOI 10.7326/0003-4819-144-12-200606200-00126; Salpeter SR, 2004, ANN INTERN MED, V140, P802, DOI 10.7326/0003-4819-140-10-200405180-00010; Shenoy SK, 2011, NATURE, V477, P546, DOI 10.1038/477546a; Shore SA, 2003, RESP PHYSIOL NEUROBI, V137, P179, DOI 10.1016/S1569-9048(03)00146-0; Shore SA, 2003, J CLIN INVEST, V112, P495, DOI 10.1172/JCI200319642; Sontag E, 2001, CELL SIGNAL, V13, P7, DOI 10.1016/S0898-6568(00)00123-6; Stoyanova S, 1997, BIOCHEM J, V324, P489, DOI 10.1042/bj3240489; Trian T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020000; TURKI J, 1995, AM J RESP CELL MOL, V12, P531, DOI 10.1165/ajrcmb.12.5.7742016; Vasudevan NT, 2011, CELL CYCLE, V10, P3684, DOI 10.4161/cc.10.21.18042; Vasudevan NT, 2011, MOL CELL, V41, P636, DOI 10.1016/j.molcel.2011.02.025; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Walker JKL, 2011, BRIT J PHARMACOL, V163, P18, DOI 10.1111/j.1476-5381.2010.01178.x	48	12	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0125803	10.1371/journal.pone.0125803	http://dx.doi.org/10.1371/journal.pone.0125803			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26023787	Green Published, Green Submitted, gold			2022-12-26	WOS:000355319400010
J	Lei, Y; Yang, L; Ye, CY; Qin, MY; Yang, HY; Jiang, HL; Tang, XC; Zhang, HY				Lei, Yun; Yang, Ling; Ye, Chun Yan; Qin, Ming Yan; Yang, Huai Yu; Jiang, Hua Liang; Tang, Xi Can; Zhang, Hai Yan			Involvement of Intracellular and Mitochondrial A beta in the Ameliorative Effects of Huperzine A against Oligomeric A beta(42)-Induced Injury in Primary Rat Neurons	PLOS ONE			English	Article							AMYLOID-BETA; ALZHEIMERS-DISEASE; CELL-DEATH; OXIDATIVE STRESS; ACCUMULATION; DYSFUNCTION; PEPTIDE; PROTEIN; AGGREGATION; HYPOTHESIS	Considerable studies indicate huperzine A is a promising natural product to suppress neuronal damages induced by beta-amyloid (A beta), a key pathogenic event in the Alzheimer's disease (AD). As an extension, the present study for the first time explored whether the beneficial profiles of huperzine A against oligomeric A beta(42) induced neurotoxicity are associated with the accumulation and detrimental function of intraneuronal/mitochondrial A beta, on the basis of the emerging evidence that intracellular A beta is more relevant to AD progression as compared with extracellular A beta. Huperzine A treatment was shown to significantly attenuate the neurotoxicity of oligomeric A beta(42), as demonstrated by increased neuronal viability. Interestingly, our results proved that exogenous A beta(42) could accumulate intraneuronally in a dose-and time-dependent manner, while huperzine A treatment markedly reduced the level of intracellular A beta(42). Moreover, huperzine A treatment rescued mitochondrial dysfunction induced by oligomeric A beta(42), including adenosine triphosphate (ATP) reduction, reactive oxygen species (ROS) overproduction and membrane potential depolarization. Further study demonstrated that huperzine A also significantly reduced the level of A beta(42) in the mitochondria-enriched subcellular fractions, as well as the A beta(42) fluorescent signals colocalized with mitochondrial marker. This study indicates that interfering intracellular A beta especially mitochondrial A beta accumulation, together with ameliorating A beta-associated mitochondrial dysfunction, may contribute to the protective effects of huperzine A against A beta neurotoxicity. Above results may shed more light on the pharmacological mechanisms of huperzine A and provide important clues for discovering novel therapeutic strategies for AD.	[Lei, Yun; Yang, Ling; Ye, Chun Yan] Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Shanghai 200031, Peoples R China; [Qin, Ming Yan; Yang, Huai Yu; Jiang, Hua Liang; Tang, Xi Can; Zhang, Hai Yan] Chinese Acad Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr, State Key Lab Drug Res, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Zhang, HY (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr, State Key Lab Drug Res, Shanghai 200031, Peoples R China.	hzhang@simm.ac.cn		Lei, Yun/0000-0003-4572-6078	National Natural Science Foundation of China [81173034]; National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program" of China [2012ZX09301001-004]; Ministry of Science and Technology of China [2011CB510004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program" of China; Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by the National Natural Science Foundation of China (No 81173034), the National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program" of China (No. 2012ZX09301001-004), and the Ministry of Science and Technology of China (No 2011CB510004).	Agostinho P, 2003, EUR J NEUROSCI, V17, P1189, DOI 10.1046/j.1460-9568.2003.02546.x; Belluti F, 2013, EXPERT OPIN THER PAT, V23, P581, DOI 10.1517/13543776.2013.772983; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Bhaskar K, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-14; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Burton JD, 2005, METH MOLEC MED, V110, P69; Caspersen C, 2005, FASEB J, V19, P2040, DOI 10.1096/fj.05-3735fje; Cha MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034929; Choi H, 2012, NEUROTOXICOLOGY, V33, P85, DOI 10.1016/j.neuro.2011.12.005; Choy RWY, 2012, P NATL ACAD SCI USA, V109, pE2077, DOI 10.1073/pnas.1208635109; Du J, 2000, J CELL BIOL, V150, P1423, DOI 10.1083/jcb.150.6.1423; Ferreira ST, 2007, IUBMB LIFE, V59, P332, DOI 10.1080/15216540701283882; Gao X, 2006, J NEUROSCI RES, V83, P1048, DOI 10.1002/jnr.20791; Gouras GK, 2005, NEUROBIOL AGING, V26, P1235, DOI 10.1016/j.neurobiolaging.2005.05.022; Gouras GK, 2010, ACTA NEUROPATHOL, V119, P523, DOI 10.1007/s00401-010-0679-9; Guo JH, 2014, EXP THER MED, V8, P1271, DOI 10.3892/etm.2014.1885; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; He Y, 2011, ASN NEURO, V3, DOI [10.1042/AN20100025, DOI 10.1155/2012/843649]; He Y, 2011, ASN NEURO, V3, P13, DOI 10.1042/AN20100025; Hung LW, 2008, J NEUROSCI, V28, P11950, DOI 10.1523/JNEUROSCI.3916-08.2008; Kanekiyo T, 2011, J NEUROSCI, V31, P1644, DOI 10.1523/JNEUROSCI.5491-10.2011; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Kayed R, 2013, J ALZHEIMERS DIS, V33, pS67, DOI 10.3233/JAD-2012-129001; Kienlen-Campard P, 2002, J BIOL CHEM, V277, P15666, DOI 10.1074/jbc.M200887200; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Liang JH, 2009, NEUROCHEM INT, V55, P741, DOI 10.1016/j.neuint.2009.07.004; Liu RQ, 2010, J BIOL CHEM, V285, P19986, DOI 10.1074/jbc.M109.036798; Lobner D, 2000, J NEUROSCI METH, V96, P147, DOI 10.1016/S0165-0270(99)00193-4; Sosa-Ortiz AL, 2012, ARCH MED RES, V43, P600, DOI 10.1016/j.arcmed.2012.11.003; Maezawa I, 2006, J NEUROCHEM, V98, P57, DOI 10.1111/j.1471-4159.2006.03862.x; Manczak M, 2006, HUM MOL GENET, V15, P1437, DOI 10.1093/hmg/ddl066; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Petersen CAH, 2008, P NATL ACAD SCI USA, V105, P13145, DOI 10.1073/pnas.0806192105; Picone P, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/780179; Pinho CM, 2014, BBA-BIOENERGETICS, V1837, P1069, DOI 10.1016/j.bbabio.2014.02.007; Ray B, 2009, J NEUROSCI METH, V184, P294, DOI 10.1016/j.jneumeth.2009.08.018; Reed MN, 2011, NEUROBIOL AGING, V32, P1784, DOI 10.1016/j.neurobiolaging.2009.11.007; Resende R, 2008, NEUROSCIENCE, V155, P725, DOI 10.1016/j.neuroscience.2008.06.036; Ryan DA, 2010, J NEUROSCI METH, V190, P171, DOI 10.1016/j.jneumeth.2010.05.001; Sarafian TA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009532; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Song MS, 2011, NEUROSCIENCE, V178, P181, DOI 10.1016/j.neuroscience.2010.12.055; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Takahashi RH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051965; Takahashi RH, 2010, NEUROBIOL AGING, V31, P1145, DOI 10.1016/j.neurobiolaging.2008.07.021; Takuma K, 2009, P NATL ACAD SCI USA, V106, P20021, DOI 10.1073/pnas.0905686106; Umeda T, 2011, J NEUROSCI RES, V89, P1031, DOI 10.1002/jnr.22640; Voigt W, 2005, METH MOLEC MED, V110, P39; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang R, 2006, ACTA PHARMACOL SIN, V27, P1, DOI 10.1111/j.1745-7254.2006.00255.x; Wang Y, 2012, J NEUROSCI RES, V90, P508, DOI 10.1002/jnr.22775; Wirths O, 2012, LIFE SCI, V91, P1148, DOI 10.1016/j.lfs.2012.02.001; Xiao XQ, 2002, J NEUROSCI RES, V67, P30, DOI 10.1002/jnr.10075; Yamazaki T, 2001, J BIOL CHEM, V276, P4454, DOI 10.1074/jbc.M009598200; Zhang HY, 2008, CELL MOL NEUROBIOL, V28, P173, DOI 10.1007/s10571-007-9163-z; Zhang HY, 2006, TRENDS PHARMACOL SCI, V27, P619, DOI 10.1016/j.tips.2006.10.004; Zhang HY, 2002, NEUROSCI LETT, V317, P143, DOI 10.1016/S0304-3940(01)02437-5; Zhang Y, 2002, J CELL BIOL, V156, P519, DOI 10.1083/jcb.200110119	61	21	22	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128366	10.1371/journal.pone.0128366	http://dx.doi.org/10.1371/journal.pone.0128366			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024517	gold, Green Submitted, Green Published			2022-12-26	WOS:000355319400087
J	Pujari-Palmer, M; Pujari-Palmer, S; Engqvist, H; Ott, MK				Pujari-Palmer, Michael; Pujari-Palmer, Shiuli; Engqvist, Hakan; Ott, Marjam Karlsson			Rebamipide Delivered by Brushite Cement Enhances Osteoblast and Macrophage Proliferation	PLOS ONE			English	Article							WATER-SOLUBLE DRUGS; MC3T3-E1 CELLS; MECHANICAL-PROPERTIES; BONE-CEMENT; RAT MODEL; PHOSPHATE; DIFFERENTIATION; RELEASE; RECEPTOR; ACTIVATION	Many of the bioactive agents capable of stimulating osseous regeneration, such as bone morphogenetic protein-2 (BMP-2) or prostaglandin E2 (PGE2), are limited by rapid degradation, a short bioactive half-life at the target site in vivo, or are prohibitively expensive to obtain in large quantities. Rebamipide, an amino acid modified hydroxylquinoline, can alter the expression of key mediators of bone anabolism, cyclo-oxygenase 2 (COX-2), BMP-2 and vascular endothelial growth factor (VEGF), in diverse cell types such as mucosal and endothelial cells or chondrocytes. The present study investigates whether Rebamipide enhances proliferation and differentiation of osteoblasts when delivered from brushite cement. The reactive oxygen species (ROS) quenching ability of Rebampide was tested in macrophages as a measure of bioactivity following drug release incubation times, up to 14 days. Rebamipide release from brushite occurrs via non-fickian diffusion, with a rapid linear release of 9.70%+/- 0.37% of drug per day for the first 5 days, and an average of 0.5%-1% per day thereafter for 30 days. Rebamipide slows the initial and final cement setting time by up to 3 and 1 minute, respectively, but does not significantly reduce the mechanical strength below 4% (weight percentage). Pre-osteoblast proliferation increases by 24% upon exposure to 0.4uM Rebamipide, and by up to 73% when Rebamipide is delivered via brushite cement. Low doses of Rebamipide do not adversely affect peak alkaline phosphatase activity in differentiating pre-osteoblasts. Rebamipide weakly stimulates proliferation in macrophages at low concentrations (118 +/- 7.4% at 1uM), and quenches ROS by 40-60%. This is the first investigation of Rebamipide in osteoblasts.	[Pujari-Palmer, Michael; Pujari-Palmer, Shiuli; Engqvist, Hakan; Ott, Marjam Karlsson] Uppsala Univ, Dept Engn Sci, Div Appl Mat Sci, Uppsala, Sweden	Uppsala University	Ott, MK (corresponding author), Uppsala Univ, Dept Engn Sci, Div Appl Mat Sci, Uppsala, Sweden.	marjam.ott@angstrom.uu.se	Pujari-Palmer, michael/W-4362-2018	Pujari-Palmer, michael/0000-0001-7004-2853	Swedish research council [GA 621-2011-3399]	Swedish research council(Swedish Research CouncilEuropean Commission)	This work was supported by the Swedish research council GA 621-2011-3399 HE MP EU 7th framework project: Biodesign HE MP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg J, 2013, J MATER SCI-MATER M, V24, P829, DOI 10.1007/s10856-013-4855-z; [Anonymous], 1999, AM PHYSL SOC; Arakawa T, 1996, J BIOL CHEM, V271, P29569, DOI 10.1074/jbc.271.47.29569; Bamba H, 2003, ALIMENT PHARM THER, V18, P113, DOI 10.1046/j.1365-2036.18.s1.13.x; Beck GR, 2000, P NATL ACAD SCI USA, V97, P8352, DOI 10.1073/pnas.140021997; Bohner M LJ, 1996, J PHARM SCEINCES, V86, P565; Bohner M, 2012, J EUR CERAM SOC, V32, P2663, DOI 10.1016/j.jeurceramsoc.2012.02.028; Bramono DS, 2012, BONE, V50, P954, DOI 10.1016/j.bone.2011.12.013; BROXMEYER HE, 1977, CANCER RES, V37, P3578; Canal C, 2013, ACTA BIOMATER, V9, P8403, DOI 10.1016/j.actbio.2013.05.016; Chen WC, 2012, TISSUE ENG PT A, V18, P816, DOI [10.1089/ten.tea.2011.0267, 10.1089/ten.TEA.2011.0267]; Chou J, 2013, ADV HEALTHC MATER, V2, P678, DOI 10.1002/adhm.201200342; Choudhary S, 2004, BIOCHEM BIOPH RES CO, V322, P395, DOI 10.1016/j.bbrc.2004.07.129; Clarkin CE, 2008, J CELL PHYSIOL, V214, P537, DOI 10.1002/jcp.21234; Cortizo AM, 2006, EUR J PHARMACOL, V536, P38, DOI 10.1016/j.ejphar.2006.02.030; Dvorak MM, 2004, CELL CALCIUM, V35, P249, DOI 10.1016/j.ceca.2003.10.014; Engstrand J, 2014, J MECH BEHAV BIOMED, V29, P81, DOI 10.1016/j.jmbbm.2013.08.024; Engstrand J, 2013, MAT SCI ENG C-MATER, V33, P527, DOI 10.1016/j.msec.2012.09.026; Ghanaati S, 2011, BIOMATERIALS, V32, P8150, DOI 10.1016/j.biomaterials.2011.07.041; Grover LM, 2003, BIOMATERIALS, V24, P4133, DOI 10.1016/S0142-9612(03)00293-X; Hamanishi C, 1996, J BIOMED MATER RES, V33, P139, DOI 10.1002/(SICI)1097-4636(199623)33:3<139::AID-JBM3>3.0.CO;2-R; Harland AG R.S., 1988, DRUG POLYM MATRIX SW, V5, P488; Hayashi K, 2005, J BONE JOINT SURG BR, V87B, P1150, DOI 10.1302/0301-620X.87B8.15886; Hofmann MP, 2009, ACTA BIOMATER, V5, P43, DOI 10.1016/j.actbio.2008.08.005; Hong WS, 2001, PHARMACOL RES, V44, P293, DOI 10.1006/phrs.2001.0839; Ishihara T, 2010, BIOCHEM PHARMACOL, V79, P1622, DOI 10.1016/j.bcp.2010.01.030; Itoh F, 2003, EUR J PHARMACOL, V477, P9, DOI 10.1016/j.ejphar.2003.08.011; Kamolratanakul P, 2011, ARTHRITIS RHEUM-US, V63, P1021, DOI 10.1002/art.30151; Kanazawa I, 2008, BIOCHEM BIOPH RES CO, V375, P414, DOI 10.1016/j.bbrc.2008.08.034; Kang DW, 2010, EXP MOL MED, V42, P555, DOI 10.3858/emm.2010.42.8.056; Kim JS, 2003, ALIMENTARY PHARM THE, V2003; Kodama HA., 1981, JPN J ORAL BIOL, V23, P899, DOI DOI 10.2330/JORALBIOSCI1965.23.899; KUU WY, 1989, INT J PHARM, V55, P77, DOI 10.1016/0378-5173(89)90279-2; KYEYUNENYOMBI E, 1995, CALCIFIED TISSUE INT, V56, P154, DOI 10.1007/BF00296348; Liu WE, 2011, BIOMATERIALS, V32, P1796, DOI 10.1016/j.biomaterials.2010.11.029; Lubeck DP, 2003, BEST PRACT RES CL RH, V17, P529, DOI 10.1016/S1521-6942(03)00023-8; Monrad SU, 2011, CURR REV MUSCULOSKE, V4, P91, DOI 10.1007/s12178-011-9083-x; Montazerolghaem M, 2014, J BIOMED MATER RES A, V102, P340, DOI 10.1002/jbm.a.34702; Moon SJ, 2012, OSTEOARTHR CARTILAGE, V20, P1426, DOI 10.1016/j.joca.2012.08.002; Mulye N. TS, 1996, DRUG DEV IND PHARM, V22, P2621; Mulye NV, 1996, DRUG DEV IND PHARM, V22, P673, DOI 10.3109/03639049609063223; MULYE NV, 1995, DRUG DEV IND PHARM, V21, P943, DOI 10.3109/03639049509026658; Nishiya Y, 2002, CALCIFIED TISSUE INT, V70, P30, DOI 10.1007/s00223-001-1010-5; Pradhan R, 2014, ARCH PHARM RES; RITGER P L, 1987, Journal of Controlled Release, V5, P23, DOI 10.1016/0168-3659(87)90034-4; SCHOENFELD CM, 1974, MED BIOL ENG, V12, P313, DOI 10.1007/BF02477797; Seeherman HJ, 2004, J BONE JOINT SURG AM, V86A, P1961, DOI 10.2106/00004623-200409000-00015; Shamir D KS, 1994, BONE, V34, P157; Shields LB RG, 2006, SPINE, V31; Suda M, 2000, CALCIFIED TISSUE INT, V66, P217, DOI 10.1007/s002230010043; Suetsugu H, 2000, J LAB CLIN MED, V136, P50, DOI 10.1067/mlc.2000.107303; Tarnawski AS, 2004, DIGEST DIS SCI, V49, P202, DOI 10.1023/B:DDAS.0000017439.60943.5c; Temizel N, 2011, MAT SCI ENG C-MATER, V31, P1136, DOI 10.1016/j.msec.2011.04.009; Tran RT, 2012, GASTROINTEST ENDOSC, V75, P1092, DOI 10.1016/j.gie.2011.12.009; von Knoch F, 2005, BIOMATERIALS, V26, P6941, DOI 10.1016/j.biomaterials.2005.04.059; Vorndran E, 2013, ACTA BIOMATER, V9, P9558, DOI 10.1016/j.actbio.2013.08.009; Wu X, 2007, CELL DEATH DIFFER, V14, P1792, DOI 10.1038/sj.cdd.4402190; Xiaobin ZH Q, 2011, BIOACTIVE MAT MED DE; Zhang J. Q., 2014, PLOS ONE, V9; Zhang WB, 2012, J ORTHOP SCI, V17, P289, DOI 10.1007/s00776-012-0206-z; Zhong X, 2011, ACTA PHARMACOL SIN, V32, P591, DOI 10.1038/aps.2011.15	61	5	5	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128324	10.1371/journal.pone.0128324	http://dx.doi.org/10.1371/journal.pone.0128324			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26023912	Green Submitted, gold, Green Published			2022-12-26	WOS:000355319400083
J	Takeo, T; Nakagata, N				Takeo, Toru; Nakagata, Naomi			Superovulation Using the Combined Administration of Inhibin Antiserum and Equine Chorionic Gonadotropin Increases the Number of Ovulated Oocytes in C57BL/6 Female Mice	PLOS ONE			English	Article							METHYL-BETA-CYCLODEXTRIN; ASSISTED REPRODUCTIVE TECHNOLOGIES; IN-VITRO FERTILIZATION; INBRED MOUSE STRAINS; ENDOGENOUS INHIBIN; ESTROUS-CYCLE; SPERM; SECRETION; EMBRYOS; INDUCTION	Superovulation is a reproductive technique generally used to produce genetically engineered mice. Superovulation in mice involves the administration of equine chorionic gonadotropin (eCG) to promote follicle growth and then that of human chorionic gonadotropin (hCG) to induce ovulation. Previously, some published studies reported that inhibin antiserum (IAS) increased the number of ovulated oocytes in ddY and wild-derived strains of mice. However, the effect of IAS on the C57BL/6 strain, which is the most widely used inbred strain for the production of genetically engineered mice, has not been investigated. In addition, the combined effect of IAS and eCG (IASe) on the number of ovulated oocytes in superovulation treatment has not been examined. In this study, we examined the effect of IAS and eCG on the number of ovulated oocytes in immature female mice of the C57BL/6 strain in superovulation treatment. Furthermore, we evaluated the quality of obtained oocytes produced by superovulation using IASe by in vitro fertilization (IVF) with sperm from C57BL/6 or genetically engineered mice. The developmental ability of fresh or cryopreserved embryos was examined by embryo transfer. The administration of IAS or eCG had a similar effect on the number of ovulated oocytes in C57BL/6 female mice. The number of ovulated oocytes increased to about 3-fold by the administration of IASe than by the administration of IAS or eCG alone. Oocytes derived from superovulation using IASe normally developed into 2-cell embryos by IVF using sperm from C57BL/6 mice. Fresh or cryopreserved 2-cell embryos produced by IVF between oocytes of C57BL/6 mice and sperm from genetically engineered mice normally developed into live pups following embryo transfer. In summary, a novel technique of superovulation using IASe is extremely useful for producing a great number of oocytes and offspring from genetically engineered mice.	[Takeo, Toru; Nakagata, Naomi] Kumamoto Univ, Div Reprod Engn, Ctr Anim Resources & Dev, Chuo Ku, Kumamoto 8600811, Japan	Kumamoto University	Nakagata, N (corresponding author), Kumamoto Univ, Div Reprod Engn, Ctr Anim Resources & Dev, Chuo Ku, 2-2-1 Honjo, Kumamoto 8600811, Japan.	nakagata@kumamoto-u.ac.jp	Takeo, Toru/A-3119-2010	Takeo, Toru/0000-0002-8103-651X; Nakagata, Naomi/0000-0002-5737-9993	Grants-in-Aid for Scientific Research [221S0001] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Akagi S, 1997, J VET MED SCI, V59, P1129, DOI 10.1292/jvms.59.1129; Byers SL, 2006, THERIOGENOLOGY, V65, P1716, DOI 10.1016/j.theriogenology.2005.09.016; DEJONG FH, 1988, PHYSIOL REV, V68, P555, DOI 10.1152/physrev.1988.68.2.555; Eppig JT, 1999, TRENDS GENET, V15, P81, DOI 10.1016/S0168-9525(98)01665-5; FOWLER RE, 1957, J ENDOCRINOL, V15, P374, DOI 10.1677/joe.0.0150374; Guan M, 2012, MAMM GENOME, V23, P572, DOI 10.1007/s00335-012-9423-1; Hasegawa A, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.098491; HO YG, 1995, MOL REPROD DEV, V41, P232, DOI 10.1002/mrd.1080410214; Kishi H, 1996, J ENDOCRINOL, V151, P65, DOI 10.1677/joe.0.1510065; KISHI H, 1995, J ENDOCRINOL, V146, P169, DOI 10.1677/joe.0.1460169; Kito S, 2008, ZYGOTE, V16, P259, DOI 10.1017/S0967199408004619; Medan MS, 2004, ENDOCRINE, V24, P115, DOI 10.1385/ENDO:24:2:115; Mochida K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114305; NAKAGATA N, 1992, EXP ANIM TOKYO, V41, P387, DOI 10.1538/expanim1978.41.3_387; Nakagata N, 2013, CRYOBIOLOGY, V67, P188, DOI 10.1016/j.cryobiol.2013.06.011; Nakagata N, 2009, EXP ANIM TOKYO, V58, P343, DOI 10.1538/expanim.58.343; Nakao K, 1997, EXP ANIM TOKYO, V46, P231, DOI 10.1538/expanim.46.231; Nambo Y, 1998, THERIOGENOLOGY, V50, P545, DOI 10.1016/S0093-691X(98)00160-5; Ogasawara M, 2005, GENE, V349, P107, DOI 10.1016/j.gene.2004.11.050; QUINN P, 1985, FERTIL STERIL, V44, P493; RIVIER C, 1989, ENDOCRINOLOGY, V125, P152, DOI 10.1210/endo-125-1-152; Russell WMS, 2005, ANIM WELFARE, V14, P279; Shi F, 2000, J REPROD FERTIL, V118, P1, DOI 10.1530/reprod/118.1.1; Takeo T, 2010, LAB ANIM-UK, V44, P132, DOI 10.1258/la.2009.009074; Takeo T, 2008, BIOL REPROD, V78, P546, DOI 10.1095/biolreprod.107.065359; Takeo T, 2014, CRYOBIOLOGY, V68, P12, DOI 10.1016/j.cryobiol.2013.10.007; Takeo T, 2012, CRYOBIOLOGY, V65, P163, DOI 10.1016/j.cryobiol.2012.06.002; Takeo T, 2011, BIOL REPROD, V85, P1066, DOI 10.1095/biolreprod.111.092536; Takeo T, 2010, J AM ASSOC LAB ANIM, V49, P415; Takeo T, 2009, CRYOBIOLOGY, V58, P196, DOI 10.1016/j.cryobiol.2008.12.011; Taya K, 1993, CURR TRENDS EXP ENDO, V1, P97; Wade CM, 2002, NATURE, V420, P574, DOI 10.1038/nature01252; Wang H, 2001, REPRODUCTION, V122, P809, DOI 10.1530/reprod/122.5.809	33	69	72	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128330	10.1371/journal.pone.0128330	http://dx.doi.org/10.1371/journal.pone.0128330			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024317	Green Published, gold, Green Submitted			2022-12-26	WOS:000355319400085
J	Guo, ZY; Zhang, Q; Li, XG; Jing, ZY				Guo, Ziyi; Zhang, Qiang; Li, Xiaoguang; Jing, Zhengyu			Intravoxel Incoherent Motion Diffusion Weighted MR Imaging for Monitoring the Instantly Therapeutic Efficacy of Radiofrequency Ablation in Rabbit VX2 Tumors without Evident Links between Conventional Perfusion Weighted Images	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; LIVER-TUMORS; CT; PARAMETERS; EXPERIENCE; THERAPIES; DIAGNOSIS; VALUES	Objective To investigate the intravoxel incoherent motion diffusion weighted imaging (IVIM-DWI) as a potential valuable marker to monitor the therapy responses of VX2 to radiofrequency ablation (RF Ablation). Methods The institutional animal care and use committee approved this study. In 10 VX2 tumor-bearing rabbits, IVIM-DWI examinations were performed with a 3.0T imaging unit by using 16 b values from 0 to 800 sec/mm(2). The true diffusion coefficient (D), pseudodiffusion coefficient (D*) and perfusion fraction (f) of tumors were compared between before and instantly after RF Ablation treatment. The differences of D, D* and f and conventional perfusion parameters (from perfusion CT and dynamic enhanced magnetic resonance imaging, DCE-MRI) in the coagulation necrosis area, residual unablated area, untreated area, and normal control had been calculated by compared t-test. The correlation between f or D* with perfusion weighted CT including blood flow, BF (milliliter per 100 mL/min), blood volume, BV (milliliter per 100 mL/min), and capillary permeability-surface area, PMB (as a fraction) or from DCE-MRI: transfer constant (K-trans), extra-vascular extra-cellular volume fraction (V-e) and reflux constant (K-ep) values had been analyzed by region-of-interest (ROI) methods to calculate Pearson's correlation coefficients. Results In the ablated necrosis areas, f and D* significantly decreased and D significantly increased, compared with residual unblazed areas or untreated control groups and normal control groups (P < 0.001). The IVIM-DWI derived f parameters showed significant increases in the residual unablated tumor area. There was no significant correlations between f or D* and conventional perfusion parameters. Conclusions The IVIM-DWderived f, D and D* parameters have the potential to indicate therapy response immediately after RF Ablation treatment, while no significant correlations with classical tumor perfusion metrics were derived from DCE-MRI and perfusion-CT measurements.	[Guo, Ziyi; Zhang, Qiang; Li, Xiaoguang; Jing, Zhengyu] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Radiol, Beijing 100730, Peoples R China; [Guo, Ziyi; Zhang, Qiang; Li, Xiaoguang; Jing, Zhengyu] Peking Union Med Coll, Beijing 100730, Peoples R China; [Guo, Ziyi] Cent S Univ, Haikou Peoples Hosp, Xiangya Med Sch, Dept Radiol, Haikou 570208, Hainan, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Central South University	Li, XG (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Radiol, Beijing 100730, Peoples R China.	xglee88@126.com; MRI_learn@163.com			Haikou Municipal Bureau of Industry and Information Bureau of the key projects [2012075]; Hainan Natural Science Foundation Project [813261]	Haikou Municipal Bureau of Industry and Information Bureau of the key projects; Hainan Natural Science Foundation Project	This work was supported by the Haikou Municipal Bureau of Industry and Information Bureau of the key projects (contract/grant numbers 2012075) and Hainan Natural Science Foundation Project (contract/grant numbers 813261).	[Anonymous], 2009, NEOPLASIA, V11, P102, DOI 10.1593/neo.81328; Bains LJ, 2012, CANCER IMAGING, V12, P395, DOI 10.1102/1470-7330.2012.9047; Bisdas S, 2014, NMR BIOMED, V27, P1184, DOI 10.1002/nbm.3172; Cheng HLM, 2008, J MAGN RESON IMAGING, V28, P136, DOI 10.1002/jmri.21415; Federau C, 2014, AM J NEURORADIOL, V35, P256, DOI 10.3174/ajnr.A3686; Fritzsche KH, 2012, METHOD INFORM MED, V51, P441, DOI 10.3414/ME11-02-0031; Hennedige T, 2013, CANCER IMAGING, V12, P530, DOI 10.1102/1470-7330.2012.0044; Hoang JK, 2014, AM J ROENTGENOL, V203, P1104, DOI 10.2214/AJR.14.12838; Ikink ME, 2014, EUR RADIOL, V24, P2118, DOI 10.1007/s00330-014-3274-y; Joo I, 2014, RADIOLOGY, V272, P417, DOI 10.1148/radiol.14131165; Kim HS, 2014, AM J NEURORADIOL, V35, P490, DOI 10.3174/ajnr.A3719; Kim YS, 2006, J COMPUT ASSIST TOMO, V30, P578, DOI 10.1097/00004728-200607000-00005; KING MD, 1992, MAGNET RESON MED, V24, P288, DOI 10.1002/mrm.1910240210; Kitchin D, 2014, INT J HYPERTHER, V30, P299, DOI 10.3109/02656736.2014.936050; Koh DM, 2007, AM J ROENTGENOL, V188, P1001, DOI 10.2214/AJR.06.0601; Koh DM, 2014, RADIOLOGY, V272, P307, DOI 10.1148/radiol.14140714; LEBIHAN D, 1986, RADIOLOGY, V161, P401, DOI 10.1148/radiology.161.2.3763909; LEBIHAN D, 1988, RADIOLOGY, V168, P497, DOI 10.1148/radiology.168.2.3393671; Lemke A, 2011, MAGN RESON IMAGING, V29, P766, DOI 10.1016/j.mri.2011.03.004; Mazzetti S, 2012, PHYS MED BIOL, V57, DOI 10.1088/0031-9155/57/24/8443; Miki K, 2006, INT J UROL, V13, P880, DOI 10.1111/j.1442-2042.2006.01432.x; Nishikawa H, 2013, INT J HYPERTHER, V29, P558, DOI 10.3109/02656736.2013.821528; Okuma T, 2009, BRIT J RADIOL, V82, P989, DOI 10.1259/bjr/13217618; Pang YX, 2013, MAGN RESON MED, V69, P553, DOI 10.1002/mrm.24277; Park MS, 2012, HEPATOLOGY, V56, P140, DOI 10.1002/hep.25681; Patel J, 2010, J MAGN RESON IMAGING, V31, P589, DOI 10.1002/jmri.22081; Sanelli PC, 2004, ACAD RADIOL, V11, P1085, DOI 10.1016/j.acra.2004.07.002; Schima Wolfgang, 2007, Cancer Imaging, V7 Spec No A, pS28, DOI 10.1102/1470-7330.2007.9047; Sourbron SP, 2011, MAGN RESON MED, V66, P735, DOI 10.1002/mrm.22861; Viswanath S, 2013, PROC SPIE, V8671, DOI 10.1117/12.2008037; Vogl TJ, 2004, INT J HYPERTHER, V20, P713, DOI 10.1080/02656730400007212; Wirestam R, 2001, ACTA RADIOL, V42, P123, DOI 10.1080/028418501127346459; Wistuba II, 2011, NAT REV CLIN ONCOL, V8, P135, DOI 10.1038/nrclinonc.2011.2	33	17	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0127964	10.1371/journal.pone.0127964	http://dx.doi.org/10.1371/journal.pone.0127964			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020785	Green Published, gold, Green Submitted			2022-12-26	WOS:000355187300067
J	Chang, JF; Viovy, N; Vuichard, N; Ciais, P; Campioli, M; Klumpp, K; Martin, R; Leip, A; Soussana, JF				Chang, Jinfeng; Viovy, Nicolas; Vuichard, Nicolas; Ciais, Philippe; Campioli, Matteo; Klumpp, Katja; Martin, Raphael; Leip, Adrian; Soussana, Jean-Francois			Modeled Changes in Potential Grassland Productivity and in Grass-Fed Ruminant Livestock Density in Europe over 1961-2010	PLOS ONE			English	Article							EDDY-COVARIANCE MEASUREMENTS; PASTURE SIMULATION-MODEL; CO2 ENRICHMENT; CLIMATE-CHANGE; NITROGEN BUDGETS; ORGANIC-MATTER; PLANT BIOMASS; ELEVATED CO2; DATA SET; CARBON	About 25% of European livestock intake is based on permanent and sown grasslands. To fulfill rising demand for animal products, an intensification of livestock production may lead to an increased consumption of crop and compound feeds. In order to preserve an economically and environmentally sustainable agriculture, a more forage based livestock alimentation may be an advantage. However, besides management, grassland productivity is highly vulnerable to climate (i.e., temperature, precipitation, CO2 concentration), and spatial information about European grassland productivity in response to climate change is scarce. The process-based vegetation model ORCHIDEE-GM, containing an explicit representation of grassland management (i.e., herbage mowing and grazing), is used here to estimate changes in potential productivity and potential grass-fed ruminant livestock density across European grasslands over the period 1961-2010. Here "potential grass-fed ruminant livestock density" denotes the maximum density of livestock that can be supported by grassland productivity in each 25 km x 25 km grid cell. In reality, livestock density could be higher than potential (e.g., if additional feed is supplied to animals) or lower (e.g., in response to economic factors, pedo-climatic and biotic conditions ignored by the model, or policy decisions that can for instance reduce livestock numbers). When compared to agricultural statistics (Eurostat and FAOstat), ORCHIDEE-GM gave a good reproduction of the regional gradients of annual grassland productivity and ruminant livestock density. The model however tends to systematically overestimate the absolute values of productivity in most regions, suggesting that most grid cells remain below their potential grassland productivity due to possible nutrient and biotic limitations on plant growth. When ORCHIDEE-GM was run for the period 1961-2010 with variable climate and rising CO2, an increase of potential annual production (over 3%) per decade was found: 97% of this increase was attributed to the rise in CO2, -3% to climate trends and 15% to trends in nitrogen fertilization and deposition. When compared with statistical data, ORCHIDEE-GM captures well the observed phase of climate-driven interannual variability in grassland production well, whereas the magnitude of the interannual variability in modeled productivity is larger than the statistical data. Regional grass-fed livestock numbers can be reproduced by ORCHIDEE-GM based on its simple assumptions and parameterization about productivity being the only limiting factor to define the sustainable number of animals per unit area. Causes for regional model-data misfits are discussed, including uncertainties in farming practices (e.g., nitrogen fertilizer application, and mowing and grazing intensity) and in ruminant diet composition, as well as uncertainties in the statistical data and in model parameter values.	[Chang, Jinfeng; Viovy, Nicolas; Vuichard, Nicolas; Ciais, Philippe] CEA, CNRS, UVSQ, Lab Sci Climat & Environm,UMR8212, F-91198 Gif Sur Yvette, France; [Campioli, Matteo] Univ Antwerp, Dept Biol, Res Grp Plant & Vegetat Ecol, Antwerp, Belgium; [Klumpp, Katja; Martin, Raphael; Soussana, Jean-Francois] INRA, Grassland Ecosyst Res Unit, UREP, Clermont Ferrand, France; [Leip, Adrian] Commiss European Communities, Joint Res Ctr, Inst Environm & Sustainabil, Ispra, VA, Italy	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Saclay; CEA; University of Antwerp; INRAE; European Commission Joint Research Centre; EC JRC ISPRA Site	Chang, JF (corresponding author), CEA, CNRS, UVSQ, Lab Sci Climat & Environm,UMR8212, F-91198 Gif Sur Yvette, France.	jinfeng.chang@lsce.ipsl.fr	Ciais, Philippe/A-6840-2011; Viovy, Nicolas/S-2631-2018; Chang, Jinfeng/H-7884-2019; Soussana, Jean-Francois/M-2814-2017; CHANG, Jinfeng/A-4603-2019; Soussana, Jean-Francois/E-2543-2012; Vuichard, Nicolas/A-6629-2011; Soussana, Jean-Francois/P-2094-2016; Campioli, Matteo/N-9380-2015	Ciais, Philippe/0000-0001-8560-4943; Viovy, Nicolas/0000-0002-9197-6417; Chang, Jinfeng/0000-0003-4463-7778; CHANG, Jinfeng/0000-0003-4463-7778; Soussana, Jean-Francois/0000-0002-1932-6583; Leip, Adrian/0000-0001-7616-5029; Campioli, Matteo/0000-0002-3427-2368; Vuichard, Nicolas/0000-0002-3397-7948; Martin, Raphael/0000-0001-8778-7915	AnimalChange project [266018]; French l'Institut national de la recherche agronomique (INRA); French Commissariat a l'energie atomique (CEA)	AnimalChange project; French l'Institut national de la recherche agronomique (INRA); French Commissariat a l'energie atomique (CEA)(French Atomic Energy Commission)	This work was supported by the AnimalChange project (grant no. 266018). The authors' acknowledge the PhD funding for JC by the French l'Institut national de la recherche agronomique (INRA) and the French Commissariat a l'energie atomique (CEA).	Aeschlimann U, 2005, PLANT CELL ENVIRON, V28, P823, DOI 10.1111/j.1365-3040.2005.01331.x; Ainsworth EA, 2005, NEW PHYTOL, V165, P351, DOI 10.1111/j.1469-8137.2004.01224.x; Alberti G, 2010, AGR ECOSYST ENVIRON, V136, P139, DOI 10.1016/j.agee.2009.12.012; Alexandratos N., 2012, 1203 ESA FAO UN AGR, DOI [10.22004/ag.econ.288998, DOI 10.22004/AG.ECON.288998]; [Anonymous], 2000, EARTH INTERACT, DOI DOI 10.1175/1087-3562(2000)004%3C0003:PASAOT%3E2.0.CO;2; Aranjuelo I, 2005, ANN APPL BIOL, V146, P51, DOI 10.1111/j.1744-7348.2005.04074.x; Bai YF, 2010, GLOBAL CHANGE BIOL, V16, P358, DOI 10.1111/j.1365-2486.2009.01950.x; Bardgett RD, 2003, ECOLOGY, V84, P2258, DOI 10.1890/02-0274; Beer C, 2014, J CLIMATE, V27, P4815, DOI 10.1175/JCLI-D-13-00543.1; Bouwman AF., 2006, INTEGRATED MODELLING, P1; BRIGGS JM, 1995, AM J BOT, V82, P1024, DOI 10.2307/2446232; Buttner G., 2004, EARSEL EPROCEEDINGS, V3; Campolongo F, 2000, SENSITIVITY ANAL, P65; Casasus I, 2007, AGR ECOSYST ENVIRON, V121, P365, DOI 10.1016/j.agee.2006.11.012; Casella E, 1997, J EXP BOT, V48, P1309, DOI 10.1093/jxb/48.6.1309; Chang JF, 2013, GEOSCI MODEL DEV, V6, P2165, DOI 10.5194/gmd-6-2165-2013; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Eurostat, 2011, HDB ANN CROP STAT; Eurostat, 2007, 2006EU27 NUTS EUR; EVANS JR, 1989, OECOLOGIA, V78, P9, DOI 10.1007/BF00377192; Fiala Karel, 2010, Ekologia (Bratislava), V29, P182, DOI 10.4149/ekol_2010_02_182; Fischer G, 2002, GLOBAL AGROECOLOGICA; Garnier E, 1999, NEW PHYTOL, V143, P119, DOI 10.1046/j.1469-8137.1999.00426.x; Graux AI, 2011, AGR ECOSYST ENVIRON, V144, P69, DOI 10.1016/j.agee.2011.07.001; Guenet B, 2013, GEOSCI MODEL DEV, V6, P2153, DOI 10.5194/gmd-6-2153-2013; Hadjigeorgiou I, 2005, LIVEST PROD SCI, V96, P51, DOI 10.1016/j.livprodsci.2005.05.016; Harpole WS, 2007, GLOBAL CHANGE BIOL, V13, P2341, DOI 10.1111/j.1365-2486.2007.01447.x; Hasha G, 2002, LIVESTOCK FEEDING FE; Henkin Z, 2005, AGR ECOSYST ENVIRON, V109, P255, DOI 10.1016/j.agee.2005.03.004; Henry HAL, 2005, OECOLOGIA, V142, P465, DOI 10.1007/s00442-004-1713-1; HUME CJ, 1986, QUANTITATIVE STUDY E; Hussain MZ, 2011, AGR ECOSYST ENVIRON, V141, P67, DOI 10.1016/j.agee.2011.02.013; IPCC, 2006, AGR OTH LAND US; IUCN/UNEP/WWF, 1991, CAR EARTH STRAT SUST; Izaurralde RC, 2011, AGRON J, V103, P371, DOI 10.2134/agronj2010.0304; JENKINSON DS, 1992, SOIL BIOL BIOCHEM, V24, P295, DOI 10.1016/0038-0717(92)90189-5; Jones MB, 2004, NEW PHYTOL, V164, P423, DOI 10.1111/j.1469-8137.2004.01201.x; Joyce CB, 2013, ECOL ENG IN PRESS; Jung M, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002915; Kaplova M, 2011, PLANT ECOL, V212, P809, DOI 10.1007/s11258-010-9865-z; Kattge J, 2009, GLOBAL CHANGE BIOL, V15, P976, DOI 10.1111/j.1365-2486.2008.01744.x; Knapp AK, 2001, ECOSYSTEMS, V4, P19, DOI 10.1007/s100210000057; Knorr W, 2005, GLOBAL CHANGE BIOL, V11, P1333, DOI 10.1111/j.1365-2486.2005.00977.x; Knorr W, 2001, GLOBAL BIOGEOCHEM CY, V15, P207, DOI 10.1029/1998GB001059; Kramer K, 2002, GLOBAL CHANGE BIOL, V8, P213, DOI 10.1046/j.1365-2486.2002.00471.x; Krinner G, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2003GB002199; Leadley PW, 1999, OECOLOGIA, V118, P39, DOI 10.1007/s004420050701; LeBauer DS, 2008, ECOLOGY, V89, P371, DOI 10.1890/06-2057.1; LEE J, 1983, P 9 GEN M EUR GRASSL, P11; LEHOUEROU HN, 1988, J ARID ENVIRON, V15, P1, DOI 10.1016/S0140-1963(18)31001-2; Leip A, 2008, BIOGEOSCIENCES, V5, P73, DOI 10.5194/bg-5-73-2008; Leip A, 2011, EUROPEAN NITROGEN AS, P345, DOI DOI 10.1017/CBO9780511976988.019; Leip A, 2014, J AGR SCI, V152, pS22; Leip A, 2011, ENVIRON POLLUT, V159, P3243, DOI 10.1016/j.envpol.2011.01.040; Luyssaert S, 2007, GLOBAL CHANGE BIOL, V13, P2509, DOI 10.1111/j.1365-2486.2007.01439.x; Marriott CA, 2004, AGRONOMIE, V24, P447, DOI 10.1051/agro:2004041; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; Moorcroft PR, 2006, TRENDS ECOL EVOL, V21, P400, DOI 10.1016/j.tree.2006.04.009; Moral R, 2005, BIORESOURCE TECHNOL, V96, P153, DOI 10.1016/j.biortech.2004.05.003; Morgan JA, 2004, OECOLOGIA, V140, P11, DOI 10.1007/s00442-004-1550-2; New M, 2002, CLIMATE RES, V21, P1, DOI 10.3354/cr021001; Nippert JB, 2006, PLANT ECOL, V184, P65, DOI 10.1007/s11258-005-9052-9; Ordonez JC, 2009, GLOBAL ECOL BIOGEOGR, V18, P137, DOI 10.1111/j.1466-8238.2008.00441.x; Papanastasis VP, 2008, ANIM FEED SCI TECH, V140, P1, DOI 10.1016/j.anifeedsci.2007.03.012; Paruelo JM, 1997, ECOLOGY, V78, P953, DOI 10.1890/0012-9658(1997)078[0953:AEFNFT]2.0.CO;2; PAUSTIAN K, 1990, J APPL ECOL, V27, P60, DOI 10.2307/2403568; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Peeters A, 2012, GRASSLAND SCI EUR, V17, P17; Peeters Alain, 2009, Grassland Science, V55, P113, DOI 10.1111/j.1744-697X.2009.00154.x; Riedo M, 1998, ECOL MODEL, V105, P141, DOI 10.1016/S0304-3800(97)00110-5; Rotter R, 1999, CLIMATIC CHANGE, V43, P651, DOI 10.1023/A:1005541132734; Scurlock JMO, 1999, ECOL APPL, V9, P913, DOI 10.1890/1051-0761(1999)009[0913:TNTACD]2.0.CO;2; SILVERTOWN J, 1994, ECOLOGY, V75, P2430, DOI 10.2307/1940896; Smit HJ, 2008, AGR SYST, V98, P208, DOI 10.1016/j.agsy.2008.07.004; Soussana JF, 2007, GRASS FORAGE SCI, V62, P127, DOI 10.1111/j.1365-2494.2007.00577.x; Soussana JF, 2010, J EXP BOT, V61, P2217, DOI 10.1093/jxb/erq100; Tenkorang F, 2009, NUTR CYCL AGROECOSYS, V83, P233, DOI 10.1007/s10705-008-9214-y; Topp CFE, 2004, GRASS FORAGE SCI, V59, P274, DOI 10.1111/j.1365-2494.2004.00427.x; Tubiello FN, 2007, P NATL ACAD SCI USA, V104, P19686, DOI 10.1073/pnas.0701728104; Tucker CJ, 2005, INT J REMOTE SENS, V26, P4485, DOI 10.1080/01431160500168686; Van den Pol-van Dasselaar A, 2012, GRASSLAND SCI EUR, V17, P279; van Ittersum MK, 2008, AGR SYST, V96, P150, DOI 10.1016/j.agsy.2007.07.009; Vuichard N, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2005GB002611; Vuichard N, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2005GB002612; Wand SJE, 1999, GLOB CHANGE BIOL, V5, P723, DOI 10.1046/j.1365-2486.1999.00265.x; Weedon GP, 2011, J HYDROMETEOROL, V12, P823, DOI 10.1175/2011JHM1369.1; Weedon GP, 2010, 22 WATCH; Wint G. R. W., 2007, GRIDDED LIVESTOCK WO; Wirsenius, 2000, HUMAN USE LAND ORGAN; Wriedt G, 2009, AGR WATER MANAGE, V96, P771, DOI 10.1016/j.agwat.2008.10.012; Xia JY, 2008, NEW PHYTOL, V179, P428, DOI 10.1111/j.1469-8137.2008.02488.x; Yassoglou NJ, 2000, RALA REP, P27; Zaehle S, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002395; ZAEHLE S, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI DOI 10.1029/2009GB003521; Zhao Y, 2012, BIOGEOSCIENCES, V9, P2537, DOI 10.5194/bg-9-2537-2012	96	29	29	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0127554	10.1371/journal.pone.0127554	http://dx.doi.org/10.1371/journal.pone.0127554			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018186	Green Published, gold			2022-12-26	WOS:000355185600089
J	Ghazanfari, S; Driessen-Mol, A; Strijkers, GJ; Baaijens, FPT; Bouten, CVC				Ghazanfari, Samaneh; Driessen-Mol, Anita; Strijkers, Gustav J.; Baaijens, Frank P. T.; Bouten, Carlijn V. C.			The Evolution of Collagen Fiber Orientation in Engineered Cardiovascular Tissues Visualized by Diffusion Tensor Imaging	PLOS ONE			English	Article							QUANTITATIVE ASSESSMENT; ARTICULAR-CARTILAGE; CELL TRACTION; ALIGNMENT; EXPRESSION; GENERATION; ANISOTROPY; TRACKING; SYSTEM; MATRIX	The collagen architecture is the major determinant of the function and mechanical behavior of cardiovascular tissues. In order to engineer a functional and load-bearing cardiovascular tissue with a structure thatmimics the native tissue to meet in vivo mechanical demands, a complete understanding of the collagen orientation mechanism is required. Several methods have been used to visualize collagen architecture in tissue-engineered (TE) constructs, but they either have a limited imaging depth or have a complicated set up. In this study, Diffusion Tensor Imaging (DTI) is explored as a fast and reliable method to visualize collagen arrangement, and Confocal Laser Scanning Microscopy (CLSM) was used as a validation technique. Uniaxially constrained TE strips were cultured for 2 days, 10 days, 3 and 6 weeks to investigate the evolution of the collagen orientation with time. Moreover, a comparison of the collagen orientation in high and low aspect ratio (length/width) TE constructs was made with both methods. Both methods showed similar fiber orientation in TE constructs. Collagen fibers in the high aspect ratio samples were mostly aligned in the constrained direction, while the collagen fibers in low aspect ratio strips were mainly oriented in the oblique direction. The orientation changed to the oblique direction by extending culture time and could also be visualized. DTI captured the collagen orientation differences between low and high aspect ratio samples and with time. Therefore, it can be used as a fast, non-destructive and reliable tool to study the evolution of the collagen orientation in TE constructs.	[Ghazanfari, Samaneh; Driessen-Mol, Anita; Baaijens, Frank P. T.; Bouten, Carlijn V. C.] Eindhoven Univ Technol, Dept Biomed Engn, Soft Tissue Biomechan & Engn, NL-5600 MB Eindhoven, Netherlands; [Strijkers, Gustav J.] Univ Amsterdam, Acad Med Ctr, Biomed NMR Biomed Engn & Phys, NL-1105 AZ Amsterdam, Netherlands	Eindhoven University of Technology; University of Amsterdam; Academic Medical Center Amsterdam	Ghazanfari, S (corresponding author), Eindhoven Univ Technol, Dept Biomed Engn, Soft Tissue Biomechan & Engn, POB 513, NL-5600 MB Eindhoven, Netherlands.	samane.ghazanfari@gmail.com	Bouten, Carlijn/AAT-5187-2020	Bouten, Carlijn/0000-0003-1035-5094; Strijkers, Gustav/0000-0001-6700-5058; Ghazanfari, Samaneh/0000-0001-8177-7521; Baaijens, Frank/0000-0002-0975-5376	TeRM Smart Mix Program of the Netherlands Ministry of Economic Affairs; Netherlands Ministry of Education, Culture and Science	TeRM Smart Mix Program of the Netherlands Ministry of Economic Affairs; Netherlands Ministry of Education, Culture and Science	The authors gratefully acknowledge the support of the TeRM Smart Mix Program of the Netherlands Ministry of Economic Affairs and the Netherlands Ministry of Education, Culture and Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASPDEN RM, 1987, J ANAT, V155, P141; Auer M, 2005, IEEE T IMAGE PROCESS, V14, P475, DOI 10.1109/TIP.2005.843756; Baaijens F, 2010, J BIOMECH, V43, P166, DOI 10.1016/j.jbiomech.2009.09.022; Barocas VH, 1997, J BIOMECH ENG-T ASME, V119, P137, DOI 10.1115/1.2796072; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Canham PB, 1997, CARDIOVASC RES, V34, P557, DOI 10.1016/S0008-6363(97)00056-4; Capuani S, 2005, SOLID STATE NUCL MAG, V28, P266, DOI 10.1016/j.ssnmr.2005.11.001; Chiquet M, 1999, MATRIX BIOL, V18, P417, DOI 10.1016/S0945-053X(99)00039-6; Dahl SLM, 2007, ANN BIOMED ENG, V35, P1749, DOI 10.1007/s10439-007-9340-8; Daniels F, 2006, P INT C BIOM ENG BIO, V2006, P344; Driessen NJB, 2008, BIOMECH MODEL MECHAN, V7, P93, DOI 10.1007/s10237-007-0078-x; Elbischger PJ, 2005, ST HEAL T, V113, P97; Engelmayr GC, 2006, J BIOMECH, V39, P1819, DOI 10.1016/j.jbiomech.2005.05.020; Friedrichs J, 2007, J MOL BIOL, V372, P594, DOI 10.1016/j.jmb.2007.06.078; Ghazanfari S, 2012, BIOCHEM BIOPH RES CO, V426, P54, DOI 10.1016/j.bbrc.2012.08.031; Hay D, 1991, CELL BIOL EXTRACELLU; Heemskerk AM, 2009, MAGN RESON MED, V61, P467, DOI 10.1002/mrm.21819; Hoerstrup SP, 2000, CIRCULATION, V102, P44; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.0.CO;2-Q; Karlon WJ, 1998, ANAT RECORD, V252, P612, DOI 10.1002/(SICI)1097-0185(199812)252:4<612::AID-AR12>3.0.CO;2-1; KLEBE RJ, 1990, MATRIX, V9, P451, DOI 10.1016/S0934-8832(11)80014-4; Krahn KN, 2006, ANAL BIOCHEM, V350, P177, DOI 10.1016/j.ab.2006.01.013; LANIR Y, 1983, J BIOMECH, V16, P1, DOI 10.1016/0021-9290(83)90041-6; LHEUREUX N, 1993, J VASC SURG, V17, P499, DOI 10.1016/0741-5214(93)90150-K; Meder R, 2006, OSTEOARTHR CARTILAGE, V14, P875, DOI 10.1016/j.joca.2006.03.002; Mol A, 2005, BIOMATERIALS, V26, P3113, DOI 10.1016/j.biomaterials.2004.08.007; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Nimni M., 1988, MOL STRUCTURE FUNCTI; Peeters THJM, 2009, COMPUT GRAPH FORUM, V28, P2140, DOI 10.1111/j.1467-8659.2009.01421.x; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Raya JG, 2011, INVEST RADIOL, V46, P401, DOI 10.1097/RLI.0b013e3182145aa8; Rubbens MP, 2009, ANN BIOMED ENG, V37, P1263, DOI 10.1007/s10439-009-9698-x; Sacks MS, 2003, J BIOMECH ENG-T ASME, V125, P280, DOI 10.1115/1.1544508; Schnell AM, 2001, THORAC CARDIOV SURG, V49, P221, DOI 10.1055/s-2001-16113; Soares ALF, 2012, COMPUT METHOD BIOMEC, P1, DOI [10.1080/10255842.2012.650321, DOI 10.1080/10255842.2012.650321]; STOPAK D, 1982, DEV BIOL, V90, P383, DOI 10.1016/0012-1606(82)90388-8; Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100; Thomopoulos S, 2005, J BIOMECH ENG-T ASME, V127, P742, DOI 10.1115/1.1992525; Tower TT, 2001, BIOPHYS J, V81, P2964, DOI 10.1016/S0006-3495(01)75936-X; Vader D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005902; van Vlimmeren MAA, 2011, TISSUE ENG PART C-ME, V17, P983, DOI [10.1089/ten.tec.2011.0070, 10.1089/ten.TEC.2011.0070]; Venkatasubramanian RT, 2010, ANN BIOMED ENG, V38, P694, DOI 10.1007/s10439-010-9921-9; Vilanova A, 2006, VISUALIZATION AND PROCESSING OF TENSOR FIELDS, P121, DOI 10.1007/3-540-31272-2_7; Yang ZC, 2006, J THEOR BIOL, V242, P607, DOI 10.1016/j.jtbi.2006.05.005	44	26	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0127847	10.1371/journal.pone.0127847	http://dx.doi.org/10.1371/journal.pone.0127847			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26016649	gold, Green Published, Green Submitted			2022-12-26	WOS:000355185600098
J	Roldan, VA; Bossio, L; Galvan, DE				Alonso Roldan, Virginia; Bossio, Luisina; Galvan, David E.			Sources of Variation in a Two-Step Monitoring Protocol for Species Clustered in Conspicuous Points: Dolichotis patagonum as a Case Study	PLOS ONE			English	Article							VIDEO-SURVEILLANCE; WILDLIFE; SYSTEM	In species showing distributions attached to particular features of the landscape or conspicuous signs, counts are commonly made by making focal observations where animals concentrate. However, to obtain density estimates for a given area, independent searching for signs and occupancy rates of suitable sites is needed. In both cases, it is important to estimate detection probability and other possible sources of variation to avoid confounding effects on measurements of abundance variation. Our objective was to assess possible bias and sources of variation in a two-step protocol in which random designs were applied to search for signs while continuously recording video cameras were used to perform abundance counts where animals are concentrated, using mara (Dolichotis patagonum) as a case study. The protocol was successfully applied to maras within the Peninsula Valdes protected area, given that the protocol was logistically suitable, allowed warrens to be found, the associated adults to be counted, and the detection probability to be estimated. Variability was documented in both components of the two-step protocol. These sources of variation should be taken into account when applying this protocol. Warren detectability was approximately 80% with little variation. Factors related to false positive detection were more important than imperfect detection. The detectability for individuals was approximately 90% using the entire day of observations. The shortest sampling period with a similar detection capacity than a day was approximately 10 hours, and during this period, the visiting dynamic did not show trends. For individual mara, the detection capacity of the camera was not significantly different from the observer during fieldwork. The presence of the camera did not affect the visiting behavior of adults to the warren. Application of this protocol will allow monitoring of the near-threatened mara providing a minimum local population size and a baseline for measuring long-term trends.	[Alonso Roldan, Virginia; Galvan, David E.] Consejo Nacl Invest Cient & Tecn, Ctr Nacl Patagon, Puerto Madryn, Chubut, Argentina; [Bossio, Luisina] Univ Nacl Patagonia San Juan Bosco, Puerto Madryn, Chubut, Argentina	Centro Nacional Patagonico (CENPAT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional de la Patagonia San Juan Bosco	Roldan, VA (corresponding author), Consejo Nacl Invest Cient & Tecn, Ctr Nacl Patagon, Puerto Madryn, Chubut, Argentina.	virginia.a.roldan@gmail.com		Galvan, David/0000-0001-8132-6069; Alonso Roldan, Virginia/0000-0003-0702-3566	People Trust for Endangered Species; Idea Wild; ALUAR; Chubut Province Government	People Trust for Endangered Species; Idea Wild; ALUAR; Chubut Province Government	Funding for this work was provided by People Trust for Endangered Species (www.ptes.org), Idea Wild (www.ideawild.org), ALUAR (www.aluar.com.ar) and Chubut Province Government (www.chubut.gov.ar) to VAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso Roldan V, 2012, THESIS U NACL SUR; [Anonymous], 2010, R LANG ENV STAT COMP; Baldi R, 2007, J ARID ENVIRON, V68, P9, DOI 10.1016/j.jaridenv.2006.03.025; Bennetts RE, 1999, AUK, V116, P316, DOI 10.2307/4089366; Bertiller MB, 1981, CONTRIBUCION CTR NAC, V41; Bloomquist CK, 2009, J WILDLIFE MANAGE, V73, P605, DOI 10.2193/2008-200; BRANCH LC, 1993, J MAMMAL, V74, P890, DOI 10.2307/1382427; Buckland S. T., 1993, Distance sampling: estimating abundance of biological populations.; BURNHAM KP, 1980, WILDLIFE MONOGR, P7; Burton AC, 2012, BIODIVERS CONSERV, V21, P3079, DOI 10.1007/s10531-012-0355-6; Clutton-Brock TH, 1999, AFR J ECOL, V37, P69, DOI 10.1046/j.1365-2028.1999.00160.x; Condit R, 2007, MAR MAMMAL SCI, V23, P834, DOI 10.1111/j.1748-7692.2007.00141.x; Dendrinos Panagiotis, 2007, Aquatic Mammals, V33, P179, DOI 10.1578/AM.33.2.2007.179; Dixon Victoria, 2009, Ecological Management & Restoration, V10, P156; Fyfe R.W., 1976, Occasional Pap Can Wildl Serv, VNo. 23, P1; Harvey ES, 2010, MAR TECHNOL SOC J, V44, P75, DOI 10.4031/MTSJ.44.1.3; Irigoyen AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061072; KUFNER MB, 1995, STUD NEOTROP FAUNA E, V30, P37, DOI 10.1080/01650529509360939; Lambertucci SA, 2008, J FIELD ORNITHOL, V79, P138, DOI 10.1111/j.1557-9263.2008.00155.x; Lambertucci SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067304; McClanahan TR, 2007, MAR ECOL PROG SER, V340, P221, DOI 10.3354/meps340221; Ojeda R, 2008, IUCN 2009 IUCN RED L; Pelletier D, 2011, FISH RES, V107, P84, DOI 10.1016/j.fishres.2010.10.011; PINHEIRO J., 2009, NLME LINEAR NONLINEA; Pollock KH, 2002, ENVIRONMETRICS, V13, P105, DOI 10.1002/env.514; Rappole JH, 1985, NOCTURNAL MAMMALS TE; Rowcliffe JM, 2008, J APPL ECOL, V45, P1228, DOI 10.1111/j.1365-2664.2008.01473.x; Schipper J., 2007, SMALL CARNIVORE CONS, V36, P38; Schwarz CJ, 1999, STAT SCI, V14, P427; Stewart PD, 1997, MAMMAL REV, V27, P185, DOI 10.1111/j.1365-2907.1997.tb00448.x; Sutherland WJ., 1996, ECOLOGICAL CENSUS TE, V2, DOI DOI 10.1017/CBO9780511790508; TABER AB, 1992, J ZOOL, V227, P417, DOI 10.1111/j.1469-7998.1992.tb04404.x; Taber AB, 1987, BEHAV ECOLOGY MARA D; Taber AB, 1992, J ZOOLOGY LONDON, P227; Venerus LA, 2008, FISHERIES MANAG ECOL, V15, P217, DOI 10.1111/j.1365-2400.2008.00603.x; Walker R. Susan, 2000, Mastozoologia Neotropical, V7, P89; Woltmann S, 2005, ORNITOL NEOTROP, V16, P337; Yoccoz NG, 2001, TRENDS ECOL EVOL, V16, P446, DOI 10.1016/S0169-5347(01)02205-4; Zar J. H., 1996, BIOSTATISTICAL ANAL; Zuur Alain F., 2009, P1	40	5	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128133	10.1371/journal.pone.0128133	http://dx.doi.org/10.1371/journal.pone.0128133			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011026	Green Submitted, gold, Green Published			2022-12-26	WOS:000355183900195
J	Ang, LW; Tay, J; Phoon, MC; Hsu, JP; Cutter, J; James, L; Goh, KT; Chow, VTK				Ang, Li Wei; Tay, Joanne; Phoon, Meng Chee; Hsu, Jung Pu; Cutter, Jeffery; James, Lyn; Goh, Kee Tai; Chow, Vincent Tak-Kwong			Seroepidemiology of Coxsackievirus A6, Coxsackievirus A16, and Enterovirus 71 Infections among Children and Adolescents in Singapore, 2008-2010	PLOS ONE			English	Article							MOUTH-DISEASE OUTBREAK; NEUTRALIZING ANTIBODY-RESPONSES; WESTERN-AUSTRALIA; HAND; FOOT; STRAINS; TAIWAN; CHINA; MALAYSIA; EPIDEMIC	Coxsackieviruses A6 (CV-A6) and A16 (CV-A16) and Enterovirus 71 (EV-A71) have caused periodic epidemics of hand, foot and mouth disease (HFMD) among children in Singapore. We conducted a cross-sectional study to estimate the seroprevalence of these enteroviruses among Singapore children and adolescents. The study was conducted between August 2008 and July 2010. It involved 700 Singapore residents aged 1-17 years whose residual sera were obtained following the completion of routine biochemical investigations in two public acute-care hospitals. The levels of neutralizing antibodies (NtAb) against CV-A6, CV-A16 and EV-A71 were analyzed by the microneutralization test. The age-specific geometric mean titer (GMT) of antibodies against each of the three enteroviruses and the 95% confidence intervals (CI) were calculated. The seroprevalence of CV-A6 and CV-A16 was high at 62.7%(95% CI: 59.1-66.2%) and 60.6% (95% CI: 56.9-64.1%), respectively. However, the seroprevalence of EV-A71 was significantly lower at 29.3% (95% CI: 26.0-32.8%). About 89.7% of the children and adolescents had been infected by at least one of the three enteroviruses by 13-17 years of age. About half (52.3%) were seropositive for two or all three enteroviruses, while only 16.1% had no NtAb against any of the three enteroviruses. High NtAb levels were observed in the younger age groups. CV-A6 and CV-A16 infections are very common among Singapore children and adolescents, while EV-A71 infections are less common. Infection is continually acquired from early childhood to adolescent age.	[Ang, Li Wei; James, Lyn] Minist Hlth, Epidemiol & Dis Control Div, Singapore 169854, Singapore; [Tay, Joanne; Cutter, Jeffery; Goh, Kee Tai] Minist Hlth, Communicable Dis Div, Singapore 169854, Singapore; [Phoon, Meng Chee; Hsu, Jung Pu; Chow, Vincent Tak-Kwong] Natl Univ Singapore, Dept Microbiol, Yong Loo Lin Sch Med, Natl Univ Hlth Syst, Singapore 117545, Singapore; [Goh, Kee Tai] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117597, Singapore	Ministry of Health-Singapore; Ministry of Health-Singapore; National University of Singapore; National University of Singapore	Ang, LW (corresponding author), Minist Hlth, Epidemiol & Dis Control Div, Coll Med Bldg,16 Coll Rd, Singapore 169854, Singapore.	ang_li_wei@moh.gov.sg		Chow, Vincent/0000-0003-2634-6213; Ang, Li Wei/0000-0002-0036-255X	National University of Singapore	National University of Singapore(National University of Singapore)	VTC is supported by a research grant from the National University of Singapore.	AbuBakar S, 2009, EMERG INFECT DIS, V15, P79, DOI 10.3201/eid1501.080264; Ahmad K, 2000, LANCET, V356, P1338, DOI 10.1016/S0140-6736(05)74253-7; Ang LW, 2013, EPIDEMIOL INFECT, V141, P1721, DOI 10.1017/S0950268812002130; Ang LW, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-270; Ang LW, 2009, ANN ACAD MED SINGAP, V38, P106; Bland JM, 1996, BMJ-BRIT MED J, V312, P1153; Centers for Disease Control and Prevention the United States, 2013, US 10 MAY 2013 NONP; Chan KP, 2003, EMERG INFECT DIS, V9, P78; Chang LY, 1998, LANCET, V352, P367, DOI 10.1016/S0140-6736(98)24031-1; Chang LY, 1999, PEDIATR INFECT DIS J, V18, P1092, DOI 10.1097/00006454-199912000-00013; Chau BNT, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021116, 10.1371/journal.pone.0025969]; Chen KT, 2007, PEDIATRICS, V120, pE244, DOI 10.1542/peds.2006-3331; Chou AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079783; Chou AH, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/831282; Chua K B, 2007, Malays J Pathol, V29, P69; Chua Kaw Bing, 2011, Virologica Sinica, V26, P221, DOI 10.1007/s12250-011-3195-8; Flett K, 2012, EMERG INFECT DIS, V18, P1702, DOI 10.3201/eid1810.120813; Foo DGW, 2007, MICROBES INFECT, V9, P1299, DOI 10.1016/j.micinf.2007.06.002; Fujimoto T, 2012, EMERG INFECT DIS, V18, P337, DOI 10.3201/eid1802.111147; Han JF, 2014, J INFECTION, V69, P303, DOI 10.1016/j.jinf.2014.03.015; Herrero LJ, 2003, ARCH VIROL, V148, P1369, DOI 10.1007/s00705-003-0100-2; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Huang ML, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002067; Huang WC, 2012, J MICROBIOL IMMUNOL, V45, P96, DOI 10.1016/j.jmii.2011.09.025; Huiqin Z., 2012, FRONT MED, P206; Infectious Disease Surveillance Centre (IDSC) National Institute of Infectious Diseases (NID) Japan, 2004, INFECT AGENTS SURVEI, V25, P224; Jee YM, 2003, ARCH VIROL, V148, P1735, DOI 10.1007/s00705-003-0133-6; KOGON A, 1969, AM J EPIDEMIOL, V89, P51, DOI 10.1093/oxfordjournals.aje.a120915; Komatsu H, 1999, PEDIATR NEUROL, V20, P17, DOI 10.1016/S0887-8994(98)00087-3; Li JX, 2014, EXPERT REV VACCINES, V13, P609, DOI 10.1586/14760584.2014.897617; Li W, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-322; Li YY, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-246; Liang ZL, 2011, VACCINE, V29, P9668, DOI 10.1016/j.vaccine.2011.10.018; Lin YL, 2011, J IMMUNOASS IMMUNOCH, V32, P233, DOI 10.1080/15321819.2011.559297; Lo SH, 2011, J MICROBIOL IMMUNOL, V44, P252, DOI 10.1016/j.jmii.2011.01.031; Lum LCS, 1998, J PEDIATR-US, V133, P795, DOI 10.1016/S0022-3476(98)70155-6; Ma E, 2010, INT J INFECT DIS, V14, pE775, DOI 10.1016/j.ijid.2010.02.2265; McMinn P, 2001, J VIROL, V75, P7732, DOI 10.1128/JVI.75.16.7732-7738.2001; McMinn P, 2001, CLIN INFECT DIS, V32, P236, DOI 10.1086/318454; Ministry of Health Singapore, 2013, COMM DIS SURV SING 2; Mizuta K, 2009, VACCINE, V27, P3153, DOI 10.1016/j.vaccine.2009.03.060; Ooi EE, 2002, EMERG INFECT DIS, V8, P995, DOI 10.3201/eid0809.010397; Ooi EE, 2002, ENTEROVIRUS INFECT S, P66; Perera D, 2007, ARCH VIROL, V152, P1201, DOI 10.1007/s00705-006-0934-5; Podin Y, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-180; Puenpa J, 2013, EMERG INFECT DIS, V19, P641, DOI 10.3201/eid1904.121666; Qiu J, 2008, LANCET NEUROL, V7, P868, DOI 10.1016/S1474-4422(08)70207-2; Rabenau HF, 2010, MED MICROBIOL IMMUN, V199, P45, DOI 10.1007/s00430-009-0133-6; Ryu WS, 2010, EMERG INFECT DIS, V16, P1764, DOI 10.3201/eid1611.100104; Ryu WS, 2010, J CLIN MICROBIOL, V48, P2490, DOI 10.1128/JCM.02369-09; Sabanathan S, 2014, J EPIDEMIOL COMMUN H, V68, P500, DOI 10.1136/jech-2014-203836; Singh S, 2002, MICROBIOL IMMUNOL, V46, P801, DOI 10.1111/j.1348-0421.2002.tb02767.x; Tan XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025662; Khanh TH, 2012, EMERG INFECT DIS, V18, P2002, DOI 10.3201/eid1812.120929; Van Tu P, 2007, EMERG INFECT DIS, V13, P1733, DOI 10.3201/eid1311.070632; Wang JR, 2002, J CLIN MICROBIOL, V40, P10, DOI 10.1128/JCM.40.1.10-15.2002; Wei SH, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-346; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; Wu Y, 2010, INT J INFECT DIS, V14, pE1076, DOI 10.1016/j.ijid.2010.07.006; Yang F, 2009, J CLIN MICROBIOL, V47, P2351, DOI 10.1128/JCM.00563-09; Yin-Murphy Marguerite, 1993, Annals Academy of Medicine Singapore, V22, P281; Zeng M, 2011, EPIDEMIOL INFECT, V31, P1; Zeng M, 2012, J CLIN VIROL, V53, P285, DOI 10.1016/j.jcv.2011.12.025; Zhang HF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100545; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94	65	46	54	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127999	10.1371/journal.pone.0127999	http://dx.doi.org/10.1371/journal.pone.0127999			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011735	Green Published, Green Submitted, gold			2022-12-26	WOS:000355183900180
J	Benedetto, D; Rao, CM; Cefalu, C; Aguglia, DO; Cattadori, G; D'Ascola, DG; Benedetto, FA; Agostoni, P; Sciomer, S				Benedetto, Daniela; Rao, Carmelo Massimo; Cefalu, Claudia; Aguglia, Demetrio Oreste; Cattadori, Gaia; D'Ascola, Domenico Giuseppe; Benedetto, Frank Antonio; Agostoni, Piergiuseppe; Sciomer, Susanna			Effects of Blood Transfusion on Exercise Capacity in Thalassemia Major Patients	PLOS ONE			English	Article							CHRONIC HEART-FAILURE; MAGNETIC-RESONANCE; ANEMIC PATIENTS; CARDIAC IRON; PERFORMANCE; TOLERANCE	Anemia has an important role in exercise performance. However, the direct link between rapid changes of hemoglobin and exercise performance is still unknown. To find out more on this topic, we studied 18 beta-thalassemia major patients free of relevant cardiac dysfunction (age 33.5 +/- 7.2 years, males = 10). Patients performed a maximal cardiopulmolmonary exercise test (cycloergometer, personalized ramp protocol, breath-by-breath measurements of expired gases) before and the day after blood transfusion (500 cc of red cell concentrates). After blood transfusion, hemoglobin increased from 10.5 +/- 0.8 g/dL to 12.1 +/- 1.2 (p < 0.001), peak VO2 from 1408 to 1546mL/min (p< 0.05), and VO2 at anaerobic threshold from 965 to 1024mL/min (p < 0.05). No major changes were observed as regards heart and respiratory rates either at peak exercise or at anaerobic threshold. Similarly, no relevant changes were observed in ventilation efficiency, as evaluated by the ventilation vs. carbon dioxide production relationship, or in O-2 delivery to the periphery as analyzed by the VO2 vs. workload relationship. The relationship between hemoglobin and VO2 changes showed, for each g/dL of hemoglobin increase, a VO2 increase = 82.5 mL/min and 35 mL/min, at peak exercise and at anaerobic threshold, respectively. In beta-thalassemia major patients, an acute albeit partial anemia correction by blood transfusion determinates a relevant increase of exercise performance, observed both at peak exercise and at anaerobic threshold.	[Benedetto, Daniela; Cefalu, Claudia; Cattadori, Gaia; Agostoni, Piergiuseppe] IRCCS, Ctr Cardiol Monzino, Milan, Italy; [Rao, Carmelo Massimo; Aguglia, Demetrio Oreste; Benedetto, Frank Antonio] Azienda Bianchi Melacrino Morelli, Dept Cardiol, Reggio Di Calabria, Italy; [D'Ascola, Domenico Giuseppe] Azienda Bianchi Melacrino Morelli, Dept Hematol, Reggio Di Calabria, Italy; [Agostoni, Piergiuseppe] Univ Milan, Dipartimento Sci Clin & Comunita, Sez Cardiovasc, Milan, Italy; [Sciomer, Susanna] Univ Roma La Sapienza, Dipartimento Sci Cardiovasc & Respiratorie, I-00185 Rome, Italy	IRCCS Centro Cardiologico Monzino; University of Milan; Sapienza University Rome	Agostoni, P (corresponding author), IRCCS, Ctr Cardiol Monzino, Milan, Italy.	piergiuseppe.agostoni@unimi.it	Corrà, Ugo/AAF-8322-2020; Agostoni, Piergiuseppe/ABG-9556-2020	Corrà, Ugo/0000-0002-9229-3298; Agostoni, Piergiuseppe/0000-0002-8345-6382; Cattadori, Gaia/0000-0002-0954-9871; Sciomer, Susanna/0000-0001-9487-833X; benedetto, daniela/0000-0001-7069-5635				Agostoni P, 1999, AM J CARDIOL, V83, P278, DOI 10.1016/S0002-9149(98)00839-X; Agostoni P, 2010, AM J HEMATOL, V85, P414, DOI 10.1002/ajh.21698; Balady GJ, 2010, CIRCULATION, V122, P191, DOI 10.1161/CIR.0b013e3181e52e69; BISHOP JM, 1955, CLIN SCI, V14, P329; Gargiulo P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087395; Guazzi M, 2001, AM J CARDIOL, V88, P452, DOI 10.1016/S0002-9149(01)01703-9; HANSEN JE, 1984, AM REV RESPIR DIS, V129, pS49, DOI 10.1164/arrd.1984.129.2P2.S49; KOIKE A, 1990, J APPL PHYSIOL, V68, P2521, DOI 10.1152/jappl.1990.68.6.2521; Mancini DM, 2003, CIRCULATION, V107, P294, DOI 10.1161/01.CIR.0000044914.42696.6A; Marsella M, 2011, HAEMATOL-HEMATOL J, V96, P515, DOI 10.3324/haematol.2010.025510; Nanas S, 2009, SCAND J MED SCI SPOR, V19, P96, DOI 10.1111/j.1600-0838.2008.00778.x; Okonko DO, 2008, J AM COLL CARDIOL, V51, P103, DOI 10.1016/j.jacc.2007.09.036; Palazzuoli A, 2006, AM HEART J, V152, DOI 10.1016/j.ahj.2006.08.005; Pennell DJ, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-45; Pepe A, 2009, HEART, V95, P1688, DOI 10.1136/hrt.2008.156497; Pepe A, 2013, BRIT J HAEMATOL, V163, P520, DOI 10.1111/bjh.12557; Perego GB, 1996, J APPL PHYSIOL, V80, P623, DOI 10.1152/jappl.1996.80.2.623; Ponikowski P, 2007, J AM COLL CARDIOL, V49, P753, DOI 10.1016/j.jacc.2006.11.024; Positano V, 2009, NMR BIOMED, V22, P707, DOI 10.1002/nbm.1382; Robertson HT, 2004, J APPL PHYSIOL, V97, P697, DOI 10.1152/japplphysiol.00108.2004; Sohn EY, 2013, AM J HEMATOL, V88, P193, DOI 10.1002/ajh.23370; Stringer WW, 2012, PRINCIPLES EXERCISE, V5th, P154; Tanner MA, 2006, HAEMATOLOGICA, V91, P1388; Toblli JE, 2007, J AM COLL CARDIOL, V50, P1657, DOI 10.1016/j.jacc.2007.07.029; Tocco F, 2006, CLIN PHYSIOL FUNCT I, V26, P319, DOI 10.1111/j.1475-097X.2006.00692.x; Vasileiadis I, 2009, ACTA PHYSIOL, V196, P357, DOI 10.1111/j.1748-1716.2008.01937.x	26	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127553	10.1371/journal.pone.0127553	http://dx.doi.org/10.1371/journal.pone.0127553			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010540	Green Published, gold, Green Submitted			2022-12-26	WOS:000355183900108
J	Chang, J; Xue, M; Yang, SL; Yao, B; Zhang, BX; Chen, XP; Pozzi, A; Zhang, MZ				Chang, Jian; Xue, Min; Yang, Shilin; Yao, Bing; Zhang, Bixiang; Chen, Xiaoping; Pozzi, Ambra; Zhang, Ming-Zhi			Inhibition of 11 beta-Hydroxysteroid Dehydrogenase Type II Suppresses Lung Carcinogenesis by Blocking Tumor COX-2 Expression as Well as the ERK and mTOR Signaling Pathways	PLOS ONE			English	Article							PROSTAGLANDIN-E SYNTHASE; STRESS-RESPONSE; CANCER CELLS; CYCLOOXYGENASE-2; GLUCOCORTICOIDS; GROWTH; ACTIVATION; APOPTOSIS; CHEMOPREVENTION; OVEREXPRESSION	Lung cancer is by far the leading cause of cancer death. Early diagnosis and prevention remain the best approach to reduce the overall morbidity and mortality. Experimental and clinical evidence have shown that cyclooxygenase-2 (COX-2) derived prostaglandin E-2 (PGE2) contributes to lung tumorigenesis. COX-2 inhibitors suppress the development and progression of lung cancer. However, increased cardiovascular risks of COX-2 inhibitors limit their use in chemoprevention of lung cancers. Glucocorticoids are endogenous and potent COX-2 inhibitors, and their local actions are down-regulated by 11 beta-hydroxysteroid dehydrogenase type II (11 beta HSD2)-mediated metabolism. We found that 11 beta HSD2 expression was increased in human lung cancers and experimental lung tumors. Inhibition of 11 beta HSD2 activity enhanced glucocorticoid-mediated COX-2 inhibition in human lung carcinoma cells. Furthermore, 11 beta HSD2 inhibition suppressed lung tumor growth and invasion in association with increased tissue active glucocorticoid levels, decreased COX-2 expression, inhibition of ERK and mTOR signaling pathways, increased tumor endoplasmic reticulum stress as well as increased lifespan. Therefore, 11 beta HSD2 inhibition represents a novel approach for lung cancer chemoprevention and therapy by increasing tumor glucocorticoid activity, which in turn selectively blocks local COX-2 activity and/or inhibits the ERK and mTOR signaling pathways.	[Chang, Jian; Xue, Min; Yang, Shilin; Yao, Bing; Pozzi, Ambra; Zhang, Ming-Zhi] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Zhang, Ming-Zhi] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA; [Chang, Jian; Zhang, Bixiang; Chen, Xiaoping] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Hepat Surg Ctr, Wuhan 430074, Peoples R China; [Zhang, Ming-Zhi] Xuzhou Med Coll, Jiangsu Ctr Collaborat & Innovat Canc Biotherapy, Inst Canc, Xuzhou, Peoples R China	Vanderbilt University; Vanderbilt University; Huazhong University of Science & Technology; Xuzhou Medical University	Zhang, MZ (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA.	ming-zhi.zhang@vanderbilt.edu			National Institutes of Health [CA-122620, DK-95785, DK-51265, CA-162433]; NATIONAL CANCER INSTITUTE [R01CA122620, R01CA162433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095785, R01DK095761, R01DK051265] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Institutes of Health CA-122620, DK-95785, DK-51265 to MZ; CA-162433 to AP.	Bi N, 2010, CLIN CANCER RES, V16, P2383, DOI 10.1158/1078-0432.CCR-09-2793; Bresalier RS, 2005, NEW ENGL J MED, V352, P1092, DOI 10.1056/NEJMoa050493; Britson JS, 2009, BIOCHEM BIOPH RES CO, V390, P849, DOI 10.1016/j.bbrc.2009.10.061; Brognard J, 2002, CELL DEATH DIFFER, V9, P893, DOI 10.1038/sj.cdd.4401054; Chang J, 2015, ONCOTARGET, V6, P2879, DOI 10.18632/oncotarget.2994; Cheng Y, 2002, SCIENCE, V296, P539, DOI 10.1126/science.1068711; Clark AR, 2003, CURR OPIN PHARMACOL, V3, P404, DOI 10.1016/S1471-4892(03)00073-0; Croxtall JD, 2003, BIOCHEM J, V371, P927, DOI 10.1042/BJ20021856; DENIS MG, 1992, J STEROID BIOCHEM, V41, P739, DOI 10.1016/0960-0760(92)90415-F; FUNDER JW, 1988, SCIENCE, V242, P583, DOI 10.1126/science.2845584; Greenberg AK, 2002, AM J RESP CELL MOL, V27, P320, DOI 10.1165/rcmb.4710; Hanaka H, 2009, P NATL ACAD SCI USA, V106, P18757, DOI 10.1073/pnas.0910218106; Harris RC, 2011, COMPR PHYSIOL, V1, P1729, DOI 10.1002/cphy.c100077; Harris RC, 2004, ACTA PHYSIOL SCAND, V181, P543, DOI 10.1111/j.1365-201X.2004.01329.x; Hida T, 1998, CANCER RES, V58, P3761; Ho MY, 2013, CANCER RES, V73, P439, DOI 10.1158/0008-5472.CAN-12-2220; Houghton AM, 2013, NAT REV CANCER, V13, P233, DOI 10.1038/nrc3477; Hundertmark S, 1997, J ENDOCRINOL, V155, P171, DOI 10.1677/joe.0.1550171; Jakobsen CH, 2008, J LIPID RES, V49, P2089, DOI 10.1194/jlr.M700389-JLR200; Jiang L, 2013, MOL CANC RES; Jin HR, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.122; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Kamei D, 2010, BIOCHEM J, V425, P361, DOI 10.1042/BJ20090045; Khuri FR, 2001, CLIN CANCER RES, V7, P861; Kim BM, 2011, CANCER LETT, V300, P134, DOI 10.1016/j.canlet.2010.09.014; Kim BM, 2009, INT J ONCOL, V34, P1467, DOI 10.3892/ijo_00000276; Komaki R, 2004, SEMIN ONCOL, V31, P47, DOI 10.1053/j.seminoncol.2003.12.014; Koyama K, 2001, J STEROID BIOCHEM, V76, P153, DOI 10.1016/S0960-0760(00)00157-6; Krysan K, 2004, CANCER RES, V64, P6359, DOI 10.1158/0008-5472.CAN-04-1681; Kwon MC, 2013, MOL ONCOL, V7, P165, DOI 10.1016/j.molonc.2013.02.010; Lipka C, 2004, HORM METAB RES, V36, P437, DOI 10.1055/s-2004-825724; Mao JT, 2011, CANCER PREV RES, V4, P984, DOI 10.1158/1940-6207.CAPR-11-0078; Morita M, 2007, INT J ONCOL, V30, P187; Newton R, 2000, THORAX, V55, P603, DOI 10.1136/thorax.55.7.603; Qiu R, 2012, J CANCER RES CLIN, V138, P119, DOI 10.1007/s00432-011-1080-3; Rabbitt EH, 2003, J STEROID BIOCHEM, V85, P415, DOI 10.1016/S0960-0760(03)00224-3; Rioux N, 1998, CANCER RES, V58, P5354; Sandeep TC, 2004, P NATL ACAD SCI USA, V101, P6734, DOI 10.1073/pnas.0306996101; Schiffelers RM, 2005, NEOPLASIA, V7, P118, DOI 10.1593/neo.04340; Schmieder A, 2012, EUR J IMMUNOL, V42, P2971, DOI 10.1002/eji.201142331; Setia S, 2012, MOL CELL BIOCHEM, V366, P89, DOI 10.1007/s11010-012-1286-y; Shin SY, 2010, MOL CANCER RES, V8, P507, DOI 10.1158/1541-7786.MCR-09-0454; Solomon SD, 2005, NEW ENGL J MED, V352, P1071, DOI 10.1056/NEJMoa050405; Stewart PM, 2009, J CLIN INVEST, V119, P760, DOI 10.1172/JCI38936; Stichtenoth DO, 2001, J IMMUNOL, V167, P469, DOI 10.4049/jimmunol.167.1.469; Teske BF, 2011, MOL BIOL CELL, V22, P4390, DOI 10.1091/mbc.E11-06-0510; Um HJ, 2010, INT J ONCOL, V36, P1007, DOI 10.3892/ijo_00000581; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809; Wang XQ, 2009, MOL BIOL CELL, V20, P791, DOI 10.1091/mbc.E08-07-0732; White MC, 2013, J NEUROSCI RES, V91, P393, DOI 10.1002/jnr.23169; Yang L, 2003, J CLIN INVEST, V111, P727, DOI 10.1172/JCI200316492; Yao B, 2005, AM J PHYSIOL-REG I, V288, pR1767, DOI 10.1152/ajpregu.00786.2004; Zhang MZ, 2006, P NATL ACAD SCI USA, V103, P16045, DOI 10.1073/pnas.0602176103; Zhang MZ, 2009, J CLIN INVEST, V119, P876, DOI 10.1172/JCI37398; Zhang MZ, 1999, P NATL ACAD SCI USA, V96, P15280, DOI 10.1073/pnas.96.26.15280	55	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127030	10.1371/journal.pone.0127030	http://dx.doi.org/10.1371/journal.pone.0127030			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011146	gold, Green Submitted, Green Published			2022-12-26	WOS:000355183900056
J	Fujikawa, K; Fukumori, R; Nakamura, S; Kutsukake, T; Takarada, T; Yoneda, Y				Fujikawa, Koichi; Fukumori, Ryo; Nakamura, Saki; Kutsukake, Takaya; Takarada, Takeshi; Yoneda, Yukio			Potential Interactions of Calcium-Sensitive Reagents with Zinc Ion in Different Cultured Cells	PLOS ONE			English	Article							METHYL-D-ASPARTATE; NITRIC-OXIDE; MOLECULAR-MECHANISMS; RECEPTOR; NMDA; HOMEOSTASIS; EXPRESSION; DEATH; NEUROTOXICITY; MODULATION	Background Several chemicals have been widely used to evaluate the involvement of free Ca2+ in mechanisms underlying a variety of biological responses for decades. Here, we report high reactivity to zinc of well-known Ca2+-sensitive reagents in diverse cultured cells. Methodology/Principal Findings In rat astrocytic C6 glioma cells loaded with the fluorescent Ca2+ dye Fluo-3, the addition of ZnCl2 gradually increased the fluorescence intensity in a manner sensitive to the Ca2+ chelator EGTA irrespective of added CaCl2. The addition of the Ca2+ ionophore A23187 drastically increased Fluo-3 fluorescence in the absence of ZnCl2, while the addition of the Zn2+ ionophore pyrithione rapidly and additionally increased the fluorescence in the presence of ZnCl2, but not in its absence. In cells loaded with the zinc dye FluoZin-3 along with Fluo-3, a similarly gradual increase was seen in the fluorescence of Fluo-3, but not of FluoZin-3, in the presence of both CaCl2 and ZnCl2. Further addition of pyrithione drastically increased the fluorescence intensity of both dyes, while the addition of the Zn2+ chelator N, N, N', N'-tetrakis(2-pyridylmethyl) ethane-1,2-diamine (TPEN) rapidly and drastically decreased FluoZin-3 fluorescence. In cells loaded with FluoZin-3 alone, the addition of ZnCl2 induced a gradual increase in the fluorescence in a fashion independent of added CaCl2 but sensitive to EGTA. Significant inhibition was found in the vitality to reduce 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide in a manner sensitive to TPEN, EDTA and BAPTA in C6 glioma cells exposed to ZnCl2, with pyrithione accelerating the inhibition. Similar inhibition occurred in an EGTA-sensitive fashion after brief exposure to ZnCl2 in pluripotent P19 cells, neuronal Neuro2A cells and microglial BV2 cells, which all expressed mRNA for particular zinc transporters. Conclusions/Significance Taken together, comprehensive analysis is absolutely required for the demonstration of a variety of physiological and pathological responses mediated by Ca2+ in diverse cells enriched of Zn2+.	[Fujikawa, Koichi; Fukumori, Ryo; Nakamura, Saki; Kutsukake, Takaya; Takarada, Takeshi; Yoneda, Yukio] Kanazawa Univ, Div Pharmaceut Sci, Mol Pharmacol Lab, Grad Sch Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa 9201192, Japan	Kanazawa University	Yoneda, Y (corresponding author), Kanazawa Univ, Div Pharmaceut Sci, Mol Pharmacol Lab, Grad Sch Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa 9201192, Japan.	yyoneda@p.kanazawa-u.ac.jp	Yoneda, Yukio/ABI-1864-2020	Yoneda, Yukio/0000-0002-4624-177X; Takarada, Takeshi/0000-0002-2363-7704	Ministry of Education, Culture, Sports, Science and Technology, Japan [22500330, 24650196]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-Aid for Scientific Research to TT (No. 22500330) and YY (No. 24650196) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlard PA, 2010, J NEUROSCI, V30, P1631, DOI 10.1523/JNEUROSCI.5255-09.2010; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; Boom A, 2004, BBA-MOL CELL RES, V1742, P161, DOI 10.1016/j.bbamcr.2004.09.011; Bossy-Wetzel E, 2004, NEURON, V41, P351, DOI 10.1016/S0896-6273(04)00015-7; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; CHOI DW, 1988, TRENDS NEUROSCI, V11, P465, DOI 10.1016/0166-2236(88)90200-7; Choi DW, 1998, ANNU REV NEUROSCI, V21, P347, DOI 10.1146/annurev.neuro.21.1.347; Chowanadisai W, 2008, BRAIN RES, V1199, P10, DOI 10.1016/j.brainres.2008.01.015; CHRISTINE CW, 1990, J NEUROSCI, V10, P108; COLLINGRIDGE GL, 1995, TRENDS NEUROSCI, V18, P54, DOI 10.1016/0166-2236(95)93868-X; Cuajungco MP, 1998, BRAIN RES, V799, P118, DOI 10.1016/S0006-8993(98)00463-6; Fukumori R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069718; Fukumori R, 2010, J PHARMACOL SCI, V112, P273, DOI 10.1254/jphs.09294FP; Hojyo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018059; Huang LP, 2005, J BIOL CHEM, V280, P15456, DOI 10.1074/jbc.M412188200; Jagt TAV, 2009, NEUROSCIENCE, V159, P104, DOI 10.1016/j.neuroscience.2008.11.052; Jing Q, 2006, J NEUROSCI, V26, P6089, DOI 10.1523/JNEUROSCI.0475-06.2006; Kambe T, 2008, GENESIS, V46, P214, DOI 10.1002/dvg.20382; Kambe Y, 2011, NEUROCHEM INT, V59, P10, DOI 10.1016/j.neuint.2011.03.018; Kaneko M, 2015, J NEUROSCI RES, V93, P370, DOI 10.1002/jnr.23491; Koh JY, 1996, SCIENCE, V272, P1013, DOI 10.1126/science.272.5264.1013; Lichten LA, 2009, ANNU REV NUTR, V29, P153, DOI 10.1146/annurev-nutr-033009-083312; MACDERMOTT AB, 1986, NATURE, V321, P519, DOI 10.1038/321519a0; Martin JL, 2006, CELL CALCIUM, V40, P393, DOI 10.1016/j.ceca.2006.04.008; MAYER ML, 1987, PROG NEUROBIOL, V28, P197, DOI 10.1016/0301-0082(87)90011-6; Mony L, 2009, BRIT J PHARMACOL, V157, P1301, DOI 10.1111/j.1476-5381.2009.00304.x; Nakamura Y, 2012, NEUROCHEM INT, V60, P448, DOI 10.1016/j.neuint.2011.08.018; Nakazato R, 2011, J PHARMACOL SCI, V116, P350, DOI 10.1254/jphs.11069FP; Ogura M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048270; Paoletti P, 2009, NEUROSCIENCE, V158, P126, DOI 10.1016/j.neuroscience.2008.01.061; PETERS S, 1987, SCIENCE, V236, P589, DOI 10.1126/science.2883728; PUSKIN JS, 1975, BIOCHEMISTRY-US, V14, P187, DOI 10.1021/bi00672a031; Sattler R, 2000, J MOL MED, V78, P3, DOI 10.1007/s001090000077; SCHEETZ AJ, 1994, FASEB J, V8, P745, DOI 10.1096/fasebj.8.10.8050674; Sensi SL, 1997, J NEUROSCI, V17, P9554; Sensi SL, 2009, NAT REV NEUROSCI, V10, P780, DOI 10.1038/nrn2734; SMART TG, 1994, PROG NEUROBIOL, V42, P393, DOI 10.1016/0301-0082(94)90082-5; Smerin YL, 2000, J PHARMACOL EXP THER, V292, P1104; St Croix CM, 2002, AM J PHYSIOL-LUNG C, V282, pL185, DOI 10.1152/ajplung.00267.2001; Takarada T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063947; Takarada T, 2009, NEUROSCI LETT, V451, P99, DOI 10.1016/j.neulet.2008.12.037; Takeda A, 2009, BRAIN RES REV, V62, P33, DOI 10.1016/j.brainresrev.2009.09.003; Taniura H, 2007, BIOCHEM BIOPH RES CO, V362, P1096, DOI 10.1016/j.bbrc.2007.08.126; TSIEN RY, 1980, BIOCHEMISTRY-US, V19, P2396, DOI 10.1021/bi00552a018; VALLEE BL, 1995, NEUROCHEM INT, V27, P23, DOI 10.1016/0197-0186(94)00165-Q; Wei W, 2008, CANCER LETT, V260, P79, DOI 10.1016/j.canlet.2007.10.025; Weiss JH, 2000, TRENDS PHARMACOL SCI, V21, P395, DOI 10.1016/S0165-6147(00)01541-8; WESTBROOK GL, 1987, NATURE, V328, P640, DOI 10.1038/328640a0; WOLLHEIM CB, 1975, J BIOL CHEM, V250, P1354	49	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127421	10.1371/journal.pone.0127421	http://dx.doi.org/10.1371/journal.pone.0127421			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010609	Green Submitted, Green Published, gold			2022-12-26	WOS:000355183900089
J	Gianasi, BL; Verkaik, K; Hamel, JF; Mercier, A				Gianasi, Bruno L.; Verkaik, Katie; Hamel, Jean-Francois; Mercier, Annie			Novel Use of PIT Tags in Sea Cucumbers: Promising Results with the Commercial Species Cucumaria frondosa	PLOS ONE			English	Article							HOLOTHURIA-SCABRA; GROWTH; ECHINODERMATA; INVERTEBRATES; MOVEMENT; BEHAVIOR; BIOLOGY; URCHINS	The lack of a reliable and innocuous mark-recapture method has limited studies that would provide essential information for the management of commercial sea cucumbers. Tagging sea cucumbers is notoriously difficult because of their plastic nature and autolysis capacities. The markers that have so far been tested, mainly on or through the body wall, were either lost rapidly or had major drawbacks (e.g. suitable only for batch identification, requiring complex analysis, causing infections, necrosis, behavioural changes and mortality). The present study explored the efficacy of passive integrated transponder (PIT) tags for individually marking sea cucumbers by assessing retention rates and long-term side effects of tags inserted in previously unstudied tissues/organs. Individuals of the species Cucumaria frondosa were tagged in the body wall, aquapharyngeal bulb and at the base of the oral tentacles. They were monitored closely for evidence of stress, infection, change in feeding and spawning behaviour and tag retention rate. Implanting the tag in an oral tentacle to reach the hydrovascular system of the aquapharyngeal bulb achieved the best retention rates in full-size individuals: from a maximum of 92% after 30 days to 68% at the end of the experimental period (300 days). Efficacy was lower in smaller individuals (84% after 30 d and 42% after 300 d). Following a slight increase in cloacal movements for 15 h post tagging, no side effect was noted in sea cucumbers tagged in the aquapharyngeal bulb via the tentacles. Feeding and spawning behaviours were not affected and no signs of infections or abnormal cell development in the vicinity of the tags were observed. This study indicates that marking sea cucumbers with 8.2 mm long PIT tags implanted via the oral tentacle is an effective technique, yielding relatively high retention rates over long periods without any detectable physiological or behavioural effects.	[Gianasi, Bruno L.; Verkaik, Katie; Mercier, Annie] Mem Univ Newfoundland, Dept Ocean Sci OSC, St John, NF, Canada; [Hamel, Jean-Francois] Soc Explorat & Valuing Environm, St Philips, NF, Canada	Memorial University Newfoundland	Gianasi, BL (corresponding author), Mem Univ Newfoundland, Dept Ocean Sci OSC, St John, NF, Canada.	brunolg@mun.ca	Mercier, Annie/B-4254-2012; Gianasi, Bruno/A-5163-2018	Gianasi, Bruno/0000-0002-4215-6199; Mercier, Annie/0000-0003-0807-2378	Research & Development Corporation of Newfoundland Labrador (RDC); Department of Fisheries and Aquaculture of Newfoundland Labrador (DFA); Canadian Centre for Fisheries Innovation (CCFI)	Research & Development Corporation of Newfoundland Labrador (RDC); Department of Fisheries and Aquaculture of Newfoundland Labrador (DFA); Canadian Centre for Fisheries Innovation (CCFI)	This study was funded by Research & Development Corporation of Newfoundland & Labrador (RDC), Department of Fisheries and Aquaculture of Newfoundland & Labrador (DFA) and Canadian Centre for Fisheries Innovation (CCFI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SC, 2011, FISH FISH, V12, P317, DOI 10.1111/j.1467-2979.2010.00397.x; Cieciel K, 2009, N AM J FISH MANAGE, V29, P288, DOI 10.1577/M07-194.1; Conand C., 1991, P169; Conand C., 2004, PRESENT STATUS WORLD; Conand C., 1993, US NMFS MAR FISH REV, V55, P1; DOYLE WL, 1964, Q J MICROSC SCI, V105, P7; Hagen NT, 1996, AQUACULTURE, V139, P271, DOI 10.1016/0044-8486(95)01156-0; Hamel J-F, 1996, SPC BECHE DE MER INF, V8, P22; Hamel J-F, 2008, POPULATION STATUS FI; Hamel J-F, 1996, SPC BECHE DE MER INF, V8, P34; Hamel JF, 1999, J MAR BIOL ASSOC UK, V79, P121, DOI 10.1017/S0025315498000137; Hamel JF, 1998, CAN J ZOOL, V76, P1194, DOI 10.1139/cjz-76-6-1194; Hamel JF, 1996, CAN J FISH AQUAT SCI, V53, P253, DOI 10.1139/cjfas-53-2-253; Kirshenbaum S, 2006, FISH B-NOAA, V104, P299; KROPP RK, 1982, PAC SCI, V36, P445; Lauzon-Guay JS, 2008, AQUAT BIOL, V2, P105, DOI 10.3354/ab00040; LEGAULT C, 1993, J EXP MAR BIOL ECOL, V170, P55, DOI 10.1016/0022-0981(93)90129-C; Lokani P, 1992, SPC BECHE DE MER INF, V4, P9; MacTavish T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050031; Mercier A, 2013, WOODHEAD PUBL FOOD S, P431, DOI 10.1533/9780857097460.2.431; Mercier A, 2000, HYDROBIOLOGIA, V440, P81, DOI 10.1023/A:1004121818691; Mercier A, 2009, ADV MAR BIOL, V55, P1, DOI 10.1016/S0065-2881(09)55001-8; Morgan AD, 2000, J WORLD AQUACULT SOC, V31, P186, DOI 10.1111/j.1749-7345.2000.tb00352.x; Nelson EJ, 2012, REV FISH SCI, V20, P212, DOI 10.1080/10641262.2012.719043; PRIMAVERA JH, 1992, AUST J MAR FRESH RES, V43, P737; Purcell S.W., 2012, ASIA PACIFIC TROPICA, P92; Purcell SW, 2006, J EXP MAR BIOL ECOL, V334, P283, DOI 10.1016/j.jembe.2006.02.007; Purcell SW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095075; Purcell SW, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3296; Purcell SW, 2013, FISH FISH, V14, P34, DOI 10.1111/j.1467-2979.2011.00443.x; Purcell Steven W., 2008, Beche-de-mer Information Bulletin, V28, P53; Purcell SW, 2009, AQUACULTURE, V296, P263, DOI 10.1016/j.aquaculture.2009.08.027; Ramofafia C, 1997, AQUACULTURE, V152, P119, DOI 10.1016/S0044-8486(96)01525-6; Reichenbach N, 1999, B MAR SCI, V64, P103; Rich JT, 2010, OTOLARYNG HEAD NECK, V143, P331, DOI 10.1016/j.otohns.2010.05.007; Shiell GR, 2006, MAR FRESHW BEHAV PHY, V39, P153, DOI 10.1080/10236240600688789; Slater MJ, 2010, AQUAC RES, V41, pe695, DOI 10.1111/j.1365-2109.2010.02607.x; So JJ, 2010, FISHERIES MANAG ECOL, V17, P473, DOI 10.1111/j.1365-2400.2010.00747.x; So JJ, 2011, MAR BIOL, V158, P859, DOI 10.1007/s00227-010-1613-3; Uthicke S, 2004, CONSERV BIOL, V18, P1395, DOI 10.1111/j.1523-1739.2004.00309.x; Uthicke S, 2004, CAN J FISH AQUAT SCI, V61, P519, DOI 10.1139/F04-013; Uthicke S, 2002, MAR ECOL PROG SER, V241, P221, DOI 10.3354/meps241221; Wilson CD, 2011, ANIM BEHAV, V81, P341, DOI 10.1016/j.anbehav.2010.10.003	43	22	25	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127884	10.1371/journal.pone.0127884	http://dx.doi.org/10.1371/journal.pone.0127884			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011165	Green Accepted, gold, Green Published, Green Submitted			2022-12-26	WOS:000355183900157
J	Grunert, LW; Clarke, JW; Ahuja, C; Eswaran, H; Nijhout, HF				Grunert, Laura W.; Clarke, Jameson W.; Ahuja, Chaarushi; Eswaran, Harish; Nijhout, H. Frederik			A Quantitative Analysis of Growth and Size Regulation in Manduca sexta: The Physiological Basis of Variation in Size and Age at Metamorphosis	PLOS ONE			English	Article							BODY-SIZE; TOBACCO HORNWORM; CUTICULAR MORPHOGENESIS; JUVENILE-HORMONE; PUPAL COMMITMENT; SELECTION; TEMPERATURE; MECHANISMS; FECUNDITY; INSECTS	Body size and development time are important life history traits because they are often highly correlated with fitness. Although the developmental mechanisms that control growth have been well studied, the mechanisms that control how a species-characteristic body size is achieved remain poorly understood. In insects adult body size is determined by the number of larval molts, the size increment at each molt, and the mechanism that determines during which instar larval growth will stop. Adult insects do not grow, so the size at which a larva stops growing determines adult body size. Here we develop a quantitative understanding of the kinetics of growth throughout larval life of Manduca sexta, under different conditions of nutrition and temperature, and for genetic strains with different adult body sizes. We show that the generally accepted view that the size increment at each molt is constant (Dyar's Rule) is systematically violated: there is actually a progressive increase in the size increment from instar to instar that is independent of temperature. In addition, the mass-specific growth rate declines throughout the growth phase in a temperature-dependent manner. We show that growth within an instar follows a truncated Gompertz trajectory. The critical weight, which determines when in an instar a molt will occur, and the threshold size, which determines which instar is the last, are different in genetic strains with different adult body sizes. Under nutrient and temperature stress Manduca has a variable number of larval instars and we show that this is due to the fact that more molts at smaller increments are taken before threshold size is reached. We test whether the new insight into the kinetics of growth and size determination are sufficient to explain body size and development time through a mathematical model that incorporates our quantitative findings.	[Grunert, Laura W.; Clarke, Jameson W.; Ahuja, Chaarushi; Eswaran, Harish; Nijhout, H. Frederik] Duke Univ, Dept Biol, Durham, NC 27708 USA	Duke University	Nijhout, HF (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	hfn@duke.edu		Eswaran, Harish/0000-0001-9604-1138	National Science Foundation [IOS-0744952 EF-103859, IOS-1121065]; Division Of Integrative Organismal Systems [1121065] Funding Source: National Science Foundation; Emerging Frontiers [1038593] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Emerging Frontiers(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	National Science Foundation grants: IOS-0744952 EF-103859 and IOS-1121065. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angilletta MJ, 2004, INTEGR COMP BIOL, V44, P498, DOI 10.1093/icb/44.6.498; ATKINSON D, 1994, ADV ECOL RES, V25, P1, DOI 10.1016/s0065-2504(08)60212-3; BAPTIST R, 1976, THEOR APPL GENET, V47, P209, DOI 10.1007/BF00284390; BENNETCLARK HC, 1963, J INSECT PHYSIOL, V9, P43, DOI 10.1016/0022-1910(63)90083-0; Bodenheimer FS, 1933, Q REV BIOL, V8, P92, DOI 10.1086/394427; Boyko AR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000451; Callier V, 2013, BIOL REV, V88, P944, DOI 10.1111/brv.12033; Callier V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045455; Callier V, 2011, P NATL ACAD SCI USA, V108, P14664, DOI 10.1073/pnas.1106556108; Davidowitz G, 2004, INTEGR COMP BIOL, V44, P443, DOI 10.1093/icb/44.6.443; Davidowitz G, 2004, EVOL ECOL RES, V6, P49; Davidowitz G, 2003, EVOL DEV, V5, P188, DOI 10.1046/j.1525-142X.2003.03026.x; Davidowitz G, 2012, EVOLUTION, V66, P2916, DOI 10.1111/j.1558-5646.2012.01644.x; Davidowitz Goggy, 2008, Journal of Orthoptera Research, V17, P265, DOI 10.1665/1082-6467-17.2.265; Diamond SE, 2010, ECOL ENTOMOL, V35, P166, DOI 10.1111/j.1365-2311.2009.01166.x; Dyar H. G., 1890, Psyche, Vv, P420; Esperk T, 2007, J ECON ENTOMOL, V100, P627, DOI 10.1603/0022-0493(2007)100[627:IVINOL]2.0.CO;2; Flatt T, 2011, MECHANISMS OF LIFE HISTORY EVOLUTION: THE GENETICS AND PHYSIOLOGY OF LIFE HISTORY TRAITS AND TRADE-OFFS, P1; HONEK A, 1993, OIKOS, V66, P483, DOI 10.2307/3544943; Hutchinson JMC, 1997, PHILOS T R SOC B, V352, P113, DOI 10.1098/rstb.1997.0007; Kingsolver JG, 2004, EVOLUTION, V58, P1608; Kingsolver JG, 2008, SIZE TEMPERATURE FIT; Kingsolver JG, 2007, P ROY SOC B-BIOL SCI, V274, P977, DOI 10.1098/rspb.2006.0036; Koyama T, 2008, DEV BIOL, V324, P258, DOI 10.1016/j.ydbio.2008.09.017; Kremen C, 1998, J INSECT PHYSIOL, V44, P287, DOI 10.1016/S0022-1910(97)00121-2; Muramatsu D, 2008, MECH DEVELOP, V125, P411, DOI 10.1016/j.mod.2008.02.001; Nijhout H F, 2006, J Biol, V5, P16, DOI 10.1186/jbiol43; Nijhout H.F., 1994, INSECT HORMONES; Nijhout HF, 2015, ANNU REV ENTOMOL, V60, P141, DOI 10.1146/annurev-ento-010814-020841; Nijhout HF, 2014, WIRES DEV BIOL, V3, P113, DOI 10.1002/wdev.124; NIJHOUT HF, 1975, BIOL BULL, V149, P214, DOI 10.2307/1540491; NIJHOUT HF, 1974, J EXP BIOL, V61, P493; Oldham S, 2002, DEVELOPMENT, V129, P4103; Rintelen F, 2001, P NATL ACAD SCI USA, V98, P15020, DOI 10.1073/pnas.011318098; Roff Derek A., 1992; Sears KE, 2012, PHYSIOL BIOCHEM ZOOL, V85, P159, DOI 10.1086/664619; Shingleton AW, 2005, CURR BIOL, V15, pR825, DOI 10.1016/j.cub.2005.10.006; Stearns S.C., 1992, pi; STEARNS SC, 1989, FUNCT ECOL, V3, P259, DOI 10.2307/2389364; Tammaru T, 2007, FUNCT ECOL, V21, P1099, DOI 10.1111/j.1365-2435.2007.01319.x; Tobler A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010723; TRUMAN JW, 1974, J EXP BIOL, V60, P371; Turner TL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001336; WOLFGANG WJ, 1986, DEV BIOL, V113, P305, DOI 10.1016/0012-1606(86)90166-1; WOLFGANG WJ, 1981, TISSUE CELL, V13, P757, DOI 10.1016/S0040-8166(81)80012-2	45	31	31	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127988	10.1371/journal.pone.0127988	http://dx.doi.org/10.1371/journal.pone.0127988			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011714	Green Published, Green Submitted, gold			2022-12-26	WOS:000355183900178
J	Lemieux, B; Blanchette, M; Monette, A; Mouland, AJ; Wellinger, RJ; Chabot, B				Lemieux, Bruno; Blanchette, Marco; Monette, Anne; Mouland, Andrew J.; Wellinger, Raymund J.; Chabot, Benoit			A Function for the hnRNP A1/A2 Proteins in Transcription Elongation	PLOS ONE			English	Article							RNA-POLYMERASE-II; 7SK SNRNP; P-TEFB; A1; RIBONUCLEOPROTEIN; EXPRESSION; REVEALS; COMPONENT; CHROMATIN; MULTIPLE	The hnRNP A1 and A2 proteins regulate processes such as alternative pre-mRNA splicing and mRNA stability. Here, we report that a reduction in the levels of hnRNP A1 and A2 by RNA interference or their cytoplasmic retention by osmotic stress drastically increases the transcription of a reporter gene. Based on previous work, we propose that this effect may be linked to a decrease in the activity of the transcription elongation factor P-TEFb. Consistent with this hypothesis, the transcription of the reporter gene was stimulated when the catalytic component of P-TEFb, CDK9, was inhibited with DRB. While low levels of A1/A2 stimulated the association of RNA polymerase II with the reporter gene, they also increased the association of CDK9 with the repressor 7SK RNA, and compromised the recovery of promoter-distal transcription on the Kitlg gene after the release of pausing. Transcriptome analysis revealed that more than 50% of the genes whose expression was affected by the siRNA-mediated depletion of A1/A2 were also affected by DRB. RNA polymerase II-chromatin immunoprecipitation assays on DRB-treated and A1/A2-depleted cells identified a common set of repressed genes displaying increased occupancy of polymerases at promoter-proximal locations, consistent with pausing. Overall, our results suggest that lowering the levels of hnRNP A1/A2 elicits defective transcription elongation on a fraction of P-TEFb-dependent genes, hence favoring the transcription of P-TEFb-independent genes.	[Lemieux, Bruno; Wellinger, Raymund J.; Chabot, Benoit] Univ Sherbrooke, Fac Med & Hlth Sci, RNA Grp, Sherbrooke, PQ J1K 2R1, Canada; [Lemieux, Bruno; Wellinger, Raymund J.; Chabot, Benoit] Univ Sherbrooke, Fac Med & Hlth Sci, Dept Microbiol & Infect Dis, Sherbrooke, PQ J1K 2R1, Canada; [Blanchette, Marco] Stowers Inst Med Res, Kansas City, MO USA; [Monette, Anne; Mouland, Andrew J.] McGill Univ, Lady Davis Inst Med Res, Sir Mortimer B Davis Jewish Gen Hosp, Montreal, PQ, Canada	University of Sherbrooke; University of Sherbrooke; Stowers Institute for Medical Research; Lady Davis Institute; McGill University	Chabot, B (corresponding author), Univ Sherbrooke, Fac Med & Hlth Sci, RNA Grp, Sherbrooke, PQ J1K 2R1, Canada.	benoit.chabot@usherbrooke.ca	Wellinger, Raymund/K-3207-2019	Wellinger, Raymund/0000-0001-6670-2759; Chabot, Benoit/0000-0003-0994-0042	Canadian Institute of Health Research [MOP93917, MOP97874, MOP56794]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported by grants from the Canadian Institute of Health Research (MOP93917 to BC, MOP97874 to RJW and MOP56794 to AJM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allemand E, 2005, P NATL ACAD SCI USA, V102, P3605, DOI 10.1073/pnas.0409889102; Allemand E, 2008, CURR OPIN GENET DEV, V18, P145, DOI 10.1016/j.gde.2008.01.006; Barboric M, 2009, P NATL ACAD SCI USA, V106, P7798, DOI 10.1073/pnas.0903188106; Barrandon C, 2007, MOL CELL BIOL, V27, P6996, DOI 10.1128/MCB.00975-07; Bartholomeeusen K, 2012, J BIOL CHEM, V287, P36609, DOI 10.1074/jbc.M112.410746; Bensaude O, 2011, TRANSCR-AUSTIN, V2, P103, DOI 10.4161/trns.2.3.16172; Bentley DL, 2005, CURR OPIN CELL BIOL, V17, P251, DOI 10.1016/j.ceb.2005.04.006; Beriault V, 2004, J BIOL CHEM, V279, P44141, DOI 10.1074/jbc.M404691200; Buratowski S, 2003, NAT STRUCT BIOL, V10, P679, DOI 10.1038/nsb0903-679; Buxade M, 2005, IMMUNITY, V23, P177, DOI 10.1016/j.immuni.2005.06.009; Das R, 2007, MOL CELL, V26, P867, DOI 10.1016/j.molcel.2007.05.036; Egloff S, 2008, TRENDS GENET, V24, P280, DOI 10.1016/j.tig.2008.03.008; Fiset S, 2001, NUCLEIC ACIDS RES, V29, P2268, DOI 10.1093/nar/29.11.2268; Flynn RL, 2011, NATURE, V471, P532, DOI 10.1038/nature09772; Fong YW, 2001, NATURE, V414, P929, DOI 10.1038/414929a; Guil S, 2007, NAT STRUCT MOL BIOL, V14, P591, DOI 10.1038/nsmb1250; Guil S, 2006, MOL CELL BIOL, V26, P5744, DOI 10.1128/MCB.00224-06; Hogg JR, 2007, RNA, V13, P868, DOI 10.1261/rna.565207; Huelga SC, 2012, CELL REP, V1, P167, DOI 10.1016/j.celrep.2012.02.001; Ip JY, 2011, GENOME RES, V21, P390, DOI 10.1101/gr.111070.110; Jeronimo C, 2007, MOL CELL, V27, P262, DOI 10.1016/j.molcel.2007.06.027; Ji X, 2013, CELL, V153, P855, DOI 10.1016/j.cell.2013.04.028; Kornblihtt AR, 2004, RNA, V10, P1489, DOI 10.1261/rna.7100104; Krueger BJ, 2008, NUCLEIC ACIDS RES, V36, P2219, DOI 10.1093/nar/gkn061; Kukalev A, 2005, NAT STRUCT MOL BIOL, V12, P238, DOI 10.1038/nsmb904; LaBranche H, 1998, NAT GENET, V19, P199, DOI 10.1038/575; Levesque K, 2006, TRAFFIC, V7, P1177, DOI 10.1111/j.1600-0854.2006.00461.x; Levine M, 2011, CELL, V145, P502, DOI 10.1016/j.cell.2011.04.021; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin SR, 2008, NAT STRUCT MOL BIOL, V15, P819, DOI 10.1038/nsmb.1461; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Markert A, 2008, EMBO REP, V9, P569, DOI 10.1038/embor.2008.72; Martinez-Contreras R, 2006, PLOS BIOL, V4, P172, DOI 10.1371/journal.pbio.0040021; Martinez-Contreras R, 2007, ADV EXP MED BIOL, V623, P123, DOI 10.1007/978-0-387-77374-2_8; Michelotti EF, 1996, MOL CELL BIOL, V16, P2350, DOI 10.1128/mcb.16.5.2350; Moldon A, 2008, NATURE, V455, P997, DOI 10.1038/nature07325; Neugebauer KM, 2002, J CELL SCI, V115, P3865, DOI 10.1242/jcs.00073; Nguyen VT, 2001, NATURE, V414, P322, DOI 10.1038/35104581; Obrdlik A, 2008, MOL CELL BIOL, V28, P6342, DOI 10.1128/MCB.00766-08; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Rozen S, 2000, Methods Mol Biol, V132, P365; Singh J, 2009, NAT STRUCT MOL BIOL, V16, P1128, DOI 10.1038/nsmb.1666; Svotelis A, 2009, METHODS MOL BIOL, V543, P243, DOI 10.1007/978-1-60327-015-1_16; Van Herreweghe E, 2007, EMBO J, V26, P3570, DOI 10.1038/sj.emboj.7601783; van Oordt WV, 2000, J CELL BIOL, V149, P307, DOI 10.1083/jcb.149.2.307; Venables JP, 2008, MOL CELL BIOL, V28, P6033, DOI 10.1128/MCB.00726-08; Xia H, 2005, J BIOL CHEM, V280, P13171, DOI 10.1074/jbc.M414120200; Yan D, 1998, MOL CELL BIOL, V18, P5000, DOI 10.1128/MCB.18.9.5000; Yang ZY, 2001, NATURE, V414, P317, DOI 10.1038/35104575; Zhang QS, 2006, RNA, V12, P1116, DOI 10.1261/rna.58806; Zhao TT, 2009, CELL DEATH DIFFER, V16, P244, DOI 10.1038/cdd.2008.146; Zhou Q, 2012, ANNU REV BIOCHEM, V81, P119, DOI 10.1146/annurev-biochem-052610-095910	52	29	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0126654	10.1371/journal.pone.0126654	http://dx.doi.org/10.1371/journal.pone.0126654			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011126	Green Submitted, gold, Green Published			2022-12-26	WOS:000355183900037
J	Wang, YB; Jiang, Q; Yang, ZM; Sun, W; Wang, DL				Wang, Yunbo; Jiang, Qi; Yang, Zhiming; Sun, Wei; Wang, Deli			Effects of Water and Nitrogen Addition on Ecosystem Carbon Exchange in a Meadow Steppe	PLOS ONE			English	Article							RAINFALL VARIABILITY; SEASONAL WATER; TERRESTRIAL ECOSYSTEMS; EXTREME PRECIPITATION; CO2 FLUX; RESPONSES; GRASSLAND; SOIL; C-3; AVAILABILITY	A changing precipitation regime and increasing nitrogen deposition are likely to have profound impacts on arid and semiarid ecosystem C cycling, which is often constrained by the timing and availability of water and nitrogen. However, little is known about the effects of altered precipitation and nitrogen addition on grassland ecosystem C exchange. We conducted a 3-year field experiment to assess the responses of vegetation composition, ecosystem productivity, and ecosystem C exchange to manipulative water and nitrogen addition in a meadow steppe. Nitrogen addition significantly stimulated aboveground biomass and net ecosystem CO2 exchange (NEE), which suggests that nitrogen availability is a primary limiting factor for ecosystem C cycling in the meadow steppe. Water addition had no significant impacts on either ecosystem C exchange or plant biomass, but ecosystem C fluxes showed a strong correlation with early growing season precipitation, rather than whole growing season precipitation, across the 3 experimental years. After we incorporated water addition into the calculation of precipitation regimes, we found that monthly average ecosystem C fluxes correlated more strongly with precipitation frequency than with precipitation amount. These results highlight the importance of precipitation distribution in regulating ecosystem C cycling. Overall, ecosystem C fluxes in the studied ecosystem are highly sensitive to nitrogen deposition, but less sensitive to increased precipitation.	[Wang, Yunbo; Jiang, Qi; Yang, Zhiming; Sun, Wei; Wang, Deli] NE Normal Univ, Inst Grassland Sci, Minist Educ, Key Lab Vegetat Ecol, Changchun, Jilin Province, Peoples R China; [Yang, Zhiming] Heilongjiang Bayi Agr Univ, Vet & Anim Sci Coll, Daqing, Heilongjiang, Peoples R China	Northeast Normal University - China; Heilongjiang Bayi Agricultural University	Sun, W (corresponding author), NE Normal Univ, Inst Grassland Sci, Minist Educ, Key Lab Vegetat Ecol, Changchun, Jilin Province, Peoples R China.	sunwei@nenu.edu.cn; wangd@nenu.edu.cn			National Key Basic Research Program of China [2015CB150800]; National Natural Science Foundation of China [31270445, 31230012, 31201839]; Program for New Century Excellent Talents in University [NCET-12-0814]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by the National Key Basic Research Program of China (2015CB150800), National Natural Science Foundation of China (31270445, 31230012, 31201839), and Program for New Century Excellent Talents in University (NCET-12-0814). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ba L, 2012, PLANT SOIL, V352, P143, DOI 10.1007/s11104-011-0985-6; Bai YF, 2010, GLOBAL CHANGE BIOL, V16, P358, DOI 10.1111/j.1365-2486.2009.01950.x; Baldocchi DD, 2004, AGR FOREST METEOROL, V123, P13, DOI 10.1016/j.agrformet.2003.11.006; Bates JD, 2006, J ARID ENVIRON, V64, P670, DOI 10.1016/j.jaridenv.2005.06.026; Bronikowski A, 1996, BEHAV ECOL SOCIOBIOL, V39, P27, DOI 10.1007/s002650050263; Brueck H, 2010, PLANT SOIL, V328, P495, DOI 10.1007/s11104-009-0128-5; Chen SP, 2009, GLOBAL CHANGE BIOL, V15, P2450, DOI 10.1111/j.1365-2486.2009.01879.x; Cherwin K, 2012, OECOLOGIA, V169, P845, DOI 10.1007/s00442-011-2235-2; Christensen L, 2004, CLIMATIC CHANGE, V63, P351, DOI 10.1023/B:CLIM.0000018513.60904.fe; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Gerten D, 2008, GLOBAL CHANGE BIOL, V14, P2365, DOI 10.1111/j.1365-2486.2008.01651.x; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; [韩梅 HAN Mei], 2006, [生态学报, Acta Ecologica Sinica], V26, P1825; Harper CW, 2005, GLOBAL CHANGE BIOL, V11, P322, DOI 10.1111/j.1365-2486.2005.00899.x; Harpole WS, 2007, GLOBAL CHANGE BIOL, V13, P2341, DOI 10.1111/j.1365-2486.2007.01447.x; Hooper DU, 1999, BIOGEOCHEMISTRY, V46, P247, DOI 10.1007/BF01007582; IPCC, 2007, CLIMATE CHANGE 2007, DOI DOI 10.1260/095830507781076194; Jiang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045205; KEMP PR, 1980, ECOLOGY, V61, P846, DOI 10.2307/1936755; Knapp AK, 2002, SCIENCE, V298, P2202, DOI 10.1126/science.1076347; Knapp AK, 2008, BIOSCIENCE, V58, P811, DOI 10.1641/B580908; Koerner SE, 2014, ECOLOGY, V95, P98, DOI 10.1890/13-0526.1; Koerner SE, 2014, J VEG SCI, V25, P36, DOI 10.1111/jvs.12065; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; LeBauer DS, 2008, ECOLOGY, V89, P371, DOI 10.1890/06-2057.1; Liu XJ, 2013, NATURE, V494, P459, DOI 10.1038/nature11917; Ma LN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035165; Maragni LA, 2000, AM J BOT, V87, P230, DOI 10.2307/2656910; Menge DNL, 2007, GLOBAL CHANGE BIOL, V13, P2582, DOI 10.1111/j.1365-2486.2007.01456.x; Mo J, 2008, GLOBAL CHANGE BIOL, V14, P403, DOI 10.1111/j.1365-2486.2007.01503.x; Nadelhoffer KJ, 1999, NATURE, V398, P145, DOI 10.1038/18205; NIHLGARD B, 1985, AMBIO, V14, P2; Niu SL, 2008, J EXP BOT, V59, P1431, DOI 10.1093/jxb/ern051; Niu SL, 2010, GLOBAL CHANGE BIOL, V16, P144, DOI 10.1111/j.1365-2486.2009.01894.x; Niu SL, 2009, ECOSYSTEMS, V12, P915, DOI 10.1007/s10021-009-9265-1; Niu SL, 2005, J EXP BOT, V56, P2867, DOI 10.1093/jxb/eri281; Qu GuoHui, 2003, Acta Prataculturae Sinica, V12, P18; Raghuwanshi R, 2004, WORLD J MICROB BIOT, V20, P1, DOI 10.1023/B:WIBI.0000013274.14957.44; Reichstein M, 2013, NATURE, V500, P287, DOI 10.1038/nature12350; Risch AC, 2007, BIOGEOCHEMISTRY, V86, P91, DOI 10.1007/s10533-007-9148-5; Saarnio S, 2003, ECOSYSTEMS, V6, P46, DOI 10.1007/s10021-002-0208-3; Shaver GR, 1998, ECOL MONOGR, V68, P75, DOI 10.1890/0012-9615(1998)068[0075:BACFIW]2.0.CO;2; Smith MD, 2011, J ECOL, V99, P656, DOI 10.1111/j.1365-2745.2011.01798.x; Swemmer AM, 2007, J ECOL, V95, P780, DOI 10.1111/j.1365-2745.2007.01237.x; Tieszen L. L., 1970, Proceedings of the South Dakota Academy of Science, V49, P78; Wang ZY, 2015, PLANT SOIL, V389, P59, DOI 10.1007/s11104-014-2337-9; Weltzin JF, 2003, BIOSCIENCE, V53, P941, DOI 10.1641/0006-3568(2003)053[0941:ATROTE]2.0.CO;2; Wilcox KR, 2015, GLOBAL CHANGE BIOL, V21, P335, DOI 10.1111/gcb.12673; Winslow JC, 2003, ECOL MODEL, V163, P153, DOI 10.1016/S0304-3800(02)00415-5; Xia JY, 2008, NEW PHYTOL, V179, P428, DOI 10.1111/j.1469-8137.2008.02488.x; Xia JY, 2009, GLOBAL CHANGE BIOL, V15, P1544, DOI 10.1111/j.1365-2486.2008.01807.x; Yan LM, 2011, PLANT SOIL, V349, P227, DOI 10.1007/s11104-011-0864-1; Yang HJ, 2011, GLOBAL CHANGE BIOL, V17, P2936, DOI 10.1111/j.1365-2486.2011.02423.x; Zeppel MJB, 2014, BIOGEOSCIENCES, V11, P3083, DOI 10.5194/bg-11-3083-2014; Zhang BC, 2013, CLIMATIC CHANGE, V118, P197, DOI 10.1007/s10584-012-0622-2; Zhang YH, 2014, GLOBAL CHANGE BIOL, V20, P3520, DOI 10.1111/gcb.12611; Zhu T, 2004, YANG CAO BIOLOGICAL, P120	57	24	27	14	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127695	10.1371/journal.pone.0127695	http://dx.doi.org/10.1371/journal.pone.0127695			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010888	gold, Green Published, Green Submitted			2022-12-26	WOS:000355183900133
J	Birkholz, A; Nemcovic, M; Yu, ED; Girardi, E; Wang, J; Khurana, A; Pauwels, N; Farber, E; Chitale, S; Franck, RW; Tsuji, M; Howell, A; Van Calenbergh, S; Kronenberg, M; Zajonc, DM				Birkholz, Alysia; Nemcovic, Marek; Yu, Esther Dawen; Girardi, Enrico; Wang, Jing; Khurana, Archana; Pauwels, Nora; Farber, Elisa; Chitale, Sampada; Franck, Richard W.; Tsuji, Moriya; Howell, Amy; Van Calenbergh, Serge; Kronenberg, Mitchell; Zajonc, Dirk M.			Lipid and Carbohydrate Modifications of alpha-Galactosylcer-amide Differently Influence Mouse and Human Type I Natural Killer T Cell Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIGEN PRESENTATION; MOLECULAR-BASIS; HUMAN CD1D; NKT CELLS; RECOGNITION; TCR; GLYCOLIPIDS; LIGAND; BINDING; STIMULATION	The ability of different glycosphingolipids (GSLs) to activate type I natural killer T cells (NKT cells) has been known for 2 decades. The possible therapeutic use of these GSLs has been studied in many ways; however, studies are needed in which the efficacy of promising GSLs is compared under identical conditions. Here, we compare five unique GSLs structurally derived from alpha-galactosylceramide. We employed biophysical and biological assays, as well as x-ray crystallography to study the impact of the chemical modifications of the antigen on type I NKT cell activation. Although all glycolipids are bound by the T cell receptor of type I NKT cells in real time binding assays with high affinity, only a few activate type INKT cells in in vivo or in vitro experiments. The differences in biological responses are likely a result of different pharmacokinetic properties of each lipid, which carry modifications at different parts of the molecule. Our results indicate a need to perform a variety of assays to ascertain the therapeutic potential of type I NKT cell GSL activators.	[Birkholz, Alysia; Nemcovic, Marek; Yu, Esther Dawen; Girardi, Enrico; Wang, Jing; Zajonc, Dirk M.] La Jolla Inst Allergy & Immunol, Div Cell Biol, La Jolla, CA 92037 USA; [Birkholz, Alysia; Khurana, Archana; Kronenberg, Mitchell] La Jolla Inst Allergy & Immunol, Div Dev Immunol, La Jolla, CA 92037 USA; [Birkholz, Alysia; Kronenberg, Mitchell] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92037 USA; [Pauwels, Nora; Van Calenbergh, Serge] Univ Ghent, Dept Pharmaceut, Med Chem Lab, B-9000 Ghent, Belgium; [Franck, Richard W.] CUNY Hunter Coll, Dept Chem, New York, NY 10021 USA; [Tsuji, Moriya] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA; [Farber, Elisa; Chitale, Sampada; Howell, Amy] Univ Connecticut, Dept Chem, Storrs, CT 06269 USA; [Zajonc, Dirk M.] Univ Ghent, Fac Med & Hlth Sci, Dept Internal Med, B-9000 Ghent, Belgium	La Jolla Institute for Immunology; La Jolla Institute for Immunology; University of California System; University of California San Diego; Ghent University; City University of New York (CUNY) System; Hunter College (CUNY); Rockefeller University; University of Connecticut; Ghent University	Zajonc, DM (corresponding author), La Jolla Inst Allergy & Immunol, Div Cell Biol, 9420 Athena Circle, La Jolla, CA 92037 USA.	dzajonc@lji.org	Girardi, Enrico/AAD-2260-2020; Van Calenbergh, Serge/A-3167-2008; Kronenberg, Mitchell/AAT-6078-2021; Yu, Dawen/AAE-6444-2019; Girardi, Enrico/L-4033-2014	Girardi, Enrico/0000-0003-3508-2723; Van Calenbergh, Serge/0000-0002-4201-1264; Yu, Dawen/0000-0002-3970-3753; Girardi, Enrico/0000-0003-3508-2723; Tsuji, Moriya/0000-0001-8587-277X; Howell, Amy/0000-0003-1958-6411; Birkholz, Alysia/0000-0002-3794-5636	United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; Department of Energy Office of Biological and Environmental Research; National Institutes of Health from NIGMS [P41GM103393]; Office of Science, Office of Basic Energy Sciences, United States Department of Energy [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071922, R37AI071922, R21AI107318, R01AI070258, R01AI045053, R01AI074952] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087136, P41GM103393] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Office of Science, Office of Basic Energy Sciences, United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Stanford Synchrotron Radiation Lightsource and the Advanced Light Source for access to remote data collection. Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract No. DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the Department of Energy Office of Biological and Environmental Research, and by National Institutes of Health Grant P41GM103393 from NIGMS. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, United States Department of Energy under Contract No. DE-AC02-05CH11231.	Anderson BL, 2013, MOLECULES, V18, P15662, DOI 10.3390/molecules181215662; Aspeslagh S, 2013, J IMMUNOL, V191, P2916, DOI 10.4049/jimmunol.1203134; Aspeslagh S, 2011, EMBO J, V30, P2294, DOI 10.1038/emboj.2011.145; Banchet-Cadeddu A, 2011, ORG BIOMOL CHEM, V9, P3080, DOI 10.1039/c0ob00975j; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Borg NA, 2007, NATURE, V448, P44, DOI 10.1038/nature05907; Brennan PJ, 2013, NAT REV IMMUNOL, V13, P101, DOI 10.1038/nri3369; Brossay L, 1998, J IMMUNOL, V160, P3681; CALABI F, 1986, NATURE, V323, P540, DOI 10.1038/323540a0; Costantino V, 1997, J AM CHEM SOC, V119, P12465, DOI 10.1021/ja9727225; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Girardi E, 2012, IMMUNOL REV, V250, P167, DOI 10.1111/j.1600-065X.2012.01166.x; Huang J, 2010, NATURE, V464, P932, DOI 10.1038/nature08944; Joyce S, 2011, J IMMUNOL, V187, P1081, DOI 10.4049/jimmunol.1001910; Kakuta S, 2002, IMMUNOLOGY, V105, P92, DOI 10.1046/j.0019-2805.2001.01342.x; Koch M, 2005, NAT IMMUNOL, V6, P819, DOI 10.1038/ni1225; Lawton AP, 2005, J IMMUNOL, V174, P3179, DOI 10.4049/jimmunol.174.6.3179; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Li XM, 2010, P NATL ACAD SCI USA, V107, P13010, DOI 10.1073/pnas.1006662107; Li XM, 2009, J IMMUNOL, V183, P4415, DOI 10.4049/jimmunol.0901021; Li YL, 2010, J EXP MED, V207, P2383, DOI 10.1084/jem.20101335; Liu BY, 2014, CELL, V157, P357, DOI 10.1016/j.cell.2014.02.053; Mallevaey T, 2011, IMMUNITY, V34, P315, DOI 10.1016/j.immuni.2011.01.013; MORITA M, 1995, J MED CHEM, V38, P2176, DOI 10.1021/jm00012a018; Naidenko OV, 1999, J EXP MED, V190, P1069, DOI 10.1084/jem.190.8.1069; Padte NN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078407; Padte NN, 2011, CLIN IMMUNOL, V140, P142, DOI 10.1016/j.clim.2010.11.009; Patel O, 2011, J IMMUNOL, V187, P4705, DOI 10.4049/jimmunol.1100794; Pellicci DG, 2009, IMMUNITY, V31, P47, DOI 10.1016/j.immuni.2009.04.018; Petrovsky N, 2004, IMMUNOL CELL BIOL, V82, P488, DOI 10.1111/j.0818-9641.2004.01272.x; Robertson FC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00543; Rogers PR, 2004, J IMMUNOL METHODS, V285, P197, DOI 10.1016/j.jim.2003.12.003; Roozbeh M, 2014, IMMUNOPHARM IMMUNOT, V36, P105, DOI 10.3109/08923973.2014.897726; Rossjohn J, 2015, ANNU REV IMMUNOL, V33, P169, DOI 10.1146/annurev-immunol-032414-112334; Rossjohn J, 2012, NAT REV IMMUNOL, V12, P845, DOI 10.1038/nri3328; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Schmieg J, 2003, J EXP MED, V198, P1631, DOI 10.1084/jem.20031192; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Tyznik AJ, 2011, CHEM BIOL, V18, P1620, DOI 10.1016/j.chembiol.2011.10.015; Venkataswamy MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108383; Wang J, 2010, P NATL ACAD SCI USA, V107, P1535, DOI 10.1073/pnas.0909479107; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wun KS, 2012, J BIOL CHEM, V287, P39139, DOI 10.1074/jbc.M112.412320; Wun KS, 2011, IMMUNITY, V34, P327, DOI 10.1016/j.immuni.2011.02.001; Xu X, 2014, CANCER RES, V74, P6260, DOI 10.1158/0008-5472.CAN-14-1169; Yu KOA, 2005, IMMUNOL LETT, V100, P42, DOI 10.1016/j.imlet.2005.06.010; Zajonc DM, 2007, CURR TOP MICROBIOL, V314, P27; Zajonc DM, 2005, J EXP MED, V202, P1517, DOI 10.1084/jem.20051625	48	13	14	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17206	17217		10.1074/jbc.M115.654814	http://dx.doi.org/10.1074/jbc.M115.654814			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	26018083	hybrid, Green Published			2022-12-26	WOS:000357730900017
J	Heslehurst, N; Dinsdale, S; Sedgewick, G; Simpson, H; Sen, S; Summerbell, CD; Rankin, J				Heslehurst, Nicola; Dinsdale, Sarah; Sedgewick, Gillian; Simpson, Helen; Sen, Seema; Summerbell, Carolyn Dawn; Rankin, Judith			An Evaluation of the Implementation of Maternal Obesity Pathways of Care: A Mixed Methods Study with Data Integration	PLOS ONE			English	Article							BODY-MASS INDEX; WEIGHT-GAIN; HEALTH-CARE; PREGNANCY; TRENDS; WOMEN; RISK; OVERWEIGHT; BMI; TRIANGULATION	Objectives Maternal obesity has multiple associated risks and requires substantial intervention. This research evaluated the implementation of maternal obesity care pathways from multiple stakeholder perspectives. Study Design A simultaneous mixed methods model with data integration was used. Three component studies were given equal priority. 1: Semi-structured qualitative interviews explored obese pregnant women's experiences of being on the pathways. 2: A quantitative and qualitative postal survey explored healthcare professionals' experiences of delivering the pathways. 3: A case note audit quantitatively assessed pathway compliance. Data were integrated using following a thread and convergence coding matrix methods to search for agreement and disagreement between studies. Results Study 1: Four themes were identified: women's overall (positive and negative) views of the pathways; knowledge and understanding of the pathways; views on clinical and weight management advice and support; and views on the information leaflet. Key results included positive views of receiving additional clinical care, negative experiences of risk communication, and weight management support was considered a priority. Study 2: Healthcare professionals felt the pathways were worthwhile, facilitated good practice, and increased confidence. Training was consistently identified as being required. Healthcare professionals predominantly focussed on women's response to sensitive obesity communication. Study 3: There was good compliance with antenatal clinical interventions. However, there was poor compliance with public health and postnatal interventions. There were some strong areas of agreement between component studies which can inform future development of the pathways. However, disagreement between studies included a lack of shared priorities between healthcare professionals and women, different perspectives on communication issues, and different perspectives on women's prioritisation of weight management. Conclusion The differences between healthcare professionals' and women's priorities and perspectives are important factors to consider when developing care pathways. Shared perspectives could help facilitate more effective implementation of the pathway interventions that have poor compliance.	[Heslehurst, Nicola; Rankin, Judith] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Dinsdale, Sarah] Univ Teesside, Hlth & Social Care Inst, Middlesbrough, Cleveland, England; [Sedgewick, Gillian; Simpson, Helen; Sen, Seema] South Tees Hosp NHS Fdn Trust, Women & Children Ctr, Middlesbrough, Cleveland, England; [Summerbell, Carolyn Dawn] Univ Durham, Sch Med Pharm & Hlth, Stockton On Tees, Teesside, England	Newcastle University - UK; University of Teesside; Durham University	Heslehurst, N (corresponding author), Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	nicola.heslehurst@ncl.ac.uk	Summerbell, Carolyn D/O-3759-2015; Summerbell, Carolyn D/O-3001-2015; Summerbell, Carolyn/AAC-3159-2019	Summerbell, Carolyn D/0000-0003-1910-9383; Summerbell, Carolyn D/0000-0003-1910-9383; Summerbell, Carolyn/0000-0003-1910-9383; Heslehurst, Nicola/0000-0001-8656-2319	South Tees NHS Foundation Trust Small Grant Awards; South Tees NHS Trust; Teesside University; Medical Research Council [MR/K02325X/1] Funding Source: researchfish; National Institute for Health Research [PDF-2011-04-034] Funding Source: researchfish	South Tees NHS Foundation Trust Small Grant Awards; South Tees NHS Trust; Teesside University; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	NH, GS and HS were awarded funding for this research by the South Tees NHS Foundation Trust Small Grant Awards (co-funded by South Tees NHS Trust and Teesside University). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavi N, 2013, OBES REV, V14, P68, DOI 10.1111/j.1467-789X.2012.01059.x; Aune D, 2014, JAMA-J AM MED ASSOC, V311, P1536, DOI 10.1001/jama.2014.2269; Bastian LA, 2010, WOMEN HEALTH ISS, V20, P133, DOI 10.1016/j.whi.2009.11.005; Bazeley P, 2009, J MIX METHOD RES, V3, P203, DOI 10.1177/1558689809334443; Brannen J, 2005, INT J SOC RES METHOD, V8, P173, DOI [DOI 10.1080/13645570500154642, 10.1080/13645570500154642]; Bristowe K, 2012, QUAL HEALTH RES, V22, P1383, DOI 10.1177/1049732312451874; Bryman A., 1995, MIXING METHODS QUALI, P58; Bryman A, 2007, J MIX METHOD RES, V1, P8, DOI 10.1177/2345678906290531; Brynhildsen J, 2006, PUBLIC HEALTH, V120, P393, DOI 10.1016/j.puhe.2005.10.015; Centre for Maternal and Child Enquiries (CMACE), 2010, MAT OB UK FIND NAT P; Clinical Negligence Scheme for Trusts, 2011, MAT CLIN RISK MAN ST; CMACE-RCOG, 2010, MAN WOM OB PREGN; Cresswell JW, 1998, QUALITATIVE INQUIRY; Creswell JW, 2004, ANN FAM MED, V2, P7, DOI 10.1370/afm.104; Denison FC, 2009, BJOG-INT J OBSTET GY, V116, P1467, DOI 10.1111/j.1471-0528.2009.02222.x; Devine F, 1999, SOCIOLOGICAL RES MET; Dillman D. A., 2014, INTERNET PHONE MAIL; Duckitt K, 2005, BRIT MED J, V330, P565, DOI 10.1136/bmj.38380.674340.E0; Edwards P, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000008.pub4; Edwards P, 2002, BRIT MED J, V324, P1183, DOI 10.1136/bmj.324.7347.1183; Farmer T, 2006, QUAL HEALTH RES, V16, P377, DOI 10.1177/1049732305285708; Fisher SC, 2013, PREV MED, V56, P372, DOI 10.1016/j.ypmed.2013.02.015; General Medical Council, 2009, CONF; Gore SA, 2003, ANN BEHAV MED, V26, P149, DOI 10.1207/S15324796ABM2602_07; Heslehurst N, 2008, OBES REV, V9, P635, DOI 10.1111/j.1467-789X.2008.00511.x; Heslehurst N, 2014, OBES REV, V15, P462, DOI [10.1111/obr.12160, 10.1016/j.preghy.2014.03.017]; Heslehurst N, 2010, INT J OBESITY, V34, P420, DOI 10.1038/ijo.2009.250; Heslehurst N, 2013, HLTH EXPECTATIONS, DOI 10.111/hex.12070; Huusom LD, 2011, BJOG-INT J OBSTET GY, V118, P1, DOI 10.1111/j.1471-0528.2010.02782.x; Institute of Medicine, 2009, WEIGHT GAIN PREGNANC; Institute of Obstetricians and Gynaecologists Health Service Executive, 2011, OB PREGN CLIN PRACT; Knight Bridget A, 2010, Nurs Times, V106, P20; Knight M, 2010, OBSTET GYNECOL, V115, P989, DOI 10.1097/AOG.0b013e3181da8f09; LaCoursiere DY, 2005, AM J OBSTET GYNECOL, V192, P832, DOI 10.1016/j.ajog.2004.11.034; Maternity & Newborn Clinical Network, 2011, STAT CLIN GUID CAR O; Moran-Ellis J, 2006, QUAL RES, V6, P45, DOI [10.1177/1468794106058870, DOI 10.1177/1468794106058870]; Morgan KL, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003983; National Institute for Health and Clinical Excellence, 2008, DIAB PREGN MAN DIAB; National Institute for Health and Clinical Excellence, 2010, WEIGHT MAN PREGN; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Poston L, 2011, PEDIATR RES, V69, P175, DOI 10.1203/PDR.0b013e3182055ede; Queensland Maternity and Neonatal Clinical Guidelines Program, 2010, CLIN GUID OB, DOI [10.1038/ijo.2010.71, DOI 10.1038/IJO.2010.71]; Ray JG, 2007, EPIDEMIOLOGY, V18, P280, DOI 10.1097/01.ede.0000254686.01126.7e; Reynolds RM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4539; Ritchie JSL., 1994, QUALITATIVE DATA ANA, DOI DOI 10.4324/9780203413081_CHAPTER_9; Siega-Riz AM, 2004, NUTR REV, V62, pS105, DOI 10.1111/j.1753-4887.2004.tb00079.x; Smith D, 2011, BJOG-INT J OBSTET GY, V118, P779, DOI 10.1111/j.1471-0528.2011.02924.x; Society of Obstetricians and Gynaecologists of Canada (SOGC), 2010, J OBSTET GYNAECOL CA, V239, P165; Srivastava A, 2009, FRAMEWORK ANAL QUALI, DOI DOI 10.1002/JIA2.25572; Stothard KJ, 2009, JAMA-J AM MED ASSOC, V301, P636, DOI 10.1001/jama.2009.113; Torloni MR, 2009, OBES REV, V10, P194, DOI 10.1111/j.1467-789X.2008.00541.x; Turcksin R, 2014, MATERN CHILD NUTR, V10, P166, DOI 10.1111/j.1740-8709.2012.00439.x; Watson M, 2013, AUST NZ J OBSTET GYN, V53, P243, DOI 10.1111/ajo.12031; Yeh J, 2005, AM J OBSTET GYNECOL, V193, P1994, DOI 10.1016/j.ajog.2005.05.001	55	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0127122	10.1371/journal.pone.0127122	http://dx.doi.org/10.1371/journal.pone.0127122			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0RO	26018338	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000355185600070
J	Lingelem, ABD; Hjelseth, IA; Simm, R; Torgersen, ML; Sandvig, K				Lingelem, Anne Berit Dyve; Hjelseth, Ieva Ailte; Simm, Roger; Torgersen, Maria Lyngaas; Sandvig, Kirsten			Geldanamycin Enhances Retrograde Transport of Shiga Toxin in HEp-2 Cells	PLOS ONE			English	Article							HSP90 MOLECULAR CHAPERONE; ACTIN-FILAMENT DYNAMICS; TO-GOLGI TRANSPORT; HEAT-SHOCK; ENDOPLASMIC-RETICULUM; KINASE CASCADE; EARLY-ENDOSOME; COMPLEX; P38; PHOSPHORYLATION	The heat shock protein 90 (Hsp90) inhibitor geldanamycin (GA) has been shown to alter endosomal sorting, diverting cargo destined for the recycling pathway into the lysosomal pathway. Here we investigated whether GA also affects the sorting of cargo into the retrograde pathway from endosomes to the Golgi apparatus. As a model cargo we used the bacterial toxin Shiga toxin, which exploits the retrograde pathway as an entry route to the cytosol. Indeed, GA treatment of HEp-2 cells strongly increased the Shiga toxin transport to the Golgi apparatus. The enhanced Golgi transport was not due to increased endocytic uptake of the toxin or perturbed recycling, suggesting that GA selectively enhances endosomal sorting into the retrograde pathway. Moreover, GA activated p38 and both inhibitors of p38 or its substrate MK2 partially counteracted the GA-induced increase in Shiga toxin transport. Thus, our data suggest that GA-induced p38 and MK2 activation participate in the increased Shiga toxin transport to the Golgi apparatus.	[Lingelem, Anne Berit Dyve; Hjelseth, Ieva Ailte; Simm, Roger; Torgersen, Maria Lyngaas; Sandvig, Kirsten] Univ Oslo, Fac Med, Ctr Canc Biomed, Oslo, Norway; [Lingelem, Anne Berit Dyve; Hjelseth, Ieva Ailte; Simm, Roger; Torgersen, Maria Lyngaas; Sandvig, Kirsten] Oslo Univ Hosp, Inst Canc Res, Dept Mol Cell Biol, Oslo, Norway; [Hjelseth, Ieva Ailte; Sandvig, Kirsten] Univ Oslo, Dept Biosci, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo	Sandvig, K (corresponding author), Univ Oslo, Fac Med, Ctr Canc Biomed, Oslo, Norway.	ksandvig@radium.uio.no	Torgersen, Maria Lyngaas/O-6240-2019; Torgersen, Maria Lyngaas L/F-3492-2017; Simm, Roger/AAN-8965-2020	Torgersen, Maria Lyngaas/0000-0003-2616-7194; Torgersen, Maria Lyngaas L/0000-0003-2616-7194; Simm, Roger/0000-0001-5187-2456	Norwegian Cancer Society; Research Council of Norway through Centres of Excellence funding scheme [179571]; South-Eastern Norway Regional Health Authority; University of Oslo	Norwegian Cancer Society(Norwegian Cancer Society); Research Council of Norway through Centres of Excellence funding scheme; South-Eastern Norway Regional Health Authority; University of Oslo	This work was supported by grants from the Norwegian Cancer Society, the Research Council of Norway through its Centres of Excellence funding scheme, project number 179571, the South-Eastern Norway Regional Health Authority and the University of Oslo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiri A, 2007, MOL CANCER RES, V5, P933, DOI 10.1158/1541-7786.MCR-06-0362; Austin CD, 2004, MOL BIOL CELL, V15, P5268, DOI 10.1091/mbc.E04-07-0591; BAEUERLE PA, 1987, J CELL BIOL, V105, P2655, DOI 10.1083/jcb.105.6.2655; Basso AD, 2002, J BIOL CHEM, V277, P39858, DOI 10.1074/jbc.M206322200; Bergan J, 2012, TOXICON, V60, P1085, DOI 10.1016/j.toxicon.2012.07.016; Breusegem SY, 2014, METHOD ENZYMOL, V534, P155, DOI 10.1016/B978-0-12-397926-1.00009-3; Bujny MV, 2007, J CELL SCI, V120, P2010, DOI 10.1242/jcs.003111; Cavalli V, 2001, MOL CELL, V7, P421, DOI 10.1016/S1097-2765(01)00189-7; Correa Sonia A L, 2012, J Signal Transduct, V2012, P649079, DOI 10.1155/2012/649079; Cortese K, 2013, MOL BIOL CELL, V24, P129, DOI 10.1091/mbc.E12-04-0282; Doshi BM, 2010, ANN NY ACAD SCI, V1197, P76, DOI 10.1111/j.1749-6632.2010.05191.x; Dyve AB, 2009, BIOCHEM BIOPH RES CO, V390, P109, DOI 10.1016/j.bbrc.2009.09.076; EIKLID K, 1980, J RECEPTOR RES, V1, P199, DOI 10.3109/10799898009044098; FRESHNEY NW, 1994, CELL, V78, P1039, DOI 10.1016/0092-8674(94)90278-X; Fukuyo Y, 2010, CANCER LETT, V290, P24, DOI 10.1016/j.canlet.2009.07.010; Garcia-Carbonero R, 2013, LANCET ONCOL, V14, pE358, DOI 10.1016/S1470-2045(13)70169-4; Guay J, 1997, J CELL SCI, V110, P357; Hong DS, 2013, CANCER TREAT REV, V39, P375, DOI 10.1016/j.ctrv.2012.10.001; Johannes L, 2008, CELL, V135, P1175, DOI 10.1016/j.cell.2008.12.009; Koga F, 2006, P NATL ACAD SCI USA, V103, P11318, DOI 10.1073/pnas.0604705103; Kvalvaag AS, 2013, TRAFFIC, V14, P839, DOI 10.1111/tra.12077; Laufman O, 2011, J CELL BIOL, V194, P459, DOI 10.1083/jcb.201102045; Lauvrak SU, 2004, J CELL SCI, V117, P2321, DOI 10.1242/jcs.01081; Mace T, 2005, EMBO J, V24, P3235, DOI 10.1038/sj.emboj.7600799; Mallard F, 2002, J CELL BIOL, V156, P653, DOI 10.1083/jcb.200110081; McClellan AJ, 2007, CELL, V131, P121, DOI 10.1016/j.cell.2007.07.036; Mounier N, 2002, CELL STRESS CHAPERON, V7, P167, DOI 10.1379/1466-1268(2002)007<0167:ACASHS>2.0.CO;2; Naslavsky N, 2009, J CELL SCI, V122, P389, DOI 10.1242/jcs.037051; Ota A, 2010, CIRC RES, V106, P1404, DOI 10.1161/CIRCRESAHA.109.213769; Patki JM, 2013, PATHOL ONCOL RES, V19, P631, DOI 10.1007/s12253-013-9675-4; Pfeffer SR, 2009, FEBS LETT, V583, P3811, DOI 10.1016/j.febslet.2009.10.075; Popoff V, 2007, J CELL SCI, V120, P2022, DOI 10.1242/jcs.003020; Rane MJ, 2001, J BIOL CHEM, V276, P3517, DOI 10.1074/jbc.M005953200; Rapak A, 1997, P NATL ACAD SCI USA, V94, P3783, DOI 10.1073/pnas.94.8.3783; Roe SM, 1999, J MED CHEM, V42, P260, DOI 10.1021/jm980403y; Rosenhagen MC, 2001, BIOL CHEM, V382, P499, DOI 10.1515/BC.2001.063; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; Sandvig K, 2014, PROG LIPID RES, V54, P1, DOI 10.1016/j.plipres.2014.01.001; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Seaman MNJ, 2004, J CELL BIOL, V165, P111, DOI 10.1083/jcb.200312034; Skanland SS, 2009, CELL MICROBIOL, V11, P796, DOI 10.1111/j.1462-5822.2009.01292.x; Spooner RA, 2008, P NATL ACAD SCI USA, V105, P17408, DOI 10.1073/pnas.0809013105; Spooner RA, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-26; Taylor M, 2010, J BIOL CHEM, V285, P31261, DOI 10.1074/jbc.M110.148981; Tcatchoff L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040429; Tekle C, 2008, NANO LETT, V8, P1858, DOI 10.1021/nl0803848; Torgersen ML, 2007, J BIOL CHEM, V282, P16317, DOI 10.1074/jbc.M610886200; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Utskarpen A, 2006, TRAFFIC, V7, P663, DOI 10.1111/j.1600-0854.2006.00418.x; Utskarpen A, 2007, BIOCHEM BIOPH RES CO, V358, P566, DOI 10.1016/j.bbrc.2007.04.159; VANDEURS B, 1986, J CELL BIOL, V102, P37, DOI 10.1083/jcb.102.1.37; Walchli S, 2008, MOL BIOL CELL, V19, P95, DOI 10.1091/mbc.E07-06-0565; Zheng CL, 2006, J BIOL CHEM, V281, P37215, DOI 10.1074/jbc.M603622200; Zolov SN, 2005, J CELL BIOL, V168, P747, DOI 10.1083/jcb.200412003	54	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0129214	10.1371/journal.pone.0129214	http://dx.doi.org/10.1371/journal.pone.0129214			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26017782	Green Published, Green Submitted, gold			2022-12-26	WOS:000355185600127
J	Milde, C; Rance, M; Kirsch, P; Trojan, J; Fuchs, X; Foell, J; Bekrater-Bodmann, R; Flor, H; Diers, M				Milde, Christopher; Rance, Mariela; Kirsch, Pinar; Trojan, Joerg; Fuchs, Xaver; Foell, Jens; Bekrater-Bodmann, Robin; Flor, Herta; Diers, Martin			Do Mirror Glasses Have the Same Effect on Brain Activity as a Mirror Box? Evidence from a Functional Magnetic Resonance Imaging Study with Healthy Subjects	PLOS ONE			English	Article							HAND MOVEMENTS; VISUAL FEEDBACK; MOTOR RECOVERY; THERAPY; ILLUSION; STROKE; PAIN; CONNECTIVITY; OPTIMIZATION; EXCITABILITY	Since its original proposal, mirror therapy has been established as a successful neurorehabilitative intervention in several neurological disorders to recover motor function or to relieve pain. Mirror therapy seems to operate by reactivating the contralesional representation of the non-mirrored limb in primary motor-and somatosensory cortex. However, mirror boxes have some limitations which prompted the use of additional mirror visual feedback devices. The present study evaluated the utility of mirror glasses compared to a mirror box. We also tested the hypothesis that increased interhemispheric communication between the motor hand areas is the mechanism by which mirror visual feedback recruits the representation of the non-mirrored limb. Therefore, mirror illusion capacity and brain activations were measured in a within-subject design during both mirror visual feedback conditions in counterbalanced order with 20 healthy subjects inside a magnetic resonance imaging scanner. Furthermore, we analyzed task-dependent functional connectivity between motor hand representations using psychophysiological interaction analysis during both mirror tasks. Neither the subjective quality of mirror illusions nor the patterns of functional brain activation differed between the mirror tasks. The sensorimotor representation of the non-mirrored hand was recruited in both mirror tasks. However, a significant increase in interhemispheric connectivity between the hand areas was only observed in the mirror glasses condition, suggesting different mechanisms for the recruitment of the representation of the non-mirrored hand in the two mirror tasks. We conclude that the mirror glasses might be a promising alternative to the mirror box, as they induce similar patterns of brain activation. Moreover, the mirror glasses can be easy applied in therapy and research. We want to emphasize that the neuronal mechanisms for the recruitment of the affected limb representation might differ depending on conceptual differences between MVF devices. However, our findings need to be validated within specific patient groups.	[Milde, Christopher; Rance, Mariela; Kirsch, Pinar; Trojan, Joerg; Fuchs, Xaver; Foell, Jens; Bekrater-Bodmann, Robin; Flor, Herta; Diers, Martin] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Cognit & Clin Neurosci, Mannheim, Germany; [Trojan, Joerg] Univ Koblenz Landau, Biol Psychol, Landau, Germany; [Foell, Jens] Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA	Central Institute of Mental Health; Ruprecht Karls University Heidelberg; University of Koblenz & Landau; State University System of Florida; Florida State University	Diers, M (corresponding author), Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Cognit & Clin Neurosci, Mannheim, Germany.	martin.diers@zi-mannheim.de	Diers, Martin/M-9155-2013; Trojan, Jörg/C-1616-2009; Fuchs, Xaver/HCI-1160-2022	Diers, Martin/0000-0002-3257-7299; Trojan, Jörg/0000-0003-4110-2647; Flor, Herta/0000-0003-4809-5398	PHANTOMMIND project - European Community [230249]; Deutsche Forschungsgemeinschaft; Ruprecht-Karls-Universitat Heidelberg within funding programme Open Access Publishing	PHANTOMMIND project - European Community; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ruprecht-Karls-Universitat Heidelberg within funding programme Open Access Publishing	This research was supported by "Phantom phenomena: A window to the mind and the brain" (PHANTOMMIND project), which receives research funding from the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC Grant Agreement No. 230249 to Herta Flor. This manuscript reflects only the authors' views and the Community is not liable for any use that may be made of the information contained therein (URL: http://erc.europa.eu/projects-and-results/erc-funded-projects/phantommind? retain-filters=1). The authors also acknowledge financial support by Deutsche Forschungsgemeinschaft and Ruprecht-Karls-Universitat Heidelberg within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschuler EL, 2008, SCAND J PLAST RECONS, V42, P110, DOI 10.1080/02844310701510355; Andersson J.L.R, 2007, TR07JA2 FMRIB; Chan BL, 2007, NEW ENGL J MED, V357, P2206, DOI 10.1056/NEJMc071927; Deconinck FJA, 2014, NEUROREHABILITATION, P1; Diers M, 2015, BRAIN RES, V1594, P173, DOI 10.1016/j.brainres.2014.11.001; Diers M, 2010, PAIN, V149, P296, DOI 10.1016/j.pain.2010.02.020; Eickhoff SB, 2007, NEUROIMAGE, V36, P511, DOI 10.1016/j.neuroimage.2007.03.060; Ezendam D, 2009, DISABIL REHABIL, V31, P2135, DOI 10.3109/09638280902887768; Foell J, 2014, EUR J PAIN, V18, P729, DOI 10.1002/j.1532-2149.2013.00433.x; Fotopoulou A, 2011, NEUROPSYCHOLOGIA, V49, P3946, DOI 10.1016/j.neuropsychologia.2011.10.011; Friston KJ, 2013, CURR OPIN NEUROBIOL, V23, P172, DOI 10.1016/j.conb.2012.11.010; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Fukumura K, 2007, INT J NEUROSCI, V117, P1039, DOI 10.1080/00207450600936841; Garry MI, 2005, EXP BRAIN RES, V163, P118, DOI 10.1007/s00221-005-2226-9; Giraux P, 2003, NEUROIMAGE, V20, pS107, DOI 10.1016/j.neuroimage.2003.09.024; Hadoush H, 2013, NEUROREHABILITATION, V32, P617, DOI 10.3233/NRE-130884; Hamzei F, 2012, NEUROREHAB NEURAL RE, V26, P484, DOI 10.1177/1545968311427917; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Lappchen CH, 2012, J NEUROPHYSIOL, V108, P2857, DOI 10.1152/jn.00321.2012; Liepert J, 2001, CLIN NEUROPHYSIOL, V112, P114, DOI 10.1016/S1388-2457(00)00503-4; Lotze M, 2001, BRAIN, V124, P2268, DOI 10.1093/brain/124.11.2268; Lotze M, 1999, J COGNITIVE NEUROSCI, V11, P491, DOI 10.1162/089892999563553; Maeda F, 2014, J NEUROPHYSIOL, V87, P1329; Matthys K, 2009, ARCH PHYS MED REHAB, V90, P675, DOI 10.1016/j.apmr.2008.09.571; McCabe CS, 2008, CURR PAIN HEADACHE R, V12, P103, DOI 10.1007/s11916-008-0020-7; McCabe CS, 2003, RHEUMATOLOGY, V42, P97, DOI 10.1093/rheumatology/keg041; Michielsen ME, 2011, NEUROREHAB NEURAL RE, V25, P223, DOI 10.1177/1545968310385127; Moseley GL, 2008, PAIN, V138, P7, DOI 10.1016/j.pain.2008.06.026; Muellbacher W, 2002, NATURE, V415, P640, DOI 10.1038/nature712; Nojima I, 2013, EXP BRAIN RES, V227, P79, DOI 10.1007/s00221-013-3486-4; Nojima I, 2012, J NEUROSCI, V32, P1293, DOI 10.1523/JNEUROSCI.5364-11.2012; O'Reilly JX, 2012, SOC COGN AFFECT NEUR, V7, P604, DOI 10.1093/scan/nss055; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; RAMACHANDRAN VS, 1992, NEUROREPORT, V3, P583, DOI 10.1097/00001756-199207000-00009; Ramachandran VS, 1996, P ROY SOC B-BIOL SCI, V263, P377, DOI 10.1098/rspb.1996.0058; RAMACHANDRAN VS, 1995, NATURE, V377, P489, DOI 10.1038/377489a0; Sathian K, 2000, NEUROREHAB NEURAL RE, V14, P73, DOI 10.1177/154596830001400109; SHEEHAN PW, 1967, J CLIN PSYCHOL, V23, P386, DOI 10.1002/1097-4679(196707)23:3<386::AID-JCLP2270230328>3.0.CO;2-S; Shinoura N, 2008, NEUROREHABILITATION, V23, P245; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Stephan KE, 2010, WIRES COGN SCI, V1, P446, DOI 10.1002/wcs.58; Strafella AP, 2000, NEUROREPORT, V11, P2289, DOI 10.1097/00001756-200007140-00044; Sutbeyaz S, 2007, ARCH PHYS MED REHAB, V88, P555, DOI 10.1016/j.apmr.2007.02.034; Tsakiris M, 2007, CONSCIOUS COGN, V16, P645, DOI 10.1016/j.concog.2007.05.012; Walsh G, 2010, OPTOMETRY VISION SCI, V87, P971, DOI 10.1097/OPX.0b013e3181fcabc3; Woolrich MW, 2004, NEUROIMAGE, V21, P1732, DOI 10.1016/j.neuroimage.2003.12.023; Yavuzer G, 2008, ARCH PHYS MED REHAB, V89, P393, DOI 10.1016/j.apmr.2007.08.162	49	9	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0127694	10.1371/journal.pone.0127694	http://dx.doi.org/10.1371/journal.pone.0127694			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018572	Green Published, gold, Green Submitted			2022-12-26	WOS:000355185600092
J	Faron, M; Fletcher, JR; Rasmussen, JA; Apicella, MA; Jones, BD				Faron, Matthew; Fletcher, Joshua R.; Rasmussen, Jed A.; Apicella, Michael A.; Jones, Bradley D.			Interactions of Francisella tularensis with Alveolar Type II Epithelial Cells and the Murine Respiratory Epithelium	PLOS ONE			English	Article							LIVE VACCINE STRAIN; SCHU S4; TULAREMIA VACCINE; HOST-DEFENSE; IN-VITRO; MICE; INFECTION; INNATE; GROWTH; MODEL	Francisella tularensis is classified as a Tier 1 select agent by the CDC due to its low infectious dose and the possibility that the organism can be used as a bioweapon. The low dose of infection suggests that Francisella is unusually efficient at evading host defenses. Although similar to 50 cfu are necessary to cause human respiratory infection, the early interactions of virulent Francisella with the lung environment are not well understood. To provide additional insights into these interactions during early Francisella infection of mice, we performed TEM analysis on mouse lungs infected with F. tularensis strains Schu S4, LVS and the O-antigen mutant Schu S4 waaY:: TrgTn. For all three strains, the majority of the bacteria that we could detect were observed within alveolar type II epithelial cells at 16 hours post infection. Although there were no detectable differences in the amount of bacteria within an infected cell between the three strains, there was a significant increase in the amount of cellular debris observed in the air spaces of the lungs in the Schu S4 waaY:: TrgTn mutant compared to either the Schu S4 or LVS strain. We also studied the interactions of Francisella strains with human AT-II cells in vitro by characterizing the ability of these three strains to invade and replicate within these cells. Gentamicin assay and confocal microscopy both confirmed that F. tularensis Schu S4 replicated robustly within these cells while F. tularensis LVS displayed significantly lower levels of growth over 24 hours, although the strain was able to enter these cells at about the same level as Schu S4 (1 organism per cell), as determined by confocal imaging. The Schu S4 waaY:: TrgTn mutant that we have previously described as attenuated for growth in macrophages and mouse virulence displayed interesting properties as well. This mutant induced significant airway inflammation (cell debris) and had an attenuated growth phenotype in the human AT-II cells. These data extend our understanding of early Francisella infection by demonstrating that Francisella enter significant numbers of AT-II cells within the lung and that the capsule and LPS of wild type Schu S4 helps prevent murine lung damage during infection. Furthermore, our data identified that human AT-II cells allow growth of Schu S4, but these same cells supported poor growth of the attenuated LVS strain in vitro. Collectively, these data further our understanding of the role of AT-II cells in Francisella infections.	[Faron, Matthew; Fletcher, Joshua R.; Jones, Bradley D.] Univ Iowa, Grad Program Genet, Iowa City, IA 52242 USA; [Rasmussen, Jed A.; Apicella, Michael A.; Jones, Bradley D.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Jones, BD (corresponding author), Univ Iowa, Grad Program Genet, Iowa City, IA 52242 USA.	bradley-jones@uiowa.edu		Jones, Brad/0000-0002-2698-8251	 [2PO1 AI044642];  [2U54 AI057160]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057160, P01AI044642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008629] Funding Source: NIH RePORTER	; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by 2PO1 AI044642 MAA, BDJ; 2U54 AI057160 BDJ.	Bermudez LE, 1996, INFECT IMMUN, V64, P1400, DOI 10.1128/IAI.64.4.1400-1406.1996; Bosio CM, 2007, J IMMUNOL, V178, P4538, DOI 10.4049/jimmunol.178.7.4538; Bradburne CE, 2013, J BIOL CHEM, V288, P10780, DOI 10.1074/jbc.M112.362178; CASTRANOVA V, 1988, TOXICOL APPL PHARM, V93, P472, DOI 10.1016/0041-008X(88)90051-8; Celli J, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a010314; CRAPO JD, 1983, AM REV RESPIR DIS, V128, pS42; Craven RR, 2008, INFECT IMMUN, V76, P2833, DOI 10.1128/IAI.00043-08; David J, 2014, MICROBES INFECT, V16, P735, DOI 10.1016/j.micinf.2014.04.001; Eisele NA, 2011, J PATHOG, V2011, DOI 10.4061/2011/249802; Elkins KL, 2007, ANN NY ACAD SCI, V1105, P284, DOI 10.1196/annals.1409.014; EVANS MJ, 1972, AEROSPACE MED, V43, P620; Faron M, 2013, INFECT IMMUN, V81, P2800, DOI 10.1128/IAI.00073-13; Fehrenbach H, 2001, RESP RES, V2, P33, DOI 10.1186/rr36; FERRIOLA PC, 1990, PATHOBIOLOGY, V58, P28, DOI 10.1159/000163562; Forestal CA, 2007, J INFECT DIS, V196, P134, DOI 10.1086/518611; Francis E, 1926, J AMER MED ASSOC, V86, P1329, DOI 10.1001/jama.1926.02670440003002; FrankeUllmann G, 1996, J IMMUNOL, V157, P3097; Fujita R, 2003, CELL DEATH DIFFER, V10, P1336, DOI 10.1038/sj.cdd.4401300; Fujita R, 2003, CELL DEATH DIFFER, V10, P782, DOI 10.1038/sj.cdd.4401239; Gentry M, 2007, INFECT IMMUN, V75, P3969, DOI 10.1128/IAI.00157-07; Gibson-Corley KN, 2013, VET PATHOL, V50, P1007, DOI 10.1177/0300985813485099; Guillot L, 2013, INT J BIOCHEM CELL B, V45, P2568, DOI 10.1016/j.biocel.2013.08.009; Hall JD, 2008, INFECT IMMUN, V76, P5843, DOI 10.1128/IAI.01176-08; Hall JD, 2007, INFECT IMMUN, V75, P1034, DOI 10.1128/IAI.01254-06; Hsiao CHC, 2011, MICROBES INFECT, V13, P1033, DOI 10.1016/j.micinf.2011.05.014; JONES GS, 1982, J APPL PHYSIOL, V53, P258, DOI 10.1152/jappl.1982.53.1.258; Kato A, 2007, CURR OPIN IMMUNOL, V19, P711, DOI 10.1016/j.coi.2007.08.004; Knust J, 2009, ANAT REC, V292, P113, DOI 10.1002/ar.20747; LAURENZI GA, 1963, SCIENCE, V142, P1572, DOI 10.1126/science.142.3599.1572; Lindemann SR, 2007, INFECT IMMUN, V75, P3178, DOI 10.1128/IAI.01811-06; Lindemann SR, 2011, INFECT IMMUN, V79, P581, DOI 10.1128/IAI.00863-10; Long ME, 2013, INFECT IMMUN, V81, P850, DOI 10.1128/IAI.00822-12; Marriott HM, 2007, EXP LUNG RES, V33, P493, DOI 10.1080/01902140701756562; McCormick TS, 2010, PERIODONTOL 2000, V54, P195, DOI 10.1111/j.1600-0757.2010.00373.x; MCCRUMB FR, 1961, BACTERIOL REV, V25, P262, DOI 10.1128/MMBR.25.3.262-267.1961; Oppenheim RW, 2001, J NEUROSCI, V21, P4752, DOI 10.1523/JNEUROSCI.21-13-04752.2001; Osmanagic E, 2010, J APPL PHYSIOL, V109, P1592, DOI 10.1152/japplphysiol.00736.2010; Pechous RD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002487; Perez-Gil J, 2008, BBA-BIOMEMBRANES, V1778, P1676, DOI 10.1016/j.bbamem.2008.05.003; Rasmussen JA, 2014, INFECT IMMUN, V82, P1523, DOI 10.1128/IAI.01640-13; RAZIN A, 1991, MICROBIOL REV, V55, P451, DOI 10.1128/MMBR.55.3.451-458.1991; SASLAW S, 1961, ARCH INTERN MED, V107, P702, DOI 10.1001/archinte.1961.03620050068007; SASLAW S, 1961, ARCH INTERN MED, V107, P689, DOI 10.1001/archinte.1961.03620050055006; Schwingshackl A, 2013, AM J TRANSL RES, V5, P530; Sha Q, 2004, AM J RESP CELL MOL, V31, P358, DOI 10.1165/rcmb.2003-0388OC; Sharma J, 2011, MICROB PATHOGENESIS, V51, P39, DOI 10.1016/j.micpath.2011.03.007; Steele S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003562; STUART BM, 1945, AM J MED SCI, V210, P223, DOI 10.1097/00000441-194508000-00013; Thomas-Charles CA, 2013, INFECT IMMUN, V81, P2828, DOI 10.1128/IAI.00170-13; Townsley MI, 2012, COMPR PHYSIOL, V2, P675, DOI 10.1002/cphy.c100081; Vir P, 2014, APMIS, V122, P268, DOI 10.1111/apm.12141; Wu Q, 2011, AM J PHYSIOL-LUNG C, V300, pL579, DOI 10.1152/ajplung.00336.2010; Zarrella TM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022335; Zhou HX, 2010, J VIROL, V84, P3542, DOI 10.1128/JVI.02570-09	54	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127458	10.1371/journal.pone.0127458	http://dx.doi.org/10.1371/journal.pone.0127458			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010977	gold, Green Submitted, Green Published			2022-12-26	WOS:000355183900094
J	Kill, C; Galbas, M; Neuhaus, C; Hahn, O; Wallot, P; Kesper, K; Wulf, H; Dersch, W				Kill, Clemens; Galbas, Monika; Neuhaus, Christian; Hahn, Oliver; Wallot, Pascal; Kesper, Karl; Wulf, Hinnerk; Dersch, Wolfgang			Chest Compression Synchronized Ventilation versus Intermitted Positive Pressure Ventilation during Cardiopulmonary Resuscitation in a Pig Model	PLOS ONE			English	Article							IMPEDANCE THRESHOLD VALVE; PORCINE MODEL; MECHANICAL VENTILATION; GAS-EXCHANGE; LIFE-SUPPORT; HYPERVENTILATION; SURVIVAL; CPR	Background Guidelines recommend mechanical ventilation with Intermitted Positive Pressure Ventilation (IPPV) during resuscitation. The influence of the novel ventilator mode Chest Compression Synchronized Ventilation (CCSV) on gas exchange and arterial blood pressure compared with IPPV was investigated in a pig model. Methods In 12 pigs (general anaesthesia/intubation) ventricular fibrillation was induced and continuous chest compressions were started after 3min. Pigs were mechanically ventilated in a cross-over setting with 5 ventilation periods of 4min each: Ventilation modes were during the first and last period IPPV (100% O-2, tidalvolumes = 7ml/kgKG, respiratoryrate = 10/min), during the 2nd, 3rd and 4th period CCSV (100% O-2), a pressure-controlled and with each chest compression synchronized breathing pattern with three different presets in randomized order. Presets: CCSVA: P-insp = 60mbar, inspiratorytime = 205ms; CCSVB: P-insp = 60mbar, inspiratorytime = 265ms; CCSVC: P-insp = 45mbar, inspiratorytime = 265ms. Blood gas samples were drawn for each period, mean arterial (MAP) and centralvenous (CVP) blood pressures were continuously recorded. Results asmedian (25%/75% percentiles). Results Ventilation with each CCSV mode resulted in higher PaO2 than IPPV: PaO2: IPPVfirst: 19.6 (13.9/36.2) kPa, IPPVlast: 22.7(5.4/36.9) kPa (p = 0.77 vs IPPVfirst), CCSVA: 48.9(29.0/58.2) kPa (p = 0.028 vs IPPVfirst, p = 0.0001 vs IPPVlast), CCSVB: 54.0 (43.8/64.1) (p = 0.001 vs IPPVfirst, p = 0.0001 vs IPPVlast), CCSVC: 46.0 (20.2/58.4) (p = 0.006 vs IPPVfirst, p = 0.0001 vs IPPVlast). Both the MAP and the difference MAP-CVP did not decrease during twelve minutes CPR with all three presets of CCSV and were higher than the pressures of the last IPPV period. Conclusions All patterns of CCSV lead to a higher PaO2 and avoid an arterial blood pressure drop during resuscitation compared to IPPV in this pig model of cardiac arrest.	[Kill, Clemens; Galbas, Monika; Hahn, Oliver; Wallot, Pascal; Wulf, Hinnerk; Dersch, Wolfgang] Univ Marburg, Dept Anesthesiol & Crit Care, D-35032 Marburg, Germany; [Kill, Clemens; Dersch, Wolfgang] Univ Marburg, Dept Emergency Med, D-35032 Marburg, Germany; [Kesper, Karl] Univ Marburg, Dept Internal Med, Sect Resp Dis, D-35032 Marburg, Germany; [Neuhaus, Christian] Weinmann Emergency Med Technol GmbH Co KG, Hamburg, Germany	Philipps University Marburg; Philipps University Marburg; Philipps University Marburg	Kill, C (corresponding author), Univ Marburg, Dept Anesthesiol & Crit Care, D-35032 Marburg, Germany.	killc@staff.uni-marburg.de			German governmental grant (Bundesministerium fur Wirtschaft und Informationstechnologie) [KF2502403FR0, KF2660001FR0]; Weinmann Emergency Medical Technology GmbH+Co.KG	German governmental grant (Bundesministerium fur Wirtschaft und Informationstechnologie); Weinmann Emergency Medical Technology GmbH+Co.KG	This work as supported by the German governmental grant (Bundesministerium fur Wirtschaft und Informationstechnologie, No KF2502403FR0, KF2660001FR0) as institutional funding to Philipps-University, Marburg URL: www.zim-bmwi.de. Weinmann Emergency Medical Technology GmbH+Co.KG, provided support in the form of a salary for author CN, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Aufderheide Tom P, 2004, Crit Care Med, V32, pS345, DOI 10.1097/01.CCM.0000134335.46859.09; Aufderheide TP, 2004, CIRCULATION, V109, P1960, DOI 10.1161/01.CIR.0000126594.79136.61; Bobrow BJ, 2009, ANN EMERG MED, V54, P656, DOI 10.1016/j.annemergmed.2009.06.011; Botran M, 2011, INTENS CARE MED, V37, P1873, DOI 10.1007/s00134-011-2338-6; Brochard L, 1996, AM J RESP CRIT CARE, V154, P1323, DOI 10.1164/ajrccm.154.5.8912743; Chalkias A, 2013, EUR HEART J ACUTE CA; CRILEY JM, 1976, JAMA-J AM MED ASSOC, V236, P1246, DOI 10.1001/jama.236.11.1246; DEAKIN CD, 2010, RESUSCITATION, V81, P1305, DOI DOI 10.1016/J.RESUSCITATI0N.2010.08.017; Dorph E, 2004, RESUSCITATION, V61, P23, DOI 10.1016/j.resuscitation.2003.12.017; Ewy GA, 2005, CIRCULATION, V111, P2134, DOI 10.1161/01.CIR.0000162503.57657.FA; Gazmuri RJ, 2012, RESUSCITATION, V83, P259, DOI 10.1016/j.resuscitation.2011.07.034; HALPERIN HR, 1993, NEW ENGL J MED, V329, P762, DOI 10.1056/NEJM199309093291104; Hupfl M, 2010, LANCET, V376, P1552, DOI 10.1016/S0140-6736(10)61454-7; IDRIS AH, 1994, RESUSCITATION, V28, P143, DOI 10.1016/0300-9572(94)90087-6; Kill C, 2014, CRIT CARE MED, V42, pE89, DOI 10.1097/CCM.0b013e3182a63fa0; Kill C, 2012, CURR OPIN CRIT CARE, V18, P251, DOI 10.1097/MCC.0b013e3283523f69; Kill C, 2009, RESUSCITATION, V80, P1060, DOI 10.1016/j.resuscitation.2009.05.015; Kleinsasser A, 2002, CIRCULATION, V106, P373, DOI 10.1161/01.CIR.0000021428.94652.04; Langhelle A, 2002, RESUSCITATION, V52, P39, DOI 10.1016/S0300-9572(01)00442-7; Lurie KG, 2002, CIRCULATION, V105, P124, DOI 10.1161/hc0102.101391; Lurie KG, 2001, ANESTH ANALG, V93, P649, DOI 10.1097/00000539-200109000-00024; Iglesias JM, 2010, INTENS CARE MED, V36, P712, DOI 10.1007/s00134-010-1777-9; NOC M, 1994, AM J RESP CRIT CARE, V150, P861, DOI 10.1164/ajrccm.150.3.8087362; Richard JCM, 2011, AM J RESP CRIT CARE, V184, P32, DOI 10.1164/rccm.201103-0424UP; Timerman S, 2004, RESUSCITATION, V61, P273, DOI 10.1016/j.resuscitation.2004.01.025; Yannopoulos D, 2005, CIRCULATION, V112, P803, DOI 10.1161/CIRCULATIONAHA.105.541508; Yannopoulos D, 2007, ANESTH ANALG, V104, P157, DOI 10.1213/01.ane.0000249047.80184.5a; Yannopoulos D, 2010, CRIT CARE MED, V38, P254, DOI 10.1097/CCM.0b013e3181b42f6c	28	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127759	10.1371/journal.pone.0127759	http://dx.doi.org/10.1371/journal.pone.0127759			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011525	Green Submitted, gold, Green Published			2022-12-26	WOS:000355183900140
J	Sequeira, A; Rollins, B; Magnan, C; van Oven, M; Baldi, P; Myers, RM; Barchas, JD; Schatzberg, AF; Watson, SJ; Akil, H; Bunney, WE; Vawter, MP				Sequeira, Adolfo; Rollins, Brandi; Magnan, Christophe; van Oven, Mannis; Baldi, Pierre; Myers, Richard M.; Barchas, Jack D.; Schatzberg, Alan F.; Watson, Stanley J.; Akil, Huda; Bunney, William E.; Vawter, Marquis P.			Mitochondrial Mutations in Subjects with Psychiatric Disorders	PLOS ONE			English	Article							GENERATION SEQUENCING TECHNOLOGY; HETEROPLASMY; SCHIZOPHRENIA; MTDNA; GENOME; REGION; ORGANIZATION; HAPLOGROUPS; INVOLVEMENT; TRANSITION	A considerable body of evidence supports the role of mitochondrial dysfunction in psychiatric disorders and mitochondrial DNA (mtDNA) mutations are known to alter brain energy metabolism, neurotransmission, and cause neurodegenerative disorders. Genetic studies focusing on common nuclear genome variants associated with these disorders have produced genome wide significant results but those studies have not directly studied mtDNA variants. The purpose of this study is to investigate, using next generation sequencing, the involvement of mtDNA variation in bipolar disorder, schizophrenia, major depressive disorder, and methamphetamine use. MtDNA extracted from multiple brain regions and blood were sequenced (121 mtDNA samples with an average of 8,800x coverage) and compared to an electronic database containing 26,850 mtDNA genomes. We confirmed novel and rare variants, and confirmed next generation sequencing error hotspots by traditional sequencing and genotyping methods. We observed a significant increase of non-synonymous mutations found in individuals with schizophrenia. Novel and rare non-synonymous mutations were found in psychiatric cases in mtDNA genes: ND6, ATP6, CYTB, and ND2. We also observed mtDNA heteroplasmy in brain at a locus previously associated with schizophrenia (T16519C). Large differences in heteroplasmy levels across brain regions within subjects suggest that somatic mutations accumulate differentially in brain regions. Finally, multiplasmy, a heteroplasmic measure of repeat length, was observed in brain from selective cases at a higher frequency than controls. These results offer support for increased rates of mtDNA substitutions in schizophrenia shown in our prior results. The variable levels of heteroplasmic/multiplasmic somatic mutations that occur in brain may be indicators of genetic instability in mtDNA.	[Sequeira, Adolfo; Rollins, Brandi; Vawter, Marquis P.] Univ Calif Irvine, Dept Psychiat & Human Behav, Funct Genom Lab, Irvine, CA 92717 USA; [Magnan, Christophe; Baldi, Pierre] Univ Calif Irvine, IGB, Sch Informat & Comp Sci ICS, Irvine, CA USA; [van Oven, Mannis] Univ Med Ctr Rotterdam, Erasmus MC, Dept Forens Mol Biol, Rotterdam, Netherlands; [Myers, Richard M.] HudsonAlpha Inst Biotechnol, Huntsville, AL USA; [Barchas, Jack D.] Weill Cornell Med Coll, Dept Psychiat, New York, NY USA; [Schatzberg, Alan F.] Stanford Univ, Dept Psychiat & Behav Sci, Palo Alto, CA 94304 USA; [Watson, Stanley J.; Akil, Huda] Univ Michigan, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA; [Bunney, William E.] Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92717 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; Erasmus University Rotterdam; Erasmus MC; HudsonAlpha Institute for Biotechnology; Cornell University; Stanford University; University of Michigan System; University of Michigan; University of California System; University of California Irvine	Vawter, MP (corresponding author), Univ Calif Irvine, Dept Psychiat & Human Behav, Funct Genom Lab, Irvine, CA 92717 USA.	mvawter@uci.edu	Sequeira, Adolfo/K-7278-2015; magnan, christophe/AAJ-7622-2021	Sequeira, Adolfo/0000-0003-3040-1190; magnan, christophe/0000-0002-7044-2571; van Oven, Mannis/0000-0003-0026-7998	Pritzker Family Philanthropic Fund; NIMH [R01MH085801, MH099440, R01MH097082]; Pritzker Neuropsychiatric Disorders Research Fund L.L.C.; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH097082, R21MH099440, R01MH085801] Funding Source: NIH RePORTER	Pritzker Family Philanthropic Fund; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Pritzker Neuropsychiatric Disorders Research Fund L.L.C.; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The collection of brain tissue was supported by funding from the Pritzker Family Philanthropic Fund, and NIMH Grants R01MH085801, MH099440 (MPV) and R01MH097082 (AS). The authors (except CM, MvO, PB), are members of the Pritzker Neuropsychiatric Disorders Research Consortium, which is supported by the Pritzker Neuropsychiatric Disorders Research Fund L.L.C. A shared intellectual property agreement exists between this philanthropic fund and the University of Michigan, Stanford University, the Weill Medical College of Cornell University, HudsonAlpha Institute of Biotechnology, and the University of California at Irvine, to encourage the development of appropriate findings for research and clinical applications. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Anglin RE, 2012, J NEUROPSYCH CLIN N, V24, P394, DOI 10.1176/appi.neuropsych.11110345; Anglin RE, 2012, J CLIN PSYCHIAT, V73, P506, DOI 10.4088/JCP.11r07237; Anglin RES, 2012, AM J MED GENET B, V159B, P749, DOI 10.1002/ajmg.b.32086; Bandelt HJ, 2012, FORENSIC SCI INT-GEN, V6, P143, DOI 10.1016/j.fsigen.2011.04.004; Bandelt HJ, 2009, HUM MUTAT, V30, P191, DOI 10.1002/humu.20846; Belle EMS, 2005, GENE, V355, P58, DOI 10.1016/j.gene.2005.05.019; Bellizzi D, 2013, DNA RES, V20, P537, DOI 10.1093/dnares/dst029; Bertolin C, 2011, J HUM GENET, V56, P869, DOI 10.1038/jhg.2011.111; Caverzasi E, 2012, FUNCT NEUROL, V27, P13; Coto E, 2011, NEUROGENETICS, V12, P345, DOI 10.1007/s10048-011-0295-4; Dzitoyeva S, 2012, NEUROBIOL AGING, V33, P2881, DOI 10.1016/j.neurobiolaging.2012.02.006; Forster L, 2010, INT J LEGAL MED, V124, P133, DOI 10.1007/s00414-009-0385-0; Girard SL, 2011, NAT GENET, V43, P860, DOI 10.1038/ng.886; Goto H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r59; Gruber S, 2003, INVEST RADIOL, V38, P403, DOI 10.1097/01.rli.0000073446.43445.20; Guo Y, 2012, MUTAT RES-GEN TOX EN, V744, P154, DOI 10.1016/j.mrgentox.2012.02.006; He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802; Howell N, 2000, AM J HUM GENET, V66, P1589, DOI 10.1086/302910; Hu WF, 2014, ANNU REV GENOM HUM G, V15, P195, DOI 10.1146/annurev-genom-090413-025600; Huang Taosheng, 2011, Curr Protoc Hum Genet, VChapter 19, DOI 10.1002/0471142905.hg1908s71; Hudson G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004369; Iborra FJ, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-9; Inczedy-Farkas G, 2012, BEHAV BRAIN FUNCT, V8, DOI 10.1186/1744-9081-8-9; Ingman M, 2006, NUCLEIC ACIDS RES, V34, pD749, DOI 10.1093/nar/gkj010; Jamuar SS, 2014, NEW ENGL J MED, V371, P733, DOI 10.1056/NEJMoa1314432; Kato M, 2011, NEUROSCI RES, V69, P331, DOI 10.1016/j.neures.2010.12.013; Kazuno A, 2009, AM J MED GENET B, V150B, P243, DOI 10.1002/ajmg.b.30804; Kim SY, 2010, BRAIN RES, V1348, P105, DOI 10.1016/j.brainres.2010.05.097; Li MK, 2010, AM J HUM GENET, V87, P237, DOI 10.1016/j.ajhg.2010.07.014; Liou CW, 2010, J MED GENET, V47, P723, DOI 10.1136/jmg.2010.077552; Lutz-Bonengel S, 2004, INT J LEGAL MED, V118, P274, DOI 10.1007/s00414-004-0457-0; Manev Hari, 2012, Biomol Concepts, V3, P107; McMahon FJ, 2000, AM J PSYCHIAT, V157, P1058, DOI 10.1176/appi.ajp.157.7.1058; Mosquera-Miguel A, 2012, AM J MED GENET B, V159B, P414, DOI 10.1002/ajmg.b.32044; Nelson MR, 2012, SCIENCE, V337, P100, DOI 10.1126/science.1217876; Ongur D, 2009, PSYCHIAT RES-NEUROIM, V172, P44, DOI 10.1016/j.pscychresns.2008.06.002; Poduri A, 2013, SCIENCE, V341, P43, DOI 10.1126/science.1237758; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Rezin GT, 2009, NEUROCHEM RES, V34, P1021, DOI 10.1007/s11064-008-9865-8; Rollins B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004913; Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594; Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927; SATOH M, 1991, EXP CELL RES, V196, P137, DOI 10.1016/0014-4827(91)90467-9; Sequeira Adolfo, 2012, Frontiers in Genetics, V3, P103, DOI 10.3389/fgene.2012.00103; Shao L, 2008, ANN MED, V40, P281, DOI 10.1080/07853890801923753; Sharpley MS, 2012, CELL, V151, P333, DOI 10.1016/j.cell.2012.09.004; Shock LS, 2011, P NATL ACAD SCI USA, V108, P3630, DOI 10.1073/pnas.1012311108; Sondheimer N, 2011, HUM MOL GENET, V20, P1653, DOI 10.1093/hmg/ddr043; Sosa MX, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002737; Tang MY, 2004, CLIN CANCER RES, V10, P1041, DOI 10.1158/1078-0432.CCR-0701-3; Tang S, 2013, HUM MUTAT, V34, P882, DOI 10.1002/humu.22307; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Verge B, 2011, EUR PSYCHIAT, V26, P45, DOI 10.1016/j.eurpsy.2010.08.008; Verge B, 2012, J CLIN PSYCHIAT, V73, P684, DOI 10.4088/JCP.10m06718; Wallace DC, 2011, COLD SH Q B, V76, P1, DOI 10.1101/sqb.2011.76.010462; Wang GX, 2013, PSYCHIAT RES, V209, P279, DOI 10.1016/j.psychres.2013.01.001; Wang PN, 2009, J ALZHEIMERS DIS, V18, P345, DOI 10.3233/JAD-2009-1156; Williams SL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003990; Xu B, 2011, NAT GENET, V43, P864, DOI 10.1038/ng.902; Yamamoto BK, 2008, J NEUROIMMUNE PHARM, V3, P203, DOI 10.1007/s11481-008-9121-7; Zaragoza MV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012295	64	31	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127280	10.1371/journal.pone.0127280	http://dx.doi.org/10.1371/journal.pone.0127280			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0QZ	26011537	Green Published, gold, Green Submitted			2022-12-26	WOS:000355183900077
J	Zhang, P; Du, EQ; Ma, J; Wang, WB; Zhang, L; Tikoo, SK; Yang, ZQ				Zhang, Peng; Du, Enqi; Ma, Jing; Wang, Wenbin; Zhang, Lu; Tikoo, Suresh K.; Yang, Zengqi			A Novel and Simple Method for Rapid Generation of Recombinant Porcine Adenoviral Vectors for Transgene Expression	PLOS ONE			English	Article							CLASSICAL SWINE-FEVER; GENE-TRANSFER; NONHUMAN ADENOVIRUSES; IMMUNE-RESPONSES; INNATE IMMUNITY; PROTECTS PIGS; VACCINATION; CONSTRUCTION; EFFICIENT; TOXICITY	Many human (different serotypes) and nonhuman adenovirus vectors are being used for gene delivery. However, the current system for isolating recombinant adenoviral vectors is either time-consuming or expensive, especially for the generation of recombinant nonhuman adenoviral vectors. We herein report a new and simple cloning approach for the rapid generation of a porcine adenovirus (PAdV-3) vector which shows promise for gene transfer to human cells and evasion of human adenovirus type 5 (HAdV-5) immunity. Based on the final cloning plasmid, pFPAV3-CcdB-Cm, and our modified SLiCE strategy (SLiCE cloning and lethal CcdB screening), the process for generating recombinant PAdV-3 plasmids required only one step in 3 days, with a cloning efficiency as high as 620 +/- 49.56 clones/ng and zero background (100% accuracy). The recombinant PAdV-3 plasmids could be successfully rescued in porcine retinal pigment epithelium cells (VR1BL), which constitutively express the HAdV-5 E1 and PAdV-3 E1B 55k genes, and the foreign genes were highly expressed at 24 h after transduction into swine testicle (ST) cells. In conclusion, this strategy for generating recombinant PAdV-3 vectors based on our modified SLiCE cloning system was rapid and cost-efficient, which could be used as universal cloning method for modification the other regions of PAdV-3 genome as well as other adenoviral genomes.	[Zhang, Peng; Du, Enqi; Ma, Jing; Wang, Wenbin; Zhang, Lu; Yang, Zengqi] North West A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China; [Tikoo, Suresh K.] Univ Saskatchewan, VIDO InterVac, Saskatoon, SK, Canada; [Tikoo, Suresh K.] Univ Saskatchewan, Sch Publ Hlth, Vaccinol & Immunotherapeut Program, Saskatoon, SK, Canada; [Tikoo, Suresh K.] Univ Saskatchewan, Western Coll Vet Med, Dept Vet Microbiol, Saskatoon, SK S7N 0W0, Canada	Northwest A&F University - China; University of Saskatchewan; University of Saskatchewan; University of Saskatchewan	Tikoo, SK (corresponding author), Univ Saskatchewan, VIDO InterVac, Saskatoon, SK, Canada.	suresh.tik@usask.ca; yzq8162@163.com			Research Starting Foundation; Northwest A F University [Z111021006]; National Natural Science Foundation of China [31101803/C1803]; Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences [SKLVBF201405]	Research Starting Foundation; Northwest A F University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences	This work was supported by the Research Starting Foundation, Northwest A & F University (Grant No. Z111021006), National Natural Science Foundation of China (Grant No. 31101803/C1803), and Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences (Grant No. SKLVBF201405).	Bangari DS, 2006, VACCINE, V24, P849, DOI 10.1016/j.vaccine.2005.08.101; Bernard P, 1996, BIOTECHNIQUES, V21, P320; BETT AJ, 1994, P NATL ACAD SCI USA, V91, P8802, DOI 10.1073/pnas.91.19.8802; Campos SK, 2004, HUM GENE THER, V15, P1125, DOI 10.1089/1043034042431182; Chartier C, 1996, J VIROL, V70, P4805, DOI 10.1128/JVI.70.7.4805-4810.1996; Chirmule N, 1999, GENE THER, V6, P1574, DOI 10.1038/sj.gt.3300994; Croyle M A, 1998, Pharm Dev Technol, V3, P373, DOI 10.3109/10837459809009865; Dobbelstein M, 2004, CURR TOP MICROBIOL, V273, P291; Geisbert TW, 2011, J VIROL, V85, P4222, DOI 10.1128/JVI.02407-10; Goncalves MAFV, 2006, REV MED VIROL, V16, P167, DOI 10.1002/rmv.494; Hammond JM, 2000, VACCINE, V18, P1040, DOI 10.1016/S0264-410X(99)00347-3; Hammond JM, 2003, VIRUS RES, V97, P151, DOI 10.1016/j.virusres.2003.08.003; Hammond JM, 2001, VET MICROBIOL, V80, P101, DOI 10.1016/S0378-1135(00)00388-6; Hammond JM, 2001, ARCH VIROL, V146, P1787, DOI 10.1007/s007050170064; Hammond JM, 2001, VACCINE, V19, P3752, DOI 10.1016/S0264-410X(01)00084-6; Harui A, 1999, J VIROL, V73, P6141, DOI 10.1128/JVI.73.7.6141-6146.1999; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; Hofmann C, 1999, J VIROL, V73, P6930, DOI 10.1128/JVI.73.8.6930-6936.1999; Kremer EJ, 2000, J VIROL, V74, P505, DOI 10.1128/JVI.74.1.505-512.2000; Li XX, 2004, VIRUS RES, V104, P181, DOI 10.1016/j.virusres.2004.04.011; Lieber A, 1997, J VIROL, V71, P8798, DOI 10.1128/JVI.71.11.8798-8807.1997; Mizuguchi H, 1998, HUM GENE THER, V9, P2577, DOI 10.1089/hum.1998.9.17-2577; Moffatt S, 2000, VIROLOGY, V272, P159, DOI 10.1006/viro.2000.0350; Muruve DA, 1999, HUM GENE THER, V10, P965, DOI 10.1089/10430349950018364; Ng P, 1999, HUM GENE THER, V10, P2667, DOI 10.1089/10430349950016708; Ng P, 2001, MOL THER, V3, P809, DOI 10.1006/mthe.2001.0323; Patel A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015301; Raper SE, 2003, MOL GENET METAB, V80, P148, DOI 10.1016/j.ymgme.2003.08.016; Reddy PS, 1999, J VIROL, V73, P9137, DOI 10.1128/JVI.73.11.9137-9144.1999; Reddy PS, 1999, J GEN VIROL, V80, P563, DOI 10.1099/0022-1317-80-3-563; Reddy PS, 2003, VIROLOGY, V311, P384, DOI 10.1016/S0042-6822(03)00161-2; Reddy PS, 1999, J GEN VIROL, V80, P2909, DOI 10.1099/0022-1317-80-11-2909; Schnell MA, 2001, MOL THER, V3, P708, DOI 10.1006/mthe.2001.0330; Sharma A, 2010, GENE THER, V17, P634, DOI 10.1038/gt.2010.1; Sharma A, 2010, VIRUS RES, V153, P134, DOI 10.1016/j.virusres.2010.07.021; Sharma A, 2009, VIROLOGY, V386, P44, DOI 10.1016/j.virol.2009.01.008; Shiver JW, 2002, NATURE, V415, P331, DOI 10.1038/415331a; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Stone D, 2005, J VIROL, V79, P5090, DOI 10.1128/JVI.79.8.5090-5104.2005; Varnavski AN, 2005, GENE THER, V12, P427, DOI 10.1038/sj.gt.3302347; Varnavski AN, 2002, J VIROL, V76, P5711, DOI 10.1128/JVI.76.11.5711-5719.2002; Vlachaki MT, 2002, MOL THER, V6, P342, DOI 10.1006/mthe.2002.0669; Vogels R, 2003, J VIROL, V77, P8263, DOI 10.1128/JVI.77.15.8263-8271.2003; Volpers C, 2004, J GENE MED, V6, pS164, DOI 10.1002/jgm.496; Zakhartchouk A, 2003, VIROLOGY, V313, P377, DOI 10.1016/S0042-6822(03)00286-1; Zhang YW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1288	47	3	3	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127958	10.1371/journal.pone.0127958	http://dx.doi.org/10.1371/journal.pone.0127958			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011074	Green Published, Green Submitted, gold			2022-12-26	WOS:000355183900172
J	Ricoult, SJH; Yecies, JL; Ben-Sahra, I; Manning, BD				Ricoult, S. J. H.; Yecies, J. L.; Ben-Sahra, I.; Manning, B. D.			Oncogenic PI3K and K-Ras stimulate de novo lipid synthesis through mTORC1 and SREBP	ONCOGENE			English	Article							STEAROYL-COA DESATURASE; ELEMENT-BINDING PROTEINS; UNSATURATED FATTY-ACIDS; TUBEROUS SCLEROSIS; MAMMALIAN TARGET; CELL-GROWTH; COMPLEX 1; CANCER PATHOGENESIS; TSC1-TSC2 COMPLEX; SIGNALING AXIS	An enhanced capacity for de novo lipid synthesis is a metabolic feature of most cancer cells that distinguishes them from their cells of origin. However, the mechanisms through which oncogenes alter lipid metabolism are poorly understood. We find that expression of oncogenic PI3K (H1047R) or K-Ras (G12V) in breast epithelial cells is sufficient to induce de novo lipogenesis, and this occurs through the convergent activation of the mechanistic target of rapamycin complex 1 (mTORC1) downstream of these common oncogenes. Oncogenic stimulation of mTORC1 signaling in this isogenic setting or a panel of eight breast cancer cell lines leads to activation of the sterol regulatory element-binding proteins (SREBP1 and SREBP2) that are required for oncogene-induced lipid synthesis. The SREBPs are also required for the growth factor-independent growth and proliferation of oncogene-expressing cells. Finally, we find that elevated mTORC1 signaling is associated with increased mRNA and protein levels of canonical SREBP targets in primary human breast cancer samples. These data suggest that the mTORC1/SREBP pathway is a major mechanism through which common oncogenic signaling events induce de novo lipid synthesis to promote aberrant growth and proliferation of cancer cells.	[Ricoult, S. J. H.; Yecies, J. L.; Ben-Sahra, I.; Manning, B. D.] Harvard Univ, Dept Genet & Complex Dis, TH Chan Sch Publ Hlth, 665 Huntington Ave,SPH2-117, Boston, MA 02115 USA; [Yecies, J. L.] Genentech Inc, San Francisco, CA 94080 USA	Harvard University; Harvard T.H. Chan School of Public Health; Roche Holding; Genentech	Manning, BD (corresponding author), Harvard Univ, Dept Genet & Complex Dis, TH Chan Sch Publ Hlth, 665 Huntington Ave,SPH2-117, Boston, MA 02115 USA.	bmanning@hsph.harvard.edu	Manning, Brendan/ABD-6528-2021	Manning, Brendan/0000-0003-3895-5956	NSF [DGE-1144152]; LAM Foundation; Sanofi Innovation Award; NIH [R01-CA181390, P01-CA120964]; NATIONAL CANCER INSTITUTE [R01CA181390, R35CA197459, P01CA120964] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); LAM Foundation; Sanofi Innovation Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by NSF predoctoral fellowship DGE-1144152 (to SJHR), a postdoctoral fellowship from the LAM Foundation (to IB-S), a Sanofi Innovation Award (to BDM) and NIH Grants R01-CA181390 and P01-CA120964 (to BDM).	Amemiya-Kudo M, 2000, J BIOL CHEM, V275, P31078, DOI 10.1074/jbc.M005353200; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chakrabarti P, 2010, DIABETES, V59, P775, DOI 10.2337/db09-1602; Clendening JW, 2012, ONCOGENE, V31, P4967, DOI 10.1038/onc.2012.6; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; Dibble CC, 2013, NAT CELL BIOL, V15, P555, DOI 10.1038/ncb2763; Dibble CC, 2012, MOL CELL, V47, P535, DOI 10.1016/j.molcel.2012.06.009; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Freed-Pastor WA, 2012, CELL, V148, P244, DOI 10.1016/j.cell.2011.12.017; Fritz V, 2010, MOL CANCER THER, V9, P1740, DOI 10.1158/1535-7163.MCT-09-1064; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Griffiths B, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-3; Guo DL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000446; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Howell JJ, 2013, BIOCHEM SOC T, V41, P906, DOI 10.1042/BST20130041; Hua XX, 1996, J BIOL CHEM, V271, P10379, DOI 10.1074/jbc.271.17.10379; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Jeon TI, 2012, TRENDS ENDOCRIN MET, V23, P65, DOI 10.1016/j.tem.2011.10.004; Johannessen CM, 2005, P NATL ACAD SCI USA, V102, P8573, DOI 10.1073/pnas.0503224102; Kamphorst JJ, 2013, P NATL ACAD SCI USA, V110, P8882, DOI 10.1073/pnas.1307237110; Kasiske BL, 2008, AM J TRANSPLANT, V8, P1384, DOI 10.1111/j.1600-6143.2008.02272.x; Kidani Y, 2013, NAT IMMUNOL, V14, P489, DOI 10.1038/ni.2570; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Krycer JR, 2012, BIOCHEM J, V446, P191, DOI 10.1042/BJ20120545; KUHAJDA FP, 1994, P NATL ACAD SCI USA, V91, P6379, DOI 10.1073/pnas.91.14.6379; LI J, 1994, INT J CANCER, V57, P348, DOI 10.1002/ijc.2910570310; Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107; Li SY, 2011, BIOCHEM BIOPH RES CO, V412, P197, DOI 10.1016/j.bbrc.2011.07.038; Liu XL, 2012, BBA-MOL BASIS DIS, V1822, P1716, DOI 10.1016/j.bbadis.2012.07.008; Luyimbazi D, 2010, MOL CANCER THER, V9, P2770, DOI 10.1158/1535-7163.MCT-09-0980; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; MEDES G, 1953, CANCER RES, V13, P27; Menon S, 2008, Oncogene, V27 Suppl 2, pS43, DOI 10.1038/onc.2009.352; Migita T, 2008, CANCER RES, V68, P8547, DOI 10.1158/0008-5472.CAN-08-1235; Minville-Walz M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014363; Morrisett JD, 2002, J LIPID RES, V43, P1170, DOI 10.1194/jlr.M100392-JLR200; NAKANISHI S, 1970, EUR J BIOCHEM, V16, P161, DOI 10.1111/j.1432-1033.1970.tb01068.x; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Owen JL, 2012, P NATL ACAD SCI USA, V109, P16184, DOI 10.1073/pnas.1213343109; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Porstmann T, 2005, ONCOGENE, V24, P6465, DOI 10.1038/sj.onc.1208802; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Ricoult SJH, 2013, EMBO REP, V14, P242, DOI 10.1038/embor.2013.5; Roongta UV, 2011, MOL CANCER RES, V9, P1551, DOI 10.1158/1541-7786.MCR-11-0126; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Sakai J, 1996, CELL, V85, P1037, DOI 10.1016/S0092-8674(00)81304-5; Santos CR, 2012, FEBS J, V279, P2610, DOI 10.1111/j.1742-4658.2012.08644.x; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shimano H, 1997, J CLIN INVEST, V100, P2115, DOI 10.1172/JCI119746; Soliman GA, 2010, LIPIDS, V45, P1089, DOI 10.1007/s11745-010-3488-y; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; TWETO J, 1971, J BIOL CHEM, V246, P2468; Wang BT, 2011, P NATL ACAD SCI USA, V108, P15201, DOI 10.1073/pnas.1103746108; WANG XD, 1994, CELL, V77, P53, DOI 10.1016/0092-8674(94)90234-8; Williams KJ, 2013, CANCER RES, V73, P2850, DOI 10.1158/0008-5472.CAN-13-0382-T; Yecies JL, 2011, CELL METAB, V14, P21, DOI 10.1016/j.cmet.2011.06.002; Young RM, 2013, GENE DEV, V27, P1115, DOI 10.1101/gad.198630.112; Zhang CB, 2009, AM J PHYSIOL-ENDOC M, V296, pE862, DOI 10.1152/ajpendo.90651.2008; Zhao JJ, 2005, P NATL ACAD SCI USA, V102, P18443, DOI 10.1073/pnas.0508988102	65	133	136	1	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 10	2016	35	10					1250	1260		10.1038/onc.2015.179	http://dx.doi.org/10.1038/onc.2015.179			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DG0NY	26028026	Green Accepted			2022-12-26	WOS:000371763100005
J	Ho, JCS; Nadeem, A; Rydstrom, A; Puthia, M; Svanborg, C				Ho, J. C. S.; Nadeem, A.; Rydstrom, A.; Puthia, M.; Svanborg, C.			Targeting of nucleotide-binding proteins by HAMLET-a conserved tumor cell death mechanism	ONCOGENE			English	Article							HUMAN ALPHA-LACTALBUMIN; TYROSINE KINASES; INHIBITION; CANCER; IDENTIFICATION; FEATURES; LETHAL	HAMLET (Human Alpha-lactalbumin Made LEthal to Tumor cells) kills tumor cells broadly suggesting that conserved survival pathways are perturbed. We now identify nucleotide-binding proteins as HAMLET binding partners, accounting for about 35% of all HAMLET targets in a protein microarray comprising 8000 human proteins. Target kinases were present in all branches of the Kinome tree, including 26 tyrosine kinases, 10 tyrosine kinase-like kinases, 13 homologs of yeast sterile kinases, 4 casein kinase 1 kinases, 15 containing PKA, PKG, PKC family kinases, 15 calcium/calmodulin-dependent protein kinase kinases and 13 kinases from CDK, MAPK, GSK3, CLK families. HAMLET acted as a broad kinase inhibitor in vitro, as defined in a screen of 347 wild-type, 93 mutant, 19 atypical and 17 lipid kinases. Inhibition of phosphorylation was also detected in extracts from HAMLET-treated lung carcinoma cells. In addition, HAMLET recognized 24 Ras family proteins and bound to Ras, RasL11B and Rap1B on the cytoplasmic face of the plasma membrane. Direct cellular interactions between HAMLET and activated Ras family members including Braf were confirmed by co-immunoprecipitation. As a consequence, oncogenic Ras and Braf activity was inhibited and HAMLET and Braf inhibitors synergistically increased tumor cell death in response to HAMLET. Unlike most small molecule kinase inhibitors, HAMLET showed selectivity for tumor cells in vitro and in vivo. The results identify nucleotide-binding proteins as HAMLET targets and suggest that dysregulation of the ATPase/kinase/GTPase machinery contributes to cell death, following the initial, selective recognition of HAMLET by tumor cells. The findings thus provide a molecular basis for the conserved tumoricidal effect of HAMLET, through dysregulation of kinases and oncogenic GTPases, to which tumor cells are addicted.	[Ho, J. C. S.; Nadeem, A.; Rydstrom, A.; Puthia, M.; Svanborg, C.] Lund Univ, Inst Lab Med, Dept Microbiol Immunol & Glycobiol MIG, Solvegatan 23, S-22362 Lund, Sweden	Lund University	Svanborg, C (corresponding author), Lund Univ, Inst Lab Med, Dept Microbiol Immunol & Glycobiol MIG, Solvegatan 23, S-22362 Lund, Sweden.	catharina.svanborg@med.lu.se	Ho, James CS/AAF-8197-2022; Ho, James CS/ADQ-2735-2022; Nadeem, Aftab/GRJ-0009-2022	Ho, James CS/0000-0002-6131-1297; Ho, James CS/0000-0002-6131-1297; Nadeem, Aftab/0000-0002-1439-6216; Rydstrom, Anna/0000-0002-3404-7195; Puthia, Manoj/0000-0001-6048-7234	Sharon D Lund foundation grant; Swedish Cancer Society; Medical Faculty (Lund University); Soderberg Foundation; Segerfalk Foundation; Maggie Stephens Foundation; Gunnar Nilsson Cancer Foundation; Inga-Britt and Arne Lundberg Foundation; HJ Forssman Foundation for Medical Research; Royal Physiographic Society	Sharon D Lund foundation grant; Swedish Cancer Society(Swedish Cancer Society); Medical Faculty (Lund University); Soderberg Foundation; Segerfalk Foundation; Maggie Stephens Foundation; Gunnar Nilsson Cancer Foundation; Inga-Britt and Arne Lundberg Foundation; HJ Forssman Foundation for Medical Research; Royal Physiographic Society	This study was supported by the Sharon D Lund foundation grant, the Swedish Cancer Society, the Medical Faculty (Lund University), the Soderberg Foundation, the Segerfalk Foundation, the Maggie Stephens Foundation, the Gunnar Nilsson Cancer Foundation, the Inga-Britt and Arne Lundberg Foundation, the HJ Forssman Foundation for Medical Research and the Royal Physiographic Society. We thank Petter Storm for conducting the Biacore and Braf activity experiments.	Anastassiadis T, 2011, NAT BIOTECHNOL, V29, P1039, DOI 10.1038/nbt.2017; Baselga J, 2006, SCIENCE, V312, P1175, DOI 10.1126/science.1125951; Chandarlapaty S, 2011, CANCER CELL, V19, P58, DOI 10.1016/j.ccr.2010.10.031; Chene P, 2002, NAT REV DRUG DISCOV, V1, P665, DOI 10.1038/nrd894; Druker BJ, 2008, BLOOD, V112, P4808, DOI 10.1182/blood-2008-07-077958; Duncan JS, 2012, CELL, V149, P307, DOI 10.1016/j.cell.2012.02.053; Duringer C, 2003, J BIOL CHEM, V278, P42131, DOI 10.1074/jbc.M306462200; Egorov VV, 2007, DOKL BIOCHEM BIOPHYS, V414, P152, DOI 10.1134/S1607672907030167; Fischer W, 2004, CANCER RES, V64, P2105, DOI 10.1158/0008-5472.CAN-03-2661; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Garrett JT, 2011, P NATL ACAD SCI USA, V108, P5021, DOI 10.1073/pnas.1016140108; Garuti L, 2010, CURR MED CHEM, V17, P2804, DOI 10.2174/092986710791859333; Gustafsson L, 2004, NEW ENGL J MED, V350, P2663, DOI 10.1056/NEJMoa032454; Gustafsson L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005229; HAKANSSON A, 1995, P NATL ACAD SCI USA, V92, P8064, DOI 10.1073/pnas.92.17.8064; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; HARVEY JJ, 1964, NATURE, V204, P1104, DOI 10.1038/2041104b0; Ho J, 2015, J MOL BIOL, V427, P1866, DOI 10.1016/j.jmb.2015.01.024; Hojjat-Farsangi M, 2014, INT J MOL SCI, V15, P13768, DOI 10.3390/ijms150813768; Hu YG, 2006, P NATL ACAD SCI USA, V103, P16870, DOI 10.1073/pnas.0606509103; KIRSTEN WH, 1970, BIBL HAEMATOL, V1969, P246; MacBeath G, 2000, SCIENCE, V289, P1760; Manning Brendan D, 2002, Sci STKE, V2002, ppe49, DOI 10.1126/stke.2002.162.pe49; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; MEGGIO F, 1995, EUR J BIOCHEM, V234, P317, DOI 10.1111/j.1432-1033.1995.317_c.x; Mor A, 2006, ANNU REV IMMUNOL, V24, P771, DOI 10.1146/annurev.immunol.24.021605.090723; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Mossberg AK, 2007, INT J CANCER, V121, P1352, DOI 10.1002/ijc.22810; Mossberg AK, 2010, J UROLOGY, V183, P1590, DOI 10.1016/j.juro.2009.12.008; Nakano H, 2009, J ANTIBIOT, V62, P17, DOI 10.1038/ja.2008.4; Newman RH, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.12; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Puthia M, 2014, GUT, V63, P131, DOI 10.1136/gutjnl-2012-303715; Rebhun JF, 2000, J BIOL CHEM, V275, P34901, DOI 10.1074/jbc.M005327200; Rodrik-Outmezguine VS, 2011, CANCER DISCOV, V1, P248, DOI 10.1158/2159-8290.CD-11-0085; Satoh J, 2006, J NEUROSCI METH, V152, P278, DOI 10.1016/j.jneumeth.2005.09.015; Sekiguchi T, 2004, J BIOL CHEM, V279, P8343, DOI 10.1074/jbc.M305935200; Spang A, 2010, FEBS LETT, V584, P2646, DOI 10.1016/j.febslet.2010.04.005; Stolle K, 2007, BBA-GENE STRUCT EXPR, V1769, P514, DOI 10.1016/j.bbaexp.2007.05.005; Storm P, 2011, ONCOGENE, V30, P4765, DOI 10.1038/onc.2011.196; Storm P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058578; Svensson M, 2000, P NATL ACAD SCI USA, V97, P4221, DOI 10.1073/pnas.97.8.4221; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; TAMAOKI T, 1990, BIO-TECHNOL, V8, P732, DOI 10.1038/nbt0890-732; Tee AR, 2005, FEBS LETT, V579, P4763, DOI 10.1016/j.febslet.2005.07.054; Trulsson M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017179; Weinstein IB, 2008, CANCER RES, V68, P3077, DOI 10.1158/0008-5472.CAN-07-3293; Yan JL, 2008, MOL CELL BIOL, V28, P5803, DOI 10.1128/MCB.00393-08; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	49	14	14	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 18	2016	35	7					897	907		10.1038/onc.2015.144	http://dx.doi.org/10.1038/onc.2015.144			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DE0RO	26028028				2022-12-26	WOS:000370332200010
J	Plattner, S; Gruber, C; Stadlmann, J; Widmann, S; Gruber, CW; Altmann, F; Bohlmann, H				Plattner, Stephan; Gruber, Clemens; Stadlmann, Johannes; Widmann, Stefan; Gruber, Christian W.; Altmann, Friedrich; Bohlmann, Holger			Isolation and Characterization of a Thionin Proprotein-processing Enzyme from Barley	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEAF-SPECIFIC THIONINS; SERINE-PROTEASE; SUBSTRATE-SPECIFICITY; ARABIDOPSIS; EXPRESSION; PROTEINS; SEQUENCE; PURIFICATION; PRECURSORS; MECHANISM	Thionins are plant-specific antimicrobial peptides that have been isolated from the endosperm and leaves of cereals, from the leaves of mistletoes, and from several other plant species. They are generally basic peptides with three or four disulfide bridges and a molecular mass of similar to 5 kDa. Thionins are produced as preproproteins consisting of a signal peptide, the thionin domain, and an acidic domain. Previously, only mature thionin peptides have been isolated from plants, and in addition to removal of the signal peptide, at least one cleavage processing step between the thionin and the acidic domain is necessary to release the mature thionin. In this work, we identified a thionin proprotein-processing enzyme (TPPE) from barley. Purification of the enzyme was guided by an assay that used a quenched fluorogenic peptide comprising the amino acid sequence between the thionin and the acidic domain of barley leaf-specific thionin. The barley TPPE was identified as a serine protease (BAJ93208) and expressed in Escherichia coli as a strep tag-labeled protein. The barley BTH6 thionin proprotein was produced in E. coli using the vector pETtrx1a and used as a substrate. We isolated and sequenced the BTH6 thionin from barley to confirm the N and C terminus of the peptide in planta. Using an in vitro enzymatic assay, the recombinant TPPE was able to process the quenched fluorogenic peptide and to cleave the acidic domain at least at six sites releasing the mature thionin from the proprotein. Moreover, it was found that the intrinsic three-dimensional structure of the BTH6 thionin domain prevents cleavage of the mature BTH6 thionin by the TPPE.	[Plattner, Stephan; Widmann, Stefan; Bohlmann, Holger] Univ Nat Resources & Life Sci, Dept Crop Sci, Div Plant Protect, A-1190 Vienna, Austria; [Gruber, Clemens; Stadlmann, Johannes; Altmann, Friedrich] Univ Nat Resources & Life Sci, Dept Chem, A-1190 Vienna, Austria; [Gruber, Christian W.] Med Univ Vienna, Ctr Physiol & Pharmacol, A-1090 Vienna, Austria	University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna; Medical University of Vienna	Bohlmann, H (corresponding author), Univ Nat Resources & Life Sci Vienna, UFT Tulln, Div Plant Protect, Dept Crop Sci, Konrad Lorenz Str 24, A-3430 Tulln, Austria.	holger.bohlmann@boku.ac.at	Stadlmann, Johannes/AAC-3157-2021	Stadlmann, Johannes/0000-0001-5693-6690; Altmann, Friedrich/0000-0002-0112-7877; Gruber, Christian/0000-0001-6060-7048; Grunwald-Gruber, Clemens/0000-0002-6097-8348	Austrian Science Fund [P21896-B16]; Austrian Science Fund (FWF) [P 21896] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Grant P21896-B16 from the Austrian Science Fund. The authors declare that they have no conflicts of interest with the contents of this article.	Abbas A, 2013, BIOTECHNOL LETT, V35, P1085, DOI 10.1007/s10529-013-1180-z; Balls A. K., 1942, CEREAL CHEM, V19, P279; Basak S, 2004, BIOCHEM J, V380, P505, DOI 10.1042/BJ20031405; Benko-Iseppon AM, 2010, CURR PROTEIN PEPT SC, V11, P181, DOI 10.2174/138920310791112075; Berger D, 2000, GENE DEV, V14, P1119; Bogomolovas J, 2009, PROTEIN EXPRES PURIF, V64, P16, DOI 10.1016/j.pep.2008.10.003; BOHLMANN H, 1988, EMBO J, V7, P1559, DOI 10.1002/j.1460-2075.1988.tb02980.x; BOHLMANN H, 1991, ANNU REV PLANT PHYS, V42, P227, DOI 10.1146/annurev.pp.42.060191.001303; BOHLMANN H, 1987, MOL GEN GENET, V207, P446, DOI 10.1007/BF00331614; BOHLMANN H, 1994, CRIT REV PLANT SCI, V13, P1, DOI 10.1080/713608052; Cedzich A, 2009, J BIOL CHEM, V284, P14068, DOI 10.1074/jbc.M900370200; Epple P, 1997, PLANT CELL, V9, P509, DOI 10.1105/tpc.9.4.509; FISHER N, 1968, CEREAL CHEM, V45, P48; Fontanini D, 2002, PLANTA, V215, P885, DOI 10.1007/s00425-002-0823-4; HOLTORF S, 1995, PLANT SCI, V111, P27, DOI 10.1016/0168-9452(95)04214-F; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kraft M, 2007, PROTEIN EXPRES PURIF, V52, P478, DOI 10.1016/j.pep.2006.10.019; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lay FT, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-41; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Liu JX, 2007, PLANT CELL, V19, P4111, DOI 10.1105/tpc.106.050021; Liu JX, 2009, PLANTA, V230, P687, DOI 10.1007/s00425-009-0976-5; Lobstein J, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-56; MATAYOSHI ED, 1990, SCIENCE, V247, P954, DOI 10.1126/science.2106161; Matsumoto T, 2011, PLANT PHYSIOL, V156, P20, DOI 10.1104/pp.110.171579; Oard SV, 2011, BBA-BIOMEMBRANES, V1808, P1737, DOI 10.1016/j.bbamem.2011.02.003; Ottmann C, 2009, P NATL ACAD SCI USA, V106, P17223, DOI 10.1073/pnas.0907587106; Padovan L, 2010, CURR PROTEIN PEPT SC, V11, P210, DOI 10.2174/138920310791112093; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Plattner S, 2014, PROTEIN EXPRES PURIF, V101, P76, DOI 10.1016/j.pep.2014.05.014; PONZ F, 1983, EMBO J, V2, P1035, DOI 10.1002/j.1460-2075.1983.tb01542.x; PONZ F, 1986, EUR J BIOCHEM, V156, P131, DOI 10.1111/j.1432-1033.1986.tb09557.x; Rautengarten C, 2005, PLOS COMPUT BIOL, V1, P297, DOI 10.1371/journal.pcbi.0010040; Rautengarten C, 2008, PLANT J, V54, P466, DOI 10.1111/j.1365-313X.2008.03437.x; Rawlings ND, 2006, NUCLEIC ACIDS RES, V34, pD270, DOI 10.1093/nar/gkj089; REIMANNPHILIPP U, 1989, EUR J BIOCHEM, V182, P283, DOI 10.1111/j.1432-1033.1989.tb14828.x; REIMANNPHILIPP U, 1989, J BIOL CHEM, V264, P8978; Romero A, 1997, EUR J BIOCHEM, V243, P202, DOI 10.1111/j.1432-1033.1997.0202a.x; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHRADER G, 1991, EUR J BIOCHEM, V198, P549, DOI 10.1111/j.1432-1033.1991.tb16049.x; Siezen RJ, 1997, PROTEIN SCI, V6, P501; SMITH EL, 1966, J BIOL CHEM, V241, P5974; Srivastava R, 2008, PLANT J, V56, P219, DOI 10.1111/j.1365-313X.2008.03598.x; Srivastava R, 2009, PLANT J, V59, P930, DOI 10.1111/j.1365-313X.2009.03926.x; Stec B, 2006, CELL MOL LIFE SCI, V63, P1370, DOI 10.1007/s00018-005-5574-5; Stec B, 2004, J PEPT RES, V64, P210, DOI 10.1111/j.1399-3011.2004.00187.x; Tan-Wilson A, 2012, PLANT PHYSIOL BIOCH, V53, P27, DOI 10.1016/j.plaphy.2012.01.005; Terp N, 2000, J PLANT PHYSIOL, V156, P468, DOI 10.1016/S0176-1617(00)80161-3; Tripathi LP, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-200; van den Berg S, 2006, J BIOTECHNOL, V121, P291, DOI 10.1016/j.jbiotec.2005.08.006; Wolf S, 2009, PLANT J, V58, P361, DOI 10.1111/j.1365-313X.2009.03784.x; Yonezawa H, 2000, BIOSCI BIOTECH BIOCH, V64, P2104, DOI 10.1271/bbb.64.2104	52	18	18	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					18056	18067		10.1074/jbc.M115.647859	http://dx.doi.org/10.1074/jbc.M115.647859			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26013828	hybrid, Green Published			2022-12-26	WOS:000358511700037
J	Lim, MS; Chang, MY; Kim, SM; Yi, SH; Suh-Kim, H; Jung, SJ; Kim, MJ; Kim, JH; Lee, YS; Lee, SY; Kim, DW; Lee, SH; Park, CH				Lim, Mi-Sun; Chang, Mi-Yoon; Kim, Sang-Mi; Yi, Sang-Hoon; Suh-Kim, Haeyoung; Jung, Sung Jun; Kim, Min Jung; Kim, Jin Hyuk; Lee, Yong-Sung; Lee, Soo Young; Kim, Dong-Wook; Lee, Sang-Hun; Park, Chang-Hwan			Generation of Dopamine Neurons from Rodent Fibroblasts through the Expandable Neural Precursor Cell Stage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; IN-VITRO; MOUSE FIBROBLASTS; DIRECT CONVERSION; MICROGLIAL ACTIVATION; GENE-EXPRESSION; DEFINED FACTORS; SOMATIC-CELLS; DIFFERENTIATION; ISCHEMIA	Recent groundbreaking work has demonstrated that combined expression of the transcription factors Brn2, Ascl1, and Myt1L (BAM; also known as Wernig factors) convert mouse fibroblasts into postmitotic neuronal cells. However, questions remain regarding whether trans-conversion is achieved directly or involves an intermediary precursor stage. Trans-conversion toward expandable neural precursor cells (NPCs) is more useful than direct one-step neuron formation with respect to yielding a sufficient number of cells and the feasibility of manipulating NPC differentiation toward certain neuron subtypes. Here, we show that co-expression of Wernig factors and Bcl-xL induces fibroblast conversion into NPCs (induced NPCs (iNPCs)) that are highly expandable for > 100 passages. Gene expression analyses showed that the iNPCs exhibited high expression of common NPC genes but not genes specific to defined embryonic brain regions. This finding indicated that a regional identity of iNPCs was not established. Upon induction, iNPCs predominantly differentiated into astrocytes. However, the differentiation potential was not fixed and could be efficiently manipulated into general or specific subtypes of neurons by expression of additional genes. Specifically, overexpression of Nurr1 and Foxa2, transcription factors specific for midbrain dopamine neuron development, drove iNPCs to yield mature midbrain dopamine neurons equipped with presynaptic DA neuronal functions. We further assessed the therapeutic potential of iNPCs in Parkinson disease model rats.	[Lim, Mi-Sun; Kim, Jin Hyuk; Lee, Yong-Sung; Park, Chang-Hwan] Hanyang Univ, Coll Med, Grad Sch Biomed Sci & Engn, Seoul 133791, South Korea; [Lim, Mi-Sun; Chang, Mi-Yoon; Yi, Sang-Hoon; Jung, Sung Jun; Kim, Min Jung; Kim, Jin Hyuk; Lee, Yong-Sung; Lee, Sang-Hun; Park, Chang-Hwan] Hanyang Univ, Coll Med, Hanyang Biomed Res Inst, Seoul 133791, South Korea; [Kim, Sang-Mi] Hanyang Univ, Coll Med, Grad Sch, Dept Biomed Sci, Seoul 133791, South Korea; [Lim, Mi-Sun; Lee, Soo Young; Park, Chang-Hwan] Hanyang Univ, Coll Med, Dept Microbiol, Seoul 133791, South Korea; [Jung, Sung Jun; Kim, Min Jung; Kim, Jin Hyuk] Hanyang Univ, Coll Med, Dept Physiol, Seoul 133791, South Korea; [Chang, Mi-Yoon; Yi, Sang-Hoon; Lee, Yong-Sung; Lee, Sang-Hun] Hanyang Univ, Coll Med, Dept Biochem & Mol Biol, Seoul 133791, South Korea; [Suh-Kim, Haeyoung] Ajou Univ, Coll Med, Dept Anat, Suwon 443749, South Korea; [Suh-Kim, Haeyoung] Ajou Univ, Coll Med, Brain Dis Res Ctr, Suwon 443749, South Korea; [Kim, Dong-Wook] Yonsei Univ, Coll Med, Dept Physiol, Seoul 120752, South Korea; [Kim, Dong-Wook] Yonsei Univ, Coll Med, Cell Therapy Ctr, Seoul 120752, South Korea	Hanyang University; Hanyang University; Hanyang University; Hanyang University; Hanyang University; Hanyang University; Ajou University; Ajou University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Lee, SH (corresponding author), Hanyang Univ, Coll Med, Dept Biochem & Mol Biol, 222 Wang Simni Ro, Seoul 133791, South Korea.	leesh@hanyang.ac.kr; chshpark@hanyang.ac.kr	lee, sang hun/Q-4650-2019	lee, sang hun/0000-0002-9005-5966; Dong-Wook, Kim/0000-0002-5025-1532; Suh-Kim, Haeyoung/0000-0001-8175-1209	Medical Research Center [2008-0062190]; Basic Science Research Program [2011-0008952]; Medical Technology Development Program [2010-0020232, 2012 M3A9C7050126]; Korea National Research Council of Science and Technology Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning [NAP-09-04]	Medical Research Center; Basic Science Research Program; Medical Technology Development Program; Korea National Research Council of Science and Technology Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning	This work was supported by Medical Research Center Grant 2008-0062190; Basic Science Research Program Grant 2011-0008952; Bio & Medical Technology Development Program Grants 2010-0020232 and 2012 M3A9C7050126; and Korea National Research Council of Science and Technology Program Grant NAP-09-04 through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT, and Future Planning.	Akamatsu W, 2009, J NEUROSCI, V29, P2113, DOI 10.1523/JNEUROSCI.4527-08.2009; Campbell KHS, 1996, NATURE, V380, P64, DOI 10.1038/380064a0; Chang MY, 2007, MOL CELL BIOL, V27, P4293, DOI 10.1128/MCB.00031-07; Chang MY, 2014, STEM CELL REP, V3, P353, DOI 10.1016/j.stemcr.2014.06.013; Cowan CA, 2005, SCIENCE, V309, P1369, DOI 10.1126/science.1116447; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; GURDON JB, 1958, NATURE, V182, P64, DOI 10.1038/182064a0; Hamaguchi I, 2000, J VIROL, V74, P10778, DOI 10.1128/JVI.74.22.10778-10784.2000; Han DW, 2012, CELL STEM CELL, V10, P465, DOI 10.1016/j.stem.2012.02.021; He XB, 2011, STEM CELLS, V29, P1861, DOI 10.1002/stem.739; Jantzie LL, 2005, J CEREBR BLOOD F MET, V25, P314, DOI 10.1038/sj.jcbfm.9600025; Kim J, 2011, P NATL ACAD SCI USA, V108, P7838, DOI 10.1073/pnas.1103113108; Kim J, 2011, CELL STEM CELL, V9, P413, DOI 10.1016/j.stem.2011.09.011; Kim SM, 2014, NAT PROTOC, V9, P871, DOI 10.1038/nprot.2014.056; Laker C, 1998, J VIROL, V72, P339, DOI 10.1128/JVI.72.1.339-348.1998; Lee HS, 2010, STEM CELLS, V28, P501, DOI 10.1002/stem.294; Liu XJ, 2012, CELL RES, V22, P321, DOI 10.1038/cr.2011.181; Lujan E, 2012, CURR OPIN GENET DEV, V22, P517, DOI 10.1016/j.gde.2012.07.002; Lujan E, 2012, P NATL ACAD SCI USA, V109, P2527, DOI 10.1073/pnas.1121003109; Matsui T, 2012, STEM CELLS, V30, P1109, DOI 10.1002/stem.1091; Maucksch C, 2013, STEM CELL TRANSL MED, V2, P579, DOI 10.5966/sctm.2012-0179; MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471; Park CH, 2008, FEBS LETT, V582, P537, DOI 10.1016/j.febslet.2008.01.018; Park CH, 2006, FASEB J, V20, P2553, DOI 10.1096/fj.06-6159fje; Rhee YH, 2011, J CLIN INVEST, V121, P2326, DOI 10.1172/JCI45794; Ring KL, 2012, CELL STEM CELL, V11, P100, DOI 10.1016/j.stem.2012.05.018; Shim JW, 2004, J NEUROSCI, V24, P843, DOI 10.1523/JNEUROSCI.3977-03.2004; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thier M, 2012, CELL STEM CELL, V10, P473, DOI 10.1016/j.stem.2012.03.003; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Vroemen M, 2005, EXP NEUROL, V195, P127, DOI 10.1016/j.expneurol.2005.04.012; Yrjanheikki J, 1998, P NATL ACAD SCI USA, V95, P15769, DOI 10.1073/pnas.95.26.15769	35	25	28	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17401	17414		10.1074/jbc.M114.629808	http://dx.doi.org/10.1074/jbc.M114.629808			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	26023233	Green Published, hybrid			2022-12-26	WOS:000357730900034
J	Hamashima, C; Shabana, M; Okamoto, M; Osaki, Y; Kishimoto, T				Hamashima, Chisato; Shabana, Michiko; Okamoto, Mikizo; Osaki, Yoneatsu; Kishimoto, Takuji			Survival Analysis of Patients with Interval Cancer Undergoing Gastric Cancer Screening by Endoscopy	PLOS ONE			English	Article							BREAST-CANCER; REGISTRATION SYSTEM; PROGRAM; JAPAN; SWEDEN; COHORT; KOREA; WOMEN	Aims Interval cancer is a key factor that influences the effectiveness of a cancer screening program. To evaluate the impact of interval cancer on the effectiveness of endoscopic screening, the survival rates of patients with interval cancer were analyzed. Methods We performed gastric cancer-specific and all-causes survival analyses of patients with screen-detected cancer and patients with interval cancer in the endoscopic screening group and radiographic screening group using the Kaplan-Meier method. Since the screening interval was 1 year, interval cancer was defined as gastric cancer detected within 1 year after a negative result. A Cox proportional hazards model was used to investigate the risk factors associated with gastric cancer-specific and all-causes death. Results A total of 1,493 gastric cancer patients (endoscopic screening group: n = 347; radiographic screening group: n = 166; outpatient group: n = 980) were identified from the Tottori Cancer Registry from 2001 to 2008. The gastric cancer-specific survival rates were higher in the endoscopic screening group than in the radiographic screening group and the outpatients group. In the endoscopic screening group, the gastric cancer-specific survival rate of the patients with screen-detected cancer and the patients with interval cancer were nearly equal (P = 0.869). In the radiographic screening group, the gastric cancer-specific survival rate of the patients with screen-detected cancer was higher than that of the patients with interval cancer (P = 0.009). For gastric cancer-specific death, the hazard ratio of interval cancer in the endoscopic screening group was 0.216 for gastric cancer death (95% CI: 0.054-0.868) compared with the outpatient group. Conclusion The survival rate and the risk of gastric cancer death among the patients with screen-detected cancer and patients with interval cancer were not significantly different in the annual endoscopic screening. These results suggest the potential of endoscopic screening in reducing mortality from gastric cancer.	[Hamashima, Chisato] Natl Canc Ctr, Canc Screening Assessment & Management Div, Res Ctr Canc Prevent & Screening, Tokyo 104, Japan; [Shabana, Michiko] San In Rosai Hosp, Dept Internal Med, Yonago, Tottori, Japan; [Okamoto, Mikizo; Osaki, Yoneatsu; Kishimoto, Takuji] Tottori Univ, Fac Med, Dept Social Med, Div Environm & Prevent Med, Yonago, Tottori 683, Japan	National Cancer Center - Japan; Tottori University	Hamashima, C (corresponding author), Natl Canc Ctr, Canc Screening Assessment & Management Div, Res Ctr Canc Prevent & Screening, Tokyo 104, Japan.	chamashi@ncc.go.jp	Hamashima, Chisato/AAI-3061-2021		Japanese Ministry of Health, Labour and Welfare	Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan)	This study was supported by a Grant-in-Aid for H25-Third Term Comprehensive Control Research for Cancer 022 from the Japanese Ministry of Health, Labour and Welfare.	Bordas P, 2007, BREAST, V16, P47, DOI 10.1016/j.breast.2006.05.006; BREKELMANS CT, 1995, EUR J CANCER, V31A, P1830, DOI 10.1016/0959-8049(95)00324-C; Cho BY, 2014, EVALUATION VALIDITY; Choi KS, 2015, BRIT J CANCER, V112, P608, DOI 10.1038/bjc.2014.608; Choi KS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050041; Hamashima C, 2008, JPN J CLIN ONCOL, V38, P259, DOI 10.1093/jjco/hyn017; Hamashima C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079088; Hamashima C, 2013, INT J CANCER, V133, P653, DOI 10.1002/ijc.28065; International Agency for Research on Cancer, 2012, GLOBOCAN 2012 EST CA; Japanese Gastric Cancer Association, 2010, JAP CLASS GASTR CARC; Kalager M, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7536; Kim Y, 2011, ASIAN PAC J CANCER P, V12, P725; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Matsuda T, 2015, INT J CLIN ONCOL, V20, P11, DOI 10.1007/s10147-014-0765-4; Matsumoto S, 2013, AUST J RURAL HEALTH, V21, P319, DOI 10.1111/ajr.12064; Ministry of Health Labour and Welfare, 2012, MED I SURV 2011; Ministry of Health Welfare and Labour., 2007, JAP ETH GUID EP STUD; Nishida M, 2009, J YOUNAGO MED ASS, V60, P184; Okamoto N, 2008, INT J CLIN ONCOL, V13, P90, DOI 10.1007/s10147-008-0759-1; Perry N, 2006, EUROPEAN GUIDELINES, V4th, P35; Porter PL, 1999, J NATL CANCER I, V91, P2020, DOI 10.1093/jnci/91.23.2020; Research Group for Survival statistics of Japanese association of Clinical Cancer Centers, 2012, SURV AN CANC PAT K M; Shabana M., 2010, JPN J CANC DIAGN, V17, P229; Sobue T, 2012, MONITORING CANC INCI, P140; Sobue T, 2008, INT J CLIN ONCOL, V13, P97, DOI 10.1007/s10147-008-0761-7; Tashiro A, 2006, WORLD J GASTROENTERO, V12, P4873; Zackrisson S, 2007, J MED SCREEN, V14, P138, DOI 10.1258/096914107782066239	27	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0126796	10.1371/journal.pone.0126796	http://dx.doi.org/10.1371/journal.pone.0126796			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26023768	Green Published, gold, Green Submitted			2022-12-26	WOS:000355319400022
J	Hench, J; Henriksson, J; Abou-Zied, AM; Luppert, M; Dethlefsen, J; Mukherjee, K; Tong, YG; Tang, L; Gangishetti, U; Baillie, DL; Burglin, TR				Hench, Jurgen; Henriksson, Johan; Abou-Zied, Akram M.; Luppert, Martin; Dethlefsen, Johan; Mukherjee, Krishanu; Tong, Yong Guang; Tang, Lois; Gangishetti, Umesh; Baillie, David L.; Burglin, Thomas R.			The Homeobox Genes of Caenorhabditis elegans and Insights into Their Spatio-Temporal Expression Dynamics during Embryogenesis	PLOS ONE			English	Article							EMBRYONIC-CELL LINEAGE; C-ELEGANS; HOMEODOMAIN PROTEIN; PROSPERO GENE; INTRAFLAGELLAR TRANSPORT; TRANSCRIPTION FACTORS; PHARYNGEAL MUSCLE; SENSORY NEURON; HOX; DROSOPHILA	Homeobox genes play crucial roles for the development of multicellular eukaryotes. We have generated a revised list of all homeobox genes for Caenorhabditis elegans and provide a nomenclature for the previously unnamed ones. We show that, out of 103 homeobox genes, 70 are co-orthologous to human homeobox genes. 14 are highly divergent, lacking an obvious ortholog even in other Caenorhabditis species. One of these homeobox genes encodes 12 homeodomains, while three other highly divergent homeobox genes encode a novel type of double homeodomain, termed HOCHOB. To understand how transcription factors regulate cell fate during development, precise spatio-temporal expression data need to be obtained. Using a new imaging framework that we developed, Endrov, we have generated spatio-temporal expression profiles during embryogenesis of over 60 homeobox genes, as well as a number of other developmental control genes using GFP reporters. We used dynamic feedback during recording to automatically adjust the camera exposure time in order to increase the dynamic range beyond the limitations of the camera. We have applied the new framework to examine homeobox gene expression patterns and provide an analysis of these patterns. The methods we developed to analyze and quantify expression data are not only suitable for C. elegans, but can be applied to other model systems or even to tissue culture systems.	[Hench, Jurgen; Henriksson, Johan; Abou-Zied, Akram M.; Luppert, Martin; Dethlefsen, Johan; Mukherjee, Krishanu; Tong, Yong Guang; Tang, Lois; Gangishetti, Umesh; Burglin, Thomas R.] Karolinska Inst, Dept Biosci & Nutr, SE-14183 Novum, Sweden; [Hench, Jurgen; Henriksson, Johan; Abou-Zied, Akram M.; Luppert, Martin; Dethlefsen, Johan; Mukherjee, Krishanu; Tong, Yong Guang; Tang, Lois; Gangishetti, Umesh; Burglin, Thomas R.] Karolinska Inst, Ctr Biosci, SE-14183 Novum, Sweden; [Hench, Jurgen; Henriksson, Johan; Abou-Zied, Akram M.; Luppert, Martin; Dethlefsen, Johan; Mukherjee, Krishanu; Tong, Yong Guang; Tang, Lois; Gangishetti, Umesh; Burglin, Thomas R.] Sodertoms Hogskola, Sch Life Sci, Huddinge, Sweden; [Baillie, David L.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada	Karolinska Institutet; Karolinska Institutet; Sodertorn University; Simon Fraser University	Burglin, TR (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.	thomas.buerglin@unibas.ch	Henriksson, Johan/ABD-2430-2021	Henriksson, Johan/0000-0002-7745-2844	Swedish Research Council [621-2010-5634]; Swedish Foundation for Strategic Research; Natural Sciences and Engineering Research, Council of Canada; Wenner-Gren Stiftelserna	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Natural Sciences and Engineering Research, Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Wenner-Gren Stiftelserna	Swedish Research Council, 621-2010-5634, www.vr.se, TRB; Swedish Foundation for Strategic Research, www.stratresearch.se, TRB; Natural Sciences and Engineering Research, Council of Canada, www.nserc-crsng.gc.ca, DLB; Wenner-Gren Stiftelserna, www.swgc.org, LT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdus-Saboor I, 2011, DEVELOPMENT, V138, P3545, DOI 10.1242/dev.068148; Aspock G, 2003, DEVELOPMENT, V130, P3369, DOI 10.1242/dev.00551; Aspock G, 2001, DEV DYNAM, V222, P403, DOI 10.1002/dvdy.1201; Bao ZR, 2006, P NATL ACAD SCI USA, V103, P2707, DOI 10.1073/pnas.0511111103; Barnett AG, 2005, INT J EPIDEMIOL, V34, P215, DOI 10.1093/ije/dyh299; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Baugh LR, 2003, DEVELOPMENT, V130, P889, DOI 10.1242/dev.00302; BLUM M, 1992, CELL, V69, P1097, DOI 10.1016/0092-8674(92)90632-M; Boyl PP, 2001, INT J DEV NEUROSCI, V19, P353, DOI 10.1016/S0736-5748(01)00003-X; Boyle TJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-275; Bratic I, 2009, NUCLEIC ACIDS RES, V37, P1817, DOI 10.1093/nar/gkp018; Brunschwig K, 1999, DEVELOPMENT, V126, P1537; Burglin TR, 2011, SUBCELL BIOCHEM, V52, P95, DOI 10.1007/978-90-481-9069-0_5; Burglin TR, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-127; Burglin Thomas R., 1994, P25; Burglin TR, 2000, J MICROSC-OXFORD, V200, P75, DOI 10.1046/j.1365-2818.2000.00741.x; Burglin TR, 2002, INT J DEV BIOL, V46, P115; Burglin TR, 2001, DEVELOPMENT, V128, P779; Burglin TR, 1997, NUCLEIC ACIDS RES, V25, P4173, DOI 10.1093/nar/25.21.4173; BURGLIN TR, 1989, NATURE, V341, P239, DOI 10.1038/341239a0; BURGLIN TR, 2005, ENCY MOL CELL BIOL M, P179; Cassata G, 1998, GENE, V212, P127, DOI 10.1016/S0378-1119(98)00137-1; Cassata G, 2000, NEURON, V25, P587, DOI 10.1016/S0896-6273(00)81062-4; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chin-Sang ID, 2002, DEVELOPMENT, V129, P5499, DOI 10.1242/dev.00122; Chow RL, 2001, MECH DEVELOP, V109, P315, DOI 10.1016/S0925-4773(01)00585-8; Chowdhuri SR, 2006, DEV BIOL, V295, P664, DOI 10.1016/j.ydbio.2006.04.001; CHULAGRAFF Q, 1991, DEVELOPMENT, P79; Clouaire T, 2005, P NATL ACAD SCI USA, V102, P6907, DOI 10.1073/pnas.0406882102; De Robertis EM, 2001, INT J DEV BIOL, V45, P189; DOE CQ, 1991, CELL, V65, P451, DOI 10.1016/0092-8674(91)90463-9; Dozier C, 2001, DEV BIOL, V236, P289, DOI 10.1006/dbio.2001.0325; Duboule D, 2007, DEVELOPMENT, V134, P2549, DOI 10.1242/dev.001065; Evans T. C., 2006, WORMBOOK, DOI [10.1895/wormbook.1.108.1, DOI 10.1895/WORMBOOK.1.108.1, 10.1895/ wormbook.1.108.1]; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Goriely A, 1996, DEVELOPMENT, V122, P1641; Hamahashi S, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-125; Hejnol A, 2006, INTEGR COMP BIOL, V46, P151, DOI 10.1093/icb/icj012; Hench J, 2009, DEV BIOL, V333, P1, DOI 10.1016/j.ydbio.2009.06.014; Henriksson J, 2013, NAT METHODS, V10, P454, DOI 10.1038/nmeth.2478; Hobert O, 1999, TRENDS GENET, V15, P214, DOI 10.1016/S0168-9525(99)01731-X; Holland PWH, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-47; Hunt-Newbury R, 2007, PLOS BIOL, V5, P1981, DOI 10.1371/journal.pbio.0050237; Hunter CP, 1996, CELL, V87, P217, DOI 10.1016/S0092-8674(00)81340-9; Inoue T, 2002, MECH DEVELOP, V119, pS203, DOI 10.1016/S0925-4773(03)00117-5; Kagoshima H, 1999, DEV GENES EVOL, V209, P59, DOI 10.1007/s004270050227; Kagoshima H, 2013, DEV BIOL, V380, P314, DOI 10.1016/j.ydbio.2013.04.009; Kolotuev I, 2013, NAT CELL BIOL, V15, P157, DOI 10.1038/ncb2662; Lanjuin A, 2003, DEV CELL, V5, P621, DOI 10.1016/S1534-5807(03)00293-4; Leidenroth A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-364; Lemaire L, 1997, DEVELOPMENT, V124, P1443; Liu J, 2000, DEVELOPMENT, V127, P5179; LUNDELL MJ, 1992, DEV BIOL, V154, P84, DOI 10.1016/0012-1606(92)90050-Q; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Mann RS, 2009, CURR TOP DEV BIOL, V88, P63, DOI 10.1016/S0070-2153(09)88003-4; Mann RS, 1998, CURR OPIN GENET DEV, V8, P423, DOI 10.1016/S0959-437X(98)80113-5; MATSUZAKI F, 1992, BIOCHEM BIOPH RES CO, V182, P1326, DOI 10.1016/0006-291X(92)91878-T; McKay SJ, 2003, COLD SPRING HARB SYM, V68, P159, DOI 10.1101/sqb.2003.68.159; Mello C, 1995, METHOD CELL BIOL, V48, P451; Minguillon C, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r12; Mohler WA, 1998, BIOTECHNIQUES, V24, P1006; Mukherjee K, 2007, J MOL EVOL, V65, P137, DOI 10.1007/s00239-006-0023-0; Mukherjee K, 2009, MOL BIOL EVOL, V26, P2775, DOI 10.1093/molbev/msp201; Murray JI, 2006, NAT PROTOC, V1, P1468, DOI 10.1038/nprot.2006.222; Murray JI, 2012, GENOME RES, V22, P1282, DOI 10.1101/gr.131920.111; Nakano S, 2010, DEVELOPMENT, V137, P4017, DOI 10.1242/dev.058834; Nance J, 2003, DEVELOPMENT, V130, P5339, DOI 10.1242/dev.00735; OKKEMA PG, 1994, DEVELOPMENT, V120, P2175; Peden E, 2007, GENE DEV, V21, P3195, DOI 10.1101/gad.1607807; Perez-Bercoff A, 2006, BIOINFORMATICS, V22, P112, DOI 10.1093/bioinformatics/bti761; Perez-Bercoff A, 2010, SEQUENCE GENOME ANAL, VII; Perriere G, 1996, BIOCHIMIE, V78, P364, DOI 10.1016/0300-9084(96)84768-7; Phirke P, 2011, DEV BIOL, V357, P235, DOI 10.1016/j.ydbio.2011.06.028; Qin HT, 2004, DEV BIOL, V270, P64, DOI 10.1016/j.ydbio.2004.02.004; Reece-Hoyes JS, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-r110; Reece-Hoyes JS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2168-8-27; Riddle D, 1997, C ELEGANS; Rohrig S, 2000, EMBO J, V19, P3694, DOI 10.1093/emboj/19.14.3694; Ruvkun G, 1998, SCIENCE, V282, P2033, DOI 10.1126/science.282.5396.2033; Satterlee JS, 2001, NEURON, V31, P943, DOI 10.1016/S0896-6273(01)00431-7; Schafer JC, 2003, MOL BIOL CELL, V14, P2057, DOI 10.1091/mbc.E02-10-0677; Schnabel R, 1997, DEV BIOL, V184, P234, DOI 10.1006/dbio.1997.8509; Schulze J, 2011, EVODEVO, V2, DOI 10.1186/2041-9139-2-18; Simeone A, 2001, INT J DEV BIOL, V45, P337; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045; Streit A, 2002, DEV BIOL, V242, P96, DOI 10.1006/dbio.2001.0544; Strome S, 2001, MOL BIOL CELL, V12, P1751, DOI 10.1091/mbc.12.6.1751; Struckhoff EC, 2003, DEVELOPMENT, V130, P693, DOI 10.1242/dev.00300; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; SVENDSEN PC, 1995, DEVELOPMENT, V121, P1253; Tenenhaus C, 1998, DEV BIOL, V200, P212, DOI 10.1006/dbio.1998.8940; Thomas C, 1996, SCIENCE, V273, P603, DOI 10.1126/science.273.5275.603; Thomas CF, 1998, TRENDS BIOTECHNOL, V16, P175, DOI 10.1016/S0167-7799(97)01169-4; Underhill DA, 2012, CRIT REV EUKAR GENE, V22, P161, DOI 10.1615/CritRevEukarGeneExpr.v22.i2.70; VAESSIN H, 1991, CELL, V67, P941, DOI 10.1016/0092-8674(91)90367-8; Van Auken K, 2002, DEVELOPMENT, V129, P5255; Wittmann C, 1997, DEVELOPMENT, V124, P4193; Yanai I, 2009, GENOME RES, V19, P2214, DOI 10.1101/gr.093815.109; Yanowitz JL, 2004, DEV BIOL, V272, P389, DOI 10.1016/j.ydbio.2004.05.010; Yu H, 2003, DEVELOPMENT, V130, P5217, DOI 10.1242/dev.00678; Zhang SF, 2004, CELL, V119, P137, DOI 10.1016/j.cell.2004.09.012; Zhao ZY, 2008, DEV BIOL, V314, P93, DOI 10.1016/j.ydbio.2007.11.015	104	18	19	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0126947	10.1371/journal.pone.0126947	http://dx.doi.org/10.1371/journal.pone.0126947			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024448	Green Published, gold, Green Submitted			2022-12-26	WOS:000355319400026
J	Porter, AG; Scanes, PR				Porter, Augustine G.; Scanes, Peter R.			Scavenging Rate Ecoassay: A Potential Indicator of Estuary Condition	PLOS ONE			English	Article							CONSUMPTION	Monitoring of estuary condition is essential due to the highly productive and often intensely impacted nature of these ecosystems. Assessment of the physico-chemical condition of estuaries is expensive and difficult due to naturally fluctuating water quality and biota. Assessing the vigour of ecosystem processes is an alternative method with potential to overcome much of the variability associated with physico-chemical measures. Indicators of estuary condition should have small spatial and temporal variability, have a predictable response to perturbation and be ecologically relevant. Here, we present tests of the first criterion, the spatio-temporal variability of a potential ecoassay measuring the rate of scavenging in estuaries. We hypothesised that the proposed scavenging ecoassay would not vary significantly among A) sites in an estuary, B) trips separated by weeks, or C) days in a trip. Because not all habitats are present in all estuaries, this test was undertaken in two habitats. When conducted over bare substrate there were occasional significant differences, but no discernible patterns, within levels of the experiment. When conducted over vegetated substrate, days within a trip did not vary significantly, but later trips experienced greater scavenging. This scavenging ecoassay shows potential as a tool for assessing the condition of estuarine ecosystems, and further exploration of this protocol is warranted by implementation in estuaries across a gradient of anthropogenic stress.	[Porter, Augustine G.] Univ Sydney, Coastal & Marine Ecosyst Grp, Sydney, NSW 2006, Australia; [Porter, Augustine G.; Scanes, Peter R.] Off Environm & Heritage, Estuary & Catchment Sci, Sydney, NSW, Australia	University of Sydney; Office of Environment & Heritage - New South Wales	Porter, AG (corresponding author), Univ Sydney, Coastal & Marine Ecosyst Grp, Sydney, NSW 2006, Australia.	augustine.porter@sydney.edu.au		Scanes, Peter/0000-0002-6722-168X	NSW Office of Environment and Heritage	NSW Office of Environment and Heritage	This work was funded by NSW Office of Environment and Heritage. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Basset A, 2013, ESTUAR COAST SHELF S, V132, P5, DOI 10.1016/j.ecss.2012.04.012; Biro PA, 2009, HYDROBIOLOGIA, V635, P395, DOI 10.1007/s10750-009-9902-x; BRITTON JC, 1994, OCEANOGR MAR BIOL, V32, P369; Byrnes JE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000295; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; CROY MI, 1991, ANIM BEHAV, V41, P161, DOI 10.1016/S0003-3472(05)80511-1; Dafforn KA, 2012, ENVIRON POLLUT, V163, P207, DOI 10.1016/j.envpol.2011.12.029; De Robertis A, 2003, CAN J FISH AQUAT SCI, V60, P1517, DOI 10.1139/F03-123; Deeley D.M., 1999, ASSESSING ECOLOGICAL; DeVault TL, 2003, OIKOS, V102, P225, DOI 10.1034/j.1600-0706.2003.12378.x; Elliott M, 2007, MAR POLLUT BULL, V54, P640, DOI 10.1016/j.marpolbul.2007.02.003; Fairweather PG, 1999, AUST J ECOL, V24, P441, DOI 10.1046/j.1442-9993.1999.00976.x; Fausch Kurt D., 1990, P123; Gladstone W, 2012, J EXP MAR BIOL ECOL, V429, P28, DOI 10.1016/j.jembe.2012.06.013; Huijbers CM, 2015, DIVERS DISTRIB, V21, P55, DOI 10.1111/ddi.12282; Huijbers CM, 2013, LANDSCAPE URBAN PLAN, V119, P1, DOI 10.1016/j.landurbplan.2013.06.004; Lindenmayer D, 2008, ECOL LETT, V11, P78, DOI 10.1111/j.1461-0248.2007.01114.x; Mayer-Pinto M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047871; McCann K, 1998, NATURE, V395, P794, DOI 10.1038/27427; NIXON S W, 1986, Journal of the Limnological Society of Southern Africa, V12, P43; OEH N., 2013, ASS EST EC HLTH SAMP; Paxton JR, 1989, ZOOLOGICAL CATALOGUE, V7; Perez-Dominguez R, 2012, ECOL INDIC, V23, P34, DOI 10.1016/j.ecolind.2012.03.006; Putman R.J., 1983, CARRION DUNG DECOMPO; Ramsay K, 1997, J ANIM ECOL, V66, P884, DOI 10.2307/6004; Rapport DJ, 1998, TRENDS ECOL EVOL, V13, P397, DOI 10.1016/S0169-5347(98)01449-9; Roy PS, 2001, ESTUAR COAST SHELF S, V53, P351, DOI 10.1006/ecss.2001.0796; Scanes P., 2010, ECOLOGICAL CONDITION; Scanes P, 2007, ESTUAR COAST SHELF S, V74, P306, DOI 10.1016/j.ecss.2007.04.021; Sheaves M, 2007, ASSESSMENT TECHNIQUE; Sheaves M, 2013, ESTUAR COAST, V36, P893, DOI 10.1007/s12237-013-9610-7; Sokal R.R., 2012, BIOMETRY; Underwood, 1996, EXPT ECOLOGY THEIR L; Underwood A.J., 2002, GMAV 5 WINDOWS ANAL; VonTorne E, 1990, ASSESSING FEEDING AC, VI; Ward T., 1998, ESTUARIES SEA; Ward TJ, 2000, MAR FRESHWATER RES, V51, P435, DOI 10.1071/MF99052; Webley JA, 2008, ECOLOGY MUD CRAB SCY; Whitfield A, 2008, ECOLOGICAL INDICATOR, P1593, DOI DOI 10.1016/B978; Whitfield AK, 2002, J FISH BIOL, V61, P229, DOI 10.1006/jfbi.2002.2079; Williams R, 2007, NSW COMPREHENSIVE CO, V1005, P64; Wilson EE, 2011, TRENDS ECOL EVOL, V26, P129, DOI 10.1016/j.tree.2010.12.011	43	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0127046	10.1371/journal.pone.0127046	http://dx.doi.org/10.1371/journal.pone.0127046			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024225	gold, Green Submitted, Green Published			2022-12-26	WOS:000355319400030
J	Sovadinova, I; Babica, P; Boke, H; Kumar, E; Wilke, A; Park, JS; Trosko, JE; Upham, BL				Sovadinova, Iva; Babica, Pavel; Boeke, Hatice; Kumar, Esha; Wilke, Andrew; Park, Joon-Suk; Trosko, James E.; Upham, Brad L.			Phosphatidylcholine Specific PLC-Induced Dysregulation of Gap Junctions, a Robust Cellular Response to Environmental Toxicants, and Prevention by Resveratrol in a Rat Liver Cell Model	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; POLYCYCLIC AROMATIC-HYDROCARBONS; INTERCELLULAR COMMUNICATION; CONNEXIN43 PHOSPHORYLATION; PHOSPHOLIPASE-C; GROWTH-FACTOR; MAP-KINASE; STEM-CELLS; EPIGENETIC TOXICITY; ARACHIDONIC-ACID	Dysregulation of gap junctional intercellular communication (GJIC) has been associated with different pathologies, including cancer; however, molecular mechanisms regulating GJIC are not fully understood. Mitogen Activated Protein Kinase (MAPK)-dependent mechanisms of GJIC-dysregulation have been well-established, however recent discoveries have implicated phosphatidylcholine-specific phospholipase C (PC-PLC) in the regulation of GJIC. What is not known is how prevalent these two signaling mechanisms are in toxicant/toxin-induced dysregulation of GJIC, and do toxicants/toxins work through either signaling mechanisms or both, or through alternative signaling mechanisms. Different chemical toxicants were used to assess whether they dysregulate GJIC via MEK or PC-PLC, or both Mek and PC-PLC, or through other signaling pathways, using a pluripotent rat liver epithelial oval-cell line, WB-F344. Epidermal growth factor, 12-O-tetradecanoylphorbol-13-acetate, thrombin receptor activating peptide-6 and lindane regulated GJIC through a MEK1/2-dependent mechanism that was independent of PC-PLC; whereas PAHs, DDT, PCB 153, dicumylperoxide and perfluorodecanoic acid inhibited GJIC through PC-PLC independent of Mek. Dysregulation of GJIC by perfluorooctanoic acid and R59022 required both MEK1/2 and PC-PLC; while benzoylperoxide, arachidonic acid, 18 beta-glycyrrhetinic acid, perfluorooctane sulfonic acid, 1-monolaurin, pentachlorophenol and alachlor required neither MEK1/2 nor PC-PLC. Resveratrol prevented dysregulation of GJIC by toxicants that acted either through MEK1/2 or PC-PLC. Except for alachlor, resveratrol did not prevent dysregulation of GJIC by toxicants that worked through PC-PLC-independent and MEK1/2-independent pathways, which indicated at least two other, yet unidentified, pathways that are involved in the regulation of GJIC. In conclusion: the dysregulation of GJIC is a contributing factor to the cancer process; however the underlying mechanisms by which gap junction channels are closed by toxicants vary. Thus, accurate assessments of risk posed by toxic agents, and the role of dietary phytochemicals play in preventing or reversing the effects of these agents must take into account the specific mechanisms involved in the cancer process.	[Sovadinova, Iva; Babica, Pavel; Boeke, Hatice; Kumar, Esha; Wilke, Andrew; Park, Joon-Suk; Trosko, James E.; Upham, Brad L.] Michigan State Univ, Ctr Integrat Toxicol, Dept Pediat & Human Devel, E Lansing, MI 48824 USA; [Sovadinova, Iva; Babica, Pavel; Boeke, Hatice; Kumar, Esha; Wilke, Andrew; Park, Joon-Suk; Trosko, James E.; Upham, Brad L.] Michigan State Univ, Food Safety & Toxicol Ctr, E Lansing, MI 48824 USA; [Sovadinova, Iva] Masaryk Univ, Res Ctr Tox Cpds Environm RECETOX, CZ-62500 Brno, Czech Republic; [Babica, Pavel] ASCR, Inst Bot, Dept Expt Phycol & Ecotoxicol, CZ-60200 Brno, Czech Republic; [Park, Joon-Suk] Daegu Gyeongbuk Med Innovat Fdn, Lab Anim Ctr, Taegu, South Korea	Michigan State University; Michigan State University; Masaryk University Brno; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences	Upham, BL (corresponding author), Michigan State Univ, Ctr Integrat Toxicol, Dept Pediat & Human Devel, E Lansing, MI 48824 USA.	upham@msu.edu	Babica, Pavel/B-2587-2013; Babica, Pavel/GWC-6437-2022; Sovadinova, Iva/F-6251-2015; Trosko, James/J-5954-2019	Babica, Pavel/0000-0001-6399-3554; Sovadinova, Iva/0000-0003-0627-243X; Upham, Brad/0000-0003-4905-9145	National Institute of Environmental Health Sciences [R01 ES013268-01A2]; Czech Ministry of Youth, Education and Sports [LH12034]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013268] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Czech Ministry of Youth, Education and Sports(Ministry of Education, Youth & Sports - Czech Republic); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work received financial support from National Institute of Environmental Health Sciences (https://www.niehs.nih.gov/) grants #R01 ES013268-01A2 to BLU and this paper's contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIEHS. This work also received support from Czech Ministry of Youth, Education and Sports (http://www.msmt.cz/?lang=2) grant #LH12034 "CHEMOPREV" to PB.	Blaha L, 2002, TOXICOL SCI, V65, P43, DOI 10.1093/toxsci/65.1.43; Cameron SJ, 2003, J BIOL CHEM, V278, P18682, DOI 10.1074/jbc.M213283200; Cheng J, 1997, J BIOL CHEM, V272, P17312, DOI 10.1074/jbc.272.28.17312; Chipman JK, 2003, TOXICOL SCI, V71, P146, DOI 10.1093/toxsci/71.2.146; COLEMAN WB, 1993, AM J PATHOL, V142, P1373; Corcelle E, 2007, AUTOPHAGY, V3, P57, DOI 10.4161/auto.3424; ELFOULY MH, 1987, EXP CELL RES, V168, P422, DOI 10.1016/0014-4827(87)90014-0; Ghoshal S, 1999, ENVIRON SCI TECHNOL, V33, P1044, DOI 10.1021/es9809511; Goldberg GS, 1999, NAT CELL BIOL, V1, P457, DOI 10.1038/15693; Guan XJ, 1996, CARCINOGENESIS, V17, P1791, DOI 10.1093/carcin/17.9.1791; Guan XJ, 1996, MOL CARCINOGEN, V16, P157; Han EH, 2008, TOXICOL APPL PHARM, V233, P333, DOI 10.1016/j.taap.2008.09.003; Hossain MZ, 1999, J CELL PHYSIOL, V179, P87, DOI 10.1002/(SICI)1097-4652(199904)179:1<87::AID-JCP11>3.0.CO;2-K; Kim JH, 2009, MUTAT RES-FUND MOL M, V671, P40, DOI 10.1016/j.mrfmmm.2009.08.011; Laird DW, 2005, BBA-BIOMEMBRANES, V1711, P172, DOI 10.1016/j.bbamem.2004.09.009; Liu X, 2006, ENDOTHELIUM-J ENDOTH, V13, P205, DOI 10.1080/10623320600760423; Luttrell LM, 1997, J BIOL CHEM, V272, P31648, DOI 10.1074/jbc.272.50.31648; Machala M, 2003, TOXICOL SCI, V76, P102, DOI 10.1093/toxsci/kfg209; Malouf NN, 2001, AM J PATHOL, V158, P1929, DOI 10.1016/S0002-9440(10)64661-5; Martinez AD, 1999, BRAIN RES, V816, P411, DOI 10.1016/S0006-8993(98)01016-6; Matowe WC, 1996, PHARMACOLOGY, V53, P376, DOI 10.1159/000139453; Mehta PP, 2007, J MEMBRANE BIOL, V217, P5, DOI 10.1007/s00232-007-9068-2; Mograbi B, 2003, CARCINOGENESIS, V24, P1415, DOI 10.1093/carcin/bgg093; Nielsen M, 2000, BIOCHEM BIOPH RES CO, V275, P804, DOI 10.1006/bbrc.2000.3378; Ogawa T, 2004, J CELL SCI, V117, P2087, DOI 10.1242/jcs.01056; Park DJ, 2007, CELL COMMUN ADHES, V14, P211, DOI 10.1080/15419060701755958; Pervaiz S, 2009, ANTIOXID REDOX SIGN, V11, P2851, DOI [10.1089/ars.2008.2412, 10.1089/ARS.2008.2412]; RAO GN, 1994, J BIOL CHEM, V269, P32586; Rivedal E, 2001, CARCINOGENESIS, V22, P1543, DOI 10.1093/carcin/22.9.1543; Rivedal E, 2005, EXP CELL RES, V302, P143, DOI 10.1016/j.yexcr.2004.09.004; Ruch RJ, 2001, J CELL BIOCHEM, V83, P163, DOI 10.1002/jcb.1227; Rummel AM, 1999, TOXICOL SCI, V49, P232, DOI 10.1093/toxsci/49.2.232; Sai K, 1998, CANCER LETT, V130, P9, DOI 10.1016/S0304-3835(98)00082-2; Sirnes S, 2009, BIOCHEM BIOPH RES CO, V382, P41, DOI 10.1016/j.bbrc.2009.02.141; Solan JL, 2009, BIOCHEM J, V419, P261, DOI 10.1042/BJ20082319; Spadaro F, 2008, CANCER RES, V68, P6541, DOI 10.1158/0008-5472.CAN-07-6763; Trosko JE, 2009, VET PATHOL, V46, P176, DOI 10.1354/vp.46-2-176; Trosko JE, 2005, MUTAGENESIS, V20, P81, DOI 10.1093/mutage/gei017; Trosko JE, 2002, CURR DRUG TARGETS, V3, P465, DOI 10.2174/1389450023347371; TROSKO JE, 2008, STEM CELLS CANC; Trosko JE, 2002, COMPREHENSIVE TOXICO, Vxiv, P409; TROSKO JE, 2002, BIOMARKERS ENV ASS D, P445; TSAO MS, 1984, EXP CELL RES, V154, P38, DOI 10.1016/0014-4827(84)90666-9; Upham BL, 1997, OZONE-SCI ENG, V19, P351, DOI 10.1080/01919519708547298; Upham BL, 1998, INT J CANCER, V78, P491, DOI 10.1002/(SICI)1097-0215(19981109)78:4<491::AID-IJC16>3.0.CO;2-9; Upham BL, 1998, ENVIRON HEALTH PERSP, V106, P975, DOI 10.2307/3434140; Upham BL, 1996, FUND APPL TOXICOL, V34, P260, DOI 10.1006/faat.1996.0195; Upham BL, 2008, CANCER SCI, V99, P696, DOI 10.1111/j.1349-7006.2008.00752.x; Upham BL, 2007, NUTR CANCER, V57, P38, DOI 10.1080/01635580701268188; Upham BL, 2009, ENVIRON HEALTH PERSP, V117, P545, DOI 10.1289/ehp.11728; Upham BL, 2009, ANTIOXID REDOX SIGN, V11, P297, DOI 10.1089/ars.2008.2146; van Zeijl L, 2007, J CELL BIOL, V177, P881, DOI 10.1083/jcb.200610144; Vinken M, 2006, CELL SIGNAL, V18, P592, DOI 10.1016/j.cellsig.2005.08.012; Vinken M, 2009, CRIT REV BIOCHEM MOL, V44, P201, DOI 10.1080/10409230903061215; Wang N, 2008, INT J BIOCHEM CELL B, V40, P294, DOI 10.1016/j.biocel.2007.08.003; Warn-Cramer BJ, 2004, BBA-BIOMEMBRANES, V1662, P81, DOI 10.1016/j.bbamem.2003.10.018; Weis LM, 1998, ENVIRON HEALTH PERSP, V106, P17, DOI 10.1289/ehp.9810617; Yamasaki H, 1999, CANCER DETECT PREV, V23, P273, DOI 10.1046/j.1525-1500.1999.99037.x	58	28	29	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0124454	10.1371/journal.pone.0124454	http://dx.doi.org/10.1371/journal.pone.0124454			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26023933	Green Submitted, gold, Green Published			2022-12-26	WOS:000355319400005
J	Taujale, R; Yin, YB				Taujale, Rahil; Yin, Yanbin			Glycosyltransferase Family 43 Is Also Found in Early Eukaryotes and Has Three Subfamilies in Charophycean Green Algae	PLOS ONE			English	Article							GLUCURONOXYLAN BIOSYNTHESIS; LAND PLANTS; EVOLUTION; REVEALS; GENE; EXPRESSION; SEQUENCE; IRREGULAR-XYLEM9; MECHANISMS; DIVERSITY	The glycosyltransferase family 43 (GT43) has been suggested to be involved in the synthesis of xylans in plant cell walls and proteoglycans in animals. Very recently GT43 family was also found in Charophycean green algae (CGA), the closest relatives of extant land plants. Here we present evidence that non-plant and non-animal early eukaryotes such as fungi, Haptophyceae, Choanoflagellida, Ichthyosporea and Haptophyceae also have GT43-like genes, which are phylogenetically close to animal GT43 genes. By mining RNA sequencing data (RNA-Seq) of selected plants, we showed that CGA have evolved three major groups of GT43 genes, one orthologous to IRX14 (IRREGULAR XYLEM14), one orthologous to IRX9/IRX9L and the third one ancestral to all land plant GT43 genes. We confirmed that land plant GT43 has two major clades A and B, while in angiosperms, clade A further evolved into three subclades and the expression and motif pattern of A3 (containing IRX9) are fairly different from the other two clades likely due to rapid evolution. Our in-depth sequence analysis contributed to our overall understanding of the early evolution of GT43 family and could serve as an example for the study of other plant cell wall-related enzyme families.	[Taujale, Rahil; Yin, Yanbin] No Illinois Univ, Dept Biol Sci, De Kalb, IL 60115 USA	Northern Illinois University	Yin, YB (corresponding author), No Illinois Univ, Dept Biol Sci, De Kalb, IL 60115 USA.	yyin@niu.edu	Yin, Yanbin/AAH-2665-2020; Yin, Yanbin/C-9788-2010	Yin, Yanbin/0000-0001-7667-881X; Yin, Yanbin/0000-0001-7667-881X	Northern Illinois University	Northern Illinois University	This work was supported by the start-up funds and the research & artistry award to YY from Northern Illinois University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders N, 2010, ANN PLANT REV PLANT, V41, P251; Bell CD, 2010, AM J BOT, V97, P1296, DOI 10.3732/ajb.0900346; Brown DM, 2007, PLANT J, V52, P1154, DOI 10.1111/j.1365-313X.2007.03307.x; Brown DM, 2009, PLANT J, V57, P732, DOI 10.1111/j.1365-313X.2008.03729.x; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Fangel JU, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00152; Fondeur-Gelinotte M, 2007, GLYCOBIOLOGY, V17, P857, DOI 10.1093/glycob/cwm055; Fondeur-Gelinotte M, 2006, PROTEIN SCI, V15, P1667, DOI 10.1110/ps.062089106; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Harholt J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035846; Hori K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4978; Jia SG, 2013, ENVIRON MICROBIOL, V15, P3020, DOI 10.1111/1462-2920.12262; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kulkarni AR, 2012, GLYCOBIOLOGY, V22, P439, DOI 10.1093/glycob/cwr117; Lee CH, 2007, PLANT CELL PHYSIOL, V48, P1659, DOI 10.1093/pcp/pcm155; Lee CH, 2007, PLANT CELL PHYSIOL, V48, P1624, DOI 10.1093/pcp/pcm135; Lee C, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.27809; Lee CH, 2011, MOL PLANT, V4, P730, DOI 10.1093/mp/ssr035; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Mikkelsen MD, 2014, ANN BOT-LONDON, V114, P1217, DOI 10.1093/aob/mcu171; Pedersen LC, 2000, J BIOL CHEM, V275, P34580, DOI 10.1074/jbc.M007399200; Pena MJ, 2007, PLANT CELL, V19, P549, DOI 10.1105/tpc.106.049320; Popper ZA, 2008, CURR OPIN PLANT BIOL, V11, P286, DOI 10.1016/j.pbi.2008.02.012; Popper ZA, 2011, ANNU REV PLANT BIOL, V62, P567, DOI 10.1146/annurev-arplant-042110-103809; Popper ZA, 2010, PLANT PHYSIOL, V153, P373, DOI 10.1104/pp.110.158055; Ratke C, 2015, PLANT BIOTECHNOL J, V13, P26, DOI 10.1111/pbi.12232; Ren YF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105014; Rennie EA, 2014, CURR OPIN BIOTECH, V26, P100, DOI 10.1016/j.copbio.2013.11.013; Sato Y, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-10; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Sigrist Christian J A, 2002, Brief Bioinform, V3, P265, DOI 10.1093/bib/3.3.265; Sorensen I, 2011, PLANT J, V68, P201, DOI 10.1111/j.1365-313X.2011.04686.x; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Wodniok S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-104; Wu AM, 2010, PLANT PHYSIOL, V153, P542, DOI 10.1104/pp.110.154971; Wu AM, 2009, PLANT J, V57, P718, DOI 10.1111/j.1365-313X.2008.03724.x; Yang XH, 2008, PLANT PHYSIOL, V148, P1189, DOI 10.1104/pp.108.121921; Yin YB, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-260; Yin YB, 2012, NUCLEIC ACIDS RES, V40, pW445, DOI 10.1093/nar/gks479; Zeng W, 2010, PLANT PHYSIOL, V154, P78, DOI 10.1104/pp.110.159749; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zerbino DR, 2010, CURR PROTOC BIOINFOR, V11, P11; Zhang JY, 2013, PLANT J, V74, P160, DOI 10.1111/tpj.12104	47	9	10	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128409	10.1371/journal.pone.0128409	http://dx.doi.org/10.1371/journal.pone.0128409			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26023931	Green Submitted, Green Published, gold			2022-12-26	WOS:000355319400089
J	Lapadula, G; Chatenoud, L; Gori, A; Castelli, F; Di Giambenedetto, S; Fabbiani, M; Maggiolo, F; Foca, E; Ladisa, N; Sighinolfi, L; Di Pietro, M; Pan, A; Torti, C				Lapadula, Giuseppe; Chatenoud, Liliane; Gori, Andrea; Castelli, Francesco; Di Giambenedetto, Simona; Fabbiani, Massimiliano; Maggiolo, Franco; Foca, Emanuele; Ladisa, Nicoletta; Sighinolfi, Laura; Di Pietro, Massimo; Pan, Angelo; Torti, Carlo		Italian MASTER Cohort	Risk of Severe Non AIDS Events Is Increased among Patients Unable to Increase their CD4+T-Cell Counts >200+/mu l Despite Effective HAART	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HIV-INFECTED PATIENTS; T-CELL RECOVERY; VIROLOGICAL SUPPRESSION; HIV-1-INFECTED PATIENTS; IMMUNOLOGICAL RESPONSE; INCREASED MORTALITY; VIRAL SUPPRESSION; DEFINING EVENTS; NAIVE PATIENTS	Background Immunological non-response (INR) despite virological suppression is associated with AIDS-defining events/death (ADE). Little is known about its association with serious non-AIDS-defining events (nADE). Methods Patients highly-active antiretroviral therapy (HAART) with <200 CD4+/mu l and achieving HIV-RNA <50 copies/ml within 12 (+/- 3) months were categorized as INR if CD4+ T-cell count at year 1 was <200/mu l. Predictors of nADE (malignancies, severe infections, renal failure-ie, estimated glomerular filtration rate <30 ml/min, cardiovascular events and liver decompensation) were assessed using multivariable Cox models. Follow-up was right-censored in case of HAART discontinuation or confirmed HIV-RNA>50. Results 1221 patients were observed for a median of 3 (IQR: 1.3-6.1) years. Pre-HAART CD4+ were 77/mu l (IQR: 28-142) and 56% of patients had experienced an ADE. After 1 year, CD4+ increased to 286 (IQR: 197-387), but 26.1% of patients were INR. Thereafter, 86 nADE (30.2% malignancies, 27.9% infectious, 17.4% renal, 17.4% cardiovascular, 7% hepatic) were observed, accounting for an incidence of 1.83 events (95% CI: 1.73-2.61) per 100 PYFU. After adjusting for measurable confounders, INR had a significantly greater risk of nADE (HR 1.65; 95% CI: 1.06-2.56). Older age (per year, HR 1.03; 95% CI: 1.01-1.05), hepatitis C co-infection (HR 2.09; 95% CI: 1.19-3.7), a history of previous nADE (HR 2.16; 95% CI: 1.06-4.4) and the occurrence of ADE during the follow-up (HR 2.2; 95% CI: 1.15-4.21) were other independent predictors of newly diagnosed nADE. Conclusions Patients failing to restore CD4+ to >200 cells/mu l run a greater risk of serious nADE, which is intertwined or predicted by AIDS progression. Improved management of this fragile population and innovative therapy able to induce immune-reconstitution are urgently needed. Also, our results strengthen the importance of earlier diagnosis and HAART introduction.	[Lapadula, Giuseppe; Gori, Andrea] San Gerardo de Tintori Hosp, Clin Infect Dis, Monza, Italy; [Chatenoud, Liliane] IRCCS, Ist Ric Farmacol Mario Negri, Milan, Italy; [Castelli, Francesco; Foca, Emanuele; Torti, Carlo] Univ Brescia, Univ Div Infect & Trop Dis, Brescia, Italy; [Di Giambenedetto, Simona; Fabbiani, Massimiliano] Sacro Cuore Catholic Univ Rome, Clin Infect Dis, Rome, Italy; [Foca, Emanuele] Osped Riuniti Bergamo, Clin Infect Dis, I-24100 Bergamo, Italy; [Ladisa, Nicoletta] Osped Policlin, Clin Infect Dis, Bari, Italy; [Sighinolfi, Laura] Osped St Anna, Clin Infect Dis, Ferrara, Italy; [Di Pietro, Massimo] Osped SM Annunziata, Clin Infect Dis, Florence, Italy; [Pan, Angelo] Ist Ospitalieri, Clin Infect Dis, Cremona, Italy; [Torti, Carlo] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Infect Dis Unit, Catanzaro, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Brescia; Catholic University of the Sacred Heart; Ospedali Riuniti di Bergamo; University of Ferrara; Arcispedale Sant'Anna; Magna Graecia University of Catanzaro	Lapadula, G (corresponding author), San Gerardo de Tintori Hosp, Clin Infect Dis, Monza, Italy.	g.lapadula@hsgerardo.org	Chatenoud, Liliane/AAA-6377-2020; Gori, Andrea/AAC-6078-2022; Maggi, Paolo/K-6598-2016; Lapadula, Giuseppe/J-5163-2012; digiambenedetto, simona/AAL-4429-2020; Fabbiani, Massimiliano/K-8842-2016; Colafigli, Manuela/K-5167-2018; Sighinolfi, Laura/AAH-1426-2020; QUIROS ROLDAN, Maria Eugenia/K-7586-2015	Chatenoud, Liliane/0000-0001-9599-8229; Maggi, Paolo/0000-0002-0482-4969; Fabbiani, Massimiliano/0000-0002-1343-812X; Colafigli, Manuela/0000-0003-1610-6347; Puoti, Massimo/0000-0003-3278-7138; FOCA', Emanuele/0000-0003-4395-5379; MONNO, Laura/0000-0002-2713-4258; QUIROS ROLDAN, Maria Eugenia/0000-0003-1452-9100; ANGARANO, Gioacchino/0000-0003-3207-7523; Castelli, Francesco/0000-0001-9161-7804; CAUDA, Roberto/0000-0002-1498-4229; LAPADULA, Giuseppe/0000-0002-9976-8102	Infectious Diseases and International Health (MISI) Fundation, Brescia, Italy	Infectious Diseases and International Health (MISI) Fundation, Brescia, Italy	This work and the Italian MASTER cohort were sponsored by the Infectious Diseases and International Health (MISI) Fundation, Brescia, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agwu AL, 2014, JAMA PEDIATR, V168, P381, DOI 10.1001/jamapediatrics.2013.4531; Antinori A, 2011, HIV MED, V12, P61, DOI 10.1111/j.1468-1293.2010.00857.x; Butt AA, 2009, CLIN INFECT DIS, V49, P225, DOI 10.1086/599371; CDC (Centers for Disease Control and Prevention), 1993, MMWR RECOMM REP, V41, P1; Chene G, 2003, LANCET, V362, P679, DOI 10.1016/S0140-6736(03)14229-8; Dronda F, 2002, CLIN INFECT DIS, V35, P1005, DOI 10.1086/342695; Engsig FN, 2014, CLIN INFECT DIS; Engsig FN, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-318; Grabar S, 2000, ANN INTERN MED, V133, P401, DOI 10.7326/0003-4819-133-6-200009190-00007; Gutierrez F, 2008, CURR HIV RES, V6, P100, DOI 10.2174/157016208783885038; Hunt PW, 2011, AIDS, V25, P2123, DOI 10.1097/QAD.0b013e32834c4ac1; Hunt PW, 2003, J INFECT DIS, V187, P1534, DOI 10.1086/374786; Kaufmann GR, 2005, CLIN INFECT DIS, V41, P361, DOI 10.1086/431484; Lapadula G, 2013, AIDS, V27, P769, DOI 10.1097/QAD.0b013e32835cb747; Lau B, 2007, JAIDS-J ACQ IMM DEF, V44, P179, DOI 10.1097/01.qai.0000247229.68246.c5; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Loutfy MR, 2010, JAIDS-J ACQ IMM DEF, V55, P451, DOI 10.1097/QAI.0b013e3181ec28ff; Marchetti G, 2006, AIDS, V20, P1727, DOI 10.1097/01.aids.0000242819.72839.db; Marimoutou C, 2001, J ACQ IMMUN DEF SYND, V27, P161, DOI 10.1097/00126334-200106010-00011; Massanella M, 2010, AIDS, V24, P959, DOI 10.1097/QAD.0b013e328337b957; Mocroft A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001510; Mocroft A, 2010, JAIDS-J ACQ IMM DEF, V55, P262, DOI 10.1097/QAI.0b013e3181e9be6b; Mocroft A, 2009, CLIN INFECT DIS, V48, P1138, DOI 10.1086/597468; Moore DM, 2009, JAIDS-J ACQ IMM DEF, V52, P357, DOI 10.1097/QAI.0b013e3181b62933; Moore DM, 2005, JAIDS-J ACQ IMM DEF, V40, P288, DOI 10.1097/01.qai.0000182847.38098.d1; Ndiaye B, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-11; Neuhaus J, 2010, AIDS, V24, P697, DOI 10.1097/QAD.0b013e3283365356; Paredes R, 2000, ARCH INTERN MED, V160, P1123, DOI 10.1001/archinte.160.8.1123; Peters L, 2012, AIDS, V26, P1917, DOI 10.1097/QAD.0b013e3283574e71; Peters L, 2009, JAIDS-J ACQ IMM DEF, V50, P457, DOI 10.1097/QAI.0b013e318198a0e1; Potter M, 2010, AIDS, V24, P1857, DOI 10.1097/QAD.0b013e32833adbb5; Sighinolfi L, 2008, INFECTION, V36, P244, DOI 10.1007/s15010-007-7227-0; Tan RM, 2008, JAIDS-J ACQ IMM DEF, V47, P553, DOI 10.1097/QAI.0b013e31816856c5; Torti C, 2007, HIV CLIN TRIALS, V8, P112, DOI 10.1310/hct0803-112; van Lelyveld SFL, 2012, AIDS, V26, P465, DOI 10.1097/QAD.0b013e32834f32f8; Webster DP, 2015, LANCET, V385, P1124, DOI [10.1016/S0140-6736(14)62401-6, 10.1016/S0140-6736(14)61932-2]; Wilson KD, 2014, AIDS CARE, P1, DOI DOI 10.1080/09540121.2014.946384; Zoufaly A, 2011, J INFECT DIS, V203, P364, DOI 10.1093/jinfdis/jiq055; Zoufaly A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087160	39	30	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0124741	10.1371/journal.pone.0124741	http://dx.doi.org/10.1371/journal.pone.0124741			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020949	Green Submitted, Green Published, gold			2022-12-26	WOS:000355187300009
J	Mulinari, S; Juarez, SP; Wagner, P; Merlo, J				Mulinari, Shai; Juarez, Sol Pia; Wagner, Philippe; Merlo, Juan			Does Maternal Country of Birth Matter for Understanding Offspring's Birthweight? A Multilevel Analysis of Individual Heterogeneity in Sweden	PLOS ONE			English	Article							FOR-GESTATIONAL-AGE; BRIEF CONCEPTUAL TUTORIAL; FOREIGN-BORN STATUS; SOCIAL EPIDEMIOLOGY; ETHNIC INEQUALITIES; CAUSAL INFERENCE; BLOOD-PRESSURE; MARITAL-STATUS; HEALTH; RISK	Background Many public health and epidemiological studies have found differences between populations (e.g. maternal countries of birth) in average values of a health indicator (e.g. mean offspring birthweight). However, the approach based solely on population-level averages compromises our understanding of variability in individuals' health around the averages. If this variability is high, the exclusive study of averages may give misleading information. This idea is relevant when investigating country of birth differences in health. Methods and Results To exemplify this concept, we use information from the Swedish Medical Birth Register (2002-2010) and apply multilevel regression analysis of birthweight, with babies (n = 811,329) at the first, mothers (n = 571,876) at the second, and maternal countries of birth (n = 109) at the third level. We disentangle offspring, maternal and maternal country of birth components of the total offspring heterogeneity in birthweight for babies born within the normal timespan (37-42 weeks). We found that of such birthweight variation about 50% was at the baby level, 47% at the maternal level and only 3% at the maternal countries of birth level. Conclusion In spite of seemingly large differences in average birthweight among maternal countries of birth (range 3290-3677g), knowledge of the maternal country of birth does not provide accurate information for ascertaining individual offspring birthweight because of the high inter-offspring heterogeneity around country averages. Our study exemplifies the need for a better understanding of individual health diversity for which group averages may provide insufficient and even misleading information. The analytical approach we outline is therefore relevant to investigations of country of birth (and ethnic) differences in health in general.	[Mulinari, Shai] Lund Univ, Fac Social Sci, Dept Sociol, Lund, Sweden; [Mulinari, Shai; Juarez, Sol Pia; Wagner, Philippe; Merlo, Juan] Lund Univ, Fac Med, Unit Social Epidemiol, Malmo, Sweden; [Juarez, Sol Pia] Stockholm Univ, Ctr Hlth Equity Studies, S-10691 Stockholm, Sweden; [Juarez, Sol Pia] Karolinska Inst, Stockholm, Sweden	Lund University; Lund University; Stockholm University; Karolinska Institutet	Mulinari, S (corresponding author), Lund Univ, Fac Social Sci, Dept Sociol, Lund, Sweden.	shai.mulinari@soc.lu.se	Merlo, Juan/E-2136-2011	Merlo, Juan/0000-0001-8379-9708; Mulinari, Shai/0000-0001-8773-9796	Swedish Research Council (VR) [2013-2484, 2013-1695]	Swedish Research Council (VR)(Swedish Research Council)	Swedish Research Council, www.vr.se (VR) [2013-2484 to JM] and [2013-1695 to SM]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Garcia D, 2005, PEDIATRICS, V115, pE20, DOI 10.1542/peds.2004-1306; Acevedo-Garcia D, 2007, SOC SCI MED, V65, P2503, DOI 10.1016/j.socscimed.2007.06.033; Alexander G R, 1999, Matern Child Health J, V3, P225, DOI 10.1023/A:1022381506823; ANANTH CV, 1995, EPIDEMIOLOGY, V6, P391, DOI 10.1097/00001648-199507000-00011; Beckman A, 2004, J EPIDEMIOL COMMUN H, V58, P145, DOI 10.1136/jech.58.2.145; Bergvall N, 2008, INT J EPIDEMIOL, V37, P185, DOI 10.1093/ije/dym167; Bhopal R, 1997, BRIT MED J, V314, P1751, DOI 10.1136/bmj.314.7096.1751; Browne WJ, 2009, J R STAT SOC A STAT, V172, P579, DOI 10.1111/j.1467-985X.2009.00586.x; Browne WJ, 2009, MCMC ESTIMATION IN M; Buekens P, 1998, AM J PUBLIC HEALTH, V88, P808, DOI 10.2105/AJPH.88.5.808; CNATTINGIUS S, 1990, SCAND J SOC MED, V18, P143, DOI 10.1177/140349489001800209; Crispi F, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.05.011; CUNNINGHAM FG, 2005, WILLIAMS OBSTETRICS; D'Onofrio BM, 2010, CHILD DEV, V81, P80, DOI 10.1111/j.1467-8624.2009.01382.x; Eikenes L, 2012, PEDIATR RES, V72, P649, DOI 10.1038/pr.2012.129; Essink-Bot ML, 2013, EUR J PUBLIC HEALTH, V23, P922, DOI 10.1093/eurpub/cks170; Fang J, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.1.e5; Flores MES, 2012, WOMEN HEALTH ISS, V22, pE501, DOI 10.1016/j.whi.2012.07.005; Forssell L, 2013, CLIN GASTROENTEROL H, V11, P790, DOI 10.1016/j.cgh.2013.01.024; Forssell L, 2012, CLIN GASTROENTEROL H, V10, P1369, DOI 10.1016/j.cgh.2012.09.014; FRASER AM, 1995, NEW ENGL J MED, V332, P1113, DOI 10.1056/NEJM199504273321701; Fuentes-Afflick E, 1998, ARCH PEDIAT ADOL MED, V152, P1105; Glymour C, 2014, EPIDEMIOLOGY, V25, P488, DOI 10.1097/EDE.0000000000000122; Goldstein H., 2002, Understanding Statistics, V1, P223, DOI 10.1207/S15328031US0104_02; Gould JB, 2003, PEDIATRICS, V111, pE676, DOI 10.1542/peds.111.6.e676; Guendelman S, 1999, Matern Child Health J, V3, P177, DOI 10.1023/A:1022328020935; Harding S, 2006, INT J EPIDEMIOL, V35, P270, DOI 10.1093/ije/dyi225; Hsieh WS, 2011, J WOMENS HEALTH, V20, P1083, DOI 10.1089/jwh.2011.2809; KALLEN B, 1995, EUR J EPIDEMIOL, V11, P601, DOI 10.1007/BF01719316; Kaufman JS, 2003, SOC SCI MED, V57, P2397, DOI 10.1016/S0277-9536(03)00135-7; Kaufman JS, 1999, AM J EPIDEMIOL, V150, P113; Kaufman JS, 2002, INT J EPIDEMIOL, V31, P431, DOI 10.1093/ije/31.2.431; Kelly Y, 2009, J PUBLIC HEALTH-UK, V31, P131, DOI 10.1093/pubmed/fdn057; KRAMER MS, 1987, B WORLD HEALTH ORGAN, V65, P663; Kramer MS, 2000, PAEDIATR PERINAT EP, V14, P194, DOI 10.1046/j.1365-3016.2000.00266.x; Lawlor DA, 2009, LIFE COURSE APPROACH; Lewontin RC, 2006, INT J EPIDEMIOL, V35, P520, DOI 10.1093/ije/dyl062; Li XJ, 2012, SCAND J PUBLIC HEALT, V40, P634, DOI 10.1177/1403494812458845; Lohaugen GCC, 2013, J PEDIATR-US, V163, P447, DOI 10.1016/j.jpeds.2013.01.060; MALAMITSIPUCHNER A, 1994, PAEDIATR PERINAT EP, V8, P384, DOI 10.1111/j.1365-3016.1994.tb00477.x; Maldonado G, 2002, INT J EPIDEMIOL, V31, P422, DOI 10.1093/ije/31.2.422; Speciale AM, 2011, J IMMIGR MINOR HEALT, V13, P518, DOI 10.1007/s10903-010-9365-1; McCowan L, 2009, BEST PRACT RES CL OB, V23, P779, DOI 10.1016/j.bpobgyn.2009.06.003; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P1022, DOI 10.1136/jech.2004.028035; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P729, DOI 10.1136/jech.2004.023929; Merlo J, 2004, AM J EPIDEMIOL, V159, P1168, DOI 10.1093/aje/kwh160; Merlo J, 2009, J EPIDEMIOL COMMUN H, V63, P1043, DOI 10.1136/jech.2009.088310; Merlo J, 2001, J EPIDEMIOL COMMUN H, V55, P791, DOI 10.1136/jech.55.11.791; Merlo J, 2003, J EPIDEMIOL COMMUN H, V57, P550, DOI 10.1136/jech.57.8.550; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P443, DOI 10.1136/jech.2004.023473; Merlo J, 2006, J EPIDEMIOL COMMUN H, V60, P290, DOI 10.1136/jech.2004.029454; Merlo J, 2013, EUR J EPIDEMIOL, V28, P135; Merlo J, 2013, EUR J EPIDEMIOL S, V28, P148; Merlo J, 2010, INT J EPIDEMIOL, V39, P936; Merlo J, 2014, AM J EPIDEMIOL, V180, P208, DOI 10.1093/aje/kwu108; Merlo J, 2012, SOC SCI MED, V75, P1477, DOI 10.1016/j.socscimed.2012.06.004; Moore GS, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.01.044; Nazroo JY, 2003, AM J PUBLIC HEALTH, V93, P277, DOI 10.2105/AJPH.93.2.277; Nielsen PR, 2012, SCHIZOPHR BULL, V12, P1337; Oakes JM, 2009, INT J EPIDEMIOL, V38, P361, DOI 10.1093/ije/dyn356; Oakes JM, 2004, SOC SCI MED, V58, P1929, DOI 10.1016/j.socscimed.2003.08.004; Odibo AO, 2006, AM J PERINAT, V23, P325, DOI 10.1055/s-2006-947164; Ozaltin E, 2010, JAMA-J AM MED ASSOC, V303, P1507, DOI 10.1001/jama.2010.450; Peoples JG, 2012, HUMANITY AN INTRODUC; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Phung H, 2003, EUR J EPIDEMIOL, V18, P235, DOI 10.1023/A:1023384213536; Pozza RD, 2006, CLIN CARDIOL, V29, P215, DOI 10.1002/clc.4960290509; Rasbash J, 2009, MLWIN VERSION 21; RASMUSSEN F, 1995, PAEDIATR PERINAT EP, V9, P441, DOI 10.1111/j.1365-3016.1995.tb00167.x; Rogers John M., 2008, Birth Defects Research, V84, P1, DOI 10.1002/bdrc.20119; Rose G, 2001, INT J EPIDEMIOL, V30, P427, DOI 10.1093/ije/30.3.427; Rose G, 1992, THE STRATEGY OF PREV; Roux AVD, 2012, ANNU REV PUBL HEALTH, V33, P41, DOI 10.1146/annurev-publhealth-031811-124534; Rundle D, 1996, AUST NZ J OBSTET GYN, V36, P430, DOI 10.1111/j.1479-828X.1996.tb02186.x; Sen A, 1994, THE HUMAN DEVELOPMEN; Shah PS, 2011, MATERN CHILD HLTH J, V15, P1097, DOI 10.1007/s10995-010-0654-z; Spallek J, 2011, EMERG THEMES EPIDEMI, V8, DOI 10.1186/1742-7622-8-6; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Streimish IG, 2012, EARLY HUM DEV, V88, P765, DOI 10.1016/j.earlhumdev.2012.04.004; Stronks K, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-402; Stronks K, 2009, J PUBLIC HEALTH-UK, V31, P324, DOI 10.1093/pubmed/fdp070; Stronks K, 2009, ETHNIC HEALTH, V14, P255, DOI 10.1080/13557850802509206; Teitler JO, 2007, PEDIATRICS, V120, pE1182, DOI 10.1542/peds.2006-3526; Urquia Fernandez MA, 2009, EUR J PUBLIC HEALTH, V21, P104; Urquia ML, 2012, SOC SCI MED, V74, P1610, DOI 10.1016/j.socscimed.2012.02.013; Urquia ML, 2009, AM J PUBLIC HEALTH, V99, P285, DOI 10.2105/AJPH.2007.127498; Urquia ML, 2010, J EPIDEMIOL COMMUN H, V64, P243, DOI 10.1136/jech.2008.083535; van de Lagemaat M, 2012, BONE, V51, P441, DOI 10.1016/j.bone.2012.06.017; VanderWeele TJ, 2014, EPIDEMIOLOGY, V25, P473, DOI 10.1097/EDE.0000000000000105; WHO, 1995, B WHO S, V73, P98; WILCOX AJ, 1992, AM J PUBLIC HEALTH, V82, P378, DOI 10.2105/AJPH.82.3.378; Wilcox AJ, 2001, INT J EPIDEMIOL, V30, P1233, DOI 10.1093/ije/30.6.1233; Wingren CJ, 2012, SCAND J GASTROENTERO, V47, P632, DOI 10.3109/00365521.2012.661760; World Health Organization, 1997, MONITORING REPRODUCT	94	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0129362	10.1371/journal.pone.0129362	http://dx.doi.org/10.1371/journal.pone.0129362			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0SC	26020535	Green Submitted, Green Published, gold			2022-12-26	WOS:000355187300125
J	Palardy, G; Chitnis, AB				Palardy, Gregory; Chitnis, Ajay B.			Identification of the Mind Bomb1 Interaction Domain in Zebrafish DeltaD	PLOS ONE			English	Article							RECEPTOR INTERNALIZATION; JUXTAMEMBRANE DOMAIN; PRIMARY NEUROGENESIS; UBIQUITIN LIGASE; NOTCH; ENDOCYTOSIS; ACTIVATION; DROSOPHILA; INHIBITION; HOMOLOG	Ubiquitylation promotes endocytosis of the Notch ligands like Delta and Serrate and is essential for them to effectively activate Notch in a neighboring cell. The RING E3 ligase Mind bomb1 (Mib1) ubiquitylates DeltaD to facilitate Notch signaling in zebrafish. We have identified a domain in the intracellular part of the zebrafish Notch ligand DeltaD that is essential for effective interactions with Mib1. We show that elimination of the Mind bomb1 Interaction Domain (MID) or mutation of specific conserved motifs in this domain prevents effective Mib1-mediated ubiquitylation and internalization of DeltaD. Lateral inhibition mediated by Notch signaling regulates early neurogenesis in zebrafish. In this context, Notch activation suppresses neurogenesis, while loss of Notch-mediated lateral inhibition results in a neurogenic phenotype, where too many cells are allowed to become neurons. While Mib1-mediated endocytosis of DeltaD is essential for effective activation of Notch in a neighboring cell (in trans) it is not required for DeltaD to inhibit function of Notch receptors in the same cell (in cis). As a result, forms of DeltaD that have the MID can activate Notch in trans and suppress early neurogenesis when mRNA encoding it is ectopically expressed in zebrafish embryos. On the other hand, when the MID is eliminated/mutated in DeltaD, its ability to activate Notch in trans fails but ability to inhibit in cis is retained. As a result, ectopic expression of DeltaD lacking an effective MID results in a failure of Notch-mediated lateral inhibition and a neurogenic phenotype.	[Palardy, Gregory; Chitnis, Ajay B.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Genom Differentiat, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Chitnis, AB (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Genom Differentiat, NIH, Bethesda, MD 20892 USA.	chitnisa@mail.nih.gov			Eunice Kennedy Shriver National Insitute of Child Health and Human Development [1ZIAHD001012]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001012] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Insitute of Child Health and Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was funded by the intramural program of the Eunice Kennedy Shriver National Insitute of Child Health and Human Development 1ZIAHD001012.	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; CARPENTIER JL, 1994, DIABETOLOGIA, V37, pS117, DOI 10.1007/BF00400835; CHITNIS A, 1995, NATURE, V375, P761, DOI 10.1038/375761a0; Daskalaki A, 2011, J CELL BIOL, V195, P1017, DOI 10.1083/jcb.201105166; Fleming RJ, 2013, DEVELOPMENT, V140, P2039, DOI 10.1242/dev.087916; Haddon C, 1998, DEVELOPMENT, V125, P359; Irandoust MI, 2007, EMBO J, V26, P1782, DOI 10.1038/sj.emboj.7601640; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Kim CH, 1996, NEUROSCI LETT, V216, P109, DOI 10.1016/0304-3940(96)13021-4; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Lai EC, 2005, DEVELOPMENT, V132, P2319, DOI 10.1242/dev.01825; Le Borgne R, 2005, PLOS BIOL, V3, P688, DOI 10.1371/journal.pbio.0030096; Louvi A, 2012, SEMIN CELL DEV BIOL, V23, P473, DOI 10.1016/j.semcdb.2012.02.005; Matsuda M, 2009, DEVELOPMENT, V136, P197, DOI 10.1242/dev.027938; Miller AC, 2009, CURR BIOL, V19, P1378, DOI 10.1016/j.cub.2009.06.042; MORI S, 1994, J BIOL CHEM, V269, P4917; Musse AA, 2012, SEMIN CELL DEV BIOL, V23, P429, DOI 10.1016/j.semcdb.2012.01.011; MYLES GM, 1994, MOL CELL BIOL, V14, P4843, DOI 10.1128/MCB.14.7.4843; Palmer WH, 2014, ELIFE, V3, DOI 10.7554/eLife.04415; Penengo L, 2003, ONCOGENE, V22, P3669, DOI 10.1038/sj.onc.1206585; Penton AL, 2012, SEMIN CELL DEV BIOL, V23, P450, DOI 10.1016/j.semcdb.2012.01.010; PRAGER D, 1994, J BIOL CHEM, V269, P11934; Sprinzak D, 2010, NATURE, V465, P86, DOI 10.1038/nature08959; Wang WD, 2005, DEVELOPMENT, V132, P2883, DOI 10.1242/dev.01860; Wright GJ, 2011, DEVELOPMENT, V138, P2947, DOI 10.1242/dev.066654	25	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0127864	10.1371/journal.pone.0127864	http://dx.doi.org/10.1371/journal.pone.0127864			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020642	gold, Green Submitted, Green Published			2022-12-26	WOS:000355187300060
J	Baker, LA; Lee, KCL; Jimenez, CP; Alibhai, H; Chang, YM; Leckie, PJ; Mookerjee, RP; Davies, NA; Andreola, F; Jalan, R				Baker, Luisa A.; Lee, Karla C. L.; Jimenez, Carolina Palacios; Alibhai, Hatim; Chang, Yu-Mei; Leckie, Pamela J.; Mookerjee, Rajeshwar P.; Davies, Nathan A.; Andreola, Fausto; Jalan, Rajiv			Circulating microRNAs Reveal Time Course of Organ Injury in a Porcine Model of Acetaminophen-Induced Acute Liver Failure	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; INDUCED HEPATOTOXICITY; BIOMARKERS; CANCER; EXPRESSION; PROGNOSIS; THERAPY; MARKERS; GENES; MICE	Acute liver failure is a rare but catastrophic condition which can progress rapidly to multi-organ failure. Studies investigating the onset of individual organ injury such as the liver, kidneys and brain during the evolution of acute liver failure, are lacking. MicroRNAs are short, non-coding strands of RNA that are released into the circulation following tissue injury. In this study, we have characterised the release of both global microRNA and specific microRNA species into the plasma using a porcine model of acetaminophen-induced acute liver failure. Pigs were induced to acute liver failure with oral acetaminophen over 19h +/- 2h and death occurred 13h +/- 3h thereafter. Global microRNA concentrations increased 4h prior to acute liver failure in plasma (P<0.0001) but not in isolated exosomes, and were associated with increasing plasma levels of the damage-associated molecular pattern molecule, genomic DNA (P<0.0001). MiR122 increased around the time of onset of acute liver failure (P<0.0001) and was associated with increasing international normalised ratio (P<0.0001). MiR192 increased 8h after acute liver failure (P<0.0001) and was associated with increasing creatinine (P<0.0001). The increase in miR124-1 occurred concurrent with the pre-terminal increase in intracranial pressure (P<0.0001) and was associated with decreasing cerebral perfusion pressure (P<0.002).	[Baker, Luisa A.; Lee, Karla C. L.; Jimenez, Carolina Palacios; Alibhai, Hatim; Chang, Yu-Mei] Royal Vet Coll, Dept Clin Sci & Serv, Hatfield, Herts, England; [Leckie, Pamela J.; Mookerjee, Rajeshwar P.; Davies, Nathan A.; Andreola, Fausto; Jalan, Rajiv] UCL, Sch Med, Royal Free Hosp, Liver Failure Grp,Inst Liver & Digest Hlth, London W1N 8AA, England	University of London; University of London Royal Veterinary College; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Jalan, R (corresponding author), UCL, Sch Med, Royal Free Hosp, Liver Failure Grp,Inst Liver & Digest Hlth, Mortimer St, London W1N 8AA, England.	r.jalan@ucl.ac.uk	Jimenez, Carolina/GYD-8755-2022; Andreola, Fausto/L-2972-2018	Andreola, Fausto/0000-0003-4926-0121; Mookerjee, Rajeshwar/0000-0002-6275-9384; , Luisa/0000-0002-4526-5868	Medical Research Council, United Kingdom [G0902211]; MRC [G0902211] Funding Source: UKRI; Medical Research Council [G0902211] Funding Source: researchfish	Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding was provided to NAD by a Development Pathway Funding Scheme Grant from the Medical Research Council, United Kingdom (G0902211). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Antoine DJ, 2013, HEPATOLOGY, V58, P777, DOI 10.1002/hep.26294; Bajt ML, 2006, TOXICOL SCI, V94, P217, DOI 10.1093/toxsci/kfl077; Bala S, 2012, HEPATOLOGY, V56, P1946, DOI 10.1002/hep.25873; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Bernal W, 2010, LANCET, V376, P190, DOI 10.1016/S0140-6736(10)60274-7; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Cholongitas E, 2012, LIVER TRANSPLANT, V18, P405, DOI 10.1002/lt.23370; Ekser B, 2012, XENOTRANSPLANTATION, V19, P52, DOI 10.1111/j.1399-3089.2011.00686.x; Ge QY, 2014, MOLECULES, V19, P1568, DOI 10.3390/molecules19021568; Gilje P, 2014, CRIT CARE, V18, DOI 10.1186/cc13753; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hoffmann WE, 2008, CLINICAL BIOCHEMISTRY OF DOMESTIC ANIMALS, 6TH EDITION, P351, DOI 10.1016/B978-0-12-370491-7.00012-X; Imaeda AB, 2009, J CLIN INVEST, V119, P305, DOI 10.1172/JCI35958; John K, 2014, HEPATOLOGY, V60, P1346, DOI 10.1002/hep.27250; Karali M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022166; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kong YW, 2012, LANCET ONCOL, V13, pE249, DOI 10.1016/S1470-2045(12)70073-6; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Larson AM, 2005, HEPATOLOGY, V42, P1364, DOI 10.1002/hep.20948; Laterza OF, 2009, CLIN CHEM, V55, P1977, DOI 10.1373/clinchem.2009.131797; Lee KCL, 2013, LIVER INT, V33, P544, DOI 10.1111/liv.12042; Lee WM, 2012, NAT REV GASTRO HEPAT, V9, P192, DOI 10.1038/nrgastro.2012.34; Lewis PJS, 2011, HEPATOLOGY, V54, P1767, DOI 10.1002/hep.24538; Martino F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038269; McGill MR, 2012, J CLIN INVEST, V122, P1574, DOI 10.1172/JCI59755; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mladinov D, 2013, NUCLEIC ACIDS RES, V41, P1273, DOI 10.1093/nar/gks1228; Moore JK, 2013, EXPERT REV GASTROENT, V7, P701, DOI 10.1586/17474124.2013.837264; O'Riordan A, 2011, NEPHROL DIAL TRANSPL, V26, P3501, DOI 10.1093/ndt/gfr050; OGRADY JG, 1993, LANCET, V342, P273; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Purins K, 2012, NEUROCRIT CARE, V16, P462, DOI 10.1007/s12028-012-9675-3; Reddy AM, 2008, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-65; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Stravitz RT, 2009, CRIT CARE MED, V37, pS258, DOI 10.1097/CCM.0b013e3181aa5fb8; Sun YQ, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh186; Szabo G, 2013, NAT REV GASTRO HEPAT, V10, P542, DOI 10.1038/nrgastro.2013.87; Timoneda O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055402; Timoneda O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044413; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Wang Y, 2013, J APPL TOXICOL, V33, P1330, DOI 10.1002/jat.2864; Weiland M, 2012, RNA BIOL, V9, P850, DOI 10.4161/rna.20378; Williams CD, 2011, TOXICOL APPL PHARM, V252, P289, DOI 10.1016/j.taap.2011.03.001; Zhang Y, 2010, CLIN CHEM, V56, P1830, DOI 10.1373/clinchem.2010.147850; Zhu HT, 2012, MOL BIOTECHNOL, V50, P49, DOI 10.1007/s12033-011-9414-6	50	23	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0128076	10.1371/journal.pone.0128076	http://dx.doi.org/10.1371/journal.pone.0128076			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018205	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000355185600109
J	Wang, XJ; Yang, JF; Yang, J; Mencl, WE; Shu, H; Zevin, JD				Wang, Xiaojuan; Yang, Jianfeng; Yang, Jie; Mencl, W. Einar; Shu, Hua; Zevin, Jason David			Language Differences in the Brain Network for Reading in Naturalistic Story Reading and Lexical Decision	PLOS ONE			English	Article							VISUAL WORD RECOGNITION; DIVISION-OF-LABOR; CHINESE CHARACTERS; NEURAL SYSTEMS; FMRI; ACTIVATION; CORTEX; MODEL; TASK; ORGANIZATION	Differences in how writing systems represent language raise important questions about whether there could be a universal functional architecture for reading across languages. In order to study potential language differences in the neural networks that support reading skill, we collected fMRI data from readers of alphabetic (English) and morpho-syllabic (Chinese) writing systems during two reading tasks. In one, participants read short stories under conditions that approximate natural reading, and in the other, participants decided whether individual stimuli were real words or not. Prior work comparing these two writing systems has overwhelmingly used meta-linguistic tasks, generally supporting the conclusion that the reading system is organized differently for skilled readers of Chinese and English. We observed that language differences in the reading network were greatly dependent on task. In lexical decision, a pattern consistent with prior research was observed in which the Middle Frontal Gyrus (MFG) and right Fusiform Gyrus (rFFG) were more active for Chinese than for English, whereas the posterior temporal sulcus was more active for English than for Chinese. We found a very different pattern of language effects in a naturalistic reading paradigm, during which significant differences were only observed in visual regions not typically considered specific to the reading network, and the middle temporal gyrus, which is thought to be important for direct mapping of orthography to semantics. Indeed, in areas that are often discussed as supporting distinct cognitive or linguistic functions between the two languages, we observed interaction. Specifically, language differences were most pronounced in MFG and rFFG during the lexical decision task, whereas no language differences were observed in these areas during silent reading of text for comprehension.	[Wang, Xiaojuan; Yang, Jianfeng] Shaanxi Normal Univ, Sch Psychol, Key Lab Behav & Cognit Neurosci Shaanxi Prov, Xian, Peoples R China; [Shu, Hua] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Shu, Hua] Beijing Normal Univ, IDG McGovern Inst Brain Res, Beijing 100875, Peoples R China; [Yang, Jianfeng; Zevin, Jason David] Chinese Acad Sci, Inst Psychol, Beijing 100101, Peoples R China; [Yang, Jie] Univ Calif Irvine, Dept Neurol, Irvine, CA 92717 USA; [Mencl, W. Einar; Zevin, Jason David] Yale Univ, Haskins Labs, New Haven, CT USA; [Zevin, Jason David] Univ So Calif, Dept Psychol, Los Angeles, CA 90089 USA; [Zevin, Jason David] Univ So Calif, Dept Linguist, Los Angeles, CA 90089 USA	Shaanxi Normal University; Beijing Normal University; Beijing Normal University; Chinese Academy of Sciences; Institute of Psychology, CAS; University of California System; University of California Irvine; Yale University; Haskins Laboratories; University of Southern California; University of Southern California	Yang, J (corresponding author), Shaanxi Normal Univ, Sch Psychol, Key Lab Behav & Cognit Neurosci Shaanxi Prov, Xian, Peoples R China.	yangjf@snnu.edu.cn; zevin@usc.edu	Zevin, Jason/AAG-3266-2021; Yang, Jianfeng/P-6459-2015	Zevin, Jason/0000-0001-8929-5914; Yang, Jianfeng/0000-0002-8213-1201	National Key Basic Research Program of China [2014CB846103]; Natural Science Foundation of China [31271082, 31171077, 31400966]; Humanities and Social Sciences Foundation of the Ministry of Education [14YJC190019]; National Institutes of Health [P01 HD001994, R01 HD067364]; Chinese Academy of Sciences [2012Y1SA0004]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD001994, R01HD067364] Funding Source: NIH RePORTER	National Key Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Humanities and Social Sciences Foundation of the Ministry of Education; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese Academy of Sciences(Chinese Academy of Sciences); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by the National Key Basic Research Program of China (grant number 2014CB846103 to HS) Natural Science Foundation of China (grant numbers 31271082 to HS, 31171077 to JFY, 31400966 to XJW) Humanities and Social Sciences Foundation of the Ministry of Education (grant number 14YJC190019 to XJW) the National Institutes of Health (grant numbers P01 HD001994 and R01 HD067364 to JZ and WEM) and Chinese Academy of Sciences Fellowships for Young International Scientists (grant number 2012Y1SA0004 to JZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo HF, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00548; Argall BD, 2006, HUM BRAIN MAPP, V27, P14, DOI 10.1002/hbm.20158; Balota DA, 2004, J EXP PSYCHOL GEN, V133, P283, DOI 10.1037/0096-3445.133.2.283; BALOTA DA, 1984, J EXP PSYCHOL HUMAN, V10, P340, DOI 10.1037/0096-1523.10.3.340; Balota DA, 2006, FROM INKMARKS TO IDEAS: CURRENT ISSUES IN LEXICAL PROCESSING, P229; BERNDT RS, 1987, BEHAV RES METH INSTR, V19, P1, DOI 10.3758/BF03207663; Binder JR, 1997, J NEUROSCI, V17, P353, DOI 10.1523/JNEUROSCI.17-01-00353.1997; Blumenfeld HK, 2006, BRAIN LANG, V99, P226, DOI 10.1016/j.bandl.2005.07.004; Bolger DJ, 2005, HUM BRAIN MAPP, V25, P92, DOI 10.1002/hbm.20124; Booth JR, 2006, BRAIN RES, V1071, P197, DOI 10.1016/j.brainres.2005.11.097; Brennan J, 2012, BRAIN LANG, V120, P163, DOI 10.1016/j.bandl.2010.04.002; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Chee MWL, 2000, NEUROIMAGE, V12, P392, DOI 10.1006/nimg.2000.0631; Cohen L, 2002, BRAIN, V125, P1054, DOI 10.1093/brain/awf094; Cohen L, 2000, BRAIN, V123, P291, DOI 10.1093/brain/123.2.291; Coltheart M, 2001, PSYCHOL REV, V108, P204, DOI 10.1037//0033-295X.108.1.204; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; DeFrancis John., 1989, VISIBLE SPEECH DIVER; Dehaene S, 2004, PSYCHOL SCI, V15, P307, DOI 10.1111/j.0956-7976.2004.00674.x; Dehaene S, 2010, SCIENCE, V330, P1359, DOI 10.1126/science.1194140; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Friederici AD, 2010, HUM BRAIN MAPP, V31, P448, DOI 10.1002/hbm.20878; Friedman L, 2006, NEUROIMAGE, V33, P471, DOI 10.1016/j.neuroimage.2006.07.012; Frost R, 2012, BEHAV BRAIN SCI, V35, P263, DOI 10.1017/S0140525X11001841; Frost SJ, 2005, NEUROREPORT, V16, P621, DOI 10.1097/00001756-200504250-00021; Frost SJ, 2009, ANN DYSLEXIA, V59, P78, DOI 10.1007/s11881-009-0024-y; Hansell M, 2003, SINOTIBETAN LANGUAGE, P156; Harm MW, 2004, PSYCHOL REV, V111, P662, DOI 10.1037/0033-295X.111.3.662; Hsiao JH, 2010, COGN AFFECT BEHAV NE, V10, P552, DOI 10.3758/CABN.10.4.552; Kuperberg GR, 2006, NEUROIMAGE, V33, P343, DOI 10.1016/j.neuroimage.2006.06.001; Liu Y, 2007, HUM BRAIN MAPP, V28, P1223, DOI 10.1002/hbm.20356; Nakamura K, 2007, P NATL ACAD SCI USA, V104, P19643, DOI 10.1073/pnas.0704487104; Nakamura K, 2012, P NATL ACAD SCI USA, V109, P20762, DOI 10.1073/pnas.1217749109; Obleser J, 2010, CEREB CORTEX, V20, P633, DOI 10.1093/cercor/bhp128; Paulesu E, 2000, NAT NEUROSCI, V3, P91, DOI 10.1038/71163; Perfetti CA, 2005, PSYCHOL REV, V112, P43, DOI 10.1037/0033-295X.112.1.43; Price CJ, 2011, TRENDS COGN SCI, V15, P246, DOI 10.1016/j.tics.2011.04.001; Price CJ, 1997, J COGNITIVE NEUROSCI, V9, P727, DOI 10.1162/jocn.1997.9.6.727; Pugh KR, 1996, BRAIN, V119, P1221, DOI 10.1093/brain/119.4.1221; Pugh KR, 2001, J COMMUN DISORD, V34, P479, DOI 10.1016/S0021-9924(01)00060-0; Rogers TT, 2006, COGN AFFECT BEHAV NE, V6, P201, DOI 10.3758/CABN.6.3.201; Saad Z, 2004, INT S BIOM IM WASH D; Seidenberg M. S., 2011, DYSLEXIA LANGUAGES O, P151; Shaywitz SE, 1998, P NATL ACAD SCI USA, V95, P2636, DOI 10.1073/pnas.95.5.2636; Siok WT, 2004, NATURE, V431, P71, DOI 10.1038/nature02865; Siok WT, 2003, HUM BRAIN MAPP, V18, P201, DOI 10.1002/hbm.10094; Spreng RN, 2010, J COGNITIVE NEUROSCI, V22, P1112, DOI 10.1162/jocn.2009.21282; St George M, 1999, BRAIN, V122, P1317, DOI 10.1093/brain/122.7.1317; Stephens GJ, 2010, P NATL ACAD SCI USA, V107, P14425, DOI 10.1073/pnas.1008662107; Talairach J., 1988, COPLANAR STEREOTAXIC; Tan LH, 2005, HUM BRAIN MAPP, V25, P83, DOI 10.1002/hbm.20134; Tan LH, 2001, NEUROIMAGE, V13, P836, DOI 10.1006/nimg.2001.0749; Tan LH, 2003, HUM BRAIN MAPP, V18, P158, DOI 10.1002/hbm.10089; Taylor SF, 2007, NEUROSCIENTIST, V13, P160, DOI 10.1177/1073858406298184; Ullsperger M, 2003, J NEUROSCI, V23, P4308, DOI 10.1523/jneurosci.23-10-04308.2003; Vogel AC, 2012, CEREB CORTEX, V22, P2715, DOI 10.1093/cercor/bhr295; Wang XJ, 2011, NEUROIMAGE, V55, P1346, DOI 10.1016/j.neuroimage.2010.12.062; Wu CY, 2012, NEUROIMAGE, V63, P381, DOI 10.1016/j.neuroimage.2012.06.047; Yang J, 2014, NEUROSCIENCE, V272, P102, DOI 10.1016/j.neuroscience.2014.04.044; Yang J, 2012, 3 ANN C SOC NEUR LAN; Yang JF, 2013, BILING-LANG COGN, V16, P354, DOI 10.1017/S1366728912000296; Yang JF, 2012, NEUROIMAGE, V60, P979, DOI 10.1016/j.neuroimage.2012.01.036; Yang JF, 2011, BRAIN LANG, V119, P68, DOI 10.1016/j.bandl.2011.03.004; Yang JF, 2009, J MEM LANG, V61, P238, DOI 10.1016/j.jml.2009.05.001; Yoon HW, 2006, NEUROSCI LETT, V392, P90, DOI 10.1016/j.neulet.2005.09.027; Yoon HW, 2005, NEUROSCI LETT, V373, P206, DOI 10.1016/j.neulet.2004.10.021	66	43	45	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0124388	10.1371/journal.pone.0124388	http://dx.doi.org/10.1371/journal.pone.0124388			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26017384	Green Published, gold			2022-12-26	WOS:000355185600004
J	Soss, SE; Rose, KL; Hill, S; Jouan, S; Chazin, WJ				Soss, Sarah E.; Rose, Kristie L.; Hill, Salisha; Jouan, Sophie; Chazin, Walter J.			Biochemical and Proteomic Analysis of Ubiquitination of Hsc70 and Hsp70 by the E3 Ligase CHIP	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; IDENTIFICATION; COMPLEX; DEGRADATION; PROTEASOME; CHAPERONES; SUBSTRATE; ENZYMES; E2S	The E3 ubiquitin ligase CHIP is involved in protein triage, serving as a co-chaperone for refolding as well as catalyzing ubiquitination of substrates. CHIP functions with both the stress induced Hsp70 and constitutive Hsc70 chaperones, and also plays a role in maintaining their balance in the cell. When the chaperones carry no client proteins, CHIP catalyzes their polyubiquitination and subsequent proteasomal degradation. Although Hsp70 and Hsc70 are highly homologous in sequence and similar in structure, CHIP mediated ubiquitination promotes degradation of Hsp70 with a higher efficiency than for Hsc70. Here we report a detailed and systematic investigation to characterize if there are significant differences in the CHIP in vitro ubiquitination of human Hsp70 and Hsc70. Proteomic analysis by mass spectrometry revealed that only 12 of 39 detectable lysine residues were ubiquitinated by UbcH5a in Hsp70 and only 16 of 45 in Hsc70. The only conserved lysine identified as ubiquitinated in one but not the other heat shock protein was K159 in Hsc70. Ubiquitination assays with K-R ubiquitin mutants showed that multiple Ub chain types are formed and that the distribution is different for Hsp70 versus Hsc70. CHIP ubiquitination with the E2 enzyme Ube2W is predominantly directed to the N-terminal amine of the substrate; however, some internal lysine modifications were also detected. Together, our results provide a detailed view of the differences in CHIP ubiquitination of these two very similar proteins, and show a clear example where substantial differences in ubiquitination can be generated by a single E3 ligase in response to not only different E2 enzymes but subtle differences in the substrate.	[Soss, Sarah E.; Rose, Kristie L.; Hill, Salisha; Jouan, Sophie; Chazin, Walter J.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Soss, Sarah E.; Jouan, Sophie; Chazin, Walter J.] Vanderbilt Univ, Struct Biol Ctr, Nashville, TN 37235 USA; [Rose, Kristie L.; Hill, Salisha] Vanderbilt Univ, Mass Spectrometry Res Ctr, Nashville, TN 37235 USA; [Chazin, Walter J.] Vanderbilt Univ, Dept Chem, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Chazin, WJ (corresponding author), Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA.	walter.chazin@vanderbilt.edu			U.S. National Institutes of Health [R01 GM075156, P30 CA068485, P30 ES000267]; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075156] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The research reported in this publication was supported by grants from the U.S. National Institutes of Health: R01 GM075156 (WJC), P30 CA068485 (Vanderbilt Ingram Cancer Center), and P30 ES000267 (Vanderbilt Center for Molecular Toxicology). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Bertelsen EB, 2009, P NATL ACAD SCI USA, V106, P8471, DOI 10.1073/pnas.0903503106; Christensen DE, 2009, FEBS J, V276, P5381, DOI 10.1111/j.1742-4658.2009.07249.x; Ciechanover A, 2014, BBA-MOL CELL RES, V1843, P86, DOI 10.1016/j.bbamcr.2013.07.007; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Eddins MJ, 2006, NAT STRUCT MOL BIOL, V13, P915, DOI 10.1038/nsmb1148; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Graf C, 2010, BIOCHEMISTRY-US, V49, P2121, DOI 10.1021/bi901829f; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Jinwal UK, 2013, FASEB J, V27, P1450, DOI 10.1096/fj.12-220889; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Kundrat L, 2010, J MOL BIOL, V395, P587, DOI 10.1016/j.jmb.2009.11.017; Meyer B, 2011, AMINO ACIDS, V41, P291, DOI 10.1007/s00726-010-0680-6; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Pruneda JN, 2011, BIOCHEMISTRY-US, V50, P1624, DOI 10.1021/bi101913m; Qian SB, 2006, NATURE, V440, P551, DOI 10.1038/nature04600; Scaglione KM, 2013, J BIOL CHEM, V288, P18784, DOI 10.1074/jbc.C113.477596; Shabek N, 2012, MOL CELL, V48, P87, DOI 10.1016/j.molcel.2012.07.011; Smith MC, 2013, BIOCHEMISTRY-US, V52, P5354, DOI 10.1021/bi4009209; Soss SE, 2011, J BIOL CHEM, V286, P21277, DOI 10.1074/jbc.M111.224006; Steen H, 2004, NAT REV MOL CELL BIO, V5, P699, DOI 10.1038/nrm1468; Tatham MH, 2013, BIOCHEM J, V453, P137, DOI 10.1042/BJ20130244; Tomko RJ, 2013, ANNU REV BIOCHEM, V82, P415, DOI 10.1146/annurev-biochem-060410-150257; Vogel M, 2006, J BIOL CHEM, V281, P38705, DOI 10.1074/jbc.M609020200	27	20	21	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128240	10.1371/journal.pone.0128240	http://dx.doi.org/10.1371/journal.pone.0128240			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010904	Green Published, gold, Green Submitted			2022-12-26	WOS:000355183900213
J	Meyers, NL; Larsson, M; Olivecrona, G; Small, DM				Meyers, Nathan L.; Larsson, Mikael; Olivecrona, Gunilla; Small, Donald M.			A Pressure-dependent Model for the Regulation of Lipoprotein Lipase by Apolipoprotein C-II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; SITE-DIRECTED MUTAGENESIS; AMPHIPATHIC ALPHA-HELIX; SODIUM DODECYL-SULFATE; ESTER TRANSFER PROTEIN; RECOMBINANT WILD-TYPE; EXCHANGEABLE APOLIPOPROTEINS; PLASMA APOLIPOPROTEINS; LIPID-BINDING; A-I	Apolipoprotein C-II (apoC-II) is the co-factor for lipoprotein lipase (LPL) at the surface of triacylglycerol-rich lipoproteins. LPL hydrolyzes triacylglycerol, which increases local surface pressure as surface area decreases and amphipathic products transiently accumulate at the lipoprotein surface. To understand how apoC-II adapts to these pressure changes, we characterized the behavior of apoC-II at multiple lipid/water interfaces. ApoC-II adsorption to a triacylglycerol/water interface resulted in large increases in surface pressure. ApoC-II was exchangeable at this interface and desorbed on interfacial compressions. These compressions increase surface pressure and mimic the action of LPL. Analysis of gradual compressions showed that apoC-II undergoes a two-step desorption, which indicates that lipid-bound apoC-II can exhibit at least two conformations. We characterized apoC-II at phospholipid/triacylglycerol/water interfaces, which more closely mimic lipoprotein surfaces. ApoC-II had a large exclusion pressure, similar to that of apoC-I and apoC-III. However, apoC-II desorbed at retention pressures higher than those seen with the other apoCs. This suggests that it is unlikely that apoC-I and apoC-III inhibit LPL via displacement of apoC-II from the lipoprotein surface. Upon rapid compressions and re-expansions, re-adsorption of apoC-II increased pressure by lower amounts than its initial adsorption. This indicates that apoC-II removed phospholipid from the interface upon desorption. These results suggest that apoC-II regulates the activity of LPL in a pressure-dependent manner. ApoC-II is provided as a component of triacylglycerol-rich lipoproteins and is the co-factor for LPL as pressure increases. Above its retention pressure, apoC-II desorbs and removes phospholipid. This triggers release of LPL from lipoproteins.	[Meyers, Nathan L.; Small, Donald M.] Boston Univ, Dept Physiol & Biophys, Sch Med, Boston, MA 02118 USA; [Larsson, Mikael; Olivecrona, Gunilla] Umea Univ, Dept Med Biosci Physiol Chem, SE-90187 Umea, Sweden; [Larsson, Mikael] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA	Boston University; Umea University; University of California System; University of California Los Angeles	Small, DM (corresponding author), Boston Univ, Dept Physiol & Biophys, Sch Med, 700 Albany St W302, Boston, MA 02118 USA.	dmsmall@bu.edu	Olivecrona, Gunilla/D-2127-2018	Olivecrona, Gunilla/0000-0002-8876-6048	American Heart Association [12PRE12060584]; Swedish Science Council [12203]	American Heart Association(American Heart Association); Swedish Science Council	This work was supported by American Heart Association Grant 12PRE12060584 and Swedish Science Council Grant 12203. The authors declare that they have no conflicts of interest with the contents of this article.	Amar MJA, 2015, J PHARMACOL EXP THER, V352, P227, DOI 10.1124/jpet.114.220418; Andersson Y, 1997, J LIPID RES, V38, P2111; BENGTSSON G, 1980, EUR J BIOCHEM, V106, P549, DOI 10.1111/j.1432-1033.1980.tb04602.x; Benjamins J, 1996, COLLOID SURFACE A, V114, P245, DOI 10.1016/0927-7757(96)03533-9; BERGMAN EN, 1971, J CLIN INVEST, V50, P1831, DOI 10.1172/JCI106674; Bolanos-Garcia VM, 2008, BIOPHYS J, V94, P1735, DOI 10.1529/biophysj.107.115220; Brahm AJ, 2015, NAT REV ENDOCRINOL, V11, P352, DOI 10.1038/nrendo.2015.26; BROWN WV, 1972, BIOCHEM BIOPH RES CO, V46, P375; CISTOLA DP, 1986, BIOCHEMISTRY-US, V25, P2804, DOI 10.1021/bi00358a011; CISTOLA DP, 1988, BIOCHEMISTRY-US, V27, P1881, DOI 10.1021/bi00406a013; CLARKE AR, 1985, BIOCHIM BIOPHYS ACTA, V827, P358, DOI 10.1016/0167-4838(85)90220-1; Cohen DE, 2013, SEMIN LIVER DIS, V33, P380, DOI 10.1055/s-0033-1358519; Cohn JS, 2004, J CLIN ENDOCR METAB, V89, P3949, DOI 10.1210/jc.2003-032056; ECKEL RH, 1989, NEW ENGL J MED, V320, P1060; EKMAN R, 1975, CLIN CHIM ACTA, V63, P29, DOI 10.1016/0009-8981(75)90374-5; Gangabadage CS, 2008, J BIOL CHEM, V283, P17416, DOI 10.1074/jbc.M800756200; Hatters DM, 2002, EUR BIOPHYS J BIOPHY, V31, P2, DOI 10.1007/s002490100172; Hatters DM, 2000, BIOCHEMISTRY-US, V39, P8276, DOI 10.1021/bi000002w; HAVEL RJ, 1973, BIOCHEMISTRY-US, V12, P1828, DOI 10.1021/bi00733a026; HAVEL RJ, 1973, J CLIN INVEST, V52, P32, DOI 10.1172/JCI107171; HUFF MW, 1988, ARTERIOSCLEROSIS, V8, P471, DOI 10.1161/01.ATV.8.5.471; JACKSON RL, 1986, BIOCHIM BIOPHYS ACTA, V875, P211, DOI 10.1016/0005-2760(86)90170-0; JACKSON RL, 1979, BIOCHIM BIOPHYS ACTA, V556, P369, DOI 10.1016/0005-2736(79)90126-3; Jong MC, 1999, ARTERIOSCL THROM VAS, V19, P472, DOI 10.1161/01.ATV.19.3.472; Kei AA, 2012, METABOLISM, V61, P906, DOI 10.1016/j.metabol.2011.12.002; KINNUNEN PKJ, 1977, P NATL ACAD SCI USA, V74, P4848, DOI 10.1073/pnas.74.11.4848; KREBS KE, 1983, BIOCHIM BIOPHYS ACTA, V751, P470, DOI 10.1016/0005-2760(83)90308-9; Labourdenne S, 1997, METHOD ENZYMOL, V286, P306; LAROSA JC, 1970, BIOCHEM BIOPH RES CO, V41, P57, DOI 10.1016/0006-291X(70)90468-7; Larsson M, 2013, J BIOL CHEM, V288, P33997, DOI 10.1074/jbc.M113.495366; LEE AG, 1987, NATURE, V328, P486, DOI 10.1038/328486b0; Liu HQ, 2000, BIOCHEMISTRY-US, V39, P9201, DOI 10.1021/bi0009441; MacPhee CE, 1999, ANAL BIOCHEM, V275, P22, DOI 10.1006/abio.1999.4283; MacRaild CA, 2004, BIOCHEMISTRY-US, V43, P8084, DOI 10.1021/bi049817l; MacRaild CA, 2001, BIOCHEMISTRY-US, V40, P5414, DOI 10.1021/bi002821m; MCKEONE BJ, 1988, BIOCHEMISTRY-US, V27, P4500, DOI 10.1021/bi00412a042; MCLEAN LR, 1985, BIOCHEMISTRY-US, V24, P4196, DOI 10.1021/bi00336a057; Meyers NL, 2013, J LIPID RES, V54, P1927, DOI 10.1194/jlr.M037531; Meyers NL, 2012, BIOCHEMISTRY-US, V51, P1238, DOI 10.1021/bi2015212; MILLER KW, 1983, J BIOL CHEM, V258, P3772; Mitsche MA, 2014, J BIOL CHEM, V289, P9000, DOI 10.1074/jbc.M113.540955; Mitsche MA, 2013, J LIPID RES, V54, P1578, DOI 10.1194/jlr.M034462; Mitsche MA, 2011, BIOPHYS J, V101, P353, DOI 10.1016/j.bpj.2011.03.055; Mitsche MA, 2010, J PHYS CHEM B, V114, P3276, DOI 10.1021/jp908730t; Mitsche MA, 2009, LANGMUIR, V25, P2322, DOI 10.1021/la802663g; Murdoch SJ, 1996, BBA-LIPID LIPID MET, V1303, P222, DOI 10.1016/0005-2760(96)00105-1; Olivecrona G, 1997, ARTERIOSCL THROM VAS, V17, P1545, DOI 10.1161/01.ATV.17.8.1545; Ooi EMM, 2008, CLIN SCI, V114, P611, DOI 10.1042/CS20070308; SEGREST JP, 1990, PROTEINS, V8, P103, DOI 10.1002/prot.340080202; SEGREST JP, 1994, ADV PROTEIN CHEM, V45, P303; SEGREST JP, 1992, J LIPID RES, V33, P141; SEHAYEK E, 1991, J BIOL CHEM, V266, P18259; Shen Y, 2002, J BIOL CHEM, V277, P4334, DOI 10.1074/jbc.M105421200; Shen Y, 2010, J BIOL CHEM, V285, P7484, DOI 10.1074/jbc.M109.022046; Small DM, 2009, J LIPID RES, V50, pS329, DOI 10.1194/jlr.R800083-JLR200; Sparrow J T, 1980, Ann N Y Acad Sci, V348, P187, DOI 10.1111/j.1749-6632.1980.tb21300.x; Storjohann R, 2000, BBA-MOL CELL BIOL L, V1486, P253, DOI 10.1016/S1388-1981(00)00062-7; Sundaram M, 2010, J LIPID RES, V51, P150, DOI [10.1194/jlr.M900346-JLR200, 10.1194/M900346-JLR200]; VAINIO P, 1983, BIOCHEMISTRY-US, V22, P2270, DOI 10.1021/bi00278a033; VAINIO P, 1983, J BIOL CHEM, V258, P5477; WANG CS, 1985, J CLIN INVEST, V75, P384, DOI 10.1172/JCI111711; WANG CS, 1981, CLIN CHEM, V27, P663; WANG CS, 1991, PROG LIPID RES, V30, P253, DOI 10.1016/0163-7827(91)90022-W; Wang L, 2005, J BIOL CHEM, V280, P4154, DOI 10.1074/bc.M411618200; Wang L, 2007, BIOCHEMISTRY-US, V46, P12140, DOI 10.1021/bi7010114; Wang LB, 2014, J LIPID RES, V55, P478, DOI 10.1194/jlr.M044743; Weers PMM, 2003, BIOPHYS CHEM, V100, P481, DOI 10.1016/S0301-4622(02)00300-9; Weinberg RB, 2002, J BIOL CHEM, V277, P21549, DOI 10.1074/jbc.M202197200; Zdunek J, 2003, BIOCHEMISTRY-US, V42, P1872, DOI 10.1021/bi0267184	69	20	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					18029	18044		10.1074/jbc.M114.629865	http://dx.doi.org/10.1074/jbc.M114.629865			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26026161	Green Published, hybrid			2022-12-26	WOS:000358511700035
J	Arao, Y; Coons, LA; Zuercher, WJ; Korach, KS				Arao, Yukitomo; Coons, Laurel A.; Zuercher, William J.; Korach, Kenneth S.			Transactivation Function-2 of Estrogen Receptor alpha Contains Transactivation Function-1-regulating Element	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING DOMAIN; ASPARTATE 351; TAMOXIFEN; ACTIVATION; ANTAGONIST; PROMOTER; IDENTIFICATION; ANTIESTROGENS; RALOXIFENE; AGONIST	ER alpha has a ligand-dependent transactivation function in the ligand binding domain of ER alpha C terminus (AF-2) and a ligand-independent activation function in the N terminus (AF-1). It is still not fully understood how AF-1 and AF-2 activities are regulated cooperatively by ligands. To evaluate the AF-1 involvement in the estrogenic activities of various compounds, we analyzed these transactivation functions using AF-1-truncated and AF-2-mutated ER alpha mutants. AF-2 is composed of two domains with flexible and static regions. We used an AF-2 flexible region mutant and an AF-2 static region mutant. Both mutants have been reported as non-E2 responsive due to disruption of E2-mediated coactivator recruitment to the AF-2. The AF-2 mutants were not activated by agonists, but surprisingly antagonists and selective estrogen receptor modulators (SERMs) activated the AF-2 mutants. This antagonist reversal activity was derived from AF-1. Furthermore, we demonstrated that the AF-2 contains an AF-1 suppression function using C-terminal-truncated ER alpha mutants. From these findings we hypothesized that the mutation of AF-2 disrupted its ability to suppress AF-1, causing the antagonist reversal. To assess the AF-2-mediated AF-1 suppression, we analyzed the transcription activity of physically separated AF-1 and AF-2 using a novel hybrid reporter assay. We observed that the AF-1 activity was not suppressed by the physically separated AF-2. Furthermore, SERMs did not induce the AF-1-mediated activity from the separated mutant AF-2, which differed from the intact protein. These results imply that SERM activity is dependent on a conformational change of the full-length ER alpha molecule, which allows for AF-1 activation.	[Arao, Yukitomo; Coons, Laurel A.; Korach, Kenneth S.] NIEHS, Receptor Biol Sect, Reprod & Dev Biol Lab, NIH, Res Triangle Pk, NC 27709 USA; [Coons, Laurel A.] Duke Univ, Dept Pharmacol & Canc Biol, Med Ctr, Durham, NC 27710 USA; [Zuercher, William J.] GlaxoSmithKline, Dept Biol Chem, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Duke University; GlaxoSmithKline	Korach, KS (corresponding author), 111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	korach@niehs.nih.gov	Arao, Yukitomo/AAL-1665-2021	Arao, Yukitomo/0000-0003-1560-351X; Korach, Kenneth/0000-0002-7765-418X; Coons, Laurel/0000-0001-7132-2996	National Institutes of Health (Division of Intramural Research of the NIEHS) [Z01ES70065]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES070065] Funding Source: NIH RePORTER	National Institutes of Health (Division of Intramural Research of the NIEHS); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant Z01ES70065 (Division of Intramural Research of the NIEHS; to K. S. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Anghel SI, 2000, J BIOL CHEM, V275, P20867, DOI 10.1074/jbc.M002098200; Arao Y, 2013, J BIOL CHEM, V288, P21105, DOI 10.1074/jbc.M113.463455; Arao Y, 2012, P NATL ACAD SCI USA, V109, P21140, DOI 10.1073/pnas.1216189110; Arao Y, 2011, P NATL ACAD SCI USA, V108, P14986, DOI 10.1073/pnas.1109180108; Benecke A, 2000, EMBO REP, V1, P151, DOI 10.1093/embo-reports/kvd028; BERRY M, 1990, EMBO J, V9, P2811, DOI 10.1002/j.1460-2075.1990.tb07469.x; Blair RM, 2000, TOXICOL SCI, V54, P138, DOI 10.1093/toxsci/54.1.138; Bourguet W, 2000, TRENDS PHARMACOL SCI, V21, P381, DOI 10.1016/S0165-6147(00)01548-0; Carascossa S, 2010, GENE DEV, V24, P708, DOI 10.1101/gad.568410; Coldham NG, 1997, ENVIRON HEALTH PERSP, V105, P734, DOI 10.1289/ehp.97105734; Couse JF, 1999, ENDOCR REV, V20, P358, DOI 10.1210/er.20.3.358; Dayan G, 2006, MOL PHARMACOL, V70, P579, DOI 10.1124/mol.105.021931; Jordan VC, 2003, NAT REV DRUG DISCOV, V2, P205, DOI 10.1038/nrd1031; Jordan VC, 1999, ENDOCR REV, V20, P253, DOI 10.1210/edrv.20.3.0368; Lannigan DA, 2003, STEROIDS, V68, P1, DOI 10.1016/S0039-128X(02)00110-1; Liu H, 2001, CANCER RES, V61, P3632; Mak HY, 1999, MOL CELL BIOL, V19, P3895; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; MCDONNELL DP, 1995, MOL ENDOCRINOL, V9, P659, DOI 10.1210/me.9.6.659; Metivier R, 2002, MOL CELL, V10, P1019, DOI 10.1016/S1097-2765(02)00746-3; Nettles KW, 2005, ANNU REV PHYSIOL, V67, P309, DOI 10.1146/annurev.physiol.66.032802.154710; Norris JD, 1996, MOL ENDOCRINOL, V10, P1605, DOI 10.1210/mend.10.12.8961270; Pike ACW, 1999, EMBO J, V18, P4608, DOI 10.1093/emboj/18.17.4608; Waller CL, 1996, CHEM RES TOXICOL, V9, P1240, DOI 10.1021/tx960054f; Wu YL, 2005, MOL CELL, V18, P413, DOI 10.1016/j.molcel.2005.04.014; Yoon K, 2001, J STEROID BIOCHEM, V78, P25, DOI 10.1016/S0960-0760(01)00070-X; Yoon K, 2000, MOL CELL ENDOCRINOL, V162, P211, DOI 10.1016/S0303-7207(99)00261-0; Zwart W, 2007, EMBO J, V26, P3534, DOI 10.1038/sj.emboj.7601791	28	15	15	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17611	17627		10.1074/jbc.M115.638650	http://dx.doi.org/10.1074/jbc.M115.638650			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	26028650	hybrid, Green Published			2022-12-26	WOS:000357730900051
J	Florencio, M; Lobo, JM; Cardoso, P; Almeida-Neto, M; Borges, PAV				Florencio, Margarita; Lobo, Jorge M.; Cardoso, Pedro; Almeida-Neto, Mario; Borges, Paulo A. V.			The Colonisation of Exotic Species Does Not Have to Trigger Faunal Homogenisation: Lessons from the Assembly Patterns of Arthropods on Oceanic Islands	PLOS ONE			English	Article							NESTED SUBSET PATTERNS; BIOTIC HOMOGENIZATION; BETA-DIVERSITY; TAXONOMIC HOMOGENIZATION; POLLINATION NETWORKS; FUNCTIONAL DIVERSITY; PLANT INVASIONS; ALIEN; MODEL; CONSERVATION	Human-caused disturbances can lead to the extinction of indigenous (endemic and native) species, while facilitating and increasing the colonisation of exotic species; this increase can, in turn, promote the similarity of species compositions between sites if human-disturbed sites are consistently invaded by a regionally species-poor pool of exotic species. In this study, we analysed the extent to which epigean arthropod assemblages of four islands of the Azorean archipelago are characterised by nestedness according to a habitat-altered gradient. The degree of nestedness represents the extent to which less ubiquitous species occur in subsets of sites occupied by the more widespread species, resulting in an ordered loss/gain of species across environmental or ecological gradients. A predictable loss of species across communities while maintaining others may lead to more similar communities (i.e. lower beta-diversity). In contrast, anti-nestedness occurs when different species tend to occupy distinct sites, thus characterising a replacement of species across such gradients. Our results showed that an increase in exotic species does not promote assemblage homogenisation at the habitat level. On the contrary, exotic species were revealed as habitat specialists that constitute new and well-differentiated assemblages, even increasing the species compositional heterogeneity within human-altered landscapes. Therefore, contrary to expectations, our results show that both indigenous and exotic species established idiosyncratic assemblages within habitats and islands. We suggest that both the historical extinction of indigenous species in disturbed habitats and the habitat-specialised character of some exotic invasions have contributed to the construction of current assemblages.	[Florencio, Margarita; Cardoso, Pedro; Borges, Paulo A. V.] Univ Acores, Ctr Ecol Evolut & Environm Changes CE3C, Azorean Biodivers Grp, Dept Ciencias Agr, Angra Do Heroismo, Acores, Portugal; [Florencio, Margarita; Cardoso, Pedro; Borges, Paulo A. V.] Univ Acores, CITA A, Dept Ciencias Agr, Angra Do Heroismo, Acores, Portugal; [Florencio, Margarita; Almeida-Neto, Mario] Univ Fed Goias, Dept Ecol, Inst Ciencias Biol, Goiania, Go, Brazil; [Lobo, Jorge M.] CSIC, Museo Nacl Ciencias Nat, Dept Biogeog & Global Change, E-28006 Madrid, Spain; [Cardoso, Pedro] Univ Helsinki, Finnish Museum Nat Hist, Helsinki, Finland	Universidade dos Acores; Universidade dos Acores; Universidade Federal de Goias; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); University of Helsinki	Florencio, M (corresponding author), Univ Acores, Ctr Ecol Evolut & Environm Changes CE3C, Azorean Biodivers Grp, Dept Ciencias Agr, Angra Do Heroismo, Acores, Portugal.	mflorenciodiaz@gmail.com	Borges, Paulo/B-2780-2008; Borges, Paulo/H-5153-2019; Cardoso, Pedro/A-8820-2008; Lobo, Jorge M/E-2309-2013; Florencio, Margarita/J-5566-2016; Almeida-Neto, M./A-6389-2009; Cardoso, Pedro/AAY-9650-2020	Borges, Paulo/0000-0002-8448-7623; Borges, Paulo/0000-0002-8448-7623; Cardoso, Pedro/0000-0001-8119-9960; Lobo, Jorge M/0000-0002-3152-4769; Florencio, Margarita/0000-0002-6688-7770; Almeida-Neto, M./0000-0002-2161-2968; Cardoso, Pedro/0000-0001-8119-9960	project "Consequences of land-use change on Azorean fauna and flora - the Target" [M.2.1.2/I/003/2008]; Mapping coastal and marine biodiversity of the Azores [M2.1.2/I/027/2011]; Direccao Regional da Ciencia, Tecnologia e Comunicacoes (DRCT) [M3.1.7/F/002/2011]	project "Consequences of land-use change on Azorean fauna and flora - the Target"; Mapping coastal and marine biodiversity of the Azores; Direccao Regional da Ciencia, Tecnologia e Comunicacoes (DRCT)	For data collection, financial support was provided by the project "Consequences of land-use change on Azorean fauna and flora - the 2010 Target" (Ref: Direccao Regional da Ciencia e Tecnologia M.2.1.2/I/003/2008) and "Mapping coastal and marine biodiversity of the Azores" (Ref: M2.1.2/I/027/2011). MF received a Postdoctoral Grant: Direccao Regional da Ciencia, Tecnologia e Comunicacoes (DRCT) (M3.1.7/F/002/2011).	Alcaraz C, 2005, DIVERS DISTRIB, V11, P289, DOI 10.1111/j.1366-9516.2005.00170.x; Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; Almeida M, 2007, OIKOS, V116, P716, DOI 10.1111/j.2007.0030-1299.15803.x; Almeida-Neto M, 2012, GLOBAL ECOL BIOGEOGR, V21, P772, DOI 10.1111/j.1466-8238.2011.00709.x; Almeida-Neto M, 2011, ENVIRON MODELL SOFTW, V26, P173, DOI 10.1016/j.envsoft.2010.08.003; Angeler DG, 2008, MAR FRESHWATER RES, V59, P418, DOI 10.1071/MF07206; ATMAR W, 1993, OECOLOGIA, V96, P373, DOI 10.1007/BF00317508; Baiser B, 2012, P ROY SOC B-BIOL SCI, V279, P4772, DOI 10.1098/rspb.2012.1651; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; Blackburn TM, 2011, TRENDS ECOL EVOL, V26, P333, DOI 10.1016/j.tree.2011.03.023; Blackburn TM, 2004, SCIENCE, V305, P1955, DOI 10.1126/science.1101617; Blair R, 2004, ECOL SOC, V9; Blair RB, 2001, BIOTIC HOMOGENIZATION, P33; Borges PAV, 2006, J BIOGEOGR, V33, P169, DOI 10.1111/j.1365-2699.2005.01324.x; Borges PAV., 2010, LISTAGEM ORGANISMOS, P179; Cam E, 2000, OIKOS, V91, P428, DOI 10.1034/j.1600-0706.2000.910303.x; Cardoso P, 2015, METHODS ECOL EVOL, V6, P232, DOI 10.1111/2041-210X.12310; Cardoso P, 2014, J BIOGEOGR, V41, P749, DOI 10.1111/jbi.12239; Cardoso P, 2009, DIVERS DISTRIB, V15, P1081, DOI 10.1111/j.1472-4642.2009.00607.x; Cardoso P, 2009, ACTA OECOL, V35, P590, DOI 10.1016/j.actao.2009.05.005; Carvalho JC, 2012, GLOBAL ECOL BIOGEOGR, V21, P760, DOI 10.1111/j.1466-8238.2011.00694.x; Cassey P, 2007, DIVERS DISTRIB, V13, P458, DOI 10.1111/j.1472-4642.2007.00366.x; Castro SA, 2007, J BIOGEOGR, V34, P213, DOI 10.1111/j.1365-2699.2006.01605.x; CUTLER AH, 1994, LANDSCAPE URBAN PLAN, V28, P73, DOI 10.1016/0169-2046(94)90045-0; Florencio M, 2013, DIVERS DISTRIB, V19, P1450, DOI 10.1111/ddi.12121; Florencio M, 2011, OECOLOGIA, V166, P469, DOI 10.1007/s00442-010-1847-2; Gasso N, 2009, DIVERS DISTRIB, V15, P50, DOI 10.1111/j.1472-4642.2008.00501.x; Gotelli NJ, 2012, OIKOS, V121, P171, DOI 10.1111/j.1600-0706.2011.20301.x; Higgins CL, 2006, OIKOS, V114, P159; Lambdon PW, 2008, DIVERS DISTRIB, V14, P774, DOI 10.1111/j.1472-4642.2008.00490.x; McAbendroth L, 2005, J ANIM ECOL, V74, P41, DOI 10.1111/j.1365-2656.2004.00895.x; McCune JL, 2013, J ECOL, V101, P1542, DOI 10.1111/1365-2745.12156; McKinney M, 2008, J BIOGEOGR, V35, P1960, DOI 10.1111/j.1365-2699.2008.02011.x; McKinney ML, 2004, BIOL INVASIONS, V6, P495, DOI 10.1023/B:BINV.0000041562.31023.42; McKinney ML, 1999, TRENDS ECOL EVOL, V14, P450, DOI 10.1016/S0169-5347(99)01679-1; Naaf T, 2010, BIOL CONSERV, V143, P848, DOI 10.1016/j.biocon.2009.12.027; Olden JD, 2006, GLOBAL ECOL BIOGEOGR, V15, P113, DOI 10.1111/j.1466-822x.2006.00214.x; Olden JD, 2003, AM NAT, V162, P442, DOI 10.1086/378212; Olden JD, 2006, J BIOGEOGR, V33, P2027, DOI 10.1111/j.1365-2699.2006.01572.x; Olesen JM, 2002, DIVERS DISTRIB, V8, P181, DOI 10.1046/j.1472-4642.2002.00148.x; Padron B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006275; PATTERSON BD, 1990, OIKOS, V59, P330, DOI 10.2307/3545143; Podani J, 2013, ECOL COMPLEX, V15, P52, DOI 10.1016/j.ecocom.2013.03.002; Podani J, 2011, OIKOS, V120, P1625, DOI 10.1111/j.1600-0706.2011.19451.x; Poulin R, 2000, INT J PARASITOL, V30, P1147, DOI 10.1016/S0020-7519(00)00102-8; R Development Core Team, 2012, R LANG ENV STAT COMP; Rogers DA, 2008, ECOLOGY, V89, P2482, DOI 10.1890/07-1129.1; Rooney TP, 2004, CONSERV BIOL, V18, P787, DOI 10.1111/j.1523-1739.2004.00515.x; Ruhi A, 2013, OECOLOGIA, V171, P545, DOI 10.1007/s00442-012-2440-7; Sax DF, 2001, J BIOGEOGR, V28, P139, DOI 10.1046/j.1365-2699.2001.00536.x; Schlaepfer MA, 2011, CONSERV BIOL, V25, P428, DOI 10.1111/j.1523-1739.2010.01646.x; Shaw JD, 2010, J BIOGEOGR, V37, P217, DOI 10.1111/j.1365-2699.2009.02204.x; Thompson K, 1995, ECOGRAPHY, V18, P390, DOI 10.1111/j.1600-0587.1995.tb00142.x; Traveset A, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.3040; Triantis KA, 2010, ECOGRAPHY, V33, P285, DOI 10.1111/j.1600-0587.2010.06203.x; Ulrich W, 2007, ECOLOGY, V88, P1824, DOI 10.1890/06-1208.1; Ulrich W, 2012, ECOGRAPHY, V35, P865, DOI 10.1111/j.1600-0587.2012.07671.x; Ulrich W, 2012, ECOL MODEL, V244, P20, DOI 10.1016/j.ecolmodel.2012.06.030; Ulrich W, 2009, OIKOS, V118, P3, DOI 10.1111/j.1600-0706.2008.17053.x; Van Calster H, 2007, FOREST ECOL MANAG, V241, P258, DOI 10.1016/j.foreco.2007.01.007; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Whittaker RJ, 2014, P NATL ACAD SCI USA, V111, P13709, DOI 10.1073/pnas.1218036111; Williams PH, 1996, P ROY SOC B-BIOL SCI, V263, P579, DOI 10.1098/rspb.1996.0087; Wright DH, 1998, OECOLOGIA, V113, P1, DOI 10.1007/s004420050348; Yelenik SG, 2013, NATURE, V503, P517, DOI 10.1038/nature12798	67	15	15	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128276	10.1371/journal.pone.0128276	http://dx.doi.org/10.1371/journal.pone.0128276			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024235	Green Published, gold, Green Submitted			2022-12-26	WOS:000355319400078
J	Metushi, IG; Wriston, A; Banerjee, P; Gohlke, BO; English, M; Lucas, A; Moore, C; Sidney, J; Buus, S; Ostrov, DA; Mallal, S; Phillips, E; Shabanowitz, J; Hunt, DF; Preissner, R; Peters, B				Metushi, Imir G.; Wriston, Amanda; Banerjee, Priyanka; Gohlke, Bjoern Oliver; English, Michelle; Lucas, Andrew; Moore, Carrie; Sidney, John; Buus, Soren; Ostrov, David A.; Mallal, Simon; Phillips, Elizabeth; Shabanowitz, Jeffrey; Hunt, Donald F.; Preissner, Robert; Peters, Bjoern			Acyclovir Has Low but Detectable Influence on HLA-B*57:01 Specificity without Inducing Hypersensitivity	PLOS ONE			English	Article							ELECTRON-TRANSFER DISSOCIATION; REACTION SUBSEQUENT; DRUG; HLA; PEPTIDES; DATABASE	Immune mediated adverse drug reactions (IM-ADRs) remain a significant source of patient morbidity that have more recently been shown to be associated with specific class I and/or II human leukocyte antigen (HLA) alleles. Abacavir-induced hypersensitivity syndrome is a CD8(+) T cell dependent IM-ADR that is exclusively mediated by HLA-B*57:01. We and others have previously shown that abacavir can occupy the floor of the peptide binding groove of HLA-B*57:01 molecules, increasing the affinity of certain self peptides resulting in an altered peptide-binding repertoire. Here, we have identified another drug, acyclovir, which appears to act in a similar fashion. As with abacavir, acyclovir showed a dose dependent increase in affinity for peptides with valine and isoleucine at their C-terminus. In agreement with the binding studies, HLA-B57:01 peptide-elution studies performed in the presence of acyclovir revealed an increased number of endogenously bound peptides with a C-terminal isoleucine. Accordingly, we have hypothesized that acyclovir acts by the same mechanism as abacavir, although our data also suggest the overall effect is much smaller: the largest changes of peptide affinity for acyclovir were 2-5 fold, whereas for abacavir this effect was as much as 1000-fold. Unlike abacavir, acyclovir is not known to cause IM-ADRs. We conclude that the modest effect of acyclovir on HLA binding affinity in contrast to the large effect of abacavir is insufficient to trigger a hypersensitivity syndrome. We further support this by functional in vitro studies where acyclovir, unlike abacavir, was unable to produce an increase in IFN-gamma upon expansion of HLA-B*57:01(+) PBMCs from healthy donors. Using abacavir and acyclovir as examples we therefore propose an in vitro pre-clinical screening strategy, whereby thresholds can be applied to MHC-peptide binding assays to determine the likelihood that a drug could cause a clinically relevant IM-ADR.	[Metushi, Imir G.; Moore, Carrie; Sidney, John; Peters, Bjoern] La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA 92037 USA; [Wriston, Amanda; English, Michelle; Shabanowitz, Jeffrey; Hunt, Donald F.] Univ Virginia, Dept Chem, Charlottesville, VA USA; [Banerjee, Priyanka; Gohlke, Bjoern Oliver; Preissner, Robert] Charite, Inst Physiol, D-13353 Berlin, Germany; [Banerjee, Priyanka; Gohlke, Bjoern Oliver; Preissner, Robert] Expt Clin Res Ctr, Berlin, Germany; [Banerjee, Priyanka; Preissner, Robert] Humboldt Univ, Grad Sch Computat Syst Biol, D-10099 Berlin, Germany; [Gohlke, Bjoern Oliver; Preissner, Robert] German Canc Consortium DKTK, Heidelberg, Germany; [Lucas, Andrew; Mallal, Simon; Phillips, Elizabeth] Murdoch Univ, Inst Immunol & Infect Dis, Murdoch, WA 6150, Australia; [Buus, Soren] Univ Copenhagen, Fac Hlth Sci, Expt Immunol Lab, Copenhagen, Denmark; [Ostrov, David A.] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL USA; [Mallal, Simon; Phillips, Elizabeth] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Hunt, Donald F.] Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA	La Jolla Institute for Immunology; University of Virginia; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin; Helmholtz Association; German Cancer Research Center (DKFZ); Murdoch University; University of Copenhagen; State University System of Florida; University of Florida; Vanderbilt University; University of Virginia	Peters, B (corresponding author), La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA 92037 USA.	bpeters@liai.org	Mallal, Simon Alexander/HDM-9561-2022	Mallal, Simon Alexander/0000-0002-7036-1309; Lucas, Andrew Douglas/0000-0003-2899-1806; preissner, robert/0000-0002-2407-1087; Lucas, Michaela/0000-0001-8881-9990; banerjee, priyanka/0000-0001-8072-5594; Gohlke, Bjoern/0000-0003-3094-1031	National Institutes of Health (NIH) [RO1-AI103348-02]; European Union Seventh Frame work Pro-gramme SYNSYS; Berlin-Brandenburg Research Platform BB3R (BMBF) [031A262C]; Innovative Toxicology for the Reduction of Animal Experimentation (e:ToP), Immunotox Project (BMBF) [031A268B]; NIH [AI 33993];  [HEALTH -2009-2.1.2-1 [242167]]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI033993, R01AI033993] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union Seventh Frame work Pro-gramme SYNSYS; Berlin-Brandenburg Research Platform BB3R (BMBF)(Federal Ministry of Education & Research (BMBF)); Innovative Toxicology for the Reduction of Animal Experimentation (e:ToP), Immunotox Project (BMBF); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) grant number RO1-AI103348-02; European Union Seventh Frame work Pro-gramme SYNSYS; HEALTH -2009-2.1.2-1 [242167]; Berlin-Brandenburg Research Platform BB3R (BMBF) [031A262C]; Innovative Toxicology for the Reduction of Animal Experimentation (e:ToP), Immunotox Project (BMBF) [031A268B]. NIH grant number AI 33993 to (DFH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LC, 2015, INT J MASS SPECTROM, V377, P617, DOI 10.1016/j.ijms.2014.06.023; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P45, DOI 10.1093/nar/28.1.45; Bauer RA, 2008, NUCLEIC ACIDS RES, V36, pW47, DOI 10.1093/nar/gkn285; Chessman D, 2008, IMMUNITY, V28, P822, DOI 10.1016/j.immuni.2008.04.020; Earley L, 2013, ANAL CHEM, V85, P8385, DOI 10.1021/ac401783f; Eckert H, 2007, DRUG DISCOV TODAY, V12, P225, DOI 10.1016/j.drudis.2007.01.011; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Illing PT, 2012, NATURE, V486, P554, DOI 10.1038/nature11147; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Lammintausta K, 2001, CONTACT DERMATITIS, V45, P181, DOI 10.1034/j.1600-0536.2001.045003181.x; Lucas A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117160; Mallal S, 2008, NEW ENGL J MED, V358, P568, DOI 10.1056/NEJMoa0706135; Mir-Bonafe JM, 2013, TRANSPL INFECT DIS, V15, pE75, DOI 10.1111/tid.12058; Norcross MA, 2012, AIDS, V26, pF21, DOI 10.1097/QAD.0b013e328355fe8f; Ostrov DA, 2012, P NATL ACAD SCI USA, V109, P9959, DOI 10.1073/pnas.1207934109; Pavlos R, 2012, PHARMACOGENOMICS, V13, P1285, DOI [10.2217/PGS.12.108, 10.2217/pgs.12.108]; Pompeu YA, 2012, IMMUNOL REV, V250, P158, DOI 10.1111/j.1600-065X.2012.01163.x; ROBINSON GE, 1985, GENITOURIN MED, V61, P62; SHIMIZU Y, 1989, J IMMUNOL, V142, P3320; Sidney J, 2001, Curr Protoc Immunol, VChapter 18, DOI 10.1002/0471142735.im1803s31; Sidney J., 2013, CURR PROTOC IMMUNOL, V100, p18.3.1, DOI [DOI 10.1002/0471142735.IM1803S100, 10.1002/0471142735.im1803s100]; Sidney John, 2008, Immunome Res, V4, P2, DOI 10.1186/1745-7580-4-2; Tenzer S, 2005, CELL MOL LIFE SCI, V62, P1025, DOI 10.1007/s00018-005-4528-2; Udeshi ND, 2008, NAT PROTOC, V3, P1709, DOI 10.1038/nprot.2008.159; Vernassiere C, 2003, CONTACT DERMATITIS, V49, P155, DOI 10.1111/j.0105-1873.2003.00199.x; Willett P, 1998, J CHEM INF COMP SCI, V38, P983, DOI 10.1021/ci9800211	27	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0124878	10.1371/journal.pone.0124878	http://dx.doi.org/10.1371/journal.pone.0124878			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024233	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000355319400006
J	Pignon, JC; Grisanzio, C; Carvo, I; Werner, L; Regan, M; Wilson, EL; Signoretti, S				Pignon, Jean-Christophe; Grisanzio, Chiara; Carvo, Ingrid; Werner, Lillian; Regan, Meredith; Wilson, E. Lynette; Signoretti, Sabina			Cell Kinetic Studies Fail to Identify Sequentially Proliferating Progenitors as the Major Source of Epithelial Renewal in the Adult Murine Prostate	PLOS ONE			English	Article							INVOLVE SPECIALIZED PROGENITORS; ANDROGEN-INDUCED REGENERATION; STEM-CELLS; MOUSE PROSTATE; LUMINAL CELLS; REGIONAL-VARIATION; DUCTAL SYSTEM; RAT PROSTATE; BASAL-CELLS; BETA-CELLS	There is evidence that stem cells and their progeny play a role in the development of the prostate. Although stem cells are also considered to give rise to differentiated progeny in the adult prostate epithelium ex vivo, the cohort of adult prostate stem cells in vivo as well as the mechanisms by which the adult prostate epithelium is maintained and regenerated remain highly controversial. We have attempted to resolve this conundrum by performing in vivo tracing of serially replicating cells after the sequential administration of two thymidine analogues to mice. Our results show that, during normal prostate homeostasis, sequentially proliferating cells are detected at a rate that is consistent with a stochastic process. These findings indicate that in vivo, under steady-state conditions, most adult prostate epithelial cells do not represent the progeny of a small number of specialized progenitors that generate sequentially replicating transit-amplifying (TA) cells but are formed by stochastic cell division. Similarly, no rapidly cycling TA cells were detected during regeneration following one cycle of androgen-mediated involution/regeneration of the prostate epithelium. These findings greatly enhance our understanding of the mechanisms regulating prostate epithelial cell renewal and may have significant implications in defining the cell of origin of proliferative prostatic diseases.	[Pignon, Jean-Christophe; Grisanzio, Chiara; Carvo, Ingrid; Signoretti, Sabina] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Pignon, Jean-Christophe; Grisanzio, Chiara; Werner, Lillian; Regan, Meredith; Signoretti, Sabina] Harvard Univ, Sch Med, Boston, MA USA; [Grisanzio, Chiara; Signoretti, Sabina] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Werner, Lillian; Regan, Meredith] Dana Farber Canc Inst, Biostat & Computat Biol, Boston, MA 02115 USA; [Wilson, E. Lynette] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Wilson, E. Lynette] NYU, Sch Med, Dept Urol, New York, NY 10003 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; New York University; New York University	Signoretti, S (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.	ssignoretti@partners.org			National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases Grants [1R21DK72152, 1R01DK089975]; Harvard Stem Cell Institute [5R01CA132641]; NATIONAL CANCER INSTITUTE [P30CA016087, R01CA132641] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK072152, R01DK089975] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases Grants; Harvard Stem Cell Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases Grants 1R21DK72152 and 1R01DK089975 and the Harvard Stem Cell Institute (SS) and 5R01CA132641 (ELW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackwood JK, 2011, J PATHOL, V225, P181, DOI 10.1002/path.2965; Burger PE, 2005, P NATL ACAD SCI USA, V102, P7180, DOI 10.1073/pnas.0502761102; Choi N, 2012, CANCER CELL, V21, P253, DOI 10.1016/j.ccr.2012.01.005; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; ENGLISH HF, 1987, PROSTATE, V11, P229, DOI 10.1002/pros.2990110304; EVANS GS, 1987, PROSTATE, V11, P339, DOI 10.1002/pros.2990110406; EVANS GS, 1987, PROSTATE, V10, P163, DOI 10.1002/pros.2990100208; Fausto N, 2003, MECH DEVELOP, V120, P117, DOI 10.1016/S0925-4773(02)00338-6; Gaisa NT, 2011, J PATHOL, V225, P172, DOI 10.1002/path.2959; Goldstein AS, 2010, SCIENCE, V329, P568, DOI 10.1126/science.1189992; Goldstein AS, 2008, P NATL ACAD SCI USA, V105, P20882, DOI 10.1073/pnas.0811411106; Goto K, 2006, STEM CELLS, V24, P1859, DOI 10.1634/stemcells.2005-0585; GRATZNER HG, 1982, SCIENCE, V218, P474, DOI 10.1126/science.7123245; Hudson DL, 2000, LAB INVEST, V80, P1243, DOI 10.1038/labinvest.3780132; Humphreys BD, 2011, P NATL ACAD SCI USA, V108, P9226, DOI 10.1073/pnas.1100629108; Korsten H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005662; Kwon OJ, 2014, P NATL ACAD SCI USA, V111, pE592, DOI 10.1073/pnas.1318157111; Lamb LE, 2010, J CELL SCI, V123, P266, DOI 10.1242/jcs.054502; Lansdorp PM, 2007, CELL, V129, P1244, DOI 10.1016/j.cell.2007.06.017; Lawson DA, 2007, P NATL ACAD SCI USA, V104, P181, DOI 10.1073/pnas.0609684104; LEE C, 1990, BIOL REPROD, V43, P1079, DOI 10.1095/biolreprod43.6.1079; Liu J, 2011, MOL ENDOCRINOL, V25, P1849, DOI 10.1210/me.2011-1081; Mirosevich J, 1999, J ENDOCRINOL, V162, P341, DOI 10.1677/joe.0.1620341; Nemeth JA, 1996, PROSTATE, V28, P124; Ousset M, 2012, NAT CELL BIOL, V14, P1130, DOI 10.1038/ncb2600; Pignon JC, 2013, P NATL ACAD SCI USA, V110, P8105, DOI 10.1073/pnas.1221216110; Pine SR, 2010, P NATL ACAD SCI USA, V107, P2195, DOI 10.1073/pnas.0909390107; Rando TA, 2007, CELL, V129, P1239, DOI 10.1016/j.cell.2007.06.019; Robinson EJ, 1998, PROSTATE, V37, P149, DOI 10.1002/(SICI)1097-0045(19981101)37:3<149::AID-PROS4>3.0.CO;2-E; Rocheteau P, 2012, CELL, V148, P112, DOI 10.1016/j.cell.2011.11.049; ROOP DR, 1984, J BIOL CHEM, V259, P8037; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Senyo SE, 2013, NATURE, V493, P433, DOI 10.1038/nature11682; SUGIMURA Y, 1986, BIOL REPROD, V34, P973, DOI 10.1095/biolreprod34.5.973; Teta M, 2007, DEV CELL, V12, P817, DOI 10.1016/j.devcel.2007.04.011; Tran CP, 2002, MOL CANCER RES, V1, P113; Tsujimura A, 2002, J CELL BIOL, V157, P1257, DOI 10.1083/jcb.200202067; van Leenders G, 2000, LAB INVEST, V80, P1251, DOI 10.1038/labinvest.3780133; Waltregny D, 2001, MOL ENDOCRINOL, V15, P765, DOI 10.1210/me.15.5.765; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; Wang ZA, 2013, NAT CELL BIOL, V15, P274, DOI 10.1038/ncb2697; Xu C, 2007, PROSTATE, V67, P1621, DOI 10.1002/pros.20655	43	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128489	10.1371/journal.pone.0128489	http://dx.doi.org/10.1371/journal.pone.0128489			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024527	Green Published, gold, Green Submitted			2022-12-26	WOS:000355319400093
J	Walenda, T; Diener, Y; Jost, E; Morin-Kensicki, E; Goecke, TW; Bosio, A; Rath, B; Brummendorf, TH; Bissels, U; Wagner, W				Walenda, Thomas; Diener, Yvonne; Jost, Edgar; Morin-Kensicki, Elizabeth; Goecke, Tamme W.; Bosio, Andreas; Rath, Bjoern; Bruemmendorf, Tim H.; Bissels, Ute; Wagner, Wolfgang			MicroRNAs and Metabolites in Serum Change after Chemotherapy: Impact on Hematopoietic Stem and Progenitor Cells	PLOS ONE			English	Article							SELF-RENEWAL; CIRCULATING MICRORNAS; ARACHIDONIC-ACID; BILE-ACIDS; IN-VIVO; PLASMA; PROLIFERATION; MAINTENANCE; CHALLENGES; MECHANISM	Hematopoietic regeneration after high dose chemotherapy necessitates activation of the stem cell pool. There is evidence that serum taken after chemotherapy comprises factors stimulating proliferation and self-renewal of CD34(+) hematopoietic stem and progenitor cells (HSPCs) - however, the nature of these feedback signals is yet unclear. Here, we addressed the question if specific microRNAs (miRNAs) or metabolites are affected after high dose chemotherapy. Serum taken from the same patients before and after chemotherapy was supplemented for in vitro cultivation of HSPCs. Serum taken after chemotherapy significantly enhanced HSPC proliferation, better maintained a CD34(+) immunophenotype, and stimulated colony forming units. Microarray analysis revealed that 23 miRNAs changed in serum after chemotherapy - particularly, miRNA-320c and miRNA-1275 were down-regulated whereas miRNA-3663-3p was up-regulated. miRNA-320c was exemplarily inhibited by an antagomiR, which seemed to increase proliferation. Metabolomic profiling demonstrated that 44 metabolites were less abundant, whereas three (including 2-hydroxybutyrate and taurocholenate sulphate) increased in serum upon chemotherapy. Nine of these metabolites were subsequently tested for effects on HSPCs in vitro, but none of them exerted a clear concentration dependent effect on proliferation, immunophenotype and colony forming unit formation. Taken together, serum profiles of miRNAs and metabolites changed after chemotherapy. Rather than individually, these factors may act in concert to recruit HSPCs into action for hematopoietic regeneration.	[Walenda, Thomas; Wagner, Wolfgang] Rhein Westfal TH Aachen, Sch Med, Helmholtz Inst Biomed Engn, Aachen, Germany; [Diener, Yvonne; Bosio, Andreas; Bissels, Ute] Miltenyi Biotec GmbH, Bergisch Gladbach, Germany; [Jost, Edgar; Bruemmendorf, Tim H.] Rhein Westfal TH Aachen, Sch Med, Dept Hematol Oncol Hemostaseol & Stem Cell Transp, Aachen, Germany; [Morin-Kensicki, Elizabeth] Metabolon Inc, Durham, NC 27519 USA; [Goecke, Tamme W.] Rhein Westfal TH Aachen, Sch Med, Dept Obstet & Gynecol, Aachen, Germany; [Rath, Bjoern] Rhein Westfal TH Aachen, Sch Med, Dept Orthoped, Aachen, Germany	Helmholtz Association; RWTH Aachen University; Miltenyi Biotec; RWTH Aachen University; Metabolon; RWTH Aachen University; RWTH Aachen University	Wagner, W (corresponding author), Rhein Westfal TH Aachen, Sch Med, Helmholtz Inst Biomed Engn, Aachen, Germany.	wwagner@ukaachen.de	Rath, Björn/AFI-8239-2022; Rath, Björn/AAF-3938-2022	Bosio, Andreas/0000-0001-9776-2535; Wagner, Wolfgang/0000-0002-1971-3217	German Research Foundation [WA1706/2-1]; Stem Cell Network North Rhine Westphalia; Faculty of Medicine RWTH Aachen University within the START-Program [891208]; Interdisciplinary Center for Clinical Research [O1-1]; Miltenyi Biotec GmbH; Metabolon Inc.	German Research Foundation(German Research Foundation (DFG)); Stem Cell Network North Rhine Westphalia; Faculty of Medicine RWTH Aachen University within the START-Program; Interdisciplinary Center for Clinical Research; Miltenyi Biotec GmbH; Metabolon Inc.	This work was supported by German Research Foundation (WW; WA1706/2-1; www.dfg.de), Stem Cell Network North Rhine Westphalia (WW; www.stammzellen.nrw.de/), Faculty of Medicine RWTH Aachen University within the START-Program (TW; 891208; www.medizin.rwth-aachen.de/go/id/tfy), Interdisciplinary Center for Clinical Research (EJ, WW; O1-1; http://www.medizin.rwth-aachen.de). Miltenyi Biotec GmbH and Metabolon Inc. provided support in the form of salaries for authors YD, EMK, AB and UB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bissels U, 2012, HAEMATOL-HEMATOL J, V97, P160, DOI 10.3324/haematol.2011.051730; Blank U, 2008, BLOOD, V111, P492, DOI 10.1182/blood-2007-07-075168; Boudonck KJ, 2009, TOXICOL PATHOL, V37, P280, DOI 10.1177/0192623309332992; Brown JA, 2008, CLIN IMMUNOL, V127, P286, DOI 10.1016/j.clim.2008.02.008; Canpolat S, 2014, SCI WORLD J, DOI 10.1155/2014/624395; Chavali S, 2013, RNA, V19, P1552, DOI 10.1261/rna.038414.113; Chotinantakul K, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/909812; Desplat V, 2000, BLOOD CELL MOL DIS, V26, P427, DOI 10.1006/bcmd.2000.0321; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Farshidfar F, 2012, GENOME MED, V4, DOI 10.1186/gm341; Fimognari C, 2009, ANN NY ACAD SCI, V1171, P264, DOI 10.1111/j.1749-6632.2009.04710.x; GAILLARD D, 1989, BIOCHEM J, V257, P389, DOI 10.1042/bj2570389; Gall WE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010883; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Gerrits A, 2012, BLOOD, V119, P377, DOI 10.1182/blood-2011-01-331686; Ghiaur G, 2013, P NATL ACAD SCI USA, V110, P16121, DOI 10.1073/pnas.1305937110; Giangreco AA, 2013, J STEROID BIOCHEM, V136, P86, DOI 10.1016/j.jsbmb.2013.01.001; Grasedieck S, 2013, BLOOD, V121, P4977, DOI 10.1182/blood-2013-01-480079; Guo SQ, 2010, P NATL ACAD SCI USA, V107, P14229, DOI 10.1073/pnas.0913574107; Gysin R, 2002, FASEB J, V16, P1952, DOI 10.1096/fj.02-0362fje; Han YC, 2010, J EXP MED, V207, P475, DOI 10.1084/jem.20090831; Havelange V, 2010, AM J HEMATOL, V85, P935, DOI 10.1002/ajh.21863; Hsieh IS, 2013, CARCINOGENESIS, V34, P530, DOI 10.1093/carcin/bgs371; Hudson DM, 2013, CONNECT TISSUE RES, V54, P245, DOI 10.3109/03008207.2013.800867; Ito K, 2014, NAT REV MOL CELL BIO, V15, P243, DOI 10.1038/nrm3772; Keller A, 2011, NAT METHODS, V8, P841, DOI [10.1038/nmeth.1682, 10.1038/NMETH.1682]; Krutzfeldt J, 2006, NAT GENET, V38, pS14, DOI 10.1038/ng1799; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kurita M, 2008, PLAST RECONSTR SURG, V122, P438, DOI 10.1097/PRS.0b013e31817d618d; Lawton KA, 2008, PHARMACOGENOMICS, V9, P383, DOI 10.2217/14622416.9.4.383; Lechman ER, 2012, CELL STEM CELL, V11, P799, DOI 10.1016/j.stem.2012.09.001; Lento W, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008011; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liang HW, 2014, WIRES RNA, V5, P285, DOI 10.1002/wrna.1208; Marciniak-Czochra A, 2009, AGING-US, V1, P723, DOI 10.18632/aging.100072; Marciniak-Czochra A, 2009, STEM CELLS DEV, V18, P377, DOI 10.1089/scd.2008.0143; Phypers B, 2006, BJA EDUC, V6, P128, DOI 10.1093/bjaceaccp/mkl018; Pritchard CC, 2012, CANCER PREV RES, V5, P492, DOI 10.1158/1940-6207.CAPR-11-0370; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Qiu B, 2014, MOL MED REP, V10, P1157, DOI 10.3892/mmr.2014.2267; Rainer PP, 2013, HEART, V99, P1685, DOI 10.1136/heartjnl-2013-304163; Schaar DG, 2009, EXP HEMATOL, V37, P245, DOI 10.1016/j.exphem.2008.10.002; Spiegel A, 2008, CELL STEM CELL, V3, P484, DOI 10.1016/j.stem.2008.10.006; Takubo K, 2013, CELL STEM CELL, V12, P49, DOI 10.1016/j.stem.2012.10.011; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Undi Ram Babu, 2013, Adv Hematol, V2013, P695754, DOI 10.1155/2013/695754; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Walenda T, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003599; Walenda T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018012; Walenda T, 2011, EXP HEMATOL, V39, P617, DOI 10.1016/j.exphem.2011.02.011; Walenda T, 2010, J CELL MOL MED, V14, P337, DOI 10.1111/j.1582-4934.2009.00776.x; Wei SW, 2013, MOL ONCOL, V7, P297, DOI 10.1016/j.molonc.2012.10.003; Wells SR, 2010, J NUTR BIOCHEM, V21, P589, DOI 10.1016/j.jnutbio.2009.03.006; White AC, 2006, BONE MARROW TRANSPL, V38, P513, DOI 10.1038/sj.bmt.1705475; Williams Z, 2013, P NATL ACAD SCI USA, V110, P4255, DOI 10.1073/pnas.1214046110; Wilson A, 2007, ANN NY ACAD SCI, V1106, P64, DOI 10.1196/annals.1392.021	58	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128231	10.1371/journal.pone.0128231	http://dx.doi.org/10.1371/journal.pone.0128231			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024523	Green Submitted, Green Published, gold			2022-12-26	WOS:000355319400075
J	Yamankurt, G; Wu, HC; McCarthy, M; Cunha, SR				Yamankurt, Gokay; Wu, Henry C.; McCarthy, Michael; Cunha, Shane R.			Exon Organization and Novel Alternative Splicing of Ank3 in Mouse Heart	PLOS ONE			English	Article							BRONCHIAL EPITHELIAL-CELLS; ANKYRIN-G; LATERAL MEMBRANE; INTERCALATED DISC; SKELETAL-MUSCLE; BETA-SPECTRIN; REQUIRES; IDENTIFICATION; DOMAINS; BINDING	Ankyrin-G is an adaptor protein that links membrane proteins to the underlying cytoskeletal network. Alternative splicing of the Ank3 gene gives rise to multiple ankyrin-G isoforms in numerous tissues. To date, only one ankyrin-G isoform has been characterized in heart and transcriptional regulation of the Ank3 gene is completely unknown. In this study, we describe the first comprehensive analysis of Ank3 expression in heart. Using a PCR-based screen of cardiac mRNA transcripts, we identify two new exons and 28 alternative splice variants of the Ank3 gene. We measure the relative expression of each splice variant using quantitative real-time PCR and exon-exon boundary spanning primers that specifically amplify individual Ank3 variants. Six variants are rarely expressed (< 1%), while the remaining variants display similar expression patterns in three hearts. Of the five first exons in the Ank3 gene, exon 1d is only expressed in heart and skeletal muscle as it was not detected in brain, kidney, cerebellum, and lung. Immunoblot analysis reveals multiple ankyrin-G isoforms in heart, and two ankyrin-G subpopulations are detected in adult cardiomyocytes by immunofluorescence. One population co-localizes with the voltage-gated sodium channel NaV1.5 at the intercalated disc, while the other population expresses at the Z-line. Two of the rare splice variants excise a portion of the ZU5 motif, which encodes the minimal spectrin- binding domain, and these variants lack beta-spectrin binding. Together, these data demonstrate that Ank3 is subject to complex splicing regulation resulting in a diverse population of ankyrin-G isoforms in heart.	[Yamankurt, Gokay] Northwestern Univ, Dept Chem, Evanston, IL USA; [Wu, Henry C.; McCarthy, Michael; Cunha, Shane R.] UT Hlth, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA	Northwestern University	Cunha, SR (corresponding author), UT Hlth, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA.	shane.r.cunha@uth.tmc.edu		McCarthy, Michael/0000-0001-6534-2237	NIH NHLBI [092232]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM105538] Funding Source: NIH RePORTER	NIH NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NIH NHLBI 092232 to GY and SRC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayalon G, 2011, J BIOL CHEM, V286, P7370, DOI 10.1074/jbc.M110.187831; Ayalon G, 2008, CELL, V135, P1189, DOI 10.1016/j.cell.2008.10.018; Baskin KK, 2011, CIRC RES, V109, P1153, DOI 10.1161/CIRCRESAHA.111.252742; Cunha SR, 2008, J BIOL CHEM, V283, P31968, DOI 10.1074/jbc.M806050200; Cunha SR, 2007, J BIOL CHEM, V282, P4875, DOI 10.1074/jbc.M607096200; Cunha SR, 2008, J MOL CELL CARDIOL, V45, P724, DOI 10.1016/j.yjmcc.2008.08.005; Devarajan P, 1997, P NATL ACAD SCI USA, V94, P10711, DOI 10.1073/pnas.94.20.10711; Devarajan P, 1996, J CELL BIOL, V133, P819, DOI 10.1083/jcb.133.4.819; Gagelin C, 2002, J BIOL CHEM, V277, P12978, DOI 10.1074/jbc.M111299200; Garrido JJ, 2003, SCIENCE, V300, P2091, DOI 10.1126/science.1085167; Hopitzan AA, 2005, EXP CELL RES, V309, P86, DOI 10.1016/j.yexcr.2005.04.013; Hund TJ, 2010, J CLIN INVEST, V120, P3508, DOI 10.1172/JCI43621; Ipsaro JJ, 2009, BLOOD, V113, P5385, DOI 10.1182/blood-2008-10-184358; Jenkins PM, 2013, J BIOL CHEM, V288, P14018, DOI 10.1074/jbc.M113.454439; Kizhatil K, 2004, J BIOL CHEM, V279, P16706, DOI 10.1074/jbc.M314296200; Kizhatil K, 2007, J BIOL CHEM, V282, P2029, DOI 10.1074/jbc.M608921200; Kordeli E, 1998, J CELL SCI, V111, P2197; La-Borde PJ, 2010, BIOCHEM BIOPH RES CO, V392, P490, DOI 10.1016/j.bbrc.2010.01.046; Lopez-Santiago Luis F, 2007, J Mol Cell Cardiol, V43, P636, DOI 10.1016/j.yjmcc.2007.07.062; Lowe JS, 2008, J CELL BIOL, V180, P173, DOI 10.1083/jcb.200710107; Maier SKG, 2004, CIRCULATION, V109, P1421, DOI 10.1161/01.CIR.0000121421.61896.24; Makara MA, 2014, CIRC RES, V115, P929, DOI 10.1161/CIRCRESAHA.115.305154; Mohler PJ, 2004, P NATL ACAD SCI USA, V101, P17533, DOI 10.1073/pnas.0403711101; Noujaim SF, 2012, FASEB J, V26, P63, DOI 10.1096/fj.10-179770; Peters B, 2001, J INVEST DERMATOL, V116, P216, DOI 10.1046/j.1523-1747.2001.01210.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Sato PY, 2011, CIRC RES, V109, P193, DOI 10.1161/CIRCRESAHA.111.247023; Soeller C, 1999, CIRC RES, V84, P266, DOI 10.1161/01.RES.84.3.266; Stabach PR, 2009, BLOOD, V113, P5377, DOI 10.1182/blood-2008-10-184291; Thevananther S, 1998, J BIOL CHEM, V273, P23952, DOI 10.1074/jbc.273.37.23952; Wang C, 2012, P NATL ACAD SCI USA, V109, P4822, DOI 10.1073/pnas.1200613109; Yasunaga M, 2012, J MOL BIOL, V417, P336, DOI 10.1016/j.jmb.2012.01.041; Zhang X, 1998, J CELL BIOL, V142, P1571, DOI 10.1083/jcb.142.6.1571	33	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128177	10.1371/journal.pone.0128177	http://dx.doi.org/10.1371/journal.pone.0128177			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024478	Green Published, Green Submitted, gold			2022-12-26	WOS:000355319400074
J	Chen, J; Chen, S; Wang, JH; Zhang, MJ; Gong, ZH; Wei, YH; Li, L; Zhang, YY; Zhao, XM; Jiang, SM; Yu, L				Chen, Jian; Chen, Shuai; Wang, Jiahui; Zhang, Mingjun; Gong, Zhaohua; Wei, Youheng; Li, Li; Zhang, Yuanyuan; Zhao, Xuemei; Jiang, Songmin; Yu, Long			Cyclophilin J Is a Novel Peptidyl-Prolyl Isomerase and Target for Repressing the Growth of Hepatocellular Carcinoma	PLOS ONE			English	Article							CIS-TRANS ISOMERASES; B-VIRUS INFECTION; CYCLOSPORINE-A; CYCLIN D1; TRANSCRIPTIONAL ACTIVITY; TUMOR GROWTH; CELL-GROWTH; GENE; CALCINEURIN; EXPRESSION	Cyclophilin J (CYPJ) is a new member of the peptidyl-prolyl cis/trans-isomerase (PPIase) identified with upregulated expression in human glioma. However, the biological function of CYPJ remained unclear. We aimed to study the role of CYPJ in hepatocellular carcinoma (HCC) carcinogenesis and its therapeutic potential. We determined the expression of CYPJ in HCC/adjacent normal tissues using Western blot, Northern blot and semi-quantitative RT-PCR, analyzed the biochemical characteristics of CYPJ, and resolved the 3D-structure of CYPJ/Cyclosporin A (CsA) complex. We also studied the roles of CYPJ in cell cycle, cyclin D1 regulation, in vitro and in vivo tumor growth. We found that CYPJ expression was upregulated in over 60% HCC tissues. The PPIase activity of CYPJ could be inhibited by the widely used immunosuppressive drug CsA. CYPJ was found expressed in the whole cell of HCC with preferential location at the cell nucleus. CYPJ promoted the transition of cells from G1 phase to S phase in a PPIase-dependent manner by activating cyclin D1 promoter. CYPJ overexpression accelerated liver cell growth in vitro (cell growth assay, colony formation) and in vivo (xenograft tumor formation). Inhibition of CYPJ by its inhibitor CsA or CYPJ-specific RNAi diminished the growth of liver cancer cells in vitro and in vivo. In conclusion, CYPJ could facilitate HCC growth by promoting cell cycle transition from G1 to S phase through the upregulation of cyclin D1. Suppression of CYPJ could repress the growth of HCC, which makes CYPJ a potential target for the development of new strategies to treat this malignancy.	[Chen, Jian; Chen, Shuai; Zhang, Mingjun; Wei, Youheng; Li, Li; Zhang, Yuanyuan; Zhao, Xuemei; Jiang, Songmin; Yu, Long] Fudan Univ, Sch Life Sci, Inst Genet, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Chen, Jian; Wang, Jiahui] Qingdao Univ, Yantai Yuhuangding Hosp, Shandong Res Ctr Stem Cell Engn, Affiliated Hosp, Yantai, Shandong, Peoples R China; [Gong, Zhaohua] Qingdao Univ, Yantai Yuhuangding Hosp, Dept Oncol, Affiliated Hosp, Yantai, Shandong, Peoples R China	Fudan University; Qingdao University; Qingdao University	Chen, J (corresponding author), Fudan Univ, Sch Life Sci, Inst Genet, State Key Lab Genet Engn, Shanghai 200433, Peoples R China.	smjiang@fudan.edu.cn; jianchen2005@gmail.com	zhang, yuanyuan/GYA-4428-2022	Chen, Jian/0000-0002-1694-7763	National Key Basic Research and Development Plan of China (973 Program) [2013CB910504]; National Natural Science Foundation of China [30801338, 81071758]; Shangdong Province Young and Middle-Aged Scientists Research Awards Fund [2008BSA02012]; Yantai Science and Technology Program [2012085, 2009155-3]	National Key Basic Research and Development Plan of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shangdong Province Young and Middle-Aged Scientists Research Awards Fund; Yantai Science and Technology Program	Support for this work came from The National Key Basic Research and Development Plan of China (973 Program) (http://www.most.gov.cn/bszn/new/973/jbxx) grant number 2013CB910504 (SJ), National Natural Science Foundation of China (http://www.nsfc.gov.cn/) grant number 30801338 (JC) and 81071758 (JC), Shangdong Province Young and Middle-Aged Scientists Research Awards Fund (http://jihlx.sdstc.gov.cn/STDPMS/BS/Default.aspx) grant number 2008BSA02012 (JC), and Yantai Science and Technology Program (http://www.ytstc.gov.cn/fund.aspx) grant number 2012085 (JC) and 2009155-3 (ZG). The funding bodies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azechi H, 2001, ONCOLOGY-BASEL, V60, P346, DOI 10.1159/000058531; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bukrinsky MI, 2002, TRENDS IMMUNOL, V23, P323, DOI 10.1016/S1471-4906(02)02237-8; Chen S, 2006, CYTOGENET GENOME RES, V114, P131, DOI 10.1159/000093328; D'Costa S, 2003, LEUKEMIA LYMPHOMA, V44, P139, DOI 10.1080/1042819021000050043; Elmileik H, 2005, J SURG ONCOL, V91, P258, DOI 10.1002/jso.20304; GALAT A, 1995, PROG BIOPHYS MOL BIO, V63, P67, DOI 10.1016/0079-6107(94)00009-X; Gothel SF, 1999, CELL MOL LIFE SCI, V55, P423, DOI 10.1007/s000180050299; Gudavicius G, 2014, RNA, V20, P1014, DOI 10.1261/rna.042648.113; Howard BA, 2005, CANCER RES, V65, P8853, DOI 10.1158/0008-5472.CAN-05-1219; Hu H, 2005, ACTA CRYSTALLOGR F, V61, P216, DOI 10.1107/S1744309105000643; Huang LL, 2005, ACTA CRYSTALLOGR D, V61, P316, DOI 10.1107/S0907444904033189; Jiang JM, 2001, GENE, V281, P103, DOI 10.1016/S0378-1119(01)00787-9; Jin L, 2002, P NATL ACAD SCI USA, V99, P13522, DOI 10.1073/pnas.212504399; Kikuchi E, 2004, CLIN CANCER RES, V10, P1835, DOI 10.1158/1078-0432.CCR-03-0099; Kim H, 2005, CLIN IMMUNOL, V116, P217, DOI 10.1016/j.clim.2005.05.004; KOFRON JL, 1991, BIOCHEMISTRY-US, V30, P6127, DOI 10.1021/bi00239a007; Laurent-Puig P, 2006, ONCOGENE, V25, P3778, DOI 10.1038/sj.onc.1209547; Lee J, 2010, J INT MED RES, V38, P1561, DOI 10.1177/147323001003800501; Lee J, 2010, ARCH PHARM RES, V33, P181, DOI 10.1007/s12272-010-0200-y; Lin HL, 2003, BRIT J CANCER, V88, P973, DOI 10.1038/sj.bjc.6600788; Lin Jun, 2012, Zhonghua Yi Xue Za Zhi, V92, P388; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Lunn RM, 1997, CANCER RES, V57, P3471; MIKOL V, 1993, J MOL BIOL, V234, P1119, DOI 10.1006/jmbi.1993.1664; Minor W, 2000, STRUCTURE, V8, pR105, DOI 10.1016/S0969-2126(00)00139-8; NAVAZA J, 1993, ACTA CRYSTALLOGR D, V49, P588, DOI 10.1107/S0907444993005141; Obama K, 2006, CLIN CANCER RES, V12, P70, DOI 10.1158/1078-0432.CCR-05-0588; Ochocka AM, 2009, FEBS LETT, V583, P621, DOI 10.1016/j.febslet.2009.01.009; Qi ZY, 2005, CHINESE MED J-PEKING, V118, P799; Qian Z, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-442; Roche KC, 2004, ONCOGENE, V23, P8185, DOI 10.1038/sj.onc.1208025; ROUSSEL A, 1991, TURBOFRODO SILICON G; Satoh K, 2010, CIRC J, V74, P2249, DOI 10.1253/circj.CJ-10-0904; Schafer DF, 1999, LANCET, V353, P1253, DOI 10.1016/S0140-6736(98)09148-X; Schubert A, 2004, CANCER RES, V64, P85, DOI 10.1158/0008-5472.CAN-03-0476; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Towers GJ, 2003, NAT MED, V9, P1138, DOI 10.1038/nm910; Werneck MBF, 2012, CELL CYCLE, V11, P3997, DOI 10.4161/cc.22222; Wulf GM, 2001, EMBO J, V20, P3459, DOI 10.1093/emboj/20.13.3459; YANG WM, 1995, J BIOL CHEM, V270, P15187, DOI 10.1074/jbc.270.25.15187; Yao QZ, 2005, WORLD J SURG, V29, P276, DOI 10.1007/s00268-004-7812-7; Yeh KT, 2000, CANCER INVEST, V18, P123, DOI 10.3109/07357900009038243; Zacchi P, 2002, NATURE, V419, P853, DOI 10.1038/nature01120; Zhao J, 2001, MOL BIOL CELL, V12, P4066, DOI 10.1091/mbc.12.12.4066; Zheng HW, 2002, NATURE, V419, P849, DOI 10.1038/nature01116; Zhou Z, 2001, CYTOGENET CELL GENET, V92, P231, DOI 10.1159/000056909; ZYDOWSKY LD, 1992, PROTEIN SCI, V1, P1092, DOI 10.1002/pro.5560010903	49	13	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0127668	10.1371/journal.pone.0127668	http://dx.doi.org/10.1371/journal.pone.0127668			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020957	Green Published, Green Submitted, gold			2022-12-26	WOS:000355187300051
J	Goodman, CA; Pol, D; Zacharewicz, E; Lee-Young, RS; Snow, RJ; Russell, AP; McConell, GK				Goodman, Craig A.; Pol, Derk; Zacharewicz, Evelyn; Lee-Young, Robert S.; Snow, Rod J.; Russell, Aaron P.; McConell, Glenn K.			Statin-Induced Increases in Atrophy Gene Expression Occur Independently of Changes in PGC1 alpha Protein and Mitochondrial Content	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; PYRUVATE-DEHYDROGENASE COMPLEX; SKELETAL-MUSCLE; UP-REGULATION; LIPOPROTEIN-LIPASE; INSULIN-RESISTANCE; UBIQUITIN LIGASES; KINASE; MYOPATHY; ACTIVATION	One serious side effect of statin drugs is skeletal muscle myopathy. Although the mechanism(s) responsible for statin myopathy remains to be fully determined, an increase in muscle atrophy gene expression and changes in mitochondrial content and/or function have been proposed to play a role. In this study, we examined the relationship between statin-induced expression of muscle atrophy genes, regulators of mitochondrial biogenesis, and markers of mitochondrial content in slow-(ST) and fast-twitch (FT) rat skeletal muscles. Male Sprague Dawley rats were treated with simvastatin (60 or 80 mg.kg(-1).day(-1)) or vehicle control via oral gavage for 14 days. In the absence of overt muscle damage, simvastatin treatment induced an increase in atrogin-1, MuRF1 and myostatin mRNA expression; however, these were not associated with changes in peroxisome proliferator gamma co-activator 1 alpha (PGC-1 alpha) protein or markers of mitochondrial content. Simvastatin did, however, increase neuronal nitric oxide synthase (nNOS), endothelial NOS (eNOS) and AMPK alpha-subunit protein expression, and tended to increase total NOS activity, in FT but not ST muscles. Furthermore, simvastatin induced a decrease in beta-hydroxyacyl CoA dehydrogenase (beta-HAD) activity only in FT muscles. These findings suggest that the statin-induced activation of muscle atrophy genes occurs independent of changes in PGC-1 alpha protein and mitochondrial content. Moreover, muscle-specific increases in NOS expression and possibly NO production, and decreases in fatty acid oxidation, could contribute to the previously reported development of overt statin-induced muscle damage in FT muscles.	[Goodman, Craig A.; Pol, Derk; McConell, Glenn K.] Univ Melbourne, Dept Physiol, Parkville, Vic 3052, Australia; [Goodman, Craig A.; McConell, Glenn K.] Victoria Univ, Inst Sport Exercise & Active Living, Melbourne, Vic 8001, Australia; [Goodman, Craig A.; McConell, Glenn K.] Victoria Univ, Coll Hlth & Biomed, Melbourne, Vic 8001, Australia; [Zacharewicz, Evelyn; Snow, Rod J.; Russell, Aaron P.] Deakin Univ, Sch Exercise & Nutr Sci, Ctr Phys Act & Nutr, Burwood, Vic, Australia; [Lee-Young, Robert S.] Baker IDI Heart & Diabet Inst, Div Metab & Obes, Cellular & Mol Metab Lab, Melbourne, Australia	University of Melbourne; Victoria University; Victoria University; Deakin University; Baker Heart and Diabetes Institute	Goodman, CA (corresponding author), Univ Melbourne, Dept Physiol, Parkville, Vic 3052, Australia.	craig.goodman@vu.edu.au	Goodman, Craig/H-8085-2019; Snow, Rod J/G-1673-2010; Zacharewicz, Evelyn/T-5989-2019	Goodman, Craig/0000-0002-5874-7743; Snow, Rod J/0000-0002-4796-6916; Lee, Robert/0000-0002-8166-142X; Russell, Aaron/0000-0002-7323-9501; McConell, Glenn/0000-0002-8572-9065	Pfizer Inc., (Kent, UK)	Pfizer Inc., (Kent, UK)(Pfizer)	This research was supported by a grant from Pfizer Inc., (Kent, UK). The funder had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Bakar MH, 2015, DIABETES-METAB RES, V31, P453, DOI 10.1002/dmrr.2601; Bouitbir J, 2012, EUR HEART J, V33, P1397, DOI 10.1093/eurheartj/ehr224; Brault JJ, 2010, J BIOL CHEM, V285, P19460, DOI 10.1074/jbc.M110.113092; Bruckert E, 2005, CARDIOVASC DRUG THER, V19, P403, DOI 10.1007/s10557-005-5686-z; Buettner C, 2008, PHARMACOGENOMICS, V9, P1133, DOI 10.2217/14622416.9.8.1133; Cannata DJ, 2010, PEDIATR RES, V68, P393, DOI 10.1203/PDR.0b013e3181f1c048; Cao PR, 2009, FASEB J, V23, P2844, DOI 10.1096/fj.08-128843; Choi HC, 2008, J BIOL CHEM, V283, P20186, DOI 10.1074/jbc.M803020200; Constantin-Teodosiu D, 2013, DIABETES METAB J, V37, P301, DOI 10.4093/dmj.2013.37.5.301; Das AK, 2012, BIOCHEM BIOPH RES CO, V427, P36, DOI 10.1016/j.bbrc.2012.08.138; DePinieux G, 1996, BRIT J CLIN PHARMACO, V42, P333, DOI 10.1046/j.1365-2125.1996.04178.x; Dorajoo R, 2008, LIFE SCI, V82, P823, DOI 10.1016/j.lfs.2008.01.021; Fernandez Genaro, 2011, Cleve Clin J Med, V78, P393, DOI 10.3949/ccjm.78a.10073; Fujii T, 2008, AM J PHYSIOL-HEART C, V294, pH2785, DOI 10.1152/ajpheart.00149.2008; Gambelli S., 2004, Journal of Submicroscopic Cytology and Pathology, V36, P85; Gao L, 2008, J PHARMACOL EXP THER, V326, P278, DOI 10.1124/jpet.107.136028; Golomb BA, 2008, AM J CARDIOVASC DRUG, V8, P373, DOI 10.2165/0129784-200808060-00004; Goodman CA, 2011, CELL SIGNAL, V23, P1896, DOI 10.1016/j.cellsig.2011.07.013; Gouni-Berthold I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072858; Hanai JI, 2007, J CLIN INVEST, V117, P3940, DOI 10.1172/JCI32741; Harper CR, 2007, CURR OPIN LIPIDOL, V18, P401, DOI 10.1097/MOL.0b013e32825a6773; Hermida N, 2013, CARDIOVASC RES, V99, P44, DOI 10.1093/cvr/cvt070; Ito D, 2010, J HYPERTENS, V28, P2278, DOI 10.1097/HJH.0b013e32833e0924; Jukema JW, 2008, HEART, V94, P1656, DOI 10.1136/hrt.2008.151506; Kaji H, 2008, HORM METAB RES, V40, P746, DOI 10.1055/s-0028-1082051; Kaufmann P, 2006, CELL MOL LIFE SCI, V63, P2415, DOI 10.1007/s00018-006-6235-z; Kosmidou I, 2007, ARTERIOSCL THROM VAS, V27, P2642, DOI 10.1161/ATVBAHA.107.154492; Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185; Laufs U, 1998, J BIOL CHEM, V273, P24266, DOI 10.1074/jbc.273.37.24266; Laufs U, 2003, EUR J CLIN PHARMACOL, V58, P719, DOI 10.1007/s00228-002-0556-0; Laufs U, 1998, CIRCULATION, V97, P1129, DOI 10.1161/01.CIR.97.12.1129; Lee DH, 2014, JAMA INTERNAL MEDICI; Lee-Young RS, 2009, J BIOL CHEM, V284, P23925, DOI 10.1074/jbc.M109.021048; Leger B, 2006, FASEB J, V20, P583, DOI 10.1096/fj.05-5249fje; Li XX, 2008, ARTERIOSCL THROM VAS, V28, P1789, DOI 10.1161/ATVBAHA.108.172452; Lokireddy S, 2011, MOL ENDOCRINOL, V25, P1936, DOI 10.1210/me.2011-1124; Mallinson JE, 2012, J PHYSIOL-LONDON, V590, P6389, DOI 10.1113/jphysiol.2012.238022; Mallinson JE, 2009, J PHYSIOL-LONDON, V587, P219, DOI 10.1113/jphysiol.2008.164699; Meador BM, 2010, MUSCLE NERVE, V42, P469, DOI 10.1002/mus.21817; Mullen PJ, 2011, BBA-MOL CELL RES, V1813, P2079, DOI 10.1016/j.bbamcr.2011.07.019; Nadanaciva S, 2007, TOXICOL APPL PHARM, V223, P277, DOI 10.1016/j.taap.2007.06.003; Nakata S, 2007, ARTERIOSCL THROM VAS, V27, P92, DOI 10.1161/01.ATV.0000251615.61858.33; O'Neill HM, 2013, MOL CELL ENDOCRINOL, V366, P135, DOI 10.1016/j.mce.2012.06.019; Ohira M, 2012, METABOLISM, V61, P1452, DOI 10.1016/j.metabol.2012.03.010; Paiva H, 2005, CLIN PHARMACOL THER, V78, P60, DOI 10.1016/j.clpt.2005.03.006; Parker BA, 2012, EXERC SPORT SCI REV, V40, P188, DOI 10.1097/JES.0b013e31826c169e; Pencina MJ, 2014, NEW ENGLAND JOURNAL, DOI [10.1056/NEJMoa1315665:null, DOI 10.1056/NEJMOA1315665:NULL]; Phillips PS, 2004, ATHEROSCLEROSIS, V177, P183, DOI 10.1016/j.atherosclerosis.2004.06.014; Phillips PS, 2002, ANN INTERN MED, V137, P581, DOI 10.7326/0003-4819-137-7-200210010-00009; Phillips PS, 2002, ATHEROSCLER THROMB V, V22, P878; Rikitake Y, 2005, CIRC RES, V97, P1232, DOI 10.1161/01.RES.0000196564.18314.23; Rodriguez-Vita J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003959; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Sartori R, 2009, AM J PHYSIOL-CELL PH, V296, pC1248, DOI 10.1152/ajpcell.00104.2009; SATO A, 1991, BIOCHEM PHARMACOL, V41, P1163, DOI 10.1016/0006-2952(91)90654-N; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Schaefer WH, 2004, TOXICOL APPL PHARM, V194, P10, DOI 10.1016/j.taap.2003.08.013; Schick BA, 2007, CLIN PHARMACOL THER, V81, P650, DOI 10.1038/sj.clpt.6100124; Sirvent P, 2005, BIOCHEM BIOPH RES CO, V338, P1426, DOI 10.1016/j.bbrc.2005.10.108; SMITH PF, 1991, J PHARMACOL EXP THER, V257, P1225; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Stringer HAJ, 2013, J NEUROL SCI, V325, P142, DOI 10.1016/j.jns.2012.12.023; Sun W, 2006, CIRCULATION, V114, P2655, DOI 10.1161/CIRCULATIONAHA.106.630194; Suzuki N, 2007, J CLIN INVEST, V117, P2468, DOI 10.1172/JCI30654; Suzuki N, 2010, J NEUROL SCI, V294, P95, DOI 10.1016/j.jns.2010.03.022; Tobert JA, 2003, NAT REV DRUG DISCOV, V2, P517, DOI 10.1038/nrd1112; Vaughan RA, 2013, EUR J PHARMACOL, V711, P1, DOI 10.1016/j.ejphar.2013.04.009; Venero CV, 2009, ENDOCRIN METAB CLIN, V38, P121, DOI 10.1016/j.ecl.2008.11.002; Wadley GD, 2007, J APPL PHYSIOL, V102, P314, DOI 10.1152/japplphysiol.00549.2006; Westwood FR, 2005, TOXICOL PATHOL, V33, P246, DOI 10.1080/01926230590908213; Westwood FR, 2008, TOXICOL PATHOL; Williams D, 2002, CLIN PHARMACOKINET, V41, P343, DOI 10.2165/00003088-200241050-00003; Yokoyama M, 2007, J LIPID RES, V48, P646, DOI 10.1194/jlr.M600301-JLR200	74	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128398	10.1371/journal.pone.0128398	http://dx.doi.org/10.1371/journal.pone.0128398			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020641	Green Published, Green Accepted, gold			2022-12-26	WOS:000355187300108
J	Nascimento, CS; Barbosa, LT; Brito, C; Fernandes, RPM; Mann, RS; Pinto, APG; Oliveira, HC; Dodson, MV; Guimaraes, SEF; Duarte, MS				Nascimento, Carlos S.; Barbosa, Leandro T.; Brito, Claudson; Fernandes, Roberta P. M.; Mann, Renata S.; Pinto, Ana Paula G.; Oliveira, Haniel C.; Dodson, Mike V.; Guimaraes, Simone E. F.; Duarte, Marcio S.			Identification of Suitable Reference Genes for Real Time Quantitative Polymerase Chain Reaction Assays on Pectoralis major Muscle in Chicken (Gallus gallus)	PLOS ONE			English	Article							RT-PCR; EXPRESSION; NORMALIZATION; QUANTIFICATION; MODEL	Thirteen reference genes were investigated to determine their stability to be used as a housekeeping in gene expression studies in skeletal muscle of chickens. Five different algorithms were used for ranking of reference genes and results suggested that individual rankings of the genes differed among them. The stability of the expression of reference genes were validated using samples obtained from the Pectoralis major muscle in chicken. Samples were obtained from chickens in different development periods post hatch and under different nutritional diets. For gene expression calculation the Delta Delta Ct approach was applied to compare relative expression of pairs of genes within each of 52 samples when normalized to mitochondrially encoded cytochrome c oxidase II (MT-CO2) target gene. Our findings showed that hydroxymethylbilane synthase (HMBS) and hypoxanthine phosphoribosyl transferase 1 (HPRT1) are the most stable reference genes while transferrin receptor (TFRC) and beta-2-microglobulin (B2M) ranked as the least stable genes in the Pectoralis major muscle of chickens. Moreover, our results revealed that HMBS and HPRT1 gene expression did not change due to dietary variations and thus it is recommended for accurate normalization of RT-qPCR data in chicken Pectoralis major muscle.	[Nascimento, Carlos S.; Barbosa, Leandro T.; Brito, Claudson; Pinto, Ana Paula G.] Univ Fed Sergipe, Dept Anim Sci, Sao Cristovao, Sergipe, Brazil; [Fernandes, Roberta P. M.] Univ Fed Sergipe, Dept Physiol, Sao Cristovao, Sergipe, Brazil; [Mann, Renata S.] Univ Fed Sergipe, Dept Crop Sci, Sao Cristovao, Sergipe, Brazil; [Oliveira, Haniel C.] Univ Estadual Santa Cruz, Dept Anim Sci, Ilheus, BA, Brazil; [Dodson, Mike V.] Washington State Univ, Dept Anim Sci, Pullman, WA 99164 USA; [Guimaraes, Simone E. F.; Duarte, Marcio S.] Univ Fed Vicosa, Dept Anim Sci, Anim Biotechnol Lab LABTEC, Vicosa, MG, Brazil	Universidade Federal de Sergipe; Universidade Federal de Sergipe; Universidade Federal de Sergipe; Universidade Estadual de Santa Cruz; Washington State University; Universidade Federal de Vicosa	Duarte, MS (corresponding author), Univ Fed Vicosa, Dept Anim Sci, Anim Biotechnol Lab LABTEC, Vicosa, MG, Brazil.	marcio.duarte@ufv.br	Silva-Mann, Renata/ABB-7192-2020; Fernandes, Roberta/J-4301-2014; Duarte, Marcio/G-3815-2015; Silva-Mann, Renata/J-7954-2012; Brito, Claudson/AAE-3380-2019; Barbosa, Leandro/V-3649-2019; facioni guimaraes, simone eliza/HHZ-5341-2022	Silva-Mann, Renata/0000-0001-5993-3161; Fernandes, Roberta/0000-0003-1467-3946; Duarte, Marcio/0000-0002-5795-6420; Silva-Mann, Renata/0000-0001-5993-3161; Brito, Claudson/0000-0002-3339-8647; Barbosa, Leandro/0000-0002-1580-8913; facioni guimaraes, simone eliza/0000-0003-3704-8131	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Apoio a Pesquisa e a Inovacao Tecnologica do Estado de Sergipe (FAPITEC) in Brazil	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Apoio a Pesquisa e a Inovacao Tecnologica do Estado de Sergipe (FAPITEC) in Brazil	This work was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao de Apoio a Pesquisa e a Inovacao Tecnologica do Estado de Sergipe (FAPITEC) in Brazil for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn K, 2011, GENES GENOM, V33, P245, DOI 10.1007/s13258-010-0114-6; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Basu U, 2009, NUTR BIOCH GENOMICS, P30; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Kuchipudi SV, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-230; Lee PD, 2002, GENOME RES, V12, P292, DOI 10.1101/gr.217802; Ling DJ, 2012, PLOS ONE, P7; Lisowski P, 2008, J APPL GENET, V49, P367, DOI 10.1007/BF03195635; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martinez-Giner M, 2013, PLOS ONE, P8; McCurley AT, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-102; Najafpanah MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083041; Olias P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099678; Olsvik PA, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-21; Perez R, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-79; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rostagno H.S., 2011, COMPOSICAO ALIMENTOS, V2, P186; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Yang CG, 2013, GENE, V527, P183, DOI 10.1016/j.gene.2013.06.013; Yang Falong, 2013, BMC Res Notes, V6, P402, DOI 10.1186/1756-0500-6-402; Zang R, 2011, ASIAN J ANIM VET ADV, V6, P789, DOI 10.3923/ajava.2011.789.804	23	35	37	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0127935	10.1371/journal.pone.0127935	http://dx.doi.org/10.1371/journal.pone.0127935			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020643	Green Published, gold, Green Submitted			2022-12-26	WOS:000355187300066
J	Lin, FY; Tsao, NW; Shih, CM; Lin, YW; Yeh, JS; Chen, JW; Nakagami, H; Morishita, R; Sawamura, T; Huang, CY				Lin, Feng-Yen; Tsao, Nai-Wen; Shih, Chun-Ming; Lin, Yi-Wen; Yeh, Jong-Shiua; Chen, Jaw-Wen; Nakagami, Hironori; Morishita, Ryuichi; Sawamura, Tatsuya; Huang, Chun-Yao			The Biphasic Effects of Oxidized-Low Density Lipoprotein on the Vasculogenic Function of Endothelial Progenitor Cells	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; CARDIOVASCULAR RISK-FACTORS; NITRIC-OXIDE SYNTHASE; OXIDATIVE STRESS; HEART-DISEASE; GENERAL-POPULATION; IN-VIVO; OX-LDL; PATHWAY; MORTALITY	Late-outgrowth endothelial progenitor cells (EPCs) are stress-resistant and responsible for reparative functions in the cardiovascular system. Oxidized-LDL (oxLDL) plays a critical role in cardiovascular disease pathogenesis. However, it is largely unknown what the impacts of oxLDL are on late-outgrowth EPCs. This study aimed to investigate the concentration- related effects of oxLDL on EPC functions and related angiogenesis, in vitro and in vivo. In this study, early and late-outgrowth EPCs were generated from circulating human mononuclear cells. oxLDL may regulate EPC vasculogenic function via the lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1). Lower concentrations (5 mu g/mL) of oxLDL can potentiate EPC tube formation in vitro and in vivo by activating eNOS mechanisms, which are mediated by p38 MAPK-and SAPK/JNK-related pathways. Higher concentrations of oxLDL (10-50 mu g/mL) impaired EPC function via the activation of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase pathways and consequent inhibition of eNOS activity, which could be reversed by anti-oxidants (diphenylene iodonium and apocynin) and gp91(phox) siRNA. In conclusion, oxLDL has concentration-dependent biphasic effects on human late-outgrowth EPC tube formation in vitro and in vivo.	[Lin, Feng-Yen; Shih, Chun-Ming; Huang, Chun-Yao] Taipei Med Univ, Coll Med, Sch Med, Dept Internal Med, Taipei, Taiwan; [Lin, Feng-Yen; Shih, Chun-Ming; Lin, Yi-Wen; Huang, Chun-Yao] Taipei Med Univ Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan; [Tsao, Nai-Wen] Taipei Med Univ Hosp, Div Cardiovasc Surg, Taipei, Taiwan; [Yeh, Jong-Shiua] Taipei Med Univ, Wan Fang Hosp, Dept Internal Med, Div Cardiovasc Med, Taipei, Taiwan; [Chen, Jaw-Wen] Taipei Vet Gen Hosp, Dept Med Educ & Res, Taipei, Taiwan; [Nakagami, Hironori] Osaka Univ, Div Vasc Med & Epigenet, Osaka, Japan; [Morishita, Ryuichi] Osaka Univ, Dept Clin Gene Therapy, Osaka, Japan; [Sawamura, Tatsuya] Natl Cardiovasc Ctr Hosp & Res Inst, Dept Biosci, Osaka, Japan	Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Veterans General Hospital; Osaka University; Osaka University; National Cerebral & Cardiovascular Center - Japan	Huang, CY (corresponding author), Taipei Med Univ, Coll Med, Sch Med, Dept Internal Med, Taipei, Taiwan.	cyhuang@tmu.edu.tw	Nakagami, Hironori/GLU-0570-2022; Sawamura, Tatsuya/E-7103-2010	Nakagami, Hironori/0000-0003-4494-3601; 	Taipei Medical University [101TMU-TMUH-01-4, 103TMU-TMUH-10]; National Science Council in Taiwan [NSC 99-2314-B-038-007-MY3, NSC 102-2314-B-038-031]	Taipei Medical University; National Science Council in Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by Taipei Medical University (101TMU-TMUH-01-4 and 103TMU-TMUH-10), the National Science Council (NSC 99-2314-B-038-007-MY3 and NSC 102-2314-B-038-031) in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2004, CIRC RES, V94, P385, DOI 10.1161/01.RES.0000111804.34509.94; Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; Aicher A, 2003, NAT MED, V9, P1370, DOI 10.1038/nm948; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Besler C, 2011, J CLIN INVEST, V121, P2693, DOI 10.1172/JCI42946; Brinkley TE, 2009, HYPERTENSION, V53, P846, DOI 10.1161/HYPERTENSIONAHA.108.127043; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Calmarza P, 2014, ANGIOLOGY, V65, P357, DOI 10.1177/0003319713488639; CASTELLI WP, 1984, AM J MED, V76, P4, DOI 10.1016/0002-9343(84)90952-5; Chen JZ, 2004, J MOL CELL CARDIOL, V36, P233, DOI 10.1016/j.yjmcc.2003.10.005; Chen YH, 2007, DIABETES, V56, P1559, DOI 10.2337/db06-1103; Dandapat A, 2007, ARTERIOSCL THROM VAS, V27, P2435, DOI 10.1161/ATVBAHA.107.152272; Dernbach E, 2004, BLOOD, V104, P3591, DOI 10.1182/blood-2003-12-4103; Di Santo S, 2008, BIOCHEM BIOPH RES CO, V373, P528, DOI 10.1016/j.bbrc.2008.06.066; Drogan D, 2010, ARTERIOSCL THROM VAS, V30, P2053, DOI 10.1161/ATVBAHA.110.209346; Duan J, 2000, CIRCULATION, V102, P370; Everaert BR, 2010, INT J CARDIOL, V144, P350, DOI 10.1016/j.ijcard.2010.04.018; Fang LH, 2014, TRANSL RES, V163, P99, DOI 10.1016/j.trsl.2013.09.004; Feng J, 2010, ARTERIOSCL THROM VAS, V30, P1703, DOI 10.1161/ATVBAHA.110.209726; Gothert JR, 2004, BLOOD, V104, P1769, DOI 10.1182/blood-2003-11-3952; Hamed S, 2010, THROMB RES, V126, P166, DOI 10.1016/j.thromres.2010.03.002; Holvoet P, 1998, CIRCULATION, V98, P1487, DOI 10.1161/01.CIR.98.15.1487; Holvoet P, 2000, ARTERIOSCL THROM VAS, V20, P698, DOI 10.1161/01.ATV.20.3.698; Holvoet P, 2001, ARTERIOSCL THROM VAS, V21, P844, DOI 10.1161/01.ATV.21.5.844; Holvoet P, 2007, ATHEROSCLEROSIS, V194, P245, DOI 10.1016/j.atherosclerosis.2006.08.002; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Hur J, 2004, ARTERIOSCL THROM VAS, V24, P288, DOI 10.1161/01.ATV.0000114236.77009.06; Imanishi T, 2004, CLIN EXP PHARMACOL P, V31, P407, DOI 10.1111/j.1440-1681.2004.04022.x; Ingram DA, 2007, STEM CELLS, V25, P297, DOI 10.1634/stemcells.2006-0340; Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; Jang JJ, 2000, CIRCULATION, V102, P1414, DOI 10.1161/01.CIR.102.12.1414; Khakoo AY, 2005, ANNU REV MED, V56, P79, DOI 10.1146/annurev.med.56.090203.104149; Koenig W, 2011, CLIN CHEM, V57, P1196, DOI 10.1373/clinchem.2011.165134; Linna M, 2013, AGE AGEING, V42, P110, DOI 10.1093/ageing/afs074; Ma FX, 2006, J LIPID RES, V47, P1227, DOI 10.1194/jlr.M500507-JLR200; MARTIN MJ, 1986, LANCET, V2, P933; Mehta JL, 1998, BIOCHEM BIOPH RES CO, V248, P511, DOI 10.1006/bbrc.1998.9004; Meisinger C, 2005, CIRCULATION, V112, P651, DOI 10.1161/CIRCULATIONAHA.104.529297; Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Schechner JS, 2000, P NATL ACAD SCI USA, V97, P9191, DOI 10.1073/pnas.150242297; Sorrentino SA, 2010, CIRCULATION, V121, P110, DOI 10.1161/CIRCULATIONAHA.108.836346; Stadtfeld M, 2005, DEVELOPMENT, V132, P203, DOI 10.1242/dev.01558; Tie GD, 2010, J VASC RES, V47, P519, DOI 10.1159/000313879; Trevisan M, 1998, AM J EPIDEMIOL, V148, P958; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; van der Zwan LP, 2009, J LIPID RES, V50, P342, DOI 10.1194/jlr.P800030-JLR200; van Weel V, 2006, ARTERIOSCL THROM VAS, V26, P1383, DOI 10.1161/01.ATV.0000219234.78165.85; Wang XX, 2004, DRUG CHEM TOXICOL, V27, P243, DOI 10.1081/DCT-120037505; Wu YG, 2009, J CARDIOVASC PHARM, V53, P151, DOI 10.1097/FJC.0b013e318197c637; Zhou B, 2007, J LIPID RES, V48, P518, DOI 10.1194/jlr.M600251-JLR200	51	21	23	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0123971	10.1371/journal.pone.0123971	http://dx.doi.org/10.1371/journal.pone.0123971			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26017136	Green Published, Green Submitted, gold			2022-12-26	WOS:000355185600002
J	Maldonado, M; Aguilar, R; Blanco, J; Garcia, S; Serrano, A; Punzon, A				Maldonado, Manuel; Aguilar, Ricardo; Blanco, Jorge; Garcia, Silvia; Serrano, Alberto; Punzon, Antonio			Aggregated Clumps of Lithistid Sponges: A Singular, Reef-Like Bathyal Habitat with Relevant Paleontological Connections	PLOS ONE			English	Article							HEXACTINELLID SPONGE; SEA; OCEAN; WATER; BIODIVERSITY; ASSEMBLAGES; ECOLOGY	The advent of deep-sea exploration using video cameras has uncovered extensive sponge aggregations in virtually all oceans. Yet, a distinct type is herein reported from the Mediterranean: a monospecific reef-like formation built by the lithistid demosponge Leiodermatium pfeifferae. Erect, plate-like individuals (up to 80 cm) form bulky clumps, making up to 1.8 m high mounds (1.14 m on average) on the bottom, at a 760 m-deep seamount named SSS. The siliceous skeletal frameworks of the lithistids persist after sponge death, serving as a complex 3D substratum where new lithistids recruit, along with a varied fauna of other sessile and vagile organisms. The intricate aggregation of lithistid mounds functions as a "reef" formation, architecturally different from the archetypal "demosponge gardens" with disaggregating siliceous skeletons. Leiodermatium pfeifferae also occurred at two additional, close seamounts (EBJ and EBS), but, unlike at SSS, the isolated individuals never formed accretive clumps. The general oceanographic variables (temperature, salinity, dissolved nutrients, chlorophyll, and oxygen) revealed only minimal between-seamount differences, which cannot explain why sponge abundance at SSS is about two orders of magnitude higher than at EBJ or EBS. Large areas of the dense SSS aggregation were damaged, with detached and broken sponges and a few tangled fishing lines. Satellite vessel monitoring revealed low fishing activity around these seamounts. In contrast, international plans for gas and oil extraction at those locations raise serious concerns over the need for protecting urgently this unique, vulnerable habitat to avoid further alteration. Modern lithistids are a relict fauna from Jurassic and Cretaceous reefs and the roots of the very genus Leiodermatium can be traced back to those fossil formations. Therefore, understanding the causes behind the discovered lithistid aggregation is critical not only to its preservation, but also to elucidate how the extraordinary Mesozoic lithistid formations developed and functioned.	[Maldonado, Manuel] CSIC, CEAB, Blanes, Girona, Spain; [Aguilar, Ricardo; Blanco, Jorge; Garcia, Silvia] Oceana, Madrid, Spain; [Serrano, Alberto; Punzon, Antonio] Ctr Oceanog Santander, Inst Espanol Oceanog, Santander, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); Spanish Institute of Oceanography	Maldonado, M (corresponding author), CSIC, CEAB, Blanes, Girona, Spain.	maldonado@ceab.csic.es	Maldonado, Manuel/J-9331-2012; Punzón, Antonio/AAC-6717-2020	Maldonado, Manuel/0000-0002-7447-4212; Aguilar, Ricardo/0000-0001-6615-8626	Adessium Foundation; Georg Waechter Memorial Fund; Pictet Foundation; Spanish Government [CTM2012-37787]	Adessium Foundation; Georg Waechter Memorial Fund; Pictet Foundation; Spanish Government(Spanish GovernmentEuropean Commission)	This study was made possible through the generous funding support by Adessium Foundation, Georg Waechter Memorial Fund, and Pictet Foundation to OCEANA. The study also benefited from a CTM2012-37787 grant of the Spanish Government to MM.	Acosta J, 2004, MAR GEOL, V207, P247, DOI 10.1016/j.margeo.2004.04.003; Adachi NS, 2011, PALAIOS, V26, P106, DOI 10.2110/palo.2010.p10-097r; Antcliffe JB, 2014, BIOL REV, V89, P972, DOI 10.1111/brv.12090; Beaulieu SE, 2001, MAR BIOL, V138, P803, DOI 10.1007/s002270000500; Bell JJ, 2008, ESTUAR COAST SHELF S, V79, P341, DOI 10.1016/j.ecss.2008.05.002; Bo M, 2012, HYDROBIOLOGIA, V687, P163, DOI 10.1007/s10750-011-0964-1; Buhl-Mortensen L, 2010, MAR ECOL-EVOL PERSP, V31, P21, DOI 10.1111/j.1439-0485.2010.00359.x; Carter HJ, 1873, ANN MAGAZINE NATURAL, V12, P349, DOI [DOI 10.1080/00222937308680782, 10.1080/00222937308680782]; Carter HJ, 1876, ANN MAGAZINE NATURAL, V18, P225; Charbonnier S, 2007, PALAEOGEOGR PALAEOCL, V250, P216, DOI 10.1016/j.palaeo.2007.03.013; Chu JWF, 2011, MAR ECOL PROG SER, V441, P1, DOI 10.3354/meps09381; Clark M. R., 2007, SEAMOUNTS ECOLOGY FI, P413, DOI 10.1002/9780470691953.; Conway K. W., 2007, 2007A2 GEOL SURV CAN, VA2, P1, DOI DOI 10.1002/9780470344620.FMATTER; CONWAY KW, 1991, CONT SHELF RES, V11, P771, DOI 10.1016/0278-4343(91)90079-L; Conway KW, 2005, GEO-MAR LETT, V25, P205, DOI 10.1007/s00367-004-0204-z; Cook SE, 2008, MAR ENVIRON RES, V66, pS80, DOI 10.1016/j.marenvres.2008.09.002; de Goeij JM, 2013, SCIENCE, V342, P108, DOI 10.1126/science.1241981; Elliott GRD, 2007, J EXP BIOL, V210, P3736, DOI 10.1242/jeb.003392; FAO, 2013, WORKSH DEV GLOB DAT, P1018; FINKS ROBERT M., 1960, BULL AMER MUS NAT HIST, V120, P1; Frohlich H, 1997, MAR BIOL, V128, P115, DOI 10.1007/s002270050075; GHIOLD J, 1991, NEW SCI, V129, P58; Glasby GP, 2003, MAR PETROL GEOL, V20, P163, DOI 10.1016/S0264-8172(03)00021-7; GYGI RA, 1986, ECLOGAE GEOL HELV, V79, P455; Hansell DA, 2003, LIMNOL OCEANOGR, V48, P150, DOI 10.4319/lo.2003.48.1.0150; Hintzen NT, 2012, FISH RES, V115, P31, DOI 10.1016/j.fishres.2011.11.007; Hogg M.M., 2010, DEEP SEA SPONGE GROU; Johns RA, 1994, ORDOVICIAN LITHISTID; Kahn AS, 2015, LIMNOL OCEANOGR, V60, P78, DOI 10.1002/lno.10002; Kauffman EG, 2000, LETHAIA, V33, P214, DOI 10.1080/00241160025100071; Kelly M, 2007, MARINE FAUNA NZ PORI; Kelly Michelle, 2000, Zoosystema, V22, P265; Kenchington E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109365; Klitgaard AB, 2004, PROG OCEANOGR, V61, P57, DOI 10.1016/j.pocean.2004.06.002; Knudby A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082306; Krautter M, 2001, FACIES, V44, P265, DOI 10.1007/BF02668178; Lazarus DB, 2009, P NATL ACAD SCI USA, V106, P9333, DOI 10.1073/pnas.0812979106; Lee J, 2010, ICES J MAR SCI, V67, P1260, DOI 10.1093/icesjms/fsq010; Levi C., 1991, P72; LEVI C, 1983, Bulletin du Museum National d'Histoire Naturelle Section A Zoologie Biologie et Ecologie Animales, V5, P101; LEVI C, 1989, Memoires du Museum National d'Histoire Naturelle Serie A Zoologie, V143, P25; Levi C, 1993, MEM MUS NATL HIST NA, V158, P1; Levin LA, 2012, ANNU REV MAR SCI, V4, P79, DOI 10.1146/annurev-marine-120709-142714; Longo C, 2005, J MAR BIOL ASSOC UK, V85, P1341, DOI 10.1017/S0025315405012518; Lowenstam HA, 1989, BIOMINERALIZATION; Luna GM, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004168; Magnino G., 1999, Biologia Marina Mediterranea, V6, P391; Maldonado M, 1999, NATURE, V401, P785, DOI 10.1038/44560; Maldonado M, 1996, DEEP-SEA RES PT I, V43, P897, DOI 10.1016/0967-0637(96)00042-8; Maldonado M, 2006, CAN J ZOOL, V84, P175, DOI 10.1139/Z05-177; Maldonado M, 2005, LIMNOL OCEANOGR, V50, P799, DOI 10.4319/lo.2005.50.3.0799; Maldonado M, 1999, MAR ECOL PROG SER, V185, P239, DOI 10.3354/meps185239; Maldonado M, 2008, TREBALLS SOC CATALAN, V59, P29; Maldonado M, 2012, ADV MAR BIOL, V62, P113, DOI 10.1016/B978-0-12-394283-8.00003-5; Maldonado M, 2011, SCI REP-UK, V1, DOI 10.1038/srep00030; MALIVA R G, 1989, Palaios, V4, P519, DOI 10.2307/3514743; Manconi R, 2008, ZOOKEYS, P71, DOI 10.3897/zookeys.4.39; Milkov AV, 2004, EARTH-SCI REV, V66, P183, DOI 10.1016/j.earscirev.2003.11.002; Moret L., 1928, Travaux du Laboratoire de Geologie Lyon, V13, P123; Moret L, 1924, MEMOIRES SOC GEOLOGI, V1, P1; Moret L, 1925, MEM SOC GEOL FR, V5, P1; MORET L., 1926, MEMOIRES SOC GEOLOGI, V5, P1; Pile AJ, 2006, DEEP-SEA RES PT I, V53, P1148, DOI 10.1016/j.dsr.2006.03.008; Pisera A, 2011, SCI MAR, V75, P17, DOI 10.3989/scsimar.2011.75n1017; Pomponi Shirley A., 2001, Bulletin of the Biological Society of Washington, V10, P344; Reid REH., 1967, ASPECTS TETHYAN BIOG, V7, P171; REISWIG HM, 1973, J EXP MAR BIOL ECOL, V14, P231; RICE AL, 1990, PROG OCEANOGR, V24, P179, DOI 10.1016/0079-6611(90)90029-2; Rutzler K, 2012, ADV MAR BIOL, V61, P211, DOI 10.1016/B978-0-12-387787-1.00002-7; Samadi Sarah, 2007, Fish and Aquatic Resources Series, V12, P119; Schlacher-Hoenlinger MA, 2005, ZOOSYSTEMA, V27, P649; Schmidt O., 1870, GRUNDZUGE SPONGIEN F; SIEVER R, 1991, P287; Stone RP, 2014, NMESAFSC264 NOAA; UNEP, 2006, EC BIOD DEEP WAT HIG; Vamvakas CN, 1971, HELLENIC OCEANOLOGY, V20, P129; Watson R., 2007, SEAMOUNTS ECOLOGY FI, P400; Werner W., 1994, Courier Forschungsinstitut Senckenberg, V172, P381; Whitney F, 2005, CONT SHELF RES, V25, P211, DOI 10.1016/j.csr.2004.09.003; Wiedenmayer F, 1980, LIVING FOSSIL SPONGE, P55; Wiedenmeyer Felix, 1994, Schweizerische Palaeontologische Abhandlungen, V116, P1	81	32	32	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0125378	10.1371/journal.pone.0125378	http://dx.doi.org/10.1371/journal.pone.0125378			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26016786	Green Published, Green Submitted, gold			2022-12-26	WOS:000355185600019
J	Tareque, MI; Koshio, A; Tiedt, AD; Hasegawa, T				Tareque, Md. Ismail; Koshio, Atsushi; Tiedt, Andrew D.; Hasegawa, Toshihiko			Are the Rates of Hypertension and Diabetes Higher in People from Lower Socioeconomic Status in Bangladesh? Results from a Nationally Representative Survey	PLOS ONE			English	Article							BODY-MASS INDEX; NONCOMMUNICABLE DISEASES; RISK-FACTORS; HEALTH; INEQUALITIES; ADULTS; INCOME	Objective A well-established belief regarding inequalities in health around the world is that hypertension and diabetes are higher in groups of lower socioeconomic status. We examined whether rates of hypertension, diabetes, and the coexistence of hypertension and diabetes are higher in people from a lower socioeconomic status than in those from a higher socioeconomic status in Bangladesh. Methods We investigated a nationally representative dataset from the 2011 Bangladesh Demographic and Health Survey with objective measures for hypertension and diabetes. A wealth index was constructed from data on household assets using principal components analysis. Chi-square tests and logistic regressions were performed to test the associations between wealth level, hypertension and diabetes. Findings People from the highest wealth quintile were significantly more likely to have hypertension (Adjusted odds ratios [AOR] = 1.65, 95% confidence interval [CI] = 1.22-2.25), diabetes (AOR = 1.81, 95% CI = 1.21-2.71), and the coexistence of hypertension and diabetes (AOR = 2.17, 95% CI = 1.05-4.49) than people from the lowest wealth quintile. The odds of having hypertension, diabetes, and their coexistence were higher for older people, women, people who engaged in less physical labor, and people who were overweight and obese. Conclusion Wealthier people, particularly people from the fourth and highest wealth quintiles, should be careful to avoid unhealthy lifestyles to prevent hypertension and diabetes. Health policy makers and planners are urged to target wealthier strata in terms of hypertension and diabetes initiatives while paying special attention to older people, women, people who engage in less physical labor, and individuals who are overweight.	[Tareque, Md. Ismail] Rajshahi Univ, Dept Populat Sci & Human Resource Dev, Rajshahi 6205, Bangladesh; [Koshio, Atsushi] Grad Sch Project Design, Tokyo, Japan; [Tiedt, Andrew D.] US Dept Justice, Washington, DC 20530 USA; [Hasegawa, Toshihiko] Nippon Med Sch, Dept Hlth Policy & Management, Tokyo 113, Japan	University of Rajshahi; Nippon Medical School	Tareque, MI (corresponding author), Rajshahi Univ, Dept Populat Sci & Human Resource Dev, Rajshahi 6205, Bangladesh.	tareque_pshd@yahoo.com		Tareque, Md Ismail/0000-0002-6507-1171; Tiedt, Andrew/0000-0002-3774-3452	Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan [24790522]	Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Opinions or points of view expressed are those of the authors and do not necessarily reflect the official position or policies of the United States Department of Justice. Andrew D. Tiedt received no financial support for the research, authorship, and/or publication of this article. Md. Ismail Tareque received financial support from the Grant-in-Aid for Young Scientists 24790522 while working as a research analyst and preparing the manuscript in Nippon Medical School. The Grant-in-Aid for Young Scientists 24790522, funded by the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan, was awarded to Atsushi Koshio. MEXT had no further role in the interpretation of data or preparation of this article.	American Heart Association [AHA], 2012, HIGH BLOOD PRESSURE; Anderson G H, 1999, Saudi J Kidney Dis Transpl, V10, P286; August P, 1999, J CLIN ENDOCR METAB, V84, P1862, DOI 10.1210/jc.84.6.1862; Bays HE, 2007, INT J CLIN PRACT, V61, P737, DOI 10.1111/j.1742-1241.2007.01336.x; Busingye D, 2014, INT J EPIDEMIOL, V43, P1563, DOI 10.1093/ije/dyu112; Centers for Disease Control and Prevention [CDC], 2009, THE POWER OF PREVENT; Chan Y. H., 2004, SMJ Singapore Medical Journal, V45, P149; D'Orazio P, 2005, CLIN CHEM, V51, P1573, DOI 10.1373/clinchem.2005.051979; de Gaudemaris R, 2002, HYPERTENSION, V39, P1119, DOI 10.1161/01.HYP.0000018912.05345.55; Di Cesare M, 2013, LANCET, V381, P585, DOI 10.1016/S0140-6736(12)61851-0; Ferrannini E, 2012, LANCET, V380, P601, DOI 10.1016/S0140-6736(12)60987-8; Fleischer NL, 2011, AM J PUBLIC HEALTH, V101, P294, DOI 10.2105/AJPH.2009.190165; Ganz ML, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-50; Grant JF, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-6; Hughes ME, 2009, J HEALTH SOC BEHAV, V50, P344, DOI 10.1177/002214650905000307; Isaacs SL, 2004, NEW ENGL J MED, V351, P1137, DOI 10.1056/NEJMsb040329; James SA, 2006, AM J PUBLIC HEALTH, V96, P812, DOI 10.2105/AJPH.2005.076158; Karakelides H, 2010, DIABETES, V59, P89, DOI 10.2337/db09-0591; Lago RM, 2007, NAT CLIN PRACT ENDOC, V3, P667, DOI 10.1038/ncpendmet0638; Lehmann HP, 2001, CLINICAL DIAGNOSIS A; LILLARD LA, 1995, AM J SOCIOL, V100, P1131, DOI 10.1086/230634; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Minkler M, 2006, NEW ENGL J MED, V355, P695, DOI 10.1056/NEJMsa044316; National Institute of Population Research and Training [NIPORT] Mitra and Associates ICF International, 2013, INTERNATIONAL BANGLA; Razzaque A, 2011, ASIA-PAC J PUBLIC HE, V23, P183, DOI 10.1177/1010539510392743; Rutstein SO, 2004, DHS COMPARATIVE REPO; Saquib N, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1032; Saquib N, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-434; Siegrist J, 2004, SOC SCI MED, V58, P1463, DOI 10.1016/S0277-9536(03)00349-6; Stringhini S, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5452; Sturm R, 2002, BMJ-BRIT MED J, V324, P20, DOI 10.1136/bmj.324.7328.20; Tareque MI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103681; Tesfaye F, 2007, J HUM HYPERTENS, V21, P28, DOI 10.1038/sj.jhh.1002104; WHO, 2006, DEFINITION AND DIAGN; World Health Organization, 2009, GLOBAL HEALTH RISKS; Zimmer Z, 2008, SOC SCI MED, V66, P57, DOI 10.1016/j.socscimed.2007.08.032	36	36	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0127954	10.1371/journal.pone.0127954	http://dx.doi.org/10.1371/journal.pone.0127954			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0RO	26017066	Green Published, Green Submitted, gold			2022-12-26	WOS:000355185600102
J	Alharbi, NK; Chinnakannan, SK; Gilbert, SC; Draper, SJ				Alharbi, Naif Khalaf; Chinnakannan, Senthil K.; Gilbert, Sarah C.; Draper, Simon J.			Investigation of IRES Insertion into the Genome of Recombinant MVA as a Translation Enhancer in the Context of Transcript Decapping	PLOS ONE			English	Article							VIRUS D10 PROTEIN; GENE-EXPRESSION; PROMOTER; VACCINES; SEQUENCE; DETERMINANTS; EFFICIENCY; STABILITY; SELECTION; IMPROVES	Recombinant modified vaccinia virus Ankara (MVA) has been used to deliver vaccine candidate antigens against infectious diseases and cancer. MVA is a potent viral vector for inducing high magnitudes of antigen-specific CD8(+) T cells; however the cellular immune responses to a recombinant antigen in MVA could be further enhanced by increasing transgene expression. Previous reports showed the importance of utilizing an early poxviral promoter for increasing transgene expression and therefore enhancing cellular immune responses. However, the vaccinia D10 decapping enzyme is reported to target and decap vaccinia virus early transcripts - a mechanism that could limit the usefulness of early promoters in MVA viral vectors if this enzyme shows the same activity in this closely related virus. Therefore, we attempted to increase transgene expression in recombinant MVA by inserting the encephalomyocarditis virus (EMCV) internal ribosome entry site (IRES) upstream of a transgene sequence that is controlled by the B8R early promoter, and assessed D10 enzyme decapping activity in MVA. The aim of the IRES element was to initiate translation of the transgene transcript (after the removal of the cap structure by the D10 decapping protein) in a cap-independent manner. Here, we report that overexpression of the D10 decapping protein, in trans, in MVA reduced growth and transgene expression; however, the IRES element was not able to compensate for the negative effect of the D10 decapping protein. Recombinant MVA with EMCV IRES induced levels of both gene expression and transcription that were similar to the control recombinant MVA, encoding the same transgene but without the IRES element. Both viruses were tested in BALB/c mice and induced similar magnitudes of epitope-specific CD8(+) T cells. This work indicates that the MVA version of the D10 decapping enzyme, overexpressed using a plasmid, is functional, but its negative effect on transgene expression by recombinant MVA cannot be overcome by the use of the EMCV IRES inserted upstream of the transgene initiation codon.	[Alharbi, Naif Khalaf; Chinnakannan, Senthil K.; Gilbert, Sarah C.; Draper, Simon J.] Univ Oxford, Jenner Inst, Oxford OX3 7DQ, England; [Alharbi, Naif Khalaf] King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia	University of Oxford; Jenner Institute; King Saud Bin Abdulaziz University for Health Sciences; King Abdullah International Medical Research Center (KAIMRC)	Alharbi, NK (corresponding author), Univ Oxford, Jenner Inst, Oxford OX3 7DQ, England.	naif.alharbi@ndm.ox.ac.uk	Draper, Simon J/F-1758-2011; Chinnakannan, Senthil/AAP-9369-2020; Gilbert, Sarah C./H-2857-2019	Draper, Simon J/0000-0002-9415-1357; Chinnakannan, Senthil/0000-0002-4404-0229; Gilbert, Sarah C./0000-0002-6823-9750; Alharbi, Naif/0000-0002-6049-3383	UK MRC [G1000527]; UK Department for International Development (DFID) under the MRC/DFID [G1000527]; Medical Research Council [G1000527] Funding Source: researchfish; MRC [G1000527] Funding Source: UKRI	UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department for International Development (DFID) under the MRC/DFID; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	SCG and SJD are Jenner Investigators (http://www.jenner.ac.uk). SJD is a Lister Institute Research Prize Fellow (http://www.lister-institute.org.uk) and a UK Medical Research Council (MRC; http://www.mrc.ac.uk) Career Development Fellow [grant number G1000527; this Fellowship is jointly funded by the UK MRC and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoine G, 1998, VIROLOGY, V244, P365, DOI 10.1006/viro.1998.9123; Balvay L, 2009, BBA-GENE REGUL MECH, V1789, P542, DOI 10.1016/j.bbagrm.2009.07.005; Bochkov YA, 2006, BIOTECHNIQUES, V41, P283, DOI 10.2144/000112243; BORMAN AM, 1995, NUCLEIC ACIDS RES, V23, P3656, DOI 10.1093/nar/23.18.3656; Carter GC, 2005, J GEN VIROL, V86, P1279, DOI 10.1099/vir.0.80831-0; Cottingham Matthew G, 2012, Methods Mol Biol, V890, P37, DOI 10.1007/978-1-61779-876-4_3; Cottingham MG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001638; Di Pilato M, 2013, J GEN VIROL, V94, P2771, DOI 10.1099/vir.0.057299-0; ELROYSTEIN O, 1989, P NATL ACAD SCI USA, V86, P6126, DOI 10.1073/pnas.86.16.6126; Filbin ME, 2009, CURR OPIN STRUC BIOL, V19, P267, DOI 10.1016/j.sbi.2009.03.005; Garcia-Arriaza J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066894; Gilbert SC, 2013, VACCINE, V31, P4241, DOI 10.1016/j.vaccine.2013.03.020; Hopkins R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020067; Kastenmuller W, 2006, VIROLOGY, V350, P276, DOI 10.1016/j.virol.2006.02.039; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loening AM, 2006, PROTEIN ENG DES SEL, V19, P391, DOI 10.1093/protein/gzl023; Orubu T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040167; Oseroff C, 2008, J IMMUNOL, V180, P7193, DOI 10.4049/jimmunol.180.11.7193; Parrish S, 2006, J VIROL, V80, P553, DOI 10.1128/JVI.80.2.553-561.2006; Parrish S, 2007, P NATL ACAD SCI USA, V104, P2139, DOI 10.1073/pnas.0611685104; Popov S, 2009, DNA CELL BIOL, V28, P103, DOI 10.1089/dna.2008.0792; Rehm KE, 2011, VACCINE, V29, P3276, DOI 10.1016/j.vaccine.2011.02.023; ROMERO P, 1990, IMMUNOL LETT, V25, P27, DOI 10.1016/0165-2478(90)90086-6; Shors T, 1999, J VIROL, V73, P791, DOI 10.1128/JVI.73.1.791-796.1999; Souliere MF, 2010, NUCLEIC ACIDS RES, V38, P7599, DOI 10.1093/nar/gkq628; Sridhar S, 2008, J VIROL, V82, P3822, DOI 10.1128/JVI.02568-07; Tscharke DC, 2006, J VIROL, V80, P6318, DOI 10.1128/JVI.00427-06; Wang ZD, 2010, VACCINE, V28, P1547, DOI 10.1016/j.vaccine.2009.11.056; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035	29	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127978	10.1371/journal.pone.0127978	http://dx.doi.org/10.1371/journal.pone.0127978			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011541	Green Published, gold, Green Submitted			2022-12-26	WOS:000355183900176
J	Krukovets, I; Legerski, M; Sul, P; Stenina-Adognravi, O				Krukovets, Irene; Legerski, Matthew; Sul, Pavel; Stenina-Adognravi, Olga			Inhibition of hyperglycemia-induced angiogenesis and breast cancer tumor growth by systemic injection of microRNA-467 antagonist	FASEB JOURNAL			English	Article						extracellular matrix; thrombospondin; vascular complications; diabetes; neovascularization	MMTV-WNT-1 TRANSGENIC MICE; MOUSE MAMMARY-TUMOR; DIABETES-MELLITUS; HEART-DISEASE; CELL-LINES; EXPRESSION; RISK; THROMBOSPONDIN-1; HYPEROSMOLARITY	Abnormal angiogenesis in multiple tissues is a key characteristic of the vascular complications of diabetes. However, angiogenesis may be increased in one tissue but decreased in another in the same patient at the same time point in the disease. The mechanisms of aberrant angiogenesis in diabetes are not understood. There are no selective therapeutic approaches to target increased neovascularization without affecting physiologic angiogenesis and angiogenesis in ischemic tissues. We recently reported a novel miRNA-dependent pathway that up-regulates angiogenesis in response to hyperglycemia in a cell-and tissue-specific manner. The goal of the work described herein was to test whether systemic administration of an antagonist of miR-467 would prevent hyperglycemia-induced local angiogenesis in a tissue-specific manner. We examined the effect of the antagonist on hyperglycemia-induced tumor growth and angiogenesis and on skin wound healing in mouse models of diabetes. Our data demonstrated that the systemic injection of the antagonist prevented hyperglycemia-induced angiogenesis and growth of mouse and human breast cancer tumors, where the miR-467 pathway was active in hyperglycemia. In tissues where the miR-467-dependent mechanism was not activated by hyperglycemia, there was no effect of the antagonist: the systemic injection did not affect skin wound healing or the growth of prostate tumors. The data show that systemic administration of the miR-467 antagonist could be a breakthrough approach in the treatment and prevention of diabetes-associated breast cancer in a tissue-specific manner without affecting physiologic angiogenesis and angiogenesis in ischemic tissues.	[Krukovets, Irene; Legerski, Matthew; Sul, Pavel; Stenina-Adognravi, Olga] Cleveland Clin, Dept Mol Cardiol, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Stenina-Adognravi, O (corresponding author), Cleveland Clin, Dept Mol Cardiol, 9500 Euclid Ave,NB50-66, Cleveland, OH 44195 USA.	stenino@ccf.org		Sul, Pavel/0000-0002-3149-722X; , Olga/0000-0002-1256-0545	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grant [R01-HL117216]; U.S. NIH National Institute of Diabetes and Digestive and Kidney Diseases Grant [R01-DK067532]; U.S. NIH National Cancer Institute Grant [CA177771]; Scott Hamilton Cares Foundation; NATIONAL CANCER INSTITUTE [R01CA177771] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067532] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grant; U.S. NIH National Institute of Diabetes and Digestive and Kidney Diseases Grant; U.S. NIH National Cancer Institute Grant; Scott Hamilton Cares Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Ms. Nadia Hoppe (Department of Slavic Languages and Literatures, University of Illinois at Urbana-Champaign) for technical help with the manuscript preparation and editorial assistance. This work was supported by U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grant R01-HL117216, U.S. NIH National Institute of Diabetes and Digestive and Kidney Diseases Grant R01-DK067532, U.S. NIH National Cancer Institute Grant CA177771, and by funds from the Scott Hamilton Cares Foundation.	Amundadottir LT, 1998, ONCOGENE, V16, P737, DOI 10.1038/sj.onc.1201829; Atchison EA, 2011, INT J CANCER, V128, P635, DOI 10.1002/ijc.25362; Bhattacharyya S, 2008, J BIOL CHEM, V283, P5699, DOI 10.1074/jbc.M706435200; Bhattacharyya S, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.005967; BIELEFELD DR, 1983, AM J PHYSIOL, V245, pE568, DOI 10.1152/ajpendo.1983.245.6.E568; Bordeleau L, 2011, CANCER-AM CANCER SOC, V117, P1812, DOI 10.1002/cncr.25595; CAILLEAU R, 1978, IN VITRO CELL DEV B, V14, P911; CHOOI KF, 1994, CANCER RES, V54, P6434; Di Peppe SR, 2002, GENE THER, V9, P1271, DOI 10.1038/sj.gt.3301798; Driver JA, 2010, AM J EPIDEMIOL, V172, P299, DOI 10.1093/aje/kwq127; ELSON A, 1995, J BIOL CHEM, V270, P26116, DOI 10.1074/jbc.270.44.26116; Engel S, 2003, NEW ENGL J MED, V348, P2294; Erickson K, 2011, J CLIN ONCOL, V29, P54, DOI 10.1200/JCO.2010.29.3183; Fantin VR, 2002, CANCER CELL, V2, P29, DOI 10.1016/S1535-6108(02)00082-X; Habib SL, 2013, ISRN ONCOL; Hemminki K, 2010, ONCOLOGIST, V15, P548, DOI 10.1634/theoncologist.2009-0300; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Jang YC, 1999, WOUND REPAIR REGEN, V7, P375, DOI 10.1046/j.1524-475X.1999.00375.x; Janssen HLA, 2013, NEW ENGL J MED, V368, P1685, DOI 10.1056/NEJMoa1209026; Klein SA, 1999, J SURG RES, V82, P268, DOI 10.1006/jsre.1998.5551; Lee PC, 1999, AM J PHYSIOL-HEART C, V277, pH1600, DOI 10.1152/ajpheart.1999.277.4.H1600; Li Y, 2000, ONCOGENE, V19, P1002, DOI 10.1038/sj.onc.1203273; McFarland MS, 2010, PHARMACOTHERAPY, V30, P1159, DOI 10.1592/phco.30.11.1159; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; Nunez NP, 2008, NUTR CANCER, V60, P534, DOI 10.1080/01635580801966195; O'Grady SP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011699; Peairs KS, 2011, J CLIN ONCOL, V29, P40, DOI 10.1200/JCO.2009.27.3011; Polednak Anthony P, 2010, J Registry Manag, V37, P57; ROCKWELL SC, 1972, J NATL CANCER I, V49, P735; Schrauder MG, 2011, J CANCER RES CLIN, V137, P975, DOI 10.1007/s00432-010-0960-2; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; SICILIANO MJ, 1979, CANCER RES, V39, P919; Simon D, 2010, DIABETES METAB, V36, P182, DOI 10.1016/j.diabet.2010.04.001; Stenina OI, 2003, CIRCULATION, V107, P3209, DOI 10.1161/01.CIR.0000074223.56882.97; Turner EL, 2011, INT J CANCER, V128, P440, DOI 10.1002/ijc.25360; van Rooij E, 2008, CIRC RES, V103, P919, DOI 10.1161/CIRCRESAHA.108.183426; Van Rooij E, 2007, J CLIN INVEST, V117, P2369, DOI 10.1172/JCI33099; van Rooij E, 2012, CIRC RES, V110, P496, DOI 10.1161/CIRCRESAHA.111.247916; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; WACHTEL TJ, 1991, J GEN INTERN MED, V6, P495, DOI 10.1007/BF02598216; Wang SS, 2009, CURR OPIN GENET DEV, V19, P205, DOI 10.1016/j.gde.2009.04.002; Wotton CJ, 2011, DIABETOLOGIA, V54, P527, DOI 10.1007/s00125-010-1987-2; Zheng Q, 2011, ENDOCR-RELAT CANCER, V18, P491, DOI 10.1530/ERC-11-0102	43	16	16	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2015	29	9					3726	3736		10.1096/fj.14-267799	http://dx.doi.org/10.1096/fj.14-267799			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CP5IU	26018675	Green Published			2022-12-26	WOS:000359915600011
J	Zhang, WL; Ogando, DG; Bonanno, JA; Obukhov, AG				Zhang, Wenlin; Ogando, Diego G.; Bonanno, Joseph A.; Obukhov, Alexander G.			Human SLC4A11 Is a Novel NH3/H+ Co-transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL DYSTROPHY; CORNEAL ENDOTHELIUM; TRANSPORTER FAMILY; AMMONIA; EXPRESSION; MUTATIONS; GLUTAMINE; PROTEINS; GLYCOPROTEIN; AMT/MEP/RH	SLC4A11 has been proposed to be an electrogenic membrane transporter, permeable to Na+, H+ (OH-), bicarbonate, borate, and NH4+. Recent studies indicate, however, that neither bicarbonate or borate is a substrate. Here, we examined potential NH4+, Na+, and H+ contributions to electrogenic ion transport through SLC4A11 stably expressed in Na+/H+ exchanger-deficient PS120 fibroblasts. Inward currents observed during exposure to NH4Cl were determined by the [NH3](o), not [NH4+](o), and current amplitudes varied with the [H+] gradient. These currents were relatively unaffected by removal of Na+, K+, or Cl- from the bath but could be reduced by inclusion of NH4Cl in the pipette solution. Bath pH changes alone did not generate significant currents through SLC4A11, except immediately following exposure to NH4Cl. Reversal potential shifts in response to changing [NH3](o) and pH(o) suggested an NH3/H4C-coupled transport mode for SLC4A11. Proton flux through SLC4A11 in the absence of ammonia was relatively small, suggesting that ammonia transport is of more physiological relevance. Methylammonia produced currents similar to NH3 but with reduced amplitude. Estimated stoichiometry of SLC4A11 transport was 1: 2 (NH3/H4C). NH3-dependent currents were insensitive to 10 mu M ethyl-isopropyl amiloride or 100 mu M 4,4'-diisothiocyanatostilbene-2,2'-disulfonic acid. We propose that SLC4A11 is an NH3/2H(4)C co-transporter exhibiting unique characteristics.	[Zhang, Wenlin; Ogando, Diego G.; Bonanno, Joseph A.] Indiana Univ, Sch Optometry, Bloomington, IN 47405 USA; [Obukhov, Alexander G.] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Bonanno, JA (corresponding author), 800 Atwater Ave, Bloomington, IN 47405 USA.	jbonanno@indiana.edu; aobukhov@iu.edu	Obukhov, Alexander G/C-7246-2008; Zhang, Wenlin/AAW-7646-2021; Zhang, Wenlin/B-6955-2013; Regan, Clinton/E-6250-2012	Obukhov, Alexander G/0000-0002-3862-6004; Zhang, Wenlin/0000-0003-3229-9177; Zhang, Wenlin/0000-0003-3229-9177; 	National Institutes of Health [R01EY008834, P30EY019008, R01HL115140]; NATIONAL EYE INSTITUTE [P30EY019008, R01EY008834] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115140] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants 5R01EY008834 (to J. A. B.), P30EY019008 (Core Grant of Vision Science), and R01HL115140 (to A. G. O). The authors declare that they have no conflicts of interest with the contents of this article.	Albrecht J, 2006, HEPATOLOGY, V44, P788, DOI 10.1002/hep.21357; Aldave AJ, 2013, CLIN GENET, V84, P109, DOI 10.1111/cge.12191; Beitz E, 2006, P NATL ACAD SCI USA, V103, P269, DOI 10.1073/pnas.0507225103; BORON WF, 1976, J GEN PHYSIOL, V67, P91, DOI 10.1085/jgp.67.1.91; COHEN BN, 1992, J GEN PHYSIOL, V100, P373, DOI 10.1085/jgp.100.3.373; Damkier HH, 2007, AM J PHYSIOL-REG I, V293, pR2136, DOI 10.1152/ajpregu.00356.2007; Gottsch JD, 2003, INVEST OPHTH VIS SCI, V44, P594, DOI 10.1167/iovs.02-0300; Groger N, 2010, J BIOL CHEM, V285, P14467, DOI 10.1074/jbc.M109.094680; Han KH, 2009, AM J PHYSIOL-LUNG C, V297, pL153, DOI 10.1152/ajplung.90524.2008; Han SB, 2013, INVEST OPHTH VIS SCI, V54, P6179, DOI 10.1167/iovs.13-12089; Handlogten ME, 2005, AM J PHYSIOL-GASTR L, V288, pG1036, DOI 10.1152/ajpgi.00418.2004; Houillier P, 2012, AM J PHYSIOL-RENAL, V302, pF293, DOI 10.1152/ajprenal.00307.2011; Jalimarada SS, 2013, INVEST OPHTH VIS SCI, V54, P4330, DOI 10.1167/iovs.13-11929; Kao LY, 2015, AM J PHYSIOL-CELL PH, V308, pC176, DOI 10.1152/ajpcell.00271.2014; Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952; Lee HW, 2013, REPRODUCTION, V146, P283, DOI 10.1530/REP-13-0154; Lima AS, 2009, SENSORS-BASEL, V9, P6613, DOI 10.3390/s90906613; Litman Thomas, 2009, Handb Exp Pharmacol, P327, DOI 10.1007/978-3-540-79885-9_17; Lopez IA, 2009, J BIOL CHEM, V284, P26882, DOI 10.1074/jbc.M109.008102; Nakhoul NL, 2010, AM J PHYSIOL-CELL PH, V299, pC1386, DOI 10.1152/ajpcell.00211.2010; Nakhoul NL, 2010, AM J PHYSIOL-CELL PH, V299, pC695, DOI 10.1152/ajpcell.00019.2010; Newsholme P, 2003, CELL BIOCHEM FUNCT, V21, P1, DOI 10.1002/cbf.1003; Newsholme P, 2003, BRAZ J MED BIOL RES, V36, P153, DOI 10.1590/S0100-879X2003000200002; Nowak DM, 2013, INVEST OPHTH VIS SCI, V54, P2207, DOI 10.1167/iovs.13-11592; Ogando DG, 2013, AM J PHYSIOL-CELL PH, V305, pC716, DOI 10.1152/ajpcell.00056.2013; PACKER RK, 1991, J AM SOC NEPHROL, V2, P77; Park M, 2004, MOL CELL, V16, P331, DOI 10.1016/j.molcel.2004.09.030; Parker MD, 2001, BIOCHEM BIOPH RES CO, V282, P1103, DOI 10.1006/bbrc.2001.4692; Ramprasad VL, 2007, ONLINE HUM MUTAT, V28, P522, DOI [DOI 10.1002/humu.9487, 10.1002/humu.9487]; Shei W, 2013, MOL VIS, V19, P1096; Siddiqui S, 2014, CORNEA, V33, P247, DOI 10.1097/ICO.0000000000000041; Soria LR, 2013, HEPATOLOGY, V57, P2061, DOI 10.1002/hep.26236; Tanaka M, 2008, PLANT CELL, V20, P2860, DOI 10.1105/tpc.108.058628; ten Hoopen F, 2010, J EXP BOT, V61, P2303, DOI 10.1093/jxb/erq057; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012; Vilas GL, 2013, HUM MOL GENET, V22, P4579, DOI 10.1093/hmg/ddt307; Vilas GL, 2011, BIOCHEMISTRY-US, V50, P2157, DOI 10.1021/bi101887z; Virkki LV, 2002, AM J PHYSIOL-CELL PH, V282, pC1278, DOI 10.1152/ajpcell.00589.2001; Vithana EN, 2008, HUM MOL GENET, V17, P656, DOI 10.1093/hmg/ddm337; Weiner ID, 2010, CURR OPIN NEPHROL HY, V19, P471, DOI 10.1097/MNH.0b013e32833bfa4e; Winkler F, 2006, PFLUG ARCH EUR J PHY, V451, P701, DOI 10.1007/s00424-005-1511-6; Yao H, 1999, J CLIN INVEST, V104, P637, DOI 10.1172/JCI6785	42	46	47	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2015	290	27					16894	16905		10.1074/jbc.M114.627455	http://dx.doi.org/10.1074/jbc.M114.627455			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM3HN	26018076	Green Published, hybrid			2022-12-26	WOS:000357572800034
J	Stern, J; Kahn, A; Vazana, Y; Shamshoum, M; Morais, S; Lamed, R; Bayer, EA				Stern, Johanna; Kahn, Amaranta; Vazana, Yael; Shamshoum, Melina; Morais, Sarah; Lamed, Raphael; Bayer, Edward A.			Significance of Relative Position of Cellulases in Designer Cellulosomes for Optimized Cellulolysis	PLOS ONE			English	Article							CLOSTRIDIUM-THERMOCELLUM; GENE-CLUSTER; MECHANISM; BINDING; DEGRADATION; COMPONENTS; SUBSTRATE; FAMILIES; INSIGHTS; SYSTEM	Degradation of cellulose is of major interest in the quest for alternative sources of renewable energy, for its positive effects on environment and ecology, and for use in advanced biotechnological applications. Due to its microcrystalline organization, celluose is extremely difficult to degrade, although numerous microbes have evolved that produce the appropriate enzymes. The most efficient known natural cellulolytic system is produced by anaerobic bacteria, such as C. thermocellum, that possess a multi-enzymatic complex termed the cellulosome. Our laboratory has devised and developed the designer cellulosome concept, which consists of chimaeric scaffoldins for controlled incorporation of recombinant polysaccharide-degrading enzymes. Recently, we reported the creation of a combinatorial library of four cellulosomal modules comprising a basic chimaeric scaffoldin, i.e., a CBM and 3 divergent cohesin modules. Here, we employed selected members of this library to determine whether the position of defined cellulolytic enzymes is important for optimized degradation of a microcrystalline cellulosic substrate. For this purpose, 10 chimaeric scaffoldins were used for incorporation of three recombinant Thermobifida fusca enzymes: the processive endoglucanase Cel9A, endoglucanase Cel5A and exoglucanase Cel48A. In addition, we examined whether the characteristic properties of the T. fusca enzymes as designer cellulosome components are unique to this bacterium by replacing them with parallel enzymes from Clostridium thermocellum. The results support the contention that for a given set of cellulosomal enzymes, their relative position within a scaffoldin can be critical for optimal degradation of microcrystaline cellulosic substrates.	[Stern, Johanna; Kahn, Amaranta; Vazana, Yael; Shamshoum, Melina; Morais, Sarah; Bayer, Edward A.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Lamed, Raphael] Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Ramat Aviv, Israel	Weizmann Institute of Science; Tel Aviv University	Bayer, EA (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	ed.bayer@weizmann.ac.il		kahn, amaranta/0000-0001-8516-7296; Morais, Sarah/0000-0001-9026-2386	European Union [604530]; ERA-IB Consortium [EIB.12.022]; F. Warren Hellman Grant for Alternative Energy Research in Israel; Israel Science Foundation (ISF) [1349]; Sidney E. Frank Foundation through the ISF [24/11]; Israeli Center of Research Excellence (I-CORE Center) [152/11]; Weizmann Institute of Science Alternative Energy Research Initiative (AERI); Helmsley Foundation	European Union(European Commission); ERA-IB Consortium; F. Warren Hellman Grant for Alternative Energy Research in Israel; Israel Science Foundation (ISF)(Israel Science Foundation); Sidney E. Frank Foundation through the ISF; Israeli Center of Research Excellence (I-CORE Center); Weizmann Institute of Science Alternative Energy Research Initiative (AERI); Helmsley Foundation	The authors acknowledge the support of the European Union, Area NMP.2013.1.1-2: Self-assembly of naturally occurring nanosystems: CellulosomePlus Project number: 604530 and an ERA-IB Consortium (EIB.12.022), acronym FiberFuel. In addition, EAB is grateful for a grant from the F. Warren Hellman Grant for Alternative Energy Research in Israel in support of alternative energy research in Israel administered by the Israel Strategic Alternative Energy Foundation (I-SAEF). This research was also supported by a grant (No. 1349) to EAB also from the Israel Science Foundation (ISF) and a grant (No. 24/11) issued to RL by The Sidney E. Frank Foundation also through the ISF. Additional support was obtained from the establishment of an Israeli Center of Research Excellence (I-CORE Center No. 152/11) managed by the ISF, Jerusalem, Israel, by the Weizmann Institute of Science Alternative Energy Research Initiative (AERI) and the Helmsley Foundation. E.A.B. is the incumbent of The Maynard I. and Elaine Wishner Chair of Bio-organic Chemistry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdou L, 2008, J BACTERIOL, V190, P1499, DOI 10.1128/JB.01160-07; Barak Y, 2005, J MOL RECOGNIT, V18, P491, DOI 10.1002/jmr.749; BAYER EA, 1985, J BACTERIOL, V163, P552, DOI 10.1128/JB.163.2.552-559.1985; BAYER EA, 1994, TRENDS BIOTECHNOL, V12, P379, DOI 10.1016/0167-7799(94)90039-6; Bayer EA, 1995, PROGR BIOTECHNOL, V10, P251, DOI 10.1016/S0921-0423(06)80108-5; Belaich JP, 1997, J BIOTECHNOL, V57, P3, DOI 10.1016/S0168-1656(97)00085-0; Blouzard JC, 2010, PROTEOMICS, V10, P541, DOI 10.1002/pmic.200900311; Bomble YJ, 2011, J BIOL CHEM, V286, P5614, DOI 10.1074/jbc.M110.186031; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Borne R, 2013, FEBS J, V280, P5764, DOI 10.1111/febs.12497; Caspi Jonathan, 2010, Systems and Synthetic Biology, V4, P193, DOI 10.1007/s11693-010-9056-1; Caspi J, 2007, EFFECT CELLULOSOMAL; Caspi J, 2008, J BIOTECHNOL, V135, P351, DOI 10.1016/j.jbiotec.2008.05.003; Caspi J, 2006, BIOCATAL BIOTRANSFOR, V24, P3, DOI 10.1080/10242420600598046; Caspi J, 2009, APPL ENVIRON MICROB, V75, P7335, DOI 10.1128/AEM.01241-09; Fierobe HP, 2005, J BIOL CHEM, V280, P16325, DOI 10.1074/jbc.M414449200; Haimovitz R, 2008, PROTEOMICS, V8, P968, DOI 10.1002/pmic.200700486; Hammel M, 2004, J BIOL CHEM, V279, P55985, DOI 10.1074/jbc.M408979200; JOHNSON EA, 1982, APPL ENVIRON MICROB, V43, P1125, DOI 10.1128/AEM.43.5.1125-1132.1982; LAMED R, 1983, BIOTECHNOL BIOENG, P163; LAMED R, 1988, ADV APPL MICROBIOL, V33, P1, DOI 10.1016/S0065-2164(08)70203-X; Li YC, 2007, APPL ENVIRON MICROB, V73, P3165, DOI 10.1128/AEM.02960-06; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Mingardon F, 2011, APPL ENVIRON MICROB, V77, P1436, DOI 10.1128/AEM.01802-10; MORAG E, 1995, APPL ENVIRON MICROB, V61, P1980, DOI 10.1128/AEM.61.5.1980-1986.1995; Morais S, 2012, MBIO, V3, DOI 10.1128/mBio.00508-12; Morais S, 2011, MBIO, V2, DOI 10.1128/mBio.00233-11; Morais S, 2010, MBIO, V1, DOI 10.1128/mBio.00285-10; Morais S, 2010, APPL ENVIRON MICROB, V76, P3787, DOI 10.1128/AEM.00266-10; Raman B, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-134; Raman B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005271; Sabathe F, 2002, FEMS MICROBIOL LETT, V217, P15, DOI 10.1016/S0378-1097(02)00991-6; Sakka M, 2010, BIOSCI BIOTECH BIOCH, V74, P2077, DOI 10.1271/bbb.100458; Sakon J, 1997, NAT STRUCT BIOL, V4, P810, DOI 10.1038/nsb1097-810; Shimon LJW, 1997, STRUCTURE, V5, P381, DOI 10.1016/S0969-2126(97)00195-0; Shoham Y, 1999, TRENDS MICROBIOL, V7, P275, DOI 10.1016/S0966-842X(99)01533-4; Tamaru Y, 2000, J BACTERIOL, V182, P5906, DOI 10.1128/JB.182.20.5906-5910.2000; Vazana Y, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-182; Wilson DB, 2004, CHEM REC, V4, P72, DOI 10.1002/tcr.20002	39	30	32	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0127326	10.1371/journal.pone.0127326	http://dx.doi.org/10.1371/journal.pone.0127326			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024227	Green Published, Green Submitted, gold			2022-12-26	WOS:000355319400036
J	Vieira, AE; Repeke, CE; Ferreira, SD; Colavite, PM; Biguetti, CC; Oliveira, RC; Assis, GF; Taga, R; Trombone, APF; Garlet, GP				Vieira, Andreia Espindola; Repeke, Carlos Eduardo; Ferreira Junior, Samuel de Barros; Colavite, Priscila Maria; Biguetti, Claudia Cristina; Oliveira, Rodrigo Cardoso; Assis, Gerson Francisco; Taga, Rumio; Favaro Trombone, Ana Paula; Garlet, Gustavo Pompermaier			Intramembranous Bone Healing Process Subsequent to Tooth Extraction in Mice: Micro-Computed Tomography, Histomorphometric and Molecular Characterization	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; MATRIX METALLOPROTEINASES; POLARIZATION METHOD; NECROSIS-FACTOR; EXPRESSION; ANGIOGENESIS; REPAIR; PERIODONTITIS; REGENERATION; CYTOKINES	Bone tissue has a significant potential for healing, which involves a significant the interplay between bone and immune cells. While fracture healing represents a useful model to investigate endochondral bone healing, intramembranous bone healing models are yet to be developed and characterized. In this study, a micro-computed tomography, histomorphometric and molecular (RealTimePCRarray) characterization of post tooth-extraction alveolar bone healing was performed on C57Bl/6 WT mice. After the initial clot dominance (0h), the development of a provisional immature granulation tissue is evident (7d), characterized by marked cell proliferation, angiogenesis and inflammatory cells infiltration; associated with peaks of growth factors (BMP-2-4-7, TGF beta 1, VEGFa), cytokines (TNF alpha, IL-10), chemokines & receptors (CXCL12, CCL25, CCR5, CXCR4), matrix (Col1a1-2, ITGA4, VTN, MMP1a) and MSCs (CD105, CD106, OCT4, NANOG, CD34, CD146) markers expression. Granulation tissue is sequentially replaced by more mature connective tissue (14d), characterized by inflammatory infiltrate reduction along the increased bone formation, marked expression of matrix remodeling enzymes (MMP-2-9), bone formation/maturation (RUNX2, ALP, DMP1, PHEX, SOST) markers, and chemokines & receptors associated with healing (CCL2, CCL17, CCR2). No evidences of cartilage cells or tissue were observed, strengthening the intramembranous nature of bone healing. Bone microarchitecture analysis supports the evolving healing, with total tissue and bone volumes as trabecular number and thickness showing a progressive increase over time. The extraction socket healing process is considered complete (21d) when the dental socket is filled by trabeculae bone with well-defined medullary canals; it being the expression of mature bone markers prevalent at this period. Our data confirms the intramembranous bone healing nature of the model used, revealing parallels between the gene expression profile and the histomorphometric events and the potential participation of MCSs and immune cells in the healing process, supporting the forthcoming application of the model for the better understanding of the bone healing process.	[Vieira, Andreia Espindola; Repeke, Carlos Eduardo; Ferreira Junior, Samuel de Barros; Colavite, Priscila Maria; Biguetti, Claudia Cristina; Oliveira, Rodrigo Cardoso; Assis, Gerson Francisco; Taga, Rumio; Garlet, Gustavo Pompermaier] Univ Sao Paulo, Bauru Sch Dent, Dept Biol Sci, Bauru, SP, Brazil; [Favaro Trombone, Ana Paula] Univ Sagrado Coracao, Dept Biol & Allied Hlth Sci, Bauru, Brazil	Universidade de Sao Paulo; Universidade do Sagrado Coracao	Garlet, GP (corresponding author), Univ Sao Paulo, Bauru Sch Dent, Dept Biol Sci, Bauru, SP, Brazil.	garletgp@usp.br	Taga, Rumio/E-5794-2012; Garlet, Gustavo Pompermaier/E-6762-2012; Garlet, Ana Paula Trombone/N-9346-2013; Repeke, Carlos Eduardo/AAQ-2968-2020; Vieira, Andreia Espindola/F-5892-2012; Biguetti, Claudia C/F-5118-2012; de Oliveira, Rodrigo Cardoso/E-2551-2012; Vieira, Andreia/HGC-4528-2022; Assis, Gerson Francisco/E-5871-2012	Garlet, Gustavo Pompermaier/0000-0002-5071-8382; Garlet, Ana Paula Trombone/0000-0002-8102-6098; Vieira, Andreia Espindola/0000-0002-1344-1185; Biguetti, Claudia C/0000-0003-4503-3108; de Oliveira, Rodrigo Cardoso/0000-0003-3070-5960; Assis, Gerson Francisco/0000-0001-8225-3164; Repeke, Carlos Eduardo/0000-0001-7933-0114	Sao Paulo Research Foundation (FAPESP) [09/11496-1, 10/15755-9]; National Counsel of Technological and Scientific Development (CNPq) [470933/2011-9]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by grants and scholarships from the Sao Paulo Research Foundation (FAPESP) (#09/11496-1 and #10/15755-9) and the National Counsel of Technological and Scientific Development (CNPq) (#470933/2011-9). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accorsi-Mendonca T, 2008, J MOL HISTOL, V39, P201, DOI 10.1007/s10735-007-9152-z; Ai-Aql ZS, 2008, J DENT RES, V87, P107, DOI 10.1177/154405910808700215; AMLER MH, 1969, ORAL SURG ORAL MED O, V27, P309, DOI 10.1016/0030-4220(69)90357-0; Araujo-Pires AC, 2015, J BONE MINER RES, V30, P400, DOI 10.1002/jbmr.2376; Araujo-Pires AC, 2014, J ENDODONT, V40, P1560, DOI 10.1016/j.joen.2014.02.012; Bais MV, 2009, BONE, V45, P254, DOI 10.1016/j.bone.2009.04.239; Bandyopadhyay A, 2006, PLOS GENET, V2, P2116, DOI 10.1371/journal.pgen.0020216; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berendsen AD, 2014, MATRIX BIOL, V35, P223, DOI 10.1016/j.matbio.2013.12.004; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Bossini PS, 2012, EXP GERONTOL, V47, P136, DOI 10.1016/j.exger.2011.11.005; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Caetano-Lopes J, 2009, AUTOIMMUN REV, V8, P250, DOI 10.1016/j.autrev.2008.07.038; Campos K, 2015, J ENDODONT, V41, P212, DOI 10.1016/j.joen.2014.10.003; Carano RAD, 2003, DRUG DISCOV TODAY, V8, P980, DOI 10.1016/S1359-6446(03)02866-6; Cardaropoli G, 2003, J CLIN PERIODONTOL, V30, P809, DOI 10.1034/j.1600-051X.2003.00366.x; Cardoso CL, 2011, ACTA CIR BRAS, V26, P365, DOI 10.1590/S0102-86502011000500007; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Claudino M, 2010, EUR J ORAL SCI, V118, P19, DOI 10.1111/j.1600-0722.2009.00706.x; Clover AJP, 2011, BURNS, V37, P1386, DOI 10.1016/j.burns.2011.08.001; Coleman R, 2011, ACTA HISTOCHEM, V113, P231, DOI 10.1016/j.acthis.2010.02.002; Dai J, 2007, J DENT RES, V86, P937, DOI 10.1177/154405910708601006; Dallas SL, 2013, ENDOCR REV, V34, P658, DOI 10.1210/er.2012-1026; Taddei SRD, 2012, AM J ORTHOD DENTOFAC, V141, P153, DOI 10.1016/j.ajodo.2011.07.019; Devlin H, 1997, J BONE MINER RES, V12, P2061, DOI 10.1359/jbmr.1997.12.12.2061; Dimitriou R, 2005, INJURY, V36, P1392, DOI 10.1016/j.injury.2005.07.019; Discepoli N, 2013, J CLIN PERIODONTOL, V40, P638, DOI 10.1111/jcpe.12074; Einhorn TA, 2015, NAT REV RHEUMATOL, V11, P45, DOI 10.1038/nrrheum.2014.164; Eming SA, 2009, SEMIN CELL DEV BIOL, V20, P517, DOI 10.1016/j.semcdb.2009.04.009; Aranha AMF, 2013, J ENDODONT, V39, P83, DOI 10.1016/j.joen.2012.10.015; Ferreira SB, 2011, J DENT RES, V90, P632, DOI 10.1177/0022034510395021; Franceschi RT, 2003, CONNECT TISSUE RES, V44, P109, DOI 10.1080/03008200390152188; Garavello-Freltas I, 2003, J PHOTOCH PHOTOBIO B, V70, P81, DOI 10.1016/S1011-1344(03)00058-7; Garlet GP, 2007, CLIN EXP IMMUNOL, V147, P128, DOI 10.1111/j.1365-2249.2006.03260.x; Garlet GP, 2014, J DENT RES, V93, P834, DOI 10.1177/0022034514544300; Garlet GP, 2010, J DENT RES, V89, P1349, DOI 10.1177/0022034510376402; Garlet GP, 2013, J APPL ORAL SCI, V21, P98, DOI [10.1590/1678-77572013ed004, 10.1590/1678-77572013ed002]; Garlet GP, 2012, J ENDODONT, V38, P185, DOI 10.1016/j.joen.2011.09.011; Garlet TP, 2010, J ENDODONT, V36, P244, DOI 10.1016/j.joen.2009.09.004; Glowacki AJ, 2013, P NATL ACAD SCI USA, V110, P18525, DOI 10.1073/pnas.1302829110; Goodman SC, 2014, J ENDODONT, V40, P830, DOI 10.1016/j.joen.2013.10.021; Graves Dana T, 2011, J Oral Microbiol, V3, DOI 10.3402/jom.v3i0.5304; Hankenson KD, 2011, INJURY, V42, P556, DOI 10.1016/j.injury.2011.03.035; Ishida Y, 2008, J IMMUNOL, V180, P569, DOI 10.4049/jimmunol.180.1.569; Javed A, 2010, ORAL MAXIL SURG CLIN, V22, P283, DOI 10.1016/j.coms.2010.05.001; JURGENS TM, 1990, PHARMACEUT RES, V7, P742, DOI 10.1023/A:1015871723330; Kanczler JM, 2008, EUR CELLS MATER, V15, P100, DOI 10.22203/eCM.v015a08; Kanyama M, 2003, ARCH ORAL BIOL, V48, P723, DOI 10.1016/S0003-9969(03)00153-5; Kato T, 2011, EXP DERMATOL, V20, P669, DOI 10.1111/j.1600-0625.2011.01286.x; Knight MN, 2013, ADV WOUND CARE, V2, P306, DOI 10.1089/wound.2012.0420; Konnecke I, 2014, BONE, V64, P155, DOI 10.1016/j.bone.2014.03.052; Korpi JT, 2009, EUR J ORAL SCI, V117, P248, DOI 10.1111/j.1600-0722.2009.00620.x; Kuroshima S, 2013, J DENT RES, V92, P553, DOI 10.1177/0022034513487558; Lalani Z, 2003, J ORAL MAXIL SURG, V61, P1061, DOI 10.1016/S0278-2391(03)00319-7; Lattouf R, 2014, J HISTOCHEM CYTOCHEM, V62, P751, DOI 10.1369/0022155414545787; Lee SH, 2008, BMB REP, V41, P495, DOI 10.5483/BMBRep.2008.41.7.495; Lieberman JR, 2002, J BONE JOINT SURG AM, V84A, P1032, DOI 10.2106/00004623-200206000-00022; Lin Z, 2011, J PERIODONTOL, V82, P1007, DOI 10.1902/jop.2010.100577; Lorenzo J, 2005, IMMUNOL REV, V208, P5, DOI 10.1111/j.0105-2896.2005.00340.x; Martin TJ, 2009, CRIT REV EUKAR GENE, V19, P73, DOI 10.1615/CritRevEukarGeneExpr.v19.i1.40; McGrory K, 2004, BIOCHEM BIOPH RES CO, V324, P317, DOI 10.1016/j.bbrc.2004.09.056; MONTES GS, 1991, MEM I OSWALDO CRUZ, V86, P1; Morko J, 2009, BONE, V44, P717, DOI 10.1016/j.bone.2008.11.019; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; Arantes RVN, 2015, J PERIODONTOL, V86, P162, DOI 10.1902/jop.2014.140259; Ohira T, 2004, J DENT RES, V83, P546, DOI 10.1177/154405910408300707; Okamoto T, 1990, Rev Odontol UNESP, V19, P63; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Pagni G, 2012, INT J DENT, V2012, DOI 10.1155/2012/151030; Pereira NB, 2014, TOXICON, V84, P7, DOI 10.1016/j.toxicon.2014.03.003; PIERARD GE, 1989, MATRIX, V9, P68, DOI 10.1016/S0934-8832(89)80021-6; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Repeke CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022526; Repeke CE, 2009, J CLIN PERIODONTOL, V36, P726, DOI 10.1111/j.1600-051X.2009.01447.x; Sato H, 2007, CELLS TISSUES ORGANS, V186, P104, DOI 10.1159/000103513; Scala A, 2014, CLIN ORAL IMPLAN RES, V25, P288, DOI 10.1111/clr.12148; Schipani E, 2009, J BONE MINER RES, V24, P1347, DOI [10.1359/JBMR.090602, 10.1359/jbmr.090602]; Schmidt-Bleek K, 2012, CELL TISSUE RES, V347, P567, DOI 10.1007/s00441-011-1205-7; Sedgwick JD, 2000, IMMUNOL TODAY, V21, P110, DOI 10.1016/S0167-5699(99)01573-X; Shah K, 2013, CURR OSTEOPOROS REP, V11, P130, DOI 10.1007/s11914-013-0146-3; Sinha KM, 2013, J CELL BIOCHEM, V114, P975, DOI 10.1002/jcb.24439; Sodek J, 2000, PERIODONTOL 2000, V24, P99, DOI 10.1034/j.1600-0757.2000.2240106.x; Stover DA, 2011, MOL BIOL EVOL, V28, P533, DOI 10.1093/molbev/msq221; Takayanagi H, 2005, J PERIODONTAL RES, V40, P287, DOI 10.1111/j.1600-0765.2005.00814.x; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Teofilo JM, 2011, IMPLANT DENT, V20, pE7, DOI 10.1097/ID.0b013e31820fbacf; Thomas MV, 2011, J DENT RES, V90, P1052, DOI 10.1177/0022034510393967; Ting K, 1999, AM J PATHOL, V155, P1993, DOI 10.1016/S0002-9440(10)65518-6; TING K, 1993, J BONE MINER RES, V8, P1377; Torisawa YS, 2014, NAT METHODS, V11, P663, DOI [10.1038/NMETH.2938, 10.1038/nmeth.2938]; Trombelli L, 2008, J CLIN PERIODONTOL, V35, P630, DOI 10.1111/j.1600-051X.2008.01246.x; Trombone AP, 2010, GENES IMMUN, V11, P479, DOI 10.1038/gene.2010.13; Tsiridis E, 2007, INJURY, V38, pS11, DOI 10.1016/j.injury.2007.02.006; Tsuji K, 2006, NAT GENET, V38, P1424, DOI 10.1038/ng1916; Upton Z, 2008, J INVEST DERMATOL, V128, P1535, DOI 10.1038/sj.jid.5701148; Vaday GG, 2001, J LEUKOCYTE BIOL, V69, P885; Rodrigues MTV, 2011, J APPL ORAL SCI, V19, P260, DOI 10.1590/S1678-77572011000300015; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; Wang X, 2013, INT ORTHOP, V37, P2491, DOI 10.1007/s00264-013-2059-2; Wu YF, 2010, MATRIX BIOL, V29, P701, DOI 10.1016/j.matbio.2010.09.002; Yang XH, 2014, CALCIFIED TISSUE INT, V94, P338, DOI 10.1007/s00223-013-9815-6; Yugoshi Luciana Ibara, 2002, Braz. Dent. J., V13, P92, DOI 10.1590/S0103-64402002000200003	102	73	75	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128021	10.1371/journal.pone.0128021	http://dx.doi.org/10.1371/journal.pone.0128021			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26023920	gold, Green Published, Green Submitted			2022-12-26	WOS:000355319400065
J	Chang, SJ; Li, S; Andreasen, A; Sha, XZ; Zhai, XY				Chang, Shi-Jie; Li, Shuo; Andreasen, Arne; Sha, Xian-Zheng; Zhai, Xiao-Yue			A Reference-Free Method for Brightness Compensation and Contrast Enhancement of Micrographs of Serial Sections	PLOS ONE			English	Article							3-DIMENSIONAL RECONSTRUCTION; CONFOCAL MICROSCOPY; LIGHT ATTENUATION; IMAGES; SCALE; MODEL; VISUALIZATION; NEPHRONS; MOUSE	Three-dimensional (3D) reconstruction of an organ or tissue from a stack of histologic serial sections provides valuable morphological information. The procedure includes section preparation of the organ or tissue, micrographs acquisition, image registration, 3D reconstruction, and visualization. However, the brightness and contrast through the image stack may not be consistent due to imperfections in the staining procedure, which may cause difficulties in micro-structure identification using virtual sections, region segmentation, automatic target tracing, etc. In the present study, a reference-free method, Sequential Histogram Fitting Algorithm (SHFA), is therefore developed for adjusting the severe and irregular variance of brightness and contrast within the image stack. To apply the SHFA, the gray value histograms of individual images are first calculated over the entire image stack and a set of landmark gray values are chosen. Then the histograms are transformed so that there are no abrupt changes in progressing through the stack. Finally, the pixel gray values of the original images are transformed into the desired ones based on the relationship between the original and the transformed histograms. The SHFA is tested on an image stacks from mouse kidney sections stained with toluidine blue, and captured by a slide scanner. As results, the images through the entire stack reveal homogenous brightness and consistent contrast. In addition, subtle color differences in the tissue are well preserved so that the morphological details can be recognized, even in virtual sections. In conclusion, compared with the existing histogram-based methods, the present study provides a practical method suitable for compensating brightness, and improving contrast of images derived from a large number of serial sections of biological organ.	[Chang, Shi-Jie; Sha, Xian-Zheng] China Med Univ, Dept Biomed Engn, Shenyang 110001, Liaoning, Peoples R China; [Li, Shuo] China Med Univ, Dept Biochem, Shenyang 110001, Liaoning, Peoples R China; [Andreasen, Arne] Aarhus Univ, Dept Biomed Anat, Aarhus, Denmark; [Zhai, Xiao-Yue] China Med Univ, Dept Histol & Embryol, Shenyang 110001, Liaoning, Peoples R China	China Medical University; China Medical University; Aarhus University; China Medical University	Zhai, XY (corresponding author), China Med Univ, Dept Histol & Embryol, Shenyang 110001, Liaoning, Peoples R China.	zhaixy@mail.cmu.edu.cn			National Science Foundation of China [31371219]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	Support was provided by the National Science Foundation of China (Grant No. 31371219).	Ballesteros R, 2012, J DIGIT IMAGING, V25, P527, DOI 10.1007/s10278-011-9440-8; Capek M, 2006, MICROSC RES TECHNIQ, V69, P624, DOI 10.1002/jemt.20330; Chernov N., 2011, COMPUTER VISION, P285; Colin C, 2009, STAT COMPUT, V19, P271, DOI [10.1007/s11222-008-9091-x, DOI 10.1007/S11222-008-9091-X]; Dusch E, 2007, J MICROSC-OXFORD, V228, P132, DOI 10.1111/j.1365-2818.2007.01844.x; Eramian M, 2005, P 2 CAN C COMP ROB V, DOI [10.1109/CRV.2005.47, DOI 10.1109/CRV.2005.47]; KIKINIS R, 1992, JMRI-J MAGN RESON IM, V2, P619, DOI 10.1002/jmri.1880020603; Liang FM, 2001, STAT SINICA, V11, P1005; Molvaer RK, 2013, ACTA OPHTHALMOL, V91, P457, DOI 10.1111/j.1755-3768.2012.02446.x; Nyul LG, 1999, MAGNET RESON MED, V42, P1072, DOI 10.1002/(SICI)1522-2594(199912)42:6<1072::AID-MRM11>3.0.CO;2-M; Nyul LG, 2000, IEEE T MED IMAGING, V19, P143, DOI 10.1109/42.836373; Song XF, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032771, 10.1371/journal.pone.0049545]; Stanciu SG, 2010, MICROSC RES TECHNIQ, V73, P165, DOI 10.1002/jemt.20767; Sun K, 2009, MICROSURG, V29, P573, DOI 10.1002/micr.20646; Sun YL, 2004, MICROSC RES TECHNIQ, V64, P156, DOI 10.1002/jemt.20064; Udupa JK, 1997, IEEE T MED IMAGING, V16, P598, DOI 10.1109/42.640750; Wu HX, 2005, J MICROSC-OXFORD, V220, P9, DOI 10.1111/j.1365-2818.2005.01508.x; Zhai XY, 2007, J AM SOC NEPHROL, V18, P2937, DOI 10.1681/ASN.2007010056; Zhai XY, 2006, J AM SOC NEPHROL, V17, P77, DOI 10.1681/ASN.2005080796; Zhang YL, 2015, MICRON, V68, P122, DOI 10.1016/j.micron.2014.10.002	20	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0127855	10.1371/journal.pone.0127855	http://dx.doi.org/10.1371/journal.pone.0127855			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020531	Green Submitted, gold, Green Published			2022-12-26	WOS:000355187300059
J	Hara, T; Kobayashi, T; Ito, S; Zhou, XR; Katafuchi, T; Fujita, H				Hara, Takeshi; Kobayashi, Tatsunori; Ito, Satoshi; Zhou, Xiangrong; Katafuchi, Tetsuro; Fujita, Hiroshi			Quantitative Analysis of Torso FDG-PET Scans by Using Anatomical Standardization of Normal Cases from Thorough Physical Examinations	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; BODY; BRAIN; ATLAS; SUV	Understanding of standardized uptake value (SUV) of 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography (FDG-PET) depends on the background accumulations of glucose because the SUV often varies the status of patients. The purpose of this study was to develop a new method for quantitative analysis of SUV of FDG-PET scan images. The method included an anatomical standardization and a statistical comparison with normal cases by using Z-score that are often used in SPM or 3D-SSP approach for brain function analysis. Our scheme consisted of two approaches, which included the construction of a normal model and the determination of the SUV scores as Z-score index for measuring the abnormality of an FDG-PET scan image. To construct the normal torso model, all of the normal images were registered into one shape, which indicated the normal range of SUV at all voxels. The image deformation process consisted of a whole body rigid registration of shoulder to bladder region and liver registration and a non-linear registration of body surface by using the thin-plate spline technique. In order to validate usefulness of our method, we segment suspicious regions on FDG-PET images manually, and obtained the Z-scores of the regions based on the corresponding voxels that stores the mean and the standard deviations from the normal model. We collected 243 (143 males and 100 females) normal cases to construct the normal model. We also extracted 432 abnormal spots from 63 abnormal cases (73 cancer lesions) to validate the Z-scores. The Z-scores of 417 out of 432 abnormal spots were higher than 2.0, which statistically indicated the severity of the spots. In conclusions, the Z-scores obtained by our computerized scheme with anatomical standardization of torso region would be useful for visualization and detection of subtle lesions on FDG-PET scan images even when the SUV may not clearly show an abnormality.	[Hara, Takeshi; Kobayashi, Tatsunori; Zhou, Xiangrong; Fujita, Hiroshi] Gifu Univ, Grad Sch Med, Dept Intelligent Image Informat, Div Regenerat & Adv Med Sci, Gifu, Gifu, Japan; [Kobayashi, Tatsunori] Junshin Gakuen Univ, Fac Hlth Sci, Dept Radiol Sci, Fukuoka, Fukuoka, Japan; [Ito, Satoshi] Daiyukai Gen Hosp, Dept Radiol, Ichinomiya, Aichi, Japan; [Katafuchi, Tetsuro] Gifu Univ Med Sci, Dept Radiol Technol, Seki, Gifu, Japan	Gifu University	Hara, T (corresponding author), Gifu Univ, Grad Sch Med, Dept Intelligent Image Informat, Div Regenerat & Adv Med Sci, Gifu, Gifu, Japan.	takeshi.hara@mac.com	Kobayashi, Tatsunori/AAF-9774-2020		Ministry of Education, Culture, Sports, Sciences and Technology of the Japanese government [19500385, 21103004, 10283285, 26108001]	Ministry of Education, Culture, Sports, Sciences and Technology of the Japanese government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a Grant-in-Aid for Academic Research (#19500385, #21103004, #10283285, #26108001) from the Ministry of Education, Culture, Sports, Sciences and Technology of the Japanese government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOOKSTEIN FL, 1989, IEEE T PATTERN ANAL, V11, P567, DOI 10.1109/34.24792; Delbeke D, 2006, J NUCL MED, V47, P885; Engel H, 1996, J NUCL MED, V37, P441; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Huang SC, 2000, NUCL MED BIOL, V27, P643; Ide M, 2005, EUR J NUCL MED MOL I, V32, P339, DOI 10.1007/s00259-005-1774-3; Ishii K, 2009, EUR J NUCL MED MOL I, V36, P831, DOI 10.1007/s00259-008-1051-3; Kamiya N, 2013, IEICE T INF SYST, VE96D, P869, DOI 10.1587/transinf.E96.D.869; KANO A, 1994, MED PHYS, V21, P453, DOI 10.1118/1.597308; KEYES JW, 1995, J NUCL MED, V36, P1836; KIM CK, 1994, J NUCL MED, V35, P164; Minamimoto R, 2007, ANN NUCL MED, V21, P481, DOI 10.1007/s12149-007-0061-8; Minamimoto R, 2011, ANN NUCL MED, V25, P45, DOI 10.1007/s12149-010-0428-0; MINOSHIMA S, 1995, J NUCL MED, V36, P1238; MINOSHIMA S, 1994, J NUCL MED, V35, P949; Sadik M, 2008, EUR J NUCL MED MOL I, V35, P1464, DOI 10.1007/s00259-008-0721-5; Sadik M, 2008, J NUCL MED, V49, P1958, DOI 10.2967/jnumed.108.055061; Shiraishi J, 2007, MED PHYS, V34, P25, DOI 10.1118/1.2401044; Tang BNT, 2004, EUR J NUCL MED MOL I, V31, P1487, DOI 10.1007/s00259-004-1597-7; Visser EP, 2010, J NUCL MED, V51, P173, DOI 10.2967/jnumed.109.068411; Wang YB, 2007, MOL IMAGING BIOL, V9, P83, DOI 10.1007/s11307-006-0075-y; Weckesser M, 2005, EUR J NUCL MED MOL I, V32, P342, DOI 10.1007/s00259-005-1775-2; Yasuda S, 1997, LANCET, V350, P1819, DOI 10.1016/S0140-6736(97)24051-1; Yasuda S, 2000, BRIT J CANCER, V83, P1607, DOI 10.1054/bjoc.2000.1496; Zhou XR, 2014, RADIOL PHYS TECHNOL, V7, P277, DOI 10.1007/s12194-014-0261-6	25	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0125713	10.1371/journal.pone.0125713	http://dx.doi.org/10.1371/journal.pone.0125713			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020960	gold, Green Published, Green Submitted			2022-12-26	WOS:000355187300015
J	Blundell, GM; Pendleton, GW				Blundell, Gail M.; Pendleton, Grey W.			Factors Affecting Haul-Out Behavior of Harbor Seals (Phoca vitulina) in Tidewater Glacier Inlets in Alaska: Can Tourism Vessels and Seals Coexist?	PLOS ONE			English	Article							BAY NATIONAL-PARK; DIVING BEHAVIOR; ABUNDANCE; GULF; DISTURBANCE; RICHARDSI; RESPONSES; PATTERNS; NUMBERS; BUDGET	Large numbers of harbor seals (Phoca vitulina) use habitat in tidewater glaciers in Alaska for pupping, breeding, and molting. Glacial fjords are also popular tourist destinations; however, visitation by numerous vessels can result in disturbance of seals during critical life-history phases. We explored factors affecting haul-out behavior of harbor seals at a glacial site frequented by tourism vessels. In 2008-10, we deployed VHF transmitters on 107 seals in Endicott Arm, Alaska. We remotely monitored presence and haul-out behavior of tagged seals and documented vessel presence with time-lapse cameras. We evaluated the influence of environmental and physical factors on the probability of being hauled out, duration of haul-out bouts, and as factors associated with the start and end of a haulout. Location, season, hour, and interactions of location by year, season, hour, and sex significantly influenced haul-out probability, as did ice, weather, and vessels. Seals were more likely to be hauled out with greater ice availability during the middle of the day, and less likely to be hauled out if vessels were present. Cruise ships had the strongest negative effect; however, most vessel types negatively affected haul-out probability. Haul-out duration was longest in association with starting on incoming tides, clear skies, no precipitation, occurring in the middle of the day, and ending in the late afternoon or evening. End of haulouts was associated with increasing cloud cover, low ice availability, and vessel presence; large-sized tourism vessels or all-vessel-types combined were significant predictors of ending a haul-out bout. Probability of being hauled out was highest in June, during pupping season. Potential disturbances of harbor seals could be reduced, enabling longer resting times for seals and fewer interruptions for nursing pups, if vessels focused the majority of visits to glacial habitat to before or after the hours of 08:00-17:00 or, less optimally, 09:00-16:00.	[Blundell, Gail M.; Pendleton, Grey W.] Alaska Dept Fish & Game, Div Wildlife Conservat, Juneau, AK 99811 USA	Alaska Department of Fish & Game	Blundell, GM (corresponding author), Alaska Dept Fish & Game, Div Wildlife Conservat, Juneau, AK 99811 USA.	gail.blundell@alaska.gov			National Oceanographic and Atmospheric Agency/National Marine Fisheries Service/Alaska Region	National Oceanographic and Atmospheric Agency/National Marine Fisheries Service/Alaska Region	Grant Numbers NA04NMF4390143 and NA08NMF4390544 awarded to Alaska Department of Fish and Game by the National Oceanographic and Atmospheric Agency/National Marine Fisheries Service/Alaska Region. The funders reviewed research proposals that described the intention to collect these data, the intended purpose for the data and, the ultimate purpose of the manuscript. The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	ALLEN SG, 1984, FISH B-NOAA, V82, P493; Andersen SM, 2012, AQUAT CONSERV, V22, P113, DOI 10.1002/aqc.1244; [Anonymous], 2006, SAS MIXED MODELS; Arendt AA, 2002, SCIENCE, V297, P382, DOI 10.1126/science.1072497; Bejder L, 2006, CONSERV BIOL, V20, P1791, DOI 10.1111/j.1523-1739.2006.00540.x; Blundell GM, 2008, MAR MAMMAL SCI, V24, P577, DOI 10.1111/j.1748-7692.2008.00194.x; Blundell GM, 2011, MAR ECOL PROG SER, V429, P277, DOI 10.3354/meps09073; Boveng PL, 2003, MAR MAMMAL SCI, V19, P111, DOI 10.1111/j.1748-7692.2003.tb01096.x; Brasseur S, 1996, MAR MAMMAL SCI, V12, P619; CALAMBOKIDIS J, 1987, CAN J ZOOL, V65, P1391, DOI 10.1139/z87-219; Christiansen Fredrik, 2010, Endangered Species Research, V11, P91, DOI 10.3354/esr00265; Frost KJ, 2001, MAR MAMMAL SCI, V17, P813, DOI 10.1111/j.1748-7692.2001.tb01300.x; Harding KC, 2005, FUNCT ECOL, V19, P129, DOI 10.1111/j.0269-8463.2005.00945.x; Hastings KK, 2004, CAN J ZOOL, V82, P1755, DOI 10.1139/Z04-145; Henry Edwige, 2001, Aquatic Mammals, V27, P140; Herreman JK, 2009, CAN J ZOOL, V87, P498, DOI 10.1139/Z09-033; Hoover-Miller A, 2013, J WILDLIFE MANAGE, V77, P689, DOI 10.1002/jwmg.510; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Jansen JK, 2015, MAR MAMMAL SCI, V31, P66, DOI 10.1111/mms.12140; Jansen JK, 2010, J WILDLIFE MANAGE, V74, P1186, DOI 10.2193/2008-192; Jeffries Steven J., 1993, Aquatic Mammals, V19, P21; Jensen FH, 2009, MAR ECOL PROG SER, V395, P161, DOI 10.3354/meps08204; Johnson A, 2007, CAN J ZOOL, V85, P290, DOI 10.1139/Z06-213; Lesage V, 1999, CAN J ZOOL, V77, P74, DOI 10.1139/cjz-77-1-74; London JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038180; Mathews EA, 2006, MAR MAMMAL SCI, V22, P167, DOI 10.1111/j.1748-7692.2006.00011.x; Mathews EA, 1996, MAR MAMMAL SCI, V12, P483, DOI 10.1111/j.1748-7692.1996.tb00603.x; McNabb RW, 2014, J GEOPHYS RES-EARTH, V119, P153, DOI 10.1002/2013JF002915; MUELBERT MMC, 1993, CAN J ZOOL, V71, P1405, DOI 10.1139/z93-194; Osinga N, 2012, MAMM BIOL, V77, P281, DOI 10.1016/j.mambio.2012.02.005; Paterson W, 2012, J THERM BIOL, V37, P454, DOI 10.1016/j.jtherbio.2012.03.004; Pfeffer WT, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000590; Ramasco V, 2014, ANIM BEHAV, V94, P117, DOI 10.1016/j.anbehav.2014.05.015; Simpkins MA, 2003, MAR MAMMAL SCI, V19, P791, DOI 10.1111/j.1748-7692.2003.tb01130.x; Small RJ, 2003, MAR MAMMAL SCI, V19, P344, DOI 10.1111/j.1748-7692.2003.tb01113.x; Stamation KA, 2010, MAR MAMMAL SCI, V26, P98, DOI 10.1111/j.1748-7692.2009.00320.x; Stensland E, 2007, MAR ECOL PROG SER, V332, P225, DOI 10.3354/meps332225; Stockin KA, 2008, MAR ECOL PROG SER, V355, P287, DOI 10.3354/meps07386; Suryan RM, 1999, FISH B-NOAA, V97, P332; Thompson PM, 2008, MAR MAMMAL SCI, V24, P138, DOI 10.1111/j.1748-7692.2007.00179.x; Ver Hoef JM, 2001, BAYESIAN HIERARCHICA; Weilgart LS, 2007, CAN J ZOOL, V85, P1091, DOI 10.1139/Z07-101; Williams R, 2007, J ZOOL, V272, P390, DOI 10.1111/j.1469-7998.2006.00280.x; WILLIAMS TM, 1991, J COMP PHYSIOL B, V160, P637, DOI 10.1007/BF00571261; Womble JN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055386; Womble JN, 2010, MAR MAMMAL SCI, V26, P686, DOI 10.1111/j.1748-7692.2009.00360.x; Young C., 2014, Tourism in Marine Environments, V10, P5, DOI 10.3727/154427314X14056884441626	47	8	8	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0125486	10.1371/journal.pone.0125486	http://dx.doi.org/10.1371/journal.pone.0125486			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26017404	Green Submitted, gold, Green Published			2022-12-26	WOS:000355185600024
J	Boone, DR; Micci, MA; Taglialatela, IG; Hellmich, JL; Weisz, HA; Bi, M; Prough, DS; DeWitt, DS; Hellmich, HL				Boone, Deborah R.; Micci, Maria-Adelaide; Taglialatela, Isabella G.; Hellmich, Judy L.; Weisz, Harris A.; Bi, Min; Prough, Donald S.; DeWitt, Douglas S.; Hellmich, Helen L.			Pathway-Focused PCR Array Profiling of Enriched Populations of Laser Capture Microdissected Hippocampal Cells after Traumatic Brain Injury	PLOS ONE			English	Article							GENE-EXPRESSION; MESSENGER-RNA; FLUORO-JADE; ACTIVATION; NEUROPROTECTION; PROTEIN; DEATH; REPRODUCIBILITY; MODULATION; MECHANISMS	Cognitive deficits in survivors of traumatic brain injury (TBI) are associated with irreversible neurodegeneration in brain regions such as the hippocampus. Comparative gene expression analysis of dying and surviving neurons could provide insight into potential therapeutic targets. We used two pathway-specific PCR arrays (RT2 Profiler Apoptosis and Neurotrophins & Receptors PCR arrays) to identify and validate TBI-induced gene expression in dying (Fluoro-Jade-positive) or surviving (Fluoro-Jade-negative) pyramidal neurons obtained by laser capture microdissection (LCM). In the Apoptosis PCR array, dying neurons showed significant increases in expression of genes associated with cell death, inflammation, and endoplasmic reticulum (ER) stress compared with adjacent, surviving neurons. Pro-survival genes with pleiotropic functions were also significantly increased in dying neurons compared to surviving neurons, suggesting that even irreversibly injured neurons are able to mount a protective response. In the Neurotrophins & Receptors PCR array, which consists of genes that are normally expected to be expressed in both groups of hippocampal neurons, only a few genes were expressed at significantly different levels between dying and surviving neurons. Immunohistochemical analysis of selected, differentially expressed proteins supported the gene expression data. This is the first demonstration of pathway-focused PCR array profiling of identified populations of dying and surviving neurons in the brain after TBI. Combining precise laser microdissection of identifiable cells with pathway-focused PCR array analysis is a practical, low-cost alternative to microarrays that provided insight into neuroprotective signals that could be therapeutically targeted to ameliorate TBI-induced neurodegeneration.	[Boone, Deborah R.; Micci, Maria-Adelaide; Taglialatela, Isabella G.; Hellmich, Judy L.; Weisz, Harris A.; Bi, Min; Prough, Donald S.; DeWitt, Douglas S.; Hellmich, Helen L.] Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston	Hellmich, HL (corresponding author), Univ Texas Med Branch, Dept Anesthesiol, 301 Univ Blvd, Galveston, TX 77555 USA.	hhellmic@utmb.edu	Prough, Donald S/G-5793-2013	Prough, Donald S/0000-0001-7994-532X	department of Anesthesiology (UTMB); Moody Foundation;  [RO1 NS052532]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052532] Funding Source: NIH RePORTER	department of Anesthesiology (UTMB); Moody Foundation; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by RO1 NS052532 (HLH), and in part by the department of Anesthesiology (UTMB) and a Moody Foundation grant to DSD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltonen Kristina E, 2011, BMC Res Notes, V4, P69, DOI 10.1186/1756-0500-4-69; Adamides AA, 2006, ANZ J SURG, V76, P163, DOI 10.1111/j.1445-2197.2006.03674.x; Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS2, DOI 10.1097/01.CCM.0000066600.71233.01; Arikawa E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-328; Asztalos S, 2010, CANCER PREV RES, V3, P301, DOI 10.1158/1940-6207.CAPR-09-0069; Boone DR, 2013, JOVE-J VIS EXP, DOI 10.3791/50308; Boone DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046204; Bota M, 2003, NAT NEUROSCI, V6, P795, DOI 10.1038/nn1096; Brain Trauma Foundation AAoNSCoNSJSoNaCC, 2003, GUID MAN SEV TRAUM B; Cao GD, 2002, J CEREBR BLOOD F MET, V22, P534, DOI 10.1097/00004647-200205000-00005; Cernak I, 2006, EXPERT OPIN INV DRUG, V15, P1371, DOI 10.1517/13543784.15.11.1371; Chen W, 2007, TOHOKU J EXP MED, V212, P319, DOI 10.1620/tjem.212.319; Choi HJ, 2011, BRIT J PHARMACOL, V162, P175, DOI 10.1111/j.1476-5381.2010.01041.x; Ciotti P, 2009, DIAGN MOL PATHOL, V18, P112, DOI 10.1097/PDM.0b013e3181831320; Clark RE, 2013, P NATL ACAD SCI USA, V110, P10365, DOI 10.1073/pnas.1301225110; d'Hellencourt CL, 2005, J NEUROCHEM, V93, P206, DOI 10.1111/j.1471-4159.2004.03017.x; Dai C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015008; Dziennis S, 2008, REV NEUROSCIENCE, V19, P341; Ebadi M, 1997, NEUROCHEM INT, V30, P347, DOI 10.1016/S0197-0186(96)00071-X; Elliott-Hunt CR, 2007, J NEUROCHEM, V100, P780, DOI 10.1111/j.1471-4159.2006.04239.x; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Haines B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031739; Hansel NN, 2008, ALLERGY, V63, P366, DOI 10.1111/j.1398-9995.2007.01540.x; Hellmich HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053230; Hellmich HL, 2005, ANESTHESIOLOGY, V102, P806, DOI 10.1097/00000542-200504000-00017; Hernandez-Baltazar D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070951; Hisaoka K, 2007, J PHARMACOL EXP THER, V321, P148, DOI 10.1124/jpet.106.116558; Hou H, 2008, BIOCHEM BIOPH RES CO, V369, P641, DOI 10.1016/j.bbrc.2008.02.094; Hua F, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-42; Ikeda T, 2000, ACTA NEUROPATHOL, V100, P161, DOI 10.1007/s004019900162; Kendziorski CM, 2003, BIOSTATISTICS, V4, P465, DOI 10.1093/biostatistics/4.3.465; Knoblach SM, 2002, J NEUROTRAUM, V19, P1155, DOI 10.1089/08977150260337967; Kuga D, 2008, NEURO-ONCOLOGY, V10, P995, DOI 10.1215/15228517-2008-064; Larner SF, 2004, J NEUROCHEM, V88, P78, DOI 10.1046/j.1471-4159.2003.02141.x; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; McIntosh TK, 1998, NEUROPATH APPL NEURO, V24, P251; Mori M, 2004, CELL DEATH DIFFER, V11, P1223, DOI 10.1038/sj.cdd.4401483; Murakami H, 2000, KIDNEY INT, V58, P1346, DOI 10.1046/j.1523-1755.2000.00295.x; Nogueira-Silva C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030517; Nonn L, 2010, EXP MOL PATHOL, V88, P45, DOI 10.1016/j.yexmp.2009.10.005; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; Pan CQ, 2012, FEBS LETT, V586, P2674, DOI 10.1016/j.febslet.2012.04.023; Petito CK, 2001, J NEUROPATH EXP NEUR, V60, P377, DOI 10.1093/jnen/60.4.377; Rapoport MJ, 2012, CNS DRUGS, V26, P111, DOI 10.2165/11599560-000000000-00000; Rojo DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023111; Ruan YL, 1997, J NEUROSCI RES, V50, P383, DOI 10.1002/(SICI)1097-4547(19971101)50:3<383::AID-JNR4>3.0.CO;2-E; Sajja VSSS, 2012, NMR BIOMED, V25, P1331, DOI 10.1002/nbm.2805; Salminen A, 1998, MOL BRAIN RES, V61, P203, DOI 10.1016/S0169-328X(98)00210-1; Satoh T, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.169; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schouten JW, 2007, CURR OPIN CRIT CARE, V13, P134, DOI 10.1097/MCC.0b013e3280895d5c; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Shi LM, 2010, NAT BIOTECHNOL, V28, P827, DOI 10.1038/nbt.1665; Shimamura M, 2004, MOL BRAIN RES, V122, P47, DOI 10.1016/j.molbrainres.2003.11.015; Slevin M, 2010, J VASC RES, V47, P323, DOI 10.1159/000265566; So T, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00139; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; SUGIMOTO A, 1995, EMBO J, V14, P4434, DOI 10.1002/j.1460-2075.1995.tb00122.x; Tamatani M, 1999, J BIOL CHEM, V274, P8531, DOI 10.1074/jbc.274.13.8531; Mena JET, 2014, ANAL BIOCHEM, V447, P126, DOI 10.1016/j.ab.2013.11.015; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vink R, 2009, NEUROTHERAPEUTICS, V6, P28, DOI 10.1016/j.nurt.2008.10.036; Wang GB, 2013, NEUROSCI LETT, V543, P72, DOI 10.1016/j.neulet.2013.02.067; Wang SY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-163; Williamson LL, 2013, BRAIN BEHAV IMMUN, V30, P186, DOI 10.1016/j.bbi.2013.01.077; Wu H, 2013, J MOL NEUROSCI, V49, P512, DOI 10.1007/s12031-012-9910-6; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]; Zaheer S, 2013, NEUROCHEM RES, V38, P218, DOI 10.1007/s11064-012-0913-z; Zhang JH, 2004, DEV BRAIN RES, V152, P255, DOI 10.1016/j.devbrainres.2004.07.008	74	25	29	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0127287	10.1371/journal.pone.0127287	http://dx.doi.org/10.1371/journal.pone.0127287			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26016641	Green Submitted, gold, Green Published			2022-12-26	WOS:000355185600078
J	Korotkevych, NV; Labyntsev, AJ; Kolybo, DV; Komisarenko, SV				Korotkevych, Nataliia V.; Labyntsev, Andrii Ju.; Kolybo, Denis V.; Komisarenko, Serhiy V.			The Soluble Heparin-Binding EGF-Like Growth Factor Stimulates EGF Receptor Trafficking to the Nucleus	PLOS ONE			English	Article							ERBB RECEPTORS; LOCALIZATION; CELLS; PROTEIN; ACTIVATION; EXPRESSION; PATHWAY; KINASE; CANCER	Most ligands of epidermal growth factor receptor (EGFR) have the ability to induce EGFR translocation into the nucleus, where EGFR acts as an important transcriptional regulator. Soluble form of heparin-binding EGF-like growth factor (sHB-EGF) is one of the ligands for EGFR in many cell types; however, there is no evidence for the ability of sHB-EGF to induce EGFR nuclear importation. Here, we demonstrated that treatment of A431 cells with sHB-EGF resulted in nuclear localization of EGFR and such translocation occurs via retrograde pathway. It was shown by confocal microscopy and co-immunoprecipitation assay that the translocation complex consisted of both ligand and receptor. The chromatin immunoprecipitation assay showed the association of sHB-EGF-EGFR complex with promoter region of cyclin D1 in the cell nucleus and this association was prevented by application of EGFR kinase inhibitor AG-1478. The obtained data suggest that sHB-EGF acts similarly to other EGFR ligands and is capable to induce EGFR nuclear translocation as a part of ligand-receptor complex in a tyrosine phosphorylation-dependent manner.	[Korotkevych, Nataliia V.; Labyntsev, Andrii Ju.; Kolybo, Denis V.; Komisarenko, Serhiy V.] Natl Acad Sci Ukraine, Palladin Inst Biochem, Dept Mol Immunol, Kiev, Ukraine	National Academy of Sciences Ukraine; Palladin Institute of Biochemistry of NASU	Korotkevych, NV (corresponding author), Natl Acad Sci Ukraine, Palladin Inst Biochem, Dept Mol Immunol, Kiev, Ukraine.	gnr.nata@gmail.com	Labyntsev, Andrii/AAQ-5021-2020; Komisarenko, Sergiy/AAT-3457-2020	Labyntsev, Andrii/0000-0002-1793-4630; Komisarenko, Serhiy/0000-0002-3244-3194				Adam RM, 2003, CANCER RES, V63, P484; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brand TM, 2013, RADIOTHER ONCOL, V108, P370, DOI 10.1016/j.radonc.2013.06.010; Bueter W, 2006, CYTOKINE, V36, P267, DOI 10.1016/j.cyto.2007.02.002; Dittmann K, 2005, J BIOL CHEM, V280, P31182, DOI 10.1074/jbc.M506591200; Dittmann K, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-69; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Higashiyama S, 2005, BBA-PROTEINS PROTEOM, V1751, P110, DOI 10.1016/j.bbapap.2004.11.009; HIGASHIYAMA S, 1991, SCIENCE, V251, P936, DOI 10.1126/science.1840698; Hsu SC, 2007, J BIOL CHEM, V282, P10432, DOI 10.1074/jbc.M610014200; Hung LY, 2008, NUCLEIC ACIDS RES, V36, P4337, DOI 10.1093/nar/gkn417; Kim J, 2005, CANCER RES, V65, P8242, DOI 10.1158/0008-5472.CAN-05-0942; Kim JS, 2007, CLIN CANCER RES, V13, P6509, DOI 10.1158/1078-0432.CCR-07-1428; Korotkevich NV, 2014, BIOTECHNOL ACTA, V7, P46; Korotkevich NV, 2010, BIOTECHNOL ACTA, V3, P44; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Lo HW, 2005, CANCER CELL, V7, P575, DOI 10.1016/j.ccr.2005.05.007; MARTI U, 1991, HEPATOLOGY, V13, P15, DOI 10.1016/0270-9139(91)90210-M; NAKANE PK, 1974, J HISTOCHEM CYTOCHEM, V22, P1084, DOI 10.1177/22.12.1084; Nickel W, 1997, P NATL ACAD SCI USA, V94, P11393, DOI 10.1073/pnas.94.21.11393; Oliinyk ES, 2009, BIOTECHNOL ACTA, V2, P59; Planque Nathalie, 2006, Cell Commun Signal, V4, P7, DOI 10.1186/1478-811X-4-7; Raabe TD, 2004, GLIA, V45, P197, DOI 10.1002/glia.10311; Roepstorff K, 2009, TRAFFIC, V10, P1115, DOI 10.1111/j.1600-0854.2009.00943.x; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Thompson M, 2007, BRAIN RES, V1139, P95, DOI 10.1016/j.brainres.2006.11.047; Wang YN, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-13; Wheeler DL, 2010, NAT REV CLIN ONCOL, V7, P493, DOI 10.1038/nrclinonc.2010.97; XIE YM, 1994, BIOCHEM BIOPH RES CO, V203, P1589, DOI 10.1006/bbrc.1994.2368; Zscheppang K, 2006, PEDIATR PULM, V41, P1205, DOI 10.1002/ppul.20518	31	5	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0127887	10.1371/journal.pone.0127887	http://dx.doi.org/10.1371/journal.pone.0127887			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26016774	gold, Green Submitted, Green Published			2022-12-26	WOS:000355185600099
J	Lambrus, BG; Cochet-Escartin, O; Gao, JR; Newmark, PA; Collins, EMS; Collins, JJ				Lambrus, Bramwell G.; Cochet-Escartin, Olivier; Gao, Jiarong; Newmark, Phillip A.; Collins, Eva-Maria S.; Collins, James J., Jr.			Tryptophan hydroxylase Is Required for Eye Melanogenesis in the Planarian Schmidtea mediterranea	PLOS ONE			English	Article							PIGMENTATION; REGENERATION; SYSTEM; BIOSYNTHESIS; MAINTENANCE; EVOLUTION; RECEPTOR; NEURONS; MODEL; COLOR	Melanins are ubiquitous and biologically important pigments, yet the molecular mechanisms that regulate their synthesis and biochemical composition are not fully understood. Here we present a study that supports a role for serotonin in melanin synthesis in the planarian Schmidtea mediterranea. We characterize the tryptophan hydroxylase (tph) gene, which encodes the rate-limiting enzyme in serotonin synthesis, and demonstrate by RNA interference that tph is essential for melanin production in the pigment cups of the planarian photoreceptors. We exploit this phenotype to investigate the biological function of pigment cups using a quantitative light-avoidance behavioral assay. Planarians lacking eye pigment remain phototactic, indicating that eye pigmentation is not essential for light avoidance in S. mediterranea, though it improves the efficiency of the photophobic response. Finally, we show that the eye pigmentation defect observed in tph knockdown animals can be rescued by injection of either the product of TPH, 5-hydroxytryptophan (5-HTP), or serotonin. Together, these results highlight a role for serotonin in melanogenesis, perhaps as a regulatory signal or as a pigment substrate. To our knowledge, this is the first example of this relationship to be reported outside of mammalian systems.	[Lambrus, Bramwell G.; Gao, Jiarong; Newmark, Phillip A.; Collins, James J., Jr.] Univ Illinois, Howard Hughes Med Inst, Urbana, IL USA; [Lambrus, Bramwell G.; Gao, Jiarong; Newmark, Phillip A.; Collins, James J., Jr.] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL USA; [Collins, James J., Jr.] Univ Illinois, Neurosci Program, Urbana, IL USA; [Cochet-Escartin, Olivier; Collins, Eva-Maria S.] Univ Calif San Diego, Div Biol Sci, San Diego, CA 92093 USA; [Cochet-Escartin, Olivier; Collins, Eva-Maria S.] Univ Calif San Diego, Dept Phys, San Diego, CA USA	Howard Hughes Medical Institute; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of California System; University of California San Diego; University of California System; University of California San Diego	Collins, EMS (corresponding author), Univ Calif San Diego, Div Biol Sci, San Diego, CA 92093 USA.	emscollins@physics.ucsd.edu; jamesj.collins@utsouthwestern.edu		Newmark, Phillip/0000-0003-0793-022X; Cochet-Escartin, Olivier/0000-0001-7924-702X	Burroughs Welcome Fund	Burroughs Welcome Fund(Burroughs Wellcome Fund)	This work was supported by the Burroughs Welcome Fund (E.M.S.C., B.G.L, O.C.E). P.A.N is an investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Brubacher JL, 2014, NAT PROTOC, V9, P661, DOI 10.1038/nprot.2014.041; CARPENTER KS, 1974, CELL TISSUE RES, V148, P143; Cebria F, 2005, DEVELOPMENT, V132, P3691, DOI 10.1242/dev.01941; Collins JJ, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000509; Cook LM, 2013, HEREDITY, V110, P207, DOI 10.1038/hdy.2012.92; Currie KW, 2013, DEVELOPMENT, V140, P3577, DOI 10.1242/dev.098590; Gurley KA, 2008, SCIENCE, V319, P323, DOI 10.1126/science.1150029; Hase S, 2006, PIGM CELL RES, V19, P248, DOI 10.1111/j.1600-0749.2006.00306.x; Inoue T, 2004, ZOOL SCI, V21, P275, DOI 10.2108/zsj.21.275; Ito S, 2000, PIGM CELL RES, V13, P103, DOI 10.1034/j.1600-0749.13.s8.19.x; KORNER A, 1982, SCIENCE, V217, P1163, DOI 10.1126/science.6810464; Lapan SW, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002226; Lee HJ, 2011, BRIT J DERMATOL, V165, P1344, DOI 10.1111/j.1365-2133.2011.10490.x; Liao S, 2012, EXP DERMATOL, V21, P635, DOI 10.1111/j.1600-0625.2012.01531.x; Miyamura Y, 2007, PIGM CELL RES, V20, P2, DOI 10.1111/j.1600-0749.2006.00358.x; Ness DK, 1996, FUND APPL TOXICOL, V30, P153, DOI 10.1006/faat.1996.0052; Newmark PA, 2002, NAT REV GENET, V3, P210, DOI 10.1038/nrg759; Nilsson DE, 2009, PHILOS T R SOC B, V364, P2833, DOI 10.1098/rstb.2009.0083; Nishimura K, 2007, NEUROSCI RES, V59, P101, DOI 10.1016/j.neures.2007.05.014; Parker GH, 1900, AM J PHYSIOL, V4, P1; Pearson BJ, 2009, DEV DYNAM, V238, P443, DOI 10.1002/dvdy.21849; Price TD, 2006, J EXP BIOL, V209, P2368, DOI 10.1242/jeb.02183; Schallreuter KU, 2008, EXP DERMATOL, V17, P395, DOI 10.1111/j.1600-0625.2007.00675.x; Schiaffino MV, 2010, INT J BIOCHEM CELL B, V42, P1094, DOI 10.1016/j.biocel.2010.03.023; Simon JD, 2010, ACCOUNTS CHEM RES, V43, P1452, DOI 10.1021/ar100079y; Simon JD, 2009, PIGM CELL MELANOMA R, V22, P563, DOI 10.1111/j.1755-148X.2009.00610.x; Slominski A, 2005, FASEB J, V19, P176, DOI 10.1096/fj.04-2079rev; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Sturm RA, 2009, PIGM CELL MELANOMA R, V22, P544, DOI 10.1111/j.1755-148X.2009.00606.x; Talbot J, 2011, J EXP BIOL, V214, P1063, DOI 10.1242/jeb.052290; Taliaferro WH, 1918, J EXPT ZOOLOGY, P1; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Tobin DJ, 2011, PIGM CELL MELANOMA R, V24, P75, DOI 10.1111/j.1755-148X.2010.00803.x; VENABLE JH, 1965, J CELL BIOL, V25, P407, DOI 10.1083/jcb.25.2.407; Vogliardi S, 2002, J MASS SPECTROM, V37, P1292, DOI 10.1002/jms.383; Zayas RM, 2005, P NATL ACAD SCI USA, V102, P18491, DOI 10.1073/pnas.0509507102	37	13	13	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0127074	10.1371/journal.pone.0127074	http://dx.doi.org/10.1371/journal.pone.0127074			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26017970	Green Submitted, Green Published, gold			2022-12-26	WOS:000355185600068
J	Lang, A; Koch, R; Rohn, K; Gasse, H				Lang, Anja; Koch, Ruediger; Rohn, Karl; Gasse, Hagen			The Histological Components of the Phoniatrical Body-Cover Model in Minipigs of Different Ages	PLOS ONE			English	Article							HUMAN VOCAL FOLDS; LAMINA PROPRIA; EXTRACELLULAR-MATRIX; COW LARYNGES; EXCISED PIG; COLLAGEN; ELASTICITY; PHONATION; FIBERS; TISSUE	Pigs are models in human phoniatry. However, features of maturation and ageing have not been considered with regard to the so-called body-cover model in this species. Therefore, the glottis of "young" (2-3 months; n = 6) and "old" (4-7 years; n = 6) minipigs was investigated. Their cranial (CraF) and caudal (CauF) vocal folds were histomorphometrically and stratigraphically analysed with emphasis on their amounts of collagen structures and elastic fibres. A dense subepithelial layer (SEL) was a distinct feature of CraF and CauF of both age groups; it was spread upon the underlying loose, flexible "cover" like a fibro-elastic membrane. The "cover" was characterised by the so-called superficial layer (SL), which was distinctly loose in the "young" minipigs, but had a much denser texture in the "old" minipigs. Here, the SL was dominated by elastic fibres in the CraF, but was of mixed qualities (collagenous and elastic) in the CauF. The structural requirements for the SL's function as a loose "cover" were thus met only in the "young" animals. A clearly demarcated intermediate layer (IL)-characterised by high amounts of elastic fibres (as in humans)-was only found in the CraF of the "young" animals. In the "old" animals, it had lost its demarcation. In the depth of the CraF of the "old" animals, many thick collagen fibre bundles were detected in a location equivalent to that of the vocal muscle in the CauF. The development of their large diameters was interpreted as part of the maturation process, thereby supporting the hypothesis of their functional importance as a component of the "body." In the CauF, the amounts of collagen structures increased throughout the entire lamina propria, resulting in a loss of demarcated stratigraphical subdivisions in the "old" minipigs. This situation resembled that described in the vocal fold of geriatric humans.	[Lang, Anja; Koch, Ruediger; Gasse, Hagen] Univ Vet Med Hannover, Inst Anat, Hannover, NH, Germany; [Rohn, Karl] Univ Vet Med Hannover, Dept Biometry Epidemiol & Informat Proc, Hannover, NH, Germany	University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation	Lang, A (corresponding author), Univ Vet Med Hannover, Inst Anat, Hannover, NH, Germany.	anja.lang@tiho-hannover.de						Alipour F, 2009, J VOICE, V23, P40, DOI 10.1016/j.jvoice.2007.03.007; Alipoura F, 2008, J ACOUST SOC AM, V123, P4572, DOI 10.1121/1.2908289; Bailey AJ, 2001, MECH AGEING DEV, V122, P735, DOI 10.1016/S0047-6374(01)00225-1; BIEVER D M, 1989, Journal of Voice, V3, P120, DOI 10.1016/S0892-1997(89)80138-9; BLAKESLEE DB, 1995, J INVEST SURG, V8, P409, DOI 10.3109/08941939509031607; Chan RW, 2007, ANN BIOMED ENG, V35, P1471, DOI 10.1007/s10439-007-9314-x; Ganderup NC, 2012, INT J TOXICOL, V31, P507, DOI 10.1177/1091581812462039; Garrett CG, 2000, LARYNGOSCOPE, V110, P814, DOI 10.1097/00005537-200005000-00011; Gray SD, 2000, ANN OTO RHINOL LARYN, V109, P77, DOI 10.1177/000348940010900115; Hahn MS, 2006, ANN OTO RHINOL LARYN, V115, P225, DOI 10.1177/000348940611500311; Hahn MS, 2006, ANN OTO RHINOL LARYN, V115, P156, DOI 10.1177/000348940611500213; Hahn MS, 2005, ANN OTO RHINOL LARYN, V114, P451, DOI 10.1177/000348940511400607; Hammond TH, 1998, OTOLARYNG HEAD NECK, V119, P314, DOI 10.1016/S0194-5998(98)70071-3; Hammond TH, 2000, ANN OTO RHINOL LARYN, V109, P913, DOI 10.1177/000348940010901004; HIRANO M, 1989, ACTA OTO-LARYNGOL, V107, P428, DOI 10.3109/00016488909127535; HIRANO M, 1974, FOLIA PHONIATR, V26, P89, DOI 10.1159/000263771; Hirano M., 1981, CLIN EXAMINATION VOI; Hirano M., 1983, VOCAL FOLD PHYSL, P22; Hirano M., 1977, DYNAMIC ASPECTS SPEE, P13; Hirano M., 1985, SPEECH SCI, P1; Infusino SA, 2013, INT J PEDIATR OTORHI, V77, P1651, DOI 10.1016/j.ijporl.2013.07.018; Ishii K, 1996, ACTA OTO-LARYNGOL, V116, P778, DOI 10.3109/00016489609137924; Jiang JJ, 2001, ANN OTO RHINOL LARYN, V110, P1120, DOI 10.1177/000348940111001207; Kurita S., 1983, VOCAL FOLD PHYSL CON, P3; Lang A, 2015, ANAT HISTOL EMBRYOL, V44, P186, DOI 10.1111/ahe.12125; Lang A, 2014, THESIS U VET MED HAN; Michael Swindle M., 2008, SOURCEBOOK MODELS BI, P233, DOI DOI 10.1007/978-1-59745-285-4_26; Roberts T, 2011, CLIN ANAT, V24, P544, DOI 10.1002/ca.21114; Sato K, 2002, ANN OTO RHINOL LARYN, V111, P15, DOI 10.1177/000348940211100103; Sato K, 2001, ANN OTO RHINOL LARYN, V110, P417, DOI 10.1177/000348940111000505; Sherratt MJ, 2009, AGE, V31, P305, DOI 10.1007/s11357-009-9103-6; Swindle MM, 2012, VET PATHOL, V49, P344, DOI 10.1177/0300985811402846; Swindle MM, 2006, LAB ANIMAL MED MANAG; Tateya T, 2006, ANN OTO RHINOL LARYN, V115, P469, DOI 10.1177/000348940611500612; Titze IR, 1994, PRINCIPLES VOICE PRO; Woodson G, 2012, J VOICE, V26, P706, DOI 10.1016/j.jvoice.2012.03.003; Yumoto E, 1998, ARCH OTOLARYNGOL, V124, P897, DOI 10.1001/archotol.124.8.897	37	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0128085	10.1371/journal.pone.0128085	http://dx.doi.org/10.1371/journal.pone.0128085			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018404	Green Submitted, Green Published, gold			2022-12-26	WOS:000355185600110
J	Varman, DR; Rajan, KE				Varman, Durairaj Ragu; Rajan, Koilmani Emmanuvel			Environmental Enrichment Reduces Anxiety by Differentially Activating Serotonergic and Neuropeptide Y (NPY)-Ergic System in Indian Field Mouse (Mus booduga): An Animal Model of Post-Traumatic Stress Disorder	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING HORMONE; ELEVATED PLUS-MAZE; NEUROTROPHIC FACTOR; BASOLATERAL AMYGDALA; HIPPOCAMPAL BDNF; 5-HT1A RECEPTORS; BRAIN; MICE; RATS; DEPRESSION	Exposure to a predator elicits an innate fear response and mimics several behavioral disorders related to post-traumatic stress disorder (PTSD). The protective role of an enriched condition (EC) against psychogenic stressors in various animal models has been well documented. However, this condition has not been tested in field mice in the context of PTSD. In this study, we show that field mice (Mus booduga) housed under EC exhibit predominantly proactive and less reactive behavior compared with mice housed under standard conditions (SC) during exposure to their natural predator (field rat Rattus rattus). Furthermore, we observed that EC mice displayed less anxiety-like behavior in an elevated plus maze (EPM) and light/dark-box after exposure to the predator (7 hrs/7 days). In EC mice, predator exposure elevated the level of serotonin (5-Hydroxytrypamine, [5-HT]) in the amygdala as part of the coping response. Subsequently, the serotonin transporter (SERT) and 5-HT1A receptor were up-regulated significantly, but the same did not occur in the 5-HT2C receptor, which is associated with the activation of calmodulin-dependent protein kinase-II (CaMKII) and a transcription factor cAMP response element binding protein (CREB). Our results show that predator exposure induced the activation of CaMKII/CREB, which is accompanied with increased levels of histone acetylation (H3, H4) and decreased histone deacetylases (HDAC1, 2). Subsequently, in the amygdala, the transcription of brain-derived neurotrophic factor (BDNF), neuropeptide Y (NPY) and its Y1 receptor were up-regulated, whereas the Y2 receptor was down-regulated. Therefore, EC facilitated a coping response against a fear associated cue in a PTSD animal model and reduced anxiety by differentially activating serotonergic and NPY-ergic systems.	[Varman, Durairaj Ragu; Rajan, Koilmani Emmanuvel] Bharathidasan Univ, Sch Life Sci, Dept Anim Sci, Tiruchirappalli, Tamil Nadu, India	Bharathidasan University	Rajan, KE (corresponding author), Bharathidasan Univ, Sch Life Sci, Dept Anim Sci, Palkalaiperur Campus, Tiruchirappalli, Tamil Nadu, India.	emmanuvel1972@yahoo.com	Durairaj, Ragu Varman/AAU-7637-2021; Rajan, Koilman Emmanuvel/GSM-7214-2022	Durairaj, Ragu Varman/0000-0002-9409-9456; 	Council of Scientific and Industrial Research (CSIR) [37(1426)/10/EMR-II/2010]; DRV [09/475(0183) 2012,-EMR-I]; UGC-SAP-DRS-II	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); DRV; UGC-SAP-DRS-II	This research was partially supported by Council of Scientific and Industrial Research (CSIR) through a major project to KER [37(1426)/10/EMR-II/2010] and DRV through Senior Research Fellowship [09/475(0183) 2012,-EMR-I]; KER thanks UGC-SAP-DRS-II.	Adamec R, 1998, NEUROSCI BIOBEHAV R, V23, P301, DOI 10.1016/S0149-7634(98)00032-3; Adamec R, 2004, PHYSIOL BEHAV, V83, P401, DOI 10.1016/j.physbeh.2004.08.029; Adamec RE, 2005, NEUROSCI BIOBEHAV R, V29, P1225, DOI 10.1016/j.neubiorev.2005.05.007; Akimova E, 2009, BIOL PSYCHIAT, V66, P627, DOI 10.1016/j.biopsych.2009.03.012; Asan E, 2013, HISTOCHEM CELL BIOL, V139, P785, DOI 10.1007/s00418-013-1081-1; Bacchi F, 2006, PEPTIDES, V27, P3202, DOI 10.1016/j.peptides.2006.07.020; BLANCHARD RJ, 1995, AGGRESSIVE BEHAV, V21, P123, DOI 10.1002/1098-2337(1995)21:2<123::AID-AB2480210205>3.0.CO;2-E; BLANCHARD RJ, 1989, J COMP PSYCHOL, V103, P70, DOI 10.1037/0735-7036.103.1.70; Boer U, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000431; Branchi I, 2011, NEUROSCI LETT, V495, P168, DOI 10.1016/j.neulet.2011.03.038; Breuillaud L, 2012, BIOL PSYCHIAT, V72, P528, DOI 10.1016/j.biopsych.2012.04.011; Campos AC, 2013, NEUROSCI LETT, V533, P34, DOI 10.1016/j.neulet.2012.11.016; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; Charoenphandhu N, 2013, MOL CELL BIOCHEM, V375, P49, DOI 10.1007/s11010-012-1527-0; Christianson JP, 2010, BIOL PSYCHIAT, V67, P339, DOI 10.1016/j.biopsych.2009.09.011; Cohen H, 2012, NEUROPSYCHOPHARMACOL, V37, P350, DOI 10.1038/npp.2011.230; Daftary SS, 2012, NEUROSCIENCE, V224, P125, DOI 10.1016/j.neuroscience.2012.08.025; Daws LC, 2009, PHARMACOL THERAPEUT, V121, P89, DOI 10.1016/j.pharmthera.2008.10.004; Dell'Osso L, 2009, PROG NEURO-PSYCHOPH, V33, P899, DOI 10.1016/j.pnpbp.2009.04.018; Fendt M, 2009, PSYCHOPHARMACOLOGY, V206, P291, DOI 10.1007/s00213-009-1610-8; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Fox C, 2006, BEHAV BRAIN RES, V175, P1, DOI 10.1016/j.bbr.2006.08.016; Frielingsdorf H, 2010, ANN NY ACAD SCI, V1208, P150, DOI 10.1111/j.1749-6632.2010.05722.x; Fu AL, 2008, J PSYCHIATR RES, V43, P55, DOI 10.1016/j.jpsychires.2008.01.018; Ganesh A, 2010, BRAIN RES, V1352, P108, DOI 10.1016/j.brainres.2010.06.058; Giesbrecht CJ, 2010, J NEUROSCI, V30, P16970, DOI 10.1523/JNEUROSCI.2306-10.2010; Goyal SN, 2009, BRAIN RES, V1266, P45, DOI 10.1016/j.brainres.2009.02.033; Hannon J, 2008, BEHAV BRAIN RES, V195, P198, DOI 10.1016/j.bbr.2008.03.020; Heisler LK, 2007, GENES BRAIN BEHAV, V6, P491, DOI 10.1111/j.1601-183X.2007.00316.x; Hendriksen H, 2012, NEUROPHARMACOLOGY, V63, P733, DOI 10.1016/j.neuropharm.2012.05.028; Holmes A, 2002, J MOL NEUROSCI, V18, P151, DOI 10.1385/JMN:18:1-2:151; Holmes A, 2000, PHYSIOL BEHAV, V71, P509, DOI 10.1016/S0031-9384(00)00373-5; Holmes A, 2008, NEUROSCI BIOBEHAV R, V32, P1293, DOI 10.1016/j.neubiorev.2008.03.006; Hsieh J, 2005, CURR OPIN CELL BIOL, V17, P664, DOI 10.1016/j.ceb.2005.09.002; Jasinska AJ, 2012, TRENDS NEUROSCI, V35, P395, DOI 10.1016/j.tins.2012.01.001; Jorgensen H, 2002, J NEUROENDOCRINOL, V14, P788, DOI 10.1046/j.1365-2826.2002.00839.x; Jovanovic T, 2010, AM J PSYCHIAT, V167, P648, DOI 10.1176/appi.ajp.2009.09071074; KALIN NH, 1994, BRAIN RES, V656, P182, DOI 10.1016/0006-8993(94)91382-X; Kalkhoven E, 2004, BIOCHEM PHARMACOL, V68, P1145, DOI 10.1016/j.bcp.2004.03.045; Karlsson RM, 2008, PSYCHOPHARMACOLOGY, V195, P547, DOI 10.1007/s00213-007-0945-2; Koh S, 2007, EPILEPSY BEHAV, V10, P26, DOI 10.1016/j.yebeh.2006.11.008; Korzus E, 2004, NEURON, V42, P961, DOI 10.1016/j.neuron.2004.06.002; Kroeze Wesley K., 2002, Current Topics in Medicinal Chemistry, V2, P507, DOI 10.2174/1568026023393796; Kusserow H, 2004, MOL BRAIN RES, V129, P104, DOI 10.1016/j.molbrainres.2004.06.028; Lee HJ, 2005, DEPRESS ANXIETY, V21, P135, DOI 10.1002/da.20064; Li XB, 2006, EUR J PHARMACOL, V532, P74, DOI 10.1016/j.ejphar.2005.12.008; Masini CV, 2005, BEHAV NEUROSCI, V119, P280, DOI 10.1037/0735-7044.119.1.280; Matsumoto Y, 2013, PSYCHOPHARMACOLOGY, V229, P51, DOI 10.1007/s00213-013-3078-9; MCDONALD AJ, 1989, BRAIN RES, V500, P37, DOI 10.1016/0006-8993(89)90297-7; Mifsud KR, 2011, BRAIN BEHAV IMMUN, V25, P1305, DOI 10.1016/j.bbi.2011.06.005; Miyagawa K, 2012, BEHAV BRAIN RES, V235, P318, DOI 10.1016/j.bbr.2012.08.010; Mongeau R, 2010, J NEUROCHEM, V115, P438, DOI 10.1111/j.1471-4159.2010.06932.x; Mora F, 2007, BRAIN RES REV, V55, P78, DOI 10.1016/j.brainresrev.2007.03.011; Morrison KE, 2012, PHARMACOL BIOCHEM BE, V100, P592, DOI 10.1016/j.pbb.2011.09.005; Naert G, 2011, MOL CELL NEUROSCI, V46, P55, DOI 10.1016/j.mcn.2010.08.006; Nakajima M, 1998, PEPTIDES, V19, P359, DOI 10.1016/S0196-9781(97)00298-2; Nunes-de-Souza Ricardo Luiz, 2010, Psychol. Neurosci., V3, P59, DOI 10.3922/j.psns.2010.1.007; Olivier JDA, 2008, NEUROSCIENCE, V152, P573, DOI 10.1016/j.neuroscience.2007.12.032; Oztan O, 2011, NEUROSCI LETT, V501, P107, DOI 10.1016/j.neulet.2011.06.058; Pandey SC, 2003, ALCOHOL CLIN EXP RES, V27, P396, DOI 10.1097/01.ALC.0000056616.81971.49; Polter AM, 2010, CELL SIGNAL, V22, P1406, DOI 10.1016/j.cellsig.2010.03.019; Roth TL, 2011, J PSYCHIATR RES, V45, P919, DOI 10.1016/j.jpsychires.2011.01.013; Sah R, 2013, MOL PSYCHIATR, V18, P646, DOI 10.1038/mp.2012.101; Sah R, 2009, BIOL PSYCHIAT, V66, P705, DOI 10.1016/j.biopsych.2009.04.037; Sajdyk TJ, 2002, PHARMACOL BIOCHEM BE, V71, P419, DOI 10.1016/S0091-3057(01)00679-7; Sakharkar AJ, 2012, ALCOHOL CLIN EXP RES, V36, P61, DOI 10.1111/j.1530-0277.2011.01581.x; Amaral VCS, 2010, HORM BEHAV, V57, P128, DOI 10.1016/j.yhbeh.2009.09.018; Sharma VK, 1999, J PINEAL RES, V26, P153, DOI 10.1111/j.1600-079X.1999.tb00577.x; Simpson J, 2011, BEHAV BRAIN RES, V222, P246, DOI 10.1016/j.bbr.2011.04.002; St Jacques PL, 2011, NEUROIMAGE, V57, P608, DOI 10.1016/j.neuroimage.2011.04.039; Takahashi LK, 2005, NEUROSCI BIOBEHAV R, V29, P1157, DOI 10.1016/j.neubiorev.2005.04.008; Takahashi LK, 2007, BEHAV NEUROSCI, V121, P100, DOI 10.1037/0735-7044.121.1.100; TREIT D, 1988, PHARMACOL BIOCHEM BE, V31, P959, DOI 10.1016/0091-3057(88)90413-3; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; Tschenett A, 2003, EUR J NEUROSCI, V18, P143, DOI 10.1046/j.1460-9568.2003.02725.x; Tyagi E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057945; Vicente MA, 2012, INT J NEUROPSYCHOPH, V15, P389, DOI 10.1017/S1461145711000873; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Yang M, 2004, PHYSIOL BEHAV, V81, P465, DOI 10.1016/j.physbeh.2004.02.010; Yehuda R, 2006, BIOL PSYCHIAT, V59, P660, DOI 10.1016/j.biopsych.2005.08.027; Zhang LL, 2011, NEUROSCIENCE, V196, P203, DOI 10.1016/j.neuroscience.2011.08.069	82	34	34	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0127945	10.1371/journal.pone.0127945	http://dx.doi.org/10.1371/journal.pone.0127945			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26016844	Green Published, Green Submitted, gold			2022-12-26	WOS:000355185600100
J	Betge, J; Kerr, G; Miersch, T; Leible, S; Erdmann, G; Galata, CL; Zhan, TZ; Gaiser, T; Post, S; Ebert, MP; Horisberger, K; Boutros, M				Betge, Johannes; Kerr, Grainne; Miersch, Thilo; Leible, Svenja; Erdmann, Gerrit; Galata, Christian L.; Zhan, Tianzuo; Gaiser, Timo; Post, Stefan; Ebert, Matthias P.; Horisberger, Karoline; Boutros, Michael			Amplicon Sequencing of Colorectal Cancer: Variant Calling in Frozen and Formalin-Fixed Samples	PLOS ONE			English	Article							FFPE TUMOR-TISSUES; GENOME; SPECIMENS; TUMORIGENESIS; MUTATIONS; BIOPSIES; VIEWER	Next generation sequencing (NGS) is an emerging technology becoming relevant for genotyping of clinical samples. Here, we assessed the stability of amplicon sequencing from formalin-fixed paraffin-embedded (FFPE) and paired frozen samples from colorectal cancer metastases with different analysis pipelines. 212 amplicon regions in 48 cancer related genes were sequenced with Illumina MiSeq using DNA isolated from resection specimens from 17 patients with colorectal cancer liver metastases. From ten of these patients, paired fresh frozen and routinely processed FFPE tissue was available for comparative study. Sample quality of FFPE tissues was determined by the amount of amplifiable DNA using qPCR, sequencing libraries were evaluated using Bioanalyzer. Three bioinformatic pipelines were compared for analysis of amplicon sequencing data. Selected hot spot mutations were reviewed using Sanger sequencing. In the sequenced samples from 16 patients, 29 non-synonymous coding mutations were identified in eleven genes. Most frequent were mutations in TP53 (10), APC (7), PIK3CA (3) and KRAS (2). A high concordance of FFPE and paired frozen tissue samples was observed in ten matched samples, revealing 21 identical mutation calls and only two mutations differing. Comparison of these results with two other commonly used variant calling tools, however, showed high discrepancies. Hence, amplicon sequencing can potentially be used to identify hot spot mutations in colorectal cancer metastases in frozen and FFPE tissue. However, remarkable differences exist among results of different variant calling tools, which are not only related to DNA sample quality. Our study highlights the need for standardization and benchmarking of variant calling pipelines, which will be required for translational and clinical applications.	[Betge, Johannes; Kerr, Grainne; Miersch, Thilo; Leible, Svenja; Erdmann, Gerrit; Zhan, Tianzuo; Boutros, Michael] Heidelberg Univ, Div Signaling & Funct Gen, German Canc Res Ctr DKFZ, Heidelberg, Germany; [Betge, Johannes; Kerr, Grainne; Miersch, Thilo; Leible, Svenja; Erdmann, Gerrit; Zhan, Tianzuo; Boutros, Michael] Heidelberg Univ, Dept Cell & Mol Biol, Med Fac Mannheim, Heidelberg, Germany; [Betge, Johannes; Zhan, Tianzuo; Ebert, Matthias P.] Heidelberg Univ, Med Fac Mannheim, Univ Hosp Mannheim, Dept Med 2, Heidelberg, Germany; [Galata, Christian L.; Post, Stefan; Horisberger, Karoline] Heidelberg Univ, Med Fac Mannheim, Univ Hosp Mannheim, Dept Surg, Heidelberg, Germany; [Gaiser, Timo] Heidelberg Univ, Med Fac Mannheim, Univ Hosp Mannheim, Inst Pathol, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Betge, J (corresponding author), Heidelberg Univ, Div Signaling & Funct Gen, German Canc Res Ctr DKFZ, Heidelberg, Germany.	j.betge@dkfz.de; m.boutros@dkfz.de	Boutros, Michael/C-3566-2008	Boutros, Michael/0000-0002-9458-817X; Betge, Johannes/0000-0001-9549-1866; Horisberger, Karoline/0000-0001-6143-6607; Zhan, Tianzuo/0000-0002-9346-3180; Erdmann, Gerrit/0000-0002-4183-3995	Hartmut-Hoffmann-Berling International Graduate School (HBIGS)	Hartmut-Hoffmann-Berling International Graduate School (HBIGS)	JB has been supported by a fellowship from the Hartmut-Hoffmann-Berling International Graduate School (HBIGS).	Ahls MG, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-11; BAKER SJ, 1990, CANCER RES, V50, P7717; Bardou P, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-293; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Becker K, 2013, J CLIN PATHOL, V66, P803, DOI 10.1136/jclinpath-2013-201549; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Do HD, 2012, ONCOTARGET, V3, P546; Endris V, 2013, J MOL DIAGN, V15, P765, DOI 10.1016/j.jmoldx.2013.06.002; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Frampton GM, 2013, NAT BIOTECHNOL, V31, P1023, DOI 10.1038/nbt.2696; Hadd AG, 2013, J MOL DIAGN, V15, P234, DOI 10.1016/j.jmoldx.2012.11.006; Han SW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064271; Kerick M, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-68; Kim SY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-189; Lower M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002714; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; O'Rawe J, 2013, GENOME MED, V5, DOI 10.1186/gm432; Pabinger S, 2014, BRIEF BIOINFORM, V15, P256, DOI 10.1093/bib/bbs086; Pritchard CC, 2014, J MOL DIAGN, V16, P56, DOI 10.1016/j.jmoldx.2013.08.004; Roberts ND, 2013, BIOINFORMATICS, V29, P2223, DOI 10.1093/bioinformatics/btt375; Sah S, 2013, GENOME MED, V5, DOI 10.1186/gm481; Schweiger MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005548; Simbolo M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062692; Spencer DH, 2013, J MOL DIAGN, V15, P623, DOI 10.1016/j.jmoldx.2013.05.004; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tougeron D, 2013, ANN ONCOL, V24, P1267, DOI 10.1093/annonc/mds620; Wagle N, 2012, CANCER DISCOV, V2, P82, DOI 10.1158/2159-8290.CD-11-0184; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720	30	27	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127146	10.1371/journal.pone.0127146	http://dx.doi.org/10.1371/journal.pone.0127146			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010451	Green Published, Green Submitted, gold			2022-12-26	WOS:000355183900067
J	Chang, YJ; Hua, Y; Jiang, XQ; Tao, SH				Chang, Yujun; Hua, Yuan; Jiang, Xiaoqian; Tao, Shiheng			Influences of Dominance and Evolution of Sex in Finite Diploid Populations	PLOS ONE			English	Article							MUTATION-SELECTION BALANCE; DELETERIOUS MUTATIONS; RECOMBINATION; ACCUMULATION; SEGREGATION; FITNESS; MAINTENANCE; ADVANTAGE; LINKAGE; LIMITS	Most eukaryotes reproduce sexually. Although the benefits of sex in diploids mainly stem from recombination and segregation, the relative effects of recombination and segregation are relatively less known. In this study, we adopt an infinite loci model to illustrate how dominance coefficient of mutations affects the above-mentioned genetic events. However, we assume mutational effects to be independent and also ignore the effects of epistasis within loci. Our simulations show that with different levels of dominance, segregation and recombination may play different roles. In particular, recombination more commonly has a major impact on the evolution of sex when deleterious mutations are partially recessive. In contrast, when deleterious mutations are dominant, segregation becomes more important than recombination, a finding that is consistent with previous studies stating that segregation, rather than recombination, is more likely to drive the evolution of sex. Moreover, beneficial mutations alone remarkably increases the effects of recombination. We also note that populations favor sexual reproduction when deleterious mutations become more dominant or beneficial mutations become more recessive. Overall, these results illustrate that the existence of dominance is an important mechanism that affects the evolution of sex.	[Chang, Yujun; Hua, Yuan; Jiang, Xiaoqian; Tao, Shiheng] Northwest A&F Univ, Coll Life Sci, Bioinformat Ctr, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Jiang, Xiaoqian] Indiana Univ, Dept Biol, Bloomington, IN USA	Northwest A&F University - China; Indiana University System; Indiana University Bloomington	Tao, SH (corresponding author), Northwest A&F Univ, Coll Life Sci, Bioinformat Ctr, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.	shihengt@nwsuaf.edu.cn		Chang, Yujun/0000-0002-8987-4980				Agrawal AF, 2001, GENETICS, V158, P913; Agrawal AF, 2006, CURR BIOL, V16, pR696, DOI 10.1016/j.cub.2006.07.063; Agrawal AF, 2006, AM NAT, V168, P617, DOI 10.1086/508029; Agrawal AF, 2006, PLOS BIOL, V4, P1364, DOI 10.1371/journal.pbio.0040265; Agrawal AF, 2009, AM NAT, V174, pS54, DOI 10.1086/599082; Agrawal AF, 2009, EVOLUTION, V63, P2131, DOI 10.1111/j.1558-5646.2009.00695.x; Barton NH, 2005, GENETICS, V169, P2353, DOI 10.1534/genetics.104.032821; BELL G, 1988, J EVOLUTION BIOL, V1, P67, DOI 10.1046/j.1420-9101.1988.1010067.x; Bruggeman J, 2003, GENETICS, V164, P479; Charlesworth B, 1997, GENET RES, V70, P63, DOI 10.1017/S0016672397002899; CHARLESWORTH B, 1990, GENET RES, V55, P199, DOI 10.1017/S0016672300025532; CHARLESWORTH D, 1993, GENET RES, V61, P39, DOI 10.1017/S0016672300031086; CHARLESWORTH D, 1993, J HERED, V84, P321, DOI 10.1093/oxfordjournals.jhered.a111351; Chasnov JR, 2000, GENETICS, V156, P1419; Colegrave N, 2002, NATURE, V420, P664, DOI 10.1038/nature01191; Comeron JM, 2008, HEREDITY, V100, P19, DOI 10.1038/sj.hdy.6801059; FELSENSTEIN J, 1974, GENETICS, V78, P737; Fernandez B, 2004, GENETICS, V168, P1053, DOI 10.1534/genetics.104.027706; Garcia-Dorado A, 1999, GENET RES, V74, P341, DOI 10.1017/S0016672399004206; Goddard MR, 2005, NATURE, V434, P636, DOI 10.1038/nature03405; Haag CR, 2007, GENETICS, V176, P1663, DOI 10.1534/genetics.107.073080; Haag-Liautard C, 2007, NATURE, V445, P82, DOI 10.1038/nature05388; Hadany L, 2008, ANN NY ACAD SCI, V1133, P26, DOI 10.1196/annals.1438.011; Haldane JBS, 1927, P CAMB PHILOS SOC, V23, P607, DOI 10.1017/S0305004100011750; Halligan DL, 2006, GENOME RES, V16, P875, DOI 10.1101/gr.5022906; Hartfield M, 2010, GENETICS, V184, P1153, DOI 10.1534/genetics.109.112920; HILL WG, 1966, GENET RES, V8, P269, DOI 10.1017/S0016672300010156; Jiang X, 2013, HEREDITY, V111, P505, DOI 10.1038/hdy.2013.72; Keightley PD, 2009, GENOME RES, V19, P1195, DOI 10.1101/gr.091231.109; Keightley PD, 2006, NATURE, V443, P89, DOI 10.1038/nature05049; Lloyd RG, 1992, CURR OPIN GENET DEV, V2, P683, DOI 10.1016/S0959-437X(05)80127-3; Loewe L, 2006, BIOL LETTERS, V2, P426, DOI 10.1098/rsbl.2006.0481; Mandegar MA, 2007, P ROY SOC B-BIOL SCI, V274, P1301, DOI 10.1098/rspb.2007.0056; Martin G, 2006, GENETICS, V172, P593, DOI 10.1534/genetics.104.039982; MULLER HJ, 1950, AM J HUM GENET, V2, P111; Otto SP, 2009, AM NAT, V174, pS1, DOI 10.1086/599084; Otto SP, 2004, SCIENCE, V304, P1018, DOI 10.1126/science.1094072; Otto SP, 1997, GENETICS, V147, P879; Otto SP, 2003, GENETICS, V164, P1099; Otto SP, 2002, NAT REV GENET, V3, P252, DOI 10.1038/nrg761; Otto SP, 2001, EVOLUTION, V55, P1921, DOI 10.1111/j.0014-3820.2001.tb01310.x; PAMILO P, 1987, GENET RES, V49, P135, DOI 10.1017/S0016672300026938; Roze D, 2006, GENETICS, V173, P1793, DOI 10.1534/genetics.106.058586; Roze D, 2010, GENETICS, V184, P1095, DOI 10.1534/genetics.109.108258; Roze D, 2009, AM NAT, V174, pS79, DOI 10.1086/599083; Salathe M, 2008, EVOLUTION, V62, P295, DOI 10.1111/j.1558-5646.2007.00265.x; Sella G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000495; SIMMONS MJ, 1977, ANNU REV GENET, V11, P49, DOI 10.1146/annurev.ge.11.120177.000405; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Szafraniec K, 2003, GENET RES, V82, P19, DOI 10.1017/S001667230300630X; UYENOYAMA MK, 1989, GENETICS, V123, P873; Wang JL, 2003, GENETICS, V163, P429; Weissman DB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002740; Wright S, 1934, AM NAT, V68, P24, DOI 10.1086/280521; YUAN LW, 1990, GENETICS, V124, P263	55	0	0	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128459	10.1371/journal.pone.0128459	http://dx.doi.org/10.1371/journal.pone.0128459			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011082	Green Published, gold, Green Submitted			2022-12-26	WOS:000355183900236
J	Kim, G; Gaitas, A				Kim, Gwangseong; Gaitas, Angelo			Extracorporeal Photo-Immunotherapy for Circulating Tumor Cells	PLOS ONE			English	Article							INTRAOPERATIVE BLOOD SALVAGE; BREAST-CANCER PATIENTS; DEPLETION; CAPTURE; FILTER; TRAIL	It is well established that metastasis through the circulatory system is primarily caused by circulating tumor cells (CTCs). In this preliminary effort, we report an approach to eliminate circulating tumor cells from the blood stream by flowing the blood though an extracorporeal tube and applying photodynamic therapy (PDT). Chlorin e6 (Ce6), a photosensitizer, was conjugated to CD44 antibody in order to target PC-3, a prostate cancer cell line. PC-3 cells were successfully stained by the Ce6-CD44 antibody conjugate. PDT was performed on whole blood spiked with stained PC-3 cells. As the blood circulated through a thin transparent medical tube, it was exposed to light of 660 nm wavelength generated by an LED array. An exposure of two minutes was sufficient to achieve selective cancer cell necrosis. In comparison, to PDT of cells growing inside a tissue culture, the PDT on thin tube exhibited significantly enhanced efficiency in cell killing, by minimizing light attenuation by blood. It suggests a new extracorporeal methodology of PDT for treating CTCs as well as other hematological pathogens.	[Kim, Gwangseong; Gaitas, Angelo] Kytaro Inc, Miami, FL 33199 USA; [Kim, Gwangseong; Gaitas, Angelo] Florida Int Univ, Miami, FL 33199 USA	State University System of Florida; Florida International University	Gaitas, A (corresponding author), Kytaro Inc, Miami, FL 33199 USA.	agaitas@fiu.edu		Gaitas, Angelo/0000-0003-4428-3949	National Institutes of Health [GM084520]; Kytaro, Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R44GM084520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kytaro, Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was funded by National Institutes of Health (grant # GM084520). Kytaro, Inc. provided support in the form of salaries for authors AG and GK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adams D, CANC DET DIAGN TECHN, V301, P983; Adams D, 2011, P 102 AACE M; Angelo Gaitas GK, 2014, PLOSONE; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Doiron DR, 1983, LIGHT DOSIMETRY TISS, P63; Draffin JE, 2004, CANCER RES, V64, P5702, DOI 10.1158/0008-5472.CAN-04-0389; Edelman MJ, 1996, UROLOGY, V47, P179, DOI 10.1016/S0090-4295(99)80411-7; EDELSON R, 1987, NEW ENGL J MED, V316, P297, DOI 10.1056/NEJM198702053160603; Fruhauf NR, 2001, PERFUSION-UK, V16, P51, DOI 10.1177/026765910101600i107; Gertler R, 2003, RECENT RES CANCER, V162, P149; Hu YJ, 2010, CYTOM PART A, V77A, P213, DOI 10.1002/cyto.a.20838; Kim MY, 2009, CELL, V139, P1315, DOI 10.1016/j.cell.2009.11.025; King MR, 2009, J BIONIC ENG, V6, P311, DOI 10.1016/S1672-6529(08)60129-8; Lopez-Riquelme N, 2013, APMIS, V121, P1139, DOI 10.1111/apm.12061; Lu J, 2010, INT J CANCER, V126, P669, DOI 10.1002/ijc.24814; Mitchell MJ, 2014, P NATL ACAD SCI USA, V111, P930, DOI 10.1073/pnas.1316312111; MOAN J, 1991, PHOTOCHEM PHOTOBIOL, V53, P549, DOI 10.1111/j.1751-1097.1991.tb03669.x; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Niedre M, 2002, PHOTOCHEM PHOTOBIOL, V75, P382, DOI 10.1562/0031-8655(2002)075<0382:DNILDO>2.0.CO;2; Perseghin P, 1997, VOX SANG, V72, P221, DOI 10.1046/j.1423-0410.1997.7240221.x; Rana K, 2009, BIOTECHNOL BIOENG, V102, P1692, DOI 10.1002/bit.22204; Sieben S, 2001, J MAGN MAGN MATER, V225, P175, DOI 10.1016/S0304-8853(00)01248-8; Stolik S, 2000, J PHOTOCH PHOTOBIO B, V57, P90, DOI 10.1016/S1011-1344(00)00082-8; Talasaz AH, 2009, P NATL ACAD SCI USA, V106, P3970, DOI 10.1073/pnas.0813188106; TALIAFERRO WH, 1957, J CELL COMPAR PHYSL, V50, P1, DOI 10.1002/jcp.1030500403; Yoon HJ, 2013, NAT NANOTECHNOL, V8, P735, DOI 10.1038/nnano.2013.194	26	12	15	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127219	10.1371/journal.pone.0127219	http://dx.doi.org/10.1371/journal.pone.0127219			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011055	Green Submitted, gold, Green Published			2022-12-26	WOS:000355183900073
J	Ling, ZM; Tang, Y; Li, YQ; Luo, HX; Liu, LL; Tu, QQ; Zhou, LH				Ling, Ze-Min; Tang, Ying; Li, Ying-Qin; Luo, Hao-Xuan; Liu, Lin-Lin; Tu, Qing-Qiang; Zhou, Li-Hua			Evaluation of Avulsion-Induced Neuropathology in Rat Spinal Cords with F-18-FDG Micro-PET/CT	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; VENTRAL ROOT AVULSION; NERVE GROWTH-FACTOR; NITRIC-OXIDE; AXONAL INJURY; GLUCOSE-TRANSPORTER; NEUROTROPHIC FACTOR; OXIDATIVE STRESS; C-JUN; MOTONEURONS	Brachial plexus root avulsion (BPRA) leads to dramatic motoneuron death and glial reactions in the corresponding spinal segments at the late stage of injury. To protect spinal motoneurons, assessment of the affected spinal segments should be done at an earlier stage of the injury. In this study, we employed F-18-FDG small-animal PET/CT to assess the severity of BPRA-induced cervical spinal cord injuries. Adult Sprague-Dawley rats were randomly treated and divided into three groups: Av+NS (brachial plexus root avulsion (Av) treated with normal saline), Av+GM1 (treated with monosialoganglioside), and control. At time points of 3 day (d), 1 week (w), 2 w, 4 w and 8 w post-injury, F-18-FDG micro-PET/CT scans and neuropathology assessments of the injured spinal roots, as well as the spinal cord, were performed. The outcomes of the different treatments were compared. The results showed that BPRA induced local bleeding and typicalWallerian degeneration of the avulsed roots accompanied by F-18-FDG accumulations at the ipsilateral cervical intervertebral foramen. BPRA-induced astrocyte reactions and overexpression of neuronal nitric oxide synthase in the motoneurons correlated with higher F-18-FDG uptake in the ipsilateral cervical spinal cord during the first 2 w post-injury. The GM1 treatment reduced BPRA-induced astrocyte reactions and inhibited the de novo nNOS expressions in spinal motoneurons. The GM1 treatment also protected spinal motoneurons from avulsion within the first 4 w post-injury. The data from this study suggest that F-18-FDG PET/CT could be used to assess the severity of BPRA-induced primary and secondary injuries in the spinal cord. Furthermore, GM1 is an effective drug for reducing primary and secondary spinal cord injuries following BPRA.	[Ling, Ze-Min; Tang, Ying; Li, Ying-Qin; Luo, Hao-Xuan; Liu, Lin-Lin; Zhou, Li-Hua] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Anat, Guangzhou 510080, Guangdong, Peoples R China; [Tu, Qing-Qiang] Sun Yat Sen Univ, Labs Translat Med & Clin Res, Small Anim Mol Imaging Ctr, Guangzhou 510080, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Zhou, LH (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Dept Anat, 74 Zhongshan Rd, Guangzhou 510080, Guangdong, Peoples R China.	zhoulih@mail.sysu.edu.cn			National Natural Science Foundation of China [31171290, 31471030]; Doctorial Research Foundation of the Ministry of Education, P.R. China [20110171110048]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctorial Research Foundation of the Ministry of Education, P.R. China	This study was supported by grants from the National Natural Science Foundation of China (31171290, 31471030), the Doctorial Research Foundation of the Ministry of Education, P.R. China (20110171110048).	Avrova NF, 1998, NEUROCHEM RES, V23, P945, DOI 10.1023/A:1021076220411; Bach HG, 2009, J RECONSTR MICROSURG, V25, P97, DOI 10.1055/s-0028-1090615; Balsara RD, 2014, JOVE-J VIS EXP, DOI 10.3791/51495; Barbizan R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063260; Bigbee AJ, 2007, EXP NEUROL, V204, P273, DOI 10.1016/j.expneurol.2006.11.003; Blight A R, 2001, Curr Opin Investig Drugs, V2, P801; Boutin H, 2015, EUR J NUCL MED MOL I, V42, P503, DOI 10.1007/s00259-014-2939-8; Buck D, 2012, J NUCL MED, V53, P1269, DOI 10.2967/jnumed.111.102608; Carlstedt T, 2008, RESTOR NEUROL NEUROS, V26, P225; Chai H, 1999, NEUROSCI LETT, V274, P147, DOI 10.1016/S0304-3940(99)00671-0; Cheng X, 2010, J BRACHIAL PLEX PERI, V5, DOI 10.1186/1749-7221-5-12; Cheng XR, 2014, AGEING RES REV, V13, P13, DOI 10.1016/j.arr.2013.10.002; Chong Ari, 2013, Chonnam Med J, V49, P38, DOI 10.4068/cmj.2013.49.1.38; CUELLO AC, 1989, P NATL ACAD SCI USA, V86, P2056, DOI 10.1073/pnas.86.6.2056; Cullheim S, 2007, BRAIN RES REV, V55, P89, DOI 10.1016/j.brainresrev.2007.03.012; Ferrari G, 1996, PERSPECT DEV NEUROBI, V3, P93; Floeth FW, 2010, EUR RADIOL, V20, P2925, DOI 10.1007/s00330-010-1877-5; Fu R, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-84; Geisler FH, 2001, SPINE, V26, pS87, DOI 10.1097/00007632-200112151-00015; Grieco G, 1996, STROKE, V27, P858, DOI 10.1161/01.STR.27.5.858; Haberkorn U, 2001, EUR J NUCL MED, V28, P418, DOI 10.1007/s002590100489; Hsu CH, 2003, ANN NUCL MED, V17, P609, DOI 10.1007/BF03006677; Hu S, 2014, HANDCHIR MIKROCHIR P, V46, P80, DOI 10.1055/s-0034-1370958; Hyder F, 2006, J CEREBR BLOOD F MET, V26, P865, DOI 10.1038/sj.jcbfm.9600263; Kacem K, 1998, GLIA, V23, P1; Kinkel K, 1999, RADIOLOGY, V212, P711, DOI 10.1148/radiology.212.3.r99au29711; KOLIATSOS VE, 1994, J COMP NEUROL, V342, P35, DOI 10.1002/cne.903420105; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Lavisse S, 2015, EUR J NUCL MED MOL I, V42, P478, DOI 10.1007/s00259-014-2962-9; Lee SH, 2014, J NUCL MED, V55, P1737, DOI 10.2967/jnumed.114.140731; LI LX, 1995, P NATL ACAD SCI USA, V92, P9771, DOI 10.1073/pnas.92.21.9771; Lieberman BP, 2011, J NUCL MED, V52, P1947, DOI 10.2967/jnumed.111.093815; Marconi S, 2005, J NEUROIMMUNOL, V170, P115, DOI 10.1016/j.jneuroim.2005.03.025; Martin LJ, 1999, J NEUROBIOL, V40, P185, DOI 10.1002/(SICI)1097-4695(199908)40:2<185::AID-NEU5>3.3.CO;2-R; Martin LJ, 2005, J NEUROSCI, V25, P6449, DOI 10.1523/JNEUROSCI.0911-05.2005; Moran CM, 2011, ULTRASOUND MED BIOL, V37, P493, DOI 10.1016/j.ultrasmedbio.2010.11.010; MORGELLO S, 1995, GLIA, V14, P43, DOI 10.1002/glia.440140107; Nakahara M, 2015, ACTA RADIOL, V56, P829, DOI 10.1177/0284185114541983; NARAKAS AO, 1988, CLIN ORTHOP RELAT R, P43; NOVIKOV L, 1995, NEUROSCI LETT, V200, P45, DOI 10.1016/0304-3940(95)12078-I; Ohlsson M, 2006, EXP BRAIN RES, V170, P52, DOI 10.1007/s00221-005-0188-6; Oliet SHR, 2001, SCIENCE, V292, P923, DOI 10.1126/science.1059162; Padma S, 2010, INDIAN J NUCL MED, V25, P173, DOI 10.4103/0972-3919.78257; Patel AB, 2014, P NATL ACAD SCI USA, V111, P5385, DOI 10.1073/pnas.1403576111; Rabin SJ, 2002, J BIOL CHEM, V277, P49466, DOI 10.1074/jbc.M203240200; RISLING M, 1989, BRAIN RES, V494, P13, DOI 10.1016/0006-8993(89)90138-8; Russell DS, 2014, JAMA NEUROL, V71, P1520, DOI 10.1001/jamaneurol.2014.1954; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870; SJOGREN A, 1991, BRAIN RES, V559, P276, DOI 10.1016/0006-8993(91)90012-K; Strobel K, 2007, CLIN NUCL MED, V32, P646, DOI 10.1097/RLU.0b013e3180a1ac74; Tatsumi M, 2003, RADIOLOGY, V229, P831, DOI 10.1148/radiol.2293021168; Terzis JK, 2001, WORLD J SURG, V25, P1049, DOI 10.1007/s00268-001-0058-8; TYURIN VA, 1992, NEUROCHEM INT, V20, P401, DOI 10.1016/0197-0186(92)90055-V; Wang DD, 2008, PROG NEUROBIOL, V86, P342, DOI 10.1016/j.pneurobio.2008.09.015; Wang JC, 2013, J NUCL MED, V54, P785, DOI 10.2967/jnumed.112.111112; Wu WT, 1996, EXP NEUROL, V141, P190, DOI 10.1006/exnr.1996.0153; WU WT, 1993, EXP NEUROL, V120, P153, DOI 10.1006/exnr.1993.1050; Yu S, 1998, BRAIN RES, V797, P65, DOI 10.1016/S0006-8993(98)00372-2; Yuan QJ, 2003, DEV NEUROSCI-BASEL, V25, P72, DOI 10.1159/000071470; Yun MJ, 2002, SEMIN NUCL MED, V32, P70, DOI 10.1053/snuc.2002.29279; Zhou LH, 2006, EXP NEUROL, V197, P84, DOI 10.1016/j.expneurol.2005.08.019; Zhou LH, 2008, BRAIN CELL BIOL, V36, P213, DOI 10.1007/s11068-009-9040-4; Zhuang HM, 2002, SEMIN NUCL MED, V32, P47, DOI 10.1053/snuc.2002.29278	64	3	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127685	10.1371/journal.pone.0127685	http://dx.doi.org/10.1371/journal.pone.0127685			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010770	Green Published, Green Submitted, gold			2022-12-26	WOS:000355183900131
J	Pistol, GC; Braicu, C; Motiu, M; Gras, MA; Marin, DE; Stancu, M; Calin, L; Israel-Roming, F; Berindan-Neagoe, I; Taranu, I				Pistol, Gina Cecilia; Braicu, Cornelia; Motiu, Monica; Gras, Mihail Alexandru; Marin, Daniela Eliza; Stancu, Mariana; Calin, Loredana; Israel-Roming, Florentina; Berindan-Neagoe, Ioana; Taranu, Ionelia			Zearalenone Mycotoxin Affects Immune Mediators, MAPK Signalling Molecules, Nuclear Receptors and Genome-Wide Gene Expression in Pig Spleen	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASES; FUMONISIN B-1; IN-VITRO; PORCINE; CELLS; FOOD; DEOXYNIVALENOL; TRANSCRIPTION; MACROPHAGES; ASSOCIATION	The toxicity of zearalenone (ZEA) was evaluated in swine spleen, a key organ for the innate and adaptative immune response. Weaned pigs were fed for 18 days with a control or a ZEA contaminated diet. The effect of ZEA was assessed on wide genome expression, pro-(TNF-alpha, IL-8, IL-6, IL-1 beta, IFN-gamma) and anti-inflammatory (IL-10, IL-4) cytokines, other molecules involved in inflammatory processes (MMPs/TIMPs), as well as signaling molecules, (p38/JNK1/JNK2-MAPKs) and nuclear receptors (PPAR gamma/NFkB/AP-1/STAT3/c-JUN). Microarray analysis showed that 46% of total number of differentially expressed genes was involved in cellular signaling pathway, 13% in cytokine network and 10% in the inflammatory response. ZEA increased expression and synthesis of pro-inflammatory (TNF-alpha, IL-8, IL-6, IL-1 beta) and had no effect on IFN-gamma, IL-4 and IL-10 cytokines in spleen. The inflammatory stimulation might be a consequence of JNK pathway activation rather than of p-38MAPK and NF-kB involvement whose gene and protein expression were suppressed by ZEA action. In summary, our findings indicated the role of ZEA as an immune disruptor at spleen level.	[Pistol, Gina Cecilia; Motiu, Monica; Gras, Mihail Alexandru; Marin, Daniela Eliza; Stancu, Mariana; Calin, Loredana; Taranu, Ionelia] Natl Inst Res & Dev Biol & Anim Nutr, Lab Anim Biol, Balotesti 077015, Ilfov, Romania; [Braicu, Cornelia; Berindan-Neagoe, Ioana] Oncol Inst Prof Dr I Chiricuta, Cluj Napoca 400015, Romania; [Braicu, Cornelia; Berindan-Neagoe, Ioana] Iuliu Hatieganu Univ Med & Pharm, Res Ctr Funct Gen Biomed & Translat Med, Cluj Napoca 400565, Romania; [Israel-Roming, Florentina] Univ Agr & Vet Med, Dept Biotechnol, Bucharest 011464, Romania; [Berindan-Neagoe, Ioana] Univ Texas Houston, MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA	Oncology Institute Prof. Dr. Ion Chiricuta; Iuliu Hatieganu University of Medicine & Pharmacy; University of Agronomic Science & Veterinary Medicine - Bucharest; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center	Pistol, GC (corresponding author), Natl Inst Res & Dev Biol & Anim Nutr, Lab Anim Biol, Balotesti 077015, Ilfov, Romania.	gina.pistol@ibna.ro	Pistol, Gina Cecilia/B-5801-2011; Berindan-Neagoe, Ioana/AAH-9854-2019; GRAS, MIHAIL ALEXANDRU C/B-7134-2012; Cecilia, Pistol Gina/ABB-4600-2020	Cecilia, Pistol Gina/0000-0003-1139-604X; Taranu, Ionelia/0000-0003-0727-5827; Motiu, Monica/0000-0003-3751-1608	National Research Project - Romanian Ministry of Research and Technology [PNII-PCCA 2011-102/2011-2016]	National Research Project - Romanian Ministry of Research and Technology	This work was supported by funds from the National Research Project PNII-PCCA 2011-102/2011-2016, granted by the Romanian Ministry of Research and Technology.	Alexander J, 2011, EFSA J, V9, DOI 10.2903/j.efsa.2011.2197; Alexopoulos C, 2001, THERIOGENOLOGY, V55, P1745, DOI 10.1016/S0093-691X(01)00517-9; AZCONAOLIVERA JI, 1995, FOOD CHEM TOXICOL, V33, P433, DOI 10.1016/0278-6915(95)00012-Q; Bathgate RAD, 2013, PHYSIOL REV, V93, P405, DOI 10.1152/physrev.00001.2012; Bennett JW, 2003, CLIN MICROBIOL REV, V16, P497, DOI 10.1128/CMR.16.3.497-516.2003; Bronte V, 2013, IMMUNITY, V39, P806, DOI 10.1016/j.immuni.2013.10.010; Buske C, 2001, BLOOD, V97, P2286, DOI 10.1182/blood.V97.8.2286; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Calemine J, 2003, TOXICOLOGY, V194, P115, DOI 10.1016/S0300-483X(03)00286-5; Cano PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053647; Chalubinski M, 2006, ALLERGY, V61, P1326, DOI 10.1111/j.1398-9995.2006.01135.x; Chen JC, 2009, ANN NY ACAD SCI, V1160, P188, DOI 10.1111/j.1749-6632.2008.03815.x; Choi BK, 2012, TOX RESEARCH, V28, P279, DOI 10.5487/TR.2012.28.4.279; Choi K, 2009, J BIOL CHEM, V284, P17766, DOI 10.1074/jbc.M109.003111; Chowdhury Shankar R, 2007, BMC Genomics, V8, P215, DOI 10.1186/1471-2164-8-215; Devriendt B, 2009, VET RES, V40, DOI 10.1051/vetres/2009023; Ding Q, 2011, J LEUKOCYTE BIOL, V90, P77, DOI 10.1189/jlb.1210691; EFSA (European Food Safety Authority), 2004, EFSA J, V39, P1, DOI DOI 10.2903/J.EFSA.2004.39; Engelhardt G, 2006, MOL NUTR FOOD RES, V50, P401, DOI 10.1002/mnfr.200500191; Fink-Gremmels J, 2007, ANIM FEED SCI TECH, V137, P326, DOI 10.1016/j.anifeedsci.2007.06.008; Fishbourne E, 2013, VET MICROBIOL, V162, P937, DOI 10.1016/j.vetmic.2012.11.027; Gesslein B, 2010, MOL VIS, V16, P392; Ghisletti S, 2005, MOL CELL BIOL, V25, P2957, DOI 10.1128/MCB.25.8.2957-2968.2005; Grenier B, 2012, BIOCHEM PHARMACOL, V83, P1465, DOI 10.1016/j.bcp.2012.02.007; Hueza IM, 2014, TOXINS, V6, P1080, DOI 10.3390/toxins6031080; Jackowska M, 2013, ACTA VET HUNG, V61, P99, DOI 10.1556/AVet.2012.061; KUIPERGOODMAN T, 1987, REGUL TOXICOL PHARM, V7, P253, DOI 10.1016/0273-2300(87)90037-7; Lang TJ, 2004, CLIN IMMUNOL, V113, P224, DOI 10.1016/j.clim.2004.05.011; Lee JY, 2009, CARCINOGENESIS, V30, P1528, DOI 10.1093/carcin/bgp084; Lemmer ER, 1999, CARCINOGENESIS, V20, P817, DOI 10.1093/carcin/20.5.817; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luongo D, 2008, TOXICON, V52, P156, DOI 10.1016/j.toxicon.2008.04.162; MacDonald SJ, 2005, J AOAC INT, V88, P1733; Marin DE, 2011, TOXICOL IN VITRO, V25, P1981, DOI 10.1016/j.tiv.2011.06.022; Marin DE, 2010, TOXICON, V56, P956, DOI 10.1016/j.toxicon.2010.06.020; Meadus WJ, 2002, J MOL ENDOCRINOL, V28, P79, DOI 10.1677/jme.0.0280079; Meissonnier GM, 2008, TOXICOL APPL PHARM, V231, P142, DOI 10.1016/j.taap.2008.04.004; Meurens F, 2009, VET RES, V40, DOI 10.1051/vetres:2008043; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Parveen M, 2009, FEBS LETT, V583, P2377, DOI 10.1016/j.febslet.2009.06.035; Perisic L, 2013, ARTERIOSCL THROM VAS, V33, P2432, DOI 10.1161/ATVBAHA.113.301743; Pistol G, 2007, J CELL MOL MED, V11, P339, DOI 10.1111/j.1582-4934.2007.00022.x; Pistol GC, 2014, BRIT J NUTR, V111, P452, DOI 10.1017/S0007114513002675; Ravindran J, 2011, TOXICOLOGY, V280, P44, DOI 10.1016/j.tox.2010.11.006; Richard JL, 2007, INT J FOOD MICROBIOL, V119, P3, DOI 10.1016/j.ijfoodmicro.2007.07.019; Richette P, 2007, ANN RHEUM DIS, V66, P345, DOI 10.1136/ard.2006.059550; Royaee AR, 2004, VET IMMUNOL IMMUNOP, V102, P199, DOI 10.1016/j.vetimm.2004.09.018; Ruh MF, 1998, ENDOCRINE, V9, P207, DOI 10.1385/ENDO:9:2:207; Sanchez-Lemus E, 2009, AM J PHYSIOL-REG I, V296, pR1376, DOI 10.1152/ajpregu.90962.2008; Seeboth J, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-35; Singh NK, 2007, J ANIM SCI, V85, P1126, DOI 10.2527/jas.2006-524; Stec J, 2009, B VET I PULAWY, V53, P129; Stoeker L, 2011, CLIN VACCINE IMMUNOL, V18, P1834, DOI 10.1128/CVI.05277-11; Tabuc C, 2009, J FOOD PROTECT, V72, P662, DOI 10.4315/0362-028X-72.3.662; Taranu I, 2011, BRIT J NUTR, V106, P398, DOI 10.1017/S0007114511000341; Tiemann U, 2008, TOXICOL LETT, V179, P113, DOI 10.1016/j.toxlet.2008.04.016; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; von der Hardt K, 2004, CRIT CARE MED, V32, P1200, DOI 10.1097/01.CCM.0000124876.31138.F6; Wang YC, 2012, POULTRY SCI, V91, P1956, DOI 10.3382/ps.2011-02128; Wluka Anna, 2006, Ann Transplant, V11, P22; Xu J, 2007, J BIOL CHEM, V282, P16401, DOI 10.1074/jbc.M701684200; Yang J, 2012, MOL VIS, V18, P1484; Zeni P, 2007, AM J PHYSIOL-CELL PH, V293, pC855, DOI 10.1152/ajpcell.00470.2006; Zhang LL, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-135; Zhou HR, 2003, TOXICOL SCI, V72, P130, DOI 10.1093/toxsci/kfg006	65	74	80	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127503	10.1371/journal.pone.0127503	http://dx.doi.org/10.1371/journal.pone.0127503			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011631	Green Published, gold, Green Submitted			2022-12-26	WOS:000355183900100
J	Rodriguez, M; Siwko, S; Zeng, L; Li, J; Yi, Z; Liu, M				Rodriguez, M.; Siwko, S.; Zeng, L.; Li, J.; Yi, Z.; Liu, M.			Prostate-specific G-protein-coupled receptor collaborates with loss of PTEN to promote prostate cancer progression	ONCOGENE			English	Article							STROMAL ANDROGEN RECEPTOR; INTRAEPITHELIAL NEOPLASIA; TUMOR-SUPPRESSOR; EXPRESSION; PSGR; GENE; TISSUE; MICROENVIRONMENT; INACTIVATION; INFLAMMATION	Among frequent events in prostate cancer are loss of the tumor-suppressor phosphatase and tensin homologue (PTEN) and overexpression of prostate-specific G-protein-coupled receptor (PSGR), but the potential tumorigenic synergy between these lesions is unknown. Here, we report a new mouse model (PSGR-Pten(Delta/Delta)) combining prostate-specific loss of Pten with probasin promoter-driven PSGR overexpression. By 12 months PSGR-Pten(Delta/Delta) mice developed invasive prostate tumors featuring Akt activation and extensive inflammatory cell infiltration. PSGR-Pten(Delta/Delta) tumors exhibited E-cadherin loss and increased stromal androgen receptor (AR) expression. PSGR overexpression increased LNCaP proliferation, whereas PSGR short hairpin RNA knockdown inhibited proliferation and migration. In conclusion, we demonstrate that PSGR overexpression synergizes with loss of PTEN to accelerate prostate cancer development, and present a novel bigenic mouse model that mimics the human condition, where both PSGR overexpression and loss of PTEN occur concordantly in the majority of advanced prostate cancers, yielding an environment more relevant to studying human prostate cancer.	[Rodriguez, M.; Siwko, S.; Zeng, L.; Liu, M.] Texas A&M Univ, Hlth Sci Ctr, Ctr Canc & Stem Cell Biol, Inst Biosci & Technol,Dept Cellular & Mol Med, 2121 W Holcombe Blvd, Houston, TX 77030 USA; [Li, J.; Yi, Z.; Liu, M.] E China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200062, Peoples R China; [Li, J.; Yi, Z.; Liu, M.] E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; East China Normal University; East China Normal University	Liu, M (corresponding author), Texas A&M Univ, Hlth Sci Ctr, Ctr Canc & Stem Cell Biol, Inst Biosci & Technol, 2121 W Holcombe Blvd, Houston, TX 77030 USA.	mliu@ibt.tamhsc.edu		Siwko, Stefan/0000-0003-4260-2985	State Key Development Programs of China [2012CB910400]; DOD Prostate Cancer Research Program (PCRP) [W81XWH-10-1-0612, W81XWH-10-10147]; NIH [5R01CA134731]; NATIONAL CANCER INSTITUTE [R01CA134731] Funding Source: NIH RePORTER	State Key Development Programs of China; DOD Prostate Cancer Research Program (PCRP); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Michael Ittmann (Baylor College of Medicine) for his insights and suggestions. We thank Dr Fen Wang (Texas A&M Health Science Center) for the gift of the PTEN<SUP>fl/fl</SUP> Cre mice and for valuable discussions and suggestions, and Dr Dekai Zhang (Texas A&M Health Science Center) for the gift of the RAW264.7 cells. This work was partially supported by grants from the State Key Development Programs of China (2012CB910400), DOD Prostate Cancer Research Program (PCRP, W81XWH-10-1-0612, W81XWH-10-10147) and NIH (5R01CA134731). This work was partially supported by grants from the State Key Development Programs of China (2012CB910400), DOD Prostate Cancer Research Program (PCRP, W81XWH-10-1-0612, W81XWH-10-10147) and NIH (5R01CA134731).	Cairns P, 1997, CANCER RES, V57, P4997; Cano P, 2007, CANCER RES, V67, P511, DOI 10.1158/0008-5472.CAN-06-1478; Carver BS, 2009, NAT GENET, V41, P619, DOI 10.1038/ng.370; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Cunha GR, 2003, INT J CANCER, V107, P1, DOI 10.1002/ijc.11335; Giles Graham G, 2003, Methods Mol Med, V81, P1; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Gurel B, 2014, CANCER EPIDEM BIOMAR, V23, P847, DOI 10.1158/1055-9965.EPI-13-1126; Kwon OJ, 2014, P NATL ACAD SCI USA, V111, pE592, DOI 10.1073/pnas.1318157111; Lai KP, 2012, EMBO MOL MED, V4, P791, DOI 10.1002/emmm.201101140; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Lee JT, 2008, CELL CYCLE, V7, P1745, DOI 10.4161/cc.7.12.6166; Liu PB, 2006, CANCER RES, V66, P4011, DOI 10.1158/0008-5472.CAN-05-3055; MacKenzie L, 2012, HUM PATHOL, V43, P1491, DOI 10.1016/j.humpath.2011.11.009; McCall P, 2012, BRIT J CANCER, V107, P1554, DOI 10.1038/bjc.2012.372; Nelson WG, 2003, NEW ENGL J MED, V349, P366, DOI 10.1056/NEJMra021562; Niu YJ, 2008, P NATL ACAD SCI USA, V105, P12188, DOI 10.1073/pnas.0804701105; Niu YJ, 2008, P NATL ACAD SCI USA, V105, P12182, DOI 10.1073/pnas.0804700105; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Rodriguez M, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.29; Roy AK, 1999, VITAM HORM, V55, P309; Russell Pamela J, 2003, Methods Mol Med, V81, P21; Sanz G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085110; Shen MM, 2007, CANCER RES, V67, P6535, DOI 10.1158/0008-5472.CAN-07-1271; Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810; Suh J, 2004, J CELL BIOCHEM, V91, P100, DOI 10.1002/jcb.10729; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Vanaja DK, 2003, CANCER RES, V63, P3877; Wang JH, 2006, PROSTATE, V66, P847, DOI 10.1002/pros.20389; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Weng JS, 2005, J CELL BIOCHEM, V96, P1034, DOI 10.1002/jcb.20600; Weng JS, 2005, INT J CANCER, V113, P811, DOI 10.1002/ijc.20635; Wikstrom P, 2009, PROSTATE, V69, P799, DOI 10.1002/pros.20927; Xia CZ, 2001, ONCOGENE, V20, P5903, DOI 10.1038/sj.onc.1204803; Xu LL, 2000, CANCER RES, V60, P6568; Xu LL, 2006, PROSTATE CANCER P D, V9, P56, DOI 10.1038/sj.pcan.4500836; Yoshimoto M, 2007, BRIT J CANCER, V97, P678, DOI 10.1038/sj.bjc.6603924; Yoshimoto M, 2008, MODERN PATHOL, V21, P1451, DOI 10.1038/modpathol.2008.96; Zhang LY, 2009, AM J PATHOL, V175, P489, DOI 10.2353/ajpath.2009.080727; Zhou Y, 2015, J MOL ENDOCRINOL, V54, pR15, DOI 10.1530/JME-14-0203	40	24	24	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 3	2016	35	9					1153	1162		10.1038/onc.2015.170	http://dx.doi.org/10.1038/onc.2015.170			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DF4WH	26028029	Green Accepted			2022-12-26	WOS:000371351700009
J	Sun, CC; Li, SJ; Yang, CL; Xue, RL; Xi, YY; Wang, L; Zhao, QL; Li, DJ				Sun, Cheng-Cao; Li, Shu-Jun; Yang, Cui-Li; Xue, Rui-Lin; Xi, Yong-Yong; Wang, Liang; Zhao, Qian-Long; Li, De-Jia			Sulforaphane Attenuates Muscle Inflammation in Dystrophin-deficient mdx Mice via NF-E2-related Factor 2 (Nrf2)-mediated Inhibition of NF-kappa B Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; NRF2 ENHANCES SUSCEPTIBILITY; NRF2-DEFICIENT MICE; SKELETAL-MUSCLE; ORAL TREATMENT; ACTIVATION; APOPTOSIS; MECHANISMS; EXPRESSION; PATHOLOGY	Inflammation is widely distributed in patients with Duchenne muscular dystrophy and ultimately leads to progressive deterioration of muscle function with chronic muscle damage, oxidative stress, and reduced oxidative capacity. NF-E2-related factor 2 (Nrf2) plays a critical role in defending against inflammation in different tissues via activation of phase II enzyme heme oxygenase-1 and inhibition of the NF-kappa B signaling pathway. However, the role of Nrf2 in the inflammation of dystrophic muscle remains unknown. To determine whether Nrf2 may counteract inflammation in dystrophic muscle, we treated 4-week-old male mdx mice with the Nrf2 activator sulforaphane (SFN) by gavage (2 mg/kg of body weight/day) for 4 weeks. The experimental results demonstrated that SFN treatment increased the expression of muscle phase II enzyme heme oxygenase-1 in an Nrf2-dependent manner. Inflammation in mice was reduced by SFN treatment as indicated by decreased infiltration of immune cells and expression of the inflammatory cytokine CD45 and proinflammatory cytokines tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 in the skeletal muscles of mdx mice. In addition, SFN treatment also decreased the expression of NF-kappa B(p65) and phosphorylated I kappa B kinase-alpha as well as increased inhibitor of kappa B-alpha expression in mdx mice in an Nrf2-dependent manner. Collectively, these results show that SFN-induced Nrf2 can alleviate muscle inflammation in mdx mice by inhibiting the NF-kappa B signaling pathway.	[Sun, Cheng-Cao; Li, Shu-Jun; Yang, Cui-Li; Xue, Rui-Lin; Xi, Yong-Yong; Wang, Liang; Li, De-Jia] Wuhan Univ, Dept Occupat & Environm Hlth, Sch Publ Hlth, Wuhan 430071, Peoples R China; [Zhao, Qian-Long] Lanzhou Univ, Sch Publ Hlth, Dept Occupat & Environm Hlth, Lanzhou 730000, Peoples R China	Wuhan University; Lanzhou University	Li, DJ (corresponding author), Wuhan Univ, Dept Occupat & Environm Hlth, Sch Publ Hlth, 115N Donghu Rd, Wuhan 430071, Peoples R China.	lodjlwhu@sina.com	Sun, Cheng-Cao/E-9504-2016	Sun, Cheng-Cao/0000-0002-0554-3165	National Natural Science Foundation of China [81271943]; Fundamental Research Funds for the Central Universities [2015305020202]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (Grant 81271943 to D.-J. L.) and Fundamental Research Funds for the Central Universities (Grant 2015305020202). The authors declare that they have no conflicts of interest with the contents of this article.	Aires A, 2009, J APPL MICROBIOL, V106, P2086, DOI 10.1111/j.1365-2672.2009.04180.x; ANDERSON JE, 1987, ANAT REC, V219, P243, DOI 10.1002/ar.1092190305; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Barton ER, 2002, J CELL BIOL, V157, P137, DOI 10.1083/jcb.200108071; Bauer R, 2009, EUR J HEART FAIL, V11, P463, DOI 10.1093/eurjhf/hfp028; Bhatnagar S, 2010, J MOL MED, V88, P155, DOI 10.1007/s00109-009-0550-4; Blaauw B, 2008, HUM MOL GENET, V17, P3686, DOI 10.1093/hmg/ddn264; Bogdanovich S, 2002, NATURE, V420, P418, DOI 10.1038/nature01154; Briguet A, 2004, NEUROMUSCULAR DISORD, V14, P675, DOI 10.1016/j.nmd.2004.06.008; Bushby K, 2010, LANCET NEUROL, V9, P77, DOI 10.1016/S1474-4422(09)70271-6; CAMPBELL KP, 1995, CELL, V80, P675, DOI 10.1016/0092-8674(95)90344-5; Charan RA, 2012, FASEB J, V26, P587, DOI 10.1096/fj.11-189829; Davies KE, 2006, CELL, V127, P1304, DOI 10.1016/j.cell.2006.12.010; de Souza CG, 2012, J MED FOOD, V15, P795, DOI 10.1089/jmf.2012.0016; Deconinck N, 2007, PEDIATR NEUROL, V36, P1, DOI 10.1016/j.pediatrneurol.2006.09.016; Durham WJ, 2006, MUSCLE NERVE, V34, P298, DOI 10.1002/mus.20579; Evans NP, 2010, CLIN NUTR, V29, P391, DOI 10.1016/j.clnu.2009.10.001; Farkas D, 2014, AM J RESP CELL MOL, V51, P413, DOI 10.1165/rcmb.2013-0355OC; GOROSPE JRM, 1994, NEUROMUSCULAR DISORD, V4, P325, DOI 10.1016/0960-8966(94)90068-X; Govoni A, 2013, CELL MOL LIFE SCI, V70, P4585, DOI 10.1007/s00018-013-1396-z; GRANCHELLI JA, 1995, J NEUROL SCI, V131, P1, DOI 10.1016/0022-510X(95)00089-K; Heier CR, 2013, EMBO MOL MED, V5, P1569, DOI 10.1002/emmm.201302621; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Hori YS, 2011, J PHARMACOL EXP THER, V338, P784, DOI 10.1124/jpet.111.183210; Jin W, 2008, ANN CLIN LAB SCI, V38, P221; Jin W, 2009, J NEUROTRAUM, V26, P131, DOI 10.1089/neu.2008.0655; Jorgensen LH, 2011, AM J PATHOL, V178, P273, DOI 10.1016/j.ajpath.2010.11.027; Juge N, 2007, CELL MOL LIFE SCI, V64, P1105, DOI 10.1007/s00018-007-6484-5; Khor TO, 2006, CANCER RES, V66, P11580, DOI 10.1158/0008-5472.CAN-06-3562; Lee JH, 2013, PHARMACOL THERAPEUT, V137, P153, DOI 10.1016/j.pharmthera.2012.09.008; Li YY, 2010, CLIN CANCER RES, V16, P2580, DOI 10.1158/1078-0432.CCR-09-2937; Mao L, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/238321; Moon DO, 2009, CANCER LETT, V274, P132, DOI 10.1016/j.canlet.2008.09.013; Nahirney PC, 1997, ANAT REC, V247, P341; Nakaso K, 2003, FEBS LETT, V546, P181, DOI 10.1016/S0014-5793(03)00517-9; Nallasamy P, 2014, J NUTR BIOCHEM, V25, P824, DOI 10.1016/j.jnutbio.2014.03.011; Nguyen B., 2014, J THORAC CARDIOVASC, V148, P690; Osburn WO, 2007, INT J CANCER, V121, P1883, DOI 10.1002/ijc.22943; Price LC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075415; Rangasamy T, 2005, J EXP MED, V202, P47, DOI 10.1084/jem.20050538; Rangasamy T, 2004, J CLIN INVEST, V114, P1248, DOI 10.1172/JCI200421146; Scaife CL, 2002, CANCER RES, V62, P6870; Souza CG, 2013, FOOD FUNCT, V4, P1271, DOI 10.1039/c3fo60039d; Spencer MJ, 1997, J CLIN INVEST, V99, P2745, DOI 10.1172/JCI119464; Straub V, 1997, J CELL BIOL, V139, P375, DOI 10.1083/jcb.139.2.375; Sun CC, 2015, J APPL PHYSIOL, V118, P224, DOI 10.1152/japplphysiol.00744.2014; Tidball JG, 2005, CURR OPIN RHEUMATOL, V17, P707, DOI 10.1097/01.bor.0000179948.65895.1a; Tidball JG, 2004, PEDIATR RES, V56, P831, DOI 10.1203/01.PDR.0000145578.01985.D0; Trollet C, 2009, EXPERT OPIN BIOL TH, V9, P849, DOI 10.1517/14712590903029164; Villalta SA, 2009, HUM MOL GENET, V18, P482, DOI 10.1093/hmg/ddn376; Wehling M, 2001, J CELL BIOL, V155, P123, DOI 10.1083/jcb.200105110	51	117	123	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					17784	17795		10.1074/jbc.M115.655019	http://dx.doi.org/10.1074/jbc.M115.655019			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26013831	hybrid, Green Published			2022-12-26	WOS:000358511700013
J	Wibberley, A; Staunton, CA; Feetham, CH; Vereninov, AA; Barrett-Jolley, R				Wibberley, Anna; Staunton, Caroline A.; Feetham, Claire H.; Vereninov, Alexey A.; Barrett-Jolley, Richard			An In Vitro Model of Skeletal Muscle Volume Regulation	PLOS ONE			English	Article							MEDULLOBLASTOMA CELL-LINE; HYPERTONIC SHRINKAGE; DEATH MACHINERY; DECREASE AVD; APOPTOSIS; CHANNELS; TE671; DIFFERENTIATION; PROGRESSION; MECHANISMS	Introduction Hypertonic media causes cells to shrink due to water loss through aquaporin channels. After acute shrinkage, cells either regulate their volume or, alternatively, undergo a number of metabolic changes which ultimately lead to cell death. In many cell types, hypertonic shrinkage is followed by apoptosis. Due to the complex 3D morphology of skeletal muscle and the difficulty in obtaining isolated human tissue, we have begun skeletal muscle volume regulation studies using the human skeletal muscle cell line TE671RD. In this study we investigated whether hypertonic challenge of the human skeletal muscle cell line TE671RD triggered cell death or evoked a cell volume recovery response. Methods The cellular volume of TE671RD cells was calculated from the 2D surface area. Cell death was assessed by both the trypan blue live/dead assay and the TUNEL assay. Results Medium osmolality was increased by addition of up to 200mM sucrose. Addition of 200mM sucrose resulted in mean cell shrinkage of 44 +/- 1% after 30mins. At later time points (2 and 4 hrs) two separate cell subpopulations with differing mean cell volume became apparent. The first subpopulation (15 +/- 2% of the total cell number) continued to shrink whereas the second subpopulation had an increased cell volume. Cell death was observed in a small proportion of cells (approximately 6-8%). Conclusion We have established that a substantial proportion of TE671RD cells respond to hypertonic challenge with RVI, but that these cells are resistant to hypertonicity triggered cell death.	[Wibberley, Anna; Staunton, Caroline A.; Feetham, Claire H.; Barrett-Jolley, Richard] Univ Liverpool, Inst Ageing & Chron Dis, Dept Musculoskeletal Biol, Liverpool L69 3BX, Merseyside, England; [Vereninov, Alexey A.] Russian Acad Sci, Inst Cytol, Lab Cell Physiol, St Petersburg 194064, Russia	University of Liverpool; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Institute of Cytology RAS	Barrett-Jolley, R (corresponding author), Univ Liverpool, Inst Ageing & Chron Dis, Dept Musculoskeletal Biol, Liverpool L69 3BX, Merseyside, England.	RBJ@liv.ac.uk	Barrett-Jolley, Richard/G-7704-2011	Barrett-Jolley, Richard/0000-0003-0449-9972; Staunton, Caroline Amy/0000-0003-0647-3063; Vereninov, Alexey/0000-0002-3602-7059; Feetham, Claire/0000-0002-7712-8825	Russian Foundation for Basic Research [15-04-00776-A]; BBSRC	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	AAV was supported by the Russian Foundation for Basic Research, project no. 15-04-00776-A, and CHF was supported by the BBSRC. The funders had no role in the design, data collection and analysis, decision to publish, or the preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Allen DL, 1997, AM J PHYSIOL-CELL PH, V273, pC579, DOI 10.1152/ajpcell.1997.273.2.C579; Barrett-Jolley R, 1998, BRIT J PHARMACOL, V123, P1103, DOI 10.1038/sj.bjp.0701727; BARRETTJOLLEY R, 1994, PFLUG ARCH EUR J PHY, V428, P492, DOI 10.1007/BF00374570; BLINKS JR, 1965, J PHYSIOL-LONDON, V177, P42, DOI 10.1113/jphysiol.1965.sp007574; Bortner CD, 1996, AM J PHYSIOL-CELL PH, V271, pC950, DOI 10.1152/ajpcell.1996.271.3.C950; Bourque CW, 2008, NAT REV NEUROSCI, V9, P519, DOI 10.1038/nrn2400; DalL'Asta V, 1999, AM J PHYSIOL-CELL PH, V276, pC865, DOI 10.1152/ajpcell.1999.276.4.C865; Dirks A, 2002, AM J PHYSIOL-REG I, V282, pR519, DOI 10.1152/ajpregu.00458.2001; Edwards YS, 1998, AM J PHYSIOL-LUNG C, V275, pL670, DOI 10.1152/ajplung.1998.275.4.L670; FAKLER B, 1990, PFLUG ARCH EUR J PHY, V415, P693, DOI 10.1007/BF02584007; Farrugia ME, 2007, J NEUROIMMUNOL, V185, P136, DOI 10.1016/j.jneuroim.2007.01.010; Feetham CH, 2015, BRIT J PHARMACOL, V172, P1753, DOI 10.1111/bph.13023; Ferenczi EA, 2004, J PHYSIOL-LONDON, V555, P423, DOI 10.1113/jphysiol.2003.058545; Frigeri A, 2004, FASEB J, V18, P905, DOI 10.1096/fj.03-0987fje; Friis MB, 2005, J PHYSIOL-LONDON, V567, P427, DOI 10.1113/jphysiol.2005.087130; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Ghosh A, 2007, APOPTOSIS, V12, P1281, DOI 10.1007/s10495-007-0054-z; Goljanek-Whysall K, 2012, J CELL SCI, V125, P3590, DOI 10.1242/jcs.101758; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Lang F, 2013, J PHYSIOL-LONDON, V591, P6119, DOI 10.1113/jphysiol.2013.258632; Lewis R, 2011, J CELL PHYSIOL, V226, P2979, DOI 10.1002/jcp.22646; Lindinger MI, 2011, J PHYSIOL-LONDON, V589, P2887, DOI 10.1113/jphysiol.2011.206730; LUTHER MA, 1989, J NEUROSCI, V9, P1082; Maeno E, 2006, FEBS LETT, V580, P6513, DOI 10.1016/j.febslet.2006.10.074; Marzetti E, 2006, EXP GERONTOL, V41, P1234, DOI 10.1016/j.exger.2006.08.011; Marzetti E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032829; MCLEAN KA, 1992, AGE AGEING, V21, P56, DOI 10.1093/ageing/21.1.56; Miller TR, 1999, EUR J PHARMACOL, V370, P179, DOI 10.1016/S0014-2999(99)00128-4; Okada Y, 2001, J PHYSIOL-LONDON, V532, P3, DOI 10.1111/j.1469-7793.2001.0003g.x; Orlov SN, 2013, J PHYSIOL-LONDON, V591, P6123, DOI 10.1113/jphysiol.2013.258624; PHILLIPS PA, 1991, AM J PHYSIOL, V261, pR166, DOI 10.1152/ajpregu.1991.261.1.R166; Phillips T, 2005, FASEB J, V19, P668, DOI 10.1096/fj.04-2870fje; Platonova A, 2012, APOPTOSIS, V17, P429, DOI 10.1007/s10495-011-0694-x; Pollack M, ANN NEW YORK ACAD SC, P93; Racz B, 2007, BONE, V40, P1536, DOI 10.1016/j.bone.2007.02.011; Skulachev VP, 2012, BIOCHEMISTRY-MOSCOW+, V77, P689, DOI 10.1134/S0006297912070012; SOTOS JF, 1960, PEDIATRICS, V26, P925; Stachenfeld NS, 1997, AM J PHYSIOL-REG I, V272, pR148, DOI 10.1152/ajpregu.1997.272.1.R148; STRATTON MR, 1989, CARCINOGENESIS, V10, P899, DOI 10.1093/carcin/10.5.899; Taulli R, 2009, J CLIN INVEST, V119, P2366, DOI 10.1172/JCI38075; Troshin AS, 1966, PROBLEMS OF CELL PER, V26, P30; Welle S, 2003, PHYSIOL GENOMICS, V14, P149, DOI 10.1152/physiolgenomics.00049.2003; Williams AH, 2009, SCIENCE, V326, P1549, DOI 10.1126/science.1181046; Yurinskaya VE, 2012, CELL PHYSIOL BIOCHEM, V30, P964, DOI 10.1159/000341473	46	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0127889	10.1371/journal.pone.0127889	http://dx.doi.org/10.1371/journal.pone.0127889			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26029913	Green Submitted, gold, Green Published			2022-12-26	WOS:000356630900088
J	Goldinger, A; Shakhbazov, K; Henders, AK; Mcrae, AF; Montgomery, GW; Powell, JE				Goldinger, Anita; Shakhbazov, Konstantin; Henders, Anjali K.; Mcrae, Allan F.; Montgomery, Grant W.; Powell, Joseph E.			Seasonal Effects on Gene Expression	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MESSENGER-RNA; DISORDERS; BLOOD; METABOLITES; DISCOVERY; BEHAVIOR; DISEASE; HUMANS	Many health conditions, ranging from psychiatric disorders to cardiovascular disease, display notable seasonal variation in severity and onset. In order to understand the molecular processes underlying this phenomenon, we have examined seasonal variation in the transcriptome of 606 healthy individuals. We show that 74 transcripts associated with a 12-month seasonal cycle were enriched for processes involved in DNA repair and binding. An additional 94 transcripts demonstrated significant seasonal variability that was largely influenced by blood cell count levels. These transcripts were enriched for immune function, protein production, and specific cellular markers for lymphocytes. Accordingly, cell counts for erythrocytes, platelets, neutrophils, monocytes, and CD19 cells demonstrated significant association with a 12-month seasonal cycle. These results demonstrate that seasonal variation is an important environmental regulator of gene expression and blood cell composition. Notable changes in leukocyte counts and genes involved in immune function indicate that immune cell physiology varies throughout the year in healthy individuals.	[Goldinger, Anita; Shakhbazov, Konstantin; Mcrae, Allan F.] Univ Queensland, Diamantina Inst, Translat Res Inst, Brisbane, Qld 4102, Australia; [Goldinger, Anita; Henders, Anjali K.; Mcrae, Allan F.; Powell, Joseph E.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; [Henders, Anjali K.; Mcrae, Allan F.; Montgomery, Grant W.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia	University of Queensland; University of Queensland; QIMR Berghofer Medical Research Institute	Goldinger, A (corresponding author), Univ Queensland, Diamantina Inst, Translat Res Inst, Brisbane, Qld 4102, Australia.	a.goldinger@uq.edu.au	Goldinger, Anita/K-9171-2018; McRae, Allan F/J-2644-2014; Montgomery, Grant W/B-7148-2008; Henders, Anjali/E-3126-2017	Goldinger, Anita/0000-0002-7688-1823; McRae, Allan F/0000-0001-5286-5485; Montgomery, Grant W/0000-0002-4140-8139; Powell, Joseph/0000-0002-5070-4124; Henders, Anjali/0000-0003-3672-1451	Australian National Health and Medical Research Council (NHMRC) [389892, 496667, 613601, 1010374, 1046880]; National Institutes of Health (NIH) [GM057091]; NHMRC; Australia Research Council (ARC); Australian Postgraduate Award	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australia Research Council (ARC)(Australian Research Council); Australian Postgraduate Award(Australian Government)	This research was supported by Australian National Health and Medical Research Council (NHMRC) grants 389892, 496667, 613601, 1010374, and 1046880 and National Institutes of Health (NIH) grant GM057091. Dr. Montgomery is supported by the NHMRC Fellowship Scheme. Dr. Powell is supported by the Australia Research Council (ARC) Fellowship Scheme. Anita Goldinger is supported by an Australian Postgraduate Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alstadhaug KB, 2005, CEPHALALGIA, V25, P811, DOI 10.1111/j.1468-2982.2005.01018.x; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Azzi A, 2014, NAT NEUROSCI, V17, P377, DOI 10.1038/nn.3651; Barnett AG, 2008, AUST NZ J PUBL HEAL, V32, P408, DOI 10.1111/j.1753-6405.2008.00270.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bloom-Feshbach K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054445; Cheung VG, 2009, NAT REV GENET, V10, P595, DOI 10.1038/nrg2630; Cleveland R.B., 1990, J OFF STAT, V6, P3; Davie A, 2009, CHRONOBIOL INT, V26, P379, DOI 10.1080/07420520902820947; de Jong S, 2014, HUM MOL GENET; De Vriese SR, 2004, PROSTAG LEUKOTR ESS, V71, P13, DOI 10.1016/j.plefa.2003.12.002; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; FAEDDA GL, 1993, ARCH GEN PSYCHIAT, V50, P17; Falconer D. S., 1996, Introduction to quantitative genetics.; Friedman E, 2006, ACTA PSYCHIAT SCAND, V113, P510, DOI 10.1111/j.1600-0447.2005.00701.x; Gallerani M, 2013, EUR J MED RES, V18, DOI 10.1186/2047-783X-18-31; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; Goldinger A, 2013, GENETICS, V195, P1117, DOI 10.1534/genetics.113.153221; Green A, 2001, DIABETOLOGIA, V44, pB3, DOI 10.1007/PL00002950; Harris SS, 1998, AM J CLIN NUTR, V67, P1232, DOI 10.1093/ajcn/67.6.1232; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Idaghdour Y, 2010, NAT GENET, V42, P62, DOI 10.1038/ng.495; Iuliano G, 2012, J NEUROL, P1; JUTTMANN JR, 1981, BRIT MED J, V282, P1349, DOI 10.1136/bmj.282.6273.1349; Kao CC, 2005, PEDIAT ALLERG IMM-UK, V16, P408, DOI 10.1111/j.1399-3038.2005.00268.x; KASPER S, 1988, NERVENARZT, V59, P191; KIYOHARA T, 1995, BRAIN RES BULL, V38, P193, DOI 10.1016/0361-9230(95)00093-T; Kristal-Boneh E, 2008, BRIT J HAEMATOL, V85, P603; KRUESI MJP, 1990, ARCH GEN PSYCHIAT, V47, P419; Lambert GW, 2002, LANCET, V360, P1840, DOI 10.1016/S0140-6736(02)11737-5; Landi L, 2011, J AGR FOOD CHEM, V59, P6628, DOI 10.1021/jf104297n; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Levis S, 2005, J CLIN ENDOCR METAB, V90, P1557, DOI 10.1210/jc.2004-0746; Li QY, 2013, CELL, V152, P633, DOI 10.1016/j.cell.2012.12.034; LJUNG GM, 1978, BIOMETRIKA, V65, P297, DOI 10.2307/2335207; LOSONCZY MF, 1984, PSYCHIAT RES, V12, P79, DOI 10.1016/0165-1781(84)90140-9; Luykx JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030497; Messias E, 2004, ARCH GEN PSYCHIAT, V61, P985, DOI 10.1001/archpsyc.61.10.985; Mikulich SK, 2003, STAT MED, V22, P3195, DOI 10.1002/sim.1560; Miller JA, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-322; Okamoto M, 2009, PLANT PHYSIOL, V149, P825, DOI 10.1104/pp.108.130823; Parnell GP, 2014, MULT SCLER J, V20, P675, DOI 10.1177/1352458513507819; Powell JE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003502; Powell JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035430; Powell JE, 2012, GENOME RES, V22, P456, DOI 10.1101/gr.126540.111; Powell JE, 2010, NAT REV GENET, V11, P800, DOI 10.1038/nrg2865; SCRAGG R, 1981, INT J EPIDEMIOL, V10, P337, DOI 10.1093/ije/10.4.337; Sieberts SK, 2007, MAMM GENOME, V18, P389, DOI 10.1007/s00335-007-9040-6; STAMP TCB, 1974, NATURE, V247, P563, DOI 10.1038/247563a0; Stolwijk AM, 1999, J EPIDEMIOL COMMUN H, V53, P235, DOI 10.1136/jech.53.4.235; STRYD RP, 1979, J CLIN ENDOCR METAB, V48, P771, DOI 10.1210/jcem-48-5-771; Tangpricha V, 2002, AM J MED, V112, P659, DOI 10.1016/S0002-9343(02)01091-4; Tournier BB, 2007, EUR J NEUROSCI, V25, P1529, DOI 10.1111/j.1460-9568.2007.05421.x; Vogel U, 2002, CARCINOGENESIS, V23, P1505, DOI 10.1093/carcin/23.9.1505; Weinkauf B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039411; Xiao XL, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004006; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yang SH, 2005, TREE PHYSIOL, V25, P1063, DOI 10.1093/treephys/25.8.1063; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693	61	28	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0126995	10.1371/journal.pone.0126995	http://dx.doi.org/10.1371/journal.pone.0126995			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26023781	Green Published, gold, Green Submitted			2022-12-26	WOS:000355319400028
J	Kabu, S; Jaffer, H; Petro, M; Dudzinski, D; Stewart, D; Courtney, A; Courtney, M; Labhasetwar, V				Kabu, Shushi; Jaffer, Hayder; Petro, Marianne; Dudzinski, Dave; Stewart, Desiree; Courtney, Amy; Courtney, Michael; Labhasetwar, Vinod			Blast-Associated Shock Waves Result in Increased Brain Vascular Leakage and Elevated ROS Levels in a Rat Model of Traumatic Brain Injury	PLOS ONE			English	Article							OXIDATIVE STRESS; SUPEROXIDE-DISMUTASE; BARRIER DISRUPTION; HUMAN NEURONS; MOUSE MODEL; EDEMA; DEFICITS; DIFFUSE; OVERPRESSURE; BREAKDOWN	Blast-associated shock wave-induced traumatic brain injury (bTBI) remains a persistent risk for armed forces worldwide, yet its detailed pathophysiology remains to be fully investigated. In this study, we have designed and characterized a laboratory-scale shock tube to develop a rodent model of bTBI. Our blast tube, driven by a mixture of oxygen and acetylene, effectively generates blast overpressures of 20-130 psi, with pressure-time profiles similar to those of free-field blast waves. We tested our shock tube for brain injury response to various blast wave conditions in rats. The results show that blast waves cause diffuse vascular brain damage, as determined using a sensitive optical imaging method based on the fluorescence signal of Evans Blue dye extravasation developed in our laboratory. Vascular leakage increased with increasing blast overpressures and mapping of the brain slices for optical signal intensity indicated nonhomogeneous damage to the cerebral vasculature. We confirmed vascular leakage due to disruption in the blood-brain barrier (BBB) integrity following blast exposure. Reactive oxygen species (ROS) levels in the brain also increased with increasing blast pressures and with time post-blast wave exposure. Immunohistochemical analysis of the brain sections analyzed at different time points post blast exposure demonstrated astrocytosis and cell apoptosis, confirming sustained neuronal injury response. The main advantages of our shock-tube design are minimal jet effect and no requirement for specialized equipment or facilities, and effectively generate blast-associated shock waves that are relevant to battle-field conditions. Overall data suggest that increased oxidative stress and BBB disruption could be the crucial factors in the propagation and spread of neuronal degeneration following blast injury. Further studies are required to determine the interplay between increased ROS activity and BBB disruption to develop effective therapeutic strategies that can prevent the resulting cascade of neurodegeneration.	[Kabu, Shushi; Jaffer, Hayder; Petro, Marianne; Stewart, Desiree; Labhasetwar, Vinod] Cleveland Clin, Dept Biomed Engn, Lerner Res Inst, Cleveland, OH 44106 USA; [Dudzinski, Dave] Cleveland Clin, Med Device Solut, Lerner Res Inst, Cleveland, OH 44106 USA; [Courtney, Amy; Courtney, Michael] BTG Res, Colorado Springs, CO USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation	Labhasetwar, V (corresponding author), Cleveland Clin, Dept Biomed Engn, Lerner Res Inst, Cleveland, OH 44106 USA.	labhasv@ccf.org	Labhasetwar, Vinod/J-9660-2016	Labhasetwar, Vinod/0000-0001-7950-1542; Courtney, Amy/0000-0002-1925-8736				Ahn HY, 2012, J AM CHEM SOC, V134, P4721, DOI 10.1021/ja210315x; Alley M., 2009, THESIS PURDUE U W LA; Azbill RD, 1997, BRAIN RES, V765, P283, DOI 10.1016/S0006-8993(97)00573-8; Baskaya MK, 2000, J NEUROSURG, V92, P448, DOI 10.3171/jns.2000.92.3.0448; Blixt J, 2015, BRAIN RES; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Cernak Ibolja, 2010, Front Neurol, V1, P151, DOI 10.3389/fneur.2010.00151; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chen Y, 2013, J NEUROPSYCH CLIN N, V25, P103, DOI 10.1176/appi.neuropsych.12030058; Chen Y, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00117; Chen Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039353; Chen Y, 2011, BRAIN INJURY, V25, P641, DOI 10.3109/02699052.2011.580313; Choi BY, 2012, BRAIN RES, V1481, P49, DOI 10.1016/j.brainres.2012.08.032; Courtney AC, 2009, MED HYPOTHESES, V72, P76, DOI 10.1016/j.mehy.2008.08.015; Courtney AC, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.3702803; Courtney E, 2014, DEF TECHNOL, V10, P245, DOI 10.1016/j.dt.2014.04.003; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; DeWitt DS, 2013, J NEUROTRAUM, V30, P688, DOI 10.1089/neu.2012.2349; DeWitt DS, 2009, J NEUROTRAUM, V26, P877, DOI 10.1089/neu.2007.0439; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Gilgun-Sherki Y, 2001, NEUROPHARMACOLOGY, V40, P959, DOI 10.1016/S0028-3908(01)00019-3; Her H, 2012, QUANTIFYING MOMENTUM; Hicks RR, 2010, J TRAUMA, V68, P1257, DOI 10.1097/TA.0b013e3181d8956d; Higashida T, 2011, J NEUROSURG, V114, P92, DOI 10.3171/2010.6.JNS10207; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Iffland PH, 2013, NEUROBIOL DIS, V59, P206, DOI 10.1016/j.nbd.2013.07.006; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jaffer H, 2013, SCI REP-UK, V3, DOI 10.1038/srep03117; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; Kuehn R, 2011, J NEUROTRAUM, V28, P2155, DOI 10.1089/neu.2010.1532; Lew HL, 2005, AM J PHYS MED REHAB, V84, P393, DOI 10.1097/01.phm.0000163703.91647.a7; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Liu LD, 2012, NATURE, V483, P608, DOI 10.1038/nature10927; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Magnuson J, 2012, CURR NEUROL NEUROSCI, V12, P570, DOI 10.1007/s11910-012-0303-6; Mediavilla Varas Jesus, 2011, Front Neurol, V2, P58, DOI 10.3389/fneur.2011.00058; Newman AJ, 2015, J NEUROSCI METH, V242, P82, DOI 10.1016/j.jneumeth.2015.01.009; Nimmo AJ, 2004, NEUROPEPTIDES, V38, P40, DOI 10.1016/j.npep.2003.12.003; O'Connor WT, 2011, PHARMACOL THERAPEUT, V130, P106, DOI 10.1016/j.pharmthera.2011.01.001; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Pasco A, 2007, J NEUROTRAUM, V24, P1321, DOI 10.1089/neu.2006.0136; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Pun Pamela B L, 2011, Front Neurol, V2, P19, DOI 10.3389/fneur.2011.00019; Pun PBL, 2009, FREE RADICAL RES, V43, P348, DOI 10.1080/10715760902751902; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Reddy MK, 2008, APPL BIOCHEM BIOTECH, V151, P565, DOI 10.1007/s12010-008-8232-1; Reddy MK, 2009, FASEB J, V23, P1384, DOI 10.1096/fj.08-116947; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Shetty AK, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00232; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Singhal A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.362; Stuhmiller J. H., 2008, MILITARY QUANTITATIV, P267; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Turner RC, 2013, EXP NEUROL, V248, P520, DOI 10.1016/j.expneurol.2013.07.008; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Wang Y, 2011, J NEUROTRAUM, V28, P2171, DOI 10.1089/neu.2011.1990; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yeoh S, 2013, ANN BIOMED ENG, V41, P2206, DOI 10.1007/s10439-013-0805-7	64	46	49	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0127971	10.1371/journal.pone.0127971	http://dx.doi.org/10.1371/journal.pone.0127971			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024446	gold, Green Published			2022-12-26	WOS:000355319400062
J	Sun, J; Li, FN; Zhao, Y; Zhao, L; Qiao, C; Li, ZY; Guo, QL; Lu, N				Sun, Jie; Li, Fanni; Zhao, Yue; Zhao, Li; Qiao, Chen; Li, Zhiyu; Guo, Qinglong; Lu, Na			LZ-207, a Newly Synthesized Flavonoid, Induces Apoptosis and Suppresses Inflammation-Related Colon Cancer by Inhibiting the NF-kappa B Signaling Pathway	PLOS ONE			English	Article							PHASE ARREST; CELLS; WOGONIN; TUMOR; EXPRESSION; PROGRESSION; PREVENTION; INDUCTION; ACID	Flavonoids and flavonoid derivatives, which have significant biological and pharmacological activities, including antitumor and anti-inflammatory activities, have been widely used in human healthcare. To design a more effective flavonoid antitumor agent, we altered the flavonoid backbone with substitutions of piperazine and methoxy groups to synthesize a novel flavonoid derivative, LZ-207. The anticancer effect of LZ-207 against HCT116 colon cancer cells and the underlying mechanism of this effect were explored in this study. Specifically, LZ-207 exhibited inhibitory effects on growth and viability in several human colon cancer cell lines and induced apoptosis in HCT116 cells both in vitro and in vivo. LZ-207 treatment also suppressed the nuclear translocation of NF-kappa B and the phosphorylation of I kappa B and IKK alpha/beta in a dose-dependent manner in both HCT116 cells and human acute monocytic leukemia THP-1 cells. Moreover, LZ-207 also reduced the secretion of the pro-inflammatory cytokine interleukin-6 (IL-6) in LPS-induced THP-1 cells, and this effect was confirmed at the transcriptional level. Furthermore, LZ-207 significantly inhibited HCT116 cell proliferation that was elicited by LPS-induced THP-1 cells in a co-culture system. These findings elucidated some potential molecular mechanisms for preventing inflammation-driven colon cancer using the newly synthesized flavonoid LZ-207 and suggested the possibility of further developing novel therapeutic agents derived from flavonoids.	[Sun, Jie; Li, Fanni; Zhao, Yue; Zhao, Li; Qiao, Chen; Guo, Qinglong; Lu, Na] China Pharmaceut Univ, Jiangsu Key Lab Carcinogenesis & Intervent, State Key Lab Nat Med, Nanjing 210009, Jiangsu, Peoples R China; [Li, Zhiyu] China Pharmaceut Univ, Sch Pharm, Nanjing 210009, Jiangsu, Peoples R China	China Pharmaceutical University; China Pharmaceutical University	Guo, QL (corresponding author), China Pharmaceut Univ, Jiangsu Key Lab Carcinogenesis & Intervent, State Key Lab Nat Med, 24 Tongjiaxiang, Nanjing 210009, Jiangsu, Peoples R China.	anticancer_drug@163.com; luna555@163.com	sun, jie/H-8312-2018; Sun, Jie/M-9620-2013	Sun, Jie/0000-0002-8368-3091	National Science & Technology Major Project [2012ZX09304-001]; State Key Laboratory of Natural Medicines, China Pharmaceutical University [JKGZ201101, SKLNMZZ201210, SKLNMZZCX201303, SKLNMZZJQ201302, G140042]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1193]; National Natural Science Foundation of China [91029744]	National Science & Technology Major Project; State Key Laboratory of Natural Medicines, China Pharmaceutical University; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Science & Technology Major Project (No.2012ZX09304-001), the Project Program of State Key Laboratory of Natural Medicines, China Pharmaceutical University (No. JKGZ201101, SKLNMZZ201210, SKLNMZZCX201303 and SKLNMZZJQ201302, G140042), the Program for Changjiang Scholars and Innovative Research Team in University (IRT1193), the National Natural Science Foundation of China (No. 91029744).	Becker C, 2004, IMMUNITY, V21, P491, DOI 10.1016/j.immuni.2004.07.020; Becker C, 2010, METHODS, V50, P237, DOI 10.1016/j.ymeth.2010.01.010; Bondar T, 2013, CANCER CELL, V24, P143, DOI 10.1016/j.ccr.2013.07.016; Brard Laurent, 2009, Drug Des Devel Ther, V2, P61; Chen FH, 2010, CANCER LETT, V296, P96, DOI 10.1016/j.canlet.2010.04.004; Chen P, 2011, TOXICOLOGY, V282, P122, DOI 10.1016/j.tox.2011.01.018; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dann SM, 2008, J IMMUNOL, V180, P6816, DOI 10.4049/jimmunol.180.10.6816; Dolcet X, 2005, VIRCHOWS ARCH, V446, P475, DOI 10.1007/s00428-005-1264-9; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Grothey A, 2013, LANCET, V381, P303, DOI 10.1016/S0140-6736(12)61900-X; Hellstrom I, 2010, CANCER LETT, V296, P43, DOI 10.1016/j.canlet.2010.03.013; Huang HL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043645; Kanadaswami C, 2005, IN VIVO, V19, P895; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Li LW, 2011, EUR J PHARM SCI, V43, P393, DOI 10.1016/j.ejps.2011.06.001; Li-Weber M, 2009, CANCER TREAT REV, V35, P57, DOI 10.1016/j.ctrv.2008.09.005; Lin Y, 2008, CURR CANCER DRUG TAR, V8, P634, DOI 10.2174/156800908786241050; Liu TZ, 2007, MOL CANCER THER, V6, P1814, DOI 10.1158/1535-7163.MCT-06-0279; Liu W, 2011, BIOCHEM CELL BIOL, V89, P287, DOI 10.1139/O10-162; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Middleton E, 2000, PHARMACOL REV, V52, P673; Murakami A, 2008, CANCER LETT, V269, P315, DOI 10.1016/j.canlet.2008.03.046; Neuhouser ML, 2004, NUTR CANCER, V50, P1, DOI 10.1207/s15327914nc5001_1; Nguyen IS, 2006, INT C SERIES, P257; Nijveldt RJ, 2001, AM J CLIN NUTR, V74, P418; Pan D, 2014, BIOCHEM PHARMACOL, V87, P598, DOI 10.1016/j.bcp.2013.12.010; Popivanova BK, 2008, J CLIN INVEST, V118, P560, DOI [10.1172/JC132453, 10.1172/JCI32453]; Qiang L, 2008, BIOCHEM PHARMACOL, V75, P1083, DOI 10.1016/j.bcp.2007.10.033; Ramasamy K, 2008, CANCER LETT, V269, P352, DOI 10.1016/j.canlet.2008.03.053; Rong JJ, 2009, CANCER LETT, V284, P102, DOI 10.1016/j.canlet.2009.04.011; Solinas G, 2010, J IMMUNOL, V185, P642, DOI 10.4049/jimmunol.1000413; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Vuletic S, 2011, BBA-MOL CELL RES, V1813, P1917, DOI 10.1016/j.bbamcr.2011.06.013; Wang QX, 2009, J CLIN BIOCHEM NUTR, V45, P163, DOI 10.3164/jcbn.09-21; Wei LB, 2010, J CELL BIOCHEM, V111, P1629, DOI 10.1002/jcb.22898; Yang L, 2009, BIOCHEM CELL BIOL, V87, P933, DOI [10.1139/O09-060, 10.1139/o09-060]; Yao J, 2014, MOL CARCINOGEN, V53, P145, DOI 10.1002/mc.21958; Zeng S, 2009, BIOCHEM BIOPH RES CO, V385, P551, DOI 10.1016/j.bbrc.2009.05.099; Zhang HW, 2008, EUR J PHARMACOL, V591, P7, DOI 10.1016/j.ejphar.2008.06.024; Zhang LB, 2011, EUR J PHARMACOL, V651, P33, DOI 10.1016/j.ejphar.2010.10.067; Zhang Y, 2014, ARCH TOXICOL, V88, P97, DOI 10.1007/s00204-013-1085-6; Zhao Q, 2010, TOXICOL LETT, V197, P201, DOI 10.1016/j.toxlet.2010.05.019; Zhou YX, 2013, EUR J PHARM SCI, V49, P649, DOI 10.1016/j.ejps.2013.04.016	45	7	8	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0127282	10.1371/journal.pone.0127282	http://dx.doi.org/10.1371/journal.pone.0127282			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26023926	Green Submitted, Green Published, gold			2022-12-26	WOS:000355319400035
J	Uji, A; Murakami, T; Muraoka, Y; Hosoda, Y; Yoshitake, S; Dodo, Y; Arichika, S; Yoshimura, N				Uji, Akihito; Murakami, Tomoaki; Muraoka, Yuki; Hosoda, Yoshikatsu; Yoshitake, Shin; Dodo, Yoko; Arichika, Shigeta; Yoshimura, Nagahisa			Potential Measurement Errors Due to Image Enlargement in Optical Coherence Tomography Imaging	PLOS ONE			English	Article							HYPERREFLECTIVE FOCI; VISUAL-ACUITY; PARALLELISM; SPEED	The effect of interpolation and super-resolution (SR) algorithms on quantitative and qualitative assessments of enlarged optical coherence tomography (OCT) images was investigated in this report. Spectral-domain OCT images from 30 eyes in 30 consecutive patients with diabetic macular edema (DME) and 20 healthy eyes in 20 consecutive volunteers were analyzed. Original image (OR) resolution was reduced by a factor of four. Images were then magnified by a factor of four with and without application of one of the following algorithms: bilinear (BL), bicubic (BC), Lanczos3 (LA), and SR. Differences in peak signal-to-noise ratio (PSNR), retinal nerve fiber layer (RNFL) thickness, photoreceptor layer status, and parallelism (reflects the complexity of photoreceptor layer alterations) were analyzed in each image type. The order of PSNRs from highest to lowest was SR > LA > BC > BL > non-processed enlarged images (NONE). The PSNR was statistically different in all groups. The NONE, BC, and LA images resulted in significantly thicker RNFL measurements than the OR image. In eyes with DME, the photoreceptor layer, which was hardly identifiable in NONE images, became detectable with algorithm application. However, OCT photoreceptor parameters were still assessed as more undetectable than in OR images. Parallelism was not statistically different in OR and NONE images, but other image groups had significantly higher parallelism than OR images. Our results indicated that interpolation and SR algorithms increased OCT image resolution. However, qualitative and quantitative assessments were influenced by algorithm use. Additionally, each algorithm affected the assessments differently.	[Uji, Akihito; Murakami, Tomoaki; Muraoka, Yuki; Hosoda, Yoshikatsu; Yoshitake, Shin; Dodo, Yoko; Arichika, Shigeta; Yoshimura, Nagahisa] Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto 6068507, Japan	Kyoto University	Uji, A (corresponding author), Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto 6068507, Japan.	akihito1@kuhp.kyoto-u.ac.jp		Murakami, Tomoaki/0000-0002-0314-8807	Innovative Techno-Hub for Integrated Medical BioImaging of the Project for Developing Innovation Systems (Ministry of Education, Culture, Sports, Science, and Technology [MEXT], Japan)	Innovative Techno-Hub for Integrated Medical BioImaging of the Project for Developing Innovation Systems (Ministry of Education, Culture, Sports, Science, and Technology [MEXT], Japan)	This work was supported in part by the Innovative Techno-Hub for Integrated Medical Bio-Imaging of the Project for Developing Innovation Systems (Ministry of Education, Culture, Sports, Science, and Technology [MEXT], Japan) (AU, NY), (http://ckpj.t.kyoto-u.ac.jp/?lang = en). No additional external funding was received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alasil T, 2010, OPHTHALMOLOGY, V117, P2379, DOI 10.1016/j.ophtha.2010.03.051; Bolz M, 2009, OPHTHALMOLOGY, V116, P914, DOI 10.1016/j.ophtha.2008.12.039; Chen TC, 2005, ARCH OPHTHALMOL-CHIC, V123, P1715, DOI 10.1001/archopht.123.12.1715; DUCHON CE, 1979, J APPL METEOROL, V18, P1016, DOI 10.1175/1520-0450(1979)018<1016:LFIOAT>2.0.CO;2; Forooghian F, 2010, RETINA-J RET VIT DIS, V30, P63, DOI 10.1097/IAE.0b013e3181bd2c5a; Freeman WT, 2000, INT J COMPUT VISION, V40, P25, DOI 10.1023/A:1026501619075; Gonzalez R.C., 2011, DIGITAL IMAGE PROCES; Greenspan H, 2009, COMPUT J, V52, P43, DOI 10.1093/comjnl/bxm075; Hangai M, 2006, CLIN APPL HIGH CONTR; Horii T, 2010, AM J OPHTHALMOL, V150, P840, DOI 10.1016/j.ajo.2010.06.015; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Huynh-Thu Q, 2008, ELECTRON LETT, V44, P800, DOI 10.1049/el:20080522; KEYS RG, 1981, IEEE T ACOUST SPEECH, V29, P1153, DOI 10.1109/TASSP.1981.1163711; Kitayama T, 2012, HARDWARE ARCHITECTUR, P492; Makwana RR, 2013, INT J SOFT COMPUTING; Murakami T, 2012, INVEST OPHTH VIS SCI, V53, P1506, DOI 10.1167/iovs.11-9231; Nassif N, 2004, OPT LETT, V29, P480, DOI 10.1364/OL.29.000480; Park SC, 2003, IEEE SIGNAL PROC MAG, V20, P21, DOI 10.1109/MSP.2003.1203207; Sakamoto A, 2008, OPHTHALMOLOGY, V115, P1071, DOI 10.1016/j.ophtha.2007.09.001; Takayama K, 2012, INVEST OPHTH VIS SCI, V53, P6904, DOI 10.1167/iovs.12-10210; Ueda H, 2010, P NATL ACAD SCI USA, V107, P6894, DOI 10.1073/pnas.0911482107; Uji A, 2014, INVEST OPHTH VIS SCI, V55, P3361, DOI 10.1167/iovs.14-13948; Uji A, 2014, AM J OPHTHALMOL, V157, P227, DOI 10.1016/j.ajo.2013.09.008; Uji A, 2012, AM J OPHTHALMOL, V153, P710, DOI 10.1016/j.ajo.2011.08.041; Yoneda A, 2007, PLANT CELL PHYSIOL, V48, P1393, DOI 10.1093/pcp/pcm120; Zhu TP, 2014, MICROVASC RES, V95, P7, DOI 10.1016/j.mvr.2014.06.007; [No title captured]	27	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128512	10.1371/journal.pone.0128512	http://dx.doi.org/10.1371/journal.pone.0128512			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024236	Green Published, gold, Green Submitted			2022-12-26	WOS:000355319400096
J	van der Schans, J; Kotsopoulos, N; Hoekstra, PJ; Hak, E; Postma, MJ				van der Schans, Jurjen; Kotsopoulos, Nikos; Hoekstra, Pieter J.; Hak, Eelko; Postma, Maarten J.			Cost-Effectiveness of Extended-Release Methylphenidate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder Sub-Optimally Treated with Immediate Release Methylphenidate	PLOS ONE			English	Article							DEFICIT-HYPERACTIVITY DISORDER; MULTIMODAL TREATMENT; ADHD; EPIDEMIOLOGY; UTILITIES; EFFICACY; PATTERNS; OUTCOMES; LIFE	Background Attention-Deficit/Hyperactivity Disorder (ADHD) is a common psychiatric disorder in children and adolescents. Immediate-release methylphenidate (IR-MPH) is the medical treatment of first choice. The necessity to use several IR-MPH tablets per day and associated potential social stigma at school often leads to reduced compliance, sub-optimal treatment, and therefore economic loss. Replacement of IR-MPH with a single-dose extended release (ER-MPH) formulation may improve drug response and economic efficiency. Objective To evaluate the cost-effectiveness from a societal perspective of a switch from IR-MPH to ER-MPH in patients who are sub-optimally treated. Methods A daily Markov-cycle model covering a time-span of 10 years was developed including four different health states: (1) optimal response, (2) sub-optimal response, (3) discontinued treatment, and (4) natural remission. ER-MPH options included methylphenidate osmotic release oral system (MPH-OROS) and Equasym XL/Medikinet CR. Both direct costs and indirect costs were included in the analysis, and effects were expressed as quality-adjusted life years (QALYs). Univariate, multivariate as well as probabilistic sensitivity analysis were conducted and the main outcomes were incremental cost-effectiveness ratios. Results Switching sub-optimally treated patients from IR-MPH to MPH-OROS or Equasym XL/Medikinet CR led to per-patient cost-savings of sic4200 and sic5400, respectively, over a 10-year treatment span. Sensitivity analysis with plausible variations of input parameters resulted in cost-savings in the vast majority of estimations. Conclusions This study lends economic support to switching patients with ADHD with suboptimal response to short-acting IR-MPH to long-acting ER-MPH regimens.	[van der Schans, Jurjen; Kotsopoulos, Nikos; Hak, Eelko; Postma, Maarten J.] Univ Groningen RUG, Dept Pharm, Unit PharmacoEpidemiol & PharmacoEcon PE2, Groningen, Netherlands; [Hoekstra, Pieter J.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Groningen, Netherlands; [Postma, Maarten J.] Univ Groningen, Univ Med Ctr Groningen, Inst Sci Healthy Aging & HealthcaRE, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	van der Schans, J (corresponding author), Univ Groningen RUG, Dept Pharm, Unit PharmacoEpidemiol & PharmacoEcon PE2, Groningen, Netherlands.	j.van.der.schans@rug.nl; m.j.postma@rug.nl		Postma, Maarten/0000-0002-6306-3653; KOTSOPOULOS, NIKOLAOS/0000-0002-8248-7697	Netherlands Organisation for Health Research and Development (ZonMW) [836011014]	Netherlands Organisation for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development)	All phases of this study were supported by a Netherlands Organisation for Health Research and Development (ZonMW) grant, #836011014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biederman J, 2000, AM J PSYCHIAT, V157, P816, DOI 10.1176/appi.ajp.157.5.816; Briggs A, 1998, PHARMACOECONOMICS, V13, P397, DOI 10.2165/00019053-199813040-00003; Briggs A, 2006, DECISION MODELING HL; College voor zorgverzekeringen (CVZ), 2006, GUID PHARM RES UPD V; Faber A, 2008, CNS DRUGS, V22, P157, DOI 10.2165/00023210-200822020-00006; Faber A, 2010, EUR CHILD ADOLES PSY, V19, P159, DOI 10.1007/s00787-009-0075-y; Feldman HM, 2014, NEW ENGL J MED, V370, P838, DOI 10.1056/NEJMcp1307215; Gau SSF, 2008, J CLIN PSYCHIAT, V69, P131, DOI 10.4088/JCP.v69n0118; Hak E, 2013, ANN ALLERG ASTHMA IM, V111, P102, DOI 10.1016/j.anai.2013.05.023; Hakkaart-van Roijen L, 2007, EUR CHILD ADOLES PSY, V16, P316, DOI 10.1007/s00787-007-0603-6; Jensen PS, 2007, J AM ACAD CHILD PSY, V46, P989, DOI 10.1097/chi.0b013e3180686d48; Jensen PS, 2005, AM J PSYCHIAT, V162, P1628, DOI 10.1176/appi.ajp.162.9.1628; Lage M, 2004, J CHILD ADOL PSYCHOP, V14, P575, DOI 10.1089/cap.2004.14.575; Le HH, 2014, EUR CHILD ADOLES PSY, V23, P587, DOI 10.1007/s00787-013-0477-8; Lloyd A, 2011, PATIENT, V4, P247, DOI 10.2165/11592150-000000000-00000; Maldonado R, 2013, EXPERT OPIN DRUG MET, V9, P1001, DOI 10.1517/17425255.2013.786041; Marcus SC, 2005, ARCH PEDIAT ADOL MED, V159, P572, DOI 10.1001/archpedi.159.6.572; McCarthy S, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-78; Monster TBM, 2002, PHARMACOEPIDEM DR S, V11, P379, DOI 10.1002/pds.722; National Institute for Health and Care Excellence, 2008, DIAGN MAN ADHD CHILD; National institute for health and clinical excellence (NICE), 2006, TECHN APPR 98 METH A; Polanczyk G, 2007, CURR OPIN PSYCHIATR, V20, P386, DOI 10.1097/YCO.0b013e3281568d7a; Rothenberger Aribert, 2011, Eur Child Adolesc Psychiatry, V20 Suppl 2, pS235, DOI 10.1007/s00787-011-0201-5; Rothenberger Aribert, 2011, Eur Child Adolesc Psychiatry, V20 Suppl 2, pS257, DOI 10.1007/s00787-011-0203-3; Secnik K, 2005, MED DECIS MAKING, V25, P56, DOI 10.1177/0272989X04273140; Statistics Netherlands (CBS), 2014, POP KEY FIG; Steele M, 2006, CAN J CLIN PHARM, V13, P50; Swanson J, 2008, J ATTEN DISORD, V12, P4, DOI 10.1177/1087054708319345; The Health Care Insurance Board (CVZ), 2013, PHARM LIST PRIC; Trip AM, 2009, BRIT J CLIN PHARMACO, V67, P466, DOI 10.1111/j.1365-2125.2009.03373.x; Willcutt E, 2012, NEUROTHERAPEUTICS, V9, P490, DOI 10.1007/s13311-012-0135-8; Wong ICK, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13490	32	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0127237	10.1371/journal.pone.0127237	http://dx.doi.org/10.1371/journal.pone.0127237			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ2MQ	26024479	Green Published, gold, Green Submitted			2022-12-26	WOS:000355319400032
J	Gudenkauf, BM; Hewson, I				Gudenkauf, Brent M.; Hewson, Ian			Metatranscriptomic Analysis of Pycnopodia helianthoides (Asteroidea) Affected by Sea Star Wasting Disease	PLOS ONE			English	Article							OF-THORNS STARFISH; DIADEMA-ANTILLARUM; MASS MORTALITY	Sea star wasting disease (SSWD) describes a suite of symptoms reported in asteroids of the North American Pacific Coast. We performed a metatranscriptomic survey of asymptomatic and symptomatic sunflower star (Pycnopodia helianthoides) body wall tissues to understand holobiont gene expression in tissues affected by SSWD. Metatranscriptomes were highly variable between replicate libraries, and most differentially expressed genes represented either transcripts of associated microorganisms (particularly Pseudomonasand Vibriorelatives) or low-level echinoderm transcripts of unknown function. However, the pattern of annotated host functional genes reflects enhanced apoptotic and tissue degradation processes and decreased energy metabolism, while signalling of death-related proteins was greater in asymptomatic and symptomatic tissues. Our results suggest that the body wall tissues of SSWD-affected asteroids may undergo structural changes during disease progression, and that they are stimulated to undergo autocatalytic cell death processes.	[Gudenkauf, Brent M.; Hewson, Ian] Cornell Univ, Dept Microbiol, Ithaca, NY 14850 USA	Cornell University	Hewson, I (corresponding author), Cornell Univ, Dept Microbiol, Ithaca, NY 14850 USA.	hewson@cornell.edu			Rapid Response grants [OCE-1401727]; David R. Atkinson Center for Sustainable Futures	Rapid Response grants; David R. Atkinson Center for Sustainable Futures	This work was supported by Rapid Response grants OCE-1401727 ( to IH and B. Miner) and from the David R. Atkinson Center for Sustainable Futures.	Allikian MJ, 2004, J CELL SCI, V117, P3821, DOI 10.1242/jcs.01234; Bates AE, 2009, DIS AQUAT ORGAN, V86, P245, DOI 10.3354/dao02125; DUNGAN ML, 1982, SCIENCE, V216, P989, DOI 10.1126/science.216.4549.989; Eckert G, 1999, SEA STAR DIS POPULAT, P435; Ferguson JC, 1996, BIOL BULL, V191, P431, DOI 10.2307/1543016; Gudenkauf BM, 2014, J GEN VIROL, V95, P652, DOI 10.1099/vir.0.060780-0; Hewson I, 2014, P NATL ACAD SCI USA, V111, P17278, DOI 10.1073/pnas.1416625111; Lessios HA, 2005, CORAL REEFS, V24, P125, DOI 10.1007/s00338-004-0443-5; LESSIOS HA, 1984, CORAL REEFS, V3, P173, DOI 10.1007/BF00288252; LESSIOS HA, 1995, P ROY SOC B-BIOL SCI, V259, P331, DOI 10.1098/rspb.1995.0049; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; Pincebourde S, 2013, J EXP BIOL, V216, P2183, DOI 10.1242/jeb.083881; Poretsky RS, 2009, ENVIRON MICROBIOL, V11, P1358, DOI 10.1111/j.1462-2920.2008.01863.x; Pratchett MS, 1999, CORAL REEFS, V18, P272, DOI 10.1007/s003380050192; Scheibling RE, 1997, MAR ECOL PROG SER, V125, P167; ZANN L, 1990, CORAL REEFS, V9, P135, DOI 10.1007/BF00258225	16	17	17	1	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128150	10.1371/journal.pone.0128150	http://dx.doi.org/10.1371/journal.pone.0128150			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020776	gold, Green Published			2022-12-26	WOS:000355187300085
J	Guo, Y; Huang, JY; Shi, Z; Li, HY				Guo, Yan; Huang, Jingyi; Shi, Zhou; Li, Hongyi			Mapping Spatial Variability of Soil Salinity in a Coastal Paddy Field Based on Electromagnetic Sensors	PLOS ONE			English	Article							MULTIPLE LINEAR-REGRESSION; ELECTRICAL-CONDUCTIVITY; INDUCTION TECHNIQUES; INVERSION; PROFILES; PREDICTION; MODELS	In coastal China, there is an urgent need to increase land area for agricultural production and urban development, where there is a rapid growing population. One solution is land reclamation from coastal tidelands, but soil salinization is problematic. As such, it is very important to characterize and map the within-field variability of soil salinity in space and time. Conventional methods are often time-consuming, expensive, labor-intensive, and unpractical. Fortunately, proximal sensing has become an important technology in characterizing within-field spatial variability. In this study, we employed the EM38 to study spatial variability of soil salinity in a coastal paddy field. Significant correlation relationship between ECa and EC1:5 (i.e. r >0.9) allowed us to use EM38 data to characterize the spatial variability of soil salinity. Geostatistical methods were used to determine the horizontal spatio-temporal variability of soil salinity over three consecutive years. The study found that the distribution of salinity was heterogeneous and the leaching of salts was more significant in the edges of the study field. By inverting the EM38 data using a Quasi-3D inversion algorithm, the vertical spatio-temporal variability of soil salinity was determined and the leaching of salts over time was easily identified. The methodology of this study can be used as guidance for researchers interested in understanding soil salinity development as well as land managers aiming for effective soil salinity monitoring and management practices. In order to better characterize the variations in soil salinity to a deeper soil profile, the deeper mode of EM38 (i.e., EM38v) as well as other EMI instruments (e.g. DUALEM-421) can be incorporated to conduct Quasi-3D inversions for deeper soil profiles.	[Guo, Yan; Shi, Zhou] Zhejiang Univ, Coll Environm & Resource Sci, Inst Agr Remote Sensing & Informat Technol Applic, Hangzhou 310003, Zhejiang, Peoples R China; [Guo, Yan] Henan Acad Agr Sci, Inst Agr Econ & Informat, Zhengzhou, Peoples R China; [Huang, Jingyi] Univ New S Wales, Sch Biol Earth & Environm Sci, Kensington, NSW 2052, Australia; [Li, Hongyi] Jiangxi Univ Finance & Econ, Sch Tourism & Urban Management, Nanchang, Peoples R China	Zhejiang University; Henan Academy of Agricultural Sciences; University of New South Wales Sydney; Jiangxi University of Finance & Economics	Shi, Z (corresponding author), Zhejiang Univ, Coll Environm & Resource Sci, Inst Agr Remote Sensing & Informat Technol Applic, Hangzhou 310003, Zhejiang, Peoples R China.	shizhou@zju.edu.cn	LI, H.Y./B-3427-2014; Huang, Jingyi/ABI-5860-2020; Guo, Yan/GOE-6973-2022; Huang, Jingyi/B-5541-2015; shi, Zhou/M-7845-2019; shi, Zhou/A-2283-2015	Huang, Jingyi/0000-0002-1209-9699; Huang, Jingyi/0000-0002-1209-9699; shi, Zhou/0000-0003-3914-5402; shi, Zhou/0000-0003-3914-5402	National Natural Science Foundation of China [41271234, 41101197]; National High-tech R&D Program of China [2013AA102301]; Key National Projects of High-Resolution Earth Observing System [09-Y30B03-9001-13/15]; Independent Innovative Project of Henan Academy of Agricultural Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-tech R&D Program of China(National High Technology Research and Development Program of China); Key National Projects of High-Resolution Earth Observing System; Independent Innovative Project of Henan Academy of Agricultural Sciences	This research was supported by National Natural Science Foundation of China (No. 41271234; No. 41101197), the National High-tech R&D Program of China (No. 2013AA102301), the Key National Projects of High-Resolution Earth Observing System (09-Y30B03-9001-13/15) and by the Independent Innovative Project of Henan Academy of Agricultural Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akramkhanov A, 2011, GEODERMA, V163, P55, DOI 10.1016/j.geoderma.2011.04.001; Blackmore S, 2000, COMPUT ELECTRON AGR, V26, P37, DOI 10.1016/S0168-1699(99)00075-7; COOK PG, 1992, SOIL SCI SOC AM J, V56, P1015, DOI 10.2136/sssaj1992.03615995005600040003x; Corwin DL, 2008, BOOKS SOIL PLANT ENV, P17; Corwin DL, 2005, COMPUT ELECTRON AGR, V46, P135, DOI 10.1016/j.compag.2004.11.003; Corwin DL, 2003, AGRON J, V95, P352, DOI 10.2134/agronj2003.0455; CORWIN DL, 1984, SOIL SCI SOC AM J, V48, P288, DOI 10.2136/sssaj1984.03615995004800020011x; CORWIN DL, 1982, SOIL SCI SOC AM J, V46, P517, DOI 10.2136/sssaj1982.03615995004600030014x; DEGROOTHEDLIN C, 1990, GEOPHYSICS, V55, P1613, DOI 10.1190/1.1442813; Doolittle JA, 2014, GEODERMA, V223, P33, DOI [10.1016/j.geoderma2014.01.027, 10.1016/j.geoderma.2014.01.027]; GALLICHAND J, 1992, CAN J SOIL SCI, V72, P503, DOI 10.4141/cjss92-042; Hendrickx JMH, 2002, SOIL SCI SOC AM J, V66, P673, DOI 10.2136/sssaj2002.0673; Huang J, 2014, SOIL USE MANAGE, V30, P241, DOI 10.1111/sum.12106; Huang MX, 2008, J COASTAL RES, V24, P170, DOI 10.2112/06-0651.1; LESCH SM, 1995, WATER RESOUR RES, V31, P373, DOI 10.1029/94WR02179; LESCH SM, 1995, WATER RESOUR RES, V31, P387, DOI 10.1029/94WR02180; Li HY, 2015, GEODERMA, V237, P71, DOI 10.1016/j.geoderma.2014.08.008; Li HY, 2013, GEODERMA, V195, P31, DOI 10.1016/j.geoderma.2012.11.005; Li J, 2011, ECOL INFORM, V6, P228, DOI 10.1016/j.ecoinf.2010.12.003; MCNEILL JD, 1980, TN6 GEON LTD, P15; Mester A, 2011, VADOSE ZONE J, V10, P1319, DOI 10.2136/vzj2011.0035; Santos FAM, 2010, J ENVIRON ENG GEOPH, V15, P163, DOI 10.2113/JEEG15.3.163; Santos FAM, 2011, GEOPHYSICS, V76, pB43, DOI 10.1190/1.3537834; Padhi J, 2011, SOIL TILL RES, V117, P93, DOI 10.1016/j.still.2011.09.003; Robinson DA, 2004, SOIL SCI SOC AM J, V68, P339, DOI 10.2136/sssaj2004.3390; SASAKI Y, 1989, GEOPHYSICS, V54, P254, DOI 10.1190/1.1442649; SHEETS KR, 1995, WATER RESOUR RES, V31, P2401, DOI 10.1029/95WR01949; Shi Z, 2005, ENVIRON GEOL, V48, P967, DOI [10.1007/s00254-005-0035-x, 10.1007/s00254-005-1285-3]; Shi Z, 2002, SOIL USE MANAGE, V18, P353, DOI 10.1079/SUM2002144; Shiraz FA, 2013, EXPLOR GEOPHYS, V44, P16, DOI 10.1071/EG12006; Triantafilis J, 2013, VADOSE ZONE J, V12, DOI 10.2136/vzj2012.0086; Triantafilis J, 2000, SOIL SCI SOC AM J, V64, P1009, DOI 10.2136/sssaj2000.6431009x; Viganotti M, 2013, J APPL GEOPHYS, V92, P110, DOI 10.1016/j.jappgeo.2013.03.001; WEBSTER R, 1992, J SOIL SCI, V43, P177, DOI 10.1111/j.1365-2389.1992.tb00128.x; Webster R., 2007, STAT PRACTICE; Yao RJ, 2010, AGR WATER MANAGE, V97, P1961, DOI 10.1016/j.agwat.2010.02.001; Yu TongHai, 1996, Journal of Zhejiang Agricultural University, V22, P201	37	28	29	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0127996	10.1371/journal.pone.0127996	http://dx.doi.org/10.1371/journal.pone.0127996			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020969	gold, Green Submitted, Green Published			2022-12-26	WOS:000355187300069
J	Luna-Ramirez, K; Quintero-Hernandez, V; Juarez-Gonzalez, VR; Possani, LD				Luna-Ramirez, Karen; Quintero-Hernandez, Veronica; Juarez-Gonzalez, Victor Rivelino; Possani, Lourival D.			Whole Transcriptome of the Venom Gland from Urodacus yaschenkoi Scorpion	PLOS ONE			English	Article							AMINO-ACID-SEQUENCE; MASS-SPECTROMETRY ANALYSIS; PROTEOMIC ANALYSIS; ANTIMICROBIAL PEPTIDES; MOLECULAR DIVERSITY; FUNCTIONAL-CHARACTERIZATION; DISULFIDE BRIDGES; TITYUS-STIGMURUS; TOXIC FRACTIONS; CDNA SEQUENCES	Australian scorpion venoms have been poorly studied, probably because they do not pose an evident threat to humans. In addition, the continent has other medically important venomous animals capable of causing serious health problems. Urodacus yaschenkoi belongs to the most widely distributed family of Australian scorpions (Urodacidae) and it is found all over the continent, making it a useful model system for studying venom composition and evolution. This communication reports the whole set of mRNA transcripts produced by the venom gland. U. yaschenkoi venom is as complex as its overseas counterparts. These transcripts certainly code for several components similar to known scorpion venom components, such as: alpha-KTxs, beta-KTxs, calcins, protease inhibitors, antimicrobial peptides, sodium-channel toxins, toxin-like peptides, allergens, La1-like, hyaluronidases, ribosomal proteins, proteasome components and proteins related to cellular processes. A comparison with the venom gland transcriptome of Centruroides noxius (Buthidae) showed that these two scorpions have similar components related to biological processes, although important differences occur among the venom toxins. In contrast, a comparison with sequences reported for Urodacus manicatus revealed that these two Urodacidae species possess the same subfamily of scorpion toxins. A comparison with sequences of an U. yaschenkoi cDNA library previously reported by our group showed that both techniques are reliable for the description of the venom components, but the whole transcriptome generated with Next Generation Sequencing platform provides sequences of all transcripts expressed. Several of which were identified in the proteome, but many more transcripts were identified including uncommon transcripts. The information reported here constitutes a reference for non-Buthidae scorpion venoms, providing a comprehensive view of genes that are involved in venom production. Further, this work identifies new putative bioactive compounds that could be used to seed research into new pharmacological compounds and increase our understanding of the function of different ion channels.	[Luna-Ramirez, Karen] Univ Melbourne, Dept Pharmacol & Therapeut, Australian Venom Res Unit, Melbourne, Vic 3010, Australia; [Quintero-Hernandez, Veronica; Juarez-Gonzalez, Victor Rivelino; Possani, Lourival D.] Univ Nacl Autonoma Mexico, Inst Biotechnol, Dept Med Mol & Bioproc, Cuernavaca 62191, Morelos, Mexico	University of Melbourne; Universidad Nacional Autonoma de Mexico	Luna-Ramirez, K (corresponding author), Univ Melbourne, Dept Pharmacol & Therapeut, Australian Venom Res Unit, Melbourne, Vic 3010, Australia.	karen.luna@unimelb.edu.au; possani@ibt.unam.mx		Quintero-Hernandez, Veronica/0000-0002-1856-8134; Luna-Ramirez, Karen/0000-0002-1485-2576	Struan Sutherland Fund; Direccion General de Asuntos del Personal Academico (DGAPA-UNAM) [IN200113]; Consejo Nacional de Ciencia y Tecnologia (CONACyT)	Struan Sutherland Fund; Direccion General de Asuntos del Personal Academico (DGAPA-UNAM)(Universidad Nacional Autonoma de Mexico); Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by the Struan Sutherland Fund awarded to the Australian Venom Research Unit (KLR). Partial support came from the grant IN200113 of Direccion General de Asuntos del Personal Academico (DGAPA-UNAM) and Consejo Nacional de Ciencia y Tecnologia (CONACyT) given to LDP.	Abdel-Rahman MA, 2013, TOXICON, V74, P193, DOI 10.1016/j.toxicon.2013.08.064; ADAMS ME, 1993, MOL PHARMACOL, V44, P681; Almaaytah A, 2014, PEPTIDES, V51, P35, DOI 10.1016/j.peptides.2013.10.021; Almaaytah A, 2012, PEPTIDES, V35, P291, DOI 10.1016/j.peptides.2012.03.016; Almeida DD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-362; Alvarenga E.R., 2012, OJGEN, V02, P210, DOI [10.4236/ojgen.2012.24027, DOI 10.4236/OJGEN.2012.24027]; Andreotti N, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 5: AMINO ACIDS, PEPTIDES AND PROTEINS, P287; Angeloni F, 2011, MOL ECOL RESOUR, V11, P662, DOI 10.1111/j.1755-0998.2011.02990.x; Baek JH, 2013, J ASIA-PAC ENTOMOL, V16, P497, DOI 10.1016/j.aspen.2013.08.003; Barona J, 2006, BBA-PROTEINS PROTEOM, V1764, P76, DOI 10.1016/j.bbapap.2005.08.010; Batista CVF, 2007, COMP BIOCHEM PHYS C, V146, P147, DOI 10.1016/j.cbpc.2006.12.004; Batista CVF, 2006, PROTEOMICS, V6, P3718, DOI 10.1002/pmic.200500525; Batista CVF, 2004, J CHROMATOGR B, V803, P55, DOI 10.1016/j.jchromb.2003.09.002; Bouzid W, 2013, TOXICON, V70, P70, DOI 10.1016/j.toxicon.2013.03.010; Bringans S, 2008, PROTEOMICS, V8, P1081, DOI 10.1002/pmic.200700948; Cahais V, 2012, MOL ECOLOGY RESOURCE; Caliskan F, 2012, TOXICON, V59, P408, DOI 10.1016/j.toxicon.2011.12.013; Caliskan F, 2006, TOXICON, V48, P12, DOI 10.1016/j.toxicon.2006.04.003; Cao ZJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3602; Cao ZJ, 2003, PEPTIDES, V24, P187, DOI 10.1016/S0196-9781(03)00025-1; Carballar-Lejarazu R, 2008, CELL MOL LIFE SCI, V65, P3081, DOI 10.1007/s00018-008-8250-8; CATTERALL WA, 1980, ANNU REV PHARMACOL, V20, P15, DOI 10.1146/annurev.pa.20.040180.000311; Chen YP, 2012, PLOS ONE, V7; Chen Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082288; Chen ZY, 2012, J BIOL CHEM, V287, P13813, DOI 10.1074/jbc.M112.343996; Chen ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057529; Cheng YC, 2005, BBA-PROTEINS PROTEOM, V1747, P213, DOI 10.1016/j.bbapap.2004.11.006; Conde R, 2000, FEBS LETT, V471, P165, DOI 10.1016/S0014-5793(00)01384-3; Conde R, 1999, FEBS LETT, V460, P447, DOI 10.1016/S0014-5793(99)01392-7; Corzo G, 2001, BIOCHEM J, V359, P35, DOI 10.1042/0264-6021:3590035; Costa V, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/853916; D'Suze G, 2009, BIOCHIMIE, V91, P1010, DOI 10.1016/j.biochi.2009.05.005; de la Vega R.C.R., 2013, HDB BIOL ACT PEPT, P423, DOI [10.1016/B978-0-12-385095-9.00059-2, DOI 10.1016/B978-0-12-385095-9.00059-2]; de la Vega RCR, 2005, TOXICON, V46, P831, DOI 10.1016/j.toxicon.2005.09.006; de la Vega RCR, 2004, TOXICON, V43, P865, DOI 10.1016/j.toxicon.2004.03.022; Diego-Garcia E, 2008, CELL MOL LIFE SCI, V65, P187, DOI 10.1007/s00018-007-7370-x; Diego-Garcia E, 2005, TOXICON, V45, P273, DOI 10.1016/j.toxicon.2004.10.014; Diego-Garcia E, 2007, PEPTIDES, V28, P31, DOI 10.1016/j.peptides.2006.06.012; Diego-Garcia E, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-295; Diego-Garcia E, 2012, PROTEOMICS, V12, P313, DOI 10.1002/pmic.201100409; Durban J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-259; Fet V, 2000, CATALOG SCORPIONS WO; Gordon D, 1998, J TOXICOL-TOXIN REV, V17, P131, DOI 10.3109/15569549809009247; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Harrison PL, 2014, TOXICON, V88, P115, DOI 10.1016/j.toxicon.2014.06.006; He YW, 2013, J PROTEOMICS, V89, P1, DOI 10.1016/j.jprot.2013.06.007; Heavner ME, 2013, GENE, V526, P195, DOI 10.1016/j.gene.2013.04.080; Inceoglu B, 2003, P NATL ACAD SCI USA, V100, P922, DOI 10.1073/pnas.242735499; Jeyaprakash A, 2009, EXP APPL ACAROL, V47, P1, DOI 10.1007/s10493-008-9203-5; KING TP, 1978, BIOCHEMISTRY-US, V17, P5165, DOI 10.1021/bi00617a016; Koch L.E., 1977, Records W Aust Mus, V5, P83; Kozminsky-Atias A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-333; Lee K, 2004, BIOCHEM BIOPH RES CO, V323, P712, DOI 10.1016/j.bbrc.2004.08.144; Li CZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047442; Liu ZC, 2012, J PROTEOME RES, V11, P6197, DOI 10.1021/pr300881d; Lu J, 2008, PEPTIDES, V29, P369, DOI 10.1016/j.peptides.2007.11.013; Lulin H., 2012, PLOS ONE, V7; Luna-Ramirez K, 2014, BIOCHIM BIOPHYS ACTA, V9, P4; Luna-Ramirez K, 2014, MOL PHARMACOL, V86, P28, DOI 10.1124/mol.113.090183; Luna-Ramirez K, 2013, TOXICON, V63, P44, DOI 10.1016/j.toxicon.2012.11.017; Ma YB, 2012, J PROTEOMICS, V75, P1563, DOI 10.1016/j.jprot.2011.11.029; Ma YB, 2010, PROTEOMICS, V10, P2471, DOI 10.1002/pmic.200900763; Ma YB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-290; Matsushita N, 2007, TOXICON, V50, P861, DOI 10.1016/j.toxicon.2007.06.014; Mille BG, 2014, TOXICON, V83, P75, DOI 10.1016/j.toxicon.2014.03.001; Minagawa S, 1997, COMP BIOCHEM PHYS B, V118, P381, DOI 10.1016/S0305-0491(97)00174-0; Morgenstern D, 2011, TOXICON, V57, P695, DOI 10.1016/j.toxicon.2011.02.001; NARASIMHAN L, 1994, NAT STRUCT BIOL, V1, P850, DOI 10.1038/nsb1294-850; Nascimento DG, 2006, TOXICON, V47, P628, DOI 10.1016/j.toxicon.2006.01.015; Newton KA, 2007, RAPID COMMUN MASS SP, V21, P3467, DOI 10.1002/rcm.3240; Ortiz E, 2014, BIOCHIM BIOPHYS ACTA, V6, P19; Oukkache N, 2008, TOXICON, V51, P835, DOI 10.1016/j.toxicon.2007.12.012; PALLAGHY PK, 1994, PROTEIN SCI, V3, P1833, DOI 10.1002/pro.5560031022; Pimenta AMC, 2001, RAPID COMMUN MASS SP, V15, P1562, DOI 10.1002/rcm.415; Possani LD, 1999, EUR J BIOCHEM, V264, P287, DOI 10.1046/j.1432-1327.1999.00625.x; Prendini L, 2005, CLADISTICS, V21, P446, DOI 10.1111/j.1096-0031.2005.00073.x; Quintero-Hernandez V, 2013, TOXICON, V76, P328, DOI 10.1016/j.toxicon.2013.07.012; Rendon-Anaya M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043331; ROCHAT C, 1967, BIOCHEMISTRY-US, V6, P578, DOI 10.1021/bi00854a028; ROCHAT H, 1970, EUR J BIOCHEM, V17, P262, DOI 10.1111/j.1432-1033.1970.tb01162.x; ROCHAT H, 1970, FEBS LETT, V10, P349, DOI 10.1016/0014-5793(70)80470-7; de la Vega RCR, 2010, TOXICON, V56, P1155, DOI 10.1016/j.toxicon.2009.11.010; Roeding F, 2009, MOL PHYLOGENET EVOL, V53, P826, DOI 10.1016/j.ympev.2009.08.014; Schwartz EF, 2008, TOXICON, V51, P1499, DOI 10.1016/j.toxicon.2008.03.029; Schwartz EF, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-119; Silva ECN, 2009, TOXICON, V54, P252, DOI 10.1016/j.toxicon.2009.04.010; Smith JJ, 2013, P NATL ACAD SCI USA, V110, P8906, DOI 10.1073/pnas.1214062110; Smith Jennifer J, 2012, J Venom Res, V3, P7; Smith JJ, 2011, P NATL ACAD SCI USA, V108, P10478, DOI 10.1073/pnas.1103501108; Sunagar K, 2013, TOXINS, V5, P2456, DOI 10.3390/toxins5122456; Terrat Y, 2012, TOXICON, V59, P34, DOI 10.1016/j.toxicon.2011.10.001; Torres-Larios A, 2000, EUR J BIOCHEM, V267, P5023, DOI 10.1046/j.1432-1327.2000.01556.x; Tytgat J, 1999, TRENDS PHARMACOL SCI, V20, P444, DOI 10.1016/S0165-6147(99)01398-X; Valdez-Velazquez LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066486; VALDIVIA HH, 1992, P NATL ACAD SCI USA, V89, P12185, DOI 10.1073/pnas.89.24.12185; Wu WL, 2007, PEPTIDES, V28, P2306, DOI 10.1016/j.peptides.2007.10.009; Xu XB, 2014, J PROTEOMICS, V106, P162, DOI 10.1016/j.jprot.2014.04.032; Zeng XC, 2013, PEPTIDES, V45, P28, DOI 10.1016/j.peptides.2013.03.026; Zhao RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027548; Zhao RM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-452; Zhao ZH, 2012, J BIOL CHEM, V287, P30181, DOI 10.1074/jbc.M112.370312; Zhu S, 2004, CELL MOL LIFE SCI, V61, P1751, DOI 10.1007/s00018-004-4149-1; Zhu SY, 2010, BBA-PROTEINS PROTEOM, V1804, P872, DOI 10.1016/j.bbapap.2009.12.017	103	51	52	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0127883	10.1371/journal.pone.0127883	http://dx.doi.org/10.1371/journal.pone.0127883			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020943	Green Submitted, Green Published, gold			2022-12-26	WOS:000355187300062
J	Park, L				Park, Leeyoung			Ancestral Alleles in the Human Genome Based on Population Sequencing Data	PLOS ONE			English	Article							BIASED GENE CONVERSION; GC-CONTENT; SUBSTITUTION RATES; MUTATION-RATES; EVOLUTION; DELETIONS; INSERTIONS; NUCLEOTIDE	Ancestral allele information is useful for genetics studies. Previously, the identification of ancestral alleles was primarily based on sequence alignments between species. Alternative ways to identify ancestral alleles were proposed in this study based on population sequencing data. The methods described here utilized the diversity between haplotypes harboring ancestral and newly emerged alleles. Simulations showed that these methods were reliable for identifying ancestral alleles when the variants had not aged too greatly. Application to the human genome sequencing data suggested the role of indels in maintaining the GC content in the human genome. The deletion-to-insertion ratios and GC proportions were correlated depending on the sizes of insertions and deletions in the direction of increasing GC content. There were GC-biased fixations in single base-pair insertions and AT-biased fixations in single base-pair deletions in the results based on the proposed methods. In the current study, GC-biased gene conversions in nucleotide substitutions were very slight or insignificant. In the variants of several quantitative trait loci (QTLs), slight GC-biased gene conversion was observed in nucleotide substitutions. For the QTL indels, insertions were observed more often than deletions, and deletion-biased fixation was observed, providing new insights into the evolution of functional genes.	Yonsei Univ, Nat Sci Res Inst, Seoul 120749, South Korea	Yonsei University	Park, L (corresponding author), Yonsei Univ, Nat Sci Res Inst, Seoul 120749, South Korea.	lypark@yonsei.ac.kr			National Research Foundation of Korea (NRF) - Korean Government (MSIP) [353-2009-2-C00061, 2013R1A1A3006685]; Korea Institute of Science and Technology Information (KISTI) [KSC-2011-C2-47]	National Research Foundation of Korea (NRF) - Korean Government (MSIP); Korea Institute of Science and Technology Information (KISTI)(Korea Institute of Science & Technology Information (KISTI))	This work was supported by the National Research Foundation of Korea (NRF) grants funded by the Korean Government (MSIP) (353-2009-2-C00061 and 2013R1A1A3006685). The key calculations were performed using the supercomputing resource at the Korea Institute of Science and Technology Information (KISTI), which provided support through grant no. KSC-2011-C2-47. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Arndt PF, 2005, J MOL EVOL, V60, P748, DOI 10.1007/s00239-004-0222-5; Berglund J, 2009, PLOS BIOL, V7, P45, DOI 10.1371/journal.pbio.1000026; Chen FC, 2007, GENOME RES, V17, P16, DOI 10.1101/gr.5429606; Chong ZC, 2013, MOL BIOL EVOL, V30, P2699, DOI 10.1093/molbev/mst167; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Delaneau O, 2013, AM J HUM GENET, V93, P687, DOI 10.1016/j.ajhg.2013.09.002; Duret L, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000071; Eyre-Walker A, 2001, NAT REV GENET, V2, P549, DOI 10.1038/35080577; Fry AE, 2006, AM J HUM GENET, V78, P1053, DOI 10.1086/504160; Galtier N, 2001, GENETICS, V159, P907; Gregory TR, 2004, GENE, V324, P15, DOI 10.1016/j.gene.2003.09.030; Hernandez RD, 2007, MOL BIOL EVOL, V24, P2196, DOI 10.1093/molbev/msm149; Karro JE, 2008, MOL BIOL EVOL, V25, P362, DOI 10.1093/molbev/msm261; Kimura M., 1971, THEORETICAL ASPECTS; Kuo CH, 2009, GENOME BIOL EVOL, V1, P145, DOI 10.1093/gbe/evp016; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Laurie S, 2012, GENOME RES, V22, P478, DOI 10.1101/gr.121897.111; Leushkin EV, 2013, GENOME BIOL EVOL, V5, P514, DOI 10.1093/gbe/evt021; Lin MW, 2010, EUR J HUM GENET, V18, P26, DOI 10.1038/ejhg.2009.135; Loytynoja A, 2008, SCIENCE, V320, P1632, DOI 10.1126/science.1158395; Lynch M, 2007, THE ORIGINS OF GENOM; Martinez-Cadenas C, 2013, MOL BIOL EVOL, V30, P2654, DOI 10.1093/molbev/mst158; Maruta Y, 2008, CANCER GENET CYTOGEN, V180, P24, DOI 10.1016/j.cancergencyto.2007.09.011; Montgomery SB, 2013, GENOME RES, V23, P749, DOI 10.1101/gr.148718.112; Murray J., 1910, REPORTS SCI EXPEDITI, P17; Nei M., 2000, Molecular evolution and phylogenetics.; Park L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046603; Park L, 2009, GENET RES, V91, P293, DOI 10.1017/S0016672309990164; Paten B, 2008, GENOME RES, V18, P1829, DOI 10.1101/gr.076521.108; Paten B, 2008, GENOME RES, V18, P1814, DOI 10.1101/gr.076554.108; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Tyekucheva S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r76; Wang SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026949; WEIR BS, 1980, GENETICS, V95, P477; Weller AM, 2014, GENETICS, V196, P1145, DOI 10.1534/genetics.113.159863; Wright S, 1931, GENETICS, V16, P0097	39	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128186	10.1371/journal.pone.0128186	http://dx.doi.org/10.1371/journal.pone.0128186			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020928	Green Submitted, gold, Green Published			2022-12-26	WOS:000355187300086
J	Prabu, P; Rome, S; Sathishkumar, C; Aravind, S; Mahalingam, B; Shanthirani, CS; Gastebois, C; Villard, A; Mohan, V; Balasubramanyam, M				Prabu, Paramasivam; Rome, Sophie; Sathishkumar, Chandrakumar; Aravind, Sankaramoorthy; Mahalingam, Balakumar; Shanthirani, Coimbatore Subramanian; Gastebois, Caroline; Villard, Audrey; Mohan, Viswanathan; Balasubramanyam, Muthuswamy			Circulating MiRNAs of 'Asian Indian Phenotype' Identified in Subjects with Impaired Glucose Tolerance and Patients with Type 2 Diabetes	PLOS ONE			English	Article							INSULIN-RESISTANCE; CELL FUNCTION; MICRORNAS; PLASMA; FAT; BRAIN; ASSOCIATIONS; PREVALENCE; MECHANISMS; BIOMARKERS	Several omics technologies are underway worldwide with an aim to unravel the pathophysiology of a complex phenotype such as type 2 diabetes mellitus (T2DM). While recent studies imply a clinically relevant and potential biomarker role of circulatory miRNAs in the etiology of T2DM, there is lack of data on this aspect in Indians-an ethnic population characterized to represent 'Asian Indian phenotype' known to be more prone to develop T2DM and cardiovascular disease than Europeans. We performed global serum miRNA profiling and the validation of candidate miRNAs by qRT-PCR in a cohort of subjects comprised of normal glucose tolerance (NGT), impaired glucose tolerance (IGT) and patients with T2DM. Our study revealed 4 differentially expressed miRNAs (miR-128, miR-130b-3p, miR-374a5p, miR-423-5p) in subjects with IGT and T2DM patients compared to control subjects. They were positively or negatively correlated to cholesterol levels, HbA1C, HOMA-IR and fasting insulin. Interestingly, circulating level of miR-128 and miR-130b-3p were also altered in serum of diet-induced diabetic mice compared to control animals. Among the altered circulating miRNAs, miR-128 had never been described in previous studies/populations and appeared to be a ` New Lead' in Indians. It was positively correlated with cholesterol both in prediabetic subjects and in diet-induced diabetic mice, suggesting that its increased level might be associated with the development of dyslipedemia associated with T2DM. Our findings imply directionality towards biomarker potential of miRNAs in the prevention/diagnosis/treatment outcomes of diabetes.	[Prabu, Paramasivam; Sathishkumar, Chandrakumar; Aravind, Sankaramoorthy; Mahalingam, Balakumar; Shanthirani, Coimbatore Subramanian; Mohan, Viswanathan; Balasubramanyam, Muthuswamy] Madras Diabet Res Fdn, Madras 600086, Tamil Nadu, India; [Prabu, Paramasivam; Sathishkumar, Chandrakumar; Aravind, Sankaramoorthy; Mahalingam, Balakumar; Shanthirani, Coimbatore Subramanian; Mohan, Viswanathan; Balasubramanyam, Muthuswamy] WHO, Collaborating Ctr Noncommunicable Dis Prevent & C, Dr Mohans Diabet Special Ctr, Madras 600086, Tamil Nadu, India; [Prabu, Paramasivam; Sathishkumar, Chandrakumar; Aravind, Sankaramoorthy; Mahalingam, Balakumar; Shanthirani, Coimbatore Subramanian; Mohan, Viswanathan; Balasubramanyam, Muthuswamy] IDF Ctr Educ, Madras 600086, Tamil Nadu, India; [Rome, Sophie; Gastebois, Caroline; Villard, Audrey] Univ Lyon, Fac Med Lyon Sud, INSA, INRA 1397,IMSERM 1060,CarMeN Lab, F-69600 Oullins, France	Madras Diabetes Research Foundation; World Health Organization; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm)	Balasubramanyam, M (corresponding author), Madras Diabet Res Fdn, Madras 600086, Tamil Nadu, India.	diasignal@gmail.com	Paramasivam, Prabu/AAT-4515-2020; Prabu, Paramasivam/V-8323-2018; Chandrakumar, Sathishkumar/AAM-3149-2020	Prabu, Paramasivam/0000-0002-8626-1601; Chandrakumar, Sathishkumar/0000-0003-2320-050X	Department of Biotechnology (DBT), Government of India; French Fondation pour la Recherche Medicale [FRM-20101220456]; French-Indian medical research cooperation program	Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India); French Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); French-Indian medical research cooperation program	Authors acknowledge the financial support from the Department of Biotechnology (DBT), Government of India. This work was also supported by grants from the French Fondation pour la Recherche Medicale (FRM-20101220456) and is supported by the French-Indian medical research cooperation program between INSERM and ICMR. The authors thank the study participants, and the clinical assistants and administrative personnel at the Madras Diabetes Research Foundation, Chennai, India.	Adlakha YK, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.46; Anjana M, 2004, DIABETES CARE, V27, P2948, DOI 10.2337/diacare.27.12.2948; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Biessels GJ, 2014, DIABETES, V63, P2244, DOI 10.2337/db14-0348; Blondal T, 2013, METHODS, V59, pS1, DOI 10.1016/j.ymeth.2012.09.015; Chen X, 2012, PROTEIN CELL, V3, P28, DOI 10.1007/s13238-012-2003-z; Eastwood SV, 2015, OBESITY, V23, P699, DOI 10.1002/oby.20997; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Granjon A, 2009, DIABETES, V58, P2555, DOI 10.2337/db09-0165; Guay C, 2012, DIABETES OBES METAB, V14, P12, DOI 10.1111/j.1463-1326.2012.01654.x; Gujral UP, 2013, ANN NY ACAD SCI, V1281, P51, DOI 10.1111/j.1749-6632.2012.06838.x; Jacovetti C, 2013, CELL CYCLE, V12, P197, DOI 10.4161/cc.23378; Karolina DS, 2012, J CLIN ENDOCR METAB, V97, pE2271, DOI 10.1210/jc.2012-1996; Karolina DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022839; Kong L, 2011, ACTA DIABETOL, V48, P61, DOI 10.1007/s00592-010-0226-0; Lin Q, 2011, NAT NEUROSCI, V14, P1115, DOI 10.1038/nn.2891; MCKEIGUE PM, 1991, LANCET, V337, P382, DOI 10.1016/0140-6736(91)91164-P; Misra A, 2004, INT J OBESITY, V28, P1217, DOI 10.1038/sj.ijo.0802704; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; MOHAN V, 1986, DIABETOLOGIA, V29, P235, DOI 10.1007/BF00454882; Mohan V, 2007, INDIAN J MED RES, V125, P217; Mohan V, 2013, DIABETES TECHNOL THE, V15, P315, DOI 10.1089/dia.2012.0259; Motohashi N, 2013, J CELL SCI, V126, P2678, DOI 10.1242/jcs.119966; Ortega FJ, 2014, DIABETES CARE, V37, P1375, DOI 10.2337/dc13-1847; Pescador N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077251; Plaisance V, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/618652; Regazzi R, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/217387; Rong Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073272; Schwartz MW, 2013, NATURE, V503, P59, DOI 10.1038/nature12709; Shantikumar S, 2012, CARDIOVASC RES, V93, P583, DOI 10.1093/cvr/cvr300; SHARP PS, 1987, HORM METAB RES, V19, P84, DOI 10.1055/s-2007-1011745; Sheinerman KS, 2013, AGING-US, V5, P925, DOI 10.18632/aging.100624; Staimez LR, 2013, DIABETES CARE, V36, P2772, DOI 10.2337/dc12-2290; Tabassum R, 2013, DIABETES, V62, P977, DOI 10.2337/db12-0406; Tan CL, 2013, SCIENCE, V342, P1254, DOI 10.1126/science.1244193; Tijsen AJ, 2010, CIRC RES, V106, P1035, DOI 10.1161/CIRCRESAHA.110.218297; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Wagner J, 2013, ARTERIOSCL THROM VAS, V33, P1392, DOI 10.1161/ATVBAHA.112.300741; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Wang YC, 2013, DIABETOLOGIA, V56, P2275, DOI 10.1007/s00125-013-2996-8; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Yajnik CS, 2002, J CLIN ENDOCR METAB, V87, P5575, DOI 10.1210/jc.2002-020434; Zampetaki A, 2010, CIRC RES, V107, P810, DOI 10.1161/CIRCRESAHA.110.226357; Zhu HM, 2015, DIABETOLOGIA, V58, P900, DOI 10.1007/s00125-015-3510-2	45	44	45	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128372	10.1371/journal.pone.0128372	http://dx.doi.org/10.1371/journal.pone.0128372			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020947	Green Published, Green Submitted, gold			2022-12-26	WOS:000355187300105
J	Shin, SK; Kim, J; Ha, SM; Oh, HS; Chun, J; Sohn, J; Yi, H				Shin, Su-Kyoung; Kim, Jinman; Ha, Sung-min; Oh, Hyun-Seok; Chun, Jongsik; Sohn, Jongryeul; Yi, Hana			Metagenomic Insights into the Bioaerosols in the Indoor and Outdoor Environments of Childcare Facilities	PLOS ONE			English	Article							CULTURE-INDEPENDENT ANALYSIS; SP NOV.; MICROBIAL COMMUNITIES; BACTERIAL COMMUNITY; AIRBORNE BACTERIAL; TEMPORAL VARIABILITY; EDIRNE CITY; FUNGI; DIVERSITY; AIR	Airborne microorganisms have significant effects on human health, and children are more vulnerable to pathogens and allergens than adults. However, little is known about the microbial communities in the air of childcare facilities. Here, we analyzed the bacterial and fungal communities in 50 air samples collected from five daycare centers and five elementary schools located in Seoul, Korea using culture-independent high-throughput pyrosequencing. The microbial communities contained a wide variety of taxa not previously identified in child daycare centers and schools. Moreover, the dominant species differed from those reported in previous studies using culture-dependent methods. The well-known fungi detected in previous culture-based studies (Alternaria, Aspergillus, Penicillium, and Cladosporium) represented less than 12% of the total sequence reads. The composition of the fungal and bacterial communities in the indoor air differed greatly with regard to the source of the microorganisms. The bacterial community in the indoor air appeared to contain diverse bacteria associated with both humans and the outside environment. In contrast, the fungal community was largely derived from the surrounding outdoor environment and not from human activity. The profile of the microorganisms in bioaerosols identified in this study provides the fundamental knowledge needed to develop public health policies regarding the monitoring and management of indoor air quality.	[Kim, Jinman; Sohn, Jongryeul; Yi, Hana] Korea Univ, Grad Sch, Dept Publ Hlth Sci, PLUS Program Embodiment Hlth Soc Interact BK21, Seoul, South Korea; [Ha, Sung-min; Oh, Hyun-Seok; Chun, Jongsik] Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea; [Ha, Sung-min; Oh, Hyun-Seok; Chun, Jongsik] Seoul Natl Univ, Interdisciplinary Program Bioinformat, Seoul, South Korea; [Yi, Hana] Korea Univ, Sch Biosyst & Biomed Sci, Seoul, South Korea	Korea University; Seoul National University (SNU); Seoul National University (SNU); Korea University	Yi, H (corresponding author), Korea Univ, Grad Sch, Dept Publ Hlth Sci, PLUS Program Embodiment Hlth Soc Interact BK21, Seoul, South Korea.	hanayi@korea.ac.kr	Chun, Jongsik/R-8458-2017	Chun, Jongsik/0000-0003-3385-5171; Ha, Sung-min/0000-0003-3945-8329	Korea Ministry of Environment [ARQ201303173002, 2013001650001]; Basic Science Research Programs through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning [NRF-2013R1A1A3010041]	Korea Ministry of Environment(Ministry of Environment (ME), Republic of Korea); Basic Science Research Programs through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning(National Research Foundation of Korea)	This work was supported by the Korea Ministry of Environment as "The Environmental Health Action Program (ARQ201303173002)" and " Converging Technology Project (2013001650001)", and by Basic Science Research Programs through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT, and Future Planning (NRF-2013R1A1A3010041).	Adams RI, 2013, MICROB ECOL, V66, P735, DOI 10.1007/s00248-013-0266-4; Adams RI, 2013, ISME J, V7, P1262, DOI 10.1038/ismej.2013.28; Adams RI, 2013, PLOS ONE, V8, P78866, DOI DOI 10.1371/journal.pone.0078866; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Amend AS, 2010, P NATL ACAD SCI USA, V107, P13748, DOI 10.1073/pnas.1000454107; Andersson AM, 1999, J APPL MICROBIOL, V86, P622, DOI 10.1046/j.1365-2672.1999.00706.x; Aydogdu H, 2005, INDOOR BUILT ENVIRON, V14, P411, DOI 10.1177/1420326X05057539; Aydogdu H, 2010, ENVIRON MONIT ASSESS, V164, P53, DOI 10.1007/s10661-009-0874-0; Bartlett KH, 2004, J OCCUP ENVIRON HYG, V1, P639, DOI 10.1080/15459620490497744; Bauer H, 2002, ATMOS RES, V64, P109, DOI 10.1016/S0169-8095(02)00084-4; Bertolini V, 2013, APPL MICROBIOL BIOT, V97, P6561, DOI 10.1007/s00253-012-4450-0; Bowers RM, 2011, APPL ENVIRON MICROB, V77, P6350, DOI 10.1128/AEM.05498-11; Bridge P, 2001, PLANT SOIL, V232, P147, DOI 10.1023/A:1010346305799; Brodie EL, 2007, P NATL ACAD SCI USA, V104, P299, DOI 10.1073/pnas.0608255104; Burrows SM, 2009, ATMOS CHEM PHYS, V9, P9263, DOI 10.5194/acp-9-9263-2009; Chao A, 2002, BIOMETRICS, V58, P531, DOI 10.1111/j.0006-341X.2002.00531.x; Chen NT, 2012, J ENVIRON MONITOR, V14, P2692, DOI 10.1039/c2em30113j; Cho BC, 2011, FEMS MICROBIOL ECOL, V76, P327, DOI 10.1111/j.1574-6941.2011.01053.x; Chun J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-101; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Crameri R, 2014, ALLERGY, V69, P176, DOI 10.1111/all.12325; Denning DW, 2006, EUR RESPIR J, V27, P615, DOI 10.1183/09031936.06.00074705; Despres VR, 2012, TELLUS B, V64, DOI 10.3402/tellusb.v64i0.15598; Dziewit L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-124; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Elbert W, 2007, ATMOS CHEM PHYS, V7, P4569, DOI 10.5194/acp-7-4569-2007; Faergemann J, 2002, CLIN MICROBIOL REV, V15, P545, DOI 10.1128/CMR.15.4.545-563.2002; Fahlgren C, 2010, APPL ENVIRON MICROB, V76, P3015, DOI 10.1128/AEM.02092-09; Fang ZG, 2007, MICROB ECOL, V54, P487, DOI 10.1007/s00248-007-9216-3; Fierer N, 2008, APPL ENVIRON MICROB, V74, P200, DOI 10.1128/AEM.01467-07; Flores GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028132; Frohlich-Nowoisky J, 2012, BIOGEOSCIENCES, V9, P1125, DOI 10.5194/bg-9-1125-2012; Frohlich-Nowoisky J, 2009, P NATL ACAD SCI USA, V106, P12814, DOI 10.1073/pnas.0811003106; Gaitanis G, 2012, CLIN MICROBIOL REV, V25, P106, DOI 10.1128/CMR.00021-11; Gandolfi I, 2013, APPL MICROBIOL BIOT, V97, P4727, DOI 10.1007/s00253-013-4901-2; Gauzere C, 2014, INDOOR AIR, V24, P29, DOI 10.1111/ina.12053; Gupta AK, 2004, J AM ACAD DERMATOL, V51, P785, DOI 10.1016/j.jaad.2003.12.034; Hewitt KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054703; HIGGINS DG, 1989, COMPUT APPL BIOSCI, V5, P151; Hill TCJ, 2003, FEMS MICROBIOL ECOL, V43, P1, DOI 10.1111/j.1574-6941.2003.tb01040.x; Hospodsky D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034867; Huffnagle GB, 2013, TRENDS MICROBIOL, V21, P334, DOI 10.1016/j.tim.2013.04.002; Hugenholtz P, 1998, J BACTERIOL, V180, P4765, DOI 10.1128/JB.180.18.4765-4774.1998; Hur M, 2011, APPL ENVIRON MICROB, V77, P7611, DOI 10.1128/AEM.06102-11; Ihrmark K, 2012, FEMS MICROBIOL ECOL, V82, P666, DOI 10.1111/j.1574-6941.2012.01437.x; Jeon YS, 2013, CURR MICROBIOL, V67, P557, DOI 10.1007/s00284-013-0401-y; Jo WK, 2005, CHEMOSPHERE, V61, P1570, DOI 10.1016/j.chemosphere.2005.04.103; Kampfer P, 2012, INT J SYST EVOL MICR, V62, P2750, DOI 10.1099/ijs.0.039057-0; Kembel SW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087093; Khan ST, 2008, INT J SYST EVOL MICR, V58, P383, DOI 10.1099/ijs.0.65103-0; Kim JL, 2007, INDOOR AIR, V17, P153, DOI 10.1111/j.1600-0668.2006.00466.x; Kim KY, 2007, BUILD ENVIRON, V42, P2188, DOI 10.1016/j.buildenv.2006.04.013; Kim KY, 2011, IND HEALTH, V49, P242, DOI 10.2486/indhealth.MS1199; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; KLOOS WE, 1975, APPL MICROBIOL, V30, P381, DOI 10.1128/AEM.30.3.381-395.1975; Knutsen AP, 2012, J ALLERGY CLIN IMMUN, V129, P280, DOI 10.1016/j.jaci.2011.12.970; Lax S, 2014, SCIENCE, V345, P1048, DOI 10.1126/science.1254529; Lee JH, 2012, J MICROBIOL, V50, P181, DOI 10.1007/s12275-012-1214-6; Lee L, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-27; Leung MHY, 2014, APPL ENVIRON MICROB, V80, P6760, DOI 10.1128/AEM.02244-14; Lis DO, 2013, AM J INFECT CONTROL, V41, P438, DOI 10.1016/j.ajic.2012.05.023; Meadow JF, 2014, INDOOR AIR, V24, P41, DOI 10.1111/ina.12047; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; MYERS EW, 1988, COMPUT APPL BIOSCI, V4, P11, DOI 10.1093/bioinformatics/4.1.11; Neri M, 2006, MUTAT RES-REV MUTAT, V612, P1, DOI 10.1016/j.mrrev.2005.04.001; NOBLE WC, 1984, J MED MICROBIOL, V17, P1, DOI 10.1099/00222615-17-1-1; Qian J, 2012, INDOOR AIR, V22, P339, DOI 10.1111/j.1600-0668.2012.00769.x; Robertson CE, 2013, APPL ENVIRON MICROB, V79, P3485, DOI 10.1128/AEM.00331-13; Roda C, 2011, ENVIRON RES, V111, P1010, DOI 10.1016/j.envres.2011.06.009; Saunders CW, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002701; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Shannon C. E., 1949, MATH THEORY COMMUNIC; Shelton BG, 2002, APPL ENVIRON MICROB, V68, P1743, DOI 10.1128/AEM.68.4.1743-1753.2002; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Suk WA, 2003, MUTAT RES-REV MUTAT, V544, P235, DOI 10.1016/j.mrrev.2003.06.007; Toju H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040863; Tringe SG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001862; URAKAMI T, 1990, INT J SYST BACTERIOL, V40, P287, DOI 10.1099/00207713-40-3-287; Veyisoglu A, 2013, INT J SYST EVOL MICR, V63, P2823, DOI 10.1099/ijs.0.049551-0; Wellner S, 2013, INT J SYST EVOL MICR, V63, P2690, DOI 10.1099/ijs.0.047787-0; Womack AM, 2010, PHILOS T R SOC B, V365, P3645, DOI 10.1098/rstb.2010.0283; Yamamoto N, 2012, ISME J, V6, P1801, DOI 10.1038/ismej.2012.30; Yi H, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0583-3; Yooseph S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081862; Zukiewicz-Sobczak WA, 2013, POSTEP DERM ALERGOL, V30, P42, DOI 10.5114/pdia.2013.33377	86	64	65	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0126960	10.1371/journal.pone.0126960	http://dx.doi.org/10.1371/journal.pone.0126960			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020512	Green Published, gold, Green Submitted			2022-12-26	WOS:000355187300029
J	Cooper-Knock, J; Bury, JJ; Heath, PR; Wyles, M; Higginbottom, A; Gelsthorpe, C; Highley, JR; Hautbergue, G; Rattray, M; Kirby, J; Shaw, PJ				Cooper-Knock, Johnathan; Bury, Joanna J.; Heath, Paul R.; Wyles, Matthew; Higginbottom, Adrian; Gelsthorpe, Catherine; Highley, J. Robin; Hautbergue, Guillaume; Rattray, Magnus; Kirby, Janine; Shaw, Pamela J.			C9ORF72 GGGGCC Expanded Repeats Produce Splicing Dysregulation which Correlates with Disease Severity in Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							HEXANUCLEOTIDE REPEAT; RNA FOCI; ALS; EXPANSION; PROTEINS; MUTATIONS; ONSET; SENSE	Objective An intronic GGGGCC-repeat expansion of C9ORF72 is the most common genetic variant of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia. The mechanism of neurodegeneration is unknown, but a direct effect on RNA processing mediated by RNA foci transcribed from the repeat sequence has been proposed. Methods Gene expression profiling utilised total RNA extracted from motor neurons and lymphoblastoid cell lines derived from human ALS patients, including those with an expansion of C9ORF72, and controls. In lymphoblastoid cell lines, expansion length and the frequency of sense and antisense RNA foci was also examined. Results Gene level analysis revealed a number of differentially expressed networks and both cell types exhibited dysregulation of a network functionally enriched for genes encoding 'RNA splicing' proteins. There was a significant overlap of these genes with an independently generated list of GGGGCC-repeat protein binding partners. At the exon level, in lymphoblastoid cells derived from C9ORF72-ALS patients splicing consistency was lower than in lines derived from non-C9ORF72 ALS patients or controls; furthermore splicing consistency was lower in samples derived from patients with faster disease progression. Frequency of sense RNA foci showed a trend towards being higher in lymphoblastoid cells derived from patients with shorter survival, but there was no detectable correlation between disease severity and DNA expansion length. Significance Up-regulation of genes encoding predicted binding partners of the C9ORF72 expansion is consistent with an attempted compensation for sequestration of these proteins. A number of studies have analysed changes in the transcriptome caused by C9ORF72 expansion, but to date findings have been inconsistent. As a potential explanation we suggest that dynamic sequestration of RNA processing proteins by RNA foci might lead to a loss of splicing consistency; indeed in our samples measurement of splicing consistency correlates with disease severity.	[Cooper-Knock, Johnathan; Bury, Joanna J.; Heath, Paul R.; Wyles, Matthew; Higginbottom, Adrian; Gelsthorpe, Catherine; Highley, J. Robin; Hautbergue, Guillaume; Kirby, Janine; Shaw, Pamela J.] Univ Sheffield, Sheffield Inst Translat Neurosci SITraN, Sheffield S10 2HQ, S Yorkshire, England; [Rattray, Magnus] Univ Manchester, Life Sci, Manchester M13 9PT, Lancs, England	University of Sheffield; University of Manchester	Shaw, PJ (corresponding author), Univ Sheffield, Sheffield Inst Translat Neurosci SITraN, 385A Glossop Rd, Sheffield S10 2HQ, S Yorkshire, England.	pamela.shaw@sheffield.ac.uk	Rattray, Magnus/B-4393-2009; Rattray, Magnus/AAE-3297-2021; Kirby, Janine/B-3980-2009	Rattray, Magnus/0000-0001-8196-5565; Rattray, Magnus/0000-0001-8196-5565; Kirby, Janine/0000-0002-7468-5917; Cooper-Knock, Johnathan/0000-0002-0873-8689; Shaw, Pamela/0000-0002-8925-2567; Highley, Robin/0000-0002-4969-6526; Bury, Joanna J/0000-0002-8735-2791	EU [259867]; SOPHIA project; EU Joint Programme - Neurodegenerative Disease Research; Medical Research Council; Motor Neurone Disease Association [MR/K003771/1]; Medical Research Council [G0 800380]; Motor Neurone Disease Association; Wellcome Trust; Medical Research Council [G0800380, MR/K003771/1, MR/K000039/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10082] Funding Source: researchfish; MRC [MR/K003771/1, G0800380, MR/K000039/1] Funding Source: UKRI	EU(European Commission); SOPHIA project; EU Joint Programme - Neurodegenerative Disease Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Motor Neurone Disease Association; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Motor Neurone Disease Association; Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors acknowledge grants from the 'EU Framework 7' (Euromotor No259867) and the SOPHIA project (funded by 'EU Joint Programme - Neurodegenerative Disease Research' and 'Medical Research Council') to PJS and JK. PJS is an NIHR Senior Investigator. JCK and JRH are supported by 'Motor Neurone Disease Association' / 'Medical Research Council' Lady Edith Wolfson Fellowship awards ([MR/K003771/1] and [G0 800380] respectively). Samples used in this research were in part obtained from the UK MND DNA Bank for MND Research, funded by the 'Motor Neurone Disease Association' and the 'Wellcome Trust'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ash PEA, 2013, NEURON, V77, P639, DOI 10.1016/j.neuron.2013.02.004; Bengtsson H., 2008, 745 U CAL DEP STAT; Blokhuis AM, 2013, ACTA NEUROPATHOL, V125, P777, DOI 10.1007/s00401-013-1125-6; Buchman VL, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-12; Cooper-Knock J, 2014, BRAIN, V137, P2040, DOI 10.1093/brain/awu120; Cooper-Knock J, 2014, ACTA NEUROPATHOL, V127, P333, DOI 10.1007/s00401-014-1251-9; Cooper-Knock J, 2012, NAT REV NEUROL, V8, P518, DOI 10.1038/nrneurol.2012.156; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353; Donnelly CJ, 2013, NEURON, V80, P415, DOI 10.1016/j.neuron.2013.10.015; Ferraiuolo L, 2007, J NEUROSCI, V27, P9201, DOI 10.1523/JNEUROSCI.1470-07.2007; Ghazalpour A, 2006, PLOS GENET, V2, P1182, DOI 10.1371/journal.pgen.0020130; Haeusler AR, 2014, NATURE, V507, P195, DOI 10.1038/nature13124; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; INCE PG, 1995, DEMENTIA, V6, P162, DOI 10.1159/000106940; Ismail A, 2013, J NEUROL NEUROSUR PS, V84, P79, DOI 10.1136/jnnp-2012-303326; Jawaid A, 2010, EUR J NEUROL, V17, P733, DOI 10.1111/j.1468-1331.2009.02923.x; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Kirby J, 2005, BRAIN, V128, P1686, DOI 10.1093/brain/awh503; Lagier-Tourenne C, 2013, P NATL ACAD SCI USA, V110, pE4530, DOI 10.1073/pnas.1318835110; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lee YB, 2013, CELL REP, V5, P1178, DOI 10.1016/j.celrep.2013.10.049; Mackenzie IR, 2013, ACTA NEUROPATHOL, V126, P859, DOI 10.1007/s00401-013-1181-y; Matus Soledad, 2013, Int J Cell Biol, V2013, P674751, DOI 10.1155/2013/674751; Mizielinska S, 2013, ACTA NEUROPATHOL, V126, P845, DOI 10.1007/s00401-013-1200-z; Mori K, 2013, SCIENCE, V339, P1335, DOI 10.1126/science.1232927; Mori K, 2013, ACTA NEUROPATHOL, V125, P413, DOI 10.1007/s00401-013-1088-7; Parakh S, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/408681; Pearson RD, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-211; Pickrell JK, 2014, PLOS GENET, V6; Purdom E, 2008, BIOINFORMATICS, V24, P1707, DOI 10.1093/bioinformatics/btn284; Raman R, 2015, NEUROPATH APPL NEURO, V41, P201, DOI 10.1111/nan.12147; Rattray M, 2006, BRIEF BIOINFORM, V7, P37, DOI 10.1093/bib/bbk003; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Rohrl C, 2014, J LIPID RES, V55, P94, DOI 10.1194/jlr.M043299; Sareen D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007529; Sathasivam S, 2005, LANCET NEUROL, V4, P500, DOI 10.1016/S1474-4422(05)70142-3; Sveen A, 2011, GENOME MED, V3, DOI 10.1186/gm248; Vijayalakshmi K, 2011, NEUROBIOL DIS, V41, P695, DOI 10.1016/j.nbd.2010.12.005; Wang W, 2009, PROG NEUROBIOL, V89, P1, DOI 10.1016/j.pneurobio.2009.01.007	41	71	71	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0127376	10.1371/journal.pone.0127376	http://dx.doi.org/10.1371/journal.pone.0127376			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26016851	Green Published, gold, Green Accepted			2022-12-26	WOS:000355185600080
J	Duc, KD; Lee, CY; Parutto, P; Cohen, D; Segal, M; Rouach, N; Holcman, D				Duc, K. Dao; Lee, C. Y.; Parutto, Pierre; Cohen, Dror; Segal, Menahem; Rouach, Nathalie; Holcman, David			Bursting Reverberation as a Multiscale Neuronal Network Process Driven by Synaptic Depression-Facilitation	PLOS ONE			English	Article							NEURAL-NETWORKS; HIPPOCAMPAL; OSCILLATIONS; MECHANISMS	Neuronal networks can generate complex patterns of activity that depend on membrane properties of individual neurons as well as on functional synapses. To decipher the impact of synaptic properties and connectivity on neuronal network behavior, we investigate the responses of neuronal ensembles from small (5-30 cells in a restricted sphere) and large (acute hippocampal slice) networks to single electrical stimulation: in both cases, a single stimulus generated a synchronous long-lasting bursting activity. While an initial spike triggered a reverberating network activity that lasted 2-5 seconds for small networks, we found here that it lasted only up to 300 milliseconds in slices. To explain this phenomena present at different scales, we generalize the depression-facilitation model and extracted the network time constants. The model predicts that the reverberation time has a bell shaped relation with the synaptic density, revealing that the bursting time cannot exceed a maximum value. Furthermore, before reaching its maximum, the reverberation time increases sub-linearly with the synaptic density of the network. We conclude that synaptic dynamics and connectivity shape the mean burst duration, a property present at various scales of the networks. Thus bursting reverberation is a property of sufficiently connected neural networks, and can be generated by collective depression and facilitation of underlying functional synapses.	[Duc, K. Dao; Parutto, Pierre; Holcman, David] Ecole Normale Super, IBENS, F-75005 Paris, France; [Lee, C. Y.; Rouach, Nathalie] Coll France, CNRS, Ctr Interdisciplinary Res Biol,U 1050,UMR 7241, Neuroglial Interact Cerebral Physiopathol,INSERM, Paris, France; [Cohen, Dror; Segal, Menahem] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; College de France; Ecole Normale Superieure (ENS); Institut National de la Sante et de la Recherche Medicale (Inserm); Weizmann Institute of Science	Holcman, D (corresponding author), Ecole Normale Super, IBENS, 46 Rue Ulm, F-75005 Paris, France.	david.holcman@ens.fr	Rouach, Nathalie/L-4767-2017; SEGAL, MENAHEM/K-1577-2012	Rouach, Nathalie/0000-0002-5574-888X; holcman, david/0000-0001-9854-5014; Dao Duc, Khanh/0000-0002-9685-5171; Parutto, Pierre/0000-0002-9866-407X				Andersson M, 2010, J NEUROSCI, V30, P5776, DOI 10.1523/JNEUROSCI.3957-09.2010; Andersson MS, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-87; Atluri PP, 1996, J NEUROSCI, V16, P5661; Bacci A, 1999, EUR J NEUROSCI, V11, P389, DOI 10.1046/j.1460-9568.1999.00440.x; Bart E, 2005, J COMPUT NEUROSCI, V19, P357, DOI 10.1007/s10827-005-3099-4; Blatow M, 2003, NEURON, V38, P79, DOI 10.1016/S0896-6273(03)00196-X; Bressloff PC, 2011, J MATH NEUROSCI, V1, DOI 10.1186/2190-8567-1-2; Brunel N, 2008, CHAOS, V18, DOI 10.1063/1.2779858; Cohen D, 2011, J NEUROPHYSIOL, V106, P2314, DOI 10.1152/jn.00969.2010; Cohen D, 2009, J NEUROPHYSIOL, V101, P2077, DOI 10.1152/jn.91085.2008; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; Holcman D, 2006, PLOS COMPUT BIOL, V2, P174, DOI 10.1371/journal.pcbi.0020023; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; Lau PM, 2005, P NATL ACAD SCI USA, V102, P10333, DOI 10.1073/pnas.0500717102; Maeda H, 1999, NEURON, V24, P989, DOI 10.1016/S0896-6273(00)81045-4; Melamed O, 2008, J COMPUT NEUROSCI, V25, P308, DOI 10.1007/s10827-008-0080-z; Mills JD, 1999, J NEUROPHYSIOL, V81, P2253, DOI 10.1152/jn.1999.81.5.2253; Muller M, 2010, J NEUROSCI, V30, P2007, DOI 10.1523/JNEUROSCI.4378-09.2010; Pannasch U, 2012, JOVE-J VIS EXP, DOI 10.3791/4418; Picardo MA, 2011, NEURON, V71, P695, DOI 10.1016/j.neuron.2011.06.018; Sah P, 1996, TRENDS NEUROSCI, V19, P150, DOI 10.1016/S0166-2236(96)80026-9; Staley KJ, 1998, NAT NEUROSCI, V1, P201, DOI 10.1038/651; Tabak J, 2001, J NEUROSCI, V21, P8966, DOI 10.1523/JNEUROSCI.21-22-08966.2001; Traub R.D., 1991, NEURONAL NETWORKS HI; Tsodyks M, 1998, NEURAL COMPUT, V10, P821, DOI 10.1162/089976698300017502; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Wang XJ, 2001, TRENDS NEUROSCI, V24, P455, DOI 10.1016/S0166-2236(00)01868-3; Wyart C, 2005, J NEUROPHYSIOL, V93, P3370, DOI 10.1152/jn.00530.2004; Xu J, 2009, NAT NEUROSCI, V12, P759, DOI 10.1038/nn.2320; Xu-Friedman MA, 2004, PHYSIOL REV, V84, P69, DOI 10.1152/physrev.00016.2003	30	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0124694	10.1371/journal.pone.0124694	http://dx.doi.org/10.1371/journal.pone.0124694			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26017681	Green Submitted, Green Published, gold			2022-12-26	WOS:000355185600006
J	Fan, L; Xiao, HP; Mai, GL; Su, B; Ernst, J; Hu, ZY				Fan, Lin; Xiao, Heping; Mai, Guangliang; Su, Bo; Ernst, Joel; Hu, Zhongyi			Impaired M. tuberculosis Antigen-Specific IFN-gamma Response without IL-17 Enhancement in Patients with Severe Cavitary Pulmonary Tuberculosis	PLOS ONE			English	Article							CD4 T-CELLS; INTERFERON-GAMMA; IMMUNE-RESPONSE; MYCOBACTERIUM-BOVIS; BCG VACCINATION; MICE; INFECTION; APOPTOSIS; ABSENCE; DEATH	Background Th1 cells play an essential role in immune protection against tuberculosis. Th17 cells might be involved with immune pathology in active human tuberculosis (TB). The balance between Th1 and Th17 cells in patients with cavitary tuberculosis needs to be clarified which might help understanding the immunological basis of pathologic pathogenesis in TB. Method Initially treated pulmonary TB (PTB) patients with or without cavities were recruited before chemotherapy. We isolated peripheral blood mononuclear cells, stimulated with phytohemagglutinin (PHA), PPD, or ESAT-6 antigens, and assayed supernatant IFN-gamma and IL-17 by ELISA after 24 or 72 hours incubation, respectively. Cells were also stained with antibodies to CD3, CD4, CD8, IFN-gamma or IL-17 and the proportion of stained cells was measured by flow cytometry. Results We found wide variation of IFN-gamma response in active PTB patients, but less subject-to-subject variation of IL-17 was observed as we previously reported. There were no significant differences in IFN-gamma and IL-17 between cavitary and non-cavitary PTB; however, we found decreased IFN-gamma secretion in severe cavitary PTB compared to mild lesion non-cavitary PTB (p < 0.05). We also found a decrease in the proportion of CD3+CD4+ T cells in the blood of severe cavitary PTB patients (p < 0.05). Conclusions IL-17 seemed to have no association with the formation of cavities in active PTB from the study of PBMC. Impaired IFN-gamma without IL-17 enhancement occurs in peripheral blood during severe cavitary PTB. Our results demonstrate that M. tuberculosis antigen-specific Th1 response is decreased when PTB lesions develop to severe cavities.	[Fan, Lin; Xiao, Heping; Mai, Guangliang; Hu, Zhongyi] Tongji Univ, Sch Med, Clin & Res Ctr TB, Shanghai Key Lab TB,Shanghai Pulm Hosp, Shanghai 200433, Peoples R China; [Su, Bo] Tongji Univ, Sch Med, Cent Lab, Shanghai Pulm Hosp, Shanghai 200433, Peoples R China; [Ernst, Joel] NYU, Sch Med, Div Infect Dis, New York, NY 10016 USA	Tongji University; Tongji University; New York University	Ernst, J (corresponding author), NYU, Sch Med, Div Infect Dis, New York, NY 10016 USA.	joel.ernst@med.nyu.edu; fanlinsj@aliyun.com		Ernst, Joel/0000-0001-9951-6207	National Key Basic Research Program (973) sub-project in China [2012CB518706]	National Key Basic Research Program (973) sub-project in China	This study was supported by the National Key Basic Research Program (973) sub-project in China (2012CB518706). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Barry S, 2009, TUBERCULOSIS, V89, P48, DOI 10.1016/j.tube.2008.07.002; Caruso AM, 1999, J IMMUNOL, V162, P5407; Condos R, 1998, AM J RESP CRIT CARE, V157, P729, DOI 10.1164/ajrccm.157.3.9705044; Cruz A, 2010, J EXP MED, V207, P1609, DOI 10.1084/jem.20100265; Desvignes L, 2009, IMMUNITY, V31, P974, DOI 10.1016/j.immuni.2009.10.007; Di Carlo P, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-108; Divangahi M, 2010, NAT IMMUNOL, V11, P751, DOI 10.1038/ni.1904; Dorhoi A, 2011, IMMUNOL REV, V240, P235, DOI 10.1111/j.1600-065X.2010.00994.x; Eurosurveillance editorial team, 2013, EURO SURVEILL, V18, P20615; Fan L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042716; Geldmacher C, 2012, CURR OPIN HIV AIDS, V7, P268, DOI 10.1097/COH.0b013e3283524e32; Geldmacher C, 2010, J EXP MED, V207, P2869, DOI 10.1084/jem.20100090; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Green AM, 2013, J IMMUNOL, V190, P270, DOI 10.4049/jimmunol.1200061; Jurado JO, 2012, J LEUKOCYTE BIOL, V91, P991, DOI 10.1189/jlb.1211619; Kaplan G, 2003, INFECT IMMUN, V71, P7099, DOI 10.1128/IAI.71.12.7099-7108.2003; Kubler A, 2015, J PATHOL, V235, P431, DOI 10.1002/path.4432; Kwan CK, 2011, CLIN MICROBIOL REV, V24, P351, DOI 10.1128/CMR.00042-10; Lawn SD, 2009, AIDS, V23, P1717, DOI 10.1097/QAD.0b013e32832d3b6d; Lyadova IV, 2001, CLIN EXP IMMUNOL, V126, P274, DOI 10.1046/j.1365-2249.2001.01667.x; Mazzarella G, 2003, CLIN EXP IMMUNOL, V132, P283, DOI 10.1046/j.1365-2249.2003.02121.x; MUKADI Y, 1993, LANCET, V342, P143, DOI 10.1016/0140-6736(93)91346-N; Nandi B, 2011, J EXP MED, V208, P2251, DOI 10.1084/jem.20110919; Nunnari G, 2013, CLIN INVEST MED, V36, pE64; Peng MY, 2008, CELL MOL IMMUNOL, V5, P203, DOI 10.1038/cmi.2008.25; Rodriguez-Guell E, 2008, CLIN VACCINE IMMUNOL, V15, P1485, DOI 10.1128/CVI.00131-08; Saunders BM, 2007, IMMUNOL CELL BIOL, V85, P103, DOI 10.1038/sj.icb.7100027; Singh A, 2013, J INFECT DIS, V208, P603, DOI 10.1093/infdis/jit206; Ulrichs T, 2005, J INFECT DIS, V192, P89, DOI 10.1086/430621; Umemura M, 2007, J IMMUNOL, V178, P3786, DOI 10.4049/jimmunol.178.6.3786; Wallis RS, 2010, LANCET, V375, P1920, DOI 10.1016/S0140-6736(10)60359-5; Wozniak TM, 2010, INFECT IMMUN, V78, P4187, DOI 10.1128/IAI.01392-09; Wu HP, 2007, RESP MED, V101, P48, DOI 10.1016/j.rmed.2006.04.016; Yoshida YO, 2010, J IMMUNOL, V184, P4414, DOI 10.4049/jimmunol.0903332	34	13	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0127087	10.1371/journal.pone.0127087	http://dx.doi.org/10.1371/journal.pone.0127087			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018190	gold, Green Published, Green Submitted			2022-12-26	WOS:000355185600069
J	Stanton, BA; Coutermarsh, B; Barnaby, R; Hogan, D				Stanton, Bruce A.; Coutermarsh, Bonita; Barnaby, Roxanna; Hogan, Deborah			Pseudomonas aeruginosa Reduces VX-809 Stimulated F508del-CFTR Chloride Secretion by Airway Epithelial Cells	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS; CFTR POTENTIATOR; IN-VITRO; TRAFFICKING; DELTA-F508-CFTR; DEGRADATION; COMBINATION; LUMACAFTOR; PROTEASOME	Background P. aeruginosa is an opportunistic pathogen that chronically infects the lungs of 85% of adult patients with Cystic Fibrosis (CF). Previously, we demonstrated that P. aeruginosa reduced wt-CFTR Cl secretion by airway epithelial cells. Recently, a new investigational drug VX-809 has been shown to increase F508del-CFTR Cl secretion in human bronchial epithelial (HBE) cells, and, in combination with VX-770, to increase FEV1 (forced expiratory volume in 1 second) by an average of 3-5% in CF patients homozygous for the F508del-CFTR mutation. We propose that P. aeruginosa infection of CF lungs reduces VX-809 + VX-770-stimulated F508del-CFTR Cl secretion, and thereby reduces the clinical efficacy of VX-809 + VX-770. Methods and Results F508del-CFBE cells and primary cultures of CF-HBE cells (F508del/F508del) were exposed to VX-809 alone or a combination of VX-809 + VX-770 for 48 hours and the effect of P. aeruginosa on F508del-CFTR Cl secretion was measured in Ussing chambers. The effect of VX-809 on F508del-CFTR abundance was measured by cell surface biotinylation and western blot analysis. PAO1, PA14, PAK and 6 clinical isolates of P. aeruginosa (3 mucoid and 3 non-mucoid) significantly reduced drug stimulated F508del-CFTR Cl secretion, and plasma membrane F508del-CFTR. Conclusion The observation that P. aeruginosa reduces VX-809 and VX-809 + VX-770 stimulated F508del CFTR Cl secretion may explain, in part, why VX-809 + VX-770 has modest efficacy in clinical trials.	[Stanton, Bruce A.; Coutermarsh, Bonita; Barnaby, Roxanna; Hogan, Deborah] Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Hanover, NH 03755 USA	Dartmouth College	Stanton, BA (corresponding author), Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Hanover, NH 03755 USA.	BAS@dartmouth.edu			National Institutes of Health [R01-HL074175, R01-DK/HL45881, P30GM106394]; Cystic Fibrosis Foundation [STANTO07R0]; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074175] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045881] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM106394] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants R01-HL074175, R01-DK/HL45881 and P30GM106394 (BAS) (http://www.nih.gov/) and Cystic Fibrosis Foundation grant STANTO07R0 (BAS) (http://www.cff.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahl CD, 2014, J BIOL CHEM, V289, P7460, DOI 10.1074/jbc.M113.518092; Ballok AE, 2013, J BACTERIOL, V195, P4013, DOI 10.1128/JB.00339-13; Bomberger JM, 2012, J BIOL CHEM, V287, P17130, DOI 10.1074/jbc.M111.338855; Bomberger JM, 2011, METHODS MOL BIOL, V741, P271, DOI 10.1007/978-1-61779-117-8_18; Bomberger JM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001325; Bomberger JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000382; Boyle MP, 2014, LANCET RESP MED, V2, P527, DOI 10.1016/S2213-2600(14)70132-8; Cholon DM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008680; Cohen TS, 2012, NAT MED, V18, P509, DOI 10.1038/nm.2715; Collawn JF, 2014, AM J PHYSIOL-LUNG C, V307, pL917, DOI 10.1152/ajplung.00326.2014; Fulcher M Leslie, 2013, Methods Mol Biol, V945, P109, DOI 10.1007/978-1-62703-125-7_8; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; Guimbellot JS, 2014, PEDIATR PULM, V49, P217; Haws CM, 1996, AM J PHYSIOL-CELL PH, V270, pC1544, DOI 10.1152/ajpcell.1996.270.5.C1544; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; MacEachran DP, 2007, INFECT IMMUN, V75, P3902, DOI 10.1128/IAI.00338-07; Machen TE, 2006, AM J PHYSIOL-CELL PH, V291, pC218, DOI 10.1152/ajpcell.00605.2005; Moreau-Marquis S, 2013, PEDIATR PULM, V48, P255; Moreau-Marquis S, 2015, J ANTIMICROB CHEMOTH, V70, P160, DOI 10.1093/jac/dku357; Ramsey B, 2014, PEDIATR PULM, V49, P305; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; Stanke F, 2014, EUR J HUM GENET, V22, P660, DOI 10.1038/ejhg.2013.209; Stanke F, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-62; Swiatecka-Urban A, 2005, J BIOL CHEM, V280, P36762, DOI 10.1074/jbc.M508944200; Swiatecka-Urban A, 2007, J BIOL CHEM, V282, P23725, DOI 10.1074/jbc.M608531200; Talebian L, 2009, CELL PHYSIOL BIOCHEM, V23, P199, DOI 10.1159/000204108; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Veit G, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008889; Wang YT, 2014, INT J BIOCHEM CELL B, V52, P47, DOI 10.1016/j.biocel.2014.04.001; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6	31	50	50	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0127742	10.1371/journal.pone.0127742	http://dx.doi.org/10.1371/journal.pone.0127742			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018799	Green Published, Green Submitted, gold			2022-12-26	WOS:000355185600095
J	Zarate-Barrera, TG; Maldonado, JH				Zarate-Barrera, Tatiana G.; Maldonado, Jorge H.			Valuing Blue Carbon: Carbon Sequestration Benefits Provided by the Marine Protected Areas in Colombia	PLOS ONE			English	Article								Marine protected areas are aimed to protect and conserve key ecosystems for the provision of a number of ecosystem services that are the basis for numerous economic activities. Among the several services that these areas provide, the capacity of sequestering (capturing and storing) organic carbon is a regulating service, provided mainly by mangroves and seagrasses, that gains importance as alternatives for mitigating global warming become a priority in the international agenda. The objective of this study is to value the services associated with the capture and storage of oceanic carbon, known as Blue Carbon, provided by a new network of marine protected areas in Colombia. We approach the monetary value associated to these services through the simulation of a hypothetical market for oceanic carbon. To do that, we construct a benefit function that considers the capacity of mangroves and seagrasses for capturing and storing blue carbon, and simulate scenarios for the variation of key variables such as the market carbon price, the discount rate, the natural rate of loss of the ecosystems, and the expectations about the post-Kyoto negotiations. The results indicate that the expected benefits associated to carbon capture and storage provided by these ecosystems are substantial but highly dependent on the expectations in terms of the negotiations surrounding the extension of the Kyoto Protocol and the dynamics of the carbon credit's demand and supply. We also find that the natural loss rate of these ecosystems does not seem to have a significant effect on the annual value of the benefits. This approach constitutes one of the first attempts to value blue carbon as one of the services provided by conservation.	[Zarate-Barrera, Tatiana G.; Maldonado, Jorge H.] Univ Los Andes, CEDE, Dept Econ, Bogota, Colombia	Universidad de los Andes (Colombia)	Maldonado, JH (corresponding author), Univ Los Andes, CEDE, Dept Econ, Bogota, Colombia.	jmaldona@uniandes.edu.co		Maldonado, Jorge/0000-0001-5501-6374	Americas Business Council through Universidad de los Andes	Americas Business Council through Universidad de los Andes	The authors thank the Americas Business Council, who funded the project through a contract with Universidad de los Andes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alongi DM, 2002, ENVIRON CONSERV, V29, P331, DOI 10.1017/S0376892902000231; Alonso D, 2008, ANALISIS VACIOS PROP; [Anonymous], 2005, EC HUM WELL BEING SY; [Anonymous], 2007, WORLDS MANGR 1980 20; Barrera CA, 2013, DOCUMENTO CEDE, V56, P1; Bowen A., 2016, CASE CARBON PRICING; Boyle K, 1985, TOTAL VALUE WILDLIFE; Carbon Finance, 2013, MAPP CARB PRIC IN 20; Carbon Finance, 2012, CARB FIN SUST DEV; Casas-Monroy O, 2000, INFORME ESTADO AMBIE, P45; CDB UNEP, 2004, CONV BIOL DIV CONC I; CI GCRMN NOAA, 2008, SOC COND WORLDS TROP; Conservation International, 2008, EC VAL COR REEFS MAN; Cuervo R., 2014, DOCUMENTO CEDE, V2014, P1; Duarte CM, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2010GB003793; Emerton L, 2005, WORKSH BUILD DIV POR; EONG OJ, 1993, CHEMOSPHERE, V27, P1097, DOI 10.1016/0045-6535(93)90070-L; FAMA EF, 1965, J BUS, V38, P34, DOI 10.1086/294743; Greiner JT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072469; Harrison M., 2010, VALUING FUTURE SOCIA; HighLevel Panel on the CDM Policy Dialogue, 2012, CLIMATE CHANGE CARBO; IAvH IDEAM IIAP INVEMAR & SINCHI, 2011, INF EST MED AMB REC; ICE, 2010, CHIC CLIM EXCH CLOS; INVEMAR UAESPNN TNC, 2008, PLAN ACC CREAC SUBS; IPCC, 2007, CONTRIBUTION WORKING; IUCN TNC World Bank, 2004, MUCH IS EC WORTH ASS; Jenkins WA, 2010, ECOL ECON, V69, P1051, DOI 10.1016/j.ecolecon.2009.11.022; Kennedy H, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2010GB003848; 김민규, 2008, [JOURNAL OF KOREA WATER RESOURCES ASSOCITION, 한국수자원학회 논문집], V41, P1; Lavery PS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073748; Lopez H, 2008, SOCIAL DISCOUNT RATE; Maldonado JH, 2013, DOCUMENTO CEDE, V52, P1; Mcleod E, 2011, FRONT ECOL ENVIRON, V9, P552, DOI 10.1890/110004; Ministerio de Medio Ambiente y Desarrollo Sostenible, 2011, INF MDL COL; Montanez-Gil AM, 2014, DOCUMENTO CEDE, V11, P1; Moreno-Sanchez RP, 2013, DOCUMENTO CEDE, V55, P1; Murray B., 2011, GREEN PAYMENTS BLUE; Nellemann C., 2009, BLUE CARBON RAPID RE; Pendleton L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043542; Price R, 2007, SOCIAL COAST CARBON; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Sedjo R, 2012, ANNU REV RESOUR ECON, V4, P126, DOI 10.1146/annurev-resource-083110-115941; Seeberg-Elverfeldt C, 2010, CARBON FINANCE POSSI; Sifleet S., 2011, 1106 NI R; Suzuki A, 2004, GLOBAL ENV CHANGE OC, P229; U.S. Environmental Protection Agency, 2013, FACT SHEET SOC COST; UNEP, 2011, OTH 70 UNEP MAR COAS; UNEP-WCMC, 2006, FRONT LIN SHOR PROT, P33; United Nations, 2021, CLIM CHANG REC THREA; Valiela I, 2001, BIOSCIENCE, V51, P807, DOI 10.1641/0006-3568(2001)051[0807:MFOOTW]2.0.CO;2; Zarate TG, 2014, DOCUMENTO CEDE, V6, P1	51	29	29	8	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0126627	10.1371/journal.pone.0126627	http://dx.doi.org/10.1371/journal.pone.0126627			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018814	gold, Green Published, Green Submitted			2022-12-26	WOS:000355185600056
J	Gera, N; Yang, AR; Holtzman, TS; Lee, SX; Wong, ET; Swanson, KD				Gera, Nidhi; Yang, Aaron; Holtzman, Talia S.; Lee, Sze Xian; Wong, Eric T.; Swanson, Kenneth D.			Tumor Treating Fields Perturb the Localization of Septins and Cause Aberrant Mitotic Exit	PLOS ONE			English	Article							SPINDLE ASSEMBLY CHECKPOINT; ANAPHASE-PROMOTING COMPLEX/CYCLOSOME; ALTERNATING ELECTRIC-FIELDS; MYOSIN-II; MAMMALIAN SEPTINS; CONTRACTILE RING; SPATIAL CONTROL; HELA-CELLS; CYTOKINESIS; ANILLIN	The anti-tumor effects of chemotherapy and radiation are thought to be mediated by triggering G(1)/S or G(2)/M cell cycle checkpoints, while spindle poisons, such as paclitaxel, block metaphase exit by initiating the spindle assembly checkpoint. In contrast, we have found that 150 kilohertz (kHz) alternating electric fields, also known as Tumor Treating Fields (TTFields), perturbed cells at the transition from metaphase to anaphase. Cells exposed to the TTFields during mitosis showed normal progression to this point, but exhibited uncontrolled membrane blebbing that coincided with metaphase exit. The ability of such alternating electric fields to affect cellular physiology is likely to be dependent on their interactions with proteins possessing high dipole moments. The mitotic Septin complex consisting of Septin 2, 6 and 7, possesses a high calculated dipole moment of 2711 Debyes (D) and plays a central role in positioning the cytokinetic cleavage furrow, and governing its contraction during ingression. We showed that during anaphase, TTFields inhibited Septin localization to the anaphase spindle midline and cytokinetic furrow, as well as its association with microtubules during cell attachment and spreading on fibronectin. After aberrant metaphase exit as a consequence of TTFields exposure, cells exhibited aberrant nuclear architecture and signs of cellular stress including an overall decrease in cellular proliferation, followed by apoptosis that was strongly influenced by the p53 mutational status. Thus, TTFields are able to diminish cell proliferation by specifically perturbing key proteins involved in cell division, leading to mitotic catastrophe and subsequent cell death.	[Gera, Nidhi] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Yang, Aaron; Holtzman, Talia S.; Lee, Sze Xian; Wong, Eric T.; Swanson, Kenneth D.] Beth Israel Deaconess Med Ctr, Dept Neurol, Div Neurooncol, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Swanson, KD (corresponding author), Beth Israel Deaconess Med Ctr, Dept Neurol, Div Neurooncol, Boston, MA 02215 USA.	kswanson@bidmc.harvard.edu		Yang, Aaron/0000-0003-3319-4916	National Institutes of Health [R56AI085131]; NovoCure Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116327] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI085131] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NovoCure Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health R56AI085131 to K. D. S., and an unrestricted grant from NovoCure Inc. to K. D. S. and E. T. W. (http://www.novocure.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreassen PR, 2001, MOL BIOL CELL, V12, P1315, DOI 10.1091/mbc.12.5.1315; Antoons G, 2002, J PHYSIOL-LONDON, V543, P889, DOI 10.1113/jphysiol.2002.025619; Bertin A, 2012, MOL BIOL CELL, V23, P423, DOI 10.1091/mbc.E11-10-0850; Bowen JR, 2011, J CELL BIOL, V194, P187, DOI 10.1083/jcb.201102076; Brito DA, 2006, CURR BIOL, V16, P1194, DOI 10.1016/j.cub.2006.04.043; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; DELOZANNE A, 1987, SCIENCE, V236, P1086, DOI 10.1126/science.3576222; DeMay BS, 2011, BIOPHYS J, V101, P985, DOI 10.1016/j.bpj.2011.07.008; DeMay BS, 2011, J CELL BIOL, V193, P1065, DOI 10.1083/jcb.201012143; Durand DM, 2001, P IEEE, V89, P1065, DOI 10.1109/5.939821; Elhajouji A, 1998, MUTAGENESIS, V13, P193; Estey MP, 2010, J CELL BIOL, V191, P741, DOI 10.1083/jcb.201006031; Felder CE, 2007, NUCLEIC ACIDS RES, V35, pW512, DOI 10.1093/nar/gkm307; Field CM, 2005, DEVELOPMENT, V132, P2849, DOI 10.1242/dev.01843; Frenette P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034888; Ganem NJ, 2007, CELL, V131, P437, DOI 10.1016/j.cell.2007.10.024; Geley S, 2001, J CELL BIOL, V153, P137, DOI 10.1083/jcb.153.1.137; Ghossoub R, 2013, J CELL SCI, V126, P2583, DOI 10.1242/jcs.111377; Giansanti MG, 1999, J CELL SCI, V112, P2323; Gilden JK, 2012, J CELL BIOL, V196, P103, DOI 10.1083/jcb.201105127; Goldbach P, 2010, MOL BIOL CELL, V21, P1482, DOI 10.1091/mbc.E09-08-0714; Gregory SL, 2008, CURR BIOL, V18, P25, DOI 10.1016/j.cub.2007.11.050; Gruber S, 2003, CELL, V112, P765, DOI 10.1016/S0092-8674(03)00162-4; Haering CH, 2008, NATURE, V454, P297, DOI 10.1038/nature07098; Huang HC, 2009, CANCER CELL, V16, P347, DOI 10.1016/j.ccr.2009.08.020; Kinoshita M, 2002, DEV CELL, V3, P791, DOI 10.1016/S1534-5807(02)00366-0; Kirson ED, 2004, CANCER RES, V64, P3288, DOI 10.1158/0008-5472.CAN-04-0083; Kirson ED, 2007, P NATL ACAD SCI USA, V104, P10152, DOI 10.1073/pnas.0702916104; Kirson Eilon D, 2009, BMC Med Phys, V9, P1, DOI 10.1186/1756-6649-9-1; Kirson ED, 2009, CLIN EXP METASTAS, V26, P633, DOI 10.1007/s10585-009-9262-y; Kops GJPL, 2012, CHROMOSOMA, V121, P509, DOI 10.1007/s00412-012-0378-5; Liu JH, 2012, CURR BIOL, V22, P64, DOI 10.1016/j.cub.2011.11.040; Ma HT, 2011, METHODS MOL BIOL, V761, P151, DOI 10.1007/978-1-61779-182-6_10; MABUCHI I, 1977, J CELL BIOL, V74, P251, DOI 10.1083/jcb.74.1.251; Margolis RL, 2003, J CELL BIOCHEM, V88, P673, DOI 10.1002/jcb.10411; Norden C, 2006, CELL, V125, P85, DOI 10.1016/j.cell.2006.01.045; Oliveira RA, 2010, NAT CELL BIOL, V12, P185, DOI 10.1038/ncb2018; Orth JD, 2011, CANCER RES, V71, P4608, DOI 10.1158/0008-5472.CAN-11-0412; Orth JD, 2008, MOL CANCER THER, V7, P3480, DOI 10.1158/1535-7163.MCT-08-0684; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pethig R, 1996, CRIT REV BIOTECHNOL, V16, P331, DOI 10.3109/07388559609147425; Piekny AJ, 2008, CURR BIOL, V18, P30, DOI 10.1016/j.cub.2007.11.068; Posterino GS, 2000, J PHYSIOL-LONDON, V527, P131, DOI 10.1111/j.1469-7793.2000.t01-2-00131.x; Rieder CL, 2004, DEV CELL, V7, P637, DOI 10.1016/j.devcel.2004.09.002; SATTERWHITE LL, 1992, J CELL BIOL, V118, P595, DOI 10.1083/jcb.118.3.595; Shirayama M, 1999, NATURE, V402, P203, DOI 10.1038/46080; Sirajuddin M, 2007, NATURE, V449, P311, DOI 10.1038/nature06052; Spiliotis ET, 2005, SCIENCE, V307, P1781, DOI 10.1126/science.1106823; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; Straight AF, 2005, MOL BIOL CELL, V16, P193, DOI 10.1091/mbc.E04-08-0758; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Stupp R, 2012, EUR J CANCER, V48, P2192, DOI 10.1016/j.ejca.2012.04.011; Su KC, 2011, DEV CELL, V21, P1104, DOI 10.1016/j.devcel.2011.11.003; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Tooley AJ, 2009, NAT CELL BIOL, V11, P17, DOI 10.1038/ncb1808; Vitale I, 2011, NAT REV MOL CELL BIO, V12, P384, DOI 10.1038/nrm3115; Wolfe BA, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000110; Wong ET, 2014, CANCER MED-US, V3, P592, DOI 10.1002/cam4.210	59	112	116	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0125269	10.1371/journal.pone.0125269	http://dx.doi.org/10.1371/journal.pone.0125269			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010837	Green Published, gold, Green Submitted			2022-12-26	WOS:000355183900011
J	McGowan, I; Anton, PA; Elliott, J; Cranston, RD; Duffill, K; Althouse, AD; Hawkins, KL; De Rosa, SC				McGowan, Ian; Anton, Peter A.; Elliott, Julie; Cranston, Ross D.; Duffill, Kathryn; Althouse, Andrew D.; Hawkins, Kevin L.; De Rosa, Stephen C.			Exploring the Feasibility of Multi-Site Flow Cytometric Processing of Gut Associated Lymphoid Tissue with Centralized Data Analysis for Multi-Site Clinical Trials	PLOS ONE			English	Article							INFECTION; CELLS	The purpose of this study was to determine whether the development of a standardized approach to the collection of intestinal tissue from healthy volunteers, isolation of gut associated lymphoid tissue mucosal mononuclear cells (MMC), and characterization of mucosal T cell phenotypes by flow cytometry was sufficient to minimize differences in the normative ranges of flow parameters generated at two trial sites. Forty healthy male study participants were enrolled in Pittsburgh and Los Angeles. MMC were isolated from rectal biopsies using the same biopsy acquisition and enzymatic digestion protocols. As an additional comparator, peripheral blood mononuclear cells (PBMC) were collected from the study participants. For quality control, cryopreserved PBMC from a single donor were supplied to both sites from a central repository (qPBMC). Using a jointly optimized standard operating procedure, cells were isolated from tissue and blood and stained with monoclonal antibodies targeted to T cell phenotypic markers. Site-specific flow data were analyzed by an independent center which analyzed all data from both sites. Ranges for frequencies for overall CD4+ and CD8+ T cells, derived from the qPBMC samples, were equivalent at both UCLA and MWRI. However, there were significant differences across sites for the majority of T cell activation and memory subsets in qPBMC as well as PBMC and MMC. Standardized protocols to collect, stain, and analyze MMC and PBMC, including centralized analysis, can reduce but not exclude variability in reporting flow data within multi-site studies. Based on these data, centralized processing, flow cytometry, and analysis of samples may provide more robust data across multi-site studies. Centralized processing requires either shipping of fresh samples or cryopreservation and the decision to perform centralized versus site processing needs to take into account the drawbacks and restrictions associated with each method.	[McGowan, Ian; Cranston, Ross D.; Althouse, Andrew D.] Univ Pittsburgh, Sch Med, Pittsburgh, PA 15260 USA; [Anton, Peter A.; Elliott, Julie] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Anton, Peter A.; Elliott, Julie] Univ Calif Los Angeles, David Geffen Sch Med, AIDS Inst, Los Angeles, CA 90095 USA; [Duffill, Kathryn; Althouse, Andrew D.] Magee Womens Res Inst, Pittsburgh, PA USA; [Hawkins, Kevin L.; De Rosa, Stephen C.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [De Rosa, Stephen C.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	McGowan, I (corresponding author), Univ Pittsburgh, Sch Med, Pittsburgh, PA 15260 USA.	imcgowan@pitt.edu	Althouse, Andrew/AAF-5053-2019; Althouse, Andrew/AAF-4836-2019; M, Ian/AAP-1032-2021; M, i/HCI-9242-2022	Althouse, Andrew/0000-0002-8654-5014; M, Ian/0000-0002-6470-8476; Cranston, Ross/0000-0002-2687-6217	HIV Vaccine Trials Network (HVTN) [UM1AI068618]; Center for HIV/AIDS Vaccine Immunology [U19AI067854]; Mucosal Immunology Group [UM1AI068618]; CFARs at UCLA (Mucosal Immunology Core Laboratory and Flow Cytometry Core) [AI028697-20]; University of Washington/Fred Hutchinson Cancer Research Center [AI027757]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757, UM1AI068614, U01AI068618, U19AI067854, UM1AI068618, P30AI028697, U01AI068614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041301] Funding Source: NIH RePORTER	HIV Vaccine Trials Network (HVTN); Center for HIV/AIDS Vaccine Immunology; Mucosal Immunology Group; CFARs at UCLA (Mucosal Immunology Core Laboratory and Flow Cytometry Core); University of Washington/Fred Hutchinson Cancer Research Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the HIV Vaccine Trials Network (HVTN) (UM1AI068618), the Center for HIV/AIDS Vaccine Immunology (U19AI067854), and by funds received through the Mucosal Immunology Group (http://public.hivmucosalgroup.org), a group funded by a supplement to the HVTN Laboratory Program (UM1AI068618). This work was also supported by the CFARs at UCLA (Mucosal Immunology Core Laboratory and Flow Cytometry Core: AI028697-20) and University of Washington/Fred Hutchinson Cancer Research Center (AI027757). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bainbridge J, 2014, J IMMUNOL METHODS; Baumgarth N, 2000, J IMMUNOL METHODS, V243, P77, DOI 10.1016/S0022-1759(00)00229-5; Bissessor M, 2013, SEX TRANSM DIS, V40, P768, DOI 10.1097/OLQ.0000000000000022; Esparza J, 2013, VACCINE, V31, P3502, DOI 10.1016/j.vaccine.2013.05.018; Ibarrondo FJ, 2013, MUCOSAL IMMUNOL, V6, P591, DOI 10.1038/mi.2012.101; KAGAN J, 1993, ANN NY ACAD SCI, V677, P50, DOI 10.1111/j.1749-6632.1993.tb38763.x; Mcgowan I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060147; Poles MA, 2001, J VIROL, V75, P8390, DOI 10.1128/JVI.75.18.8390-8399.2001; Shacklett BL, 2003, J IMMUNOL METHODS, V279, P17, DOI 10.1016/S0022-1759(03)00255-2; Shattock RJ, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007385; Shete A, 2013, J IMMUNOASS IMMUNOCH, V34, P333, DOI 10.1080/15321819.2012.741087; Yang OO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088621; Zhu J, 2009, NAT MED, V15, P886, DOI 10.1038/nm.2006	13	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0126454	10.1371/journal.pone.0126454	http://dx.doi.org/10.1371/journal.pone.0126454			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010577	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000355183900029
J	Rango, M; Bonifati, C; Bresolin, N				Rango, Mario; Bonifati, Cristiana; Bresolin, Nereo			Post-Activation Brain Warming: A 1-H MRS Thermometry Study	PLOS ONE			English	Article							OXIDATIVE-METABOLISM; CEREBRAL OXYGEN; TEMPERATURE; BLOOD; MODEL	Purpose Temperature plays a fundamental role for the proper functioning of the brain. However, there are only fragmentary data on brain temperature (T-br) and its regulation under different physiological conditions. Methods We studied T-br in the visual cortex of 20 normal subjects serially with a wide temporal window under different states including rest, activation and recovery by a visual stimulation-Magnetic Resonance Spectroscopy Thermometry combined approach. We also studied T-br in a control region, the centrum semiovale, under the same conditions. Results Visual cortex mean baseline T-br was higher than mean body temperature (37.38 vs 36.60, P< 0.001). During activation T-br remained unchanged at first and then showed a small decrease (-0.20 C degrees) around the baseline value. After the end of activation T-br increased consistently (+ 0.60 C degrees) and then returned to baseline values after some minutes. Centrum semiovale T-br remained unchanged through rest, visual stimulation and recovery. Conclusion These findings have several implications, among them that neuronal firing itself is not a major source of heat release in the brain and that there is an aftermath of brain activation that lasts minutes before returning to baseline conditions.	[Rango, Mario; Bonifati, Cristiana; Bresolin, Nereo] Univ Milan, Dept Neurol Sci, IRCCS Ca Granda Osped Maggiore Policlin Fdn, Milan, Italy; [Rango, Mario; Bonifati, Cristiana; Bresolin, Nereo] Univ Milan, Magnet Resonance Spect Ctr, IRCCS Ca Granda Osped Maggiore Policlin Fdn, Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan	Rango, M (corresponding author), Univ Milan, Dept Neurol Sci, IRCCS Ca Granda Osped Maggiore Policlin Fdn, Milan, Italy.	mariocristia@yahoo.it	rango, mario/AIA-9372-2022	Bresolin, Nereo/0000-0001-6694-3595				CADY EB, 1995, MAGN RESON MED, V33, P862, DOI 10.1002/mrm.1910330620; Chadzynski GL, 2011, J MAGN RESON, V212, P55, DOI 10.1016/j.jmr.2011.06.009; Corbett R, 1997, J CEREBR BLOOD F MET, V17, P363, DOI 10.1097/00004647-199704000-00001; CORBETT RJT, 1995, J NEUROCHEM, V64, P1224; Edden RAE, 2007, MAGN RESON MED, V57, P977, DOI 10.1002/mrm.21234; Frahm J, 1996, MAGNET RESON MED, V35, P143, DOI 10.1002/mrm.1910350202; GEORGE JS, 1993, ADV EXP MED BIOL, V333, P125; Gorbach AM, 2003, ANN NEUROL, V54, P297, DOI 10.1002/ana.10646; Katz-Brull R, 2006, MAGN RESON MED, V56, P348, DOI 10.1002/mrm.20972; Kim SG, 2012, J CEREBR BLOOD F MET, V32, P1188, DOI 10.1038/jcbfm.2012.23; Kiyatkin EA, 2002, EUR J NEUROSCI, V16, P164, DOI 10.1046/j.1460-9568.2002.02066.x; Kiyatkin EA, 2010, FRONT BIOSCI-LANDMRK, V15, P73, DOI 10.2741/3608; Lu HZ, 2004, J CEREBR BLOOD F MET, V24, P764, DOI 10.1097/01.WCB.0000124322.60992.5C; Madsen PL, 1998, J CEREBR BLOOD F MET, V18, P742, DOI 10.1097/00004647-199807000-00005; Marrett S., 1992, Society for Neuroscience Abstracts, V18, P1394; Martin JH, 1996, NEUROANATOMY, V17, P345; PENNES HH, 1948, J APPL PHYSIOL, V1, P93, DOI 10.1152/jappl.1948.1.2.93; Pouwels PJW, 1997, NMR BIOMED, V10, P73, DOI 10.1002/(SICI)1099-1492(199704)10:2<73::AID-NBM448>3.0.CO;2-4; Rango M, 1997, MAGNET RESON MED, V38, P878, DOI 10.1002/mrm.1910380605; Rango M, 2012, NEUROREPORT, V23, P483, DOI 10.1097/WNR.0b013e3283534a60; Siegel GJ, 1981, BASIC NEUROCHEMISTRY, V13, P231; Siesjo B, 1978, BRAIN ENERGY METABOL, V4, P79; SIGGAARDANDERSEN O, 1984, CLIN CHEM, V30, P1646; Sukstanskii AL, 2006, P NATL ACAD SCI USA, V103, P12144, DOI 10.1073/pnas.0604376103; Tang B, 2013, BRAIN IMAGING BEHAV, V7, P177, DOI 10.1007/s11682-012-9212-1; Trubel HKF, 2006, J CEREBR BLOOD F MET, V26, P68, DOI 10.1038/sj.jcbfm.9600164; Volgushev M, 2000, J PHYSIOL-LONDON, V528, P669; Volgushev M, 2000, J PHYSIOL-LONDON, V522, P59, DOI 10.1111/j.1469-7793.2000.0059m.x; Yablonskiy DA, 2000, P NATL ACAD SCI USA, V97, P7603, DOI 10.1073/pnas.97.13.7603; Zhu M, 2008, MAGN RESON MED, V60, P536, DOI 10.1002/mrm.21699; Zhu XH, 2001, MAGN RESON MED, V46, P841, DOI 10.1002/mrm.1267	31	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127314	10.1371/journal.pone.0127314	http://dx.doi.org/10.1371/journal.pone.0127314			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011731	Green Published, gold, Green Submitted			2022-12-26	WOS:000355183900081
J	Ruzo, A; Ismailoglu, I; Popowski, M; Haremaki, T; Croft, GF; Deglincerti, A; Brivanlou, AH				Ruzo, Albert; Ismailoglu, Ismail; Popowski, Melissa; Haremaki, Tomomi; Croft, Gist F.; Deglincerti, Alessia; Brivanlou, Ali H.			Discovery of Novel Isoforms of Huntingtin Reveals a New Hominid-Specific Exon	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; DISEASE GENE; CASPASE CLEAVAGE; NUCLEAR; PROTEIN; LETHALITY; BIOGPS; DOMAIN	Huntington's disease (HD) is a devastating neurological disorder that is caused by an expansion of the poly-Q tract in exon 1 of the Huntingtin gene (HTT). HTT is an evolutionarily conserved and ubiquitously expressed protein that has been linked to a variety of functions including transcriptional regulation, mitochondrial function, and vesicle transport. This large protein has numerous caspase and calpain cleavage sites and can be decorated with several post-translational modifications such as phosphorylations, acetylations, sumoylations, and palmitoylations. However, the exact function of HTT and the role played by its modifications in the cell are still not well understood. Scrutiny of HTT function has been focused on a single, full length mRNA. In this study, we report the discovery of 5 novel HTT mRNA splice isoforms that are expressed in normal and HTT-expanded human embryonic stem cell (hESC) lines as well as in cortical neurons differentiated from hESCs. Interestingly, none of the novel isoforms generates a truncated protein. Instead, 4 of the 5 new isoforms specifically eliminate domains and modifications to generate smaller HTT proteins. The fifth novel isoform incorporates a previously unreported additional exon, dubbed 41b, which is hominid-specific and introduces a potential phosphorylation site in the protein. The discovery of this hominid-specific isoform may shed light on human-specific pathogenic mechanisms of HTT, which could not be investigated with current mouse models of the disease.	[Ruzo, Albert; Ismailoglu, Ismail; Popowski, Melissa; Haremaki, Tomomi; Croft, Gist F.; Deglincerti, Alessia; Brivanlou, Ali H.] Rockefeller Univ, Mol Embryol Lab, New York, NY 10021 USA	Rockefeller University	Brivanlou, AH (corresponding author), Rockefeller Univ, Mol Embryol Lab, 1230 York Ave, New York, NY 10021 USA.	brvnlou@rockefeller.edu		Croft, Gist/0000-0002-9721-0148; Ismailoglu, Ismail/0000-0003-4865-273X	Cure Huntington's Disease Initiative (CHDI) Foundation [A-8185]	Cure Huntington's Disease Initiative (CHDI) Foundation	This work is supported by a grant from the Cure Huntington's Disease Initiative (CHDI) Foundation #A-8185 (http://chdifoundation.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwal RS, 2008, AUTOPHAGY, V4, P91, DOI 10.4161/auto.5201; Atwal RS, 2007, HUM MOL GENET, V16, P2600, DOI 10.1093/hmg/ddm217; Bradley CK, 2011, STEM CELLS DEV, V20, P495, DOI 10.1089/scd.2010.0120; Desmond CR, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.412379; Dragatsis I, 1998, DEVELOPMENT, V125, P1529; Feyeux M, 2012, HUM MOL GENET, V21, P3883, DOI 10.1093/hmg/dds216; Gill BJ, 2014, P NATL ACAD SCI USA, V111, P12550, DOI 10.1073/pnas.1405839111; Hermel E, 2004, CELL DEATH DIFFER, V11, P424, DOI 10.1038/sj.cdd.4401358; Hughes AC, 2014, J MOL BIOL, V426, P1428, DOI 10.1016/j.jmb.2013.12.028; James D, 2006, DEV BIOL, V295, P90, DOI 10.1016/j.ydbio.2006.03.026; LIN BY, 1994, HUM MOL GENET, V3, P85, DOI 10.1093/hmg/3.1.85; Luo SQ, 2005, J CELL BIOL, V169, P647, DOI 10.1083/jcb.200412071; Maiuri T, 2013, HUM MOL GENET, V22, P1383, DOI 10.1093/hmg/dds554; Menalled LB, 2002, TRENDS PHARMACOL SCI, V23, P32, DOI 10.1016/S0165-6147(00)01884-8; Menalled Liliana B, 2005, NeuroRx, V2, P465, DOI 10.1602/neurorx.2.3.465; Rosa A, 2009, DEV CELL, V16, P517, DOI 10.1016/j.devcel.2009.02.007; Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3; Sathasivam K, 2013, P NATL ACAD SCI USA, V110, P2366, DOI 10.1073/pnas.1221891110; Sawa A, 2005, NEUROBIOL DIS, V20, P267, DOI 10.1016/j.nbd.2005.02.013; Shi YC, 2012, NAT NEUROSCI, V15, P477, DOI 10.1038/nn.3041; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wellington CL, 2002, J NEUROSCI, V22, P7862; Wellington CL, 2000, J BIOL CHEM, V275, P19831, DOI 10.1074/jbc.M001475200; Woda JM, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-17; Wu CL, 2013, NUCLEIC ACIDS RES, V41, pD561, DOI 10.1093/nar/gks1114; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Wu JQ, 2010, P NATL ACAD SCI USA, V107, P5254, DOI 10.1073/pnas.0914114107; Xia JR, 2003, HUM MOL GENET, V12, P1393, DOI 10.1093/hmg/ddg156; ZEITLIN S, 1995, NAT GENET, V11, P155, DOI 10.1038/ng1095-155	29	19	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127687	10.1371/journal.pone.0127687	http://dx.doi.org/10.1371/journal.pone.0127687			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010866	Green Published, gold, Green Submitted			2022-12-26	WOS:000355183900132
J	Steinhoff-Wagner, J; Schonhusen, U; Zitnan, R; Hudakova, M; Pfannkuche, H; Hammon, HM				Steinhoff-Wagner, Julia; Schoenhusen, Ulrike; Zitnan, Rudolf; Hudakova, Monika; Pfannkuche, Helga; Hammon, Harald M.			Ontogenic Changes of Villus Growth, Lactase Activity, and Intestinal Glucose Transporters in Preterm and Term Born Calves with or without Prolonged Colostrum Feeding	PLOS ONE			English	Article							BRUSH-BORDER MEMBRANE; NEONATAL CALVES; GASTROINTESTINAL-TRACT; ENZYME-ACTIVITIES; DAIRY-COWS; METABOLISM; MATURATION; ABSORPTION; MORPHOLOGY; MUCOSA	Oral glucose supply is important for neonatal calves to stabilize postnatal plasma glucose concentration. The objective of this study was to investigate ontogenic development of small intestinal growth, lactase activity, and glucose transporter in calves (n = 7 per group) that were born either preterm (PT; delivered by section 9 d before term) or at term (T; spontaneous vaginal delivery) or spontaneously born and fed colostrum for 4 days (TC). Tissue samples from duodenum and proximal, mid, and distal jejunum were taken to measure villus size and crypt depth, protein concentration of mucosa and brush border membrane vesicles (BBMV), total DNA and RNA concentration of mucosa, mRNA expression and activity of lactase, and mRNA expression of sodium-dependent glucose co-transporter-1 (SGLT1) and facilitative glucose transporter 2 (GLUT2) in mucosal tissue. Additionally, protein expression of SGLT1 in BBMV and GLUT2 in crude mucosal membranes and immunochemical localization of GLUT2 in the enterocytes were determined. Villus height in distal jejunum was lower in TC than in T. Crypt depth in all segments was largest and the villus height/crypt depth ratio in jejunum was smallest in TC calves. Concentration of RNA was highest in duodenal mucosa of TC calves, but neither lactase mRNA and activity nor SGLT1 and GLUT2 mRNA and protein expression differed among groups. Localization of GLUT2 in the apical membrane was greater, whereas in the basolateral membrane was lower in TC than in T and PT calves. Our study indicates maturation processes after birth for mucosal growth and trafficking of GLUT2 from the basolateral to the apical membrane. Minor differences of mucosal growth, lactase activity, and intestinal glucose transporters were seen between PT and T calves, pointing at the importance of postnatal maturation and feeding for mucosal growth and GLUT2 trafficking.	[Steinhoff-Wagner, Julia; Schoenhusen, Ulrike; Hammon, Harald M.] Leibniz Inst Farm Anim Biol FBN, Inst Nutr Physiol Oskar Kellner, D-18196 Dummerstorf, Germany; [Zitnan, Rudolf] Natl Ctr Agr & Food Nitra, Inst Nutr, Kosice 04181, Slovakia; [Hudakova, Monika] Sch Econ & Management Publ Adm, Bratislava 85104, Slovakia; [Pfannkuche, Helga] Univ Leipzig, Inst Vet Physiol, D-04103 Leipzig, Germany	Forschungsinstitut fur Nutztierbiologie (FBN); Leipzig University	Hammon, HM (corresponding author), Leibniz Inst Farm Anim Biol FBN, Inst Nutr Physiol Oskar Kellner, D-18196 Dummerstorf, Germany.	hammon@fbn-dummerstorf.de	Hammon, Harald/AAD-9990-2020; Hudáková, Monika/ABG-2596-2020; Steinhoff-Wagner, Julia/H-9730-2019	Hudáková, Monika/0000-0003-0454-9626; Steinhoff-Wagner, Julia/0000-0003-0180-9859	German Research Foundation [HA 4372/5-1]	German Research Foundation(German Research Foundation (DFG))	This work was supported by the German Research Foundation (HA 4372/5-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bird AR, 1996, J ANIM SCI, V74, P2523; Bittrich S, 2004, J DAIRY SCI, V87, P1786, DOI 10.3168/jds.S0022-0302(04)73334-2; Bittrich S, 2002, J ANIM PHYSIOL AN N, V86, P185, DOI 10.1046/j.1439-0396.2002.00372.x; Blattler U, 2001, J NUTR, V131, P1256; Blum JW, 2006, J ANIM PHYSIOL AN N, V90, P1, DOI 10.1111/j.1439-0396.2005.00614.x; Blum JW, 2000, LIVEST PROD SCI, V66, P151, DOI 10.1016/S0301-6226(00)00222-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRITT DG, 1974, J DAIRY SCI, V57, P416, DOI 10.3168/jds.S0022-0302(74)84906-4; Buhler C, 1998, J ANIM SCI, V76, P758; Cherbuy C, 1997, AM J PHYSIOL-GASTR L, V272, pG1530, DOI 10.1152/ajpgi.1997.272.6.G1530; Cohen M, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.140091; CREAMER B, 1961, GUT, V2, P110, DOI 10.1136/gut.2.2.110; FUJITA M, 1971, BIOCHIM BIOPHYS ACTA, V233, P404, DOI 10.1016/0005-2736(71)90337-3; GALJAARD H, 1972, EXP CELL RES, V73, P197, DOI 10.1016/0014-4827(72)90120-6; GIRARD J, 1992, PHYSIOL REV, V72, P507, DOI 10.1152/physrev.1992.72.2.507; Guilloteau P, 2009, J PHYSIOL PHARMACOL, V60, P37; Hadorn U, 1997, J NUTR, V127, P2011, DOI 10.1093/jn/127.10.2011; Hammon HM, 2013, J ANIM SCI, V91, P685, DOI 10.2527/jas.2012-5758; Hammon HM, 2009, J DAIRY SCI, V92, P1554, DOI 10.3168/jds.2008-1634; HEDIGER MA, 1994, PHYSIOL REV, V74, P993, DOI 10.1152/physrev.1994.74.4.993; Kellett GL, 2008, ANNU REV NUTR, V28, P35, DOI 10.1146/annurev.nutr.28.061807.155518; Kellett GL, 2000, BIOCHEM J, V350, P155, DOI 10.1042/0264-6021:3500155; Lohrenz AK, 2011, J DAIRY SCI, V94, P4546, DOI 10.3168/jds.2011-4333; Mir PS, 1997, CAN J ANIM SCI, V77, P441, DOI 10.4141/A96-097; Ontsouka EC, 2004, J DAIRY SCI, V87, P4230, DOI 10.3168/jds.S0022-0302(04)73568-7; Pacha J, 2000, PHYSIOL REV, V80, P1633, DOI 10.1152/physrev.2000.80.4.1633; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pfannkuche H, 2014, J ANIM PHYSIOL AN N, V98, P140, DOI 10.1111/jpn.12057; Roder PV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089977; Sangild P. T., 2001, P3, DOI 10.1079/9780851995175.0003; SANGILD PT, 1995, PEDIATR RES, V37, P207, DOI 10.1203/00006450-199502000-00014; Sangild PT, 2002, J NUTR, V132, P3785, DOI 10.1093/jn/132.9.2673; Sauter SN, 2004, BIOL NEONATE, V85, P94, DOI 10.1159/000074965; Schmidt M, 2004, THERIOGENOLOGY, V61, P1729, DOI 10.1016/j.theriogenology.2003.10.002; Schroder B, 1996, J COMP PHYSIOL B, V166, P230, DOI 10.1007/BF00263987; Shirazi-Beechey S. P., 1995, Ruminant physiology: digestion, metabolism, growth and reproduction. Proceedings 8th International Symposium on Ruminant Physiology., P117; Steinhoff-Wagner J, 2011, J DAIRY SCI, V94, P5111, DOI 10.3168/jds.2011-4355; Steinhoff-Wagner J, 2014, J DAIRY SCI, V97, P6358, DOI 10.3168/jds.2014-8391; Steinhoff-Wagner J, 2011, J NUTR, V141, P48, DOI 10.3945/jn.110.128652; TIVEY DR, 1994, EXP PHYSIOL, V79, P189, DOI 10.1113/expphysiol.1994.sp003752; TRAHAIR JF, 1987, Q J EXP PHYSIOL CMS, V72, P71, DOI 10.1113/expphysiol.1987.sp003056; Zierler K, 1999, AM J PHYSIOL-ENDOC M, V276, pE409, DOI 10.1152/ajpendo.1999.276.3.E409; Zitnan R, 2008, VET MED-CZECH, V53, P525, DOI 10.17221/1968-VETMED	43	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128154	10.1371/journal.pone.0128154	http://dx.doi.org/10.1371/journal.pone.0128154			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011395	Green Published, gold, Green Submitted			2022-12-26	WOS:000355183900198
J	Zheng, W; Zhang, XY; Lu, Q				Zheng, Wei; Zhang, Xiaoya; Lu, Qi			A BHR Composite Network-Based Visualization Method for Deformation Risk Level of Underground Space	PLOS ONE			English	Article							TUNNEL CONSTRUCTION; 3D; TECHNOLOGY; STATION; SYSTEM	This study proposes a visualization processing method for the deformation risk level of underground space. The proposed method is based on a BP-Hopfield-RGB (BHR) composite network. Complex environmental factors are integrated in the BP neural network. Dynamic monitoring data are then automatically classified in the Hopfield network. The deformation risk level is combined with the RGB color space model and is displayed visually in real time, after which experiments are conducted with the use of an ultrasonic omnidirectional sensor device for structural deformation monitoring. The proposed method is also compared with some typical methods using a benchmark dataset. Results show that the BHR composite network visualizes the deformation monitoring process in real time and can dynamically indicate dangerous zones.	[Zheng, Wei; Zhang, Xiaoya; Lu, Qi] Chongqing Univ, Coll Optoelect Engn, Educ Minist China, Key Lab Optoelect Technol & Syst, Chongqing 630044, Peoples R China	Chongqing University	Zheng, W (corresponding author), Chongqing Univ, Coll Optoelect Engn, Educ Minist China, Key Lab Optoelect Technol & Syst, Chongqing 630044, Peoples R China.	zw3475@163.com			National Natural Science Foundation of China [61174006]; Fundamental Research Funds for the Central Universities [106112015CDJXY120014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The project is supported by the National Natural Science Foundation of China (Grant No. 61174006) and the Fundamental Research Funds for the Central Universities (Project No. 106112015CDJXY120014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmet M, 2014, NEUROCOMPUTING, V145, P230, DOI 10.1016/j.neucom.2014.05.038; Albertini MK, 2013, ADV DATA ANAL CLASSI, V7, P435, DOI 10.1007/s11634-013-0145-3; BENJAMIN CO, 1995, COMPUT IND ENG, V28, P43, DOI 10.1016/0360-8352(94)00021-E; Chen LH, 2014, APPL MECH MATER, V501-504, P839, DOI 10.4028/www.scientific.net/AMM.501-504.839; Chia CC, 2012, STRUCT CONTROL HLTH, V19, P605, DOI 10.1002/stc.1504; Giangarra PP, 2011, IBM J RES DEV, V55, DOI 10.1147/JRD.2010.2086250; Glisic B, 2014, COMPUT-AIDED CIV INF, V29, P382, DOI 10.1111/mice.12060; Heddam S, 2014, ENVIRON MONIT ASSESS, V186, P7837, DOI 10.1007/s10661-014-3971-7; Kai C, 2013, PROC SPIE, V8769, DOI 10.1117/12.2020749; Kamat VR, 2011, J CONSTR ENG M, V137, P853, DOI 10.1061/(ASCE)CO.1943-7862.0000262; Kim S, 2013, IEEE T VIS COMPUT GR, V19, P1438, DOI 10.1109/TVCG.2013.66; Koo B, 2010, IEICE T COMMUN, VE93B, P2963, DOI 10.1587/transcom.E93.B.2963; Lavine A, 2003, ENG GEOL, V70, P71, DOI 10.1016/S0013-7952(03)00083-8; Li XJ, 2009, J COMPUT CIVIL ENG, V23, P348, DOI 10.1061/(ASCE)0887-3801(2009)23:6(348); Liang GL, 2012, DISASTER ADV, V5, P312; Linderman LE, 2013, STRUCT CONTROL HLTH, V20, P1007, DOI 10.1002/stc.1514; Marzouk MM, 2014, SMART STRUCT SYST, V13, P407, DOI 10.12989/sss.2014.13.3.407; Scaioni M, 2014, EARTH SCI INFORM, V7, P83, DOI 10.1007/s12145-014-0152-8; Sikora M, 2010, ARCH MIN SCI, V55, P91; Silvestrini M, 2009, J LOSS PREVENT PROC, V22, P449, DOI 10.1016/j.jlp.2009.02.018; Simbeye DS, 2014, COMPUT ELECTRON AGR, V102, P31, DOI 10.1016/j.compag.2014.01.004; Smith DV, 2002, P SOC PHOTO-OPT INS, V4758, P251, DOI 10.1117/12.462230; Sousa H, 2013, SMART STRUCT SYST, V11, P365, DOI 10.12989/sss.2013.11.4.365; Sun P, 2012, MATH PROBL ENG, V2012, DOI 10.1155/2012/542501; Szedlak A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105842; Tang SL, 2011, ADV MATER RES-SWITZ, V225-226, P26, DOI 10.4028/www.scientific.net/AMR.225-226.26; Wu SL, 2013, ADV MATER RES-SWITZ, V779-780, P463, DOI 10.4028/www.scientific.net/AMR.779-780.463; Ye XW, 2012, INT J DISTRIB SENS N, DOI 10.1155/2012/685054; Yeung JS, 2013, TUNN UNDERGR SP TECH, V38, P534, DOI 10.1016/j.tust.2013.09.002; Zheng W, 2014, MEAS SCI TECHNOL, V25, DOI 10.1088/0957-0233/25/3/037001; Zhou Y, 2013, AUTOMAT CONSTR, V34, P25, DOI 10.1016/j.autcon.2012.10.011	31	1	1	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127088	10.1371/journal.pone.0127088	http://dx.doi.org/10.1371/journal.pone.0127088			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011618	Green Published, gold, Green Submitted			2022-12-26	WOS:000355183900060
J	Zeng, LL; Hu, C; Zhang, FQ; Xu, DC; Cui, MZ; Xu, XM				Zeng, Linlin; Hu, Chen; Zhang, Fuqiang; Xu, Daniel C.; Cui, Mei-Zhen; Xu, Xuemin			Cellular FLICE-like Inhibitory Protein (c-FLIP) and PS1-associated Protein (PSAP) Mediate Presenilin 1-induced gamma-Secretase-dependent and -independent Apoptosis, Respectively	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; PERTURBED CALCIUM HOMEOSTASIS; ALZHEIMERS-DISEASE; TRANSMEMBRANE DOMAIN; MUTANT PRESENILIN-1; INCREASED SENSITIVITY; CASPASE-8 ACTIVATION; SIGNALING PATHWAY; CANCER CELLS; DEATH	Presenilin 1 (PS1) has been implicated in apoptosis; however, its mechanism remains elusive. We report that PS1-induced apoptosis was associated with cellular FLICE-like inhibitory protein (c-FLIP) turnover and that gamma-secretase inhibitor blocked c-FLIP turnover and also partially blocked PS1-induced apoptosis. A complete inhibition of PS1-induced apoptosis was achieved by knockdown of PS1-associated protein (PSAP), a mitochondrial proapoptotic protein that forms a complex with Bax upon induction of apoptosis, in the presence of gamma-secretase inhibitor. PS1-induced apoptosis was partially inhibited by knockdown of caspase-8, Fas-associated protein with death domain (FADD), or Bid. However, knockdown of Bax or overexpression of Bcl-2 resulted in complete inhibition of PS1-induced apoptosis. These data suggest that PS1 induces apoptosis through two pathways: the gamma-secretase-dependent pathway mediated by turnover of c-FLIP and the gamma-secretase-independent pathway mediated by PSAP-Bax complex formation. These two pathways converge on Bax to activate mitochondria-dependent apoptosis. These findings provide new insight into the mechanisms by which PS1 is involved in apoptosis and the mechanism by which PS1 exerts its pathogenic effects. In addition, our results suggest that PS2 induces apoptosis through a pathway that is different from that of PS1.	[Zeng, Linlin; Hu, Chen; Zhang, Fuqiang; Cui, Mei-Zhen; Xu, Xuemin] Univ Tennessee, Dept Biomed & Diagnost Sci, Coll Vet Med, Knoxville, TN 37996 USA; [Hu, Chen] Univ Tennessee, Dept Comparat & Expt Med, Knoxville, TN 37996 USA; [Xu, Daniel C.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; Princeton University	Xu, XM (corresponding author), Univ Tennessee, Dept Biomed & Diagnost Sci, Coll Vet Med, 2407 River Dr, Knoxville, TN 37996 USA.	xmx@utk.edu	Regan, Clinton/E-6250-2012	Cui, Mei-Zhen/0000-0003-4745-6999; xu, xuemin/0000-0002-7426-272X	National Institutes of Health [R181741110, R21AG039596, 0355339B]; Alzheimer's Association grant; American Health Assistance Foundation; University of Tennessee Center of Excellence in Livestock Diseases and Human Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107466] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG039596, R01AG026640] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association grant(Alzheimer's Association); American Health Assistance Foundation(BrightFocus Foundation); University of Tennessee Center of Excellence in Livestock Diseases and Human Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R181741110 and R21AG039596 (to X. X.) and 0355339B (to M.-Z.C.). This work was also supported by an Alzheimer's Association grant and a grant from the American Health Assistance Foundation (to X. X.) and by the University of Tennessee Center of Excellence in Livestock Diseases and Human Health (to X. X.). The authors declare that they have no conflicts of interest with the contents of this article.	Alberici A, 1999, J BIOL CHEM, V274, P30764, DOI 10.1074/jbc.274.43.30764; Berezovska O, 2000, J NEUROCHEM, V75, P583, DOI 10.1046/j.1471-4159.2000.0750583.x; Chan SL, 2002, NEUROBIOL DIS, V11, P2, DOI 10.1006/nbdi.2002.0542; Chandu D, 2006, J NEUROCHEM, V96, P228, DOI 10.1111/j.1471-4159.2005.03547.x; Chui DH, 1999, NAT MED, V5, P560, DOI 10.1038/8438; Coen K, 2010, BIOCHEM SOC T, V38, P1474, DOI 10.1042/BST0381474; Daniel PT, 2001, LEUKEMIA, V15, P1022, DOI 10.1038/sj.leu.2402169; Day TW, 2008, BIOCHEM PHARMACOL, V76, P1694, DOI 10.1016/j.bcp.2008.09.007; De Strooper B, 2010, ANNU REV CELL DEV BI, V26, P235, DOI 10.1146/annurev-cellbio-100109-104117; Deng GM, 1996, FEBS LETT, V397, P50, DOI 10.1016/S0014-5793(96)01142-8; Dickens LS, 2012, EXP CELL RES, V318, P1269, DOI 10.1016/j.yexcr.2012.04.005; Dubrez L, 1996, EMBO J, V15, P5504, DOI 10.1002/j.1460-2075.1996.tb00935.x; Engidawork E, 2001, NEUROSCI LETT, V303, P79, DOI 10.1016/S0304-3940(01)01618-4; Fukumori A, 2010, J NEUROSCI, V30, P7853, DOI 10.1523/JNEUROSCI.1443-10.2010; Haapasalo A, 2011, J ALZHEIMERS DIS, V25, P3, DOI 10.3233/JAD-2011-101065; Jost PJ, 2009, NATURE, V460, P1035, DOI 10.1038/nature08229; Kantari C, 2011, BBA-MOL CELL RES, V1813, P558, DOI 10.1016/j.bbamcr.2011.01.026; Katayama T, 1999, NAT CELL BIOL, V1, P479, DOI 10.1038/70265; Kaufmann T, 2012, CELL DEATH DIFFER, V19, P42, DOI 10.1038/cdd.2011.121; Keller JN, 1998, J NEUROSCI, V18, P4439; Kim SH, 2001, J BIOL CHEM, V276, P43343, DOI 10.1074/jbc.M108245200; Kim TW, 1997, SCIENCE, V277, P373, DOI 10.1126/science.277.5324.373; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Krueger A, 2001, J BIOL CHEM, V276, P20633, DOI 10.1074/jbc.M101780200; Lamarca V, 2008, EUR J CELL BIOL, V87, P325, DOI 10.1016/j.ejcb.2008.02.004; Li T, 2013, BBA-MOL BASIS DIS, V1832, P453, DOI 10.1016/j.bbadis.2012.11.016; Loetscher H, 1997, J BIOL CHEM, V272, P20655, DOI 10.1074/jbc.272.33.20655; Mao GZ, 2008, BBA-GEN SUBJECTS, V1780, P696, DOI 10.1016/j.bbagen.2008.01.013; Mattson MP, 2006, NAT REV NEUROSCI, V7, P278, DOI 10.1038/nrn1886; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; Mosser DD, 2000, MOL CELL BIOL, V20, P7146, DOI 10.1128/MCB.20.19.7146-7159.2000; Ozturk S, 2012, EXP CELL RES, V318, P1324, DOI 10.1016/j.yexcr.2012.01.019; Ola MS, 2011, MOL CELL BIOCHEM, V351, P41, DOI 10.1007/s11010-010-0709-x; Popescu B. O., 2000, J Cell Mol Med, V4, P249, DOI 10.1111/j.1582-4934.2000.tb00124.x; Robinson AJ, 2012, EXP CELL RES, V318, P1316, DOI 10.1016/j.yexcr.2012.01.026; Selkoe DJ, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004457; Sharp DA, 2005, J BIOL CHEM, V280, P19401, DOI 10.1074/jbc.M413962200; Shirley S, 2013, CANCER LETT, V332, P141, DOI 10.1016/j.canlet.2010.10.009; Soriano S, 2001, J CELL BIOL, V152, P785, DOI 10.1083/jcb.152.4.785; Tanzi RE, 2013, J ALZHEIMERS DIS, V33, pS5, DOI 10.3233/JAD-2012-129044; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Vito P, 1996, SCIENCE, V271, P521, DOI 10.1126/science.271.5248.521; Weihl CC, 1999, J NEUROSCI, V19, P5360; Wilson TR, 2009, ONCOGENE, V28, P63, DOI 10.1038/onc.2008.366; Wilson TR, 2007, CANCER RES, V67, P5754, DOI 10.1158/0008-5472.CAN-06-3585; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Wolozin B, 1998, NEUROBIOL AGING, V19, pS23, DOI 10.1016/S0197-4580(98)00041-4; Wolozin B, 1996, SCIENCE, V274, P1710, DOI 10.1126/science.274.5293.1710; Xu XM, 1999, J BIOL CHEM, V274, P32543, DOI 10.1074/jbc.274.46.32543; Xu XM, 2002, J BIOL CHEM, V277, P48913, DOI 10.1074/jbc.M209613200; Xu XM, 2009, J ALZHEIMERS DIS, V16, P211, DOI 10.3233/JAD-2009-0957; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zaltsman Y, 2010, NAT CELL BIOL, V12, P553, DOI 10.1038/ncb2057; Zhao GJ, 2005, J BIOL CHEM, V280, P37689, DOI 10.1074/jbc.M507993200; Zhao M, 2003, NEUROCHEM RES, V28, P307, DOI 10.1023/A:1022337519035	55	12	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18269	18280		10.1074/jbc.M115.640177	http://dx.doi.org/10.1074/jbc.M115.640177			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26025363	hybrid, Green Published			2022-12-26	WOS:000358512100002
J	Jamros, MA; Aubol, BE; Keshwani, MM; Zhang, ZY; Stamm, S; Adams, JA				Jamros, Michael A.; Aubol, Brandon E.; Keshwani, Malik M.; Zhang, Zhaiyi; Stamm, Stefan; Adams, Joseph A.			Intra-domain Cross-talk Regulates Serine-arginine Protein Kinase 1-dependent Phosphorylation and Splicing Function of Transformer 2 beta 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; SR PROTEIN; NUCLEAR IMPORT; PROCESSIVE PHOSPHORYLATION; KINETIC-ANALYSIS; FACTOR ASF/SF2; SMN GENE; SRPK1; PHOSPHATASE-1; RECOGNITION	Transformer 2 beta 1 (Tra2 beta 1) is a splicing effector protein composed of a core RNA recognition motif flanked by two arwginine-serine-rich (RS) domains, RS1 and RS2. Although Tra2 beta 1-dependent splicing is regulated by phosphorylation, very little is known about how protein kinases phosphorylate these two RS domains. We now show that the serine-arginine protein kinase-1 (SRPK1) is a regulator of Tra2 beta 1 and promotes exon inclusion in the survival motor neuron gene 2 (SMN2). To understand how SRPK1 phosphorylates this splicing factor, we performed mass spectrometric and kinetic experiments. We found that SRPK1 specifically phosphorylates 21 serines in RS1, a process facilitated by a docking groove in the kinase domain. Although SRPK1 readily phosphorylates RS2 in a splice variant lacking the N-terminal RS domain (Tra2 beta 3), RS1 blocks phosphorylation of these serines in the full-length Tra2 beta 1. Thus, RS2 serves two new functions. First, RS2 positively regulates binding of the central RNA recognition motif to an exonic splicing enhancer sequence, a phenomenon reversed by SRPK1 phosphorylation on RS1. Second, RS2 enhances ligand exchange in the SRPK1 active site allowing highly efficient Tra2 beta 1 phosphorylation. These studies demonstrate that SRPK1 is a regulator of Tra2 beta 1 splicing function and that the individual RS domains engage in considerable cross-talk, assuming novel functions with regard to RNA binding, splicing, and SRPK1 catalysis.	[Jamros, Michael A.; Aubol, Brandon E.; Keshwani, Malik M.; Adams, Joseph A.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Zhang, Zhaiyi; Stamm, Stefan] Univ Kentucky, Mol & Cellular Biochem Dept, Lexington, KY 40536 USA	University of California System; University of California San Diego; University of Kentucky	Adams, JA (corresponding author), Univ Calif San Diego, Dept Pharmacol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	j2adams@ucsd.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [RO1 GM067969, GM067969]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752, R01GM067969] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 GM067969 (to J. A. A.) and a supplement to GM067969. The authors declare that they have no conflicts of interest with the contents of this article.	ADAMS JA, 1992, BIOCHEMISTRY-US, V31, P8516, DOI 10.1021/bi00151a019; Allemand E, 2005, P NATL ACAD SCI USA, V102, P3605, DOI 10.1073/pnas.0409889102; Aubol BE, 2003, P NATL ACAD SCI USA, V100, P12601, DOI 10.1073/pnas.1635129100; Aubol BE, 2014, BIOCHEM J, V462, P143, DOI 10.1042/BJ20140494; Aubol BE, 2014, BIOCHEMISTRY-US, V53, P4625, DOI 10.1021/bi500483m; Aubol BE, 2013, BIOCHEMISTRY-US, V52, P7595, DOI 10.1021/bi4010864; Aubol BE, 2012, BIOCHEMISTRY-US, V51, P6584, DOI 10.1021/bi300876h; Aubol BE, 2011, BIOCHEMISTRY-US, V50, P6888, DOI 10.1021/bi2007993; Chalfant CE, 2002, J BIOL CHEM, V277, P12587, DOI 10.1074/jbc.M112010200; Cho SY, 2011, P NATL ACAD SCI USA, V108, P8233, DOI 10.1073/pnas.1017700108; Clery A, 2011, NAT STRUCT MOL BIOL, V18, P443, DOI 10.1038/nsmb.2001; Cowper AE, 2001, J BIOL CHEM, V276, P48908, DOI 10.1074/jbc.M103967200; Daoud R, 2002, J NEUROSCI, V22, P5889; Glatz DC, 2006, J NEUROCHEM, V96, P635, DOI 10.1111/j.1471-4159.2005.03552.x; Grant BD, 1996, BIOCHEMISTRY-US, V35, P2022, DOI 10.1021/bi952144+; Hagopian JC, 2008, J MOL BIOL, V382, P894, DOI 10.1016/j.jmb.2008.07.055; Haynes C, 2006, NUCLEIC ACIDS RES, V34, P305, DOI 10.1093/nar/gkj424; Hofmann Y, 2000, P NATL ACAD SCI USA, V97, P9618, DOI 10.1073/pnas.160181697; HOSHIJIMA K, 1991, SCIENCE, V252, P833, DOI 10.1126/science.1902987; Jiang ZH, 2003, J BIOL CHEM, V278, P18997, DOI 10.1074/jbc.M301800200; Kataoka N, 1999, J CELL BIOL, V145, P1145, DOI 10.1083/jcb.145.6.1145; Keshwani MM, 2015, BIOCHEM J, V466, P311, DOI 10.1042/BJ20141373; KOHTZ JD, 1994, NATURE, V368, P119, DOI 10.1038/368119a0; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Lai MC, 2001, P NATL ACAD SCI USA, V98, P10154, DOI 10.1073/pnas.181354098; Li SJ, 2013, J BIOL CHEM, V288, P8898, DOI 10.1074/jbc.M113.456715; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; LYNCH KW, 1995, GENE DEV, V9, P284, DOI 10.1101/gad.9.3.284; Ma CT, 2008, J MOL BIOL, V376, P55, DOI 10.1016/j.jmb.2007.08.029; Ma CT, 2009, J MOL BIOL, V390, P618, DOI 10.1016/j.jmb.2009.05.060; MERMOUD JE, 1994, EMBO J, V13, P5679, DOI 10.1002/j.1460-2075.1994.tb06906.x; Ngo JCK, 2008, MOL CELL, V29, P563, DOI 10.1016/j.molcel.2007.12.017; Ngo JCK, 2005, MOL CELL, V20, P77, DOI 10.1016/j.molcel.2005.08.025; Novoyatleva T, 2008, HUM MOL GENET, V17, P52, DOI 10.1093/hmg/ddm284; ROSCIGNO RF, 1995, RNA, V1, P692; Singh NN, 2004, CRIT REV EUKAR GENE, V14, P271, DOI 10.1615/CritRevEukaryotGeneExpr.v14.i4.30; Stoilov P, 2004, HUM MOL GENET, V13, P509, DOI 10.1093/hmg/ddh051; Stojdl DF, 1999, BIOCHEM CELL BIOL, V77, P293, DOI 10.1139/bcb-77-4-293; Stoss O, 1999, BRAIN RES PROTOC, V4, P383, DOI 10.1016/S1385-299X(99)00043-4; Sumanasekera C, 2012, NUCLEIC ACIDS RES, V40, P4025, DOI 10.1093/nar/gkr1289; Tacke R, 1998, CELL, V93, P139, DOI 10.1016/S0092-8674(00)81153-8; TAZI J, 1992, J BIOL CHEM, V267, P4322; Velazquez-Dones A, 2005, J BIOL CHEM, V280, P41761, DOI 10.1074/jbc.M504156200; Ward AJ, 2010, J PATHOL, V220, P152, DOI 10.1002/path.2649; WU JY, 1993, CELL, V75, P1061, DOI 10.1016/0092-8674(93)90316-I; Xiang SQ, 2013, STRUCTURE, V21, P2162, DOI 10.1016/j.str.2013.09.014; Yu FX, 2013, GENE DEV, V27, P1223, DOI 10.1101/gad.219402.113; Yun CY, 2003, J BIOL CHEM, V278, P18050, DOI 10.1074/jbc.M211714200; ZAHLER AM, 1992, GENE DEV, V6, P837, DOI 10.1101/gad.6.5.837; Zhang ZY, 2011, J BIOL CHEM, V286, P10126, DOI 10.1074/jbc.M110.183970; Zhou J, 1997, BIOCHEMISTRY-US, V36, P15733, DOI 10.1021/bi971438n; Zhou ZH, 2012, MOL CELL, V47, P422, DOI 10.1016/j.molcel.2012.05.014	52	7	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17269	17281		10.1074/jbc.M115.656579	http://dx.doi.org/10.1074/jbc.M115.656579			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	26013829	Green Published, hybrid			2022-12-26	WOS:000357730900023
J	Fusco, G; Lesniewska, M; Congiu, L; Bertorelle, G				Fusco, Giuseppe; Lesniewska, Malgorzata; Congiu, Leonardo; Bertorelle, Giorgio			Population Genetic Structure of a Centipede Species with High Levels of Developmental Instability	PLOS ONE			English	Article							FLUCTUATING ASYMMETRY; SEGMENTATION; GEOPHILOMORPHA; MITOCHONDRIAL; ANOMALIES; ECOLOGY	European populations of the geophilomorph centipede Haplophilus subterraneus show a high proportion of individuals with morphological anomalies, suggesting high levels of developmental instability. The broad geographic distribution of this phenomenon seems to exclude local environmental causes, but the source of instability is still to be identified. The goal of the present study was to collect quantitative data on the occurrence of phenodeviants in different populations, along with data on the patterns of genetic variation within and between populations, in order to investigate possible association between developmental instability and genetic features. In a sample of 11 populations of H. subterraneus, distributed in western and central Europe, we looked for phenodeviants, in particular with respect to trunk morphology, and studied genetic variation through the genotyping of microsatellite loci. Overall, no support was found to the idea that developmental instability in H. subterraneus is related to a specific patterns of genetic variation, including inbreeding estimates. We identified a major genetic partition that subdivides French populations from the others, and a low divergence among northwestern areas, which are possibly related to the post-glacial recolonization from southern refugia and/or to recent anthropogenic soil displacements. A weak correlation between individual number of leg bearing segments and the occurrence of trunk anomalies seems to support a trade-off between these two developmental traits. These results, complemented by preliminary data on developmental stability in two related species, suggest that the phenomenon has not a simple taxonomic distribution, while it exhibits an apparent localization in central and eastern Europe.	[Fusco, Giuseppe; Congiu, Leonardo] Univ Padua, Dept Biol, Padua, Italy; [Lesniewska, Malgorzata] Adam Mickiewicz Univ, Dept Gen Zool, Poznan, Poland; [Bertorelle, Giorgio] Univ Ferrara, Dept Life Sci & Biotechnol, I-44100 Ferrara, Italy	University of Padua; Adam Mickiewicz University; University of Ferrara	Congiu, L (corresponding author), Univ Padua, Dept Biol, Padua, Italy.	leonardo.congiu@unipd.it	Bertorelle, Giorgio/AAE-9078-2022	CONGIU, LEONARDO/0000-0002-9293-9837; Bertorelle, Giorgio/0000-0002-2498-2702; Lesniewska, Malgorzata/0000-0001-9526-7389; FUSCO, GIUSEPPE/0000-0002-4690-6049	Italian Ministry of Education, University and Research (MIUR) [60A06-2190/12]	Italian Ministry of Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work has been supported by a grant (60A06-2190/12) from the Italian Ministry of Education, University and Research (MIUR) to GF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agata K, 2011, MOL ECOL RESOUR, V11, P586, DOI 10.1111/j.1755-0998.2011.03004.x; Barber A.D., 1988, PROVISIONAL ATLAS CE; Beasley DE, 2013, ECOL INDIC, V30, P218, DOI 10.1016/j.ecolind.2013.02.024; Belkhir K, 2004, GENETIX 4 04 LOGICIE; Berto D, 1997, ENTOMOL SCAND, P61; Bonato L, 2014, CLADISTICS, V30, P485, DOI 10.1111/cla.12060; Brena C, 2014, FRONT ZOOL, V11, DOI 10.1186/s12983-014-0058-9; Brena C, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-112; Brena C, 2012, DEV BIOL, V363, P290, DOI 10.1016/j.ydbio.2011.11.006; Clune J, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2863; Edgecombe Gregory D., 2011, P1; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fusco G, 2005, EVOL DEV, V7, P608, DOI 10.1111/j.1525-142X.2005.05064.x; Fusco Giuseppe, 2013, P197; Fusco Giuseppe, 2000, Fragmenta Faunistica (Warsaw), V43, P73; Fusco G, 2010, PHILOS T R SOC B, V365, P547, DOI 10.1098/rstb.2009.0267; Graham John H., 2003, P35; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Homburg K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061185; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Kotlik P, 2006, P NATL ACAD SCI USA, V103, P14860, DOI 10.1073/pnas.0603237103; Kuznetsova A., 2014, R PACKAGE VERSION 2; Lesniewska M., 2012, MORPHOLOGICAL ANOMA; Lesniewska Malgorzata, 2009, Soil Organisms, V81, P347; Lesniewska M, 2009, ARTHROPOD STRUCT DEV, V38, P417, DOI 10.1016/j.asd.2009.05.001; Lindner E. Norman, 2007, Schubartiana, V2, P49; MARKOW TA, 1995, ANNU REV ENTOMOL, V40, P105, DOI 10.1146/annurev.en.40.010195.000541; Maruzzo D, 2005, CRUSTACEAN ISS, V16, P215, DOI 10.1201/9781420037548.ch9; Maruzzo Diego, 2013, P149; Minelli A, 2004, TRENDS ECOL EVOL, V19, P423, DOI 10.1016/j.tree.2004.06.007; Moller AP, 1997, ASYMMETRY DEV STABIL; Nijhout H. F., 2003, P3; PALMER AR, 1986, ANNU REV ECOL SYST, V17, P391, DOI 10.1146/annurev.es.17.110186.002135; PATWARY MU, 1994, J SHELLFISH RES, V13, P547; Polak M., 2003, CAUSES CONSEQUENCES; Pritchard JK, 2000, GENETICS, V155, P945; Ruedi M, 2003, MOL ECOL, V12, P1527, DOI 10.1046/j.1365-294X.2003.01828.x; Savriama Y, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-280; Stewart JR, 2001, TRENDS ECOL EVOL, V16, P608, DOI 10.1016/S0169-5347(01)02338-2; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vilaca ST, 2014, J BIOGEOGR, V41, P987, DOI 10.1111/jbi.12268; Wang JL, 2011, MOL ECOL RESOUR, V11, P141, DOI 10.1111/j.1755-0998.2010.02885.x	42	2	2	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0126245	10.1371/journal.pone.0126245	http://dx.doi.org/10.1371/journal.pone.0126245			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26029915	Green Published, Green Submitted, gold			2022-12-26	WOS:000356630900024
J	Marteinson, SC; Giroux, JF; Helie, JF; Gentes, ML; Verreault, J				Marteinson, Sarah C.; Giroux, Jean-Francois; Helie, Jean-Francois; Gentes, Marie-Line; Verreault, Jonathan			Field Metabolic Rate Is Dependent on Time-Activity Budget in Ring-Billed Gulls (Larus delawarensis) Breeding in an Anthropogenic Environment	PLOS ONE			English	Article							DAILY ENERGY-EXPENDITURE; KITTIWAKES RISSA-TRIDACTYLA; DOUBLY LABELED WATER; REPRODUCTIVE ENERGETICS; FORAGING BEHAVIOR; HEART-RATE; PREY; ALBATROSSES; INCUBATION; SEABIRDS	Environmental and behavioral factors have long been assumed to affect variation in avian field metabolic rate (FMR). However, due to the difficulties in measuring continuous behavior of birds over prolonged periods of time, complete time-activity budgets have rarely been examined in relation to FMR. Our objective was to determine the effect of activity (measured by detailed time-activity budgets) and a series of extrinsic and intrinsic factors on FMR of the omnivorous ring-billed gull (Larus delawarensis). The experiment was conducted during the incubation period when both members of the pair alternate between attending the nest-site and leaving the colony to forage in aquatic and anthropogenic environments (city, agricultural). FMR was determined using the doubly labeled water method. Time-activity budgets were extrapolated from spatio-temporal data (2-5 days) obtained from bird-borne GPS data loggers. Gulls had low FMRs compared to those predicted by allometric equations based on recorded FMRs from several seabird species. Gulls proportioned their time mainly to nest-site attendance (71% of total tracking time), which reduced FMR/g bodymass, and was the best variable explaining energy expenditure. The next best variable was the duration of foraging trips, which increased FMR/g; FMR/g was also elevated by the proportion of time spent foraging or flying (17% and 8% of tracking time respectively). Most environmental variables-measured did not impact FMR/g, however, the percent of time birds were subjected to temperatures below their lower critical temperature increased FMR. Time-activity budgets varied between the sexes, and with temperature and capture date suggesting that these variables indirectly affected FMR/g. The gulls foraged preferentially in anthropogenic-related habitats, which may have contributed to their low FMR/g due to the high availability of protein-and lipid-rich foods. This study demonstrates that activities were the best predictors of FMR/g in ring-billed gulls, thus providing strong support for this long-standing theory in bioenergetics.	[Marteinson, Sarah C.; Gentes, Marie-Line; Verreault, Jonathan] Univ Quebec, Ctr Rech Toxicol Environm TOXEN, Dept Sci Biol, Montreal, PQ H3C 3P8, Canada; [Giroux, Jean-Francois] Univ Quebec, Dept Sci Biol, GRECA, Montreal, PQ H3C 3P8, Canada; [Helie, Jean-Francois] Univ Quebec, Ctr Rech Geochim & Geodynam GEOTOP, Montreal, PQ H3C 3P8, Canada	University of Quebec; University of Quebec Montreal; University of Quebec; University of Quebec Montreal; University of Quebec; University of Quebec Montreal	Verreault, J (corresponding author), Univ Quebec, Ctr Rech Toxicol Environm TOXEN, Dept Sci Biol, Montreal, PQ H3C 3P8, Canada.	verreault.jonathan@uqam.ca	Marteinson, Sarah/AAE-6614-2020; Giroux, Jean-François/L-7945-2019	Giroux, Jean-François/0000-0002-6732-489X; Helie, Jean-Francois/0000-0002-0994-5620	Natural Sciences and Engineering Research Council of Canada [385787]; Canada Research Chair in Comparative Avian Toxicology [225707]; Fonds quebecois de la recherche sur la nature et les technologies [168434]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chair in Comparative Avian Toxicology; Fonds quebecois de la recherche sur la nature et les technologies(FQRNT)	Funding was provided by the Natural Sciences and Engineering Research Council of Canada, http://www.nserc-crsng.gc.ca, to JV (#385787) and J-FG, the Canada Research Chair in Comparative Avian Toxicology, http://www.chairschaires.gc.ca/(#225707) to JV and Fonds quebecois de la recherche sur la nature et les technologies, http://www.frqnt.gouv.qc.ca/, (#168434) to SCM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KJ, 2005, ECOL LETT, V8, P310, DOI 10.1111/j.1461-0248.2005.00723.x; Auman HJ, 2008, WATERBIRDS, V31, P122, DOI 10.1675/1524-4695(2008)31[122:SMDAFC]2.0.CO;2; BAERTSCHI P, 1976, EARTH PLANET SC LETT, V31, P341, DOI 10.1016/0012-821X(76)90115-1; Ballance LT, 2009, J AVIAN BIOL, V40, P279, DOI 10.1111/j.1600-048X.2008.04538.x; Bech C, 2002, COMP BIOCHEM PHYS A, V133, P765, DOI 10.1016/S1095-6433(02)00153-8; Belant JL, 1997, LANDSCAPE URBAN PLAN, V38, P245, DOI 10.1016/S0169-2046(97)00037-6; BIRTFRIESEN VL, 1989, ECOLOGY, V70, P357, DOI 10.2307/1937540; BRYANT DM, 1991, IBIS, V133, P236, DOI 10.1111/j.1474-919X.1991.tb04565.x; BURGER J, 1988, COLON WATERBIRD, V11, P9, DOI 10.2307/1521165; Burnham KP, 2002, MODEL SELECTION MULT, DOI [10.1111/1365-2656.12141, DOI 10.1111/1365-2656.12141]; Butler PJ, 2004, FUNCT ECOL, V18, P168, DOI 10.1111/j.0269-8463.2004.00821.x; Caron-Beaudoin E, 2013, CAN J ZOOL, V91, P689, DOI 10.1139/cjz-2013-0008; DAAN S, 1990, AM J PHYSIOL, V259, pR333, DOI 10.1152/ajpregu.1990.259.2.R333; DAVIS RW, 1989, J ANIM ECOL, V58, P59, DOI 10.2307/4986; De Wit JC., 1980, GEOSTANDARD NEWSLETT, V4, P33, DOI [DOI 10.1111/J.1751-908X.1980.TB00270.X, 10.1111/j.1751-908X.1980.tb00270.x]; ELLIS HI, 1980, FED PROC, V39, P1165; Ellis Hugh I., 2002, P359; Fort J, 2011, COMP BIOCHEM PHYS A, V158, P358, DOI 10.1016/j.cbpa.2010.05.004; Furness RW, 1996, ECOLOGY, V77, P1181, DOI 10.2307/2265587; Fyhn M, 2001, PHYSIOL BIOCHEM ZOOL, V74, P343, DOI 10.1086/320419; GABRIELSEN GW, 1991, AUK, V108, P71; GABRIELSEN GW, 1987, CONDOR, V89, P126, DOI 10.2307/1368766; Horita J., 2004, HDB STABLE ISOTOPE A; Jodice PGR, 2003, PHYSIOL BIOCHEM ZOOL, V76, P375, DOI 10.1086/375431; Marzluff John M., 2001, P1; MONTEVECCHI WA, 1992, ECOLOGY, V73, P823, DOI 10.2307/1940160; Mullers RHE, 2009, MAR ECOL PROG SER, V393, P161, DOI 10.3354/meps08250; Nagy KA, 2005, J EXP BIOL, V208, P1621, DOI 10.1242/jeb.01553; Pallet I.L., 2012, BIRDS N AM ONLINE; Patenaude-Monette M, 2014, PLOS ONE, V9, P1, DOI [10.1371/ journal. pone. 0102162, DOI 10.1371/J0URNAL.P0NE.0102162, 10.1371/journal.pone.0102162]; Peronnet F, 2012, EUR J APPL PHYSIOL, V112, P2213, DOI 10.1007/s00421-011-2194-7; Pichegru L, 2007, MAR ECOL PROG SER, V350, P127, DOI 10.3354/meps07128; Racine F, 2012, ANIM BEHAV, V84, P175, DOI 10.1016/j.anbehav.2012.04.028; RICKLEFS RE, 1984, AUK, V101, P707, DOI 10.2307/4086898; Ryder JP, 2012, BIRDS N AM; Shaffer SA, 2004, J AVIAN BIOL, V35, P551, DOI 10.1111/j.0908-8857.2004.03264.x; Shaffer SA, 2001, J ANIM ECOL, V70, P864, DOI 10.1046/j.0021-8790.2001.00548.x; Speakman J. R., 1999, DLW ANAL PROGRAM; Speakman JR, 1997, DOUBLY LABELED WATER; STAHEL CD, 1984, J COMP PHYSIOL, V154, P487, DOI 10.1007/BF02515153; Thomson DL, 1998, ARDEA, V86, P169; TINBERGEN JM, 1994, FUNCT ECOL, V8, P563, DOI 10.2307/2389916; Tinbergen JM, 2002, ENERGETICS INCUBATIO; WEATHERS WW, 1980, AUK, V97, P861; Weimerskirch H, 2000, P ROY SOC B-BIOL SCI, V267, P1869, DOI 10.1098/rspb.2000.1223; Weimerskirch H, 2002, J EXP BIOL, V205, P475; Welcker J, 2009, FUNCT ECOL, V23, P1081, DOI 10.1111/j.1365-2435.2009.01585.x; Whittow G. Causey, 2002, P409; Williams TD, 2001, CURR ORNITHOL, V16, P355	49	11	11	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0126964	10.1371/journal.pone.0126964	http://dx.doi.org/10.1371/journal.pone.0126964			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020626	Green Published, gold, Green Submitted			2022-12-26	WOS:000355187300030
J	Wang, N; Rajasekaran, N; Hou, TY; Macaubas, C; Mellins, ED				Wang, Nan; Rajasekaran, Narendiran; Hou, Tieying; Macaubas, Claudia; Mellins, Elizabeth D.			Immunological Basis for Rapid Progression of Diabetes in Older NOD Mouse Recipients Post BM-HSC Transplantation	PLOS ONE			English	Article							BONE-MARROW-TRANSPLANTATION; REGULATORY T-CELLS; PANCREATIC LYMPH-NODES; TOTAL-BODY IRRADIATION; HEMATOPOIETIC STEM; ADJUVANT IMMUNOTHERAPY; MICE; AUTOIMMUNE; DISEASE; PREVENTION	Type I diabetes (T1D), mediated by autoreactive T cell destruction of insulin-producing islet beta cells, has been treated with bone marrow-derived hematopoietic stem cell (BM-HSC) transplantation. Older non-obese diabetic (NOD) mice recipients (3m, at disease-onset stage) receiving syngeneic BM-HSC progressed more rapidly to end-stage diabetes posttransplantation than younger recipients (4-6w, at disease-initiation stage). FACS analyses showed a higher percentage and absolute number of regulatory T cells (Treg) and lower proportion of proliferating T conventional cells (Tcon) in pancreatic lymph nodes from the resistant mice among the younger recipients compared to the rapid progressors among the older recipients. Treg distribution in spleen, mesenteric lymph nodes (MLN), blood and thymus between the two groups was similar. However, the percentage of thymic Tcon and the proliferation of Tcon in MLN and blood were lower in the young resistants. These results suggest recipient age and associated disease stage as a variable to consider in BM-HSC transplantation for treating T1D.	[Wang, Nan; Rajasekaran, Narendiran; Hou, Tieying; Macaubas, Claudia; Mellins, Elizabeth D.] Stanford Univ, Dept Pediat, Sch Med, Div Human Gene Therapy,Program Immunol, Stanford, CA 94305 USA	Stanford University	Mellins, ED (corresponding author), Stanford Univ, Dept Pediat, Sch Med, Div Human Gene Therapy,Program Immunol, Stanford, CA 94305 USA.	mellins@stanford.edu		Mellins, Elizabeth/0000-0003-2577-139X; Rajasekaran, Narendiran/0000-0002-0740-0272	Juvenile Diabetes Research Foundation; Stanford Medical School Child Health Research Institute - Stanford NIH/NCRR CTSA award [UL1 RR025744]; Lucile Packard Foundation for Children's Health; Arthritis Foundation; NIH/NIAID [F32AI089080]; American College of Rheumatology Research and Education Foundation; NIH [AI075253, DK079163]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI075253, F32AI089080] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK079163] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Stanford Medical School Child Health Research Institute - Stanford NIH/NCRR CTSA award; Lucile Packard Foundation for Children's Health; Arthritis Foundation; NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American College of Rheumatology Research and Education Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from Juvenile Diabetes Research Foundation, Stanford Medical School Child Health Research Institute funded by Stanford NIH/NCRR CTSA award number UL1 RR025744 and by the Lucile Packard Foundation for Children's Health (to N.W.), Arthritis Foundation (to N.R.), NIH/NIAID F32AI089080 for postdoctoral fellows (to T.H.), American College of Rheumatology Research and Education Foundation, the Juvenile Diabetes Research Foundation and NIH AI075253 and DK079163 (to E.D.M.).	Alard P, 2006, DIABETES, V55, P2098, DOI 10.2337/db05-0810; Aribi M, 2007, MED SCI MONITOR, V13, pCR372; Atkinson MA, 2001, LANCET, V358, P221, DOI 10.1016/S0140-6736(01)05415-0; Avanzini MA, 2005, EXP CLIN ENDOCR DIAB, V113, P313, DOI 10.1055/s-2005-865643; Beilhack GF, 2005, DIABETES, V54, P1770, DOI 10.2337/diabetes.54.6.1770; Bonetti F, 1999, J CLIN ONCOL, V17, P3729, DOI 10.1200/JCO.1999.17.12.3729; Brode S, 2006, J IMMUNOL, V177, P6603, DOI 10.4049/jimmunol.177.10.6603; Bryson JS, 1997, BONE MARROW TRANSPL, V19, P721, DOI 10.1038/sj.bmt.1700719; Chan J, 2006, J GENE MED, V8, P1281, DOI 10.1002/jgm.968; Chilton PM, 2004, DIABETES, V53, P1995, DOI 10.2337/diabetes.53.8.1995; D'Alise AM, 2008, P NATL ACAD SCI USA, V105, P19857, DOI 10.1073/pnas.0810713105; Domenick MA, 2001, WORLD J SURG, V25, P474, DOI 10.1007/s002680020340; Edelman Steven V, 2002, Diabetes Technol Ther, V4, P175, DOI 10.1089/15209150260007390; Elkin G, 2004, EXP HEMATOL, V32, P579, DOI 10.1016/j.exphem.2004.03.007; Ferraro A, 2011, DIABETES, V60, P2903, DOI 10.2337/db11-0090; Filippi CM, 2011, EUR J IMMUNOL, V41, P1399, DOI 10.1002/eji.200939841; Filippi CM, 2009, J CLIN INVEST, V119, P1515, DOI 10.1172/JCI38503; Gagnerault MC, 2002, J EXP MED, V196, P369, DOI 10.1084/jem.20011353; Guo Z, 2013, J IMMUNOL, V190; Hausmann DHF, 1999, J EXP MED, V189, P1723, DOI 10.1084/jem.189.11.1723; Holland AM, 2012, J CLIN INVEST, V122, P4716, DOI 10.1172/JCI60630; Honkanen J, 2010, J IMMUNOL, V185, P1959, DOI 10.4049/jimmunol.1000788; JOHNSON FL, 1988, BLOOD, V71, P1277; Kodama K, 2008, CLIN IMMUNOL, V129, P195, DOI 10.1016/j.clim.2008.07.028; Kukreja A, 2002, J CLIN INVEST, V109, P131, DOI 10.1172/JCI13605; Li H, 1996, J IMMUNOL, V156, P380; Liang Y, 2005, BLOOD, V106, P1479, DOI 10.1182/blood-2004-11-4282; Liu Q, 2009, INFECT IMMUN, V77, P5347, DOI 10.1128/IAI.01170-08; Mathieu C, 1997, J IMMUNOL, V158, P1453; McClymont SA, 2011, J IMMUNOL, V186, P3918, DOI 10.4049/jimmunol.1003099; MCINERNEY MF, 1991, DIABETES, V40, P715, DOI 10.2337/diabetes.40.6.715; Mellanby RJ, 2007, IMMUNOLOGY, V121, P15, DOI 10.1111/j.1365-2567.2007.02546.x; Miranda SRP, 1997, BLOOD, V90, P444; Nelson JL, 1997, J RHEUMATOL, V24, P23; Nti BK, 2012, CELL MOL IMMUNOL, V9, P455, DOI 10.1038/cmi.2012.36; Okada H, 2010, CLIN EXP IMMUNOL, V160, P1, DOI 10.1111/j.1365-2249.2010.04139.x; Popplewell LL, 2002, BONE MARROW TRANSPL, V29, P277, DOI 10.1038/sj.bmt.1703382; POZZILLI P, 1993, IMMUNOL TODAY, V14, P193, DOI 10.1016/0167-5699(93)90160-M; Rachmiel M, 2011, PEDIATR DIABETES, V12, P596, DOI 10.1111/j.1399-5448.2010.00751.x; Racine J, 2011, DIABETES, V60, P555, DOI 10.2337/db10-0827; Rajasekaran N, 2013, CLIN EXP IMMUNOL, V174, P27, DOI 10.1111/cei.12163; Rinderknecht CH, 2010, INT IMMUNOL, V22, P705, DOI 10.1093/intimm/dxq056; Roncarolo MG, 2007, NAT REV IMMUNOL, V7, P585, DOI 10.1038/nri2138; SADELAIN MWJ, 1990, DIABETES, V39, P583, DOI 10.2337/diabetes.39.5.583; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Schneider A, 2008, J IMMUNOL, V181, P7350, DOI 10.4049/jimmunol.181.10.7350; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Schulz AS, 2011, BLOOD, V117, P4642, DOI 10.1182/blood-2010-06-284349; Snell-Bergeon JK, 2010, J CLIN ENDOCR METAB, V95, P2868, DOI 10.1210/jc.2009-1993; Steptoe RJ, 2003, J CLIN INVEST, V111, P1357, DOI 10.1172/JCI200315995; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; Tian B, 2009, TRANSPLANTATION, V87, P198, DOI 10.1097/TP.0b013e3181933261; van Bekkum DW, 1999, RHEUMATOLOGY, V38, P757, DOI 10.1093/rheumatology/38.8.757; Voltarelli JC, 2007, JAMA-J AM MED ASSOC, V297, P1568, DOI 10.1001/jama.297.14.1568; Wang J, 2009, MED HYPOTHESES, V72, P36, DOI 10.1016/j.mehy.2008.07.049; Wang N, 2014, STEM CELL RES, V12, P209, DOI 10.1016/j.scr.2013.10.010; Wang N, 2013, EXP HEMATOL, V41, P934, DOI 10.1016/j.exphem.2013.07.002; Wucherpfennig KW, 2003, ANN NY ACAD SCI, V1005, P119, DOI 10.1196/annals.1288.013; Zhang YX, 2012, CURR OPIN ENDOCRINOL, V19, P271, DOI 10.1097/MED.0b013e328355a2d5	60	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128494	10.1371/journal.pone.0128494	http://dx.doi.org/10.1371/journal.pone.0128494			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020954	gold, Green Published, Green Submitted			2022-12-26	WOS:000355187300117
J	Kaur, H; Allan, EL; Mamadu, I; Hall, Z; Ibe, O; El Sherbiny, M; van Wyk, A; Yeung, S; Swamidoss, I; Green, MD; Dwivedi, P; Culzoni, MJ; Clarke, S; Schellenberg, D; Fernandez, FM; Onwujekwe, O				Kaur, Harparkash; Allan, Elizabeth Louise; Mamadu, Ibrahim; Hall, Zoe; Ibe, Ogochukwu; El Sherbiny, Mohamed; van Wyk, Albert; Yeung, Shunmay; Swamidoss, Isabel; Green, Michael D.; Dwivedi, Prabha; Julia Culzoni, Maria; Clarke, Sian; Schellenberg, David; Fernandez, Facundo M.; Onwujekwe, Obinna			Quality of Artemisinin-Based Combination Formulations for Malaria Treatment: Prevalence and Risk Factors for Poor Quality Medicines in Public Facilities and Private Sector Drug Outlets in Enugu, Nigeria	PLOS ONE			English	Article							ANTIMALARIAL-DRUGS	Background Artemisinin-based combination therapies are recommended by the World Health Organisation (WHO) as first-line treatment for Plasmodium falciparum malaria, yet medication must be of good quality for efficacious treatment. A recent meta-analysis reported 35% (796/2, 296) of antimalarial drug samples from 21 Sub-Saharan African countries, purchased from outlets predominantly using convenience sampling, failed chemical content analysis. We used three sampling strategies to purchase artemisinin-containing antimalarials (ACAs) in Enugu metropolis, Nigeria, and compared the resulting quality estimates. Methods ACAs were purchased using three sampling approaches - convenience, mystery clients and overt, within a defined area and sampling frame in Enugu metropolis. The active pharmaceutical ingredients were assessed using high-performance liquid chromatography and confirmed by mass spectrometry at three independent laboratories. Results were expressed as percentage of APIs stated on the packaging and used to categorise each sample as acceptable quality, substandard, degraded, or falsified. Results Content analysis of 3024 samples purchased from 421 outlets using convenience (n=200), mystery (n=1,919) and overt (n=905) approaches, showed overall 90.8% ACAs to be of acceptable quality, 6.8% substandard, 1.3% degraded and 1.2% falsified. Convenience sampling yielded a significantly higher prevalence of poor quality ACAs, but was not evident by the mystery and overt sampling strategies both of which yielded results that were comparable between each other. Artesunate (n=135; 4 falsified) and dihydroartemisinin (n=14) monotherapy tablets, not recommended by WHO, were also identified. Conclusion Randomised sampling identified fewer falsified ACAs than previously reported by convenience approaches. Our findings emphasise the need for specific consideration to be given to sampling frame and sampling approach if representative information on drug quality is to be obtained.	[Kaur, Harparkash; Allan, Elizabeth Louise; Hall, Zoe; van Wyk, Albert; Yeung, Shunmay] London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England; [Mamadu, Ibrahim; El Sherbiny, Mohamed; Yeung, Shunmay] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1, England; [Ibe, Ogochukwu; Onwujekwe, Obinna] Univ Nigeria, Dept Pharmacol & Therapeut, Enugu, Nigeria; [Swamidoss, Isabel; Green, Michael D.] US Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Atlanta, GA USA; [Dwivedi, Prabha] Ctr Dis Control & Prevent, Atlanta, GA USA; [Julia Culzoni, Maria] Univ Nacl Litoral, Fac Bioquim & Ciencias Biol, Santa Fe, Argentina; [Julia Culzoni, Maria] Consejo Nacl Invest Cient & Tecn, Santa Fe, Argentina; [Clarke, Sian; Schellenberg, David] London Sch Hyg & Trop Med, Dept Dis Control, London WC1, England; [Fernandez, Facundo M.] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of Nigeria; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; National University of the Littoral; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of London; London School of Hygiene & Tropical Medicine; University System of Georgia; Georgia Institute of Technology	Kaur, H (corresponding author), London Sch Hyg & Trop Med, Dept Clin Res, Keppel St, London WC1, England.	harparkash.kaur@lshtm.ac.uk	Fernandez, Facundo Martin/B-7015-2008; Onwujekwe, Obinna/O-6232-2014; Clarke, Sian/AAF-5805-2019	Fernandez, Facundo Martin/0000-0002-0302-2534; Onwujekwe, Obinna/0000-0002-1214-4285; Yeung, Shunmay/0000-0002-0997-0850; Schellenberg, David/0000-0001-8222-0186; Hall, Zoe/0000-0002-1434-8329; Dwivedi, Prabha/0000-0002-6435-2166	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	The authors are grateful to the Artemisinin Combination Therapy consortium via an award from the Bill & Melinda Gates Foundation to the London School of Hygiene and Tropical Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldhous P, 2005, NATURE, V434, P132, DOI 10.1038/434132a; Almuzaini T, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002923; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Blessy M, 2014, J Pharm Anal, V4, P159, DOI 10.1016/j.jpha.2013.09.003; Chaccour CJ, 2012, LANCET, V380; Culzoni MJ, 2014, MEDCHEMCOMM, V5, P9, DOI 10.1039/c3md00235g; Faucon B, 2013, WALL STREET J; Federal Ministry of Health National Malaria Control Programme Abuja Nigeria, 2009, AB NIG STRAT PLAN 20; Lon CT, 2006, T ROY SOC TROP MED H, V100, P1019, DOI 10.1016/j.trstmh.2006.01.003; Malaria Operational Plan Nigeria, 2013, MAL OP PLAN NIG; Mangham LJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-155; Monge ME, 2013, CHEM REV, V113, P2269, DOI 10.1021/cr300309q; Nayyar GML, 2012, LANCET INFECT DIS, V12, P488, DOI 10.1016/S1473-3099(12)70064-6; Newton P, 2001, LANCET, V357, P1948, DOI 10.1016/S0140-6736(00)05085-6; Newton PN, 2006, PLOS MED, V3, P752, DOI 10.1371/journal.pmed.0030197; Newton PN, 2014, LANCET GLOB HEALTH, V2, pE509, DOI 10.1016/S2214-109X(14)70279-7; Newton PN, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001139; Newton PN, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-352; Newton PN, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000052; Onwujekwe O, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-22; Phanouvong S., 2005, 7 INT C AIDS AS PAC; Roberts M, 2012, 3 MALARIA DRUGS FAKE; Rozendaal J, 2001, LANCET, V357, P890, DOI 10.1016/S0140-6736(05)71830-4; Tabernero P, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-139; United States Pharmacopeia, 2001, GUID SAMPL ANT DRUG	25	44	44	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0125577	10.1371/journal.pone.0125577	http://dx.doi.org/10.1371/journal.pone.0125577			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018221	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000355185600029
J	Machado, MV; Michelotti, GA; Xie, GH; de Almeida, TP; Boursier, J; Bohnic, B; Guy, CD; Diehl, AM				Machado, Mariana Verdelho; Michelotti, Gregory Alexander; Xie, Guanhua; de Almeida, Thiago Pereira; Boursier, Jerome; Bohnic, Brittany; Guy, Cynthia D.; Diehl, Anna Mae			Mouse Models of Diet-Induced Nonalcoholic Steatohepatitis Reproduce the Heterogeneity of the Human Disease	PLOS ONE			English	Article							FATTY LIVER-DISEASE; ENDOPLASMIC-RETICULUM STRESS; CHOLINE-DEFICIENT DIET; INSULIN-RESISTANCE; VITAMIN-E; FIBROSIS; MICE; SEVERITY; HEDGEHOG; INJURY	Background and aims Non-alcoholic steatohepatitis (NASH), the potentially progressive form of nonalcoholic fatty liver disease (NAFLD), is the pandemic liver disease of our time. Although there are several animal models of NASH, consensus regarding the optimal model is lacking. We aimed to compare features of NASH in the two most widely-used mouse models: methionine-choline deficient (MCD) diet and Western diet. Methods Mice were fed standard chow, MCD diet for 8 weeks, or Western diet (45% energy from fat, predominantly saturated fat, with 0.2% cholesterol, plus drinking water supplemented with fructose and glucose) for 16 weeks. Liver pathology and metabolic profile were compared. Results The metabolic profile associated with human NASH was better mimicked by Western diet. Although hepatic steatosis (i.e., triglyceride accumulation) was also more severe, liver nonesterified fatty acid content was lower than in the MCD diet group. NASH was also less severe and less reproducible in the Western diet model, as evidenced by less liver cell death/apoptosis, inflammation, ductular reaction, and fibrosis. Various mechanisms implicated in human NASH pathogenesis/progression were also less robust in the Western diet model, including oxidative stress, ER stress, autophagy deregulation, and hedgehog pathway activation. Conclusion Feeding mice a Western diet models metabolic perturbations that are common in humans with mild NASH, whereas administration of a MCD diet better models the pathobiological mechanisms that cause human NAFLD to progress to advanced NASH.	[Machado, Mariana Verdelho; Michelotti, Gregory Alexander; Xie, Guanhua; de Almeida, Thiago Pereira; Boursier, Jerome; Diehl, Anna Mae] Duke Univ, Med Ctr, Dept Med, Div Gastroenterol, Durham, NC 27710 USA; [Machado, Mariana Verdelho] Hosp Santa Maria, CHLN, Dept Gastroenterol, Lisbon, Portugal; [Bohnic, Brittany] Duke Univ, Med Ctr, Div Endocrinol, Durham, NC 27710 USA; [Guy, Cynthia D.] Duke Univ, Med Ctr, Div Pathol, Durham, NC 27710 USA	Duke University; Universidade de Lisboa; Hospital Santa Maria; Duke University; Duke University	Diehl, AM (corresponding author), Duke Univ, Med Ctr, Dept Med, Div Gastroenterol, Durham, NC 27710 USA.	diehl004@mc.duke.edu		de Almeida Pereira, Thiago/0000-0002-8755-0683; , Gregory/0000-0002-3936-4675	NIH [DK0077794, DK053792]; Duke Endowment: The Florence McAlister Professorship; Fundacao para a Ciencia e Tecnologia, FCT, Portugal; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R55DK053792, R01DK053792, R01DK077794] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Duke Endowment: The Florence McAlister Professorship; Fundacao para a Ciencia e Tecnologia, FCT, Portugal(Portuguese Foundation for Science and Technology); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research is supported by NIH DK0077794 and DK053792 (Diehl AM), and Duke Endowment: The Florence McAlister Professorship (Diehl AM). MVM received a PhD grant from Fundacao para a Ciencia e Tecnologia, FCT, Portugal. The funders had no role in study design, dara collection and analysis, decision to publish, or preparation of the manuscript.	Alkhouri N, 2014, DIGEST DIS SCI, V59, P1617, DOI 10.1007/s10620-014-3031-8; Asai A, 2014, AM J PHYSIOL-GASTR L, V306, pG496, DOI 10.1152/ajpgi.00291.2013; Athyros VG, 2010, LANCET, V376, P1916, DOI 10.1016/S0140-6736(10)61272-X; Choi AMK, 1996, AM J RESP CELL MOL, V15, P9, DOI 10.1165/ajrcmb.15.1.8679227; Choi SS, 2006, HEPATOLOGY, V44, P1267, DOI 10.1002/hep.21375; Clark JM, 2003, AM J GASTROENTEROL, V98, P960, DOI [10.1016/S0002-9270(03)00265-X, 10.1111/j.1572-0241.2003.07486.x]; Ekstedt M, 2015, HEPATOLOGY, V61, P1547, DOI 10.1002/hep.27368; Fleig SV, 2007, LAB INVEST, V87, P1227, DOI 10.1038/labinvest.3700689; Gonzalez-Rodriguez A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.162; Guy CD, 2012, HEPATOLOGY, V55, P1711, DOI 10.1002/hep.25559; Hardwick RN, 2010, DRUG METAB DISPOS, V38, P2293, DOI 10.1124/dmd.110.035006; Henkel A, 2013, SEMIN LIVER DIS, V33, P321, DOI 10.1055/s-0033-1358522; Hirsova P, 2015, HEPATOLOGY, V61, P15, DOI 10.1002/hep.27279; Horie Y, 2004, J CLIN INVEST, V113, P1774, DOI 10.1172/JCI200420513; Ibrahim SH, 2011, J PEDIATR GASTR NUTR, V53, P109, DOI 10.1097/MPG.0b013e31820e82a1; Itagaki H, 2013, INT J CLIN EXP PATHO, V6, P2683; Jha P, 2014, BBA-MOL BASIS DIS, V1842, P959, DOI 10.1016/j.bbadis.2014.02.012; Kashima J, 2014, HEPATOL RES, V44, P779, DOI 10.1111/hepr.12183; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Krawczyk M, 2013, SEMIN LIVER DIS, V33, P369, DOI 10.1055/s-0033-1358525; Lake AD, 2014, TOXICOL SCI, V137, P26, DOI 10.1093/toxsci/kft230; Larter CZ, 2008, J HEPATOL, V49, P407, DOI 10.1016/j.jhep.2008.03.026; Leclercq IA, 2007, LAB INVEST, V87, P56, DOI 10.1038/labinvest.3700489; Loomba R, 2013, NAT REV GASTRO HEPAT, V10, P686, DOI 10.1038/nrgastro.2013.171; Luedde T, 2007, CANCER CELL, V11, P119, DOI 10.1016/j.ccr.2006.12.016; Machado MV, 2014, WORLD J GASTROENTERO, V20, P12956, DOI 10.3748/wjg.v20.i36.12956; Machado MV, 2014, GUT; Mells JE, 2012, AM J PHYSIOL-GASTR L, V302, pG225, DOI 10.1152/ajpgi.00274.2011; Michelotti GA, 2013, J CLIN INVEST, V123, P2380, DOI 10.1172/JCI66904; Murphy SK, 2013, GASTROENTEROLOGY, V145, P1076, DOI 10.1053/j.gastro.2013.07.047; Neuschwander-Tetri BA, 2015, LANCET, V385, P956, DOI 10.1016/S0140-6736(14)61933-4; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Oz HS, 2008, DIGEST DIS SCI, V53, P767, DOI 10.1007/s10620-007-9900-7; Park HW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5834; Purnell JQ, 2013, JAMA-J AM MED ASSOC, V309, P85, DOI 10.1001/jama.2012.190505; Rizki G, 2006, J LIPID RES, V47, P2280, DOI 10.1194/jlr.M600198-JLR200; Samra R.A., 2010, FAT DETECTION TASTE; Sanyal AJ, 2010, NEW ENGL J MED, V362, P1675, DOI 10.1056/NEJMoa0907929; Schattenberg JRM, 2005, J BIOL CHEM, V280, P9887, DOI 10.1074/jbc.M410310200; Singh S, 2015, CLIN GASTROENTEROL H, V13, P643, DOI 10.1016/j.cgh.2014.04.014; Sreekumar R, 2003, HEPATOLOGY, V38, P244, DOI 10.1053/jhep.2003.50290; Syn WK, 2009, GASTROENTEROLOGY, V137, P1478, DOI 10.1053/j.gastro.2009.06.051; Ucar F, 2013, REDOX REP, V18, P127, DOI 10.1179/1351000213Y.0000000050; Wong RJ, 2014, HEPATOLOGY, V59, P2188, DOI 10.1002/hep.26986; Wortham M, 2008, DIGEST DIS SCI, V53, P2761, DOI 10.1007/s10620-007-0193-7; Zeybel M, 2012, NAT MED, V18, P1369, DOI 10.1038/nm.2893	46	216	225	8	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0127991	10.1371/journal.pone.0127991	http://dx.doi.org/10.1371/journal.pone.0127991			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26017539	Green Published, gold			2022-12-26	WOS:000355185600105
J	McKerr, C; Adak, GK; Nichols, G; Gorton, R; Chalmers, RM; Kafatos, G; Cosford, P; Charlett, A; Reacher, M; Pollock, KG; Alexander, CL; Morton, S				McKerr, Caoimhe; Adak, Goutam K.; Nichols, Gordon; Gorton, Russell; Chalmers, Rachel M.; Kafatos, George; Cosford, Paul; Charlett, Andre; Reacher, Mark; Pollock, Kevin G.; Alexander, Claire L.; Morton, Stephen			An Outbreak of Cryptosporidium parvum across England & Scotland Associated with Consumption of Fresh Pre-Cut Salad Leaves, May 2012	PLOS ONE			English	Article							FOOD	Background We report a widespread foodborne outbreak of Cryptosporidium parvum in England and Scotland in May 2012. Cases were more common in female adults, and had no history of foreign travel. Over 300 excess cases were identified during the period of the outbreak. Speciation and microbiological typing revealed the outbreak strain to be C. parvum gp60 subtype IIaA15G2R1. Methods Hypothesis generation questionnaires were administered and an unmatched case control study was undertaken to test the hypotheses raised. Cases and controls were interviewed by telephone. Controls were selected using sequential digit dialling. Information was gathered on demographics, foods consumed and retailers where foods were purchased. Results Seventy-four laboratory confirmed cases and 74 controls were included in analyses. Infection was found to be strongly associated with the consumption of pre-cut mixed salad leaves sold by a single retailer. This is the largest documented outbreak of cryptosporidiosis attributed to a food vehicle.	[McKerr, Caoimhe; Gorton, Russell; Reacher, Mark] Publ Hlth England, Field Epidemiol Serv, London, England; [Adak, Goutam K.; Nichols, Gordon] Publ Hlth England, Dept Gastrointestinal Emerging & Zoonot Infect, London, England; [Chalmers, Rachel M.] Publ Hlth Wales, Cryptosporidium Reference Unit, Swansea, W Glam, Wales; [Kafatos, George; Charlett, Andre] Publ Hlth England, Stat Modelling & Econ Dept, London, England; [Cosford, Paul] Publ Hlth England, London, England; [Pollock, Kevin G.; Alexander, Claire L.] Hlth Protect Scotland, Glasgow, Lanark, Scotland; [Morton, Stephen] Publ Hlth England Ctr, Yorkshire Humber, England; [McKerr, Caoimhe] Publ Hlth England, Field Epidemiol Training Programme, London, England; [Nichols, Gordon] Univ E Anglia, Norwich Med Sch, Norwich, England; [Nichols, Gordon] Univ Thessaly, Fac Med, Larisa, Greece; [Nichols, Gordon] Univ Exeter, European Ctr Environm & Human Hlth, Exeter, Devon, England	Public Health England; Public Health England; Public Health England; Public Health England; Public Health England; University of East Anglia; University of Thessaly; University of Exeter	Morton, S (corresponding author), Publ Hlth England Ctr, Yorkshire Humber, England.	stephen.morton@phe.gov.uk	Reacher, Mark/Y-6979-2018; Nichols, Gordon L./J-1114-2014	Reacher, Mark/0000-0001-6871-7903; Nichols, Gordon L./0000-0003-0773-9556; Kafatos, George/0000-0001-7871-9216; Morton, William Stephen/0000-0001-7122-0201				Alves M, 2003, J CLIN MICROBIOL, V41, P2744, DOI 10.1128/JCM.41.6.2744-2747.2003; Amoros I, 2012, J FOOD PROTECT, V73, P1138; Buchholz U, 2011, NEW ENGL J MED, V365, P1763, DOI 10.1056/NEJMoa1106482; CASEMORE DP, 1990, EPIDEMIOL INFECT, V104, P1, DOI 10.1017/S0950268800054480; Cleary P, 2010, EURO SURVEILL, V15, P19732; Doherty L, 1997, Commun Dis Rep CDR Rev, V7, pR73; Ethelberg S, 2009, EPIDEMIOL INFECT, V137, P348, DOI 10.1017/S0950268808001817; Hadfield SJ, 2011, J CLIN MICROBIOL, V49, P918, DOI 10.1128/JCM.01733-10; Insulander M, 2008, Euro Surveill, V13; Irvine WN, 2009, EPIDEMIOL INFECT, V137, P1449, DOI 10.1017/S0950268809002416; Lake Iain R., 2005, Journal of Water and Health, V3, P469; Macarisin D, 2010, APPL ENVIRON MICROB, V76, P555, DOI 10.1128/AEM.02118-09; Mota A, 2009, J FOOD PROTECT, V72, P2184, DOI 10.4315/0362-028X-72.10.2184; Nichols GL., 2014, CRYPTOSPORIDIUM PARA, P81; Nygard K, 2008, FOODBORNE PATHOG DIS, V5, P165, DOI 10.1089/fpd.2007.0053; Ponka A, 2009, EUROSURVEILLANCE, V14, P8; Quiroz ES, 2000, J INFECT DIS, V181, P695, DOI 10.1086/315279; Robertson L J, 2003, TRENDS PARASITOL, V1, P39; Slayton RB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055300; Smith A, 2006, EPIDEMIOL INFECT, V134, P1141, DOI 10.1017/S0950268806006406; Sulaiman IM, 2005, J CLIN MICROBIOL, V43, P2805, DOI 10.1128/JCM.43.6.2805-2809.2005; Wall PG, 1996, CDR REV, V6, P93; Yoshida H, 2007, JPN J INFECT DIS, V60, P405	23	49	50	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0125955	10.1371/journal.pone.0125955	http://dx.doi.org/10.1371/journal.pone.0125955			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26017538	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000355185600045
J	Ayturk, DG; Castrucci, AM; Carr, DE; Keller, SR; Provencio, I				Aytuerk, Didem Goez; Castrucci, Ana Maria; Carr, David E.; Keller, Susanna R.; Provencio, Ignacio			Lack of Melanopsin Is Associated with Extreme Weight Loss in Mice upon Dietary Challenge	PLOS ONE			English	Article							GANGLION-CELLS; RD MOUSE; LIGHT; MELATONIN; GLYCOGEN; LIVER; GENE; FAT	Metabolic disorders have been established as major risk factors for ocular complications and poor vision. However, little is known about the inverse possibility that ocular disease may cause metabolic dysfunction. To test this hypothesis, we assessed the metabolic consequences of a robust dietary challenge in several mouse models suffering from retinal mutations. To this end, mice null for melanopsin (Opn4(-/-)), the photopigment of intrinsically photosensitive retinal ganglion cells (ipRGCs), were subjected to five weeks of a ketogenic diet. These mice lost significantly more weight than wild-type controls or mice lacking rod and cone photoreceptors (Pde6b(rd1/rd1)). Although ipRGCs are critical for proper circadian entrainment, and circadian misalignment has been implicated in metabolic pathology, we observed no differences in entrainment between Opn4(-/-) and control mice. Additionally, we observed no differences in any tested metabolic parameter between these mouse strains. Further studies are required to establish the mechanism giving rise to this dramatic phenotype observed in melanopsin-null mice. We conclude that the causality between ocular disease and metabolic disorders merits further investigation due to the popularity of diets that rely on the induction of a ketogenic state. Our study is a first step toward understanding retinal pathology as a potential cause of metabolic dysfunction.	[Aytuerk, Didem Goez; Castrucci, Ana Maria; Provencio, Ignacio] Univ Virginia, Dept Biol, Charlottesville, VA 22904 USA; [Carr, David E.] Univ Virginia, Dept Environm Sci, Charlottesville, VA 22903 USA; [Keller, Susanna R.] Univ Virginia, Sch Med, Dept Med, Div Endocrinol, Charlottesville, VA 22908 USA; [Castrucci, Ana Maria] Univ Sao Paulo, Dept Fisiol, Sao Paulo, Brazil	University of Virginia; University of Virginia; University of Virginia; Universidade de Sao Paulo	Provencio, I (corresponding author), Univ Virginia, Dept Biol, Charlottesville, VA 22904 USA.	ip7m@virginia.edu		Provencio, Ignacio/0000-0003-1175-920X; Castrucci, Ana Maria/0000-0002-2065-8198; Keller, Susanna/0000-0002-3089-7766	National Institutes of Health [R01 NS052112]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052112] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by a National Institutes of Health (R01 NS052112) and a gift of the Owens Family Foundation to IP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abcouwer SF, 2014, ANN NY ACAD SCI, V1311, P174, DOI 10.1111/nyas.12412; Bartness TJ, 2010, MOL CELL ENDOCRINOL, V318, P34, DOI 10.1016/j.mce.2009.08.031; BOWES C, 1989, P NATL ACAD SCI USA, V86, P9722, DOI 10.1073/pnas.86.24.9722; Cajochen C, 2005, J CLIN ENDOCR METAB, V90, P1311, DOI 10.1210/jc.2004-0957; Cheung N, 2007, SURV OPHTHALMOL, V52, P180, DOI 10.1016/j.survophthal.2006.12.003; Do MTH, 2010, PHYSIOL REV, V90, P1547, DOI 10.1152/physrev.00013.2010; Izumida Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3316; Kennedy AR, 2007, AM J PHYSIOL-ENDOC M, V292, pE1724, DOI 10.1152/ajpendo.00717.2006; Kirkby LA, 2013, P NATL ACAD SCI USA, V110, P12090, DOI 10.1073/pnas.1222150110; KLEIN DC, 1971, P NATL ACAD SCI USA, V68, P3107, DOI 10.1073/pnas.68.12.3107; Kreitzman SN, 1992, THE AMERICAN JOURNAL, V56, p292S; Lingappa JR, 2013, J NEUROSCI, V33, P4867, DOI 10.1523/JNEUROSCI.3829-12.2013; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; MacKay EM, 1932, J BIOL CHEM, V96, P373; Maury E, 2014, DIABETES METAB, V40, P338, DOI 10.1016/j.diabet.2013.12.005; Neuhuber W, 2011, AUTON NEUROSCI-BASIC, V165, P67, DOI 10.1016/j.autneu.2010.10.004; Panda S, 2002, SCIENCE, V298, P2213, DOI 10.1126/science.1076848; PITTLER SJ, 1991, P NATL ACAD SCI USA, V88, P8322, DOI 10.1073/pnas.88.19.8322; Rao S, 2013, NATURE, V494, P243, DOI 10.1038/nature11823; Renna JM, 2011, NAT NEUROSCI, V14, P827, DOI 10.1038/nn.2845; Sekaran S, 2005, CURR BIOL, V15, P1099, DOI 10.1016/j.cub.2005.05.053; Shen WL, 2011, SCIENCE, V331, P1333, DOI 10.1126/science.1198904	22	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127031	10.1371/journal.pone.0127031	http://dx.doi.org/10.1371/journal.pone.0127031			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011287	Green Published, Green Submitted, gold			2022-12-26	WOS:000355183900057
J	Tyndale, RF; Zhu, AZX; George, TP; Cinciripini, P; Hawk, LW; Schnoll, RA; Swan, GE; Benowitz, NL; Heitjan, DF; Lerman, C				Tyndale, Rachel F.; Zhu, Andy Z. X.; George, Tony P.; Cinciripini, Paul; Hawk, Larry W., Jr.; Schnoll, Robert A.; Swan, Gary E.; Benowitz, Neal L.; Heitjan, Daniel F.; Lerman, Caryn		PGRN-PNAT Res Grp	Lack of Associations of CHRNA5-A3-B4 Genetic Variants with Smoking Cessation Treatment Outcomes in Caucasian Smokers despite Associations with Baseline Smoking	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; NICOTINE DEPENDENCE; LUNG-CANCER; MOLECULAR-GENETICS; CHRNA5-CHRNA3-CHRNB4; CYP2A6; VARENICLINE; COTININE; AFRICAN; CLUSTER	CHRNA5-A3-B4 variants, rs16969968, rs588765 and rs578776, are consistently associated with tobacco consumption among smokers, but the association with smoking cessation is less consistent. Among the studies that reported significant associations with cessation, the effects were observed in smokers treated with placebo treatment in some studies and conversely in those receiving active pharmacological therapy (bupropion and nicotine replacement therapies) in others. Thus, it remains unclear whether CHRNA5-A3-B4 is a useful marker for optimizing smoking cessation. Using data from 654 Caucasian smokers treated with placebo, nicotine patch or varenicline, we investigated whether CHRNA5-A3-B4 variants were associated with smoking cessation outcomes, and whether there were significant genotype-by-treatment or haplotype-by-treatment interactions. We observed no significant associations between CHRNA5-A3-B4 variants and smoking cessation, despite replicating previous associations with baseline tobacco consumption. At end of treatment the effect size on smoking cessation in the placebo, patch and varenicline groups for rs16969968 [GG vs. GA+AA] was OR = 0.66 (P = 0.23), OR = 1.01 (P = 0.99), and OR = 1.30 (P = 0.36) respectively, of rs588765 [CC vs. CT+TT] was OR = 0.96 (P = 0.90), OR = 0.84 (P = 0.58), and OR = 0.74 (P = 0.29) respectively, and for rs578776 [GG vs. GA+ AA] on smoking cessation was OR = 1.02 (P = 0.95), OR = 0.75 (P = 0.35), and OR = 1.20 (P = 0.51) respectively. Furthermore, we observed no associations with cessation using the CHRNA5-A3-B4 haplotype (constructed using rs16969968 and rs588765), nor did we observe any significant genotype-by-treatment interactions, with or without adjusting for the rate of nicotine metabolism (all P>0.05). We also observed no significant genetic associations with 6 month or 12 month smoking abstinence. In conclusion, we found no association between CHRNA5-A3-B4 variants and smoking cessation rates in this clinical trial; however, as expected, significant associations with baseline tobacco consumption were replicated. Our data suggest that CHRNA5-A3-B4 gene variants do not exhibit a robust association with smoking cessation and are unlikely to be useful for clinically optimizing smoking cessation pharmacotherapy for Caucasian smokers.	[Tyndale, Rachel F.; George, Tony P.] Campbell Family Mental Hlth Res Inst, CAMH, Toronto, ON, Canada; [Tyndale, Rachel F.; Zhu, Andy Z. X.] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada; [Tyndale, Rachel F.; George, Tony P.] Univ Toronto, Dept Psychiat, Div Brain & Therapeut, Toronto, ON, Canada; [Cinciripini, Paul] Univ Texas MD Anderson Canc Ctr, Dept Behav Sci, Houston, TX 77030 USA; [Hawk, Larry W., Jr.] SUNY Buffalo, Dept Psychol, Buffalo, NY 14260 USA; [Hawk, Larry W., Jr.] SUNY Buffalo, Ctr Children & Families, Buffalo, NY 14260 USA; [Schnoll, Robert A.; Lerman, Caryn] Univ Penn, Ctr Interdisciplinary Res Nicotine Addict, Dept Psychiat, Philadelphia, PA 19104 USA; [Swan, Gary E.] Stanford Univ, Dept Med, Palo Alto, CA 94304 USA; [Benowitz, Neal L.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Benowitz, Neal L.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA USA; [Heitjan, Daniel F.] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University of Toronto; University of Texas System; UTMD Anderson Cancer Center; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Pennsylvania; Stanford University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Pennsylvania	Tyndale, RF (corresponding author), Campbell Family Mental Hlth Res Inst, CAMH, Toronto, ON, Canada.	r.tyndale@utoronto.ca	Lerman, Caryn/AHC-5180-2022	Hawk, Larry/0000-0001-6593-9746; Tyndale, Rachel/0000-0003-1297-2053; Bergen, Andrew/0000-0002-1237-7644	National Institute on Drug Abuse; National Cancer Institute; National Human Genome Research Institute; National Institute on General Medical Sciences [U01 DA20830]; Abramson Cancer Center at the University of Pennsylvania [P30 CA16520]; Commonwealth of Pennsylvania Department of Health; Canadian Institutes of Health Research [CIHR TMH109787]; endowed Chair in Addiction for the Department of Psychiatry; CAMH foundation; Canada Foundation for Innovation [20289, 16014]; Ontario Ministry of Research and Innovation; NATIONAL CANCER INSTITUTE [P30CA016520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH109787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U01DA020830] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute on General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Abramson Cancer Center at the University of Pennsylvania; Commonwealth of Pennsylvania Department of Health; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); endowed Chair in Addiction for the Department of Psychiatry; CAMH foundation; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by a grant from the National Institute on Drug Abuse, the National Cancer Institute, the National Human Genome Research Institute, and the National Institute on General Medical Sciences (U01 DA20830; CL and RFT), funding from the Abramson Cancer Center at the University of Pennsylvania (P30 CA16520; CL), a grant from the Commonwealth of Pennsylvania Department of Health (CL), a grant from the Canadian Institutes of Health Research (CIHR TMH109787), an endowed Chair in Addiction for the Department of Psychiatry (RFT), CAMH foundation (RFT), the Canada Foundation for Innovation (#20289 and #16014), and the Ontario Ministry of Research and Innovation (RFT). No funder had a role in study design, collection and analysis of data, writing of the manuscript, or in the decision to submit this manuscript for review.	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Baker TB, 2009, NICOTINE TOB RES, V11, P785, DOI 10.1093/ntr/ntp064; Benowitz NL, 2010, NEW ENGL J MED, V362, P2295, DOI 10.1056/NEJMra0809890; Bergen AW, 2013, PHARMACOGENET GENOM, V23, P94, DOI 10.1097/FPC.0b013e32835cdabd; Breitling LP, 2010, PHARMACOGENOMICS, V11, P527, DOI [10.2217/pgs.10.1, 10.2217/PGS.10.1]; Brennan P, 2011, LANCET ONCOL, V12, P399, DOI 10.1016/S1470-2045(10)70126-1; Cahill K, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009329.pub2, 10.1002/14651858.CD006103.pub6]; Chen LS, 2014, ADDICTION, V109, P128, DOI 10.1111/add.12353; Chen LS, 2012, AM J PSYCHIAT, V169, P735, DOI 10.1176/appi.ajp.2012.11101545; Conti DV, 2008, HUM MOL GENET, V17, P2834, DOI 10.1093/hmg/ddn181; Freathy RM, 2009, HUM MOL GENET, V18, P2922, DOI 10.1093/hmg/ddp216; Furberg H, 2010, NAT GENET, V42, P441, DOI 10.1038/ng.571; Gonzales D, 2006, JAMA-J AM MED ASSOC, V296, P47, DOI 10.1001/jama.296.1.47; Helen GS, 2012, CANCER EPIDEM BIOMAR, V21, P1105, DOI 10.1158/1055-9965.EPI-12-0236; Jacob P, 2011, J CHROMATOGR B, V879, P267, DOI 10.1016/j.jchromb.2010.12.012; Jha P, 2013, NEW ENGL J MED, V368, P341, DOI 10.1056/NEJMsa1211128; Keskitalo K, 2009, HUM MOL GENET, V18, P4007, DOI 10.1093/hmg/ddp322; Lea RA, 2006, J ANAL TOXICOL, V30, P386, DOI 10.1093/jat/30.6.386; Lerman C, 2015, LANCET RESP MED, V3, P131, DOI 10.1016/S2213-2600(14)70294-2; Lessov CN, 2004, PSYCHOL MED, V34, P865, DOI 10.1017/S0033291703001582; Liu JZ, 2010, NAT GENET, V42, P436, DOI 10.1038/ng.572; Munafo MR, 2012, JNCI-J NATL CANCER I, V104, P740, DOI 10.1093/jnci/djs191; Munafo MR, 2011, NICOTINE TOB RES, V13, P982, DOI 10.1093/ntr/ntr106; Pillai SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000421; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Saccone NL, 2010, GENES BRAIN BEHAV, V9, P741, DOI 10.1111/j.1601-183X.2010.00608.x; Saccone NL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001053; Saccone NL, 2009, CANCER RES, V69, P6848, DOI 10.1158/0008-5472.CAN-09-0786; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Sarginson JE, 2011, AM J MED GENET B, V156B, P275, DOI 10.1002/ajmg.b.31155; Siedlinski M, 2011, THORAX, V66, P894, DOI 10.1136/thoraxjnl-2011-200154; Spitz MR, 2012, J NATL CANCER I, V104, P720, DOI 10.1093/jnci/djs211; SRNT Subcommittee on Biochemical Verification, 2002, Nicotine Tob Res, V4, P149, DOI 10.1080/14622200210123581; Stead LF, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000146.pub4; Swan GE, 2012, PHARMACOGENOMICS J, V12, P349, DOI 10.1038/tpj.2011.19; Tanner J, 2015, CANC EPIDEM IN PRESS; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Thorgeirsson TE, 2010, NAT GENET, V42, P448, DOI 10.1038/ng.573; Uhl GR, 2008, ARCH GEN PSYCHIAT, V65, P683, DOI 10.1001/archpsyc.65.6.683; Uhl GR, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-10; Uhl GR, 2010, MOL MED, V16, P513, DOI 10.2119/molmed.2010.00052; Wassenaar CA, 2011, J NATL CANCER I, V103, P1342, DOI 10.1093/jnci/djr237; World Health Organization, 2019, WHO REPORT GLOBAL TO; Xian H, 2003, NICOTINE TOB RES, V5, P245, DOI 10.1080/1462220031000073667; Zhu AZX, 2014, CLIN PHARMACOL THER, V96, P256, DOI 10.1038/clpt.2014.88; Zhu AZX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070938; Zhu AZX, 2013, ADDICTION, V108, P1818, DOI 10.1111/add.12250; Zhu AZX, 2013, CANCER EPIDEM BIOMAR, V22, P708, DOI 10.1158/1055-9965.EPI-12-1234-T	48	29	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128109	10.1371/journal.pone.0128109	http://dx.doi.org/10.1371/journal.pone.0128109			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010901	Green Published, gold, Green Submitted			2022-12-26	WOS:000355183900193
J	Zhang, XY; Guo, Q; Zhang, YX; Lou, LD; Ding, DQ				Zhang, Xiangyi; Guo, Qi; Zhang, Youxue; Lou, Liandi; Ding, Daoqun			Different Timing Features in Brain Processing of Core and Moral Disgust Pictures: An Event-Related Potentials Study	PLOS ONE			English	Article							EMOTIONALLY NEGATIVE STIMULI; TIME-COURSE; ERP; ATTENTION; WORDS; P300; BIAS; REAPPRAISAL; INFORMATION; AVOIDANCE	Disgust, an emotion motivating withdrawal from offensive stimuli, protects us from the risk of biological pathogens and sociomoral violations. Homogeneity of its two types, namely, core and moral disgust has been under intensive debate. To examine the dynamic relationship between them, we recorded event-related potentials (ERPs) for core disgust, moral disgust and neutral pictures while participants performed a modified oddball task. ERP analysis revealed that N1 and P2 amplitudes were largest for the core disgust pictures, indicating automatic processing of the core disgust-evoking pictures. N2 amplitudes were higher for pictures evoking moral disgust relative to core disgust and neutral pictures, reflecting a violation of social norms. The core disgust pictures elicited larger P3 and late positive potential (LPP) amplitudes in comparison with the moral disgust pictures which, in turn, elicited larger P3 and LPP amplitudes when compared to the neutral pictures. Taken together, these findings indicated that core and moral disgust pictures elicited different neural activities at various stages of information processing, which provided supporting evidence for the heterogeneity of disgust.	[Zhang, Xiangyi; Ding, Daoqun] Hunan Normal Univ, Dept Psychol, Key Lab Cognit & Human Behav Hunan Prov, Changsha, Hunan, Peoples R China; [Guo, Qi] Liaoning Normal Univ, Sch Psychol, Dalian, Peoples R China; [Zhang, Youxue] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Chengdu 610054, Peoples R China; [Lou, Liandi] E China Normal Univ, Sch Psychol & Cognit Sci, Shanghai 200062, Peoples R China	Hunan Normal University; Liaoning Normal University; University of Electronic Science & Technology of China; East China Normal University	Ding, DQ (corresponding author), Hunan Normal Univ, Dept Psychol, Key Lab Cognit & Human Behav Hunan Prov, Changsha, Hunan, Peoples R China.	psychding@hunnu.edu.cn		zhang, xiangyi/0000-0002-1115-9573	National Social Science Foundation of China [11BSH046]; Hunan Provincial Natural Science Foundation of China [14JJ 4027]; Program for Excellent Talents in Hunan Normal University [2012 YX04]	National Social Science Foundation of China; Hunan Provincial Natural Science Foundation of China(Natural Science Foundation of Hunan Province); Program for Excellent Talents in Hunan Normal University	This research was supported by the National Social Science Foundation of China (No. 11BSH046), the Hunan Provincial Natural Science Foundation of China (No. 14JJ 4027), the Program for Excellent Talents in Hunan Normal University (No. 2012 YX04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[白露 BAI Lu], 2005, [中国心理卫生杂志, Chinese Mental Health Journal], V19, P719; Bentin S, 1999, J COGNITIVE NEUROSCI, V11, P235, DOI 10.1162/089892999563373; Borg JS, 2008, J COGNITIVE NEUROSCI, V20, P1529, DOI 10.1162/jocn.2008.20109; Bradley MM, 2007, PSYCHOPHYSIOLOGY, V44, P364, DOI 10.1111/j.1469-8986.2007.00520.x; Briggs KE, 2009, INT J PSYCHOPHYSIOL, V72, P299, DOI 10.1016/j.ijpsycho.2009.01.009; Campanella S, 2002, BIOL PSYCHOL, V59, P171, DOI 10.1016/S0301-0511(02)00005-4; Carretie L, 2004, HUM BRAIN MAPP, V22, P290, DOI 10.1002/hbm.20037; Carretie L, 2003, PSYCHOPHYSIOLOGY, V40, P381, DOI 10.1111/1469-8986.00041; Carretie L, 2011, BIOL PSYCHOL, V86, P247, DOI 10.1016/j.biopsycho.2010.12.005; Carretie L, 2001, INT J PSYCHOPHYSIOL, V41, P75, DOI 10.1016/S0167-8760(00)00195-1; Carretie L, 1997, ELECTROEN CLIN NEURO, V103, P298, DOI 10.1016/S0013-4694(96)96565-7; Carretie L, 2007, NEUROPSYCHOLOGIA, V45, P1187, DOI 10.1016/j.neuropsychologia.2006.10.013; Chapman HA, 2009, SCIENCE, V323, P1222, DOI 10.1126/science.1165565; Chapman HA, 2013, PSYCHOL BULL, V139, P300, DOI 10.1037/a0030964; Chen J, 2008, NEUROSCI LETT, V445, P135, DOI 10.1016/j.neulet.2008.08.061; Clark JA, 2010, BIOL PHILOS, V25, P75, DOI 10.1007/s10539-009-9170-1; Delplanque S, 2005, BIOL PSYCHOL, V68, P107, DOI 10.1016/j.biopsycho.2004.04.006; Feng CL, 2014, SOC NEUROSCI-UK, V9, P364, DOI 10.1080/17470919.2014.896827; Feng CL, 2012, BRAIN RES, V1489, P48, DOI 10.1016/j.brainres.2012.10.019; Feng CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029668; Ferrari V, 2011, PSYCHOPHYSIOLOGY, V48, P515, DOI 10.1111/j.1469-8986.2010.01083.x; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Foti D, 2008, J COGNITIVE NEUROSCI, V20, P977, DOI 10.1162/jocn.2008.20066; Foti D, 2009, PSYCHOPHYSIOLOGY, V46, P521, DOI 10.1111/j.1469-8986.2009.00796.x; Hajcak G, 2006, COGN AFFECT BEHAV NE, V6, P291, DOI 10.3758/CABN.6.4.291; Hinojosa JA, 2009, COGN AFFECT BEHAV NE, V9, P173, DOI 10.3758/CABN.9.2.173; Huang YX, 2007, NEUROSCI LETT, V412, P134, DOI 10.1016/j.neulet.2006.10.061; Ito TA, 1998, J PERS SOC PSYCHOL, V75, P887, DOI 10.1037/0022-3514.75.4.887; Keil A, 2006, PROG BRAIN RES, V156, P217, DOI 10.1016/S0079-6123(06)56011-X; Kissler J, 2006, PROG BRAIN RES, V156, P147, DOI 10.1016/S0079-6123(06)56008-X; KOK A, 1988, BIOL PSYCHOL, V27, P51, DOI 10.1016/0301-0511(88)90005-1; Krompinger JW, 2008, EMOTION, V8, P132, DOI 10.1037/1528-3542.8.1.132; Lahat A, 2013, CHILD DEV, V84, P955, DOI 10.1111/cdev.12001; Lang P. J., 2005, INT AFFECTIVE PICTUR; Lee SWS, 2011, COMPONENTS EMOTIONAL; Li H, 2008, NEUROIMAGE, V40, P1921, DOI 10.1016/j.neuroimage.2008.01.033; Liotti M, 2000, NEUROPSYCHOLOGIA, V38, P701, DOI 10.1016/S0028-3932(99)00106-2; LUCK SJ, 2000, NEW COGNITIVE NEUROS, P687; Luo PC, 2014, NEUROSCI LETT, V578, P85, DOI 10.1016/j.neulet.2014.06.032; Luo WB, 2010, NEUROIMAGE, V49, P1857, DOI 10.1016/j.neuroimage.2009.09.018; Luo Y, 2013, BIOL PSYCHOL, V94, P242, DOI 10.1016/j.biopsycho.2013.06.005; Marzillier S, 2004, COGNITION EMOTION, V18, P313, DOI 10.1080/02699930341000130; Mogg K, 1998, BEHAV RES THER, V36, P809, DOI 10.1016/S0005-7967(98)00063-1; Moll J, 2005, COGN BEHAV NEUROL, V18, P68, DOI 10.1097/01.wnn.0000152236.46475.a7; Moser JS, 2006, PSYCHOPHYSIOLOGY, V43, P292, DOI 10.1111/j.1469-8986.2006.00402.x; Nieuwenhuis S, 2003, COGN AFFECT BEHAV NE, V3, P17, DOI 10.3758/CABN.3.1.17; Oaten M, 2009, PSYCHOL BULL, V135, P303, DOI 10.1037/a0014823; Olofsson JK, 2008, BIOL PSYCHOL, V77, P247, DOI 10.1016/j.biopsycho.2007.11.006; Ottaviani C, 2013, INT J PSYCHOPHYSIOL, V89, P57, DOI 10.1016/j.ijpsycho.2013.05.003; Parkinson C, 2011, J COGNITIVE NEUROSCI, V23, P3162, DOI 10.1162/jocn_a_00017; Polezzi D, 2008, BEHAV BRAIN RES, V190, P218, DOI 10.1016/j.bbr.2008.03.003; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Roseman IJ, 2004, EMOTION, V4, P145, DOI 10.1037/1528-3542.4.2.145; Royzman EB, 2008, MOTIV EMOTION, V32, P100, DOI 10.1007/s11031-008-9089-x; ROZIN P, 1987, PSYCHOL REV, V94, P23, DOI 10.1037/0033-295X.94.1.23; Rozin P., 2000, HDB EMOTIONS, P637; Rozin P., 2008, DISGUST BODY SOUL EM, P9; Rozin P, 2013, TRENDS COGN SCI, V17, P367, DOI 10.1016/j.tics.2013.06.001; Rozin P, 2009, SCIENCE, V323, P1179, DOI 10.1126/science.1170492; Schnall S, 2008, PERS SOC PSYCHOL B, V34, P1096, DOI 10.1177/0146167208317771; Schupp HT, 2007, J NEUROSCI, V27, P1082, DOI 10.1523/JNEUROSCI.3223-06.2007; Schupp HT, 2004, PSYCHOPHYSIOLOGY, V41, P441, DOI 10.1111/j.1469-8986.2004.00174.x; Schupp HT, 2003, PSYCHOL SCI, V14, P7, DOI 10.1111/1467-9280.01411; Simpson J, 2006, MOTIV EMOTION, V30, P31, DOI 10.1007/s11031-006-9005-1; Tybur JM, 2013, PSYCHOL REV, V120, P65, DOI 10.1037/a0030778; Tybur JM, 2009, J PERS SOC PSYCHOL, V97, P103, DOI 10.1037/a0015474; Weinberg A, 2011, PSYCHOPHYSIOLOGY, V48, P842, DOI 10.1111/j.1469-8986.2010.01149.x; Weinberg A, 2010, EMOTION, V10, P767, DOI 10.1037/a0020242; Wu Y, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00131; Yang JM, 2013, BRAIN RES, V1533, P91, DOI 10.1016/j.brainres.2013.08.020; Yang Q, 2014, INT J PSYCHOPHYSIOL, V94, P84, DOI 10.1016/j.ijpsycho.2014.07.008; Yang Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065094; Yeung N, 2004, PSYCHOL REV, V111, P931, DOI 10.1037/0033-295x.111.4.931; Yoder KJ, 2014, NEUROPSYCHOLOGIA, V60, P39, DOI 10.1016/j.neuropsychologia.2014.05.022; Yuan JJ, 2008, PSYCHOPHYSIOLOGY, V45, P986, DOI 10.1111/j.1469-8986.2008.00693.x; Yuan JJ, 2007, NEUROPSYCHOLOGIA, V45, P2764, DOI 10.1016/j.neuropsychologia.2007.04.018; Yuan JJ, 2015, SCI CHINA LIFE SCI, V58, P480, DOI 10.1007/s11427-014-4739-6; Yuan JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089844; Yuan JJ, 2012, COGN AFFECT BEHAV NE, V12, P175, DOI 10.3758/s13415-011-0064-8; Zhang DD, 2014, SOC COGN AFFECT NEUR, V9, P1897, DOI 10.1093/scan/nst188	80	8	13	3	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128531	10.1371/journal.pone.0128531	http://dx.doi.org/10.1371/journal.pone.0128531			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0QZ	26011635	Green Published, gold, Green Submitted			2022-12-26	WOS:000355183900241
J	Zou, WH; Cui, DW; Wang, X; Guo, HH; Yao, X; Jin, M; Huang, QL; Gao, M; Wen, XH				Zou, Weihua; Cui, Dawei; Wang, Xiang; Guo, Huihui; Yao, Xing; Jin, Miao; Huang, Qiuling; Gao, Min; Wen, Xiaohong			Clinical Characteristics and Molecular Epidemiology of Noroviruses in Outpatient Children with Acute Gastroenteritis in Huzhou of China	PLOS ONE			English	Article							VIRAL GASTROENTERITIS; INFECTION; ROTAVIRUS; DIARRHEA; ADULTS; PREVALENCE; OUTBREAKS; ETIOLOGY; VIRUSES; AGENTS	Background Noroviruses (NoVs) are considered major causative pathogens associated with the morbidity and mortality of young children with acute gastroenteritis. However, few studies have examined NoVs causing acute diarrhea among outpatient children worldwide. This study was conducted to investigate the clinical features and molecular epidemiology of NoVs in outpatient children with acute gastroenteritis in Huzhou, China, between April 2013 and April 2014. Methods Stool specimens from 1346 outpatient children enrolled (under 5 years of age) with acute gastroenteritis were examined for NoVs by multiplex RT-PCR, and sequences of the partial capsids of NoVs were analyzed phylogenetically, while the relevant clinical data were analyzed statistically. Results Of 1346 specimens, 383 (28.5%, 383/1346) were positive for NoVs. The proportion of GII genotypes (26.9%) was significantly higher than that of GI genotypes (1.6%). The GII. 4 genotype was the most prevalent of GII genotypes and was clustered into GII. 4/Sydney (37.8%) and GII. 4/2006b (62.2%), whereas GI strains were clustered into GI. 1. Additionally, the younger children (12 to <24 months of age) were more susceptible to NoVs than children in other age groups, and the highest percentage of NoV infections occurred in April 2013. The diarrheal frequency (times/d) and WBC counts of the infected outpatient group with NoVs were significantly higher than were those of the uninfected outpatient group. Conclusion NoVs were confirmed to be the major viral agents responsible for acute gastroenteritis in outpatient children in Huzhou, China, and GII. 4/Sydney and GII. 4/2006b variants were identified as the predominant strains in this study.	[Zou, Weihua; Yao, Xing; Huang, Qiuling; Gao, Min] Huzhou Cent Hosp, Dept Clin Lab, Huzhou 313000, Peoples R China; [Cui, Dawei] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Ctr Clin Lab, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Xiang; Guo, Huihui; Wen, Xiaohong] First Peoples Hosp Huzhou, Huzhou Teachers Coll, Ctr Clin Lab, Huzhou 313000, Peoples R China; [Jin, Miao] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing 102206, Peoples R China	Huzhou University; Zhejiang University; Huzhou University; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Wen, XH (corresponding author), First Peoples Hosp Huzhou, Huzhou Teachers Coll, Ctr Clin Lab, Huzhou 313000, Peoples R China.	xiaohongwen2015@163.com	Cui, Dawei/ABG-4534-2021; guo, huihui/GYQ-8331-2022	Wang, Xiang/0000-0002-0913-0501	National Key Programs for Infectious Diseases of China [2012ZX10004-210]; Public Welfare Research Programs of Technology Application of Huzhou [2012GS05, 2012YSB27, 2013GY16]	National Key Programs for Infectious Diseases of China; Public Welfare Research Programs of Technology Application of Huzhou	This study was supported by the National Key Programs for Infectious Diseases of China (2012ZX10004-210, http://program.most.gov.cn/), and the Public Welfare Research Programs of Technology Application of Huzhou (Grant No. 2012GS05, 2012YSB27, and 2013GY16; http://www.huzhou.com.cn).	Anderson EJ, 2010, EXPERT REV ANTI-INFE, V8, P205, DOI [10.1586/eri.10.1, 10.1586/ERI.10.1]; Bereciartu A, 2002, J CLIN VIROL, V25, P197, DOI 10.1016/S1386-6532(02)00010-0; Bresee JS, 2012, J INFECT DIS, V205, P1374, DOI 10.1093/infdis/jis206; Bull RA, 2006, J CLIN MICROBIOL, V44, P327, DOI 10.1128/JCM.44.2.327-333.2006; Bull RA, 2011, TRENDS MICROBIOL, V19, P233, DOI 10.1016/j.tim.2011.01.002; Chen Y, 2013, PEDIATR INFECT DIS J, V32, pE285, DOI 10.1097/INF.0b013e31828c3de4; Dennehy PH, 2011, PEDIATR INFECT DIS J, V30, P63, DOI 10.1097/INF.0b013e3182059102; Dey SK, 2010, PEDIATR INFECT DIS J, V29, pE32, DOI 10.1097/INF.0b013e3181d742bf; El Qazoui M, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-300; Fewtrell L, 2005, LANCET INFECT DIS, V5, P42, DOI 10.1016/S1473-3099(04)01253-8; Froggatt PC, 2004, J MED VIROL, V72, P307, DOI 10.1002/jmv.10569; Hall AJ, 2014, MMWR-MORBID MORTAL W, V63, P491; Hall AJ, 2011, EMERG INFECT DIS, V17, P1381, DOI 10.3201/eid1708.101533; Kapikian AZ, 2009, OVERVIEW VIRAL GASTR, P7; King Caleb K, 2003, MMWR Recomm Rep, V52, P1; Kittigul L, 2009, J MED VIROL, V81, P345, DOI 10.1002/jmv.21380; Levett PN, 1996, J CLIN MICROBIOL, V34, P1497, DOI 10.1128/JCM.34.6.1497-1501.1996; Mai H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071483; Mladenova Z, 2008, J MED VIROL, V80, P2161, DOI 10.1002/jmv.21307; Nakanishi K, 2009, J CLIN VIROL, V46, P94, DOI 10.1016/j.jcv.2009.06.014; O'Ryan M, 2014, EXPERT REV ANTI-INFE, V12, P621, DOI 10.1586/14787210.2014.901168; Oldak E, 2009, ADV MED SCI-POLAND, V54, P183, DOI 10.2478/v10039-009-0046-z; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; Patel MM, 2009, J CLIN VIROL, V44, P1, DOI 10.1016/j.jcv.2008.10.009; Rimoldi SG, 2011, ARCH VIROL, V156, P1583, DOI 10.1007/s00705-011-1037-5; Rohayem J, 2009, CLIN MICROBIOL INFEC, V15, P524, DOI 10.1111/j.1469-0691.2009.02846.x; Sai LT, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-302; So Cheol Whoan, 2013, Korean J Pediatr, V56, P383, DOI 10.3345/kjp.2013.56.9.383; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tian G, 2014, J MED VIROL, V86, P1235, DOI 10.1002/jmv.23802; Victoria M, 2007, PEDIATR INFECT DIS J, V26, P602, DOI 10.1097/INF.0b013e3180618bea; Walker CLF, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000768; Wilhelmi de Cal Isabel, 2008, Enferm Infecc Microbiol Clin, V26 Suppl 13, P61, DOI 10.1157/13128782; World Health Organization, 2009, DIARRH WHY CHILDR AR; Wu W, 2014, ARCH VIROL, P1; Yang Y, 2010, J VIROL, V84, P9595, DOI 10.1128/JVI.02614-09; Yoon JS, 2008, J CLIN MICROBIOL, V46, P1474, DOI 10.1128/JCM.02282-07	37	4	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127596	10.1371/journal.pone.0127596	http://dx.doi.org/10.1371/journal.pone.0127596			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011043	Green Published, gold, Green Submitted			2022-12-26	WOS:000355183900115
J	Peng, C; Zeng, W; Su, J; Kuang, Y; He, Y; Zhao, S; Zhang, J; Ma, W; Bode, AM; Dong, Z; Chen, X				Peng, C.; Zeng, W.; Su, J.; Kuang, Y.; He, Y.; Zhao, S.; Zhang, J.; Ma, W.; Bode, A. M.; Dong, Z.; Chen, X.			Cyclin-dependent kinase 2 (CDK2) is a key mediator for EGF-induced cell transformation mediated through the ELK4/c-Fos signaling pathway	ONCOGENE			English	Article							TERNARY COMPLEX FACTOR; C-FOS PROMOTER; ACTIVATED PROTEIN-KINASE; TUMOR-SUPPRESSOR; TRANSCRIPTION FACTOR; PROSTATE-CANCER; FACTOR SAP-1A; INHIBITION; RB; DNA	Cyclin-dependent kinase 2 (CDK2) is a known regulator in the cell cycle control of the G1/S and S/G2 transitions. However, the role of CDK2 in tumorigenesis is controversial. Evidence from knockout mice as well as colon cancer cell lines indicated that CDK2 is dispensable for cell proliferation. In this study, we found that ectopic CDK2 enhances Ras (G12V)-induced foci formation and knocking down CDK2 expression markedly decreases epidermal growth factor (EGF)-induced cell transformation mediated through the downregulation of c-fos expression. Interestingly, CDK2 directly phosphorylates ELK4 at Thr194 and Ser387 and regulates the ELK4 transcriptional activity, which serves as a mechanism to regulate c-fos expression. In addition, ELK4 is overexpressed in melanoma and knocking down the ELK4 or CDK2 expression significantly attenuated the malignant phenotype of melanoma cells. Taken together, our study reveals a novel function of CDK2 in EGF-induced cell transformation and the associated signal transduction pathways. This indicates that CDK2 is a useful molecular target for the chemoprevention and therapy against skin cancer.	[Peng, C.; Ma, W.; Bode, A. M.; Dong, Z.] Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA; [Peng, C.; Zeng, W.; Su, J.; Kuang, Y.; He, Y.; Zhao, S.; Zhang, J.; Chen, X.] Cent S Univ, Xiangya Hosp, Dept Dermatol, Xiangya Rd 87, Changsha 410008, Hunan, Peoples R China	University of Minnesota System; Central South University	Dong, Z (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.; Chen, X (corresponding author), Cent S Univ, Xiangya Hosp, Dept Dermatol, Xiangya Rd 87, Changsha 410008, Hunan, Peoples R China.	zgdong@hi.umn.edu; chenxiangck@gmail.com		Jianglin, Zhang/0000-0003-0434-1729	Hormel Foundation; National Institutes of Health in China [CA172457, CA1669011, CA827502, R37, CA081064, 81225013, 81430075, 2015JJ2161]; NATIONAL CANCER INSTITUTE [R37CA081064, P01CA027502, R21CA172457, R01CA166011] Funding Source: NIH RePORTER	Hormel Foundation; National Institutes of Health in China; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by The Hormel Foundation and National Institutes of Health grants ZD: CA172457, CA1669011, CA827502, R37, CA081064 and by grant no. 81225013, 81430075, 2015JJ2161 in China.	Akiyama T, 1997, CANCER RES, V57, P1495; Ayadi A, 2001, MECH DEVELOP, V102, P205, DOI 10.1016/S0925-4773(01)00289-1; Berthet C, 2003, CURR BIOL, V13, P1775, DOI 10.1016/j.cub.2003.09.024; Berthet C, 2006, DEV CELL, V10, P563, DOI 10.1016/j.devcel.2006.03.004; Calbo J, 2004, CELL DEATH DIFFER, V11, P1055, DOI 10.1038/sj.cdd.4401481; Cen L, 2012, NEURO-ONCOLOGY, V14, P870, DOI 10.1093/neuonc/nos114; Chai YL, 2001, ONCOGENE, V20, P1357, DOI 10.1038/sj.onc.1204256; Elkeles A, 1999, MOL CELL BIOL, V19, P2594; Ferguson KL, 2000, J BIOL CHEM, V275, P33593, DOI 10.1074/jbc.M004879200; Findeisen M, 1999, EUR J BIOCHEM, V264, P415, DOI 10.1046/j.1432-1327.1999.00613.x; Gebhardt C, 2005, AM J PATHOL, V167, P243, DOI 10.1016/S0002-9440(10)62969-0; GRAHAM R, 1991, SCIENCE, V251, P189, DOI 10.1126/science.1898992; Guinea-Viniegra J, 2012, J CLIN INVEST, V122, P2898, DOI 10.1172/JCI63103; HANNON GJ, 1993, GENE DEV, V7, P2378, DOI 10.1101/gad.7.12a.2378; HILL CS, 1995, EMBO J, V14, P5037, DOI 10.1002/j.1460-2075.1995.tb00186.x; HILL CS, 1994, EMBO J, V13, P5421, DOI 10.1002/j.1460-2075.1994.tb06877.x; Hjortoe GM, 2005, DNA CELL BIOL, V24, P35, DOI 10.1089/dna.2005.24.35; Hua XQH, 1998, J CELL BIOL, V140, P271, DOI 10.1083/jcb.140.2.271; Ishimi Y, 2000, J BIOL CHEM, V275, P16235, DOI 10.1074/jbc.M909040199; JANKNECHT R, 1995, CARCINOGENESIS, V16, P443, DOI 10.1093/carcin/16.3.443; Janknecht R, 1996, ONCOGENE, V12, P1961; Janknecht R, 1997, J BIOL CHEM, V272, P4219, DOI 10.1074/jbc.272.7.4219; Janknecht R, 1997, EMBO J, V16, P1620, DOI 10.1093/emboj/16.7.1620; KORTENJANN M, 1994, MOL CELL BIOL, V14, P4815, DOI 10.1128/MCB.14.7.4815; Kumar-Sinha C, 2012, CANCER DISCOV, V2, P582, DOI 10.1158/2159-8290.CD-12-0212; Li J, 2003, J BIOL CHEM, V278, P13183, DOI 10.1074/jbc.M300269200; Li JN, 2002, BIOCHEMISTRY-US, V41, P3977, DOI 10.1021/bi011550s; Maher CA, 2009, NATURE, V458, P97, DOI 10.1038/nature07638; Martin A, 2005, CANCER CELL, V7, P591, DOI 10.1016/j.ccr.2005.05.006; Masutani H, 1997, ONCOGENE, V15, P1661, DOI 10.1038/sj.onc.1201328; Mo Y, 1998, MOL CELL, V2, P201, DOI 10.1016/S1097-2765(00)80130-6; Mo Y, 2000, NAT STRUCT BIOL, V7, P292; Rickman DS, 2009, CANCER RES, V69, P2734, DOI 10.1158/0008-5472.CAN-08-4926; SAEZ E, 1995, CELL, V82, P721, DOI 10.1016/0092-8674(95)90469-7; SKOUV J, 1986, CARCINOGENESIS, V7, P331, DOI 10.1093/carcin/7.2.331; Takahashi S., 1994, Journal of Dermatological Science, V7, P54, DOI 10.1016/0923-1811(94)90022-1; Takuwa N, 1997, MOL CELL BIOL, V17, P5348, DOI 10.1128/MCB.17.9.5348; Tetsu O, 2003, CANCER CELL, V3, P233, DOI 10.1016/S1535-6108(03)00053-9; TREISMAN R, 1995, EMBO J, V14, P4905, DOI 10.1002/j.1460-2075.1995.tb00173.x; Vanden Bush T.J., 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019468; Volm M, 1997, INT J CANCER, V74, P508, DOI 10.1002/(SICI)1097-0215(19971021)74:5<508::AID-IJC5>3.0.CO;2-7; Wallace M, 2004, MOL CELL BIOL, V24, P5606, DOI 10.1128/MCB.24.12.5606-5619.2004; WU WS, 1992, ONCOGENE, V7, P2287; Zheng D, 2008, CANCER RES, V68, P7650, DOI 10.1158/0008-5472.CAN-08-1137; Zhou Y, 1999, J BIOL REG HOMEOS AG, V13, P207	45	33	35	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 3	2016	35	9					1170	1179		10.1038/onc.2015.175	http://dx.doi.org/10.1038/onc.2015.175			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DF4WH	26028036	Green Accepted			2022-12-26	WOS:000371351700011
J	Chattopadhyay, MK; Keembiyehetty, CN; Chen, WP; Tabor, H				Chattopadhyay, Manas K.; Keembiyehetty, Chithra N.; Chen, Weiping; Tabor, Herbert			Polyamines Stimulate the Level of the sigma(38) Subunit (RpoS) of Escherichia coli RNA Polymerase, Resulting in the Induction of the Glutamate Decarboxylase-dependent Acid Response System via the gadE Regulon	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STATIONARY-PHASE; GENE-EXPRESSION; SHIGELLA-FLEXNERI; RESISTANCE; STRESS; PROTEIN; GROWTH; IDENTIFICATION; TRANSLATION; MECHANISMS	To study the physiological roles of polyamines, we carried out a global microarray analysis on the effect of adding polyamines to an Escherichia coli mutant that lacks polyamines because of deletions in the genes in the polyamine biosynthetic pathway. Previously, we have reported that the earliest response to polyamine addition is the increased expression of the genes for the glutamate-dependent acid resistance system (GDAR). We also presented preliminary evidence for the involvement of rpoS and gadE regulators. In the current study, further confirmation of the regulatory roles of rpoS and gadE is shown by a comparison of genome-wide expression profiling data from a series of microarrays comparing the genes induced by polyamine addition to polyamine-free rpoS(+)/gadE(+) cells with genes induced by polyamine addition to polyamine-free Delta rpoS/gadE(+) and rpoS6+/Delta gadE cells. The results indicate that most of the genes in the E. coli GDAR system that are induced by polyamines require rpoS and gadE. Our data also show that gadE is the main regulator of GDAR and other acid fitness island genes. Both polyamines and rpoS are necessary for the expression of gadE gene from the three promoters of gadE (P1, P2, and P3). The most important effect of polyamine addition is the very rapid increase in the level of RpoS sigma factor. Our current hypothesis is that polyamines increase the level of RpoS protein and that this increased RpoS level is responsible for the stimulation of gadE expression, which in turn induces the GDAR system in E. coli.	[Chattopadhyay, Manas K.; Tabor, Herbert] NIDDK, Lab Biochem & Genet, NIH, Bethesda, MD 20892 USA; [Keembiyehetty, Chithra N.; Chen, Weiping] NIDDK, Genom Core Facil, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Chattopadhyay, MK (corresponding author), NIDDK, NIH, 8 Ctr Dr,Bldg 8,Rm 219, Bethesda, MD 20892 USA.	manasc@intra.niddk.nih.gov	Chen, Weiping/C-9550-2011		National Institutes of Health NIDDK Intramural Research Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK024709] Funding Source: NIH RePORTER	National Institutes of Health NIDDK Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health NIDDK Intramural Research Program. The authors declare that they have no conflicts of interest with the contents of this article.	Atlung T, 2002, MOL GENET GENOMICS, V266, P873, DOI 10.1007/s00438-001-0610-0; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Battesti A, 2011, ANNU REV MICROBIOL, V65, P189, DOI 10.1146/annurev-micro-090110-102946; Bougdour A, 2008, MOL MICROBIOL, V68, P298, DOI 10.1111/j.1365-2958.2008.06146.x; Bougdour A, 2007, P NATL ACAD SCI USA, V104, P12896, DOI 10.1073/pnas.0705561104; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown L, 2002, J BACTERIOL, V184, P4455, DOI 10.1128/JB.184.16.4455-4465.2002; Castanie-Cornet MP, 1999, J BACTERIOL, V181, P3525, DOI 10.1128/JB.181.11.3525-3535.1999; Castanie-Cornet MP, 2001, MICROBIOL-UK, V147, P709, DOI 10.1099/00221287-147-3-709; Chattopadhyay MK, 2006, YEAST, V23, P751, DOI 10.1002/yea.1393; Chattopadhyay MK, 2013, J BIOL CHEM, V288, P33559, DOI 10.1074/jbc.M113.510552; Chattopadhyay MK, 2003, P NATL ACAD SCI USA, V100, P2261, DOI 10.1073/pnas.2627990100; Cohen S.S., 1998, GUIDE POLYAMINES, V1st ed.; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; De Biase D, 1999, MOL MICROBIOL, V32, P1198, DOI 10.1046/j.1365-2958.1999.01430.x; De Biase D, 2012, MOL MICROBIOL, V86, P770, DOI 10.1111/mmi.12020; Dukan S, 1999, J BIOL CHEM, V274, P26027, DOI 10.1074/jbc.274.37.26027; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; GENTRY DR, 1993, J BACTERIOL, V175, P7982, DOI 10.1128/JB.175.24.7982-7989.1993; GORDEN J, 1993, INFECT IMMUN, V61, P364, DOI 10.1128/IAI.61.1.364-367.1993; Gottesman S, 2004, ANNU REV MICROBIOL, V58, P303, DOI 10.1146/annurev.micro.58.030603.123841; HENGGEARONIS R, 1993, CELL, V72, P165, DOI 10.1016/0092-8674(93)90655-A; Hommais F, 2004, MICROBIOL-SGM, V150, P61, DOI 10.1099/mic.0.26659-0; Iarashi K, 2010, INT J BIOCHEM CELL B, V42, P39, DOI 10.1016/j.biocel.2009.07.009; Jung IL, 2003, J BIOL CHEM, V278, P22846, DOI 10.1074/jbc.M212055200; Kanjee U, 2013, ANNU REV MICROBIOL, V67, P65, DOI 10.1146/annurev-micro-092412-155708; Kanjee U, 2011, EMBO J, V30, P931, DOI 10.1038/emboj.2011.5; Lacour S, 2004, J BACTERIOL, V186, P7186, DOI 10.1128/JB.186.21.7186-7195.2004; Landini P, 2014, ENV MICROBIOL REP, V6, P1, DOI 10.1111/1758-2229.12112; LANGE R, 1994, GENE DEV, V8, P1600, DOI 10.1101/gad.8.13.1600; LANGE R, 1991, MOL MICROBIOL, V5, P49, DOI 10.1111/j.1365-2958.1991.tb01825.x; Lin JS, 1996, APPL ENVIRON MICROB, V62, P3094, DOI 10.1128/AEM.62.9.3094-3100.1996; LIN JS, 1995, J BACTERIOL, V177, P4097, DOI 10.1128/jb.177.14.4097-4104.1995; Ma Z, 2004, J BACTERIOL, V186, P7378, DOI 10.1128/JB.186.21.7378-7389.2004; Ma Z, 2003, MOL MICROBIOL, V49, P1309, DOI 10.1046/j.1365-2958.2003.03633.x; Masuda N, 2003, MOL MICROBIOL, V48, P699, DOI 10.1046/j.1365-2958.2003.03477.x; Miller J. H., 1992, SHORT COURSE BACTERI, P263; Patten CL, 2004, MOL GENET GENOMICS, V272, P580, DOI 10.1007/s00438-004-1089-2; Pegg AE, 2011, METHODS MOL BIOL, V720, P3, DOI 10.1007/978-1-61779-034-8_1; Richard HT, 2003, ADV APPL MICROBIOL, V52, P167, DOI 10.1016/S0065-2164(03)01007-4; Schellhorn HE, 2014, FUTURE MICROBIOL, V9, P497, DOI 10.2217/fmb.14.9; SMALL P, 1994, J BACTERIOL, V176, P1729, DOI 10.1128/jb.176.6.1729-1737.1994; Soper T, 2010, P NATL ACAD SCI USA, V107, P9602, DOI 10.1073/pnas.1004435107; StimHerndon KP, 1996, MICROBIOL-UK, V142, P1311, DOI 10.1099/13500872-142-5-1311; Subbarayan PR, 2004, MOL GENET GENOMICS, V270, P533, DOI 10.1007/s00438-003-0944-x; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; TABOR H, 1982, P NATL ACAD SCI-BIOL, V79, P7087, DOI 10.1073/pnas.79.23.7087; Tkachenko AG, 2014, FEMS MICROBIOL LETT, V361, P25, DOI 10.1111/1574-6968.12613; Vanaja SK, 2009, J BACTERIOL, V191, P1868, DOI 10.1128/JB.01481-08; Vecerek B, 2010, NUCLEIC ACIDS RES, V38, P1284, DOI 10.1093/nar/gkp1125; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; Wallace HM, 2003, BIOCHEM J, V376, P1, DOI 10.1042/BJ20031327; Williams K, 1997, BIOCHEM J, V325, P289, DOI 10.1042/bj3250289; Yoshida M, 2004, J BIOL CHEM, V279, P46008, DOI 10.1074/jbc.M404393200; Yoshida M, 2002, J BIOL CHEM, V277, P37139, DOI 10.1074/jbc.M206668200	56	19	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					17809	17821		10.1074/jbc.M115.655688	http://dx.doi.org/10.1074/jbc.M115.655688			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26025365	Green Published, hybrid			2022-12-26	WOS:000358511700018
J	Liu, D; Wen, Y; Tang, TT; Lv, LL; Tang, RN; Liu, H; Ma, KL; Crowley, SD; Liu, BC				Liu, Dan; Wen, Yi; Tang, Tao-Tao; Lv, Lin-Li; Tang, Ri-Ning; Liu, Hong; Ma, Kun-Ling; Crowley, Steve D.; Liu, Bi-Cheng			Megalin/Cubulin-Lysosome-mediated Albumin Reabsorption Is Involved in the Tubular Cell Activation of NLRP3 Inflammasome and Tubulointerstitial Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROXIMAL TUBULE; NALP3 INFLAMMASOME; KAPPA-B; PROTEIN; PROTEOLYSIS; MECHANISM; APOPTOSIS; CUBILIN; TOXINS	Albuminuria contributes to the development and progression of chronic kidney disease by inducing tubulointerstitial inflammation (TI) and fibrosis. However, the exact mechanisms of TI in response to albuminuria are unresolved. We previously demonstrated that NLRP3 and inflammasomes mediate albumin-induced lesions in tubular cells. Here, we further investigated the role of endocytic receptors and lysosome rupture in NLRP3 inflammasome activation. A murine proteinuric nephropathy model was induced by albumin overload as described previously. The priming and activation signals for inflammasome complex formation were evoked simultaneously by albumin excess in tubular epithelial cells. The former signal was dependent on a albumin-triggered NF-kappa B pathway activation. This process is mediated by the endocytic receptor, megalin and cubilin. However, the silencing of megalin or cubilin inhibited the albumin-induced NLRP3 signal. Notably, subsequent lysosome rupture and the corresponding release of lysosomal hydrolases, especially cathepsin B, were observed in tubular epithelial cells exposed to albumin. Cathepsin B release and distribution are essential for NLRP3 signal activation, and inhibitors of cathepsin B suppressed the NLRP3 signal in tubular epithelial cells. Taken together, our findings suggest that megalin/cubilin and lysosome rupture are involved in albumin-triggered tubular injury and TI. This study provides novel insights into albuminuria-induced TI and implicates the active control of albuminuria as a critical strategy to halt the progression of chronic kidney disease.	[Liu, Dan; Wen, Yi; Tang, Tao-Tao; Lv, Lin-Li; Tang, Ri-Ning; Liu, Hong; Ma, Kun-Ling; Liu, Bi-Cheng] Southeast Univ, Sch Med, Zhong Da Hosp, Inst Nephrol, Nanjing 210009, Jiangsu, Peoples R China; [Crowley, Steve D.] Duke Univ, Div Nephrol, Dept Med, Durham, NC 27710 USA; [Crowley, Steve D.] Durham Vet Affairs Med Ctr, Durham, NC 27710 USA	Southeast University - China; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center	Liu, BC (corresponding author), 87 Dingjiaqiao Rd, Nanjing 210009, Jiangsu, Peoples R China.	liubc64@163.com			National Natural Scientific Foundation [81130010]; Major State Basic Research Development Program ("973") Grant [2012CB517706]; Program for Clinical Medical Science of Jiangsu Province Grant [BL2014080]	National Natural Scientific Foundation(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program ("973") Grant; Program for Clinical Medical Science of Jiangsu Province Grant	This work was supported by National Natural Scientific Foundation Grant 81130010, Major State Basic Research Development Program ("973") Grant 2012CB517706, and Program for Clinical Medical Science of Jiangsu Province Grant BL2014080. The authors declare that they have no conflicts of interest with the contents of this article.	Abbate M, 2006, J AM SOC NEPHROL, V17, P2974, DOI 10.1681/ASN.2006040377; Amsellem S, 2010, J AM SOC NEPHROL, V21, P1859, DOI 10.1681/ASN.2010050492; Anders HJ, 2011, J AM SOC NEPHROL, V22, P1007, DOI 10.1681/ASN.2010080798; Birn H, 1997, J BIOL CHEM, V272, P26497, DOI 10.1074/jbc.272.42.26497; Cabezas F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016794; Caruso-Neves C, 2006, P NATL ACAD SCI USA, V103, P18810, DOI 10.1073/pnas.0605029103; Chang A, 2014, CURR OPIN NEPHROL HY, V23, P204, DOI 10.1097/01.mnh.0000444814.49755.90; Christensen EI, 2009, PFLUG ARCH EUR J PHY, V458, P1039, DOI 10.1007/s00424-009-0685-8; Dickson LE, 2014, J AM SOC NEPHROL, V25, P443, DOI 10.1681/ASN.2013090950; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Eddy AA, 2004, NEPHROL DIAL TRANSPL, V19, P277, DOI 10.1093/ndt/gfg533; EDDY AA, 1989, AM J PATHOL, V135, P719; Erkan E, 2007, J AM SOC NEPHROL, V18, P1199, DOI 10.1681/ASN.2006040407; Fang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072344; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Jin CC, 2010, J CLIN IMMUNOL, V30, P628, DOI 10.1007/s10875-010-9440-3; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Lee D, 2013, AM J PHYSIOL-RENAL, V304, pF1009, DOI 10.1152/ajprenal.00601.2012; Leheste JR, 2002, FASEB J, V16, P247, DOI 10.1096/fj.02-0578fje; Li XN, 2010, J AM SOC NEPHROL, V21, P1115, DOI 10.1681/ASN.2009070760; Lichtnekert J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026778; Liu BC, 2009, CLIN CHIM ACTA, V403, P23, DOI 10.1016/j.cca.2008.12.015; Liu D, 2014, INT J BIOCHEM CELL B, V57, P7, DOI 10.1016/j.biocel.2014.09.018; Liu WJ, 2015, AM J PHYSIOL-RENAL, V308, pF639, DOI 10.1152/ajprenal.00383.2014; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2012, IMMUNITY, V36, P313, DOI 10.1016/j.immuni.2012.03.005; Mason DR, 2012, J INNATE IMMUN, V4, P16, DOI 10.1159/000334247; Menu P, 2011, CLIN EXP IMMUNOL, V166, P1, DOI 10.1111/j.1365-2249.2011.04440.x; Morigi M, 2002, J AM SOC NEPHROL, V13, P1179; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Nielsen R, 2013, KIDNEY INT, V84, P902, DOI 10.1038/ki.2013.218; Nielsen R, 2010, PEDIATR NEPHROL, V25, P813, DOI 10.1007/s00467-009-1381-9; Nykjaer A, 1999, CELL, V96, P507, DOI 10.1016/S0092-8674(00)80655-8; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Vilaysane A, 2010, J AM SOC NEPHROL, V21, P1732, DOI 10.1681/ASN.2010020143; Wang YP, 1999, J AM SOC NEPHROL, V10, P1204; Yamahara K, 2013, J AM SOC NEPHROL, V24, P1769, DOI 10.1681/ASN.2012111080; Zhai XY, 2000, KIDNEY INT, V58, P1523, DOI 10.1046/j.1523-1755.2000.00314.x; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831; Zoja C, 1998, KIDNEY INT, V53, P1608, DOI 10.1046/j.1523-1755.1998.00905.x; Zoja C, 2015, NEPHROL DIAL TRANSPL, V30, P706, DOI 10.1093/ndt/gfu261	45	71	74	3	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					18018	18028		10.1074/jbc.M115.662064	http://dx.doi.org/10.1074/jbc.M115.662064			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26025362	hybrid, Green Published			2022-12-26	WOS:000358511700034
J	Makinoshima, H; Takita, M; Saruwatari, K; Umemura, S; Obata, Y; Ishii, G; Matsumoto, S; Sugiyama, E; Ochiai, A; Abe, R; Goto, K; Esumi, H; Tsuchihara, K				Makinoshima, Hideki; Takita, Masahiro; Saruwatari, Koichi; Umemura, Shigeki; Obata, Yuuki; Ishii, Genichiro; Matsumoto, Shingo; Sugiyama, Eri; Ochiai, Atsushi; Abe, Ryo; Goto, Koichi; Esumi, Hiroyasu; Tsuchihara, Katsuya			Signaling through the Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Axis Is Responsible for Aerobic Glycolysis mediated by Glucose Transporter in Epidermal Growth Factor Receptor (EGFR)-mutated Lung Adenocarcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METABOLIC PATHWAYS; CANCER-CELLS; SURVIVAL; KINASE; DEGRADATION; RESISTANCE; ONCOGENES; PROTEINS; GLUT1	Oncogenic epidermal growth factor receptor (EGFR) signaling plays an important role in regulating global metabolic pathways, including aerobic glycolysis, the pentose phosphate pathway (PPP), and pyrimidine biosynthesis. However, the molecular mechanism by which EGFR signaling regulates cancer cell metabolism is still unclear. To elucidate how EGFR signaling is linked to metabolic activity, we investigated the involvement of the RAS/MEK/ERK and PI3K/AKT/mammalian target of rapamycin (mTOR) pathways on metabolic alteration in lung adenocarcinoma (LAD) cell lines with activating EGFR mutations. Although MEK inhibition did not alter lactate production and the extracellular acidification rate, PI3K/mTOR inhibitors significantly suppressed glycolysis in EGFR-mutant LAD cells. Moreover, a comprehensive metabolomics analysis revealed that the levels of glucose 6-phosphate and 6-phosphogluconate as early metabolites in glycolysis and PPP were decreased after inhibition of the PI3K/AKT/mTOR pathway, suggesting a link between PI3K signaling and the proper function of glucose transporters or hexokinases in glycolysis. Indeed, PI3K/mTOR inhibition effectively suppressed membrane localization of facilitative glucose transporter 1 (GLUT1), which, instead, accumulated in the cytoplasm. Finally, aerobic glycolysis and cell proliferation were down-regulated when GLUT1 gene expression was suppressed by RNAi. Taken together, these results suggest that PI3K/AKT/mTOR signaling is indispensable for the regulation of aerobic glycolysis in EGFR-mutated LAD cells.	[Makinoshima, Hideki; Takita, Masahiro; Matsumoto, Shingo; Tsuchihara, Katsuya] Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Div Translat Res, Kashiwa, Chiba 2778577, Japan; [Takita, Masahiro; Tsuchihara, Katsuya] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba 2778561, Japan; [Saruwatari, Koichi; Umemura, Shigeki; Matsumoto, Shingo; Sugiyama, Eri; Goto, Koichi] Natl Canc Ctr Hosp East, Res Ctr Innovat Oncol, Thorac Oncol, Kashiwa, Chiba 2778577, Japan; [Ishii, Genichiro; Ochiai, Atsushi] Natl Canc Ctr Hosp East, Res Ctr Innovat Oncol, Div Pathol, Kashiwa, Chiba 2778577, Japan; [Obata, Yuuki; Abe, Ryo] Tokyo Univ Sci, Res Inst Biomed Sci, Div Immunobiol, Noda, Chiba 2780022, Japan; [Esumi, Hiroyasu] Tokyo Univ Sci, Res Inst Biomed Sci, Div Clin Res, Noda, Chiba 2780022, Japan	National Cancer Center - Japan; University of Tokyo; National Cancer Center - Japan; National Cancer Center - Japan; Tokyo University of Science; Tokyo University of Science	Makinoshima, H (corresponding author), Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Div Translat Res, Kashiwa, Chiba 2778577, Japan.	hmakinos@east.ncc.go.jp	将大, 田北/AAK-8626-2020		National Cancer Center Research and Development Fund [25-A-6, 26-A-16]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [26830121]	National Cancer Center Research and Development Fund(National Cancer Center - Japan); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by National Cancer Center Research and Development Fund Grants 25-A-6 and 26-A-16 and KAKENHI Grant-in-Aid for Young Scientists (B) 26830121 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Ben-Sahra I, 2013, SCIENCE, V339, P1323, DOI 10.1126/science.1228792; Bogan JS, 2012, ANNU REV BIOCHEM, V81, P507, DOI 10.1146/annurev-biochem-060109-094246; Boroughs LK, 2015, NAT CELL BIOL, V17, P351, DOI 10.1038/ncb3124; Busaidy NL, 2012, J CLIN ONCOL, V30, P2919, DOI 10.1200/JCO.2011.39.7356; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Camp ER, 2005, CLIN CANCER RES, V11, P397; Chan DA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002394; Chen LQ, 2015, ANNU REV BIOCHEM, V84, P865, DOI 10.1146/annurev-biochem-060614-033904; Cross DAE, 2014, CANCER DISCOV, V4, P1046, DOI 10.1158/2159-8290.CD-14-0337; D'Amato V, 2014, BRIT J CANCER, V110, P2887, DOI 10.1038/bjc.2014.241; Eyster CA, 2009, TRAFFIC, V10, P590, DOI 10.1111/j.1600-0854.2009.00894.x; Filipits M, 2014, CURR OPIN ONCOL, V26, P152, DOI 10.1097/CCO.0000000000000049; Fruman DA, 2014, NAT REV DRUG DISCOV, V13, P140, DOI 10.1038/nrd4204; Gainor JF, 2013, ONCOLOGIST, V18, P865, DOI 10.1634/theoncologist.2013-0095; Green DR, 2014, SCIENCE, V345, P1466, DOI 10.1126/science.1250256; Haber DA, 2005, COLD SH Q B, V70, P419, DOI 10.1101/sqb.2005.70.043; Hallberg B, 2013, NAT REV CANCER, V13, P685, DOI 10.1038/nrc3580; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Kaira K, 2014, LUNG CANCER, V83, P197, DOI 10.1016/j.lungcan.2013.11.025; Kami K, 2013, METABOLOMICS, V9, P444, DOI 10.1007/s11306-012-0452-2; Le A, 2012, CELL METAB, V15, P110, DOI 10.1016/j.cmet.2011.12.009; Lee EE, 2015, MOL CELL, V58, P845, DOI 10.1016/j.molcel.2015.04.015; Leto D, 2012, NAT REV MOL CELL BIO, V13, P383, DOI 10.1038/nrm3351; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Lopez-Serra P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4608; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Macheda ML, 2005, J CELL PHYSIOL, V202, P654, DOI 10.1002/jcp.20166; Makinoshima H, 2014, J BIOL CHEM, V289, P20813, DOI 10.1074/jbc.M114.575464; Ohashi Y, 2008, MOL BIOSYST, V4, P135, DOI 10.1039/b714176a; Ooga T, 2011, MOL BIOSYST, V7, P1217, DOI 10.1039/c0mb00141d; Ooi AT, 2015, CLIN CANCER RES, V21, P2440, DOI 10.1158/1078-0432.CCR-14-1209; Pao W, 2010, NAT REV CANCER, V10, P760, DOI 10.1038/nrc2947; Qu YQ, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/1756-9966-33-52; Reed BC, 2005, MOL BIOL CELL, V16, P4183, DOI 10.1091/mbc.e04-11-0978; Sellers K, 2015, J CLIN INVEST, V125, P687, DOI 10.1172/JCI72873; Soga T, 2013, CANCER SCI, V104, P275, DOI 10.1111/cas.12085; Spratlin JL, 2009, CLIN CANCER RES, V15, P431, DOI 10.1158/1078-0432.CCR-08-1059; Stella GM, 2013, LANCET RESP MED, V1, P251, DOI 10.1016/S2213-2600(13)70009-2; Suzuki A, 2014, NUCLEIC ACIDS RES, V42, P13557, DOI 10.1093/nar/gku885; Suzuki A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073484; Szablewski L, 2013, BBA-REV CANCER, V1835, P164, DOI 10.1016/j.bbcan.2012.12.004; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; Thurnher M, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005970; Tsuchihara K, 2013, TRANSL LUNG CANCER R, V2, P463, DOI 10.3978/j.issn.2218-6751.2013.11.02; Umemura S, 2015, JPN J CLIN ONCOL, V45, P513, DOI 10.1093/jjco/hyv017; Viale A, 2014, NATURE, V514, P628, DOI 10.1038/nature13611; Wang RN, 2012, NAT IMMUNOL, V13, P907, DOI 10.1038/ni.2386; Watson RT, 2006, TRENDS BIOCHEM SCI, V31, P215, DOI 10.1016/j.tibs.2006.02.007; Weihua Z, 2008, CANCER CELL, V13, P385, DOI 10.1016/j.ccr.2008.03.015; Wong KK, 2010, CURR OPIN GENET DEV, V20, P87, DOI 10.1016/j.gde.2009.11.002; Wu N, 2013, MOL CELL, V49, P1167, DOI 10.1016/j.molcel.2013.01.035; Zhang C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3935	52	117	126	1	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17495	17504		10.1074/jbc.M115.660498	http://dx.doi.org/10.1074/jbc.M115.660498			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	26023239	hybrid, Green Published			2022-12-26	WOS:000357730900041
J	Kok, M; Kietselaer, BLJH; Mihl, C; Altintas, S; Nijssen, EC; Wildberger, JE; Das, M				Kok, Madeleine; Kietselaer, Bas L. J. H.; Mihl, Casper; Altintas, Sibel; Nijssen, Estelle C.; Wildberger, Joachim E.; Das, Marco			Contrast Enhancement of the Right Ventricle during Coronary CT Angiography - Is It Necessary?	PLOS ONE			English	Article							MULTISLICE COMPUTED-TOMOGRAPHY; DUAL-SOURCE CT; WORKING GROUP; RIGHT HEART; MASS; ECHOCARDIOGRAPHY; REPRODUCIBILITY; QUANTIFICATION; OPTIMIZATION; MANAGEMENT	Purpose It is unclear if prolonged contrast media injection, to improve right ventricular visualization during coronary CT angiography, leads to increased detection of right ventricle pathology. The purpose of this study was to evaluate right ventricle enhancement and subsequent detection of right ventricle disease during coronary CT angiography. Materials and Methods 472 consecutive patients referred for screening coronary CT angiography were retrospectively evaluated. Every patient underwent multidetector-row CT of the coronary arteries: 128x0.6mm coll., 100-120kV, rot. time 0.28s, ref. mAs 350 and received an individualized (P3T) contrast bolus injection of iodinated contrast medium (300 mgI/ml). Patient data were analyzed to assess right ventricle enhancement (HU) and right ventricle pathology. Image quality was defined good when right ventricle enhancement >200HU, moderate when 140-200HU and poor when <140HU. Results Good image quality was found in 372 patients, moderate in 80 patients and poor in 20 patients. Mean enhancement of the right ventricle cavity was 268HU +/- 102. Patients received an average bolus of 108 +/- 24 ml at an average peak flow rate of 6.1 +/- 2.2 ml/s. In only three out of 472 patients (0.63%) pathology of the right ventricle was found (dilatation) No other right ventricle pathology was detected. Conclusion Right ventricle pathology was detected in three out of 472 patients; the dilatation observed in these three cases may have been picked up even without dedicated enhancement of the right ventricle. Based on our findings, right ventricle enhancement can be omitted during screening coronary CT angiography.	[Kok, Madeleine; Kietselaer, Bas L. J. H.; Mihl, Casper; Nijssen, Estelle C.; Wildberger, Joachim E.; Das, Marco] Maastricht Univ, Med Ctr, Dept Radiol, NL-6200 MD Maastricht, Netherlands; [Kok, Madeleine; Kietselaer, Bas L. J. H.; Mihl, Casper; Altintas, Sibel; Wildberger, Joachim E.; Das, Marco] Maastricht Univ, Med Ctr, CARIM, Cardio Vasc Res Inst Maastricht, NL-6200 MD Maastricht, Netherlands; [Kietselaer, Bas L. J. H.; Altintas, Sibel] Maastricht Univ, Med Ctr, Dept Cardiol, NL-6200 MD Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University	Kok, M (corresponding author), Maastricht Univ, Med Ctr, Dept Radiol, NL-6200 MD Maastricht, Netherlands.	madeleine.kok@mumc.nl		Wildberger, Joachim/0000-0002-4810-6854	Siemens AG; Bayer Healthcare; GE Healthcare; Philips Healthcare	Siemens AG(Siemens AG); Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); GE Healthcare(General ElectricGE Healthcare); Philips Healthcare	JEW MD received general institutional funding from Siemens AG, Bayer Healthcare, GE Healthcare and Philips Healthcare without any correlation to this specific work. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Annuar BR, 2008, EUR J RADIOL, V65, P112, DOI 10.1016/j.ejrad.2007.03.008; Becker CR, 2003, INVEST RADIOL, V38, P690, DOI 10.1097/01.rli.0000084886.44676.e4; Beygui F, 2004, INT J CARDIOVAS IMAG, V20, P509, DOI 10.1007/s10554-004-1097-7; Braunwald E, 2002, CIRCULATION, V106, P1312, DOI 10.1161/01.CIR.0000030314.11999.6A; Buechel ERV, 2012, EUR HEART J, V33, P949, DOI 10.1093/eurheartj/ehr490; Burazor I, 2014, CLIN CARDIOL, V37, P582, DOI 10.1002/clc.22295; Cademartiri F, 2004, EUR RADIOL, V14, P178, DOI 10.1007/s00330-003-2188-x; Castillo JG, 2010, SEMIN CARDIOTHORAC V, V14, P6, DOI 10.1177/1089253210362596; Davidson C, 2006, AM J CARDIOL, V98, p42K, DOI 10.1016/j.amjcard.2006.01.023; Elliott P, 2004, LANCET, V363, P1881, DOI 10.1016/S0140-6736(04)16358-7; Elliott P, 2008, EUR HEART J, V29, P270, DOI 10.1093/eurheartj/ehm342; Funabashi N, 2007, INT J CARDIOL, V114, P265, DOI 10.1016/j.ijcard.2005.11.066; Grothues F, 2004, AM HEART J, V147, P218, DOI 10.1016/j.ahj.2003.10.005; Johnson TRC, 2006, EUR RADIOL, V16, P1409, DOI 10.1007/s00330-006-0298-y; Kerl JM, 2008, RADIOLOGY, V247, P356, DOI 10.1148/radiol.2472070856; LAM KY, 1993, ARCH PATHOL LAB MED, V117, P1027; Nance JW, 2012, INVEST RADIOL, V47, P78, DOI 10.1097/RLI.0b013e31821a2142; OLDERSHAW P, 1992, BRIT HEART J, V68, P12; Puesken M, 2008, EUR RADIOL, V18, P2087, DOI 10.1007/s00330-008-0982-1; Quiroz R, 2004, CIRCULATION, V109, P2401, DOI 10.1161/01.CIR.0000129302.90476.BC; Remy-Jardin M, 2006, AM J ROENTGENOL, V187, P1605, DOI 10.2214/AJR.05.1194; Rist C, 2006, INVEST RADIOL, V41, P460, DOI 10.1097/01.rli.0000208239.34723.5d; Seifarth H, 2009, EUR RADIOL, V19, P2373, DOI 10.1007/s00330-009-1421-7; Takx RAP, 2012, EUR J RADIOL, V81, pE598, DOI 10.1016/j.ejrad.2011.07.001; Taylor AJ, 2010, J AM COLL CARDIOL, V56, P1864, DOI 10.1016/j.jacc.2010.07.005; Voelkel NF, 2006, CIRCULATION, V114, P1883, DOI 10.1161/CIRCULATIONAHA.106.632208	27	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128625	10.1371/journal.pone.0128625	http://dx.doi.org/10.1371/journal.pone.0128625			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26029905	Green Published, gold, Green Submitted			2022-12-26	WOS:000356630900176
J	Sheffield, CL; Crippen, TL; Byrd, JA; Beier, RC; Yeater, K				Sheffield, Cynthia L.; Crippen, Tawni L.; Byrd, J. Allen; Beier, Ross C.; Yeater, Kathleen			Canonical Discrimination of the Effect of a New Broiler Production Facility on Soil Chemical Profiles as Related to Current Management Practices	PLOS ONE			English	Article							GENETIC-VARIATION; PHOSPHORUS; EXTRACTANT; POTASSIUM; MANGANESE; NITROGEN; QUALITY; ZINC	The effect dirt-floored broiler houses have on the underlying native soil, and the potential for contamination of the ground water by leaching under the foundation, is an understudied area. This study examines alterations in fifteen quantitative soil parameters (Ca, Cu, electrical conductivity, Fe, K, Mg, Mn, Na, NO3, organic matter, P, pH, S, soil moisture and Zn) in the underlayment of a newly constructed dirt-floored broiler house over the first two years of production (Native through Flock 11). The experiment was conducted near NW Robertson County, Texas, where the native soil is a fine, smectitic thermic Udertic Paleustalfs and the slopes range from zero to three percent. Multiple samples were collected from under each of three water and three feed lines the length of the house, in a longitudinal study during February 2008 through August 2010. To better define the relationship between the soil parameters and sampling times, a canonical discriminant analysis approach was used. The soil profiles assembled into five distinctive clusters corresponding to time and management practices. Results of this work revealed that the majority of parameters increased over time. The management practices of partial and total house clean-outs markedly altered soil profiles the house underlayment, thus reducing the risk of infiltration into the ground water near the farm. This is important as most broiler farms consist of several houses within a small area, so the cumulative ecological impact could be substantial if not properly managed.	[Sheffield, Cynthia L.; Crippen, Tawni L.; Byrd, J. Allen; Beier, Ross C.] ARS, USDA, Food & Feed Safety Res Unit, Southern Plains Agr Res Ctr, College Stn, TX 77845 USA; [Yeater, Kathleen] ARS, USDA, Plains Area, Ft Collins, CO USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Sheffield, CL (corresponding author), ARS, USDA, Food & Feed Safety Res Unit, Southern Plains Agr Res Ctr, College Stn, TX 77845 USA.	cindy.sheffield@ars.usda.gov		Crippen, Tawni/0000-0001-5129-2371	United States Department of Agriculture	United States Department of Agriculture(United States Department of Agriculture (USDA))	The authors extend their thanks to our commercial partner for allowing us to work in cooperation with their producers. We also gratefully recognize Andrew Herndon, Denise Caldwell, Charles Hernandez, Laura Ripley and Bob Droleskey for their invaluable help in both the field and laboratory. This project was funded by the United States Department of Agriculture. There is no commercial or financial conflict of interest. Mention of trade name, proprietary product, or specific equipment does not constitute a guarantee or warranty by the United States Department of Agriculture and does not imply its approval to the exclusion of other products that may be suitable.	Arshad MA, 2002, AGR ECOSYST ENVIRON, V88, P153, DOI 10.1016/S0167-8809(01)00252-3; Batjes N, 1995, GLOBAL DATA SET SOIL; CRUZCASTILLO JG, 1994, HORTSCIENCE, V29, P1115, DOI 10.21273/HORTSCI.29.10.1115; EPA, 2013, 820R13002 EPA; EPA U. S. E. P. A, 2012, FACTS NUTR POLL; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Kachurina OM, 2000, COMMUN SOIL SCI PLAN, V31, P893, DOI 10.1080/00103620009370485; Keeney D.R, 1982, AGRON MONOGR, P643; Kratz S, 2004, J ENVIRON QUAL, V33, P1662, DOI 10.2134/jeq2004.1662; LINDSAY WL, 1978, SOIL SCI SOC AM J, V42, P421, DOI 10.2136/sssaj1978.03615995004200030009x; Lomax K. M., 1997, Applied Engineering in Agriculture, V13, P773; Mallin MA, 1997, J ENVIRON QUAL, V26, P1622, DOI 10.2134/jeq1997.00472425002600060023x; Mathews K, 2012, LDPM219 USDAERS; MEHLICH A, 1984, COMMUN SOIL SCI PLAN, V15, P1409, DOI 10.1080/00103628409367568; MEHLICH A, 1978, COMMUN SOIL SCI PLAN, V9, P477, DOI 10.1080/00103627809366824; Miles DM, 2013, POULTRY SCI, V92, P1693, DOI 10.3382/ps.2012-02809; National Chicken Council, 2010, TOP BROIL PROD STAT; Rhoades J.D., 1982, METHODS SOIL ANAL, V1, P149, DOI DOI 10.1016/J.JHAZMAT.2009.04.097; SCHOFIELD R. K., 1955, SOIL SCI SOC AMER PROC, V19, P164; SHARPLEY AN, 1994, J ENVIRON QUAL, V23, P437, DOI 10.2134/jeq1994.00472425002300030006x; Sims JT, 2005, SOIL USE MANAGE, V21, P141, DOI 10.1079/SUM2005301; Smith PM, 2012, GEOFORUM, V43, P35, DOI 10.1016/j.geoforum.2011.07.008; Soil Survey Staff, 2013, OFF SOIL SER DESCR; Turan MA, 2013, J FOOD AGRIC ENVIRON, V11, P572; Vaylay R, 2002, CROP SCI, V42, P534, DOI 10.2135/cropsci2002.0534; Wang DL, 1998, COMMUN SOIL SCI PLAN, V29, P15, DOI 10.1080/00103629809369925; Yeater KM, 2015, AGRON J, V107, P799, DOI 10.2134/agronj14.0017; Yeater KM, 2004, CROP SCI, V44, P185, DOI 10.2135/cropsci2004.0185; Zhu J, 2002, T ASAE, V45, P1971	29	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128179	10.1371/journal.pone.0128179	http://dx.doi.org/10.1371/journal.pone.0128179			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL0KF	26029909	Green Published, gold, Green Submitted			2022-12-26	WOS:000356630900120
J	Cassani, JR; Croshaw, DA; Bozzo, J; Brooks, B; Everham, EM; Ceilley, DW; Hanson, D				Cassani, John R.; Croshaw, Dean A.; Bozzo, Joseph; Brooks, Brenda; Everham, Edwin M., III; Ceilley, David W.; Hanson, Deborah			Herpetofaunal Community Change in Multiple Habitats after Fifteen Years in a Southwest Florida Preserve, USA	PLOS ONE			English	Article							DECLINING AMPHIBIAN POPULATIONS; CONSERVATION BIOLOGY; GULF-COAST; REPTILES; EXTINCTIONS; PREDATION; INVASIONS; RICHNESS; PITFALLS; CLIMATE	Herpetofaunal declines have been documented globally, and southern Florida, USA, is an especially vulnerable region because of high impacts from hydrological perturbations and nonindigenous species. To assess the extent of recent change in herpetofauna community composition, we established a baseline inventory during 1995-97 at a managed preserve in a habitat rich area of southwest Florida, and repeated our sampling methods fifteen years later (2010-11). Nine drift fence arrays were placed in four habitat types: mesic flatwood, mesic hammock, depression marsh, and wet prairie. Trapping occurred daily for one week during 7-8 sampling runs in each period (57 and 49 total sampling days, respectively). Species richness was maintained in mesic hammock habitats but varied in the others. Catch rates of several native species (Anaxyrus terrestris, Lithobates grylio, Anolis carolinensis, Nerodia fasciata) declined significantly. Other native species (Lithobates sphenocephalus, Siren lacertian, and Notophthalmus viridescens piaropicola) that were abundant in 1995-97 declined by greater than 50%. Catch rate of only two species (the nonindigenous Anolis sagrei and the native Diadophis punctatus) increased significantly. Hierarchical cluster analysis indicated similarity within habitat types but significant dissimilarity between sampling periods, confirming shifts in community composition. Analysis of individual species' contributions to overall similarity across habitats shows a shift from dominance of native species in the 1990s to increased importance of nonindigenous species in 2010-11. Although natural population fluctuations may have influenced differences between the two sampling periods, our results suggest considerable recent change in the structure and composition of this southwest Florida herpetofaunal community. The causes are unknown, but hydrological shifts and ecological impacts of nonindigenous species may have contributed.	[Cassani, John R.; Everham, Edwin M., III; Ceilley, David W.] Florida Gulf Coast Univ, Dept Marine & Ecol Sci, Ft Myers, FL USA; [Croshaw, Dean A.] Florida Gulf Coast Univ, Dept Biol Sci, Ft Myers, FL 33965 USA; [Bozzo, Joseph] South Florida Water Management Dist, Estero, FL USA; [Brooks, Brenda; Hanson, Deborah] Corkscrew Reg Ecosyst Watershed Land & Water Trus, Estero, FL USA	State University System of Florida; Florida Gulf Coast University; State University System of Florida; Florida Gulf Coast University; South Florida Water Management District	Croshaw, DA (corresponding author), Florida Gulf Coast Univ, Dept Biol Sci, Ft Myers, FL 33965 USA.	dcroshaw@fgcu.edu						Adams MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064347; [Anonymous], 2005, FLORIDAS WETLANDS UP; Araujo MB, 2006, J BIOGEOGR, V33, P1712, DOI 10.1111/j.1365-2699.2006.01482.x; Bartareau T, 2013, COLLINSORUM, V2, P16; Beebee TJC, 2005, BIOL CONSERV, V125, P271, DOI 10.1016/j.biocon.2005.04.009; BLOOM SA, 1981, MAR ECOL PROG SER, V5, P125, DOI 10.3354/meps005125; Bohm M, 2013, BIOL CONSERV, V157, P372, DOI 10.1016/j.biocon.2012.07.015; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Brodman R, 2002, AM MIDL NAT, V147, P135, DOI 10.1674/0003-0031(2002)147[0135:HCORAA]2.0.CO;2; Burbrink FT, 1998, BIOL CONSERV, V86, P107, DOI 10.1016/S0006-3207(98)00054-8; Butterfield B. P., 1997, STRANGERS PARADISE I; Campbell T. S., 2007, ROLE EARLY DETECTION; Campbell TS, 2000, THESIS U TENNESEE KN; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Collins J.P., 2009, EXTINCTION OUR TIMES; Collins JP, 2003, DIVERS DISTRIB, V9, P89, DOI 10.1046/j.1472-4642.2003.00012.x; Croshaw Dean A., 2013, Herpetology Notes, V6, P533; Daszak P, 2005, ECOLOGY, V86, P3232, DOI 10.1890/05-0598; Delis PR, 1996, BIODIVERS CONSERV, V5, P1579, DOI 10.1007/BF00052117; Dodd CK, 2007, AM MIDL NAT, V158, P29, DOI 10.1674/0003-0031(2007)158[29:CIANFG]2.0.CO;2; Dodd C. Kenneth Jr, 2003, P94; Dorcas ME, 2012, P NATL ACAD SCI USA, V109, P2418, DOI 10.1073/pnas.1115226109; ENGE KM, 1986, FOREST ECOL MANAG, V14, P177, DOI 10.1016/0378-1127(86)90116-7; Enge KM, 1997, HABITAT OCCURRENCE F; Erwin KL, 2008, ECOLOGICAL MEMORANDU; Everham Edwin M. III, 2013, Florida Scientist, V76, P138; Florida Department of Environmental Protection, 2007, FLOR DROUGHT ACT PLA; Florida Natural Areas Inventory, 2010, GUID NAT COMM FLOR; Forys EA, 2002, ECOSYSTEMS, V5, P339, DOI 10.1007/s10021-001-0078-0; Forys EA, 1999, BIOL CONSERV, V87, P341, DOI 10.1016/S0006-3207(98)00073-1; Gardner TA, 2007, BIOL CONSERV, V138, P166, DOI 10.1016/j.biocon.2007.04.017; Gerber GP, 2000, OECOLOGIA, V124, P599, DOI 10.1007/s004420000414; Gibbons JW, 2000, BIOSCIENCE, V50, P653, DOI 10.1641/0006-3568(2000)050[0653:TGDORD]2.0.CO;2; Gorley C.K., 2006, GETTING STARTED PRIM; Hayek LC, 1994, MEASURING MONITORING, P209; KIESECKER JM, 1995, P NATL ACAD SCI USA, V92, P11049, DOI 10.1073/pnas.92.24.11049; Krysko KL, 2005, AMPHIBIANS AND REPTILES: STATUS AND CONSERVATION IN FLORIDA, P132; Krysko KL, 2011, ZOOTAXA, P1; LeBuff C, 2013, AMPHIBIANS REPTILES; McCallum ML, 2007, J HERPETOL, V41, P483, DOI 10.1670/0022-1511(2007)41[483:ADOECD]2.0.CO;2; McNemar Q, 1947, PSYCHOMETRIKA, V12, P153, DOI 10.1007/BF02295996; MEANS DB, 1987, J BIOGEOGR, V14, P551, DOI 10.2307/2844880; Meshaka W.E., 2011, HERPETOL CONSERV BIO, V6, P1; Meshaka WE, 2001, CUBAN TREEFROG FLORI; Moreno-Rueda G, 2009, ECOL RES, V24, P335, DOI 10.1007/s11284-008-0509-x; PECHMANN JHK, 1991, SCIENCE, V253, P892, DOI 10.1126/science.253.5022.892; Reading CJ, 2010, BIOL LETTERS, V6, P777, DOI 10.1098/rsbl.2010.0373; Rowe LR, 1995, OECOLOGIA, V102, P397; Sexton Owen J., 1998, P340; Smith KG, 2006, BIOL CONSERV, V127, P327, DOI 10.1016/j.biocon.2005.04.026; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Surdick J. A., 2013, Florida Scientist, V76, P436; TOFT CA, 1985, COPEIA, P1; Tuberville Tracey D., 2000, Journal of the Elisha Mitchell Scientific Society, V116, P19; WAKE DB, 1991, SCIENCE, V253, P860, DOI 10.1126/science.253.5022.860; Wilson LD, 1983, SPECIAL PUBLICATION, V9; Wyatt JL, 2004, SOUTHEAST NAT, V3, P695, DOI 10.1656/1528-7092(2004)003[0695:CIOPBC]2.0.CO;2	57	8	8	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0125845	10.1371/journal.pone.0125845	http://dx.doi.org/10.1371/journal.pone.0125845			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26016475	Green Submitted, gold, Green Published			2022-12-26	WOS:000355185600037
J	Kristensen, B; Hegedus, L; Lundy, SK; Brimnes, MK; Smith, TJ; Nielsen, CH				Kristensen, Birte; Hegedus, Laszlo; Lundy, Steven K.; Brimnes, Marie K.; Smith, Terry J.; Nielsen, Claus H.			Characterization of Regulatory B Cells in Graves' Disease and Hashimoto's Thyroiditis	PLOS ONE			English	Article							T-CELLS; SELF-ANTIGEN; EXPRESSION; PROLIFERATION; ESTABLISHMENT; THYROGLOBULIN; SUPPRESSION; MECHANISMS; SUBSET; MOUSE	A hallmark of regulatory B cells is IL-10 production, hence their designation as IL-10(+) B cells. Little is known about the ability of self-antigens to induce IL-10(+) B cells in Graves' disease (GD), Hashimoto's thyroiditis (HT), or other autoimmune disease. Here we pulsed purified B cells from 12 HT patients, 12 GD patients, and 12 healthy donors with the thyroid self-antigen, thyroglobulin (TG) and added the B cells back to the remaining peripheral blood mononuclear cells (PBMCs). This procedure induced IL-10(+) B-cell differentiation in GD. A similar tendency was observed in healthy donors, but not in cells from patients with HT. In GD, B cells primed with TG induced IL-10-producing CD4(+) T cells. To assess the maximal frequency of inducible IL-10(+) B cells in the three donor groups PBMCs were stimulated with PMA/ionomycin. The resulting IL-10(+) B-cell frequency was similar in the three groups and correlated with free T-3 levels in GD patients. IL-10(+) B cells from both patient groups displayed CD25 or TIM-1 more frequently than did those from healthy donors. B-cell expression of two surface marker combinations previously associated with regulatory B-cell functions, CD24(hi)CD38(hi) and CD27(+) CD43(+), did not differ between patients and healthy donors. In conclusion, our findings indicate that autoimmune thyroiditis is not associated with reduced frequency of IL-10(+) B cells. These results do not rule out regulatory B-cell dysfunction, however. The observed phenotypic differences between IL-10(+) B cells from patients and healthy donors are discussed.	[Kristensen, Birte; Brimnes, Marie K.; Nielsen, Claus H.] Copenhagen Univ Hosp, Rigshosp, Dept Infect Dis & Rheumatol, Inst Inflammat Res, Copenhagen, Denmark; [Kristensen, Birte; Hegedus, Laszlo] Odense Univ Hosp, Dept Endocrinol & Metab, DK-5000 Odense, Denmark; [Lundy, Steven K.] Univ Michigan, Dept Internal Med, Div Rheumatol, Ann Arbor, MI 48109 USA; [Smith, Terry J.] Univ Michigan, Sch Med, Dept Ophthalmol & Visual Sci, Kellogg Eye Ctr, Ann Arbor, MI USA; [Smith, Terry J.] Univ Michigan, Sch Med, Div Metab Endocrinol & Diabet, Dept Internal Med, Ann Arbor, MI USA	Rigshospitalet; University of Copenhagen; University of Southern Denmark; Odense University Hospital; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Nielsen, CH (corresponding author), Copenhagen Univ Hosp, Rigshosp, Dept Infect Dis & Rheumatol, Inst Inflammat Res, Copenhagen, Denmark.	claus.henrik.nielsen@regionh.dk	Smith, Terry/ABG-1360-2020	Smith, Terry/0000-0002-6279-9685; Nielsen, Claus Henrik/0000-0001-7543-9016; Lundy, Steven/0000-0002-3655-2216	Novo Nordisk Foundation Aase and Ejnar Danielsen Fond [94-101-12676]; Novo Nordisk Foundation; National Institutes of Health [AI105029, EY008976, EY011708, DK063121]; Dryer Foundation; Center for Vision from the National Eye Institute [EY007003]; Research to Prevent Blindness; Bell Charitable Foundation; NATIONAL EYE INSTITUTE [R01EY008976, R01EY011708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI105029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063121] Funding Source: NIH RePORTER	Novo Nordisk Foundation Aase and Ejnar Danielsen Fond; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dryer Foundation; Center for Vision from the National Eye Institute; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Bell Charitable Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The funding sources for this work included: Novo Nordisk Foundation (94-101-12676)- http://www.novonordiskfonden.dk/en Aase and Ejnar Danielsen Fond - BK; Unrestricted grant from Novo Nordisk Foundation- http://www.novonordiskfonden.dk/en - LH; National Institutes of Health AI105029, and an unrestricted grant from the Dryer Foundation - SKL; National Institutes of Health grants EY008976, EY011708, DK063121 - http://grants.nih.gov/grants/oer.htm and Center for Vision grant EY007003 from the National Eye Institute, http://www.nei.nih.gov/ and unrestricted grant from Research to Prevent Blindness - http://www.rpbusa.org/rpb/ and the Bell Charitable Foundation http://www.hoovers.com/company-information/cs/companyprofile Bell_Charitable_Foundation.c19b01ef78f32c30.html - TJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audo R, 2014, ARTHRITIS RHEUMATOL, V66, pS168, DOI 10.1002/art.38666; Blair PA, 2010, IMMUNITY, V32, P129, DOI 10.1016/j.immuni.2009.11.009; Bouaziz JD, 2010, EUR J IMMUNOL, V40, P2686, DOI 10.1002/eji.201040673; Brent GA, 2011, NEW ENGL J MED, V358, P2594; Brix TH, 2012, CLIN ENDOCRINOL, V76, P457, DOI 10.1111/j.1365-2265.2011.04318.x; Cantaert T, 2012, ARTHRITIS RHEUM-US, V64, P1859, DOI 10.1002/art.34364; Carsetti R, 2004, IMMUNOL REV, V197, P179, DOI 10.1111/j.0105-2896.2004.0109.x; de Andres C, 2014, J NEUROIMMUNOL, V270, P37, DOI 10.1016/j.jneuroim.2014.02.003; de Souza AJ, 2005, P NATL ACAD SCI USA, V102, P17113, DOI 10.1073/pnas.0508643102; Ding Q, 2011, J CLIN INVEST, V121, P3645, DOI 10.1172/JCI46274; Effraimidis G, 2014, EUR J ENDOCRINOL, V170, pR241, DOI 10.1530/EJE-14-0047; Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833; Flores-Borja F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005407; Gary-Gouy H, 2002, BLOOD, V100, P4537, DOI 10.1182/blood-2002-05-1525; Griffin DO, 2012, MOL MED, V18, P1003, DOI 10.2119/molmed.2012.00203; Griffin DO, 2011, J EXP MED, V208, P67, DOI 10.1084/jem.20101499; Hahne M, 1996, EUR J IMMUNOL, V26, P721, DOI 10.1002/eji.1830260332; Humar M, 2008, J PHARMACOL EXP THER, V324, P1037, DOI 10.1124/jpet.107.132407; Iwata Y, 2011, BLOOD, V117, P530, DOI 10.1182/blood-2010-07-294249; Jensen E, 2004, CLIN CHEM LAB MED, V42, P824, DOI 10.1515/CCLM.2004.136; Jensen EA, 2006, CLIN CHEM LAB MED, V44, P991, DOI 10.1515/CCLM.2006.166; Kessel A, 2012, AUTOIMMUN REV, V11, P670, DOI 10.1016/j.autrev.2011.11.018; Klinker MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070131; Klinker MW, 2012, MOL MED, V18, P123, DOI 10.2119/molmed.2011.00333; Kristensen B, 2015, CLIN EXP IMMUNOL, V180, P58, DOI 10.1111/cei.12557; Kuchroo VK, 2008, NAT REV IMMUNOL, V8, P577, DOI 10.1038/nri2366; Langkjaer A, 2012, CLIN IMMUNOL, V145, P1, DOI 10.1016/j.clim.2012.07.004; Liu J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089236; Liu SG, 1997, CLIN BIOCHEM, V30, P455, DOI 10.1016/S0009-9120(97)00049-0; Mauri C, 2003, J EXP MED, V197, P489, DOI 10.1084/jem.20021293; MCGREGOR AM, 1980, NEW ENGL J MED, V303, P302, DOI 10.1056/NEJM198008073030603; MINGARI MC, 1984, NATURE, V312, P641, DOI 10.1038/312641a0; Nielsen CH, 2007, CLIN EXP IMMUNOL, V147, P287, DOI 10.1111/j.1365-2249.2006.03283.x; Nielsen CH, 2007, EXPERT OPIN BIOL TH, V7, P1061, DOI 10.1517/14712598.7.7.1061; OGARRA A, 1992, ANN NY ACAD SCI, V651, P182; Reyes JL, 2015, J IMMUNOL, V194, P364, DOI 10.4049/jimmunol.1400738; Sims GP, 2005, BLOOD, V105, P4390, DOI 10.1182/blood-2004-11-4284; WEETMAN AP, 1994, ENDOCR REV, V15, P788, DOI 10.1210/er.15.6.788; WEISS I, 1981, J CLIN ENDOCR METAB, V53, P1223, DOI 10.1210/jcem-53-6-1223; Zha BB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049835; Zhong XM, 2007, EUR J IMMUNOL, V37, P2405, DOI 10.1002/eji.200737461	41	27	31	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0127949	10.1371/journal.pone.0127949	http://dx.doi.org/10.1371/journal.pone.0127949			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26016954	Green Published, Green Submitted, gold			2022-12-26	WOS:000355185600101
J	Ma, MM; Anderson, BD; Wang, T; Chen, YA; Zhang, DM; Gray, GC; Lu, JH				Ma, Mengmeng; Anderson, Benjamin D.; Wang, Tao; Chen, Yingan; Zhang, Dingmei; Gray, Gregory C.; Lu, Jiahai			Serological Evidence and Risk Factors for Swine Influenza Infections among Chinese Swine Workers in Guangdong Province	PLOS ONE			English	Article							FARM RESIDENTS; SOUTHERN CHINA; AVIAN-LIKE; A VIRUSES; FEEDING OPERATIONS; PIGS; ANTIBODIES; TRANSMISSION; HUMANS; SEROPREVALENCE	During July to September 2014, we performed a controlled, cross-sectional, seroepidemiologic study among 203 swine workers and 115 control subjects in Guangdong Province. Sera were tested using a hemagglutination inhibition assay against locally-isolated swine H3N2 and H1N1 viruses and commercially-obtained human influenza viral antigens. We found swine workers had a greater prevalence and odds of seropositivity against the swine H3N2 virus (17.3% vs. 7.0%; adjusted OR, 3.4; 95% CI, 1.1 -10.7). Younger age, self-report of a respiratory illness during the last 12 months, and seropositivity against seasonal H3N2 virus were identified as significant risk factors for seropositivity against swine H3N2 virus. As swine workers in China may be exposed to novel influenza viruses, it seems prudent for China to conduct special surveillance for such viruses among them. It also seems wise to offer such workers seasonal influenza vaccines with a goal to reduce cross-species influenza virus transmission.	[Ma, Mengmeng; Zhang, Dingmei; Lu, Jiahai] Sun Yat Sen Univ, Sch Publ Hlth, Dept Med Stat & Epidemiol, Guangzhou 510275, Guangdong, Peoples R China; [Anderson, Benjamin D.; Gray, Gregory C.] Duke Univ, Global Hlth Inst, Div Infect Dis, Durham, NC 27708 USA; [Wang, Tao] Zhongshan Ctr Dis Control & Prevent, Zhongshan, Guangdong, Peoples R China; [Wang, Tao; Lu, Jiahai] Sun Yat Sen Univ, Zhongshan Inst, Sch Publ Hlth, Zhongshan, Guangdong, Peoples R China; [Chen, Yingan] Guangzhou Baiyun Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China; [Zhang, Dingmei; Lu, Jiahai] Sun Yat Sen Univ, Key Lab Trop Dis Control, Minist Educ, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Duke University; Sun Yat Sen University; Sun Yat Sen University	Gray, GC (corresponding author), Duke Univ, Global Hlth Inst, Div Infect Dis, Durham, NC 27708 USA.	gregory.gray@duke.edu; lujiahai@mail.sysu.edu.cn	Gray, Gregory C./ABF-1298-2020; Zhang, Dingmei/ABC-7476-2020	Gray, Gregory/0000-0002-4628-5908	Natural Science Foundation of China [81172735, 81373050]; US National Institutes of Health [R01AI108993-01A1]; National Major Science and Technology Special Projects for Infectious Diseases of China [2012ZX10004-902]; Guangzhou Medical Science and Technology Project [20141A010096]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI108993] Funding Source: NIH RePORTER	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Major Science and Technology Special Projects for Infectious Diseases of China; Guangzhou Medical Science and Technology Project; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by the Natural Science Foundation of China (grant nos. 81172735 (JL), 81373050 (JL)); the US National Institutes of Health (grant no. R01AI108993-01A1 (GCG)); the National Major Science and Technology Special Projects for Infectious Diseases of China (grant no. 2012ZX10004-902 (JL)); and the Guangzhou Medical Science and Technology Project (grant no. 20141A010096 (YC)). Specifically, JL and GCG took the roles of study design, decision to publish and preparation of the manuscript, and YC took the role of data collection.	Cao N, 2013, J CLIN VIROL, V58, P647, DOI 10.1016/j.jcv.2013.09.017; Chen JD, 2014, ARCH VIROL, V159, P2705, DOI 10.1007/s00705-014-2040-4; Cole D, 2000, ENVIRON HEALTH PERSP, V108, P685, DOI 10.2307/3434721; Coman A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098248; Fournie G, 2012, TRENDS EMERGENCE SWI; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gerloff NA, 2011, EMERG INFECT DIS, V17, P403, DOI [10.3201/eid1703100581, 10.3201/eid1703.100851]; Gray GC, 2007, EMERG INFECT DIS, V13, P1871, DOI 10.3201/eid1312.061323; Gray GC, 2013, CLIN INFECT DIS, V57, P1713, DOI 10.1093/cid/cit650; Kayali G, 2008, J CLIN VIROL, V43, P73, DOI 10.1016/j.jcv.2008.04.013; KIDA H, 1994, J GEN VIROL, V75, P2183, DOI 10.1099/0022-1317-75-9-2183; Kitikoon P, 2011, VET MICROBIOL, V148, P413, DOI 10.1016/j.vetmic.2010.09.019; Krueger WS, 2013, CURR TOP MICROBIOL, V370, P201, DOI 10.1007/82_2012_268; Krumbholz A, 2010, J MED VIROL, V82, P1617, DOI 10.1002/jmv.21869; Lopez-Robles G, 2012, TRANSBOUND EMERG DIS, V59, P183, DOI 10.1111/j.1865-1682.2011.01250.x; Ma Wenjun, 2008, J Mol Genet Med, V3, P158; Messenger AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089055; Myers KP, 2007, CLIN INFECT DIS, V44, P1084, DOI 10.1086/512813; Myers KP, 2006, CLIN INFECT DIS, V42, P14, DOI 10.1086/498977; National Bureau of Statistics of China, 2013, CENS DAT; Nelson MI, 2015, TRENDS MICROBIOL, V23, P142, DOI 10.1016/j.tim.2014.12.002; Olsen CW, 2002, EMERG INFECT DIS, V8, P814, DOI 10.3201/eid0808.010474; Peiris JSM, 2001, J VIROL, V75, P9679, DOI 10.1128/JVI.75.20.9679-9686.2001; Ramirez A, 2006, EMERG INFECT DIS, V12, P997, DOI 10.3201/eid1206.051576; Saenz RA, 2006, VECTOR-BORNE ZOONOT, V6, P338, DOI 10.1089/vbz.2006.6.338; Stephenson I, 2009, EMERG INFECT DIS, V15, P1250, DOI 10.3201/eid1508.081754; Su S, 2012, J VIROL, V86, P01315; Terebuh P, 2010, INFLUENZA OTHER RESP, V4, P387, DOI 10.1111/j.1750-2659.2010.00175.x; Tong SX, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003657; US Envriromental Protection Agency, 2014, REG DEF LARG CAFOS M; Wang DY, 2013, EMERG INFECT DIS, V19, P1709, DOI 10.3201/eid1910.130420; Yin XC, 2014, J MED VIROL, V86, P592, DOI 10.1002/jmv.23842; Zhou H, 2014, JPN J INFECT DIS, V67, P184, DOI 10.7883/yoken.67.184; Zhou L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073724; Zhou P, 2014, J MED VIROL, V86, P597, DOI 10.1002/jmv.23869; Zhu XY, 2012, P NATL ACAD SCI USA, V109, P18903, DOI 10.1073/pnas.1212579109	36	92	95	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0128479	10.1371/journal.pone.0128479	http://dx.doi.org/10.1371/journal.pone.0128479			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26016740	gold, Green Submitted, Green Published			2022-12-26	WOS:000355185600119
J	Flaherty, BR; Wang, YX; Trope, EC; Ho, TG; Muralidharan, V; Kennedy, EJ; Peterson, DS				Flaherty, Briana R.; Wang, Yuxiao; Trope, Edward C.; Ho, Tienhuei G.; Muralidharan, Vasant; Kennedy, Eileen J.; Peterson, David S.			The Stapled AKAP Disruptor Peptide STAD-2 Displays Antimalarial Activity through a PKA-Independent Mechanism	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; PLASMODIUM-FALCIPARUM; ARTEMISININ RESISTANCE; INHIBITORS; TARGETS; GENE; ERYTHROCYTES; COMBINATION; EFFICACY; SUBUNIT	Drug resistance poses a significant threat to ongoing malaria control efforts. Coupled with lack of a malaria vaccine, there is an urgent need for the development of new antimalarials with novel mechanisms of action and low susceptibility to parasite drug resistance. Protein Kinase A (PKA) has been implicated as a critical regulator of pathogenesis in malaria. Therefore, we sought to investigate the effects of disrupted PKA signaling as a possible strategy for inhibition of parasite replication. Host PKA activity is partly regulated by a class of proteins called A Kinase Anchoring Proteins (AKAPs), and interaction between HsPKA and AKAP can be inhibited by the stapled peptide Stapled AKAP Disruptor 2 (STAD-2). STAD-2 was tested for permeability to and activity against Plasmodium falciparum blood stage parasites in vitro. The compound was selectively permeable only to infected red blood cells (iRBC) and demonstrated rapid antiplasmodial activity, possibly via iRBC lysis (IC50 approximate to 1 mu M). STAD-2 localized within the parasite almost immediately post-treatment but showed no evidence of direct association with PKA, indicating that STAD-2 acts via a PKA-independent mechanism. Furosemide-insensitive parasite permeability pathways in the iRBC were largely responsible for uptake of STAD-2. Further, peptide import was highly specific to STAD-2 as evidenced by low permeability of control stapled peptides. Selective uptake and antiplasmodial activity of STAD-2 provides important groundwork for the development of stapled peptides as potential antimalarials. Such peptides may also offer an alternative strategy for studying protein-protein interactions critical to parasite development and pathogenesis.	[Flaherty, Briana R.; Trope, Edward C.; Peterson, David S.] Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA 30602 USA; [Flaherty, Briana R.; Muralidharan, Vasant; Peterson, David S.] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [Wang, Yuxiao; Ho, Tienhuei G.; Kennedy, Eileen J.] Univ Georgia, Coll Pharm, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA; [Muralidharan, Vasant] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Kennedy, EJ (corresponding author), Univ Georgia, Coll Pharm, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA.	ekennedy@uga.edu; dspete@uga.edu		Peterson, David/0000-0003-4394-6181; Kennedy, Eileen/0000-0001-5610-1677; Muralidharan, Vasant/0000-0001-6367-6284	NIH [1K22CA154600, 2T32AI060546-06]; NATIONAL CANCER INSTITUTE [R03CA188439, K22CA154600] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060546] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	NIH 1K22CA154600 for EJK, NIH 2T32AI060546-06 for DSP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhoon BA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110041; [Anonymous], 2012, Drug Discov Today Technol, V9, pe1, DOI 10.1016/j.ddtec.2012.01.004; [Anonymous], 2013, EM RESP ART RES GREA; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Beitz E, 2004, P NATL ACAD SCI USA, V101, P1153, DOI 10.1073/pnas.0307295101; Bowman JD, 2014, ANTIMICROB AGENTS CH, V58, P811, DOI 10.1128/AAC.01500-13; Chapuis H, 2012, AMINO ACIDS, V43, P2047, DOI 10.1007/s00726-012-1283-1; Chinappi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014064; Copolovici DM, 2014, ACS NANO, V8, P1972, DOI 10.1021/nn4057269; Cui HK, 2013, BIOORGAN MED CHEM, V21, P3547, DOI 10.1016/j.bmc.2013.02.011; Delfino RT, 2002, BIOPHYS CHEM, V98, P287, DOI 10.1016/S0301-4622(02)00077-7; Desai SA, 2014, TRENDS PARASITOL, V30, P151, DOI 10.1016/j.pt.2014.01.003; Doerig C, 2004, BBA-PROTEINS PROTEOM, V1697, P155, DOI 10.1016/j.bbapap.2003.11.021; Dondorp AM, 2010, NAT REV MICROBIOL, V8, P272, DOI 10.1038/nrmicro2331; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Edwards AS, 2000, CURR OPIN CELL BIOL, V12, P217, DOI 10.1016/S0955-0674(99)00085-X; Ferreira PE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023875; Fisher N, 2012, J BIOL CHEM, V287, P9731, DOI 10.1074/jbc.M111.324319; Gamo FJ, 2010, NATURE, V465, P305, DOI 10.1038/nature09107; Ghorbal M, 2014, NAT BIOTECHNOL, V32, P819, DOI 10.1038/nbt.2925; Gold MG, 2012, EMBO MOL MED, V4, P15, DOI 10.1002/emmm.201100184; Harikishore A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02501; Haste NM, 2012, MICROBES INFECT, V14, P838, DOI 10.1016/j.micinf.2012.05.004; Kamena F, 2011, CHEM BIODIVERS, V8, P1, DOI 10.1002/cbdv.201000318; Kinderman FS, 2006, MOL CELL, V24, P397, DOI 10.1016/j.molcel.2006.09.015; Kolevzon N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086802; Langeberg LK, 2005, J CELL SCI, V118, P3217, DOI 10.1242/jcs.02416; Li JL, 2000, MOL BIOCHEM PARASIT, V109, P157, DOI 10.1016/S0166-6851(00)00242-5; Liu YJ, 2007, P NATL ACAD SCI USA, V104, P12560, DOI 10.1073/pnas.0705313104; Lucet IS, 2012, FUTURE MED CHEM, V4, P2295, DOI [10.4155/FMC.12.183, 10.4155/fmc.12.183]; Maciaszek JL, 2014, BIOPHYS J, V106, P1258, DOI 10.1016/j.bpj.2014.02.001; Merckx A, 2009, TRENDS PARASITOL, V25, P139, DOI 10.1016/j.pt.2008.12.005; Merckx A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040019; Mharakurwa S, 2011, P NATL ACAD SCI USA, V108, P18796, DOI 10.1073/pnas.1116162108; Nguitragool W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093759; Nguitragool W, 2011, CELL, V145, P665, DOI 10.1016/j.cell.2011.05.002; Nomura W, 2013, ACS CHEM BIOL, V8, P2235, DOI 10.1021/cb400495h; Okutsu R, 2008, KIDNEY INT, V74, P1429, DOI 10.1038/ki.2008.402; Pavlovic-Djuranovic S, 2003, FEBS LETT, V555, P500, DOI 10.1016/S0014-5793(03)01313-9; Petersen I, 2011, FEBS LETT, V585, P1551, DOI 10.1016/j.febslet.2011.04.042; Ramdani Ghania, 2014, Biomed J, V37, P284, DOI 10.4103/2319-4170.132910; Roudier N, 1998, J BIOL CHEM, V273, P8407, DOI 10.1074/jbc.273.14.8407; Schwobel B, 2003, MALAR J, V2; Scott JD, 2013, ANNU REV PHARMACOL, V53, P187, DOI 10.1146/annurev-pharmtox-011112-140204; Shretta R, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-399; Sparr C, 2013, ANTIMICROB AGENTS CH, V57, P4689, DOI 10.1128/AAC.00427-13; Srinivasan P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3261; Verdine GL, 2007, CLIN CANCER RES, V13, P7264, DOI 10.1158/1078-0432.CCR-07-2184; Walensky LD, 2004, SCIENCE, V305, P1466, DOI 10.1126/science.1099191; Walensky LD, 2014, J MED CHEM, V57, P6275, DOI 10.1021/jm4011675; Wang YX, 2014, ACS CHEM BIOL, V9, P635, DOI 10.1021/cb400900r; White NJ, 2014, NEW ENGL J MED, V371, P403, DOI 10.1056/NEJMoa1315860; WHO, 2014, WORLD MAL REP 2014, DOI [10.1007/s00108-013-3390-9, DOI 10.1007/S00108-013-3390-9]; WHO - World Health Organization, 2012, UPD ART RES APR 2012; Winzeler EA, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0544-6; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Wurtz N, 2011, PARASITOLOGY, V138, P1, DOI 10.1017/S003118201000096X; Yang BX, 2006, FEBS LETT, V580, P6679, DOI 10.1016/j.febslet.2006.11.025; Yeung BKS, 2010, J MED CHEM, V53, P5155, DOI 10.1021/jm100410f	60	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0129239	10.1371/journal.pone.0129239	http://dx.doi.org/10.1371/journal.pone.0129239			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010880	Green Published, gold, Green Submitted			2022-12-26	WOS:000355183900252
J	Ouyang, YL; Li, FQ; Shao, Q; Heussen, FM; Keane, PA; Stubiger, N; Sadda, SR; Pleyer, U				Ouyang, Yanling; Li, Fuqiang; Shao, Qing; Heussen, Florian M.; Keane, Pearse A.; Stuebiger, Nicole; Sadda, Srinivas R.; Pleyer, Uwe			Subretinal Fluid in Eyes with Active Ocular Toxoplasmosis Observed Using Spectral Domain Optical Coherence Tomography	PLOS ONE			English	Article							NONMYDRIATIC FUNDUS PHOTOGRAPHY; RETINAL IRREGULARITIES; DISEASE; RETINOCHOROIDITIS; MANIFESTATIONS; DETACHMENT; PROGNOSIS; THERAPY; MACULA	Purpose To describe the clinical finding of subretinal fluid (SRF) in the posterior pole by spectral domain optical coherence tomography (SD-OCT) in eyes with active ocular toxoplasmosis (OT). Design Retrospective case series. Participants Thirty-eight eyes from 39 patients with active OT. Methods Eyes with active OT which underwent SD-OCT were reviewed. SRFs in the posterior pole were further analyzed. Main Outcome Measures Presence of SRF; its accompanying features, e.g. retinal necrosis, cystoid macular edema (CME), choroidal neovascularization (CNV); and longitudinal changes of SRF, including maximum height and total volume before and after treatment. Results SRF presented in 45.5%(or 15/33) of eyes with typical active OT and in 51.3%(or 20/39) of eyes with active OT. The mean maximum height and total volume of SRF were 161.0 (range: 23-478) mu m and 0.47 (range: 0.005-4.12) mm3, respectively. For 12 eyes with SRF related to active retinal necrosis, SRF was observed with complete absorption after conventional anti- toxoplasmosis treatment. The mean duration for observation of SRF clearance was 33.8 (range: 7-84) days. The mean rate of SRF clearance was 0.0128 (range: 0.0002-0.0665) mm3/day. Conclusions SRF (i.e., serous retinal detachment) is a common feature in patients with active OT when SD-OCT is performed. The majority of SRF was associated with retinal necrosis and reacted well to conventional therapy, regardless of total fluid volume. However, SRF accompanying with CME or CNV responded less favorably or remained refractory to conventional or combined intravitreal treatment, even when the SRF was small in size.	[Ouyang, Yanling; Shao, Qing; Heussen, Florian M.; Stuebiger, Nicole; Pleyer, Uwe] Charite, Dept Ophthalmol, D-13353 Berlin, Germany; [Li, Fuqiang] Jilin Univ, Affiliated Hosp 2, Ctr Eye, Changchun 130023, Peoples R China; [Keane, Pearse A.] Moorfields Eye Hosp NHS Fdn Trust, NIHR Biomed Res Ctr Ophthalmol, London, England; [Keane, Pearse A.] UCL, Inst Ophthalmol, London, England; [Sadda, Srinivas R.] Doheny Eye Inst, Los Angeles, CA 90033 USA; [Sadda, Srinivas R.] Dept Ophthalmol, Los Angeles, CA USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Jilin University; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; Doheny Eye Institute	Ouyang, YL (corresponding author), Charite, Dept Ophthalmol, D-13353 Berlin, Germany.	yanlingyouyang@gmail.com	Keane, Pearse/AAE-5709-2019	Keane, Pearse/0000-0002-9239-745X; Heussen, Florian Moritz/0000-0003-0536-9870	Federal Ministry of Education and Research of Germany (BMBF) through the Toxonet 02 research collaboration; National Institute for Health Research [CL-2010-18-004, CS-2014-14-023] Funding Source: researchfish	Federal Ministry of Education and Research of Germany (BMBF) through the Toxonet 02 research collaboration; National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by the funding from the Federal Ministry of Education and Research of Germany (BMBF) through the Toxonet 02 research collaboration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atmaca LS, 2006, GRAEF ARCH CLIN EXP, V244, P1688, DOI 10.1007/s00417-006-0345-z; Bonfioli Adriana A, 2005, Semin Ophthalmol, V20, P129, DOI 10.1080/08820530500231961; Bosch-Driessen LEH, 2002, OPHTHALMOLOGY, V109, P869, DOI 10.1016/S0161-6420(02)00990-9; Bosch-Driessen LH, 2000, OPHTHALMOLOGY, V107, P36, DOI 10.1016/S0161-6420(99)00013-5; Delair E, 2011, OCUL IMMUNOL INFLAMM, V19, P91, DOI 10.3109/09273948.2011.564068; Diniz B, 2011, CLIN OPHTHALMOL, V5, P645, DOI 10.2147/OPTH.S20033; Dodds E, 1999, FOCAL POINTS CLIN MO, VXVII; Dodds EM, 2008, AM J OPHTHALMOL, V146, P856, DOI 10.1016/j.ajo.2008.09.006; Foster C.S., 2013, DIAGNOSIS TREATMENT; FRIEDMAN.CT, 1969, ARCH OPHTHALMOL-CHIC, V81, P481; Garweg JG, 2011, OCUL IMMUNOL INFLAMM, V19, P255, DOI 10.3109/09273948.2011.595872; Garza-Leon M, 2012, OCUL IMMUNOL INFLAMM, V20, P130, DOI 10.3109/09273948.2012.656878; HOLLAND GN, 1989, ARCH OPHTHALMOL-CHIC, V107, P1759, DOI 10.1001/archopht.1989.01070020841024; Holland GN, 2004, AM J OPHTHALMOL, V137, P1, DOI 10.1016/j.ajo.2003.10.032; Keane PA, 2013, JAMA OPHTHALMOL, V131, P341, DOI 10.1001/jamaophthalmol.2013.1724; Keane PA, 2012, SURV OPHTHALMOL, V57, P389, DOI 10.1016/j.survophthal.2012.01.006; Kianersi Farzan, 2012, International Ophthalmology, V32, P539, DOI 10.1007/s10792-012-9599-0; Kovacevic-Pavicevic D, 2012, EYE, V26, P723, DOI 10.1038/eye.2012.20; KRAUSHAR MF, 1979, ANN OPHTHALMOL, V11, P1513; Lehpamer B, 2013, AM J OPHTHALMOL, V155, P143, DOI 10.1016/j.ajo.2012.06.028; Lieb DF, 2004, AM J OPHTHALMOL, V137, P940, DOI 10.1016/j.ajo.2003.10.027; Maenz M, 2014, PROG RETIN EYE RES, V39, P77, DOI 10.1016/j.preteyeres.2013.12.005; Matsubayashi H., 1961, Keio Journal of Medicine, V10, P209, DOI 10.2302/kjm.10.209; Orefice JL, 2007, BRIT J OPHTHALMOL, V91, P773, DOI 10.1136/bjo.2006.108068; Ouyang YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086626; Ouyang YL, 2013, INVEST OPHTH VIS SCI, V54, P5694, DOI 10.1167/iovs.13-12043; Ouyang YL, 2013, INVEST OPHTH VIS SCI, V54, P1460, DOI 10.1167/iovs.12-10727; Ouyang YL, 2011, INVEST OPHTH VIS SCI, V52, P7019, DOI 10.1167/iovs.11-8046; Regatieri Caio V, 2012, Int Ophthalmol Clin, V52, P33, DOI 10.1097/IIO.0b013e318265d439; SCHLAEGEL TF, 1984, ARCH OPHTHALMOL-CHIC, V102, P697, DOI 10.1001/archopht.1984.01040030553014; Smith Justine R, 2002, Curr Opin Ophthalmol, V13, P387, DOI 10.1097/00055735-200212000-00008; WILLERSON D, 1977, BRIT J OPHTHALMOL, V61, P693, DOI 10.1136/bjo.61.11.693; Wirthlin R, 2006, ARCH OPHTHALMOL-CHIC, V124, P741, DOI 10.1001/archopht.124.5.741	33	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127683	10.1371/journal.pone.0127683	http://dx.doi.org/10.1371/journal.pone.0127683			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010656	Green Published, Green Submitted, gold			2022-12-26	WOS:000355183900130
J	Yang, FY; Song, LM; Wang, HP; Wang, J; Xu, ZQ; Xing, NZ				Yang, Feiya; Song, Liming; Wang, Huiping; Wang, Jun; Xu, Zhiqing; Xing, Nianzeng			Combination of Quercetin and 2-Methoxyestradiol Enhances Inhibition of Human Prostate Cancer LNCaP and PC-3 Cells Xenograft Tumor Growth	PLOS ONE			English	Article							ANDROGEN RECEPTOR; APOPTOSIS; ANGIOGENESIS; EXPRESSION; PROLIFERATION; MECHANISMS; REDUCTION; STRESS; ROLES; CD34	Quercetin and 2-Methoxyestradiol (2-ME) are promising anti-cancer substances. Our previous in vitro study showed that quercetin synergized with 2-Methoxyestradiol exhibiting increased antiproliferative and proapoptotic activity in both androgen-dependent LNCaP and androgen-independent PC-3 human prostate cancer cell lines. In the present study, we determined whether their combination could inhibit LNCaP and PC-3 xenograft tumor growth in vivo and explored the underlying mechanism. Human prostate cancer LNCaP and PC-3 cells were inoculated subcutaneously in male BALB/c nude mice. When xenograft tumors reached about 100 mm(3), mice were randomly allocated to vehicle control, quercetin or 2-Methoxyestradiol singly treated and combination treatment groups. After therapeutic intervention for 4 weeks, combination treatment of quercetin and 2-ME i) significantly inhibited prostate cancer xenograft tumor growth by 46.8% for LNCaP and 51.3% for PC-3 as compared to vehicle control group, more effective than quercetin (28.4% for LNCaP, 24.8% for PC3) or 2-ME (32.1% for LNCaP, 28.9% for PC3) alone; ii) was well tolerated by BALB/c mice and no obvious toxic reactions were observed; iii) led to higher Bax/Bcl-2 ratio, cleaved caspase-3 protein expression and apoptosis rate; and iv) resulted in lower phosphorylated AKT (pAKT) protein level, vascular endothelial growth factor protein and mRNA expression, microvascular density and proliferation rate than single drug treatment. These effects were more remarkable compared to vehicle group. Therefore, combination of quercetin and 2-ME can serve as a novel clinical treatment regimen owning the potential of enhancing antitumor effect on prostate cancer in vivo and lessening the dose and side effects of either quercetin or 2-ME alone. These in vivo results will lay a further solid basis for subsequent researches on this novel therapeutic regimen in human prostate cancer.	[Yang, Feiya; Song, Liming; Xing, Nianzeng] Capital Med Univ, Beijing Chaoyang Hosp, Dept Urol, Beijing, Peoples R China; [Wang, Huiping] Natl Res Inst Family Planning, Dept Reprod Immunol & Pharmacol, Beijing, Peoples R China; [Wang, Jun] China Med Univ, Hosp 1, Dept Neurosurg, Shenyang 110001, Peoples R China; [Xu, Zhiqing] Capital Med Univ, Inst Neurosci, Beijing Key Lab Neural Regenerat & Repair, Beijing, Peoples R China	Capital Medical University; National Research Institute for Family Planning - China; China Medical University; Capital Medical University	Xing, NZ (corresponding author), Capital Med Univ, Beijing Chaoyang Hosp, Dept Urol, Beijing, Peoples R China.	xingnianzeng@126.com	wang, hui/GRS-4730-2022		Beijing Natural Science Foundation [7122075]	Beijing Natural Science Foundation(Beijing Natural Science Foundation)	The work was supported by Beijing Natural Science Foundation (no. 7122075).	Badziul D, 2014, MOL CELL BIOCHEM, V392, P213, DOI 10.1007/s11010-014-2032-4; Baran I, 2014, LEUKEMIA RES, V38, P836, DOI 10.1016/j.leukres.2014.04.010; Basu A, 2003, FEBS LETT, V538, P41, DOI 10.1016/S0014-5793(03)00131-5; Bettencourt MC, 1998, J UROLOGY, V160, P459, DOI 10.1016/S0022-5347(01)62925-2; Borghetti GS, 2009, AAPS PHARMSCITECH, V10, P235, DOI 10.1208/s12249-009-9196-3; Brunelle JK, 2009, J CELL SCI, V122, P437, DOI 10.1242/jcs.031682; Bu SZ, 2002, FEBS LETT, V531, P141, DOI 10.1016/S0014-5793(02)03478-6; Casarez EV, 2007, CANCER RES, V67, P8316, DOI 10.1158/0008-5472.CAN-07-1755; Chang YF, 2009, NUTR CANCER, V61, P735, DOI 10.1080/01635580902825571; Cialdella-Kam L, 2013, BRIT J NUTR, V109, P1923, DOI 10.1017/S0007114512003972; Ehteda A, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-86; Erbersdobler A, 2010, WORLD J UROL, V28, P687, DOI 10.1007/s00345-009-0471-4; Ferruelo A, 2014, Actas Urol Esp, V38, P397, DOI 10.1016/j.acuro.2014.02.012; Fleshner Neil, 2005, Can J Urol, V12 Suppl 1, P14; Ghosh R, 2009, J STEROID BIOCHEM, V113, P25, DOI 10.1016/j.jsbmb.2008.11.002; Harrison MR, 2011, INVEST NEW DRUG, V29, P1465, DOI 10.1007/s10637-010-9455-x; Hotte SJ, 2010, CURR ONCOL, V17, pS72; Kim YH, 2007, J CELL BIOCHEM, V100, P998, DOI 10.1002/jcb.21098; Kumar R, 2011, J NUTR BIOCHEM, V22, P723, DOI 10.1016/j.jnutbio.2010.06.003; Lee DH, 2008, J CELL BIOCHEM, V105, P546, DOI 10.1002/jcb.21851; Lee DH, 2008, BIOCHEM PHARMACOL, V75, P2345, DOI 10.1016/j.bcp.2008.03.013; Liu KC, 2014, ENVIRON TOXICOL, V29, P428, DOI 10.1002/tox.21769; Ma ZS, 2004, J ENDOCRINOL, V181, P493, DOI 10.1677/joe.0.1810493; Ma ZS, 2004, INT J ONCOL, V24, P1297; Mabjeesh NJ, 2003, CANCER CELL, V3, P363, DOI 10.1016/S1535-6108(03)00077-1; Mehta RG, 2010, PHARM RES-DORDR, V27, P950, DOI 10.1007/s11095-010-0085-y; Miyata Y, 2015, PROSTATE, V75, P84, DOI 10.1002/pros.22894; Miyata Y, 2013, UROLOGY, V81, P136, DOI 10.1016/j.urology.2012.08.014; Morgan TM, 2009, CURR CANCER DRUG TAR, V9, P237, DOI 10.2174/156800909787580999; Mueck AO, 2010, STEROIDS, V75, P625, DOI 10.1016/j.steroids.2010.02.016; Pratheeshkumar P, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047516, 10.1371/journal.pone.0052279]; Qadan LR, 2001, BIOCHEM BIOPH RES CO, V285, P1259, DOI 10.1006/bbrc.2001.5320; Qu SF, 2014, MOL ONCOL, V8, P311, DOI 10.1016/j.molonc.2013.12.004; Reiner T, 2009, CANCER LETT, V276, P21, DOI 10.1016/j.canlet.2008.10.026; Senthilkumar K, 2010, MOL CELL BIOCHEM, V344, P173, DOI 10.1007/s11010-010-0540-4; Sharmila G, 2014, CLIN NUTR, V33, P718, DOI 10.1016/j.clnu.2013.08.011; Shimada K, 2004, MOL CARCINOGEN, V39, P1, DOI 10.1002/mc.10158; Shoskes DA, 1999, UROLOGY, V54, P960, DOI 10.1016/S0090-4295(99)00358-1; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Song JH, 2014, J BUON, V19, P770; Tevaarwerk AJ, 2009, CLIN CANCER RES, V15, P1460, DOI 10.1158/1078-0432.CCR-08-1599; Van Veldhuizen PJ, 2008, INT J CANCER, V122, P567, DOI 10.1002/ijc.23117; Visagie M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071935; Wang GD, 2013, ONCOL REP, V30, P357, DOI 10.3892/or.2013.2469; Wang PW, 2014, J NUTR BIOCHEM, V25, P73, DOI 10.1016/j.jnutbio.2013.09.005; Wang PW, 2012, NUTR CANCER, V64, P580, DOI 10.1080/01635581.2012.661514; Xing NZ, 2001, CARCINOGENESIS, V22, P409, DOI 10.1093/carcin/22.3.409; Xu HL, 2013, BIOORG MED CHEM LETT, V23, P3631, DOI 10.1016/j.bmcl.2013.04.007; Yu PC, 2010, CIRC RES, V106, P1221, DOI 10.1161/CIRCRESAHA.109.207670	49	34	35	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128277	10.1371/journal.pone.0128277	http://dx.doi.org/10.1371/journal.pone.0128277			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011145	Green Published, gold, Green Submitted			2022-12-26	WOS:000355183900216
J	Yang, Z; Li, JJ; Liu, QS; Yuan, TT; Zhang, YY; Chen, LQ; Lou, Q; Sun, ZH; Ying, HZ; Xu, JQ; Dimitrov, DS; Zhang, MY				Yang, Zheng; Li, Jingjing; Liu, Qingsheng; Yuan, Tingting; Zhang, Yanyu; Chen, Li-Qing; Lou, Qi; Sun, Zehua; Ying, Huazhong; Xu, Jianqing; Dimitrov, Dimiter S.; Zhang, Mei-Yun			Identification of Non-HIV Immunogens That Bind to Germline b12 Predecessors and Prime for Elicitation of Cross-clade Neutralizing HIV-1 Antibodies	PLOS ONE			English	Article							B-CELL RECEPTORS; POTENT NEUTRALIZATION; MONOCLONAL-ANTIBODIES; CRYSTAL-STRUCTURE; VACCINE DESIGN; BROAD; GP120; ANTIGEN; VIRUS; EPITOPE	A fundamental challenge for developing an effective and safe HIV-1 vaccine is to identify vaccine immunogens that can initiate and maintain immune responses leading to elicitation of broadly neutralizing HIV-1 antibodies (bnAbs) through complex maturation pathways. We have previously found that HIV-1 envelope glycoproteins (Env) lack measurable binding to putative germline predecessors of known bnAbs and proposed to search for non-HIV immunogens that could initiate their somatic maturation. Using bnAb b12 as a model bnAb and yeast display technology, we isolated five (poly) peptides from plant leaves, insects, E. coli strains, and sea water microbes that bind to b12 putative germline and intermediate antibodies. Rabbit immunization with the (poly) peptides alone induced high titers of cross-reactive antibodies that neutralized HIV-1 isolates SF162 and JRFL. Priming rabbits with the (poly) peptides followed by boosts with trimeric gp140(SF162) and then resurfaced Env (RSC3) induced antibodies that competed with mature b12 and neutralized tier 1 and 2 viruses from clade B, C and E, while control rabbits without (poly) peptide priming induced antibodies that did not compete with mature b12 and neutralized fewer isolates. The degree of competition with mature b12 for binding to gp140SF162 correlated with the neutralizing activity of the rabbit IgG. Reversing the order of the two boosting immunogens significantly affected the binding profile and neutralization potency of the rabbit IgG. Our study is the first to provide evidence that appears to support the concept that non-HIV immunogens may initiate immune responses leading to elicitation of cross-clade neutralizing antibodies.	[Yang, Zheng; Li, Jingjing; Liu, Qingsheng; Yuan, Tingting; Zhang, Yanyu; Sun, Zehua; Zhang, Mei-Yun] Univ Hong Kong, Li Ka Shing Fac Med, AIDS Inst, Dept Microbiol, Pok Fu Lam, Hong Kong, Peoples R China; [Chen, Li-Qing; Lou, Qi; Ying, Huazhong] Zhejiang Acad Med Sci, Ctr Lab Anim, Shanghai, Zhejiang, Peoples R China; [Xu, Jianqing] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Inst Biomed Sci, Shanghai 201508, Peoples R China; [Dimitrov, Dimiter S.] NCI, Prot Interact Grp, Immunol Lab, Canc & Inflammat Program,Ctr Canc Res,NIH, Frederick, MD 21701 USA; [Zhang, Mei-Yun] Shenzhen Third Peoples Hosp, Liver Dis Inst, Shenzhen 518112, Peoples R China	University of Hong Kong; Zhejiang Academy of Medical Sciences; Fudan University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Zhang, MY (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, AIDS Inst, Dept Microbiol, Pok Fu Lam, Hong Kong, Peoples R China.	zhangmy2014@hotmail.com		Yang, Zheng/0000-0003-0217-6694	General Research Fund (GRF) from Hong Kong Research Grants Consuls (RGC) [785112]; China 12th 5-year Mega project for HIV/AIDS [2012ZX10001006]; NATIONAL CANCER INSTITUTE [ZIABC011155] Funding Source: NIH RePORTER	General Research Fund (GRF) from Hong Kong Research Grants Consuls (RGC); China 12th 5-year Mega project for HIV/AIDS; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a General Research Fund (GRF) (#785112) from Hong Kong Research Grants Consuls (RGC) (http://www.ugc.edu.hk/eng/rgc/index.htm) and the China 12th 5-year Mega project for HIV/AIDS (#2012ZX10001006) (http://www.most.gov.cn/tztg/index.htm) to M-Y Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astronomo RD, 2008, J VIROL, V82, P6359, DOI 10.1128/JVI.00293-08; Batista FD, 1998, IMMUNITY, V8, P751, DOI 10.1016/S1074-7613(00)80580-4; Bhattacharyya S, 2013, J BIOL CHEM, V288, P9815, DOI 10.1074/jbc.M112.425959; Bhattacharyya S, 2010, J BIOL CHEM, V285, P27100, DOI 10.1074/jbc.M110.152272; Bonsignori M, 2011, J VIROL, V85, P9998, DOI 10.1128/JVI.05045-11; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Calarese DA, 2005, P NATL ACAD SCI USA, V102, P13372, DOI 10.1073/pnas.0505763102; Chakrabarti BK, 2013, J VIROL, V87, P13239, DOI 10.1128/JVI.01247-13; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Clarke J. D., 2009, COLD SPRING HARBOR P, V2009, DOI DOI 10.1101/PDB.PR0T5177.; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Dal Porto JM, 1998, J IMMUNOL, V161, P5373; Dimitrov DS, 2010, MABS-AUSTIN, V2, P347, DOI 10.4161/mabs.2.3.11779; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Hoot S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003106; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; McGaughey GB, 2004, CURR HIV RES, V2, P193, DOI 10.2174/1570162043484933; McGuire AT, 2013, J EXP MED, V210, P655, DOI 10.1084/jem.20122824; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Ofek G, 2010, P NATL ACAD SCI USA, V107, P17880, DOI 10.1073/pnas.1004728107; Pancera M, 2010, J VIROL, V84, P8098, DOI 10.1128/JVI.00966-10; Pantophlet R, 2004, PROTEIN ENG DES SEL, V17, P749, DOI 10.1093/protein/gzh085; Pantophlet R, 2003, J VIROL, V77, P5889, DOI 10.1128/JVI.77.10.5889-5901.2003; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Prabakaran Ponraj, 2012, Front Microbiol, V3, P277, DOI 10.3389/fmicb.2012.00277; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Shang H, 2011, J BIOL CHEM, V286, P14531, DOI 10.1074/jbc.M111.224527; Srivastava V, 2013, J VIROL, V87, P5831, DOI 10.1128/JVI.00273-13; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wilson K., 1997, CURR PROTOC MOL BIOL, DOI DOI 10.1002/0471142727.MB0204S56; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Xiao XD, 2009, BIOCHEM BIOPH RES CO, V390, P404, DOI 10.1016/j.bbrc.2009.09.029; Yuan T, 2011, MABS, V3; Yuan TT, 2011, VACCINE, V29, P6903, DOI 10.1016/j.vaccine.2011.07.046; Zhang MY, 2010, MABS-AUSTIN, V2, P266, DOI 10.4161/mabs.2.3.11416; Zhang MY, 2009, VACCINE, V27, P857, DOI 10.1016/j.vaccine.2008.11.083; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	43	5	5	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0126428	10.1371/journal.pone.0126428	http://dx.doi.org/10.1371/journal.pone.0126428			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010511	gold, Green Published, Green Submitted			2022-12-26	WOS:000355183900028
J	Golmard, L; Delnatte, C; Lauge, A; Moncoutier, V; Lefol, C; Abidallah, K; Tenreiro, H; Copigny, F; Giraudeau, M; Guy, C; Barbaroux, C; Amorim, G; Briaux, A; Guibert, V; Tarabeux, J; Caputo, S; Collet, A; Gesta, P; Ingster, O; Stern, MH; Rouleau, E; De Pauw, A; Gauthier-Villars, M; Buecher, B; Bezieau, S; Stoppa-Lyonnet, D; Houdayer, C				Golmard, L.; Delnatte, C.; Lauge, A.; Moncoutier, V.; Lefol, C.; Abidallah, K.; Tenreiro, H.; Copigny, F.; Giraudeau, M.; Guy, C.; Barbaroux, C.; Amorim, G.; Briaux, A.; Guibert, V.; Tarabeux, J.; Caputo, S.; Collet, A.; Gesta, P.; Ingster, O.; Stern, M-H; Rouleau, E.; De Pauw, A.; Gauthier-Villars, M.; Buecher, B.; Bezieau, S.; Stoppa-Lyonnet, D.; Houdayer, C.			Breast and ovarian cancer predisposition due to de novo BRCA1 and BRCA2 mutations	ONCOGENE			English	Article							DE-NOVO MUTATIONS; ONSET BREAST; HEREDITARY BREAST; GENE BRCA1; PATIENT; WOMAN; SUSCEPTIBILITY; IDENTIFICATION; DIAGNOSTICS; PREVALENCE	BRCA1 and BRCA2 are the two major genes predisposing to breast and ovarian cancer. Whereas high de novo mutation rates have been demonstrated for several genes, only 11 cases of de novo BRCA1/2 mutations have been reported to date and the BRCA1/2 de novo mutation rate remains unknown. The present study was designed to fill this gap based on a series of 12 805 consecutive unrelated patients diagnosed with breast and/or ovarian cancer who met the inclusion criteria for BRCA1/2 gene analysis according to French guidelines. BRCA1/2 mutations were detected in 1527 (12%) patients, and three BRCA1 mutations and one BRCA2 mutation were de novo. The BRCA1/2 de novo mutation rate was estimated to be 0.3% (0.1%; 0.7%). Although rare, it may be useful to take the possibility of de novo BRCA1/2 mutation into account in genetic counseling of relatives and to improve the understanding of complex family histories of breast and ovarian cancers.	[Golmard, L.; Lauge, A.; Moncoutier, V.; Lefol, C.; Abidallah, K.; Tenreiro, H.; Copigny, F.; Giraudeau, M.; Guy, C.; Barbaroux, C.; Amorim, G.; Briaux, A.; Tarabeux, J.; Caputo, S.; Collet, A.; Stern, M-H; Rouleau, E.; De Pauw, A.; Gauthier-Villars, M.; Buecher, B.; Stoppa-Lyonnet, D.; Houdayer, C.] Inst Curie, Dept Biopathol, F-75005 Paris, France; [Golmard, L.; Tarabeux, J.; Stern, M-H; Stoppa-Lyonnet, D.; Houdayer, C.] Inst Curie, INSERM, U830, F-75005 Paris, France; [Delnatte, C.; Guibert, V.; Bezieau, S.] CHU Nantes, Serv Genet Med, F-44035 Nantes 01, France; [Gesta, P.] Oncogenet Poitou Charentes, Pole Oncol, Niort, France; [Ingster, O.] CHU Angers, Serv Genet Med, Angers, France; [Bezieau, S.] Univ Nantes, Fac Med Nantes, Nantes, France; [Stoppa-Lyonnet, D.] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Houdayer, C.] Univ Paris 05, Sorbonne Paris Cite, Fac Sci Pharmaceut & Biol, Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; Nantes Universite; CHU de Nantes; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Nantes Universite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Houdayer, C (corresponding author), Inst Curie, Lab Genet Constitut, 26 Rue Ulm, F-75005 Paris, France.	claude.houdayer@curie.fr	Bézieau, stéphane/G-5621-2015; Stern, Marc-Henri/A-2728-2011; De Pauw, Antoine/ABC-6019-2020; Caputo, Sandrine M/I-7460-2019; Lambert, Blandine S/O-6002-2016; Caputo, Sandrine M./C-3860-2018	Bézieau, stéphane/0000-0003-0095-1319; Stern, Marc-Henri/0000-0002-8100-2272; De Pauw, Antoine/0000-0003-3898-073X; Lambert, Blandine S/0000-0002-8429-2404; Caputo, Sandrine M./0000-0001-5338-9388				Antoniou AC, 2006, ONCOGENE, V25, P5898, DOI 10.1038/sj.onc.1209879; Antoniou AC, 2002, BRIT J CANCER, V86, P76, DOI 10.1038/sj.bjc.6600008; Biesecker LG, 2013, NAT REV GENET, V14, P307, DOI 10.1038/nrg3424; Bonaiti B, 2014, J MED GENET, V51, P114, DOI 10.1136/jmedgenet-2013-101674; Caputo S, 2012, NUCLEIC ACIDS RES, V40, pD992, DOI 10.1093/nar/gkr1160; Caux-Moncoutier V, 2011, HUM MUTAT, V32, P325, DOI 10.1002/humu.21414; De Leeneer K, 2012, BREAST CANCER RES TR, V132, P87, DOI 10.1007/s10549-011-1544-9; Delon I, 2013, CLIN GENET, V84, P297, DOI 10.1111/cge.12057; Diez O, 2010, BREAST CANCER RES TR, V121, P221, DOI 10.1007/s10549-009-0494-y; Edwards E, 2009, FAM CANCER, V8, P479, DOI 10.1007/s10689-009-9270-8; Friedman E, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1387; Garcia-Casado Z, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-134; Hansen TVO, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-58; Hodgkinson A, 2011, NAT REV GENET, V12, P756, DOI 10.1038/nrg3098; Houdayer C, 2012, RETINOBLASTOMA UPDAT, P55, DOI [10.5772/34069, DOI 10.5772/34069]; Kwong A, 2011, FAM CANCER, V10, P233, DOI 10.1007/s10689-011-9429-y; Marshall M, 2009, CLIN GENET, V76, P427, DOI 10.1111/j.1399-0004.2009.01246.x; Mavaddat N, 2013, JNCI-J NATL CANCER I, V105, P812, DOI 10.1093/jnci/djt095; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Moslehi R, 2010, AM J HUM BIOL, V22, P201, DOI 10.1002/ajhb.20978; Pal T, 2010, FERTIL STERIL, V93, P1805, DOI 10.1016/j.fertnstert.2008.12.052; Ripa R, 2002, EUR J HUM GENET, V10, P631, DOI 10.1038/sj.ejhg.5200853; Robson M, 2002, J MED GENET, V39, P126, DOI 10.1136/jmg.39.2.126; Rouleau E, 2007, CLIN GENET, V72, P199, DOI 10.1111/j.1399-0004.2007.00849.x; Tarabeux J, 2014, EUR J HUM GENET, V22, P535, DOI 10.1038/ejhg.2013.181; Tesoriero A, 1999, AM J HUM GENET, V65, P567, DOI 10.1086/302503; van der Luijt RB, 2001, J MED GENET, V38, P102, DOI 10.1136/jmg.38.2.102; van Minkelen R, 2014, CLIN GENET, V85, P318, DOI 10.1111/cge.12187; Veltman JA, 2012, NAT REV GENET, V13, P565, DOI 10.1038/nrg3241; Walsh T, 2010, P NATL ACAD SCI USA, V107, P12629, DOI 10.1073/pnas.1007983107; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Zhang L, 2011, CLIN GENET, V80, P97, DOI 10.1111/j.1399-0004.2011.01691.x	32	24	24	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 10	2016	35	10					1324	1327		10.1038/onc.2015.181	http://dx.doi.org/10.1038/onc.2015.181			4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DG0NY	26028024				2022-12-26	WOS:000371763100012
J	Terzyan, SS; Burgett, AWG; Heroux, A; Smith, CA; Mooers, BHM; Hanigan, MH				Terzyan, Simon S.; Burgett, Anthony W. G.; Heroux, Annie; Smith, Clyde A.; Mooers, Blaine H. M.; Hanigan, Marie H.			Human gamma-Glutamyl Transpeptidase 1 STRUCTURES OF THE FREE ENZYME, INHIBITOR-BOUND TETRAHEDRAL TRANSITION STATES, AND GLUTAMATE-BOUND ENZYME REVEAL NOVEL MOVEMENT WITHIN THE ACTIVE SITE DURING CATALYSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACROMOLECULAR STRUCTURES; GLUTATHIONE METABOLISM; SUBSTRATE-SPECIFICITY; ESCHERICHIA-COLI; ACID; IDENTIFICATION; TRANSFERASE; RESISTANCE; MECHANISM; CISPLATIN	gamma-Glutamyl transpeptidase 1 (GGT1) is a cell surface, N-terminal nucleophile hydrolase that cleaves glutathione and other g-glutamyl compounds. GGT1 expression is essential in cysteine homeostasis, and its induction has been implicated in the pathology of asthma, reperfusion injury, and cancer. In this study, we report four new crystal structures of human GGT1 (hGGT1) that show conformational changes within the active site as the enzyme progresses from the free enzyme to inhibitor-bound tetrahedral transition states and finally to the glutamate-bound structure prior to the release of this final product of the reaction. The structure of the apoenzyme shows flexibility within the active site. The serine-borate-bound hGGT1 crystal structure demonstrates that serine-borate occupies the active site of the enzyme, resulting in an enzyme-inhibitor complex that replicates the enzyme's tetrahedral intermediate/transition state. The structure of GGsTop-bound hGGT1 reveals its interactions with the enzyme and why neutral phosphonate diesters are more potent inhibitors than monoanionic phosphonates. These structures are the first structures for any eukaryotic GGT that include a molecule in the active site covalently bound to the catalytic Thr-381. The glutamate-bound structure shows the conformation of the enzyme prior to release of the final product and reveals novel information regarding the displacement of the main chain atoms that form the oxyanion hole and movement of the lid loop region when the active site is occupied. These data provide new insights into the mechanism of hGGT1-catalyzed reactions and will be invaluable in the development of new classes of hGGT1 inhibitors for therapeutic use.	[Terzyan, Simon S.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Macromol Crystallog Lab, Oklahoma City, OK 73104 USA; [Burgett, Anthony W. G.] Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA; [Heroux, Annie] Brookhaven Natl Lab, Photon Sci Div, Energy Sci Directorate, Upton, NY 11973 USA; [Smith, Clyde A.] SLAC Natl Accelerator Lab, Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA 94025 USA; [Mooers, Blaine H. M.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA; [Hanigan, Marie H.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Stanton L Young Biomed Res Ctr, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma - Norman; United States Department of Energy (DOE); Brookhaven National Laboratory; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Hanigan, MH (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Stanton L Young Biomed Res Ctr, Rm 264,975 NE 10th St, Oklahoma City, OK 73104 USA.	marie-hanigan@ouhsc.edu	Regan, Clinton/E-6250-2012; Mooers, Blaine/S-4383-2017	Mooers, Blaine/0000-0001-8181-8987	National Institutes of Health (NIH) from the NIGMS [P20GM103640]; National Institutes of Health (NIH) [R01AI088011]; United States Department of Energy Offices of Biological and Environmental Research and Basic Energy Sciences [DE-AC02-98CH10886, E-SC0012704]; NIH [P41RR012408, P41GM103473, P41-GM111244]; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; Department of Energy Office of Biological and Environmental Research; NIH, NIGMS [P41GM103393]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR012408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI088011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103473, P41GM103393, P41GM111244, P20GM103640] Funding Source: NIH RePORTER	National Institutes of Health (NIH) from the NIGMS; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy Offices of Biological and Environmental Research and Basic Energy Sciences; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIH, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grants P20GM103640 (an Institutional Development Award (IDeA) from the NIGMS) and R01AI088011 (to B. H. M. M.). X-ray diffraction data were collected at the National Synchrotron Light Source, for which financial support comes principally from the United States Department of Energy Offices of Biological and Environmental Research and Basic Energy Sciences Grants DE-AC02-98CH10886 and E-SC0012704 and from NIH Grants P41RR012408, P41GM103473, and P41-GM111244. X-ray diffraction data were also collected at the Stanford Synchrotron Radiation Light source, the use of which was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract DE-AC02-76SF00515. The Stanford Synchrotron Radiation Lightsource Structural Molecular Biology Program is supported by the Department of Energy Office of Biological and Environmental Research and by NIH, NIGMS, Grant P41GM103393. The authors declare that they have no conflicts of interest with the contents of this article.	AHLUWALIA GS, 1990, PHARMACOL THERAPEUT, V46, P243, DOI 10.1016/0163-7258(90)90094-I; ALLISON RD, 1985, METHOD ENZYMOL, V113, P419; Anders MW, 1998, ANNU REV PHARMACOL, V38, P501, DOI 10.1146/annurev.pharmtox.38.1.501; BEHRMAN EJ, 1970, J ORG CHEM, V35, P3063, DOI 10.1021/jo00834a043; Boanca G, 2007, J BIOL CHEM, V282, P534, DOI 10.1074/jbc.M607694200; Castonguay R, 2007, BIOCHEMISTRY-US, V46, P12253, DOI 10.1021/bi700956c; CURTHOYS NP, 1979, ENZYME, V24, P383, DOI 10.1159/000458694; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Han L, 2007, BIOCHEMISTRY-US, V46, P1432, DOI 10.1021/bi061890j; Han LY, 2006, BIOORGAN MED CHEM, V14, P6043, DOI 10.1016/j.bmc.2006.05.008; Hanigan MH, 1999, CARCINOGENESIS, V20, P553, DOI 10.1093/carcin/20.4.553; Hanigan MH, 1996, J HISTOCHEM CYTOCHEM, V44, P1101, DOI 10.1177/44.10.8813074; Hogg N, 1997, BIOCHEM J, V323, P477, DOI 10.1042/bj3230477; Inoue M, 2000, BIOCHEMISTRY-US, V39, P7764, DOI 10.1021/bi000220p; King JB, 2009, J BIOL CHEM, V284, P9059, DOI 10.1074/jbc.M809608200; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lherbet C, 2004, ORG BIOMOL CHEM, V2, P238, DOI 10.1039/b310767a; Lieberman MW, 1996, P NATL ACAD SCI USA, V93, P7923, DOI 10.1073/pnas.93.15.7923; Morrow AL, 2007, BIOCHEMISTRY-US, V46, P13407, DOI 10.1021/bi701599e; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Okada T, 2006, P NATL ACAD SCI USA, V103, P6471, DOI 10.1073/pnas.0511020103; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pompella A, 2006, BIOCHEM PHARMACOL, V71, P231, DOI 10.1016/j.bcp.2005.10.005; REVEL JP, 1959, J BIOL CHEM, V234, P577; TATE SS, 1978, P NATL ACAD SCI USA, V75, P4806, DOI 10.1073/pnas.75.10.4806; Townsend DM, 2003, J AM SOC NEPHROL, V14, P1, DOI 10.1097/01.ASN.0000042803.28024.92; Tuzova M, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00179; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; West MB, 2013, J BIOL CHEM, V288, P31902, DOI 10.1074/jbc.M113.498139; Wickham S, 2011, ANAL BIOCHEM, V414, P208, DOI 10.1016/j.ab.2011.03.026; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yamamoto S, 2011, J PHARMACOL EXP THER, V339, P945, DOI 10.1124/jpet.111.183004	33	38	42	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17576	17586		10.1074/jbc.M115.659680	http://dx.doi.org/10.1074/jbc.M115.659680			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	26013825	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000357730900048
J	Adams, RI; Bhangar, S; Pasut, W; Arens, EA; Taylor, JW; Lindow, SE; Nazaroff, WW; Bruns, TD				Adams, Rachel I.; Bhangar, Seema; Pasut, Wilmer; Arens, Edward A.; Taylor, John W.; Lindow, Steven E.; Nazaroff, William W.; Bruns, Thomas D.			Chamber Bioaerosol Study: Outdoor Air and Human Occupants as Sources of Indoor Airborne Microbes	PLOS ONE			English	Article							BACTERIAL COMMUNITIES; SPORE CONCENTRATIONS; FUNGAL; DIVERSITY; BUILDINGS; PARTICLES; SEQUENCES; MARKERS; DUST	Human occupants are an important source of microbes in indoor environments. In this study, we used DNA sequencing of filter samples to assess the fungal and bacterial composition of air in an environmental chamber under different levels of occupancy, activity, and exposed or covered carpeting. In this office-like, mechanically ventilated environment, results showed a strong influence of outdoor-derived particles, with the indoor microbial composition tracking that of outdoor air for the 2-hour sampling periods. The number of occupants and their activity played a significant but smaller role influencing the composition of indoor bioaerosols. Human-associated taxa were observed but were not particularly abundant, except in the case of one fungus that appeared to be transported into the chamber on the clothing of a study participant. Overall, this study revealed a smaller signature of human body-associated taxa than had been expected based on recent studies of indoor microbiomes, suggesting that occupants may not exert a strong influence on bioaerosol microbial composition in a space that, like many offices, is well ventilated with air that is moderately filtered and moderately occupied.	[Adams, Rachel I.; Taylor, John W.; Lindow, Steven E.; Bruns, Thomas D.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Bhangar, Seema; Nazaroff, William W.] Univ Calif Berkeley, Dept Civil & Environm Engn, Berkeley, CA 94720 USA; [Pasut, Wilmer; Arens, Edward A.] Univ Calif Berkeley, Ctr Built Environm, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Adams, RI (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.	adamsri@berkeley.edu	Nazaroff, William/AAJ-7352-2021; Nazaroff, William W/C-4106-2008	Nazaroff, William/0000-0001-5645-3357; Nazaroff, William W/0000-0001-5645-3357; Adams, Rachel/0000-0003-4499-5743; Pasut, Wilmer/0000-0001-6284-4442	Alfred P. Sloan Foundation [88391]	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation)	Funding was provided by the Alfred P. Sloan Foundation (http://www.sloan.org) to TDB, grant # 88391. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarenkov K, 2010, NEW PHYTOL, V186, P281, DOI 10.1111/j.1469-8137.2009.03160.x; Adams RI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091283; Adams RI, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0078866, 10.1371/journal.pone.0067861]; Adams RI, 2013, ISME J, V7, P1262, DOI 10.1038/ismej.2013.28; Amend AS, 2010, P NATL ACAD SCI USA, V107, P13748, DOI 10.1073/pnas.1000454107; [Anonymous], 1991, INDOOR AIR, DOI [DOI 10.1111/J.1600-0668.1991.05-13.X, 10.1111/j.1600-0668.1991.05-13.x]; ASHRAE, 2013, 6212013 ANSIASHRAE; Barns SM, 1996, P NATL ACAD SCI USA, V93, P9188, DOI 10.1073/pnas.93.17.9188; Bennett D., 2011, CEC5002011043; Bhangar S, INDOOR AIR, DOI [10.1111/12195, DOI 10.1111/12195]; Blachere FM, 2009, CLIN INFECT DIS, V48, P438, DOI 10.1086/596478; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carlsen T, 2012, FUNGAL ECOL, V5, P747, DOI 10.1016/j.funeco.2012.06.003; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Esling P, 2015, NUCLEIC ACIDS RES, V43, P2513, DOI 10.1093/nar/gkv107; Findley K, 2013, NATURE, V498, P367, DOI 10.1038/nature12171; Flannigan B, 2011, MICROORGANISMS IN HOME AND INDOOR WORK ENVIRONMENTS: DIVERSITY, HEALTH IMPACTS, INVESTIGATION AND CONTROL, 2ND EDITION; Fox A, 2003, J ENVIRON MONITOR, V5, P246, DOI 10.1039/b212341j; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hewitt KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037849; Hospodsky D, 2015, INDOOR AIR, V25, P641, DOI 10.1111/ina.12172; Hospodsky D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034867; Huse SM, 2013, SCI APPL MICROBIAL G, P188; Lax S, 2014, SCIENCE, V345, P1048, DOI 10.1126/science.1254529; Layton DW, 2009, ENVIRON SCI TECHNOL, V43, P8199, DOI 10.1021/es9003735; LEHTONEN M, 1993, INT BIODETER BIODEGR, V31, P25, DOI 10.1016/0964-8305(93)90012-Q; Leung MHY, 2014, APPL ENVIRON MICROB, V80, P6760, DOI 10.1128/AEM.02244-14; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Lindahl BD, 2013, NEW PHYTOL, V199, P288, DOI 10.1111/nph.12243; Lindsley WG, 2006, J ENVIRON MONITOR, V8, P1136, DOI 10.1039/b609083d; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Marples M. J., 1965, ECOLOGY HUMAN SKIN; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; McDonagh A, 2014, J AEROSOL SCI, V75, P94, DOI 10.1016/j.jaerosci.2014.05.007; McDonagh A, 2014, J ENVIRON RADIOACTIV, V127, P119, DOI 10.1016/j.jenvrad.2013.10.012; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; Meadow JF, 2014, INDOOR AIR, V24, P41, DOI 10.1111/ina.12047; Meadow JF, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-7; MILLER JD, 1982, WOOD FIBER SCI, V14, P54; Millington WM, 2005, AEROBIOLOGIA, V21, P105, DOI 10.1007/s10453-005-4180-1; Nguyen NH, 2015, NEW PHYTOL, V205, P1389, DOI 10.1111/nph.12923; Oh J, 2014, NATURE, V514, P59, DOI 10.1038/nature13786; PASANEN AL, 1989, AM IND HYG ASSOC J, V50, P631, DOI 10.1202/0002-8894(1989)050&lt;0631:FCFFWI&gt;2.0.CO;2; Peccia J, 2011, ATMOS ENVIRON, V45, P1896, DOI 10.1016/j.atmosenv.2010.11.037; Persily AK, 2006, BUILD RES INF, V34, P459, DOI 10.1080/09613210600809128; Pitkaranta M, 2008, APPL ENVIRON MICROB, V74, P233, DOI 10.1128/AEM.00692-07; Pitkaranta M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-235; Qian J, 2012, INDOOR AIR, V22, P339, DOI 10.1111/j.1600-0668.2012.00769.x; R Development Core Team, 2014, R LANG ENV STAT COMP; Ramos T, 2014, BUILD ENVIRON, V81, P243, DOI 10.1016/j.buildenv.2014.07.004; Robertson CE, 2013, APPL ENVIRON MICROB, V79, P3485, DOI 10.1128/AEM.00331-13; Smith DP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090234; Taubel M, 2009, J ALLERGY CLIN IMMUN, V124, P834, DOI 10.1016/j.jaci.2009.07.045; Walsh T J, 1993, Curr Top Med Mycol, V5, P79; Wirth Fernanda, 2012, Interdiscip Perspect Infect Dis, V2012, P465717, DOI 10.1155/2012/465717; Wu XM, 2012, ENVIRON SCI TECHNOL, V46, P12355, DOI 10.1021/es302140h; Yamamoto N, 2015, ENVIRON SCI TECHNOL, V49, P5098, DOI 10.1021/es506165z	61	121	125	5	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128022	10.1371/journal.pone.0128022	http://dx.doi.org/10.1371/journal.pone.0128022			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024222	Green Published, gold			2022-12-26	WOS:000355319400066
J	Li, XZ; Park, BK; Shin, JS; Choi, SH; Smith, SB; Yan, CG				Li, Xiang Z.; Park, Byung K.; Shin, Jong S.; Choi, Seong H.; Smith, Stephen B.; Yan, Chang G.			Effects of Dietary Linseed Oil and Propionate Precursors on Ruminal Microbial Community, Composition, and Diversity in Yanbian Yellow Cattle	PLOS ONE			English	Article							RUMEN BACTERIAL DIVERSITY; UNSATURATED FATTY-ACIDS; METHANE PRODUCTION; FERMENTATION CHARACTERISTICS; BUTYRIVIBRIO-FIBRISOLVENS; ORGANIC-ACIDS; LINOLEIC-ACID; MALATE; FUMARATE; ASSOCIATION	The rumen microbial ecosystem is a complex system where rumen fermentation processes involve interactions among microorganisms. There are important relationships between diet and the ruminal bacterial composition. Thus, we investigated the ruminal fermentation characteristics and compared ruminal bacterial communities using tag amplicon pyrosequencing analysis in Yanbian yellow steers, which were fed linseed oil (LO) and propionate precursors. We used eight ruminally cannulated Yanbian yellow steers (510 +/- 5.8 kg) in a replicated 4 x 4 Latin square design with four dietary treatments. Steers were fed a basal diet that comprised 80% concentrate and 20% rice straw (DM basis, CON). The CON diet was supplemented with LO at 4%. The LO diet was also supplemented with 2% DL-malate or 2% fumarate as ruminal precursors of propionate. Dietary supplementation with LO and propionate precursors increased ruminal pH, total volatile fatty acid concentrations, and the molar proportion of propionate. The most abundant bacterial operational taxonomic units in the rumen were related to dietary treatments. Bacteroidetes dominated the ruminal bacterial community and the genus Prevotella was highly represented when steers were fed LO plus propionate precursors. However, with the CON and LO diet plus malate or fumarate, Firmicutes was the most abundant phylum and the genus Ruminococcus was predominant. In summary, supplementing the diets of ruminants with a moderate level of LO plus propionate precursors modified the ruminal fermentation pattern. The most positive responses to LO and propionate precursors supplementation were in the phyla Bacteriodetes and Firmicutes, and in the genus Ruminococcus and Prevotella. Thus, diets containing LO plus malate or fumarate have significant effects on the composition of the rumen microbial community.	[Li, Xiang Z.; Yan, Chang G.] Yanbian Univ, Dept Anim Sci, Yanji 133002, Kagawa, Peoples R China; [Park, Byung K.] Nonghyup Feed Co Ltd, Feed Res Inst, Seoul 134763, South Korea; [Shin, Jong S.] Kangwon Natl Univ, Dept Anim Life Sci, Chunchoen 200701, South Korea; [Choi, Seong H.] Chungbuk Natl Univ, Dept Anim Sci, Cheongju 361763, Chungbuk, South Korea; [Smith, Stephen B.] Texas A&M Univ, Dept Anim Sci, College Stn, TX 77843 USA	Yanbian University; Kangwon National University; Chungbuk National University; Texas A&M University System; Texas A&M University College Station	Yan, CG (corresponding author), Yanbian Univ, Dept Anim Sci, Yanji 133002, Kagawa, Peoples R China.	ycg@ybu.edu.cn			Education Department of Jinlin Province [612013002]; Science and Technology Department of Jilin Province, China [201105109]; Cooperative Research Program for Agriculture Science & Technology Development: Rural Development Administration, Republic of Korea [PJ009482]	Education Department of Jinlin Province; Science and Technology Department of Jilin Province, China; Cooperative Research Program for Agriculture Science & Technology Development: Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This work was partially supported by the Education Department of Jinlin Province (No: 612013002) and the Science and Technology Department of Jilin Province (No: 201105109), China and the Cooperative Research Program for Agriculture Science & Technology Development (Project No: PJ009482): Rural Development Administration, Republic of Korea.	AOAC, 1995, OFFICIAL METHODS ANA, V16th; Asanuma N, 1999, J DAIRY SCI, V82, P780, DOI 10.3168/jds.S0022-0302(99)75296-3; BRYANT MP, 1959, BACTERIOL REV, V23, P125, DOI 10.1128/MMBR.23.3.125-153.1959; BRYANT MP, 1970, AM J CLIN NUTR, V23, P1440; Callaway TR, 1996, J ANIM SCI, V74, P1982; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carro MD, 2003, BRIT J NUTR, V90, P617, DOI 10.1079/BJN2003935; Castillo C, 2004, ANIM FEED SCI TECH, V115, P101, DOI 10.1016/j.anifeedsci.2004.02.001; Clarke R. T. J., 1977, Microbial ecology of the gut., P251; DEMEYER DI, 1995, ARCH ANIM NUTR, V48, P119, DOI 10.1080/17450399509381834; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Edwards JE, 2004, ANTON LEEUW INT J G, V86, P263, DOI 10.1023/B:ANTO.0000047942.69033.24; FAWCETT JK, 1960, J CLIN PATHOL, V13, P156, DOI 10.1136/jcp.13.2.156; Gomes NCM, 2003, APPL ENVIRON MICROB, V69, P3758, DOI 10.1128/AEM.69.7.3758-3766.2003; Jami E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033306; Khampa S, 2006, ASIAN AUSTRAL J ANIM, V19, P837, DOI 10.5713/ajas.2006.837; Kim YJ, 2000, APPL ENVIRON MICROB, V66, P5226, DOI 10.1128/AEM.66.12.5226-5230.2000; Kocherginskaya SA, 2001, ANAEROBE, V7, P119, DOI 10.1006/anae.2001.0378; Leaflet AS, 2008, USE PREVOTELLA BRYAN; Li XZ, 2010, ANIM FEED SCI TECH, V155, P132, DOI 10.1016/j.anifeedsci.2009.11.002; Li XZ, 2009, ASIAN AUSTRAL J ANIM, V22, P819, DOI 10.5713/ajas.2009.80682; Li XZ, 2009, ASIAN AUSTRAL J ANIM, V22, P82, DOI 10.5713/ajas.2009.80413; Maia MRG, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-52; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Marounek M, 1999, LETT APPL MICROBIOL, V29, P429, DOI 10.1046/j.1472-765X.1999.00671.x; Martin SA, 1998, J ANIM SCI, V76, P3123; MARTIN SA, 1995, J ANIM SCI, V73, P2141; Mitsumori M, 2002, LETT APPL MICROBIOL, V35, P251, DOI 10.1046/j.1472-765X.2002.01172.x; Mitsumori M, 2008, ASIAN AUSTRAL J ANIM, V21, P144, DOI 10.5713/ajas.2008.r01; Nagaraja TG, 2007, J DAIRY SCI, V90, pE17, DOI 10.3168/jds.2006-478; NISBET DJ, 1993, CURR MICROBIOL, V26, P133, DOI 10.1007/BF01577366; POLAN CE, 1964, J BACTERIOL, V88, P1056, DOI 10.1128/JB.88.4.1056-1064.1964; RODE LM, 1981, APPL ENVIRON MICROB, V42, P20, DOI 10.1128/AEM.42.1.20-22.1981; *SAS INC, 1985, SAS US GUID STAT AN; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Stevenson DM, 2007, APPL MICROBIOL BIOT, V75, P165, DOI 10.1007/s00253-006-0802-y; Tajima K, 1999, FEMS MICROBIOL ECOL, V29, P159, DOI 10.1111/j.1574-6941.1999.tb00607.x; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; VanNevel CJ, 1996, ENVIRON MONIT ASSESS, V42, P73, DOI 10.1007/BF00394043; Wolin M.J., 1997, RUMEN MICROBIAL ECOS, P467, DOI [10.1007/978-94-009-1453-7_11, DOI 10.1007/978-94-009-1453-7_11]	40	17	18	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0126473	10.1371/journal.pone.0126473	http://dx.doi.org/10.1371/journal.pone.0126473			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024491	Green Published, Green Submitted, gold			2022-12-26	WOS:000355319400014
J	Chen, JH; Kellner, Y; Zagrebelsky, M; Grunwald, M; Korte, M; Walla, PJ				Chen, Jian-Hua; Kellner, Yves; Zagrebelsky, Marta; Grunwald, Matthias; Korte, Martin; Walla, Peter Jomo			Two-Photon Correlation Spectroscopy in Single Dendritic Spines Reveals Fast Actin Filament Reorganization during Activity-Dependent Growth	PLOS ONE			English	Article							LONG-TERM POTENTIATION; FLUORESCENCE CORRELATION SPECTROSCOPY; DYNAMICS; PLASTICITY; FUSION	Two-photon fluorescence correlation spectroscopy (2P-FCS) within single dendritic spines of living hippocampal pyramidal neurons was used to resolve various subpopulations of mobile F-actin during activity-dependent structural changes such as potentiation induced spine head growth. Two major classes of mobile F-actin were discovered: very dynamic and about a hundred times less dynamic F-actin. Spine head enlargement upon application of Tetraethylammonium (TEA), a protocol previously used for the chemical induction of long-term potentiation (cLTP) strictly correlated to changes in the dynamics and filament numbers in the different actin filament fractions. Our observations suggest that spine enlargement is governed by a mechanism in which longer filaments are first cut into smaller filaments that cooperate with the second, increasingly dynamic shorter actin filament population to quickly reorganize and expand the actin cytoskeleton within the spine head. This process would allow a fast and efficient spine head enlargement using a major fraction of the actin filament population that was already present before spine head growth.	[Chen, Jian-Hua; Grunwald, Matthias; Walla, Peter Jomo] Max Planck Inst Biophys Chem, AG Biomol Spect & Single Mol Detect, D-37077 Gottingen, Germany; [Kellner, Yves; Zagrebelsky, Marta; Korte, Martin] TU Braunschweig, Inst Zool, Div Cellular Neurobiol, D-38106 Braunschweig, Germany; [Korte, Martin] AG NIND, HZI, D-38124 Braunschweig, Germany; [Walla, Peter Jomo] TU Braunschweig, Inst Phys & Theoret Chem, Dept Biophys Chem, D-38106 Braunschweig, Germany	Max Planck Society; Braunschweig University of Technology; Helmholtz Association; Helmholtz-Center for Infection Research; Braunschweig University of Technology	Korte, M (corresponding author), TU Braunschweig, Inst Zool, Div Cellular Neurobiol, D-38106 Braunschweig, Germany.	m.korte@tu-braunschweig.de; pwalla@gwdg.de		Zagrebelsky, Marta/0000-0003-1083-7413	German Research Foundation [DFG-ZA554/2-1]	German Research Foundation(German Research Foundation (DFG))	This work was partially supported by the German Research Foundation to MK and MZ (DFG-ZA554/2-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosch M, 2014, NEURON, V82, P444, DOI 10.1016/j.neuron.2014.03.021; Cypionka A, 2009, P NATL ACAD SCI USA, V106, P18575, DOI 10.1073/pnas.0906677106; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Gu JP, 2010, NAT NEUROSCI, V13, P1208, DOI 10.1038/nn.2634; Hernandez JM, 2012, SCIENCE, V336, P1581, DOI 10.1126/science.1221976; Honkura N, 2008, NEURON, V57, P719, DOI 10.1016/j.neuron.2008.01.013; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Kim SA, 2007, NAT METHODS, V4, P963, DOI 10.1038/NMETH1104; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Meyer D, 2014, NEURON, V82, P430, DOI 10.1016/j.neuron.2014.02.031; Michaelsen-Preusse K, 2014, NEUROMETHODS, V87, P189, DOI 10.1007/978-1-4939-0381-8_9; Roth-Alpermann C, 2006, P NATL ACAD SCI USA, V103, P11039, DOI 10.1073/pnas.0600894103; ROUSE PE, 1953, J CHEM PHYS, V21, P1272, DOI 10.1063/1.1699180; RUDDIES R, 1993, EUR BIOPHYS J BIOPHY, V22, P309, DOI 10.1007/BF00213554; Schwille P, 1999, BIOPHYS J, V77, P2251, DOI 10.1016/S0006-3495(99)77065-7; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Star EN, 2002, NAT NEUROSCI, V5, P239, DOI 10.1038/nn811; Stewart MG, 2005, EUR J NEUROSCI, V21, P3368, DOI 10.1111/j.1460-9568.2005.04174.x; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Swaminathan R, 1997, BIOPHYS J, V72, P1900, DOI 10.1016/S0006-3495(97)78835-0; Vennekate W, 2012, P NATL ACAD SCI USA, V109, P11037, DOI 10.1073/pnas.1116326109; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899; Zito K, 2004, NEURON, V44, P321, DOI 10.1016/j.neuron.2004.09.022	24	10	10	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128241	10.1371/journal.pone.0128241	http://dx.doi.org/10.1371/journal.pone.0128241			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020927	Green Published, Green Submitted, gold			2022-12-26	WOS:000355187300092
J	Huynh, MD; Page, JT; Richardson, BA; Udall, JA				Huynh, Mark D.; Page, Justin T.; Richardson, Bryce A.; Udall, Joshua A.			Insights into Transcriptomes of Big and Low Sagebrush	PLOS ONE			English	Article							SUBGENUS TRIDENTATAE; AGE DISTRIBUTIONS; EVOLUTION; ARTEMISIA; DUPLICATION; SELECTION	We report the sequencing and assembly of three transcriptomes from Big (Artemisia tridentatassp. wyomingensis and Artemisia tridentatassp. tridentata) and Low (A. arbuscula ssp. arbuscula) sagebrush. The sequence reads are available in the Sequence Read Archive of NCBI. We demonstrate the utilities of these transcriptomes for gene discovery and phylogenomic analysis. An assembly of 61,883 transcripts followed by transcript identification by the program TRAPID revealed 16 transcripts directly related to terpene synthases, proteins critical to the production of multiple secondary metabolites in sagebrush. A putative terpene synthase was identified in two of our sagebrush samples. Using paralogs with synonymous mutations we reconstructed an evolutionary time line of ancient genome duplications. By applying a constant mutation rate to the data we estimate that these three ancient duplications occurred about 18, 34 and 60 million years ago. These transcriptomes offer a foundation for future studies of sagebrush, including inferences in chemical defense and the identification of species and subspecies of sagebrush for restoration and preservation of the threatened sage-grouse.	[Huynh, Mark D.; Page, Justin T.; Udall, Joshua A.] Brigham Young Univ, Plant & Wildlife Sci Dept, Provo, UT 84602 USA; [Richardson, Bryce A.] USDA, Forest Serv, Rocky Mt Res Stn, Provo, UT 84606 USA	Brigham Young University; United States Department of Agriculture (USDA); United States Forest Service	Udall, JA (corresponding author), Brigham Young Univ, Plant & Wildlife Sci Dept, Provo, UT 84602 USA.	jaudall@byu.edu	Udall, Joshua A/A-7298-2009	Udall, Joshua A/0000-0003-0978-4764	USDA Forest Service National Fire Plan; Great Basin Native Plant Program	USDA Forest Service National Fire Plan; Great Basin Native Plant Program	This study was supported by USDA Forest Service National Fire Plan, (http://www.forestsandrangelands.gov/resources/overview/nfp_research.shtml), Great Basin Native Plant Program, (http://www.fs.fed.us/rm/boise/research/shrub/greatbasin.shtml).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bajgain P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-370; Barker MS, 2008, MOL BIOL EVOL, V25, P2445, DOI 10.1093/molbev/msn187; BEETLE A. A., 1960, STUDY SAGEBRUSH SECT, P83; Bel MV, 2012, GENOME BIO, V14, P1; Blanc G, 2004, PLANT CELL, V16, P1667, DOI 10.1105/tpc.021345; Bohlmann J, 1997, J BIOL CHEM, V272, P21784, DOI 10.1074/jbc.272.35.21784; Byrd DW, 1999, BIOCHEM SYST ECOL, V27, P11, DOI 10.1016/S0305-1978(98)00064-7; Chaudhuri P, 2012, J AM STAT ASSOC, V94, P807; Copeland HE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067261; Crow KD, 2006, MOL BIOL EVOL, V23, P887, DOI 10.1093/molbev/msj083; Degenhardt J, 2009, PHYTOCHEMISTRY, V70, P1621, DOI 10.1016/j.phytochem.2009.07.030; Frye GG, 2013, ECOLOGY, V94, P308, DOI 10.1890/12-1313.1; Funk VA, 2005, BIOL SKR, V55, P3403; Hsieh MH, 2005, PLANT PHYSIOL, V138, P641, DOI 10.1104/pp.104.058735; Irmisch S, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-84; JONES RJ, 1986, AUST VET J, V63, P259, DOI 10.1111/j.1751-0813.1986.tb02990.x; Joshi N, 2013, SICKLE SLIDING WINDO; Karban R, 2006, ECOLOGY, V87, P922, DOI 10.1890/0012-9658(2006)87[922:DRISVA]2.0.CO;2; Kim KJ, 2005, MOL BIOL EVOL, V22, P1783, DOI 10.1093/molbev/msi174; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Mahalovich M. F., 2004, Native Plants Journal, V5, P141, DOI 10.2979/NPJ.2004.5.2.141; McArthur ED, 1999, AM J BOT, V86, P1754, DOI 10.2307/2656673; MCARTHUR ED, 1988, J HERED, V79, P268, DOI 10.1093/oxfordjournals.jhered.a110508; McArthur ED, 1999, USDA FOR SERV RMRS P, V11, P3; McLachlan G.J., 1999, J STAT SOFTW, V4, DOI DOI 10.18637/JSS.V004.I02; Ohno S., 1970, EVOLUTION GENE DUPLI; REMINGTON TE, 1985, J WILDLIFE MANAGE, V49, P1055, DOI 10.2307/3801395; Rensing SA, 2014, CURR OPIN PLANT BIOL, V17, P43, DOI 10.1016/j.pbi.2013.11.002; Rosentreter R., 2005, P SAG GROUS HAB REST, P3; Sanz M., 2011, Collectanea Botanica (Barcelona), V30, P7, DOI 10.3989/collectbot.2011.v30.001; Soltis DE, 2009, AM J BOT, V96, P336, DOI 10.3732/ajb.0800079; STEVENS R, 1974, J RANGE MANAGE, V27, P325, DOI 10.2307/3896837; Thacker ET, 2012, J WILDLIFE MANAGE, V76, P588, DOI 10.1002/jwmg.273; Theis N, 2003, INT J PLANT SCI, V164, pS93, DOI 10.1086/374190; Turi CE, 2014, PHYTOCHEMISTRY, V98, P9, DOI 10.1016/j.phytochem.2013.11.016; Ulappa AC, 2014, J MAMMAL, V95, P834, DOI 10.1644/14-MAMM-A-025; Umlauf D, 2004, PHYTOCHEMISTRY, V65, P2463, DOI 10.1016/j.phytochem.2004.08.019; Vanneste K, 2013, MOL BIOL EVOL, V30, P177, DOI 10.1093/molbev/mss214; WHITE SM, 1982, J RANGE MANAGE, V35, P107, DOI 10.2307/3898533	40	5	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0127593	10.1371/journal.pone.0127593	http://dx.doi.org/10.1371/journal.pone.0127593			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020526	Green Published, Green Submitted, gold			2022-12-26	WOS:000355187300047
J	Makarova, OV; Makarov, EM				Makarova, Olga V.; Makarov, Evgeny M.			The 35S U5 snRNP Is Generated from the Activated Spliceosome during In vitro Splicing	PLOS ONE			English	Article							CATALYTIC ACTIVATION; PROTEIN-COMPOSITION; TRI-SNRNP; COMPLEXES; DESIGN; CORE; STEP	Primary gene transcripts of eukaryotes contain introns, which are removed during processing by splicing machinery. Biochemical studies In vitro have identified a specific pathway in which introns are recognised and spliced out. This occurs by progressive formation of spliceosomal complexes designated as E, A, B, and C. The composition and structure of these spliceosomal conformations have been characterised in many detail. In contrast, transitions between the complexes and the intermediates of these reactions are currently less clear. We have previously isolated a novel 35S U5 snRNP from HeLa nuclear extracts. The protein composition of this particle differed from the canonical 20S U5 snRNPs but was remarkably similar to the activated B* spliceosomes. Based on this observation we have proposed a hypothesis that 35S U5 snRNPs represent a dissociation product of the spliceosome after both transesterification reactions are completed. Here we provide experimental evidence that 35S U5 snRNPs are generated from the activated B* spliceosomes during In vitro splicing.	[Makarova, Olga V.; Makarov, Evgeny M.] Max Planck Inst Biophys Chem, Dept Cellular Biochem, D-37077 Gottingen, Germany; [Makarova, Olga V.] Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England; [Makarov, Evgeny M.] Brunel Univ London, Coll Hlth & Life Sci, Div Biosci, Uxbridge, Middx, England	Max Planck Society; University of Leicester; Brunel University	Makarov, EM (corresponding author), Max Planck Inst Biophys Chem, Dept Cellular Biochem, D-37077 Gottingen, Germany.	evgeny.makarov@brunel.ac.uk		Makarov, Evgeny/0000-0003-2543-9637				Agafonov DE, 2011, MOL CELL BIOL, V31, P2667, DOI 10.1128/MCB.05266-11; BEHRENS SE, 1991, GENE DEV, V5, P1439, DOI 10.1101/gad.5.8.1439; Behzadnia N, 2007, EMBO J, V26, P1737, DOI 10.1038/sj.emboj.7601631; Bessonov S, 2008, NATURE, V452, P846, DOI 10.1038/nature06842; Bessonov S, 2010, RNA, V16, P2384, DOI 10.1261/rna.2456210; Deckert J, 2006, MOL CELL BIOL, V26, P5528, DOI 10.1128/MCB.00582-06; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Fabrizio P, 2009, MOL CELL, V36, P593, DOI 10.1016/j.molcel.2009.09.040; Hartmuth K, 2002, P NATL ACAD SCI USA, V99, P16719, DOI 10.1073/pnas.262483899; Makarov EM, 2002, SCIENCE, V298, P2205, DOI 10.1126/science.1077783; Makarov EM, 2012, NUCLEIC ACIDS RES, V40, P2639, DOI 10.1093/nar/gkr1056; Makarova OV, 2004, EMBO J, V23, P2381, DOI 10.1038/sj.emboj.7600241; Makarova OV, 2002, EMBO J, V21, P1148, DOI 10.1093/emboj/21.5.1148; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Will CL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003707; Will CL, 2002, EMBO J, V21, P4978, DOI 10.1093/emboj/cdf480	16	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128430	10.1371/journal.pone.0128430	http://dx.doi.org/10.1371/journal.pone.0128430			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020933	Green Published, gold			2022-12-26	WOS:000355187300110
J	Yu, LY; Zhang, WJ; Liu, LM; Yang, J				Yu, Lingyu; Zhang, Wenjing; Liu, Lemian; Yang, Jun			Determining Microeukaryotic Plankton Community around Xiamen Island, Southeast China, Using Illumina MiSeq and PCR-DGGE Techniques	PLOS ONE			English	Article							MOLECULAR DIVERSITY; MICROBIAL DIVERSITY; GENETIC DIVERSITY; JIULONG RIVER; FRESH-WATER; PHYTOPLANKTON; PATTERNS; SEA; MICROZOOPLANKTON; PICOPLANKTON	Microeukaryotic plankton are important components of aquatic environments and play key roles in marine microbial food webs; however, little is known about their genetic diversity in subtropical offshore areas. Here we examined the community composition and genetic diversity of the microeukaryotic plankton in Xiamen offshore water by PCR-DGGE (polymerase chain reaction-denaturing gradient gel electrophoresis), clone-based sequencing and Illumina based sequencing. The Illumina MiSeq sequencing revealed a much (approximately two orders of magnitude) higher species richness of the microeukaryotic community than DGGE, but there were no significant difference in species richness and diversity among the northern, eastern, southern or western stations based on both methods. In this study, Copepoda, Ciliophora, Chlorophyta, Dinophyceae, Cryptophyta and Bacillariophyta (diatoms) were the dominant groups even though diatoms were not detected by DGGE. Our Illumina based results indicated that two northern communities (sites N2 and N3) were significantly different from others in having more protozoa and fewer diatoms. Redundancy analysis (RDA) showed that both temperature and salinity were the significant environmental factors influencing dominant species communities, whereas the full microeukaryotic community appeared to be affected by a complex of environmental factors. Our results suggested that extensive sampling combined with more deep sequencing are needed to obtain the complete diversity of the microeukaryotic community, and different diversity patterns for both abundant and rare taxa may be important in evaluating the marine ecosystem health.	[Yu, Lingyu; Zhang, Wenjing] Xiamen Univ, Coll Ocean & Earth Sci, Lab Marine Biodivers & Global Change MBiGC, Xiamen, Peoples R China; [Liu, Lemian; Yang, Jun] Chinese Acad Sci, Inst Urban Environm, Key Lab Urban Environm & Hlth, Aquat EcoHlth Grp, Xiamen, Peoples R China	Xiamen University; Chinese Academy of Sciences; Institute of Urban Environment, CAS	Zhang, WJ (corresponding author), Xiamen Univ, Coll Ocean & Earth Sci, Lab Marine Biodivers & Global Change MBiGC, Xiamen, Peoples R China.	zhangwenjing@xmu.edu.cn	CAS, KLUEH/T-5743-2019; Yang, Jun/E-6680-2011; Zhang, Wenjing/H-5057-2012; CAS, KLUEH-Cooperation/E-1148-2017	Yang, Jun/0000-0002-7920-2777; Zhang, Wenjing/0000-0002-2600-5040; Liu, Lemian/0000-0002-8977-6969	National Natural Science Foundation of China [41276133]; National Natural Science Foundation Committee of China; Natural Science Foundation of Fujian Province [2014J01163]; Fujian Provincial Department of Science and Technology; Global Change and Air-sea Interaction Project [GASI-03-01-02-03]; National Bureau of Oceanography of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation Committee of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province); Fujian Provincial Department of Science and Technology; Global Change and Air-sea Interaction Project; National Bureau of Oceanography of China	This work was supported by the National Natural Science Foundation of China (41276133), National Natural Science Foundation Committee of China (http://www.nsfc.gov.cn/) (WJZ); the Natural Science Foundation of Fujian Province (2014J01163), Fujian Provincial Department of Science and Technology (http://www.fjkjt.gov.cn/) (WJZ); and the Global Change and Air-sea Interaction Project (GASI-03-01-02-03), National Bureau of Oceanography of China (http://www.soa.gov.cn/) (WJZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera A, 2006, SYST APPL MICROBIOL, V29, P593, DOI 10.1016/j.syapm.2006.01.006; Amaral-Zettler LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006372; Anjusha A, 2013, J MARINE SYST, V115, P40, DOI 10.1016/j.jmarsys.2013.02.003; Anonymous, 2011, Marine Sciences (Beijing), V35, P89; Bao Lei, 2007, Marine Environmental Science, V26, P504; Behnke A, 2006, APPL ENVIRON MICROB, V72, P3626, DOI 10.1128/AEM.72.5.3626-3636.2006; Behnke A, 2011, ENVIRON MICROBIOL, V13, P340, DOI 10.1111/j.1462-2920.2010.02332.x; Bik HM, 2012, TRENDS ECOL EVOL, V27, P233, DOI 10.1016/j.tree.2011.11.010; Bowman JP, 2003, APPL ENVIRON MICROB, V69, P2448, DOI 10.1128/AEM.69.5.2448-2462.2003; Brock T D, 1987, S SOC GEN MICROBIOL, V41, P1; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; [陈纪新 Chen Jixin], 2003, [海洋环境科学, Marine Environmental Science], V22, P16; Chin T.G., 1965, OCEANOL LIMNOL SIN, V7, P373; Clarke K., 2001, PRIMER V5 USER MANUA; del Campo J, 2011, PROTIST, V162, P435, DOI 10.1016/j.protis.2010.10.003; Diez B, 2001, APPL ENVIRON MICROB, V67, P2932, DOI 10.1128/AEM.67.7.2932-2941.2001; DYAL PL, 1995, MOL ECOL, V4, P499, DOI 10.1111/j.1365-294X.1995.tb00244.x; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgcomb V, 2011, ISME J, V5, P1344, DOI 10.1038/ismej.2011.6; Estudillo CB, 2000, AQUACULTURE, V190, P155, DOI 10.1016/S0044-8486(00)00390-2; Faria DG, 2014, J OCEANOGR, V70, P11, DOI 10.1007/s10872-013-0208-2; FERRIERPAGES C, 1994, MAR ECOL PROG SER, V108, P283, DOI 10.3354/meps108283; Foucher ALJL, 2004, SOIL BIOL BIOCHEM, V36, P2027, DOI 10.1016/j.soilbio.2004.05.021; Godhe A, 2008, APPL ENVIRON MICROB, V74, P7174, DOI 10.1128/AEM.01298-08; Guan HS, 2005, Environmental Informatics, Proceedings, P185; Hambright KD, 2015, ISME J, V9, P256, DOI 10.1038/ismej.2014.103; HECKY RE, 1988, LIMNOL OCEANOGR, V33, P796, DOI 10.4319/lo.1988.33.4_part_2.0796; Herrera ML, 2009, J CLIN MICROBIOL, V47, P1325, DOI 10.1128/JCM.02073-08; Hong H, 2007, J MICROBIOL METH, V69, P52, DOI 10.1016/j.mimet.2006.11.016; Huang BQ, 2000, J OCEANOGR TAIWAN ST, V19, P329; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; LaybournParry J, 1997, POLAR BIOL, V17, P54, DOI 10.1007/s003000050104; Legatzki A, 2011, GEOMICROBIOL J, V28, P99, DOI 10.1080/01490451003738465; Leps J, 2003, MULTIVARIATE ANAL EC; Lindstrom ES, 2000, MICROBIAL ECOL, V40, P104; Liu LM, 2011, HYDROBIOLOGIA, V678, P113, DOI 10.1007/s10750-011-0834-x; Liu ZZ, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm541; Logares R, 2014, CURR BIOL, V24, P813, DOI 10.1016/j.cub.2014.02.050; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Maidak BL, 2001, NUCLEIC ACIDS RES, V29, P173, DOI 10.1093/nar/29.1.173; Maskaoui K, 2002, ENVIRON POLLUT, V118, P109, DOI 10.1016/S0269-7491(01)00208-1; Medinger R, 2010, MOL ECOL, V19, P32, DOI 10.1111/j.1365-294X.2009.04478.x; Nubel U, 1999, APPL ENVIRON MICROB, V65, P422; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Savin MC, 2004, MICROBIAL ECOL, V48, P51, DOI 10.1007/s00248-003-1033-8; Sun J, 2010, CHIN J OCEANOL LIMN, V28, P315, DOI 10.1007/s00343-010-9285-x; Tan SZ, 2013, OPTIK, V124, P6611, DOI 10.1016/j.ijleo.2013.05.025; Wang YB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101121; Wang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090053; Zeng Xiang-bo, 2010, Xiamen Daxue Xuebao (Ziran Kexue Ban), V49, P109; Zhu F, 2005, FEMS MICROBIOL ECOL, V52, P79, DOI 10.1016/j.femsec.2004.10.006; Zinger L, 2012, MOL ECOL, V21, P1878, DOI 10.1111/j.1365-294X.2011.05362.x	54	37	40	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0127721	10.1371/journal.pone.0127721	http://dx.doi.org/10.1371/journal.pone.0127721			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020532	Green Submitted, Green Published, gold			2022-12-26	WOS:000355187300053
J	Kaye, TG; Falk, AR; Pittman, M; Sereno, PC; Martin, LD; Burnham, DA; Gong, EP; Xu, X; Wang, YN				Kaye, Thomas G.; Falk, Amanda R.; Pittman, Michael; Sereno, Paul C.; Martin, Larry D.; Burnham, David A.; Gong, Enpu; Xu, Xing; Wang, Yinan			Laser-Stimulated Fluorescence in Paleontology	PLOS ONE			English	Article							MICRORAPTOR; FEATHERS	Fluorescence using ultraviolet (UV) light has seen increased use as a tool in paleontology over the last decade. Laser-stimulated fluorescence (LSF) is a next generation technique that is emerging as a way to fluoresce paleontological specimens that remain dark under typical UV. A laser's ability to concentrate very high flux rates both at the macroscopic and microscopic levels results in specimens fluorescing in ways a standard UV bulb cannot induce. Presented here are five paleontological case histories that illustrate the technique across a broad range of specimens and scales. Novel uses such as back-lighting opaque specimens to reveal detail and detection of specimens completely obscured by matrix are highlighted in these examples. The recent cost reductions in medium-power short wavelength lasers and use of standard photographic filters has now made this technique widely accessible to researchers. This technology has the potential to automate multiple aspects of paleontology, including preparation and sorting of microfossils. This represents a highly cost-effective way to address paleontology's preparatory bottleneck.	[Kaye, Thomas G.] Burke Museum Nat Hist & Culture, Seattle, WA 98195 USA; [Falk, Amanda R.] Southwestern Oklahoma State Univ, Dept Biol, Weatherford, OK USA; [Pittman, Michael] Univ Hong Kong, Dept Earth Sci, Vertebrate Palaeontol Lab, Pokfulam, Hong Kong, Peoples R China; [Sereno, Paul C.] Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; [Martin, Larry D.; Burnham, David A.] Univ Kansas, Div Vertebrate Paleontol, Nat Hist Museum, Biodivers Inst, Lawrence, KS 66045 USA; [Gong, Enpu] Northeastern Univ, Dept Geol, Shenyang, Liaoning, Peoples R China; [Xu, Xing] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing, Peoples R China	University of Hong Kong; University of Chicago; University of Kansas; Northeastern University - China; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Kaye, TG (corresponding author), Burke Museum Nat Hist & Culture, Seattle, WA 98195 USA.	tomkaye@u.washington.edu	Pittman, Michael/F-9779-2012	Pittman, Michael/0000-0002-6149-3078; Burnham, David/0000-0001-9561-1450; Kaye, Thomas/0000-0001-7996-618X	Dr. Stephen S. F. Hui Trust Fund [201403173007]; Faculty of Science and Department of Earth Sciences of the University of Hong Kong; National Natural Science Foundation of China [41120124002]; 973 (National Basic Research) program [2012CB821900]; University of Kansas Natural History Museum and Biodiversity Institute	Dr. Stephen S. F. Hui Trust Fund; Faculty of Science and Department of Earth Sciences of the University of Hong Kong; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 (National Basic Research) program(National Basic Research Program of China); University of Kansas Natural History Museum and Biodiversity Institute	This work was supported by the Dr. Stephen S. F. Hui Trust Fund (201403173007), Faculty of Science and Department of Earth Sciences of the University of Hong Kong, the National Natural Science Foundation of China (41120124002), the 973 (National Basic Research) program (2012CB821900) and a Panorama grant supplied by the University of Kansas Natural History Museum and Biodiversity Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1966, EFF LOW DOS RAD CROP; Bergmann U, 2010, P NATL ACAD SCI USA, V107, P9060, DOI 10.1073/pnas.1001569107; Bever GS, 2009, AM MUS NOVIT, P1, DOI 10.1206/650.1; Birkmann H, 1996, J PALEONTOL, V70, P1084, DOI 10.1017/S0022336000038774; Carr TD, 1999, J VERTEBR PALEONTOL, V19, P497, DOI 10.1080/02724634.1999.10011161; Chen JG, 2000, P NATL ACAD SCI USA, V97, P1044, DOI 10.1073/pnas.97.3.1044; COOK SF, 1962, J PALEONTOL, V36, P483; Croft DA, 2004, PALAEONTOLOGY, V47, P795, DOI 10.1111/j.0031-0239.2004.00398.x; Donnert G, 2006, P NATL ACAD SCI USA, V103, P11440, DOI 10.1073/pnas.0604965103; Eichler Bernd, 2010, Geologica Saxonica, V56, P137; Electric G., 2014, UVA BLUB CATALOG; Endo H., 2008, ANATOMICAL IMAGING N; Frey E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031945; Gong En-Pu, 2012, Palaeoworld, V21, P81, DOI 10.1016/j.palwor.2012.05.003; Hibbs AR, 2004, CONFOCAL MICROSCOPY; Hone DWE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009223; Kaye TG, 2010, 70 ANN M SOC VERT PA; Kaye T, 2007, J VERTEBR PALEONTOL, V27, p98A; Mateus Octavio, 2008, Journal of Paleontological Techniques, V2, P1; Matsumoto B., 2003, CELL BIOL APPL CONFO; MIETHE A., 1928, PALAEONTOL ZEITSCHR, V9, P343; Rauhut OWM, 2005, P ROY SOC B-BIOL SCI, V272, P1179, DOI 10.1098/rspb.2005.3071; Rowe T, 2001, NATURE, V410, P539, DOI 10.1038/35069145; SCHOMACKER KT, 1992, LASER SURG MED, V12, P63, DOI 10.1002/lsm.1900120111; Schopf JW, 2005, GEOBIOLOGY, V3, P1, DOI 10.1111/j.1472-4669.2005.00044.x; Schopf JW, 2011, TOP GEOBIOL, V36, P241, DOI 10.1007/978-94-007-0680-4_10; Schopf JW, 2006, ASTROBIOLOGY, V6, P1, DOI 10.1089/ast.2006.6.1; Sereno PC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002995; Tischlinger H., 2005, ZITTELIANA B, V26, P26; Tischlinger H, 2010, ULTRAVIOLET LIGHT TO; Tischlinger Helmut, 2013, P549; Warren TS, 1999, GEM GUIDES BOOK; Xu X, 2003, NATURE, V421, P335, DOI 10.1038/nature01342	33	43	44	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0125923	10.1371/journal.pone.0125923	http://dx.doi.org/10.1371/journal.pone.0125923			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26016843	Green Submitted, Green Published, gold			2022-12-26	WOS:000355185600040
J	Khalil, HA; Lei, NY; Nie, WX; Lewis, MS; Stelzner, MG; Martin, MG; Dunn, JCY; Yoo, J				Khalil, Hassan A.; Lei, Nan Ye; Nie, Wenxian; Lewis, Michael S.; Stelzner, Matthias G.; Martin, Martin G.; Dunn, James C. Y.; Yoo, James			Primary Myofibroblasts Maintain Short-Term Viability following Submucosal Injection in Syngeneic, Immune-Competent Mice Utilizing Murine Colonoscopy	PLOS ONE			English	Article							TNF-ALPHA; EXPRESSION; MODELS; COX-2	The myofibroblast is an important stromal cell of the gastrointestinal tract. Current in vitro and in vivo models either do not accurately recreate stromal-epithelial interactions or are not specific to myofibroblasts. We sought to create an animal model that would allow the study of myofibroblast-epithelial interactions. We isolated and cultured colonic myofibroblasts from FVB mice. Cells were alpha-SMA and vimentin positive but desmin negative on immunoblot analysis. We injected the myofibroblasts into the colonic submucosa of syngeneic adult mice (n = 8) via a miniendoscopic system. We then isolated green fluorescent protein (GFP) positive colonic myofibroblasts from C57BL/6-Tg(CAG-EGFP) 1Osb/Jmice and injected them into the colonic lamina propria of C57BL/6J mice at 1x10(5) (n = 14), 1x10(6) (n = 9), or 5x10(6) cells/mL (n = 4). A subset of mice were injected with serum-free media and ink without cells (n = 3). Mice underwent repeat endoscopy and euthanasia one or 7 days after injection. Colons were isolated and either fixed in 10% formalin or the inked sites were individually excised and lysed for DNA. We assessed the injection sites via histology and immunohistochemical stains for alpha-SMA and GFP. We used qPCR to quantify GFP DNA transcripts at the lamina propria injection sites. Submucosal injection ofmyofibroblasts resulted in the formation of a subepithelial wheal on endoscopy, which persisted to day 7. Myofibroblasts injected either into the submucosa or lamina propria maintained viability on post-injection day 7 as evidenced by positive alpha-SMA staining. qPCR of lamina propria injections showed a dose-dependent increase in GFP DNA transcripts on post-injection day 1, whereas the number of transcripts on day 7 was equivalent for the concentrations injected. We demonstrate short-term survival of primary cultured colonic myofibroblasts in syngeneic mice. This may prove to be a valuable model for studying the role ofmyofibroblasts in states of health and disease.	[Khalil, Hassan A.; Lei, Nan Ye; Nie, Wenxian; Stelzner, Matthias G.; Dunn, James C. Y.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg, Los Angeles, CA 90095 USA; [Lewis, Michael S.] VA Greater Los Angeles Hlth Syst, Dept Pathol & Lab Med, Los Angeles, CA USA; [Stelzner, Matthias G.] VA Greater Los Angeles Hlth Syst, Dept Surg, Los Angeles, CA USA; [Martin, Martin G.] Univ Calif Los Angeles, Dept Pediat, Div Gastroenterol & Nutr, Los Angeles, CA 90024 USA; [Yoo, James] Tufts Med Ctr, Dept Surg, Boston, MA 02111 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; Tufts Medical Center	Yoo, J (corresponding author), Tufts Med Ctr, Dept Surg, Boston, MA 02111 USA.	JYoo@tuftsmedicalcenter.org	Martín, María/HDL-9512-2022; Khalil, Hassan A/AAM-7914-2021	Khalil, Hassan A/0000-0002-3835-1290	National Institutes of Health K08 award [DK085136-03]; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Allergy and Infectious Diseases [DK085535]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK085535, P30DK041301, K08DK085136] Funding Source: NIH RePORTER	National Institutes of Health K08 award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This project was funded by a National Institutes of Health K08 award #DK085136-03 (JY), and was performed as a project of the Intestinal Stem Cell Consortium (https://iscc.coh.org), a collaborative research project funded by the National Institute of Diabetes and Digestive and Kidney Diseases and the National Institute of Allergy and Infectious Diseases #DK085535 (MGM, JCYD, MS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Canfield JG, 2006, J NEUROSCI METHODS; Ernst M, 2012, J GASTROEN HEPATOL, V27, P39, DOI 10.1111/j.1440-1746.2011.06883.x; Hayashi Y, 2008, J PHARMACOL EXP THER, V326, P523, DOI 10.1124/jpet.108.137083; Khalil H, 2013, JOVE-J VIS EXP, DOI 10.3791/50611; Koliaraki V, 2012, J CLIN INVEST, V122, P4231, DOI 10.1172/JCI63917; Lahar N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026898; Mehner C, 2013, CELL RES; Mifflin RC, 2011, AM J PHYSIOL-GASTR L, V300, pG684, DOI 10.1152/ajpgi.00474.2010; Mizoguchi A, 2012, PROG MOL BIOL TRANSL, V105, P263, DOI 10.1016/B978-0-12-394596-9.00009-3; Perez CER, 2011, AM J PHYSIOL-GASTR L, V300, pG637, DOI 10.1152/ajpgi.00381.2010; Troeger JS, 2012, GASTROENTEROLOGY, V143, P1073, DOI 10.1053/j.gastro.2012.06.036; Yoo J, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-90; Yoo J, 2012, AM J PHYSIOL-GASTR L, V302, pG805, DOI 10.1152/ajpgi.00522.2011; Yoo J, 2011, BIOCHEM BIOPH RES CO, V413, P30, DOI 10.1016/j.bbrc.2011.08.029; Zigmond E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028858	15	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0127258	10.1371/journal.pone.0127258	http://dx.doi.org/10.1371/journal.pone.0127258			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26016485	Green Published, gold, Green Submitted			2022-12-26	WOS:000355185600077
J	Asbe, A; Matsushita, SC; Gordon, S; Kirkpatrick, HE; Madlung, A				Asbe, Amelia; Matsushita, Starr C.; Gordon, Spencer; Kirkpatrick, H. E.; Madlung, Andreas			Floral Reversion in Arabidopsis suecica Is Correlated with the Onset of Flowering and Meristem Transitioning	PLOS ONE			English	Article							MADS-BOX PROTEINS; INFLORESCENCE ARCHITECTURE; NATURAL VARIATION; THALIANA; PLANTS; GYNOECIUM; TIME; PHOTOPERIOD; MORPHOLOGY; IMPATIENS	Angiosperm flowers are usually determinate structures that may produce seeds. In some species, flowers can revert from committed flower development back to an earlier developmental phase in a process called floral reversion. The allopolyploid Arabidopsis suecica displays photoperiod-dependent floral reversion in a subset of its flowers, yet little is known about the environmental conditions enhancing this phenotype, or the morphological processes leading to reversion. We have used light and electron microscopy to further describe this phenomenon. Additionally, we have further studied the phenology of flowering and floral reversion in A. suecica. In this study we confirm and expand upon our previous findings that floral reversion in the allopolyploid A. suecica is photoperiod-dependent, and show that its frequency is correlated with the timing for the onset of flowering. Our results also suggest that floral reversion in A. suecica displays natural variation in its penetrance between geographic populations of A. suecica.	[Asbe, Amelia; Matsushita, Starr C.; Gordon, Spencer; Kirkpatrick, H. E.; Madlung, Andreas] Univ Puget Sound, Dept Biol, Tacoma, WA 98416 USA		Madlung, A (corresponding author), Univ Puget Sound, Dept Biol, Tacoma, WA 98416 USA.	amadlung@pugetsound.edu			National Science Foundation [IOS-1118539]; University of Puget Sound	National Science Foundation(National Science Foundation (NSF)); University of Puget Sound	This work was supported by National Science Foundation, grant #IOS-1118539 (to AM), www.nsf.gov; University of Puget Sound, Summer Research Fellowship (to AA, SG), www.pugetsound.edu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albani MC, 2010, CURR TOP DEV BIOL, V91, P323, DOI 10.1016/S0070-2153(10)91011-9; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; BATTEY NH, 1990, BOT REV, V56, P162, DOI 10.1007/BF02858534; Battey NH, 2002, CURR OPIN PLANT BIOL, V5, P62, DOI 10.1016/S1369-5266(01)00229-1; Chen ZJ, 2013, NAT REV GENET, V14, P471, DOI 10.1038/nrg3503; Davies B, 1996, EMBO J, V15, P4330, DOI 10.1002/j.1460-2075.1996.tb00807.x; de Folter S, 2005, PLANT CELL, V17, P1424, DOI 10.1105/tpc.105.031831; Debieu M, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0061075, 10.1371/journal.pone.0082943]; DIGGLE PK, 1995, ANNU REV ECOL SYST, V26, P531, DOI 10.1146/annurev.es.26.110195.002531; DIOMAIUTO J, 1988, Phytomorphology, V38, P163; Egea-Cortines M, 1999, EMBO J, V18, P5370, DOI 10.1093/emboj/18.19.5370; Ghasemi A, 2012, INT J ENDOCRINOL MET, V10, P486, DOI 10.5812/ijem.3505; Grbic V, 1996, DEVELOPMENT, V122, P2395; Gregis V, 2008, PLANT J, V56, P891, DOI 10.1111/j.1365-313X.2008.03648.x; Gregis V, 2009, PLANT J, V60, P626, DOI 10.1111/j.1365-313X.2009.03985.x; Hegarty M, 2013, CYTOGENET GENOME RES, V140, P204, DOI 10.1159/000353361; Jackson SD, 2009, NEW PHYTOL, V181, P517, DOI 10.1111/j.1469-8137.2008.02681.x; Jakobsson M, 2006, MOL BIOL EVOL, V23, P1217, DOI 10.1093/molbev/msk006; Johansson M, J EXP BOT; JSTOR, GLOB PLANTS LUN ANN; Jung JH, 2014, PLANT SCI, V215, P29, DOI 10.1016/j.plantsci.2013.10.010; KAMM A, 1995, PLANT MOL BIOL, V27, P853, DOI 10.1007/BF00037014; Kaufmann K, 2009, PLOS BIOL, V7, P854, DOI 10.1371/journal.pbio.1000090; Liu C, 2008, DEVELOPMENT, V135, P1481, DOI 10.1242/dev.020255; LLOYD DG, 1980, NEW PHYTOL, V86, P69, DOI 10.1111/j.1469-8137.1980.tb00780.x; Madlung A, 2013, Cytogenet Genome Res, V140, P270, DOI 10.1159/000351430; Madlung A, 2012, PHYSIOL PLANTARUM, V144, P123, DOI 10.1111/j.1399-3054.2011.01526.x; McCullough E, 2010, NEW PHYTOL, V186, P239, DOI 10.1111/j.1469-8137.2009.03141.x; Mouradov A, 2002, PLANT CELL, V14, pS111, DOI 10.1105/tpc.001362; Nooden LD, 2001, J EXP BOT, V52, P2151, DOI 10.1093/jexbot/52.364.2151; Ordidge M, 2005, PLANT J, V44, P985, DOI 10.1111/j.1365-313X.2005.02607.x; Park SJ, 2012, P NATL ACAD SCI USA, V109, P639, DOI 10.1073/pnas.1114963109; Payne T, 2004, DEVELOPMENT, V131, P3737, DOI 10.1242/dev.01216; Poduska B, 2003, GENETICS, V163, P1457; Poethig RS, 2003, SCIENCE, V301, P334, DOI 10.1126/science.1085328; Prenner G, 2009, TRENDS PLANT SCI, V14, P302, DOI 10.1016/j.tplants.2009.03.004; Sall T, 2004, HEREDITAS, V141, P313, DOI 10.1111/j.1601-5223.2004.01833.x; Savolainen O, 2011, SCIENCE, V334, P49, DOI 10.1126/science.1213788; Stinchcombe JR, 2004, P NATL ACAD SCI USA, V101, P4712, DOI 10.1073/pnas.0306401101; Sun B, 2009, GENE DEV, V23, P1791, DOI 10.1101/gad.1800409; Teo ZWN, 2014, TRENDS PLANT SCI, V19, P158, DOI 10.1016/j.tplants.2013.11.001; Tooke F, 2000, PLANT CELL, V12, P1837, DOI 10.1105/tpc.12.10.1837; Tooke F, 2005, J EXP BOT, V56, P2587, DOI 10.1093/jxb/eri254; Trigueros M, 2009, PLANT CELL, V21, P1394, DOI 10.1105/tpc.109.065508; Wang JL, 2006, GENETICS, V173, P965, DOI 10.1534/genetics.106.056580; Wang Q, 2007, CURR BIOL, V17, P1513, DOI 10.1016/j.cub.2007.07.059; Xing SP, 2013, PLANT J, V75, P566, DOI 10.1111/tpj.12221; Zeevaart JAD, 2008, CURR OPIN PLANT BIOL, V11, P541, DOI 10.1016/j.pbi.2008.06.009	48	9	9	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127897	10.1371/journal.pone.0127897	http://dx.doi.org/10.1371/journal.pone.0127897			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011630	Green Published, gold, Green Submitted			2022-12-26	WOS:000355183900161
J	Chen, Y; Wang, ZT; Wang, ZY; Chen, DY; Chai, YC; Pang, XH; Sun, LH; Wang, XW; Yang, T; Wu, H				Chen, Ying; Wang, Zhentao; Wang, Zhaoyan; Chen, Dongye; Chai, Yongchuan; Pang, Xiuhong; Sun, Lianhua; Wang, Xiaowen; Yang, Tao; Wu, Hao			Targeted Next-Generation Sequencing in Uyghur Families with Non-Syndromic Sensorineural Hearing Loss	PLOS ONE			English	Article							RECESSIVE DEAFNESS; MUTATIONS; GENE; SPECTRUM	The mutation spectrum of deafness genes may vary in different ethnical groups. In this study, we investigated the genetic etiology of nonsyndromic deafness in four consanguineous and two multiplex Uyghur families in which mutations in common deafness genes GJB2, SLC26A4 and MT-RNR1 were excluded. Targeted next-generation sequencing of 97 deafness genes was performed in the probands of each family. Novel pathogenic mutations were identified in four probands including the p.L416R/p.A438T compound heterozygous mutations in TMC1, the homozygous p.V1880E mutation in MYO7A, c.1238delT frameshifting deletion in PCDH15 and c.9690+1G>A splice site mutation in MYO15A. Co-segregation of the mutations and the deafness were confirmed within each family by Sanger sequencing. No pathogenic mutations were identified in one multiplex family and one consanguineous family. Our study provided a useful piece of information for the genetic etiology of deafness in Uyghurs.	[Chen, Ying; Wang, Zhentao; Wang, Zhaoyan; Chen, Dongye; Chai, Yongchuan; Pang, Xiuhong; Sun, Lianhua; Wang, Xiaowen; Yang, Tao; Wu, Hao] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Otorhinolaryngol Head & Neck Surg, Shanghai 200030, Peoples R China; [Chen, Ying; Wang, Zhentao; Wang, Zhaoyan; Chen, Dongye; Chai, Yongchuan; Pang, Xiuhong; Sun, Lianhua; Wang, Xiaowen; Yang, Tao; Wu, Hao] Shanghai Jiao Tong Univ, Ear Inst, Shanghai 200030, Peoples R China; [Chen, Ying; Wang, Zhentao; Wang, Zhaoyan; Chen, Dongye; Chai, Yongchuan; Pang, Xiuhong; Sun, Lianhua; Wang, Xiaowen; Yang, Tao; Wu, Hao] Shanghai Key Lab Translat Med Ear & Nose Dis, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Yang, T (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Otorhinolaryngol Head & Neck Surg, Shanghai 200030, Peoples R China.	yangtfxl@sina.com; wuhao622@sina.cn	Pang, Xiuhong/ABE-2751-2021	Yang, Tao/0000-0001-6011-987X	Shanghai Municipal Science and Technology Commission [14DZ2260300]; National Basic Research Program of China [2011CB504501]; National Science Foundation of China [81170924, 81330023, 81222010, 81371101]; Shanghai Municipal Education Commission; Specialized Research Fund for the Doctoral Program of Higher Education [20130073110011];  [2012BAI09B02]	Shanghai Municipal Science and Technology Commission(Science & Technology Commission of Shanghai Municipality (STCSM)); National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); 	This research was supported by grants from Shanghai Municipal Science and Technology Commission (14DZ2260300 to HW), National Basic Research Program of China (2011CB504501 to HW), National Science Foundation of China (81170924, 81330023 to HW and 81222010, 81371101 to TY), Minister of Science and Technology (2012BAI09B02 to HW), the Oriental Scholar project from Shanghai Municipal Education Commission (to TY) and Specialized Research Fund for the Doctoral Program of Higher Education (20130073110011 to TY).	Baek JI, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-60; Chen Y, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-154; Dai P, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-26; Ji YB, 2011, ACTA OTO-LARYNGOL, V131, P124, DOI 10.3109/00016489.2010.483479; Kurima K, 2002, NAT GENET, V30, P277, DOI 10.1038/ng842; Lezirovitz K, 2008, EUR J HUM GENET, V16, P89, DOI 10.1038/sj.ejhg.5201917; Liu XZ, 1997, NAT GENET, V16, P188, DOI 10.1038/ng0697-188; Mutai H, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-172; Nance WE, 2003, MENT RETARD DEV D R, V9, P109, DOI 10.1002/mrdd.10067; Tekin M, 2008, CLIN GENET, V73, P554, DOI 10.1111/j.1399-0004.2008.01004.x; Vozzi D, 2014, GENE, V542, P209, DOI 10.1016/j.gene.2014.03.033; Wang ZT, 2014, INT J PEDIATR OTORHI, V78, P1513, DOI 10.1016/j.ijporl.2014.06.023; Xu DR, 2011, J TRANSL MED, V9, DOI [10.1186/1479-5876-9-167, 10.1186/1479-5876-9-74]; Yang T, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-85; Yuan YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030720	15	18	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127879	10.1371/journal.pone.0127879	http://dx.doi.org/10.1371/journal.pone.0127879			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011067	Green Published, gold, Green Submitted			2022-12-26	WOS:000355183900156
J	Korhonen, MJ; Halonen, JI; Brookhart, MA; Kawachi, I; Pentti, J; Karlsson, H; Kivimaki, M; Vahtera, J				Korhonen, Maarit Jaana; Halonen, Jaana I.; Brookhart, M. Alan; Kawachi, Ichiro; Pentti, Jaana; Karlsson, Hasse; Kivimaeki, Mika; Vahtera, Jussi			Childhood Adversity as a Predictor of Non-Adherence to Statin Therapy in Adulthood	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; HEALTH-CARE UTILIZATION; CARDIOVASCULAR-DISEASE; MEDICATION ADHERENCE; PSYCHOSOCIAL FACTORS; LIVING-CONDITIONS; RISK; ASSOCIATION; EXPERIENCES; ONSET	Purpose To investigate whether adverse experiences in childhood predict non-adherence to statin therapy in adulthood. Methods A cohort of 1378 women and 538 men who initiated statin therapy during 2008-2010 after responding to a survey on childhood adversities, was followed for non-adherence during the first treatment year. Log-binomial regression was used to estimate predictors of non-adherence, defined as the proportion of days covered by dispensed statin tablets <80%. In fully adjusted models including age, education, marital status, current smoking, heavy alcohol use, physical inactivity, obesity, presence of depression and cardiovascular comorbidity, the number of women ranged from 1172 to 1299 and that of men from 473 to 516, because of missing data on specific adversities and covariates. Results Two in three respondents reported at least one of the following six adversities in the family: divorce/separation of the parents, long-term financial difficulties, severe conflicts, frequent fear, severe illness, or alcohol problem of a family member. 51% of women and 44% of men were non-adherent. In men, the number of childhood adversities predicted an increased risk of non-adherence (risk ratio [RR] per adversity 1.11, 95% confidence interval [CI] 1.01-1.21], P for linear trend 0.013). Compared with those reporting no adversities, men reporting 3-6 adversities had a 1.44-fold risk of non-adherence (95% CI 1.12-1.85). Experiencing severe conflicts in the family (RR 1.27, 95% CI 1.03-1.57]) and frequent fear of a family member (RR 1.27, 95% CI 1.00-1.62]) in particular, predicted an increased risk of non-adherence. In women, neither the number of adversities nor any specific type of adversity predicted non-adherence. Conclusions Exposure to childhood adversity may predict non-adherence to preventive cardiovascular medication in men. Usefulness of information on childhood adversities in identification of adults at high risk of non-adherence deserves further research.	[Korhonen, Maarit Jaana] Univ Turku, Dept Pharmacol Drug Dev & Therapeut, Turku, Finland; [Korhonen, Maarit Jaana; Vahtera, Jussi] Univ Turku, Dept Publ Hlth, Turku, Finland; [Halonen, Jaana I.] Finnish Inst Occupat Hlth, Helsinki, Finland; [Halonen, Jaana I.] London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, London WC1, England; [Brookhart, M. Alan] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Kawachi, Ichiro] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Pentti, Jaana] Finnish Inst Occupat Hlth, Turku, Finland; [Karlsson, Hasse] Univ Turku, Dept Clin Sci, Turku, Finland; [Kivimaeki, Mika] UCL, Dept Epidemiol & Publ Hlth, London, England; [Vahtera, Jussi] Turku Univ Hosp, FIN-20520 Turku, Finland	University of Turku; University of Turku; Finnish Institute of Occupational Health; University of London; London School of Hygiene & Tropical Medicine; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Harvard T.H. Chan School of Public Health; Finnish Institute of Occupational Health; University of Turku; University of London; University College London; University of Turku	Korhonen, MJ (corresponding author), Univ Turku, Dept Pharmacol Drug Dev & Therapeut, Turku, Finland.	maarit.korhonen@utu.fi	Kivimaki, Mika/B-3607-2012	Kivimaki, Mika/0000-0002-4699-5627; Korhonen, Maarit/0000-0002-2953-4757; Vahtera, Jussi/0000-0002-6036-061X; Karlsson, Hasse/0000-0002-4992-1893; Halonen, Jaana/0000-0003-1142-0388	Academy of Finland ERA-AGE2 program [264944]; Finnish Work Environment Foundation; United Kingdom Medical Research Council [K013351]; Economic and Social Research Council, United Kingdom; ESRC [ES/J023299/1] Funding Source: UKRI; MRC [MR/K013351/1] Funding Source: UKRI; British Heart Foundation [RG/13/2/30098] Funding Source: researchfish; Economic and Social Research Council [ES/J023299/1] Funding Source: researchfish; Medical Research Council [MR/K013351/1] Funding Source: researchfish	Academy of Finland ERA-AGE2 program; Finnish Work Environment Foundation; United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council, United Kingdom(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Academy of Finland (www.aka.fi) ERA-AGE2 program, grant number 264944), the Finnish Work Environment Foundation (www.tsr.fi) to MK, the United Kingdom Medical Research Council (www.mrc.ac.uk) to MK (grant number K013351) and the Economic and Social Research Council, United Kingdom, (www.esrc.ac.uk) to MK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advisory Board of Official Statistics of Finland (OSF), 2011, OFF STAT FINL CLASS; Anda RF, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-198; Andrade SE, 2006, PHARMACOEPIDEM DR S, V15, P565, DOI 10.1002/pds.1230; Bonomi AE, 2008, J GEN INTERN MED, V23, P294, DOI 10.1007/s11606-008-0516-1; Chan DC, 2010, MED CARE, V48, P196, DOI 10.1097/MLR.0b013e3181c132ad; Chartier MJ, 2007, AM J EPIDEMIOL, V165, P1031, DOI 10.1093/aje/kwk113; Chowdhury R, 2013, EUR HEART J, V34, P2940, DOI 10.1093/eurheartj/eht295; Ciechanowski P, 2006, GEN HOSP PSYCHIAT, V28, P9, DOI 10.1016/j.genhosppsych.2005.07.004; Ciechanowski P, 2004, PSYCHOSOM MED, V66, P720, DOI 10.1097/01.psy.0000138125.59122.23; Dormuth CR, 2009, CIRCULATION, V119, P2051, DOI 10.1161/CIRCULATIONAHA.108.824151; Fuller-Thomson E, 2013, PUBLIC HEALTH, V127, P449, DOI 10.1016/j.puhe.2013.01.006; Furu K, 2010, BASIC CLIN PHARMACOL, V106, P86, DOI 10.1111/j.1742-7843.2009.00494.x; Gadkari AS, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-98; Galobardes B, 2006, ANN EPIDEMIOL, V16, P91, DOI 10.1016/j.annepidem.2005.06.053; Gentil L, 2012, J AM GERIATR SOC, V60, P2297, DOI 10.1111/j.1532-5415.2012.04239.x; Gilman SE, 2010, ACAD PEDIATR, V10, P159, DOI 10.1016/j.acap.2010.03.008; Grenard JL, 2011, J GEN INTERN MED, V26, P1175, DOI 10.1007/s11606-011-1704-y; Hardt J, 2004, J CHILD PSYCHOL PSYC, V45, P260, DOI 10.1111/j.1469-7610.2004.00218.x; Kauhanen Laura, 2011, Adv Prev Med, V2011, P478741, DOI 10.4061/2011/478741; Kelly-Irving M, 2013, EUR J EPIDEMIOL, V28, P721, DOI 10.1007/s10654-013-9832-9; Kestila L, 2006, EUR J PUBLIC HEALTH, V16, P617, DOI 10.1093/eurpub/ckl054; Kivimaki M, 2006, ANN EPIDEMIOL, V16, P737, DOI 10.1016/j.annepidem.2006.01.004; Kivimaki M, 2013, CAN MED ASSOC J, V185, pE784, DOI 10.1503/cmaj.122010; Korkeila J, 2010, J AFFECT DISORDERS, V127, P130, DOI 10.1016/j.jad.2010.04.031; Korkeila J, 2010, HEART, V96, P298, DOI 10.1136/hrt.2009.188250; Kriegbaum M, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004178; Lewey J, 2013, AM HEART J, V165, P665, DOI 10.1016/j.ahj.2013.02.011; Lovallo WR, 2013, INT J PSYCHOPHYSIOL, V90, P8, DOI 10.1016/j.ijpsycho.2012.10.006; Maunder Robert G, 2008, J Am Acad Psychoanal Dyn Psychiatry, V36, P11, DOI 10.1521/jaap.2008.36.1.11; Mullainathan Sendhil, 2013, SCARCITY; Nandi A, 2012, EPIDEMIOLOGY, V23, P223, DOI 10.1097/EDE.0b013e31824570bd; Nichols M, 2013, EUR HEART J, V34, P3028, DOI 10.1093/eurheartj/eht356; Non AL, 2014, AM J EPIDEMIOL, V180, P263, DOI 10.1093/aje/kwu127; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Peura S., 2007, PHARM PRICING REIMBU; Rahkonen O, 1997, SOC SCI MED, V44, P327, DOI 10.1016/S0277-9536(96)00102-5; Rich-Edwards JW, 2012, CIRCULATION, V126, P920, DOI 10.1161/CIRCULATIONAHA.111.076877; Rikala M, 2013, BASIC CLIN PHARMACOL, V113, P173, DOI 10.1111/bcpt.12075; Rimm EB, 1999, BMJ-BRIT MED J, V319, P1523, DOI 10.1136/bmj.319.7224.1523; Romppainen T, 2014, EUR J CLIN PHARMACOL, V70, P1275, DOI 10.1007/s00228-014-1737-3; Schisterman EF, 2009, EPIDEMIOLOGY, V20, P488, DOI 10.1097/EDE.0b013e3181a819a1; Sjosten N, 2013, J HYPERTENS, V31, P1477, DOI 10.1097/HJH.0b013e32836098d1; Stilley CS, 2010, HEALTH PSYCHOL, V29, P50, DOI 10.1037/a0016940; Sumanen M, 2005, J PSYCHOSOM RES, V59, P331, DOI 10.1016/j.jpsychores.2005.04.005; Tamayo T, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-525; Thunander Sundbom Lena, 2012, Pharmacy Practice (Internet), V10, P207, DOI 10.4321/s1886-36552012000400005; Vahtera J, 2010, OCCUP ENVIRON MED, V67, P479, DOI 10.1136/oem.2008.045096; World Health Organization Collaborating Centre for Drug Statistics Methodology, 2014, US ATC DDD	48	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127638	10.1371/journal.pone.0127638	http://dx.doi.org/10.1371/journal.pone.0127638			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0QZ	26011609	Green Published, Green Accepted, gold			2022-12-26	WOS:000355183900120
J	Modakh, JK; Liu, YC; Machuca, MA; Supuran, CT; Roujeinikova, A				Modakh, Joyanta K.; Liu, Yu C.; Machuca, Mayra A.; Supuran, Claudiu T.; Roujeinikova, Anna			Structural Basis for the Inhibition of Helicobacter pylori alpha-Carbonic Anhydrase by Sulfonamides	PLOS ONE			English	Article							CLONING; ULCER; EXPRESSION; FEATURES; COMPLEX; TARGETS	Periplasmic alpha-carbonic anhydrase of Helicobacter pylori (HpaCA), an oncogenic bacterium in the human stomach, is essential for its acclimation to low pH. It catalyses the conversion of carbon dioxide to bicarbonate using Zn(II) as the cofactor. In H. pylori, Neisseria spp., Brucella suis and Streptococcus pneumoniae this enzyme is the target for sulfonamide antibacterial agents. We present structural analysis correlated with inhibition data, on the complexes of HpaCA with two pharmacological inhibitors of human carbonic anhydrases, acetazolamide and methazolamide. This analysis reveals that two sulfonamide oxygen atoms of the inhibitors are positioned proximal to the putative location of the oxygens of the CO2 substrate in the Michaelis complex, whilst the zinc-coordinating sulfonamide nitrogen occupies the position of the catalytic water molecule. The structures are consistent with acetazolamide acting as site-directed, nanomolar inhibitors of the enzyme by mimicking its reaction transition state. Additionally, inhibitor binding provides insights into the channel for substrate entry and product exit. This analysis has implications for the structure-based design of inhibitors of bacterial carbonic anhydrases.	[Modakh, Joyanta K.; Liu, Yu C.; Machuca, Mayra A.; Roujeinikova, Anna] Monash Univ, Dept Microbiol, Fac Biomed & Psychol Sci, Clayton, Vic 3168, Australia; [Supuran, Claudiu T.] Univ Florence, Polo Sci, Lab Chim Bioinorgan, Florence, Italy; [Supuran, Claudiu T.] Univ Florence, Sez Sci Farmaceut, Neurofarba Dept, Florence, Italy; [Roujeinikova, Anna] Monash Univ, Dept Biochem & Mol Biol, Fac Biomed & Psychol Sci, Clayton, Vic, Australia	Monash University; University of Florence; University of Florence; Monash University	Roujeinikova, A (corresponding author), Monash Univ, Dept Microbiol, Fac Biomed & Psychol Sci, Clayton, Vic 3168, Australia.	anna.roujeinikova@monash.edu		Roujeinikova, Anna/0000-0001-8478-4751	Australian Research Council Fellowship [DP1094619]	Australian Research Council Fellowship(Australian Research Council)	This work was supported by the Australian Research Council Fellowship to AR (grant number DP1094619). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; [Anonymous], PYMOL MOL GRAPH SYST; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Burghout P, 2010, J BACTERIOL, V192, P4054, DOI 10.1128/JB.00151-10; Bury-Mone S, 2008, INFECT IMMUN, V76, P497, DOI 10.1128/IAI.00993-07; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chirica LC, 2002, BBA-PROTEINS PROTEOM, V1601, P192, DOI 10.1016/S1570-9639(02)00467-3; Chirica LC, 2001, BBA-PROTEIN STRUCT M, V1544, P55, DOI 10.1016/S0167-4838(00)00204-1; DAVENPORT HW, 1968, GASTROENTEROLOGY   S, V54, P702; Di Fiore A, 2013, ACTA CRYSTALLOGR D, V69, P1150, DOI 10.1107/S0907444913007208; Dunn BE, 1997, CLIN MICROBIOL REV, V10, P720, DOI 10.1128/CMR.10.4.720; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ernst PB, 2000, ANNU REV MICROBIOL, V54, P615, DOI 10.1146/annurev.micro.54.1.615; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Gisbert JP, 2010, J CLIN GASTROENTEROL, V44, P313, DOI 10.1097/MCG.0b013e3181c8a1a3; Graham DY, 2007, HELICOBACTER, V12, P275, DOI 10.1111/j.1523-5378.2007.00518.x; Graham DY, 2010, GUT, V59, P1143, DOI 10.1136/gut.2009.192757; Huang SH, 1998, J MOL BIOL, V283, P301, DOI 10.1006/jmbi.1998.2077; James P, 2014, ACTA CRYSTALLOGR D, V70, P2607, DOI 10.1107/S1399004714016526; JONES S, 1995, PROG BIOPHYS MOL BIO, V63, P31, DOI 10.1016/0079-6107(94)00008-W; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krulwich TA, 2011, NAT REV MICROBIOL, V9, P330, DOI 10.1038/nrmicro2549; Kusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05; Lindskog S, 1997, PHARMACOL THERAPEUT, V74, P1, DOI 10.1016/S0163-7258(96)00198-2; Malfertheiner P, 2011, LANCET, V377, P905, DOI 10.1016/S0140-6736(11)60020-2; Marcus EA, 2005, J BACTERIOL, V187, P729, DOI 10.1128/JB.187.2.729-738.2005; Maren T H, 1995, J Glaucoma, V4, P49; MAREN TH, 1967, PHYSIOL REV, V47, P595, DOI 10.1152/physrev.1967.47.4.595; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Modak JK, 2013, ACTA CRYSTALLOGR F, V69, P1252, DOI 10.1107/S1744309113026146; Nishimori I, 2006, J MED CHEM, V49, P2117, DOI 10.1021/jm0512600; Nishimori I, 2008, CURR PHARM DESIGN, V14, P622, DOI 10.2174/138161208783877875; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Penston JG, 1997, BRIT J CLIN PHARMACO, V43, P223, DOI 10.1046/j.1365-2125.1997.00551.x; PUSCAS I, 1984, ANN NY ACAD SCI, V429, P587, DOI 10.1111/j.1749-6632.1984.tb12392.x; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Sachs G, 2005, PHYSIOLOGY, V20, P429, DOI 10.1152/physiol.00032.2005; Sjoblom B, 2009, P NATL ACAD SCI USA, V106, P10609, DOI 10.1073/pnas.0904184106; Supuran CT, 2008, NAT REV DRUG DISCOV, V7, P168, DOI 10.1038/nrd2467; Supuran CT, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00034; SUPURAN CT, 1994, CARBONIC ANHYDRASE AND MODULATION OF PHYSIOLOGIC AND PATHOLOGIC PROCESSES IN THE ORGANISM, P30; Vakil N, 2006, AM J GASTROENTEROL, V101, P497, DOI 10.1111/j.1572-0241.2006.00454.x; VALEAN S, 1984, ANN NY ACAD SCI, V429, P597; VANEECHOUTTE M, 1988, J CLIN MICROBIOL, V26, P2544, DOI 10.1128/JCM.26.12.2544-2548.1988; WALSH JH, 1995, NEW ENGL J MED, V333, P984, DOI 10.1056/NEJM199510123331508; West D, 2012, BIOCHEMISTRY-US, V51, P9156, DOI 10.1021/bi301155z; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winum JY, 2010, CURR PHARM DESIGN, V16, P3310, DOI 10.2174/138161210793429850; Wroblewski LE, 2010, CLIN MICROBIOL REV, V23, P713, DOI 10.1128/CMR.00011-10; Zheng JY, 2008, BIOCHEMISTRY-US, V47, P12028, DOI 10.1021/bi801473w; Zwart PH, 2008, ACTA CRYSTALLOGR D, V64, P99, DOI 10.1107/S090744490705531X	52	36	36	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127149	10.1371/journal.pone.0127149	http://dx.doi.org/10.1371/journal.pone.0127149			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010545	Green Submitted, gold, Green Published			2022-12-26	WOS:000355183900068
J	Jakubauskiene, E; Vilys, L; Makino, Y; Poellinger, L; Kanopka, A				Jakubauskiene, Egle; Vilys, Laurynas; Makino, Yuichi; Poellinger, Lorenz; Kanopka, Arvydas			Increased Serine-Arginine (SR) Protein Phosphorylation Changes Pre-mRNA Splicing in Hypoxia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAS DOMAIN PROTEIN; FACTOR ASF/SF2; EXPRESSION; VARIANT; FAMILY; DEPHOSPHORYLATION; TRANSCRIPTION; MACHINERY; CANCER; CYR61	The removal of introns from mRNA precursors (pre-mRNAs) is an essential step in eukaryotic gene expression. The splicing machinery heavily contributes to biological complexity and especially to the ability of cells to adapt to altered cellular conditions. Inhibitory PAS domain protein (IPAS), a dominant negative regulator of hypoxia-inducible gene expression, is generated from hypoxia inducible transcription factor-3 alpha (HIF-3 alpha) pre-mRNA by an alternative splicing mechanism. Inactivation of the IPAS transcript in mice leads to the neo-vascularization of the cornea, suggesting that IPAS is an important regulator of anti-angiogenesis in this tissue. For the first time we demonstrate that serine-arginine (SR) proteins are involved in oxygen tension-dependent changes in pre-mRNA splicing. SR proteins isolated from hypoxic cells differentially interact with RNA (compared with proteins isolated from cells cultured under normoxic conditions). They possess the differential ability to activate hypoxia-dependent splice sites, and they are more phosphorylated than those isolated from normoxic HeLa cells. We also show that expression of SR protein kinases (CLK1, SRPK1, SRPK2) in hypoxic cells is elevated at mRNA and protein levels. Increased expression of CLK1 kinase is regulated by HIFs. Reduction of CLK1 cellular expression levels reduces hypoxia-dependent full-length carbonic anhydrase IX (CAIX) mRNA and CAIX protein formation and changes hypoxia-dependent cysteine-rich angiogenic inducer 61 (Cyr61) mRNA isoform formation profiles.	[Jakubauskiene, Egle; Vilys, Laurynas; Kanopka, Arvydas] Vilnius State Univ, Inst Biotechnol, Dept Immunol & Cell Biol, LT-02241 Vilnius, Lithuania; [Makino, Yuichi] Asahikawa Med Coll, Div Metab & Biosyst Sci, Dept Med, Asahikawa, Hokkaido 0788510, Japan; [Poellinger, Lorenz] Karolinska Inst, Med Nobel Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden; [Poellinger, Lorenz] Natl Univ Singapore, Canc Sci Inst, Singapore 117599, Singapore	Vilnius University; Asahikawa Medical College; Karolinska Institutet; National University of Singapore	Kanopka, A (corresponding author), Vilnius State Univ, Inst Biotechnol, Dept Immunol & Cell Biol, Graiciuno 8, LT-02241 Vilnius, Lithuania.	kanopka@ibt.lt			European Union [222741]	European Union(European Commission)	This work was supported by a European Union grant ("METOXIA" project 222741). The authors declare that they have no conflicts of interest with the contents of this article.	Barathova M, 2008, BRIT J CANCER, V98, P129, DOI 10.1038/sj.bjc.6604111; Cho SY, 2011, P NATL ACAD SCI USA, V108, P8233, DOI 10.1073/pnas.1017700108; Colwill K, 1996, EMBO J, V15, P265, DOI 10.1002/j.1460-2075.1996.tb00357.x; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Gang HY, 2011, CIRC RES, V108, P1084, DOI 10.1161/CIRCRESAHA.110.238709; Gardner LB, 2008, CELL CYCLE, V7, P1916, DOI 10.4161/cc.7.13.6203; Graveley BR, 1999, CURR BIOL, V9, pR6, DOI 10.1016/S0960-9822(99)80032-3; Graveley BR, 2000, RNA, V6, P1197, DOI 10.1017/S1355838200000960; Gu YZ, 1998, GENE EXPRESSION, V7, P205; Hang XY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-126; Hastings ML, 2001, CURR OPIN CELL BIOL, V13, P302, DOI 10.1016/S0955-0674(00)00212-X; Huang YQ, 2005, MOL CELL, V17, P613, DOI 10.1016/j.molcel.2005.02.020; Kanopka A, 1998, NATURE, V393, P185, DOI 10.1038/30277; KREIVI JP, 1991, NUCLEIC ACIDS RES, V19, P6956, DOI 10.1093/nar/19.24.6956; Lendahl U, 2009, NAT REV GENET, V10, P821, DOI 10.1038/nrg2665; Makino Y, 2002, J BIOL CHEM, V277, P32405, DOI 10.1074/jbc.C200328200; Makino Y, 2001, NATURE, V414, P550, DOI 10.1038/35107085; McManus CJ, 2011, CURR OPIN GENET DEV, V21, P373, DOI 10.1016/j.gde.2011.04.001; Minchenko OH, 2005, MOL CELL BIOCHEM, V280, P227, DOI 10.1007/s11010-005-8009-6; Muraki M, 2004, J BIOL CHEM, V279, P24246, DOI 10.1074/jbc.M314298200; Naro Chiara, 2013, Int J Cell Biol, V2013, P151839, DOI 10.1155/2013/151839; Ngo JCK, 2008, MOL CELL, V29, P563, DOI 10.1016/j.molcel.2007.12.017; Ngo JCK, 2005, MOL CELL, V20, P77, DOI 10.1016/j.molcel.2005.08.025; Perbal B, 2009, J CELL COMMUN SIGNAL, V3, P153, DOI 10.1007/s12079-009-0051-9; Pilarsky CP, 1998, PROSTATE, V36, P85; Prasad J, 1999, MOL CELL BIOL, V19, P6991; Ratcliffe PJ, 2013, J PHYSIOL-LONDON, V591, P2027, DOI 10.1113/jphysiol.2013.251470; Saltzman AL, 2011, GENE DEV, V25, P373, DOI 10.1101/gad.2004811; Sampath D, 2001, J CLIN ENDOCR METAB, V86, P1707, DOI 10.1210/jc.86.4.1707; Sanford JR, 1999, GENE DEV, V13, P1513, DOI 10.1101/gad.13.12.1513; Semenza GL, 2014, ANNU REV PATHOL-MECH, V9, P47, DOI 10.1146/annurev-pathol-012513-104720; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Sena JA, 2014, MOL CANCER RES, V12, P1233, DOI 10.1158/1541-7786.MCR-14-0149; Shepard PJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-242; Shi Y, 2007, MOL CELL, V28, P79, DOI 10.1016/j.molcel.2007.08.028; Smith CWJ, 2000, TRENDS BIOCHEM SCI, V25, P381, DOI 10.1016/S0968-0004(00)01604-2; Weidemann A, 2008, CELL DEATH DIFFER, V15, P621, DOI 10.1038/cdd.2008.12; Wu SP, 1997, EMBO J, V16, P4421, DOI 10.1093/emboj/16.14.4421; Xiao SH, 1998, EMBO J, V17, P6359, DOI 10.1093/emboj/17.21.6359; ZAHLER AM, 1992, GENE DEV, V6, P837, DOI 10.1101/gad.6.5.837	40	35	35	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					18079	18089		10.1074/jbc.M115.639690	http://dx.doi.org/10.1074/jbc.M115.639690			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26023237	Green Published, hybrid			2022-12-26	WOS:000358511700039
J	Date, K; Satoh, A; Iida, K; Ogawa, H				Date, Kimie; Satoh, Ayano; Iida, Kaoruko; Ogawa, Haruko			Pancreatic alpha-Amylase Controls Glucose Assimilation by Duodenal Retrieval through N-Glycan-specific Binding, Endocytosis, and Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIABETES-MELLITUS; EXOCRINE FUNCTION; STARCH DIGESTION; ACIDIFICATION; INTERNALIZATION; TRANSCYTOSIS; ABSORPTION; PATHWAYS; RECEPTOR; ENZYMES	alpha-Amylase, a major pancreatic protein and starch hydrolase, is essential for energy acquisition. Mammalian pancreatic alpha-amylase binds specifically to glycoprotein N-glycans in the brush-border membrane to activate starch digestion, whereas it significantly inhibits glucose uptake by Na+/glucose cotransporter 1 (SGLT1) at high concentrations (Asanuma-Date, K., Hirano, Y., Le, N., Sano, K., Kawasaki, N., Hashii, N., Hiruta, Y., Nakayama, K., Umemura, M., Ishikawa, K., Sakagami, H., and Ogawa, H. (2012) Functional regulation of sugar assimilation by N-glycan-specific interaction of pancreatic alpha-amylase with glycoproteins of duodenal brush border membrane. J. Biol. Chem. 287, 23104-23118). However, how the inhibition is stopped was unknown. Here, we show a new mechanism for the regulation of intestinal glucose absorption. Immunohistochemistry revealed that alpha-amylase in the duodena of non-fasted, but not fasted, pigs was internalized from the pancreatic fluid and immunostained. Wedemonstrated that after N-glycan binding, pancreatic alpha-amylase underwent internalization into lysosomes in a process that was inhibited by alpha-mannoside. The internalized alpha-amylase was degraded, showing low enzymatic activity and molecular weight at the basolateral membrane. In a human intestinal Caco-2 cell line, Alexa Fluor 488-labeled pancreatic alpha-amylase bound to the cytomembrane was transported to lysosomes through the endocytic pathway and then disappeared, suggesting degradation. Our findings indicate that N-glycan recognition by alpha-amylase protects enterocytes against a sudden increase in glucose concentration and restores glucose uptake by gradual internalization, which homeostatically controls the postprandial blood glucose level. The internalization of alpha-amylase may also enhance the supply of amino acids required for the high turnover of small intestine epithelial cells. This study provides novel and significant insights into the control of blood sugar during the absorption stage in the intestine.	[Date, Kimie; Iida, Kaoruko; Ogawa, Haruko] Ochanomizu Univ, Grad Sch Humanities & Sci, Bunkyo Ku, Tokyo 1128610, Japan; [Ogawa, Haruko] Ochanomizu Univ, Glycosci Inst, Bunkyo Ku, Tokyo 1128610, Japan; [Satoh, Ayano] Okayama Univ, Grad Sch Nat Sci & Technol, Kita Ku, Okayama 7008530, Japan	Ochanomizu University; Ochanomizu University; Okayama University	Ogawa, H (corresponding author), Ochanomizu Univ, Grad Sch Humanities & Sci, Bunkyo Ku, 2-1-1 Otsuka, Tokyo 1128610, Japan.	ogawa.haruko@ocha.ac.jp	Asanuma, Kimie/AAW-2543-2020; Satoh, Ayano/B-2423-2011	Asanuma, Kimie/0000-0003-4311-0544; Satoh, Ayano/0000-0003-3736-1283	Japan Society for the Promotion of Science [10385, 40058]; Dr. Yoshifumi Jigami Memorial Fund; Society of Yeast Scientists; Ministry of Education, Culture, Sports, Science, and Technology [22570111]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Dr. Yoshifumi Jigami Memorial Fund; Society of Yeast Scientists; Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Japan Society for the Promotion of Science Grants 10385 and 40058 (to K. D.) and the Dr. Yoshifumi Jigami Memorial Fund, the Society of Yeast Scientists (to K. D.), and Grant-in-aid for Scientific Research (C) 22570111 (to H. O.) from the Ministry of Education, Culture, Sports, Science, and Technology. The authors declare that they have no competing interests.	Ait-Slimane T, 2009, MOL BIOL CELL, V20, P3792, DOI 10.1091/mbc.E09-04-0275; Antileo E, 2013, AM J PHYSIOL-GASTR L, V304, pG655, DOI 10.1152/ajpgi.00472.2012; Asanuma-Date K, 2012, J BIOL CHEM, V287, P23104, DOI 10.1074/jbc.M111.314658; Barker N, 2014, NAT REV MOL CELL BIO, V15, P19, DOI 10.1038/nrm3721; BERNACKI E, 1976, ACTA PHYSIOL POL, V27, P337; BERNFELD P, 1951, ADV ENZYMOL REL S BI, V12, P379; Bose S, 2007, J PHYSIOL-LONDON, V581, P457, DOI 10.1113/jphysiol.2007.129171; Caballero B. E., 2013, ENCY HUMAN NUTR, P139; CAMMISOTTO PG, 2010, INT J CELL BIOL, V2010; Cammisotto PG, 2007, AM J PHYSIOL-GASTR L, V293, pG773, DOI 10.1152/ajpgi.00260.2007; CHAE C, 1995, J VET MED SCI, V57, P883, DOI 10.1292/jvms.57.883; Cloutier M, 2006, J HISTOCHEM CYTOCHEM, V54, P781, DOI 10.1369/jhc.5A6877.2006; GRAY GM, 1992, J NUTR, V122, P172, DOI 10.1093/jn/122.1.172; Guha S, 2008, INDIAN J BIOCHEM BIO, V45, P75; Hardt PD, 2003, PANCREATOLOGY, V3, P395, DOI 10.1159/000073655; HOFLACK B, 1985, J BIOL CHEM, V260, P2008; Howard A, 2004, J NUTR, V134, P2957, DOI 10.1093/jn/134.11.2957; Hubatsch I, 2007, NAT PROTOC, V2, P2111, DOI 10.1038/nprot.2007.303; HUGHSON EJ, 1990, J CELL BIOL, V110, P337, DOI 10.1083/jcb.110.2.337; Jiang RL, 2011, J CELL PHYSIOL, V226, P3022, DOI 10.1002/jcp.22650; KELLER PJ, 1967, J BIOL CHEM, V242, P281; KESSLER M, 1978, BIOCHIM BIOPHYS ACTA, V506, P136, DOI 10.1016/0005-2736(78)90440-6; Khoursandi S, 2004, AM J PHYSIOL-CELL PH, V287, pC1041, DOI 10.1152/ajpcell.00197.2004; Kipp H, 2003, AM J PHYSIOL-CELL PH, V285, pC737, DOI 10.1152/ajpcell.00041.2003; Kitazawa H, 2004, J BIOL CHEM, V279, P42867, DOI 10.1074/jbc.M408047200; KLUMPERMAN J, 1993, J CELL BIOL, V121, P997, DOI 10.1083/jcb.121.5.997; Larger E, 2012, DIABETIC MED, V29, P1047, DOI 10.1111/j.1464-5491.2012.03597.x; Leja-Szpak A, 2004, J PHYSIOL PHARMACOL, V55, P239; Lipschutz Joshua H, 2001, Curr Protoc Cell Biol, VChapter 15, DOI 10.1002/0471143030.cb1505s12; Matsushita H, 2002, J BIOL CHEM, V277, P4680, DOI 10.1074/jbc.M105877200; Mohammad-Panah R, 2003, J BIOL CHEM, V278, P29267, DOI 10.1074/jbc.M304357200; Nichols BL, 2003, P NATL ACAD SCI USA, V100, P1432, DOI 10.1073/pnas.0237170100; Nickavar B, 2013, IRAN J PHARM RES, V12, P57; ORLANDI PA, 1993, J BIOL CHEM, V268, P12010; Yadav R, 2013, J CLIN DIAGN RES, V7, P1291, DOI 10.7860/JCDR/2013/6016.3120; YAMASHIRO DJ, 1987, J CELL BIOL, V105, P2723, DOI 10.1083/jcb.105.6.2723; YAMASHIRO DJ, 1984, J CELL BIOCHEM, V26, P231, DOI 10.1002/jcb.240260404	37	17	19	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17439	17450		10.1074/jbc.M114.594937	http://dx.doi.org/10.1074/jbc.M114.594937			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	26023238	hybrid, Green Published			2022-12-26	WOS:000357730900036
J	Chen, L; Mu, ZC; Zhang, BQ; Zhang, Y				Chen, Long; Mu, Zhichun; Zhang, Baoqing; Zhang, Yi			Ear Recognition from One Sample Per Person	PLOS ONE			English	Article							SPARSE REPRESENTATION; FACE RECOGNITION; SHRINKAGE; IMAGE	Biometrics has the advantages of efficiency and convenience in identity authentication. As one of the most promising biometric-based methods, ear recognition has received broad attention and research. Previous studies have achieved remarkable performance with multiple samples per person (MSPP) in the gallery. However, most conventional methods are insufficient when there is only one sample per person (OSPP) available in the gallery. To solve the OSPP problem by maximizing the use of a single sample, this paper proposes a hybrid multi-keypoint descriptor sparse representation-based classification (MKD-SRC) ear recognition approach based on 2D and 3D information. Because most 3D sensors capture 3D data accessorizing the corresponding 2D data, it is sensible to use both types of information. First, the ear region is extracted from the profile. Second, keypoints are detected and described for both the 2D texture image and 3D range image. Then, the hybrid MKD-SRC algorithm is used to complete the recognition with only OSPP in the gallery. Experimental results on a benchmark dataset have demonstrated the feasibility and effectiveness of the proposed method in resolving the OSPP problem. A Rank-one recognition rate of 96.4% is achieved for a gallery of 415 subjects, and the time involved in the computation is satisfactory compared to conventional methods.	[Chen, Long; Mu, Zhichun; Zhang, Yi] Univ Sci & Technol Beijing, Sch Automat & Elect Engn, Beijing 100083, Peoples R China; [Zhang, Baoqing] Second Acad CASIC, Inst 208, Beijing, Peoples R China	University of Science & Technology Beijing; China Aerospace Science & Industry Corporation (CASIC)	Mu, ZC (corresponding author), Univ Sci & Technol Beijing, Sch Automat & Elect Engn, Beijing 100083, Peoples R China.	mu@ies.ustb.edu.cn			National Natural Science Foundation of China [61170116, 61472031, 61375010, 61300075]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This article is supported by the National Natural Science Foundation of China (Grant No. 61170116), the National Natural Science Foundation of China (Grant No. 61472031), the National Natural Science Foundation of China (Grant No. 61375010) and the National Natural Science Foundation of China (Grant No. 61300075). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaza A, 2013, ACM COMPUT SURV, V45, DOI 10.1145/2431211.2431221; Beck A, 2009, SIAM J IMAGING SCI, V2, P183, DOI 10.1137/080716542; Candes EJ, 2006, COMMUN PUR APPL MATH, V59, P1207, DOI 10.1002/cpa.20124; Chang K, 2003, IEEE T PATTERN ANAL, V25, P1160, DOI 10.1109/TPAMI.2003.1227990; Chen H, 2009, IEEE T PATTERN ANAL, V31, P172, DOI 10.1109/TPAMI.2008.176; Chen H, 2007, IEEE T PATTERN ANAL, V29, P718, DOI 10.1109/TPAMI.2007.1005; Dewi K, 2006, P COMP INT, P253; Donoho DL, 2008, IEEE T INFORM THEORY, V54, P4789, DOI 10.1109/TIT.2008.929958; Hoffman DD, 1997, COGNITION, V63, P29, DOI 10.1016/S0010-0277(96)00791-3; Islam SMS, 2011, INT J COMPUT VISION, V95, P52, DOI 10.1007/s11263-011-0436-0; Jain AK, 2004, IEEE T CIRC SYST VID, V14, P4, DOI 10.1109/TCSVT.2003.818349; Jain Anil K., 2007, HDB BIOMETRICS; Kisku Dakshina R., 2009, 2009 IEEE Computer Society Conference on Computer Vision and Pattern Recognition Workshops (CVPR Workshops), P60, DOI 10.1109/CVPR.2009.5204298; Kisku DR, 2009, 2009 INTERNATIONAL CONFERENCE ON ADVANCES IN COMPUTATIONAL TOOLS FOR ENGINEERING APPLICATIONS, P380, DOI 10.1109/ACTEA.2009.5227958; Kittler J., 2005, 2005 IEEE COMPUTER S, V00, P114, DOI DOI 10.1109/CVPR.2005.377; Koh KM, 2007, J MACH LEARN RES, V8, P1519; Kumar A, 2013, PATTERN RECOGN, V46, P73, DOI 10.1016/j.patcog.2012.06.020; Liao SC, 2013, IEEE T PATTERN ANAL, V35, P1193, DOI 10.1109/TPAMI.2012.191; Liu LZ, 2011, ADV MATER RES-SWITZ, V143-144, P287, DOI 10.4028/www.scientific.net/AMR.143-144.287; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Lu L, 2006, ICICIC 2006: FIRST INTERNATIONAL CONFERENCE ON INNOVATIVE COMPUTING, INFORMATION AND CONTROL, VOL 3, PROCEEDINGS, P353; Moreno B., 1999, Proceedings IEEE 33rd Annual 1999 International Carnahan Conference on Security Technology (Cat. No.99CH36303), P469, DOI 10.1109/CCST.1999.797956; Mu Z., 2005, ADV BIOMETRIC PERSON, V3338, P663; Naseem I, 2008, LECT NOTES COMPUT SC, V5359, P336, DOI 10.1007/978-3-540-89646-3_33; Park U, 2008, P SPIE DEF SEC S; Rattani A., 2007, 2007 1 IEEE INT C BI, P1, DOI DOI 10.1109/BTAS.2007.4401919; Rivera A R, 2014, LETTERS, V51, P94; Tan XY, 2006, PATTERN RECOGN, V39, P1725, DOI 10.1016/j.patcog.2006.03.013; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; TURK M, 1991, J COGNITIVE NEUROSCI, V3, P71, DOI 10.1162/jocn.1991.3.1.71; Tuytelaars T, 2007, FOUND TRENDS COMPUT, V3, P177, DOI 10.1561/0600000017; Unar JA, 2014, PATTERN RECOGN, V47, P2673, DOI 10.1016/j.patcog.2014.01.016; Victor B, 2002, INT C PATT RECOG, P429, DOI 10.1109/ICPR.2002.1044746; Wright J, 2009, IEEE T PATTERN ANAL, V31, P210, DOI 10.1109/TPAMI.2008.79; Wright SJ, 2009, IEEE T SIGNAL PROCES, V57, P2479, DOI 10.1109/TSP.2009.2016892; Yan P., 2005, 2005 IEEE COMP SOC C, P121; Yan P, 2007, IEEE T PATTERN ANAL, V29, P1297, DOI 10.1109/TPAMI.2007.1067; Yang JF, 2011, SIAM J SCI COMPUT, V33, P250, DOI 10.1137/090777761; Yuan L, 2009, PROCEEDINGS OF 2009 INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND CYBERNETICS, VOLS 1-6, P2414, DOI 10.1109/ICMLC.2009.5212166; Yuizono T, 2002, IEEE C EVOL COMPUTAT, P237, DOI 10.1109/CEC.2002.1006240; Zhang BQ, 2014, OPT ENG, V53, DOI 10.1117/1.OE.53.6.061702; Zhang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100120; Zhang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095506; Zhang XX, 2007, NEUROCOMPUTING, V70, P842, DOI 10.1016/j.neucom.2006.10.016; Zhao H, 2009, CHINESE J SCI INSTRU, V11	46	33	33	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0129505	10.1371/journal.pone.0129505	http://dx.doi.org/10.1371/journal.pone.0129505			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26024226	Green Published, gold, Green Submitted			2022-12-26	WOS:000355319400108
J	Iakovleva, I; Begum, A; Pokrzywa, M; Walfridsson, M; Sauer-Eriksson, AE; Olofsson, A				Iakovleva, Irina; Begum, Afshan; Pokrzywa, Malgorzata; Walfridsson, Malin; Sauer-Eriksson, A. Elisabeth; Olofsson, Anders			The Flavonoid Luteolin, but Not Luteolin-7-O-Glucoside, Prevents a Transthyretin Mediated Toxic Response	PLOS ONE			English	Article							FAMILIAL AMYLOID POLYNEUROPATHY; NATIVE-STATE; LIVER-TRANSPLANTATION; INHIBITORS; AMYLOIDOGENESIS; POTENT; DIFLUNISAL; TAFAMIDIS; CARDIOMYOPATHY; STABILIZATION	Transthyretin (TTR) is a homotetrameric plasma protein with amyloidogenic properties that has been linked to the development of familial amyloidotic polyneuropathy (FAP), familial amyloidotic cardiomyopathy, and senile systemic amyloidosis. The in vivo role of TTR is associated with transport of thyroxine hormone T4 and retinol-binding protein. Loss of the tetrameric integrity of TTR is a rate-limiting step in the process of TTR amyloid formation, and ligands with the ability to bind within the thyroxin binding site (TBS) can stabilize the tetramer, a feature that is currently used as a therapeutic approach for FAP. Several different flavonoids have recently been identified that impair amyloid formation. The flavonoid luteolin shows therapeutic potential with low incidence of unwanted side effects. In this work, we show that luteolin effectively attenuates the cytotoxic response to TTR in cultured neuronal cells and rescues the phenotype of a Drosophila melanogaster model of FAP. The plant-derived luteolin analogue cynaroside has a glucoside group in position 7 of the flavone A-ring and as opposed to luteolin is unable to stabilize TTR tetramers and thus prevents a cytotoxic effect. We generated high-resolution crystal-structures of both TTR wild type and the amyloidogenic mutant V30M in complex with luteolin. The results show that the A-ring of luteolin, in contrast to what was previously suggested, is buried within the TBS, consequently explaining the lack of activity from cynaroside. The flavonoids represent an interesting group of drug candidates for TTR amyloidosis. The present investigation shows the potential of luteolin as a stabilizer of TTR in vivo. We also show an alternative orientation of luteolin within the TBS which could represent a general mode of binding of flavonoids to TTR and is of importance concerning the future design of tetramer stabilizing drugs.	Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden; [Begum, Afshan; Sauer-Eriksson, A. Elisabeth] Umea Univ, Dept Chem, S-90187 Umea, Sweden; [Pokrzywa, Malgorzata] Airopt Sp Zoo ZIWT, PL-61612 Poznan, Poland	Umea University; Umea University	Olofsson, A (corresponding author), Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden.	anders.olofsson@medchem.umu.se	Pokrzywa, Małgorzata/GQA-6257-2022	Sauer-Eriksson, Elisabeth/0000-0003-0124-0199; BEGUM, AFSHAN/0000-0001-5047-5168	Swedish Research Council; Parkinsonfonden; Insamlingsstiftelsen vid Umea Universitet; Alzheimerfonden; J.C. Kempes stiftelse; Hjarnfonden; Magnus-Bergvalls stiftelse; O.E. och Edlas stiftelse; Torsten Soderbergs stiftelse; Vasterbottens Lans lasting; Patientforeningen FAMY/AMYL; Medical Faculty of Umea University	Swedish Research Council(Swedish Research CouncilEuropean Commission); Parkinsonfonden; Insamlingsstiftelsen vid Umea Universitet; Alzheimerfonden; J.C. Kempes stiftelse; Hjarnfonden; Magnus-Bergvalls stiftelse; O.E. och Edlas stiftelse; Torsten Soderbergs stiftelse; Vasterbottens Lans lasting; Patientforeningen FAMY/AMYL; Medical Faculty of Umea University	The authors thank the Swedish Research Council (www.vr.se), Parkinsonfonden (www.parkinsonfonden.se), Insamlingsstiftelsen vid Umea Universitet (www.medforsk.org.umu.se/), Alzheimerfonden (www.alzheimerfonden.se), J.C. Kempes stiftelse (www.kempe.com, Hjarnfonden (www.hjarnfonden.se), Magnus-Bergvalls stiftelse (www.magnbergvallsstiftelse.nu/), O.E. och Edlas stiftelse, Torsten Soderbergs stiftelse (www.torstensoderbergsstiftelse.se), Vasterbottens Lans lasting (ALF-medel), Patientforeningen FAMY/AMYL (www.famy.se), and the Medical Faculty of Umea University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Airoptic Sp provided support in the form of a salary for author MP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adamski-Werner SL, 2004, J MED CHEM, V47, P355, DOI 10.1021/jm030347n; Bastianetto S, 2011, CURR ALZHEIMER RES, V8, P445, DOI 10.2174/156720511796391854; Berk JL, 2013, JAMA-J AM MED ASSOC, V310, P2658, DOI 10.1001/jama.2013.283815; Bulawa CE, 2012, P NATL ACAD SCI USA, V109, P9629, DOI 10.1073/pnas.1121005109; Cardoso I, 2007, BIOCHEM J, V408, P131, DOI 10.1042/BJ20070689; Coelho T, 2013, J NEUROL, V260, P2802, DOI 10.1007/s00415-013-7051-7; Coelho T, 2013, NEW ENGL J MED, V369, P819, DOI 10.1056/NEJMoa1208760; Coelho T, 2012, NEUROLOGY, V79, P785, DOI 10.1212/WNL.0b013e3182661eb1; Colon W, 1996, CIBA F SYMP, V199, P228; Connelly S, 2010, CURR OPIN STRUC BIOL, V20, P54, DOI 10.1016/j.sbi.2009.12.009; Connors LH, 2003, AMYLOID, V10, P160, DOI 10.3109/13506120308998998; Dajas Federico, 2013, Central Nervous System Agents in Medicinal Chemistry, V13, P30; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Foss TR, 2005, J MOL BIOL, V347, P841, DOI 10.1016/j.jmb.2005.01.050; Gavrin LK, 2012, J MED CHEM, V55, P10823, DOI 10.1021/jm301182j; Green NS, 2003, J AM CHEM SOC, V125, P13404, DOI 10.1021/ja030294z; Grimster NP, 2013, J AM CHEM SOC, V135, P5656, DOI 10.1021/ja311729d; Hammarstrom P, 2001, SCIENCE, V293, P2459, DOI 10.1126/science.1062245; Hornberg A, 2000, J MOL BIOL, V302, P649, DOI 10.1006/jmbi.2000.4078; Ihse E, 2013, AMYLOID, V20, P142, DOI 10.3109/13506129.2013.797890; Johnson SM, 2005, J MED CHEM, V48, P1576, DOI 10.1021/jm049274d; Johnson SM, 2009, J MED CHEM, V52, P1115, DOI 10.1021/jm801347s; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kalkunte SS, 2013, AM J PATHOL, V183, P1425, DOI 10.1016/j.ajpath.2013.07.022; Lai ZH, 1996, BIOCHEMISTRY-US, V35, P6470, DOI 10.1021/bi952501g; Lindhagen-Persson M, 2008, AMYLOID, V15, P240, DOI 10.1080/13506120802524916; Lu XY, 2011, PHARMAZIE, V66, P600, DOI 10.1691/ph.2011.1517; MCCUTCHEN SL, 1993, BIOCHEMISTRY-US, V32, P12119, DOI 10.1021/bi00096a024; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Miller SR, 2004, LAB INVEST, V84, P545, DOI 10.1038/labinvest.3700059; Miroy GJ, 1996, P NATL ACAD SCI USA, V93, P15051, DOI 10.1073/pnas.93.26.15051; Morais-de-Sa E, 2004, J BIOL CHEM, V279, P53483, DOI 10.1074/jbc.M408053200; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Okamoto S, 2011, AMYLOID, V18, P200, DOI 10.3109/13506129.2011.615872; Penchala SC, 2013, P NATL ACAD SCI USA, V110, P9992, DOI 10.1073/pnas.1300761110; Pokrzywa M, 2007, EUR J NEUROSCI, V26, P913, DOI 10.1111/j.1460-9568.2007.05728.x; Pokrzywa M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014343; Reixach N, 2004, P NATL ACAD SCI USA, V101, P2817, DOI 10.1073/pnas.0400062101; Reixach N, 2006, BIOCHEM BIOPH RES CO, V348, P889, DOI 10.1016/j.bbrc.2006.07.109; Sant'Anna RO, 2013, INT J MOL SCI, V14, P5284, DOI 10.3390/ijms14035284; Sekijima Y, 2005, CELL, V121, P73, DOI 10.1016/j.cell.2005.01.018; Sekijima Y, 2008, CURR PHARM DESIGN, V14, P3219, DOI 10.2174/138161208786404155; Sharma P, 2003, LIVER TRANSPLANT, V9, P1273, DOI 10.1016/j.lts.2003.09.016; Taliou A, 2013, CLIN THER, V35, P592, DOI 10.1016/j.clinthera.2013.04.006; Trivella DBB, 2012, J STRUCT BIOL, V180, P143, DOI 10.1016/j.jsb.2012.07.008; Trivella DBB, 2011, J STRUCT BIOL, V173, P323, DOI 10.1016/j.jsb.2010.10.003; TURNER RA, 1986, CLIN THER, V9, P37; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yokoyama T, 2014, J MED CHEM, V57, P1090, DOI 10.1021/jm401832j	52	22	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128222	10.1371/journal.pone.0128222	http://dx.doi.org/10.1371/journal.pone.0128222			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020516	Green Published, Green Submitted, gold			2022-12-26	WOS:000355187300089
J	Liu, YX; Pang, CK; Liu, Y; Sun, XB; Li, XX; Jiang, SW; Xue, FZ				Liu, Yun-Xia; Pang, Chun-Kun; Liu, Yanxun; Sun, Xiu-Bin; Li, Xin-Xu; Jiang, Shi-Wen; Xue, Fuzhong			Association between Multidrug-Resistant Tuberculosis and Risk Factors in China: Applying Partial Least Squares Path Modeling	PLOS ONE			English	Article							DRUG-RESISTANCE; PREVALENCE; PLS	Background Multidrug-resistant tuberculosis (MDR-TB) resulting from various factors has raised serious public health concerns worldwide. Identifying the ecological risk factors associated with MDR-TB is critical to its prevention and control. This study aimed to explore the association between the development of MDR-TB and the risk factors at the group-level (ecological risk factors) in China. Methods Data on MDR-TB in 120 counties were obtained from the National Tuberculosis Information Management System, and data on risk-factor variables were extracted from the Health Statistical Yearbook, provincial databases, and the meteorological bureau of each province (municipality). Partial Least Square Path Modeling was used to detect the associations. Results The median proportion of MDR-TB in new TB cases was 3.96% (range, 0-39.39%). Six latent factors were extracted from the ecological risk factors, which explained 27.60% of the total variance overall in the prevalence of MDR-TB. Based on the results of PLS-PM, TB prevention, health resources, health services, TB treatment, TB detection, geography and climate factors were all associated with the risk of MDR-TB, but socioeconomic factors were not significant. Conclusions The development of MDR-TB was influenced by TB prevention, health resources, health services, TB treatment, TB detection, geography and climate factors. Such information may help us to establish appropriate public health intervention strategies to prevent and control MDR-TB and yield benefits to the entire public health system in China.	[Liu, Yun-Xia; Liu, Yanxun; Sun, Xiu-Bin; Xue, Fuzhong] Shandong Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Jinan 250100, Peoples R China; [Pang, Chun-Kun] Shandong Acad Med Sci, Inst Off, Jinan, Peoples R China; [Li, Xin-Xu; Jiang, Shi-Wen] Chinese Ctr Dis Control & Prevent, Inst TB Control & Prevent, Beijing, Peoples R China	Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan; Chinese Center for Disease Control & Prevention	Xue, FZ (corresponding author), Shandong Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Jinan 250100, Peoples R China.	xuefzh@sdu.edu.cn	Xue, Fuzhong/AAG-4808-2020	Xue, Fuzhong/0000-0003-0378-7956	National Natural Science Foundation of China [81001292]; National Special Science and Technology Major Projects [2008ZX10003-007]; China postdoctoral Science Foundation [2013M531619]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Special Science and Technology Major Projects; China postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This study was funded by grants from the National Natural Science Foundation of China (no. 81001292), the National Special Science and Technology Major Projects (no. 2008ZX10003-007), and the China postdoctoral Science Foundation (2013M531619).	Amin MN, 2009, IBRAHIM MED COLL J, V3, P29, DOI DOI 10.3329/imcj.v3i1.2917; Caws M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000034; Chen K, 2007, EPIDEMIOLOGY DESCRIP; Cohen T, 2014, DRUG RESIST UPDATE, V17, P105, DOI 10.1016/j.drup.2014.10.001; Ejaz M, 2010, T ROY SOC TROP MED H, V104, P511, DOI 10.1016/j.trstmh.2010.03.005; Espinal MA, 2001, INT J TUBERC LUNG D, V5, P887; Farazi A, 2013, CASP J INTERN MED, V4, P785; Faustini A, 2006, THORAX, V61, P158, DOI 10.1136/thx.2005.045963; FRANCIS DJ, 1988, J CLIN EXP NEUROPSYC, V10, P623, DOI 10.1080/01688638808402800; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Gaude Gajanan S, 2014, Niger Med J, V55, P327, DOI 10.4103/0300-1652.137194; Harling G, 2008, SOC SCI MED, V66, P492, DOI 10.1016/j.socscimed.2007.08.026; Horna-Campos OJ, 2010, INT J TUBERC LUNG D, V14, P714; Huang F., 2011, CHINA DIGIT MED, V6, P97, DOI [10.3969/j.issn.1673-7571.2011.10.032, DOI 10.3969/J.ISSN.1673-7571.2011.10.032]; Hulland J, 1999, STRATEGIC MANAGE J, V20, P195, DOI 10.1002/(SICI)1097-0266(199902)20:2<195::AID-SMJ13>3.3.CO;2-Z; ISEMAN MD, 1993, NEW ENGL J MED, V329, P784, DOI 10.1056/NEJM199309093291108; Liu Q, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1171; Liu YX, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-50; Hang NTL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071867; Norris M, 2010, J AUTISM DEV DISORD, V40, P8, DOI 10.1007/s10803-009-0816-2; Pritchard AJ, 2003, EPIDEMIOL INFECT, V130, P481, DOI 10.1017/S0950268803008367; Rifat M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105214; Skrahina A, 2013, B WORLD HEALTH ORGAN, V91, P36, DOI 10.2471/BLT.12.104588; Tanrikulu AC, 2008, TROP DOCT, V38, P91, DOI 10.1258/td.2007.070131; Tanrikulu AC, 2010, MED SCI MONITOR, V16, pPH57; Tenenhaus M, 2005, COMPUT STAT DATA AN, V48, P159, DOI 10.1016/j.csda.2004.03.005; Tenenhaus M, 2008, TOTAL QUAL MANAG BUS, V19, P871, DOI 10.1080/14783360802159543; Terlikbayeva A, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-262; Ulmasova DJ, 2013, EUROSURVEILLANCE, V18, P5, DOI 10.2807/1560-7917.ES2013.18.42.20609; Vashakidze L, 2009, INT J TUBERC LUNG D, V13, P1148; Wardani DWSR, 2014, OPEN J EPIDEMIOLOGY, V4, P76, DOI DOI 10.4236/OJEPI.2014.420; Weiss RA, 2004, NAT MED, V10, pS70, DOI 10.1038/nm1150; WHO, 1998, INT J TUBERC LUNG D, V2, P71; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2014, GLOB TUB REP 2014; World Health Organization, DRUG RES TB SURV R S; World Health Organization, 1994, 1 WHO; Zhang JF, 2002, MED MULTIVARIATE STA; Zhao YL, 2012, NEW ENGL J MED, V366, P2161, DOI 10.1056/NEJMoa1108789	39	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128298	10.1371/journal.pone.0128298	http://dx.doi.org/10.1371/journal.pone.0128298			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020921	gold, Green Submitted, Green Published			2022-12-26	WOS:000355187300098
J	Tornevi, A; Barregard, L; Forsberg, B				Tornevi, Andreas; Barregard, Lars; Forsberg, Bertil			Precipitation and Primary Health Care Visits for Gastrointestinal Illness in Gothenburg, Sweden	PLOS ONE			English	Article							DRINKING-WATER TURBIDITY; EXTREME PRECIPITATION; UNITED-STATES; ASSOCIATION; OUTBREAKS; RAINFALL; DISEASE	Background The river Gota Alv is a source of freshwater for the City of Gothenburg, Sweden, and we recently identified a clear influence of upstream precipitation on concentrations of indicator bacteria in the river water, as well as an association with the daily number of phone calls to the nurse advice line related to acute gastrointestinal illnesses (AGI calls). This study aimed to examine visits to primary health-care centers owing to similar symptoms (AGI visits) in the same area, to explore associations with precipitation, and to compare variability in AGI visits and AGI calls. Methods We obtained data covering six years (2007-2012) of daily AGI visits and studied their association with prior precipitation (0-28 days) using a distributed lag nonlinear Poisson regression model, adjusting for seasonal patterns and covariates. In addition, we studied the effects of prolonged wet and dry weather on AGI visits. We analyzed lagged short-term relations between AGI visits and AGI calls, and we studied differences in their seasonal patterns using a binomial regression model. Results The study period saw a total of 17,030 AGI visits, and the number of daily visits decreased on days when precipitation occurred. However, prolonged wet weather was associated with an elevated number of AGI visits. Differences in seasonality patterns were observed between AGI visits and AGI calls, as visits were relatively less frequent during winter and relatively more frequent in August, and only weak short-term relations were found. Conclusion AGI visits and AGI calls seems to partly reflect different types of AGI illnesses, and the patients' choice of medical contact (in-person visits versus phone calls) appears to depend on current weather conditions. An association between prolonged wet weather and increased AGI visits supports the hypothesis that the drinking water is related to an increased risk of AGI illnesses.	[Tornevi, Andreas; Forsberg, Bertil] Umea Univ, Dept Publ Hlth & Clin Med, Div Occupat & Environm Med, Umea, Sweden; [Barregard, Lars] Univ Gothenburg, Dept Publ Hlth & Community Med, Div Occupat & Environm Med, Gothenburg, Sweden	Umea University; University of Gothenburg	Tornevi, A (corresponding author), Umea Univ, Dept Publ Hlth & Clin Med, Div Occupat & Environm Med, Umea, Sweden.	andreas.tornevi@envmed.umu.se			Swedish Water & Wastewater Association; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning	Swedish Water & Wastewater Association; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas)	The Swedish Water & Wastewater Association; The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aramini J, 2000, Can Commun Dis Rep, V26, P211; Bush KF, 2014, ENVIRON HEALTH PERSP, V122, P249, DOI 10.1289/ehp.1306807; Chui KKH, 2011, AM J PUBLIC HEALTH, V101, P2082, DOI 10.2105/AJPH.2010.300096; Curriero FC, 2001, AM J PUBLIC HEALTH, V91, P1194, DOI 10.2105/AJPH.91.8.1194; Drayna P, 2010, ENVIRON HEALTH PERSP, V118, P1439, DOI 10.1289/ehp.0901671; Gasparrini A, 2010, STAT MED, V29, P2224, DOI 10.1002/sim.3940; Leclerc H, 2002, CRIT REV MICROBIOL, V28, P371, DOI 10.1080/1040-840291046768; Mendel V., 2005, THESIS CHALMERS U TE; Morris RD, 1996, AM J PUBLIC HEALTH, V86, P237, DOI 10.2105/AJPH.86.2.237; Naumova Elena N., 2005, Journal of Water and Health, V3, P185; Nichols G, 2009, J WATER HEALTH, V7, P1, DOI 10.2166/wh.2009.143; Reynolds KA, 2008, REV ENVIRON CONTAM T, V192, P117, DOI 10.1007/978-0-387-71724-1_4; Schwartz J, 2000, J EPIDEMIOL COMMUN H, V54, P45, DOI 10.1136/jech.54.1.45; Schwartz J, 1997, EPIDEMIOLOGY, V8, P615, DOI 10.1097/00001648-199710000-00001; Swedish Commission on Climate and Vulnerability, 2007, SWED GOV OFF REP, VSOU 2007:60; Team R, 2007, R LANG ENV STAT COMP; Thomas MK, 2006, INT J ENVIRON HEAL R, V16, P167, DOI 10.1080/09603120600641326; Tinker SC, 2010, J EXPO SCI ENV EPID, V20, P19, DOI 10.1038/jes.2008.68; Toljander J., 2012, Journal of Public Health and Epidemiology, V4, P30; Tornevi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098546; Tornevi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069918; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x	22	9	9	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128487	10.1371/journal.pone.0128487	http://dx.doi.org/10.1371/journal.pone.0128487			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0SC	26020929	gold, Green Published, Green Submitted			2022-12-26	WOS:000355187300116
J	Fujiwara, K; Koyama, K; Suga, K; Ikemura, M; Saito, Y; Hino, A; Iwanari, H; Kusano-Arai, O; Mitsui, K; Kasahara, H; Fukayama, M; Kodama, T; Hamakubo, T; Momose, T				Fujiwara, Kentaro; Koyama, Keitaro; Suga, Kosuke; Ikemura, Masako; Saito, Yasutaka; Hino, Akihiro; Iwanari, Hiroko; Kusano-Arai, Osamu; Mitsui, Kenichi; Kasahara, Hiroyuki; Fukayama, Masashi; Kodama, Tatsuhiko; Hamakubo, Takao; Momose, Toshimitsu			Y-90-Labeled Anti-ROBO1 Monoclonal Antibody Exhibits Antitumor Activity against Small Cell Lung Cancer Xenografts	PLOS ONE			English	Article							PHASE I/II; RADIOIMMUNOTHERAPY; CARCINOMA; ANTIGEN; Y-90; RECEPTORS; MIGRATION; ROBO1	Introduction ROBO1 is a membrane protein that contributes to tumor metastasis and angiogenesis. We previously reported that Y-90-labeled anti-ROBO1 monoclonal antibody (Y-90-anti-ROBO1 IgG) showed an antitumor effect against ROBO1-positive tumors. In this study, we performed a biodistribution study and radioimmunotherapy (RIT) against ROBO1-positive small cell lung cancer (SCLC) models. Methods For the biodistribution study, In-111-labeled anti-ROBO1 monoclonal antibody (In-111-anti-ROBO1 IgG) was injected into ROBO1-positive SCLC xenograft mice via the tail vein. To evaluate antitumor effects, an RIT study was performed, and SCLC xenograft mice were treated with Y-90-anti-ROBO1 IgG. Tumor volume and body weight were periodically measured throughout the experiments. The tumors and organs of mice were then collected, and a pathological analysis was carried out. Results As a result of the biodistribution study, we observed tumor uptake of In-111-anti-ROBO1 IgG. The liver, kidney, spleen, and lung showed comparably high accumulation of In-111-labeled anti-ROBO1. In the RIT study, Y-90-anti-ROBO1 IgG significantly reduced tumor volume compared with baseline. Pathological analyses of tumors revealed coagulation necrosis and fatal degeneration of tumor cells, significant reduction in the number of Ki-67-positive cells, and an increase in the number of apoptotic cells. A transient reduction of hematopoietic cells was observed in the spleen, sternum, and femur. Conclusions These results suggest that RIT with Y-90-anti-ROBO1 IgG is a promising treatment for ROBO1-positive SCLC.	[Fujiwara, Kentaro; Koyama, Keitaro; Momose, Toshimitsu] Univ Tokyo, Grad Sch Med, Dept Radiol, Bunkyo Ku, Tokyo, Japan; [Suga, Kosuke] SANKYO LABO SERV Co Ltd, Edogawa Ku, Tokyo, Japan; [Ikemura, Masako; Fukayama, Masashi] Univ Tokyo, Grad Sch Med, Dept Pathol, Bunkyo Ku, Tokyo, Japan; [Saito, Yasutaka; Hino, Akihiro; Kasahara, Hiroyuki] FUJIFILM RI Pharma Co Ltd, Sammu City, Chiba, Japan; [Iwanari, Hiroko; Kusano-Arai, Osamu; Mitsui, Kenichi; Hamakubo, Takao] Univ Tokyo, Res Ctr Adv Sci & Technol, Dept Quantitat Biol & Med, Meguro Ku, Tokyo, Japan; [Kodama, Tatsuhiko] Univ Tokyo, Res Ctr Adv Sci & Technol, Dept Syst Biol & Med, Meguro Ku, Tokyo, Japan	University of Tokyo; University of Tokyo; Fujifilm Corporation; University of Tokyo; University of Tokyo	Momose, T (corresponding author), Univ Tokyo, Grad Sch Med, Dept Radiol, Bunkyo Ku, Tokyo, Japan.	tmomo-tky@umin.ac.jp			Japan Society for the Promotion of Science (JSPS) through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program); Council for Science and Technology Policy (CSTP); SANKYO LABO SERVICE Co., Ltd.	Japan Society for the Promotion of Science (JSPS) through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Council for Science and Technology Policy (CSTP)(Council for Science and Technology Policy (CSTP)); SANKYO LABO SERVICE Co., Ltd.	This research was supported by a grant from the Japan Society for the Promotion of Science (JSPS) through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)," initiated by the Council for Science and Technology Policy (CSTP). Co-authors Yasutaka Saito, Akihiro Hino and Hiroyuki Kasahara are employed by FUJIFILM RI Pharma Co., Ltd. FUJIFILM RI Pharma Co., Ltd. joined this study as a collaborating company in the Japan Society for the Promotion of Science through the "Funding Program for World-Leading Innovative R&D on Science and Technology." It was responsible for radiolabelling of antibodies. Co-author Kosuke Suga is employed by SANKYO LABO SERVICE Co., Ltd. SANKYO LABO SERVICE Co., Ltd. provided support in the form of salary for author KS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Al-Ejeh F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004630; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Brouwers AH, 2004, J NUCL MED, V45, P327; Dubben HH, 1998, RADIOTHER ONCOL, V47, P167, DOI 10.1016/S0167-8140(97)00215-6; Forrer F, 2013, J NUCL MED, V54, P1045, DOI 10.2967/jnumed.112.115170; Fujiwara K, 2014, EJNMMI RES, V4, DOI 10.1186/s13550-014-0029-3; GOLDENBERG DM, 1993, AM J MED, V94, P297, DOI 10.1016/0002-9343(93)90062-T; HUI TE, 1994, CANCER, V73, P951; Ito H, 2006, CLIN CANCER RES, V12, P3257, DOI 10.1158/1078-0432.CCR-05-2787; Jhanwar YS, 2005, J NUCL MED, V46, p141S; Kalemkerian GP, 2011, J NATL COMPR CANC NE, V9, P1086, DOI 10.6004/jnccn.2011.0092; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Lobo ED, 2004, J PHARM SCI-US, V93, P2645, DOI 10.1002/jps.20178; Mertsch S, 2008, J NEURO-ONCOL, V87, P1, DOI 10.1007/s11060-007-9484-2; Milenic DE, 2004, NAT REV DRUG DISCOV, V3, P488, DOI 10.1038/nrd1413; Onthank DC, 2004, BIOCONJUGATE CHEM, V15, P235, DOI 10.1021/bc034108q; Oriuchi N, 1998, CANCER IMMUNOL IMMUN, V46, P311, DOI 10.1007/s002620050492; PARK CH, 1987, NUCL MED COMMUN, V8, P1075, DOI 10.1097/00006231-198712000-00018; Scott AM, 2005, J CLIN ONCOL, V23, P4567, DOI 10.1200/JCO.2005.01.903; Sharkey RM, 2005, J NUCL MED, V46, p115S; Stabin MG, 1996, J NUCL MED, V37, P538; Staudacher AH, 2014, EJNMMI RES, V4, DOI 10.1186/2191-219X-4-2; Takahashi K, 2010, RADIAT RES, V173, P184, DOI 10.1667/RR1839.1; Takai T, 2002, NAT REV IMMUNOL, V2, P580, DOI 10.1038/nri856; USUDA S, 1986, J IMMUNOL METHODS, V87, P203, DOI 10.1016/0022-1759(86)90532-6; van Meerbeeck JP, 2011, LANCET, V378, P1741, DOI 10.1016/S0140-6736(11)60165-7; Veeravagu A, 2008, CLIN CANCER RES, V14, P7330, DOI 10.1158/1078-0432.CCR-08-0797; Wang B, 2003, CANCER CELL, V4, P19, DOI 10.1016/S1535-6108(03)00164-8; Wiseman GA, 2000, EUR J NUCL MED, V27, P766, DOI 10.1007/s002590000276; Xian J, 2004, CANCER RES, V64, P6432, DOI 10.1158/0008-5472.CAN-04-2561; Xu Y, 2010, NEUROSCI BULL, V26, P474, DOI 10.1007/s12264-010-0730-9; Yoshida C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059248; Zhan JB, 2013, EXPERT OPIN INV DRUG, V22, P235, DOI 10.1517/13543784.2013.750293	33	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0125468	10.1371/journal.pone.0125468	http://dx.doi.org/10.1371/journal.pone.0125468			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26017283	Green Published, gold, Green Submitted			2022-12-26	WOS:000355185600023
J	Jancic, S; Nguyen, HDT; Frisvad, JC; Zalar, P; Schroers, HJ; Seifert, KA; Gunde-Cimerman, N				Jancic, Saso; Nguyen, Hai D. T.; Frisvad, Jens C.; Zalar, Polona; Schroers, Hans-Josef; Seifert, Keith A.; Gunde-Cimerman, Nina			Taxonomic Revision of the Wallemia sebi Species Complex	PLOS ONE			English	Article							FARMERS LUNG-DISEASE; METABOLITE PRODUCTION; GENUS WALLEMIA; WATER ACTIVITY; ENVIRONMENTS; DIVERSITY; PHYLOGENY; LIFE; TEMPERATURE; PREVALENCE	Wallemia sebi is a xerophilic food-and air-borne fungus. The name has been used for strains that prevail in cold, temperate and tropical climates. In this study, multi-locus phylogenetic analyses, using the internal transcribed spacer (ITS) regions, DNA replication licensing factor (MCM7), pre-rRNA processing protein (TSR1), RNA polymerase II largest subunit (RPB1), RNA polymerase II second largest subunit (RPB2) and a new marker 3'-phosphoadenosine-5'-phosphatase (HAL2), confirmed the previous hypothesis that W. sebi presents a complex of at least four species. Here, we confirm and apply the phylogenetic analyses based species hypotheses from a companion study to guide phenotypic assessment of W. sebi like strains from a wide range of substrates, climates and continents allowed the recognition of W. sebi sensu stricto and three new species described as W. mellicola, W. Canadensis, and W. tropicalis. The species differ in their conidial size, xerotolerance, halotolerance, chaotolerance, growth temperature regimes, extracellular enzyme activity profiles, and secondary metabolite patterns. A key to all currently accepted Wallemia species is provided that allow their identification on the basis of physiological, micromorphological and culture characters.	[Jancic, Saso; Zalar, Polona; Gunde-Cimerman, Nina] Univ Ljubljana, Dept Biol, Biotech Fac, Ljubljana, Slovenia; [Nguyen, Hai D. T.; Seifert, Keith A.] Univ Ottawa, Dept Biol, Fac Sci, Ottawa, ON, Canada; [Frisvad, Jens C.] Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Schroers, Hans-Josef] Agr Inst Slovenia, Ljubljana, Slovenia; [Seifert, Keith A.] Agr & Agri Food Canada, Eastern Cereal & Oilseed Res Ctr, Biodivers Mycol, Ottawa, ON, Canada; [Gunde-Cimerman, Nina] Ctr Excellence Integrated Approaches Chem & Biol, Ljubljana, Slovenia	University of Ljubljana; University of Ottawa; Technical University of Denmark; Agricultural Institute Slovenia; Agriculture & Agri Food Canada	Gunde-Cimerman, N (corresponding author), Univ Ljubljana, Dept Biol, Biotech Fac, Ljubljana, Slovenia.	ninagunde-cimerman@bf.uni-lj.si	Frisvad, Jens C/K-2818-2017	Frisvad, Jens C/0000-0002-0573-4340; Gunde-Cimerman, Nina/0000-0002-9464-3263	Slovenian Research Agency through the Infrastructural Centre Mycosmo; Slovenian Ministry of Higher Education, Science and Technology; European Regional Development Fund through the Centre of Excellence for Integrated Approaches in Chemistry and Biology of Proteins (CIPKeBiP) [OP13.1.1.2.02.0005]; Alfred P. Sloan Foundation Program on the Microbiology of the Built Environment; FP7 Project CropSustaIn [FP7-REGPOT-CT2012-316205];  [1000-11-310102]	Slovenian Research Agency through the Infrastructural Centre Mycosmo; Slovenian Ministry of Higher Education, Science and Technology; European Regional Development Fund through the Centre of Excellence for Integrated Approaches in Chemistry and Biology of Proteins (CIPKeBiP); Alfred P. Sloan Foundation Program on the Microbiology of the Built Environment(Alfred P. Sloan Foundation); FP7 Project CropSustaIn; 	This work was funded by the Slovenian Research Agency (https://www.arrs.gov.si/en/dobrodoslica.asp) through the Infrastructural Centre Mycosmo (http://www.ex-genebank.com/) and the Young Researcher Grant to SJ, 1000-11-310102. This work was partly funded by Slovenian Ministry of Higher Education, Science and Technology (http://www.arhiv.mvzt.gov.si/en/) and European Regional Development Fund through the Centre of Excellence for Integrated Approaches in Chemistry and Biology of Proteins (CIPKeBiP, http://cipkebip.org/, OP13.1.1.2.02.0005), and by grants to KAS and HDTN from the Alfred P. Sloan Foundation Program on the Microbiology of the Built Environment (http://www.sloan.org/major-program-areas/). Parts of this work were realized within the frame of FP7 Project CropSustaIn (FP7-REGPOT-CT2012-316205). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amend AS, 2010, P NATL ACAD SCI USA, V107, P13748, DOI 10.1073/pnas.1000454107; [Anonymous], 2002, PAUP 4 0 PHYLOGENETI; [Anonymous], 1997, FUNGI FOOD SPOILAGE; Botic T, 2012, FEMS MICROBIOL LETT, V326, P40, DOI 10.1111/j.1574-6968.2011.02428.x; Brizzio S, 2007, CAN J MICROBIOL, V53, P519, DOI 10.1139/W07-010; Cantrell SA, 2013, MYCOLOGIA, V105, P827, DOI 10.3852/12-288; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; de Garcia V, 2012, FEMS MICROBIOL ECOL, V82, P523, DOI 10.1111/j.1574-6941.2012.01465.x; Desroches TC, 2014, INDOOR AIR, P1, DOI [10.1111/ina.12081, DOI 10.1111/INA.12081]; Frank M, 1999, TETRAHEDRON LETT, V40, P133, DOI 10.1016/S0040-4039(98)80039-7; FRISVAD JC, 1987, J CHROMATOGR, V404, P195, DOI 10.1016/S0021-9673(01)86850-3; Frisvad JC, 2008, MYCOL RES, V112, P231, DOI 10.1016/j.mycres.2007.08.018; Frisvad Jens C, 2012, Methods Mol Biol, V944, P47, DOI 10.1007/978-1-62703-122-6_3; Frohlich-Nowoisky J, 2009, P NATL ACAD SCI USA, V106, P12814, DOI 10.1073/pnas.0811003106; Gams W, 1998, CBS COURSE MYCOLOGY; Gock MA, 2003, INT J FOOD MICROBIOL, V81, P11, DOI 10.1016/S0168-1605(02)00166-6; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guarro J, 2008, J CLIN MICROBIOL, V46, P1129, DOI 10.1128/JCM.01920-07; Hallsworth JE, 2007, ENVIRON MICROBIOL, V9, P801, DOI 10.1111/j.1462-2920.2006.01212.x; HANHELA R, 1995, SCAND J WORK ENV HEA, V21, P223, DOI 10.5271/sjweh.31; Hibbett DS, 2006, MYCOLOGIA, V98, P917, DOI 10.3852/mycologia.98.6.917; Hu L, 2014, WORLD J MICROB BIOT, V30, P1085, DOI 10.1007/s11274-013-1528-5; Johan-Olsen O., 1887, SOP KLIPFISK SAKALDT; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kralj Kuncic M, 2013, FUNGAL BIOL-UK, V117, P466, DOI 10.1016/j.funbio.2013.04.003; Kuncic MK, 2010, APPL ENVIRON MICROB, V76, P329, DOI 10.1128/AEM.02318-09; Lappalainen MHJ, 2012, INT ARCH ALLERGY IMM, V159, P194, DOI 10.1159/000335596; Lappalainen S, 1998, ANN ALLERG ASTHMA IM, V81, P585, DOI 10.1016/S1081-1206(10)62710-X; Liu WC, 2010, FUNGAL DIVERS, V42, P1, DOI 10.1007/s13225-010-0022-8; Liu YJJ, 1999, MOL BIOL EVOL, V16, P1799, DOI 10.1093/oxfordjournals.molbev.a026092; Lutzoni F, 2004, AM J BOT, V91, P1446, DOI 10.3732/ajb.91.10.1446; Matheny PB, 2007, MOL PHYLOGENET EVOL, V43, P430, DOI 10.1016/j.ympev.2006.08.024; McNEILL J., 2012, INT CODE NOMENCLATUR; Miller JD, 2010, CHEM-BIOL INTERACT, V183, P113, DOI 10.1016/j.cbi.2009.09.023; Moore RT, 1996, RHIZOCTONIA SPECIES: TAXONOMY, MOLECULAR BIOLOGY, ECOLOGY, PATHOLOGY AND DISEASE CONTROL, P13; Moss MO, 1998, J APPL MICROBIOL, V84, p62S, DOI 10.1046/j.1365-2672.1998.0840s162S.x; Nguyen HDT, 2013, MYCOLOGIA, V105, P1231, DOI 10.3852/12-351; Nguyen HDT, PLOS ONE IN PRESS; Padamsee M, 2012, FUNGAL GENET BIOL, V49, P217, DOI 10.1016/j.fgb.2012.01.007; PATERSON R.R.M., 1994, IMI TECHNICAL HDB; Peng XP, 2011, ARCH PHARM RES, V34, P907, DOI 10.1007/s12272-011-0607-0; Quaedvlieg W, 2014, PERSOONIA, V33, P1, DOI 10.3767/003158514X681981; Reboux G, 2001, AM J RESP CRIT CARE, V163, P1534, DOI 10.1164/ajrccm.163.7.2006077; Rittenour William R, 2014, Environ Sci Process Impacts, V16, P33, DOI 10.1039/c3em00441d; Rohlf F.J., 2002, NTSYS PC NUMERICAL T; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Roussel S, 2005, ANN AGR ENV MED, V12, P217; Sakamoto T, 1989, Arerugi, V38, P352; Sampaio JP, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P1873, DOI 10.1016/B978-0-444-52149-1.00155-5; Samson R. A., 2002, INTRO FOOD AIRBORNE; Schmitt I, 2009, PERSOONIA, V23, P35, DOI 10.3767/003158509X470602; Singh P, 2011, MICROB ECOL, V61, P507, DOI 10.1007/s00248-010-9765-8; Smedsgaard J, 1997, J CHROMATOGR A, V760, P264, DOI 10.1016/S0021-9673(96)00803-5; Sonjak S, 2005, FEMS MICROBIOL ECOL, V53, P51, DOI 10.1016/j.femsec.2004.10.014; Strauss MLA, 2001, J APPL MICROBIOL, V91, P182, DOI 10.1046/j.1365-2672.2001.01379.x; Suchodolski JS, 2008, VET MICROBIOL, V132, P379, DOI 10.1016/j.vetmic.2008.05.017; TAKAHASHI I, 1993, J ANTIBIOT, V46, P1312, DOI 10.7164/antibiotics.46.1312; Takahashi T, 1997, MYCOPATHOLOGIA, V139, P23, DOI 10.1023/A:1006831111595; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; Vandamme P, 1996, MICROBIOL REV, V60, P407, DOI 10.1128/MMBR.60.2.407-438.1996; Vaupotic T, 2007, FUNGAL GENET BIOL, V44, P1109, DOI 10.1016/j.fgb.2007.02.005; Vestergren T, 1902, MICROMYCETES RARIORE, VXXII; Visagie CM, 2014, STUD MYCOL, P63, DOI 10.1016/j.simyco.2014.07.002; von Arx JA, 1970, GENERA FUNGI SPORULA; WHEELER KA, 1988, T BRIT MYCOL SOC, V90, P365, DOI 10.1016/S0007-1536(88)80144-X; Whewell William, 1840, PHILOS INDUCTIVE SCI; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Williams JP, 2009, ENVIRON MICROBIOL, V11, P3292, DOI 10.1111/j.1462-2920.2009.02079.x; Wilson E. O., 1998, CONSILIENCE UNITY KN; WOOD GM, 1990, FOOD ADDIT CONTAM, V7, P69, DOI 10.1080/02652039009373822; Yuan ZL, 2010, APPL ENVIRON MICROB, V76, P1642, DOI 10.1128/AEM.01911-09; Zajc J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-617; Zalar P, 2005, ANTON LEEUW INT J G, V87, P311, DOI 10.1007/s10482-004-6783-x; Zeng QY, 2004, APPL ENVIRON MICROB, V70, P7295, DOI 10.1128/AEM.70.12.7295-7302.2004	75	24	25	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0125933	10.1371/journal.pone.0125933	http://dx.doi.org/10.1371/journal.pone.0125933			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26017053	gold, Green Published, Green Submitted			2022-12-26	WOS:000355185600042
J	de Carvalho, APM; Lima, JY; Azevedo, CT; Botta, S; de Queiroz, FF; Campos, AS; Barbosa, LD; da Silveira, LS				Martins de Carvalho, Anna Paula; Lima, Juliana Ywasaki; Azevedo, Carolina Torres; Botta, Silvina; de Queiroz, Fybio Ferreira; Campos, Adelia Seplveda; Barbosa, Lupercio de Araujo; da Silveira, Leonardo Serafim			Ossification Pattern of Estuarine Dolphin (Sotalia guianensis) Forelimbs, from the Coast of the State of Espirito Santo, Brazil	PLOS ONE			English	Article							AGE; GROWTH; MATURITY; CETACEA	The estuarine dolphin, Sotalia guianensis, is one of the most abundant cetacean species in Brazil. Determination of age and of aspects associated with the development of this species is significant new studies. Counts of growth layer groups in dentin are used to estimate age of these animals, though other ways to evaluate development are also adopted, like the measurement of total length (TL). This study presents a procedure to evaluate the development of the estuarine dolphin based on the ossification pattern of forelimbs. Thirty-seven estuarine dolphins found in the state of Espirito Santo, Brazil, were examined. Age was estimated, TL was measured and ossification of epiphyses was examined by radiography. We analyzed results using the Spearman correlation. Inspection of radiographs allowed evaluation of the significance of the correlation between age and development of the proximal (r = 0.9109) and distal (r = 0.9092) radial epiphyses, and of the distal ulnar epiphyses (r = 0.9055). Radiographic analysis of forelimbs proved to be an appropriate method to evaluate physical maturity, and may be a helpful tool to estimate age of these animals in ecological and population studies.	[Martins de Carvalho, Anna Paula; Lima, Juliana Ywasaki; Azevedo, Carolina Torres; de Queiroz, Fybio Ferreira; da Silveira, Leonardo Serafim] Univ Estadual Norte Fluminense, Lab Morphol & Anim Pathol, Rio De Janeiro, Brazil; [Botta, Silvina] Univ Fed Rio Grande do Sul, Coll Oceanog, EcoMega, Lab Ecol & Marine Megafauna Conservat Studies, Rio Grande, RS, Brazil; [Campos, Adelia Seplveda] Doctor Vet Med, Rio De Janeiro, Brazil; [Barbosa, Lupercio de Araujo] Inst Consciencia Ambiental, Vila Velha, ES, England	Universidade Estadual do Norte Fluminense; Universidade Federal do Rio Grande do Sul	de Carvalho, APM (corresponding author), Univ Estadual Norte Fluminense, Lab Morphol & Anim Pathol, Campos Goytacazes, Rio De Janeiro, Brazil.	annapmcarvalho@gmail.com	Lima, Juliana/U-2098-2019; botta, silvina/D-7528-2016	Ywasaki Lima, Juliana/0000-0002-5494-6809; Botta, Silvina/0000-0001-6219-6932	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Funding was provided by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), http://www.capes.gov.br/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Butti C, 2007, J ANAT, V211, P639, DOI 10.1111/j.1469-7580.2007.00805.x; Calzada N, 1997, CAN J ZOOL, V75, P632, DOI 10.1139/z97-078; Carvalho APM, 2012, ARQ BRAS MED VET ZOO, V64, P205, DOI 10.1590/S0102-09352012000100029; Di Giancamillo M, 1998, CAN J ZOOL, V76, P1286, DOI 10.1139/cjz-76-7-1286; Fettuccia DC, 2006, THESIS U FEDERAL AAM; Flores PAC, 2008, ENCY MARINE MAMMALS, P1188; Galatius A, 2006, ACTA ZOOL-STOCKHOLM, V87, P77, DOI 10.1111/j.1463-6395.2006.00223.x; Hohn A.A., 1990, P575; HOHN AA, 1989, MAR MAMMAL SCI, V5, P315, DOI 10.1111/j.1748-7692.1989.tb00346.x; HUI CA, 1979, FISH B-NOAA, V77, P295; IBAMA, 2001, NAM AQ BRAS PLAN AC; IUCN, LIST VERM ESP AM VER; Martins RJC, 1977, ORTOD, V10, P164; Mellor L, 2009, PAEDOMORPHIC OSSIFIC; Menezes ME, 1996, ESTUDOS BIOL CURITIB, V4, P23, DOI [10.1002/(SICI)1097-0193(1996)4:1<23::AID-HBM2>3.0.CO;2-R, DOI 10.1002/(SICI)1097-0193(1996)4:1<23::AID-HBM2>3.0.CO;2-R, DOI 10.1002/(SICI)1097-0193(1996)4:1&LT;23::AID-HBM2&GT;3.0.CO;2-R]; Moscatiello VAM, 2008, ORTODON ORTOP FACIAL, V13, P92; NORRIS KENNETH S., 1961, JOUR MAMMAL, V42, P471, DOI 10.2307/1377364; OGDEN JA, 1981, SKELETAL RADIOL, V7, P119, DOI 10.1007/BF00347376; Perrin W.F., 1980, REPORTS INT WHALING, V3, P1; Perrin WF., 1975, B SCRIPPS I OCEANOGR, V21; Ramos Renata Maria Arruda, 2000, Aquatic Mammals, V26, P65; Rosas FCW, 2003, FISH B-NOAA, V101, P377; Santos SCBN, 1999, ORTOD, V32, P33; Simoes-Lopes P.C., 1988, BIOTRONICS, V1, P57; Sp?nola JL., 2006, THESIS U FEDERAL PAR; Stockin KA, 2008, NEW ZEAL J MAR FRESH, V42, P307, DOI 10.1080/00288330809509958; Sydney NV, 2011, J BIOSCIENCES, V36, P117, DOI 10.1007/s12038-011-9005-5; Tavano O, 1982, PEDIAT CLIN, V6, P7	28	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0127435	10.1371/journal.pone.0127435	http://dx.doi.org/10.1371/journal.pone.0127435			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26017269	Green Published, Green Submitted, gold			2022-12-26	WOS:000355185600083
J	Sirikharin, R; Taengchaiyaphum, S; Sanguanrut, P; Chi, TD; Mavichak, R; Proespraiwong, P; Nuangsaeng, B; Thitamadee, S; Flegel, TW; Sritunyalucksana, K				Sirikharin, Ratchanok; Taengchaiyaphum, Suparat; Sanguanrut, Piyachat; Thanh Duong Chi; Mavichak, Rapeepat; Proespraiwong, Porranee; Nuangsaeng, Bunlung; Thitamadee, Siripong; Flegel, Timothy W.; Sritunyalucksana, Kallaya			Characterization and PCR Detection Of Binary, Pir-Like Toxins from Vibrio parahaemolyticus Isolates that Cause Acute Hepatopancreatic Necrosis Disease (AHPND) in Shrimp	PLOS ONE			English	Article								Unique isolates of Vibrio parahaemolyticus (VPAHPND) have previously been identified as the causative agent of acute hepatopancreatic necrosis disease (AHPND) in shrimp. AHPND is characterized by massive sloughing of tubule epithelial cells of the hepatopancreas (HP), proposed to be induced by soluble toxins released from VPAHPND that colonize the shrimp stomach. Since these toxins (produced in broth culture) have been reported to cause AHPND pathology in reverse gavage bioassays with shrimp, we used ammonium sulfate precipitation to prepare protein fractions from broth cultures of VPAHPND isolates for screening by reverse gavage assays. The dialyzed 60% ammonium sulfate fraction caused high mortality within 24-48 hours post-administration, and histological analysis of the moribund shrimp showed typical massive sloughing of hepatopancreatic tubule epithelial cells characteristic of AHPND. Analysis of the active fraction by SDS-PAGE revealed two major bands at marker levels of approximately 16 kDa (ToxA) and 50 kDa (ToxB). Mass spectrometry analysis followed by MASCOT analysis revealed that both proteins had similarity to hypothetical proteins of V. parahaemolyticus M0605 (contig034 GenBank accession no. JALL01000066.1) and similarity to known binary insecticidal toxins called 'Photorhabdus insect related' proteins A and B (Pir-A and Pir-B), respectively, produced by the symbiotic, nematode bacterium Photorhabdus luminescens. In in vivo tests, it was shown that recombinant ToxA and ToxB were both required in a dose dependent manner to cause AHPND pathology, indicating further similarity to Pir-A and -B. A single-step PCR method was designed for detection of the ToxA gene and was validated using 104 bacterial isolates consisting of 51 VPAHPND isolates, 34 non-AHPND VP isolates and 19 other isolates of bacteria commonly found in shrimp ponds (including other species of Vibrio and Photobacterium). The results showed 100% specificity and sensitivity for detection of VPAHPND isolates in the test set.	[Sirikharin, Ratchanok; Taengchaiyaphum, Suparat; Sanguanrut, Piyachat; Thanh Duong Chi; Sritunyalucksana, Kallaya] NSTDA, Natl Ctr Genet Engn & Biotechnol BIOTEC, Shrimp Virus Interact Lab ASVI, Bangkok 10400, Thailand; [Sirikharin, Ratchanok; Sanguanrut, Piyachat; Thanh Duong Chi; Thitamadee, Siripong; Flegel, Timothy W.; Sritunyalucksana, Kallaya] Mahidol Univ, Fac Sci, Ctr Excellence Shrimp Mol Biol & Biotechnol Cente, Bangkok 10400, Thailand; [Sirikharin, Ratchanok; Thitamadee, Siripong] Mahidol Univ, Fac Sci, Dept Biotechnol, Bangkok 10400, Thailand; [Mavichak, Rapeepat; Proespraiwong, Porranee] Charoen Pokphand Co Ltd, Aquat Anim Hlth Res Ctr, Samutsakorn 74000, Thailand; [Nuangsaeng, Bunlung] Burapha Univ, BMC, Chanthaburi 22170, Thailand	National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Mahidol University; Mahidol University; Burapha University	Sritunyalucksana, K (corresponding author), NSTDA, Natl Ctr Genet Engn & Biotechnol BIOTEC, Shrimp Virus Interact Lab ASVI, Rama 6 Rd, Bangkok 10400, Thailand.	kallaya@biotec.or.th	Taengchaiyaphum, Suparat/AAU-6637-2021	Flegel, Timothy W./0000-0002-1913-213X	Royal Golden Jubilee Ph.D. Program; Thailand Research Fund; National Research Council of Thailand; Agricultural Research and Development Agency; Charoen Pokphand Co. Ltd.	Royal Golden Jubilee Ph.D. Program(Thailand Research Fund (TRF)); Thailand Research Fund(Thailand Research Fund (TRF)); National Research Council of Thailand(National Research Council of Thailand (NRCT)); Agricultural Research and Development Agency; Charoen Pokphand Co. Ltd.	This work was supported by The Royal Golden Jubilee Ph.D. Program, the Thailand Research Fund, http://rgj.trf.or.th, to RS; National Research Council of Thailand, http://en.nrct.go.th/, to KS; and The Agricultural Research and Development Agency, http://www.arda.or.th/, to TWF. Charoen Pokphand Co. Ltd. provided support in the form of salaries for authors RM and PP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bell T.A., 1988, HDB NORMAL PENAEID S; Chen C, 2003, OCEANOL LIMNOL SIN, V34, P2; ENGLARD S, 1990, METHOD ENZYMOL, V182, P285; Forst S, 1997, ANNU REV MICROBIOL, V51, P47, DOI 10.1146/annurev.micro.51.1.47; Gomez-Gil B, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00055-14; Gomez-Jimenez S, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00800-14; Joshi J, 2014, AQUACULTURE, V428, P297, DOI 10.1016/j.aquaculture.2014.03.030; Kondo H, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00221-14; Tran L, 2013, DIS AQUAT ORGAN, V105, P45, DOI 10.3354/dao02621; Nunan L, 2014, DIS AQUAT ORGAN, V111, P81, DOI 10.3354/dao02776; Rodou A, 2010, TOXINS, V2, P1250, DOI 10.3390/toxins2061250; Sambrook J., 2001, MOL CLONING LAB MANU; Soto-Rodriguez SA, 2015, APPL ENV MI IN PRESS, V81; Su Y.Y., 2014, INT C INF COMM TECHN; TANIGUCHI H, 1985, J BACTERIOL, V162, P510, DOI 10.1128/JB.162.2.510-515.1985; Waterfield N, 2005, FEMS MICROBIOL LETT, V245, P47, DOI 10.1016/j.femsle.2005.02.018; Waterfield NR, 2009, ANNU REV MICROBIOL, V63, P557, DOI 10.1146/annurev.micro.091208.073507; Yang YT, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00816-14	18	141	156	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0126987	10.1371/journal.pone.0126987	http://dx.doi.org/10.1371/journal.pone.0126987			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26017673	gold, Green Published, Green Submitted			2022-12-26	WOS:000355185600066
J	Behling, J; Chan, AK; Zeh, C; Nekesa, C; Heinzerling, L				Behling, Juliane; Chan, Adrienne K.; Zeh, Clement; Nekesa, Carolyne; Heinzerling, Lucie			Evaluating HIV Prevention Programs: Herpes Simplex Virus Type 2 Antibodies as Biomarker for Sexual Risk Behavior in Young Adults in Resource-Poor Countries	PLOS ONE			English	Article							GENITAL ULCER DISEASE; LINKED IMMUNOSORBENT ASSAYS; WESTERN KENYA; INFECTION; PREVALENCE; PERFORMANCE; UGANDA; RAKAI; HSV-2; POPULATIONS	Background Measuring effectiveness of HIV prevention interventions is challenged by bias when using self-reported knowledge, attitude or behavior change. HIV incidence is an objective marker to measure effectiveness of HIV prevention interventions, however, because new infection rates are relatively low, prevention studies require large sample sizes. Herpes simplex virus type 2 (HSV-2) is similarly transmitted and more prevalent and could thus serve as a proxy marker for sexual risk behavior and therefore HIV infection. Methods HSV-2 antibodies were assessed in a sub-study of 70,000 students participating in an education intervention in Western Province, Kenya. Feasibility of testing for HSV-2 antibodies was assessed comparing two methods using Fisher's exact test. Three hundred and ninety four students (aged 18 to 22 years) were randomly chosen from the cohort and tested for HIV, Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis. Out of these, 139 students were tested for HSV-2 with ELISA and surveyed for sexual risk behavior and 89 students were additionally tested for HSV-2 with a point-of-contact (POC) test. Results Prevalence rates were 0.5%, 1.8%, 0.3% and 2.3% for HIV, Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis, respectively. Prevalence of HSV-2 antibodies was 3.4 % as measured by POC test (n=89) and 14.4 % by ELISA (n=139). Specificity of the POC test compared with ELISA was 100%, and the sensitivity only 23.1%. Associations between self-reported sexual behavior and HSV-2 serostatus could not be shown. Conclusions Associations between self-reported sexual risk behavior and HSV-2 serostatus could not be shown, probably due to social bias in interviews since its transmission is clearly linked. HSV-2 antibody testing is feasible in resource-poor settings and shows higher prevalence rates than other sexually transmitted diseases thus representing a potential biomarker for evaluation of HIV prevention interventions.	[Behling, Juliane; Heinzerling, Lucie] Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Dermatol STIs & Allergy, D-91054 Erlangen, Germany; [Chan, Adrienne K.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Med, Div Infect Dis, Toronto, ON, Canada; [Zeh, Clement] Ctr Dis Control & Prevent, Kisumu, Kenya; [Nekesa, Carolyne] Innovat Poverty Act, Busia, Kenya	University of Erlangen Nuremberg; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Innovations for Poverty Action (IPA)	Heinzerling, L (corresponding author), Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Dermatol STIs & Allergy, D-91054 Erlangen, Germany.	lucie.heinzerling@uk-erlangen.de		, lucie/0000-0003-4587-007X	William and Flora Hewlett Foundation [2007-9148]	William and Flora Hewlett Foundation	Funding was provided by The William and Flora Hewlett Foundation (Grant No. 2007-9148). (http://www.hewlett.org/about-us), Focus Diagnostics Inc. generously provided the ELISA as well as the POC kits free of charge for this study. (http://www.focusdx.com/) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Raddad LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002230; Amornkul PN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006470; Ashley RL, 2000, SEX TRANSM DIS, V27, P266, DOI 10.1097/00007435-200005000-00005; Ashley-Morrow R, 2004, CLIN MICROBIOL INFEC, V10, P530, DOI 10.1111/j.1469-0691.2004.00836.x; Baird SJ, 2012, LANCET, V379, P1320, DOI 10.1016/S0140-6736(11)61709-1; Bastien S, 2012, INT J STD AIDS, V23, P761, DOI 10.1258/ijsa.2012.011433; Celum CL, 2005, J INFECT DIS, V191, pS107, DOI 10.1086/425272; COWAN FM, 1994, BRIT MED J, V309, P1325, DOI 10.1136/bmj.309.6965.1325; Cusini M, 2001, J ANTIMICROB CHEMOTH, V47, P9, DOI 10.1093/jac/47.suppl_1.9; DANGOR Y, 1990, SEX TRANSM DIS, V17, P184, DOI 10.1097/00007435-199010000-00007; Delany-Moretlwe S, 2010, SEX TRANSM INFECT, V86, P46, DOI 10.1136/sti.2009.036541; Duflo E., 2012, ED HIV EARLY FERTILI; Duflo E, 2006, ED HIV AIDS PREVENTI; Emonyi IW, 2000, E AFR MED J, V77, P428; Feldblum PJ, 2000, SEX TRANSM INFECT, V76, P454, DOI 10.1136/sti.76.6.454; Ferry B, 2001, AIDS, V15, pS41, DOI 10.1097/00002030-200108004-00005; Gamiel JL, 2008, CLIN VACCINE IMMUNOL, V15, P888, DOI 10.1128/CVI.00453-07; Geretti AM, 2005, SEX TRANSM INFECT, V81, P316, DOI 10.1136/sti.2004.013110; Hogrefe W, 2002, J CLIN MICROBIOL, V40, P3635, DOI 10.1128/JCM.40.10.3635-3640.2002; Huygens P, 1996, SOC SCI MED, V42, P221, DOI 10.1016/0277-9536(95)00088-7; Laeyendecker O, 2004, J CLIN MICROBIOL, V42, P1794, DOI 10.1128/JCM.42.4.1794-1796.2004; Looker KJ, 2008, B WORLD HEALTH ORGAN, V86, P805, DOI 10.2471/BLT.07.046128; Luseno WK, 2014, J PRIM PREV; Morrow RA, 2003, J CLIN MICROBIOL, V41, P5212, DOI 10.1128/JCM.41.11.5212-5214.2003; Organization. WH, 2003, WHORHI0110; Paz-Bailey G, 2005, CLIN INFECT DIS, V41, P1304, DOI 10.1086/496979; Philip SS, 2008, CLIN INFECT DIS, V47, pE79, DOI 10.1086/592696; Remis RS, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-550; Sangani P, 2004, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD001220.PUB2, 10.1002/14651858.CD001220.pub2]; Serwadda D, 2003, J INFECT DIS, V188, P1492, DOI 10.1086/379333; Smith JS, 2009, SEX TRANSM INFECT, V85, P92, DOI 10.1136/sti.2008.031815; Smith JS, 2002, J INFECT DIS, V186, pS3, DOI 10.1086/343739; Stephenson J, 2004, LANCET, V363, P1177, DOI 10.1016/S0140-6736(04)15983-7; Tan Darrell H S, 2009, Can J Infect Dis Med Microbiol, V20, pe1; Tobian AAR, 2009, J INFECT DIS, V199, P945, DOI 10.1086/597074; Turner KR, 2002, SEX TRANSM DIS, V29, P422, DOI 10.1097/00007435-200207000-00011; Van Dyck E, 2004, J CLIN MICROBIOL, V42, P2961, DOI 10.1128/JCM.42.7.2961-2965.2004; Wald A, 2000, NEW ENGL J MED, V342, P844, DOI 10.1056/NEJM200003233421203; Wald A, 2002, J INFECT DIS, V185, P45, DOI 10.1086/338231; Wools KK, 1998, E AFR MED J, V75, P679	40	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128370	10.1371/journal.pone.0128370	http://dx.doi.org/10.1371/journal.pone.0128370			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010772	gold, Green Submitted, Green Published			2022-12-26	WOS:000355183900231
J	Herzog, D; Poellinger, A; Doellinger, F; Schuermann, D; Temmesfeld-Wollbrueck, B; Froeling, V; Schreiter, NF; Neumann, K; Hippenstiel, S; Suttorp, N; Hubner, RH				Herzog, Dominik; Poellinger, Alexander; Doellinger, Felix; Schuermann, Dirk; Temmesfeld-Wollbrueck, Bettina; Froeling, Vera; Schreiter, Nils F.; Neumann, Konrad; Hippenstiel, Stefan; Suttorp, Norbert; Hubner, Ralf-Harto			Modifying Post-Operative Medical Care after EBV Implant May Reduce Pneumothorax Incidence	PLOS ONE			English	Article							LUNG-VOLUME REDUCTION; ADVANCED EMPHYSEMA; ENDOBRONCHIAL VALVES; CLINICAL-OUTCOMES; THERAPY; COPD	Objective Endoscopic lung volume reduction (ELVR) with valves has been shown to improve COPD patients with severe emphysema. However, a major complication is pneumothoraces, occurring typically soon after valve implantation, with severe consequences if not managed promptly. Based on the knowledge that strain activity is related to a higher risk of pneumothoraces, we asked whether modifying post-operative medical care with the inclusion of strict short-term limitation of strain activity is associated with a lower incidence of pneumothorax. Methods Seventy-two (72) emphysematous patients without collateral ventilation were treated with bronchial valves and included in the study. Thirty-two (32) patients received standard post-implantation medical management (Standard Medical Care (SMC)), and 40 patients received a modified medical care that included an additional bed rest for 48 hours and cough suppression, as needed (Modified Medical Care (MMC)). Results The baseline characteristics were similar for the two groups, except there were more males in the SMC cohort. Overall, ten pneumothoraces occurred up to four days after ELVR, eight pneumothoraces in the SMC, and only two in the MMC cohorts (p=0.02). Complicated pneumothoraces and pneumothoraces after upper lobe treatment were significantly lower in MMC (p=0.02). Major clinical outcomes showed no significant differences between the two cohorts. Conclusions In conclusion, modifying post-operative medical care to include bed rest for 48 hours after ELVR and cough suppression, if needed, might reduce the incidence of pneumothoraces. Prospective randomized studies with larger numbers of well-matched patients are needed to confirm the data.	[Herzog, Dominik; Schuermann, Dirk; Temmesfeld-Wollbrueck, Bettina; Hippenstiel, Stefan; Suttorp, Norbert; Hubner, Ralf-Harto] Charite, Dept Internal Med Infect Dis & Resp Med, D-13353 Berlin, Germany; [Poellinger, Alexander; Doellinger, Felix; Schreiter, Nils F.] Charite, Inst Radiol, D-13353 Berlin, Germany; [Froeling, Vera] Charite, Dept Nucl Med, D-13353 Berlin, Germany; [Neumann, Konrad] Charite, Inst Biometry & Clin Epidemiol, D-12203 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Hubner, RH (corresponding author), Charite, Dept Internal Med Infect Dis & Resp Med, Augustenburger Pl 1, D-13353 Berlin, Germany.	ralf-harto.huebner@charite.de	Hubner, Ralf-Harto/G-4665-2016	Schurmann, Dirk/0000-0002-6879-9213; Hubner, Ralf-Harto/0000-0001-5969-2089; Suttorp, Norbert/0000-0002-3958-1151; Doellinger, Felix/0000-0003-3661-8569; Hippenstiel, Stefan/0000-0002-5146-1064	Pulmonx	Pulmonx	I have read the journal's policy and the authors of this manuscript have the following competing interests: Ralf-Harto Huebner has received lecture fees for educational activities from Pulmonx. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. The other authors have declared that no competing interests exist.	Bellemare F, 2003, AM J RESP CRIT CARE, V168, P305, DOI 10.1164/rccm.200208-876OC; BENSE L, 1992, CHEST, V101, P891, DOI 10.1378/chest.101.4.891; BENSE L, 1987, EUR J RESPIR DIS, V71, P181; Bosc C, 2014, EUR RESPIR J, V44; Casha AR, 2014, EUR J CARDIO-THORAC, V45, P1011, DOI 10.1093/ejcts/ezt659; CRAN IR, 1967, THORAX, V22, P462, DOI 10.1136/thx.22.5.462; Criner GJ, 2010, SEMIN RESP CRIT CARE, V31, P348, DOI 10.1055/s-0030-1254075; Dejene S, 2013, ANN THORAC MED, V8, P176, DOI 10.4103/1817-1737.114283; Dransfield MT, 2007, CHEST, V132, P464, DOI 10.1378/chest.07-0863; Giesirich W, 2014, EUR RESPIR J, V9, P44; Gompelmann D, 2010, RESPIRATION, V80, P419, DOI 10.1159/000319441; Gompelmann D, 2014, DTSCH ARZTEBL INT, V111, P827, DOI 10.3238/arztebl.2014.0827; Gompelmann D, 2014, RESPIRATION, V87, P485, DOI 10.1159/000360641; Herth FJF, 2013, EUR RESPIR J, V41, P302, DOI 10.1183/09031936.00015312; Herth FJF, 2012, EUR RESPIR J, V39, P1334, DOI 10.1183/09031936.00161611; Herzog D, 2014, PNEUMOLOGE, V11, P135, DOI 10.1007/s10405-013-0738-8; Higuchi T, 2006, THORAX, V61, P409, DOI 10.1136/thx.2005.051219; Hoshino A, 2014, PEDIATR INT, V56, P510, DOI 10.1111/ped.12325; Leppert PM, 2014, AM J RESP CRIT CARE, V189; Sahn SA, 2000, NEW ENGL J MED, V342, P868, DOI 10.1056/NEJM200003233421207; Sciurba FC, 2010, NEW ENGL J MED, V363, P1233, DOI 10.1056/NEJMoa0900928; Shah PL, 2014, THORAX, V69, P280, DOI 10.1136/thoraxjnl-2013-203743; Tidwell SL, 2012, SOUTH MED J, V105, P56, DOI 10.1097/SMJ.0b013e31823c5c49; Toma TP, 2003, LANCET, V361, P931, DOI 10.1016/S0140-6736(03)12762-6; Valipour A, 2014, RESPIRATION, V87, P513, DOI 10.1159/000360642; Venuta F, 2005, ANN THORAC SURG, V79, P411, DOI 10.1016/j.athoracsur.2004.07.048; Wan IYP, 2006, CHEST, V129, P518, DOI 10.1378/chest.129.3.518	27	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128097	10.1371/journal.pone.0128097	http://dx.doi.org/10.1371/journal.pone.0128097			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010886	Green Published, gold			2022-12-26	WOS:000355183900192
J	Kiss, K; Baghy, K; Spisak, S; Szanyi, S; Tulassay, Z; Zalatnai, A; Lohr, JM; Jesenofsky, R; Kovalszky, I; Firneisz, G				Kiss, Katalin; Baghy, Kornelia; Spisak, Sandor; Szanyi, Szilard; Tulassay, Zsolt; Zalatnai, Attila; Lohr, J. -Matthias; Jesenofsky, Ralf; Kovalszky, Ilona; Firneisz, Gabor			Chronic Hyperglycemia Induces Trans-Differentiation of Human Pancreatic Stellate Cells and Enhances the Malignant Molecular Communication with Human Pancreatic Cancer Cells	PLOS ONE			English	Article							GENE-TRANSCRIPTION; DIABETES-MELLITUS; SP1; ADENOCARCINOMA; IDENTIFICATION; PROLIFERATION; ACTIVATION; FIBROSIS; GROWTH; CXCR4	Background Diabetes mellitus is linked to pancreatic cancer. We hypothesized a role for pancreatic stellate cells (PSC) in the hyperglycemia induced deterioration of pancreatic cancer and therefore studied two human cell lines (RLT-PSC, T3M4) in hyperglycemic environment. Methodology/Principal Findings The effect of chronic hyperglycemia (CHG) on PSCs was studied using mRNA expression array with real-time PCR validation and bioinformatic pathway analysis, and confirmatory protein studies. The stress fiber formation (IC: alpha SMA) indicated that PSCs tend to transdifferentiate to a myofibroblast-like state after exposure to CHG. The phosphorylation of p38 and ERK1/2 was increased with a consecutive upregulation of CDC25, SP1, cFOS and p21, and with downregulation of PPAR. after PSCs were exposed to chronic hyperglycemia. CXCL12 levels increased significantly in PSC supernatant after CHG exposure independently from TGF-beta 1 treatment (3.09-fold with a 2.73-fold without TGF-beta 1, p<0.05). The upregualtion of the SP1 transcription factor in PSCs after CHG exposure may be implicated in the increased CXCL12 and IGFBP2 production. In cancer cells, hyperglycemia induced an increased expression of CXCR4, a CXCL12 receptor that was also induced by PSC's conditioned medium. The receptor-ligand interaction increased the phosphorylation of ERK1/2 and p38 resulting in activation of MAP kinase pathway, one of the most powerful stimuli for cell proliferation. Certainly, conditioned medium of PSC increased pancreatic cancer cell proliferation and this effect could be partially inhibited by a CXCR4 inhibitor. As the PSC conditioned medium (normal glucose concentration) increased the ERK1/2 and p38 phosphorylation, we concluded that PSCs produce other factor(s) that influence(s) pancreatic cancer behaviour. Conclusions Hyperglycemia induces increased CXCL12 production by the PSCs, and its receptor, CXCR4 on cancer cells. The ligand-receptor interaction activates MAP kinase signaling that causes increased cancer cell proliferation and migration.	[Kiss, Katalin; Baghy, Kornelia; Zalatnai, Attila; Kovalszky, Ilona] Semmelweis Univ, Dept Pathol & Expt Canc Res 1, H-1085 Budapest, Hungary; [Spisak, Sandor] Harvard Univ, Sch Med, Childrens Hosp, Boston, MA USA; [Szanyi, Szilard] Heidelberg Univ, Dept Gen Surg, Heidelberg, Germany; [Szanyi, Szilard] Semmelweis Univ, Sch PhD Studies, H-1085 Budapest, Hungary; [Tulassay, Zsolt; Firneisz, Gabor] Semmelweis Univ, Dept Internal Med 2, H-1085 Budapest, Hungary; [Lohr, J. -Matthias] Karolinska Univ Hosp, Gastroctr, Karolinska Inst, Stockholm, Sweden; [Jesenofsky, Ralf] Heidelberg Univ, Dept Med 2, Mannheim, Germany	Semmelweis University; Harvard University; Boston Children's Hospital; Harvard Medical School; Ruprecht Karls University Heidelberg; Semmelweis University; Semmelweis University; Karolinska Institutet; Karolinska University Hospital; Ruprecht Karls University Heidelberg	Firneisz, G (corresponding author), Semmelweis Univ, Dept Internal Med 2, H-1085 Budapest, Hungary.	firneisz.gabor@med.semmelweis-univ.hu	Löhr, Matthias/A-3692-2012; Firneisz, Gabor/AAC-9654-2021; Kovalszky, Ilona/ABH-2832-2020; Baghy, Kornélia/ABH-2549-2020	Löhr, Matthias/0000-0002-7647-198X; Firneisz, Gabor/0000-0002-9123-8131; Kovalszky, Ilona/0000-0002-0179-3378; Baghy, Kornélia/0000-0002-5323-2775	OTKA [100904]; School of Ph.D. Studies, Semmelweis University, Hungary	OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); School of Ph.D. Studies, Semmelweis University, Hungary	This study has been supported in part by the OTKA 100904 grant. The balance of support came from: School of Ph.D. Studies, Semmelweis University, Hungary. The authors would not have had been able to conduct any of these experiments without the gifted materials as follows: JML, RJ transferred the immortalized human pancreatic stellate (RLT-PSC) cell line to the Semmelweis University under an MTA agreement. The T3M4 human pancreatic ductal adenocarcinoma cell line was a kind gift from the European Pancreas Center in Heidelberg. The reagents used in the mRNA expression array were kind gifts by GF, such as AMD3100 and the reagents that were used to assess CXCL12, IGFBP2, CXCR4, CXCR7 at protein and mRNA levels. The funders at OTKA had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Assar O, 2014, RADIOTHER ONCOL, V111, P243, DOI 10.1016/j.radonc.2014.03.014; American Cancer Society, 2013, CANC FACTS FIG 2013; Apte MV, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00344; Apte MV, 1998, GUT, V43, P128, DOI 10.1136/gut.43.1.128; Bachem MG, 2008, LANGENBECK ARCH SURG, V393, P891, DOI 10.1007/s00423-008-0279-5; Bachem MG, 1998, GASTROENTEROLOGY, V115, P421, DOI 10.1016/S0016-5085(98)70209-4; Bachet JB, 2012, ANN ONCOL, V23, P2327, DOI 10.1093/annonc/mdr617; Ben QW, 2011, EUR J CANCER, V47, P1928, DOI 10.1016/j.ejca.2011.03.003; Biankin AV, 2001, CANCER RES, V61, P8830; Carstensen B, 2014, DIABETOLOGIA, V57, pA245; Chen R, 2006, PROTEOMICS, V6, P3871, DOI 10.1002/pmic.200500702; D'Addario M, 2006, GENE, V379, P51, DOI 10.1016/j.gene.2006.04.012; Dovzhanskiy DI, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-226; Erkan M, 2012, GUT, V61, P172, DOI 10.1136/gutjnl-2011-301220; Fujita H, 2010, PANCREAS; Gao ZJ, 2010, PANCREATOLOGY, V10, P186, DOI 10.1159/000236012; Garcia-Moruja C, 2005, J MOL BIOL, V348, P43, DOI 10.1016/j.jmb.2005.02.016; Gartel AL, 2000, ONCOGENE, V19, P5182, DOI 10.1038/sj.onc.1203900; Hamada S, 2012, BIOCHEM BIOPH RES CO, V421, P349, DOI 10.1016/j.bbrc.2012.04.014; Haugwitz U, 2002, NUCLEIC ACIDS RES, V30, P1967, DOI 10.1093/nar/30.9.1967; Heinrich EL, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-68; Hong OK, 2007, J CELL BIOCHEM, V101, P665, DOI 10.1002/jcb.21222; Huxley R, 2005, BRIT J CANCER, V92, P2076, DOI 10.1038/sj.bjc.6602619; Issad T, 2008, TRENDS ENDOCRIN MET, V19, P380, DOI 10.1016/j.tem.2008.09.001; Jee SH, 2005, JAMA-J AM MED ASSOC, V293, P194, DOI 10.1001/jama.293.2.194; Jesnowski R, 2005, LAB INVEST, V85, P1276, DOI 10.1038/labinvest.3700329; Jiang NY, 2008, CANCER EPIDEM BIOMAR, V17, P1648, DOI 10.1158/1055-9965.EPI-07-2791; Klein AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072311; Ko SH, 2006, J CELL BIOCHEM, V98, P343, DOI 10.1002/jcb.20797; Kraman M, 2010, SCIENCE, V330, P827, DOI 10.1126/science.1195300; Kulkarni AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015909; Liao WC, 2015, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7371; Lohr JM, 2009, J PANCREAS, V10, P472; Lohr M, 2001, CANCER RES, V61, P550; Lu SY, 2010, INT J CANCER, V126, P416, DOI 10.1002/ijc.24761; Lv ZM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022806; Marchesi F, 2004, CANCER RES, V64, P8420, DOI 10.1158/0008-5472.CAN-04-1343; Megyesi J, 2014, AM J PHYSL RENAL PHY; Milanini-Mongiat J, 2002, J BIOL CHEM, V277, P20631, DOI 10.1074/jbc.M201753200; Nomiyama Y, 2007, PANCREAS, V34, P364, DOI 10.1097/MPA.0b013e31802f0531; Ozdemir BC, 2014, CANCER CELL, V25, P719, DOI 10.1016/j.ccr.2014.04.005; Rajagopal S, 2010, P NATL ACAD SCI USA, V107, P628, DOI 10.1073/pnas.0912852107; Shi C, 2009, ARCH PATHOL LAB MED, V133, P365, DOI 10.1043/1543-2165-133.3.365; Shibuya K, 2015, ONCOTARGET, V6, P651, DOI 10.18632/oncotarget.2892; Shmelkov E, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-15; Srichai MB, 2010, CELL-EXTRACELLULAR MATRIX INTERACTIONS IN CANCER, P19, DOI 10.1007/978-1-4419-0814-8_2; Sun K, 2006, ACTA PHARMACOL SIN, V27, P715, DOI 10.1111/j.1745-7254.2006.00299.x; Vonlaufen A, 2008, CANCER RES, V68, P2085, DOI 10.1158/0008-5472.CAN-07-2477; Xu ZG, 2003, KIDNEY INT, V63, P958, DOI 10.1046/j.1523-1755.2003.00836.x; Xu ZH, 2010, AM J PATHOL, V177, P2585, DOI 10.2353/ajpath.2010.090899; Zhou LL, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/834528	51	20	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128059	10.1371/journal.pone.0128059	http://dx.doi.org/10.1371/journal.pone.0128059			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010611	Green Published, gold, Green Submitted			2022-12-26	WOS:000355183900189
J	Wachowicz, B; Beldzik, E; Domagalik, A; Fafrowicz, M; Gawlowska, M; Janik, J; Lewandowska, K; Oginska, H; Marek, T				Wachowicz, Barbara; Beldzik, Ewa; Domagalik, Aleksandra; Fafrowicz, Magdalena; Gawlowska, Magda; Janik, Justyna; Lewandowska, Koryna; Oginska, Halszka; Marek, Tadeusz			Different Types of Errors in Saccadic Task Are Sensitive to Either Time of Day or Chronic Sleep Restriction	PLOS ONE			English	Article							CIRCADIAN-RHYTHMS; ATTENTION SYSTEM; HUMAN BRAIN; DEPRIVATION; INHIBITION; COMPONENTS; VIGILANCE; COGNITION; NETWORKS; MODEL	Circadian rhythms and restricted sleep length affect cognitive functions and, consequently, the performance of day to day activities. To date, no more than a few studies have explored the consequences of these factors on oculomotor behaviour. We have implemented a spatial cuing paradigm in an eye tracking experiment conducted four times of the day after one week of rested wakefulness and after one week of chronic partial sleep restriction. Our aim was to verify whether these conditions affect the number of a variety of saccadic task errors. Interestingly, we found that failures in response selection, i.e. premature responses and direction errors, were prone to time of day variations, whereas failures in response execution, i.e. omissions and commissions, were considerably affected by sleep deprivation. The former can be linked to the cue facilitation mechanism, while the latter to wake state instability and the diminished ability of top-down inhibition. Together, these results may be interpreted in terms of distinctive sensitivity of orienting and alerting systems to fatigue. Saccadic eye movements proved to be a novel and effective measure with which to study the susceptibility of attentional systems to time factors, thus, this approach is recommended for future research.	[Wachowicz, Barbara; Beldzik, Ewa; Domagalik, Aleksandra; Fafrowicz, Magdalena; Lewandowska, Koryna; Oginska, Halszka; Marek, Tadeusz] Jagiellonian Univ, Inst Appl Psychol, Dept Cognit Neurosci & Neuroergon, Krakow, Poland; [Wachowicz, Barbara; Beldzik, Ewa; Domagalik, Aleksandra; Fafrowicz, Magdalena; Gawlowska, Magda; Janik, Justyna; Marek, Tadeusz] Jagiellonian Univ, Malopolska Ctr Biotechnol, Dept Neurobiol, Krakow, Poland; [Lewandowska, Koryna] Jagiellonian Univ, Inst Culture, Krakow, Poland	Jagiellonian University; Jagiellonian University; Jagiellonian University	Domagalik, A (corresponding author), Jagiellonian Univ, Inst Appl Psychol, Dept Cognit Neurosci & Neuroergon, Krakow, Poland.	aleksandra.domagalik@uj.edu.pl	Beldzik, Ewa/V-5522-2019; Domagalik, Aleksandra/E-7980-2013	Beldzik, Ewa/0000-0002-5511-4131; Domagalik, Aleksandra/0000-0003-3183-6719; Sikora-Wachowicz, Barbara/0000-0002-7398-9767; Gawlowska, Magda/0000-0003-2079-9211; Lewandowska, Koryna/0000-0003-4826-6361	Polish National Science Centre [2011/01/B/HS6/00446]	Polish National Science Centre	This research was supported by the Polish National Science Centre (http://www.ncn.gov.pl/). Grant number: 2011/01/B/HS6/00446.	AKERSTEDT T, 1990, INT J NEUROSCI, V52, P29, DOI 10.3109/00207459008994241; Blatter K, 2007, PHYSIOL BEHAV, V90, P196, DOI 10.1016/j.physbeh.2006.09.009; Bukhtiyarov I. V., 2013, Human Physiology, V39, P741, DOI 10.1134/S0362119713070062; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Drummond SPA, 2006, J SLEEP RES, V15, P261, DOI 10.1111/j.1365-2869.2006.00535.x; Durmer JS, 2005, SEMIN NEUROL, V25, P117, DOI 10.1055/s-0029-1237117; Fafrowicz M, 2006, ERGONOMIA INT J ERGO, V29, P13; FISCHER B, 1995, BIOL CYBERN, V72, P185, DOI 10.1007/BF00201483; Friedman NP, 2004, J EXP PSYCHOL GEN, V133, P101, DOI 10.1037/0096-3445.133.1.101; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Killgore WDS, 2010, PROG BRAIN RES, V185, P105, DOI 10.1016/B978-0-444-53702-7.00007-5; Kuhn G, 2009, ATTEN PERCEPT PSYCHO, V71, P314, DOI 10.3758/APP.71.2.314; Lim JL, 2008, ANN NY ACAD SCI, V1129, P305, DOI 10.1196/annals.1417.002; Lo JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045987; Marek T, 2010, CHRONOBIOL INT, V27, P945, DOI 10.3109/07420528.2010.489400; Martella D, 2014, EXP PSYCHOL, V61, P99, DOI 10.1027/1618-3169/a000229; Monk T, 2005, CLIN SPORTS MED, DOI [10.1016/J.CSN.2004.12.002, DOI 10.1016/J.CSN.2004.12.002]; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; Nieuwenhuis S, 2013, J EXP PSYCHOL HUMAN, V39, P1797, DOI 10.1037/a0033980; Oginska H, 2014, J SLEEP RES, V23, P339, DOI 10.1111/jsr.12115; Oginska H, 2011, PERS INDIV DIFFER, V50, P1039, DOI 10.1016/j.paid.2011.01.020; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; Pierrot-Deseilligny C, 2003, PROG BRAIN RES, V142, P3; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; POSNER MI, 1984, ATTENTION PERFORM, V10, P531; Postma A, 2000, COGNITION, V77, P97, DOI 10.1016/S0010-0277(00)00090-1; Roca J, 2012, ACTA PSYCHOL, V140, P164, DOI 10.1016/j.actpsy.2012.03.007; Sagaspe P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039410; Schmidt C, 2007, COGN NEUROPSYCHOL, V24, P755, DOI 10.1080/02643290701754158; Tomasi D, 2009, CEREB CORTEX, V19, P233, DOI 10.1093/cercor/bhn073; Valdez P, 2005, BIOL RHYTHM RES, V36, P57, DOI 10.1080/09291010400028633; Valdez P, 2010, CHRONOBIOL INT, V27, P393, DOI 10.3109/07420521003765861; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117	35	4	4	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0126502	10.1371/journal.pone.0126502	http://dx.doi.org/10.1371/journal.pone.0126502			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0QZ	26010673	Green Submitted, gold, Green Published			2022-12-26	WOS:000355183900030
J	Liu, ZG; Patil, IY; Jiang, TY; Sancheti, H; Walsh, JP; Stiles, BL; Yin, F; Cadenas, E				Liu, Zhigang; Patil, Ishan Y.; Jiang, Tianyi; Sancheti, Harsh; Walsh, John P.; Stiles, Bangyan L.; Yin, Fei; Cadenas, Enrique			High-Fat Diet Induces Hepatic Insulin Resistance and Impairment of Synaptic Plasticity	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; DIABETES-MELLITUS; ENERGY-METABOLISM; INDUCED OBESITY; LIVER-DISEASE; ER STRESS; BRAIN; PHOSPHORYLATION; MECHANISMS; ROLES	High-fat diet (HFD)-induced obesity is associated with insulin resistance, which may affect brain synaptic plasticity through impairment of insulin-sensitive processes underlying neuronal survival, learning, and memory. The experimental model consisted of 3 month-old C57BL/6J mice fed either a normal chow diet (control group) or a HFD (60% of calorie from fat; HFD group) for 12 weeks. This model was characterized as a function of time in terms of body weight, fasting blood glucose and insulin levels, HOMA-IR values, and plasma triglycerides. IRS-1/Akt pathway was assessed in primary hepatocytes and brain homogenates. The effect of HFD in brain was assessed by electrophysiology, input/output responses and long-term potentiation. HFD-fed mice exhibited a significant increase in body weight, higher fasting glucose-and insulin levels in plasma, lower glucose tolerance, and higher HOMA-IR values. In liver, HFD elicited (a) a significant decrease of insulin receptor substrate (IRS-1) phosphorylation on Tyr608 and increase of Ser307 phosphorylation, indicative of IRS-1 inactivation; (b) these changes were accompanied by inflammatory responses in terms of increases in the expression of NF kappa B and iNOS and activation of the MAP kinases p38 and JNK; (c) primary hepatocytes from mice fed a HFD showed decreased cellular oxygen consumption rates (indicative of mitochondrial functional impairment); this can be ascribed partly to a decreased expression of PGC1 alpha and mitochondrial biogenesis. In brain, HFD feeding elicited (a) an inactivation of the IRS-1 and, consequentially, (b) a decreased expression and plasma membrane localization of the insulin-sensitive neuronal glucose transporters GLUT3/GLUT4; (c) a suppression of the ERK/CREB pathway, and (d) a substantial decrease in long-term potentiation in the CA1 region of hippocampus (indicative of impaired synaptic plasticity). It may be surmised that 12 weeks fed with HFD induce a systemic insulin resistance that impacts profoundly on brain activity, i.e., synaptic plasticity.	[Liu, Zhigang; Patil, Ishan Y.; Jiang, Tianyi; Sancheti, Harsh; Stiles, Bangyan L.; Yin, Fei; Cadenas, Enrique] Univ So Calif, Sch Pharm, Los Angeles, CA 90089 USA; [Liu, Zhigang] Northwest A&F Univ, Coll Food Sci & Engn, Yangling, Peoples R China; [Walsh, John P.] Univ So Calif, Davis Sch Gerontol, Los Angeles, CA 90089 USA; [Walsh, John P.] Univ So Calif, Program Neurosci, Los Angeles, CA 90089 USA	University of Southern California; Northwest A&F University - China; University of Southern California; University of Southern California	Cadenas, E (corresponding author), Univ So Calif, Sch Pharm, 1985 Zonal Ave, Los Angeles, CA 90089 USA.	cadenas@usc.edu	Liu, Zhigang/H-4818-2016; Walsh, John/GQI-2785-2022; Liu, Z/H-7536-2012	Liu, Zhigang/0000-0002-6863-6561; Yin, Fei/0000-0002-5996-2410; Liu, Z/0000-0002-0086-5659	National Institutes of Health [RO1AG016718, R01CA154986-01A1]; NATIONAL CANCER INSTITUTE [R01CA154986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016718] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by the National Institutes of Health RO1AG016718 and R01CA154986-01A1.	Arnold SE, 2014, NEUROBIOL DIS, V67, P79, DOI 10.1016/j.nbd.2014.03.011; Benarroch EE, 2012, NEUROLOGY, V79, P2148, DOI 10.1212/WNL.0b013e3182752eef; Biessels GJ, 2006, LANCET NEUROL, V5, P64, DOI 10.1016/S1474-4422(05)70284-2; Bingham EM, 2002, DIABETES, V51, P3384, DOI 10.2337/diabetes.51.12.3384; Bocarsly ME, 2013, NEUROSCIENCE, V248, P61, DOI 10.1016/j.neuroscience.2013.05.046; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Calvo-Ochoa E, 2014, J CEREB BLOOD FLOW M, P1, DOI [10.1038/jcbfm.2014.180, DOI 10.1038/JCBFM.2014.180]; Carmiel-Haggai M, 2004, FASEB J, V18, P136, DOI 10.1096/fj.04-2291fje; Chen L, 2007, J NEUROPHYSIOL, V98, P1538, DOI 10.1152/jn.01151.2006; Cole GM, 2007, EXP GERONTOL, V42, P10, DOI 10.1016/j.exger.2006.08.009; Craft S, 1999, ARCH GEN PSYCHIAT, V56, P1135, DOI 10.1001/archpsyc.56.12.1135; Craft S, 2004, LANCET NEUROL, V3, P169, DOI 10.1016/S1474-4422(04)00681-7; Curtis J, 1999, J NEUROSCI RES, V58, P88, DOI 10.1002/(SICI)1097-4547(19991001)58:1<88::AID-JNR9>3.3.CO;2-I; de la Monte SM, 2012, J ALZHEIMERS DIS, V30, pS231, DOI 10.3233/JAD-2012-111727; de la Monte SM, 2009, CURR OPIN INVEST DR, V10, P1049; de la Monte SM, 2009, BMB REP, V42, P475, DOI 10.5483/BMBRep.2009.42.8.475; Ferreira JM, 2011, J NEUROSCI, V31, P1991, DOI 10.1523/JNEUROSCI.1850-09.2011; Finkbeiner S, 2000, NEURON, V25, P11, DOI 10.1016/S0896-6273(00)80866-1; Fujimoto M, 2005, DIABETES, V54, P1340, DOI 10.2337/diabetes.54.5.1340; Gao ZG, 2002, J BIOL CHEM, V277, P48115, DOI 10.1074/jbc.M209459200; Grillo CA, 2009, BRAIN RES, V1296, P35, DOI 10.1016/j.brainres.2009.08.005; Ha SK, 2010, EXP ANIM TOKYO, V59, P595, DOI 10.1538/expanim.59.595; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hwang LL, 2010, OBESITY, V18, P463, DOI 10.1038/oby.2009.273; Jiang TY, 2013, AGING CELL, V12, P1021, DOI 10.1111/acel.12127; Kaneki M, 2007, ANTIOXID REDOX SIGN, V9, P319, DOI 10.1089/ars.2006.1464; Karpac J, 2009, TRENDS ENDOCRIN MET, V20, P100, DOI 10.1016/j.tem.2008.11.004; KLECKNER NW, 1988, SCIENCE, V241, P835, DOI 10.1126/science.2841759; Lindqvist A, 2006, EUR J NEUROL, V13, P1385, DOI 10.1111/j.1468-1331.2006.01500.x; Marchesini G, 1999, AM J MED, V107, P450, DOI 10.1016/S0002-9343(99)00271-5; McNay EC, 2010, NEUROBIOL LEARN MEM, V93, P546, DOI 10.1016/j.nlm.2010.02.002; Mielke JG, 2005, J NEUROCHEM, V93, P1568, DOI 10.1111/j.1471-4159.2005.03155.x; Molteni R, 2004, NEUROSCIENCE, V123, P429, DOI 10.1016/j.neuroscience.2003.09.020; Oakes ND, 1997, DIABETES, V46, P1768, DOI 10.2337/diabetes.46.11.1768; Ott A, 1999, NEUROLOGY, V53, P1937, DOI 10.1212/WNL.53.9.1937; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Park HR, 2010, NEUROSCI LETT, V482, P235, DOI 10.1016/j.neulet.2010.07.046; Porter DW, 2010, DIABETES OBES METAB, V12, P891, DOI 10.1111/j.1463-1326.2010.01259.x; Saberi B, 2014, HEPATOLOGY, V59, P1543, DOI 10.1002/hep.26625; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Sancheti H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069830; Storlien LH, 2000, BRIT J NUTR, V83, pS85; Stranahan AM, 2008, HIPPOCAMPUS, V18, P1085, DOI 10.1002/hipo.20470; Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595; Uemura E, 2006, EXP NEUROL, V198, P48, DOI 10.1016/j.expneurol.2005.10.035; UNGER JW, 1991, PROG NEUROBIOL, V36, P343, DOI 10.1016/0301-0082(91)90015-S; van der Heide LP, 2006, PROG NEUROBIOL, V79, P205, DOI 10.1016/j.pneurobio.2006.06.003; Wan Q, 1997, NATURE, V388, P686, DOI 10.1038/41792; Win S, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.522; Win S, 2011, J BIOL CHEM, V286, P35071, DOI 10.1074/jbc.M111.276089; Winzell MS, 2004, DIABETES, V53, pS215, DOI 10.2337/diabetes.53.suppl_3.S215; Yang KT, 2014, DIABETOLOGIA, V57, P352, DOI 10.1007/s00125-013-3085-8; Yin F, 2014, ANTIOXID REDOX SIGN, V20, P353, DOI 10.1089/ars.2012.4774; Yin F, 2013, BIOCHEM SOC T, V41, P101, DOI 10.1042/BST20120260; Yin F, 2012, BBA-BIOENERGETICS, V1817, P401, DOI 10.1016/j.bbabio.2011.12.004	58	151	156	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128274	10.1371/journal.pone.0128274	http://dx.doi.org/10.1371/journal.pone.0128274			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2MQ	26465959	gold, Green Published, Green Submitted			2022-12-26	WOS:000355319400077
